data_1xqq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xqq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 124.209 1.957 . . . . 17.170000000000002 109.691 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -98.41 145.96 26.21 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 113.94 -5.475 . . . . 21.890000000000001 115.352 -176.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 pt -127.52 -176.49 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.414 -3.18 . . . . 10.83 102.414 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -121.61 130.47 53.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.901 -1.954 . . . . 10.609999999999999 116.084 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.75 132.66 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 122.371 2.35 . . . . 9.1300000000000008 107.289 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -117.89 128.32 54.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.618 -1.623 . . . . 20.550000000000001 106.618 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.8 p -74.35 179.64 4.46 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.256 1.947 . . . . 11.779999999999999 116.256 170.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.03 -58.46 8.07 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.388 2.518 . . . . 19.309999999999999 117.571 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.94 -38.97 93.16 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 126.537 3.065 . . . . 23.140000000000001 114.55 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.27 49.57 0.27 Allowed Glycine 0 N--CA 1.431 -1.699 0 CA-C-N 111.589 -2.55 . . . . 19.739999999999998 115.667 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 22.1 ttpt -89.74 129.55 36.13 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.613 -4.463 . . . . 21.93 109.235 160.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.2 m -92.01 126.7 37.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 117.316 -1.754 . . . . 12.33 114.243 169.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 94.8 mt -102.91 103.53 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 C-N-CA 132.39 4.276 . . . . 17.079999999999998 105.505 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.9 m -74.66 131.52 40.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.264 -2.773 . . . . 16.300000000000001 106.787 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 tp -143.3 128.62 18.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 115.979 -1.962 . . . . 15.880000000000001 115.735 -166.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -103.4 142.95 33.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.222 1.963 . . . . 28.899999999999999 114.383 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 m -157.72 165.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.167 1.937 . . . . 12.050000000000001 111.128 -158.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.47 124.35 25.07 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.673 -2.584 . . . . 18.170000000000002 111.819 -172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.29 -20.85 9.5 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 C-N-CA 124.267 3.311 . . . . 8.1600000000000001 116.677 -154.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.1 p -95.66 7.23 46.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.412 1.885 . . . . 11.130000000000001 113.687 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.94 177.29 5.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 105.129 -2.174 . . . . 18.030000000000001 105.129 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.7 p -104.31 173.23 6.39 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.596 2.141 . . . . 10.220000000000001 111.215 -158.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.38 26.1 mm -65.33 -29.48 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 127.825 3.679 . . . . 12.300000000000001 113.737 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -55.8 -40.66 73.02 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 115.276 -4.64 . . . . 36.509999999999998 114.526 164.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.98 -26.8 66.99 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.883 -1.127 . . . . 25.66 113.46 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.79 -43.22 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 115.145 -2.622 . . . . 8.1199999999999992 110.577 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -63.41 -33.62 75.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.534 -2.604 . . . . 15.470000000000001 117.2 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -14.92 58.62 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.798 3.259 . . . . 11.449999999999999 119.798 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -84.97 -39.12 18.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.056 -2.278 . . . . 24.98 114.162 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 mt -63.3 -40.94 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 130.066 3.347 . . . . 9.4600000000000009 112.666 170.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -68.03 -31.47 71.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.343 1.457 . . . . 14.76 114.07 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.257 43.2 t0 -71.1 -59.75 2.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.574 -3.204 . . . . 26.289999999999999 108.278 172.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.301 3.6 tppp? -51.08 -67.34 0.26 Allowed 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 121.251 3.797 . . . . 30.059999999999999 121.251 -176.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.497 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 10.7 mm-40 -89.51 -48.0 7.6 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.7 1.37 . . . . 25.190000000000001 114.7 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.52 71.77 1.09 Allowed Glycine 0 N--CA 1.43 -1.755 0 O-C-N 127.381 2.926 . . . . 7.4100000000000001 114.883 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mt -128.75 132.37 24.32 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 103.676 -2.713 . . . . 9.4900000000000002 103.676 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -82.96 158.31 15.62 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 CA-C-N 124.931 2.797 . . . . 11.42 112.9 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -73.85 -20.94 19.21 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 123.373 2.715 . . . . 12.0 110.86 -153.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -65.64 -41.31 92.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.306 2.243 . . . . 35.549999999999997 112.755 167.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.61 -34.53 53.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.68 -1.263 . . . . 20.52 112.406 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.13 124.17 19.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 121.123 3.749 . . . . 7.1299999999999999 121.123 165.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -127.35 120.2 27.98 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.612 1.195 . . . . 36.390000000000001 109.169 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.3 mt -111.7 120.17 41.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.082 -2.261 . . . . 9.5500000000000007 106.68 -173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.68 112.29 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 129.768 3.227 . . . . 13.9 112.944 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -99.2 120.85 40.19 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.939 2.304 . . . . 6.8600000000000003 106.403 165.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 65.29 -102.08 0.08 Allowed 'General case' 0 N--CA 1.431 -1.422 1 CA-C-O 129.27 4.367 . . . . 11.15 116.146 -177.591 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.34 55.18 0.59 Allowed Glycine 0 N--CA 1.43 -1.752 1 O-C-N 114.782 -4.949 . . . . 13.93 109.047 160.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.254 31.9 ttmt -135.08 139.23 44.57 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.9 1.68 . . . . 23.920000000000002 106.688 163.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -82.51 133.95 35.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.052 -1.03 . . . . 23.23 110.934 165.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.79 131.01 37.41 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.073 1.879 . . . . 9.1099999999999994 116.073 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -75.68 160.02 30.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.813 2.72 . . . . 33.439999999999998 108.458 -175.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.81 -52.95 20.66 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.665 -4.397 . . . . 28.370000000000001 110.042 -167.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.37 23.65 35.07 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 129.649 3.5 . . . . 15.0 112.588 -160.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.1 mtt-85 -116.65 160.7 20.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.808 2.122 . . . . 25.5 106.811 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 p -95.0 177.81 5.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.427 2.537 . . . . 11.949999999999999 113.438 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.17 -29.95 48.83 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.718 -3.114 . . . . 10.17 112.647 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 m -62.13 -19.56 63.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.347 1.61 . . . . 13.59 115.347 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.6 -46.27 22.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.525 -1.657 . . . . 11.699999999999999 106.525 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -73.5 -31.47 63.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.389 -1.732 . . . . 12.949999999999999 113.33 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 87.1 53.16 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.486 3.514 . . . . 25.449999999999999 107.52 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.1 mt -101.34 132.3 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.412 -3.181 . . . . 14.6 102.412 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -128.27 177.11 7.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.001 2.52 . . . . 33.229999999999997 113.008 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -51.31 128.08 21.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.011 2.339 . . . . 25.969999999999999 116.807 172.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 63.72 52.24 2.25 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.361 2.029 . . . . 32.609999999999999 116.277 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.7 m -113.45 146.04 40.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.084 2.954 . . . . 10.56 106.031 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.3 m -101.3 118.66 37.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.23 1.967 . . . . 5.3300000000000001 115.769 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.9 145.8 34.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.395 -3.316 . . . . 11.66 105.78 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -109.27 128.47 55.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 125.385 2.517 . . . . 16.300000000000001 113.659 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.3 tp -102.6 111.47 23.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.592 2.357 . . . . 9.9600000000000009 106.787 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.22 174.35 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 102.87 -3.011 . . . . 9.7599999999999998 102.87 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.43 -1.455 0 CA-C-O 123.225 1.488 . . . . 19.57 113.687 -169.18 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.213 -0.662 . . . . 17.170000000000002 109.213 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -113.58 143.33 44.74 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 100.366 -3.938 . . . . 21.890000000000001 100.366 -170.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -119.32 164.91 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.447 -2.033 . . . . 10.83 108.352 170.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -98.83 122.41 42.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.117 -2.92 . . . . 10.609999999999999 103.117 170.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.7 113.53 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.564 -2.585 . . . . 9.1300000000000008 108.36 154.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -84.61 134.58 34.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.842 -2.411 . . . . 20.550000000000001 113.309 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 18.6 p -89.56 179.73 5.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.297 -3.377 . . . . 11.779999999999999 106.377 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -71.83 -44.53 63.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 128.171 3.843 . . . . 19.309999999999999 111.91 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.1 p -79.97 -78.52 0.16 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 109.382 -3.554 . . . . 23.140000000000001 115.642 -168.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.24 50.1 0.21 Allowed Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 119.575 1.079 . . . . 19.739999999999998 113.377 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 46.9 tttt -139.98 137.15 34.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.77 -1.429 . . . . 21.93 111.627 163.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -119.7 103.18 9.16 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.592 2.615 . . . . 12.33 110.535 171.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.435 HG23 HD13 ' A' ' 13' ' ' ILE . 83.8 mt -79.59 120.42 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 114.506 -2.664 . . . . 17.079999999999998 107.704 -165.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 p -105.12 94.04 5.02 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 123.364 2.802 . . . . 16.300000000000001 108.74 -172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.67 116.17 31.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.934 2.493 . . . . 15.880000000000001 109.031 -158.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -73.41 119.32 17.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.123 1.369 . . . . 28.899999999999999 111.846 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.79 178.6 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 113.888 -1.505 . . . . 12.050000000000001 108.802 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.17 158.33 44.67 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 126.524 2.39 . . . . 18.170000000000002 106.394 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -70.02 -3.76 12.84 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 N-CA-C 118.666 2.525 . . . . 8.1600000000000001 118.666 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 p -90.84 -0.51 57.74 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.121 4.168 . . . . 11.130000000000001 109.834 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.66 147.18 35.64 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.446 1.93 . . . . 18.030000000000001 112.06 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -92.0 -165.94 1.45 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.809 -2.432 . . . . 10.220000000000001 111.804 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -85.76 -39.24 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.278 2.631 . . . . 12.300000000000001 105.611 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.4 -33.24 69.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.265 -3.397 . . . . 36.509999999999998 116.65 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.02 -56.65 15.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.925 1.345 . . . . 25.66 110.8 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -53.17 -47.19 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.199 -1.563 . . . . 8.1199999999999992 113.7 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -54.53 -39.21 67.44 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.783 -3.073 . . . . 15.470000000000001 114.761 171.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -32.92 71.13 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.241 -3.412 . . . . 11.449999999999999 114.73 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -81.14 -23.6 38.2 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.396 1.093 . . . . 24.98 109.45 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.36 -25.73 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 117.307 -3.371 . . . . 9.4600000000000009 113.184 169.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -75.49 -30.2 59.8 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.941 2.496 . . . . 14.76 109.675 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.7 -55.95 19.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.477 -2.014 . . . . 26.289999999999999 108.482 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -79.83 -43.31 22.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 116.545 -1.693 . . . . 30.059999999999999 112.333 -161.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.444 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 67.8 mm-40 -104.35 -44.05 5.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.462 1.028 . . . . 25.190000000000001 108.603 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.34 37.99 4.14 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 121.109 -0.995 . . . . 7.4100000000000001 111.449 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.7 mt -101.58 135.74 19.74 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 108.036 -1.098 . . . . 9.4900000000000002 108.036 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -65.36 137.94 53.33 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 C-N-CA 123.258 2.639 . . . . 11.42 113.567 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -68.31 -19.54 43.8 Favored 'Trans proline' 0 C--N 1.3 -1.988 1 C-N-CA 126.065 4.51 . . . . 12.0 118.178 -172.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -87.74 -27.28 22.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.948 1.699 . . . . 35.549999999999997 112.769 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.07 -40.37 82.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.106 2.162 . . . . 20.52 109.471 165.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.91 129.75 43.37 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.699 2.852 . . . . 7.1299999999999999 118.699 167.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -130.44 129.16 42.65 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.94 -4.225 . . . . 36.390000000000001 110.823 168.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.2 mt -112.93 129.08 56.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.856 1.262 . . . . 9.5500000000000007 110.145 -173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -130.5 140.09 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.988 1.852 . . . . 13.9 107.17 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.57 -75.83 0.51 Allowed 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 114.738 -2.785 . . . . 6.8600000000000003 112.187 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.61 -66.06 1.01 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.319 -2.845 . . . . 11.15 103.319 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.85 10.11 2.09 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 127.068 2.271 . . . . 13.93 115.523 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -112.26 142.1 45.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.287 1.042 . . . . 23.920000000000002 109.451 170.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -86.23 145.88 26.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.24 1.416 . . . . 23.23 107.784 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.03 130.12 45.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.067 -3.521 . . . . 9.1099999999999994 110.324 -171.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -103.89 151.32 23.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 118.31 -1.356 . . . . 33.439999999999998 109.979 -171.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -47.78 -53.53 15.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.733 2.864 . . . . 28.370000000000001 118.733 -152.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.94 50.82 0.74 Allowed Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 126.644 2.068 . . . . 15.0 114.465 -166.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -127.21 160.04 32.49 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.423 1.889 . . . . 25.5 109.899 154.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.341 48.0 p -79.24 164.17 24.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.041 2.536 . . . . 11.949999999999999 111.269 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.86 -31.22 72.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.829 1.776 . . . . 10.17 111.875 165.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -68.15 -31.09 70.4 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.7 -2.5 . . . . 13.59 114.919 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -71.99 -48.2 46.55 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.335 1.854 . . . . 11.699999999999999 106.596 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -74.15 -11.3 60.26 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.67 2.841 . . . . 12.949999999999999 118.67 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m120 69.24 49.01 0.63 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.753 2.021 . . . . 25.449999999999999 113.896 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.4 mt -105.24 108.01 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.333 -2.839 . . . . 14.6 103.333 173.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -101.5 -172.81 2.22 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.638 3.589 . . . . 33.229999999999997 109.859 -166.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp -61.59 126.75 28.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.208 -3.432 . . . . 25.969999999999999 113.898 169.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 41.7 mt-10 64.78 27.8 12.96 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.403 2.742 . . . . 32.609999999999999 118.403 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.2 m -90.67 154.44 19.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.056 2.836 . . . . 10.56 105.073 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -98.76 126.98 44.54 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.361 -2.2 . . . . 5.3300000000000001 105.249 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.4 mt -102.48 149.66 24.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.44 -2.037 . . . . 11.66 113.259 153.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -93.71 129.09 40.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.081 2.219 . . . . 16.300000000000001 112.246 172.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 10.4 tp -96.31 126.3 41.42 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.153 2.981 . . . . 9.9600000000000009 109.466 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.71 126.21 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 113.713 -1.585 . . . . 9.7599999999999998 108.602 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 N--CA 1.43 -1.437 0 O-C-N 125.795 1.934 . . . . 19.57 110.865 -179.549 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 122.143 0.973 . . . . 17.170000000000002 113.216 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -80.12 109.78 14.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.969 -2.332 . . . . 21.890000000000001 111.863 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -96.67 154.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 116.106 -1.902 . . . . 10.83 113.984 165.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.283 21.2 m-85 -101.79 113.56 26.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.252 1.842 . . . . 10.609999999999999 111.398 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.2 t -111.67 95.77 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 101.01 -3.7 . . . . 9.1300000000000008 101.01 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.284 55.5 tttt -87.5 126.97 35.23 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.169 -1.832 . . . . 20.550000000000001 114.492 -167.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.1 p -83.46 158.04 22.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.265 1.983 . . . . 11.779999999999999 113.554 -173.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -74.1 -27.66 60.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.101 -3.5 . . . . 19.309999999999999 107.996 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -62.25 -60.24 3.86 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.873 -4.267 . . . . 23.140000000000001 113.77 175.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.12 41.98 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.755 0 O-C-N 117.109 -3.494 . . . . 19.739999999999998 114.566 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -140.21 163.11 33.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.868 2.834 . . . . 21.93 105.784 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -128.53 123.05 32.52 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.955 2.659 . . . . 12.33 106.073 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -83.49 119.84 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.991 -1.693 . . . . 17.079999999999998 113.96 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 p -81.47 90.72 6.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.657 -2.527 . . . . 16.300000000000001 114.996 165.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 tp -94.39 118.9 32.33 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.387 2.275 . . . . 15.880000000000001 108.184 -167.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -81.51 109.4 15.93 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.544 -1.348 . . . . 28.899999999999999 112.456 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.07 171.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 127.76 2.424 . . . . 12.050000000000001 110.243 167.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -108.27 173.94 2.74 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 126.673 1.989 . . . . 18.170000000000002 107.273 158.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -71.32 -3.09 12.28 Favored 'Trans proline' 0 N--CA 1.434 -2.015 1 C-N-CA 125.601 4.201 . . . . 8.1600000000000001 113.136 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -88.7 -25.42 22.35 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 111.634 -2.53 . . . . 11.130000000000001 111.276 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.8 138.64 46.53 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.594 2.14 . . . . 18.030000000000001 113.121 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -91.2 177.7 6.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.267 -1.788 . . . . 10.220000000000001 108.309 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -82.26 -22.09 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.084 -1.01 . . . . 12.300000000000001 109.318 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -61.26 -37.74 84.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.665 1.986 . . . . 36.509999999999998 114.483 161.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -68.5 -25.8 65.14 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 118.931 -2.356 . . . . 25.66 115.452 167.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.1 t -64.79 -56.68 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 128.493 2.717 . . . . 8.1199999999999992 111.115 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -56.46 -30.1 62.48 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 117.336 2.347 . . . . 15.470000000000001 117.336 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.67 -45.53 64.91 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.308 2.243 . . . . 11.449999999999999 111.84 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -69.74 -34.91 74.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.797 2.439 . . . . 24.98 112.454 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.9 mt -73.02 -27.24 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 113.489 0.922 . . . . 9.4600000000000009 113.489 166.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.256 16.6 tt0 -66.9 -33.04 74.71 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.662 -5.649 . . . . 14.76 111.504 170.327 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.56 -58.46 4.25 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.45 2.7 . . . . 26.289999999999999 115.281 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -63.67 -71.97 0.15 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 114.808 1.411 . . . . 30.059999999999999 114.808 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -96.66 -22.39 17.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.326 -2.734 . . . . 25.190000000000001 113.222 -169.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.58 31.76 8.6 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.487 -1.383 . . . . 7.4100000000000001 114.484 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.6 mt -97.03 126.17 43.39 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 114.65 -2.595 . . . . 9.4900000000000002 106.606 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.26 0.1 OUTLIER -68.2 160.35 49.2 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 124.599 1.842 . . . . 11.42 114.969 -176.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -74.9 -11.76 21.7 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 123.321 2.222 . . . . 12.0 113.905 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -77.51 -7.84 56.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.987 -2.946 . . . . 35.549999999999997 112.969 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -110.22 -18.94 13.18 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.398 -2.064 . . . . 20.52 110.045 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -80.61 108.87 14.61 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 121.034 3.716 . . . . 7.1299999999999999 121.034 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -104.7 153.21 21.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.583 -1.189 . . . . 36.390000000000001 110.351 160.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -127.46 141.99 51.52 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.444 -2.035 . . . . 9.5500000000000007 112.665 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 pt -130.09 164.66 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 106.976 -1.491 . . . . 13.9 106.976 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.88 -88.77 0.17 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.325 2.266 . . . . 6.8600000000000003 111.345 167.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.98 -61.79 1.39 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.261 -3.399 . . . . 11.15 104.542 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.37 -37.84 0.9 Allowed Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 118.696 2.238 . . . . 13.93 118.696 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -71.38 128.98 37.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.312 2.338 . . . . 23.920000000000002 117.312 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -75.29 118.17 17.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.515 -2.616 . . . . 23.23 112.005 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.7 mt -72.52 132.61 44.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.142 2.401 . . . . 9.1099999999999994 111.144 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.272 28.7 mt-10 -97.09 155.66 16.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.427 -2.064 . . . . 33.439999999999998 105.427 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.81 -62.1 1.62 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.56 3.144 . . . . 28.370000000000001 112.392 -166.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.38 21.72 30.55 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 124.906 3.503 . . . . 15.0 115.249 -157.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.501 HH21 ' CG ' ' A' ' 58' ' ' ASP . 72.2 mtp180 -115.97 156.22 26.65 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 121.106 2.453 . . . . 25.5 108.375 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.9 p -84.73 163.65 19.03 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.007 -2.933 . . . . 11.949999999999999 111.206 -169.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.8 mt -73.34 -13.6 61.14 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.965 -4.834 . . . . 10.17 114.869 170.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 t -70.19 -39.14 75.39 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.499 -3.251 . . . . 13.59 108.665 167.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.501 ' CG ' HH21 ' A' ' 54' ' ' ARG . 16.7 t0 -63.29 -40.34 97.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.983 1.845 . . . . 11.699999999999999 115.983 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -79.4 -31.3 42.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 117.3 -1.333 . . . . 12.949999999999999 111.833 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.274 68.7 m-80 72.77 54.02 0.14 Allowed 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.365 4.266 . . . . 25.449999999999999 106.829 -176.835 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.3 mt -98.51 106.95 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.217 3.007 . . . . 14.6 107.704 169.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -102.94 -166.5 1.28 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.368 -2.083 . . . . 33.229999999999997 111.567 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -66.33 135.62 54.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.425 1.49 . . . . 25.969999999999999 110.063 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.359 51.4 mt-10 65.37 40.91 4.52 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.229 1.566 . . . . 32.609999999999999 115.229 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 t -109.13 149.48 29.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.565 -3.834 . . . . 10.56 111.055 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.295 78.2 m -97.66 109.55 22.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.814 1.646 . . . . 5.3300000000000001 110.1 -170.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.1 mt -108.13 155.11 20.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.745 -1.946 . . . . 11.66 105.745 171.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -120.3 137.34 54.31 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.143 -1.598 . . . . 16.300000000000001 113.569 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.1 tp -91.75 110.35 21.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.193 -1.367 . . . . 9.9600000000000009 111.611 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.97 144.79 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 127.846 2.459 . . . . 9.7599999999999998 112.162 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.429 -1.477 1 O-C-N 115.205 -4.685 . . . . 19.57 110.483 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HG3' ' A' ' 63' ' ' LYS 0.25 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.331 0 N-CA-C 115.738 1.755 . . . . 17.170000000000002 115.738 . . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.34 29.9 mt-30 -103.16 145.2 30.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.159 3.022 . . . . 21.890000000000001 119.159 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.32 29.3 pt -123.36 155.12 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 122.483 2.401 . . . . 10.83 106.679 166.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -112.12 137.43 50.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.396 -2.184 . . . . 10.609999999999999 108.505 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.22 123.07 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 123.023 1.392 . . . . 9.1300000000000008 111.253 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -100.14 125.79 46.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.001 -1.952 . . . . 20.550000000000001 113.434 -170.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.418 HG21 HD23 ' A' ' 69' ' ' LEU . 22.3 p -83.48 173.85 11.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.28 1.215 . . . . 11.779999999999999 114.28 175.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.7 tp -71.84 -43.06 66.18 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.836 1.779 . . . . 19.309999999999999 112.878 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -67.56 -23.05 65.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.003 -1.061 . . . . 23.140000000000001 109.603 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.53 10.9 8.29 Favored Glycine 0 N--CA 1.429 -1.786 1 N-CA-C 123.781 4.272 . . . . 19.739999999999998 123.781 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.519 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 77.0 tttt -86.49 146.35 26.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.112 -2.551 . . . . 21.93 104.112 -171.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 m -110.16 104.62 13.49 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.588 0.709 . . . . 12.33 112.736 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -84.04 129.23 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.69 2.796 . . . . 17.079999999999998 112.401 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -106.19 116.56 32.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.982 -2.324 . . . . 16.300000000000001 113.196 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.271 0.6 OUTLIER -118.77 131.4 56.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.642 1.839 . . . . 15.880000000000001 106.177 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -94.49 122.09 36.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.197 -2.815 . . . . 28.899999999999999 108.46 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.18 174.38 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.059 -1.428 . . . . 12.050000000000001 113.462 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -103.05 -173.97 0.32 Allowed Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 103.829 -2.656 . . . . 18.170000000000002 103.829 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -74.41 -29.5 9.25 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 C-N-CA 127.309 5.34 . . . . 8.1600000000000001 110.184 160.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 94.7 p -68.25 -28.55 67.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.797 2.888 . . . . 11.130000000000001 118.797 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -71.86 162.35 29.58 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.728 1.251 . . . . 18.030000000000001 112.94 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.6 p -104.61 175.25 5.55 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.83 -3.669 . . . . 10.220000000000001 112.389 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -65.24 -25.39 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.652 -2.53 . . . . 12.300000000000001 113.122 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.13 -37.76 88.47 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 117.726 2.491 . . . . 36.509999999999998 117.726 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.423 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 28.2 m120 -62.84 -43.4 98.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.363 1.246 . . . . 25.66 114.363 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -54.44 -38.2 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 126.095 1.758 . . . . 8.1199999999999992 107.506 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -75.72 -26.66 57.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.409 -1.432 . . . . 15.470000000000001 113.16 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.11 74.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.964 -2.96 . . . . 11.449999999999999 109.073 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 50.4 mttm -72.23 -43.24 64.72 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.801 3.641 . . . . 24.98 114.424 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 91.2 mt -55.25 -40.04 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 128.224 3.869 . . . . 9.4600000000000009 117.503 164.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -63.37 -44.28 95.24 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 110.904 -7.372 . . . . 14.76 114.584 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.14 -50.99 68.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.395 2.739 . . . . 26.289999999999999 118.395 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -67.49 -56.4 9.7 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.714 2.005 . . . . 30.059999999999999 115.582 -175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.519 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 61.3 mm-40 -98.58 -22.78 15.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.688 1.595 . . . . 25.190000000000001 113.525 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.59 23.39 31.16 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 125.601 2.778 . . . . 7.4100000000000001 116.464 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 mt -102.7 120.11 53.78 Favored Pre-proline 0 N--CA 1.43 -1.441 1 O-C-N 115.553 -4.498 . . . . 9.4900000000000002 104.21 -168.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -66.6 150.39 83.87 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 CA-C-N 126.784 3.459 . . . . 11.42 116.95 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -85.98 -4.75 8.82 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 CA-C-O 115.513 -1.953 . . . . 12.0 114.244 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -70.48 -36.37 73.82 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.38 1.9 . . . . 35.549999999999997 110.27 165.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -70.07 -28.43 65.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.053 2.541 . . . . 20.52 112.817 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -83.38 130.77 35.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 126.24 2.924 . . . . 7.1299999999999999 116.229 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -122.14 135.8 54.83 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 103.692 -2.707 . . . . 36.390000000000001 103.692 170.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.2 mt -113.67 137.33 51.76 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 124.253 0.97 . . . . 9.5500000000000007 109.643 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 pt -123.4 169.44 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 117.305 -1.758 . . . . 13.9 110.893 171.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -85.61 -90.46 0.1 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 117.217 -1.793 . . . . 6.8600000000000003 106.681 161.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.8 -16.55 13.15 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.023 1.86 . . . . 11.15 116.023 171.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.55 -32.63 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 O-C-N 117.782 -3.074 . . . . 13.93 115.931 172.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -76.99 135.24 38.68 Favored 'General case' 0 N--CA 1.43 -1.465 1 CA-C-O 129.406 4.431 . . . . 23.920000000000002 109.482 174.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -75.83 152.48 37.25 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 114.584 -5.073 . . . . 23.23 117.866 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.0 mt -118.31 117.71 29.82 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.457 -2.027 . . . . 9.1099999999999994 106.19 -171.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -108.2 151.6 25.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.579 3.085 . . . . 33.439999999999998 114.73 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.335 2.1 m-20 -37.06 -70.48 0.09 Allowed 'General case' 0 N--CA 1.429 -1.484 1 C-N-CA 134.754 5.222 . . . . 28.370000000000001 113.827 -166.47 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.37 23.15 33.29 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 116.958 -2.544 . . . . 15.0 117.04 -156.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.431 HH21 ' CG ' ' A' ' 58' ' ' ASP . 73.0 mtp180 -105.71 161.32 14.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.206 1.503 . . . . 25.5 111.477 169.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 p -91.03 170.18 10.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.678 -3.139 . . . . 11.949999999999999 112.465 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.64 -38.78 84.33 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 117.92 -2.987 . . . . 10.17 113.675 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.59 -39.21 16.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.438 -3.289 . . . . 13.59 112.153 162.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.431 ' CG ' HH21 ' A' ' 54' ' ' ARG . 23.9 t0 -82.69 -32.57 27.99 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 119.7 -1.875 . . . . 11.699999999999999 112.281 -173.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.287 77.0 m-85 -88.72 -7.78 55.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.676 1.58 . . . . 12.949999999999999 111.438 170.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 m120 81.23 29.83 0.16 Allowed 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 131.721 4.009 . . . . 25.449999999999999 108.415 166.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mt -75.99 132.54 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 117.72 -3.113 . . . . 14.6 104.099 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -96.43 -177.51 3.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.199 -1.819 . . . . 33.229999999999997 113.117 -171.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.56 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 19.8 ttpp -69.51 131.08 44.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.653 -1.905 . . . . 25.969999999999999 106.551 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 53.29 59.34 4.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.208 1.403 . . . . 32.609999999999999 108.145 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 t -98.84 147.42 24.95 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.799 -1.186 . . . . 10.56 107.799 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -90.6 114.52 26.8 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.869 1.356 . . . . 5.3300000000000001 108.306 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 mt -100.76 154.63 18.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.927 -1.733 . . . . 11.66 109.473 167.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -108.7 132.21 54.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.254 2.454 . . . . 16.300000000000001 111.016 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.418 HD23 HG21 ' A' ' 7' ' ' THR . 33.8 tp -102.0 128.39 48.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.53 -3.231 . . . . 9.9600000000000009 109.221 -175.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.8 98.47 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 112.492 -2.14 . . . . 9.7599999999999998 107.031 -167.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 117.486 2.402 . . . . 19.57 117.486 -178.386 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 116.606 -1.664 . . . . 17.170000000000002 112.437 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.86 138.77 31.29 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 125.809 1.943 . . . . 21.890000000000001 109.868 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.5 pt -119.97 148.52 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 129.797 3.239 . . . . 10.83 104.664 158.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -100.41 118.9 37.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.367 1.467 . . . . 10.609999999999999 112.944 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.81 122.52 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 116.891 -3.631 . . . . 9.1300000000000008 112.114 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -102.3 141.94 34.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.187 -1.005 . . . . 20.550000000000001 109.76 -173.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.6 p -84.66 176.15 8.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.089 -2.257 . . . . 11.779999999999999 110.8 171.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -60.74 -49.95 75.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.495 -2.628 . . . . 19.309999999999999 114.427 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 66.2 p -62.53 -57.36 11.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.901 3.68 . . . . 23.140000000000001 109.257 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.0 49.43 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 126.797 2.141 . . . . 19.739999999999998 110.767 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -93.17 143.73 25.97 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.794 -3.18 . . . . 21.93 112.01 161.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.272 25.1 m -108.85 107.28 17.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 126.285 2.945 . . . . 12.33 113.801 -176.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -86.09 117.37 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 110.151 -3.204 . . . . 17.079999999999998 109.287 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.47 131.2 49.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.921 -1.737 . . . . 16.300000000000001 109.333 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -123.55 134.37 53.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.892 -1.151 . . . . 15.880000000000001 107.892 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -109.7 114.57 28.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.772 -1.936 . . . . 28.899999999999999 105.772 -170.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.9 177.59 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 104.784 -2.302 . . . . 12.050000000000001 104.784 -152.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -111.42 171.1 4.6 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 126.828 2.051 . . . . 18.170000000000002 107.453 168.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -79.53 -14.15 13.04 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 123.142 2.158 . . . . 8.1600000000000001 107.647 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -93.54 9.74 35.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.541 1.682 . . . . 11.130000000000001 115.541 -175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -80.62 139.41 36.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.288 1.835 . . . . 18.030000000000001 114.522 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -90.49 170.34 10.29 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.442 -3.911 . . . . 10.220000000000001 107.901 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.7 mm -71.38 -29.0 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 116.845 -3.659 . . . . 12.300000000000001 108.235 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -51.81 -51.51 55.97 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.284 3.033 . . . . 36.509999999999998 112.902 164.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -54.44 -43.34 71.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.729 2.862 . . . . 25.66 118.729 172.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.17 -43.15 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 117.88 -1.057 . . . . 8.1199999999999992 109.039 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -57.96 -36.04 72.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.267 1.951 . . . . 15.470000000000001 116.267 166.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.22 -35.84 65.34 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.117 2.567 . . . . 11.449999999999999 115.741 170.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -81.26 -29.99 34.2 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 127.398 2.936 . . . . 24.98 109.446 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.7 mt -65.42 -43.3 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 121.256 1.844 . . . . 9.4600000000000009 115.951 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -53.95 -39.61 66.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.154 -2.355 . . . . 14.76 114.521 167.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.258 21.2 t70 -68.33 -53.44 24.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.386 2.357 . . . . 26.289999999999999 115.159 164.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -63.02 -43.8 97.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 120.191 3.404 . . . . 30.059999999999999 120.191 -169.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -100.28 -30.19 12.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.961 -2.337 . . . . 25.190000000000001 108.874 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.4 37.46 12.23 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 112.715 -2.039 . . . . 7.4100000000000001 110.188 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mt -102.68 128.47 27.91 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 118.627 -2.69 . . . . 9.4900000000000002 111.919 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -67.85 146.15 71.08 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 124.914 3.743 . . . . 11.42 108.299 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -81.15 2.28 8.69 Favored 'Trans proline' 0 C--N 1.3 -2.005 1 C-N-CA 127.345 5.364 . . . . 12.0 114.533 -165.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.43 -47.56 6.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.67 -1.894 . . . . 35.549999999999997 107.818 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -52.05 -29.44 21.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.967 1.84 . . . . 20.52 115.967 162.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -71.84 136.21 46.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.771 2.829 . . . . 7.1299999999999999 116.731 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -118.09 105.98 12.4 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.851 -1.537 . . . . 36.390000000000001 106.851 161.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.3 tp -102.11 120.75 40.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.546 -3.222 . . . . 9.5500000000000007 105.995 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 pt -127.24 170.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 125.323 1.449 . . . . 13.9 107.132 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -96.6 -55.57 2.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.058 1.743 . . . . 6.8600000000000003 113.364 169.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.44 -80.71 0.4 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.074 1.35 . . . . 11.15 113.75 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.47 -12.81 2.98 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.545 -1.347 . . . . 13.93 115.578 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -97.18 124.94 41.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 114.604 -2.617 . . . . 23.920000000000002 113.673 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -52.25 119.36 4.31 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.962 1.71 . . . . 23.23 111.965 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.2 mt -81.76 142.72 32.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.836 2.732 . . . . 9.1099999999999994 114.364 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -80.56 124.69 29.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.502 2.721 . . . . 33.439999999999998 107.288 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.319 36.4 m-20 -45.29 -56.28 5.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.323 3.083 . . . . 28.370000000000001 119.323 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.59 10.84 65.77 Favored Glycine 0 N--CA 1.43 -1.735 0 CA-C-O 117.024 -1.987 . . . . 15.0 116.631 -157.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -98.87 152.07 20.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 118.155 0.978 . . . . 25.5 108.864 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.5 p -80.55 161.54 24.73 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.684 2.105 . . . . 11.949999999999999 116.684 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.07 -29.71 58.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.084 -2.562 . . . . 10.17 104.084 -171.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.2 t -60.99 -46.88 88.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.119 2.137 . . . . 13.59 112.928 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -58.32 -47.96 82.04 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.596 2.758 . . . . 11.699999999999999 111.085 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -61.98 -34.23 75.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 131.391 3.876 . . . . 12.949999999999999 114.332 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.481 10.3 m120 92.49 29.53 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.038 2.086 . . . . 25.449999999999999 113.051 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.11 108.64 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 127.542 2.337 . . . . 14.6 111.409 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -87.55 179.26 6.58 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.04 -4.162 . . . . 33.229999999999997 114.978 -169.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -63.31 126.19 26.61 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.497 3.046 . . . . 25.969999999999999 114.888 167.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.394 68.4 mt-10 75.43 42.8 0.22 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.881 3.273 . . . . 32.609999999999999 110.27 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -109.93 141.78 42.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.688 1.995 . . . . 10.56 107.969 -173.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.1 m -90.74 129.04 36.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.281 1.956 . . . . 5.3300000000000001 116.281 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.49 171.85 7.24 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.054 -1.462 . . . . 11.66 107.054 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -135.39 127.41 29.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.937 2.78 . . . . 16.300000000000001 105.285 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.7 tp -96.84 114.63 26.27 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.138 2.399 . . . . 9.9600000000000009 108.285 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.252 37.6 t -101.25 151.58 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 101.543 -3.503 . . . . 9.7599999999999998 101.543 170.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 107.429 -1.323 . . . . 19.57 107.429 173.924 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.268 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 118.151 2.649 . . . . 17.170000000000002 118.151 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -80.61 134.15 35.86 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.22 1.933 . . . . 21.890000000000001 116.22 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.6 pt -124.45 149.34 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 112.833 -1.985 . . . . 10.83 109.195 166.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.96 132.68 49.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 102.567 -3.123 . . . . 10.609999999999999 102.567 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.45 109.25 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 126.224 1.81 . . . . 9.1300000000000008 106.729 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -95.58 132.35 40.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.045 3.307 . . . . 20.550000000000001 108.693 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -91.29 175.91 6.76 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.316 -3.365 . . . . 11.779999999999999 114.287 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.485 HD11 ' H ' ' A' ' 71' ' ' LEU . 84.5 mt -75.47 -28.19 59.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.536 -1.211 . . . . 19.309999999999999 113.775 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.354 82.5 p -83.63 -24.33 31.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 120.496 1.498 . . . . 23.140000000000001 107.968 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.29 52.12 0.22 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.397 -2.689 . . . . 19.739999999999998 107.861 161.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -131.01 135.26 47.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.296 -4.061 . . . . 21.93 103.738 -175.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.7 m -106.65 107.45 18.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.309 2.48 . . . . 12.33 108.29 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -98.99 133.02 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 128.416 2.687 . . . . 17.079999999999998 110.329 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.4 m -98.42 112.63 24.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.673 -1.232 . . . . 16.300000000000001 107.673 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -102.35 164.48 11.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.372 2.511 . . . . 15.880000000000001 107.338 172.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.67 106.28 9.61 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 115.302 -4.624 . . . . 28.899999999999999 102.326 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -109.44 175.66 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 123.445 1.593 . . . . 12.050000000000001 109.726 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -115.89 143.48 30.87 Favored Pre-proline 0 N--CA 1.43 -1.46 1 CA-C-O 109.792 -4.909 . . . . 18.170000000000002 105.795 162.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -60.13 -11.12 14.62 Favored 'Trans proline' 0 N--CA 1.434 -2.023 2 CA-C-N 130.774 4.883 . . . . 8.1600000000000001 117.737 176.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.8 m -74.0 -19.09 60.76 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.252 2.221 . . . . 11.130000000000001 116.183 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.13 156.28 38.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.542 2.337 . . . . 18.030000000000001 111.039 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 p -107.95 163.61 12.99 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.775 -1.557 . . . . 10.220000000000001 115.072 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -63.24 -26.02 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 114.319 -2.753 . . . . 12.300000000000001 109.952 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.89 -44.96 93.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.586 1.803 . . . . 36.509999999999998 108.777 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -63.95 -47.53 80.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.819 -3.05 . . . . 25.66 111.776 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 t -60.8 -43.39 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 120.938 1.699 . . . . 8.1199999999999992 113.098 173.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -59.46 -32.16 69.98 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 115.682 -2.104 . . . . 15.470000000000001 114.657 170.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.09 -51.15 65.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.204 1.82 . . . . 11.449999999999999 110.881 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.05 -36.09 78.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.953 2.205 . . . . 24.98 116.953 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 mt -70.1 -39.66 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 124.822 2.249 . . . . 9.4600000000000009 111.531 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.4 -36.93 76.74 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 111.811 -6.806 . . . . 14.76 113.791 168.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -75.18 -29.92 60.52 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 116.227 -4.046 . . . . 26.289999999999999 109.754 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -75.91 -47.12 26.52 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 117.837 2.532 . . . . 30.059999999999999 117.837 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -100.34 -27.1 13.65 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.71 -1.132 . . . . 25.190000000000001 113.406 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.92 6.4 54.19 Favored Glycine 0 N--CA 1.431 -1.668 0 O-C-N 116.77 -3.706 . . . . 7.4100000000000001 117.415 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.9 mm -99.05 137.04 20.4 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-N 120.657 2.229 . . . . 9.4900000000000002 106.206 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -65.71 154.21 74.84 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 N-CA-C 119.094 2.69 . . . . 11.42 119.094 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -88.46 -7.49 5.74 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-N 125.953 3.162 . . . . 12.0 107.396 -155.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -82.39 -18.29 42.48 Favored 'General case' 0 N--CA 1.429 -1.483 1 C-N-CA 131.789 4.036 . . . . 35.549999999999997 112.248 167.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -85.81 -24.84 26.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.644 -1.91 . . . . 20.52 113.313 165.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -83.84 138.3 33.27 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.615 2.366 . . . . 7.1299999999999999 113.759 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -142.61 122.28 13.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.864 -1.902 . . . . 36.390000000000001 105.864 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -101.23 125.96 47.91 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.363 1.865 . . . . 9.5500000000000007 108.533 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.421 HG13 ' HB2' ' A' ' 68' ' ' HIS . 5.8 pt -127.56 154.27 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.149 -2.908 . . . . 13.9 103.149 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.43 -63.31 1.22 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.889 -1.757 . . . . 6.8600000000000003 113.382 173.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.58 -36.39 0.78 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.904 -2.373 . . . . 11.15 106.64 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.06 -14.72 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.109 1.814 . . . . 13.93 116.253 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -103.12 148.66 25.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.622 -2.031 . . . . 23.920000000000002 106.708 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -81.97 110.37 17.17 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 127.784 6.216 . . . . 23.23 127.784 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.8 mt -87.32 112.87 22.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.9 -2.375 . . . . 9.1099999999999994 107.191 -169.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -110.11 148.49 31.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.542 2.591 . . . . 33.439999999999998 107.447 -159.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -44.07 -61.82 1.35 Allowed 'General case' 0 N--CA 1.431 -1.424 1 C-N-CA 131.815 4.046 . . . . 28.370000000000001 118.365 -169.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.37 -22.21 72.8 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 128.422 2.915 . . . . 15.0 110.326 -155.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -100.27 159.65 14.95 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.773 1.229 . . . . 25.5 112.814 -167.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.419 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 22.6 p -74.69 156.33 36.76 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 114.432 -2.699 . . . . 11.949999999999999 117.425 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.272 14.8 mt -54.39 -37.11 64.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 120.031 3.345 . . . . 10.17 120.031 160.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -64.1 -25.9 68.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.751 2.13 . . . . 13.59 116.751 171.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 60.6 m-20 -73.02 -22.28 60.68 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.033 -1.937 . . . . 11.699999999999999 110.117 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -96.75 -12.5 23.63 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.534 1.97 . . . . 12.949999999999999 114.257 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.29 14.4 m120 59.5 46.0 12.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.666 3.986 . . . . 25.449999999999999 114.589 -172.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -81.48 108.86 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.067 -2.896 . . . . 14.6 112.154 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -88.07 178.72 6.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.318 2.34 . . . . 33.229999999999997 117.318 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -61.96 138.34 58.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 127.453 3.501 . . . . 25.969999999999999 113.103 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 60.52 31.03 20.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.705 3.202 . . . . 32.609999999999999 115.276 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.4 m -70.69 144.91 50.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.417 -1.719 . . . . 10.56 108.752 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -95.66 122.53 38.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.007 -2.59 . . . . 5.3300000000000001 104.007 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.3 mt -116.71 152.61 33.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.246 -2.501 . . . . 11.66 104.246 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.421 ' HB2' HG13 ' A' ' 44' ' ' ILE . 73.2 m80 -111.89 122.04 46.69 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-O 128.67 4.081 . . . . 16.300000000000001 107.748 -175.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.0 tp -85.51 135.62 33.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.827 -3.046 . . . . 9.9600000000000009 105.466 171.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.2 t -130.76 151.91 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 102.761 -3.052 . . . . 9.7599999999999998 102.761 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.485 ' H ' HD11 ' A' ' 8' ' ' LEU . 54.5 mt . . . . . 0 N--CA 1.431 -1.417 0 O-C-N 120.24 -1.538 . . . . 19.57 110.952 170.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.607 1.336 . . . . 17.170000000000002 114.607 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -95.15 142.47 27.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.168 0.987 . . . . 21.890000000000001 111.595 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.29 168.57 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.346 -2.094 . . . . 10.83 105.346 159.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -118.34 158.04 25.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.862 1.792 . . . . 10.609999999999999 114.321 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -124.4 121.25 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.389 3.476 . . . . 9.1300000000000008 106.866 167.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -106.48 127.58 53.41 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 124.018 1.866 . . . . 20.550000000000001 107.772 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 p -88.84 166.24 14.12 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.678 1.704 . . . . 11.779999999999999 106.642 -173.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.2 mt -65.95 -45.35 82.11 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 129.703 3.201 . . . . 19.309999999999999 110.53 169.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.0 p -64.31 -29.67 70.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.901 2.481 . . . . 23.140000000000001 117.576 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.39 29.46 1.92 Allowed Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 114.157 -1.383 . . . . 19.739999999999998 109.916 167.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -92.66 133.44 35.99 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.798 -3.766 . . . . 21.93 112.714 164.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.3 m -100.63 119.02 37.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.935 -1.876 . . . . 12.33 105.935 167.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.7 mt -113.3 115.5 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 117.99 -2.943 . . . . 17.079999999999998 105.94 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.3 m -83.78 124.78 31.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 112.846 -3.454 . . . . 16.300000000000001 108.307 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.16 145.03 30.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 123.901 3.046 . . . . 15.880000000000001 111.211 167.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -98.87 131.74 44.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 118.816 -1.154 . . . . 28.899999999999999 112.225 167.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.08 171.94 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.889 1.676 . . . . 12.050000000000001 110.029 -166.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -118.6 171.79 4.88 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-N 122.105 2.23 . . . . 18.170000000000002 109.21 156.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.2 -30.57 72.05 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 N-CA-C 119.5 2.846 . . . . 8.1600000000000001 119.5 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.7 m -92.58 14.64 16.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.805 -3.059 . . . . 11.130000000000001 112.474 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.47 138.08 41.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.052 -3.53 . . . . 18.030000000000001 115.944 171.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 p -85.05 164.1 18.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 112.592 -2.095 . . . . 10.220000000000001 109.822 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.351 3.9 mm -78.62 -17.6 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 117.876 -3.015 . . . . 12.300000000000001 111.29 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -62.26 -51.73 66.56 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.902 2.881 . . . . 36.509999999999998 110.678 164.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -66.63 -25.29 66.52 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.411 -1.431 . . . . 25.66 110.693 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.67 -56.2 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.595 2.072 . . . . 8.1199999999999992 116.595 167.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -50.6 -30.55 13.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.271 3.434 . . . . 15.470000000000001 120.271 164.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.83 -42.76 97.54 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.253 2.316 . . . . 11.449999999999999 117.253 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -61.78 -31.53 71.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.3 1.963 . . . . 24.98 116.3 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.0 -40.52 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.092 1.757 . . . . 9.4600000000000009 111.143 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -48.24 -51.34 25.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.595 2.758 . . . . 14.76 116.915 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.58 -39.78 74.09 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.776 2.83 . . . . 26.289999999999999 112.662 166.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -87.42 -70.99 0.59 Allowed 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.051 -4.156 . . . . 30.059999999999999 109.209 -168.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -89.96 -26.47 20.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.117 -3.489 . . . . 25.190000000000001 117.802 -171.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.81 43.45 4.48 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 117.22 -1.878 . . . . 7.4100000000000001 115.75 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mm -90.82 124.39 62.29 Favored Pre-proline 0 N--CA 1.43 -1.468 1 CA-C-O 110.872 -4.394 . . . . 9.4900000000000002 107.397 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -77.04 147.25 26.42 Favored 'Trans proline' 0 C--N 1.3 -2.022 1 CA-C-N 129.741 4.515 . . . . 11.42 112.033 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.08 -21.03 32.59 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-O 117.3 -1.208 . . . . 12.0 114.153 -159.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -71.45 -27.86 63.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 123.563 2.892 . . . . 35.549999999999997 111.994 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.277 88.4 mm-40 -77.24 -23.42 51.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.422 1.889 . . . . 20.52 111.096 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -77.28 107.37 9.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 113.812 1.041 . . . . 7.1299999999999999 113.812 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -112.78 114.23 26.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.346 2.022 . . . . 36.390000000000001 109.921 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.7 mt -100.2 117.85 35.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.892 -1.755 . . . . 9.5500000000000007 109.839 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.552 HG13 ' HB2' ' A' ' 68' ' ' HIS . 36.5 pt -98.19 156.64 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.415 2.286 . . . . 13.9 112.797 166.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -79.86 -68.87 0.63 Allowed 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 123.396 1.569 . . . . 6.8600000000000003 107.929 162.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.54 -60.79 0.98 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.051 -2.203 . . . . 11.15 105.051 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.16 -25.18 1.71 Allowed Glycine 0 N--CA 1.43 -1.731 1 C-N-CA 134.965 6.031 . . . . 13.93 114.451 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 139.72 33.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.012 -3.052 . . . . 23.920000000000002 109.482 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -90.29 147.82 23.27 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.162 0.982 . . . . 23.23 112.661 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mt -99.71 118.72 36.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.118 1.767 . . . . 9.1099999999999994 110.391 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -95.21 147.85 23.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.939 -1.105 . . . . 33.439999999999998 111.002 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.04 -47.62 8.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.435 3.094 . . . . 28.370000000000001 116.094 -166.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.19 31.61 7.81 Favored Glycine 0 N--CA 1.431 -1.694 1 CA-C-O 112.914 -4.27 . . . . 15.0 115.746 -165.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -129.42 171.63 12.33 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.797 3.299 . . . . 25.5 105.588 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.4 p -99.97 169.0 9.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.942 2.155 . . . . 11.949999999999999 112.223 -174.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.6 -40.03 68.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.311 1.226 . . . . 10.17 114.311 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.9 t -63.83 -49.92 70.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 131.495 3.918 . . . . 13.59 112.384 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 38.6 m-20 -43.83 -58.0 2.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.665 3.186 . . . . 11.699999999999999 110.892 168.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.269 32.6 m-85 -54.58 -21.11 9.38 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 120.574 3.546 . . . . 12.949999999999999 120.574 171.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 m120 53.86 56.39 7.2 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.024 1.729 . . . . 25.449999999999999 112.234 -162.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -93.74 132.07 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.77 -3.081 . . . . 14.6 110.024 165.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -105.6 -165.56 1.12 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 119.76 -0.776 . . . . 33.229999999999997 111.506 -166.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -79.12 125.44 29.43 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 117.395 -1.722 . . . . 25.969999999999999 112.521 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.3 34.6 mt-10 68.22 27.43 6.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.115 2.166 . . . . 32.609999999999999 114.348 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -74.7 153.99 38.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.905 -3.622 . . . . 10.56 116.503 163.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.1 m -93.27 125.7 38.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.375 2.297 . . . . 5.3300000000000001 111.447 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -93.33 154.91 17.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.004 -2.591 . . . . 11.66 104.004 169.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.552 ' HB2' HG13 ' A' ' 44' ' ' ILE . 75.5 m80 -122.46 107.26 11.83 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 108.912 -0.773 . . . . 16.300000000000001 108.912 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -78.24 120.71 23.41 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 122.876 1.322 . . . . 9.9600000000000009 109.545 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.39 -179.65 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.737 2.415 . . . . 9.7599999999999998 107.421 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.9 mt . . . . . 0 N--CA 1.43 -1.438 0 CA-C-O 123.504 1.621 . . . . 19.57 112.789 178.663 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptt? . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 109.027 -0.731 . . . . 17.170000000000002 109.027 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -100.09 125.4 46.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.929 -2.357 . . . . 21.890000000000001 105.251 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -123.37 159.12 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.62 -3.175 . . . . 10.83 105.898 159.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -111.91 137.03 50.45 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.846 -3.034 . . . . 10.609999999999999 112.021 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.481 HG21 HD11 ' A' ' 30' ' ' ILE . 60.8 t -112.07 125.41 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 111.504 -2.589 . . . . 9.1300000000000008 109.572 169.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -107.11 124.62 49.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.567 -3.208 . . . . 20.550000000000001 110.535 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p -89.88 163.61 14.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.76 1.743 . . . . 11.779999999999999 111.438 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.04 -39.95 94.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.628 1.571 . . . . 19.309999999999999 113.987 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -73.59 -33.04 64.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.376 3.07 . . . . 23.140000000000001 105.915 -175.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.42 48.33 0.47 Allowed Glycine 0 N--CA 1.431 -1.696 0 CA-C-O 122.622 1.124 . . . . 19.739999999999998 115.651 160.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.23 125.84 52.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.053 -3.027 . . . . 21.93 108.241 168.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.6 m -93.21 95.06 9.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.084 2.554 . . . . 12.33 112.309 169.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.4 mt -102.9 125.47 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 131.064 3.746 . . . . 17.079999999999998 106.677 -159.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -81.55 119.84 24.28 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.285 -3.384 . . . . 16.300000000000001 114.308 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.2 142.71 36.5 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.884 -4.26 . . . . 15.880000000000001 109.465 174.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -110.28 105.52 14.59 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.4 3.88 . . . . 28.899999999999999 111.333 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.73 157.77 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 111.571 -2.559 . . . . 12.050000000000001 108.281 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -88.9 168.11 16.52 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 124.547 1.154 . . . . 18.170000000000002 113.247 159.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.56 -24.24 26.22 Favored 'Trans proline' 0 C--N 1.299 -2.036 1 O-C-N 112.537 -4.507 . . . . 8.1600000000000001 113.485 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -97.33 16.47 19.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.45 2.344 . . . . 11.130000000000001 116.106 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -67.89 136.76 54.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.712 2.805 . . . . 18.030000000000001 108.164 163.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.342 60.9 p -80.27 168.14 19.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.035 2.534 . . . . 10.220000000000001 107.145 -176.088 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 mm -75.9 -35.11 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 105.034 -2.21 . . . . 12.300000000000001 105.034 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -44.17 -46.28 8.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.795 2.146 . . . . 36.509999999999998 116.795 161.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.269 11.4 m120 -69.24 -32.48 71.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.65 -3.781 . . . . 25.66 111.843 173.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.12 -38.67 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 116.215 1.931 . . . . 8.1199999999999992 116.215 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -71.19 -22.34 62.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.065 -2.897 . . . . 15.470000000000001 116.085 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.86 72.91 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.029 -1.669 . . . . 11.449999999999999 114.333 171.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -70.97 -40.95 71.65 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.067 2.988 . . . . 24.98 119.067 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 5' ' ' VAL . 74.8 mt -66.96 -32.28 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.622 -1.923 . . . . 9.4600000000000009 112.038 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -66.15 -43.1 88.0 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.674 2.39 . . . . 14.76 115.437 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -78.49 -28.31 46.38 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.553 1.979 . . . . 26.289999999999999 115.747 168.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.24 -68.35 0.5 Allowed 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.095 -4.128 . . . . 30.059999999999999 110.101 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -81.97 -49.08 10.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.653 2.933 . . . . 25.190000000000001 110.352 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.66 7.85 13.02 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.645 -2.534 . . . . 7.4100000000000001 111.711 -170.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mm -82.88 127.82 68.16 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 116.25 1.945 . . . . 9.4900000000000002 116.25 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -64.14 150.49 88.24 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 CA-C-O 115.515 -1.952 . . . . 11.42 116.915 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -71.89 -20.82 25.39 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 123.98 2.457 . . . . 12.0 114.488 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -64.35 -39.36 93.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.458 -2.211 . . . . 35.549999999999997 115.645 165.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -78.03 -24.74 47.71 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 127.204 2.815 . . . . 20.52 110.657 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -70.6 119.17 14.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.522 2.329 . . . . 7.1299999999999999 112.358 168.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -130.94 103.1 6.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.421 -2.807 . . . . 36.390000000000001 103.421 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -92.13 118.27 30.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.144 -2.222 . . . . 9.5500000000000007 108.789 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 pt -90.21 -179.22 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 113.821 1.045 . . . . 13.9 113.821 159.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -111.68 -77.68 0.59 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.061 -2.2 . . . . 6.8600000000000003 105.061 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.73 -50.63 2.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.29 2.236 . . . . 11.15 112.489 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.55 -24.17 0.85 Allowed Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 126.782 2.134 . . . . 13.93 112.356 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -113.78 146.27 40.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.733 -2.039 . . . . 23.920000000000002 114.697 -167.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -78.12 152.4 32.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.305 3.431 . . . . 23.23 115.928 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.1 mt -114.5 136.25 53.22 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 102.928 -2.989 . . . . 9.1099999999999994 102.928 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -104.77 139.12 40.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.628 -2.545 . . . . 33.439999999999998 108.85 -173.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -28.2 -55.36 0.11 Allowed 'General case' 0 N--CA 1.429 -1.482 1 N-CA-C 123.444 4.609 . . . . 28.370000000000001 123.444 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.93 -1.75 81.96 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.765 -2.459 . . . . 15.0 117.922 -164.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -93.35 167.61 11.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.879 3.271 . . . . 25.5 107.949 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -101.37 168.49 9.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.831 2.052 . . . . 11.949999999999999 111.811 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.26 -25.87 68.25 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 131.713 4.005 . . . . 10.17 111.677 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -59.6 -46.45 88.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.363 -3.336 . . . . 13.59 114.744 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.8 -40.0 87.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.675 -2.057 . . . . 11.699999999999999 110.363 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -85.05 -2.38 57.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.789 0.804 . . . . 12.949999999999999 109.486 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m120 65.09 46.7 2.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.274 2.464 . . . . 25.449999999999999 112.724 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.0 mt -90.02 114.12 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.985 -2.322 . . . . 14.6 110.175 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -97.16 166.18 11.7 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.194 2.998 . . . . 33.229999999999997 112.188 -175.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -55.63 134.11 50.95 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.88 1.808 . . . . 25.969999999999999 115.88 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 55.55 58.12 4.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.179 -1.828 . . . . 32.609999999999999 111.78 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 t -115.74 142.82 46.24 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.25 1.42 . . . . 10.56 108.972 173.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -98.5 124.18 43.08 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.66 1.695 . . . . 5.3300000000000001 115.47 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.79 156.59 17.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.152 3.381 . . . . 11.66 107.681 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -129.07 122.21 29.47 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.44 -2.059 . . . . 16.300000000000001 105.44 -172.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.43 105.76 17.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 112.886 -1.961 . . . . 9.9600000000000009 111.32 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 m -104.95 178.15 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 127.74 2.416 . . . . 9.7599999999999998 112.507 168.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt . . . . . 0 N--CA 1.43 -1.449 0 CA-C-O 124.877 2.275 . . . . 19.57 115.711 176.201 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 ttp . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 122.407 1.098 . . . . 17.170000000000002 108.85 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -82.65 135.95 34.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.065 -1.647 . . . . 21.890000000000001 108.184 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.77 166.46 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 124.789 1.236 . . . . 10.83 109.296 165.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -125.61 104.05 8.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.563 -2.014 . . . . 10.609999999999999 105.563 -167.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.43 105.12 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.515 -2.031 . . . . 9.1300000000000008 105.515 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -108.68 126.15 52.67 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.474 0.654 . . . . 20.550000000000001 110.125 -174.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -80.69 -179.35 7.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.504 1.668 . . . . 11.779999999999999 115.504 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.06 -43.32 78.9 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.004 -4.185 . . . . 19.309999999999999 112.056 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -84.99 -21.22 29.59 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.271 -1.786 . . . . 23.140000000000001 108.927 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.28 70.82 0.93 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-O 124.928 2.404 . . . . 19.739999999999998 115.957 166.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -116.66 118.48 32.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 110.398 -2.901 . . . . 21.93 106.724 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -90.39 103.7 16.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 127.245 2.841 . . . . 12.33 110.383 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.2 mt -94.42 98.79 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.746 2.418 . . . . 17.079999999999998 113.075 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -73.47 122.42 22.11 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 119.991 1.268 . . . . 16.300000000000001 113.068 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.95 147.87 37.82 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.765 -3.709 . . . . 15.880000000000001 102.816 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -105.32 134.92 47.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.819 1.771 . . . . 28.899999999999999 108.209 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -148.87 -174.52 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.57 3.148 . . . . 12.050000000000001 105.968 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -141.6 162.77 45.08 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 114.75 -2.548 . . . . 18.170000000000002 108.227 170.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -23.23 76.64 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 C-N-CA 127.014 5.142 . . . . 8.1600000000000001 118.024 -169.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 5.3 p -94.28 -6.05 45.36 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.559 2.344 . . . . 11.130000000000001 110.683 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -74.93 167.09 22.58 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.495 -3.878 . . . . 18.030000000000001 115.201 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -89.42 170.13 10.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.283 2.697 . . . . 10.220000000000001 118.283 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mt -87.63 -13.15 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 117.53 -1.668 . . . . 12.300000000000001 108.527 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -59.31 -47.51 85.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.01 1.324 . . . . 36.509999999999998 113.556 160.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -55.83 -40.67 73.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.134 -2.854 . . . . 25.66 116.104 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.9 t -52.63 -54.93 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 117.145 -3.472 . . . . 8.1199999999999992 113.213 167.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -61.22 -30.12 70.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.791 1.636 . . . . 15.470000000000001 114.955 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -30.24 70.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.528 3.531 . . . . 11.449999999999999 113.997 166.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -92.78 -14.4 27.9 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 116.742 -1.983 . . . . 24.98 112.174 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.27 67.8 mt -64.2 -36.18 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.398 1.57 . . . . 9.4600000000000009 114.418 158.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -67.76 -21.52 65.26 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.748 -3.095 . . . . 14.76 116.112 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.48 -58.63 2.66 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.085 -2.561 . . . . 26.289999999999999 104.085 -175.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -64.83 -62.06 1.8 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.112 2.565 . . . . 30.059999999999999 115.89 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -81.16 -58.15 3.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.302 1.864 . . . . 25.190000000000001 111.734 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.25 17.35 3.67 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.111 -1.596 . . . . 7.4100000000000001 109.111 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.1 mt -90.58 131.21 38.65 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-O 115.445 -2.217 . . . . 9.4900000000000002 109.085 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -66.18 156.59 64.08 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 125.497 2.999 . . . . 11.42 116.606 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -68.73 -23.03 36.4 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 124.374 3.383 . . . . 12.0 112.319 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.252 10.1 p-10 -77.85 -28.46 50.09 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.248 3.019 . . . . 35.549999999999997 107.801 -170.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -69.38 -35.4 75.78 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.192 -1.568 . . . . 20.52 110.841 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -96.39 133.56 40.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.237 -0.887 . . . . 7.1299999999999999 111.606 -151.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -111.61 131.87 54.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 103.274 -2.861 . . . . 36.390000000000001 103.274 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -116.91 125.06 50.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.24 1.495 . . . . 9.5500000000000007 110.724 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 23.2 mm -95.11 132.32 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.288 2.235 . . . . 13.9 114.298 170.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -123.17 115.94 22.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.481 -2.637 . . . . 6.8600000000000003 109.013 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.84 -102.56 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.364 -0.835 . . . . 11.15 110.007 -172.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.42 34.2 2.39 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 118.822 -2.424 . . . . 13.93 113.017 164.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.345 21.2 ttmm -120.16 144.11 47.85 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 112.735 -1.732 . . . . 23.920000000000002 115.145 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -81.42 135.49 35.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.763 1.744 . . . . 23.23 113.372 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.8 mt -89.26 145.74 25.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.069 -2.197 . . . . 9.1099999999999994 105.069 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -87.12 160.78 18.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.013 -2.422 . . . . 33.439999999999998 114.41 159.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.95 -41.55 13.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.888 2.551 . . . . 28.370000000000001 117.888 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.58 17.87 58.5 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 116.7 -2.667 . . . . 15.0 108.473 -170.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -90.18 165.92 13.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.163 -3.551 . . . . 25.5 109.817 161.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.9 p -102.13 174.26 6.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.849 3.214 . . . . 11.949999999999999 104.111 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.14 -37.5 83.91 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.691 2.796 . . . . 10.17 109.783 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.254 67.7 m -61.5 -42.67 99.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 113.241 0.83 . . . . 13.59 113.241 176.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -53.0 -44.45 67.26 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 121.057 3.725 . . . . 11.699999999999999 121.057 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -79.33 -15.76 57.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 125.715 1.884 . . . . 12.949999999999999 115.865 165.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 68.56 71.57 0.29 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.357 2.663 . . . . 25.449999999999999 110.303 -169.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.274 82.4 mt -109.15 114.51 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 113.332 -3.347 . . . . 14.6 110.004 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -100.13 -166.39 1.32 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.9 2.185 . . . . 33.229999999999997 116.9 -171.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 137.62 55.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.63 1.681 . . . . 25.969999999999999 112.197 -171.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.47 80.4 mt-10 72.74 12.12 5.35 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 116.703 -3.748 . . . . 32.609999999999999 118.091 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.1 t -86.46 137.66 32.37 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 125.763 1.914 . . . . 10.56 108.704 -165.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 m -87.25 115.34 24.59 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.234 -1.803 . . . . 5.3300000000000001 112.147 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.1 mt -93.13 149.69 21.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.402 -1.436 . . . . 11.66 109.368 167.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 77.7 m-70 -99.72 109.75 22.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 125.871 1.982 . . . . 16.300000000000001 109.972 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.1 tp -96.41 117.68 31.38 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.292 2.473 . . . . 9.9600000000000009 110.303 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.4 t -92.65 130.88 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 128.607 2.763 . . . . 9.7599999999999998 106.339 164.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.5 mt . . . . . 0 N--CA 1.43 -1.451 0 N-CA-C 107.115 -1.439 . . . . 19.57 107.115 161.704 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.4 ttp . . . . . 0 CA--C 1.49 -1.342 0 CA-C-O 121.162 0.506 . . . . 17.170000000000002 109.732 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -84.82 125.29 32.47 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.723 -2.486 . . . . 21.890000000000001 114.667 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 17' ' ' VAL 0.264 8.7 pt -114.04 165.25 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 124.109 3.14 . . . . 10.83 104.415 167.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -106.47 138.43 42.66 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 111.0 -2.818 . . . . 10.609999999999999 111.96 166.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.0 t -118.67 103.41 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.657 3.122 . . . . 9.1300000000000008 105.77 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -88.42 134.92 33.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.544 -2.598 . . . . 20.550000000000001 111.101 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -81.56 -170.51 2.83 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 123.791 2.996 . . . . 11.779999999999999 114.46 169.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.7 tp -100.74 -27.72 13.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.399 2.047 . . . . 19.309999999999999 112.907 -171.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 p -69.33 -41.79 76.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.529 -3.232 . . . . 23.140000000000001 107.598 160.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.68 72.1 0.67 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 117.959 -2.963 . . . . 19.739999999999998 116.045 173.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -123.97 133.63 53.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.074 -1.917 . . . . 21.93 109.476 160.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.4 m -93.57 105.01 17.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.277 2.86 . . . . 12.33 109.313 -170.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -95.34 118.86 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 CA-C-O 129.507 4.479 . . . . 17.079999999999998 110.267 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.42 102.77 14.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.017 -3.552 . . . . 16.300000000000001 112.609 -175.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.56 129.44 36.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.282 -2.136 . . . . 15.880000000000001 110.65 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -98.04 92.09 5.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 127.145 3.355 . . . . 28.899999999999999 106.667 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.493 HG21 HG12 ' A' ' 3' ' ' ILE . 14.8 m -102.81 174.25 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 130.979 3.712 . . . . 12.050000000000001 110.063 -173.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.349 73.6 mm-40 -115.36 141.53 27.34 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 112.594 -3.574 . . . . 18.170000000000002 105.51 163.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -56.25 -16.16 16.71 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 N-CA-C 119.879 2.992 . . . . 8.1600000000000001 119.879 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -82.15 -10.86 59.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.971 1.843 . . . . 11.130000000000001 111.922 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -74.0 142.94 45.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.58 -3.825 . . . . 18.030000000000001 118.028 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -92.0 152.52 19.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.635 1.683 . . . . 10.220000000000001 108.25 -171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.2 mm -57.68 -27.1 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 116.287 1.958 . . . . 12.300000000000001 116.287 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.318 37.0 tt0 -64.23 -45.21 89.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.616 1.674 . . . . 36.509999999999998 115.415 166.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -73.04 -29.2 62.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.506 -3.871 . . . . 25.66 113.05 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.94 -46.85 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.244 -2.785 . . . . 8.1199999999999992 107.026 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -60.19 -18.19 46.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.991 1.716 . . . . 15.470000000000001 114.96 171.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.16 -24.09 40.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.556 -2.59 . . . . 11.449999999999999 112.17 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttt -78.81 -36.02 43.29 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.757 -4.34 . . . . 24.98 107.666 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -69.72 -37.45 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 125.994 2.059 . . . . 9.4600000000000009 109.82 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -54.64 -53.52 53.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.713 1.597 . . . . 14.76 114.468 157.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.77 -30.29 71.29 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 123.128 2.695 . . . . 26.289999999999999 116.688 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -61.24 -67.1 0.44 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 126.289 2.947 . . . . 30.059999999999999 113.857 168.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -95.83 -48.47 5.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.872 -2.392 . . . . 25.190000000000001 113.123 -160.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.45 12.57 10.52 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 113.744 -1.571 . . . . 7.4100000000000001 114.108 -172.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 50.3 mt -97.0 113.48 63.06 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 107.881 -1.155 . . . . 9.4900000000000002 107.881 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 13.7 Cg_exo -76.91 164.1 30.3 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 125.445 2.98 . . . . 11.42 109.813 -169.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.256 68.0 Cg_exo -63.33 -31.16 73.48 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 N-CA-C 120.827 3.357 . . . . 12.0 120.827 -166.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -97.95 9.0 43.84 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 118.331 -1.347 . . . . 35.549999999999997 111.38 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -78.86 -24.49 44.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.361 2.346 . . . . 20.52 111.889 156.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -83.5 144.79 29.31 Favored 'General case' 0 N--CA 1.429 -1.481 1 N-CA-C 121.811 4.004 . . . . 7.1299999999999999 121.811 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -136.19 111.4 9.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 103.965 -2.606 . . . . 36.390000000000001 103.965 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 mt -97.85 120.39 38.16 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 117.655 -1.618 . . . . 9.5500000000000007 115.282 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -99.85 133.62 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 128.001 3.762 . . . . 13.9 109.924 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -125.69 114.88 19.25 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.025 -4.797 . . . . 6.8600000000000003 105.625 157.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.65 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 131.803 4.041 . . . . 11.15 109.17 -170.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.91 7.17 3.52 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 128.384 2.897 . . . . 13.93 112.332 172.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.307 24.5 ttmm -98.7 137.72 36.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 122.113 2.957 . . . . 23.920000000000002 108.483 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -96.53 127.95 43.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.428 -2.045 . . . . 23.23 107.398 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.2 mt -83.71 152.02 24.94 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 112.742 -2.026 . . . . 9.1099999999999994 106.69 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -99.07 141.46 31.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.961 3.304 . . . . 33.439999999999998 117.355 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.14 -43.96 98.08 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 121.612 3.93 . . . . 28.370000000000001 121.612 -171.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.22 35.37 5.06 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 125.421 1.486 . . . . 15.0 110.028 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -117.65 157.41 26.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.845 0.683 . . . . 25.5 112.845 161.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.3 p -101.54 164.97 11.49 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.068 2.842 . . . . 11.949999999999999 113.494 -169.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.0 mt -56.26 -41.95 76.6 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.144 -4.722 . . . . 10.17 115.467 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 t -63.77 -33.12 74.95 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 130.305 3.442 . . . . 13.59 114.884 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.22 -50.13 56.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.926 2.89 . . . . 11.699999999999999 107.583 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -76.93 -1.84 30.64 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.217 -2.177 . . . . 12.949999999999999 113.514 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.9 t30 54.28 68.46 0.85 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.762 3.625 . . . . 25.449999999999999 110.11 -170.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -108.89 102.61 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 127.473 2.309 . . . . 14.6 108.17 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -90.74 -174.05 3.93 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 114.052 1.131 . . . . 33.229999999999997 114.052 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -59.02 154.88 14.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.605 -3.184 . . . . 25.969999999999999 115.218 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 64.97 25.57 12.71 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.535 4.334 . . . . 32.609999999999999 113.256 169.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -82.48 130.99 35.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.306 1.043 . . . . 10.56 109.647 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.6 m -83.11 113.04 20.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.178 -1.045 . . . . 5.3300000000000001 108.178 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.52 149.57 24.26 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.758 -1.941 . . . . 11.66 105.758 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -113.99 116.69 29.61 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.531 -1.356 . . . . 16.300000000000001 111.714 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 71' ' ' LEU . 44.7 tp -84.6 125.76 32.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.02 2.819 . . . . 9.9600000000000009 111.11 171.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -118.81 123.54 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 130.382 3.473 . . . . 9.7599999999999998 111.849 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 69' ' ' LEU . 75.8 mt . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 123.745 1.736 . . . . 19.57 107.48 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 120.912 0.387 . . . . 17.170000000000002 111.451 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.263 52.5 mt-30 -114.8 138.61 50.55 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.485 1.291 . . . . 21.890000000000001 114.485 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 pt -116.19 140.47 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 119.825 -1.797 . . . . 10.83 110.337 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -99.81 115.47 29.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.261 1.505 . . . . 10.609999999999999 111.069 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -100.36 107.42 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 115.123 -2.37 . . . . 9.1300000000000008 107.98 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.264 19.5 ttmm -90.64 124.34 34.99 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 126.398 2.311 . . . . 20.550000000000001 110.943 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -74.65 164.27 26.77 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 121.241 1.837 . . . . 11.779999999999999 109.595 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.1 tp -71.59 -22.57 61.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.64 1.348 . . . . 19.309999999999999 114.64 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.253 27.4 p -72.42 -78.55 0.08 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.602 2.761 . . . . 23.140000000000001 111.235 173.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.06 43.64 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.707 1 C-N-CA 132.117 4.675 . . . . 19.739999999999998 114.801 170.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 82.5 tttt -117.16 143.57 45.69 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 102.927 -2.99 . . . . 21.93 102.927 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.4 m -123.24 115.5 21.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.299 -1.741 . . . . 12.33 106.299 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.73 132.64 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.084 -2.26 . . . . 17.079999999999998 109.396 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 m -101.85 100.54 10.87 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.736 -1.95 . . . . 16.300000000000001 105.736 -172.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.511 HD12 HG13 ' A' ' 26' ' ' VAL 0.277 62.0 mt -97.89 137.03 37.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.955 2.788 . . . . 15.880000000000001 104.108 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -85.95 118.68 25.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.686 -3.134 . . . . 28.899999999999999 112.007 168.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.02 158.46 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.738 -2.69 . . . . 12.050000000000001 103.738 -169.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -92.95 146.91 32.92 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 113.467 -3.158 . . . . 18.170000000000002 114.001 158.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.74 -7.92 22.09 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 CA-C-N 124.617 2.685 . . . . 8.1600000000000001 114.069 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -90.92 -7.4 52.24 Favored 'General case' 0 N--CA 1.43 -1.457 1 C-N-CA 132.969 4.508 . . . . 11.130000000000001 113.654 174.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.78 153.11 44.37 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.231 -2.793 . . . . 18.030000000000001 114.666 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -106.42 163.15 13.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.169 -1.049 . . . . 10.220000000000001 108.169 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 mm -65.9 -28.69 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 121.011 -1.055 . . . . 12.300000000000001 110.827 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -44.49 -41.31 6.27 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.78 3.622 . . . . 36.509999999999998 120.78 157.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -80.33 -29.22 38.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.009 -3.557 . . . . 25.66 113.499 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.511 HG13 HD12 ' A' ' 15' ' ' LEU . 69.0 t -67.97 -38.77 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 105.09 -2.189 . . . . 8.1199999999999992 105.09 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -70.91 -42.26 70.16 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.248 1.819 . . . . 15.470000000000001 113.543 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.8 -43.64 27.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.444 2.069 . . . . 11.449999999999999 111.789 169.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -77.3 -31.66 54.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.79 -3.069 . . . . 24.98 109.032 -173.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.6 mt -70.61 -40.79 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.188 -3.445 . . . . 9.4600000000000009 115.834 171.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -50.26 -47.69 55.1 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 133.055 4.542 . . . . 14.76 109.435 172.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -60.28 -56.55 20.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.212 1.482 . . . . 26.289999999999999 113.744 171.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -74.15 -37.89 63.89 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.384 3.476 . . . . 30.059999999999999 120.384 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 56.2 mm-40 -107.83 -40.13 5.36 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.401 1.909 . . . . 25.190000000000001 114.233 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.2 44.23 4.45 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 120.598 1.545 . . . . 7.4100000000000001 112.963 -169.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 mt -111.68 126.6 28.24 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 100.314 -3.958 . . . . 9.4900000000000002 100.314 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -67.35 153.41 77.04 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 C-N-CA 126.335 4.69 . . . . 11.42 115.765 -174.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -78.27 -18.89 12.29 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 126.412 3.326 . . . . 12.0 112.998 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.9 -11.76 60.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 114.885 -2.483 . . . . 35.549999999999997 115.69 165.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -97.07 -16.73 20.39 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 121.901 2.137 . . . . 20.52 112.763 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 76.7 mt-30 -92.04 118.07 30.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.747 3.154 . . . . 7.1299999999999999 111.098 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -116.37 111.02 19.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.933 -1.877 . . . . 36.390000000000001 105.933 170.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -86.75 113.94 23.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.879 2.752 . . . . 9.5500000000000007 110.638 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.2 mm -99.43 142.12 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.243 -2.786 . . . . 13.9 105.878 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HB2' HD12 ' A' ' 50' ' ' LEU . 25.5 t80 -128.65 112.24 14.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.69 -1.881 . . . . 6.8600000000000003 108.08 171.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.33 . . 68.86 -91.65 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.343 -3.973 . . . . 11.15 117.354 -162.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.68 34.68 0.95 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 118.842 -1.646 . . . . 13.93 111.804 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -149.98 144.83 26.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 129.513 3.714 . . . . 23.920000000000002 113.709 173.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -73.43 134.41 43.98 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 125.832 2.73 . . . . 23.23 115.125 -176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 45' ' ' PHE . 14.7 mt -86.51 151.1 23.78 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 110.727 -2.942 . . . . 9.1099999999999994 109.925 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.36 133.31 46.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.216 -3.428 . . . . 33.439999999999998 105.214 -158.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -40.45 -58.8 1.47 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 130.466 3.506 . . . . 28.370000000000001 117.789 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.7 14.16 43.6 Favored Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 121.055 1.752 . . . . 15.0 114.288 -169.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -113.44 159.68 19.23 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.671 -2.664 . . . . 25.5 108.626 -172.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 p -114.27 -178.12 3.29 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.476 -3.265 . . . . 11.949999999999999 112.571 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.3 mt -74.51 -28.71 61.11 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 110.656 -2.975 . . . . 10.17 114.319 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.6 m -65.52 -31.11 72.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 119.167 3.025 . . . . 13.59 119.167 170.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -65.89 -45.63 81.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 127.62 3.075 . . . . 11.699999999999999 110.388 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -92.38 -8.41 44.97 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.695 -2.098 . . . . 12.949999999999999 109.51 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 60.35 54.24 4.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.508 3.051 . . . . 25.449999999999999 114.305 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mt -93.44 108.39 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 109.602 -3.454 . . . . 14.6 105.744 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -88.2 -179.09 6.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 124.769 2.223 . . . . 33.229999999999997 111.419 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.269 17.9 pttp -53.37 141.69 23.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.723 -3.111 . . . . 25.969999999999999 116.146 159.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 70.98 20.87 5.15 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.785 -3.072 . . . . 32.609999999999999 112.545 168.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -89.71 135.21 33.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.972 3.709 . . . . 10.56 114.786 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -95.0 117.71 30.6 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.869 2.914 . . . . 5.3300000000000001 118.869 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mp -108.83 151.35 26.36 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.89 -2.263 . . . . 11.66 104.89 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -107.13 140.66 39.62 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.231 -1.766 . . . . 16.300000000000001 106.231 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -106.37 106.48 17.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.535 1.772 . . . . 9.9600000000000009 111.952 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.3 t -94.42 134.33 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 126.948 2.655 . . . . 9.7599999999999998 107.029 173.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 N--CA 1.43 -1.44 0 CA-C-N 115.417 -0.811 . . . . 19.57 110.314 166.256 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 112.505 0.558 . . . . 17.170000000000002 112.505 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -102.73 147.86 26.32 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.517 3.532 . . . . 21.890000000000001 112.94 170.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 pt -128.6 163.66 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 115.802 -4.311 . . . . 10.83 103.908 169.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.57 101.67 7.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 105.057 -2.201 . . . . 10.609999999999999 105.057 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.0 t -93.53 123.3 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 107.015 -1.476 . . . . 9.1300000000000008 107.015 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -124.36 152.75 42.78 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.246 1.839 . . . . 20.550000000000001 111.004 -171.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -88.42 -178.37 5.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.614 1.709 . . . . 11.779999999999999 115.614 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.269 36.1 tp -67.77 -40.08 84.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.719 2.859 . . . . 19.309999999999999 118.719 158.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -56.55 7.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.899 -2.376 . . . . 23.140000000000001 111.74 -169.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.74 24.52 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 119.03 -2.294 . . . . 19.739999999999998 115.197 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -100.38 148.48 24.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.911 -3.111 . . . . 21.93 115.849 166.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.8 m -125.34 135.77 52.79 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.744 2.818 . . . . 12.33 104.883 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.6 mt -121.59 110.78 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 103.273 -2.862 . . . . 17.079999999999998 103.273 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -79.57 118.72 21.67 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.07 -1.644 . . . . 16.300000000000001 113.852 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -112.68 145.12 41.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.425 -3.297 . . . . 15.880000000000001 113.119 -174.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -100.61 98.25 8.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.496 -1.668 . . . . 28.899999999999999 106.496 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 m -104.42 174.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 124.883 1.364 . . . . 12.050000000000001 113.025 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -121.02 152.02 55.96 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 127.367 2.267 . . . . 18.170000000000002 106.213 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -68.35 -14.72 40.87 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 122.784 2.03 . . . . 8.1600000000000001 115.224 -172.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.255 53.3 p -99.8 1.34 43.0 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.737 2.815 . . . . 11.130000000000001 114.596 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.264 11.3 m-20 -71.0 155.23 41.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.882 2.277 . . . . 18.030000000000001 110.638 161.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 p -85.36 161.68 19.37 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.04 2.829 . . . . 10.220000000000001 108.487 173.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mm -57.01 -29.12 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.161 -2.837 . . . . 12.300000000000001 115.068 163.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -62.68 -46.65 87.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.021 -3.55 . . . . 36.509999999999998 109.538 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -52.85 -52.75 56.07 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.892 1.277 . . . . 25.66 113.325 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -45.12 -50.35 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.911 1.684 . . . . 8.1199999999999992 113.409 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.19 -36.21 77.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.038 1.875 . . . . 15.470000000000001 115.011 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.97 82.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.641 -2.537 . . . . 11.449999999999999 116.408 170.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -63.92 -40.03 95.54 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.795 1.776 . . . . 24.98 115.795 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -60.05 -45.2 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 C-N-CA 135.097 5.359 . . . . 9.4600000000000009 110.693 168.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -54.54 -48.23 72.25 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.991 1.717 . . . . 14.76 113.386 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.21 -35.57 80.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.535 2.05 . . . . 26.289999999999999 116.535 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -87.37 -46.31 9.77 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.637 1.684 . . . . 30.059999999999999 114.694 -172.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -78.63 -55.61 5.06 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 114.225 -1.352 . . . . 25.190000000000001 114.51 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.1 44.84 1.97 Allowed Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 110.066 -1.213 . . . . 7.4100000000000001 110.066 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.405 HG23 ' HB3' ' A' ' 40' ' ' GLN . 6.8 mt -125.38 127.24 25.0 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 104.806 -2.294 . . . . 9.4900000000000002 104.806 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -67.22 160.36 47.92 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-O 115.998 -1.751 . . . . 11.42 116.052 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -70.29 -27.34 24.05 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 124.74 3.626 . . . . 12.0 110.993 -169.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -77.64 -37.2 50.49 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 117.92 -1.038 . . . . 35.549999999999997 109.457 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.405 ' HB3' HG23 ' A' ' 36' ' ' ILE . 7.1 tp-100 -59.96 -33.08 71.45 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.559 2.344 . . . . 20.52 115.498 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -98.93 145.32 27.15 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.346 2.022 . . . . 7.1299999999999999 116.418 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -115.03 153.71 30.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.692 2.797 . . . . 36.390000000000001 107.683 165.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 tp -133.93 114.89 13.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.413 1.085 . . . . 9.5500000000000007 108.966 -171.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.4 mm -103.71 128.57 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 117.26 -3.4 . . . . 13.9 112.452 -171.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -109.87 128.62 55.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.02 1.328 . . . . 6.8600000000000003 108.674 160.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.42 -108.25 0.42 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.81 -2.432 . . . . 11.15 112.262 -168.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.67 31.55 3.53 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 109.212 -1.555 . . . . 13.93 109.212 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -121.8 124.18 43.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.269 1.428 . . . . 23.920000000000002 111.054 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -76.31 107.41 8.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.217 1.807 . . . . 23.23 110.682 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.82 136.63 34.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.247 1.019 . . . . 9.1099999999999994 111.696 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -93.24 159.1 15.42 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.483 2.087 . . . . 33.439999999999998 111.101 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -73.15 -42.07 63.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.226 -2.796 . . . . 28.370000000000001 108.764 -156.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.84 41.5 2.13 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 117.217 -3.427 . . . . 15.0 113.01 -165.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -122.37 159.71 26.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.158 2.328 . . . . 25.5 108.842 166.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.9 p -85.99 167.92 14.62 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.964 2.106 . . . . 11.949999999999999 116.396 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -68.36 -26.66 65.7 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.794 -1.191 . . . . 10.17 111.416 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 t -76.37 -40.76 50.24 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 118.431 2.752 . . . . 13.59 118.431 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -43.16 -48.11 6.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.922 -2.361 . . . . 11.699999999999999 117.251 158.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -78.85 -6.99 57.49 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 120.575 3.546 . . . . 12.949999999999999 120.575 170.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 t30 53.75 40.06 31.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.064 2.616 . . . . 25.449999999999999 118.064 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.8 mt -81.47 118.91 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 105.044 -2.206 . . . . 14.6 105.044 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -81.31 -173.07 4.13 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.878 2.751 . . . . 33.229999999999997 113.79 -176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -74.42 146.06 43.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.009 -2.932 . . . . 25.969999999999999 112.605 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 65.57 30.16 10.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.364 1.665 . . . . 32.609999999999999 114.821 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -79.45 152.53 30.24 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 103.763 -2.68 . . . . 10.56 103.763 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.6 m -103.51 124.16 48.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.103 2.961 . . . . 5.3300000000000001 108.309 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.282 4.9 mp -117.11 162.13 18.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.106 1.762 . . . . 11.66 107.894 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.27 127.08 52.9 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.705 -2.497 . . . . 16.300000000000001 111.182 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.72 107.73 18.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.414 2.686 . . . . 9.9600000000000009 114.739 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -122.12 121.34 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 108.057 -1.09 . . . . 9.7599999999999998 108.057 -171.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.405 HD11 HD11 ' A' ' 36' ' ' ILE . 7.9 mp . . . . . 0 N--CA 1.431 -1.409 0 C-N-CA 117.092 -1.843 . . . . 19.57 110.151 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 112.747 0.647 . . . . 17.170000000000002 112.747 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -95.95 121.8 38.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.907 -1.886 . . . . 21.890000000000001 105.907 -176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 pt -109.62 164.85 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 107.268 -1.382 . . . . 10.83 107.268 170.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -114.83 105.79 13.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.432 -2.433 . . . . 10.609999999999999 104.432 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.4 t -86.57 124.84 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 126.931 3.253 . . . . 9.1300000000000008 109.483 166.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -106.4 134.62 49.25 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.431 -2.668 . . . . 20.550000000000001 107.684 -173.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.253 47.5 p -75.79 161.14 29.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.775 2.03 . . . . 11.779999999999999 112.042 170.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.5 tp -59.28 -37.93 78.88 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.378 -3.326 . . . . 19.309999999999999 115.613 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -68.1 -64.58 0.83 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.651 2.167 . . . . 23.140000000000001 115.085 169.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.51 71.55 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 O-C-N 117.113 -3.492 . . . . 19.739999999999998 107.826 174.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -104.02 160.14 15.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.549 1.174 . . . . 21.93 113.885 147.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.1 m -90.96 118.98 30.78 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 115.824 -4.298 . . . . 12.33 105.92 168.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.71 119.17 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 123.914 1.816 . . . . 17.079999999999998 107.737 156.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 84.7 m -98.96 108.65 21.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 111.595 -2.548 . . . . 16.300000000000001 106.723 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.484 ' CD1' HG11 ' A' ' 26' ' ' VAL . 87.7 mt -107.2 116.87 32.69 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.598 2.359 . . . . 15.880000000000001 115.719 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.31 112.42 15.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.531 -1.668 . . . . 28.899999999999999 110.211 167.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.29 158.32 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 123.284 0.634 . . . . 12.050000000000001 109.949 167.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 56.7 mt-10 -115.79 151.73 46.65 Favored Pre-proline 0 N--CA 1.429 -1.478 0 N-CA-C 102.834 -3.024 . . . . 18.170000000000002 102.834 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -76.03 -16.4 18.02 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 CA-C-O 114.889 -2.213 . . . . 8.1600000000000001 113.456 -159.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -70.51 -14.83 62.68 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-N 127.26 4.573 . . . . 11.130000000000001 112.931 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 18.3 m-20 -78.32 146.8 34.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.703 -3.748 . . . . 18.030000000000001 106.19 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.7 p -78.77 167.89 20.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.336 -3.978 . . . . 10.220000000000001 116.489 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.95 -39.88 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 117.427 -1.273 . . . . 12.300000000000001 110.234 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -51.1 -39.51 56.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 123.422 2.828 . . . . 36.509999999999998 113.233 170.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -57.57 -38.67 75.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.565 -1.335 . . . . 25.66 112.811 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.484 HG11 ' CD1' ' A' ' 15' ' ' LEU . 58.5 t -56.77 -54.42 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 125.925 2.774 . . . . 8.1199999999999992 111.183 176.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -56.57 -37.38 70.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.981 3.326 . . . . 15.470000000000001 119.981 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.23 -32.08 69.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.231 1.491 . . . . 11.449999999999999 112.475 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -80.22 -27.89 38.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 118.585 -1.246 . . . . 24.98 108.461 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.9 mt -58.65 -42.21 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 114.749 1.389 . . . . 9.4600000000000009 114.749 159.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -65.05 -24.91 67.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.867 -2.395 . . . . 14.76 115.96 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.23 -59.82 3.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.442 -3.287 . . . . 26.289999999999999 109.445 166.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -73.1 -56.83 4.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.331 2.715 . . . . 30.059999999999999 118.331 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -93.95 -53.3 4.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.751 1.621 . . . . 25.190000000000001 115.094 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.52 2.9 6.21 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 125.173 2.54 . . . . 7.4100000000000001 115.995 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.5 mt -68.18 127.55 93.27 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 113.691 -3.052 . . . . 9.4900000000000002 112.767 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -70.63 155.57 62.82 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 126.974 3.527 . . . . 11.42 115.337 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -62.45 -39.45 45.78 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 CA-C-N 124.552 2.661 . . . . 12.0 110.636 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.73 -8.7 11.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.65 2.833 . . . . 35.549999999999997 118.65 170.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -94.68 -32.26 13.45 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.785 -2.447 . . . . 20.52 110.402 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -107.96 154.33 21.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.737 1.384 . . . . 7.1299999999999999 114.737 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 mtt85 -134.55 164.34 27.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 117.823 -1.084 . . . . 36.390000000000001 108.222 157.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -113.31 136.62 52.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.059 3.344 . . . . 9.5500000000000007 107.15 -174.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -115.76 122.72 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.131 -1.433 . . . . 13.9 107.131 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -113.63 111.14 21.35 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.968 -2.975 . . . . 6.8600000000000003 102.968 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.08 -75.83 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.446 -2.034 . . . . 11.15 114.972 -164.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.59 9.09 2.61 Favored Glycine 0 N--CA 1.429 -1.807 0 CA-C-N 121.021 1.737 . . . . 13.93 116.463 169.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -107.62 123.76 48.96 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.719 2.2 . . . . 23.920000000000002 108.249 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -82.19 121.34 26.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 110.362 -3.108 . . . . 23.23 111.721 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 mt -86.27 156.17 20.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 115.749 -2.072 . . . . 9.1099999999999994 110.547 -165.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -109.25 142.42 40.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 123.034 2.652 . . . . 33.439999999999998 111.265 -173.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.61 -48.75 79.93 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.374 2.67 . . . . 28.370000000000001 115.564 -163.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.29 -3.69 71.24 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 118.163 2.025 . . . . 15.0 118.163 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.8 mtt-85 -98.0 170.25 9.06 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.889 1.328 . . . . 25.5 110.286 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -106.43 162.04 14.05 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.927 -1.733 . . . . 11.949999999999999 112.521 -170.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.58 -25.37 68.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.884 -2.385 . . . . 10.17 114.611 175.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.96 -30.19 55.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.664 2.386 . . . . 13.59 112.493 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -63.73 -42.23 97.93 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.542 -3.223 . . . . 11.699999999999999 111.246 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -88.99 5.68 43.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.033 2.975 . . . . 12.949999999999999 119.033 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 55.36 59.64 3.82 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.833 2.453 . . . . 25.449999999999999 111.994 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.6 mt -96.38 122.94 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.125 -1.805 . . . . 14.6 106.125 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -102.34 -174.73 2.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.646 1.688 . . . . 33.229999999999997 111.978 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -56.03 149.33 15.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.148 -3.47 . . . . 25.969999999999999 115.919 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 39.2 mt-10 66.98 31.04 7.23 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.367 -2.708 . . . . 32.609999999999999 113.434 171.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.3 m -93.29 132.21 37.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.798 -2.001 . . . . 10.56 113.375 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.1 m -90.74 124.64 35.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.452 -2.655 . . . . 5.3300000000000001 108.09 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.322 11.2 mp -109.61 140.02 43.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.997 1.719 . . . . 11.66 111.838 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -98.48 135.36 40.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.135 2.243 . . . . 16.300000000000001 115.505 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.5 tp -98.14 125.43 43.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.44 1.59 . . . . 9.9600000000000009 110.189 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -133.37 148.08 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 121.032 -1.042 . . . . 9.7599999999999998 110.187 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 105.079 -2.193 . . . . 19.57 105.079 -170.078 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 122.931 1.348 . . . . 17.170000000000002 114.554 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -107.77 155.98 19.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 120.036 3.347 . . . . 21.890000000000001 120.036 172.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -138.73 154.54 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 106.817 -1.549 . . . . 10.83 106.817 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -106.83 126.73 52.69 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.401 -2.074 . . . . 10.609999999999999 105.401 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.01 108.83 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 120.09 1.314 . . . . 9.1300000000000008 109.581 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -96.97 135.66 38.65 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.735 -1.121 . . . . 20.550000000000001 109.568 -167.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -77.61 171.11 15.42 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.412 1.695 . . . . 11.779999999999999 112.007 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -51.5 -56.39 13.63 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 117.093 2.257 . . . . 19.309999999999999 117.093 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -85.93 -72.95 0.47 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.442 -2.036 . . . . 23.140000000000001 109.324 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.41 48.0 0.17 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 118.658 2.223 . . . . 19.739999999999998 118.658 -162.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -110.85 156.27 21.38 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 116.304 -4.056 . . . . 21.93 110.299 157.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.9 m -129.14 135.82 49.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 103.148 -2.908 . . . . 12.33 103.148 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 mt -121.54 112.97 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 114.5 -1.227 . . . . 17.079999999999998 108.989 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.7 m -88.19 107.17 18.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.995 0.903 . . . . 16.300000000000001 111.479 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.92 112.35 24.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 120.233 3.42 . . . . 15.880000000000001 120.233 -173.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -83.59 117.74 23.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.723 -3.735 . . . . 28.899999999999999 111.892 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.62 177.84 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.547 -1.971 . . . . 12.050000000000001 109.377 -166.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -117.46 160.13 39.13 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 118.488 -2.633 . . . . 18.170000000000002 109.951 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -79.48 -6.78 14.72 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 125.253 3.969 . . . . 8.1600000000000001 110.091 -166.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 m -88.58 -7.22 56.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.711 2.804 . . . . 11.130000000000001 115.064 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.49 169.74 11.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 118.703 0.683 . . . . 18.030000000000001 112.79 -175.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.5 p -107.9 164.91 11.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.421 2.288 . . . . 10.220000000000001 109.029 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 mm -55.83 -47.01 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 126.499 1.92 . . . . 12.300000000000001 112.37 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -60.99 -32.7 72.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.21 2.604 . . . . 36.509999999999998 115.642 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -67.04 -43.2 83.36 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 122.714 2.507 . . . . 25.66 115.38 162.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.89 -29.24 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 118.435 -2.666 . . . . 8.1199999999999992 113.004 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -72.68 -34.68 67.35 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.968 2.507 . . . . 15.470000000000001 110.476 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -34.92 73.56 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.788 2.835 . . . . 11.449999999999999 115.771 169.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -57.87 -52.14 66.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.939 2.896 . . . . 24.98 117.069 162.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.453 HD13 ' OE1' ' A' ' 41' ' ' GLN . 58.2 mt -60.6 -40.3 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 117.794 -3.066 . . . . 9.4600000000000009 113.404 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -50.45 -49.0 56.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.513 2.578 . . . . 14.76 112.006 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -46.47 80.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.359 -3.963 . . . . 26.289999999999999 116.941 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -63.22 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.063 -2.335 . . . . 30.059999999999999 114.954 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -58.97 -64.65 0.86 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.166 2.186 . . . . 25.190000000000001 113.663 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.54 62.24 0.33 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 108.476 -1.849 . . . . 7.4100000000000001 108.476 -171.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.0 mt -127.84 114.05 20.58 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.326 -2.75 . . . . 9.4900000000000002 113.89 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -73.77 150.8 45.16 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 124.809 2.753 . . . . 11.42 113.737 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -57.97 -35.07 99.01 Favored 'Trans proline' 0 N--CA 1.434 -2.003 2 C-N-CA 129.514 6.81 . . . . 12.0 117.451 -166.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.299 38.7 m-20 -74.21 -21.65 59.71 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.603 1.161 . . . . 35.549999999999997 111.15 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -78.23 -31.86 49.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.355 3.455 . . . . 20.52 114.097 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' OE1' HD13 ' A' ' 30' ' ' ILE . 14.5 pt20 -109.65 140.24 43.73 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 113.287 -5.883 . . . . 7.1299999999999999 111.203 -175.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -123.17 171.74 9.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.747 -1.945 . . . . 36.390000000000001 105.747 163.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.25 35.3 mt -123.32 143.32 50.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 125.773 1.92 . . . . 9.5500000000000007 107.519 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.88 138.68 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.431 2.062 . . . . 13.9 106.38 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -114.07 102.19 9.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.318 -2.739 . . . . 6.8600000000000003 107.882 171.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.297 . . 58.58 -98.33 0.08 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.735 1.754 . . . . 11.15 115.735 -166.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.47 -6.89 24.95 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 120.704 1.593 . . . . 13.93 109.195 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.8 120.32 30.09 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 113.382 0.882 . . . . 23.920000000000002 113.382 -171.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -87.61 116.97 26.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.235 -3.416 . . . . 23.23 111.386 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.0 mt -84.58 126.86 33.7 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.331 -1.481 . . . . 9.1099999999999994 112.315 -169.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -78.0 134.91 37.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.359 2.664 . . . . 33.439999999999998 114.084 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.52 -46.03 91.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.332 1.853 . . . . 28.370000000000001 112.657 -155.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.23 -8.02 86.95 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 125.818 1.675 . . . . 15.0 117.247 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.8 mtt-85 -76.64 148.18 37.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.035 -2.45 . . . . 25.5 112.122 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.2 p -81.66 166.41 20.18 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.729 -4.357 . . . . 11.949999999999999 110.034 -176.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.74 -19.28 63.54 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.957 1.836 . . . . 10.17 115.957 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 t -91.05 -18.21 24.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.753 2.821 . . . . 13.59 108.563 -172.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -66.78 -21.88 66.04 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.444 -4.535 . . . . 11.699999999999999 114.082 163.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -104.24 -20.68 13.71 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.66 -1.154 . . . . 12.949999999999999 111.582 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 66.44 61.03 0.58 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.419 1.888 . . . . 25.449999999999999 112.083 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -101.29 103.46 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.241 1.816 . . . . 14.6 108.789 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -83.49 -163.42 0.75 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.348 1.61 . . . . 33.229999999999997 115.348 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -71.75 159.02 35.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.424 1.89 . . . . 25.969999999999999 112.756 170.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 54.04 22.14 3.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.749 2.82 . . . . 32.609999999999999 110.206 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -66.22 140.64 58.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.587 1.955 . . . . 10.56 116.08 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -90.75 116.99 29.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.677 3.991 . . . . 5.3300000000000001 106.498 171.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -112.2 166.53 11.18 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 127.023 2.702 . . . . 11.66 110.498 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -122.86 135.54 54.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 117.81 -1.091 . . . . 16.300000000000001 111.269 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 tp -94.16 133.4 37.7 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.974 1.369 . . . . 9.9600000000000009 107.411 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.9 152.79 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 O-C-N 114.605 -5.059 . . . . 9.7599999999999998 106.735 161.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 115.057 -2.402 . . . . 19.57 110.493 171.868 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 114.464 1.283 . . . . 17.170000000000002 114.464 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -113.78 135.0 54.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.549 1.643 . . . . 21.890000000000001 109.123 -178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.6 pt -124.19 158.09 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 112.463 -2.153 . . . . 10.83 105.513 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -104.07 114.29 28.43 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.623 1.169 . . . . 10.609999999999999 113.38 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.23 116.0 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 116.724 -3.735 . . . . 9.1300000000000008 102.588 166.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -107.99 133.74 51.88 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.703 3.601 . . . . 20.550000000000001 109.97 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.392 17.6 p -79.88 -173.39 3.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.002 1.853 . . . . 11.779999999999999 116.002 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.5 tp -79.37 -42.41 25.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.889 2.757 . . . . 19.309999999999999 111.817 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p -68.49 -70.2 0.28 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.343 4.257 . . . . 23.140000000000001 110.129 174.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.44 55.98 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 104.089 -3.604 . . . . 19.739999999999998 104.089 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -117.33 146.19 43.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 120.728 2.264 . . . . 21.93 108.76 159.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -114.48 117.58 31.38 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.286 -2.759 . . . . 12.33 110.392 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.27 0.3 OUTLIER -104.45 104.32 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 103.154 -2.906 . . . . 17.079999999999998 103.154 175.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.4 m -88.88 111.72 22.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.711 1.204 . . . . 16.300000000000001 110.796 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.4 mt -114.26 148.92 36.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 122.853 2.57 . . . . 15.880000000000001 107.875 -160.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -106.34 118.93 37.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.382 -1.449 . . . . 28.899999999999999 114.697 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.56 170.66 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 124.061 1.886 . . . . 12.050000000000001 112.425 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -107.99 164.24 15.21 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.07 -2.894 . . . . 18.170000000000002 109.445 167.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -71.06 -24.85 23.32 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.263 1.975 . . . . 8.1600000000000001 112.447 -172.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.9 m -73.45 -8.08 54.43 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.727 2.811 . . . . 11.130000000000001 116.552 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -84.28 142.59 30.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.077 -1.874 . . . . 18.030000000000001 112.428 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -80.04 165.05 22.92 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.288 2.47 . . . . 10.220000000000001 113.807 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.408 HD12 HD11 ' A' ' 50' ' ' LEU . 35.6 mm -69.73 -32.31 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 119.535 -1.978 . . . . 12.300000000000001 109.448 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -51.66 -35.89 44.16 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.777 1.769 . . . . 36.509999999999998 115.777 159.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.69 -35.91 65.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.405 2.526 . . . . 25.66 109.845 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.05 -43.77 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 1 O-C-N 115.841 -4.287 . . . . 8.1199999999999992 109.785 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -56.64 -33.64 66.5 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.164 2.653 . . . . 15.470000000000001 118.164 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.77 -29.21 64.24 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.544 2.592 . . . . 11.449999999999999 109.281 -167.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -78.47 -34.08 47.85 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.794 2.037 . . . . 24.98 111.251 174.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.33 -33.57 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 123.859 1.79 . . . . 9.4600000000000009 110.769 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -59.4 -44.22 92.84 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.418 -2.676 . . . . 14.76 110.607 166.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.94 -41.47 91.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.446 1.098 . . . . 26.289999999999999 110.242 -172.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -78.96 -63.94 1.3 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 119.026 0.83 . . . . 30.059999999999999 110.041 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -89.72 -20.88 23.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.561 2.06 . . . . 25.190000000000001 116.561 -158.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.39 34.24 23.51 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 118.632 2.213 . . . . 7.4100000000000001 118.632 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -107.99 124.0 36.04 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 119.157 -0.449 . . . . 9.4900000000000002 111.598 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -66.0 148.02 85.25 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.636 2.224 . . . . 11.42 115.641 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.08 -21.48 12.09 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.162 2.575 . . . . 12.0 109.983 -148.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -70.28 -28.12 64.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.858 1.799 . . . . 35.549999999999997 115.858 173.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -81.81 -26.74 34.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.448 -2.033 . . . . 20.52 115.813 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -96.03 152.25 18.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.221 1.408 . . . . 7.1299999999999999 108.533 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -135.51 168.2 19.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 117.205 -1.378 . . . . 36.390000000000001 109.685 167.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.43 HD12 HD12 ' A' ' 67' ' ' LEU . 35.2 mt -131.71 130.75 42.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 125.388 3.722 . . . . 9.5500000000000007 110.714 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 70' ' ' VAL . 22.3 mt -110.77 116.59 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 112.124 -2.307 . . . . 13.9 110.657 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -96.73 102.07 13.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.107 3.363 . . . . 6.8600000000000003 109.905 169.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.1 -95.84 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.746 2.018 . . . . 11.15 114.714 -165.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.03 -12.91 26.47 Favored Glycine 0 N--CA 1.43 -1.703 1 C-N-CA 131.204 4.24 . . . . 13.93 112.694 -175.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -104.25 150.14 24.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.705 -2.644 . . . . 23.920000000000002 115.354 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -109.79 149.33 29.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.151 2.405 . . . . 23.23 109.752 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.408 HD11 HD12 ' A' ' 23' ' ' ILE . 23.4 mt -90.03 118.84 29.89 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.878 2.071 . . . . 9.1099999999999994 113.234 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -79.04 150.68 31.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.993 1.378 . . . . 33.439999999999998 110.475 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.97 -24.66 55.43 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 115.474 -4.517 . . . . 28.370000000000001 112.284 -157.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.18 27.2 10.37 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 121.145 3.218 . . . . 15.0 121.145 -171.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -110.79 174.91 5.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.309 1.843 . . . . 25.5 111.278 162.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.2 p -95.88 167.32 11.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 113.661 0.986 . . . . 11.949999999999999 113.661 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.4 -33.66 74.05 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 114.637 1.347 . . . . 10.17 114.637 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.39 -39.65 84.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.698 1.599 . . . . 13.59 114.681 171.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.287 72.5 m-20 -57.57 -37.25 72.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.802 2.041 . . . . 11.699999999999999 114.976 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -110.41 4.92 21.04 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.822 -1.547 . . . . 12.949999999999999 106.822 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 t30 72.34 45.03 0.39 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.147 -2.22 . . . . 25.449999999999999 109.75 162.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.6 mt -94.59 119.89 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 128.11 3.814 . . . . 14.6 111.227 168.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -99.35 175.29 5.92 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.885 -4.259 . . . . 33.229999999999997 108.043 169.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -40.77 145.56 0.19 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.347 -3.346 . . . . 25.969999999999999 117.446 165.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 70.76 9.5 6.85 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.155 3.382 . . . . 32.609999999999999 116.759 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.8 m -78.11 145.58 35.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.398 3.079 . . . . 10.56 108.824 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.3 m -100.69 121.22 41.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.202 1.401 . . . . 5.3300000000000001 109.145 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.43 HD12 HD12 ' A' ' 43' ' ' LEU . 33.7 mt -104.8 149.36 25.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.317 -0.994 . . . . 11.66 108.317 164.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -99.86 108.42 20.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.577 2.351 . . . . 16.300000000000001 110.142 169.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tp -84.54 98.12 9.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.716 -1.865 . . . . 9.9600000000000009 109.347 171.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.459 HG12 HD13 ' A' ' 44' ' ' ILE . 27.3 m -101.2 156.18 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 119.332 -2.105 . . . . 9.7599999999999998 107.429 169.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 N--CA 1.43 -1.436 0 CA-C-O 125.741 2.686 . . . . 19.57 107.63 172.835 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.338 18.0 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 119.101 3.0 . . . . 17.170000000000002 119.101 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -102.04 128.72 48.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 119.314 -0.954 . . . . 21.890000000000001 112.414 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.321 31.1 pt -118.42 169.33 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.377 1.471 . . . . 10.83 112.649 171.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -132.88 131.6 41.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.46 -2.65 . . . . 10.609999999999999 111.953 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.4 t -106.01 114.5 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 103.822 -2.659 . . . . 9.1300000000000008 103.822 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -79.72 142.43 35.47 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.027 2.822 . . . . 20.550000000000001 109.548 167.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.276 17.0 p -93.67 -176.82 4.18 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.686 -2.509 . . . . 11.779999999999999 112.167 176.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.66 -25.92 24.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 120.472 1.487 . . . . 19.309999999999999 113.169 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -69.7 -55.45 9.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.02 2.343 . . . . 23.140000000000001 109.34 161.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.37 58.02 0.18 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.381 -1.45 . . . . 19.739999999999998 112.999 164.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU 0.254 42.1 pttt -101.83 149.33 24.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.47 1.108 . . . . 21.93 113.878 172.151 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.1 m -74.83 114.01 12.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.105 -2.872 . . . . 12.33 118.149 164.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.8 mt -96.52 123.62 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 122.104 0.954 . . . . 17.079999999999998 109.052 160.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.5 m -110.5 121.15 44.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 102.508 -3.145 . . . . 16.300000000000001 102.508 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.4 mt -115.07 146.49 41.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.742 -2.474 . . . . 15.880000000000001 113.074 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -113.35 103.74 11.61 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.701 2.801 . . . . 28.899999999999999 104.506 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.2 169.37 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 115.523 -2.179 . . . . 12.050000000000001 108.57 -167.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -114.75 158.71 39.73 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 128.491 2.717 . . . . 18.170000000000002 104.21 161.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -91.22 -4.83 4.25 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 115.615 -2.457 . . . . 8.1600000000000001 108.364 -167.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.287 33.1 m -72.67 -11.31 60.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.582 2.438 . . . . 11.130000000000001 117.582 164.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -84.22 159.57 20.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 121.451 1.932 . . . . 18.030000000000001 112.185 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.2 p -95.63 155.5 16.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.238 -2.164 . . . . 10.220000000000001 107.964 -169.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.24 -31.78 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 O-C-N 115.487 -4.508 . . . . 12.300000000000001 106.708 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -52.34 -38.89 59.82 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.652 -4.405 . . . . 36.509999999999998 112.051 166.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -75.41 -33.01 60.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.651 -2.53 . . . . 25.66 112.514 170.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -72.92 -41.43 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.133 -3.479 . . . . 8.1199999999999992 111.68 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.32 -23.47 65.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.876 2.917 . . . . 15.470000000000001 118.876 166.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.76 -32.2 65.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.603 1.547 . . . . 11.449999999999999 114.485 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.254 37.0 mttm -59.3 -40.41 86.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.034 1.734 . . . . 24.98 113.694 163.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.351 55.6 mt -54.27 -43.24 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.773 -3.08 . . . . 9.4600000000000009 116.629 165.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -66.78 -42.56 85.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.939 1.696 . . . . 14.76 107.031 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -61.53 -59.44 5.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.898 -1.752 . . . . 26.289999999999999 113.206 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -61.09 -72.27 0.12 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.806 2.842 . . . . 30.059999999999999 112.121 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.502 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 61.1 mm-40 -77.25 -44.26 30.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 113.473 0.916 . . . . 25.190000000000001 113.473 -172.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.92 43.0 2.71 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 129.61 3.481 . . . . 7.4100000000000001 116.96 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 mt -111.25 117.82 48.86 Favored Pre-proline 0 N--CA 1.43 -1.427 0 O-C-N 121.394 -1.062 . . . . 9.4900000000000002 111.195 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.66 160.2 31.49 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-O 124.828 1.928 . . . . 11.42 114.784 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -86.57 -2.23 8.36 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 114.827 -3.302 . . . . 12.0 111.152 -155.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -88.63 -1.63 58.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 124.428 3.286 . . . . 35.549999999999997 112.142 164.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -99.22 -31.07 11.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.334 2.716 . . . . 20.52 118.334 169.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -109.2 152.49 25.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.334 1.854 . . . . 7.1299999999999999 111.893 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -148.45 154.25 39.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.822 -1.547 . . . . 36.390000000000001 106.822 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.7 mt -119.3 148.95 42.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.251 -1.759 . . . . 9.5500000000000007 106.251 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -127.06 136.64 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 114.161 -1.381 . . . . 13.9 107.537 171.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -114.46 107.94 16.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.766 1.746 . . . . 6.8600000000000003 107.769 169.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.289 . . 61.89 -68.01 0.06 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.159 3.384 . . . . 11.15 111.155 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.53 -16.56 0.11 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 105.961 -2.856 . . . . 13.93 105.961 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -88.08 131.26 34.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 126.334 2.968 . . . . 23.920000000000002 115.349 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -88.6 120.86 30.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.422 -3.923 . . . . 23.23 108.483 -172.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.4 mt -82.72 145.02 29.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.051 2.241 . . . . 9.1099999999999994 117.051 -167.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -110.54 139.17 46.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.229 2.918 . . . . 33.439999999999998 106.388 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.22 -41.2 64.02 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.039 -1.891 . . . . 28.370000000000001 112.46 -159.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.11 31.74 4.94 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 121.476 1.944 . . . . 15.0 115.584 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -106.67 -175.33 2.76 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 128.043 2.849 . . . . 25.5 116.257 155.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.7 p -113.27 177.47 4.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.56 1.544 . . . . 11.949999999999999 111.311 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.84 -22.65 45.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.066 1.136 . . . . 10.17 114.066 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -74.93 -25.61 59.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.698 -3.126 . . . . 13.59 111.637 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -67.85 -53.77 24.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.092 -2.255 . . . . 11.699999999999999 114.481 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -81.56 -17.11 49.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 118.726 -0.654 . . . . 12.949999999999999 110.487 -174.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 0.3 OUTLIER 81.51 55.69 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.208 2.432 . . . . 25.449999999999999 106.214 -173.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -90.87 101.4 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 1 O-C-N 116.263 -4.023 . . . . 14.6 108.914 171.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.322 12.9 pt20 -90.99 176.0 6.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.247 0.967 . . . . 33.229999999999997 112.001 -171.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -70.69 148.08 48.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 120.944 3.683 . . . . 25.969999999999999 120.944 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.425 24.1 mt-10 51.59 32.64 9.34 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.107 2.861 . . . . 32.609999999999999 117.193 -171.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 166.55 10.39 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.365 1.866 . . . . 10.56 108.58 -174.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.0 m -115.99 132.66 56.59 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 112.625 -2.08 . . . . 5.3300000000000001 110.362 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.45 150.0 28.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 131.148 3.779 . . . . 11.66 107.315 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -105.54 114.75 29.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.771 -1.104 . . . . 16.300000000000001 111.246 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 tp -78.18 130.8 36.76 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.202 -2.811 . . . . 9.9600000000000009 108.732 169.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.3 167.45 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 112.703 -2.044 . . . . 9.7599999999999998 111.251 156.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 105.457 -2.053 . . . . 19.57 105.457 -175.973 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.289 0.8 OUTLIER . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 113.715 1.006 . . . . 17.170000000000002 113.715 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -79.01 135.87 37.02 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.087 -4.758 . . . . 21.890000000000001 113.134 169.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -120.57 155.54 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.845 -2.409 . . . . 10.83 104.746 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -107.96 123.79 49.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.728 1.611 . . . . 10.609999999999999 114.594 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.6 t -109.37 114.9 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 126.087 2.117 . . . . 9.1300000000000008 111.554 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -101.18 122.61 43.93 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.379 -2.075 . . . . 20.550000000000001 111.38 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -79.08 168.95 18.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.389 2.276 . . . . 11.779999999999999 114.016 -175.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.43 -16.35 57.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 118.866 2.913 . . . . 19.309999999999999 118.866 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 p -76.71 -50.68 13.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.647 -1.615 . . . . 23.140000000000001 112.393 166.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.94 39.87 0.19 Allowed Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 125.259 2.589 . . . . 19.739999999999998 118.911 162.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -99.27 124.85 44.68 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.692 2.397 . . . . 21.93 112.642 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.277 7.1 m -82.85 97.7 8.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.065 -2.272 . . . . 12.33 110.553 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.7 mt -72.89 123.18 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 106.527 -1.657 . . . . 17.079999999999998 106.527 170.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 p -101.21 110.66 22.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.228 2.211 . . . . 16.300000000000001 111.427 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.4 mt -118.51 143.82 46.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.697 -1.877 . . . . 15.880000000000001 106.913 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -109.85 121.61 45.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.859 2.464 . . . . 28.899999999999999 106.891 170.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.94 172.73 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.141 0.972 . . . . 12.050000000000001 111.331 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -111.5 160.57 28.9 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 118.727 -2.483 . . . . 18.170000000000002 113.27 171.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -86.46 3.31 6.88 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 CA-C-N 125.996 3.177 . . . . 8.1600000000000001 116.611 -162.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 m -92.98 4.65 53.61 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.274 2.23 . . . . 11.130000000000001 109.689 167.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -70.46 131.42 44.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.363 2.801 . . . . 18.030000000000001 117.262 161.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.1 p -74.3 158.94 33.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.358 -3.339 . . . . 10.220000000000001 114.542 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -57.2 -28.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 112.178 0.436 . . . . 12.300000000000001 112.178 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -55.93 -46.26 78.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.83 2.728 . . . . 36.509999999999998 111.424 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -63.95 -45.22 90.13 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.307 -2.745 . . . . 25.66 112.399 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.4 t -57.63 -44.91 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.038 -1.664 . . . . 8.1199999999999992 114.426 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -60.11 -32.29 70.85 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 119.246 3.054 . . . . 15.470000000000001 119.246 165.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.42 82.55 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.05 -4.156 . . . . 11.449999999999999 114.661 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -66.03 -21.54 66.39 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 120.02 3.341 . . . . 24.98 120.02 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -74.72 -41.61 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 120.235 -1.541 . . . . 9.4600000000000009 112.252 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -52.91 -59.64 4.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.605 1.962 . . . . 14.76 114.405 167.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -42.7 -44.73 4.44 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 119.301 3.075 . . . . 26.289999999999999 119.301 161.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -76.78 -49.12 16.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.866 -1.771 . . . . 30.059999999999999 110.374 -173.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -114.01 -17.61 11.92 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 115.9 1.815 . . . . 25.190000000000001 115.9 -160.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.29 29.38 19.84 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 124.726 1.155 . . . . 7.4100000000000001 115.016 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.7 mt -110.86 115.92 52.65 Favored Pre-proline 0 N--CA 1.43 -1.443 0 C-N-CA 129.067 2.947 . . . . 9.4900000000000002 109.603 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.7 Cg_exo -62.53 141.68 87.26 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 N-CA-C 121.672 3.682 . . . . 11.42 121.672 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.1 Cg_exo -74.95 -5.11 16.38 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 127.306 3.645 . . . . 12.0 116.89 -162.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -96.99 -21.06 17.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.016 -2.302 . . . . 35.549999999999997 109.762 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -69.75 -41.58 75.04 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 127.127 2.767 . . . . 20.52 110.873 168.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -60.57 141.71 56.3 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 114.976 1.473 . . . . 7.1299999999999999 114.976 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -132.42 151.65 51.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.375 -2.824 . . . . 36.390000000000001 103.375 150.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.1 mt -110.96 141.92 43.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 111.503 -2.59 . . . . 9.5500000000000007 111.407 166.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 mt -109.53 142.87 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 126.577 1.951 . . . . 13.9 109.194 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -131.5 129.68 41.41 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 123.503 2.865 . . . . 6.8600000000000003 111.762 157.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.12 44.38 5.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.351 -2.093 . . . . 11.15 109.118 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.81 -30.46 4.62 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 130.49 3.9 . . . . 13.93 114.372 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -94.9 132.73 39.4 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.421 2.058 . . . . 23.920000000000002 112.522 -167.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -76.29 137.72 40.08 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.896 -3.002 . . . . 23.23 109.262 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.9 mt -94.42 133.76 37.66 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.022 -2.298 . . . . 9.1099999999999994 112.658 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.95 173.59 8.14 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 124.9 3.5 . . . . 33.439999999999998 111.254 170.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.77 -51.87 10.59 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 124.947 1.404 . . . . 28.370000000000001 113.099 -159.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.72 -28.76 73.75 Favored Glycine 0 N--CA 1.43 -1.75 1 O-C-N 131.946 5.779 . . . . 15.0 120.041 -162.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.0 mtt180 -105.66 169.96 8.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 121.421 2.61 . . . . 25.5 111.329 -163.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -83.69 169.73 14.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.634 2.635 . . . . 11.949999999999999 114.865 -174.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.2 mt -73.24 -34.03 65.64 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.026 -1.671 . . . . 10.17 110.857 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 t -57.74 -40.02 78.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.472 2.027 . . . . 13.59 116.472 163.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -64.27 -49.89 70.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.518 1.673 . . . . 11.699999999999999 115.518 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -57.71 -41.18 81.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.557 1.543 . . . . 12.949999999999999 111.194 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 81.96 60.5 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.46 3.504 . . . . 25.449999999999999 111.41 -172.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.5 mt -103.0 103.74 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 128.823 2.849 . . . . 14.6 108.878 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -84.88 -179.36 7.07 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.587 2.137 . . . . 33.229999999999997 112.075 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -65.39 158.19 27.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.863 -3.648 . . . . 25.969999999999999 117.05 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 36.9 mt-10 55.19 27.51 9.75 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 129.473 3.109 . . . . 32.609999999999999 114.622 176.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.335 21.8 m -83.22 157.08 22.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 125.427 1.705 . . . . 10.56 114.516 164.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -110.67 95.3 5.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.702 -1.874 . . . . 5.3300000000000001 113.427 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.17 141.61 35.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.425 1.89 . . . . 11.66 112.316 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -116.4 114.02 23.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.505 -1.372 . . . . 16.300000000000001 114.192 -167.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -86.86 115.69 24.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.166 1.913 . . . . 9.9600000000000009 116.166 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.297 12.3 m -107.92 156.36 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 129.786 3.234 . . . . 9.7599999999999998 107.386 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 127.729 3.633 . . . . 19.57 106.821 -179.186 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 124.375 2.036 . . . . 17.170000000000002 110.69 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -94.03 135.97 34.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.198 -2.519 . . . . 21.890000000000001 104.198 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.2 pt -125.31 135.0 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 116.23 -1.843 . . . . 10.83 108.168 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.1 133.29 34.02 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.528 2.047 . . . . 10.609999999999999 116.528 166.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 t -126.9 109.14 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.55 -0.907 . . . . 9.1300000000000008 108.55 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -89.81 133.58 34.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.768 2.427 . . . . 20.550000000000001 113.644 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.6 p -89.54 -167.59 1.9 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.596 -1.184 . . . . 11.779999999999999 108.142 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mt -70.47 -66.49 0.59 Allowed 'General case' 0 N--CA 1.43 -1.435 1 C-N-CA 135.113 5.365 . . . . 19.309999999999999 114.845 166.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -63.74 -81.96 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.563 -2.585 . . . . 23.140000000000001 117.265 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.94 46.86 0.29 Allowed Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 117.908 -1.495 . . . . 19.739999999999998 110.798 -166.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -140.46 147.62 39.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 118.906 1.353 . . . . 21.93 110.758 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.4 m -129.51 137.03 50.57 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.203 2.43 . . . . 12.33 107.308 166.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.3 mt -105.62 121.7 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 118.821 -2.425 . . . . 17.079999999999998 106.009 -175.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.7 m -90.33 120.74 31.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 116.454 -1.736 . . . . 16.300000000000001 109.451 172.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.17 134.33 55.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.357 -1.782 . . . . 15.880000000000001 109.839 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -88.44 132.03 34.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 114.938 -2.458 . . . . 28.899999999999999 107.379 163.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.27 173.32 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 C-N-CA 133.288 4.635 . . . . 12.050000000000001 110.702 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -123.53 143.53 41.78 Favored Pre-proline 0 N--CA 1.43 -1.429 1 O-C-N 116.082 -4.136 . . . . 18.170000000000002 110.694 174.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -63.71 -28.66 68.75 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 123.761 2.379 . . . . 8.1600000000000001 117.558 -159.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.2 p -87.34 4.83 41.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 125.836 1.96 . . . . 11.130000000000001 110.489 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -72.88 151.81 41.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.856 3.025 . . . . 18.030000000000001 110.079 170.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -82.93 158.18 22.72 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 111.706 -2.497 . . . . 10.220000000000001 111.009 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.6 -29.02 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 O-C-N 121.07 -1.019 . . . . 12.300000000000001 110.641 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -48.99 -39.57 27.2 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.137 4.175 . . . . 36.509999999999998 116.834 158.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -89.32 -16.99 29.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.402 -3.936 . . . . 25.66 109.996 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -78.36 -35.28 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 O-C-N 115.51 -4.494 . . . . 8.1199999999999992 105.521 173.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -69.23 -29.58 67.54 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.675 2.655 . . . . 15.470000000000001 112.47 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.13 -34.19 69.98 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.012 -3.555 . . . . 11.449999999999999 114.932 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -84.17 -19.41 34.15 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.482 -2.145 . . . . 24.98 115.102 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mt -80.11 -35.02 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 116.048 -4.157 . . . . 9.4600000000000009 112.86 167.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.278 0.8 OUTLIER -54.11 -52.52 60.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.944 -2.348 . . . . 14.76 113.039 161.093 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -71.99 -27.17 62.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.835 2.107 . . . . 26.289999999999999 114.977 -174.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG3' ' HG2' ' A' ' 34' ' ' GLU . 49.8 tptt -74.4 -57.74 3.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.65 -3.156 . . . . 30.059999999999999 111.431 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 33' ' ' LYS 0.303 33.6 mm-40 -112.4 -29.08 7.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.676 -1.89 . . . . 25.190000000000001 110.926 -168.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.01 28.19 42.49 Favored Glycine 0 N--CA 1.429 -1.771 0 O-C-N 118.035 -2.916 . . . . 7.4100000000000001 117.314 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -80.37 119.51 76.62 Favored Pre-proline 0 N--CA 1.43 -1.47 0 CA-C-O 115.318 -2.277 . . . . 9.4900000000000002 110.718 162.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -65.1 156.71 61.29 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 122.44 1.907 . . . . 11.42 114.003 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -11.96 33.74 Favored 'Trans proline' 0 N--CA 1.434 -2.021 1 C-N-CA 125.844 4.362 . . . . 12.0 120.671 -174.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -77.54 -38.22 49.17 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 125.206 2.431 . . . . 35.549999999999997 116.233 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -61.74 -32.31 72.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.141 2.645 . . . . 20.52 118.141 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -70.95 123.27 21.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.716 2.006 . . . . 7.1299999999999999 115.118 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -132.38 117.09 17.66 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.241 1.837 . . . . 36.390000000000001 109.738 165.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.74 115.89 27.43 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.006 1.322 . . . . 9.5500000000000007 111.988 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.6 mm -96.42 136.01 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 118.25 -0.881 . . . . 13.9 109.209 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -115.4 117.19 29.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.565 2.439 . . . . 6.8600000000000003 104.844 162.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.91 -93.08 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.075 2.95 . . . . 11.15 108.142 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.48 4.54 7.15 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 126.564 2.031 . . . . 13.93 109.051 171.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.39 144.1 31.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 121.653 2.727 . . . . 23.920000000000002 113.969 -171.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -69.46 137.99 53.09 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.399 2.37 . . . . 23.23 117.399 171.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -106.74 118.28 36.26 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.306 -3.996 . . . . 9.1099999999999994 108.62 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -85.41 151.04 24.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.017 1.865 . . . . 33.439999999999998 113.279 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.01 -49.12 72.33 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 118.038 2.607 . . . . 28.370000000000001 118.038 -170.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.75 77.54 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 119.792 2.677 . . . . 15.0 119.792 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 36.0 mmt180 -76.33 170.56 16.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.75 -3.206 . . . . 25.5 113.104 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.252 69.8 p -100.0 167.36 10.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.678 2.18 . . . . 11.949999999999999 113.174 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mt -54.45 -45.87 73.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.338 2.255 . . . . 10.17 111.909 164.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -76.24 -22.18 55.48 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.841 -1.527 . . . . 13.59 112.689 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -67.43 -48.3 67.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.933 2.093 . . . . 11.699999999999999 109.152 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 55.5 m-85 -85.08 4.7 32.87 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.995 2.591 . . . . 12.949999999999999 117.995 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.9 m120 65.96 45.61 2.42 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.458 2.303 . . . . 25.449999999999999 110.079 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.2 mt -98.18 108.62 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 127.034 2.134 . . . . 14.6 107.91 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -107.93 -172.87 2.15 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.923 2.297 . . . . 33.229999999999997 106.619 -168.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -73.84 134.5 43.32 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.418 -5.176 . . . . 25.969999999999999 109.895 -173.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.326 88.8 mt-10 68.96 30.22 4.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.522 3.014 . . . . 32.609999999999999 113.536 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -56.31 149.05 17.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 122.172 2.26 . . . . 10.56 110.56 167.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.0 m -106.71 110.94 23.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.536 2.397 . . . . 5.3300000000000001 104.794 159.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.8 mt -99.53 145.29 27.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.325 -2.734 . . . . 11.66 107.886 170.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -104.61 116.78 32.66 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.351 -1.468 . . . . 16.300000000000001 110.509 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.4 tp -95.62 115.26 27.17 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.497 1.498 . . . . 9.9600000000000009 107.8 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.5 m -109.04 143.92 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.761 1.743 . . . . 9.7599999999999998 109.278 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.9 mt . . . . . 0 N--CA 1.429 -1.489 0 CA-C-N 113.699 -1.591 . . . . 19.57 114.701 -168.293 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptt? . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 120.436 0.16 . . . . 17.170000000000002 111.175 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -94.04 131.32 39.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.766 1.765 . . . . 21.890000000000001 115.766 170.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -103.13 152.55 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 103.741 -2.688 . . . . 10.83 103.741 163.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -101.82 146.82 27.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.861 2.743 . . . . 10.609999999999999 110.239 162.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.15 113.67 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 110.121 -3.218 . . . . 9.1300000000000008 104.489 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.272 9.2 ttmt -107.12 127.32 53.39 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.472 -3.268 . . . . 20.550000000000001 110.852 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -95.97 170.38 9.33 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.93 -2.981 . . . . 11.779999999999999 109.736 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -68.27 -31.83 71.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.447 2.017 . . . . 19.309999999999999 116.447 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -53.62 -64.63 0.76 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.704 -3.123 . . . . 23.140000000000001 111.823 166.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.87 76.1 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 106.57 -2.612 . . . . 19.739999999999998 106.57 170.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -140.74 153.89 46.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 113.351 -3.339 . . . . 21.93 104.036 163.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -108.75 87.79 2.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.048 2.718 . . . . 12.33 109.811 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.22 124.11 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 124.208 1.956 . . . . 17.079999999999998 112.305 168.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.5 m -99.71 111.1 23.47 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.019 -2.355 . . . . 16.300000000000001 111.826 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.19 133.86 51.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.186 -2.34 . . . . 15.880000000000001 110.239 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -96.1 106.68 18.89 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 116.667 -1.635 . . . . 28.899999999999999 110.727 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.48 158.82 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 128.187 3.429 . . . . 12.050000000000001 107.063 -174.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -108.94 157.85 35.79 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 107.139 -1.43 . . . . 18.170000000000002 107.139 173.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HA ' HD11 ' A' ' 56' ' ' LEU . 94.3 Cg_endo -77.82 -8.86 16.93 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 O-C-N 116.008 -2.68 . . . . 8.1600000000000001 114.239 -168.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.4 p -82.81 1.75 37.56 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 118.432 2.752 . . . . 11.130000000000001 118.432 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -83.52 156.88 22.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.726 -3.109 . . . . 18.030000000000001 111.116 169.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -93.83 164.23 13.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.471 -3.893 . . . . 10.220000000000001 115.048 -174.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.67 -39.09 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 119.782 -1.824 . . . . 12.300000000000001 109.917 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.39 -43.78 23.73 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.214 2.672 . . . . 36.509999999999998 118.214 165.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -67.08 -43.19 83.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.628 2.085 . . . . 25.66 116.628 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -53.24 -52.99 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.029 1.732 . . . . 8.1199999999999992 110.469 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -70.79 -19.99 62.64 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.81 -3.681 . . . . 15.470000000000001 116.832 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.08 65.69 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.872 -4.267 . . . . 11.449999999999999 115.056 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -84.51 -28.02 27.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.033 2.933 . . . . 24.98 114.513 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.7 mt -72.89 -44.91 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.168 -1.378 . . . . 9.4600000000000009 111.229 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -52.14 -50.13 62.35 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.862 2.912 . . . . 14.76 118.862 165.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -49.59 -48.47 48.73 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.974 1.842 . . . . 26.289999999999999 115.974 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -78.67 -71.76 0.42 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.088 3.328 . . . . 30.059999999999999 115.488 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -74.15 -35.26 64.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.513 -3.867 . . . . 25.190000000000001 116.799 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.47 42.73 7.72 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 127.676 3.931 . . . . 7.4100000000000001 113.433 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.4 mt -104.44 137.72 19.31 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 102.822 -3.029 . . . . 9.4900000000000002 102.822 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -82.48 146.78 13.83 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 CA-C-N 124.813 2.755 . . . . 11.42 108.821 -174.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -70.78 -3.37 12.55 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 124.265 2.559 . . . . 12.0 115.806 -162.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.42 -22.15 19.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.769 -2.457 . . . . 35.549999999999997 110.667 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -80.16 -25.86 39.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.456 3.102 . . . . 20.52 109.794 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -71.7 121.73 19.37 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.786 2.034 . . . . 7.1299999999999999 112.071 170.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -123.1 116.7 23.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.953 1.835 . . . . 36.390000000000001 111.268 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.1 tp -102.61 116.41 32.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.953 -1.476 . . . . 9.5500000000000007 111.976 -166.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mm -103.79 117.17 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 125.92 1.688 . . . . 13.9 109.022 -172.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -97.03 114.44 26.07 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 120.919 1.69 . . . . 6.8600000000000003 108.93 161.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.89 -98.09 0.06 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 123.892 0.877 . . . . 11.15 111.397 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.85 12.06 8.25 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 127.321 2.391 . . . . 13.93 113.863 166.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -102.19 126.05 49.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.561 -3.905 . . . . 23.920000000000002 105.837 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -85.43 126.81 34.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 125.157 1.535 . . . . 23.23 108.059 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.8 mt -90.14 144.86 25.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.44 2.543 . . . . 9.1099999999999994 116.003 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -100.91 146.76 26.94 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.666 -4.396 . . . . 33.439999999999998 110.077 -168.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -45.17 -54.45 6.87 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 129.114 2.965 . . . . 28.370000000000001 118.373 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.54 24.56 8.34 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 129.324 3.345 . . . . 15.0 114.593 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -115.63 171.75 7.55 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.849 -1.537 . . . . 25.5 106.849 172.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.8 p -104.86 -177.45 3.37 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.311 -0.859 . . . . 11.949999999999999 112.195 172.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 19' ' ' PRO . 45.8 mt -80.31 -28.01 38.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.309 -1.769 . . . . 10.17 110.541 169.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -65.95 -43.18 88.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.72 -3.113 . . . . 13.59 116.437 170.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.298 10.8 m-20 -49.75 -39.84 38.98 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.241 2.682 . . . . 11.699999999999999 118.241 165.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -94.29 -18.72 21.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.549 -2.594 . . . . 12.949999999999999 116.88 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 73.57 54.52 0.11 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.418 2.949 . . . . 25.449999999999999 110.104 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mt -93.83 120.7 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 113.73 -1.577 . . . . 14.6 109.487 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -89.48 168.76 11.94 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.992 1.853 . . . . 33.229999999999997 108.406 -167.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -64.12 153.95 36.11 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.815 -3.678 . . . . 25.969999999999999 109.764 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 41.23 35.11 0.37 Allowed 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 113.808 -5.557 . . . . 32.609999999999999 118.621 -169.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -91.88 129.24 37.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.572 -3.205 . . . . 10.56 108.341 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -87.77 122.54 31.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.832 1.049 . . . . 5.3300000000000001 113.832 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.341 1.5 mt -101.63 149.8 23.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.086 -2.259 . . . . 11.66 110.255 170.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -98.22 130.93 44.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.491 -1.38 . . . . 16.300000000000001 107.539 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.5 tp -114.46 115.58 27.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.47 -2.789 . . . . 9.9600000000000009 103.47 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.11 164.98 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.518 -2.03 . . . . 9.7599999999999998 105.518 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.6 mt . . . . . 0 N--CA 1.431 -1.415 0 CA-C-O 123.941 1.829 . . . . 19.57 109.787 177.855 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 108.957 -0.757 . . . . 17.170000000000002 108.957 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -103.34 144.7 31.01 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 116.223 -4.048 . . . . 21.890000000000001 111.849 -176.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.83 160.69 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 109.095 -3.684 . . . . 10.83 107.901 164.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -125.19 112.56 16.59 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.088 2.743 . . . . 10.609999999999999 105.558 -166.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 67' ' ' LEU . 48.2 t -104.94 125.42 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.817 -1.179 . . . . 9.1300000000000008 107.817 -174.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -121.3 127.18 51.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.419 2.372 . . . . 20.550000000000001 111.621 -167.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -70.67 169.86 13.52 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 112.642 -2.072 . . . . 11.779999999999999 111.047 168.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.3 mt -81.59 -12.69 58.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.921 -2.987 . . . . 19.309999999999999 112.55 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -91.27 -37.32 13.37 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 124.199 1.952 . . . . 23.140000000000001 110.431 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.39 38.05 0.35 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 116.53 -2.261 . . . . 19.739999999999998 111.871 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 60.3 tttm -98.99 138.74 35.66 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.741 -2.688 . . . . 21.93 103.741 172.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.1 m -114.97 122.81 47.41 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.603 -1.31 . . . . 12.33 108.572 -172.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -101.47 128.76 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 101.721 -3.437 . . . . 17.079999999999998 101.721 -170.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.6 m -112.59 112.76 24.51 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.461 2.076 . . . . 16.300000000000001 111.999 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.264 73.0 mt -116.25 158.91 22.61 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 111.839 -2.437 . . . . 15.880000000000001 112.685 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -113.39 117.52 31.99 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.77 -2.678 . . . . 28.899999999999999 103.77 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.23 154.87 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 115.447 -0.797 . . . . 12.050000000000001 108.874 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -94.66 147.46 33.23 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 117.517 -1.23 . . . . 18.170000000000002 109.173 170.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -66.15 -8.66 20.9 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 127.629 3.76 . . . . 8.1600000000000001 118.994 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -100.18 12.5 36.85 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 129.642 4.339 . . . . 11.130000000000001 120.847 164.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.55 163.99 26.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.141 -1.424 . . . . 18.030000000000001 111.47 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.0 p -104.25 164.45 11.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.624 2.083 . . . . 10.220000000000001 116.624 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.1 mm -63.57 -36.09 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.943 2.497 . . . . 12.300000000000001 111.814 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -53.52 -45.08 69.62 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.48 1.659 . . . . 36.509999999999998 115.48 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.17 -41.52 94.58 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.822 2.849 . . . . 25.66 114.729 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.56 -52.99 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 118.682 -2.511 . . . . 8.1199999999999992 105.635 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -58.69 -35.37 72.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.579 2.609 . . . . 15.470000000000001 116.014 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.28 94.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.776 -1.827 . . . . 11.449999999999999 114.447 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -74.28 -26.59 60.29 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 115.637 -2.125 . . . . 24.98 108.775 -174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.9 mt -66.92 -29.75 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 124.895 2.283 . . . . 9.4600000000000009 110.599 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -66.91 -48.3 69.13 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.96 -4.212 . . . . 14.76 114.463 175.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -62.36 -48.39 79.99 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.397 1.999 . . . . 26.289999999999999 116.397 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -69.95 -67.15 0.51 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.445 2.069 . . . . 30.059999999999999 109.707 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 65.9 mm-40 -84.04 -22.12 31.38 Favored 'General case' 0 N--CA 1.43 -1.425 1 O-C-N 115.838 -4.289 . . . . 25.190000000000001 118.75 -165.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.08 27.9 14.92 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 126.106 1.813 . . . . 7.4100000000000001 111.874 171.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -104.82 125.06 34.82 Favored Pre-proline 0 N--CA 1.43 -1.45 0 C-N-CA 125.908 1.683 . . . . 9.4900000000000002 109.35 -173.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.65 146.33 30.31 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 122.91 2.075 . . . . 11.42 114.748 -176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.98 -7.27 12.24 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 124.908 2.788 . . . . 12.0 111.269 -162.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.74 -19.04 64.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.024 2.93 . . . . 35.549999999999997 114.166 169.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -104.91 -10.32 17.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.558 2.743 . . . . 20.52 109.102 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -94.65 137.12 34.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.468 -2.02 . . . . 7.1299999999999999 106.068 -173.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -121.81 140.98 51.69 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.704 -1.591 . . . . 36.390000000000001 106.704 162.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.26 136.64 54.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.922 -1.111 . . . . 9.5500000000000007 108.004 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 26.8 mm -118.34 129.46 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.058 2.143 . . . . 13.9 110.904 -173.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -128.46 117.23 20.98 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.835 -3.666 . . . . 6.8600000000000003 108.328 169.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.34 . . 58.37 -91.56 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.416 1.887 . . . . 11.15 114.338 -166.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.18 26.08 2.33 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.256 -2.153 . . . . 13.93 112.309 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -115.12 155.33 27.29 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.119 2.568 . . . . 23.920000000000002 104.177 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -114.14 137.09 52.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.145 -2.847 . . . . 23.23 106.163 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' A' ' 59' ' ' TYR . 30.1 mt -81.77 154.26 26.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.848 2.166 . . . . 9.1099999999999994 116.848 -167.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -102.11 157.31 16.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.994 2.33 . . . . 33.439999999999998 111.541 172.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -76.75 -52.34 9.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 118.789 2.885 . . . . 28.370000000000001 118.789 -161.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.82 24.49 5.15 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 116.908 -2.568 . . . . 15.0 118.384 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -90.23 167.29 12.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.952 2.876 . . . . 25.5 111.125 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.1 p -90.24 166.85 13.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.694 -2.504 . . . . 11.949999999999999 116.083 171.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -54.15 -31.94 53.95 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.658 -1.901 . . . . 10.17 114.346 158.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -74.72 -42.08 58.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.006 -1.077 . . . . 13.59 109.619 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -47.95 -34.37 9.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 114.979 -2.438 . . . . 11.699999999999999 115.03 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CD2' HD21 ' A' ' 50' ' ' LEU . 93.3 m-85 -104.89 -0.87 26.64 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 121.96 2.164 . . . . 12.949999999999999 107.273 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.5 m120 71.6 46.25 0.41 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.738 2.815 . . . . 25.449999999999999 105.579 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mt -82.6 106.67 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 O-C-N 117.998 -2.939 . . . . 14.6 108.792 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -96.07 -175.11 3.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.148 1.53 . . . . 33.229999999999997 111.02 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -65.76 141.91 58.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 124.674 3.397 . . . . 25.969999999999999 112.851 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.362 15.3 tt0 80.19 21.08 0.52 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.202 2.601 . . . . 32.609999999999999 113.993 174.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.6 m -80.69 144.76 32.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.243 3.417 . . . . 10.56 113.243 -174.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -98.78 101.97 13.55 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.212 2.605 . . . . 5.3300000000000001 115.009 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.43 ' HB2' HG21 ' A' ' 5' ' ' VAL . 8.6 mp -99.94 130.8 46.15 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.119 -3.488 . . . . 11.66 109.233 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 44' ' ' ILE 0.261 17.2 m-70 -101.01 142.91 31.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.786 -2.446 . . . . 16.300000000000001 108.755 -175.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 tp -119.86 101.86 8.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.522 -0.763 . . . . 9.9600000000000009 109.929 -171.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.0 t -96.2 119.0 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 126.493 3.044 . . . . 9.7599999999999998 108.387 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.43 -1.472 0 O-C-N 119.036 -2.29 . . . . 19.57 105.551 176.973 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 122.937 1.351 . . . . 17.170000000000002 112.899 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -94.25 145.93 24.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 127.646 3.593 . . . . 21.890000000000001 108.254 177.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -130.88 167.5 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 103.777 -2.675 . . . . 10.83 103.777 172.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -126.81 137.18 53.16 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 102.841 -3.022 . . . . 10.609999999999999 102.841 -174.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 69' ' ' LEU . 2.7 t -106.75 135.44 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.2 -1.778 . . . . 9.1300000000000008 106.2 171.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -135.38 135.46 40.69 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.486 2.403 . . . . 20.550000000000001 112.769 173.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.2 p -77.87 173.07 12.53 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 113.601 -1.636 . . . . 11.779999999999999 113.573 173.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.73 -28.23 62.52 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.124 -2.86 . . . . 19.309999999999999 112.524 -172.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.6 p -75.11 -36.5 61.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.357 -3.339 . . . . 23.140000000000001 109.953 166.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.12 42.25 0.37 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 120.972 3.149 . . . . 19.739999999999998 120.972 170.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 57.5 tttm -88.98 115.51 26.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.844 1.794 . . . . 21.93 115.844 176.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 m -92.18 114.24 26.73 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.162 2.585 . . . . 12.33 108.343 -165.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.0 mt -105.07 102.83 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 106.343 -1.725 . . . . 17.079999999999998 106.343 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -87.42 115.52 24.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 116.062 1.875 . . . . 16.300000000000001 116.062 175.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.7 mt -123.95 151.44 43.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.246 -1.835 . . . . 15.880000000000001 115.396 -174.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.5 138.55 31.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.388 1.055 . . . . 28.899999999999999 109.651 176.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.305 0.1 OUTLIER -144.84 161.43 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.85 -1.907 . . . . 12.050000000000001 105.85 170.235 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -103.23 165.84 12.88 Favored Pre-proline 0 N--CA 1.429 -1.477 0 CA-C-O 115.685 -2.103 . . . . 18.170000000000002 106.721 164.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.39 -9.64 14.94 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 124.829 2.76 . . . . 8.1600000000000001 115.342 -178.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 p -84.13 -19.02 34.91 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 129.766 4.416 . . . . 11.130000000000001 109.263 169.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -61.17 149.84 36.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 118.44 -1.304 . . . . 18.030000000000001 114.395 167.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.292 35.5 p -78.17 174.8 10.79 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.068 -3.52 . . . . 10.220000000000001 116.06 171.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mt -93.59 -17.42 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 117.224 -3.423 . . . . 12.300000000000001 107.743 -176.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -72.46 -40.57 66.89 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 131.751 4.02 . . . . 36.509999999999998 107.298 172.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -51.41 -49.82 60.86 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 130.969 3.708 . . . . 25.66 112.457 169.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.18 -52.25 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 124.371 1.044 . . . . 8.1199999999999992 113.075 173.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.73 -29.55 70.08 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 126.45 1.9 . . . . 15.470000000000001 111.066 -178.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.77 -27.24 62.82 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 115.221 -2.591 . . . . 11.449999999999999 116.56 175.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -72.41 -18.65 61.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.531 1.678 . . . . 24.98 115.531 168.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.3 mt -75.38 -27.96 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 112.494 0.553 . . . . 9.4600000000000009 112.494 170.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.341 18.1 tt0 -52.31 -42.85 64.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.314 1.968 . . . . 14.76 116.314 160.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -78.11 -49.01 14.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.551 1.54 . . . . 26.289999999999999 110.116 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -79.63 -58.8 3.01 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.917 2.932 . . . . 30.059999999999999 118.917 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS 0.313 6.6 mm-40 -74.53 -44.05 52.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 113.478 0.918 . . . . 25.190000000000001 113.478 -177.555 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.76 53.96 3.05 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 128.369 2.89 . . . . 7.4100000000000001 107.372 -171.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -118.18 120.1 32.68 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 102.384 -3.191 . . . . 9.4900000000000002 102.384 174.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -72.85 154.48 53.62 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 CA-C-N 122.825 2.045 . . . . 11.42 114.094 176.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -62.48 -16.47 52.27 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 N-CA-C 118.666 2.525 . . . . 12.0 118.666 -173.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -76.24 -31.32 58.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 117.607 -1.187 . . . . 35.549999999999997 111.948 -174.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -78.4 -18.07 55.53 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 127.4 2.937 . . . . 20.52 114.447 170.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -82.02 122.57 27.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.919 -1.738 . . . . 7.1299999999999999 114.577 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -111.29 120.8 43.46 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.412 -2.44 . . . . 36.390000000000001 104.412 166.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.7 mt -96.32 106.96 19.25 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.339 -2.1 . . . . 9.5500000000000007 112.26 164.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -89.53 145.28 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 O-C-N 125.619 1.825 . . . . 13.9 108.059 173.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -122.83 107.78 12.26 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.086 -1.82 . . . . 6.8600000000000003 106.086 170.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.0 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.4 3.48 . . . . 11.15 111.817 -160.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.74 1.08 9.33 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 116.629 -3.795 . . . . 13.93 114.937 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -102.45 126.88 49.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.717 -2.637 . . . . 23.920000000000002 113.349 177.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -72.59 125.3 27.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.205 1.821 . . . . 23.23 111.168 171.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 mt -81.92 166.3 20.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.54 1.064 . . . . 9.1099999999999994 110.479 -174.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -98.65 158.18 15.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.868 -1.77 . . . . 33.439999999999998 113.02 167.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.58 -56.25 6.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.286 2.234 . . . . 28.370000000000001 112.163 -174.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.45 13.93 31.93 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 118.272 -2.768 . . . . 15.0 118.852 -175.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -106.79 159.15 16.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.619 2.368 . . . . 25.5 107.401 172.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -103.37 170.89 7.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 111.385 -2.643 . . . . 11.949999999999999 112.874 -173.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -58.35 -43.14 88.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 126.18 2.175 . . . . 10.17 111.654 174.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -53.84 -35.2 61.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.686 2.794 . . . . 13.59 115.994 174.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 14.9 m-20 -80.91 -25.25 37.66 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 112.763 -3.494 . . . . 11.699999999999999 114.51 -171.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -95.8 -10.32 29.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 128.879 3.862 . . . . 12.949999999999999 110.538 171.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.2 m120 77.72 45.64 0.07 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.542 3.537 . . . . 25.449999999999999 113.583 173.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -74.56 140.23 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 127.788 2.435 . . . . 14.6 109.141 170.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -97.79 175.98 5.97 Favored 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 132.926 4.49 . . . . 33.229999999999997 108.759 178.321 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -68.35 156.11 38.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.094 1.887 . . . . 25.969999999999999 116.094 162.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 56.62 17.58 3.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.12 1.438 . . . . 32.609999999999999 114.1 -178.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -85.03 154.05 22.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.915 -2.991 . . . . 10.56 110.262 177.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -99.73 109.96 22.38 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 111.979 -2.373 . . . . 5.3300000000000001 114.517 -178.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -86.1 156.38 20.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 128.773 3.795 . . . . 11.66 110.111 171.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -112.07 140.57 46.64 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 116.915 -3.616 . . . . 16.300000000000001 109.014 178.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.561 ' HB2' HG13 ' A' ' 5' ' ' VAL . 48.8 tp -110.53 119.55 39.54 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.854 -1.975 . . . . 9.9600000000000009 110.484 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.45 135.18 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 101.855 -3.387 . . . . 9.7599999999999998 101.855 -178.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.429 -1.487 0 N-CA-C 104.555 -2.387 . . . . 19.57 104.555 -179.016 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 114.851 -2.5 . . . . 17.170000000000002 116.933 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -90.62 132.57 35.68 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.964 -1.493 . . . . 21.890000000000001 107.101 -179.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -119.64 153.28 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.938 -1.875 . . . . 10.83 105.938 162.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -115.18 135.22 54.42 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.409 -2.682 . . . . 10.609999999999999 110.628 177.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -100.8 123.78 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.369 -2.707 . . . . 9.1300000000000008 107.487 176.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -108.8 128.28 54.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.458 1.099 . . . . 20.550000000000001 108.117 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.3 p -81.17 173.76 12.22 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 117.603 2.446 . . . . 11.779999999999999 117.603 -177.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.6 mt -67.56 -27.46 66.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.42 -2.05 . . . . 19.309999999999999 114.772 166.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -74.08 -48.78 27.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.501 2.32 . . . . 23.140000000000001 114.907 175.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 68.06 0.32 Allowed Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.483 -1.447 . . . . 19.739999999999998 109.483 178.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -139.63 160.35 40.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.927 -1.511 . . . . 21.93 111.259 164.101 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -124.27 109.61 13.59 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.008 2.068 . . . . 12.33 112.54 -166.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mp -96.96 132.01 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.477 -2.416 . . . . 17.079999999999998 104.477 -173.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.302 31.6 m -88.53 96.11 10.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.232 0.958 . . . . 16.300000000000001 112.891 -178.031 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.39 119.64 39.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.839 -1.944 . . . . 15.880000000000001 110.55 -169.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.79 123.01 32.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.958 -2.339 . . . . 28.899999999999999 114.772 169.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.34 154.06 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.744 2.818 . . . . 12.050000000000001 115.088 -172.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -107.57 158.33 33.54 Favored Pre-proline 0 N--CA 1.43 -1.435 0 CA-C-O 115.771 -2.061 . . . . 18.170000000000002 112.063 173.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.51 -21.45 40.07 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 123.314 2.219 . . . . 8.1600000000000001 117.216 -175.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -67.88 -11.84 59.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.692 3.597 . . . . 11.130000000000001 114.291 172.033 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -79.61 133.6 36.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.683 2.793 . . . . 18.030000000000001 113.592 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.8 p -74.2 154.43 39.04 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.881 1.672 . . . . 10.220000000000001 110.019 168.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.439 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.3 mp -76.28 -9.24 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.528 -3.233 . . . . 12.300000000000001 114.778 174.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.01 -35.83 61.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 112.983 -3.389 . . . . 36.509999999999998 112.264 162.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -58.95 -42.28 89.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.17 2.414 . . . . 25.66 113.665 173.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -66.65 -34.38 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 113.472 -1.695 . . . . 8.1199999999999992 112.461 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 62.6 mttt -71.07 -30.5 66.65 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.971 2.319 . . . . 15.470000000000001 111.759 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.09 -25.94 63.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.472 2.309 . . . . 11.449999999999999 114.917 174.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -88.22 -29.84 20.16 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.633 2.159 . . . . 24.98 109.1 -176.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.6 mt -74.65 -37.31 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 118.502 -2.624 . . . . 9.4600000000000009 116.048 169.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -47.42 -38.33 13.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 119.436 3.125 . . . . 14.76 119.436 159.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.273 10.9 t70 -71.77 -53.73 12.45 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 114.816 -2.516 . . . . 26.289999999999999 107.137 -176.14 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -71.75 -57.7 4.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.447 2.299 . . . . 30.059999999999999 112.483 -172.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -92.83 -38.5 11.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.567 -0.901 . . . . 25.190000000000001 108.567 -166.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.26 37.54 5.34 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 120.619 3.008 . . . . 7.4100000000000001 120.619 -173.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -98.61 127.6 35.32 Favored Pre-proline 0 N--CA 1.429 -1.476 0 O-C-N 119.619 -2.106 . . . . 9.4900000000000002 108.594 171.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.13 139.21 54.81 Favored 'Trans proline' 0 C--N 1.3 -1.997 1 CA-C-O 110.134 -4.194 . . . . 11.42 110.816 175.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -82.5 -7.44 11.7 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 CA-C-N 127.836 3.834 . . . . 12.0 117.129 -161.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -67.36 -32.68 73.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.165 3.786 . . . . 35.549999999999997 113.412 169.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -68.7 -50.45 50.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 111.41 -2.632 . . . . 20.52 116.251 168.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -59.69 145.07 46.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 118.891 2.923 . . . . 7.1299999999999999 118.891 -168.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -123.65 120.95 34.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 124.434 3.288 . . . . 36.390000000000001 109.523 167.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.6 mt -103.97 121.45 43.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.633 -1.988 . . . . 9.5500000000000007 105.633 -178.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -118.13 129.26 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 102.436 -3.172 . . . . 13.9 102.436 -169.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -104.62 106.15 16.53 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.532 -3.855 . . . . 6.8600000000000003 106.77 170.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 72.5 -91.09 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 125.255 2.455 . . . . 11.15 116.748 -171.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.64 -19.24 4.18 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 111.716 -2.493 . . . . 13.93 111.966 168.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -88.67 121.42 31.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.181 -3.541 . . . . 23.920000000000002 111.375 -166.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -80.12 122.22 26.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.323 -3.986 . . . . 23.23 109.191 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.52 134.92 46.84 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 128.35 3.531 . . . . 9.1099999999999994 115.593 175.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -95.56 130.18 42.5 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.542 3.137 . . . . 33.439999999999998 111.583 -178.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.12 -42.41 69.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 110.944 -2.844 . . . . 28.370000000000001 111.703 -165.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.6 4.84 85.18 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 118.762 -2.461 . . . . 15.0 114.888 -176.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.27 95.0 mtt180 -95.0 163.65 13.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.005 2.402 . . . . 25.5 106.554 176.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.0 p -95.15 166.35 11.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.9 1.815 . . . . 11.949999999999999 115.9 168.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -64.18 -29.68 70.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.578 2.351 . . . . 10.17 111.835 168.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.251 8.5 t -67.73 -42.07 82.48 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.96 -4.213 . . . . 13.59 112.433 178.484 . . . . . . . . 3 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -58.16 -42.84 86.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 117.19 2.293 . . . . 11.699999999999999 117.19 174.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -82.69 4.92 23.03 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 116.485 2.031 . . . . 12.949999999999999 116.485 170.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 m120 48.16 55.03 9.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.456 -2.653 . . . . 25.449999999999999 113.744 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.83 111.35 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 125.349 1.655 . . . . 14.6 106.744 -177.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -81.33 166.4 20.51 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.502 1.521 . . . . 33.229999999999997 111.343 174.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -63.06 158.87 18.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.553 1.541 . . . . 25.969999999999999 114.378 -171.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.289 38.5 mt-10 58.86 24.66 12.68 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.575 2.131 . . . . 32.609999999999999 116.534 -177.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m -77.71 125.63 29.63 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.113 -1.617 . . . . 10.56 113.687 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.9 m -80.06 126.48 31.12 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.593 1.557 . . . . 5.3300000000000001 112.002 174.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.3 mt -103.69 150.2 24.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.569 1.148 . . . . 11.66 108.527 169.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -101.43 124.38 47.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.318 -1.734 . . . . 16.300000000000001 106.318 170.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.8 tp -96.86 128.09 43.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.282 -1.747 . . . . 9.9600000000000009 106.282 171.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.63 155.23 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.735 -2.32 . . . . 9.7599999999999998 104.735 168.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 43.5 mt . . . . . 0 N--CA 1.43 -1.462 0 O-C-N 121.027 -1.045 . . . . 19.57 109.418 175.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 122.88 1.324 . . . . 17.170000000000002 111.403 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.76 110.65 21.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.134 -1.604 . . . . 21.890000000000001 108.132 -175.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -84.81 145.96 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.195 -1.566 . . . . 10.83 110.841 153.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -123.15 89.21 3.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.489 -2.782 . . . . 10.609999999999999 103.489 -172.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 62.0 t -80.7 123.17 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.181 -1.414 . . . . 9.1300000000000008 107.181 179.309 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -114.21 119.26 36.43 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.497 3.522 . . . . 20.550000000000001 110.977 -172.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.7 p -77.91 161.56 27.48 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.082 -4.761 . . . . 11.779999999999999 113.004 -176.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.6 mt -78.83 -21.78 47.15 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 117.34 -1.744 . . . . 19.309999999999999 109.657 -175.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.0 p -70.55 -43.71 68.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.083 -2.886 . . . . 23.140000000000001 114.16 173.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.66 -2.26 0.21 Allowed Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 118.173 2.029 . . . . 19.739999999999998 118.173 178.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -91.49 145.49 24.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.756 -1.222 . . . . 21.93 110.955 -167.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.6 m -115.63 115.35 26.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.873 -2.269 . . . . 12.33 104.873 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.8 mt -96.52 105.51 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.735 2.414 . . . . 17.079999999999998 107.318 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -74.59 119.92 19.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.563 1.649 . . . . 16.300000000000001 110.655 169.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.322 97.8 mt -130.46 134.62 47.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.333 2.968 . . . . 15.880000000000001 103.922 168.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.361 2.2 mt-10 -84.86 107.65 17.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 127.511 3.529 . . . . 28.899999999999999 113.678 169.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -116.87 171.34 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.031 -2.293 . . . . 12.050000000000001 108.978 177.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -114.72 160.29 33.94 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 127.895 2.478 . . . . 18.170000000000002 108.03 176.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -68.3 -24.5 37.36 Favored 'Trans proline' 0 N--CA 1.434 -1.978 0 O-C-N 116.216 -2.57 . . . . 8.1600000000000001 112.726 -170.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.391 7.1 m -88.12 -2.52 58.65 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.917 -1.739 . . . . 11.130000000000001 114.686 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -72.96 158.14 36.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 128.328 3.918 . . . . 18.030000000000001 114.84 174.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.414 43.1 p -95.47 149.62 21.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.296 -2.229 . . . . 10.220000000000001 114.804 -176.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mp -66.06 -37.3 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.513 -1.291 . . . . 12.300000000000001 107.513 173.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -50.27 -45.46 54.31 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.296 -2.128 . . . . 36.509999999999998 113.906 169.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -84.63 7.21 21.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 123.766 2.984 . . . . 25.66 112.797 177.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.269 23.5 t -77.42 -60.04 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 O-C-N 116.746 -3.721 . . . . 8.1199999999999992 107.255 159.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -43.65 -40.66 4.26 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.968 2.581 . . . . 15.470000000000001 117.968 175.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.315 . . -50.05 -47.47 53.38 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 128.079 2.552 . . . . 11.449999999999999 116.697 171.301 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -76.99 -30.94 56.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.102 -2.249 . . . . 24.98 108.252 -175.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.84 -31.75 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 O-C-N 115.967 -4.208 . . . . 9.4600000000000009 112.86 174.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -69.01 -33.34 73.49 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.161 -1.587 . . . . 14.76 109.611 176.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -76.16 -51.92 11.17 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.728 1.611 . . . . 26.289999999999999 115.109 177.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -76.91 -42.34 39.92 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 119.669 3.211 . . . . 30.059999999999999 119.669 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 48.2 mm-40 -106.4 -25.6 11.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.391 1.682 . . . . 25.190000000000001 110.69 -178.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.4 18.82 51.74 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 120.305 2.882 . . . . 7.4100000000000001 120.305 175.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.2 mt -91.12 126.85 53.72 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 101.32 -3.585 . . . . 9.4900000000000002 101.32 -175.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -56.06 151.56 41.74 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 N-CA-C 120.639 3.284 . . . . 11.42 120.639 171.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -86.02 -22.22 2.36 Favored 'Trans proline' 0 C--N 1.3 -2.014 1 CA-C-N 130.077 4.635 . . . . 12.0 116.128 -161.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -84.12 -23.09 30.87 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.37 2.033 . . . . 35.549999999999997 110.821 -174.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -61.52 -28.15 69.11 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.201 2.6 . . . . 20.52 114.385 162.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -87.8 122.93 32.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 116.716 -1.612 . . . . 7.1299999999999999 112.34 -170.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -113.97 131.24 56.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 122.363 2.347 . . . . 36.390000000000001 112.181 166.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.53 122.25 39.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.207 -3.433 . . . . 9.5500000000000007 114.698 171.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.7 mt -106.95 118.58 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.88 -2.267 . . . . 13.9 104.88 172.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -106.04 121.81 44.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.603 1.668 . . . . 6.8600000000000003 107.978 167.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.318 . . 52.55 -99.2 0.08 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.098 1.888 . . . . 11.15 116.098 -174.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.26 -17.82 13.18 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 117.554 1.782 . . . . 13.93 117.554 -173.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -109.6 133.08 53.52 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.513 2.725 . . . . 23.920000000000002 111.236 -165.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -79.63 128.25 33.17 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.655 -1.278 . . . . 23.23 108.719 173.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 mt -95.05 126.52 40.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.782 2.083 . . . . 9.1099999999999994 115.856 -165.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -82.28 139.38 34.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.786 2.232 . . . . 33.439999999999998 111.308 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.24 -50.16 61.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.157 2.583 . . . . 28.370000000000001 113.471 -160.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.03 3.93 86.53 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 127.385 2.421 . . . . 15.0 113.34 -162.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.284 22.6 mtt180 -85.5 162.52 18.9 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.988 2.115 . . . . 25.5 111.689 172.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -88.91 168.4 12.43 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 116.563 -2.055 . . . . 11.949999999999999 110.562 178.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.94 -25.25 60.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.994 -1.912 . . . . 10.17 111.655 169.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.8 t -63.77 -41.61 97.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.652 2.093 . . . . 13.59 116.652 172.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -47.31 -46.93 25.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.626 2.631 . . . . 11.699999999999999 116.259 175.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -86.14 1.24 51.3 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.122 -2.236 . . . . 12.949999999999999 115.601 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.37 17.3 m-20 75.98 32.45 0.64 Allowed 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.734 2.683 . . . . 25.449999999999999 113.501 169.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.56 113.85 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.35 -2.719 . . . . 14.6 109.129 -170.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -111.29 -171.11 1.77 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.284 1.992 . . . . 33.229999999999997 109.182 -174.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -71.36 148.13 47.32 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 115.142 -2.361 . . . . 25.969999999999999 112.773 -168.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 49.65 29.48 3.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 119.728 3.233 . . . . 32.609999999999999 119.728 -165.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -68.66 148.26 50.69 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 116.091 1.885 . . . . 10.56 116.091 170.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -104.08 117.63 34.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 121.235 0.541 . . . . 5.3300000000000001 110.805 171.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.37 151.04 25.4 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.364 -3.335 . . . . 11.66 108.343 175.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -93.77 130.03 39.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.35 1.656 . . . . 16.300000000000001 115.038 178.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.5 tp -109.69 95.12 5.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.315 2.007 . . . . 9.9600000000000009 112.611 178.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -97.24 126.37 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 128.13 2.572 . . . . 9.7599999999999998 111.807 176.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.43 -1.454 0 O-C-N 120.281 -1.512 . . . . 19.57 112.085 177.906 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 107.733 -1.21 . . . . 17.170000000000002 107.733 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -112.61 147.18 37.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.206 -1.559 . . . . 21.890000000000001 112.09 174.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.98 170.77 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.851 -1.907 . . . . 10.83 105.851 164.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -131.71 126.1 33.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.432 -3.292 . . . . 10.609999999999999 107.825 -175.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.0 t -97.77 118.76 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.983 -2.323 . . . . 9.1300000000000008 110.138 168.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -103.56 137.23 41.91 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.452 -2.795 . . . . 20.550000000000001 103.452 -176.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.9 p -97.84 179.79 4.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.504 -0.748 . . . . 11.779999999999999 111.685 -168.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.94 -33.78 75.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.358 -2.714 . . . . 19.309999999999999 113.705 177.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.1 p -76.49 -32.13 58.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.176 -2.821 . . . . 23.140000000000001 105.643 175.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.54 30.03 4.81 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-O 124.096 1.942 . . . . 19.739999999999998 116.994 -166.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -84.97 138.92 32.18 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 114.427 -5.16 . . . . 21.93 107.525 160.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -109.14 129.11 55.48 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 129.1 2.96 . . . . 12.33 110.923 177.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.94 115.01 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.423 1.889 . . . . 17.079999999999998 109.183 -174.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.9 m -79.86 124.74 28.92 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.835 -2.416 . . . . 16.300000000000001 113.628 175.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' A' ' 29' ' ' LYS . 85.5 mt -128.26 134.07 48.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.324 -1.732 . . . . 15.880000000000001 106.324 -173.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -101.89 111.8 24.19 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.186 1.921 . . . . 28.899999999999999 116.186 -173.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.24 170.66 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.433 -1.417 . . . . 12.050000000000001 111.904 -165.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -120.95 162.54 34.62 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 113.696 -3.049 . . . . 18.170000000000002 107.584 177.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.32 51.1 Cg_exo -51.77 -21.58 11.79 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 N-CA-C 121.685 3.687 . . . . 8.1600000000000001 121.685 173.068 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 t -106.81 4.02 27.07 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.01 1.724 . . . . 11.130000000000001 113.466 -171.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -75.74 161.69 28.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.385 1.254 . . . . 18.030000000000001 114.385 159.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.1 p -103.96 175.41 5.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.565 -1.198 . . . . 10.220000000000001 113.797 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.88 -31.63 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.181 -2.199 . . . . 12.300000000000001 109.713 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -44.93 -41.69 7.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.547 2.425 . . . . 36.509999999999998 117.547 164.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -68.9 -26.91 65.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.979 -1.918 . . . . 25.66 114.713 177.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.16 -42.52 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 126.693 1.997 . . . . 8.1199999999999992 109.729 176.123 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -53.88 -44.27 70.31 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.334 1.605 . . . . 15.470000000000001 115.334 171.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.26 -38.48 41.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.145 2.646 . . . . 11.449999999999999 118.145 170.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HB3' HD22 ' A' ' 15' ' ' LEU . 45.9 mttm -75.63 -29.0 59.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 124.598 1.186 . . . . 24.98 111.693 -177.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.94 -33.56 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 122.591 1.186 . . . . 9.4600000000000009 109.033 175.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -64.26 -53.06 54.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.245 -1.798 . . . . 14.76 115.583 178.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -54.0 -53.06 58.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.147 -2.751 . . . . 26.289999999999999 115.039 165.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -78.43 -71.49 0.43 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.119 1.438 . . . . 30.059999999999999 111.732 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -79.18 -25.04 42.83 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 115.692 -4.38 . . . . 25.190000000000001 114.94 -167.22 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.61 46.96 4.43 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 128.87 3.128 . . . . 7.4100000000000001 115.666 -178.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.58 132.99 22.85 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 118.793 1.297 . . . . 9.4900000000000002 113.271 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -67.35 147.77 78.5 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 CA-C-O 110.233 -4.153 . . . . 11.42 118.532 -178.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -64.78 -18.95 64.01 Favored 'Trans proline' 0 C--N 1.299 -2.027 2 C-N-CA 130.096 7.197 . . . . 12.0 108.429 -172.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.362 7.5 t70 -102.55 -33.39 9.5 Favored 'General case' 0 N--CA 1.429 -1.477 1 CA-C-N 126.383 4.174 . . . . 35.549999999999997 108.976 -169.105 . . . . . . . . 3 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -46.89 -41.36 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.809 2.444 . . . . 20.52 113.452 165.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -97.96 148.21 23.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.616 2.627 . . . . 7.1299999999999999 113.86 178.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -136.06 137.51 41.18 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.38 -4.575 . . . . 36.390000000000001 108.408 173.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.93 143.43 38.18 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.107 -4.121 . . . . 9.5500000000000007 109.357 -172.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mt -122.52 147.82 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 129.186 2.994 . . . . 13.9 109.342 -177.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -137.59 116.09 12.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 100.257 -3.979 . . . . 6.8600000000000003 100.257 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.29 -104.01 0.13 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.246 -1.797 . . . . 11.15 113.072 -164.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.06 16.53 5.24 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 107.312 -2.315 . . . . 13.93 107.312 171.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -100.89 143.43 31.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 120.878 2.339 . . . . 23.920000000000002 107.633 170.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -91.91 133.15 35.94 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.372 3.469 . . . . 23.23 113.447 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.16 157.64 16.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.443 3.021 . . . . 9.1099999999999994 117.957 -175.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -90.83 154.23 19.65 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.846 2.26 . . . . 33.439999999999998 111.104 161.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -77.05 -47.95 19.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.299 -2.228 . . . . 28.370000000000001 108.219 -163.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.84 11.46 62.55 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.439 -1.413 . . . . 15.0 114.578 -159.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -101.95 146.91 27.19 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.371 2.268 . . . . 25.5 105.361 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 8.4 p -82.07 156.98 24.3 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.24 2.448 . . . . 11.949999999999999 113.959 -169.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.56 -35.23 72.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.523 -3.236 . . . . 10.17 105.456 -177.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.5 t -69.04 -29.24 67.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.816 2.553 . . . . 13.59 113.884 174.139 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -59.44 -56.6 19.95 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.838 -4.289 . . . . 11.699999999999999 111.86 176.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -79.96 0.39 31.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.149 0.98 . . . . 12.949999999999999 112.677 -177.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.428 72.2 m-80 65.9 49.18 1.69 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.843 2.905 . . . . 25.449999999999999 118.843 -176.178 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mt -93.34 110.27 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.122 2.569 . . . . 14.6 108.304 179.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -96.14 -168.03 1.68 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.602 -1.635 . . . . 33.229999999999997 110.407 -172.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -72.26 146.05 47.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.891 -1.049 . . . . 25.969999999999999 109.389 176.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 28.6 mt-10 73.3 30.01 1.59 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.737 -1.208 . . . . 32.609999999999999 107.737 170.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 m -90.18 116.89 28.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.567 2.127 . . . . 10.56 108.221 -170.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.8 m -72.21 108.08 5.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.486 -3.258 . . . . 5.3300000000000001 113.73 165.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -98.69 166.03 11.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.998 3.319 . . . . 11.66 102.884 173.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -121.19 138.77 54.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.049 -1.657 . . . . 16.300000000000001 113.506 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -103.04 121.76 43.23 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.157 -1.423 . . . . 9.9600000000000009 107.157 -179.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.91 131.36 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.995 -2.224 . . . . 9.7599999999999998 104.995 170.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.431 -1.415 0 CA-C-O 122.31 1.052 . . . . 19.57 109.259 -177.932 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 114.604 1.335 . . . . 17.170000000000002 114.604 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.25 138.01 52.25 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 118.236 -1.386 . . . . 21.890000000000001 109.996 -173.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.3 pt -123.22 151.87 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 123.318 0.647 . . . . 10.83 111.886 170.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -106.71 134.74 49.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.153 -2.217 . . . . 10.609999999999999 106.684 -168.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.84 108.62 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 126.785 3.183 . . . . 9.1300000000000008 107.849 -175.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -91.65 129.76 37.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.283 -3.386 . . . . 20.550000000000001 116.895 -173.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.65 156.85 16.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.725 -1.954 . . . . 11.779999999999999 105.725 173.626 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.76 -49.3 40.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.471 -3.268 . . . . 19.309999999999999 113.148 -164.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.364 29.8 p -49.69 -79.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.908 2.483 . . . . 23.140000000000001 115.176 166.232 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.93 161.34 29.54 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 116.869 -3.645 . . . . 19.739999999999998 105.243 -177.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.8 tttt 86.23 126.9 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.97 2.508 . . . . 21.93 115.585 166.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.7 m -120.22 105.67 11.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.57 2.348 . . . . 12.33 106.897 -175.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.0 pt -88.02 152.03 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.059 -1.65 . . . . 17.079999999999998 112.955 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -111.5 113.06 25.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 113.225 -1.807 . . . . 16.300000000000001 110.145 -173.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -108.62 139.38 43.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.951 2.786 . . . . 15.880000000000001 107.409 176.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -84.3 125.8 32.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.781 -3.075 . . . . 28.899999999999999 108.589 172.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -149.82 175.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 117.488 -3.257 . . . . 12.050000000000001 110.768 -176.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -115.34 148.92 41.88 Favored Pre-proline 0 N--CA 1.429 -1.493 1 O-C-N 116.277 -4.015 . . . . 18.170000000000002 109.279 176.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -64.6 -8.48 17.49 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 125.735 4.29 . . . . 8.1600000000000001 115.74 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.8 m -105.76 16.52 25.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.541 -2.022 . . . . 11.130000000000001 105.541 177.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.84 153.51 25.13 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.523 -2.611 . . . . 18.030000000000001 111.921 168.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.8 p -87.01 164.61 16.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.517 2.58 . . . . 10.220000000000001 105.249 -176.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -75.6 -21.9 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 116.708 -3.745 . . . . 12.300000000000001 109.796 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.29 -32.6 66.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.731 2.412 . . . . 36.509999999999998 113.057 163.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -88.37 -21.84 24.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.892 -1.049 . . . . 25.66 110.715 -177.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -73.92 -49.56 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 118.104 -2.873 . . . . 8.1199999999999992 107.023 169.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -46.57 -45.18 18.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.45 1.9 . . . . 15.470000000000001 112.071 170.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.14 95.68 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.634 2.774 . . . . 11.449999999999999 111.746 -175.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -62.5 -43.22 99.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.223 1.809 . . . . 24.98 113.638 169.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 mt -63.19 -38.83 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 116.879 2.177 . . . . 9.4600000000000009 116.879 171.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.1 -29.24 70.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.317 2.247 . . . . 14.76 111.102 177.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -79.93 -56.59 4.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.904 -2.372 . . . . 26.289999999999999 116.412 166.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -78.13 -48.43 15.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.622 -1.251 . . . . 30.059999999999999 107.622 -156.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 6.1 mm-40 -85.89 -45.66 11.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.931 1.086 . . . . 25.190000000000001 113.931 169.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.44 66.36 1.65 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 121.789 0.66 . . . . 7.4100000000000001 111.73 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.7 mt -112.36 118.99 44.68 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 102.066 -3.309 . . . . 9.4900000000000002 102.066 166.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.53 154.64 63.28 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 CA-C-N 124.767 2.738 . . . . 11.42 113.784 -178.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -73.52 -13.15 25.01 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 O-C-N 112.611 -4.468 . . . . 12.0 117.906 -165.259 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -92.91 -10.13 37.63 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 125.06 1.475 . . . . 35.549999999999997 112.069 175.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -84.14 -7.23 59.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.23 -1.544 . . . . 20.52 114.21 168.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -95.64 123.68 39.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 113.937 -2.935 . . . . 7.1299999999999999 108.663 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -105.51 102.21 11.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.167 3.417 . . . . 36.390000000000001 106.877 165.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.8 mt -90.9 99.17 12.25 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 123.376 2.807 . . . . 9.5500000000000007 110.693 -177.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.4 mt -104.49 116.71 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 129.369 3.068 . . . . 13.9 109.608 -176.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -93.09 113.74 26.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.944 -2.613 . . . . 6.8600000000000003 103.944 165.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.12 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.527 2.584 . . . . 11.15 116.695 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.02 18.3 1.21 Allowed Glycine 0 N--CA 1.429 -1.775 1 O-C-N 116.049 -4.157 . . . . 13.93 117.054 176.067 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -135.18 142.8 46.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 101.139 -3.652 . . . . 23.920000000000002 101.139 171.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -96.35 165.89 11.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.613 -3.179 . . . . 23.23 113.528 173.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.08 156.96 17.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 127.156 2.785 . . . . 9.1099999999999994 112.329 -162.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.261 40.2 mt-10 -99.51 141.09 32.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.009 2.338 . . . . 33.439999999999998 112.14 -173.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -70.31 -51.26 31.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.668 -3.145 . . . . 28.370000000000001 115.615 -154.239 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.46 15.3 41.37 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 123.03 3.972 . . . . 15.0 123.03 171.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -101.44 162.72 12.69 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.47 2.308 . . . . 25.5 109.302 168.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.0 p -107.31 172.35 6.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 114.692 1.367 . . . . 11.949999999999999 114.692 -169.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.39 -35.41 80.81 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.081 -2.262 . . . . 10.17 114.917 166.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -54.25 -46.69 72.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.881 2.178 . . . . 13.59 116.881 161.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -59.07 -37.03 76.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 124.23 3.195 . . . . 11.699999999999999 115.447 176.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -90.55 12.7 17.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.363 -2.711 . . . . 12.949999999999999 115.385 173.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.52 6.5 t30 46.61 42.36 11.17 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.95 2.574 . . . . 25.449999999999999 117.95 -172.262 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -93.07 99.07 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 118.437 -2.665 . . . . 14.6 108.119 -178.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -79.93 176.13 10.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.225 2.61 . . . . 33.229999999999997 109.682 172.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -71.48 151.61 43.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.248 -2.782 . . . . 25.969999999999999 116.549 -174.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.29 45.2 mt-10 75.17 11.68 3.47 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.733 2.52 . . . . 32.609999999999999 114.687 -173.442 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.309 70.9 m -73.76 145.93 44.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.896 1.331 . . . . 10.56 112.199 -176.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -96.73 123.06 40.31 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.388 -2.695 . . . . 5.3300000000000001 113.288 173.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.305 65.7 tp -126.16 150.08 48.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.137 -2.852 . . . . 11.66 105.974 175.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -111.59 122.47 47.91 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.658 -2.526 . . . . 16.300000000000001 112.623 -167.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -98.56 103.17 15.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.223 -2.88 . . . . 9.9600000000000009 103.223 -178.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.257 15.3 t -100.14 168.26 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 110.316 -3.129 . . . . 9.7599999999999998 111.496 170.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tp . . . . . 0 N--CA 1.431 -1.423 0 N-CA-C 107.746 -1.205 . . . . 19.57 107.746 176.264 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptt? . . . . . 0 CA--C 1.489 -1.367 0 CA-C-O 123.058 1.409 . . . . 17.170000000000002 111.717 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -96.66 137.29 35.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.978 2.799 . . . . 21.890000000000001 112.339 167.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.6 pt -119.5 162.29 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 117.349 -3.345 . . . . 10.83 105.87 175.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -119.73 136.39 54.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.219 2.208 . . . . 10.609999999999999 109.176 -177.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.35 103.02 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 102.524 -3.139 . . . . 9.1300000000000008 102.524 -173.028 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -86.4 118.41 25.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.411 -2.056 . . . . 20.550000000000001 108.584 -176.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -84.07 -170.96 3.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.289 1.618 . . . . 11.779999999999999 109.267 -173.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.0 -25.37 19.74 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.753 -4.342 . . . . 19.309999999999999 109.329 -171.417 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.7 p -90.43 -72.14 0.59 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.232 2.208 . . . . 23.140000000000001 115.695 -173.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.8 35.9 0.18 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-O 117.065 -1.964 . . . . 19.739999999999998 111.876 177.162 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -122.84 151.58 41.55 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.534 -2.025 . . . . 21.93 105.534 175.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.7 m -125.71 121.9 34.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.374 -2.084 . . . . 12.33 105.374 169.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.305 48.5 pt -103.39 141.56 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.503 -2.623 . . . . 17.079999999999998 113.065 -178.61 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -104.08 116.03 31.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.969 -2.234 . . . . 16.300000000000001 104.969 -173.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.91 133.07 56.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.262 1.392 . . . . 15.880000000000001 111.256 175.227 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -106.95 118.21 36.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.459 2.552 . . . . 28.899999999999999 108.678 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 m -139.71 145.3 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 131.469 3.908 . . . . 12.050000000000001 107.501 -152.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.2 147.85 34.55 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 125.305 1.442 . . . . 18.170000000000002 107.906 166.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.92 -26.3 22.3 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 123.746 2.964 . . . . 8.1600000000000001 114.565 -177.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.0 m -70.12 0.24 6.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.525 2.417 . . . . 11.130000000000001 117.525 161.054 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -70.72 142.3 51.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.704 -3.123 . . . . 18.030000000000001 117.674 163.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.269 7.3 p -73.9 158.61 34.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.644 2.778 . . . . 10.220000000000001 109.759 178.601 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.452 HG13 ' HB3' ' A' ' 50' ' ' LEU 0.284 26.9 mm -67.07 -34.45 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 119.283 0.947 . . . . 12.300000000000001 111.884 173.38 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -47.94 -42.7 28.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.623 -2.548 . . . . 36.509999999999998 115.306 162.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -71.91 -27.36 62.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.546 -3.846 . . . . 25.66 112.456 -178.335 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -68.38 -49.0 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 130.55 3.54 . . . . 8.1199999999999992 110.639 172.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -55.16 -38.62 68.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.569 2.063 . . . . 15.470000000000001 116.569 173.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.46 -35.71 53.11 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.13 -1.606 . . . . 11.449999999999999 114.974 173.245 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -76.9 -31.5 56.77 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 117.276 2.324 . . . . 24.98 117.276 176.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 mt -70.23 -32.63 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.58 1.552 . . . . 9.4600000000000009 109.282 172.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -74.14 -36.0 64.11 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.36 -1.462 . . . . 14.76 109.802 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.99 -51.28 62.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.068 1.413 . . . . 26.289999999999999 112.476 177.508 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -80.62 -55.37 4.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.256 -3.403 . . . . 30.059999999999999 112.132 -168.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -94.73 -34.36 12.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.316 0.962 . . . . 25.190000000000001 111.485 -167.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.72 54.06 1.99 Allowed Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 127.114 2.292 . . . . 7.4100000000000001 113.276 -177.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.0 mt -113.37 103.45 55.5 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 113.671 -3.061 . . . . 9.4900000000000002 104.121 -175.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -57.56 141.45 95.24 Favored 'Trans proline' 0 C--N 1.3 -1.999 1 CA-C-N 131.862 5.272 . . . . 11.42 116.688 -178.522 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.267 19.7 Cg_endo -70.72 -18.82 32.23 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 125.018 3.812 . . . . 12.0 114.177 -159.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.26 -32.07 58.65 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.195 2.902 . . . . 35.549999999999997 108.552 -178.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -73.35 -5.73 41.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.493 -2.629 . . . . 20.52 116.322 172.156 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -105.39 139.86 39.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.709 1.243 . . . . 7.1299999999999999 108.682 -177.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -138.58 118.04 12.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.703 -3.123 . . . . 36.390000000000001 109.276 162.497 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.2 mt -86.38 129.67 34.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 113.975 1.102 . . . . 9.5500000000000007 113.975 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mt -120.12 135.59 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 117.829 -1.082 . . . . 13.9 113.706 177.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -106.22 103.18 12.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.841 -2.281 . . . . 6.8600000000000003 104.841 172.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.359 . . 62.9 -110.89 0.35 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.242 1.817 . . . . 11.15 113.646 -170.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.19 -8.31 78.62 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 121.19 3.236 . . . . 13.93 121.19 169.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -115.47 115.65 26.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.745 1.26 . . . . 23.920000000000002 110.502 -165.037 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -71.73 133.93 45.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.714 2.406 . . . . 23.23 108.904 170.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.452 ' HB3' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -95.38 137.53 34.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.423 -2.227 . . . . 9.1099999999999994 112.332 -177.618 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.06 139.8 30.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 123.503 2.865 . . . . 33.439999999999998 109.14 174.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -32.39 -74.52 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 136.12 5.768 . . . . 28.370000000000001 113.407 172.478 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.03 43.13 3.14 Favored Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 117.853 -2.118 . . . . 15.0 113.738 -171.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -130.49 157.25 43.17 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.861 2.064 . . . . 25.5 107.779 174.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.0 p -87.33 176.32 7.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 124.089 3.131 . . . . 11.949999999999999 113.243 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.21 -43.03 92.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 130.064 3.346 . . . . 10.17 106.848 161.244 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -64.67 -31.95 73.4 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 115.2 1.555 . . . . 13.59 115.2 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -60.78 -55.22 35.72 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.0 -2.313 . . . . 11.699999999999999 112.995 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -71.61 15.32 0.14 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 114.489 -2.672 . . . . 12.949999999999999 116.816 166.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 41.39 40.0 1.15 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.98 2.627 . . . . 25.449999999999999 116.939 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -82.15 116.35 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.011 -1.848 . . . . 14.6 106.011 -178.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -98.2 -150.59 0.36 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.841 -2.412 . . . . 33.229999999999997 108.883 -175.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -76.73 156.02 32.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.956 -1.474 . . . . 25.969999999999999 111.087 -167.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 16.8 mt-10 65.3 9.1 5.39 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.029 1.732 . . . . 32.609999999999999 112.843 164.025 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -65.29 132.79 49.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.135 -3.478 . . . . 10.56 117.96 177.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.291 85.3 m -82.97 113.55 20.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.132 1.901 . . . . 5.3300000000000001 116.132 169.161 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.79 156.0 18.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.147 2.403 . . . . 11.66 108.824 171.658 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -107.46 126.99 53.19 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.385 -2.45 . . . . 16.300000000000001 104.385 -171.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.6 tp -103.82 124.66 49.34 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 116.119 -4.113 . . . . 9.9600000000000009 110.26 178.119 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.267 46.0 t -111.92 147.86 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 101.968 -3.345 . . . . 9.7599999999999998 101.968 -171.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.43 -1.461 0 CA-C-O 119.719 -0.181 . . . . 19.57 111.056 170.522 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.41 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 14.1 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 113.616 0.969 . . . . 17.170000000000002 113.616 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.286 14.5 pt20 -90.53 134.15 34.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 121.558 1.981 . . . . 21.890000000000001 114.911 172.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.8 pt -132.06 166.61 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.671 -1.603 . . . . 10.83 106.671 177.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -107.3 131.73 53.89 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.401 -3.937 . . . . 10.609999999999999 112.484 177.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.0 t -116.57 109.32 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.258 -1.377 . . . . 9.1300000000000008 110.171 170.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -99.16 117.62 34.04 Favored 'General case' 0 N--CA 1.429 -1.481 1 CA-C-O 130.117 4.77 . . . . 20.550000000000001 110.098 -172.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 30.7 p -75.16 164.66 26.26 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 110.738 -7.477 . . . . 11.779999999999999 114.455 -171.94 . . . . . . . . 3 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 tp -53.16 -52.08 59.93 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.177 2.191 . . . . 19.309999999999999 115.603 174.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -59.0 -70.4 0.15 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 128.783 3.802 . . . . 23.140000000000001 114.599 169.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.49 59.01 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.774 0 O-C-N 118.988 -2.32 . . . . 19.739999999999998 113.834 156.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.33 85.7 tttt -108.06 134.18 51.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.398 -2.236 . . . . 21.93 106.737 173.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.2 m -97.45 111.67 23.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.439 -1.71 . . . . 12.33 108.35 173.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.5 pt -108.75 127.33 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.312 -1.492 . . . . 17.079999999999998 113.178 172.491 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.3 m -86.33 122.51 30.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.572 1.549 . . . . 16.300000000000001 110.506 -178.365 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -110.53 123.04 49.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.251 3.021 . . . . 15.880000000000001 111.05 -172.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -102.89 117.4 34.54 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.638 3.113 . . . . 28.899999999999999 107.087 171.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.72 167.34 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 110.404 -3.089 . . . . 12.050000000000001 110.341 -174.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -110.81 164.88 13.81 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 113.885 -2.96 . . . . 18.170000000000002 115.782 165.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.283 60.7 Cg_endo -69.83 -24.91 28.82 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 CA-C-N 127.813 3.826 . . . . 8.1600000000000001 113.279 -171.408 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.256 3.9 m -82.99 -5.57 59.15 Favored 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 133.819 4.847 . . . . 11.130000000000001 114.464 -176.363 . . . . . . . . 3 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -59.67 126.41 27.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.377 2.271 . . . . 18.030000000000001 114.104 167.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.4 p -77.3 158.15 30.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.056 -2.277 . . . . 10.220000000000001 111.59 170.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.295 35.8 mm -60.91 -34.55 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.829 -1.169 . . . . 12.300000000000001 113.732 176.662 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -33.96 -60.69 0.38 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.99 -3.569 . . . . 36.509999999999998 117.775 157.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -70.67 -31.86 68.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 110.75 -2.932 . . . . 25.66 111.024 -177.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -66.21 -43.85 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.093 -1.629 . . . . 8.1199999999999992 112.435 -178.121 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -57.46 -42.79 83.23 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.149 2.18 . . . . 15.470000000000001 113.771 176.037 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.329 . . -64.45 -35.43 80.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.851 -2.406 . . . . 11.449999999999999 114.374 175.269 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -59.67 -35.02 73.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.274 2.94 . . . . 24.98 115.968 170.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -75.74 -36.92 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.617 -2.552 . . . . 9.4600000000000009 109.281 172.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -56.32 -32.61 64.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.423 2.059 . . . . 14.76 113.326 174.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.64 -36.09 67.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 128.215 3.864 . . . . 26.289999999999999 111.463 -177.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -65.13 -51.4 61.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.063 -2.79 . . . . 30.059999999999999 115.196 171.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -110.67 -59.02 2.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.519 2.104 . . . . 25.190000000000001 112.018 -168.132 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.15 49.29 0.88 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 126.942 2.211 . . . . 7.4100000000000001 110.509 -176.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -100.25 130.55 25.72 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 114.299 -2.762 . . . . 9.4900000000000002 107.732 169.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -71.25 148.98 56.69 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 124.417 2.613 . . . . 11.42 113.364 179.444 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -68.99 -17.96 40.82 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 CA-C-N 125.55 3.018 . . . . 12.0 117.768 -172.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.262 1.1 m-20 -69.41 -20.64 63.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.926 2.775 . . . . 35.549999999999997 117.028 172.902 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -94.6 -23.26 17.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.225 2.917 . . . . 20.52 108.5 -177.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -84.17 119.67 25.28 Favored 'General case' 0 N--CA 1.431 -1.418 1 O-C-N 115.767 -4.333 . . . . 7.1299999999999999 116.791 178.114 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -113.57 106.59 14.72 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.068 2.947 . . . . 36.390000000000001 111.066 177.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -88.3 124.27 33.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.096 -1.816 . . . . 9.5500000000000007 106.096 -175.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -116.99 106.71 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 122.576 2.444 . . . . 13.9 108.534 176.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -95.66 108.94 21.27 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 125.628 2.632 . . . . 6.8600000000000003 111.876 170.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.426 . . 70.57 -96.95 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.465 -2.647 . . . . 11.15 116.692 -178.754 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.76 -2.36 19.08 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.508 -1.37 . . . . 13.93 112.57 170.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -109.06 126.54 53.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.501 1.143 . . . . 23.920000000000002 111.261 -166.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -93.31 130.73 38.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 112.487 -2.142 . . . . 23.23 109.109 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -96.46 149.95 21.15 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.762 2.134 . . . . 9.1099999999999994 116.762 -164.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -111.22 148.65 32.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.741 2.21 . . . . 33.439999999999998 111.041 -176.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -60.15 -47.28 86.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.276 2.695 . . . . 28.370000000000001 118.276 -166.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.83 26.67 8.08 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 117.995 -2.05 . . . . 15.0 112.982 -166.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -113.68 154.35 27.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 131.136 3.775 . . . . 25.5 106.24 -176.186 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -90.29 168.41 11.92 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.594 1.701 . . . . 11.949999999999999 115.594 168.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.0 mt -73.28 -36.14 66.26 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 118.031 -0.985 . . . . 10.17 112.406 177.25 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -45.89 -53.33 9.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.602 3.064 . . . . 13.59 115.837 160.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -49.76 -44.07 48.43 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.251 -4.656 . . . . 11.699999999999999 117.205 179.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -79.35 -18.95 51.41 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.431 -2.043 . . . . 12.949999999999999 108.265 -173.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 66.07 71.83 0.4 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.316 2.246 . . . . 25.449999999999999 110.238 -170.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -115.82 117.94 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 102.855 -3.017 . . . . 14.6 102.855 178.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -100.41 174.44 6.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.447 3.499 . . . . 33.229999999999997 112.239 174.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 13.3 pttp -53.69 161.88 0.99 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.829 -4.92 . . . . 25.969999999999999 115.293 165.243 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 50.96 46.57 26.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.292 3.037 . . . . 32.609999999999999 109.461 174.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -130.53 155.9 45.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.767 -3.083 . . . . 10.56 102.694 179.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.6 m -119.16 118.65 31.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.043 -1.435 . . . . 5.3300000000000001 108.818 -155.14 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 mt -100.55 147.36 26.01 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.546 -2.391 . . . . 11.66 104.546 -173.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -108.8 133.89 52.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.625 -2.43 . . . . 16.300000000000001 111.41 167.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -106.34 97.79 7.55 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.682 1.734 . . . . 9.9600000000000009 115.682 -175.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -95.13 150.31 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 101.493 -3.521 . . . . 9.7599999999999998 101.493 -171.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt . . . . . 0 N--CA 1.43 -1.442 1 CA-C-O 128.51 4.005 . . . . 19.57 106.772 173.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 118.366 -0.826 . . . . 17.170000000000002 113.012 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -98.75 142.0 30.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.478 2.361 . . . . 21.890000000000001 114.147 161.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.464 HD11 HD22 ' A' ' 67' ' ' LEU . 21.1 pt -128.04 153.94 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.14 -1.43 . . . . 10.83 107.14 176.049 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -100.2 105.31 16.88 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 117.586 2.439 . . . . 10.609999999999999 117.586 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -88.44 117.58 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 119.635 1.107 . . . . 9.1300000000000008 110.619 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -93.23 129.36 39.3 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.992 2.917 . . . . 20.550000000000001 110.39 174.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -98.01 170.53 8.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.169 -1.378 . . . . 11.779999999999999 108.164 178.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.02 -49.72 75.9 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.705 1.742 . . . . 19.309999999999999 115.705 173.348 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 p -74.78 -73.21 0.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.261 2.458 . . . . 23.140000000000001 111.507 -172.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.27 32.89 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 117.331 -3.355 . . . . 19.739999999999998 116.854 167.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -84.39 154.91 22.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.384 2.516 . . . . 21.93 110.054 167.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.9 m -112.18 113.52 25.82 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.117 -1.856 . . . . 12.33 106.376 163.246 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.6 mt -102.2 129.17 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 118.602 -2.561 . . . . 17.079999999999998 105.137 177.345 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.9 m -107.57 115.47 30.2 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.854 -2.404 . . . . 16.300000000000001 106.582 -169.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 tp -118.74 125.1 48.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.5 -2.625 . . . . 15.880000000000001 109.388 -156.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -95.34 119.53 33.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.468 -2.645 . . . . 28.899999999999999 114.873 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.7 158.18 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 106.903 -1.517 . . . . 12.050000000000001 106.903 -167.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -81.09 146.85 59.71 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 126.717 2.007 . . . . 18.170000000000002 109.9 175.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -82.87 -3.49 11.16 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 119.599 0.893 . . . . 8.1600000000000001 113.434 -165.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 t -113.59 7.91 17.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.937 2.153 . . . . 11.130000000000001 112.396 171.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -88.89 177.22 6.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.364 2.357 . . . . 18.030000000000001 117.364 -172.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.1 p -92.8 159.94 15.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 118.293 2.701 . . . . 10.220000000000001 118.293 -167.658 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -67.17 -36.24 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 127.132 2.173 . . . . 12.300000000000001 107.741 179.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -54.73 -44.87 73.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.606 1.963 . . . . 36.509999999999998 112.967 172.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -69.63 -31.14 69.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.835 2.161 . . . . 25.66 116.835 170.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.1 -48.11 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 122.091 2.223 . . . . 8.1199999999999992 113.71 164.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -60.79 -31.35 70.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.978 1.711 . . . . 15.470000000000001 113.529 173.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.269 . . -79.24 -28.7 42.47 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 115.654 1.724 . . . . 11.449999999999999 115.654 177.716 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -63.43 -45.71 89.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.841 -1.527 . . . . 24.98 114.496 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.3 mt -70.0 -35.48 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.42 -2.173 . . . . 9.4600000000000009 110.589 172.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -56.85 -29.68 63.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 125.974 3.988 . . . . 14.76 110.377 168.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.93 -50.73 7.76 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 114.857 -4.902 . . . . 26.289999999999999 111.439 -174.699 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -65.54 -52.27 53.73 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.661 -2.525 . . . . 30.059999999999999 113.417 175.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -107.82 -39.65 5.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.504 -0.924 . . . . 25.190000000000001 108.504 -162.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.99 37.6 5.97 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 106.587 -2.605 . . . . 7.4100000000000001 106.587 176.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.74 123.66 37.93 Favored Pre-proline 0 N--CA 1.43 -1.446 1 N-CA-C 97.13 -5.137 . . . . 9.4900000000000002 97.13 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -90.52 166.97 4.2 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 CA-C-N 125.278 2.921 . . . . 11.42 107.757 -168.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.26 36.4 Cg_endo -65.58 -24.83 55.45 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 122.793 2.328 . . . . 12.0 116.307 -169.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.282 18.0 m-20 -82.29 -22.33 35.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 114.516 -2.874 . . . . 35.549999999999997 111.476 178.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -91.56 -12.14 35.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 124.412 3.278 . . . . 20.52 112.77 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -75.46 99.93 4.34 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.74 2.416 . . . . 7.1299999999999999 113.64 171.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -84.99 113.05 21.14 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 101.051 -3.685 . . . . 36.390000000000001 101.051 168.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.0 mt -101.31 115.24 30.05 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.405 -2.059 . . . . 9.5500000000000007 110.343 165.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mt -112.53 137.6 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 C-N-CA 131.717 4.007 . . . . 13.9 109.234 178.576 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -133.75 99.37 4.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.738 2.015 . . . . 6.8600000000000003 106.262 -171.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.394 . . 66.46 -108.65 0.13 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.954 -1.716 . . . . 11.15 113.471 -158.658 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.59 17.53 11.11 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 126.522 2.01 . . . . 13.93 112.106 172.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -107.06 119.74 40.18 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.661 3.23 . . . . 23.920000000000002 110.826 174.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -70.06 124.5 24.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.994 -2.941 . . . . 23.23 112.946 160.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.494 HD23 ' CD2' ' A' ' 59' ' ' TYR . 29.1 mt -79.41 162.74 25.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.352 1.461 . . . . 9.1099999999999994 112.106 -178.187 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.28 141.47 52.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 126.748 3.166 . . . . 33.439999999999998 104.105 -177.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.67 -48.29 72.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.331 2.252 . . . . 28.370000000000001 114.848 -152.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.32 0.96 88.45 Favored Glycine 0 N--CA 1.43 -1.706 0 O-C-N 119.094 -2.254 . . . . 15.0 116.827 -178.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.252 23.3 mmt180 -74.9 161.43 29.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.105 3.336 . . . . 25.5 111.458 170.329 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.343 31.0 p -87.75 163.62 16.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.503 -2.623 . . . . 11.949999999999999 112.624 178.121 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.9 mt -60.15 -32.03 70.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.021 1.86 . . . . 10.17 116.021 163.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -56.55 -38.26 71.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.243 2.449 . . . . 13.59 114.426 166.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.79 -32.51 74.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.35 -2.719 . . . . 11.699999999999999 116.472 -169.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.494 ' CD2' HD23 ' A' ' 50' ' ' LEU . 34.2 m-85 -104.39 1.88 30.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.029 -2.919 . . . . 12.949999999999999 112.596 175.369 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.252 81.0 m-20 70.99 48.96 0.36 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.379 2.363 . . . . 25.449999999999999 117.379 -177.271 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.1 mt -92.41 124.79 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 114.545 -2.862 . . . . 14.6 110.614 -174.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -108.87 169.95 8.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 123.941 0.775 . . . . 33.229999999999997 110.635 -169.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 143.87 57.24 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.694 2.797 . . . . 25.969999999999999 110.262 -170.033 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 57.67 23.42 9.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.646 -3.784 . . . . 32.609999999999999 115.957 -174.392 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.0 t -92.93 160.36 14.93 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.269 3.414 . . . . 10.56 110.151 -178.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 m -92.52 126.16 37.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.599 -3.188 . . . . 5.3300000000000001 114.749 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.464 HD22 HD11 ' A' ' 3' ' ' ILE . 6.9 mp -119.44 155.63 31.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.524 -2.399 . . . . 11.66 104.524 173.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -130.61 111.03 11.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 119.024 0.829 . . . . 16.300000000000001 111.329 -173.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -87.16 108.56 18.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 131.0 3.72 . . . . 9.9600000000000009 114.406 175.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -111.22 141.31 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 129.681 3.192 . . . . 9.7599999999999998 102.7 -173.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.43 -1.454 0 C-N-CA 127.746 2.418 . . . . 19.57 109.187 -170.906 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 CA--C 1.49 -1.365 0 CA-C-O 116.449 -1.739 . . . . 17.170000000000002 109.209 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -88.38 140.59 29.32 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 123.247 2.749 . . . . 21.890000000000001 116.81 171.478 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.1 pt -110.41 167.83 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 102.628 -3.101 . . . . 10.83 102.628 173.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -109.03 139.2 44.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.403 -2.814 . . . . 10.609999999999999 103.403 167.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -122.85 123.17 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.435 -2.041 . . . . 9.1300000000000008 109.677 165.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -96.91 134.89 39.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.127 -0.942 . . . . 20.550000000000001 112.508 172.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -91.77 -173.97 3.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.37 2.986 . . . . 11.779999999999999 113.207 177.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 tp -65.49 -52.95 49.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.635 -3.791 . . . . 19.309999999999999 116.661 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -61.8 -40.5 95.45 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.325 -2.11 . . . . 23.140000000000001 110.204 171.075 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.01 37.15 0.44 Allowed Glycine 0 N--CA 1.43 -1.738 0 CA-C-O 115.186 -3.008 . . . . 19.739999999999998 116.837 177.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 77.1 mttt -86.17 141.05 29.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.483 3.641 . . . . 21.93 111.079 175.502 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 m -92.74 101.75 14.15 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 119.954 1.252 . . . . 12.33 108.995 175.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.6 mt -93.05 118.43 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 125.072 1.349 . . . . 17.079999999999998 111.149 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -86.66 105.58 17.01 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.471 1.908 . . . . 16.300000000000001 112.338 175.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 tp -120.57 116.24 24.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.73 -1.856 . . . . 15.880000000000001 110.329 -160.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -78.76 100.51 7.14 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.562 4.345 . . . . 28.899999999999999 120.351 178.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 m -122.93 148.46 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-O 125.452 2.549 . . . . 12.050000000000001 109.138 -171.666 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -94.64 141.73 23.8 Favored Pre-proline 0 N--CA 1.43 -1.474 1 O-C-N 116.277 -4.015 . . . . 18.170000000000002 106.01 162.542 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.49 -14.51 45.26 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-O 114.086 -2.548 . . . . 8.1600000000000001 111.091 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.7 p -67.83 -9.88 48.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 120.931 3.678 . . . . 11.130000000000001 120.931 160.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -71.06 134.92 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.55 -3.843 . . . . 18.030000000000001 111.679 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.3 p -82.48 153.14 25.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 117.332 -1.318 . . . . 10.220000000000001 111.974 177.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.0 mm -51.61 -37.73 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 113.907 -2.949 . . . . 12.300000000000001 113.795 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -49.64 -43.56 46.9 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.959 3.704 . . . . 36.509999999999998 113.86 168.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 14.7 m-80 -90.54 -25.56 20.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.693 3.197 . . . . 25.66 110.295 -176.848 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.46 -51.84 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.238 1.495 . . . . 8.1199999999999992 110.736 164.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -51.74 -31.92 28.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.66 -3.775 . . . . 15.470000000000001 115.183 170.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.05 -39.38 86.92 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.808 1.643 . . . . 11.449999999999999 113.018 171.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 66.3 mttm -69.19 -35.08 75.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.473 1.13 . . . . 24.98 108.4 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.5 mt -79.51 -35.59 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.833 -2.417 . . . . 9.4600000000000009 110.77 -173.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -49.41 -50.54 40.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.542 2.423 . . . . 14.76 117.542 158.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.56 -33.44 69.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.266 3.027 . . . . 26.289999999999999 113.91 170.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -73.69 -69.83 0.41 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.925 2.565 . . . . 30.059999999999999 117.925 173.378 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.474 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 63.0 mm-40 -90.42 -37.89 13.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 111.189 -2.732 . . . . 25.190000000000001 115.215 -172.146 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.35 46.39 1.85 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 120.743 1.61 . . . . 7.4100000000000001 110.784 176.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.41 105.32 48.64 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 113.195 -3.288 . . . . 9.4900000000000002 105.031 -178.324 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -58.36 159.01 20.66 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.497 3.356 . . . . 11.42 113.62 -175.463 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -76.39 -20.4 14.23 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 122.826 2.045 . . . . 12.0 115.227 -161.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.33 -40.01 67.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.649 -1.907 . . . . 35.549999999999997 110.005 178.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.99 -29.8 69.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.812 -1.805 . . . . 20.52 111.697 172.075 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -78.98 140.9 37.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 117.865 -3.022 . . . . 7.1299999999999999 109.952 -177.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -123.12 124.43 43.06 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.563 -3.21 . . . . 36.390000000000001 107.393 158.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.2 mt -106.4 129.79 54.33 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 123.957 0.786 . . . . 9.5500000000000007 112.609 176.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.1 109.82 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 125.991 1.716 . . . . 13.9 112.004 -171.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -94.09 129.52 40.6 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.346 -3.346 . . . . 6.8600000000000003 107.33 163.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.52 -97.92 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.019 2.97 . . . . 11.15 119.019 -169.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.84 27.82 3.81 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.44 -2.037 . . . . 13.93 113.819 -179.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -138.93 128.39 24.4 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.903 -1.888 . . . . 23.920000000000002 105.903 -176.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -84.34 127.34 33.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 111.799 -2.455 . . . . 23.23 113.664 171.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.4 mt -87.02 137.16 32.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.074 -1.875 . . . . 9.1099999999999994 108.353 -161.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -106.26 140.41 39.25 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.31 -0.869 . . . . 33.439999999999998 111.936 -160.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -46.17 -54.03 9.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 121.3 3.815 . . . . 28.370000000000001 121.3 -162.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.11 -0.44 74.17 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-O 117.906 -1.497 . . . . 15.0 112.706 -178.417 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -75.4 158.47 32.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.106 1.953 . . . . 25.5 114.308 169.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 p -93.68 173.46 7.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.746 2.212 . . . . 11.949999999999999 110.452 174.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.5 mt -66.39 -29.84 70.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.331 -3.356 . . . . 10.17 113.965 166.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.6 t -66.05 -39.73 90.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.856 -3.028 . . . . 13.59 110.892 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -61.2 -33.64 73.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.911 -1.743 . . . . 11.699999999999999 113.634 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.83 -20.44 30.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.187 0.81 . . . . 12.949999999999999 113.187 174.314 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 m120 72.47 51.78 0.18 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.604 3.962 . . . . 25.449999999999999 112.539 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.259 60.0 mt -80.79 121.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 110.192 -3.185 . . . . 14.6 110.026 -178.288 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -106.54 -175.2 2.73 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 118.704 -1.198 . . . . 33.229999999999997 112.228 -175.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.427 0.0 OUTLIER -66.46 150.85 48.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.234 2.309 . . . . 25.969999999999999 117.234 173.219 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 48.24 39.0 11.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.047 2.832 . . . . 32.609999999999999 116.408 -168.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.373 63.9 m -94.29 137.21 33.72 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.013 -4.804 . . . . 10.56 107.826 173.841 . . . . . . . . 3 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -103.52 113.92 27.79 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.563 1.529 . . . . 5.3300000000000001 111.665 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -84.78 146.54 27.32 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.238 2.215 . . . . 11.66 111.63 169.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -110.93 129.49 55.86 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.603 -1.936 . . . . 16.300000000000001 114.41 172.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.7 tp -87.78 124.82 34.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.32 -2.474 . . . . 9.9600000000000009 104.32 170.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.12 146.03 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 112.816 -1.993 . . . . 9.7599999999999998 109.34 163.489 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.257 14.2 mt . . . . . 0 N--CA 1.431 -1.418 1 O-C-N 115.578 -4.451 . . . . 19.57 111.452 -176.253 . . . . . . . . 2 1 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.348 0 CA-C-O 119.242 -0.409 . . . . 17.170000000000002 111.932 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.29 133.99 39.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 119.324 0.965 . . . . 21.890000000000001 113.157 -178.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 pt -114.63 171.24 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.703 -1.873 . . . . 10.83 111.024 168.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -107.82 135.95 48.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.563 1.649 . . . . 10.609999999999999 111.876 173.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.25 128.62 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 117.523 -3.235 . . . . 9.1300000000000008 102.288 175.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -120.89 121.74 38.73 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.068 1.413 . . . . 20.550000000000001 111.143 -178.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -69.79 164.06 24.42 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.539 2.336 . . . . 11.779999999999999 109.632 -174.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.4 tp -61.76 -44.19 97.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.092 1.901 . . . . 19.309999999999999 111.154 174.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 p -67.32 -51.57 50.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.765 -1.835 . . . . 23.140000000000001 113.045 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.56 59.9 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 119.439 2.536 . . . . 19.739999999999998 119.439 162.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -116.42 138.5 51.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.522 -0.918 . . . . 21.93 108.522 172.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.2 m -90.15 113.86 25.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 118.37 -0.824 . . . . 12.33 109.164 178.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mt -96.39 137.57 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.694 -3.129 . . . . 17.079999999999998 106.872 -177.27 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.3 m -97.28 121.43 39.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 114.821 -2.514 . . . . 16.300000000000001 104.301 171.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 tp -121.97 138.37 54.44 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.648 2.166 . . . . 15.880000000000001 115.895 178.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.294 71.6 tt0 -100.1 111.16 23.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.339 -3.976 . . . . 28.899999999999999 109.1 -172.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.2 152.99 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 1 O-C-N 113.29 -5.881 . . . . 12.050000000000001 117.937 -172.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -117.36 161.03 35.32 Favored Pre-proline 0 N--CA 1.43 -1.446 1 O-C-N 116.154 -4.091 . . . . 18.170000000000002 119.327 170.467 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -66.59 -17.63 53.15 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 CA-C-N 129.859 4.557 . . . . 8.1600000000000001 117.468 -175.117 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.4 m -76.74 -17.19 59.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.403 1.91 . . . . 11.130000000000001 114.414 177.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -67.98 151.78 46.55 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.925 2.774 . . . . 18.030000000000001 111.094 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -97.82 158.77 15.33 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.778 -1.826 . . . . 10.220000000000001 112.012 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.269 4.7 mm -61.34 -31.52 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 CA-C-O 128.941 4.21 . . . . 12.300000000000001 116.294 -178.648 . . . . . . . . 3 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -50.21 -43.42 52.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.051 -3.531 . . . . 36.509999999999998 114.76 162.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -73.16 -19.37 61.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.643 -2.535 . . . . 25.66 117.2 173.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.263 94.5 t -66.36 -37.87 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 117.723 -3.11 . . . . 8.1199999999999992 111.813 176.802 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -68.67 -40.63 80.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.414 3.086 . . . . 15.470000000000001 112.56 176.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.11 -52.87 59.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 121.184 3.772 . . . . 11.449999999999999 121.184 167.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -56.86 -41.15 77.43 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.674 2.034 . . . . 24.98 115.797 165.321 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -64.57 -36.8 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 125.202 2.43 . . . . 9.4600000000000009 110.585 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -53.92 -55.0 30.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.851 1.786 . . . . 14.76 113.285 171.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.259 29.4 t70 -57.89 -56.13 25.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.587 -2.571 . . . . 26.289999999999999 116.22 179.316 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -69.67 -65.35 0.73 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 125.865 2.745 . . . . 30.059999999999999 113.928 -176.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -86.39 -46.24 10.44 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.596 -4.44 . . . . 25.190000000000001 118.439 177.34 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.28 28.72 6.31 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.107 -1.997 . . . . 7.4100000000000001 108.107 168.219 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.0 mt -83.35 118.97 73.15 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.005 -1.95 . . . . 9.4900000000000002 108.641 169.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -73.63 157.25 48.72 Favored 'Trans proline' 0 N--CA 1.433 -2.036 1 CA-C-N 128.467 4.06 . . . . 11.42 114.412 -166.375 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.42 -23.72 64.79 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 123.02 2.48 . . . . 12.0 116.659 -168.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.88 -28.53 39.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.317 1.969 . . . . 35.549999999999997 116.317 177.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -18.03 59.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.792 2.515 . . . . 20.52 117.792 170.481 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -79.98 138.41 37.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.063 -2.273 . . . . 7.1299999999999999 116.735 177.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -137.94 129.26 27.71 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 125.666 2.651 . . . . 36.390000000000001 106.423 164.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mt -110.91 117.42 33.32 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 111.522 -2.581 . . . . 9.5500000000000007 112.584 -173.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.15 131.19 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.984 2.114 . . . . 13.9 109.532 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.437 ' HB3' HD23 ' A' ' 50' ' ' LEU . 11.5 t80 -122.75 107.4 11.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.826 -2.287 . . . . 6.8600000000000003 104.826 178.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.315 . . 69.93 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 125.572 1.795 . . . . 11.15 113.971 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.9 -29.87 3.66 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-O 118.419 -1.211 . . . . 13.93 112.796 175.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -94.79 127.95 41.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 126.248 1.793 . . . . 23.920000000000002 115.116 -162.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -77.13 132.72 38.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.378 2.037 . . . . 23.23 115.533 166.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 45' ' ' PHE 0.26 7.6 mt -91.07 133.29 35.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.263 -2.773 . . . . 9.1099999999999994 113.125 -163.692 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -88.86 121.85 31.65 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.227 -1.545 . . . . 33.439999999999998 114.07 -176.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -29.49 -57.75 0.16 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.032 3.733 . . . . 28.370000000000001 115.941 -178.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.87 25.35 25.59 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 119.278 -2.139 . . . . 15.0 116.188 -168.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.1 mtt-85 -108.91 155.33 20.96 Favored 'General case' 0 N--CA 1.43 -1.463 1 C-N-CA 132.081 4.153 . . . . 25.5 113.216 170.123 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.44 23.9 p -80.69 158.93 25.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 128.292 3.901 . . . . 11.949999999999999 115.045 177.615 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mp -68.86 -8.36 43.1 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.782 -5.574 . . . . 10.17 116.358 166.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.33 -42.85 18.21 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 112.686 -3.53 . . . . 13.59 103.294 177.52 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -62.47 -28.56 69.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 123.27 2.759 . . . . 11.699999999999999 114.466 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -94.32 -4.68 48.2 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.483 2.313 . . . . 12.949999999999999 112.088 175.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 m120 63.52 44.22 5.42 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.734 3.214 . . . . 25.449999999999999 110.007 169.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.7 mt -80.22 113.58 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 119.89 -1.756 . . . . 14.6 111.41 -178.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.261 14.6 mm100 -71.4 -179.56 2.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 124.644 2.164 . . . . 33.229999999999997 109.455 173.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -79.21 144.57 34.28 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-O 128.752 4.12 . . . . 25.969999999999999 109.95 165.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.366 65.8 mt-10 71.09 32.99 2.15 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.334 -2.666 . . . . 32.609999999999999 110.26 174.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.269 2.9 m -98.55 144.93 27.34 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 116.559 -3.838 . . . . 10.56 107.269 175.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -94.82 115.36 27.4 Favored 'General case' 0 N--CA 1.431 -1.423 1 C-N-CA 132.147 4.179 . . . . 5.3300000000000001 110.267 176.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.69 129.83 34.72 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.62 -1.622 . . . . 11.66 106.62 170.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -81.1 105.91 12.68 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.932 -2.355 . . . . 16.300000000000001 108.413 168.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -84.93 108.72 17.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.226 2.61 . . . . 9.9600000000000009 109.893 168.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 m -113.74 168.59 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.237 2.215 . . . . 9.7599999999999998 106.264 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.9 tp . . . . . 0 N--CA 1.43 -1.465 0 O-C-N 127.748 3.155 . . . . 19.57 108.886 -167.491 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.335 0 N-CA-C 104.455 -2.424 . . . . 17.170000000000002 104.455 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -114.3 160.12 19.44 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.938 -1.726 . . . . 21.890000000000001 115.459 173.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.4 pt -133.7 154.17 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 1 CA-C-O 129.434 4.445 . . . . 10.83 105.32 169.842 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -106.96 105.03 14.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.026 3.298 . . . . 10.609999999999999 102.872 177.073 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.32 105.19 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.009 -2.307 . . . . 9.1300000000000008 112.838 171.173 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -95.64 128.04 42.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.258 1.98 . . . . 20.550000000000001 111.499 -175.498 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -82.29 -179.16 7.31 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.939 -3.601 . . . . 11.779999999999999 113.845 -172.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.0 tp -75.22 -48.52 23.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.467 -3.896 . . . . 19.309999999999999 112.114 -176.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.0 p -70.22 -24.0 63.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.93 2.776 . . . . 23.140000000000001 116.647 -178.632 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.36 75.88 0.52 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 118.657 -2.527 . . . . 19.739999999999998 110.517 170.916 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 80.3 tttt -142.16 139.38 32.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.882 -3.007 . . . . 21.93 102.882 170.141 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.3 m -106.52 104.19 13.82 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.296 1.438 . . . . 12.33 110.626 176.112 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 mt -92.31 118.21 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 118.468 -0.777 . . . . 17.079999999999998 109.636 176.817 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.5 m -95.83 122.72 38.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.229 -3.248 . . . . 16.300000000000001 102.229 179.005 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 tp -127.85 147.53 50.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.364 -0.835 . . . . 15.880000000000001 112.386 -176.216 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -95.87 122.73 38.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.284 -1.817 . . . . 28.899999999999999 108.787 178.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.23 168.06 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.196 2.599 . . . . 12.050000000000001 109.187 177.686 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -107.12 153.41 41.04 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 116.756 -3.715 . . . . 18.170000000000002 101.264 163.644 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.43 -12.96 32.49 Favored 'Trans proline' 0 N--CA 1.433 -2.036 2 C-N-CA 128.323 6.016 . . . . 8.1600000000000001 105.122 179.699 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p -83.97 12.44 6.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.017 2.927 . . . . 11.130000000000001 114.387 171.538 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -93.34 146.12 23.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.599 -2.0 . . . . 18.030000000000001 105.599 176.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.9 p -89.1 168.58 12.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.852 -1.536 . . . . 10.220000000000001 106.852 -175.456 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -82.24 -28.08 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 116.151 1.908 . . . . 12.300000000000001 116.151 -173.671 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -48.27 -50.31 30.29 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.745 -2.48 . . . . 36.509999999999998 112.078 155.349 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -59.0 -53.03 63.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.239 2.681 . . . . 25.66 118.239 168.021 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 t -50.22 -37.99 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 116.552 2.056 . . . . 8.1199999999999992 116.552 171.087 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -68.33 -41.55 80.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 117.725 -1.131 . . . . 15.470000000000001 113.984 173.598 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.69 70.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.907 3.299 . . . . 11.449999999999999 119.907 174.197 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -61.89 -47.42 85.04 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.976 2.911 . . . . 24.98 113.002 170.17 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.51 -35.0 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.982 -1.698 . . . . 9.4600000000000009 108.595 -176.814 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -62.02 -46.79 87.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.428 -3.295 . . . . 14.76 113.876 170.29 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -49.27 -58.97 4.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.458 2.762 . . . . 26.289999999999999 118.458 163.711 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -71.04 -67.41 0.51 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.237 -2.789 . . . . 30.059999999999999 116.203 -178.58 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.422 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 60.5 mm-40 -85.33 -24.87 27.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.916 1.817 . . . . 25.190000000000001 114.077 -171.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.82 38.89 14.8 Favored Glycine 0 N--CA 1.43 -1.727 0 O-C-N 119.611 -1.931 . . . . 7.4100000000000001 115.235 -178.614 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.1 mt -102.98 109.91 62.42 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 114.3 -2.762 . . . . 9.4900000000000002 109.013 -179.168 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.7 142.23 82.98 Favored 'Trans proline' 0 N--CA 1.434 -1.987 2 C-N-CA 127.181 5.254 . . . . 11.42 114.321 -171.649 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.47 -17.97 6.08 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 123.026 2.116 . . . . 12.0 109.946 -159.807 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.269 37.0 m-20 -60.49 -23.67 64.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 126.551 2.407 . . . . 35.549999999999997 116.486 161.954 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -84.3 -33.04 24.04 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 117.261 -3.399 . . . . 20.52 115.263 176.595 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -67.41 138.03 56.37 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.026 3.343 . . . . 7.1299999999999999 120.026 -179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -136.71 132.09 34.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 105.181 -2.155 . . . . 36.390000000000001 105.181 161.441 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.253 11.4 mt -111.91 124.89 53.33 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 129.279 4.112 . . . . 9.5500000000000007 107.702 -174.621 . . . . . . . . 3 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 34.3 mt -117.79 117.84 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.704 2.402 . . . . 13.9 111.2 -173.165 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -94.55 102.97 14.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.567 -1.958 . . . . 6.8600000000000003 110.96 168.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.99 -81.35 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.767 2.136 . . . . 11.15 116.767 -163.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.85 16.91 2.39 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 104.666 -3.374 . . . . 13.93 104.666 172.773 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -95.73 111.49 23.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 119.255 1.528 . . . . 23.920000000000002 114.671 171.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -76.73 116.55 17.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.836 -1.529 . . . . 23.23 111.721 -179.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.0 mt -87.26 138.64 31.31 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.457 -3.277 . . . . 9.1099999999999994 112.806 -164.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -97.21 161.23 13.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.428 2.01 . . . . 33.439999999999998 116.428 -175.894 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.269 7.8 m-20 -46.4 -68.78 0.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 119.829 3.27 . . . . 28.370000000000001 119.829 -166.844 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.14 8.4 70.85 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 118.013 1.965 . . . . 15.0 118.013 -165.977 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.44 HH21 ' CG ' ' A' ' 58' ' ' ASP . 7.2 mmm180 -94.92 158.88 15.29 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 126.866 3.222 . . . . 25.5 112.092 -176.844 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.95 164.03 12.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.089 2.376 . . . . 11.949999999999999 109.229 -179.335 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.69 -18.92 62.14 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 112.762 -3.494 . . . . 10.17 113.207 171.482 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -71.22 -31.86 68.09 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 126.046 2.091 . . . . 13.59 112.464 169.587 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' CG ' HH21 ' A' ' 54' ' ' ARG . 61.0 m-20 -66.41 -53.1 39.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.55 -3.219 . . . . 11.699999999999999 109.269 179.012 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -66.42 -19.76 65.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.704 -3.122 . . . . 12.949999999999999 110.683 -179.454 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 m120 73.64 47.54 0.17 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.616 1.71 . . . . 25.449999999999999 115.616 -178.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.72 111.65 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.179 2.419 . . . . 14.6 110.003 -177.021 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -71.03 174.5 6.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 112.327 -2.215 . . . . 33.229999999999997 111.681 -176.17 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -52.46 133.22 35.48 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.561 3.171 . . . . 25.969999999999999 119.561 168.68 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 60.53 50.71 5.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.666 -3.146 . . . . 32.609999999999999 113.392 175.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 m -107.35 154.6 21.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.875 -1.511 . . . . 10.56 110.74 -179.426 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -102.08 126.68 49.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.377 3.548 . . . . 5.3300000000000001 107.244 -168.294 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.23 145.9 39.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 117.524 -1.227 . . . . 11.66 109.243 178.339 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 89.8 m-70 -101.59 123.84 46.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.495 -1.668 . . . . 16.300000000000001 106.495 177.942 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 tp -100.4 117.88 35.49 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.613 2.365 . . . . 9.9600000000000009 107.62 174.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -115.46 -165.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.602 2.075 . . . . 9.7599999999999998 116.602 171.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 N--CA 1.43 -1.437 0 O-C-N 120.043 -1.661 . . . . 19.57 113.327 168.293 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.409 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 39.7 ttm . . . . . 0 CA--C 1.49 -1.365 0 N-CA-C 110.297 -0.26 . . . . 17.170000000000002 110.297 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -87.82 134.12 33.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.741 -1.85 . . . . 21.890000000000001 112.454 171.06 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -122.09 171.22 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 119.162 0.892 . . . . 10.83 110.675 162.497 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -116.09 121.65 42.8 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.133 -2.854 . . . . 10.609999999999999 109.319 174.39 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.3 t -106.2 104.49 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 124.971 2.319 . . . . 9.1300000000000008 111.483 173.11 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -82.74 134.37 35.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.906 -3.621 . . . . 20.550000000000001 113.822 -177.804 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.7 p -87.12 176.22 7.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.364 1.665 . . . . 11.779999999999999 110.963 -174.376 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.64 -44.4 64.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.75 1.22 . . . . 19.309999999999999 109.636 177.707 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -69.55 -63.7 1.02 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.47 1.508 . . . . 23.140000000000001 114.231 -177.426 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.23 21.82 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 115.589 -3.196 . . . . 19.739999999999998 115.42 176.178 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.581 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 80.4 tttt -105.28 138.58 41.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.318 -1.364 . . . . 21.93 107.318 -173.929 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -105.43 118.45 36.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.717 -2.489 . . . . 12.33 107.182 168.713 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.39 126.68 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 114.102 -2.856 . . . . 17.079999999999998 107.211 -173.553 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.3 m -101.37 125.69 48.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 102.888 -3.004 . . . . 16.300000000000001 102.888 -171.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -141.05 131.0 24.48 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.721 -2.696 . . . . 15.880000000000001 103.721 -154.91 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -114.85 107.13 15.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.025 -2.954 . . . . 28.899999999999999 103.025 -168.082 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.6 155.76 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 128.541 2.737 . . . . 12.050000000000001 112.727 -177.412 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -89.47 143.86 31.28 Favored Pre-proline 0 N--CA 1.43 -1.443 1 CA-C-O 111.465 -4.112 . . . . 18.170000000000002 108.494 171.152 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -87.47 -5.77 7.21 Favored 'Trans proline' 0 N--CA 1.433 -2.043 2 CA-C-N 129.132 4.297 . . . . 8.1600000000000001 105.628 -173.767 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.267 65.9 m -84.11 -6.51 59.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.014 -1.074 . . . . 11.130000000000001 113.726 171.817 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -107.91 161.14 15.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 128.16 3.838 . . . . 18.030000000000001 108.843 -179.132 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -77.23 166.9 22.61 Favored 'General case' 0 N--CA 1.43 -1.446 1 N-CA-C 121.849 4.018 . . . . 10.220000000000001 121.849 -176.006 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -63.25 -32.85 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.039 1.335 . . . . 12.300000000000001 111.64 174.587 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -53.61 -44.15 69.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.109 -1.619 . . . . 36.509999999999998 112.032 172.537 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -79.84 -14.3 58.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.3 -3.375 . . . . 25.66 114.309 178.004 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.0 t -69.22 -47.62 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.251 -2.156 . . . . 8.1199999999999992 109.866 165.522 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.25 90.7 mttt -69.68 -28.39 65.81 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.07 1.748 . . . . 15.470000000000001 111.527 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.271 . . -65.8 -38.04 87.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.832 2.053 . . . . 11.449999999999999 106.885 175.502 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -73.32 -31.69 64.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.004 2.638 . . . . 24.98 116.55 178.199 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.25 70.8 mt -72.34 -42.21 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.081 2.372 . . . . 9.4600000000000009 111.317 172.108 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -49.93 -35.63 24.72 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.475 2.028 . . . . 14.76 116.475 169.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -85.59 -55.28 4.07 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.814 -1.921 . . . . 26.289999999999999 105.814 -173.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -71.85 -44.46 63.8 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.507 -1.371 . . . . 30.059999999999999 112.774 -169.419 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.581 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 67.5 mm-40 -106.89 -33.09 7.64 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.529 -1.357 . . . . 25.190000000000001 109.589 -162.054 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.4 46.69 4.88 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 128.124 2.774 . . . . 7.4100000000000001 113.81 170.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.0 mt -106.93 128.6 25.79 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 101.364 -3.569 . . . . 9.4900000000000002 101.364 176.355 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -82.86 162.95 16.06 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 O-C-N 117.029 -2.143 . . . . 11.42 110.857 179.409 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.15 -23.23 4.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 N-CA-C 121.386 3.571 . . . . 12.0 121.386 166.087 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -68.08 -23.65 64.96 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.608 -2.557 . . . . 35.549999999999997 106.936 178.258 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -108.73 -12.94 14.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 127.266 3.412 . . . . 20.52 116.267 -179.304 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -86.84 115.46 24.27 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 115.678 -4.389 . . . . 7.1299999999999999 113.46 -177.384 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -111.89 117.24 32.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.297 -1.001 . . . . 36.390000000000001 108.297 163.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -98.98 131.44 45.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.889 1.676 . . . . 9.5500000000000007 106.716 178.813 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.8 mt -131.2 140.51 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 119.487 -2.008 . . . . 13.9 107.062 177.397 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -101.28 100.92 11.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.228 3.811 . . . . 6.8600000000000003 108.678 161.674 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.09 -91.48 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.532 2.333 . . . . 11.15 116.704 -169.366 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.84 14.49 6.69 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 116.928 -2.04 . . . . 13.93 111.241 175.724 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -98.46 108.81 21.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 126.514 1.949 . . . . 23.920000000000002 106.785 173.899 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -79.74 102.28 8.93 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 119.963 3.32 . . . . 23.23 119.963 171.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.12 146.18 55.32 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 124.737 2.208 . . . . 9.1099999999999994 114.729 -155.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -107.06 143.87 34.54 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.119 -4.113 . . . . 33.439999999999998 112.835 178.805 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.96 -38.95 20.35 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 114.571 -2.633 . . . . 28.370000000000001 114.313 -153.379 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.88 45.78 3.57 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 124.024 3.102 . . . . 15.0 113.818 163.901 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -131.46 162.51 30.04 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.119 -4.754 . . . . 25.5 105.252 170.622 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -108.26 172.86 6.6 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 117.591 -3.193 . . . . 11.949999999999999 114.82 -175.669 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mt -64.81 -37.87 89.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.16 1.457 . . . . 10.17 108.191 169.006 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.356 1.2 m -56.2 -36.95 68.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.468 3.507 . . . . 13.59 120.468 167.626 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -58.75 -42.67 89.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.351 -2.718 . . . . 11.699999999999999 114.009 165.527 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -81.07 -7.39 59.55 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.731 -1.855 . . . . 12.949999999999999 111.426 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.256 60.8 m-80 55.78 48.42 18.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.321 2.249 . . . . 25.449999999999999 116.023 -171.872 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -84.32 140.47 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.009 1.723 . . . . 14.6 113.014 175.625 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -109.1 -175.06 2.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.122 1.769 . . . . 33.229999999999997 106.879 -170.247 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HG2' ' HG3' ' A' ' 1' ' ' MET 0.299 18.3 mtmm -72.63 147.53 45.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.662 -1.899 . . . . 25.969999999999999 112.532 174.97 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 78.51 20.85 0.83 Allowed 'General case' 0 N--CA 1.43 -1.441 1 C-N-CA 132.027 4.131 . . . . 32.609999999999999 106.863 166.341 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -88.48 159.97 17.72 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 116.08 -4.137 . . . . 10.56 109.779 -163.934 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 m -103.84 134.98 46.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 124.328 2.013 . . . . 5.3300000000000001 112.473 -175.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -114.71 169.24 9.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 130.447 3.499 . . . . 11.66 108.302 165.222 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -123.62 136.5 54.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 114.775 -2.536 . . . . 16.300000000000001 107.753 174.002 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tp -97.04 113.95 25.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.542 2.428 . . . . 9.9600000000000009 113.96 159.572 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -116.96 -166.01 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 116.764 -3.71 . . . . 9.7599999999999998 108.542 162.515 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.43 -1.452 0 C-N-CA 127.345 2.258 . . . . 19.57 109.668 -172.359 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 CA--C 1.49 -1.346 0 N-CA-C 115.65 1.722 . . . . 17.170000000000002 115.65 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -86.75 133.62 33.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.967 3.707 . . . . 21.890000000000001 110.941 171.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.39 158.83 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 119.569 1.077 . . . . 10.83 108.376 172.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.93 145.09 31.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.324 1.059 . . . . 10.609999999999999 109.935 168.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.511 HG22 ' HB2' ' A' ' 67' ' ' LEU . 85.7 t -122.3 139.08 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 101.22 -3.622 . . . . 9.1300000000000008 101.22 168.994 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -117.6 124.5 48.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.162 -0.926 . . . . 20.550000000000001 112.843 177.245 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -79.69 166.84 21.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.073 -1.876 . . . . 11.779999999999999 115.563 -177.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.9 tt -74.5 -43.61 55.16 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.687 -4.383 . . . . 19.309999999999999 108.912 -172.948 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -60.06 -44.06 94.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.575 -3.203 . . . . 23.140000000000001 110.024 173.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.21 59.87 0.21 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 126.233 2.208 . . . . 19.739999999999998 111.123 177.37 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.576 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 72.9 tttt -107.53 127.16 53.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.453 1.101 . . . . 21.93 109.553 161.561 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -101.07 112.2 24.61 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.124 -0.985 . . . . 12.33 108.892 174.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 pt -109.94 134.98 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 125.963 2.792 . . . . 17.079999999999998 111.01 -172.397 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.2 m -89.25 115.22 26.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.512 -1.992 . . . . 16.300000000000001 109.142 -174.769 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 mt -104.0 167.23 9.9 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.373 -2.079 . . . . 15.880000000000001 114.629 170.015 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.321 9.2 tt0 -130.47 113.69 14.6 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.565 1.546 . . . . 28.899999999999999 115.169 168.45 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.76 145.28 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.957 1.703 . . . . 12.050000000000001 110.363 -173.176 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.84 148.17 94.59 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 117.267 -3.396 . . . . 18.170000000000002 113.018 158.596 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -65.97 -21.68 56.45 Favored 'Trans proline' 0 C--N 1.3 -2.019 3 C-N-CA 126.214 4.609 . . . . 8.1600000000000001 113.414 172.096 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.8 m -84.61 8.11 17.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.681 1.705 . . . . 11.130000000000001 115.483 173.756 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -87.82 157.98 18.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.546 -2.596 . . . . 18.030000000000001 109.248 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -95.1 167.7 11.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.091 2.957 . . . . 10.220000000000001 115.061 -176.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -67.26 -26.35 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.211 1.93 . . . . 12.300000000000001 116.211 172.321 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -63.41 -47.52 81.64 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.073 -2.267 . . . . 36.509999999999998 112.03 175.264 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.91 -23.36 65.98 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.001 2.52 . . . . 25.66 113.738 176.096 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.31 -58.16 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.955 2.902 . . . . 8.1199999999999992 107.87 167.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -70.56 -17.99 62.92 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 115.353 -4.592 . . . . 15.470000000000001 116.495 -173.896 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.55 -28.26 65.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.061 -1.65 . . . . 11.449999999999999 109.315 167.171 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -77.93 -33.36 51.76 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.497 1.499 . . . . 24.98 111.05 -177.036 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.1 -34.74 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 128.368 2.667 . . . . 9.4600000000000009 110.213 178.529 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -56.75 -47.53 79.85 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 117.959 -1.02 . . . . 14.76 113.057 165.756 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -65.78 -57.95 6.8 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.059 2.614 . . . . 26.289999999999999 118.059 171.798 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -59.28 -52.16 66.87 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.46 3.133 . . . . 30.059999999999999 119.46 -173.359 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.576 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 64.5 mm-40 -107.09 -43.64 4.57 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 122.079 0.943 . . . . 25.190000000000001 109.681 176.418 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.32 47.43 2.02 Favored Glycine 0 N--CA 1.43 -1.741 0 O-C-N 118.264 -2.772 . . . . 7.4100000000000001 110.733 -173.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 mt -104.55 114.61 63.9 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 101.516 -3.513 . . . . 9.4900000000000002 101.516 168.249 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -83.62 163.41 14.4 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 CA-C-O 111.719 -3.534 . . . . 11.42 116.55 -171.061 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -81.6 -3.61 11.96 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 130.279 4.707 . . . . 12.0 111.281 -162.265 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.51 -26.4 45.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.001 1.273 . . . . 35.549999999999997 112.945 176.215 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -69.24 -51.24 39.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.912 3.671 . . . . 20.52 120.912 158.062 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -68.45 116.5 9.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.787 2.708 . . . . 7.1299999999999999 115.858 -168.892 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -111.83 113.84 26.44 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.216 -4.678 . . . . 36.390000000000001 105.961 168.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 mt -83.61 127.65 33.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.155 1.798 . . . . 9.5500000000000007 110.88 -179.919 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.6 mm -121.45 139.81 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 125.947 1.699 . . . . 13.9 108.282 177.774 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -135.25 139.99 44.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 104.206 -2.516 . . . . 6.8600000000000003 104.206 157.207 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.266 . . 47.92 -98.86 0.05 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.504 2.721 . . . . 11.15 112.052 -164.899 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.91 31.05 1.35 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 114.376 -3.773 . . . . 13.93 110.252 167.568 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -95.18 147.34 23.56 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.242 1.417 . . . . 23.920000000000002 108.11 166.689 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -99.62 139.46 35.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.927 -1.511 . . . . 23.23 110.692 170.595 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.258 0.4 OUTLIER -113.74 131.75 56.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.092 1.495 . . . . 9.1099999999999994 107.574 -163.756 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -101.08 157.36 16.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 125.333 1.646 . . . . 33.439999999999998 115.075 -162.71 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.259 33.6 m-20 -59.8 -53.72 54.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 121.447 3.869 . . . . 28.370000000000001 121.447 -165.283 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.86 33.93 5.24 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-N 121.109 1.777 . . . . 15.0 115.695 -179.408 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -113.92 150.34 33.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.18 -2.953 . . . . 25.5 105.092 169.712 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -90.16 171.48 9.49 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.939 2.78 . . . . 11.949999999999999 111.653 -170.21 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.63 -30.49 26.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.978 -3.576 . . . . 10.17 108.722 -176.789 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -59.05 -39.83 83.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.792 2.837 . . . . 13.59 108.233 170.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -58.03 -59.92 4.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.631 -3.793 . . . . 11.699999999999999 111.247 179.496 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -70.74 -11.96 61.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 130.099 3.359 . . . . 12.949999999999999 112.056 -170.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 65.71 60.04 0.72 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.92 -2.988 . . . . 25.449999999999999 112.851 -179.193 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mm -90.69 137.05 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.319 -2.738 . . . . 14.6 110.646 179.556 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -101.06 -175.8 2.98 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.507 -1.995 . . . . 33.229999999999997 114.883 -171.876 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -78.17 142.12 38.21 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.124 1.157 . . . . 25.969999999999999 114.124 178.661 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 61.11 30.84 19.65 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.214 2.206 . . . . 32.609999999999999 112.401 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.1 t -81.35 158.44 24.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 117.053 2.242 . . . . 10.56 117.053 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.3 m -121.37 103.76 9.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.145 -2.222 . . . . 5.3300000000000001 107.805 -166.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.511 ' HB2' HG22 ' A' ' 5' ' ' VAL 0.273 91.6 mt -88.48 147.35 24.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.142 2.977 . . . . 11.66 107.438 175.542 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -100.84 137.72 38.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.303 2.252 . . . . 16.300000000000001 110.093 -178.625 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 mt -106.07 141.22 37.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.908 -1.745 . . . . 9.9600000000000009 111.778 165.122 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.85 -169.85 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.62 2.368 . . . . 9.7599999999999998 108.517 169.969 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.43 -1.448 0 C-N-CA 131.369 3.868 . . . . 19.57 116.06 -173.103 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 CA--C 1.49 -1.361 0 CA-C-O 121.447 0.642 . . . . 17.170000000000002 110.874 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -89.39 152.07 21.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.239 1.971 . . . . 21.890000000000001 109.987 170.549 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.471 HD13 HD13 ' A' ' 67' ' ' LEU . 10.2 pt -126.33 168.71 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.668 2.787 . . . . 10.83 109.401 154.811 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -119.15 145.75 45.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.775 1.75 . . . . 10.609999999999999 110.927 164.255 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.9 123.53 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 116.618 -3.801 . . . . 9.1300000000000008 107.897 169.305 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -93.09 121.14 34.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.884 3.23 . . . . 20.550000000000001 109.72 176.227 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 30.2 p -78.18 -176.88 4.83 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.098 -4.751 . . . . 11.779999999999999 111.663 -174.138 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.3 tp -81.9 -34.36 30.02 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 111.823 -6.798 . . . . 19.309999999999999 113.337 -175.666 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.1 p -88.15 -26.29 22.52 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.12 -2.238 . . . . 23.140000000000001 107.06 -173.18 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.41 0.21 Allowed Glycine 0 N--CA 1.43 -1.738 0 CA-C-N 118.968 0.804 . . . . 19.739999999999998 113.161 166.121 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -112.1 145.62 39.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.367 -1.666 . . . . 21.93 108.043 169.552 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -111.15 123.78 50.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.991 2.057 . . . . 12.33 106.743 176.08 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.6 pt -110.7 141.99 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.76 -1.212 . . . . 17.079999999999998 113.856 177.232 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.7 m -110.57 112.85 25.03 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 115.491 -4.506 . . . . 16.300000000000001 111.047 -174.782 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 mt -106.35 124.13 49.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.443 2.068 . . . . 15.880000000000001 108.967 -173.953 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -97.6 105.43 17.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.865 -3.022 . . . . 28.899999999999999 111.987 176.698 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -131.47 149.25 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.921 2.088 . . . . 12.050000000000001 107.677 -159.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -85.5 151.83 56.59 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 112.592 -3.575 . . . . 18.170000000000002 113.182 176.334 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -84.71 -6.06 9.8 Favored 'Trans proline' 0 N--CA 1.434 -2.028 1 CA-C-N 132.554 5.519 . . . . 8.1600000000000001 109.072 -168.866 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -98.64 5.68 47.57 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.559 -3.213 . . . . 11.130000000000001 110.117 176.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -75.76 157.73 33.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.79 3.186 . . . . 18.030000000000001 108.677 173.394 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 p -96.37 164.26 12.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.812 -3.68 . . . . 10.220000000000001 108.29 -175.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mm -76.96 -16.6 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 119.516 -1.99 . . . . 12.300000000000001 111.692 -176.326 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -64.27 -46.88 81.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.343 -1.725 . . . . 36.509999999999998 106.343 172.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.77 -30.95 71.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.617 -2.552 . . . . 25.66 113.48 -178.296 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.77 -44.07 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 126.707 3.146 . . . . 8.1199999999999992 108.265 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -62.78 -39.25 93.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 120.67 3.581 . . . . 15.470000000000001 120.67 172.756 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.76 -41.1 77.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.741 2.817 . . . . 11.449999999999999 113.76 175.045 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -57.13 -32.47 66.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.847 1.259 . . . . 24.98 110.4 178.82 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 mt -82.41 -37.71 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.977 1.846 . . . . 9.4600000000000009 109.194 -173.075 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -62.1 -39.53 92.79 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.143 -1.598 . . . . 14.76 112.602 168.509 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.5 -55.16 30.13 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 115.621 -2.133 . . . . 26.289999999999999 113.052 175.236 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -78.52 -54.9 5.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.964 3.32 . . . . 30.059999999999999 119.964 -171.98 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -92.87 -36.13 12.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.548 -2.595 . . . . 25.190000000000001 112.115 176.991 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.84 55.98 2.56 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 117.763 -3.086 . . . . 7.4100000000000001 115.425 -174.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.0 mt -108.93 135.87 20.1 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 116.111 -1.899 . . . . 9.4900000000000002 105.982 172.945 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -71.53 146.58 49.98 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-O 112.397 -3.251 . . . . 11.42 119.591 -170.149 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -91.53 8.57 3.1 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 CA-C-N 128.163 3.951 . . . . 12.0 112.96 -165.729 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.42 -44.19 10.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.799 2.839 . . . . 35.549999999999997 109.142 165.393 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.31 -42.11 65.81 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 113.826 -2.988 . . . . 20.52 111.555 175.253 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.268 72.6 mt-30 -66.45 108.97 2.57 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 126.616 3.103 . . . . 7.1299999999999999 115.67 -174.169 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -106.51 110.02 22.11 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.114 4.165 . . . . 36.390000000000001 105.278 -174.223 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.49 ' HG ' HD13 ' A' ' 50' ' ' LEU . 25.8 tp -100.27 108.87 21.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 126.037 2.827 . . . . 9.5500000000000007 108.182 -162.735 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -106.66 145.82 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.141 -3.475 . . . . 13.9 113.09 -173.54 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -129.99 100.17 5.35 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.624 2.631 . . . . 6.8600000000000003 106.642 172.736 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.88 -75.51 0.07 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.638 -2.539 . . . . 11.15 115.63 -176.352 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.58 1.2 1.33 Allowed Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 126.527 2.013 . . . . 13.93 113.621 171.532 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -99.13 146.55 26.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.201 -2.352 . . . . 23.920000000000002 110.079 173.659 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.296 10.0 tt0 -91.1 117.29 29.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.045 2.609 . . . . 23.23 118.045 164.119 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.49 HD13 ' HG ' ' A' ' 43' ' ' LEU . 19.4 mt -65.85 131.92 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 1 C-N-CA 133.177 4.591 . . . . 9.1099999999999994 113.581 170.841 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.9 146.33 44.01 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.811 -1.181 . . . . 33.439999999999998 107.811 -169.084 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.65 -27.45 68.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.19 -2.277 . . . . 28.370000000000001 115.563 -158.65 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.04 24.43 30.53 Favored Glycine 0 N--CA 1.43 -1.729 1 O-C-N 114.526 -5.109 . . . . 15.0 117.353 -166.335 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -129.22 166.46 19.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.479 -0.934 . . . . 25.5 108.479 -176.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.295 22.2 p -92.93 157.91 16.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.251 1.501 . . . . 11.949999999999999 111.052 -173.708 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.2 mt -55.76 -34.04 64.87 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.449 1.595 . . . . 10.17 113.463 168.77 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 t -78.42 -25.43 46.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.895 3.278 . . . . 13.59 118.869 170.751 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -61.77 -47.58 84.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.734 -2.479 . . . . 11.699999999999999 113.044 166.871 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -81.76 -16.63 50.43 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.456 3.102 . . . . 12.949999999999999 111.271 -179.205 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 56.51 51.46 11.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.125 2.97 . . . . 25.449999999999999 109.39 -178.583 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.39 120.19 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 110.851 -2.886 . . . . 14.6 108.679 163.24 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -83.49 176.82 8.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.451 1.9 . . . . 33.229999999999997 110.365 -176.564 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.274 47.7 mttp -81.98 134.39 35.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.141 2.576 . . . . 25.969999999999999 109.55 179.81 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 56.83 34.03 24.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.787 2.835 . . . . 32.609999999999999 116.141 -175.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -72.14 127.44 32.55 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 127.591 3.567 . . . . 10.56 111.67 166.007 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.6 m -95.65 109.12 21.43 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 112.16 -2.291 . . . . 5.3300000000000001 112.499 179.297 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.471 HD13 HD13 ' A' ' 3' ' ' ILE . 20.4 mt -96.36 175.26 6.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.815 -1.178 . . . . 11.66 109.899 -172.945 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -128.65 136.13 50.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.827 -1.171 . . . . 16.300000000000001 112.432 -175.478 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 57.4 tp -120.6 129.77 53.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.552 -1.967 . . . . 9.9600000000000009 108.004 -176.063 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.53 163.43 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.366 1.066 . . . . 9.7599999999999998 109.727 170.186 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.43 -1.447 0 O-C-N 120.182 -1.574 . . . . 19.57 109.548 -169.172 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.366 0 CA-C-O 123.144 1.449 . . . . 17.170000000000002 108.774 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -108.29 138.06 45.22 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.202 -4.061 . . . . 21.890000000000001 108.74 -172.576 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -133.78 148.85 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.609 -2.557 . . . . 10.83 107.361 -179.842 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.68 110.88 22.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.729 2.122 . . . . 10.609999999999999 116.729 177.311 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 t -101.14 122.7 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 120.918 1.69 . . . . 9.1300000000000008 108.863 175.635 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -90.32 111.32 22.48 Favored 'General case' 0 N--CA 1.429 -1.495 1 C-N-CA 131.881 4.072 . . . . 20.550000000000001 113.247 175.249 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 11' ' ' LYS . 5.3 p -76.93 159.49 29.94 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.253 1.945 . . . . 11.779999999999999 116.253 176.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 tp -53.52 -49.69 67.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.239 2.215 . . . . 19.309999999999999 110.981 -178.605 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.4 p -65.85 -38.1 87.95 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.533 3.533 . . . . 23.140000000000001 113.751 178.37 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.66 51.07 0.26 Allowed Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 127.785 2.612 . . . . 19.739999999999998 116.496 -178.195 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 7' ' ' THR . 53.3 mtpt -121.53 128.92 52.54 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.961 -1.905 . . . . 21.93 108.764 165.645 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.6 m -99.59 108.22 20.57 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.697 -3.752 . . . . 12.33 105.9 171.199 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pt -105.15 140.79 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 130.25 3.42 . . . . 17.079999999999998 104.536 -171.818 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -109.14 131.22 55.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.143 -2.848 . . . . 16.300000000000001 108.624 -170.239 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.0 mt -113.3 140.55 47.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.89 -1.893 . . . . 15.880000000000001 105.89 -179.147 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -100.24 128.25 46.35 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.585 -1.265 . . . . 28.899999999999999 107.585 171.127 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.05 152.15 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.193 -2.817 . . . . 12.050000000000001 117.188 -168.847 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.26 32.5 mt-10 -97.03 148.78 34.89 Favored Pre-proline 0 N--CA 1.43 -1.456 1 O-C-N 115.795 -4.316 . . . . 18.170000000000002 105.863 172.246 . . . . . . . . 3 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -82.31 -8.57 11.7 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.687 1.888 . . . . 8.1600000000000001 111.899 -169.544 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -81.06 -12.47 59.31 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.944 2.097 . . . . 11.130000000000001 109.976 -179.086 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -90.7 154.36 19.61 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 126.457 3.027 . . . . 18.030000000000001 109.259 -176.582 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.9 p -83.11 175.83 9.69 Favored 'General case' 0 N--CA 1.43 -1.43 2 O-C-N 114.63 -5.043 . . . . 10.220000000000001 117.758 -170.386 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.0 mm -79.65 -25.79 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 1 O-C-N 113.432 -5.792 . . . . 12.300000000000001 111.862 178.647 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -47.58 -40.71 19.89 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.97 2.211 . . . . 36.509999999999998 116.97 165.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -70.29 -42.33 72.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.274 2.629 . . . . 25.66 111.855 176.711 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.422 HG21 HD23 ' A' ' 56' ' ' LEU . 68.4 t -67.86 -34.14 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 117.37 -3.331 . . . . 8.1199999999999992 110.592 178.309 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.256 35.5 mtmt -65.4 -37.19 86.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.977 2.111 . . . . 15.470000000000001 112.541 166.792 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.88 -24.34 64.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.083 2.114 . . . . 11.449999999999999 112.559 -174.516 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -71.22 -37.89 72.02 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 133.599 4.76 . . . . 24.98 109.096 175.215 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.428 ' CG2' HD11 ' A' ' 36' ' ' ILE . 52.6 mt -80.51 -31.02 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.322 -1.487 . . . . 9.4600000000000009 107.575 -174.535 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.06 -31.33 68.89 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.24 1.416 . . . . 14.76 112.971 177.201 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -82.28 -52.3 7.07 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.283 2.327 . . . . 26.289999999999999 117.283 -175.471 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -86.06 -54.55 4.41 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.269 1.985 . . . . 30.059999999999999 116.046 -177.657 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -72.32 -39.89 67.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.315 -1.491 . . . . 25.190000000000001 114.484 177.291 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.89 51.78 2.94 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 116.449 -3.907 . . . . 7.4100000000000001 115.9 174.064 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.428 HD11 ' CG2' ' A' ' 30' ' ' ILE . 63.9 mt -113.18 129.21 24.78 Favored Pre-proline 0 N--CA 1.431 -1.421 0 C-N-CA 127.304 2.242 . . . . 9.4900000000000002 107.909 -176.516 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -77.39 148.95 27.15 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 114.568 -3.438 . . . . 11.42 110.01 -164.682 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -71.3 -24.39 23.06 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.805 2.337 . . . . 12.0 113.919 -156.596 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.292 5.2 p-10 -63.61 -53.23 54.8 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.687 -2.508 . . . . 35.549999999999997 110.124 173.751 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -57.43 -13.81 4.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.522 -2.611 . . . . 20.52 117.376 -177.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -93.63 95.61 9.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.351 1.46 . . . . 7.1299999999999999 109.311 -178.737 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -89.89 142.79 27.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 118.448 -1.301 . . . . 36.390000000000001 109.927 156.49 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -120.29 135.67 54.93 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.36 -0.978 . . . . 9.5500000000000007 108.36 -177.19 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mm -120.31 138.22 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.667 2.787 . . . . 13.9 106.22 -179.685 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -112.76 114.72 27.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.995 2.918 . . . . 6.8600000000000003 106.439 165.632 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.62 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.912 2.19 . . . . 11.15 116.912 -173.649 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.51 8.01 2.04 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 129.115 3.245 . . . . 13.93 106.525 -175.571 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -125.4 144.95 50.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.196 2.498 . . . . 23.920000000000002 111.927 -173.539 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -103.13 134.5 46.45 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.884 1.326 . . . . 23.23 111.127 -161.682 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.1 mt -84.68 143.89 28.91 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 115.882 -2.008 . . . . 9.1099999999999994 110.674 -176.105 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -135.11 156.37 49.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 126.529 2.393 . . . . 33.439999999999998 111.134 -173.059 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.79 -50.55 19.99 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 118.807 2.892 . . . . 28.370000000000001 118.807 -147.407 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.65 2.07 18.38 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 121.078 3.191 . . . . 15.0 121.078 -177.964 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -106.92 148.89 28.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.269 1.509 . . . . 25.5 109.613 -174.415 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -90.85 159.26 16.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.027 2.531 . . . . 11.949999999999999 111.17 -162.023 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.422 HD23 HG21 ' A' ' 26' ' ' VAL . 8.4 mt -58.23 -45.23 88.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.809 2.844 . . . . 10.17 108.378 172.111 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -57.58 -50.14 74.08 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.798 2.09 . . . . 13.59 114.505 178.325 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -60.53 -35.89 77.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.524 -1.36 . . . . 11.699999999999999 113.509 174.61 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -79.11 2.31 21.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.361 -3.337 . . . . 12.949999999999999 116.554 177.941 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.376 4.2 m120 71.39 34.52 1.7 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.213 -1.554 . . . . 25.449999999999999 111.932 -179.602 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.8 98.63 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 105.826 -1.916 . . . . 14.6 105.826 -165.84 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -107.13 -152.89 0.49 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.347 2.022 . . . . 33.229999999999997 112.16 -174.729 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -73.87 116.96 15.09 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.882 2.549 . . . . 25.969999999999999 117.882 -170.314 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 81.38 50.2 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.287 2.635 . . . . 32.609999999999999 106.468 163.601 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 152.66 25.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.983 1.713 . . . . 10.56 112.554 -169.859 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -94.58 115.91 28.13 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.483 3.513 . . . . 5.3300000000000001 112.754 -164.416 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -116.07 147.51 41.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.024 -3.548 . . . . 11.66 111.261 173.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -121.2 127.69 51.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.916 -2.253 . . . . 16.300000000000001 104.916 -175.618 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 tp -91.11 109.94 21.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.533 2.42 . . . . 9.9600000000000009 117.533 178.473 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.87 156.09 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.199 2.599 . . . . 9.7599999999999998 106.458 -172.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.7 tp . . . . . 0 N--CA 1.43 -1.45 0 O-C-N 119.162 -2.211 . . . . 19.57 112.524 173.289 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 115.061 1.504 . . . . 17.170000000000002 115.061 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -113.2 145.49 40.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.165 -2.21 . . . . 21.890000000000001 110.467 -174.654 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 15' ' ' LEU . 6.1 pt -127.35 154.42 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.311 -1.737 . . . . 10.83 106.311 173.042 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -119.43 115.5 24.2 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.274 2.306 . . . . 10.609999999999999 106.987 -176.656 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.97 106.85 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.292 -1.505 . . . . 9.1300000000000008 113.471 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -83.56 110.2 18.03 Favored 'General case' 0 N--CA 1.43 -1.466 1 CA-C-O 128.648 4.07 . . . . 20.550000000000001 110.855 175.845 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.258 15.1 p -74.04 176.85 6.11 Favored 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 131.914 4.086 . . . . 11.779999999999999 113.238 -171.269 . . . . . . . . 3 2 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.66 -46.93 62.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.843 2.259 . . . . 19.309999999999999 114.743 -170.844 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.3 p -74.88 -91.24 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.216 3.006 . . . . 23.140000000000001 109.339 179.355 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.18 33.55 0.34 Allowed Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 121.59 1.995 . . . . 19.739999999999998 113.454 -174.675 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -122.64 141.99 51.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.136 -3.567 . . . . 21.93 115.089 178.108 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -109.54 123.56 49.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.768 -1.832 . . . . 12.33 111.461 170.477 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.0 pt -101.0 144.9 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 117.554 -1.212 . . . . 17.079999999999998 110.556 178.86 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.8 m -104.55 114.45 28.69 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.186 -2.34 . . . . 16.300000000000001 107.86 176.309 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.458 ' HB2' HG13 ' A' ' 3' ' ' ILE 0.313 96.5 mt -106.76 158.31 17.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.144 2.878 . . . . 15.880000000000001 105.234 176.021 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.323 27.0 tt0 -104.64 121.19 43.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 113.165 -1.834 . . . . 28.899999999999999 108.914 173.206 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -141.39 154.71 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 120.064 -1.647 . . . . 12.050000000000001 107.501 -179.517 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -87.87 158.37 50.53 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 119.603 -1.936 . . . . 18.170000000000002 106.907 167.229 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.12 -1.6 11.75 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 CA-C-N 122.169 1.81 . . . . 8.1600000000000001 115.664 174.117 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.5 m -86.25 -16.57 37.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.834 3.272 . . . . 11.130000000000001 119.834 173.75 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -84.26 170.25 13.9 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.872 2.869 . . . . 18.030000000000001 109.196 -174.766 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.5 p -90.92 -176.77 4.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.463 -3.273 . . . . 10.220000000000001 116.615 -173.084 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -83.16 -19.3 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 116.419 -3.926 . . . . 12.300000000000001 108.703 173.986 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -73.0 -42.51 63.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.055 -2.903 . . . . 36.509999999999998 107.309 178.216 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -54.82 -26.67 36.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.203 -1.856 . . . . 25.66 111.337 174.34 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.448 HG12 ' CD1' ' A' ' 15' ' ' LEU . 20.0 t -67.24 -54.85 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 117.795 2.517 . . . . 8.1199999999999992 117.795 167.703 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -62.48 -30.55 71.34 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 118.306 -2.746 . . . . 15.470000000000001 116.092 -177.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.68 -49.79 56.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.827 3.651 . . . . 11.449999999999999 116.153 164.074 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -63.89 -35.89 82.14 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.381 2.672 . . . . 24.98 109.845 178.04 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.49 -43.39 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.806 1.288 . . . . 9.4600000000000009 112.372 177.521 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -72.43 -37.89 68.49 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 113.899 -2.953 . . . . 14.76 109.586 -179.479 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.68 -45.79 42.2 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.408 2.822 . . . . 26.289999999999999 111.18 179.398 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -88.49 -55.29 3.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.202 -0.999 . . . . 30.059999999999999 112.703 -168.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -75.62 -63.28 1.33 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.094 1.426 . . . . 25.190000000000001 110.774 -176.214 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.11 40.3 0.45 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 125.376 1.465 . . . . 7.4100000000000001 115.099 173.804 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -104.07 118.46 57.0 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-O 116.581 -1.676 . . . . 9.4900000000000002 108.443 175.255 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -64.21 156.89 56.86 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 124.752 3.635 . . . . 11.42 112.11 -170.595 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.6 -18.78 25.24 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 115.57 1.335 . . . . 12.0 115.57 -161.171 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.59 -13.23 32.33 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 127.132 3.349 . . . . 35.549999999999997 107.013 -165.269 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.99 -6.65 58.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 112.171 -2.286 . . . . 20.52 115.778 175.193 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -102.35 107.28 18.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.735 2.124 . . . . 7.1299999999999999 116.735 -162.723 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -117.77 125.3 50.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.693 -1.254 . . . . 36.390000000000001 107.9 172.754 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 mt -102.12 128.22 48.7 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.971 -2.33 . . . . 9.5500000000000007 111.302 179.43 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.8 mt -110.01 141.72 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.608 2.363 . . . . 13.9 108.246 169.811 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.505 ' HB2' HD21 ' A' ' 67' ' ' LEU . 21.0 t80 -136.09 131.35 34.71 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.233 -2.136 . . . . 6.8600000000000003 105.233 174.148 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.15 -97.54 0.07 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.303 1.841 . . . . 11.15 112.354 -167.633 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.66 5.15 7.06 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 119.914 -1.741 . . . . 13.93 115.901 171.61 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -111.71 143.88 41.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.947 3.699 . . . . 23.920000000000002 112.146 -175.817 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -90.41 132.83 35.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 114.641 1.349 . . . . 23.23 114.641 176.643 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.4 mt -87.86 139.74 30.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.756 2.422 . . . . 9.1099999999999994 113.855 -172.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.03 -176.25 6.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.028 2.531 . . . . 33.439999999999998 110.76 168.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -83.02 -69.54 0.62 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 116.397 -3.939 . . . . 28.370000000000001 113.743 -176.557 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.9 56.35 4.36 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 120.387 -1.445 . . . . 15.0 116.007 -167.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -148.5 138.78 22.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 114.584 -2.627 . . . . 25.5 106.438 -172.669 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 44.3 p -79.68 163.87 24.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.309 2.956 . . . . 11.949999999999999 112.043 -167.926 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.51 -45.98 91.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 110.488 -3.051 . . . . 10.17 108.347 172.119 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 m -54.85 -39.47 68.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 125.56 1.787 . . . . 13.59 115.017 174.312 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -63.36 -53.5 51.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.306 -2.121 . . . . 11.699999999999999 113.213 176.199 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -70.25 -5.56 28.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.857 -1.065 . . . . 12.949999999999999 113.734 178.017 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 66.61 52.28 1.02 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.93 2.492 . . . . 25.449999999999999 110.595 179.237 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.9 119.13 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.041 -2.207 . . . . 14.6 105.041 175.758 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -120.05 -172.47 2.36 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.163 2.585 . . . . 33.229999999999997 108.72 -163.93 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -64.24 115.93 5.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 112.926 -3.416 . . . . 25.969999999999999 116.246 -174.368 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 76.93 18.7 1.5 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.986 3.314 . . . . 32.609999999999999 114.181 -176.164 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.0 m -61.12 145.27 51.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.643 -3.161 . . . . 10.56 115.68 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -94.42 126.29 39.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.705 -2.497 . . . . 5.3300000000000001 115.899 171.457 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.505 HD21 ' HB2' ' A' ' 45' ' ' PHE 0.251 22.0 mt -108.31 152.81 24.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.727 1.01 . . . . 11.66 113.727 172.62 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -114.45 131.59 56.55 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.919 -3.613 . . . . 16.300000000000001 111.656 -177.928 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.6 tp -109.56 122.6 47.79 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 118.457 -0.782 . . . . 9.9600000000000009 109.705 -178.85 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.86 -168.77 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.413 -1.699 . . . . 9.7599999999999998 106.413 -170.522 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.0 tp . . . . . 0 N--CA 1.43 -1.446 0 N-CA-C 105.405 -2.072 . . . . 19.57 105.405 -169.742 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 119.589 3.181 . . . . 17.170000000000002 119.589 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -65.37 140.33 58.64 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 117.049 2.241 . . . . 21.890000000000001 117.049 163.354 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.4 pt -124.6 159.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.517 -1.99 . . . . 10.83 111.45 166.262 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -110.41 122.12 46.95 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 115.679 -2.105 . . . . 10.609999999999999 115.555 170.478 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.436 HG12 HD13 ' A' ' 30' ' ' ILE . 85.6 t -110.43 110.1 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 101.827 -3.397 . . . . 9.1300000000000008 101.827 -179.096 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -75.72 134.86 40.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.187 2.195 . . . . 20.550000000000001 114.124 175.684 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -98.42 -169.14 1.75 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.944 -1.132 . . . . 11.779999999999999 107.944 -172.963 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.6 tp -91.01 -38.33 12.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.254 -1.758 . . . . 19.309999999999999 106.254 -168.353 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.328 62.1 p -71.67 -69.77 0.36 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.067 1.877 . . . . 23.140000000000001 116.067 171.858 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.5 42.36 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 O-C-N 116.977 -3.577 . . . . 19.739999999999998 119.417 177.895 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -112.48 129.42 56.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 114.317 -2.754 . . . . 21.93 104.96 -172.517 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -88.71 105.72 17.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.726 2.679 . . . . 12.33 109.862 165.266 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.0 mt -86.12 110.91 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 116.616 -3.802 . . . . 17.079999999999998 111.427 175.253 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -100.55 113.75 26.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.274 1.852 . . . . 16.300000000000001 114.712 -172.925 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -116.26 139.39 50.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.359 0.982 . . . . 15.880000000000001 111.886 -167.014 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -96.73 109.13 21.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.434 -2.042 . . . . 28.899999999999999 110.808 -179.164 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.42 156.13 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 118.266 -2.771 . . . . 12.050000000000001 108.645 -174.629 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -107.55 136.79 19.59 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.243 -1.536 . . . . 18.170000000000002 110.172 170.576 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.11 -5.45 14.46 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 122.578 2.185 . . . . 8.1600000000000001 113.275 -155.425 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -93.12 -8.81 41.59 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 112.187 -3.768 . . . . 11.130000000000001 110.876 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -77.71 177.57 8.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 128.628 3.705 . . . . 18.030000000000001 115.204 166.415 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -115.62 -178.23 3.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.383 -2.698 . . . . 10.220000000000001 109.615 -169.401 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.308 11.9 mm -63.09 -35.53 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 116.939 -3.601 . . . . 12.300000000000001 113.09 175.725 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.2 -33.17 51.62 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.157 -4.089 . . . . 36.509999999999998 114.629 174.953 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -64.97 -39.24 93.18 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.294 -2.129 . . . . 25.66 111.832 174.857 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.6 t -73.91 -45.63 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.843 -1.785 . . . . 8.1199999999999992 107.27 -174.228 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.288 38.9 ttmt -63.9 -30.63 71.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.709 -3.744 . . . . 15.470000000000001 111.478 -178.766 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.03 89.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.696 2.799 . . . . 11.449999999999999 117.328 171.021 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -71.97 -21.86 61.52 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.527 2.417 . . . . 24.98 117.527 174.127 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 HD13 HG12 ' A' ' 5' ' ' VAL . 5.2 mt -75.24 -30.84 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 127.675 3.607 . . . . 9.4600000000000009 114.077 164.217 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.92 -47.53 82.87 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.529 -4.482 . . . . 14.76 111.798 168.08 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.94 -47.24 21.51 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.321 -1.487 . . . . 26.289999999999999 111.678 -172.711 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -74.18 -76.84 0.12 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 116.825 -1.559 . . . . 30.059999999999999 112.373 -176.332 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -80.26 -38.34 31.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.829 3.251 . . . . 25.190000000000001 108.099 -161.564 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.01 50.83 3.36 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-O 123.952 1.862 . . . . 7.4100000000000001 111.669 -176.144 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.1 mt -101.66 120.01 55.58 Favored Pre-proline 0 N--CA 1.43 -1.468 1 O-C-N 114.703 -4.998 . . . . 9.4900000000000002 109.605 165.216 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.9 158.66 56.35 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 126.883 3.494 . . . . 11.42 114.671 -174.27 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.85 -7.83 5.24 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 CA-C-N 128.995 4.248 . . . . 12.0 110.977 -157.618 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -70.83 -32.26 69.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.767 2.827 . . . . 35.549999999999997 106.626 175.521 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -88.02 -11.79 46.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.981 -2.949 . . . . 20.52 113.755 177.994 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.401 ' HB3' HD12 ' A' ' 69' ' ' LEU . 62.1 mt-30 -84.74 122.51 29.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.853 2.861 . . . . 7.1299999999999999 112.818 176.577 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -129.95 146.96 51.66 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.147 -2.221 . . . . 36.390000000000001 105.014 154.061 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.85 122.19 44.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.16 1.457 . . . . 9.5500000000000007 107.72 -173.371 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -110.22 131.69 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 128.298 2.639 . . . . 13.9 111.907 -179.412 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -126.02 118.75 26.0 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 114.417 -5.177 . . . . 6.8600000000000003 103.763 176.386 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.395 . . 65.8 -98.8 0.06 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.483 2.031 . . . . 11.15 116.483 -164.944 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.13 13.82 4.35 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 127.759 2.599 . . . . 13.93 109.951 -173.861 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -132.02 147.28 52.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.217 -2.343 . . . . 23.920000000000002 113.025 -177.408 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -85.76 146.34 26.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.293 2.473 . . . . 23.23 110.533 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.1 mt -93.55 148.4 22.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.673 -2.517 . . . . 9.1099999999999994 110.987 178.049 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.305 10.0 pt-20 -80.69 -168.86 1.91 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.572 1.949 . . . . 33.439999999999998 110.111 175.969 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -105.77 -47.39 3.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.111 3.338 . . . . 28.370000000000001 113.186 174.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.93 59.92 1.01 Allowed Glycine 0 N--CA 1.43 -1.715 1 O-C-N 115.394 -4.566 . . . . 15.0 115.088 -173.022 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -139.42 139.29 37.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.387 -1.338 . . . . 25.5 107.387 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.1 p -80.07 163.75 23.92 Favored 'General case' 0 N--CA 1.43 -1.45 1 CA-C-O 128.903 4.192 . . . . 11.949999999999999 111.351 -166.887 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -67.3 -37.52 83.53 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.619 -4.425 . . . . 10.17 114.342 -179.761 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -72.53 -27.13 62.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.802 1.641 . . . . 13.59 115.064 176.187 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -73.13 -39.16 65.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.073 -3.517 . . . . 11.699999999999999 107.019 172.483 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.06 -0.07 23.28 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.453 1.101 . . . . 12.949999999999999 111.779 178.801 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 51.09 60.12 4.11 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.363 -2.711 . . . . 25.449999999999999 114.685 179.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.0 mm -104.28 132.9 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 127.971 2.509 . . . . 14.6 109.191 170.592 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -111.1 -179.82 3.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.007 1.861 . . . . 33.229999999999997 114.362 -179.07 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -59.33 118.7 6.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.087 -1.87 . . . . 25.969999999999999 114.902 172.55 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.321 55.7 mt-10 76.27 35.0 0.48 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.437 -3.914 . . . . 32.609999999999999 112.874 173.464 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -90.63 141.92 28.28 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.094 1.757 . . . . 10.56 109.818 -175.553 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -87.55 128.14 35.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 113.878 -1.51 . . . . 5.3300000000000001 113.528 176.239 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.57 149.35 42.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.144 2.978 . . . . 11.66 104.693 174.357 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -119.78 135.41 54.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.088 -1.008 . . . . 16.300000000000001 111.598 176.304 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.401 HD12 ' HB3' ' A' ' 41' ' ' GLN . 15.8 tp -105.75 110.98 23.47 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.051 1.405 . . . . 9.9600000000000009 112.609 177.584 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -99.18 -174.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.207 2.432 . . . . 9.7599999999999998 108.837 -178.653 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 tp . . . . . 0 N--CA 1.43 -1.448 1 O-C-N 115.796 -4.315 . . . . 19.57 106.706 -177.437 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 117.057 2.243 . . . . 17.170000000000002 117.057 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -80.92 135.63 35.93 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 116.084 -4.135 . . . . 21.890000000000001 111.73 -176.107 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.71 153.24 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.177 -2.527 . . . . 10.83 104.177 161.049 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.279 50.2 m-85 -115.06 121.86 44.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 126.798 2.561 . . . . 10.609999999999999 111.634 -174.085 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.07 112.69 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 116.501 -3.875 . . . . 9.1300000000000008 110.504 -173.288 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -95.45 147.28 23.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.919 2.295 . . . . 20.550000000000001 106.36 -176.437 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.3 p -89.06 -178.14 5.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.785 -3.072 . . . . 11.779999999999999 106.635 174.109 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.2 tp -63.37 -47.8 80.59 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 117.912 -1.042 . . . . 19.309999999999999 112.87 168.576 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -55.63 -50.16 70.93 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.103 2.561 . . . . 23.140000000000001 111.16 171.319 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.9 49.78 0.3 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 118.887 -2.383 . . . . 19.739999999999998 109.311 169.391 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -90.42 124.48 34.99 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 103.179 -2.897 . . . . 21.93 103.179 176.918 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -97.67 115.13 27.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.345 2.498 . . . . 12.33 109.068 -175.672 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.5 mt -105.81 113.88 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.29 -2.232 . . . . 17.079999999999998 106.249 178.419 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -88.49 133.69 34.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.604 -3.185 . . . . 16.300000000000001 111.342 173.298 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.0 mt -120.6 172.25 7.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.986 2.054 . . . . 15.880000000000001 108.937 -175.101 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -128.26 114.65 17.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.094 -1.628 . . . . 28.899999999999999 108.748 170.182 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.37 152.53 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 125.801 1.938 . . . . 12.050000000000001 108.366 -177.812 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.26 140.22 28.67 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-O 114.21 -2.805 . . . . 18.170000000000002 113.799 157.641 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.7 -4.69 12.25 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 123.987 2.46 . . . . 8.1600000000000001 111.258 -169.722 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 m -82.68 4.09 26.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.85 2.907 . . . . 11.130000000000001 118.85 163.553 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -99.94 176.86 5.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.015 2.189 . . . . 18.030000000000001 106.572 173.876 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.369 11.0 p -89.3 -169.92 2.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.48 -1.236 . . . . 10.220000000000001 113.827 -166.404 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 mm -81.05 -18.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.672 2.389 . . . . 12.300000000000001 115.258 161.478 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -71.32 -29.64 65.27 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 123.88 0.872 . . . . 36.509999999999998 109.08 173.659 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -60.57 -45.67 93.05 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.047 1.739 . . . . 25.66 110.819 169.29 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -65.29 -35.56 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 119.16 0.891 . . . . 8.1199999999999992 109.198 -175.496 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -65.15 -37.59 87.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.857 1.429 . . . . 15.470000000000001 114.857 168.889 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.274 . . -70.0 -33.02 71.5 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.299 2.703 . . . . 11.449999999999999 118.299 172.469 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -65.93 -33.04 74.9 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.358 -3.964 . . . . 24.98 110.775 173.729 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.5 mt -65.98 -44.87 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 117.051 -3.53 . . . . 9.4600000000000009 108.386 167.122 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.76 -38.65 82.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.959 1.709 . . . . 14.76 112.344 176.099 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.99 -46.87 49.79 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.304 -0.872 . . . . 26.289999999999999 110.871 179.316 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -77.01 -57.78 3.65 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 116.498 -2.081 . . . . 30.059999999999999 113.059 -173.362 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -91.5 -52.14 4.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.908 1.337 . . . . 25.190000000000001 109.267 -167.934 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.22 30.02 3.05 Favored Glycine 0 N--CA 1.43 -1.708 1 C-N-CA 132.061 4.648 . . . . 7.4100000000000001 115.037 173.534 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.5 mt -81.34 135.15 50.64 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 119.068 -2.431 . . . . 9.4900000000000002 106.055 175.071 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 51.2 Cg_exo -68.88 137.67 38.71 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-O 114.203 -2.499 . . . . 11.42 116.354 177.819 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.39 -12.14 22.81 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 124.158 3.239 . . . . 12.0 113.933 -175.532 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -74.56 -26.82 60.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.583 1.992 . . . . 35.549999999999997 113.826 167.655 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -95.37 3.81 54.01 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.008 2.523 . . . . 20.52 113.138 178.25 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' HG2' HD13 ' A' ' 69' ' ' LEU . 72.8 mt-30 -99.06 133.66 43.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.264 -2.148 . . . . 7.1299999999999999 114.751 178.201 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -113.4 121.0 43.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.187 2.595 . . . . 36.390000000000001 109.947 158.63 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 mt -100.67 140.85 34.36 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.269 -2.77 . . . . 9.5500000000000007 109.829 174.945 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mt -141.73 138.62 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 105.013 -2.217 . . . . 13.9 105.013 -169.36 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -123.46 117.99 26.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.07 -1.019 . . . . 6.8600000000000003 111.027 172.871 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.299 . . 74.63 -108.01 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.525 -2.398 . . . . 11.15 104.525 176.002 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.34 6.18 5.63 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 119.031 -2.293 . . . . 13.93 113.629 168.699 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.283 38.3 pttt -81.12 135.52 35.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.671 2.1 . . . . 23.920000000000002 116.671 159.79 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -82.76 162.31 21.77 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.462 -3.899 . . . . 23.23 107.908 172.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.6 mt -110.42 133.5 53.22 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.23 1.967 . . . . 9.1099999999999994 115.044 175.104 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.79 153.08 19.09 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.739 2.126 . . . . 33.439999999999998 116.739 163.856 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.23 -30.63 60.62 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 131.306 3.842 . . . . 28.370000000000001 116.819 -160.213 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.94 34.48 4.64 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 126.244 2.215 . . . . 15.0 117.665 177.312 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -140.2 146.86 39.25 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 118.547 1.173 . . . . 25.5 109.109 -170.874 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 68.4 p -89.66 164.18 14.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.537 1.517 . . . . 11.949999999999999 114.537 -173.088 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.9 mt -55.19 -46.28 75.85 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.522 3.529 . . . . 10.17 110.878 166.372 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 m -58.53 -52.12 67.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.621 1.568 . . . . 13.59 109.717 173.481 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.93 -32.82 30.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.493 2.406 . . . . 11.699999999999999 109.965 -168.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.451 ' HB2' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -61.88 -34.5 76.12 Favored 'General case' 0 N--CA 1.43 -1.45 1 N-CA-C 122.269 4.174 . . . . 12.949999999999999 122.269 161.873 . . . . . . . . 4 4 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 66.8 m-80 90.35 59.86 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.108 2.163 . . . . 25.449999999999999 109.781 177.415 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mm -107.53 108.84 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 113.253 -1.794 . . . . 14.6 106.621 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.313 10.0 pt20 -83.84 176.65 8.76 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.108 -2.87 . . . . 33.229999999999997 117.858 -178.223 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -68.73 125.08 25.46 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 130.487 3.515 . . . . 25.969999999999999 110.533 168.574 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 64.63 39.28 6.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 130.516 3.526 . . . . 32.609999999999999 115.922 -171.216 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.8 m -78.18 165.03 24.43 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 113.308 0.855 . . . . 10.56 113.308 172.165 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m -106.01 139.04 41.16 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 126.534 1.933 . . . . 5.3300000000000001 106.855 170.52 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.38 156.78 41.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.86 -3.025 . . . . 11.66 107.707 171.235 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -112.69 117.7 32.96 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.173 -3.455 . . . . 16.300000000000001 107.436 -175.887 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.46 HD13 ' HG2' ' A' ' 41' ' ' GLN 0.257 12.4 tp -101.37 121.39 41.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.524 -2.61 . . . . 9.9600000000000009 114.97 169.206 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.307 10.7 m -121.4 158.52 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 130.425 3.49 . . . . 9.7599999999999998 102.83 177.945 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tp . . . . . 0 N--CA 1.43 -1.471 0 CA-C-N 114.672 -1.149 . . . . 19.57 113.881 166.641 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.491 -1.32 0 CA-C-O 118.34 -0.838 . . . . 17.170000000000002 112.882 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.09 150.07 23.62 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.537 -3.852 . . . . 21.890000000000001 109.156 177.202 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.487 HG12 HG23 ' A' ' 17' ' ' VAL 0.282 32.0 pt -131.45 159.03 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 128.59 2.756 . . . . 10.83 109.815 169.345 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -110.95 141.87 43.81 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.696 -1.965 . . . . 10.609999999999999 105.696 173.41 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 t -108.47 120.02 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 120.457 1.48 . . . . 9.1300000000000008 108.851 161.205 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -103.03 125.18 49.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.557 2.343 . . . . 20.550000000000001 110.851 -179.135 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -88.01 148.23 24.62 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.215 1.006 . . . . 11.779999999999999 112.751 177.889 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.338 14.5 tp -51.16 -40.2 58.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.659 2.384 . . . . 19.309999999999999 110.825 162.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.5 m -64.58 -50.77 65.95 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 121.105 1.775 . . . . 23.140000000000001 112.481 -179.19 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.0 19.34 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 123.787 1.771 . . . . 19.739999999999998 116.675 169.351 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 19.9 ttmt -103.37 138.42 40.14 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.243 -3.504 . . . . 21.93 112.417 177.864 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.9 m -99.59 124.73 45.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.244 -2.16 . . . . 12.33 108.796 162.894 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 13' ' ' ILE . 42.8 mt -119.75 119.38 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 126.41 1.884 . . . . 17.079999999999998 110.093 -171.053 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -82.76 119.08 23.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.08 -3.512 . . . . 16.300000000000001 106.446 -169.047 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 mt -106.27 159.39 16.15 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 116.226 -4.046 . . . . 15.880000000000001 111.352 169.378 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -99.45 134.92 41.62 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 121.605 2.002 . . . . 28.899999999999999 109.5 154.735 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.487 HG23 HG12 ' A' ' 3' ' ' ILE . 33.6 m -139.69 156.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 125.416 2.532 . . . . 12.050000000000001 106.589 175.727 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -96.94 153.18 38.65 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 112.354 -2.203 . . . . 18.170000000000002 110.633 173.922 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.11 -24.16 28.37 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 127.251 3.625 . . . . 8.1600000000000001 111.319 178.997 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 p -81.21 -13.88 58.11 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.404 3.002 . . . . 11.130000000000001 111.49 -171.736 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -67.19 151.23 47.92 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.729 -4.982 . . . . 18.030000000000001 113.809 176.785 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.275 22.3 p -80.66 153.36 27.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 120.282 3.438 . . . . 10.220000000000001 120.282 162.973 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.3 mm -64.75 -26.61 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 125.772 2.701 . . . . 12.300000000000001 112.123 -179.218 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.257 20.4 tt0 -44.37 -46.63 9.48 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.855 -4.278 . . . . 36.509999999999998 116.345 162.663 . . . . . . . . 3 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -69.32 -37.82 77.92 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.012 2.925 . . . . 25.66 111.329 172.097 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.256 58.5 t -63.44 -47.36 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 119.398 0.999 . . . . 8.1199999999999992 113.167 170.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -49.24 -43.24 42.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.167 2.284 . . . . 15.470000000000001 117.167 168.315 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.37 -28.6 69.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 117.915 2.561 . . . . 11.449999999999999 117.915 173.496 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -83.32 -29.09 28.57 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.603 1.334 . . . . 24.98 114.603 175.304 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -70.68 -36.3 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.837 -1.074 . . . . 9.4600000000000009 108.202 169.61 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.12 -37.75 88.46 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.547 -1.692 . . . . 14.76 115.337 171.025 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.16 -43.62 67.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.703 2.047 . . . . 26.289999999999999 111.334 179.619 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -70.7 -76.16 0.11 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.032 2.133 . . . . 30.059999999999999 115.347 177.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.401 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 31.2 tp10 -81.44 -28.75 34.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.16 2.584 . . . . 25.190000000000001 108.974 -169.725 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.63 43.57 6.08 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 116.437 -2.313 . . . . 7.4100000000000001 113.64 -176.231 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 mt -105.25 121.63 45.69 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 115.966 -1.968 . . . . 9.4900000000000002 114.671 176.18 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.5 149.8 74.78 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 126.436 3.334 . . . . 11.42 115.292 -175.288 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -73.67 -18.4 22.36 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 127.075 3.562 . . . . 12.0 118.291 -168.378 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -71.06 -32.64 69.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.409 -2.682 . . . . 35.549999999999997 111.672 179.194 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -91.92 2.76 56.33 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 117.211 -1.376 . . . . 20.52 111.856 -179.693 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -89.17 119.72 29.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.698 3.199 . . . . 7.1299999999999999 116.164 177.619 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -138.7 119.62 14.34 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 123.865 0.866 . . . . 36.390000000000001 108.957 171.701 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -101.12 136.7 40.55 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.953 1.835 . . . . 9.5500000000000007 113.822 -177.557 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mt -114.61 127.81 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 C-N-CA 134.338 5.055 . . . . 13.9 107.213 -179.46 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -116.32 106.04 13.21 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.56 -1.274 . . . . 6.8600000000000003 107.56 166.551 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.05 -71.97 0.07 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 116.364 1.987 . . . . 11.15 116.364 -170.298 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.32 -14.0 0.97 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 128.571 2.986 . . . . 13.93 116.33 174.458 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -101.74 144.63 30.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.019 2.91 . . . . 23.920000000000002 111.028 -167.382 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.265 15.2 pt20 -65.49 123.12 18.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.744 2.818 . . . . 23.23 113.539 167.067 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.421 ' CD1' HD22 ' A' ' 67' ' ' LEU . 33.9 mt -94.42 139.32 31.28 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 101.325 -3.583 . . . . 9.1099999999999994 101.325 -174.853 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.88 176.61 8.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.328 2.251 . . . . 33.439999999999998 111.213 168.241 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.31 -53.41 3.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.36 -2.712 . . . . 28.370000000000001 112.619 -172.251 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 53.05 4.82 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 118.035 -2.915 . . . . 15.0 119.118 175.222 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -132.03 139.3 48.53 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 119.44 1.62 . . . . 25.5 110.123 166.951 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.286 56.9 p -75.33 150.77 38.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.757 -1.839 . . . . 11.949999999999999 112.977 -172.098 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.1 mt -51.44 -33.41 30.63 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.289 2.636 . . . . 10.17 114.601 165.443 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.309 22.7 t -59.9 -50.05 75.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.479 3.511 . . . . 13.59 110.216 168.328 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -86.1 -32.63 21.24 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.363 -2.088 . . . . 11.699999999999999 105.363 -163.618 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -60.16 -25.42 65.52 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.172 -2.83 . . . . 12.949999999999999 113.341 167.093 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 68.65 54.56 0.5 Allowed 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 131.679 3.992 . . . . 25.449999999999999 113.027 -179.058 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.03 131.39 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.596 -2.001 . . . . 14.6 105.596 174.307 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -108.01 -171.66 1.91 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.579 1.326 . . . . 33.229999999999997 114.579 178.099 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -76.83 134.82 38.94 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.009 2.596 . . . . 25.969999999999999 118.009 -174.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 53.12 45.43 28.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 116.937 2.199 . . . . 32.609999999999999 116.937 -166.835 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.357 49.3 m -94.85 139.59 31.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 100.303 -3.962 . . . . 10.56 100.303 -175.356 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -98.83 122.47 42.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.092 0.86 . . . . 5.3300000000000001 108.952 179.465 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.421 HD22 ' CD1' ' A' ' 50' ' ' LEU . 3.3 mp -98.03 147.39 24.57 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.576 -1.327 . . . . 11.66 111.393 167.118 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -103.92 127.43 51.45 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.243 -3.41 . . . . 16.300000000000001 119.215 172.366 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.09 132.54 35.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.402 -2.061 . . . . 9.9600000000000009 113.883 175.163 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.28 -176.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 125.383 1.473 . . . . 9.7599999999999998 109.437 168.418 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 N--CA 1.431 -1.416 0 O-C-N 116.402 -3.936 . . . . 19.57 110.986 175.403 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 118.551 2.797 . . . . 17.170000000000002 118.551 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -93.3 113.15 25.27 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 101.864 -3.384 . . . . 21.890000000000001 101.864 178.467 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -120.1 149.74 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 104.331 -2.47 . . . . 10.83 104.331 170.936 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -107.05 121.28 44.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.189 1.471 . . . . 10.609999999999999 109.629 -172.103 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -100.12 117.46 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 O-C-N 115.15 -4.719 . . . . 9.1300000000000008 102.129 175.312 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -100.56 123.95 45.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.654 -2.529 . . . . 20.550000000000001 111.127 176.902 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -86.5 -176.54 5.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.422 -2.674 . . . . 11.779999999999999 109.28 -174.12 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 tp -70.55 -50.08 41.24 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.225 2.21 . . . . 19.309999999999999 110.075 178.633 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.4 p -72.93 -29.57 63.21 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.261 -1.755 . . . . 23.140000000000001 106.261 -178.065 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.2 54.03 0.31 Allowed Glycine 0 N--CA 1.43 -1.753 0 O-C-N 118.692 -2.505 . . . . 19.739999999999998 107.67 162.626 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -107.54 135.7 48.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.536 2.112 . . . . 21.93 109.608 171.473 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -96.42 109.61 22.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.629 -1.919 . . . . 12.33 106.046 -173.803 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 mt -102.22 96.26 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 126.424 3.011 . . . . 17.079999999999998 105.512 178.816 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.9 m -88.83 117.43 27.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.345 -3.347 . . . . 16.300000000000001 108.989 -172.969 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 mt -109.71 137.49 47.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.903 -2.373 . . . . 15.880000000000001 112.259 -167.549 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -106.66 101.44 10.89 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.696 -1.878 . . . . 28.899999999999999 109.47 177.311 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.26 163.01 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 118.802 -2.436 . . . . 12.050000000000001 109.396 -175.318 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -85.55 164.9 38.31 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 118.44 -2.663 . . . . 18.170000000000002 109.493 173.4 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.82 -4.45 3.33 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 C-N-CA 123.223 2.616 . . . . 8.1600000000000001 111.573 -174.463 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -87.85 -6.45 58.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.006 2.923 . . . . 11.130000000000001 111.838 175.665 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.48 159.03 18.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.273 -3.392 . . . . 18.030000000000001 114.443 -179.323 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -90.44 165.67 13.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.394 1.569 . . . . 10.220000000000001 111.985 -173.964 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -69.17 -20.42 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 127.415 3.483 . . . . 12.300000000000001 113.636 171.905 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.11 -43.34 87.47 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.047 -5.408 . . . . 36.509999999999998 112.759 174.037 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -70.93 -32.53 69.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.061 -1.447 . . . . 25.66 113.717 178.362 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.2 t -61.08 -38.61 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 131.231 3.813 . . . . 8.1199999999999992 111.927 169.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -67.01 -42.44 84.95 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.742 -1.599 . . . . 15.470000000000001 114.43 165.401 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.02 -37.28 74.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 117.56 2.429 . . . . 11.449999999999999 117.56 172.098 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.281 57.5 mmtt -46.26 -35.91 5.69 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 126.073 2.844 . . . . 24.98 117.712 165.398 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.2 mt -93.95 -34.47 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 117.776 -3.077 . . . . 9.4600000000000009 111.429 -172.695 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -48.01 81.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.76 0.824 . . . . 14.76 111.961 160.842 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.279 12.5 t70 -53.52 -57.76 9.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.149 1.928 . . . . 26.289999999999999 114.246 169.942 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -81.16 -51.64 8.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.659 -1.275 . . . . 30.059999999999999 112.364 -170.506 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -96.43 -42.09 8.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 116.814 -3.679 . . . . 25.190000000000001 101.791 -163.257 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.88 42.9 3.7 Favored Glycine 0 N--CA 1.43 -1.744 1 O-C-N 115.935 -4.228 . . . . 7.4100000000000001 115.852 -170.502 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 90.6 mt -111.12 120.36 43.39 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 113.393 -3.194 . . . . 9.4900000000000002 107.94 177.077 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -66.96 148.89 82.72 Favored 'Trans proline' 0 N--CA 1.434 -1.975 0 CA-C-N 125.778 3.099 . . . . 11.42 114.425 -178.093 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -74.05 -18.86 20.92 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 123.645 2.338 . . . . 12.0 117.868 -161.815 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -60.63 -18.86 55.94 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.815 2.524 . . . . 35.549999999999997 117.815 173.962 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -97.33 -12.57 22.68 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.03 2.132 . . . . 20.52 114.002 -175.139 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -98.91 141.07 32.16 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.48 -2.013 . . . . 7.1299999999999999 111.713 -169.356 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -143.73 108.1 4.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 114.015 -2.897 . . . . 36.390000000000001 107.472 -177.89 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 mt -91.78 144.96 24.96 Favored 'General case' 0 N--CA 1.43 -1.426 1 CA-C-N 126.2 4.091 . . . . 9.5500000000000007 112.837 -175.67 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 mt -128.24 138.84 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.628 1.971 . . . . 13.9 109.886 -176.935 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -122.19 112.74 18.55 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 115.082 -4.761 . . . . 6.8600000000000003 100.446 175.055 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.34 -74.96 0.07 Allowed 'General case' 0 N--CA 1.431 -1.41 1 CA-C-O 111.436 -4.126 . . . . 11.15 113.967 177.758 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.76 21.62 0.32 Allowed Glycine 0 N--CA 1.43 -1.729 1 O-C-N 130.178 4.674 . . . . 13.93 114.342 167.685 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -115.45 131.03 57.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.396 -1.705 . . . . 23.920000000000002 106.396 174.955 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -71.48 147.51 47.72 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.327 1.421 . . . . 23.23 114.593 173.924 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.445 HD12 HD21 ' A' ' 67' ' ' LEU . 21.3 mt -101.13 109.16 21.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.376 1.87 . . . . 9.1099999999999994 112.821 170.95 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -95.77 142.84 27.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 113.493 0.923 . . . . 33.439999999999998 113.493 179.186 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -22.01 -68.05 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 134.421 5.088 . . . . 28.370000000000001 118.893 179.255 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.69 62.58 4.58 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 122.54 2.427 . . . . 15.0 115.676 -174.778 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -160.91 156.59 25.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.525 -2.162 . . . . 25.5 107.834 164.156 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.316 82.8 p -82.08 150.82 27.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.39 -3.319 . . . . 11.949999999999999 114.355 -172.56 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mt -65.51 -46.21 80.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.799 -1.188 . . . . 10.17 112.882 -173.002 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -58.11 -43.64 87.3 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.279 0.987 . . . . 13.59 111.829 171.075 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -69.01 -17.11 63.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.714 -3.741 . . . . 11.699999999999999 111.186 -172.899 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.49 -17.75 38.04 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.929 2.892 . . . . 12.949999999999999 114.956 169.523 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.354 16.5 m120 87.61 39.02 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 129.311 3.045 . . . . 25.449999999999999 112.267 177.437 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -107.9 105.97 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.59 2.138 . . . . 14.6 105.932 -172.717 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.51 -162.96 0.83 Allowed 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 116.127 -4.108 . . . . 33.229999999999997 112.288 -174.861 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.252 37.9 tttp -64.37 120.93 13.16 Favored 'General case' 0 N--CA 1.431 -1.424 2 O-C-N 114.976 -4.827 . . . . 25.969999999999999 112.39 -173.741 . . . . . . . . 3 2 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 20.6 mt-10 65.23 51.79 1.56 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.494 1.918 . . . . 32.609999999999999 108.857 -174.143 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.285 63.0 m -95.45 155.44 16.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.766 2.076 . . . . 10.56 107.75 168.948 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.4 m -119.68 128.94 54.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 126.092 2.12 . . . . 5.3300000000000001 106.388 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.445 HD21 HD12 ' A' ' 50' ' ' LEU . 14.3 mt -113.44 116.36 29.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.27 1.828 . . . . 11.66 111.519 -177.41 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -93.17 125.13 37.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.489 2.404 . . . . 16.300000000000001 113.103 -175.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -101.33 123.58 45.65 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.804 2.042 . . . . 9.9600000000000009 111.062 -169.842 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.23 -178.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 126.15 2.881 . . . . 9.7599999999999998 112.747 173.76 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.7 tp . . . . . 0 N--CA 1.43 -1.429 0 O-C-N 116.539 -3.851 . . . . 19.57 119.369 175.863 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 10.8 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 113.433 0.901 . . . . 17.170000000000002 113.433 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -94.92 125.52 39.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 113.826 1.047 . . . . 21.890000000000001 113.826 178.963 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -124.3 162.88 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.148 1.379 . . . . 10.83 112.627 167.76 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -118.62 139.81 50.9 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.82 -3.05 . . . . 10.609999999999999 107.178 176.393 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.66 118.7 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.381 1.873 . . . . 9.1300000000000008 106.152 172.086 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -116.93 143.6 45.52 Favored 'General case' 0 N--CA 1.43 -1.438 1 CA-C-O 128.74 4.114 . . . . 20.550000000000001 114.07 -171.896 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -81.88 172.78 12.91 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 114.743 -4.973 . . . . 11.779999999999999 111.472 179.767 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.2 -33.69 70.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.555 2.057 . . . . 19.309999999999999 116.555 176.787 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -72.19 -69.53 0.39 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.966 1.099 . . . . 23.140000000000001 113.966 171.547 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.14 31.8 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 118.319 -1.896 . . . . 19.739999999999998 114.305 -175.797 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -106.86 121.98 45.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.162 1.458 . . . . 21.93 112.686 176.728 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.1 m -97.37 127.94 43.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.516 -1.99 . . . . 12.33 108.841 176.951 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.75 116.8 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 102.437 -3.172 . . . . 17.079999999999998 102.437 172.757 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 m -93.38 131.73 38.28 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.913 -1.742 . . . . 16.300000000000001 109.502 173.361 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -125.61 143.26 51.1 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.833 -1.792 . . . . 15.880000000000001 109.427 -179.59 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 1' ' ' MET . 42.9 mt-10 -99.13 77.71 2.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.546 3.138 . . . . 28.899999999999999 116.342 165.183 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -104.83 147.72 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 126.72 3.152 . . . . 12.050000000000001 106.987 -177.995 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -83.82 149.1 55.96 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 117.748 -3.095 . . . . 18.170000000000002 108.712 178.391 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -88.42 -6.29 6.17 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 127.172 3.597 . . . . 8.1600000000000001 109.543 -157.38 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.7 m -84.6 -14.06 49.84 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.624 3.106 . . . . 11.130000000000001 114.49 -179.492 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -80.12 163.67 23.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.859 2.54 . . . . 18.030000000000001 117.859 -167.982 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.322 22.1 p -79.34 158.19 27.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.618 2.367 . . . . 10.220000000000001 111.621 -172.16 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.67 -36.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.224 -1.353 . . . . 12.300000000000001 107.772 178.631 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -45.16 -45.84 11.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 117.504 2.409 . . . . 36.509999999999998 117.504 160.01 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.23 -14.32 59.49 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.808 -4.307 . . . . 25.66 116.163 173.472 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.6 t -62.8 -48.94 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 124.607 2.146 . . . . 8.1199999999999992 112.377 162.334 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -63.7 -32.45 73.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.107 2.86 . . . . 15.470000000000001 112.04 178.287 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.54 -13.27 61.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.863 -2.398 . . . . 11.449999999999999 117.472 -177.007 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -79.1 -36.43 40.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.324 2.265 . . . . 24.98 115.13 166.33 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 mt -69.72 -26.26 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 121.149 -0.969 . . . . 9.4600000000000009 113.405 176.162 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -65.48 -39.83 92.4 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 112.437 -2.165 . . . . 14.76 110.539 173.366 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -70.93 -46.26 62.78 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.85 2.167 . . . . 26.289999999999999 116.85 171.394 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -76.73 -67.2 0.72 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.09 -2.256 . . . . 30.059999999999999 108.918 -171.536 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -94.17 -20.5 19.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 123.839 3.018 . . . . 25.190000000000001 107.14 -164.363 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.42 34.83 9.99 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 126.753 2.121 . . . . 7.4100000000000001 114.445 173.867 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 mt -110.91 130.62 22.75 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 118.342 -2.858 . . . . 9.4900000000000002 104.181 -169.206 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -85.15 153.26 10.94 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 112.509 -4.528 . . . . 11.42 114.485 -167.418 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -71.05 -14.48 32.05 Favored 'Trans proline' 0 N--CA 1.433 -2.045 1 C-N-CA 125.308 4.005 . . . . 12.0 113.444 -162.56 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.69 -39.12 73.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.442 0.904 . . . . 35.549999999999997 113.442 168.851 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -77.97 -26.32 48.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.79 2.885 . . . . 20.52 118.79 175.171 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -72.15 118.95 15.67 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.739 1.216 . . . . 7.1299999999999999 111.502 -177.261 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -102.97 121.43 42.52 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.455 -3.278 . . . . 36.390000000000001 105.807 169.532 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 mt -106.11 123.06 47.41 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.674 3.59 . . . . 9.5500000000000007 115.24 170.02 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -123.21 110.31 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 128.954 2.902 . . . . 13.9 114.893 -174.646 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.416 ' CD1' HG12 ' A' ' 61' ' ' ILE . 51.2 t80 -94.8 117.88 30.86 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.222 -1.399 . . . . 6.8600000000000003 107.222 169.977 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.36 -84.3 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.42 1 C-N-CA 132.35 4.26 . . . . 11.15 110.507 -169.704 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.44 31.05 1.28 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-O 124.078 1.932 . . . . 13.93 112.239 169.952 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -99.13 142.11 31.03 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.968 -3.078 . . . . 23.920000000000002 109.539 174.706 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -88.08 108.74 19.39 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 116.577 2.066 . . . . 23.23 116.577 173.405 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.339 85.4 mt -71.47 118.26 14.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.078 -2.889 . . . . 9.1099999999999994 116.907 -162.171 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -74.31 114.94 13.25 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.72 2.408 . . . . 33.439999999999998 109.271 178.423 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.32 -33.93 76.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.405 1.882 . . . . 28.370000000000001 114.472 -162.895 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.05 15.49 60.85 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 127.031 2.253 . . . . 15.0 113.37 -175.849 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -99.25 171.02 8.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 126.693 3.139 . . . . 25.5 108.961 160.928 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.9 p -102.72 -178.92 3.82 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.105 -4.122 . . . . 11.949999999999999 114.231 174.805 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.1 mt -80.64 -17.7 50.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.937 -2.977 . . . . 10.17 110.073 178.989 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t -69.48 -42.36 74.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.065 -2.272 . . . . 13.59 109.672 177.319 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -54.68 -45.22 73.89 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.87 2.468 . . . . 11.699999999999999 114.412 178.849 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -92.58 0.6 57.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.756 -2.465 . . . . 12.949999999999999 109.48 -174.616 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 50.27 51.23 17.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.973 3.709 . . . . 25.449999999999999 112.134 -171.177 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' CD1' ' A' ' 45' ' ' PHE . 16.6 mt -98.38 114.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 120.418 1.463 . . . . 14.6 107.722 179.429 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -99.54 -173.14 2.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.391 3.076 . . . . 33.229999999999997 110.785 -169.424 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -70.05 147.39 50.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.601 1.191 . . . . 25.969999999999999 109.892 -174.182 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.377 86.7 mt-10 70.89 16.41 6.58 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.187 1.795 . . . . 32.609999999999999 113.668 174.047 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.16 136.75 34.33 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 116.631 -1.652 . . . . 10.56 111.657 179.23 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.2 m -92.81 130.48 38.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 115.373 -2.251 . . . . 5.3300000000000001 110.655 -178.358 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.97 172.07 6.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.806 2.443 . . . . 11.66 110.628 166.941 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -111.99 145.16 40.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.799 2.714 . . . . 16.300000000000001 111.421 171.842 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 tp -120.11 132.97 55.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.435 -3.916 . . . . 9.9600000000000009 109.069 176.12 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.56 131.03 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.905 1.682 . . . . 9.7599999999999998 108.993 -172.87 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 N--CA 1.43 -1.459 0 O-C-N 119.815 -1.803 . . . . 19.57 109.002 166.878 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 125.768 2.699 . . . . 17.170000000000002 113.851 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -114.54 137.32 52.01 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 112.983 -6.073 . . . . 21.890000000000001 110.738 -177.7 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.3 pt -129.07 178.21 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 118.018 -2.926 . . . . 10.83 109.239 164.942 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -125.55 137.86 53.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.299 2.952 . . . . 10.609999999999999 107.91 -179.66 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.27 116.11 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 105.054 -2.202 . . . . 9.1300000000000008 105.054 167.983 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -102.97 126.31 50.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.079 2.152 . . . . 20.550000000000001 113.911 176.372 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.526 15.7 p -67.99 175.15 3.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.312 1.845 . . . . 11.779999999999999 115.43 -178.201 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.44 -45.57 45.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.276 -2.765 . . . . 19.309999999999999 114.306 177.053 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -63.85 -56.31 16.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.768 2.699 . . . . 23.140000000000001 117.065 175.56 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 54.21 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 117.963 -2.065 . . . . 19.739999999999998 115.352 172.854 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -114.08 140.8 48.18 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.426 -1.75 . . . . 21.93 110.806 165.005 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -103.67 129.91 51.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.032 2.708 . . . . 12.33 110.092 165.69 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -96.73 104.93 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 128.335 2.654 . . . . 17.079999999999998 106.223 169.431 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.2 m -79.97 114.91 19.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 120.48 1.491 . . . . 16.300000000000001 114.7 170.783 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -121.78 133.21 54.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.647 -1.615 . . . . 15.880000000000001 113.547 -166.623 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -90.94 112.86 24.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.345 1.858 . . . . 28.899999999999999 114.612 -175.602 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.8 m -128.59 178.84 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.121 -2.862 . . . . 12.050000000000001 107.318 -168.968 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -123.94 168.14 13.5 Favored Pre-proline 0 N--CA 1.431 -1.416 0 CA-C-O 114.598 -2.62 . . . . 18.170000000000002 104.549 168.654 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.73 -14.89 43.12 Favored 'Trans proline' 0 C--N 1.3 -2.01 2 CA-C-N 129.076 4.277 . . . . 8.1600000000000001 108.853 173.311 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -93.05 -3.56 54.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.782 2.083 . . . . 11.130000000000001 115.084 -169.725 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -72.68 141.86 48.25 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.354 1.462 . . . . 18.030000000000001 108.759 -179.909 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -86.93 160.66 18.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.264 2.626 . . . . 10.220000000000001 104.525 178.722 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -69.29 -30.06 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 122.593 1.187 . . . . 12.300000000000001 112.849 177.675 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -65.94 -41.83 90.81 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.52 2.728 . . . . 36.509999999999998 110.532 177.539 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -66.52 -43.28 85.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.712 -1.959 . . . . 25.66 105.712 -179.918 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.79 -45.77 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 125.876 1.67 . . . . 8.1199999999999992 114.004 -178.051 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -57.6 -33.19 67.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.622 2.153 . . . . 15.470000000000001 113.09 172.532 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.46 -26.89 60.32 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.674 1.731 . . . . 11.449999999999999 115.674 179.355 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.315 52.6 mttp -75.07 -31.74 61.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.84 -2.344 . . . . 24.98 112.277 171.944 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.1 mt -63.71 -34.51 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 124.898 2.285 . . . . 9.4600000000000009 116.554 175.326 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -62.19 -41.81 98.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.135 -1.848 . . . . 14.76 113.419 165.592 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.49 -48.3 41.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.087 -1.633 . . . . 26.289999999999999 112.969 -179.263 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -60.83 -66.82 0.47 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.121 -2.237 . . . . 30.059999999999999 114.022 174.146 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.411 ' HB2' HG13 ' A' ' 36' ' ' ILE . 60.5 mm-40 -87.37 -26.69 23.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.809 -3.057 . . . . 25.190000000000001 111.243 -162.499 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.29 11.35 48.86 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 119.341 -1.409 . . . . 7.4100000000000001 114.086 -178.672 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 34' ' ' GLU . 49.2 mt -80.79 130.7 62.92 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 117.461 -3.376 . . . . 9.4900000000000002 111.596 -168.421 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -74.02 147.75 39.04 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 128.126 3.938 . . . . 11.42 113.066 -167.383 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.48 -16.59 24.27 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 CA-C-N 122.903 2.073 . . . . 12.0 113.4 -174.935 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.63 -30.53 70.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.622 -3.799 . . . . 35.549999999999997 118.285 163.647 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -75.46 -21.6 57.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.3 1.409 . . . . 20.52 113.392 177.819 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -83.43 114.9 21.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 115.947 -1.978 . . . . 7.1299999999999999 111.634 -160.58 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -119.37 108.1 14.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.401 2.524 . . . . 36.390000000000001 114.227 164.893 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mt -88.54 129.81 35.38 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.762 2.22 . . . . 9.5500000000000007 109.363 179.218 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 mt -116.83 139.71 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 119.182 -2.199 . . . . 13.9 106.027 177.052 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -126.53 112.14 15.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.013 -1.477 . . . . 6.8600000000000003 107.013 172.814 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.271 . . 81.29 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.938 1.695 . . . . 11.15 111.194 -174.537 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.12 43.39 0.23 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.304 -1.498 . . . . 13.93 116.181 173.993 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.28 155.09 46.98 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.148 2.579 . . . . 23.920000000000002 111.42 164.58 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.262 9.3 tt0 -79.93 129.58 34.61 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.3 -2.125 . . . . 23.23 111.953 -176.727 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.252 98.4 mt -83.71 121.51 27.38 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.685 -1.884 . . . . 9.1099999999999994 109.916 172.704 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -99.14 154.51 18.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.437 -1.69 . . . . 33.439999999999998 106.437 -168.534 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.09 -32.04 71.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.281 2.326 . . . . 28.370000000000001 117.281 -162.438 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.95 21.66 43.75 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 120.788 1.631 . . . . 15.0 112.065 -169.673 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -118.36 -179.48 3.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.369 -1.665 . . . . 25.5 113.858 164.225 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.7 p -108.91 176.27 5.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.897 2.76 . . . . 11.949999999999999 118.332 178.01 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.6 mt -71.03 -35.02 71.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 113.775 -1.557 . . . . 10.17 113.223 176.026 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -57.3 -45.93 83.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.668 1.987 . . . . 13.59 113.667 165.756 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -61.99 -35.33 78.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.495 2.718 . . . . 11.699999999999999 114.757 175.056 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.4 -4.19 42.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 114.666 -2.587 . . . . 12.949999999999999 111.976 -174.638 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.2 m120 72.79 43.4 0.43 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 123.539 2.882 . . . . 25.449999999999999 110.396 173.831 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -102.99 115.62 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.383 -2.073 . . . . 14.6 111.349 179.936 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -95.82 -177.89 4.19 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.161 1.934 . . . . 33.229999999999997 111.79 175.207 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.258 21.7 ptmt -53.75 138.15 36.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 131.163 3.785 . . . . 25.969999999999999 116.686 175.747 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 71.89 24.53 3.31 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 123.118 1.437 . . . . 32.609999999999999 113.243 171.897 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -92.89 142.5 27.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.983 -1.073 . . . . 10.56 112.071 -178.774 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -101.89 97.91 8.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.244 2.618 . . . . 5.3300000000000001 112.713 -172.973 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.48 145.55 28.07 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.73 2.519 . . . . 11.66 110.478 174.924 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -109.02 134.03 52.2 Favored 'General case' 0 N--CA 1.43 -1.425 1 O-C-N 115.646 -4.408 . . . . 16.300000000000001 100.537 -169.768 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.78 125.75 51.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.607 1.194 . . . . 9.9600000000000009 109.729 170.979 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.6 t -113.79 152.3 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 126.738 3.161 . . . . 9.7599999999999998 106.329 179.947 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 N--CA 1.43 -1.434 0 O-C-N 118.678 -2.514 . . . . 19.57 110.97 -179.306 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 127.171 3.367 . . . . 17.170000000000002 104.451 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -93.22 123.7 36.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.234 -2.257 . . . . 21.890000000000001 105.241 177.924 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -117.59 166.96 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 118.322 -2.736 . . . . 10.83 106.414 170.149 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.86 100.94 7.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.411 -3.306 . . . . 10.609999999999999 115.01 -176.049 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.44 105.89 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 118.89 -2.381 . . . . 9.1300000000000008 109.394 -163.265 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -99.45 132.69 44.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.612 -1.176 . . . . 20.550000000000001 111.042 -172.345 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 p -98.11 -177.88 3.88 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.226 2.21 . . . . 11.779999999999999 113.194 -178.555 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 mt -83.6 -33.52 25.33 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.838 -2.414 . . . . 19.309999999999999 111.637 -164.304 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 p -88.49 -66.79 0.88 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.73 2.012 . . . . 23.140000000000001 112.523 -177.038 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.24 48.76 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 117.505 -2.283 . . . . 19.739999999999998 109.665 -174.031 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -136.07 119.37 16.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.012 2.339 . . . . 21.93 105.506 176.379 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -92.23 106.87 18.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.376 2.989 . . . . 12.33 111.832 163.666 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 mt -88.46 114.89 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.661 -2.063 . . . . 17.079999999999998 106.308 -179.717 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -94.18 125.14 38.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.698 -0.482 . . . . 16.300000000000001 109.698 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 tp -153.8 135.86 14.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.965 -2.959 . . . . 15.880000000000001 115.212 -157.232 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.9 97.32 11.11 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 132.398 4.279 . . . . 28.899999999999999 117.021 -177.287 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.69 150.57 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.674 2.39 . . . . 12.050000000000001 111.714 179.158 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -87.04 152.77 53.77 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 112.867 -3.444 . . . . 18.170000000000002 109.394 176.671 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -71.99 -23.49 21.76 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 CA-C-N 123.321 2.222 . . . . 8.1600000000000001 112.949 173.682 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -81.44 2.27 29.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.97 3.919 . . . . 11.130000000000001 113.821 168.22 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -72.05 148.48 45.78 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 124.529 3.332 . . . . 18.030000000000001 110.887 165.08 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 73.4 p -84.54 173.25 10.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.767 -1.833 . . . . 10.220000000000001 109.522 177.344 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -63.43 -23.18 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 124.525 2.107 . . . . 12.300000000000001 112.263 168.407 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -80.88 -37.93 28.92 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.031 -4.168 . . . . 36.509999999999998 109.749 176.433 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.321 17.1 m120 -73.68 -35.12 65.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.62 -1.3 . . . . 25.66 112.26 179.773 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.489 81.4 t -45.83 -59.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 129.937 3.295 . . . . 8.1199999999999992 113.619 163.106 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HZ1' ' CG ' ' A' ' 52' ' ' ASP . 28.9 mtmt -60.67 -30.53 69.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.177 3.391 . . . . 15.470000000000001 113.051 174.144 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.7 -42.59 88.99 Favored 'General case' 0 N--CA 1.429 -1.48 1 CA-C-O 131.011 5.196 . . . . 11.449999999999999 118.047 163.297 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -75.5 -35.97 60.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.72 -3.737 . . . . 24.98 111.764 -179.065 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mt -64.57 -41.87 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 125.381 1.675 . . . . 9.4600000000000009 114.53 168.46 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -50.16 -57.88 6.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.66 2.171 . . . . 14.76 115.421 174.545 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -47.81 -60.96 2.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.546 3.538 . . . . 26.289999999999999 114.627 167.962 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -65.73 -58.4 5.76 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.252 1.025 . . . . 30.059999999999999 109.975 -168.737 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -83.93 -48.81 9.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.807 2.151 . . . . 25.190000000000001 116.807 179.988 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.08 9.86 5.94 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 129.683 3.516 . . . . 7.4100000000000001 112.617 179.424 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mt -85.81 128.93 56.5 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-N 121.356 2.578 . . . . 9.4900000000000002 108.115 -162.799 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.83 153.86 29.75 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 CA-C-O 109.941 -4.275 . . . . 11.42 114.439 -166.732 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.6 -24.1 26.22 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 124.13 3.22 . . . . 12.0 117.671 -168.881 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -80.63 -6.68 58.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.338 3.055 . . . . 35.549999999999997 112.733 171.843 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -93.46 -36.79 12.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.298 -2.126 . . . . 20.52 111.412 169.565 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -72.51 144.78 47.88 Favored 'General case' 0 N--CA 1.429 -1.48 1 N-CA-C 123.509 4.633 . . . . 7.1299999999999999 123.509 179.975 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -160.74 135.41 7.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.776 -0.824 . . . . 36.390000000000001 108.776 175.465 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.7 mt -117.51 116.44 27.14 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.149 1.928 . . . . 9.5500000000000007 108.6 -170.372 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 70' ' ' VAL . 33.9 mt -110.52 133.54 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 126.767 2.027 . . . . 13.9 111.066 175.117 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -118.37 118.95 33.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 102.269 -3.234 . . . . 6.8600000000000003 102.269 177.854 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.92 -62.69 0.07 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.263 3.425 . . . . 11.15 118.32 -176.551 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.99 7.89 0.79 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 115.895 1.118 . . . . 13.93 115.895 178.684 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -153.81 154.89 34.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.741 2.686 . . . . 23.920000000000002 105.76 177.84 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -66.76 150.04 49.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.377 3.471 . . . . 23.23 113.648 -179.227 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 mt -112.61 134.47 54.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.481 2.312 . . . . 9.1099999999999994 105.519 -173.986 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -97.55 130.67 44.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.835 2.731 . . . . 33.439999999999998 111.248 -171.524 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -34.2 -42.95 0.14 Allowed 'General case' 0 N--CA 1.43 -1.445 1 N-CA-C 122.704 4.335 . . . . 28.370000000000001 122.704 178.365 . . . . . . . . 4 4 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.95 -15.84 69.05 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.237 -1.539 . . . . 15.0 113.664 -168.485 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -87.73 147.18 25.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.36 2.664 . . . . 25.5 109.845 178.175 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 37.6 p -81.88 163.77 22.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.303 2.241 . . . . 11.949999999999999 110.088 173.017 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -61.29 -37.31 82.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.674 1.702 . . . . 10.17 115.43 171.798 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.9 m -45.77 -46.17 15.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.36 -3.338 . . . . 13.59 118.448 161.888 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -55.98 -13.6 2.01 Favored 'General case' 0 N--CA 1.43 -1.463 2 O-C-N 114.084 -5.385 . . . . 11.699999999999999 118.058 166.044 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -121.17 -7.73 9.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 115.894 -2.003 . . . . 12.949999999999999 107.134 -174.352 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.4 m120 74.58 34.68 0.74 Allowed 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 135.935 5.694 . . . . 25.449999999999999 107.955 176.664 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -82.6 106.42 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.42 -1.696 . . . . 14.6 106.42 -175.827 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -92.01 -175.39 4.08 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.468 2.707 . . . . 33.229999999999997 113.725 174.944 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -58.65 153.13 17.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.276 -3.39 . . . . 25.969999999999999 115.023 179.6 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 74.66 -1.16 3.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 125.996 2.06 . . . . 32.609999999999999 115.332 171.356 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.3 m -61.51 141.94 57.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 120.517 3.525 . . . . 10.56 120.517 178.05 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.3 m -98.63 109.76 22.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.085 2.116 . . . . 5.3300000000000001 107.628 -170.604 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mt -110.25 141.29 43.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.173 -2.158 . . . . 11.66 105.173 -173.278 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -104.91 118.83 37.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.06 1.41 . . . . 16.300000000000001 109.967 -177.539 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -95.55 99.24 11.14 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.814 2.446 . . . . 9.9600000000000009 108.273 176.572 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 44' ' ' ILE . 61.7 t -87.1 110.26 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.986 3.315 . . . . 9.7599999999999998 111.06 174.124 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.43 -1.446 0 N-CA-C 103.592 -2.744 . . . . 19.57 103.592 -178.137 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 111.202 0.075 . . . . 17.170000000000002 111.202 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -104.44 141.48 36.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.043 -2.286 . . . . 21.890000000000001 109.741 178.158 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 pt -119.56 159.84 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 131.295 3.838 . . . . 10.83 108.694 170.984 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -114.58 92.06 3.83 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.094 2.158 . . . . 10.609999999999999 107.123 -175.139 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.442 HG11 ' HB2' ' A' ' 69' ' ' LEU . 80.0 t -93.74 108.61 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.112 -2.242 . . . . 9.1300000000000008 106.952 175.765 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -102.96 145.09 30.38 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 122.729 1.252 . . . . 20.550000000000001 113.697 -171.706 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.8 p -90.94 171.89 8.97 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.744 -2.074 . . . . 11.779999999999999 110.81 177.145 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.95 -51.66 68.33 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 129.116 4.01 . . . . 19.309999999999999 115.16 171.351 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.251 78.9 p -46.33 -48.98 18.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 125.274 3.67 . . . . 23.140000000000001 113.186 161.24 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.19 52.62 0.56 Allowed Glycine 0 N--CA 1.43 -1.72 1 C-N-CA 132.526 4.869 . . . . 19.739999999999998 108.909 176.138 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -84.98 132.18 34.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.618 -2.033 . . . . 21.93 106.512 161.826 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -103.65 110.06 21.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 128.342 3.925 . . . . 12.33 109.733 -178.468 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.54 109.31 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 O-C-N 112.222 -6.549 . . . . 17.079999999999998 105.751 177.651 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 p -83.14 66.27 8.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.958 2.103 . . . . 16.300000000000001 108.532 -178.23 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.29 127.12 39.95 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.764 -3.085 . . . . 15.880000000000001 116.744 -164.313 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -103.51 102.46 12.36 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.595 -4.44 . . . . 28.899999999999999 115.663 -163.72 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 17' ' ' VAL . 15.9 m -125.0 167.96 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.734 1.255 . . . . 12.050000000000001 109.455 -172.106 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.289 27.8 mt-10 -98.15 170.6 6.84 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 118.369 -2.707 . . . . 18.170000000000002 108.898 161.568 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.15 -4.35 9.56 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 O-C-N 117.288 -2.006 . . . . 8.1600000000000001 108.673 -175.038 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 m -95.03 18.69 11.62 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.112 -1.44 . . . . 11.130000000000001 107.112 178.908 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -93.7 139.42 30.83 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.52 -1.987 . . . . 18.030000000000001 108.779 175.143 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 p -84.72 165.77 17.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.05 1.295 . . . . 10.220000000000001 114.198 173.809 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mm -71.95 -27.38 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.904 2.082 . . . . 12.300000000000001 106.869 -167.346 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -58.73 -50.09 75.22 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.929 2.892 . . . . 36.509999999999998 116.848 167.354 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -69.78 -22.11 63.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.584 2.809 . . . . 25.66 118.584 169.608 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.307 21.1 t -66.0 -55.93 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 C-N-CA 132.041 4.136 . . . . 8.1199999999999992 107.522 166.791 . . . . . . . . 3 2 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -61.88 -44.29 97.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.441 2.385 . . . . 15.470000000000001 117.441 173.059 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.57 -32.05 64.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.602 -2.561 . . . . 11.449999999999999 113.676 174.093 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -66.68 -38.78 87.5 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.445 3.022 . . . . 24.98 110.677 176.206 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -70.36 -33.87 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.998 -2.939 . . . . 9.4600000000000009 113.877 177.963 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.291 27.3 tt0 -52.81 -49.82 64.89 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.845 3.212 . . . . 14.76 113.83 171.915 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.66 -53.44 47.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.891 2.876 . . . . 26.289999999999999 112.92 174.039 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -68.27 -76.09 0.09 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.063 2.945 . . . . 30.059999999999999 112.185 -179.224 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.95 -51.4 67.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 124.625 3.375 . . . . 25.190000000000001 118.356 175.041 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.01 28.92 9.46 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.221 -1.549 . . . . 7.4100000000000001 113.63 -174.741 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mt -96.67 117.54 65.89 Favored Pre-proline 0 N--CA 1.429 -1.513 0 C-N-CA 131.537 3.935 . . . . 9.4900000000000002 105.205 177.114 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -69.04 158.34 58.28 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 CA-C-N 125.503 3.001 . . . . 11.42 112.45 -171.731 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.36 -24.12 8.11 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 122.485 2.123 . . . . 12.0 112.017 -149.649 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.98 -17.0 64.39 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.294 2.638 . . . . 35.549999999999997 113.295 -173.905 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -92.61 -26.0 18.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.63 1.972 . . . . 20.52 115.108 -172.905 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -70.88 86.74 0.7 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 121.063 3.727 . . . . 7.1299999999999999 121.063 -179.243 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.411 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 20.6 ttt180 -79.17 112.17 16.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.839 -3.663 . . . . 36.390000000000001 117.439 167.146 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.16 109.44 20.84 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 116.007 -4.183 . . . . 9.5500000000000007 112.013 -173.932 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mm -103.67 125.95 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 118.764 -2.46 . . . . 13.9 110.047 176.732 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -102.65 117.86 35.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.644 -2.071 . . . . 6.8600000000000003 106.121 166.714 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.7 -110.93 0.53 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.935 -2.353 . . . . 11.15 113.01 178.14 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.95 17.12 25.12 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 118.984 -1.579 . . . . 13.93 113.498 168.187 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -119.83 139.3 52.57 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.27 3.428 . . . . 23.920000000000002 108.519 -161.588 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -104.71 128.03 52.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.418 -2.808 . . . . 23.23 103.418 -166.487 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.65 128.75 35.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.097 -2.877 . . . . 9.1099999999999994 111.749 -176.844 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.256 43.1 mt-10 -107.28 158.66 16.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 117.479 -1.688 . . . . 33.439999999999998 111.092 -176.716 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -58.54 -53.46 58.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.468 3.507 . . . . 28.370000000000001 113.956 -155.264 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.81 -2.91 71.45 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 113.548 -1.66 . . . . 15.0 111.887 -161.936 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -88.28 155.26 19.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 113.889 -2.958 . . . . 25.5 113.583 166.383 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.0 p -92.72 173.05 7.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.565 2.346 . . . . 11.949999999999999 114.198 178.923 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.52 -46.0 47.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.782 2.512 . . . . 10.17 117.782 160.216 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -54.86 -46.38 74.67 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.739 2.816 . . . . 13.59 117.291 170.912 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -48.2 -63.94 0.93 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.566 1.946 . . . . 11.699999999999999 109.56 172.438 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -73.36 3.96 5.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.215 -2.326 . . . . 12.949999999999999 116.015 179.726 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.468 66.8 t30 67.72 54.0 0.67 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.555 3.034 . . . . 25.449999999999999 112.42 171.114 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.71 103.47 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 127.051 2.14 . . . . 14.6 111.636 -174.647 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -68.25 168.58 12.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.224 3.81 . . . . 33.229999999999997 106.561 174.293 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.34 154.2 14.01 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.424 1.639 . . . . 25.969999999999999 115.424 172.293 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 56.75 41.1 28.68 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.808 2.567 . . . . 32.609999999999999 114.873 176.802 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.263 47.2 m -86.78 126.9 34.91 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.489 1.916 . . . . 10.56 108.607 173.326 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -72.52 127.15 31.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 117.088 -1.845 . . . . 5.3300000000000001 115.212 163.748 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mt -114.62 164.86 13.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.702 3.62 . . . . 11.66 111.851 159.627 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -120.45 121.31 38.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.875 -2.639 . . . . 16.300000000000001 103.875 -172.886 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HB2' HG11 ' A' ' 5' ' ' VAL . 11.6 tp -91.47 108.74 20.1 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.247 -2.131 . . . . 9.9600000000000009 105.247 173.201 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 19.3 t -96.61 144.28 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.056 2.836 . . . . 9.7599999999999998 107.224 168.931 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt . . . . . 0 N--CA 1.431 -1.414 0 O-C-N 116.514 -3.866 . . . . 19.57 111.333 -179.087 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptt? . . . . . 0 CA--C 1.491 -1.323 0 CA-C-O 124.233 1.968 . . . . 17.170000000000002 108.446 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -98.47 140.8 32.17 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.011 -2.931 . . . . 21.890000000000001 109.778 176.838 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pp -131.16 166.4 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 112.22 -2.264 . . . . 10.83 109.403 168.02 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.3 145.79 42.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.786 -3.071 . . . . 10.609999999999999 108.692 177.659 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 2.9 t -102.43 118.55 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.358 2.663 . . . . 9.1300000000000008 112.724 163.935 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -111.68 110.9 21.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.391 2.996 . . . . 20.550000000000001 112.488 179.271 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.8 p -76.72 171.26 15.0 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.647 -4.408 . . . . 11.779999999999999 113.102 -170.179 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mt -52.8 -54.26 36.66 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.898 -1.049 . . . . 19.309999999999999 111.506 174.778 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.4 p -56.93 -31.5 65.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.575 2.35 . . . . 23.140000000000001 116.86 167.989 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.91 27.28 4.36 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 120.006 -1.684 . . . . 19.739999999999998 113.685 168.219 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -80.24 131.84 35.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 121.05 2.425 . . . . 21.93 105.074 175.978 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -85.42 109.5 18.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.082 2.153 . . . . 12.33 112.452 163.85 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 4.1 mt -103.06 123.43 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 114.806 -1.088 . . . . 17.079999999999998 108.786 171.949 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -84.74 121.82 28.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 117.24 -1.362 . . . . 16.300000000000001 112.341 173.852 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 tp -129.91 121.17 26.11 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.126 1.37 . . . . 15.880000000000001 110.7 -172.959 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -87.5 122.76 31.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.768 1.747 . . . . 28.899999999999999 108.873 173.204 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.44 149.68 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 129.707 3.203 . . . . 12.050000000000001 108.782 -179.491 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -87.0 149.01 46.72 Favored Pre-proline 0 N--CA 1.43 -1.426 0 C-N-CA 127.253 2.221 . . . . 18.170000000000002 106.248 166.683 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -73.55 -15.03 24.8 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 115.847 -2.302 . . . . 8.1600000000000001 111.44 -173.983 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -87.73 3.65 47.21 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 116.028 -4.17 . . . . 11.130000000000001 118.02 172.831 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.3 150.8 35.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.346 -1.471 . . . . 18.030000000000001 113.092 167.654 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 24.8 p -96.01 177.67 5.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.395 1.685 . . . . 10.220000000000001 109.438 -172.729 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.48 -23.73 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 121.424 1.92 . . . . 12.300000000000001 113.344 -177.019 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -52.5 -48.51 65.94 Favored 'General case' 0 N--CA 1.431 -1.394 1 C-N-CA 133.101 4.561 . . . . 36.509999999999998 111.021 158.071 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -72.01 -27.39 62.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.65 2.093 . . . . 25.66 116.65 179.661 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -73.2 -41.06 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 128.081 2.552 . . . . 8.1199999999999992 112.563 175.958 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -59.63 -31.01 69.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 117.25 -1.357 . . . . 15.470000000000001 111.886 165.085 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -41.84 67.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.931 1.395 . . . . 11.449999999999999 109.669 -177.822 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.285 21.1 mmtp -63.38 -28.12 69.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.814 3.246 . . . . 24.98 113.059 173.96 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.7 mt -87.48 -41.71 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 1 O-C-N 113.91 -5.494 . . . . 9.4600000000000009 112.726 178.973 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -46.22 -47.14 17.94 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.847 -2.408 . . . . 14.76 114.806 159.126 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.31 -25.51 61.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.015 1.857 . . . . 26.289999999999999 116.015 -178.437 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -87.73 -52.81 5.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 116.914 2.19 . . . . 30.059999999999999 116.914 178.837 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -98.77 -25.28 14.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.085 1.354 . . . . 25.190000000000001 112.011 -168.832 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.01 17.11 28.56 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 118.262 -1.299 . . . . 7.4100000000000001 115.267 168.276 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.2 mt -94.77 126.5 47.05 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 130.715 3.606 . . . . 9.4900000000000002 108.254 -168.855 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.51 139.68 54.59 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 124.322 3.348 . . . . 11.42 113.349 -179.504 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.04 -2.63 12.79 Favored 'Trans proline' 0 C--N 1.3 -2.019 1 C-N-CA 126.415 4.743 . . . . 12.0 114.108 -166.538 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.273 9.5 p-10 -84.61 -31.98 23.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 122.678 2.49 . . . . 35.549999999999997 111.182 174.178 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.91 -13.17 60.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.041 2.088 . . . . 20.52 114.183 -179.274 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -88.98 121.62 31.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 111.504 -2.589 . . . . 7.1299999999999999 114.677 177.924 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -111.95 118.09 34.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 115.544 -2.169 . . . . 36.390000000000001 113.66 166.034 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.7 mt -109.93 123.48 49.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.335 1.647 . . . . 9.5500000000000007 108.142 -174.376 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.14 127.09 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.946 2.098 . . . . 13.9 106.731 -174.813 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -103.77 114.11 28.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.58 -1.637 . . . . 6.8600000000000003 106.58 169.061 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.01 -96.98 0.05 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.92 2.488 . . . . 11.15 110.338 178.115 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.82 -7.71 17.07 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 125.37 1.462 . . . . 13.93 115.781 173.865 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -90.89 130.62 36.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 128.426 3.965 . . . . 23.920000000000002 108.429 -171.131 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -98.52 157.96 15.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 111.285 -2.689 . . . . 23.23 104.812 166.947 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.3 mt -122.01 166.48 14.42 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.619 -1.628 . . . . 9.1099999999999994 111.533 -155.9 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.27 176.94 5.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.141 -1.429 . . . . 33.439999999999998 107.141 166.569 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -102.44 -53.14 2.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.372 1.469 . . . . 28.370000000000001 111.043 -168.135 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.04 16.38 7.23 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 118.791 2.276 . . . . 15.0 118.791 -170.139 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -116.62 153.55 32.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.514 1.925 . . . . 25.5 110.938 -173.142 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 20.3 p -88.57 170.67 10.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 113.851 1.056 . . . . 11.949999999999999 113.851 -173.328 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.52 -31.25 71.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.774 1.749 . . . . 10.17 108.418 177.69 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -70.48 -43.2 70.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.101 1.76 . . . . 13.59 111.78 -175.928 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -59.39 -28.11 66.6 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 128.467 3.984 . . . . 11.699999999999999 118.24 176.884 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -82.06 -27.11 33.15 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 113.558 -5.714 . . . . 12.949999999999999 121.078 169.784 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 t30 71.95 48.66 0.27 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.508 2.575 . . . . 25.449999999999999 117.372 -157.503 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mt -94.75 99.66 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 118.452 -2.655 . . . . 14.6 104.995 174.35 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.45 -175.73 2.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.701 -1.874 . . . . 33.229999999999997 107.134 -165.121 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.305 20.3 pttm -67.13 148.38 51.91 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 120.295 1.407 . . . . 25.969999999999999 112.247 -178.396 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 76.57 7.22 3.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.557 2.343 . . . . 32.609999999999999 114.451 178.962 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 t -63.96 140.68 58.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.689 1.366 . . . . 10.56 114.689 -177.488 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 m -93.9 104.21 16.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.517 -3.239 . . . . 5.3300000000000001 113.117 170.949 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.7 mt -84.45 128.18 34.44 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 114.531 -5.106 . . . . 11.66 110.131 169.718 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -106.22 125.27 50.79 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.374 -2.079 . . . . 16.300000000000001 111.668 -172.183 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.25 12.1 tp -92.22 134.16 35.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.764 -1.569 . . . . 9.9600000000000009 106.764 -177.961 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.1 t -116.31 112.04 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 126.709 3.147 . . . . 9.7599999999999998 109.153 162.407 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.0 tp . . . . . 0 N--CA 1.43 -1.465 0 O-C-N 118.811 -2.431 . . . . 19.57 114.022 -167.382 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 123.624 1.678 . . . . 17.170000000000002 112.04 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -101.79 131.09 48.3 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.583 -4.448 . . . . 21.890000000000001 109.057 -171.584 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -116.81 156.78 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.469 -3.269 . . . . 10.83 105.089 162.686 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -120.28 126.32 50.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.94 2.781 . . . . 10.609999999999999 108.629 -178.513 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.49 105.86 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 119.17 -2.206 . . . . 9.1300000000000008 112.826 -179.32 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -92.42 151.12 20.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.56 -1.338 . . . . 20.550000000000001 112.289 -176.264 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -104.18 -166.57 1.26 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.098 1.759 . . . . 11.779999999999999 113.383 -178.003 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.35 -62.48 1.38 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 115.57 -2.157 . . . . 19.309999999999999 114.1 172.23 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.2 p -63.19 -35.14 79.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.319 2.647 . . . . 23.140000000000001 111.576 177.898 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.49 53.87 0.67 Allowed Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 127.029 3.572 . . . . 19.739999999999998 111.769 167.209 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -89.44 139.58 30.37 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.563 -4.492 . . . . 21.93 102.121 162.216 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.1 m -83.48 110.68 18.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 115.813 -2.042 . . . . 12.33 113.457 161.399 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -88.04 123.99 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 126.197 2.185 . . . . 17.079999999999998 107.238 169.858 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.7 m -94.45 115.43 27.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.751 -1.203 . . . . 16.300000000000001 107.751 177.883 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -109.37 134.42 51.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.592 -3.817 . . . . 15.880000000000001 115.71 168.782 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.69 109.12 20.93 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.599 -2.0 . . . . 28.899999999999999 105.599 175.217 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -121.6 152.06 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 C-N-CA 133.583 4.753 . . . . 12.050000000000001 112.388 -177.015 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -90.4 146.25 34.16 Favored Pre-proline 0 N--CA 1.429 -1.495 0 O-C-N 117.805 -3.059 . . . . 18.170000000000002 108.288 164.546 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.3 -18.4 62.4 Favored 'Trans proline' 0 C--N 1.299 -2.06 1 C-N-CA 128.245 5.964 . . . . 8.1600000000000001 111.788 172.758 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.7 p -83.9 -7.42 59.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.791 1.636 . . . . 11.130000000000001 110.113 174.607 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -81.01 165.88 21.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.078 2.672 . . . . 18.030000000000001 111.606 178.448 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 p -85.36 164.24 18.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.948 2.899 . . . . 10.220000000000001 113.365 168.395 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.0 mm -67.28 -35.61 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.355 1.862 . . . . 12.300000000000001 110.199 178.914 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -50.91 -48.95 60.44 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.16 -2.213 . . . . 36.509999999999998 115.998 168.11 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.98 -32.79 71.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.941 -3.6 . . . . 25.66 118.203 169.281 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.91 -54.31 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 124.966 1.306 . . . . 8.1199999999999992 108.273 169.654 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -56.95 -36.72 70.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.006 2.225 . . . . 15.470000000000001 117.006 178.349 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.29 -24.12 64.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.05 2.982 . . . . 11.449999999999999 119.05 173.078 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -69.99 -56.99 5.54 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.514 -1.991 . . . . 24.98 113.096 173.516 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -51.42 -46.85 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 127.228 2.211 . . . . 9.4600000000000009 110.517 169.394 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -49.49 -41.93 42.08 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.427 2.01 . . . . 14.76 116.427 171.894 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -81.01 -77.53 0.2 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.905 3.241 . . . . 26.289999999999999 106.352 -178.893 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -64.4 -42.01 96.33 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.519 -5.113 . . . . 30.059999999999999 114.148 -162.574 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -94.61 -43.04 8.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.169 -3.457 . . . . 25.190000000000001 115.316 178.897 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.18 41.62 3.69 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.018 -2.301 . . . . 7.4100000000000001 114.863 176.609 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -109.55 113.15 58.34 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 103.952 -2.61 . . . . 9.4900000000000002 103.952 168.351 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_exo -57.7 159.3 17.51 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 C-N-CA 126.424 4.749 . . . . 11.42 112.953 -173.726 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -86.42 -1.34 8.39 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 124.8 3.667 . . . . 12.0 112.22 -169.916 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -87.39 -26.86 23.11 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.397 2.936 . . . . 35.549999999999997 111.747 169.319 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.03 -31.05 71.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.352 1.612 . . . . 20.52 115.352 175.03 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -83.44 136.23 34.39 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.441 2.015 . . . . 7.1299999999999999 116.441 -173.726 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -132.07 143.36 49.97 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 115.198 -2.601 . . . . 36.390000000000001 110.143 140.763 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.7 mt -94.05 128.31 40.34 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.792 -2.004 . . . . 9.5500000000000007 111.824 -178.51 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.416 HD11 ' HG2' ' A' ' 49' ' ' GLN . 43.5 mm -113.4 138.47 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 107.367 -1.346 . . . . 13.9 107.367 -176.596 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -114.89 100.99 8.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.274 2.464 . . . . 6.8600000000000003 109.797 171.251 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.501 . . 82.34 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.626 -3.796 . . . . 11.15 110.646 172.919 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.04 3.47 6.86 Favored Glycine 0 N--CA 1.429 -1.768 0 CA-C-N 113.262 -1.79 . . . . 13.93 112.745 159.367 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -89.03 124.88 34.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 120.727 2.264 . . . . 23.920000000000002 113.193 178.798 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.416 ' HG2' HD11 ' A' ' 44' ' ' ILE . 4.0 mt-30 -89.82 118.88 29.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.245 -2.159 . . . . 23.23 110.616 179.817 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.98 159.37 31.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.109 2.385 . . . . 9.1099999999999994 110.117 -164.843 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.42 142.19 50.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.742 -1.572 . . . . 33.439999999999998 113.98 175.942 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.04 -45.31 95.31 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 122.535 4.272 . . . . 28.370000000000001 122.535 -162.678 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.24 -4.78 31.27 Favored Glycine 0 N--CA 1.43 -1.721 1 N-CA-C 124.44 4.536 . . . . 15.0 124.44 172.71 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -100.37 171.75 7.57 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.36 2.029 . . . . 25.5 111.164 -176.819 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.27 30.8 p -94.4 157.35 16.06 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.524 -2.61 . . . . 11.949999999999999 114.167 179.82 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.88 -46.83 60.59 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 117.571 2.434 . . . . 10.17 117.571 163.074 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -56.4 -33.45 65.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 120.382 3.475 . . . . 13.59 120.382 169.003 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -58.88 -37.64 77.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.187 -2.82 . . . . 11.699999999999999 113.656 172.746 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -88.78 -13.17 40.09 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.935 -4.228 . . . . 12.949999999999999 110.112 177.35 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.439 40.8 t30 62.03 72.42 0.5 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 129.055 2.942 . . . . 25.449999999999999 114.379 -165.231 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -111.16 106.17 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 N-CA-C 99.478 -4.267 . . . . 14.6 99.478 -179.785 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -100.33 -173.98 2.55 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.586 -0.697 . . . . 33.229999999999997 110.675 -178.848 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.262 25.1 pttt -55.25 131.74 46.15 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.771 2.428 . . . . 25.969999999999999 113.981 179.656 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 58.99 45.54 14.76 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 127.215 3.388 . . . . 32.609999999999999 115.232 -176.313 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 t -110.28 137.18 48.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.884 -2.385 . . . . 10.56 107.798 179.208 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 m -105.16 129.47 53.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.932 2.093 . . . . 5.3300000000000001 107.614 -159.396 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -118.48 150.42 39.63 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 128.086 3.803 . . . . 11.66 106.271 179.12 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -112.03 124.37 52.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.149 -2.219 . . . . 16.300000000000001 105.201 -178.643 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -90.45 124.78 35.25 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 129.148 4.03 . . . . 9.9600000000000009 108.629 -178.496 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.6 m -99.1 151.62 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.992 2.517 . . . . 9.7599999999999998 109.065 167.192 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 mt . . . . . 0 N--CA 1.43 -1.461 0 O-C-N 118.508 -2.62 . . . . 19.57 109.487 163.13 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 123.46 1.6 . . . . 17.170000000000002 114.12 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -82.39 138.06 34.56 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.422 -4.549 . . . . 21.890000000000001 107.75 168.556 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 pt -118.95 177.48 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 124.849 1.26 . . . . 10.83 109.69 157.904 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -134.89 112.02 10.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.429 2.011 . . . . 10.609999999999999 116.429 -173.915 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.96 115.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 125.87 2.748 . . . . 9.1300000000000008 110.493 177.547 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.263 28.2 tttp -107.32 140.56 40.04 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.977 -4.202 . . . . 20.550000000000001 113.588 -179.866 . . . . . . . . 3 2 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.5 p -102.09 172.7 6.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.983 -2.323 . . . . 11.779999999999999 109.797 -179.429 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.9 -46.75 88.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.501 3.12 . . . . 19.309999999999999 111.853 172.081 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -69.38 -26.86 64.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.905 -2.372 . . . . 23.140000000000001 114.185 171.77 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.4 62.29 0.95 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 116.717 1.447 . . . . 19.739999999999998 116.717 162.97 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -103.13 175.18 5.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.929 2.092 . . . . 21.93 107.905 155.389 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 m -128.46 134.12 48.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.3 -3.375 . . . . 12.33 105.792 172.817 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -114.57 117.4 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 107.896 -1.15 . . . . 17.079999999999998 107.896 174.566 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 m -85.36 107.79 17.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.227 -2.26 . . . . 16.300000000000001 105.955 -175.581 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.0 mt -102.67 135.93 43.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.088 2.375 . . . . 15.880000000000001 115.185 172.668 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -99.7 129.34 45.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.779 -3.701 . . . . 28.899999999999999 110.63 173.248 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -151.09 159.63 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.842 1.657 . . . . 12.050000000000001 109.458 -167.628 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 62.2 mm-40 -107.08 159.63 29.3 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 120.554 -1.341 . . . . 18.170000000000002 110.328 163.132 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -72.7 -6.58 19.29 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 124.856 3.704 . . . . 8.1600000000000001 112.374 -176.66 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.8 p -72.64 -26.0 61.49 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 125.355 1.66 . . . . 11.130000000000001 114.338 171.779 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -64.82 157.75 26.87 Favored 'General case' 0 N--CA 1.43 -1.456 1 N-CA-C 124.425 4.972 . . . . 18.030000000000001 124.425 174.687 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 62.5 p -101.29 167.64 10.06 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 114.074 -2.869 . . . . 10.220000000000001 113.899 -173.49 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.317 7.0 mm -64.65 -35.41 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 125.392 1.682 . . . . 12.300000000000001 109.65 172.001 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -44.55 -48.82 10.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.683 3.586 . . . . 36.509999999999998 120.683 160.049 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -62.79 -40.72 98.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.122 1.514 . . . . 25.66 109.255 174.375 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.299 57.6 t -55.07 -59.76 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 116.721 -1.609 . . . . 8.1199999999999992 113.652 171.371 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.79 -27.48 68.78 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.073 1.76 . . . . 15.470000000000001 112.735 176.875 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.48 -32.53 62.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 122.549 2.431 . . . . 11.449999999999999 115.148 175.923 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -70.04 -26.65 64.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.303 -3.373 . . . . 24.98 109.375 176.189 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.4 mm -70.48 -37.87 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.224 1.409 . . . . 9.4600000000000009 110.988 168.723 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -43.84 78.37 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.301 -2.124 . . . . 14.76 111.612 -178.033 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.35 -69.09 0.12 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 126.948 2.655 . . . . 26.289999999999999 110.984 170.443 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -69.73 -52.32 26.52 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.835 -3.041 . . . . 30.059999999999999 118.485 -171.093 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -84.53 -65.51 1.0 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.877 -1.764 . . . . 25.190000000000001 107.589 -178.272 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.01 17.79 1.0 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 122.64 2.473 . . . . 7.4100000000000001 113.884 -175.048 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.8 mt -97.3 131.19 27.85 Favored Pre-proline 0 N--CA 1.431 -1.41 0 N-CA-C 116.07 1.878 . . . . 9.4900000000000002 116.07 -175.61 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.86 154.79 70.4 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 CA-C-N 124.157 2.521 . . . . 11.42 109.549 -178.946 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 -17.69 13.6 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 N-CA-C 117.221 1.97 . . . . 12.0 117.221 -170.716 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.26 -15.64 57.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.216 1.484 . . . . 35.549999999999997 110.704 178.111 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -86.96 -33.18 19.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.74 2.816 . . . . 20.52 113.036 176.462 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -71.03 139.02 50.33 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.231 1.937 . . . . 7.1299999999999999 116.231 171.013 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -131.67 131.7 43.35 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.015 2.341 . . . . 36.390000000000001 114.497 160.008 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.1 mt -109.37 125.95 52.9 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.154 -4.716 . . . . 9.5500000000000007 110.881 -170.993 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.7 mm -116.45 112.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.531 -1.355 . . . . 13.9 110.132 -176.038 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -102.06 116.38 32.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.879 2.276 . . . . 6.8600000000000003 112.348 163.578 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.447 . . 63.1 -81.81 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.91 1.818 . . . . 11.15 115.91 -167.252 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.95 15.94 1.18 Allowed Glycine 0 N--CA 1.431 -1.687 0 CA-C-O 125.204 2.558 . . . . 13.93 112.569 174.517 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -101.09 131.39 47.03 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.607 -1.525 . . . . 23.920000000000002 110.976 -175.004 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -75.97 120.82 21.83 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.658 -1.155 . . . . 23.23 112.955 170.308 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 mt -89.56 121.29 31.62 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.179 -1.576 . . . . 9.1099999999999994 111.49 -172.893 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -80.95 143.55 32.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.248 1.573 . . . . 33.439999999999998 115.248 172.407 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.78 -42.19 99.59 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.04 4.136 . . . . 28.370000000000001 110.538 -171.812 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.76 -7.69 88.3 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 127.238 2.352 . . . . 15.0 114.012 -170.476 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -101.6 155.68 17.94 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.742 1.617 . . . . 25.5 109.62 -169.875 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.4 p -95.11 167.06 11.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.04 -2.288 . . . . 11.949999999999999 110.256 -174.487 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 mt -57.69 -56.34 23.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.52 3.128 . . . . 10.17 111.886 174.306 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.406 6.6 t -36.13 -37.88 0.13 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.673 3.589 . . . . 13.59 118.822 156.283 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -72.3 -46.66 54.73 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.829 -4.919 . . . . 11.699999999999999 110.829 -176.828 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -67.96 -3.44 9.97 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 120.028 3.344 . . . . 12.949999999999999 120.028 167.26 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.0 m120 64.69 27.45 13.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.461 1.504 . . . . 25.449999999999999 114.381 -175.71 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -85.27 116.29 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.215 1.483 . . . . 14.6 109.059 -174.277 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -97.8 -165.21 1.22 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.902 3.239 . . . . 33.229999999999997 110.598 -176.733 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -76.35 150.11 36.9 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.436 -4.54 . . . . 25.969999999999999 112.979 -174.356 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 50.6 mt-10 54.6 35.64 24.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 125.344 1.652 . . . . 32.609999999999999 113.411 -174.763 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -86.71 133.97 33.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.053 1.882 . . . . 10.56 108.731 -174.668 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m -95.38 118.4 32.05 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.911 -2.368 . . . . 5.3300000000000001 107.725 -177.498 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -109.31 144.58 37.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 100.827 -3.768 . . . . 11.66 100.827 -178.802 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -117.36 126.86 53.39 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.307 -3.996 . . . . 16.300000000000001 104.945 -177.164 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.4 tp -100.11 119.8 38.87 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.567 1.547 . . . . 9.9600000000000009 108.044 -176.446 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.7 m -117.99 159.14 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.051 -1.656 . . . . 9.7599999999999998 113.384 169.368 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 N--CA 1.429 -1.481 0 N-CA-C 106.705 -1.591 . . . . 19.57 106.705 -179.276 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 117.601 2.445 . . . . 17.170000000000002 117.601 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -98.85 134.52 41.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 115.785 -2.055 . . . . 21.890000000000001 113.459 170.308 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -130.77 155.53 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 125.546 2.594 . . . . 10.83 107.18 172.078 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -119.29 105.16 11.05 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.577 -3.827 . . . . 10.609999999999999 107.489 -161.221 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.68 100.15 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 1 O-C-N 129.64 4.338 . . . . 9.1300000000000008 107.705 177.177 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -92.03 120.27 32.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.834 -1.53 . . . . 20.550000000000001 109.975 -177.455 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -74.18 -174.01 1.82 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.872 2.069 . . . . 11.779999999999999 113.739 -178.967 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.2 tp -77.76 -32.25 52.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.932 2.197 . . . . 19.309999999999999 116.932 177.334 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.8 p -70.67 -31.15 67.95 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.542 2.337 . . . . 23.140000000000001 114.637 170.75 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.8 20.15 8.23 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 117.758 -1.579 . . . . 19.739999999999998 114.538 179.849 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.292 44.4 pttt -89.07 142.96 27.19 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 124.733 1.213 . . . . 21.93 111.747 169.357 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.7 m -98.29 130.89 44.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.817 -1.802 . . . . 12.33 108.669 178.0 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.9 mt -106.56 104.64 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 1 N-CA-C 99.737 -4.171 . . . . 17.079999999999998 99.737 171.508 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -73.89 119.52 18.21 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.284 -1.51 . . . . 16.300000000000001 111.702 173.559 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.5 mt -100.17 126.07 46.39 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 114.964 -4.835 . . . . 15.880000000000001 114.13 170.588 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -78.93 92.83 4.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 125.797 1.936 . . . . 28.899999999999999 113.349 174.805 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.286 16.3 m -132.8 165.26 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 121.903 2.138 . . . . 12.050000000000001 111.325 -175.701 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -97.07 165.31 16.03 Favored Pre-proline 0 N--CA 1.429 -1.483 0 O-C-N 116.36 -3.963 . . . . 18.170000000000002 109.461 174.409 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.85 -23.66 73.16 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.811 3.111 . . . . 8.1600000000000001 119.539 164.833 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -63.38 -22.39 66.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.04 2.536 . . . . 11.130000000000001 112.823 174.748 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.18 148.69 39.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.315 -2.74 . . . . 18.030000000000001 109.492 -172.174 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 7.8 p -86.91 171.77 10.56 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.46 2.076 . . . . 10.220000000000001 109.425 179.145 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mm -76.93 -22.93 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.064 -2.897 . . . . 12.300000000000001 107.204 176.407 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.82 -46.79 74.59 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.737 -1.852 . . . . 36.509999999999998 110.828 171.132 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 72.4 m-20 -70.64 -21.49 62.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.238 2.615 . . . . 25.66 115.784 -179.612 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 t -83.72 -57.22 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 112.413 -2.176 . . . . 8.1199999999999992 107.113 174.191 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -45.19 -39.73 6.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.121 -2.862 . . . . 15.470000000000001 117.024 169.714 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.35 89.86 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.722 3.23 . . . . 11.449999999999999 119.722 173.047 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.31 -36.0 80.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.113 1.894 . . . . 24.98 116.113 169.127 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mm -69.43 -31.32 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.924 -1.735 . . . . 9.4600000000000009 107.624 -179.11 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -72.17 -44.67 62.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.417 -2.677 . . . . 14.76 113.182 169.709 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -54.64 -45.36 73.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.102 2.561 . . . . 26.289999999999999 114.57 177.511 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -91.46 -56.93 2.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.455 -2.028 . . . . 30.059999999999999 114.061 -177.994 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.269 52.6 mm-40 -85.81 -31.07 22.51 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.564 -4.46 . . . . 25.190000000000001 114.53 -175.156 . . . . . . . . 3 2 . 1 . 048 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.76 7.55 59.99 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 119.568 -1.958 . . . . 7.4100000000000001 112.902 173.702 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.2 116.95 59.22 Favored Pre-proline 0 N--CA 1.429 -1.485 0 CA-C-O 114.856 -2.497 . . . . 9.4900000000000002 113.819 177.415 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -63.94 150.74 87.72 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 125.227 3.952 . . . . 11.42 114.08 -172.074 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -73.95 -20.69 19.25 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 O-C-N 114.941 -3.241 . . . . 12.0 113.843 -166.964 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -80.61 -18.73 47.3 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.685 -1.969 . . . . 35.549999999999997 105.685 178.596 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -89.93 -18.34 26.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.753 -1.842 . . . . 20.52 113.478 176.744 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -72.95 137.33 45.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.71 -2.494 . . . . 7.1299999999999999 109.163 -177.485 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -130.89 129.54 42.38 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.668 1.576 . . . . 36.390000000000001 109.837 168.878 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HB3' HD11 ' A' ' 50' ' ' LEU . 22.9 mt -118.95 124.32 46.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.704 -1.135 . . . . 9.5500000000000007 111.33 -173.928 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 21.7 mm -118.01 134.38 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.171 2.588 . . . . 13.9 106.647 -171.071 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -121.24 113.32 19.79 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.324 2.342 . . . . 6.8600000000000003 117.324 161.245 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.86 -98.44 0.08 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.786 1.402 . . . . 11.15 114.786 -164.725 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.21 4.04 9.62 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 124.762 1.172 . . . . 13.93 113.875 166.116 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -90.98 139.24 30.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.294 1.521 . . . . 23.920000000000002 109.56 177.809 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -87.73 117.07 26.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.204 2.202 . . . . 23.23 110.386 178.721 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 43' ' ' LEU . 83.2 mt -83.61 129.27 34.96 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.962 2.905 . . . . 9.1099999999999994 107.898 -178.553 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -111.74 154.43 25.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.224 -1.807 . . . . 33.439999999999998 109.245 -173.995 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.38 -48.57 67.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.49 1.614 . . . . 28.370000000000001 110.876 -158.404 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.58 15.75 44.58 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.972 1.749 . . . . 15.0 114.605 177.279 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -100.36 167.8 10.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.79 -1.93 . . . . 25.5 105.79 171.005 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 11.4 p -105.04 176.86 5.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.514 -1.991 . . . . 11.949999999999999 107.955 -177.865 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.78 -43.55 88.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.957 2.661 . . . . 10.17 115.272 164.856 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.2 t -51.85 -43.74 63.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.414 2.686 . . . . 13.59 113.663 173.717 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -67.17 -29.24 68.88 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 117.147 2.277 . . . . 11.699999999999999 117.147 -173.914 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.07 -10.23 50.83 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 119.441 3.126 . . . . 12.949999999999999 119.441 171.296 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.4 m120 85.06 56.69 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.471 1 C-N-CA 133.679 4.791 . . . . 25.449999999999999 107.244 172.466 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.7 mt -104.92 101.38 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 N-CA-C 99.375 -4.305 . . . . 14.6 99.375 -172.844 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -91.07 -177.48 4.92 Favored 'General case' 0 N--CA 1.43 -1.433 2 C-N-CA 134.561 5.144 . . . . 33.229999999999997 107.265 179.973 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -66.57 145.57 55.46 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.001 1.32 . . . . 25.969999999999999 114.37 -179.311 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.381 17.0 mt-10 66.64 52.56 0.99 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 126.715 3.15 . . . . 32.609999999999999 117.337 176.866 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.1 t -131.76 134.01 45.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.689 -3.132 . . . . 10.56 113.166 -153.227 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.2 m -77.25 117.08 18.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.745 2.528 . . . . 5.3300000000000001 115.16 -179.231 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -115.05 138.37 50.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 115.388 -2.244 . . . . 11.66 108.305 165.39 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.432 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.5 m-70 -100.49 122.64 43.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.766 1.166 . . . . 16.300000000000001 111.288 -177.329 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.69 117.46 31.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.099 2.381 . . . . 9.9600000000000009 110.197 172.575 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.85 176.7 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 130.596 3.558 . . . . 9.7599999999999998 109.266 172.772 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.43 -1.434 0 O-C-N 119.688 -1.882 . . . . 19.57 115.858 175.441 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 104.832 -2.284 . . . . 17.170000000000002 104.832 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -116.3 130.51 56.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.815 -2.291 . . . . 21.890000000000001 104.815 -175.6 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -117.68 154.45 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.785 -2.302 . . . . 10.83 104.785 161.161 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.314 98.1 m-85 -116.14 152.06 34.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.603 -3.186 . . . . 10.609999999999999 106.121 176.801 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -125.41 113.18 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 106.746 -1.575 . . . . 9.1300000000000008 106.746 177.942 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -122.4 150.95 41.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.699 1.249 . . . . 20.550000000000001 113.234 -169.357 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -89.7 176.2 6.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.242 1.817 . . . . 11.779999999999999 108.246 176.65 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 mt -68.79 -38.82 80.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.124 -2.235 . . . . 19.309999999999999 107.064 -175.4 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -83.83 -61.84 1.72 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.771 -2.456 . . . . 23.140000000000001 114.268 -172.832 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.55 68.69 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 117.737 -2.173 . . . . 19.739999999999998 109.402 177.42 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tmmm? -120.09 121.25 38.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.112 -2.922 . . . . 21.93 103.112 155.407 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.0 m -111.88 112.03 23.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.709 -2.495 . . . . 12.33 108.093 -173.73 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.26 136.73 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 105.468 -2.049 . . . . 17.079999999999998 105.468 173.654 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.2 m -101.78 119.8 39.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.721 -1.214 . . . . 16.300000000000001 107.721 -171.283 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.432 HD12 HG13 ' A' ' 26' ' ' VAL . 77.6 mt -103.84 134.91 46.35 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 119.279 3.066 . . . . 15.880000000000001 119.279 178.943 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.18 109.49 21.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.205 -1.56 . . . . 28.899999999999999 108.686 178.691 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -130.1 148.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 116.765 -3.709 . . . . 12.050000000000001 112.291 -169.884 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -97.44 146.68 31.81 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 118.997 -2.315 . . . . 18.170000000000002 109.312 171.34 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.8 -17.74 17.6 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-O 112.393 -3.253 . . . . 8.1600000000000001 107.602 -172.651 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -85.29 7.37 22.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 123.896 3.044 . . . . 11.130000000000001 112.042 177.035 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -92.71 171.81 8.76 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.213 -2.804 . . . . 18.030000000000001 107.217 -174.717 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -112.48 153.45 27.41 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.046 -1.659 . . . . 10.220000000000001 109.975 -169.12 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 3.0 mt -74.21 -20.74 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.209 2.604 . . . . 12.300000000000001 106.383 -174.311 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.94 -44.87 91.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.283 1.033 . . . . 36.509999999999998 112.101 169.614 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -66.37 -34.96 79.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.293 3.437 . . . . 25.66 109.66 174.439 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 97.6 t -62.84 -49.77 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 119.852 -1.78 . . . . 8.1199999999999992 111.948 177.703 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -65.7 -27.63 68.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.468 2.355 . . . . 15.470000000000001 110.429 -172.802 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.81 -28.35 67.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.562 2.345 . . . . 11.449999999999999 110.02 177.932 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -93.04 -28.94 16.07 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 121.719 2.054 . . . . 24.98 108.26 -178.253 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 mt -65.1 -42.13 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 118.687 -2.508 . . . . 9.4600000000000009 111.377 164.763 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -59.36 -51.84 68.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.109 -3.495 . . . . 14.76 117.691 168.087 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -46.24 -50.08 16.39 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 122.268 2.303 . . . . 26.289999999999999 115.018 174.324 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -68.68 -63.76 1.0 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.496 2.719 . . . . 30.059999999999999 117.109 174.16 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -88.24 -29.82 20.16 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.64 2.089 . . . . 25.190000000000001 116.64 -174.092 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.13 14.83 59.94 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 119.058 2.383 . . . . 7.4100000000000001 119.058 -178.44 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 tt -103.15 115.31 64.2 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 114.903 -2.475 . . . . 9.4900000000000002 106.536 -178.275 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -60.27 170.03 4.47 Favored 'Trans proline' 0 N--CA 1.434 -1.988 2 C-N-CA 131.058 7.839 . . . . 11.42 116.256 -168.977 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.88 -21.09 7.17 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 125.365 2.952 . . . . 12.0 108.126 -164.307 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -75.43 -33.92 60.95 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.445 -2.66 . . . . 35.549999999999997 113.005 175.946 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -73.59 -37.52 65.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.516 -3.24 . . . . 20.52 113.929 176.265 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -54.74 124.55 16.8 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.967 -2.333 . . . . 7.1299999999999999 114.269 173.952 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -124.32 99.34 6.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.369 1.44 . . . . 36.390000000000001 108.43 -178.123 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.3 mt -96.93 107.33 19.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.384 1.874 . . . . 9.5500000000000007 110.705 -173.131 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 mm -110.37 120.41 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 128.471 2.708 . . . . 13.9 105.67 -175.406 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -107.95 115.93 31.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.734 -2.03 . . . . 6.8600000000000003 108.022 169.132 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.29 -94.04 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 112.32 -2.218 . . . . 11.15 113.306 -164.168 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.72 12.56 4.53 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 129.361 3.362 . . . . 13.93 113.149 169.997 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -117.91 148.79 41.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.757 2.279 . . . . 23.920000000000002 108.843 -179.82 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -110.77 114.71 28.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.217 -1.031 . . . . 23.23 108.217 -169.115 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.55 157.67 35.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.94 -2.35 . . . . 9.1099999999999994 115.108 -171.947 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -100.21 154.95 18.04 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.775 -1.194 . . . . 33.439999999999998 107.775 178.465 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -75.87 -50.0 16.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.013 -2.899 . . . . 28.370000000000001 116.309 -160.23 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.9 52.93 2.94 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 123.197 2.726 . . . . 15.0 111.855 179.726 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.259 6.7 mmt180 -121.41 160.3 24.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 103.874 -2.639 . . . . 25.5 103.874 171.207 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.303 66.2 p -86.62 151.85 23.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.33 1.452 . . . . 11.949999999999999 111.971 175.937 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.252 33.3 mt -47.51 -50.78 22.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.677 1.191 . . . . 10.17 111.699 165.545 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 p -54.12 -26.73 28.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.328 1.973 . . . . 13.59 116.328 176.866 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.35 -43.45 98.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.396 -2.69 . . . . 11.699999999999999 110.505 173.455 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.23 -16.01 28.32 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 126.601 2.438 . . . . 12.949999999999999 115.724 176.532 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 70.63 36.95 1.51 Allowed 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.601 1.561 . . . . 25.449999999999999 113.381 -172.226 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -68.63 101.43 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.49 -2.006 . . . . 14.6 116.121 170.901 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -76.52 163.43 26.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.82 2.896 . . . . 33.229999999999997 118.82 -175.829 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -61.35 147.85 43.41 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.605 2.817 . . . . 25.969999999999999 118.605 169.593 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.333 26.2 mt-10 68.74 23.98 6.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.07 1.89 . . . . 32.609999999999999 112.773 179.916 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -84.79 152.39 23.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.275 3.417 . . . . 10.56 107.945 -179.997 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -110.41 97.81 7.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 110.766 -2.925 . . . . 5.3300000000000001 107.887 175.825 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -80.81 152.26 28.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.267 3.027 . . . . 11.66 112.119 165.446 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -104.41 140.15 38.33 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.253 -2.78 . . . . 16.300000000000001 106.376 -178.136 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 tp -102.73 104.27 14.57 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.994 2.33 . . . . 9.9600000000000009 110.225 156.939 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.53 138.21 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 117.357 -3.34 . . . . 9.7599999999999998 108.047 -176.62 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 N--CA 1.43 -1.453 0 O-C-N 118.79 -2.444 . . . . 19.57 105.769 172.632 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 125.08 2.372 . . . . 17.170000000000002 114.308 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -104.92 131.1 52.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.539 -3.851 . . . . 21.890000000000001 111.92 166.162 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.297 2.3 pp -124.08 162.52 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 1 O-C-N 114.61 -5.056 . . . . 10.83 105.283 169.679 . . . . . . . . 3 2 . 1 . 050 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.411 ' HB3' ' CG2' ' A' ' 12' ' ' THR . 21.5 m-30 -107.04 128.39 54.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.484 3.113 . . . . 10.609999999999999 106.607 -175.189 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.59 104.89 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 100.319 -3.956 . . . . 9.1300000000000008 100.319 -177.859 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 tttt -89.4 162.22 15.89 Favored 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 131.913 4.085 . . . . 20.550000000000001 108.661 175.008 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -101.99 -151.72 0.42 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.818 -2.426 . . . . 11.779999999999999 105.899 173.703 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.3 mt -91.58 -42.39 10.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.004 1.275 . . . . 19.309999999999999 111.459 170.07 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -66.53 -36.66 83.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.875 -1.766 . . . . 23.140000000000001 113.182 174.455 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.01 22.13 1.28 Allowed Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 120.057 2.783 . . . . 19.739999999999998 120.057 158.053 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -72.99 106.02 4.7 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.216 2.206 . . . . 21.93 116.438 168.261 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.411 ' CG2' ' HB3' ' A' ' 4' ' ' PHE . 94.0 m -81.13 130.33 34.97 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.818 -1.083 . . . . 12.33 109.69 173.511 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -107.38 157.25 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 119.912 -1.743 . . . . 17.079999999999998 106.871 158.79 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.7 m -125.57 106.59 9.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.315 -1.735 . . . . 16.300000000000001 106.315 -169.147 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.261 86.5 mt -125.24 144.95 50.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.829 -0.545 . . . . 15.880000000000001 112.047 -168.345 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -97.1 105.69 17.88 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.375 2.731 . . . . 28.899999999999999 118.375 -171.005 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 m -125.61 161.33 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.375 2.27 . . . . 12.050000000000001 108.146 -168.476 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -103.92 169.58 7.13 Favored Pre-proline 0 N--CA 1.429 -1.476 1 O-C-N 113.232 -5.917 . . . . 18.170000000000002 106.653 167.72 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -77.96 -17.25 13.83 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 116.301 -2.526 . . . . 8.1600000000000001 107.74 174.639 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -75.85 -6.44 50.76 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 117.788 -3.07 . . . . 11.130000000000001 112.654 173.02 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -77.26 145.01 37.77 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.98 -3.575 . . . . 18.030000000000001 108.935 174.76 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.324 20.1 p -77.76 151.75 33.93 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 133.175 4.59 . . . . 10.220000000000001 110.655 176.458 . . . . . . . . 3 2 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.5 -38.96 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 120.264 -1.523 . . . . 12.300000000000001 113.031 175.431 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -46.13 -45.37 16.47 Favored 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 132.463 4.305 . . . . 36.509999999999998 113.72 168.591 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -74.57 -23.12 58.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.721 -3.737 . . . . 25.66 114.26 174.738 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.36 -44.93 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.503 -1.998 . . . . 8.1199999999999992 110.576 174.28 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.17 -40.24 73.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.485 1.514 . . . . 15.470000000000001 114.008 173.426 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.06 -42.11 65.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.232 2.308 . . . . 11.449999999999999 117.232 167.648 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -79.54 -14.26 58.98 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 116.151 -4.093 . . . . 24.98 116.259 179.037 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -88.1 -26.29 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.892 -1.755 . . . . 9.4600000000000009 110.17 168.119 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -63.97 -48.9 74.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.642 -3.161 . . . . 14.76 115.933 162.876 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -42.4 -51.42 4.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.0 3.333 . . . . 26.289999999999999 120.0 157.209 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -90.67 -68.11 0.81 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.347 -0.845 . . . . 30.059999999999999 111.326 -166.474 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -86.78 -34.43 19.58 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.303 1.441 . . . . 25.190000000000001 112.648 -176.249 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.55 67.27 1.57 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 115.997 1.159 . . . . 7.4100000000000001 115.997 173.797 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.5 tt -126.9 133.55 25.15 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-N 110.138 -3.031 . . . . 9.4900000000000002 110.97 164.864 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -74.44 157.36 45.18 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 123.924 3.083 . . . . 11.42 113.368 -172.435 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -72.85 -15.5 26.53 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 CA-C-O 112.567 -3.181 . . . . 12.0 114.171 -153.775 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.49 -17.63 29.93 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 128.639 3.712 . . . . 35.549999999999997 106.068 -176.216 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -89.11 -27.17 20.94 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.781 -3.074 . . . . 20.52 104.832 -178.711 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -78.62 109.61 12.99 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.006 -3.559 . . . . 7.1299999999999999 111.541 -175.538 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -100.44 104.52 15.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.107 -2.553 . . . . 36.390000000000001 104.107 174.587 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -96.45 140.56 30.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.855 -2.403 . . . . 9.5500000000000007 109.16 179.014 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -134.88 146.58 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.722 1.725 . . . . 13.9 107.815 -173.073 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -121.84 104.5 9.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.702 2.001 . . . . 6.8600000000000003 106.482 166.376 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.36 -102.64 0.16 Allowed 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 116.064 -4.147 . . . . 11.15 113.975 173.147 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.11 -25.05 27.72 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 124.461 3.3 . . . . 13.93 113.233 171.526 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -83.8 136.81 34.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.95 1.357 . . . . 23.920000000000002 113.364 -173.021 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -78.67 147.52 33.51 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.644 -3.16 . . . . 23.23 111.146 163.056 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.8 mt -110.42 110.45 21.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 114.662 -2.59 . . . . 9.1099999999999994 104.914 -172.282 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.296 20.8 mt-10 -81.08 145.41 31.11 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.714 3.606 . . . . 33.439999999999998 113.47 177.427 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.59 -49.56 74.74 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 119.847 3.277 . . . . 28.370000000000001 119.847 -158.429 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.17 15.32 56.48 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.589 -3.819 . . . . 15.0 116.345 -174.045 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.471 ' HD2' ' CE2' ' A' ' 59' ' ' TYR . 31.2 mtt-85 -93.87 161.21 14.4 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.627 1.204 . . . . 25.5 109.147 169.292 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.1 p -91.52 173.77 7.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.101 1.905 . . . . 11.949999999999999 111.211 177.183 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.5 -24.82 53.75 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.38 -1.45 . . . . 10.17 109.434 173.133 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.5 t -72.5 -36.32 68.35 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.805 -1.809 . . . . 13.59 113.132 -177.196 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -59.01 -39.93 83.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.318 2.261 . . . . 11.699999999999999 114.724 173.762 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.471 ' CE2' ' HD2' ' A' ' 54' ' ' ARG . 24.9 m-85 -84.73 2.08 43.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.761 -3.087 . . . . 12.949999999999999 113.551 -179.874 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.292 29.3 m120 54.47 51.49 14.03 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.061 2.615 . . . . 25.449999999999999 118.061 -168.829 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -99.11 112.53 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 122.741 2.518 . . . . 14.6 107.752 -179.808 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -103.24 176.94 4.98 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.889 1.676 . . . . 33.229999999999997 108.527 -173.975 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 pttp -73.79 148.76 42.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.021 -2.299 . . . . 25.969999999999999 112.897 -173.674 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.81 19.75 10.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 111.367 -2.651 . . . . 32.609999999999999 110.802 -173.456 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -82.39 160.66 22.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.217 -2.142 . . . . 10.56 105.217 179.31 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -116.68 120.55 38.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 126.185 2.898 . . . . 5.3300000000000001 104.766 -171.994 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.41 64.2 mt -100.37 155.55 17.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.489 -2.141 . . . . 11.66 108.508 169.207 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -107.52 131.51 54.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.562 1.69 . . . . 16.300000000000001 115.562 173.482 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.0 107.61 19.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.433 1.893 . . . . 9.9600000000000009 106.096 178.915 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.82 152.75 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.049 -1.657 . . . . 9.7599999999999998 107.47 172.629 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 tp . . . . . 0 N--CA 1.43 -1.453 0 O-C-N 119.165 -2.209 . . . . 19.57 105.164 172.679 . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 114.518 1.303 . . . . 17.170000000000002 114.518 . . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -79.55 127.04 31.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.094 -1.432 . . . . 21.890000000000001 114.475 178.36 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -119.25 159.65 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 122.161 2.255 . . . . 10.83 113.943 159.011 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.64 135.6 53.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 104.479 -2.415 . . . . 10.609999999999999 104.479 -172.052 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.63 119.03 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 105.408 -2.071 . . . . 9.1300000000000008 105.408 174.743 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -107.38 136.49 47.09 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.15 -2.167 . . . . 20.550000000000001 105.15 -171.523 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.272 72.0 p -97.62 172.95 7.39 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.371 2.986 . . . . 11.779999999999999 107.52 -172.02 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mt -77.78 -35.72 51.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.096 -1.866 . . . . 19.309999999999999 115.845 176.875 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -65.42 -69.78 0.27 Allowed 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 121.697 2.044 . . . . 23.140000000000001 106.243 170.405 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.84 68.81 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 113.418 -1.719 . . . . 19.739999999999998 113.556 178.623 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -132.75 150.07 52.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.776 -3.046 . . . . 21.93 102.776 170.346 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.6 m -127.33 90.98 3.22 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 116.573 -1.68 . . . . 12.33 107.211 -178.219 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 pt -77.07 125.37 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 128.377 2.671 . . . . 17.079999999999998 110.964 -179.784 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.7 m -97.47 117.11 30.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.126 1.516 . . . . 16.300000000000001 113.047 177.008 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -99.12 144.41 28.29 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.037 -1.097 . . . . 15.880000000000001 108.037 178.618 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -87.08 112.69 22.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.669 -3.144 . . . . 28.899999999999999 113.873 165.427 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.68 -176.25 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.416 1 O-C-N 115.917 -4.24 . . . . 12.050000000000001 114.374 176.438 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -132.06 141.47 41.58 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 116.849 -3.657 . . . . 18.170000000000002 111.717 169.696 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.87 -18.19 41.41 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 119.296 2.768 . . . . 8.1600000000000001 119.296 -170.79 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -76.65 -10.31 59.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.223 1.934 . . . . 11.130000000000001 116.223 173.535 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.271 10.9 t0 -94.43 164.77 12.87 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.496 -2.003 . . . . 18.030000000000001 114.173 -175.76 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -75.49 161.41 29.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.819 -2.425 . . . . 10.220000000000001 114.828 -170.197 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 mt -77.83 -31.21 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.891 -3.006 . . . . 12.300000000000001 112.389 177.855 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -49.3 -48.0 46.51 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.384 2.274 . . . . 36.509999999999998 112.385 167.404 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -74.1 -13.66 60.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.372 1.869 . . . . 25.66 113.066 179.657 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.95 -49.27 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 116.553 -3.842 . . . . 8.1199999999999992 108.034 165.368 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -62.96 -33.22 74.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.376 2.67 . . . . 15.470000000000001 110.601 -179.236 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.63 -44.78 85.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.491 3.043 . . . . 11.449999999999999 107.953 -177.087 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.277 65.9 mttm -63.66 -35.06 79.29 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 120.503 3.52 . . . . 24.98 120.503 173.391 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.93 -28.06 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.54 3.067 . . . . 9.4600000000000009 111.15 178.911 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -70.88 -50.36 35.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.499 -3.25 . . . . 14.76 106.056 177.992 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -48.38 -46.64 37.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.703 3.62 . . . . 26.289999999999999 114.895 178.159 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -82.49 -56.96 3.57 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.034 -2.348 . . . . 30.059999999999999 109.517 -165.614 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -100.1 -22.82 15.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.598 3.184 . . . . 25.190000000000001 119.598 -174.841 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.31 27.64 8.04 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 117.228 -3.42 . . . . 7.4100000000000001 115.238 170.204 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 tt -111.98 135.14 21.26 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-O 113.686 -3.054 . . . . 9.4900000000000002 107.073 -168.426 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.55 167.21 27.05 Favored 'Trans proline' 0 C--N 1.299 -2.045 1 CA-C-O 109.448 -4.48 . . . . 11.42 113.307 -174.383 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.18 -11.12 7.6 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 126.026 3.188 . . . . 12.0 111.833 -179.924 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -71.93 -18.66 62.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.611 -2.556 . . . . 35.549999999999997 110.796 173.036 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -92.03 -17.77 24.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 116.562 -1.685 . . . . 20.52 110.43 172.724 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -89.02 128.25 35.71 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.81 1.29 . . . . 7.1299999999999999 112.768 -168.516 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -140.66 143.94 35.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 112.562 -2.108 . . . . 36.390000000000001 107.324 152.274 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.4 mt -110.23 136.31 49.64 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.712 2.405 . . . . 9.5500000000000007 106.092 -171.92 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -128.13 136.02 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 116.658 -3.776 . . . . 13.9 105.874 -170.314 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -120.9 108.01 13.39 Favored 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 98.938 -4.467 . . . . 6.8600000000000003 98.938 -177.076 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.53 -64.91 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 131.41 3.884 . . . . 11.15 115.056 178.181 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.64 -0.81 1.73 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 116.906 1.522 . . . . 13.93 116.906 169.208 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -119.11 153.28 35.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 120.552 2.176 . . . . 23.920000000000002 107.575 -169.603 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -84.52 137.28 33.42 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.56 1.171 . . . . 23.23 113.676 177.256 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.1 mt -94.15 120.55 34.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.152 1.381 . . . . 9.1099999999999994 107.31 -178.547 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -78.85 141.26 37.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.009 1.861 . . . . 33.439999999999998 113.894 177.499 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.7 -63.5 1.07 Allowed 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 132.157 4.183 . . . . 28.370000000000001 115.386 -179.588 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.15 4.32 6.21 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 128.103 2.763 . . . . 15.0 119.569 -179.003 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -105.89 165.82 10.92 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 125.165 2.412 . . . . 25.5 106.439 -177.882 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.6 p -94.38 177.2 6.02 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.11 -2.869 . . . . 11.949999999999999 117.64 172.048 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.38 -25.96 38.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.606 1.962 . . . . 10.17 108.849 179.242 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 m -76.2 -24.86 54.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 121.293 1.86 . . . . 13.59 112.962 172.259 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -54.61 -38.95 67.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.712 1.745 . . . . 11.699999999999999 115.712 171.595 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -99.19 -11.99 20.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.37 2.668 . . . . 12.949999999999999 111.428 -175.359 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.12 60.07 3.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.625 1.97 . . . . 25.449999999999999 114.68 -162.499 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -92.31 118.43 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 126.899 2.08 . . . . 14.6 106.336 173.679 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -103.75 -174.76 2.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.166 1.543 . . . . 33.229999999999997 115.166 178.486 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -69.54 155.77 39.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.041 -2.287 . . . . 25.969999999999999 108.948 176.193 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 53.9 40.01 31.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.88 2.472 . . . . 32.609999999999999 112.021 -178.283 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -92.93 136.43 33.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 129.156 2.983 . . . . 10.56 106.23 176.715 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.4 m -81.13 110.47 16.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.707 -2.331 . . . . 5.3300000000000001 104.707 171.027 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.99 148.85 25.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.489 2.859 . . . . 11.66 108.451 165.989 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -111.24 138.6 47.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.024 -2.213 . . . . 16.300000000000001 105.024 -179.733 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tp -116.45 122.25 44.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.17 -2.529 . . . . 9.9600000000000009 104.17 -179.39 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -108.52 171.47 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 124.811 1.32 . . . . 9.7599999999999998 110.759 -179.617 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 tp . . . . . 0 N--CA 1.43 -1.473 0 O-C-N 118.084 -2.885 . . . . 19.57 113.287 167.335 . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 CA--C 1.489 -1.377 0 N-CA-C 120.027 3.343 . . . . 17.170000000000002 120.027 . . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -92.03 132.9 36.2 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 116.017 -4.177 . . . . 21.890000000000001 109.216 -176.908 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.482 HG13 ' HB2' ' A' ' 15' ' ' LEU . 9.8 pt -135.68 150.66 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 116.646 -3.784 . . . . 10.83 105.795 174.836 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.3 134.46 52.87 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.36 -1.291 . . . . 10.609999999999999 109.498 -177.102 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -115.02 120.25 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 119.478 -2.014 . . . . 9.1300000000000008 109.901 173.695 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -89.98 128.48 36.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.711 2.672 . . . . 20.550000000000001 114.46 167.151 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -80.48 -167.51 1.37 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.125 -2.234 . . . . 11.779999999999999 109.711 -165.731 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.2 -55.65 31.14 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.554 2.742 . . . . 19.309999999999999 112.682 169.409 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -91.04 -34.65 15.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.077 1.751 . . . . 23.140000000000001 110.785 -164.341 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.26 79.02 0.2 Allowed Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 128.776 3.084 . . . . 19.739999999999998 111.223 170.023 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -141.76 137.59 31.71 Favored 'General case' 0 N--CA 1.43 -1.451 1 N-CA-C 97.533 -4.988 . . . . 21.93 97.533 177.682 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -109.38 101.23 10.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.846 -1.168 . . . . 12.33 107.846 174.803 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.42 153.91 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 130.242 3.417 . . . . 17.079999999999998 110.283 164.251 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.3 m -120.03 139.87 51.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.41 -1.7 . . . . 16.300000000000001 106.41 -176.17 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.482 ' HB2' HG13 ' A' ' 3' ' ' ILE 0.302 96.0 mt -134.63 152.2 51.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 121.436 1.925 . . . . 15.880000000000001 112.294 173.362 . . . . . . . . 3 3 . 1 . 052 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -102.48 117.58 35.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.132 1.333 . . . . 28.899999999999999 112.761 176.838 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.68 172.3 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 121.704 2.047 . . . . 12.050000000000001 112.769 -178.892 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -111.99 155.64 43.03 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 104.969 -2.234 . . . . 18.170000000000002 104.969 170.252 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.271 21.6 Cg_exo -71.22 -12.08 29.58 Favored 'Trans proline' 0 N--CA 1.433 -2.033 1 C-N-CA 126.115 4.543 . . . . 8.1600000000000001 111.631 -175.273 . . . . . . . . 3 2 . 1 . 052 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 p -92.42 -1.88 56.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 127.646 3.091 . . . . 11.130000000000001 108.379 179.401 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -71.79 143.48 49.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 127.846 3.689 . . . . 18.030000000000001 113.948 170.071 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -86.53 169.42 12.81 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 109.631 -3.44 . . . . 10.220000000000001 110.598 -169.649 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -69.73 -37.48 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.434 -1.321 . . . . 12.300000000000001 107.434 175.619 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -54.3 -50.68 66.75 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.503 -1.998 . . . . 36.509999999999998 113.653 171.3 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -61.09 -34.1 74.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 122.843 2.565 . . . . 25.66 115.472 173.196 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.388 75.9 t -54.02 -54.53 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 124.597 1.186 . . . . 8.1199999999999992 113.553 169.124 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -53.3 -24.25 11.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.968 3.307 . . . . 15.470000000000001 119.507 170.266 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.72 -38.78 58.26 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.695 3.617 . . . . 11.449999999999999 111.033 176.489 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -68.29 -33.08 73.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.071 -3.518 . . . . 24.98 115.471 174.361 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -75.02 -47.25 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.782 2.033 . . . . 9.4600000000000009 107.412 175.462 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -46.06 -48.43 16.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 114.704 -2.569 . . . . 14.76 113.37 169.46 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.65 -48.12 60.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 120.398 1.453 . . . . 26.289999999999999 114.39 -176.472 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -71.88 -52.8 15.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.956 -1.497 . . . . 30.059999999999999 113.324 -172.948 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -91.67 -41.61 10.63 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 126.502 2.376 . . . . 25.190000000000001 113.989 -167.271 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.71 40.61 1.56 Allowed Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 119.11 -0.828 . . . . 7.4100000000000001 113.551 173.54 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 tt -113.49 139.86 23.8 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-O 114.826 -2.511 . . . . 9.4900000000000002 106.271 -179.511 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -68.77 153.04 73.79 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 126.964 3.523 . . . . 11.42 109.582 177.624 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.01 -22.82 70.81 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 127.894 5.729 . . . . 12.0 119.356 176.814 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.84 -24.59 48.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.762 -2.681 . . . . 35.549999999999997 103.762 -171.381 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.15 -25.02 25.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.424 -1.423 . . . . 20.52 114.114 -171.225 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -74.95 117.9 17.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.504 -1.998 . . . . 7.1299999999999999 116.101 179.742 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -108.71 110.6 22.05 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.564 2.345 . . . . 36.390000000000001 111.223 167.598 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.69 135.58 33.62 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.141 3.015 . . . . 9.5500000000000007 119.141 173.955 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 mm -121.13 137.15 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 124.107 1.908 . . . . 13.9 110.626 176.202 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -117.08 130.0 56.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.293 -2.754 . . . . 6.8600000000000003 105.67 164.417 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 48.25 -94.62 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.902 1.816 . . . . 11.15 115.902 -176.028 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.03 15.14 7.4 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 118.578 -2.576 . . . . 13.93 114.365 165.307 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -103.4 138.33 40.28 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.695 -3.238 . . . . 23.920000000000002 108.916 -174.553 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -91.27 114.19 26.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.422 2.289 . . . . 23.23 112.688 173.075 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 mt -74.99 129.47 37.71 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 124.527 1.142 . . . . 9.1099999999999994 111.576 -171.469 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -71.81 143.34 49.53 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.179 2.659 . . . . 33.439999999999998 118.179 172.72 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -53.78 -54.49 37.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.543 3.137 . . . . 28.370000000000001 113.302 -169.347 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.86 18.8 55.38 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-O 116.479 -2.29 . . . . 15.0 116.498 -172.321 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -92.92 168.84 10.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.134 1.967 . . . . 25.5 112.206 169.345 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 p -100.81 166.01 11.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 113.974 1.101 . . . . 11.949999999999999 113.974 170.488 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.59 -25.31 62.13 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 114.411 -2.709 . . . . 10.17 112.66 -177.044 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -70.07 -31.17 68.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.852 3.261 . . . . 13.59 110.887 176.224 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -67.84 -33.51 74.91 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.154 1.797 . . . . 11.699999999999999 111.337 175.962 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.16 13.38 17.17 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.775 -6.203 . . . . 12.949999999999999 115.343 166.116 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.73 27.52 14.5 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 114.904 -4.873 . . . . 25.449999999999999 114.693 179.334 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.6 121.98 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.973 -3.579 . . . . 14.6 107.127 -174.15 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -109.92 179.08 4.22 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.21 2.604 . . . . 33.229999999999997 108.302 -169.653 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -48.76 145.32 3.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.734 1.613 . . . . 25.969999999999999 110.733 172.551 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.257 54.0 mt-10 67.64 30.62 6.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.008 -1.906 . . . . 32.609999999999999 115.121 165.039 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -108.28 141.48 40.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.234 1.969 . . . . 10.56 110.335 -175.015 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 m -89.13 105.82 18.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.746 -2.024 . . . . 5.3300000000000001 107.093 -174.789 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.11 148.42 34.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.147 3.379 . . . . 11.66 108.361 158.213 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -115.3 134.5 55.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.933 -1.73 . . . . 16.300000000000001 110.209 170.753 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.7 tp -106.67 116.97 32.85 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.96 1.413 . . . . 9.9600000000000009 109.674 -176.127 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.6 m -127.26 -173.14 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.542 -2.762 . . . . 9.7599999999999998 103.542 175.699 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.2 mt . . . . . 0 N--CA 1.43 -1.464 0 O-C-N 119.859 -1.775 . . . . 19.57 109.996 -173.532 . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 114.407 1.262 . . . . 17.170000000000002 114.407 . . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -109.66 149.51 29.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.086 1.884 . . . . 21.890000000000001 116.086 178.84 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -133.08 157.28 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.331 -3.356 . . . . 10.83 112.205 163.6 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -109.29 131.7 54.82 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 128.293 3.496 . . . . 10.609999999999999 106.425 179.669 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -135.75 131.81 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 117.071 -3.518 . . . . 9.1300000000000008 106.986 -176.37 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -103.41 147.13 27.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.126 -2.234 . . . . 20.550000000000001 109.738 -179.283 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.6 p -85.48 -178.19 6.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.24 1.495 . . . . 11.779999999999999 108.394 172.297 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.06 -47.45 85.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.049 1.74 . . . . 19.309999999999999 113.485 172.936 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -93.29 -79.42 0.4 Allowed 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 118.226 -2.796 . . . . 23.140000000000001 112.718 -172.408 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.19 63.62 0.32 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 127.157 2.313 . . . . 19.739999999999998 115.111 -177.362 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 74.4 tttt -140.87 129.54 22.84 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.056 1.884 . . . . 21.93 110.825 172.265 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -110.79 109.89 20.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.259 -3.401 . . . . 12.33 103.908 178.41 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.439 HD12 HG12 ' A' ' 30' ' ' ILE . 1.8 pt -98.88 142.79 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 127.097 2.159 . . . . 17.079999999999998 111.692 178.531 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.9 m -115.31 112.47 22.45 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.222 -2.174 . . . . 16.300000000000001 110.709 -178.61 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -103.64 155.11 18.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.01 1.862 . . . . 15.880000000000001 106.952 -172.278 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.56 121.67 42.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.021 2.343 . . . . 28.899999999999999 111.667 165.425 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.456 HG11 ' HE3' ' A' ' 29' ' ' LYS . 5.6 m -134.73 164.88 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 103.082 -2.933 . . . . 12.050000000000001 103.082 -175.838 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -120.8 153.42 57.02 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 115.798 -2.049 . . . . 18.170000000000002 109.196 165.103 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -67.61 -13.76 39.94 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 124.859 3.706 . . . . 8.1600000000000001 115.759 -172.612 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 75.2 m -79.73 -2.33 42.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.976 2.91 . . . . 11.130000000000001 116.375 166.501 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -74.21 132.93 42.63 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.567 -3.123 . . . . 18.030000000000001 102.567 172.734 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -78.06 154.36 31.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.379 3.072 . . . . 10.220000000000001 106.463 165.026 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -69.07 -28.15 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 118.507 -0.759 . . . . 12.300000000000001 110.024 178.531 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -51.06 -43.09 60.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 121.523 1.965 . . . . 36.509999999999998 113.883 163.529 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -70.48 -33.64 71.48 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.816 1.643 . . . . 25.66 113.132 173.118 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.24 -40.37 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 123.203 1.478 . . . . 8.1199999999999992 109.477 176.19 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -69.61 -35.27 75.12 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.129 -3.482 . . . . 15.470000000000001 114.065 179.257 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.69 -33.66 76.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.02 -2.925 . . . . 11.449999999999999 112.541 171.121 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HE3' HG11 ' A' ' 17' ' ' VAL . 35.2 mttm -70.62 -39.49 73.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.357 2.027 . . . . 24.98 108.452 -179.224 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.439 HG12 HD12 ' A' ' 13' ' ' ILE . 45.7 mt -65.68 -38.24 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.263 -1.523 . . . . 9.4600000000000009 111.105 176.203 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -51.27 -48.95 62.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.99 -3.569 . . . . 14.76 117.098 165.195 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -68.67 -42.04 78.41 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.178 1.808 . . . . 26.289999999999999 111.174 178.309 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -68.26 -57.16 6.4 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 123.652 2.933 . . . . 30.059999999999999 113.052 -179.947 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.433 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 38.0 mm-40 -103.46 -19.69 14.32 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.434 2.013 . . . . 25.190000000000001 116.434 -161.624 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.63 58.23 3.6 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 128.453 2.93 . . . . 7.4100000000000001 112.858 176.042 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.2 tt -127.65 136.41 28.92 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 127.353 2.261 . . . . 9.4900000000000002 108.451 -179.596 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -83.41 161.46 14.93 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 122.922 2.079 . . . . 11.42 107.321 -166.672 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.06 -18.35 10.12 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 CA-C-O 114.264 -2.473 . . . . 12.0 115.546 -170.757 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.259 16.3 t0 -66.41 -42.4 87.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.343 3.857 . . . . 35.549999999999997 108.179 176.851 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -65.36 -30.32 71.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.484 -2.635 . . . . 20.52 116.022 174.973 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -82.95 121.52 27.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.621 1.555 . . . . 7.1299999999999999 113.785 -168.88 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.424 ' HG2' HG22 ' A' ' 70' ' ' VAL . 22.8 ttm180 -117.7 101.99 8.78 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 102.99 -2.967 . . . . 36.390000000000001 102.99 167.905 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -80.11 113.38 18.23 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.859 1.314 . . . . 9.5500000000000007 113.745 171.271 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -93.93 127.89 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 118.335 -2.728 . . . . 13.9 111.711 171.555 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -105.54 114.25 28.31 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.276 2.235 . . . . 6.8600000000000003 107.792 162.793 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.54 -106.51 0.09 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.037 -2.914 . . . . 11.15 110.502 178.38 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.31 20.34 8.44 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 128.67 3.732 . . . . 13.93 116.554 170.957 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -115.52 139.0 50.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 102.348 -3.204 . . . . 23.920000000000002 102.348 -173.502 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -89.25 133.46 34.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 111.234 -2.712 . . . . 23.23 110.405 170.633 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.499 HD22 ' CD1' ' A' ' 59' ' ' TYR . 11.7 mt -112.55 133.61 54.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.703 1.601 . . . . 9.1099999999999994 109.012 -168.278 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -111.08 170.89 7.8 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.73 2.059 . . . . 33.439999999999998 113.434 -176.589 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.75 -43.21 38.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.919 2.488 . . . . 28.370000000000001 112.399 -156.725 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.84 -2.32 51.01 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 118.81 2.284 . . . . 15.0 118.81 179.149 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -121.12 170.64 9.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.782 -2.599 . . . . 25.5 113.677 -175.91 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -101.74 -172.46 2.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 105.879 -1.897 . . . . 11.949999999999999 105.879 -161.228 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.4 mt -79.32 -37.5 37.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.118 -1.401 . . . . 10.17 110.782 172.276 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p -61.4 -31.61 71.53 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.787 2.884 . . . . 13.59 118.787 172.173 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.76 -39.05 93.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.319 2.248 . . . . 11.699999999999999 109.551 -179.613 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD1' HD22 ' A' ' 50' ' ' LEU . 79.4 m-85 -92.31 -0.17 57.41 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 131.143 3.777 . . . . 12.949999999999999 113.785 178.509 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 m120 72.99 35.6 0.95 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.478 2.311 . . . . 25.449999999999999 108.761 173.733 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -95.32 114.61 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 125.349 2.499 . . . . 14.6 109.036 -178.079 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -113.44 -179.43 3.64 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 112.357 -6.464 . . . . 33.229999999999997 109.307 178.61 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -47.67 147.03 1.99 Allowed 'General case' 0 N--CA 1.43 -1.474 1 N-CA-C 123.952 4.797 . . . . 25.969999999999999 123.952 179.339 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 55.88 29.34 13.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.542 -3.849 . . . . 32.609999999999999 116.383 -177.091 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -82.38 139.98 33.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.864 -2.017 . . . . 10.56 111.626 174.565 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.9 m -83.49 122.41 28.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.996 2.06 . . . . 5.3300000000000001 112.605 166.754 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.31 157.1 25.51 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.022 -1.844 . . . . 11.66 106.022 172.132 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -129.45 127.04 40.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.23 1.196 . . . . 16.300000000000001 114.23 177.777 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 mt -77.06 120.38 22.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.779 -3.701 . . . . 9.9600000000000009 112.356 163.893 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.424 HG22 ' HG2' ' A' ' 42' ' ' ARG . 27.5 m -110.79 -178.85 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 104.87 -2.27 . . . . 9.7599999999999998 104.87 -170.126 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 N--CA 1.43 -1.444 0 O-C-N 126.189 2.18 . . . . 19.57 113.815 172.935 . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 108.651 -0.87 . . . . 17.170000000000002 108.651 . . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.262 29.7 mt-30 -94.22 130.26 40.52 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.579 -1.201 . . . . 21.890000000000001 113.745 177.742 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -120.35 150.21 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.97 1.708 . . . . 10.83 106.722 170.526 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -106.01 141.73 36.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.713 -2.492 . . . . 10.609999999999999 106.681 -172.69 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.49 128.57 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 117.21 -1.796 . . . . 9.1300000000000008 107.864 -179.462 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -105.62 110.87 23.35 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.719 -4.363 . . . . 20.550000000000001 103.631 -173.992 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.1 p -72.41 166.85 21.76 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.132 1.773 . . . . 11.779999999999999 107.964 -175.044 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.9 tp -75.43 -41.01 56.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.05 -2.281 . . . . 19.309999999999999 113.293 -172.257 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -56.92 -57.82 10.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.373 1.559 . . . . 23.140000000000001 112.401 168.194 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.24 68.0 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.834 1.797 . . . . 19.739999999999998 114.372 171.765 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -127.79 129.96 47.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.595 -2.709 . . . . 21.93 108.681 165.349 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -81.44 96.29 7.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.141 -0.974 . . . . 12.33 112.366 173.283 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 pt -92.43 142.2 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.583 -1.948 . . . . 17.079999999999998 113.793 -178.019 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.4 m -96.08 128.54 43.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.188 -1.57 . . . . 16.300000000000001 113.686 178.307 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.3 mt -124.12 133.13 53.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.99 -2.944 . . . . 15.880000000000001 107.578 -178.739 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.361 13.7 mt-10 -84.41 113.58 21.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.796 3.238 . . . . 28.899999999999999 113.093 162.816 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.83 155.72 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 1 N-CA-C 99.556 -4.239 . . . . 12.050000000000001 99.556 175.572 . . . . . . . . 3 3 . 1 . 054 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.46 144.65 32.45 Favored Pre-proline 0 N--CA 1.429 -1.492 1 O-C-N 116.229 -4.044 . . . . 18.170000000000002 105.482 163.764 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -78.16 4.67 6.01 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-O 113.662 -2.724 . . . . 8.1600000000000001 117.022 -175.97 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.1 m -91.52 -9.61 43.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.594 3.361 . . . . 11.130000000000001 110.958 171.411 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -80.19 171.0 15.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 125.262 3.664 . . . . 18.030000000000001 109.353 -179.318 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.7 p -80.75 159.03 25.31 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 133.274 4.629 . . . . 10.220000000000001 113.526 173.445 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 26' ' ' VAL 0.275 31.0 mm -67.13 -17.02 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 125.007 2.337 . . . . 12.300000000000001 111.031 -179.409 . . . . . . . . 3 3 . 1 . 054 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -55.22 -37.26 66.92 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 116.146 -4.096 . . . . 36.509999999999998 117.495 171.711 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -67.43 -41.61 84.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.189 2.996 . . . . 25.66 112.435 169.644 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 23' ' ' ILE . 57.7 t -61.41 -43.73 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.274 -2.766 . . . . 8.1199999999999992 111.188 174.224 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.258 79.8 mttt -62.89 -39.03 93.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.78 -2.45 . . . . 15.470000000000001 111.277 172.84 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.13 86.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.628 1.971 . . . . 11.449999999999999 111.309 -178.768 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -61.78 -37.59 84.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.739 2.126 . . . . 24.98 116.739 169.203 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mt -72.84 -32.16 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 118.939 -1.104 . . . . 9.4600000000000009 109.568 170.615 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -58.95 -48.41 81.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 116.388 -3.945 . . . . 14.76 113.389 172.136 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.48 -39.43 90.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 131.307 3.843 . . . . 26.289999999999999 110.713 -177.376 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -75.9 -55.1 5.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.617 3.191 . . . . 30.059999999999999 119.617 174.994 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -104.68 -37.87 6.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 114.129 -2.843 . . . . 25.190000000000001 111.066 -167.254 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.28 10.68 31.16 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 122.684 2.493 . . . . 7.4100000000000001 110.205 173.858 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.368 14.1 tt -75.47 115.38 45.06 Favored Pre-proline 0 N--CA 1.429 -1.501 0 C-N-CA 130.683 3.593 . . . . 9.4900000000000002 116.834 169.839 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.66 159.26 21.93 Favored 'Trans proline' 0 N--CA 1.434 -2.027 2 CA-C-N 130.411 4.754 . . . . 11.42 110.351 -172.378 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -62.12 -22.61 74.5 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 124.954 3.769 . . . . 12.0 114.715 -168.827 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.83 -36.26 82.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.334 1.453 . . . . 35.549999999999997 111.937 -175.805 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -91.57 -15.63 28.37 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.68 3.133 . . . . 20.52 110.493 -171.525 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -77.85 131.24 37.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.215 -2.803 . . . . 7.1299999999999999 116.451 170.756 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -120.8 122.4 40.25 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.386 -3.321 . . . . 36.390000000000001 108.701 162.518 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.9 mt -114.03 105.44 13.22 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.796 -2.44 . . . . 9.5500000000000007 111.85 -171.728 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -90.27 136.51 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 127.773 2.429 . . . . 13.9 112.194 179.639 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -122.83 94.01 4.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.415 2.286 . . . . 6.8600000000000003 106.657 -178.951 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.297 . . 73.44 -77.75 0.05 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.565 -2.584 . . . . 11.15 111.23 -172.517 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.29 16.76 0.59 Allowed Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 114.214 -1.357 . . . . 13.93 111.889 -177.757 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -120.98 164.67 16.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.442 3.097 . . . . 23.920000000000002 113.391 170.845 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -119.29 120.53 37.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 122.183 -0.323 . . . . 23.23 110.699 -167.441 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.59 147.86 28.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.511 2.1 . . . . 9.1099999999999994 110.897 -167.535 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -110.8 167.12 10.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.647 -2.533 . . . . 33.439999999999998 104.749 -168.17 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.16 -66.72 0.69 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 122.989 1.376 . . . . 28.370000000000001 113.682 -169.038 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.63 18.64 2.22 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 116.394 1.318 . . . . 15.0 116.394 -170.472 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -115.94 154.95 28.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.938 -2.615 . . . . 25.5 103.938 -176.151 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -87.67 146.28 25.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.605 3.557 . . . . 11.949999999999999 120.605 -179.456 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.04 -43.72 74.01 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 118.712 2.856 . . . . 10.17 118.712 173.717 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 p -66.26 -33.45 75.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.996 2.591 . . . . 13.59 117.996 170.052 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.77 -36.46 80.54 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 122.607 2.458 . . . . 11.699999999999999 112.663 177.038 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -69.62 -18.03 63.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.808 3.243 . . . . 12.949999999999999 113.817 174.808 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 m120 65.09 51.69 1.63 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.51 1.524 . . . . 25.449999999999999 111.822 -174.801 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -94.7 111.41 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-O 123.62 1.676 . . . . 14.6 108.392 174.92 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -101.72 165.62 11.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 111.5 -2.591 . . . . 33.229999999999997 108.98 -162.775 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -61.73 133.85 56.05 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.628 -2.545 . . . . 25.969999999999999 116.298 178.729 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 49.9 mt-10 71.59 25.41 3.34 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.289 2.329 . . . . 32.609999999999999 117.289 -177.539 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -94.29 146.29 24.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.676 2.472 . . . . 10.56 117.676 174.94 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -104.32 116.93 33.02 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.996 -4.19 . . . . 5.3300000000000001 108.931 -163.737 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.37 132.59 36.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.867 2.467 . . . . 11.66 110.088 167.636 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -81.93 127.79 33.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.16 -3.462 . . . . 16.300000000000001 116.173 159.747 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -94.79 103.03 14.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 125.129 1.518 . . . . 9.9600000000000009 110.695 159.013 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.38 -177.05 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 117.819 -1.552 . . . . 9.7599999999999998 107.252 -179.676 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.4 tp . . . . . 0 N--CA 1.43 -1.44 0 CA-C-N 110.798 -2.91 . . . . 19.57 107.282 170.73 . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.49 -1.344 0 CA-C-O 122.832 1.301 . . . . 17.170000000000002 107.949 . . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -87.67 135.83 33.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.929 2.196 . . . . 21.890000000000001 116.929 160.752 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -125.99 142.41 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 128.739 2.815 . . . . 10.83 105.694 -175.223 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -102.45 143.09 32.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.897 1.808 . . . . 10.609999999999999 106.713 175.917 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.8 t -124.46 130.94 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.311 -1.768 . . . . 9.1300000000000008 110.777 162.811 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -96.2 126.19 41.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.791 1.632 . . . . 20.550000000000001 111.261 168.099 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.259 72.2 p -89.73 176.26 6.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.67 3.188 . . . . 11.779999999999999 114.36 -171.168 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.0 tp -79.48 -54.93 5.43 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.264 -2.148 . . . . 19.309999999999999 112.613 -178.174 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -38.06 -72.34 0.06 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.312 2.708 . . . . 23.140000000000001 118.312 161.418 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.84 45.79 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.232 -3.418 . . . . 19.739999999999998 112.944 167.771 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 22.0 mtpt -119.08 149.25 42.0 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.485 -1.302 . . . . 21.93 107.485 179.717 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.2 m -110.26 101.15 9.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.254 -2.499 . . . . 12.33 104.254 171.405 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.6 pt -94.86 126.3 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 127.256 3.408 . . . . 17.079999999999998 112.193 -176.389 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.275 3.2 m -74.91 114.4 13.32 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.332 -3.355 . . . . 16.300000000000001 117.369 161.994 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 29' ' ' LYS . 10.2 mt -122.42 149.16 44.21 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 116.014 -4.179 . . . . 15.880000000000001 106.623 174.475 . . . . . . . . 3 3 . 1 . 055 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -102.4 125.75 49.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.509 2.576 . . . . 28.899999999999999 108.621 -178.291 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 m -147.77 165.1 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 118.492 -2.63 . . . . 12.050000000000001 106.945 -178.118 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -102.28 170.84 5.88 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 125.675 2.655 . . . . 18.170000000000002 110.093 161.852 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -56.89 -41.68 72.7 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 114.801 -3.315 . . . . 8.1600000000000001 117.374 166.46 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.2 p -70.68 -3.51 18.84 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.591 2.757 . . . . 11.130000000000001 115.223 176.239 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -83.88 153.54 23.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.32 -2.113 . . . . 18.030000000000001 113.894 167.552 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.6 p -95.16 176.53 6.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.689 -3.757 . . . . 10.220000000000001 115.846 -172.493 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mm -66.55 -43.55 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.86 -2.4 . . . . 12.300000000000001 107.607 173.923 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -47.82 -46.09 30.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.795 2.517 . . . . 36.509999999999998 117.795 168.535 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -75.75 -28.72 58.58 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.99 -1.068 . . . . 25.66 110.26 -178.685 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.65 -54.54 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.666 -3.146 . . . . 8.1199999999999992 110.881 169.867 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -58.74 -24.32 61.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.545 -1.972 . . . . 15.470000000000001 115.951 179.159 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.253 . . -76.4 -28.29 56.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.321 -0.862 . . . . 11.449999999999999 111.29 -177.738 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.467 ' HB3' HD22 ' A' ' 15' ' ' LEU . 59.4 mmtt -68.83 -49.25 60.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.186 2.595 . . . . 24.98 105.346 176.901 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mt -61.42 -39.32 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 127.89 3.709 . . . . 9.4600000000000009 114.261 -178.533 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.4 -39.7 80.39 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.124 -4.11 . . . . 14.76 115.647 171.517 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -67.31 -70.41 0.25 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.436 -1.69 . . . . 26.289999999999999 106.436 178.149 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -77.8 -33.87 52.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.708 2.114 . . . . 30.059999999999999 116.708 -161.277 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.471 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 41.8 mm-40 -99.22 -63.13 1.15 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 120.991 1.723 . . . . 25.190000000000001 109.248 179.203 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.94 89.02 1.22 Allowed Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.505 -1.997 . . . . 7.4100000000000001 111.61 174.501 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.5 mt -146.18 128.45 7.81 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 115.856 -2.021 . . . . 9.4900000000000002 106.898 179.669 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -61.49 145.5 97.88 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 125.132 2.869 . . . . 11.42 117.998 176.681 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -79.26 -15.34 12.78 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 123.568 2.845 . . . . 12.0 116.252 -166.506 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.35 -35.07 25.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.113 1.911 . . . . 35.549999999999997 108.748 174.545 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -72.86 -30.06 63.69 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.576 -3.828 . . . . 20.52 108.896 -179.737 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -64.57 134.95 55.42 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.225 -2.797 . . . . 7.1299999999999999 115.953 173.787 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HB3' HG23 ' A' ' 70' ' ' VAL . 32.8 ttm180 -129.08 114.8 16.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.775 2.226 . . . . 36.390000000000001 112.299 167.907 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.87 119.8 33.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.453 -3.067 . . . . 9.5500000000000007 112.643 179.709 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.9 130.74 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 123.575 1.655 . . . . 13.9 108.597 -179.816 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -111.19 104.96 13.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.534 2.587 . . . . 6.8600000000000003 113.204 166.051 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.292 . . 71.6 -83.82 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.219 -3.425 . . . . 11.15 109.575 -168.489 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.59 28.82 0.85 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 107.847 -2.101 . . . . 13.93 107.847 166.624 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -107.53 111.89 24.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.366 -2.457 . . . . 23.920000000000002 104.366 175.911 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -70.32 130.39 41.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.687 2.184 . . . . 23.23 109.359 176.852 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -91.7 123.86 35.41 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.369 -1.287 . . . . 9.1099999999999994 114.155 -171.391 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -74.79 136.85 41.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 116.467 2.025 . . . . 33.439999999999998 116.467 173.198 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -39.29 -60.83 0.86 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.351 2.723 . . . . 28.370000000000001 118.351 175.38 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.52 -10.19 47.8 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 117.057 -3.527 . . . . 15.0 121.2 -177.936 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -96.1 165.02 12.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 120.53 2.165 . . . . 25.5 114.803 -172.298 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.5 p -88.57 158.51 18.26 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.929 -4.232 . . . . 11.949999999999999 109.271 -172.073 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.74 -40.45 97.25 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.61 -0.723 . . . . 10.17 111.978 171.101 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 p -47.85 -36.72 12.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.735 -2.478 . . . . 13.59 116.755 168.981 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.3 -42.08 65.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.825 1.65 . . . . 11.699999999999999 108.532 -166.679 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -84.15 0.52 48.27 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.904 -1.747 . . . . 12.949999999999999 111.533 179.937 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.8 m120 73.03 41.68 0.49 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.043 0.937 . . . . 25.449999999999999 108.908 174.142 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.5 mt -85.85 122.18 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 116.877 -1.535 . . . . 14.6 113.392 177.577 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -112.75 175.31 5.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 119.429 1.013 . . . . 33.229999999999997 111.86 -175.125 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.295 19.2 pttp -66.3 151.33 47.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.523 3.058 . . . . 25.969999999999999 108.916 175.763 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 63.35 4.58 1.73 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 120.09 3.367 . . . . 32.609999999999999 120.09 -172.22 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -72.08 162.21 29.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.297 -1.774 . . . . 10.56 107.265 172.601 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.8 m -130.64 121.34 25.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.844 -1.551 . . . . 5.3300000000000001 108.994 -177.074 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.1 mt -92.51 150.33 20.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.739 2.685 . . . . 11.66 112.422 172.62 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -108.46 127.68 54.13 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.845 -3.659 . . . . 16.300000000000001 110.149 -178.088 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.6 tp -94.2 103.81 15.84 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.181 -0.918 . . . . 9.9600000000000009 112.309 -171.963 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 42' ' ' ARG 0.317 18.4 m -116.98 -169.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 106.369 -1.715 . . . . 9.7599999999999998 106.369 -174.981 . . . . . . . . 3 3 . 1 . 055 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 mt . . . . . 0 N--CA 1.43 -1.446 0 C-N-CA 125.97 1.708 . . . . 19.57 110.285 -168.46 . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ptm . . . . . 0 CA--C 1.49 -1.336 0 N-CA-C 118.434 2.753 . . . . 17.170000000000002 118.434 . . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -87.47 125.62 34.41 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.744 -1.848 . . . . 21.890000000000001 107.089 -174.897 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.0 pt -115.91 163.69 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 112.069 -2.332 . . . . 10.83 107.168 174.034 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -124.72 132.94 53.34 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.147 2.579 . . . . 10.609999999999999 106.532 -177.354 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.24 117.63 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 121.142 -0.974 . . . . 9.1300000000000008 109.57 176.661 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -109.94 141.22 43.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.341 -2.724 . . . . 20.550000000000001 115.745 -179.62 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.4 p -83.59 -171.87 3.83 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.295 1.22 . . . . 11.779999999999999 114.295 179.744 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 tp -72.62 -35.07 67.74 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.729 -3.107 . . . . 19.309999999999999 109.802 -178.34 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 p -87.15 -49.16 7.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 104.247 -2.501 . . . . 23.140000000000001 104.247 -178.083 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.98 59.48 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 117.403 -1.776 . . . . 19.739999999999998 116.599 166.156 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 75.7 tttt -96.51 125.41 40.98 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.706 -3.442 . . . . 21.93 101.706 166.687 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -105.23 122.37 45.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.976 -2.601 . . . . 12.33 103.976 -175.853 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 pt -108.49 130.76 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 125.808 2.718 . . . . 17.079999999999998 116.06 168.759 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -86.34 116.45 24.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.664 -3.772 . . . . 16.300000000000001 107.915 179.513 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.0 mt -121.39 156.38 32.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.906 -2.371 . . . . 15.880000000000001 109.319 -179.341 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -130.98 129.99 42.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.097 -2.557 . . . . 28.899999999999999 104.097 179.995 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -148.57 179.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.882 1.673 . . . . 12.050000000000001 108.652 177.009 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -107.58 169.14 7.01 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 119.677 -1.889 . . . . 18.170000000000002 107.533 174.953 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.67 -2.24 10.33 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 124.712 3.608 . . . . 8.1600000000000001 113.021 -173.103 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.273 73.4 m -101.68 -0.44 34.6 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 126.266 2.229 . . . . 11.130000000000001 110.499 174.14 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.4 145.15 49.52 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.396 -3.315 . . . . 18.030000000000001 110.099 173.029 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -79.63 164.51 23.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.066 -2.271 . . . . 10.220000000000001 113.848 173.038 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -57.21 -38.52 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 126.668 1.987 . . . . 12.300000000000001 109.604 171.08 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.65 -51.97 19.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.001 1.721 . . . . 36.509999999999998 114.066 167.943 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -72.65 -12.38 61.01 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.458 1.503 . . . . 25.66 114.288 176.565 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.4 t -80.03 -50.05 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 104.165 -2.531 . . . . 8.1199999999999992 104.165 172.668 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.298 62.7 mttt -47.78 -38.65 16.12 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.415 2.686 . . . . 15.470000000000001 113.875 170.039 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.56 -44.34 93.31 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.672 2.789 . . . . 11.449999999999999 115.136 -178.271 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -69.89 -40.4 75.68 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.814 2.846 . . . . 24.98 107.731 178.307 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.45 -33.58 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 124.454 1.096 . . . . 9.4600000000000009 109.153 179.484 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.42 -44.03 92.95 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.153 -2.217 . . . . 14.76 114.139 172.708 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -59.7 -61.21 2.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.572 1.949 . . . . 26.289999999999999 113.855 171.727 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.99 -52.02 67.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 121.059 3.725 . . . . 30.059999999999999 121.059 -179.991 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.472 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 14.2 mm-40 -108.97 -29.87 8.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.584 1.327 . . . . 25.190000000000001 114.584 -157.584 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.19 41.21 8.11 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.201 -1.16 . . . . 7.4100000000000001 110.201 177.244 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.1 mt -102.73 120.06 53.89 Favored Pre-proline 0 N--CA 1.431 -1.424 0 CA-C-O 115.461 -2.209 . . . . 9.4900000000000002 111.678 169.055 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -59.14 146.25 95.06 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 CA-C-N 126.305 3.287 . . . . 11.42 114.227 172.424 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -29.53 90.59 Favored 'Trans proline' 0 C--N 1.299 -2.027 1 C-N-CA 125.333 4.022 . . . . 12.0 116.438 179.93 . . . . . . . . 3 3 . 1 . 056 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.9 -42.37 94.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.988 -3.57 . . . . 35.549999999999997 113.266 168.851 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.434 ' HG2' HD22 ' A' ' 71' ' ' LEU 0.287 12.7 tt0 -64.95 -35.17 80.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.748 2.019 . . . . 20.52 112.618 173.092 . . . . . . . . 3 3 . 1 . 056 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -81.14 136.81 35.94 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.418 -2.676 . . . . 7.1299999999999999 115.647 -177.462 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -128.94 117.46 21.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 128.062 3.351 . . . . 36.390000000000001 110.031 167.077 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.8 mt -91.68 121.91 33.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.493 -1.717 . . . . 9.5500000000000007 109.24 179.599 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mt -111.05 133.27 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 124.525 3.329 . . . . 13.9 108.262 178.041 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -115.38 107.59 15.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.148 2.979 . . . . 6.8600000000000003 107.147 172.196 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 63.38 -96.07 0.05 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.331 2.652 . . . . 11.15 111.823 -166.545 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.71 -5.5 9.11 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.675 1.708 . . . . 13.93 109.541 -178.372 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -98.75 126.55 44.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.49 -3.947 . . . . 23.920000000000002 105.985 -166.832 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -90.61 141.31 28.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 127.712 3.625 . . . . 23.23 106.344 176.071 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.365 97.1 mt -104.52 133.77 48.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.748 -3.72 . . . . 9.1099999999999994 114.312 -168.827 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -74.63 154.83 38.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.687 2.395 . . . . 33.439999999999998 112.231 174.881 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -73.16 -55.57 6.29 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 130.053 3.341 . . . . 28.370000000000001 112.346 -167.131 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.73 18.47 30.09 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 119.136 2.415 . . . . 15.0 119.136 -172.766 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -114.01 146.6 39.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.606 2.146 . . . . 25.5 109.897 169.763 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.264 73.3 p -75.99 162.82 27.74 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 128.937 2.895 . . . . 11.949999999999999 116.866 -179.105 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.9 mt -58.43 -49.57 76.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 128.807 3.817 . . . . 10.17 109.92 174.873 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.357 88.9 p -57.54 -43.96 84.77 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.795 3.238 . . . . 13.59 119.487 178.698 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -53.81 -53.42 52.58 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 121.588 3.921 . . . . 11.699999999999999 121.588 162.924 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -62.44 -21.01 65.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.66 2.467 . . . . 12.949999999999999 117.66 169.325 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.347 58.2 t30 60.04 67.64 0.85 Allowed 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.508 2.04 . . . . 25.449999999999999 116.508 -161.556 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -118.5 117.39 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.5 -2.778 . . . . 14.6 103.5 170.198 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.35 -163.15 1.01 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.48 2.562 . . . . 33.229999999999997 112.685 -175.536 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -76.0 156.71 33.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.213 -3.43 . . . . 25.969999999999999 115.427 168.548 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.85 23.33 13.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.31 2.244 . . . . 32.609999999999999 110.741 176.663 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -85.36 122.53 29.65 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.071 1.748 . . . . 10.56 113.335 175.631 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.9 m -88.52 98.9 11.91 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 116.132 -1.89 . . . . 5.3300000000000001 112.498 170.667 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.96 140.04 29.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.704 2.002 . . . . 11.66 109.015 -179.966 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -98.64 107.61 20.1 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.428 -1.42 . . . . 16.300000000000001 113.49 -173.267 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -82.88 109.78 17.31 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 129.156 2.982 . . . . 9.9600000000000009 112.368 -177.172 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.9 m -121.58 161.76 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 116.726 -3.733 . . . . 9.7599999999999998 106.912 177.981 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.434 HD22 ' HG2' ' A' ' 40' ' ' GLN . 29.8 mt . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 107.591 -1.263 . . . . 19.57 107.591 -173.087 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 106.484 -1.672 . . . . 17.170000000000002 106.484 . . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.273 4.2 pt20 -113.28 127.69 56.23 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.712 -2.493 . . . . 21.890000000000001 112.773 176.189 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -120.34 174.48 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 125.293 2.473 . . . . 10.83 108.102 171.883 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -120.96 145.9 47.23 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 112.744 -2.026 . . . . 10.609999999999999 109.802 -176.78 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.99 122.53 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 107.402 -1.333 . . . . 9.1300000000000008 107.402 173.218 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -136.05 142.21 44.37 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.394 -3.941 . . . . 20.550000000000001 115.338 -164.33 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.278 80.7 p -80.85 -171.5 3.2 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 126.533 3.064 . . . . 11.779999999999999 110.03 -170.612 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.89 -40.5 60.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 131.556 3.943 . . . . 19.309999999999999 114.266 166.945 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.18 -47.6 49.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.544 -3.223 . . . . 23.140000000000001 111.031 173.606 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.91 35.91 0.23 Allowed Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 114.637 -3.313 . . . . 19.739999999999998 115.593 172.782 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -88.03 121.58 30.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 113.746 -3.026 . . . . 21.93 110.701 178.784 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -108.19 137.57 45.94 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 121.695 2.043 . . . . 12.33 114.037 -172.331 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.1 pt -124.6 136.78 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 118.532 -1.267 . . . . 17.079999999999998 107.804 172.776 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.3 m -82.81 120.89 26.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.176 3.39 . . . . 16.300000000000001 108.564 168.862 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -115.17 132.73 56.51 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.966 -2.334 . . . . 15.880000000000001 107.123 174.504 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -107.82 115.09 29.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.191 -2.818 . . . . 28.899999999999999 108.762 -178.681 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.31 162.04 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 124.559 1.162 . . . . 12.050000000000001 109.473 -166.928 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -90.7 155.08 45.89 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 120.374 -1.454 . . . . 18.170000000000002 107.444 159.512 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -60.95 -23.39 77.17 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 122.722 2.282 . . . . 8.1600000000000001 112.674 168.536 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 m -69.39 -18.32 63.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.003 2.638 . . . . 11.130000000000001 113.498 173.427 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -65.53 147.15 53.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.525 2.875 . . . . 18.030000000000001 108.574 179.162 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -85.08 172.91 10.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.933 1.827 . . . . 10.220000000000001 115.933 179.061 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.15 -27.11 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 124.053 0.846 . . . . 12.300000000000001 109.326 178.432 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -50.81 -59.54 4.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.386 -2.188 . . . . 36.509999999999998 114.143 167.634 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -55.14 -45.77 75.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.98 3.712 . . . . 25.66 109.984 176.082 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -60.4 -50.32 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.363 -2.086 . . . . 8.1199999999999992 113.156 -176.508 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -63.39 -37.19 86.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.014 1.864 . . . . 15.470000000000001 110.354 176.584 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.38 -13.12 36.05 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.324 -4.61 . . . . 11.449999999999999 114.206 174.726 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 mtpt -80.04 -49.24 12.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.909 -2.994 . . . . 24.98 117.487 169.189 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.9 mt -60.23 -30.26 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 126.096 2.855 . . . . 9.4600000000000009 112.523 171.944 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -70.7 -43.35 69.17 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.346 -3.971 . . . . 14.76 117.143 172.969 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.33 -49.53 74.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.793 2.516 . . . . 26.289999999999999 117.793 159.313 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -79.94 -74.73 0.29 Allowed 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 116.266 -4.021 . . . . 30.059999999999999 111.274 -176.606 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -64.94 -43.3 93.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 120.322 1.419 . . . . 25.190000000000001 113.824 -173.509 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.69 68.83 1.19 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 107.06 -2.416 . . . . 7.4100000000000001 107.06 179.53 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.8 128.44 23.87 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-N 113.393 -1.403 . . . . 9.4900000000000002 108.644 176.643 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -66.69 143.53 68.3 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-O 114.342 -2.441 . . . . 11.42 115.015 -174.596 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.81 -14.69 42.34 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 122.841 2.361 . . . . 12.0 113.027 -163.68 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -95.96 -22.31 17.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 123.021 2.646 . . . . 35.549999999999997 110.318 -179.66 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.378 32.9 mt-30 -71.47 -22.6 61.8 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 117.645 -1.169 . . . . 20.52 112.87 164.355 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -79.33 124.58 28.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.955 -2.609 . . . . 7.1299999999999999 103.955 175.601 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -110.89 122.13 47.09 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.978 3.311 . . . . 36.390000000000001 109.685 156.217 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.3 mt -113.78 133.23 55.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.368 2.509 . . . . 9.5500000000000007 105.435 178.101 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 mm -130.39 119.4 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 111.033 -2.803 . . . . 13.9 103.733 -163.244 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -93.98 108.88 20.65 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.453 1.501 . . . . 6.8600000000000003 110.773 158.194 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.53 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.48 -2.637 . . . . 11.15 112.118 179.825 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.88 36.72 1.21 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 126.192 1.853 . . . . 13.93 110.756 165.965 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -108.28 123.74 49.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.5 -2.177 . . . . 23.920000000000002 113.68 162.581 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -81.57 136.07 35.57 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.186 -3.446 . . . . 23.23 109.386 166.246 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.428 HD21 ' H ' ' A' ' 50' ' ' LEU . 1.1 mm? -87.73 127.98 35.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.776 1.231 . . . . 9.1099999999999994 111.071 179.595 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -78.43 133.14 37.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.954 2.576 . . . . 33.439999999999998 117.954 -178.214 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -49.14 -45.37 43.6 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.363 -3.335 . . . . 28.370000000000001 116.288 -168.129 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.73 4.49 75.8 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-N 119.981 1.264 . . . . 15.0 112.586 -169.107 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.3 40.0 mtt180 -95.19 166.17 12.04 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.069 -3.607 . . . . 25.5 109.262 -178.495 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.8 p -92.66 156.24 17.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.161 -2.212 . . . . 11.949999999999999 106.475 -178.516 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.4 mt -51.14 -45.25 61.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.971 -3.581 . . . . 10.17 113.726 164.7 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.4 t -57.12 -36.6 70.85 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.826 2.051 . . . . 13.59 108.316 -177.391 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -64.59 -30.9 71.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.289 -2.132 . . . . 11.699999999999999 113.512 -167.486 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -87.27 0.61 55.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.165 -1.38 . . . . 12.949999999999999 113.044 178.423 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 62.23 49.21 4.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.837 1.655 . . . . 25.449999999999999 112.605 -178.742 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.94 112.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.895 2.478 . . . . 14.6 109.85 172.037 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -84.68 -162.57 0.7 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.375 2.036 . . . . 33.229999999999997 112.222 178.087 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.06 164.86 15.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.779 -3.7 . . . . 25.969999999999999 111.141 172.815 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.381 37.3 mt-10 73.54 1.1 3.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.683 1.593 . . . . 32.609999999999999 112.439 173.7 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.346 8.7 t -88.06 140.13 29.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.363 -2.71 . . . . 10.56 112.277 -168.581 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.0 m -100.68 113.93 27.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 126.059 2.837 . . . . 5.3300000000000001 108.826 -178.507 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.1 mt -87.6 144.99 26.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.515 2.783 . . . . 11.66 118.515 165.519 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -96.39 120.59 36.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.318 -3.989 . . . . 16.300000000000001 112.501 179.522 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 tp -94.08 120.99 35.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.167 -2.288 . . . . 9.9600000000000009 110.43 -177.325 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.1 t -118.27 138.22 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 129.735 3.214 . . . . 9.7599999999999998 111.254 -173.56 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.3 tp . . . . . 0 N--CA 1.43 -1.436 0 O-C-N 126.867 2.604 . . . . 19.57 106.535 176.615 . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.491 -1.325 0 CA-C-O 121.382 0.61 . . . . 17.170000000000002 109.687 . . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.92 133.76 35.78 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.139 -3.475 . . . . 21.890000000000001 112.836 171.012 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -118.94 147.89 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 128.599 4.047 . . . . 10.83 116.021 164.664 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -97.17 128.16 43.81 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.893 -3.63 . . . . 10.609999999999999 108.323 176.391 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -118.58 131.61 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.153 -2.536 . . . . 9.1300000000000008 104.153 173.214 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -105.82 157.17 17.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.331 -3.355 . . . . 20.550000000000001 109.607 173.749 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 56.1 p -99.79 178.32 4.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.742 3.217 . . . . 11.779999999999999 109.403 175.517 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.4 tp -77.2 -36.9 54.46 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.517 -2.614 . . . . 19.309999999999999 110.84 178.744 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -38.18 72.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.96 -1.713 . . . . 23.140000000000001 111.991 160.662 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.51 33.72 2.23 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 117.382 1.713 . . . . 19.739999999999998 117.382 171.529 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -80.8 119.44 23.38 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.919 2.487 . . . . 21.93 105.807 -179.775 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -81.34 104.51 11.84 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.693 3.121 . . . . 12.33 116.578 169.833 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 pt -100.83 147.4 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 124.622 1.169 . . . . 17.079999999999998 112.583 174.587 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 m -111.28 99.47 8.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.816 -2.291 . . . . 16.300000000000001 104.816 -172.248 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.7 mt -97.33 118.67 34.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.799 -3.688 . . . . 15.880000000000001 110.412 179.288 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -80.82 128.37 33.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.734 -1.229 . . . . 28.899999999999999 108.142 165.302 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 m -147.72 164.35 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 103.794 -2.669 . . . . 12.050000000000001 103.794 -178.48 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -105.81 140.72 21.49 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 116.44 -1.743 . . . . 18.170000000000002 109.103 171.91 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.44 -5.71 11.79 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 124.767 2.738 . . . . 8.1600000000000001 113.036 -167.046 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.4 p -69.28 -26.2 64.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.744 0.818 . . . . 11.130000000000001 112.483 169.522 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -75.73 178.28 6.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.522 2.415 . . . . 18.030000000000001 117.522 174.935 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 9.2 p -106.76 178.8 4.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.719 -3.113 . . . . 10.220000000000001 111.617 -165.71 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 11.3 mm -69.81 -35.47 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 116.854 -3.654 . . . . 12.300000000000001 114.261 168.479 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -52.31 -44.59 65.16 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 117.124 -1.417 . . . . 36.509999999999998 114.431 167.051 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -52.49 -49.36 64.89 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 114.947 -2.454 . . . . 25.66 114.612 163.477 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.18 -43.34 97.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 122.091 2.223 . . . . 8.1199999999999992 109.37 -177.084 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.66 -35.54 70.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.161 2.282 . . . . 15.470000000000001 117.161 172.883 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.21 -25.65 63.51 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 126.898 3.237 . . . . 11.449999999999999 116.968 170.662 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -75.2 -27.35 59.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.792 -2.458 . . . . 24.98 111.786 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -80.47 -37.51 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 118.057 -2.902 . . . . 9.4600000000000009 107.923 178.851 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -63.11 -52.49 62.4 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 115.205 -2.331 . . . . 14.76 107.769 -178.773 . . . . . . . . 3 3 . 1 . 058 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -52.99 -45.52 67.88 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.981 2.912 . . . . 26.289999999999999 113.495 173.362 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -74.33 -95.84 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.277 4.231 . . . . 30.059999999999999 112.643 176.879 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -71.36 -9.41 58.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.122 2.237 . . . . 25.190000000000001 111.449 -162.608 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.46 52.66 5.92 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.51 -1.994 . . . . 7.4100000000000001 117.105 179.975 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.68 110.62 22.69 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.086 -2.864 . . . . 9.4900000000000002 106.321 -170.876 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 31' ' ' GLN . 30.7 Cg_exo -59.06 147.03 92.24 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 128.782 4.172 . . . . 11.42 111.531 -177.58 . . . . . . . . 3 3 . 1 . 058 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -75.12 -8.19 19.72 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 121.397 1.398 . . . . 12.0 112.925 -161.943 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -74.81 -39.86 61.43 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.201 1.953 . . . . 35.549999999999997 115.167 -174.299 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -66.95 -28.05 67.96 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 132.691 4.397 . . . . 20.52 114.913 173.12 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.4 117.54 12.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.955 2.788 . . . . 7.1299999999999999 114.489 -169.969 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -111.55 98.37 7.4 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.512 -3.243 . . . . 36.390000000000001 107.499 176.727 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.05 122.3 33.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 111.779 -2.464 . . . . 9.5500000000000007 111.59 176.466 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mm -112.26 144.37 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 124.119 1.914 . . . . 13.9 110.424 -177.887 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -123.31 114.17 19.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.854 2.74 . . . . 6.8600000000000003 107.962 161.394 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.306 . . 70.6 -88.05 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.677 -2.514 . . . . 11.15 115.889 -177.046 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.22 8.28 2.13 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 126.4 1.952 . . . . 13.93 110.291 165.073 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -88.29 149.96 23.51 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 114.704 -4.998 . . . . 23.920000000000002 108.173 168.5 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -109.96 146.99 34.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.961 -3.348 . . . . 23.23 101.961 -179.02 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.9 mt -104.25 137.87 41.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.589 1.699 . . . . 9.1099999999999994 115.589 -171.819 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 19.4 tp10 -97.4 155.46 16.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 120.524 1.511 . . . . 33.439999999999998 112.735 -169.661 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.438 ' O ' ' HB ' ' A' ' 22' ' ' THR . 15.0 m-20 -69.52 -61.39 1.81 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.374 1.25 . . . . 28.370000000000001 114.374 -162.448 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.16 42.46 2.74 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 117.08 1.592 . . . . 15.0 117.08 -179.962 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -131.59 154.93 48.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 119.141 1.47 . . . . 25.5 107.44 175.393 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -88.67 146.22 25.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 121.325 3.824 . . . . 11.949999999999999 121.325 -176.913 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.7 mt -54.74 -38.19 66.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.078 1.751 . . . . 10.17 114.984 171.854 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -51.62 -55.19 20.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.486 3.143 . . . . 13.59 119.486 166.861 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.74 -49.12 73.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.796 2.438 . . . . 11.699999999999999 115.093 176.923 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -71.53 -6.55 41.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.339 3.456 . . . . 12.949999999999999 112.825 173.72 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 54.32 44.21 29.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.949 2.203 . . . . 25.449999999999999 116.949 -179.961 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.0 120.55 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 129.593 3.157 . . . . 14.6 105.179 171.763 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -103.68 170.38 7.97 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.955 -1.716 . . . . 33.229999999999997 109.555 -178.205 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -47.06 141.12 4.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.506 2.378 . . . . 25.969999999999999 110.863 167.355 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 66.6 mt-10 51.9 20.37 1.19 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.818 2.896 . . . . 32.609999999999999 118.818 -175.674 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 t -75.18 165.21 25.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.078 2.551 . . . . 10.56 110.815 171.901 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.5 m -122.47 101.77 7.69 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 112.877 -3.44 . . . . 5.3300000000000001 108.021 -164.496 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.94 156.98 19.59 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 125.661 1.851 . . . . 11.66 110.506 163.313 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -118.73 119.9 35.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.019 -2.301 . . . . 16.300000000000001 112.817 -177.452 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.39 98.45 11.49 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.505 -2.622 . . . . 9.9600000000000009 111.42 -175.969 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.48 156.84 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 125.386 1.679 . . . . 9.7599999999999998 110.198 167.652 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 N--CA 1.43 -1.45 0 O-C-N 119.321 -2.112 . . . . 19.57 111.645 -172.871 . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.49 -1.332 0 N-CA-C 115.445 1.646 . . . . 17.170000000000002 115.445 . . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.51 132.78 46.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.649 -2.532 . . . . 21.890000000000001 105.738 171.842 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 pt -110.2 156.77 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 113.752 -1.567 . . . . 10.83 109.851 170.005 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -98.0 135.76 39.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 118.292 -0.861 . . . . 10.609999999999999 109.706 177.727 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.36 121.67 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 N-CA-C 99.337 -4.32 . . . . 9.1300000000000008 99.337 171.197 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -102.81 128.83 49.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 126.791 2.557 . . . . 20.550000000000001 109.072 177.063 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.7 p -96.09 176.59 6.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.497 -2.627 . . . . 11.779999999999999 112.511 -170.563 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.1 tp -80.61 -30.32 36.8 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.644 -5.035 . . . . 19.309999999999999 111.116 -173.658 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.7 p -68.33 -69.74 0.31 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.42 2.748 . . . . 23.140000000000001 118.42 162.538 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.98 38.39 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.712 0 O-C-N 119.891 -1.756 . . . . 19.739999999999998 112.144 174.226 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -99.6 132.33 45.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 119.388 1.594 . . . . 21.93 110.856 171.646 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.2 m -111.74 111.28 22.15 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.612 -2.736 . . . . 12.33 103.612 172.862 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -96.35 145.46 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 112.934 -1.939 . . . . 17.079999999999998 110.11 -178.736 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.7 m -106.33 112.22 25.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.964 -1.085 . . . . 16.300000000000001 113.593 178.613 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -111.54 130.12 55.84 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.366 1.467 . . . . 15.880000000000001 109.196 -175.132 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -97.58 132.33 43.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.316 -1.49 . . . . 28.899999999999999 109.621 173.898 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -155.88 162.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 119.389 -2.07 . . . . 12.050000000000001 113.191 -168.396 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -93.72 153.94 41.06 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 126.113 1.765 . . . . 18.170000000000002 109.026 177.378 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -60.83 -26.1 82.45 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 O-C-N 116.343 -2.503 . . . . 8.1600000000000001 115.941 171.667 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.0 p -82.16 -16.44 49.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.18 1.792 . . . . 11.130000000000001 114.78 -177.625 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.77 143.01 55.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.705 1.241 . . . . 18.030000000000001 113.273 170.185 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -97.84 158.78 15.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.053 -2.279 . . . . 10.220000000000001 109.587 -175.79 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.0 mm -53.19 -46.44 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 128.558 2.743 . . . . 12.300000000000001 111.722 171.501 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -45.82 -55.54 6.49 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.362 1.615 . . . . 36.509999999999998 115.362 161.962 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -54.65 -34.53 62.3 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.102 3.761 . . . . 25.66 112.851 173.643 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.34 -33.39 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.199 -2.188 . . . . 8.1199999999999992 110.028 177.79 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -67.28 -35.78 80.19 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.84 0.856 . . . . 15.470000000000001 111.81 179.898 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.1 82.43 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 132.212 4.205 . . . . 11.449999999999999 118.102 166.319 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.422 -3.924 . . . . 24.98 111.417 169.935 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 mt -53.06 -48.23 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 113.112 -3.328 . . . . 9.4600000000000009 110.927 170.103 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -37.45 78.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 124.903 3.501 . . . . 14.76 116.363 176.996 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -77.34 -38.46 50.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.057 -2.277 . . . . 26.289999999999999 111.734 -177.661 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -81.25 -42.44 20.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.279 2.309 . . . . 30.059999999999999 110.96 -176.194 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -99.57 -44.2 6.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.012 1.863 . . . . 25.190000000000001 114.899 -169.179 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.74 45.46 4.56 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 118.424 -2.673 . . . . 7.4100000000000001 108.91 -177.489 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.7 mt -102.7 133.6 20.35 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 107.021 -1.474 . . . . 9.4900000000000002 107.021 161.714 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.77 157.06 27.75 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 121.697 1.642 . . . . 11.42 113.464 175.83 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -68.67 -24.01 35.68 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.969 3.112 . . . . 12.0 118.406 -169.127 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.73 -24.76 65.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.034 -2.348 . . . . 35.549999999999997 111.36 172.918 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -75.77 -31.82 59.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.288 -3.382 . . . . 20.52 111.132 175.521 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -94.72 89.2 5.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.104 -1.623 . . . . 7.1299999999999999 111.037 -145.257 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -88.34 115.2 25.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.994 -3.566 . . . . 36.390000000000001 106.284 171.527 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.6 mt -91.26 121.83 33.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.471 -2.789 . . . . 9.5500000000000007 103.471 177.157 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.65 132.24 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 124.501 2.096 . . . . 13.9 110.61 176.208 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.401 ' HB2' HD13 ' A' ' 50' ' ' LEU . 5.7 t80 -107.21 105.48 15.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.459 -3.276 . . . . 6.8600000000000003 107.866 166.754 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.309 . . 60.49 -76.42 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.617 2.367 . . . . 11.15 115.838 -168.554 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.03 -20.0 3.48 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 126.689 2.09 . . . . 13.93 117.413 173.347 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.278 50.3 pttt -109.42 142.03 40.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.378 3.089 . . . . 23.920000000000002 105.118 -160.919 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -79.82 140.09 36.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.439 1.114 . . . . 23.23 109.782 -176.767 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' A' ' 45' ' ' PHE . 23.2 mt -84.3 128.7 34.73 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.617 -3.802 . . . . 9.1099999999999994 112.847 177.432 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -83.6 136.83 34.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.117 2.967 . . . . 33.439999999999998 108.635 -174.68 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.277 0.9 OUTLIER -42.84 -63.53 0.77 Allowed 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 122.332 4.197 . . . . 28.370000000000001 122.332 -174.063 . . . . . . . . 4 3 . 1 . 059 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.97 37.11 2.34 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 128.974 3.178 . . . . 15.0 115.191 -171.517 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -132.06 148.25 52.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.984 2.216 . . . . 25.5 116.984 178.338 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.7 p -88.62 157.54 18.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 123.512 1.625 . . . . 11.949999999999999 113.126 -172.236 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.9 mt -71.69 -28.36 63.66 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.513 3.53 . . . . 10.17 110.685 -174.46 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.6 t -68.05 -44.42 76.44 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 118.042 -2.911 . . . . 13.59 113.004 173.386 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -56.35 -40.51 74.62 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.364 1.866 . . . . 11.699999999999999 111.79 177.179 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -85.34 -17.83 35.61 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.849 1.425 . . . . 12.949999999999999 114.849 175.632 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.508 12.9 m120 83.89 44.41 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.929 -2.357 . . . . 25.449999999999999 112.772 172.799 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.7 mm -79.24 117.12 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 113.965 -1.47 . . . . 14.6 112.685 174.837 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -91.72 178.47 5.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.069 -3.519 . . . . 33.229999999999997 108.351 -178.821 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -65.57 154.8 37.67 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 115.492 -2.483 . . . . 25.969999999999999 112.005 172.874 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.47 36.42 11.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.115 -2.241 . . . . 32.609999999999999 110.645 172.075 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 t -109.1 142.27 40.08 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.828 1.955 . . . . 10.56 112.437 -174.708 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -97.62 115.97 28.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 116.011 -1.947 . . . . 5.3300000000000001 113.158 -170.883 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.31 141.43 28.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.022 1.451 . . . . 11.66 107.389 167.376 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.2 113.22 25.73 Favored 'General case' 0 N--CA 1.43 -1.433 1 CA-C-O 129.145 4.307 . . . . 16.300000000000001 107.803 -170.546 . . . . . . . . 3 3 . 1 . 059 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.9 tp -81.84 105.53 13.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 117.287 -3.383 . . . . 9.9600000000000009 110.843 -178.016 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.19 113.52 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 123.329 1.538 . . . . 9.7599999999999998 112.615 174.064 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 N--CA 1.43 -1.463 0 O-C-N 118.229 -2.794 . . . . 19.57 115.467 -178.333 . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptt? . . . . . 0 CA--C 1.49 -1.328 0 N-CA-C 116.686 2.106 . . . . 17.170000000000002 116.686 . . . . . . . . . 0 0 . 1 . 060 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.77 147.09 37.62 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 117.124 -1.417 . . . . 21.890000000000001 110.268 178.478 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 67' ' ' LEU . 15.0 pt -125.93 156.23 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.638 -2.727 . . . . 10.83 103.638 160.727 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -99.11 117.25 33.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 112.001 -2.363 . . . . 10.609999999999999 115.196 169.233 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.8 t -107.05 111.43 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.108 -3.495 . . . . 9.1300000000000008 109.291 179.796 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -90.23 113.48 25.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.63 -1.623 . . . . 20.550000000000001 111.479 -171.727 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.391 9.0 p -70.72 172.55 8.54 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.533 -2.605 . . . . 11.779999999999999 115.302 173.672 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.1 tp -98.23 3.85 48.88 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.901 3.239 . . . . 19.309999999999999 109.48 177.763 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -85.59 -71.22 0.54 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.663 -3.773 . . . . 23.140000000000001 106.34 168.937 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.36 13.67 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.725 0 O-C-N 126.452 2.345 . . . . 19.739999999999998 114.499 -174.502 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -98.37 132.48 43.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.533 -3.333 . . . . 21.93 108.208 179.68 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -104.91 103.1 12.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.483 -3.885 . . . . 12.33 115.294 165.485 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -80.36 136.82 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.538 -2.601 . . . . 17.079999999999998 111.091 179.206 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 m -107.76 135.84 48.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.286 3.422 . . . . 16.300000000000001 106.13 175.733 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -132.47 157.15 45.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.386 -2.696 . . . . 15.880000000000001 107.163 -176.691 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -112.21 111.28 22.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.265 2.226 . . . . 28.899999999999999 108.195 -176.341 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.22 155.78 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 124.248 1.975 . . . . 12.050000000000001 110.466 -168.23 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.94 165.67 16.57 Favored Pre-proline 0 N--CA 1.43 -1.429 1 O-C-N 115.36 -4.587 . . . . 18.170000000000002 106.179 165.814 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -62.8 -22.56 73.98 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 123.155 2.57 . . . . 8.1600000000000001 115.528 168.394 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.9 m -87.07 3.51 45.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.021 3.296 . . . . 11.130000000000001 115.147 -178.429 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -77.87 145.59 36.15 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.179 -5.326 . . . . 18.030000000000001 109.32 171.533 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -78.14 170.89 15.86 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.2 1.926 . . . . 10.220000000000001 116.2 173.172 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -61.85 -35.61 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 125.316 1.446 . . . . 12.300000000000001 112.228 161.76 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.12 -43.63 97.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.803 -2.435 . . . . 36.509999999999998 111.92 174.368 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -61.02 -32.59 72.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.169 2.285 . . . . 25.66 117.169 170.741 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.333 95.6 t -60.2 -53.66 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.366 3.066 . . . . 8.1199999999999992 113.626 167.584 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -55.68 -44.53 77.4 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 121.924 4.046 . . . . 15.470000000000001 121.924 169.886 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.51 -34.26 64.49 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 125.942 2.782 . . . . 11.449999999999999 117.57 175.93 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -82.12 -27.35 32.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.199 -2.148 . . . . 24.98 105.199 -171.796 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.67 -29.94 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 103.416 -2.809 . . . . 9.4600000000000009 103.416 -176.127 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.13 -51.3 68.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.221 3.009 . . . . 14.76 110.608 170.393 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -55.43 -43.35 75.29 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.191 1.922 . . . . 26.289999999999999 116.191 173.069 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -84.04 -71.86 0.49 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.094 -1.866 . . . . 30.059999999999999 108.312 -169.138 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -74.28 -54.09 8.4 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.791 2.71 . . . . 25.190000000000001 115.526 -170.893 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.11 -24.78 1.27 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.136 -2.227 . . . . 7.4100000000000001 112.158 -177.975 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mt -69.87 122.97 87.68 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 116.658 -1.639 . . . . 9.4900000000000002 112.801 -160.802 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.44 153.39 65.83 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 C-N-CA 126.326 4.684 . . . . 11.42 110.979 176.378 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.95 -21.95 49.16 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 C-N-CA 124.627 3.552 . . . . 12.0 118.743 -168.702 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -65.58 -37.37 86.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.361 3.464 . . . . 35.549999999999997 111.127 178.695 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.26 65.7 mt-30 -76.49 -16.7 59.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.553 2.341 . . . . 20.52 113.917 -177.37 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -97.85 124.5 42.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.403 -3.311 . . . . 7.1299999999999999 110.715 -165.783 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -101.97 126.98 49.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.513 -3.867 . . . . 36.390000000000001 105.969 160.121 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mt -115.48 132.0 56.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.578 -1.326 . . . . 9.5500000000000007 107.697 177.504 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.57 134.24 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 126.554 1.941 . . . . 13.9 109.681 -159.266 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.401 ' CZ ' HG12 ' A' ' 61' ' ' ILE . 13.3 t80 -140.68 116.48 10.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.733 1.73 . . . . 6.8600000000000003 107.938 179.848 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.71 -93.92 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.739 3.216 . . . . 11.15 110.223 -178.027 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.86 11.11 7.43 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.683 -2.511 . . . . 13.93 116.625 178.591 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -128.92 153.02 47.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.222 -2.929 . . . . 23.920000000000002 112.46 -178.01 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -89.15 138.81 31.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.173 -2.529 . . . . 23.23 104.173 169.319 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.68 126.11 33.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.378 -2.646 . . . . 9.1099999999999994 115.499 -176.997 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.56 140.97 31.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 121.343 1.883 . . . . 33.439999999999998 109.967 -173.355 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.39 -62.43 1.78 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.798 3.639 . . . . 28.370000000000001 115.493 -158.377 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.83 28.04 3.69 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 118.568 -2.582 . . . . 15.0 111.965 -177.078 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -103.95 154.07 20.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.828 -2.572 . . . . 25.5 107.134 174.72 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -97.0 177.59 5.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.709 3.147 . . . . 11.949999999999999 103.769 -170.559 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.78 -34.16 73.37 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 112.567 -6.333 . . . . 10.17 117.764 172.894 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 m -64.15 -21.43 66.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.592 -1.67 . . . . 13.59 112.588 174.237 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.16 -39.64 54.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.388 1.475 . . . . 11.699999999999999 111.698 177.72 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -90.15 3.15 54.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.845 2.906 . . . . 12.949999999999999 118.845 171.239 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.379 17.9 m120 73.18 25.49 2.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.739 2.416 . . . . 25.449999999999999 116.11 171.304 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.401 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 11.3 mt -83.83 127.74 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 128.855 2.862 . . . . 14.6 109.304 -176.692 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -126.37 -155.59 0.69 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.178 0.924 . . . . 33.229999999999997 110.157 179.451 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -83.33 144.87 29.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.598 -1.939 . . . . 25.969999999999999 112.412 179.673 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 87.0 6.93 0.26 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.289 3.836 . . . . 32.609999999999999 108.23 176.625 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -84.5 151.6 24.49 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 115.894 -4.254 . . . . 10.56 109.768 -167.657 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.452 5.2 m -93.24 112.56 24.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.345 2.658 . . . . 5.3300000000000001 116.258 172.87 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.424 ' CD1' HD13 ' A' ' 3' ' ' ILE . 18.4 mt -90.52 168.28 11.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.375 -3.328 . . . . 11.66 107.324 168.336 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -130.43 133.02 46.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.73 -2.481 . . . . 16.300000000000001 104.316 177.078 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -102.03 133.34 47.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.02 1.728 . . . . 9.9600000000000009 113.405 177.887 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.3 t -131.71 161.17 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.867 -2.271 . . . . 9.7599999999999998 104.867 174.066 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.2 mt . . . . . 0 N--CA 1.429 -1.483 0 CA-C-N 121.848 2.113 . . . . 19.57 110.594 178.981 . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 106.795 -1.557 . . . . 17.170000000000002 106.795 . . . . . . . . . 0 0 . 1 . 061 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.85 151.6 25.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.871 -1.899 . . . . 21.890000000000001 105.871 -178.278 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -134.5 167.42 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.593 2.139 . . . . 10.83 108.595 169.663 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -121.14 130.69 53.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.191 -2.818 . . . . 10.609999999999999 109.738 177.657 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -110.62 124.49 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 1 O-C-N 113.774 -5.579 . . . . 9.1300000000000008 105.848 161.041 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.252 77.8 tttt -109.15 134.0 52.29 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.386 -2.696 . . . . 20.550000000000001 115.752 -179.39 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -71.0 170.29 13.11 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.966 2.794 . . . . 11.779999999999999 110.678 178.745 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.4 tp -78.11 -29.82 49.11 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.33 -2.668 . . . . 19.309999999999999 114.956 177.801 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -58.6 -56.01 27.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 122.198 2.272 . . . . 23.140000000000001 112.547 165.35 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.41 38.16 0.11 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 128.709 3.052 . . . . 19.739999999999998 113.799 163.302 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -92.79 132.11 37.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 126.837 2.139 . . . . 21.93 106.42 -179.421 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -105.89 126.58 52.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.03 2.348 . . . . 12.33 110.572 -175.692 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -97.06 118.86 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 111.291 -2.686 . . . . 17.079999999999998 105.905 174.864 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.7 m -82.54 128.9 34.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.817 -1.802 . . . . 16.300000000000001 115.137 166.523 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 mt -123.55 148.91 45.88 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.695 -1.224 . . . . 15.880000000000001 107.695 -179.895 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -118.77 116.89 27.48 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.616 2.366 . . . . 28.899999999999999 106.485 177.799 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.293 34.1 m -141.29 -179.22 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 126.394 2.309 . . . . 12.050000000000001 106.443 -177.329 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -117.13 157.86 45.76 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 118.502 -2.624 . . . . 18.170000000000002 108.582 171.418 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -64.3 -8.85 17.85 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-N 126.161 3.236 . . . . 8.1600000000000001 118.029 178.818 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.1 m -88.99 -1.94 58.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.741 1.616 . . . . 11.130000000000001 113.976 -178.149 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -89.35 164.9 14.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.357 1.075 . . . . 18.030000000000001 108.976 176.831 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -87.96 168.07 13.18 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.826 2.45 . . . . 10.220000000000001 114.846 -179.624 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -75.1 -26.35 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 115.393 1.627 . . . . 12.300000000000001 115.393 172.65 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -61.77 -43.35 99.03 Favored 'General case' 0 N--CA 1.43 -1.452 2 C-N-CA 133.994 4.918 . . . . 36.509999999999998 106.999 166.113 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -65.07 -33.92 77.18 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.017 2.599 . . . . 25.66 118.017 169.647 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -60.19 -44.42 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.668 -1.27 . . . . 8.1199999999999992 111.501 171.38 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -75.25 -39.79 59.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.368 -3.332 . . . . 15.470000000000001 111.433 -175.691 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.53 -23.5 64.53 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.274 -2.141 . . . . 11.449999999999999 116.737 172.972 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -63.99 -45.22 90.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 125.095 3.588 . . . . 24.98 107.672 169.625 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.6 mt -67.09 -30.74 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.468 -2.645 . . . . 9.4600000000000009 109.952 177.36 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -60.45 -41.32 93.86 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.805 2.842 . . . . 14.76 113.963 171.777 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -68.3 -59.7 3.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.084 1.883 . . . . 26.289999999999999 116.084 163.294 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 mttm -63.57 -58.38 7.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 120.122 3.379 . . . . 30.059999999999999 120.122 -171.802 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -88.72 -55.26 3.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.718 2.007 . . . . 25.190000000000001 113.429 -174.565 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.37 20.89 2.6 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 112.077 -2.329 . . . . 7.4100000000000001 117.202 -178.152 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.0 mt -100.34 117.25 63.37 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 119.007 -2.467 . . . . 9.4900000000000002 110.829 178.641 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -73.43 154.7 50.77 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-N 127.732 3.797 . . . . 11.42 112.774 -175.694 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -69.85 -22.58 31.46 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 CA-C-O 117.682 -1.049 . . . . 12.0 113.217 -167.287 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -54.09 -41.23 68.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.649 -2.596 . . . . 35.549999999999997 117.092 175.302 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -77.38 -36.03 53.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.024 2.703 . . . . 20.52 111.854 170.221 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -69.32 115.07 8.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.16 2.652 . . . . 7.1299999999999999 118.16 -176.476 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -102.87 121.66 42.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.952 -1.499 . . . . 36.390000000000001 107.335 161.083 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 mt -99.15 132.43 44.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.382 1.901 . . . . 9.5500000000000007 109.382 175.971 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -125.56 122.74 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.739 2.416 . . . . 13.9 109.523 -170.001 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -104.3 120.0 40.21 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.185 1.357 . . . . 6.8600000000000003 109.19 168.76 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.49 . . 62.98 -102.59 0.11 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.941 -1.1 . . . . 11.15 113.457 -167.717 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.75 16.85 5.3 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 117.424 -3.298 . . . . 13.93 107.497 171.306 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -95.52 131.64 41.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.778 2.831 . . . . 23.920000000000002 109.335 177.209 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -87.99 133.0 34.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 124.872 1.358 . . . . 23.23 110.355 178.665 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 mt -93.13 120.47 33.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.662 1.185 . . . . 9.1099999999999994 110.998 -175.116 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -78.55 139.0 38.66 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.607 1.563 . . . . 33.439999999999998 113.576 169.024 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.75 -40.23 94.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.372 2.269 . . . . 28.370000000000001 113.33 -165.575 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.53 29.14 5.0 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 116.725 1.45 . . . . 15.0 116.725 177.23 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -109.75 164.09 12.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.903 -2.528 . . . . 25.5 107.27 162.873 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -93.31 165.17 12.92 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.772 1.748 . . . . 11.949999999999999 114.06 173.581 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -59.48 -35.24 73.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.748 -1.845 . . . . 10.17 112.669 174.473 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 t -66.55 -32.01 73.08 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 119.807 3.262 . . . . 13.59 119.807 174.085 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -63.37 -39.22 93.92 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 123.615 1.674 . . . . 11.699999999999999 110.638 175.571 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -88.14 -4.53 58.74 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.351 2.26 . . . . 12.949999999999999 112.376 178.727 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.8 m120 50.96 56.05 8.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.666 1.986 . . . . 25.449999999999999 114.504 -168.43 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.0 mt -103.16 103.57 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 101.204 -3.628 . . . . 14.6 101.204 178.278 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -89.74 -171.85 3.33 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.501 2.72 . . . . 33.229999999999997 111.288 -177.444 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -69.06 143.77 54.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 105.461 -2.051 . . . . 25.969999999999999 105.461 -170.831 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 25.3 mt-10 64.67 26.43 13.15 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.951 2.204 . . . . 32.609999999999999 116.951 172.673 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 t -93.34 144.5 25.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 104.383 -2.451 . . . . 10.56 104.383 -173.535 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.6 m -110.78 124.15 51.45 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 114.277 -1.329 . . . . 5.3300000000000001 110.737 -171.951 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mt -95.22 140.94 29.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.114 3.365 . . . . 11.66 108.136 174.603 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -89.03 143.26 26.97 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.142 1.449 . . . . 16.300000000000001 108.952 165.894 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -119.51 119.82 34.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.167 -2.16 . . . . 9.9600000000000009 105.167 -171.989 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.1 t -109.76 132.42 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 114.563 -1.199 . . . . 9.7599999999999998 110.568 -179.778 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 N--CA 1.43 -1.431 0 O-C-N 118.231 -2.793 . . . . 19.57 113.569 174.716 . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 116.845 2.165 . . . . 17.170000000000002 116.845 . . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.64 128.46 33.64 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.496 -2.628 . . . . 21.890000000000001 108.77 172.221 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -124.01 173.33 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.935 -2.978 . . . . 10.83 103.548 163.901 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.269 77.5 m-85 -128.18 136.3 50.91 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.782 -0.821 . . . . 10.609999999999999 108.782 -176.31 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -113.62 117.16 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 125.971 2.796 . . . . 9.1300000000000008 106.768 175.401 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -95.91 136.77 35.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.343 -1.753 . . . . 20.550000000000001 111.117 174.666 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -88.89 -169.29 2.47 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 128.15 3.833 . . . . 11.779999999999999 111.51 -175.34 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.3 tp -80.57 -44.15 19.47 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.691 -3.755 . . . . 19.309999999999999 110.543 -176.71 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -62.28 1.93 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.417 1.887 . . . . 23.140000000000001 110.006 168.562 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.84 41.34 0.11 Allowed Glycine 0 N--CA 1.431 -1.687 0 O-C-N 119.139 -2.226 . . . . 19.739999999999998 111.593 169.63 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -84.29 142.9 29.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 128.94 3.377 . . . . 21.93 113.833 166.489 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.5 m -106.94 112.21 25.07 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.593 1.663 . . . . 12.33 109.466 -176.254 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 mt -104.27 108.91 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 119.562 -1.961 . . . . 17.079999999999998 110.358 -174.974 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -87.82 123.09 32.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.489 -1.382 . . . . 16.300000000000001 108.564 -174.164 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.3 mt -120.17 158.26 27.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.087 2.155 . . . . 15.880000000000001 116.29 179.636 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -120.77 89.33 3.11 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.556 3.074 . . . . 28.899999999999999 114.893 177.377 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -109.55 164.39 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 119.86 -1.775 . . . . 12.050000000000001 114.473 -178.624 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -98.26 159.69 30.04 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 116.551 -2.059 . . . . 18.170000000000002 106.444 167.793 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.53 -17.68 23.37 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 O-C-N 116.012 -2.678 . . . . 8.1600000000000001 110.066 174.904 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -59.78 -20.25 55.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.005 2.522 . . . . 11.130000000000001 116.19 164.785 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -71.57 142.3 50.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.562 2.601 . . . . 18.030000000000001 112.0 175.964 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.7 p -79.94 165.64 22.43 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.09 -4.131 . . . . 10.220000000000001 107.932 167.233 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 mm -66.18 -24.69 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.589 1.955 . . . . 12.300000000000001 108.558 177.637 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.29 35.0 tt0 -65.73 -39.85 91.57 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 118.19 -0.91 . . . . 36.509999999999998 108.596 174.19 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -72.25 -24.31 61.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.895 2.134 . . . . 25.66 114.237 179.109 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t -72.77 -42.06 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.385 -2.697 . . . . 8.1199999999999992 110.834 175.189 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP 0.274 93.0 mttt -51.57 -36.88 47.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 117.581 2.438 . . . . 15.470000000000001 117.581 163.512 . . . . . . . . 3 3 . 1 . 062 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.76 61.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.504 -1.372 . . . . 11.449999999999999 111.265 -177.232 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -58.67 -47.98 82.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.164 2.986 . . . . 24.98 113.814 175.487 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -69.92 -34.16 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.553 -1.658 . . . . 9.4600000000000009 109.147 175.401 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -60.59 -46.71 89.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.144 2.247 . . . . 14.76 110.794 172.978 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.26 -58.7 6.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.759 -1.838 . . . . 26.289999999999999 111.305 -177.308 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -75.61 -55.43 5.67 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 132.805 4.442 . . . . 30.059999999999999 111.264 -168.068 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -89.43 -31.8 17.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.968 -2.333 . . . . 25.190000000000001 115.241 -179.016 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.01 11.42 20.57 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 121.269 3.268 . . . . 7.4100000000000001 121.269 179.536 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.307 71.5 mt -109.5 135.16 20.35 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 102.447 -3.168 . . . . 9.4900000000000002 102.447 -153.502 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -61.44 158.03 38.22 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 124.079 3.186 . . . . 11.42 117.481 179.605 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -78.53 -13.35 14.93 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 127.847 3.838 . . . . 12.0 118.066 179.932 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.92 -17.8 64.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.996 -1.457 . . . . 35.549999999999997 114.93 -178.634 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -86.2 -22.38 26.98 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 124.07 1.89 . . . . 20.52 111.24 178.025 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -89.07 108.01 19.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.819 2.525 . . . . 7.1299999999999999 117.819 -163.303 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -104.49 100.15 9.84 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.994 -1.113 . . . . 36.390000000000001 107.994 171.517 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 mt -81.81 130.33 35.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.182 -2.824 . . . . 9.5500000000000007 112.884 178.33 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mm -128.8 136.06 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 104.148 -2.538 . . . . 13.9 104.148 -167.739 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -135.08 133.5 39.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.843 -1.539 . . . . 6.8600000000000003 106.843 176.604 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.262 . . 49.98 -111.34 0.49 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.844 2.535 . . . . 11.15 117.844 -164.163 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.36 2.53 37.27 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 119.007 -0.885 . . . . 13.93 114.405 169.341 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -105.7 126.33 52.03 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.237 3.015 . . . . 23.920000000000002 111.024 -161.508 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -80.54 130.41 35.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.523 -1.217 . . . . 23.23 110.49 171.712 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -86.47 166.01 15.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.61 -1.186 . . . . 9.1099999999999994 113.756 -167.908 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -132.48 128.91 38.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 114.791 -2.528 . . . . 33.439999999999998 109.085 -170.4 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.406 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 2.2 m-20 -56.05 -44.49 78.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 127.157 2.785 . . . . 28.370000000000001 115.573 -162.954 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.55 -8.72 14.89 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 128.546 2.974 . . . . 15.0 118.634 -179.394 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -95.8 150.92 19.87 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 116.234 -4.098 . . . . 25.5 110.851 178.583 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.7 p -78.53 161.68 26.86 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.298 2.475 . . . . 11.949999999999999 112.144 168.041 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.29 -42.88 92.64 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.0 -5.438 . . . . 10.17 111.904 172.348 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -42.14 -40.27 2.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.626 2.824 . . . . 13.59 118.626 160.685 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.34 -22.82 67.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.193 -2.192 . . . . 11.699999999999999 116.531 172.677 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -101.82 3.59 39.52 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.023 -1.673 . . . . 12.949999999999999 111.276 -178.75 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.478 26.9 m120 63.37 32.12 14.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.127 2.87 . . . . 25.449999999999999 118.191 -174.204 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.6 mt -95.51 123.06 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.026 -2.296 . . . . 14.6 106.38 -171.493 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -124.78 -171.17 2.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.093 2.557 . . . . 33.229999999999997 107.305 -168.673 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -76.33 150.68 36.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.512 -1.992 . . . . 25.969999999999999 115.949 -169.001 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 63.15 15.34 8.46 Favored 'General case' 0 N--CA 1.43 -1.464 1 CA-C-O 128.535 4.017 . . . . 32.609999999999999 118.894 -169.711 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.37 147.34 40.13 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 112.884 -6.135 . . . . 10.56 113.981 172.47 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.8 m -108.15 123.37 48.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.612 1.565 . . . . 5.3300000000000001 114.486 -176.823 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.25 166.51 10.91 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.666 0.746 . . . . 11.66 110.163 174.313 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -126.27 144.96 50.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.076 -2.89 . . . . 16.300000000000001 108.295 -175.769 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.3 tp -121.55 102.47 8.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.965 1.306 . . . . 9.9600000000000009 108.747 -165.026 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 t -87.9 128.84 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 123.105 0.562 . . . . 9.7599999999999998 110.226 176.265 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 103.425 -2.805 . . . . 19.57 103.425 -169.637 . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 CA--C 1.49 -1.338 0 CA-C-O 123.909 1.814 . . . . 17.170000000000002 114.597 . . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -74.92 125.29 28.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.386 -3.321 . . . . 21.890000000000001 114.092 168.465 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 pt -120.88 161.95 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 112.965 -1.925 . . . . 10.83 112.064 170.048 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -119.76 125.34 48.37 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.573 1.654 . . . . 10.609999999999999 111.615 -177.259 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.1 111.84 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 121.118 -0.988 . . . . 9.1300000000000008 110.237 174.632 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -88.37 138.52 31.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.608 -3.182 . . . . 20.550000000000001 118.261 179.088 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.264 28.2 p -87.25 175.79 7.87 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.301 2.334 . . . . 11.779999999999999 117.301 178.672 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -75.39 -38.21 60.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.729 -2.082 . . . . 19.309999999999999 115.095 173.978 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 63.0 p -70.64 -52.77 19.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.486 -2.673 . . . . 23.140000000000001 116.688 161.036 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.7 58.17 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 124.927 3.512 . . . . 19.739999999999998 110.899 158.494 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -97.14 147.11 24.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.29 -1.712 . . . . 21.93 110.485 165.411 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 m -93.62 108.41 20.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.208 1.004 . . . . 12.33 109.632 167.175 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 mt -75.93 127.7 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 117.738 -3.101 . . . . 17.079999999999998 107.605 166.185 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.6 p -114.15 127.46 55.92 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.742 -3.099 . . . . 16.300000000000001 111.97 177.573 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -127.81 133.19 49.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 128.172 3.42 . . . . 15.880000000000001 113.759 -171.567 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -95.75 91.7 6.21 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 132.242 4.217 . . . . 28.899999999999999 109.42 -179.516 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -126.52 167.47 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.513 -1.662 . . . . 12.050000000000001 106.513 178.927 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -102.44 154.19 37.61 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 117.39 -3.319 . . . . 18.170000000000002 105.838 174.255 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -68.99 -5.33 15.46 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 124.079 2.493 . . . . 8.1600000000000001 117.631 -173.494 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -98.37 4.38 48.56 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 124.442 1.089 . . . . 11.130000000000001 108.298 174.963 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.49 147.3 53.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.902 2.186 . . . . 18.030000000000001 116.902 162.052 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 7.5 p -89.67 158.84 17.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.318 -1.765 . . . . 10.220000000000001 106.681 -173.665 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -64.7 -32.69 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.385 -2.697 . . . . 12.300000000000001 114.486 -178.766 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -44.21 -50.81 8.63 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.206 3.002 . . . . 36.509999999999998 109.783 162.238 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -74.12 -21.24 59.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.936 -2.977 . . . . 25.66 117.128 178.333 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -71.63 -43.61 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 123.25 1.5 . . . . 8.1199999999999992 109.838 172.909 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -61.51 -30.65 70.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.087 2.995 . . . . 15.470000000000001 119.087 168.66 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.37 -34.65 61.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.88 -3.013 . . . . 11.449999999999999 112.922 171.204 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -49.04 76.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 127.063 3.316 . . . . 24.98 116.103 167.953 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.6 mt -57.79 -42.23 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 117.645 -3.16 . . . . 9.4600000000000009 113.528 166.54 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -63.2 -39.55 94.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.426 -3.921 . . . . 14.76 116.176 172.977 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -68.05 -50.56 54.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.12 0.887 . . . . 26.289999999999999 113.121 176.126 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -70.14 -66.02 0.65 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.112 1.152 . . . . 30.059999999999999 114.112 176.889 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -76.96 -35.28 57.36 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.856 2.909 . . . . 25.190000000000001 118.856 -170.221 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.01 60.16 1.79 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 119.827 -1.796 . . . . 7.4100000000000001 111.246 -173.169 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.99 119.54 15.82 Favored Pre-proline 0 N--CA 1.43 -1.439 0 C-N-CA 125.151 1.38 . . . . 9.4900000000000002 108.091 178.255 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.49 154.41 45.1 Favored 'Trans proline' 0 N--CA 1.433 -2.059 1 C-N-CA 125.893 4.395 . . . . 11.42 111.716 -172.218 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.299 52.3 Cg_endo -64.27 -14.3 43.09 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 O-C-N 123.891 1.469 . . . . 12.0 111.507 174.726 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -67.29 -34.34 77.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.361 2.505 . . . . 35.549999999999997 113.779 176.605 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -96.58 -37.74 10.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.012 -2.305 . . . . 20.52 108.639 -164.684 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -75.21 136.89 40.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 117.067 2.247 . . . . 7.1299999999999999 117.067 -176.345 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.41 ' HB3' HG21 ' A' ' 70' ' ' VAL . 37.3 ttm180 -120.06 133.25 55.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.197 -3.26 . . . . 36.390000000000001 102.197 161.339 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.7 mt -108.53 141.93 39.7 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.386 -2.071 . . . . 9.5500000000000007 106.389 179.903 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.1 mt -126.83 138.54 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.214 3.406 . . . . 13.9 103.367 -170.476 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -121.03 121.24 37.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.974 1.369 . . . . 6.8600000000000003 111.471 161.185 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.61 -78.58 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.719 -2.488 . . . . 11.15 114.843 -174.613 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.25 -4.94 0.24 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 123.882 3.037 . . . . 13.93 110.638 -177.998 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -113.07 146.03 39.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.747 2.419 . . . . 23.920000000000002 112.689 -173.391 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -89.52 156.07 18.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.597 1.959 . . . . 23.23 110.288 -171.773 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -118.86 127.24 53.32 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 129.455 4.222 . . . . 9.1099999999999994 107.8 -170.413 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -103.14 165.07 11.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.837 -3.04 . . . . 33.439999999999998 112.384 -172.118 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -69.91 -58.13 4.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.477 -2.639 . . . . 28.370000000000001 113.848 -157.645 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.35 31.03 5.95 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 117.919 -1.489 . . . . 15.0 115.523 -167.714 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -107.96 162.09 14.34 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.94 1.696 . . . . 25.5 114.202 159.831 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 29.2 p -92.72 173.48 7.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.305 1.526 . . . . 11.949999999999999 107.626 -171.65 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.67 -44.26 86.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.026 -0.988 . . . . 10.17 110.469 171.729 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.1 m -63.89 -32.21 73.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.198 2.295 . . . . 13.59 117.198 178.704 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -58.21 -42.81 87.03 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.267 3.432 . . . . 11.699999999999999 120.267 173.54 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -70.5 -13.89 62.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 117.46 -1.257 . . . . 12.949999999999999 114.275 163.849 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 30.2 m120 68.68 38.59 2.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.474 2.71 . . . . 25.449999999999999 114.265 -171.61 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.16 129.16 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.053 2.095 . . . . 14.6 110.339 164.557 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.44 -173.77 3.26 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.128 2.971 . . . . 33.229999999999997 108.944 -164.217 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -65.26 136.22 56.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.57 -3.831 . . . . 25.969999999999999 111.14 172.629 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 55.42 53.19 10.16 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-N 108.039 -4.164 . . . . 32.609999999999999 113.442 -170.889 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -96.37 150.67 20.33 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.057 -4.152 . . . . 10.56 110.121 -178.136 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.5 m -103.46 111.1 23.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 127.4 2.937 . . . . 5.3300000000000001 108.444 -174.9 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -100.07 162.09 13.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.293 -1.002 . . . . 11.66 108.293 176.215 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -122.75 128.06 50.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.35 -1.469 . . . . 16.300000000000001 111.347 170.422 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -93.92 121.9 35.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.737 1.014 . . . . 9.9600000000000009 113.737 176.638 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 42' ' ' ARG . 18.7 m -121.68 155.87 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.778 -1.934 . . . . 9.7599999999999998 105.778 174.445 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.2 mt . . . . . 0 N--CA 1.43 -1.451 0 O-C-N 118.872 -2.393 . . . . 19.57 109.787 172.056 . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 111.932 0.345 . . . . 17.170000000000002 111.932 . . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -89.74 115.26 26.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.569 1.548 . . . . 21.890000000000001 113.084 -175.662 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.48 18.0 pt -107.29 155.27 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 126.076 1.75 . . . . 10.83 115.593 168.874 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -121.2 116.57 25.16 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.333 2.653 . . . . 10.609999999999999 105.681 -178.006 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.32 109.36 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 118.064 -2.897 . . . . 9.1300000000000008 108.26 172.074 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -101.29 132.67 46.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.281 1.515 . . . . 20.550000000000001 107.12 -173.798 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -87.12 171.56 10.6 Favored 'General case' 0 N--CA 1.429 -1.486 1 O-C-N 115.732 -4.355 . . . . 11.779999999999999 113.495 177.708 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.4 tp -70.23 -42.2 72.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 127.047 3.308 . . . . 19.309999999999999 109.495 177.699 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 p -56.81 -31.69 64.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.751 -3.093 . . . . 23.140000000000001 116.928 167.889 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.62 37.29 2.09 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 122.632 2.469 . . . . 19.739999999999998 113.137 173.235 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -99.55 152.9 19.5 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.451 -2.796 . . . . 21.93 103.451 167.446 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -110.97 106.23 15.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 114.06 1.133 . . . . 12.33 114.06 160.246 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.5 mt -81.27 108.25 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.876 -1.765 . . . . 17.079999999999998 108.571 169.973 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.9 p -78.39 137.8 38.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.49 -2.006 . . . . 16.300000000000001 111.039 172.34 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.2 139.32 44.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 125.197 1.561 . . . . 15.880000000000001 110.366 -177.166 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -95.46 111.6 23.46 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.298 2.639 . . . . 28.899999999999999 109.784 164.579 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.252 29.0 m -135.51 162.26 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 1 O-C-N 114.446 -5.159 . . . . 12.050000000000001 107.344 175.133 . . . . . . . . 3 2 . 1 . 064 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -97.95 166.05 14.23 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 120.239 -1.538 . . . . 18.170000000000002 107.967 179.682 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.74 -19.9 48.59 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 123.721 2.365 . . . . 8.1600000000000001 118.1 174.184 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -98.5 12.94 33.53 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 125.032 1.458 . . . . 11.130000000000001 112.066 -172.182 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.34 131.16 34.73 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.429 -2.044 . . . . 18.030000000000001 108.87 176.952 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 52' ' ' ASP 0.314 65.1 p -59.26 163.55 3.77 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.913 1.82 . . . . 10.220000000000001 115.913 164.889 . . . . . . . . 3 3 . 1 . 064 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.444 HG23 ' HE3' ' A' ' 27' ' ' LYS . 37.2 mm -76.05 -17.1 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 O-C-N 116.291 -4.005 . . . . 12.300000000000001 106.335 -179.72 . . . . . . . . 3 3 . 1 . 064 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 36.7 tt0 -69.12 -47.24 65.64 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.074 -1.642 . . . . 36.509999999999998 107.538 172.127 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.273 70.4 m-80 -66.49 -29.43 69.54 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.508 3.151 . . . . 25.66 119.508 175.677 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.269 60.2 t -51.4 -51.56 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 114.155 1.168 . . . . 8.1199999999999992 114.155 163.621 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HE3' HG23 ' A' ' 23' ' ' ILE . 98.1 mttt -71.61 -40.48 69.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.556 1.942 . . . . 15.470000000000001 110.618 -174.995 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.264 . . -52.34 -49.34 64.5 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.336 3.054 . . . . 11.449999999999999 109.809 170.051 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -62.51 -36.72 83.45 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.556 -3.215 . . . . 24.98 116.812 172.836 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -58.91 -47.25 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.763 -3.086 . . . . 9.4600000000000009 111.538 167.455 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -55.86 -35.78 66.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.231 2.678 . . . . 14.76 118.231 173.931 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.9 -43.06 69.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.992 -1.485 . . . . 26.289999999999999 106.992 -179.894 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -79.03 -57.47 3.72 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.785 -1.822 . . . . 30.059999999999999 115.31 -173.935 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -85.74 -49.7 7.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.779 -2.01 . . . . 25.190000000000001 111.572 -173.947 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.6 28.66 5.91 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 116.396 -3.94 . . . . 7.4100000000000001 110.885 -169.436 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.23 122.9 41.4 Favored Pre-proline 0 N--CA 1.429 -1.5 1 CA-C-O 111.541 -4.076 . . . . 9.4900000000000002 105.997 176.161 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -87.63 159.77 7.83 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-O 114.543 -2.357 . . . . 11.42 112.199 -165.369 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -64.26 -9.48 20.01 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 122.912 2.408 . . . . 12.0 116.227 -175.626 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -82.36 -34.61 28.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 124.165 3.166 . . . . 35.549999999999997 109.907 -169.568 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -83.19 -19.45 36.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.539 1.536 . . . . 20.52 108.467 -174.775 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -90.95 127.96 36.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.054 2.983 . . . . 7.1299999999999999 119.054 -166.839 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -120.4 123.61 43.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 128.273 3.892 . . . . 36.390000000000001 111.174 168.674 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.0 mt -112.42 141.37 46.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.538 -2.601 . . . . 9.5500000000000007 112.541 177.923 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.91 134.91 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.484 -1.673 . . . . 13.9 106.484 -164.796 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -117.46 112.43 20.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.959 -2.978 . . . . 6.8600000000000003 102.959 171.608 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.321 . . 60.48 -108.29 0.35 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.068 1.889 . . . . 11.15 113.537 -167.748 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.17 -12.2 22.4 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 113.08 -1.873 . . . . 13.93 109.97 170.141 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -74.17 107.97 6.68 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.387 3.593 . . . . 23.920000000000002 112.835 179.618 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.8 122.36 22.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.239 -4.663 . . . . 23.23 110.897 176.528 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.274 6.5 mt -90.67 127.28 36.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.861 2.911 . . . . 9.1099999999999994 118.861 -165.244 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -83.55 143.58 30.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.35 -2.094 . . . . 33.439999999999998 114.926 173.005 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 36.0 m-20 -65.31 -41.44 94.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.755 2.217 . . . . 28.370000000000001 114.985 -163.977 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.51 21.46 38.32 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 118.614 -2.554 . . . . 15.0 113.58 -174.411 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -106.23 165.29 11.35 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.391 -1.337 . . . . 25.5 107.391 162.892 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -104.49 178.15 4.64 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.086 2.155 . . . . 11.949999999999999 111.54 -173.333 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.2 mt -80.1 -36.84 34.82 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.546 3.138 . . . . 10.17 106.445 173.945 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -51.77 -38.91 57.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.934 2.152 . . . . 13.59 114.931 163.509 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -70.96 -54.73 10.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.6 3.56 . . . . 11.699999999999999 109.234 -179.179 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -77.19 0.03 23.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.59 1.181 . . . . 12.949999999999999 113.213 -178.979 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 48.97 46.43 22.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.537 2.589 . . . . 25.449999999999999 117.034 -176.902 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mt -84.88 120.05 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 111.962 -2.381 . . . . 14.6 108.577 176.909 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -107.69 172.84 6.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.972 1.844 . . . . 33.229999999999997 113.831 177.96 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -60.14 141.73 55.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.423 -2.673 . . . . 25.969999999999999 113.038 179.462 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.313 12.2 mt-10 71.29 20.68 4.93 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 126.238 2.923 . . . . 32.609999999999999 117.876 177.863 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -87.63 124.72 33.82 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.448 -2.033 . . . . 10.56 109.958 173.833 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 m -74.26 100.93 3.86 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.383 2.04 . . . . 5.3300000000000001 112.157 177.698 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.75 141.95 30.18 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 117.659 -3.15 . . . . 11.66 113.508 167.144 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -107.16 128.2 54.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.264 1.983 . . . . 16.300000000000001 109.754 -178.808 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.7 tp -97.58 128.44 44.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.207 -3.433 . . . . 9.9600000000000009 109.2 173.367 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.07 136.52 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.303 2.954 . . . . 9.7599999999999998 105.084 171.015 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 N--CA 1.43 -1.448 0 O-C-N 117.975 -2.953 . . . . 19.57 109.572 179.054 . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 117.795 -1.098 . . . . 17.170000000000002 111.997 . . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.336 2.8 pt20 -95.87 145.29 25.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.794 2.088 . . . . 21.890000000000001 115.928 166.472 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.1 pt -138.39 167.26 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 103.361 -2.829 . . . . 10.83 103.361 174.865 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -122.22 145.28 48.36 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.891 -2.413 . . . . 10.609999999999999 108.272 179.177 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.5 t -128.66 111.12 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 103.457 -2.794 . . . . 9.1300000000000008 103.457 176.937 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -107.26 137.49 45.21 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.676 2.655 . . . . 20.550000000000001 112.293 179.415 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.9 p -79.38 -166.45 0.96 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.916 -2.365 . . . . 11.779999999999999 105.541 -173.489 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.5 tp -81.59 -47.13 13.45 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.653 -1.904 . . . . 19.309999999999999 109.277 173.129 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 -31.2 61.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.711 2.804 . . . . 23.140000000000001 109.07 -170.059 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.43 42.17 0.47 Allowed Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 125.579 3.809 . . . . 19.739999999999998 115.226 174.326 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -108.27 133.98 51.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 102.27 -3.233 . . . . 21.93 102.27 168.358 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -104.54 113.17 26.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 124.888 1.368 . . . . 12.33 108.64 168.934 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -87.6 100.45 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.331 1.852 . . . . 17.079999999999998 112.562 166.618 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.9 m -77.23 136.51 38.54 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 118.143 -0.932 . . . . 16.300000000000001 108.879 177.778 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.296 32.0 mt -134.64 128.08 32.4 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.901 2.137 . . . . 15.880000000000001 105.519 178.548 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -88.26 132.33 34.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.367 -3.333 . . . . 28.899999999999999 107.676 161.296 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.2 m -133.27 171.32 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 1 C-N-CA 132.194 4.198 . . . . 12.050000000000001 113.118 -164.146 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -108.0 148.06 36.7 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 129.109 2.964 . . . . 18.170000000000002 112.604 161.753 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.6 -23.12 69.99 Favored 'Trans proline' 0 N--CA 1.434 -2.017 1 C-N-CA 126.162 4.575 . . . . 8.1600000000000001 115.364 173.086 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -86.58 -7.16 58.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.145 1.535 . . . . 11.130000000000001 115.145 -179.101 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -73.61 146.53 44.59 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.039 -2.913 . . . . 18.030000000000001 110.452 179.33 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.8 p -99.28 -176.81 3.41 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 104.331 -2.47 . . . . 10.220000000000001 104.331 -172.507 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -70.45 -34.61 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 127.353 2.261 . . . . 12.300000000000001 109.569 -177.638 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -55.23 -43.33 74.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.695 2.798 . . . . 36.509999999999998 110.822 172.209 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -70.68 -34.92 72.49 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.755 2.502 . . . . 25.66 117.755 174.346 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.3 t -55.24 -48.81 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 132.031 4.133 . . . . 8.1199999999999992 108.058 174.002 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.413 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 28.0 mtmt -63.81 -27.86 69.47 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.036 2.934 . . . . 15.470000000000001 115.066 177.488 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.34 -31.06 54.24 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.542 1.974 . . . . 11.449999999999999 110.997 177.374 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -65.04 -44.88 87.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.64 -2.538 . . . . 24.98 109.414 178.734 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.59 -24.11 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.729 2.122 . . . . 9.4600000000000009 116.729 173.189 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -64.89 -57.42 8.85 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.798 -3.689 . . . . 14.76 114.342 162.276 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -52.24 -60.62 3.0 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.517 3.527 . . . . 26.289999999999999 114.729 175.757 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -79.5 -39.73 31.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.913 2.085 . . . . 30.059999999999999 112.612 -166.432 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -106.87 -42.2 5.0 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.029 1.732 . . . . 25.190000000000001 110.009 -163.287 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.63 7.09 30.22 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 117.709 -2.186 . . . . 7.4100000000000001 117.85 -173.118 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 11.6 mm -90.97 126.91 53.82 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-N 122.25 3.025 . . . . 9.4900000000000002 108.917 -170.314 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 86.4 Cg_exo -68.51 152.97 74.69 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 122.261 1.843 . . . . 11.42 111.867 -178.617 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -92.98 -10.53 1.9 Allowed 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-O 113.241 -2.9 . . . . 12.0 111.797 -151.995 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -85.85 -28.43 24.44 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 128.671 3.732 . . . . 35.549999999999997 111.356 174.872 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.17 -17.35 37.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 118.884 -0.579 . . . . 20.52 111.625 -171.807 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.413 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 79.7 mt-30 -66.85 115.66 6.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.593 2.757 . . . . 7.1299999999999999 111.049 171.866 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -114.64 124.11 51.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.317 2.008 . . . . 36.390000000000001 108.772 171.967 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mt -103.35 134.9 45.96 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.041 -2.287 . . . . 9.5500000000000007 107.221 -177.854 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 7.5 mm -112.38 122.62 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 130.522 3.529 . . . . 13.9 115.144 171.053 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -108.8 118.81 37.77 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.755 -1.202 . . . . 6.8600000000000003 107.755 170.965 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.55 -78.37 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 131.134 3.774 . . . . 11.15 113.611 -170.545 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.47 40.41 0.28 Allowed Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 107.193 -2.363 . . . . 13.93 107.193 -179.808 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -137.2 139.33 41.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.525 -2.75 . . . . 23.920000000000002 111.473 159.7 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -67.79 167.52 13.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 117.518 2.414 . . . . 23.23 117.518 175.361 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.49 149.83 35.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.679 2.392 . . . . 9.1099999999999994 107.508 178.41 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.9 146.92 48.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 123.528 0.518 . . . . 33.439999999999998 109.786 -177.665 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.74 -47.27 41.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 120.577 3.547 . . . . 28.370000000000001 120.577 -158.651 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.56 53.7 0.63 Allowed Glycine 0 N--CA 1.429 -1.77 0 O-C-N 117.068 -3.52 . . . . 15.0 111.131 -170.338 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 67.6 mtt180 -120.62 159.27 25.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 117.574 -1.65 . . . . 25.5 106.997 155.969 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -85.12 165.38 17.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.969 2.508 . . . . 11.949999999999999 112.348 -169.914 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.6 mt -72.09 -38.04 69.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.685 -1.885 . . . . 10.17 110.012 -176.639 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -54.09 -49.15 69.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 114.891 -2.48 . . . . 13.59 113.105 169.706 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -44.53 -50.05 9.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 124.989 3.54 . . . . 11.699999999999999 113.787 174.702 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 68.8 m-85 -76.93 -7.63 55.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.669 -2.519 . . . . 12.949999999999999 116.839 -178.981 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 69.19 37.47 2.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.966 3.307 . . . . 25.449999999999999 115.258 -179.42 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.2 mt -85.01 109.19 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 130.878 3.671 . . . . 14.6 105.677 -172.867 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -91.07 165.26 13.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.826 2.727 . . . . 33.229999999999997 113.035 -179.751 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 147.25 12.83 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.798 -3.689 . . . . 25.969999999999999 115.532 168.308 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 58.37 32.23 21.84 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.046 2.61 . . . . 32.609999999999999 118.046 -170.762 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -98.74 142.63 30.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.495 1.747 . . . . 10.56 108.796 177.071 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.2 m -93.24 102.91 15.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.137 3.775 . . . . 5.3300000000000001 115.636 169.473 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.25 153.58 23.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.842 -2.281 . . . . 11.66 104.842 168.602 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.45 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 89.2 m-70 -92.04 152.96 19.72 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.735 1.383 . . . . 16.300000000000001 114.735 168.191 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.2 tp -120.01 108.78 14.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.977 2.111 . . . . 9.9600000000000009 110.998 169.082 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.327 16.0 m -119.65 168.74 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 126.922 2.639 . . . . 9.7599999999999998 112.505 171.495 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.2 mt . . . . . 0 N--CA 1.431 -1.411 0 CA-C-O 125.534 2.588 . . . . 19.57 106.591 179.053 . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 108.119 -1.067 . . . . 17.170000000000002 108.119 . . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -83.15 132.93 35.06 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.919 -2.363 . . . . 21.890000000000001 114.764 175.734 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -131.84 163.14 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 124.716 1.26 . . . . 10.83 110.039 172.489 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -124.67 166.27 16.44 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 102.282 -3.229 . . . . 10.609999999999999 102.282 -174.949 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -150.18 143.17 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 100.877 -3.749 . . . . 9.1300000000000008 100.877 179.464 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -119.2 139.05 52.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.467 1.939 . . . . 20.550000000000001 106.271 -178.649 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.0 p -81.81 167.84 18.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.744 1.903 . . . . 11.779999999999999 107.565 178.654 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 tp -56.17 -54.8 40.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.014 3.326 . . . . 19.309999999999999 113.132 -178.946 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.3 p -62.62 -53.76 49.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.891 2.476 . . . . 23.140000000000001 110.57 175.727 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.18 70.61 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 CA-C-O 117.601 -1.666 . . . . 19.739999999999998 112.768 169.587 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -125.78 124.42 40.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.909 1.855 . . . . 21.93 109.665 176.858 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -79.57 106.03 11.31 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.383 -5.198 . . . . 12.33 111.177 177.387 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.7 mt -81.35 115.07 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 123.259 1.504 . . . . 17.079999999999998 107.139 171.934 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -94.47 104.11 16.08 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 114.344 -5.222 . . . . 16.300000000000001 114.818 171.518 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -97.35 162.29 13.4 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.436 -4.54 . . . . 15.880000000000001 112.244 179.378 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -116.22 118.99 34.34 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 102.913 -2.995 . . . . 28.899999999999999 102.913 174.322 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.27 165.55 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 121.844 2.111 . . . . 12.050000000000001 112.707 173.653 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -104.57 161.78 21.79 Favored Pre-proline 0 N--CA 1.43 -1.46 0 N-CA-C 105.658 -1.979 . . . . 18.170000000000002 105.658 164.169 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.17 -6.29 12.96 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 123.978 3.119 . . . . 8.1600000000000001 109.311 -169.412 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -88.22 2.97 51.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 131.54 3.936 . . . . 11.130000000000001 113.379 168.0 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -87.15 152.71 22.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.21 -3.431 . . . . 18.030000000000001 109.91 -178.859 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p -94.86 164.05 13.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.149 2.704 . . . . 10.220000000000001 110.7 -167.042 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.5 mm -69.37 -34.87 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 O-C-N 115.489 -4.507 . . . . 12.300000000000001 109.164 -179.864 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.24 -42.78 77.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.737 2.866 . . . . 36.509999999999998 118.737 168.045 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -71.21 -32.43 68.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.02 2.128 . . . . 25.66 110.403 175.643 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.359 44.4 t -52.06 -61.27 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 118.98 -2.325 . . . . 8.1199999999999992 111.094 165.396 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -52.59 -35.43 54.11 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 127.109 2.164 . . . . 15.470000000000001 114.479 177.772 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -71.6 -35.37 70.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.296 -2.753 . . . . 11.449999999999999 109.481 -178.302 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -62.27 -41.65 98.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.145 -0.972 . . . . 24.98 112.925 171.846 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.7 mt -63.71 -36.34 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 127.459 2.974 . . . . 9.4600000000000009 114.348 179.428 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 36.3 tt0 -53.91 -33.19 55.92 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.509 3.924 . . . . 14.76 117.834 166.643 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.68 -51.48 9.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 124.12 1.914 . . . . 26.289999999999999 108.841 178.053 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -56.46 -63.15 1.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.274 1.987 . . . . 30.059999999999999 114.991 -176.771 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -110.91 -13.51 14.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.693 -3.129 . . . . 25.190000000000001 114.28 -172.765 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.78 43.86 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 119.524 2.57 . . . . 7.4100000000000001 119.524 -172.623 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.6 115.9 65.85 Favored Pre-proline 0 N--CA 1.43 -1.425 0 CA-C-O 115.154 -2.355 . . . . 9.4900000000000002 105.903 169.575 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -66.32 152.43 81.03 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 CA-C-N 126.906 3.502 . . . . 11.42 113.57 -177.856 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.14 -0.26 10.6 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.06 2.506 . . . . 12.0 112.92 -166.109 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -90.66 -54.79 3.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.836 3.207 . . . . 35.549999999999997 109.123 -173.897 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -84.28 -8.56 58.99 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.252 2.315 . . . . 20.52 117.252 -174.616 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -88.85 157.33 18.49 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.942 -2.974 . . . . 7.1299999999999999 109.923 171.52 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -143.46 144.69 32.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.018 -1.676 . . . . 36.390000000000001 107.593 168.637 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.8 mt -97.59 140.07 32.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.017 1.327 . . . . 9.5500000000000007 113.673 -175.983 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mm -134.52 139.35 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 104.009 -2.589 . . . . 13.9 104.009 -173.707 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -111.93 108.36 17.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.559 2.344 . . . . 6.8600000000000003 107.834 173.389 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.41 -88.6 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.362 2.289 . . . . 11.15 112.781 -169.99 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.42 -8.48 4.89 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 117.012 -3.555 . . . . 13.93 109.953 175.841 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -81.56 141.07 34.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 118.032 0.916 . . . . 23.920000000000002 111.32 -177.345 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -94.61 120.84 35.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.272 1.429 . . . . 23.23 108.168 -178.168 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.84 133.25 35.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.593 1.957 . . . . 9.1099999999999994 110.588 -165.138 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -94.84 136.25 35.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.772 -2.455 . . . . 33.439999999999998 114.92 179.098 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.82 -38.23 64.62 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.205 2.298 . . . . 28.370000000000001 117.205 -143.214 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.85 11.95 4.16 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 120.904 3.121 . . . . 15.0 120.904 164.66 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -106.18 172.88 6.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.39 2.595 . . . . 25.5 112.586 172.367 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -98.69 171.45 8.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.478 2.085 . . . . 11.949999999999999 115.436 176.128 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.01 -40.35 95.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.434 2.294 . . . . 10.17 109.391 173.394 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -60.41 -33.68 72.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 118.856 2.91 . . . . 13.59 118.856 173.17 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.286 28.5 m-20 -68.06 -44.78 75.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.629 1.715 . . . . 11.699999999999999 115.629 174.046 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -76.02 -32.55 59.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.424 1.489 . . . . 12.949999999999999 114.57 175.897 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t30 83.08 67.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 1 C-N-CA 131.884 4.073 . . . . 25.449999999999999 108.978 177.951 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.4 mt -101.49 118.15 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 127.485 2.314 . . . . 14.6 107.985 -177.916 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -89.25 177.92 6.48 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.097 -1.041 . . . . 33.229999999999997 110.518 -171.314 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -70.61 149.76 46.73 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.138 1.335 . . . . 25.969999999999999 110.882 175.916 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 70.03 51.41 0.41 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.778 3.231 . . . . 32.609999999999999 107.508 170.374 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -126.38 132.26 51.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.798 3.239 . . . . 10.56 115.398 -169.045 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.361 6.8 m -103.02 106.15 16.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.895 1.68 . . . . 5.3300000000000001 115.48 -172.751 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 mt -83.67 156.13 22.81 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.346 3.451 . . . . 11.66 107.523 177.854 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -111.39 157.8 19.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.028 -3.545 . . . . 16.300000000000001 106.979 -174.971 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -126.85 106.86 9.63 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.923 1.344 . . . . 9.9600000000000009 109.853 -169.696 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -118.88 171.49 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 100.896 -3.742 . . . . 9.7599999999999998 100.896 -166.99 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 N--CA 1.43 -1.462 0 O-C-N 116.606 -3.809 . . . . 19.57 101.851 -177.54 . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 118.873 -0.585 . . . . 17.170000000000002 111.193 . . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -96.57 138.76 33.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.001 -2.312 . . . . 21.890000000000001 113.455 170.324 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.8 pt -115.04 154.15 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 127.231 2.212 . . . . 10.83 105.249 165.803 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -113.18 114.31 26.58 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.839 -1.788 . . . . 10.609999999999999 107.17 -176.991 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.8 105.93 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 105.504 -2.036 . . . . 9.1300000000000008 105.504 177.784 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -101.03 152.43 20.6 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.827 -2.657 . . . . 20.550000000000001 103.827 -172.73 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -97.11 172.19 7.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.135 -0.978 . . . . 11.779999999999999 110.803 178.348 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.5 tp -45.72 -57.17 4.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.424 2.009 . . . . 19.309999999999999 116.424 170.191 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.06 -42.78 77.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 131.562 3.945 . . . . 23.140000000000001 111.235 175.13 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.1 55.86 0.47 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 126.811 3.451 . . . . 19.739999999999998 109.653 172.407 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -115.2 135.82 53.76 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.231 -2.334 . . . . 21.93 107.815 175.058 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -106.79 119.5 39.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.214 -3.429 . . . . 12.33 117.102 -164.544 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.2 mt -104.14 102.69 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 119.047 -2.283 . . . . 17.079999999999998 111.283 -172.567 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -84.76 118.27 24.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.967 1.707 . . . . 16.300000000000001 106.812 -176.714 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 mt -115.52 131.32 56.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.611 -2.556 . . . . 15.880000000000001 106.952 -173.919 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -100.06 91.04 4.6 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.727 1.751 . . . . 28.899999999999999 115.727 179.824 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.77 163.88 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 128.053 3.787 . . . . 12.050000000000001 112.208 -171.44 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -92.45 157.12 40.78 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.791 -2.443 . . . . 18.170000000000002 106.478 167.799 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.54 -3.61 14.01 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 114.748 -3.343 . . . . 8.1600000000000001 111.39 176.749 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 p -87.59 -7.55 57.36 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 118.732 -2.48 . . . . 11.130000000000001 111.007 175.33 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.74 137.57 54.18 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.147 1.379 . . . . 18.030000000000001 109.531 176.127 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.448 ' O ' HG22 ' A' ' 26' ' ' VAL . 4.7 p -85.28 164.11 18.22 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.341 2.256 . . . . 10.220000000000001 109.136 -173.131 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.416 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 35.8 mm -62.29 -37.83 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 O-C-N 114.669 -5.02 . . . . 12.300000000000001 110.559 178.299 . . . . . . . . 3 3 . 1 . 067 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.27 19.1 tt0 -52.54 -54.05 37.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.49 1.916 . . . . 36.509999999999998 115.421 169.463 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 15.2 t-20 -55.68 -45.76 77.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.422 1.889 . . . . 25.66 112.568 170.889 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 22' ' ' THR . 40.4 t -57.39 -42.95 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.294 1.438 . . . . 8.1199999999999992 112.747 175.16 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 51.2 mtmt -68.41 -33.45 74.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.658 2.481 . . . . 15.470000000000001 108.609 179.8 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.2 -30.75 71.67 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 116.124 1.898 . . . . 11.449999999999999 116.124 178.773 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -70.28 -33.59 71.75 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 117.234 -1.365 . . . . 24.98 112.047 173.454 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.6 mt -71.26 -45.62 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 119.56 1.073 . . . . 9.4600000000000009 112.717 169.372 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.309 36.5 tt0 -44.04 -52.93 6.73 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.79 1.636 . . . . 14.76 115.239 166.617 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -55.7 -39.49 71.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.623 -1.923 . . . . 26.289999999999999 115.123 173.56 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -88.81 -67.74 0.82 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.338 2.018 . . . . 30.059999999999999 114.932 -165.518 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -88.78 -43.49 11.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.35 2.5 . . . . 25.190000000000001 109.552 -168.119 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.24 19.83 3.45 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.032 -1.895 . . . . 7.4100000000000001 110.283 168.424 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.2 mt -90.31 120.19 69.12 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-N 121.616 2.708 . . . . 9.4900000000000002 104.219 -167.501 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -81.16 162.66 20.21 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 CA-C-N 123.152 2.161 . . . . 11.42 115.27 -179.88 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -84.57 -8.34 9.47 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 N-CA-C 116.286 1.61 . . . . 12.0 116.286 -161.452 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -79.03 -20.88 47.86 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.101 3.137 . . . . 35.549999999999997 114.791 164.972 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -79.71 -37.66 35.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.695 2.188 . . . . 20.52 112.961 -178.306 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -102.61 136.44 42.44 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.961 -4.212 . . . . 7.1299999999999999 110.211 -172.834 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -115.44 148.67 39.12 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.199 1.399 . . . . 36.390000000000001 110.346 164.826 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.9 mt -114.8 125.43 53.68 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.664 -1.607 . . . . 9.5500000000000007 111.578 -178.021 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -103.8 139.14 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 125.931 2.019 . . . . 13.9 106.624 174.241 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -122.17 138.12 54.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.335 -1.793 . . . . 6.8600000000000003 113.482 162.668 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.325 . . 52.26 -99.17 0.08 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.368 1.895 . . . . 11.15 112.955 -174.707 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.13 51.71 0.58 Allowed Glycine 0 N--CA 1.43 -1.748 1 O-C-N 115.468 -4.52 . . . . 13.93 108.484 169.78 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -153.83 165.26 36.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 127.408 2.475 . . . . 23.920000000000002 115.485 177.039 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -91.7 127.97 37.35 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.071 2.948 . . . . 23.23 115.7 -174.47 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.411 HD22 HD12 ' A' ' 61' ' ' ILE . 83.9 mt -90.79 123.9 34.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.025 -2.297 . . . . 9.1099999999999994 114.453 175.099 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -97.93 131.83 44.04 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.801 2.04 . . . . 33.439999999999998 112.818 -171.793 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -32.36 -50.04 0.22 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.382 3.873 . . . . 28.370000000000001 118.369 176.942 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.98 -12.44 76.89 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 119.133 2.413 . . . . 15.0 119.133 -174.14 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -91.23 167.78 12.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.428 -2.219 . . . . 25.5 111.35 -178.418 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 p -88.13 160.68 17.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 127.313 2.883 . . . . 11.949999999999999 112.301 173.081 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -68.01 -30.7 70.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.999 2.592 . . . . 10.17 117.999 169.031 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 29.4 m -56.19 -41.73 75.99 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 131.02 3.728 . . . . 13.59 110.062 168.352 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.95 -32.49 74.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.303 -2.123 . . . . 11.699999999999999 114.95 -176.347 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -82.8 -31.76 28.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.221 2.608 . . . . 12.949999999999999 109.448 178.7 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.6 m120 74.03 58.96 0.09 Allowed 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 129.216 4.073 . . . . 25.449999999999999 115.498 -166.845 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.411 HD12 HD22 ' A' ' 50' ' ' LEU . 41.7 mt -104.6 135.47 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 117.813 -3.055 . . . . 14.6 106.571 -176.748 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -117.49 -168.28 1.46 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.124 1.37 . . . . 33.229999999999997 113.348 -155.354 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -83.34 134.59 34.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.184 -2.197 . . . . 25.969999999999999 109.947 168.488 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 69.21 38.09 1.97 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.917 2.77 . . . . 32.609999999999999 113.938 -176.781 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 m -98.33 133.71 42.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.034 1.873 . . . . 10.56 107.682 -173.918 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.6 m -95.73 123.47 39.31 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.064 -1.648 . . . . 5.3300000000000001 111.212 -174.236 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.5 132.93 53.68 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 130.637 3.575 . . . . 11.66 108.611 -179.339 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -104.18 105.87 16.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.298 1.863 . . . . 16.300000000000001 112.067 -175.225 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 tt -79.36 120.97 24.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.346 2.658 . . . . 9.9600000000000009 111.39 -179.466 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -126.49 173.73 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.447 3.023 . . . . 9.7599999999999998 104.08 -173.503 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 N--CA 1.43 -1.438 0 O-C-N 118.703 -2.498 . . . . 19.57 110.342 174.291 . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 117.505 2.409 . . . . 17.170000000000002 117.505 . . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -130.41 145.74 51.86 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.589 -0.893 . . . . 21.890000000000001 108.589 174.629 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.8 pt -139.68 162.43 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 117.64 -3.162 . . . . 10.83 107.601 174.523 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -121.09 127.21 51.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.674 -0.861 . . . . 10.609999999999999 108.674 -178.536 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.516 HG13 HD13 ' A' ' 69' ' ' LEU . 60.5 t -96.32 120.33 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 128.181 3.425 . . . . 9.1300000000000008 107.959 170.231 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -125.46 145.27 50.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.524 3.059 . . . . 20.550000000000001 108.743 178.734 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -94.55 -161.53 0.86 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 112.405 -2.18 . . . . 11.779999999999999 113.88 174.941 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tt -77.64 -47.58 18.91 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 115.555 -2.164 . . . . 19.309999999999999 109.56 -170.292 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.4 p -71.08 -47.59 57.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.347 2.022 . . . . 23.140000000000001 111.194 175.848 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.54 63.09 0.17 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.505 -2.622 . . . . 19.739999999999998 109.156 176.213 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -91.51 116.26 28.71 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.957 2.903 . . . . 21.93 111.153 167.985 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -88.29 106.82 18.47 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.083 1.765 . . . . 12.33 114.567 -173.389 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 mt -104.99 104.86 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 125.663 1.585 . . . . 17.079999999999998 107.495 -178.435 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -90.88 125.06 35.63 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 114.97 -4.831 . . . . 16.300000000000001 108.701 -172.357 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.266 87.6 mt -127.84 147.64 50.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 120.474 3.509 . . . . 15.880000000000001 120.474 -179.589 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -107.18 117.06 33.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.15 -1.426 . . . . 28.899999999999999 107.15 -166.972 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.72 158.24 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 131.414 3.886 . . . . 12.050000000000001 112.297 -170.944 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -121.11 160.36 45.61 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 114.821 -2.514 . . . . 18.170000000000002 105.773 172.73 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -72.19 -19.85 25.51 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 CA-C-N 128.496 4.07 . . . . 8.1600000000000001 111.195 -159.253 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 m -84.58 3.18 38.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.885 -3.009 . . . . 11.130000000000001 112.561 -177.197 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.88 144.32 41.24 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 117.323 -1.751 . . . . 18.030000000000001 115.225 175.138 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 69.2 p -82.45 159.4 22.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.754 2.692 . . . . 10.220000000000001 113.794 -173.153 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 43' ' ' LEU . 31.9 mm -64.45 -35.89 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.896 -3.003 . . . . 12.300000000000001 113.103 176.409 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.278 54.9 tt0 -37.72 -65.07 0.35 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.119 2.568 . . . . 36.509999999999998 112.221 160.88 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -57.81 -34.91 70.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.194 2.197 . . . . 25.66 114.521 -177.642 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 t -62.63 -52.94 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.05 2.094 . . . . 8.1199999999999992 110.129 179.664 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -64.31 -30.55 71.6 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.605 3.098 . . . . 15.470000000000001 113.398 -177.287 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.35 -40.28 74.23 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.575 -4.453 . . . . 11.449999999999999 113.949 179.266 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -62.56 -47.93 81.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.181 1.792 . . . . 24.98 111.079 169.516 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.436 ' HB ' HE22 ' A' ' 41' ' ' GLN . 70.9 mt -63.88 -41.55 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 127.011 2.124 . . . . 9.4600000000000009 112.384 -176.094 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -62.33 -56.91 13.86 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.156 -2.215 . . . . 14.76 114.948 168.625 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.67 -40.66 92.63 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 116.274 -4.017 . . . . 26.289999999999999 116.32 -176.027 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -89.25 -64.29 1.16 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.607 -3.808 . . . . 30.059999999999999 110.407 -172.184 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -83.75 -29.6 27.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.848 -3.657 . . . . 25.190000000000001 109.286 -173.302 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.92 46.17 2.12 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 123.367 2.803 . . . . 7.4100000000000001 108.724 159.779 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.2 mt -114.96 113.94 44.0 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.462 -2.051 . . . . 9.4900000000000002 105.462 -176.374 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.98 156.52 34.33 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.111 2.541 . . . . 11.42 112.581 -158.957 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -80.28 -8.49 13.97 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 123.907 3.071 . . . . 12.0 108.984 -161.88 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.341 4.0 p30 -79.39 -25.47 42.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.263 1.506 . . . . 35.549999999999997 109.503 175.889 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -95.06 -38.51 10.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.208 1.48 . . . . 20.52 111.707 -166.946 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.436 HE22 ' HB ' ' A' ' 30' ' ' ILE . 26.4 pt20 -83.57 147.2 27.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.488 -2.007 . . . . 7.1299999999999999 114.038 178.034 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -144.55 145.18 31.69 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 99.998 -4.075 . . . . 36.390000000000001 99.998 166.055 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.426 HD11 HG21 ' A' ' 23' ' ' ILE . 61.9 mt -109.97 130.61 55.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.739 -1.226 . . . . 9.5500000000000007 113.696 179.645 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.5 138.86 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 103.264 -2.865 . . . . 13.9 103.264 173.148 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.566 ' HB2' HD11 ' A' ' 50' ' ' LEU . 86.3 t80 -126.53 119.05 26.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.931 -1.486 . . . . 6.8600000000000003 109.099 169.964 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.11 -54.13 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 132.614 4.365 . . . . 11.15 116.108 -163.558 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.99 19.56 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 127.953 2.692 . . . . 13.93 112.08 177.417 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -104.36 146.16 29.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.051 -2.203 . . . . 23.920000000000002 105.051 164.012 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.257 10.8 tt0 -87.45 125.09 34.08 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.281 1.832 . . . . 23.23 111.969 176.241 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 45' ' ' PHE . 64.2 mt -97.08 107.29 19.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.53 2.048 . . . . 9.1099999999999994 116.53 -170.619 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -69.49 141.75 53.87 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.055 2.097 . . . . 33.439999999999998 113.92 -173.904 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -24.34 -75.95 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 1 N-CA-C 123.682 4.697 . . . . 28.370000000000001 123.682 176.251 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.91 28.54 14.01 Favored Glycine 0 N--CA 1.43 -1.737 1 O-C-N 114.817 -4.927 . . . . 15.0 113.003 -157.186 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -107.79 153.79 22.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.015 1.388 . . . . 25.5 113.366 177.566 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -90.39 161.07 15.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 115.504 -2.479 . . . . 11.949999999999999 109.242 -172.21 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.42 -31.45 69.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.996 2.119 . . . . 10.17 113.045 170.311 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.27 8.6 t -55.34 -59.2 5.12 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 131.05 3.74 . . . . 13.59 116.744 167.489 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.8 -33.72 74.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.386 3.106 . . . . 11.699999999999999 119.386 172.531 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -82.77 3.62 28.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.718 -3.114 . . . . 12.949999999999999 114.506 174.577 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 65.84 30.21 10.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.864 3.666 . . . . 25.449999999999999 114.965 172.668 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -91.05 104.88 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.485 -2.634 . . . . 14.6 115.657 -173.517 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -101.6 -178.16 3.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.084 1.897 . . . . 33.229999999999997 112.757 -169.462 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.329 15.1 pttp -54.38 146.92 14.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.893 1.812 . . . . 25.969999999999999 115.893 -172.113 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 39.79 45.57 1.5 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.368 2.267 . . . . 32.609999999999999 116.933 -166.407 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 m -84.05 138.3 33.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.584 3.564 . . . . 10.56 108.051 178.265 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 m -84.46 111.09 19.16 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 110.649 -2.978 . . . . 5.3300000000000001 109.37 176.356 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.401 9.2 mp -94.65 119.73 33.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.166 -3.459 . . . . 11.66 118.467 172.12 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -93.53 99.26 11.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.195 2.902 . . . . 16.300000000000001 105.964 -172.411 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.516 HD13 HG13 ' A' ' 5' ' ' VAL . 7.8 tt -82.65 116.83 22.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.559 -2.564 . . . . 9.9600000000000009 109.929 174.516 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.272 2.7 m -114.89 166.04 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 124.65 2.167 . . . . 9.7599999999999998 112.997 -167.169 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 N--CA 1.431 -1.425 0 O-C-N 118.018 -2.926 . . . . 19.57 115.156 173.313 . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 122.77 1.271 . . . . 17.170000000000002 114.182 . . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -105.78 124.0 48.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.353 3.461 . . . . 21.890000000000001 108.068 -163.333 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.301 13.1 pt -118.18 163.55 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 128.723 2.809 . . . . 10.83 114.606 179.311 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -133.73 117.6 17.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.206 -2.809 . . . . 10.609999999999999 112.274 -164.572 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.78 114.31 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 124.546 2.117 . . . . 9.1300000000000008 106.932 -174.127 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -94.71 136.77 34.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.071 -1.643 . . . . 20.550000000000001 109.112 177.37 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.262 7.8 p -80.24 -169.62 2.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.613 1.965 . . . . 11.779999999999999 112.917 -177.82 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.29 -56.88 4.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.213 1.006 . . . . 19.309999999999999 113.238 166.029 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.3 p -61.45 -62.44 1.82 Allowed 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 115.416 1.636 . . . . 23.140000000000001 115.416 -173.458 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.89 40.66 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 122.935 1.297 . . . . 19.739999999999998 116.152 -170.692 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -118.11 140.72 49.36 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.241 -1.741 . . . . 21.93 112.024 172.069 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.8 m -117.12 115.05 24.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.532 -1.655 . . . . 12.33 106.532 -178.409 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -98.1 126.43 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 124.983 1.427 . . . . 17.079999999999998 109.564 -170.98 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -96.82 135.43 38.8 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.667 -2.521 . . . . 16.300000000000001 105.903 178.474 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.7 mt -125.67 155.77 40.32 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 103.918 -2.623 . . . . 15.880000000000001 103.918 173.706 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -118.62 132.38 56.18 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.853 -1.536 . . . . 28.899999999999999 106.853 167.961 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -148.73 165.03 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 126.322 2.263 . . . . 12.050000000000001 105.336 -162.563 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -117.93 145.37 36.57 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 127.72 2.408 . . . . 18.170000000000002 106.224 173.872 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.5 -24.1 31.24 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 124.944 3.763 . . . . 8.1600000000000001 115.288 -165.562 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -77.91 -0.51 27.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.926 2.641 . . . . 11.130000000000001 117.027 173.326 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -90.55 152.31 20.96 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.675 -1.89 . . . . 18.030000000000001 112.082 177.924 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 28.9 p -82.22 174.85 10.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.175 2.287 . . . . 10.220000000000001 117.175 -177.992 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mm -69.17 -32.26 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.695 2.798 . . . . 12.300000000000001 103.647 175.962 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.83 -31.19 66.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 124.396 3.271 . . . . 36.509999999999998 119.288 174.557 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -76.62 -30.4 56.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.178 2.191 . . . . 25.66 109.156 179.757 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -76.46 -38.59 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 115.651 -2.118 . . . . 8.1199999999999992 108.316 177.222 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -60.77 -57.49 12.46 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 125.17 1.543 . . . . 15.470000000000001 110.81 175.564 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.22 -48.02 17.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.984 2.914 . . . . 11.449999999999999 115.089 169.923 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -75.16 -30.28 60.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 121.265 1.848 . . . . 24.98 114.304 -179.27 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.1 mt -55.84 -56.36 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 114.103 1.149 . . . . 9.4600000000000009 114.103 161.209 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -45.49 -45.55 13.26 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.179 2.592 . . . . 14.76 112.11 179.328 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -59.29 -34.95 72.91 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.454 2.761 . . . . 26.289999999999999 118.454 173.233 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -71.93 -72.61 0.22 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.074 1.879 . . . . 30.059999999999999 116.074 166.846 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -87.89 -30.65 19.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 119.877 3.288 . . . . 25.190000000000001 119.877 -176.432 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.66 73.44 0.98 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 123.926 1.848 . . . . 7.4100000000000001 115.1 -173.226 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 94.3 mt -124.91 127.73 25.04 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-O 112.36 -3.686 . . . . 9.4900000000000002 105.51 178.515 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -63.94 146.94 92.0 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 127.782 3.815 . . . . 11.42 114.98 -166.714 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.29 -20.98 36.33 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 119.718 2.93 . . . . 12.0 119.718 179.058 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -81.3 -30.13 34.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.854 3.216 . . . . 35.549999999999997 113.05 172.999 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -71.97 -47.6 50.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.897 -3.627 . . . . 20.52 113.041 175.396 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -72.54 161.56 30.63 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 116.079 -4.138 . . . . 7.1299999999999999 116.818 -179.808 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -147.22 136.93 22.97 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.136 2.174 . . . . 36.390000000000001 111.988 170.864 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 mt -105.33 122.38 45.83 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 116.333 -1.794 . . . . 9.5500000000000007 114.505 178.822 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mm -93.6 140.74 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 131.607 3.963 . . . . 13.9 111.026 167.753 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CE1' HG12 ' A' ' 61' ' ' ILE . 21.2 t80 -134.71 117.22 15.8 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.118 2.967 . . . . 6.8600000000000003 112.503 167.158 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.84 -105.74 0.23 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.134 2.574 . . . . 11.15 111.531 -159.853 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.81 27.24 5.47 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.838 -1.164 . . . . 13.93 114.65 -172.337 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -153.69 141.87 20.45 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 126.535 3.064 . . . . 23.920000000000002 110.64 -179.706 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.45 165.06 23.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 112.469 -2.151 . . . . 23.23 112.605 172.879 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.363 12.0 mt -110.1 161.78 15.21 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.766 -1.834 . . . . 9.1099999999999994 110.049 -172.665 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -108.47 132.5 53.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.38 2.3 . . . . 33.439999999999998 109.971 179.228 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -45.48 -50.49 12.66 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 122.379 4.214 . . . . 28.370000000000001 122.379 -169.022 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.51 14.52 45.99 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 111.701 -2.5 . . . . 15.0 113.848 -175.664 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -99.37 155.15 17.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 116.902 -1.523 . . . . 25.5 111.747 174.744 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 34.9 p -87.34 161.46 17.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.129 1.518 . . . . 11.949999999999999 109.63 -177.119 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.7 mt -57.38 -44.38 84.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.961 2.791 . . . . 10.17 112.897 169.592 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -64.76 -15.45 61.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.303 -3.998 . . . . 13.59 115.486 -179.663 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -79.96 -44.7 19.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.57 -2.581 . . . . 11.699999999999999 110.583 179.951 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -85.6 -4.18 59.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.056 1.408 . . . . 12.949999999999999 112.64 174.746 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.435 22.9 m120 82.62 36.32 0.06 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.091 -3.505 . . . . 25.449999999999999 108.97 171.127 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.41 HG12 ' CE1' ' A' ' 45' ' ' PHE . 72.3 mt -89.44 98.12 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 119.601 -1.937 . . . . 14.6 109.277 -176.482 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -86.68 -172.25 3.92 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 117.341 2.348 . . . . 33.229999999999997 117.341 -171.044 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -73.26 138.74 45.7 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.941 0.877 . . . . 25.969999999999999 112.149 176.697 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 62.86 12.51 5.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.801 -2.437 . . . . 32.609999999999999 116.793 -171.977 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m -78.04 134.88 37.7 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 119.8 3.259 . . . . 10.56 119.8 169.019 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -87.16 123.84 32.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.676 1.58 . . . . 5.3300000000000001 109.549 -177.061 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -93.49 163.36 13.6 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.339 -2.1 . . . . 11.66 114.518 153.755 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -123.62 119.23 29.25 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.778 -1.556 . . . . 16.300000000000001 114.556 177.583 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.82 128.97 35.66 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 117.956 -1.021 . . . . 9.9600000000000009 111.373 177.517 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 m -127.43 -167.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 127.648 3.092 . . . . 9.7599999999999998 107.281 179.707 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 tp . . . . . 0 N--CA 1.43 -1.475 0 N-CA-C 105.744 -1.947 . . . . 19.57 105.744 -172.665 . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttm . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 107.315 -1.365 . . . . 17.170000000000002 107.315 . . . . . . . . . 0 0 . 1 . 070 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -100.19 161.17 13.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.891 -3.63 . . . . 21.890000000000001 111.506 169.734 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.456 HG22 ' H ' ' A' ' 65' ' ' SER . 12.4 pt -152.96 157.7 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 129.083 2.953 . . . . 10.83 110.401 172.587 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.29 108.46 16.59 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 114.917 -4.864 . . . . 10.609999999999999 113.148 -172.557 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.3 t -103.13 114.59 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.596 -2.565 . . . . 9.1300000000000008 109.705 -176.667 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -98.06 146.02 25.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.625 1.678 . . . . 20.550000000000001 114.163 -173.863 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.311 81.4 p -86.56 -176.84 5.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.75 1.262 . . . . 11.779999999999999 109.41 172.678 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.4 tp -68.32 -62.37 1.43 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.692 2.797 . . . . 19.309999999999999 110.49 168.114 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -60.79 -68.77 0.27 Allowed 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.857 -3.652 . . . . 23.140000000000001 119.409 176.418 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.4 46.28 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 O-C-N 116.549 -3.844 . . . . 19.739999999999998 109.611 -173.552 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -118.88 141.15 48.91 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.673 -0.898 . . . . 21.93 110.415 157.95 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -110.41 124.9 52.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.612 -1.625 . . . . 12.33 106.612 169.077 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.488 HG21 HG12 ' A' ' 30' ' ' ILE . 12.9 mt -84.39 108.6 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 128.437 2.695 . . . . 17.079999999999998 107.994 169.188 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.4 m -96.64 97.94 9.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.128 -2.858 . . . . 16.300000000000001 111.95 -176.405 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.18 147.18 25.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.149 -2.844 . . . . 15.880000000000001 112.053 -169.125 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -111.16 133.05 53.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.485 1.612 . . . . 28.899999999999999 111.992 162.07 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.04 158.08 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 2 CA-C-N 107.04 -4.618 . . . . 12.050000000000001 111.592 -167.441 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -95.71 160.86 29.37 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 123.925 0.766 . . . . 18.170000000000002 112.035 159.145 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -87.85 -2.35 7.29 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 124.498 2.642 . . . . 8.1600000000000001 108.689 -175.561 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -81.8 -18.38 44.24 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.396 3.078 . . . . 11.130000000000001 111.709 170.208 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.24 153.08 34.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.019 1.489 . . . . 18.030000000000001 115.019 177.327 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 41.7 p -89.69 172.76 8.71 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.532 1.133 . . . . 10.220000000000001 110.468 -173.967 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -70.24 -24.32 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 118.526 -1.27 . . . . 12.300000000000001 111.597 171.26 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.53 -39.7 85.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.76 1.267 . . . . 36.509999999999998 113.414 171.336 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -65.53 -37.28 86.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.359 -3.963 . . . . 25.66 114.035 167.735 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.85 -34.18 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 122.716 2.507 . . . . 8.1199999999999992 108.746 -171.679 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -67.88 -41.26 83.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.147 3.779 . . . . 15.470000000000001 108.557 172.837 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.54 -33.52 66.9 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.713 2.405 . . . . 11.449999999999999 112.403 -177.666 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -61.97 -33.73 74.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.715 -3.116 . . . . 24.98 114.597 166.887 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.488 HG12 HG21 ' A' ' 13' ' ' ILE . 80.4 mt -73.0 -41.69 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 117.034 -1.46 . . . . 9.4600000000000009 110.333 173.157 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -56.98 -42.12 79.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.606 2.362 . . . . 14.76 113.797 178.407 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.01 -43.46 82.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 112.974 -3.393 . . . . 26.289999999999999 110.825 179.806 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -100.79 -43.13 6.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 124.395 3.27 . . . . 30.059999999999999 118.33 -173.209 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -91.75 -38.06 12.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 123.461 0.705 . . . . 25.190000000000001 109.429 -175.977 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.27 21.84 9.12 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 120.373 -1.454 . . . . 7.4100000000000001 114.61 170.847 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -91.73 122.44 65.53 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 113.392 -3.194 . . . . 9.4900000000000002 109.263 -175.718 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.87 147.72 85.45 Favored 'Trans proline' 0 N--CA 1.434 -2.014 1 CA-C-N 129.786 4.531 . . . . 11.42 114.501 -179.972 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -79.58 -8.42 14.8 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 122.395 2.063 . . . . 12.0 112.792 -162.61 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -83.84 -34.65 24.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.999 -3.563 . . . . 35.549999999999997 109.065 179.045 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -83.87 -28.41 28.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 131.072 3.749 . . . . 20.52 112.04 -167.696 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -92.05 155.5 18.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.584 2.611 . . . . 7.1299999999999999 112.793 166.3 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -142.16 142.45 32.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.052 -2.28 . . . . 36.390000000000001 109.998 167.708 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.5 mt -101.1 111.14 23.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 116.561 2.06 . . . . 9.5500000000000007 116.561 176.904 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.7 mm -95.71 132.1 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 126.432 2.332 . . . . 13.9 111.705 172.148 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -111.86 123.0 49.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.818 2.723 . . . . 6.8600000000000003 105.949 169.677 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.451 . . 59.61 -99.36 0.09 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 116.255 -1.831 . . . . 11.15 115.66 -170.338 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.98 18.39 4.5 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 106.426 -2.669 . . . . 13.93 106.426 179.67 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -124.21 130.42 52.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.236 2.214 . . . . 23.920000000000002 110.301 -173.636 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -91.3 125.72 36.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.342 -2.096 . . . . 23.23 105.342 -169.977 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.413 HD23 ' CD2' ' A' ' 59' ' ' TYR . 92.9 mt -86.28 148.5 25.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.095 0.958 . . . . 9.1099999999999994 112.275 -179.296 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -123.42 148.76 45.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.182 -2.824 . . . . 33.439999999999998 116.87 -171.171 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -19.15 -76.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 133.491 4.716 . . . . 28.370000000000001 121.387 178.691 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.49 16.22 61.19 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 117.458 1.743 . . . . 15.0 117.458 -168.474 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 22' ' ' THR . 19.7 mtt180 -99.11 160.99 13.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.955 -2.497 . . . . 25.5 110.32 167.351 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -103.76 168.26 9.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 104.792 -2.299 . . . . 11.949999999999999 104.792 -178.829 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -55.88 -36.59 67.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.617 -2.083 . . . . 10.17 115.994 167.768 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 t -61.63 -43.69 98.38 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.123 -2.861 . . . . 13.59 117.114 167.35 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -64.64 -26.64 68.48 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.095 1.887 . . . . 11.699999999999999 116.095 -177.182 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.413 ' CD2' HD23 ' A' ' 50' ' ' LEU . 66.9 m-85 -83.94 -32.34 25.12 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 116.912 -3.618 . . . . 12.949999999999999 111.043 170.717 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.301 26.2 m120 96.25 51.83 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.98 2.112 . . . . 25.449999999999999 114.379 -175.271 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.78 125.63 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 125.067 1.48 . . . . 14.6 113.96 177.837 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -110.03 177.27 4.76 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.972 1.841 . . . . 33.229999999999997 115.972 -176.957 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -60.41 145.75 46.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 124.404 3.275 . . . . 25.969999999999999 119.066 -174.54 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 67.74 32.19 5.52 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 132.129 4.171 . . . . 32.609999999999999 111.466 178.558 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 3' ' ' ILE . 22.7 t -89.35 151.7 21.93 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.685 -3.134 . . . . 10.56 110.145 -174.95 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -92.2 120.81 33.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.88 2.072 . . . . 5.3300000000000001 112.584 -172.32 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -117.77 159.99 22.11 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.222 2.915 . . . . 11.66 105.582 172.758 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -116.99 117.51 29.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.45 -3.281 . . . . 16.300000000000001 113.577 177.503 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -91.72 116.46 28.9 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.168 -1.583 . . . . 9.9600000000000009 111.191 174.487 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.6 m -112.27 134.15 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 127.819 2.448 . . . . 9.7599999999999998 106.193 178.551 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 124.309 2.004 . . . . 19.57 106.481 -175.783 . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 117.454 2.39 . . . . 17.170000000000002 117.454 . . . . . . . . . 0 0 . 1 . 071 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -90.36 133.49 34.95 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.07 -4.769 . . . . 21.890000000000001 106.708 -179.462 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.8 pt -118.04 164.89 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 104.456 -2.424 . . . . 10.83 104.456 163.369 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -119.29 127.29 53.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.885 -2.416 . . . . 10.609999999999999 105.038 -174.561 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.5 139.13 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.159 -2.534 . . . . 9.1300000000000008 104.159 176.202 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -125.23 133.63 52.64 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.325 -3.36 . . . . 20.550000000000001 116.029 178.742 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.2 p -77.98 171.79 14.47 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 127.128 3.347 . . . . 11.779999999999999 111.277 175.558 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -79.35 -24.05 42.98 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.514 -2.13 . . . . 19.309999999999999 110.95 -172.993 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -77.21 -69.16 0.55 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.902 1.334 . . . . 23.140000000000001 108.338 170.181 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.23 66.19 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 O-C-N 119.143 -2.223 . . . . 19.739999999999998 112.018 169.303 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -99.76 134.26 42.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.54 1.536 . . . . 21.93 114.041 155.686 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.7 m -80.06 119.91 23.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.357 -1.464 . . . . 12.33 113.124 164.597 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.49 95.67 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 128.519 2.727 . . . . 17.079999999999998 107.53 -171.844 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.0 m -89.82 99.23 12.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.206 -1.035 . . . . 16.300000000000001 108.206 -165.137 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.295 47.0 mt -104.49 149.12 25.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.602 -3.186 . . . . 15.880000000000001 110.653 -170.788 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -108.0 123.33 48.49 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 121.66 2.027 . . . . 28.899999999999999 113.664 173.356 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -135.27 162.53 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.582 -1.948 . . . . 12.050000000000001 107.262 -164.839 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -101.69 165.31 14.24 Favored Pre-proline 0 N--CA 1.429 -1.486 0 O-C-N 118.421 -2.674 . . . . 18.170000000000002 108.334 165.299 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -64.06 -23.71 67.13 Favored 'Trans proline' 0 C--N 1.3 -2.012 2 C-N-CA 125.721 4.281 . . . . 8.1600000000000001 112.597 174.053 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 m -87.68 3.15 48.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.987 -1.695 . . . . 11.130000000000001 109.907 -174.627 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -88.89 148.02 24.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.331 1.062 . . . . 18.030000000000001 109.286 -178.286 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 p -91.76 169.47 10.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.01 -1.904 . . . . 10.220000000000001 110.048 -175.828 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -46.65 -49.83 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.972 2.509 . . . . 12.300000000000001 114.46 160.513 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.301 23.8 tt0 -42.53 -43.21 3.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 117.03 2.233 . . . . 36.509999999999998 117.03 165.577 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -69.22 -30.32 68.46 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.402 1.91 . . . . 25.66 112.637 172.78 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.1 -56.2 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.568 -3.833 . . . . 8.1199999999999992 113.585 175.909 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -49.15 -46.13 44.75 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 130.439 3.496 . . . . 15.470000000000001 112.292 171.592 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.8 -36.95 76.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.339 -3.35 . . . . 11.449999999999999 114.828 -178.419 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -68.63 -33.8 74.64 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.986 1.476 . . . . 24.98 114.986 173.507 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.5 mt -70.39 -42.77 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.662 -4.399 . . . . 9.4600000000000009 111.167 175.528 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -55.75 -43.24 76.47 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.97 -1.706 . . . . 14.76 110.001 170.358 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.263 21.5 t70 -48.95 -67.31 0.28 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.075 3.35 . . . . 26.289999999999999 114.683 177.751 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -93.99 -46.66 7.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.061 2.986 . . . . 30.059999999999999 119.061 178.847 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.98 -33.08 70.08 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 116.283 -1.818 . . . . 25.190000000000001 111.294 -171.591 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.74 18.68 46.99 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 116.446 -2.308 . . . . 7.4100000000000001 115.213 -179.164 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.4 mt -99.71 121.38 54.69 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 119.737 1.768 . . . . 9.4900000000000002 108.879 175.158 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -68.36 157.07 63.38 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 122.982 2.455 . . . . 11.42 117.958 178.328 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.02 -28.53 10.97 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 122.417 2.078 . . . . 12.0 111.675 -170.083 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.64 -31.43 68.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 126.108 2.13 . . . . 35.549999999999997 110.427 173.41 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -72.64 -15.95 61.71 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.363 -2.711 . . . . 20.52 115.413 -175.488 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -118.15 161.08 20.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.695 2.497 . . . . 7.1299999999999999 112.563 -168.999 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -138.09 133.66 33.74 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.772 -1.566 . . . . 36.390000000000001 106.772 164.223 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.29 129.72 43.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.932 -2.355 . . . . 9.5500000000000007 107.306 178.666 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.7 mm -116.04 133.58 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.366 -1.459 . . . . 13.9 109.898 -178.579 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -114.26 115.31 27.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.088 -3.508 . . . . 6.8600000000000003 108.143 165.032 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.25 -83.46 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.273 2.323 . . . . 11.15 117.273 -176.385 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.25 -36.7 5.6 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 116.981 -3.574 . . . . 13.93 111.444 -178.328 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -105.42 148.49 27.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.62 1.341 . . . . 23.920000000000002 114.62 -162.599 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -92.95 131.15 38.21 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.126 -4.734 . . . . 23.23 108.592 173.403 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.9 mt -74.25 143.3 45.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.531 1.678 . . . . 9.1099999999999994 115.531 -176.584 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.56 133.49 55.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.231 -1.543 . . . . 33.439999999999998 108.043 -168.739 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -30.72 -53.58 0.19 Allowed 'General case' 0 N--CA 1.429 -1.476 1 N-CA-C 124.261 4.912 . . . . 28.370000000000001 124.261 -173.014 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.98 17.41 44.94 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 121.305 1.866 . . . . 15.0 116.23 -160.443 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -115.71 145.15 43.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.869 -2.491 . . . . 25.5 113.449 -173.341 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.352 5.8 p -82.5 165.91 19.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 122.486 2.403 . . . . 11.949999999999999 114.354 -171.855 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.6 mt -78.14 -22.11 49.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.158 -2.214 . . . . 10.17 112.69 177.947 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.267 3.7 t -70.31 -37.84 74.83 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 127.937 3.732 . . . . 13.59 114.983 175.32 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -55.97 -43.78 77.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.891 2.876 . . . . 11.699999999999999 111.205 164.605 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -86.62 -3.22 59.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.484 1.661 . . . . 12.949999999999999 115.484 -176.736 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 m120 54.96 51.61 13.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.529 2.732 . . . . 25.449999999999999 112.12 -178.298 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.6 mt -103.28 116.6 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 116.92 -3.612 . . . . 14.6 106.566 173.223 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -94.44 -160.32 0.77 Allowed 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.581 -2.574 . . . . 33.229999999999997 109.214 178.944 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -83.11 161.61 21.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.12 -1.067 . . . . 25.969999999999999 108.12 -173.143 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.357 27.9 mt-10 55.42 28.65 11.89 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.752 2.421 . . . . 32.609999999999999 112.97 178.336 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.1 t -87.93 154.6 20.38 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.662 1.985 . . . . 10.56 113.191 172.27 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.306 1.3 m -121.45 90.34 3.3 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 125.481 1.738 . . . . 5.3300000000000001 113.603 -160.342 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -92.53 150.78 20.54 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.815 2.245 . . . . 11.66 107.604 176.65 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -116.67 139.31 50.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.001 2.81 . . . . 16.300000000000001 108.271 -176.964 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.25 113.87 27.32 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.301 -2.227 . . . . 9.9600000000000009 113.373 170.449 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 m -110.14 171.44 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 113.086 -1.87 . . . . 9.7599999999999998 106.443 175.194 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt . . . . . 0 N--CA 1.43 -1.433 0 O-C-N 119.393 -2.067 . . . . 19.57 112.431 172.227 . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 105.93 -1.878 . . . . 17.170000000000002 105.93 . . . . . . . . . 0 0 . 1 . 072 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -108.46 158.8 17.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.041 -2.577 . . . . 21.890000000000001 104.041 168.088 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -125.78 172.04 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.097 2.959 . . . . 10.83 105.511 171.585 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -123.9 146.78 48.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.71 -1.869 . . . . 10.609999999999999 109.808 167.906 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.3 125.88 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.587 1.955 . . . . 9.1300000000000008 106.153 175.71 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -105.67 140.66 38.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.187 1.47 . . . . 20.550000000000001 107.326 177.51 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -81.89 -164.07 0.75 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.034 2.35 . . . . 11.779999999999999 112.429 172.364 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.3 tp -82.93 -48.47 10.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.364 -3.335 . . . . 19.309999999999999 114.613 177.121 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.7 p -65.86 -40.94 92.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.325 -1.484 . . . . 23.140000000000001 113.288 171.033 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.07 62.57 0.26 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 117.768 1.867 . . . . 19.739999999999998 117.768 175.41 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -112.48 145.97 39.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.096 -1.816 . . . . 21.93 106.096 167.495 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.2 m -112.73 106.62 15.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 101.908 -3.367 . . . . 12.33 101.908 -166.315 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.8 mt -92.1 117.62 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 101.186 -3.635 . . . . 17.079999999999998 101.186 -172.317 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.9 m -94.05 130.11 40.33 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 116.795 -1.962 . . . . 16.300000000000001 109.976 174.628 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -129.9 142.63 50.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 124.649 1.218 . . . . 15.880000000000001 111.058 178.301 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -97.1 128.25 43.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.4 -2.687 . . . . 28.899999999999999 114.811 179.673 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.263 6.9 m -149.22 176.85 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.123 -1.611 . . . . 12.050000000000001 111.424 -174.068 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -110.74 179.64 0.78 Allowed Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.845 1.202 . . . . 18.170000000000002 111.663 168.123 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -71.2 -22.56 25.55 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-N 123.274 2.205 . . . . 8.1600000000000001 109.019 173.886 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 m -95.36 1.75 54.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.04 1.4 . . . . 11.130000000000001 110.534 -165.052 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.19 139.6 31.55 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.227 -4.671 . . . . 18.030000000000001 108.705 -176.419 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 p -76.4 166.58 23.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.129 1.159 . . . . 10.220000000000001 114.129 173.021 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.1 mm -70.5 -18.86 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 119.345 -0.942 . . . . 12.300000000000001 108.785 -179.127 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -69.54 -31.16 69.19 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.39 -2.694 . . . . 36.509999999999998 115.245 172.635 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -66.1 -42.13 89.7 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.788 2.835 . . . . 25.66 109.461 167.676 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.63 -51.2 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 125.546 1.779 . . . . 8.1199999999999992 110.835 176.237 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.63 -19.97 64.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.789 1.774 . . . . 15.470000000000001 115.789 -174.697 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.78 -27.54 66.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.48 1.912 . . . . 11.449999999999999 114.764 172.488 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -93.4 -20.52 20.26 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.321 -1.733 . . . . 24.98 106.321 -176.269 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.3 mt -75.12 -44.43 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 119.927 -1.733 . . . . 9.4600000000000009 113.557 167.307 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -56.91 -30.6 64.1 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.253 -2.78 . . . . 14.76 114.428 167.31 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.4 -52.88 14.05 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.627 -4.421 . . . . 26.289999999999999 108.523 178.53 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -66.13 -59.76 3.46 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.519 2.415 . . . . 30.059999999999999 117.519 172.23 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -97.53 -11.97 23.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 119.142 3.016 . . . . 25.190000000000001 119.142 -169.215 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.87 27.05 65.45 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 118.198 -2.814 . . . . 7.4100000000000001 115.489 -176.442 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -103.23 109.38 61.55 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 108.207 -1.035 . . . . 9.4900000000000002 108.207 -174.613 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -76.73 166.79 26.52 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.669 1.989 . . . . 11.42 116.14 -167.253 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.02 -20.86 16.41 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 123.126 2.152 . . . . 12.0 114.77 -156.277 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -83.61 -17.49 41.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.817 3.198 . . . . 35.549999999999997 114.795 178.686 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.468 ' HG2' HD23 ' A' ' 71' ' ' LEU . 49.4 tt0 -79.1 -31.72 44.37 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.844 2.59 . . . . 20.52 105.39 -179.53 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -111.41 176.01 5.19 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.589 1.995 . . . . 7.1299999999999999 115.285 -170.426 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -131.8 146.09 51.94 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 113.02 -3.371 . . . . 36.390000000000001 109.649 169.887 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.1 mt -109.16 134.5 51.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.723 1.889 . . . . 9.5500000000000007 106.649 172.449 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mm -121.23 143.17 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.697 -2.705 . . . . 13.9 103.697 -169.576 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -130.31 100.79 5.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.491 2.716 . . . . 6.8600000000000003 113.519 163.748 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.52 -107.28 0.19 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.997 1.719 . . . . 11.15 110.768 -165.708 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.29 -20.96 10.38 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-O 115.958 -2.579 . . . . 13.93 111.042 177.044 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -77.54 122.1 24.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.31 3.433 . . . . 23.920000000000002 104.772 -170.293 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -89.02 138.22 31.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.629 -3.169 . . . . 23.23 107.004 178.605 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.7 mt -106.03 127.68 53.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.112 -3.492 . . . . 9.1099999999999994 112.673 -161.236 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -77.37 146.14 36.84 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.187 2.595 . . . . 33.439999999999998 105.74 -175.111 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -65.74 -45.51 82.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.302 -2.124 . . . . 28.370000000000001 112.684 -171.667 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.82 41.85 2.98 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 117.496 -1.724 . . . . 15.0 114.354 177.883 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -124.75 157.5 35.56 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 119.884 1.842 . . . . 25.5 108.584 168.315 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -91.16 164.16 14.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.028 -3.545 . . . . 11.949999999999999 117.085 -177.204 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.9 mt -54.36 -43.57 71.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.505 -1.68 . . . . 10.17 112.677 163.77 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -55.39 -42.29 73.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.286 -3.384 . . . . 13.59 118.271 167.596 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -56.97 -39.28 74.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.865 -1.772 . . . . 11.699999999999999 113.712 179.237 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -83.65 -13.58 53.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.599 1.333 . . . . 12.949999999999999 114.599 175.446 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.55 52.34 4.64 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.084 1.883 . . . . 25.449999999999999 116.084 -167.384 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.296 11.8 mt -87.64 123.78 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 102.276 -3.231 . . . . 14.6 102.276 176.733 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.273 23.1 mt-30 -100.92 179.76 4.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.621 -1.924 . . . . 33.229999999999997 114.709 179.427 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -64.3 147.17 53.09 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.585 -2.572 . . . . 25.969999999999999 110.691 -174.097 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 48.76 37.51 9.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.156 2.583 . . . . 32.609999999999999 116.883 179.899 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 t -108.19 151.36 26.03 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.487 1.915 . . . . 10.56 108.621 -169.366 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.324 41.1 p -102.23 115.52 30.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.642 -2.536 . . . . 5.3300000000000001 111.099 -165.587 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.51 149.52 21.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.419 3.088 . . . . 11.66 103.429 172.39 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -114.6 130.8 56.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.695 -1.253 . . . . 16.300000000000001 108.94 178.366 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tt -105.18 120.93 42.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.004 1.722 . . . . 9.9600000000000009 110.249 -178.437 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 147.53 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 101.74 -3.43 . . . . 9.7599999999999998 101.74 -177.212 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.468 HD23 ' HG2' ' A' ' 40' ' ' GLN . 16.5 mt . . . . . 0 N--CA 1.43 -1.432 0 CA-C-O 123.87 1.795 . . . . 19.57 109.101 177.892 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttp . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 124.829 2.252 . . . . 17.170000000000002 113.606 . . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -89.46 126.28 35.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 126.29 2.948 . . . . 21.890000000000001 111.897 178.834 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -128.31 147.22 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 116.83 -3.669 . . . . 10.83 109.199 176.364 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.419 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 53.0 m-85 -100.79 137.86 38.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.34 3.856 . . . . 10.609999999999999 105.87 175.669 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.45 110.46 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 117.076 -1.44 . . . . 9.1300000000000008 111.106 170.743 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -93.61 143.22 26.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 116.813 -1.565 . . . . 20.550000000000001 111.122 -176.167 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.6 p -96.53 174.16 6.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.807 1.64 . . . . 11.779999999999999 107.1 -175.488 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.84 -51.3 70.32 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.744 -2.472 . . . . 19.309999999999999 114.617 177.582 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.1 p -67.32 -40.25 85.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.584 1.953 . . . . 23.140000000000001 115.841 172.351 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.15 59.89 0.3 Allowed Glycine 0 N--CA 1.43 -1.748 0 O-C-N 127.309 2.88 . . . . 19.739999999999998 114.315 151.449 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -95.17 126.27 40.38 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 115.625 -2.131 . . . . 21.93 108.638 163.667 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.7 m -95.8 113.22 24.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 116.916 -1.914 . . . . 12.33 107.025 179.271 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.1 pt -91.59 141.29 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.997 1.719 . . . . 17.079999999999998 107.374 178.276 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.1 m -107.3 124.97 50.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.749 -1.22 . . . . 16.300000000000001 111.529 178.821 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.25 141.87 51.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.725 -2.484 . . . . 15.880000000000001 106.445 177.876 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -108.47 107.76 18.42 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.885 2.474 . . . . 28.899999999999999 107.172 179.246 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.87 -177.52 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.733 -2.321 . . . . 12.050000000000001 104.733 -173.006 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -104.96 159.2 30.15 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 129.759 3.224 . . . . 18.170000000000002 108.475 170.49 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -81.04 -10.11 12.71 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 123.409 2.74 . . . . 8.1600000000000001 110.989 -172.051 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -94.68 2.2 55.57 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.227 2.829 . . . . 11.130000000000001 111.965 175.685 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -75.83 161.61 28.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 123.749 2.977 . . . . 18.030000000000001 111.945 178.415 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.6 p -87.31 164.64 16.16 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.398 -2.689 . . . . 10.220000000000001 116.633 179.479 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.15 -39.6 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 120.194 1.361 . . . . 12.300000000000001 109.005 174.473 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -53.43 -45.08 69.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.429 -2.045 . . . . 36.509999999999998 111.684 174.304 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -58.31 -42.64 87.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.863 2.542 . . . . 25.66 117.863 170.489 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 30' ' ' ILE . 21.4 t -56.8 -54.22 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.301 -2.75 . . . . 8.1199999999999992 109.011 171.434 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 30' ' ' ILE . 34.7 mtmt -58.87 -28.18 65.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 116.768 -3.707 . . . . 15.470000000000001 118.449 -177.153 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.16 94.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.498 2.719 . . . . 11.449999999999999 113.471 168.211 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -71.43 -39.34 71.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.526 -2.609 . . . . 24.98 111.661 -178.663 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 27' ' ' LYS . 21.3 mt -60.52 -36.87 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.228 2.611 . . . . 9.4600000000000009 109.1 173.771 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -66.85 -52.08 47.84 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.923 1.344 . . . . 14.76 113.432 175.882 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -50.53 -45.31 56.69 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.932 -2.98 . . . . 26.289999999999999 115.889 170.177 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -79.95 -51.61 8.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.777 -3.077 . . . . 30.059999999999999 115.404 -165.891 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -102.02 -30.9 10.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.428 1.091 . . . . 25.190000000000001 110.673 -175.107 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.55 34.08 5.92 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 127.977 2.703 . . . . 7.4100000000000001 110.182 164.805 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.0 mt -91.64 125.15 58.59 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 127.194 2.197 . . . . 9.4900000000000002 106.021 -174.809 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.65 171.57 4.43 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 126.233 3.262 . . . . 11.42 115.511 -179.234 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -76.41 -27.17 8.04 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 124.209 3.273 . . . . 12.0 114.059 -173.678 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -81.6 -20.32 40.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.951 -3.593 . . . . 35.549999999999997 114.618 -173.504 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -86.0 -45.93 11.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.505 1.922 . . . . 20.52 110.613 179.913 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -51.23 113.32 0.91 Allowed 'General case' 0 N--CA 1.43 -1.452 1 N-CA-C 123.674 4.694 . . . . 7.1299999999999999 123.674 163.153 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -117.0 119.58 35.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.562 -2.586 . . . . 36.390000000000001 109.198 157.494 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.38 128.34 39.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.196 -2.275 . . . . 9.5500000000000007 109.565 -177.441 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.29 23.8 mm -118.58 148.99 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.942 2.897 . . . . 13.9 105.637 -177.684 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.19 -83.58 0.16 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.1 0.864 . . . . 6.8600000000000003 112.459 177.252 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.93 -71.16 0.7 Allowed 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 106.651 -1.611 . . . . 11.15 106.651 166.668 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.2 -4.52 5.45 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 119.983 2.753 . . . . 13.93 119.983 172.652 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -101.69 160.18 14.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 112.485 -1.858 . . . . 23.920000000000002 115.435 171.918 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -87.66 170.77 10.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.828 -2.42 . . . . 23.23 115.999 -171.269 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.3 mt -131.23 105.81 7.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.995 1.379 . . . . 9.1099999999999994 108.683 176.086 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -72.76 140.51 47.81 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 121.711 3.967 . . . . 33.439999999999998 121.711 166.153 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -36.93 -66.3 0.24 Allowed 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 135.199 5.4 . . . . 28.370000000000001 119.958 -170.462 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.88 13.25 9.08 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 129.841 3.591 . . . . 15.0 116.857 -165.458 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -117.61 141.95 47.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.33 1.452 . . . . 25.5 111.989 -168.064 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.0 p -87.22 161.51 17.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.643 2.639 . . . . 11.949999999999999 111.03 -179.937 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 mt -49.09 -50.52 36.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.923 3.289 . . . . 10.17 113.565 176.126 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 t -50.58 -48.71 57.55 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 129.544 4.277 . . . . 13.59 115.585 172.416 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -61.06 -38.56 86.63 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.514 1.926 . . . . 11.699999999999999 112.219 177.276 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -85.8 -2.04 57.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.92 2.563 . . . . 12.949999999999999 117.92 171.483 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m120 65.82 48.47 1.86 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 127.278 2.861 . . . . 25.449999999999999 113.055 176.31 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.4 mt -94.57 108.0 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.942 3.297 . . . . 14.6 103.555 177.133 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -101.6 176.88 5.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.069 2.366 . . . . 33.229999999999997 110.871 177.568 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -60.61 146.18 46.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.713 -3.117 . . . . 25.969999999999999 117.124 -173.18 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.306 35.5 mt-10 71.94 -1.26 2.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 127.025 2.703 . . . . 32.609999999999999 117.25 174.09 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.316 56.0 m -48.39 138.56 9.95 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.37 2.668 . . . . 10.56 116.833 162.549 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 24.4 m -103.13 124.96 49.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.124 -1.61 . . . . 5.3300000000000001 111.007 167.253 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.73 169.28 8.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.858 -2.645 . . . . 11.66 103.858 -177.955 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -139.37 132.44 29.58 Favored 'General case' 0 N--CA 1.43 -1.444 1 CA-C-O 130.053 4.74 . . . . 16.300000000000001 113.324 -169.868 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.8 tp -115.81 107.74 15.43 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.387 -2.696 . . . . 9.9600000000000009 107.385 -168.187 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.6 172.09 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 2 C-N-CA 132.415 4.286 . . . . 9.7599999999999998 112.012 -171.011 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 N--CA 1.429 -1.481 0 CA-C-O 123.016 1.388 . . . . 19.57 112.463 -178.73 . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.42 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 3.5 ptt? . . . . . 0 CA--C 1.49 -1.346 0 CA-C-O 125.05 2.357 . . . . 17.170000000000002 110.327 . . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -92.13 150.84 20.71 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.566 -2.753 . . . . 21.890000000000001 103.566 -177.821 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -127.37 155.32 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.797 1.239 . . . . 10.83 109.848 159.736 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -105.82 158.05 17.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.649 -1.282 . . . . 10.609999999999999 109.174 174.649 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -148.32 120.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 N-CA-C 99.302 -4.333 . . . . 9.1300000000000008 99.302 -178.213 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -108.82 121.78 45.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.41 2.284 . . . . 20.550000000000001 116.978 -178.512 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -73.21 -178.41 2.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.222 1.963 . . . . 11.779999999999999 113.68 -169.074 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.257 15.1 tp -51.88 -57.04 10.54 Favored 'General case' 0 N--CA 1.431 -1.401 1 C-N-CA 134.109 4.964 . . . . 19.309999999999999 108.942 178.356 . . . . . . . . 3 2 . 1 . 074 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -73.28 -54.11 9.19 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.44 -4.537 . . . . 23.140000000000001 112.444 175.595 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.11 45.61 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 114.245 -3.531 . . . . 19.739999999999998 113.104 177.983 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -96.01 100.54 12.2 Favored 'General case' 0 N--CA 1.43 -1.472 2 C-N-CA 132.072 4.149 . . . . 21.93 103.536 178.097 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -82.87 102.21 11.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.7 2.0 . . . . 12.33 106.186 -177.975 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.255 3.5 pt -90.28 170.09 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 128.492 2.717 . . . . 17.079999999999998 106.327 178.584 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 m -121.53 149.91 42.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.085 3.354 . . . . 16.300000000000001 105.981 177.061 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.7 mt -143.38 145.09 32.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.013 -2.304 . . . . 15.880000000000001 105.18 171.954 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -106.11 104.84 14.64 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.142 1.925 . . . . 28.899999999999999 111.723 -177.936 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.251 20.9 m -120.38 128.67 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.171 -1.58 . . . . 12.050000000000001 114.57 -162.041 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -88.62 134.93 33.07 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 104.515 -2.402 . . . . 18.170000000000002 104.515 171.89 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.87 -0.52 10.01 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 120.864 1.344 . . . . 8.1600000000000001 114.241 -171.087 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 m -70.07 -26.36 63.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.252 3.056 . . . . 11.130000000000001 119.252 169.308 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -81.79 176.36 9.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.761 1.393 . . . . 18.030000000000001 114.761 179.347 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -76.38 157.14 32.63 Favored 'General case' 0 N--CA 1.43 -1.455 1 N-CA-C 123.324 4.564 . . . . 10.220000000000001 123.324 173.371 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -73.66 -28.08 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 117.746 -3.096 . . . . 12.300000000000001 113.307 173.614 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -52.08 -36.48 50.83 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 116.742 -3.724 . . . . 36.509999999999998 113.551 163.583 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -80.02 -22.08 42.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.803 1.641 . . . . 25.66 115.17 -177.811 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.47 -49.78 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 119.96 3.319 . . . . 8.1199999999999992 119.96 153.673 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.251 55.9 mtmt -70.98 -30.37 66.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.299 1.039 . . . . 15.470000000000001 113.199 -175.773 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.81 78.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.117 -1.615 . . . . 11.449999999999999 112.296 175.796 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 35.3 tptt -77.69 -21.52 51.9 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.548 1.139 . . . . 24.98 112.423 -175.766 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.7 mt -74.06 -40.75 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 128.061 2.545 . . . . 9.4600000000000009 109.013 170.389 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -65.86 -32.72 74.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.188 1.555 . . . . 14.76 111.999 177.71 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.35 -58.16 4.05 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.19 -2.194 . . . . 26.289999999999999 112.28 172.59 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -57.72 -60.82 3.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 119.883 3.29 . . . . 30.059999999999999 119.883 -177.975 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -101.8 -48.34 4.31 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.575 3.15 . . . . 25.190000000000001 108.311 -171.248 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.11 24.59 5.66 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 127.375 2.417 . . . . 7.4100000000000001 118.593 177.554 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.0 mt -92.04 103.94 9.44 Favored Pre-proline 0 N--CA 1.43 -1.453 1 CA-C-O 111.516 -4.088 . . . . 9.4900000000000002 108.476 -170.711 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.51 154.16 72.27 Favored 'Trans proline' 0 N--CA 1.434 -2.002 1 CA-C-N 130.542 4.801 . . . . 11.42 116.481 -168.31 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.32 -19.88 60.11 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 N-CA-C 119.048 2.672 . . . . 12.0 119.048 -174.344 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.35 -21.03 53.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 122.221 2.282 . . . . 35.549999999999997 115.106 173.04 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -83.27 -13.01 56.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.379 1.992 . . . . 20.52 116.379 168.865 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 75.6 mt-30 -96.17 119.15 34.14 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.199 -4.063 . . . . 7.1299999999999999 111.225 -173.638 . . . . . . . . 3 2 . 1 . 074 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -90.95 116.86 29.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 101.639 -3.467 . . . . 36.390000000000001 101.639 164.584 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 tp -105.58 113.91 27.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.623 2.011 . . . . 9.5500000000000007 110.946 -179.799 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -116.2 152.54 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 125.572 2.606 . . . . 13.9 104.625 -164.748 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -82.41 -80.49 0.16 Allowed 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.199 -4.063 . . . . 6.8600000000000003 112.789 162.871 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.3 -72.71 0.7 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.193 2.197 . . . . 11.15 109.001 172.105 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.97 -27.32 4.91 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 125.951 2.973 . . . . 13.93 117.144 174.085 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -106.64 150.83 25.82 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.366 -2.255 . . . . 23.920000000000002 109.786 -165.76 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -102.19 144.77 30.31 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.018 -2.926 . . . . 23.23 106.629 -170.197 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.1 mt -77.84 145.65 36.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.462 -2.608 . . . . 9.1099999999999994 111.19 179.764 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.55 151.59 27.41 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.105 1.362 . . . . 33.439999999999998 110.211 -175.256 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.36 -59.51 4.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.541 2.736 . . . . 28.370000000000001 112.24 -161.422 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.08 33.12 5.8 Favored Glycine 0 N--CA 1.43 -1.741 0 O-C-N 116.635 -3.791 . . . . 15.0 116.442 -168.912 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -121.76 160.47 24.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.518 -1.66 . . . . 25.5 106.518 174.363 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.4 p -104.56 173.47 6.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.95 2.786 . . . . 11.949999999999999 117.194 -174.32 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.6 -25.56 41.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.073 -2.267 . . . . 10.17 114.046 -177.926 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.7 m -59.58 -59.14 5.91 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.661 1.696 . . . . 13.59 110.789 168.523 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -67.0 -32.56 73.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.347 -2.096 . . . . 11.699999999999999 114.494 -173.186 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -69.43 -19.36 63.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.257 1.823 . . . . 12.949999999999999 113.019 171.902 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.299 42.5 m-80 58.98 50.36 8.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.514 1.926 . . . . 25.449999999999999 114.962 -173.232 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 mt -95.43 125.76 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.296 -1.372 . . . . 14.6 107.296 174.516 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -85.48 174.0 9.82 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.481 -3.887 . . . . 33.229999999999997 109.998 177.393 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 34.9 pttt -72.53 152.5 41.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 125.125 2.393 . . . . 25.969999999999999 113.881 174.016 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.52 41.48 30.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.664 3.586 . . . . 32.609999999999999 111.232 -171.564 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.5 t -107.73 142.05 38.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 127.22 3.39 . . . . 10.56 103.048 -179.062 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.9 m -98.94 123.56 43.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 110.632 -2.985 . . . . 5.3300000000000001 114.175 -179.119 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.6 mt -95.9 144.12 26.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.041 2.829 . . . . 11.66 108.045 174.838 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -111.14 124.89 53.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.414 -2.679 . . . . 16.300000000000001 114.449 -169.44 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.9 mt -100.78 126.86 47.38 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.123 1.44 . . . . 9.9600000000000009 110.441 -179.584 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.04 177.82 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.411 -1.329 . . . . 9.7599999999999998 107.411 162.539 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp . . . . . 0 N--CA 1.43 -1.44 0 O-C-N 119.463 -2.023 . . . . 19.57 106.827 175.123 . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.329 4.1 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 122.438 1.113 . . . . 17.170000000000002 109.809 . . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -113.83 145.32 41.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.283 1.516 . . . . 21.890000000000001 107.237 177.684 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -123.75 -175.1 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 119.793 -1.817 . . . . 10.83 107.423 160.224 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.294 0.7 OUTLIER -129.59 140.21 51.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 127.013 2.695 . . . . 10.609999999999999 109.051 171.146 . . . . . . . . 3 3 . 1 . 075 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.58 137.52 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 1 O-C-N 114.382 -5.199 . . . . 9.1300000000000008 111.819 169.353 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -100.66 115.29 29.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 124.215 3.189 . . . . 20.550000000000001 109.783 162.352 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 p -67.41 -164.7 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 127.459 2.975 . . . . 11.779999999999999 116.692 -169.458 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.32 -56.54 17.45 Favored 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 131.922 4.089 . . . . 19.309999999999999 110.232 -179.487 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 p -76.35 -41.89 46.7 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.776 2.227 . . . . 23.140000000000001 111.601 -176.53 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.28 72.78 0.39 Allowed Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 127.405 2.431 . . . . 19.739999999999998 114.417 -174.419 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.33 80.1 tttt -135.34 124.4 24.31 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.421 1.088 . . . . 21.93 108.107 170.785 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -88.11 118.12 27.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.95 -2.968 . . . . 12.33 112.125 -179.21 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.5 pt -111.69 148.02 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 O-C-N 115.788 -4.32 . . . . 17.079999999999998 109.53 -173.829 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -98.21 137.55 36.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.839 -1.541 . . . . 16.300000000000001 106.839 -177.363 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -124.57 159.01 31.61 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.476 2.31 . . . . 15.880000000000001 107.185 178.994 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -123.06 126.85 47.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.508 -2.034 . . . . 28.899999999999999 105.508 173.986 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.07 169.18 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.032 -2.581 . . . . 12.050000000000001 104.032 -174.269 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -109.16 156.95 38.38 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 125.338 1.455 . . . . 18.170000000000002 107.938 165.077 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.19 -16.03 31.77 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 116.711 -1.726 . . . . 8.1600000000000001 114.106 176.942 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -72.7 -15.54 61.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.437 -1.32 . . . . 11.130000000000001 107.437 179.586 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -76.83 141.27 40.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.354 -2.716 . . . . 18.030000000000001 115.466 -170.961 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -70.58 168.51 16.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 121.67 3.952 . . . . 10.220000000000001 121.67 170.685 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.37 5.7 mm -62.43 -40.45 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.444 -1.41 . . . . 12.300000000000001 111.816 174.173 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -51.02 -31.84 19.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.48 2.03 . . . . 36.509999999999998 116.48 168.051 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -81.81 -29.42 32.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.024 -1.048 . . . . 25.66 111.097 176.665 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.27 4.0 t -62.1 -54.1 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 124.754 1.221 . . . . 8.1199999999999992 109.529 174.613 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -56.38 -37.45 70.12 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.824 2.157 . . . . 15.470000000000001 116.824 176.565 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.72 81.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.83 2.159 . . . . 11.449999999999999 116.83 175.284 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -71.71 -29.01 64.08 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 117.076 2.25 . . . . 24.98 117.076 168.888 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.342 48.5 mt -73.11 -43.25 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.191 -1.781 . . . . 9.4600000000000009 106.191 172.734 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -67.77 -26.67 66.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.734 2.124 . . . . 14.76 116.734 178.72 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.99 -51.53 25.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.484 -1.689 . . . . 26.289999999999999 114.117 169.381 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -64.99 -66.08 0.59 Allowed 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 131.78 4.032 . . . . 30.059999999999999 115.64 -179.896 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -95.71 -25.97 15.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.515 1.672 . . . . 25.190000000000001 115.515 -172.872 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.07 -27.51 8.56 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 120.75 -1.219 . . . . 7.4100000000000001 115.385 -178.967 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.3 mt -52.38 125.59 35.48 Favored Pre-proline 0 N--CA 1.43 -1.451 1 C-N-CA 131.807 4.043 . . . . 9.4900000000000002 109.237 -172.512 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.65 164.33 24.3 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-O 115.324 -2.032 . . . . 11.42 115.18 -178.44 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -80.98 -16.98 9.7 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 126.245 3.266 . . . . 12.0 114.239 -177.219 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -86.3 -5.1 59.25 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.876 -2.39 . . . . 35.549999999999997 106.865 -175.259 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.62 -28.19 22.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.046 -2.284 . . . . 20.52 112.278 171.676 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -88.05 123.13 32.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.961 1.097 . . . . 7.1299999999999999 113.961 -165.182 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -114.92 117.19 29.97 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.045 2.138 . . . . 36.390000000000001 115.365 160.86 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.17 112.89 24.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.565 1.65 . . . . 9.5500000000000007 109.31 -169.079 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -100.43 143.85 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 O-C-N 115.828 -4.295 . . . . 13.9 107.297 175.841 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -81.06 -92.07 0.06 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.106 1.763 . . . . 6.8600000000000003 112.35 169.848 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.28 -48.97 3.85 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 121.199 1.818 . . . . 11.15 109.51 162.017 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.9 9.12 0.73 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 119.792 -1.818 . . . . 13.93 115.607 -177.419 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -112.17 134.89 53.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.806 -1.924 . . . . 23.920000000000002 105.806 175.613 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -74.49 148.32 41.1 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.815 -1.803 . . . . 23.23 112.125 168.765 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 mt -91.83 127.0 37.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.016 -2.303 . . . . 9.1099999999999994 105.865 -177.486 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -79.46 131.89 36.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.412 1.885 . . . . 33.439999999999998 113.734 177.878 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -51.7 -51.91 52.39 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.343 2.257 . . . . 28.370000000000001 111.77 -162.189 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.94 9.56 59.82 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 119.741 -1.849 . . . . 15.0 116.927 -174.862 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -101.57 158.62 15.95 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.453 -3.969 . . . . 25.5 112.545 177.334 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -84.15 158.1 21.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.365 1.866 . . . . 11.949999999999999 112.402 -178.09 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -62.41 -32.14 72.94 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.676 -4.39 . . . . 10.17 111.294 164.749 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -57.86 -45.72 85.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.592 2.357 . . . . 13.59 116.648 174.252 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.98 -35.56 76.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.81 -1.541 . . . . 11.699999999999999 114.447 -178.444 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -79.79 2.9 21.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.263 -1.523 . . . . 12.949999999999999 111.839 169.698 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.7 t30 40.79 40.93 1.06 Allowed 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.582 2.353 . . . . 25.449999999999999 116.006 -168.761 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.8 mt -74.74 126.08 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 104.324 -2.473 . . . . 14.6 104.324 175.452 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -115.21 165.75 12.59 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 132.636 4.374 . . . . 33.229999999999997 114.191 179.881 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.345 45.8 pttt -55.25 157.67 3.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.498 3.519 . . . . 25.969999999999999 115.213 -172.829 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 75.01 0.22 3.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.98 2.112 . . . . 32.609999999999999 113.977 168.63 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t -91.61 157.44 16.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.72 -2.488 . . . . 10.56 110.771 -173.287 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -99.55 116.83 32.59 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 127.043 2.715 . . . . 5.3300000000000001 109.416 178.459 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.7 mt -99.98 152.61 19.99 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.073 1.749 . . . . 11.66 107.817 174.297 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -116.03 142.68 46.48 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.614 -1.624 . . . . 16.300000000000001 106.614 -166.659 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tp -111.41 112.16 23.72 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 115.832 -4.293 . . . . 9.9600000000000009 111.383 -175.541 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.86 139.03 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.67 -2.345 . . . . 9.7599999999999998 104.67 -173.701 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 tp . . . . . 0 N--CA 1.43 -1.433 0 O-C-N 118.558 -2.589 . . . . 19.57 114.217 177.53 . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 109.464 -0.569 . . . . 17.170000000000002 109.464 . . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -75.43 126.4 30.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.709 -1.244 . . . . 21.890000000000001 112.736 -179.06 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -107.73 141.27 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 125.277 2.465 . . . . 10.83 104.902 151.552 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -101.06 144.48 29.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.876 -2.39 . . . . 10.609999999999999 107.007 165.665 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.287 58.1 t -106.54 124.0 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 116.735 -1.602 . . . . 9.1300000000000008 111.772 169.484 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -102.41 113.92 27.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 119.701 1.137 . . . . 20.550000000000001 111.825 -178.181 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.374 3.1 p -63.5 -174.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.135 2.642 . . . . 11.779999999999999 118.135 176.509 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.4 mt -81.54 -60.28 2.32 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.236 -2.79 . . . . 19.309999999999999 110.819 175.944 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.297 62.2 p -71.89 -64.45 0.93 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 116.062 -1.923 . . . . 23.140000000000001 114.566 -174.188 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.18 54.72 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.765 1 CA-C-N 126.13 4.059 . . . . 19.739999999999998 114.639 -175.584 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -135.49 138.46 43.15 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 128.057 2.857 . . . . 21.93 107.847 -176.192 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.288 72.9 m -139.79 107.58 5.66 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.225 -2.139 . . . . 12.33 105.225 -179.874 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 pt -112.36 161.06 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 124.254 1.978 . . . . 17.079999999999998 108.345 -166.692 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 m -117.38 126.78 53.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.726 -1.859 . . . . 16.300000000000001 111.885 -174.54 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -111.06 163.11 14.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.988 -1.07 . . . . 15.880000000000001 110.992 172.543 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -116.4 110.15 18.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.859 -2.275 . . . . 28.899999999999999 104.859 179.395 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.46 154.08 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.047 -2.283 . . . . 12.050000000000001 113.437 -176.833 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -97.34 153.08 38.53 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 114.862 -2.494 . . . . 18.170000000000002 113.973 167.142 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -59.96 -22.04 67.26 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-N 125.728 3.081 . . . . 8.1600000000000001 116.856 -179.834 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -76.72 -9.04 58.39 Favored 'General case' 0 N--CA 1.43 -1.457 1 C-N-CA 132.073 4.149 . . . . 11.130000000000001 116.875 170.758 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.72 127.5 33.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.77 -3.706 . . . . 18.030000000000001 114.971 175.583 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.291 45.1 p -68.53 159.09 32.51 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.257 2.623 . . . . 10.220000000000001 112.719 179.045 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.259 45.2 mm -57.25 -35.33 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.27 1.828 . . . . 12.300000000000001 112.461 168.021 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -60.79 -52.9 63.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.206 1.821 . . . . 36.509999999999998 115.337 173.46 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.271 33.0 m-80 -60.65 -36.05 77.72 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 115.34 -2.267 . . . . 25.66 113.328 174.497 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.421 50.1 t -46.81 -48.02 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 131.262 3.825 . . . . 8.1199999999999992 113.905 167.781 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -76.01 -20.72 57.59 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.79 -1.55 . . . . 15.470000000000001 110.868 -169.887 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.77 -28.75 55.82 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 112.631 0.604 . . . . 11.449999999999999 112.631 174.293 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -70.03 -32.45 70.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.471 0.915 . . . . 24.98 113.471 173.181 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -69.95 -35.0 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 123.936 1.827 . . . . 9.4600000000000009 109.594 172.33 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -69.63 -29.11 66.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.878 -2.389 . . . . 14.76 113.508 174.205 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.5 -54.3 21.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.289 -2.132 . . . . 26.289999999999999 112.604 168.575 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -64.38 -63.35 1.16 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 117.229 -1.367 . . . . 30.059999999999999 109.599 -175.955 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.74 -48.53 7.79 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.298 2.333 . . . . 25.190000000000001 117.298 177.916 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.46 52.02 1.63 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 117.474 -3.266 . . . . 7.4100000000000001 115.585 -171.915 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.0 mt -113.99 127.72 26.53 Favored Pre-proline 0 N--CA 1.43 -1.44 1 N-CA-C 99.132 -4.396 . . . . 9.4900000000000002 99.132 -169.399 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -72.7 157.86 51.47 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 O-C-N 117.053 -2.13 . . . . 11.42 109.075 -170.335 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -77.38 -29.1 5.07 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 C-N-CA 125.027 3.818 . . . . 12.0 111.639 -153.001 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.16 -26.79 42.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 130.579 3.552 . . . . 35.549999999999997 108.3 175.367 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -80.19 -26.99 38.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.477 -3.89 . . . . 20.52 111.596 -176.078 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -71.48 138.55 49.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.386 2.041 . . . . 7.1299999999999999 110.314 174.685 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -142.16 137.42 30.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.881 -2.387 . . . . 36.390000000000001 110.676 161.519 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -104.34 135.19 46.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.434 2.54 . . . . 9.5500000000000007 111.933 178.654 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mm -111.25 138.92 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.408 -1.724 . . . . 13.9 110.957 163.823 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.31 5.6 t80 -70.09 -87.82 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.892 1.677 . . . . 6.8600000000000003 109.742 167.762 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.23 -62.94 1.41 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 121.179 -0.951 . . . . 11.15 108.867 165.873 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.86 -24.87 2.21 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.033 1.778 . . . . 13.93 110.333 177.311 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.269 0.1 OUTLIER -74.36 123.52 24.78 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.147 -1.427 . . . . 23.920000000000002 107.147 -178.047 . . . . . . . . 3 3 . 1 . 076 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.269 16.2 pt20 -70.39 122.09 18.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.786 2.554 . . . . 23.23 111.137 164.292 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.3 mt -95.37 150.45 20.26 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 118.343 -2.723 . . . . 9.1099999999999994 111.282 -171.354 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -120.14 141.37 49.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.801 3.191 . . . . 33.439999999999998 116.019 -169.263 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.01 -52.97 56.71 Favored 'General case' 0 N--CA 1.43 -1.451 2 O-C-N 115.653 -4.404 . . . . 28.370000000000001 112.943 -156.988 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.88 29.59 7.85 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 124.216 3.189 . . . . 15.0 115.034 -169.862 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 -114.88 147.3 40.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.2 2.2 . . . . 25.5 109.332 177.359 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 p -94.19 173.04 7.84 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 129.584 3.154 . . . . 11.949999999999999 112.229 179.37 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.5 mt -86.28 -18.17 32.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 104.498 -2.408 . . . . 10.17 104.498 -173.259 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.18 -41.47 77.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.397 -2.064 . . . . 13.59 110.137 168.617 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.71 -41.43 92.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.95 2.1 . . . . 11.699999999999999 112.676 -177.585 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -78.44 -28.72 46.73 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 115.575 -2.45 . . . . 12.949999999999999 116.563 173.142 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.288 29.8 t30 74.5 56.36 0.08 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.63 3.172 . . . . 25.449999999999999 112.544 -168.242 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.405 HD13 HD21 ' A' ' 67' ' ' LEU . 31.4 mt -99.9 101.94 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 104.435 -2.432 . . . . 14.6 104.435 170.898 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -100.35 -156.28 0.55 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.522 2.329 . . . . 33.229999999999997 108.084 -172.113 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -61.41 157.6 16.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.905 -3.622 . . . . 25.969999999999999 119.336 174.799 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 71.78 15.98 5.73 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.016 -1.053 . . . . 32.609999999999999 112.603 163.623 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -101.22 142.78 32.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.742 2.526 . . . . 10.56 108.371 -156.999 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.3 m -111.58 129.26 56.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.8 -3.687 . . . . 5.3300000000000001 107.09 -178.3 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.405 HD21 HD13 ' A' ' 61' ' ' ILE . 66.8 mt -103.61 164.09 11.89 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.31 -1.366 . . . . 11.66 107.31 168.715 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -122.13 124.16 43.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.729 2.412 . . . . 16.300000000000001 110.966 -177.936 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.1 tp -106.01 110.78 23.16 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.598 -1.939 . . . . 9.9600000000000009 109.379 -172.032 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 m -114.53 174.38 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 117.966 -2.959 . . . . 9.7599999999999998 107.207 -174.743 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 123.621 1.677 . . . . 19.57 111.007 168.151 . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 ttp . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 115.505 1.669 . . . . 17.170000000000002 115.505 . . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -93.47 133.33 36.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.057 2.208 . . . . 21.890000000000001 107.923 -175.522 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.85 150.83 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.655 -2.528 . . . . 10.83 111.106 175.126 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.447 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 21.2 m-85 -112.31 100.68 8.99 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.61 2.364 . . . . 10.609999999999999 116.896 176.867 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.3 t -92.63 114.86 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 120.294 -0.562 . . . . 9.1300000000000008 111.227 179.731 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -98.88 125.03 44.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.067 -2.896 . . . . 20.550000000000001 112.662 177.269 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.3 p -84.24 -179.07 7.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.488 -1.233 . . . . 11.779999999999999 113.481 -179.373 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 tt -50.72 -47.94 59.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.045 3.338 . . . . 19.309999999999999 112.573 179.405 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -93.15 -66.8 0.9 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.049 2.139 . . . . 23.140000000000001 107.287 -165.752 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.56 75.57 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 104.062 -3.615 . . . . 19.739999999999998 104.062 161.9 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -115.15 116.97 29.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.839 -0.8 . . . . 21.93 108.839 164.001 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.285 28.1 m -83.87 93.94 8.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.098 2.559 . . . . 12.33 109.689 173.907 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 mt -85.78 105.45 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 123.769 1.747 . . . . 17.079999999999998 107.394 -174.922 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -87.07 110.4 20.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.054 -4.154 . . . . 16.300000000000001 108.37 179.98 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.05 140.62 47.69 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.944 -1.873 . . . . 15.880000000000001 105.944 176.272 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -104.23 131.2 51.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.32 1.057 . . . . 28.899999999999999 111.812 167.781 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.24 178.94 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 115.142 -0.936 . . . . 12.050000000000001 109.529 -178.612 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -85.1 163.15 46.82 Favored Pre-proline 0 N--CA 1.429 -1.479 0 O-C-N 118.426 -2.671 . . . . 18.170000000000002 110.949 163.98 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.257 0.1 OUTLIER -76.24 -12.35 19.16 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 125.148 2.874 . . . . 8.1600000000000001 114.169 179.812 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -102.89 2.53 35.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.421 2.325 . . . . 11.130000000000001 108.063 -168.617 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -76.33 154.62 34.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.017 1.858 . . . . 18.030000000000001 116.017 169.298 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -93.06 169.65 10.25 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.823 2.527 . . . . 10.220000000000001 117.823 -179.316 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.54 -42.72 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 126.026 2.079 . . . . 12.300000000000001 116.185 -178.627 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 5.7 mm-40 -29.47 -50.3 0.1 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.9 2.48 . . . . 36.509999999999998 114.791 158.446 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.41 -37.91 63.23 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.161 -2.212 . . . . 25.66 108.092 -175.899 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.74 -43.46 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 124.379 2.038 . . . . 8.1199999999999992 111.613 176.083 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 50.0 mtpt -62.78 -36.79 84.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.276 -2.14 . . . . 15.470000000000001 115.392 173.659 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.46 89.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.994 2.518 . . . . 11.449999999999999 113.176 175.473 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -71.45 -30.3 65.87 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 124.391 1.076 . . . . 24.98 110.083 -178.095 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.5 mt -71.39 -39.15 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.327 -1.306 . . . . 9.4600000000000009 111.274 174.092 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -62.92 -40.59 98.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.887 -2.383 . . . . 14.76 109.35 170.476 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.19 -43.82 63.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 115.952 -1.975 . . . . 26.289999999999999 110.681 -171.664 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HB3' ' HG2' ' A' ' 34' ' ' GLU 0.303 28.8 tptt -69.25 -51.14 40.53 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.554 1.645 . . . . 30.059999999999999 113.516 -176.785 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 33' ' ' LYS . 76.8 mm-40 -106.02 -32.7 8.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.268 3.027 . . . . 25.190000000000001 113.833 -157.818 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.42 56.71 4.17 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 128.429 2.919 . . . . 7.4100000000000001 113.329 -175.072 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mt -110.87 124.19 33.58 Favored Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 103.824 -2.658 . . . . 9.4900000000000002 103.824 -178.456 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.98 139.62 85.71 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 124.071 3.181 . . . . 11.42 117.085 175.589 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.95 -14.84 45.69 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 C-N-CA 127.422 5.415 . . . . 12.0 111.474 -174.757 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.401 2.5 p30 -81.37 -24.73 36.84 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.119 2.266 . . . . 35.549999999999997 117.119 178.351 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -75.72 -25.15 56.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 126.248 2.217 . . . . 20.52 116.83 167.142 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -79.51 121.72 25.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.638 2.459 . . . . 7.1299999999999999 117.638 -179.043 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -128.4 151.6 49.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.438 -2.664 . . . . 36.390000000000001 107.137 157.493 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.6 mt -131.12 143.57 50.74 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.332 2.015 . . . . 9.5500000000000007 111.089 -169.943 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.4 mm -120.65 140.74 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.401 3.08 . . . . 13.9 105.476 -176.28 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -104.16 -55.02 2.44 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 124.404 2.049 . . . . 6.8600000000000003 108.93 155.643 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.66 107.62 3.22 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.488 -2.008 . . . . 11.15 107.716 -176.661 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.81 -69.96 0.75 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 126.634 2.064 . . . . 13.93 116.619 175.853 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -96.3 166.95 11.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 119.138 1.469 . . . . 23.920000000000002 114.254 -175.727 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -60.39 139.11 57.84 Favored 'General case' 0 N--CA 1.43 -1.47 1 N-CA-C 123.489 4.626 . . . . 23.23 123.489 172.887 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.2 mt -83.4 120.42 25.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.825 1.65 . . . . 9.1099999999999994 114.759 173.642 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -89.25 155.09 19.61 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.682 -2.511 . . . . 33.439999999999998 110.075 -174.803 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.09 -53.72 49.22 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.165 1.786 . . . . 28.370000000000001 112.999 -158.433 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.15 36.23 4.54 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 117.673 -1.626 . . . . 15.0 114.273 -173.71 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -107.2 147.39 30.2 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.401 -2.074 . . . . 25.5 105.401 174.171 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.315 32.2 p -77.89 169.74 17.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.179 1.55 . . . . 11.949999999999999 112.272 -178.48 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.08 -30.99 55.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 113.953 -1.476 . . . . 10.17 109.17 178.999 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -66.49 -49.87 65.16 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 131.039 3.736 . . . . 13.59 110.233 179.155 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 33.1 t70 -56.63 -43.3 80.12 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.137 -2.227 . . . . 11.699999999999999 116.553 174.796 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -69.72 -27.61 65.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 124.952 1.408 . . . . 12.949999999999999 110.176 176.778 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 70.69 46.6 0.51 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 129.045 2.938 . . . . 25.449999999999999 107.795 -175.509 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.15 119.9 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 112.249 -2.25 . . . . 14.6 106.58 162.578 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -107.64 -176.15 2.98 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.802 2.441 . . . . 33.229999999999997 111.205 -174.987 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.276 54.7 pttt -69.92 135.03 49.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.661 -1.899 . . . . 25.969999999999999 115.099 -172.024 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 73.46 38.62 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.109 2.164 . . . . 32.609999999999999 109.809 179.9 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.6 m -94.21 150.76 20.01 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 112.865 -6.147 . . . . 10.56 110.15 -169.95 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 99.0 m -98.63 123.35 42.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.33 -2.731 . . . . 5.3300000000000001 105.244 -175.717 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.27 4.8 mp -116.03 148.21 40.42 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.676 -3.14 . . . . 11.66 109.746 168.9 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -95.05 121.87 37.12 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.157 1.932 . . . . 16.300000000000001 114.716 173.185 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.274 44.5 tp -81.62 114.89 20.61 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.489 -4.507 . . . . 9.9600000000000009 113.385 171.27 . . . . . . . . 3 2 . 1 . 077 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.86 157.09 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.695 2.043 . . . . 9.7599999999999998 113.951 -178.529 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.1 tp . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 112.942 0.719 . . . . 19.57 112.942 177.148 . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 120.007 3.336 . . . . 17.170000000000002 120.007 . . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -94.08 136.48 34.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.675 -1.972 . . . . 21.890000000000001 105.675 -164.98 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 pt -132.09 162.19 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 128.161 2.585 . . . . 10.83 110.731 168.666 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -113.58 143.29 44.81 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 124.346 2.022 . . . . 10.609999999999999 109.221 175.457 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -133.62 115.47 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.175 -4.703 . . . . 9.1300000000000008 104.881 175.832 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -94.01 126.89 39.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.911 -1.885 . . . . 20.550000000000001 105.911 179.013 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -72.56 168.52 18.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.603 -1.936 . . . . 11.779999999999999 115.175 171.911 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.0 tp -66.82 -47.49 71.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.275 -1.515 . . . . 19.309999999999999 110.837 -175.463 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -73.58 -50.1 22.93 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.286 1.835 . . . . 23.140000000000001 115.068 -179.055 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.53 49.75 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 114.924 -3.513 . . . . 19.739999999999998 115.403 -169.906 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -138.71 137.17 36.54 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 116.945 -1.902 . . . . 21.93 110.698 165.047 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -95.82 103.24 15.11 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 125.224 1.577 . . . . 12.33 108.588 172.529 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.98 120.05 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.974 -2.954 . . . . 17.079999999999998 111.786 177.641 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -99.28 120.55 39.73 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.915 -3.616 . . . . 16.300000000000001 102.396 -176.069 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 mt -122.77 168.95 11.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.376 3.071 . . . . 15.880000000000001 110.883 -170.538 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -135.58 120.42 18.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.635 1.574 . . . . 28.899999999999999 107.5 179.859 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.82 168.81 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.302 -2.481 . . . . 12.050000000000001 104.302 -172.972 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.266 32.4 mt-10 -106.14 170.83 5.37 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 117.822 -3.048 . . . . 18.170000000000002 110.188 162.045 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.11 5.04 6.5 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 CA-C-N 121.983 1.744 . . . . 8.1600000000000001 112.101 -179.325 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -93.95 -16.03 24.35 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.133 2.573 . . . . 11.130000000000001 108.797 -179.089 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -80.5 142.24 34.4 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.88 1.218 . . . . 18.030000000000001 113.497 -173.078 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -74.79 159.03 32.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.684 -1.885 . . . . 10.220000000000001 111.3 176.489 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mm -49.35 -40.72 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 119.425 -2.047 . . . . 12.300000000000001 115.042 170.059 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -47.82 -50.02 27.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 115.227 -2.321 . . . . 36.509999999999998 115.782 167.529 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -68.28 -29.68 68.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 123.496 2.862 . . . . 25.66 115.337 177.013 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.87 -37.62 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 115.734 -0.666 . . . . 8.1199999999999992 111.487 177.059 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -58.95 -34.77 72.15 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 120.045 3.35 . . . . 15.470000000000001 120.045 163.273 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.42 -37.32 65.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.042 -2.911 . . . . 11.449999999999999 110.887 -178.133 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -52.99 -45.02 67.66 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.17 2.188 . . . . 24.98 116.502 159.937 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.59 -48.09 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 1 O-C-N 115.813 -4.305 . . . . 9.4600000000000009 108.625 179.236 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -49.57 -50.44 42.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.007 1.854 . . . . 14.76 116.007 169.605 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -54.07 -49.05 69.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.535 1.68 . . . . 26.289999999999999 115.535 174.044 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -67.66 -57.65 6.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.007 -1.451 . . . . 30.059999999999999 113.433 -179.676 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -95.81 -36.82 11.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.582 2.753 . . . . 25.190000000000001 112.493 -161.763 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.23 0.3 50.85 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 116.938 -2.034 . . . . 7.4100000000000001 116.572 -178.116 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.3 mt -72.56 124.77 91.19 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 128.69 2.796 . . . . 9.4900000000000002 108.588 179.948 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.48 160.42 9.52 Favored 'Trans proline' 0 C--N 1.3 -2.013 1 C-N-CA 126.294 4.662 . . . . 11.42 116.28 -178.555 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.19 -7.25 18.83 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 123.668 2.912 . . . . 12.0 113.964 -161.715 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -76.65 -57.23 3.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 131.069 3.748 . . . . 35.549999999999997 106.469 -179.847 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -56.98 -45.3 83.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.361 1.986 . . . . 20.52 116.361 168.82 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -62.03 110.52 1.6 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.402 -3.311 . . . . 7.1299999999999999 116.715 175.451 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -110.18 130.56 55.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.119 1.437 . . . . 36.390000000000001 107.326 163.458 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.0 mt -110.83 128.77 55.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.819 2.247 . . . . 9.5500000000000007 106.828 179.906 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.65 152.74 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.323 -3.36 . . . . 13.9 103.857 173.413 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -96.04 -66.96 0.87 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.806 -2.434 . . . . 6.8600000000000003 104.923 162.26 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.283 . . -156.33 130.56 8.68 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 104.486 -2.413 . . . . 11.15 104.486 173.766 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.59 -49.94 1.17 Allowed Glycine 0 N--CA 1.43 -1.753 0 CA-C-O 116.863 -2.076 . . . . 13.93 112.953 154.011 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -145.13 172.55 12.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.62 2.71 . . . . 23.920000000000002 107.378 -172.476 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.256 5.4 pm0 -83.66 135.23 34.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.229 -2.17 . . . . 23.23 115.553 -175.847 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.4 mt -77.27 151.41 35.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.485 -3.259 . . . . 9.1099999999999994 111.924 175.885 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.4 155.46 28.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.927 -2.983 . . . . 33.439999999999998 111.706 175.791 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -77.9 -43.09 31.07 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 120.83 1.65 . . . . 28.370000000000001 113.406 -173.564 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.16 29.4 11.9 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 118.462 0.574 . . . . 15.0 112.115 -175.873 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -114.51 149.19 36.78 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.425 -2.065 . . . . 25.5 105.425 178.025 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.286 30.1 p -100.1 176.39 5.42 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 111.568 -2.56 . . . . 11.949999999999999 117.547 -164.372 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.7 mt -73.8 -8.25 55.3 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.268 -3.395 . . . . 10.17 114.1 168.181 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.0 m -94.9 -28.61 15.11 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.551 -3.843 . . . . 13.59 102.332 -172.796 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -62.43 -51.71 66.43 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 131.673 3.989 . . . . 11.699999999999999 116.553 169.574 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -90.17 -6.4 55.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.361 -2.199 . . . . 12.949999999999999 111.707 -177.829 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.326 35.2 m120 72.13 36.3 1.13 Allowed 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 116.001 -4.187 . . . . 25.449999999999999 113.264 174.25 . . . . . . . . 3 2 . 1 . 078 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.77 109.19 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.72 2.408 . . . . 14.6 107.867 -172.612 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.12 -178.37 3.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.564 2.602 . . . . 33.229999999999997 111.213 -179.772 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -49.89 148.89 2.89 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 118.853 -2.404 . . . . 25.969999999999999 116.685 175.972 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 35.1 mt-10 53.48 36.97 24.57 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.302 -3.374 . . . . 32.609999999999999 118.616 -172.637 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -97.57 144.39 27.3 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.171 -2.159 . . . . 10.56 105.171 178.752 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -101.22 105.86 17.02 Favored 'General case' 0 N--CA 1.43 -1.442 1 CA-C-O 128.844 4.164 . . . . 5.3300000000000001 110.583 175.595 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.57 150.3 21.79 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.542 -2.599 . . . . 11.66 111.832 173.777 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -103.36 127.5 50.7 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.825 -1.172 . . . . 16.300000000000001 112.128 178.274 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 tp -105.26 116.52 32.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.41 3.481 . . . . 9.9600000000000009 109.347 169.947 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.76 174.16 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 112.781 -2.009 . . . . 9.7599999999999998 110.996 -179.114 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.9 tp . . . . . 0 N--CA 1.43 -1.442 0 C-N-CA 127.788 2.435 . . . . 19.57 111.386 -175.748 . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 116.746 2.128 . . . . 17.170000000000002 116.746 . . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.251 85.8 mt-30 -85.05 122.23 28.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.096 1.903 . . . . 21.890000000000001 113.331 177.168 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -113.09 159.92 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.12 -2.548 . . . . 10.83 104.12 175.916 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -111.87 127.15 55.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 123.586 1.66 . . . . 10.609999999999999 109.298 -177.756 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.7 t -122.85 109.6 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.204 1.954 . . . . 9.1300000000000008 110.93 179.528 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -90.48 144.2 26.02 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 113.235 -5.916 . . . . 20.550000000000001 115.914 176.054 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -85.61 164.25 17.84 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.148 2.979 . . . . 11.779999999999999 113.653 175.582 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.94 -26.23 68.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.311 -2.743 . . . . 19.309999999999999 114.795 168.401 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 38.9 p -75.38 -44.06 46.87 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.455 1.934 . . . . 23.140000000000001 112.339 178.632 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.8 38.6 0.23 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-N 115.08 -0.964 . . . . 19.739999999999998 112.291 169.458 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -103.08 125.79 49.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.188 -1.042 . . . . 21.93 108.188 172.353 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.4 m -91.66 128.05 37.35 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 102.339 -3.208 . . . . 12.33 102.339 168.965 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.254 28.7 mt -102.06 136.22 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 117.828 -3.045 . . . . 17.079999999999998 105.309 178.295 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.7 m -105.99 100.17 9.73 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 100.607 -3.849 . . . . 16.300000000000001 100.607 -175.095 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 mt -96.14 119.74 35.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.907 1.683 . . . . 15.880000000000001 110.334 -177.939 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -93.97 96.72 9.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.063 -2.569 . . . . 28.899999999999999 104.063 178.837 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.71 168.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.733 2.013 . . . . 12.050000000000001 108.831 179.178 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -116.22 154.27 48.68 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-N 120.011 1.278 . . . . 18.170000000000002 108.98 -169.98 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.79 -4.32 14.49 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 CA-C-N 122.56 1.95 . . . . 8.1600000000000001 115.185 -173.127 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.4 m -88.59 -12.39 42.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 125.238 1.586 . . . . 11.130000000000001 113.987 172.431 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.67 149.78 48.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.034 -2.916 . . . . 18.030000000000001 114.511 -179.462 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.284 37.2 p -90.55 175.34 7.09 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 111.245 -2.707 . . . . 10.220000000000001 107.699 -179.105 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 mm -73.55 -27.36 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 119.456 -2.027 . . . . 12.300000000000001 109.791 171.992 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.73 -52.16 65.39 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.509 -2.619 . . . . 36.509999999999998 108.532 170.333 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -47.58 -39.86 17.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.654 2.381 . . . . 25.66 115.807 172.87 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.66 -46.63 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 127.1 3.333 . . . . 8.1199999999999992 114.657 -171.572 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.46 -27.63 66.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.934 -2.979 . . . . 15.470000000000001 115.19 160.636 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.88 -19.84 60.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.369 2.35 . . . . 11.449999999999999 111.211 178.073 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -69.34 -30.53 68.58 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 112.739 -6.225 . . . . 24.98 112.373 165.449 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -87.76 -18.03 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 126.005 2.812 . . . . 9.4600000000000009 113.068 174.593 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -69.67 -33.24 72.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.52 -3.863 . . . . 14.76 110.558 167.662 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.85 -54.11 12.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.202 -2.811 . . . . 26.289999999999999 110.767 178.481 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -71.31 -62.94 1.22 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.178 -1.576 . . . . 30.059999999999999 113.432 -176.774 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -91.5 -33.37 15.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.435 2.541 . . . . 25.190000000000001 110.779 -174.051 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.73 59.28 2.24 Favored Glycine 0 N--CA 1.43 -1.751 2 O-C-N 114.577 -5.077 . . . . 7.4100000000000001 109.371 179.55 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 mt -118.48 146.48 39.78 Favored Pre-proline 0 N--CA 1.43 -1.459 0 N-CA-C 103.236 -2.876 . . . . 9.4900000000000002 103.236 -177.127 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.266 53.1 Cg_exo -75.1 138.79 23.24 Favored 'Trans proline' 0 C--N 1.3 -1.996 2 C-N-CA 128.48 6.12 . . . . 11.42 112.064 -176.295 . . . . . . . . 3 2 . 1 . 079 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.88 -29.18 89.49 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 C-N-CA 122.748 2.299 . . . . 12.0 112.711 175.425 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.31 7.8 p-10 -70.87 -38.28 73.09 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.523 1.965 . . . . 35.549999999999997 112.084 175.825 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -73.44 -35.41 65.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.6 2.36 . . . . 20.52 110.379 -176.469 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -69.12 116.93 10.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.54 2.736 . . . . 7.1299999999999999 110.781 169.319 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -110.76 129.12 55.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 128.612 3.695 . . . . 36.390000000000001 111.692 165.628 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 tp -116.45 133.37 56.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.408 -1.433 . . . . 9.5500000000000007 109.843 -172.691 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.5 mt -127.08 130.13 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 116.664 -3.772 . . . . 13.9 109.383 -175.108 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -89.87 -58.59 2.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 123.121 2.691 . . . . 6.8600000000000003 115.492 172.634 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.4 -73.94 0.63 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.19 1.396 . . . . 11.15 107.684 -178.608 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.25 -64.16 0.26 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 117.206 -2.426 . . . . 13.93 111.108 -173.569 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.275 17.6 ptmt -67.04 168.0 10.84 Favored 'General case' 0 N--CA 1.429 -1.491 2 CA-C-O 128.924 4.202 . . . . 23.920000000000002 113.496 171.961 . . . . . . . . 3 2 . 1 . 079 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -86.12 145.68 26.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.175 -2.739 . . . . 23.23 113.692 172.922 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -80.74 137.97 36.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.093 -1.629 . . . . 9.1099999999999994 107.793 -178.054 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -102.6 145.84 29.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.081 2.953 . . . . 33.439999999999998 107.884 -170.525 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -39.36 -73.97 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 119.77 3.248 . . . . 28.370000000000001 119.77 -174.692 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.02 17.52 41.28 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 129.073 3.225 . . . . 15.0 111.808 -164.16 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -96.4 163.66 12.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.687 -2.066 . . . . 25.5 105.46 173.395 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -101.55 163.89 12.04 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.42 -2.437 . . . . 11.949999999999999 104.42 -179.577 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.37 -26.46 66.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.358 -1.292 . . . . 10.17 114.424 162.592 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -65.93 -35.62 81.12 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 123.49 0.716 . . . . 13.59 111.895 168.421 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.8 -34.09 73.97 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 116.045 -4.159 . . . . 11.699999999999999 120.201 175.168 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -92.37 -22.26 19.78 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.476 -3.265 . . . . 12.949999999999999 105.79 -178.267 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.8 m120 71.89 75.44 0.17 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.5 2.72 . . . . 25.449999999999999 108.91 -177.563 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.2 mt -115.56 126.8 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 125.557 1.786 . . . . 14.6 106.637 -175.34 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.94 -178.79 4.54 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.398 -1.439 . . . . 33.229999999999997 109.323 179.848 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -66.61 156.06 36.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.948 2.309 . . . . 25.969999999999999 115.768 -168.231 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.291 46.7 mt-10 58.21 42.22 22.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.435 2.754 . . . . 32.609999999999999 118.435 -171.202 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 m -116.84 132.82 56.6 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.069 -1.826 . . . . 10.56 106.069 -175.759 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.6 m -84.09 140.41 31.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.984 -2.947 . . . . 5.3300000000000001 114.183 173.262 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -125.04 165.57 17.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.135 2.574 . . . . 11.66 110.096 174.344 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -110.27 104.4 13.2 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.271 1.952 . . . . 16.300000000000001 116.271 176.294 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.6 tp -73.06 118.74 16.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 123.876 0.735 . . . . 9.9600000000000009 110.236 165.817 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 m -129.64 155.53 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 105.592 -2.003 . . . . 9.7599999999999998 105.592 176.254 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.9 mt . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 103.539 -2.763 . . . . 19.57 103.539 -166.558 . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ptt? . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 124.582 2.134 . . . . 17.170000000000002 108.851 . . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -99.03 132.7 44.15 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 116.585 -3.822 . . . . 21.890000000000001 113.089 -169.551 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 pt -120.46 154.5 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.08 -1.013 . . . . 10.83 110.331 175.661 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -124.52 125.01 43.51 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.073 -1.642 . . . . 10.609999999999999 106.706 -174.315 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 22.7 t -109.54 102.56 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 124.46 2.076 . . . . 9.1300000000000008 110.335 -178.229 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -83.61 126.28 32.68 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 127.284 3.421 . . . . 20.550000000000001 116.311 172.725 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.6 p -78.96 174.31 11.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.928 2.299 . . . . 11.779999999999999 112.612 -175.745 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.413 HD12 HG13 ' A' ' 70' ' ' VAL . 12.5 tp -75.6 -36.23 60.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.61 -2.556 . . . . 19.309999999999999 109.889 -177.018 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -61.68 -37.63 84.82 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.076 -3.515 . . . . 23.140000000000001 116.678 170.519 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.36 43.28 0.6 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 120.227 1.376 . . . . 19.739999999999998 111.066 174.546 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -111.18 151.17 28.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.611 1.708 . . . . 21.93 115.611 161.911 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -97.36 115.51 27.85 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.214 -1.554 . . . . 12.33 113.568 171.577 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 10.0 mt -93.04 92.18 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 126.366 2.984 . . . . 17.079999999999998 111.165 170.699 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.3 m -82.91 105.22 13.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.551 -2.113 . . . . 16.300000000000001 113.122 -173.956 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.86 158.38 17.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.738 -2.69 . . . . 15.880000000000001 103.738 -169.938 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -110.97 133.29 53.5 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.395 -2.69 . . . . 28.899999999999999 108.437 164.146 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.92 169.15 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.006 -2.961 . . . . 12.050000000000001 103.006 -171.502 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -100.88 174.15 3.16 Favored Pre-proline 0 N--CA 1.429 -1.485 1 O-C-N 114.432 -5.168 . . . . 18.170000000000002 104.14 165.882 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.29 -15.3 14.34 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 CA-C-N 123.239 2.192 . . . . 8.1600000000000001 116.133 168.937 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.7 p -77.91 -5.46 51.16 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.57 2.348 . . . . 11.130000000000001 114.688 176.366 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -70.84 148.25 48.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.588 -3.82 . . . . 18.030000000000001 112.456 178.428 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.9 p -93.0 148.01 22.35 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 129.477 4.236 . . . . 10.220000000000001 108.644 178.134 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.8 mm -52.21 -32.49 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 125.781 2.705 . . . . 12.300000000000001 116.144 173.144 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -67.61 -39.18 84.74 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.617 -3.802 . . . . 36.509999999999998 113.106 174.742 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -78.64 -6.76 56.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 114.483 -2.887 . . . . 25.66 110.548 -179.665 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.3 t -86.56 -43.59 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 130.762 3.625 . . . . 8.1199999999999992 110.026 171.806 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -51.25 -33.27 27.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.36 -3.338 . . . . 15.470000000000001 119.093 161.4 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.7 -19.04 63.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.327 -2.108 . . . . 11.449999999999999 114.407 177.849 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -78.89 -39.98 33.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.364 -1.347 . . . . 24.98 107.364 174.117 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 mt -74.36 -40.48 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.742 -1.849 . . . . 9.4600000000000009 107.965 -176.652 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -54.1 -45.44 71.82 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.99 -2.944 . . . . 14.76 110.714 173.014 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -64.81 -52.64 55.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.749 -1.844 . . . . 26.289999999999999 111.081 -176.65 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.58 -66.96 0.54 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.102 2.26 . . . . 30.059999999999999 117.102 -176.393 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -67.47 -49.73 62.25 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.507 2.379 . . . . 25.190000000000001 113.334 -172.174 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.85 13.34 16.39 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-N 113.22 -1.809 . . . . 7.4100000000000001 115.387 178.49 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.1 mt -89.08 127.15 56.62 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 126.926 2.091 . . . . 9.4900000000000002 108.801 -171.559 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -67.71 139.37 48.02 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-O 116.192 -1.67 . . . . 11.42 113.397 -177.878 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -73.34 -14.57 25.37 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 124.253 2.554 . . . . 12.0 118.301 -166.371 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -35.94 63.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 120.374 1.443 . . . . 35.549999999999997 111.299 172.172 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.55 -41.13 89.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 117.061 2.245 . . . . 20.52 117.061 166.688 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -63.65 117.53 6.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.904 3.282 . . . . 7.1299999999999999 109.375 -176.031 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HB3' HG22 ' A' ' 70' ' ' VAL . 27.3 ttm180 -116.88 101.25 8.37 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.054 -2.904 . . . . 36.390000000000001 104.649 176.429 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.6 tp -96.43 115.33 27.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.749 3.219 . . . . 9.5500000000000007 108.95 -172.32 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -114.97 154.38 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.928 2.891 . . . . 13.9 110.761 -171.391 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.89 -91.4 0.24 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 116.58 -1.676 . . . . 6.8600000000000003 106.622 174.264 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.54 -75.46 0.6 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.183 2.177 . . . . 11.15 106.019 178.786 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.95 -32.57 3.77 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 109.347 -3.57 . . . . 13.93 117.407 -175.062 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 8.2 ptpt -99.08 152.08 20.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.758 3.17 . . . . 23.920000000000002 116.869 173.083 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -88.89 133.5 34.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.852 -2.405 . . . . 23.23 113.014 171.557 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.8 mt -89.82 123.71 34.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.343 -1.473 . . . . 9.1099999999999994 110.973 -176.485 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -95.62 138.48 33.23 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.302 2.241 . . . . 33.439999999999998 107.562 -169.174 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -34.27 -49.89 0.39 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.843 3.657 . . . . 28.370000000000001 120.668 -168.869 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.55 -8.46 59.63 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 119.899 -1.751 . . . . 15.0 115.657 -164.453 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -83.59 154.38 23.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.864 -2.551 . . . . 25.5 108.43 -175.903 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -89.27 166.77 13.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.839 1.781 . . . . 11.949999999999999 115.312 176.759 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.47 -31.6 71.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 118.976 2.954 . . . . 10.17 118.976 169.71 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -61.12 -30.71 70.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.032 2.133 . . . . 13.59 115.33 163.325 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -72.02 -42.86 65.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.865 1.793 . . . . 11.699999999999999 110.82 174.41 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -83.31 -17.04 43.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.796 2.517 . . . . 12.949999999999999 117.796 -174.612 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 28.0 m120 78.52 45.96 0.06 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 131.0 3.72 . . . . 25.449999999999999 109.941 -179.005 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -83.06 123.91 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.413 -2.679 . . . . 14.6 105.78 167.605 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -112.42 -157.07 0.61 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.861 -2.274 . . . . 33.229999999999997 104.861 -179.382 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -85.32 153.23 22.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.097 1.147 . . . . 25.969999999999999 114.097 -178.826 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 57.03 34.11 24.41 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.526 -3.234 . . . . 32.609999999999999 111.749 -176.747 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -77.88 138.85 39.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.077 -1.083 . . . . 10.56 108.077 -178.288 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 m -98.93 118.79 36.5 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.437 -1.32 . . . . 5.3300000000000001 107.437 167.801 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.7 mt -106.36 176.41 5.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 123.386 0.674 . . . . 11.66 109.992 169.994 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -136.55 135.91 38.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 103.577 -2.749 . . . . 16.300000000000001 103.577 -168.444 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.4 tp -117.17 119.97 36.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.967 -3.583 . . . . 9.9600000000000009 108.42 173.28 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 42' ' ' ARG . 27.9 m -116.9 166.97 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.734 2.207 . . . . 9.7599999999999998 110.055 163.091 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.429 -1.481 0 O-C-N 120.211 -1.556 . . . . 19.57 108.992 179.673 . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.441 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 121.271 0.558 . . . . 17.170000000000002 111.406 . . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -77.69 126.47 30.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.593 -3.817 . . . . 21.890000000000001 112.39 -173.614 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -115.19 139.45 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 119.369 0.986 . . . . 10.83 110.569 168.601 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -99.91 109.13 21.51 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.568 2.604 . . . . 10.609999999999999 111.555 179.282 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.8 t -92.03 105.82 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 119.576 -1.953 . . . . 9.1300000000000008 106.195 175.411 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.281 71.8 mttt -86.3 138.08 32.11 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.974 1.102 . . . . 20.550000000000001 113.974 -179.867 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.273 8.7 p -99.93 176.05 5.56 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.516 -3.24 . . . . 11.779999999999999 112.702 -167.89 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.278 27.7 tp -71.58 -55.6 7.47 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.424 3.489 . . . . 19.309999999999999 115.158 -174.453 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.414 67.6 p -56.53 -63.3 1.24 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.059 -1.65 . . . . 23.140000000000001 113.727 165.142 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.64 60.49 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 122.502 3.761 . . . . 19.739999999999998 122.502 -177.979 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.15 166.51 13.85 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.753 -3.204 . . . . 21.93 105.882 175.543 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -117.51 130.24 56.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.036 2.236 . . . . 12.33 117.036 158.678 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.461 HG23 ' HG ' ' A' ' 15' ' ' LEU . 77.8 mt -101.37 112.05 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 117.373 -1.731 . . . . 17.079999999999998 110.027 175.214 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.272 90.6 m -93.57 115.36 27.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.891 -3.631 . . . . 16.300000000000001 110.99 177.768 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.461 ' HG ' HG23 ' A' ' 13' ' ' ILE 0.28 50.9 mt -119.42 134.37 55.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.737 -1.579 . . . . 15.880000000000001 106.737 -173.455 . . . . . . . . 3 3 . 1 . 081 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -96.94 94.68 7.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.918 3.287 . . . . 28.899999999999999 109.038 -179.53 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.9 m -119.45 159.2 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 118.01 -2.931 . . . . 12.050000000000001 105.477 -169.133 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -113.87 155.85 44.64 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 116.556 -3.84 . . . . 18.170000000000002 106.959 171.351 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.306 69.2 Cg_endo -65.54 -9.61 23.16 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 125.153 3.902 . . . . 8.1600000000000001 121.387 -164.203 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -94.61 -11.37 29.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.359 -1.463 . . . . 11.130000000000001 113.676 -179.612 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -64.22 143.52 57.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.158 2.183 . . . . 18.030000000000001 113.902 171.743 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -93.49 165.12 12.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.523 -1.361 . . . . 10.220000000000001 110.266 -166.464 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -66.91 -31.57 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 115.878 1.807 . . . . 12.300000000000001 115.878 171.235 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -49.51 -48.02 48.41 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.111 1.507 . . . . 36.509999999999998 113.39 166.766 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -81.11 -16.26 53.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.283 -1.326 . . . . 25.66 109.177 -178.375 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.81 -47.01 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 123.358 2.799 . . . . 8.1199999999999992 109.924 173.722 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -50.68 -38.52 47.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.289 2.235 . . . . 15.470000000000001 114.375 174.365 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.309 . . -62.53 -37.17 85.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.253 -2.308 . . . . 11.449999999999999 112.757 173.325 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -67.9 -49.06 64.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.382 1.446 . . . . 24.98 112.662 175.443 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.99 -36.86 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 O-C-N 115.978 -4.201 . . . . 9.4600000000000009 107.99 -179.096 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.43 -38.34 86.81 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.151 -3.468 . . . . 14.76 115.569 174.305 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -72.95 -43.51 62.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.242 1.942 . . . . 26.289999999999999 116.242 178.655 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -64.41 -69.86 0.26 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 120.847 3.647 . . . . 30.059999999999999 120.847 175.512 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HB2' HG12 ' A' ' 36' ' ' ILE . 67.4 mm-40 -94.28 -2.56 52.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.068 -1.645 . . . . 25.190000000000001 111.966 -175.845 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.99 41.65 87.05 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 122.411 2.369 . . . . 7.4100000000000001 118.215 -178.302 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.412 HG12 ' HB2' ' A' ' 34' ' ' GLU . 18.9 mm -106.28 107.87 60.69 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 114.416 -2.707 . . . . 9.4900000000000002 108.972 -178.053 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.18 144.98 78.93 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 123.466 2.273 . . . . 11.42 117.319 177.165 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.34 -13.19 32.96 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 123.67 2.913 . . . . 12.0 112.0 -166.875 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -85.87 -9.38 57.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.839 3.255 . . . . 35.549999999999997 107.863 179.016 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -107.07 -15.45 14.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.53 -1.356 . . . . 20.52 114.413 171.088 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -81.47 99.26 8.66 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.613 -3.179 . . . . 7.1299999999999999 113.867 -179.258 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -91.88 107.1 18.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.685 -3.135 . . . . 36.390000000000001 107.011 170.56 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.9 134.47 41.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.742 -1.947 . . . . 9.5500000000000007 105.742 -177.685 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -123.39 132.91 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 130.257 3.423 . . . . 13.9 110.458 -179.522 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -107.98 112.06 24.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.536 -2.602 . . . . 6.8600000000000003 106.62 158.372 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.35 -86.84 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 131.927 4.091 . . . . 11.15 109.276 178.712 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.14 16.67 3.42 Favored Glycine 0 N--CA 1.43 -1.742 1 O-C-N 115.396 -4.565 . . . . 13.93 111.801 162.441 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.255 88.7 mttt -87.17 122.53 31.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.848 2.324 . . . . 23.920000000000002 111.105 172.988 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -84.86 106.48 16.42 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 121.099 1.772 . . . . 23.23 108.165 178.377 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.35 139.48 58.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.52 2.328 . . . . 9.1099999999999994 109.732 -174.015 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -100.35 140.74 34.16 Favored 'General case' 0 N--CA 1.43 -1.474 1 C-N-CA 131.735 4.014 . . . . 33.439999999999998 111.907 -175.785 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -54.88 -54.01 48.07 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.133 2.573 . . . . 28.370000000000001 113.661 -168.49 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.32 7.12 61.66 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 129.86 3.6 . . . . 15.0 114.978 -173.73 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -107.82 170.46 7.97 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.823 -1.177 . . . . 25.5 107.823 176.603 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.0 p -110.07 172.37 6.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.772 2.701 . . . . 11.949999999999999 115.877 -174.672 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.1 mt -59.2 -48.43 81.63 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.985 -2.947 . . . . 10.17 112.988 162.791 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.6 p -58.49 -23.18 57.22 Favored 'General case' 0 N--CA 1.43 -1.451 1 N-CA-C 123.196 4.517 . . . . 13.59 123.196 173.17 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.313 15.6 t70 -74.16 -50.47 19.19 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.741 -2.475 . . . . 11.699999999999999 110.989 177.106 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -73.62 -21.62 60.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.188 1.921 . . . . 12.949999999999999 116.188 177.92 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 67.8 m-20 80.78 47.93 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 127.958 3.742 . . . . 25.449999999999999 114.071 -176.604 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.7 mt -77.88 134.97 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.29 -2.756 . . . . 14.6 108.37 168.976 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -121.14 -158.11 0.75 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.296 1.622 . . . . 33.229999999999997 108.57 176.525 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 7.2 ptmm? -77.67 158.72 29.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.984 3.278 . . . . 25.969999999999999 113.334 170.814 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 64.91 24.69 12.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.032 -2.293 . . . . 32.609999999999999 109.333 168.658 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -91.35 148.51 22.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.031 -2.293 . . . . 10.56 109.62 -170.02 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -102.86 120.83 41.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.986 -1.696 . . . . 5.3300000000000001 109.156 173.921 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.28 160.27 16.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 102.932 -2.988 . . . . 11.66 102.932 174.025 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -122.54 134.18 54.55 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.026 -4.171 . . . . 16.300000000000001 105.332 179.395 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tp -100.52 129.93 46.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 128.613 3.696 . . . . 9.9600000000000009 105.663 167.788 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.66 168.32 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 101.833 -3.395 . . . . 9.7599999999999998 101.833 175.575 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.8 tp . . . . . 0 N--CA 1.431 -1.417 0 N-CA-C 117.403 2.371 . . . . 19.57 117.403 -176.151 . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 CA--C 1.489 -1.387 0 CA-C-O 124.832 2.254 . . . . 17.170000000000002 113.517 . . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -105.46 148.39 27.24 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.649 -3.157 . . . . 21.890000000000001 106.38 179.405 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.1 pt -130.27 153.84 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.286 -2.487 . . . . 10.83 104.286 172.64 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -109.21 113.77 26.9 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.881 -1.509 . . . . 10.609999999999999 110.75 173.574 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -95.5 110.83 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.294 -1.002 . . . . 9.1300000000000008 108.294 170.599 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -102.57 142.71 33.3 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.46 1.124 . . . . 20.550000000000001 113.06 -176.334 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 p -87.43 174.65 8.39 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 110.779 -2.919 . . . . 11.779999999999999 114.816 175.522 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.32 -49.75 62.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.538 -2.601 . . . . 19.309999999999999 115.027 167.957 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.8 p -69.89 -46.09 66.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.769 1.622 . . . . 23.140000000000001 112.41 176.914 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.36 54.25 0.13 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 119.7 -1.875 . . . . 19.739999999999998 108.523 173.589 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 78.8 tttt -109.26 132.41 54.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.497 1.519 . . . . 21.93 112.059 159.023 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -99.25 112.71 24.81 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 121.12 1.782 . . . . 12.33 111.842 178.378 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 mt -85.98 109.22 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.269 -2.863 . . . . 17.079999999999998 103.269 176.314 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.2 m -104.08 101.02 10.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.016 -1.476 . . . . 16.300000000000001 107.016 -175.185 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.0 mt -97.93 131.59 44.25 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.719 1.748 . . . . 15.880000000000001 115.719 173.412 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -75.75 124.35 27.12 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.578 2.132 . . . . 28.899999999999999 105.997 160.999 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.1 169.33 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 104.701 -2.333 . . . . 12.050000000000001 104.701 -179.988 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -104.49 152.3 39.33 Favored Pre-proline 0 N--CA 1.43 -1.444 0 C-N-CA 124.093 0.957 . . . . 18.170000000000002 112.67 155.009 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -63.74 -9.95 20.52 Favored 'Trans proline' 0 N--CA 1.434 -2.005 1 C-N-CA 127.248 5.299 . . . . 8.1600000000000001 113.124 -179.378 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.5 m -90.93 -7.76 51.22 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.645 1.72 . . . . 11.130000000000001 115.645 170.429 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -67.31 159.79 28.53 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.709 1.719 . . . . 18.030000000000001 114.328 174.011 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.326 71.1 p -86.83 168.9 13.04 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.869 -1.144 . . . . 10.220000000000001 114.035 -177.398 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.1 mm -60.61 -36.29 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 119.219 -2.176 . . . . 12.300000000000001 115.504 158.311 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -57.47 -33.75 68.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 126.837 3.208 . . . . 36.509999999999998 114.61 171.961 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -79.76 -23.98 41.84 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.537 -5.727 . . . . 25.66 111.154 179.547 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.11 -51.46 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 115.485 -0.779 . . . . 8.1199999999999992 112.736 168.458 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -56.62 -31.76 64.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.92 1.688 . . . . 15.470000000000001 112.815 178.448 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.47 75.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.901 2.137 . . . . 11.449999999999999 114.457 176.9 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -80.09 -31.12 39.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.747 2.689 . . . . 24.98 112.485 178.321 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.28 -38.11 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 1 O-C-N 115.538 -4.477 . . . . 9.4600000000000009 110.59 171.399 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -69.7 -29.94 67.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.585 -3.197 . . . . 14.76 119.152 171.268 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -76.24 -57.6 3.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.401 1.572 . . . . 26.289999999999999 113.286 171.336 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -78.1 -66.96 0.78 Allowed 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 115.114 -4.742 . . . . 30.059999999999999 109.567 -167.155 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.45 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 28.5 mm-40 -72.03 -38.71 69.5 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.981 2.8 . . . . 25.190000000000001 116.848 -175.084 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.04 43.12 2.28 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.968 -2.333 . . . . 7.4100000000000001 114.952 178.796 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mm -98.66 117.25 64.8 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 112.786 -3.483 . . . . 9.4900000000000002 111.073 -179.792 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -68.27 165.11 29.82 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 CA-C-N 125.207 2.895 . . . . 11.42 114.8 -177.553 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -79.34 -28.17 3.83 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 121.791 1.675 . . . . 12.0 112.737 -153.84 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -79.55 -30.65 41.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 127.513 3.008 . . . . 35.549999999999997 107.251 177.191 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -74.0 -16.65 61.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.238 -3.414 . . . . 20.52 112.222 -178.314 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -86.68 118.6 26.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.145 2.402 . . . . 7.1299999999999999 112.815 176.714 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -108.22 125.81 52.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.515 -3.143 . . . . 36.390000000000001 102.515 160.665 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -102.03 123.82 46.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 110.999 -2.818 . . . . 9.5500000000000007 106.391 168.035 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.6 mm -121.62 140.83 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 100.975 -3.713 . . . . 13.9 100.975 -173.266 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -126.72 122.77 35.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 116.323 -1.799 . . . . 6.8600000000000003 106.773 165.053 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.67 -92.28 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.785 1.63 . . . . 11.15 112.383 -164.478 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.67 -7.28 5.73 Favored Glycine 0 N--CA 1.431 -1.678 0 C-N-CA 127.659 2.552 . . . . 13.93 109.394 -179.305 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -103.52 119.79 39.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 118.497 2.777 . . . . 23.920000000000002 118.497 -166.874 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -69.43 112.19 5.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.668 1.359 . . . . 23.23 114.668 -178.621 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.2 mt -80.46 112.14 17.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.562 0.696 . . . . 9.1099999999999994 112.017 -179.862 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -85.94 168.48 14.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.409 2.684 . . . . 33.439999999999998 109.83 -170.808 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.62 -46.86 62.54 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 113.359 -5.838 . . . . 28.370000000000001 115.351 -165.441 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.63 32.0 6.68 Favored Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 126.922 2.201 . . . . 15.0 116.418 -168.607 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.8 mtt-85 -130.68 159.09 38.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.594 -3.484 . . . . 25.5 101.594 -177.771 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 p -87.8 156.79 19.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 131.511 3.925 . . . . 11.949999999999999 111.815 174.046 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.86 -28.78 68.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.016 -1.447 . . . . 10.17 111.612 178.843 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.291 68.8 p -59.28 -36.58 75.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.03 2.233 . . . . 13.59 117.03 165.972 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -81.93 -29.3 32.35 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.686 -4.384 . . . . 11.699999999999999 106.158 -170.816 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -72.86 -20.79 61.05 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 121.187 3.773 . . . . 12.949999999999999 121.187 160.874 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.389 15.6 m120 70.86 34.65 1.91 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.386 -2.071 . . . . 25.449999999999999 112.892 -174.479 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -88.46 132.21 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 101.42 -3.548 . . . . 14.6 101.42 171.859 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.271 81.9 mt-30 -98.53 175.22 6.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 109.864 -3.335 . . . . 33.229999999999997 114.869 174.211 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -45.71 137.73 5.14 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.549 2.74 . . . . 25.969999999999999 111.963 160.467 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 60.04 24.34 13.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.915 2.561 . . . . 32.609999999999999 117.915 177.466 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -78.08 154.22 31.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.215 -2.178 . . . . 10.56 106.408 -168.049 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.4 m -98.0 108.71 21.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 117.246 -1.359 . . . . 5.3300000000000001 111.975 173.277 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.07 158.2 16.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 125.114 1.509 . . . . 11.66 109.457 175.781 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -121.71 130.86 53.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.115 -2.241 . . . . 16.300000000000001 113.079 -178.167 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -87.55 100.8 13.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.314 3.046 . . . . 9.9600000000000009 110.928 169.402 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 t -96.94 120.26 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.99 -1.694 . . . . 9.7599999999999998 113.031 174.05 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 tp . . . . . 0 N--CA 1.43 -1.459 0 O-C-N 116.541 -3.849 . . . . 19.57 108.655 -175.797 . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 117.664 2.468 . . . . 17.170000000000002 117.664 . . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -91.71 134.75 34.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 126.243 2.925 . . . . 21.890000000000001 113.688 179.971 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.4 pt -121.69 161.86 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 117.422 -3.299 . . . . 10.83 112.83 172.763 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -111.33 116.59 31.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 123.694 0.621 . . . . 10.609999999999999 111.589 179.806 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 t -103.56 108.6 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 118.728 -2.482 . . . . 9.1300000000000008 107.924 -175.383 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -97.5 119.96 37.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.41 2.052 . . . . 20.550000000000001 110.689 -172.108 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 2.2 p -76.66 175.35 9.41 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.568 -1.197 . . . . 11.779999999999999 111.931 -173.803 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.04 -40.52 75.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 124.219 1.961 . . . . 19.309999999999999 112.869 175.796 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 p -76.91 -21.14 55.34 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.483 2.313 . . . . 23.140000000000001 114.538 177.33 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.51 26.81 2.77 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 118.956 -1.592 . . . . 19.739999999999998 110.069 153.403 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -83.6 139.06 33.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 116.831 -1.556 . . . . 21.93 111.487 178.329 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -93.34 105.34 17.42 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.339 2.336 . . . . 12.33 109.837 168.161 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.18 119.94 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 125.013 2.339 . . . . 17.079999999999998 106.886 176.249 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.7 m -81.14 115.71 20.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.845 -2.409 . . . . 16.300000000000001 109.216 169.683 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.9 mt -123.41 144.65 49.35 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 113.186 -5.946 . . . . 15.880000000000001 106.922 177.361 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -89.99 108.78 19.93 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.051 1.74 . . . . 28.899999999999999 115.136 167.835 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.85 155.92 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 114.655 -1.157 . . . . 12.050000000000001 108.915 -179.412 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -109.06 152.4 42.47 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 101.081 -3.674 . . . . 18.170000000000002 101.081 163.148 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -65.83 -23.39 55.34 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 C-N-CA 126.271 4.647 . . . . 8.1600000000000001 112.34 -172.991 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.5 m -90.61 1.73 56.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.795 -3.066 . . . . 11.130000000000001 110.731 179.179 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -78.96 161.22 26.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 123.572 2.897 . . . . 18.030000000000001 104.177 175.374 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.0 p -108.03 167.36 10.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.803 -1.925 . . . . 10.220000000000001 105.803 -168.062 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.4 mm -74.62 -34.51 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 C-N-CA 128.921 2.888 . . . . 12.300000000000001 104.662 -171.587 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.87 -38.55 72.91 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.846 -4.284 . . . . 36.509999999999998 119.428 169.933 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -70.6 -19.3 62.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.006 -1.906 . . . . 25.66 114.839 169.916 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -79.14 -37.31 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 118.048 -1.461 . . . . 8.1199999999999992 110.948 175.884 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -67.96 -30.31 69.57 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 130.575 3.55 . . . . 15.470000000000001 111.033 176.568 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.69 -41.84 36.63 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.874 -2.391 . . . . 11.449999999999999 111.771 -175.755 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -61.21 -34.23 74.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.102 -2.874 . . . . 24.98 113.546 170.304 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.299 65.9 mt -65.17 -39.8 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 125.532 1.77 . . . . 9.4600000000000009 115.701 169.531 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -57.64 -53.41 58.51 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.728 -3.733 . . . . 14.76 112.541 173.78 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -67.83 -44.82 76.33 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.112 -2.313 . . . . 26.289999999999999 115.68 -177.6 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -83.02 -50.22 8.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.088 -1.434 . . . . 30.059999999999999 113.985 -178.678 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -94.76 -55.64 3.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.134 2.397 . . . . 25.190000000000001 111.438 -176.655 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.64 40.74 2.47 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 118.559 -1.781 . . . . 7.4100000000000001 117.141 -176.512 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.1 mm -90.04 131.17 39.87 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 118.275 -2.897 . . . . 9.4900000000000002 109.006 167.778 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -67.93 144.21 63.61 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 128.101 3.929 . . . . 11.42 118.298 -174.58 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -81.61 -3.59 11.96 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 124.082 3.188 . . . . 12.0 114.639 -163.502 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.83 -23.57 45.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.066 -1.646 . . . . 35.549999999999997 115.428 165.661 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -89.53 -24.18 21.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.35 1.86 . . . . 20.52 111.234 -179.754 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -78.8 96.63 5.67 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.195 -2.191 . . . . 7.1299999999999999 109.951 -173.177 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -109.28 127.05 53.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.408 -2.441 . . . . 36.390000000000001 104.408 171.706 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.8 mt -107.28 127.26 53.39 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 116.871 -1.538 . . . . 9.5500000000000007 108.672 -168.368 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 51.7 mm -117.92 137.79 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 125.323 1.639 . . . . 13.9 109.14 179.404 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -131.42 127.59 37.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 125.211 3.642 . . . . 6.8600000000000003 106.736 155.951 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.75 -106.89 0.35 Allowed 'General case' 0 N--CA 1.429 -1.482 1 C-N-CA 132.203 4.201 . . . . 11.15 113.649 -171.759 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.32 6.2 19.13 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.118 -2.239 . . . . 13.93 109.267 -177.761 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -122.4 142.1 50.89 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 116.068 -4.196 . . . . 23.920000000000002 107.989 -174.194 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -76.26 137.55 40.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.22 -1.355 . . . . 23.23 110.594 175.093 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.5 mt -86.04 112.85 21.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.0 -1.0 . . . . 9.1099999999999994 111.01 179.845 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -88.3 137.57 32.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 128.127 3.822 . . . . 33.439999999999998 109.907 -178.442 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.32 -62.44 1.48 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 110.023 -3.262 . . . . 28.370000000000001 116.372 -164.054 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.7 19.4 37.33 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 117.735 -3.103 . . . . 15.0 114.077 -171.73 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -92.38 171.08 9.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.452 2.019 . . . . 25.5 116.452 166.348 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 p -98.38 161.23 13.79 Favored 'General case' 0 N--CA 1.43 -1.459 1 CA-C-O 128.569 4.033 . . . . 11.949999999999999 110.269 178.856 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.325 5.5 mp -68.8 -36.99 78.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 111.362 -2.654 . . . . 10.17 110.604 172.377 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 p -50.92 -39.57 54.88 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.132 2.271 . . . . 13.59 117.132 162.865 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.9 -29.37 67.63 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.127 1.899 . . . . 11.699999999999999 116.127 -177.369 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -94.58 0.73 55.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.783 2.433 . . . . 12.949999999999999 115.382 178.002 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m120 68.05 33.0 4.73 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.299 -1.319 . . . . 25.449999999999999 113.701 -179.733 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.255 86.5 mt -78.47 116.4 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 124.848 1.259 . . . . 14.6 109.099 -174.065 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -93.05 173.35 7.78 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.117 -2.864 . . . . 33.229999999999997 109.974 -174.126 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -75.8 150.25 37.75 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.642 -3.161 . . . . 25.969999999999999 113.237 175.127 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.311 88.4 mt-10 64.83 39.97 5.78 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 131.568 3.947 . . . . 32.609999999999999 109.985 176.813 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.1 m -103.09 145.85 29.28 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.358 3.063 . . . . 10.56 112.064 -179.725 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -96.43 116.35 28.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 118.17 -1.412 . . . . 5.3300000000000001 112.828 -178.073 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.02 157.3 20.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.767 1.765 . . . . 11.66 115.767 165.364 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.457 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 10.9 m-70 -105.52 112.23 25.24 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.01 -2.931 . . . . 16.300000000000001 116.108 172.086 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 15.5 tp -96.21 104.86 16.85 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 119.857 -0.737 . . . . 9.9600000000000009 111.391 175.886 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.02 155.86 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 125.466 1.506 . . . . 9.7599999999999998 114.304 -166.259 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.3 tp . . . . . 0 N--CA 1.43 -1.436 0 O-C-N 118.662 -2.523 . . . . 19.57 115.384 -179.548 . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 118.112 -0.947 . . . . 17.170000000000002 110.291 . . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -101.58 159.22 15.48 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.033 1.873 . . . . 21.890000000000001 113.826 165.719 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -135.8 157.29 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 126.227 1.811 . . . . 10.83 106.452 -179.696 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -112.07 117.46 32.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.874 -3.016 . . . . 10.609999999999999 112.809 175.613 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.7 t -99.15 122.26 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 102.919 -2.993 . . . . 9.1300000000000008 102.919 -175.435 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -122.87 120.87 34.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.136 -1.602 . . . . 20.550000000000001 112.071 -171.021 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.402 HG22 HD23 ' A' ' 69' ' ' LEU . 30.6 p -92.86 176.87 6.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.889 1.675 . . . . 11.779999999999999 109.626 -169.672 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -79.59 -31.8 41.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.863 -1.971 . . . . 19.309999999999999 113.027 -171.446 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.15 -62.88 1.36 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.047 1.739 . . . . 23.140000000000001 108.573 174.904 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.9 37.56 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.66 1 C-N-CA 113.35 -4.262 . . . . 19.739999999999998 106.365 156.921 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -88.77 130.33 35.38 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.105 -2.409 . . . . 21.93 109.646 -176.846 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -103.26 101.8 11.74 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.746 -1.575 . . . . 12.33 106.746 -178.11 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mt -93.19 131.82 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.892 -1.892 . . . . 17.079999999999998 105.892 -175.027 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 m -80.78 114.72 19.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.126 -1.805 . . . . 16.300000000000001 106.126 166.074 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 tp -127.89 125.28 39.34 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.954 2.101 . . . . 15.880000000000001 106.721 -177.946 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -103.26 133.63 48.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.945 -2.972 . . . . 28.899999999999999 110.937 -176.415 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -162.05 164.37 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 104.886 -2.264 . . . . 12.050000000000001 104.886 -160.252 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -126.64 141.25 39.68 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 117.594 -1.193 . . . . 18.170000000000002 111.244 177.953 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -67.17 -15.41 46.23 Favored 'Trans proline' 0 C--N 1.3 -1.98 1 C-N-CA 127.05 5.167 . . . . 8.1600000000000001 113.389 -166.739 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -89.49 -13.62 37.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 123.226 2.739 . . . . 11.130000000000001 112.27 -172.774 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.75 170.35 9.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.831 2.729 . . . . 18.030000000000001 108.019 -177.177 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -89.49 172.1 9.24 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.901 -2.999 . . . . 10.220000000000001 110.617 -164.496 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -70.83 -30.21 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.142 -2.224 . . . . 12.300000000000001 109.474 175.486 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -49.09 -39.06 26.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.513 -3.242 . . . . 36.509999999999998 115.702 161.711 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -64.63 -48.72 73.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.58 -1.95 . . . . 25.66 111.512 171.408 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.7 -44.51 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 117.899 2.555 . . . . 8.1199999999999992 117.899 173.322 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -53.69 -35.64 61.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.286 -2.759 . . . . 15.470000000000001 116.922 168.49 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.56 -21.65 61.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.02 2.6 . . . . 11.449999999999999 118.02 -177.98 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -86.52 -32.63 20.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 130.61 3.564 . . . . 24.98 108.432 -175.992 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.2 mt -76.81 -33.07 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 119.768 1.167 . . . . 9.4600000000000009 109.28 175.036 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -54.1 -36.53 63.31 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.509 2.04 . . . . 14.76 116.509 167.641 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.54 -54.9 4.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.475 1.287 . . . . 26.289999999999999 114.475 -178.658 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -71.15 -73.86 0.16 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.805 1.941 . . . . 30.059999999999999 112.107 -174.951 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.44 -37.18 82.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.015 2.228 . . . . 25.190000000000001 117.015 173.49 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.0 30.11 11.68 Favored Glycine 0 N--CA 1.43 -1.718 1 O-C-N 115.624 -4.423 . . . . 7.4100000000000001 115.611 -176.493 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mm -87.12 125.59 65.67 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-O 115.911 -1.995 . . . . 9.4900000000000002 116.221 169.692 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -83.87 161.91 13.99 Favored 'Trans proline' 0 C--N 1.3 -2.002 1 CA-C-N 129.345 4.373 . . . . 11.42 114.91 -172.799 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -86.02 -11.8 6.33 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 123.465 2.273 . . . . 12.0 114.333 -142.658 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.52 -4.5 59.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.873 3.669 . . . . 35.549999999999997 114.971 168.059 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.27 57.9 mt-30 -106.54 6.0 29.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.34 -1.475 . . . . 20.52 110.964 176.471 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -99.57 101.16 12.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.813 2.097 . . . . 7.1299999999999999 113.126 -177.002 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -99.15 109.81 22.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.355 1.074 . . . . 36.390000000000001 112.229 174.423 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 mt -103.92 136.22 43.98 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.642 -1.163 . . . . 9.5500000000000007 113.729 177.914 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.33 131.91 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.955 2.034 . . . . 13.9 106.267 -179.92 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -116.62 125.66 52.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.111 -1.44 . . . . 6.8600000000000003 107.111 163.884 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.346 . . 59.18 -106.09 0.28 Allowed 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.613 2.149 . . . . 11.15 116.112 -171.107 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.88 57.14 0.71 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 120.074 -1.641 . . . . 13.93 114.435 159.92 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -145.45 146.2 31.4 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.704 2.802 . . . . 23.920000000000002 108.803 178.817 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -93.48 130.65 39.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.864 2.603 . . . . 23.23 110.618 175.405 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -87.26 114.47 23.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.573 -3.204 . . . . 9.1099999999999994 110.73 -170.817 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.21 153.36 18.66 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.318 2.485 . . . . 33.439999999999998 109.331 -169.979 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -52.61 -49.26 65.42 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 117.01 -3.556 . . . . 28.370000000000001 116.756 -159.036 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.18 4.52 77.65 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 119.74 -1.85 . . . . 15.0 114.709 -171.376 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -83.71 163.88 19.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.302 -2.881 . . . . 25.5 106.896 -178.373 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -102.66 173.55 6.28 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.424 2.009 . . . . 11.949999999999999 116.424 170.949 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 mt -79.39 -29.46 42.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.455 -1.403 . . . . 10.17 108.327 177.378 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.9 p -65.51 -27.84 68.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.434 -1.27 . . . . 13.59 111.953 177.715 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.28 -56.48 21.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.825 2.05 . . . . 11.699999999999999 110.143 177.62 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.529 ' HB2' HG13 ' A' ' 61' ' ' ILE . 49.7 m-85 -83.11 3.42 30.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.479 -1.237 . . . . 12.949999999999999 113.327 -173.443 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 m120 49.05 61.56 3.06 Favored 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 134.361 5.064 . . . . 25.449999999999999 112.343 -169.274 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.529 HG13 ' HB2' ' A' ' 59' ' ' TYR . 74.9 mt -89.88 116.26 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 103.267 -2.864 . . . . 14.6 103.267 -177.604 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -99.19 -167.85 1.54 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.041 3.782 . . . . 33.229999999999997 110.816 -171.368 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -75.8 148.3 38.54 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 113.718 -5.614 . . . . 25.969999999999999 110.213 -177.411 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 35.17 63.55 0.49 Allowed 'General case' 0 N--CA 1.43 -1.459 2 C-N-CA 134.846 5.258 . . . . 32.609999999999999 115.463 -172.992 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.9 t -120.33 146.45 46.12 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 129.461 3.105 . . . . 10.56 108.602 -172.639 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.7 m -77.98 119.05 20.88 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.642 2.464 . . . . 5.3300000000000001 107.543 -175.266 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.96 132.0 53.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.029 -1.045 . . . . 11.66 108.2 158.128 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -85.58 141.23 29.99 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.987 -4.196 . . . . 16.300000000000001 110.71 174.802 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 7' ' ' THR . 18.2 tp -119.28 127.51 53.29 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.273 2.694 . . . . 9.9600000000000009 118.273 175.094 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.31 -160.73 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 123.463 1.601 . . . . 9.7599999999999998 108.548 -178.601 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp . . . . . 0 N--CA 1.429 -1.503 0 CA-C-N 112.535 -2.12 . . . . 19.57 114.161 -174.494 . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.36 0.3 OUTLIER . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 122.441 1.115 . . . . 17.170000000000002 110.066 . . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -88.65 115.67 26.34 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.451 3.1 . . . . 21.890000000000001 113.344 179.923 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.81 171.05 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 118.88 -2.388 . . . . 10.83 104.998 166.565 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -121.6 147.56 45.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.71 2.804 . . . . 10.609999999999999 106.24 173.615 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -128.68 120.92 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 104.009 -2.589 . . . . 9.1300000000000008 104.009 172.671 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -102.29 127.8 49.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.602 2.361 . . . . 20.550000000000001 110.994 -171.355 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.9 p -89.6 169.09 11.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.195 2.426 . . . . 11.779999999999999 109.223 -173.941 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.7 mt -51.55 -40.53 59.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.347 2.259 . . . . 19.309999999999999 115.488 164.384 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.8 p -94.54 -71.69 0.65 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 125.336 1.648 . . . . 23.140000000000001 111.861 -165.507 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.97 48.67 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 120.611 -1.306 . . . . 19.739999999999998 115.94 178.053 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -119.09 140.68 49.69 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.218 1.562 . . . . 21.93 115.218 170.077 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.5 m -104.8 105.85 16.1 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.074 -4.766 . . . . 12.33 108.817 174.181 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.5 mt -91.4 105.43 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 O-C-N 114.552 -5.093 . . . . 17.079999999999998 107.747 -171.539 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -82.52 122.8 28.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.674 1.731 . . . . 16.300000000000001 115.674 178.19 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.5 tp -123.86 154.92 38.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.101 2.228 . . . . 15.880000000000001 113.966 -167.221 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -112.35 129.14 56.4 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.203 1.954 . . . . 28.899999999999999 110.848 165.181 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -148.46 170.34 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 130.292 3.437 . . . . 12.050000000000001 107.781 -179.237 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -120.95 165.18 19.6 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 107.035 -1.468 . . . . 18.170000000000002 107.035 166.564 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -69.9 -21.44 32.82 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-O 127.374 2.989 . . . . 8.1600000000000001 117.789 -172.325 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 m -78.83 -4.91 51.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 111.374 -2.648 . . . . 11.130000000000001 113.279 177.411 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.291 69.3 m-20 -78.35 143.04 37.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.34 2.019 . . . . 18.030000000000001 114.12 173.888 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 2.3 p -89.05 156.59 18.75 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.003 -2.311 . . . . 10.220000000000001 111.524 -168.894 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.7 mm -61.86 -33.92 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 118.55 2.796 . . . . 12.300000000000001 118.55 -179.072 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -44.79 -45.86 10.27 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 120.124 3.379 . . . . 36.509999999999998 120.124 161.623 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -72.63 -44.76 61.5 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.675 2.39 . . . . 25.66 111.097 -177.991 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.92 -48.48 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 114.849 1.426 . . . . 8.1199999999999992 114.849 177.735 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -54.44 -44.34 72.4 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.719 2.008 . . . . 15.470000000000001 115.412 171.439 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.309 . . -48.21 -46.25 34.88 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 120.117 3.377 . . . . 11.449999999999999 120.117 160.663 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -68.7 -35.36 77.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.883 -3.011 . . . . 24.98 114.946 175.066 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.302 63.2 mt -51.62 -49.57 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 110.74 -2.936 . . . . 9.4600000000000009 111.227 172.641 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -64.52 -24.57 67.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.79 3.236 . . . . 14.76 114.704 -179.776 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.48 -30.76 69.68 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.198 -4.064 . . . . 26.289999999999999 111.799 168.882 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -79.3 -66.65 0.84 Allowed 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 116.169 -4.082 . . . . 30.059999999999999 107.588 -173.711 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -121.71 145.57 47.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 103.133 -2.914 . . . . 25.190000000000001 103.133 -173.705 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.64 64.56 4.27 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 117.444 -1.753 . . . . 7.4100000000000001 112.824 -169.84 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.9 mm -110.97 109.7 57.19 Favored Pre-proline 0 N--CA 1.43 -1.473 1 CA-C-O 109.491 -5.052 . . . . 9.4900000000000002 108.443 -173.658 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.12 135.56 69.39 Favored 'Trans proline' 0 C--N 1.299 -2.034 1 C-N-CA 125.445 4.096 . . . . 11.42 115.276 -173.954 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.89 -19.32 65.31 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 CA-C-N 125.3 2.929 . . . . 12.0 116.442 -177.313 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.16 -16.46 49.72 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.271 -1.518 . . . . 35.549999999999997 112.053 175.191 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -99.36 -15.18 18.88 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.162 -2.211 . . . . 20.52 106.447 -177.112 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -77.71 121.76 24.44 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.91 -2.369 . . . . 7.1299999999999999 111.884 -175.987 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -121.31 110.45 16.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.295 -3.378 . . . . 36.390000000000001 104.93 175.055 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.7 mt -94.22 105.48 17.46 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 103.644 -2.724 . . . . 9.5500000000000007 103.644 -174.831 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mm -88.22 133.98 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 126.945 2.098 . . . . 13.9 108.874 167.777 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CE2' HG12 ' A' ' 61' ' ' ILE . 70.6 t80 -137.51 109.09 6.98 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 101.444 -3.539 . . . . 6.8600000000000003 101.444 -175.495 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.43 -108.0 0.22 Allowed 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 114.236 -1.347 . . . . 11.15 113.9 -164.784 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.67 -16.71 25.74 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-O 115.774 -2.681 . . . . 13.93 112.584 177.837 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -113.59 147.25 38.39 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.965 2.383 . . . . 23.920000000000002 112.947 -163.001 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -73.95 127.73 33.64 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 127.506 3.527 . . . . 23.23 113.899 159.389 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.32 83.7 mt -78.4 132.99 37.57 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.556 -1.965 . . . . 9.1099999999999994 107.278 170.787 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -106.37 151.27 25.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.628 2.156 . . . . 33.439999999999998 115.473 -170.164 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.35 3.6 m-20 -46.99 -55.05 8.82 Favored 'General case' 0 N--CA 1.43 -1.469 1 N-CA-C 123.673 4.694 . . . . 28.370000000000001 123.673 -164.766 . . . . . . . . 3 2 . 1 . 085 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 5.35 78.52 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 122.128 0.849 . . . . 15.0 113.016 -170.812 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -105.11 152.77 22.38 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.532 1.933 . . . . 25.5 111.626 -172.384 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 56.3 p -89.47 174.25 7.89 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 118.907 -0.568 . . . . 11.949999999999999 109.666 179.582 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.71 -34.91 60.39 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.021 0.915 . . . . 10.17 110.078 174.603 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.7 p -57.57 -40.93 80.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.507 3.523 . . . . 13.59 110.342 173.416 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.11 -44.92 32.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.654 -3.154 . . . . 11.699999999999999 115.904 174.952 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.313 98.3 m-85 -92.37 2.23 56.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.06 -2.9 . . . . 12.949999999999999 115.338 172.101 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.285 18.0 m120 65.38 38.99 5.45 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 117.724 2.491 . . . . 25.449999999999999 117.724 176.267 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.487 HG12 ' CE2' ' A' ' 45' ' ' PHE . 57.2 mt -74.19 138.67 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.665 2.386 . . . . 14.6 108.015 172.934 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -129.66 -167.07 1.75 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.83 -2.419 . . . . 33.229999999999997 108.125 -176.3 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -76.77 158.56 30.81 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.863 -3.023 . . . . 25.969999999999999 113.318 -173.836 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 68.05 20.32 9.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.967 -2.958 . . . . 32.609999999999999 113.306 177.043 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.8 t -106.56 143.49 34.6 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.106 2.962 . . . . 10.56 116.857 -172.682 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -100.97 129.44 46.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.696 0.998 . . . . 5.3300000000000001 113.696 -173.993 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -104.12 152.56 21.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.474 -1.676 . . . . 11.66 106.474 173.171 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -115.74 124.53 51.02 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 116.863 -3.648 . . . . 16.300000000000001 108.677 -176.726 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tp -103.66 107.69 18.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.13 -1.606 . . . . 9.9600000000000009 108.851 -170.075 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.89 158.81 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 124.874 1.359 . . . . 9.7599999999999998 109.739 -179.265 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.7 tp . . . . . 0 N--CA 1.43 -1.446 0 CA-C-O 124.557 2.123 . . . . 19.57 112.394 -178.925 . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 121.559 0.695 . . . . 17.170000000000002 111.82 . . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -113.77 145.05 41.97 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.199 -4.688 . . . . 21.890000000000001 111.435 -172.196 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.26 161.55 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.339 -2.725 . . . . 10.83 109.15 169.799 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -105.11 145.33 30.68 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.259 2.624 . . . . 10.609999999999999 110.753 167.923 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 73.8 t -123.2 125.05 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.064 -1.648 . . . . 9.1300000000000008 107.854 171.996 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -97.92 143.09 28.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.352 -2.717 . . . . 20.550000000000001 111.481 176.549 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.2 p -97.2 -177.28 3.79 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 122.407 2.367 . . . . 11.779999999999999 109.236 -173.611 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tt -76.68 -45.34 30.07 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 117.626 -1.178 . . . . 19.309999999999999 110.666 177.466 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -66.97 -54.55 20.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.264 1.393 . . . . 23.140000000000001 112.939 174.805 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.83 84.48 0.13 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 129.394 3.378 . . . . 19.739999999999998 114.18 168.328 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -132.83 152.71 51.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.845 -2.177 . . . . 21.93 106.976 171.843 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.291 26.2 m -108.83 108.61 19.47 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.465 -1.698 . . . . 12.33 112.407 171.986 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.1 mt -91.81 137.18 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 104.668 -2.345 . . . . 17.079999999999998 104.668 174.695 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 m -116.65 120.58 39.1 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.964 1.705 . . . . 16.300000000000001 111.629 175.533 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.7 mt -114.13 146.64 40.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.551 -3.218 . . . . 15.880000000000001 107.601 179.968 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.68 137.85 32.03 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 116.012 -2.275 . . . . 28.899999999999999 114.573 148.915 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 m -140.73 157.84 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.314 2.646 . . . . 12.050000000000001 104.719 -171.286 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.54 145.75 31.29 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 101.893 -3.373 . . . . 18.170000000000002 101.893 165.703 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -78.19 -7.6 16.2 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 N-CA-C 118.389 2.419 . . . . 8.1600000000000001 118.389 -174.453 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -100.46 14.64 30.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.957 -1.496 . . . . 11.130000000000001 110.614 178.566 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -107.9 160.47 15.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.912 2.142 . . . . 18.030000000000001 108.058 166.292 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -88.04 173.46 8.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 126.326 2.267 . . . . 10.220000000000001 112.748 -162.604 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mm -73.47 -26.8 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.26 -3.4 . . . . 12.300000000000001 110.027 -177.18 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.56 -21.95 66.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.45 -3.281 . . . . 36.509999999999998 117.159 169.914 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.29 -41.24 20.4 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 117.581 -1.2 . . . . 25.66 112.841 168.765 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.1 t -57.57 -40.94 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 127.547 3.03 . . . . 8.1199999999999992 116.936 173.944 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -63.73 -41.58 98.03 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 131.781 4.033 . . . . 15.470000000000001 113.183 170.694 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.71 -25.42 65.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.319 2.009 . . . . 11.449999999999999 113.495 176.458 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -79.17 -31.23 43.85 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.257 -1.527 . . . . 24.98 112.783 173.66 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.41 -34.87 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 125.401 2.524 . . . . 9.4600000000000009 112.504 170.249 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -60.0 -46.77 88.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.754 3.222 . . . . 14.76 115.849 166.671 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -54.07 -56.75 15.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.617 -3.177 . . . . 26.289999999999999 115.116 168.844 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -66.48 -80.29 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.402 -3.311 . . . . 30.059999999999999 116.829 171.703 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.89 -30.19 50.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 114.338 -5.226 . . . . 25.190000000000001 117.125 -178.126 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.18 5.17 50.06 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 125.011 3.55 . . . . 7.4100000000000001 117.148 179.524 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mm -69.92 128.83 91.5 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 114.684 1.364 . . . . 9.4900000000000002 114.684 -177.76 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -67.9 149.93 78.07 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 O-C-N 115.103 -3.157 . . . . 11.42 111.92 -170.428 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -73.68 -18.56 22.19 Favored 'Trans proline' 0 N--CA 1.433 -2.043 2 C-N-CA 127.794 5.663 . . . . 12.0 116.286 -175.853 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -68.86 -26.31 65.07 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.198 3.399 . . . . 35.549999999999997 115.258 168.797 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -95.08 -23.08 17.49 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.553 -1.658 . . . . 20.52 114.896 -172.598 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -85.75 118.43 25.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.678 -0.86 . . . . 7.1299999999999999 108.678 -171.895 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -108.79 116.14 31.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.612 1.965 . . . . 36.390000000000001 106.983 171.476 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.56 111.58 23.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.87 1.356 . . . . 9.5500000000000007 109.768 -176.788 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.93 125.09 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.062 -1.649 . . . . 13.9 106.789 179.562 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -117.71 127.16 53.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.381 2.991 . . . . 6.8600000000000003 108.84 168.39 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.31 -98.11 0.08 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.425 -3.922 . . . . 11.15 113.466 -153.503 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.07 33.96 1.69 Allowed Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 127.426 2.441 . . . . 13.93 110.432 -179.523 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -145.05 143.15 30.3 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.515 1.626 . . . . 23.920000000000002 109.437 173.273 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -80.37 124.91 29.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.575 1.655 . . . . 23.23 114.194 -178.419 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -66.24 131.59 46.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.545 2.116 . . . . 9.1099999999999994 109.184 172.813 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -82.71 158.85 22.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.633 -3.167 . . . . 33.439999999999998 113.107 178.158 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.22 -45.3 81.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.109 1.909 . . . . 28.370000000000001 115.304 -162.186 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.9 4.67 85.6 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 113.39 -1.732 . . . . 15.0 115.21 -178.434 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 -92.53 159.99 15.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 122.358 3.079 . . . . 25.5 108.735 178.969 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.4 p -86.57 171.19 11.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.72 1.248 . . . . 11.949999999999999 112.229 171.945 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.73 -33.76 66.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.334 -1.728 . . . . 10.17 106.334 172.222 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.5 p -65.7 -7.85 17.69 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 121.226 3.788 . . . . 13.59 121.226 174.179 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.11 -42.58 15.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.118 2.866 . . . . 11.699999999999999 109.518 -176.493 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -77.88 -13.56 59.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.678 2.391 . . . . 12.949999999999999 112.419 177.084 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 64.87 51.28 1.81 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.768 1.627 . . . . 25.449999999999999 112.956 -172.958 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -84.94 137.92 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.788 -2.301 . . . . 14.6 104.788 179.778 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -110.57 168.83 9.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.849 -2.407 . . . . 33.229999999999997 113.126 -175.369 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -66.81 155.41 38.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.511 -0.743 . . . . 25.969999999999999 111.569 174.221 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 50.2 mt-10 53.22 25.72 4.56 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.147 2.277 . . . . 32.609999999999999 117.147 -170.381 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 t -91.32 152.02 20.63 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.384 0.612 . . . . 10.56 110.765 169.695 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -107.98 121.37 44.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.45 3.9 . . . . 5.3300000000000001 113.145 179.664 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -97.38 163.69 12.77 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.22 1.962 . . . . 11.66 107.034 174.896 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -119.34 129.36 54.81 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.503 -4.498 . . . . 16.300000000000001 109.141 175.603 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.3 tp -105.61 119.95 40.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.293 2.637 . . . . 9.9600000000000009 112.013 179.928 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.29 -160.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.412 1 CA-C-O 128.979 4.228 . . . . 9.7599999999999998 111.05 168.903 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.5 tp . . . . . 0 N--CA 1.43 -1.451 1 O-C-N 113.997 -5.439 . . . . 19.57 112.579 -168.842 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 123.704 1.716 . . . . 17.170000000000002 112.1 . . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -97.77 130.81 44.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.066 -2.896 . . . . 21.890000000000001 110.624 177.498 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.365 9.9 pt -129.67 157.67 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 124.752 1.221 . . . . 10.83 110.941 174.389 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -111.32 143.63 41.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.163 -1.791 . . . . 10.609999999999999 106.163 -177.134 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.68 127.5 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.482 -1.235 . . . . 9.1300000000000008 107.993 167.82 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -106.13 129.4 54.22 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.533 1.635 . . . . 20.550000000000001 113.862 170.448 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -82.37 -175.15 5.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.414 1.635 . . . . 11.779999999999999 115.414 179.65 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.348 5.9 tp -67.02 -40.03 87.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.87 2.174 . . . . 19.309999999999999 116.87 177.635 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -73.05 -22.12 60.67 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.08 2.552 . . . . 23.140000000000001 112.238 -171.244 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.68 40.59 3.83 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 127.67 2.557 . . . . 19.739999999999998 109.757 -174.961 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -104.64 126.98 52.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.517 -2.073 . . . . 21.93 108.557 164.395 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -94.0 116.37 28.8 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.714 2.006 . . . . 12.33 113.412 173.827 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 pt -113.15 148.33 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.365 -2.709 . . . . 17.079999999999998 106.882 -179.291 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.422 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 15.7 m -98.81 129.37 45.21 Favored 'General case' 0 N--CA 1.43 -1.475 1 C-N-CA 134.003 4.921 . . . . 16.300000000000001 113.615 -178.21 . . . . . . . . 3 3 . 1 . 087 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.73 128.99 40.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.78 -3.075 . . . . 15.880000000000001 102.993 -177.494 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -87.16 93.97 9.52 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.721 2.808 . . . . 28.899999999999999 109.825 164.724 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.14 154.59 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 123.531 2.878 . . . . 12.050000000000001 109.494 175.973 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.88 140.09 37.43 Favored Pre-proline 0 N--CA 1.43 -1.426 0 C-N-CA 129.434 3.094 . . . . 18.170000000000002 110.841 -178.717 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -79.87 -3.56 12.86 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 124.518 2.649 . . . . 8.1600000000000001 109.432 -167.746 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -83.95 -26.02 29.61 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 114.929 -2.462 . . . . 11.130000000000001 113.368 -176.093 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -84.2 163.02 19.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.79 2.036 . . . . 18.030000000000001 114.25 -174.424 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -70.11 158.12 36.32 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.27 1.581 . . . . 10.220000000000001 115.27 -177.225 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 42.0 mm -63.52 -19.94 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 125.762 2.696 . . . . 12.300000000000001 116.954 166.382 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -74.89 -27.37 60.2 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.83 -3.044 . . . . 36.509999999999998 113.878 179.869 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -70.11 -34.05 72.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.521 2.328 . . . . 25.66 112.912 175.049 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.49 -56.93 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 CA-C-O 129.166 4.317 . . . . 8.1199999999999992 110.717 175.967 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.14 -27.13 61.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.845 -3.034 . . . . 15.470000000000001 114.604 -171.854 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.19 83.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.72 2.2 . . . . 11.449999999999999 109.286 -178.898 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -78.35 -35.65 47.17 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.285 -1.51 . . . . 24.98 108.576 -174.261 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mt -67.87 -32.26 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 125.796 2.712 . . . . 9.4600000000000009 108.233 177.183 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -69.04 -56.28 8.23 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 116.165 -4.084 . . . . 14.76 110.039 174.553 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -58.73 -24.07 60.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.061 1.744 . . . . 26.289999999999999 114.329 -178.871 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 14' ' ' THR . 50.6 mttm -78.13 -80.66 0.11 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.484 -2.01 . . . . 30.059999999999999 112.778 165.536 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -99.06 10.69 40.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.11 -3.494 . . . . 25.190000000000001 115.826 -161.124 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.87 3.5 90.46 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 117.995 -2.941 . . . . 7.4100000000000001 116.6 -175.736 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.6 mt -77.59 115.69 51.81 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 118.906 1.353 . . . . 9.4900000000000002 111.202 -169.599 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -67.95 142.31 56.42 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 O-C-N 114.313 -3.572 . . . . 11.42 112.342 -179.355 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -62.87 -21.68 73.29 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 N-CA-C 119.772 2.951 . . . . 12.0 119.772 -173.167 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -56.69 -39.06 73.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.665 1.586 . . . . 35.549999999999997 113.594 171.25 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -80.17 7.36 9.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.199 2.296 . . . . 20.52 117.199 -173.923 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -113.89 117.98 32.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 114.79 -2.529 . . . . 7.1299999999999999 110.642 -160.344 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -128.62 115.78 18.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.681 3.738 . . . . 36.390000000000001 113.011 170.985 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.9 mt -92.89 125.89 37.71 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 116.276 -4.015 . . . . 9.5500000000000007 111.81 -173.844 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -105.37 126.08 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.618 1.967 . . . . 13.9 109.518 172.132 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.4 ' HB3' HD21 ' A' ' 50' ' ' LEU . 12.9 t80 -110.22 120.0 41.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.896 3.236 . . . . 6.8600000000000003 105.401 171.886 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.409 . . 59.77 -91.07 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.548 -3.845 . . . . 11.15 118.394 -164.818 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.23 13.01 5.75 Favored Glycine 0 N--CA 1.43 -1.729 1 CA-C-O 111.115 -5.269 . . . . 13.93 109.957 160.847 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -93.31 135.86 34.13 Favored 'General case' 0 N--CA 1.43 -1.433 1 CA-C-N 124.549 4.175 . . . . 23.920000000000002 110.963 -176.918 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -75.07 99.92 4.06 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 113.938 -5.477 . . . . 23.23 113.324 167.354 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' A' ' 45' ' ' PHE . 19.6 mt -69.77 136.94 51.48 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.253 -3.404 . . . . 9.1099999999999994 113.912 178.265 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.48 136.18 38.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.286 -1.325 . . . . 33.439999999999998 113.475 -177.938 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.421 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -69.75 -30.79 68.47 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 115.055 1.502 . . . . 28.370000000000001 115.055 -156.27 . . . . . . . . 3 3 . 1 . 087 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.5 23.54 12.27 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 115.716 -2.713 . . . . 15.0 115.316 179.727 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -125.42 174.48 8.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.085 2.943 . . . . 25.5 106.841 175.56 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -96.04 167.41 11.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.728 1.728 . . . . 11.949999999999999 114.875 179.949 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.39 -43.72 79.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.111 2.862 . . . . 10.17 114.383 162.535 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.3 p -61.1 -19.44 61.46 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 114.374 -5.204 . . . . 13.59 119.243 170.831 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -58.7 -52.38 65.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.308 2.336 . . . . 11.699999999999999 117.308 167.304 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -88.36 -13.33 40.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.596 3.558 . . . . 12.949999999999999 115.002 177.884 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 m120 73.92 58.08 0.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.332 -1.729 . . . . 25.449999999999999 106.332 167.749 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -85.73 121.61 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.861 2.267 . . . . 14.6 107.055 166.571 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -107.03 175.09 5.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 109.548 -3.478 . . . . 33.229999999999997 107.306 -174.913 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -58.61 137.08 57.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.005 -2.309 . . . . 25.969999999999999 116.862 -176.318 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 84.47 7.39 0.54 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.679 3.992 . . . . 32.609999999999999 113.96 170.18 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 t -72.46 134.38 45.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.131 -1.395 . . . . 10.56 110.678 -175.496 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.5 m -102.26 103.08 13.54 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.706 -3.746 . . . . 5.3300000000000001 113.418 -171.785 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.63 159.55 14.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.231 -3.248 . . . . 11.66 102.231 -165.085 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -101.73 140.85 35.46 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 118.181 -2.824 . . . . 16.300000000000001 108.92 170.897 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.5 tp -102.22 136.66 41.66 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 102.138 -3.282 . . . . 9.9600000000000009 102.138 169.369 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 m -134.71 175.01 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.615 2.366 . . . . 9.7599999999999998 105.991 173.576 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.6 tp . . . . . 0 N--CA 1.43 -1.447 0 CA-C-N 112.235 -2.257 . . . . 19.57 116.685 -171.341 . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ptt? . . . . . 0 CA--C 1.491 -1.309 0 CA-C-O 125.056 2.36 . . . . 17.170000000000002 109.477 . . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -104.57 138.93 40.19 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.796 -2.456 . . . . 21.890000000000001 110.883 -172.822 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.284 44.0 pt -136.21 144.84 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 102.505 -3.146 . . . . 10.83 102.505 165.785 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -107.97 139.05 43.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.52 0.728 . . . . 10.609999999999999 109.647 173.903 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.7 t -121.58 114.38 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.657 -2.349 . . . . 9.1300000000000008 104.657 179.027 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 42.4 mttm -83.89 124.79 31.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.115 2.388 . . . . 20.550000000000001 105.405 166.283 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.323 17.7 p -77.85 178.24 7.57 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.962 2.315 . . . . 11.779999999999999 110.2 -174.886 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 tp -78.38 -32.7 49.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.274 -3.391 . . . . 19.309999999999999 111.705 171.947 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -74.79 -33.19 62.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.966 -2.333 . . . . 23.140000000000001 113.44 170.576 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.42 60.26 0.52 Allowed Glycine 0 N--CA 1.429 -1.77 0 CA-C-O 123.197 1.443 . . . . 19.739999999999998 115.124 169.436 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 30.8 mtpt -118.54 152.5 35.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.563 1.945 . . . . 21.93 113.585 162.099 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -105.72 96.89 6.81 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.248 1.975 . . . . 12.33 108.813 174.084 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.286 3.4 pt -89.45 150.24 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.407 -3.308 . . . . 17.079999999999998 109.943 -179.98 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -111.22 124.4 52.14 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.819 -0.752 . . . . 16.300000000000001 110.573 -176.046 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.66 147.11 29.93 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.865 1.317 . . . . 15.880000000000001 108.045 176.897 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -105.35 90.36 3.4 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 130.051 3.34 . . . . 28.899999999999999 111.599 166.327 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.95 162.1 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 125.975 2.797 . . . . 12.050000000000001 112.528 175.979 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.43 147.83 33.55 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 119.461 -2.024 . . . . 18.170000000000002 106.601 173.738 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.37 -9.47 23.08 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-O 115.99 -1.754 . . . . 8.1600000000000001 111.939 -177.54 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.5 p -88.62 -3.92 58.68 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.258 2.623 . . . . 11.130000000000001 114.238 173.078 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -68.84 148.6 50.02 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.374 -2.454 . . . . 18.030000000000001 104.374 178.897 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.8 p -87.9 155.13 20.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.62 -1.173 . . . . 10.220000000000001 109.789 172.096 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.6 mm -52.08 -37.57 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 128.461 2.704 . . . . 12.300000000000001 110.69 176.605 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.83 -42.53 99.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.685 3.194 . . . . 36.509999999999998 114.978 174.924 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -67.06 -36.28 81.67 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.751 -2.022 . . . . 25.66 115.171 173.186 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.72 -37.33 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 114.569 1.322 . . . . 8.1199999999999992 114.569 177.663 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 55.3 mtmt -57.51 -42.02 81.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.206 -2.809 . . . . 15.470000000000001 117.898 171.966 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.16 -31.68 61.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.128 2.269 . . . . 11.449999999999999 117.128 170.889 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -67.76 -36.2 80.08 Favored 'General case' 0 N--CA 1.43 -1.44 1 N-CA-C 122.081 4.104 . . . . 24.98 122.081 165.094 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.5 mt -57.71 -40.58 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 116.17 1.915 . . . . 9.4600000000000009 116.17 159.821 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -56.89 -40.68 76.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 113.617 -3.087 . . . . 14.76 117.224 162.481 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -65.77 -38.07 88.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.622 3.076 . . . . 26.289999999999999 111.694 177.717 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -73.88 -70.39 0.38 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.697 1.999 . . . . 30.059999999999999 115.191 178.226 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -92.4 -9.28 42.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.495 3.517 . . . . 25.190000000000001 120.495 -172.335 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.52 53.27 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 117.678 -3.139 . . . . 7.4100000000000001 109.777 177.535 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.6 mt -107.45 123.28 38.58 Favored Pre-proline 0 N--CA 1.43 -1.469 0 O-C-N 125.331 1.254 . . . . 9.4900000000000002 109.879 -178.518 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.02 127.72 27.23 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 124.098 3.199 . . . . 11.42 115.084 177.903 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -63.75 -7.61 13.43 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 125.059 3.839 . . . . 12.0 116.762 171.586 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -68.83 -28.62 66.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.716 2.487 . . . . 35.549999999999997 117.716 164.263 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -101.99 4.37 39.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.025 -3.547 . . . . 20.52 111.182 -172.324 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -95.02 134.32 37.83 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.285 1.993 . . . . 7.1299999999999999 113.04 -173.804 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.307 40.1 ttm180 -133.07 107.38 8.19 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.172 -1.831 . . . . 36.390000000000001 111.309 168.725 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.48 116.87 12.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 114.319 -2.753 . . . . 9.5500000000000007 112.867 170.979 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 49' ' ' GLN . 34.3 mm -109.07 135.95 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 123.151 2.705 . . . . 13.9 113.346 171.186 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -112.99 114.48 26.97 Favored 'General case' 0 N--CA 1.429 -1.475 2 O-C-N 113.141 -5.975 . . . . 6.8600000000000003 110.074 173.802 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.365 . . 68.18 -87.58 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.176 -3.452 . . . . 11.15 113.879 -170.012 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.64 5.03 6.2 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 126.253 1.882 . . . . 13.93 111.643 163.394 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -92.38 120.82 33.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 118.558 1.179 . . . . 23.920000000000002 113.638 -171.099 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.453 ' HA ' HD11 ' A' ' 44' ' ' ILE . 32.6 tt0 -82.17 111.87 18.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.373 3.464 . . . . 23.23 112.88 173.058 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -69.53 139.74 53.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.209 -2.807 . . . . 9.1099999999999994 110.007 -173.232 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -81.54 156.73 25.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.832 -1.556 . . . . 33.439999999999998 109.593 169.156 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -84.03 -47.27 11.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.027 1.739 . . . . 28.370000000000001 111.847 -167.695 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.98 37.91 2.36 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 116.514 -3.866 . . . . 15.0 117.658 176.957 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -113.2 178.12 4.39 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.575 -2.72 . . . . 25.5 110.736 164.361 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.8 p -101.55 173.81 6.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.338 -1.476 . . . . 11.949999999999999 111.62 168.695 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.6 mt -67.79 -26.92 66.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.344 1.069 . . . . 10.17 112.175 171.597 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.5 p -82.36 -25.14 34.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.096 1.358 . . . . 13.59 111.738 -175.992 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -58.05 -39.9 79.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 123.193 2.724 . . . . 11.699999999999999 116.453 162.339 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.297 24.3 m-85 -89.93 3.7 52.27 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.552 2.427 . . . . 12.949999999999999 117.552 175.843 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 73.4 m-20 67.82 38.73 2.81 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.475 1.51 . . . . 25.449999999999999 112.133 171.161 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.9 mt -89.71 108.84 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.167 -2.16 . . . . 14.6 105.167 178.847 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -83.67 174.85 10.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 128.069 3.795 . . . . 33.229999999999997 110.31 174.249 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -66.68 158.52 29.86 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.258 -3.401 . . . . 25.969999999999999 112.846 176.568 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.316 10.5 mt-10 57.28 20.76 6.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.357 2.263 . . . . 32.609999999999999 116.638 -179.919 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 m -80.57 129.8 34.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.227 2.611 . . . . 10.56 115.96 172.808 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 m -90.45 116.86 28.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.788 -3.07 . . . . 5.3300000000000001 111.354 172.836 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -91.6 155.61 18.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.403 -2.073 . . . . 11.66 105.403 174.123 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -106.23 152.23 23.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 114.325 -2.95 . . . . 16.300000000000001 110.39 169.088 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.4 tp -121.95 113.32 19.44 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.918 3.886 . . . . 9.9600000000000009 109.533 174.685 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 m -121.47 -172.43 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 128.617 2.767 . . . . 9.7599999999999998 104.897 178.17 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 124.901 2.286 . . . . 19.57 110.123 -164.834 . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.573 1.323 . . . . 17.170000000000002 114.573 . . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.68 129.73 38.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 126.911 3.243 . . . . 21.890000000000001 107.673 -167.98 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.301 24.9 pt -124.21 154.21 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 O-C-N 117.023 -3.548 . . . . 10.83 110.077 171.831 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -114.21 136.32 53.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.532 1.933 . . . . 10.609999999999999 114.092 -178.858 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.6 t -117.31 103.39 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 100.322 -3.955 . . . . 9.1300000000000008 100.322 178.309 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -94.42 152.78 18.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.104 -3.497 . . . . 20.550000000000001 110.105 -177.713 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.269 58.4 p -106.71 175.77 5.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 118.005 2.595 . . . . 11.779999999999999 118.005 -163.743 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.4 tp -77.52 -51.79 10.14 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.621 -1.172 . . . . 19.309999999999999 113.25 167.92 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 81.7 p -64.47 -59.71 4.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.197 -3.439 . . . . 23.140000000000001 115.252 174.773 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.77 -35.98 0.21 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 114.933 -3.148 . . . . 19.739999999999998 118.931 179.078 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -82.96 98.98 9.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 125.905 1.591 . . . . 21.93 110.107 -168.193 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -50.92 133.54 26.7 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.783 1.401 . . . . 12.33 114.783 178.441 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 mt -93.4 129.92 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 129.488 3.115 . . . . 17.079999999999998 106.891 176.426 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.3 m -119.6 111.43 18.06 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.854 -3.654 . . . . 16.300000000000001 108.493 -170.177 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.7 mt -113.8 149.62 34.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.499 -2.625 . . . . 15.880000000000001 111.82 178.22 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -104.67 136.34 44.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.329 -1.482 . . . . 28.899999999999999 110.65 163.172 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 m -132.82 172.64 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.021 -1.675 . . . . 12.050000000000001 107.641 -173.142 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -113.28 150.37 42.96 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 102.31 -3.218 . . . . 18.170000000000002 102.31 166.797 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.87 -2.97 13.21 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 CA-C-N 122.943 2.087 . . . . 8.1600000000000001 116.468 -175.547 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -70.82 -25.49 62.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 128.284 3.49 . . . . 11.130000000000001 117.078 159.037 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -67.81 150.45 48.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 129.407 3.083 . . . . 18.030000000000001 110.79 179.646 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -98.1 160.45 14.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.035 -2.888 . . . . 10.220000000000001 114.41 -173.865 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.7 mm -52.44 -32.53 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 121.668 2.031 . . . . 12.300000000000001 113.065 166.441 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.32 1.5 tt0 -51.78 -51.27 57.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 117.873 2.546 . . . . 36.509999999999998 117.873 160.761 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -63.71 -33.31 75.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 124.531 3.332 . . . . 25.66 111.036 177.344 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.12 -37.65 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.639 -1.913 . . . . 8.1199999999999992 109.564 177.595 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.794 1.775 . . . . 15.470000000000001 115.794 173.486 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.39 -19.25 62.29 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.736 1.614 . . . . 11.449999999999999 114.595 -179.079 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -91.21 -19.82 22.63 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.735 -3.103 . . . . 24.98 108.179 176.535 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.9 mt -76.71 -34.15 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 117.803 -3.061 . . . . 9.4600000000000009 108.476 167.098 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -52.86 -49.05 66.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.646 2.165 . . . . 14.76 110.962 169.823 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.04 -52.96 44.31 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.946 1.699 . . . . 26.289999999999999 110.427 -178.204 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -67.43 -69.23 0.33 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.196 -1.565 . . . . 30.059999999999999 115.052 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -87.81 -53.99 4.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.418 -2.676 . . . . 25.190000000000001 113.389 -175.518 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.05 54.21 0.39 Allowed Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 117.632 1.813 . . . . 7.4100000000000001 117.632 -165.601 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.43 123.61 27.56 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 128.377 3.046 . . . . 9.4900000000000002 104.859 176.022 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.69 125.25 18.41 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 124.837 3.691 . . . . 11.42 113.44 168.224 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.74 -28.17 55.84 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 121.336 3.552 . . . . 12.0 121.336 174.192 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.25 17.1 p-10 -51.73 -37.22 50.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.242 2.312 . . . . 35.549999999999997 117.242 167.174 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -86.91 -7.79 57.86 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.918 1.451 . . . . 20.52 114.918 -175.892 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -89.06 141.36 28.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.059 2.361 . . . . 7.1299999999999999 114.284 177.92 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -132.66 140.78 48.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.902 3.239 . . . . 36.390000000000001 106.155 164.018 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -118.81 130.59 55.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.674 -3.766 . . . . 9.5500000000000007 105.668 -177.683 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.7 tt -122.92 133.14 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.149 -3.47 . . . . 13.9 110.129 174.154 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -82.76 -66.75 0.85 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.193 1.949 . . . . 6.8600000000000003 109.458 174.389 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.81 -75.4 0.58 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.152 3.381 . . . . 11.15 115.547 -178.847 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.89 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.081 -0.963 . . . . 13.93 115.403 -174.306 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -83.51 138.06 33.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.596 1.665 . . . . 23.920000000000002 110.373 -172.938 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.21 133.87 36.06 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 118.484 2.772 . . . . 23.23 118.484 -169.757 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.3 mt -90.36 151.15 21.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.438 2.695 . . . . 9.1099999999999994 113.927 -169.724 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -100.59 137.31 39.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.409 3.083 . . . . 33.439999999999998 109.873 177.892 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -72.32 -50.35 27.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.439 -2.663 . . . . 28.370000000000001 104.969 -157.537 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.4 37.75 3.32 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 118.123 -2.861 . . . . 15.0 110.874 -169.623 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -93.14 152.51 19.2 Favored 'General case' 0 N--CA 1.431 -1.413 1 C-N-CA 132.929 4.491 . . . . 25.5 111.756 158.594 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.1 p -97.96 171.55 8.2 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.957 1.837 . . . . 11.949999999999999 106.416 -172.24 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.14 -47.42 68.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.558 1.647 . . . . 10.17 112.571 173.276 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -84.96 -11.35 55.71 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.477 3.111 . . . . 13.59 113.932 -173.17 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.1 -47.99 77.87 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.705 1.717 . . . . 11.699999999999999 108.657 164.277 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -93.0 12.45 23.94 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 114.837 -4.914 . . . . 12.949999999999999 112.214 -176.464 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 59.92 31.07 20.53 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.279 2.232 . . . . 25.449999999999999 111.205 171.954 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.3 mt -82.45 120.75 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 124.204 1.001 . . . . 14.6 108.535 177.384 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -100.7 -172.31 2.17 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.962 1.363 . . . . 33.229999999999997 113.284 179.419 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -69.15 151.15 46.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.403 -3.31 . . . . 25.969999999999999 115.829 177.342 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 28.4 mt-10 66.66 20.28 10.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.429 2.692 . . . . 32.609999999999999 112.214 177.711 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -88.07 144.08 26.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.431 1.892 . . . . 10.56 112.87 179.833 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -97.79 122.33 40.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.395 -1.729 . . . . 5.3300000000000001 107.371 -174.363 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mp -97.19 166.41 11.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.796 3.238 . . . . 11.66 108.418 159.238 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -137.57 132.17 32.73 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.496 -2.628 . . . . 16.300000000000001 111.656 174.411 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.6 tp -87.98 121.6 30.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.14 2.576 . . . . 9.9600000000000009 106.6 -171.069 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.9 t -113.69 113.2 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 128.266 2.626 . . . . 9.7599999999999998 112.312 175.42 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 N--CA 1.431 -1.423 1 O-C-N 115.819 -4.301 . . . . 19.57 112.128 -171.26 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 CA--C 1.489 -1.374 0 CA-C-O 120.865 0.364 . . . . 17.170000000000002 111.1 . . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -94.51 112.17 23.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.546 2.117 . . . . 21.890000000000001 111.099 -176.065 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 pt -120.31 150.99 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 116.379 -3.951 . . . . 10.83 111.833 174.039 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -116.27 150.52 37.46 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.606 -1.998 . . . . 10.609999999999999 105.606 -174.248 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.2 t -132.18 135.42 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 100.423 -3.917 . . . . 9.1300000000000008 100.423 -176.539 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -119.81 143.49 47.84 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.735 3.159 . . . . 20.550000000000001 107.17 175.36 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.2 p -83.85 -175.43 5.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.082 -3.511 . . . . 11.779999999999999 114.212 172.82 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.1 tp -66.57 -51.53 55.41 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.826 -0.435 . . . . 19.309999999999999 109.826 -176.9 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -75.07 -31.96 61.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.252 -1.356 . . . . 23.140000000000001 109.004 -177.567 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.11 71.62 0.6 Allowed Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 122.95 2.613 . . . . 19.739999999999998 116.206 174.012 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 35.3 pttt -118.81 147.9 43.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 100.471 -3.9 . . . . 21.93 100.471 159.915 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 m -104.06 116.15 31.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.316 1.446 . . . . 12.33 108.439 -179.488 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -81.07 128.92 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.793 -2.299 . . . . 17.079999999999998 104.793 166.122 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.0 m -104.74 135.02 46.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.645 0.657 . . . . 16.300000000000001 109.846 173.288 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.4 mt -122.43 119.67 31.67 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 118.572 2.805 . . . . 15.880000000000001 118.572 179.984 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -86.79 103.33 15.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.912 1.233 . . . . 28.899999999999999 108.715 167.509 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 m -110.23 169.59 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 129.574 3.15 . . . . 12.050000000000001 109.698 179.447 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -108.03 145.67 31.9 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 117.488 -1.244 . . . . 18.170000000000002 110.044 177.227 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.335 42.4 Cg_exo -47.51 -36.03 23.32 Favored 'Trans proline' 0 C--N 1.3 -2.02 1 N-CA-C 123.002 4.193 . . . . 8.1600000000000001 123.002 -175.238 . . . . . . . . 3 2 . 1 . 090 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.18 5.37 34.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.11 2.164 . . . . 11.130000000000001 114.567 176.947 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -62.1 132.38 52.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.082 -2.886 . . . . 18.030000000000001 116.212 176.623 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.266 8.0 p -67.14 161.84 23.74 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.857 -4.277 . . . . 10.220000000000001 107.591 171.915 . . . . . . . . 3 2 . 1 . 090 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -61.55 -41.29 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.007 -2.308 . . . . 12.300000000000001 115.498 171.064 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -64.2 -27.53 69.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.814 2.552 . . . . 36.509999999999998 112.725 172.665 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -70.14 -34.94 73.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.956 -1.715 . . . . 25.66 112.735 169.411 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.52 -41.89 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 1 O-C-N 115.419 -4.551 . . . . 8.1199999999999992 116.914 169.493 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -54.95 -29.46 56.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.532 2.733 . . . . 15.470000000000001 115.713 166.024 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.19 -32.47 66.85 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 118.431 -0.795 . . . . 11.449999999999999 110.991 -177.111 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -70.25 -20.33 63.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.959 1.838 . . . . 24.98 114.965 170.3 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -86.19 -28.47 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 O-C-N 115.537 -4.477 . . . . 9.4600000000000009 111.531 177.111 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -64.57 -40.35 95.4 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.744 4.018 . . . . 14.76 109.484 174.358 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.6 -50.49 15.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.107 -0.996 . . . . 26.289999999999999 111.064 173.922 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -73.15 -70.05 0.38 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.521 1.674 . . . . 30.059999999999999 115.521 -175.956 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.42 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 38.1 mm-40 -67.69 -50.88 55.35 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.853 0.751 . . . . 25.190000000000001 112.658 -177.64 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.54 21.72 10.29 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 118.332 2.093 . . . . 7.4100000000000001 118.332 -176.37 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -82.85 126.59 72.52 Favored Pre-proline 0 N--CA 1.43 -1.471 0 C-N-CA 127.082 2.153 . . . . 9.4900000000000002 108.9 168.743 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -72.63 167.96 25.72 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-O 117.187 -1.255 . . . . 11.42 110.195 -172.455 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 12.2 Cg_endo -86.08 -15.86 4.45 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 CA-C-N 124.557 2.663 . . . . 12.0 112.676 -169.302 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -73.14 -32.82 65.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.32 1.533 . . . . 35.549999999999997 115.059 171.258 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -76.32 -36.04 58.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.526 1.631 . . . . 20.52 114.779 -177.943 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' HG2' HD13 ' A' ' 69' ' ' LEU 0.254 72.0 mt-30 -64.15 135.42 56.32 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.526 3.536 . . . . 7.1299999999999999 113.36 170.532 . . . . . . . . 3 3 . 1 . 090 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -131.97 116.16 16.78 Favored 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 132.001 4.12 . . . . 36.390000000000001 108.893 169.784 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -97.24 144.22 27.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.558 1.786 . . . . 9.5500000000000007 109.51 176.569 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 68' ' ' HIS . 7.8 tp -139.72 137.16 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 119.168 -2.208 . . . . 13.9 113.49 171.388 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.338 76.7 t80 -88.18 -62.06 1.57 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.266 -0.896 . . . . 6.8600000000000003 113.347 171.772 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.8 -89.17 0.28 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.881 -1.525 . . . . 11.15 106.881 -177.763 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.76 9.01 2.56 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-O 116.303 -2.387 . . . . 13.93 116.815 175.964 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -82.64 131.98 35.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 121.311 2.556 . . . . 23.920000000000002 110.121 162.798 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -75.13 114.0 13.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.364 2.03 . . . . 23.23 111.189 -177.928 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.335 10.2 mt -73.08 101.57 3.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 130.06 3.344 . . . . 9.1099999999999994 111.716 -177.924 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.81 -172.92 0.3 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.908 -2.995 . . . . 33.439999999999998 116.475 170.172 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.58 -63.49 1.32 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.993 -4.192 . . . . 28.370000000000001 113.973 -176.143 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.96 40.32 2.85 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 125.574 1.559 . . . . 15.0 115.842 -170.625 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -124.46 145.2 49.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.67 -1.974 . . . . 25.5 105.67 -174.061 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.528 1.1 p -89.36 157.15 18.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.747 3.641 . . . . 11.949999999999999 116.347 -169.032 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.7 mt -63.02 -36.33 83.19 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 116.041 -4.162 . . . . 10.17 110.346 174.418 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 t -65.39 -42.01 93.1 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.27 3.028 . . . . 13.59 112.077 -177.546 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.41 -14.43 57.14 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.602 2.144 . . . . 11.699999999999999 110.744 -171.262 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -103.27 4.64 36.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.708 -3.745 . . . . 12.949999999999999 103.93 176.919 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 50.51 47.2 24.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.576 2.751 . . . . 25.449999999999999 117.521 -176.461 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.0 mt -84.39 106.55 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 112.664 -2.062 . . . . 14.6 109.23 172.328 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -104.96 -174.17 2.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.083 -2.326 . . . . 33.229999999999997 110.958 -167.646 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -83.97 136.08 34.21 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.536 1.516 . . . . 25.969999999999999 112.399 -161.761 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.298 18.2 mt-10 81.38 20.75 0.37 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.296 1.838 . . . . 32.609999999999999 115.909 -169.368 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -70.54 131.82 44.58 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 116.679 -1.629 . . . . 10.56 111.972 172.081 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.4 m -103.57 125.82 50.34 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.246 -1.391 . . . . 5.3300000000000001 107.246 -179.536 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -109.52 164.16 12.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.397 -2.689 . . . . 11.66 106.562 -173.262 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.445 ' HB3' HG23 ' A' ' 44' ' ' ILE . 52.7 t60 -117.12 139.6 50.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.566 -3.209 . . . . 16.300000000000001 110.198 176.811 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.419 HD13 ' HG2' ' A' ' 41' ' ' GLN . 43.2 tp -106.23 104.04 13.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.713 2.805 . . . . 9.9600000000000009 111.475 -178.222 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -97.05 140.4 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.345 -1.752 . . . . 9.7599999999999998 111.54 174.236 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt . . . . . 0 N--CA 1.43 -1.451 0 CA-C-N 119.718 1.145 . . . . 19.57 112.744 162.314 . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 ttp . . . . . 0 CA--C 1.489 -1.374 0 CA-C-O 121.746 0.784 . . . . 17.170000000000002 112.989 . . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -84.77 121.35 27.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.396 -2.69 . . . . 21.890000000000001 110.293 -175.451 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -127.7 168.88 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 123.191 2.723 . . . . 10.83 110.974 160.187 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -120.47 147.69 44.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 125.064 1.477 . . . . 10.609999999999999 110.929 -176.635 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 67' ' ' LEU . 19.3 t -117.08 118.93 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 C-N-CA 131.782 4.033 . . . . 9.1300000000000008 112.365 163.774 . . . . . . . . 3 3 . 1 . 091 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -103.46 124.89 49.58 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.859 -2.401 . . . . 20.550000000000001 111.563 176.701 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.305 34.7 p -77.79 175.56 9.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.105 1.431 . . . . 11.779999999999999 113.44 -174.594 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.1 tp -65.07 -55.27 19.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.358 2.663 . . . . 19.309999999999999 115.378 -178.788 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.3 p -60.73 -62.75 1.63 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.881 1.219 . . . . 23.140000000000001 110.633 165.253 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.24 64.14 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 122.417 2.371 . . . . 19.739999999999998 115.092 176.875 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 77.2 tttt -118.7 128.26 54.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 114.019 -2.896 . . . . 21.93 106.885 178.197 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -109.46 115.37 29.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 125.471 3.76 . . . . 12.33 101.681 -173.866 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.27 132.07 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 119.002 -2.312 . . . . 17.079999999999998 109.888 178.102 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.9 m -98.38 119.65 37.43 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.109 -4.12 . . . . 16.300000000000001 111.196 179.361 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.9 mt -106.39 162.55 13.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.966 2.506 . . . . 15.880000000000001 109.928 -175.477 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -135.22 97.68 3.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 101.689 -3.449 . . . . 28.899999999999999 101.689 178.734 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 m -105.66 163.15 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 117.416 2.376 . . . . 12.050000000000001 117.416 -174.666 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.256 2.9 mp0 -73.46 138.57 77.86 Favored Pre-proline 0 N--CA 1.431 -1.422 0 CA-C-O 114.749 -2.548 . . . . 18.170000000000002 108.285 162.35 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -58.97 -24.53 73.6 Favored 'Trans proline' 0 C--N 1.299 -2.04 1 C-N-CA 128.073 5.848 . . . . 8.1600000000000001 119.442 -179.868 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -117.41 28.63 8.35 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 122.454 4.242 . . . . 11.130000000000001 122.454 173.437 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -77.18 170.7 16.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.402 -2.061 . . . . 18.030000000000001 113.802 -179.289 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.328 69.0 p -90.48 154.39 19.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.418 2.007 . . . . 10.220000000000001 116.418 -174.982 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.4 -19.84 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 119.447 1.021 . . . . 12.300000000000001 112.237 178.003 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -62.77 -39.43 94.16 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.138 -4.101 . . . . 36.509999999999998 106.359 166.435 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -82.01 -29.55 31.97 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.213 2.279 . . . . 25.66 112.457 -174.398 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.36 40.5 t -46.22 -62.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 118.012 -2.93 . . . . 8.1199999999999992 114.544 154.252 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -54.21 -39.67 66.93 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.039 2.237 . . . . 15.470000000000001 117.039 172.039 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.29 92.5 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.641 -4.412 . . . . 11.449999999999999 111.852 173.919 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -61.36 -38.82 88.38 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.417 2.377 . . . . 24.98 117.417 163.063 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.267 72.5 mt -63.35 -41.53 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 122.145 2.248 . . . . 9.4600000000000009 116.132 172.497 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.75 -40.49 92.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.067 1.747 . . . . 14.76 115.324 173.689 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.02 -50.18 74.76 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 125.828 2.728 . . . . 26.289999999999999 115.629 173.107 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -75.31 -68.27 0.57 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 109.405 -3.543 . . . . 30.059999999999999 115.377 -175.121 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 79.1 mm-40 -87.82 -16.3 34.45 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.743 3.617 . . . . 25.190000000000001 111.445 -170.729 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.39 13.15 83.56 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 120.534 2.974 . . . . 7.4100000000000001 120.534 -178.942 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -76.03 115.67 48.74 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 116.521 -1.704 . . . . 9.4900000000000002 110.622 176.84 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.07 155.43 45.04 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 C-N-CA 123.673 2.915 . . . . 11.42 109.805 -172.797 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.41 -25.66 17.97 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 124.071 2.49 . . . . 12.0 112.376 -167.782 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.84 -40.55 88.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.305 -3.372 . . . . 35.549999999999997 108.864 -175.087 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.446 ' OE1' HD23 ' A' ' 71' ' ' LEU . 7.2 tt0 -63.33 -23.75 67.55 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.519 -1.673 . . . . 20.52 114.446 -177.974 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -87.91 131.7 34.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 126.417 3.008 . . . . 7.1299999999999999 118.295 -173.628 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -120.06 106.16 11.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.126 -2.859 . . . . 36.390000000000001 110.23 166.629 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.52 132.75 36.07 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 115.56 -4.463 . . . . 9.5500000000000007 113.299 175.698 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.5 mt -106.88 141.92 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.516 2.327 . . . . 13.9 107.931 176.815 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -91.5 -83.03 0.29 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.328 2.489 . . . . 6.8600000000000003 107.792 163.04 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.05 -71.43 0.74 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.473 1.909 . . . . 11.15 115.887 176.459 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.74 -41.66 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 124.083 1.935 . . . . 13.93 114.207 -166.886 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -103.38 155.36 18.54 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 121.493 -1.004 . . . . 23.920000000000002 112.94 -169.594 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -86.59 132.08 33.99 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.016 2.599 . . . . 23.23 118.016 -156.396 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -92.84 146.2 23.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.395 2.309 . . . . 9.1099999999999994 109.93 -174.398 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.98 153.45 17.9 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.145 -3.472 . . . . 33.439999999999998 106.573 177.767 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.66 -63.17 1.3 Allowed 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.066 -4.772 . . . . 28.370000000000001 114.315 -178.906 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.06 35.55 3.4 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 119.229 -1.462 . . . . 15.0 110.451 -172.225 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -106.55 161.18 14.84 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.367 -5.196 . . . . 25.5 111.478 164.813 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -97.89 171.96 7.96 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 114.284 -5.26 . . . . 11.949999999999999 111.878 -166.842 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.79 -37.09 78.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 112.863 -1.971 . . . . 10.17 109.027 169.338 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 t -81.71 -10.7 59.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 123.881 0.872 . . . . 13.59 112.71 -169.012 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.13 -50.29 12.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.504 3.526 . . . . 11.699999999999999 114.815 173.694 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -82.8 -20.71 35.22 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.949 -4.845 . . . . 12.949999999999999 112.164 179.849 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 23.2 m-80 72.63 65.94 0.12 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.233 3.049 . . . . 25.449999999999999 119.233 179.862 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.7 mt -106.13 93.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 109.157 -3.656 . . . . 14.6 105.104 -178.894 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -85.3 -166.19 1.43 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.033 -3.542 . . . . 33.229999999999997 114.381 179.223 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.368 14.8 pttp -62.43 134.85 57.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.36 -3.338 . . . . 25.969999999999999 114.271 -177.068 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.322 21.5 mt-10 70.05 15.87 7.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.527 2.047 . . . . 32.609999999999999 116.527 169.23 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.7 m -61.45 140.32 58.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.068 3.347 . . . . 10.56 112.457 159.427 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -110.54 111.03 21.99 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 119.865 1.212 . . . . 5.3300000000000001 113.515 175.24 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.403 ' HB2' HG23 ' A' ' 5' ' ' VAL . 53.6 mt -78.86 153.46 30.56 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.276 -2.14 . . . . 11.66 108.605 173.589 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -121.79 137.56 54.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.323 2.011 . . . . 16.300000000000001 107.619 175.935 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.3 tp -116.19 124.91 51.46 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.454 -2.029 . . . . 9.9600000000000009 109.019 -174.668 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.8 t -112.08 139.68 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 125.039 1.336 . . . . 9.7599999999999998 110.068 -179.53 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.446 HD23 ' OE1' ' A' ' 40' ' ' GLN . 7.8 mp . . . . . 0 N--CA 1.43 -1.431 0 C-N-CA 115.861 -2.336 . . . . 19.57 113.942 -176.682 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 CA--C 1.491 -1.326 0 N-CA-C 114.308 1.225 . . . . 17.170000000000002 114.308 . . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -93.13 118.29 31.05 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 116.525 -1.702 . . . . 21.890000000000001 107.345 -174.228 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.295 19.4 pt -120.22 151.78 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 126.446 2.341 . . . . 10.83 108.51 169.926 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -118.55 149.18 41.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.244 -2.873 . . . . 10.609999999999999 103.244 178.073 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 26.1 t -111.03 140.6 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 110.376 -3.102 . . . . 9.1300000000000008 117.019 162.653 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -123.28 128.31 49.78 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.779 -4.325 . . . . 20.550000000000001 110.835 -178.363 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.264 39.7 p -91.33 174.1 7.56 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.518 -1.989 . . . . 11.779999999999999 112.247 -176.229 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.264 12.8 tp -63.94 -52.82 58.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.785 -2.462 . . . . 19.309999999999999 115.192 171.369 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.4 -58.69 3.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.995 -2.316 . . . . 23.140000000000001 115.85 -175.804 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.44 53.92 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 120.571 1.532 . . . . 19.739999999999998 111.909 167.745 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -112.74 136.65 52.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.121 -1.811 . . . . 21.93 109.473 163.599 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -104.23 110.86 23.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 128.334 3.521 . . . . 12.33 101.864 170.488 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 19.6 mt -102.42 129.96 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 101.142 -3.651 . . . . 17.079999999999998 101.142 -176.013 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 m -97.77 128.27 44.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.046 1.738 . . . . 16.300000000000001 107.462 177.089 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.2 mt -118.72 158.2 26.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.353 2.342 . . . . 15.880000000000001 110.993 170.735 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -102.6 122.18 43.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.144 -2.909 . . . . 28.899999999999999 103.144 165.092 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 m -137.46 177.62 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 117.989 -1.484 . . . . 12.050000000000001 110.147 176.451 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.26 157.82 34.59 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 105.863 -1.902 . . . . 18.170000000000002 105.863 173.904 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.307 18.5 Cg_endo -66.82 -15.02 46.03 Favored 'Trans proline' 0 C--N 1.3 -1.996 1 C-N-CA 126.829 5.019 . . . . 8.1600000000000001 110.502 168.273 . . . . . . . . 3 2 . 1 . 092 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.2 m -94.69 0.12 54.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.577 -2.577 . . . . 11.130000000000001 115.67 -175.888 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -78.18 145.32 35.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.724 -2.485 . . . . 18.030000000000001 114.224 178.116 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 p -81.12 148.88 29.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.38 -2.7 . . . . 10.220000000000001 104.201 176.589 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 23' ' ' ILE . 25.7 mt -76.37 -26.61 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 121.261 -0.899 . . . . 12.300000000000001 111.06 -173.402 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.296 17.0 pt-20 -51.8 -35.69 45.09 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 117.104 -1.426 . . . . 36.509999999999998 114.68 161.488 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -77.7 -39.85 43.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 117.167 -1.397 . . . . 25.66 113.73 176.128 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.4 t -57.91 -40.32 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 121.086 1.766 . . . . 8.1199999999999992 109.472 176.875 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 55.8 mtmt -73.57 -35.67 65.48 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.499 1.12 . . . . 15.470000000000001 112.755 177.985 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.13 83.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 118.476 -1.289 . . . . 11.449999999999999 113.647 171.574 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.347 29.8 ttmt -48.09 -40.38 23.14 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.219 -3.426 . . . . 24.98 112.022 161.382 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.1 -35.94 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 120.706 1.594 . . . . 9.4600000000000009 111.296 177.865 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -49.9 -47.85 51.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 115.607 -2.14 . . . . 14.76 114.188 163.424 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -63.33 -38.43 91.11 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.315 1.871 . . . . 26.289999999999999 113.951 177.65 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -72.48 -67.21 0.57 Allowed 'General case' 0 N--CA 1.429 -1.486 1 C-N-CA 131.868 4.067 . . . . 30.059999999999999 110.238 -178.686 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -97.84 -72.83 0.63 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.473 -2.017 . . . . 25.190000000000001 110.56 -166.859 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.47 64.73 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 118.427 2.131 . . . . 7.4100000000000001 118.427 169.714 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.6 mt -133.56 116.18 13.83 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 128.151 2.58 . . . . 9.4900000000000002 104.244 -168.359 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.39 156.34 26.45 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 123.731 2.368 . . . . 11.42 116.007 -172.325 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -78.66 -15.29 13.73 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 CA-C-N 124.39 2.604 . . . . 12.0 112.51 -172.596 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -75.08 -42.4 56.81 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.792 0.806 . . . . 35.549999999999997 110.753 175.268 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -68.56 -26.59 65.48 Favored 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 134.126 4.971 . . . . 20.52 111.784 -175.239 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.427 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 69.6 mt-30 -86.84 135.68 33.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.925 -2.36 . . . . 7.1299999999999999 110.213 178.239 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -121.35 118.63 29.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.42 -2.067 . . . . 36.390000000000001 105.42 166.684 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.421 HD21 ' HA ' ' A' ' 43' ' ' LEU . 62.3 mt -93.46 120.97 34.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.482 3.113 . . . . 9.5500000000000007 111.849 177.86 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mt -109.29 134.07 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 117.119 -3.488 . . . . 13.9 107.488 173.957 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -91.27 -73.09 0.55 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 123.764 2.984 . . . . 6.8600000000000003 103.56 163.909 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.32 -140.19 0.2 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.475 2.083 . . . . 11.15 107.122 -172.387 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.03 -23.65 69.7 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 122.609 3.803 . . . . 13.93 122.609 -176.191 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -76.81 162.7 27.44 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.989 -4.242 . . . . 23.920000000000002 118.149 174.491 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.282 81.6 mm-40 -84.87 133.93 34.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.719 -1.238 . . . . 23.23 111.806 167.456 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 mt -93.25 132.78 37.12 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.384 -0.822 . . . . 9.1099999999999994 110.733 177.328 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -93.27 122.34 35.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.012 2.125 . . . . 33.439999999999998 107.897 168.78 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.06 -25.12 65.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.459 1.904 . . . . 28.370000000000001 114.149 -168.794 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.78 -2.69 86.45 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 126.253 1.882 . . . . 15.0 117.723 -179.573 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -104.9 -176.61 3.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.908 1.337 . . . . 25.5 107.984 172.63 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.4 p -100.43 178.07 4.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.724 1.75 . . . . 11.949999999999999 115.724 -173.557 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.95 -35.95 81.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.97 3.308 . . . . 10.17 112.408 167.79 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 t -72.77 -36.71 67.7 Favored 'General case' 0 N--CA 1.431 -1.387 1 O-C-N 113.947 -5.471 . . . . 13.59 112.485 -179.052 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -66.98 -38.34 85.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.854 3.261 . . . . 11.699999999999999 110.938 176.11 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -88.57 -4.13 58.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.659 -1.9 . . . . 12.949999999999999 110.738 176.301 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 m120 57.68 58.85 3.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 131.508 3.923 . . . . 25.449999999999999 111.677 178.083 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mm -102.28 108.81 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.309 -2.108 . . . . 14.6 105.309 -178.113 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -108.79 169.23 8.8 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 127.361 2.913 . . . . 33.229999999999997 109.335 -171.577 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -44.68 138.69 3.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.587 2.613 . . . . 25.969999999999999 112.343 -176.345 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.281 18.1 mt-10 60.16 6.16 0.94 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.119 3.368 . . . . 32.609999999999999 115.296 175.702 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.6 m -62.73 140.83 58.75 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.183 -4.073 . . . . 10.56 113.354 160.838 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -103.91 122.32 44.94 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.493 3.517 . . . . 5.3300000000000001 110.557 -175.407 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -86.24 156.35 20.32 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.089 2.743 . . . . 11.66 113.608 170.85 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -121.46 120.32 34.6 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 123.089 2.677 . . . . 16.300000000000001 111.223 168.365 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.6 tp -84.46 124.08 30.96 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 126.582 2.426 . . . . 9.9600000000000009 116.702 173.962 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.3 127.8 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 103.433 -2.803 . . . . 9.7599999999999998 103.433 179.423 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.286 1.3 mm? . . . . . 0 N--CA 1.43 -1.427 0 O-C-N 119.867 -1.77 . . . . 19.57 115.212 175.43 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 113.766 1.024 . . . . 17.170000000000002 113.766 . . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -90.49 121.44 32.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.412 1.577 . . . . 21.890000000000001 113.795 -178.643 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.9 pt -123.54 151.92 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 O-C-N 114.145 -5.347 . . . . 10.83 108.653 168.449 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -115.93 137.01 52.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 119.484 1.038 . . . . 10.609999999999999 111.447 -179.451 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -109.82 130.23 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 130.134 3.374 . . . . 9.1300000000000008 109.028 168.049 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -122.84 137.61 54.88 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.586 -2.552 . . . . 20.550000000000001 107.097 -173.251 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.329 55.2 p -100.88 -173.38 2.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 119.696 1.134 . . . . 11.779999999999999 110.881 -170.085 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.4 mt -74.01 -41.27 62.13 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.855 -3.028 . . . . 19.309999999999999 111.982 177.62 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.95 -57.56 9.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.237 -1.54 . . . . 23.140000000000001 108.135 165.768 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.25 6.86 0.17 Allowed Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 117.618 -2.229 . . . . 19.739999999999998 115.436 177.55 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -77.29 149.46 35.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 122.661 3.231 . . . . 21.93 110.715 -161.786 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -113.72 110.73 20.64 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.974 -3.579 . . . . 12.33 105.939 -174.601 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.436 HG22 ' HE3' ' A' ' 33' ' ' LYS . 1.9 mp -103.04 121.66 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 111.212 -2.722 . . . . 17.079999999999998 112.289 169.392 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.3 m -103.66 114.07 28.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 128.003 3.314 . . . . 16.300000000000001 106.832 -174.37 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -104.14 141.7 35.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.147 -1.596 . . . . 15.880000000000001 112.295 178.651 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -84.13 100.81 11.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.406 1.883 . . . . 28.899999999999999 107.87 164.592 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.93 151.34 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.295 -1.002 . . . . 12.050000000000001 108.295 179.103 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -91.23 164.08 26.4 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 116.906 -1.918 . . . . 18.170000000000002 106.394 171.263 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -82.76 -8.06 11.31 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.515 2.144 . . . . 8.1600000000000001 108.872 -177.635 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -86.67 -4.54 59.19 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.795 1.759 . . . . 11.130000000000001 115.717 171.722 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -83.13 137.74 33.95 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.499 -2.001 . . . . 18.030000000000001 107.282 -168.284 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 p -74.21 157.84 35.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.631 3.11 . . . . 10.220000000000001 112.57 174.169 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.8 mt -69.19 -21.4 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 1 O-C-N 115.907 -4.246 . . . . 12.300000000000001 110.499 175.6 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.06 -48.18 82.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.02 2.343 . . . . 36.509999999999998 115.328 161.752 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.76 -41.03 94.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.38 3.072 . . . . 25.66 114.566 173.037 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.44 -55.68 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 129.191 2.997 . . . . 8.1199999999999992 114.986 164.23 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -46.58 -44.89 18.49 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 114.683 -5.011 . . . . 15.470000000000001 118.73 164.964 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.96 -36.71 75.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 124.725 2.202 . . . . 11.449999999999999 115.768 -177.854 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -69.83 -34.9 74.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.269 -2.242 . . . . 24.98 110.951 178.602 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -59.36 -43.61 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 125.861 1.665 . . . . 9.4600000000000009 109.892 171.403 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -68.05 -42.93 79.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.072 -1.642 . . . . 14.76 108.752 -174.882 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.36 -46.92 87.31 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.399 2.28 . . . . 26.289999999999999 112.602 176.598 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HE3' HG22 ' A' ' 13' ' ' ILE . 61.0 tttp -79.31 -57.25 3.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.703 2.112 . . . . 30.059999999999999 116.703 179.561 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -85.31 -54.64 4.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.708 -3.745 . . . . 25.190000000000001 116.003 -179.78 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.05 54.26 0.98 Allowed Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 124.509 1.052 . . . . 7.4100000000000001 115.161 -176.012 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.7 mt -119.48 125.57 27.44 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 104.585 -2.376 . . . . 9.4900000000000002 104.585 165.614 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -75.32 159.17 40.48 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 123.721 2.948 . . . . 11.42 113.276 -176.672 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.65 -11.41 20.27 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 124.952 3.768 . . . . 12.0 115.651 -179.765 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -85.7 -28.72 24.48 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 121.488 1.949 . . . . 35.549999999999997 106.414 -173.935 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -85.43 -28.66 24.94 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 115.365 -4.584 . . . . 20.52 110.222 -178.191 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -74.29 130.42 39.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.978 2.323 . . . . 7.1299999999999999 114.443 -177.858 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -132.89 126.86 33.11 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 112.81 -1.996 . . . . 36.390000000000001 111.172 164.584 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.2 mt -108.25 114.88 29.09 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 109.286 -3.597 . . . . 9.5500000000000007 113.89 -163.646 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.57 135.19 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 118.685 -2.51 . . . . 13.9 106.132 -172.217 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -96.02 -54.89 3.15 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.185 1.945 . . . . 6.8600000000000003 110.701 173.308 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.28 -126.35 0.27 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 108.899 -3.773 . . . . 11.15 108.026 -176.064 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.5 6.51 12.69 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 127.755 2.598 . . . . 13.93 107.55 -170.732 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -110.16 145.11 37.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.352 1.612 . . . . 23.920000000000002 115.352 -175.553 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -75.1 121.59 22.28 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.239 1.816 . . . . 23.23 111.919 -174.515 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.5 mt -94.68 120.7 35.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.393 2.677 . . . . 9.1099999999999994 110.496 176.61 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.74 143.26 28.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.81 -3.057 . . . . 33.439999999999998 107.641 -177.53 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -65.38 -39.48 92.3 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.027 -1.442 . . . . 28.370000000000001 112.076 -162.45 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.35 -11.77 81.6 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 120.289 2.875 . . . . 15.0 120.289 -168.672 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -91.26 173.57 7.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.657 -2.084 . . . . 25.5 105.765 -178.209 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.2 p -113.83 174.36 5.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.72 2.2 . . . . 11.949999999999999 108.142 -166.91 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.06 -31.11 72.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.444 -2.035 . . . . 10.17 113.989 173.164 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -67.77 -31.99 72.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.781 2.141 . . . . 13.59 116.781 175.716 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -61.92 -50.29 72.75 Favored 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.342 4.257 . . . . 11.699999999999999 110.214 176.811 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -89.87 -20.93 22.83 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 124.172 1.939 . . . . 12.949999999999999 115.198 -178.533 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.339 16.1 m120 85.65 41.73 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 127.346 2.258 . . . . 25.449999999999999 111.88 175.193 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.3 mm -79.31 115.52 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 124.323 2.011 . . . . 14.6 109.002 169.148 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -95.04 -174.16 3.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.405 -1.27 . . . . 33.229999999999997 111.941 -177.559 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -66.82 146.27 54.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.689 1.596 . . . . 25.969999999999999 112.583 175.853 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.461 65.3 mt-10 76.43 11.73 2.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.979 2.214 . . . . 32.609999999999999 116.979 -179.417 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.254 56.2 m -84.42 141.69 30.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.318 1.97 . . . . 10.56 116.318 -169.579 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.4 m -107.7 98.0 7.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.24 -2.162 . . . . 5.3300000000000001 109.843 -166.769 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -88.93 151.57 22.24 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.517 1.927 . . . . 11.66 107.594 -177.036 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.84 123.32 39.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.64 2.638 . . . . 16.300000000000001 108.228 -171.874 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -94.41 112.29 24.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.81 -2.45 . . . . 9.9600000000000009 110.591 -176.624 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.254 38.5 t -103.88 131.57 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 105.594 -2.002 . . . . 9.7599999999999998 105.594 -171.925 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.429 -1.481 0 O-C-N 117.789 -3.069 . . . . 19.57 112.7 -171.401 . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.49 -1.344 0 N-CA-C 116.607 2.077 . . . . 17.170000000000002 116.607 . . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -90.87 144.2 25.93 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.97 -4.206 . . . . 21.890000000000001 112.444 -175.122 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.4 pt -122.09 155.16 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 126.023 2.82 . . . . 10.83 103.946 165.543 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -114.95 111.11 20.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.034 -3.542 . . . . 10.609999999999999 103.597 -172.302 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.19 135.44 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 116.699 -3.751 . . . . 9.1300000000000008 107.736 179.648 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -115.15 122.79 47.16 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 125.715 1.606 . . . . 20.550000000000001 112.813 -172.491 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -77.02 172.69 12.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.19 -2.819 . . . . 11.779999999999999 115.112 177.675 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.442 HD21 ' CE1' ' A' ' 68' ' ' HIS . 40.8 mt -76.58 -23.74 53.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.274 2.694 . . . . 19.309999999999999 118.274 170.498 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -83.66 -24.8 31.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 115.805 -2.045 . . . . 23.140000000000001 113.501 166.613 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.33 49.8 0.35 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 113.636 -3.869 . . . . 19.739999999999998 113.786 161.388 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -114.69 140.16 49.08 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.665 2.038 . . . . 21.93 107.511 175.499 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -84.4 117.13 23.43 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 116.13 -4.106 . . . . 12.33 108.431 160.856 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -86.2 116.21 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.658 -2.349 . . . . 17.079999999999998 104.658 162.984 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.2 m -106.21 97.39 7.21 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 124.834 2.254 . . . . 16.300000000000001 108.808 -172.415 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 mt -103.45 116.08 31.73 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.892 -1.958 . . . . 15.880000000000001 112.224 -162.428 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.93 119.16 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.727 -1.579 . . . . 28.899999999999999 112.893 170.869 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.78 177.55 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.226 2.441 . . . . 12.050000000000001 109.387 -179.514 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.88 167.3 14.81 Favored Pre-proline 0 N--CA 1.43 -1.471 0 O-C-N 117.176 -3.452 . . . . 18.170000000000002 103.781 172.784 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -76.61 -19.35 14.68 Favored 'Trans proline' 0 C--N 1.3 -2.021 1 C-N-CA 125.595 4.196 . . . . 8.1600000000000001 114.985 179.713 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -79.89 -14.55 58.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.196 2.665 . . . . 11.130000000000001 118.196 171.755 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -72.58 144.83 47.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.303 -2.748 . . . . 18.030000000000001 106.263 -168.87 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.5 p -82.69 157.13 23.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.567 -1.253 . . . . 10.220000000000001 111.854 177.338 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.29 -21.54 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 CA-C-O 128.868 4.175 . . . . 12.300000000000001 114.979 -172.822 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -58.62 -53.77 54.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.488 -3.258 . . . . 36.509999999999998 114.612 157.899 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -50.73 -32.83 20.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.583 -3.823 . . . . 25.66 115.934 173.974 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.11 -53.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 128.496 2.718 . . . . 8.1199999999999992 108.971 173.092 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -65.28 -35.49 81.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.606 1.548 . . . . 15.470000000000001 112.849 -179.887 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.53 92.47 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.254 1.022 . . . . 11.449999999999999 112.318 169.88 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -53.0 -43.35 66.41 Favored 'General case' 0 N--CA 1.43 -1.458 2 O-C-N 113.938 -5.476 . . . . 24.98 113.802 169.866 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -64.88 -29.55 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 127.894 2.478 . . . . 9.4600000000000009 112.807 172.67 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -72.92 -45.79 56.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 123.48 2.854 . . . . 14.76 109.21 167.897 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -59.81 -37.04 78.05 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.165 -2.209 . . . . 26.289999999999999 114.997 177.551 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -85.69 -51.1 6.68 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.563 2.801 . . . . 30.059999999999999 118.563 171.107 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -102.91 -8.14 20.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.155 3.02 . . . . 25.190000000000001 119.155 -178.658 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.29 51.42 58.25 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 117.811 -3.055 . . . . 7.4100000000000001 114.768 -175.512 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.8 mt -111.02 106.25 57.45 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 128.337 2.655 . . . . 9.4900000000000002 108.625 165.775 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -72.59 157.45 52.5 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 N-CA-C 118.134 2.321 . . . . 11.42 118.134 -172.048 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -71.84 -15.97 29.65 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-N 126.47 3.346 . . . . 12.0 119.467 -163.78 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.8 -24.43 67.55 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 120.713 3.597 . . . . 35.549999999999997 120.713 160.274 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -72.07 -28.93 63.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.903 2.592 . . . . 20.52 114.257 170.594 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -86.85 133.27 33.64 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.54 -3.225 . . . . 7.1299999999999999 115.534 -159.321 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -125.95 108.27 11.25 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.965 1.841 . . . . 36.390000000000001 108.516 167.317 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.8 mt -87.39 113.94 23.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.444 -1.707 . . . . 9.5500000000000007 108.572 -179.021 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -116.85 134.82 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 1 O-C-N 115.844 -4.285 . . . . 13.9 103.137 175.614 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -103.79 -63.62 1.17 Allowed 'General case' 0 N--CA 1.431 -1.419 1 O-C-N 115.061 -4.774 . . . . 6.8600000000000003 109.952 166.832 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.95 -66.47 0.93 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.797 -3.69 . . . . 11.15 109.122 -168.453 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.11 -53.75 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 O-C-N 116.854 -3.654 . . . . 13.93 118.931 -174.065 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -71.91 169.19 16.36 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.725 2.12 . . . . 23.920000000000002 116.725 -170.035 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -88.46 129.28 35.48 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 114.77 -4.956 . . . . 23.23 106.177 -178.686 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.5 mt -84.47 127.2 33.89 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 111.891 -2.413 . . . . 9.1099999999999994 112.647 175.767 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.29 163.89 26.07 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 129.221 4.075 . . . . 33.439999999999998 111.709 166.493 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -91.07 -63.39 1.27 Allowed 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 115.539 -4.475 . . . . 28.370000000000001 108.936 -172.473 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.25 -5.87 9.1 Favored Glycine 0 N--CA 1.431 -1.667 1 C-N-CA 130.873 4.082 . . . . 15.0 113.561 -178.484 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -91.34 168.43 11.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.119 3.46 . . . . 25.5 110.759 174.763 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 29.6 p -94.72 170.02 9.75 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.237 4.215 . . . . 11.949999999999999 111.334 179.466 . . . . . . . . 3 2 . 1 . 094 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.61 -26.04 62.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.393 -3.942 . . . . 10.17 115.753 172.823 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -63.99 -49.75 71.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 111.447 -2.615 . . . . 13.59 111.119 172.762 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -45.14 -44.48 10.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.767 2.506 . . . . 11.699999999999999 117.767 169.533 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -88.54 3.66 49.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 116.622 -1.656 . . . . 12.949999999999999 114.647 179.257 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.336 3.7 m-80 57.01 52.93 8.55 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.747 3.24 . . . . 25.449999999999999 119.747 -175.227 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mt -115.19 122.8 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 113.926 -1.488 . . . . 14.6 108.214 -177.785 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -112.24 -150.55 0.47 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.37 -2.706 . . . . 33.229999999999997 113.252 175.417 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -76.59 165.88 24.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.699 2.045 . . . . 25.969999999999999 111.996 -173.252 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 57.23 25.45 11.06 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 133.012 4.525 . . . . 32.609999999999999 109.668 174.528 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.286 52.6 m -76.29 121.94 23.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 129.507 3.123 . . . . 10.56 107.979 -176.709 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.4 m -90.8 116.75 28.88 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 124.697 1.248 . . . . 5.3300000000000001 111.313 175.885 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.35 158.37 17.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.111 2.164 . . . . 11.66 107.502 178.889 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.442 ' CE1' HD21 ' A' ' 8' ' ' LEU . 5.9 t60 -114.84 131.79 56.72 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.446 1.593 . . . . 16.300000000000001 110.505 172.661 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.65 103.88 14.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 127.715 3.626 . . . . 9.9600000000000009 104.387 172.176 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 t -95.15 133.82 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 1 C-N-CA 135.459 5.504 . . . . 9.7599999999999998 109.94 171.824 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 N--CA 1.431 -1.408 0 N-CA-C 116.102 1.89 . . . . 19.57 116.102 -171.688 . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 113.614 0.968 . . . . 17.170000000000002 113.614 . . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -91.98 132.5 36.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.746 1.387 . . . . 21.890000000000001 114.746 -170.772 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 pt -131.21 150.24 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 119.118 -2.239 . . . . 10.83 113.257 167.745 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -99.48 123.61 43.9 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 125.685 1.865 . . . . 10.609999999999999 108.529 -176.796 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.7 t -104.22 121.98 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 117.178 -1.809 . . . . 9.1300000000000008 107.786 171.835 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -103.21 105.98 16.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.112 2.965 . . . . 20.550000000000001 110.958 -170.026 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -69.96 177.39 3.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.832 1.419 . . . . 11.779999999999999 114.832 178.673 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.1 mt -66.29 -43.71 85.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 114.989 -2.434 . . . . 19.309999999999999 111.739 -170.295 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -67.48 -47.83 68.91 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 132.594 6.184 . . . . 23.140000000000001 106.708 172.928 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.32 41.77 0.62 Allowed Glycine 0 N--CA 1.43 -1.708 0 O-C-N 117.669 -3.145 . . . . 19.739999999999998 115.333 -176.879 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -83.38 135.23 34.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 101.889 -3.374 . . . . 21.93 101.889 175.356 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -90.11 101.93 14.64 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 122.183 2.265 . . . . 12.33 106.105 -177.934 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 mt -85.34 109.26 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.445 -0.784 . . . . 17.079999999999998 109.392 172.708 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -92.0 116.8 29.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.317 2.961 . . . . 16.300000000000001 111.302 -178.673 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.2 mt -116.13 137.04 52.47 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.818 -4.301 . . . . 15.880000000000001 111.475 -174.082 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -111.19 108.65 18.38 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.476 -2.64 . . . . 28.899999999999999 106.521 -175.331 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.86 164.62 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 125.116 1.51 . . . . 12.050000000000001 112.786 -172.448 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.33 154.79 37.93 Favored Pre-proline 0 N--CA 1.43 -1.464 0 O-C-N 116.952 -3.592 . . . . 18.170000000000002 110.663 165.419 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -60.55 -24.51 78.38 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 125.101 3.867 . . . . 8.1600000000000001 110.789 179.125 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -98.33 26.01 5.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.211 -1.556 . . . . 11.130000000000001 109.44 -179.408 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -94.86 158.91 15.28 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.998 -2.939 . . . . 18.030000000000001 112.247 161.951 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -105.09 169.8 8.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.447 1.594 . . . . 10.220000000000001 109.578 -170.775 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.11 -40.21 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.666 -2.521 . . . . 12.300000000000001 113.558 178.383 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 30.8 tt0 -43.04 -41.62 3.56 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 121.082 3.734 . . . . 36.509999999999998 121.082 160.653 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -63.19 -60.7 3.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.397 -3.314 . . . . 25.66 111.948 174.913 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 t -46.94 -41.36 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 116.313 -3.992 . . . . 8.1199999999999992 117.182 170.939 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -56.3 -35.67 67.79 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.354 -1.466 . . . . 15.470000000000001 111.091 177.696 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.1 -24.23 60.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.922 -3.611 . . . . 11.449999999999999 114.341 -179.13 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -65.03 -30.1 71.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.416 2.747 . . . . 24.98 118.416 166.028 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.8 mt -78.24 -33.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 124.291 1.996 . . . . 9.4600000000000009 110.492 178.544 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -66.18 -31.33 72.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.87 -1.768 . . . . 14.76 115.073 169.093 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -62.41 -60.8 3.03 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.442 3.097 . . . . 26.289999999999999 109.218 173.251 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -79.87 -63.7 1.35 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 115.059 1.503 . . . . 30.059999999999999 115.059 -174.142 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 45.2 mm-40 -82.53 -28.88 30.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.239 3.051 . . . . 25.190000000000001 119.239 -177.28 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.98 7.79 49.45 Favored Glycine 0 N--CA 1.43 -1.75 1 O-C-N 116.056 -4.153 . . . . 7.4100000000000001 120.956 173.25 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.67 129.65 51.95 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 118.656 -2.673 . . . . 9.4900000000000002 111.815 -179.529 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -66.66 146.61 79.63 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 N-CA-C 118.411 2.427 . . . . 11.42 118.411 174.979 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -16.95 57.51 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 120.125 3.087 . . . . 12.0 120.125 -169.335 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.67 -19.85 34.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.587 -1.946 . . . . 35.549999999999997 110.738 176.766 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -91.6 -24.12 19.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.064 2.364 . . . . 20.52 107.843 -169.22 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -73.45 155.56 39.16 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.191 -3.443 . . . . 7.1299999999999999 111.391 175.171 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.291 51.5 ttt180 -139.5 120.0 14.03 Favored 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 132.471 4.308 . . . . 36.390000000000001 113.672 167.604 . . . . . . . . 3 2 . 1 . 095 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.84 132.77 49.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.809 -1.807 . . . . 9.5500000000000007 109.698 -179.471 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 3.6 mt -120.61 130.61 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.007 -1.108 . . . . 13.9 108.007 179.215 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -86.45 -77.5 0.31 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.43 -2.044 . . . . 6.8600000000000003 110.135 163.002 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.07 -73.37 0.67 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.053 1.341 . . . . 11.15 107.864 173.973 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.46 1.2 0.42 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 113.699 -3.834 . . . . 13.93 115.129 -171.733 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -105.54 166.83 10.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 123.875 3.838 . . . . 23.920000000000002 107.832 -167.176 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -97.31 139.94 32.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.818 1.645 . . . . 23.23 111.365 177.729 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -101.61 141.95 33.7 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.308 -0.86 . . . . 9.1099999999999994 108.881 -174.661 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.253 43.6 mt-10 -97.93 149.25 22.61 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.127 -2.233 . . . . 33.439999999999998 107.397 174.182 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.0 m-20 -67.03 -31.21 71.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.303 2.241 . . . . 28.370000000000001 112.436 -175.299 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.71 36.26 4.52 Favored Glycine 0 N--CA 1.43 -1.728 1 N-CA-C 125.189 4.835 . . . . 15.0 125.189 -177.179 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -126.35 162.15 26.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.161 -2.376 . . . . 25.5 107.179 170.871 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.255 29.9 p -88.24 166.49 14.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.146 -2.846 . . . . 11.949999999999999 111.432 -175.479 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.57 -41.67 90.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.495 2.569 . . . . 10.17 111.301 164.789 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -58.51 -39.17 79.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.482 -3.261 . . . . 13.59 114.539 175.064 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -67.43 -36.71 81.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.228 1.966 . . . . 11.699999999999999 111.66 -174.256 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -85.32 -0.61 55.28 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.869 -3.019 . . . . 12.949999999999999 108.716 176.1 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.301 3.3 m120 56.67 36.87 28.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.884 2.179 . . . . 25.449999999999999 116.884 -179.329 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.5 mt -99.02 111.07 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 117.182 -1.39 . . . . 14.6 108.848 177.816 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.307 28.8 mm100 -96.0 -167.04 1.52 Allowed 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.927 3.267 . . . . 33.229999999999997 107.134 -167.294 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -57.33 159.92 4.34 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 117.161 2.282 . . . . 25.969999999999999 117.161 167.089 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 65.24 14.37 9.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.542 1.937 . . . . 32.609999999999999 113.546 -178.045 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -81.04 133.7 35.53 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.566 1.691 . . . . 10.56 115.566 -171.248 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.4 m -93.25 112.11 23.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.472 -1.694 . . . . 5.3300000000000001 108.737 -173.232 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.9 mt -98.06 133.48 42.45 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.379 -3.326 . . . . 11.66 106.163 176.248 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.451 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 15.3 t60 -94.75 119.09 32.8 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 126.67 1.988 . . . . 16.300000000000001 112.819 167.918 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.9 tp -103.81 121.51 43.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 126.153 2.882 . . . . 9.9600000000000009 114.418 -179.981 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.72 176.98 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 1 O-C-N 114.668 -5.02 . . . . 9.7599999999999998 103.104 -177.243 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 N--CA 1.43 -1.443 1 O-C-N 114.212 -5.305 . . . . 19.57 115.282 -179.049 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 116.981 -1.485 . . . . 17.170000000000002 112.864 . . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -101.67 149.42 24.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 114.51 -2.876 . . . . 21.890000000000001 113.934 -173.836 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.74 174.98 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 119.636 -1.915 . . . . 10.83 109.034 160.145 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -126.18 149.5 48.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 115.349 -2.54 . . . . 10.609999999999999 108.098 -175.319 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.8 t -112.94 127.59 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 104.659 -2.349 . . . . 9.1300000000000008 104.659 168.051 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -105.85 117.69 34.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.853 2.168 . . . . 20.550000000000001 116.853 164.58 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -92.05 169.54 10.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.723 3.154 . . . . 11.779999999999999 109.068 -168.966 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 mt -62.93 -38.36 90.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.499 -2.625 . . . . 19.309999999999999 111.668 166.501 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 m -61.37 -61.32 2.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.48 3.512 . . . . 23.140000000000001 112.718 -178.982 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.52 52.42 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 118.567 -1.778 . . . . 19.739999999999998 111.373 177.869 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -123.87 167.37 14.18 Favored 'General case' 0 N--CA 1.43 -1.454 1 CA-C-O 129.648 4.546 . . . . 21.93 108.18 179.759 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.2 m -131.06 108.28 9.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 110.368 -3.105 . . . . 12.33 103.155 166.771 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.8 mt -101.28 131.52 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 111.953 -3.88 . . . . 17.079999999999998 107.123 175.545 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.6 m -104.59 114.88 29.39 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 123.996 3.089 . . . . 16.300000000000001 106.551 173.846 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.3 mt -104.1 129.03 51.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.145 1.778 . . . . 15.880000000000001 111.824 174.074 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -87.03 106.3 17.75 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.657 3.122 . . . . 28.899999999999999 105.081 -178.545 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.19 155.7 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.031 -2.918 . . . . 12.050000000000001 110.418 -171.266 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -109.89 137.42 20.45 Favored Pre-proline 0 N--CA 1.43 -1.432 0 O-C-N 116.723 -3.735 . . . . 18.170000000000002 107.759 164.881 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.69 -10.25 13.11 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 124.828 3.686 . . . . 8.1600000000000001 113.074 -164.077 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -89.22 -12.98 39.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.024 2.345 . . . . 11.130000000000001 110.958 174.511 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -81.88 157.9 24.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.105 -1.407 . . . . 18.030000000000001 111.749 176.007 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -87.51 170.33 11.43 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.54 -2.6 . . . . 10.220000000000001 116.007 -150.895 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.0 mt -80.95 -27.3 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 118.3 -2.75 . . . . 12.300000000000001 110.892 -175.471 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -62.21 -45.14 94.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.767 -2.063 . . . . 36.509999999999998 112.619 166.98 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -64.25 -20.43 66.04 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 117.516 -1.23 . . . . 25.66 112.238 178.055 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.1 t -73.06 -40.4 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 122.16 2.255 . . . . 8.1199999999999992 111.82 168.473 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -66.94 -38.45 86.18 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.491 2.994 . . . . 15.470000000000001 113.989 176.807 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.44 -11.07 29.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.617 2.821 . . . . 11.449999999999999 118.617 169.564 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -84.04 -38.88 20.3 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.506 1.622 . . . . 24.98 113.506 166.35 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.7 -40.51 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 117.561 -3.212 . . . . 9.4600000000000009 115.545 160.618 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -55.01 -35.34 64.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.15 -2.844 . . . . 14.76 114.438 170.289 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.4 -57.07 11.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.892 -1.755 . . . . 26.289999999999999 115.344 166.452 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -66.27 -65.11 0.72 Allowed 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 133.415 4.686 . . . . 30.059999999999999 109.714 -168.452 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -93.32 -26.53 17.26 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.903 1.811 . . . . 25.190000000000001 114.454 -173.471 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.8 28.6 9.32 Favored Glycine 0 N--CA 1.43 -1.709 1 O-C-N 114.152 -5.342 . . . . 7.4100000000000001 116.358 177.126 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 90.2 mt -120.12 118.54 31.41 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 116.256 -1.83 . . . . 9.4900000000000002 108.263 -162.62 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -73.05 162.0 41.99 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.867 3.488 . . . . 11.42 114.961 -164.004 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.63 -15.53 19.35 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 125.616 3.041 . . . . 12.0 114.338 -174.016 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.4 -29.78 42.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.599 2.454 . . . . 35.549999999999997 114.078 176.351 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -78.11 -23.63 47.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.653 1.981 . . . . 20.52 115.38 171.866 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -71.79 139.48 49.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.266 3.062 . . . . 7.1299999999999999 119.266 170.562 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -119.71 147.46 44.55 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.488 -2.007 . . . . 36.390000000000001 113.949 158.604 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -127.64 112.52 14.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.858 -2.401 . . . . 9.5500000000000007 111.047 179.419 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.6 mt -95.71 125.35 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.124 -3.485 . . . . 13.9 107.044 -175.663 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -98.1 -62.51 1.23 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.909 -3.62 . . . . 6.8600000000000003 105.952 178.107 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.69 -128.5 0.1 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.135 2.574 . . . . 11.15 104.497 177.976 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.04 7.07 32.81 Favored Glycine 0 N--CA 1.431 -1.699 0 O-C-N 121.043 -1.036 . . . . 13.93 114.609 -172.482 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -111.98 117.36 32.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.206 1.558 . . . . 23.920000000000002 115.206 169.661 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -68.6 129.3 39.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.319 2.009 . . . . 23.23 111.191 -170.345 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.37 153.3 35.89 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.61 -3.181 . . . . 9.1099999999999994 113.891 -176.687 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -101.65 150.41 23.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.107 0.956 . . . . 33.439999999999998 111.676 162.253 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -67.02 -43.99 81.42 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 120.44 3.496 . . . . 28.370000000000001 120.44 -178.145 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.73 48.04 1.85 Allowed Glycine 0 N--CA 1.43 -1.709 0 CA-C-O 123.777 1.765 . . . . 15.0 111.873 -178.449 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -127.39 162.22 26.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.8 -2.296 . . . . 25.5 104.8 174.544 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.2 p -91.09 169.42 10.87 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.77 -3.081 . . . . 11.949999999999999 108.605 178.097 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.7 -34.28 71.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.345 -3.347 . . . . 10.17 114.319 171.442 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 t -65.81 -34.69 78.75 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 128.358 3.536 . . . . 13.59 116.008 -178.482 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -56.58 -43.33 79.95 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.83 -1.794 . . . . 11.699999999999999 113.323 177.834 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -95.11 8.82 41.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 122.354 2.343 . . . . 12.949999999999999 113.437 -178.882 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.493 10.6 m120 66.0 41.23 3.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.847 2.059 . . . . 25.449999999999999 113.274 175.96 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.3 mt -91.05 138.09 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 106.632 -1.618 . . . . 14.6 106.632 -178.233 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -128.98 -177.28 4.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.943 -2.973 . . . . 33.229999999999997 112.426 -168.746 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.327 19.9 pttp -60.93 149.6 35.93 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 120.862 3.653 . . . . 25.969999999999999 120.862 168.916 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 48.1 27.49 1.26 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.965 3.306 . . . . 32.609999999999999 116.802 -171.905 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.334 54.5 m -92.99 144.94 24.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.409 -3.307 . . . . 10.56 114.986 177.277 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.5 m -99.91 120.99 40.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.057 -1.925 . . . . 5.3300000000000001 115.937 -171.761 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -103.51 137.92 40.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.11 -1.441 . . . . 11.66 107.11 174.567 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -93.6 114.44 26.78 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 114.445 1.276 . . . . 16.300000000000001 114.445 177.08 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.253 49.6 tp -83.4 115.2 21.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 124.288 0.992 . . . . 9.9600000000000009 110.353 -179.595 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.57 -175.05 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 115.068 -0.969 . . . . 9.7599999999999998 110.102 166.92 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.43 -1.432 0 CA-C-O 122.606 1.193 . . . . 19.57 113.147 172.334 . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 116.08 -1.914 . . . . 17.170000000000002 113.758 . . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -104.24 131.58 51.4 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.267 2.23 . . . . 21.890000000000001 110.383 -179.08 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.38 152.51 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.182 -2.525 . . . . 10.83 104.182 -178.696 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -107.31 125.08 50.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.269 2.228 . . . . 10.609999999999999 111.289 -176.69 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 t -110.84 115.63 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.23 -2.794 . . . . 9.1300000000000008 109.221 176.513 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.262 31.3 tttt -97.79 130.59 44.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.741 0.781 . . . . 20.550000000000001 109.626 -171.535 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.271 13.9 p -74.92 166.25 23.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.841 -3.662 . . . . 11.779999999999999 115.12 -179.001 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.263 1.6 tp -54.96 -43.33 73.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.618 3.567 . . . . 19.309999999999999 106.288 171.607 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 p -89.49 -50.25 6.21 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.177 -3.452 . . . . 23.140000000000001 115.64 179.529 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.75 67.61 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.763 0 O-C-N 117.533 -3.23 . . . . 19.739999999999998 111.34 163.475 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -137.24 139.83 41.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.503 -2.763 . . . . 21.93 106.545 173.784 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -104.57 112.9 26.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.799 1.64 . . . . 12.33 107.655 -166.816 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 60.1 mt -91.03 144.22 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 118.17 -2.831 . . . . 17.079999999999998 107.348 179.328 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.1 m -108.5 121.01 44.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 122.799 2.545 . . . . 16.300000000000001 112.779 164.867 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.66 130.7 55.5 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.688 2.795 . . . . 15.880000000000001 111.715 -179.997 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -90.54 114.83 27.13 Favored 'General case' 0 N--CA 1.43 -1.453 1 CA-C-O 128.596 4.046 . . . . 28.899999999999999 108.81 173.687 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.61 171.63 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.56 -3.212 . . . . 12.050000000000001 110.89 -173.621 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.36 147.94 36.63 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 102.387 -3.19 . . . . 18.170000000000002 102.387 166.663 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -65.11 -14.07 43.19 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 121.695 1.597 . . . . 8.1600000000000001 113.938 171.671 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.34 -4.95 50.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.936 2.303 . . . . 11.130000000000001 116.142 171.895 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -81.18 146.47 30.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 114.596 -2.621 . . . . 18.030000000000001 109.753 178.919 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.0 p -79.75 166.71 21.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 125.717 3.871 . . . . 10.220000000000001 114.111 167.627 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.7 mm -49.77 -43.36 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 111.624 -2.534 . . . . 12.300000000000001 113.738 169.234 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.254 36.0 tt0 -54.11 -24.83 19.08 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.663 -2.113 . . . . 36.509999999999998 115.632 176.632 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -86.9 -34.71 19.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.156 2.408 . . . . 25.66 111.043 178.206 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.22 -48.4 88.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.457 2.075 . . . . 8.1199999999999992 108.521 178.677 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -61.31 -27.04 68.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 119.134 3.012 . . . . 15.470000000000001 119.134 175.278 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.258 . . -74.2 -29.51 61.78 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.83 -3.044 . . . . 11.449999999999999 109.827 -175.959 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -64.52 -36.75 85.22 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.399 2.523 . . . . 24.98 115.904 169.254 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.344 39.1 mt -65.08 -42.05 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 O-C-N 116.198 -4.063 . . . . 9.4600000000000009 110.701 171.766 . . . . . . . . 3 2 . 1 . 097 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.07 -29.83 68.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.914 -3.616 . . . . 14.76 118.367 168.211 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.65 -48.67 16.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 126.42 2.325 . . . . 26.289999999999999 111.194 -179.023 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -83.03 -57.48 3.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 126.21 2.194 . . . . 30.059999999999999 112.005 -169.883 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -78.32 -45.8 21.73 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.62 2.768 . . . . 25.190000000000001 111.537 177.757 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.2 50.15 5.59 Favored Glycine 0 N--CA 1.43 -1.763 0 O-C-N 119.407 -2.058 . . . . 7.4100000000000001 113.25 -169.126 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mt -113.31 140.81 24.81 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.114 -2.18 . . . . 9.4900000000000002 105.114 170.38 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -72.75 148.88 47.39 Favored 'Trans proline' 0 N--CA 1.433 -2.032 1 C-N-CA 125.885 4.39 . . . . 11.42 111.164 -176.837 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.8 -30.16 9.68 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 N-CA-C 116.44 1.669 . . . . 12.0 116.44 -165.3 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -66.23 -26.21 67.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 120.333 3.457 . . . . 35.549999999999997 120.333 172.356 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -78.09 -29.7 49.18 Favored 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 132.327 4.251 . . . . 20.52 108.528 -178.163 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.432 ' HA ' HD11 ' A' ' 69' ' ' LEU 0.262 56.6 mt-30 -67.74 91.44 0.31 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.693 3.197 . . . . 7.1299999999999999 110.283 170.799 . . . . . . . . 3 3 . 1 . 097 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -93.77 98.54 11.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 126.74 3.162 . . . . 36.390000000000001 109.51 171.417 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -98.22 130.52 44.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.08 2.848 . . . . 9.5500000000000007 104.496 -170.374 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mt -123.08 134.27 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.544 -3.847 . . . . 13.9 107.095 -173.72 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -115.54 103.36 10.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 102.491 -3.151 . . . . 6.8600000000000003 102.491 175.794 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.69 -97.48 0.06 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.407 2.283 . . . . 11.15 111.368 -172.679 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.58 16.23 9.05 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-O 124.083 1.935 . . . . 13.93 117.353 161.679 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -84.33 115.0 22.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.659 -3.26 . . . . 23.920000000000002 106.833 174.963 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -74.13 123.58 24.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 117.142 -1.409 . . . . 23.23 110.916 166.82 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.07 132.66 39.71 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 116.618 -2.033 . . . . 9.1099999999999994 108.648 -160.301 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -78.37 151.0 33.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.496 -3.877 . . . . 33.439999999999998 107.325 174.929 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.16 -36.85 75.0 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.485 2.088 . . . . 28.370000000000001 111.843 -169.572 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.03 25.15 27.23 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-O 125.415 2.675 . . . . 15.0 113.043 -160.754 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -115.56 142.19 47.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 124.288 1.994 . . . . 25.5 108.414 -174.231 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -76.31 153.89 35.51 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.166 2.412 . . . . 11.949999999999999 112.73 178.959 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.9 mt -70.9 -32.27 69.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.552 -3.217 . . . . 10.17 111.88 178.586 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.5 p -70.93 -17.58 62.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.347 -1.471 . . . . 13.59 114.844 168.843 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -77.73 -44.86 26.47 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 119.059 -2.275 . . . . 11.699999999999999 110.37 178.769 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -70.03 -25.44 63.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.799 -3.688 . . . . 12.949999999999999 115.76 173.975 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.501 20.3 t30 81.6 43.8 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 131.399 3.879 . . . . 25.449999999999999 115.905 -170.553 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.9 mt -94.13 94.25 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 105.68 -1.97 . . . . 14.6 105.68 174.009 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -93.07 -177.45 4.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.784 -1.553 . . . . 33.229999999999997 114.94 176.067 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -55.96 139.03 47.73 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.241 2.311 . . . . 25.969999999999999 117.241 -174.19 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 80.0 mt-10 68.98 12.27 8.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 128.634 3.709 . . . . 32.609999999999999 114.015 -179.854 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.275 16.1 m -64.69 144.05 57.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.392 1.477 . . . . 10.56 112.876 170.0 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 m -102.06 116.25 32.28 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 102.076 -3.305 . . . . 5.3300000000000001 102.076 -176.602 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.36 134.72 42.88 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.191 -1.568 . . . . 11.66 111.455 168.245 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -109.5 120.75 43.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 113.317 -3.23 . . . . 16.300000000000001 112.115 -163.993 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.432 HD11 ' HA ' ' A' ' 41' ' ' GLN . 62.7 tp -94.43 117.88 30.79 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.686 1.866 . . . . 9.9600000000000009 108.51 -170.292 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.55 149.3 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.293 -1.504 . . . . 9.7599999999999998 107.625 167.283 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.264 80.2 mt . . . . . 0 N--CA 1.43 -1.43 0 O-C-N 120.481 -1.387 . . . . 19.57 113.589 -179.06 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 114.311 1.226 . . . . 17.170000000000002 114.311 . . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.259 61.8 mt-30 -98.4 135.58 39.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.183 1.793 . . . . 21.890000000000001 107.28 171.306 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.313 18.3 pt -131.23 150.64 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.416 -2.053 . . . . 10.83 110.14 166.947 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.255 17.5 m-85 -115.78 111.57 20.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.108 2.163 . . . . 10.609999999999999 112.713 -172.675 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.4 t -96.92 121.51 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.65 -1.281 . . . . 9.1300000000000008 107.943 177.459 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.29 38.6 ttmt -114.27 133.68 55.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.144 -1.408 . . . . 20.550000000000001 113.107 -170.844 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.8 p -83.9 173.54 11.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 127.982 3.302 . . . . 11.779999999999999 114.429 178.248 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 mt -75.93 -29.48 58.39 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.642 2.46 . . . . 19.309999999999999 117.642 -178.686 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -68.07 -64.53 0.84 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.072 2.549 . . . . 23.140000000000001 107.367 169.846 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.26 51.72 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 104.656 -3.378 . . . . 19.739999999999998 104.656 170.016 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.515 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 78.7 tttt -97.13 125.64 41.76 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.161 2.984 . . . . 21.93 108.757 161.019 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -99.19 127.68 45.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.063 -2.273 . . . . 12.33 106.0 176.662 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.55 115.77 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 128.741 2.816 . . . . 17.079999999999998 111.297 161.576 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.3 m -84.8 124.74 31.91 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 119.327 0.967 . . . . 16.300000000000001 112.005 165.037 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.18 128.43 56.36 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 126.969 2.668 . . . . 15.880000000000001 104.733 -175.645 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -99.77 110.92 23.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.577 -2.749 . . . . 28.899999999999999 103.577 178.843 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.4 155.55 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 117.863 -1.065 . . . . 12.050000000000001 110.264 -169.477 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -104.08 139.23 19.9 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 115.933 -1.984 . . . . 18.170000000000002 112.153 171.166 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.66 -15.56 21.58 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 126.165 3.237 . . . . 8.1600000000000001 111.369 -158.484 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.3 p -82.45 -1.8 51.3 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 121.121 3.749 . . . . 11.130000000000001 121.121 -177.414 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -89.1 174.2 8.01 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.922 3.689 . . . . 18.030000000000001 110.384 -179.036 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.4 p -91.51 157.43 17.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.482 -3.261 . . . . 10.220000000000001 113.843 -173.671 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 50' ' ' LEU . 24.7 mt -73.89 -31.21 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.056 -2.572 . . . . 12.300000000000001 104.056 172.96 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -40.23 -48.74 2.63 Favored 'General case' 0 N--CA 1.43 -1.429 2 O-C-N 114.13 -5.356 . . . . 36.509999999999998 110.656 164.982 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.306 8.8 t-20 -61.73 -41.82 98.15 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.026 2.93 . . . . 25.66 112.956 177.744 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -59.35 -45.19 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 125.436 1.495 . . . . 8.1199999999999992 111.352 174.976 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -68.91 -40.63 78.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.686 3.194 . . . . 15.470000000000001 109.315 -179.087 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.32 -26.3 68.42 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.508 3.123 . . . . 11.449999999999999 111.886 176.493 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -72.18 -37.68 69.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.269 1.85 . . . . 24.98 111.594 172.496 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mt -76.49 -29.03 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 125.809 1.644 . . . . 9.4600000000000009 109.879 178.43 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.27 -50.34 74.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.885 -3.01 . . . . 14.76 110.641 165.873 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.09 -68.27 0.26 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 129.158 2.983 . . . . 26.289999999999999 112.712 179.974 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -71.68 -62.87 1.26 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 114.719 -2.562 . . . . 30.059999999999999 115.197 -176.541 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.515 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 53.2 mm-40 -72.1 -51.18 22.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.403 2.049 . . . . 25.190000000000001 113.549 -175.079 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.74 38.83 1.52 Allowed Glycine 0 N--CA 1.43 -1.718 0 O-C-N 116.716 -3.74 . . . . 7.4100000000000001 113.934 -179.509 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.272 78.9 mt -124.92 124.51 25.47 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 103.311 -2.848 . . . . 9.4900000000000002 103.311 -174.249 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -76.84 175.82 10.9 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-O 114.904 -2.207 . . . . 11.42 110.789 -171.38 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.85 -32.84 5.29 Favored 'Trans proline' 0 C--N 1.299 -2.027 1 C-N-CA 126.53 4.82 . . . . 12.0 110.759 171.925 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.272 11.6 t70 -58.26 -42.55 86.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.401 1.08 . . . . 35.549999999999997 113.809 176.322 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -79.54 -38.71 33.59 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.248 2.219 . . . . 20.52 112.314 -178.66 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -80.08 167.28 20.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 127.342 3.448 . . . . 7.1299999999999999 118.71 -175.31 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -131.43 121.8 25.18 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.612 -3.18 . . . . 36.390000000000001 111.975 162.086 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.3 tp -108.66 119.0 38.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.24 -1.393 . . . . 9.5500000000000007 107.24 -170.469 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.1 mt -118.31 135.67 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.959 -2.963 . . . . 13.9 113.128 -169.68 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -118.7 109.54 16.22 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.879 -3.013 . . . . 6.8600000000000003 106.323 167.798 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.4 -92.85 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.385 3.074 . . . . 11.15 113.566 -172.371 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.04 -37.89 8.16 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 119.486 -2.009 . . . . 13.93 116.611 175.545 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -107.71 146.56 31.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 124.794 0.938 . . . . 23.920000000000002 112.546 -159.742 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -81.02 138.37 36.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.43 2.538 . . . . 23.23 112.699 171.9 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.427 ' HB3' HD11 ' A' ' 23' ' ' ILE . 43.2 mt -89.78 114.83 26.61 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.757 -3.715 . . . . 9.1099999999999994 112.306 -175.914 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.85 143.98 27.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.26 -2.15 . . . . 33.439999999999998 114.578 -173.084 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.8 -49.86 72.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.61 3.164 . . . . 28.370000000000001 112.447 -165.875 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.12 -4.63 77.78 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 118.325 2.09 . . . . 15.0 118.325 -163.303 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -84.06 178.94 7.64 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.776 3.179 . . . . 25.5 113.854 166.105 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.5 p -110.83 175.84 5.27 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.732 -3.105 . . . . 11.949999999999999 104.651 -177.667 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.49 -26.9 32.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.152 2.181 . . . . 10.17 105.374 -178.589 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.1 p -65.99 -36.33 83.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 131.461 3.905 . . . . 13.59 113.147 174.264 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.4 -52.84 63.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 126.972 2.67 . . . . 11.699999999999999 116.001 171.048 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -67.56 -17.49 64.66 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.767 1.627 . . . . 12.949999999999999 111.357 176.822 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 59.51 55.08 4.27 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.545 2.338 . . . . 25.449999999999999 111.754 -170.405 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -86.79 116.96 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 104.038 -2.579 . . . . 14.6 104.038 -178.417 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -98.3 159.69 14.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 126.925 2.641 . . . . 33.229999999999997 110.011 -178.212 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -52.18 131.98 32.97 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.878 2.071 . . . . 25.969999999999999 112.909 -178.051 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 73.09 32.57 1.29 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.716 -2.947 . . . . 32.609999999999999 111.938 176.666 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -75.66 141.49 42.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.843 1.783 . . . . 10.56 110.636 169.48 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -86.54 120.48 27.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.505 -2.035 . . . . 5.3300000000000001 105.505 171.63 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.86 146.73 38.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.754 1.622 . . . . 11.66 106.827 175.959 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -117.73 140.57 49.49 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.422 2.058 . . . . 16.300000000000001 108.134 -172.177 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 tp -119.68 135.69 54.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.024 -2.954 . . . . 9.9600000000000009 103.024 -174.534 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 71' ' ' LEU . 2.3 t -135.03 -176.6 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.381 2.672 . . . . 9.7599999999999998 105.283 174.805 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.564 ' H ' HG12 ' A' ' 70' ' ' VAL . 7.2 mt . . . . . 0 N--CA 1.431 -1.414 0 C-N-CA 126.792 2.037 . . . . 19.57 108.973 169.111 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tmm? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 112.485 0.55 . . . . 17.170000000000002 112.485 . . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -85.83 123.47 31.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.206 1.402 . . . . 21.890000000000001 108.066 -178.659 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -106.29 161.01 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.871 -2.393 . . . . 10.83 109.769 151.855 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -114.23 131.81 56.35 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.851 -3.389 . . . . 10.609999999999999 101.851 -178.765 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.95 102.83 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 101.867 -3.383 . . . . 9.1300000000000008 101.867 -178.079 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -94.89 128.5 41.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.174 2.19 . . . . 20.550000000000001 116.403 -173.206 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.267 18.9 p -89.41 173.17 8.51 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.121 -2.862 . . . . 11.779999999999999 116.407 -177.012 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.95 -48.56 15.99 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.118 -2.239 . . . . 19.309999999999999 109.004 174.502 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -67.69 -46.98 70.72 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.929 3.291 . . . . 23.140000000000001 107.188 -168.54 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.63 24.58 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 116.074 -2.514 . . . . 19.739999999999998 118.799 173.083 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -110.89 124.91 53.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 120.082 1.941 . . . . 21.93 107.243 -174.489 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 m -105.53 114.1 28.06 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.729 -1.857 . . . . 12.33 109.846 171.745 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -95.34 122.1 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 103.698 -2.705 . . . . 17.079999999999998 103.698 -165.735 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -91.48 110.92 22.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.985 -2.969 . . . . 16.300000000000001 102.985 175.244 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.5 mt -106.26 136.77 45.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.986 1.314 . . . . 15.880000000000001 108.404 169.126 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -93.58 116.02 28.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.342 2.02 . . . . 28.899999999999999 108.938 169.275 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.85 167.57 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.529 3.132 . . . . 12.050000000000001 110.694 175.487 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -105.64 158.44 32.31 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 114.485 -2.674 . . . . 18.170000000000002 110.878 157.68 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -74.38 -25.12 13.54 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 126.174 3.241 . . . . 8.1600000000000001 117.478 -172.453 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -75.24 -11.4 60.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 131.223 3.809 . . . . 11.130000000000001 115.788 163.629 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -72.46 158.24 36.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.998 2.333 . . . . 18.030000000000001 113.522 178.382 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -92.98 161.41 14.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.244 -3.41 . . . . 10.220000000000001 112.478 -173.926 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.7 mt -82.82 -8.75 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 126.661 2.476 . . . . 12.300000000000001 111.224 -179.398 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -57.7 -54.91 41.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.941 -2.349 . . . . 36.509999999999998 111.313 166.421 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -61.27 -16.08 41.85 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 116.291 -4.005 . . . . 25.66 115.012 168.776 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -74.64 -43.93 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 CA-C-N 126.381 4.173 . . . . 8.1199999999999992 108.302 167.906 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -67.15 -32.29 73.3 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.311 1.869 . . . . 15.470000000000001 114.79 175.51 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.98 -25.14 58.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.108 1.892 . . . . 11.449999999999999 116.108 172.176 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -74.08 -30.58 62.44 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.493 1.497 . . . . 24.98 107.052 178.233 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.9 mm -69.9 -34.67 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 118.368 -0.825 . . . . 9.4600000000000009 111.857 173.639 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -65.13 -43.49 91.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.802 2.841 . . . . 14.76 109.741 173.466 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.02 -56.77 14.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 117.49 2.404 . . . . 26.289999999999999 117.49 176.311 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -56.53 -65.16 0.66 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.875 3.27 . . . . 30.059999999999999 112.235 173.322 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -101.17 -36.03 9.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.682 -1.145 . . . . 25.190000000000001 113.133 -159.673 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.08 4.72 31.08 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 118.231 -2.793 . . . . 7.4100000000000001 114.078 -177.402 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 mt -88.34 112.25 48.6 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-O 116.831 -1.557 . . . . 9.4900000000000002 109.121 -173.02 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -81.74 -176.7 3.17 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 122.568 1.953 . . . . 11.42 114.472 -171.819 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -74.4 -16.31 21.91 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 122.412 2.074 . . . . 12.0 115.764 -178.924 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.42 -24.08 42.77 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.88 2.752 . . . . 35.549999999999997 116.614 -175.904 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -98.33 -35.52 10.29 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.501 -2.136 . . . . 20.52 110.057 -168.587 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -91.89 166.26 12.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.635 -1.29 . . . . 7.1299999999999999 108.515 -172.333 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.2 139.02 37.39 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 131.778 4.031 . . . . 36.390000000000001 104.102 165.632 . . . . . . . . 3 3 . 1 . 099 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.1 mt -104.2 132.9 49.96 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.647 1.979 . . . . 9.5500000000000007 106.401 178.069 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.02 142.07 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.809 -1.807 . . . . 13.9 107.846 177.514 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -148.83 108.54 4.02 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.308 -2.12 . . . . 6.8600000000000003 108.484 -175.066 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 57.05 -114.31 0.81 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 120.541 3.534 . . . . 11.15 120.541 -158.54 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.34 -36.53 20.39 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.605 -1.31 . . . . 13.93 114.607 -178.901 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -116.06 170.49 8.46 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 120.729 2.264 . . . . 23.920000000000002 114.499 -162.54 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.19 146.54 24.99 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 102.799 -3.037 . . . . 23.23 102.799 -176.676 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.8 mt -99.86 128.79 45.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.489 -2.782 . . . . 9.1099999999999994 103.489 -166.397 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -75.3 153.81 37.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.736 1.614 . . . . 33.439999999999998 113.868 168.76 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.55 -61.69 1.73 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.782 -3.699 . . . . 28.370000000000001 108.56 -162.671 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.93 59.2 3.21 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 122.297 2.317 . . . . 15.0 111.147 -169.438 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -140.72 153.07 45.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.472 2.309 . . . . 25.5 106.987 -177.354 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.25 46.7 p -82.94 154.53 24.5 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.674 -2.516 . . . . 11.949999999999999 113.174 -173.151 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 61' ' ' ILE . 17.5 mt -63.88 -39.52 94.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.933 -2.354 . . . . 10.17 111.642 165.503 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 p -54.59 -37.5 65.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.408 2.744 . . . . 13.59 118.408 172.578 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.37 -50.35 53.76 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.287 -5.258 . . . . 11.699999999999999 113.941 174.745 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -69.88 -14.09 62.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.295 2.638 . . . . 12.949999999999999 114.03 -177.909 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.492 27.6 m-20 75.23 41.15 0.3 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 116.963 2.209 . . . . 25.449999999999999 116.963 -176.289 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.462 HD12 HD22 ' A' ' 56' ' ' LEU . 71.7 mt -83.0 116.12 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 118.21 -2.806 . . . . 14.6 107.77 177.522 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -97.95 167.46 10.9 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.615 -0.721 . . . . 33.229999999999997 110.012 -176.65 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -70.23 144.65 51.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 120.874 1.67 . . . . 25.969999999999999 112.605 -174.86 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 67.16 21.5 10.04 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.661 3.6 . . . . 32.609999999999999 112.134 176.81 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 t -97.67 151.61 19.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.896 -2.378 . . . . 10.56 108.682 -178.081 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.8 m -101.47 111.3 23.5 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.244 2.618 . . . . 5.3300000000000001 113.07 -168.502 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -90.88 145.89 24.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.293 2.637 . . . . 11.66 106.206 164.065 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -97.26 132.46 42.98 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 119.824 -0.75 . . . . 16.300000000000001 112.583 171.48 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 tp -95.03 121.01 36.22 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.432 -1.692 . . . . 9.9600000000000009 106.432 166.732 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.76 153.77 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 114.959 -2.448 . . . . 9.7599999999999998 105.596 178.699 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.6 mt . . . . . 0 N--CA 1.43 -1.465 0 CA-C-N 124.692 3.406 . . . . 19.57 107.465 175.541 . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttp . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 123.704 1.716 . . . . 17.170000000000002 107.499 . . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -99.98 116.61 32.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.613 2.765 . . . . 21.890000000000001 111.036 175.776 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -124.83 167.69 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 106.79 -1.559 . . . . 10.83 106.79 178.884 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -122.48 115.82 22.88 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.663 -1.273 . . . . 10.609999999999999 110.823 -169.364 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.05 123.48 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 121.295 -0.878 . . . . 9.1300000000000008 109.128 171.351 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.493 ' HD2' HG23 ' A' ' 66' ' ' THR . 85.2 mttt -117.38 137.17 52.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.171 1.788 . . . . 20.550000000000001 108.846 -175.907 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -102.94 -176.77 3.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.488 1.742 . . . . 11.779999999999999 109.035 -175.16 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.266 95.9 mt -69.93 -27.1 64.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.805 2.442 . . . . 19.309999999999999 116.698 -172.091 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -96.2 -89.08 0.26 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.451 2.3 . . . . 23.140000000000001 111.079 -177.679 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.74 36.85 0.47 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.811 -3.681 . . . . 19.739999999999998 111.321 168.765 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -97.04 137.96 35.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 116.732 -1.987 . . . . 21.93 109.721 179.423 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.3 m -123.26 121.97 37.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.36 1.552 . . . . 12.33 107.103 171.144 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.9 mt -101.38 119.35 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 103.382 -2.822 . . . . 17.079999999999998 103.382 179.96 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -89.36 105.34 17.73 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.237 1.494 . . . . 16.300000000000001 108.874 165.241 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.7 mt -92.13 146.12 23.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.602 3.572 . . . . 15.880000000000001 106.076 -178.32 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -95.2 108.56 20.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.284 -2.689 . . . . 28.899999999999999 112.33 171.272 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.86 -177.28 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.439 -1.689 . . . . 12.050000000000001 106.439 -176.183 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -132.63 159.9 70.58 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 119.157 -2.215 . . . . 18.170000000000002 107.279 164.547 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 19.4 Cg_endo -77.48 -16.03 15.33 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 O-C-N 116.417 -2.464 . . . . 8.1600000000000001 114.691 -168.131 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 m -90.11 9.09 29.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 116.425 -2.11 . . . . 11.130000000000001 114.665 177.605 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -86.9 162.54 17.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.755 2.693 . . . . 18.030000000000001 113.703 165.048 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -99.56 169.79 9.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.84 2.733 . . . . 10.220000000000001 112.622 -170.7 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.372 36.8 mm -52.89 -32.72 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 116.164 1.913 . . . . 12.300000000000001 116.164 171.78 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.24 -28.65 69.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.933 -3.604 . . . . 36.509999999999998 116.263 170.769 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -75.79 -20.21 58.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.995 -2.315 . . . . 25.66 113.825 171.423 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.7 t -83.6 -45.33 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 116.694 -1.622 . . . . 8.1199999999999992 107.392 -179.491 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP . 34.7 mtmt -63.58 -31.58 72.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.656 2.383 . . . . 15.470000000000001 110.94 173.682 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.6 -25.05 68.05 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 117.525 -1.67 . . . . 11.449999999999999 114.251 175.181 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -90.29 -15.24 31.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 116.702 -3.749 . . . . 24.98 115.768 173.3 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mm -80.44 -24.6 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 126.159 2.162 . . . . 9.4600000000000009 110.59 167.88 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -81.82 -26.77 34.06 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.524 1.93 . . . . 14.76 108.478 -177.537 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.89 -68.9 0.38 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.566 -3.208 . . . . 26.289999999999999 111.497 164.542 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -73.64 -49.36 26.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.11 1.893 . . . . 30.059999999999999 116.11 -169.375 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -86.81 -47.82 8.74 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.666 2.03 . . . . 25.190000000000001 113.396 178.95 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.06 59.11 1.51 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.288 3.804 . . . . 7.4100000000000001 107.152 169.33 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.461 HD13 HD23 ' A' ' 71' ' ' LEU . 15.9 mm -102.41 140.0 20.74 Favored Pre-proline 0 N--CA 1.43 -1.469 0 O-C-N 129.099 3.47 . . . . 9.4900000000000002 104.004 177.79 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -62.07 161.22 26.99 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 O-C-N 114.304 -3.577 . . . . 11.42 115.953 173.582 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -72.66 -27.49 15.14 Favored 'Trans proline' 0 N--CA 1.434 -1.987 1 CA-C-N 128.85 4.196 . . . . 12.0 110.682 -168.408 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -87.13 -24.08 24.64 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.669 2.84 . . . . 35.549999999999997 118.669 179.425 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -66.9 -42.06 86.08 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.828 2.529 . . . . 20.52 117.828 172.624 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -72.64 131.74 42.82 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.117 3.377 . . . . 7.1299999999999999 120.117 176.155 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -131.9 104.96 7.14 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.685 1.994 . . . . 36.390000000000001 108.624 -170.082 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.1 mt -83.84 112.43 20.11 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 115.22 -4.675 . . . . 9.5500000000000007 114.293 174.84 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.7 mt -99.89 115.81 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 114.041 -1.436 . . . . 13.9 111.585 175.402 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -108.21 120.65 42.96 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.06 -1.65 . . . . 6.8600000000000003 106.55 163.436 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.52 . . 69.21 -111.16 0.09 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.627 -2.546 . . . . 11.15 111.65 -176.77 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.69 6.15 12.6 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 116.507 -2.758 . . . . 13.93 108.58 172.027 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -86.39 139.22 31.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.468 -2.783 . . . . 23.920000000000002 111.702 -158.15 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -89.41 125.16 35.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 102.998 -2.964 . . . . 23.23 102.998 166.132 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 mt -94.33 144.18 25.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.544 2.116 . . . . 9.1099999999999994 110.447 -167.806 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -90.68 130.46 36.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.622 -2.549 . . . . 33.439999999999998 116.402 172.686 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.484 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 9.8 m-20 -36.54 -51.1 0.82 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.992 4.517 . . . . 28.370000000000001 119.612 176.074 . . . . . . . . 3 3 . 1 . 100 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.29 20.9 36.58 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 114.23 -1.35 . . . . 15.0 113.773 -169.341 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mtt-85 -93.3 163.91 13.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.146 -2.973 . . . . 25.5 110.468 160.872 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.0 p -104.74 158.16 16.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.037 -1.664 . . . . 11.949999999999999 108.276 -173.978 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 17.2 mt -56.06 -35.88 67.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.728 2.68 . . . . 10.17 115.522 -179.648 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 19' ' ' PRO . 44.7 p -63.04 -48.2 79.75 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 136.82 6.048 . . . . 13.59 113.653 169.663 . . . . . . . . 3 3 . 1 . 100 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -60.35 -44.78 95.24 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.579 1.952 . . . . 11.699999999999999 112.896 176.803 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -74.7 -10.41 59.49 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 116.239 -4.038 . . . . 12.949999999999999 114.323 173.96 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.394 60.5 m-80 71.33 36.08 1.41 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.93 2.492 . . . . 25.449999999999999 112.313 178.803 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.9 mt -87.87 86.18 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 125.604 1.815 . . . . 14.6 109.52 -175.776 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -77.04 -178.1 4.81 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 125.708 1.88 . . . . 33.229999999999997 114.5 -173.408 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -72.29 135.72 46.05 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.797 1.639 . . . . 25.969999999999999 110.463 -178.69 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.306 47.6 mt-10 61.91 35.21 16.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.241 1.02 . . . . 32.609999999999999 112.377 -176.304 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.288 0.2 OUTLIER -105.47 147.23 28.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.466 -2.152 . . . . 10.56 109.587 172.224 . . . . . . . . 3 3 . 1 . 100 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.493 HG23 ' HD2' ' A' ' 6' ' ' LYS . 61.9 m -122.65 120.42 33.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.728 2.204 . . . . 5.3300000000000001 112.586 -157.198 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -101.89 130.23 48.33 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 130.337 3.455 . . . . 11.66 109.959 -177.393 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -102.7 104.23 14.54 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.348 -3.97 . . . . 16.300000000000001 104.953 -174.208 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.5 tp -80.05 119.37 22.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.479 -2.045 . . . . 9.9600000000000009 105.479 172.957 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.06 141.01 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 126.223 2.202 . . . . 9.7599999999999998 108.361 170.739 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.461 HD23 HD13 ' A' ' 36' ' ' ILE . 82.5 mt . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 112.99 0.737 . . . . 19.57 112.99 177.395 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 115.456 1.65 . . . . 17.170000000000002 115.456 . . . . . . . . . 0 0 . 1 . 101 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -80.55 118.88 22.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.881 -3.012 . . . . 21.890000000000001 118.336 -179.924 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 pt -100.8 165.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 126.957 2.103 . . . . 10.83 111.819 168.937 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.294 15.8 m-30 -123.15 112.6 17.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.838 -2.414 . . . . 10.609999999999999 112.656 -176.016 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.3 t -90.91 105.38 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 117.972 -2.955 . . . . 9.1300000000000008 117.206 170.46 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -88.99 137.11 32.62 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 124.208 1.956 . . . . 20.550000000000001 115.343 -175.591 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.1 p -87.15 178.41 6.9 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 113.314 -5.866 . . . . 11.779999999999999 110.648 -176.183 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tp -58.63 -50.02 75.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.473 -3.892 . . . . 19.309999999999999 114.681 173.006 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -77.78 -38.63 46.25 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 116.211 -4.056 . . . . 23.140000000000001 112.99 -177.412 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.76 52.18 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.999 -1.688 . . . . 19.739999999999998 115.485 169.589 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -111.3 126.74 55.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.906 1.336 . . . . 21.93 107.924 179.331 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -86.06 116.08 24.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.573 -2.58 . . . . 12.33 111.789 169.936 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.4 mt -92.97 117.27 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 112.969 0.729 . . . . 17.079999999999998 112.969 168.254 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.0 m -88.11 122.26 31.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 119.118 -2.238 . . . . 16.300000000000001 109.936 177.865 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 29' ' ' LYS . 64.8 mt -115.36 131.13 57.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.602 2.62 . . . . 15.880000000000001 111.52 172.553 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -87.75 103.25 15.44 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.504 2.722 . . . . 28.899999999999999 105.146 -177.068 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.433 HG13 ' HE3' ' A' ' 29' ' ' LYS . 28.4 m -119.33 167.8 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 105.662 -1.977 . . . . 12.050000000000001 105.662 -178.321 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -123.56 147.05 51.81 Favored Pre-proline 0 N--CA 1.431 -1.402 0 C-N-CA 126.471 1.908 . . . . 18.170000000000002 106.407 176.609 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -67.52 -22.5 44.71 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 O-C-N 115.796 -2.791 . . . . 8.1600000000000001 117.245 -158.094 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 m -94.53 33.85 1.38 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 123.934 3.061 . . . . 11.130000000000001 113.612 171.34 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -84.92 139.14 32.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 127.193 3.378 . . . . 18.030000000000001 113.243 162.665 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 p -80.05 163.07 24.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.651 -2.068 . . . . 10.220000000000001 112.614 176.275 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.91 -26.04 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.712 -1.868 . . . . 12.300000000000001 112.321 -179.624 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.398 15.2 pt-20 -60.58 -28.38 68.43 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.687 2.106 . . . . 36.509999999999998 116.687 168.959 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.293 5.7 t-20 -72.83 -37.92 67.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.955 3.302 . . . . 25.66 111.152 173.719 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 39.6 t -52.34 -53.93 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 129.213 3.005 . . . . 8.1199999999999992 111.59 173.55 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -69.76 -11.01 60.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.728 3.211 . . . . 15.470000000000001 112.184 -179.303 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.44 -44.7 70.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 121.423 1.919 . . . . 11.449999999999999 107.623 174.074 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' HE3' HG13 ' A' ' 17' ' ' VAL . 64.0 mttm -76.0 -37.81 58.07 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.346 2.659 . . . . 24.98 106.023 -168.247 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.315 8.8 mm -57.37 -35.51 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 118.594 2.813 . . . . 9.4600000000000009 118.594 171.233 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -71.46 -40.4 70.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.473 2.709 . . . . 14.76 114.895 167.339 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -60.3 -67.26 0.41 Allowed 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 128.23 3.871 . . . . 26.289999999999999 111.495 169.687 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -72.62 -50.97 21.69 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 110.502 -7.624 . . . . 30.059999999999999 112.48 -160.629 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -97.1 -71.64 0.67 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.112 1.911 . . . . 25.190000000000001 111.479 175.104 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.41 26.01 0.5 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 116.276 -2.869 . . . . 7.4100000000000001 120.178 -175.662 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.53 133.5 28.09 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 115.323 -2.275 . . . . 9.4900000000000002 107.72 -178.519 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -73.49 160.09 45.07 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 126.566 3.381 . . . . 11.42 114.639 179.525 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.5 -16.06 9.53 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 123.552 2.835 . . . . 12.0 110.521 -162.266 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -82.03 -37.61 26.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 125.056 3.571 . . . . 35.549999999999997 114.474 -179.899 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -69.49 -27.57 65.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.636 2.458 . . . . 20.52 117.636 -178.139 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -87.65 139.24 30.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.33 -1.359 . . . . 7.1299999999999999 107.33 -174.318 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -106.63 142.59 36.03 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 105.007 -2.22 . . . . 36.390000000000001 105.007 165.526 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.4 mt -118.96 108.85 15.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.704 -3.122 . . . . 9.5500000000000007 112.879 171.119 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.56 ' HB ' ' HD1' ' A' ' 68' ' ' HIS . 40.5 mt -92.82 137.86 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.441 -1.689 . . . . 13.9 106.441 -177.363 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -110.38 118.95 37.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.304 2.241 . . . . 6.8600000000000003 105.576 167.125 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.18 -96.63 0.05 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.919 1.288 . . . . 11.15 111.899 -167.277 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.86 5.55 6.13 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 117.36 -3.337 . . . . 13.93 112.065 172.769 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -82.03 152.65 26.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.609 -2.701 . . . . 23.920000000000002 110.487 -168.079 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -92.02 124.62 36.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.94 -1.505 . . . . 23.23 112.361 169.098 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.2 mt -104.72 168.7 8.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.693 1.246 . . . . 9.1099999999999994 112.467 -175.173 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -132.06 166.44 21.74 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.643 1.977 . . . . 33.439999999999998 107.374 -178.403 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -93.9 -42.86 8.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.913 -1.742 . . . . 28.370000000000001 111.104 -149.305 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.83 44.96 1.44 Allowed Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 118.462 -1.828 . . . . 15.0 115.193 -179.042 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -120.82 159.12 26.12 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.486 2.314 . . . . 25.5 107.748 173.293 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -97.98 160.31 14.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.384 1.564 . . . . 11.949999999999999 114.506 -169.461 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.52 -38.83 82.03 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.902 -1.749 . . . . 10.17 112.496 168.179 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 p -52.73 -45.6 67.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 118.498 2.777 . . . . 13.59 118.498 171.281 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.47 -41.68 96.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 114.549 -2.644 . . . . 11.699999999999999 114.92 176.436 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -78.91 -10.13 59.72 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.41 2.368 . . . . 12.949999999999999 115.13 172.966 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.422 1.0 OUTLIER 71.82 42.7 0.61 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.776 1.769 . . . . 25.449999999999999 115.776 -178.832 . . . . . . . . 3 3 . 1 . 101 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.5 mt -88.11 111.84 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 1 O-C-N 129.418 4.199 . . . . 14.6 108.756 -177.4 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.319 40.1 mt-30 -93.1 -175.55 3.89 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.876 -3.64 . . . . 33.229999999999997 110.671 -177.938 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttt -69.69 147.36 50.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.053 -1.655 . . . . 25.969999999999999 112.722 171.571 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 56.26 41.57 29.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.652 2.381 . . . . 32.609999999999999 116.786 -168.122 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.6 m -104.34 145.61 30.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 125.023 1.452 . . . . 10.56 107.441 178.82 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -105.81 124.02 48.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.593 2.14 . . . . 5.3300000000000001 106.221 -165.578 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.3 mt -104.34 143.03 33.53 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.108 -3.495 . . . . 11.66 106.751 168.499 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.56 ' HD1' ' HB ' ' A' ' 44' ' ' ILE . 6.5 m80 -98.84 111.33 23.75 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.264 1.95 . . . . 16.300000000000001 116.264 -179.524 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.88 108.36 5.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.251 -3.406 . . . . 9.9600000000000009 109.249 179.747 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 t -117.04 149.32 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 104.818 -2.29 . . . . 9.7599999999999998 104.818 177.206 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 tp . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 116.833 2.16 . . . . 19.57 116.833 171.212 . . . . . . . . 0 0 . 1 . 102 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 124.191 1.948 . . . . 17.170000000000002 111.683 . . . . . . . . . 0 0 . 1 . 102 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -76.85 119.51 20.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.397 -2.69 . . . . 21.890000000000001 110.334 -178.775 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.4 pt -112.06 154.66 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.614 -1.254 . . . . 10.83 107.614 169.548 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.24 133.02 52.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 126.568 3.08 . . . . 10.609999999999999 108.643 175.152 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -110.91 117.81 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 126.812 2.045 . . . . 9.1300000000000008 111.17 165.437 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.22 135.57 55.11 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.557 -1.339 . . . . 20.550000000000001 108.289 -170.752 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.8 p -95.32 179.81 5.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.803 1.287 . . . . 11.779999999999999 109.421 -163.501 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 tp -71.99 -46.46 57.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.111 1.91 . . . . 19.309999999999999 114.851 173.618 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -73.21 -40.14 64.98 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.259 -2.15 . . . . 23.140000000000001 115.546 175.842 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.17 64.65 0.15 Allowed Glycine 0 N--CA 1.431 -1.691 0 CA-C-O 122.897 1.276 . . . . 19.739999999999998 111.715 176.254 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -123.99 136.48 54.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.708 2.194 . . . . 21.93 108.016 159.263 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -105.01 108.22 19.62 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.973 -2.329 . . . . 12.33 112.69 168.451 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.02 126.21 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.041 -1.662 . . . . 17.079999999999998 109.054 178.64 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -96.91 111.63 23.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.875 1.065 . . . . 16.300000000000001 113.875 179.465 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.3 mt -96.59 138.57 33.97 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.119 -2.863 . . . . 15.880000000000001 110.498 -176.025 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -107.28 73.35 0.92 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.389 2.995 . . . . 28.899999999999999 110.915 -175.394 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -102.46 169.47 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 O-C-N 115.792 -4.318 . . . . 12.050000000000001 106.798 -175.143 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -95.87 159.09 33.13 Favored Pre-proline 0 N--CA 1.43 -1.453 1 O-C-N 130.002 4.564 . . . . 18.170000000000002 106.871 174.647 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.25 -26.68 20.64 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 O-C-N 126.268 2.72 . . . . 8.1600000000000001 110.964 172.645 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 p -72.64 -7.09 48.56 Favored 'General case' 0 N--CA 1.43 -1.453 1 CA-C-N 127.237 4.562 . . . . 11.130000000000001 112.742 175.915 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -77.67 154.14 32.43 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 123.196 2.725 . . . . 18.030000000000001 112.724 -175.19 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.4 p -89.34 151.33 22.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.302 3.041 . . . . 10.220000000000001 110.95 178.976 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.25 39.7 mm -56.97 -30.26 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.308 2.643 . . . . 12.300000000000001 114.198 178.691 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -49.25 -45.56 44.9 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.974 -2.954 . . . . 36.509999999999998 113.733 166.303 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -68.91 -37.0 78.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 124.249 0.968 . . . . 25.66 111.266 177.987 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.62 -40.31 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 113.741 1.015 . . . . 8.1199999999999992 113.741 -179.678 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HZ2' ' CG ' ' A' ' 52' ' ' ASP 0.26 49.8 mtpt -59.1 -48.88 79.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.544 2.737 . . . . 15.470000000000001 112.823 174.521 . . . . . . . . 3 3 . 1 . 102 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.87 -32.33 63.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.867 3.267 . . . . 11.449999999999999 111.094 172.581 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -74.27 -39.82 62.72 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 124.005 3.093 . . . . 24.98 109.455 -177.374 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.326 81.8 mt -59.36 -37.52 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 129.991 3.317 . . . . 9.4600000000000009 112.732 173.928 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -59.91 -54.36 47.08 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.555 1.525 . . . . 14.76 112.9 167.039 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.23 -51.41 68.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.702 1.239 . . . . 26.289999999999999 112.123 -173.723 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -78.17 -69.54 0.55 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.364 2.666 . . . . 30.059999999999999 114.351 179.398 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -87.29 -11.24 50.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.087 2.254 . . . . 25.190000000000001 117.087 -170.34 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.68 20.52 34.09 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 128.151 2.786 . . . . 7.4100000000000001 116.253 160.895 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mm -113.32 125.45 29.65 Favored Pre-proline 0 N--CA 1.43 -1.459 0 O-C-N 120.493 -1.592 . . . . 9.4900000000000002 110.036 -173.164 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.309 53.9 Cg_exo -76.55 167.58 25.29 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-O 115.423 -1.991 . . . . 11.42 116.61 -173.968 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -63.9 -23.5 68.29 Favored 'Trans proline' 0 C--N 1.3 -2.019 1 C-N-CA 126.533 4.822 . . . . 12.0 115.907 -170.445 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -89.89 -21.81 22.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 124.008 3.095 . . . . 35.549999999999997 112.258 177.277 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -75.72 -9.54 58.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.627 -2.606 . . . . 20.52 116.1 -176.893 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -112.1 150.54 30.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.102 2.751 . . . . 7.1299999999999999 114.656 -167.502 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -127.22 93.25 3.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.851 -1.781 . . . . 36.390000000000001 109.357 -176.518 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.401 HD11 ' HG3' ' A' ' 27' ' ' LYS . 52.9 mt -82.17 91.59 6.74 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 113.831 1.049 . . . . 9.5500000000000007 113.831 172.24 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.4 mt -91.07 135.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 118.764 -0.636 . . . . 13.9 110.202 -177.816 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -122.66 112.7 18.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.603 -2.369 . . . . 6.8600000000000003 104.603 179.65 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.86 -108.53 0.44 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.187 -2.196 . . . . 11.15 113.004 -169.721 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.91 -19.66 39.31 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 115.536 -2.813 . . . . 13.93 117.041 167.43 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -105.34 134.08 49.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.791 1.795 . . . . 23.920000000000002 114.414 -165.564 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.45 138.4 47.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.303 2.002 . . . . 23.23 112.327 167.636 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.86 141.78 31.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.222 2.209 . . . . 9.1099999999999994 111.185 -169.099 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -119.62 135.88 54.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.467 1.603 . . . . 33.439999999999998 112.791 -166.453 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.42 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS . 4.1 m-20 -48.86 -58.95 4.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.883 2.873 . . . . 28.370000000000001 111.882 -160.376 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.57 -10.18 75.28 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 122.85 3.9 . . . . 15.0 122.85 -173.843 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -79.66 156.59 27.52 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.548 1.969 . . . . 25.5 114.95 174.586 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.9 p -93.88 168.81 10.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.748 3.166 . . . . 11.949999999999999 108.663 -176.001 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mt -72.64 -40.04 66.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.685 -2.052 . . . . 10.17 106.615 -176.198 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -63.79 -28.66 70.02 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 127.853 3.22 . . . . 13.59 116.139 174.114 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.76 -50.38 69.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.177 3.791 . . . . 11.699999999999999 113.406 170.805 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -64.95 -30.73 71.74 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.917 1.821 . . . . 12.949999999999999 115.917 167.144 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 49.4 m-80 82.11 41.27 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.43 1 C-N-CA 131.939 4.096 . . . . 25.449999999999999 110.921 176.908 . . . . . . . . 3 2 . 1 . 102 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -78.82 92.53 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 CA-C-O 129.469 4.461 . . . . 14.6 108.935 170.919 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -84.66 175.65 9.08 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 113.202 -5.936 . . . . 33.229999999999997 111.168 179.707 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -54.03 127.76 27.79 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.278 1.99 . . . . 25.969999999999999 116.173 172.201 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 78.37 29.29 0.44 Allowed 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 132.744 4.418 . . . . 32.609999999999999 117.016 176.877 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.3 m -81.49 149.03 28.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.955 -1.498 . . . . 10.56 106.955 -169.693 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.7 m -94.43 118.01 31.0 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.701 -2.5 . . . . 5.3300000000000001 112.492 177.45 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.0 137.6 40.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.508 -3.245 . . . . 11.66 106.039 168.565 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -98.25 109.97 22.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.067 2.247 . . . . 16.300000000000001 117.067 169.868 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.2 tp -91.43 105.32 17.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.342 1.857 . . . . 9.9600000000000009 115.713 -179.944 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -109.32 162.68 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 101.81 -3.404 . . . . 9.7599999999999998 101.81 178.412 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 N--CA 1.429 -1.483 0 C-N-CA 127.267 2.227 . . . . 19.57 112.411 168.78 . . . . . . . . 0 0 . 1 . 103 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 123.628 1.68 . . . . 17.170000000000002 108.738 . . . . . . . . . 0 0 . 1 . 103 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -88.66 126.85 35.49 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 111.47 -2.604 . . . . 21.890000000000001 111.401 -179.68 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.256 20.8 pt -130.9 159.29 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 107.221 -1.4 . . . . 10.83 107.221 168.721 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -106.89 132.92 52.3 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 118.433 -0.794 . . . . 10.609999999999999 109.481 179.414 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.4 t -101.19 112.89 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.219 2.438 . . . . 9.1300000000000008 111.704 160.325 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -95.73 127.17 41.53 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 113.129 -5.982 . . . . 20.550000000000001 112.99 177.274 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -76.87 -177.26 4.28 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.492 -4.505 . . . . 11.779999999999999 118.146 178.494 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 tp -79.53 -21.74 44.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.484 2.564 . . . . 19.309999999999999 113.658 178.849 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.372 0.1 OUTLIER -75.32 -48.23 24.09 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 116.055 -4.153 . . . . 23.140000000000001 108.72 174.219 . . . . . . . . 4 3 . 1 . 103 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.15 20.92 1.11 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 112.749 -2.023 . . . . 19.739999999999998 109.593 172.246 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -78.62 117.83 20.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.354 2.502 . . . . 21.93 110.751 173.581 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -88.26 110.96 21.15 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.693 -3.129 . . . . 12.33 114.241 -178.9 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 mt -99.61 107.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.901 2.08 . . . . 17.079999999999998 110.983 -172.268 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.2 m -71.97 127.29 32.09 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.101 -1.624 . . . . 16.300000000000001 112.835 173.524 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 mt -111.63 151.34 28.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.532 -1.355 . . . . 15.880000000000001 114.313 167.303 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -108.96 99.05 8.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.808 2.043 . . . . 28.899999999999999 111.253 177.325 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.15 166.13 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.188 -3.445 . . . . 12.050000000000001 103.882 -171.801 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -120.0 161.88 36.18 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 118.959 -2.338 . . . . 18.170000000000002 106.348 177.656 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.68 -8.54 8.21 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 127.501 3.715 . . . . 8.1600000000000001 107.73 -155.901 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -76.17 -9.63 58.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 130.153 3.381 . . . . 11.130000000000001 109.136 172.168 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -81.99 141.34 33.34 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.58 2.352 . . . . 18.030000000000001 112.67 -175.316 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 35.6 p -88.14 163.15 16.33 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.901 -1.749 . . . . 10.220000000000001 108.59 -171.576 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mm -76.42 -17.6 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 125.936 2.023 . . . . 12.300000000000001 109.081 -172.595 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -64.26 -30.19 71.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.562 -1.961 . . . . 36.509999999999998 116.243 162.259 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -76.17 -36.1 58.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.175 1.39 . . . . 25.66 109.696 -179.887 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.45 -48.74 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 128.865 2.866 . . . . 8.1199999999999992 115.959 172.752 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.02 -35.9 78.08 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.256 -1.831 . . . . 15.470000000000001 114.069 164.728 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.66 -39.25 80.09 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.752 2.978 . . . . 11.449999999999999 115.138 173.671 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -57.28 -42.78 82.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 124.371 3.259 . . . . 24.98 115.814 169.205 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.18 -29.79 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 O-C-N 114.18 -5.325 . . . . 9.4600000000000009 112.625 176.447 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -66.26 -52.7 44.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.603 -2.561 . . . . 14.76 108.504 167.804 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.337 34.1 t70 -51.81 -42.3 62.38 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 114.869 -2.491 . . . . 26.289999999999999 115.053 176.349 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -80.99 -86.06 0.09 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 128.944 3.903 . . . . 30.059999999999999 112.052 -178.151 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -72.51 -33.68 67.08 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.237 1.94 . . . . 25.190000000000001 116.237 -175.275 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.15 39.46 4.53 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.089 -3.507 . . . . 7.4100000000000001 114.218 -175.945 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mm -100.03 113.4 65.21 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 117.391 -3.417 . . . . 9.4900000000000002 110.601 175.849 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -64.85 151.56 85.33 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 124.811 3.674 . . . . 11.42 114.075 -176.49 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.23 -9.87 16.39 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-N 127.013 3.54 . . . . 12.0 114.836 -165.605 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.06 -28.56 61.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.216 2.436 . . . . 35.549999999999997 107.577 178.406 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -84.62 -20.34 31.53 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.198 -2.189 . . . . 20.52 112.018 -174.764 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -93.53 149.52 21.16 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.17 2.891 . . . . 7.1299999999999999 114.094 -172.873 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -141.64 126.31 17.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.324 -3.36 . . . . 36.390000000000001 108.175 167.146 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.83 121.06 43.98 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 110.048 -3.251 . . . . 9.5500000000000007 106.864 -175.556 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.7 mt -113.83 135.19 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 1 N-CA-C 98.916 -4.476 . . . . 13.9 98.916 -171.185 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -115.64 103.41 10.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 127.429 2.292 . . . . 6.8600000000000003 106.479 170.212 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.29 -105.16 0.07 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.154 1.782 . . . . 11.15 114.034 -174.7 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.14 27.29 9.16 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 115.54 -2.811 . . . . 13.93 116.289 170.561 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -147.49 158.97 44.21 Favored 'General case' 0 N--CA 1.43 -1.458 1 CA-C-N 124.363 4.082 . . . . 23.920000000000002 111.872 171.822 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.259 15.8 pt20 -85.31 137.81 32.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.501 1.52 . . . . 23.23 110.784 -175.84 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -83.67 131.05 34.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.218 -1.771 . . . . 9.1099999999999994 106.218 175.043 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -93.97 134.25 36.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.534 1.679 . . . . 33.439999999999998 115.534 -179.081 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.66 -46.52 49.81 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 132.073 4.149 . . . . 28.370000000000001 111.665 -168.859 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.78 -8.79 87.57 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 129.96 3.648 . . . . 15.0 112.148 -167.761 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 22' ' ' THR . 31.4 mmt180 -102.7 167.19 10.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.99 -4.241 . . . . 25.5 111.914 -179.522 . . . . . . . . 3 3 . 1 . 103 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.9 p -89.67 170.95 10.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.903 -1.748 . . . . 11.949999999999999 108.296 176.327 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.0 mt -72.53 -30.92 64.89 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.629 3.172 . . . . 10.17 110.662 169.3 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 p -65.8 -30.87 71.57 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 132.488 4.315 . . . . 13.59 112.435 179.393 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.87 -44.58 96.54 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.558 -4.464 . . . . 11.699999999999999 111.261 175.757 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -78.03 -12.62 60.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.43 2.292 . . . . 12.949999999999999 113.017 -177.784 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.439 35.8 m120 65.69 31.53 9.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.64 2.376 . . . . 25.449999999999999 116.659 -166.078 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -79.69 125.89 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 1 O-C-N 116.252 -4.03 . . . . 14.6 103.888 -169.483 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -104.78 -173.94 2.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.269 3.427 . . . . 33.229999999999997 113.283 -169.447 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -67.74 137.46 55.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.961 3.304 . . . . 25.969999999999999 109.895 174.687 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 52.5 33.56 13.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.093 2.957 . . . . 32.609999999999999 111.288 179.373 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -76.21 151.52 36.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 114.204 -2.808 . . . . 10.56 110.422 163.909 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.9 m -110.17 112.54 24.58 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 133.046 6.466 . . . . 5.3300000000000001 110.166 179.555 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.1 mt -97.62 159.06 15.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 110.654 -2.976 . . . . 11.66 106.566 170.704 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -124.82 123.71 40.55 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 115.992 -1.956 . . . . 16.300000000000001 106.76 -169.266 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -112.33 125.18 53.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.937 2.153 . . . . 9.9600000000000009 109.315 -172.303 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.298 16.5 m -127.01 150.89 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 124.432 2.063 . . . . 9.7599999999999998 109.119 169.63 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 N--CA 1.43 -1.441 0 CA-C-N 113.023 -1.899 . . . . 19.57 110.86 -167.174 . . . . . . . . 0 0 . 1 . 104 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 107.668 -1.234 . . . . 17.170000000000002 107.668 . . . . . . . . . 0 0 . 1 . 104 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -112.08 140.58 46.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.802 -2.295 . . . . 21.890000000000001 104.802 -175.817 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -128.62 154.48 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 123.422 1.582 . . . . 10.83 111.083 167.764 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -113.37 107.84 16.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.48 -2.012 . . . . 10.609999999999999 110.823 -173.517 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t -102.04 106.26 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.473 -1.392 . . . . 9.1300000000000008 109.671 178.251 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -89.39 128.89 35.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.489 1.662 . . . . 20.550000000000001 115.489 179.557 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -78.63 164.45 24.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.86 -1.775 . . . . 11.779999999999999 110.572 171.103 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.0 mt -77.5 -22.41 51.28 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.485 -4.509 . . . . 19.309999999999999 110.833 -172.76 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -92.74 -67.84 0.83 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.425 -1.324 . . . . 23.140000000000001 107.425 176.583 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.12 76.75 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 114.521 -3.377 . . . . 19.739999999999998 121.496 -178.701 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -156.91 131.67 8.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.609 2.704 . . . . 21.93 106.577 171.556 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.0 m -105.76 108.17 19.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.52 1.629 . . . . 12.33 107.248 172.843 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 mt -86.71 117.03 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 105.509 -2.034 . . . . 17.079999999999998 105.509 176.311 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -93.88 127.31 39.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.408 1.693 . . . . 16.300000000000001 112.232 171.479 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -117.7 132.91 56.41 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.898 2.079 . . . . 15.880000000000001 112.816 -177.74 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -92.09 107.07 18.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.511 -1.663 . . . . 28.899999999999999 106.511 172.601 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.85 166.97 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 104.628 -2.36 . . . . 12.050000000000001 104.628 179.482 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -118.17 138.37 25.49 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 126.698 1.999 . . . . 18.170000000000002 109.069 168.872 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 38.0 Cg_endo -67.54 -10.0 27.26 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 124.579 3.519 . . . . 8.1600000000000001 117.965 -171.721 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -76.64 -14.32 59.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.984 1.846 . . . . 11.130000000000001 115.984 170.399 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -85.06 172.65 11.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.531 1.514 . . . . 18.030000000000001 108.455 -178.767 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 70.8 p -103.54 157.08 17.29 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 117.229 -1.367 . . . . 10.220000000000001 113.296 -176.731 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -53.65 -36.59 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 122.065 2.211 . . . . 12.300000000000001 113.842 177.61 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -53.47 -25.55 16.75 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.095 -2.253 . . . . 36.509999999999998 116.191 169.525 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -87.62 -18.82 28.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 117.666 -1.159 . . . . 25.66 113.025 173.334 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -75.38 -44.03 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 122.136 2.244 . . . . 8.1199999999999992 112.486 176.196 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -62.84 -37.52 87.12 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 110.559 -3.019 . . . . 15.470000000000001 109.195 173.381 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.28 -19.43 61.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.387 -1.768 . . . . 11.449999999999999 114.084 173.309 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -77.2 -29.4 54.26 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.924 2.602 . . . . 24.98 110.628 171.313 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.7 mt -64.58 -45.6 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 116.615 -1.659 . . . . 9.4600000000000009 114.924 167.695 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -48.03 -49.95 29.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 121.292 3.812 . . . . 14.76 121.292 167.995 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -59.52 -65.56 0.65 Allowed 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 127.7 2.4 . . . . 26.289999999999999 115.484 170.849 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -74.62 -71.53 0.34 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.544 -3.847 . . . . 30.059999999999999 112.388 -177.725 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -71.51 -31.11 66.71 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.676 -6.265 . . . . 25.190000000000001 113.616 -170.132 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.08 52.16 4.42 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.353 2.882 . . . . 7.4100000000000001 110.704 178.56 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.85 143.02 28.26 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-N 119.959 1.88 . . . . 9.4900000000000002 106.18 168.125 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -72.5 168.33 24.63 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 125.266 2.917 . . . . 11.42 113.16 -173.34 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -81.91 -11.95 11.05 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.547 3.017 . . . . 12.0 112.546 177.699 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.94 -33.39 75.47 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.135 -2.228 . . . . 35.549999999999997 113.281 172.135 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.261 46.5 mt-30 -95.38 -8.85 34.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.044 2.831 . . . . 20.52 110.756 -167.731 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -87.05 122.01 30.29 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 111.902 -6.749 . . . . 7.1299999999999999 115.418 175.33 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -122.05 121.05 36.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.244 -2.16 . . . . 36.390000000000001 107.13 165.431 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.0 mt -105.98 139.04 41.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.677 -1.63 . . . . 9.5500000000000007 110.115 -177.58 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.5 mt -117.21 141.98 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 100.433 -3.914 . . . . 13.9 100.433 -175.474 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -136.85 104.23 5.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.15 -2.167 . . . . 6.8600000000000003 105.15 172.7 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.266 . . 65.99 -127.83 0.27 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.758 -1.839 . . . . 11.15 111.927 -177.06 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.8 24.04 30.05 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 119.753 2.661 . . . . 13.93 119.753 -178.468 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.5 157.74 40.26 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 110.818 -2.691 . . . . 23.920000000000002 112.085 -168.018 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.88 152.56 23.12 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.155 -1.794 . . . . 23.23 106.155 -176.188 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.3 mt -88.59 146.76 24.94 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.767 2.222 . . . . 9.1099999999999994 111.014 -177.03 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.488 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 17.5 tt0 -100.77 139.36 36.56 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 126.545 1.938 . . . . 33.439999999999998 107.217 -176.706 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.44 -55.54 32.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.153 2.581 . . . . 28.370000000000001 111.992 -168.937 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.97 31.47 7.92 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 113.45 -1.705 . . . . 15.0 110.878 -162.667 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.488 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 29.6 mtt180 -103.89 170.06 8.14 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.689 -3.83 . . . . 25.5 104.004 169.57 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.4 p -85.93 158.68 19.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.012 2.925 . . . . 11.949999999999999 105.908 -179.196 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 1.2 mt -69.41 -32.36 71.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.757 -3.089 . . . . 10.17 116.215 171.385 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.6 p -53.41 -40.33 65.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.404 3.082 . . . . 13.59 115.98 167.643 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.93 -20.47 61.75 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.2 -2.812 . . . . 11.699999999999999 117.073 -176.597 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -91.64 -1.12 57.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.325 1.85 . . . . 12.949999999999999 110.844 174.037 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 44.05 63.32 1.65 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.53 -2.123 . . . . 25.449999999999999 115.171 -161.497 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.69 127.17 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.825 -1.546 . . . . 14.6 106.825 168.539 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -124.35 179.74 4.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.188 2.595 . . . . 33.229999999999997 106.28 -168.16 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -67.54 145.92 54.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.886 -3.634 . . . . 25.969999999999999 111.537 -172.315 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 51.46 26.53 3.23 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.447 2.018 . . . . 32.609999999999999 116.447 -175.847 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 m -56.18 145.79 25.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.937 -1.727 . . . . 10.56 113.201 167.628 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -98.58 120.56 39.21 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.142 -2.224 . . . . 5.3300000000000001 114.192 167.974 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -110.27 160.41 16.55 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.344 0.974 . . . . 11.66 110.547 169.669 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -112.87 133.4 54.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 102.424 -3.176 . . . . 16.300000000000001 102.424 176.271 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -103.12 117.48 34.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.437 1.895 . . . . 9.9600000000000009 113.313 166.633 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.0 t -116.62 123.21 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.931 -2.248 . . . . 9.7599999999999998 104.931 -173.567 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 N--CA 1.43 -1.436 0 O-C-N 119.677 -1.889 . . . . 19.57 113.75 -173.95 . . . . . . . . 0 0 . 1 . 105 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.26 7.9 ptt? . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 117.756 2.502 . . . . 17.170000000000002 117.756 . . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -113.29 130.64 56.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 105.844 -1.91 . . . . 21.890000000000001 105.844 -177.421 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 pt -131.29 160.02 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 100.569 -3.863 . . . . 10.83 100.569 -177.673 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -112.41 151.59 29.66 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.527 2.584 . . . . 10.609999999999999 106.785 -177.739 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.413 HG21 HD22 ' A' ' 15' ' ' LEU . 40.3 t -128.33 124.56 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 117.456 -3.277 . . . . 9.1300000000000008 109.66 166.745 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -136.66 135.7 38.48 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.772 -1.558 . . . . 20.550000000000001 109.934 -170.366 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -80.83 -174.25 4.67 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.448 2.547 . . . . 11.779999999999999 111.271 175.985 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.16 -43.42 74.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.027 -2.296 . . . . 19.309999999999999 111.47 177.077 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -76.62 -34.8 58.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.361 -2.257 . . . . 23.140000000000001 108.07 179.658 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.15 70.2 0.63 Allowed Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 126.523 2.011 . . . . 19.739999999999998 114.162 173.72 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -96.55 103.07 14.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 131.051 3.74 . . . . 21.93 106.877 160.491 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -100.08 135.81 40.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.21 2.433 . . . . 12.33 110.445 -178.866 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 pt -139.99 162.33 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.445 2.698 . . . . 17.079999999999998 111.79 175.054 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 m -126.81 119.47 26.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.794 1.309 . . . . 16.300000000000001 110.145 -172.218 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -104.42 134.13 48.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.218 -1.81 . . . . 15.880000000000001 107.83 -178.321 . . . . . . . . 3 3 . 1 . 105 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -98.86 115.49 28.96 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.352 -2.833 . . . . 28.899999999999999 103.352 178.689 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.37 177.86 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.818 -1.549 . . . . 12.050000000000001 106.818 177.183 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -116.89 160.17 37.89 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 104.497 -2.408 . . . . 18.170000000000002 104.497 179.228 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -76.67 2.53 7.34 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 115.837 -2.309 . . . . 8.1600000000000001 116.427 -175.099 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.0 p -77.47 -13.8 59.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 124.871 1.357 . . . . 11.130000000000001 112.175 169.557 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.89 137.57 33.6 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 122.728 1.251 . . . . 18.030000000000001 111.805 -170.766 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -76.13 158.12 32.08 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 109.283 -3.599 . . . . 10.220000000000001 112.266 -169.781 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mm -52.93 -45.62 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 1 O-C-N 115.377 -4.577 . . . . 12.300000000000001 110.242 168.376 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -59.97 -32.09 70.51 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.278 -2.764 . . . . 36.509999999999998 118.176 168.887 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -63.84 -38.74 92.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.924 -2.985 . . . . 25.66 111.555 168.871 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.84 -47.18 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.014 1.326 . . . . 8.1199999999999992 108.771 171.9 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -58.81 -39.82 82.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.864 -1.772 . . . . 15.470000000000001 112.954 178.436 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.43 61.79 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.499 3.148 . . . . 11.449999999999999 119.499 171.326 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.26 4.6 tppt? -66.84 -44.07 82.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.151 2.881 . . . . 24.98 117.127 167.854 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -74.01 -43.12 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.659 2.384 . . . . 9.4600000000000009 107.416 179.144 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -48.27 -45.09 34.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.75 2.5 . . . . 14.76 117.75 169.67 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.03 -57.18 8.32 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.279 2.696 . . . . 26.289999999999999 118.279 169.502 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -64.67 -58.06 7.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.637 2.458 . . . . 30.059999999999999 117.637 173.32 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.45 -67.93 0.61 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.353 -1.467 . . . . 25.190000000000001 112.775 -176.475 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.82 27.01 2.88 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 122.53 1.072 . . . . 7.4100000000000001 111.731 -176.863 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.7 mt -88.23 125.79 62.78 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 114.063 -2.875 . . . . 9.4900000000000002 111.95 174.764 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.13 154.81 62.06 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 CA-C-N 126.698 3.428 . . . . 11.42 112.827 -174.89 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -70.18 -15.24 35.45 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.22 1.946 . . . . 12.0 110.068 -170.703 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -87.14 -16.58 35.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.828 1.775 . . . . 35.549999999999997 115.54 177.486 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -94.79 -34.86 12.33 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.06 -1.65 . . . . 20.52 108.687 -178.838 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.39 135.27 55.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.083 0.944 . . . . 7.1299999999999999 111.877 174.811 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.258 21.6 tpp180 -139.27 130.59 26.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.012 -2.93 . . . . 36.390000000000001 106.566 160.906 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.5 mt -94.33 135.66 35.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.95 2.5 . . . . 9.5500000000000007 112.779 -179.629 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.569 HG12 ' HG2' ' A' ' 49' ' ' GLN . 11.8 mt -127.09 132.09 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 1 N-CA-C 97.688 -4.931 . . . . 13.9 97.688 -172.28 . . . . . . . . 3 3 . 1 . 105 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -116.19 130.84 56.99 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.025 -2.297 . . . . 6.8600000000000003 107.368 166.563 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.83 -109.85 0.51 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.694 -2.504 . . . . 11.15 117.388 -172.059 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.17 -7.46 56.12 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 130.663 3.983 . . . . 13.93 114.636 174.844 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -127.05 144.86 50.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.588 3.194 . . . . 23.920000000000002 112.999 -159.532 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.569 ' HG2' HG12 ' A' ' 44' ' ' ILE . 65.1 mt-30 -98.44 124.19 43.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.476 -1.693 . . . . 23.23 106.643 -176.2 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -88.69 143.29 27.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.953 -1.092 . . . . 9.1099999999999994 112.372 -167.552 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.256 74.1 mm-40 -85.62 149.87 25.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.408 2.744 . . . . 33.439999999999998 118.408 -178.435 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -40.75 -64.08 0.58 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 131.031 3.733 . . . . 28.370000000000001 118.798 -173.034 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.59 51.51 0.76 Allowed Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 123.284 1.491 . . . . 15.0 111.153 -171.081 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.273 13.7 mmt85 -123.83 173.35 8.23 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.743 -4.386 . . . . 25.5 108.775 173.693 . . . . . . . . 3 2 . 1 . 105 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 p -112.39 175.1 5.57 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.424 2.375 . . . . 11.949999999999999 113.525 175.201 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.3 mt -58.81 -41.08 85.94 Favored 'General case' 0 N--CA 1.43 -1.449 2 CA-C-N 106.801 -4.727 . . . . 10.17 113.648 169.322 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -70.52 -35.53 73.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.751 -1.218 . . . . 13.59 113.769 177.778 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -62.14 -48.56 79.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.407 -2.058 . . . . 11.699999999999999 114.261 178.979 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -72.86 -25.83 61.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.801 -3.687 . . . . 12.949999999999999 115.86 174.575 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.288 9.0 m120 83.16 67.2 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.013 2.125 . . . . 25.449999999999999 109.007 -173.424 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.49 117.12 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 101.81 -3.404 . . . . 14.6 101.81 172.208 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -102.55 -164.53 1.09 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.51 -2.619 . . . . 33.229999999999997 109.225 -179.893 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -72.72 131.32 42.21 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 131.601 3.961 . . . . 25.969999999999999 111.132 -172.171 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 60.71 24.66 14.48 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.785 1.63 . . . . 32.609999999999999 113.385 179.526 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.8 m -89.58 153.62 20.63 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 101.21 -3.626 . . . . 10.56 101.21 171.723 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -116.46 109.68 17.62 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.039 1.735 . . . . 5.3300000000000001 107.33 -167.142 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mp -90.88 131.74 36.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 120.0 1.273 . . . . 11.66 110.082 178.418 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 47.2 m-70 -80.38 132.0 35.7 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 127.066 3.317 . . . . 16.300000000000001 107.796 -176.076 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.256 5.1 tp -102.03 116.63 33.11 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 115.353 -4.592 . . . . 9.9600000000000009 109.804 173.261 . . . . . . . . 3 2 . 1 . 105 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.0 t -106.09 109.96 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 127.574 2.35 . . . . 9.7599999999999998 114.924 168.883 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.431 -1.416 0 N-CA-C 102.836 -3.024 . . . . 19.57 102.836 -171.648 . . . . . . . . 0 0 . 1 . 106 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.451 ' HE1' ' HB3' ' A' ' 19' ' ' PRO . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 121.011 0.434 . . . . 17.170000000000002 109.877 . . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -107.78 153.36 23.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.489 -2.141 . . . . 21.890000000000001 114.473 173.577 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -126.78 147.19 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 102.669 -3.086 . . . . 10.83 102.669 171.374 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.55 135.85 45.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.8 2.148 . . . . 10.609999999999999 116.8 156.768 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.57 141.97 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.603 1.961 . . . . 9.1300000000000008 107.081 174.241 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -140.02 130.97 26.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.57 2.348 . . . . 20.550000000000001 112.543 -163.719 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -91.36 -176.7 4.63 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.642 -1.911 . . . . 11.779999999999999 107.153 -176.334 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.98 -48.4 74.13 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.416 -2.678 . . . . 19.309999999999999 111.562 175.874 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.1 p -79.83 -62.57 1.64 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.385 -3.322 . . . . 23.140000000000001 110.585 -174.851 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.71 41.25 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 116.999 -2.524 . . . . 19.739999999999998 114.348 175.409 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU 0.3 19.7 tptm -88.54 109.06 19.76 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.035 -1.469 . . . . 21.93 107.035 165.313 . . . . . . . . 3 3 . 1 . 106 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -104.14 108.91 20.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.316 -1.49 . . . . 12.33 108.08 -179.619 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.264 36.6 pt -97.03 134.22 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 116.412 -1.756 . . . . 17.079999999999998 110.312 175.156 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 3.6 m -109.66 112.13 24.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.977 2.911 . . . . 16.300000000000001 107.745 -179.893 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -106.61 160.07 15.72 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.823 -3.048 . . . . 15.880000000000001 110.553 -176.084 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -115.44 132.26 56.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.756 -2.465 . . . . 28.899999999999999 109.296 176.024 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.52 167.24 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.294 2.237 . . . . 12.050000000000001 114.608 -167.756 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -90.97 140.5 26.1 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 119.087 -2.258 . . . . 18.170000000000002 115.623 155.762 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 72.2 Cg_endo -68.65 -10.86 30.28 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 122.55 1.946 . . . . 8.1600000000000001 117.048 174.868 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.337 83.7 p -74.8 -14.55 60.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.736 2.865 . . . . 11.130000000000001 118.736 166.817 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -81.06 165.97 21.17 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.125 1.516 . . . . 18.030000000000001 114.936 -164.63 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 45.7 p -87.77 157.52 19.01 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.349 2.5 . . . . 10.220000000000001 112.31 -172.092 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.4 mm -68.91 -28.62 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.638 -3.164 . . . . 12.300000000000001 111.679 -178.057 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -48.71 -48.98 39.98 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.274 2.23 . . . . 36.509999999999998 115.528 153.116 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -75.09 1.62 12.71 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.79 -4.319 . . . . 25.66 119.687 175.012 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.6 t -82.91 -39.56 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.189 -2.152 . . . . 8.1199999999999992 105.189 160.545 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -63.97 -25.56 68.19 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.303 -3.998 . . . . 15.470000000000001 113.633 -179.109 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.33 92.06 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.434 -2.666 . . . . 11.449999999999999 114.926 170.74 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -72.78 -27.76 62.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.7 -3.125 . . . . 24.98 111.639 -177.285 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.44 -44.04 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 115.051 1.5 . . . . 9.4600000000000009 115.051 170.021 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -60.52 -45.18 94.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.782 1.401 . . . . 14.76 114.782 167.799 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -65.31 -43.92 89.53 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.656 2.48 . . . . 26.289999999999999 111.698 178.926 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -75.38 -67.16 0.69 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.858 2.17 . . . . 30.059999999999999 116.858 -179.027 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.44 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 8.8 tp10 -82.69 -43.07 17.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.003 -2.311 . . . . 25.190000000000001 115.194 179.905 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.7 52.32 2.84 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-O 124.548 2.193 . . . . 7.4100000000000001 117.521 177.861 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.5 mt -111.97 125.74 29.7 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 102.145 -3.28 . . . . 9.4900000000000002 102.145 -178.386 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.44 160.5 22.59 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 127.754 3.805 . . . . 11.42 113.098 -173.393 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -77.04 -17.24 15.38 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 CA-C-N 127.949 3.874 . . . . 12.0 111.045 -148.168 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.54 -24.27 45.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.76 -3.088 . . . . 35.549999999999997 110.647 -171.721 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -90.01 -0.67 57.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.697 2.399 . . . . 20.52 110.764 -173.714 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -100.05 129.6 46.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.233 2.213 . . . . 7.1299999999999999 115.803 -177.728 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -130.76 114.48 15.4 Favored 'General case' 0 N--CA 1.431 -1.404 1 O-C-N 115.918 -4.238 . . . . 36.390000000000001 110.602 167.317 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.7 mt -103.54 137.87 41.02 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 116.576 -1.678 . . . . 9.5500000000000007 114.455 -174.666 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 mt -125.53 133.95 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 101.079 -3.675 . . . . 13.9 101.079 -164.703 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -118.12 96.15 5.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 101.441 -3.541 . . . . 6.8600000000000003 101.441 172.956 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.91 -93.96 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.653 -2.067 . . . . 11.15 113.262 -170.667 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.48 -16.64 45.43 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 116.812 -2.105 . . . . 13.93 116.525 174.389 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -105.57 126.35 52.04 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 126.323 1.837 . . . . 23.920000000000002 113.032 -157.72 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -98.39 123.83 42.73 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 125.379 1.674 . . . . 23.23 113.13 -167.023 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.24 125.65 36.99 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.827 -1.082 . . . . 9.1099999999999994 110.578 -158.378 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -87.63 152.21 22.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 131.608 3.963 . . . . 33.439999999999998 116.511 171.238 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -75.02 -49.12 20.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.382 2.515 . . . . 28.370000000000001 108.405 -152.227 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.69 34.76 4.08 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 117.548 -3.22 . . . . 15.0 114.342 -171.791 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -123.23 161.94 23.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 100.426 -3.916 . . . . 25.5 100.426 176.231 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.3 p -99.8 164.38 12.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.106 -1.621 . . . . 11.949999999999999 114.822 -179.809 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mt -48.06 -37.71 15.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.342 -3.349 . . . . 10.17 119.247 167.505 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -76.02 -14.92 60.21 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.539 -1.664 . . . . 13.59 113.025 174.963 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -74.92 -38.38 61.82 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 123.798 2.999 . . . . 11.699999999999999 110.552 172.205 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -91.82 2.13 56.71 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.396 -1.335 . . . . 12.949999999999999 107.396 -172.603 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m120 60.33 45.33 11.31 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.927 2.566 . . . . 25.449999999999999 117.927 179.98 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.4 mt -86.91 135.49 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 126.594 3.092 . . . . 14.6 106.399 -178.884 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -113.72 167.3 10.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.309 -2.119 . . . . 33.229999999999997 109.558 -163.864 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -55.22 114.37 1.76 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.531 1.634 . . . . 25.969999999999999 111.774 166.14 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 63.12 37.96 11.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 110.453 -3.067 . . . . 32.609999999999999 113.254 -175.383 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -72.18 148.62 45.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.464 1.484 . . . . 10.56 113.815 159.497 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.4 m -109.32 128.53 55.16 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.566 -3.209 . . . . 5.3300000000000001 110.16 179.77 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -101.85 140.3 36.33 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 116.214 1.931 . . . . 11.66 116.214 177.12 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -100.36 110.72 22.94 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 125.175 2.416 . . . . 16.300000000000001 111.704 -179.511 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -94.6 127.61 40.67 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.792 -2.443 . . . . 9.9600000000000009 110.49 -175.243 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.7 123.13 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.256 3.023 . . . . 9.7599999999999998 113.755 163.563 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 128.325 3.917 . . . . 19.57 108.751 173.935 . . . . . . . . 0 0 . 1 . 107 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptt? . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 110.752 -0.092 . . . . 17.170000000000002 110.752 . . . . . . . . . 0 0 . 1 . 107 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -90.04 148.27 23.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 123.664 0.786 . . . . 21.890000000000001 111.232 177.464 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.31 141.61 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.701 -2.333 . . . . 10.83 104.701 -179.118 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -97.0 143.05 28.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.935 1.457 . . . . 10.609999999999999 114.935 170.169 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -128.86 112.04 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.232 2.92 . . . . 9.1300000000000008 107.165 177.841 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -109.2 130.66 55.49 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.594 -3.816 . . . . 20.550000000000001 115.164 -172.753 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 p -82.09 162.55 22.48 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.398 -5.813 . . . . 11.779999999999999 107.851 179.532 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mt -59.17 -39.03 81.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.293 -2.755 . . . . 19.309999999999999 115.274 169.019 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 p -65.58 -58.64 5.27 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.344 2.497 . . . . 23.140000000000001 112.662 -178.151 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.03 64.14 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 O-C-N 118.129 -2.857 . . . . 19.739999999999998 113.555 164.935 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -129.88 134.8 47.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 119.712 1.756 . . . . 21.93 107.606 157.408 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -105.57 121.35 43.78 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.84 1.781 . . . . 12.33 108.898 175.302 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.6 pt -111.23 144.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 118.082 -2.886 . . . . 17.079999999999998 105.837 -179.569 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -107.39 123.09 47.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.686 1.241 . . . . 16.300000000000001 110.627 -177.197 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -119.98 162.79 18.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.023 -1.103 . . . . 15.880000000000001 108.023 -177.027 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -106.35 133.41 51.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.197 1.799 . . . . 28.899999999999999 111.3 172.726 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.262 16.1 m -147.96 162.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 119.448 -2.032 . . . . 12.050000000000001 106.365 167.344 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -82.24 170.43 14.91 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 105.21 -2.144 . . . . 18.170000000000002 105.21 161.151 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.287 1.1 Cg_exo -69.84 -24.93 28.73 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 120.79 1.318 . . . . 8.1600000000000001 111.704 170.438 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -78.7 8.13 5.85 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 115.347 -2.264 . . . . 11.130000000000001 111.075 -174.265 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.255 75.2 m-20 -108.31 162.07 14.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 123.198 2.727 . . . . 18.030000000000001 107.33 -176.669 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.9 p -92.21 163.72 13.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.846 -3.034 . . . . 10.220000000000001 114.204 -171.556 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -69.44 -24.65 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 118.814 -2.429 . . . . 12.300000000000001 112.121 176.753 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -53.69 -48.77 69.2 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.69 -4.381 . . . . 36.509999999999998 114.303 162.458 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -62.97 -30.74 71.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.311 2.337 . . . . 25.66 117.311 169.661 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.2 t -65.68 -49.41 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 121.767 2.076 . . . . 8.1199999999999992 113.435 166.319 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -61.82 -31.53 71.77 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.709 1.604 . . . . 15.470000000000001 113.451 178.839 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.72 -35.33 78.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.145 2.578 . . . . 11.449999999999999 106.678 169.94 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -75.67 -21.26 57.81 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.862 -4.274 . . . . 24.98 116.901 177.05 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 mt -69.44 -45.85 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.39 -2.069 . . . . 9.4600000000000009 110.316 164.599 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -49.75 -39.98 39.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.583 2.611 . . . . 14.76 111.44 171.862 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.71 -64.16 1.06 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.233 -3.417 . . . . 26.289999999999999 110.464 -179.99 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -80.66 -27.47 37.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.45 -3.906 . . . . 30.059999999999999 114.359 -163.167 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -103.89 -56.05 2.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 113.946 1.091 . . . . 25.190000000000001 113.946 -177.728 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.28 26.79 2.59 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 126.963 2.221 . . . . 7.4100000000000001 116.89 172.841 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -94.42 135.36 24.29 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 108.127 -1.064 . . . . 9.4900000000000002 108.127 -176.438 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.48 157.4 61.91 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 115.221 -3.094 . . . . 11.42 112.885 -177.65 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -84.83 -11.32 7.89 Favored 'Trans proline' 0 C--N 1.299 -2.029 1 C-N-CA 128.157 5.905 . . . . 12.0 112.779 -175.198 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.82 -43.47 58.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.358 0.981 . . . . 35.549999999999997 111.567 173.392 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -72.12 12.01 0.48 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.785 -2.447 . . . . 20.52 114.588 -179.051 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -116.89 128.42 55.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.625 1.202 . . . . 7.1299999999999999 114.082 -164.613 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -129.13 130.06 45.96 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.793 -1.817 . . . . 36.390000000000001 106.184 171.763 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.5 mt -102.47 143.56 32.03 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 120.357 -0.537 . . . . 9.5500000000000007 111.546 171.617 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -124.82 127.95 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 128.036 2.534 . . . . 13.9 104.798 177.726 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -112.67 107.9 16.75 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.116 -2.865 . . . . 6.8600000000000003 104.504 177.201 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.388 . . 60.29 -91.45 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.188 -1.57 . . . . 11.15 115.017 -169.08 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.0 5.58 7.35 Favored Glycine 0 N--CA 1.43 -1.703 1 C-N-CA 131.064 4.173 . . . . 13.93 119.074 171.745 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -113.96 156.91 23.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.921 1.343 . . . . 23.920000000000002 108.319 175.384 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -84.11 151.8 24.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.385 -1.279 . . . . 23.23 111.937 175.742 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.2 mt -110.24 128.34 55.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.458 1.935 . . . . 9.1099999999999994 111.777 178.773 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -92.18 163.62 13.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.063 3.316 . . . . 33.439999999999998 105.983 179.096 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -63.26 -61.1 2.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 109.402 -3.544 . . . . 28.370000000000001 118.939 -171.938 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.54 15.55 13.13 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 119.476 2.55 . . . . 15.0 119.476 -171.849 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -101.45 156.85 17.22 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.398 -1.648 . . . . 25.5 110.116 173.46 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.5 p -94.37 167.43 11.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.406 -1.331 . . . . 11.949999999999999 107.406 -175.636 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mp -67.96 -25.94 65.69 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.348 2.259 . . . . 10.17 108.752 165.713 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.3 t -71.62 -43.29 66.45 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.653 2.381 . . . . 13.59 110.243 175.526 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -59.28 -44.74 92.44 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.945 -4.222 . . . . 11.699999999999999 116.768 175.316 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -79.89 -11.64 59.79 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.642 2.83 . . . . 12.949999999999999 118.642 169.734 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.315 31.0 m120 75.75 34.86 0.55 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.644 -3.16 . . . . 25.449999999999999 115.002 174.434 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 mt -73.47 118.91 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.347 -1.297 . . . . 14.6 110.757 167.619 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 65' ' ' SER . 45.5 mt-30 -90.75 169.91 10.57 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 124.155 1.931 . . . . 33.229999999999997 113.609 174.219 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -61.94 146.88 48.64 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.742 -4.349 . . . . 25.969999999999999 108.064 -174.32 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 85.7 mt-10 62.48 46.88 5.4 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.889 1.804 . . . . 32.609999999999999 113.167 174.273 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 62' ' ' GLN . 9.2 t -111.09 131.94 54.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.355 2.662 . . . . 10.56 103.994 -168.531 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -89.59 109.95 20.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.385 2.517 . . . . 5.3300000000000001 108.562 177.233 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.7 mt -89.74 150.58 22.23 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.776 2.03 . . . . 11.66 107.95 172.626 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -106.23 113.39 26.9 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 114.965 1.469 . . . . 16.300000000000001 114.965 -178.283 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.7 tp -89.93 120.2 30.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.276 1.988 . . . . 9.9600000000000009 114.493 177.152 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.81 145.58 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 112.651 -2.068 . . . . 9.7599999999999998 105.829 172.964 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.9 mt . . . . . 0 N--CA 1.43 -1.451 0 CA-C-O 123.372 1.558 . . . . 19.57 111.331 -176.258 . . . . . . . . 0 0 . 1 . 108 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 106.413 -1.699 . . . . 17.170000000000002 106.413 . . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -106.38 140.08 39.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.707 2.114 . . . . 21.890000000000001 116.707 -176.671 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.6 pt -119.17 143.88 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 129.036 2.934 . . . . 10.83 114.324 169.979 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -104.92 126.1 51.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.05 -2.906 . . . . 10.609999999999999 107.827 -179.409 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.38 109.75 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 127.67 3.605 . . . . 9.1300000000000008 105.94 -176.773 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -117.93 138.79 51.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 125.897 2.761 . . . . 20.550000000000001 108.969 -167.665 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 p -72.68 -179.09 2.92 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.956 -2.34 . . . . 11.779999999999999 117.051 163.805 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -76.14 -39.83 54.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 131.118 3.767 . . . . 19.309999999999999 110.431 -160.66 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -73.17 -56.6 4.87 Favored 'General case' 0 N--CA 1.429 -1.488 1 C-N-CA 133.94 4.896 . . . . 23.140000000000001 105.93 175.67 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.04 30.98 0.34 Allowed Glycine 0 N--CA 1.43 -1.741 0 O-C-N 125.873 1.983 . . . . 19.739999999999998 115.003 173.204 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -79.32 109.77 13.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.287 2.043 . . . . 21.93 109.779 168.664 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -95.79 126.43 41.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.007 -2.308 . . . . 12.33 112.684 -176.387 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.313 28.4 pt -109.47 152.93 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.433 2.063 . . . . 17.079999999999998 108.241 165.863 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -122.53 125.6 46.07 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.321 -2.737 . . . . 16.300000000000001 110.672 -175.78 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.284 52.4 mt -119.1 144.16 46.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.315 2.339 . . . . 15.880000000000001 117.315 179.442 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -101.16 101.86 12.67 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.705 2.002 . . . . 28.899999999999999 112.17 -179.161 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.18 165.1 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 C-N-CA 134.028 4.931 . . . . 12.050000000000001 108.284 -165.301 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 9.0 mt-10 -112.67 173.37 2.89 Favored Pre-proline 0 N--CA 1.429 -1.486 0 N-CA-C 114.836 1.421 . . . . 18.170000000000002 114.836 162.305 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -74.07 -14.12 23.57 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 115.963 -2.704 . . . . 8.1600000000000001 112.763 -179.111 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -95.11 0.9 54.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.159 0.912 . . . . 11.130000000000001 110.311 177.688 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.267 35.2 m-20 -85.98 152.23 23.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.877 -3.639 . . . . 18.030000000000001 109.812 -173.308 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 71.0 p -100.63 160.76 14.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.334 2.492 . . . . 10.220000000000001 107.859 -160.714 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.515 HG22 HD13 ' A' ' 43' ' ' LEU . 18.9 mm -64.48 -40.22 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 124.65 2.167 . . . . 12.300000000000001 108.624 -174.419 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -56.24 -35.47 67.41 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.03 -2.919 . . . . 36.509999999999998 117.021 168.121 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -72.14 -31.49 66.04 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 113.362 -5.836 . . . . 25.66 112.613 167.55 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.79 -43.55 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.724 -1.584 . . . . 8.1199999999999992 106.724 -177.021 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.25 -35.96 72.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.763 1.625 . . . . 15.470000000000001 113.361 174.907 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.99 -42.29 76.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.221 -2.174 . . . . 11.449999999999999 116.0 175.824 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -75.17 -32.03 61.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.649 3.179 . . . . 24.98 112.89 -176.989 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -60.88 -48.1 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.529 2.585 . . . . 9.4600000000000009 113.029 174.253 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -52.53 -45.88 66.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 113.15 -3.31 . . . . 14.76 117.037 166.386 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.53 -62.93 1.18 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.721 3.138 . . . . 26.289999999999999 110.032 179.291 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -53.71 -57.16 11.85 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.412 -3.305 . . . . 30.059999999999999 112.093 -176.757 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -93.96 -64.63 1.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.534 2.05 . . . . 25.190000000000001 116.534 -173.64 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.79 23.71 0.86 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 120.9 3.12 . . . . 7.4100000000000001 120.9 -176.939 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.69 118.14 60.27 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 114.723 -2.56 . . . . 9.4900000000000002 106.945 -169.191 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -51.89 147.16 26.35 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 121.238 3.515 . . . . 11.42 121.238 178.318 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -68.69 -35.68 16.0 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 123.793 2.39 . . . . 12.0 113.261 -160.378 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -78.21 -27.34 47.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.904 -2.372 . . . . 35.549999999999997 113.971 -177.462 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -62.89 -39.16 93.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.173 2.189 . . . . 20.52 115.365 170.776 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -65.9 140.17 58.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.342 2.349 . . . . 7.1299999999999999 117.342 173.585 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -128.32 99.61 5.49 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.855 -2.403 . . . . 36.390000000000001 114.192 169.866 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.515 HD13 HG22 ' A' ' 23' ' ' ILE . 80.9 mt -86.06 131.43 34.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.065 -2.334 . . . . 9.5500000000000007 109.629 -177.728 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.6 mt -130.47 136.59 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 126.282 2.944 . . . . 13.9 103.253 -179.846 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -113.5 114.98 27.29 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 115.055 -4.778 . . . . 6.8600000000000003 107.897 164.393 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.277 . . 72.31 -86.33 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.738 2.815 . . . . 11.15 111.331 -179.221 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.38 22.71 1.71 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 109.121 -1.591 . . . . 13.93 109.121 165.42 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.259 81.6 mttt -103.69 124.57 49.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.473 -3.369 . . . . 23.920000000000002 105.365 176.282 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -91.72 132.9 36.06 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 123.295 1.521 . . . . 23.23 108.941 -179.929 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.4 mt -94.15 128.86 40.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 115.715 -2.394 . . . . 9.1099999999999994 109.794 -151.377 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -78.32 139.73 38.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 119.038 2.977 . . . . 33.439999999999998 119.038 172.166 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.57 -50.14 70.85 Favored 'General case' 0 N--CA 1.431 -1.394 1 N-CA-C 122.654 4.316 . . . . 28.370000000000001 122.654 -162.62 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.49 0.72 89.24 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.232 -2.793 . . . . 15.0 115.775 175.333 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -81.78 165.33 21.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.835 -1.979 . . . . 25.5 108.143 171.382 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.3 p -104.97 -178.2 3.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 116.447 -3.908 . . . . 11.949999999999999 111.353 -172.98 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.3 mt -81.48 -29.31 33.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.699 -1.593 . . . . 10.17 106.699 178.712 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.9 t -66.08 -38.12 87.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.409 -2.057 . . . . 13.59 111.355 -176.589 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -54.95 -40.89 70.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.347 3.059 . . . . 11.699999999999999 113.788 176.924 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -93.49 1.16 56.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.322 2.342 . . . . 12.949999999999999 117.322 174.995 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.459 3.7 m120 79.52 18.83 0.73 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.263 1.579 . . . . 25.449999999999999 115.263 174.494 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.9 mt -87.01 99.4 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 118.446 -2.659 . . . . 14.6 105.014 -174.477 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.36 10.4 mt-30 -112.39 -165.11 0.96 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.324 2.249 . . . . 33.229999999999997 112.02 -169.874 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -61.55 106.8 0.7 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.103 2.961 . . . . 25.969999999999999 113.4 -170.061 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 82.76 41.92 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.011 2.525 . . . . 32.609999999999999 111.749 172.003 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.6 m -92.27 142.69 27.19 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.582 1.953 . . . . 10.56 111.376 179.388 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 m -102.41 121.18 41.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.334 -2.104 . . . . 5.3300000000000001 112.365 178.387 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -85.26 160.09 19.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 117.403 -1.284 . . . . 11.66 110.228 167.814 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -105.41 136.03 45.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 127.5 3.0 . . . . 16.300000000000001 104.84 167.473 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.1 tp -116.11 111.57 20.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.749 -2.315 . . . . 9.9600000000000009 104.749 -179.639 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.46 140.87 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 127.3 2.24 . . . . 9.7599999999999998 106.275 -179.994 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 N--CA 1.43 -1.456 0 C-N-CA 129.357 3.063 . . . . 19.57 106.079 176.873 . . . . . . . . 0 0 . 1 . 109 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 108.139 -1.059 . . . . 17.170000000000002 108.139 . . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -100.11 116.17 31.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.549 1.166 . . . . 21.890000000000001 112.442 -177.37 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.1 pt -97.4 151.92 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.192 -1.367 . . . . 10.83 113.996 148.554 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -107.67 149.46 28.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.434 2.958 . . . . 10.609999999999999 110.951 174.66 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 67' ' ' LEU . 47.3 t -126.43 133.99 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 106.224 -1.769 . . . . 9.1300000000000008 106.224 162.092 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -108.73 139.45 43.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.742 2.017 . . . . 20.550000000000001 113.62 174.591 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 p -88.07 -169.54 2.61 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 114.973 1.471 . . . . 11.779999999999999 114.973 -171.659 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.87 -59.08 4.6 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 120.163 1.347 . . . . 19.309999999999999 113.435 179.175 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -69.6 -30.06 67.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.023 -1.673 . . . . 23.140000000000001 110.689 179.714 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.2 54.3 0.27 Allowed Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 129.168 3.27 . . . . 19.739999999999998 108.422 152.083 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -82.67 116.09 21.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.238 2.019 . . . . 21.93 108.839 167.623 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -84.32 112.02 19.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.691 -2.576 . . . . 12.33 115.898 176.285 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.61 162.22 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 122.357 2.344 . . . . 17.079999999999998 108.232 -172.848 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.5 m -123.75 98.22 5.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.492 2.717 . . . . 16.300000000000001 113.83 -174.504 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 29' ' ' LYS . 73.0 mt -92.68 160.3 15.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.025 0.83 . . . . 15.880000000000001 111.554 -170.62 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -106.13 103.91 13.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.372 1.442 . . . . 28.899999999999999 113.757 175.044 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.74 165.02 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.7 2.4 . . . . 12.050000000000001 108.347 -174.771 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.15 170.9 7.89 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-O 115.75 -2.071 . . . . 18.170000000000002 109.621 162.513 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.291 0.0 OUTLIER -66.7 -9.51 24.75 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 N-CA-C 120.205 3.117 . . . . 8.1600000000000001 120.205 179.83 . . . . . . . . 3 3 . 1 . 109 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -82.52 -21.58 35.36 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.207 -2.33 . . . . 11.130000000000001 113.927 176.474 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -57.75 146.29 31.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 119.745 3.239 . . . . 18.030000000000001 119.745 172.93 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.4 p -105.08 159.95 15.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.256 -3.403 . . . . 10.220000000000001 108.087 -178.013 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.62 -40.66 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 112.917 -1.947 . . . . 12.300000000000001 112.781 178.111 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -49.63 -41.88 43.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.509 1.924 . . . . 36.509999999999998 112.975 165.092 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -80.63 -21.31 41.59 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.565 -3.834 . . . . 25.66 116.942 176.14 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 t -59.91 -50.08 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.471 -2.643 . . . . 8.1199999999999992 107.782 165.375 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -59.56 -39.8 85.22 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.687 1.708 . . . . 15.470000000000001 113.013 -179.305 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.323 . . -71.58 -28.99 64.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.621 -1.627 . . . . 11.449999999999999 112.653 -176.996 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.486 ' HB3' HD21 ' A' ' 15' ' ' LEU . 55.8 mttm -69.0 -31.29 70.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.086 3.355 . . . . 24.98 111.899 171.803 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.2 mt -79.51 -37.6 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.853 0.835 . . . . 9.4600000000000009 111.921 173.401 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -61.94 -38.64 89.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.157 1.932 . . . . 14.76 114.129 168.808 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.7 -55.62 25.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.794 1.405 . . . . 26.289999999999999 114.794 172.069 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -67.78 -58.01 5.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.664 -3.147 . . . . 30.059999999999999 115.807 -174.812 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -95.52 -52.29 4.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.28 2.238 . . . . 25.190000000000001 115.533 -168.202 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.59 38.18 0.86 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 116.58 -2.724 . . . . 7.4100000000000001 114.402 174.091 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.2 mt -114.56 120.86 37.0 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-O 111.936 -3.888 . . . . 9.4900000000000002 103.609 -176.007 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -72.46 157.82 52.3 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 125.124 2.866 . . . . 11.42 112.508 -173.992 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -73.8 -32.34 7.47 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 122.813 2.041 . . . . 12.0 110.674 -162.518 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -59.73 -41.87 91.89 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.006 1.854 . . . . 35.549999999999997 116.006 -178.058 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -65.64 -27.75 68.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.095 2.258 . . . . 20.52 117.095 179.258 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -74.97 155.32 37.51 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.236 3.05 . . . . 7.1299999999999999 119.236 177.849 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -143.71 97.16 3.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.084 2.153 . . . . 36.390000000000001 113.779 177.549 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.6 mt -91.69 129.49 37.66 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.666 2.65 . . . . 9.5500000000000007 116.104 -167.201 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -120.1 128.71 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 2 O-C-N 115.692 -4.38 . . . . 13.9 115.532 -169.048 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -118.06 119.57 35.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.902 -2.374 . . . . 6.8600000000000003 104.94 176.916 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.51 -96.6 0.05 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.774 3.23 . . . . 11.15 109.825 -168.622 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.94 21.31 4.43 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 126.727 2.108 . . . . 13.93 114.099 176.594 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -134.85 145.27 48.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.465 -1.609 . . . . 23.920000000000002 108.091 -170.164 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -95.73 139.38 32.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.443 2.339 . . . . 23.23 114.456 -168.955 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.2 mt -87.31 136.13 33.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.124 2.392 . . . . 9.1099999999999994 112.14 -166.846 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -96.3 147.96 23.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.374 -2.704 . . . . 33.439999999999998 112.65 176.036 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -62.25 -43.49 98.71 Favored 'General case' 0 N--CA 1.431 -1.413 1 CA-C-O 128.821 4.153 . . . . 28.370000000000001 117.607 -160.394 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.76 -23.39 75.66 Favored Glycine 0 N--CA 1.43 -1.727 0 O-C-N 117.939 -2.976 . . . . 15.0 112.766 -173.375 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 mmm-85 -84.39 151.35 24.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.517 2.658 . . . . 25.5 107.913 -158.856 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -81.13 171.92 14.31 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.457 -6.402 . . . . 11.949999999999999 114.208 175.721 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.2 mt -69.82 -24.72 63.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.371 -2.706 . . . . 10.17 115.061 166.102 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -56.82 -43.93 81.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.802 2.89 . . . . 13.59 118.802 167.722 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -57.72 -56.23 24.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 110.812 -2.904 . . . . 11.699999999999999 110.371 -176.562 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -75.38 -21.52 58.22 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.504 -2.134 . . . . 12.949999999999999 115.358 -177.028 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 62.15 55.37 2.47 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.969 3.307 . . . . 25.449999999999999 107.878 -171.787 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 mt -88.34 112.52 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 116.079 -1.915 . . . . 14.6 106.675 161.371 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -108.93 -158.37 0.65 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.118 2.266 . . . . 33.229999999999997 117.118 -179.195 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -61.47 124.95 22.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.287 3.435 . . . . 25.969999999999999 114.549 168.17 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.307 38.5 mt-10 78.14 2.99 2.81 Favored 'General case' 0 N--CA 1.43 -1.434 1 N-CA-C 122.164 4.135 . . . . 32.609999999999999 122.164 -169.47 . . . . . . . . 3 2 . 1 . 109 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -75.24 122.59 23.91 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.105 -4.122 . . . . 10.56 113.547 -175.752 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -102.22 118.02 36.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.419 1.918 . . . . 5.3300000000000001 113.673 177.854 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 5' ' ' VAL . 85.7 mt -88.18 159.4 18.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.684 -1.969 . . . . 11.66 105.684 -178.204 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -110.3 136.92 48.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.086 -2.259 . . . . 16.300000000000001 106.977 173.787 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -105.72 140.49 38.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.519 -1.988 . . . . 9.9600000000000009 107.41 170.506 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.273 28.4 t -114.6 140.17 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 128.003 2.521 . . . . 9.7599999999999998 106.737 167.998 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt . . . . . 0 N--CA 1.43 -1.465 0 C-N-CA 127.181 2.192 . . . . 19.57 108.707 178.986 . . . . . . . . 0 0 . 1 . 110 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 11.2 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 117.94 2.57 . . . . 17.170000000000002 117.94 . . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.266 31.1 mt-30 -71.96 131.15 42.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.655 -3.153 . . . . 21.890000000000001 112.098 -178.813 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 pt -135.96 155.06 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 101.324 -3.584 . . . . 10.83 101.324 -169.795 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.29 118.66 37.31 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.826 2.05 . . . . 10.609999999999999 114.508 175.683 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -114.67 104.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 104.762 -2.31 . . . . 9.1300000000000008 104.762 -177.063 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -89.89 123.3 33.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.813 2.845 . . . . 20.550000000000001 112.66 -175.904 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -78.33 166.58 22.51 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.87 1.319 . . . . 11.779999999999999 113.619 -172.36 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 71' ' ' LEU . 32.5 tp -58.43 -47.64 83.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.405 -3.934 . . . . 19.309999999999999 115.03 175.112 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -63.02 -69.82 0.24 Allowed 'General case' 0 N--CA 1.43 -1.471 2 CA-C-O 111.163 -4.255 . . . . 23.140000000000001 108.804 176.26 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.66 45.27 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 O-C-N 126.706 2.504 . . . . 19.739999999999998 116.129 179.438 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -127.24 142.23 51.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.712 -1.464 . . . . 21.93 107.105 -172.766 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.5 m -112.44 131.75 55.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.391 1.567 . . . . 12.33 107.644 175.203 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 pt -122.56 145.4 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.654 -2.529 . . . . 17.079999999999998 105.38 171.149 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m -113.21 110.44 20.4 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.772 -3.705 . . . . 16.300000000000001 107.66 -166.991 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 mt -115.49 152.02 33.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 118.026 -0.988 . . . . 15.880000000000001 112.256 -170.52 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -97.86 125.63 42.83 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 127.088 3.327 . . . . 28.899999999999999 117.672 162.935 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.0 175.36 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 111.307 -2.679 . . . . 12.050000000000001 111.511 167.425 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -102.04 178.42 1.22 Allowed Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.647 -2.121 . . . . 18.170000000000002 107.628 168.012 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -71.84 -26.54 18.88 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 C-N-CA 122.297 1.998 . . . . 8.1600000000000001 115.235 163.966 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -83.14 -8.97 59.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.782 2.882 . . . . 11.130000000000001 118.782 177.133 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -69.11 155.34 40.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.934 2.198 . . . . 18.030000000000001 116.934 171.853 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.8 p -106.35 -172.83 2.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.651 -1.28 . . . . 10.220000000000001 107.731 -176.258 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 43.3 mm -81.38 -25.99 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 125.139 2.4 . . . . 12.300000000000001 111.895 -178.746 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -53.23 -43.3 67.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.192 -3.442 . . . . 36.509999999999998 112.705 164.139 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -75.33 -45.25 40.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.736 -2.477 . . . . 25.66 111.775 -178.443 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.1 t -50.37 -56.93 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 124.874 1.269 . . . . 8.1199999999999992 111.402 166.593 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -58.63 -32.33 68.94 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 119.84 3.274 . . . . 15.470000000000001 119.84 179.26 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.32 -49.09 59.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.87 -3.019 . . . . 11.449999999999999 109.718 173.051 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -46.64 -47.48 20.14 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.17 -2.831 . . . . 24.98 116.7 172.197 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.94 -44.4 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.353 2.661 . . . . 9.4600000000000009 113.412 171.903 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -67.0 -50.64 61.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.738 2.415 . . . . 14.76 111.751 173.595 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.7 -56.83 17.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.228 -2.795 . . . . 26.289999999999999 113.909 173.307 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.262 35.4 tptt -57.93 -80.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.31 2.005 . . . . 30.059999999999999 116.043 174.334 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -68.25 -56.86 7.18 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 126.79 3.186 . . . . 25.190000000000001 112.787 -170.632 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.75 13.77 0.93 Allowed Glycine 0 N--CA 1.431 -1.666 1 O-C-N 115.361 -4.587 . . . . 7.4100000000000001 110.096 169.535 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.68 134.07 27.01 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 116.334 -1.793 . . . . 9.4900000000000002 112.713 -169.04 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -76.22 150.44 33.08 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 121.603 1.608 . . . . 11.42 109.487 177.041 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 89.3 Cg_endo -78.3 -9.56 16.34 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 123.799 3.0 . . . . 12.0 111.692 -170.384 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -65.13 -22.6 66.95 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 127.315 3.436 . . . . 35.549999999999997 111.348 165.442 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -90.78 -23.28 20.67 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.723 -4.36 . . . . 20.52 113.372 -173.969 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -89.06 131.29 35.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.025 -2.922 . . . . 7.1299999999999999 114.144 -166.053 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -121.84 126.85 49.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.013 -1.847 . . . . 36.390000000000001 106.013 156.995 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -106.96 127.05 53.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.119 1.367 . . . . 9.5500000000000007 112.778 178.974 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -129.25 138.17 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 126.9 2.08 . . . . 13.9 111.998 -165.988 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -120.62 122.04 39.66 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 114.914 -4.867 . . . . 6.8600000000000003 102.39 166.851 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.27 -85.51 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.067 2.147 . . . . 11.15 111.82 -174.927 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.59 23.08 1.34 Allowed Glycine 0 N--CA 1.429 -1.787 0 O-C-N 118.935 -2.353 . . . . 13.93 109.687 171.631 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -95.12 116.9 29.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.073 2.149 . . . . 23.920000000000002 114.136 168.196 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -70.36 119.22 14.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 118.817 2.895 . . . . 23.23 118.817 169.571 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.83 134.79 33.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.425 -3.297 . . . . 9.1099999999999994 116.899 -167.958 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -103.6 143.25 33.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.485 1.948 . . . . 33.439999999999998 115.426 -172.592 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.543 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 9.0 m-20 -50.46 -37.74 39.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.702 3.201 . . . . 28.370000000000001 119.272 -161.784 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.74 35.3 4.57 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 115.218 -2.99 . . . . 15.0 111.473 -178.425 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.44 HH21 ' CG ' ' A' ' 58' ' ' ASP . 21.1 mmm180 -110.77 153.91 24.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 122.566 3.183 . . . . 25.5 106.151 166.448 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.307 10.9 p -86.25 162.03 18.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.153 2.581 . . . . 11.949999999999999 107.1 -176.348 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.07 -32.63 73.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.287 -2.133 . . . . 10.17 115.37 169.014 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.1 t -60.08 -40.37 89.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.688 2.395 . . . . 13.59 112.762 167.199 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' CG ' HH21 ' A' ' 54' ' ' ARG . 11.5 t70 -59.5 -48.63 80.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.716 -2.49 . . . . 11.699999999999999 115.583 169.173 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 54' ' ' ARG 0.273 10.5 m-85 -82.46 4.88 22.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.752 1.39 . . . . 12.949999999999999 114.752 -179.979 . . . . . . . . 3 3 . 1 . 110 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 59.37 28.31 17.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 114.805 -2.521 . . . . 25.449999999999999 114.79 -176.588 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.9 mt -76.18 126.58 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 124.21 3.186 . . . . 14.6 111.944 166.408 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -102.73 -179.29 3.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.221 2.439 . . . . 33.229999999999997 116.317 178.834 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -78.33 136.34 37.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 112.838 -1.983 . . . . 25.969999999999999 110.253 179.684 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.26 11.5 tt0 75.12 30.64 0.87 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.424 2.379 . . . . 32.609999999999999 117.424 -177.083 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -113.54 160.0 18.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.466 -2.021 . . . . 10.56 110.324 -175.965 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -109.39 115.25 29.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.203 2.601 . . . . 5.3300000000000001 113.869 -173.068 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.54 156.91 18.31 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 111.662 -2.517 . . . . 11.66 113.611 170.869 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -116.33 109.46 17.41 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 112.415 -2.175 . . . . 16.300000000000001 107.838 -176.03 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.8 tp -89.31 114.33 25.71 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.583 -3.198 . . . . 9.9600000000000009 103.674 179.177 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.3 t -114.51 132.27 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 118.07 -2.894 . . . . 9.7599999999999998 108.129 -178.697 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.461 ' H ' HD22 ' A' ' 8' ' ' LEU . 11.4 mt . . . . . 0 N--CA 1.43 -1.457 0 CA-C-O 124.419 2.056 . . . . 19.57 106.005 -165.332 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 121.102 0.477 . . . . 17.170000000000002 110.039 . . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -89.5 134.37 34.14 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.911 -1.743 . . . . 21.890000000000001 113.079 -171.302 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -115.18 139.2 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.072 -2.893 . . . . 10.83 112.062 160.595 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.285 12.3 m-85 -109.89 88.91 2.86 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.55 -5.094 . . . . 10.609999999999999 107.972 -169.248 . . . . . . . . 3 2 . 1 . 111 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.13 100.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 CA-C-O 129.184 4.326 . . . . 9.1300000000000008 113.522 173.353 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.28 46.7 mttt -83.31 148.57 27.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.15 -3.469 . . . . 20.550000000000001 113.752 178.536 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -104.27 -179.35 3.92 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.164 -2.21 . . . . 11.779999999999999 110.678 -168.322 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.325 1.9 tp -66.34 -41.18 89.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.996 1.48 . . . . 19.309999999999999 114.996 171.833 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.31 16.2 p -71.55 -66.22 0.66 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.589 2.614 . . . . 23.140000000000001 117.348 177.797 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.09 22.49 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 125.205 2.559 . . . . 19.739999999999998 119.451 -166.483 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -106.12 147.59 28.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.412 -2.394 . . . . 21.93 108.98 179.182 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -124.22 106.28 10.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.375 -2.454 . . . . 12.33 104.375 178.827 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -90.59 102.85 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 105.247 -2.131 . . . . 17.079999999999998 105.247 -177.933 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.2 m -81.14 121.65 26.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.081 -2.563 . . . . 16.300000000000001 104.081 -177.015 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.4 mt -112.37 133.97 54.17 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.38 2.363 . . . . 15.880000000000001 117.38 175.411 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.338 32.7 mt-10 -87.47 97.89 11.08 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.943 -4.223 . . . . 28.899999999999999 107.521 -177.677 . . . . . . . . 3 2 . 1 . 111 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -123.56 177.24 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.24 -1.538 . . . . 12.050000000000001 113.328 178.234 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -128.17 171.18 8.91 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.208 -1.853 . . . . 18.170000000000002 111.852 168.685 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -70.0 -16.37 36.54 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 C-N-CA 125.512 4.141 . . . . 8.1600000000000001 113.829 -174.312 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.2 m -92.96 -3.62 54.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.849 2.86 . . . . 11.130000000000001 110.919 179.476 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.54 154.72 40.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.368 -2.707 . . . . 18.030000000000001 115.348 176.507 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 4.8 p -93.65 156.5 16.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.286 -2.487 . . . . 10.220000000000001 104.286 -179.807 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -51.85 -36.5 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.637 -3.789 . . . . 12.300000000000001 113.52 167.561 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.67 -39.42 88.33 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.276 -2.765 . . . . 36.509999999999998 112.186 174.801 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -62.01 -47.17 85.98 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.764 -2.065 . . . . 25.66 113.049 170.421 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.5 t -44.83 -56.13 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 1 C-N-CA 131.915 4.086 . . . . 8.1199999999999992 111.068 172.213 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.95 -34.25 76.23 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.329 -3.357 . . . . 15.470000000000001 113.338 -174.024 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.55 85.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 114.68 1.363 . . . . 11.449999999999999 114.68 165.482 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -65.28 -32.2 73.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.072 -2.893 . . . . 24.98 113.012 173.669 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -70.96 -44.75 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.147 -1.596 . . . . 9.4600000000000009 109.189 176.527 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -57.44 -52.4 65.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.861 -2.399 . . . . 14.76 110.906 169.076 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -48.62 -53.23 19.33 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.899 3.296 . . . . 26.289999999999999 119.899 171.622 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -82.67 -57.88 3.14 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.191 -4.068 . . . . 30.059999999999999 118.38 179.63 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -86.75 -25.47 24.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.893 1.442 . . . . 25.190000000000001 114.893 -172.563 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.44 23.0 38.31 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 126.703 2.502 . . . . 7.4100000000000001 119.004 -176.585 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.6 mt -96.95 127.23 39.71 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 113.016 -3.374 . . . . 9.4900000000000002 106.466 -175.223 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.3 153.97 18.67 Favored 'Trans proline' 0 C--N 1.299 -2.034 2 C-N-CA 126.941 5.094 . . . . 11.42 112.736 179.038 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.58 -18.19 29.33 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 124.679 3.586 . . . . 12.0 108.469 -159.982 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.261 41.4 m-20 -73.96 -22.97 59.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.1 2.125 . . . . 35.549999999999997 113.206 179.341 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -91.03 -3.57 57.11 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.68 2.487 . . . . 20.52 110.993 179.122 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -94.36 102.66 14.65 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.364 2.347 . . . . 7.1299999999999999 115.77 -166.256 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -90.83 100.6 13.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.392 -3.318 . . . . 36.390000000000001 107.38 158.405 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.0 tp -95.14 106.89 18.94 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.119 -1.855 . . . . 9.5500000000000007 109.659 174.435 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.11 127.24 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 127.619 2.367 . . . . 13.9 109.921 -168.681 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -118.77 111.82 18.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.481 -1.387 . . . . 6.8600000000000003 110.663 173.869 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.01 -103.14 0.11 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.264 2.626 . . . . 11.15 111.666 -165.663 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.42 20.53 3.71 Favored Glycine 0 N--CA 1.431 -1.697 0 O-C-N 118.314 -2.741 . . . . 13.93 107.239 166.469 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -85.93 133.77 33.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.987 2.327 . . . . 23.920000000000002 114.28 165.069 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -93.01 125.91 37.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.628 -1.624 . . . . 23.23 107.628 178.614 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -98.89 144.39 28.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.135 2.772 . . . . 9.1099999999999994 111.593 -174.389 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -113.01 149.51 33.23 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.216 1.96 . . . . 33.439999999999998 110.416 -175.655 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.32 -48.86 79.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.894 2.183 . . . . 28.370000000000001 116.894 -160.917 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.96 7.53 78.85 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 118.761 2.264 . . . . 15.0 118.761 -175.39 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -88.37 149.91 23.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.307 -0.946 . . . . 25.5 109.556 170.775 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 64.8 p -84.86 168.45 15.07 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.38 -2.075 . . . . 11.949999999999999 115.296 176.7 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.0 mt -73.13 -39.23 65.9 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 127.804 2.441 . . . . 10.17 110.605 178.451 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -68.54 -39.27 81.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.874 2.07 . . . . 13.59 112.651 178.383 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.56 -32.86 71.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 121.568 1.985 . . . . 11.699999999999999 109.506 175.739 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.27 -13.04 53.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 122.181 2.264 . . . . 12.949999999999999 106.331 176.358 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.327 59.7 m-20 80.66 28.0 0.23 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.968 2.507 . . . . 25.449999999999999 113.098 -178.471 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.46 HG23 HD13 ' A' ' 61' ' ' ILE . 75.9 mt -81.66 109.33 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.517 -2.614 . . . . 14.6 110.196 -174.555 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -90.71 -178.97 5.41 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.831 2.453 . . . . 33.229999999999997 109.5 -177.282 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HA ' ' SD ' ' A' ' 1' ' ' MET 0.258 20.2 pttp -64.78 151.69 44.63 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.077 1.88 . . . . 25.969999999999999 116.077 173.174 . . . . . . . . 3 3 . 1 . 111 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 69.01 19.62 8.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.254 3.421 . . . . 32.609999999999999 117.877 177.03 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -76.39 125.81 29.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.971 2.908 . . . . 10.56 111.654 -176.619 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.6 m -77.66 113.41 15.48 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.065 2.728 . . . . 5.3300000000000001 112.556 177.582 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.91 161.22 14.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.381 1.473 . . . . 11.66 113.62 167.315 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -106.35 132.92 51.82 Favored 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 131.727 4.011 . . . . 16.300000000000001 109.654 164.692 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -116.28 101.62 8.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.229 2.919 . . . . 9.9600000000000009 109.55 171.694 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -99.93 143.65 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 118.89 -2.381 . . . . 9.7599999999999998 108.618 170.704 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.43 -1.446 1 O-C-N 114.878 -4.889 . . . . 19.57 109.241 -178.012 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptt? . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 113.642 0.979 . . . . 17.170000000000002 113.642 . . . . . . . . . 0 0 . 1 . 112 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -103.59 121.71 43.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.08 2.371 . . . . 21.890000000000001 110.142 176.206 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -111.1 146.41 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.986 -2.321 . . . . 10.83 113.052 168.73 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -108.01 142.74 37.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.22 -1.809 . . . . 10.609999999999999 114.643 -176.876 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 48.4 t -131.41 119.47 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.847 -3.02 . . . . 9.1300000000000008 102.847 -172.957 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -118.31 115.82 25.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 112.896 -3.431 . . . . 20.550000000000001 110.304 -165.793 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -63.19 175.77 0.88 Allowed 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 129.917 4.51 . . . . 11.779999999999999 112.863 174.992 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.9 tp -67.82 -36.71 80.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.608 -0.724 . . . . 19.309999999999999 112.501 -179.677 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -86.17 -47.87 9.09 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.162 1.785 . . . . 23.140000000000001 107.182 -168.896 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.24 40.69 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 CA-C-O 123.165 1.425 . . . . 19.739999999999998 112.026 168.73 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -90.81 123.83 34.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.211 1.957 . . . . 21.93 111.305 163.101 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -99.54 106.73 18.76 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 111.946 -2.388 . . . . 12.33 108.868 -176.472 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 46.8 mt -96.32 118.53 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.548 -1.345 . . . . 17.079999999999998 109.668 -177.949 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 m -100.19 121.93 42.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.395 -3.316 . . . . 16.300000000000001 105.033 -173.023 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.4 mt -122.42 141.16 51.9 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.421 1.888 . . . . 15.880000000000001 108.357 -176.951 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -100.43 132.87 45.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 127.99 3.757 . . . . 28.899999999999999 107.702 174.24 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -137.23 174.51 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.328 -3.357 . . . . 12.050000000000001 109.456 -175.447 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -122.54 157.11 60.14 Favored Pre-proline 0 N--CA 1.43 -1.464 0 C-N-CA 123.928 0.891 . . . . 18.170000000000002 109.015 151.123 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.5 -25.17 75.69 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.363 2.709 . . . . 8.1600000000000001 113.703 -171.087 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -86.41 7.45 25.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.645 1.566 . . . . 11.130000000000001 112.471 -171.515 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -87.35 147.39 25.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.215 -2.178 . . . . 18.030000000000001 105.62 -172.145 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.4 p -82.77 151.63 26.05 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.301 -2.125 . . . . 10.220000000000001 112.685 -177.658 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -51.94 -43.22 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 130.607 3.563 . . . . 12.300000000000001 109.149 176.84 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.76 -37.74 79.86 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 125.96 2.037 . . . . 36.509999999999998 114.449 178.325 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.254 71.9 m-80 -72.83 -32.91 65.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.662 -2.524 . . . . 25.66 114.803 176.786 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.77 -36.03 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 127.127 2.171 . . . . 8.1199999999999992 110.771 167.188 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -70.69 -26.93 63.65 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.399 -2.688 . . . . 15.470000000000001 115.809 169.05 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.41 72.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.294 1.861 . . . . 11.449999999999999 109.999 167.923 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -63.87 -33.04 74.81 Favored 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 115.694 -4.378 . . . . 24.98 115.24 178.905 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 mt -69.77 -32.3 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.847 -2.408 . . . . 9.4600000000000009 108.682 172.651 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -69.98 -44.88 68.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.927 -3.608 . . . . 14.76 109.188 173.479 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -61.17 -46.03 92.17 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.736 2.208 . . . . 26.289999999999999 116.335 179.286 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -79.01 -60.82 2.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.742 -3.724 . . . . 30.059999999999999 116.647 -174.106 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -86.59 -53.86 4.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 126.182 2.176 . . . . 25.190000000000001 111.443 177.21 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.08 33.58 2.75 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 115.958 -2.579 . . . . 7.4100000000000001 113.958 -172.796 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.52 127.82 36.6 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 130.185 3.394 . . . . 9.4900000000000002 103.826 166.366 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -77.75 161.67 30.39 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-O 112.905 -3.04 . . . . 11.42 115.271 -177.498 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -66.84 -24.7 46.27 Favored 'Trans proline' 0 N--CA 1.434 -1.999 1 CA-C-N 129.772 4.526 . . . . 12.0 116.693 -172.079 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.06 -31.94 72.41 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.491 2.369 . . . . 35.549999999999997 113.418 -174.222 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.402 45.0 mt-30 -72.95 -16.91 61.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 119.427 3.121 . . . . 20.52 119.427 -179.53 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -102.68 110.16 22.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.105 -3.497 . . . . 7.1299999999999999 114.268 -155.521 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -94.14 103.94 15.97 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.178 -2.527 . . . . 36.390000000000001 104.178 169.178 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.08 118.46 31.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.086 2.374 . . . . 9.5500000000000007 110.114 174.773 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.1 mt -113.6 136.72 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 110.563 -3.017 . . . . 13.9 107.584 -179.393 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -120.36 113.35 20.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 101.494 -3.521 . . . . 6.8600000000000003 101.494 172.368 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.74 -117.14 0.47 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.085 -2.26 . . . . 11.15 111.314 -176.125 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.37 25.29 13.97 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 117.911 -2.993 . . . . 13.93 116.656 175.234 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -131.35 142.6 50.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.51 2.576 . . . . 23.920000000000002 109.305 -173.3 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -110.29 141.78 42.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.394 -2.691 . . . . 23.23 111.82 -177.284 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mt -95.2 140.54 29.96 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.134 2.397 . . . . 9.1099999999999994 110.606 -166.646 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -109.61 136.54 48.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.936 -1.938 . . . . 33.439999999999998 111.67 -172.359 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.7 -60.26 2.1 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.532 1.678 . . . . 28.370000000000001 115.532 -170.944 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.82 -4.03 61.04 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 118.797 -2.439 . . . . 15.0 117.805 -173.905 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -83.63 178.78 7.82 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 118.634 1.217 . . . . 25.5 110.689 170.883 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 76.6 p -106.09 178.44 4.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.333 -1.479 . . . . 11.949999999999999 109.958 177.058 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.9 mt -74.18 -33.89 63.6 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.591 1.156 . . . . 10.17 108.29 179.897 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -78.06 -27.35 48.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.389 3.076 . . . . 13.59 111.219 -175.007 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.02 -34.92 79.09 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 116.81 -1.567 . . . . 11.699999999999999 110.005 179.993 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -88.33 1.87 53.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.922 3.289 . . . . 12.949999999999999 114.103 167.521 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m120 58.31 49.07 11.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.25 1.204 . . . . 25.449999999999999 114.25 -178.098 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mm -79.18 113.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.22 -2.175 . . . . 14.6 106.767 170.436 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -87.62 -177.68 5.92 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.924 2.015 . . . . 33.229999999999997 112.42 174.087 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -64.03 134.42 54.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.667 -3.145 . . . . 25.969999999999999 115.408 164.508 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 69.84 31.22 3.53 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.757 2.217 . . . . 32.609999999999999 111.425 173.719 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.267 45.6 t -83.69 134.27 34.77 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.932 1.693 . . . . 10.56 108.54 166.499 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 m -103.96 122.84 46.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.716 -1.24 . . . . 5.3300000000000001 108.377 -179.573 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -81.99 138.71 34.85 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 115.135 -2.364 . . . . 11.66 116.073 165.185 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -88.5 114.61 25.29 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.172 2.17 . . . . 16.300000000000001 107.352 175.281 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.268 9.5 tp -92.55 106.45 18.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 117.672 -1.611 . . . . 9.9600000000000009 112.216 176.092 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.61 138.68 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.836 2.455 . . . . 9.7599999999999998 105.37 179.267 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 mt . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 116.485 2.032 . . . . 19.57 116.485 -171.897 . . . . . . . . 0 0 . 1 . 113 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.283 -0.636 . . . . 17.170000000000002 109.283 . . . . . . . . . 0 0 . 1 . 113 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -89.88 120.97 31.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.185 -0.672 . . . . 21.890000000000001 109.185 165.744 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -117.01 167.88 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 118.499 -2.626 . . . . 10.83 108.129 157.043 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.1 133.96 55.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.847 -2.408 . . . . 10.609999999999999 115.529 -176.163 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -112.62 117.76 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 123.875 1.798 . . . . 9.1300000000000008 110.661 175.323 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -96.58 151.86 19.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 112.278 -3.725 . . . . 20.550000000000001 110.771 177.142 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.6 p -85.21 -176.07 6.0 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 121.675 2.034 . . . . 11.779999999999999 113.327 159.88 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.252 36.5 mt -86.15 -17.93 33.62 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.407 1.003 . . . . 19.309999999999999 113.595 169.329 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 p -77.97 -69.56 0.54 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.575 2.35 . . . . 23.140000000000001 113.196 175.985 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.9 28.25 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.719 1 O-C-N 115.117 -4.739 . . . . 19.739999999999998 111.022 -177.504 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -109.06 130.65 55.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.116 -1.226 . . . . 21.93 111.085 179.091 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -111.17 115.99 30.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.015 -3.553 . . . . 12.33 108.151 173.577 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 pt -105.15 155.39 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 117.261 -1.776 . . . . 17.079999999999998 108.537 171.625 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.1 m -111.91 131.95 55.05 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.917 -2.623 . . . . 16.300000000000001 103.917 -177.287 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.3 tp -144.87 125.94 14.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.679 -2.513 . . . . 15.880000000000001 109.047 -164.885 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.82 103.47 15.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.045 -2.284 . . . . 28.899999999999999 110.996 -172.833 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -131.95 155.45 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 115.379 -0.828 . . . . 12.050000000000001 110.483 176.891 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -85.79 146.41 43.6 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 117.517 -1.23 . . . . 18.170000000000002 110.035 178.153 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.03 -10.69 21.53 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 N-CA-C 118.197 2.345 . . . . 8.1600000000000001 118.197 177.288 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 p -90.83 -7.19 53.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.363 2.665 . . . . 11.130000000000001 114.746 175.927 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -69.56 149.27 48.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.741 -1.224 . . . . 18.030000000000001 110.415 176.402 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -79.78 170.13 16.96 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 117.026 -1.464 . . . . 10.220000000000001 110.492 175.931 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -72.24 -29.04 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 127.062 2.145 . . . . 12.300000000000001 110.761 178.392 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -59.44 -47.39 85.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.369 -2.707 . . . . 36.509999999999998 113.246 163.483 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -62.63 -40.17 96.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.052 2.206 . . . . 25.66 115.163 170.499 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -56.59 -50.91 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 121.499 1.954 . . . . 8.1199999999999992 112.98 171.471 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -68.52 -30.19 68.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.256 -2.778 . . . . 15.470000000000001 112.892 -176.507 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.29 77.53 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.216 1.806 . . . . 11.449999999999999 109.844 174.088 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -80.48 -39.77 27.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.207 1.479 . . . . 24.98 109.882 -176.454 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.4 mt -56.32 -39.26 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.408 -3.932 . . . . 9.4600000000000009 113.665 162.746 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.351 17.6 tt0 -56.31 -51.65 67.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.131 2.972 . . . . 14.76 108.334 167.374 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.62 -37.75 76.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 121.711 2.051 . . . . 26.289999999999999 112.318 -168.181 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -83.01 -66.0 0.94 Allowed 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 129.212 4.07 . . . . 30.059999999999999 116.77 -178.399 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -93.48 -26.16 17.3 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.671 1.188 . . . . 25.190000000000001 112.748 -169.995 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.62 37.88 8.48 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.389 1.471 . . . . 7.4100000000000001 114.427 178.526 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.402 HD12 HD23 ' A' ' 71' ' ' LEU . 4.7 mt -88.9 128.86 50.54 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 118.739 -1.184 . . . . 9.4900000000000002 113.105 160.862 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.39 158.2 36.79 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 123.288 2.659 . . . . 11.42 111.815 170.186 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -90.31 0.28 5.35 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 116.808 -2.259 . . . . 12.0 109.916 -159.931 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -77.09 -29.73 55.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.665 -2.522 . . . . 35.549999999999997 110.755 169.626 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -71.23 -37.77 72.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.089 -2.257 . . . . 20.52 109.174 175.433 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -76.99 116.89 18.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.023 2.231 . . . . 7.1299999999999999 117.023 -164.909 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -115.59 120.31 39.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.1 1.905 . . . . 36.390000000000001 108.482 166.75 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -111.77 112.97 25.03 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.245 -4.034 . . . . 9.5500000000000007 110.442 -169.447 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.6 mm -102.89 137.84 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.479 -2.013 . . . . 13.9 110.026 -177.93 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -106.46 111.58 24.22 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.747 -5.596 . . . . 6.8600000000000003 108.079 153.786 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.44 -99.17 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.192 2.597 . . . . 11.15 115.615 -174.534 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -122.53 8.62 9.46 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 118.985 -2.322 . . . . 13.93 115.018 161.174 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -89.27 124.89 34.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.033 1.333 . . . . 23.920000000000002 114.546 172.475 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -85.47 131.51 34.37 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.145 -2.539 . . . . 23.23 104.145 -179.341 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -93.37 126.76 38.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.379 1.472 . . . . 9.1099999999999994 110.17 -175.653 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -121.0 150.45 41.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.911 2.141 . . . . 33.439999999999998 113.011 -164.77 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.365 67.2 m-20 -18.02 -74.7 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.432 1 C-N-CA 132.285 4.234 . . . . 28.370000000000001 120.039 -168.968 . . . . . . . . 3 2 . 1 . 113 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.38 34.34 5.19 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.713 -2.492 . . . . 15.0 116.339 -164.802 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -133.55 171.34 14.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.862 -1.964 . . . . 25.5 111.949 175.989 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -95.54 167.21 11.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.664 2.029 . . . . 11.949999999999999 112.889 -167.519 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.53 -34.25 76.54 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.53 -2.606 . . . . 10.17 112.908 166.828 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -38.22 79.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.426 1.269 . . . . 13.59 114.426 178.129 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -56.4 -50.38 71.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.596 -3.815 . . . . 11.699999999999999 114.044 177.914 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -77.78 8.42 4.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 127.576 3.048 . . . . 12.949999999999999 113.631 178.163 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 2.0 m120 54.4 40.33 31.69 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 131.748 4.019 . . . . 25.449999999999999 117.222 -179.519 . . . . . . . . 3 2 . 1 . 113 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.346 10.1 mt -77.77 115.72 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.407 -1.433 . . . . 14.6 109.307 178.962 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -91.85 176.06 6.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.207 -3.433 . . . . 33.229999999999997 108.473 176.361 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -69.38 146.91 51.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.346 -2.721 . . . . 25.969999999999999 114.023 176.817 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 71.35 18.59 5.55 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 129.652 3.181 . . . . 32.609999999999999 112.561 -179.102 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.8 m -76.69 148.95 36.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.199 -2.813 . . . . 10.56 112.507 178.949 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.4 m -90.96 106.09 18.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.472 2.309 . . . . 5.3300000000000001 115.735 170.507 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -91.44 152.24 20.46 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.422 2.289 . . . . 11.66 114.311 166.164 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -119.77 125.84 49.57 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.184 -2.822 . . . . 16.300000000000001 103.956 -169.76 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -102.2 123.53 46.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.723 2.409 . . . . 9.9600000000000009 108.053 177.915 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.76 130.6 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 113.41 -1.723 . . . . 9.7599999999999998 114.089 162.292 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.402 HD23 HD12 ' A' ' 36' ' ' ILE . 10.8 mt . . . . . 0 N--CA 1.43 -1.455 0 C-N-CA 129.486 3.114 . . . . 19.57 117.926 176.531 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ptt? . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 118.514 2.783 . . . . 17.170000000000002 118.514 . . . . . . . . . 0 0 . 1 . 114 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.371 36.7 mt-30 -69.01 128.48 36.85 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.253 -2.129 . . . . 21.890000000000001 105.253 170.569 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 pt -123.4 151.8 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.677 -2.056 . . . . 10.83 110.972 161.983 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -96.37 130.01 43.58 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.738 -0.785 . . . . 10.609999999999999 111.402 174.778 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -119.26 125.14 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 103.126 -2.916 . . . . 9.1300000000000008 103.126 160.966 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -119.48 132.22 55.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 109.983 -3.28 . . . . 20.550000000000001 105.985 -175.942 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.481 HG22 HD21 ' A' ' 69' ' ' LEU . 10.5 p -75.34 157.58 34.07 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.794 -3.066 . . . . 11.779999999999999 109.109 174.552 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.5 mt -61.59 -39.76 92.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.514 -3.241 . . . . 19.309999999999999 114.43 159.283 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -48.02 -34.57 9.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.001 2.12 . . . . 23.140000000000001 112.794 172.141 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.04 -62.88 0.32 Allowed Glycine 0 N--CA 1.43 -1.725 1 O-C-N 114.156 -5.34 . . . . 19.739999999999998 119.801 -178.638 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -80.78 160.76 24.78 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 115.296 -2.561 . . . . 21.93 117.084 -158.251 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.69 131.29 48.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.427 -1.42 . . . . 12.33 109.493 166.641 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 pt -112.9 144.54 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 129.216 3.006 . . . . 17.079999999999998 109.017 157.219 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -106.34 128.22 53.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.129 2.571 . . . . 16.300000000000001 104.97 179.231 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.471 HD13 HG12 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -107.15 129.33 54.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.577 1.551 . . . . 15.880000000000001 110.978 172.902 . . . . . . . . 3 3 . 1 . 114 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -79.73 101.84 8.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 120.318 1.417 . . . . 28.899999999999999 113.451 159.899 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -111.22 166.76 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.624 -3.173 . . . . 12.050000000000001 115.221 173.996 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -95.76 154.96 38.97 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.926 -1.879 . . . . 18.170000000000002 105.926 167.838 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.252 14.1 Cg_exo -63.0 -21.56 73.3 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 N-CA-C 116.008 1.503 . . . . 8.1600000000000001 116.008 170.26 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.5 p -80.96 -2.48 47.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.878 1.671 . . . . 11.130000000000001 115.475 175.351 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.77 148.72 28.76 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.94 3.296 . . . . 18.030000000000001 106.533 -171.017 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.9 p -91.18 164.12 14.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.256 -2.247 . . . . 10.220000000000001 105.551 -179.392 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.414 HG23 ' CD2' ' A' ' 43' ' ' LEU . 41.1 mm -72.48 -30.9 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 116.948 -1.501 . . . . 12.300000000000001 107.124 174.592 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -51.53 -50.96 59.0 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 125.47 3.759 . . . . 36.509999999999998 114.503 168.777 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -60.39 -28.28 68.1 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.388 2.366 . . . . 25.66 117.388 174.087 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.66 -47.86 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 129.251 3.02 . . . . 8.1199999999999992 110.825 172.018 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -70.48 -30.05 66.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.166 2.412 . . . . 15.470000000000001 109.794 178.402 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.62 74.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.365 -3.959 . . . . 11.449999999999999 109.783 -179.133 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -70.48 -27.81 64.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.302 -2.124 . . . . 24.98 108.601 -177.189 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 HD13 ' A' ' 15' ' ' LEU . 89.5 mt -78.17 -24.63 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 114.017 1.117 . . . . 9.4600000000000009 114.017 170.879 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -62.45 -46.12 89.94 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 115.649 -4.407 . . . . 14.76 110.878 169.081 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.5 -42.01 99.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.627 -1.296 . . . . 26.289999999999999 112.953 174.627 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -73.99 -67.81 0.57 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.521 -1.362 . . . . 30.059999999999999 110.711 -171.017 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -90.57 -29.69 17.68 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 113.74 -5.6 . . . . 25.190000000000001 113.191 -177.215 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.0 40.73 1.78 Allowed Glycine 0 N--CA 1.43 -1.752 0 O-C-N 120.082 -1.636 . . . . 7.4100000000000001 111.601 -177.085 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.4 119.54 37.99 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 119.031 -2.452 . . . . 9.4900000000000002 111.539 -171.786 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HB2' ' HG3' ' A' ' 40' ' ' GLN . 8.2 Cg_exo -58.8 140.6 95.8 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.567 2.178 . . . . 11.42 113.313 177.69 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.36 -17.79 42.13 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 124.901 3.734 . . . . 12.0 118.441 179.458 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.8 -37.21 56.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.799 1.407 . . . . 35.549999999999997 114.799 179.386 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 37' ' ' PRO . 13.2 mt-30 -61.4 -21.74 64.35 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 121.711 3.967 . . . . 20.52 121.711 167.193 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -88.6 101.73 14.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.482 2.401 . . . . 7.1299999999999999 117.482 -171.378 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -100.74 107.36 18.93 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 125.288 2.471 . . . . 36.390000000000001 110.982 177.072 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' CD2' HG23 ' A' ' 23' ' ' ILE . 8.7 tp -105.99 118.7 37.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.432 -2.667 . . . . 9.5500000000000007 107.375 -161.469 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 36.3 mm -111.99 124.48 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 128.969 2.908 . . . . 13.9 115.988 -166.351 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -112.87 87.13 2.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.651 -3.155 . . . . 6.8600000000000003 108.473 -179.314 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.283 . . 62.52 -93.16 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 114.39 -5.193 . . . . 11.15 110.291 -177.122 . . . . . . . . 3 2 . 1 . 114 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.43 -10.99 22.65 Favored Glycine 0 N--CA 1.43 -1.712 0 O-C-N 126.244 2.215 . . . . 13.93 111.253 176.653 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -88.6 137.27 32.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.417 3.087 . . . . 23.920000000000002 108.395 -172.779 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -107.3 117.93 35.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.354 2.026 . . . . 23.23 107.791 177.322 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -80.66 163.41 23.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.023 -1.673 . . . . 9.1099999999999994 111.989 -170.925 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -106.94 165.39 11.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.284 3.034 . . . . 33.439999999999998 105.447 179.443 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.337 23.7 m-20 -84.12 -54.39 4.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.03 2.348 . . . . 28.370000000000001 117.069 -168.549 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.87 50.79 2.26 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.682 -1.599 . . . . 15.0 116.056 177.749 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -133.39 156.05 48.37 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 100.11 -4.033 . . . . 25.5 100.11 175.811 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 30.2 p -86.04 158.54 19.81 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.258 1.98 . . . . 11.949999999999999 113.242 -170.218 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.28 -36.65 80.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.097 -2.252 . . . . 10.17 116.782 167.239 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.4 t -65.8 -38.14 88.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.341 1.856 . . . . 13.59 111.963 -179.519 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -63.36 -54.37 37.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.387 2.275 . . . . 11.699999999999999 112.129 178.721 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -64.14 -17.99 64.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 120.025 3.343 . . . . 12.949999999999999 120.025 170.588 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 69.9 43.4 0.93 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.399 2.37 . . . . 25.449999999999999 117.399 -172.742 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.01 112.47 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.339 -2.21 . . . . 14.6 112.132 165.416 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -83.31 -179.29 7.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.568 1.651 . . . . 33.229999999999997 108.706 -172.91 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.96 152.45 44.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.414 -1.429 . . . . 25.969999999999999 114.787 162.223 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 57.36 21.69 7.08 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.191 1.922 . . . . 32.609999999999999 116.191 -172.23 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 t -90.47 141.14 29.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.795 1.035 . . . . 10.56 113.795 -179.932 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 m -96.94 93.77 6.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.603 2.816 . . . . 5.3300000000000001 118.603 -174.682 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.6 mt -79.02 161.57 26.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.107 -0.995 . . . . 11.66 109.221 174.893 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 79.0 m-70 -104.37 137.22 42.58 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.44 -2.059 . . . . 16.300000000000001 105.44 173.646 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.481 HD21 HG22 ' A' ' 7' ' ' THR . 62.1 tp -95.02 119.49 33.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 127.491 2.994 . . . . 9.9600000000000009 112.655 160.231 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 t -104.25 120.56 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 106.226 -1.768 . . . . 9.7599999999999998 106.226 174.664 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 N--CA 1.429 -1.485 0 C-N-CA 129.699 3.2 . . . . 19.57 113.577 -171.155 . . . . . . . . 0 0 . 1 . 115 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptt? . . . . . 0 CA--C 1.49 -1.33 0 CA-C-O 117.706 -1.14 . . . . 17.170000000000002 113.719 . . . . . . . . . 0 0 . 1 . 115 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.22 144.17 45.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.621 2.153 . . . . 21.890000000000001 115.243 167.729 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.8 pt -127.32 163.29 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.529 -1.669 . . . . 10.83 107.861 175.03 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -123.18 130.13 52.34 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 115.28 -2.295 . . . . 10.609999999999999 111.147 -171.037 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.54 112.13 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 CA-C-N 126.331 4.151 . . . . 9.1300000000000008 102.718 -167.511 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -81.94 144.0 31.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.494 1.517 . . . . 20.550000000000001 113.967 -176.849 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.302 81.8 p -98.91 -140.86 0.32 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.722 -2.486 . . . . 11.779999999999999 112.731 -178.45 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.8 -44.97 1.92 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 100.741 -3.8 . . . . 19.309999999999999 100.741 174.003 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -92.24 -74.45 0.51 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.552 1.541 . . . . 23.140000000000001 112.649 -169.692 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.94 -137.04 3.76 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 108.319 -1.913 . . . . 19.739999999999998 108.319 -157.99 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -91.7 160.45 15.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.651 2.167 . . . . 21.93 112.062 -172.512 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.6 m -77.01 116.72 17.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.651 -3.78 . . . . 12.33 109.691 172.098 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.3 pt -79.37 160.39 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.79 -2.444 . . . . 17.079999999999998 112.356 179.403 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -124.79 132.96 53.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.504 -2.622 . . . . 16.300000000000001 107.422 -175.893 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 mt -121.8 142.39 50.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.261 -0.644 . . . . 15.880000000000001 109.261 177.565 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -99.82 110.57 22.94 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.206 -2.184 . . . . 28.899999999999999 109.217 168.227 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.5 164.84 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 131.252 3.821 . . . . 12.050000000000001 109.915 -170.532 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.272 52.0 mm-40 -110.42 155.14 42.51 Favored Pre-proline 0 N--CA 1.43 -1.453 1 O-C-N 116.011 -4.181 . . . . 18.170000000000002 102.558 172.896 . . . . . . . . 3 2 . 1 . 115 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -66.07 -19.62 57.28 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 127.876 3.849 . . . . 8.1600000000000001 114.654 176.47 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 p -75.99 -5.63 47.2 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.751 2.021 . . . . 11.130000000000001 115.292 179.526 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -78.2 142.45 37.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.1 -1.0 . . . . 18.030000000000001 110.161 171.903 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 40.8 p -81.66 169.19 17.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.1 2.381 . . . . 10.220000000000001 113.501 177.359 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.38 -29.11 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.693 -2.504 . . . . 12.300000000000001 107.942 -178.438 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.18 -34.91 66.26 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.785 1.634 . . . . 36.509999999999998 113.627 175.886 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.6 -40.22 78.62 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.385 -2.721 . . . . 25.66 116.578 161.424 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.65 -38.26 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 123.143 1.449 . . . . 8.1199999999999992 108.369 176.468 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 89.6 mttt -57.29 -36.02 70.53 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 115.336 -4.603 . . . . 15.470000000000001 114.618 171.871 . . . . . . . . 3 3 . 1 . 115 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.91 94.06 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 130.376 4.797 . . . . 11.449999999999999 110.685 176.124 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.284 56.2 mttm -61.4 -42.41 98.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.771 1.623 . . . . 24.98 114.943 167.987 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 27' ' ' LYS . 63.8 mt -60.55 -32.71 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.733 -3.105 . . . . 9.4600000000000009 117.34 176.358 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -58.86 -48.94 79.61 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.979 -2.95 . . . . 14.76 115.475 167.497 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.54 -62.79 1.42 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.142 -3.474 . . . . 26.289999999999999 114.224 162.386 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -64.87 -42.03 95.18 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.673 2.101 . . . . 30.059999999999999 116.673 -170.528 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -106.59 -50.55 3.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.264 -1.522 . . . . 25.190000000000001 113.258 174.143 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.37 5.18 6.16 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 125.029 2.461 . . . . 7.4100000000000001 116.524 -178.039 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.1 mt -82.86 133.69 48.3 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 119.741 -2.035 . . . . 9.4900000000000002 109.655 -177.502 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -64.12 146.35 90.58 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 125.771 4.314 . . . . 11.42 118.021 174.278 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.485 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 72.4 Cg_exo -61.54 -20.71 69.75 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 124.273 2.562 . . . . 12.0 116.736 -173.057 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -82.44 -18.17 42.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.523 1.139 . . . . 35.549999999999997 112.922 -179.874 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -100.06 -4.44 29.88 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 117.592 -1.194 . . . . 20.52 113.709 -176.256 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.05 135.23 33.71 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.106 3.362 . . . . 7.1299999999999999 114.999 175.6 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -129.57 118.38 21.93 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.943 -1.723 . . . . 36.390000000000001 107.946 176.336 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mt -101.5 137.29 40.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.421 1.581 . . . . 9.5500000000000007 109.529 -177.338 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.9 mm -137.36 130.93 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 100.268 -3.975 . . . . 13.9 100.268 -173.191 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -119.94 121.18 38.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 113.377 -3.202 . . . . 6.8600000000000003 109.105 170.705 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.33 -116.26 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.931 2.605 . . . . 11.15 107.599 -174.664 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.5 34.41 4.55 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 118.739 -2.476 . . . . 13.93 113.091 164.375 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -113.36 123.98 51.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.644 -2.092 . . . . 23.920000000000002 108.681 -179.882 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -77.21 119.38 20.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.647 -2.533 . . . . 23.23 111.625 171.743 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.6 mt -90.52 136.16 33.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.995 -2.315 . . . . 9.1099999999999994 115.466 -174.89 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -96.45 128.67 43.59 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.111 -1.618 . . . . 33.439999999999998 114.082 178.855 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -31.72 -52.93 0.25 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.94 3.696 . . . . 28.370000000000001 117.037 -177.627 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.57 0.46 82.97 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 119.012 -2.305 . . . . 15.0 110.322 -165.161 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -91.33 168.35 11.64 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 118.145 0.972 . . . . 25.5 112.212 170.756 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 66.4 p -109.37 178.82 4.33 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.4 -3.312 . . . . 11.949999999999999 108.118 -176.11 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -75.32 -33.81 61.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.422 2.535 . . . . 10.17 111.003 179.579 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -35.89 77.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.445 -3.909 . . . . 13.59 109.242 168.383 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.27 -36.64 71.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 122.42 2.373 . . . . 11.699999999999999 112.798 -176.336 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -83.16 3.43 30.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.277 2.231 . . . . 12.949999999999999 109.794 -177.706 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 49.59 51.52 16.29 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 115.069 1.507 . . . . 25.449999999999999 115.069 -169.766 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mt -102.81 113.86 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 127.161 2.788 . . . . 14.6 113.092 -179.784 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -97.31 -175.25 3.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.778 3.18 . . . . 33.229999999999997 109.535 -174.377 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -73.3 154.5 40.12 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.426 -3.296 . . . . 25.969999999999999 112.889 -175.156 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 76.33 13.68 2.49 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.022 2.129 . . . . 32.609999999999999 109.303 170.499 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 m -87.41 141.77 28.38 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 127.214 2.821 . . . . 10.56 109.703 -172.901 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.1 m -83.94 115.55 22.36 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 123.528 1.632 . . . . 5.3300000000000001 112.804 176.116 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.4 mt -87.29 147.65 25.43 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.923 1.344 . . . . 11.66 110.906 162.674 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -105.36 131.06 53.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.97 -3.582 . . . . 16.300000000000001 109.661 172.85 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 tp -112.39 117.66 33.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.255 3.407 . . . . 9.9600000000000009 107.721 179.929 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.37 151.9 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 101.366 -3.568 . . . . 9.7599999999999998 101.366 -168.15 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 N--CA 1.43 -1.438 0 O-C-N 117.702 -3.124 . . . . 19.57 109.431 -171.669 . . . . . . . . 0 0 . 1 . 116 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 118.71 2.856 . . . . 17.170000000000002 118.71 . . . . . . . . . 0 0 . 1 . 116 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -93.24 124.66 37.37 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.241 -4.037 . . . . 21.890000000000001 106.225 -174.043 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.327 0.9 OUTLIER -110.31 166.69 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 119.784 -1.822 . . . . 10.83 109.578 167.341 . . . . . . . . 3 3 . 1 . 116 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -117.56 120.74 39.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.636 2.16 . . . . 10.609999999999999 116.534 176.241 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -99.17 105.78 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.222 -2.799 . . . . 9.1300000000000008 114.941 176.766 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -102.94 133.89 47.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.802 -3.061 . . . . 20.550000000000001 109.39 -171.74 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.316 17.1 p -93.29 -177.71 4.53 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.119 -4.113 . . . . 11.779999999999999 110.559 -172.77 . . . . . . . . 3 2 . 1 . 116 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.8 mt -74.42 -67.13 0.65 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.233 2.613 . . . . 19.309999999999999 105.322 175.947 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -125.76 129.42 49.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.309 2.256 . . . . 23.140000000000001 106.645 176.166 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.81 -114.06 0.73 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.506 -2.621 . . . . 19.739999999999998 108.492 176.994 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -158.43 163.54 37.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 126.948 3.261 . . . . 21.93 103.581 -178.01 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.7 m -92.38 135.17 34.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.195 -2.191 . . . . 12.33 112.669 178.31 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 pt -110.12 139.47 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.453 -3.28 . . . . 17.079999999999998 111.025 -174.517 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.4 m -101.5 121.11 41.36 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.033 -2.58 . . . . 16.300000000000001 104.033 -175.572 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 mt -119.95 172.42 7.74 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.169 -2.207 . . . . 15.880000000000001 111.504 179.995 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -120.42 120.43 35.91 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.264 -2.772 . . . . 28.899999999999999 114.085 178.062 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -138.2 167.65 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 126.763 2.539 . . . . 12.050000000000001 109.558 -177.756 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -122.96 158.34 57.7 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 121.05 1.75 . . . . 18.170000000000002 108.168 176.902 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.16 -19.58 66.22 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 O-C-N 113.932 -3.772 . . . . 8.1600000000000001 118.278 -179.838 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -82.9 -1.83 53.22 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 118.937 2.94 . . . . 11.130000000000001 118.937 177.577 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -78.78 144.69 34.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.703 -0.623 . . . . 18.030000000000001 109.4 173.719 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 p -76.42 173.84 10.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.206 -2.184 . . . . 10.220000000000001 114.97 165.012 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.6 mm -63.33 -42.99 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.869 1.795 . . . . 12.300000000000001 112.572 174.414 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -49.43 -39.29 32.41 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 131.006 3.723 . . . . 36.509999999999998 113.511 175.583 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -75.45 -17.02 60.26 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.664 -2.522 . . . . 25.66 115.374 172.271 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.54 -44.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.139 -1.601 . . . . 8.1199999999999992 114.234 167.463 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -51.71 -22.89 3.85 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.227 1.936 . . . . 15.470000000000001 116.227 175.659 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.01 -27.3 23.3 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.209 0.913 . . . . 11.449999999999999 109.073 -174.847 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.26 -26.06 65.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.883 2.873 . . . . 24.98 113.428 167.352 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 mt -89.35 -31.75 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.522 -1.986 . . . . 9.4600000000000009 111.261 175.1 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -57.26 -37.45 72.35 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.769 -4.332 . . . . 14.76 114.307 168.461 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -64.68 -55.64 18.83 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.289 -1.815 . . . . 26.289999999999999 112.205 168.191 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -75.97 -51.53 12.2 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.708 1.88 . . . . 30.059999999999999 114.592 -161.171 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -94.59 -42.92 8.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.008 2.813 . . . . 25.190000000000001 116.659 179.578 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.38 33.14 2.57 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 109.94 -3.3 . . . . 7.4100000000000001 113.563 161.388 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.6 mt -91.22 137.88 26.04 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 114.626 -2.607 . . . . 9.4900000000000002 109.399 -179.071 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -61.9 137.56 68.34 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 124.759 3.639 . . . . 11.42 114.087 178.985 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.42 -26.54 62.96 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 127.126 3.581 . . . . 12.0 118.241 -168.564 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -63.03 -31.41 72.54 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.26 2.224 . . . . 35.549999999999997 113.405 171.552 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -86.55 -25.78 24.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.229 2.212 . . . . 20.52 112.964 -179.909 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -73.54 118.0 15.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.674 -2.516 . . . . 7.1299999999999999 112.228 178.328 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -110.15 118.39 36.26 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.411 1.46 . . . . 36.390000000000001 111.45 166.418 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.3 mt -98.9 124.52 43.88 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.097 -2.186 . . . . 9.5500000000000007 105.097 178.719 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.402 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 51.4 mm -105.21 120.06 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 126.621 1.969 . . . . 13.9 110.9 173.126 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.73 111.32 22.42 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.37 2.51 . . . . 6.8600000000000003 105.277 167.853 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.342 . . 55.37 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.17 2.188 . . . . 11.15 116.189 -167.763 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.81 -23.5 6.47 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 116.33 1.292 . . . . 13.93 116.33 -177.294 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.44 167.8 9.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.938 -2.131 . . . . 23.920000000000002 114.393 -172.832 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -92.42 148.98 21.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.536 -2.12 . . . . 23.23 108.851 176.691 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -102.5 121.5 42.48 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.942 -2.349 . . . . 9.1099999999999994 111.517 177.317 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.276 35.2 mt-10 -103.56 139.99 38.13 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.189 -1.569 . . . . 33.439999999999998 114.494 -166.498 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -29.37 -67.43 0.08 Allowed 'General case' 0 N--CA 1.43 -1.453 1 N-CA-C 122.068 4.099 . . . . 28.370000000000001 122.068 -161.466 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.97 24.99 28.88 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.7 -1.875 . . . . 15.0 115.814 -175.658 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -99.58 146.73 26.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.586 3.168 . . . . 25.5 109.966 166.23 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -85.95 167.26 15.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.857 1.663 . . . . 11.949999999999999 110.24 -162.46 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.19 -12.33 59.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.039 -1.467 . . . . 10.17 107.039 176.729 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -68.47 -50.91 48.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.146 1.378 . . . . 13.59 111.037 175.991 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -56.48 -49.35 74.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.848 3.259 . . . . 11.699999999999999 108.738 176.287 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -71.18 -20.15 62.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.16 1.541 . . . . 12.949999999999999 115.16 -178.851 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.346 32.5 t30 51.05 68.63 0.76 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.308 -2.12 . . . . 25.449999999999999 109.891 -172.335 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.68 138.2 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 100.929 -3.73 . . . . 14.6 100.929 167.215 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -123.77 -173.29 2.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.621 -1.925 . . . . 33.229999999999997 111.014 -176.455 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -75.35 146.65 40.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.045 -2.284 . . . . 25.969999999999999 109.128 -177.369 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 65.12 22.79 12.33 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 128.118 2.567 . . . . 32.609999999999999 112.408 166.901 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 t -101.09 159.78 14.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.985 2.326 . . . . 10.56 112.031 -175.56 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.8 m -111.36 109.34 19.28 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.261 -4.649 . . . . 5.3300000000000001 111.168 -166.088 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.0 mt -84.86 146.86 27.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.177 -1.577 . . . . 11.66 110.445 162.565 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 14.7 m170 -106.9 125.69 51.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.068 -3.52 . . . . 16.300000000000001 107.433 179.841 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.256 47.3 tp -103.93 111.43 23.96 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 123.83 3.014 . . . . 9.9600000000000009 102.927 -172.832 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.3 t -107.34 152.46 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 104.849 -2.278 . . . . 9.7599999999999998 104.849 -176.526 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 104.8 -2.296 . . . . 19.57 104.8 165.809 . . . . . . . . 0 0 . 1 . 117 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 CA--C 1.49 -1.362 0 CA-C-O 125.934 2.778 . . . . 17.170000000000002 114.697 . . . . . . . . . 0 0 . 1 . 117 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.51 119.11 11.77 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 121.361 3.837 . . . . 21.890000000000001 121.361 168.191 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.443 HG13 ' HB2' ' A' ' 15' ' ' LEU 0.417 29.7 pt -111.31 130.08 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 103.652 -2.721 . . . . 10.83 103.652 169.693 . . . . . . . . 3 3 . 1 . 117 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -91.05 121.66 33.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.794 0.807 . . . . 10.609999999999999 111.986 171.92 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -116.75 106.61 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 O-C-N 114.882 -4.887 . . . . 9.1300000000000008 108.871 176.27 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 12' ' ' THR . 76.4 tttt -84.94 112.44 20.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 118.27 2.692 . . . . 20.550000000000001 118.27 169.753 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 m -76.84 134.88 38.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.034 -3.541 . . . . 11.779999999999999 107.398 163.971 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.93 -48.79 33.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.807 -3.058 . . . . 19.309999999999999 112.179 -175.23 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 m -93.48 98.26 11.08 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.186 -2.821 . . . . 23.140000000000001 107.546 161.879 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.57 -126.19 2.16 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 106.268 -2.733 . . . . 19.739999999999998 106.268 -175.973 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -156.77 170.44 22.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.793 -2.592 . . . . 21.93 109.879 173.641 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 41.6 m -79.97 104.61 10.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.024 2.345 . . . . 12.33 114.662 167.233 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.8 pt -90.42 165.6 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 124.321 2.01 . . . . 17.079999999999998 108.379 171.077 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 13.1 m -118.65 125.28 49.38 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.287 3.035 . . . . 16.300000000000001 107.431 179.064 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 3' ' ' ILE . 59.6 mt -116.24 127.26 54.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.135 1.921 . . . . 15.880000000000001 107.658 -178.779 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -89.57 95.05 10.1 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.256 -4.653 . . . . 28.899999999999999 116.628 175.267 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.89 160.68 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.541 -1.974 . . . . 12.050000000000001 110.253 -171.575 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -97.82 147.41 33.0 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 118.968 -2.332 . . . . 18.170000000000002 108.526 163.176 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.3 -13.21 31.14 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 N-CA-C 120.779 3.338 . . . . 8.1600000000000001 120.779 -175.437 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 m -99.91 -7.95 24.62 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.369 -1.457 . . . . 11.130000000000001 113.752 -168.526 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.58 172.63 13.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.79 -2.444 . . . . 18.030000000000001 111.492 178.964 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -92.14 161.83 14.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.322 1.601 . . . . 10.220000000000001 115.322 178.07 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -65.63 -30.13 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.891 3.276 . . . . 12.300000000000001 111.482 -172.654 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -70.23 -22.7 62.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.97 1.708 . . . . 36.509999999999998 113.318 176.481 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -82.64 -18.48 40.95 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.65 2.38 . . . . 25.66 110.902 170.744 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.46 -43.42 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 121.034 1.743 . . . . 8.1199999999999992 107.709 176.966 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -54.86 -24.55 23.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 121.486 3.884 . . . . 15.470000000000001 121.486 173.441 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.271 . . -70.87 -29.44 65.54 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.659 2.783 . . . . 11.449999999999999 114.04 177.738 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -85.94 -35.12 20.67 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.968 -2.957 . . . . 24.98 107.132 -177.192 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 mt -54.29 -52.23 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 129.399 3.08 . . . . 9.4600000000000009 113.138 168.397 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -53.18 -49.29 66.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 131.13 3.772 . . . . 14.76 118.307 167.355 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -53.8 -57.95 9.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 121.85 2.114 . . . . 26.289999999999999 111.142 164.25 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -77.73 -54.9 5.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.957 -2.339 . . . . 30.059999999999999 116.291 -162.071 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -92.15 -35.9 13.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.19 -1.569 . . . . 25.190000000000001 112.82 178.782 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.53 69.86 1.15 Allowed Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 109.524 -1.43 . . . . 7.4100000000000001 109.524 -178.118 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.5 mt -138.12 123.41 12.36 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 102.352 -3.203 . . . . 9.4900000000000002 102.352 171.481 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -72.43 164.11 36.61 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 124.504 3.47 . . . . 11.42 111.807 179.366 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.14 -1.34 9.82 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 C-N-CA 123.042 2.495 . . . . 12.0 114.583 -163.319 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -93.94 -19.99 20.42 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.004 2.522 . . . . 35.549999999999997 109.732 173.757 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -84.62 -33.79 23.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 126.479 3.038 . . . . 20.52 112.727 175.833 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.36 143.44 51.94 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 126.366 2.984 . . . . 7.1299999999999999 117.815 177.983 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -154.13 123.88 6.7 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 114.111 -5.368 . . . . 36.390000000000001 100.41 179.813 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.87 126.84 50.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.6 3.16 . . . . 9.5500000000000007 107.428 -172.827 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.9 mm -118.41 132.98 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.451 -1.685 . . . . 13.9 106.451 -174.362 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -106.11 93.81 4.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 105.222 -2.14 . . . . 6.8600000000000003 105.222 178.151 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.98 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.535 2.334 . . . . 11.15 114.812 -171.813 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.14 -1.44 7.35 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 118.093 -2.88 . . . . 13.93 112.336 -179.578 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -90.65 147.8 23.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 115.807 -2.044 . . . . 23.920000000000002 116.075 170.547 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -98.94 138.74 35.62 Favored 'General case' 0 N--CA 1.43 -1.462 1 CA-C-O 129.351 4.405 . . . . 23.23 105.214 171.094 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.4 mt -88.62 151.96 22.13 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.434 -3.916 . . . . 9.1099999999999994 114.133 171.197 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -116.14 157.49 24.7 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.943 1.402 . . . . 33.439999999999998 110.806 178.098 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -63.51 -50.71 68.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.504 2.779 . . . . 28.370000000000001 118.504 -163.027 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.99 -2.05 90.46 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 118.402 2.121 . . . . 15.0 118.402 -161.127 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -101.8 158.85 15.82 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.521 2.105 . . . . 25.5 107.617 -169.979 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.301 45.0 p -83.74 159.1 21.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.3 -2.75 . . . . 11.949999999999999 111.029 -169.766 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.75 -43.97 69.57 Favored 'General case' 0 N--CA 1.43 -1.473 2 CA-C-O 129.674 4.559 . . . . 10.17 119.353 169.014 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 p -51.64 -42.87 62.36 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.603 -3.185 . . . . 13.59 117.543 166.684 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -56.7 -50.14 73.05 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.598 -3.189 . . . . 11.699999999999999 116.682 -179.942 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -65.43 -29.1 69.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 111.832 -2.44 . . . . 12.949999999999999 117.077 169.604 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 m120 83.49 55.5 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 129.041 3.963 . . . . 25.449999999999999 112.125 174.722 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.334 72.7 mt -84.92 149.17 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.529 -1.982 . . . . 14.6 107.941 177.507 . . . . . . . . 2 2 . 1 . 117 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -147.99 -162.44 1.55 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.702 -3.124 . . . . 33.229999999999997 108.022 -173.172 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -76.42 132.79 39.88 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.734 -1.229 . . . . 25.969999999999999 108.024 -170.268 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 74.42 10.26 4.25 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 131.346 3.858 . . . . 32.609999999999999 110.84 167.095 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -58.97 141.04 54.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.631 1.105 . . . . 10.56 112.799 170.139 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.0 m -112.3 102.52 10.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.72 -2.696 . . . . 5.3300000000000001 103.72 -168.345 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.17 148.86 22.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.845 3.658 . . . . 11.66 105.004 179.223 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -115.54 127.9 55.59 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.377 -1.452 . . . . 16.300000000000001 109.06 176.897 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.2 tp -95.27 116.05 28.24 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.336 2.493 . . . . 9.9600000000000009 107.213 -178.706 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.71 141.36 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 100.295 -3.965 . . . . 9.7599999999999998 100.295 -171.505 . . . . . . . . 1 1 . 1 . 117 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.429 -1.477 0 O-C-N 118.892 -2.38 . . . . 19.57 113.906 174.962 . . . . . . . . 0 0 . 1 . 118 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 108.375 -0.972 . . . . 17.170000000000002 108.375 . . . . . . . . . 0 0 . 1 . 118 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -83.03 115.2 21.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.788 2.435 . . . . 21.890000000000001 110.424 -173.081 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pp -120.27 155.71 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.152 -2.536 . . . . 10.83 104.152 175.959 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -100.85 134.55 43.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.312 -3.367 . . . . 10.609999999999999 106.607 -176.338 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.88 117.69 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 121.111 -0.993 . . . . 9.1300000000000008 108.971 160.87 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -98.66 117.22 32.63 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.748 0.819 . . . . 20.550000000000001 111.694 -178.093 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 m -79.02 127.7 32.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.23 -2.169 . . . . 11.779999999999999 113.135 161.098 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.61 -59.79 2.57 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.207 -2.145 . . . . 19.309999999999999 105.207 -174.968 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.259 8.2 m -87.54 71.43 9.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 112.888 0.699 . . . . 23.140000000000001 112.888 168.346 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.11 -128.48 1.42 Allowed Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 109.627 -1.389 . . . . 19.739999999999998 109.627 -175.342 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.258 20.6 pttm -132.45 179.45 6.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 131.107 3.763 . . . . 21.93 117.157 173.465 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -105.52 119.16 38.4 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.167 -4.083 . . . . 12.33 108.709 178.098 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 pt -104.02 143.02 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 117.314 -3.366 . . . . 17.079999999999998 110.462 173.847 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -96.9 134.33 40.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.626 2.632 . . . . 16.300000000000001 107.129 170.811 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.7 mt -121.86 140.89 51.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.197 -2.274 . . . . 15.880000000000001 111.118 175.474 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -103.95 90.39 3.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.155 2.883 . . . . 28.899999999999999 111.968 177.596 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.56 176.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 C-N-CA 132.07 4.148 . . . . 12.050000000000001 111.504 -170.204 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.259 37.5 tt0 -134.34 144.06 49.54 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 117.703 -1.142 . . . . 18.170000000000002 112.862 167.551 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -65.69 -16.92 55.37 Favored 'Trans proline' 0 C--N 1.3 -2.025 1 C-N-CA 126.876 5.051 . . . . 8.1600000000000001 115.184 -169.912 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -66.83 -20.92 66.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.112 3.765 . . . . 11.130000000000001 117.245 166.165 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -73.04 159.65 33.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.141 1.924 . . . . 18.030000000000001 113.029 179.878 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.6 p -86.9 154.16 21.06 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.552 1.541 . . . . 10.220000000000001 109.225 166.062 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 mm -56.58 -51.15 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 125.016 1.448 . . . . 12.300000000000001 108.597 167.334 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.279 37.8 tp10 -37.25 -35.54 0.11 Allowed 'General case' 0 N--CA 1.43 -1.436 1 N-CA-C 123.37 4.582 . . . . 36.509999999999998 123.37 166.823 . . . . . . . . 3 2 . 1 . 118 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -74.84 -33.72 62.18 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 111.733 -6.854 . . . . 25.66 118.535 167.756 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -67.86 -45.22 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 128.36 2.664 . . . . 8.1199999999999992 106.623 175.678 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -55.47 -40.99 72.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.898 3.237 . . . . 15.470000000000001 111.107 176.358 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.33 -17.39 60.84 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 111.586 -6.946 . . . . 11.449999999999999 120.652 176.49 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -75.36 -34.54 61.17 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.098 -2.876 . . . . 24.98 112.708 173.198 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.3 mt -63.82 -43.23 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 119.601 -1.937 . . . . 9.4600000000000009 113.736 173.004 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -50.93 -51.05 56.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.805 2.566 . . . . 14.76 116.527 167.399 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.63 -42.7 70.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.619 1.967 . . . . 26.289999999999999 112.513 -169.281 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -76.32 -47.44 23.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.386 -1.768 . . . . 30.059999999999999 114.717 -178.682 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -102.78 -53.64 2.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 116.12 -1.895 . . . . 25.190000000000001 107.913 -169.267 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.91 -31.69 1.33 Allowed Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 122.549 2.431 . . . . 7.4100000000000001 112.08 -175.962 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 19.8 mt -61.32 115.9 16.96 Favored Pre-proline 0 N--CA 1.431 -1.403 1 O-C-N 131.579 4.929 . . . . 9.4900000000000002 117.089 -164.287 . . . . . . . . 3 2 . 1 . 118 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -82.16 148.89 15.19 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 CA-C-N 129.263 4.344 . . . . 11.42 108.448 -169.825 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.5 -12.61 25.17 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 124.652 3.568 . . . . 12.0 119.642 -170.094 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -79.84 -33.51 40.14 Favored 'General case' 0 N--CA 1.43 -1.459 1 CA-C-O 131.789 5.566 . . . . 35.549999999999997 110.778 179.123 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -76.94 -20.41 56.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 110.019 -3.264 . . . . 20.52 112.671 -176.92 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -76.34 149.34 37.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.53 2.586 . . . . 7.1299999999999999 108.268 -178.795 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -145.29 95.89 2.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.739 -2.476 . . . . 36.390000000000001 111.741 161.549 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.2 mt -84.37 121.41 27.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.035 -0.984 . . . . 9.5500000000000007 113.296 -175.753 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.1 mm -107.2 136.47 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 122.886 1.327 . . . . 13.9 110.239 171.284 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -116.3 114.84 24.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.562 -2.014 . . . . 6.8600000000000003 105.562 167.674 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.82 -112.28 0.5 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.855 1.262 . . . . 11.15 113.431 -164.405 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.5 -4.49 43.3 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 126.211 2.195 . . . . 13.93 112.992 -174.398 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -93.89 121.64 35.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.076 2.551 . . . . 23.920000000000002 105.544 -175.912 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -83.81 102.45 12.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.67 1.988 . . . . 23.23 107.335 169.238 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -51.81 132.57 31.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.104 3.002 . . . . 9.1099999999999994 119.104 -173.511 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -109.23 139.89 43.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.618 2.628 . . . . 33.439999999999998 111.325 179.943 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -64.24 -43.23 95.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 109.893 -3.321 . . . . 28.370000000000001 116.065 -148.322 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.52 -6.15 88.86 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 127.652 2.549 . . . . 15.0 110.752 -171.787 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -86.9 158.45 19.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.405 3.002 . . . . 25.5 109.78 -177.464 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.9 p -89.81 158.65 17.39 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.627 -3.171 . . . . 11.949999999999999 110.45 179.658 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.5 mt -59.16 -45.0 92.13 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.797 -1.547 . . . . 10.17 113.951 175.056 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.377 71.5 p -43.57 -43.55 5.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.348 2.659 . . . . 13.59 114.509 165.7 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -63.25 -40.91 98.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.53 1.633 . . . . 11.699999999999999 115.198 179.829 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -82.58 -18.79 40.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.842 2.057 . . . . 12.949999999999999 110.564 -176.673 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.382 12.5 m120 80.8 32.41 0.15 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.145 2.178 . . . . 25.449999999999999 111.513 -179.09 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.4 mt -91.57 106.18 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 128.072 2.549 . . . . 14.6 109.165 179.177 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -103.18 -173.58 2.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.744 3.217 . . . . 33.229999999999997 110.755 -169.354 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -68.22 158.33 33.52 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.072 2.669 . . . . 25.969999999999999 114.248 178.022 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 41.1 mt-10 72.75 5.02 5.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.438 1.895 . . . . 32.609999999999999 108.528 169.004 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -70.01 149.69 47.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.659 -1.901 . . . . 10.56 115.854 169.507 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.6 m -120.08 121.7 39.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.124 2.392 . . . . 5.3300000000000001 105.265 -168.942 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.54 128.04 43.1 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.297 -4.627 . . . . 11.66 109.052 172.978 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.326 35.1 m80 -97.7 132.78 43.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.644 2.474 . . . . 16.300000000000001 113.699 175.465 . . . . . . . . 2 2 . 1 . 118 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tt -108.45 112.63 25.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.21 1.481 . . . . 9.9600000000000009 109.482 -169.558 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 t -92.45 129.28 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 116.401 -1.762 . . . . 9.7599999999999998 110.491 164.46 . . . . . . . . 1 1 . 1 . 118 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.43 -1.43 0 C-N-CA 127.527 2.331 . . . . 19.57 106.821 177.063 . . . . . . . . 0 0 . 1 . 119 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 114.839 1.422 . . . . 17.170000000000002 114.839 . . . . . . . . . 0 0 . 1 . 119 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.53 135.32 39.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.588 -3.82 . . . . 21.890000000000001 112.833 168.352 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.2 pt -127.63 160.0 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.43 3.014 . . . . 10.83 106.397 159.956 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -103.07 148.48 25.67 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 109.355 -3.566 . . . . 10.609999999999999 112.67 -178.473 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -125.03 119.58 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 121.086 1.766 . . . . 9.1300000000000008 108.616 167.465 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -95.43 85.67 4.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 125.261 1.601 . . . . 20.550000000000001 114.819 -176.977 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.5 m -83.32 141.47 31.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.45 -0.945 . . . . 11.779999999999999 108.45 171.962 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.1 mt -86.2 -54.1 4.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.965 1.306 . . . . 19.309999999999999 112.56 179.706 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -89.43 63.77 6.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.746 2.213 . . . . 23.140000000000001 107.054 -176.385 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.74 -135.15 3.71 Favored Glycine 0 N--CA 1.429 -1.77 1 CA-C-N 107.994 -4.184 . . . . 19.739999999999998 103.774 -174.035 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -143.45 174.2 10.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.363 2.357 . . . . 21.93 117.363 -178.148 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -92.31 117.65 30.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.952 2.575 . . . . 12.33 117.952 176.884 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 pt -102.95 156.32 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 128.824 2.85 . . . . 17.079999999999998 116.809 -172.536 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -127.72 104.02 7.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.939 -1.101 . . . . 16.300000000000001 110.89 -168.746 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.1 mt -104.02 138.11 41.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.241 1.817 . . . . 15.880000000000001 111.962 -165.645 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -108.0 86.99 2.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 128.122 3.82 . . . . 28.899999999999999 110.804 -170.247 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -101.73 172.98 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 111.971 -2.377 . . . . 12.050000000000001 114.437 -175.71 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.86 146.87 63.12 Favored Pre-proline 0 N--CA 1.431 -1.416 0 O-C-N 125.56 1.788 . . . . 18.170000000000002 108.452 171.339 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.3 -4.56 13.17 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 115.955 -1.769 . . . . 8.1600000000000001 116.406 -150.097 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 m -90.91 6.22 45.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.732 2.06 . . . . 11.130000000000001 111.172 172.598 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.91 154.68 20.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.5 2.778 . . . . 18.030000000000001 118.5 -176.252 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -91.45 163.05 14.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.062 -2.899 . . . . 10.220000000000001 111.669 -164.338 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mm -64.51 -34.89 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 117.342 -1.313 . . . . 12.300000000000001 108.315 -178.188 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -51.0 -49.32 60.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 114.294 1.22 . . . . 36.509999999999998 114.294 169.646 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.08 -25.07 62.46 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.915 2.931 . . . . 25.66 118.915 176.393 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.7 t -62.99 -44.79 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 116.249 -1.834 . . . . 8.1199999999999992 109.098 167.637 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -52.35 -48.97 65.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.823 3.638 . . . . 15.470000000000001 120.823 171.504 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.09 67.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.937 3.695 . . . . 11.449999999999999 114.975 170.594 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.98 -43.72 98.01 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.748 1.758 . . . . 24.98 115.748 170.455 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.6 -54.29 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.774 -1.829 . . . . 9.4600000000000009 112.931 174.505 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.41 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 56.2 tt0 -41.7 -46.03 3.64 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.42 2.288 . . . . 14.76 113.045 172.573 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -76.03 -46.59 28.57 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.049 1.74 . . . . 26.289999999999999 111.586 -178.118 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -68.2 -62.43 1.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.321 -1.487 . . . . 30.059999999999999 113.852 -172.65 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -92.53 -49.57 6.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.573 -0.899 . . . . 25.190000000000001 108.573 -173.642 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 117.85 28.24 2.32 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 122.568 1.093 . . . . 7.4100000000000001 112.672 177.825 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mt -87.18 119.75 71.07 Favored Pre-proline 0 N--CA 1.431 -1.413 0 O-C-N 117.985 -3.068 . . . . 9.4900000000000002 104.075 -171.757 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -64.77 133.63 37.2 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 N-CA-C 121.633 3.666 . . . . 11.42 121.633 -176.068 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -78.9 -10.8 15.34 Favored 'Trans proline' 0 N--CA 1.433 -2.05 1 C-N-CA 128.698 6.266 . . . . 12.0 113.947 -159.039 . . . . . . . . 3 3 . 1 . 119 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -76.87 -36.07 57.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.01 1.732 . . . . 35.549999999999997 113.175 168.808 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -74.55 -27.45 60.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.533 3.933 . . . . 20.52 112.63 -178.982 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 76.7 mt-30 -74.49 119.33 18.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.338 -2.101 . . . . 7.1299999999999999 110.466 172.968 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.325 40.5 ttm180 -114.65 108.8 17.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.048 2.539 . . . . 36.390000000000001 104.857 159.681 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.19 130.55 35.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.321 3.452 . . . . 9.5500000000000007 120.321 166.876 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.9 mm -117.83 131.61 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.018 2.127 . . . . 13.9 111.168 -174.538 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -128.17 123.63 34.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.639 -3.788 . . . . 6.8600000000000003 106.314 170.965 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.19 -99.65 0.1 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.705 -1.588 . . . . 11.15 112.727 -163.198 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.17 22.3 2.76 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 104.359 -3.496 . . . . 13.93 104.359 -176.736 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -107.47 135.27 49.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.403 3.481 . . . . 23.920000000000002 101.952 -177.282 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -97.98 118.6 34.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.463 -2.648 . . . . 23.23 109.623 177.297 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.3 mt -88.67 135.81 33.31 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.215 -2.803 . . . . 9.1099999999999994 109.246 -160.719 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -80.11 159.08 26.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.124 2.569 . . . . 33.439999999999998 111.924 179.286 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -75.75 -47.7 24.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 124.982 1.426 . . . . 28.370000000000001 111.973 -172.936 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.29 29.62 11.51 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 124.639 1.212 . . . . 15.0 113.046 -166.396 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 58' ' ' ASP . 77.7 mtp180 -117.47 157.06 26.91 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 126.186 1.794 . . . . 25.5 108.818 177.727 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -96.2 162.38 13.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.096 2.628 . . . . 11.949999999999999 118.096 -169.705 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.6 mt -63.09 -33.4 75.36 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.919 -2.363 . . . . 10.17 113.75 170.367 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 p -66.61 -39.52 88.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.51 -3.869 . . . . 13.59 114.403 171.148 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CG ' HH21 ' A' ' 54' ' ' ARG . 66.2 t0 -64.34 -54.53 31.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.246 2.618 . . . . 11.699999999999999 107.671 179.801 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -73.09 -15.32 61.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 115.313 -2.555 . . . . 12.949999999999999 108.887 -178.933 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.271 35.1 m120 85.91 37.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 127.255 3.407 . . . . 25.449999999999999 113.368 176.251 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.7 mt -95.78 79.85 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.478 1 O-C-N 116.243 -4.036 . . . . 14.6 110.413 -172.166 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -59.33 174.17 0.43 Allowed 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.435 2.754 . . . . 33.229999999999997 118.435 172.719 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -62.57 141.02 58.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.111 1.522 . . . . 25.969999999999999 115.111 174.733 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 22.3 tt0 67.88 27.02 7.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.613 3.165 . . . . 32.609999999999999 114.672 -176.196 . . . . . . . . 2 2 . 1 . 119 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -91.49 139.79 30.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.899 -3.625 . . . . 10.56 112.014 174.634 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -113.78 118.94 35.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.309 -1.357 . . . . 5.3300000000000001 111.883 -172.099 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -97.35 141.48 30.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 103.87 -2.641 . . . . 11.66 103.87 -176.109 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -108.49 135.1 50.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.254 -2.499 . . . . 16.300000000000001 104.254 -176.36 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.91 108.52 20.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.64 -1.985 . . . . 9.9600000000000009 105.64 -172.013 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.9 t -76.95 130.43 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 125.3 1.625 . . . . 9.7599999999999998 113.985 162.633 . . . . . . . . 1 1 . 1 . 119 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 N--CA 1.429 -1.479 0 CA-C-O 125.325 2.488 . . . . 19.57 105.137 174.652 . . . . . . . . 0 0 . 1 . 120 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptt? . . . . . 0 CA--C 1.489 -1.367 0 CA-C-O 123.587 1.66 . . . . 17.170000000000002 110.316 . . . . . . . . . 0 0 . 1 . 120 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -96.83 140.33 31.55 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.413 -2.055 . . . . 21.890000000000001 106.872 -179.195 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 pt -136.79 157.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 124.007 0.923 . . . . 10.83 108.793 177.467 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -112.61 133.94 54.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.55 -2.759 . . . . 10.609999999999999 103.55 -178.498 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.16 121.23 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 1 O-C-N 115.359 -4.588 . . . . 9.1300000000000008 106.859 165.713 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -105.66 115.9 31.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.084 2.115 . . . . 20.550000000000001 107.856 -167.569 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.486 HG23 HD22 ' A' ' 69' ' ' LEU 0.335 0.2 OUTLIER -101.27 126.92 48.06 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.738 -1.949 . . . . 11.779999999999999 105.738 -168.471 . . . . . . . . 4 4 . 1 . 120 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.72 -49.65 8.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.157 -1.59 . . . . 19.309999999999999 107.468 -178.142 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 m -95.03 75.52 3.5 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.931 2.3 . . . . 23.140000000000001 112.71 172.556 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.47 -111.3 0.46 Allowed Glycine 0 N--CA 1.431 -1.695 0 O-C-N 119.394 -2.066 . . . . 19.739999999999998 110.329 -166.721 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 9.3 pttm -175.32 177.97 1.76 Allowed 'General case' 0 N--CA 1.43 -1.459 1 CA-C-N 124.497 4.148 . . . . 21.93 106.122 178.932 . . . . . . . . 3 3 . 1 . 120 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -97.23 122.33 40.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.402 -2.061 . . . . 12.33 106.67 -176.771 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 pt -106.63 148.66 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 122.94 1.352 . . . . 17.079999999999998 108.329 -178.869 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.9 m -111.3 112.44 24.21 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.916 -2.253 . . . . 16.300000000000001 104.916 -175.357 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -111.33 142.7 43.21 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.501 2.096 . . . . 15.880000000000001 112.478 179.924 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -97.78 117.39 31.98 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.563 -3.211 . . . . 28.899999999999999 109.711 172.977 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.46 153.66 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.613 -3.179 . . . . 12.050000000000001 108.146 -171.797 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -105.54 137.97 19.45 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 112.491 -3.623 . . . . 18.170000000000002 107.281 173.428 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -75.25 -9.88 20.59 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 123.67 2.346 . . . . 8.1600000000000001 113.045 -158.588 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.8 m -84.1 -20.44 32.57 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 126.935 2.647 . . . . 11.130000000000001 113.947 -176.418 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -85.12 159.67 20.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.184 -2.198 . . . . 18.030000000000001 109.053 -169.284 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -78.86 163.58 25.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.18 -2.825 . . . . 10.220000000000001 109.935 -167.385 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.6 mm -64.46 -38.45 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.613 -1.929 . . . . 12.300000000000001 109.875 174.667 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -44.77 -36.57 3.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.017 2.927 . . . . 36.509999999999998 115.012 164.405 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -71.97 -44.56 63.36 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.971 1.708 . . . . 25.66 110.14 173.138 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 t -55.92 -43.24 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.614 2.366 . . . . 8.1199999999999992 112.497 173.055 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -62.98 -26.22 68.74 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.561 -3.212 . . . . 15.470000000000001 113.902 173.085 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.02 -36.04 59.29 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.983 -2.323 . . . . 11.449999999999999 107.605 177.517 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -73.26 -36.67 66.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.209 -1.557 . . . . 24.98 114.097 -178.241 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 mt -65.55 -34.62 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.713 1.605 . . . . 9.4600000000000009 113.569 168.237 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -61.59 -52.22 65.32 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.227 1.489 . . . . 14.76 112.741 170.859 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.74 -46.67 88.42 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.367 2.267 . . . . 26.289999999999999 112.102 -179.652 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -65.58 -59.29 4.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.15 1.537 . . . . 30.059999999999999 115.15 178.309 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS 0.378 65.9 mm-40 -87.98 -43.69 11.56 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.203 2.201 . . . . 25.190000000000001 111.84 -165.927 . . . . . . . . 3 3 . 1 . 120 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.78 29.64 5.49 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-O 117.562 -1.688 . . . . 7.4100000000000001 109.878 -174.775 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.2 mt -104.49 99.83 19.75 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 130.189 3.396 . . . . 9.4900000000000002 109.203 175.886 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -58.77 160.62 17.26 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 115.628 -2.88 . . . . 11.42 115.628 173.406 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -102.15 12.1 0.39 Allowed 'Trans proline' 0 N--CA 1.434 -1.997 0 N-CA-C 121.517 3.622 . . . . 12.0 121.517 -163.811 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.11 -13.55 55.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 125.647 1.842 . . . . 35.549999999999997 114.669 151.044 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -90.86 -3.05 57.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.993 -2.317 . . . . 20.52 107.744 178.273 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -95.34 131.68 41.19 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.589 -2.569 . . . . 7.1299999999999999 113.179 -175.995 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -119.48 103.38 9.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.459 -2.422 . . . . 36.390000000000001 104.459 166.2 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.72 109.43 21.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.915 -2.99 . . . . 9.5500000000000007 107.057 -165.764 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.08 135.56 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 123.714 1.721 . . . . 13.9 107.581 -159.011 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -124.11 115.3 20.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.197 -2.814 . . . . 6.8600000000000003 103.846 176.816 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.282 . . 63.2 -103.14 0.11 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.414 1.886 . . . . 11.15 113.305 -169.17 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.69 40.84 1.54 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 118.406 -2.684 . . . . 13.93 113.016 168.704 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -147.37 137.46 23.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.542 2.337 . . . . 23.920000000000002 106.153 -178.103 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -76.44 158.51 31.27 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.798 -3.689 . . . . 23.23 111.377 -171.498 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 mt -97.07 147.36 24.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 113.346 0.869 . . . . 9.1099999999999994 113.346 165.224 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -95.38 167.92 11.04 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 123.614 0.571 . . . . 33.439999999999998 111.72 177.421 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.09 -46.21 13.07 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.054 -2.904 . . . . 28.370000000000001 114.538 -163.284 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.23 27.57 13.06 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.121 -2.862 . . . . 15.0 112.291 -176.33 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -106.43 166.63 10.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 115.621 -2.133 . . . . 25.5 111.486 173.097 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -104.1 176.87 5.01 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 121.763 2.074 . . . . 11.949999999999999 111.575 -175.288 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.38 -40.52 73.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.412 2.529 . . . . 10.17 106.511 173.251 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.3 p -78.79 -8.11 58.46 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.065 -2.272 . . . . 13.59 111.245 -171.966 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -75.26 -51.17 13.91 Favored 'General case' 0 N--CA 1.431 -1.406 2 O-C-N 115.315 -4.616 . . . . 11.699999999999999 104.477 174.422 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -82.22 -10.26 59.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.792 -2.442 . . . . 12.949999999999999 113.574 179.435 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 71.51 58.96 0.17 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.132 1.373 . . . . 25.449999999999999 109.962 -177.656 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mt -80.71 111.44 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.184 2.594 . . . . 14.6 110.567 159.925 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -97.53 175.04 6.36 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.397 -2.183 . . . . 33.229999999999997 110.17 174.401 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -58.79 143.07 48.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.702 3.201 . . . . 25.969999999999999 106.811 -178.679 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.317 3.2 mp0 60.96 20.2 10.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.829 2.159 . . . . 32.609999999999999 116.829 -178.871 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 m -72.37 147.23 46.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.242 2.312 . . . . 10.56 117.242 167.131 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.4 m -95.11 126.56 40.52 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.086 2.155 . . . . 5.3300000000000001 109.071 165.521 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.59 152.26 20.63 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.141 -2.17 . . . . 11.66 105.141 164.623 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -105.78 128.43 53.71 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.08 -5.388 . . . . 16.300000000000001 108.675 179.164 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.486 HD22 HG23 ' A' ' 7' ' ' THR . 16.9 tp -97.05 131.66 43.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 116.074 -2.25 . . . . 9.9600000000000009 108.717 179.53 . . . . . . . . 2 2 . 1 . 120 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.5 t -107.84 129.38 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.789 -3.069 . . . . 9.7599999999999998 107.67 172.288 . . . . . . . . 1 1 . 1 . 120 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.43 -1.447 0 CA-C-N 114.514 -1.221 . . . . 19.57 110.261 176.239 . . . . . . . . 0 0 . 1 . 121 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.349 0 CA-C-O 117.293 -1.336 . . . . 17.170000000000002 112.388 . . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -96.88 137.49 35.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.946 2.654 . . . . 21.890000000000001 111.169 176.956 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.29 172.02 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 126.919 2.088 . . . . 10.83 112.711 176.952 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -123.66 115.7 21.87 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.614 -2.735 . . . . 10.609999999999999 103.614 -167.89 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.72 115.35 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 102.623 -3.103 . . . . 9.1300000000000008 102.623 170.445 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -86.67 131.21 34.21 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.235 -3.416 . . . . 20.550000000000001 112.183 167.397 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -87.18 162.39 17.52 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.746 1.279 . . . . 11.779999999999999 114.231 172.104 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.9 tp -69.13 -28.42 66.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.419 2.687 . . . . 19.309999999999999 111.599 -174.935 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 53.3 m -59.1 -47.54 84.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.818 -2.515 . . . . 23.140000000000001 114.961 167.39 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.44 49.06 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 105.691 -2.964 . . . . 19.739999999999998 105.691 167.269 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.307 41.7 mttt -138.69 145.33 40.23 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.621 -5.047 . . . . 21.93 104.266 178.592 . . . . . . . . 3 2 . 1 . 121 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -99.85 116.01 30.93 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.494 -2.594 . . . . 12.33 106.394 168.722 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 pt -106.27 133.28 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 105.15 -2.166 . . . . 17.079999999999998 105.15 176.337 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 m -93.78 117.81 30.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 126.869 2.605 . . . . 16.300000000000001 110.082 -177.127 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.274 95.8 mt -119.15 141.76 48.54 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.978 -2.23 . . . . 15.880000000000001 104.978 -177.296 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -104.38 111.48 24.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.318 3.047 . . . . 28.899999999999999 112.955 172.346 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.5 169.15 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 124.719 2.199 . . . . 12.050000000000001 111.805 -178.132 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -92.13 154.88 43.25 Favored Pre-proline 0 N--CA 1.43 -1.446 0 O-C-N 117.283 -3.385 . . . . 18.170000000000002 107.163 167.308 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.01 -3.89 12.98 Favored 'Trans proline' 0 C--N 1.3 -1.99 1 CA-C-N 129.355 4.377 . . . . 8.1600000000000001 111.974 175.019 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -76.2 -22.19 55.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.311 -2.743 . . . . 11.130000000000001 114.325 169.614 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -67.76 151.25 47.52 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.618 2.152 . . . . 18.030000000000001 111.054 173.167 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.4 p -99.43 -170.93 1.98 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.469 2.557 . . . . 10.220000000000001 110.781 -173.86 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.7 mm -86.92 -17.43 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 O-C-N 115.975 -4.203 . . . . 12.300000000000001 108.662 -173.171 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.57 -26.56 55.22 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.613 -4.429 . . . . 36.509999999999998 110.501 174.142 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -73.06 -33.89 65.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.334 -0.947 . . . . 25.66 108.719 176.455 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.353 65.6 t -65.53 -47.43 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 124.622 1.169 . . . . 8.1199999999999992 113.695 178.034 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -55.36 -43.19 74.84 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.675 1.99 . . . . 15.470000000000001 113.869 171.944 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.5 90.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 120.732 3.604 . . . . 11.449999999999999 120.732 168.193 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -70.26 -38.87 75.19 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.589 -1.944 . . . . 24.98 111.701 174.968 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -66.66 -35.5 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 127.277 2.231 . . . . 9.4600000000000009 108.999 177.429 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -64.75 -39.4 93.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.725 -3.109 . . . . 14.76 107.834 174.929 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -72.85 -60.19 2.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.179 2.895 . . . . 26.289999999999999 111.094 -173.866 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -61.8 -49.72 75.21 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 120.677 3.584 . . . . 30.059999999999999 120.677 177.176 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -108.8 -18.29 13.73 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.208 -1.557 . . . . 25.190000000000001 111.9 -174.935 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.89 27.25 29.41 Favored Glycine 0 N--CA 1.429 -1.772 1 O-C-N 114.919 -4.863 . . . . 7.4100000000000001 113.657 170.972 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -91.65 133.56 30.78 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 118.52 -2.753 . . . . 9.4900000000000002 111.439 175.499 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.54 153.87 65.05 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 O-C-N 115.784 -2.798 . . . . 11.42 117.741 -179.292 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.31 -29.0 8.19 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 CA-C-N 122.863 2.058 . . . . 12.0 116.206 -166.477 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.99 -14.72 60.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.178 -2.826 . . . . 35.549999999999997 107.992 -169.733 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -109.55 3.2 20.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.385 -3.322 . . . . 20.52 111.828 -172.15 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -87.59 134.96 33.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.71 3.604 . . . . 7.1299999999999999 105.172 168.607 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -129.55 125.3 35.94 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 101.719 -3.438 . . . . 36.390000000000001 101.719 178.651 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.2 mt -126.1 132.91 51.79 Favored 'General case' 0 N--CA 1.43 -1.427 2 O-C-N 115.597 -4.439 . . . . 9.5500000000000007 99.45 -167.995 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 mm -119.31 134.75 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 109.74 -3.391 . . . . 13.9 111.824 -178.042 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -128.77 124.02 34.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 117.077 -1.44 . . . . 6.8600000000000003 112.244 163.18 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.61 -101.64 0.11 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.319 2.248 . . . . 11.15 106.773 -168.693 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.05 17.46 5.41 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 119.961 -1.712 . . . . 13.93 115.781 170.829 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -103.92 141.19 36.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.138 -1.801 . . . . 23.920000000000002 106.138 -172.906 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -83.18 124.29 30.38 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.605 2.362 . . . . 23.23 114.0 166.684 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.19 111.56 23.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.236 3.05 . . . . 9.1099999999999994 119.236 -174.647 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.83 140.17 58.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 120.519 3.526 . . . . 33.439999999999998 120.519 -178.714 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -49.24 -51.33 33.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.623 3.169 . . . . 28.370000000000001 118.289 -163.83 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.37 18.5 56.83 Favored Glycine 0 N--CA 1.43 -1.706 0 O-C-N 117.844 -3.035 . . . . 15.0 116.024 -178.154 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -97.62 148.02 23.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 122.83 3.315 . . . . 25.5 108.015 -177.196 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -78.56 151.15 32.59 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 115.785 -4.322 . . . . 11.949999999999999 110.32 179.908 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.0 mt -65.62 -30.81 71.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.571 -2.581 . . . . 10.17 112.809 179.38 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -59.42 -44.37 92.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.321 3.448 . . . . 13.59 112.083 170.952 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.72 -40.99 89.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.304 -3.372 . . . . 11.699999999999999 117.378 172.841 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -77.37 -21.24 53.56 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.534 -1.979 . . . . 12.949999999999999 111.505 175.496 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.5 t30 56.71 53.15 8.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.929 3.292 . . . . 25.449999999999999 117.009 -175.043 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.1 mm -64.38 121.8 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 118.671 -2.518 . . . . 14.6 112.266 164.387 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -96.67 167.5 11.08 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.632 2.634 . . . . 33.229999999999997 111.451 179.221 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -72.28 145.52 47.82 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 112.796 -6.19 . . . . 25.969999999999999 120.52 174.787 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 63.17 19.95 11.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.0 2.52 . . . . 32.609999999999999 115.688 -175.287 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.49 143.3 27.28 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.071 -2.786 . . . . 10.56 118.446 170.041 . . . . . . . . 2 2 . 1 . 121 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.2 m -92.05 117.01 29.43 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.402 3.112 . . . . 5.3300000000000001 119.402 -179.756 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.83 143.51 26.27 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.554 1.524 . . . . 11.66 108.126 171.743 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -93.53 134.85 35.38 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.841 -2.412 . . . . 16.300000000000001 109.858 167.785 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 tt -106.24 132.5 52.22 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.399 -2.815 . . . . 9.9600000000000009 103.399 166.357 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -120.34 174.18 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 129.731 3.212 . . . . 9.7599999999999998 106.044 160.351 . . . . . . . . 1 1 . 1 . 121 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 N--CA 1.43 -1.467 1 O-C-N 114.245 -5.284 . . . . 19.57 111.881 -173.265 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.419 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 13.4 ptt? . . . . . 0 CA--C 1.489 -1.368 0 CA-C-O 121.471 0.653 . . . . 17.170000000000002 110.859 . . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -106.1 129.83 54.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.576 -1.647 . . . . 21.890000000000001 115.36 175.319 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -123.46 169.39 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.621 -2.55 . . . . 10.83 105.475 170.784 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.68 140.81 52.62 Favored 'General case' 0 N--CA 1.429 -1.485 1 N-CA-C 99.994 -4.076 . . . . 10.609999999999999 99.994 -169.403 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 t -129.99 126.27 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 105.622 -1.992 . . . . 9.1300000000000008 105.622 175.227 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -102.35 125.82 49.17 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 124.9 1.375 . . . . 20.550000000000001 108.232 177.816 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -89.63 -166.26 1.55 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.521 -2.612 . . . . 11.779999999999999 112.656 -162.079 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.5 tp -73.44 -60.23 2.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.143 2.247 . . . . 19.309999999999999 112.449 -176.919 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 m -48.45 -49.6 34.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 110.218 -3.174 . . . . 23.140000000000001 110.08 174.332 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.36 64.15 0.16 Allowed Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 117.893 -1.504 . . . . 19.739999999999998 113.187 176.842 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 40.4 mtpt -123.23 137.11 54.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.739 -1.578 . . . . 21.93 106.739 176.691 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -100.38 103.88 15.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.969 2.168 . . . . 12.33 111.737 176.394 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.438 16.9 pt -93.1 147.24 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 124.204 1.954 . . . . 17.079999999999998 109.806 -176.314 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 m -101.0 123.03 44.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.134 -2.229 . . . . 16.300000000000001 106.115 175.846 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -116.21 152.71 33.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.632 2.373 . . . . 15.880000000000001 111.582 176.261 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -111.76 114.03 26.76 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.189 -2.278 . . . . 28.899999999999999 108.278 177.145 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.62 173.77 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 113.417 -1.719 . . . . 12.050000000000001 110.521 -178.867 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -123.07 142.16 37.57 Favored Pre-proline 0 N--CA 1.43 -1.431 0 N-CA-C 107.889 -1.152 . . . . 18.170000000000002 107.889 175.481 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -68.84 -9.12 25.35 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 O-C-N 114.434 -3.508 . . . . 8.1600000000000001 116.228 -169.011 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -83.82 -19.86 34.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.649 2.022 . . . . 11.130000000000001 110.362 179.184 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -69.86 144.83 52.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.265 2.226 . . . . 18.030000000000001 112.392 172.871 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 27.1 p -82.75 172.04 13.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.597 -3.189 . . . . 10.220000000000001 115.768 -175.402 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mm -61.17 -41.97 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 117.653 2.464 . . . . 12.300000000000001 117.653 173.657 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -31.57 -61.4 0.22 Allowed 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.586 -3.196 . . . . 36.509999999999998 118.486 152.578 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -50.94 -39.58 55.2 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.698 2.11 . . . . 25.66 116.698 171.287 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 t -68.57 -43.83 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 118.516 -2.615 . . . . 8.1199999999999992 113.471 178.016 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.18 -34.67 76.87 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.479 2.029 . . . . 15.470000000000001 116.479 168.473 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.31 -32.86 63.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.079 -2.263 . . . . 11.449999999999999 110.767 178.017 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.253 66.6 mttt -64.65 -29.52 70.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.841 -2.412 . . . . 24.98 115.644 168.166 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.8 mt -67.97 -36.42 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.647 1.567 . . . . 9.4600000000000009 113.248 170.348 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -61.15 -42.16 98.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.448 -2.032 . . . . 14.76 113.728 169.027 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.63 -53.06 17.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.082 1.896 . . . . 26.289999999999999 107.702 -174.802 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -56.8 -62.8 1.49 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 116.164 -4.085 . . . . 30.059999999999999 114.35 173.573 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 10.5 mm-40 -92.33 -41.88 10.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 119.236 3.05 . . . . 25.190000000000001 119.236 -173.669 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.58 46.65 2.1 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 116.536 -2.258 . . . . 7.4100000000000001 112.706 -171.894 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.4 mt -109.99 116.37 53.73 Favored Pre-proline 0 N--CA 1.429 -1.479 0 C-N-CA 130.098 3.359 . . . . 9.4900000000000002 110.892 173.698 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.02 149.29 92.01 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 127.279 3.635 . . . . 11.42 115.223 -178.876 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -76.36 -24.81 10.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 120.336 1.156 . . . . 12.0 114.475 -164.114 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.28 -22.42 52.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.336 1.454 . . . . 35.549999999999997 110.618 -169.562 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.33 3.78 51.03 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 121.771 2.078 . . . . 20.52 108.94 176.184 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -86.38 135.13 33.62 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.949 -2.969 . . . . 7.1299999999999999 111.289 172.755 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.2 ttm105 -127.5 125.43 40.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.622 -1.924 . . . . 36.390000000000001 110.51 153.51 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.88 135.0 33.59 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 124.909 2.29 . . . . 9.5500000000000007 113.678 178.654 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.31 146.92 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 103.424 -2.806 . . . . 13.9 103.424 -178.954 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -122.47 125.91 46.79 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 114.595 -5.065 . . . . 6.8600000000000003 101.499 157.47 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.65 -94.46 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.487 1.613 . . . . 11.15 112.895 -178.186 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.22 22.42 1.4 Allowed Glycine 0 N--CA 1.43 -1.751 0 O-C-N 117.43 -3.294 . . . . 13.93 113.723 166.719 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -87.18 120.75 28.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.615 2.766 . . . . 23.920000000000002 112.123 167.32 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -78.44 129.29 34.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.23 -3.419 . . . . 23.23 113.543 176.98 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.1 mt -108.3 124.86 50.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.62 -2.55 . . . . 9.1099999999999994 105.494 -154.524 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -93.25 138.55 31.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.291 -2.756 . . . . 33.439999999999998 111.971 -175.187 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -43.73 -43.74 6.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.919 3.287 . . . . 28.370000000000001 119.67 -179.099 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.56 18.0 45.29 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.49 -2.631 . . . . 15.0 113.932 -169.855 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -95.38 149.22 21.61 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.288 1.518 . . . . 25.5 110.128 163.519 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 p -71.52 146.49 48.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 111.958 -2.383 . . . . 11.949999999999999 108.093 171.349 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -49.19 -49.35 43.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.947 1.832 . . . . 10.17 115.947 161.332 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 p -49.48 -35.27 19.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 119.014 2.968 . . . . 13.59 119.014 166.29 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.83 -26.73 54.68 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 127.639 3.59 . . . . 11.699999999999999 114.646 -178.452 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -87.51 1.52 53.28 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.699 2.481 . . . . 12.949999999999999 117.699 168.297 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 72.68 31.92 1.58 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.215 2.822 . . . . 25.449999999999999 112.127 172.411 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mm -89.1 118.78 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 121.326 -0.859 . . . . 14.6 109.698 -169.919 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -106.28 172.72 6.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.354 -1.466 . . . . 33.229999999999997 107.155 -179.416 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 53.4 pttt -70.3 160.86 31.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 118.437 -1.305 . . . . 25.969999999999999 113.563 -175.703 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.253 52.5 mt-10 65.69 9.09 5.67 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.569 2.433 . . . . 32.609999999999999 117.569 -168.622 . . . . . . . . 2 2 . 1 . 122 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.0 m -69.48 135.2 49.85 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 112.445 -2.161 . . . . 10.56 113.179 171.939 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.8 m -110.97 122.03 46.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.768 -3.083 . . . . 5.3300000000000001 106.466 -174.593 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.29 164.92 11.4 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 100.793 -3.78 . . . . 11.66 100.793 -172.508 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -123.45 130.59 52.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.139 -1.886 . . . . 16.300000000000001 109.912 -179.691 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -84.69 134.19 34.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.569 2.062 . . . . 9.9600000000000009 116.569 169.719 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.52 164.66 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.68 -1.887 . . . . 9.7599999999999998 107.668 169.881 . . . . . . . . 1 1 . 1 . 122 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.268 24.1 tp . . . . . 0 N--CA 1.429 -1.476 0 O-C-N 117.981 -2.949 . . . . 19.57 104.806 -172.059 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 117.614 2.45 . . . . 17.170000000000002 117.614 . . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -93.41 123.53 36.77 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 118.167 -0.92 . . . . 21.890000000000001 110.274 -163.945 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 pt -92.48 171.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 127.084 3.326 . . . . 10.83 109.394 165.567 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 26.1 m-85 -115.13 112.48 22.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.794 2.837 . . . . 10.609999999999999 107.688 169.545 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.5 t -105.71 118.43 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.858 -2.402 . . . . 9.1300000000000008 105.13 172.08 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -97.57 113.12 24.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.843 2.857 . . . . 20.550000000000001 112.826 175.218 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.456 26.7 p -66.45 161.52 22.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 119.65 3.204 . . . . 11.779999999999999 119.65 174.979 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 tp -70.12 -34.06 72.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.26 -3.4 . . . . 19.309999999999999 107.31 -178.267 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -68.63 -61.84 1.65 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.184 0.993 . . . . 23.140000000000001 110.174 170.826 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.71 46.45 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 117.26 -3.4 . . . . 19.739999999999998 114.369 -170.436 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 41.7 mtpt -126.1 135.96 52.34 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.981 -2.482 . . . . 21.93 112.678 162.868 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.4 m -105.85 114.04 27.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.692 -3.755 . . . . 12.33 106.291 -179.678 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -97.78 129.01 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 130.954 3.702 . . . . 17.079999999999998 109.278 -177.844 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -98.22 102.92 14.8 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.426 2.536 . . . . 16.300000000000001 105.409 -178.725 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.88 124.04 45.07 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.212 -2.18 . . . . 15.880000000000001 110.521 -155.216 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.73 113.49 18.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.83 -2.441 . . . . 28.899999999999999 114.922 -176.413 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.57 156.03 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 125.191 2.424 . . . . 12.050000000000001 111.469 178.33 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -91.97 158.32 39.84 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 116.041 -1.933 . . . . 18.170000000000002 108.988 174.704 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -83.32 -22.13 4.11 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 126.379 3.314 . . . . 8.1600000000000001 118.027 -179.331 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 m -86.43 14.25 7.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 125.047 1.467 . . . . 11.130000000000001 114.483 -175.535 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -110.79 151.91 27.24 Favored 'General case' 0 N--CA 1.43 -1.449 1 C-N-CA 133.438 4.695 . . . . 18.030000000000001 111.334 -177.643 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -75.37 157.55 34.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 127.74 3.638 . . . . 10.220000000000001 113.046 -177.648 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.37 -28.24 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 126.03 2.824 . . . . 12.300000000000001 109.832 -179.137 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -69.24 -24.29 63.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.373 -3.954 . . . . 36.509999999999998 108.498 176.455 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -83.08 -38.98 21.76 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.192 2.997 . . . . 25.66 108.631 -179.077 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.8 t -55.84 -47.99 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 123.78 1.752 . . . . 8.1199999999999992 112.711 162.483 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -60.69 -39.04 87.04 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.717 -4.364 . . . . 15.470000000000001 114.997 177.052 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.15 -43.14 66.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.31 3.078 . . . . 11.449999999999999 119.31 164.57 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -65.18 -41.41 94.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.791 -1.818 . . . . 24.98 111.629 177.114 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -60.38 -44.02 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 126.55 1.94 . . . . 9.4600000000000009 113.151 172.482 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -51.12 -37.13 44.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.725 3.21 . . . . 14.76 113.988 167.615 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -83.76 -38.01 21.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.077 -1.639 . . . . 26.289999999999999 108.37 -176.921 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -63.93 -58.9 5.36 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.124 1.898 . . . . 30.059999999999999 116.124 177.4 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 14.3 mm-40 -100.14 -69.32 0.77 Allowed 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 124.724 2.202 . . . . 25.190000000000001 110.641 -171.351 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.49 46.07 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.766 0 O-C-N 117.418 -3.302 . . . . 7.4100000000000001 105.593 -175.34 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -106.32 130.9 22.24 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 116.932 -1.509 . . . . 9.4900000000000002 110.298 167.821 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -76.21 154.66 37.04 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 119.79 2.958 . . . . 11.42 119.79 177.858 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -70.5 -17.82 33.95 Favored 'Trans proline' 0 N--CA 1.434 -1.993 1 C-N-CA 126.142 4.561 . . . . 12.0 112.207 -169.229 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -84.55 -21.01 30.62 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 115.267 -4.646 . . . . 35.549999999999997 114.408 176.451 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.95 -16.06 30.7 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.987 -1.695 . . . . 20.52 111.109 -175.549 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -86.1 153.13 22.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 118.834 -1.146 . . . . 7.1299999999999999 112.842 -174.613 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -140.98 125.57 17.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 102.362 -3.199 . . . . 36.390000000000001 102.362 169.35 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.3 mt -105.63 125.68 51.27 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.03 1.395 . . . . 9.5500000000000007 109.473 175.014 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mm -106.57 128.2 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 121.16 -0.963 . . . . 13.9 111.03 177.307 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -112.97 115.51 28.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 118.859 -1.136 . . . . 6.8600000000000003 109.476 160.8 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.307 . . 64.31 -101.28 0.09 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.859 2.463 . . . . 11.15 111.613 -170.911 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.63 2.19 23.31 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 130.057 3.694 . . . . 13.93 114.158 172.11 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.258 14.3 tppt? -102.7 132.86 48.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 119.916 1.858 . . . . 23.920000000000002 111.019 -177.97 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -91.6 138.16 31.79 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.902 -1.954 . . . . 23.23 110.88 176.819 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.287 3.3 mt -106.59 114.24 28.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.974 3.273 . . . . 9.1099999999999994 110.255 -166.018 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.37 130.27 35.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.271 -2.768 . . . . 33.439999999999998 114.063 -167.789 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -31.35 -67.35 0.1 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 121.245 3.795 . . . . 28.370000000000001 121.245 -164.336 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.56 21.9 43.15 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 115.177 -3.392 . . . . 15.0 111.334 -168.233 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -91.63 153.98 19.33 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.183 -4.716 . . . . 25.5 112.333 166.832 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.9 p -76.01 166.5 23.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.739 -2.476 . . . . 11.949999999999999 116.668 179.248 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 124.977 2.322 . . . . 10.17 116.758 163.526 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -60.94 -24.93 66.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 112.329 -3.701 . . . . 13.59 117.981 177.978 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -71.82 -38.55 70.16 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.497 2.408 . . . . 11.699999999999999 115.356 167.448 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -77.78 -2.99 39.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.673 -2.517 . . . . 12.949999999999999 114.709 170.645 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 2.6 m-80 52.62 49.05 21.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.58 3.086 . . . . 25.449999999999999 115.644 177.093 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.66 112.7 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 109.645 -3.434 . . . . 14.6 110.124 176.629 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -96.49 166.57 11.62 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.559 -2.588 . . . . 33.229999999999997 107.215 179.566 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -52.55 146.86 9.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.08 2.552 . . . . 25.969999999999999 114.704 171.507 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 57.81 38.69 27.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.856 3.693 . . . . 32.609999999999999 115.534 -178.516 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.254 72.5 m -102.35 131.21 49.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.833 -3.042 . . . . 10.56 110.206 -173.544 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 96.3 m -102.9 101.0 11.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.766 1.746 . . . . 5.3300000000000001 108.787 -164.309 . . . . . . . . 2 2 . 1 . 123 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 mt -81.75 134.34 35.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.913 -3.617 . . . . 11.66 113.353 172.47 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -89.28 101.19 13.86 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 113.424 -3.179 . . . . 16.300000000000001 105.406 -179.521 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -71.2 114.76 9.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 124.458 3.299 . . . . 9.9600000000000009 114.489 169.602 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.95 -174.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.35 2.976 . . . . 9.7599999999999998 107.622 -176.024 . . . . . . . . 1 1 . 1 . 123 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 tp . . . . . 0 N--CA 1.431 -1.424 1 O-C-N 113.467 -5.771 . . . . 19.57 115.779 176.808 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.341 9.5 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 113.954 -2.927 . . . . 17.170000000000002 117.243 . . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -74.93 124.97 27.89 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 131.799 4.039 . . . . 21.890000000000001 113.684 165.054 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.4 pt -120.16 162.08 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 103.36 -2.83 . . . . 10.83 103.36 159.675 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -114.93 135.44 54.21 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.024 -1.843 . . . . 10.609999999999999 106.024 -179.371 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.39 106.34 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 1 O-C-N 113.024 -6.047 . . . . 9.1300000000000008 111.369 179.7 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -84.51 138.64 32.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.517 2.579 . . . . 20.550000000000001 112.947 179.957 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -106.9 174.79 5.73 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.31 -2.118 . . . . 11.779999999999999 106.872 -178.16 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -74.69 -50.11 18.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.202 2.201 . . . . 19.309999999999999 108.225 -169.396 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 p -71.43 -73.36 0.18 Allowed 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.131 1.9 . . . . 23.140000000000001 116.131 176.591 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.37 68.98 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.699 1 O-C-N 112.348 -6.47 . . . . 19.739999999999998 115.729 168.528 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -132.83 146.05 51.49 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.578 -1.542 . . . . 21.93 109.109 163.398 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.2 m -119.48 129.22 54.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.283 -1.767 . . . . 12.33 107.975 166.428 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.07 127.88 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 113.118 -1.855 . . . . 17.079999999999998 107.253 -177.209 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -86.39 128.87 34.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.22 -2.881 . . . . 16.300000000000001 103.22 169.007 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 tp -128.2 139.2 52.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.06 -1.427 . . . . 15.880000000000001 111.687 173.258 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -86.81 118.45 26.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.541 -1.35 . . . . 28.899999999999999 113.945 171.574 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -129.05 157.01 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.027 1.862 . . . . 12.050000000000001 116.027 173.266 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -103.78 140.05 20.69 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 125.572 1.549 . . . . 18.170000000000002 108.011 171.439 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -70.18 -18.13 35.23 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 122.356 1.877 . . . . 8.1600000000000001 111.884 -170.407 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.39 -8.81 58.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.771 2.429 . . . . 11.130000000000001 116.031 178.361 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.26 164.41 25.75 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.985 -4.197 . . . . 18.030000000000001 111.625 171.558 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 59.1 p -79.88 170.65 16.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.623 -2.548 . . . . 10.220000000000001 115.654 156.431 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -73.95 -26.19 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.707 2.003 . . . . 12.300000000000001 111.37 175.234 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -57.91 -39.2 77.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 116.598 -3.814 . . . . 36.509999999999998 114.237 166.68 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -76.35 -31.06 57.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.846 -3.659 . . . . 25.66 112.042 -175.334 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.72 -42.07 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.245 1.818 . . . . 8.1199999999999992 112.06 172.274 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -69.16 -23.8 63.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 119.708 3.225 . . . . 15.470000000000001 119.708 172.472 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.43 -23.45 67.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.77 2.428 . . . . 11.449999999999999 116.916 159.412 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -94.57 -19.21 20.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.444 1.592 . . . . 24.98 111.274 175.431 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.72 -34.97 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-O 116.314 -1.803 . . . . 9.4600000000000009 106.451 175.868 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -67.63 -29.09 68.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.625 1.679 . . . . 14.76 111.943 174.957 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.81 -47.71 51.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.729 -2.482 . . . . 26.289999999999999 115.79 172.928 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -78.81 -47.82 15.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.332 1.975 . . . . 30.059999999999999 116.332 -177.257 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -105.2 -17.28 14.52 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.996 -2.94 . . . . 25.190000000000001 116.612 -178.88 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.17 61.4 5.19 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 127.077 2.275 . . . . 7.4100000000000001 112.052 172.978 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -121.93 142.14 35.66 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 100.274 -3.972 . . . . 9.4900000000000002 100.274 170.834 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -65.49 157.71 56.81 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 124.834 2.762 . . . . 11.42 110.531 -177.389 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -64.41 -27.05 62.79 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 123.867 3.044 . . . . 12.0 114.697 -178.982 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.5 -31.7 65.57 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 115.953 -4.217 . . . . 35.549999999999997 108.748 -176.154 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -81.71 -23.17 36.93 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.113 -2.867 . . . . 20.52 113.74 -179.815 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -71.0 120.29 16.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.413 2.285 . . . . 7.1299999999999999 113.272 171.224 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -121.71 126.37 48.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 118.062 -0.97 . . . . 36.390000000000001 108.592 159.555 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.27 136.75 43.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.759 2.695 . . . . 9.5500000000000007 108.536 -179.077 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.7 mm -120.31 146.78 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.649 -2.532 . . . . 13.9 105.779 -178.064 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -127.02 127.26 44.5 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 100.427 -3.916 . . . . 6.8600000000000003 100.427 164.604 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.526 . . 59.34 -88.64 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 120.789 3.625 . . . . 11.15 120.789 -172.884 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.13 19.39 1.56 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 123.659 0.599 . . . . 13.93 112.029 153.025 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -77.38 132.99 38.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.732 0.777 . . . . 23.920000000000002 112.017 160.751 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -79.01 124.1 27.93 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.87 -3.644 . . . . 23.23 113.597 173.728 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -99.48 120.82 40.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.091 -2.255 . . . . 9.1099999999999994 107.987 -178.91 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -102.79 153.12 20.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.426 2.953 . . . . 33.439999999999998 110.42 -178.146 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.09 -51.59 30.75 Favored 'General case' 0 N--CA 1.43 -1.441 1 N-CA-C 122.677 4.325 . . . . 28.370000000000001 122.677 -166.545 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.44 -5.07 85.46 Favored Glycine 0 N--CA 1.43 -1.753 0 O-C-N 124.955 1.41 . . . . 15.0 114.945 -176.624 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -78.53 150.11 32.93 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.427 1.108 . . . . 25.5 110.214 168.102 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.5 p -88.31 179.06 6.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.176 -1.829 . . . . 11.949999999999999 113.029 169.044 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.6 mt -76.34 -45.03 33.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.944 -1.502 . . . . 10.17 106.944 -174.544 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 p -50.57 -41.63 54.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.938 2.895 . . . . 13.59 114.408 176.147 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.6 -38.35 90.77 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.198 1.799 . . . . 11.699999999999999 111.125 -174.277 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -96.15 17.0 16.57 Favored 'General case' 0 N--CA 1.43 -1.468 2 O-C-N 115.145 -4.722 . . . . 12.949999999999999 111.788 169.718 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 47.36 55.32 8.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 127.693 3.616 . . . . 25.449999999999999 118.756 -172.558 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.4 mm -82.42 119.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 111.117 -2.765 . . . . 14.6 113.843 171.57 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -97.84 170.36 9.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.573 2.421 . . . . 33.229999999999997 110.191 -176.039 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -76.39 155.65 33.88 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 115.647 -2.12 . . . . 25.969999999999999 108.062 -179.482 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.354 46.7 mt-10 58.2 39.35 25.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.685 1.994 . . . . 32.609999999999999 116.089 177.94 . . . . . . . . 2 2 . 1 . 124 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -124.14 136.36 54.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.921 -1.881 . . . . 10.56 105.921 -173.458 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.9 m -85.1 121.42 27.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.924 -1.988 . . . . 5.3300000000000001 109.692 -171.834 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.62 158.65 15.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.402 2.681 . . . . 11.66 108.88 174.118 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -111.88 113.26 25.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.063 1.301 . . . . 16.300000000000001 110.185 -179.55 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.9 tp -81.34 119.16 23.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.547 -1.216 . . . . 9.9600000000000009 111.063 173.355 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.77 166.73 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 118.75 -1.18 . . . . 9.7599999999999998 110.971 173.304 . . . . . . . . 1 1 . 1 . 124 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 N--CA 1.43 -1.453 0 O-C-N 118.609 -2.557 . . . . 19.57 110.781 176.527 . . . . . . . . 0 0 . 1 . 125 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 CA--C 1.489 -1.366 0 N-CA-C 108.08 -1.081 . . . . 17.170000000000002 108.08 . . . . . . . . . 0 0 . 1 . 125 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -88.67 145.47 25.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.887 -2.383 . . . . 21.890000000000001 110.656 178.558 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.0 pt -133.17 164.69 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 104.785 -2.302 . . . . 10.83 104.785 166.677 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -121.44 142.6 49.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 128.372 3.545 . . . . 10.609999999999999 108.344 -175.195 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -118.31 116.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 111.652 -2.522 . . . . 9.1300000000000008 107.843 177.16 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -101.89 138.51 38.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.218 -2.176 . . . . 20.550000000000001 111.126 179.819 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.9 p -98.81 170.35 8.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.688 -2.051 . . . . 11.779999999999999 108.421 -172.487 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.3 tp -49.59 -60.63 2.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.738 2.496 . . . . 19.309999999999999 117.738 177.688 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.275 17.7 p -74.26 -32.81 63.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 111.587 -2.552 . . . . 23.140000000000001 112.144 -178.781 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.17 69.85 0.26 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 118.694 -2.504 . . . . 19.739999999999998 114.256 159.919 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -107.92 143.5 36.47 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.795 -0.826 . . . . 21.93 112.982 164.511 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -94.0 98.53 11.08 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.038 1.866 . . . . 12.33 116.038 167.874 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.5 mt -86.06 92.59 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 116.164 -4.085 . . . . 17.079999999999998 106.577 176.873 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 m -61.57 127.46 31.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 117.089 -1.434 . . . . 16.300000000000001 113.185 164.902 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.431 HD13 HG11 ' A' ' 26' ' ' VAL . 30.8 mt -110.34 150.3 28.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.953 2.901 . . . . 15.880000000000001 115.669 163.756 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -104.83 125.19 50.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.6 -3.188 . . . . 28.899999999999999 103.824 170.485 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -139.53 156.18 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.57 -2.581 . . . . 12.050000000000001 116.489 -171.195 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -105.43 149.3 37.63 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 117.973 -2.954 . . . . 18.170000000000002 111.242 168.054 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.68 -25.53 75.75 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 123.947 3.098 . . . . 8.1600000000000001 113.882 172.776 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 p -81.58 -5.76 58.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.844 1.258 . . . . 11.130000000000001 111.777 -175.537 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -74.66 145.93 42.79 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 118.334 2.716 . . . . 18.030000000000001 118.334 179.674 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -88.66 154.4 20.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.917 -2.364 . . . . 10.220000000000001 108.901 177.451 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 mm -63.29 -27.81 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.843 2.735 . . . . 12.300000000000001 112.786 179.511 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -54.06 -54.42 39.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.313 -3.992 . . . . 36.509999999999998 112.048 168.075 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.63 -41.34 98.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.583 1.698 . . . . 25.66 115.583 174.562 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 15' ' ' LEU . 72.8 t -61.42 -46.14 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 119.597 -1.939 . . . . 8.1199999999999992 111.937 176.045 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -67.68 -20.67 65.32 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.254 -3.404 . . . . 15.470000000000001 114.47 177.986 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.4 -27.85 66.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.579 1.325 . . . . 11.449999999999999 114.579 174.361 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -83.75 -29.05 27.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.503 1.127 . . . . 24.98 110.906 175.658 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.95 -29.87 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 120.746 1.612 . . . . 9.4600000000000009 111.511 165.897 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -76.81 -45.19 29.65 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.47 1.655 . . . . 14.76 115.47 176.649 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.378 20.7 t70 -41.5 -54.97 2.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.521 2.328 . . . . 26.289999999999999 112.171 163.058 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -79.32 -61.88 1.87 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 121.377 3.843 . . . . 30.059999999999999 121.377 -177.145 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.63 -36.48 16.24 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 115.525 -4.485 . . . . 25.190000000000001 105.994 -171.226 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.22 81.15 0.46 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 118.932 -2.355 . . . . 7.4100000000000001 112.743 -171.112 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.3 mt -135.34 131.01 19.36 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 100.686 -3.82 . . . . 9.4900000000000002 100.686 170.58 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -69.29 149.43 69.91 Favored 'Trans proline' 0 N--CA 1.434 -2.022 1 CA-C-N 128.604 4.108 . . . . 11.42 115.213 -178.543 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -93.88 4.45 2.92 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 C-N-CA 115.992 -2.205 . . . . 12.0 112.651 -154.102 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.44 -38.97 21.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.523 3.129 . . . . 35.549999999999997 105.827 176.236 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -67.67 -37.72 82.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.064 2.946 . . . . 20.52 109.52 174.003 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.36 69.0 mt-30 -83.93 132.55 34.76 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 128.059 3.79 . . . . 7.1299999999999999 110.189 -176.163 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.599 ' HB3' HG21 ' A' ' 70' ' ' VAL . 45.0 ttt180 -127.31 133.77 50.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 110.786 -2.915 . . . . 36.390000000000001 108.997 175.229 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.3 mt -103.92 139.41 39.12 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-O 131.272 5.32 . . . . 9.5500000000000007 108.507 178.512 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.612 HD12 ' HG2' ' A' ' 49' ' ' GLN . 10.7 mm -123.06 137.22 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 1 O-C-N 115.974 -4.204 . . . . 13.9 111.762 172.449 . . . . . . . . 3 3 . 1 . 125 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -127.01 124.92 40.52 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.933 -4.229 . . . . 6.8600000000000003 102.629 165.363 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.9 -98.5 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 134.392 5.077 . . . . 11.15 117.717 -173.62 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.04 -18.61 36.37 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 124.71 1.148 . . . . 13.93 114.238 -174.564 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -128.96 133.03 47.67 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.991 2.219 . . . . 23.920000000000002 116.991 -166.761 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.612 ' HG2' HD12 ' A' ' 44' ' ' ILE . 33.1 mt-30 -83.04 134.33 35.04 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.08 -1.822 . . . . 23.23 106.08 -170.585 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.0 mt -92.39 132.21 36.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.24 -1.345 . . . . 9.1099999999999994 111.262 -166.417 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.37 164.76 11.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.872 -3.017 . . . . 33.439999999999998 108.163 -176.558 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.75 -57.2 12.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.703 -2.044 . . . . 28.370000000000001 115.339 -161.742 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.82 18.94 36.27 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 117.273 -1.849 . . . . 15.0 115.324 -174.711 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.4 mtt-85 -104.5 150.76 24.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.698 1.749 . . . . 25.5 108.615 -178.478 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 p -91.56 153.43 19.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.682 -2.511 . . . . 11.949999999999999 110.583 -164.432 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.1 mt -53.68 -35.68 61.35 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.257 2.623 . . . . 10.17 112.797 167.991 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.0 p -70.72 -37.99 73.57 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.662 1.696 . . . . 13.59 115.274 178.652 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -78.93 -29.68 44.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.23 -2.169 . . . . 11.699999999999999 109.502 173.45 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -77.79 -2.45 36.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 123.816 3.007 . . . . 12.949999999999999 116.882 166.133 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 61.38 34.74 18.18 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 126.039 2.828 . . . . 25.449999999999999 114.753 177.884 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.93 116.28 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 113.507 -1.679 . . . . 14.6 114.986 174.543 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -98.29 174.61 6.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.318 -2.845 . . . . 33.229999999999997 103.318 -175.234 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -65.5 147.23 53.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.49 1.293 . . . . 25.969999999999999 114.49 173.387 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 8.5 mt-10 55.3 25.74 7.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.803 -2.436 . . . . 32.609999999999999 113.252 179.73 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -93.96 151.55 19.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.174 -2.346 . . . . 10.56 110.859 169.908 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.5 m -114.09 125.44 53.97 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.138 2.149 . . . . 5.3300000000000001 108.731 -169.72 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -92.11 151.26 20.5 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 116.895 -3.628 . . . . 11.66 112.983 165.705 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -91.51 135.28 33.97 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.152 -2.536 . . . . 16.300000000000001 104.152 172.158 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.5 tp -84.86 125.95 33.06 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.638 -1.914 . . . . 9.9600000000000009 113.846 154.909 . . . . . . . . 1 1 . 1 . 125 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 42' ' ' ARG . 24.9 m -114.17 165.58 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 127.597 2.359 . . . . 9.7599999999999998 112.036 168.476 . . . . . . . . 2 2 . 1 . 125 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.0 tp . . . . . 0 N--CA 1.43 -1.454 0 O-C-N 118.904 -2.372 . . . . 19.57 114.319 170.943 . . . . . . . . 0 0 . 1 . 126 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 CA--C 1.49 -1.35 0 N-CA-C 117.855 2.539 . . . . 17.170000000000002 117.855 . . . . . . . . . 0 0 . 1 . 126 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -82.05 131.68 35.25 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.059 -1.924 . . . . 21.890000000000001 108.536 177.017 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -117.13 176.0 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 123.435 2.834 . . . . 10.83 107.719 160.071 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -135.89 109.79 8.18 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.862 -3.024 . . . . 10.609999999999999 111.654 179.659 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.73 128.95 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 120.171 1.351 . . . . 9.1300000000000008 111.271 -177.629 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -90.68 134.46 34.39 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.296 -1.503 . . . . 20.550000000000001 113.0 173.657 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.7 p -88.09 172.08 9.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.273 3.029 . . . . 11.779999999999999 113.09 -178.281 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.73 -36.96 79.07 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.204 -4.06 . . . . 19.309999999999999 116.772 177.14 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -70.81 -58.5 3.56 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 114.992 -4.817 . . . . 23.140000000000001 109.673 172.548 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.96 46.76 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 123.973 1.874 . . . . 19.739999999999998 112.241 -176.668 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 45.7 mtpt -96.46 160.09 14.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 105.137 -2.171 . . . . 21.93 105.137 162.309 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.8 m -117.94 121.93 41.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.033 -1.667 . . . . 12.33 110.032 157.003 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.431 HD13 ' HG3' ' A' ' 34' ' ' GLU . 21.1 mt -105.79 120.07 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.021 -1.844 . . . . 17.079999999999998 106.021 -168.371 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m -84.44 94.72 8.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.534 -1.212 . . . . 16.300000000000001 109.189 -179.145 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.43 132.66 40.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 115.161 -2.352 . . . . 15.880000000000001 108.485 -175.941 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.273 26.0 tt0 -89.5 102.67 15.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.291 2.314 . . . . 28.899999999999999 114.295 173.692 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.5 155.19 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.493 1.951 . . . . 12.050000000000001 111.399 -166.999 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.18 152.8 39.83 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 115.72 -2.086 . . . . 18.170000000000002 107.671 170.511 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -85.88 -10.08 7.31 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 129.123 4.294 . . . . 8.1600000000000001 110.14 -164.513 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 p -85.77 -1.75 57.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 118.827 -1.149 . . . . 11.130000000000001 112.776 174.616 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -69.6 151.01 46.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.759 -3.713 . . . . 18.030000000000001 114.713 -178.878 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 10.2 p -77.26 161.76 27.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.044 -1.836 . . . . 10.220000000000001 106.044 177.356 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mm -57.94 -41.32 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 117.071 -3.518 . . . . 12.300000000000001 110.946 165.513 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.281 22.6 tt0 -42.42 -44.12 3.87 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.709 2.404 . . . . 36.509999999999998 115.215 164.254 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -65.86 -48.4 71.7 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.708 -3.12 . . . . 25.66 114.223 170.68 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.1 t -49.98 -38.77 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.291 -1.506 . . . . 8.1199999999999992 112.769 177.928 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -76.16 -21.63 56.32 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.417 2.006 . . . . 15.470000000000001 116.417 179.522 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.02 -23.82 62.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.921 2.888 . . . . 11.449999999999999 113.708 178.357 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -81.99 -33.32 30.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 126.644 3.116 . . . . 24.98 113.763 171.778 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.4 mt -68.72 -43.86 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.612 -1.93 . . . . 9.4600000000000009 112.529 165.083 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -45.23 -47.48 12.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.275 2.324 . . . . 14.76 117.275 165.188 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -75.85 -54.43 6.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.485 2.714 . . . . 26.289999999999999 114.775 -173.012 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -81.12 -70.43 0.53 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.185 1.394 . . . . 30.059999999999999 110.951 -169.57 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.434 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 75.3 mm-40 -58.83 -43.35 90.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.002 2.223 . . . . 25.190000000000001 117.002 175.085 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.25 13.05 50.18 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 126.38 3.211 . . . . 7.4100000000000001 120.145 -168.001 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.7 mt -76.72 125.29 87.39 Favored Pre-proline 0 N--CA 1.43 -1.439 1 O-C-N 116.381 -4.011 . . . . 9.4900000000000002 114.019 174.443 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -78.06 158.82 30.53 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-O 113.999 -2.584 . . . . 11.42 113.545 -164.477 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -71.12 -23.85 24.29 Favored 'Trans proline' 0 C--N 1.3 -2.026 1 CA-C-N 128.988 4.246 . . . . 12.0 111.149 -170.519 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.46 0.27 30.18 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.509 3.152 . . . . 35.549999999999997 119.509 174.805 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.306 60.2 mt-30 -84.24 -25.42 29.43 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.141 -5.35 . . . . 20.52 108.346 169.687 . . . . . . . . 3 2 . 1 . 126 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -92.83 129.44 38.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.684 2.105 . . . . 7.1299999999999999 116.684 -152.205 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -142.03 120.82 12.68 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 115.689 -2.101 . . . . 36.390000000000001 108.803 168.953 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -104.43 138.55 40.66 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 122.593 2.451 . . . . 9.5500000000000007 110.988 -177.629 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mm -116.14 136.22 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 125.969 1.707 . . . . 13.9 110.75 -177.317 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -108.94 102.9 11.87 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 114.738 -4.976 . . . . 6.8600000000000003 106.453 161.663 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.2 -77.62 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.784 3.253 . . . . 11.15 119.784 -168.614 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.62 20.87 2.02 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.108 -1.597 . . . . 13.93 109.108 175.906 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -117.19 129.91 56.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.549 -2.736 . . . . 23.920000000000002 104.184 -179.588 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -76.48 143.59 40.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.069 -1.878 . . . . 23.23 112.575 179.515 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.2 mt -103.57 111.52 24.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 116.982 -1.485 . . . . 9.1099999999999994 107.936 -178.389 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -93.88 150.57 20.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.921 2.013 . . . . 33.439999999999998 111.733 -177.128 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -39.63 -63.4 0.58 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.635 3.084 . . . . 28.370000000000001 115.482 -169.727 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.38 -25.9 64.79 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.815 -1.803 . . . . 15.0 113.702 -159.022 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -83.93 164.35 19.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 114.582 -2.847 . . . . 25.5 112.866 -178.088 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 61.0 p -97.36 169.07 10.01 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.754 1.264 . . . . 11.949999999999999 113.836 -171.431 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.51 -41.92 98.49 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.193 1.397 . . . . 10.17 112.305 172.903 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 p -55.35 -43.82 75.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.898 2.136 . . . . 13.59 114.561 165.893 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.38 -35.91 76.29 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.245 -3.409 . . . . 11.699999999999999 111.676 -174.044 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.332 2.3 m-85 -91.55 6.23 46.48 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 127.975 3.297 . . . . 12.949999999999999 111.814 179.974 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.292 8.0 m120 58.87 40.78 22.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.163 2.653 . . . . 25.449999999999999 118.163 175.268 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 mm -75.06 131.59 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 104.928 -2.249 . . . . 14.6 104.928 178.361 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -92.21 175.48 6.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.247 -2.783 . . . . 33.229999999999997 113.452 169.159 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -63.64 124.0 20.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 131.629 3.972 . . . . 25.969999999999999 112.123 169.541 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 68.12 34.54 3.98 Favored 'General case' 0 N--CA 1.43 -1.461 2 O-C-N 112.188 -6.57 . . . . 32.609999999999999 107.317 175.907 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.356 61.7 m -90.86 143.72 26.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.783 2.083 . . . . 10.56 108.727 179.308 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 m -84.73 124.35 31.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.109 -2.869 . . . . 5.3300000000000001 111.754 -176.15 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.76 151.7 29.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.671 -1.893 . . . . 11.66 107.958 179.643 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.296 63.3 m170 -115.49 129.94 56.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.666 2.03 . . . . 16.300000000000001 113.546 170.307 . . . . . . . . 2 2 . 1 . 126 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.6 tp -94.09 122.74 36.92 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.353 1.861 . . . . 9.9600000000000009 113.969 176.467 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 m -114.38 167.03 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 122.955 2.616 . . . . 9.7599999999999998 111.751 -175.666 . . . . . . . . 1 1 . 1 . 126 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.7 tp . . . . . 0 N--CA 1.43 -1.463 0 O-C-N 124.626 1.204 . . . . 19.57 109.517 176.514 . . . . . . . . 0 0 . 1 . 127 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.49 -1.36 0 N-CA-C 114.273 1.212 . . . . 17.170000000000002 114.273 . . . . . . . . . 0 0 . 1 . 127 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -86.5 151.59 23.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.032 -2.211 . . . . 21.890000000000001 105.032 -175.288 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 pt -134.86 171.62 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 115.678 -4.389 . . . . 10.83 106.267 152.355 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -112.82 132.91 55.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.233 1.813 . . . . 10.609999999999999 107.417 -177.553 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.01 102.21 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.202 -2.518 . . . . 9.1300000000000008 104.202 176.429 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -87.02 127.26 35.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 128.355 3.931 . . . . 20.550000000000001 114.462 -178.967 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.9 p -81.04 170.8 15.76 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 116.043 -4.161 . . . . 11.779999999999999 119.149 -178.097 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.5 mt -57.69 -34.85 69.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.107 1.763 . . . . 19.309999999999999 114.199 171.012 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.8 p -69.26 -23.55 63.86 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.465 -3.272 . . . . 23.140000000000001 112.634 172.554 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.63 -5.18 40.27 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 118.036 -2.915 . . . . 19.739999999999998 117.529 -161.167 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -76.3 154.06 35.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 120.232 -0.587 . . . . 21.93 111.969 -177.334 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 m -113.1 126.39 55.42 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.559 -3.213 . . . . 12.33 108.868 175.239 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 mt -114.38 112.73 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 102.091 -3.3 . . . . 17.079999999999998 102.091 176.355 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.6 m -95.85 107.24 19.47 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 116.782 -3.699 . . . . 16.300000000000001 110.497 -174.706 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.3 mt -112.41 151.36 29.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.022 2.344 . . . . 15.880000000000001 115.751 -173.539 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.7 104.81 14.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.592 -1.317 . . . . 28.899999999999999 109.611 -177.511 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.28 172.22 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 112.862 0.69 . . . . 12.050000000000001 112.862 171.145 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -106.06 174.45 2.6 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 107.833 -1.173 . . . . 18.170000000000002 107.833 166.577 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -72.8 -17.73 25.44 Favored 'Trans proline' 0 C--N 1.299 -2.048 0 CA-C-O 116.527 -1.53 . . . . 8.1600000000000001 110.515 175.156 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 m -90.69 9.24 30.63 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 120.877 1.671 . . . . 11.130000000000001 112.161 -174.405 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -94.28 154.33 17.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.401 2.048 . . . . 18.030000000000001 107.821 -179.103 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -92.59 164.26 13.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 114.695 1.369 . . . . 10.220000000000001 114.695 -177.314 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.276 22.1 mm -56.07 -41.05 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 127.842 2.457 . . . . 12.300000000000001 112.487 175.296 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.08 -39.94 69.82 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.427 2.291 . . . . 36.509999999999998 115.172 173.285 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -57.46 -38.44 74.5 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 130.962 3.705 . . . . 25.66 115.516 165.622 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.76 -45.46 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 123.998 3.09 . . . . 8.1199999999999992 108.317 -175.146 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.329 17.9 mtmt -55.7 -36.26 66.98 Favored 'General case' 0 N--CA 1.43 -1.456 1 C-N-CA 132.498 4.319 . . . . 15.470000000000001 116.619 171.338 . . . . . . . . 3 2 . 1 . 127 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.35 -38.22 83.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.158 3.021 . . . . 11.449999999999999 119.158 167.693 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -76.24 -24.61 54.58 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 115.082 1.512 . . . . 24.98 115.082 176.162 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -79.24 -33.45 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 119.043 -2.286 . . . . 9.4600000000000009 111.184 178.57 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -62.07 -39.91 94.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.297 -1.32 . . . . 14.76 108.562 168.706 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.7 -40.63 79.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.582 2.438 . . . . 26.289999999999999 117.582 -176.696 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -82.31 -59.3 2.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 114.816 -2.516 . . . . 30.059999999999999 109.129 176.299 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -87.94 -46.28 9.52 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.333 2.271 . . . . 25.190000000000001 109.505 -160.495 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.72 45.12 4.99 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 107.815 -2.114 . . . . 7.4100000000000001 107.815 175.823 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.259 68.3 mt -98.86 121.22 56.68 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 103.993 -2.595 . . . . 9.4900000000000002 103.993 173.172 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.327 1.1 Cg_exo -71.79 166.21 30.2 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 127.599 3.75 . . . . 11.42 118.491 -171.007 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.48 -6.09 4.49 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 CA-C-N 124.47 2.632 . . . . 12.0 112.667 -157.398 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -82.71 -29.53 29.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.28 1.613 . . . . 35.549999999999997 108.445 172.099 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -80.75 -26.44 37.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.095 1.358 . . . . 20.52 112.744 -175.177 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -83.61 128.93 34.9 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.055 -0.975 . . . . 7.1299999999999999 112.263 175.906 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -126.1 131.2 52.15 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.971 -1.122 . . . . 36.390000000000001 107.971 167.663 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.62 137.9 34.04 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.424 3.49 . . . . 9.5500000000000007 105.742 176.978 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mt -134.2 136.37 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.102 2.561 . . . . 13.9 110.818 179.698 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -120.86 95.09 4.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.323 -1.732 . . . . 6.8600000000000003 106.323 -174.393 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.64 -82.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.739 2.415 . . . . 11.15 111.994 -163.223 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.39 -1.49 6.11 Favored Glycine 0 N--CA 1.429 -1.794 0 O-C-N 116.959 -3.588 . . . . 13.93 112.5 171.172 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -83.74 113.25 20.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.708 -2.642 . . . . 23.920000000000002 113.488 176.51 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -70.38 142.03 52.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.387 -3.321 . . . . 23.23 109.974 171.794 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -107.55 110.66 22.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.963 -1.495 . . . . 9.1099999999999994 106.963 -166.323 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -87.77 153.74 21.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.129 -2.857 . . . . 33.439999999999998 114.479 -175.906 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.366 1.7 m-20 -48.73 -58.92 4.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.781 2.511 . . . . 28.370000000000001 117.781 -160.621 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.96 51.86 0.7 Allowed Glycine 0 N--CA 1.43 -1.756 0 CA-C-O 127.514 3.841 . . . . 15.0 114.73 -171.515 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -128.18 158.78 37.13 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.66 -4.435 . . . . 25.5 109.63 174.459 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.7 p -88.16 159.47 18.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.483 2.087 . . . . 11.949999999999999 106.869 -171.184 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.63 -30.33 69.79 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 116.064 -4.147 . . . . 10.17 113.354 169.167 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.2 p -64.91 -20.1 66.27 Favored 'General case' 0 N--CA 1.43 -1.47 1 C-N-CA 135.493 5.517 . . . . 13.59 116.294 176.237 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -82.73 -39.04 22.45 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.466 1.907 . . . . 11.699999999999999 112.536 172.31 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -79.69 -19.7 48.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.414 -2.679 . . . . 12.949999999999999 117.849 163.079 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.496 32.3 m120 75.26 57.28 0.06 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.745 2.212 . . . . 25.449999999999999 113.782 174.187 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mm -85.64 126.79 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 129.048 2.939 . . . . 14.6 106.727 -178.7 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -104.18 167.89 9.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.532 -1.655 . . . . 33.229999999999997 106.532 172.981 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -60.5 148.64 37.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.658 2.783 . . . . 25.969999999999999 110.816 -175.494 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 60.25 28.48 18.08 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 116.041 1.867 . . . . 32.609999999999999 116.041 176.879 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 m -77.09 150.28 35.67 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.18 -1.045 . . . . 10.56 108.18 174.191 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.6 m -98.62 104.16 16.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.799 -2.297 . . . . 5.3300000000000001 104.799 168.143 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -85.88 133.77 33.94 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.178 -2.283 . . . . 11.66 105.043 168.746 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.262 47.5 p-80 -106.13 145.34 31.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.796 2.713 . . . . 16.300000000000001 112.917 176.826 . . . . . . . . 2 2 . 1 . 127 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -104.36 127.47 52.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.687 -2.508 . . . . 9.9600000000000009 109.8 -171.063 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.75 164.27 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 124.018 3.099 . . . . 9.7599999999999998 109.52 177.6 . . . . . . . . 1 1 . 1 . 127 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.9 tp . . . . . 0 N--CA 1.429 -1.485 0 CA-C-N 113.205 -1.816 . . . . 19.57 108.319 -171.294 . . . . . . . . 0 0 . 1 . 128 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.489 -1.37 0 N-CA-C 106.501 -1.666 . . . . 17.170000000000002 106.501 . . . . . . . . . 0 0 . 1 . 128 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -114.04 121.16 43.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.401 3.08 . . . . 21.890000000000001 104.636 -175.644 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -120.23 162.6 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 126.891 2.619 . . . . 10.83 106.023 165.048 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -124.94 130.06 51.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.006 -2.961 . . . . 10.609999999999999 103.006 -169.608 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.2 111.8 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 116.423 -2.111 . . . . 9.1300000000000008 108.435 172.798 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -78.41 124.32 27.99 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 124.598 3.363 . . . . 20.550000000000001 112.077 174.646 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -69.31 164.28 23.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.397 -2.69 . . . . 11.779999999999999 117.768 169.503 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.33 -19.37 65.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.373 1.99 . . . . 19.309999999999999 116.373 172.241 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -93.15 -20.68 20.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.823 1.786 . . . . 23.140000000000001 115.823 179.488 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.73 34.38 2.64 Favored Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 116.421 1.329 . . . . 19.739999999999998 116.421 175.374 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -99.62 129.52 45.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.758 1.623 . . . . 21.93 110.187 164.072 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -91.67 119.99 32.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.34 -2.1 . . . . 12.33 105.542 167.915 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 30' ' ' ILE 0.3 7.8 mt -86.11 104.89 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 126.994 2.118 . . . . 17.079999999999998 110.353 172.873 . . . . . . . . 3 3 . 1 . 128 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.0 m -84.7 106.77 16.5 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.991 -1.484 . . . . 16.300000000000001 108.599 177.433 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.6 mt -110.34 139.84 45.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.913 -1.117 . . . . 15.880000000000001 110.01 -178.765 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -96.41 128.62 43.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.254 1.978 . . . . 28.899999999999999 106.464 174.215 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -137.11 155.15 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.378 -2.076 . . . . 12.050000000000001 108.333 -173.232 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -101.61 129.68 26.24 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 113.703 -3.046 . . . . 18.170000000000002 105.851 178.008 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.52 -16.17 46.02 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 CA-C-N 123.834 2.405 . . . . 8.1600000000000001 114.621 -168.825 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.6 p -94.55 -3.53 49.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 123.083 2.674 . . . . 11.130000000000001 110.668 -171.555 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.14 153.3 34.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 127.035 3.302 . . . . 18.030000000000001 115.93 175.883 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.7 p -75.36 162.88 28.01 Favored 'General case' 0 N--CA 1.43 -1.469 1 C-N-CA 131.787 4.035 . . . . 10.220000000000001 110.982 -178.456 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.293 6.3 mm -71.29 -34.74 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 1 O-C-N 115.392 -4.568 . . . . 12.300000000000001 112.546 178.754 . . . . . . . . 3 2 . 1 . 128 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -53.05 -43.27 66.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.241 1.817 . . . . 36.509999999999998 112.643 169.006 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -71.08 -22.66 62.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.898 2.184 . . . . 25.66 116.898 170.995 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.9 t -66.07 -43.76 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 1 CA-C-N 126.873 4.397 . . . . 8.1199999999999992 114.016 166.817 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -59.78 -39.12 83.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.963 2.105 . . . . 15.470000000000001 110.275 179.409 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.52 66.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.407 -3.308 . . . . 11.449999999999999 119.656 177.954 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -74.9 -33.45 62.04 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.834 2.454 . . . . 24.98 110.877 173.672 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.458 HG23 HD13 ' A' ' 13' ' ' ILE 0.253 6.8 mt -75.19 -40.71 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.004 -2.935 . . . . 9.4600000000000009 110.289 175.322 . . . . . . . . 3 3 . 1 . 128 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.48 -48.82 56.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.499 -2.625 . . . . 14.76 114.6 160.219 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -66.0 -42.85 89.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.588 1.995 . . . . 26.289999999999999 114.661 176.827 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -72.85 -69.58 0.4 Allowed 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.016 -2.303 . . . . 30.059999999999999 111.959 178.169 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -97.92 -2.01 41.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.523 1.929 . . . . 25.190000000000001 114.518 -164.428 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.51 21.43 79.5 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 118.579 2.191 . . . . 7.4100000000000001 118.579 174.526 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 98.0 mt -98.91 130.12 28.26 Favored Pre-proline 0 N--CA 1.431 -1.421 0 O-C-N 116.794 -3.768 . . . . 9.4900000000000002 102.623 -169.153 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -76.92 154.81 33.91 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 117.928 -1.67 . . . . 11.42 110.021 -172.105 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.344 9.7 Cg_endo -63.96 -30.16 66.94 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 123.463 2.775 . . . . 12.0 115.25 -169.525 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -63.63 -31.84 73.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.558 3.54 . . . . 35.549999999999997 120.558 -179.206 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -70.06 -34.53 73.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.853 -2.404 . . . . 20.52 114.39 166.777 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -64.25 103.79 0.67 Allowed 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.337 -4.602 . . . . 7.1299999999999999 121.327 178.743 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -102.77 125.25 49.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.556 -2.59 . . . . 36.390000000000001 110.897 163.332 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.7 mt -96.61 139.17 33.08 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.649 1.214 . . . . 9.5500000000000007 111.872 170.329 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.45 HG21 ' HE1' ' A' ' 68' ' ' HIS . 7.9 mt -133.13 122.26 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 129.337 3.055 . . . . 13.9 109.534 173.035 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -93.44 112.58 24.53 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.981 2.912 . . . . 6.8600000000000003 108.696 164.106 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.27 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 127.877 2.471 . . . . 11.15 114.128 -177.51 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 27.86 2.5 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 127.711 2.576 . . . . 13.93 111.757 166.431 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -104.95 137.09 43.24 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.975 2.91 . . . . 23.920000000000002 111.949 172.662 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -99.46 124.14 44.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.535 1.516 . . . . 23.23 112.415 -172.535 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.9 mt -97.59 137.35 36.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.575 -2.578 . . . . 9.1099999999999994 110.666 -171.307 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -118.69 135.17 54.62 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 127.128 3.346 . . . . 33.439999999999998 104.122 -166.193 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -43.53 -37.33 2.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 113.793 -3.003 . . . . 28.370000000000001 118.82 -166.502 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.6 11.66 27.95 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 107.001 -2.439 . . . . 15.0 107.001 -167.935 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -91.0 160.29 15.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.521 -3.929 . . . . 25.5 103.549 168.399 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.2 p -103.88 170.09 8.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.75 -1.843 . . . . 11.949999999999999 108.983 -170.329 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -57.64 -42.23 83.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 124.001 1.857 . . . . 10.17 114.226 168.751 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.3 p -62.89 -18.46 63.01 Favored 'General case' 0 N--CA 1.43 -1.459 1 N-CA-C 122.661 4.319 . . . . 13.59 122.661 173.303 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -77.96 -41.43 36.18 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.289 -4.632 . . . . 11.699999999999999 112.656 -173.667 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -86.08 -10.68 54.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.655 -1.612 . . . . 12.949999999999999 111.802 179.078 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.316 71.9 m-20 71.11 54.88 0.23 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.89 3.276 . . . . 25.449999999999999 113.232 -176.517 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.285 59.6 mt -89.28 108.6 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 127.933 3.27 . . . . 14.6 113.623 -179.352 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -89.34 176.24 7.01 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.515 3.526 . . . . 33.229999999999997 113.396 -166.404 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -69.14 139.32 54.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.474 2.027 . . . . 25.969999999999999 116.474 172.173 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 50.59 68.71 0.73 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.689 1.868 . . . . 32.609999999999999 112.771 -171.793 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -125.24 156.97 37.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.898 2.879 . . . . 10.56 103.536 176.485 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.0 m -126.37 124.81 41.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 124.413 1.071 . . . . 5.3300000000000001 109.292 -178.086 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.04 167.39 10.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.223 3.009 . . . . 11.66 109.332 -179.583 . . . . . . . . 1 1 . 1 . 128 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.45 ' HE1' HG21 ' A' ' 44' ' ' ILE . 7.4 p-80 -135.73 158.81 43.47 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.475 2.559 . . . . 16.300000000000001 112.184 179.056 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -118.04 136.82 53.31 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.162 -4.087 . . . . 9.9600000000000009 103.382 -168.597 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.81 172.95 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.295 -1.743 . . . . 9.7599999999999998 106.295 -175.522 . . . . . . . . 2 2 . 1 . 128 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.431 -1.416 0 C-N-CA 115.845 -2.342 . . . . 19.57 111.773 176.787 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 124.209 1.957 . . . . 17.170000000000002 109.691 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -98.41 145.96 26.21 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 113.94 -5.475 . . . . 21.890000000000001 115.352 -176.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 pt -127.52 -176.49 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.414 -3.18 . . . . 10.83 102.414 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -121.61 130.47 53.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.901 -1.954 . . . . 10.609999999999999 116.084 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.75 132.66 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 122.371 2.35 . . . . 9.1300000000000008 107.289 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -117.89 128.32 54.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.618 -1.623 . . . . 20.550000000000001 106.618 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.8 p -74.35 179.64 4.46 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.256 1.947 . . . . 11.779999999999999 116.256 170.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.03 -58.46 8.07 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.388 2.518 . . . . 19.309999999999999 117.571 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.94 -38.97 93.16 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 126.537 3.065 . . . . 23.140000000000001 114.55 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.27 49.57 0.27 Allowed Glycine 0 N--CA 1.431 -1.699 0 CA-C-N 111.589 -2.55 . . . . 19.739999999999998 115.667 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 22.1 ttpt -89.74 129.55 36.13 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.613 -4.463 . . . . 21.93 109.235 160.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.2 m -92.01 126.7 37.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 117.316 -1.754 . . . . 12.33 114.243 169.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 94.8 mt -102.91 103.53 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 C-N-CA 132.39 4.276 . . . . 17.079999999999998 105.505 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.9 m -74.66 131.52 40.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.264 -2.773 . . . . 16.300000000000001 106.787 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 tp -143.3 128.62 18.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 115.979 -1.962 . . . . 15.880000000000001 115.735 -166.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -103.4 142.95 33.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.222 1.963 . . . . 28.899999999999999 114.383 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 m -157.72 165.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.167 1.937 . . . . 12.050000000000001 111.128 -158.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.47 124.35 25.07 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.673 -2.584 . . . . 18.170000000000002 111.819 -172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.29 -20.85 9.5 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 C-N-CA 124.267 3.311 . . . . 8.1600000000000001 116.677 -154.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.1 p -95.66 7.23 46.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.412 1.885 . . . . 11.130000000000001 113.687 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.94 177.29 5.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 105.129 -2.174 . . . . 18.030000000000001 105.129 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.7 p -104.31 173.23 6.39 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.596 2.141 . . . . 10.220000000000001 111.215 -158.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.38 26.1 mm -65.33 -29.48 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 127.825 3.679 . . . . 12.300000000000001 113.737 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -55.8 -40.66 73.02 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 115.276 -4.64 . . . . 36.509999999999998 114.526 164.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.98 -26.8 66.99 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.883 -1.127 . . . . 25.66 113.46 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -71.79 -43.22 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 115.145 -2.622 . . . . 8.1199999999999992 110.577 175.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -63.41 -33.62 75.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.534 -2.604 . . . . 15.470000000000001 117.2 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -14.92 58.62 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.798 3.259 . . . . 11.449999999999999 119.798 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -84.97 -39.12 18.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.056 -2.278 . . . . 24.98 114.162 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 mt -63.3 -40.94 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 130.066 3.347 . . . . 9.4600000000000009 112.666 170.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -68.03 -31.47 71.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.343 1.457 . . . . 14.76 114.07 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.257 43.2 t0 -71.1 -59.75 2.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.574 -3.204 . . . . 26.289999999999999 108.278 172.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.301 3.6 tppp? -51.08 -67.34 0.26 Allowed 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 121.251 3.797 . . . . 30.059999999999999 121.251 -176.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.497 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 10.7 mm-40 -89.51 -48.0 7.6 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.7 1.37 . . . . 25.190000000000001 114.7 -178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.52 71.77 1.09 Allowed Glycine 0 N--CA 1.43 -1.755 0 O-C-N 127.381 2.926 . . . . 7.4100000000000001 114.883 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mt -128.75 132.37 24.32 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 103.676 -2.713 . . . . 9.4900000000000002 103.676 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -82.96 158.31 15.62 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 CA-C-N 124.931 2.797 . . . . 11.42 112.9 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -73.85 -20.94 19.21 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 123.373 2.715 . . . . 12.0 110.86 -153.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -65.64 -41.31 92.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.306 2.243 . . . . 35.549999999999997 112.755 167.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.61 -34.53 53.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.68 -1.263 . . . . 20.52 112.406 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.13 124.17 19.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 121.123 3.749 . . . . 7.1299999999999999 121.123 165.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -127.35 120.2 27.98 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.612 1.195 . . . . 36.390000000000001 109.169 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.3 mt -111.7 120.17 41.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.082 -2.261 . . . . 9.5500000000000007 106.68 -173.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.68 112.29 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 129.768 3.227 . . . . 13.9 112.944 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -99.2 120.85 40.19 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.939 2.304 . . . . 6.8600000000000003 106.403 165.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 65.29 -102.08 0.08 Allowed 'General case' 0 N--CA 1.431 -1.422 1 CA-C-O 129.27 4.367 . . . . 11.15 116.146 -177.591 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.34 55.18 0.59 Allowed Glycine 0 N--CA 1.43 -1.752 1 O-C-N 114.782 -4.949 . . . . 13.93 109.047 160.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.254 31.9 ttmt -135.08 139.23 44.57 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.9 1.68 . . . . 23.920000000000002 106.688 163.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -82.51 133.95 35.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.052 -1.03 . . . . 23.23 110.934 165.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -77.79 131.01 37.41 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.073 1.879 . . . . 9.1099999999999994 116.073 -176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -75.68 160.02 30.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.813 2.72 . . . . 33.439999999999998 108.458 -175.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.81 -52.95 20.66 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.665 -4.397 . . . . 28.370000000000001 110.042 -167.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.37 23.65 35.07 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 129.649 3.5 . . . . 15.0 112.588 -160.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.1 mtt-85 -116.65 160.7 20.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.808 2.122 . . . . 25.5 106.811 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 p -95.0 177.81 5.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.427 2.537 . . . . 11.949999999999999 113.438 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.17 -29.95 48.83 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.718 -3.114 . . . . 10.17 112.647 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 m -62.13 -19.56 63.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.347 1.61 . . . . 13.59 115.347 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.6 -46.27 22.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.525 -1.657 . . . . 11.699999999999999 106.525 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -73.5 -31.47 63.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.389 -1.732 . . . . 12.949999999999999 113.33 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 87.1 53.16 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.486 3.514 . . . . 25.449999999999999 107.52 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.1 mt -101.34 132.3 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.412 -3.181 . . . . 14.6 102.412 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -128.27 177.11 7.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.001 2.52 . . . . 33.229999999999997 113.008 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -51.31 128.08 21.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.011 2.339 . . . . 25.969999999999999 116.807 172.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 63.72 52.24 2.25 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.361 2.029 . . . . 32.609999999999999 116.277 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.7 m -113.45 146.04 40.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.084 2.954 . . . . 10.56 106.031 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.3 m -101.3 118.66 37.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.23 1.967 . . . . 5.3300000000000001 115.769 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.9 145.8 34.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.395 -3.316 . . . . 11.66 105.78 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -109.27 128.47 55.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 125.385 2.517 . . . . 16.300000000000001 113.659 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.3 tp -102.6 111.47 23.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.592 2.357 . . . . 9.9600000000000009 106.787 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.22 174.35 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 102.87 -3.011 . . . . 9.7599999999999998 102.87 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 mt -105.46 171.87 7.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.225 1.488 . . . . 19.57 113.687 -169.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -119.51 111.07 17.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.284 3.421 . . . . 35.079999999999998 107.403 167.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.8 mt -99.15 -139.5 0.31 Allowed 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 112.782 -6.199 . . . . 32.310000000000002 107.186 165.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.42 -69.81 0.68 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.463 -2.648 . . . . 42.75 110.393 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.73 174.31 54.81 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.019 -1.676 . . . . 36.310000000000002 112.642 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.772 0 N-CA-C 108.428 -1.869 . . . . 36.270000000000003 108.428 178.374 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.213 -0.662 . . . . 17.170000000000002 109.213 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -113.58 143.33 44.74 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 100.366 -3.938 . . . . 21.890000000000001 100.366 -170.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -119.32 164.91 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.447 -2.033 . . . . 10.83 108.352 170.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -98.83 122.41 42.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.117 -2.92 . . . . 10.609999999999999 103.117 170.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.7 113.53 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.564 -2.585 . . . . 9.1300000000000008 108.36 154.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -84.61 134.58 34.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.842 -2.411 . . . . 20.550000000000001 113.309 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 18.6 p -89.56 179.73 5.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.297 -3.377 . . . . 11.779999999999999 106.377 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -71.83 -44.53 63.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 128.171 3.843 . . . . 19.309999999999999 111.91 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.1 p -79.97 -78.52 0.16 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 109.382 -3.554 . . . . 23.140000000000001 115.642 -168.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.24 50.1 0.21 Allowed Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 119.575 1.079 . . . . 19.739999999999998 113.377 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 46.9 tttt -139.98 137.15 34.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.77 -1.429 . . . . 21.93 111.627 163.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -119.7 103.18 9.16 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.592 2.615 . . . . 12.33 110.535 171.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.435 HG23 HD13 ' A' ' 13' ' ' ILE . 83.8 mt -79.59 120.42 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 114.506 -2.664 . . . . 17.079999999999998 107.704 -165.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 p -105.12 94.04 5.02 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 123.364 2.802 . . . . 16.300000000000001 108.74 -172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.67 116.17 31.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.934 2.493 . . . . 15.880000000000001 109.031 -158.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -73.41 119.32 17.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.123 1.369 . . . . 28.899999999999999 111.846 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.79 178.6 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 113.888 -1.505 . . . . 12.050000000000001 108.802 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.17 158.33 44.67 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 126.524 2.39 . . . . 18.170000000000002 106.394 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -70.02 -3.76 12.84 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 N-CA-C 118.666 2.525 . . . . 8.1600000000000001 118.666 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 p -90.84 -0.51 57.74 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.121 4.168 . . . . 11.130000000000001 109.834 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.66 147.18 35.64 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.446 1.93 . . . . 18.030000000000001 112.06 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.5 p -92.0 -165.94 1.45 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.809 -2.432 . . . . 10.220000000000001 111.804 177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -85.76 -39.24 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.278 2.631 . . . . 12.300000000000001 105.611 175.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.4 -33.24 69.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.265 -3.397 . . . . 36.509999999999998 116.65 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.02 -56.65 15.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.925 1.345 . . . . 25.66 110.8 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -53.17 -47.19 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.199 -1.563 . . . . 8.1199999999999992 113.7 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -54.53 -39.21 67.44 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.783 -3.073 . . . . 15.470000000000001 114.761 171.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -32.92 71.13 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.241 -3.412 . . . . 11.449999999999999 114.73 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -81.14 -23.6 38.2 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.396 1.093 . . . . 24.98 109.45 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.36 -25.73 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 117.307 -3.371 . . . . 9.4600000000000009 113.184 169.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -75.49 -30.2 59.8 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.941 2.496 . . . . 14.76 109.675 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.7 -55.95 19.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.477 -2.014 . . . . 26.289999999999999 108.482 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -79.83 -43.31 22.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 116.545 -1.693 . . . . 30.059999999999999 112.333 -161.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.444 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 67.8 mm-40 -104.35 -44.05 5.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.462 1.028 . . . . 25.190000000000001 108.603 -177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.34 37.99 4.14 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 121.109 -0.995 . . . . 7.4100000000000001 111.449 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.7 mt -101.58 135.74 19.74 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 108.036 -1.098 . . . . 9.4900000000000002 108.036 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -65.36 137.94 53.33 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 C-N-CA 123.258 2.639 . . . . 11.42 113.567 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -68.31 -19.54 43.8 Favored 'Trans proline' 0 C--N 1.3 -1.988 1 C-N-CA 126.065 4.51 . . . . 12.0 118.178 -172.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -87.74 -27.28 22.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.948 1.699 . . . . 35.549999999999997 112.769 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.07 -40.37 82.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.106 2.162 . . . . 20.52 109.471 165.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.91 129.75 43.37 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.699 2.852 . . . . 7.1299999999999999 118.699 167.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -130.44 129.16 42.65 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.94 -4.225 . . . . 36.390000000000001 110.823 168.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.2 mt -112.93 129.08 56.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.856 1.262 . . . . 9.5500000000000007 110.145 -173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -130.5 140.09 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.988 1.852 . . . . 13.9 107.17 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.57 -75.83 0.51 Allowed 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 114.738 -2.785 . . . . 6.8600000000000003 112.187 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.61 -66.06 1.01 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.319 -2.845 . . . . 11.15 103.319 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.85 10.11 2.09 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 127.068 2.271 . . . . 13.93 115.523 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -112.26 142.1 45.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.287 1.042 . . . . 23.920000000000002 109.451 170.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -86.23 145.88 26.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.24 1.416 . . . . 23.23 107.784 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.03 130.12 45.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.067 -3.521 . . . . 9.1099999999999994 110.324 -171.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -103.89 151.32 23.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 118.31 -1.356 . . . . 33.439999999999998 109.979 -171.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -47.78 -53.53 15.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.733 2.864 . . . . 28.370000000000001 118.733 -152.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.94 50.82 0.74 Allowed Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 126.644 2.068 . . . . 15.0 114.465 -166.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -127.21 160.04 32.49 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.423 1.889 . . . . 25.5 109.899 154.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.341 48.0 p -79.24 164.17 24.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.041 2.536 . . . . 11.949999999999999 111.269 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.86 -31.22 72.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.829 1.776 . . . . 10.17 111.875 165.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -68.15 -31.09 70.4 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.7 -2.5 . . . . 13.59 114.919 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -71.99 -48.2 46.55 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.335 1.854 . . . . 11.699999999999999 106.596 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -74.15 -11.3 60.26 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.67 2.841 . . . . 12.949999999999999 118.67 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m120 69.24 49.01 0.63 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.753 2.021 . . . . 25.449999999999999 113.896 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.4 mt -105.24 108.01 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.333 -2.839 . . . . 14.6 103.333 173.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -101.5 -172.81 2.22 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.638 3.589 . . . . 33.229999999999997 109.859 -166.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp -61.59 126.75 28.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.208 -3.432 . . . . 25.969999999999999 113.898 169.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 41.7 mt-10 64.78 27.8 12.96 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.403 2.742 . . . . 32.609999999999999 118.403 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.2 m -90.67 154.44 19.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.056 2.836 . . . . 10.56 105.073 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.9 m -98.76 126.98 44.54 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.361 -2.2 . . . . 5.3300000000000001 105.249 -179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.4 mt -102.48 149.66 24.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.44 -2.037 . . . . 11.66 113.259 153.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -93.71 129.09 40.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.081 2.219 . . . . 16.300000000000001 112.246 172.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 10.4 tp -96.31 126.3 41.42 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.153 2.981 . . . . 9.9600000000000009 109.466 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.71 126.21 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 113.713 -1.585 . . . . 9.7599999999999998 108.602 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.7 mt -106.97 -178.75 3.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.795 1.934 . . . . 19.57 110.865 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -82.24 111.61 18.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.593 -3.192 . . . . 35.079999999999998 110.792 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.36 -52.11 3.32 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.445 -3.539 . . . . 32.310000000000002 101.445 172.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -101.99 -73.19 0.66 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 116.402 -3.936 . . . . 42.75 114.242 -175.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.31 140.62 3.36 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-O 117.194 -1.892 . . . . 36.310000000000002 110.253 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.76 0 CA-C-N 120.235 2.018 . . . . 36.270000000000003 116.515 -169.438 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 122.143 0.973 . . . . 17.170000000000002 113.216 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -80.12 109.78 14.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.969 -2.332 . . . . 21.890000000000001 111.863 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -96.67 154.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 116.106 -1.902 . . . . 10.83 113.984 165.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.283 21.2 m-85 -101.79 113.56 26.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.252 1.842 . . . . 10.609999999999999 111.398 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.2 t -111.67 95.77 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 101.01 -3.7 . . . . 9.1300000000000008 101.01 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.284 55.5 tttt -87.5 126.97 35.23 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.169 -1.832 . . . . 20.550000000000001 114.492 -167.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.1 p -83.46 158.04 22.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.265 1.983 . . . . 11.779999999999999 113.554 -173.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -74.1 -27.66 60.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.101 -3.5 . . . . 19.309999999999999 107.996 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -62.25 -60.24 3.86 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.873 -4.267 . . . . 23.140000000000001 113.77 175.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.12 41.98 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.755 0 O-C-N 117.109 -3.494 . . . . 19.739999999999998 114.566 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -140.21 163.11 33.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.868 2.834 . . . . 21.93 105.784 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.1 m -128.53 123.05 32.52 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.955 2.659 . . . . 12.33 106.073 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -83.49 119.84 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.991 -1.693 . . . . 17.079999999999998 113.96 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 p -81.47 90.72 6.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.657 -2.527 . . . . 16.300000000000001 114.996 165.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 tp -94.39 118.9 32.33 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.387 2.275 . . . . 15.880000000000001 108.184 -167.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -81.51 109.4 15.93 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.544 -1.348 . . . . 28.899999999999999 112.456 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.07 171.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 127.76 2.424 . . . . 12.050000000000001 110.243 167.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -108.27 173.94 2.74 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 126.673 1.989 . . . . 18.170000000000002 107.273 158.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -71.32 -3.09 12.28 Favored 'Trans proline' 0 N--CA 1.434 -2.015 1 C-N-CA 125.601 4.201 . . . . 8.1600000000000001 113.136 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -88.7 -25.42 22.35 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 111.634 -2.53 . . . . 11.130000000000001 111.276 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.8 138.64 46.53 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.594 2.14 . . . . 18.030000000000001 113.121 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -91.2 177.7 6.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.267 -1.788 . . . . 10.220000000000001 108.309 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -82.26 -22.09 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.084 -1.01 . . . . 12.300000000000001 109.318 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -61.26 -37.74 84.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.665 1.986 . . . . 36.509999999999998 114.483 161.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -68.5 -25.8 65.14 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 118.931 -2.356 . . . . 25.66 115.452 167.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.1 t -64.79 -56.68 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 128.493 2.717 . . . . 8.1199999999999992 111.115 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -56.46 -30.1 62.48 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 117.336 2.347 . . . . 15.470000000000001 117.336 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.67 -45.53 64.91 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.308 2.243 . . . . 11.449999999999999 111.84 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -69.74 -34.91 74.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.797 2.439 . . . . 24.98 112.454 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.9 mt -73.02 -27.24 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 113.489 0.922 . . . . 9.4600000000000009 113.489 166.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.256 16.6 tt0 -66.9 -33.04 74.71 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.662 -5.649 . . . . 14.76 111.504 170.327 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.56 -58.46 4.25 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.45 2.7 . . . . 26.289999999999999 115.281 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -63.67 -71.97 0.15 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 114.808 1.411 . . . . 30.059999999999999 114.808 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -96.66 -22.39 17.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.326 -2.734 . . . . 25.190000000000001 113.222 -169.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.58 31.76 8.6 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.487 -1.383 . . . . 7.4100000000000001 114.484 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.6 mt -97.03 126.17 43.39 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 114.65 -2.595 . . . . 9.4900000000000002 106.606 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.26 0.1 OUTLIER -68.2 160.35 49.2 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 124.599 1.842 . . . . 11.42 114.969 -176.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -74.9 -11.76 21.7 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 123.321 2.222 . . . . 12.0 113.905 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -77.51 -7.84 56.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.987 -2.946 . . . . 35.549999999999997 112.969 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -110.22 -18.94 13.18 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.398 -2.064 . . . . 20.52 110.045 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -80.61 108.87 14.61 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 121.034 3.716 . . . . 7.1299999999999999 121.034 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -104.7 153.21 21.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.583 -1.189 . . . . 36.390000000000001 110.351 160.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -127.46 141.99 51.52 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.444 -2.035 . . . . 9.5500000000000007 112.665 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 pt -130.09 164.66 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 106.976 -1.491 . . . . 13.9 106.976 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.88 -88.77 0.17 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.325 2.266 . . . . 6.8600000000000003 111.345 167.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.98 -61.79 1.39 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.261 -3.399 . . . . 11.15 104.542 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.37 -37.84 0.9 Allowed Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 118.696 2.238 . . . . 13.93 118.696 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -71.38 128.98 37.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.312 2.338 . . . . 23.920000000000002 117.312 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -75.29 118.17 17.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.515 -2.616 . . . . 23.23 112.005 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.7 mt -72.52 132.61 44.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.142 2.401 . . . . 9.1099999999999994 111.144 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.272 28.7 mt-10 -97.09 155.66 16.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.427 -2.064 . . . . 33.439999999999998 105.427 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.81 -62.1 1.62 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.56 3.144 . . . . 28.370000000000001 112.392 -166.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.38 21.72 30.55 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 124.906 3.503 . . . . 15.0 115.249 -157.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.501 HH21 ' CG ' ' A' ' 58' ' ' ASP . 72.2 mtp180 -115.97 156.22 26.65 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 121.106 2.453 . . . . 25.5 108.375 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.9 p -84.73 163.65 19.03 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.007 -2.933 . . . . 11.949999999999999 111.206 -169.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.8 mt -73.34 -13.6 61.14 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.965 -4.834 . . . . 10.17 114.869 170.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 t -70.19 -39.14 75.39 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.499 -3.251 . . . . 13.59 108.665 167.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.501 ' CG ' HH21 ' A' ' 54' ' ' ARG . 16.7 t0 -63.29 -40.34 97.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.983 1.845 . . . . 11.699999999999999 115.983 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -79.4 -31.3 42.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 117.3 -1.333 . . . . 12.949999999999999 111.833 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.274 68.7 m-80 72.77 54.02 0.14 Allowed 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.365 4.266 . . . . 25.449999999999999 106.829 -176.835 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.3 mt -98.51 106.95 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.217 3.007 . . . . 14.6 107.704 169.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -102.94 -166.5 1.28 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.368 -2.083 . . . . 33.229999999999997 111.567 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -66.33 135.62 54.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.425 1.49 . . . . 25.969999999999999 110.063 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.359 51.4 mt-10 65.37 40.91 4.52 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.229 1.566 . . . . 32.609999999999999 115.229 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 t -109.13 149.48 29.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.565 -3.834 . . . . 10.56 111.055 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.295 78.2 m -97.66 109.55 22.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.814 1.646 . . . . 5.3300000000000001 110.1 -170.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.1 mt -108.13 155.11 20.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.745 -1.946 . . . . 11.66 105.745 171.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -120.3 137.34 54.31 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.143 -1.598 . . . . 16.300000000000001 113.569 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.1 tp -91.75 110.35 21.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.193 -1.367 . . . . 9.9600000000000009 111.611 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.97 144.79 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 127.846 2.459 . . . . 9.7599999999999998 112.162 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -107.16 170.64 7.83 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 115.205 -4.685 . . . . 19.57 110.483 -175.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -109.26 164.66 12.26 Favored 'General case' 0 N--CA 1.43 -1.434 1 N-CA-C 99.791 -4.152 . . . . 35.079999999999998 99.791 -175.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.2 tp -89.36 -61.44 1.7 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.383 -2.08 . . . . 32.310000000000002 105.383 163.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.4 tpp180 -167.44 -91.77 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.79 -3.693 . . . . 42.75 110.694 -166.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.26 120.16 5.91 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 106.58 -2.608 . . . . 36.310000000000002 106.58 177.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.792 0 CA-C-O 113.971 -3.683 . . . . 36.270000000000003 107.32 -178.549 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HB2' ' HG3' ' A' ' 63' ' ' LYS 0.25 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.331 0 N-CA-C 115.738 1.755 . . . . 17.170000000000002 115.738 . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.34 29.9 mt-30 -103.16 145.2 30.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.159 3.022 . . . . 21.890000000000001 119.159 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.32 29.3 pt -123.36 155.12 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 122.483 2.401 . . . . 10.83 106.679 166.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -112.12 137.43 50.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.396 -2.184 . . . . 10.609999999999999 108.505 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.22 123.07 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 123.023 1.392 . . . . 9.1300000000000008 111.253 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -100.14 125.79 46.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.001 -1.952 . . . . 20.550000000000001 113.434 -170.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.418 HG21 HD23 ' A' ' 69' ' ' LEU . 22.3 p -83.48 173.85 11.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.28 1.215 . . . . 11.779999999999999 114.28 175.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.7 tp -71.84 -43.06 66.18 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.836 1.779 . . . . 19.309999999999999 112.878 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -67.56 -23.05 65.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.003 -1.061 . . . . 23.140000000000001 109.603 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.53 10.9 8.29 Favored Glycine 0 N--CA 1.429 -1.786 1 N-CA-C 123.781 4.272 . . . . 19.739999999999998 123.781 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.519 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 77.0 tttt -86.49 146.35 26.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.112 -2.551 . . . . 21.93 104.112 -171.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 m -110.16 104.62 13.49 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.588 0.709 . . . . 12.33 112.736 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -84.04 129.23 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.69 2.796 . . . . 17.079999999999998 112.401 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -106.19 116.56 32.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.982 -2.324 . . . . 16.300000000000001 113.196 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.271 0.6 OUTLIER -118.77 131.4 56.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.642 1.839 . . . . 15.880000000000001 106.177 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -94.49 122.09 36.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.197 -2.815 . . . . 28.899999999999999 108.46 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.18 174.38 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.059 -1.428 . . . . 12.050000000000001 113.462 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -103.05 -173.97 0.32 Allowed Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 103.829 -2.656 . . . . 18.170000000000002 103.829 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -74.41 -29.5 9.25 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 C-N-CA 127.309 5.34 . . . . 8.1600000000000001 110.184 160.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 94.7 p -68.25 -28.55 67.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.797 2.888 . . . . 11.130000000000001 118.797 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -71.86 162.35 29.58 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.728 1.251 . . . . 18.030000000000001 112.94 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.6 p -104.61 175.25 5.55 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.83 -3.669 . . . . 10.220000000000001 112.389 -173.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -65.24 -25.39 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.652 -2.53 . . . . 12.300000000000001 113.122 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.13 -37.76 88.47 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 117.726 2.491 . . . . 36.509999999999998 117.726 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.423 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 28.2 m120 -62.84 -43.4 98.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.363 1.246 . . . . 25.66 114.363 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -54.44 -38.2 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 126.095 1.758 . . . . 8.1199999999999992 107.506 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -75.72 -26.66 57.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.409 -1.432 . . . . 15.470000000000001 113.16 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.11 74.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.964 -2.96 . . . . 11.449999999999999 109.073 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 50.4 mttm -72.23 -43.24 64.72 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.801 3.641 . . . . 24.98 114.424 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 91.2 mt -55.25 -40.04 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 128.224 3.869 . . . . 9.4600000000000009 117.503 164.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -63.37 -44.28 95.24 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 110.904 -7.372 . . . . 14.76 114.584 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.14 -50.99 68.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.395 2.739 . . . . 26.289999999999999 118.395 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -67.49 -56.4 9.7 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.714 2.005 . . . . 30.059999999999999 115.582 -175.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.519 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 61.3 mm-40 -98.58 -22.78 15.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.688 1.595 . . . . 25.190000000000001 113.525 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.59 23.39 31.16 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 125.601 2.778 . . . . 7.4100000000000001 116.464 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 mt -102.7 120.11 53.78 Favored Pre-proline 0 N--CA 1.43 -1.441 1 O-C-N 115.553 -4.498 . . . . 9.4900000000000002 104.21 -168.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -66.6 150.39 83.87 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 CA-C-N 126.784 3.459 . . . . 11.42 116.95 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -85.98 -4.75 8.82 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 CA-C-O 115.513 -1.953 . . . . 12.0 114.244 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -70.48 -36.37 73.82 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.38 1.9 . . . . 35.549999999999997 110.27 165.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -70.07 -28.43 65.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.053 2.541 . . . . 20.52 112.817 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -83.38 130.77 35.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 126.24 2.924 . . . . 7.1299999999999999 116.229 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -122.14 135.8 54.83 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 103.692 -2.707 . . . . 36.390000000000001 103.692 170.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.2 mt -113.67 137.33 51.76 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 124.253 0.97 . . . . 9.5500000000000007 109.643 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 pt -123.4 169.44 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 117.305 -1.758 . . . . 13.9 110.893 171.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.5 t80 -85.61 -90.46 0.1 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 117.217 -1.793 . . . . 6.8600000000000003 106.681 161.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.8 -16.55 13.15 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.023 1.86 . . . . 11.15 116.023 171.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.55 -32.63 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 O-C-N 117.782 -3.074 . . . . 13.93 115.931 172.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -76.99 135.24 38.68 Favored 'General case' 0 N--CA 1.43 -1.465 1 CA-C-O 129.406 4.431 . . . . 23.920000000000002 109.482 174.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -75.83 152.48 37.25 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 114.584 -5.073 . . . . 23.23 117.866 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.0 mt -118.31 117.71 29.82 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.457 -2.027 . . . . 9.1099999999999994 106.19 -171.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -108.2 151.6 25.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.579 3.085 . . . . 33.439999999999998 114.73 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.335 2.1 m-20 -37.06 -70.48 0.09 Allowed 'General case' 0 N--CA 1.429 -1.484 1 C-N-CA 134.754 5.222 . . . . 28.370000000000001 113.827 -166.47 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.37 23.15 33.29 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 116.958 -2.544 . . . . 15.0 117.04 -156.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.431 HH21 ' CG ' ' A' ' 58' ' ' ASP . 73.0 mtp180 -105.71 161.32 14.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.206 1.503 . . . . 25.5 111.477 169.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 p -91.03 170.18 10.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.678 -3.139 . . . . 11.949999999999999 112.465 -174.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.64 -38.78 84.33 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 117.92 -2.987 . . . . 10.17 113.675 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.59 -39.21 16.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.438 -3.289 . . . . 13.59 112.153 162.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.431 ' CG ' HH21 ' A' ' 54' ' ' ARG . 23.9 t0 -82.69 -32.57 27.99 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 119.7 -1.875 . . . . 11.699999999999999 112.281 -173.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.287 77.0 m-85 -88.72 -7.78 55.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.676 1.58 . . . . 12.949999999999999 111.438 170.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 m120 81.23 29.83 0.16 Allowed 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 131.721 4.009 . . . . 25.449999999999999 108.415 166.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mt -75.99 132.54 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 117.72 -3.113 . . . . 14.6 104.099 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -96.43 -177.51 3.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.199 -1.819 . . . . 33.229999999999997 113.117 -171.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.56 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 19.8 ttpp -69.51 131.08 44.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.653 -1.905 . . . . 25.969999999999999 106.551 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 53.29 59.34 4.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.208 1.403 . . . . 32.609999999999999 108.145 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 t -98.84 147.42 24.95 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.799 -1.186 . . . . 10.56 107.799 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -90.6 114.52 26.8 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.869 1.356 . . . . 5.3300000000000001 108.306 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 mt -100.76 154.63 18.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.927 -1.733 . . . . 11.66 109.473 167.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -108.7 132.21 54.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.254 2.454 . . . . 16.300000000000001 111.016 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.418 HD23 HG21 ' A' ' 7' ' ' THR . 33.8 tp -102.0 128.39 48.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.53 -3.231 . . . . 9.9600000000000009 109.221 -175.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.8 98.47 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 112.492 -2.14 . . . . 9.7599999999999998 107.031 -167.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.33 -159.3 0.3 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.486 2.402 . . . . 19.57 117.486 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -101.49 100.92 11.42 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 116.385 -3.947 . . . . 35.079999999999998 110.651 173.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 tp -102.73 -62.35 1.29 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.677 1.126 . . . . 32.310000000000002 111.541 -171.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.32 -83.46 0.15 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 101.858 -3.386 . . . . 42.75 101.858 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.3 150.09 21.58 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 122.871 2.578 . . . . 36.310000000000002 115.57 168.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 O-C-N 116.955 -3.674 . . . . 36.270000000000003 111.445 173.617 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 116.606 -1.664 . . . . 17.170000000000002 112.437 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.86 138.77 31.29 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 125.809 1.943 . . . . 21.890000000000001 109.868 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.5 pt -119.97 148.52 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 129.797 3.239 . . . . 10.83 104.664 158.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -100.41 118.9 37.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.367 1.467 . . . . 10.609999999999999 112.944 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.81 122.52 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 116.891 -3.631 . . . . 9.1300000000000008 112.114 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -102.3 141.94 34.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.187 -1.005 . . . . 20.550000000000001 109.76 -173.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.6 p -84.66 176.15 8.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.089 -2.257 . . . . 11.779999999999999 110.8 171.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -60.74 -49.95 75.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.495 -2.628 . . . . 19.309999999999999 114.427 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 66.2 p -62.53 -57.36 11.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.901 3.68 . . . . 23.140000000000001 109.257 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.0 49.43 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 126.797 2.141 . . . . 19.739999999999998 110.767 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -93.17 143.73 25.97 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.794 -3.18 . . . . 21.93 112.01 161.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.272 25.1 m -108.85 107.28 17.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 126.285 2.945 . . . . 12.33 113.801 -176.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -86.09 117.37 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 110.151 -3.204 . . . . 17.079999999999998 109.287 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.47 131.2 49.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.921 -1.737 . . . . 16.300000000000001 109.333 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -123.55 134.37 53.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.892 -1.151 . . . . 15.880000000000001 107.892 176.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -109.7 114.57 28.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.772 -1.936 . . . . 28.899999999999999 105.772 -170.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.9 177.59 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 104.784 -2.302 . . . . 12.050000000000001 104.784 -152.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -111.42 171.1 4.6 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 126.828 2.051 . . . . 18.170000000000002 107.453 168.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -79.53 -14.15 13.04 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 123.142 2.158 . . . . 8.1600000000000001 107.647 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -93.54 9.74 35.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.541 1.682 . . . . 11.130000000000001 115.541 -175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -80.62 139.41 36.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.288 1.835 . . . . 18.030000000000001 114.522 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -90.49 170.34 10.29 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.442 -3.911 . . . . 10.220000000000001 107.901 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.7 mm -71.38 -29.0 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 116.845 -3.659 . . . . 12.300000000000001 108.235 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -51.81 -51.51 55.97 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.284 3.033 . . . . 36.509999999999998 112.902 164.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -54.44 -43.34 71.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.729 2.862 . . . . 25.66 118.729 172.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.17 -43.15 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 117.88 -1.057 . . . . 8.1199999999999992 109.039 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -57.96 -36.04 72.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.267 1.951 . . . . 15.470000000000001 116.267 166.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.22 -35.84 65.34 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.117 2.567 . . . . 11.449999999999999 115.741 170.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -81.26 -29.99 34.2 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 127.398 2.936 . . . . 24.98 109.446 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.7 mt -65.42 -43.3 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 121.256 1.844 . . . . 9.4600000000000009 115.951 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -53.95 -39.61 66.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.154 -2.355 . . . . 14.76 114.521 167.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.258 21.2 t70 -68.33 -53.44 24.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.386 2.357 . . . . 26.289999999999999 115.159 164.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -63.02 -43.8 97.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 120.191 3.404 . . . . 30.059999999999999 120.191 -169.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -100.28 -30.19 12.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.961 -2.337 . . . . 25.190000000000001 108.874 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.4 37.46 12.23 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 112.715 -2.039 . . . . 7.4100000000000001 110.188 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mt -102.68 128.47 27.91 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 118.627 -2.69 . . . . 9.4900000000000002 111.919 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -67.85 146.15 71.08 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 124.914 3.743 . . . . 11.42 108.299 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -81.15 2.28 8.69 Favored 'Trans proline' 0 C--N 1.3 -2.005 1 C-N-CA 127.345 5.364 . . . . 12.0 114.533 -165.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.43 -47.56 6.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.67 -1.894 . . . . 35.549999999999997 107.818 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -52.05 -29.44 21.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.967 1.84 . . . . 20.52 115.967 162.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -71.84 136.21 46.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.771 2.829 . . . . 7.1299999999999999 116.731 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -118.09 105.98 12.4 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.851 -1.537 . . . . 36.390000000000001 106.851 161.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.3 tp -102.11 120.75 40.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.546 -3.222 . . . . 9.5500000000000007 105.995 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 pt -127.24 170.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 125.323 1.449 . . . . 13.9 107.132 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -96.6 -55.57 2.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.058 1.743 . . . . 6.8600000000000003 113.364 169.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.44 -80.71 0.4 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.074 1.35 . . . . 11.15 113.75 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.47 -12.81 2.98 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.545 -1.347 . . . . 13.93 115.578 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -97.18 124.94 41.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 114.604 -2.617 . . . . 23.920000000000002 113.673 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -52.25 119.36 4.31 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.962 1.71 . . . . 23.23 111.965 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.2 mt -81.76 142.72 32.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.836 2.732 . . . . 9.1099999999999994 114.364 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -80.56 124.69 29.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.502 2.721 . . . . 33.439999999999998 107.288 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.319 36.4 m-20 -45.29 -56.28 5.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.323 3.083 . . . . 28.370000000000001 119.323 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.59 10.84 65.77 Favored Glycine 0 N--CA 1.43 -1.735 0 CA-C-O 117.024 -1.987 . . . . 15.0 116.631 -157.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -98.87 152.07 20.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 118.155 0.978 . . . . 25.5 108.864 -176.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.5 p -80.55 161.54 24.73 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.684 2.105 . . . . 11.949999999999999 116.684 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.6 mt -76.07 -29.71 58.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.084 -2.562 . . . . 10.17 104.084 -171.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.2 t -60.99 -46.88 88.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.119 2.137 . . . . 13.59 112.928 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -58.32 -47.96 82.04 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.596 2.758 . . . . 11.699999999999999 111.085 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -61.98 -34.23 75.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 131.391 3.876 . . . . 12.949999999999999 114.332 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.481 10.3 m120 92.49 29.53 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.038 2.086 . . . . 25.449999999999999 113.051 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.7 mt -89.11 108.64 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 127.542 2.337 . . . . 14.6 111.409 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -87.55 179.26 6.58 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.04 -4.162 . . . . 33.229999999999997 114.978 -169.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -63.31 126.19 26.61 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.497 3.046 . . . . 25.969999999999999 114.888 167.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.394 68.4 mt-10 75.43 42.8 0.22 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.881 3.273 . . . . 32.609999999999999 110.27 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -109.93 141.78 42.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.688 1.995 . . . . 10.56 107.969 -173.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.1 m -90.74 129.04 36.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.281 1.956 . . . . 5.3300000000000001 116.281 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.49 171.85 7.24 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.054 -1.462 . . . . 11.66 107.054 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -135.39 127.41 29.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.937 2.78 . . . . 16.300000000000001 105.285 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.7 tp -96.84 114.63 26.27 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.138 2.399 . . . . 9.9600000000000009 108.285 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.252 37.6 t -101.25 151.58 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 101.543 -3.503 . . . . 9.7599999999999998 101.543 170.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.7 mt -100.49 -172.83 2.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.429 -1.323 . . . . 19.57 107.429 173.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -87.74 -46.38 9.52 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.533 2.587 . . . . 35.079999999999998 115.657 -168.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.8 tp -83.72 -75.2 0.34 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.31 -3.994 . . . . 32.310000000000002 113.83 -171.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -94.92 141.94 28.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.189 -0.914 . . . . 42.75 111.499 -172.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.77 -161.79 11.02 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 108.515 -1.834 . . . . 36.310000000000002 108.515 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 CA-C-O 116.245 -2.419 . . . . 36.270000000000003 113.315 178.068 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.268 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 118.151 2.649 . . . . 17.170000000000002 118.151 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -80.61 134.15 35.86 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.22 1.933 . . . . 21.890000000000001 116.22 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.6 pt -124.45 149.34 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 112.833 -1.985 . . . . 10.83 109.195 166.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -103.96 132.68 49.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 102.567 -3.123 . . . . 10.609999999999999 102.567 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.45 109.25 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 126.224 1.81 . . . . 9.1300000000000008 106.729 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -95.58 132.35 40.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.045 3.307 . . . . 20.550000000000001 108.693 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -91.29 175.91 6.76 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.316 -3.365 . . . . 11.779999999999999 114.287 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.485 HD11 ' H ' ' A' ' 71' ' ' LEU . 84.5 mt -75.47 -28.19 59.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.536 -1.211 . . . . 19.309999999999999 113.775 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.354 82.5 p -83.63 -24.33 31.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 120.496 1.498 . . . . 23.140000000000001 107.968 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.29 52.12 0.22 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.397 -2.689 . . . . 19.739999999999998 107.861 161.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -131.01 135.26 47.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.296 -4.061 . . . . 21.93 103.738 -175.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.7 m -106.65 107.45 18.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.309 2.48 . . . . 12.33 108.29 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -98.99 133.02 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 128.416 2.687 . . . . 17.079999999999998 110.329 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.4 m -98.42 112.63 24.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.673 -1.232 . . . . 16.300000000000001 107.673 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -102.35 164.48 11.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.372 2.511 . . . . 15.880000000000001 107.338 172.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.67 106.28 9.61 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 115.302 -4.624 . . . . 28.899999999999999 102.326 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -109.44 175.66 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 123.445 1.593 . . . . 12.050000000000001 109.726 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -115.89 143.48 30.87 Favored Pre-proline 0 N--CA 1.43 -1.46 1 CA-C-O 109.792 -4.909 . . . . 18.170000000000002 105.795 162.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -60.13 -11.12 14.62 Favored 'Trans proline' 0 N--CA 1.434 -2.023 2 CA-C-N 130.774 4.883 . . . . 8.1600000000000001 117.737 176.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.8 m -74.0 -19.09 60.76 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.252 2.221 . . . . 11.130000000000001 116.183 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.13 156.28 38.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.542 2.337 . . . . 18.030000000000001 111.039 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 p -107.95 163.61 12.99 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.775 -1.557 . . . . 10.220000000000001 115.072 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -63.24 -26.02 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 114.319 -2.753 . . . . 12.300000000000001 109.952 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.89 -44.96 93.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.586 1.803 . . . . 36.509999999999998 108.777 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -63.95 -47.53 80.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.819 -3.05 . . . . 25.66 111.776 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 1.5 t -60.8 -43.39 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 120.938 1.699 . . . . 8.1199999999999992 113.098 173.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -59.46 -32.16 69.98 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 115.682 -2.104 . . . . 15.470000000000001 114.657 170.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.09 -51.15 65.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.204 1.82 . . . . 11.449999999999999 110.881 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.05 -36.09 78.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.953 2.205 . . . . 24.98 116.953 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 mt -70.1 -39.66 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 124.822 2.249 . . . . 9.4600000000000009 111.531 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.4 -36.93 76.74 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 111.811 -6.806 . . . . 14.76 113.791 168.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -75.18 -29.92 60.52 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 116.227 -4.046 . . . . 26.289999999999999 109.754 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -75.91 -47.12 26.52 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 117.837 2.532 . . . . 30.059999999999999 117.837 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -100.34 -27.1 13.65 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.71 -1.132 . . . . 25.190000000000001 113.406 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.92 6.4 54.19 Favored Glycine 0 N--CA 1.431 -1.668 0 O-C-N 116.77 -3.706 . . . . 7.4100000000000001 117.415 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.9 mm -99.05 137.04 20.4 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-N 120.657 2.229 . . . . 9.4900000000000002 106.206 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -65.71 154.21 74.84 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 N-CA-C 119.094 2.69 . . . . 11.42 119.094 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -88.46 -7.49 5.74 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-N 125.953 3.162 . . . . 12.0 107.396 -155.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -82.39 -18.29 42.48 Favored 'General case' 0 N--CA 1.429 -1.483 1 C-N-CA 131.789 4.036 . . . . 35.549999999999997 112.248 167.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -85.81 -24.84 26.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.644 -1.91 . . . . 20.52 113.313 165.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -83.84 138.3 33.27 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.615 2.366 . . . . 7.1299999999999999 113.759 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -142.61 122.28 13.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.864 -1.902 . . . . 36.390000000000001 105.864 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -101.23 125.96 47.91 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.363 1.865 . . . . 9.5500000000000007 108.533 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.421 HG13 ' HB2' ' A' ' 68' ' ' HIS . 5.8 pt -127.56 154.27 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.149 -2.908 . . . . 13.9 103.149 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.43 -63.31 1.22 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.889 -1.757 . . . . 6.8600000000000003 113.382 173.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.58 -36.39 0.78 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.904 -2.373 . . . . 11.15 106.64 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.06 -14.72 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.109 1.814 . . . . 13.93 116.253 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -103.12 148.66 25.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.622 -2.031 . . . . 23.920000000000002 106.708 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -81.97 110.37 17.17 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 127.784 6.216 . . . . 23.23 127.784 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.8 mt -87.32 112.87 22.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.9 -2.375 . . . . 9.1099999999999994 107.191 -169.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -110.11 148.49 31.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.542 2.591 . . . . 33.439999999999998 107.447 -159.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -44.07 -61.82 1.35 Allowed 'General case' 0 N--CA 1.431 -1.424 1 C-N-CA 131.815 4.046 . . . . 28.370000000000001 118.365 -169.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.37 -22.21 72.8 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 128.422 2.915 . . . . 15.0 110.326 -155.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -100.27 159.65 14.95 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.773 1.229 . . . . 25.5 112.814 -167.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.419 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 22.6 p -74.69 156.33 36.76 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 114.432 -2.699 . . . . 11.949999999999999 117.425 177.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.272 14.8 mt -54.39 -37.11 64.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 120.031 3.345 . . . . 10.17 120.031 160.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -64.1 -25.9 68.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.751 2.13 . . . . 13.59 116.751 171.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 60.6 m-20 -73.02 -22.28 60.68 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.033 -1.937 . . . . 11.699999999999999 110.117 169.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -96.75 -12.5 23.63 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.534 1.97 . . . . 12.949999999999999 114.257 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.29 14.4 m120 59.5 46.0 12.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.666 3.986 . . . . 25.449999999999999 114.589 -172.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -81.48 108.86 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.067 -2.896 . . . . 14.6 112.154 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -88.07 178.72 6.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.318 2.34 . . . . 33.229999999999997 117.318 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -61.96 138.34 58.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 127.453 3.501 . . . . 25.969999999999999 113.103 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 60.52 31.03 20.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.705 3.202 . . . . 32.609999999999999 115.276 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.4 m -70.69 144.91 50.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.417 -1.719 . . . . 10.56 108.752 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -95.66 122.53 38.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.007 -2.59 . . . . 5.3300000000000001 104.007 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.3 mt -116.71 152.61 33.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.246 -2.501 . . . . 11.66 104.246 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.421 ' HB2' HG13 ' A' ' 44' ' ' ILE . 73.2 m80 -111.89 122.04 46.69 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-O 128.67 4.081 . . . . 16.300000000000001 107.748 -175.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.0 tp -85.51 135.62 33.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.827 -3.046 . . . . 9.9600000000000009 105.466 171.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.2 t -130.76 151.91 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 102.761 -3.052 . . . . 9.7599999999999998 102.761 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.485 ' H ' HD11 ' A' ' 8' ' ' LEU . 54.5 mt -114.23 157.39 22.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.24 -1.538 . . . . 19.57 110.952 170.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -63.29 -63.13 1.28 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.572 2.42 . . . . 35.079999999999998 109.84 -165.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.85 -50.23 6.0 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.387 1.875 . . . . 32.310000000000002 114.899 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -79.77 75.8 6.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.985 1.476 . . . . 42.75 114.985 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.98 161.7 16.27 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 119.561 2.584 . . . . 36.310000000000002 119.561 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.755 0 O-C-N 121.422 -1.046 . . . . 36.270000000000003 115.481 176.423 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.607 1.336 . . . . 17.170000000000002 114.607 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -95.15 142.47 27.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.168 0.987 . . . . 21.890000000000001 111.595 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.29 168.57 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.346 -2.094 . . . . 10.83 105.346 159.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -118.34 158.04 25.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.862 1.792 . . . . 10.609999999999999 114.321 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -124.4 121.25 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.389 3.476 . . . . 9.1300000000000008 106.866 167.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -106.48 127.58 53.41 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 124.018 1.866 . . . . 20.550000000000001 107.772 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 p -88.84 166.24 14.12 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.678 1.704 . . . . 11.779999999999999 106.642 -173.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.2 mt -65.95 -45.35 82.11 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 129.703 3.201 . . . . 19.309999999999999 110.53 169.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.0 p -64.31 -29.67 70.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.901 2.481 . . . . 23.140000000000001 117.576 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.39 29.46 1.92 Allowed Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 114.157 -1.383 . . . . 19.739999999999998 109.916 167.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -92.66 133.44 35.99 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.798 -3.766 . . . . 21.93 112.714 164.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.3 m -100.63 119.02 37.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.935 -1.876 . . . . 12.33 105.935 167.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.7 mt -113.3 115.5 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 117.99 -2.943 . . . . 17.079999999999998 105.94 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.3 m -83.78 124.78 31.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 112.846 -3.454 . . . . 16.300000000000001 108.307 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.16 145.03 30.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 123.901 3.046 . . . . 15.880000000000001 111.211 167.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -98.87 131.74 44.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 118.816 -1.154 . . . . 28.899999999999999 112.225 167.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.08 171.94 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.889 1.676 . . . . 12.050000000000001 110.029 -166.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -118.6 171.79 4.88 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-N 122.105 2.23 . . . . 18.170000000000002 109.21 156.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.2 -30.57 72.05 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 N-CA-C 119.5 2.846 . . . . 8.1600000000000001 119.5 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.7 m -92.58 14.64 16.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.805 -3.059 . . . . 11.130000000000001 112.474 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.47 138.08 41.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.052 -3.53 . . . . 18.030000000000001 115.944 171.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 p -85.05 164.1 18.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 112.592 -2.095 . . . . 10.220000000000001 109.822 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.351 3.9 mm -78.62 -17.6 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 117.876 -3.015 . . . . 12.300000000000001 111.29 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -62.26 -51.73 66.56 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.902 2.881 . . . . 36.509999999999998 110.678 164.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -66.63 -25.29 66.52 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.411 -1.431 . . . . 25.66 110.693 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.67 -56.2 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.595 2.072 . . . . 8.1199999999999992 116.595 167.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -50.6 -30.55 13.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.271 3.434 . . . . 15.470000000000001 120.271 164.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.83 -42.76 97.54 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.253 2.316 . . . . 11.449999999999999 117.253 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -61.78 -31.53 71.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.3 1.963 . . . . 24.98 116.3 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -85.0 -40.52 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.092 1.757 . . . . 9.4600000000000009 111.143 -179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -48.24 -51.34 25.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.595 2.758 . . . . 14.76 116.915 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.58 -39.78 74.09 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.776 2.83 . . . . 26.289999999999999 112.662 166.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -87.42 -70.99 0.59 Allowed 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.051 -4.156 . . . . 30.059999999999999 109.209 -168.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -89.96 -26.47 20.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.117 -3.489 . . . . 25.190000000000001 117.802 -171.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.81 43.45 4.48 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 117.22 -1.878 . . . . 7.4100000000000001 115.75 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mm -90.82 124.39 62.29 Favored Pre-proline 0 N--CA 1.43 -1.468 1 CA-C-O 110.872 -4.394 . . . . 9.4900000000000002 107.397 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -77.04 147.25 26.42 Favored 'Trans proline' 0 C--N 1.3 -2.022 1 CA-C-N 129.741 4.515 . . . . 11.42 112.033 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.08 -21.03 32.59 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-O 117.3 -1.208 . . . . 12.0 114.153 -159.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -71.45 -27.86 63.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 123.563 2.892 . . . . 35.549999999999997 111.994 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.277 88.4 mm-40 -77.24 -23.42 51.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.422 1.889 . . . . 20.52 111.096 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -77.28 107.37 9.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 113.812 1.041 . . . . 7.1299999999999999 113.812 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -112.78 114.23 26.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.346 2.022 . . . . 36.390000000000001 109.921 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.7 mt -100.2 117.85 35.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.892 -1.755 . . . . 9.5500000000000007 109.839 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.552 HG13 ' HB2' ' A' ' 68' ' ' HIS . 36.5 pt -98.19 156.64 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.415 2.286 . . . . 13.9 112.797 166.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -79.86 -68.87 0.63 Allowed 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 123.396 1.569 . . . . 6.8600000000000003 107.929 162.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.54 -60.79 0.98 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.051 -2.203 . . . . 11.15 105.051 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.16 -25.18 1.71 Allowed Glycine 0 N--CA 1.43 -1.731 1 C-N-CA 134.965 6.031 . . . . 13.93 114.451 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 139.72 33.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.012 -3.052 . . . . 23.920000000000002 109.482 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -90.29 147.82 23.27 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.162 0.982 . . . . 23.23 112.661 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mt -99.71 118.72 36.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.118 1.767 . . . . 9.1099999999999994 110.391 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -95.21 147.85 23.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.939 -1.105 . . . . 33.439999999999998 111.002 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.04 -47.62 8.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.435 3.094 . . . . 28.370000000000001 116.094 -166.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.19 31.61 7.81 Favored Glycine 0 N--CA 1.431 -1.694 1 CA-C-O 112.914 -4.27 . . . . 15.0 115.746 -165.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -129.42 171.63 12.33 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.797 3.299 . . . . 25.5 105.588 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.4 p -99.97 169.0 9.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.942 2.155 . . . . 11.949999999999999 112.223 -174.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.6 -40.03 68.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.311 1.226 . . . . 10.17 114.311 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.9 t -63.83 -49.92 70.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 131.495 3.918 . . . . 13.59 112.384 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 38.6 m-20 -43.83 -58.0 2.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.665 3.186 . . . . 11.699999999999999 110.892 168.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.269 32.6 m-85 -54.58 -21.11 9.38 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 120.574 3.546 . . . . 12.949999999999999 120.574 171.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 m120 53.86 56.39 7.2 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.024 1.729 . . . . 25.449999999999999 112.234 -162.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -93.74 132.07 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.77 -3.081 . . . . 14.6 110.024 165.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -105.6 -165.56 1.12 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 119.76 -0.776 . . . . 33.229999999999997 111.506 -166.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -79.12 125.44 29.43 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 117.395 -1.722 . . . . 25.969999999999999 112.521 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.3 34.6 mt-10 68.22 27.43 6.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.115 2.166 . . . . 32.609999999999999 114.348 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -74.7 153.99 38.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.905 -3.622 . . . . 10.56 116.503 163.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.1 m -93.27 125.7 38.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.375 2.297 . . . . 5.3300000000000001 111.447 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -93.33 154.91 17.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.004 -2.591 . . . . 11.66 104.004 169.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.552 ' HB2' HG13 ' A' ' 44' ' ' ILE . 75.5 m80 -122.46 107.26 11.83 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 108.912 -0.773 . . . . 16.300000000000001 108.912 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -78.24 120.71 23.41 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 122.876 1.322 . . . . 9.9600000000000009 109.545 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.39 -179.65 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.737 2.415 . . . . 9.7599999999999998 107.421 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.9 mt -98.52 171.79 7.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.504 1.621 . . . . 19.57 112.789 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -83.74 -43.91 14.99 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.191 2.293 . . . . 35.079999999999998 117.191 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.53 -55.28 3.2 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.058 1.503 . . . . 32.310000000000002 115.058 173.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 mtm105 -86.57 152.6 22.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.539 0.94 . . . . 42.75 113.539 -170.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.99 88.32 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.72 1 CA-C-O 128.175 4.208 . . . . 36.310000000000002 112.789 -175.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.754 0 C-N-CA 128.925 3.155 . . . . 36.270000000000003 109.773 -174.257 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptt? . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 109.027 -0.731 . . . . 17.170000000000002 109.027 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -100.09 125.4 46.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.929 -2.357 . . . . 21.890000000000001 105.251 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -123.37 159.12 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.62 -3.175 . . . . 10.83 105.898 159.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -111.91 137.03 50.45 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.846 -3.034 . . . . 10.609999999999999 112.021 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.481 HG21 HD11 ' A' ' 30' ' ' ILE . 60.8 t -112.07 125.41 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 111.504 -2.589 . . . . 9.1300000000000008 109.572 169.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -107.11 124.62 49.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.567 -3.208 . . . . 20.550000000000001 110.535 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p -89.88 163.61 14.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.76 1.743 . . . . 11.779999999999999 111.438 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.04 -39.95 94.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.628 1.571 . . . . 19.309999999999999 113.987 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -73.59 -33.04 64.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.376 3.07 . . . . 23.140000000000001 105.915 -175.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.42 48.33 0.47 Allowed Glycine 0 N--CA 1.431 -1.696 0 CA-C-O 122.622 1.124 . . . . 19.739999999999998 115.651 160.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.23 125.84 52.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.053 -3.027 . . . . 21.93 108.241 168.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.6 m -93.21 95.06 9.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.084 2.554 . . . . 12.33 112.309 169.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.4 mt -102.9 125.47 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 131.064 3.746 . . . . 17.079999999999998 106.677 -159.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -81.55 119.84 24.28 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.285 -3.384 . . . . 16.300000000000001 114.308 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.2 142.71 36.5 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.884 -4.26 . . . . 15.880000000000001 109.465 174.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -110.28 105.52 14.59 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.4 3.88 . . . . 28.899999999999999 111.333 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.73 157.77 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 111.571 -2.559 . . . . 12.050000000000001 108.281 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -88.9 168.11 16.52 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 124.547 1.154 . . . . 18.170000000000002 113.247 159.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -70.56 -24.24 26.22 Favored 'Trans proline' 0 C--N 1.299 -2.036 1 O-C-N 112.537 -4.507 . . . . 8.1600000000000001 113.485 177.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -97.33 16.47 19.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.45 2.344 . . . . 11.130000000000001 116.106 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -67.89 136.76 54.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.712 2.805 . . . . 18.030000000000001 108.164 163.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.342 60.9 p -80.27 168.14 19.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.035 2.534 . . . . 10.220000000000001 107.145 -176.088 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 mm -75.9 -35.11 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 105.034 -2.21 . . . . 12.300000000000001 105.034 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -44.17 -46.28 8.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.795 2.146 . . . . 36.509999999999998 116.795 161.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.269 11.4 m120 -69.24 -32.48 71.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.65 -3.781 . . . . 25.66 111.843 173.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.12 -38.67 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 116.215 1.931 . . . . 8.1199999999999992 116.215 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -71.19 -22.34 62.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.065 -2.897 . . . . 15.470000000000001 116.085 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.86 72.91 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.029 -1.669 . . . . 11.449999999999999 114.333 171.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -70.97 -40.95 71.65 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.067 2.988 . . . . 24.98 119.067 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.481 HD11 HG21 ' A' ' 5' ' ' VAL . 74.8 mt -66.96 -32.28 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.622 -1.923 . . . . 9.4600000000000009 112.038 174.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -66.15 -43.1 88.0 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.674 2.39 . . . . 14.76 115.437 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -78.49 -28.31 46.38 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.553 1.979 . . . . 26.289999999999999 115.747 168.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.24 -68.35 0.5 Allowed 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.095 -4.128 . . . . 30.059999999999999 110.101 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -81.97 -49.08 10.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.653 2.933 . . . . 25.190000000000001 110.352 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.66 7.85 13.02 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.645 -2.534 . . . . 7.4100000000000001 111.711 -170.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mm -82.88 127.82 68.16 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 116.25 1.945 . . . . 9.4900000000000002 116.25 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -64.14 150.49 88.24 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 CA-C-O 115.515 -1.952 . . . . 11.42 116.915 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -71.89 -20.82 25.39 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 123.98 2.457 . . . . 12.0 114.488 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -64.35 -39.36 93.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.458 -2.211 . . . . 35.549999999999997 115.645 165.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -78.03 -24.74 47.71 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 127.204 2.815 . . . . 20.52 110.657 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -70.6 119.17 14.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.522 2.329 . . . . 7.1299999999999999 112.358 168.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -130.94 103.1 6.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.421 -2.807 . . . . 36.390000000000001 103.421 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -92.13 118.27 30.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.144 -2.222 . . . . 9.5500000000000007 108.789 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 pt -90.21 -179.22 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 113.821 1.045 . . . . 13.9 113.821 159.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -111.68 -77.68 0.59 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.061 -2.2 . . . . 6.8600000000000003 105.061 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.73 -50.63 2.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.29 2.236 . . . . 11.15 112.489 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.55 -24.17 0.85 Allowed Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 126.782 2.134 . . . . 13.93 112.356 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -113.78 146.27 40.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.733 -2.039 . . . . 23.920000000000002 114.697 -167.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -78.12 152.4 32.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.305 3.431 . . . . 23.23 115.928 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.1 mt -114.5 136.25 53.22 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 102.928 -2.989 . . . . 9.1099999999999994 102.928 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -104.77 139.12 40.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.628 -2.545 . . . . 33.439999999999998 108.85 -173.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -28.2 -55.36 0.11 Allowed 'General case' 0 N--CA 1.429 -1.482 1 N-CA-C 123.444 4.609 . . . . 28.370000000000001 123.444 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.93 -1.75 81.96 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.765 -2.459 . . . . 15.0 117.922 -164.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -93.35 167.61 11.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.879 3.271 . . . . 25.5 107.949 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.426 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -101.37 168.49 9.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.831 2.052 . . . . 11.949999999999999 111.811 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.26 -25.87 68.25 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 131.713 4.005 . . . . 10.17 111.677 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -59.6 -46.45 88.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.363 -3.336 . . . . 13.59 114.744 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.8 -40.0 87.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.675 -2.057 . . . . 11.699999999999999 110.363 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -85.05 -2.38 57.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.789 0.804 . . . . 12.949999999999999 109.486 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m120 65.09 46.7 2.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.274 2.464 . . . . 25.449999999999999 112.724 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 10.0 mt -90.02 114.12 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.985 -2.322 . . . . 14.6 110.175 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -97.16 166.18 11.7 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.194 2.998 . . . . 33.229999999999997 112.188 -175.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -55.63 134.11 50.95 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.88 1.808 . . . . 25.969999999999999 115.88 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 55.55 58.12 4.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.179 -1.828 . . . . 32.609999999999999 111.78 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 t -115.74 142.82 46.24 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.25 1.42 . . . . 10.56 108.972 173.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -98.5 124.18 43.08 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.66 1.695 . . . . 5.3300000000000001 115.47 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.79 156.59 17.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.152 3.381 . . . . 11.66 107.681 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -129.07 122.21 29.47 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.44 -2.059 . . . . 16.300000000000001 105.44 -172.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.43 105.76 17.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 112.886 -1.961 . . . . 9.9600000000000009 111.32 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 m -104.95 178.15 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 127.74 2.416 . . . . 9.7599999999999998 112.507 168.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -75.93 174.18 10.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.877 2.275 . . . . 19.57 115.711 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -59.04 -65.4 0.67 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.668 -3.145 . . . . 35.079999999999998 112.907 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.6 tp -89.9 -61.26 1.73 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 116.021 -0.536 . . . . 32.310000000000002 111.118 -172.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -87.47 142.35 27.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.666 2.469 . . . . 42.75 117.666 -168.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.38 156.78 28.52 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 119.235 -1.459 . . . . 36.310000000000002 112.627 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.764 0 CA-C-O 124.058 1.921 . . . . 36.270000000000003 116.181 176.308 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 ttp . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 122.407 1.098 . . . . 17.170000000000002 108.85 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -82.65 135.95 34.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.065 -1.647 . . . . 21.890000000000001 108.184 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.77 166.46 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 124.789 1.236 . . . . 10.83 109.296 165.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -125.61 104.05 8.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.563 -2.014 . . . . 10.609999999999999 105.563 -167.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.43 105.12 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.515 -2.031 . . . . 9.1300000000000008 105.515 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -108.68 126.15 52.67 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.474 0.654 . . . . 20.550000000000001 110.125 -174.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -80.69 -179.35 7.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.504 1.668 . . . . 11.779999999999999 115.504 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.06 -43.32 78.9 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.004 -4.185 . . . . 19.309999999999999 112.056 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -84.99 -21.22 29.59 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.271 -1.786 . . . . 23.140000000000001 108.927 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.28 70.82 0.93 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-O 124.928 2.404 . . . . 19.739999999999998 115.957 166.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -116.66 118.48 32.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 110.398 -2.901 . . . . 21.93 106.724 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -90.39 103.7 16.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 127.245 2.841 . . . . 12.33 110.383 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.2 mt -94.42 98.79 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.746 2.418 . . . . 17.079999999999998 113.075 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -73.47 122.42 22.11 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 119.991 1.268 . . . . 16.300000000000001 113.068 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.95 147.87 37.82 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.765 -3.709 . . . . 15.880000000000001 102.816 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -105.32 134.92 47.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.819 1.771 . . . . 28.899999999999999 108.209 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -148.87 -174.52 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.57 3.148 . . . . 12.050000000000001 105.968 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -141.6 162.77 45.08 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 114.75 -2.548 . . . . 18.170000000000002 108.227 170.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -23.23 76.64 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 C-N-CA 127.014 5.142 . . . . 8.1600000000000001 118.024 -169.15 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 5.3 p -94.28 -6.05 45.36 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.559 2.344 . . . . 11.130000000000001 110.683 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -74.93 167.09 22.58 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.495 -3.878 . . . . 18.030000000000001 115.201 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -89.42 170.13 10.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.283 2.697 . . . . 10.220000000000001 118.283 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mt -87.63 -13.15 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 117.53 -1.668 . . . . 12.300000000000001 108.527 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -59.31 -47.51 85.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.01 1.324 . . . . 36.509999999999998 113.556 160.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -55.83 -40.67 73.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.134 -2.854 . . . . 25.66 116.104 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.9 t -52.63 -54.93 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 117.145 -3.472 . . . . 8.1199999999999992 113.213 167.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -61.22 -30.12 70.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.791 1.636 . . . . 15.470000000000001 114.955 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -30.24 70.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.528 3.531 . . . . 11.449999999999999 113.997 166.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -92.78 -14.4 27.9 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 116.742 -1.983 . . . . 24.98 112.174 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.27 67.8 mt -64.2 -36.18 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.398 1.57 . . . . 9.4600000000000009 114.418 158.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -67.76 -21.52 65.26 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.748 -3.095 . . . . 14.76 116.112 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.48 -58.63 2.66 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.085 -2.561 . . . . 26.289999999999999 104.085 -175.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -64.83 -62.06 1.8 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.112 2.565 . . . . 30.059999999999999 115.89 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -81.16 -58.15 3.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.302 1.864 . . . . 25.190000000000001 111.734 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.25 17.35 3.67 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.111 -1.596 . . . . 7.4100000000000001 109.111 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.1 mt -90.58 131.21 38.65 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-O 115.445 -2.217 . . . . 9.4900000000000002 109.085 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -66.18 156.59 64.08 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 125.497 2.999 . . . . 11.42 116.606 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -68.73 -23.03 36.4 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 124.374 3.383 . . . . 12.0 112.319 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.252 10.1 p-10 -77.85 -28.46 50.09 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.248 3.019 . . . . 35.549999999999997 107.801 -170.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -69.38 -35.4 75.78 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.192 -1.568 . . . . 20.52 110.841 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -96.39 133.56 40.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.237 -0.887 . . . . 7.1299999999999999 111.606 -151.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -111.61 131.87 54.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 103.274 -2.861 . . . . 36.390000000000001 103.274 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -116.91 125.06 50.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.24 1.495 . . . . 9.5500000000000007 110.724 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 23.2 mm -95.11 132.32 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.288 2.235 . . . . 13.9 114.298 170.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -123.17 115.94 22.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.481 -2.637 . . . . 6.8600000000000003 109.013 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.84 -102.56 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.364 -0.835 . . . . 11.15 110.007 -172.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.42 34.2 2.39 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 118.822 -2.424 . . . . 13.93 113.017 164.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.345 21.2 ttmm -120.16 144.11 47.85 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 112.735 -1.732 . . . . 23.920000000000002 115.145 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -81.42 135.49 35.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.763 1.744 . . . . 23.23 113.372 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.8 mt -89.26 145.74 25.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.069 -2.197 . . . . 9.1099999999999994 105.069 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -87.12 160.78 18.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.013 -2.422 . . . . 33.439999999999998 114.41 159.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.95 -41.55 13.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.888 2.551 . . . . 28.370000000000001 117.888 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.58 17.87 58.5 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 116.7 -2.667 . . . . 15.0 108.473 -170.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -90.18 165.92 13.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.163 -3.551 . . . . 25.5 109.817 161.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.9 p -102.13 174.26 6.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.849 3.214 . . . . 11.949999999999999 104.111 -176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.14 -37.5 83.91 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.691 2.796 . . . . 10.17 109.783 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.254 67.7 m -61.5 -42.67 99.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 113.241 0.83 . . . . 13.59 113.241 176.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -53.0 -44.45 67.26 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 121.057 3.725 . . . . 11.699999999999999 121.057 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -79.33 -15.76 57.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 125.715 1.884 . . . . 12.949999999999999 115.865 165.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 68.56 71.57 0.29 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.357 2.663 . . . . 25.449999999999999 110.303 -169.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.274 82.4 mt -109.15 114.51 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 113.332 -3.347 . . . . 14.6 110.004 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -100.13 -166.39 1.32 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.9 2.185 . . . . 33.229999999999997 116.9 -171.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 137.62 55.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.63 1.681 . . . . 25.969999999999999 112.197 -171.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.47 80.4 mt-10 72.74 12.12 5.35 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 116.703 -3.748 . . . . 32.609999999999999 118.091 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.1 t -86.46 137.66 32.37 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 125.763 1.914 . . . . 10.56 108.704 -165.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 m -87.25 115.34 24.59 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.234 -1.803 . . . . 5.3300000000000001 112.147 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.1 mt -93.13 149.69 21.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.402 -1.436 . . . . 11.66 109.368 167.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 77.7 m-70 -99.72 109.75 22.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 125.871 1.982 . . . . 16.300000000000001 109.972 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.1 tp -96.41 117.68 31.38 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.292 2.473 . . . . 9.9600000000000009 110.303 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.4 t -92.65 130.88 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 128.607 2.763 . . . . 9.7599999999999998 106.339 164.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.5 mt -118.54 139.71 51.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.115 -1.439 . . . . 19.57 107.115 161.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -92.12 -54.09 3.98 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.615 2.366 . . . . 35.079999999999998 108.793 -159.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.2 mt -88.73 -68.4 0.77 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.801 2.715 . . . . 32.310000000000002 113.245 -168.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -86.25 -64.54 1.13 Allowed 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.15 -4.719 . . . . 42.75 116.977 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.37 -147.09 17.54 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.877 -0.889 . . . . 36.310000000000002 110.877 -161.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.761 0 O-C-N 121.298 -1.119 . . . . 36.270000000000003 114.487 176.237 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.4 ttp . . . . . 0 CA--C 1.49 -1.342 0 CA-C-O 121.162 0.506 . . . . 17.170000000000002 109.732 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -84.82 125.29 32.47 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.723 -2.486 . . . . 21.890000000000001 114.667 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 17' ' ' VAL 0.264 8.7 pt -114.04 165.25 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 124.109 3.14 . . . . 10.83 104.415 167.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -106.47 138.43 42.66 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 111.0 -2.818 . . . . 10.609999999999999 111.96 166.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.0 t -118.67 103.41 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.657 3.122 . . . . 9.1300000000000008 105.77 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -88.42 134.92 33.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.544 -2.598 . . . . 20.550000000000001 111.101 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -81.56 -170.51 2.83 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 123.791 2.996 . . . . 11.779999999999999 114.46 169.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.7 tp -100.74 -27.72 13.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.399 2.047 . . . . 19.309999999999999 112.907 -171.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 p -69.33 -41.79 76.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.529 -3.232 . . . . 23.140000000000001 107.598 160.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.68 72.1 0.67 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 117.959 -2.963 . . . . 19.739999999999998 116.045 173.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -123.97 133.63 53.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.074 -1.917 . . . . 21.93 109.476 160.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.4 m -93.57 105.01 17.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.277 2.86 . . . . 12.33 109.313 -170.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 mt -95.34 118.86 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 CA-C-O 129.507 4.479 . . . . 17.079999999999998 110.267 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.42 102.77 14.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.017 -3.552 . . . . 16.300000000000001 112.609 -175.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.56 129.44 36.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.282 -2.136 . . . . 15.880000000000001 110.65 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -98.04 92.09 5.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 127.145 3.355 . . . . 28.899999999999999 106.667 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.493 HG21 HG12 ' A' ' 3' ' ' ILE . 14.8 m -102.81 174.25 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 130.979 3.712 . . . . 12.050000000000001 110.063 -173.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.349 73.6 mm-40 -115.36 141.53 27.34 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 112.594 -3.574 . . . . 18.170000000000002 105.51 163.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -56.25 -16.16 16.71 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 N-CA-C 119.879 2.992 . . . . 8.1600000000000001 119.879 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -82.15 -10.86 59.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.971 1.843 . . . . 11.130000000000001 111.922 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -74.0 142.94 45.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.58 -3.825 . . . . 18.030000000000001 118.028 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -92.0 152.52 19.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.635 1.683 . . . . 10.220000000000001 108.25 -171.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.2 mm -57.68 -27.1 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 116.287 1.958 . . . . 12.300000000000001 116.287 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.318 37.0 tt0 -64.23 -45.21 89.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.616 1.674 . . . . 36.509999999999998 115.415 166.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -73.04 -29.2 62.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.506 -3.871 . . . . 25.66 113.05 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.94 -46.85 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.244 -2.785 . . . . 8.1199999999999992 107.026 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -60.19 -18.19 46.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.991 1.716 . . . . 15.470000000000001 114.96 171.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.16 -24.09 40.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.556 -2.59 . . . . 11.449999999999999 112.17 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttt -78.81 -36.02 43.29 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.757 -4.34 . . . . 24.98 107.666 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -69.72 -37.45 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 125.994 2.059 . . . . 9.4600000000000009 109.82 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -54.64 -53.52 53.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.713 1.597 . . . . 14.76 114.468 157.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.77 -30.29 71.29 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 123.128 2.695 . . . . 26.289999999999999 116.688 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.0 mttm -61.24 -67.1 0.44 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 126.289 2.947 . . . . 30.059999999999999 113.857 168.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -95.83 -48.47 5.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.872 -2.392 . . . . 25.190000000000001 113.123 -160.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.45 12.57 10.52 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 113.744 -1.571 . . . . 7.4100000000000001 114.108 -172.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 50.3 mt -97.0 113.48 63.06 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 107.881 -1.155 . . . . 9.4900000000000002 107.881 -176.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 13.7 Cg_exo -76.91 164.1 30.3 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 125.445 2.98 . . . . 11.42 109.813 -169.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.256 68.0 Cg_exo -63.33 -31.16 73.48 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 N-CA-C 120.827 3.357 . . . . 12.0 120.827 -166.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -97.95 9.0 43.84 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 118.331 -1.347 . . . . 35.549999999999997 111.38 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -78.86 -24.49 44.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.361 2.346 . . . . 20.52 111.889 156.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -83.5 144.79 29.31 Favored 'General case' 0 N--CA 1.429 -1.481 1 N-CA-C 121.811 4.004 . . . . 7.1299999999999999 121.811 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -136.19 111.4 9.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 103.965 -2.606 . . . . 36.390000000000001 103.965 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 mt -97.85 120.39 38.16 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 117.655 -1.618 . . . . 9.5500000000000007 115.282 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -99.85 133.62 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 128.001 3.762 . . . . 13.9 109.924 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -125.69 114.88 19.25 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.025 -4.797 . . . . 6.8600000000000003 105.625 157.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.65 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 131.803 4.041 . . . . 11.15 109.17 -170.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.91 7.17 3.52 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 128.384 2.897 . . . . 13.93 112.332 172.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.307 24.5 ttmm -98.7 137.72 36.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 122.113 2.957 . . . . 23.920000000000002 108.483 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -96.53 127.95 43.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.428 -2.045 . . . . 23.23 107.398 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.2 mt -83.71 152.02 24.94 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 112.742 -2.026 . . . . 9.1099999999999994 106.69 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -99.07 141.46 31.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.961 3.304 . . . . 33.439999999999998 117.355 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.14 -43.96 98.08 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 121.612 3.93 . . . . 28.370000000000001 121.612 -171.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.22 35.37 5.06 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 125.421 1.486 . . . . 15.0 110.028 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -117.65 157.41 26.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.845 0.683 . . . . 25.5 112.845 161.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.3 p -101.54 164.97 11.49 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.068 2.842 . . . . 11.949999999999999 113.494 -169.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.0 mt -56.26 -41.95 76.6 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.144 -4.722 . . . . 10.17 115.467 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 t -63.77 -33.12 74.95 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 130.305 3.442 . . . . 13.59 114.884 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.22 -50.13 56.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.926 2.89 . . . . 11.699999999999999 107.583 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -76.93 -1.84 30.64 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.217 -2.177 . . . . 12.949999999999999 113.514 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.9 t30 54.28 68.46 0.85 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.762 3.625 . . . . 25.449999999999999 110.11 -170.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -108.89 102.61 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 127.473 2.309 . . . . 14.6 108.17 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -90.74 -174.05 3.93 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 114.052 1.131 . . . . 33.229999999999997 114.052 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -59.02 154.88 14.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.605 -3.184 . . . . 25.969999999999999 115.218 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 64.97 25.57 12.71 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.535 4.334 . . . . 32.609999999999999 113.256 169.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -82.48 130.99 35.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.306 1.043 . . . . 10.56 109.647 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.6 m -83.11 113.04 20.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.178 -1.045 . . . . 5.3300000000000001 108.178 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.52 149.57 24.26 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.758 -1.941 . . . . 11.66 105.758 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -113.99 116.69 29.61 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.531 -1.356 . . . . 16.300000000000001 111.714 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 71' ' ' LEU . 44.7 tp -84.6 125.76 32.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.02 2.819 . . . . 9.9600000000000009 111.11 171.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -118.81 123.54 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 130.382 3.473 . . . . 9.7599999999999998 111.849 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.408 HD22 HD22 ' A' ' 69' ' ' LEU . 75.8 mt -95.6 146.34 24.55 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.745 1.736 . . . . 19.57 107.48 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -78.29 -62.22 1.75 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.783 2.23 . . . . 35.079999999999998 105.47 -164.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.8 mt -87.47 -44.5 11.27 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 118.627 2.825 . . . . 32.310000000000002 118.627 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -83.48 102.84 12.37 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.478 2.085 . . . . 42.75 116.195 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.1 37.75 3.32 Favored Glycine 0 N--CA 1.43 -1.739 1 C-N-CA 130.983 4.135 . . . . 36.310000000000002 109.029 -173.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.725 0 N-CA-C 108.708 -1.757 . . . . 36.270000000000003 108.708 174.06 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 120.912 0.387 . . . . 17.170000000000002 111.451 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.263 52.5 mt-30 -114.8 138.61 50.55 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.485 1.291 . . . . 21.890000000000001 114.485 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 pt -116.19 140.47 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 119.825 -1.797 . . . . 10.83 110.337 174.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -99.81 115.47 29.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.261 1.505 . . . . 10.609999999999999 111.069 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -100.36 107.42 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 115.123 -2.37 . . . . 9.1300000000000008 107.98 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.264 19.5 ttmm -90.64 124.34 34.99 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 126.398 2.311 . . . . 20.550000000000001 110.943 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -74.65 164.27 26.77 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 121.241 1.837 . . . . 11.779999999999999 109.595 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.1 tp -71.59 -22.57 61.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.64 1.348 . . . . 19.309999999999999 114.64 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.253 27.4 p -72.42 -78.55 0.08 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.602 2.761 . . . . 23.140000000000001 111.235 173.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.06 43.64 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.707 1 C-N-CA 132.117 4.675 . . . . 19.739999999999998 114.801 170.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 82.5 tttt -117.16 143.57 45.69 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 102.927 -2.99 . . . . 21.93 102.927 177.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.4 m -123.24 115.5 21.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.299 -1.741 . . . . 12.33 106.299 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.73 132.64 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.084 -2.26 . . . . 17.079999999999998 109.396 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 m -101.85 100.54 10.87 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.736 -1.95 . . . . 16.300000000000001 105.736 -172.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.511 HD12 HG13 ' A' ' 26' ' ' VAL 0.277 62.0 mt -97.89 137.03 37.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.955 2.788 . . . . 15.880000000000001 104.108 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -85.95 118.68 25.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.686 -3.134 . . . . 28.899999999999999 112.007 168.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.6 m -131.02 158.46 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.738 -2.69 . . . . 12.050000000000001 103.738 -169.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -92.95 146.91 32.92 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 113.467 -3.158 . . . . 18.170000000000002 114.001 158.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.74 -7.92 22.09 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 CA-C-N 124.617 2.685 . . . . 8.1600000000000001 114.069 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -90.92 -7.4 52.24 Favored 'General case' 0 N--CA 1.43 -1.457 1 C-N-CA 132.969 4.508 . . . . 11.130000000000001 113.654 174.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.78 153.11 44.37 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.231 -2.793 . . . . 18.030000000000001 114.666 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -106.42 163.15 13.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.169 -1.049 . . . . 10.220000000000001 108.169 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 mm -65.9 -28.69 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 121.011 -1.055 . . . . 12.300000000000001 110.827 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -44.49 -41.31 6.27 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.78 3.622 . . . . 36.509999999999998 120.78 157.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -80.33 -29.22 38.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.009 -3.557 . . . . 25.66 113.499 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.511 HG13 HD12 ' A' ' 15' ' ' LEU . 69.0 t -67.97 -38.77 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 105.09 -2.189 . . . . 8.1199999999999992 105.09 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -70.91 -42.26 70.16 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.248 1.819 . . . . 15.470000000000001 113.543 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.8 -43.64 27.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.444 2.069 . . . . 11.449999999999999 111.789 169.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -77.3 -31.66 54.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.79 -3.069 . . . . 24.98 109.032 -173.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.6 mt -70.61 -40.79 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.188 -3.445 . . . . 9.4600000000000009 115.834 171.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -50.26 -47.69 55.1 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 133.055 4.542 . . . . 14.76 109.435 172.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -60.28 -56.55 20.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.212 1.482 . . . . 26.289999999999999 113.744 171.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -74.15 -37.89 63.89 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.384 3.476 . . . . 30.059999999999999 120.384 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 56.2 mm-40 -107.83 -40.13 5.36 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.401 1.909 . . . . 25.190000000000001 114.233 -177.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.2 44.23 4.45 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 120.598 1.545 . . . . 7.4100000000000001 112.963 -169.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 mt -111.68 126.6 28.24 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 100.314 -3.958 . . . . 9.4900000000000002 100.314 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -67.35 153.41 77.04 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 C-N-CA 126.335 4.69 . . . . 11.42 115.765 -174.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -78.27 -18.89 12.29 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 126.412 3.326 . . . . 12.0 112.998 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.9 -11.76 60.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 114.885 -2.483 . . . . 35.549999999999997 115.69 165.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -97.07 -16.73 20.39 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 121.901 2.137 . . . . 20.52 112.763 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 76.7 mt-30 -92.04 118.07 30.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.747 3.154 . . . . 7.1299999999999999 111.098 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -116.37 111.02 19.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.933 -1.877 . . . . 36.390000000000001 105.933 170.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -86.75 113.94 23.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.879 2.752 . . . . 9.5500000000000007 110.638 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.2 mm -99.43 142.12 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.243 -2.786 . . . . 13.9 105.878 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HB2' HD12 ' A' ' 50' ' ' LEU . 25.5 t80 -128.65 112.24 14.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.69 -1.881 . . . . 6.8600000000000003 108.08 171.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.33 . . 68.86 -91.65 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.343 -3.973 . . . . 11.15 117.354 -162.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.68 34.68 0.95 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 118.842 -1.646 . . . . 13.93 111.804 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -149.98 144.83 26.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 129.513 3.714 . . . . 23.920000000000002 113.709 173.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -73.43 134.41 43.98 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 125.832 2.73 . . . . 23.23 115.125 -176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 45' ' ' PHE . 14.7 mt -86.51 151.1 23.78 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 110.727 -2.942 . . . . 9.1099999999999994 109.925 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.36 133.31 46.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.216 -3.428 . . . . 33.439999999999998 105.214 -158.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -40.45 -58.8 1.47 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 130.466 3.506 . . . . 28.370000000000001 117.789 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.7 14.16 43.6 Favored Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 121.055 1.752 . . . . 15.0 114.288 -169.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -113.44 159.68 19.23 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.671 -2.664 . . . . 25.5 108.626 -172.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 p -114.27 -178.12 3.29 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.476 -3.265 . . . . 11.949999999999999 112.571 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.3 mt -74.51 -28.71 61.11 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 110.656 -2.975 . . . . 10.17 114.319 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.6 m -65.52 -31.11 72.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 119.167 3.025 . . . . 13.59 119.167 170.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -65.89 -45.63 81.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 127.62 3.075 . . . . 11.699999999999999 110.388 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -92.38 -8.41 44.97 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.695 -2.098 . . . . 12.949999999999999 109.51 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 60.35 54.24 4.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.508 3.051 . . . . 25.449999999999999 114.305 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mt -93.44 108.39 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 109.602 -3.454 . . . . 14.6 105.744 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -88.2 -179.09 6.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 124.769 2.223 . . . . 33.229999999999997 111.419 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.269 17.9 pttp -53.37 141.69 23.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.723 -3.111 . . . . 25.969999999999999 116.146 159.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 70.98 20.87 5.15 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.785 -3.072 . . . . 32.609999999999999 112.545 168.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -89.71 135.21 33.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.972 3.709 . . . . 10.56 114.786 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -95.0 117.71 30.6 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.869 2.914 . . . . 5.3300000000000001 118.869 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mp -108.83 151.35 26.36 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.89 -2.263 . . . . 11.66 104.89 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -107.13 140.66 39.62 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.231 -1.766 . . . . 16.300000000000001 106.231 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -106.37 106.48 17.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.535 1.772 . . . . 9.9600000000000009 111.952 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.3 t -94.42 134.33 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 126.948 2.655 . . . . 9.7599999999999998 107.029 173.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 mt -77.06 126.88 31.69 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.417 -0.811 . . . . 19.57 110.314 166.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -68.86 -82.31 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.286 2.946 . . . . 35.079999999999998 117.162 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.8 tp -77.64 -42.42 34.9 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 112.528 -2.124 . . . . 32.310000000000002 109.813 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -68.81 143.08 54.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.409 2.683 . . . . 42.75 115.645 169.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.62 -53.64 4.57 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 128.984 3.183 . . . . 36.310000000000002 113.306 159.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.738 0 CA-C-O 116.067 -2.518 . . . . 36.270000000000003 108.106 -169.088 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 112.505 0.558 . . . . 17.170000000000002 112.505 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -102.73 147.86 26.32 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.517 3.532 . . . . 21.890000000000001 112.94 170.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 pt -128.6 163.66 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 115.802 -4.311 . . . . 10.83 103.908 169.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.57 101.67 7.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 105.057 -2.201 . . . . 10.609999999999999 105.057 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.0 t -93.53 123.3 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 107.015 -1.476 . . . . 9.1300000000000008 107.015 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -124.36 152.75 42.78 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.246 1.839 . . . . 20.550000000000001 111.004 -171.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -88.42 -178.37 5.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.614 1.709 . . . . 11.779999999999999 115.614 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.269 36.1 tp -67.77 -40.08 84.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.719 2.859 . . . . 19.309999999999999 118.719 158.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -56.55 7.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.899 -2.376 . . . . 23.140000000000001 111.74 -169.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.74 24.52 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 119.03 -2.294 . . . . 19.739999999999998 115.197 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -100.38 148.48 24.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.911 -3.111 . . . . 21.93 115.849 166.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.8 m -125.34 135.77 52.79 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.744 2.818 . . . . 12.33 104.883 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.6 mt -121.59 110.78 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 103.273 -2.862 . . . . 17.079999999999998 103.273 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -79.57 118.72 21.67 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.07 -1.644 . . . . 16.300000000000001 113.852 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -112.68 145.12 41.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.425 -3.297 . . . . 15.880000000000001 113.119 -174.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -100.61 98.25 8.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.496 -1.668 . . . . 28.899999999999999 106.496 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 m -104.42 174.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 124.883 1.364 . . . . 12.050000000000001 113.025 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -121.02 152.02 55.96 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 127.367 2.267 . . . . 18.170000000000002 106.213 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -68.35 -14.72 40.87 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 122.784 2.03 . . . . 8.1600000000000001 115.224 -172.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.255 53.3 p -99.8 1.34 43.0 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.737 2.815 . . . . 11.130000000000001 114.596 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.264 11.3 m-20 -71.0 155.23 41.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.882 2.277 . . . . 18.030000000000001 110.638 161.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 p -85.36 161.68 19.37 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.04 2.829 . . . . 10.220000000000001 108.487 173.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mm -57.01 -29.12 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.161 -2.837 . . . . 12.300000000000001 115.068 163.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -62.68 -46.65 87.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.021 -3.55 . . . . 36.509999999999998 109.538 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -52.85 -52.75 56.07 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.892 1.277 . . . . 25.66 113.325 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -45.12 -50.35 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.911 1.684 . . . . 8.1199999999999992 113.409 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.19 -36.21 77.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.038 1.875 . . . . 15.470000000000001 115.011 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.97 82.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.641 -2.537 . . . . 11.449999999999999 116.408 170.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -63.92 -40.03 95.54 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.795 1.776 . . . . 24.98 115.795 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -60.05 -45.2 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 C-N-CA 135.097 5.359 . . . . 9.4600000000000009 110.693 168.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -54.54 -48.23 72.25 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.991 1.717 . . . . 14.76 113.386 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.21 -35.57 80.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.535 2.05 . . . . 26.289999999999999 116.535 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -87.37 -46.31 9.77 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.637 1.684 . . . . 30.059999999999999 114.694 -172.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -78.63 -55.61 5.06 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 114.225 -1.352 . . . . 25.190000000000001 114.51 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.1 44.84 1.97 Allowed Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 110.066 -1.213 . . . . 7.4100000000000001 110.066 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.405 HG23 ' HB3' ' A' ' 40' ' ' GLN . 6.8 mt -125.38 127.24 25.0 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 104.806 -2.294 . . . . 9.4900000000000002 104.806 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -67.22 160.36 47.92 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-O 115.998 -1.751 . . . . 11.42 116.052 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -70.29 -27.34 24.05 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 124.74 3.626 . . . . 12.0 110.993 -169.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -77.64 -37.2 50.49 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 117.92 -1.038 . . . . 35.549999999999997 109.457 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.405 ' HB3' HG23 ' A' ' 36' ' ' ILE . 7.1 tp-100 -59.96 -33.08 71.45 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.559 2.344 . . . . 20.52 115.498 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -98.93 145.32 27.15 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.346 2.022 . . . . 7.1299999999999999 116.418 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -115.03 153.71 30.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.692 2.797 . . . . 36.390000000000001 107.683 165.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 tp -133.93 114.89 13.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.413 1.085 . . . . 9.5500000000000007 108.966 -171.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.4 mm -103.71 128.57 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 117.26 -3.4 . . . . 13.9 112.452 -171.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -109.87 128.62 55.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.02 1.328 . . . . 6.8600000000000003 108.674 160.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.42 -108.25 0.42 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.81 -2.432 . . . . 11.15 112.262 -168.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.67 31.55 3.53 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 109.212 -1.555 . . . . 13.93 109.212 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -121.8 124.18 43.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.269 1.428 . . . . 23.920000000000002 111.054 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -76.31 107.41 8.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.217 1.807 . . . . 23.23 110.682 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.82 136.63 34.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.247 1.019 . . . . 9.1099999999999994 111.696 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -93.24 159.1 15.42 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.483 2.087 . . . . 33.439999999999998 111.101 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -73.15 -42.07 63.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.226 -2.796 . . . . 28.370000000000001 108.764 -156.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.84 41.5 2.13 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 117.217 -3.427 . . . . 15.0 113.01 -165.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -122.37 159.71 26.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.158 2.328 . . . . 25.5 108.842 166.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.9 p -85.99 167.92 14.62 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.964 2.106 . . . . 11.949999999999999 116.396 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -68.36 -26.66 65.7 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.794 -1.191 . . . . 10.17 111.416 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 t -76.37 -40.76 50.24 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 118.431 2.752 . . . . 13.59 118.431 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -43.16 -48.11 6.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.922 -2.361 . . . . 11.699999999999999 117.251 158.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -78.85 -6.99 57.49 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 120.575 3.546 . . . . 12.949999999999999 120.575 170.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 t30 53.75 40.06 31.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.064 2.616 . . . . 25.449999999999999 118.064 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.8 mt -81.47 118.91 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 105.044 -2.206 . . . . 14.6 105.044 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -81.31 -173.07 4.13 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.878 2.751 . . . . 33.229999999999997 113.79 -176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -74.42 146.06 43.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.009 -2.932 . . . . 25.969999999999999 112.605 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 65.57 30.16 10.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.364 1.665 . . . . 32.609999999999999 114.821 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -79.45 152.53 30.24 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 103.763 -2.68 . . . . 10.56 103.763 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.6 m -103.51 124.16 48.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.103 2.961 . . . . 5.3300000000000001 108.309 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.282 4.9 mp -117.11 162.13 18.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.106 1.762 . . . . 11.66 107.894 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.27 127.08 52.9 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.705 -2.497 . . . . 16.300000000000001 111.182 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.72 107.73 18.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.414 2.686 . . . . 9.9600000000000009 114.739 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -122.12 121.34 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 108.057 -1.09 . . . . 9.7599999999999998 108.057 -171.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.405 HD11 HD11 ' A' ' 36' ' ' ILE . 7.9 mp -107.35 138.24 43.91 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 117.092 -1.843 . . . . 19.57 110.151 -177.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -65.48 -87.8 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.288 1.588 . . . . 35.079999999999998 115.288 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 tp -82.37 -63.52 1.36 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.561 -1.685 . . . . 32.310000000000002 113.181 -172.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -92.57 150.55 20.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.692 -2.336 . . . . 42.75 104.692 -171.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.02 62.57 0.53 Allowed Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 105.908 -2.877 . . . . 36.310000000000002 105.908 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.749 0 C-N-CA 125.63 1.586 . . . . 36.270000000000003 111.918 -171.71 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 112.747 0.647 . . . . 17.170000000000002 112.747 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -95.95 121.8 38.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.907 -1.886 . . . . 21.890000000000001 105.907 -176.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 pt -109.62 164.85 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 107.268 -1.382 . . . . 10.83 107.268 170.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -114.83 105.79 13.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.432 -2.433 . . . . 10.609999999999999 104.432 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.4 t -86.57 124.84 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 126.931 3.253 . . . . 9.1300000000000008 109.483 166.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -106.4 134.62 49.25 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.431 -2.668 . . . . 20.550000000000001 107.684 -173.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.253 47.5 p -75.79 161.14 29.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.775 2.03 . . . . 11.779999999999999 112.042 170.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.5 tp -59.28 -37.93 78.88 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.378 -3.326 . . . . 19.309999999999999 115.613 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -68.1 -64.58 0.83 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.651 2.167 . . . . 23.140000000000001 115.085 169.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.51 71.55 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 O-C-N 117.113 -3.492 . . . . 19.739999999999998 107.826 174.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -104.02 160.14 15.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.549 1.174 . . . . 21.93 113.885 147.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.1 m -90.96 118.98 30.78 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 115.824 -4.298 . . . . 12.33 105.92 168.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.71 119.17 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 123.914 1.816 . . . . 17.079999999999998 107.737 156.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 84.7 m -98.96 108.65 21.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 111.595 -2.548 . . . . 16.300000000000001 106.723 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.484 ' CD1' HG11 ' A' ' 26' ' ' VAL . 87.7 mt -107.2 116.87 32.69 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.598 2.359 . . . . 15.880000000000001 115.719 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.31 112.42 15.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.531 -1.668 . . . . 28.899999999999999 110.211 167.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.29 158.32 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 123.284 0.634 . . . . 12.050000000000001 109.949 167.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.496 ' O ' ' HB2' ' A' ' 21' ' ' ASP . 56.7 mt-10 -115.79 151.73 46.65 Favored Pre-proline 0 N--CA 1.429 -1.478 0 N-CA-C 102.834 -3.024 . . . . 18.170000000000002 102.834 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -76.03 -16.4 18.02 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 CA-C-O 114.889 -2.213 . . . . 8.1600000000000001 113.456 -159.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -70.51 -14.83 62.68 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-N 127.26 4.573 . . . . 11.130000000000001 112.931 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 18.3 m-20 -78.32 146.8 34.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.703 -3.748 . . . . 18.030000000000001 106.19 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.7 p -78.77 167.89 20.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.336 -3.978 . . . . 10.220000000000001 116.489 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.95 -39.88 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 117.427 -1.273 . . . . 12.300000000000001 110.234 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -51.1 -39.51 56.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 123.422 2.828 . . . . 36.509999999999998 113.233 170.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -57.57 -38.67 75.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.565 -1.335 . . . . 25.66 112.811 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.484 HG11 ' CD1' ' A' ' 15' ' ' LEU . 58.5 t -56.77 -54.42 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 125.925 2.774 . . . . 8.1199999999999992 111.183 176.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -56.57 -37.38 70.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.981 3.326 . . . . 15.470000000000001 119.981 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.23 -32.08 69.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.231 1.491 . . . . 11.449999999999999 112.475 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -80.22 -27.89 38.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 118.585 -1.246 . . . . 24.98 108.461 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.9 mt -58.65 -42.21 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 114.749 1.389 . . . . 9.4600000000000009 114.749 159.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -65.05 -24.91 67.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.867 -2.395 . . . . 14.76 115.96 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.23 -59.82 3.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.442 -3.287 . . . . 26.289999999999999 109.445 166.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -73.1 -56.83 4.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.331 2.715 . . . . 30.059999999999999 118.331 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -93.95 -53.3 4.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.751 1.621 . . . . 25.190000000000001 115.094 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.52 2.9 6.21 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 125.173 2.54 . . . . 7.4100000000000001 115.995 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.5 mt -68.18 127.55 93.27 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 113.691 -3.052 . . . . 9.4900000000000002 112.767 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -70.63 155.57 62.82 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 126.974 3.527 . . . . 11.42 115.337 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -62.45 -39.45 45.78 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 CA-C-N 124.552 2.661 . . . . 12.0 110.636 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.73 -8.7 11.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.65 2.833 . . . . 35.549999999999997 118.65 170.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -94.68 -32.26 13.45 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.785 -2.447 . . . . 20.52 110.402 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -107.96 154.33 21.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.737 1.384 . . . . 7.1299999999999999 114.737 -172.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 mtt85 -134.55 164.34 27.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 117.823 -1.084 . . . . 36.390000000000001 108.222 157.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -113.31 136.62 52.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.059 3.344 . . . . 9.5500000000000007 107.15 -174.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -115.76 122.72 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.131 -1.433 . . . . 13.9 107.131 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -113.63 111.14 21.35 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.968 -2.975 . . . . 6.8600000000000003 102.968 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.08 -75.83 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.446 -2.034 . . . . 11.15 114.972 -164.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.59 9.09 2.61 Favored Glycine 0 N--CA 1.429 -1.807 0 CA-C-N 121.021 1.737 . . . . 13.93 116.463 169.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -107.62 123.76 48.96 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.719 2.2 . . . . 23.920000000000002 108.249 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -82.19 121.34 26.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 110.362 -3.108 . . . . 23.23 111.721 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 mt -86.27 156.17 20.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 115.749 -2.072 . . . . 9.1099999999999994 110.547 -165.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -109.25 142.42 40.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 123.034 2.652 . . . . 33.439999999999998 111.265 -173.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.61 -48.75 79.93 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.374 2.67 . . . . 28.370000000000001 115.564 -163.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.29 -3.69 71.24 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 118.163 2.025 . . . . 15.0 118.163 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.8 mtt-85 -98.0 170.25 9.06 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.889 1.328 . . . . 25.5 110.286 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -106.43 162.04 14.05 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.927 -1.733 . . . . 11.949999999999999 112.521 -170.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -63.58 -25.37 68.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.884 -2.385 . . . . 10.17 114.611 175.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.96 -30.19 55.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.664 2.386 . . . . 13.59 112.493 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -63.73 -42.23 97.93 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.542 -3.223 . . . . 11.699999999999999 111.246 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -88.99 5.68 43.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.033 2.975 . . . . 12.949999999999999 119.033 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 55.36 59.64 3.82 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.833 2.453 . . . . 25.449999999999999 111.994 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.6 mt -96.38 122.94 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.125 -1.805 . . . . 14.6 106.125 178.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -102.34 -174.73 2.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.646 1.688 . . . . 33.229999999999997 111.978 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -56.03 149.33 15.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.148 -3.47 . . . . 25.969999999999999 115.919 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 39.2 mt-10 66.98 31.04 7.23 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.367 -2.708 . . . . 32.609999999999999 113.434 171.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.3 m -93.29 132.21 37.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.798 -2.001 . . . . 10.56 113.375 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.1 m -90.74 124.64 35.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.452 -2.655 . . . . 5.3300000000000001 108.09 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.322 11.2 mp -109.61 140.02 43.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.997 1.719 . . . . 11.66 111.838 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -98.48 135.36 40.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.135 2.243 . . . . 16.300000000000001 115.505 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.5 tp -98.14 125.43 43.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.44 1.59 . . . . 9.9600000000000009 110.189 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -133.37 148.08 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 121.032 -1.042 . . . . 9.7599999999999998 110.187 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp -132.49 152.52 51.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.079 -2.193 . . . . 19.57 105.079 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -90.38 -82.87 0.27 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.56 1.544 . . . . 35.079999999999998 111.761 -161.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.8 tp -88.11 -35.01 17.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 125.158 2.408 . . . . 32.310000000000002 115.573 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -110.65 168.81 9.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.121 -2.237 . . . . 42.75 111.82 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.09 98.54 0.12 Allowed Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 119.491 1.042 . . . . 36.310000000000002 111.119 162.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.734 0 N-CA-C 103.768 -3.733 . . . . 36.270000000000003 103.768 -164.075 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 122.931 1.348 . . . . 17.170000000000002 114.554 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -107.77 155.98 19.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 120.036 3.347 . . . . 21.890000000000001 120.036 172.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -138.73 154.54 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 106.817 -1.549 . . . . 10.83 106.817 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -106.83 126.73 52.69 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.401 -2.074 . . . . 10.609999999999999 105.401 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.01 108.83 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 120.09 1.314 . . . . 9.1300000000000008 109.581 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -96.97 135.66 38.65 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.735 -1.121 . . . . 20.550000000000001 109.568 -167.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -77.61 171.11 15.42 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.412 1.695 . . . . 11.779999999999999 112.007 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -51.5 -56.39 13.63 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 117.093 2.257 . . . . 19.309999999999999 117.093 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -85.93 -72.95 0.47 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.442 -2.036 . . . . 23.140000000000001 109.324 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.41 48.0 0.17 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 118.658 2.223 . . . . 19.739999999999998 118.658 -162.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -110.85 156.27 21.38 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 116.304 -4.056 . . . . 21.93 110.299 157.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.9 m -129.14 135.82 49.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 103.148 -2.908 . . . . 12.33 103.148 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 mt -121.54 112.97 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 114.5 -1.227 . . . . 17.079999999999998 108.989 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.7 m -88.19 107.17 18.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.995 0.903 . . . . 16.300000000000001 111.479 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.92 112.35 24.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 120.233 3.42 . . . . 15.880000000000001 120.233 -173.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -83.59 117.74 23.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.723 -3.735 . . . . 28.899999999999999 111.892 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.62 177.84 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.547 -1.971 . . . . 12.050000000000001 109.377 -166.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -117.46 160.13 39.13 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 118.488 -2.633 . . . . 18.170000000000002 109.951 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -79.48 -6.78 14.72 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 125.253 3.969 . . . . 8.1600000000000001 110.091 -166.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 m -88.58 -7.22 56.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.711 2.804 . . . . 11.130000000000001 115.064 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.49 169.74 11.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 118.703 0.683 . . . . 18.030000000000001 112.79 -175.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.5 p -107.9 164.91 11.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.421 2.288 . . . . 10.220000000000001 109.029 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 mm -55.83 -47.01 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 126.499 1.92 . . . . 12.300000000000001 112.37 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -60.99 -32.7 72.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.21 2.604 . . . . 36.509999999999998 115.642 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -67.04 -43.2 83.36 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 122.714 2.507 . . . . 25.66 115.38 162.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.89 -29.24 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 118.435 -2.666 . . . . 8.1199999999999992 113.004 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -72.68 -34.68 67.35 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.968 2.507 . . . . 15.470000000000001 110.476 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -34.92 73.56 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.788 2.835 . . . . 11.449999999999999 115.771 169.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -57.87 -52.14 66.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.939 2.896 . . . . 24.98 117.069 162.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.453 HD13 ' OE1' ' A' ' 41' ' ' GLN . 58.2 mt -60.6 -40.3 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 117.794 -3.066 . . . . 9.4600000000000009 113.404 174.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -50.45 -49.0 56.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.513 2.578 . . . . 14.76 112.006 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -46.47 80.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.359 -3.963 . . . . 26.289999999999999 116.941 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -63.22 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.063 -2.335 . . . . 30.059999999999999 114.954 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -58.97 -64.65 0.86 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.166 2.186 . . . . 25.190000000000001 113.663 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.54 62.24 0.33 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 108.476 -1.849 . . . . 7.4100000000000001 108.476 -171.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.0 mt -127.84 114.05 20.58 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.326 -2.75 . . . . 9.4900000000000002 113.89 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -73.77 150.8 45.16 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 124.809 2.753 . . . . 11.42 113.737 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -57.97 -35.07 99.01 Favored 'Trans proline' 0 N--CA 1.434 -2.003 2 C-N-CA 129.514 6.81 . . . . 12.0 117.451 -166.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.299 38.7 m-20 -74.21 -21.65 59.71 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.603 1.161 . . . . 35.549999999999997 111.15 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -78.23 -31.86 49.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.355 3.455 . . . . 20.52 114.097 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' OE1' HD13 ' A' ' 30' ' ' ILE . 14.5 pt20 -109.65 140.24 43.73 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 113.287 -5.883 . . . . 7.1299999999999999 111.203 -175.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -123.17 171.74 9.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.747 -1.945 . . . . 36.390000000000001 105.747 163.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.25 35.3 mt -123.32 143.32 50.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 125.773 1.92 . . . . 9.5500000000000007 107.519 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.88 138.68 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.431 2.062 . . . . 13.9 106.38 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -114.07 102.19 9.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.318 -2.739 . . . . 6.8600000000000003 107.882 171.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.297 . . 58.58 -98.33 0.08 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.735 1.754 . . . . 11.15 115.735 -166.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.47 -6.89 24.95 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 120.704 1.593 . . . . 13.93 109.195 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.8 120.32 30.09 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 113.382 0.882 . . . . 23.920000000000002 113.382 -171.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -87.61 116.97 26.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.235 -3.416 . . . . 23.23 111.386 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.0 mt -84.58 126.86 33.7 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.331 -1.481 . . . . 9.1099999999999994 112.315 -169.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -78.0 134.91 37.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.359 2.664 . . . . 33.439999999999998 114.084 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.52 -46.03 91.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.332 1.853 . . . . 28.370000000000001 112.657 -155.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.23 -8.02 86.95 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 125.818 1.675 . . . . 15.0 117.247 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.8 mtt-85 -76.64 148.18 37.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.035 -2.45 . . . . 25.5 112.122 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.2 p -81.66 166.41 20.18 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.729 -4.357 . . . . 11.949999999999999 110.034 -176.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.74 -19.28 63.54 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.957 1.836 . . . . 10.17 115.957 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 t -91.05 -18.21 24.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.753 2.821 . . . . 13.59 108.563 -172.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -66.78 -21.88 66.04 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.444 -4.535 . . . . 11.699999999999999 114.082 163.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -104.24 -20.68 13.71 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.66 -1.154 . . . . 12.949999999999999 111.582 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 66.44 61.03 0.58 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.419 1.888 . . . . 25.449999999999999 112.083 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -101.29 103.46 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.241 1.816 . . . . 14.6 108.789 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -83.49 -163.42 0.75 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.348 1.61 . . . . 33.229999999999997 115.348 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -71.75 159.02 35.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.424 1.89 . . . . 25.969999999999999 112.756 170.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 54.04 22.14 3.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.749 2.82 . . . . 32.609999999999999 110.206 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -66.22 140.64 58.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.587 1.955 . . . . 10.56 116.08 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -90.75 116.99 29.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.677 3.991 . . . . 5.3300000000000001 106.498 171.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -112.2 166.53 11.18 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 127.023 2.702 . . . . 11.66 110.498 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -122.86 135.54 54.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 117.81 -1.091 . . . . 16.300000000000001 111.269 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 tp -94.16 133.4 37.7 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.974 1.369 . . . . 9.9600000000000009 107.411 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.9 152.79 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 O-C-N 114.605 -5.059 . . . . 9.7599999999999998 106.735 161.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp -109.92 151.6 26.87 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 115.057 -2.402 . . . . 19.57 110.493 171.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -86.93 -80.43 0.25 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.572 1.987 . . . . 35.079999999999998 110.307 -164.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.269 65.4 mt -86.71 -44.44 11.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.431 -2.043 . . . . 32.310000000000002 113.476 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -73.67 -164.83 0.23 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.069 2.366 . . . . 42.75 116.683 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.28 123.81 0.67 Allowed Glycine 0 N--CA 1.429 -1.774 0 O-C-N 117.638 -3.164 . . . . 36.310000000000002 108.746 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.758 0 C-N-CA 117.239 -2.41 . . . . 36.270000000000003 111.88 -176.37 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 114.464 1.283 . . . . 17.170000000000002 114.464 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -113.78 135.0 54.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.549 1.643 . . . . 21.890000000000001 109.123 -178.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.6 pt -124.19 158.09 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 112.463 -2.153 . . . . 10.83 105.513 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -104.07 114.29 28.43 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.623 1.169 . . . . 10.609999999999999 113.38 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.23 116.0 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 116.724 -3.735 . . . . 9.1300000000000008 102.588 166.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -107.99 133.74 51.88 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.703 3.601 . . . . 20.550000000000001 109.97 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.392 17.6 p -79.88 -173.39 3.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.002 1.853 . . . . 11.779999999999999 116.002 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.5 tp -79.37 -42.41 25.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.889 2.757 . . . . 19.309999999999999 111.817 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p -68.49 -70.2 0.28 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.343 4.257 . . . . 23.140000000000001 110.129 174.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.44 55.98 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 104.089 -3.604 . . . . 19.739999999999998 104.089 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -117.33 146.19 43.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 120.728 2.264 . . . . 21.93 108.76 159.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -114.48 117.58 31.38 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.286 -2.759 . . . . 12.33 110.392 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.27 0.3 OUTLIER -104.45 104.32 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 103.154 -2.906 . . . . 17.079999999999998 103.154 175.178 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.4 m -88.88 111.72 22.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.711 1.204 . . . . 16.300000000000001 110.796 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.4 mt -114.26 148.92 36.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 122.853 2.57 . . . . 15.880000000000001 107.875 -160.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -106.34 118.93 37.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.382 -1.449 . . . . 28.899999999999999 114.697 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.56 170.66 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 124.061 1.886 . . . . 12.050000000000001 112.425 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -107.99 164.24 15.21 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.07 -2.894 . . . . 18.170000000000002 109.445 167.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -71.06 -24.85 23.32 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.263 1.975 . . . . 8.1600000000000001 112.447 -172.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.9 m -73.45 -8.08 54.43 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.727 2.811 . . . . 11.130000000000001 116.552 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -84.28 142.59 30.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.077 -1.874 . . . . 18.030000000000001 112.428 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -80.04 165.05 22.92 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.288 2.47 . . . . 10.220000000000001 113.807 -176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.408 HD12 HD11 ' A' ' 50' ' ' LEU . 35.6 mm -69.73 -32.31 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 119.535 -1.978 . . . . 12.300000000000001 109.448 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -51.66 -35.89 44.16 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.777 1.769 . . . . 36.509999999999998 115.777 159.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.69 -35.91 65.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.405 2.526 . . . . 25.66 109.845 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.05 -43.77 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 1 O-C-N 115.841 -4.287 . . . . 8.1199999999999992 109.785 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -56.64 -33.64 66.5 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.164 2.653 . . . . 15.470000000000001 118.164 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.77 -29.21 64.24 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.544 2.592 . . . . 11.449999999999999 109.281 -167.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -78.47 -34.08 47.85 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.794 2.037 . . . . 24.98 111.251 174.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.33 -33.57 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 123.859 1.79 . . . . 9.4600000000000009 110.769 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -59.4 -44.22 92.84 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.418 -2.676 . . . . 14.76 110.607 166.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.94 -41.47 91.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.446 1.098 . . . . 26.289999999999999 110.242 -172.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -78.96 -63.94 1.3 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 119.026 0.83 . . . . 30.059999999999999 110.041 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -89.72 -20.88 23.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.561 2.06 . . . . 25.190000000000001 116.561 -158.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.39 34.24 23.51 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 118.632 2.213 . . . . 7.4100000000000001 118.632 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -107.99 124.0 36.04 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 119.157 -0.449 . . . . 9.4900000000000002 111.598 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -66.0 148.02 85.25 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.636 2.224 . . . . 11.42 115.641 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.08 -21.48 12.09 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.162 2.575 . . . . 12.0 109.983 -148.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -70.28 -28.12 64.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.858 1.799 . . . . 35.549999999999997 115.858 173.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -81.81 -26.74 34.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.448 -2.033 . . . . 20.52 115.813 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -96.03 152.25 18.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.221 1.408 . . . . 7.1299999999999999 108.533 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -135.51 168.2 19.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 117.205 -1.378 . . . . 36.390000000000001 109.685 167.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.43 HD12 HD12 ' A' ' 67' ' ' LEU . 35.2 mt -131.71 130.75 42.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 125.388 3.722 . . . . 9.5500000000000007 110.714 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.459 HD13 HG12 ' A' ' 70' ' ' VAL . 22.3 mt -110.77 116.59 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 112.124 -2.307 . . . . 13.9 110.657 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -96.73 102.07 13.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.107 3.363 . . . . 6.8600000000000003 109.905 169.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.1 -95.84 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.746 2.018 . . . . 11.15 114.714 -165.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.03 -12.91 26.47 Favored Glycine 0 N--CA 1.43 -1.703 1 C-N-CA 131.204 4.24 . . . . 13.93 112.694 -175.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -104.25 150.14 24.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.705 -2.644 . . . . 23.920000000000002 115.354 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -109.79 149.33 29.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.151 2.405 . . . . 23.23 109.752 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.408 HD11 HD12 ' A' ' 23' ' ' ILE . 23.4 mt -90.03 118.84 29.89 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.878 2.071 . . . . 9.1099999999999994 113.234 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -79.04 150.68 31.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.993 1.378 . . . . 33.439999999999998 110.475 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.97 -24.66 55.43 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 115.474 -4.517 . . . . 28.370000000000001 112.284 -157.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.18 27.2 10.37 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 121.145 3.218 . . . . 15.0 121.145 -171.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -110.79 174.91 5.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.309 1.843 . . . . 25.5 111.278 162.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.2 p -95.88 167.32 11.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 113.661 0.986 . . . . 11.949999999999999 113.661 -178.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.4 -33.66 74.05 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 114.637 1.347 . . . . 10.17 114.637 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.39 -39.65 84.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.698 1.599 . . . . 13.59 114.681 171.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.287 72.5 m-20 -57.57 -37.25 72.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.802 2.041 . . . . 11.699999999999999 114.976 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -110.41 4.92 21.04 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.822 -1.547 . . . . 12.949999999999999 106.822 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 t30 72.34 45.03 0.39 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.147 -2.22 . . . . 25.449999999999999 109.75 162.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.6 mt -94.59 119.89 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 128.11 3.814 . . . . 14.6 111.227 168.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -99.35 175.29 5.92 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.885 -4.259 . . . . 33.229999999999997 108.043 169.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -40.77 145.56 0.19 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.347 -3.346 . . . . 25.969999999999999 117.446 165.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 70.76 9.5 6.85 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.155 3.382 . . . . 32.609999999999999 116.759 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.8 m -78.11 145.58 35.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.398 3.079 . . . . 10.56 108.824 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.3 m -100.69 121.22 41.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.202 1.401 . . . . 5.3300000000000001 109.145 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.43 HD12 HD12 ' A' ' 43' ' ' LEU . 33.7 mt -104.8 149.36 25.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.317 -0.994 . . . . 11.66 108.317 164.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -99.86 108.42 20.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.577 2.351 . . . . 16.300000000000001 110.142 169.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tp -84.54 98.12 9.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.716 -1.865 . . . . 9.9600000000000009 109.347 171.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.459 HG12 HD13 ' A' ' 44' ' ' ILE . 27.3 m -101.2 156.18 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 119.332 -2.105 . . . . 9.7599999999999998 107.429 169.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp -112.09 155.25 24.18 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.741 2.686 . . . . 19.57 107.63 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -76.42 -51.1 12.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.711 3.226 . . . . 35.079999999999998 119.711 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.6 mt -143.54 -56.32 0.39 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.079 -2.934 . . . . 32.310000000000002 103.079 -161.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -76.43 156.22 33.3 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 114.132 -1.395 . . . . 42.75 112.997 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.87 135.45 1.86 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.383 -1.487 . . . . 36.310000000000002 109.383 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.777 0 N-CA-C 103.523 -3.831 . . . . 36.270000000000003 103.523 -178.179 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.338 18.0 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 119.101 3.0 . . . . 17.170000000000002 119.101 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -102.04 128.72 48.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 119.314 -0.954 . . . . 21.890000000000001 112.414 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.321 31.1 pt -118.42 169.33 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.377 1.471 . . . . 10.83 112.649 171.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -132.88 131.6 41.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.46 -2.65 . . . . 10.609999999999999 111.953 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.4 t -106.01 114.5 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 103.822 -2.659 . . . . 9.1300000000000008 103.822 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -79.72 142.43 35.47 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.027 2.822 . . . . 20.550000000000001 109.548 167.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.276 17.0 p -93.67 -176.82 4.18 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.686 -2.509 . . . . 11.779999999999999 112.167 176.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.66 -25.92 24.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 120.472 1.487 . . . . 19.309999999999999 113.169 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -69.7 -55.45 9.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.02 2.343 . . . . 23.140000000000001 109.34 161.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.37 58.02 0.18 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.381 -1.45 . . . . 19.739999999999998 112.999 164.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.502 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU 0.254 42.1 pttt -101.83 149.33 24.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.47 1.108 . . . . 21.93 113.878 172.151 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.1 m -74.83 114.01 12.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.105 -2.872 . . . . 12.33 118.149 164.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.8 mt -96.52 123.62 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 122.104 0.954 . . . . 17.079999999999998 109.052 160.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.5 m -110.5 121.15 44.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 102.508 -3.145 . . . . 16.300000000000001 102.508 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.4 mt -115.07 146.49 41.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.742 -2.474 . . . . 15.880000000000001 113.074 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -113.35 103.74 11.61 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.701 2.801 . . . . 28.899999999999999 104.506 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.2 169.37 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 115.523 -2.179 . . . . 12.050000000000001 108.57 -167.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -114.75 158.71 39.73 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 128.491 2.717 . . . . 18.170000000000002 104.21 161.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -91.22 -4.83 4.25 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 115.615 -2.457 . . . . 8.1600000000000001 108.364 -167.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.287 33.1 m -72.67 -11.31 60.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.582 2.438 . . . . 11.130000000000001 117.582 164.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -84.22 159.57 20.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 121.451 1.932 . . . . 18.030000000000001 112.185 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.2 p -95.63 155.5 16.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.238 -2.164 . . . . 10.220000000000001 107.964 -169.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.24 -31.78 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 O-C-N 115.487 -4.508 . . . . 12.300000000000001 106.708 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -52.34 -38.89 59.82 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.652 -4.405 . . . . 36.509999999999998 112.051 166.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -75.41 -33.01 60.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.651 -2.53 . . . . 25.66 112.514 170.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -72.92 -41.43 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.133 -3.479 . . . . 8.1199999999999992 111.68 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.32 -23.47 65.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.876 2.917 . . . . 15.470000000000001 118.876 166.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.76 -32.2 65.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.603 1.547 . . . . 11.449999999999999 114.485 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.254 37.0 mttm -59.3 -40.41 86.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.034 1.734 . . . . 24.98 113.694 163.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.351 55.6 mt -54.27 -43.24 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.773 -3.08 . . . . 9.4600000000000009 116.629 165.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -66.78 -42.56 85.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.939 1.696 . . . . 14.76 107.031 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -61.53 -59.44 5.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.898 -1.752 . . . . 26.289999999999999 113.206 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -61.09 -72.27 0.12 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.806 2.842 . . . . 30.059999999999999 112.121 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.502 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 61.1 mm-40 -77.25 -44.26 30.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 113.473 0.916 . . . . 25.190000000000001 113.473 -172.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.92 43.0 2.71 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 129.61 3.481 . . . . 7.4100000000000001 116.96 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 mt -111.25 117.82 48.86 Favored Pre-proline 0 N--CA 1.43 -1.427 0 O-C-N 121.394 -1.062 . . . . 9.4900000000000002 111.195 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.66 160.2 31.49 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-O 124.828 1.928 . . . . 11.42 114.784 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -86.57 -2.23 8.36 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 114.827 -3.302 . . . . 12.0 111.152 -155.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -88.63 -1.63 58.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 124.428 3.286 . . . . 35.549999999999997 112.142 164.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -99.22 -31.07 11.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.334 2.716 . . . . 20.52 118.334 169.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -109.2 152.49 25.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.334 1.854 . . . . 7.1299999999999999 111.893 -176.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -148.45 154.25 39.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.822 -1.547 . . . . 36.390000000000001 106.822 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.7 mt -119.3 148.95 42.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.251 -1.759 . . . . 9.5500000000000007 106.251 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -127.06 136.64 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 114.161 -1.381 . . . . 13.9 107.537 171.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -114.46 107.94 16.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.766 1.746 . . . . 6.8600000000000003 107.769 169.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.289 . . 61.89 -68.01 0.06 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.159 3.384 . . . . 11.15 111.155 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.53 -16.56 0.11 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 105.961 -2.856 . . . . 13.93 105.961 -172.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -88.08 131.26 34.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 126.334 2.968 . . . . 23.920000000000002 115.349 174.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -88.6 120.86 30.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.422 -3.923 . . . . 23.23 108.483 -172.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.4 mt -82.72 145.02 29.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.051 2.241 . . . . 9.1099999999999994 117.051 -167.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -110.54 139.17 46.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.229 2.918 . . . . 33.439999999999998 106.388 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.22 -41.2 64.02 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.039 -1.891 . . . . 28.370000000000001 112.46 -159.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.11 31.74 4.94 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 121.476 1.944 . . . . 15.0 115.584 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -106.67 -175.33 2.76 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 128.043 2.849 . . . . 25.5 116.257 155.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.7 p -113.27 177.47 4.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.56 1.544 . . . . 11.949999999999999 111.311 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.84 -22.65 45.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.066 1.136 . . . . 10.17 114.066 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -74.93 -25.61 59.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.698 -3.126 . . . . 13.59 111.637 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -67.85 -53.77 24.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.092 -2.255 . . . . 11.699999999999999 114.481 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -81.56 -17.11 49.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 118.726 -0.654 . . . . 12.949999999999999 110.487 -174.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 0.3 OUTLIER 81.51 55.69 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.208 2.432 . . . . 25.449999999999999 106.214 -173.902 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -90.87 101.4 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 1 O-C-N 116.263 -4.023 . . . . 14.6 108.914 171.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.322 12.9 pt20 -90.99 176.0 6.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.247 0.967 . . . . 33.229999999999997 112.001 -171.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -70.69 148.08 48.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 120.944 3.683 . . . . 25.969999999999999 120.944 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.425 24.1 mt-10 51.59 32.64 9.34 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.107 2.861 . . . . 32.609999999999999 117.193 -171.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 166.55 10.39 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.365 1.866 . . . . 10.56 108.58 -174.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.0 m -115.99 132.66 56.59 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 112.625 -2.08 . . . . 5.3300000000000001 110.362 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.45 150.0 28.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 131.148 3.779 . . . . 11.66 107.315 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -105.54 114.75 29.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.771 -1.104 . . . . 16.300000000000001 111.246 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 tp -78.18 130.8 36.76 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.202 -2.811 . . . . 9.9600000000000009 108.732 169.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.3 167.45 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 112.703 -2.044 . . . . 9.7599999999999998 111.251 156.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.52 178.72 5.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.457 -2.053 . . . . 19.57 105.457 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -114.3 -63.11 1.5 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 117.798 -1.561 . . . . 35.079999999999998 111.666 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.7 mt -122.07 -69.71 0.82 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.792 2.037 . . . . 32.310000000000002 106.63 -164.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -89.23 149.91 22.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.028 -2.295 . . . . 42.75 114.216 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.62 -28.9 7.67 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 109.239 -3.619 . . . . 36.310000000000002 112.598 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.728 0 CA-C-O 116.752 -2.138 . . . . 36.270000000000003 111.363 -173.458 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.289 0.8 OUTLIER . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 113.715 1.006 . . . . 17.170000000000002 113.715 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -79.01 135.87 37.02 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.087 -4.758 . . . . 21.890000000000001 113.134 169.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -120.57 155.54 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.845 -2.409 . . . . 10.83 104.746 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -107.96 123.79 49.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.728 1.611 . . . . 10.609999999999999 114.594 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.6 t -109.37 114.9 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 126.087 2.117 . . . . 9.1300000000000008 111.554 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -101.18 122.61 43.93 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.379 -2.075 . . . . 20.550000000000001 111.38 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -79.08 168.95 18.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.389 2.276 . . . . 11.779999999999999 114.016 -175.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.43 -16.35 57.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 118.866 2.913 . . . . 19.309999999999999 118.866 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 p -76.71 -50.68 13.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.647 -1.615 . . . . 23.140000000000001 112.393 166.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.94 39.87 0.19 Allowed Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 125.259 2.589 . . . . 19.739999999999998 118.911 162.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -99.27 124.85 44.68 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.692 2.397 . . . . 21.93 112.642 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.277 7.1 m -82.85 97.7 8.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.065 -2.272 . . . . 12.33 110.553 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.7 mt -72.89 123.18 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 106.527 -1.657 . . . . 17.079999999999998 106.527 170.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 p -101.21 110.66 22.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.228 2.211 . . . . 16.300000000000001 111.427 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.4 mt -118.51 143.82 46.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.697 -1.877 . . . . 15.880000000000001 106.913 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -109.85 121.61 45.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.859 2.464 . . . . 28.899999999999999 106.891 170.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.94 172.73 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.141 0.972 . . . . 12.050000000000001 111.331 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -111.5 160.57 28.9 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 118.727 -2.483 . . . . 18.170000000000002 113.27 171.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -86.46 3.31 6.88 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 CA-C-N 125.996 3.177 . . . . 8.1600000000000001 116.611 -162.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 m -92.98 4.65 53.61 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.274 2.23 . . . . 11.130000000000001 109.689 167.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -70.46 131.42 44.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.363 2.801 . . . . 18.030000000000001 117.262 161.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.1 p -74.3 158.94 33.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.358 -3.339 . . . . 10.220000000000001 114.542 174.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -57.2 -28.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 112.178 0.436 . . . . 12.300000000000001 112.178 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -55.93 -46.26 78.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.83 2.728 . . . . 36.509999999999998 111.424 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -63.95 -45.22 90.13 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.307 -2.745 . . . . 25.66 112.399 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.4 t -57.63 -44.91 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.038 -1.664 . . . . 8.1199999999999992 114.426 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -60.11 -32.29 70.85 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 119.246 3.054 . . . . 15.470000000000001 119.246 165.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.42 82.55 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.05 -4.156 . . . . 11.449999999999999 114.661 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -66.03 -21.54 66.39 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 120.02 3.341 . . . . 24.98 120.02 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -74.72 -41.61 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 120.235 -1.541 . . . . 9.4600000000000009 112.252 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -52.91 -59.64 4.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.605 1.962 . . . . 14.76 114.405 167.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -42.7 -44.73 4.44 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 119.301 3.075 . . . . 26.289999999999999 119.301 161.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -76.78 -49.12 16.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.866 -1.771 . . . . 30.059999999999999 110.374 -173.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -114.01 -17.61 11.92 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 115.9 1.815 . . . . 25.190000000000001 115.9 -160.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.29 29.38 19.84 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 124.726 1.155 . . . . 7.4100000000000001 115.016 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.7 mt -110.86 115.92 52.65 Favored Pre-proline 0 N--CA 1.43 -1.443 0 C-N-CA 129.067 2.947 . . . . 9.4900000000000002 109.603 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.7 Cg_exo -62.53 141.68 87.26 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 N-CA-C 121.672 3.682 . . . . 11.42 121.672 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.1 Cg_exo -74.95 -5.11 16.38 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 127.306 3.645 . . . . 12.0 116.89 -162.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -96.99 -21.06 17.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.016 -2.302 . . . . 35.549999999999997 109.762 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -69.75 -41.58 75.04 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 127.127 2.767 . . . . 20.52 110.873 168.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -60.57 141.71 56.3 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 114.976 1.473 . . . . 7.1299999999999999 114.976 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -132.42 151.65 51.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.375 -2.824 . . . . 36.390000000000001 103.375 150.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.1 mt -110.96 141.92 43.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 111.503 -2.59 . . . . 9.5500000000000007 111.407 166.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 mt -109.53 142.87 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 126.577 1.951 . . . . 13.9 109.194 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -131.5 129.68 41.41 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 123.503 2.865 . . . . 6.8600000000000003 111.762 157.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.12 44.38 5.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.351 -2.093 . . . . 11.15 109.118 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.81 -30.46 4.62 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 130.49 3.9 . . . . 13.93 114.372 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -94.9 132.73 39.4 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.421 2.058 . . . . 23.920000000000002 112.522 -167.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -76.29 137.72 40.08 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.896 -3.002 . . . . 23.23 109.262 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.9 mt -94.42 133.76 37.66 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.022 -2.298 . . . . 9.1099999999999994 112.658 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.95 173.59 8.14 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 124.9 3.5 . . . . 33.439999999999998 111.254 170.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.77 -51.87 10.59 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 124.947 1.404 . . . . 28.370000000000001 113.099 -159.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.72 -28.76 73.75 Favored Glycine 0 N--CA 1.43 -1.75 1 O-C-N 131.946 5.779 . . . . 15.0 120.041 -162.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.0 mtt180 -105.66 169.96 8.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 121.421 2.61 . . . . 25.5 111.329 -163.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -83.69 169.73 14.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.634 2.635 . . . . 11.949999999999999 114.865 -174.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.2 mt -73.24 -34.03 65.64 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.026 -1.671 . . . . 10.17 110.857 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 t -57.74 -40.02 78.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.472 2.027 . . . . 13.59 116.472 163.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -64.27 -49.89 70.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.518 1.673 . . . . 11.699999999999999 115.518 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -57.71 -41.18 81.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.557 1.543 . . . . 12.949999999999999 111.194 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 81.96 60.5 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.46 3.504 . . . . 25.449999999999999 111.41 -172.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.5 mt -103.0 103.74 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 128.823 2.849 . . . . 14.6 108.878 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -84.88 -179.36 7.07 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.587 2.137 . . . . 33.229999999999997 112.075 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -65.39 158.19 27.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.863 -3.648 . . . . 25.969999999999999 117.05 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 36.9 mt-10 55.19 27.51 9.75 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 129.473 3.109 . . . . 32.609999999999999 114.622 176.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.335 21.8 m -83.22 157.08 22.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 125.427 1.705 . . . . 10.56 114.516 164.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -110.67 95.3 5.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.702 -1.874 . . . . 5.3300000000000001 113.427 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.17 141.61 35.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.425 1.89 . . . . 11.66 112.316 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -116.4 114.02 23.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.505 -1.372 . . . . 16.300000000000001 114.192 -167.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -86.86 115.69 24.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.166 1.913 . . . . 9.9600000000000009 116.166 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.297 12.3 m -107.92 156.36 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 129.786 3.234 . . . . 9.7599999999999998 107.386 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.1 mt -120.23 -165.46 1.19 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.729 3.633 . . . . 19.57 106.821 -179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -132.63 139.78 47.9 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 109.983 -3.28 . . . . 35.079999999999998 107.561 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.6 tp -65.45 115.02 5.26 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.889 -1.505 . . . . 32.310000000000002 112.563 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -100.96 -44.52 5.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.999 -1.852 . . . . 42.75 105.999 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.32 -91.1 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.761 1 C-N-CA 131.248 4.261 . . . . 36.310000000000002 108.146 176.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.744 0 N-CA-C 105.672 -2.971 . . . . 36.270000000000003 105.672 -176.287 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 124.375 2.036 . . . . 17.170000000000002 110.69 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -94.03 135.97 34.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.198 -2.519 . . . . 21.890000000000001 104.198 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.2 pt -125.31 135.0 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 116.23 -1.843 . . . . 10.83 108.168 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.1 133.29 34.02 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.528 2.047 . . . . 10.609999999999999 116.528 166.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 t -126.9 109.14 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.55 -0.907 . . . . 9.1300000000000008 108.55 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -89.81 133.58 34.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.768 2.427 . . . . 20.550000000000001 113.644 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.6 p -89.54 -167.59 1.9 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.596 -1.184 . . . . 11.779999999999999 108.142 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mt -70.47 -66.49 0.59 Allowed 'General case' 0 N--CA 1.43 -1.435 1 C-N-CA 135.113 5.365 . . . . 19.309999999999999 114.845 166.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -63.74 -81.96 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.563 -2.585 . . . . 23.140000000000001 117.265 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.94 46.86 0.29 Allowed Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 117.908 -1.495 . . . . 19.739999999999998 110.798 -166.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -140.46 147.62 39.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 118.906 1.353 . . . . 21.93 110.758 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.4 m -129.51 137.03 50.57 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.203 2.43 . . . . 12.33 107.308 166.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.3 mt -105.62 121.7 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 118.821 -2.425 . . . . 17.079999999999998 106.009 -175.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.7 m -90.33 120.74 31.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 116.454 -1.736 . . . . 16.300000000000001 109.451 172.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.17 134.33 55.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.357 -1.782 . . . . 15.880000000000001 109.839 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -88.44 132.03 34.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 114.938 -2.458 . . . . 28.899999999999999 107.379 163.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.27 173.32 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 C-N-CA 133.288 4.635 . . . . 12.050000000000001 110.702 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -123.53 143.53 41.78 Favored Pre-proline 0 N--CA 1.43 -1.429 1 O-C-N 116.082 -4.136 . . . . 18.170000000000002 110.694 174.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -63.71 -28.66 68.75 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 123.761 2.379 . . . . 8.1600000000000001 117.558 -159.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.2 p -87.34 4.83 41.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 125.836 1.96 . . . . 11.130000000000001 110.489 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -72.88 151.81 41.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.856 3.025 . . . . 18.030000000000001 110.079 170.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -82.93 158.18 22.72 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 111.706 -2.497 . . . . 10.220000000000001 111.009 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.6 -29.02 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 O-C-N 121.07 -1.019 . . . . 12.300000000000001 110.641 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -48.99 -39.57 27.2 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.137 4.175 . . . . 36.509999999999998 116.834 158.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -89.32 -16.99 29.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.402 -3.936 . . . . 25.66 109.996 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -78.36 -35.28 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 O-C-N 115.51 -4.494 . . . . 8.1199999999999992 105.521 173.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -69.23 -29.58 67.54 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.675 2.655 . . . . 15.470000000000001 112.47 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.13 -34.19 69.98 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.012 -3.555 . . . . 11.449999999999999 114.932 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -84.17 -19.41 34.15 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.482 -2.145 . . . . 24.98 115.102 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mt -80.11 -35.02 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 116.048 -4.157 . . . . 9.4600000000000009 112.86 167.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.278 0.8 OUTLIER -54.11 -52.52 60.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.944 -2.348 . . . . 14.76 113.039 161.093 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -71.99 -27.17 62.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.835 2.107 . . . . 26.289999999999999 114.977 -174.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.427 ' HG3' ' HG2' ' A' ' 34' ' ' GLU . 49.8 tptt -74.4 -57.74 3.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.65 -3.156 . . . . 30.059999999999999 111.431 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' HG3' ' A' ' 33' ' ' LYS 0.303 33.6 mm-40 -112.4 -29.08 7.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.676 -1.89 . . . . 25.190000000000001 110.926 -168.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.01 28.19 42.49 Favored Glycine 0 N--CA 1.429 -1.771 0 O-C-N 118.035 -2.916 . . . . 7.4100000000000001 117.314 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.4 mt -80.37 119.51 76.62 Favored Pre-proline 0 N--CA 1.43 -1.47 0 CA-C-O 115.318 -2.277 . . . . 9.4900000000000002 110.718 162.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -65.1 156.71 61.29 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 122.44 1.907 . . . . 11.42 114.003 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -11.96 33.74 Favored 'Trans proline' 0 N--CA 1.434 -2.021 1 C-N-CA 125.844 4.362 . . . . 12.0 120.671 -174.949 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -77.54 -38.22 49.17 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 125.206 2.431 . . . . 35.549999999999997 116.233 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -61.74 -32.31 72.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.141 2.645 . . . . 20.52 118.141 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -70.95 123.27 21.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.716 2.006 . . . . 7.1299999999999999 115.118 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -132.38 117.09 17.66 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.241 1.837 . . . . 36.390000000000001 109.738 165.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.74 115.89 27.43 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.006 1.322 . . . . 9.5500000000000007 111.988 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.6 mm -96.42 136.01 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 118.25 -0.881 . . . . 13.9 109.209 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -115.4 117.19 29.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.565 2.439 . . . . 6.8600000000000003 104.844 162.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.91 -93.08 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.075 2.95 . . . . 11.15 108.142 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.48 4.54 7.15 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 126.564 2.031 . . . . 13.93 109.051 171.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.39 144.1 31.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 121.653 2.727 . . . . 23.920000000000002 113.969 -171.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -69.46 137.99 53.09 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.399 2.37 . . . . 23.23 117.399 171.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -106.74 118.28 36.26 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.306 -3.996 . . . . 9.1099999999999994 108.62 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -85.41 151.04 24.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.017 1.865 . . . . 33.439999999999998 113.279 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.01 -49.12 72.33 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 118.038 2.607 . . . . 28.370000000000001 118.038 -170.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.75 77.54 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 119.792 2.677 . . . . 15.0 119.792 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 36.0 mmt180 -76.33 170.56 16.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.75 -3.206 . . . . 25.5 113.104 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.252 69.8 p -100.0 167.36 10.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.678 2.18 . . . . 11.949999999999999 113.174 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mt -54.45 -45.87 73.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.338 2.255 . . . . 10.17 111.909 164.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -76.24 -22.18 55.48 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.841 -1.527 . . . . 13.59 112.689 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -67.43 -48.3 67.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.933 2.093 . . . . 11.699999999999999 109.152 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.477 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 55.5 m-85 -85.08 4.7 32.87 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.995 2.591 . . . . 12.949999999999999 117.995 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.9 m120 65.96 45.61 2.42 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.458 2.303 . . . . 25.449999999999999 110.079 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.2 mt -98.18 108.62 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 127.034 2.134 . . . . 14.6 107.91 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -107.93 -172.87 2.15 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.923 2.297 . . . . 33.229999999999997 106.619 -168.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -73.84 134.5 43.32 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.418 -5.176 . . . . 25.969999999999999 109.895 -173.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.326 88.8 mt-10 68.96 30.22 4.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.522 3.014 . . . . 32.609999999999999 113.536 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -56.31 149.05 17.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 122.172 2.26 . . . . 10.56 110.56 167.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.0 m -106.71 110.94 23.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.536 2.397 . . . . 5.3300000000000001 104.794 159.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.8 mt -99.53 145.29 27.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.325 -2.734 . . . . 11.66 107.886 170.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -104.61 116.78 32.66 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.351 -1.468 . . . . 16.300000000000001 110.509 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.4 tp -95.62 115.26 27.17 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.497 1.498 . . . . 9.9600000000000009 107.8 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.5 m -109.04 143.92 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.761 1.743 . . . . 9.7599999999999998 109.278 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.9 mt -124.25 147.81 47.81 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.699 -1.591 . . . . 19.57 114.701 -168.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -84.03 139.56 32.43 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.826 -2.657 . . . . 35.079999999999998 103.826 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 tp -74.91 124.89 27.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.305 2.478 . . . . 32.310000000000002 113.605 -167.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -122.42 -38.65 2.64 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.925 1.69 . . . . 42.75 110.649 171.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.38 -59.51 0.18 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 116.421 -2.799 . . . . 36.310000000000002 119.402 170.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.777 1 O-C-N 115.664 -4.433 . . . . 36.270000000000003 105.364 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptt? . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 120.436 0.16 . . . . 17.170000000000002 111.175 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -94.04 131.32 39.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.766 1.765 . . . . 21.890000000000001 115.766 170.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -103.13 152.55 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 103.741 -2.688 . . . . 10.83 103.741 163.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -101.82 146.82 27.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.861 2.743 . . . . 10.609999999999999 110.239 162.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.15 113.67 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 110.121 -3.218 . . . . 9.1300000000000008 104.489 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.272 9.2 ttmt -107.12 127.32 53.39 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.472 -3.268 . . . . 20.550000000000001 110.852 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -95.97 170.38 9.33 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.93 -2.981 . . . . 11.779999999999999 109.736 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -68.27 -31.83 71.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.447 2.017 . . . . 19.309999999999999 116.447 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -53.62 -64.63 0.76 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.704 -3.123 . . . . 23.140000000000001 111.823 166.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.87 76.1 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 106.57 -2.612 . . . . 19.739999999999998 106.57 170.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -140.74 153.89 46.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 113.351 -3.339 . . . . 21.93 104.036 163.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -108.75 87.79 2.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.048 2.718 . . . . 12.33 109.811 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.22 124.11 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 124.208 1.956 . . . . 17.079999999999998 112.305 168.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.5 m -99.71 111.1 23.47 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.019 -2.355 . . . . 16.300000000000001 111.826 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.19 133.86 51.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.186 -2.34 . . . . 15.880000000000001 110.239 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -96.1 106.68 18.89 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 116.667 -1.635 . . . . 28.899999999999999 110.727 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.48 158.82 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 128.187 3.429 . . . . 12.050000000000001 107.063 -174.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -108.94 157.85 35.79 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 107.139 -1.43 . . . . 18.170000000000002 107.139 173.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.417 ' HA ' HD11 ' A' ' 56' ' ' LEU . 94.3 Cg_endo -77.82 -8.86 16.93 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 O-C-N 116.008 -2.68 . . . . 8.1600000000000001 114.239 -168.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.4 p -82.81 1.75 37.56 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 118.432 2.752 . . . . 11.130000000000001 118.432 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -83.52 156.88 22.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.726 -3.109 . . . . 18.030000000000001 111.116 169.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -93.83 164.23 13.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.471 -3.893 . . . . 10.220000000000001 115.048 -174.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.67 -39.09 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 119.782 -1.824 . . . . 12.300000000000001 109.917 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.39 -43.78 23.73 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.214 2.672 . . . . 36.509999999999998 118.214 165.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -67.08 -43.19 83.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.628 2.085 . . . . 25.66 116.628 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -53.24 -52.99 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.029 1.732 . . . . 8.1199999999999992 110.469 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -70.79 -19.99 62.64 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.81 -3.681 . . . . 15.470000000000001 116.832 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.08 65.69 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.872 -4.267 . . . . 11.449999999999999 115.056 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -84.51 -28.02 27.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.033 2.933 . . . . 24.98 114.513 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.7 mt -72.89 -44.91 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.168 -1.378 . . . . 9.4600000000000009 111.229 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -52.14 -50.13 62.35 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.862 2.912 . . . . 14.76 118.862 165.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -49.59 -48.47 48.73 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.974 1.842 . . . . 26.289999999999999 115.974 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -78.67 -71.76 0.42 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.088 3.328 . . . . 30.059999999999999 115.488 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -74.15 -35.26 64.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.513 -3.867 . . . . 25.190000000000001 116.799 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.47 42.73 7.72 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 127.676 3.931 . . . . 7.4100000000000001 113.433 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.4 mt -104.44 137.72 19.31 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 102.822 -3.029 . . . . 9.4900000000000002 102.822 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -82.48 146.78 13.83 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 CA-C-N 124.813 2.755 . . . . 11.42 108.821 -174.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -70.78 -3.37 12.55 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 124.265 2.559 . . . . 12.0 115.806 -162.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.42 -22.15 19.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.769 -2.457 . . . . 35.549999999999997 110.667 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -80.16 -25.86 39.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.456 3.102 . . . . 20.52 109.794 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -71.7 121.73 19.37 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.786 2.034 . . . . 7.1299999999999999 112.071 170.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -123.1 116.7 23.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.953 1.835 . . . . 36.390000000000001 111.268 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.1 tp -102.61 116.41 32.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.953 -1.476 . . . . 9.5500000000000007 111.976 -166.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mm -103.79 117.17 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 125.92 1.688 . . . . 13.9 109.022 -172.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -97.03 114.44 26.07 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 120.919 1.69 . . . . 6.8600000000000003 108.93 161.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.89 -98.09 0.06 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 123.892 0.877 . . . . 11.15 111.397 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.85 12.06 8.25 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 127.321 2.391 . . . . 13.93 113.863 166.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -102.19 126.05 49.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.561 -3.905 . . . . 23.920000000000002 105.837 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -85.43 126.81 34.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 125.157 1.535 . . . . 23.23 108.059 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.8 mt -90.14 144.86 25.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.44 2.543 . . . . 9.1099999999999994 116.003 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -100.91 146.76 26.94 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.666 -4.396 . . . . 33.439999999999998 110.077 -168.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -45.17 -54.45 6.87 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 129.114 2.965 . . . . 28.370000000000001 118.373 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.54 24.56 8.34 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 129.324 3.345 . . . . 15.0 114.593 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -115.63 171.75 7.55 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.849 -1.537 . . . . 25.5 106.849 172.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.8 p -104.86 -177.45 3.37 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.311 -0.859 . . . . 11.949999999999999 112.195 172.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 19' ' ' PRO . 45.8 mt -80.31 -28.01 38.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.309 -1.769 . . . . 10.17 110.541 169.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -65.95 -43.18 88.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.72 -3.113 . . . . 13.59 116.437 170.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.298 10.8 m-20 -49.75 -39.84 38.98 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.241 2.682 . . . . 11.699999999999999 118.241 165.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -94.29 -18.72 21.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.549 -2.594 . . . . 12.949999999999999 116.88 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 73.57 54.52 0.11 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.418 2.949 . . . . 25.449999999999999 110.104 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mt -93.83 120.7 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 113.73 -1.577 . . . . 14.6 109.487 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -89.48 168.76 11.94 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.992 1.853 . . . . 33.229999999999997 108.406 -167.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -64.12 153.95 36.11 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.815 -3.678 . . . . 25.969999999999999 109.764 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 41.23 35.11 0.37 Allowed 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 113.808 -5.557 . . . . 32.609999999999999 118.621 -169.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -91.88 129.24 37.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.572 -3.205 . . . . 10.56 108.341 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -87.77 122.54 31.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.832 1.049 . . . . 5.3300000000000001 113.832 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.341 1.5 mt -101.63 149.8 23.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.086 -2.259 . . . . 11.66 110.255 170.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -98.22 130.93 44.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.491 -1.38 . . . . 16.300000000000001 107.539 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.5 tp -114.46 115.58 27.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.47 -2.789 . . . . 9.9600000000000009 103.47 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.11 164.98 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.518 -2.03 . . . . 9.7599999999999998 105.518 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.6 mt -105.81 151.68 24.19 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 123.941 1.829 . . . . 19.57 109.787 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -62.6 132.59 52.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.414 2.005 . . . . 35.079999999999998 116.414 161.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 tp -97.91 130.23 44.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 115.143 1.535 . . . . 32.310000000000002 115.143 174.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -138.42 -111.38 0.17 Allowed 'General case' 0 N--CA 1.43 -1.431 1 C-N-CA 132.426 4.291 . . . . 42.75 105.135 169.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.86 122.87 1.22 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 116.43 -3.919 . . . . 36.310000000000002 114.91 165.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.79 0 CA-C-O 115.927 -2.596 . . . . 36.270000000000003 116.225 -161.837 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 108.957 -0.757 . . . . 17.170000000000002 108.957 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -103.34 144.7 31.01 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 116.223 -4.048 . . . . 21.890000000000001 111.849 -176.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.83 160.69 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 109.095 -3.684 . . . . 10.83 107.901 164.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -125.19 112.56 16.59 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.088 2.743 . . . . 10.609999999999999 105.558 -166.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 67' ' ' LEU . 48.2 t -104.94 125.42 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.817 -1.179 . . . . 9.1300000000000008 107.817 -174.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -121.3 127.18 51.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.419 2.372 . . . . 20.550000000000001 111.621 -167.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -70.67 169.86 13.52 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 112.642 -2.072 . . . . 11.779999999999999 111.047 168.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.3 mt -81.59 -12.69 58.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.921 -2.987 . . . . 19.309999999999999 112.55 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -91.27 -37.32 13.37 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 124.199 1.952 . . . . 23.140000000000001 110.431 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.39 38.05 0.35 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 116.53 -2.261 . . . . 19.739999999999998 111.871 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.418 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 60.3 tttm -98.99 138.74 35.66 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.741 -2.688 . . . . 21.93 103.741 172.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.1 m -114.97 122.81 47.41 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.603 -1.31 . . . . 12.33 108.572 -172.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -101.47 128.76 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 101.721 -3.437 . . . . 17.079999999999998 101.721 -170.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.6 m -112.59 112.76 24.51 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.461 2.076 . . . . 16.300000000000001 111.999 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.264 73.0 mt -116.25 158.91 22.61 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 111.839 -2.437 . . . . 15.880000000000001 112.685 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -113.39 117.52 31.99 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.77 -2.678 . . . . 28.899999999999999 103.77 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.23 154.87 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 115.447 -0.797 . . . . 12.050000000000001 108.874 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -94.66 147.46 33.23 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 117.517 -1.23 . . . . 18.170000000000002 109.173 170.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -66.15 -8.66 20.9 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 127.629 3.76 . . . . 8.1600000000000001 118.994 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -100.18 12.5 36.85 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 129.642 4.339 . . . . 11.130000000000001 120.847 164.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.55 163.99 26.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.141 -1.424 . . . . 18.030000000000001 111.47 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.0 p -104.25 164.45 11.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.624 2.083 . . . . 10.220000000000001 116.624 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.1 mm -63.57 -36.09 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.943 2.497 . . . . 12.300000000000001 111.814 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -53.52 -45.08 69.62 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.48 1.659 . . . . 36.509999999999998 115.48 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.17 -41.52 94.58 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.822 2.849 . . . . 25.66 114.729 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.56 -52.99 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 118.682 -2.511 . . . . 8.1199999999999992 105.635 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -58.69 -35.37 72.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.579 2.609 . . . . 15.470000000000001 116.014 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.28 94.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.776 -1.827 . . . . 11.449999999999999 114.447 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -74.28 -26.59 60.29 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 115.637 -2.125 . . . . 24.98 108.775 -174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.9 mt -66.92 -29.75 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 124.895 2.283 . . . . 9.4600000000000009 110.599 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -66.91 -48.3 69.13 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.96 -4.212 . . . . 14.76 114.463 175.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -62.36 -48.39 79.99 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.397 1.999 . . . . 26.289999999999999 116.397 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -69.95 -67.15 0.51 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.445 2.069 . . . . 30.059999999999999 109.707 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 65.9 mm-40 -84.04 -22.12 31.38 Favored 'General case' 0 N--CA 1.43 -1.425 1 O-C-N 115.838 -4.289 . . . . 25.190000000000001 118.75 -165.428 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.08 27.9 14.92 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 126.106 1.813 . . . . 7.4100000000000001 111.874 171.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -104.82 125.06 34.82 Favored Pre-proline 0 N--CA 1.43 -1.45 0 C-N-CA 125.908 1.683 . . . . 9.4900000000000002 109.35 -173.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.65 146.33 30.31 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 122.91 2.075 . . . . 11.42 114.748 -176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.98 -7.27 12.24 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 124.908 2.788 . . . . 12.0 111.269 -162.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.74 -19.04 64.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.024 2.93 . . . . 35.549999999999997 114.166 169.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -104.91 -10.32 17.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.558 2.743 . . . . 20.52 109.102 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -94.65 137.12 34.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.468 -2.02 . . . . 7.1299999999999999 106.068 -173.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -121.81 140.98 51.69 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.704 -1.591 . . . . 36.390000000000001 106.704 162.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.26 136.64 54.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.922 -1.111 . . . . 9.5500000000000007 108.004 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.454 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 26.8 mm -118.34 129.46 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.058 2.143 . . . . 13.9 110.904 -173.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -128.46 117.23 20.98 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.835 -3.666 . . . . 6.8600000000000003 108.328 169.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.34 . . 58.37 -91.56 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.416 1.887 . . . . 11.15 114.338 -166.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.18 26.08 2.33 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.256 -2.153 . . . . 13.93 112.309 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -115.12 155.33 27.29 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.119 2.568 . . . . 23.920000000000002 104.177 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -114.14 137.09 52.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.145 -2.847 . . . . 23.23 106.163 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.427 HD21 ' CD2' ' A' ' 59' ' ' TYR . 30.1 mt -81.77 154.26 26.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.848 2.166 . . . . 9.1099999999999994 116.848 -167.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -102.11 157.31 16.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.994 2.33 . . . . 33.439999999999998 111.541 172.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -76.75 -52.34 9.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 118.789 2.885 . . . . 28.370000000000001 118.789 -161.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.82 24.49 5.15 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 116.908 -2.568 . . . . 15.0 118.384 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -90.23 167.29 12.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.952 2.876 . . . . 25.5 111.125 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.1 p -90.24 166.85 13.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.694 -2.504 . . . . 11.949999999999999 116.083 171.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -54.15 -31.94 53.95 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.658 -1.901 . . . . 10.17 114.346 158.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -74.72 -42.08 58.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.006 -1.077 . . . . 13.59 109.619 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -47.95 -34.37 9.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 114.979 -2.438 . . . . 11.699999999999999 115.03 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.427 ' CD2' HD21 ' A' ' 50' ' ' LEU . 93.3 m-85 -104.89 -0.87 26.64 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 121.96 2.164 . . . . 12.949999999999999 107.273 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.5 m120 71.6 46.25 0.41 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.738 2.815 . . . . 25.449999999999999 105.579 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mt -82.6 106.67 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 O-C-N 117.998 -2.939 . . . . 14.6 108.792 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -96.07 -175.11 3.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.148 1.53 . . . . 33.229999999999997 111.02 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -65.76 141.91 58.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 124.674 3.397 . . . . 25.969999999999999 112.851 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.362 15.3 tt0 80.19 21.08 0.52 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.202 2.601 . . . . 32.609999999999999 113.993 174.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.6 m -80.69 144.76 32.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.243 3.417 . . . . 10.56 113.243 -174.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -98.78 101.97 13.55 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.212 2.605 . . . . 5.3300000000000001 115.009 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.43 ' HB2' HG21 ' A' ' 5' ' ' VAL . 8.6 mp -99.94 130.8 46.15 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.119 -3.488 . . . . 11.66 109.233 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.454 ' HB2' ' HB ' ' A' ' 44' ' ' ILE 0.261 17.2 m-70 -101.01 142.91 31.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.786 -2.446 . . . . 16.300000000000001 108.755 -175.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.1 tp -119.86 101.86 8.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.522 -0.763 . . . . 9.9600000000000009 109.929 -171.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.0 t -96.2 119.0 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 126.493 3.044 . . . . 9.7599999999999998 108.387 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 mt -84.52 130.44 34.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.036 -2.29 . . . . 19.57 105.551 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -61.56 116.7 4.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 122.875 0.47 . . . . 35.079999999999998 111.659 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.71 122.82 27.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.896 -2.378 . . . . 32.310000000000002 110.611 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -109.31 -55.03 2.47 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.918 2.087 . . . . 42.75 113.474 159.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.45 -53.13 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.687 0 CA-C-O 125.768 2.871 . . . . 36.310000000000002 109.058 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 N-CA-C 106.697 -2.561 . . . . 36.270000000000003 106.697 -171.051 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 122.937 1.351 . . . . 17.170000000000002 112.899 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -94.25 145.93 24.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 127.646 3.593 . . . . 21.890000000000001 108.254 177.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -130.88 167.5 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 103.777 -2.675 . . . . 10.83 103.777 172.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -126.81 137.18 53.16 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 102.841 -3.022 . . . . 10.609999999999999 102.841 -174.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 69' ' ' LEU . 2.7 t -106.75 135.44 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.2 -1.778 . . . . 9.1300000000000008 106.2 171.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -135.38 135.46 40.69 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.486 2.403 . . . . 20.550000000000001 112.769 173.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.2 p -77.87 173.07 12.53 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 113.601 -1.636 . . . . 11.779999999999999 113.573 173.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.73 -28.23 62.52 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.124 -2.86 . . . . 19.309999999999999 112.524 -172.541 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.6 p -75.11 -36.5 61.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.357 -3.339 . . . . 23.140000000000001 109.953 166.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.12 42.25 0.37 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 120.972 3.149 . . . . 19.739999999999998 120.972 170.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 57.5 tttm -88.98 115.51 26.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.844 1.794 . . . . 21.93 115.844 176.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 m -92.18 114.24 26.73 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.162 2.585 . . . . 12.33 108.343 -165.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.0 mt -105.07 102.83 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 106.343 -1.725 . . . . 17.079999999999998 106.343 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -87.42 115.52 24.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 116.062 1.875 . . . . 16.300000000000001 116.062 175.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.7 mt -123.95 151.44 43.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.246 -1.835 . . . . 15.880000000000001 115.396 -174.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.5 138.55 31.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.388 1.055 . . . . 28.899999999999999 109.651 176.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.305 0.1 OUTLIER -144.84 161.43 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.85 -1.907 . . . . 12.050000000000001 105.85 170.235 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -103.23 165.84 12.88 Favored Pre-proline 0 N--CA 1.429 -1.477 0 CA-C-O 115.685 -2.103 . . . . 18.170000000000002 106.721 164.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.39 -9.64 14.94 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 124.829 2.76 . . . . 8.1600000000000001 115.342 -178.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 p -84.13 -19.02 34.91 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 129.766 4.416 . . . . 11.130000000000001 109.263 169.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -61.17 149.84 36.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 118.44 -1.304 . . . . 18.030000000000001 114.395 167.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.292 35.5 p -78.17 174.8 10.79 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.068 -3.52 . . . . 10.220000000000001 116.06 171.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.7 mt -93.59 -17.42 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 117.224 -3.423 . . . . 12.300000000000001 107.743 -176.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -72.46 -40.57 66.89 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 131.751 4.02 . . . . 36.509999999999998 107.298 172.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -51.41 -49.82 60.86 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 130.969 3.708 . . . . 25.66 112.457 169.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.18 -52.25 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 124.371 1.044 . . . . 8.1199999999999992 113.075 173.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.73 -29.55 70.08 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 126.45 1.9 . . . . 15.470000000000001 111.066 -178.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.77 -27.24 62.82 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 115.221 -2.591 . . . . 11.449999999999999 116.56 175.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -72.41 -18.65 61.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.531 1.678 . . . . 24.98 115.531 168.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.3 mt -75.38 -27.96 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 112.494 0.553 . . . . 9.4600000000000009 112.494 170.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.341 18.1 tt0 -52.31 -42.85 64.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.314 1.968 . . . . 14.76 116.314 160.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -78.11 -49.01 14.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.551 1.54 . . . . 26.289999999999999 110.116 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -79.63 -58.8 3.01 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.917 2.932 . . . . 30.059999999999999 118.917 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS 0.313 6.6 mm-40 -74.53 -44.05 52.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 113.478 0.918 . . . . 25.190000000000001 113.478 -177.555 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.76 53.96 3.05 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 128.369 2.89 . . . . 7.4100000000000001 107.372 -171.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -118.18 120.1 32.68 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 102.384 -3.191 . . . . 9.4900000000000002 102.384 174.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -72.85 154.48 53.62 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 CA-C-N 122.825 2.045 . . . . 11.42 114.094 176.375 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -62.48 -16.47 52.27 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 N-CA-C 118.666 2.525 . . . . 12.0 118.666 -173.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.463 ' CG ' HH12 ' A' ' 72' ' ' ARG . 37.5 t70 -76.24 -31.32 58.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 117.607 -1.187 . . . . 35.549999999999997 111.948 -174.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -78.4 -18.07 55.53 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 127.4 2.937 . . . . 20.52 114.447 170.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -82.02 122.57 27.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.919 -1.738 . . . . 7.1299999999999999 114.577 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -111.29 120.8 43.46 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.412 -2.44 . . . . 36.390000000000001 104.412 166.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.7 mt -96.32 106.96 19.25 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.339 -2.1 . . . . 9.5500000000000007 112.26 164.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -89.53 145.28 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 O-C-N 125.619 1.825 . . . . 13.9 108.059 173.066 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -122.83 107.78 12.26 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.086 -1.82 . . . . 6.8600000000000003 106.086 170.203 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.0 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.4 3.48 . . . . 11.15 111.817 -160.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.74 1.08 9.33 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 116.629 -3.795 . . . . 13.93 114.937 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -102.45 126.88 49.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.717 -2.637 . . . . 23.920000000000002 113.349 177.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -72.59 125.3 27.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.205 1.821 . . . . 23.23 111.168 171.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.4 mt -81.92 166.3 20.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.54 1.064 . . . . 9.1099999999999994 110.479 -174.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -98.65 158.18 15.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.868 -1.77 . . . . 33.439999999999998 113.02 167.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.58 -56.25 6.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.286 2.234 . . . . 28.370000000000001 112.163 -174.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.45 13.93 31.93 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 118.272 -2.768 . . . . 15.0 118.852 -175.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -106.79 159.15 16.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.619 2.368 . . . . 25.5 107.401 172.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -103.37 170.89 7.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 111.385 -2.643 . . . . 11.949999999999999 112.874 -173.005 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -58.35 -43.14 88.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 126.18 2.175 . . . . 10.17 111.654 174.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -53.84 -35.2 61.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.686 2.794 . . . . 13.59 115.994 174.65 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 14.9 m-20 -80.91 -25.25 37.66 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 112.763 -3.494 . . . . 11.699999999999999 114.51 -171.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -95.8 -10.32 29.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 128.879 3.862 . . . . 12.949999999999999 110.538 171.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.2 m120 77.72 45.64 0.07 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.542 3.537 . . . . 25.449999999999999 113.583 173.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -74.56 140.23 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 127.788 2.435 . . . . 14.6 109.141 170.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -97.79 175.98 5.97 Favored 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 132.926 4.49 . . . . 33.229999999999997 108.759 178.321 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -68.35 156.11 38.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.094 1.887 . . . . 25.969999999999999 116.094 162.077 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 56.62 17.58 3.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.12 1.438 . . . . 32.609999999999999 114.1 -178.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -85.03 154.05 22.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.915 -2.991 . . . . 10.56 110.262 177.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -99.73 109.96 22.38 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 111.979 -2.373 . . . . 5.3300000000000001 114.517 -178.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -86.1 156.38 20.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 128.773 3.795 . . . . 11.66 110.111 171.262 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -112.07 140.57 46.64 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 116.915 -3.616 . . . . 16.300000000000001 109.014 178.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.561 ' HB2' HG13 ' A' ' 5' ' ' VAL . 48.8 tp -110.53 119.55 39.54 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.854 -1.975 . . . . 9.9600000000000009 110.484 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.45 135.18 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 101.855 -3.387 . . . . 9.7599999999999998 101.855 -178.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mt -93.28 153.41 18.59 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.555 -2.387 . . . . 19.57 104.555 -179.016 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.463 HH12 ' CG ' ' A' ' 39' ' ' ASP . 52.2 ttp180 -79.43 119.57 22.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.042 1.877 . . . . 35.079999999999998 111.306 166.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.3 mt -92.18 91.79 7.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.426 -2.671 . . . . 32.310000000000002 112.023 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -86.06 -56.82 3.28 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.54 -1.35 . . . . 42.75 110.269 166.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.82 116.38 0.59 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 107.373 -2.291 . . . . 36.310000000000002 107.373 163.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.759 0 CA-C-O 123.42 1.567 . . . . 36.270000000000003 113.46 -165.081 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 114.851 -2.5 . . . . 17.170000000000002 116.933 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -90.62 132.57 35.68 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.964 -1.493 . . . . 21.890000000000001 107.101 -179.267 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -119.64 153.28 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.938 -1.875 . . . . 10.83 105.938 162.718 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -115.18 135.22 54.42 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.409 -2.682 . . . . 10.609999999999999 110.628 177.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -100.8 123.78 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.369 -2.707 . . . . 9.1300000000000008 107.487 176.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -108.8 128.28 54.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.458 1.099 . . . . 20.550000000000001 108.117 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.3 p -81.17 173.76 12.22 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 117.603 2.446 . . . . 11.779999999999999 117.603 -177.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.6 mt -67.56 -27.46 66.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.42 -2.05 . . . . 19.309999999999999 114.772 166.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -74.08 -48.78 27.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.501 2.32 . . . . 23.140000000000001 114.907 175.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 68.06 0.32 Allowed Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.483 -1.447 . . . . 19.739999999999998 109.483 178.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -139.63 160.35 40.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.927 -1.511 . . . . 21.93 111.259 164.101 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -124.27 109.61 13.59 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.008 2.068 . . . . 12.33 112.54 -166.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mp -96.96 132.01 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.477 -2.416 . . . . 17.079999999999998 104.477 -173.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.302 31.6 m -88.53 96.11 10.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.232 0.958 . . . . 16.300000000000001 112.891 -178.031 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.39 119.64 39.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.839 -1.944 . . . . 15.880000000000001 110.55 -169.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.79 123.01 32.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.958 -2.339 . . . . 28.899999999999999 114.772 169.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.34 154.06 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.744 2.818 . . . . 12.050000000000001 115.088 -172.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -107.57 158.33 33.54 Favored Pre-proline 0 N--CA 1.43 -1.435 0 CA-C-O 115.771 -2.061 . . . . 18.170000000000002 112.063 173.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.51 -21.45 40.07 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 123.314 2.219 . . . . 8.1600000000000001 117.216 -175.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -67.88 -11.84 59.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.692 3.597 . . . . 11.130000000000001 114.291 172.033 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -79.61 133.6 36.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.683 2.793 . . . . 18.030000000000001 113.592 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.8 p -74.2 154.43 39.04 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.881 1.672 . . . . 10.220000000000001 110.019 168.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.439 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 4.3 mp -76.28 -9.24 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.528 -3.233 . . . . 12.300000000000001 114.778 174.12 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.01 -35.83 61.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 112.983 -3.389 . . . . 36.509999999999998 112.264 162.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -58.95 -42.28 89.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.17 2.414 . . . . 25.66 113.665 173.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -66.65 -34.38 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 113.472 -1.695 . . . . 8.1199999999999992 112.461 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 62.6 mttt -71.07 -30.5 66.65 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.971 2.319 . . . . 15.470000000000001 111.759 -179.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.09 -25.94 63.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.472 2.309 . . . . 11.449999999999999 114.917 174.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -88.22 -29.84 20.16 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.633 2.159 . . . . 24.98 109.1 -176.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.6 mt -74.65 -37.31 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 118.502 -2.624 . . . . 9.4600000000000009 116.048 169.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -47.42 -38.33 13.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 119.436 3.125 . . . . 14.76 119.436 159.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.273 10.9 t70 -71.77 -53.73 12.45 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 114.816 -2.516 . . . . 26.289999999999999 107.137 -176.14 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -71.75 -57.7 4.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.447 2.299 . . . . 30.059999999999999 112.483 -172.638 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -92.83 -38.5 11.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.567 -0.901 . . . . 25.190000000000001 108.567 -166.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.26 37.54 5.34 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 120.619 3.008 . . . . 7.4100000000000001 120.619 -173.167 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -98.61 127.6 35.32 Favored Pre-proline 0 N--CA 1.429 -1.476 0 O-C-N 119.619 -2.106 . . . . 9.4900000000000002 108.594 171.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.13 139.21 54.81 Favored 'Trans proline' 0 C--N 1.3 -1.997 1 CA-C-O 110.134 -4.194 . . . . 11.42 110.816 175.266 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -82.5 -7.44 11.7 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 CA-C-N 127.836 3.834 . . . . 12.0 117.129 -161.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -67.36 -32.68 73.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.165 3.786 . . . . 35.549999999999997 113.412 169.603 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -68.7 -50.45 50.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 111.41 -2.632 . . . . 20.52 116.251 168.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -59.69 145.07 46.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 118.891 2.923 . . . . 7.1299999999999999 118.891 -168.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -123.65 120.95 34.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 124.434 3.288 . . . . 36.390000000000001 109.523 167.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 35.6 mt -103.97 121.45 43.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.633 -1.988 . . . . 9.5500000000000007 105.633 -178.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -118.13 129.26 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 102.436 -3.172 . . . . 13.9 102.436 -169.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -104.62 106.15 16.53 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.532 -3.855 . . . . 6.8600000000000003 106.77 170.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 72.5 -91.09 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 125.255 2.455 . . . . 11.15 116.748 -171.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.64 -19.24 4.18 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 111.716 -2.493 . . . . 13.93 111.966 168.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -88.67 121.42 31.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.181 -3.541 . . . . 23.920000000000002 111.375 -166.136 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -80.12 122.22 26.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.323 -3.986 . . . . 23.23 109.191 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.52 134.92 46.84 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 128.35 3.531 . . . . 9.1099999999999994 115.593 175.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -95.56 130.18 42.5 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.542 3.137 . . . . 33.439999999999998 111.583 -178.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.12 -42.41 69.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 110.944 -2.844 . . . . 28.370000000000001 111.703 -165.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.6 4.84 85.18 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 118.762 -2.461 . . . . 15.0 114.888 -176.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.27 95.0 mtt180 -95.0 163.65 13.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.005 2.402 . . . . 25.5 106.554 176.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.0 p -95.15 166.35 11.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.9 1.815 . . . . 11.949999999999999 115.9 168.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -64.18 -29.68 70.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.578 2.351 . . . . 10.17 111.835 168.006 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.251 8.5 t -67.73 -42.07 82.48 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.96 -4.213 . . . . 13.59 112.433 178.484 . . . . . . . . 3 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -58.16 -42.84 86.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 117.19 2.293 . . . . 11.699999999999999 117.19 174.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -82.69 4.92 23.03 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 116.485 2.031 . . . . 12.949999999999999 116.485 170.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 m120 48.16 55.03 9.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.456 -2.653 . . . . 25.449999999999999 113.744 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.83 111.35 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 125.349 1.655 . . . . 14.6 106.744 -177.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -81.33 166.4 20.51 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.502 1.521 . . . . 33.229999999999997 111.343 174.059 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -63.06 158.87 18.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.553 1.541 . . . . 25.969999999999999 114.378 -171.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.289 38.5 mt-10 58.86 24.66 12.68 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.575 2.131 . . . . 32.609999999999999 116.534 -177.375 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m -77.71 125.63 29.63 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.113 -1.617 . . . . 10.56 113.687 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.9 m -80.06 126.48 31.12 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.593 1.557 . . . . 5.3300000000000001 112.002 174.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 80.3 mt -103.69 150.2 24.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.569 1.148 . . . . 11.66 108.527 169.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -101.43 124.38 47.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.318 -1.734 . . . . 16.300000000000001 106.318 170.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.8 tp -96.86 128.09 43.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.282 -1.747 . . . . 9.9600000000000009 106.282 171.172 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.63 155.23 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.735 -2.32 . . . . 9.7599999999999998 104.735 168.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 43.5 mt -104.2 177.54 4.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 121.027 -1.045 . . . . 19.57 109.418 175.476 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -105.16 118.02 35.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.589 1.956 . . . . 35.079999999999998 112.75 -164.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.7 tp -100.84 112.16 24.53 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.993 1.479 . . . . 32.310000000000002 114.993 -175.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.95 -55.01 1.05 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.254 2.221 . . . . 42.75 109.941 169.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.42 98.09 0.12 Allowed Glycine 0 N--CA 1.43 -1.763 1 C-N-CA 131.599 4.428 . . . . 36.310000000000002 109.468 169.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.762 1 CA-C-O 112.974 -4.237 . . . . 36.270000000000003 122.044 175.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 122.88 1.324 . . . . 17.170000000000002 111.403 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.76 110.65 21.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.134 -1.604 . . . . 21.890000000000001 108.132 -175.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -84.81 145.96 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.195 -1.566 . . . . 10.83 110.841 153.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -123.15 89.21 3.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.489 -2.782 . . . . 10.609999999999999 103.489 -172.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 62.0 t -80.7 123.17 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.181 -1.414 . . . . 9.1300000000000008 107.181 179.309 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -114.21 119.26 36.43 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.497 3.522 . . . . 20.550000000000001 110.977 -172.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.7 p -77.91 161.56 27.48 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.082 -4.761 . . . . 11.779999999999999 113.004 -176.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.6 mt -78.83 -21.78 47.15 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 117.34 -1.744 . . . . 19.309999999999999 109.657 -175.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.0 p -70.55 -43.71 68.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.083 -2.886 . . . . 23.140000000000001 114.16 173.081 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.66 -2.26 0.21 Allowed Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 118.173 2.029 . . . . 19.739999999999998 118.173 178.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -91.49 145.49 24.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.756 -1.222 . . . . 21.93 110.955 -167.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.6 m -115.63 115.35 26.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.873 -2.269 . . . . 12.33 104.873 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.8 mt -96.52 105.51 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.735 2.414 . . . . 17.079999999999998 107.318 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -74.59 119.92 19.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.563 1.649 . . . . 16.300000000000001 110.655 169.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.322 97.8 mt -130.46 134.62 47.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.333 2.968 . . . . 15.880000000000001 103.922 168.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.361 2.2 mt-10 -84.86 107.65 17.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 127.511 3.529 . . . . 28.899999999999999 113.678 169.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -116.87 171.34 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.031 -2.293 . . . . 12.050000000000001 108.978 177.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -114.72 160.29 33.94 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 127.895 2.478 . . . . 18.170000000000002 108.03 176.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -68.3 -24.5 37.36 Favored 'Trans proline' 0 N--CA 1.434 -1.978 0 O-C-N 116.216 -2.57 . . . . 8.1600000000000001 112.726 -170.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.391 7.1 m -88.12 -2.52 58.65 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.917 -1.739 . . . . 11.130000000000001 114.686 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -72.96 158.14 36.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 128.328 3.918 . . . . 18.030000000000001 114.84 174.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.414 43.1 p -95.47 149.62 21.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.296 -2.229 . . . . 10.220000000000001 114.804 -176.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mp -66.06 -37.3 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.513 -1.291 . . . . 12.300000000000001 107.513 173.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -50.27 -45.46 54.31 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.296 -2.128 . . . . 36.509999999999998 113.906 169.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -84.63 7.21 21.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 123.766 2.984 . . . . 25.66 112.797 177.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.269 23.5 t -77.42 -60.04 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 O-C-N 116.746 -3.721 . . . . 8.1199999999999992 107.255 159.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -43.65 -40.66 4.26 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.968 2.581 . . . . 15.470000000000001 117.968 175.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.315 . . -50.05 -47.47 53.38 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 128.079 2.552 . . . . 11.449999999999999 116.697 171.301 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -76.99 -30.94 56.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.102 -2.249 . . . . 24.98 108.252 -175.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.84 -31.75 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 O-C-N 115.967 -4.208 . . . . 9.4600000000000009 112.86 174.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -69.01 -33.34 73.49 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.161 -1.587 . . . . 14.76 109.611 176.038 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -76.16 -51.92 11.17 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.728 1.611 . . . . 26.289999999999999 115.109 177.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -76.91 -42.34 39.92 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 119.669 3.211 . . . . 30.059999999999999 119.669 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 48.2 mm-40 -106.4 -25.6 11.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.391 1.682 . . . . 25.190000000000001 110.69 -178.252 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.4 18.82 51.74 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 120.305 2.882 . . . . 7.4100000000000001 120.305 175.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.2 mt -91.12 126.85 53.72 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 101.32 -3.585 . . . . 9.4900000000000002 101.32 -175.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -56.06 151.56 41.74 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 N-CA-C 120.639 3.284 . . . . 11.42 120.639 171.515 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -86.02 -22.22 2.36 Favored 'Trans proline' 0 C--N 1.3 -2.014 1 CA-C-N 130.077 4.635 . . . . 12.0 116.128 -161.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -84.12 -23.09 30.87 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.37 2.033 . . . . 35.549999999999997 110.821 -174.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -61.52 -28.15 69.11 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.201 2.6 . . . . 20.52 114.385 162.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -87.8 122.93 32.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 116.716 -1.612 . . . . 7.1299999999999999 112.34 -170.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -113.97 131.24 56.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 122.363 2.347 . . . . 36.390000000000001 112.181 166.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.53 122.25 39.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.207 -3.433 . . . . 9.5500000000000007 114.698 171.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.7 mt -106.95 118.58 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.88 -2.267 . . . . 13.9 104.88 172.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -106.04 121.81 44.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.603 1.668 . . . . 6.8600000000000003 107.978 167.247 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.318 . . 52.55 -99.2 0.08 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.098 1.888 . . . . 11.15 116.098 -174.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.26 -17.82 13.18 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 117.554 1.782 . . . . 13.93 117.554 -173.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -109.6 133.08 53.52 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.513 2.725 . . . . 23.920000000000002 111.236 -165.586 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -79.63 128.25 33.17 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.655 -1.278 . . . . 23.23 108.719 173.622 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 mt -95.05 126.52 40.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.782 2.083 . . . . 9.1099999999999994 115.856 -165.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -82.28 139.38 34.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.786 2.232 . . . . 33.439999999999998 111.308 171.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.24 -50.16 61.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.157 2.583 . . . . 28.370000000000001 113.471 -160.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.03 3.93 86.53 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 127.385 2.421 . . . . 15.0 113.34 -162.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.284 22.6 mtt180 -85.5 162.52 18.9 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.988 2.115 . . . . 25.5 111.689 172.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -88.91 168.4 12.43 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 116.563 -2.055 . . . . 11.949999999999999 110.562 178.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.94 -25.25 60.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.994 -1.912 . . . . 10.17 111.655 169.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.8 t -63.77 -41.61 97.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.652 2.093 . . . . 13.59 116.652 172.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -47.31 -46.93 25.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.626 2.631 . . . . 11.699999999999999 116.259 175.086 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -86.14 1.24 51.3 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.122 -2.236 . . . . 12.949999999999999 115.601 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.37 17.3 m-20 75.98 32.45 0.64 Allowed 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.734 2.683 . . . . 25.449999999999999 113.501 169.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.56 113.85 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.35 -2.719 . . . . 14.6 109.129 -170.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -111.29 -171.11 1.77 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.284 1.992 . . . . 33.229999999999997 109.182 -174.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -71.36 148.13 47.32 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 115.142 -2.361 . . . . 25.969999999999999 112.773 -168.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 49.65 29.48 3.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 119.728 3.233 . . . . 32.609999999999999 119.728 -165.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -68.66 148.26 50.69 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 116.091 1.885 . . . . 10.56 116.091 170.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -104.08 117.63 34.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 121.235 0.541 . . . . 5.3300000000000001 110.805 171.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.37 151.04 25.4 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.364 -3.335 . . . . 11.66 108.343 175.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -93.77 130.03 39.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.35 1.656 . . . . 16.300000000000001 115.038 178.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.5 tp -109.69 95.12 5.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.315 2.007 . . . . 9.9600000000000009 112.611 178.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -97.24 126.37 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 128.13 2.572 . . . . 9.7599999999999998 111.807 176.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.3 mt -93.19 162.85 13.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.281 -1.512 . . . . 19.57 112.085 177.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -90.4 131.81 35.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.876 -2.39 . . . . 35.079999999999998 113.147 -178.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.313 84.5 mt -97.32 94.52 7.13 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 121.382 -0.824 . . . . 32.310000000000002 111.469 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -114.71 -67.49 0.99 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.408 2.283 . . . . 42.75 113.043 -176.275 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.14 62.55 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.718 0 O-C-N 127.259 2.849 . . . . 36.310000000000002 108.387 -175.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.716 0 O-C-N 119.22 -2.341 . . . . 36.270000000000003 116.631 179.447 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 107.733 -1.21 . . . . 17.170000000000002 107.733 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -112.61 147.18 37.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.206 -1.559 . . . . 21.890000000000001 112.09 174.034 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.98 170.77 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.851 -1.907 . . . . 10.83 105.851 164.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -131.71 126.1 33.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.432 -3.292 . . . . 10.609999999999999 107.825 -175.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.0 t -97.77 118.76 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.983 -2.323 . . . . 9.1300000000000008 110.138 168.08 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -103.56 137.23 41.91 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.452 -2.795 . . . . 20.550000000000001 103.452 -176.175 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.9 p -97.84 179.79 4.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.504 -0.748 . . . . 11.779999999999999 111.685 -168.33 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.94 -33.78 75.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.358 -2.714 . . . . 19.309999999999999 113.705 177.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.1 p -76.49 -32.13 58.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.176 -2.821 . . . . 23.140000000000001 105.643 175.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.54 30.03 4.81 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-O 124.096 1.942 . . . . 19.739999999999998 116.994 -166.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -84.97 138.92 32.18 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 114.427 -5.16 . . . . 21.93 107.525 160.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -109.14 129.11 55.48 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 129.1 2.96 . . . . 12.33 110.923 177.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.94 115.01 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.423 1.889 . . . . 17.079999999999998 109.183 -174.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.9 m -79.86 124.74 28.92 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.835 -2.416 . . . . 16.300000000000001 113.628 175.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.465 HD22 ' HB3' ' A' ' 29' ' ' LYS . 85.5 mt -128.26 134.07 48.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.324 -1.732 . . . . 15.880000000000001 106.324 -173.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -101.89 111.8 24.19 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.186 1.921 . . . . 28.899999999999999 116.186 -173.617 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.24 170.66 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.433 -1.417 . . . . 12.050000000000001 111.904 -165.541 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -120.95 162.54 34.62 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 113.696 -3.049 . . . . 18.170000000000002 107.584 177.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.32 51.1 Cg_exo -51.77 -21.58 11.79 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 N-CA-C 121.685 3.687 . . . . 8.1600000000000001 121.685 173.068 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 t -106.81 4.02 27.07 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.01 1.724 . . . . 11.130000000000001 113.466 -171.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -75.74 161.69 28.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.385 1.254 . . . . 18.030000000000001 114.385 159.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.1 p -103.96 175.41 5.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.565 -1.198 . . . . 10.220000000000001 113.797 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.4 mp -71.88 -31.63 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.181 -2.199 . . . . 12.300000000000001 109.713 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -44.93 -41.69 7.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.547 2.425 . . . . 36.509999999999998 117.547 164.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -68.9 -26.91 65.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.979 -1.918 . . . . 25.66 114.713 177.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.16 -42.52 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 126.693 1.997 . . . . 8.1199999999999992 109.729 176.123 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -53.88 -44.27 70.31 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.334 1.605 . . . . 15.470000000000001 115.334 171.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.26 -38.48 41.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.145 2.646 . . . . 11.449999999999999 118.145 170.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HB3' HD22 ' A' ' 15' ' ' LEU . 45.9 mttm -75.63 -29.0 59.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 124.598 1.186 . . . . 24.98 111.693 -177.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.94 -33.56 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 122.591 1.186 . . . . 9.4600000000000009 109.033 175.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -64.26 -53.06 54.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.245 -1.798 . . . . 14.76 115.583 178.38 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -54.0 -53.06 58.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.147 -2.751 . . . . 26.289999999999999 115.039 165.774 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -78.43 -71.49 0.43 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.119 1.438 . . . . 30.059999999999999 111.732 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -79.18 -25.04 42.83 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 115.692 -4.38 . . . . 25.190000000000001 114.94 -167.22 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.61 46.96 4.43 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 128.87 3.128 . . . . 7.4100000000000001 115.666 -178.543 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.58 132.99 22.85 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 118.793 1.297 . . . . 9.4900000000000002 113.271 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -67.35 147.77 78.5 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 CA-C-O 110.233 -4.153 . . . . 11.42 118.532 -178.763 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -64.78 -18.95 64.01 Favored 'Trans proline' 0 C--N 1.299 -2.027 2 C-N-CA 130.096 7.197 . . . . 12.0 108.429 -172.146 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.362 7.5 t70 -102.55 -33.39 9.5 Favored 'General case' 0 N--CA 1.429 -1.477 1 CA-C-N 126.383 4.174 . . . . 35.549999999999997 108.976 -169.105 . . . . . . . . 3 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -46.89 -41.36 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.809 2.444 . . . . 20.52 113.452 165.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -97.96 148.21 23.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.616 2.627 . . . . 7.1299999999999999 113.86 178.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -136.06 137.51 41.18 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.38 -4.575 . . . . 36.390000000000001 108.408 173.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.93 143.43 38.18 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.107 -4.121 . . . . 9.5500000000000007 109.357 -172.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mt -122.52 147.82 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 129.186 2.994 . . . . 13.9 109.342 -177.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -137.59 116.09 12.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 100.257 -3.979 . . . . 6.8600000000000003 100.257 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.29 -104.01 0.13 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.246 -1.797 . . . . 11.15 113.072 -164.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.06 16.53 5.24 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 107.312 -2.315 . . . . 13.93 107.312 171.063 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -100.89 143.43 31.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 120.878 2.339 . . . . 23.920000000000002 107.633 170.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -91.91 133.15 35.94 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.372 3.469 . . . . 23.23 113.447 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.16 157.64 16.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.443 3.021 . . . . 9.1099999999999994 117.957 -175.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -90.83 154.23 19.65 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.846 2.26 . . . . 33.439999999999998 111.104 161.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -77.05 -47.95 19.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.299 -2.228 . . . . 28.370000000000001 108.219 -163.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.84 11.46 62.55 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.439 -1.413 . . . . 15.0 114.578 -159.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -101.95 146.91 27.19 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.371 2.268 . . . . 25.5 105.361 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 8.4 p -82.07 156.98 24.3 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.24 2.448 . . . . 11.949999999999999 113.959 -169.558 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.56 -35.23 72.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.523 -3.236 . . . . 10.17 105.456 -177.105 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.5 t -69.04 -29.24 67.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.816 2.553 . . . . 13.59 113.884 174.139 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -59.44 -56.6 19.95 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.838 -4.289 . . . . 11.699999999999999 111.86 176.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -79.96 0.39 31.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.149 0.98 . . . . 12.949999999999999 112.677 -177.584 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.428 72.2 m-80 65.9 49.18 1.69 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.843 2.905 . . . . 25.449999999999999 118.843 -176.178 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mt -93.34 110.27 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.122 2.569 . . . . 14.6 108.304 179.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -96.14 -168.03 1.68 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.602 -1.635 . . . . 33.229999999999997 110.407 -172.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -72.26 146.05 47.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.891 -1.049 . . . . 25.969999999999999 109.389 176.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 28.6 mt-10 73.3 30.01 1.59 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.737 -1.208 . . . . 32.609999999999999 107.737 170.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 m -90.18 116.89 28.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.567 2.127 . . . . 10.56 108.221 -170.271 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.8 m -72.21 108.08 5.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.486 -3.258 . . . . 5.3300000000000001 113.73 165.244 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -98.69 166.03 11.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.998 3.319 . . . . 11.66 102.884 173.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -121.19 138.77 54.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.049 -1.657 . . . . 16.300000000000001 113.506 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.6 tp -103.04 121.76 43.23 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.157 -1.423 . . . . 9.9600000000000009 107.157 -179.249 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.91 131.36 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.995 -2.224 . . . . 9.7599999999999998 104.995 170.62 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -104.61 144.64 31.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 122.31 1.052 . . . . 19.57 109.259 -177.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -79.51 143.13 35.16 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.341 1.056 . . . . 35.079999999999998 113.773 176.02 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 tp -83.08 87.62 6.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.982 3.313 . . . . 32.310000000000002 108.74 170.446 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -130.3 -76.51 0.54 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.242 2.448 . . . . 42.75 105.592 165.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 166.02 16.35 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 120.762 3.065 . . . . 36.310000000000002 120.762 -175.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.781 0 CA-C-O 115.709 -2.717 . . . . 36.270000000000003 111.642 -175.522 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 114.604 1.335 . . . . 17.170000000000002 114.604 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.25 138.01 52.25 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 118.236 -1.386 . . . . 21.890000000000001 109.996 -173.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.3 pt -123.22 151.87 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 123.318 0.647 . . . . 10.83 111.886 170.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -106.71 134.74 49.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.153 -2.217 . . . . 10.609999999999999 106.684 -168.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.84 108.62 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 126.785 3.183 . . . . 9.1300000000000008 107.849 -175.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -91.65 129.76 37.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.283 -3.386 . . . . 20.550000000000001 116.895 -173.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.65 156.85 16.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.725 -1.954 . . . . 11.779999999999999 105.725 173.626 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.76 -49.3 40.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.471 -3.268 . . . . 19.309999999999999 113.148 -164.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.364 29.8 p -49.69 -79.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.908 2.483 . . . . 23.140000000000001 115.176 166.232 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.93 161.34 29.54 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 116.869 -3.645 . . . . 19.739999999999998 105.243 -177.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.8 tttt 86.23 126.9 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.97 2.508 . . . . 21.93 115.585 166.642 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.7 m -120.22 105.67 11.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.57 2.348 . . . . 12.33 106.897 -175.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.0 pt -88.02 152.03 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.059 -1.65 . . . . 17.079999999999998 112.955 179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -111.5 113.06 25.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 113.225 -1.807 . . . . 16.300000000000001 110.145 -173.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -108.62 139.38 43.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.951 2.786 . . . . 15.880000000000001 107.409 176.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -84.3 125.8 32.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.781 -3.075 . . . . 28.899999999999999 108.589 172.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -149.82 175.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 117.488 -3.257 . . . . 12.050000000000001 110.768 -176.913 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -115.34 148.92 41.88 Favored Pre-proline 0 N--CA 1.429 -1.493 1 O-C-N 116.277 -4.015 . . . . 18.170000000000002 109.279 176.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -64.6 -8.48 17.49 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 125.735 4.29 . . . . 8.1600000000000001 115.74 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.8 m -105.76 16.52 25.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.541 -2.022 . . . . 11.130000000000001 105.541 177.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.84 153.51 25.13 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.523 -2.611 . . . . 18.030000000000001 111.921 168.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.8 p -87.01 164.61 16.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.517 2.58 . . . . 10.220000000000001 105.249 -176.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -75.6 -21.9 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 116.708 -3.745 . . . . 12.300000000000001 109.796 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.29 -32.6 66.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.731 2.412 . . . . 36.509999999999998 113.057 163.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -88.37 -21.84 24.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.892 -1.049 . . . . 25.66 110.715 -177.692 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -73.92 -49.56 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 118.104 -2.873 . . . . 8.1199999999999992 107.023 169.55 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -46.57 -45.18 18.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.45 1.9 . . . . 15.470000000000001 112.071 170.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.14 95.68 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.634 2.774 . . . . 11.449999999999999 111.746 -175.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -62.5 -43.22 99.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.223 1.809 . . . . 24.98 113.638 169.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 mt -63.19 -38.83 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 116.879 2.177 . . . . 9.4600000000000009 116.879 171.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.1 -29.24 70.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.317 2.247 . . . . 14.76 111.102 177.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -79.93 -56.59 4.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.904 -2.372 . . . . 26.289999999999999 116.412 166.168 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -78.13 -48.43 15.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.622 -1.251 . . . . 30.059999999999999 107.622 -156.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 6.1 mm-40 -85.89 -45.66 11.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.931 1.086 . . . . 25.190000000000001 113.931 169.745 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.44 66.36 1.65 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 121.789 0.66 . . . . 7.4100000000000001 111.73 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.7 mt -112.36 118.99 44.68 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 102.066 -3.309 . . . . 9.4900000000000002 102.066 166.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.53 154.64 63.28 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 CA-C-N 124.767 2.738 . . . . 11.42 113.784 -178.244 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -73.52 -13.15 25.01 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 O-C-N 112.611 -4.468 . . . . 12.0 117.906 -165.259 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -92.91 -10.13 37.63 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 125.06 1.475 . . . . 35.549999999999997 112.069 175.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -84.14 -7.23 59.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.23 -1.544 . . . . 20.52 114.21 168.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -95.64 123.68 39.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 113.937 -2.935 . . . . 7.1299999999999999 108.663 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 -105.51 102.21 11.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.167 3.417 . . . . 36.390000000000001 106.877 165.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.8 mt -90.9 99.17 12.25 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 123.376 2.807 . . . . 9.5500000000000007 110.693 -177.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.4 mt -104.49 116.71 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 129.369 3.068 . . . . 13.9 109.608 -176.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -93.09 113.74 26.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.944 -2.613 . . . . 6.8600000000000003 103.944 165.257 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.12 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.527 2.584 . . . . 11.15 116.695 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.02 18.3 1.21 Allowed Glycine 0 N--CA 1.429 -1.775 1 O-C-N 116.049 -4.157 . . . . 13.93 117.054 176.067 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -135.18 142.8 46.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 101.139 -3.652 . . . . 23.920000000000002 101.139 171.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -96.35 165.89 11.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.613 -3.179 . . . . 23.23 113.528 173.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.08 156.96 17.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 127.156 2.785 . . . . 9.1099999999999994 112.329 -162.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.261 40.2 mt-10 -99.51 141.09 32.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.009 2.338 . . . . 33.439999999999998 112.14 -173.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -70.31 -51.26 31.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.668 -3.145 . . . . 28.370000000000001 115.615 -154.239 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.46 15.3 41.37 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 123.03 3.972 . . . . 15.0 123.03 171.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -101.44 162.72 12.69 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.47 2.308 . . . . 25.5 109.302 168.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.0 p -107.31 172.35 6.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 114.692 1.367 . . . . 11.949999999999999 114.692 -169.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.39 -35.41 80.81 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.081 -2.262 . . . . 10.17 114.917 166.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -54.25 -46.69 72.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.881 2.178 . . . . 13.59 116.881 161.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -59.07 -37.03 76.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 124.23 3.195 . . . . 11.699999999999999 115.447 176.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -90.55 12.7 17.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.363 -2.711 . . . . 12.949999999999999 115.385 173.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.52 6.5 t30 46.61 42.36 11.17 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.95 2.574 . . . . 25.449999999999999 117.95 -172.262 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -93.07 99.07 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 118.437 -2.665 . . . . 14.6 108.119 -178.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -79.93 176.13 10.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.225 2.61 . . . . 33.229999999999997 109.682 172.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -71.48 151.61 43.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.248 -2.782 . . . . 25.969999999999999 116.549 -174.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.29 45.2 mt-10 75.17 11.68 3.47 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.733 2.52 . . . . 32.609999999999999 114.687 -173.442 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.309 70.9 m -73.76 145.93 44.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.896 1.331 . . . . 10.56 112.199 -176.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -96.73 123.06 40.31 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.388 -2.695 . . . . 5.3300000000000001 113.288 173.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.305 65.7 tp -126.16 150.08 48.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.137 -2.852 . . . . 11.66 105.974 175.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -111.59 122.47 47.91 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.658 -2.526 . . . . 16.300000000000001 112.623 -167.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -98.56 103.17 15.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.223 -2.88 . . . . 9.9600000000000009 103.223 -178.18 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.257 15.3 t -100.14 168.26 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 110.316 -3.129 . . . . 9.7599999999999998 111.496 170.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tp -78.77 138.37 38.18 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.746 -1.205 . . . . 19.57 107.746 176.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -106.25 128.1 53.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 127.056 3.312 . . . . 35.079999999999998 113.458 166.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.5 mt -93.9 154.87 17.48 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.138 -5.351 . . . . 32.310000000000002 111.533 173.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -82.32 122.64 28.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 127.011 3.291 . . . . 42.75 112.239 177.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.13 57.55 0.15 Allowed Glycine 0 N--CA 1.43 -1.742 1 N-CA-C 102.362 -4.295 . . . . 36.310000000000002 102.362 -171.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.749 0 CA-C-O 116.272 -2.404 . . . . 36.270000000000003 114.666 -170.392 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptt? . . . . . 0 CA--C 1.489 -1.367 0 CA-C-O 123.058 1.409 . . . . 17.170000000000002 111.717 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -96.66 137.29 35.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.978 2.799 . . . . 21.890000000000001 112.339 167.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.6 pt -119.5 162.29 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 117.349 -3.345 . . . . 10.83 105.87 175.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -119.73 136.39 54.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.219 2.208 . . . . 10.609999999999999 109.176 -177.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.35 103.02 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 102.524 -3.139 . . . . 9.1300000000000008 102.524 -173.028 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -86.4 118.41 25.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.411 -2.056 . . . . 20.550000000000001 108.584 -176.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -84.07 -170.96 3.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.289 1.618 . . . . 11.779999999999999 109.267 -173.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.0 -25.37 19.74 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.753 -4.342 . . . . 19.309999999999999 109.329 -171.417 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.7 p -90.43 -72.14 0.59 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.232 2.208 . . . . 23.140000000000001 115.695 -173.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.8 35.9 0.18 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-O 117.065 -1.964 . . . . 19.739999999999998 111.876 177.162 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -122.84 151.58 41.55 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.534 -2.025 . . . . 21.93 105.534 175.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.7 m -125.71 121.9 34.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.374 -2.084 . . . . 12.33 105.374 169.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.305 48.5 pt -103.39 141.56 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.503 -2.623 . . . . 17.079999999999998 113.065 -178.61 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -104.08 116.03 31.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.969 -2.234 . . . . 16.300000000000001 104.969 -173.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.91 133.07 56.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.262 1.392 . . . . 15.880000000000001 111.256 175.227 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -106.95 118.21 36.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.459 2.552 . . . . 28.899999999999999 108.678 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 m -139.71 145.3 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 131.469 3.908 . . . . 12.050000000000001 107.501 -152.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.2 147.85 34.55 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 125.305 1.442 . . . . 18.170000000000002 107.906 166.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.92 -26.3 22.3 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 123.746 2.964 . . . . 8.1600000000000001 114.565 -177.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.0 m -70.12 0.24 6.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.525 2.417 . . . . 11.130000000000001 117.525 161.054 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -70.72 142.3 51.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.704 -3.123 . . . . 18.030000000000001 117.674 163.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.269 7.3 p -73.9 158.61 34.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.644 2.778 . . . . 10.220000000000001 109.759 178.601 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.452 HG13 ' HB3' ' A' ' 50' ' ' LEU 0.284 26.9 mm -67.07 -34.45 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 119.283 0.947 . . . . 12.300000000000001 111.884 173.38 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -47.94 -42.7 28.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.623 -2.548 . . . . 36.509999999999998 115.306 162.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -71.91 -27.36 62.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.546 -3.846 . . . . 25.66 112.456 -178.335 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -68.38 -49.0 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 130.55 3.54 . . . . 8.1199999999999992 110.639 172.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -55.16 -38.62 68.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.569 2.063 . . . . 15.470000000000001 116.569 173.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.46 -35.71 53.11 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.13 -1.606 . . . . 11.449999999999999 114.974 173.245 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -76.9 -31.5 56.77 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 117.276 2.324 . . . . 24.98 117.276 176.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.2 mt -70.23 -32.63 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.58 1.552 . . . . 9.4600000000000009 109.282 172.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -74.14 -36.0 64.11 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.36 -1.462 . . . . 14.76 109.802 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.99 -51.28 62.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.068 1.413 . . . . 26.289999999999999 112.476 177.508 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -80.62 -55.37 4.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.256 -3.403 . . . . 30.059999999999999 112.132 -168.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -94.73 -34.36 12.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.316 0.962 . . . . 25.190000000000001 111.485 -167.618 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.72 54.06 1.99 Allowed Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 127.114 2.292 . . . . 7.4100000000000001 113.276 -177.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.0 mt -113.37 103.45 55.5 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 113.671 -3.061 . . . . 9.4900000000000002 104.121 -175.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -57.56 141.45 95.24 Favored 'Trans proline' 0 C--N 1.3 -1.999 1 CA-C-N 131.862 5.272 . . . . 11.42 116.688 -178.522 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.267 19.7 Cg_endo -70.72 -18.82 32.23 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 125.018 3.812 . . . . 12.0 114.177 -159.785 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.26 -32.07 58.65 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.195 2.902 . . . . 35.549999999999997 108.552 -178.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -73.35 -5.73 41.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.493 -2.629 . . . . 20.52 116.322 172.156 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -105.39 139.86 39.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.709 1.243 . . . . 7.1299999999999999 108.682 -177.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -138.58 118.04 12.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.703 -3.123 . . . . 36.390000000000001 109.276 162.497 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.2 mt -86.38 129.67 34.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 113.975 1.102 . . . . 9.5500000000000007 113.975 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mt -120.12 135.59 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 117.829 -1.082 . . . . 13.9 113.706 177.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -106.22 103.18 12.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.841 -2.281 . . . . 6.8600000000000003 104.841 172.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.359 . . 62.9 -110.89 0.35 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.242 1.817 . . . . 11.15 113.646 -170.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.19 -8.31 78.62 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 121.19 3.236 . . . . 13.93 121.19 169.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -115.47 115.65 26.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.745 1.26 . . . . 23.920000000000002 110.502 -165.037 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -71.73 133.93 45.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.714 2.406 . . . . 23.23 108.904 170.542 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.452 ' HB3' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -95.38 137.53 34.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.423 -2.227 . . . . 9.1099999999999994 112.332 -177.618 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -88.06 139.8 30.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 123.503 2.865 . . . . 33.439999999999998 109.14 174.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -32.39 -74.52 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 136.12 5.768 . . . . 28.370000000000001 113.407 172.478 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.03 43.13 3.14 Favored Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 117.853 -2.118 . . . . 15.0 113.738 -171.403 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -130.49 157.25 43.17 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.861 2.064 . . . . 25.5 107.779 174.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.0 p -87.33 176.32 7.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 124.089 3.131 . . . . 11.949999999999999 113.243 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.21 -43.03 92.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 130.064 3.346 . . . . 10.17 106.848 161.244 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -64.67 -31.95 73.4 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 115.2 1.555 . . . . 13.59 115.2 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -60.78 -55.22 35.72 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.0 -2.313 . . . . 11.699999999999999 112.995 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -71.61 15.32 0.14 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 114.489 -2.672 . . . . 12.949999999999999 116.816 166.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 41.39 40.0 1.15 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.98 2.627 . . . . 25.449999999999999 116.939 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -82.15 116.35 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.011 -1.848 . . . . 14.6 106.011 -178.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -98.2 -150.59 0.36 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.841 -2.412 . . . . 33.229999999999997 108.883 -175.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -76.73 156.02 32.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.956 -1.474 . . . . 25.969999999999999 111.087 -167.413 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 16.8 mt-10 65.3 9.1 5.39 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.029 1.732 . . . . 32.609999999999999 112.843 164.025 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -65.29 132.79 49.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.135 -3.478 . . . . 10.56 117.96 177.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.291 85.3 m -82.97 113.55 20.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.132 1.901 . . . . 5.3300000000000001 116.132 169.161 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.79 156.0 18.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.147 2.403 . . . . 11.66 108.824 171.658 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -107.46 126.99 53.19 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.385 -2.45 . . . . 16.300000000000001 104.385 -171.622 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.6 tp -103.82 124.66 49.34 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 116.119 -4.113 . . . . 9.9600000000000009 110.26 178.119 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.267 46.0 t -111.92 147.86 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 101.968 -3.345 . . . . 9.7599999999999998 101.968 -171.916 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.2 mt -89.82 131.74 35.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 119.719 -0.181 . . . . 19.57 111.056 170.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -109.46 131.99 54.55 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 123.936 0.772 . . . . 35.079999999999998 112.321 -171.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.3 mt -93.34 161.81 14.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.857 -3.027 . . . . 32.310000000000002 107.175 178.459 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -73.45 157.95 35.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.358 -2.714 . . . . 42.75 109.398 177.305 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.16 51.67 3.67 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 125.302 1.429 . . . . 36.310000000000002 110.176 175.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.756 0 O-C-N 127.42 2.482 . . . . 36.270000000000003 113.482 179.44 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 14.1 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 113.616 0.969 . . . . 17.170000000000002 113.616 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.286 14.5 pt20 -90.53 134.15 34.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 121.558 1.981 . . . . 21.890000000000001 114.911 172.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.8 pt -132.06 166.61 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.671 -1.603 . . . . 10.83 106.671 177.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -107.3 131.73 53.89 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.401 -3.937 . . . . 10.609999999999999 112.484 177.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.0 t -116.57 109.32 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.258 -1.377 . . . . 9.1300000000000008 110.171 170.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -99.16 117.62 34.04 Favored 'General case' 0 N--CA 1.429 -1.481 1 CA-C-O 130.117 4.77 . . . . 20.550000000000001 110.098 -172.734 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 30.7 p -75.16 164.66 26.26 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 110.738 -7.477 . . . . 11.779999999999999 114.455 -171.94 . . . . . . . . 3 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.8 tp -53.16 -52.08 59.93 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.177 2.191 . . . . 19.309999999999999 115.603 174.701 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -59.0 -70.4 0.15 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 128.783 3.802 . . . . 23.140000000000001 114.599 169.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.49 59.01 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.774 0 O-C-N 118.988 -2.32 . . . . 19.739999999999998 113.834 156.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.33 85.7 tttt -108.06 134.18 51.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.398 -2.236 . . . . 21.93 106.737 173.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.2 m -97.45 111.67 23.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.439 -1.71 . . . . 12.33 108.35 173.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.5 pt -108.75 127.33 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.312 -1.492 . . . . 17.079999999999998 113.178 172.491 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.3 m -86.33 122.51 30.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.572 1.549 . . . . 16.300000000000001 110.506 -178.365 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -110.53 123.04 49.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.251 3.021 . . . . 15.880000000000001 111.05 -172.723 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -102.89 117.4 34.54 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.638 3.113 . . . . 28.899999999999999 107.087 171.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.72 167.34 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 110.404 -3.089 . . . . 12.050000000000001 110.341 -174.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -110.81 164.88 13.81 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 113.885 -2.96 . . . . 18.170000000000002 115.782 165.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.283 60.7 Cg_endo -69.83 -24.91 28.82 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 CA-C-N 127.813 3.826 . . . . 8.1600000000000001 113.279 -171.408 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.256 3.9 m -82.99 -5.57 59.15 Favored 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 133.819 4.847 . . . . 11.130000000000001 114.464 -176.363 . . . . . . . . 3 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -59.67 126.41 27.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.377 2.271 . . . . 18.030000000000001 114.104 167.05 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.4 p -77.3 158.15 30.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.056 -2.277 . . . . 10.220000000000001 111.59 170.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.295 35.8 mm -60.91 -34.55 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.829 -1.169 . . . . 12.300000000000001 113.732 176.662 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -33.96 -60.69 0.38 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.99 -3.569 . . . . 36.509999999999998 117.775 157.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -70.67 -31.86 68.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 110.75 -2.932 . . . . 25.66 111.024 -177.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.9 t -66.21 -43.85 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.093 -1.629 . . . . 8.1199999999999992 112.435 -178.121 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -57.46 -42.79 83.23 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.149 2.18 . . . . 15.470000000000001 113.771 176.037 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.329 . . -64.45 -35.43 80.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.851 -2.406 . . . . 11.449999999999999 114.374 175.269 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -59.67 -35.02 73.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.274 2.94 . . . . 24.98 115.968 170.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -75.74 -36.92 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.617 -2.552 . . . . 9.4600000000000009 109.281 172.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -56.32 -32.61 64.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.423 2.059 . . . . 14.76 113.326 174.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.64 -36.09 67.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 128.215 3.864 . . . . 26.289999999999999 111.463 -177.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -65.13 -51.4 61.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.063 -2.79 . . . . 30.059999999999999 115.196 171.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -110.67 -59.02 2.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.519 2.104 . . . . 25.190000000000001 112.018 -168.132 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.15 49.29 0.88 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 126.942 2.211 . . . . 7.4100000000000001 110.509 -176.358 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -100.25 130.55 25.72 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 114.299 -2.762 . . . . 9.4900000000000002 107.732 169.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -71.25 148.98 56.69 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 124.417 2.613 . . . . 11.42 113.364 179.444 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -68.99 -17.96 40.82 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 CA-C-N 125.55 3.018 . . . . 12.0 117.768 -172.843 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.262 1.1 m-20 -69.41 -20.64 63.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.926 2.775 . . . . 35.549999999999997 117.028 172.902 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -94.6 -23.26 17.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.225 2.917 . . . . 20.52 108.5 -177.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -84.17 119.67 25.28 Favored 'General case' 0 N--CA 1.431 -1.418 1 O-C-N 115.767 -4.333 . . . . 7.1299999999999999 116.791 178.114 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -113.57 106.59 14.72 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.068 2.947 . . . . 36.390000000000001 111.066 177.721 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.3 mt -88.3 124.27 33.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.096 -1.816 . . . . 9.5500000000000007 106.096 -175.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -116.99 106.71 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 122.576 2.444 . . . . 13.9 108.534 176.825 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -95.66 108.94 21.27 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 125.628 2.632 . . . . 6.8600000000000003 111.876 170.565 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.426 . . 70.57 -96.95 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.465 -2.647 . . . . 11.15 116.692 -178.754 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.76 -2.36 19.08 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.508 -1.37 . . . . 13.93 112.57 170.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -109.06 126.54 53.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.501 1.143 . . . . 23.920000000000002 111.261 -166.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -93.31 130.73 38.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 112.487 -2.142 . . . . 23.23 109.109 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -96.46 149.95 21.15 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.762 2.134 . . . . 9.1099999999999994 116.762 -164.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -111.22 148.65 32.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.741 2.21 . . . . 33.439999999999998 111.041 -176.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -60.15 -47.28 86.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.276 2.695 . . . . 28.370000000000001 118.276 -166.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.83 26.67 8.08 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 117.995 -2.05 . . . . 15.0 112.982 -166.406 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -113.68 154.35 27.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 131.136 3.775 . . . . 25.5 106.24 -176.186 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -90.29 168.41 11.92 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.594 1.701 . . . . 11.949999999999999 115.594 168.436 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.0 mt -73.28 -36.14 66.26 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 118.031 -0.985 . . . . 10.17 112.406 177.25 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -45.89 -53.33 9.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.602 3.064 . . . . 13.59 115.837 160.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -49.76 -44.07 48.43 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.251 -4.656 . . . . 11.699999999999999 117.205 179.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -79.35 -18.95 51.41 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.431 -2.043 . . . . 12.949999999999999 108.265 -173.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 66.07 71.83 0.4 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.316 2.246 . . . . 25.449999999999999 110.238 -170.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -115.82 117.94 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 102.855 -3.017 . . . . 14.6 102.855 178.401 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -100.41 174.44 6.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.447 3.499 . . . . 33.229999999999997 112.239 174.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 13.3 pttp -53.69 161.88 0.99 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.829 -4.92 . . . . 25.969999999999999 115.293 165.243 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 50.96 46.57 26.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.292 3.037 . . . . 32.609999999999999 109.461 174.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -130.53 155.9 45.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.767 -3.083 . . . . 10.56 102.694 179.414 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.6 m -119.16 118.65 31.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.043 -1.435 . . . . 5.3300000000000001 108.818 -155.14 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 mt -100.55 147.36 26.01 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.546 -2.391 . . . . 11.66 104.546 -173.773 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -108.8 133.89 52.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.625 -2.43 . . . . 16.300000000000001 111.41 167.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -106.34 97.79 7.55 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.682 1.734 . . . . 9.9600000000000009 115.682 -175.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.6 t -95.13 150.31 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 101.493 -3.521 . . . . 9.7599999999999998 101.493 -171.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt -104.19 141.44 36.27 Favored 'General case' 0 N--CA 1.43 -1.442 1 CA-C-O 128.51 4.005 . . . . 19.57 106.772 173.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -77.58 135.79 38.2 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.555 -3.84 . . . . 35.079999999999998 115.705 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.1 mt -122.67 131.49 53.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.326 -1.306 . . . . 32.310000000000002 109.583 161.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -76.69 125.41 29.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.72 -1.863 . . . . 42.75 110.218 -153.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.7 -93.02 0.12 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 106.555 -2.618 . . . . 36.310000000000002 106.555 -175.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.767 0 CA-C-N 119.139 1.47 . . . . 36.270000000000003 113.1 171.714 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 118.366 -0.826 . . . . 17.170000000000002 113.012 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -98.75 142.0 30.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.478 2.361 . . . . 21.890000000000001 114.147 161.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.464 HD11 HD22 ' A' ' 67' ' ' LEU . 21.1 pt -128.04 153.94 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.14 -1.43 . . . . 10.83 107.14 176.049 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -100.2 105.31 16.88 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 117.586 2.439 . . . . 10.609999999999999 117.586 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -88.44 117.58 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 119.635 1.107 . . . . 9.1300000000000008 110.619 -179.832 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -93.23 129.36 39.3 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.992 2.917 . . . . 20.550000000000001 110.39 174.81 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -98.01 170.53 8.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.169 -1.378 . . . . 11.779999999999999 108.164 178.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.02 -49.72 75.9 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.705 1.742 . . . . 19.309999999999999 115.705 173.348 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 p -74.78 -73.21 0.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.261 2.458 . . . . 23.140000000000001 111.507 -172.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.27 32.89 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 117.331 -3.355 . . . . 19.739999999999998 116.854 167.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -84.39 154.91 22.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.384 2.516 . . . . 21.93 110.054 167.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.9 m -112.18 113.52 25.82 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.117 -1.856 . . . . 12.33 106.376 163.246 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.6 mt -102.2 129.17 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 118.602 -2.561 . . . . 17.079999999999998 105.137 177.345 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.9 m -107.57 115.47 30.2 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.854 -2.404 . . . . 16.300000000000001 106.582 -169.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 tp -118.74 125.1 48.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.5 -2.625 . . . . 15.880000000000001 109.388 -156.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -95.34 119.53 33.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.468 -2.645 . . . . 28.899999999999999 114.873 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.7 158.18 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 106.903 -1.517 . . . . 12.050000000000001 106.903 -167.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -81.09 146.85 59.71 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 126.717 2.007 . . . . 18.170000000000002 109.9 175.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -82.87 -3.49 11.16 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 119.599 0.893 . . . . 8.1600000000000001 113.434 -165.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 t -113.59 7.91 17.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.937 2.153 . . . . 11.130000000000001 112.396 171.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -88.89 177.22 6.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.364 2.357 . . . . 18.030000000000001 117.364 -172.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.1 p -92.8 159.94 15.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 118.293 2.701 . . . . 10.220000000000001 118.293 -167.658 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -67.17 -36.24 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 127.132 2.173 . . . . 12.300000000000001 107.741 179.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -54.73 -44.87 73.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.606 1.963 . . . . 36.509999999999998 112.967 172.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -69.63 -31.14 69.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.835 2.161 . . . . 25.66 116.835 170.553 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.1 -48.11 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 122.091 2.223 . . . . 8.1199999999999992 113.71 164.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -60.79 -31.35 70.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.978 1.711 . . . . 15.470000000000001 113.529 173.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.269 . . -79.24 -28.7 42.47 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 115.654 1.724 . . . . 11.449999999999999 115.654 177.716 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -63.43 -45.71 89.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.841 -1.527 . . . . 24.98 114.496 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.3 mt -70.0 -35.48 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.42 -2.173 . . . . 9.4600000000000009 110.589 172.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -56.85 -29.68 63.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 125.974 3.988 . . . . 14.76 110.377 168.616 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.93 -50.73 7.76 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 114.857 -4.902 . . . . 26.289999999999999 111.439 -174.699 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -65.54 -52.27 53.73 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.661 -2.525 . . . . 30.059999999999999 113.417 175.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -107.82 -39.65 5.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.504 -0.924 . . . . 25.190000000000001 108.504 -162.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.99 37.6 5.97 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 106.587 -2.605 . . . . 7.4100000000000001 106.587 176.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.74 123.66 37.93 Favored Pre-proline 0 N--CA 1.43 -1.446 1 N-CA-C 97.13 -5.137 . . . . 9.4900000000000002 97.13 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -90.52 166.97 4.2 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 CA-C-N 125.278 2.921 . . . . 11.42 107.757 -168.564 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.26 36.4 Cg_endo -65.58 -24.83 55.45 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 122.793 2.328 . . . . 12.0 116.307 -169.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.282 18.0 m-20 -82.29 -22.33 35.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 114.516 -2.874 . . . . 35.549999999999997 111.476 178.906 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -91.56 -12.14 35.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 124.412 3.278 . . . . 20.52 112.77 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -75.46 99.93 4.34 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.74 2.416 . . . . 7.1299999999999999 113.64 171.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -84.99 113.05 21.14 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 101.051 -3.685 . . . . 36.390000000000001 101.051 168.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.0 mt -101.31 115.24 30.05 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.405 -2.059 . . . . 9.5500000000000007 110.343 165.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mt -112.53 137.6 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 C-N-CA 131.717 4.007 . . . . 13.9 109.234 178.576 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -133.75 99.37 4.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.738 2.015 . . . . 6.8600000000000003 106.262 -171.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.394 . . 66.46 -108.65 0.13 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.954 -1.716 . . . . 11.15 113.471 -158.658 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.59 17.53 11.11 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 126.522 2.01 . . . . 13.93 112.106 172.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -107.06 119.74 40.18 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.661 3.23 . . . . 23.920000000000002 110.826 174.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -70.06 124.5 24.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.994 -2.941 . . . . 23.23 112.946 160.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.494 HD23 ' CD2' ' A' ' 59' ' ' TYR . 29.1 mt -79.41 162.74 25.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.352 1.461 . . . . 9.1099999999999994 112.106 -178.187 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.28 141.47 52.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 126.748 3.166 . . . . 33.439999999999998 104.105 -177.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.67 -48.29 72.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.331 2.252 . . . . 28.370000000000001 114.848 -152.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.32 0.96 88.45 Favored Glycine 0 N--CA 1.43 -1.706 0 O-C-N 119.094 -2.254 . . . . 15.0 116.827 -178.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.252 23.3 mmt180 -74.9 161.43 29.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.105 3.336 . . . . 25.5 111.458 170.329 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.343 31.0 p -87.75 163.62 16.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.503 -2.623 . . . . 11.949999999999999 112.624 178.121 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.9 mt -60.15 -32.03 70.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.021 1.86 . . . . 10.17 116.021 163.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -56.55 -38.26 71.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.243 2.449 . . . . 13.59 114.426 166.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.79 -32.51 74.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.35 -2.719 . . . . 11.699999999999999 116.472 -169.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.494 ' CD2' HD23 ' A' ' 50' ' ' LEU . 34.2 m-85 -104.39 1.88 30.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.029 -2.919 . . . . 12.949999999999999 112.596 175.369 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.252 81.0 m-20 70.99 48.96 0.36 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.379 2.363 . . . . 25.449999999999999 117.379 -177.271 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.1 mt -92.41 124.79 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 114.545 -2.862 . . . . 14.6 110.614 -174.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -108.87 169.95 8.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 123.941 0.775 . . . . 33.229999999999997 110.635 -169.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 143.87 57.24 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.694 2.797 . . . . 25.969999999999999 110.262 -170.033 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 57.67 23.42 9.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.646 -3.784 . . . . 32.609999999999999 115.957 -174.392 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.0 t -92.93 160.36 14.93 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.269 3.414 . . . . 10.56 110.151 -178.622 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 m -92.52 126.16 37.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.599 -3.188 . . . . 5.3300000000000001 114.749 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.464 HD22 HD11 ' A' ' 3' ' ' ILE . 6.9 mp -119.44 155.63 31.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.524 -2.399 . . . . 11.66 104.524 173.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -130.61 111.03 11.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 119.024 0.829 . . . . 16.300000000000001 111.329 -173.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -87.16 108.56 18.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 131.0 3.72 . . . . 9.9600000000000009 114.406 175.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -111.22 141.31 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 129.681 3.192 . . . . 9.7599999999999998 102.7 -173.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt -94.6 118.25 31.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.746 2.418 . . . . 19.57 109.187 -170.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -91.64 157.89 16.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.197 0.999 . . . . 35.079999999999998 110.445 167.843 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.7 mt -70.71 162.85 28.32 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.521 2.415 . . . . 32.310000000000002 117.521 168.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -95.32 96.67 9.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.112 2.565 . . . . 42.75 106.411 162.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.45 72.28 0.99 Allowed Glycine 0 N--CA 1.43 -1.736 0 O-C-N 124.941 1.401 . . . . 36.310000000000002 114.658 -166.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.785 2 CA-C-N 124.922 4.361 . . . . 36.270000000000003 105.12 -174.183 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 CA--C 1.49 -1.365 0 CA-C-O 116.449 -1.739 . . . . 17.170000000000002 109.209 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -88.38 140.59 29.32 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 123.247 2.749 . . . . 21.890000000000001 116.81 171.478 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.1 pt -110.41 167.83 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 102.628 -3.101 . . . . 10.83 102.628 173.082 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -109.03 139.2 44.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.403 -2.814 . . . . 10.609999999999999 103.403 167.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -122.85 123.17 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.435 -2.041 . . . . 9.1300000000000008 109.677 165.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -96.91 134.89 39.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.127 -0.942 . . . . 20.550000000000001 112.508 172.361 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -91.77 -173.97 3.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.37 2.986 . . . . 11.779999999999999 113.207 177.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 tp -65.49 -52.95 49.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.635 -3.791 . . . . 19.309999999999999 116.661 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -61.8 -40.5 95.45 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.325 -2.11 . . . . 23.140000000000001 110.204 171.075 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.01 37.15 0.44 Allowed Glycine 0 N--CA 1.43 -1.738 0 CA-C-O 115.186 -3.008 . . . . 19.739999999999998 116.837 177.209 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 77.1 mttt -86.17 141.05 29.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.483 3.641 . . . . 21.93 111.079 175.502 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 m -92.74 101.75 14.15 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 119.954 1.252 . . . . 12.33 108.995 175.711 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.6 mt -93.05 118.43 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 125.072 1.349 . . . . 17.079999999999998 111.149 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -86.66 105.58 17.01 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.471 1.908 . . . . 16.300000000000001 112.338 175.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 tp -120.57 116.24 24.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.73 -1.856 . . . . 15.880000000000001 110.329 -160.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -78.76 100.51 7.14 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.562 4.345 . . . . 28.899999999999999 120.351 178.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 m -122.93 148.46 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-O 125.452 2.549 . . . . 12.050000000000001 109.138 -171.666 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -94.64 141.73 23.8 Favored Pre-proline 0 N--CA 1.43 -1.474 1 O-C-N 116.277 -4.015 . . . . 18.170000000000002 106.01 162.542 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.49 -14.51 45.26 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-O 114.086 -2.548 . . . . 8.1600000000000001 111.091 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.7 p -67.83 -9.88 48.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 120.931 3.678 . . . . 11.130000000000001 120.931 160.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -71.06 134.92 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.55 -3.843 . . . . 18.030000000000001 111.679 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.3 p -82.48 153.14 25.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 117.332 -1.318 . . . . 10.220000000000001 111.974 177.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.0 mm -51.61 -37.73 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 113.907 -2.949 . . . . 12.300000000000001 113.795 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -49.64 -43.56 46.9 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.959 3.704 . . . . 36.509999999999998 113.86 168.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 14.7 m-80 -90.54 -25.56 20.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.693 3.197 . . . . 25.66 110.295 -176.848 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.46 -51.84 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.238 1.495 . . . . 8.1199999999999992 110.736 164.634 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -51.74 -31.92 28.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.66 -3.775 . . . . 15.470000000000001 115.183 170.639 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.05 -39.38 86.92 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.808 1.643 . . . . 11.449999999999999 113.018 171.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 66.3 mttm -69.19 -35.08 75.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.473 1.13 . . . . 24.98 108.4 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.5 mt -79.51 -35.59 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.833 -2.417 . . . . 9.4600000000000009 110.77 -173.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -49.41 -50.54 40.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.542 2.423 . . . . 14.76 117.542 158.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.56 -33.44 69.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.266 3.027 . . . . 26.289999999999999 113.91 170.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -73.69 -69.83 0.41 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.925 2.565 . . . . 30.059999999999999 117.925 173.378 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.474 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 63.0 mm-40 -90.42 -37.89 13.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 111.189 -2.732 . . . . 25.190000000000001 115.215 -172.146 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.35 46.39 1.85 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 120.743 1.61 . . . . 7.4100000000000001 110.784 176.452 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.41 105.32 48.64 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 113.195 -3.288 . . . . 9.4900000000000002 105.031 -178.324 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -58.36 159.01 20.66 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.497 3.356 . . . . 11.42 113.62 -175.463 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -76.39 -20.4 14.23 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 122.826 2.045 . . . . 12.0 115.227 -161.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.33 -40.01 67.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.649 -1.907 . . . . 35.549999999999997 110.005 178.439 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.99 -29.8 69.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.812 -1.805 . . . . 20.52 111.697 172.075 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -78.98 140.9 37.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 117.865 -3.022 . . . . 7.1299999999999999 109.952 -177.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -123.12 124.43 43.06 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.563 -3.21 . . . . 36.390000000000001 107.393 158.078 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.2 mt -106.4 129.79 54.33 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 123.957 0.786 . . . . 9.5500000000000007 112.609 176.69 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.1 109.82 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 125.991 1.716 . . . . 13.9 112.004 -171.462 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -94.09 129.52 40.6 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.346 -3.346 . . . . 6.8600000000000003 107.33 163.278 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.52 -97.92 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.019 2.97 . . . . 11.15 119.019 -169.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.84 27.82 3.81 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.44 -2.037 . . . . 13.93 113.819 -179.413 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -138.93 128.39 24.4 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.903 -1.888 . . . . 23.920000000000002 105.903 -176.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -84.34 127.34 33.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 111.799 -2.455 . . . . 23.23 113.664 171.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.4 mt -87.02 137.16 32.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.074 -1.875 . . . . 9.1099999999999994 108.353 -161.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -106.26 140.41 39.25 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.31 -0.869 . . . . 33.439999999999998 111.936 -160.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -46.17 -54.03 9.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 121.3 3.815 . . . . 28.370000000000001 121.3 -162.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.11 -0.44 74.17 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-O 117.906 -1.497 . . . . 15.0 112.706 -178.417 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -75.4 158.47 32.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.106 1.953 . . . . 25.5 114.308 169.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 p -93.68 173.46 7.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.746 2.212 . . . . 11.949999999999999 110.452 174.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.5 mt -66.39 -29.84 70.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.331 -3.356 . . . . 10.17 113.965 166.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.6 t -66.05 -39.73 90.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.856 -3.028 . . . . 13.59 110.892 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -61.2 -33.64 73.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.911 -1.743 . . . . 11.699999999999999 113.634 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.83 -20.44 30.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.187 0.81 . . . . 12.949999999999999 113.187 174.314 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 m120 72.47 51.78 0.18 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.604 3.962 . . . . 25.449999999999999 112.539 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.259 60.0 mt -80.79 121.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 110.192 -3.185 . . . . 14.6 110.026 -178.288 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -106.54 -175.2 2.73 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 118.704 -1.198 . . . . 33.229999999999997 112.228 -175.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.427 0.0 OUTLIER -66.46 150.85 48.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.234 2.309 . . . . 25.969999999999999 117.234 173.219 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 48.24 39.0 11.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.047 2.832 . . . . 32.609999999999999 116.408 -168.697 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.373 63.9 m -94.29 137.21 33.72 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.013 -4.804 . . . . 10.56 107.826 173.841 . . . . . . . . 3 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -103.52 113.92 27.79 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.563 1.529 . . . . 5.3300000000000001 111.665 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -84.78 146.54 27.32 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.238 2.215 . . . . 11.66 111.63 169.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -110.93 129.49 55.86 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.603 -1.936 . . . . 16.300000000000001 114.41 172.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.7 tp -87.78 124.82 34.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.32 -2.474 . . . . 9.9600000000000009 104.32 170.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.12 146.03 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 112.816 -1.993 . . . . 9.7599999999999998 109.34 163.489 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.257 14.2 mt -91.75 148.39 22.28 Favored 'General case' 0 N--CA 1.431 -1.418 1 O-C-N 115.578 -4.451 . . . . 19.57 111.452 -176.253 . . . . . . . . 3 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.3 ttt180 -105.87 137.59 43.49 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.089 -2.882 . . . . 35.079999999999998 107.166 171.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mp -87.09 176.6 7.53 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.407 -2.235 . . . . 32.310000000000002 109.94 178.019 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -101.28 114.86 29.22 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.523 1.675 . . . . 42.75 115.523 -178.174 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.24 -9.72 22.53 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 123.892 1.829 . . . . 36.310000000000002 116.635 -175.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.784 0 C-N-CA 127.339 2.399 . . . . 36.270000000000003 112.903 -178.838 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.348 0 CA-C-O 119.242 -0.409 . . . . 17.170000000000002 111.932 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.29 133.99 39.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 119.324 0.965 . . . . 21.890000000000001 113.157 -178.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 pt -114.63 171.24 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.703 -1.873 . . . . 10.83 111.024 168.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -107.82 135.95 48.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.563 1.649 . . . . 10.609999999999999 111.876 173.132 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.25 128.62 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 117.523 -3.235 . . . . 9.1300000000000008 102.288 175.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -120.89 121.74 38.73 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.068 1.413 . . . . 20.550000000000001 111.143 -178.741 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.5 p -69.79 164.06 24.42 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.539 2.336 . . . . 11.779999999999999 109.632 -174.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.4 tp -61.76 -44.19 97.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.092 1.901 . . . . 19.309999999999999 111.154 174.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 p -67.32 -51.57 50.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.765 -1.835 . . . . 23.140000000000001 113.045 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.56 59.9 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 119.439 2.536 . . . . 19.739999999999998 119.439 162.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -116.42 138.5 51.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.522 -0.918 . . . . 21.93 108.522 172.494 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.2 m -90.15 113.86 25.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 118.37 -0.824 . . . . 12.33 109.164 178.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mt -96.39 137.57 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.694 -3.129 . . . . 17.079999999999998 106.872 -177.27 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.3 m -97.28 121.43 39.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 114.821 -2.514 . . . . 16.300000000000001 104.301 171.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 tp -121.97 138.37 54.44 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.648 2.166 . . . . 15.880000000000001 115.895 178.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.294 71.6 tt0 -100.1 111.16 23.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.339 -3.976 . . . . 28.899999999999999 109.1 -172.858 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.2 152.99 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 1 O-C-N 113.29 -5.881 . . . . 12.050000000000001 117.937 -172.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -117.36 161.03 35.32 Favored Pre-proline 0 N--CA 1.43 -1.446 1 O-C-N 116.154 -4.091 . . . . 18.170000000000002 119.327 170.467 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -66.59 -17.63 53.15 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 CA-C-N 129.859 4.557 . . . . 8.1600000000000001 117.468 -175.117 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.4 m -76.74 -17.19 59.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.403 1.91 . . . . 11.130000000000001 114.414 177.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -67.98 151.78 46.55 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.925 2.774 . . . . 18.030000000000001 111.094 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -97.82 158.77 15.33 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.778 -1.826 . . . . 10.220000000000001 112.012 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.269 4.7 mm -61.34 -31.52 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 CA-C-O 128.941 4.21 . . . . 12.300000000000001 116.294 -178.648 . . . . . . . . 3 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -50.21 -43.42 52.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.051 -3.531 . . . . 36.509999999999998 114.76 162.812 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -73.16 -19.37 61.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.643 -2.535 . . . . 25.66 117.2 173.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.263 94.5 t -66.36 -37.87 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 117.723 -3.11 . . . . 8.1199999999999992 111.813 176.802 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -68.67 -40.63 80.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.414 3.086 . . . . 15.470000000000001 112.56 176.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.11 -52.87 59.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 121.184 3.772 . . . . 11.449999999999999 121.184 167.752 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -56.86 -41.15 77.43 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.674 2.034 . . . . 24.98 115.797 165.321 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -64.57 -36.8 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 125.202 2.43 . . . . 9.4600000000000009 110.585 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -53.92 -55.0 30.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.851 1.786 . . . . 14.76 113.285 171.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.259 29.4 t70 -57.89 -56.13 25.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.587 -2.571 . . . . 26.289999999999999 116.22 179.316 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -69.67 -65.35 0.73 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 125.865 2.745 . . . . 30.059999999999999 113.928 -176.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -86.39 -46.24 10.44 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.596 -4.44 . . . . 25.190000000000001 118.439 177.34 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.28 28.72 6.31 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.107 -1.997 . . . . 7.4100000000000001 108.107 168.219 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.0 mt -83.35 118.97 73.15 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.005 -1.95 . . . . 9.4900000000000002 108.641 169.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -73.63 157.25 48.72 Favored 'Trans proline' 0 N--CA 1.433 -2.036 1 CA-C-N 128.467 4.06 . . . . 11.42 114.412 -166.375 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.42 -23.72 64.79 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 123.02 2.48 . . . . 12.0 116.659 -168.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.88 -28.53 39.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.317 1.969 . . . . 35.549999999999997 116.317 177.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -18.03 59.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.792 2.515 . . . . 20.52 117.792 170.481 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -79.98 138.41 37.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.063 -2.273 . . . . 7.1299999999999999 116.735 177.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -137.94 129.26 27.71 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 125.666 2.651 . . . . 36.390000000000001 106.423 164.964 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mt -110.91 117.42 33.32 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 111.522 -2.581 . . . . 9.5500000000000007 112.584 -173.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.15 131.19 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.984 2.114 . . . . 13.9 109.532 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.437 ' HB3' HD23 ' A' ' 50' ' ' LEU . 11.5 t80 -122.75 107.4 11.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.826 -2.287 . . . . 6.8600000000000003 104.826 178.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.315 . . 69.93 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 125.572 1.795 . . . . 11.15 113.971 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.9 -29.87 3.66 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-O 118.419 -1.211 . . . . 13.93 112.796 175.557 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -94.79 127.95 41.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 126.248 1.793 . . . . 23.920000000000002 115.116 -162.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -77.13 132.72 38.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.378 2.037 . . . . 23.23 115.533 166.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 45' ' ' PHE 0.26 7.6 mt -91.07 133.29 35.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.263 -2.773 . . . . 9.1099999999999994 113.125 -163.692 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -88.86 121.85 31.65 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.227 -1.545 . . . . 33.439999999999998 114.07 -176.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -29.49 -57.75 0.16 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.032 3.733 . . . . 28.370000000000001 115.941 -178.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.87 25.35 25.59 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 119.278 -2.139 . . . . 15.0 116.188 -168.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.1 mtt-85 -108.91 155.33 20.96 Favored 'General case' 0 N--CA 1.43 -1.463 1 C-N-CA 132.081 4.153 . . . . 25.5 113.216 170.123 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.44 23.9 p -80.69 158.93 25.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 128.292 3.901 . . . . 11.949999999999999 115.045 177.615 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mp -68.86 -8.36 43.1 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.782 -5.574 . . . . 10.17 116.358 166.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.33 -42.85 18.21 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 112.686 -3.53 . . . . 13.59 103.294 177.52 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -62.47 -28.56 69.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 123.27 2.759 . . . . 11.699999999999999 114.466 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -94.32 -4.68 48.2 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.483 2.313 . . . . 12.949999999999999 112.088 175.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 m120 63.52 44.22 5.42 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.734 3.214 . . . . 25.449999999999999 110.007 169.303 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.7 mt -80.22 113.58 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 119.89 -1.756 . . . . 14.6 111.41 -178.256 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.261 14.6 mm100 -71.4 -179.56 2.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 124.644 2.164 . . . . 33.229999999999997 109.455 173.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -79.21 144.57 34.28 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-O 128.752 4.12 . . . . 25.969999999999999 109.95 165.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.366 65.8 mt-10 71.09 32.99 2.15 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.334 -2.666 . . . . 32.609999999999999 110.26 174.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.269 2.9 m -98.55 144.93 27.34 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 116.559 -3.838 . . . . 10.56 107.269 175.617 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -94.82 115.36 27.4 Favored 'General case' 0 N--CA 1.431 -1.423 1 C-N-CA 132.147 4.179 . . . . 5.3300000000000001 110.267 176.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.69 129.83 34.72 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.62 -1.622 . . . . 11.66 106.62 170.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -81.1 105.91 12.68 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.932 -2.355 . . . . 16.300000000000001 108.413 168.563 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.3 tp -84.93 108.72 17.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.226 2.61 . . . . 9.9600000000000009 109.893 168.154 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 m -113.74 168.59 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.237 2.215 . . . . 9.7599999999999998 106.264 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.9 tp -86.97 123.71 32.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 127.748 3.155 . . . . 19.57 108.886 -167.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.423 HH21 ' C ' ' A' ' 76' ' ' GLY . 71.6 ttt180 -92.91 115.05 27.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.492 1.615 . . . . 35.079999999999998 108.544 173.368 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.58 163.61 19.22 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.106 -1.406 . . . . 32.310000000000002 111.855 175.252 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -65.64 140.33 58.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.946 2.308 . . . . 42.75 113.396 172.239 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.58 78.47 1.22 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-O 116.184 -2.453 . . . . 36.310000000000002 114.725 -175.328 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.423 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 N--CA 1.43 -1.734 0 CA-C-O 115.717 -2.713 . . . . 36.270000000000003 111.833 -167.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.335 0 N-CA-C 104.455 -2.424 . . . . 17.170000000000002 104.455 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -114.3 160.12 19.44 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.938 -1.726 . . . . 21.890000000000001 115.459 173.942 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.4 pt -133.7 154.17 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 1 CA-C-O 129.434 4.445 . . . . 10.83 105.32 169.842 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -106.96 105.03 14.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.026 3.298 . . . . 10.609999999999999 102.872 177.073 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.32 105.19 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.009 -2.307 . . . . 9.1300000000000008 112.838 171.173 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -95.64 128.04 42.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.258 1.98 . . . . 20.550000000000001 111.499 -175.498 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -82.29 -179.16 7.31 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.939 -3.601 . . . . 11.779999999999999 113.845 -172.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.0 tp -75.22 -48.52 23.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.467 -3.896 . . . . 19.309999999999999 112.114 -176.701 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.0 p -70.22 -24.0 63.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.93 2.776 . . . . 23.140000000000001 116.647 -178.632 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.36 75.88 0.52 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 118.657 -2.527 . . . . 19.739999999999998 110.517 170.916 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 80.3 tttt -142.16 139.38 32.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.882 -3.007 . . . . 21.93 102.882 170.141 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.3 m -106.52 104.19 13.82 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.296 1.438 . . . . 12.33 110.626 176.112 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 mt -92.31 118.21 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 118.468 -0.777 . . . . 17.079999999999998 109.636 176.817 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.5 m -95.83 122.72 38.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.229 -3.248 . . . . 16.300000000000001 102.229 179.005 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 tp -127.85 147.53 50.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.364 -0.835 . . . . 15.880000000000001 112.386 -176.216 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -95.87 122.73 38.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.284 -1.817 . . . . 28.899999999999999 108.787 178.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.23 168.06 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.196 2.599 . . . . 12.050000000000001 109.187 177.686 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -107.12 153.41 41.04 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 116.756 -3.715 . . . . 18.170000000000002 101.264 163.644 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.43 -12.96 32.49 Favored 'Trans proline' 0 N--CA 1.433 -2.036 2 C-N-CA 128.323 6.016 . . . . 8.1600000000000001 105.122 179.699 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p -83.97 12.44 6.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.017 2.927 . . . . 11.130000000000001 114.387 171.538 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -93.34 146.12 23.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.599 -2.0 . . . . 18.030000000000001 105.599 176.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.9 p -89.1 168.58 12.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.852 -1.536 . . . . 10.220000000000001 106.852 -175.456 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -82.24 -28.08 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 116.151 1.908 . . . . 12.300000000000001 116.151 -173.671 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -48.27 -50.31 30.29 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.745 -2.48 . . . . 36.509999999999998 112.078 155.349 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -59.0 -53.03 63.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.239 2.681 . . . . 25.66 118.239 168.021 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 t -50.22 -37.99 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 116.552 2.056 . . . . 8.1199999999999992 116.552 171.087 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -68.33 -41.55 80.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 117.725 -1.131 . . . . 15.470000000000001 113.984 173.598 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.69 70.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.907 3.299 . . . . 11.449999999999999 119.907 174.197 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -61.89 -47.42 85.04 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.976 2.911 . . . . 24.98 113.002 170.17 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.51 -35.0 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.982 -1.698 . . . . 9.4600000000000009 108.595 -176.814 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -62.02 -46.79 87.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.428 -3.295 . . . . 14.76 113.876 170.29 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -49.27 -58.97 4.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.458 2.762 . . . . 26.289999999999999 118.458 163.711 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -71.04 -67.41 0.51 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.237 -2.789 . . . . 30.059999999999999 116.203 -178.58 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.422 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 60.5 mm-40 -85.33 -24.87 27.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.916 1.817 . . . . 25.190000000000001 114.077 -171.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.82 38.89 14.8 Favored Glycine 0 N--CA 1.43 -1.727 0 O-C-N 119.611 -1.931 . . . . 7.4100000000000001 115.235 -178.614 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.1 mt -102.98 109.91 62.42 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 114.3 -2.762 . . . . 9.4900000000000002 109.013 -179.168 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.7 142.23 82.98 Favored 'Trans proline' 0 N--CA 1.434 -1.987 2 C-N-CA 127.181 5.254 . . . . 11.42 114.321 -171.649 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.47 -17.97 6.08 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 123.026 2.116 . . . . 12.0 109.946 -159.807 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.269 37.0 m-20 -60.49 -23.67 64.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 126.551 2.407 . . . . 35.549999999999997 116.486 161.954 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -84.3 -33.04 24.04 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 117.261 -3.399 . . . . 20.52 115.263 176.595 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -67.41 138.03 56.37 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.026 3.343 . . . . 7.1299999999999999 120.026 -179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -136.71 132.09 34.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 105.181 -2.155 . . . . 36.390000000000001 105.181 161.441 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.253 11.4 mt -111.91 124.89 53.33 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 129.279 4.112 . . . . 9.5500000000000007 107.702 -174.621 . . . . . . . . 3 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 34.3 mt -117.79 117.84 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.704 2.402 . . . . 13.9 111.2 -173.165 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -94.55 102.97 14.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.567 -1.958 . . . . 6.8600000000000003 110.96 168.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.99 -81.35 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.767 2.136 . . . . 11.15 116.767 -163.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.85 16.91 2.39 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 104.666 -3.374 . . . . 13.93 104.666 172.773 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -95.73 111.49 23.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 119.255 1.528 . . . . 23.920000000000002 114.671 171.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -76.73 116.55 17.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.836 -1.529 . . . . 23.23 111.721 -179.503 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.0 mt -87.26 138.64 31.31 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.457 -3.277 . . . . 9.1099999999999994 112.806 -164.909 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -97.21 161.23 13.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.428 2.01 . . . . 33.439999999999998 116.428 -175.894 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.269 7.8 m-20 -46.4 -68.78 0.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 119.829 3.27 . . . . 28.370000000000001 119.829 -166.844 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.14 8.4 70.85 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 118.013 1.965 . . . . 15.0 118.013 -165.977 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.44 HH21 ' CG ' ' A' ' 58' ' ' ASP . 7.2 mmm180 -94.92 158.88 15.29 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 126.866 3.222 . . . . 25.5 112.092 -176.844 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.95 164.03 12.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.089 2.376 . . . . 11.949999999999999 109.229 -179.335 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.69 -18.92 62.14 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 112.762 -3.494 . . . . 10.17 113.207 171.482 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -71.22 -31.86 68.09 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 126.046 2.091 . . . . 13.59 112.464 169.587 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' CG ' HH21 ' A' ' 54' ' ' ARG . 61.0 m-20 -66.41 -53.1 39.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.55 -3.219 . . . . 11.699999999999999 109.269 179.012 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -66.42 -19.76 65.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.704 -3.122 . . . . 12.949999999999999 110.683 -179.454 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 m120 73.64 47.54 0.17 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.616 1.71 . . . . 25.449999999999999 115.616 -178.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.72 111.65 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.179 2.419 . . . . 14.6 110.003 -177.021 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -71.03 174.5 6.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 112.327 -2.215 . . . . 33.229999999999997 111.681 -176.17 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -52.46 133.22 35.48 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.561 3.171 . . . . 25.969999999999999 119.561 168.68 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 60.53 50.71 5.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.666 -3.146 . . . . 32.609999999999999 113.392 175.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 m -107.35 154.6 21.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.875 -1.511 . . . . 10.56 110.74 -179.426 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -102.08 126.68 49.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.377 3.548 . . . . 5.3300000000000001 107.244 -168.294 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.23 145.9 39.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 117.524 -1.227 . . . . 11.66 109.243 178.339 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 89.8 m-70 -101.59 123.84 46.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.495 -1.668 . . . . 16.300000000000001 106.495 177.942 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 tp -100.4 117.88 35.49 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.613 2.365 . . . . 9.9600000000000009 107.62 174.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -115.46 -165.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.602 2.075 . . . . 9.7599999999999998 116.602 171.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 tp -88.68 123.89 33.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.043 -1.661 . . . . 19.57 113.327 168.293 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -82.16 117.17 22.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.371 1.557 . . . . 35.079999999999998 108.439 174.637 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.1 mt -101.02 -174.16 2.55 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.027 -2.295 . . . . 32.310000000000002 107.98 172.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -126.19 156.73 39.73 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.225 -2.172 . . . . 42.75 108.246 -172.789 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.73 21.19 64.26 Favored Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 115.233 -2.982 . . . . 36.310000000000002 112.713 -162.512 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.761 0 CA-C-N 123.006 3.403 . . . . 36.270000000000003 121.026 177.174 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.409 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 39.7 ttm . . . . . 0 CA--C 1.49 -1.365 0 N-CA-C 110.297 -0.26 . . . . 17.170000000000002 110.297 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -87.82 134.12 33.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.741 -1.85 . . . . 21.890000000000001 112.454 171.06 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -122.09 171.22 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 119.162 0.892 . . . . 10.83 110.675 162.497 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -116.09 121.65 42.8 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.133 -2.854 . . . . 10.609999999999999 109.319 174.39 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.3 t -106.2 104.49 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 124.971 2.319 . . . . 9.1300000000000008 111.483 173.11 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -82.74 134.37 35.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.906 -3.621 . . . . 20.550000000000001 113.822 -177.804 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.7 p -87.12 176.22 7.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.364 1.665 . . . . 11.779999999999999 110.963 -174.376 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.64 -44.4 64.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.75 1.22 . . . . 19.309999999999999 109.636 177.707 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -69.55 -63.7 1.02 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.47 1.508 . . . . 23.140000000000001 114.231 -177.426 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.23 21.82 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 115.589 -3.196 . . . . 19.739999999999998 115.42 176.178 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.581 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 80.4 tttt -105.28 138.58 41.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.318 -1.364 . . . . 21.93 107.318 -173.929 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -105.43 118.45 36.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.717 -2.489 . . . . 12.33 107.182 168.713 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.39 126.68 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 114.102 -2.856 . . . . 17.079999999999998 107.211 -173.553 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.3 m -101.37 125.69 48.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 102.888 -3.004 . . . . 16.300000000000001 102.888 -171.782 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -141.05 131.0 24.48 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.721 -2.696 . . . . 15.880000000000001 103.721 -154.91 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -114.85 107.13 15.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.025 -2.954 . . . . 28.899999999999999 103.025 -168.082 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.8 m -116.6 155.76 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 128.541 2.737 . . . . 12.050000000000001 112.727 -177.412 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -89.47 143.86 31.28 Favored Pre-proline 0 N--CA 1.43 -1.443 1 CA-C-O 111.465 -4.112 . . . . 18.170000000000002 108.494 171.152 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -87.47 -5.77 7.21 Favored 'Trans proline' 0 N--CA 1.433 -2.043 2 CA-C-N 129.132 4.297 . . . . 8.1600000000000001 105.628 -173.767 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.267 65.9 m -84.11 -6.51 59.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.014 -1.074 . . . . 11.130000000000001 113.726 171.817 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -107.91 161.14 15.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 128.16 3.838 . . . . 18.030000000000001 108.843 -179.132 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -77.23 166.9 22.61 Favored 'General case' 0 N--CA 1.43 -1.446 1 N-CA-C 121.849 4.018 . . . . 10.220000000000001 121.849 -176.006 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -63.25 -32.85 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.039 1.335 . . . . 12.300000000000001 111.64 174.587 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -53.61 -44.15 69.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.109 -1.619 . . . . 36.509999999999998 112.032 172.537 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -79.84 -14.3 58.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.3 -3.375 . . . . 25.66 114.309 178.004 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.0 t -69.22 -47.62 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.251 -2.156 . . . . 8.1199999999999992 109.866 165.522 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.25 90.7 mttt -69.68 -28.39 65.81 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.07 1.748 . . . . 15.470000000000001 111.527 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.271 . . -65.8 -38.04 87.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.832 2.053 . . . . 11.449999999999999 106.885 175.502 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -73.32 -31.69 64.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.004 2.638 . . . . 24.98 116.55 178.199 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.25 70.8 mt -72.34 -42.21 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.081 2.372 . . . . 9.4600000000000009 111.317 172.108 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -49.93 -35.63 24.72 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.475 2.028 . . . . 14.76 116.475 169.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -85.59 -55.28 4.07 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.814 -1.921 . . . . 26.289999999999999 105.814 -173.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -71.85 -44.46 63.8 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.507 -1.371 . . . . 30.059999999999999 112.774 -169.419 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.581 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 67.5 mm-40 -106.89 -33.09 7.64 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.529 -1.357 . . . . 25.190000000000001 109.589 -162.054 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.4 46.69 4.88 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 128.124 2.774 . . . . 7.4100000000000001 113.81 170.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.0 mt -106.93 128.6 25.79 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 101.364 -3.569 . . . . 9.4900000000000002 101.364 176.355 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -82.86 162.95 16.06 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 O-C-N 117.029 -2.143 . . . . 11.42 110.857 179.409 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.15 -23.23 4.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 N-CA-C 121.386 3.571 . . . . 12.0 121.386 166.087 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -68.08 -23.65 64.96 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.608 -2.557 . . . . 35.549999999999997 106.936 178.258 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -108.73 -12.94 14.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 127.266 3.412 . . . . 20.52 116.267 -179.304 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -86.84 115.46 24.27 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 115.678 -4.389 . . . . 7.1299999999999999 113.46 -177.384 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -111.89 117.24 32.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.297 -1.001 . . . . 36.390000000000001 108.297 163.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -98.98 131.44 45.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.889 1.676 . . . . 9.5500000000000007 106.716 178.813 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.8 mt -131.2 140.51 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 119.487 -2.008 . . . . 13.9 107.062 177.397 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -101.28 100.92 11.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.228 3.811 . . . . 6.8600000000000003 108.678 161.674 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.09 -91.48 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.532 2.333 . . . . 11.15 116.704 -169.366 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.84 14.49 6.69 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 116.928 -2.04 . . . . 13.93 111.241 175.724 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -98.46 108.81 21.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 126.514 1.949 . . . . 23.920000000000002 106.785 173.899 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -79.74 102.28 8.93 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 119.963 3.32 . . . . 23.23 119.963 171.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.12 146.18 55.32 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 124.737 2.208 . . . . 9.1099999999999994 114.729 -155.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -107.06 143.87 34.54 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.119 -4.113 . . . . 33.439999999999998 112.835 178.805 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.96 -38.95 20.35 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 114.571 -2.633 . . . . 28.370000000000001 114.313 -153.379 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.88 45.78 3.57 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 124.024 3.102 . . . . 15.0 113.818 163.901 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -131.46 162.51 30.04 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.119 -4.754 . . . . 25.5 105.252 170.622 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -108.26 172.86 6.6 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 117.591 -3.193 . . . . 11.949999999999999 114.82 -175.669 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mt -64.81 -37.87 89.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.16 1.457 . . . . 10.17 108.191 169.006 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.356 1.2 m -56.2 -36.95 68.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.468 3.507 . . . . 13.59 120.468 167.626 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -58.75 -42.67 89.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.351 -2.718 . . . . 11.699999999999999 114.009 165.527 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -81.07 -7.39 59.55 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.731 -1.855 . . . . 12.949999999999999 111.426 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.256 60.8 m-80 55.78 48.42 18.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.321 2.249 . . . . 25.449999999999999 116.023 -171.872 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -84.32 140.47 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.009 1.723 . . . . 14.6 113.014 175.625 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -109.1 -175.06 2.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.122 1.769 . . . . 33.229999999999997 106.879 -170.247 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.409 ' HG2' ' HG3' ' A' ' 1' ' ' MET 0.299 18.3 mtmm -72.63 147.53 45.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.662 -1.899 . . . . 25.969999999999999 112.532 174.97 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 78.51 20.85 0.83 Allowed 'General case' 0 N--CA 1.43 -1.441 1 C-N-CA 132.027 4.131 . . . . 32.609999999999999 106.863 166.341 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -88.48 159.97 17.72 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 116.08 -4.137 . . . . 10.56 109.779 -163.934 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 m -103.84 134.98 46.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 124.328 2.013 . . . . 5.3300000000000001 112.473 -175.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -114.71 169.24 9.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 130.447 3.499 . . . . 11.66 108.302 165.222 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -123.62 136.5 54.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 114.775 -2.536 . . . . 16.300000000000001 107.753 174.002 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tp -97.04 113.95 25.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.542 2.428 . . . . 9.9600000000000009 113.96 159.572 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -116.96 -166.01 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 116.764 -3.71 . . . . 9.7599999999999998 108.542 162.515 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -84.85 145.16 27.97 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.345 2.258 . . . . 19.57 109.668 -172.359 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -103.29 124.16 48.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.388 -2.07 . . . . 35.079999999999998 106.115 -178.077 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.1 mt -124.58 136.1 53.68 Favored 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 133.039 4.535 . . . . 32.310000000000002 106.465 177.632 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -52.47 -52.31 54.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.695 2.48 . . . . 42.75 117.695 -175.545 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.35 68.57 0.54 Allowed Glycine 0 N--CA 1.43 -1.743 0 O-C-N 117.977 -2.952 . . . . 36.310000000000002 108.749 152.985 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.744 0 CA-C-O 124.779 2.322 . . . . 36.270000000000003 112.164 163.667 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 CA--C 1.49 -1.346 0 N-CA-C 115.65 1.722 . . . . 17.170000000000002 115.65 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -86.75 133.62 33.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.967 3.707 . . . . 21.890000000000001 110.941 171.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.39 158.83 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 119.569 1.077 . . . . 10.83 108.376 172.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.93 145.09 31.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.324 1.059 . . . . 10.609999999999999 109.935 168.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.511 HG22 ' HB2' ' A' ' 67' ' ' LEU . 85.7 t -122.3 139.08 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 101.22 -3.622 . . . . 9.1300000000000008 101.22 168.994 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -117.6 124.5 48.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.162 -0.926 . . . . 20.550000000000001 112.843 177.245 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -79.69 166.84 21.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.073 -1.876 . . . . 11.779999999999999 115.563 -177.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.9 tt -74.5 -43.61 55.16 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.687 -4.383 . . . . 19.309999999999999 108.912 -172.948 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -60.06 -44.06 94.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.575 -3.203 . . . . 23.140000000000001 110.024 173.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.21 59.87 0.21 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 126.233 2.208 . . . . 19.739999999999998 111.123 177.37 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.576 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 72.9 tttt -107.53 127.16 53.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.453 1.101 . . . . 21.93 109.553 161.561 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -101.07 112.2 24.61 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.124 -0.985 . . . . 12.33 108.892 174.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 pt -109.94 134.98 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 125.963 2.792 . . . . 17.079999999999998 111.01 -172.397 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.2 m -89.25 115.22 26.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.512 -1.992 . . . . 16.300000000000001 109.142 -174.769 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 mt -104.0 167.23 9.9 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.373 -2.079 . . . . 15.880000000000001 114.629 170.015 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.321 9.2 tt0 -130.47 113.69 14.6 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.565 1.546 . . . . 28.899999999999999 115.169 168.45 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.76 145.28 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.957 1.703 . . . . 12.050000000000001 110.363 -173.176 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.84 148.17 94.59 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 117.267 -3.396 . . . . 18.170000000000002 113.018 158.596 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -65.97 -21.68 56.45 Favored 'Trans proline' 0 C--N 1.3 -2.019 3 C-N-CA 126.214 4.609 . . . . 8.1600000000000001 113.414 172.096 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.8 m -84.61 8.11 17.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.681 1.705 . . . . 11.130000000000001 115.483 173.756 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -87.82 157.98 18.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.546 -2.596 . . . . 18.030000000000001 109.248 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -95.1 167.7 11.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.091 2.957 . . . . 10.220000000000001 115.061 -176.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -67.26 -26.35 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.211 1.93 . . . . 12.300000000000001 116.211 172.321 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -63.41 -47.52 81.64 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.073 -2.267 . . . . 36.509999999999998 112.03 175.264 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.91 -23.36 65.98 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.001 2.52 . . . . 25.66 113.738 176.096 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.31 -58.16 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.955 2.902 . . . . 8.1199999999999992 107.87 167.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -70.56 -17.99 62.92 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 115.353 -4.592 . . . . 15.470000000000001 116.495 -173.896 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.55 -28.26 65.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.061 -1.65 . . . . 11.449999999999999 109.315 167.171 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -77.93 -33.36 51.76 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.497 1.499 . . . . 24.98 111.05 -177.036 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.1 -34.74 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 128.368 2.667 . . . . 9.4600000000000009 110.213 178.529 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -56.75 -47.53 79.85 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 117.959 -1.02 . . . . 14.76 113.057 165.756 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -65.78 -57.95 6.8 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.059 2.614 . . . . 26.289999999999999 118.059 171.798 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -59.28 -52.16 66.87 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.46 3.133 . . . . 30.059999999999999 119.46 -173.359 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.576 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 64.5 mm-40 -107.09 -43.64 4.57 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 122.079 0.943 . . . . 25.190000000000001 109.681 176.418 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.32 47.43 2.02 Favored Glycine 0 N--CA 1.43 -1.741 0 O-C-N 118.264 -2.772 . . . . 7.4100000000000001 110.733 -173.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 mt -104.55 114.61 63.9 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 101.516 -3.513 . . . . 9.4900000000000002 101.516 168.249 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -83.62 163.41 14.4 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 CA-C-O 111.719 -3.534 . . . . 11.42 116.55 -171.061 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -81.6 -3.61 11.96 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 130.279 4.707 . . . . 12.0 111.281 -162.265 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.51 -26.4 45.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.001 1.273 . . . . 35.549999999999997 112.945 176.215 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -69.24 -51.24 39.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.912 3.671 . . . . 20.52 120.912 158.062 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -68.45 116.5 9.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.787 2.708 . . . . 7.1299999999999999 115.858 -168.892 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -111.83 113.84 26.44 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.216 -4.678 . . . . 36.390000000000001 105.961 168.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 mt -83.61 127.65 33.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.155 1.798 . . . . 9.5500000000000007 110.88 -179.919 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.6 mm -121.45 139.81 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 125.947 1.699 . . . . 13.9 108.282 177.774 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -135.25 139.99 44.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 104.206 -2.516 . . . . 6.8600000000000003 104.206 157.207 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.266 . . 47.92 -98.86 0.05 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.504 2.721 . . . . 11.15 112.052 -164.899 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.91 31.05 1.35 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 114.376 -3.773 . . . . 13.93 110.252 167.568 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -95.18 147.34 23.56 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.242 1.417 . . . . 23.920000000000002 108.11 166.689 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -99.62 139.46 35.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.927 -1.511 . . . . 23.23 110.692 170.595 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.258 0.4 OUTLIER -113.74 131.75 56.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.092 1.495 . . . . 9.1099999999999994 107.574 -163.756 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -101.08 157.36 16.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 125.333 1.646 . . . . 33.439999999999998 115.075 -162.71 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.259 33.6 m-20 -59.8 -53.72 54.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 121.447 3.869 . . . . 28.370000000000001 121.447 -165.283 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.86 33.93 5.24 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-N 121.109 1.777 . . . . 15.0 115.695 -179.408 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -113.92 150.34 33.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.18 -2.953 . . . . 25.5 105.092 169.712 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -90.16 171.48 9.49 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.939 2.78 . . . . 11.949999999999999 111.653 -170.21 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.63 -30.49 26.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.978 -3.576 . . . . 10.17 108.722 -176.789 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -59.05 -39.83 83.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.792 2.837 . . . . 13.59 108.233 170.816 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -58.03 -59.92 4.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.631 -3.793 . . . . 11.699999999999999 111.247 179.496 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -70.74 -11.96 61.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 130.099 3.359 . . . . 12.949999999999999 112.056 -170.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 65.71 60.04 0.72 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.92 -2.988 . . . . 25.449999999999999 112.851 -179.193 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mm -90.69 137.05 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.319 -2.738 . . . . 14.6 110.646 179.556 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -101.06 -175.8 2.98 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.507 -1.995 . . . . 33.229999999999997 114.883 -171.876 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -78.17 142.12 38.21 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.124 1.157 . . . . 25.969999999999999 114.124 178.661 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 61.11 30.84 19.65 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.214 2.206 . . . . 32.609999999999999 112.401 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.1 t -81.35 158.44 24.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 117.053 2.242 . . . . 10.56 117.053 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.3 m -121.37 103.76 9.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.145 -2.222 . . . . 5.3300000000000001 107.805 -166.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.511 ' HB2' HG22 ' A' ' 5' ' ' VAL 0.273 91.6 mt -88.48 147.35 24.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.142 2.977 . . . . 11.66 107.438 175.542 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -100.84 137.72 38.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.303 2.252 . . . . 16.300000000000001 110.093 -178.625 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 mt -106.07 141.22 37.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.908 -1.745 . . . . 9.9600000000000009 111.778 165.122 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.85 -169.85 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.62 2.368 . . . . 9.7599999999999998 108.517 169.969 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.6 mt -94.79 126.08 39.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.369 3.868 . . . . 19.57 116.06 -173.103 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -104.31 148.86 25.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.852 -1.78 . . . . 35.079999999999998 112.764 170.313 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.56 -64.45 0.9 Allowed 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 127.082 2.153 . . . . 32.310000000000002 110.055 173.639 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.312 29.7 ttt180 -155.67 -79.45 0.09 Allowed 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.922 -3.611 . . . . 42.75 112.661 173.755 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.83 50.88 0.85 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 109.473 -1.451 . . . . 36.310000000000002 109.473 -173.599 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 O-C-N 119.811 -1.994 . . . . 36.270000000000003 109.448 -170.21 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 CA--C 1.49 -1.361 0 CA-C-O 121.447 0.642 . . . . 17.170000000000002 110.874 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -89.39 152.07 21.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.239 1.971 . . . . 21.890000000000001 109.987 170.549 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.471 HD13 HD13 ' A' ' 67' ' ' LEU . 10.2 pt -126.33 168.71 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.668 2.787 . . . . 10.83 109.401 154.811 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -119.15 145.75 45.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.775 1.75 . . . . 10.609999999999999 110.927 164.255 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.9 123.53 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 116.618 -3.801 . . . . 9.1300000000000008 107.897 169.305 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -93.09 121.14 34.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.884 3.23 . . . . 20.550000000000001 109.72 176.227 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.44 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 30.2 p -78.18 -176.88 4.83 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.098 -4.751 . . . . 11.779999999999999 111.663 -174.138 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.3 tp -81.9 -34.36 30.02 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 111.823 -6.798 . . . . 19.309999999999999 113.337 -175.666 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.1 p -88.15 -26.29 22.52 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.12 -2.238 . . . . 23.140000000000001 107.06 -173.18 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.41 0.21 Allowed Glycine 0 N--CA 1.43 -1.738 0 CA-C-N 118.968 0.804 . . . . 19.739999999999998 113.161 166.121 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -112.1 145.62 39.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.367 -1.666 . . . . 21.93 108.043 169.552 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -111.15 123.78 50.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.991 2.057 . . . . 12.33 106.743 176.08 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.6 pt -110.7 141.99 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.76 -1.212 . . . . 17.079999999999998 113.856 177.232 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.7 m -110.57 112.85 25.03 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 115.491 -4.506 . . . . 16.300000000000001 111.047 -174.782 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 45.6 mt -106.35 124.13 49.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.443 2.068 . . . . 15.880000000000001 108.967 -173.953 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -97.6 105.43 17.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.865 -3.022 . . . . 28.899999999999999 111.987 176.698 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -131.47 149.25 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.921 2.088 . . . . 12.050000000000001 107.677 -159.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -85.5 151.83 56.59 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 112.592 -3.575 . . . . 18.170000000000002 113.182 176.334 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -84.71 -6.06 9.8 Favored 'Trans proline' 0 N--CA 1.434 -2.028 1 CA-C-N 132.554 5.519 . . . . 8.1600000000000001 109.072 -168.866 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -98.64 5.68 47.57 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.559 -3.213 . . . . 11.130000000000001 110.117 176.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -75.76 157.73 33.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.79 3.186 . . . . 18.030000000000001 108.677 173.394 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 p -96.37 164.26 12.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.812 -3.68 . . . . 10.220000000000001 108.29 -175.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mm -76.96 -16.6 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 119.516 -1.99 . . . . 12.300000000000001 111.692 -176.326 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -64.27 -46.88 81.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.343 -1.725 . . . . 36.509999999999998 106.343 172.865 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.77 -30.95 71.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.617 -2.552 . . . . 25.66 113.48 -178.296 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.77 -44.07 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 126.707 3.146 . . . . 8.1199999999999992 108.265 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -62.78 -39.25 93.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 120.67 3.581 . . . . 15.470000000000001 120.67 172.756 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.76 -41.1 77.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.741 2.817 . . . . 11.449999999999999 113.76 175.045 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -57.13 -32.47 66.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.847 1.259 . . . . 24.98 110.4 178.82 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 mt -82.41 -37.71 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.977 1.846 . . . . 9.4600000000000009 109.194 -173.075 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -62.1 -39.53 92.79 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.143 -1.598 . . . . 14.76 112.602 168.509 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.5 -55.16 30.13 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 115.621 -2.133 . . . . 26.289999999999999 113.052 175.236 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -78.52 -54.9 5.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.964 3.32 . . . . 30.059999999999999 119.964 -171.98 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -92.87 -36.13 12.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.548 -2.595 . . . . 25.190000000000001 112.115 176.991 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.84 55.98 2.56 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 117.763 -3.086 . . . . 7.4100000000000001 115.425 -174.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.0 mt -108.93 135.87 20.1 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 116.111 -1.899 . . . . 9.4900000000000002 105.982 172.945 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -71.53 146.58 49.98 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-O 112.397 -3.251 . . . . 11.42 119.591 -170.149 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -91.53 8.57 3.1 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 CA-C-N 128.163 3.951 . . . . 12.0 112.96 -165.729 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.42 -44.19 10.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.799 2.839 . . . . 35.549999999999997 109.142 165.393 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.31 -42.11 65.81 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 113.826 -2.988 . . . . 20.52 111.555 175.253 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.268 72.6 mt-30 -66.45 108.97 2.57 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 126.616 3.103 . . . . 7.1299999999999999 115.67 -174.169 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -106.51 110.02 22.11 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.114 4.165 . . . . 36.390000000000001 105.278 -174.223 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.49 ' HG ' HD13 ' A' ' 50' ' ' LEU . 25.8 tp -100.27 108.87 21.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 126.037 2.827 . . . . 9.5500000000000007 108.182 -162.735 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -106.66 145.82 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.141 -3.475 . . . . 13.9 113.09 -173.54 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -129.99 100.17 5.35 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.624 2.631 . . . . 6.8600000000000003 106.642 172.736 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.88 -75.51 0.07 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.638 -2.539 . . . . 11.15 115.63 -176.352 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.58 1.2 1.33 Allowed Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 126.527 2.013 . . . . 13.93 113.621 171.532 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -99.13 146.55 26.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.201 -2.352 . . . . 23.920000000000002 110.079 173.659 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.296 10.0 tt0 -91.1 117.29 29.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.045 2.609 . . . . 23.23 118.045 164.119 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.49 HD13 ' HG ' ' A' ' 43' ' ' LEU . 19.4 mt -65.85 131.92 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 1 C-N-CA 133.177 4.591 . . . . 9.1099999999999994 113.581 170.841 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.9 146.33 44.01 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.811 -1.181 . . . . 33.439999999999998 107.811 -169.084 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.65 -27.45 68.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.19 -2.277 . . . . 28.370000000000001 115.563 -158.65 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.04 24.43 30.53 Favored Glycine 0 N--CA 1.43 -1.729 1 O-C-N 114.526 -5.109 . . . . 15.0 117.353 -166.335 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -129.22 166.46 19.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.479 -0.934 . . . . 25.5 108.479 -176.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.295 22.2 p -92.93 157.91 16.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.251 1.501 . . . . 11.949999999999999 111.052 -173.708 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.2 mt -55.76 -34.04 64.87 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.449 1.595 . . . . 10.17 113.463 168.77 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 t -78.42 -25.43 46.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.895 3.278 . . . . 13.59 118.869 170.751 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -61.77 -47.58 84.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.734 -2.479 . . . . 11.699999999999999 113.044 166.871 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -81.76 -16.63 50.43 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.456 3.102 . . . . 12.949999999999999 111.271 -179.205 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 56.51 51.46 11.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.125 2.97 . . . . 25.449999999999999 109.39 -178.583 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.39 120.19 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 110.851 -2.886 . . . . 14.6 108.679 163.24 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -83.49 176.82 8.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.451 1.9 . . . . 33.229999999999997 110.365 -176.564 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.274 47.7 mttp -81.98 134.39 35.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.141 2.576 . . . . 25.969999999999999 109.55 179.81 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 56.83 34.03 24.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.787 2.835 . . . . 32.609999999999999 116.141 -175.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -72.14 127.44 32.55 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 127.591 3.567 . . . . 10.56 111.67 166.007 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.6 m -95.65 109.12 21.43 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 112.16 -2.291 . . . . 5.3300000000000001 112.499 179.297 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.471 HD13 HD13 ' A' ' 3' ' ' ILE . 20.4 mt -96.36 175.26 6.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.815 -1.178 . . . . 11.66 109.899 -172.945 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -128.65 136.13 50.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.827 -1.171 . . . . 16.300000000000001 112.432 -175.478 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 57.4 tp -120.6 129.77 53.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.552 -1.967 . . . . 9.9600000000000009 108.004 -176.063 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.53 163.43 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.366 1.066 . . . . 9.7599999999999998 109.727 170.186 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.8 mt -102.43 155.21 18.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.182 -1.574 . . . . 19.57 109.548 -169.172 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.432 HH21 ' C ' ' A' ' 76' ' ' GLY . 26.7 ttt180 -149.72 164.42 35.29 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.673 1.989 . . . . 35.079999999999998 106.504 -171.627 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.9 mt -103.3 -164.97 1.12 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.869 -1.514 . . . . 32.310000000000002 111.245 164.166 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -94.37 -39.36 10.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.237 -3.414 . . . . 42.75 115.349 -164.263 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.71 69.5 0.22 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 126.578 2.037 . . . . 36.310000000000002 115.292 179.072 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.432 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 N--CA 1.43 -1.732 0 N-CA-C 108.274 -1.93 . . . . 36.270000000000003 108.274 162.51 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.366 0 CA-C-O 123.144 1.449 . . . . 17.170000000000002 108.774 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -108.29 138.06 45.22 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.202 -4.061 . . . . 21.890000000000001 108.74 -172.576 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -133.78 148.85 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.609 -2.557 . . . . 10.83 107.361 -179.842 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.68 110.88 22.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.729 2.122 . . . . 10.609999999999999 116.729 177.311 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 t -101.14 122.7 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 120.918 1.69 . . . . 9.1300000000000008 108.863 175.635 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -90.32 111.32 22.48 Favored 'General case' 0 N--CA 1.429 -1.495 1 C-N-CA 131.881 4.072 . . . . 20.550000000000001 113.247 175.249 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 11' ' ' LYS . 5.3 p -76.93 159.49 29.94 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.253 1.945 . . . . 11.779999999999999 116.253 176.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 tp -53.52 -49.69 67.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.239 2.215 . . . . 19.309999999999999 110.981 -178.605 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.4 p -65.85 -38.1 87.95 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.533 3.533 . . . . 23.140000000000001 113.751 178.37 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.66 51.07 0.26 Allowed Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 127.785 2.612 . . . . 19.739999999999998 116.496 -178.195 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.426 ' O ' HG23 ' A' ' 7' ' ' THR . 53.3 mtpt -121.53 128.92 52.54 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.961 -1.905 . . . . 21.93 108.764 165.645 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.6 m -99.59 108.22 20.57 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.697 -3.752 . . . . 12.33 105.9 171.199 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pt -105.15 140.79 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 130.25 3.42 . . . . 17.079999999999998 104.536 -171.818 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -109.14 131.22 55.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.143 -2.848 . . . . 16.300000000000001 108.624 -170.239 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.0 mt -113.3 140.55 47.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.89 -1.893 . . . . 15.880000000000001 105.89 -179.147 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -100.24 128.25 46.35 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.585 -1.265 . . . . 28.899999999999999 107.585 171.127 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.05 152.15 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.193 -2.817 . . . . 12.050000000000001 117.188 -168.847 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.26 32.5 mt-10 -97.03 148.78 34.89 Favored Pre-proline 0 N--CA 1.43 -1.456 1 O-C-N 115.795 -4.316 . . . . 18.170000000000002 105.863 172.246 . . . . . . . . 3 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -82.31 -8.57 11.7 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.687 1.888 . . . . 8.1600000000000001 111.899 -169.544 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -81.06 -12.47 59.31 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.944 2.097 . . . . 11.130000000000001 109.976 -179.086 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -90.7 154.36 19.61 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 126.457 3.027 . . . . 18.030000000000001 109.259 -176.582 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.9 p -83.11 175.83 9.69 Favored 'General case' 0 N--CA 1.43 -1.43 2 O-C-N 114.63 -5.043 . . . . 10.220000000000001 117.758 -170.386 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.0 mm -79.65 -25.79 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 1 O-C-N 113.432 -5.792 . . . . 12.300000000000001 111.862 178.647 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -47.58 -40.71 19.89 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.97 2.211 . . . . 36.509999999999998 116.97 165.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -70.29 -42.33 72.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.274 2.629 . . . . 25.66 111.855 176.711 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.422 HG21 HD23 ' A' ' 56' ' ' LEU . 68.4 t -67.86 -34.14 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 117.37 -3.331 . . . . 8.1199999999999992 110.592 178.309 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.256 35.5 mtmt -65.4 -37.19 86.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.977 2.111 . . . . 15.470000000000001 112.541 166.792 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.88 -24.34 64.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.083 2.114 . . . . 11.449999999999999 112.559 -174.516 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -71.22 -37.89 72.02 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 133.599 4.76 . . . . 24.98 109.096 175.215 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.428 ' CG2' HD11 ' A' ' 36' ' ' ILE . 52.6 mt -80.51 -31.02 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.322 -1.487 . . . . 9.4600000000000009 107.575 -174.535 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.06 -31.33 68.89 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.24 1.416 . . . . 14.76 112.971 177.201 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -82.28 -52.3 7.07 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.283 2.327 . . . . 26.289999999999999 117.283 -175.471 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -86.06 -54.55 4.41 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.269 1.985 . . . . 30.059999999999999 116.046 -177.657 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -72.32 -39.89 67.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.315 -1.491 . . . . 25.190000000000001 114.484 177.291 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.89 51.78 2.94 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 116.449 -3.907 . . . . 7.4100000000000001 115.9 174.064 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.428 HD11 ' CG2' ' A' ' 30' ' ' ILE . 63.9 mt -113.18 129.21 24.78 Favored Pre-proline 0 N--CA 1.431 -1.421 0 C-N-CA 127.304 2.242 . . . . 9.4900000000000002 107.909 -176.516 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -77.39 148.95 27.15 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 114.568 -3.438 . . . . 11.42 110.01 -164.682 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -71.3 -24.39 23.06 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.805 2.337 . . . . 12.0 113.919 -156.596 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 72' ' ' ARG 0.292 5.2 p-10 -63.61 -53.23 54.8 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.687 -2.508 . . . . 35.549999999999997 110.124 173.751 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -57.43 -13.81 4.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.522 -2.611 . . . . 20.52 117.376 -177.98 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -93.63 95.61 9.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.351 1.46 . . . . 7.1299999999999999 109.311 -178.737 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -89.89 142.79 27.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 118.448 -1.301 . . . . 36.390000000000001 109.927 156.49 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -120.29 135.67 54.93 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.36 -0.978 . . . . 9.5500000000000007 108.36 -177.19 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mm -120.31 138.22 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.667 2.787 . . . . 13.9 106.22 -179.685 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -112.76 114.72 27.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.995 2.918 . . . . 6.8600000000000003 106.439 165.632 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.62 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.912 2.19 . . . . 11.15 116.912 -173.649 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.51 8.01 2.04 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 129.115 3.245 . . . . 13.93 106.525 -175.571 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -125.4 144.95 50.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.196 2.498 . . . . 23.920000000000002 111.927 -173.539 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -103.13 134.5 46.45 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.884 1.326 . . . . 23.23 111.127 -161.682 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.1 mt -84.68 143.89 28.91 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 115.882 -2.008 . . . . 9.1099999999999994 110.674 -176.105 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -135.11 156.37 49.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 126.529 2.393 . . . . 33.439999999999998 111.134 -173.059 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.79 -50.55 19.99 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 118.807 2.892 . . . . 28.370000000000001 118.807 -147.407 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.65 2.07 18.38 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 121.078 3.191 . . . . 15.0 121.078 -177.964 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -106.92 148.89 28.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.269 1.509 . . . . 25.5 109.613 -174.415 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -90.85 159.26 16.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.027 2.531 . . . . 11.949999999999999 111.17 -162.023 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.422 HD23 HG21 ' A' ' 26' ' ' VAL . 8.4 mt -58.23 -45.23 88.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.809 2.844 . . . . 10.17 108.378 172.111 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -57.58 -50.14 74.08 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.798 2.09 . . . . 13.59 114.505 178.325 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -60.53 -35.89 77.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.524 -1.36 . . . . 11.699999999999999 113.509 174.61 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -79.11 2.31 21.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.361 -3.337 . . . . 12.949999999999999 116.554 177.941 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.376 4.2 m120 71.39 34.52 1.7 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.213 -1.554 . . . . 25.449999999999999 111.932 -179.602 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.8 98.63 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 105.826 -1.916 . . . . 14.6 105.826 -165.84 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -107.13 -152.89 0.49 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.347 2.022 . . . . 33.229999999999997 112.16 -174.729 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -73.87 116.96 15.09 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.882 2.549 . . . . 25.969999999999999 117.882 -170.314 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 81.38 50.2 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.287 2.635 . . . . 32.609999999999999 106.468 163.601 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 152.66 25.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.983 1.713 . . . . 10.56 112.554 -169.859 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -94.58 115.91 28.13 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.483 3.513 . . . . 5.3300000000000001 112.754 -164.416 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -116.07 147.51 41.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.024 -3.548 . . . . 11.66 111.261 173.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -121.2 127.69 51.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.916 -2.253 . . . . 16.300000000000001 104.916 -175.618 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 tp -91.11 109.94 21.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.533 2.42 . . . . 9.9600000000000009 117.533 178.473 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.87 156.09 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.199 2.599 . . . . 9.7599999999999998 106.458 -172.763 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.7 tp -89.22 111.41 22.2 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.162 -2.211 . . . . 19.57 112.524 173.289 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 39' ' ' ASP . 57.7 ttt180 -90.12 116.92 28.5 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.206 -0.934 . . . . 35.079999999999998 110.141 -175.055 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.89 148.42 49.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 131.51 3.924 . . . . 32.310000000000002 112.111 169.492 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -83.81 118.37 23.89 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.729 -3.107 . . . . 42.75 118.419 177.072 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.21 79.62 0.55 Allowed Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 127.226 2.346 . . . . 36.310000000000002 114.344 -177.329 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 N-CA-C 107.102 -2.399 . . . . 36.270000000000003 107.102 178.324 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 115.061 1.504 . . . . 17.170000000000002 115.061 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -113.2 145.49 40.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.165 -2.21 . . . . 21.890000000000001 110.467 -174.654 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.458 HG13 ' HB2' ' A' ' 15' ' ' LEU . 6.1 pt -127.35 154.42 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.311 -1.737 . . . . 10.83 106.311 173.042 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -119.43 115.5 24.2 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.274 2.306 . . . . 10.609999999999999 106.987 -176.656 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.97 106.85 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.292 -1.505 . . . . 9.1300000000000008 113.471 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -83.56 110.2 18.03 Favored 'General case' 0 N--CA 1.43 -1.466 1 CA-C-O 128.648 4.07 . . . . 20.550000000000001 110.855 175.845 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.258 15.1 p -74.04 176.85 6.11 Favored 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 131.914 4.086 . . . . 11.779999999999999 113.238 -171.269 . . . . . . . . 3 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.66 -46.93 62.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.843 2.259 . . . . 19.309999999999999 114.743 -170.844 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.3 p -74.88 -91.24 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.216 3.006 . . . . 23.140000000000001 109.339 179.355 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.18 33.55 0.34 Allowed Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 121.59 1.995 . . . . 19.739999999999998 113.454 -174.675 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -122.64 141.99 51.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.136 -3.567 . . . . 21.93 115.089 178.108 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -109.54 123.56 49.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.768 -1.832 . . . . 12.33 111.461 170.477 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.0 pt -101.0 144.9 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 117.554 -1.212 . . . . 17.079999999999998 110.556 178.86 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.8 m -104.55 114.45 28.69 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.186 -2.34 . . . . 16.300000000000001 107.86 176.309 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.458 ' HB2' HG13 ' A' ' 3' ' ' ILE 0.313 96.5 mt -106.76 158.31 17.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.144 2.878 . . . . 15.880000000000001 105.234 176.021 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.323 27.0 tt0 -104.64 121.19 43.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 113.165 -1.834 . . . . 28.899999999999999 108.914 173.206 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -141.39 154.71 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 120.064 -1.647 . . . . 12.050000000000001 107.501 -179.517 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -87.87 158.37 50.53 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 119.603 -1.936 . . . . 18.170000000000002 106.907 167.229 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.12 -1.6 11.75 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 CA-C-N 122.169 1.81 . . . . 8.1600000000000001 115.664 174.117 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.5 m -86.25 -16.57 37.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.834 3.272 . . . . 11.130000000000001 119.834 173.75 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -84.26 170.25 13.9 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.872 2.869 . . . . 18.030000000000001 109.196 -174.766 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.5 p -90.92 -176.77 4.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.463 -3.273 . . . . 10.220000000000001 116.615 -173.084 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -83.16 -19.3 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 116.419 -3.926 . . . . 12.300000000000001 108.703 173.986 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -73.0 -42.51 63.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.055 -2.903 . . . . 36.509999999999998 107.309 178.216 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -54.82 -26.67 36.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.203 -1.856 . . . . 25.66 111.337 174.34 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.448 HG12 ' CD1' ' A' ' 15' ' ' LEU . 20.0 t -67.24 -54.85 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 117.795 2.517 . . . . 8.1199999999999992 117.795 167.703 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -62.48 -30.55 71.34 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 118.306 -2.746 . . . . 15.470000000000001 116.092 -177.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.68 -49.79 56.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.827 3.651 . . . . 11.449999999999999 116.153 164.074 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -63.89 -35.89 82.14 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.381 2.672 . . . . 24.98 109.845 178.04 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.49 -43.39 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.806 1.288 . . . . 9.4600000000000009 112.372 177.521 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -72.43 -37.89 68.49 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 113.899 -2.953 . . . . 14.76 109.586 -179.479 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.68 -45.79 42.2 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.408 2.822 . . . . 26.289999999999999 111.18 179.398 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -88.49 -55.29 3.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.202 -0.999 . . . . 30.059999999999999 112.703 -168.926 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -75.62 -63.28 1.33 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.094 1.426 . . . . 25.190000000000001 110.774 -176.214 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.11 40.3 0.45 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 125.376 1.465 . . . . 7.4100000000000001 115.099 173.804 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -104.07 118.46 57.0 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-O 116.581 -1.676 . . . . 9.4900000000000002 108.443 175.255 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -64.21 156.89 56.86 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 124.752 3.635 . . . . 11.42 112.11 -170.595 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.6 -18.78 25.24 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 115.57 1.335 . . . . 12.0 115.57 -161.171 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.59 -13.23 32.33 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 127.132 3.349 . . . . 35.549999999999997 107.013 -165.269 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.99 -6.65 58.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 112.171 -2.286 . . . . 20.52 115.778 175.193 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -102.35 107.28 18.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.735 2.124 . . . . 7.1299999999999999 116.735 -162.723 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -117.77 125.3 50.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.693 -1.254 . . . . 36.390000000000001 107.9 172.754 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 mt -102.12 128.22 48.7 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.971 -2.33 . . . . 9.5500000000000007 111.302 179.43 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.8 mt -110.01 141.72 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.608 2.363 . . . . 13.9 108.246 169.811 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.505 ' HB2' HD21 ' A' ' 67' ' ' LEU . 21.0 t80 -136.09 131.35 34.71 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.233 -2.136 . . . . 6.8600000000000003 105.233 174.148 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.15 -97.54 0.07 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.303 1.841 . . . . 11.15 112.354 -167.633 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.66 5.15 7.06 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 119.914 -1.741 . . . . 13.93 115.901 171.61 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -111.71 143.88 41.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.947 3.699 . . . . 23.920000000000002 112.146 -175.817 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -90.41 132.83 35.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 114.641 1.349 . . . . 23.23 114.641 176.643 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.4 mt -87.86 139.74 30.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.756 2.422 . . . . 9.1099999999999994 113.855 -172.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.03 -176.25 6.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.028 2.531 . . . . 33.439999999999998 110.76 168.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -83.02 -69.54 0.62 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 116.397 -3.939 . . . . 28.370000000000001 113.743 -176.557 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.9 56.35 4.36 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 120.387 -1.445 . . . . 15.0 116.007 -167.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -148.5 138.78 22.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 114.584 -2.627 . . . . 25.5 106.438 -172.669 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 44.3 p -79.68 163.87 24.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.309 2.956 . . . . 11.949999999999999 112.043 -167.926 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.51 -45.98 91.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 110.488 -3.051 . . . . 10.17 108.347 172.119 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 m -54.85 -39.47 68.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 125.56 1.787 . . . . 13.59 115.017 174.312 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -63.36 -53.5 51.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.306 -2.121 . . . . 11.699999999999999 113.213 176.199 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -70.25 -5.56 28.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.857 -1.065 . . . . 12.949999999999999 113.734 178.017 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 66.61 52.28 1.02 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.93 2.492 . . . . 25.449999999999999 110.595 179.237 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.9 119.13 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.041 -2.207 . . . . 14.6 105.041 175.758 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -120.05 -172.47 2.36 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.163 2.585 . . . . 33.229999999999997 108.72 -163.93 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -64.24 115.93 5.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 112.926 -3.416 . . . . 25.969999999999999 116.246 -174.368 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 76.93 18.7 1.5 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.986 3.314 . . . . 32.609999999999999 114.181 -176.164 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.0 m -61.12 145.27 51.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.643 -3.161 . . . . 10.56 115.68 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -94.42 126.29 39.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.705 -2.497 . . . . 5.3300000000000001 115.899 171.457 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.505 HD21 ' HB2' ' A' ' 45' ' ' PHE 0.251 22.0 mt -108.31 152.81 24.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.727 1.01 . . . . 11.66 113.727 172.62 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -114.45 131.59 56.55 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.919 -3.613 . . . . 16.300000000000001 111.656 -177.928 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.6 tp -109.56 122.6 47.79 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 118.457 -0.782 . . . . 9.9600000000000009 109.705 -178.85 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.86 -168.77 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.413 -1.699 . . . . 9.7599999999999998 106.413 -170.522 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.0 tp -90.25 129.82 36.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.405 -2.072 . . . . 19.57 105.405 -169.742 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -90.95 120.21 31.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.19 -2.204 . . . . 35.079999999999998 111.348 157.384 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mt -101.99 145.07 29.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 110.409 -3.087 . . . . 32.310000000000002 105.661 179.197 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -55.53 111.4 0.88 Allowed 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.292 -4.005 . . . . 42.75 114.499 -178.975 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.78 69.91 0.34 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 121.146 3.218 . . . . 36.310000000000002 121.146 -170.667 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 O-C-N 129.068 3.451 . . . . 36.270000000000003 112.492 -167.849 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 119.589 3.181 . . . . 17.170000000000002 119.589 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -65.37 140.33 58.64 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 117.049 2.241 . . . . 21.890000000000001 117.049 163.354 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.4 pt -124.6 159.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.517 -1.99 . . . . 10.83 111.45 166.262 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -110.41 122.12 46.95 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 115.679 -2.105 . . . . 10.609999999999999 115.555 170.478 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.436 HG12 HD13 ' A' ' 30' ' ' ILE . 85.6 t -110.43 110.1 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 101.827 -3.397 . . . . 9.1300000000000008 101.827 -179.096 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -75.72 134.86 40.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.187 2.195 . . . . 20.550000000000001 114.124 175.684 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -98.42 -169.14 1.75 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.944 -1.132 . . . . 11.779999999999999 107.944 -172.963 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.6 tp -91.01 -38.33 12.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.254 -1.758 . . . . 19.309999999999999 106.254 -168.353 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.328 62.1 p -71.67 -69.77 0.36 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.067 1.877 . . . . 23.140000000000001 116.067 171.858 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.5 42.36 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 O-C-N 116.977 -3.577 . . . . 19.739999999999998 119.417 177.895 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -112.48 129.42 56.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 114.317 -2.754 . . . . 21.93 104.96 -172.517 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -88.71 105.72 17.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.726 2.679 . . . . 12.33 109.862 165.266 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.0 mt -86.12 110.91 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 116.616 -3.802 . . . . 17.079999999999998 111.427 175.253 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -100.55 113.75 26.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.274 1.852 . . . . 16.300000000000001 114.712 -172.925 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -116.26 139.39 50.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.359 0.982 . . . . 15.880000000000001 111.886 -167.014 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -96.73 109.13 21.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.434 -2.042 . . . . 28.899999999999999 110.808 -179.164 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.42 156.13 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 118.266 -2.771 . . . . 12.050000000000001 108.645 -174.629 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -107.55 136.79 19.59 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.243 -1.536 . . . . 18.170000000000002 110.172 170.576 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.11 -5.45 14.46 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 122.578 2.185 . . . . 8.1600000000000001 113.275 -155.425 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -93.12 -8.81 41.59 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 112.187 -3.768 . . . . 11.130000000000001 110.876 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -77.71 177.57 8.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 128.628 3.705 . . . . 18.030000000000001 115.204 166.415 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.2 p -115.62 -178.23 3.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.383 -2.698 . . . . 10.220000000000001 109.615 -169.401 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.308 11.9 mm -63.09 -35.53 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 116.939 -3.601 . . . . 12.300000000000001 113.09 175.725 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.2 -33.17 51.62 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.157 -4.089 . . . . 36.509999999999998 114.629 174.953 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -64.97 -39.24 93.18 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.294 -2.129 . . . . 25.66 111.832 174.857 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.6 t -73.91 -45.63 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.843 -1.785 . . . . 8.1199999999999992 107.27 -174.228 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.288 38.9 ttmt -63.9 -30.63 71.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.709 -3.744 . . . . 15.470000000000001 111.478 -178.766 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.03 89.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.696 2.799 . . . . 11.449999999999999 117.328 171.021 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -71.97 -21.86 61.52 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.527 2.417 . . . . 24.98 117.527 174.127 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 HD13 HG12 ' A' ' 5' ' ' VAL . 5.2 mt -75.24 -30.84 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 127.675 3.607 . . . . 9.4600000000000009 114.077 164.217 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.92 -47.53 82.87 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.529 -4.482 . . . . 14.76 111.798 168.08 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.94 -47.24 21.51 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.321 -1.487 . . . . 26.289999999999999 111.678 -172.711 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -74.18 -76.84 0.12 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 116.825 -1.559 . . . . 30.059999999999999 112.373 -176.332 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -80.26 -38.34 31.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.829 3.251 . . . . 25.190000000000001 108.099 -161.564 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.01 50.83 3.36 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-O 123.952 1.862 . . . . 7.4100000000000001 111.669 -176.144 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.1 mt -101.66 120.01 55.58 Favored Pre-proline 0 N--CA 1.43 -1.468 1 O-C-N 114.703 -4.998 . . . . 9.4900000000000002 109.605 165.216 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.9 158.66 56.35 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 126.883 3.494 . . . . 11.42 114.671 -174.27 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.85 -7.83 5.24 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 CA-C-N 128.995 4.248 . . . . 12.0 110.977 -157.618 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 3.0 p-10 -70.83 -32.26 69.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.767 2.827 . . . . 35.549999999999997 106.626 175.521 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -88.02 -11.79 46.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.981 -2.949 . . . . 20.52 113.755 177.994 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.401 ' HB3' HD12 ' A' ' 69' ' ' LEU . 62.1 mt-30 -84.74 122.51 29.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.853 2.861 . . . . 7.1299999999999999 112.818 176.577 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -129.95 146.96 51.66 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.147 -2.221 . . . . 36.390000000000001 105.014 154.061 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.85 122.19 44.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.16 1.457 . . . . 9.5500000000000007 107.72 -173.371 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -110.22 131.69 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 128.298 2.639 . . . . 13.9 111.907 -179.412 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -126.02 118.75 26.0 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 114.417 -5.177 . . . . 6.8600000000000003 103.763 176.386 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.395 . . 65.8 -98.8 0.06 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.483 2.031 . . . . 11.15 116.483 -164.944 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.13 13.82 4.35 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 127.759 2.599 . . . . 13.93 109.951 -173.861 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -132.02 147.28 52.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.217 -2.343 . . . . 23.920000000000002 113.025 -177.408 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -85.76 146.34 26.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.293 2.473 . . . . 23.23 110.533 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.1 mt -93.55 148.4 22.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.673 -2.517 . . . . 9.1099999999999994 110.987 178.049 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.305 10.0 pt-20 -80.69 -168.86 1.91 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.572 1.949 . . . . 33.439999999999998 110.111 175.969 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -105.77 -47.39 3.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.111 3.338 . . . . 28.370000000000001 113.186 174.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.93 59.92 1.01 Allowed Glycine 0 N--CA 1.43 -1.715 1 O-C-N 115.394 -4.566 . . . . 15.0 115.088 -173.022 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -139.42 139.29 37.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.387 -1.338 . . . . 25.5 107.387 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.1 p -80.07 163.75 23.92 Favored 'General case' 0 N--CA 1.43 -1.45 1 CA-C-O 128.903 4.192 . . . . 11.949999999999999 111.351 -166.887 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -67.3 -37.52 83.53 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.619 -4.425 . . . . 10.17 114.342 -179.761 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -72.53 -27.13 62.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.802 1.641 . . . . 13.59 115.064 176.187 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -73.13 -39.16 65.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.073 -3.517 . . . . 11.699999999999999 107.019 172.483 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.06 -0.07 23.28 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.453 1.101 . . . . 12.949999999999999 111.779 178.801 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 51.09 60.12 4.11 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.363 -2.711 . . . . 25.449999999999999 114.685 179.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.0 mm -104.28 132.9 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 127.971 2.509 . . . . 14.6 109.191 170.592 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -111.1 -179.82 3.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.007 1.861 . . . . 33.229999999999997 114.362 -179.07 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -59.33 118.7 6.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.087 -1.87 . . . . 25.969999999999999 114.902 172.55 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.321 55.7 mt-10 76.27 35.0 0.48 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.437 -3.914 . . . . 32.609999999999999 112.874 173.464 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -90.63 141.92 28.28 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.094 1.757 . . . . 10.56 109.818 -175.553 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -87.55 128.14 35.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 113.878 -1.51 . . . . 5.3300000000000001 113.528 176.239 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.57 149.35 42.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.144 2.978 . . . . 11.66 104.693 174.357 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -119.78 135.41 54.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.088 -1.008 . . . . 16.300000000000001 111.598 176.304 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.401 HD12 ' HB3' ' A' ' 41' ' ' GLN . 15.8 tp -105.75 110.98 23.47 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.051 1.405 . . . . 9.9600000000000009 112.609 177.584 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -99.18 -174.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.207 2.432 . . . . 9.7599999999999998 108.837 -178.653 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 tp -101.12 110.83 22.91 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 115.796 -4.315 . . . . 19.57 106.706 -177.437 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 39' ' ' ASP 0.253 58.0 ttt180 -78.05 133.63 37.9 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.433 2.693 . . . . 35.079999999999998 111.127 172.63 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -101.62 -163.64 1.03 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.645 -1.284 . . . . 32.310000000000002 107.757 -174.356 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -86.35 135.37 33.54 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.128 1.529 . . . . 42.75 115.128 169.546 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.24 -82.7 0.33 Allowed Glycine 0 N--CA 1.43 -1.765 0 CA-C-O 122.016 0.787 . . . . 36.310000000000002 113.522 -174.713 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.735 0 N-CA-C 118.54 2.176 . . . . 36.270000000000003 118.54 -170.358 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 117.057 2.243 . . . . 17.170000000000002 117.057 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -80.92 135.63 35.93 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 116.084 -4.135 . . . . 21.890000000000001 111.73 -176.107 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.71 153.24 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.177 -2.527 . . . . 10.83 104.177 161.049 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.279 50.2 m-85 -115.06 121.86 44.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 126.798 2.561 . . . . 10.609999999999999 111.634 -174.085 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.07 112.69 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 116.501 -3.875 . . . . 9.1300000000000008 110.504 -173.288 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -95.45 147.28 23.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.919 2.295 . . . . 20.550000000000001 106.36 -176.437 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.3 p -89.06 -178.14 5.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.785 -3.072 . . . . 11.779999999999999 106.635 174.109 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.2 tp -63.37 -47.8 80.59 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 117.912 -1.042 . . . . 19.309999999999999 112.87 168.576 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -55.63 -50.16 70.93 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.103 2.561 . . . . 23.140000000000001 111.16 171.319 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.9 49.78 0.3 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 118.887 -2.383 . . . . 19.739999999999998 109.311 169.391 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -90.42 124.48 34.99 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 103.179 -2.897 . . . . 21.93 103.179 176.918 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -97.67 115.13 27.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.345 2.498 . . . . 12.33 109.068 -175.672 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.5 mt -105.81 113.88 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.29 -2.232 . . . . 17.079999999999998 106.249 178.419 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -88.49 133.69 34.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.604 -3.185 . . . . 16.300000000000001 111.342 173.298 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.0 mt -120.6 172.25 7.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.986 2.054 . . . . 15.880000000000001 108.937 -175.101 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -128.26 114.65 17.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.094 -1.628 . . . . 28.899999999999999 108.748 170.182 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.37 152.53 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 125.801 1.938 . . . . 12.050000000000001 108.366 -177.812 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.26 140.22 28.67 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-O 114.21 -2.805 . . . . 18.170000000000002 113.799 157.641 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -81.7 -4.69 12.25 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 123.987 2.46 . . . . 8.1600000000000001 111.258 -169.722 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 m -82.68 4.09 26.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.85 2.907 . . . . 11.130000000000001 118.85 163.553 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -99.94 176.86 5.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.015 2.189 . . . . 18.030000000000001 106.572 173.876 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.369 11.0 p -89.3 -169.92 2.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.48 -1.236 . . . . 10.220000000000001 113.827 -166.404 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 mm -81.05 -18.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.672 2.389 . . . . 12.300000000000001 115.258 161.478 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -71.32 -29.64 65.27 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 123.88 0.872 . . . . 36.509999999999998 109.08 173.659 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -60.57 -45.67 93.05 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.047 1.739 . . . . 25.66 110.819 169.29 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -65.29 -35.56 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 119.16 0.891 . . . . 8.1199999999999992 109.198 -175.496 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -65.15 -37.59 87.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.857 1.429 . . . . 15.470000000000001 114.857 168.889 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.274 . . -70.0 -33.02 71.5 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.299 2.703 . . . . 11.449999999999999 118.299 172.469 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -65.93 -33.04 74.9 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.358 -3.964 . . . . 24.98 110.775 173.729 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.5 mt -65.98 -44.87 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 117.051 -3.53 . . . . 9.4600000000000009 108.386 167.122 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.76 -38.65 82.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.959 1.709 . . . . 14.76 112.344 176.099 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.99 -46.87 49.79 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.304 -0.872 . . . . 26.289999999999999 110.871 179.316 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -77.01 -57.78 3.65 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 116.498 -2.081 . . . . 30.059999999999999 113.059 -173.362 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -91.5 -52.14 4.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.908 1.337 . . . . 25.190000000000001 109.267 -167.934 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.22 30.02 3.05 Favored Glycine 0 N--CA 1.43 -1.708 1 C-N-CA 132.061 4.648 . . . . 7.4100000000000001 115.037 173.534 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.5 mt -81.34 135.15 50.64 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 119.068 -2.431 . . . . 9.4900000000000002 106.055 175.071 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 51.2 Cg_exo -68.88 137.67 38.71 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-O 114.203 -2.499 . . . . 11.42 116.354 177.819 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.39 -12.14 22.81 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 124.158 3.239 . . . . 12.0 113.933 -175.532 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -74.56 -26.82 60.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.583 1.992 . . . . 35.549999999999997 113.826 167.655 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -95.37 3.81 54.01 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.008 2.523 . . . . 20.52 113.138 178.25 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' HG2' HD13 ' A' ' 69' ' ' LEU . 72.8 mt-30 -99.06 133.66 43.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.264 -2.148 . . . . 7.1299999999999999 114.751 178.201 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -113.4 121.0 43.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.187 2.595 . . . . 36.390000000000001 109.947 158.63 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 mt -100.67 140.85 34.36 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.269 -2.77 . . . . 9.5500000000000007 109.829 174.945 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mt -141.73 138.62 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 105.013 -2.217 . . . . 13.9 105.013 -169.36 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -123.46 117.99 26.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.07 -1.019 . . . . 6.8600000000000003 111.027 172.871 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.299 . . 74.63 -108.01 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.525 -2.398 . . . . 11.15 104.525 176.002 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.34 6.18 5.63 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 119.031 -2.293 . . . . 13.93 113.629 168.699 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.283 38.3 pttt -81.12 135.52 35.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.671 2.1 . . . . 23.920000000000002 116.671 159.79 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -82.76 162.31 21.77 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.462 -3.899 . . . . 23.23 107.908 172.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.6 mt -110.42 133.5 53.22 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.23 1.967 . . . . 9.1099999999999994 115.044 175.104 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.79 153.08 19.09 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.739 2.126 . . . . 33.439999999999998 116.739 163.856 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.23 -30.63 60.62 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 131.306 3.842 . . . . 28.370000000000001 116.819 -160.213 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.94 34.48 4.64 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 126.244 2.215 . . . . 15.0 117.665 177.312 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -140.2 146.86 39.25 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 118.547 1.173 . . . . 25.5 109.109 -170.874 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 68.4 p -89.66 164.18 14.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.537 1.517 . . . . 11.949999999999999 114.537 -173.088 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.9 mt -55.19 -46.28 75.85 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.522 3.529 . . . . 10.17 110.878 166.372 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 m -58.53 -52.12 67.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.621 1.568 . . . . 13.59 109.717 173.481 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.93 -32.82 30.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.493 2.406 . . . . 11.699999999999999 109.965 -168.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.451 ' HB2' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -61.88 -34.5 76.12 Favored 'General case' 0 N--CA 1.43 -1.45 1 N-CA-C 122.269 4.174 . . . . 12.949999999999999 122.269 161.873 . . . . . . . . 4 4 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 66.8 m-80 90.35 59.86 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.108 2.163 . . . . 25.449999999999999 109.781 177.415 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mm -107.53 108.84 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 113.253 -1.794 . . . . 14.6 106.621 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.313 10.0 pt20 -83.84 176.65 8.76 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.108 -2.87 . . . . 33.229999999999997 117.858 -178.223 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -68.73 125.08 25.46 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 130.487 3.515 . . . . 25.969999999999999 110.533 168.574 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 64.63 39.28 6.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 130.516 3.526 . . . . 32.609999999999999 115.922 -171.216 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.8 m -78.18 165.03 24.43 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 113.308 0.855 . . . . 10.56 113.308 172.165 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m -106.01 139.04 41.16 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 126.534 1.933 . . . . 5.3300000000000001 106.855 170.52 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.38 156.78 41.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.86 -3.025 . . . . 11.66 107.707 171.235 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -112.69 117.7 32.96 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.173 -3.455 . . . . 16.300000000000001 107.436 -175.887 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.46 HD13 ' HG2' ' A' ' 41' ' ' GLN 0.257 12.4 tp -101.37 121.39 41.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.524 -2.61 . . . . 9.9600000000000009 114.97 169.206 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.307 10.7 m -121.4 158.52 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 130.425 3.49 . . . . 9.7599999999999998 102.83 177.945 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tp -64.01 139.52 58.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.672 -1.149 . . . . 19.57 113.881 166.641 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.343 63.2 ttt180 -76.56 127.22 32.4 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.063 2.616 . . . . 35.079999999999998 118.063 173.284 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.3 mt -113.4 165.44 12.45 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 122.455 2.389 . . . . 32.310000000000002 107.576 -175.796 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -66.24 105.23 1.36 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.527 1.531 . . . . 42.75 113.096 168.272 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.59 87.4 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 113.881 -1.509 . . . . 36.310000000000002 113.753 -178.576 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.758 0 O-C-N 125.077 1.104 . . . . 36.270000000000003 111.988 -166.401 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.491 -1.32 0 CA-C-O 118.34 -0.838 . . . . 17.170000000000002 112.882 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.09 150.07 23.62 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.537 -3.852 . . . . 21.890000000000001 109.156 177.202 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.487 HG12 HG23 ' A' ' 17' ' ' VAL 0.282 32.0 pt -131.45 159.03 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 128.59 2.756 . . . . 10.83 109.815 169.345 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -110.95 141.87 43.81 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.696 -1.965 . . . . 10.609999999999999 105.696 173.41 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.9 t -108.47 120.02 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 120.457 1.48 . . . . 9.1300000000000008 108.851 161.205 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -103.03 125.18 49.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.557 2.343 . . . . 20.550000000000001 110.851 -179.135 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -88.01 148.23 24.62 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.215 1.006 . . . . 11.779999999999999 112.751 177.889 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.338 14.5 tp -51.16 -40.2 58.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.659 2.384 . . . . 19.309999999999999 110.825 162.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.5 m -64.58 -50.77 65.95 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 121.105 1.775 . . . . 23.140000000000001 112.481 -179.19 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.0 19.34 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 123.787 1.771 . . . . 19.739999999999998 116.675 169.351 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 19.9 ttmt -103.37 138.42 40.14 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.243 -3.504 . . . . 21.93 112.417 177.864 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.9 m -99.59 124.73 45.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.244 -2.16 . . . . 12.33 108.796 162.894 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 13' ' ' ILE . 42.8 mt -119.75 119.38 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 126.41 1.884 . . . . 17.079999999999998 110.093 -171.053 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -82.76 119.08 23.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.08 -3.512 . . . . 16.300000000000001 106.446 -169.047 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 mt -106.27 159.39 16.15 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 116.226 -4.046 . . . . 15.880000000000001 111.352 169.378 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -99.45 134.92 41.62 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 121.605 2.002 . . . . 28.899999999999999 109.5 154.735 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.487 HG23 HG12 ' A' ' 3' ' ' ILE . 33.6 m -139.69 156.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 125.416 2.532 . . . . 12.050000000000001 106.589 175.727 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -96.94 153.18 38.65 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 112.354 -2.203 . . . . 18.170000000000002 110.633 173.922 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.11 -24.16 28.37 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 127.251 3.625 . . . . 8.1600000000000001 111.319 178.997 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 p -81.21 -13.88 58.11 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.404 3.002 . . . . 11.130000000000001 111.49 -171.736 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -67.19 151.23 47.92 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.729 -4.982 . . . . 18.030000000000001 113.809 176.785 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.275 22.3 p -80.66 153.36 27.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 120.282 3.438 . . . . 10.220000000000001 120.282 162.973 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.3 mm -64.75 -26.61 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 125.772 2.701 . . . . 12.300000000000001 112.123 -179.218 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.257 20.4 tt0 -44.37 -46.63 9.48 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.855 -4.278 . . . . 36.509999999999998 116.345 162.663 . . . . . . . . 3 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -69.32 -37.82 77.92 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.012 2.925 . . . . 25.66 111.329 172.097 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.256 58.5 t -63.44 -47.36 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 119.398 0.999 . . . . 8.1199999999999992 113.167 170.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -49.24 -43.24 42.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.167 2.284 . . . . 15.470000000000001 117.167 168.315 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.37 -28.6 69.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 117.915 2.561 . . . . 11.449999999999999 117.915 173.496 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -83.32 -29.09 28.57 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.603 1.334 . . . . 24.98 114.603 175.304 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.4 mt -70.68 -36.3 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.837 -1.074 . . . . 9.4600000000000009 108.202 169.61 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.12 -37.75 88.46 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.547 -1.692 . . . . 14.76 115.337 171.025 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.16 -43.62 67.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.703 2.047 . . . . 26.289999999999999 111.334 179.619 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -70.7 -76.16 0.11 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.032 2.133 . . . . 30.059999999999999 115.347 177.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.401 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 31.2 tp10 -81.44 -28.75 34.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.16 2.584 . . . . 25.190000000000001 108.974 -169.725 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.63 43.57 6.08 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 116.437 -2.313 . . . . 7.4100000000000001 113.64 -176.231 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 mt -105.25 121.63 45.69 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 115.966 -1.968 . . . . 9.4900000000000002 114.671 176.18 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.5 149.8 74.78 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 126.436 3.334 . . . . 11.42 115.292 -175.288 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -73.67 -18.4 22.36 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 127.075 3.562 . . . . 12.0 118.291 -168.378 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -71.06 -32.64 69.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.409 -2.682 . . . . 35.549999999999997 111.672 179.194 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -91.92 2.76 56.33 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 117.211 -1.376 . . . . 20.52 111.856 -179.693 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -89.17 119.72 29.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.698 3.199 . . . . 7.1299999999999999 116.164 177.619 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -138.7 119.62 14.34 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 123.865 0.866 . . . . 36.390000000000001 108.957 171.701 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -101.12 136.7 40.55 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.953 1.835 . . . . 9.5500000000000007 113.822 -177.557 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mt -114.61 127.81 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 C-N-CA 134.338 5.055 . . . . 13.9 107.213 -179.46 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -116.32 106.04 13.21 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.56 -1.274 . . . . 6.8600000000000003 107.56 166.551 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.05 -71.97 0.07 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 116.364 1.987 . . . . 11.15 116.364 -170.298 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.32 -14.0 0.97 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 128.571 2.986 . . . . 13.93 116.33 174.458 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -101.74 144.63 30.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.019 2.91 . . . . 23.920000000000002 111.028 -167.382 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.265 15.2 pt20 -65.49 123.12 18.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.744 2.818 . . . . 23.23 113.539 167.067 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.421 ' CD1' HD22 ' A' ' 67' ' ' LEU . 33.9 mt -94.42 139.32 31.28 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 101.325 -3.583 . . . . 9.1099999999999994 101.325 -174.853 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.88 176.61 8.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.328 2.251 . . . . 33.439999999999998 111.213 168.241 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.31 -53.41 3.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.36 -2.712 . . . . 28.370000000000001 112.619 -172.251 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 53.05 4.82 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 118.035 -2.915 . . . . 15.0 119.118 175.222 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -132.03 139.3 48.53 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 119.44 1.62 . . . . 25.5 110.123 166.951 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.286 56.9 p -75.33 150.77 38.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.757 -1.839 . . . . 11.949999999999999 112.977 -172.098 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.1 mt -51.44 -33.41 30.63 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.289 2.636 . . . . 10.17 114.601 165.443 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.309 22.7 t -59.9 -50.05 75.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.479 3.511 . . . . 13.59 110.216 168.328 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -86.1 -32.63 21.24 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.363 -2.088 . . . . 11.699999999999999 105.363 -163.618 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -60.16 -25.42 65.52 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.172 -2.83 . . . . 12.949999999999999 113.341 167.093 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 68.65 54.56 0.5 Allowed 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 131.679 3.992 . . . . 25.449999999999999 113.027 -179.058 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.03 131.39 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.596 -2.001 . . . . 14.6 105.596 174.307 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -108.01 -171.66 1.91 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.579 1.326 . . . . 33.229999999999997 114.579 178.099 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -76.83 134.82 38.94 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.009 2.596 . . . . 25.969999999999999 118.009 -174.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 53.12 45.43 28.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 116.937 2.199 . . . . 32.609999999999999 116.937 -166.835 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.357 49.3 m -94.85 139.59 31.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 100.303 -3.962 . . . . 10.56 100.303 -175.356 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -98.83 122.47 42.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.092 0.86 . . . . 5.3300000000000001 108.952 179.465 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.421 HD22 ' CD1' ' A' ' 50' ' ' LEU . 3.3 mp -98.03 147.39 24.57 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.576 -1.327 . . . . 11.66 111.393 167.118 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -103.92 127.43 51.45 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.243 -3.41 . . . . 16.300000000000001 119.215 172.366 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.09 132.54 35.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.402 -2.061 . . . . 9.9600000000000009 113.883 175.163 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.28 -176.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 125.383 1.473 . . . . 9.7599999999999998 109.437 168.418 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.3 tp -86.73 135.18 33.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 116.402 -3.936 . . . . 19.57 110.986 175.403 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -89.64 116.19 27.58 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 125.206 1.566 . . . . 35.079999999999998 109.55 172.076 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -97.57 167.16 11.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.592 -2.744 . . . . 32.310000000000002 103.592 -174.693 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -87.29 131.27 34.3 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.079 -1.638 . . . . 42.75 110.209 -178.542 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.62 -37.94 1.02 Allowed Glycine 0 N--CA 1.431 -1.661 1 O-C-N 129.191 4.057 . . . . 36.310000000000002 107.729 -174.26 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.738 0 C-N-CA 124.715 1.15 . . . . 36.270000000000003 115.142 176.096 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 118.551 2.797 . . . . 17.170000000000002 118.551 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -93.3 113.15 25.27 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 101.864 -3.384 . . . . 21.890000000000001 101.864 178.467 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -120.1 149.74 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 104.331 -2.47 . . . . 10.83 104.331 170.936 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -107.05 121.28 44.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.189 1.471 . . . . 10.609999999999999 109.629 -172.103 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -100.12 117.46 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 O-C-N 115.15 -4.719 . . . . 9.1300000000000008 102.129 175.312 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -100.56 123.95 45.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.654 -2.529 . . . . 20.550000000000001 111.127 176.902 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -86.5 -176.54 5.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.422 -2.674 . . . . 11.779999999999999 109.28 -174.12 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 tp -70.55 -50.08 41.24 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.225 2.21 . . . . 19.309999999999999 110.075 178.633 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.4 p -72.93 -29.57 63.21 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.261 -1.755 . . . . 23.140000000000001 106.261 -178.065 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.2 54.03 0.31 Allowed Glycine 0 N--CA 1.43 -1.753 0 O-C-N 118.692 -2.505 . . . . 19.739999999999998 107.67 162.626 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -107.54 135.7 48.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.536 2.112 . . . . 21.93 109.608 171.473 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -96.42 109.61 22.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.629 -1.919 . . . . 12.33 106.046 -173.803 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 mt -102.22 96.26 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 126.424 3.011 . . . . 17.079999999999998 105.512 178.816 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.9 m -88.83 117.43 27.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.345 -3.347 . . . . 16.300000000000001 108.989 -172.969 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 mt -109.71 137.49 47.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.903 -2.373 . . . . 15.880000000000001 112.259 -167.549 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -106.66 101.44 10.89 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.696 -1.878 . . . . 28.899999999999999 109.47 177.311 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.26 163.01 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 118.802 -2.436 . . . . 12.050000000000001 109.396 -175.318 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -85.55 164.9 38.31 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 118.44 -2.663 . . . . 18.170000000000002 109.493 173.4 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.82 -4.45 3.33 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 C-N-CA 123.223 2.616 . . . . 8.1600000000000001 111.573 -174.463 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -87.85 -6.45 58.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.006 2.923 . . . . 11.130000000000001 111.838 175.665 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.48 159.03 18.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.273 -3.392 . . . . 18.030000000000001 114.443 -179.323 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -90.44 165.67 13.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.394 1.569 . . . . 10.220000000000001 111.985 -173.964 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -69.17 -20.42 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 127.415 3.483 . . . . 12.300000000000001 113.636 171.905 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.11 -43.34 87.47 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.047 -5.408 . . . . 36.509999999999998 112.759 174.037 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -70.93 -32.53 69.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.061 -1.447 . . . . 25.66 113.717 178.362 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.2 t -61.08 -38.61 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 131.231 3.813 . . . . 8.1199999999999992 111.927 169.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -67.01 -42.44 84.95 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.742 -1.599 . . . . 15.470000000000001 114.43 165.401 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.02 -37.28 74.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 117.56 2.429 . . . . 11.449999999999999 117.56 172.098 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.281 57.5 mmtt -46.26 -35.91 5.69 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 126.073 2.844 . . . . 24.98 117.712 165.398 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.2 mt -93.95 -34.47 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 117.776 -3.077 . . . . 9.4600000000000009 111.429 -172.695 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -48.01 81.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.76 0.824 . . . . 14.76 111.961 160.842 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.279 12.5 t70 -53.52 -57.76 9.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.149 1.928 . . . . 26.289999999999999 114.246 169.942 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -81.16 -51.64 8.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.659 -1.275 . . . . 30.059999999999999 112.364 -170.506 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -96.43 -42.09 8.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 116.814 -3.679 . . . . 25.190000000000001 101.791 -163.257 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.88 42.9 3.7 Favored Glycine 0 N--CA 1.43 -1.744 1 O-C-N 115.935 -4.228 . . . . 7.4100000000000001 115.852 -170.502 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 90.6 mt -111.12 120.36 43.39 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 113.393 -3.194 . . . . 9.4900000000000002 107.94 177.077 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -66.96 148.89 82.72 Favored 'Trans proline' 0 N--CA 1.434 -1.975 0 CA-C-N 125.778 3.099 . . . . 11.42 114.425 -178.093 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -74.05 -18.86 20.92 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 123.645 2.338 . . . . 12.0 117.868 -161.815 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -60.63 -18.86 55.94 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.815 2.524 . . . . 35.549999999999997 117.815 173.962 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -97.33 -12.57 22.68 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.03 2.132 . . . . 20.52 114.002 -175.139 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -98.91 141.07 32.16 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.48 -2.013 . . . . 7.1299999999999999 111.713 -169.356 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -143.73 108.1 4.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 114.015 -2.897 . . . . 36.390000000000001 107.472 -177.89 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 mt -91.78 144.96 24.96 Favored 'General case' 0 N--CA 1.43 -1.426 1 CA-C-N 126.2 4.091 . . . . 9.5500000000000007 112.837 -175.67 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 mt -128.24 138.84 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.628 1.971 . . . . 13.9 109.886 -176.935 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -122.19 112.74 18.55 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 115.082 -4.761 . . . . 6.8600000000000003 100.446 175.055 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.34 -74.96 0.07 Allowed 'General case' 0 N--CA 1.431 -1.41 1 CA-C-O 111.436 -4.126 . . . . 11.15 113.967 177.758 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.76 21.62 0.32 Allowed Glycine 0 N--CA 1.43 -1.729 1 O-C-N 130.178 4.674 . . . . 13.93 114.342 167.685 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -115.45 131.03 57.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.396 -1.705 . . . . 23.920000000000002 106.396 174.955 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -71.48 147.51 47.72 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.327 1.421 . . . . 23.23 114.593 173.924 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.445 HD12 HD21 ' A' ' 67' ' ' LEU . 21.3 mt -101.13 109.16 21.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.376 1.87 . . . . 9.1099999999999994 112.821 170.95 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -95.77 142.84 27.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 113.493 0.923 . . . . 33.439999999999998 113.493 179.186 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -22.01 -68.05 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 134.421 5.088 . . . . 28.370000000000001 118.893 179.255 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.69 62.58 4.58 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 122.54 2.427 . . . . 15.0 115.676 -174.778 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -160.91 156.59 25.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.525 -2.162 . . . . 25.5 107.834 164.156 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.316 82.8 p -82.08 150.82 27.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.39 -3.319 . . . . 11.949999999999999 114.355 -172.56 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mt -65.51 -46.21 80.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.799 -1.188 . . . . 10.17 112.882 -173.002 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -58.11 -43.64 87.3 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.279 0.987 . . . . 13.59 111.829 171.075 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -69.01 -17.11 63.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.714 -3.741 . . . . 11.699999999999999 111.186 -172.899 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.49 -17.75 38.04 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.929 2.892 . . . . 12.949999999999999 114.956 169.523 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.354 16.5 m120 87.61 39.02 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 129.311 3.045 . . . . 25.449999999999999 112.267 177.437 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -107.9 105.97 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.59 2.138 . . . . 14.6 105.932 -172.717 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.51 -162.96 0.83 Allowed 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 116.127 -4.108 . . . . 33.229999999999997 112.288 -174.861 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.252 37.9 tttp -64.37 120.93 13.16 Favored 'General case' 0 N--CA 1.431 -1.424 2 O-C-N 114.976 -4.827 . . . . 25.969999999999999 112.39 -173.741 . . . . . . . . 3 2 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 20.6 mt-10 65.23 51.79 1.56 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.494 1.918 . . . . 32.609999999999999 108.857 -174.143 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.285 63.0 m -95.45 155.44 16.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.766 2.076 . . . . 10.56 107.75 168.948 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.4 m -119.68 128.94 54.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 126.092 2.12 . . . . 5.3300000000000001 106.388 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.445 HD21 HD12 ' A' ' 50' ' ' LEU . 14.3 mt -113.44 116.36 29.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.27 1.828 . . . . 11.66 111.519 -177.41 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -93.17 125.13 37.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.489 2.404 . . . . 16.300000000000001 113.103 -175.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -101.33 123.58 45.65 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.804 2.042 . . . . 9.9600000000000009 111.062 -169.842 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.23 -178.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 126.15 2.881 . . . . 9.7599999999999998 112.747 173.76 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.7 tp -92.15 124.18 36.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.539 -3.851 . . . . 19.57 119.369 175.863 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -75.84 110.23 10.11 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 129.248 3.019 . . . . 35.079999999999998 114.217 175.298 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.272 40.3 mt -96.92 174.18 6.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.573 -2.38 . . . . 32.310000000000002 104.573 -174.444 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -92.03 46.48 1.27 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.707 -1.87 . . . . 42.75 112.686 -179.443 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.43 66.23 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.732 0 O-C-N 119.121 -2.237 . . . . 36.310000000000002 116.466 178.489 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.752 0 C-N-CA 126.606 2.051 . . . . 36.270000000000003 112.825 177.032 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 10.8 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 113.433 0.901 . . . . 17.170000000000002 113.433 . . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -94.92 125.52 39.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 113.826 1.047 . . . . 21.890000000000001 113.826 178.963 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -124.3 162.88 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.148 1.379 . . . . 10.83 112.627 167.76 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -118.62 139.81 50.9 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.82 -3.05 . . . . 10.609999999999999 107.178 176.393 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.66 118.7 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.381 1.873 . . . . 9.1300000000000008 106.152 172.086 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -116.93 143.6 45.52 Favored 'General case' 0 N--CA 1.43 -1.438 1 CA-C-O 128.74 4.114 . . . . 20.550000000000001 114.07 -171.896 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -81.88 172.78 12.91 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 114.743 -4.973 . . . . 11.779999999999999 111.472 179.767 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.2 -33.69 70.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.555 2.057 . . . . 19.309999999999999 116.555 176.787 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -72.19 -69.53 0.39 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.966 1.099 . . . . 23.140000000000001 113.966 171.547 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.14 31.8 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 118.319 -1.896 . . . . 19.739999999999998 114.305 -175.797 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -106.86 121.98 45.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.162 1.458 . . . . 21.93 112.686 176.728 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.1 m -97.37 127.94 43.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.516 -1.99 . . . . 12.33 108.841 176.951 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.75 116.8 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 102.437 -3.172 . . . . 17.079999999999998 102.437 172.757 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 m -93.38 131.73 38.28 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.913 -1.742 . . . . 16.300000000000001 109.502 173.361 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -125.61 143.26 51.1 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.833 -1.792 . . . . 15.880000000000001 109.427 -179.59 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 1' ' ' MET . 42.9 mt-10 -99.13 77.71 2.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.546 3.138 . . . . 28.899999999999999 116.342 165.183 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -104.83 147.72 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 126.72 3.152 . . . . 12.050000000000001 106.987 -177.995 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -83.82 149.1 55.96 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 117.748 -3.095 . . . . 18.170000000000002 108.712 178.391 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -88.42 -6.29 6.17 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 127.172 3.597 . . . . 8.1600000000000001 109.543 -157.38 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.7 m -84.6 -14.06 49.84 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.624 3.106 . . . . 11.130000000000001 114.49 -179.492 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -80.12 163.67 23.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.859 2.54 . . . . 18.030000000000001 117.859 -167.982 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.322 22.1 p -79.34 158.19 27.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.618 2.367 . . . . 10.220000000000001 111.621 -172.16 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.67 -36.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.224 -1.353 . . . . 12.300000000000001 107.772 178.631 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -45.16 -45.84 11.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 117.504 2.409 . . . . 36.509999999999998 117.504 160.01 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.23 -14.32 59.49 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.808 -4.307 . . . . 25.66 116.163 173.472 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.6 t -62.8 -48.94 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 124.607 2.146 . . . . 8.1199999999999992 112.377 162.334 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -63.7 -32.45 73.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.107 2.86 . . . . 15.470000000000001 112.04 178.287 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.54 -13.27 61.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.863 -2.398 . . . . 11.449999999999999 117.472 -177.007 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -79.1 -36.43 40.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.324 2.265 . . . . 24.98 115.13 166.33 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 mt -69.72 -26.26 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 121.149 -0.969 . . . . 9.4600000000000009 113.405 176.162 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -65.48 -39.83 92.4 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 112.437 -2.165 . . . . 14.76 110.539 173.366 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -70.93 -46.26 62.78 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.85 2.167 . . . . 26.289999999999999 116.85 171.394 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -76.73 -67.2 0.72 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.09 -2.256 . . . . 30.059999999999999 108.918 -171.536 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -94.17 -20.5 19.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 123.839 3.018 . . . . 25.190000000000001 107.14 -164.363 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.42 34.83 9.99 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 126.753 2.121 . . . . 7.4100000000000001 114.445 173.867 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 mt -110.91 130.62 22.75 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 118.342 -2.858 . . . . 9.4900000000000002 104.181 -169.206 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -85.15 153.26 10.94 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 112.509 -4.528 . . . . 11.42 114.485 -167.418 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -71.05 -14.48 32.05 Favored 'Trans proline' 0 N--CA 1.433 -2.045 1 C-N-CA 125.308 4.005 . . . . 12.0 113.444 -162.56 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.69 -39.12 73.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.442 0.904 . . . . 35.549999999999997 113.442 168.851 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -77.97 -26.32 48.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.79 2.885 . . . . 20.52 118.79 175.171 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -72.15 118.95 15.67 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.739 1.216 . . . . 7.1299999999999999 111.502 -177.261 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -102.97 121.43 42.52 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.455 -3.278 . . . . 36.390000000000001 105.807 169.532 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 mt -106.11 123.06 47.41 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.674 3.59 . . . . 9.5500000000000007 115.24 170.02 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -123.21 110.31 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 128.954 2.902 . . . . 13.9 114.893 -174.646 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.416 ' CD1' HG12 ' A' ' 61' ' ' ILE . 51.2 t80 -94.8 117.88 30.86 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.222 -1.399 . . . . 6.8600000000000003 107.222 169.977 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.36 -84.3 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.42 1 C-N-CA 132.35 4.26 . . . . 11.15 110.507 -169.704 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.44 31.05 1.28 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-O 124.078 1.932 . . . . 13.93 112.239 169.952 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -99.13 142.11 31.03 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.968 -3.078 . . . . 23.920000000000002 109.539 174.706 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -88.08 108.74 19.39 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 116.577 2.066 . . . . 23.23 116.577 173.405 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.339 85.4 mt -71.47 118.26 14.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.078 -2.889 . . . . 9.1099999999999994 116.907 -162.171 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -74.31 114.94 13.25 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.72 2.408 . . . . 33.439999999999998 109.271 178.423 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.32 -33.93 76.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.405 1.882 . . . . 28.370000000000001 114.472 -162.895 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.05 15.49 60.85 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 127.031 2.253 . . . . 15.0 113.37 -175.849 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -99.25 171.02 8.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 126.693 3.139 . . . . 25.5 108.961 160.928 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.9 p -102.72 -178.92 3.82 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.105 -4.122 . . . . 11.949999999999999 114.231 174.805 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.1 mt -80.64 -17.7 50.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.937 -2.977 . . . . 10.17 110.073 178.989 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t -69.48 -42.36 74.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.065 -2.272 . . . . 13.59 109.672 177.319 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -54.68 -45.22 73.89 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.87 2.468 . . . . 11.699999999999999 114.412 178.849 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -92.58 0.6 57.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.756 -2.465 . . . . 12.949999999999999 109.48 -174.616 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 50.27 51.23 17.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.973 3.709 . . . . 25.449999999999999 112.134 -171.177 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.416 HG12 ' CD1' ' A' ' 45' ' ' PHE . 16.6 mt -98.38 114.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 120.418 1.463 . . . . 14.6 107.722 179.429 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -99.54 -173.14 2.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.391 3.076 . . . . 33.229999999999997 110.785 -169.424 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -70.05 147.39 50.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.601 1.191 . . . . 25.969999999999999 109.892 -174.182 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.377 86.7 mt-10 70.89 16.41 6.58 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.187 1.795 . . . . 32.609999999999999 113.668 174.047 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.16 136.75 34.33 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 116.631 -1.652 . . . . 10.56 111.657 179.23 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.2 m -92.81 130.48 38.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 115.373 -2.251 . . . . 5.3300000000000001 110.655 -178.358 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.97 172.07 6.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.806 2.443 . . . . 11.66 110.628 166.941 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -111.99 145.16 40.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.799 2.714 . . . . 16.300000000000001 111.421 171.842 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 tp -120.11 132.97 55.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.435 -3.916 . . . . 9.9600000000000009 109.069 176.12 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.56 131.03 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.905 1.682 . . . . 9.7599999999999998 108.993 -172.87 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.6 mt -73.17 116.31 13.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.815 -1.803 . . . . 19.57 109.002 166.878 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -90.84 168.9 11.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.155 -2.355 . . . . 35.079999999999998 111.414 177.956 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.3 mt -94.9 151.42 19.22 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.678 2.486 . . . . 32.310000000000002 107.031 159.975 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.256 67.2 mtp180 -108.51 162.13 14.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.466 2.555 . . . . 42.75 110.382 179.599 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.36 62.48 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 106.275 -2.73 . . . . 36.310000000000002 106.275 -175.261 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.751 0 C-N-CA 116.807 -2.616 . . . . 36.270000000000003 110.685 169.061 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 125.768 2.699 . . . . 17.170000000000002 113.851 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -114.54 137.32 52.01 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 112.983 -6.073 . . . . 21.890000000000001 110.738 -177.7 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.3 pt -129.07 178.21 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 118.018 -2.926 . . . . 10.83 109.239 164.942 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -125.55 137.86 53.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.299 2.952 . . . . 10.609999999999999 107.91 -179.66 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.27 116.11 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 105.054 -2.202 . . . . 9.1300000000000008 105.054 167.983 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -102.97 126.31 50.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.079 2.152 . . . . 20.550000000000001 113.911 176.372 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.526 15.7 p -67.99 175.15 3.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.312 1.845 . . . . 11.779999999999999 115.43 -178.201 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.44 -45.57 45.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.276 -2.765 . . . . 19.309999999999999 114.306 177.053 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -63.85 -56.31 16.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.768 2.699 . . . . 23.140000000000001 117.065 175.56 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 54.21 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 117.963 -2.065 . . . . 19.739999999999998 115.352 172.854 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -114.08 140.8 48.18 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.426 -1.75 . . . . 21.93 110.806 165.005 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -103.67 129.91 51.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.032 2.708 . . . . 12.33 110.092 165.69 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -96.73 104.93 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 128.335 2.654 . . . . 17.079999999999998 106.223 169.431 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.2 m -79.97 114.91 19.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 120.48 1.491 . . . . 16.300000000000001 114.7 170.783 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.0 tp -121.78 133.21 54.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.647 -1.615 . . . . 15.880000000000001 113.547 -166.623 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -90.94 112.86 24.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.345 1.858 . . . . 28.899999999999999 114.612 -175.602 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.8 m -128.59 178.84 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.121 -2.862 . . . . 12.050000000000001 107.318 -168.968 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -123.94 168.14 13.5 Favored Pre-proline 0 N--CA 1.431 -1.416 0 CA-C-O 114.598 -2.62 . . . . 18.170000000000002 104.549 168.654 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.73 -14.89 43.12 Favored 'Trans proline' 0 C--N 1.3 -2.01 2 CA-C-N 129.076 4.277 . . . . 8.1600000000000001 108.853 173.311 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -93.05 -3.56 54.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.782 2.083 . . . . 11.130000000000001 115.084 -169.725 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -72.68 141.86 48.25 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.354 1.462 . . . . 18.030000000000001 108.759 -179.909 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -86.93 160.66 18.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.264 2.626 . . . . 10.220000000000001 104.525 178.722 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 mm -69.29 -30.06 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 122.593 1.187 . . . . 12.300000000000001 112.849 177.675 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -65.94 -41.83 90.81 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.52 2.728 . . . . 36.509999999999998 110.532 177.539 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -66.52 -43.28 85.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.712 -1.959 . . . . 25.66 105.712 -179.918 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.79 -45.77 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 125.876 1.67 . . . . 8.1199999999999992 114.004 -178.051 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -57.6 -33.19 67.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.622 2.153 . . . . 15.470000000000001 113.09 172.532 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.46 -26.89 60.32 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.674 1.731 . . . . 11.449999999999999 115.674 179.355 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.315 52.6 mttp -75.07 -31.74 61.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.84 -2.344 . . . . 24.98 112.277 171.944 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.1 mt -63.71 -34.51 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 124.898 2.285 . . . . 9.4600000000000009 116.554 175.326 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -62.19 -41.81 98.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.135 -1.848 . . . . 14.76 113.419 165.592 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.49 -48.3 41.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.087 -1.633 . . . . 26.289999999999999 112.969 -179.263 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -60.83 -66.82 0.47 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.121 -2.237 . . . . 30.059999999999999 114.022 174.146 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.411 ' HB2' HG13 ' A' ' 36' ' ' ILE . 60.5 mm-40 -87.37 -26.69 23.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.809 -3.057 . . . . 25.190000000000001 111.243 -162.499 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.29 11.35 48.86 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 119.341 -1.409 . . . . 7.4100000000000001 114.086 -178.672 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.411 HG13 ' HB2' ' A' ' 34' ' ' GLU . 49.2 mt -80.79 130.7 62.92 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 117.461 -3.376 . . . . 9.4900000000000002 111.596 -168.421 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -74.02 147.75 39.04 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 128.126 3.938 . . . . 11.42 113.066 -167.383 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.48 -16.59 24.27 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 CA-C-N 122.903 2.073 . . . . 12.0 113.4 -174.935 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.63 -30.53 70.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.622 -3.799 . . . . 35.549999999999997 118.285 163.647 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -75.46 -21.6 57.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.3 1.409 . . . . 20.52 113.392 177.819 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -83.43 114.9 21.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 115.947 -1.978 . . . . 7.1299999999999999 111.634 -160.58 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -119.37 108.1 14.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.401 2.524 . . . . 36.390000000000001 114.227 164.893 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mt -88.54 129.81 35.38 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.762 2.22 . . . . 9.5500000000000007 109.363 179.218 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 mt -116.83 139.71 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 119.182 -2.199 . . . . 13.9 106.027 177.052 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -126.53 112.14 15.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.013 -1.477 . . . . 6.8600000000000003 107.013 172.814 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.271 . . 81.29 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.938 1.695 . . . . 11.15 111.194 -174.537 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.12 43.39 0.23 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.304 -1.498 . . . . 13.93 116.181 173.993 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.28 155.09 46.98 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.148 2.579 . . . . 23.920000000000002 111.42 164.58 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.262 9.3 tt0 -79.93 129.58 34.61 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.3 -2.125 . . . . 23.23 111.953 -176.727 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.252 98.4 mt -83.71 121.51 27.38 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.685 -1.884 . . . . 9.1099999999999994 109.916 172.704 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -99.14 154.51 18.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.437 -1.69 . . . . 33.439999999999998 106.437 -168.534 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.09 -32.04 71.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.281 2.326 . . . . 28.370000000000001 117.281 -162.438 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.95 21.66 43.75 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 120.788 1.631 . . . . 15.0 112.065 -169.673 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -118.36 -179.48 3.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.369 -1.665 . . . . 25.5 113.858 164.225 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.7 p -108.91 176.27 5.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.897 2.76 . . . . 11.949999999999999 118.332 178.01 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.6 mt -71.03 -35.02 71.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 113.775 -1.557 . . . . 10.17 113.223 176.026 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -57.3 -45.93 83.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.668 1.987 . . . . 13.59 113.667 165.756 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -61.99 -35.33 78.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.495 2.718 . . . . 11.699999999999999 114.757 175.056 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.4 -4.19 42.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 114.666 -2.587 . . . . 12.949999999999999 111.976 -174.638 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.2 m120 72.79 43.4 0.43 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 123.539 2.882 . . . . 25.449999999999999 110.396 173.831 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -102.99 115.62 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.383 -2.073 . . . . 14.6 111.349 179.936 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -95.82 -177.89 4.19 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.161 1.934 . . . . 33.229999999999997 111.79 175.207 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.258 21.7 ptmt -53.75 138.15 36.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 131.163 3.785 . . . . 25.969999999999999 116.686 175.747 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 71.89 24.53 3.31 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 123.118 1.437 . . . . 32.609999999999999 113.243 171.897 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -92.89 142.5 27.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.983 -1.073 . . . . 10.56 112.071 -178.774 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -101.89 97.91 8.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.244 2.618 . . . . 5.3300000000000001 112.713 -172.973 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.6 mp -84.48 145.55 28.07 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.73 2.519 . . . . 11.66 110.478 174.924 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -109.02 134.03 52.2 Favored 'General case' 0 N--CA 1.43 -1.425 1 O-C-N 115.646 -4.408 . . . . 16.300000000000001 100.537 -169.768 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.78 125.75 51.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.607 1.194 . . . . 9.9600000000000009 109.729 170.979 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.6 t -113.79 152.3 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 126.738 3.161 . . . . 9.7599999999999998 106.329 179.947 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.1 mt -121.47 111.56 17.44 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.678 -2.514 . . . . 19.57 110.97 -179.306 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.18 161.7 18.56 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.115 3.366 . . . . 35.079999999999998 111.026 -172.498 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.2 mt -80.36 159.15 25.84 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.615 -4.428 . . . . 32.310000000000002 109.823 171.28 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -84.42 132.74 34.54 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.357 -3.34 . . . . 42.75 117.698 -164.3 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.5 -105.42 0.19 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 126.653 3.363 . . . . 36.310000000000002 118.29 -172.068 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.783 0 CA-C-O 114.64 -3.311 . . . . 36.270000000000003 111.23 -173.092 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 127.171 3.367 . . . . 17.170000000000002 104.451 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -93.22 123.7 36.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.234 -2.257 . . . . 21.890000000000001 105.241 177.924 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -117.59 166.96 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 118.322 -2.736 . . . . 10.83 106.414 170.149 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.86 100.94 7.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.411 -3.306 . . . . 10.609999999999999 115.01 -176.049 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.44 105.89 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 118.89 -2.381 . . . . 9.1300000000000008 109.394 -163.265 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -99.45 132.69 44.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.612 -1.176 . . . . 20.550000000000001 111.042 -172.345 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 p -98.11 -177.88 3.88 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.226 2.21 . . . . 11.779999999999999 113.194 -178.555 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 mt -83.6 -33.52 25.33 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.838 -2.414 . . . . 19.309999999999999 111.637 -164.304 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 p -88.49 -66.79 0.88 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.73 2.012 . . . . 23.140000000000001 112.523 -177.038 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.24 48.76 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 117.505 -2.283 . . . . 19.739999999999998 109.665 -174.031 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -136.07 119.37 16.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.012 2.339 . . . . 21.93 105.506 176.379 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -92.23 106.87 18.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.376 2.989 . . . . 12.33 111.832 163.666 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 mt -88.46 114.89 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.661 -2.063 . . . . 17.079999999999998 106.308 -179.717 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -94.18 125.14 38.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.698 -0.482 . . . . 16.300000000000001 109.698 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 tp -153.8 135.86 14.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.965 -2.959 . . . . 15.880000000000001 115.212 -157.232 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.9 97.32 11.11 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 132.398 4.279 . . . . 28.899999999999999 117.021 -177.287 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.69 150.57 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.674 2.39 . . . . 12.050000000000001 111.714 179.158 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -87.04 152.77 53.77 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 112.867 -3.444 . . . . 18.170000000000002 109.394 176.671 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -71.99 -23.49 21.76 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 CA-C-N 123.321 2.222 . . . . 8.1600000000000001 112.949 173.682 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -81.44 2.27 29.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.97 3.919 . . . . 11.130000000000001 113.821 168.22 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -72.05 148.48 45.78 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 124.529 3.332 . . . . 18.030000000000001 110.887 165.08 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 73.4 p -84.54 173.25 10.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.767 -1.833 . . . . 10.220000000000001 109.522 177.344 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -63.43 -23.18 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 124.525 2.107 . . . . 12.300000000000001 112.263 168.407 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -80.88 -37.93 28.92 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.031 -4.168 . . . . 36.509999999999998 109.749 176.433 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.321 17.1 m120 -73.68 -35.12 65.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.62 -1.3 . . . . 25.66 112.26 179.773 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.489 81.4 t -45.83 -59.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 129.937 3.295 . . . . 8.1199999999999992 113.619 163.106 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HZ1' ' CG ' ' A' ' 52' ' ' ASP . 28.9 mtmt -60.67 -30.53 69.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.177 3.391 . . . . 15.470000000000001 113.051 174.144 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.7 -42.59 88.99 Favored 'General case' 0 N--CA 1.429 -1.48 1 CA-C-O 131.011 5.196 . . . . 11.449999999999999 118.047 163.297 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -75.5 -35.97 60.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.72 -3.737 . . . . 24.98 111.764 -179.065 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mt -64.57 -41.87 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 125.381 1.675 . . . . 9.4600000000000009 114.53 168.46 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -50.16 -57.88 6.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.66 2.171 . . . . 14.76 115.421 174.545 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -47.81 -60.96 2.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.546 3.538 . . . . 26.289999999999999 114.627 167.962 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -65.73 -58.4 5.76 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.252 1.025 . . . . 30.059999999999999 109.975 -168.737 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -83.93 -48.81 9.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.807 2.151 . . . . 25.190000000000001 116.807 179.988 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.08 9.86 5.94 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 129.683 3.516 . . . . 7.4100000000000001 112.617 179.424 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mt -85.81 128.93 56.5 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-N 121.356 2.578 . . . . 9.4900000000000002 108.115 -162.799 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.83 153.86 29.75 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 CA-C-O 109.941 -4.275 . . . . 11.42 114.439 -166.732 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.6 -24.1 26.22 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 124.13 3.22 . . . . 12.0 117.671 -168.881 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.521 ' HB2' ' HD2' ' A' ' 74' ' ' ARG . 12.2 p-10 -80.63 -6.68 58.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.338 3.055 . . . . 35.549999999999997 112.733 171.843 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -93.46 -36.79 12.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.298 -2.126 . . . . 20.52 111.412 169.565 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -72.51 144.78 47.88 Favored 'General case' 0 N--CA 1.429 -1.48 1 N-CA-C 123.509 4.633 . . . . 7.1299999999999999 123.509 179.975 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -160.74 135.41 7.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.776 -0.824 . . . . 36.390000000000001 108.776 175.465 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.7 mt -117.51 116.44 27.14 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.149 1.928 . . . . 9.5500000000000007 108.6 -170.372 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 70' ' ' VAL . 33.9 mt -110.52 133.54 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 126.767 2.027 . . . . 13.9 111.066 175.117 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -118.37 118.95 33.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 102.269 -3.234 . . . . 6.8600000000000003 102.269 177.854 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.92 -62.69 0.07 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.263 3.425 . . . . 11.15 118.32 -176.551 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.99 7.89 0.79 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 115.895 1.118 . . . . 13.93 115.895 178.684 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -153.81 154.89 34.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.741 2.686 . . . . 23.920000000000002 105.76 177.84 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -66.76 150.04 49.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.377 3.471 . . . . 23.23 113.648 -179.227 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 mt -112.61 134.47 54.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.481 2.312 . . . . 9.1099999999999994 105.519 -173.986 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -97.55 130.67 44.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.835 2.731 . . . . 33.439999999999998 111.248 -171.524 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -34.2 -42.95 0.14 Allowed 'General case' 0 N--CA 1.43 -1.445 1 N-CA-C 122.704 4.335 . . . . 28.370000000000001 122.704 178.365 . . . . . . . . 4 4 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.95 -15.84 69.05 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.237 -1.539 . . . . 15.0 113.664 -168.485 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -87.73 147.18 25.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.36 2.664 . . . . 25.5 109.845 178.175 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 37.6 p -81.88 163.77 22.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.303 2.241 . . . . 11.949999999999999 110.088 173.017 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.2 mt -61.29 -37.31 82.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.674 1.702 . . . . 10.17 115.43 171.798 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.9 m -45.77 -46.17 15.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.36 -3.338 . . . . 13.59 118.448 161.888 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -55.98 -13.6 2.01 Favored 'General case' 0 N--CA 1.43 -1.463 2 O-C-N 114.084 -5.385 . . . . 11.699999999999999 118.058 166.044 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -121.17 -7.73 9.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 115.894 -2.003 . . . . 12.949999999999999 107.134 -174.352 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.4 m120 74.58 34.68 0.74 Allowed 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 135.935 5.694 . . . . 25.449999999999999 107.955 176.664 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -82.6 106.42 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.42 -1.696 . . . . 14.6 106.42 -175.827 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -92.01 -175.39 4.08 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.468 2.707 . . . . 33.229999999999997 113.725 174.944 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -58.65 153.13 17.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.276 -3.39 . . . . 25.969999999999999 115.023 179.6 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 74.66 -1.16 3.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 125.996 2.06 . . . . 32.609999999999999 115.332 171.356 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.3 m -61.51 141.94 57.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 120.517 3.525 . . . . 10.56 120.517 178.05 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.3 m -98.63 109.76 22.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.085 2.116 . . . . 5.3300000000000001 107.628 -170.604 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mt -110.25 141.29 43.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.173 -2.158 . . . . 11.66 105.173 -173.278 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -104.91 118.83 37.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.06 1.41 . . . . 16.300000000000001 109.967 -177.539 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -95.55 99.24 11.14 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.814 2.446 . . . . 9.9600000000000009 108.273 176.572 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 44' ' ' ILE . 61.7 t -87.1 110.26 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.986 3.315 . . . . 9.7599999999999998 111.06 174.124 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.77 112.94 20.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.592 -2.744 . . . . 19.57 103.592 -178.137 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -129.1 168.4 16.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.859 1.429 . . . . 35.079999999999998 114.859 -172.324 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.258 78.5 mt -90.52 156.18 18.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.408 -1.758 . . . . 32.310000000000002 111.072 173.672 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.521 ' HD2' ' HB2' ' A' ' 39' ' ' ASP . 60.4 ttt180 -82.09 109.47 16.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.528 3.018 . . . . 42.75 115.138 -171.841 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.25 -70.22 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 O-C-N 117.935 -2.978 . . . . 36.310000000000002 110.409 177.64 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.77 0 N-CA-C 105.869 -2.893 . . . . 36.270000000000003 105.869 -174.561 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 111.202 0.075 . . . . 17.170000000000002 111.202 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -104.44 141.48 36.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.043 -2.286 . . . . 21.890000000000001 109.741 178.158 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 pt -119.56 159.84 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 131.295 3.838 . . . . 10.83 108.694 170.984 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -114.58 92.06 3.83 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.094 2.158 . . . . 10.609999999999999 107.123 -175.139 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.442 HG11 ' HB2' ' A' ' 69' ' ' LEU . 80.0 t -93.74 108.61 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.112 -2.242 . . . . 9.1300000000000008 106.952 175.765 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -102.96 145.09 30.38 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 122.729 1.252 . . . . 20.550000000000001 113.697 -171.706 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.8 p -90.94 171.89 8.97 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.744 -2.074 . . . . 11.779999999999999 110.81 177.145 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.95 -51.66 68.33 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 129.116 4.01 . . . . 19.309999999999999 115.16 171.351 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.251 78.9 p -46.33 -48.98 18.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 125.274 3.67 . . . . 23.140000000000001 113.186 161.24 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.19 52.62 0.56 Allowed Glycine 0 N--CA 1.43 -1.72 1 C-N-CA 132.526 4.869 . . . . 19.739999999999998 108.909 176.138 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -84.98 132.18 34.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.618 -2.033 . . . . 21.93 106.512 161.826 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -103.65 110.06 21.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 128.342 3.925 . . . . 12.33 109.733 -178.468 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.8 mt -81.54 109.31 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 O-C-N 112.222 -6.549 . . . . 17.079999999999998 105.751 177.651 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 p -83.14 66.27 8.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.958 2.103 . . . . 16.300000000000001 108.532 -178.23 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.29 127.12 39.95 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.764 -3.085 . . . . 15.880000000000001 116.744 -164.313 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -103.51 102.46 12.36 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.595 -4.44 . . . . 28.899999999999999 115.663 -163.72 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 17' ' ' VAL . 15.9 m -125.0 167.96 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.734 1.255 . . . . 12.050000000000001 109.455 -172.106 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.289 27.8 mt-10 -98.15 170.6 6.84 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 118.369 -2.707 . . . . 18.170000000000002 108.898 161.568 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.15 -4.35 9.56 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 O-C-N 117.288 -2.006 . . . . 8.1600000000000001 108.673 -175.038 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 m -95.03 18.69 11.62 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.112 -1.44 . . . . 11.130000000000001 107.112 178.908 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -93.7 139.42 30.83 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.52 -1.987 . . . . 18.030000000000001 108.779 175.143 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 p -84.72 165.77 17.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.05 1.295 . . . . 10.220000000000001 114.198 173.809 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.5 mm -71.95 -27.38 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.904 2.082 . . . . 12.300000000000001 106.869 -167.346 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -58.73 -50.09 75.22 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.929 2.892 . . . . 36.509999999999998 116.848 167.354 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -69.78 -22.11 63.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.584 2.809 . . . . 25.66 118.584 169.608 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.307 21.1 t -66.0 -55.93 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 C-N-CA 132.041 4.136 . . . . 8.1199999999999992 107.522 166.791 . . . . . . . . 3 2 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -61.88 -44.29 97.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.441 2.385 . . . . 15.470000000000001 117.441 173.059 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.57 -32.05 64.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.602 -2.561 . . . . 11.449999999999999 113.676 174.093 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -66.68 -38.78 87.5 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.445 3.022 . . . . 24.98 110.677 176.206 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -70.36 -33.87 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.998 -2.939 . . . . 9.4600000000000009 113.877 177.963 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.291 27.3 tt0 -52.81 -49.82 64.89 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.845 3.212 . . . . 14.76 113.83 171.915 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.66 -53.44 47.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.891 2.876 . . . . 26.289999999999999 112.92 174.039 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -68.27 -76.09 0.09 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.063 2.945 . . . . 30.059999999999999 112.185 -179.224 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.95 -51.4 67.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 124.625 3.375 . . . . 25.190000000000001 118.356 175.041 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.01 28.92 9.46 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.221 -1.549 . . . . 7.4100000000000001 113.63 -174.741 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mt -96.67 117.54 65.89 Favored Pre-proline 0 N--CA 1.429 -1.513 0 C-N-CA 131.537 3.935 . . . . 9.4900000000000002 105.205 177.114 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -69.04 158.34 58.28 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 CA-C-N 125.503 3.001 . . . . 11.42 112.45 -171.731 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.36 -24.12 8.11 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 122.485 2.123 . . . . 12.0 112.017 -149.649 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.98 -17.0 64.39 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.294 2.638 . . . . 35.549999999999997 113.295 -173.905 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -92.61 -26.0 18.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.63 1.972 . . . . 20.52 115.108 -172.905 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -70.88 86.74 0.7 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 121.063 3.727 . . . . 7.1299999999999999 121.063 -179.243 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.411 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 20.6 ttt180 -79.17 112.17 16.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.839 -3.663 . . . . 36.390000000000001 117.439 167.146 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.16 109.44 20.84 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 116.007 -4.183 . . . . 9.5500000000000007 112.013 -173.932 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mm -103.67 125.95 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 118.764 -2.46 . . . . 13.9 110.047 176.732 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -102.65 117.86 35.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.644 -2.071 . . . . 6.8600000000000003 106.121 166.714 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.7 -110.93 0.53 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.935 -2.353 . . . . 11.15 113.01 178.14 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.95 17.12 25.12 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 118.984 -1.579 . . . . 13.93 113.498 168.187 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -119.83 139.3 52.57 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.27 3.428 . . . . 23.920000000000002 108.519 -161.588 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -104.71 128.03 52.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.418 -2.808 . . . . 23.23 103.418 -166.487 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.65 128.75 35.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.097 -2.877 . . . . 9.1099999999999994 111.749 -176.844 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.256 43.1 mt-10 -107.28 158.66 16.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 117.479 -1.688 . . . . 33.439999999999998 111.092 -176.716 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -58.54 -53.46 58.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.468 3.507 . . . . 28.370000000000001 113.956 -155.264 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.81 -2.91 71.45 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 113.548 -1.66 . . . . 15.0 111.887 -161.936 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -88.28 155.26 19.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 113.889 -2.958 . . . . 25.5 113.583 166.383 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.0 p -92.72 173.05 7.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.565 2.346 . . . . 11.949999999999999 114.198 178.923 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.52 -46.0 47.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.782 2.512 . . . . 10.17 117.782 160.216 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -54.86 -46.38 74.67 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.739 2.816 . . . . 13.59 117.291 170.912 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -48.2 -63.94 0.93 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.566 1.946 . . . . 11.699999999999999 109.56 172.438 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -73.36 3.96 5.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.215 -2.326 . . . . 12.949999999999999 116.015 179.726 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.468 66.8 t30 67.72 54.0 0.67 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.555 3.034 . . . . 25.449999999999999 112.42 171.114 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.71 103.47 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 127.051 2.14 . . . . 14.6 111.636 -174.647 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -68.25 168.58 12.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.224 3.81 . . . . 33.229999999999997 106.561 174.293 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.34 154.2 14.01 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.424 1.639 . . . . 25.969999999999999 115.424 172.293 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 56.75 41.1 28.68 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.808 2.567 . . . . 32.609999999999999 114.873 176.802 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.263 47.2 m -86.78 126.9 34.91 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.489 1.916 . . . . 10.56 108.607 173.326 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -72.52 127.15 31.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 117.088 -1.845 . . . . 5.3300000000000001 115.212 163.748 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mt -114.62 164.86 13.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.702 3.62 . . . . 11.66 111.851 159.627 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -120.45 121.31 38.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.875 -2.639 . . . . 16.300000000000001 103.875 -172.886 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.442 ' HB2' HG11 ' A' ' 5' ' ' VAL . 11.6 tp -91.47 108.74 20.1 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.247 -2.131 . . . . 9.9600000000000009 105.247 173.201 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.411 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 19.3 t -96.61 144.28 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.056 2.836 . . . . 9.7599999999999998 107.224 168.931 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.0 mt -115.8 115.78 26.87 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.514 -3.866 . . . . 19.57 111.333 -179.087 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -121.87 -178.68 3.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.762 -1.563 . . . . 35.079999999999998 107.296 -177.126 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 mt -107.56 171.92 7.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.806 2.717 . . . . 32.310000000000002 103.739 164.978 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -76.12 138.19 40.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 112.296 -2.229 . . . . 42.75 111.766 -173.5 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.6 -119.99 0.69 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 106.896 -2.482 . . . . 36.310000000000002 106.896 -179.193 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.77 1 CA-C-O 108.926 -6.486 . . . . 36.270000000000003 108.461 -165.677 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptt? . . . . . 0 CA--C 1.491 -1.323 0 CA-C-O 124.233 1.968 . . . . 17.170000000000002 108.446 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -98.47 140.8 32.17 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.011 -2.931 . . . . 21.890000000000001 109.778 176.838 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.2 pp -131.16 166.4 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 112.22 -2.264 . . . . 10.83 109.403 168.02 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.3 145.79 42.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.786 -3.071 . . . . 10.609999999999999 108.692 177.659 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.413 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 2.9 t -102.43 118.55 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.358 2.663 . . . . 9.1300000000000008 112.724 163.935 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -111.68 110.9 21.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.391 2.996 . . . . 20.550000000000001 112.488 179.271 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.8 p -76.72 171.26 15.0 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.647 -4.408 . . . . 11.779999999999999 113.102 -170.179 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mt -52.8 -54.26 36.66 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.898 -1.049 . . . . 19.309999999999999 111.506 174.778 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.4 p -56.93 -31.5 65.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.575 2.35 . . . . 23.140000000000001 116.86 167.989 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.91 27.28 4.36 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 120.006 -1.684 . . . . 19.739999999999998 113.685 168.219 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -80.24 131.84 35.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 121.05 2.425 . . . . 21.93 105.074 175.978 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -85.42 109.5 18.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.082 2.153 . . . . 12.33 112.452 163.85 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 4.1 mt -103.06 123.43 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 114.806 -1.088 . . . . 17.079999999999998 108.786 171.949 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -84.74 121.82 28.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 117.24 -1.362 . . . . 16.300000000000001 112.341 173.852 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 tp -129.91 121.17 26.11 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.126 1.37 . . . . 15.880000000000001 110.7 -172.959 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -87.5 122.76 31.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.768 1.747 . . . . 28.899999999999999 108.873 173.204 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.44 149.68 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 129.707 3.203 . . . . 12.050000000000001 108.782 -179.491 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -87.0 149.01 46.72 Favored Pre-proline 0 N--CA 1.43 -1.426 0 C-N-CA 127.253 2.221 . . . . 18.170000000000002 106.248 166.683 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -73.55 -15.03 24.8 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 115.847 -2.302 . . . . 8.1600000000000001 111.44 -173.983 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -87.73 3.65 47.21 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 116.028 -4.17 . . . . 11.130000000000001 118.02 172.831 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.3 150.8 35.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.346 -1.471 . . . . 18.030000000000001 113.092 167.654 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 24.8 p -96.01 177.67 5.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.395 1.685 . . . . 10.220000000000001 109.438 -172.729 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.48 -23.73 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 121.424 1.92 . . . . 12.300000000000001 113.344 -177.019 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -52.5 -48.51 65.94 Favored 'General case' 0 N--CA 1.431 -1.394 1 C-N-CA 133.101 4.561 . . . . 36.509999999999998 111.021 158.071 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -72.01 -27.39 62.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.65 2.093 . . . . 25.66 116.65 179.661 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -73.2 -41.06 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 128.081 2.552 . . . . 8.1199999999999992 112.563 175.958 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -59.63 -31.01 69.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 117.25 -1.357 . . . . 15.470000000000001 111.886 165.085 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.85 -41.84 67.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.931 1.395 . . . . 11.449999999999999 109.669 -177.822 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.285 21.1 mmtp -63.38 -28.12 69.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.814 3.246 . . . . 24.98 113.059 173.96 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.7 mt -87.48 -41.71 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 1 O-C-N 113.91 -5.494 . . . . 9.4600000000000009 112.726 178.973 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -46.22 -47.14 17.94 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.847 -2.408 . . . . 14.76 114.806 159.126 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.31 -25.51 61.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.015 1.857 . . . . 26.289999999999999 116.015 -178.437 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -87.73 -52.81 5.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 116.914 2.19 . . . . 30.059999999999999 116.914 178.837 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -98.77 -25.28 14.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.085 1.354 . . . . 25.190000000000001 112.011 -168.832 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.01 17.11 28.56 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 118.262 -1.299 . . . . 7.4100000000000001 115.267 168.276 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.2 mt -94.77 126.5 47.05 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 130.715 3.606 . . . . 9.4900000000000002 108.254 -168.855 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.51 139.68 54.59 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 124.322 3.348 . . . . 11.42 113.349 -179.504 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.04 -2.63 12.79 Favored 'Trans proline' 0 C--N 1.3 -2.019 1 C-N-CA 126.415 4.743 . . . . 12.0 114.108 -166.538 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.273 9.5 p-10 -84.61 -31.98 23.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 122.678 2.49 . . . . 35.549999999999997 111.182 174.178 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.91 -13.17 60.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.041 2.088 . . . . 20.52 114.183 -179.274 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -88.98 121.62 31.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 111.504 -2.589 . . . . 7.1299999999999999 114.677 177.924 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -111.95 118.09 34.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 115.544 -2.169 . . . . 36.390000000000001 113.66 166.034 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.7 mt -109.93 123.48 49.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.335 1.647 . . . . 9.5500000000000007 108.142 -174.376 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.14 127.09 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.946 2.098 . . . . 13.9 106.731 -174.813 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -103.77 114.11 28.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.58 -1.637 . . . . 6.8600000000000003 106.58 169.061 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.01 -96.98 0.05 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.92 2.488 . . . . 11.15 110.338 178.115 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.82 -7.71 17.07 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 125.37 1.462 . . . . 13.93 115.781 173.865 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -90.89 130.62 36.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 128.426 3.965 . . . . 23.920000000000002 108.429 -171.131 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -98.52 157.96 15.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 111.285 -2.689 . . . . 23.23 104.812 166.947 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.3 mt -122.01 166.48 14.42 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.619 -1.628 . . . . 9.1099999999999994 111.533 -155.9 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.27 176.94 5.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.141 -1.429 . . . . 33.439999999999998 107.141 166.569 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -102.44 -53.14 2.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.372 1.469 . . . . 28.370000000000001 111.043 -168.135 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.04 16.38 7.23 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 118.791 2.276 . . . . 15.0 118.791 -170.139 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -116.62 153.55 32.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.514 1.925 . . . . 25.5 110.938 -173.142 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 20.3 p -88.57 170.67 10.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 113.851 1.056 . . . . 11.949999999999999 113.851 -173.328 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.52 -31.25 71.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.774 1.749 . . . . 10.17 108.418 177.69 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -70.48 -43.2 70.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.101 1.76 . . . . 13.59 111.78 -175.928 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -59.39 -28.11 66.6 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 128.467 3.984 . . . . 11.699999999999999 118.24 176.884 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -82.06 -27.11 33.15 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 113.558 -5.714 . . . . 12.949999999999999 121.078 169.784 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 t30 71.95 48.66 0.27 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.508 2.575 . . . . 25.449999999999999 117.372 -157.503 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mt -94.75 99.66 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 118.452 -2.655 . . . . 14.6 104.995 174.35 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.45 -175.73 2.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.701 -1.874 . . . . 33.229999999999997 107.134 -165.121 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.305 20.3 pttm -67.13 148.38 51.91 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 120.295 1.407 . . . . 25.969999999999999 112.247 -178.396 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 76.57 7.22 3.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.557 2.343 . . . . 32.609999999999999 114.451 178.962 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 t -63.96 140.68 58.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.689 1.366 . . . . 10.56 114.689 -177.488 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 m -93.9 104.21 16.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.517 -3.239 . . . . 5.3300000000000001 113.117 170.949 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.7 mt -84.45 128.18 34.44 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 114.531 -5.106 . . . . 11.66 110.131 169.718 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -106.22 125.27 50.79 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.374 -2.079 . . . . 16.300000000000001 111.668 -172.183 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.25 12.1 tp -92.22 134.16 35.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.764 -1.569 . . . . 9.9600000000000009 106.764 -177.961 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.1 t -116.31 112.04 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 126.709 3.147 . . . . 9.7599999999999998 109.153 162.407 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.0 tp -97.57 112.68 24.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.811 -2.431 . . . . 19.57 114.022 -167.382 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -156.27 -161.58 1.15 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.408 -2.683 . . . . 35.079999999999998 106.013 -158.548 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.3 mt -110.69 166.05 11.33 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.892 -4.88 . . . . 32.310000000000002 110.582 171.296 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -57.79 131.95 51.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.123 2.268 . . . . 42.75 117.123 -176.603 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.38 -114.29 1.38 Allowed Glycine 0 N--CA 1.43 -1.753 0 CA-C-O 125.982 2.99 . . . . 36.310000000000002 107.453 -173.385 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.729 0 CA-C-N 111.195 -2.503 . . . . 36.270000000000003 113.022 -179.981 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 123.624 1.678 . . . . 17.170000000000002 112.04 . . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -101.79 131.09 48.3 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.583 -4.448 . . . . 21.890000000000001 109.057 -171.584 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -116.81 156.78 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.469 -3.269 . . . . 10.83 105.089 162.686 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -120.28 126.32 50.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.94 2.781 . . . . 10.609999999999999 108.629 -178.513 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.49 105.86 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 119.17 -2.206 . . . . 9.1300000000000008 112.826 -179.32 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -92.42 151.12 20.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.56 -1.338 . . . . 20.550000000000001 112.289 -176.264 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -104.18 -166.57 1.26 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.098 1.759 . . . . 11.779999999999999 113.383 -178.003 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.35 -62.48 1.38 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 115.57 -2.157 . . . . 19.309999999999999 114.1 172.23 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.2 p -63.19 -35.14 79.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.319 2.647 . . . . 23.140000000000001 111.576 177.898 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.49 53.87 0.67 Allowed Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 127.029 3.572 . . . . 19.739999999999998 111.769 167.209 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -89.44 139.58 30.37 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.563 -4.492 . . . . 21.93 102.121 162.216 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.1 m -83.48 110.68 18.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 115.813 -2.042 . . . . 12.33 113.457 161.399 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -88.04 123.99 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 126.197 2.185 . . . . 17.079999999999998 107.238 169.858 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.7 m -94.45 115.43 27.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.751 -1.203 . . . . 16.300000000000001 107.751 177.883 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -109.37 134.42 51.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.592 -3.817 . . . . 15.880000000000001 115.71 168.782 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.69 109.12 20.93 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.599 -2.0 . . . . 28.899999999999999 105.599 175.217 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -121.6 152.06 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 C-N-CA 133.583 4.753 . . . . 12.050000000000001 112.388 -177.015 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -90.4 146.25 34.16 Favored Pre-proline 0 N--CA 1.429 -1.495 0 O-C-N 117.805 -3.059 . . . . 18.170000000000002 108.288 164.546 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.3 -18.4 62.4 Favored 'Trans proline' 0 C--N 1.299 -2.06 1 C-N-CA 128.245 5.964 . . . . 8.1600000000000001 111.788 172.758 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.7 p -83.9 -7.42 59.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.791 1.636 . . . . 11.130000000000001 110.113 174.607 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -81.01 165.88 21.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.078 2.672 . . . . 18.030000000000001 111.606 178.448 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 p -85.36 164.24 18.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.948 2.899 . . . . 10.220000000000001 113.365 168.395 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.0 mm -67.28 -35.61 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.355 1.862 . . . . 12.300000000000001 110.199 178.914 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -50.91 -48.95 60.44 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.16 -2.213 . . . . 36.509999999999998 115.998 168.11 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.98 -32.79 71.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.941 -3.6 . . . . 25.66 118.203 169.281 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.91 -54.31 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 124.966 1.306 . . . . 8.1199999999999992 108.273 169.654 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -56.95 -36.72 70.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.006 2.225 . . . . 15.470000000000001 117.006 178.349 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.29 -24.12 64.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.05 2.982 . . . . 11.449999999999999 119.05 173.078 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -69.99 -56.99 5.54 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.514 -1.991 . . . . 24.98 113.096 173.516 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -51.42 -46.85 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 127.228 2.211 . . . . 9.4600000000000009 110.517 169.394 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -49.49 -41.93 42.08 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.427 2.01 . . . . 14.76 116.427 171.894 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -81.01 -77.53 0.2 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.905 3.241 . . . . 26.289999999999999 106.352 -178.893 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -64.4 -42.01 96.33 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.519 -5.113 . . . . 30.059999999999999 114.148 -162.574 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -94.61 -43.04 8.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.169 -3.457 . . . . 25.190000000000001 115.316 178.897 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.18 41.62 3.69 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.018 -2.301 . . . . 7.4100000000000001 114.863 176.609 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -109.55 113.15 58.34 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 103.952 -2.61 . . . . 9.4900000000000002 103.952 168.351 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_exo -57.7 159.3 17.51 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 C-N-CA 126.424 4.749 . . . . 11.42 112.953 -173.726 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -86.42 -1.34 8.39 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 124.8 3.667 . . . . 12.0 112.22 -169.916 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -87.39 -26.86 23.11 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.397 2.936 . . . . 35.549999999999997 111.747 169.319 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.03 -31.05 71.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.352 1.612 . . . . 20.52 115.352 175.03 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -83.44 136.23 34.39 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.441 2.015 . . . . 7.1299999999999999 116.441 -173.726 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -132.07 143.36 49.97 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 115.198 -2.601 . . . . 36.390000000000001 110.143 140.763 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.7 mt -94.05 128.31 40.34 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.792 -2.004 . . . . 9.5500000000000007 111.824 -178.51 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.416 HD11 ' HG2' ' A' ' 49' ' ' GLN . 43.5 mm -113.4 138.47 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 107.367 -1.346 . . . . 13.9 107.367 -176.596 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -114.89 100.99 8.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.274 2.464 . . . . 6.8600000000000003 109.797 171.251 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.501 . . 82.34 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.626 -3.796 . . . . 11.15 110.646 172.919 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.04 3.47 6.86 Favored Glycine 0 N--CA 1.429 -1.768 0 CA-C-N 113.262 -1.79 . . . . 13.93 112.745 159.367 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -89.03 124.88 34.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 120.727 2.264 . . . . 23.920000000000002 113.193 178.798 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.416 ' HG2' HD11 ' A' ' 44' ' ' ILE . 4.0 mt-30 -89.82 118.88 29.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.245 -2.159 . . . . 23.23 110.616 179.817 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.98 159.37 31.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.109 2.385 . . . . 9.1099999999999994 110.117 -164.843 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.42 142.19 50.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.742 -1.572 . . . . 33.439999999999998 113.98 175.942 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.04 -45.31 95.31 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 122.535 4.272 . . . . 28.370000000000001 122.535 -162.678 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.24 -4.78 31.27 Favored Glycine 0 N--CA 1.43 -1.721 1 N-CA-C 124.44 4.536 . . . . 15.0 124.44 172.71 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -100.37 171.75 7.57 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.36 2.029 . . . . 25.5 111.164 -176.819 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.27 30.8 p -94.4 157.35 16.06 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.524 -2.61 . . . . 11.949999999999999 114.167 179.82 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.88 -46.83 60.59 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 117.571 2.434 . . . . 10.17 117.571 163.074 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -56.4 -33.45 65.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 120.382 3.475 . . . . 13.59 120.382 169.003 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -58.88 -37.64 77.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.187 -2.82 . . . . 11.699999999999999 113.656 172.746 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -88.78 -13.17 40.09 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.935 -4.228 . . . . 12.949999999999999 110.112 177.35 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.439 40.8 t30 62.03 72.42 0.5 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 129.055 2.942 . . . . 25.449999999999999 114.379 -165.231 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -111.16 106.17 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 N-CA-C 99.478 -4.267 . . . . 14.6 99.478 -179.785 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -100.33 -173.98 2.55 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.586 -0.697 . . . . 33.229999999999997 110.675 -178.848 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.262 25.1 pttt -55.25 131.74 46.15 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.771 2.428 . . . . 25.969999999999999 113.981 179.656 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 58.99 45.54 14.76 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 127.215 3.388 . . . . 32.609999999999999 115.232 -176.313 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 t -110.28 137.18 48.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.884 -2.385 . . . . 10.56 107.798 179.208 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 m -105.16 129.47 53.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.932 2.093 . . . . 5.3300000000000001 107.614 -159.396 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -118.48 150.42 39.63 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 128.086 3.803 . . . . 11.66 106.271 179.12 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -112.03 124.37 52.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.149 -2.219 . . . . 16.300000000000001 105.201 -178.643 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -90.45 124.78 35.25 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 129.148 4.03 . . . . 9.9600000000000009 108.629 -178.496 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.6 m -99.1 151.62 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.992 2.517 . . . . 9.7599999999999998 109.065 167.192 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.76 151.93 22.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.508 -2.62 . . . . 19.57 109.487 163.13 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -135.42 177.49 7.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.527 -1.358 . . . . 35.079999999999998 109.174 175.69 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.7 mt -77.33 142.64 39.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.457 -2.027 . . . . 32.310000000000002 109.131 -173.961 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -81.77 163.02 22.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.417 2.006 . . . . 42.75 116.417 -168.055 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.29 -82.35 0.35 Allowed Glycine 0 N--CA 1.43 -1.701 0 O-C-N 118.229 -2.794 . . . . 36.310000000000002 115.161 -172.939 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.735 0 O-C-N 118.98 -2.482 . . . . 36.270000000000003 108.333 -174.208 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 123.46 1.6 . . . . 17.170000000000002 114.12 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -82.39 138.06 34.56 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.422 -4.549 . . . . 21.890000000000001 107.75 168.556 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.9 pt -118.95 177.48 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 124.849 1.26 . . . . 10.83 109.69 157.904 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -134.89 112.02 10.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.429 2.011 . . . . 10.609999999999999 116.429 -173.915 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.96 115.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 125.87 2.748 . . . . 9.1300000000000008 110.493 177.547 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.263 28.2 tttp -107.32 140.56 40.04 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.977 -4.202 . . . . 20.550000000000001 113.588 -179.866 . . . . . . . . 3 2 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.5 p -102.09 172.7 6.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.983 -2.323 . . . . 11.779999999999999 109.797 -179.429 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.9 -46.75 88.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.501 3.12 . . . . 19.309999999999999 111.853 172.081 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -69.38 -26.86 64.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.905 -2.372 . . . . 23.140000000000001 114.185 171.77 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.4 62.29 0.95 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 116.717 1.447 . . . . 19.739999999999998 116.717 162.97 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -103.13 175.18 5.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.929 2.092 . . . . 21.93 107.905 155.389 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 m -128.46 134.12 48.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.3 -3.375 . . . . 12.33 105.792 172.817 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -114.57 117.4 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 107.896 -1.15 . . . . 17.079999999999998 107.896 174.566 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 m -85.36 107.79 17.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.227 -2.26 . . . . 16.300000000000001 105.955 -175.581 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.0 mt -102.67 135.93 43.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.088 2.375 . . . . 15.880000000000001 115.185 172.668 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -99.7 129.34 45.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.779 -3.701 . . . . 28.899999999999999 110.63 173.248 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -151.09 159.63 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.842 1.657 . . . . 12.050000000000001 109.458 -167.628 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 62.2 mm-40 -107.08 159.63 29.3 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 120.554 -1.341 . . . . 18.170000000000002 110.328 163.132 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -72.7 -6.58 19.29 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 124.856 3.704 . . . . 8.1600000000000001 112.374 -176.66 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.8 p -72.64 -26.0 61.49 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 125.355 1.66 . . . . 11.130000000000001 114.338 171.779 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -64.82 157.75 26.87 Favored 'General case' 0 N--CA 1.43 -1.456 1 N-CA-C 124.425 4.972 . . . . 18.030000000000001 124.425 174.687 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 62.5 p -101.29 167.64 10.06 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 114.074 -2.869 . . . . 10.220000000000001 113.899 -173.49 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.317 7.0 mm -64.65 -35.41 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 125.392 1.682 . . . . 12.300000000000001 109.65 172.001 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -44.55 -48.82 10.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.683 3.586 . . . . 36.509999999999998 120.683 160.049 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -62.79 -40.72 98.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.122 1.514 . . . . 25.66 109.255 174.375 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.299 57.6 t -55.07 -59.76 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 116.721 -1.609 . . . . 8.1199999999999992 113.652 171.371 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.79 -27.48 68.78 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.073 1.76 . . . . 15.470000000000001 112.735 176.875 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.48 -32.53 62.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 122.549 2.431 . . . . 11.449999999999999 115.148 175.923 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -70.04 -26.65 64.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.303 -3.373 . . . . 24.98 109.375 176.189 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.4 mm -70.48 -37.87 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.224 1.409 . . . . 9.4600000000000009 110.988 168.723 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -43.84 78.37 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.301 -2.124 . . . . 14.76 111.612 -178.033 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.35 -69.09 0.12 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 126.948 2.655 . . . . 26.289999999999999 110.984 170.443 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -69.73 -52.32 26.52 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.835 -3.041 . . . . 30.059999999999999 118.485 -171.093 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -84.53 -65.51 1.0 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.877 -1.764 . . . . 25.190000000000001 107.589 -178.272 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.01 17.79 1.0 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 122.64 2.473 . . . . 7.4100000000000001 113.884 -175.048 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.8 mt -97.3 131.19 27.85 Favored Pre-proline 0 N--CA 1.431 -1.41 0 N-CA-C 116.07 1.878 . . . . 9.4900000000000002 116.07 -175.61 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.86 154.79 70.4 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 CA-C-N 124.157 2.521 . . . . 11.42 109.549 -178.946 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 -17.69 13.6 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 N-CA-C 117.221 1.97 . . . . 12.0 117.221 -170.716 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.26 -15.64 57.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.216 1.484 . . . . 35.549999999999997 110.704 178.111 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -86.96 -33.18 19.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.74 2.816 . . . . 20.52 113.036 176.462 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -71.03 139.02 50.33 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.231 1.937 . . . . 7.1299999999999999 116.231 171.013 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -131.67 131.7 43.35 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.015 2.341 . . . . 36.390000000000001 114.497 160.008 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.1 mt -109.37 125.95 52.9 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.154 -4.716 . . . . 9.5500000000000007 110.881 -170.993 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.7 mm -116.45 112.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.531 -1.355 . . . . 13.9 110.132 -176.038 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -102.06 116.38 32.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.879 2.276 . . . . 6.8600000000000003 112.348 163.578 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.447 . . 63.1 -81.81 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.91 1.818 . . . . 11.15 115.91 -167.252 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.95 15.94 1.18 Allowed Glycine 0 N--CA 1.431 -1.687 0 CA-C-O 125.204 2.558 . . . . 13.93 112.569 174.517 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -101.09 131.39 47.03 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.607 -1.525 . . . . 23.920000000000002 110.976 -175.004 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -75.97 120.82 21.83 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.658 -1.155 . . . . 23.23 112.955 170.308 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 mt -89.56 121.29 31.62 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.179 -1.576 . . . . 9.1099999999999994 111.49 -172.893 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -80.95 143.55 32.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.248 1.573 . . . . 33.439999999999998 115.248 172.407 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.78 -42.19 99.59 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.04 4.136 . . . . 28.370000000000001 110.538 -171.812 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.76 -7.69 88.3 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 127.238 2.352 . . . . 15.0 114.012 -170.476 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -101.6 155.68 17.94 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.742 1.617 . . . . 25.5 109.62 -169.875 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.4 p -95.11 167.06 11.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.04 -2.288 . . . . 11.949999999999999 110.256 -174.487 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 mt -57.69 -56.34 23.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.52 3.128 . . . . 10.17 111.886 174.306 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.406 6.6 t -36.13 -37.88 0.13 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.673 3.589 . . . . 13.59 118.822 156.283 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -72.3 -46.66 54.73 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.829 -4.919 . . . . 11.699999999999999 110.829 -176.828 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -67.96 -3.44 9.97 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 120.028 3.344 . . . . 12.949999999999999 120.028 167.26 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.0 m120 64.69 27.45 13.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.461 1.504 . . . . 25.449999999999999 114.381 -175.71 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -85.27 116.29 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.215 1.483 . . . . 14.6 109.059 -174.277 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -97.8 -165.21 1.22 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.902 3.239 . . . . 33.229999999999997 110.598 -176.733 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -76.35 150.11 36.9 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.436 -4.54 . . . . 25.969999999999999 112.979 -174.356 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 50.6 mt-10 54.6 35.64 24.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 125.344 1.652 . . . . 32.609999999999999 113.411 -174.763 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -86.71 133.97 33.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.053 1.882 . . . . 10.56 108.731 -174.668 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m -95.38 118.4 32.05 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.911 -2.368 . . . . 5.3300000000000001 107.725 -177.498 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -109.31 144.58 37.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 100.827 -3.768 . . . . 11.66 100.827 -178.802 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -117.36 126.86 53.39 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.307 -3.996 . . . . 16.300000000000001 104.945 -177.164 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.4 tp -100.11 119.8 38.87 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.567 1.547 . . . . 9.9600000000000009 108.044 -176.446 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.7 m -117.99 159.14 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.051 -1.656 . . . . 9.7599999999999998 113.384 169.368 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.7 mt -92.34 112.77 24.84 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.705 -1.591 . . . . 19.57 106.705 -179.276 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -99.92 -179.8 4.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.423 -2.673 . . . . 35.079999999999998 114.271 170.396 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.288 96.0 mt -74.43 159.71 31.94 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.678 1.228 . . . . 32.310000000000002 108.548 166.059 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -80.47 122.72 27.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.422 -2.049 . . . . 42.75 113.489 -172.372 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.5 147.06 8.3 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 124.839 1.337 . . . . 36.310000000000002 110.16 169.883 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.778 0 C-N-CA 125.123 1.344 . . . . 36.270000000000003 110.024 -173.442 . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 117.601 2.445 . . . . 17.170000000000002 117.601 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -98.85 134.52 41.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 115.785 -2.055 . . . . 21.890000000000001 113.459 170.308 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -130.77 155.53 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 125.546 2.594 . . . . 10.83 107.18 172.078 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -119.29 105.16 11.05 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.577 -3.827 . . . . 10.609999999999999 107.489 -161.221 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.68 100.15 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 1 O-C-N 129.64 4.338 . . . . 9.1300000000000008 107.705 177.177 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -92.03 120.27 32.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.834 -1.53 . . . . 20.550000000000001 109.975 -177.455 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -74.18 -174.01 1.82 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.872 2.069 . . . . 11.779999999999999 113.739 -178.967 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.2 tp -77.76 -32.25 52.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.932 2.197 . . . . 19.309999999999999 116.932 177.334 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.8 p -70.67 -31.15 67.95 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.542 2.337 . . . . 23.140000000000001 114.637 170.75 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.8 20.15 8.23 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 117.758 -1.579 . . . . 19.739999999999998 114.538 179.849 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.292 44.4 pttt -89.07 142.96 27.19 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 124.733 1.213 . . . . 21.93 111.747 169.357 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.7 m -98.29 130.89 44.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.817 -1.802 . . . . 12.33 108.669 178.0 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.9 mt -106.56 104.64 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 1 N-CA-C 99.737 -4.171 . . . . 17.079999999999998 99.737 171.508 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -73.89 119.52 18.21 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.284 -1.51 . . . . 16.300000000000001 111.702 173.559 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.5 mt -100.17 126.07 46.39 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 114.964 -4.835 . . . . 15.880000000000001 114.13 170.588 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -78.93 92.83 4.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 125.797 1.936 . . . . 28.899999999999999 113.349 174.805 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.286 16.3 m -132.8 165.26 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 121.903 2.138 . . . . 12.050000000000001 111.325 -175.701 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -97.07 165.31 16.03 Favored Pre-proline 0 N--CA 1.429 -1.483 0 O-C-N 116.36 -3.963 . . . . 18.170000000000002 109.461 174.409 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.85 -23.66 73.16 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.811 3.111 . . . . 8.1600000000000001 119.539 164.833 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -63.38 -22.39 66.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.04 2.536 . . . . 11.130000000000001 112.823 174.748 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.18 148.69 39.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.315 -2.74 . . . . 18.030000000000001 109.492 -172.174 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 7.8 p -86.91 171.77 10.56 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.46 2.076 . . . . 10.220000000000001 109.425 179.145 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mm -76.93 -22.93 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.064 -2.897 . . . . 12.300000000000001 107.204 176.407 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.82 -46.79 74.59 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.737 -1.852 . . . . 36.509999999999998 110.828 171.132 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 72.4 m-20 -70.64 -21.49 62.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.238 2.615 . . . . 25.66 115.784 -179.612 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.8 t -83.72 -57.22 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 112.413 -2.176 . . . . 8.1199999999999992 107.113 174.191 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -45.19 -39.73 6.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.121 -2.862 . . . . 15.470000000000001 117.024 169.714 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.35 89.86 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.722 3.23 . . . . 11.449999999999999 119.722 173.047 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.31 -36.0 80.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.113 1.894 . . . . 24.98 116.113 169.127 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mm -69.43 -31.32 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.924 -1.735 . . . . 9.4600000000000009 107.624 -179.11 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -72.17 -44.67 62.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.417 -2.677 . . . . 14.76 113.182 169.709 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -54.64 -45.36 73.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.102 2.561 . . . . 26.289999999999999 114.57 177.511 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -91.46 -56.93 2.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.455 -2.028 . . . . 30.059999999999999 114.061 -177.994 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.269 52.6 mm-40 -85.81 -31.07 22.51 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.564 -4.46 . . . . 25.190000000000001 114.53 -175.156 . . . . . . . . 3 2 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.76 7.55 59.99 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 119.568 -1.958 . . . . 7.4100000000000001 112.902 173.702 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.2 116.95 59.22 Favored Pre-proline 0 N--CA 1.429 -1.485 0 CA-C-O 114.856 -2.497 . . . . 9.4900000000000002 113.819 177.415 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -63.94 150.74 87.72 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 125.227 3.952 . . . . 11.42 114.08 -172.074 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -73.95 -20.69 19.25 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 O-C-N 114.941 -3.241 . . . . 12.0 113.843 -166.964 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -80.61 -18.73 47.3 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.685 -1.969 . . . . 35.549999999999997 105.685 178.596 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -89.93 -18.34 26.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.753 -1.842 . . . . 20.52 113.478 176.744 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -72.95 137.33 45.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.71 -2.494 . . . . 7.1299999999999999 109.163 -177.485 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttt180 -130.89 129.54 42.38 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.668 1.576 . . . . 36.390000000000001 109.837 168.878 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HB3' HD11 ' A' ' 50' ' ' LEU . 22.9 mt -118.95 124.32 46.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.704 -1.135 . . . . 9.5500000000000007 111.33 -173.928 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 21.7 mm -118.01 134.38 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.171 2.588 . . . . 13.9 106.647 -171.071 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -121.24 113.32 19.79 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.324 2.342 . . . . 6.8600000000000003 117.324 161.245 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.86 -98.44 0.08 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.786 1.402 . . . . 11.15 114.786 -164.725 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.21 4.04 9.62 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 124.762 1.172 . . . . 13.93 113.875 166.116 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -90.98 139.24 30.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.294 1.521 . . . . 23.920000000000002 109.56 177.809 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -87.73 117.07 26.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.204 2.202 . . . . 23.23 110.386 178.721 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 43' ' ' LEU . 83.2 mt -83.61 129.27 34.96 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.962 2.905 . . . . 9.1099999999999994 107.898 -178.553 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -111.74 154.43 25.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.224 -1.807 . . . . 33.439999999999998 109.245 -173.995 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.38 -48.57 67.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.49 1.614 . . . . 28.370000000000001 110.876 -158.404 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.58 15.75 44.58 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.972 1.749 . . . . 15.0 114.605 177.279 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -100.36 167.8 10.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.79 -1.93 . . . . 25.5 105.79 171.005 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 11.4 p -105.04 176.86 5.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.514 -1.991 . . . . 11.949999999999999 107.955 -177.865 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.78 -43.55 88.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.957 2.661 . . . . 10.17 115.272 164.856 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.2 t -51.85 -43.74 63.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.414 2.686 . . . . 13.59 113.663 173.717 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -67.17 -29.24 68.88 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 117.147 2.277 . . . . 11.699999999999999 117.147 -173.914 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.07 -10.23 50.83 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 119.441 3.126 . . . . 12.949999999999999 119.441 171.296 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.4 m120 85.06 56.69 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.471 1 C-N-CA 133.679 4.791 . . . . 25.449999999999999 107.244 172.466 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.7 mt -104.92 101.38 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 N-CA-C 99.375 -4.305 . . . . 14.6 99.375 -172.844 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -91.07 -177.48 4.92 Favored 'General case' 0 N--CA 1.43 -1.433 2 C-N-CA 134.561 5.144 . . . . 33.229999999999997 107.265 179.973 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -66.57 145.57 55.46 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.001 1.32 . . . . 25.969999999999999 114.37 -179.311 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.381 17.0 mt-10 66.64 52.56 0.99 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 126.715 3.15 . . . . 32.609999999999999 117.337 176.866 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.1 t -131.76 134.01 45.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.689 -3.132 . . . . 10.56 113.166 -153.227 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.2 m -77.25 117.08 18.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.745 2.528 . . . . 5.3300000000000001 115.16 -179.231 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -115.05 138.37 50.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 115.388 -2.244 . . . . 11.66 108.305 165.39 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.432 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.5 m-70 -100.49 122.64 43.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.766 1.166 . . . . 16.300000000000001 111.288 -177.329 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.69 117.46 31.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.099 2.381 . . . . 9.9600000000000009 110.197 172.575 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.85 176.7 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 130.596 3.558 . . . . 9.7599999999999998 109.266 172.772 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 mp -122.43 144.1 49.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.688 -1.882 . . . . 19.57 115.858 175.441 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -118.84 -177.87 3.42 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.529 2.585 . . . . 35.079999999999998 106.649 177.579 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.1 mt -81.26 155.93 25.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.552 3.072 . . . . 32.310000000000002 111.741 172.497 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -79.32 155.37 28.5 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 113.523 -5.736 . . . . 42.75 117.303 -169.054 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.41 -81.58 0.09 OUTLIER Glycine 0 N--CA 1.431 -1.695 0 O-C-N 128.016 3.323 . . . . 36.310000000000002 113.393 168.465 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.771 0 CA-C-O 126.348 3.193 . . . . 36.270000000000003 110.757 -173.039 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 104.832 -2.284 . . . . 17.170000000000002 104.832 . . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -116.3 130.51 56.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.815 -2.291 . . . . 21.890000000000001 104.815 -175.6 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -117.68 154.45 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.785 -2.302 . . . . 10.83 104.785 161.161 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.314 98.1 m-85 -116.14 152.06 34.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.603 -3.186 . . . . 10.609999999999999 106.121 176.801 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -125.41 113.18 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 106.746 -1.575 . . . . 9.1300000000000008 106.746 177.942 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -122.4 150.95 41.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.699 1.249 . . . . 20.550000000000001 113.234 -169.357 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -89.7 176.2 6.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.242 1.817 . . . . 11.779999999999999 108.246 176.65 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 mt -68.79 -38.82 80.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.124 -2.235 . . . . 19.309999999999999 107.064 -175.4 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -83.83 -61.84 1.72 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.771 -2.456 . . . . 23.140000000000001 114.268 -172.832 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.55 68.69 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 117.737 -2.173 . . . . 19.739999999999998 109.402 177.42 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tmmm? -120.09 121.25 38.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.112 -2.922 . . . . 21.93 103.112 155.407 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.0 m -111.88 112.03 23.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.709 -2.495 . . . . 12.33 108.093 -173.73 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.26 136.73 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 105.468 -2.049 . . . . 17.079999999999998 105.468 173.654 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.2 m -101.78 119.8 39.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.721 -1.214 . . . . 16.300000000000001 107.721 -171.283 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.432 HD12 HG13 ' A' ' 26' ' ' VAL . 77.6 mt -103.84 134.91 46.35 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 119.279 3.066 . . . . 15.880000000000001 119.279 178.943 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.18 109.49 21.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.205 -1.56 . . . . 28.899999999999999 108.686 178.691 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -130.1 148.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 116.765 -3.709 . . . . 12.050000000000001 112.291 -169.884 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -97.44 146.68 31.81 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 118.997 -2.315 . . . . 18.170000000000002 109.312 171.34 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.8 -17.74 17.6 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-O 112.393 -3.253 . . . . 8.1600000000000001 107.602 -172.651 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -85.29 7.37 22.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 123.896 3.044 . . . . 11.130000000000001 112.042 177.035 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -92.71 171.81 8.76 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.213 -2.804 . . . . 18.030000000000001 107.217 -174.717 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -112.48 153.45 27.41 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.046 -1.659 . . . . 10.220000000000001 109.975 -169.12 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 3.0 mt -74.21 -20.74 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.209 2.604 . . . . 12.300000000000001 106.383 -174.311 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.94 -44.87 91.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.283 1.033 . . . . 36.509999999999998 112.101 169.614 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -66.37 -34.96 79.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.293 3.437 . . . . 25.66 109.66 174.439 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 97.6 t -62.84 -49.77 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 119.852 -1.78 . . . . 8.1199999999999992 111.948 177.703 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -65.7 -27.63 68.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.468 2.355 . . . . 15.470000000000001 110.429 -172.802 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.81 -28.35 67.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.562 2.345 . . . . 11.449999999999999 110.02 177.932 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -93.04 -28.94 16.07 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 121.719 2.054 . . . . 24.98 108.26 -178.253 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 mt -65.1 -42.13 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 118.687 -2.508 . . . . 9.4600000000000009 111.377 164.763 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -59.36 -51.84 68.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.109 -3.495 . . . . 14.76 117.691 168.087 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -46.24 -50.08 16.39 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 122.268 2.303 . . . . 26.289999999999999 115.018 174.324 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -68.68 -63.76 1.0 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.496 2.719 . . . . 30.059999999999999 117.109 174.16 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -88.24 -29.82 20.16 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.64 2.089 . . . . 25.190000000000001 116.64 -174.092 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.13 14.83 59.94 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 119.058 2.383 . . . . 7.4100000000000001 119.058 -178.44 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 tt -103.15 115.31 64.2 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 114.903 -2.475 . . . . 9.4900000000000002 106.536 -178.275 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -60.27 170.03 4.47 Favored 'Trans proline' 0 N--CA 1.434 -1.988 2 C-N-CA 131.058 7.839 . . . . 11.42 116.256 -168.977 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.88 -21.09 7.17 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 125.365 2.952 . . . . 12.0 108.126 -164.307 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -75.43 -33.92 60.95 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.445 -2.66 . . . . 35.549999999999997 113.005 175.946 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -73.59 -37.52 65.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.516 -3.24 . . . . 20.52 113.929 176.265 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -54.74 124.55 16.8 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.967 -2.333 . . . . 7.1299999999999999 114.269 173.952 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -124.32 99.34 6.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.369 1.44 . . . . 36.390000000000001 108.43 -178.123 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.3 mt -96.93 107.33 19.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.384 1.874 . . . . 9.5500000000000007 110.705 -173.131 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.2 mm -110.37 120.41 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 128.471 2.708 . . . . 13.9 105.67 -175.406 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -107.95 115.93 31.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.734 -2.03 . . . . 6.8600000000000003 108.022 169.132 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.29 -94.04 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 112.32 -2.218 . . . . 11.15 113.306 -164.168 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.72 12.56 4.53 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 129.361 3.362 . . . . 13.93 113.149 169.997 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -117.91 148.79 41.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.757 2.279 . . . . 23.920000000000002 108.843 -179.82 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -110.77 114.71 28.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.217 -1.031 . . . . 23.23 108.217 -169.115 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.55 157.67 35.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.94 -2.35 . . . . 9.1099999999999994 115.108 -171.947 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -100.21 154.95 18.04 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.775 -1.194 . . . . 33.439999999999998 107.775 178.465 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -75.87 -50.0 16.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.013 -2.899 . . . . 28.370000000000001 116.309 -160.23 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.9 52.93 2.94 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 123.197 2.726 . . . . 15.0 111.855 179.726 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.259 6.7 mmt180 -121.41 160.3 24.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 103.874 -2.639 . . . . 25.5 103.874 171.207 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.303 66.2 p -86.62 151.85 23.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.33 1.452 . . . . 11.949999999999999 111.971 175.937 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.252 33.3 mt -47.51 -50.78 22.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.677 1.191 . . . . 10.17 111.699 165.545 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 p -54.12 -26.73 28.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.328 1.973 . . . . 13.59 116.328 176.866 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.35 -43.45 98.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.396 -2.69 . . . . 11.699999999999999 110.505 173.455 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.23 -16.01 28.32 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 126.601 2.438 . . . . 12.949999999999999 115.724 176.532 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 70.63 36.95 1.51 Allowed 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.601 1.561 . . . . 25.449999999999999 113.381 -172.226 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -68.63 101.43 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.49 -2.006 . . . . 14.6 116.121 170.901 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -76.52 163.43 26.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.82 2.896 . . . . 33.229999999999997 118.82 -175.829 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -61.35 147.85 43.41 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.605 2.817 . . . . 25.969999999999999 118.605 169.593 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.333 26.2 mt-10 68.74 23.98 6.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.07 1.89 . . . . 32.609999999999999 112.773 179.916 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -84.79 152.39 23.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.275 3.417 . . . . 10.56 107.945 -179.997 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -110.41 97.81 7.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 110.766 -2.925 . . . . 5.3300000000000001 107.887 175.825 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -80.81 152.26 28.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.267 3.027 . . . . 11.66 112.119 165.446 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -104.41 140.15 38.33 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.253 -2.78 . . . . 16.300000000000001 106.376 -178.136 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 tp -102.73 104.27 14.57 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.994 2.33 . . . . 9.9600000000000009 110.225 156.939 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.53 138.21 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 117.357 -3.34 . . . . 9.7599999999999998 108.047 -176.62 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.6 tp -87.38 127.14 35.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.79 -2.444 . . . . 19.57 105.769 172.632 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -126.94 148.78 50.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 128.162 3.414 . . . . 35.079999999999998 113.133 164.752 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 mt -76.54 140.16 41.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.779 -2.45 . . . . 32.310000000000002 110.386 -179.496 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -79.35 127.9 32.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.541 1.936 . . . . 42.75 108.267 -175.926 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.31 -58.56 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.746 0 O-C-N 121.101 -0.999 . . . . 36.310000000000002 113.279 -162.182 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 CA-C-O 117.218 -1.879 . . . . 36.270000000000003 109.756 169.008 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 125.08 2.372 . . . . 17.170000000000002 114.308 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -104.92 131.1 52.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.539 -3.851 . . . . 21.890000000000001 111.92 166.162 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.297 2.3 pp -124.08 162.52 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 1 O-C-N 114.61 -5.056 . . . . 10.83 105.283 169.679 . . . . . . . . 3 2 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.411 ' HB3' ' CG2' ' A' ' 12' ' ' THR . 21.5 m-30 -107.04 128.39 54.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.484 3.113 . . . . 10.609999999999999 106.607 -175.189 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.59 104.89 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 100.319 -3.956 . . . . 9.1300000000000008 100.319 -177.859 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 tttt -89.4 162.22 15.89 Favored 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 131.913 4.085 . . . . 20.550000000000001 108.661 175.008 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -101.99 -151.72 0.42 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.818 -2.426 . . . . 11.779999999999999 105.899 173.703 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.3 mt -91.58 -42.39 10.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.004 1.275 . . . . 19.309999999999999 111.459 170.07 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -66.53 -36.66 83.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.875 -1.766 . . . . 23.140000000000001 113.182 174.455 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.01 22.13 1.28 Allowed Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 120.057 2.783 . . . . 19.739999999999998 120.057 158.053 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -72.99 106.02 4.7 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.216 2.206 . . . . 21.93 116.438 168.261 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.411 ' CG2' ' HB3' ' A' ' 4' ' ' PHE . 94.0 m -81.13 130.33 34.97 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.818 -1.083 . . . . 12.33 109.69 173.511 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -107.38 157.25 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 119.912 -1.743 . . . . 17.079999999999998 106.871 158.79 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.7 m -125.57 106.59 9.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.315 -1.735 . . . . 16.300000000000001 106.315 -169.147 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.261 86.5 mt -125.24 144.95 50.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.829 -0.545 . . . . 15.880000000000001 112.047 -168.345 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -97.1 105.69 17.88 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.375 2.731 . . . . 28.899999999999999 118.375 -171.005 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 m -125.61 161.33 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.375 2.27 . . . . 12.050000000000001 108.146 -168.476 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -103.92 169.58 7.13 Favored Pre-proline 0 N--CA 1.429 -1.476 1 O-C-N 113.232 -5.917 . . . . 18.170000000000002 106.653 167.72 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -77.96 -17.25 13.83 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 116.301 -2.526 . . . . 8.1600000000000001 107.74 174.639 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -75.85 -6.44 50.76 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 117.788 -3.07 . . . . 11.130000000000001 112.654 173.02 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -77.26 145.01 37.77 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.98 -3.575 . . . . 18.030000000000001 108.935 174.76 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.324 20.1 p -77.76 151.75 33.93 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 133.175 4.59 . . . . 10.220000000000001 110.655 176.458 . . . . . . . . 3 2 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -63.5 -38.96 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 120.264 -1.523 . . . . 12.300000000000001 113.031 175.431 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -46.13 -45.37 16.47 Favored 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 132.463 4.305 . . . . 36.509999999999998 113.72 168.591 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -74.57 -23.12 58.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.721 -3.737 . . . . 25.66 114.26 174.738 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.36 -44.93 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.503 -1.998 . . . . 8.1199999999999992 110.576 174.28 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.17 -40.24 73.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.485 1.514 . . . . 15.470000000000001 114.008 173.426 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.06 -42.11 65.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.232 2.308 . . . . 11.449999999999999 117.232 167.648 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -79.54 -14.26 58.98 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 116.151 -4.093 . . . . 24.98 116.259 179.037 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -88.1 -26.29 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.892 -1.755 . . . . 9.4600000000000009 110.17 168.119 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -63.97 -48.9 74.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.642 -3.161 . . . . 14.76 115.933 162.876 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -42.4 -51.42 4.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.0 3.333 . . . . 26.289999999999999 120.0 157.209 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -90.67 -68.11 0.81 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.347 -0.845 . . . . 30.059999999999999 111.326 -166.474 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -86.78 -34.43 19.58 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.303 1.441 . . . . 25.190000000000001 112.648 -176.249 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.55 67.27 1.57 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 115.997 1.159 . . . . 7.4100000000000001 115.997 173.797 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.5 tt -126.9 133.55 25.15 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-N 110.138 -3.031 . . . . 9.4900000000000002 110.97 164.864 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -74.44 157.36 45.18 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 123.924 3.083 . . . . 11.42 113.368 -172.435 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -72.85 -15.5 26.53 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 CA-C-O 112.567 -3.181 . . . . 12.0 114.171 -153.775 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.49 -17.63 29.93 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 128.639 3.712 . . . . 35.549999999999997 106.068 -176.216 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -89.11 -27.17 20.94 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.781 -3.074 . . . . 20.52 104.832 -178.711 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -78.62 109.61 12.99 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.006 -3.559 . . . . 7.1299999999999999 111.541 -175.538 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -100.44 104.52 15.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.107 -2.553 . . . . 36.390000000000001 104.107 174.587 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -96.45 140.56 30.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.855 -2.403 . . . . 9.5500000000000007 109.16 179.014 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -134.88 146.58 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.722 1.725 . . . . 13.9 107.815 -173.073 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -121.84 104.5 9.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.702 2.001 . . . . 6.8600000000000003 106.482 166.376 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.36 -102.64 0.16 Allowed 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 116.064 -4.147 . . . . 11.15 113.975 173.147 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.11 -25.05 27.72 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 124.461 3.3 . . . . 13.93 113.233 171.526 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -83.8 136.81 34.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.95 1.357 . . . . 23.920000000000002 113.364 -173.021 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -78.67 147.52 33.51 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.644 -3.16 . . . . 23.23 111.146 163.056 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.8 mt -110.42 110.45 21.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 114.662 -2.59 . . . . 9.1099999999999994 104.914 -172.282 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.296 20.8 mt-10 -81.08 145.41 31.11 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.714 3.606 . . . . 33.439999999999998 113.47 177.427 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.59 -49.56 74.74 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 119.847 3.277 . . . . 28.370000000000001 119.847 -158.429 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.17 15.32 56.48 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.589 -3.819 . . . . 15.0 116.345 -174.045 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.471 ' HD2' ' CE2' ' A' ' 59' ' ' TYR . 31.2 mtt-85 -93.87 161.21 14.4 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.627 1.204 . . . . 25.5 109.147 169.292 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.1 p -91.52 173.77 7.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.101 1.905 . . . . 11.949999999999999 111.211 177.183 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.5 -24.82 53.75 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.38 -1.45 . . . . 10.17 109.434 173.133 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.5 t -72.5 -36.32 68.35 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.805 -1.809 . . . . 13.59 113.132 -177.196 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -59.01 -39.93 83.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.318 2.261 . . . . 11.699999999999999 114.724 173.762 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.471 ' CE2' ' HD2' ' A' ' 54' ' ' ARG . 24.9 m-85 -84.73 2.08 43.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.761 -3.087 . . . . 12.949999999999999 113.551 -179.874 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.292 29.3 m120 54.47 51.49 14.03 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.061 2.615 . . . . 25.449999999999999 118.061 -168.829 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -99.11 112.53 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 122.741 2.518 . . . . 14.6 107.752 -179.808 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -103.24 176.94 4.98 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.889 1.676 . . . . 33.229999999999997 108.527 -173.975 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 pttp -73.79 148.76 42.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.021 -2.299 . . . . 25.969999999999999 112.897 -173.674 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.81 19.75 10.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 111.367 -2.651 . . . . 32.609999999999999 110.802 -173.456 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -82.39 160.66 22.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.217 -2.142 . . . . 10.56 105.217 179.31 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -116.68 120.55 38.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 126.185 2.898 . . . . 5.3300000000000001 104.766 -171.994 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.41 64.2 mt -100.37 155.55 17.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.489 -2.141 . . . . 11.66 108.508 169.207 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -107.52 131.51 54.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.562 1.69 . . . . 16.300000000000001 115.562 173.482 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.0 107.61 19.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.433 1.893 . . . . 9.9600000000000009 106.096 178.915 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.82 152.75 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.049 -1.657 . . . . 9.7599999999999998 107.47 172.629 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 tp -101.55 125.89 48.27 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.165 -2.209 . . . . 19.57 105.164 172.679 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -130.8 132.73 45.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 128.343 3.925 . . . . 35.079999999999998 107.35 170.626 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.8 mt -73.57 -155.28 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.321 -3.987 . . . . 32.310000000000002 112.628 178.666 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -92.68 145.18 24.62 Favored 'General case' 0 N--CA 1.429 -1.487 1 CA-C-O 129.253 4.359 . . . . 42.75 115.396 -178.995 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.14 -103.18 0.18 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 117.979 -2.951 . . . . 36.310000000000002 115.24 177.954 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.777 0 N-CA-C 104.048 -3.621 . . . . 36.270000000000003 104.048 -171.555 . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 114.518 1.303 . . . . 17.170000000000002 114.518 . . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -79.55 127.04 31.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.094 -1.432 . . . . 21.890000000000001 114.475 178.36 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -119.25 159.65 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 122.161 2.255 . . . . 10.83 113.943 159.011 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.64 135.6 53.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 104.479 -2.415 . . . . 10.609999999999999 104.479 -172.052 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.63 119.03 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 105.408 -2.071 . . . . 9.1300000000000008 105.408 174.743 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 mttt -107.38 136.49 47.09 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.15 -2.167 . . . . 20.550000000000001 105.15 -171.523 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.272 72.0 p -97.62 172.95 7.39 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.371 2.986 . . . . 11.779999999999999 107.52 -172.02 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mt -77.78 -35.72 51.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.096 -1.866 . . . . 19.309999999999999 115.845 176.875 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -65.42 -69.78 0.27 Allowed 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 121.697 2.044 . . . . 23.140000000000001 106.243 170.405 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.84 68.81 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 113.418 -1.719 . . . . 19.739999999999998 113.556 178.623 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -132.75 150.07 52.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.776 -3.046 . . . . 21.93 102.776 170.346 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.6 m -127.33 90.98 3.22 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 116.573 -1.68 . . . . 12.33 107.211 -178.219 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 pt -77.07 125.37 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 128.377 2.671 . . . . 17.079999999999998 110.964 -179.784 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.7 m -97.47 117.11 30.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.126 1.516 . . . . 16.300000000000001 113.047 177.008 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -99.12 144.41 28.29 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.037 -1.097 . . . . 15.880000000000001 108.037 178.618 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -87.08 112.69 22.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.669 -3.144 . . . . 28.899999999999999 113.873 165.427 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.68 -176.25 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.416 1 O-C-N 115.917 -4.24 . . . . 12.050000000000001 114.374 176.438 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -132.06 141.47 41.58 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 116.849 -3.657 . . . . 18.170000000000002 111.717 169.696 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.87 -18.19 41.41 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 119.296 2.768 . . . . 8.1600000000000001 119.296 -170.79 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -76.65 -10.31 59.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.223 1.934 . . . . 11.130000000000001 116.223 173.535 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.271 10.9 t0 -94.43 164.77 12.87 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.496 -2.003 . . . . 18.030000000000001 114.173 -175.76 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -75.49 161.41 29.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.819 -2.425 . . . . 10.220000000000001 114.828 -170.197 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 mt -77.83 -31.21 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.891 -3.006 . . . . 12.300000000000001 112.389 177.855 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -49.3 -48.0 46.51 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.384 2.274 . . . . 36.509999999999998 112.385 167.404 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -74.1 -13.66 60.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.372 1.869 . . . . 25.66 113.066 179.657 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.95 -49.27 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 116.553 -3.842 . . . . 8.1199999999999992 108.034 165.368 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -62.96 -33.22 74.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.376 2.67 . . . . 15.470000000000001 110.601 -179.236 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.63 -44.78 85.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.491 3.043 . . . . 11.449999999999999 107.953 -177.087 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.277 65.9 mttm -63.66 -35.06 79.29 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 120.503 3.52 . . . . 24.98 120.503 173.391 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.93 -28.06 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.54 3.067 . . . . 9.4600000000000009 111.15 178.911 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -70.88 -50.36 35.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.499 -3.25 . . . . 14.76 106.056 177.992 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -48.38 -46.64 37.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.703 3.62 . . . . 26.289999999999999 114.895 178.159 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -82.49 -56.96 3.57 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.034 -2.348 . . . . 30.059999999999999 109.517 -165.614 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -100.1 -22.82 15.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.598 3.184 . . . . 25.190000000000001 119.598 -174.841 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.31 27.64 8.04 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 117.228 -3.42 . . . . 7.4100000000000001 115.238 170.204 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 tt -111.98 135.14 21.26 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-O 113.686 -3.054 . . . . 9.4900000000000002 107.073 -168.426 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.55 167.21 27.05 Favored 'Trans proline' 0 C--N 1.299 -2.045 1 CA-C-O 109.448 -4.48 . . . . 11.42 113.307 -174.383 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.18 -11.12 7.6 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 126.026 3.188 . . . . 12.0 111.833 -179.924 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -71.93 -18.66 62.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.611 -2.556 . . . . 35.549999999999997 110.796 173.036 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -92.03 -17.77 24.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 116.562 -1.685 . . . . 20.52 110.43 172.724 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -89.02 128.25 35.71 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.81 1.29 . . . . 7.1299999999999999 112.768 -168.516 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -140.66 143.94 35.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 112.562 -2.108 . . . . 36.390000000000001 107.324 152.274 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.4 mt -110.23 136.31 49.64 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.712 2.405 . . . . 9.5500000000000007 106.092 -171.92 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -128.13 136.02 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 116.658 -3.776 . . . . 13.9 105.874 -170.314 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -120.9 108.01 13.39 Favored 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 98.938 -4.467 . . . . 6.8600000000000003 98.938 -177.076 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.53 -64.91 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 131.41 3.884 . . . . 11.15 115.056 178.181 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.64 -0.81 1.73 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 116.906 1.522 . . . . 13.93 116.906 169.208 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -119.11 153.28 35.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 120.552 2.176 . . . . 23.920000000000002 107.575 -169.603 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -84.52 137.28 33.42 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.56 1.171 . . . . 23.23 113.676 177.256 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.1 mt -94.15 120.55 34.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.152 1.381 . . . . 9.1099999999999994 107.31 -178.547 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -78.85 141.26 37.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.009 1.861 . . . . 33.439999999999998 113.894 177.499 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.7 -63.5 1.07 Allowed 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 132.157 4.183 . . . . 28.370000000000001 115.386 -179.588 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.15 4.32 6.21 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 128.103 2.763 . . . . 15.0 119.569 -179.003 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -105.89 165.82 10.92 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 125.165 2.412 . . . . 25.5 106.439 -177.882 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.6 p -94.38 177.2 6.02 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.11 -2.869 . . . . 11.949999999999999 117.64 172.048 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.38 -25.96 38.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.606 1.962 . . . . 10.17 108.849 179.242 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 m -76.2 -24.86 54.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 121.293 1.86 . . . . 13.59 112.962 172.259 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -54.61 -38.95 67.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.712 1.745 . . . . 11.699999999999999 115.712 171.595 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -99.19 -11.99 20.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.37 2.668 . . . . 12.949999999999999 111.428 -175.359 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.12 60.07 3.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.625 1.97 . . . . 25.449999999999999 114.68 -162.499 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -92.31 118.43 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 126.899 2.08 . . . . 14.6 106.336 173.679 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -103.75 -174.76 2.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.166 1.543 . . . . 33.229999999999997 115.166 178.486 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -69.54 155.77 39.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.041 -2.287 . . . . 25.969999999999999 108.948 176.193 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 53.9 40.01 31.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.88 2.472 . . . . 32.609999999999999 112.021 -178.283 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -92.93 136.43 33.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 129.156 2.983 . . . . 10.56 106.23 176.715 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.4 m -81.13 110.47 16.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.707 -2.331 . . . . 5.3300000000000001 104.707 171.027 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.99 148.85 25.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.489 2.859 . . . . 11.66 108.451 165.989 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -111.24 138.6 47.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.024 -2.213 . . . . 16.300000000000001 105.024 -179.733 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tp -116.45 122.25 44.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.17 -2.529 . . . . 9.9600000000000009 104.17 -179.39 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -108.52 171.47 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 124.811 1.32 . . . . 9.7599999999999998 110.759 -179.617 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 tp -83.49 133.61 34.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.084 -2.885 . . . . 19.57 113.287 167.335 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -91.32 112.14 23.93 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.31 2.005 . . . . 35.079999999999998 112.175 -178.501 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.9 mt -79.43 149.03 31.72 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 112.176 -6.578 . . . . 32.310000000000002 109.159 169.894 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -85.55 125.89 33.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.036 -2.29 . . . . 42.75 113.811 -168.014 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.54 -75.58 0.14 Allowed Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 107.058 -2.417 . . . . 36.310000000000002 107.058 -172.336 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.745 0 N-CA-C 104.108 -3.597 . . . . 36.270000000000003 104.108 167.771 . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 CA--C 1.489 -1.377 0 N-CA-C 120.027 3.343 . . . . 17.170000000000002 120.027 . . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -92.03 132.9 36.2 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 116.017 -4.177 . . . . 21.890000000000001 109.216 -176.908 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.482 HG13 ' HB2' ' A' ' 15' ' ' LEU . 9.8 pt -135.68 150.66 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 116.646 -3.784 . . . . 10.83 105.795 174.836 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.3 134.46 52.87 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.36 -1.291 . . . . 10.609999999999999 109.498 -177.102 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -115.02 120.25 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 119.478 -2.014 . . . . 9.1300000000000008 109.901 173.695 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -89.98 128.48 36.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.711 2.672 . . . . 20.550000000000001 114.46 167.151 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -80.48 -167.51 1.37 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.125 -2.234 . . . . 11.779999999999999 109.711 -165.731 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.2 -55.65 31.14 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.554 2.742 . . . . 19.309999999999999 112.682 169.409 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -91.04 -34.65 15.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.077 1.751 . . . . 23.140000000000001 110.785 -164.341 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.26 79.02 0.2 Allowed Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 128.776 3.084 . . . . 19.739999999999998 111.223 170.023 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -141.76 137.59 31.71 Favored 'General case' 0 N--CA 1.43 -1.451 1 N-CA-C 97.533 -4.988 . . . . 21.93 97.533 177.682 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -109.38 101.23 10.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.846 -1.168 . . . . 12.33 107.846 174.803 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.42 153.91 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 130.242 3.417 . . . . 17.079999999999998 110.283 164.251 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.3 m -120.03 139.87 51.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.41 -1.7 . . . . 16.300000000000001 106.41 -176.17 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.482 ' HB2' HG13 ' A' ' 3' ' ' ILE 0.302 96.0 mt -134.63 152.2 51.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 121.436 1.925 . . . . 15.880000000000001 112.294 173.362 . . . . . . . . 3 3 . 1 . 052 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -102.48 117.58 35.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.132 1.333 . . . . 28.899999999999999 112.761 176.838 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.68 172.3 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 121.704 2.047 . . . . 12.050000000000001 112.769 -178.892 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -111.99 155.64 43.03 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 104.969 -2.234 . . . . 18.170000000000002 104.969 170.252 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.271 21.6 Cg_exo -71.22 -12.08 29.58 Favored 'Trans proline' 0 N--CA 1.433 -2.033 1 C-N-CA 126.115 4.543 . . . . 8.1600000000000001 111.631 -175.273 . . . . . . . . 3 2 . 1 . 052 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 p -92.42 -1.88 56.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 127.646 3.091 . . . . 11.130000000000001 108.379 179.401 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -71.79 143.48 49.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 127.846 3.689 . . . . 18.030000000000001 113.948 170.071 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -86.53 169.42 12.81 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 109.631 -3.44 . . . . 10.220000000000001 110.598 -169.649 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -69.73 -37.48 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.434 -1.321 . . . . 12.300000000000001 107.434 175.619 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -54.3 -50.68 66.75 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.503 -1.998 . . . . 36.509999999999998 113.653 171.3 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -61.09 -34.1 74.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 122.843 2.565 . . . . 25.66 115.472 173.196 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.388 75.9 t -54.02 -54.53 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 124.597 1.186 . . . . 8.1199999999999992 113.553 169.124 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -53.3 -24.25 11.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.968 3.307 . . . . 15.470000000000001 119.507 170.266 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.72 -38.78 58.26 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.695 3.617 . . . . 11.449999999999999 111.033 176.489 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -68.29 -33.08 73.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.071 -3.518 . . . . 24.98 115.471 174.361 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -75.02 -47.25 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.782 2.033 . . . . 9.4600000000000009 107.412 175.462 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -46.06 -48.43 16.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 114.704 -2.569 . . . . 14.76 113.37 169.46 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.65 -48.12 60.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 120.398 1.453 . . . . 26.289999999999999 114.39 -176.472 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -71.88 -52.8 15.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.956 -1.497 . . . . 30.059999999999999 113.324 -172.948 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -91.67 -41.61 10.63 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 126.502 2.376 . . . . 25.190000000000001 113.989 -167.271 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.71 40.61 1.56 Allowed Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 119.11 -0.828 . . . . 7.4100000000000001 113.551 173.54 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 tt -113.49 139.86 23.8 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-O 114.826 -2.511 . . . . 9.4900000000000002 106.271 -179.511 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -68.77 153.04 73.79 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 126.964 3.523 . . . . 11.42 109.582 177.624 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.01 -22.82 70.81 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 127.894 5.729 . . . . 12.0 119.356 176.814 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.84 -24.59 48.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.762 -2.681 . . . . 35.549999999999997 103.762 -171.381 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.15 -25.02 25.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.424 -1.423 . . . . 20.52 114.114 -171.225 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -74.95 117.9 17.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.504 -1.998 . . . . 7.1299999999999999 116.101 179.742 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -108.71 110.6 22.05 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.564 2.345 . . . . 36.390000000000001 111.223 167.598 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.69 135.58 33.62 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.141 3.015 . . . . 9.5500000000000007 119.141 173.955 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 mm -121.13 137.15 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 124.107 1.908 . . . . 13.9 110.626 176.202 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -117.08 130.0 56.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.293 -2.754 . . . . 6.8600000000000003 105.67 164.417 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 48.25 -94.62 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.902 1.816 . . . . 11.15 115.902 -176.028 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.03 15.14 7.4 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 118.578 -2.576 . . . . 13.93 114.365 165.307 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -103.4 138.33 40.28 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.695 -3.238 . . . . 23.920000000000002 108.916 -174.553 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -91.27 114.19 26.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.422 2.289 . . . . 23.23 112.688 173.075 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 mt -74.99 129.47 37.71 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 124.527 1.142 . . . . 9.1099999999999994 111.576 -171.469 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -71.81 143.34 49.53 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.179 2.659 . . . . 33.439999999999998 118.179 172.72 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -53.78 -54.49 37.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.543 3.137 . . . . 28.370000000000001 113.302 -169.347 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.86 18.8 55.38 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-O 116.479 -2.29 . . . . 15.0 116.498 -172.321 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -92.92 168.84 10.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.134 1.967 . . . . 25.5 112.206 169.345 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 p -100.81 166.01 11.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 113.974 1.101 . . . . 11.949999999999999 113.974 170.488 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.59 -25.31 62.13 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 114.411 -2.709 . . . . 10.17 112.66 -177.044 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -70.07 -31.17 68.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.852 3.261 . . . . 13.59 110.887 176.224 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -67.84 -33.51 74.91 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.154 1.797 . . . . 11.699999999999999 111.337 175.962 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.16 13.38 17.17 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.775 -6.203 . . . . 12.949999999999999 115.343 166.116 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.73 27.52 14.5 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 114.904 -4.873 . . . . 25.449999999999999 114.693 179.334 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.6 121.98 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.973 -3.579 . . . . 14.6 107.127 -174.15 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -109.92 179.08 4.22 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.21 2.604 . . . . 33.229999999999997 108.302 -169.653 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -48.76 145.32 3.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.734 1.613 . . . . 25.969999999999999 110.733 172.551 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.257 54.0 mt-10 67.64 30.62 6.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.008 -1.906 . . . . 32.609999999999999 115.121 165.039 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -108.28 141.48 40.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.234 1.969 . . . . 10.56 110.335 -175.015 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 m -89.13 105.82 18.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.746 -2.024 . . . . 5.3300000000000001 107.093 -174.789 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.11 148.42 34.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.147 3.379 . . . . 11.66 108.361 158.213 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -115.3 134.5 55.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.933 -1.73 . . . . 16.300000000000001 110.209 170.753 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.7 tp -106.67 116.97 32.85 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.96 1.413 . . . . 9.9600000000000009 109.674 -176.127 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.6 m -127.26 -173.14 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.542 -2.762 . . . . 9.7599999999999998 103.542 175.699 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.2 mt -100.53 138.24 37.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.859 -1.775 . . . . 19.57 109.996 -173.532 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -88.7 135.06 33.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.257 2.317 . . . . 35.079999999999998 117.257 178.484 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.45 155.46 18.9 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 128.461 2.704 . . . . 32.310000000000002 109.263 174.999 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -77.12 143.52 39.11 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.403 -0.591 . . . . 42.75 109.403 154.689 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.62 -67.72 3.68 Favored Glycine 0 N--CA 1.43 -1.745 1 C-N-CA 131.088 4.185 . . . . 36.310000000000002 116.424 -174.935 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.762 0 CA-C-N 113.388 -1.406 . . . . 36.270000000000003 112.741 -166.361 . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 114.407 1.262 . . . . 17.170000000000002 114.407 . . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -109.66 149.51 29.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.086 1.884 . . . . 21.890000000000001 116.086 178.84 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -133.08 157.28 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.331 -3.356 . . . . 10.83 112.205 163.6 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -109.29 131.7 54.82 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 128.293 3.496 . . . . 10.609999999999999 106.425 179.669 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -135.75 131.81 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 117.071 -3.518 . . . . 9.1300000000000008 106.986 -176.37 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -103.41 147.13 27.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.126 -2.234 . . . . 20.550000000000001 109.738 -179.283 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.6 p -85.48 -178.19 6.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.24 1.495 . . . . 11.779999999999999 108.394 172.297 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.06 -47.45 85.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.049 1.74 . . . . 19.309999999999999 113.485 172.936 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -93.29 -79.42 0.4 Allowed 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 118.226 -2.796 . . . . 23.140000000000001 112.718 -172.408 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.19 63.62 0.32 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 127.157 2.313 . . . . 19.739999999999998 115.111 -177.362 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.433 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 74.4 tttt -140.87 129.54 22.84 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.056 1.884 . . . . 21.93 110.825 172.265 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -110.79 109.89 20.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.259 -3.401 . . . . 12.33 103.908 178.41 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.439 HD12 HG12 ' A' ' 30' ' ' ILE . 1.8 pt -98.88 142.79 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 127.097 2.159 . . . . 17.079999999999998 111.692 178.531 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.9 m -115.31 112.47 22.45 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.222 -2.174 . . . . 16.300000000000001 110.709 -178.61 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -103.64 155.11 18.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.01 1.862 . . . . 15.880000000000001 106.952 -172.278 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.56 121.67 42.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.021 2.343 . . . . 28.899999999999999 111.667 165.425 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.456 HG11 ' HE3' ' A' ' 29' ' ' LYS . 5.6 m -134.73 164.88 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 103.082 -2.933 . . . . 12.050000000000001 103.082 -175.838 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -120.8 153.42 57.02 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 115.798 -2.049 . . . . 18.170000000000002 109.196 165.103 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -67.61 -13.76 39.94 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 124.859 3.706 . . . . 8.1600000000000001 115.759 -172.612 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 75.2 m -79.73 -2.33 42.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.976 2.91 . . . . 11.130000000000001 116.375 166.501 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -74.21 132.93 42.63 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.567 -3.123 . . . . 18.030000000000001 102.567 172.734 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -78.06 154.36 31.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.379 3.072 . . . . 10.220000000000001 106.463 165.026 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -69.07 -28.15 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 118.507 -0.759 . . . . 12.300000000000001 110.024 178.531 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -51.06 -43.09 60.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 121.523 1.965 . . . . 36.509999999999998 113.883 163.529 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -70.48 -33.64 71.48 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.816 1.643 . . . . 25.66 113.132 173.118 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.24 -40.37 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 123.203 1.478 . . . . 8.1199999999999992 109.477 176.19 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -69.61 -35.27 75.12 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.129 -3.482 . . . . 15.470000000000001 114.065 179.257 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.69 -33.66 76.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.02 -2.925 . . . . 11.449999999999999 112.541 171.121 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HE3' HG11 ' A' ' 17' ' ' VAL . 35.2 mttm -70.62 -39.49 73.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.357 2.027 . . . . 24.98 108.452 -179.224 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.439 HG12 HD12 ' A' ' 13' ' ' ILE . 45.7 mt -65.68 -38.24 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.263 -1.523 . . . . 9.4600000000000009 111.105 176.203 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -51.27 -48.95 62.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.99 -3.569 . . . . 14.76 117.098 165.195 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -68.67 -42.04 78.41 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.178 1.808 . . . . 26.289999999999999 111.174 178.309 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -68.26 -57.16 6.4 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 123.652 2.933 . . . . 30.059999999999999 113.052 -179.947 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.433 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 38.0 mm-40 -103.46 -19.69 14.32 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.434 2.013 . . . . 25.190000000000001 116.434 -161.624 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.63 58.23 3.6 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 128.453 2.93 . . . . 7.4100000000000001 112.858 176.042 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.2 tt -127.65 136.41 28.92 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 127.353 2.261 . . . . 9.4900000000000002 108.451 -179.596 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -83.41 161.46 14.93 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 122.922 2.079 . . . . 11.42 107.321 -166.672 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.06 -18.35 10.12 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 CA-C-O 114.264 -2.473 . . . . 12.0 115.546 -170.757 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.259 16.3 t0 -66.41 -42.4 87.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.343 3.857 . . . . 35.549999999999997 108.179 176.851 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -65.36 -30.32 71.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.484 -2.635 . . . . 20.52 116.022 174.973 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -82.95 121.52 27.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.621 1.555 . . . . 7.1299999999999999 113.785 -168.88 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.424 ' HG2' HG22 ' A' ' 70' ' ' VAL . 22.8 ttm180 -117.7 101.99 8.78 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 102.99 -2.967 . . . . 36.390000000000001 102.99 167.905 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -80.11 113.38 18.23 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.859 1.314 . . . . 9.5500000000000007 113.745 171.271 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -93.93 127.89 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 118.335 -2.728 . . . . 13.9 111.711 171.555 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -105.54 114.25 28.31 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.276 2.235 . . . . 6.8600000000000003 107.792 162.793 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.54 -106.51 0.09 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.037 -2.914 . . . . 11.15 110.502 178.38 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.31 20.34 8.44 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 128.67 3.732 . . . . 13.93 116.554 170.957 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -115.52 139.0 50.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 102.348 -3.204 . . . . 23.920000000000002 102.348 -173.502 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -89.25 133.46 34.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 111.234 -2.712 . . . . 23.23 110.405 170.633 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.499 HD22 ' CD1' ' A' ' 59' ' ' TYR . 11.7 mt -112.55 133.61 54.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.703 1.601 . . . . 9.1099999999999994 109.012 -168.278 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -111.08 170.89 7.8 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.73 2.059 . . . . 33.439999999999998 113.434 -176.589 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.75 -43.21 38.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.919 2.488 . . . . 28.370000000000001 112.399 -156.725 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.84 -2.32 51.01 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 118.81 2.284 . . . . 15.0 118.81 179.149 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -121.12 170.64 9.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.782 -2.599 . . . . 25.5 113.677 -175.91 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -101.74 -172.46 2.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 105.879 -1.897 . . . . 11.949999999999999 105.879 -161.228 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.4 mt -79.32 -37.5 37.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.118 -1.401 . . . . 10.17 110.782 172.276 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p -61.4 -31.61 71.53 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.787 2.884 . . . . 13.59 118.787 172.173 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.76 -39.05 93.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.319 2.248 . . . . 11.699999999999999 109.551 -179.613 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.499 ' CD1' HD22 ' A' ' 50' ' ' LEU . 79.4 m-85 -92.31 -0.17 57.41 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 131.143 3.777 . . . . 12.949999999999999 113.785 178.509 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 m120 72.99 35.6 0.95 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.478 2.311 . . . . 25.449999999999999 108.761 173.733 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -95.32 114.61 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 125.349 2.499 . . . . 14.6 109.036 -178.079 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -113.44 -179.43 3.64 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 112.357 -6.464 . . . . 33.229999999999997 109.307 178.61 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -47.67 147.03 1.99 Allowed 'General case' 0 N--CA 1.43 -1.474 1 N-CA-C 123.952 4.797 . . . . 25.969999999999999 123.952 179.339 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 55.88 29.34 13.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.542 -3.849 . . . . 32.609999999999999 116.383 -177.091 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -82.38 139.98 33.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.864 -2.017 . . . . 10.56 111.626 174.565 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.9 m -83.49 122.41 28.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.996 2.06 . . . . 5.3300000000000001 112.605 166.754 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.31 157.1 25.51 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.022 -1.844 . . . . 11.66 106.022 172.132 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -129.45 127.04 40.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.23 1.196 . . . . 16.300000000000001 114.23 177.777 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 mt -77.06 120.38 22.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.779 -3.701 . . . . 9.9600000000000009 112.356 163.893 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.424 HG22 ' HG2' ' A' ' 42' ' ' ARG . 27.5 m -110.79 -178.85 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 104.87 -2.27 . . . . 9.7599999999999998 104.87 -170.126 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.8 tp -86.41 119.79 27.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.189 2.18 . . . . 19.57 113.815 172.935 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -98.75 114.21 26.65 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.815 1.783 . . . . 35.079999999999998 115.815 177.436 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.8 tp -92.45 139.2 30.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.047 2.939 . . . . 32.310000000000002 107.603 167.411 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -81.65 132.63 35.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.681 -1.887 . . . . 42.75 112.841 177.29 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.9 53.14 0.19 Allowed Glycine 0 N--CA 1.43 -1.734 1 C-N-CA 131.021 4.153 . . . . 36.310000000000002 108.313 -172.303 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.741 0 C-N-CA 124.749 1.166 . . . . 36.270000000000003 111.497 -178.678 . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 108.651 -0.87 . . . . 17.170000000000002 108.651 . . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.262 29.7 mt-30 -94.22 130.26 40.52 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.579 -1.201 . . . . 21.890000000000001 113.745 177.742 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -120.35 150.21 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.97 1.708 . . . . 10.83 106.722 170.526 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -106.01 141.73 36.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.713 -2.492 . . . . 10.609999999999999 106.681 -172.69 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.49 128.57 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 117.21 -1.796 . . . . 9.1300000000000008 107.864 -179.462 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -105.62 110.87 23.35 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.719 -4.363 . . . . 20.550000000000001 103.631 -173.992 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.1 p -72.41 166.85 21.76 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.132 1.773 . . . . 11.779999999999999 107.964 -175.044 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.9 tp -75.43 -41.01 56.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.05 -2.281 . . . . 19.309999999999999 113.293 -172.257 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -56.92 -57.82 10.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.373 1.559 . . . . 23.140000000000001 112.401 168.194 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.24 68.0 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.834 1.797 . . . . 19.739999999999998 114.372 171.765 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -127.79 129.96 47.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.595 -2.709 . . . . 21.93 108.681 165.349 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -81.44 96.29 7.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.141 -0.974 . . . . 12.33 112.366 173.283 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 pt -92.43 142.2 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.583 -1.948 . . . . 17.079999999999998 113.793 -178.019 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.4 m -96.08 128.54 43.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.188 -1.57 . . . . 16.300000000000001 113.686 178.307 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.3 mt -124.12 133.13 53.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.99 -2.944 . . . . 15.880000000000001 107.578 -178.739 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.361 13.7 mt-10 -84.41 113.58 21.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.796 3.238 . . . . 28.899999999999999 113.093 162.816 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.83 155.72 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 1 N-CA-C 99.556 -4.239 . . . . 12.050000000000001 99.556 175.572 . . . . . . . . 3 3 . 1 . 054 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.46 144.65 32.45 Favored Pre-proline 0 N--CA 1.429 -1.492 1 O-C-N 116.229 -4.044 . . . . 18.170000000000002 105.482 163.764 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -78.16 4.67 6.01 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-O 113.662 -2.724 . . . . 8.1600000000000001 117.022 -175.97 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.1 m -91.52 -9.61 43.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.594 3.361 . . . . 11.130000000000001 110.958 171.411 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -80.19 171.0 15.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 125.262 3.664 . . . . 18.030000000000001 109.353 -179.318 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.7 p -80.75 159.03 25.31 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 133.274 4.629 . . . . 10.220000000000001 113.526 173.445 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 26' ' ' VAL 0.275 31.0 mm -67.13 -17.02 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 125.007 2.337 . . . . 12.300000000000001 111.031 -179.409 . . . . . . . . 3 3 . 1 . 054 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -55.22 -37.26 66.92 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 116.146 -4.096 . . . . 36.509999999999998 117.495 171.711 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -67.43 -41.61 84.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.189 2.996 . . . . 25.66 112.435 169.644 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG21 HD12 ' A' ' 23' ' ' ILE . 57.7 t -61.41 -43.73 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.274 -2.766 . . . . 8.1199999999999992 111.188 174.224 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.258 79.8 mttt -62.89 -39.03 93.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.78 -2.45 . . . . 15.470000000000001 111.277 172.84 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.13 86.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.628 1.971 . . . . 11.449999999999999 111.309 -178.768 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -61.78 -37.59 84.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.739 2.126 . . . . 24.98 116.739 169.203 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mt -72.84 -32.16 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 118.939 -1.104 . . . . 9.4600000000000009 109.568 170.615 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -58.95 -48.41 81.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 116.388 -3.945 . . . . 14.76 113.389 172.136 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.48 -39.43 90.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 131.307 3.843 . . . . 26.289999999999999 110.713 -177.376 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -75.9 -55.1 5.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.617 3.191 . . . . 30.059999999999999 119.617 174.994 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -104.68 -37.87 6.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 114.129 -2.843 . . . . 25.190000000000001 111.066 -167.254 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.28 10.68 31.16 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 122.684 2.493 . . . . 7.4100000000000001 110.205 173.858 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.368 14.1 tt -75.47 115.38 45.06 Favored Pre-proline 0 N--CA 1.429 -1.501 0 C-N-CA 130.683 3.593 . . . . 9.4900000000000002 116.834 169.839 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.66 159.26 21.93 Favored 'Trans proline' 0 N--CA 1.434 -2.027 2 CA-C-N 130.411 4.754 . . . . 11.42 110.351 -172.378 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -62.12 -22.61 74.5 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 124.954 3.769 . . . . 12.0 114.715 -168.827 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.45 ' CG ' HH22 ' A' ' 74' ' ' ARG . 27.7 t70 -65.83 -36.26 82.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.334 1.453 . . . . 35.549999999999997 111.937 -175.805 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -91.57 -15.63 28.37 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.68 3.133 . . . . 20.52 110.493 -171.525 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -77.85 131.24 37.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.215 -2.803 . . . . 7.1299999999999999 116.451 170.756 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -120.8 122.4 40.25 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.386 -3.321 . . . . 36.390000000000001 108.701 162.518 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.9 mt -114.03 105.44 13.22 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.796 -2.44 . . . . 9.5500000000000007 111.85 -171.728 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -90.27 136.51 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 127.773 2.429 . . . . 13.9 112.194 179.639 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -122.83 94.01 4.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.415 2.286 . . . . 6.8600000000000003 106.657 -178.951 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.297 . . 73.44 -77.75 0.05 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.565 -2.584 . . . . 11.15 111.23 -172.517 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.29 16.76 0.59 Allowed Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 114.214 -1.357 . . . . 13.93 111.889 -177.757 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -120.98 164.67 16.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.442 3.097 . . . . 23.920000000000002 113.391 170.845 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -119.29 120.53 37.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 122.183 -0.323 . . . . 23.23 110.699 -167.441 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.59 147.86 28.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.511 2.1 . . . . 9.1099999999999994 110.897 -167.535 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -110.8 167.12 10.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.647 -2.533 . . . . 33.439999999999998 104.749 -168.17 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.16 -66.72 0.69 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 122.989 1.376 . . . . 28.370000000000001 113.682 -169.038 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.63 18.64 2.22 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 116.394 1.318 . . . . 15.0 116.394 -170.472 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -115.94 154.95 28.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.938 -2.615 . . . . 25.5 103.938 -176.151 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -87.67 146.28 25.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.605 3.557 . . . . 11.949999999999999 120.605 -179.456 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.04 -43.72 74.01 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 118.712 2.856 . . . . 10.17 118.712 173.717 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 p -66.26 -33.45 75.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.996 2.591 . . . . 13.59 117.996 170.052 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.77 -36.46 80.54 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 122.607 2.458 . . . . 11.699999999999999 112.663 177.038 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -69.62 -18.03 63.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.808 3.243 . . . . 12.949999999999999 113.817 174.808 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 m120 65.09 51.69 1.63 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.51 1.524 . . . . 25.449999999999999 111.822 -174.801 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -94.7 111.41 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-O 123.62 1.676 . . . . 14.6 108.392 174.92 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -101.72 165.62 11.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 111.5 -2.591 . . . . 33.229999999999997 108.98 -162.775 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -61.73 133.85 56.05 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.628 -2.545 . . . . 25.969999999999999 116.298 178.729 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 49.9 mt-10 71.59 25.41 3.34 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.289 2.329 . . . . 32.609999999999999 117.289 -177.539 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -94.29 146.29 24.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.676 2.472 . . . . 10.56 117.676 174.94 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -104.32 116.93 33.02 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.996 -4.19 . . . . 5.3300000000000001 108.931 -163.737 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.37 132.59 36.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.867 2.467 . . . . 11.66 110.088 167.636 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -81.93 127.79 33.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.16 -3.462 . . . . 16.300000000000001 116.173 159.747 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 60.7 tp -94.79 103.03 14.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 125.129 1.518 . . . . 9.9600000000000009 110.695 159.013 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.38 -177.05 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 117.819 -1.552 . . . . 9.7599999999999998 107.252 -179.676 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.4 tp -76.68 138.04 39.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 110.798 -2.91 . . . . 19.57 107.282 170.73 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -92.97 125.36 37.53 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.746 -3.096 . . . . 35.079999999999998 112.335 173.141 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.3 mt -104.5 132.34 50.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.298 -2.126 . . . . 32.310000000000002 107.801 166.137 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.45 HH22 ' CG ' ' A' ' 39' ' ' ASP . 21.8 mmt180 -80.41 139.46 36.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.276 3.43 . . . . 42.75 107.331 -176.452 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.77 -75.51 0.26 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 118.184 -2.823 . . . . 36.310000000000002 106.19 -166.357 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.778 1 C-N-CA 134.18 5.657 . . . . 36.270000000000003 111.66 -178.79 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.49 -1.344 0 CA-C-O 122.832 1.301 . . . . 17.170000000000002 107.949 . . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -87.67 135.83 33.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.929 2.196 . . . . 21.890000000000001 116.929 160.752 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -125.99 142.41 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 128.739 2.815 . . . . 10.83 105.694 -175.223 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -102.45 143.09 32.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.897 1.808 . . . . 10.609999999999999 106.713 175.917 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.8 t -124.46 130.94 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.311 -1.768 . . . . 9.1300000000000008 110.777 162.811 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -96.2 126.19 41.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.791 1.632 . . . . 20.550000000000001 111.261 168.099 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.259 72.2 p -89.73 176.26 6.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.67 3.188 . . . . 11.779999999999999 114.36 -171.168 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.0 tp -79.48 -54.93 5.43 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.264 -2.148 . . . . 19.309999999999999 112.613 -178.174 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -38.06 -72.34 0.06 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.312 2.708 . . . . 23.140000000000001 118.312 161.418 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.84 45.79 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.232 -3.418 . . . . 19.739999999999998 112.944 167.771 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.471 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 22.0 mtpt -119.08 149.25 42.0 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.485 -1.302 . . . . 21.93 107.485 179.717 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.2 m -110.26 101.15 9.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.254 -2.499 . . . . 12.33 104.254 171.405 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.6 pt -94.86 126.3 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 127.256 3.408 . . . . 17.079999999999998 112.193 -176.389 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.275 3.2 m -74.91 114.4 13.32 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.332 -3.355 . . . . 16.300000000000001 117.369 161.994 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.467 HD22 ' HB3' ' A' ' 29' ' ' LYS . 10.2 mt -122.42 149.16 44.21 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 116.014 -4.179 . . . . 15.880000000000001 106.623 174.475 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -102.4 125.75 49.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.509 2.576 . . . . 28.899999999999999 108.621 -178.291 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.9 m -147.77 165.1 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 118.492 -2.63 . . . . 12.050000000000001 106.945 -178.118 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -102.28 170.84 5.88 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 125.675 2.655 . . . . 18.170000000000002 110.093 161.852 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -56.89 -41.68 72.7 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 114.801 -3.315 . . . . 8.1600000000000001 117.374 166.46 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.2 p -70.68 -3.51 18.84 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.591 2.757 . . . . 11.130000000000001 115.223 176.239 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -83.88 153.54 23.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.32 -2.113 . . . . 18.030000000000001 113.894 167.552 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.6 p -95.16 176.53 6.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.689 -3.757 . . . . 10.220000000000001 115.846 -172.493 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mm -66.55 -43.55 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.86 -2.4 . . . . 12.300000000000001 107.607 173.923 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -47.82 -46.09 30.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.795 2.517 . . . . 36.509999999999998 117.795 168.535 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -75.75 -28.72 58.58 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.99 -1.068 . . . . 25.66 110.26 -178.685 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 83.9 t -59.65 -54.54 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.666 -3.146 . . . . 8.1199999999999992 110.881 169.867 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -58.74 -24.32 61.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.545 -1.972 . . . . 15.470000000000001 115.951 179.159 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.253 . . -76.4 -28.29 56.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.321 -0.862 . . . . 11.449999999999999 111.29 -177.738 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.467 ' HB3' HD22 ' A' ' 15' ' ' LEU . 59.4 mmtt -68.83 -49.25 60.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.186 2.595 . . . . 24.98 105.346 176.901 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mt -61.42 -39.32 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 127.89 3.709 . . . . 9.4600000000000009 114.261 -178.533 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.4 -39.7 80.39 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.124 -4.11 . . . . 14.76 115.647 171.517 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -67.31 -70.41 0.25 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.436 -1.69 . . . . 26.289999999999999 106.436 178.149 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -77.8 -33.87 52.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.708 2.114 . . . . 30.059999999999999 116.708 -161.277 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.471 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 41.8 mm-40 -99.22 -63.13 1.15 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 120.991 1.723 . . . . 25.190000000000001 109.248 179.203 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.94 89.02 1.22 Allowed Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.505 -1.997 . . . . 7.4100000000000001 111.61 174.501 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.5 mt -146.18 128.45 7.81 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 115.856 -2.021 . . . . 9.4900000000000002 106.898 179.669 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -61.49 145.5 97.88 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 125.132 2.869 . . . . 11.42 117.998 176.681 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -79.26 -15.34 12.78 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 123.568 2.845 . . . . 12.0 116.252 -166.506 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.35 -35.07 25.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.113 1.911 . . . . 35.549999999999997 108.748 174.545 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -72.86 -30.06 63.69 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.576 -3.828 . . . . 20.52 108.896 -179.737 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -64.57 134.95 55.42 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.225 -2.797 . . . . 7.1299999999999999 115.953 173.787 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.434 ' HB3' HG23 ' A' ' 70' ' ' VAL . 32.8 ttm180 -129.08 114.8 16.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.775 2.226 . . . . 36.390000000000001 112.299 167.907 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.87 119.8 33.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.453 -3.067 . . . . 9.5500000000000007 112.643 179.709 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.9 130.74 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 123.575 1.655 . . . . 13.9 108.597 -179.816 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -111.19 104.96 13.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.534 2.587 . . . . 6.8600000000000003 113.204 166.051 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.292 . . 71.6 -83.82 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.219 -3.425 . . . . 11.15 109.575 -168.489 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.59 28.82 0.85 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 107.847 -2.101 . . . . 13.93 107.847 166.624 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -107.53 111.89 24.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.366 -2.457 . . . . 23.920000000000002 104.366 175.911 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -70.32 130.39 41.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.687 2.184 . . . . 23.23 109.359 176.852 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -91.7 123.86 35.41 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.369 -1.287 . . . . 9.1099999999999994 114.155 -171.391 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -74.79 136.85 41.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 116.467 2.025 . . . . 33.439999999999998 116.467 173.198 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -39.29 -60.83 0.86 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.351 2.723 . . . . 28.370000000000001 118.351 175.38 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.52 -10.19 47.8 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 117.057 -3.527 . . . . 15.0 121.2 -177.936 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -96.1 165.02 12.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 120.53 2.165 . . . . 25.5 114.803 -172.298 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.5 p -88.57 158.51 18.26 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.929 -4.232 . . . . 11.949999999999999 109.271 -172.073 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -62.74 -40.45 97.25 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.61 -0.723 . . . . 10.17 111.978 171.101 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 p -47.85 -36.72 12.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.735 -2.478 . . . . 13.59 116.755 168.981 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.3 -42.08 65.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.825 1.65 . . . . 11.699999999999999 108.532 -166.679 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -84.15 0.52 48.27 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.904 -1.747 . . . . 12.949999999999999 111.533 179.937 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.8 m120 73.03 41.68 0.49 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.043 0.937 . . . . 25.449999999999999 108.908 174.142 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.5 mt -85.85 122.18 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 116.877 -1.535 . . . . 14.6 113.392 177.577 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -112.75 175.31 5.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 119.429 1.013 . . . . 33.229999999999997 111.86 -175.125 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.295 19.2 pttp -66.3 151.33 47.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.523 3.058 . . . . 25.969999999999999 108.916 175.763 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 63.35 4.58 1.73 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 120.09 3.367 . . . . 32.609999999999999 120.09 -172.22 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -72.08 162.21 29.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.297 -1.774 . . . . 10.56 107.265 172.601 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.8 m -130.64 121.34 25.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.844 -1.551 . . . . 5.3300000000000001 108.994 -177.074 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.1 mt -92.51 150.33 20.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.739 2.685 . . . . 11.66 112.422 172.62 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -108.46 127.68 54.13 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.845 -3.659 . . . . 16.300000000000001 110.149 -178.088 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.6 tp -94.2 103.81 15.84 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.181 -0.918 . . . . 9.9600000000000009 112.309 -171.963 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 42' ' ' ARG 0.317 18.4 m -116.98 -169.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 106.369 -1.715 . . . . 9.7599999999999998 106.369 -174.981 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.7 mt -112.83 147.56 36.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.97 1.708 . . . . 19.57 110.285 -168.46 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -98.54 123.27 42.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.571 -1.33 . . . . 35.079999999999998 111.23 176.507 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.8 mt -111.07 166.29 11.18 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 127.787 2.435 . . . . 32.310000000000002 106.852 175.235 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.469 68.8 mtt-85 -70.99 155.94 40.23 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 126.013 2.071 . . . . 42.75 115.639 -168.831 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.14 -72.5 0.25 Allowed Glycine 0 N--CA 1.43 -1.767 0 CA-C-N 122.522 2.419 . . . . 36.310000000000002 113.023 178.868 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.706 0 CA-C-O 124.735 2.297 . . . . 36.270000000000003 112.969 -168.614 . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.9 ptm . . . . . 0 CA--C 1.49 -1.336 0 N-CA-C 118.434 2.753 . . . . 17.170000000000002 118.434 . . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -87.47 125.62 34.41 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.744 -1.848 . . . . 21.890000000000001 107.089 -174.897 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.0 pt -115.91 163.69 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 112.069 -2.332 . . . . 10.83 107.168 174.034 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -124.72 132.94 53.34 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.147 2.579 . . . . 10.609999999999999 106.532 -177.354 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.24 117.63 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 121.142 -0.974 . . . . 9.1300000000000008 109.57 176.661 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -109.94 141.22 43.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.341 -2.724 . . . . 20.550000000000001 115.745 -179.62 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.4 p -83.59 -171.87 3.83 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.295 1.22 . . . . 11.779999999999999 114.295 179.744 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 tp -72.62 -35.07 67.74 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.729 -3.107 . . . . 19.309999999999999 109.802 -178.34 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 p -87.15 -49.16 7.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 104.247 -2.501 . . . . 23.140000000000001 104.247 -178.083 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.98 59.48 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 117.403 -1.776 . . . . 19.739999999999998 116.599 166.156 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.472 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 75.7 tttt -96.51 125.41 40.98 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.706 -3.442 . . . . 21.93 101.706 166.687 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -105.23 122.37 45.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.976 -2.601 . . . . 12.33 103.976 -175.853 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 pt -108.49 130.76 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 125.808 2.718 . . . . 17.079999999999998 116.06 168.759 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -86.34 116.45 24.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.664 -3.772 . . . . 16.300000000000001 107.915 179.513 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.0 mt -121.39 156.38 32.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.906 -2.371 . . . . 15.880000000000001 109.319 -179.341 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -130.98 129.99 42.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.097 -2.557 . . . . 28.899999999999999 104.097 179.995 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -148.57 179.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.882 1.673 . . . . 12.050000000000001 108.652 177.009 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -107.58 169.14 7.01 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 119.677 -1.889 . . . . 18.170000000000002 107.533 174.953 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -83.67 -2.24 10.33 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 124.712 3.608 . . . . 8.1600000000000001 113.021 -173.103 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.273 73.4 m -101.68 -0.44 34.6 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 126.266 2.229 . . . . 11.130000000000001 110.499 174.14 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.4 145.15 49.52 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.396 -3.315 . . . . 18.030000000000001 110.099 173.029 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -79.63 164.51 23.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.066 -2.271 . . . . 10.220000000000001 113.848 173.038 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -57.21 -38.52 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 126.668 1.987 . . . . 12.300000000000001 109.604 171.08 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.65 -51.97 19.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.001 1.721 . . . . 36.509999999999998 114.066 167.943 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -72.65 -12.38 61.01 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.458 1.503 . . . . 25.66 114.288 176.565 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.4 t -80.03 -50.05 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 104.165 -2.531 . . . . 8.1199999999999992 104.165 172.668 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.298 62.7 mttt -47.78 -38.65 16.12 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.415 2.686 . . . . 15.470000000000001 113.875 170.039 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.56 -44.34 93.31 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.672 2.789 . . . . 11.449999999999999 115.136 -178.271 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -69.89 -40.4 75.68 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.814 2.846 . . . . 24.98 107.731 178.307 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.45 -33.58 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 124.454 1.096 . . . . 9.4600000000000009 109.153 179.484 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.42 -44.03 92.95 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.153 -2.217 . . . . 14.76 114.139 172.708 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -59.7 -61.21 2.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.572 1.949 . . . . 26.289999999999999 113.855 171.727 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.99 -52.02 67.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 121.059 3.725 . . . . 30.059999999999999 121.059 -179.991 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.472 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 14.2 mm-40 -108.97 -29.87 8.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.584 1.327 . . . . 25.190000000000001 114.584 -157.584 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.19 41.21 8.11 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.201 -1.16 . . . . 7.4100000000000001 110.201 177.244 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.1 mt -102.73 120.06 53.89 Favored Pre-proline 0 N--CA 1.431 -1.424 0 CA-C-O 115.461 -2.209 . . . . 9.4900000000000002 111.678 169.055 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -59.14 146.25 95.06 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 CA-C-N 126.305 3.287 . . . . 11.42 114.227 172.424 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.24 -29.53 90.59 Favored 'Trans proline' 0 C--N 1.299 -2.027 1 C-N-CA 125.333 4.022 . . . . 12.0 116.438 179.93 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.9 -42.37 94.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.988 -3.57 . . . . 35.549999999999997 113.266 168.851 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.434 ' HG2' HD22 ' A' ' 71' ' ' LEU 0.287 12.7 tt0 -64.95 -35.17 80.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.748 2.019 . . . . 20.52 112.618 173.092 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -81.14 136.81 35.94 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.418 -2.676 . . . . 7.1299999999999999 115.647 -177.462 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -128.94 117.46 21.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 128.062 3.351 . . . . 36.390000000000001 110.031 167.077 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.8 mt -91.68 121.91 33.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.493 -1.717 . . . . 9.5500000000000007 109.24 179.599 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mt -111.05 133.27 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 124.525 3.329 . . . . 13.9 108.262 178.041 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -115.38 107.59 15.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.148 2.979 . . . . 6.8600000000000003 107.147 172.196 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 63.38 -96.07 0.05 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.331 2.652 . . . . 11.15 111.823 -166.545 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.71 -5.5 9.11 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.675 1.708 . . . . 13.93 109.541 -178.372 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -98.75 126.55 44.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.49 -3.947 . . . . 23.920000000000002 105.985 -166.832 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -90.61 141.31 28.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 127.712 3.625 . . . . 23.23 106.344 176.071 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.365 97.1 mt -104.52 133.77 48.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.748 -3.72 . . . . 9.1099999999999994 114.312 -168.827 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -74.63 154.83 38.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.687 2.395 . . . . 33.439999999999998 112.231 174.881 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -73.16 -55.57 6.29 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 130.053 3.341 . . . . 28.370000000000001 112.346 -167.131 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.73 18.47 30.09 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 119.136 2.415 . . . . 15.0 119.136 -172.766 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -114.01 146.6 39.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.606 2.146 . . . . 25.5 109.897 169.763 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.264 73.3 p -75.99 162.82 27.74 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 128.937 2.895 . . . . 11.949999999999999 116.866 -179.105 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.9 mt -58.43 -49.57 76.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 128.807 3.817 . . . . 10.17 109.92 174.873 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.357 88.9 p -57.54 -43.96 84.77 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.795 3.238 . . . . 13.59 119.487 178.698 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -53.81 -53.42 52.58 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 121.588 3.921 . . . . 11.699999999999999 121.588 162.924 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -62.44 -21.01 65.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.66 2.467 . . . . 12.949999999999999 117.66 169.325 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.347 58.2 t30 60.04 67.64 0.85 Allowed 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.508 2.04 . . . . 25.449999999999999 116.508 -161.556 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -118.5 117.39 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.5 -2.778 . . . . 14.6 103.5 170.198 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.35 -163.15 1.01 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.48 2.562 . . . . 33.229999999999997 112.685 -175.536 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -76.0 156.71 33.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.213 -3.43 . . . . 25.969999999999999 115.427 168.548 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.85 23.33 13.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.31 2.244 . . . . 32.609999999999999 110.741 176.663 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -85.36 122.53 29.65 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.071 1.748 . . . . 10.56 113.335 175.631 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.9 m -88.52 98.9 11.91 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 116.132 -1.89 . . . . 5.3300000000000001 112.498 170.667 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.96 140.04 29.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.704 2.002 . . . . 11.66 109.015 -179.966 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -98.64 107.61 20.1 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.428 -1.42 . . . . 16.300000000000001 113.49 -173.267 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -82.88 109.78 17.31 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 129.156 2.982 . . . . 9.9600000000000009 112.368 -177.172 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.9 m -121.58 161.76 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 116.726 -3.733 . . . . 9.7599999999999998 106.912 177.981 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.434 HD22 ' HG2' ' A' ' 40' ' ' GLN . 29.8 mt -81.28 138.67 35.71 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.591 -1.263 . . . . 19.57 107.591 -173.087 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -109.78 107.38 17.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.579 2.751 . . . . 35.079999999999998 104.525 171.048 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 71' ' ' LEU . 1.2 mm? -91.35 -142.68 0.18 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.303 -3.998 . . . . 32.310000000000002 108.778 168.951 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -96.11 171.93 8.3 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.202 1.953 . . . . 42.75 108.379 174.03 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.4 -62.74 4.04 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 111.496 -2.593 . . . . 36.310000000000002 115.428 -170.876 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 C-N-CA 115.121 -3.418 . . . . 36.270000000000003 110.618 -176.13 . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 106.484 -1.672 . . . . 17.170000000000002 106.484 . . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.273 4.2 pt20 -113.28 127.69 56.23 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.712 -2.493 . . . . 21.890000000000001 112.773 176.189 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -120.34 174.48 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 125.293 2.473 . . . . 10.83 108.102 171.883 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -120.96 145.9 47.23 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 112.744 -2.026 . . . . 10.609999999999999 109.802 -176.78 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.99 122.53 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 107.402 -1.333 . . . . 9.1300000000000008 107.402 173.218 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -136.05 142.21 44.37 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.394 -3.941 . . . . 20.550000000000001 115.338 -164.33 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.278 80.7 p -80.85 -171.5 3.2 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 126.533 3.064 . . . . 11.779999999999999 110.03 -170.612 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.89 -40.5 60.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 131.556 3.943 . . . . 19.309999999999999 114.266 166.945 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.18 -47.6 49.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.544 -3.223 . . . . 23.140000000000001 111.031 173.606 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.91 35.91 0.23 Allowed Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 114.637 -3.313 . . . . 19.739999999999998 115.593 172.782 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -88.03 121.58 30.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 113.746 -3.026 . . . . 21.93 110.701 178.784 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -108.19 137.57 45.94 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 121.695 2.043 . . . . 12.33 114.037 -172.331 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.1 pt -124.6 136.78 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 118.532 -1.267 . . . . 17.079999999999998 107.804 172.776 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.3 m -82.81 120.89 26.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.176 3.39 . . . . 16.300000000000001 108.564 168.862 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -115.17 132.73 56.51 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.966 -2.334 . . . . 15.880000000000001 107.123 174.504 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -107.82 115.09 29.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.191 -2.818 . . . . 28.899999999999999 108.762 -178.681 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.31 162.04 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 124.559 1.162 . . . . 12.050000000000001 109.473 -166.928 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -90.7 155.08 45.89 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 120.374 -1.454 . . . . 18.170000000000002 107.444 159.512 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -60.95 -23.39 77.17 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 122.722 2.282 . . . . 8.1600000000000001 112.674 168.536 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 m -69.39 -18.32 63.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.003 2.638 . . . . 11.130000000000001 113.498 173.427 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -65.53 147.15 53.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.525 2.875 . . . . 18.030000000000001 108.574 179.162 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -85.08 172.91 10.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.933 1.827 . . . . 10.220000000000001 115.933 179.061 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.15 -27.11 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 124.053 0.846 . . . . 12.300000000000001 109.326 178.432 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -50.81 -59.54 4.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.386 -2.188 . . . . 36.509999999999998 114.143 167.634 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -55.14 -45.77 75.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.98 3.712 . . . . 25.66 109.984 176.082 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -60.4 -50.32 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.363 -2.086 . . . . 8.1199999999999992 113.156 -176.508 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -63.39 -37.19 86.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.014 1.864 . . . . 15.470000000000001 110.354 176.584 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.38 -13.12 36.05 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.324 -4.61 . . . . 11.449999999999999 114.206 174.726 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.7 mtpt -80.04 -49.24 12.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.909 -2.994 . . . . 24.98 117.487 169.189 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.9 mt -60.23 -30.26 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 126.096 2.855 . . . . 9.4600000000000009 112.523 171.944 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -70.7 -43.35 69.17 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.346 -3.971 . . . . 14.76 117.143 172.969 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.33 -49.53 74.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.793 2.516 . . . . 26.289999999999999 117.793 159.313 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -79.94 -74.73 0.29 Allowed 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 116.266 -4.021 . . . . 30.059999999999999 111.274 -176.606 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -64.94 -43.3 93.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 120.322 1.419 . . . . 25.190000000000001 113.824 -173.509 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.69 68.83 1.19 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 107.06 -2.416 . . . . 7.4100000000000001 107.06 179.53 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.8 128.44 23.87 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-N 113.393 -1.403 . . . . 9.4900000000000002 108.644 176.643 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -66.69 143.53 68.3 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-O 114.342 -2.441 . . . . 11.42 115.015 -174.596 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.81 -14.69 42.34 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 122.841 2.361 . . . . 12.0 113.027 -163.68 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -95.96 -22.31 17.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 123.021 2.646 . . . . 35.549999999999997 110.318 -179.66 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.378 32.9 mt-30 -71.47 -22.6 61.8 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 117.645 -1.169 . . . . 20.52 112.87 164.355 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -79.33 124.58 28.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.955 -2.609 . . . . 7.1299999999999999 103.955 175.601 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.6 mtp180 -110.89 122.13 47.09 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.978 3.311 . . . . 36.390000000000001 109.685 156.217 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.3 mt -113.78 133.23 55.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.368 2.509 . . . . 9.5500000000000007 105.435 178.101 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 mm -130.39 119.4 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 111.033 -2.803 . . . . 13.9 103.733 -163.244 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -93.98 108.88 20.65 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.453 1.501 . . . . 6.8600000000000003 110.773 158.194 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.53 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.48 -2.637 . . . . 11.15 112.118 179.825 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.88 36.72 1.21 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 126.192 1.853 . . . . 13.93 110.756 165.965 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -108.28 123.74 49.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.5 -2.177 . . . . 23.920000000000002 113.68 162.581 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -81.57 136.07 35.57 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.186 -3.446 . . . . 23.23 109.386 166.246 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.428 HD21 ' H ' ' A' ' 50' ' ' LEU . 1.1 mm? -87.73 127.98 35.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.776 1.231 . . . . 9.1099999999999994 111.071 179.595 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -78.43 133.14 37.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.954 2.576 . . . . 33.439999999999998 117.954 -178.214 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -49.14 -45.37 43.6 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.363 -3.335 . . . . 28.370000000000001 116.288 -168.129 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.73 4.49 75.8 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-N 119.981 1.264 . . . . 15.0 112.586 -169.107 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.3 40.0 mtt180 -95.19 166.17 12.04 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.069 -3.607 . . . . 25.5 109.262 -178.495 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.8 p -92.66 156.24 17.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.161 -2.212 . . . . 11.949999999999999 106.475 -178.516 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.4 mt -51.14 -45.25 61.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.971 -3.581 . . . . 10.17 113.726 164.7 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.4 t -57.12 -36.6 70.85 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.826 2.051 . . . . 13.59 108.316 -177.391 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -64.59 -30.9 71.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.289 -2.132 . . . . 11.699999999999999 113.512 -167.486 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -87.27 0.61 55.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.165 -1.38 . . . . 12.949999999999999 113.044 178.423 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 62.23 49.21 4.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.837 1.655 . . . . 25.449999999999999 112.605 -178.742 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.94 112.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.895 2.478 . . . . 14.6 109.85 172.037 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -84.68 -162.57 0.7 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.375 2.036 . . . . 33.229999999999997 112.222 178.087 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -88.06 164.86 15.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.779 -3.7 . . . . 25.969999999999999 111.141 172.815 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.381 37.3 mt-10 73.54 1.1 3.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.683 1.593 . . . . 32.609999999999999 112.439 173.7 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.346 8.7 t -88.06 140.13 29.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.363 -2.71 . . . . 10.56 112.277 -168.581 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.0 m -100.68 113.93 27.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 126.059 2.837 . . . . 5.3300000000000001 108.826 -178.507 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.1 mt -87.6 144.99 26.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.515 2.783 . . . . 11.66 118.515 165.519 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -96.39 120.59 36.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.318 -3.989 . . . . 16.300000000000001 112.501 179.522 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 tp -94.08 120.99 35.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.167 -2.288 . . . . 9.9600000000000009 110.43 -177.325 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.1 t -118.27 138.22 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 129.735 3.214 . . . . 9.7599999999999998 111.254 -173.56 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.3 tp -96.35 151.29 19.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.867 2.604 . . . . 19.57 106.535 176.615 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -118.14 139.94 50.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 117.657 -1.164 . . . . 35.079999999999998 108.418 148.583 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.264 77.7 mt -73.38 167.74 20.63 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.407 2.942 . . . . 32.310000000000002 115.434 173.071 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -78.38 143.61 36.69 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.765 1.745 . . . . 42.75 110.299 172.398 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.5 84.85 1.83 Allowed Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 106.718 -2.553 . . . . 36.310000000000002 106.718 -178.693 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 CA-C-N 113.086 -1.557 . . . . 36.270000000000003 110.96 177.518 . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.491 -1.325 0 CA-C-O 121.382 0.61 . . . . 17.170000000000002 109.687 . . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.92 133.76 35.78 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.139 -3.475 . . . . 21.890000000000001 112.836 171.012 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -118.94 147.89 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 128.599 4.047 . . . . 10.83 116.021 164.664 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -97.17 128.16 43.81 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.893 -3.63 . . . . 10.609999999999999 108.323 176.391 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -118.58 131.61 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.153 -2.536 . . . . 9.1300000000000008 104.153 173.214 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -105.82 157.17 17.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.331 -3.355 . . . . 20.550000000000001 109.607 173.749 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 56.1 p -99.79 178.32 4.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.742 3.217 . . . . 11.779999999999999 109.403 175.517 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.4 tp -77.2 -36.9 54.46 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.517 -2.614 . . . . 19.309999999999999 110.84 178.744 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -38.18 72.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.96 -1.713 . . . . 23.140000000000001 111.991 160.662 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.51 33.72 2.23 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 117.382 1.713 . . . . 19.739999999999998 117.382 171.529 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -80.8 119.44 23.38 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.919 2.487 . . . . 21.93 105.807 -179.775 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -81.34 104.51 11.84 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.693 3.121 . . . . 12.33 116.578 169.833 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 pt -100.83 147.4 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 124.622 1.169 . . . . 17.079999999999998 112.583 174.587 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 m -111.28 99.47 8.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.816 -2.291 . . . . 16.300000000000001 104.816 -172.248 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.7 mt -97.33 118.67 34.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.799 -3.688 . . . . 15.880000000000001 110.412 179.288 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -80.82 128.37 33.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.734 -1.229 . . . . 28.899999999999999 108.142 165.302 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 m -147.72 164.35 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 103.794 -2.669 . . . . 12.050000000000001 103.794 -178.48 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -105.81 140.72 21.49 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 116.44 -1.743 . . . . 18.170000000000002 109.103 171.91 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.44 -5.71 11.79 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 124.767 2.738 . . . . 8.1600000000000001 113.036 -167.046 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.4 p -69.28 -26.2 64.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.744 0.818 . . . . 11.130000000000001 112.483 169.522 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -75.73 178.28 6.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.522 2.415 . . . . 18.030000000000001 117.522 174.935 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 9.2 p -106.76 178.8 4.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.719 -3.113 . . . . 10.220000000000001 111.617 -165.71 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 11.3 mm -69.81 -35.47 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 116.854 -3.654 . . . . 12.300000000000001 114.261 168.479 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -52.31 -44.59 65.16 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 117.124 -1.417 . . . . 36.509999999999998 114.431 167.051 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -52.49 -49.36 64.89 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 114.947 -2.454 . . . . 25.66 114.612 163.477 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.18 -43.34 97.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 122.091 2.223 . . . . 8.1199999999999992 109.37 -177.084 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.66 -35.54 70.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.161 2.282 . . . . 15.470000000000001 117.161 172.883 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.21 -25.65 63.51 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 126.898 3.237 . . . . 11.449999999999999 116.968 170.662 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -75.2 -27.35 59.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.792 -2.458 . . . . 24.98 111.786 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -80.47 -37.51 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 118.057 -2.902 . . . . 9.4600000000000009 107.923 178.851 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.418 ' HG2' ' HA ' ' A' ' 37' ' ' PRO . 0.3 OUTLIER -63.11 -52.49 62.4 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 115.205 -2.331 . . . . 14.76 107.769 -178.773 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -52.99 -45.52 67.88 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.981 2.912 . . . . 26.289999999999999 113.495 173.362 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -74.33 -95.84 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.277 4.231 . . . . 30.059999999999999 112.643 176.879 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -71.36 -9.41 58.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.122 2.237 . . . . 25.190000000000001 111.449 -162.608 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.46 52.66 5.92 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.51 -1.994 . . . . 7.4100000000000001 117.105 179.975 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.68 110.62 22.69 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.086 -2.864 . . . . 9.4900000000000002 106.321 -170.876 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.418 ' HA ' ' HG2' ' A' ' 31' ' ' GLN . 30.7 Cg_exo -59.06 147.03 92.24 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 128.782 4.172 . . . . 11.42 111.531 -177.58 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -75.12 -8.19 19.72 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 121.397 1.398 . . . . 12.0 112.925 -161.943 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -74.81 -39.86 61.43 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.201 1.953 . . . . 35.549999999999997 115.167 -174.299 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -66.95 -28.05 67.96 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 132.691 4.397 . . . . 20.52 114.913 173.12 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.4 117.54 12.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.955 2.788 . . . . 7.1299999999999999 114.489 -169.969 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -111.55 98.37 7.4 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.512 -3.243 . . . . 36.390000000000001 107.499 176.727 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.05 122.3 33.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 111.779 -2.464 . . . . 9.5500000000000007 111.59 176.466 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mm -112.26 144.37 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 124.119 1.914 . . . . 13.9 110.424 -177.887 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -123.31 114.17 19.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.854 2.74 . . . . 6.8600000000000003 107.962 161.394 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.306 . . 70.6 -88.05 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.677 -2.514 . . . . 11.15 115.889 -177.046 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.22 8.28 2.13 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 126.4 1.952 . . . . 13.93 110.291 165.073 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -88.29 149.96 23.51 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 114.704 -4.998 . . . . 23.920000000000002 108.173 168.5 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -109.96 146.99 34.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.961 -3.348 . . . . 23.23 101.961 -179.02 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.9 mt -104.25 137.87 41.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.589 1.699 . . . . 9.1099999999999994 115.589 -171.819 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.407 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 19.4 tp10 -97.4 155.46 16.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 120.524 1.511 . . . . 33.439999999999998 112.735 -169.661 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.438 ' O ' ' HB ' ' A' ' 22' ' ' THR . 15.0 m-20 -69.52 -61.39 1.81 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.374 1.25 . . . . 28.370000000000001 114.374 -162.448 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.16 42.46 2.74 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 117.08 1.592 . . . . 15.0 117.08 -179.962 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -131.59 154.93 48.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 119.141 1.47 . . . . 25.5 107.44 175.393 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -88.67 146.22 25.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 121.325 3.824 . . . . 11.949999999999999 121.325 -176.913 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.7 mt -54.74 -38.19 66.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.078 1.751 . . . . 10.17 114.984 171.854 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -51.62 -55.19 20.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.486 3.143 . . . . 13.59 119.486 166.861 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.74 -49.12 73.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.796 2.438 . . . . 11.699999999999999 115.093 176.923 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -71.53 -6.55 41.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.339 3.456 . . . . 12.949999999999999 112.825 173.72 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 54.32 44.21 29.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.949 2.203 . . . . 25.449999999999999 116.949 -179.961 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.0 120.55 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 129.593 3.157 . . . . 14.6 105.179 171.763 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -103.68 170.38 7.97 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.955 -1.716 . . . . 33.229999999999997 109.555 -178.205 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -47.06 141.12 4.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.506 2.378 . . . . 25.969999999999999 110.863 167.355 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 66.6 mt-10 51.9 20.37 1.19 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.818 2.896 . . . . 32.609999999999999 118.818 -175.674 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 t -75.18 165.21 25.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.078 2.551 . . . . 10.56 110.815 171.901 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.5 m -122.47 101.77 7.69 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 112.877 -3.44 . . . . 5.3300000000000001 108.021 -164.496 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.94 156.98 19.59 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 125.661 1.851 . . . . 11.66 110.506 163.313 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -118.73 119.9 35.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.019 -2.301 . . . . 16.300000000000001 112.817 -177.452 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.39 98.45 11.49 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.505 -2.622 . . . . 9.9600000000000009 111.42 -175.969 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.48 156.84 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 125.386 1.679 . . . . 9.7599999999999998 110.198 167.652 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.2 mt -136.26 139.86 43.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.321 -2.112 . . . . 19.57 111.645 -172.871 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -112.42 176.94 4.81 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.905 4.082 . . . . 35.079999999999998 115.985 165.723 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.407 ' HB3' ' H ' ' A' ' 74' ' ' ARG . 75.9 mt -108.05 -161.99 0.8 Allowed 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 124.206 1.955 . . . . 32.310000000000002 106.394 -171.188 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.407 ' H ' ' HB3' ' A' ' 73' ' ' LEU . 26.0 mmt180 -94.15 152.62 18.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.295 1.998 . . . . 42.75 109.717 173.991 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.14 -45.3 1.16 Allowed Glycine 0 N--CA 1.431 -1.672 0 O-C-N 120.284 -1.51 . . . . 36.310000000000002 111.616 175.348 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 N-CA-C 105.294 -3.122 . . . . 36.270000000000003 105.294 -172.323 . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.49 -1.332 0 N-CA-C 115.445 1.646 . . . . 17.170000000000002 115.445 . . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.51 132.78 46.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.649 -2.532 . . . . 21.890000000000001 105.738 171.842 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 pt -110.2 156.77 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 113.752 -1.567 . . . . 10.83 109.851 170.005 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -98.0 135.76 39.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 118.292 -0.861 . . . . 10.609999999999999 109.706 177.727 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.36 121.67 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 N-CA-C 99.337 -4.32 . . . . 9.1300000000000008 99.337 171.197 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -102.81 128.83 49.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 126.791 2.557 . . . . 20.550000000000001 109.072 177.063 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.7 p -96.09 176.59 6.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.497 -2.627 . . . . 11.779999999999999 112.511 -170.563 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.1 tp -80.61 -30.32 36.8 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.644 -5.035 . . . . 19.309999999999999 111.116 -173.658 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.7 p -68.33 -69.74 0.31 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.42 2.748 . . . . 23.140000000000001 118.42 162.538 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.98 38.39 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.712 0 O-C-N 119.891 -1.756 . . . . 19.739999999999998 112.144 174.226 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -99.6 132.33 45.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 119.388 1.594 . . . . 21.93 110.856 171.646 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.2 m -111.74 111.28 22.15 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.612 -2.736 . . . . 12.33 103.612 172.862 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -96.35 145.46 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 112.934 -1.939 . . . . 17.079999999999998 110.11 -178.736 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.7 m -106.33 112.22 25.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.964 -1.085 . . . . 16.300000000000001 113.593 178.613 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -111.54 130.12 55.84 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.366 1.467 . . . . 15.880000000000001 109.196 -175.132 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -97.58 132.33 43.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.316 -1.49 . . . . 28.899999999999999 109.621 173.898 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -155.88 162.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 119.389 -2.07 . . . . 12.050000000000001 113.191 -168.396 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -93.72 153.94 41.06 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 126.113 1.765 . . . . 18.170000000000002 109.026 177.378 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -60.83 -26.1 82.45 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 O-C-N 116.343 -2.503 . . . . 8.1600000000000001 115.941 171.667 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.0 p -82.16 -16.44 49.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.18 1.792 . . . . 11.130000000000001 114.78 -177.625 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.77 143.01 55.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.705 1.241 . . . . 18.030000000000001 113.273 170.185 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -97.84 158.78 15.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.053 -2.279 . . . . 10.220000000000001 109.587 -175.79 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.0 mm -53.19 -46.44 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 128.558 2.743 . . . . 12.300000000000001 111.722 171.501 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -45.82 -55.54 6.49 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.362 1.615 . . . . 36.509999999999998 115.362 161.962 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -54.65 -34.53 62.3 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.102 3.761 . . . . 25.66 112.851 173.643 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.34 -33.39 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.199 -2.188 . . . . 8.1199999999999992 110.028 177.79 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -67.28 -35.78 80.19 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.84 0.856 . . . . 15.470000000000001 111.81 179.898 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.1 82.43 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 132.212 4.205 . . . . 11.449999999999999 118.102 166.319 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.422 -3.924 . . . . 24.98 111.417 169.935 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 mt -53.06 -48.23 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 113.112 -3.328 . . . . 9.4600000000000009 110.927 170.103 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -37.45 78.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 124.903 3.501 . . . . 14.76 116.363 176.996 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -77.34 -38.46 50.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.057 -2.277 . . . . 26.289999999999999 111.734 -177.661 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -81.25 -42.44 20.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.279 2.309 . . . . 30.059999999999999 110.96 -176.194 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -99.57 -44.2 6.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.012 1.863 . . . . 25.190000000000001 114.899 -169.179 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.74 45.46 4.56 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 118.424 -2.673 . . . . 7.4100000000000001 108.91 -177.489 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.7 mt -102.7 133.6 20.35 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 107.021 -1.474 . . . . 9.4900000000000002 107.021 161.714 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.77 157.06 27.75 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 121.697 1.642 . . . . 11.42 113.464 175.83 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -68.67 -24.01 35.68 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.969 3.112 . . . . 12.0 118.406 -169.127 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.73 -24.76 65.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.034 -2.348 . . . . 35.549999999999997 111.36 172.918 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -75.77 -31.82 59.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.288 -3.382 . . . . 20.52 111.132 175.521 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -94.72 89.2 5.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.104 -1.623 . . . . 7.1299999999999999 111.037 -145.257 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -88.34 115.2 25.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.994 -3.566 . . . . 36.390000000000001 106.284 171.527 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.6 mt -91.26 121.83 33.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.471 -2.789 . . . . 9.5500000000000007 103.471 177.157 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.65 132.24 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 124.501 2.096 . . . . 13.9 110.61 176.208 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.401 ' HB2' HD13 ' A' ' 50' ' ' LEU . 5.7 t80 -107.21 105.48 15.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.459 -3.276 . . . . 6.8600000000000003 107.866 166.754 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.309 . . 60.49 -76.42 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.617 2.367 . . . . 11.15 115.838 -168.554 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.03 -20.0 3.48 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 126.689 2.09 . . . . 13.93 117.413 173.347 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.278 50.3 pttt -109.42 142.03 40.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.378 3.089 . . . . 23.920000000000002 105.118 -160.919 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -79.82 140.09 36.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.439 1.114 . . . . 23.23 109.782 -176.767 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.401 HD13 ' HB2' ' A' ' 45' ' ' PHE . 23.2 mt -84.3 128.7 34.73 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.617 -3.802 . . . . 9.1099999999999994 112.847 177.432 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -83.6 136.83 34.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.117 2.967 . . . . 33.439999999999998 108.635 -174.68 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.277 0.9 OUTLIER -42.84 -63.53 0.77 Allowed 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 122.332 4.197 . . . . 28.370000000000001 122.332 -174.063 . . . . . . . . 4 3 . 1 . 059 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.97 37.11 2.34 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 128.974 3.178 . . . . 15.0 115.191 -171.517 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -132.06 148.25 52.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.984 2.216 . . . . 25.5 116.984 178.338 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.7 p -88.62 157.54 18.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 123.512 1.625 . . . . 11.949999999999999 113.126 -172.236 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.9 mt -71.69 -28.36 63.66 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.513 3.53 . . . . 10.17 110.685 -174.46 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.6 t -68.05 -44.42 76.44 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 118.042 -2.911 . . . . 13.59 113.004 173.386 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -56.35 -40.51 74.62 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.364 1.866 . . . . 11.699999999999999 111.79 177.179 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -85.34 -17.83 35.61 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.849 1.425 . . . . 12.949999999999999 114.849 175.632 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.508 12.9 m120 83.89 44.41 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.929 -2.357 . . . . 25.449999999999999 112.772 172.799 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.7 mm -79.24 117.12 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 113.965 -1.47 . . . . 14.6 112.685 174.837 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -91.72 178.47 5.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.069 -3.519 . . . . 33.229999999999997 108.351 -178.821 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -65.57 154.8 37.67 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 115.492 -2.483 . . . . 25.969999999999999 112.005 172.874 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.47 36.42 11.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.115 -2.241 . . . . 32.609999999999999 110.645 172.075 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 t -109.1 142.27 40.08 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.828 1.955 . . . . 10.56 112.437 -174.708 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -97.62 115.97 28.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 116.011 -1.947 . . . . 5.3300000000000001 113.158 -170.883 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.31 141.43 28.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.022 1.451 . . . . 11.66 107.389 167.376 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.2 113.22 25.73 Favored 'General case' 0 N--CA 1.43 -1.433 1 CA-C-O 129.145 4.307 . . . . 16.300000000000001 107.803 -170.546 . . . . . . . . 3 3 . 1 . 059 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.9 tp -81.84 105.53 13.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 117.287 -3.383 . . . . 9.9600000000000009 110.843 -178.016 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.19 113.52 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 123.329 1.538 . . . . 9.7599999999999998 112.615 174.064 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.5 mt -89.5 143.55 26.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.229 -2.794 . . . . 19.57 115.467 -178.333 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -108.18 154.36 21.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.599 2.142 . . . . 35.079999999999998 107.624 178.133 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 mt -78.56 145.26 34.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.683 -3.136 . . . . 32.310000000000002 105.355 -179.319 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -64.29 120.62 12.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.035 1.494 . . . . 42.75 115.035 -167.259 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.45 29.84 8.56 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 126.473 2.358 . . . . 36.310000000000002 114.688 171.216 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.735 0 O-C-N 125.861 1.565 . . . . 36.270000000000003 114.299 -170.244 . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptt? . . . . . 0 CA--C 1.49 -1.328 0 N-CA-C 116.686 2.106 . . . . 17.170000000000002 116.686 . . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.77 147.09 37.62 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 117.124 -1.417 . . . . 21.890000000000001 110.268 178.478 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.424 HD13 ' CD1' ' A' ' 67' ' ' LEU . 15.0 pt -125.93 156.23 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.638 -2.727 . . . . 10.83 103.638 160.727 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -99.11 117.25 33.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 112.001 -2.363 . . . . 10.609999999999999 115.196 169.233 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.8 t -107.05 111.43 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.108 -3.495 . . . . 9.1300000000000008 109.291 179.796 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -90.23 113.48 25.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.63 -1.623 . . . . 20.550000000000001 111.479 -171.727 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.391 9.0 p -70.72 172.55 8.54 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.533 -2.605 . . . . 11.779999999999999 115.302 173.672 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.1 tp -98.23 3.85 48.88 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.901 3.239 . . . . 19.309999999999999 109.48 177.763 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -85.59 -71.22 0.54 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.663 -3.773 . . . . 23.140000000000001 106.34 168.937 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.36 13.67 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.725 0 O-C-N 126.452 2.345 . . . . 19.739999999999998 114.499 -174.502 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -98.37 132.48 43.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.533 -3.333 . . . . 21.93 108.208 179.68 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -104.91 103.1 12.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.483 -3.885 . . . . 12.33 115.294 165.485 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -80.36 136.82 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.538 -2.601 . . . . 17.079999999999998 111.091 179.206 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 m -107.76 135.84 48.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.286 3.422 . . . . 16.300000000000001 106.13 175.733 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -132.47 157.15 45.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.386 -2.696 . . . . 15.880000000000001 107.163 -176.691 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -112.21 111.28 22.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.265 2.226 . . . . 28.899999999999999 108.195 -176.341 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.22 155.78 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 124.248 1.975 . . . . 12.050000000000001 110.466 -168.23 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.94 165.67 16.57 Favored Pre-proline 0 N--CA 1.43 -1.429 1 O-C-N 115.36 -4.587 . . . . 18.170000000000002 106.179 165.814 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -62.8 -22.56 73.98 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 123.155 2.57 . . . . 8.1600000000000001 115.528 168.394 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.9 m -87.07 3.51 45.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.021 3.296 . . . . 11.130000000000001 115.147 -178.429 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -77.87 145.59 36.15 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.179 -5.326 . . . . 18.030000000000001 109.32 171.533 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -78.14 170.89 15.86 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.2 1.926 . . . . 10.220000000000001 116.2 173.172 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -61.85 -35.61 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 125.316 1.446 . . . . 12.300000000000001 112.228 161.76 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.12 -43.63 97.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.803 -2.435 . . . . 36.509999999999998 111.92 174.368 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -61.02 -32.59 72.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.169 2.285 . . . . 25.66 117.169 170.741 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.333 95.6 t -60.2 -53.66 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.366 3.066 . . . . 8.1199999999999992 113.626 167.584 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -55.68 -44.53 77.4 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 121.924 4.046 . . . . 15.470000000000001 121.924 169.886 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.51 -34.26 64.49 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 125.942 2.782 . . . . 11.449999999999999 117.57 175.93 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -82.12 -27.35 32.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.199 -2.148 . . . . 24.98 105.199 -171.796 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.67 -29.94 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 103.416 -2.809 . . . . 9.4600000000000009 103.416 -176.127 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.13 -51.3 68.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.221 3.009 . . . . 14.76 110.608 170.393 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -55.43 -43.35 75.29 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.191 1.922 . . . . 26.289999999999999 116.191 173.069 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -84.04 -71.86 0.49 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.094 -1.866 . . . . 30.059999999999999 108.312 -169.138 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -74.28 -54.09 8.4 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.791 2.71 . . . . 25.190000000000001 115.526 -170.893 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.11 -24.78 1.27 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.136 -2.227 . . . . 7.4100000000000001 112.158 -177.975 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mt -69.87 122.97 87.68 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 116.658 -1.639 . . . . 9.4900000000000002 112.801 -160.802 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.44 153.39 65.83 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 C-N-CA 126.326 4.684 . . . . 11.42 110.979 176.378 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.95 -21.95 49.16 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 C-N-CA 124.627 3.552 . . . . 12.0 118.743 -168.702 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -65.58 -37.37 86.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.361 3.464 . . . . 35.549999999999997 111.127 178.695 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.26 65.7 mt-30 -76.49 -16.7 59.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.553 2.341 . . . . 20.52 113.917 -177.37 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -97.85 124.5 42.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.403 -3.311 . . . . 7.1299999999999999 110.715 -165.783 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.4 mtp180 -101.97 126.98 49.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.513 -3.867 . . . . 36.390000000000001 105.969 160.121 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mt -115.48 132.0 56.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.578 -1.326 . . . . 9.5500000000000007 107.697 177.504 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.57 134.24 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 126.554 1.941 . . . . 13.9 109.681 -159.266 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.401 ' CZ ' HG12 ' A' ' 61' ' ' ILE . 13.3 t80 -140.68 116.48 10.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.733 1.73 . . . . 6.8600000000000003 107.938 179.848 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.71 -93.92 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.739 3.216 . . . . 11.15 110.223 -178.027 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.86 11.11 7.43 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.683 -2.511 . . . . 13.93 116.625 178.591 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -128.92 153.02 47.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.222 -2.929 . . . . 23.920000000000002 112.46 -178.01 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -89.15 138.81 31.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.173 -2.529 . . . . 23.23 104.173 169.319 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.68 126.11 33.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.378 -2.646 . . . . 9.1099999999999994 115.499 -176.997 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.56 140.97 31.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 121.343 1.883 . . . . 33.439999999999998 109.967 -173.355 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.39 -62.43 1.78 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.798 3.639 . . . . 28.370000000000001 115.493 -158.377 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.83 28.04 3.69 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 118.568 -2.582 . . . . 15.0 111.965 -177.078 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -103.95 154.07 20.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.828 -2.572 . . . . 25.5 107.134 174.72 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -97.0 177.59 5.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.709 3.147 . . . . 11.949999999999999 103.769 -170.559 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.78 -34.16 73.37 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 112.567 -6.333 . . . . 10.17 117.764 172.894 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 m -64.15 -21.43 66.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.592 -1.67 . . . . 13.59 112.588 174.237 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.16 -39.64 54.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.388 1.475 . . . . 11.699999999999999 111.698 177.72 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -90.15 3.15 54.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.845 2.906 . . . . 12.949999999999999 118.845 171.239 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.379 17.9 m120 73.18 25.49 2.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.739 2.416 . . . . 25.449999999999999 116.11 171.304 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.401 HG12 ' CZ ' ' A' ' 45' ' ' PHE . 11.3 mt -83.83 127.74 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 128.855 2.862 . . . . 14.6 109.304 -176.692 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -126.37 -155.59 0.69 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.178 0.924 . . . . 33.229999999999997 110.157 179.451 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -83.33 144.87 29.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.598 -1.939 . . . . 25.969999999999999 112.412 179.673 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 87.0 6.93 0.26 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.289 3.836 . . . . 32.609999999999999 108.23 176.625 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -84.5 151.6 24.49 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 115.894 -4.254 . . . . 10.56 109.768 -167.657 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.452 5.2 m -93.24 112.56 24.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.345 2.658 . . . . 5.3300000000000001 116.258 172.87 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.424 ' CD1' HD13 ' A' ' 3' ' ' ILE . 18.4 mt -90.52 168.28 11.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.375 -3.328 . . . . 11.66 107.324 168.336 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -130.43 133.02 46.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.73 -2.481 . . . . 16.300000000000001 104.316 177.078 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -102.03 133.34 47.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.02 1.728 . . . . 9.9600000000000009 113.405 177.887 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 88.3 t -131.71 161.17 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.867 -2.271 . . . . 9.7599999999999998 104.867 174.066 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.2 mt -113.85 159.82 19.41 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.848 2.113 . . . . 19.57 110.594 178.981 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -135.41 168.25 19.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 129.734 3.214 . . . . 35.079999999999998 106.83 176.119 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 tp -94.8 -51.35 4.74 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.157 2.884 . . . . 32.310000000000002 107.049 -174.957 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -142.1 151.77 42.64 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.627 -4.421 . . . . 42.75 110.219 174.154 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.66 160.05 27.89 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 119.319 -1.419 . . . . 36.310000000000002 111.047 -177.751 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.747 0 N-CA-C 110.696 -0.961 . . . . 36.270000000000003 110.696 -168.735 . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 106.795 -1.557 . . . . 17.170000000000002 106.795 . . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.85 151.6 25.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.871 -1.899 . . . . 21.890000000000001 105.871 -178.278 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -134.5 167.42 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.593 2.139 . . . . 10.83 108.595 169.663 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -121.14 130.69 53.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.191 -2.818 . . . . 10.609999999999999 109.738 177.657 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -110.62 124.49 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 1 O-C-N 113.774 -5.579 . . . . 9.1300000000000008 105.848 161.041 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.252 77.8 tttt -109.15 134.0 52.29 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.386 -2.696 . . . . 20.550000000000001 115.752 -179.39 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -71.0 170.29 13.11 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.966 2.794 . . . . 11.779999999999999 110.678 178.745 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.4 tp -78.11 -29.82 49.11 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.33 -2.668 . . . . 19.309999999999999 114.956 177.801 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -58.6 -56.01 27.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 122.198 2.272 . . . . 23.140000000000001 112.547 165.35 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.41 38.16 0.11 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 128.709 3.052 . . . . 19.739999999999998 113.799 163.302 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -92.79 132.11 37.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 126.837 2.139 . . . . 21.93 106.42 -179.421 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -105.89 126.58 52.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.03 2.348 . . . . 12.33 110.572 -175.692 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -97.06 118.86 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 111.291 -2.686 . . . . 17.079999999999998 105.905 174.864 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.7 m -82.54 128.9 34.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.817 -1.802 . . . . 16.300000000000001 115.137 166.523 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 mt -123.55 148.91 45.88 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.695 -1.224 . . . . 15.880000000000001 107.695 -179.895 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -118.77 116.89 27.48 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.616 2.366 . . . . 28.899999999999999 106.485 177.799 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.293 34.1 m -141.29 -179.22 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 126.394 2.309 . . . . 12.050000000000001 106.443 -177.329 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -117.13 157.86 45.76 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 118.502 -2.624 . . . . 18.170000000000002 108.582 171.418 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -64.3 -8.85 17.85 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-N 126.161 3.236 . . . . 8.1600000000000001 118.029 178.818 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.1 m -88.99 -1.94 58.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.741 1.616 . . . . 11.130000000000001 113.976 -178.149 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -89.35 164.9 14.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.357 1.075 . . . . 18.030000000000001 108.976 176.831 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -87.96 168.07 13.18 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.826 2.45 . . . . 10.220000000000001 114.846 -179.624 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -75.1 -26.35 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 115.393 1.627 . . . . 12.300000000000001 115.393 172.65 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -61.77 -43.35 99.03 Favored 'General case' 0 N--CA 1.43 -1.452 2 C-N-CA 133.994 4.918 . . . . 36.509999999999998 106.999 166.113 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -65.07 -33.92 77.18 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.017 2.599 . . . . 25.66 118.017 169.647 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -60.19 -44.42 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.668 -1.27 . . . . 8.1199999999999992 111.501 171.38 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -75.25 -39.79 59.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.368 -3.332 . . . . 15.470000000000001 111.433 -175.691 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.53 -23.5 64.53 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.274 -2.141 . . . . 11.449999999999999 116.737 172.972 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -63.99 -45.22 90.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 125.095 3.588 . . . . 24.98 107.672 169.625 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.6 mt -67.09 -30.74 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.468 -2.645 . . . . 9.4600000000000009 109.952 177.36 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -60.45 -41.32 93.86 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.805 2.842 . . . . 14.76 113.963 171.777 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -68.3 -59.7 3.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.084 1.883 . . . . 26.289999999999999 116.084 163.294 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 mttm -63.57 -58.38 7.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 120.122 3.379 . . . . 30.059999999999999 120.122 -171.802 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -88.72 -55.26 3.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.718 2.007 . . . . 25.190000000000001 113.429 -174.565 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.37 20.89 2.6 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 112.077 -2.329 . . . . 7.4100000000000001 117.202 -178.152 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.0 mt -100.34 117.25 63.37 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 119.007 -2.467 . . . . 9.4900000000000002 110.829 178.641 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -73.43 154.7 50.77 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-N 127.732 3.797 . . . . 11.42 112.774 -175.694 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -69.85 -22.58 31.46 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 CA-C-O 117.682 -1.049 . . . . 12.0 113.217 -167.287 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -54.09 -41.23 68.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.649 -2.596 . . . . 35.549999999999997 117.092 175.302 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -77.38 -36.03 53.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.024 2.703 . . . . 20.52 111.854 170.221 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -69.32 115.07 8.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.16 2.652 . . . . 7.1299999999999999 118.16 -176.476 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -102.87 121.66 42.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.952 -1.499 . . . . 36.390000000000001 107.335 161.083 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 mt -99.15 132.43 44.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.382 1.901 . . . . 9.5500000000000007 109.382 175.971 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -125.56 122.74 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.739 2.416 . . . . 13.9 109.523 -170.001 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -104.3 120.0 40.21 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.185 1.357 . . . . 6.8600000000000003 109.19 168.76 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.49 . . 62.98 -102.59 0.11 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.941 -1.1 . . . . 11.15 113.457 -167.717 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.75 16.85 5.3 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 117.424 -3.298 . . . . 13.93 107.497 171.306 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -95.52 131.64 41.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.778 2.831 . . . . 23.920000000000002 109.335 177.209 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -87.99 133.0 34.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 124.872 1.358 . . . . 23.23 110.355 178.665 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 mt -93.13 120.47 33.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.662 1.185 . . . . 9.1099999999999994 110.998 -175.116 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -78.55 139.0 38.66 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.607 1.563 . . . . 33.439999999999998 113.576 169.024 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -64.75 -40.23 94.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.372 2.269 . . . . 28.370000000000001 113.33 -165.575 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.53 29.14 5.0 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 116.725 1.45 . . . . 15.0 116.725 177.23 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -109.75 164.09 12.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.903 -2.528 . . . . 25.5 107.27 162.873 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -93.31 165.17 12.92 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.772 1.748 . . . . 11.949999999999999 114.06 173.581 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -59.48 -35.24 73.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.748 -1.845 . . . . 10.17 112.669 174.473 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 t -66.55 -32.01 73.08 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 119.807 3.262 . . . . 13.59 119.807 174.085 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -63.37 -39.22 93.92 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 123.615 1.674 . . . . 11.699999999999999 110.638 175.571 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -88.14 -4.53 58.74 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.351 2.26 . . . . 12.949999999999999 112.376 178.727 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.8 m120 50.96 56.05 8.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.666 1.986 . . . . 25.449999999999999 114.504 -168.43 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.0 mt -103.16 103.57 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 101.204 -3.628 . . . . 14.6 101.204 178.278 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -89.74 -171.85 3.33 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.501 2.72 . . . . 33.229999999999997 111.288 -177.444 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -69.06 143.77 54.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 105.461 -2.051 . . . . 25.969999999999999 105.461 -170.831 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 25.3 mt-10 64.67 26.43 13.15 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.951 2.204 . . . . 32.609999999999999 116.951 172.673 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 t -93.34 144.5 25.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 104.383 -2.451 . . . . 10.56 104.383 -173.535 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.6 m -110.78 124.15 51.45 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 114.277 -1.329 . . . . 5.3300000000000001 110.737 -171.951 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mt -95.22 140.94 29.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.114 3.365 . . . . 11.66 108.136 174.603 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -89.03 143.26 26.97 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.142 1.449 . . . . 16.300000000000001 108.952 165.894 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -119.51 119.82 34.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.167 -2.16 . . . . 9.9600000000000009 105.167 -171.989 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.1 t -109.76 132.42 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 114.563 -1.199 . . . . 9.7599999999999998 110.568 -179.778 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.1 mt -98.13 118.59 35.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.231 -2.793 . . . . 19.57 113.569 174.716 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.567 HH12 ' C ' ' A' ' 76' ' ' GLY . 30.3 ptt180 -92.87 170.03 10.0 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.673 -1.232 . . . . 35.079999999999998 107.673 163.585 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.1 tp -79.63 -85.62 0.08 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 116.242 1.942 . . . . 32.310000000000002 116.242 173.776 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -153.41 141.88 20.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.005 1.73 . . . . 42.75 110.165 167.814 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.59 -82.58 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 CA-C-O 125.21 2.561 . . . . 36.310000000000002 114.931 176.064 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.567 ' C ' HH12 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.261 1.783 0 CA-C-N 111.542 -2.329 . . . . 36.270000000000003 112.937 168.984 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 116.845 2.165 . . . . 17.170000000000002 116.845 . . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.64 128.46 33.64 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.496 -2.628 . . . . 21.890000000000001 108.77 172.221 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -124.01 173.33 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.935 -2.978 . . . . 10.83 103.548 163.901 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.269 77.5 m-85 -128.18 136.3 50.91 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.782 -0.821 . . . . 10.609999999999999 108.782 -176.31 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -113.62 117.16 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 125.971 2.796 . . . . 9.1300000000000008 106.768 175.401 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 ttpt -95.91 136.77 35.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.343 -1.753 . . . . 20.550000000000001 111.117 174.666 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -88.89 -169.29 2.47 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 128.15 3.833 . . . . 11.779999999999999 111.51 -175.34 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.3 tp -80.57 -44.15 19.47 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.691 -3.755 . . . . 19.309999999999999 110.543 -176.71 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -62.28 1.93 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.417 1.887 . . . . 23.140000000000001 110.006 168.562 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.84 41.34 0.11 Allowed Glycine 0 N--CA 1.431 -1.687 0 O-C-N 119.139 -2.226 . . . . 19.739999999999998 111.593 169.63 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -84.29 142.9 29.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 128.94 3.377 . . . . 21.93 113.833 166.489 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.5 m -106.94 112.21 25.07 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.593 1.663 . . . . 12.33 109.466 -176.254 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.3 mt -104.27 108.91 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 119.562 -1.961 . . . . 17.079999999999998 110.358 -174.974 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -87.82 123.09 32.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.489 -1.382 . . . . 16.300000000000001 108.564 -174.164 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.3 mt -120.17 158.26 27.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.087 2.155 . . . . 15.880000000000001 116.29 179.636 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -120.77 89.33 3.11 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.556 3.074 . . . . 28.899999999999999 114.893 177.377 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -109.55 164.39 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 119.86 -1.775 . . . . 12.050000000000001 114.473 -178.624 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -98.26 159.69 30.04 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 116.551 -2.059 . . . . 18.170000000000002 106.444 167.793 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.53 -17.68 23.37 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 O-C-N 116.012 -2.678 . . . . 8.1600000000000001 110.066 174.904 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -59.78 -20.25 55.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.005 2.522 . . . . 11.130000000000001 116.19 164.785 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -71.57 142.3 50.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.562 2.601 . . . . 18.030000000000001 112.0 175.964 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.7 p -79.94 165.64 22.43 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.09 -4.131 . . . . 10.220000000000001 107.932 167.233 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 mm -66.18 -24.69 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.589 1.955 . . . . 12.300000000000001 108.558 177.637 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.29 35.0 tt0 -65.73 -39.85 91.57 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 118.19 -0.91 . . . . 36.509999999999998 108.596 174.19 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -72.25 -24.31 61.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.895 2.134 . . . . 25.66 114.237 179.109 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t -72.77 -42.06 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.385 -2.697 . . . . 8.1199999999999992 110.834 175.189 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP 0.274 93.0 mttt -51.57 -36.88 47.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 117.581 2.438 . . . . 15.470000000000001 117.581 163.512 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.76 61.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.504 -1.372 . . . . 11.449999999999999 111.265 -177.232 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -58.67 -47.98 82.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.164 2.986 . . . . 24.98 113.814 175.487 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -69.92 -34.16 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.553 -1.658 . . . . 9.4600000000000009 109.147 175.401 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -60.59 -46.71 89.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.144 2.247 . . . . 14.76 110.794 172.978 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.26 -58.7 6.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.759 -1.838 . . . . 26.289999999999999 111.305 -177.308 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -75.61 -55.43 5.67 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 132.805 4.442 . . . . 30.059999999999999 111.264 -168.068 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -89.43 -31.8 17.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.968 -2.333 . . . . 25.190000000000001 115.241 -179.016 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.01 11.42 20.57 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 121.269 3.268 . . . . 7.4100000000000001 121.269 179.536 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.307 71.5 mt -109.5 135.16 20.35 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 102.447 -3.168 . . . . 9.4900000000000002 102.447 -153.502 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -61.44 158.03 38.22 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 124.079 3.186 . . . . 11.42 117.481 179.605 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -78.53 -13.35 14.93 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 127.847 3.838 . . . . 12.0 118.066 179.932 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.92 -17.8 64.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.996 -1.457 . . . . 35.549999999999997 114.93 -178.634 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -86.2 -22.38 26.98 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 124.07 1.89 . . . . 20.52 111.24 178.025 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -89.07 108.01 19.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.819 2.525 . . . . 7.1299999999999999 117.819 -163.303 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -104.49 100.15 9.84 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.994 -1.113 . . . . 36.390000000000001 107.994 171.517 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 mt -81.81 130.33 35.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.182 -2.824 . . . . 9.5500000000000007 112.884 178.33 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mm -128.8 136.06 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 104.148 -2.538 . . . . 13.9 104.148 -167.739 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -135.08 133.5 39.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.843 -1.539 . . . . 6.8600000000000003 106.843 176.604 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.262 . . 49.98 -111.34 0.49 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.844 2.535 . . . . 11.15 117.844 -164.163 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.36 2.53 37.27 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 119.007 -0.885 . . . . 13.93 114.405 169.341 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -105.7 126.33 52.03 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.237 3.015 . . . . 23.920000000000002 111.024 -161.508 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -80.54 130.41 35.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.523 -1.217 . . . . 23.23 110.49 171.712 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.3 mt -86.47 166.01 15.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.61 -1.186 . . . . 9.1099999999999994 113.756 -167.908 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -132.48 128.91 38.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 114.791 -2.528 . . . . 33.439999999999998 109.085 -170.4 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.406 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 2.2 m-20 -56.05 -44.49 78.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 127.157 2.785 . . . . 28.370000000000001 115.573 -162.954 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.55 -8.72 14.89 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 128.546 2.974 . . . . 15.0 118.634 -179.394 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -95.8 150.92 19.87 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 116.234 -4.098 . . . . 25.5 110.851 178.583 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.7 p -78.53 161.68 26.86 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.298 2.475 . . . . 11.949999999999999 112.144 168.041 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.29 -42.88 92.64 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.0 -5.438 . . . . 10.17 111.904 172.348 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -42.14 -40.27 2.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.626 2.824 . . . . 13.59 118.626 160.685 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.34 -22.82 67.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.193 -2.192 . . . . 11.699999999999999 116.531 172.677 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -101.82 3.59 39.52 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.023 -1.673 . . . . 12.949999999999999 111.276 -178.75 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.478 26.9 m120 63.37 32.12 14.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.127 2.87 . . . . 25.449999999999999 118.191 -174.204 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.6 mt -95.51 123.06 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.026 -2.296 . . . . 14.6 106.38 -171.493 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -124.78 -171.17 2.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.093 2.557 . . . . 33.229999999999997 107.305 -168.673 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -76.33 150.68 36.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.512 -1.992 . . . . 25.969999999999999 115.949 -169.001 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 63.15 15.34 8.46 Favored 'General case' 0 N--CA 1.43 -1.464 1 CA-C-O 128.535 4.017 . . . . 32.609999999999999 118.894 -169.711 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.37 147.34 40.13 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 112.884 -6.135 . . . . 10.56 113.981 172.47 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.8 m -108.15 123.37 48.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.612 1.565 . . . . 5.3300000000000001 114.486 -176.823 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.25 166.51 10.91 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.666 0.746 . . . . 11.66 110.163 174.313 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -126.27 144.96 50.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.076 -2.89 . . . . 16.300000000000001 108.295 -175.769 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.3 tp -121.55 102.47 8.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.965 1.306 . . . . 9.9600000000000009 108.747 -165.026 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 t -87.9 128.84 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 123.105 0.562 . . . . 9.7599999999999998 110.226 176.265 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -105.07 161.77 13.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.425 -2.805 . . . . 19.57 103.425 -169.637 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -166.39 179.14 5.74 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.842 -1.072 . . . . 35.079999999999998 109.73 -178.735 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.8 mt -109.0 149.88 28.58 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.925 1.69 . . . . 32.310000000000002 113.899 179.163 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -56.39 126.02 24.53 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.643 2.46 . . . . 42.75 117.643 -173.461 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.0 -54.64 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 116.992 1.557 . . . . 36.310000000000002 116.992 177.369 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.743 0 CA-C-O 114.317 -3.491 . . . . 36.270000000000003 106.104 169.258 . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 CA--C 1.49 -1.338 0 CA-C-O 123.909 1.814 . . . . 17.170000000000002 114.597 . . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -74.92 125.29 28.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.386 -3.321 . . . . 21.890000000000001 114.092 168.465 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 pt -120.88 161.95 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 112.965 -1.925 . . . . 10.83 112.064 170.048 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -119.76 125.34 48.37 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.573 1.654 . . . . 10.609999999999999 111.615 -177.259 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.1 111.84 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 121.118 -0.988 . . . . 9.1300000000000008 110.237 174.632 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -88.37 138.52 31.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.608 -3.182 . . . . 20.550000000000001 118.261 179.088 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.264 28.2 p -87.25 175.79 7.87 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.301 2.334 . . . . 11.779999999999999 117.301 178.672 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -75.39 -38.21 60.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.729 -2.082 . . . . 19.309999999999999 115.095 173.978 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 63.0 p -70.64 -52.77 19.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.486 -2.673 . . . . 23.140000000000001 116.688 161.036 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.7 58.17 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 124.927 3.512 . . . . 19.739999999999998 110.899 158.494 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -97.14 147.11 24.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.29 -1.712 . . . . 21.93 110.485 165.411 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 m -93.62 108.41 20.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.208 1.004 . . . . 12.33 109.632 167.175 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 mt -75.93 127.7 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 117.738 -3.101 . . . . 17.079999999999998 107.605 166.185 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.6 p -114.15 127.46 55.92 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.742 -3.099 . . . . 16.300000000000001 111.97 177.573 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -127.81 133.19 49.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 128.172 3.42 . . . . 15.880000000000001 113.759 -171.567 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -95.75 91.7 6.21 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 132.242 4.217 . . . . 28.899999999999999 109.42 -179.516 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -126.52 167.47 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.513 -1.662 . . . . 12.050000000000001 106.513 178.927 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -102.44 154.19 37.61 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 117.39 -3.319 . . . . 18.170000000000002 105.838 174.255 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -68.99 -5.33 15.46 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 124.079 2.493 . . . . 8.1600000000000001 117.631 -173.494 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -98.37 4.38 48.56 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 124.442 1.089 . . . . 11.130000000000001 108.298 174.963 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.49 147.3 53.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.902 2.186 . . . . 18.030000000000001 116.902 162.052 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 7.5 p -89.67 158.84 17.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.318 -1.765 . . . . 10.220000000000001 106.681 -173.665 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -64.7 -32.69 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.385 -2.697 . . . . 12.300000000000001 114.486 -178.766 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -44.21 -50.81 8.63 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.206 3.002 . . . . 36.509999999999998 109.783 162.238 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -74.12 -21.24 59.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.936 -2.977 . . . . 25.66 117.128 178.333 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.8 t -71.63 -43.61 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 123.25 1.5 . . . . 8.1199999999999992 109.838 172.909 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -61.51 -30.65 70.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.087 2.995 . . . . 15.470000000000001 119.087 168.66 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.37 -34.65 61.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.88 -3.013 . . . . 11.449999999999999 112.922 171.204 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -49.04 76.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 127.063 3.316 . . . . 24.98 116.103 167.953 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.6 mt -57.79 -42.23 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 117.645 -3.16 . . . . 9.4600000000000009 113.528 166.54 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -63.2 -39.55 94.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.426 -3.921 . . . . 14.76 116.176 172.977 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -68.05 -50.56 54.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.12 0.887 . . . . 26.289999999999999 113.121 176.126 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -70.14 -66.02 0.65 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.112 1.152 . . . . 30.059999999999999 114.112 176.889 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -76.96 -35.28 57.36 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.856 2.909 . . . . 25.190000000000001 118.856 -170.221 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.01 60.16 1.79 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 119.827 -1.796 . . . . 7.4100000000000001 111.246 -173.169 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.99 119.54 15.82 Favored Pre-proline 0 N--CA 1.43 -1.439 0 C-N-CA 125.151 1.38 . . . . 9.4900000000000002 108.091 178.255 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.49 154.41 45.1 Favored 'Trans proline' 0 N--CA 1.433 -2.059 1 C-N-CA 125.893 4.395 . . . . 11.42 111.716 -172.218 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.299 52.3 Cg_endo -64.27 -14.3 43.09 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 O-C-N 123.891 1.469 . . . . 12.0 111.507 174.726 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -67.29 -34.34 77.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.361 2.505 . . . . 35.549999999999997 113.779 176.605 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -96.58 -37.74 10.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.012 -2.305 . . . . 20.52 108.639 -164.684 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -75.21 136.89 40.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 117.067 2.247 . . . . 7.1299999999999999 117.067 -176.345 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' HB3' HG21 ' A' ' 70' ' ' VAL . 37.3 ttm180 -120.06 133.25 55.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.197 -3.26 . . . . 36.390000000000001 102.197 161.339 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.7 mt -108.53 141.93 39.7 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.386 -2.071 . . . . 9.5500000000000007 106.389 179.903 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.1 mt -126.83 138.54 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.214 3.406 . . . . 13.9 103.367 -170.476 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -121.03 121.24 37.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.974 1.369 . . . . 6.8600000000000003 111.471 161.185 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.61 -78.58 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.719 -2.488 . . . . 11.15 114.843 -174.613 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.25 -4.94 0.24 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 123.882 3.037 . . . . 13.93 110.638 -177.998 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -113.07 146.03 39.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.747 2.419 . . . . 23.920000000000002 112.689 -173.391 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -89.52 156.07 18.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.597 1.959 . . . . 23.23 110.288 -171.773 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -118.86 127.24 53.32 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 129.455 4.222 . . . . 9.1099999999999994 107.8 -170.413 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -103.14 165.07 11.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.837 -3.04 . . . . 33.439999999999998 112.384 -172.118 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -69.91 -58.13 4.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.477 -2.639 . . . . 28.370000000000001 113.848 -157.645 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.35 31.03 5.95 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 117.919 -1.489 . . . . 15.0 115.523 -167.714 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -107.96 162.09 14.34 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.94 1.696 . . . . 25.5 114.202 159.831 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 29.2 p -92.72 173.48 7.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.305 1.526 . . . . 11.949999999999999 107.626 -171.65 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.5 mt -65.67 -44.26 86.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.026 -0.988 . . . . 10.17 110.469 171.729 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.1 m -63.89 -32.21 73.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.198 2.295 . . . . 13.59 117.198 178.704 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -58.21 -42.81 87.03 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.267 3.432 . . . . 11.699999999999999 120.267 173.54 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -70.5 -13.89 62.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 117.46 -1.257 . . . . 12.949999999999999 114.275 163.849 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 30.2 m120 68.68 38.59 2.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.474 2.71 . . . . 25.449999999999999 114.265 -171.61 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.16 129.16 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.053 2.095 . . . . 14.6 110.339 164.557 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.44 -173.77 3.26 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.128 2.971 . . . . 33.229999999999997 108.944 -164.217 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -65.26 136.22 56.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.57 -3.831 . . . . 25.969999999999999 111.14 172.629 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 55.42 53.19 10.16 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-N 108.039 -4.164 . . . . 32.609999999999999 113.442 -170.889 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -96.37 150.67 20.33 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.057 -4.152 . . . . 10.56 110.121 -178.136 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.5 m -103.46 111.1 23.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 127.4 2.937 . . . . 5.3300000000000001 108.444 -174.9 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -100.07 162.09 13.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.293 -1.002 . . . . 11.66 108.293 176.215 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -122.75 128.06 50.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.35 -1.469 . . . . 16.300000000000001 111.347 170.422 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -93.92 121.9 35.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.737 1.014 . . . . 9.9600000000000009 113.737 176.638 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.41 HG21 ' HB3' ' A' ' 42' ' ' ARG . 18.7 m -121.68 155.87 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.778 -1.934 . . . . 9.7599999999999998 105.778 174.445 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.2 mt -101.17 117.64 35.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.872 -2.393 . . . . 19.57 109.787 172.056 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -92.13 177.71 6.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.918 2.487 . . . . 35.079999999999998 109.673 178.876 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.6 mt -112.01 176.94 4.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.442 1.497 . . . . 32.310000000000002 108.844 158.253 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.8 ttt85 -67.63 136.16 53.97 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 119.664 1.12 . . . . 42.75 112.139 -172.477 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.3 -120.42 0.96 Allowed Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 116.722 -2.154 . . . . 36.310000000000002 108.575 -169.371 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 CA-C-N 118.961 1.381 . . . . 36.270000000000003 110.455 179.964 . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 111.932 0.345 . . . . 17.170000000000002 111.932 . . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -89.74 115.26 26.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.569 1.548 . . . . 21.890000000000001 113.084 -175.662 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.48 18.0 pt -107.29 155.27 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 126.076 1.75 . . . . 10.83 115.593 168.874 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -121.2 116.57 25.16 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.333 2.653 . . . . 10.609999999999999 105.681 -178.006 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.32 109.36 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 118.064 -2.897 . . . . 9.1300000000000008 108.26 172.074 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -101.29 132.67 46.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.281 1.515 . . . . 20.550000000000001 107.12 -173.798 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -87.12 171.56 10.6 Favored 'General case' 0 N--CA 1.429 -1.486 1 O-C-N 115.732 -4.355 . . . . 11.779999999999999 113.495 177.708 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.4 tp -70.23 -42.2 72.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 127.047 3.308 . . . . 19.309999999999999 109.495 177.699 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 p -56.81 -31.69 64.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.751 -3.093 . . . . 23.140000000000001 116.928 167.889 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.62 37.29 2.09 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 122.632 2.469 . . . . 19.739999999999998 113.137 173.235 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -99.55 152.9 19.5 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.451 -2.796 . . . . 21.93 103.451 167.446 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -110.97 106.23 15.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 114.06 1.133 . . . . 12.33 114.06 160.246 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.5 mt -81.27 108.25 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.876 -1.765 . . . . 17.079999999999998 108.571 169.973 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.9 p -78.39 137.8 38.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.49 -2.006 . . . . 16.300000000000001 111.039 172.34 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.2 139.32 44.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 125.197 1.561 . . . . 15.880000000000001 110.366 -177.166 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -95.46 111.6 23.46 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.298 2.639 . . . . 28.899999999999999 109.784 164.579 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.252 29.0 m -135.51 162.26 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 1 O-C-N 114.446 -5.159 . . . . 12.050000000000001 107.344 175.133 . . . . . . . . 3 2 . 1 . 064 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -97.95 166.05 14.23 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 120.239 -1.538 . . . . 18.170000000000002 107.967 179.682 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.74 -19.9 48.59 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 123.721 2.365 . . . . 8.1600000000000001 118.1 174.184 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -98.5 12.94 33.53 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 125.032 1.458 . . . . 11.130000000000001 112.066 -172.182 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.34 131.16 34.73 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.429 -2.044 . . . . 18.030000000000001 108.87 176.952 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 52' ' ' ASP 0.314 65.1 p -59.26 163.55 3.77 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.913 1.82 . . . . 10.220000000000001 115.913 164.889 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.444 HG23 ' HE3' ' A' ' 27' ' ' LYS . 37.2 mm -76.05 -17.1 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 O-C-N 116.291 -4.005 . . . . 12.300000000000001 106.335 -179.72 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 36.7 tt0 -69.12 -47.24 65.64 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.074 -1.642 . . . . 36.509999999999998 107.538 172.127 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.273 70.4 m-80 -66.49 -29.43 69.54 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.508 3.151 . . . . 25.66 119.508 175.677 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.269 60.2 t -51.4 -51.56 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 114.155 1.168 . . . . 8.1199999999999992 114.155 163.621 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HE3' HG23 ' A' ' 23' ' ' ILE . 98.1 mttt -71.61 -40.48 69.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.556 1.942 . . . . 15.470000000000001 110.618 -174.995 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.264 . . -52.34 -49.34 64.5 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.336 3.054 . . . . 11.449999999999999 109.809 170.051 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -62.51 -36.72 83.45 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.556 -3.215 . . . . 24.98 116.812 172.836 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -58.91 -47.25 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.763 -3.086 . . . . 9.4600000000000009 111.538 167.455 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -55.86 -35.78 66.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.231 2.678 . . . . 14.76 118.231 173.931 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.9 -43.06 69.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.992 -1.485 . . . . 26.289999999999999 106.992 -179.894 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -79.03 -57.47 3.72 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.785 -1.822 . . . . 30.059999999999999 115.31 -173.935 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -85.74 -49.7 7.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.779 -2.01 . . . . 25.190000000000001 111.572 -173.947 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.6 28.66 5.91 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 116.396 -3.94 . . . . 7.4100000000000001 110.885 -169.436 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.23 122.9 41.4 Favored Pre-proline 0 N--CA 1.429 -1.5 1 CA-C-O 111.541 -4.076 . . . . 9.4900000000000002 105.997 176.161 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -87.63 159.77 7.83 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-O 114.543 -2.357 . . . . 11.42 112.199 -165.369 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -64.26 -9.48 20.01 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 122.912 2.408 . . . . 12.0 116.227 -175.626 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -82.36 -34.61 28.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 124.165 3.166 . . . . 35.549999999999997 109.907 -169.568 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -83.19 -19.45 36.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.539 1.536 . . . . 20.52 108.467 -174.775 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -90.95 127.96 36.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.054 2.983 . . . . 7.1299999999999999 119.054 -166.839 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.423 HH21 ' C ' ' A' ' 76' ' ' GLY . 42.8 ttm180 -120.4 123.61 43.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 128.273 3.892 . . . . 36.390000000000001 111.174 168.674 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.0 mt -112.42 141.37 46.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.538 -2.601 . . . . 9.5500000000000007 112.541 177.923 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.91 134.91 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.484 -1.673 . . . . 13.9 106.484 -164.796 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -117.46 112.43 20.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.959 -2.978 . . . . 6.8600000000000003 102.959 171.608 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.321 . . 60.48 -108.29 0.35 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.068 1.889 . . . . 11.15 113.537 -167.748 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.17 -12.2 22.4 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 113.08 -1.873 . . . . 13.93 109.97 170.141 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -74.17 107.97 6.68 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.387 3.593 . . . . 23.920000000000002 112.835 179.618 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.8 122.36 22.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.239 -4.663 . . . . 23.23 110.897 176.528 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.274 6.5 mt -90.67 127.28 36.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.861 2.911 . . . . 9.1099999999999994 118.861 -165.244 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -83.55 143.58 30.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.35 -2.094 . . . . 33.439999999999998 114.926 173.005 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 36.0 m-20 -65.31 -41.44 94.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.755 2.217 . . . . 28.370000000000001 114.985 -163.977 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.51 21.46 38.32 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 118.614 -2.554 . . . . 15.0 113.58 -174.411 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -106.23 165.29 11.35 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.391 -1.337 . . . . 25.5 107.391 162.892 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -104.49 178.15 4.64 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.086 2.155 . . . . 11.949999999999999 111.54 -173.333 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.2 mt -80.1 -36.84 34.82 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.546 3.138 . . . . 10.17 106.445 173.945 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -51.77 -38.91 57.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.934 2.152 . . . . 13.59 114.931 163.509 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -70.96 -54.73 10.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.6 3.56 . . . . 11.699999999999999 109.234 -179.179 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -77.19 0.03 23.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.59 1.181 . . . . 12.949999999999999 113.213 -178.979 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 48.97 46.43 22.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.537 2.589 . . . . 25.449999999999999 117.034 -176.902 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mt -84.88 120.05 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 111.962 -2.381 . . . . 14.6 108.577 176.909 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -107.69 172.84 6.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.972 1.844 . . . . 33.229999999999997 113.831 177.96 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -60.14 141.73 55.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.423 -2.673 . . . . 25.969999999999999 113.038 179.462 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.313 12.2 mt-10 71.29 20.68 4.93 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 126.238 2.923 . . . . 32.609999999999999 117.876 177.863 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -87.63 124.72 33.82 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.448 -2.033 . . . . 10.56 109.958 173.833 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 m -74.26 100.93 3.86 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.383 2.04 . . . . 5.3300000000000001 112.157 177.698 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.75 141.95 30.18 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 117.659 -3.15 . . . . 11.66 113.508 167.144 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -107.16 128.2 54.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.264 1.983 . . . . 16.300000000000001 109.754 -178.808 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.7 tp -97.58 128.44 44.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.207 -3.433 . . . . 9.9600000000000009 109.2 173.367 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.07 136.52 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.303 2.954 . . . . 9.7599999999999998 105.084 171.015 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt -102.03 115.08 29.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.975 -2.953 . . . . 19.57 109.572 179.054 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -85.82 -176.95 6.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.673 -2.517 . . . . 35.079999999999998 112.751 -170.237 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.5 mt -107.29 160.41 15.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 115.936 -2.306 . . . . 32.310000000000002 108.688 149.198 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.291 0.5 OUTLIER -67.46 90.1 0.24 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.574 2.35 . . . . 42.75 111.202 -167.879 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.94 106.75 0.22 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 119.382 -1.389 . . . . 36.310000000000002 111.049 -174.308 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.423 ' C ' HH21 ' A' ' 42' ' ' ARG . . . . . . . . 0 N--CA 1.43 -1.752 0 CA-C-O 117.062 -1.966 . . . . 36.270000000000003 110.025 -168.932 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 117.795 -1.098 . . . . 17.170000000000002 111.997 . . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.336 2.8 pt20 -95.87 145.29 25.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.794 2.088 . . . . 21.890000000000001 115.928 166.472 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.1 pt -138.39 167.26 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 103.361 -2.829 . . . . 10.83 103.361 174.865 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -122.22 145.28 48.36 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.891 -2.413 . . . . 10.609999999999999 108.272 179.177 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.5 t -128.66 111.12 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 103.457 -2.794 . . . . 9.1300000000000008 103.457 176.937 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -107.26 137.49 45.21 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.676 2.655 . . . . 20.550000000000001 112.293 179.415 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.9 p -79.38 -166.45 0.96 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.916 -2.365 . . . . 11.779999999999999 105.541 -173.489 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.5 tp -81.59 -47.13 13.45 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.653 -1.904 . . . . 19.309999999999999 109.277 173.129 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 -31.2 61.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.711 2.804 . . . . 23.140000000000001 109.07 -170.059 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.43 42.17 0.47 Allowed Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 125.579 3.809 . . . . 19.739999999999998 115.226 174.326 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -108.27 133.98 51.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 102.27 -3.233 . . . . 21.93 102.27 168.358 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -104.54 113.17 26.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 124.888 1.368 . . . . 12.33 108.64 168.934 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -87.6 100.45 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.331 1.852 . . . . 17.079999999999998 112.562 166.618 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.9 m -77.23 136.51 38.54 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 118.143 -0.932 . . . . 16.300000000000001 108.879 177.778 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.296 32.0 mt -134.64 128.08 32.4 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.901 2.137 . . . . 15.880000000000001 105.519 178.548 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -88.26 132.33 34.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.367 -3.333 . . . . 28.899999999999999 107.676 161.296 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.2 m -133.27 171.32 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 1 C-N-CA 132.194 4.198 . . . . 12.050000000000001 113.118 -164.146 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -108.0 148.06 36.7 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 129.109 2.964 . . . . 18.170000000000002 112.604 161.753 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.6 -23.12 69.99 Favored 'Trans proline' 0 N--CA 1.434 -2.017 1 C-N-CA 126.162 4.575 . . . . 8.1600000000000001 115.364 173.086 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -86.58 -7.16 58.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.145 1.535 . . . . 11.130000000000001 115.145 -179.101 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -73.61 146.53 44.59 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.039 -2.913 . . . . 18.030000000000001 110.452 179.33 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.8 p -99.28 -176.81 3.41 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 104.331 -2.47 . . . . 10.220000000000001 104.331 -172.507 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -70.45 -34.61 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 127.353 2.261 . . . . 12.300000000000001 109.569 -177.638 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -55.23 -43.33 74.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.695 2.798 . . . . 36.509999999999998 110.822 172.209 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -70.68 -34.92 72.49 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.755 2.502 . . . . 25.66 117.755 174.346 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.3 t -55.24 -48.81 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 132.031 4.133 . . . . 8.1199999999999992 108.058 174.002 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.413 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 28.0 mtmt -63.81 -27.86 69.47 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.036 2.934 . . . . 15.470000000000001 115.066 177.488 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.34 -31.06 54.24 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.542 1.974 . . . . 11.449999999999999 110.997 177.374 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -65.04 -44.88 87.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.64 -2.538 . . . . 24.98 109.414 178.734 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 15.6 mt -65.59 -24.11 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.729 2.122 . . . . 9.4600000000000009 116.729 173.189 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -64.89 -57.42 8.85 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.798 -3.689 . . . . 14.76 114.342 162.276 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -52.24 -60.62 3.0 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.517 3.527 . . . . 26.289999999999999 114.729 175.757 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -79.5 -39.73 31.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.913 2.085 . . . . 30.059999999999999 112.612 -166.432 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -106.87 -42.2 5.0 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.029 1.732 . . . . 25.190000000000001 110.009 -163.287 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.63 7.09 30.22 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 117.709 -2.186 . . . . 7.4100000000000001 117.85 -173.118 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 11.6 mm -90.97 126.91 53.82 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-N 122.25 3.025 . . . . 9.4900000000000002 108.917 -170.314 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 86.4 Cg_exo -68.51 152.97 74.69 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 122.261 1.843 . . . . 11.42 111.867 -178.617 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -92.98 -10.53 1.9 Allowed 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-O 113.241 -2.9 . . . . 12.0 111.797 -151.995 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -85.85 -28.43 24.44 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 128.671 3.732 . . . . 35.549999999999997 111.356 174.872 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.17 -17.35 37.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 118.884 -0.579 . . . . 20.52 111.625 -171.807 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.413 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 79.7 mt-30 -66.85 115.66 6.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.593 2.757 . . . . 7.1299999999999999 111.049 171.866 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -114.64 124.11 51.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.317 2.008 . . . . 36.390000000000001 108.772 171.967 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mt -103.35 134.9 45.96 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.041 -2.287 . . . . 9.5500000000000007 107.221 -177.854 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.45 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 7.5 mm -112.38 122.62 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 130.522 3.529 . . . . 13.9 115.144 171.053 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -108.8 118.81 37.77 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.755 -1.202 . . . . 6.8600000000000003 107.755 170.965 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.55 -78.37 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 131.134 3.774 . . . . 11.15 113.611 -170.545 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.47 40.41 0.28 Allowed Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 107.193 -2.363 . . . . 13.93 107.193 -179.808 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -137.2 139.33 41.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.525 -2.75 . . . . 23.920000000000002 111.473 159.7 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -67.79 167.52 13.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 117.518 2.414 . . . . 23.23 117.518 175.361 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.49 149.83 35.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.679 2.392 . . . . 9.1099999999999994 107.508 178.41 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.9 146.92 48.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 123.528 0.518 . . . . 33.439999999999998 109.786 -177.665 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.74 -47.27 41.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 120.577 3.547 . . . . 28.370000000000001 120.577 -158.651 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.56 53.7 0.63 Allowed Glycine 0 N--CA 1.429 -1.77 0 O-C-N 117.068 -3.52 . . . . 15.0 111.131 -170.338 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.405 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 67.6 mtt180 -120.62 159.27 25.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 117.574 -1.65 . . . . 25.5 106.997 155.969 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -85.12 165.38 17.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.969 2.508 . . . . 11.949999999999999 112.348 -169.914 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.6 mt -72.09 -38.04 69.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.685 -1.885 . . . . 10.17 110.012 -176.639 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -54.09 -49.15 69.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 114.891 -2.48 . . . . 13.59 113.105 169.706 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -44.53 -50.05 9.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 124.989 3.54 . . . . 11.699999999999999 113.787 174.702 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.405 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 68.8 m-85 -76.93 -7.63 55.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.669 -2.519 . . . . 12.949999999999999 116.839 -178.981 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 69.19 37.47 2.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.966 3.307 . . . . 25.449999999999999 115.258 -179.42 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.2 mt -85.01 109.19 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 130.878 3.671 . . . . 14.6 105.677 -172.867 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -91.07 165.26 13.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.826 2.727 . . . . 33.229999999999997 113.035 -179.751 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 147.25 12.83 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.798 -3.689 . . . . 25.969999999999999 115.532 168.308 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 58.37 32.23 21.84 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.046 2.61 . . . . 32.609999999999999 118.046 -170.762 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -98.74 142.63 30.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.495 1.747 . . . . 10.56 108.796 177.071 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.2 m -93.24 102.91 15.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.137 3.775 . . . . 5.3300000000000001 115.636 169.473 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.25 153.58 23.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.842 -2.281 . . . . 11.66 104.842 168.602 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.45 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 89.2 m-70 -92.04 152.96 19.72 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.735 1.383 . . . . 16.300000000000001 114.735 168.191 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.2 tp -120.01 108.78 14.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.977 2.111 . . . . 9.9600000000000009 110.998 169.082 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.327 16.0 m -119.65 168.74 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 126.922 2.639 . . . . 9.7599999999999998 112.505 171.495 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.2 mt -98.32 147.46 24.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 125.534 2.588 . . . . 19.57 106.591 179.053 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -85.15 112.75 20.97 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.951 -1.931 . . . . 35.079999999999998 112.951 176.654 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.2 mt -91.69 178.2 5.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.341 -3.349 . . . . 32.310000000000002 112.26 -178.117 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.4 tpp180 -82.01 83.66 7.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.351 1.432 . . . . 42.75 114.759 -162.548 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.82 -84.5 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 117.206 -2.426 . . . . 36.310000000000002 110.827 176.025 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.746 0 N-CA-C 106.818 -2.513 . . . . 36.270000000000003 106.818 156.757 . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 108.119 -1.067 . . . . 17.170000000000002 108.119 . . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -83.15 132.93 35.06 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.919 -2.363 . . . . 21.890000000000001 114.764 175.734 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -131.84 163.14 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 124.716 1.26 . . . . 10.83 110.039 172.489 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -124.67 166.27 16.44 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 102.282 -3.229 . . . . 10.609999999999999 102.282 -174.949 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -150.18 143.17 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 100.877 -3.749 . . . . 9.1300000000000008 100.877 179.464 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -119.2 139.05 52.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.467 1.939 . . . . 20.550000000000001 106.271 -178.649 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.0 p -81.81 167.84 18.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.744 1.903 . . . . 11.779999999999999 107.565 178.654 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 tp -56.17 -54.8 40.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.014 3.326 . . . . 19.309999999999999 113.132 -178.946 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.3 p -62.62 -53.76 49.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.891 2.476 . . . . 23.140000000000001 110.57 175.727 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.18 70.61 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 CA-C-O 117.601 -1.666 . . . . 19.739999999999998 112.768 169.587 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -125.78 124.42 40.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.909 1.855 . . . . 21.93 109.665 176.858 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -79.57 106.03 11.31 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.383 -5.198 . . . . 12.33 111.177 177.387 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.7 mt -81.35 115.07 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 123.259 1.504 . . . . 17.079999999999998 107.139 171.934 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -94.47 104.11 16.08 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 114.344 -5.222 . . . . 16.300000000000001 114.818 171.518 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -97.35 162.29 13.4 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.436 -4.54 . . . . 15.880000000000001 112.244 179.378 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -116.22 118.99 34.34 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 102.913 -2.995 . . . . 28.899999999999999 102.913 174.322 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.27 165.55 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 121.844 2.111 . . . . 12.050000000000001 112.707 173.653 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -104.57 161.78 21.79 Favored Pre-proline 0 N--CA 1.43 -1.46 0 N-CA-C 105.658 -1.979 . . . . 18.170000000000002 105.658 164.169 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.17 -6.29 12.96 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 123.978 3.119 . . . . 8.1600000000000001 109.311 -169.412 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -88.22 2.97 51.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 131.54 3.936 . . . . 11.130000000000001 113.379 168.0 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -87.15 152.71 22.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.21 -3.431 . . . . 18.030000000000001 109.91 -178.859 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p -94.86 164.05 13.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.149 2.704 . . . . 10.220000000000001 110.7 -167.042 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.5 mm -69.37 -34.87 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 O-C-N 115.489 -4.507 . . . . 12.300000000000001 109.164 -179.864 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.24 -42.78 77.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.737 2.866 . . . . 36.509999999999998 118.737 168.045 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -71.21 -32.43 68.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.02 2.128 . . . . 25.66 110.403 175.643 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.359 44.4 t -52.06 -61.27 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 118.98 -2.325 . . . . 8.1199999999999992 111.094 165.396 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -52.59 -35.43 54.11 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 127.109 2.164 . . . . 15.470000000000001 114.479 177.772 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -71.6 -35.37 70.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.296 -2.753 . . . . 11.449999999999999 109.481 -178.302 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -62.27 -41.65 98.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.145 -0.972 . . . . 24.98 112.925 171.846 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.7 mt -63.71 -36.34 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 127.459 2.974 . . . . 9.4600000000000009 114.348 179.428 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.413 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 36.3 tt0 -53.91 -33.19 55.92 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.509 3.924 . . . . 14.76 117.834 166.643 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.68 -51.48 9.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 124.12 1.914 . . . . 26.289999999999999 108.841 178.053 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -56.46 -63.15 1.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.274 1.987 . . . . 30.059999999999999 114.991 -176.771 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -110.91 -13.51 14.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.693 -3.129 . . . . 25.190000000000001 114.28 -172.765 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.78 43.86 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 119.524 2.57 . . . . 7.4100000000000001 119.524 -172.623 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.6 115.9 65.85 Favored Pre-proline 0 N--CA 1.43 -1.425 0 CA-C-O 115.154 -2.355 . . . . 9.4900000000000002 105.903 169.575 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -66.32 152.43 81.03 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 CA-C-N 126.906 3.502 . . . . 11.42 113.57 -177.856 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.14 -0.26 10.6 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.06 2.506 . . . . 12.0 112.92 -166.109 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -90.66 -54.79 3.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.836 3.207 . . . . 35.549999999999997 109.123 -173.897 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -84.28 -8.56 58.99 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.252 2.315 . . . . 20.52 117.252 -174.616 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -88.85 157.33 18.49 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.942 -2.974 . . . . 7.1299999999999999 109.923 171.52 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.454 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 21.1 ttt180 -143.46 144.69 32.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.018 -1.676 . . . . 36.390000000000001 107.593 168.637 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.8 mt -97.59 140.07 32.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.017 1.327 . . . . 9.5500000000000007 113.673 -175.983 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mm -134.52 139.35 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 104.009 -2.589 . . . . 13.9 104.009 -173.707 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -111.93 108.36 17.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.559 2.344 . . . . 6.8600000000000003 107.834 173.389 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.41 -88.6 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.362 2.289 . . . . 11.15 112.781 -169.99 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.42 -8.48 4.89 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 117.012 -3.555 . . . . 13.93 109.953 175.841 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -81.56 141.07 34.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 118.032 0.916 . . . . 23.920000000000002 111.32 -177.345 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -94.61 120.84 35.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.272 1.429 . . . . 23.23 108.168 -178.168 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -91.84 133.25 35.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.593 1.957 . . . . 9.1099999999999994 110.588 -165.138 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -94.84 136.25 35.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.772 -2.455 . . . . 33.439999999999998 114.92 179.098 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.82 -38.23 64.62 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.205 2.298 . . . . 28.370000000000001 117.205 -143.214 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.85 11.95 4.16 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 120.904 3.121 . . . . 15.0 120.904 164.66 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -106.18 172.88 6.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.39 2.595 . . . . 25.5 112.586 172.367 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -98.69 171.45 8.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.478 2.085 . . . . 11.949999999999999 115.436 176.128 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.01 -40.35 95.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.434 2.294 . . . . 10.17 109.391 173.394 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -60.41 -33.68 72.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 118.856 2.91 . . . . 13.59 118.856 173.17 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.286 28.5 m-20 -68.06 -44.78 75.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.629 1.715 . . . . 11.699999999999999 115.629 174.046 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -76.02 -32.55 59.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.424 1.489 . . . . 12.949999999999999 114.57 175.897 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t30 83.08 67.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 1 C-N-CA 131.884 4.073 . . . . 25.449999999999999 108.978 177.951 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.4 mt -101.49 118.15 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 127.485 2.314 . . . . 14.6 107.985 -177.916 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -89.25 177.92 6.48 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.097 -1.041 . . . . 33.229999999999997 110.518 -171.314 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -70.61 149.76 46.73 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.138 1.335 . . . . 25.969999999999999 110.882 175.916 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 70.03 51.41 0.41 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.778 3.231 . . . . 32.609999999999999 107.508 170.374 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -126.38 132.26 51.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.798 3.239 . . . . 10.56 115.398 -169.045 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.361 6.8 m -103.02 106.15 16.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.895 1.68 . . . . 5.3300000000000001 115.48 -172.751 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 mt -83.67 156.13 22.81 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.346 3.451 . . . . 11.66 107.523 177.854 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -111.39 157.8 19.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.028 -3.545 . . . . 16.300000000000001 106.979 -174.971 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -126.85 106.86 9.63 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.923 1.344 . . . . 9.9600000000000009 109.853 -169.696 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -118.88 171.49 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 100.896 -3.742 . . . . 9.7599999999999998 100.896 -166.99 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt -97.1 147.1 24.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.606 -3.809 . . . . 19.57 101.851 -177.54 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.454 ' HB2' ' HB2' ' A' ' 42' ' ' ARG . 55.2 ttp180 -97.59 119.69 36.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.622 -3.174 . . . . 35.079999999999998 112.316 175.956 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 mt -91.41 164.66 13.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 116.12 1.896 . . . . 32.310000000000002 116.12 168.472 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -74.98 134.24 41.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.428 2.061 . . . . 42.75 114.401 -179.052 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.71 -74.08 0.25 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 113.359 -1.746 . . . . 36.310000000000002 114.367 171.419 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.794 0 O-C-N 120.48 -1.6 . . . . 36.270000000000003 111.327 170.864 . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 118.873 -0.585 . . . . 17.170000000000002 111.193 . . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -96.57 138.76 33.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.001 -2.312 . . . . 21.890000000000001 113.455 170.324 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.8 pt -115.04 154.15 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 127.231 2.212 . . . . 10.83 105.249 165.803 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -113.18 114.31 26.58 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.839 -1.788 . . . . 10.609999999999999 107.17 -176.991 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.8 105.93 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 105.504 -2.036 . . . . 9.1300000000000008 105.504 177.784 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -101.03 152.43 20.6 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.827 -2.657 . . . . 20.550000000000001 103.827 -172.73 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -97.11 172.19 7.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.135 -0.978 . . . . 11.779999999999999 110.803 178.348 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.5 tp -45.72 -57.17 4.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.424 2.009 . . . . 19.309999999999999 116.424 170.191 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.06 -42.78 77.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 131.562 3.945 . . . . 23.140000000000001 111.235 175.13 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.1 55.86 0.47 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 126.811 3.451 . . . . 19.739999999999998 109.653 172.407 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -115.2 135.82 53.76 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.231 -2.334 . . . . 21.93 107.815 175.058 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -106.79 119.5 39.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.214 -3.429 . . . . 12.33 117.102 -164.544 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.2 mt -104.14 102.69 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 119.047 -2.283 . . . . 17.079999999999998 111.283 -172.567 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -84.76 118.27 24.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.967 1.707 . . . . 16.300000000000001 106.812 -176.714 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.3 mt -115.52 131.32 56.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.611 -2.556 . . . . 15.880000000000001 106.952 -173.919 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -100.06 91.04 4.6 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.727 1.751 . . . . 28.899999999999999 115.727 179.824 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.77 163.88 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 128.053 3.787 . . . . 12.050000000000001 112.208 -171.44 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -92.45 157.12 40.78 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.791 -2.443 . . . . 18.170000000000002 106.478 167.799 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.54 -3.61 14.01 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 114.748 -3.343 . . . . 8.1600000000000001 111.39 176.749 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 p -87.59 -7.55 57.36 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 118.732 -2.48 . . . . 11.130000000000001 111.007 175.33 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.74 137.57 54.18 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.147 1.379 . . . . 18.030000000000001 109.531 176.127 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.448 ' O ' HG22 ' A' ' 26' ' ' VAL . 4.7 p -85.28 164.11 18.22 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.341 2.256 . . . . 10.220000000000001 109.136 -173.131 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.416 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 35.8 mm -62.29 -37.83 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 O-C-N 114.669 -5.02 . . . . 12.300000000000001 110.559 178.299 . . . . . . . . 3 3 . 1 . 067 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.27 19.1 tt0 -52.54 -54.05 37.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.49 1.916 . . . . 36.509999999999998 115.421 169.463 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 15.2 t-20 -55.68 -45.76 77.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.422 1.889 . . . . 25.66 112.568 170.889 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 22' ' ' THR . 40.4 t -57.39 -42.95 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.294 1.438 . . . . 8.1199999999999992 112.747 175.16 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 51.2 mtmt -68.41 -33.45 74.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.658 2.481 . . . . 15.470000000000001 108.609 179.8 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.2 -30.75 71.67 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 116.124 1.898 . . . . 11.449999999999999 116.124 178.773 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -70.28 -33.59 71.75 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 117.234 -1.365 . . . . 24.98 112.047 173.454 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 25.6 mt -71.26 -45.62 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 119.56 1.073 . . . . 9.4600000000000009 112.717 169.372 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.309 36.5 tt0 -44.04 -52.93 6.73 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.79 1.636 . . . . 14.76 115.239 166.617 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -55.7 -39.49 71.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.623 -1.923 . . . . 26.289999999999999 115.123 173.56 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -88.81 -67.74 0.82 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.338 2.018 . . . . 30.059999999999999 114.932 -165.518 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -88.78 -43.49 11.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.35 2.5 . . . . 25.190000000000001 109.552 -168.119 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.24 19.83 3.45 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.032 -1.895 . . . . 7.4100000000000001 110.283 168.424 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.2 mt -90.31 120.19 69.12 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-N 121.616 2.708 . . . . 9.4900000000000002 104.219 -167.501 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -81.16 162.66 20.21 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 CA-C-N 123.152 2.161 . . . . 11.42 115.27 -179.88 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -84.57 -8.34 9.47 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 N-CA-C 116.286 1.61 . . . . 12.0 116.286 -161.452 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -79.03 -20.88 47.86 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.101 3.137 . . . . 35.549999999999997 114.791 164.972 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -79.71 -37.66 35.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.695 2.188 . . . . 20.52 112.961 -178.306 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -102.61 136.44 42.44 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.961 -4.212 . . . . 7.1299999999999999 110.211 -172.834 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -115.44 148.67 39.12 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.199 1.399 . . . . 36.390000000000001 110.346 164.826 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.9 mt -114.8 125.43 53.68 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.664 -1.607 . . . . 9.5500000000000007 111.578 -178.021 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -103.8 139.14 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 125.931 2.019 . . . . 13.9 106.624 174.241 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -122.17 138.12 54.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.335 -1.793 . . . . 6.8600000000000003 113.482 162.668 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.325 . . 52.26 -99.17 0.08 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.368 1.895 . . . . 11.15 112.955 -174.707 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.13 51.71 0.58 Allowed Glycine 0 N--CA 1.43 -1.748 1 O-C-N 115.468 -4.52 . . . . 13.93 108.484 169.78 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -153.83 165.26 36.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 127.408 2.475 . . . . 23.920000000000002 115.485 177.039 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -91.7 127.97 37.35 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.071 2.948 . . . . 23.23 115.7 -174.47 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.411 HD22 HD12 ' A' ' 61' ' ' ILE . 83.9 mt -90.79 123.9 34.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.025 -2.297 . . . . 9.1099999999999994 114.453 175.099 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -97.93 131.83 44.04 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.801 2.04 . . . . 33.439999999999998 112.818 -171.793 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -32.36 -50.04 0.22 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.382 3.873 . . . . 28.370000000000001 118.369 176.942 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.98 -12.44 76.89 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 119.133 2.413 . . . . 15.0 119.133 -174.14 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -91.23 167.78 12.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.428 -2.219 . . . . 25.5 111.35 -178.418 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 p -88.13 160.68 17.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 127.313 2.883 . . . . 11.949999999999999 112.301 173.081 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -68.01 -30.7 70.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.999 2.592 . . . . 10.17 117.999 169.031 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 29.4 m -56.19 -41.73 75.99 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 131.02 3.728 . . . . 13.59 110.062 168.352 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.95 -32.49 74.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.303 -2.123 . . . . 11.699999999999999 114.95 -176.347 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -82.8 -31.76 28.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.221 2.608 . . . . 12.949999999999999 109.448 178.7 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.6 m120 74.03 58.96 0.09 Allowed 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 129.216 4.073 . . . . 25.449999999999999 115.498 -166.845 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.411 HD12 HD22 ' A' ' 50' ' ' LEU . 41.7 mt -104.6 135.47 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 117.813 -3.055 . . . . 14.6 106.571 -176.748 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -117.49 -168.28 1.46 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.124 1.37 . . . . 33.229999999999997 113.348 -155.354 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -83.34 134.59 34.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.184 -2.197 . . . . 25.969999999999999 109.947 168.488 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 69.21 38.09 1.97 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.917 2.77 . . . . 32.609999999999999 113.938 -176.781 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 m -98.33 133.71 42.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.034 1.873 . . . . 10.56 107.682 -173.918 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.6 m -95.73 123.47 39.31 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.064 -1.648 . . . . 5.3300000000000001 111.212 -174.236 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.5 132.93 53.68 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 130.637 3.575 . . . . 11.66 108.611 -179.339 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -104.18 105.87 16.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.298 1.863 . . . . 16.300000000000001 112.067 -175.225 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 tt -79.36 120.97 24.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.346 2.658 . . . . 9.9600000000000009 111.39 -179.466 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -126.49 173.73 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.447 3.023 . . . . 9.7599999999999998 104.08 -173.503 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -85.48 129.45 34.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.703 -2.498 . . . . 19.57 110.342 174.291 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -86.4 129.77 34.74 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 122.953 1.358 . . . . 35.079999999999998 108.029 165.21 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.0 mt -104.38 -179.04 3.83 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.243 -1.391 . . . . 32.310000000000002 107.243 170.32 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -78.31 141.94 38.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.343 -1.313 . . . . 42.75 111.181 161.929 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.35 -94.8 0.17 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 117.267 -2.397 . . . . 36.310000000000002 108.793 178.638 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.732 0 N-CA-C 110.579 -1.009 . . . . 36.270000000000003 110.579 179.881 . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 117.505 2.409 . . . . 17.170000000000002 117.505 . . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -130.41 145.74 51.86 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.589 -0.893 . . . . 21.890000000000001 108.589 174.629 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.8 pt -139.68 162.43 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 117.64 -3.162 . . . . 10.83 107.601 174.523 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -121.09 127.21 51.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.674 -0.861 . . . . 10.609999999999999 108.674 -178.536 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.516 HG13 HD13 ' A' ' 69' ' ' LEU . 60.5 t -96.32 120.33 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 128.181 3.425 . . . . 9.1300000000000008 107.959 170.231 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -125.46 145.27 50.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.524 3.059 . . . . 20.550000000000001 108.743 178.734 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -94.55 -161.53 0.86 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 112.405 -2.18 . . . . 11.779999999999999 113.88 174.941 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tt -77.64 -47.58 18.91 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 115.555 -2.164 . . . . 19.309999999999999 109.56 -170.292 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.4 p -71.08 -47.59 57.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.347 2.022 . . . . 23.140000000000001 111.194 175.848 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.54 63.09 0.17 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.505 -2.622 . . . . 19.739999999999998 109.156 176.213 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -91.51 116.26 28.71 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.957 2.903 . . . . 21.93 111.153 167.985 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -88.29 106.82 18.47 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.083 1.765 . . . . 12.33 114.567 -173.389 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 mt -104.99 104.86 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 125.663 1.585 . . . . 17.079999999999998 107.495 -178.435 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -90.88 125.06 35.63 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 114.97 -4.831 . . . . 16.300000000000001 108.701 -172.357 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.266 87.6 mt -127.84 147.64 50.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 120.474 3.509 . . . . 15.880000000000001 120.474 -179.589 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -107.18 117.06 33.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.15 -1.426 . . . . 28.899999999999999 107.15 -166.972 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.72 158.24 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 131.414 3.886 . . . . 12.050000000000001 112.297 -170.944 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -121.11 160.36 45.61 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 114.821 -2.514 . . . . 18.170000000000002 105.773 172.73 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -72.19 -19.85 25.51 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 CA-C-N 128.496 4.07 . . . . 8.1600000000000001 111.195 -159.253 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 m -84.58 3.18 38.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.885 -3.009 . . . . 11.130000000000001 112.561 -177.197 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.88 144.32 41.24 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 117.323 -1.751 . . . . 18.030000000000001 115.225 175.138 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 69.2 p -82.45 159.4 22.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.754 2.692 . . . . 10.220000000000001 113.794 -173.153 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.426 HG21 HD11 ' A' ' 43' ' ' LEU . 31.9 mm -64.45 -35.89 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.896 -3.003 . . . . 12.300000000000001 113.103 176.409 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.278 54.9 tt0 -37.72 -65.07 0.35 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.119 2.568 . . . . 36.509999999999998 112.221 160.88 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -57.81 -34.91 70.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.194 2.197 . . . . 25.66 114.521 -177.642 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 t -62.63 -52.94 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.05 2.094 . . . . 8.1199999999999992 110.129 179.664 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -64.31 -30.55 71.6 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.605 3.098 . . . . 15.470000000000001 113.398 -177.287 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.35 -40.28 74.23 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.575 -4.453 . . . . 11.449999999999999 113.949 179.266 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -62.56 -47.93 81.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.181 1.792 . . . . 24.98 111.079 169.516 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.436 ' HB ' HE22 ' A' ' 41' ' ' GLN . 70.9 mt -63.88 -41.55 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 127.011 2.124 . . . . 9.4600000000000009 112.384 -176.094 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -62.33 -56.91 13.86 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.156 -2.215 . . . . 14.76 114.948 168.625 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.67 -40.66 92.63 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 116.274 -4.017 . . . . 26.289999999999999 116.32 -176.027 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -89.25 -64.29 1.16 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.607 -3.808 . . . . 30.059999999999999 110.407 -172.184 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -83.75 -29.6 27.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.848 -3.657 . . . . 25.190000000000001 109.286 -173.302 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.92 46.17 2.12 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 123.367 2.803 . . . . 7.4100000000000001 108.724 159.779 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.2 mt -114.96 113.94 44.0 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.462 -2.051 . . . . 9.4900000000000002 105.462 -176.374 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.98 156.52 34.33 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.111 2.541 . . . . 11.42 112.581 -158.957 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -80.28 -8.49 13.97 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 123.907 3.071 . . . . 12.0 108.984 -161.88 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.341 4.0 p30 -79.39 -25.47 42.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.263 1.506 . . . . 35.549999999999997 109.503 175.889 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -95.06 -38.51 10.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.208 1.48 . . . . 20.52 111.707 -166.946 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.436 HE22 ' HB ' ' A' ' 30' ' ' ILE . 26.4 pt20 -83.57 147.2 27.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.488 -2.007 . . . . 7.1299999999999999 114.038 178.034 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -144.55 145.18 31.69 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 99.998 -4.075 . . . . 36.390000000000001 99.998 166.055 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.426 HD11 HG21 ' A' ' 23' ' ' ILE . 61.9 mt -109.97 130.61 55.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.739 -1.226 . . . . 9.5500000000000007 113.696 179.645 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.5 138.86 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 103.264 -2.865 . . . . 13.9 103.264 173.148 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.566 ' HB2' HD11 ' A' ' 50' ' ' LEU . 86.3 t80 -126.53 119.05 26.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.931 -1.486 . . . . 6.8600000000000003 109.099 169.964 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.11 -54.13 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 132.614 4.365 . . . . 11.15 116.108 -163.558 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.99 19.56 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 127.953 2.692 . . . . 13.93 112.08 177.417 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -104.36 146.16 29.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.051 -2.203 . . . . 23.920000000000002 105.051 164.012 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.257 10.8 tt0 -87.45 125.09 34.08 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.281 1.832 . . . . 23.23 111.969 176.241 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 45' ' ' PHE . 64.2 mt -97.08 107.29 19.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.53 2.048 . . . . 9.1099999999999994 116.53 -170.619 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -69.49 141.75 53.87 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.055 2.097 . . . . 33.439999999999998 113.92 -173.904 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -24.34 -75.95 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 1 N-CA-C 123.682 4.697 . . . . 28.370000000000001 123.682 176.251 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.91 28.54 14.01 Favored Glycine 0 N--CA 1.43 -1.737 1 O-C-N 114.817 -4.927 . . . . 15.0 113.003 -157.186 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -107.79 153.79 22.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.015 1.388 . . . . 25.5 113.366 177.566 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -90.39 161.07 15.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 115.504 -2.479 . . . . 11.949999999999999 109.242 -172.21 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.42 -31.45 69.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.996 2.119 . . . . 10.17 113.045 170.311 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.27 8.6 t -55.34 -59.2 5.12 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 131.05 3.74 . . . . 13.59 116.744 167.489 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.8 -33.72 74.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.386 3.106 . . . . 11.699999999999999 119.386 172.531 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -82.77 3.62 28.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.718 -3.114 . . . . 12.949999999999999 114.506 174.577 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 65.84 30.21 10.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.864 3.666 . . . . 25.449999999999999 114.965 172.668 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -91.05 104.88 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.485 -2.634 . . . . 14.6 115.657 -173.517 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -101.6 -178.16 3.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.084 1.897 . . . . 33.229999999999997 112.757 -169.462 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.329 15.1 pttp -54.38 146.92 14.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.893 1.812 . . . . 25.969999999999999 115.893 -172.113 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 39.79 45.57 1.5 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.368 2.267 . . . . 32.609999999999999 116.933 -166.407 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 m -84.05 138.3 33.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.584 3.564 . . . . 10.56 108.051 178.265 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 m -84.46 111.09 19.16 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 110.649 -2.978 . . . . 5.3300000000000001 109.37 176.356 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.401 9.2 mp -94.65 119.73 33.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.166 -3.459 . . . . 11.66 118.467 172.12 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -93.53 99.26 11.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.195 2.902 . . . . 16.300000000000001 105.964 -172.411 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.516 HD13 HG13 ' A' ' 5' ' ' VAL . 7.8 tt -82.65 116.83 22.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.559 -2.564 . . . . 9.9600000000000009 109.929 174.516 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.272 2.7 m -114.89 166.04 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 124.65 2.167 . . . . 9.7599999999999998 112.997 -167.169 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 tp -71.22 123.71 22.83 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.018 -2.926 . . . . 19.57 115.156 173.313 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -101.44 131.43 47.55 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.077 -3.515 . . . . 35.079999999999998 114.601 -176.653 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.92 162.71 26.92 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.117 -1.401 . . . . 32.310000000000002 109.51 -172.609 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -67.02 148.29 52.13 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.424 2.379 . . . . 42.75 117.424 -176.52 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.09 -53.37 0.81 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 127.185 2.326 . . . . 36.310000000000002 112.992 178.261 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.781 0 N-CA-C 110.982 -0.847 . . . . 36.270000000000003 110.982 176.707 . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 122.77 1.271 . . . . 17.170000000000002 114.182 . . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -105.78 124.0 48.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.353 3.461 . . . . 21.890000000000001 108.068 -163.333 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.301 13.1 pt -118.18 163.55 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 128.723 2.809 . . . . 10.83 114.606 179.311 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -133.73 117.6 17.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.206 -2.809 . . . . 10.609999999999999 112.274 -164.572 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.78 114.31 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 124.546 2.117 . . . . 9.1300000000000008 106.932 -174.127 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -94.71 136.77 34.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.071 -1.643 . . . . 20.550000000000001 109.112 177.37 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.262 7.8 p -80.24 -169.62 2.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.613 1.965 . . . . 11.779999999999999 112.917 -177.82 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.29 -56.88 4.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.213 1.006 . . . . 19.309999999999999 113.238 166.029 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.3 p -61.45 -62.44 1.82 Allowed 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 115.416 1.636 . . . . 23.140000000000001 115.416 -173.458 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.89 40.66 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 122.935 1.297 . . . . 19.739999999999998 116.152 -170.692 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -118.11 140.72 49.36 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.241 -1.741 . . . . 21.93 112.024 172.069 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.8 m -117.12 115.05 24.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.532 -1.655 . . . . 12.33 106.532 -178.409 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -98.1 126.43 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 124.983 1.427 . . . . 17.079999999999998 109.564 -170.98 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -96.82 135.43 38.8 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.667 -2.521 . . . . 16.300000000000001 105.903 178.474 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.7 mt -125.67 155.77 40.32 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 103.918 -2.623 . . . . 15.880000000000001 103.918 173.706 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -118.62 132.38 56.18 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.853 -1.536 . . . . 28.899999999999999 106.853 167.961 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -148.73 165.03 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 126.322 2.263 . . . . 12.050000000000001 105.336 -162.563 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -117.93 145.37 36.57 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 127.72 2.408 . . . . 18.170000000000002 106.224 173.872 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.5 -24.1 31.24 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 124.944 3.763 . . . . 8.1600000000000001 115.288 -165.562 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -77.91 -0.51 27.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.926 2.641 . . . . 11.130000000000001 117.027 173.326 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -90.55 152.31 20.96 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.675 -1.89 . . . . 18.030000000000001 112.082 177.924 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 28.9 p -82.22 174.85 10.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.175 2.287 . . . . 10.220000000000001 117.175 -177.992 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mm -69.17 -32.26 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.695 2.798 . . . . 12.300000000000001 103.647 175.962 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.83 -31.19 66.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 124.396 3.271 . . . . 36.509999999999998 119.288 174.557 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -76.62 -30.4 56.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.178 2.191 . . . . 25.66 109.156 179.757 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.8 t -76.46 -38.59 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 115.651 -2.118 . . . . 8.1199999999999992 108.316 177.222 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -60.77 -57.49 12.46 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 125.17 1.543 . . . . 15.470000000000001 110.81 175.564 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.22 -48.02 17.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.984 2.914 . . . . 11.449999999999999 115.089 169.923 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -75.16 -30.28 60.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 121.265 1.848 . . . . 24.98 114.304 -179.27 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.1 mt -55.84 -56.36 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 114.103 1.149 . . . . 9.4600000000000009 114.103 161.209 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -45.49 -45.55 13.26 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.179 2.592 . . . . 14.76 112.11 179.328 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -59.29 -34.95 72.91 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.454 2.761 . . . . 26.289999999999999 118.454 173.233 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -71.93 -72.61 0.22 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.074 1.879 . . . . 30.059999999999999 116.074 166.846 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -87.89 -30.65 19.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 119.877 3.288 . . . . 25.190000000000001 119.877 -176.432 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.66 73.44 0.98 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 123.926 1.848 . . . . 7.4100000000000001 115.1 -173.226 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 94.3 mt -124.91 127.73 25.04 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-O 112.36 -3.686 . . . . 9.4900000000000002 105.51 178.515 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -63.94 146.94 92.0 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 127.782 3.815 . . . . 11.42 114.98 -166.714 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.29 -20.98 36.33 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 119.718 2.93 . . . . 12.0 119.718 179.058 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -81.3 -30.13 34.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.854 3.216 . . . . 35.549999999999997 113.05 172.999 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -71.97 -47.6 50.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.897 -3.627 . . . . 20.52 113.041 175.396 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -72.54 161.56 30.63 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 116.079 -4.138 . . . . 7.1299999999999999 116.818 -179.808 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -147.22 136.93 22.97 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.136 2.174 . . . . 36.390000000000001 111.988 170.864 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 mt -105.33 122.38 45.83 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 116.333 -1.794 . . . . 9.5500000000000007 114.505 178.822 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mm -93.6 140.74 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 131.607 3.963 . . . . 13.9 111.026 167.753 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CE1' HG12 ' A' ' 61' ' ' ILE . 21.2 t80 -134.71 117.22 15.8 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.118 2.967 . . . . 6.8600000000000003 112.503 167.158 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.84 -105.74 0.23 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.134 2.574 . . . . 11.15 111.531 -159.853 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.81 27.24 5.47 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.838 -1.164 . . . . 13.93 114.65 -172.337 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -153.69 141.87 20.45 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 126.535 3.064 . . . . 23.920000000000002 110.64 -179.706 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.45 165.06 23.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 112.469 -2.151 . . . . 23.23 112.605 172.879 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.363 12.0 mt -110.1 161.78 15.21 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.766 -1.834 . . . . 9.1099999999999994 110.049 -172.665 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -108.47 132.5 53.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.38 2.3 . . . . 33.439999999999998 109.971 179.228 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -45.48 -50.49 12.66 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 122.379 4.214 . . . . 28.370000000000001 122.379 -169.022 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.51 14.52 45.99 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 111.701 -2.5 . . . . 15.0 113.848 -175.664 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -99.37 155.15 17.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 116.902 -1.523 . . . . 25.5 111.747 174.744 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 34.9 p -87.34 161.46 17.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.129 1.518 . . . . 11.949999999999999 109.63 -177.119 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.7 mt -57.38 -44.38 84.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.961 2.791 . . . . 10.17 112.897 169.592 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -64.76 -15.45 61.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.303 -3.998 . . . . 13.59 115.486 -179.663 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -79.96 -44.7 19.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.57 -2.581 . . . . 11.699999999999999 110.583 179.951 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -85.6 -4.18 59.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.056 1.408 . . . . 12.949999999999999 112.64 174.746 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.435 22.9 m120 82.62 36.32 0.06 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.091 -3.505 . . . . 25.449999999999999 108.97 171.127 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.41 HG12 ' CE1' ' A' ' 45' ' ' PHE . 72.3 mt -89.44 98.12 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 119.601 -1.937 . . . . 14.6 109.277 -176.482 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -86.68 -172.25 3.92 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 117.341 2.348 . . . . 33.229999999999997 117.341 -171.044 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -73.26 138.74 45.7 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.941 0.877 . . . . 25.969999999999999 112.149 176.697 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 62.86 12.51 5.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.801 -2.437 . . . . 32.609999999999999 116.793 -171.977 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m -78.04 134.88 37.7 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 119.8 3.259 . . . . 10.56 119.8 169.019 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -87.16 123.84 32.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.676 1.58 . . . . 5.3300000000000001 109.549 -177.061 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -93.49 163.36 13.6 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.339 -2.1 . . . . 11.66 114.518 153.755 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -123.62 119.23 29.25 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.778 -1.556 . . . . 16.300000000000001 114.556 177.583 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.82 128.97 35.66 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 117.956 -1.021 . . . . 9.9600000000000009 111.373 177.517 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 m -127.43 -167.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 127.648 3.092 . . . . 9.7599999999999998 107.281 179.707 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 tp -111.81 142.32 44.31 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 105.744 -1.947 . . . . 19.57 105.744 -172.665 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -97.07 117.39 31.15 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.485 -1.234 . . . . 35.079999999999998 107.776 179.571 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.8 mt -107.65 134.52 50.52 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.423 -2.048 . . . . 32.310000000000002 113.137 159.46 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.281 3.8 tpp180 -72.96 115.51 12.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.135 -1.603 . . . . 42.75 110.482 -173.937 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.82 -51.16 0.43 Allowed Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 109.685 -1.366 . . . . 36.310000000000002 109.685 -173.091 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.814 0 CA-C-O 124.17 1.983 . . . . 36.270000000000003 109.528 171.957 . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttm . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 107.315 -1.365 . . . . 17.170000000000002 107.315 . . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -100.19 161.17 13.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.891 -3.63 . . . . 21.890000000000001 111.506 169.734 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.456 HG22 ' H ' ' A' ' 65' ' ' SER . 12.4 pt -152.96 157.7 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 129.083 2.953 . . . . 10.83 110.401 172.587 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.29 108.46 16.59 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 114.917 -4.864 . . . . 10.609999999999999 113.148 -172.557 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.3 t -103.13 114.59 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.596 -2.565 . . . . 9.1300000000000008 109.705 -176.667 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -98.06 146.02 25.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.625 1.678 . . . . 20.550000000000001 114.163 -173.863 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.311 81.4 p -86.56 -176.84 5.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.75 1.262 . . . . 11.779999999999999 109.41 172.678 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.4 tp -68.32 -62.37 1.43 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.692 2.797 . . . . 19.309999999999999 110.49 168.114 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -60.79 -68.77 0.27 Allowed 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.857 -3.652 . . . . 23.140000000000001 119.409 176.418 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.4 46.28 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 O-C-N 116.549 -3.844 . . . . 19.739999999999998 109.611 -173.552 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -118.88 141.15 48.91 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.673 -0.898 . . . . 21.93 110.415 157.95 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -110.41 124.9 52.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.612 -1.625 . . . . 12.33 106.612 169.077 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.488 HG21 HG12 ' A' ' 30' ' ' ILE . 12.9 mt -84.39 108.6 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 128.437 2.695 . . . . 17.079999999999998 107.994 169.188 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.4 m -96.64 97.94 9.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.128 -2.858 . . . . 16.300000000000001 111.95 -176.405 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.18 147.18 25.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.149 -2.844 . . . . 15.880000000000001 112.053 -169.125 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -111.16 133.05 53.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.485 1.612 . . . . 28.899999999999999 111.992 162.07 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.04 158.08 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 2 CA-C-N 107.04 -4.618 . . . . 12.050000000000001 111.592 -167.441 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -95.71 160.86 29.37 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 123.925 0.766 . . . . 18.170000000000002 112.035 159.145 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -87.85 -2.35 7.29 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 124.498 2.642 . . . . 8.1600000000000001 108.689 -175.561 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -81.8 -18.38 44.24 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.396 3.078 . . . . 11.130000000000001 111.709 170.208 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.24 153.08 34.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.019 1.489 . . . . 18.030000000000001 115.019 177.327 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 41.7 p -89.69 172.76 8.71 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.532 1.133 . . . . 10.220000000000001 110.468 -173.967 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -70.24 -24.32 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 118.526 -1.27 . . . . 12.300000000000001 111.597 171.26 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.53 -39.7 85.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.76 1.267 . . . . 36.509999999999998 113.414 171.336 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -65.53 -37.28 86.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.359 -3.963 . . . . 25.66 114.035 167.735 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.0 t -73.85 -34.18 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 122.716 2.507 . . . . 8.1199999999999992 108.746 -171.679 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -67.88 -41.26 83.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.147 3.779 . . . . 15.470000000000001 108.557 172.837 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.54 -33.52 66.9 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.713 2.405 . . . . 11.449999999999999 112.403 -177.666 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -61.97 -33.73 74.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.715 -3.116 . . . . 24.98 114.597 166.887 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.488 HG12 HG21 ' A' ' 13' ' ' ILE . 80.4 mt -73.0 -41.69 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 117.034 -1.46 . . . . 9.4600000000000009 110.333 173.157 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -56.98 -42.12 79.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.606 2.362 . . . . 14.76 113.797 178.407 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.01 -43.46 82.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 112.974 -3.393 . . . . 26.289999999999999 110.825 179.806 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -100.79 -43.13 6.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 124.395 3.27 . . . . 30.059999999999999 118.33 -173.209 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -91.75 -38.06 12.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 123.461 0.705 . . . . 25.190000000000001 109.429 -175.977 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.27 21.84 9.12 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 120.373 -1.454 . . . . 7.4100000000000001 114.61 170.847 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -91.73 122.44 65.53 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 113.392 -3.194 . . . . 9.4900000000000002 109.263 -175.718 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.87 147.72 85.45 Favored 'Trans proline' 0 N--CA 1.434 -2.014 1 CA-C-N 129.786 4.531 . . . . 11.42 114.501 -179.972 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -79.58 -8.42 14.8 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 122.395 2.063 . . . . 12.0 112.792 -162.61 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -83.84 -34.65 24.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.999 -3.563 . . . . 35.549999999999997 109.065 179.045 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -83.87 -28.41 28.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 131.072 3.749 . . . . 20.52 112.04 -167.696 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -92.05 155.5 18.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.584 2.611 . . . . 7.1299999999999999 112.793 166.3 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -142.16 142.45 32.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.052 -2.28 . . . . 36.390000000000001 109.998 167.708 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.5 mt -101.1 111.14 23.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 116.561 2.06 . . . . 9.5500000000000007 116.561 176.904 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.7 mm -95.71 132.1 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 126.432 2.332 . . . . 13.9 111.705 172.148 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -111.86 123.0 49.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.818 2.723 . . . . 6.8600000000000003 105.949 169.677 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.451 . . 59.61 -99.36 0.09 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 116.255 -1.831 . . . . 11.15 115.66 -170.338 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.98 18.39 4.5 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 106.426 -2.669 . . . . 13.93 106.426 179.67 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -124.21 130.42 52.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.236 2.214 . . . . 23.920000000000002 110.301 -173.636 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -91.3 125.72 36.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.342 -2.096 . . . . 23.23 105.342 -169.977 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.413 HD23 ' CD2' ' A' ' 59' ' ' TYR . 92.9 mt -86.28 148.5 25.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.095 0.958 . . . . 9.1099999999999994 112.275 -179.296 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -123.42 148.76 45.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.182 -2.824 . . . . 33.439999999999998 116.87 -171.171 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -19.15 -76.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 133.491 4.716 . . . . 28.370000000000001 121.387 178.691 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.49 16.22 61.19 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 117.458 1.743 . . . . 15.0 117.458 -168.474 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.416 ' O ' ' HA ' ' A' ' 22' ' ' THR . 19.7 mtt180 -99.11 160.99 13.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.955 -2.497 . . . . 25.5 110.32 167.351 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -103.76 168.26 9.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 104.792 -2.299 . . . . 11.949999999999999 104.792 -178.829 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -55.88 -36.59 67.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.617 -2.083 . . . . 10.17 115.994 167.768 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 t -61.63 -43.69 98.38 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.123 -2.861 . . . . 13.59 117.114 167.35 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -64.64 -26.64 68.48 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.095 1.887 . . . . 11.699999999999999 116.095 -177.182 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.413 ' CD2' HD23 ' A' ' 50' ' ' LEU . 66.9 m-85 -83.94 -32.34 25.12 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 116.912 -3.618 . . . . 12.949999999999999 111.043 170.717 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.301 26.2 m120 96.25 51.83 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.98 2.112 . . . . 25.449999999999999 114.379 -175.271 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.78 125.63 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 125.067 1.48 . . . . 14.6 113.96 177.837 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -110.03 177.27 4.76 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.972 1.841 . . . . 33.229999999999997 115.972 -176.957 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -60.41 145.75 46.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 124.404 3.275 . . . . 25.969999999999999 119.066 -174.54 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 67.74 32.19 5.52 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 132.129 4.171 . . . . 32.609999999999999 111.466 178.558 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.456 ' H ' HG22 ' A' ' 3' ' ' ILE . 22.7 t -89.35 151.7 21.93 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.685 -3.134 . . . . 10.56 110.145 -174.95 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -92.2 120.81 33.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.88 2.072 . . . . 5.3300000000000001 112.584 -172.32 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -117.77 159.99 22.11 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.222 2.915 . . . . 11.66 105.582 172.758 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -116.99 117.51 29.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.45 -3.281 . . . . 16.300000000000001 113.577 177.503 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -91.72 116.46 28.9 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.168 -1.583 . . . . 9.9600000000000009 111.191 174.487 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.6 m -112.27 134.15 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 127.819 2.448 . . . . 9.7599999999999998 106.193 178.551 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.55 144.31 30.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.309 2.004 . . . . 19.57 106.481 -175.783 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -79.64 116.15 19.66 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.579 2.437 . . . . 35.079999999999998 117.579 -172.783 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.1 mt -108.85 169.04 8.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.754 2.822 . . . . 32.310000000000002 108.355 -179.856 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -80.2 -44.21 20.15 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.267 -1.333 . . . . 42.75 113.943 -167.2 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.36 50.36 0.8 Allowed Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 130.459 3.885 . . . . 36.310000000000002 107.673 -174.793 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.739 0 CA-C-N 119.241 1.521 . . . . 36.270000000000003 110.399 176.332 . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 117.454 2.39 . . . . 17.170000000000002 117.454 . . . . . . . . . 0 0 . 1 . 071 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -90.36 133.49 34.95 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.07 -4.769 . . . . 21.890000000000001 106.708 -179.462 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.8 pt -118.04 164.89 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 104.456 -2.424 . . . . 10.83 104.456 163.369 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -119.29 127.29 53.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.885 -2.416 . . . . 10.609999999999999 105.038 -174.561 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.5 139.13 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.159 -2.534 . . . . 9.1300000000000008 104.159 176.202 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -125.23 133.63 52.64 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.325 -3.36 . . . . 20.550000000000001 116.029 178.742 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.2 p -77.98 171.79 14.47 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 127.128 3.347 . . . . 11.779999999999999 111.277 175.558 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -79.35 -24.05 42.98 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.514 -2.13 . . . . 19.309999999999999 110.95 -172.993 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -77.21 -69.16 0.55 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.902 1.334 . . . . 23.140000000000001 108.338 170.181 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.23 66.19 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 O-C-N 119.143 -2.223 . . . . 19.739999999999998 112.018 169.303 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -99.76 134.26 42.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.54 1.536 . . . . 21.93 114.041 155.686 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.7 m -80.06 119.91 23.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.357 -1.464 . . . . 12.33 113.124 164.597 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.49 95.67 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 128.519 2.727 . . . . 17.079999999999998 107.53 -171.844 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.0 m -89.82 99.23 12.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.206 -1.035 . . . . 16.300000000000001 108.206 -165.137 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.295 47.0 mt -104.49 149.12 25.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.602 -3.186 . . . . 15.880000000000001 110.653 -170.788 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -108.0 123.33 48.49 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 121.66 2.027 . . . . 28.899999999999999 113.664 173.356 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -135.27 162.53 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.582 -1.948 . . . . 12.050000000000001 107.262 -164.839 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -101.69 165.31 14.24 Favored Pre-proline 0 N--CA 1.429 -1.486 0 O-C-N 118.421 -2.674 . . . . 18.170000000000002 108.334 165.299 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -64.06 -23.71 67.13 Favored 'Trans proline' 0 C--N 1.3 -2.012 2 C-N-CA 125.721 4.281 . . . . 8.1600000000000001 112.597 174.053 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 m -87.68 3.15 48.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.987 -1.695 . . . . 11.130000000000001 109.907 -174.627 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -88.89 148.02 24.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.331 1.062 . . . . 18.030000000000001 109.286 -178.286 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 p -91.76 169.47 10.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.01 -1.904 . . . . 10.220000000000001 110.048 -175.828 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -46.65 -49.83 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.972 2.509 . . . . 12.300000000000001 114.46 160.513 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.301 23.8 tt0 -42.53 -43.21 3.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 117.03 2.233 . . . . 36.509999999999998 117.03 165.577 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -69.22 -30.32 68.46 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.402 1.91 . . . . 25.66 112.637 172.78 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.1 -56.2 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.568 -3.833 . . . . 8.1199999999999992 113.585 175.909 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -49.15 -46.13 44.75 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 130.439 3.496 . . . . 15.470000000000001 112.292 171.592 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.8 -36.95 76.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.339 -3.35 . . . . 11.449999999999999 114.828 -178.419 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -68.63 -33.8 74.64 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.986 1.476 . . . . 24.98 114.986 173.507 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.5 mt -70.39 -42.77 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.662 -4.399 . . . . 9.4600000000000009 111.167 175.528 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -55.75 -43.24 76.47 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.97 -1.706 . . . . 14.76 110.001 170.358 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.263 21.5 t70 -48.95 -67.31 0.28 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.075 3.35 . . . . 26.289999999999999 114.683 177.751 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -93.99 -46.66 7.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.061 2.986 . . . . 30.059999999999999 119.061 178.847 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.98 -33.08 70.08 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 116.283 -1.818 . . . . 25.190000000000001 111.294 -171.591 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.74 18.68 46.99 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 116.446 -2.308 . . . . 7.4100000000000001 115.213 -179.164 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.4 mt -99.71 121.38 54.69 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 119.737 1.768 . . . . 9.4900000000000002 108.879 175.158 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -68.36 157.07 63.38 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 122.982 2.455 . . . . 11.42 117.958 178.328 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.02 -28.53 10.97 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 122.417 2.078 . . . . 12.0 111.675 -170.083 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.64 -31.43 68.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 126.108 2.13 . . . . 35.549999999999997 110.427 173.41 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -72.64 -15.95 61.71 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.363 -2.711 . . . . 20.52 115.413 -175.488 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -118.15 161.08 20.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.695 2.497 . . . . 7.1299999999999999 112.563 -168.999 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -138.09 133.66 33.74 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.772 -1.566 . . . . 36.390000000000001 106.772 164.223 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.29 129.72 43.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.932 -2.355 . . . . 9.5500000000000007 107.306 178.666 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.7 mm -116.04 133.58 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.366 -1.459 . . . . 13.9 109.898 -178.579 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -114.26 115.31 27.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.088 -3.508 . . . . 6.8600000000000003 108.143 165.032 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.25 -83.46 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.273 2.323 . . . . 11.15 117.273 -176.385 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.25 -36.7 5.6 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 116.981 -3.574 . . . . 13.93 111.444 -178.328 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -105.42 148.49 27.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.62 1.341 . . . . 23.920000000000002 114.62 -162.599 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -92.95 131.15 38.21 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.126 -4.734 . . . . 23.23 108.592 173.403 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.9 mt -74.25 143.3 45.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.531 1.678 . . . . 9.1099999999999994 115.531 -176.584 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.56 133.49 55.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.231 -1.543 . . . . 33.439999999999998 108.043 -168.739 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -30.72 -53.58 0.19 Allowed 'General case' 0 N--CA 1.429 -1.476 1 N-CA-C 124.261 4.912 . . . . 28.370000000000001 124.261 -173.014 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.98 17.41 44.94 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 121.305 1.866 . . . . 15.0 116.23 -160.443 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -115.71 145.15 43.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.869 -2.491 . . . . 25.5 113.449 -173.341 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.352 5.8 p -82.5 165.91 19.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 122.486 2.403 . . . . 11.949999999999999 114.354 -171.855 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.6 mt -78.14 -22.11 49.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.158 -2.214 . . . . 10.17 112.69 177.947 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.267 3.7 t -70.31 -37.84 74.83 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 127.937 3.732 . . . . 13.59 114.983 175.32 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -55.97 -43.78 77.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.891 2.876 . . . . 11.699999999999999 111.205 164.605 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -86.62 -3.22 59.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.484 1.661 . . . . 12.949999999999999 115.484 -176.736 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 m120 54.96 51.61 13.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.529 2.732 . . . . 25.449999999999999 112.12 -178.298 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.6 mt -103.28 116.6 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 116.92 -3.612 . . . . 14.6 106.566 173.223 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -94.44 -160.32 0.77 Allowed 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.581 -2.574 . . . . 33.229999999999997 109.214 178.944 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -83.11 161.61 21.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.12 -1.067 . . . . 25.969999999999999 108.12 -173.143 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.357 27.9 mt-10 55.42 28.65 11.89 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.752 2.421 . . . . 32.609999999999999 112.97 178.336 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.1 t -87.93 154.6 20.38 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.662 1.985 . . . . 10.56 113.191 172.27 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.306 1.3 m -121.45 90.34 3.3 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 125.481 1.738 . . . . 5.3300000000000001 113.603 -160.342 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -92.53 150.78 20.54 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.815 2.245 . . . . 11.66 107.604 176.65 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -116.67 139.31 50.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.001 2.81 . . . . 16.300000000000001 108.271 -176.964 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.25 113.87 27.32 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.301 -2.227 . . . . 9.9600000000000009 113.373 170.449 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 m -110.14 171.44 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 113.086 -1.87 . . . . 9.7599999999999998 106.443 175.194 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt -83.08 154.68 24.26 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.393 -2.067 . . . . 19.57 112.431 172.227 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -112.27 122.98 49.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.161 -1.587 . . . . 35.079999999999998 109.094 176.981 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.07 168.09 12.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.12 -2.862 . . . . 32.310000000000002 109.739 -178.477 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -75.95 -60.15 2.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.949 -1.719 . . . . 42.75 111.772 165.625 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.46 79.35 0.8 Allowed Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 128.008 2.718 . . . . 36.310000000000002 113.456 168.1 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.785 0 C-N-CA 127.882 2.658 . . . . 36.270000000000003 114.41 -177.093 . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 105.93 -1.878 . . . . 17.170000000000002 105.93 . . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -108.46 158.8 17.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.041 -2.577 . . . . 21.890000000000001 104.041 168.088 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -125.78 172.04 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.097 2.959 . . . . 10.83 105.511 171.585 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -123.9 146.78 48.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.71 -1.869 . . . . 10.609999999999999 109.808 167.906 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.3 125.88 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.587 1.955 . . . . 9.1300000000000008 106.153 175.71 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -105.67 140.66 38.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.187 1.47 . . . . 20.550000000000001 107.326 177.51 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -81.89 -164.07 0.75 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.034 2.35 . . . . 11.779999999999999 112.429 172.364 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.3 tp -82.93 -48.47 10.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.364 -3.335 . . . . 19.309999999999999 114.613 177.121 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.7 p -65.86 -40.94 92.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.325 -1.484 . . . . 23.140000000000001 113.288 171.033 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.07 62.57 0.26 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 117.768 1.867 . . . . 19.739999999999998 117.768 175.41 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -112.48 145.97 39.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.096 -1.816 . . . . 21.93 106.096 167.495 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.2 m -112.73 106.62 15.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 101.908 -3.367 . . . . 12.33 101.908 -166.315 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.8 mt -92.1 117.62 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 101.186 -3.635 . . . . 17.079999999999998 101.186 -172.317 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.9 m -94.05 130.11 40.33 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 116.795 -1.962 . . . . 16.300000000000001 109.976 174.628 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -129.9 142.63 50.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 124.649 1.218 . . . . 15.880000000000001 111.058 178.301 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -97.1 128.25 43.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.4 -2.687 . . . . 28.899999999999999 114.811 179.673 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.263 6.9 m -149.22 176.85 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.123 -1.611 . . . . 12.050000000000001 111.424 -174.068 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -110.74 179.64 0.78 Allowed Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.845 1.202 . . . . 18.170000000000002 111.663 168.123 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -71.2 -22.56 25.55 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-N 123.274 2.205 . . . . 8.1600000000000001 109.019 173.886 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 m -95.36 1.75 54.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.04 1.4 . . . . 11.130000000000001 110.534 -165.052 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.19 139.6 31.55 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.227 -4.671 . . . . 18.030000000000001 108.705 -176.419 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.6 p -76.4 166.58 23.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.129 1.159 . . . . 10.220000000000001 114.129 173.021 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.1 mm -70.5 -18.86 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 119.345 -0.942 . . . . 12.300000000000001 108.785 -179.127 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -69.54 -31.16 69.19 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.39 -2.694 . . . . 36.509999999999998 115.245 172.635 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -66.1 -42.13 89.7 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.788 2.835 . . . . 25.66 109.461 167.676 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.63 -51.2 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 125.546 1.779 . . . . 8.1199999999999992 110.835 176.237 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.63 -19.97 64.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.789 1.774 . . . . 15.470000000000001 115.789 -174.697 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.78 -27.54 66.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.48 1.912 . . . . 11.449999999999999 114.764 172.488 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -93.4 -20.52 20.26 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.321 -1.733 . . . . 24.98 106.321 -176.269 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.3 mt -75.12 -44.43 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 119.927 -1.733 . . . . 9.4600000000000009 113.557 167.307 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -56.91 -30.6 64.1 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.253 -2.78 . . . . 14.76 114.428 167.31 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.4 -52.88 14.05 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.627 -4.421 . . . . 26.289999999999999 108.523 178.53 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -66.13 -59.76 3.46 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.519 2.415 . . . . 30.059999999999999 117.519 172.23 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -97.53 -11.97 23.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 119.142 3.016 . . . . 25.190000000000001 119.142 -169.215 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.87 27.05 65.45 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 118.198 -2.814 . . . . 7.4100000000000001 115.489 -176.442 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -103.23 109.38 61.55 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 108.207 -1.035 . . . . 9.4900000000000002 108.207 -174.613 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -76.73 166.79 26.52 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.669 1.989 . . . . 11.42 116.14 -167.253 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.02 -20.86 16.41 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 123.126 2.152 . . . . 12.0 114.77 -156.277 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -83.61 -17.49 41.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.817 3.198 . . . . 35.549999999999997 114.795 178.686 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.468 ' HG2' HD23 ' A' ' 71' ' ' LEU . 49.4 tt0 -79.1 -31.72 44.37 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.844 2.59 . . . . 20.52 105.39 -179.53 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -111.41 176.01 5.19 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.589 1.995 . . . . 7.1299999999999999 115.285 -170.426 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.459 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 42.7 mtp180 -131.8 146.09 51.94 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 113.02 -3.371 . . . . 36.390000000000001 109.649 169.887 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.1 mt -109.16 134.5 51.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.723 1.889 . . . . 9.5500000000000007 106.649 172.449 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mm -121.23 143.17 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.697 -2.705 . . . . 13.9 103.697 -169.576 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -130.31 100.79 5.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.491 2.716 . . . . 6.8600000000000003 113.519 163.748 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.52 -107.28 0.19 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.997 1.719 . . . . 11.15 110.768 -165.708 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.29 -20.96 10.38 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-O 115.958 -2.579 . . . . 13.93 111.042 177.044 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -77.54 122.1 24.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.31 3.433 . . . . 23.920000000000002 104.772 -170.293 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -89.02 138.22 31.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.629 -3.169 . . . . 23.23 107.004 178.605 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.7 mt -106.03 127.68 53.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.112 -3.492 . . . . 9.1099999999999994 112.673 -161.236 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -77.37 146.14 36.84 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.187 2.595 . . . . 33.439999999999998 105.74 -175.111 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -65.74 -45.51 82.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.302 -2.124 . . . . 28.370000000000001 112.684 -171.667 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.82 41.85 2.98 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 117.496 -1.724 . . . . 15.0 114.354 177.883 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -124.75 157.5 35.56 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 119.884 1.842 . . . . 25.5 108.584 168.315 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.0 p -91.16 164.16 14.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.028 -3.545 . . . . 11.949999999999999 117.085 -177.204 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.9 mt -54.36 -43.57 71.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.505 -1.68 . . . . 10.17 112.677 163.77 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -55.39 -42.29 73.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.286 -3.384 . . . . 13.59 118.271 167.596 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -56.97 -39.28 74.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.865 -1.772 . . . . 11.699999999999999 113.712 179.237 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -83.65 -13.58 53.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.599 1.333 . . . . 12.949999999999999 114.599 175.446 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.55 52.34 4.64 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.084 1.883 . . . . 25.449999999999999 116.084 -167.384 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.296 11.8 mt -87.64 123.78 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 102.276 -3.231 . . . . 14.6 102.276 176.733 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.273 23.1 mt-30 -100.92 179.76 4.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.621 -1.924 . . . . 33.229999999999997 114.709 179.427 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -64.3 147.17 53.09 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.585 -2.572 . . . . 25.969999999999999 110.691 -174.097 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 48.76 37.51 9.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.156 2.583 . . . . 32.609999999999999 116.883 179.899 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 t -108.19 151.36 26.03 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.487 1.915 . . . . 10.56 108.621 -169.366 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.324 41.1 p -102.23 115.52 30.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.642 -2.536 . . . . 5.3300000000000001 111.099 -165.587 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.51 149.52 21.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.419 3.088 . . . . 11.66 103.429 172.39 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -114.6 130.8 56.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.695 -1.253 . . . . 16.300000000000001 108.94 178.366 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tt -105.18 120.93 42.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.004 1.722 . . . . 9.9600000000000009 110.249 -178.437 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 147.53 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 101.74 -3.43 . . . . 9.7599999999999998 101.74 -177.212 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.468 HD23 ' HG2' ' A' ' 40' ' ' GLN . 16.5 mt -81.81 152.88 26.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.87 1.795 . . . . 19.57 109.101 177.892 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.459 ' HG3' ' HD2' ' A' ' 42' ' ' ARG . 74.8 ttt180 -79.39 122.42 26.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 116.051 -1.928 . . . . 35.079999999999998 108.899 -167.993 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.1 mt -93.04 162.24 14.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 113.518 -3.134 . . . . 32.310000000000002 111.56 179.883 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -93.01 116.12 28.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.41 2.368 . . . . 42.75 109.218 -166.432 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.5 67.96 0.52 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.9 -1.68 . . . . 36.310000000000002 108.9 -167.996 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.7 2 O-C-N 131.923 5.131 . . . . 36.270000000000003 105.145 155.653 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttp . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 124.829 2.252 . . . . 17.170000000000002 113.606 . . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -89.46 126.28 35.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 126.29 2.948 . . . . 21.890000000000001 111.897 178.834 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -128.31 147.22 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 116.83 -3.669 . . . . 10.83 109.199 176.364 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.419 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 53.0 m-85 -100.79 137.86 38.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.34 3.856 . . . . 10.609999999999999 105.87 175.669 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.45 110.46 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 117.076 -1.44 . . . . 9.1300000000000008 111.106 170.743 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -93.61 143.22 26.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 116.813 -1.565 . . . . 20.550000000000001 111.122 -176.167 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.6 p -96.53 174.16 6.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.807 1.64 . . . . 11.779999999999999 107.1 -175.488 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.84 -51.3 70.32 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.744 -2.472 . . . . 19.309999999999999 114.617 177.582 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.1 p -67.32 -40.25 85.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.584 1.953 . . . . 23.140000000000001 115.841 172.351 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.15 59.89 0.3 Allowed Glycine 0 N--CA 1.43 -1.748 0 O-C-N 127.309 2.88 . . . . 19.739999999999998 114.315 151.449 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -95.17 126.27 40.38 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 115.625 -2.131 . . . . 21.93 108.638 163.667 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.7 m -95.8 113.22 24.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 116.916 -1.914 . . . . 12.33 107.025 179.271 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.1 pt -91.59 141.29 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.997 1.719 . . . . 17.079999999999998 107.374 178.276 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.1 m -107.3 124.97 50.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.749 -1.22 . . . . 16.300000000000001 111.529 178.821 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.25 141.87 51.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.725 -2.484 . . . . 15.880000000000001 106.445 177.876 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -108.47 107.76 18.42 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.885 2.474 . . . . 28.899999999999999 107.172 179.246 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.87 -177.52 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.733 -2.321 . . . . 12.050000000000001 104.733 -173.006 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -104.96 159.2 30.15 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 129.759 3.224 . . . . 18.170000000000002 108.475 170.49 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -81.04 -10.11 12.71 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 123.409 2.74 . . . . 8.1600000000000001 110.989 -172.051 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -94.68 2.2 55.57 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.227 2.829 . . . . 11.130000000000001 111.965 175.685 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -75.83 161.61 28.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 123.749 2.977 . . . . 18.030000000000001 111.945 178.415 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.6 p -87.31 164.64 16.16 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.398 -2.689 . . . . 10.220000000000001 116.633 179.479 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.15 -39.6 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 120.194 1.361 . . . . 12.300000000000001 109.005 174.473 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -53.43 -45.08 69.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.429 -2.045 . . . . 36.509999999999998 111.684 174.304 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -58.31 -42.64 87.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.863 2.542 . . . . 25.66 117.863 170.489 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 30' ' ' ILE . 21.4 t -56.8 -54.22 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.301 -2.75 . . . . 8.1199999999999992 109.011 171.434 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HA ' HD12 ' A' ' 30' ' ' ILE . 34.7 mtmt -58.87 -28.18 65.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 116.768 -3.707 . . . . 15.470000000000001 118.449 -177.153 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.16 94.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.498 2.719 . . . . 11.449999999999999 113.471 168.211 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -71.43 -39.34 71.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.526 -2.609 . . . . 24.98 111.661 -178.663 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 27' ' ' LYS . 21.3 mt -60.52 -36.87 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.228 2.611 . . . . 9.4600000000000009 109.1 173.771 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -66.85 -52.08 47.84 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.923 1.344 . . . . 14.76 113.432 175.882 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -50.53 -45.31 56.69 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.932 -2.98 . . . . 26.289999999999999 115.889 170.177 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -79.95 -51.61 8.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.777 -3.077 . . . . 30.059999999999999 115.404 -165.891 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -102.02 -30.9 10.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.428 1.091 . . . . 25.190000000000001 110.673 -175.107 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.55 34.08 5.92 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 127.977 2.703 . . . . 7.4100000000000001 110.182 164.805 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.0 mt -91.64 125.15 58.59 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 127.194 2.197 . . . . 9.4900000000000002 106.021 -174.809 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.65 171.57 4.43 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 126.233 3.262 . . . . 11.42 115.511 -179.234 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -76.41 -27.17 8.04 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 124.209 3.273 . . . . 12.0 114.059 -173.678 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -81.6 -20.32 40.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.951 -3.593 . . . . 35.549999999999997 114.618 -173.504 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -86.0 -45.93 11.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.505 1.922 . . . . 20.52 110.613 179.913 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -51.23 113.32 0.91 Allowed 'General case' 0 N--CA 1.43 -1.452 1 N-CA-C 123.674 4.694 . . . . 7.1299999999999999 123.674 163.153 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -117.0 119.58 35.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.562 -2.586 . . . . 36.390000000000001 109.198 157.494 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.38 128.34 39.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.196 -2.275 . . . . 9.5500000000000007 109.565 -177.441 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.29 23.8 mm -118.58 148.99 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.942 2.897 . . . . 13.9 105.637 -177.684 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -85.19 -83.58 0.16 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.1 0.864 . . . . 6.8600000000000003 112.459 177.252 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -98.93 -71.16 0.7 Allowed 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 106.651 -1.611 . . . . 11.15 106.651 166.668 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.2 -4.52 5.45 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 119.983 2.753 . . . . 13.93 119.983 172.652 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -101.69 160.18 14.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 112.485 -1.858 . . . . 23.920000000000002 115.435 171.918 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -87.66 170.77 10.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.828 -2.42 . . . . 23.23 115.999 -171.269 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.3 mt -131.23 105.81 7.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.995 1.379 . . . . 9.1099999999999994 108.683 176.086 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -72.76 140.51 47.81 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 121.711 3.967 . . . . 33.439999999999998 121.711 166.153 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -36.93 -66.3 0.24 Allowed 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 135.199 5.4 . . . . 28.370000000000001 119.958 -170.462 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.88 13.25 9.08 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 129.841 3.591 . . . . 15.0 116.857 -165.458 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -117.61 141.95 47.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.33 1.452 . . . . 25.5 111.989 -168.064 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.0 p -87.22 161.51 17.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.643 2.639 . . . . 11.949999999999999 111.03 -179.937 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 mt -49.09 -50.52 36.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.923 3.289 . . . . 10.17 113.565 176.126 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 t -50.58 -48.71 57.55 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 129.544 4.277 . . . . 13.59 115.585 172.416 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -61.06 -38.56 86.63 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.514 1.926 . . . . 11.699999999999999 112.219 177.276 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -85.8 -2.04 57.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.92 2.563 . . . . 12.949999999999999 117.92 171.483 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m120 65.82 48.47 1.86 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 127.278 2.861 . . . . 25.449999999999999 113.055 176.31 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.4 mt -94.57 108.0 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.942 3.297 . . . . 14.6 103.555 177.133 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -101.6 176.88 5.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.069 2.366 . . . . 33.229999999999997 110.871 177.568 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -60.61 146.18 46.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.713 -3.117 . . . . 25.969999999999999 117.124 -173.18 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.306 35.5 mt-10 71.94 -1.26 2.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 127.025 2.703 . . . . 32.609999999999999 117.25 174.09 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.316 56.0 m -48.39 138.56 9.95 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.37 2.668 . . . . 10.56 116.833 162.549 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.419 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 24.4 m -103.13 124.96 49.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.124 -1.61 . . . . 5.3300000000000001 111.007 167.253 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.73 169.28 8.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.858 -2.645 . . . . 11.66 103.858 -177.955 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -139.37 132.44 29.58 Favored 'General case' 0 N--CA 1.43 -1.444 1 CA-C-O 130.053 4.74 . . . . 16.300000000000001 113.324 -169.868 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.8 tp -115.81 107.74 15.43 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.387 -2.696 . . . . 9.9600000000000009 107.385 -168.187 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.6 172.09 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 2 C-N-CA 132.415 4.286 . . . . 9.7599999999999998 112.012 -171.011 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.8 tp -84.66 148.11 26.59 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.016 1.388 . . . . 19.57 112.463 -178.73 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -92.86 135.3 34.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.745 -3.097 . . . . 35.079999999999998 112.996 176.033 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.4 tt -123.5 113.45 18.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.249 1.976 . . . . 32.310000000000002 107.605 153.081 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -76.65 -53.72 7.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.461 -2.649 . . . . 42.75 116.023 -164.941 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.04 -83.6 1.19 Allowed Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 120.105 1.32 . . . . 36.310000000000002 114.753 172.893 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.752 0 C-N-CA 127.375 2.417 . . . . 36.270000000000003 112.745 -173.969 . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 3.5 ptt? . . . . . 0 CA--C 1.49 -1.346 0 CA-C-O 125.05 2.357 . . . . 17.170000000000002 110.327 . . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -92.13 150.84 20.71 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.566 -2.753 . . . . 21.890000000000001 103.566 -177.821 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -127.37 155.32 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.797 1.239 . . . . 10.83 109.848 159.736 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -105.82 158.05 17.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.649 -1.282 . . . . 10.609999999999999 109.174 174.649 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -148.32 120.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 N-CA-C 99.302 -4.333 . . . . 9.1300000000000008 99.302 -178.213 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -108.82 121.78 45.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.41 2.284 . . . . 20.550000000000001 116.978 -178.512 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -73.21 -178.41 2.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.222 1.963 . . . . 11.779999999999999 113.68 -169.074 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.257 15.1 tp -51.88 -57.04 10.54 Favored 'General case' 0 N--CA 1.431 -1.401 1 C-N-CA 134.109 4.964 . . . . 19.309999999999999 108.942 178.356 . . . . . . . . 3 2 . 1 . 074 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -73.28 -54.11 9.19 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.44 -4.537 . . . . 23.140000000000001 112.444 175.595 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.11 45.61 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 114.245 -3.531 . . . . 19.739999999999998 113.104 177.983 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -96.01 100.54 12.2 Favored 'General case' 0 N--CA 1.43 -1.472 2 C-N-CA 132.072 4.149 . . . . 21.93 103.536 178.097 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -82.87 102.21 11.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.7 2.0 . . . . 12.33 106.186 -177.975 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.255 3.5 pt -90.28 170.09 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 128.492 2.717 . . . . 17.079999999999998 106.327 178.584 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 m -121.53 149.91 42.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.085 3.354 . . . . 16.300000000000001 105.981 177.061 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.7 mt -143.38 145.09 32.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.013 -2.304 . . . . 15.880000000000001 105.18 171.954 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -106.11 104.84 14.64 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.142 1.925 . . . . 28.899999999999999 111.723 -177.936 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.251 20.9 m -120.38 128.67 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.171 -1.58 . . . . 12.050000000000001 114.57 -162.041 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -88.62 134.93 33.07 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 104.515 -2.402 . . . . 18.170000000000002 104.515 171.89 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.87 -0.52 10.01 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 120.864 1.344 . . . . 8.1600000000000001 114.241 -171.087 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 m -70.07 -26.36 63.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.252 3.056 . . . . 11.130000000000001 119.252 169.308 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -81.79 176.36 9.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.761 1.393 . . . . 18.030000000000001 114.761 179.347 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -76.38 157.14 32.63 Favored 'General case' 0 N--CA 1.43 -1.455 1 N-CA-C 123.324 4.564 . . . . 10.220000000000001 123.324 173.371 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -73.66 -28.08 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 117.746 -3.096 . . . . 12.300000000000001 113.307 173.614 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -52.08 -36.48 50.83 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 116.742 -3.724 . . . . 36.509999999999998 113.551 163.583 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -80.02 -22.08 42.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.803 1.641 . . . . 25.66 115.17 -177.811 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.47 -49.78 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 119.96 3.319 . . . . 8.1199999999999992 119.96 153.673 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.251 55.9 mtmt -70.98 -30.37 66.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.299 1.039 . . . . 15.470000000000001 113.199 -175.773 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.81 78.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.117 -1.615 . . . . 11.449999999999999 112.296 175.796 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 35.3 tptt -77.69 -21.52 51.9 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.548 1.139 . . . . 24.98 112.423 -175.766 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.7 mt -74.06 -40.75 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 128.061 2.545 . . . . 9.4600000000000009 109.013 170.389 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -65.86 -32.72 74.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.188 1.555 . . . . 14.76 111.999 177.71 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.35 -58.16 4.05 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.19 -2.194 . . . . 26.289999999999999 112.28 172.59 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -57.72 -60.82 3.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 119.883 3.29 . . . . 30.059999999999999 119.883 -177.975 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -101.8 -48.34 4.31 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.575 3.15 . . . . 25.190000000000001 108.311 -171.248 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.11 24.59 5.66 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 127.375 2.417 . . . . 7.4100000000000001 118.593 177.554 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.0 mt -92.04 103.94 9.44 Favored Pre-proline 0 N--CA 1.43 -1.453 1 CA-C-O 111.516 -4.088 . . . . 9.4900000000000002 108.476 -170.711 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.51 154.16 72.27 Favored 'Trans proline' 0 N--CA 1.434 -2.002 1 CA-C-N 130.542 4.801 . . . . 11.42 116.481 -168.31 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.32 -19.88 60.11 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 N-CA-C 119.048 2.672 . . . . 12.0 119.048 -174.344 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.35 -21.03 53.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 122.221 2.282 . . . . 35.549999999999997 115.106 173.04 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -83.27 -13.01 56.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.379 1.992 . . . . 20.52 116.379 168.865 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 75.6 mt-30 -96.17 119.15 34.14 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.199 -4.063 . . . . 7.1299999999999999 111.225 -173.638 . . . . . . . . 3 2 . 1 . 074 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -90.95 116.86 29.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 101.639 -3.467 . . . . 36.390000000000001 101.639 164.584 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 tp -105.58 113.91 27.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.623 2.011 . . . . 9.5500000000000007 110.946 -179.799 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -116.2 152.54 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 125.572 2.606 . . . . 13.9 104.625 -164.748 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -82.41 -80.49 0.16 Allowed 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.199 -4.063 . . . . 6.8600000000000003 112.789 162.871 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.3 -72.71 0.7 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.193 2.197 . . . . 11.15 109.001 172.105 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.97 -27.32 4.91 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 125.951 2.973 . . . . 13.93 117.144 174.085 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -106.64 150.83 25.82 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.366 -2.255 . . . . 23.920000000000002 109.786 -165.76 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -102.19 144.77 30.31 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.018 -2.926 . . . . 23.23 106.629 -170.197 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.1 mt -77.84 145.65 36.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.462 -2.608 . . . . 9.1099999999999994 111.19 179.764 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.55 151.59 27.41 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.105 1.362 . . . . 33.439999999999998 110.211 -175.256 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.36 -59.51 4.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.541 2.736 . . . . 28.370000000000001 112.24 -161.422 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.08 33.12 5.8 Favored Glycine 0 N--CA 1.43 -1.741 0 O-C-N 116.635 -3.791 . . . . 15.0 116.442 -168.912 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -121.76 160.47 24.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.518 -1.66 . . . . 25.5 106.518 174.363 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.4 p -104.56 173.47 6.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.95 2.786 . . . . 11.949999999999999 117.194 -174.32 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.6 -25.56 41.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.073 -2.267 . . . . 10.17 114.046 -177.926 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.7 m -59.58 -59.14 5.91 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.661 1.696 . . . . 13.59 110.789 168.523 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -67.0 -32.56 73.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.347 -2.096 . . . . 11.699999999999999 114.494 -173.186 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -69.43 -19.36 63.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.257 1.823 . . . . 12.949999999999999 113.019 171.902 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.299 42.5 m-80 58.98 50.36 8.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.514 1.926 . . . . 25.449999999999999 114.962 -173.232 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 mt -95.43 125.76 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.296 -1.372 . . . . 14.6 107.296 174.516 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -85.48 174.0 9.82 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.481 -3.887 . . . . 33.229999999999997 109.998 177.393 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 34.9 pttt -72.53 152.5 41.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 125.125 2.393 . . . . 25.969999999999999 113.881 174.016 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.52 41.48 30.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.664 3.586 . . . . 32.609999999999999 111.232 -171.564 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.5 t -107.73 142.05 38.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 127.22 3.39 . . . . 10.56 103.048 -179.062 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.9 m -98.94 123.56 43.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 110.632 -2.985 . . . . 5.3300000000000001 114.175 -179.119 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.6 mt -95.9 144.12 26.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.041 2.829 . . . . 11.66 108.045 174.838 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -111.14 124.89 53.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.414 -2.679 . . . . 16.300000000000001 114.449 -169.44 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.9 mt -100.78 126.86 47.38 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.123 1.44 . . . . 9.9600000000000009 110.441 -179.584 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.04 177.82 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.411 -1.329 . . . . 9.7599999999999998 107.411 162.539 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -85.05 122.97 30.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.463 -2.023 . . . . 19.57 106.827 175.123 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -93.89 148.29 22.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.026 3.33 . . . . 35.079999999999998 110.112 171.774 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 mt -85.81 172.56 10.68 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.401 -2.062 . . . . 32.310000000000002 111.876 172.252 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -75.37 -65.21 0.92 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.638 -1.289 . . . . 42.75 111.596 -167.506 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.82 -82.81 0.6 Allowed Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 124.974 1.274 . . . . 36.310000000000002 112.096 -165.259 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.752 1 CA-C-O 112.21 -4.661 . . . . 36.270000000000003 107.882 -178.371 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.329 4.1 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 122.438 1.113 . . . . 17.170000000000002 109.809 . . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -113.83 145.32 41.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.283 1.516 . . . . 21.890000000000001 107.237 177.684 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -123.75 -175.1 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 119.793 -1.817 . . . . 10.83 107.423 160.224 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.294 0.7 OUTLIER -129.59 140.21 51.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 127.013 2.695 . . . . 10.609999999999999 109.051 171.146 . . . . . . . . 3 3 . 1 . 075 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.58 137.52 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 1 O-C-N 114.382 -5.199 . . . . 9.1300000000000008 111.819 169.353 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -100.66 115.29 29.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 124.215 3.189 . . . . 20.550000000000001 109.783 162.352 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 p -67.41 -164.7 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 127.459 2.975 . . . . 11.779999999999999 116.692 -169.458 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.32 -56.54 17.45 Favored 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 131.922 4.089 . . . . 19.309999999999999 110.232 -179.487 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 p -76.35 -41.89 46.7 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.776 2.227 . . . . 23.140000000000001 111.601 -176.53 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.28 72.78 0.39 Allowed Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 127.405 2.431 . . . . 19.739999999999998 114.417 -174.419 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.33 80.1 tttt -135.34 124.4 24.31 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.421 1.088 . . . . 21.93 108.107 170.785 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -88.11 118.12 27.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.95 -2.968 . . . . 12.33 112.125 -179.21 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.5 pt -111.69 148.02 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 O-C-N 115.788 -4.32 . . . . 17.079999999999998 109.53 -173.829 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -98.21 137.55 36.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.839 -1.541 . . . . 16.300000000000001 106.839 -177.363 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -124.57 159.01 31.61 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.476 2.31 . . . . 15.880000000000001 107.185 178.994 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -123.06 126.85 47.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.508 -2.034 . . . . 28.899999999999999 105.508 173.986 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.07 169.18 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.032 -2.581 . . . . 12.050000000000001 104.032 -174.269 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -109.16 156.95 38.38 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 125.338 1.455 . . . . 18.170000000000002 107.938 165.077 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.19 -16.03 31.77 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 116.711 -1.726 . . . . 8.1600000000000001 114.106 176.942 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -72.7 -15.54 61.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.437 -1.32 . . . . 11.130000000000001 107.437 179.586 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -76.83 141.27 40.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.354 -2.716 . . . . 18.030000000000001 115.466 -170.961 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -70.58 168.51 16.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 121.67 3.952 . . . . 10.220000000000001 121.67 170.685 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.37 5.7 mm -62.43 -40.45 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.444 -1.41 . . . . 12.300000000000001 111.816 174.173 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -51.02 -31.84 19.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.48 2.03 . . . . 36.509999999999998 116.48 168.051 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -81.81 -29.42 32.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.024 -1.048 . . . . 25.66 111.097 176.665 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.27 4.0 t -62.1 -54.1 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 124.754 1.221 . . . . 8.1199999999999992 109.529 174.613 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -56.38 -37.45 70.12 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.824 2.157 . . . . 15.470000000000001 116.824 176.565 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.72 81.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.83 2.159 . . . . 11.449999999999999 116.83 175.284 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -71.71 -29.01 64.08 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 117.076 2.25 . . . . 24.98 117.076 168.888 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.342 48.5 mt -73.11 -43.25 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.191 -1.781 . . . . 9.4600000000000009 106.191 172.734 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -67.77 -26.67 66.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.734 2.124 . . . . 14.76 116.734 178.72 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.99 -51.53 25.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.484 -1.689 . . . . 26.289999999999999 114.117 169.381 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -64.99 -66.08 0.59 Allowed 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 131.78 4.032 . . . . 30.059999999999999 115.64 -179.896 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -95.71 -25.97 15.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.515 1.672 . . . . 25.190000000000001 115.515 -172.872 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.07 -27.51 8.56 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 120.75 -1.219 . . . . 7.4100000000000001 115.385 -178.967 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.3 mt -52.38 125.59 35.48 Favored Pre-proline 0 N--CA 1.43 -1.451 1 C-N-CA 131.807 4.043 . . . . 9.4900000000000002 109.237 -172.512 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.65 164.33 24.3 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-O 115.324 -2.032 . . . . 11.42 115.18 -178.44 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -80.98 -16.98 9.7 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 126.245 3.266 . . . . 12.0 114.239 -177.219 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -86.3 -5.1 59.25 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.876 -2.39 . . . . 35.549999999999997 106.865 -175.259 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.62 -28.19 22.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.046 -2.284 . . . . 20.52 112.278 171.676 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -88.05 123.13 32.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.961 1.097 . . . . 7.1299999999999999 113.961 -165.182 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -114.92 117.19 29.97 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.045 2.138 . . . . 36.390000000000001 115.365 160.86 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.17 112.89 24.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.565 1.65 . . . . 9.5500000000000007 109.31 -169.079 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -100.43 143.85 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 O-C-N 115.828 -4.295 . . . . 13.9 107.297 175.841 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -81.06 -92.07 0.06 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.106 1.763 . . . . 6.8600000000000003 112.35 169.848 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.28 -48.97 3.85 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 121.199 1.818 . . . . 11.15 109.51 162.017 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.9 9.12 0.73 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 119.792 -1.818 . . . . 13.93 115.607 -177.419 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -112.17 134.89 53.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.806 -1.924 . . . . 23.920000000000002 105.806 175.613 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -74.49 148.32 41.1 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.815 -1.803 . . . . 23.23 112.125 168.765 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 mt -91.83 127.0 37.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.016 -2.303 . . . . 9.1099999999999994 105.865 -177.486 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -79.46 131.89 36.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.412 1.885 . . . . 33.439999999999998 113.734 177.878 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -51.7 -51.91 52.39 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.343 2.257 . . . . 28.370000000000001 111.77 -162.189 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.94 9.56 59.82 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 119.741 -1.849 . . . . 15.0 116.927 -174.862 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -101.57 158.62 15.95 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.453 -3.969 . . . . 25.5 112.545 177.334 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -84.15 158.1 21.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.365 1.866 . . . . 11.949999999999999 112.402 -178.09 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -62.41 -32.14 72.94 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.676 -4.39 . . . . 10.17 111.294 164.749 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -57.86 -45.72 85.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.592 2.357 . . . . 13.59 116.648 174.252 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.98 -35.56 76.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.81 -1.541 . . . . 11.699999999999999 114.447 -178.444 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -79.79 2.9 21.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.263 -1.523 . . . . 12.949999999999999 111.839 169.698 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.7 t30 40.79 40.93 1.06 Allowed 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.582 2.353 . . . . 25.449999999999999 116.006 -168.761 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.8 mt -74.74 126.08 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 104.324 -2.473 . . . . 14.6 104.324 175.452 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -115.21 165.75 12.59 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 132.636 4.374 . . . . 33.229999999999997 114.191 179.881 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.345 45.8 pttt -55.25 157.67 3.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.498 3.519 . . . . 25.969999999999999 115.213 -172.829 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 75.01 0.22 3.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.98 2.112 . . . . 32.609999999999999 113.977 168.63 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t -91.61 157.44 16.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.72 -2.488 . . . . 10.56 110.771 -173.287 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -99.55 116.83 32.59 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 127.043 2.715 . . . . 5.3300000000000001 109.416 178.459 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.7 mt -99.98 152.61 19.99 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.073 1.749 . . . . 11.66 107.817 174.297 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -116.03 142.68 46.48 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.614 -1.624 . . . . 16.300000000000001 106.614 -166.659 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tp -111.41 112.16 23.72 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 115.832 -4.293 . . . . 9.9600000000000009 111.383 -175.541 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.86 139.03 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.67 -2.345 . . . . 9.7599999999999998 104.67 -173.701 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 tp -66.52 127.94 34.29 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.558 -2.589 . . . . 19.57 114.217 177.53 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -93.57 126.67 38.85 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.615 -1.928 . . . . 35.079999999999998 108.158 -170.961 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.276 26.5 mt -79.09 -75.06 0.25 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 121.777 2.08 . . . . 32.310000000000002 115.111 176.313 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -103.04 -50.22 3.56 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.88 2.472 . . . . 42.75 107.687 -158.24 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.31 -178.37 43.71 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 122.929 1.294 . . . . 36.310000000000002 112.182 -177.263 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 C-N-CA 129.598 3.475 . . . . 36.270000000000003 112.962 165.25 . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 109.464 -0.569 . . . . 17.170000000000002 109.464 . . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -75.43 126.4 30.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.709 -1.244 . . . . 21.890000000000001 112.736 -179.06 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -107.73 141.27 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 125.277 2.465 . . . . 10.83 104.902 151.552 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -101.06 144.48 29.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.876 -2.39 . . . . 10.609999999999999 107.007 165.665 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.287 58.1 t -106.54 124.0 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 116.735 -1.602 . . . . 9.1300000000000008 111.772 169.484 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -102.41 113.92 27.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 119.701 1.137 . . . . 20.550000000000001 111.825 -178.181 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.374 3.1 p -63.5 -174.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.135 2.642 . . . . 11.779999999999999 118.135 176.509 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.4 mt -81.54 -60.28 2.32 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.236 -2.79 . . . . 19.309999999999999 110.819 175.944 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.297 62.2 p -71.89 -64.45 0.93 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 116.062 -1.923 . . . . 23.140000000000001 114.566 -174.188 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.18 54.72 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.765 1 CA-C-N 126.13 4.059 . . . . 19.739999999999998 114.639 -175.584 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -135.49 138.46 43.15 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 128.057 2.857 . . . . 21.93 107.847 -176.192 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.288 72.9 m -139.79 107.58 5.66 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.225 -2.139 . . . . 12.33 105.225 -179.874 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.9 pt -112.36 161.06 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 124.254 1.978 . . . . 17.079999999999998 108.345 -166.692 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 m -117.38 126.78 53.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.726 -1.859 . . . . 16.300000000000001 111.885 -174.54 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -111.06 163.11 14.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.988 -1.07 . . . . 15.880000000000001 110.992 172.543 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -116.4 110.15 18.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.859 -2.275 . . . . 28.899999999999999 104.859 179.395 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.46 154.08 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.047 -2.283 . . . . 12.050000000000001 113.437 -176.833 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -97.34 153.08 38.53 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 114.862 -2.494 . . . . 18.170000000000002 113.973 167.142 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -59.96 -22.04 67.26 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-N 125.728 3.081 . . . . 8.1600000000000001 116.856 -179.834 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -76.72 -9.04 58.39 Favored 'General case' 0 N--CA 1.43 -1.457 1 C-N-CA 132.073 4.149 . . . . 11.130000000000001 116.875 170.758 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.72 127.5 33.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.77 -3.706 . . . . 18.030000000000001 114.971 175.583 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.291 45.1 p -68.53 159.09 32.51 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.257 2.623 . . . . 10.220000000000001 112.719 179.045 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.259 45.2 mm -57.25 -35.33 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.27 1.828 . . . . 12.300000000000001 112.461 168.021 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -60.79 -52.9 63.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.206 1.821 . . . . 36.509999999999998 115.337 173.46 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.271 33.0 m-80 -60.65 -36.05 77.72 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 115.34 -2.267 . . . . 25.66 113.328 174.497 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.421 50.1 t -46.81 -48.02 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 131.262 3.825 . . . . 8.1199999999999992 113.905 167.781 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -76.01 -20.72 57.59 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.79 -1.55 . . . . 15.470000000000001 110.868 -169.887 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.77 -28.75 55.82 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 112.631 0.604 . . . . 11.449999999999999 112.631 174.293 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -70.03 -32.45 70.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.471 0.915 . . . . 24.98 113.471 173.181 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -69.95 -35.0 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 123.936 1.827 . . . . 9.4600000000000009 109.594 172.33 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -69.63 -29.11 66.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.878 -2.389 . . . . 14.76 113.508 174.205 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.5 -54.3 21.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.289 -2.132 . . . . 26.289999999999999 112.604 168.575 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -64.38 -63.35 1.16 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 117.229 -1.367 . . . . 30.059999999999999 109.599 -175.955 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.74 -48.53 7.79 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.298 2.333 . . . . 25.190000000000001 117.298 177.916 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.46 52.02 1.63 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 117.474 -3.266 . . . . 7.4100000000000001 115.585 -171.915 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.0 mt -113.99 127.72 26.53 Favored Pre-proline 0 N--CA 1.43 -1.44 1 N-CA-C 99.132 -4.396 . . . . 9.4900000000000002 99.132 -169.399 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -72.7 157.86 51.47 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 O-C-N 117.053 -2.13 . . . . 11.42 109.075 -170.335 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -77.38 -29.1 5.07 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 C-N-CA 125.027 3.818 . . . . 12.0 111.639 -153.001 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.16 -26.79 42.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 130.579 3.552 . . . . 35.549999999999997 108.3 175.367 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -80.19 -26.99 38.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.477 -3.89 . . . . 20.52 111.596 -176.078 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -71.48 138.55 49.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.386 2.041 . . . . 7.1299999999999999 110.314 174.685 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -142.16 137.42 30.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.881 -2.387 . . . . 36.390000000000001 110.676 161.519 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -104.34 135.19 46.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.434 2.54 . . . . 9.5500000000000007 111.933 178.654 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mm -111.25 138.92 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.408 -1.724 . . . . 13.9 110.957 163.823 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.31 5.6 t80 -70.09 -87.82 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.892 1.677 . . . . 6.8600000000000003 109.742 167.762 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.23 -62.94 1.41 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 121.179 -0.951 . . . . 11.15 108.867 165.873 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.86 -24.87 2.21 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.033 1.778 . . . . 13.93 110.333 177.311 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.269 0.1 OUTLIER -74.36 123.52 24.78 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.147 -1.427 . . . . 23.920000000000002 107.147 -178.047 . . . . . . . . 3 3 . 1 . 076 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.269 16.2 pt20 -70.39 122.09 18.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.786 2.554 . . . . 23.23 111.137 164.292 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.3 mt -95.37 150.45 20.26 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 118.343 -2.723 . . . . 9.1099999999999994 111.282 -171.354 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -120.14 141.37 49.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.801 3.191 . . . . 33.439999999999998 116.019 -169.263 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.01 -52.97 56.71 Favored 'General case' 0 N--CA 1.43 -1.451 2 O-C-N 115.653 -4.404 . . . . 28.370000000000001 112.943 -156.988 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.88 29.59 7.85 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 124.216 3.189 . . . . 15.0 115.034 -169.862 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 -114.88 147.3 40.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.2 2.2 . . . . 25.5 109.332 177.359 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 p -94.19 173.04 7.84 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 129.584 3.154 . . . . 11.949999999999999 112.229 179.37 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.5 mt -86.28 -18.17 32.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 104.498 -2.408 . . . . 10.17 104.498 -173.259 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.18 -41.47 77.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.397 -2.064 . . . . 13.59 110.137 168.617 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.71 -41.43 92.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.95 2.1 . . . . 11.699999999999999 112.676 -177.585 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -78.44 -28.72 46.73 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 115.575 -2.45 . . . . 12.949999999999999 116.563 173.142 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.288 29.8 t30 74.5 56.36 0.08 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.63 3.172 . . . . 25.449999999999999 112.544 -168.242 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.405 HD13 HD21 ' A' ' 67' ' ' LEU . 31.4 mt -99.9 101.94 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 104.435 -2.432 . . . . 14.6 104.435 170.898 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -100.35 -156.28 0.55 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.522 2.329 . . . . 33.229999999999997 108.084 -172.113 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -61.41 157.6 16.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.905 -3.622 . . . . 25.969999999999999 119.336 174.799 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 71.78 15.98 5.73 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.016 -1.053 . . . . 32.609999999999999 112.603 163.623 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -101.22 142.78 32.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.742 2.526 . . . . 10.56 108.371 -156.999 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.3 m -111.58 129.26 56.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.8 -3.687 . . . . 5.3300000000000001 107.09 -178.3 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.405 HD21 HD13 ' A' ' 61' ' ' ILE . 66.8 mt -103.61 164.09 11.89 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.31 -1.366 . . . . 11.66 107.31 168.715 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -122.13 124.16 43.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.729 2.412 . . . . 16.300000000000001 110.966 -177.936 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.1 tp -106.01 110.78 23.16 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.598 -1.939 . . . . 9.9600000000000009 109.379 -172.032 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 m -114.53 174.38 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 117.966 -2.959 . . . . 9.7599999999999998 107.207 -174.743 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.6 mt -81.95 141.96 32.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.621 1.677 . . . . 19.57 111.007 168.151 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -75.89 103.31 5.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.06 -2.275 . . . . 35.079999999999998 111.695 159.814 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.7 mt -99.68 92.98 5.59 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.546 2.338 . . . . 32.310000000000002 114.6 171.604 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -123.37 -74.58 0.61 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.486 -1.384 . . . . 42.75 110.145 179.634 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.33 49.16 1.34 Allowed Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 125.505 2.725 . . . . 36.310000000000002 113.775 -170.18 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.812 0 CA-C-N 111.404 -2.398 . . . . 36.270000000000003 112.232 -165.12 . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 ttp . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 115.505 1.669 . . . . 17.170000000000002 115.505 . . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -93.47 133.33 36.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.057 2.208 . . . . 21.890000000000001 107.923 -175.522 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.85 150.83 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.655 -2.528 . . . . 10.83 111.106 175.126 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.447 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 21.2 m-85 -112.31 100.68 8.99 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.61 2.364 . . . . 10.609999999999999 116.896 176.867 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.3 t -92.63 114.86 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 120.294 -0.562 . . . . 9.1300000000000008 111.227 179.731 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -98.88 125.03 44.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.067 -2.896 . . . . 20.550000000000001 112.662 177.269 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.3 p -84.24 -179.07 7.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.488 -1.233 . . . . 11.779999999999999 113.481 -179.373 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 tt -50.72 -47.94 59.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.045 3.338 . . . . 19.309999999999999 112.573 179.405 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -93.15 -66.8 0.9 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.049 2.139 . . . . 23.140000000000001 107.287 -165.752 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.56 75.57 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 104.062 -3.615 . . . . 19.739999999999998 104.062 161.9 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -115.15 116.97 29.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.839 -0.8 . . . . 21.93 108.839 164.001 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.285 28.1 m -83.87 93.94 8.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.098 2.559 . . . . 12.33 109.689 173.907 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 mt -85.78 105.45 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 123.769 1.747 . . . . 17.079999999999998 107.394 -174.922 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -87.07 110.4 20.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.054 -4.154 . . . . 16.300000000000001 108.37 179.98 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.05 140.62 47.69 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.944 -1.873 . . . . 15.880000000000001 105.944 176.272 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -104.23 131.2 51.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.32 1.057 . . . . 28.899999999999999 111.812 167.781 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.24 178.94 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 115.142 -0.936 . . . . 12.050000000000001 109.529 -178.612 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -85.1 163.15 46.82 Favored Pre-proline 0 N--CA 1.429 -1.479 0 O-C-N 118.426 -2.671 . . . . 18.170000000000002 110.949 163.98 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.257 0.1 OUTLIER -76.24 -12.35 19.16 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 125.148 2.874 . . . . 8.1600000000000001 114.169 179.812 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -102.89 2.53 35.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.421 2.325 . . . . 11.130000000000001 108.063 -168.617 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -76.33 154.62 34.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.017 1.858 . . . . 18.030000000000001 116.017 169.298 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -93.06 169.65 10.25 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.823 2.527 . . . . 10.220000000000001 117.823 -179.316 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.54 -42.72 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 126.026 2.079 . . . . 12.300000000000001 116.185 -178.627 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 5.7 mm-40 -29.47 -50.3 0.1 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.9 2.48 . . . . 36.509999999999998 114.791 158.446 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.41 -37.91 63.23 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.161 -2.212 . . . . 25.66 108.092 -175.899 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.74 -43.46 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 124.379 2.038 . . . . 8.1199999999999992 111.613 176.083 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 50.0 mtpt -62.78 -36.79 84.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.276 -2.14 . . . . 15.470000000000001 115.392 173.659 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.46 89.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.994 2.518 . . . . 11.449999999999999 113.176 175.473 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -71.45 -30.3 65.87 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 124.391 1.076 . . . . 24.98 110.083 -178.095 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.5 mt -71.39 -39.15 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.327 -1.306 . . . . 9.4600000000000009 111.274 174.092 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -62.92 -40.59 98.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.887 -2.383 . . . . 14.76 109.35 170.476 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.19 -43.82 63.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 115.952 -1.975 . . . . 26.289999999999999 110.681 -171.664 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HB3' ' HG2' ' A' ' 34' ' ' GLU 0.303 28.8 tptt -69.25 -51.14 40.53 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.554 1.645 . . . . 30.059999999999999 113.516 -176.785 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.467 ' HG2' ' HB3' ' A' ' 33' ' ' LYS . 76.8 mm-40 -106.02 -32.7 8.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.268 3.027 . . . . 25.190000000000001 113.833 -157.818 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.42 56.71 4.17 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 128.429 2.919 . . . . 7.4100000000000001 113.329 -175.072 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mt -110.87 124.19 33.58 Favored Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 103.824 -2.658 . . . . 9.4900000000000002 103.824 -178.456 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.98 139.62 85.71 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 124.071 3.181 . . . . 11.42 117.085 175.589 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.95 -14.84 45.69 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 C-N-CA 127.422 5.415 . . . . 12.0 111.474 -174.757 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.401 2.5 p30 -81.37 -24.73 36.84 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.119 2.266 . . . . 35.549999999999997 117.119 178.351 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -75.72 -25.15 56.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 126.248 2.217 . . . . 20.52 116.83 167.142 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -79.51 121.72 25.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.638 2.459 . . . . 7.1299999999999999 117.638 -179.043 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -128.4 151.6 49.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.438 -2.664 . . . . 36.390000000000001 107.137 157.493 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.6 mt -131.12 143.57 50.74 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.332 2.015 . . . . 9.5500000000000007 111.089 -169.943 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.4 mm -120.65 140.74 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.401 3.08 . . . . 13.9 105.476 -176.28 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -104.16 -55.02 2.44 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 124.404 2.049 . . . . 6.8600000000000003 108.93 155.643 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.66 107.62 3.22 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.488 -2.008 . . . . 11.15 107.716 -176.661 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.81 -69.96 0.75 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 126.634 2.064 . . . . 13.93 116.619 175.853 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -96.3 166.95 11.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 119.138 1.469 . . . . 23.920000000000002 114.254 -175.727 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -60.39 139.11 57.84 Favored 'General case' 0 N--CA 1.43 -1.47 1 N-CA-C 123.489 4.626 . . . . 23.23 123.489 172.887 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.2 mt -83.4 120.42 25.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.825 1.65 . . . . 9.1099999999999994 114.759 173.642 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -89.25 155.09 19.61 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.682 -2.511 . . . . 33.439999999999998 110.075 -174.803 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.09 -53.72 49.22 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.165 1.786 . . . . 28.370000000000001 112.999 -158.433 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.15 36.23 4.54 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 117.673 -1.626 . . . . 15.0 114.273 -173.71 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -107.2 147.39 30.2 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.401 -2.074 . . . . 25.5 105.401 174.171 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.315 32.2 p -77.89 169.74 17.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.179 1.55 . . . . 11.949999999999999 112.272 -178.48 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.08 -30.99 55.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 113.953 -1.476 . . . . 10.17 109.17 178.999 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -66.49 -49.87 65.16 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 131.039 3.736 . . . . 13.59 110.233 179.155 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 33.1 t70 -56.63 -43.3 80.12 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.137 -2.227 . . . . 11.699999999999999 116.553 174.796 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -69.72 -27.61 65.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 124.952 1.408 . . . . 12.949999999999999 110.176 176.778 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 70.69 46.6 0.51 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 129.045 2.938 . . . . 25.449999999999999 107.795 -175.509 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.15 119.9 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 112.249 -2.25 . . . . 14.6 106.58 162.578 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -107.64 -176.15 2.98 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.802 2.441 . . . . 33.229999999999997 111.205 -174.987 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.276 54.7 pttt -69.92 135.03 49.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.661 -1.899 . . . . 25.969999999999999 115.099 -172.024 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 73.46 38.62 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.109 2.164 . . . . 32.609999999999999 109.809 179.9 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.6 m -94.21 150.76 20.01 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 112.865 -6.147 . . . . 10.56 110.15 -169.95 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.447 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 99.0 m -98.63 123.35 42.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.33 -2.731 . . . . 5.3300000000000001 105.244 -175.717 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.27 4.8 mp -116.03 148.21 40.42 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.676 -3.14 . . . . 11.66 109.746 168.9 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -95.05 121.87 37.12 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.157 1.932 . . . . 16.300000000000001 114.716 173.185 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.274 44.5 tp -81.62 114.89 20.61 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.489 -4.507 . . . . 9.9600000000000009 113.385 171.27 . . . . . . . . 3 2 . 1 . 077 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.86 157.09 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.695 2.043 . . . . 9.7599999999999998 113.951 -178.529 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.426 ' HG ' HD21 ' A' ' 73' ' ' LEU . 21.1 tp -73.29 122.41 21.93 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 112.942 0.719 . . . . 19.57 112.942 177.148 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -78.21 115.1 17.69 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.565 1.946 . . . . 35.079999999999998 114.32 170.201 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.426 HD21 ' HG ' ' A' ' 71' ' ' LEU . 62.3 mt -113.72 79.01 1.19 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.218 1.961 . . . . 32.310000000000002 109.403 179.65 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -130.12 171.43 12.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.031 -1.895 . . . . 42.75 110.473 177.468 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.48 77.71 0.29 Allowed Glycine 0 N--CA 1.43 -1.715 0 CA-C-O 124.001 1.889 . . . . 36.310000000000002 115.698 175.256 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.762 0 N-CA-C 107.049 -2.42 . . . . 36.270000000000003 107.049 -165.767 . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 120.007 3.336 . . . . 17.170000000000002 120.007 . . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -94.08 136.48 34.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.675 -1.972 . . . . 21.890000000000001 105.675 -164.98 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 pt -132.09 162.19 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 128.161 2.585 . . . . 10.83 110.731 168.666 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -113.58 143.29 44.81 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 124.346 2.022 . . . . 10.609999999999999 109.221 175.457 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -133.62 115.47 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.175 -4.703 . . . . 9.1300000000000008 104.881 175.832 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -94.01 126.89 39.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.911 -1.885 . . . . 20.550000000000001 105.911 179.013 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -72.56 168.52 18.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.603 -1.936 . . . . 11.779999999999999 115.175 171.911 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.0 tp -66.82 -47.49 71.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.275 -1.515 . . . . 19.309999999999999 110.837 -175.463 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -73.58 -50.1 22.93 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.286 1.835 . . . . 23.140000000000001 115.068 -179.055 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.53 49.75 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 114.924 -3.513 . . . . 19.739999999999998 115.403 -169.906 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -138.71 137.17 36.54 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 116.945 -1.902 . . . . 21.93 110.698 165.047 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -95.82 103.24 15.11 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 125.224 1.577 . . . . 12.33 108.588 172.529 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.98 120.05 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.974 -2.954 . . . . 17.079999999999998 111.786 177.641 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -99.28 120.55 39.73 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.915 -3.616 . . . . 16.300000000000001 102.396 -176.069 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.4 mt -122.77 168.95 11.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.376 3.071 . . . . 15.880000000000001 110.883 -170.538 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -135.58 120.42 18.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.635 1.574 . . . . 28.899999999999999 107.5 179.859 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.82 168.81 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.302 -2.481 . . . . 12.050000000000001 104.302 -172.972 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.266 32.4 mt-10 -106.14 170.83 5.37 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 117.822 -3.048 . . . . 18.170000000000002 110.188 162.045 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -81.11 5.04 6.5 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 CA-C-N 121.983 1.744 . . . . 8.1600000000000001 112.101 -179.325 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -93.95 -16.03 24.35 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.133 2.573 . . . . 11.130000000000001 108.797 -179.089 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -80.5 142.24 34.4 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.88 1.218 . . . . 18.030000000000001 113.497 -173.078 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -74.79 159.03 32.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.684 -1.885 . . . . 10.220000000000001 111.3 176.489 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mm -49.35 -40.72 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 119.425 -2.047 . . . . 12.300000000000001 115.042 170.059 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -47.82 -50.02 27.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 115.227 -2.321 . . . . 36.509999999999998 115.782 167.529 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -68.28 -29.68 68.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 123.496 2.862 . . . . 25.66 115.337 177.013 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.87 -37.62 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 115.734 -0.666 . . . . 8.1199999999999992 111.487 177.059 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -58.95 -34.77 72.15 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 120.045 3.35 . . . . 15.470000000000001 120.045 163.273 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.42 -37.32 65.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.042 -2.911 . . . . 11.449999999999999 110.887 -178.133 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -52.99 -45.02 67.66 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.17 2.188 . . . . 24.98 116.502 159.937 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.59 -48.09 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 1 O-C-N 115.813 -4.305 . . . . 9.4600000000000009 108.625 179.236 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -49.57 -50.44 42.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.007 1.854 . . . . 14.76 116.007 169.605 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -54.07 -49.05 69.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.535 1.68 . . . . 26.289999999999999 115.535 174.044 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -67.66 -57.65 6.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.007 -1.451 . . . . 30.059999999999999 113.433 -179.676 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -95.81 -36.82 11.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.582 2.753 . . . . 25.190000000000001 112.493 -161.763 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.23 0.3 50.85 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 116.938 -2.034 . . . . 7.4100000000000001 116.572 -178.116 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.3 mt -72.56 124.77 91.19 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 128.69 2.796 . . . . 9.4900000000000002 108.588 179.948 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.48 160.42 9.52 Favored 'Trans proline' 0 C--N 1.3 -2.013 1 C-N-CA 126.294 4.662 . . . . 11.42 116.28 -178.555 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.19 -7.25 18.83 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 123.668 2.912 . . . . 12.0 113.964 -161.715 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -76.65 -57.23 3.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 131.069 3.748 . . . . 35.549999999999997 106.469 -179.847 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -56.98 -45.3 83.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.361 1.986 . . . . 20.52 116.361 168.82 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -62.03 110.52 1.6 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.402 -3.311 . . . . 7.1299999999999999 116.715 175.451 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -110.18 130.56 55.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.119 1.437 . . . . 36.390000000000001 107.326 163.458 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.0 mt -110.83 128.77 55.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.819 2.247 . . . . 9.5500000000000007 106.828 179.906 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.65 152.74 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.323 -3.36 . . . . 13.9 103.857 173.413 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -96.04 -66.96 0.87 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.806 -2.434 . . . . 6.8600000000000003 104.923 162.26 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.283 . . -156.33 130.56 8.68 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 104.486 -2.413 . . . . 11.15 104.486 173.766 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.59 -49.94 1.17 Allowed Glycine 0 N--CA 1.43 -1.753 0 CA-C-O 116.863 -2.076 . . . . 13.93 112.953 154.011 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -145.13 172.55 12.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.62 2.71 . . . . 23.920000000000002 107.378 -172.476 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.256 5.4 pm0 -83.66 135.23 34.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.229 -2.17 . . . . 23.23 115.553 -175.847 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.4 mt -77.27 151.41 35.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.485 -3.259 . . . . 9.1099999999999994 111.924 175.885 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -79.4 155.46 28.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.927 -2.983 . . . . 33.439999999999998 111.706 175.791 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -77.9 -43.09 31.07 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 120.83 1.65 . . . . 28.370000000000001 113.406 -173.564 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.16 29.4 11.9 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 118.462 0.574 . . . . 15.0 112.115 -175.873 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -114.51 149.19 36.78 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.425 -2.065 . . . . 25.5 105.425 178.025 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.286 30.1 p -100.1 176.39 5.42 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 111.568 -2.56 . . . . 11.949999999999999 117.547 -164.372 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.7 mt -73.8 -8.25 55.3 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.268 -3.395 . . . . 10.17 114.1 168.181 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.0 m -94.9 -28.61 15.11 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.551 -3.843 . . . . 13.59 102.332 -172.796 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -62.43 -51.71 66.43 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 131.673 3.989 . . . . 11.699999999999999 116.553 169.574 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -90.17 -6.4 55.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.361 -2.199 . . . . 12.949999999999999 111.707 -177.829 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.326 35.2 m120 72.13 36.3 1.13 Allowed 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 116.001 -4.187 . . . . 25.449999999999999 113.264 174.25 . . . . . . . . 3 2 . 1 . 078 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.77 109.19 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.72 2.408 . . . . 14.6 107.867 -172.612 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.12 -178.37 3.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.564 2.602 . . . . 33.229999999999997 111.213 -179.772 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -49.89 148.89 2.89 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 118.853 -2.404 . . . . 25.969999999999999 116.685 175.972 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 35.1 mt-10 53.48 36.97 24.57 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.302 -3.374 . . . . 32.609999999999999 118.616 -172.637 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -97.57 144.39 27.3 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.171 -2.159 . . . . 10.56 105.171 178.752 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -101.22 105.86 17.02 Favored 'General case' 0 N--CA 1.43 -1.442 1 CA-C-O 128.844 4.164 . . . . 5.3300000000000001 110.583 175.595 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.57 150.3 21.79 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.542 -2.599 . . . . 11.66 111.832 173.777 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -103.36 127.5 50.7 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.825 -1.172 . . . . 16.300000000000001 112.128 178.274 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.2 tp -105.26 116.52 32.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.41 3.481 . . . . 9.9600000000000009 109.347 169.947 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.76 174.16 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 112.781 -2.009 . . . . 9.7599999999999998 110.996 -179.114 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.9 tp -96.47 123.81 40.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.788 2.435 . . . . 19.57 111.386 -175.748 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -73.8 139.71 45.35 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.2 -1.562 . . . . 35.079999999999998 114.634 -176.091 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.6 mt -86.38 -53.49 4.97 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.081 -4.762 . . . . 32.310000000000002 108.29 -176.04 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.3 mtm-85 -119.49 -80.3 0.61 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.364 -3.335 . . . . 42.75 111.265 -167.115 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.08 -57.27 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.734 0 O-C-N 126.377 2.298 . . . . 36.310000000000002 110.459 -175.58 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.733 0 C-N-CA 125.679 1.609 . . . . 36.270000000000003 112.737 -178.434 . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 116.746 2.128 . . . . 17.170000000000002 116.746 . . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.251 85.8 mt-30 -85.05 122.23 28.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.096 1.903 . . . . 21.890000000000001 113.331 177.168 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -113.09 159.92 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.12 -2.548 . . . . 10.83 104.12 175.916 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -111.87 127.15 55.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 123.586 1.66 . . . . 10.609999999999999 109.298 -177.756 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.7 t -122.85 109.6 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.204 1.954 . . . . 9.1300000000000008 110.93 179.528 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -90.48 144.2 26.02 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 113.235 -5.916 . . . . 20.550000000000001 115.914 176.054 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -85.61 164.25 17.84 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.148 2.979 . . . . 11.779999999999999 113.653 175.582 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.94 -26.23 68.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.311 -2.743 . . . . 19.309999999999999 114.795 168.401 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 38.9 p -75.38 -44.06 46.87 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.455 1.934 . . . . 23.140000000000001 112.339 178.632 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.8 38.6 0.23 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-N 115.08 -0.964 . . . . 19.739999999999998 112.291 169.458 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -103.08 125.79 49.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.188 -1.042 . . . . 21.93 108.188 172.353 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.4 m -91.66 128.05 37.35 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 102.339 -3.208 . . . . 12.33 102.339 168.965 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.254 28.7 mt -102.06 136.22 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 117.828 -3.045 . . . . 17.079999999999998 105.309 178.295 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.7 m -105.99 100.17 9.73 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 100.607 -3.849 . . . . 16.300000000000001 100.607 -175.095 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 mt -96.14 119.74 35.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.907 1.683 . . . . 15.880000000000001 110.334 -177.939 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -93.97 96.72 9.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.063 -2.569 . . . . 28.899999999999999 104.063 178.837 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.71 168.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.733 2.013 . . . . 12.050000000000001 108.831 179.178 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -116.22 154.27 48.68 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-N 120.011 1.278 . . . . 18.170000000000002 108.98 -169.98 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.79 -4.32 14.49 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 CA-C-N 122.56 1.95 . . . . 8.1600000000000001 115.185 -173.127 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.4 m -88.59 -12.39 42.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 125.238 1.586 . . . . 11.130000000000001 113.987 172.431 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.67 149.78 48.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.034 -2.916 . . . . 18.030000000000001 114.511 -179.462 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.284 37.2 p -90.55 175.34 7.09 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 111.245 -2.707 . . . . 10.220000000000001 107.699 -179.105 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 mm -73.55 -27.36 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 119.456 -2.027 . . . . 12.300000000000001 109.791 171.992 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.73 -52.16 65.39 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.509 -2.619 . . . . 36.509999999999998 108.532 170.333 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -47.58 -39.86 17.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.654 2.381 . . . . 25.66 115.807 172.87 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.66 -46.63 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 127.1 3.333 . . . . 8.1199999999999992 114.657 -171.572 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.46 -27.63 66.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.934 -2.979 . . . . 15.470000000000001 115.19 160.636 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.88 -19.84 60.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.369 2.35 . . . . 11.449999999999999 111.211 178.073 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -69.34 -30.53 68.58 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 112.739 -6.225 . . . . 24.98 112.373 165.449 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -87.76 -18.03 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 126.005 2.812 . . . . 9.4600000000000009 113.068 174.593 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -69.67 -33.24 72.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.52 -3.863 . . . . 14.76 110.558 167.662 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.85 -54.11 12.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.202 -2.811 . . . . 26.289999999999999 110.767 178.481 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -71.31 -62.94 1.22 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.178 -1.576 . . . . 30.059999999999999 113.432 -176.774 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -91.5 -33.37 15.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.435 2.541 . . . . 25.190000000000001 110.779 -174.051 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.73 59.28 2.24 Favored Glycine 0 N--CA 1.43 -1.751 2 O-C-N 114.577 -5.077 . . . . 7.4100000000000001 109.371 179.55 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 mt -118.48 146.48 39.78 Favored Pre-proline 0 N--CA 1.43 -1.459 0 N-CA-C 103.236 -2.876 . . . . 9.4900000000000002 103.236 -177.127 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.266 53.1 Cg_exo -75.1 138.79 23.24 Favored 'Trans proline' 0 C--N 1.3 -1.996 2 C-N-CA 128.48 6.12 . . . . 11.42 112.064 -176.295 . . . . . . . . 3 2 . 1 . 079 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.88 -29.18 89.49 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 C-N-CA 122.748 2.299 . . . . 12.0 112.711 175.425 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.31 7.8 p-10 -70.87 -38.28 73.09 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.523 1.965 . . . . 35.549999999999997 112.084 175.825 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -73.44 -35.41 65.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.6 2.36 . . . . 20.52 110.379 -176.469 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -69.12 116.93 10.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.54 2.736 . . . . 7.1299999999999999 110.781 169.319 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.42 HH12 ' C ' ' A' ' 76' ' ' GLY . 30.7 ttm180 -110.76 129.12 55.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 128.612 3.695 . . . . 36.390000000000001 111.692 165.628 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 tp -116.45 133.37 56.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.408 -1.433 . . . . 9.5500000000000007 109.843 -172.691 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.5 mt -127.08 130.13 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 116.664 -3.772 . . . . 13.9 109.383 -175.108 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -89.87 -58.59 2.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 123.121 2.691 . . . . 6.8600000000000003 115.492 172.634 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.4 -73.94 0.63 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.19 1.396 . . . . 11.15 107.684 -178.608 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.25 -64.16 0.26 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 117.206 -2.426 . . . . 13.93 111.108 -173.569 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.275 17.6 ptmt -67.04 168.0 10.84 Favored 'General case' 0 N--CA 1.429 -1.491 2 CA-C-O 128.924 4.202 . . . . 23.920000000000002 113.496 171.961 . . . . . . . . 3 2 . 1 . 079 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -86.12 145.68 26.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.175 -2.739 . . . . 23.23 113.692 172.922 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -80.74 137.97 36.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.093 -1.629 . . . . 9.1099999999999994 107.793 -178.054 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -102.6 145.84 29.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.081 2.953 . . . . 33.439999999999998 107.884 -170.525 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -39.36 -73.97 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 119.77 3.248 . . . . 28.370000000000001 119.77 -174.692 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.02 17.52 41.28 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 129.073 3.225 . . . . 15.0 111.808 -164.16 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -96.4 163.66 12.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.687 -2.066 . . . . 25.5 105.46 173.395 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -101.55 163.89 12.04 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.42 -2.437 . . . . 11.949999999999999 104.42 -179.577 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.37 -26.46 66.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.358 -1.292 . . . . 10.17 114.424 162.592 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -65.93 -35.62 81.12 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 123.49 0.716 . . . . 13.59 111.895 168.421 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.8 -34.09 73.97 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 116.045 -4.159 . . . . 11.699999999999999 120.201 175.168 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -92.37 -22.26 19.78 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.476 -3.265 . . . . 12.949999999999999 105.79 -178.267 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.8 m120 71.89 75.44 0.17 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.5 2.72 . . . . 25.449999999999999 108.91 -177.563 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.2 mt -115.56 126.8 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 125.557 1.786 . . . . 14.6 106.637 -175.34 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.94 -178.79 4.54 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.398 -1.439 . . . . 33.229999999999997 109.323 179.848 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -66.61 156.06 36.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.948 2.309 . . . . 25.969999999999999 115.768 -168.231 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.291 46.7 mt-10 58.21 42.22 22.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.435 2.754 . . . . 32.609999999999999 118.435 -171.202 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 m -116.84 132.82 56.6 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.069 -1.826 . . . . 10.56 106.069 -175.759 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.6 m -84.09 140.41 31.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.984 -2.947 . . . . 5.3300000000000001 114.183 173.262 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -125.04 165.57 17.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.135 2.574 . . . . 11.66 110.096 174.344 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -110.27 104.4 13.2 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.271 1.952 . . . . 16.300000000000001 116.271 176.294 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.6 tp -73.06 118.74 16.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 123.876 0.735 . . . . 9.9600000000000009 110.236 165.817 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 m -129.64 155.53 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 105.592 -2.003 . . . . 9.7599999999999998 105.592 176.254 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.9 mt -112.0 169.31 8.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.539 -2.763 . . . . 19.57 103.539 -166.558 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -84.1 123.55 30.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.335 -1.302 . . . . 35.079999999999998 114.073 -178.9 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mt -93.86 -72.48 0.61 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 101.16 -3.644 . . . . 32.310000000000002 101.16 -175.858 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -121.13 -51.56 2.1 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.267 1.984 . . . . 42.75 109.235 170.351 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.42 151.3 5.45 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 105.362 -3.095 . . . . 36.310000000000002 105.362 174.569 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.42 ' C ' HH12 ' A' ' 42' ' ' ARG . . . . . . . . 0 C--O 1.26 1.745 0 C-N-CA 118.595 -1.764 . . . . 36.270000000000003 111.51 174.787 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ptt? . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 124.582 2.134 . . . . 17.170000000000002 108.851 . . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -99.03 132.7 44.15 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 116.585 -3.822 . . . . 21.890000000000001 113.089 -169.551 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 pt -120.46 154.5 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.08 -1.013 . . . . 10.83 110.331 175.661 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -124.52 125.01 43.51 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.073 -1.642 . . . . 10.609999999999999 106.706 -174.315 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.528 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 22.7 t -109.54 102.56 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 124.46 2.076 . . . . 9.1300000000000008 110.335 -178.229 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -83.61 126.28 32.68 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 127.284 3.421 . . . . 20.550000000000001 116.311 172.725 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.6 p -78.96 174.31 11.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.928 2.299 . . . . 11.779999999999999 112.612 -175.745 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.413 HD12 HG13 ' A' ' 70' ' ' VAL . 12.5 tp -75.6 -36.23 60.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.61 -2.556 . . . . 19.309999999999999 109.889 -177.018 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -61.68 -37.63 84.82 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.076 -3.515 . . . . 23.140000000000001 116.678 170.519 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.36 43.28 0.6 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 120.227 1.376 . . . . 19.739999999999998 111.066 174.546 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -111.18 151.17 28.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.611 1.708 . . . . 21.93 115.611 161.911 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -97.36 115.51 27.85 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.214 -1.554 . . . . 12.33 113.568 171.577 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.528 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 10.0 mt -93.04 92.18 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 126.366 2.984 . . . . 17.079999999999998 111.165 170.699 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.3 m -82.91 105.22 13.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.551 -2.113 . . . . 16.300000000000001 113.122 -173.956 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.86 158.38 17.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.738 -2.69 . . . . 15.880000000000001 103.738 -169.938 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -110.97 133.29 53.5 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.395 -2.69 . . . . 28.899999999999999 108.437 164.146 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.92 169.15 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.006 -2.961 . . . . 12.050000000000001 103.006 -171.502 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -100.88 174.15 3.16 Favored Pre-proline 0 N--CA 1.429 -1.485 1 O-C-N 114.432 -5.168 . . . . 18.170000000000002 104.14 165.882 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.29 -15.3 14.34 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 CA-C-N 123.239 2.192 . . . . 8.1600000000000001 116.133 168.937 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.7 p -77.91 -5.46 51.16 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.57 2.348 . . . . 11.130000000000001 114.688 176.366 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -70.84 148.25 48.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.588 -3.82 . . . . 18.030000000000001 112.456 178.428 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.9 p -93.0 148.01 22.35 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 129.477 4.236 . . . . 10.220000000000001 108.644 178.134 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.8 mm -52.21 -32.49 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 125.781 2.705 . . . . 12.300000000000001 116.144 173.144 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -67.61 -39.18 84.74 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.617 -3.802 . . . . 36.509999999999998 113.106 174.742 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -78.64 -6.76 56.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 114.483 -2.887 . . . . 25.66 110.548 -179.665 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.3 t -86.56 -43.59 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 130.762 3.625 . . . . 8.1199999999999992 110.026 171.806 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -51.25 -33.27 27.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.36 -3.338 . . . . 15.470000000000001 119.093 161.4 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.7 -19.04 63.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.327 -2.108 . . . . 11.449999999999999 114.407 177.849 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -78.89 -39.98 33.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.364 -1.347 . . . . 24.98 107.364 174.117 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 mt -74.36 -40.48 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.742 -1.849 . . . . 9.4600000000000009 107.965 -176.652 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -54.1 -45.44 71.82 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.99 -2.944 . . . . 14.76 110.714 173.014 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -64.81 -52.64 55.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.749 -1.844 . . . . 26.289999999999999 111.081 -176.65 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.58 -66.96 0.54 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.102 2.26 . . . . 30.059999999999999 117.102 -176.393 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -67.47 -49.73 62.25 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.507 2.379 . . . . 25.190000000000001 113.334 -172.174 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.85 13.34 16.39 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-N 113.22 -1.809 . . . . 7.4100000000000001 115.387 178.49 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.1 mt -89.08 127.15 56.62 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 126.926 2.091 . . . . 9.4900000000000002 108.801 -171.559 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -67.71 139.37 48.02 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-O 116.192 -1.67 . . . . 11.42 113.397 -177.878 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -73.34 -14.57 25.37 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 124.253 2.554 . . . . 12.0 118.301 -166.371 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -35.94 63.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 120.374 1.443 . . . . 35.549999999999997 111.299 172.172 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.55 -41.13 89.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 117.061 2.245 . . . . 20.52 117.061 166.688 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -63.65 117.53 6.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.904 3.282 . . . . 7.1299999999999999 109.375 -176.031 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HB3' HG22 ' A' ' 70' ' ' VAL . 27.3 ttm180 -116.88 101.25 8.37 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.054 -2.904 . . . . 36.390000000000001 104.649 176.429 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.6 tp -96.43 115.33 27.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.749 3.219 . . . . 9.5500000000000007 108.95 -172.32 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -114.97 154.38 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.928 2.891 . . . . 13.9 110.761 -171.391 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.89 -91.4 0.24 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 116.58 -1.676 . . . . 6.8600000000000003 106.622 174.264 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.54 -75.46 0.6 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.183 2.177 . . . . 11.15 106.019 178.786 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.95 -32.57 3.77 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 109.347 -3.57 . . . . 13.93 117.407 -175.062 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 8.2 ptpt -99.08 152.08 20.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.758 3.17 . . . . 23.920000000000002 116.869 173.083 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -88.89 133.5 34.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.852 -2.405 . . . . 23.23 113.014 171.557 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.8 mt -89.82 123.71 34.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.343 -1.473 . . . . 9.1099999999999994 110.973 -176.485 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -95.62 138.48 33.23 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.302 2.241 . . . . 33.439999999999998 107.562 -169.174 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -34.27 -49.89 0.39 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.843 3.657 . . . . 28.370000000000001 120.668 -168.869 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.55 -8.46 59.63 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 119.899 -1.751 . . . . 15.0 115.657 -164.453 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -83.59 154.38 23.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.864 -2.551 . . . . 25.5 108.43 -175.903 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -89.27 166.77 13.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.839 1.781 . . . . 11.949999999999999 115.312 176.759 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.47 -31.6 71.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 118.976 2.954 . . . . 10.17 118.976 169.71 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -61.12 -30.71 70.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.032 2.133 . . . . 13.59 115.33 163.325 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -72.02 -42.86 65.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.865 1.793 . . . . 11.699999999999999 110.82 174.41 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -83.31 -17.04 43.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.796 2.517 . . . . 12.949999999999999 117.796 -174.612 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 28.0 m120 78.52 45.96 0.06 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 131.0 3.72 . . . . 25.449999999999999 109.941 -179.005 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -83.06 123.91 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.413 -2.679 . . . . 14.6 105.78 167.605 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -112.42 -157.07 0.61 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.861 -2.274 . . . . 33.229999999999997 104.861 -179.382 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -85.32 153.23 22.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.097 1.147 . . . . 25.969999999999999 114.097 -178.826 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 57.03 34.11 24.41 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.526 -3.234 . . . . 32.609999999999999 111.749 -176.747 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -77.88 138.85 39.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.077 -1.083 . . . . 10.56 108.077 -178.288 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 m -98.93 118.79 36.5 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.437 -1.32 . . . . 5.3300000000000001 107.437 167.801 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.7 mt -106.36 176.41 5.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 123.386 0.674 . . . . 11.66 109.992 169.994 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -136.55 135.91 38.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 103.577 -2.749 . . . . 16.300000000000001 103.577 -168.444 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.4 tp -117.17 119.97 36.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.967 -3.583 . . . . 9.9600000000000009 108.42 173.28 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.433 HG22 ' HB3' ' A' ' 42' ' ' ARG . 27.9 m -116.9 166.97 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.734 2.207 . . . . 9.7599999999999998 110.055 163.091 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt -106.72 124.5 49.7 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.211 -1.556 . . . . 19.57 108.992 179.673 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -58.2 108.34 0.59 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.841 1.793 . . . . 35.079999999999998 115.841 178.908 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 mt -86.02 -145.75 0.11 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.275 -2.141 . . . . 32.310000000000002 111.68 167.074 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -124.31 96.77 5.04 Favored 'General case' 0 N--CA 1.43 -1.442 1 C-N-CA 133.614 4.766 . . . . 42.75 108.376 -167.547 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.22 -121.73 0.71 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 105.074 -3.21 . . . . 36.310000000000002 105.074 -168.33 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.751 0 CA-C-O 115.672 -2.738 . . . . 36.270000000000003 114.904 179.47 . . . . . . . . 0 0 . 1 . 081 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 121.271 0.558 . . . . 17.170000000000002 111.406 . . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -77.69 126.47 30.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.593 -3.817 . . . . 21.890000000000001 112.39 -173.614 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -115.19 139.45 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 119.369 0.986 . . . . 10.83 110.569 168.601 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -99.91 109.13 21.51 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.568 2.604 . . . . 10.609999999999999 111.555 179.282 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.8 t -92.03 105.82 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 119.576 -1.953 . . . . 9.1300000000000008 106.195 175.411 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.281 71.8 mttt -86.3 138.08 32.11 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.974 1.102 . . . . 20.550000000000001 113.974 -179.867 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.273 8.7 p -99.93 176.05 5.56 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.516 -3.24 . . . . 11.779999999999999 112.702 -167.89 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.278 27.7 tp -71.58 -55.6 7.47 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.424 3.489 . . . . 19.309999999999999 115.158 -174.453 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.414 67.6 p -56.53 -63.3 1.24 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.059 -1.65 . . . . 23.140000000000001 113.727 165.142 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.64 60.49 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 122.502 3.761 . . . . 19.739999999999998 122.502 -177.979 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.15 166.51 13.85 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.753 -3.204 . . . . 21.93 105.882 175.543 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -117.51 130.24 56.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.036 2.236 . . . . 12.33 117.036 158.678 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.461 HG23 ' HG ' ' A' ' 15' ' ' LEU . 77.8 mt -101.37 112.05 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 117.373 -1.731 . . . . 17.079999999999998 110.027 175.214 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.272 90.6 m -93.57 115.36 27.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.891 -3.631 . . . . 16.300000000000001 110.99 177.768 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.461 ' HG ' HG23 ' A' ' 13' ' ' ILE 0.28 50.9 mt -119.42 134.37 55.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.737 -1.579 . . . . 15.880000000000001 106.737 -173.455 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -96.94 94.68 7.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.918 3.287 . . . . 28.899999999999999 109.038 -179.53 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.9 m -119.45 159.2 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 118.01 -2.931 . . . . 12.050000000000001 105.477 -169.133 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -113.87 155.85 44.64 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 116.556 -3.84 . . . . 18.170000000000002 106.959 171.351 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.306 69.2 Cg_endo -65.54 -9.61 23.16 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 125.153 3.902 . . . . 8.1600000000000001 121.387 -164.203 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -94.61 -11.37 29.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.359 -1.463 . . . . 11.130000000000001 113.676 -179.612 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -64.22 143.52 57.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.158 2.183 . . . . 18.030000000000001 113.902 171.743 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -93.49 165.12 12.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.523 -1.361 . . . . 10.220000000000001 110.266 -166.464 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -66.91 -31.57 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 115.878 1.807 . . . . 12.300000000000001 115.878 171.235 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -49.51 -48.02 48.41 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.111 1.507 . . . . 36.509999999999998 113.39 166.766 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -81.11 -16.26 53.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.283 -1.326 . . . . 25.66 109.177 -178.375 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.81 -47.01 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 123.358 2.799 . . . . 8.1199999999999992 109.924 173.722 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -50.68 -38.52 47.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.289 2.235 . . . . 15.470000000000001 114.375 174.365 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.309 . . -62.53 -37.17 85.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.253 -2.308 . . . . 11.449999999999999 112.757 173.325 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -67.9 -49.06 64.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.382 1.446 . . . . 24.98 112.662 175.443 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.99 -36.86 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 O-C-N 115.978 -4.201 . . . . 9.4600000000000009 107.99 -179.096 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.43 -38.34 86.81 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.151 -3.468 . . . . 14.76 115.569 174.305 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -72.95 -43.51 62.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.242 1.942 . . . . 26.289999999999999 116.242 178.655 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -64.41 -69.86 0.26 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 120.847 3.647 . . . . 30.059999999999999 120.847 175.512 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' HB2' HG12 ' A' ' 36' ' ' ILE . 67.4 mm-40 -94.28 -2.56 52.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.068 -1.645 . . . . 25.190000000000001 111.966 -175.845 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.99 41.65 87.05 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 122.411 2.369 . . . . 7.4100000000000001 118.215 -178.302 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.412 HG12 ' HB2' ' A' ' 34' ' ' GLU . 18.9 mm -106.28 107.87 60.69 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 114.416 -2.707 . . . . 9.4900000000000002 108.972 -178.053 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.18 144.98 78.93 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 123.466 2.273 . . . . 11.42 117.319 177.165 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.34 -13.19 32.96 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 123.67 2.913 . . . . 12.0 112.0 -166.875 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -85.87 -9.38 57.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.839 3.255 . . . . 35.549999999999997 107.863 179.016 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -107.07 -15.45 14.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.53 -1.356 . . . . 20.52 114.413 171.088 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -81.47 99.26 8.66 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.613 -3.179 . . . . 7.1299999999999999 113.867 -179.258 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -91.88 107.1 18.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.685 -3.135 . . . . 36.390000000000001 107.011 170.56 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.9 134.47 41.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.742 -1.947 . . . . 9.5500000000000007 105.742 -177.685 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -123.39 132.91 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 130.257 3.423 . . . . 13.9 110.458 -179.522 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -107.98 112.06 24.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.536 -2.602 . . . . 6.8600000000000003 106.62 158.372 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.35 -86.84 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 131.927 4.091 . . . . 11.15 109.276 178.712 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.14 16.67 3.42 Favored Glycine 0 N--CA 1.43 -1.742 1 O-C-N 115.396 -4.565 . . . . 13.93 111.801 162.441 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.255 88.7 mttt -87.17 122.53 31.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.848 2.324 . . . . 23.920000000000002 111.105 172.988 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -84.86 106.48 16.42 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 121.099 1.772 . . . . 23.23 108.165 178.377 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.35 139.48 58.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.52 2.328 . . . . 9.1099999999999994 109.732 -174.015 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -100.35 140.74 34.16 Favored 'General case' 0 N--CA 1.43 -1.474 1 C-N-CA 131.735 4.014 . . . . 33.439999999999998 111.907 -175.785 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -54.88 -54.01 48.07 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.133 2.573 . . . . 28.370000000000001 113.661 -168.49 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.32 7.12 61.66 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 129.86 3.6 . . . . 15.0 114.978 -173.73 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -107.82 170.46 7.97 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.823 -1.177 . . . . 25.5 107.823 176.603 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.0 p -110.07 172.37 6.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.772 2.701 . . . . 11.949999999999999 115.877 -174.672 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.1 mt -59.2 -48.43 81.63 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.985 -2.947 . . . . 10.17 112.988 162.791 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.6 p -58.49 -23.18 57.22 Favored 'General case' 0 N--CA 1.43 -1.451 1 N-CA-C 123.196 4.517 . . . . 13.59 123.196 173.17 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.313 15.6 t70 -74.16 -50.47 19.19 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.741 -2.475 . . . . 11.699999999999999 110.989 177.106 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -73.62 -21.62 60.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.188 1.921 . . . . 12.949999999999999 116.188 177.92 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 67.8 m-20 80.78 47.93 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 127.958 3.742 . . . . 25.449999999999999 114.071 -176.604 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.7 mt -77.88 134.97 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.29 -2.756 . . . . 14.6 108.37 168.976 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -121.14 -158.11 0.75 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.296 1.622 . . . . 33.229999999999997 108.57 176.525 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 7.2 ptmm? -77.67 158.72 29.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.984 3.278 . . . . 25.969999999999999 113.334 170.814 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 64.91 24.69 12.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.032 -2.293 . . . . 32.609999999999999 109.333 168.658 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -91.35 148.51 22.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.031 -2.293 . . . . 10.56 109.62 -170.02 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -102.86 120.83 41.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.986 -1.696 . . . . 5.3300000000000001 109.156 173.921 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.28 160.27 16.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 102.932 -2.988 . . . . 11.66 102.932 174.025 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -122.54 134.18 54.55 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.026 -4.171 . . . . 16.300000000000001 105.332 179.395 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tp -100.52 129.93 46.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 128.613 3.696 . . . . 9.9600000000000009 105.663 167.788 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.66 168.32 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 101.833 -3.395 . . . . 9.7599999999999998 101.833 175.575 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.8 tp -88.8 126.21 35.25 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.403 2.371 . . . . 19.57 117.403 -176.151 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -87.6 136.35 32.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 113.573 0.953 . . . . 35.079999999999998 113.573 -171.132 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.3 mt -110.86 134.32 52.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.38 2.672 . . . . 32.310000000000002 106.106 174.996 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -82.8 164.06 20.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.699 2.19 . . . . 42.75 116.109 173.441 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.29 -86.53 0.22 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 110.364 -3.107 . . . . 36.310000000000002 107.505 -151.879 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.756 0 N-CA-C 108.213 -1.955 . . . . 36.270000000000003 108.213 177.291 . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 CA--C 1.489 -1.387 0 CA-C-O 124.832 2.254 . . . . 17.170000000000002 113.517 . . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -105.46 148.39 27.24 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.649 -3.157 . . . . 21.890000000000001 106.38 179.405 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.1 pt -130.27 153.84 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.286 -2.487 . . . . 10.83 104.286 172.64 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -109.21 113.77 26.9 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.881 -1.509 . . . . 10.609999999999999 110.75 173.574 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -95.5 110.83 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.294 -1.002 . . . . 9.1300000000000008 108.294 170.599 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -102.57 142.71 33.3 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.46 1.124 . . . . 20.550000000000001 113.06 -176.334 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 p -87.43 174.65 8.39 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 110.779 -2.919 . . . . 11.779999999999999 114.816 175.522 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.32 -49.75 62.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.538 -2.601 . . . . 19.309999999999999 115.027 167.957 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.8 p -69.89 -46.09 66.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.769 1.622 . . . . 23.140000000000001 112.41 176.914 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.36 54.25 0.13 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 119.7 -1.875 . . . . 19.739999999999998 108.523 173.589 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 78.8 tttt -109.26 132.41 54.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.497 1.519 . . . . 21.93 112.059 159.023 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -99.25 112.71 24.81 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 121.12 1.782 . . . . 12.33 111.842 178.378 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 mt -85.98 109.22 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.269 -2.863 . . . . 17.079999999999998 103.269 176.314 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.2 m -104.08 101.02 10.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.016 -1.476 . . . . 16.300000000000001 107.016 -175.185 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.0 mt -97.93 131.59 44.25 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.719 1.748 . . . . 15.880000000000001 115.719 173.412 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -75.75 124.35 27.12 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.578 2.132 . . . . 28.899999999999999 105.997 160.999 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.1 169.33 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 104.701 -2.333 . . . . 12.050000000000001 104.701 -179.988 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -104.49 152.3 39.33 Favored Pre-proline 0 N--CA 1.43 -1.444 0 C-N-CA 124.093 0.957 . . . . 18.170000000000002 112.67 155.009 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -63.74 -9.95 20.52 Favored 'Trans proline' 0 N--CA 1.434 -2.005 1 C-N-CA 127.248 5.299 . . . . 8.1600000000000001 113.124 -179.378 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.5 m -90.93 -7.76 51.22 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.645 1.72 . . . . 11.130000000000001 115.645 170.429 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -67.31 159.79 28.53 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.709 1.719 . . . . 18.030000000000001 114.328 174.011 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.326 71.1 p -86.83 168.9 13.04 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.869 -1.144 . . . . 10.220000000000001 114.035 -177.398 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.1 mm -60.61 -36.29 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 119.219 -2.176 . . . . 12.300000000000001 115.504 158.311 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -57.47 -33.75 68.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 126.837 3.208 . . . . 36.509999999999998 114.61 171.961 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -79.76 -23.98 41.84 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.537 -5.727 . . . . 25.66 111.154 179.547 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -69.11 -51.46 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 115.485 -0.779 . . . . 8.1199999999999992 112.736 168.458 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -56.62 -31.76 64.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.92 1.688 . . . . 15.470000000000001 112.815 178.448 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.47 75.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.901 2.137 . . . . 11.449999999999999 114.457 176.9 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -80.09 -31.12 39.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.747 2.689 . . . . 24.98 112.485 178.321 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.28 -38.11 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 1 O-C-N 115.538 -4.477 . . . . 9.4600000000000009 110.59 171.399 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -69.7 -29.94 67.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.585 -3.197 . . . . 14.76 119.152 171.268 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -76.24 -57.6 3.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.401 1.572 . . . . 26.289999999999999 113.286 171.336 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -78.1 -66.96 0.78 Allowed 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 115.114 -4.742 . . . . 30.059999999999999 109.567 -167.155 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.45 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 28.5 mm-40 -72.03 -38.71 69.5 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.981 2.8 . . . . 25.190000000000001 116.848 -175.084 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.04 43.12 2.28 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.968 -2.333 . . . . 7.4100000000000001 114.952 178.796 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mm -98.66 117.25 64.8 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 112.786 -3.483 . . . . 9.4900000000000002 111.073 -179.792 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -68.27 165.11 29.82 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 CA-C-N 125.207 2.895 . . . . 11.42 114.8 -177.553 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -79.34 -28.17 3.83 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 121.791 1.675 . . . . 12.0 112.737 -153.84 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -79.55 -30.65 41.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 127.513 3.008 . . . . 35.549999999999997 107.251 177.191 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -74.0 -16.65 61.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.238 -3.414 . . . . 20.52 112.222 -178.314 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -86.68 118.6 26.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.145 2.402 . . . . 7.1299999999999999 112.815 176.714 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -108.22 125.81 52.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.515 -3.143 . . . . 36.390000000000001 102.515 160.665 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -102.03 123.82 46.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 110.999 -2.818 . . . . 9.5500000000000007 106.391 168.035 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.6 mm -121.62 140.83 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 100.975 -3.713 . . . . 13.9 100.975 -173.266 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -126.72 122.77 35.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 116.323 -1.799 . . . . 6.8600000000000003 106.773 165.053 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.67 -92.28 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.785 1.63 . . . . 11.15 112.383 -164.478 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.67 -7.28 5.73 Favored Glycine 0 N--CA 1.431 -1.678 0 C-N-CA 127.659 2.552 . . . . 13.93 109.394 -179.305 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -103.52 119.79 39.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 118.497 2.777 . . . . 23.920000000000002 118.497 -166.874 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -69.43 112.19 5.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.668 1.359 . . . . 23.23 114.668 -178.621 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.2 mt -80.46 112.14 17.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.562 0.696 . . . . 9.1099999999999994 112.017 -179.862 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -85.94 168.48 14.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.409 2.684 . . . . 33.439999999999998 109.83 -170.808 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.62 -46.86 62.54 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 113.359 -5.838 . . . . 28.370000000000001 115.351 -165.441 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.63 32.0 6.68 Favored Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 126.922 2.201 . . . . 15.0 116.418 -168.607 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.8 mtt-85 -130.68 159.09 38.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.594 -3.484 . . . . 25.5 101.594 -177.771 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 p -87.8 156.79 19.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 131.511 3.925 . . . . 11.949999999999999 111.815 174.046 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.86 -28.78 68.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.016 -1.447 . . . . 10.17 111.612 178.843 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.291 68.8 p -59.28 -36.58 75.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.03 2.233 . . . . 13.59 117.03 165.972 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -81.93 -29.3 32.35 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.686 -4.384 . . . . 11.699999999999999 106.158 -170.816 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -72.86 -20.79 61.05 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 121.187 3.773 . . . . 12.949999999999999 121.187 160.874 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.389 15.6 m120 70.86 34.65 1.91 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.386 -2.071 . . . . 25.449999999999999 112.892 -174.479 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -88.46 132.21 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 101.42 -3.548 . . . . 14.6 101.42 171.859 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.271 81.9 mt-30 -98.53 175.22 6.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 109.864 -3.335 . . . . 33.229999999999997 114.869 174.211 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -45.71 137.73 5.14 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.549 2.74 . . . . 25.969999999999999 111.963 160.467 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 60.04 24.34 13.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.915 2.561 . . . . 32.609999999999999 117.915 177.466 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -78.08 154.22 31.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.215 -2.178 . . . . 10.56 106.408 -168.049 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.4 m -98.0 108.71 21.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 117.246 -1.359 . . . . 5.3300000000000001 111.975 173.277 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.07 158.2 16.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 125.114 1.509 . . . . 11.66 109.457 175.781 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -121.71 130.86 53.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.115 -2.241 . . . . 16.300000000000001 113.079 -178.167 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -87.55 100.8 13.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.314 3.046 . . . . 9.9600000000000009 110.928 169.402 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 t -96.94 120.26 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.99 -1.694 . . . . 9.7599999999999998 113.031 174.05 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 tp -75.57 116.13 15.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.541 -3.849 . . . . 19.57 108.655 -175.797 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.274 9.2 ttt180 -101.58 152.58 20.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.82 2.048 . . . . 35.079999999999998 112.515 -174.281 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.276 7.6 tp -89.64 163.39 15.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.27 2.628 . . . . 32.310000000000002 116.203 173.385 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -88.54 141.72 28.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.807 -1.808 . . . . 42.75 110.958 167.815 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.52 57.74 3.79 Favored Glycine 0 N--CA 1.429 -1.801 0 O-C-N 119.87 -1.769 . . . . 36.310000000000002 113.081 -165.585 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.78 0 O-C-N 121.231 -1.158 . . . . 36.270000000000003 114.687 -168.924 . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 117.664 2.468 . . . . 17.170000000000002 117.664 . . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -91.71 134.75 34.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 126.243 2.925 . . . . 21.890000000000001 113.688 179.971 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.4 pt -121.69 161.86 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 117.422 -3.299 . . . . 10.83 112.83 172.763 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -111.33 116.59 31.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 123.694 0.621 . . . . 10.609999999999999 111.589 179.806 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 t -103.56 108.6 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 118.728 -2.482 . . . . 9.1300000000000008 107.924 -175.383 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -97.5 119.96 37.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.41 2.052 . . . . 20.550000000000001 110.689 -172.108 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.507 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 2.2 p -76.66 175.35 9.41 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.568 -1.197 . . . . 11.779999999999999 111.931 -173.803 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.04 -40.52 75.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 124.219 1.961 . . . . 19.309999999999999 112.869 175.796 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 p -76.91 -21.14 55.34 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.483 2.313 . . . . 23.140000000000001 114.538 177.33 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.51 26.81 2.77 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 118.956 -1.592 . . . . 19.739999999999998 110.069 153.403 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -83.6 139.06 33.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 116.831 -1.556 . . . . 21.93 111.487 178.329 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -93.34 105.34 17.42 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.339 2.336 . . . . 12.33 109.837 168.161 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.18 119.94 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 125.013 2.339 . . . . 17.079999999999998 106.886 176.249 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.7 m -81.14 115.71 20.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.845 -2.409 . . . . 16.300000000000001 109.216 169.683 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.9 mt -123.41 144.65 49.35 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 113.186 -5.946 . . . . 15.880000000000001 106.922 177.361 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -89.99 108.78 19.93 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.051 1.74 . . . . 28.899999999999999 115.136 167.835 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.85 155.92 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 114.655 -1.157 . . . . 12.050000000000001 108.915 -179.412 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -109.06 152.4 42.47 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 101.081 -3.674 . . . . 18.170000000000002 101.081 163.148 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -65.83 -23.39 55.34 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 C-N-CA 126.271 4.647 . . . . 8.1600000000000001 112.34 -172.991 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.5 m -90.61 1.73 56.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.795 -3.066 . . . . 11.130000000000001 110.731 179.179 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -78.96 161.22 26.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 123.572 2.897 . . . . 18.030000000000001 104.177 175.374 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.0 p -108.03 167.36 10.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.803 -1.925 . . . . 10.220000000000001 105.803 -168.062 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.4 mm -74.62 -34.51 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 C-N-CA 128.921 2.888 . . . . 12.300000000000001 104.662 -171.587 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.87 -38.55 72.91 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.846 -4.284 . . . . 36.509999999999998 119.428 169.933 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -70.6 -19.3 62.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.006 -1.906 . . . . 25.66 114.839 169.916 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -79.14 -37.31 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 118.048 -1.461 . . . . 8.1199999999999992 110.948 175.884 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -67.96 -30.31 69.57 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 130.575 3.55 . . . . 15.470000000000001 111.033 176.568 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.69 -41.84 36.63 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.874 -2.391 . . . . 11.449999999999999 111.771 -175.755 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -61.21 -34.23 74.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.102 -2.874 . . . . 24.98 113.546 170.304 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.299 65.9 mt -65.17 -39.8 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 125.532 1.77 . . . . 9.4600000000000009 115.701 169.531 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -57.64 -53.41 58.51 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.728 -3.733 . . . . 14.76 112.541 173.78 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -67.83 -44.82 76.33 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.112 -2.313 . . . . 26.289999999999999 115.68 -177.6 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -83.02 -50.22 8.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.088 -1.434 . . . . 30.059999999999999 113.985 -178.678 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -94.76 -55.64 3.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.134 2.397 . . . . 25.190000000000001 111.438 -176.655 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.64 40.74 2.47 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 118.559 -1.781 . . . . 7.4100000000000001 117.141 -176.512 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.1 mm -90.04 131.17 39.87 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 118.275 -2.897 . . . . 9.4900000000000002 109.006 167.778 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -67.93 144.21 63.61 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 128.101 3.929 . . . . 11.42 118.298 -174.58 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -81.61 -3.59 11.96 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 124.082 3.188 . . . . 12.0 114.639 -163.502 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.83 -23.57 45.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.066 -1.646 . . . . 35.549999999999997 115.428 165.661 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -89.53 -24.18 21.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.35 1.86 . . . . 20.52 111.234 -179.754 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -78.8 96.63 5.67 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.195 -2.191 . . . . 7.1299999999999999 109.951 -173.177 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -109.28 127.05 53.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.408 -2.441 . . . . 36.390000000000001 104.408 171.706 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.8 mt -107.28 127.26 53.39 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 116.871 -1.538 . . . . 9.5500000000000007 108.672 -168.368 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 51.7 mm -117.92 137.79 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 125.323 1.639 . . . . 13.9 109.14 179.404 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -131.42 127.59 37.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 125.211 3.642 . . . . 6.8600000000000003 106.736 155.951 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.75 -106.89 0.35 Allowed 'General case' 0 N--CA 1.429 -1.482 1 C-N-CA 132.203 4.201 . . . . 11.15 113.649 -171.759 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.32 6.2 19.13 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.118 -2.239 . . . . 13.93 109.267 -177.761 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -122.4 142.1 50.89 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 116.068 -4.196 . . . . 23.920000000000002 107.989 -174.194 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -76.26 137.55 40.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.22 -1.355 . . . . 23.23 110.594 175.093 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.5 mt -86.04 112.85 21.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.0 -1.0 . . . . 9.1099999999999994 111.01 179.845 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -88.3 137.57 32.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 128.127 3.822 . . . . 33.439999999999998 109.907 -178.442 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.32 -62.44 1.48 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 110.023 -3.262 . . . . 28.370000000000001 116.372 -164.054 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.7 19.4 37.33 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 117.735 -3.103 . . . . 15.0 114.077 -171.73 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -92.38 171.08 9.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.452 2.019 . . . . 25.5 116.452 166.348 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 p -98.38 161.23 13.79 Favored 'General case' 0 N--CA 1.43 -1.459 1 CA-C-O 128.569 4.033 . . . . 11.949999999999999 110.269 178.856 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.325 5.5 mp -68.8 -36.99 78.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 111.362 -2.654 . . . . 10.17 110.604 172.377 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 p -50.92 -39.57 54.88 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.132 2.271 . . . . 13.59 117.132 162.865 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.9 -29.37 67.63 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.127 1.899 . . . . 11.699999999999999 116.127 -177.369 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -94.58 0.73 55.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.783 2.433 . . . . 12.949999999999999 115.382 178.002 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m120 68.05 33.0 4.73 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.299 -1.319 . . . . 25.449999999999999 113.701 -179.733 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.255 86.5 mt -78.47 116.4 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 124.848 1.259 . . . . 14.6 109.099 -174.065 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -93.05 173.35 7.78 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.117 -2.864 . . . . 33.229999999999997 109.974 -174.126 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -75.8 150.25 37.75 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.642 -3.161 . . . . 25.969999999999999 113.237 175.127 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.311 88.4 mt-10 64.83 39.97 5.78 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 131.568 3.947 . . . . 32.609999999999999 109.985 176.813 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.1 m -103.09 145.85 29.28 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.358 3.063 . . . . 10.56 112.064 -179.725 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -96.43 116.35 28.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 118.17 -1.412 . . . . 5.3300000000000001 112.828 -178.073 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.02 157.3 20.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.767 1.765 . . . . 11.66 115.767 165.364 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.457 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 10.9 m-70 -105.52 112.23 25.24 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.01 -2.931 . . . . 16.300000000000001 116.108 172.086 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 15.5 tp -96.21 104.86 16.85 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 119.857 -0.737 . . . . 9.9600000000000009 111.391 175.886 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.02 155.86 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 125.466 1.506 . . . . 9.7599999999999998 114.304 -166.259 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.3 tp -71.42 102.45 2.65 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.662 -2.523 . . . . 19.57 115.384 -179.548 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.4 ttt180 -63.82 129.75 41.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.683 1.706 . . . . 35.079999999999998 115.292 177.876 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.9 tp -105.76 130.76 53.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 100.329 -3.952 . . . . 32.310000000000002 100.329 170.827 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -62.12 151.91 34.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.188 1.921 . . . . 42.75 116.188 -176.396 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.66 -129.1 1.59 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.887 -2.085 . . . . 36.310000000000002 107.887 177.338 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 1 CA-C-O 111.36 -5.134 . . . . 36.270000000000003 106.685 -178.355 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 118.112 -0.947 . . . . 17.170000000000002 110.291 . . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -101.58 159.22 15.48 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.033 1.873 . . . . 21.890000000000001 113.826 165.719 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -135.8 157.29 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 126.227 1.811 . . . . 10.83 106.452 -179.696 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -112.07 117.46 32.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.874 -3.016 . . . . 10.609999999999999 112.809 175.613 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.7 t -99.15 122.26 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 102.919 -2.993 . . . . 9.1300000000000008 102.919 -175.435 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -122.87 120.87 34.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.136 -1.602 . . . . 20.550000000000001 112.071 -171.021 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.402 HG22 HD23 ' A' ' 69' ' ' LEU . 30.6 p -92.86 176.87 6.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.889 1.675 . . . . 11.779999999999999 109.626 -169.672 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -79.59 -31.8 41.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.863 -1.971 . . . . 19.309999999999999 113.027 -171.446 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.15 -62.88 1.36 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.047 1.739 . . . . 23.140000000000001 108.573 174.904 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.9 37.56 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.66 1 C-N-CA 113.35 -4.262 . . . . 19.739999999999998 106.365 156.921 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -88.77 130.33 35.38 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.105 -2.409 . . . . 21.93 109.646 -176.846 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -103.26 101.8 11.74 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.746 -1.575 . . . . 12.33 106.746 -178.11 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mt -93.19 131.82 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.892 -1.892 . . . . 17.079999999999998 105.892 -175.027 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 m -80.78 114.72 19.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.126 -1.805 . . . . 16.300000000000001 106.126 166.074 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 tp -127.89 125.28 39.34 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.954 2.101 . . . . 15.880000000000001 106.721 -177.946 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -103.26 133.63 48.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.945 -2.972 . . . . 28.899999999999999 110.937 -176.415 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -162.05 164.37 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 104.886 -2.264 . . . . 12.050000000000001 104.886 -160.252 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -126.64 141.25 39.68 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 117.594 -1.193 . . . . 18.170000000000002 111.244 177.953 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -67.17 -15.41 46.23 Favored 'Trans proline' 0 C--N 1.3 -1.98 1 C-N-CA 127.05 5.167 . . . . 8.1600000000000001 113.389 -166.739 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -89.49 -13.62 37.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 123.226 2.739 . . . . 11.130000000000001 112.27 -172.774 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.75 170.35 9.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.831 2.729 . . . . 18.030000000000001 108.019 -177.177 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -89.49 172.1 9.24 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.901 -2.999 . . . . 10.220000000000001 110.617 -164.496 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -70.83 -30.21 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.142 -2.224 . . . . 12.300000000000001 109.474 175.486 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -49.09 -39.06 26.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.513 -3.242 . . . . 36.509999999999998 115.702 161.711 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -64.63 -48.72 73.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.58 -1.95 . . . . 25.66 111.512 171.408 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.7 -44.51 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 117.899 2.555 . . . . 8.1199999999999992 117.899 173.322 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.0 ttmt -53.69 -35.64 61.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.286 -2.759 . . . . 15.470000000000001 116.922 168.49 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.56 -21.65 61.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.02 2.6 . . . . 11.449999999999999 118.02 -177.98 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -86.52 -32.63 20.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 130.61 3.564 . . . . 24.98 108.432 -175.992 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.2 mt -76.81 -33.07 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 119.768 1.167 . . . . 9.4600000000000009 109.28 175.036 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -54.1 -36.53 63.31 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.509 2.04 . . . . 14.76 116.509 167.641 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.54 -54.9 4.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.475 1.287 . . . . 26.289999999999999 114.475 -178.658 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -71.15 -73.86 0.16 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.805 1.941 . . . . 30.059999999999999 112.107 -174.951 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.44 -37.18 82.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.015 2.228 . . . . 25.190000000000001 117.015 173.49 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.0 30.11 11.68 Favored Glycine 0 N--CA 1.43 -1.718 1 O-C-N 115.624 -4.423 . . . . 7.4100000000000001 115.611 -176.493 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mm -87.12 125.59 65.67 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-O 115.911 -1.995 . . . . 9.4900000000000002 116.221 169.692 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -83.87 161.91 13.99 Favored 'Trans proline' 0 C--N 1.3 -2.002 1 CA-C-N 129.345 4.373 . . . . 11.42 114.91 -172.799 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -86.02 -11.8 6.33 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 123.465 2.273 . . . . 12.0 114.333 -142.658 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.52 ' CG ' HH21 ' A' ' 74' ' ' ARG . 5.4 p-10 -86.52 -4.5 59.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.873 3.669 . . . . 35.549999999999997 114.971 168.059 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.27 57.9 mt-30 -106.54 6.0 29.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.34 -1.475 . . . . 20.52 110.964 176.471 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -99.57 101.16 12.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.813 2.097 . . . . 7.1299999999999999 113.126 -177.002 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -99.15 109.81 22.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.355 1.074 . . . . 36.390000000000001 112.229 174.423 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 mt -103.92 136.22 43.98 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.642 -1.163 . . . . 9.5500000000000007 113.729 177.914 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.33 131.91 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.955 2.034 . . . . 13.9 106.267 -179.92 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -116.62 125.66 52.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.111 -1.44 . . . . 6.8600000000000003 107.111 163.884 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.346 . . 59.18 -106.09 0.28 Allowed 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.613 2.149 . . . . 11.15 116.112 -171.107 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.88 57.14 0.71 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 120.074 -1.641 . . . . 13.93 114.435 159.92 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -145.45 146.2 31.4 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.704 2.802 . . . . 23.920000000000002 108.803 178.817 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -93.48 130.65 39.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.864 2.603 . . . . 23.23 110.618 175.405 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -87.26 114.47 23.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.573 -3.204 . . . . 9.1099999999999994 110.73 -170.817 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.21 153.36 18.66 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.318 2.485 . . . . 33.439999999999998 109.331 -169.979 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -52.61 -49.26 65.42 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 117.01 -3.556 . . . . 28.370000000000001 116.756 -159.036 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.18 4.52 77.65 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 119.74 -1.85 . . . . 15.0 114.709 -171.376 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -83.71 163.88 19.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.302 -2.881 . . . . 25.5 106.896 -178.373 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -102.66 173.55 6.28 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.424 2.009 . . . . 11.949999999999999 116.424 170.949 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 mt -79.39 -29.46 42.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.455 -1.403 . . . . 10.17 108.327 177.378 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.9 p -65.51 -27.84 68.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.434 -1.27 . . . . 13.59 111.953 177.715 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.28 -56.48 21.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.825 2.05 . . . . 11.699999999999999 110.143 177.62 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.529 ' HB2' HG13 ' A' ' 61' ' ' ILE . 49.7 m-85 -83.11 3.42 30.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.479 -1.237 . . . . 12.949999999999999 113.327 -173.443 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 m120 49.05 61.56 3.06 Favored 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 134.361 5.064 . . . . 25.449999999999999 112.343 -169.274 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.529 HG13 ' HB2' ' A' ' 59' ' ' TYR . 74.9 mt -89.88 116.26 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 103.267 -2.864 . . . . 14.6 103.267 -177.604 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -99.19 -167.85 1.54 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.041 3.782 . . . . 33.229999999999997 110.816 -171.368 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -75.8 148.3 38.54 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 113.718 -5.614 . . . . 25.969999999999999 110.213 -177.411 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 35.17 63.55 0.49 Allowed 'General case' 0 N--CA 1.43 -1.459 2 C-N-CA 134.846 5.258 . . . . 32.609999999999999 115.463 -172.992 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.9 t -120.33 146.45 46.12 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 129.461 3.105 . . . . 10.56 108.602 -172.639 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.7 m -77.98 119.05 20.88 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.642 2.464 . . . . 5.3300000000000001 107.543 -175.266 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.96 132.0 53.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.029 -1.045 . . . . 11.66 108.2 158.128 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -85.58 141.23 29.99 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.987 -4.196 . . . . 16.300000000000001 110.71 174.802 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.402 HD23 HG22 ' A' ' 7' ' ' THR . 18.2 tp -119.28 127.51 53.29 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.273 2.694 . . . . 9.9600000000000009 118.273 175.094 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.31 -160.73 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 123.463 1.601 . . . . 9.7599999999999998 108.548 -178.601 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp -98.27 126.97 43.98 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 112.535 -2.12 . . . . 19.57 114.161 -174.494 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.422 HH21 ' C ' ' A' ' 76' ' ' GLY . 16.7 ttt180 -99.5 142.41 31.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.25 -2.156 . . . . 35.079999999999998 106.264 176.852 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mp -101.21 153.26 19.76 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.195 -2.191 . . . . 32.310000000000002 105.396 170.007 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.52 HH21 ' CG ' ' A' ' 39' ' ' ASP . 7.6 ptp180 -88.14 156.18 19.39 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 115.841 -2.344 . . . . 42.75 113.238 -175.258 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.52 50.53 1.19 Allowed Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 122.898 1.277 . . . . 36.310000000000002 112.895 -177.299 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 N--CA 1.43 -1.752 0 CA-C-O 115.199 -3.001 . . . . 36.270000000000003 105.687 -168.705 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.36 0.3 OUTLIER . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 122.441 1.115 . . . . 17.170000000000002 110.066 . . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -88.65 115.67 26.34 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.451 3.1 . . . . 21.890000000000001 113.344 179.923 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.81 171.05 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 118.88 -2.388 . . . . 10.83 104.998 166.565 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -121.6 147.56 45.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.71 2.804 . . . . 10.609999999999999 106.24 173.615 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -128.68 120.92 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 104.009 -2.589 . . . . 9.1300000000000008 104.009 172.671 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -102.29 127.8 49.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.602 2.361 . . . . 20.550000000000001 110.994 -171.355 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.9 p -89.6 169.09 11.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.195 2.426 . . . . 11.779999999999999 109.223 -173.941 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.7 mt -51.55 -40.53 59.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.347 2.259 . . . . 19.309999999999999 115.488 164.384 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.8 p -94.54 -71.69 0.65 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 125.336 1.648 . . . . 23.140000000000001 111.861 -165.507 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.97 48.67 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 120.611 -1.306 . . . . 19.739999999999998 115.94 178.053 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -119.09 140.68 49.69 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.218 1.562 . . . . 21.93 115.218 170.077 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.5 m -104.8 105.85 16.1 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.074 -4.766 . . . . 12.33 108.817 174.181 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.5 mt -91.4 105.43 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 O-C-N 114.552 -5.093 . . . . 17.079999999999998 107.747 -171.539 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -82.52 122.8 28.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.674 1.731 . . . . 16.300000000000001 115.674 178.19 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.5 tp -123.86 154.92 38.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.101 2.228 . . . . 15.880000000000001 113.966 -167.221 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -112.35 129.14 56.4 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.203 1.954 . . . . 28.899999999999999 110.848 165.181 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -148.46 170.34 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 130.292 3.437 . . . . 12.050000000000001 107.781 -179.237 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -120.95 165.18 19.6 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 107.035 -1.468 . . . . 18.170000000000002 107.035 166.564 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -69.9 -21.44 32.82 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-O 127.374 2.989 . . . . 8.1600000000000001 117.789 -172.325 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 m -78.83 -4.91 51.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 111.374 -2.648 . . . . 11.130000000000001 113.279 177.411 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.291 69.3 m-20 -78.35 143.04 37.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.34 2.019 . . . . 18.030000000000001 114.12 173.888 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 2.3 p -89.05 156.59 18.75 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.003 -2.311 . . . . 10.220000000000001 111.524 -168.894 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.7 mm -61.86 -33.92 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 118.55 2.796 . . . . 12.300000000000001 118.55 -179.072 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -44.79 -45.86 10.27 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 120.124 3.379 . . . . 36.509999999999998 120.124 161.623 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -72.63 -44.76 61.5 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.675 2.39 . . . . 25.66 111.097 -177.991 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.92 -48.48 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 114.849 1.426 . . . . 8.1199999999999992 114.849 177.735 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -54.44 -44.34 72.4 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.719 2.008 . . . . 15.470000000000001 115.412 171.439 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.309 . . -48.21 -46.25 34.88 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 120.117 3.377 . . . . 11.449999999999999 120.117 160.663 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -68.7 -35.36 77.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.883 -3.011 . . . . 24.98 114.946 175.066 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.302 63.2 mt -51.62 -49.57 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 110.74 -2.936 . . . . 9.4600000000000009 111.227 172.641 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -64.52 -24.57 67.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.79 3.236 . . . . 14.76 114.704 -179.776 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.48 -30.76 69.68 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.198 -4.064 . . . . 26.289999999999999 111.799 168.882 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -79.3 -66.65 0.84 Allowed 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 116.169 -4.082 . . . . 30.059999999999999 107.588 -173.711 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -121.71 145.57 47.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 103.133 -2.914 . . . . 25.190000000000001 103.133 -173.705 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.64 64.56 4.27 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 117.444 -1.753 . . . . 7.4100000000000001 112.824 -169.84 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.9 mm -110.97 109.7 57.19 Favored Pre-proline 0 N--CA 1.43 -1.473 1 CA-C-O 109.491 -5.052 . . . . 9.4900000000000002 108.443 -173.658 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.12 135.56 69.39 Favored 'Trans proline' 0 C--N 1.299 -2.034 1 C-N-CA 125.445 4.096 . . . . 11.42 115.276 -173.954 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.89 -19.32 65.31 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 CA-C-N 125.3 2.929 . . . . 12.0 116.442 -177.313 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.16 -16.46 49.72 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.271 -1.518 . . . . 35.549999999999997 112.053 175.191 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -99.36 -15.18 18.88 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.162 -2.211 . . . . 20.52 106.447 -177.112 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -77.71 121.76 24.44 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.91 -2.369 . . . . 7.1299999999999999 111.884 -175.987 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -121.31 110.45 16.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.295 -3.378 . . . . 36.390000000000001 104.93 175.055 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.7 mt -94.22 105.48 17.46 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 103.644 -2.724 . . . . 9.5500000000000007 103.644 -174.831 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mm -88.22 133.98 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 126.945 2.098 . . . . 13.9 108.874 167.777 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.487 ' CE2' HG12 ' A' ' 61' ' ' ILE . 70.6 t80 -137.51 109.09 6.98 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 101.444 -3.539 . . . . 6.8600000000000003 101.444 -175.495 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.43 -108.0 0.22 Allowed 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 114.236 -1.347 . . . . 11.15 113.9 -164.784 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.67 -16.71 25.74 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-O 115.774 -2.681 . . . . 13.93 112.584 177.837 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -113.59 147.25 38.39 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.965 2.383 . . . . 23.920000000000002 112.947 -163.001 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -73.95 127.73 33.64 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 127.506 3.527 . . . . 23.23 113.899 159.389 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.32 83.7 mt -78.4 132.99 37.57 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.556 -1.965 . . . . 9.1099999999999994 107.278 170.787 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -106.37 151.27 25.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.628 2.156 . . . . 33.439999999999998 115.473 -170.164 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.35 3.6 m-20 -46.99 -55.05 8.82 Favored 'General case' 0 N--CA 1.43 -1.469 1 N-CA-C 123.673 4.694 . . . . 28.370000000000001 123.673 -164.766 . . . . . . . . 3 2 . 1 . 085 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 5.35 78.52 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 122.128 0.849 . . . . 15.0 113.016 -170.812 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -105.11 152.77 22.38 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.532 1.933 . . . . 25.5 111.626 -172.384 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 56.3 p -89.47 174.25 7.89 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 118.907 -0.568 . . . . 11.949999999999999 109.666 179.582 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.71 -34.91 60.39 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.021 0.915 . . . . 10.17 110.078 174.603 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.7 p -57.57 -40.93 80.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.507 3.523 . . . . 13.59 110.342 173.416 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.11 -44.92 32.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.654 -3.154 . . . . 11.699999999999999 115.904 174.952 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.313 98.3 m-85 -92.37 2.23 56.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.06 -2.9 . . . . 12.949999999999999 115.338 172.101 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.285 18.0 m120 65.38 38.99 5.45 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 117.724 2.491 . . . . 25.449999999999999 117.724 176.267 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.487 HG12 ' CE2' ' A' ' 45' ' ' PHE . 57.2 mt -74.19 138.67 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.665 2.386 . . . . 14.6 108.015 172.934 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -129.66 -167.07 1.75 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.83 -2.419 . . . . 33.229999999999997 108.125 -176.3 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -76.77 158.56 30.81 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.863 -3.023 . . . . 25.969999999999999 113.318 -173.836 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 68.05 20.32 9.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.967 -2.958 . . . . 32.609999999999999 113.306 177.043 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.8 t -106.56 143.49 34.6 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.106 2.962 . . . . 10.56 116.857 -172.682 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -100.97 129.44 46.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.696 0.998 . . . . 5.3300000000000001 113.696 -173.993 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -104.12 152.56 21.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.474 -1.676 . . . . 11.66 106.474 173.171 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -115.74 124.53 51.02 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 116.863 -3.648 . . . . 16.300000000000001 108.677 -176.726 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tp -103.66 107.69 18.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.13 -1.606 . . . . 9.9600000000000009 108.851 -170.075 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.89 158.81 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 124.874 1.359 . . . . 9.7599999999999998 109.739 -179.265 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.7 tp -81.24 113.38 19.33 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.557 2.123 . . . . 19.57 112.394 -178.925 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -59.55 140.02 56.66 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.516 2.579 . . . . 35.079999999999998 113.389 170.003 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.4 tp -97.25 142.78 28.73 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 130.285 3.434 . . . . 32.310000000000002 105.769 173.769 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -80.93 161.56 24.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.509 -1.994 . . . . 42.75 110.436 -179.718 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.46 -61.79 0.64 Allowed Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 107.544 -2.223 . . . . 36.310000000000002 107.544 -172.916 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.77 0 O-C-N 126.026 1.662 . . . . 36.270000000000003 111.217 173.832 . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 121.559 0.695 . . . . 17.170000000000002 111.82 . . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -113.77 145.05 41.97 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.199 -4.688 . . . . 21.890000000000001 111.435 -172.196 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.26 161.55 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.339 -2.725 . . . . 10.83 109.15 169.799 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -105.11 145.33 30.68 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.259 2.624 . . . . 10.609999999999999 110.753 167.923 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 73.8 t -123.2 125.05 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.064 -1.648 . . . . 9.1300000000000008 107.854 171.996 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -97.92 143.09 28.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.352 -2.717 . . . . 20.550000000000001 111.481 176.549 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.2 p -97.2 -177.28 3.79 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 122.407 2.367 . . . . 11.779999999999999 109.236 -173.611 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tt -76.68 -45.34 30.07 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 117.626 -1.178 . . . . 19.309999999999999 110.666 177.466 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -66.97 -54.55 20.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.264 1.393 . . . . 23.140000000000001 112.939 174.805 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.83 84.48 0.13 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 129.394 3.378 . . . . 19.739999999999998 114.18 168.328 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -132.83 152.71 51.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.845 -2.177 . . . . 21.93 106.976 171.843 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.291 26.2 m -108.83 108.61 19.47 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.465 -1.698 . . . . 12.33 112.407 171.986 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.1 mt -91.81 137.18 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 104.668 -2.345 . . . . 17.079999999999998 104.668 174.695 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 m -116.65 120.58 39.1 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.964 1.705 . . . . 16.300000000000001 111.629 175.533 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.7 mt -114.13 146.64 40.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.551 -3.218 . . . . 15.880000000000001 107.601 179.968 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.68 137.85 32.03 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 116.012 -2.275 . . . . 28.899999999999999 114.573 148.915 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 m -140.73 157.84 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.314 2.646 . . . . 12.050000000000001 104.719 -171.286 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.54 145.75 31.29 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 101.893 -3.373 . . . . 18.170000000000002 101.893 165.703 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -78.19 -7.6 16.2 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 N-CA-C 118.389 2.419 . . . . 8.1600000000000001 118.389 -174.453 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -100.46 14.64 30.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.957 -1.496 . . . . 11.130000000000001 110.614 178.566 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -107.9 160.47 15.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.912 2.142 . . . . 18.030000000000001 108.058 166.292 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -88.04 173.46 8.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 126.326 2.267 . . . . 10.220000000000001 112.748 -162.604 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mm -73.47 -26.8 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.26 -3.4 . . . . 12.300000000000001 110.027 -177.18 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.56 -21.95 66.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.45 -3.281 . . . . 36.509999999999998 117.159 169.914 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.29 -41.24 20.4 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 117.581 -1.2 . . . . 25.66 112.841 168.765 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.1 t -57.57 -40.94 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 127.547 3.03 . . . . 8.1199999999999992 116.936 173.944 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -63.73 -41.58 98.03 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 131.781 4.033 . . . . 15.470000000000001 113.183 170.694 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.71 -25.42 65.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.319 2.009 . . . . 11.449999999999999 113.495 176.458 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.3 mttm -79.17 -31.23 43.85 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.257 -1.527 . . . . 24.98 112.783 173.66 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.41 -34.87 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 125.401 2.524 . . . . 9.4600000000000009 112.504 170.249 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -60.0 -46.77 88.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.754 3.222 . . . . 14.76 115.849 166.671 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -54.07 -56.75 15.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.617 -3.177 . . . . 26.289999999999999 115.116 168.844 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -66.48 -80.29 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.402 -3.311 . . . . 30.059999999999999 116.829 171.703 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.89 -30.19 50.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 114.338 -5.226 . . . . 25.190000000000001 117.125 -178.126 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.18 5.17 50.06 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 125.011 3.55 . . . . 7.4100000000000001 117.148 179.524 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mm -69.92 128.83 91.5 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 114.684 1.364 . . . . 9.4900000000000002 114.684 -177.76 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -67.9 149.93 78.07 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 O-C-N 115.103 -3.157 . . . . 11.42 111.92 -170.428 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -73.68 -18.56 22.19 Favored 'Trans proline' 0 N--CA 1.433 -2.043 2 C-N-CA 127.794 5.663 . . . . 12.0 116.286 -175.853 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -68.86 -26.31 65.07 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.198 3.399 . . . . 35.549999999999997 115.258 168.797 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -95.08 -23.08 17.49 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.553 -1.658 . . . . 20.52 114.896 -172.598 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -85.75 118.43 25.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.678 -0.86 . . . . 7.1299999999999999 108.678 -171.895 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -108.79 116.14 31.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.612 1.965 . . . . 36.390000000000001 106.983 171.476 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.56 111.58 23.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.87 1.356 . . . . 9.5500000000000007 109.768 -176.788 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.93 125.09 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.062 -1.649 . . . . 13.9 106.789 179.562 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -117.71 127.16 53.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.381 2.991 . . . . 6.8600000000000003 108.84 168.39 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.31 -98.11 0.08 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.425 -3.922 . . . . 11.15 113.466 -153.503 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.07 33.96 1.69 Allowed Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 127.426 2.441 . . . . 13.93 110.432 -179.523 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -145.05 143.15 30.3 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.515 1.626 . . . . 23.920000000000002 109.437 173.273 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.412 HE22 ' CZ ' ' A' ' 72' ' ' ARG . 3.5 tt0 -80.37 124.91 29.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.575 1.655 . . . . 23.23 114.194 -178.419 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -66.24 131.59 46.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.545 2.116 . . . . 9.1099999999999994 109.184 172.813 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -82.71 158.85 22.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.633 -3.167 . . . . 33.439999999999998 113.107 178.158 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.22 -45.3 81.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.109 1.909 . . . . 28.370000000000001 115.304 -162.186 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.9 4.67 85.6 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 113.39 -1.732 . . . . 15.0 115.21 -178.434 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 -92.53 159.99 15.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 122.358 3.079 . . . . 25.5 108.735 178.969 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.4 p -86.57 171.19 11.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.72 1.248 . . . . 11.949999999999999 112.229 171.945 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.73 -33.76 66.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.334 -1.728 . . . . 10.17 106.334 172.222 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.5 p -65.7 -7.85 17.69 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 121.226 3.788 . . . . 13.59 121.226 174.179 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.11 -42.58 15.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.118 2.866 . . . . 11.699999999999999 109.518 -176.493 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -77.88 -13.56 59.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.678 2.391 . . . . 12.949999999999999 112.419 177.084 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 64.87 51.28 1.81 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.768 1.627 . . . . 25.449999999999999 112.956 -172.958 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -84.94 137.92 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.788 -2.301 . . . . 14.6 104.788 179.778 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -110.57 168.83 9.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.849 -2.407 . . . . 33.229999999999997 113.126 -175.369 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -66.81 155.41 38.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.511 -0.743 . . . . 25.969999999999999 111.569 174.221 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 50.2 mt-10 53.22 25.72 4.56 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.147 2.277 . . . . 32.609999999999999 117.147 -170.381 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 t -91.32 152.02 20.63 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.384 0.612 . . . . 10.56 110.765 169.695 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -107.98 121.37 44.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.45 3.9 . . . . 5.3300000000000001 113.145 179.664 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -97.38 163.69 12.77 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.22 1.962 . . . . 11.66 107.034 174.896 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -119.34 129.36 54.81 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.503 -4.498 . . . . 16.300000000000001 109.141 175.603 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.3 tp -105.61 119.95 40.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.293 2.637 . . . . 9.9600000000000009 112.013 179.928 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.8 m -130.29 -160.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.412 1 CA-C-O 128.979 4.228 . . . . 9.7599999999999998 111.05 168.903 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 16.5 tp -91.44 142.21 27.91 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 113.997 -5.439 . . . . 19.57 112.579 -168.842 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.412 ' CZ ' HE22 ' A' ' 49' ' ' GLN . 44.5 ttt180 -110.71 135.14 51.76 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.23 1.581 . . . . 35.079999999999998 114.439 174.575 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 mt -90.59 143.18 26.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.032 2.133 . . . . 32.310000000000002 110.991 161.898 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -77.73 125.93 30.09 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.065 -2.272 . . . . 42.75 108.396 -171.956 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.51 -29.36 0.3 Allowed Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 114.377 -3.773 . . . . 36.310000000000002 112.686 174.809 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.405 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.731 0 N-CA-C 106.419 -2.672 . . . . 36.270000000000003 106.419 177.062 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 123.704 1.716 . . . . 17.170000000000002 112.1 . . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -97.77 130.81 44.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.066 -2.896 . . . . 21.890000000000001 110.624 177.498 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.365 9.9 pt -129.67 157.67 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 124.752 1.221 . . . . 10.83 110.941 174.389 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -111.32 143.63 41.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.163 -1.791 . . . . 10.609999999999999 106.163 -177.134 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.68 127.5 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.482 -1.235 . . . . 9.1300000000000008 107.993 167.82 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -106.13 129.4 54.22 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.533 1.635 . . . . 20.550000000000001 113.862 170.448 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -82.37 -175.15 5.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.414 1.635 . . . . 11.779999999999999 115.414 179.65 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.348 5.9 tp -67.02 -40.03 87.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.87 2.174 . . . . 19.309999999999999 116.87 177.635 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -73.05 -22.12 60.67 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.08 2.552 . . . . 23.140000000000001 112.238 -171.244 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.68 40.59 3.83 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 127.67 2.557 . . . . 19.739999999999998 109.757 -174.961 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -104.64 126.98 52.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.517 -2.073 . . . . 21.93 108.557 164.395 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -94.0 116.37 28.8 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.714 2.006 . . . . 12.33 113.412 173.827 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 pt -113.15 148.33 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.365 -2.709 . . . . 17.079999999999998 106.882 -179.291 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.422 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 15.7 m -98.81 129.37 45.21 Favored 'General case' 0 N--CA 1.43 -1.475 1 C-N-CA 134.003 4.921 . . . . 16.300000000000001 113.615 -178.21 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.73 128.99 40.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.78 -3.075 . . . . 15.880000000000001 102.993 -177.494 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -87.16 93.97 9.52 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.721 2.808 . . . . 28.899999999999999 109.825 164.724 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -121.14 154.59 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 123.531 2.878 . . . . 12.050000000000001 109.494 175.973 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.88 140.09 37.43 Favored Pre-proline 0 N--CA 1.43 -1.426 0 C-N-CA 129.434 3.094 . . . . 18.170000000000002 110.841 -178.717 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -79.87 -3.56 12.86 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 124.518 2.649 . . . . 8.1600000000000001 109.432 -167.746 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -83.95 -26.02 29.61 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 114.929 -2.462 . . . . 11.130000000000001 113.368 -176.093 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -84.2 163.02 19.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.79 2.036 . . . . 18.030000000000001 114.25 -174.424 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -70.11 158.12 36.32 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.27 1.581 . . . . 10.220000000000001 115.27 -177.225 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.421 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 42.0 mm -63.52 -19.94 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 125.762 2.696 . . . . 12.300000000000001 116.954 166.382 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -74.89 -27.37 60.2 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.83 -3.044 . . . . 36.509999999999998 113.878 179.869 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -70.11 -34.05 72.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.521 2.328 . . . . 25.66 112.912 175.049 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.49 -56.93 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 CA-C-O 129.166 4.317 . . . . 8.1199999999999992 110.717 175.967 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.14 -27.13 61.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.845 -3.034 . . . . 15.470000000000001 114.604 -171.854 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.19 83.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.72 2.2 . . . . 11.449999999999999 109.286 -178.898 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -78.35 -35.65 47.17 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.285 -1.51 . . . . 24.98 108.576 -174.261 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mt -67.87 -32.26 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 125.796 2.712 . . . . 9.4600000000000009 108.233 177.183 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -69.04 -56.28 8.23 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 116.165 -4.084 . . . . 14.76 110.039 174.553 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -58.73 -24.07 60.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.061 1.744 . . . . 26.289999999999999 114.329 -178.871 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 14' ' ' THR . 50.6 mttm -78.13 -80.66 0.11 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.484 -2.01 . . . . 30.059999999999999 112.778 165.536 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -99.06 10.69 40.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.11 -3.494 . . . . 25.190000000000001 115.826 -161.124 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.87 3.5 90.46 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 117.995 -2.941 . . . . 7.4100000000000001 116.6 -175.736 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.6 mt -77.59 115.69 51.81 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 118.906 1.353 . . . . 9.4900000000000002 111.202 -169.599 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -67.95 142.31 56.42 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 O-C-N 114.313 -3.572 . . . . 11.42 112.342 -179.355 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -62.87 -21.68 73.29 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 N-CA-C 119.772 2.951 . . . . 12.0 119.772 -173.167 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -56.69 -39.06 73.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.665 1.586 . . . . 35.549999999999997 113.594 171.25 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -80.17 7.36 9.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.199 2.296 . . . . 20.52 117.199 -173.923 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -113.89 117.98 32.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 114.79 -2.529 . . . . 7.1299999999999999 110.642 -160.344 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -128.62 115.78 18.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.681 3.738 . . . . 36.390000000000001 113.011 170.985 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.9 mt -92.89 125.89 37.71 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 116.276 -4.015 . . . . 9.5500000000000007 111.81 -173.844 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -105.37 126.08 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.618 1.967 . . . . 13.9 109.518 172.132 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.4 ' HB3' HD21 ' A' ' 50' ' ' LEU . 12.9 t80 -110.22 120.0 41.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.896 3.236 . . . . 6.8600000000000003 105.401 171.886 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.409 . . 59.77 -91.07 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.548 -3.845 . . . . 11.15 118.394 -164.818 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.23 13.01 5.75 Favored Glycine 0 N--CA 1.43 -1.729 1 CA-C-O 111.115 -5.269 . . . . 13.93 109.957 160.847 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -93.31 135.86 34.13 Favored 'General case' 0 N--CA 1.43 -1.433 1 CA-C-N 124.549 4.175 . . . . 23.920000000000002 110.963 -176.918 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -75.07 99.92 4.06 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 113.938 -5.477 . . . . 23.23 113.324 167.354 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' A' ' 45' ' ' PHE . 19.6 mt -69.77 136.94 51.48 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.253 -3.404 . . . . 9.1099999999999994 113.912 178.265 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.48 136.18 38.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.286 -1.325 . . . . 33.439999999999998 113.475 -177.938 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.8 OUTLIER -69.75 -30.79 68.47 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 115.055 1.502 . . . . 28.370000000000001 115.055 -156.27 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.5 23.54 12.27 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 115.716 -2.713 . . . . 15.0 115.316 179.727 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -125.42 174.48 8.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.085 2.943 . . . . 25.5 106.841 175.56 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -96.04 167.41 11.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.728 1.728 . . . . 11.949999999999999 114.875 179.949 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.3 mp -56.39 -43.72 79.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.111 2.862 . . . . 10.17 114.383 162.535 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.3 p -61.1 -19.44 61.46 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 114.374 -5.204 . . . . 13.59 119.243 170.831 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -58.7 -52.38 65.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.308 2.336 . . . . 11.699999999999999 117.308 167.304 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -88.36 -13.33 40.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.596 3.558 . . . . 12.949999999999999 115.002 177.884 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 m120 73.92 58.08 0.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.332 -1.729 . . . . 25.449999999999999 106.332 167.749 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -85.73 121.61 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.861 2.267 . . . . 14.6 107.055 166.571 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -107.03 175.09 5.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 109.548 -3.478 . . . . 33.229999999999997 107.306 -174.913 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -58.61 137.08 57.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.005 -2.309 . . . . 25.969999999999999 116.862 -176.318 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 84.47 7.39 0.54 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.679 3.992 . . . . 32.609999999999999 113.96 170.18 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 t -72.46 134.38 45.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.131 -1.395 . . . . 10.56 110.678 -175.496 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.5 m -102.26 103.08 13.54 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.706 -3.746 . . . . 5.3300000000000001 113.418 -171.785 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.63 159.55 14.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.231 -3.248 . . . . 11.66 102.231 -165.085 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -101.73 140.85 35.46 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 118.181 -2.824 . . . . 16.300000000000001 108.92 170.897 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.5 tp -102.22 136.66 41.66 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 102.138 -3.282 . . . . 9.9600000000000009 102.138 169.369 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 m -134.71 175.01 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.615 2.366 . . . . 9.7599999999999998 105.991 173.576 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.6 tp -82.31 127.82 33.6 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.235 -2.257 . . . . 19.57 116.685 -171.341 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -89.74 126.89 35.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.937 -2.977 . . . . 35.079999999999998 108.355 169.211 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.4 mt -91.64 155.94 17.97 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.815 2.446 . . . . 32.310000000000002 111.126 170.229 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.358 50.4 ttm-85 -82.75 117.94 23.02 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.027 -4.795 . . . . 42.75 107.652 -174.299 . . . . . . . . 3 2 . 1 . 087 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.88 50.17 0.01 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 O-C-N 126.588 2.43 . . . . 36.310000000000002 115.419 169.5 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.755 1 C-N-CA 130.712 4.006 . . . . 36.270000000000003 105.149 176.859 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ptt? . . . . . 0 CA--C 1.491 -1.309 0 CA-C-O 125.056 2.36 . . . . 17.170000000000002 109.477 . . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -104.57 138.93 40.19 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.796 -2.456 . . . . 21.890000000000001 110.883 -172.822 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.284 44.0 pt -136.21 144.84 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 102.505 -3.146 . . . . 10.83 102.505 165.785 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -107.97 139.05 43.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.52 0.728 . . . . 10.609999999999999 109.647 173.903 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.7 t -121.58 114.38 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.657 -2.349 . . . . 9.1300000000000008 104.657 179.027 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 42.4 mttm -83.89 124.79 31.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.115 2.388 . . . . 20.550000000000001 105.405 166.283 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.323 17.7 p -77.85 178.24 7.57 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.962 2.315 . . . . 11.779999999999999 110.2 -174.886 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 tp -78.38 -32.7 49.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.274 -3.391 . . . . 19.309999999999999 111.705 171.947 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -74.79 -33.19 62.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.966 -2.333 . . . . 23.140000000000001 113.44 170.576 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.42 60.26 0.52 Allowed Glycine 0 N--CA 1.429 -1.77 0 CA-C-O 123.197 1.443 . . . . 19.739999999999998 115.124 169.436 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 30.8 mtpt -118.54 152.5 35.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.563 1.945 . . . . 21.93 113.585 162.099 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -105.72 96.89 6.81 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.248 1.975 . . . . 12.33 108.813 174.084 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.286 3.4 pt -89.45 150.24 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.407 -3.308 . . . . 17.079999999999998 109.943 -179.98 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -111.22 124.4 52.14 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.819 -0.752 . . . . 16.300000000000001 110.573 -176.046 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.66 147.11 29.93 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.865 1.317 . . . . 15.880000000000001 108.045 176.897 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -105.35 90.36 3.4 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 130.051 3.34 . . . . 28.899999999999999 111.599 166.327 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.95 162.1 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 125.975 2.797 . . . . 12.050000000000001 112.528 175.979 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.43 147.83 33.55 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 119.461 -2.024 . . . . 18.170000000000002 106.601 173.738 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.37 -9.47 23.08 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-O 115.99 -1.754 . . . . 8.1600000000000001 111.939 -177.54 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.5 p -88.62 -3.92 58.68 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.258 2.623 . . . . 11.130000000000001 114.238 173.078 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -68.84 148.6 50.02 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.374 -2.454 . . . . 18.030000000000001 104.374 178.897 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.8 p -87.9 155.13 20.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.62 -1.173 . . . . 10.220000000000001 109.789 172.096 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.6 mm -52.08 -37.57 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 128.461 2.704 . . . . 12.300000000000001 110.69 176.605 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.83 -42.53 99.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.685 3.194 . . . . 36.509999999999998 114.978 174.924 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -67.06 -36.28 81.67 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.751 -2.022 . . . . 25.66 115.171 173.186 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.72 -37.33 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 114.569 1.322 . . . . 8.1199999999999992 114.569 177.663 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 55.3 mtmt -57.51 -42.02 81.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.206 -2.809 . . . . 15.470000000000001 117.898 171.966 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.16 -31.68 61.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.128 2.269 . . . . 11.449999999999999 117.128 170.889 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -67.76 -36.2 80.08 Favored 'General case' 0 N--CA 1.43 -1.44 1 N-CA-C 122.081 4.104 . . . . 24.98 122.081 165.094 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.5 mt -57.71 -40.58 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 116.17 1.915 . . . . 9.4600000000000009 116.17 159.821 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -56.89 -40.68 76.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 113.617 -3.087 . . . . 14.76 117.224 162.481 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -65.77 -38.07 88.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.622 3.076 . . . . 26.289999999999999 111.694 177.717 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -73.88 -70.39 0.38 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.697 1.999 . . . . 30.059999999999999 115.191 178.226 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -92.4 -9.28 42.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.495 3.517 . . . . 25.190000000000001 120.495 -172.335 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.52 53.27 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 117.678 -3.139 . . . . 7.4100000000000001 109.777 177.535 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.6 mt -107.45 123.28 38.58 Favored Pre-proline 0 N--CA 1.43 -1.469 0 O-C-N 125.331 1.254 . . . . 9.4900000000000002 109.879 -178.518 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.02 127.72 27.23 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 124.098 3.199 . . . . 11.42 115.084 177.903 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -63.75 -7.61 13.43 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 125.059 3.839 . . . . 12.0 116.762 171.586 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -68.83 -28.62 66.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.716 2.487 . . . . 35.549999999999997 117.716 164.263 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -101.99 4.37 39.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.025 -3.547 . . . . 20.52 111.182 -172.324 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -95.02 134.32 37.83 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.285 1.993 . . . . 7.1299999999999999 113.04 -173.804 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.307 40.1 ttm180 -133.07 107.38 8.19 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.172 -1.831 . . . . 36.390000000000001 111.309 168.725 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.48 116.87 12.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 114.319 -2.753 . . . . 9.5500000000000007 112.867 170.979 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.453 HD11 ' HA ' ' A' ' 49' ' ' GLN . 34.3 mm -109.07 135.95 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 123.151 2.705 . . . . 13.9 113.346 171.186 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -112.99 114.48 26.97 Favored 'General case' 0 N--CA 1.429 -1.475 2 O-C-N 113.141 -5.975 . . . . 6.8600000000000003 110.074 173.802 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.365 . . 68.18 -87.58 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.176 -3.452 . . . . 11.15 113.879 -170.012 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.64 5.03 6.2 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 126.253 1.882 . . . . 13.93 111.643 163.394 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -92.38 120.82 33.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 118.558 1.179 . . . . 23.920000000000002 113.638 -171.099 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.453 ' HA ' HD11 ' A' ' 44' ' ' ILE . 32.6 tt0 -82.17 111.87 18.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.373 3.464 . . . . 23.23 112.88 173.058 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -69.53 139.74 53.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.209 -2.807 . . . . 9.1099999999999994 110.007 -173.232 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -81.54 156.73 25.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.832 -1.556 . . . . 33.439999999999998 109.593 169.156 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -84.03 -47.27 11.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.027 1.739 . . . . 28.370000000000001 111.847 -167.695 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.98 37.91 2.36 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 116.514 -3.866 . . . . 15.0 117.658 176.957 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.6 mtt-85 -113.2 178.12 4.39 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.575 -2.72 . . . . 25.5 110.736 164.361 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.8 p -101.55 173.81 6.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.338 -1.476 . . . . 11.949999999999999 111.62 168.695 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 35.6 mt -67.79 -26.92 66.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.344 1.069 . . . . 10.17 112.175 171.597 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.5 p -82.36 -25.14 34.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.096 1.358 . . . . 13.59 111.738 -175.992 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -58.05 -39.9 79.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 123.193 2.724 . . . . 11.699999999999999 116.453 162.339 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.297 24.3 m-85 -89.93 3.7 52.27 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.552 2.427 . . . . 12.949999999999999 117.552 175.843 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 73.4 m-20 67.82 38.73 2.81 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.475 1.51 . . . . 25.449999999999999 112.133 171.161 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.9 mt -89.71 108.84 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.167 -2.16 . . . . 14.6 105.167 178.847 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -83.67 174.85 10.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 128.069 3.795 . . . . 33.229999999999997 110.31 174.249 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -66.68 158.52 29.86 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.258 -3.401 . . . . 25.969999999999999 112.846 176.568 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.316 10.5 mt-10 57.28 20.76 6.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.357 2.263 . . . . 32.609999999999999 116.638 -179.919 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 m -80.57 129.8 34.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.227 2.611 . . . . 10.56 115.96 172.808 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 m -90.45 116.86 28.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.788 -3.07 . . . . 5.3300000000000001 111.354 172.836 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -91.6 155.61 18.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.403 -2.073 . . . . 11.66 105.403 174.123 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -106.23 152.23 23.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 114.325 -2.95 . . . . 16.300000000000001 110.39 169.088 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.4 tp -121.95 113.32 19.44 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.918 3.886 . . . . 9.9600000000000009 109.533 174.685 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 m -121.47 -172.43 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 128.617 2.767 . . . . 9.7599999999999998 104.897 178.17 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -104.68 146.47 28.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.901 2.286 . . . . 19.57 110.123 -164.834 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -113.73 140.67 48.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.495 1.918 . . . . 35.079999999999998 107.752 176.404 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.9 mt -101.78 155.37 18.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.828 -1.795 . . . . 32.310000000000002 109.683 170.354 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -58.19 111.85 1.34 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.317 -2.739 . . . . 42.75 111.968 172.934 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.13 -46.08 0.23 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 114.141 -1.39 . . . . 36.310000000000002 112.988 174.068 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.759 0 C-N-CA 124.86 1.219 . . . . 36.270000000000003 110.839 176.474 . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.573 1.323 . . . . 17.170000000000002 114.573 . . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.68 129.73 38.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 126.911 3.243 . . . . 21.890000000000001 107.673 -167.98 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.301 24.9 pt -124.21 154.21 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 O-C-N 117.023 -3.548 . . . . 10.83 110.077 171.831 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -114.21 136.32 53.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.532 1.933 . . . . 10.609999999999999 114.092 -178.858 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.6 t -117.31 103.39 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 100.322 -3.955 . . . . 9.1300000000000008 100.322 178.309 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -94.42 152.78 18.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.104 -3.497 . . . . 20.550000000000001 110.105 -177.713 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.269 58.4 p -106.71 175.77 5.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 118.005 2.595 . . . . 11.779999999999999 118.005 -163.743 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.4 tp -77.52 -51.79 10.14 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.621 -1.172 . . . . 19.309999999999999 113.25 167.92 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 81.7 p -64.47 -59.71 4.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.197 -3.439 . . . . 23.140000000000001 115.252 174.773 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.77 -35.98 0.21 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 114.933 -3.148 . . . . 19.739999999999998 118.931 179.078 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -82.96 98.98 9.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 125.905 1.591 . . . . 21.93 110.107 -168.193 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -50.92 133.54 26.7 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.783 1.401 . . . . 12.33 114.783 178.441 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 mt -93.4 129.92 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 129.488 3.115 . . . . 17.079999999999998 106.891 176.426 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.3 m -119.6 111.43 18.06 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.854 -3.654 . . . . 16.300000000000001 108.493 -170.177 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.7 mt -113.8 149.62 34.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.499 -2.625 . . . . 15.880000000000001 111.82 178.22 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -104.67 136.34 44.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.329 -1.482 . . . . 28.899999999999999 110.65 163.172 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 m -132.82 172.64 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.021 -1.675 . . . . 12.050000000000001 107.641 -173.142 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -113.28 150.37 42.96 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 102.31 -3.218 . . . . 18.170000000000002 102.31 166.797 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.87 -2.97 13.21 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 CA-C-N 122.943 2.087 . . . . 8.1600000000000001 116.468 -175.547 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -70.82 -25.49 62.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 128.284 3.49 . . . . 11.130000000000001 117.078 159.037 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -67.81 150.45 48.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 129.407 3.083 . . . . 18.030000000000001 110.79 179.646 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -98.1 160.45 14.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.035 -2.888 . . . . 10.220000000000001 114.41 -173.865 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.7 mm -52.44 -32.53 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 121.668 2.031 . . . . 12.300000000000001 113.065 166.441 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.32 1.5 tt0 -51.78 -51.27 57.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 117.873 2.546 . . . . 36.509999999999998 117.873 160.761 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -63.71 -33.31 75.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 124.531 3.332 . . . . 25.66 111.036 177.344 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.12 -37.65 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.639 -1.913 . . . . 8.1199999999999992 109.564 177.595 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.794 1.775 . . . . 15.470000000000001 115.794 173.486 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.39 -19.25 62.29 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.736 1.614 . . . . 11.449999999999999 114.595 -179.079 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -91.21 -19.82 22.63 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.735 -3.103 . . . . 24.98 108.179 176.535 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.9 mt -76.71 -34.15 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 117.803 -3.061 . . . . 9.4600000000000009 108.476 167.098 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -52.86 -49.05 66.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.646 2.165 . . . . 14.76 110.962 169.823 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.04 -52.96 44.31 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.946 1.699 . . . . 26.289999999999999 110.427 -178.204 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -67.43 -69.23 0.33 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.196 -1.565 . . . . 30.059999999999999 115.052 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -87.81 -53.99 4.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.418 -2.676 . . . . 25.190000000000001 113.389 -175.518 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.05 54.21 0.39 Allowed Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 117.632 1.813 . . . . 7.4100000000000001 117.632 -165.601 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.43 123.61 27.56 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 128.377 3.046 . . . . 9.4900000000000002 104.859 176.022 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.69 125.25 18.41 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 124.837 3.691 . . . . 11.42 113.44 168.224 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.74 -28.17 55.84 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 121.336 3.552 . . . . 12.0 121.336 174.192 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.25 17.1 p-10 -51.73 -37.22 50.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.242 2.312 . . . . 35.549999999999997 117.242 167.174 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -86.91 -7.79 57.86 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.918 1.451 . . . . 20.52 114.918 -175.892 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -89.06 141.36 28.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.059 2.361 . . . . 7.1299999999999999 114.284 177.92 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -132.66 140.78 48.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.902 3.239 . . . . 36.390000000000001 106.155 164.018 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -118.81 130.59 55.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.674 -3.766 . . . . 9.5500000000000007 105.668 -177.683 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.7 tt -122.92 133.14 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.149 -3.47 . . . . 13.9 110.129 174.154 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -82.76 -66.75 0.85 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.193 1.949 . . . . 6.8600000000000003 109.458 174.389 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.81 -75.4 0.58 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.152 3.381 . . . . 11.15 115.547 -178.847 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.89 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.081 -0.963 . . . . 13.93 115.403 -174.306 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -83.51 138.06 33.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.596 1.665 . . . . 23.920000000000002 110.373 -172.938 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.21 133.87 36.06 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 118.484 2.772 . . . . 23.23 118.484 -169.757 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.3 mt -90.36 151.15 21.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.438 2.695 . . . . 9.1099999999999994 113.927 -169.724 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -100.59 137.31 39.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.409 3.083 . . . . 33.439999999999998 109.873 177.892 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -72.32 -50.35 27.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.439 -2.663 . . . . 28.370000000000001 104.969 -157.537 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.4 37.75 3.32 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 118.123 -2.861 . . . . 15.0 110.874 -169.623 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -93.14 152.51 19.2 Favored 'General case' 0 N--CA 1.431 -1.413 1 C-N-CA 132.929 4.491 . . . . 25.5 111.756 158.594 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.1 p -97.96 171.55 8.2 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.957 1.837 . . . . 11.949999999999999 106.416 -172.24 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.14 -47.42 68.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.558 1.647 . . . . 10.17 112.571 173.276 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -84.96 -11.35 55.71 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.477 3.111 . . . . 13.59 113.932 -173.17 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.1 -47.99 77.87 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.705 1.717 . . . . 11.699999999999999 108.657 164.277 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -93.0 12.45 23.94 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 114.837 -4.914 . . . . 12.949999999999999 112.214 -176.464 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 59.92 31.07 20.53 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.279 2.232 . . . . 25.449999999999999 111.205 171.954 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.3 mt -82.45 120.75 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 124.204 1.001 . . . . 14.6 108.535 177.384 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -100.7 -172.31 2.17 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.962 1.363 . . . . 33.229999999999997 113.284 179.419 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -69.15 151.15 46.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.403 -3.31 . . . . 25.969999999999999 115.829 177.342 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 28.4 mt-10 66.66 20.28 10.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.429 2.692 . . . . 32.609999999999999 112.214 177.711 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -88.07 144.08 26.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.431 1.892 . . . . 10.56 112.87 179.833 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -97.79 122.33 40.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.395 -1.729 . . . . 5.3300000000000001 107.371 -174.363 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mp -97.19 166.41 11.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.796 3.238 . . . . 11.66 108.418 159.238 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -137.57 132.17 32.73 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.496 -2.628 . . . . 16.300000000000001 111.656 174.411 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.6 tp -87.98 121.6 30.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.14 2.576 . . . . 9.9600000000000009 106.6 -171.069 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.9 t -113.69 113.2 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 128.266 2.626 . . . . 9.7599999999999998 112.312 175.42 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.6 tp -83.23 119.53 24.67 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 115.819 -4.301 . . . . 19.57 112.128 -171.26 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -111.21 150.35 29.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.389 2.676 . . . . 35.079999999999998 112.309 177.811 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.6 tp -83.26 -64.3 1.2 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.293 2.237 . . . . 32.310000000000002 115.683 176.283 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -152.32 154.49 35.79 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.172 -1.788 . . . . 42.75 106.172 173.521 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.07 -177.45 46.31 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.24 -2.787 . . . . 36.310000000000002 111.434 171.658 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.796 0 C-N-CA 125.582 1.563 . . . . 36.270000000000003 115.477 -171.75 . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 CA--C 1.489 -1.374 0 CA-C-O 120.865 0.364 . . . . 17.170000000000002 111.1 . . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -94.51 112.17 23.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.546 2.117 . . . . 21.890000000000001 111.099 -176.065 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 pt -120.31 150.99 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 116.379 -3.951 . . . . 10.83 111.833 174.039 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -116.27 150.52 37.46 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.606 -1.998 . . . . 10.609999999999999 105.606 -174.248 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.2 t -132.18 135.42 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 100.423 -3.917 . . . . 9.1300000000000008 100.423 -176.539 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -119.81 143.49 47.84 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.735 3.159 . . . . 20.550000000000001 107.17 175.36 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.2 p -83.85 -175.43 5.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.082 -3.511 . . . . 11.779999999999999 114.212 172.82 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.1 tp -66.57 -51.53 55.41 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.826 -0.435 . . . . 19.309999999999999 109.826 -176.9 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -75.07 -31.96 61.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.252 -1.356 . . . . 23.140000000000001 109.004 -177.567 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.11 71.62 0.6 Allowed Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 122.95 2.613 . . . . 19.739999999999998 116.206 174.012 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 35.3 pttt -118.81 147.9 43.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 100.471 -3.9 . . . . 21.93 100.471 159.915 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 m -104.06 116.15 31.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.316 1.446 . . . . 12.33 108.439 -179.488 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -81.07 128.92 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.793 -2.299 . . . . 17.079999999999998 104.793 166.122 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.0 m -104.74 135.02 46.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.645 0.657 . . . . 16.300000000000001 109.846 173.288 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.4 mt -122.43 119.67 31.67 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 118.572 2.805 . . . . 15.880000000000001 118.572 179.984 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -86.79 103.33 15.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.912 1.233 . . . . 28.899999999999999 108.715 167.509 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 m -110.23 169.59 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 129.574 3.15 . . . . 12.050000000000001 109.698 179.447 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -108.03 145.67 31.9 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 117.488 -1.244 . . . . 18.170000000000002 110.044 177.227 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.335 42.4 Cg_exo -47.51 -36.03 23.32 Favored 'Trans proline' 0 C--N 1.3 -2.02 1 N-CA-C 123.002 4.193 . . . . 8.1600000000000001 123.002 -175.238 . . . . . . . . 3 2 . 1 . 090 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.18 5.37 34.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.11 2.164 . . . . 11.130000000000001 114.567 176.947 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -62.1 132.38 52.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.082 -2.886 . . . . 18.030000000000001 116.212 176.623 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.266 8.0 p -67.14 161.84 23.74 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.857 -4.277 . . . . 10.220000000000001 107.591 171.915 . . . . . . . . 3 2 . 1 . 090 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -61.55 -41.29 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.007 -2.308 . . . . 12.300000000000001 115.498 171.064 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -64.2 -27.53 69.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.814 2.552 . . . . 36.509999999999998 112.725 172.665 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -70.14 -34.94 73.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.956 -1.715 . . . . 25.66 112.735 169.411 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.52 -41.89 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 1 O-C-N 115.419 -4.551 . . . . 8.1199999999999992 116.914 169.493 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -54.95 -29.46 56.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.532 2.733 . . . . 15.470000000000001 115.713 166.024 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.19 -32.47 66.85 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 118.431 -0.795 . . . . 11.449999999999999 110.991 -177.111 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -70.25 -20.33 63.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.959 1.838 . . . . 24.98 114.965 170.3 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -86.19 -28.47 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 O-C-N 115.537 -4.477 . . . . 9.4600000000000009 111.531 177.111 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -64.57 -40.35 95.4 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.744 4.018 . . . . 14.76 109.484 174.358 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.6 -50.49 15.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.107 -0.996 . . . . 26.289999999999999 111.064 173.922 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -73.15 -70.05 0.38 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.521 1.674 . . . . 30.059999999999999 115.521 -175.956 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.42 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 38.1 mm-40 -67.69 -50.88 55.35 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.853 0.751 . . . . 25.190000000000001 112.658 -177.64 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.54 21.72 10.29 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 118.332 2.093 . . . . 7.4100000000000001 118.332 -176.37 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -82.85 126.59 72.52 Favored Pre-proline 0 N--CA 1.43 -1.471 0 C-N-CA 127.082 2.153 . . . . 9.4900000000000002 108.9 168.743 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -72.63 167.96 25.72 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-O 117.187 -1.255 . . . . 11.42 110.195 -172.455 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 12.2 Cg_endo -86.08 -15.86 4.45 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 CA-C-N 124.557 2.663 . . . . 12.0 112.676 -169.302 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -73.14 -32.82 65.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.32 1.533 . . . . 35.549999999999997 115.059 171.258 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -76.32 -36.04 58.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.526 1.631 . . . . 20.52 114.779 -177.943 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' HG2' HD13 ' A' ' 69' ' ' LEU 0.254 72.0 mt-30 -64.15 135.42 56.32 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.526 3.536 . . . . 7.1299999999999999 113.36 170.532 . . . . . . . . 3 3 . 1 . 090 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -131.97 116.16 16.78 Favored 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 132.001 4.12 . . . . 36.390000000000001 108.893 169.784 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -97.24 144.22 27.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.558 1.786 . . . . 9.5500000000000007 109.51 176.569 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.445 HG23 ' HB3' ' A' ' 68' ' ' HIS . 7.8 tp -139.72 137.16 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 119.168 -2.208 . . . . 13.9 113.49 171.388 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.338 76.7 t80 -88.18 -62.06 1.57 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.266 -0.896 . . . . 6.8600000000000003 113.347 171.772 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.8 -89.17 0.28 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.881 -1.525 . . . . 11.15 106.881 -177.763 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.76 9.01 2.56 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-O 116.303 -2.387 . . . . 13.93 116.815 175.964 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -82.64 131.98 35.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 121.311 2.556 . . . . 23.920000000000002 110.121 162.798 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -75.13 114.0 13.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.364 2.03 . . . . 23.23 111.189 -177.928 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.335 10.2 mt -73.08 101.57 3.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 130.06 3.344 . . . . 9.1099999999999994 111.716 -177.924 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.81 -172.92 0.3 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.908 -2.995 . . . . 33.439999999999998 116.475 170.172 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.58 -63.49 1.32 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.993 -4.192 . . . . 28.370000000000001 113.973 -176.143 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.96 40.32 2.85 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 125.574 1.559 . . . . 15.0 115.842 -170.625 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.6 mmt180 -124.46 145.2 49.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.67 -1.974 . . . . 25.5 105.67 -174.061 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.528 1.1 p -89.36 157.15 18.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.747 3.641 . . . . 11.949999999999999 116.347 -169.032 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.7 mt -63.02 -36.33 83.19 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 116.041 -4.162 . . . . 10.17 110.346 174.418 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 t -65.39 -42.01 93.1 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.27 3.028 . . . . 13.59 112.077 -177.546 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.41 -14.43 57.14 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.602 2.144 . . . . 11.699999999999999 110.744 -171.262 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -103.27 4.64 36.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.708 -3.745 . . . . 12.949999999999999 103.93 176.919 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 50.51 47.2 24.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.576 2.751 . . . . 25.449999999999999 117.521 -176.461 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.0 mt -84.39 106.55 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 112.664 -2.062 . . . . 14.6 109.23 172.328 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -104.96 -174.17 2.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.083 -2.326 . . . . 33.229999999999997 110.958 -167.646 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -83.97 136.08 34.21 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.536 1.516 . . . . 25.969999999999999 112.399 -161.761 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.298 18.2 mt-10 81.38 20.75 0.37 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.296 1.838 . . . . 32.609999999999999 115.909 -169.368 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -70.54 131.82 44.58 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 116.679 -1.629 . . . . 10.56 111.972 172.081 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.4 m -103.57 125.82 50.34 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.246 -1.391 . . . . 5.3300000000000001 107.246 -179.536 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -109.52 164.16 12.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.397 -2.689 . . . . 11.66 106.562 -173.262 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.445 ' HB3' HG23 ' A' ' 44' ' ' ILE . 52.7 t60 -117.12 139.6 50.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.566 -3.209 . . . . 16.300000000000001 110.198 176.811 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.419 HD13 ' HG2' ' A' ' 41' ' ' GLN . 43.2 tp -106.23 104.04 13.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.713 2.805 . . . . 9.9600000000000009 111.475 -178.222 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -97.05 140.4 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.345 -1.752 . . . . 9.7599999999999998 111.54 174.236 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 37.6 mt -101.8 150.94 22.64 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.718 1.145 . . . . 19.57 112.744 162.314 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.292 43.4 ttp180 -113.71 134.39 54.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.414 -0.812 . . . . 35.079999999999998 109.186 -175.811 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.1 tp -93.02 -80.9 0.37 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.895 -2.378 . . . . 32.310000000000002 110.913 174.281 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -163.35 130.73 3.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.379 -2.452 . . . . 42.75 104.379 -176.602 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.75 -120.87 0.61 Allowed Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 117.078 -1.957 . . . . 36.310000000000002 110.697 177.635 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.761 0 CA-C-O 116.072 -2.516 . . . . 36.270000000000003 114.506 175.677 . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 ttp . . . . . 0 CA--C 1.489 -1.374 0 CA-C-O 121.746 0.784 . . . . 17.170000000000002 112.989 . . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -84.77 121.35 27.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.396 -2.69 . . . . 21.890000000000001 110.293 -175.451 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -127.7 168.88 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 123.191 2.723 . . . . 10.83 110.974 160.187 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -120.47 147.69 44.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 125.064 1.477 . . . . 10.609999999999999 110.929 -176.635 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 67' ' ' LEU . 19.3 t -117.08 118.93 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 C-N-CA 131.782 4.033 . . . . 9.1300000000000008 112.365 163.774 . . . . . . . . 3 3 . 1 . 091 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -103.46 124.89 49.58 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.859 -2.401 . . . . 20.550000000000001 111.563 176.701 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.305 34.7 p -77.79 175.56 9.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.105 1.431 . . . . 11.779999999999999 113.44 -174.594 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.1 tp -65.07 -55.27 19.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.358 2.663 . . . . 19.309999999999999 115.378 -178.788 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.3 p -60.73 -62.75 1.63 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.881 1.219 . . . . 23.140000000000001 110.633 165.253 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.24 64.14 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 122.417 2.371 . . . . 19.739999999999998 115.092 176.875 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 77.2 tttt -118.7 128.26 54.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 114.019 -2.896 . . . . 21.93 106.885 178.197 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -109.46 115.37 29.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 125.471 3.76 . . . . 12.33 101.681 -173.866 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.27 132.07 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 119.002 -2.312 . . . . 17.079999999999998 109.888 178.102 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.9 m -98.38 119.65 37.43 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.109 -4.12 . . . . 16.300000000000001 111.196 179.361 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.9 mt -106.39 162.55 13.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.966 2.506 . . . . 15.880000000000001 109.928 -175.477 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -135.22 97.68 3.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 101.689 -3.449 . . . . 28.899999999999999 101.689 178.734 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 m -105.66 163.15 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 117.416 2.376 . . . . 12.050000000000001 117.416 -174.666 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.256 2.9 mp0 -73.46 138.57 77.86 Favored Pre-proline 0 N--CA 1.431 -1.422 0 CA-C-O 114.749 -2.548 . . . . 18.170000000000002 108.285 162.35 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -58.97 -24.53 73.6 Favored 'Trans proline' 0 C--N 1.299 -2.04 1 C-N-CA 128.073 5.848 . . . . 8.1600000000000001 119.442 -179.868 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -117.41 28.63 8.35 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 122.454 4.242 . . . . 11.130000000000001 122.454 173.437 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -77.18 170.7 16.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.402 -2.061 . . . . 18.030000000000001 113.802 -179.289 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.328 69.0 p -90.48 154.39 19.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.418 2.007 . . . . 10.220000000000001 116.418 -174.982 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.4 -19.84 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 119.447 1.021 . . . . 12.300000000000001 112.237 178.003 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -62.77 -39.43 94.16 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.138 -4.101 . . . . 36.509999999999998 106.359 166.435 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -82.01 -29.55 31.97 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.213 2.279 . . . . 25.66 112.457 -174.398 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.36 40.5 t -46.22 -62.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 118.012 -2.93 . . . . 8.1199999999999992 114.544 154.252 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -54.21 -39.67 66.93 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.039 2.237 . . . . 15.470000000000001 117.039 172.039 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.29 92.5 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.641 -4.412 . . . . 11.449999999999999 111.852 173.919 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -61.36 -38.82 88.38 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.417 2.377 . . . . 24.98 117.417 163.063 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.267 72.5 mt -63.35 -41.53 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 122.145 2.248 . . . . 9.4600000000000009 116.132 172.497 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.75 -40.49 92.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.067 1.747 . . . . 14.76 115.324 173.689 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.02 -50.18 74.76 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 125.828 2.728 . . . . 26.289999999999999 115.629 173.107 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -75.31 -68.27 0.57 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 109.405 -3.543 . . . . 30.059999999999999 115.377 -175.121 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 79.1 mm-40 -87.82 -16.3 34.45 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.743 3.617 . . . . 25.190000000000001 111.445 -170.729 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.39 13.15 83.56 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 120.534 2.974 . . . . 7.4100000000000001 120.534 -178.942 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -76.03 115.67 48.74 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 116.521 -1.704 . . . . 9.4900000000000002 110.622 176.84 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.07 155.43 45.04 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 C-N-CA 123.673 2.915 . . . . 11.42 109.805 -172.797 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.41 -25.66 17.97 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 124.071 2.49 . . . . 12.0 112.376 -167.782 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.84 -40.55 88.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.305 -3.372 . . . . 35.549999999999997 108.864 -175.087 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.446 ' OE1' HD23 ' A' ' 71' ' ' LEU . 7.2 tt0 -63.33 -23.75 67.55 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.519 -1.673 . . . . 20.52 114.446 -177.974 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -87.91 131.7 34.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 126.417 3.008 . . . . 7.1299999999999999 118.295 -173.628 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -120.06 106.16 11.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.126 -2.859 . . . . 36.390000000000001 110.23 166.629 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.52 132.75 36.07 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 115.56 -4.463 . . . . 9.5500000000000007 113.299 175.698 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.5 mt -106.88 141.92 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.516 2.327 . . . . 13.9 107.931 176.815 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -91.5 -83.03 0.29 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.328 2.489 . . . . 6.8600000000000003 107.792 163.04 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.05 -71.43 0.74 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.473 1.909 . . . . 11.15 115.887 176.459 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.74 -41.66 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 124.083 1.935 . . . . 13.93 114.207 -166.886 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -103.38 155.36 18.54 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 121.493 -1.004 . . . . 23.920000000000002 112.94 -169.594 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -86.59 132.08 33.99 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.016 2.599 . . . . 23.23 118.016 -156.396 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -92.84 146.2 23.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.395 2.309 . . . . 9.1099999999999994 109.93 -174.398 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.98 153.45 17.9 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.145 -3.472 . . . . 33.439999999999998 106.573 177.767 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.66 -63.17 1.3 Allowed 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.066 -4.772 . . . . 28.370000000000001 114.315 -178.906 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.06 35.55 3.4 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 119.229 -1.462 . . . . 15.0 110.451 -172.225 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -106.55 161.18 14.84 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.367 -5.196 . . . . 25.5 111.478 164.813 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -97.89 171.96 7.96 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 114.284 -5.26 . . . . 11.949999999999999 111.878 -166.842 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.79 -37.09 78.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 112.863 -1.971 . . . . 10.17 109.027 169.338 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 t -81.71 -10.7 59.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 123.881 0.872 . . . . 13.59 112.71 -169.012 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.13 -50.29 12.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.504 3.526 . . . . 11.699999999999999 114.815 173.694 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -82.8 -20.71 35.22 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.949 -4.845 . . . . 12.949999999999999 112.164 179.849 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 23.2 m-80 72.63 65.94 0.12 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.233 3.049 . . . . 25.449999999999999 119.233 179.862 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.7 mt -106.13 93.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 109.157 -3.656 . . . . 14.6 105.104 -178.894 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -85.3 -166.19 1.43 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.033 -3.542 . . . . 33.229999999999997 114.381 179.223 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.368 14.8 pttp -62.43 134.85 57.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.36 -3.338 . . . . 25.969999999999999 114.271 -177.068 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.322 21.5 mt-10 70.05 15.87 7.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.527 2.047 . . . . 32.609999999999999 116.527 169.23 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.7 m -61.45 140.32 58.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.068 3.347 . . . . 10.56 112.457 159.427 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -110.54 111.03 21.99 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 119.865 1.212 . . . . 5.3300000000000001 113.515 175.24 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.403 ' HB2' HG23 ' A' ' 5' ' ' VAL . 53.6 mt -78.86 153.46 30.56 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.276 -2.14 . . . . 11.66 108.605 173.589 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.9 t60 -121.79 137.56 54.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.323 2.011 . . . . 16.300000000000001 107.619 175.935 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.3 tp -116.19 124.91 51.46 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.454 -2.029 . . . . 9.9600000000000009 109.019 -174.668 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.8 t -112.08 139.68 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 125.039 1.336 . . . . 9.7599999999999998 110.068 -179.53 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.446 HD23 ' OE1' ' A' ' 40' ' ' GLN . 7.8 mp -95.05 139.0 32.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 115.861 -2.336 . . . . 19.57 113.942 -176.682 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -119.67 157.03 29.33 Favored 'General case' 0 N--CA 1.431 -1.423 1 N-CA-C 100.046 -4.057 . . . . 35.079999999999998 100.046 -162.928 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.3 tp -113.79 -54.27 2.61 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 125.979 2.8 . . . . 32.310000000000002 105.042 177.237 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -159.63 123.61 3.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.846 -1.979 . . . . 42.75 111.04 177.627 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.47 25.2 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 118.44 -1.838 . . . . 36.310000000000002 117.448 171.012 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.79 0 C-N-CA 118.029 -2.034 . . . . 36.270000000000003 109.45 164.476 . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 CA--C 1.491 -1.326 0 N-CA-C 114.308 1.225 . . . . 17.170000000000002 114.308 . . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -93.13 118.29 31.05 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 116.525 -1.702 . . . . 21.890000000000001 107.345 -174.228 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.295 19.4 pt -120.22 151.78 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 126.446 2.341 . . . . 10.83 108.51 169.926 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -118.55 149.18 41.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.244 -2.873 . . . . 10.609999999999999 103.244 178.073 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 26.1 t -111.03 140.6 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 110.376 -3.102 . . . . 9.1300000000000008 117.019 162.653 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -123.28 128.31 49.78 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.779 -4.325 . . . . 20.550000000000001 110.835 -178.363 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.264 39.7 p -91.33 174.1 7.56 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.518 -1.989 . . . . 11.779999999999999 112.247 -176.229 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.264 12.8 tp -63.94 -52.82 58.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.785 -2.462 . . . . 19.309999999999999 115.192 171.369 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.4 -58.69 3.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.995 -2.316 . . . . 23.140000000000001 115.85 -175.804 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.44 53.92 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 120.571 1.532 . . . . 19.739999999999998 111.909 167.745 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -112.74 136.65 52.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.121 -1.811 . . . . 21.93 109.473 163.599 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -104.23 110.86 23.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 128.334 3.521 . . . . 12.33 101.864 170.488 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 19.6 mt -102.42 129.96 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 101.142 -3.651 . . . . 17.079999999999998 101.142 -176.013 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 m -97.77 128.27 44.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.046 1.738 . . . . 16.300000000000001 107.462 177.089 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.2 mt -118.72 158.2 26.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.353 2.342 . . . . 15.880000000000001 110.993 170.735 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -102.6 122.18 43.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.144 -2.909 . . . . 28.899999999999999 103.144 165.092 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 m -137.46 177.62 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 117.989 -1.484 . . . . 12.050000000000001 110.147 176.451 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.26 157.82 34.59 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 105.863 -1.902 . . . . 18.170000000000002 105.863 173.904 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.307 18.5 Cg_endo -66.82 -15.02 46.03 Favored 'Trans proline' 0 C--N 1.3 -1.996 1 C-N-CA 126.829 5.019 . . . . 8.1600000000000001 110.502 168.273 . . . . . . . . 3 2 . 1 . 092 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.2 m -94.69 0.12 54.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.577 -2.577 . . . . 11.130000000000001 115.67 -175.888 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -78.18 145.32 35.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.724 -2.485 . . . . 18.030000000000001 114.224 178.116 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 p -81.12 148.88 29.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.38 -2.7 . . . . 10.220000000000001 104.201 176.589 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 23' ' ' ILE . 25.7 mt -76.37 -26.61 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 121.261 -0.899 . . . . 12.300000000000001 111.06 -173.402 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.296 17.0 pt-20 -51.8 -35.69 45.09 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 117.104 -1.426 . . . . 36.509999999999998 114.68 161.488 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -77.7 -39.85 43.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 117.167 -1.397 . . . . 25.66 113.73 176.128 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.4 t -57.91 -40.32 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 121.086 1.766 . . . . 8.1199999999999992 109.472 176.875 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 55.8 mtmt -73.57 -35.67 65.48 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.499 1.12 . . . . 15.470000000000001 112.755 177.985 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.13 83.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 118.476 -1.289 . . . . 11.449999999999999 113.647 171.574 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.347 29.8 ttmt -48.09 -40.38 23.14 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.219 -3.426 . . . . 24.98 112.022 161.382 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.1 -35.94 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 120.706 1.594 . . . . 9.4600000000000009 111.296 177.865 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -49.9 -47.85 51.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 115.607 -2.14 . . . . 14.76 114.188 163.424 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -63.33 -38.43 91.11 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.315 1.871 . . . . 26.289999999999999 113.951 177.65 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -72.48 -67.21 0.57 Allowed 'General case' 0 N--CA 1.429 -1.486 1 C-N-CA 131.868 4.067 . . . . 30.059999999999999 110.238 -178.686 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -97.84 -72.83 0.63 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.473 -2.017 . . . . 25.190000000000001 110.56 -166.859 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.47 64.73 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 118.427 2.131 . . . . 7.4100000000000001 118.427 169.714 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.6 mt -133.56 116.18 13.83 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 128.151 2.58 . . . . 9.4900000000000002 104.244 -168.359 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.39 156.34 26.45 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 123.731 2.368 . . . . 11.42 116.007 -172.325 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -78.66 -15.29 13.73 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 CA-C-N 124.39 2.604 . . . . 12.0 112.51 -172.596 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -75.08 -42.4 56.81 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.792 0.806 . . . . 35.549999999999997 110.753 175.268 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -68.56 -26.59 65.48 Favored 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 134.126 4.971 . . . . 20.52 111.784 -175.239 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.427 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 69.6 mt-30 -86.84 135.68 33.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.925 -2.36 . . . . 7.1299999999999999 110.213 178.239 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -121.35 118.63 29.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.42 -2.067 . . . . 36.390000000000001 105.42 166.684 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.421 HD21 ' HA ' ' A' ' 43' ' ' LEU . 62.3 mt -93.46 120.97 34.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.482 3.113 . . . . 9.5500000000000007 111.849 177.86 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mt -109.29 134.07 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 117.119 -3.488 . . . . 13.9 107.488 173.957 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -91.27 -73.09 0.55 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 123.764 2.984 . . . . 6.8600000000000003 103.56 163.909 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.32 -140.19 0.2 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.475 2.083 . . . . 11.15 107.122 -172.387 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.03 -23.65 69.7 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 122.609 3.803 . . . . 13.93 122.609 -176.191 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -76.81 162.7 27.44 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.989 -4.242 . . . . 23.920000000000002 118.149 174.491 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.282 81.6 mm-40 -84.87 133.93 34.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.719 -1.238 . . . . 23.23 111.806 167.456 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 mt -93.25 132.78 37.12 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.384 -0.822 . . . . 9.1099999999999994 110.733 177.328 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -93.27 122.34 35.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.012 2.125 . . . . 33.439999999999998 107.897 168.78 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.06 -25.12 65.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.459 1.904 . . . . 28.370000000000001 114.149 -168.794 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.78 -2.69 86.45 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 126.253 1.882 . . . . 15.0 117.723 -179.573 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -104.9 -176.61 3.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.908 1.337 . . . . 25.5 107.984 172.63 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.4 p -100.43 178.07 4.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.724 1.75 . . . . 11.949999999999999 115.724 -173.557 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.95 -35.95 81.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.97 3.308 . . . . 10.17 112.408 167.79 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 t -72.77 -36.71 67.7 Favored 'General case' 0 N--CA 1.431 -1.387 1 O-C-N 113.947 -5.471 . . . . 13.59 112.485 -179.052 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -66.98 -38.34 85.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.854 3.261 . . . . 11.699999999999999 110.938 176.11 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -88.57 -4.13 58.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.659 -1.9 . . . . 12.949999999999999 110.738 176.301 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 m120 57.68 58.85 3.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 131.508 3.923 . . . . 25.449999999999999 111.677 178.083 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mm -102.28 108.81 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.309 -2.108 . . . . 14.6 105.309 -178.113 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -108.79 169.23 8.8 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 127.361 2.913 . . . . 33.229999999999997 109.335 -171.577 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -44.68 138.69 3.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.587 2.613 . . . . 25.969999999999999 112.343 -176.345 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.281 18.1 mt-10 60.16 6.16 0.94 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.119 3.368 . . . . 32.609999999999999 115.296 175.702 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.6 m -62.73 140.83 58.75 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.183 -4.073 . . . . 10.56 113.354 160.838 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -103.91 122.32 44.94 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.493 3.517 . . . . 5.3300000000000001 110.557 -175.407 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -86.24 156.35 20.32 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.089 2.743 . . . . 11.66 113.608 170.85 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -121.46 120.32 34.6 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 123.089 2.677 . . . . 16.300000000000001 111.223 168.365 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.6 tp -84.46 124.08 30.96 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 126.582 2.426 . . . . 9.9600000000000009 116.702 173.962 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.3 127.8 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 103.433 -2.803 . . . . 9.7599999999999998 103.433 179.423 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.286 1.3 mm? -65.36 136.53 56.64 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.867 -1.77 . . . . 19.57 115.212 175.43 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -119.36 150.61 39.88 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.035 2.826 . . . . 35.079999999999998 111.473 -178.341 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.323 28.9 mt -84.66 -67.69 0.78 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.64 -5.037 . . . . 32.310000000000002 111.828 169.463 . . . . . . . . 3 2 . 1 . 092 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -153.03 144.65 23.44 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.866 -3.022 . . . . 42.75 108.519 -176.915 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.57 -73.78 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.726 0 O-C-N 117.462 -3.273 . . . . 36.310000000000002 119.339 175.298 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.759 0 N-CA-C 109.648 -1.381 . . . . 36.270000000000003 109.648 -161.671 . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 113.766 1.024 . . . . 17.170000000000002 113.766 . . . . . . . . . 0 0 . 1 . 093 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -90.49 121.44 32.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.412 1.577 . . . . 21.890000000000001 113.795 -178.643 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.9 pt -123.54 151.92 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 O-C-N 114.145 -5.347 . . . . 10.83 108.653 168.449 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -115.93 137.01 52.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 119.484 1.038 . . . . 10.609999999999999 111.447 -179.451 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -109.82 130.23 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 130.134 3.374 . . . . 9.1300000000000008 109.028 168.049 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -122.84 137.61 54.88 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.586 -2.552 . . . . 20.550000000000001 107.097 -173.251 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.329 55.2 p -100.88 -173.38 2.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 119.696 1.134 . . . . 11.779999999999999 110.881 -170.085 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.4 mt -74.01 -41.27 62.13 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.855 -3.028 . . . . 19.309999999999999 111.982 177.62 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.95 -57.56 9.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.237 -1.54 . . . . 23.140000000000001 108.135 165.768 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.25 6.86 0.17 Allowed Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 117.618 -2.229 . . . . 19.739999999999998 115.436 177.55 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -77.29 149.46 35.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 122.661 3.231 . . . . 21.93 110.715 -161.786 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -113.72 110.73 20.64 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.974 -3.579 . . . . 12.33 105.939 -174.601 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.436 HG22 ' HE3' ' A' ' 33' ' ' LYS . 1.9 mp -103.04 121.66 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 111.212 -2.722 . . . . 17.079999999999998 112.289 169.392 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.3 m -103.66 114.07 28.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 128.003 3.314 . . . . 16.300000000000001 106.832 -174.37 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -104.14 141.7 35.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.147 -1.596 . . . . 15.880000000000001 112.295 178.651 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -84.13 100.81 11.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.406 1.883 . . . . 28.899999999999999 107.87 164.592 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.93 151.34 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.295 -1.002 . . . . 12.050000000000001 108.295 179.103 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -91.23 164.08 26.4 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 116.906 -1.918 . . . . 18.170000000000002 106.394 171.263 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -82.76 -8.06 11.31 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.515 2.144 . . . . 8.1600000000000001 108.872 -177.635 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -86.67 -4.54 59.19 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.795 1.759 . . . . 11.130000000000001 115.717 171.722 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -83.13 137.74 33.95 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.499 -2.001 . . . . 18.030000000000001 107.282 -168.284 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 p -74.21 157.84 35.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.631 3.11 . . . . 10.220000000000001 112.57 174.169 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.8 mt -69.19 -21.4 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 1 O-C-N 115.907 -4.246 . . . . 12.300000000000001 110.499 175.6 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.06 -48.18 82.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.02 2.343 . . . . 36.509999999999998 115.328 161.752 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.76 -41.03 94.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.38 3.072 . . . . 25.66 114.566 173.037 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.44 -55.68 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 129.191 2.997 . . . . 8.1199999999999992 114.986 164.23 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -46.58 -44.89 18.49 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 114.683 -5.011 . . . . 15.470000000000001 118.73 164.964 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.96 -36.71 75.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 124.725 2.202 . . . . 11.449999999999999 115.768 -177.854 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -69.83 -34.9 74.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.269 -2.242 . . . . 24.98 110.951 178.602 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -59.36 -43.61 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 125.861 1.665 . . . . 9.4600000000000009 109.892 171.403 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -68.05 -42.93 79.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.072 -1.642 . . . . 14.76 108.752 -174.882 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.36 -46.92 87.31 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.399 2.28 . . . . 26.289999999999999 112.602 176.598 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HE3' HG22 ' A' ' 13' ' ' ILE . 61.0 tttp -79.31 -57.25 3.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.703 2.112 . . . . 30.059999999999999 116.703 179.561 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -85.31 -54.64 4.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.708 -3.745 . . . . 25.190000000000001 116.003 -179.78 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.05 54.26 0.98 Allowed Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 124.509 1.052 . . . . 7.4100000000000001 115.161 -176.012 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.7 mt -119.48 125.57 27.44 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 104.585 -2.376 . . . . 9.4900000000000002 104.585 165.614 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -75.32 159.17 40.48 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 123.721 2.948 . . . . 11.42 113.276 -176.672 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -61.65 -11.41 20.27 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 124.952 3.768 . . . . 12.0 115.651 -179.765 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -85.7 -28.72 24.48 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 121.488 1.949 . . . . 35.549999999999997 106.414 -173.935 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -85.43 -28.66 24.94 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 115.365 -4.584 . . . . 20.52 110.222 -178.191 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -74.29 130.42 39.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.978 2.323 . . . . 7.1299999999999999 114.443 -177.858 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -132.89 126.86 33.11 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 112.81 -1.996 . . . . 36.390000000000001 111.172 164.584 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.2 mt -108.25 114.88 29.09 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 109.286 -3.597 . . . . 9.5500000000000007 113.89 -163.646 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.57 135.19 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 118.685 -2.51 . . . . 13.9 106.132 -172.217 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -96.02 -54.89 3.15 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.185 1.945 . . . . 6.8600000000000003 110.701 173.308 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.28 -126.35 0.27 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 108.899 -3.773 . . . . 11.15 108.026 -176.064 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.5 6.51 12.69 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 127.755 2.598 . . . . 13.93 107.55 -170.732 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -110.16 145.11 37.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.352 1.612 . . . . 23.920000000000002 115.352 -175.553 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -75.1 121.59 22.28 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.239 1.816 . . . . 23.23 111.919 -174.515 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.5 mt -94.68 120.7 35.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.393 2.677 . . . . 9.1099999999999994 110.496 176.61 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.74 143.26 28.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.81 -3.057 . . . . 33.439999999999998 107.641 -177.53 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -65.38 -39.48 92.3 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.027 -1.442 . . . . 28.370000000000001 112.076 -162.45 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.35 -11.77 81.6 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 120.289 2.875 . . . . 15.0 120.289 -168.672 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -91.26 173.57 7.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.657 -2.084 . . . . 25.5 105.765 -178.209 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.2 p -113.83 174.36 5.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.72 2.2 . . . . 11.949999999999999 108.142 -166.91 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.06 -31.11 72.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.444 -2.035 . . . . 10.17 113.989 173.164 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -67.77 -31.99 72.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.781 2.141 . . . . 13.59 116.781 175.716 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -61.92 -50.29 72.75 Favored 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.342 4.257 . . . . 11.699999999999999 110.214 176.811 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -89.87 -20.93 22.83 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 124.172 1.939 . . . . 12.949999999999999 115.198 -178.533 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.339 16.1 m120 85.65 41.73 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 127.346 2.258 . . . . 25.449999999999999 111.88 175.193 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.3 mm -79.31 115.52 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 124.323 2.011 . . . . 14.6 109.002 169.148 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -95.04 -174.16 3.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.405 -1.27 . . . . 33.229999999999997 111.941 -177.559 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -66.82 146.27 54.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.689 1.596 . . . . 25.969999999999999 112.583 175.853 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.461 65.3 mt-10 76.43 11.73 2.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.979 2.214 . . . . 32.609999999999999 116.979 -179.417 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.254 56.2 m -84.42 141.69 30.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.318 1.97 . . . . 10.56 116.318 -169.579 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.4 m -107.7 98.0 7.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.24 -2.162 . . . . 5.3300000000000001 109.843 -166.769 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -88.93 151.57 22.24 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.517 1.927 . . . . 11.66 107.594 -177.036 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.84 123.32 39.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.64 2.638 . . . . 16.300000000000001 108.228 -171.874 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -94.41 112.29 24.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.81 -2.45 . . . . 9.9600000000000009 110.591 -176.624 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.254 38.5 t -103.88 131.57 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 105.594 -2.002 . . . . 9.7599999999999998 105.594 -171.925 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -99.57 115.23 28.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.789 -3.069 . . . . 19.57 112.7 -171.401 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -75.86 153.44 36.78 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 110.582 -3.008 . . . . 35.079999999999998 117.714 -160.227 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.9 mt -81.66 -99.33 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.008 -3.558 . . . . 32.310000000000002 112.812 158.551 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -135.26 155.94 49.8 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.939 -1.028 . . . . 42.75 109.739 173.95 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.75 177.17 37.79 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 125.344 1.652 . . . . 36.310000000000002 110.538 175.998 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.759 0 C-N-CA 126.039 1.781 . . . . 36.270000000000003 111.228 -179.461 . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.49 -1.344 0 N-CA-C 116.607 2.077 . . . . 17.170000000000002 116.607 . . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -90.87 144.2 25.93 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.97 -4.206 . . . . 21.890000000000001 112.444 -175.122 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.4 pt -122.09 155.16 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 126.023 2.82 . . . . 10.83 103.946 165.543 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -114.95 111.11 20.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.034 -3.542 . . . . 10.609999999999999 103.597 -172.302 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.19 135.44 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 116.699 -3.751 . . . . 9.1300000000000008 107.736 179.648 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -115.15 122.79 47.16 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 125.715 1.606 . . . . 20.550000000000001 112.813 -172.491 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -77.02 172.69 12.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.19 -2.819 . . . . 11.779999999999999 115.112 177.675 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.442 HD21 ' CE1' ' A' ' 68' ' ' HIS . 40.8 mt -76.58 -23.74 53.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.274 2.694 . . . . 19.309999999999999 118.274 170.498 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -83.66 -24.8 31.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 115.805 -2.045 . . . . 23.140000000000001 113.501 166.613 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.33 49.8 0.35 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 113.636 -3.869 . . . . 19.739999999999998 113.786 161.388 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -114.69 140.16 49.08 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.665 2.038 . . . . 21.93 107.511 175.499 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -84.4 117.13 23.43 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 116.13 -4.106 . . . . 12.33 108.431 160.856 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -86.2 116.21 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.658 -2.349 . . . . 17.079999999999998 104.658 162.984 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.2 m -106.21 97.39 7.21 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 124.834 2.254 . . . . 16.300000000000001 108.808 -172.415 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 mt -103.45 116.08 31.73 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.892 -1.958 . . . . 15.880000000000001 112.224 -162.428 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.93 119.16 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.727 -1.579 . . . . 28.899999999999999 112.893 170.869 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.78 177.55 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.226 2.441 . . . . 12.050000000000001 109.387 -179.514 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.88 167.3 14.81 Favored Pre-proline 0 N--CA 1.43 -1.471 0 O-C-N 117.176 -3.452 . . . . 18.170000000000002 103.781 172.784 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -76.61 -19.35 14.68 Favored 'Trans proline' 0 C--N 1.3 -2.021 1 C-N-CA 125.595 4.196 . . . . 8.1600000000000001 114.985 179.713 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -79.89 -14.55 58.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.196 2.665 . . . . 11.130000000000001 118.196 171.755 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -72.58 144.83 47.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.303 -2.748 . . . . 18.030000000000001 106.263 -168.87 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.5 p -82.69 157.13 23.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.567 -1.253 . . . . 10.220000000000001 111.854 177.338 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.29 -21.54 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 CA-C-O 128.868 4.175 . . . . 12.300000000000001 114.979 -172.822 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -58.62 -53.77 54.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.488 -3.258 . . . . 36.509999999999998 114.612 157.899 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -50.73 -32.83 20.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.583 -3.823 . . . . 25.66 115.934 173.974 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.11 -53.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 128.496 2.718 . . . . 8.1199999999999992 108.971 173.092 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -65.28 -35.49 81.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.606 1.548 . . . . 15.470000000000001 112.849 -179.887 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.53 92.47 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.254 1.022 . . . . 11.449999999999999 112.318 169.88 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -53.0 -43.35 66.41 Favored 'General case' 0 N--CA 1.43 -1.458 2 O-C-N 113.938 -5.476 . . . . 24.98 113.802 169.866 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -64.88 -29.55 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 127.894 2.478 . . . . 9.4600000000000009 112.807 172.67 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -72.92 -45.79 56.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 123.48 2.854 . . . . 14.76 109.21 167.897 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -59.81 -37.04 78.05 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.165 -2.209 . . . . 26.289999999999999 114.997 177.551 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -85.69 -51.1 6.68 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.563 2.801 . . . . 30.059999999999999 118.563 171.107 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -102.91 -8.14 20.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.155 3.02 . . . . 25.190000000000001 119.155 -178.658 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.29 51.42 58.25 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 117.811 -3.055 . . . . 7.4100000000000001 114.768 -175.512 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.8 mt -111.02 106.25 57.45 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 128.337 2.655 . . . . 9.4900000000000002 108.625 165.775 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -72.59 157.45 52.5 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 N-CA-C 118.134 2.321 . . . . 11.42 118.134 -172.048 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -71.84 -15.97 29.65 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-N 126.47 3.346 . . . . 12.0 119.467 -163.78 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.8 -24.43 67.55 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 120.713 3.597 . . . . 35.549999999999997 120.713 160.274 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -72.07 -28.93 63.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.903 2.592 . . . . 20.52 114.257 170.594 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -86.85 133.27 33.64 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.54 -3.225 . . . . 7.1299999999999999 115.534 -159.321 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -125.95 108.27 11.25 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.965 1.841 . . . . 36.390000000000001 108.516 167.317 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.8 mt -87.39 113.94 23.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.444 -1.707 . . . . 9.5500000000000007 108.572 -179.021 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -116.85 134.82 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 1 O-C-N 115.844 -4.285 . . . . 13.9 103.137 175.614 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -103.79 -63.62 1.17 Allowed 'General case' 0 N--CA 1.431 -1.419 1 O-C-N 115.061 -4.774 . . . . 6.8600000000000003 109.952 166.832 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.95 -66.47 0.93 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.797 -3.69 . . . . 11.15 109.122 -168.453 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.11 -53.75 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 O-C-N 116.854 -3.654 . . . . 13.93 118.931 -174.065 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -71.91 169.19 16.36 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.725 2.12 . . . . 23.920000000000002 116.725 -170.035 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -88.46 129.28 35.48 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 114.77 -4.956 . . . . 23.23 106.177 -178.686 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.5 mt -84.47 127.2 33.89 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 111.891 -2.413 . . . . 9.1099999999999994 112.647 175.767 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.29 163.89 26.07 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 129.221 4.075 . . . . 33.439999999999998 111.709 166.493 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -91.07 -63.39 1.27 Allowed 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 115.539 -4.475 . . . . 28.370000000000001 108.936 -172.473 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.25 -5.87 9.1 Favored Glycine 0 N--CA 1.431 -1.667 1 C-N-CA 130.873 4.082 . . . . 15.0 113.561 -178.484 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -91.34 168.43 11.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.119 3.46 . . . . 25.5 110.759 174.763 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 29.6 p -94.72 170.02 9.75 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.237 4.215 . . . . 11.949999999999999 111.334 179.466 . . . . . . . . 3 2 . 1 . 094 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.61 -26.04 62.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.393 -3.942 . . . . 10.17 115.753 172.823 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -63.99 -49.75 71.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 111.447 -2.615 . . . . 13.59 111.119 172.762 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -45.14 -44.48 10.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.767 2.506 . . . . 11.699999999999999 117.767 169.533 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -88.54 3.66 49.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 116.622 -1.656 . . . . 12.949999999999999 114.647 179.257 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.336 3.7 m-80 57.01 52.93 8.55 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.747 3.24 . . . . 25.449999999999999 119.747 -175.227 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mt -115.19 122.8 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 113.926 -1.488 . . . . 14.6 108.214 -177.785 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -112.24 -150.55 0.47 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.37 -2.706 . . . . 33.229999999999997 113.252 175.417 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -76.59 165.88 24.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.699 2.045 . . . . 25.969999999999999 111.996 -173.252 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 57.23 25.45 11.06 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 133.012 4.525 . . . . 32.609999999999999 109.668 174.528 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.286 52.6 m -76.29 121.94 23.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 129.507 3.123 . . . . 10.56 107.979 -176.709 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.4 m -90.8 116.75 28.88 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 124.697 1.248 . . . . 5.3300000000000001 111.313 175.885 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.8 mp -107.35 158.37 17.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.111 2.164 . . . . 11.66 107.502 178.889 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.442 ' CE1' HD21 ' A' ' 8' ' ' LEU . 5.9 t60 -114.84 131.79 56.72 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.446 1.593 . . . . 16.300000000000001 110.505 172.661 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.65 103.88 14.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 127.715 3.626 . . . . 9.9600000000000009 104.387 172.176 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 t -95.15 133.82 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 1 C-N-CA 135.459 5.504 . . . . 9.7599999999999998 109.94 171.824 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.08 113.58 25.5 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 116.102 1.89 . . . . 19.57 116.102 -171.688 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.254 27.7 ttp85 -83.08 160.0 22.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.243 3.017 . . . . 35.079999999999998 113.24 -157.106 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.38 133.01 33.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.019 -1.901 . . . . 32.310000000000002 106.887 177.148 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -74.43 139.4 43.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.369 1.248 . . . . 42.75 114.369 -174.85 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.79 85.07 0.84 Allowed Glycine 0 N--CA 1.43 -1.746 1 C-N-CA 130.959 4.123 . . . . 36.310000000000002 105.0 165.11 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.801 0 O-C-N 129.415 3.656 . . . . 36.270000000000003 111.052 178.963 . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 113.614 0.968 . . . . 17.170000000000002 113.614 . . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -91.98 132.5 36.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.746 1.387 . . . . 21.890000000000001 114.746 -170.772 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 pt -131.21 150.24 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 119.118 -2.239 . . . . 10.83 113.257 167.745 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -99.48 123.61 43.9 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 125.685 1.865 . . . . 10.609999999999999 108.529 -176.796 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.7 t -104.22 121.98 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 117.178 -1.809 . . . . 9.1300000000000008 107.786 171.835 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -103.21 105.98 16.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.112 2.965 . . . . 20.550000000000001 110.958 -170.026 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -69.96 177.39 3.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.832 1.419 . . . . 11.779999999999999 114.832 178.673 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.1 mt -66.29 -43.71 85.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 114.989 -2.434 . . . . 19.309999999999999 111.739 -170.295 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -67.48 -47.83 68.91 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 132.594 6.184 . . . . 23.140000000000001 106.708 172.928 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.32 41.77 0.62 Allowed Glycine 0 N--CA 1.43 -1.708 0 O-C-N 117.669 -3.145 . . . . 19.739999999999998 115.333 -176.879 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -83.38 135.23 34.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 101.889 -3.374 . . . . 21.93 101.889 175.356 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -90.11 101.93 14.64 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 122.183 2.265 . . . . 12.33 106.105 -177.934 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 mt -85.34 109.26 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.445 -0.784 . . . . 17.079999999999998 109.392 172.708 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -92.0 116.8 29.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.317 2.961 . . . . 16.300000000000001 111.302 -178.673 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.2 mt -116.13 137.04 52.47 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.818 -4.301 . . . . 15.880000000000001 111.475 -174.082 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -111.19 108.65 18.38 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.476 -2.64 . . . . 28.899999999999999 106.521 -175.331 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.86 164.62 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 125.116 1.51 . . . . 12.050000000000001 112.786 -172.448 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.33 154.79 37.93 Favored Pre-proline 0 N--CA 1.43 -1.464 0 O-C-N 116.952 -3.592 . . . . 18.170000000000002 110.663 165.419 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -60.55 -24.51 78.38 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 125.101 3.867 . . . . 8.1600000000000001 110.789 179.125 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -98.33 26.01 5.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.211 -1.556 . . . . 11.130000000000001 109.44 -179.408 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -94.86 158.91 15.28 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.998 -2.939 . . . . 18.030000000000001 112.247 161.951 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -105.09 169.8 8.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.447 1.594 . . . . 10.220000000000001 109.578 -170.775 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.11 -40.21 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.666 -2.521 . . . . 12.300000000000001 113.558 178.383 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 30.8 tt0 -43.04 -41.62 3.56 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 121.082 3.734 . . . . 36.509999999999998 121.082 160.653 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -63.19 -60.7 3.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.397 -3.314 . . . . 25.66 111.948 174.913 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 t -46.94 -41.36 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 116.313 -3.992 . . . . 8.1199999999999992 117.182 170.939 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -56.3 -35.67 67.79 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.354 -1.466 . . . . 15.470000000000001 111.091 177.696 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.1 -24.23 60.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.922 -3.611 . . . . 11.449999999999999 114.341 -179.13 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -65.03 -30.1 71.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.416 2.747 . . . . 24.98 118.416 166.028 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.8 mt -78.24 -33.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 124.291 1.996 . . . . 9.4600000000000009 110.492 178.544 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -66.18 -31.33 72.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.87 -1.768 . . . . 14.76 115.073 169.093 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -62.41 -60.8 3.03 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.442 3.097 . . . . 26.289999999999999 109.218 173.251 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -79.87 -63.7 1.35 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 115.059 1.503 . . . . 30.059999999999999 115.059 -174.142 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 45.2 mm-40 -82.53 -28.88 30.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.239 3.051 . . . . 25.190000000000001 119.239 -177.28 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.98 7.79 49.45 Favored Glycine 0 N--CA 1.43 -1.75 1 O-C-N 116.056 -4.153 . . . . 7.4100000000000001 120.956 173.25 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.67 129.65 51.95 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 118.656 -2.673 . . . . 9.4900000000000002 111.815 -179.529 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -66.66 146.61 79.63 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 N-CA-C 118.411 2.427 . . . . 11.42 118.411 174.979 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -16.95 57.51 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 120.125 3.087 . . . . 12.0 120.125 -169.335 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.67 -19.85 34.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.587 -1.946 . . . . 35.549999999999997 110.738 176.766 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -91.6 -24.12 19.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.064 2.364 . . . . 20.52 107.843 -169.22 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -73.45 155.56 39.16 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.191 -3.443 . . . . 7.1299999999999999 111.391 175.171 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.291 51.5 ttt180 -139.5 120.0 14.03 Favored 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 132.471 4.308 . . . . 36.390000000000001 113.672 167.604 . . . . . . . . 3 2 . 1 . 095 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.84 132.77 49.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.809 -1.807 . . . . 9.5500000000000007 109.698 -179.471 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.451 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 3.6 mt -120.61 130.61 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.007 -1.108 . . . . 13.9 108.007 179.215 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -86.45 -77.5 0.31 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.43 -2.044 . . . . 6.8600000000000003 110.135 163.002 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.07 -73.37 0.67 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.053 1.341 . . . . 11.15 107.864 173.973 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.46 1.2 0.42 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 113.699 -3.834 . . . . 13.93 115.129 -171.733 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -105.54 166.83 10.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 123.875 3.838 . . . . 23.920000000000002 107.832 -167.176 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -97.31 139.94 32.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.818 1.645 . . . . 23.23 111.365 177.729 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -101.61 141.95 33.7 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.308 -0.86 . . . . 9.1099999999999994 108.881 -174.661 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.253 43.6 mt-10 -97.93 149.25 22.61 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.127 -2.233 . . . . 33.439999999999998 107.397 174.182 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 2.0 m-20 -67.03 -31.21 71.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.303 2.241 . . . . 28.370000000000001 112.436 -175.299 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.71 36.26 4.52 Favored Glycine 0 N--CA 1.43 -1.728 1 N-CA-C 125.189 4.835 . . . . 15.0 125.189 -177.179 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -126.35 162.15 26.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.161 -2.376 . . . . 25.5 107.179 170.871 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.255 29.9 p -88.24 166.49 14.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.146 -2.846 . . . . 11.949999999999999 111.432 -175.479 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.57 -41.67 90.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.495 2.569 . . . . 10.17 111.301 164.789 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -58.51 -39.17 79.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.482 -3.261 . . . . 13.59 114.539 175.064 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -67.43 -36.71 81.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.228 1.966 . . . . 11.699999999999999 111.66 -174.256 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -85.32 -0.61 55.28 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.869 -3.019 . . . . 12.949999999999999 108.716 176.1 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.301 3.3 m120 56.67 36.87 28.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.884 2.179 . . . . 25.449999999999999 116.884 -179.329 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.5 mt -99.02 111.07 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 117.182 -1.39 . . . . 14.6 108.848 177.816 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.307 28.8 mm100 -96.0 -167.04 1.52 Allowed 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.927 3.267 . . . . 33.229999999999997 107.134 -167.294 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -57.33 159.92 4.34 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 117.161 2.282 . . . . 25.969999999999999 117.161 167.089 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 65.24 14.37 9.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.542 1.937 . . . . 32.609999999999999 113.546 -178.045 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -81.04 133.7 35.53 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.566 1.691 . . . . 10.56 115.566 -171.248 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.4 m -93.25 112.11 23.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.472 -1.694 . . . . 5.3300000000000001 108.737 -173.232 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.9 mt -98.06 133.48 42.45 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.379 -3.326 . . . . 11.66 106.163 176.248 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.451 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 15.3 t60 -94.75 119.09 32.8 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 126.67 1.988 . . . . 16.300000000000001 112.819 167.918 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.9 tp -103.81 121.51 43.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 126.153 2.882 . . . . 9.9600000000000009 114.418 -179.981 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.72 176.98 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 1 O-C-N 114.668 -5.02 . . . . 9.7599999999999998 103.104 -177.243 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.3 mp -98.18 157.19 16.3 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.212 -5.305 . . . . 19.57 115.282 -179.049 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.8 ttp85 -90.58 149.18 22.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.478 1.659 . . . . 35.079999999999998 115.478 170.768 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.2 mt -105.2 121.1 43.14 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.365 2.031 . . . . 32.310000000000002 107.705 174.274 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 -111.67 162.43 15.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.017 2.927 . . . . 42.75 118.213 -162.923 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.89 -73.68 0.21 Allowed Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 126.605 2.05 . . . . 36.310000000000002 109.79 -177.995 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 CA-C-O 114.812 -3.216 . . . . 36.270000000000003 113.173 174.952 . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 116.981 -1.485 . . . . 17.170000000000002 112.864 . . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -101.67 149.42 24.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 114.51 -2.876 . . . . 21.890000000000001 113.934 -173.836 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.74 174.98 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 119.636 -1.915 . . . . 10.83 109.034 160.145 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -126.18 149.5 48.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 115.349 -2.54 . . . . 10.609999999999999 108.098 -175.319 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.8 t -112.94 127.59 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 104.659 -2.349 . . . . 9.1300000000000008 104.659 168.051 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -105.85 117.69 34.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.853 2.168 . . . . 20.550000000000001 116.853 164.58 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -92.05 169.54 10.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.723 3.154 . . . . 11.779999999999999 109.068 -168.966 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 mt -62.93 -38.36 90.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.499 -2.625 . . . . 19.309999999999999 111.668 166.501 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 m -61.37 -61.32 2.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.48 3.512 . . . . 23.140000000000001 112.718 -178.982 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.52 52.42 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 118.567 -1.778 . . . . 19.739999999999998 111.373 177.869 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -123.87 167.37 14.18 Favored 'General case' 0 N--CA 1.43 -1.454 1 CA-C-O 129.648 4.546 . . . . 21.93 108.18 179.759 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.2 m -131.06 108.28 9.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 110.368 -3.105 . . . . 12.33 103.155 166.771 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.8 mt -101.28 131.52 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 111.953 -3.88 . . . . 17.079999999999998 107.123 175.545 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.6 m -104.59 114.88 29.39 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 123.996 3.089 . . . . 16.300000000000001 106.551 173.846 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.3 mt -104.1 129.03 51.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.145 1.778 . . . . 15.880000000000001 111.824 174.074 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -87.03 106.3 17.75 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.657 3.122 . . . . 28.899999999999999 105.081 -178.545 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.19 155.7 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.031 -2.918 . . . . 12.050000000000001 110.418 -171.266 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -109.89 137.42 20.45 Favored Pre-proline 0 N--CA 1.43 -1.432 0 O-C-N 116.723 -3.735 . . . . 18.170000000000002 107.759 164.881 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.69 -10.25 13.11 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 124.828 3.686 . . . . 8.1600000000000001 113.074 -164.077 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -89.22 -12.98 39.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.024 2.345 . . . . 11.130000000000001 110.958 174.511 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -81.88 157.9 24.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.105 -1.407 . . . . 18.030000000000001 111.749 176.007 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -87.51 170.33 11.43 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.54 -2.6 . . . . 10.220000000000001 116.007 -150.895 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.0 mt -80.95 -27.3 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 118.3 -2.75 . . . . 12.300000000000001 110.892 -175.471 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -62.21 -45.14 94.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.767 -2.063 . . . . 36.509999999999998 112.619 166.98 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -64.25 -20.43 66.04 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 117.516 -1.23 . . . . 25.66 112.238 178.055 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.1 t -73.06 -40.4 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 122.16 2.255 . . . . 8.1199999999999992 111.82 168.473 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -66.94 -38.45 86.18 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.491 2.994 . . . . 15.470000000000001 113.989 176.807 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.44 -11.07 29.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.617 2.821 . . . . 11.449999999999999 118.617 169.564 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -84.04 -38.88 20.3 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.506 1.622 . . . . 24.98 113.506 166.35 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.7 -40.51 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 117.561 -3.212 . . . . 9.4600000000000009 115.545 160.618 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -55.01 -35.34 64.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.15 -2.844 . . . . 14.76 114.438 170.289 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.4 -57.07 11.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.892 -1.755 . . . . 26.289999999999999 115.344 166.452 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -66.27 -65.11 0.72 Allowed 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 133.415 4.686 . . . . 30.059999999999999 109.714 -168.452 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -93.32 -26.53 17.26 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.903 1.811 . . . . 25.190000000000001 114.454 -173.471 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.8 28.6 9.32 Favored Glycine 0 N--CA 1.43 -1.709 1 O-C-N 114.152 -5.342 . . . . 7.4100000000000001 116.358 177.126 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 90.2 mt -120.12 118.54 31.41 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 116.256 -1.83 . . . . 9.4900000000000002 108.263 -162.62 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -73.05 162.0 41.99 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.867 3.488 . . . . 11.42 114.961 -164.004 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.63 -15.53 19.35 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 125.616 3.041 . . . . 12.0 114.338 -174.016 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.4 -29.78 42.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.599 2.454 . . . . 35.549999999999997 114.078 176.351 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -78.11 -23.63 47.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.653 1.981 . . . . 20.52 115.38 171.866 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -71.79 139.48 49.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.266 3.062 . . . . 7.1299999999999999 119.266 170.562 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 72.6 ttt180 -119.71 147.46 44.55 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.488 -2.007 . . . . 36.390000000000001 113.949 158.604 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -127.64 112.52 14.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.858 -2.401 . . . . 9.5500000000000007 111.047 179.419 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.6 mt -95.71 125.35 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.124 -3.485 . . . . 13.9 107.044 -175.663 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -98.1 -62.51 1.23 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.909 -3.62 . . . . 6.8600000000000003 105.952 178.107 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.69 -128.5 0.1 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.135 2.574 . . . . 11.15 104.497 177.976 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.04 7.07 32.81 Favored Glycine 0 N--CA 1.431 -1.699 0 O-C-N 121.043 -1.036 . . . . 13.93 114.609 -172.482 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -111.98 117.36 32.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.206 1.558 . . . . 23.920000000000002 115.206 169.661 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -68.6 129.3 39.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.319 2.009 . . . . 23.23 111.191 -170.345 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.37 153.3 35.89 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.61 -3.181 . . . . 9.1099999999999994 113.891 -176.687 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -101.65 150.41 23.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.107 0.956 . . . . 33.439999999999998 111.676 162.253 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -67.02 -43.99 81.42 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 120.44 3.496 . . . . 28.370000000000001 120.44 -178.145 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.73 48.04 1.85 Allowed Glycine 0 N--CA 1.43 -1.709 0 CA-C-O 123.777 1.765 . . . . 15.0 111.873 -178.449 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -127.39 162.22 26.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.8 -2.296 . . . . 25.5 104.8 174.544 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.2 p -91.09 169.42 10.87 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.77 -3.081 . . . . 11.949999999999999 108.605 178.097 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.7 -34.28 71.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.345 -3.347 . . . . 10.17 114.319 171.442 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 t -65.81 -34.69 78.75 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 128.358 3.536 . . . . 13.59 116.008 -178.482 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -56.58 -43.33 79.95 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.83 -1.794 . . . . 11.699999999999999 113.323 177.834 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -95.11 8.82 41.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 122.354 2.343 . . . . 12.949999999999999 113.437 -178.882 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.493 10.6 m120 66.0 41.23 3.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.847 2.059 . . . . 25.449999999999999 113.274 175.96 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.3 mt -91.05 138.09 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 106.632 -1.618 . . . . 14.6 106.632 -178.233 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -128.98 -177.28 4.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.943 -2.973 . . . . 33.229999999999997 112.426 -168.746 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.327 19.9 pttp -60.93 149.6 35.93 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 120.862 3.653 . . . . 25.969999999999999 120.862 168.916 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 48.1 27.49 1.26 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.965 3.306 . . . . 32.609999999999999 116.802 -171.905 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.334 54.5 m -92.99 144.94 24.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.409 -3.307 . . . . 10.56 114.986 177.277 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.5 m -99.91 120.99 40.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.057 -1.925 . . . . 5.3300000000000001 115.937 -171.761 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -103.51 137.92 40.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.11 -1.441 . . . . 11.66 107.11 174.567 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -93.6 114.44 26.78 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 114.445 1.276 . . . . 16.300000000000001 114.445 177.08 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.253 49.6 tp -83.4 115.2 21.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 124.288 0.992 . . . . 9.9600000000000009 110.353 -179.595 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.57 -175.05 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 115.068 -0.969 . . . . 9.7599999999999998 110.102 166.92 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 mt -94.73 154.1 17.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.606 1.193 . . . . 19.57 113.147 172.334 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -88.25 130.4 35.1 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.964 2.209 . . . . 35.079999999999998 116.964 170.968 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.6 tp -86.56 109.37 19.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.969 -2.234 . . . . 32.310000000000002 104.969 -178.745 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -92.68 150.42 20.7 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 124.088 1.899 . . . . 42.75 115.224 -170.473 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.35 95.0 1.98 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.762 -1.211 . . . . 36.310000000000002 110.542 173.402 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.773 0 C-N-CA 125.429 1.49 . . . . 36.270000000000003 110.97 171.798 . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 116.08 -1.914 . . . . 17.170000000000002 113.758 . . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -104.24 131.58 51.4 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.267 2.23 . . . . 21.890000000000001 110.383 -179.08 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.38 152.51 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.182 -2.525 . . . . 10.83 104.182 -178.696 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -107.31 125.08 50.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.269 2.228 . . . . 10.609999999999999 111.289 -176.69 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 t -110.84 115.63 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.23 -2.794 . . . . 9.1300000000000008 109.221 176.513 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.262 31.3 tttt -97.79 130.59 44.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.741 0.781 . . . . 20.550000000000001 109.626 -171.535 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.271 13.9 p -74.92 166.25 23.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.841 -3.662 . . . . 11.779999999999999 115.12 -179.001 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.263 1.6 tp -54.96 -43.33 73.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.618 3.567 . . . . 19.309999999999999 106.288 171.607 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 p -89.49 -50.25 6.21 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.177 -3.452 . . . . 23.140000000000001 115.64 179.529 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.75 67.61 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.763 0 O-C-N 117.533 -3.23 . . . . 19.739999999999998 111.34 163.475 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -137.24 139.83 41.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.503 -2.763 . . . . 21.93 106.545 173.784 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -104.57 112.9 26.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.799 1.64 . . . . 12.33 107.655 -166.816 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 60.1 mt -91.03 144.22 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 118.17 -2.831 . . . . 17.079999999999998 107.348 179.328 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.1 m -108.5 121.01 44.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 122.799 2.545 . . . . 16.300000000000001 112.779 164.867 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.66 130.7 55.5 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.688 2.795 . . . . 15.880000000000001 111.715 -179.997 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -90.54 114.83 27.13 Favored 'General case' 0 N--CA 1.43 -1.453 1 CA-C-O 128.596 4.046 . . . . 28.899999999999999 108.81 173.687 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.61 171.63 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.56 -3.212 . . . . 12.050000000000001 110.89 -173.621 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.36 147.94 36.63 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 102.387 -3.19 . . . . 18.170000000000002 102.387 166.663 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -65.11 -14.07 43.19 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 121.695 1.597 . . . . 8.1600000000000001 113.938 171.671 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.34 -4.95 50.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.936 2.303 . . . . 11.130000000000001 116.142 171.895 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -81.18 146.47 30.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 114.596 -2.621 . . . . 18.030000000000001 109.753 178.919 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.0 p -79.75 166.71 21.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 125.717 3.871 . . . . 10.220000000000001 114.111 167.627 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.7 mm -49.77 -43.36 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 111.624 -2.534 . . . . 12.300000000000001 113.738 169.234 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.254 36.0 tt0 -54.11 -24.83 19.08 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.663 -2.113 . . . . 36.509999999999998 115.632 176.632 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -86.9 -34.71 19.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.156 2.408 . . . . 25.66 111.043 178.206 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.22 -48.4 88.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.457 2.075 . . . . 8.1199999999999992 108.521 178.677 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -61.31 -27.04 68.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 119.134 3.012 . . . . 15.470000000000001 119.134 175.278 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.258 . . -74.2 -29.51 61.78 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.83 -3.044 . . . . 11.449999999999999 109.827 -175.959 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -64.52 -36.75 85.22 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.399 2.523 . . . . 24.98 115.904 169.254 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.344 39.1 mt -65.08 -42.05 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 O-C-N 116.198 -4.063 . . . . 9.4600000000000009 110.701 171.766 . . . . . . . . 3 2 . 1 . 097 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.07 -29.83 68.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.914 -3.616 . . . . 14.76 118.367 168.211 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.65 -48.67 16.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 126.42 2.325 . . . . 26.289999999999999 111.194 -179.023 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -83.03 -57.48 3.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 126.21 2.194 . . . . 30.059999999999999 112.005 -169.883 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -78.32 -45.8 21.73 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.62 2.768 . . . . 25.190000000000001 111.537 177.757 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.2 50.15 5.59 Favored Glycine 0 N--CA 1.43 -1.763 0 O-C-N 119.407 -2.058 . . . . 7.4100000000000001 113.25 -169.126 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mt -113.31 140.81 24.81 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.114 -2.18 . . . . 9.4900000000000002 105.114 170.38 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -72.75 148.88 47.39 Favored 'Trans proline' 0 N--CA 1.433 -2.032 1 C-N-CA 125.885 4.39 . . . . 11.42 111.164 -176.837 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.8 -30.16 9.68 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 N-CA-C 116.44 1.669 . . . . 12.0 116.44 -165.3 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -66.23 -26.21 67.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 120.333 3.457 . . . . 35.549999999999997 120.333 172.356 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -78.09 -29.7 49.18 Favored 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 132.327 4.251 . . . . 20.52 108.528 -178.163 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.432 ' HA ' HD11 ' A' ' 69' ' ' LEU 0.262 56.6 mt-30 -67.74 91.44 0.31 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.693 3.197 . . . . 7.1299999999999999 110.283 170.799 . . . . . . . . 3 3 . 1 . 097 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -93.77 98.54 11.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 126.74 3.162 . . . . 36.390000000000001 109.51 171.417 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -98.22 130.52 44.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.08 2.848 . . . . 9.5500000000000007 104.496 -170.374 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mt -123.08 134.27 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.544 -3.847 . . . . 13.9 107.095 -173.72 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -115.54 103.36 10.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 102.491 -3.151 . . . . 6.8600000000000003 102.491 175.794 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.69 -97.48 0.06 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.407 2.283 . . . . 11.15 111.368 -172.679 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.58 16.23 9.05 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-O 124.083 1.935 . . . . 13.93 117.353 161.679 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -84.33 115.0 22.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.659 -3.26 . . . . 23.920000000000002 106.833 174.963 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -74.13 123.58 24.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 117.142 -1.409 . . . . 23.23 110.916 166.82 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.07 132.66 39.71 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 116.618 -2.033 . . . . 9.1099999999999994 108.648 -160.301 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -78.37 151.0 33.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.496 -3.877 . . . . 33.439999999999998 107.325 174.929 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.16 -36.85 75.0 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.485 2.088 . . . . 28.370000000000001 111.843 -169.572 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.03 25.15 27.23 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-O 125.415 2.675 . . . . 15.0 113.043 -160.754 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -115.56 142.19 47.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 124.288 1.994 . . . . 25.5 108.414 -174.231 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -76.31 153.89 35.51 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.166 2.412 . . . . 11.949999999999999 112.73 178.959 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.9 mt -70.9 -32.27 69.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.552 -3.217 . . . . 10.17 111.88 178.586 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.5 p -70.93 -17.58 62.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.347 -1.471 . . . . 13.59 114.844 168.843 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -77.73 -44.86 26.47 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 119.059 -2.275 . . . . 11.699999999999999 110.37 178.769 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -70.03 -25.44 63.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.799 -3.688 . . . . 12.949999999999999 115.76 173.975 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.501 20.3 t30 81.6 43.8 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 131.399 3.879 . . . . 25.449999999999999 115.905 -170.553 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.9 mt -94.13 94.25 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 105.68 -1.97 . . . . 14.6 105.68 174.009 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -93.07 -177.45 4.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.784 -1.553 . . . . 33.229999999999997 114.94 176.067 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -55.96 139.03 47.73 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.241 2.311 . . . . 25.969999999999999 117.241 -174.19 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 80.0 mt-10 68.98 12.27 8.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 128.634 3.709 . . . . 32.609999999999999 114.015 -179.854 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.275 16.1 m -64.69 144.05 57.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.392 1.477 . . . . 10.56 112.876 170.0 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 m -102.06 116.25 32.28 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 102.076 -3.305 . . . . 5.3300000000000001 102.076 -176.602 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.36 134.72 42.88 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.191 -1.568 . . . . 11.66 111.455 168.245 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -109.5 120.75 43.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 113.317 -3.23 . . . . 16.300000000000001 112.115 -163.993 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.432 HD11 ' HA ' ' A' ' 41' ' ' GLN . 62.7 tp -94.43 117.88 30.79 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.686 1.866 . . . . 9.9600000000000009 108.51 -170.292 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.55 149.3 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.293 -1.504 . . . . 9.7599999999999998 107.625 167.283 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.264 80.2 mt -97.8 151.07 20.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.481 -1.387 . . . . 19.57 113.589 -179.06 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -137.52 172.03 13.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.866 -1.771 . . . . 35.079999999999998 107.906 164.005 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.34 41.7 mt -96.77 -82.66 0.4 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.303 -1.498 . . . . 32.310000000000002 114.041 174.253 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -107.99 -42.54 4.65 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.703 -2.498 . . . . 42.75 113.14 -171.612 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.18 169.4 38.29 Favored Glycine 0 N--CA 1.429 -1.767 0 C-N-CA 118.85 -1.643 . . . . 36.310000000000002 109.349 -176.546 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 0 CA-C-O 117.633 -1.648 . . . . 36.270000000000003 110.843 179.246 . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 114.311 1.226 . . . . 17.170000000000002 114.311 . . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.259 61.8 mt-30 -98.4 135.58 39.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.183 1.793 . . . . 21.890000000000001 107.28 171.306 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.313 18.3 pt -131.23 150.64 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.416 -2.053 . . . . 10.83 110.14 166.947 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.255 17.5 m-85 -115.78 111.57 20.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.108 2.163 . . . . 10.609999999999999 112.713 -172.675 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.4 t -96.92 121.51 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.65 -1.281 . . . . 9.1300000000000008 107.943 177.459 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.29 38.6 ttmt -114.27 133.68 55.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.144 -1.408 . . . . 20.550000000000001 113.107 -170.844 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.8 p -83.9 173.54 11.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 127.982 3.302 . . . . 11.779999999999999 114.429 178.248 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 mt -75.93 -29.48 58.39 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.642 2.46 . . . . 19.309999999999999 117.642 -178.686 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -68.07 -64.53 0.84 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.072 2.549 . . . . 23.140000000000001 107.367 169.846 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.26 51.72 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 104.656 -3.378 . . . . 19.739999999999998 104.656 170.016 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.515 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 78.7 tttt -97.13 125.64 41.76 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.161 2.984 . . . . 21.93 108.757 161.019 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -99.19 127.68 45.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.063 -2.273 . . . . 12.33 106.0 176.662 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.55 115.77 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 128.741 2.816 . . . . 17.079999999999998 111.297 161.576 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.3 m -84.8 124.74 31.91 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 119.327 0.967 . . . . 16.300000000000001 112.005 165.037 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.18 128.43 56.36 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 126.969 2.668 . . . . 15.880000000000001 104.733 -175.645 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -99.77 110.92 23.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.577 -2.749 . . . . 28.899999999999999 103.577 178.843 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.4 155.55 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 117.863 -1.065 . . . . 12.050000000000001 110.264 -169.477 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -104.08 139.23 19.9 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 115.933 -1.984 . . . . 18.170000000000002 112.153 171.166 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.66 -15.56 21.58 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 126.165 3.237 . . . . 8.1600000000000001 111.369 -158.484 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.3 p -82.45 -1.8 51.3 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 121.121 3.749 . . . . 11.130000000000001 121.121 -177.414 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -89.1 174.2 8.01 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.922 3.689 . . . . 18.030000000000001 110.384 -179.036 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.4 p -91.51 157.43 17.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.482 -3.261 . . . . 10.220000000000001 113.843 -173.671 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.427 HD11 ' HB3' ' A' ' 50' ' ' LEU . 24.7 mt -73.89 -31.21 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.056 -2.572 . . . . 12.300000000000001 104.056 172.96 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -40.23 -48.74 2.63 Favored 'General case' 0 N--CA 1.43 -1.429 2 O-C-N 114.13 -5.356 . . . . 36.509999999999998 110.656 164.982 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.306 8.8 t-20 -61.73 -41.82 98.15 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.026 2.93 . . . . 25.66 112.956 177.744 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -59.35 -45.19 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 125.436 1.495 . . . . 8.1199999999999992 111.352 174.976 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -68.91 -40.63 78.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.686 3.194 . . . . 15.470000000000001 109.315 -179.087 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.32 -26.3 68.42 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.508 3.123 . . . . 11.449999999999999 111.886 176.493 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -72.18 -37.68 69.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.269 1.85 . . . . 24.98 111.594 172.496 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mt -76.49 -29.03 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 125.809 1.644 . . . . 9.4600000000000009 109.879 178.43 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.27 -50.34 74.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.885 -3.01 . . . . 14.76 110.641 165.873 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.09 -68.27 0.26 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 129.158 2.983 . . . . 26.289999999999999 112.712 179.974 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -71.68 -62.87 1.26 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 114.719 -2.562 . . . . 30.059999999999999 115.197 -176.541 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.515 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 53.2 mm-40 -72.1 -51.18 22.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.403 2.049 . . . . 25.190000000000001 113.549 -175.079 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.74 38.83 1.52 Allowed Glycine 0 N--CA 1.43 -1.718 0 O-C-N 116.716 -3.74 . . . . 7.4100000000000001 113.934 -179.509 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.272 78.9 mt -124.92 124.51 25.47 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 103.311 -2.848 . . . . 9.4900000000000002 103.311 -174.249 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -76.84 175.82 10.9 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-O 114.904 -2.207 . . . . 11.42 110.789 -171.38 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.85 -32.84 5.29 Favored 'Trans proline' 0 C--N 1.299 -2.027 1 C-N-CA 126.53 4.82 . . . . 12.0 110.759 171.925 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.272 11.6 t70 -58.26 -42.55 86.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.401 1.08 . . . . 35.549999999999997 113.809 176.322 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -79.54 -38.71 33.59 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.248 2.219 . . . . 20.52 112.314 -178.66 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -80.08 167.28 20.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 127.342 3.448 . . . . 7.1299999999999999 118.71 -175.31 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -131.43 121.8 25.18 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.612 -3.18 . . . . 36.390000000000001 111.975 162.086 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.3 tp -108.66 119.0 38.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.24 -1.393 . . . . 9.5500000000000007 107.24 -170.469 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.1 mt -118.31 135.67 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.959 -2.963 . . . . 13.9 113.128 -169.68 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -118.7 109.54 16.22 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.879 -3.013 . . . . 6.8600000000000003 106.323 167.798 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.4 -92.85 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.385 3.074 . . . . 11.15 113.566 -172.371 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.04 -37.89 8.16 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 119.486 -2.009 . . . . 13.93 116.611 175.545 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -107.71 146.56 31.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 124.794 0.938 . . . . 23.920000000000002 112.546 -159.742 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -81.02 138.37 36.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.43 2.538 . . . . 23.23 112.699 171.9 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.427 ' HB3' HD11 ' A' ' 23' ' ' ILE . 43.2 mt -89.78 114.83 26.61 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.757 -3.715 . . . . 9.1099999999999994 112.306 -175.914 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.85 143.98 27.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.26 -2.15 . . . . 33.439999999999998 114.578 -173.084 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.8 -49.86 72.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.61 3.164 . . . . 28.370000000000001 112.447 -165.875 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.12 -4.63 77.78 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 118.325 2.09 . . . . 15.0 118.325 -163.303 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -84.06 178.94 7.64 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.776 3.179 . . . . 25.5 113.854 166.105 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.5 p -110.83 175.84 5.27 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.732 -3.105 . . . . 11.949999999999999 104.651 -177.667 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.49 -26.9 32.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.152 2.181 . . . . 10.17 105.374 -178.589 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.1 p -65.99 -36.33 83.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 131.461 3.905 . . . . 13.59 113.147 174.264 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.4 -52.84 63.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 126.972 2.67 . . . . 11.699999999999999 116.001 171.048 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -67.56 -17.49 64.66 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.767 1.627 . . . . 12.949999999999999 111.357 176.822 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 59.51 55.08 4.27 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.545 2.338 . . . . 25.449999999999999 111.754 -170.405 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -86.79 116.96 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 104.038 -2.579 . . . . 14.6 104.038 -178.417 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -98.3 159.69 14.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 126.925 2.641 . . . . 33.229999999999997 110.011 -178.212 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -52.18 131.98 32.97 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.878 2.071 . . . . 25.969999999999999 112.909 -178.051 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 73.09 32.57 1.29 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.716 -2.947 . . . . 32.609999999999999 111.938 176.666 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -75.66 141.49 42.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.843 1.783 . . . . 10.56 110.636 169.48 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -86.54 120.48 27.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.505 -2.035 . . . . 5.3300000000000001 105.505 171.63 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.86 146.73 38.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.754 1.622 . . . . 11.66 106.827 175.959 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -117.73 140.57 49.49 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.422 2.058 . . . . 16.300000000000001 108.134 -172.177 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 tp -119.68 135.69 54.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.024 -2.954 . . . . 9.9600000000000009 103.024 -174.534 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.564 HG12 ' H ' ' A' ' 71' ' ' LEU . 2.3 t -135.03 -176.6 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.381 2.672 . . . . 9.7599999999999998 105.283 174.805 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.564 ' H ' HG12 ' A' ' 70' ' ' VAL . 7.2 mt -92.11 167.49 12.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.792 2.037 . . . . 19.57 108.973 169.111 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -105.2 115.08 29.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.699 1.714 . . . . 35.079999999999998 108.716 171.108 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.4 tp -67.02 -61.31 2.0 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.508 -2.187 . . . . 32.310000000000002 112.44 178.9 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -146.84 -104.13 0.09 Allowed 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 122.825 2.557 . . . . 42.75 108.182 172.313 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.05 157.81 28.34 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 108.952 -1.659 . . . . 36.310000000000002 108.952 171.544 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.729 0 CA-C-O 117.179 -1.901 . . . . 36.270000000000003 112.833 -169.624 . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tmm? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 112.485 0.55 . . . . 17.170000000000002 112.485 . . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -85.83 123.47 31.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.206 1.402 . . . . 21.890000000000001 108.066 -178.659 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.6 pt -106.29 161.01 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.871 -2.393 . . . . 10.83 109.769 151.855 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -114.23 131.81 56.35 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.851 -3.389 . . . . 10.609999999999999 101.851 -178.765 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.95 102.83 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 101.867 -3.383 . . . . 9.1300000000000008 101.867 -178.079 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -94.89 128.5 41.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.174 2.19 . . . . 20.550000000000001 116.403 -173.206 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.267 18.9 p -89.41 173.17 8.51 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.121 -2.862 . . . . 11.779999999999999 116.407 -177.012 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.95 -48.56 15.99 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.118 -2.239 . . . . 19.309999999999999 109.004 174.502 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -67.69 -46.98 70.72 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.929 3.291 . . . . 23.140000000000001 107.188 -168.54 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.63 24.58 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 116.074 -2.514 . . . . 19.739999999999998 118.799 173.083 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -110.89 124.91 53.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 120.082 1.941 . . . . 21.93 107.243 -174.489 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 m -105.53 114.1 28.06 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.729 -1.857 . . . . 12.33 109.846 171.745 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -95.34 122.1 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 103.698 -2.705 . . . . 17.079999999999998 103.698 -165.735 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -91.48 110.92 22.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.985 -2.969 . . . . 16.300000000000001 102.985 175.244 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.5 mt -106.26 136.77 45.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.986 1.314 . . . . 15.880000000000001 108.404 169.126 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -93.58 116.02 28.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.342 2.02 . . . . 28.899999999999999 108.938 169.275 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.85 167.57 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.529 3.132 . . . . 12.050000000000001 110.694 175.487 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -105.64 158.44 32.31 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 114.485 -2.674 . . . . 18.170000000000002 110.878 157.68 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -74.38 -25.12 13.54 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 126.174 3.241 . . . . 8.1600000000000001 117.478 -172.453 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -75.24 -11.4 60.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 131.223 3.809 . . . . 11.130000000000001 115.788 163.629 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -72.46 158.24 36.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.998 2.333 . . . . 18.030000000000001 113.522 178.382 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -92.98 161.41 14.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.244 -3.41 . . . . 10.220000000000001 112.478 -173.926 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.7 mt -82.82 -8.75 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 126.661 2.476 . . . . 12.300000000000001 111.224 -179.398 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -57.7 -54.91 41.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.941 -2.349 . . . . 36.509999999999998 111.313 166.421 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -61.27 -16.08 41.85 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 116.291 -4.005 . . . . 25.66 115.012 168.776 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -74.64 -43.93 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 CA-C-N 126.381 4.173 . . . . 8.1199999999999992 108.302 167.906 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -67.15 -32.29 73.3 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.311 1.869 . . . . 15.470000000000001 114.79 175.51 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.98 -25.14 58.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.108 1.892 . . . . 11.449999999999999 116.108 172.176 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -74.08 -30.58 62.44 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.493 1.497 . . . . 24.98 107.052 178.233 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.9 mm -69.9 -34.67 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 118.368 -0.825 . . . . 9.4600000000000009 111.857 173.639 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -65.13 -43.49 91.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.802 2.841 . . . . 14.76 109.741 173.466 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.02 -56.77 14.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 117.49 2.404 . . . . 26.289999999999999 117.49 176.311 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -56.53 -65.16 0.66 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.875 3.27 . . . . 30.059999999999999 112.235 173.322 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -101.17 -36.03 9.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.682 -1.145 . . . . 25.190000000000001 113.133 -159.673 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.08 4.72 31.08 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 118.231 -2.793 . . . . 7.4100000000000001 114.078 -177.402 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 mt -88.34 112.25 48.6 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-O 116.831 -1.557 . . . . 9.4900000000000002 109.121 -173.02 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -81.74 -176.7 3.17 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 122.568 1.953 . . . . 11.42 114.472 -171.819 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -74.4 -16.31 21.91 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 122.412 2.074 . . . . 12.0 115.764 -178.924 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.42 -24.08 42.77 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.88 2.752 . . . . 35.549999999999997 116.614 -175.904 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -98.33 -35.52 10.29 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.501 -2.136 . . . . 20.52 110.057 -168.587 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -91.89 166.26 12.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.635 -1.29 . . . . 7.1299999999999999 108.515 -172.333 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.2 139.02 37.39 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 131.778 4.031 . . . . 36.390000000000001 104.102 165.632 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.1 mt -104.2 132.9 49.96 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.647 1.979 . . . . 9.5500000000000007 106.401 178.069 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.02 142.07 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.809 -1.807 . . . . 13.9 107.846 177.514 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -148.83 108.54 4.02 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.308 -2.12 . . . . 6.8600000000000003 108.484 -175.066 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 57.05 -114.31 0.81 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 120.541 3.534 . . . . 11.15 120.541 -158.54 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.34 -36.53 20.39 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.605 -1.31 . . . . 13.93 114.607 -178.901 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -116.06 170.49 8.46 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 120.729 2.264 . . . . 23.920000000000002 114.499 -162.54 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.19 146.54 24.99 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 102.799 -3.037 . . . . 23.23 102.799 -176.676 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.8 mt -99.86 128.79 45.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.489 -2.782 . . . . 9.1099999999999994 103.489 -166.397 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -75.3 153.81 37.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.736 1.614 . . . . 33.439999999999998 113.868 168.76 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.55 -61.69 1.73 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.782 -3.699 . . . . 28.370000000000001 108.56 -162.671 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.93 59.2 3.21 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 122.297 2.317 . . . . 15.0 111.147 -169.438 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -140.72 153.07 45.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.472 2.309 . . . . 25.5 106.987 -177.354 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.25 46.7 p -82.94 154.53 24.5 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.674 -2.516 . . . . 11.949999999999999 113.174 -173.151 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.462 HD22 HD12 ' A' ' 61' ' ' ILE . 17.5 mt -63.88 -39.52 94.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.933 -2.354 . . . . 10.17 111.642 165.503 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 p -54.59 -37.5 65.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.408 2.744 . . . . 13.59 118.408 172.578 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.37 -50.35 53.76 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.287 -5.258 . . . . 11.699999999999999 113.941 174.745 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -69.88 -14.09 62.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.295 2.638 . . . . 12.949999999999999 114.03 -177.909 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.492 27.6 m-20 75.23 41.15 0.3 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 116.963 2.209 . . . . 25.449999999999999 116.963 -176.289 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.462 HD12 HD22 ' A' ' 56' ' ' LEU . 71.7 mt -83.0 116.12 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 118.21 -2.806 . . . . 14.6 107.77 177.522 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -97.95 167.46 10.9 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.615 -0.721 . . . . 33.229999999999997 110.012 -176.65 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -70.23 144.65 51.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 120.874 1.67 . . . . 25.969999999999999 112.605 -174.86 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 67.16 21.5 10.04 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.661 3.6 . . . . 32.609999999999999 112.134 176.81 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 t -97.67 151.61 19.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.896 -2.378 . . . . 10.56 108.682 -178.081 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.8 m -101.47 111.3 23.5 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.244 2.618 . . . . 5.3300000000000001 113.07 -168.502 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mp -90.88 145.89 24.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.293 2.637 . . . . 11.66 106.206 164.065 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -97.26 132.46 42.98 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 119.824 -0.75 . . . . 16.300000000000001 112.583 171.48 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 tp -95.03 121.01 36.22 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.432 -1.692 . . . . 9.9600000000000009 106.432 166.732 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.76 153.77 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 114.959 -2.448 . . . . 9.7599999999999998 105.596 178.699 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.6 mt -112.18 176.05 5.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 124.692 3.406 . . . . 19.57 107.465 175.541 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -107.93 143.12 37.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.909 2.929 . . . . 35.079999999999998 118.909 -174.398 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.1 tp -84.15 -60.88 1.96 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 117.042 -1.863 . . . . 32.310000000000002 108.267 -173.854 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -96.61 -38.39 9.97 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.757 1.223 . . . . 42.75 109.191 -171.181 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.87 -51.13 0.51 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 106.522 -2.631 . . . . 36.310000000000002 106.522 -179.448 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.781 0 O-C-N 119.118 -2.401 . . . . 36.270000000000003 108.94 -175.358 . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttp . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 123.704 1.716 . . . . 17.170000000000002 107.499 . . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -99.98 116.61 32.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.613 2.765 . . . . 21.890000000000001 111.036 175.776 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -124.83 167.69 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 106.79 -1.559 . . . . 10.83 106.79 178.884 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -122.48 115.82 22.88 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.663 -1.273 . . . . 10.609999999999999 110.823 -169.364 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.05 123.48 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 121.295 -0.878 . . . . 9.1300000000000008 109.128 171.351 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.493 ' HD2' HG23 ' A' ' 66' ' ' THR . 85.2 mttt -117.38 137.17 52.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.171 1.788 . . . . 20.550000000000001 108.846 -175.907 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -102.94 -176.77 3.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.488 1.742 . . . . 11.779999999999999 109.035 -175.16 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.266 95.9 mt -69.93 -27.1 64.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.805 2.442 . . . . 19.309999999999999 116.698 -172.091 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -96.2 -89.08 0.26 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.451 2.3 . . . . 23.140000000000001 111.079 -177.679 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.74 36.85 0.47 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.811 -3.681 . . . . 19.739999999999998 111.321 168.765 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -97.04 137.96 35.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 116.732 -1.987 . . . . 21.93 109.721 179.423 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.3 m -123.26 121.97 37.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.36 1.552 . . . . 12.33 107.103 171.144 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.9 mt -101.38 119.35 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 103.382 -2.822 . . . . 17.079999999999998 103.382 179.96 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -89.36 105.34 17.73 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.237 1.494 . . . . 16.300000000000001 108.874 165.241 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.7 mt -92.13 146.12 23.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.602 3.572 . . . . 15.880000000000001 106.076 -178.32 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -95.2 108.56 20.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.284 -2.689 . . . . 28.899999999999999 112.33 171.272 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.86 -177.28 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.439 -1.689 . . . . 12.050000000000001 106.439 -176.183 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -132.63 159.9 70.58 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 119.157 -2.215 . . . . 18.170000000000002 107.279 164.547 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HB2' ' HB3' ' A' ' 57' ' ' SER . 19.4 Cg_endo -77.48 -16.03 15.33 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 O-C-N 116.417 -2.464 . . . . 8.1600000000000001 114.691 -168.131 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 m -90.11 9.09 29.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 116.425 -2.11 . . . . 11.130000000000001 114.665 177.605 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -86.9 162.54 17.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.755 2.693 . . . . 18.030000000000001 113.703 165.048 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -99.56 169.79 9.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.84 2.733 . . . . 10.220000000000001 112.622 -170.7 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.372 36.8 mm -52.89 -32.72 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 116.164 1.913 . . . . 12.300000000000001 116.164 171.78 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.24 -28.65 69.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.933 -3.604 . . . . 36.509999999999998 116.263 170.769 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -75.79 -20.21 58.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.995 -2.315 . . . . 25.66 113.825 171.423 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.7 t -83.6 -45.33 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 116.694 -1.622 . . . . 8.1199999999999992 107.392 -179.491 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP . 34.7 mtmt -63.58 -31.58 72.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.656 2.383 . . . . 15.470000000000001 110.94 173.682 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.6 -25.05 68.05 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 117.525 -1.67 . . . . 11.449999999999999 114.251 175.181 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -90.29 -15.24 31.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 116.702 -3.749 . . . . 24.98 115.768 173.3 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mm -80.44 -24.6 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 126.159 2.162 . . . . 9.4600000000000009 110.59 167.88 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -81.82 -26.77 34.06 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.524 1.93 . . . . 14.76 108.478 -177.537 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.89 -68.9 0.38 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.566 -3.208 . . . . 26.289999999999999 111.497 164.542 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -73.64 -49.36 26.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.11 1.893 . . . . 30.059999999999999 116.11 -169.375 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -86.81 -47.82 8.74 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.666 2.03 . . . . 25.190000000000001 113.396 178.95 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.06 59.11 1.51 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.288 3.804 . . . . 7.4100000000000001 107.152 169.33 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.461 HD13 HD23 ' A' ' 71' ' ' LEU . 15.9 mm -102.41 140.0 20.74 Favored Pre-proline 0 N--CA 1.43 -1.469 0 O-C-N 129.099 3.47 . . . . 9.4900000000000002 104.004 177.79 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -62.07 161.22 26.99 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 O-C-N 114.304 -3.577 . . . . 11.42 115.953 173.582 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -72.66 -27.49 15.14 Favored 'Trans proline' 0 N--CA 1.434 -1.987 1 CA-C-N 128.85 4.196 . . . . 12.0 110.682 -168.408 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -87.13 -24.08 24.64 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.669 2.84 . . . . 35.549999999999997 118.669 179.425 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -66.9 -42.06 86.08 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.828 2.529 . . . . 20.52 117.828 172.624 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -72.64 131.74 42.82 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.117 3.377 . . . . 7.1299999999999999 120.117 176.155 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -131.9 104.96 7.14 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.685 1.994 . . . . 36.390000000000001 108.624 -170.082 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.1 mt -83.84 112.43 20.11 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 115.22 -4.675 . . . . 9.5500000000000007 114.293 174.84 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.7 mt -99.89 115.81 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 114.041 -1.436 . . . . 13.9 111.585 175.402 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -108.21 120.65 42.96 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.06 -1.65 . . . . 6.8600000000000003 106.55 163.436 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.52 . . 69.21 -111.16 0.09 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.627 -2.546 . . . . 11.15 111.65 -176.77 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.69 6.15 12.6 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 116.507 -2.758 . . . . 13.93 108.58 172.027 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -86.39 139.22 31.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.468 -2.783 . . . . 23.920000000000002 111.702 -158.15 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -89.41 125.16 35.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 102.998 -2.964 . . . . 23.23 102.998 166.132 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 mt -94.33 144.18 25.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.544 2.116 . . . . 9.1099999999999994 110.447 -167.806 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -90.68 130.46 36.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.622 -2.549 . . . . 33.439999999999998 116.402 172.686 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.484 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 9.8 m-20 -36.54 -51.1 0.82 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.992 4.517 . . . . 28.370000000000001 119.612 176.074 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.29 20.9 36.58 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 114.23 -1.35 . . . . 15.0 113.773 -169.341 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mtt-85 -93.3 163.91 13.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.146 -2.973 . . . . 25.5 110.468 160.872 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.0 p -104.74 158.16 16.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.037 -1.664 . . . . 11.949999999999999 108.276 -173.978 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 17.2 mt -56.06 -35.88 67.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.728 2.68 . . . . 10.17 115.522 -179.648 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 19' ' ' PRO . 44.7 p -63.04 -48.2 79.75 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 136.82 6.048 . . . . 13.59 113.653 169.663 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -60.35 -44.78 95.24 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.579 1.952 . . . . 11.699999999999999 112.896 176.803 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -74.7 -10.41 59.49 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 116.239 -4.038 . . . . 12.949999999999999 114.323 173.96 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.394 60.5 m-80 71.33 36.08 1.41 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.93 2.492 . . . . 25.449999999999999 112.313 178.803 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.9 mt -87.87 86.18 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 125.604 1.815 . . . . 14.6 109.52 -175.776 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -77.04 -178.1 4.81 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 125.708 1.88 . . . . 33.229999999999997 114.5 -173.408 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -72.29 135.72 46.05 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.797 1.639 . . . . 25.969999999999999 110.463 -178.69 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.306 47.6 mt-10 61.91 35.21 16.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.241 1.02 . . . . 32.609999999999999 112.377 -176.304 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.288 0.2 OUTLIER -105.47 147.23 28.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.466 -2.152 . . . . 10.56 109.587 172.224 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.493 HG23 ' HD2' ' A' ' 6' ' ' LYS . 61.9 m -122.65 120.42 33.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.728 2.204 . . . . 5.3300000000000001 112.586 -157.198 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -101.89 130.23 48.33 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 130.337 3.455 . . . . 11.66 109.959 -177.393 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -102.7 104.23 14.54 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.348 -3.97 . . . . 16.300000000000001 104.953 -174.208 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.5 tp -80.05 119.37 22.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.479 -2.045 . . . . 9.9600000000000009 105.479 172.957 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.06 141.01 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 126.223 2.202 . . . . 9.7599999999999998 108.361 170.739 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.461 HD23 HD13 ' A' ' 36' ' ' ILE . 82.5 mt -95.72 146.8 24.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 112.99 0.737 . . . . 19.57 112.99 177.395 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -97.25 158.01 15.67 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.706 -1.59 . . . . 35.079999999999998 106.706 179.174 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 mt -67.96 -61.94 1.64 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.916 -2.99 . . . . 32.310000000000002 115.807 166.535 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.8 ttt-85 -83.25 -36.94 24.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.904 -1.748 . . . . 42.75 114.682 -169.973 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.48 51.44 3.29 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 119.541 -1.975 . . . . 36.310000000000002 117.089 -177.694 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.715 0 C-N-CA 117.364 -2.351 . . . . 36.270000000000003 112.36 -176.876 . . . . . . . . 0 0 . 1 . 101 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 115.456 1.65 . . . . 17.170000000000002 115.456 . . . . . . . . . 0 0 . 1 . 101 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -80.55 118.88 22.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.881 -3.012 . . . . 21.890000000000001 118.336 -179.924 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 pt -100.8 165.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 126.957 2.103 . . . . 10.83 111.819 168.937 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.294 15.8 m-30 -123.15 112.6 17.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.838 -2.414 . . . . 10.609999999999999 112.656 -176.016 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.3 t -90.91 105.38 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 117.972 -2.955 . . . . 9.1300000000000008 117.206 170.46 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -88.99 137.11 32.62 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 124.208 1.956 . . . . 20.550000000000001 115.343 -175.591 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.1 p -87.15 178.41 6.9 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 113.314 -5.866 . . . . 11.779999999999999 110.648 -176.183 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tp -58.63 -50.02 75.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.473 -3.892 . . . . 19.309999999999999 114.681 173.006 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -77.78 -38.63 46.25 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 116.211 -4.056 . . . . 23.140000000000001 112.99 -177.412 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.76 52.18 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.999 -1.688 . . . . 19.739999999999998 115.485 169.589 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -111.3 126.74 55.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.906 1.336 . . . . 21.93 107.924 179.331 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -86.06 116.08 24.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.573 -2.58 . . . . 12.33 111.789 169.936 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.4 mt -92.97 117.27 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 112.969 0.729 . . . . 17.079999999999998 112.969 168.254 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.0 m -88.11 122.26 31.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 119.118 -2.238 . . . . 16.300000000000001 109.936 177.865 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.411 HD21 ' HB3' ' A' ' 29' ' ' LYS . 64.8 mt -115.36 131.13 57.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.602 2.62 . . . . 15.880000000000001 111.52 172.553 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -87.75 103.25 15.44 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.504 2.722 . . . . 28.899999999999999 105.146 -177.068 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.433 HG13 ' HE3' ' A' ' 29' ' ' LYS . 28.4 m -119.33 167.8 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 105.662 -1.977 . . . . 12.050000000000001 105.662 -178.321 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -123.56 147.05 51.81 Favored Pre-proline 0 N--CA 1.431 -1.402 0 C-N-CA 126.471 1.908 . . . . 18.170000000000002 106.407 176.609 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -67.52 -22.5 44.71 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 O-C-N 115.796 -2.791 . . . . 8.1600000000000001 117.245 -158.094 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 m -94.53 33.85 1.38 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 123.934 3.061 . . . . 11.130000000000001 113.612 171.34 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -84.92 139.14 32.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 127.193 3.378 . . . . 18.030000000000001 113.243 162.665 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 p -80.05 163.07 24.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.651 -2.068 . . . . 10.220000000000001 112.614 176.275 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.91 -26.04 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.712 -1.868 . . . . 12.300000000000001 112.321 -179.624 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.398 15.2 pt-20 -60.58 -28.38 68.43 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.687 2.106 . . . . 36.509999999999998 116.687 168.959 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.293 5.7 t-20 -72.83 -37.92 67.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.955 3.302 . . . . 25.66 111.152 173.719 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 39.6 t -52.34 -53.93 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 129.213 3.005 . . . . 8.1199999999999992 111.59 173.55 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -69.76 -11.01 60.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.728 3.211 . . . . 15.470000000000001 112.184 -179.303 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.44 -44.7 70.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 121.423 1.919 . . . . 11.449999999999999 107.623 174.074 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' HE3' HG13 ' A' ' 17' ' ' VAL . 64.0 mttm -76.0 -37.81 58.07 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.346 2.659 . . . . 24.98 106.023 -168.247 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.315 8.8 mm -57.37 -35.51 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 118.594 2.813 . . . . 9.4600000000000009 118.594 171.233 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -71.46 -40.4 70.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.473 2.709 . . . . 14.76 114.895 167.339 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -60.3 -67.26 0.41 Allowed 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 128.23 3.871 . . . . 26.289999999999999 111.495 169.687 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -72.62 -50.97 21.69 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 110.502 -7.624 . . . . 30.059999999999999 112.48 -160.629 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -97.1 -71.64 0.67 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.112 1.911 . . . . 25.190000000000001 111.479 175.104 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.41 26.01 0.5 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 116.276 -2.869 . . . . 7.4100000000000001 120.178 -175.662 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.53 133.5 28.09 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 115.323 -2.275 . . . . 9.4900000000000002 107.72 -178.519 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -73.49 160.09 45.07 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 126.566 3.381 . . . . 11.42 114.639 179.525 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.5 -16.06 9.53 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 123.552 2.835 . . . . 12.0 110.521 -162.266 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -82.03 -37.61 26.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 125.056 3.571 . . . . 35.549999999999997 114.474 -179.899 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -69.49 -27.57 65.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.636 2.458 . . . . 20.52 117.636 -178.139 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -87.65 139.24 30.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.33 -1.359 . . . . 7.1299999999999999 107.33 -174.318 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -106.63 142.59 36.03 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 105.007 -2.22 . . . . 36.390000000000001 105.007 165.526 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.4 mt -118.96 108.85 15.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.704 -3.122 . . . . 9.5500000000000007 112.879 171.119 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.56 ' HB ' ' HD1' ' A' ' 68' ' ' HIS . 40.5 mt -92.82 137.86 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.441 -1.689 . . . . 13.9 106.441 -177.363 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -110.38 118.95 37.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.304 2.241 . . . . 6.8600000000000003 105.576 167.125 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.18 -96.63 0.05 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.919 1.288 . . . . 11.15 111.899 -167.277 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.86 5.55 6.13 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 117.36 -3.337 . . . . 13.93 112.065 172.769 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -82.03 152.65 26.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.609 -2.701 . . . . 23.920000000000002 110.487 -168.079 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -92.02 124.62 36.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.94 -1.505 . . . . 23.23 112.361 169.098 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.2 mt -104.72 168.7 8.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.693 1.246 . . . . 9.1099999999999994 112.467 -175.173 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -132.06 166.44 21.74 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.643 1.977 . . . . 33.439999999999998 107.374 -178.403 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -93.9 -42.86 8.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.913 -1.742 . . . . 28.370000000000001 111.104 -149.305 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.83 44.96 1.44 Allowed Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 118.462 -1.828 . . . . 15.0 115.193 -179.042 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -120.82 159.12 26.12 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.486 2.314 . . . . 25.5 107.748 173.293 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -97.98 160.31 14.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.384 1.564 . . . . 11.949999999999999 114.506 -169.461 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.52 -38.83 82.03 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.902 -1.749 . . . . 10.17 112.496 168.179 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 p -52.73 -45.6 67.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 118.498 2.777 . . . . 13.59 118.498 171.281 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.47 -41.68 96.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 114.549 -2.644 . . . . 11.699999999999999 114.92 176.436 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -78.91 -10.13 59.72 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.41 2.368 . . . . 12.949999999999999 115.13 172.966 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.422 1.0 OUTLIER 71.82 42.7 0.61 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.776 1.769 . . . . 25.449999999999999 115.776 -178.832 . . . . . . . . 3 3 . 1 . 101 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.5 mt -88.11 111.84 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 1 O-C-N 129.418 4.199 . . . . 14.6 108.756 -177.4 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.319 40.1 mt-30 -93.1 -175.55 3.89 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.876 -3.64 . . . . 33.229999999999997 110.671 -177.938 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttt -69.69 147.36 50.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.053 -1.655 . . . . 25.969999999999999 112.722 171.571 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 56.26 41.57 29.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.652 2.381 . . . . 32.609999999999999 116.786 -168.122 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.6 m -104.34 145.61 30.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 125.023 1.452 . . . . 10.56 107.441 178.82 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -105.81 124.02 48.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.593 2.14 . . . . 5.3300000000000001 106.221 -165.578 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.3 mt -104.34 143.03 33.53 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.108 -3.495 . . . . 11.66 106.751 168.499 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.56 ' HD1' ' HB ' ' A' ' 44' ' ' ILE . 6.5 m80 -98.84 111.33 23.75 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.264 1.95 . . . . 16.300000000000001 116.264 -179.524 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.88 108.36 5.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.251 -3.406 . . . . 9.9600000000000009 109.249 179.747 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 t -117.04 149.32 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 104.818 -2.29 . . . . 9.7599999999999998 104.818 177.206 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 tp -95.83 135.23 37.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.833 2.16 . . . . 19.57 116.833 171.212 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -87.65 155.58 19.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.732 3.145 . . . . 35.079999999999998 109.433 -179.707 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.8 tp -86.81 -62.47 1.5 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.566 2.439 . . . . 32.310000000000002 111.716 -176.163 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -77.32 -43.85 31.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.513 1.052 . . . . 42.75 112.054 177.338 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.79 17.91 59.07 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-O 116.936 -2.036 . . . . 36.310000000000002 115.685 -175.496 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.775 0 CA-C-N 123.226 3.513 . . . . 36.270000000000003 104.872 177.737 . . . . . . . . 0 0 . 1 . 102 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 124.191 1.948 . . . . 17.170000000000002 111.683 . . . . . . . . . 0 0 . 1 . 102 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -76.85 119.51 20.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.397 -2.69 . . . . 21.890000000000001 110.334 -178.775 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.4 pt -112.06 154.66 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.614 -1.254 . . . . 10.83 107.614 169.548 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.24 133.02 52.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 126.568 3.08 . . . . 10.609999999999999 108.643 175.152 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -110.91 117.81 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 126.812 2.045 . . . . 9.1300000000000008 111.17 165.437 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.22 135.57 55.11 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.557 -1.339 . . . . 20.550000000000001 108.289 -170.752 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.8 p -95.32 179.81 5.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.803 1.287 . . . . 11.779999999999999 109.421 -163.501 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 tp -71.99 -46.46 57.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.111 1.91 . . . . 19.309999999999999 114.851 173.618 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -73.21 -40.14 64.98 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.259 -2.15 . . . . 23.140000000000001 115.546 175.842 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.17 64.65 0.15 Allowed Glycine 0 N--CA 1.431 -1.691 0 CA-C-O 122.897 1.276 . . . . 19.739999999999998 111.715 176.254 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -123.99 136.48 54.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.708 2.194 . . . . 21.93 108.016 159.263 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -105.01 108.22 19.62 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.973 -2.329 . . . . 12.33 112.69 168.451 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.02 126.21 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.041 -1.662 . . . . 17.079999999999998 109.054 178.64 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -96.91 111.63 23.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.875 1.065 . . . . 16.300000000000001 113.875 179.465 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.3 mt -96.59 138.57 33.97 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.119 -2.863 . . . . 15.880000000000001 110.498 -176.025 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -107.28 73.35 0.92 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.389 2.995 . . . . 28.899999999999999 110.915 -175.394 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -102.46 169.47 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 O-C-N 115.792 -4.318 . . . . 12.050000000000001 106.798 -175.143 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -95.87 159.09 33.13 Favored Pre-proline 0 N--CA 1.43 -1.453 1 O-C-N 130.002 4.564 . . . . 18.170000000000002 106.871 174.647 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.25 -26.68 20.64 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 O-C-N 126.268 2.72 . . . . 8.1600000000000001 110.964 172.645 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 p -72.64 -7.09 48.56 Favored 'General case' 0 N--CA 1.43 -1.453 1 CA-C-N 127.237 4.562 . . . . 11.130000000000001 112.742 175.915 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -77.67 154.14 32.43 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 123.196 2.725 . . . . 18.030000000000001 112.724 -175.19 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.4 p -89.34 151.33 22.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.302 3.041 . . . . 10.220000000000001 110.95 178.976 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.25 39.7 mm -56.97 -30.26 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.308 2.643 . . . . 12.300000000000001 114.198 178.691 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -49.25 -45.56 44.9 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.974 -2.954 . . . . 36.509999999999998 113.733 166.303 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -68.91 -37.0 78.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 124.249 0.968 . . . . 25.66 111.266 177.987 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.62 -40.31 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 113.741 1.015 . . . . 8.1199999999999992 113.741 -179.678 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HZ2' ' CG ' ' A' ' 52' ' ' ASP 0.26 49.8 mtpt -59.1 -48.88 79.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.544 2.737 . . . . 15.470000000000001 112.823 174.521 . . . . . . . . 3 3 . 1 . 102 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.87 -32.33 63.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.867 3.267 . . . . 11.449999999999999 111.094 172.581 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -74.27 -39.82 62.72 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 124.005 3.093 . . . . 24.98 109.455 -177.374 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.326 81.8 mt -59.36 -37.52 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 129.991 3.317 . . . . 9.4600000000000009 112.732 173.928 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -59.91 -54.36 47.08 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.555 1.525 . . . . 14.76 112.9 167.039 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.23 -51.41 68.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.702 1.239 . . . . 26.289999999999999 112.123 -173.723 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -78.17 -69.54 0.55 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.364 2.666 . . . . 30.059999999999999 114.351 179.398 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -87.29 -11.24 50.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.087 2.254 . . . . 25.190000000000001 117.087 -170.34 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.68 20.52 34.09 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 128.151 2.786 . . . . 7.4100000000000001 116.253 160.895 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mm -113.32 125.45 29.65 Favored Pre-proline 0 N--CA 1.43 -1.459 0 O-C-N 120.493 -1.592 . . . . 9.4900000000000002 110.036 -173.164 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.309 53.9 Cg_exo -76.55 167.58 25.29 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-O 115.423 -1.991 . . . . 11.42 116.61 -173.968 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -63.9 -23.5 68.29 Favored 'Trans proline' 0 C--N 1.3 -2.019 1 C-N-CA 126.533 4.822 . . . . 12.0 115.907 -170.445 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -89.89 -21.81 22.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 124.008 3.095 . . . . 35.549999999999997 112.258 177.277 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -75.72 -9.54 58.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.627 -2.606 . . . . 20.52 116.1 -176.893 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -112.1 150.54 30.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.102 2.751 . . . . 7.1299999999999999 114.656 -167.502 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -127.22 93.25 3.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.851 -1.781 . . . . 36.390000000000001 109.357 -176.518 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.401 HD11 ' HG3' ' A' ' 27' ' ' LYS . 52.9 mt -82.17 91.59 6.74 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 113.831 1.049 . . . . 9.5500000000000007 113.831 172.24 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.4 mt -91.07 135.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 118.764 -0.636 . . . . 13.9 110.202 -177.816 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -122.66 112.7 18.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.603 -2.369 . . . . 6.8600000000000003 104.603 179.65 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.86 -108.53 0.44 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.187 -2.196 . . . . 11.15 113.004 -169.721 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.91 -19.66 39.31 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 115.536 -2.813 . . . . 13.93 117.041 167.43 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -105.34 134.08 49.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.791 1.795 . . . . 23.920000000000002 114.414 -165.564 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.45 138.4 47.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.303 2.002 . . . . 23.23 112.327 167.636 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.86 141.78 31.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.222 2.209 . . . . 9.1099999999999994 111.185 -169.099 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -119.62 135.88 54.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.467 1.603 . . . . 33.439999999999998 112.791 -166.453 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.42 ' CG ' ' HZ2' ' A' ' 27' ' ' LYS . 4.1 m-20 -48.86 -58.95 4.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.883 2.873 . . . . 28.370000000000001 111.882 -160.376 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.57 -10.18 75.28 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 122.85 3.9 . . . . 15.0 122.85 -173.843 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.4 mmt180 -79.66 156.59 27.52 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.548 1.969 . . . . 25.5 114.95 174.586 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.9 p -93.88 168.81 10.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.748 3.166 . . . . 11.949999999999999 108.663 -176.001 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mt -72.64 -40.04 66.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.685 -2.052 . . . . 10.17 106.615 -176.198 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -63.79 -28.66 70.02 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 127.853 3.22 . . . . 13.59 116.139 174.114 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.76 -50.38 69.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.177 3.791 . . . . 11.699999999999999 113.406 170.805 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -64.95 -30.73 71.74 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.917 1.821 . . . . 12.949999999999999 115.917 167.144 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 49.4 m-80 82.11 41.27 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.43 1 C-N-CA 131.939 4.096 . . . . 25.449999999999999 110.921 176.908 . . . . . . . . 3 2 . 1 . 102 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -78.82 92.53 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 CA-C-O 129.469 4.461 . . . . 14.6 108.935 170.919 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -84.66 175.65 9.08 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 113.202 -5.936 . . . . 33.229999999999997 111.168 179.707 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -54.03 127.76 27.79 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.278 1.99 . . . . 25.969999999999999 116.173 172.201 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 78.37 29.29 0.44 Allowed 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 132.744 4.418 . . . . 32.609999999999999 117.016 176.877 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.3 m -81.49 149.03 28.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.955 -1.498 . . . . 10.56 106.955 -169.693 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.7 m -94.43 118.01 31.0 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.701 -2.5 . . . . 5.3300000000000001 112.492 177.45 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.0 137.6 40.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.508 -3.245 . . . . 11.66 106.039 168.565 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -98.25 109.97 22.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.067 2.247 . . . . 16.300000000000001 117.067 169.868 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.2 tp -91.43 105.32 17.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.342 1.857 . . . . 9.9600000000000009 115.713 -179.944 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -109.32 162.68 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 101.81 -3.404 . . . . 9.7599999999999998 101.81 178.412 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -116.39 145.68 43.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.267 2.227 . . . . 19.57 112.411 168.78 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -68.34 127.56 33.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.63 2.085 . . . . 35.079999999999998 116.63 159.804 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.52 -50.44 67.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.53 -1.981 . . . . 32.310000000000002 111.049 171.822 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 -70.45 0.8 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.353 1.061 . . . . 42.75 109.135 -176.547 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.91 -144.34 4.13 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 105.513 -3.035 . . . . 36.310000000000002 105.513 -178.232 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.74 0 O-C-N 118.533 -2.745 . . . . 36.270000000000003 111.819 -162.825 . . . . . . . . 0 0 . 1 . 103 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 123.628 1.68 . . . . 17.170000000000002 108.738 . . . . . . . . . 0 0 . 1 . 103 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -88.66 126.85 35.49 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 111.47 -2.604 . . . . 21.890000000000001 111.401 -179.68 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.256 20.8 pt -130.9 159.29 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 107.221 -1.4 . . . . 10.83 107.221 168.721 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -106.89 132.92 52.3 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 118.433 -0.794 . . . . 10.609999999999999 109.481 179.414 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.4 t -101.19 112.89 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.219 2.438 . . . . 9.1300000000000008 111.704 160.325 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -95.73 127.17 41.53 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 113.129 -5.982 . . . . 20.550000000000001 112.99 177.274 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -76.87 -177.26 4.28 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.492 -4.505 . . . . 11.779999999999999 118.146 178.494 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 tp -79.53 -21.74 44.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.484 2.564 . . . . 19.309999999999999 113.658 178.849 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.372 0.1 OUTLIER -75.32 -48.23 24.09 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 116.055 -4.153 . . . . 23.140000000000001 108.72 174.219 . . . . . . . . 4 3 . 1 . 103 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.15 20.92 1.11 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 112.749 -2.023 . . . . 19.739999999999998 109.593 172.246 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -78.62 117.83 20.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.354 2.502 . . . . 21.93 110.751 173.581 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -88.26 110.96 21.15 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.693 -3.129 . . . . 12.33 114.241 -178.9 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 mt -99.61 107.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.901 2.08 . . . . 17.079999999999998 110.983 -172.268 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.2 m -71.97 127.29 32.09 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.101 -1.624 . . . . 16.300000000000001 112.835 173.524 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 mt -111.63 151.34 28.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.532 -1.355 . . . . 15.880000000000001 114.313 167.303 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -108.96 99.05 8.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.808 2.043 . . . . 28.899999999999999 111.253 177.325 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.15 166.13 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.188 -3.445 . . . . 12.050000000000001 103.882 -171.801 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -120.0 161.88 36.18 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 118.959 -2.338 . . . . 18.170000000000002 106.348 177.656 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.68 -8.54 8.21 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 127.501 3.715 . . . . 8.1600000000000001 107.73 -155.901 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -76.17 -9.63 58.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 130.153 3.381 . . . . 11.130000000000001 109.136 172.168 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -81.99 141.34 33.34 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.58 2.352 . . . . 18.030000000000001 112.67 -175.316 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 54' ' ' ARG . 35.6 p -88.14 163.15 16.33 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.901 -1.749 . . . . 10.220000000000001 108.59 -171.576 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mm -76.42 -17.6 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 125.936 2.023 . . . . 12.300000000000001 109.081 -172.595 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -64.26 -30.19 71.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.562 -1.961 . . . . 36.509999999999998 116.243 162.259 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -76.17 -36.1 58.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.175 1.39 . . . . 25.66 109.696 -179.887 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.45 -48.74 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 128.865 2.866 . . . . 8.1199999999999992 115.959 172.752 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.02 -35.9 78.08 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.256 -1.831 . . . . 15.470000000000001 114.069 164.728 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.66 -39.25 80.09 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.752 2.978 . . . . 11.449999999999999 115.138 173.671 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -57.28 -42.78 82.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 124.371 3.259 . . . . 24.98 115.814 169.205 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.18 -29.79 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 O-C-N 114.18 -5.325 . . . . 9.4600000000000009 112.625 176.447 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -66.26 -52.7 44.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.603 -2.561 . . . . 14.76 108.504 167.804 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.337 34.1 t70 -51.81 -42.3 62.38 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 114.869 -2.491 . . . . 26.289999999999999 115.053 176.349 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -80.99 -86.06 0.09 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 128.944 3.903 . . . . 30.059999999999999 112.052 -178.151 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -72.51 -33.68 67.08 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.237 1.94 . . . . 25.190000000000001 116.237 -175.275 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.15 39.46 4.53 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.089 -3.507 . . . . 7.4100000000000001 114.218 -175.945 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mm -100.03 113.4 65.21 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 117.391 -3.417 . . . . 9.4900000000000002 110.601 175.849 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -64.85 151.56 85.33 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 124.811 3.674 . . . . 11.42 114.075 -176.49 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.23 -9.87 16.39 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-N 127.013 3.54 . . . . 12.0 114.836 -165.605 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.06 -28.56 61.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.216 2.436 . . . . 35.549999999999997 107.577 178.406 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -84.62 -20.34 31.53 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.198 -2.189 . . . . 20.52 112.018 -174.764 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -93.53 149.52 21.16 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.17 2.891 . . . . 7.1299999999999999 114.094 -172.873 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -141.64 126.31 17.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.324 -3.36 . . . . 36.390000000000001 108.175 167.146 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.83 121.06 43.98 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 110.048 -3.251 . . . . 9.5500000000000007 106.864 -175.556 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.7 mt -113.83 135.19 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 1 N-CA-C 98.916 -4.476 . . . . 13.9 98.916 -171.185 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -115.64 103.41 10.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 127.429 2.292 . . . . 6.8600000000000003 106.479 170.212 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.29 -105.16 0.07 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.154 1.782 . . . . 11.15 114.034 -174.7 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.14 27.29 9.16 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 115.54 -2.811 . . . . 13.93 116.289 170.561 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -147.49 158.97 44.21 Favored 'General case' 0 N--CA 1.43 -1.458 1 CA-C-N 124.363 4.082 . . . . 23.920000000000002 111.872 171.822 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.259 15.8 pt20 -85.31 137.81 32.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.501 1.52 . . . . 23.23 110.784 -175.84 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -83.67 131.05 34.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.218 -1.771 . . . . 9.1099999999999994 106.218 175.043 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -93.97 134.25 36.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.534 1.679 . . . . 33.439999999999998 115.534 -179.081 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.66 -46.52 49.81 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 132.073 4.149 . . . . 28.370000000000001 111.665 -168.859 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.78 -8.79 87.57 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 129.96 3.648 . . . . 15.0 112.148 -167.761 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.415 ' O ' ' HA ' ' A' ' 22' ' ' THR . 31.4 mmt180 -102.7 167.19 10.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.99 -4.241 . . . . 25.5 111.914 -179.522 . . . . . . . . 3 3 . 1 . 103 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.9 p -89.67 170.95 10.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.903 -1.748 . . . . 11.949999999999999 108.296 176.327 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.0 mt -72.53 -30.92 64.89 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.629 3.172 . . . . 10.17 110.662 169.3 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 p -65.8 -30.87 71.57 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 132.488 4.315 . . . . 13.59 112.435 179.393 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.87 -44.58 96.54 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.558 -4.464 . . . . 11.699999999999999 111.261 175.757 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -78.03 -12.62 60.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.43 2.292 . . . . 12.949999999999999 113.017 -177.784 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.439 35.8 m120 65.69 31.53 9.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.64 2.376 . . . . 25.449999999999999 116.659 -166.078 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -79.69 125.89 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 1 O-C-N 116.252 -4.03 . . . . 14.6 103.888 -169.483 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -104.78 -173.94 2.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.269 3.427 . . . . 33.229999999999997 113.283 -169.447 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -67.74 137.46 55.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.961 3.304 . . . . 25.969999999999999 109.895 174.687 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 52.5 33.56 13.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.093 2.957 . . . . 32.609999999999999 111.288 179.373 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -76.21 151.52 36.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 114.204 -2.808 . . . . 10.56 110.422 163.909 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.9 m -110.17 112.54 24.58 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 133.046 6.466 . . . . 5.3300000000000001 110.166 179.555 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.1 mt -97.62 159.06 15.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 110.654 -2.976 . . . . 11.66 106.566 170.704 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -124.82 123.71 40.55 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 115.992 -1.956 . . . . 16.300000000000001 106.76 -169.266 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -112.33 125.18 53.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.937 2.153 . . . . 9.9600000000000009 109.315 -172.303 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.298 16.5 m -127.01 150.89 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 124.432 2.063 . . . . 9.7599999999999998 109.119 169.63 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.5 mt -110.63 167.81 9.94 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.023 -1.899 . . . . 19.57 110.86 -167.174 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.474 HH12 ' C ' ' A' ' 76' ' ' GLY . 73.6 mtp180 -126.34 177.84 6.19 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.052 -2.905 . . . . 35.079999999999998 107.04 -172.924 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 tp -70.21 -62.88 1.22 Allowed 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.752 2.501 . . . . 32.310000000000002 117.752 171.256 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -132.56 -51.98 0.93 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.123 -2.236 . . . . 42.75 112.941 175.396 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.97 178.88 27.12 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 122.405 2.366 . . . . 36.310000000000002 109.948 -177.511 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.474 ' C ' HH12 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.755 0 O-C-N 118.702 -2.646 . . . . 36.270000000000003 107.66 -172.893 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 107.668 -1.234 . . . . 17.170000000000002 107.668 . . . . . . . . . 0 0 . 1 . 104 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -112.08 140.58 46.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.802 -2.295 . . . . 21.890000000000001 104.802 -175.817 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -128.62 154.48 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 123.422 1.582 . . . . 10.83 111.083 167.764 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -113.37 107.84 16.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.48 -2.012 . . . . 10.609999999999999 110.823 -173.517 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t -102.04 106.26 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.473 -1.392 . . . . 9.1300000000000008 109.671 178.251 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -89.39 128.89 35.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.489 1.662 . . . . 20.550000000000001 115.489 179.557 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -78.63 164.45 24.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.86 -1.775 . . . . 11.779999999999999 110.572 171.103 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.0 mt -77.5 -22.41 51.28 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.485 -4.509 . . . . 19.309999999999999 110.833 -172.76 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -92.74 -67.84 0.83 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.425 -1.324 . . . . 23.140000000000001 107.425 176.583 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.12 76.75 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 114.521 -3.377 . . . . 19.739999999999998 121.496 -178.701 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -156.91 131.67 8.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.609 2.704 . . . . 21.93 106.577 171.556 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.0 m -105.76 108.17 19.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.52 1.629 . . . . 12.33 107.248 172.843 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 mt -86.71 117.03 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 105.509 -2.034 . . . . 17.079999999999998 105.509 176.311 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -93.88 127.31 39.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.408 1.693 . . . . 16.300000000000001 112.232 171.479 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -117.7 132.91 56.41 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.898 2.079 . . . . 15.880000000000001 112.816 -177.74 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -92.09 107.07 18.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.511 -1.663 . . . . 28.899999999999999 106.511 172.601 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.85 166.97 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 104.628 -2.36 . . . . 12.050000000000001 104.628 179.482 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -118.17 138.37 25.49 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 126.698 1.999 . . . . 18.170000000000002 109.069 168.872 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 38.0 Cg_endo -67.54 -10.0 27.26 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 124.579 3.519 . . . . 8.1600000000000001 117.965 -171.721 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -76.64 -14.32 59.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.984 1.846 . . . . 11.130000000000001 115.984 170.399 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -85.06 172.65 11.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.531 1.514 . . . . 18.030000000000001 108.455 -178.767 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 70.8 p -103.54 157.08 17.29 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 117.229 -1.367 . . . . 10.220000000000001 113.296 -176.731 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.6 mm -53.65 -36.59 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 122.065 2.211 . . . . 12.300000000000001 113.842 177.61 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -53.47 -25.55 16.75 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.095 -2.253 . . . . 36.509999999999998 116.191 169.525 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -87.62 -18.82 28.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 117.666 -1.159 . . . . 25.66 113.025 173.334 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -75.38 -44.03 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 122.136 2.244 . . . . 8.1199999999999992 112.486 176.196 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -62.84 -37.52 87.12 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 110.559 -3.019 . . . . 15.470000000000001 109.195 173.381 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.28 -19.43 61.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.387 -1.768 . . . . 11.449999999999999 114.084 173.309 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -77.2 -29.4 54.26 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.924 2.602 . . . . 24.98 110.628 171.313 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.7 mt -64.58 -45.6 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 116.615 -1.659 . . . . 9.4600000000000009 114.924 167.695 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -48.03 -49.95 29.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 121.292 3.812 . . . . 14.76 121.292 167.995 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -59.52 -65.56 0.65 Allowed 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 127.7 2.4 . . . . 26.289999999999999 115.484 170.849 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -74.62 -71.53 0.34 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.544 -3.847 . . . . 30.059999999999999 112.388 -177.725 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -71.51 -31.11 66.71 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.676 -6.265 . . . . 25.190000000000001 113.616 -170.132 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.08 52.16 4.42 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.353 2.882 . . . . 7.4100000000000001 110.704 178.56 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.85 143.02 28.26 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-N 119.959 1.88 . . . . 9.4900000000000002 106.18 168.125 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -72.5 168.33 24.63 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 125.266 2.917 . . . . 11.42 113.16 -173.34 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -81.91 -11.95 11.05 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.547 3.017 . . . . 12.0 112.546 177.699 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.94 -33.39 75.47 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.135 -2.228 . . . . 35.549999999999997 113.281 172.135 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.261 46.5 mt-30 -95.38 -8.85 34.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.044 2.831 . . . . 20.52 110.756 -167.731 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -87.05 122.01 30.29 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 111.902 -6.749 . . . . 7.1299999999999999 115.418 175.33 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -122.05 121.05 36.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.244 -2.16 . . . . 36.390000000000001 107.13 165.431 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.0 mt -105.98 139.04 41.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.677 -1.63 . . . . 9.5500000000000007 110.115 -177.58 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 75.5 mt -117.21 141.98 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 100.433 -3.914 . . . . 13.9 100.433 -175.474 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -136.85 104.23 5.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.15 -2.167 . . . . 6.8600000000000003 105.15 172.7 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.266 . . 65.99 -127.83 0.27 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.758 -1.839 . . . . 11.15 111.927 -177.06 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.8 24.04 30.05 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 119.753 2.661 . . . . 13.93 119.753 -178.468 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.5 157.74 40.26 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 110.818 -2.691 . . . . 23.920000000000002 112.085 -168.018 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.88 152.56 23.12 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.155 -1.794 . . . . 23.23 106.155 -176.188 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.3 mt -88.59 146.76 24.94 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.767 2.222 . . . . 9.1099999999999994 111.014 -177.03 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.488 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 17.5 tt0 -100.77 139.36 36.56 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 126.545 1.938 . . . . 33.439999999999998 107.217 -176.706 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.44 -55.54 32.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.153 2.581 . . . . 28.370000000000001 111.992 -168.937 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.97 31.47 7.92 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 113.45 -1.705 . . . . 15.0 110.878 -162.667 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.488 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 29.6 mtt180 -103.89 170.06 8.14 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.689 -3.83 . . . . 25.5 104.004 169.57 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.4 p -85.93 158.68 19.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.012 2.925 . . . . 11.949999999999999 105.908 -179.196 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.568 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 1.2 mt -69.41 -32.36 71.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.757 -3.089 . . . . 10.17 116.215 171.385 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.6 p -53.41 -40.33 65.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.404 3.082 . . . . 13.59 115.98 167.643 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.93 -20.47 61.75 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.2 -2.812 . . . . 11.699999999999999 117.073 -176.597 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -91.64 -1.12 57.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.325 1.85 . . . . 12.949999999999999 110.844 174.037 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 44.05 63.32 1.65 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.53 -2.123 . . . . 25.449999999999999 115.171 -161.497 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.69 127.17 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.825 -1.546 . . . . 14.6 106.825 168.539 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -124.35 179.74 4.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.188 2.595 . . . . 33.229999999999997 106.28 -168.16 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -67.54 145.92 54.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.886 -3.634 . . . . 25.969999999999999 111.537 -172.315 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 51.46 26.53 3.23 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.447 2.018 . . . . 32.609999999999999 116.447 -175.847 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 m -56.18 145.79 25.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.937 -1.727 . . . . 10.56 113.201 167.628 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -98.58 120.56 39.21 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.142 -2.224 . . . . 5.3300000000000001 114.192 167.974 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -110.27 160.41 16.55 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.344 0.974 . . . . 11.66 110.547 169.669 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -112.87 133.4 54.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 102.424 -3.176 . . . . 16.300000000000001 102.424 176.271 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -103.12 117.48 34.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.437 1.895 . . . . 9.9600000000000009 113.313 166.633 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.0 t -116.62 123.21 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.931 -2.248 . . . . 9.7599999999999998 104.931 -173.567 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt -98.65 132.46 44.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.677 -1.889 . . . . 19.57 113.75 -173.95 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.514 HH12 ' C ' ' A' ' 76' ' ' GLY . 43.4 mtp180 -112.47 -177.4 3.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.172 2.26 . . . . 35.079999999999998 114.211 -175.11 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.54 -178.57 7.01 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 114.535 -5.103 . . . . 32.310000000000002 107.524 178.465 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -92.61 82.13 4.8 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.455 -3.278 . . . . 42.75 110.671 173.098 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.63 -67.36 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.608 -3.807 . . . . 36.310000000000002 112.545 -173.635 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.514 ' C ' HH12 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.741 0 CA-C-N 121.93 2.865 . . . . 36.270000000000003 112.23 -171.804 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.26 7.9 ptt? . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 117.756 2.502 . . . . 17.170000000000002 117.756 . . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -113.29 130.64 56.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 105.844 -1.91 . . . . 21.890000000000001 105.844 -177.421 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 pt -131.29 160.02 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 100.569 -3.863 . . . . 10.83 100.569 -177.673 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -112.41 151.59 29.66 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.527 2.584 . . . . 10.609999999999999 106.785 -177.739 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.413 HG21 HD22 ' A' ' 15' ' ' LEU . 40.3 t -128.33 124.56 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 117.456 -3.277 . . . . 9.1300000000000008 109.66 166.745 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -136.66 135.7 38.48 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.772 -1.558 . . . . 20.550000000000001 109.934 -170.366 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -80.83 -174.25 4.67 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.448 2.547 . . . . 11.779999999999999 111.271 175.985 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.16 -43.42 74.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.027 -2.296 . . . . 19.309999999999999 111.47 177.077 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -76.62 -34.8 58.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.361 -2.257 . . . . 23.140000000000001 108.07 179.658 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.15 70.2 0.63 Allowed Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 126.523 2.011 . . . . 19.739999999999998 114.162 173.72 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -96.55 103.07 14.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 131.051 3.74 . . . . 21.93 106.877 160.491 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -100.08 135.81 40.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.21 2.433 . . . . 12.33 110.445 -178.866 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 pt -139.99 162.33 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.445 2.698 . . . . 17.079999999999998 111.79 175.054 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 m -126.81 119.47 26.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.794 1.309 . . . . 16.300000000000001 110.145 -172.218 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.413 HD22 HG21 ' A' ' 5' ' ' VAL . 0.9 OUTLIER -104.42 134.13 48.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.218 -1.81 . . . . 15.880000000000001 107.83 -178.321 . . . . . . . . 3 3 . 1 . 105 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -98.86 115.49 28.96 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.352 -2.833 . . . . 28.899999999999999 103.352 178.689 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.37 177.86 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.818 -1.549 . . . . 12.050000000000001 106.818 177.183 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -116.89 160.17 37.89 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 104.497 -2.408 . . . . 18.170000000000002 104.497 179.228 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -76.67 2.53 7.34 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 115.837 -2.309 . . . . 8.1600000000000001 116.427 -175.099 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.0 p -77.47 -13.8 59.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 124.871 1.357 . . . . 11.130000000000001 112.175 169.557 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.89 137.57 33.6 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 122.728 1.251 . . . . 18.030000000000001 111.805 -170.766 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -76.13 158.12 32.08 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 109.283 -3.599 . . . . 10.220000000000001 112.266 -169.781 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mm -52.93 -45.62 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 1 O-C-N 115.377 -4.577 . . . . 12.300000000000001 110.242 168.376 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -59.97 -32.09 70.51 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.278 -2.764 . . . . 36.509999999999998 118.176 168.887 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -63.84 -38.74 92.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.924 -2.985 . . . . 25.66 111.555 168.871 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.84 -47.18 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.014 1.326 . . . . 8.1199999999999992 108.771 171.9 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -58.81 -39.82 82.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.864 -1.772 . . . . 15.470000000000001 112.954 178.436 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.43 61.79 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.499 3.148 . . . . 11.449999999999999 119.499 171.326 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.26 4.6 tppt? -66.84 -44.07 82.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.151 2.881 . . . . 24.98 117.127 167.854 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -74.01 -43.12 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.659 2.384 . . . . 9.4600000000000009 107.416 179.144 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -48.27 -45.09 34.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.75 2.5 . . . . 14.76 117.75 169.67 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.03 -57.18 8.32 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.279 2.696 . . . . 26.289999999999999 118.279 169.502 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -64.67 -58.06 7.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.637 2.458 . . . . 30.059999999999999 117.637 173.32 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.45 -67.93 0.61 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.353 -1.467 . . . . 25.190000000000001 112.775 -176.475 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.82 27.01 2.88 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 122.53 1.072 . . . . 7.4100000000000001 111.731 -176.863 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.7 mt -88.23 125.79 62.78 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 114.063 -2.875 . . . . 9.4900000000000002 111.95 174.764 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -71.13 154.81 62.06 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 CA-C-N 126.698 3.428 . . . . 11.42 112.827 -174.89 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -70.18 -15.24 35.45 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.22 1.946 . . . . 12.0 110.068 -170.703 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -87.14 -16.58 35.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.828 1.775 . . . . 35.549999999999997 115.54 177.486 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -94.79 -34.86 12.33 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.06 -1.65 . . . . 20.52 108.687 -178.838 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.39 135.27 55.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.083 0.944 . . . . 7.1299999999999999 111.877 174.811 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.258 21.6 tpp180 -139.27 130.59 26.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.012 -2.93 . . . . 36.390000000000001 106.566 160.906 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.5 mt -94.33 135.66 35.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.95 2.5 . . . . 9.5500000000000007 112.779 -179.629 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.569 HG12 ' HG2' ' A' ' 49' ' ' GLN . 11.8 mt -127.09 132.09 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 1 N-CA-C 97.688 -4.931 . . . . 13.9 97.688 -172.28 . . . . . . . . 3 3 . 1 . 105 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -116.19 130.84 56.99 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.025 -2.297 . . . . 6.8600000000000003 107.368 166.563 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.83 -109.85 0.51 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.694 -2.504 . . . . 11.15 117.388 -172.059 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.17 -7.46 56.12 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 130.663 3.983 . . . . 13.93 114.636 174.844 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -127.05 144.86 50.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.588 3.194 . . . . 23.920000000000002 112.999 -159.532 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.569 ' HG2' HG12 ' A' ' 44' ' ' ILE . 65.1 mt-30 -98.44 124.19 43.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.476 -1.693 . . . . 23.23 106.643 -176.2 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -88.69 143.29 27.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.953 -1.092 . . . . 9.1099999999999994 112.372 -167.552 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.256 74.1 mm-40 -85.62 149.87 25.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.408 2.744 . . . . 33.439999999999998 118.408 -178.435 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -40.75 -64.08 0.58 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 131.031 3.733 . . . . 28.370000000000001 118.798 -173.034 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.59 51.51 0.76 Allowed Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 123.284 1.491 . . . . 15.0 111.153 -171.081 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.273 13.7 mmt85 -123.83 173.35 8.23 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.743 -4.386 . . . . 25.5 108.775 173.693 . . . . . . . . 3 2 . 1 . 105 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 p -112.39 175.1 5.57 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.424 2.375 . . . . 11.949999999999999 113.525 175.201 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.3 mt -58.81 -41.08 85.94 Favored 'General case' 0 N--CA 1.43 -1.449 2 CA-C-N 106.801 -4.727 . . . . 10.17 113.648 169.322 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -70.52 -35.53 73.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.751 -1.218 . . . . 13.59 113.769 177.778 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -62.14 -48.56 79.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.407 -2.058 . . . . 11.699999999999999 114.261 178.979 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -72.86 -25.83 61.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.801 -3.687 . . . . 12.949999999999999 115.86 174.575 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.288 9.0 m120 83.16 67.2 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.013 2.125 . . . . 25.449999999999999 109.007 -173.424 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.49 117.12 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 101.81 -3.404 . . . . 14.6 101.81 172.208 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -102.55 -164.53 1.09 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.51 -2.619 . . . . 33.229999999999997 109.225 -179.893 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -72.72 131.32 42.21 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 131.601 3.961 . . . . 25.969999999999999 111.132 -172.171 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 60.71 24.66 14.48 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.785 1.63 . . . . 32.609999999999999 113.385 179.526 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.8 m -89.58 153.62 20.63 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 101.21 -3.626 . . . . 10.56 101.21 171.723 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -116.46 109.68 17.62 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.039 1.735 . . . . 5.3300000000000001 107.33 -167.142 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mp -90.88 131.74 36.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 120.0 1.273 . . . . 11.66 110.082 178.418 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 47.2 m-70 -80.38 132.0 35.7 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 127.066 3.317 . . . . 16.300000000000001 107.796 -176.076 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.256 5.1 tp -102.03 116.63 33.11 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 115.353 -4.592 . . . . 9.9600000000000009 109.804 173.261 . . . . . . . . 3 2 . 1 . 105 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.0 t -106.09 109.96 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 127.574 2.35 . . . . 9.7599999999999998 114.924 168.883 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -93.42 121.89 35.28 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.836 -3.024 . . . . 19.57 102.836 -171.648 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -63.35 139.46 58.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.798 2.147 . . . . 35.079999999999998 116.798 179.986 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.9 tp -91.4 -42.4 10.34 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.729 -4.357 . . . . 32.310000000000002 110.96 179.407 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpp180 -158.72 -50.54 0.06 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.266 -2.146 . . . . 42.75 111.287 164.157 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.04 134.14 2.25 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 118.513 -2.617 . . . . 36.310000000000002 112.256 -174.708 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.768 0 C-N-CA 127.033 2.254 . . . . 36.270000000000003 113.62 175.049 . . . . . . . . 0 0 . 1 . 106 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' HE1' ' HB3' ' A' ' 19' ' ' PRO . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 121.011 0.434 . . . . 17.170000000000002 109.877 . . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -107.78 153.36 23.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.489 -2.141 . . . . 21.890000000000001 114.473 173.577 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -126.78 147.19 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 102.669 -3.086 . . . . 10.83 102.669 171.374 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.55 135.85 45.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.8 2.148 . . . . 10.609999999999999 116.8 156.768 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.57 141.97 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.603 1.961 . . . . 9.1300000000000008 107.081 174.241 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -140.02 130.97 26.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.57 2.348 . . . . 20.550000000000001 112.543 -163.719 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -91.36 -176.7 4.63 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.642 -1.911 . . . . 11.779999999999999 107.153 -176.334 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.98 -48.4 74.13 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.416 -2.678 . . . . 19.309999999999999 111.562 175.874 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.1 p -79.83 -62.57 1.64 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.385 -3.322 . . . . 23.140000000000001 110.585 -174.851 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.71 41.25 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 116.999 -2.524 . . . . 19.739999999999998 114.348 175.409 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU 0.3 19.7 tptm -88.54 109.06 19.76 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.035 -1.469 . . . . 21.93 107.035 165.313 . . . . . . . . 3 3 . 1 . 106 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -104.14 108.91 20.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.316 -1.49 . . . . 12.33 108.08 -179.619 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.264 36.6 pt -97.03 134.22 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 116.412 -1.756 . . . . 17.079999999999998 110.312 175.156 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 3.6 m -109.66 112.13 24.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.977 2.911 . . . . 16.300000000000001 107.745 -179.893 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -106.61 160.07 15.72 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.823 -3.048 . . . . 15.880000000000001 110.553 -176.084 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -115.44 132.26 56.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.756 -2.465 . . . . 28.899999999999999 109.296 176.024 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.52 167.24 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.294 2.237 . . . . 12.050000000000001 114.608 -167.756 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -90.97 140.5 26.1 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 119.087 -2.258 . . . . 18.170000000000002 115.623 155.762 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HB3' ' HE1' ' A' ' 1' ' ' MET . 72.2 Cg_endo -68.65 -10.86 30.28 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 122.55 1.946 . . . . 8.1600000000000001 117.048 174.868 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.337 83.7 p -74.8 -14.55 60.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.736 2.865 . . . . 11.130000000000001 118.736 166.817 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -81.06 165.97 21.17 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.125 1.516 . . . . 18.030000000000001 114.936 -164.63 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 45.7 p -87.77 157.52 19.01 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.349 2.5 . . . . 10.220000000000001 112.31 -172.092 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.4 mm -68.91 -28.62 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.638 -3.164 . . . . 12.300000000000001 111.679 -178.057 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -48.71 -48.98 39.98 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.274 2.23 . . . . 36.509999999999998 115.528 153.116 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -75.09 1.62 12.71 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.79 -4.319 . . . . 25.66 119.687 175.012 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.6 t -82.91 -39.56 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.189 -2.152 . . . . 8.1199999999999992 105.189 160.545 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -63.97 -25.56 68.19 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.303 -3.998 . . . . 15.470000000000001 113.633 -179.109 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.33 92.06 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.434 -2.666 . . . . 11.449999999999999 114.926 170.74 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -72.78 -27.76 62.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.7 -3.125 . . . . 24.98 111.639 -177.285 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.44 -44.04 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 115.051 1.5 . . . . 9.4600000000000009 115.051 170.021 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -60.52 -45.18 94.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.782 1.401 . . . . 14.76 114.782 167.799 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -65.31 -43.92 89.53 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.656 2.48 . . . . 26.289999999999999 111.698 178.926 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -75.38 -67.16 0.69 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.858 2.17 . . . . 30.059999999999999 116.858 -179.027 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.44 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 8.8 tp10 -82.69 -43.07 17.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.003 -2.311 . . . . 25.190000000000001 115.194 179.905 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.7 52.32 2.84 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-O 124.548 2.193 . . . . 7.4100000000000001 117.521 177.861 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.5 mt -111.97 125.74 29.7 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 102.145 -3.28 . . . . 9.4900000000000002 102.145 -178.386 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.44 160.5 22.59 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 127.754 3.805 . . . . 11.42 113.098 -173.393 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_exo -77.04 -17.24 15.38 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 CA-C-N 127.949 3.874 . . . . 12.0 111.045 -148.168 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.54 -24.27 45.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.76 -3.088 . . . . 35.549999999999997 110.647 -171.721 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -90.01 -0.67 57.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.697 2.399 . . . . 20.52 110.764 -173.714 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -100.05 129.6 46.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.233 2.213 . . . . 7.1299999999999999 115.803 -177.728 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -130.76 114.48 15.4 Favored 'General case' 0 N--CA 1.431 -1.404 1 O-C-N 115.918 -4.238 . . . . 36.390000000000001 110.602 167.317 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.7 mt -103.54 137.87 41.02 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 116.576 -1.678 . . . . 9.5500000000000007 114.455 -174.666 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 mt -125.53 133.95 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 101.079 -3.675 . . . . 13.9 101.079 -164.703 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -118.12 96.15 5.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 101.441 -3.541 . . . . 6.8600000000000003 101.441 172.956 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.91 -93.96 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.653 -2.067 . . . . 11.15 113.262 -170.667 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.48 -16.64 45.43 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 116.812 -2.105 . . . . 13.93 116.525 174.389 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -105.57 126.35 52.04 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 126.323 1.837 . . . . 23.920000000000002 113.032 -157.72 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -98.39 123.83 42.73 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 125.379 1.674 . . . . 23.23 113.13 -167.023 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.24 125.65 36.99 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.827 -1.082 . . . . 9.1099999999999994 110.578 -158.378 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -87.63 152.21 22.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 131.608 3.963 . . . . 33.439999999999998 116.511 171.238 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -75.02 -49.12 20.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.382 2.515 . . . . 28.370000000000001 108.405 -152.227 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.69 34.76 4.08 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 117.548 -3.22 . . . . 15.0 114.342 -171.791 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -123.23 161.94 23.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 100.426 -3.916 . . . . 25.5 100.426 176.231 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.3 p -99.8 164.38 12.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.106 -1.621 . . . . 11.949999999999999 114.822 -179.809 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mt -48.06 -37.71 15.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.342 -3.349 . . . . 10.17 119.247 167.505 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -76.02 -14.92 60.21 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.539 -1.664 . . . . 13.59 113.025 174.963 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -74.92 -38.38 61.82 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 123.798 2.999 . . . . 11.699999999999999 110.552 172.205 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -91.82 2.13 56.71 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.396 -1.335 . . . . 12.949999999999999 107.396 -172.603 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m120 60.33 45.33 11.31 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.927 2.566 . . . . 25.449999999999999 117.927 179.98 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.4 mt -86.91 135.49 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 126.594 3.092 . . . . 14.6 106.399 -178.884 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -113.72 167.3 10.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.309 -2.119 . . . . 33.229999999999997 109.558 -163.864 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -55.22 114.37 1.76 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.531 1.634 . . . . 25.969999999999999 111.774 166.14 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 63.12 37.96 11.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 110.453 -3.067 . . . . 32.609999999999999 113.254 -175.383 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -72.18 148.62 45.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.464 1.484 . . . . 10.56 113.815 159.497 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.4 m -109.32 128.53 55.16 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.566 -3.209 . . . . 5.3300000000000001 110.16 179.77 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -101.85 140.3 36.33 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 116.214 1.931 . . . . 11.66 116.214 177.12 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -100.36 110.72 22.94 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 125.175 2.416 . . . . 16.300000000000001 111.704 -179.511 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -94.6 127.61 40.67 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.792 -2.443 . . . . 9.9600000000000009 110.49 -175.243 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.7 123.13 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.256 3.023 . . . . 9.7599999999999998 113.755 163.563 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.23 129.28 34.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 128.325 3.917 . . . . 19.57 108.751 173.935 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -77.19 133.57 38.89 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.657 -3.152 . . . . 35.079999999999998 106.26 179.943 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.1 tp -121.82 -59.4 1.68 Allowed 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.184 1.468 . . . . 32.310000000000002 109.233 172.734 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -98.77 -63.67 1.1 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.925 -1.943 . . . . 42.75 112.39 177.907 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.54 161.21 31.18 Favored Glycine 0 N--CA 1.43 -1.726 1 N-CA-C 102.094 -4.402 . . . . 36.310000000000002 102.094 171.067 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 0 C-N-CA 114.935 -3.507 . . . . 36.270000000000003 114.27 169.316 . . . . . . . . 0 0 . 1 . 107 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptt? . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 110.752 -0.092 . . . . 17.170000000000002 110.752 . . . . . . . . . 0 0 . 1 . 107 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -90.04 148.27 23.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 123.664 0.786 . . . . 21.890000000000001 111.232 177.464 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.31 141.61 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.701 -2.333 . . . . 10.83 104.701 -179.118 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -97.0 143.05 28.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.935 1.457 . . . . 10.609999999999999 114.935 170.169 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -128.86 112.04 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.232 2.92 . . . . 9.1300000000000008 107.165 177.841 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -109.2 130.66 55.49 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.594 -3.816 . . . . 20.550000000000001 115.164 -172.753 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 p -82.09 162.55 22.48 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.398 -5.813 . . . . 11.779999999999999 107.851 179.532 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mt -59.17 -39.03 81.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.293 -2.755 . . . . 19.309999999999999 115.274 169.019 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 p -65.58 -58.64 5.27 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.344 2.497 . . . . 23.140000000000001 112.662 -178.151 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.03 64.14 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 O-C-N 118.129 -2.857 . . . . 19.739999999999998 113.555 164.935 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -129.88 134.8 47.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 119.712 1.756 . . . . 21.93 107.606 157.408 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -105.57 121.35 43.78 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.84 1.781 . . . . 12.33 108.898 175.302 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.6 pt -111.23 144.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 118.082 -2.886 . . . . 17.079999999999998 105.837 -179.569 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -107.39 123.09 47.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.686 1.241 . . . . 16.300000000000001 110.627 -177.197 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -119.98 162.79 18.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.023 -1.103 . . . . 15.880000000000001 108.023 -177.027 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -106.35 133.41 51.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.197 1.799 . . . . 28.899999999999999 111.3 172.726 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.262 16.1 m -147.96 162.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 119.448 -2.032 . . . . 12.050000000000001 106.365 167.344 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -82.24 170.43 14.91 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 105.21 -2.144 . . . . 18.170000000000002 105.21 161.151 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.287 1.1 Cg_exo -69.84 -24.93 28.73 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 120.79 1.318 . . . . 8.1600000000000001 111.704 170.438 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -78.7 8.13 5.85 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 115.347 -2.264 . . . . 11.130000000000001 111.075 -174.265 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.255 75.2 m-20 -108.31 162.07 14.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 123.198 2.727 . . . . 18.030000000000001 107.33 -176.669 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.9 p -92.21 163.72 13.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.846 -3.034 . . . . 10.220000000000001 114.204 -171.556 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -69.44 -24.65 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 118.814 -2.429 . . . . 12.300000000000001 112.121 176.753 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -53.69 -48.77 69.2 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.69 -4.381 . . . . 36.509999999999998 114.303 162.458 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -62.97 -30.74 71.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.311 2.337 . . . . 25.66 117.311 169.661 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.2 t -65.68 -49.41 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 121.767 2.076 . . . . 8.1199999999999992 113.435 166.319 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -61.82 -31.53 71.77 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.709 1.604 . . . . 15.470000000000001 113.451 178.839 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.72 -35.33 78.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.145 2.578 . . . . 11.449999999999999 106.678 169.94 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -75.67 -21.26 57.81 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.862 -4.274 . . . . 24.98 116.901 177.05 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.0 mt -69.44 -45.85 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.39 -2.069 . . . . 9.4600000000000009 110.316 164.599 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -49.75 -39.98 39.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.583 2.611 . . . . 14.76 111.44 171.862 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.71 -64.16 1.06 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.233 -3.417 . . . . 26.289999999999999 110.464 -179.99 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -80.66 -27.47 37.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.45 -3.906 . . . . 30.059999999999999 114.359 -163.167 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -103.89 -56.05 2.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 113.946 1.091 . . . . 25.190000000000001 113.946 -177.728 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.28 26.79 2.59 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 126.963 2.221 . . . . 7.4100000000000001 116.89 172.841 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -94.42 135.36 24.29 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 108.127 -1.064 . . . . 9.4900000000000002 108.127 -176.438 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.48 157.4 61.91 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 115.221 -3.094 . . . . 11.42 112.885 -177.65 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -84.83 -11.32 7.89 Favored 'Trans proline' 0 C--N 1.299 -2.029 1 C-N-CA 128.157 5.905 . . . . 12.0 112.779 -175.198 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.82 -43.47 58.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.358 0.981 . . . . 35.549999999999997 111.567 173.392 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -72.12 12.01 0.48 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.785 -2.447 . . . . 20.52 114.588 -179.051 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -116.89 128.42 55.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.625 1.202 . . . . 7.1299999999999999 114.082 -164.613 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -129.13 130.06 45.96 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.793 -1.817 . . . . 36.390000000000001 106.184 171.763 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.5 mt -102.47 143.56 32.03 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 120.357 -0.537 . . . . 9.5500000000000007 111.546 171.617 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -124.82 127.95 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 128.036 2.534 . . . . 13.9 104.798 177.726 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -112.67 107.9 16.75 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.116 -2.865 . . . . 6.8600000000000003 104.504 177.201 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.388 . . 60.29 -91.45 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.188 -1.57 . . . . 11.15 115.017 -169.08 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.0 5.58 7.35 Favored Glycine 0 N--CA 1.43 -1.703 1 C-N-CA 131.064 4.173 . . . . 13.93 119.074 171.745 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -113.96 156.91 23.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.921 1.343 . . . . 23.920000000000002 108.319 175.384 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -84.11 151.8 24.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.385 -1.279 . . . . 23.23 111.937 175.742 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.2 mt -110.24 128.34 55.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.458 1.935 . . . . 9.1099999999999994 111.777 178.773 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -92.18 163.62 13.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.063 3.316 . . . . 33.439999999999998 105.983 179.096 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -63.26 -61.1 2.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 109.402 -3.544 . . . . 28.370000000000001 118.939 -171.938 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.54 15.55 13.13 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 119.476 2.55 . . . . 15.0 119.476 -171.849 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -101.45 156.85 17.22 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.398 -1.648 . . . . 25.5 110.116 173.46 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.5 p -94.37 167.43 11.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.406 -1.331 . . . . 11.949999999999999 107.406 -175.636 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mp -67.96 -25.94 65.69 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.348 2.259 . . . . 10.17 108.752 165.713 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.3 t -71.62 -43.29 66.45 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.653 2.381 . . . . 13.59 110.243 175.526 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -59.28 -44.74 92.44 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.945 -4.222 . . . . 11.699999999999999 116.768 175.316 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -79.89 -11.64 59.79 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.642 2.83 . . . . 12.949999999999999 118.642 169.734 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.315 31.0 m120 75.75 34.86 0.55 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.644 -3.16 . . . . 25.449999999999999 115.002 174.434 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 mt -73.47 118.91 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.347 -1.297 . . . . 14.6 110.757 167.619 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 65' ' ' SER . 45.5 mt-30 -90.75 169.91 10.57 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 124.155 1.931 . . . . 33.229999999999997 113.609 174.219 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -61.94 146.88 48.64 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.742 -4.349 . . . . 25.969999999999999 108.064 -174.32 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 85.7 mt-10 62.48 46.88 5.4 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.889 1.804 . . . . 32.609999999999999 113.167 174.273 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 62' ' ' GLN . 9.2 t -111.09 131.94 54.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.355 2.662 . . . . 10.56 103.994 -168.531 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -89.59 109.95 20.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.385 2.517 . . . . 5.3300000000000001 108.562 177.233 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.7 mt -89.74 150.58 22.23 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.776 2.03 . . . . 11.66 107.95 172.626 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -106.23 113.39 26.9 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 114.965 1.469 . . . . 16.300000000000001 114.965 -178.283 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.7 tp -89.93 120.2 30.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.276 1.988 . . . . 9.9600000000000009 114.493 177.152 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.81 145.58 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 112.651 -2.068 . . . . 9.7599999999999998 105.829 172.964 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.9 mt -125.23 137.36 54.11 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.372 1.558 . . . . 19.57 111.331 -176.258 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -84.92 146.34 27.31 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.905 -2.997 . . . . 35.079999999999998 115.803 -166.357 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.8 tp -82.92 -84.72 0.12 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.291 1.836 . . . . 32.310000000000002 108.277 -172.506 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -91.41 -48.82 6.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.727 -2.483 . . . . 42.75 113.118 -165.154 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.81 169.35 37.33 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 118.277 -2.765 . . . . 36.310000000000002 110.309 178.929 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.791 1 N-CA-C 102.033 -4.427 . . . . 36.270000000000003 102.033 158.714 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 106.413 -1.699 . . . . 17.170000000000002 106.413 . . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -106.38 140.08 39.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.707 2.114 . . . . 21.890000000000001 116.707 -176.671 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.6 pt -119.17 143.88 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 129.036 2.934 . . . . 10.83 114.324 169.979 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -104.92 126.1 51.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.05 -2.906 . . . . 10.609999999999999 107.827 -179.409 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.38 109.75 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 127.67 3.605 . . . . 9.1300000000000008 105.94 -176.773 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -117.93 138.79 51.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 125.897 2.761 . . . . 20.550000000000001 108.969 -167.665 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 p -72.68 -179.09 2.92 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.956 -2.34 . . . . 11.779999999999999 117.051 163.805 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.4 tp -76.14 -39.83 54.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 131.118 3.767 . . . . 19.309999999999999 110.431 -160.66 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -73.17 -56.6 4.87 Favored 'General case' 0 N--CA 1.429 -1.488 1 C-N-CA 133.94 4.896 . . . . 23.140000000000001 105.93 175.67 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.04 30.98 0.34 Allowed Glycine 0 N--CA 1.43 -1.741 0 O-C-N 125.873 1.983 . . . . 19.739999999999998 115.003 173.204 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -79.32 109.77 13.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.287 2.043 . . . . 21.93 109.779 168.664 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -95.79 126.43 41.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.007 -2.308 . . . . 12.33 112.684 -176.387 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.313 28.4 pt -109.47 152.93 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.433 2.063 . . . . 17.079999999999998 108.241 165.863 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -122.53 125.6 46.07 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.321 -2.737 . . . . 16.300000000000001 110.672 -175.78 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.284 52.4 mt -119.1 144.16 46.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.315 2.339 . . . . 15.880000000000001 117.315 179.442 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -101.16 101.86 12.67 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.705 2.002 . . . . 28.899999999999999 112.17 -179.161 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.18 165.1 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 C-N-CA 134.028 4.931 . . . . 12.050000000000001 108.284 -165.301 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 9.0 mt-10 -112.67 173.37 2.89 Favored Pre-proline 0 N--CA 1.429 -1.486 0 N-CA-C 114.836 1.421 . . . . 18.170000000000002 114.836 162.305 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -74.07 -14.12 23.57 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 115.963 -2.704 . . . . 8.1600000000000001 112.763 -179.111 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -95.11 0.9 54.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.159 0.912 . . . . 11.130000000000001 110.311 177.688 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.267 35.2 m-20 -85.98 152.23 23.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.877 -3.639 . . . . 18.030000000000001 109.812 -173.308 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 71.0 p -100.63 160.76 14.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.334 2.492 . . . . 10.220000000000001 107.859 -160.714 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.515 HG22 HD13 ' A' ' 43' ' ' LEU . 18.9 mm -64.48 -40.22 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 124.65 2.167 . . . . 12.300000000000001 108.624 -174.419 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -56.24 -35.47 67.41 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.03 -2.919 . . . . 36.509999999999998 117.021 168.121 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -72.14 -31.49 66.04 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 113.362 -5.836 . . . . 25.66 112.613 167.55 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.79 -43.55 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.724 -1.584 . . . . 8.1199999999999992 106.724 -177.021 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.25 -35.96 72.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.763 1.625 . . . . 15.470000000000001 113.361 174.907 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.99 -42.29 76.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.221 -2.174 . . . . 11.449999999999999 116.0 175.824 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -75.17 -32.03 61.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.649 3.179 . . . . 24.98 112.89 -176.989 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -60.88 -48.1 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.529 2.585 . . . . 9.4600000000000009 113.029 174.253 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -52.53 -45.88 66.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 113.15 -3.31 . . . . 14.76 117.037 166.386 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.53 -62.93 1.18 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.721 3.138 . . . . 26.289999999999999 110.032 179.291 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -53.71 -57.16 11.85 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.412 -3.305 . . . . 30.059999999999999 112.093 -176.757 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -93.96 -64.63 1.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.534 2.05 . . . . 25.190000000000001 116.534 -173.64 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.79 23.71 0.86 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 120.9 3.12 . . . . 7.4100000000000001 120.9 -176.939 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.69 118.14 60.27 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 114.723 -2.56 . . . . 9.4900000000000002 106.945 -169.191 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -51.89 147.16 26.35 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 121.238 3.515 . . . . 11.42 121.238 178.318 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -68.69 -35.68 16.0 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 123.793 2.39 . . . . 12.0 113.261 -160.378 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -78.21 -27.34 47.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.904 -2.372 . . . . 35.549999999999997 113.971 -177.462 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -62.89 -39.16 93.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.173 2.189 . . . . 20.52 115.365 170.776 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -65.9 140.17 58.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.342 2.349 . . . . 7.1299999999999999 117.342 173.585 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -128.32 99.61 5.49 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.855 -2.403 . . . . 36.390000000000001 114.192 169.866 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.515 HD13 HG22 ' A' ' 23' ' ' ILE . 80.9 mt -86.06 131.43 34.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.065 -2.334 . . . . 9.5500000000000007 109.629 -177.728 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.6 mt -130.47 136.59 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 126.282 2.944 . . . . 13.9 103.253 -179.846 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -113.5 114.98 27.29 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 115.055 -4.778 . . . . 6.8600000000000003 107.897 164.393 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.277 . . 72.31 -86.33 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.738 2.815 . . . . 11.15 111.331 -179.221 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.38 22.71 1.71 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 109.121 -1.591 . . . . 13.93 109.121 165.42 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.259 81.6 mttt -103.69 124.57 49.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.473 -3.369 . . . . 23.920000000000002 105.365 176.282 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -91.72 132.9 36.06 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 123.295 1.521 . . . . 23.23 108.941 -179.929 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.4 mt -94.15 128.86 40.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 115.715 -2.394 . . . . 9.1099999999999994 109.794 -151.377 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -78.32 139.73 38.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 119.038 2.977 . . . . 33.439999999999998 119.038 172.166 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.57 -50.14 70.85 Favored 'General case' 0 N--CA 1.431 -1.394 1 N-CA-C 122.654 4.316 . . . . 28.370000000000001 122.654 -162.62 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.49 0.72 89.24 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.232 -2.793 . . . . 15.0 115.775 175.333 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -81.78 165.33 21.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.835 -1.979 . . . . 25.5 108.143 171.382 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.3 p -104.97 -178.2 3.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 116.447 -3.908 . . . . 11.949999999999999 111.353 -172.98 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.3 mt -81.48 -29.31 33.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.699 -1.593 . . . . 10.17 106.699 178.712 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.9 t -66.08 -38.12 87.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.409 -2.057 . . . . 13.59 111.355 -176.589 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -54.95 -40.89 70.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.347 3.059 . . . . 11.699999999999999 113.788 176.924 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -93.49 1.16 56.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.322 2.342 . . . . 12.949999999999999 117.322 174.995 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.459 3.7 m120 79.52 18.83 0.73 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.263 1.579 . . . . 25.449999999999999 115.263 174.494 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.9 mt -87.01 99.4 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 118.446 -2.659 . . . . 14.6 105.014 -174.477 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.36 10.4 mt-30 -112.39 -165.11 0.96 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.324 2.249 . . . . 33.229999999999997 112.02 -169.874 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -61.55 106.8 0.7 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.103 2.961 . . . . 25.969999999999999 113.4 -170.061 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 82.76 41.92 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.011 2.525 . . . . 32.609999999999999 111.749 172.003 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.6 m -92.27 142.69 27.19 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.582 1.953 . . . . 10.56 111.376 179.388 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 m -102.41 121.18 41.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.334 -2.104 . . . . 5.3300000000000001 112.365 178.387 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -85.26 160.09 19.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 117.403 -1.284 . . . . 11.66 110.228 167.814 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -105.41 136.03 45.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 127.5 3.0 . . . . 16.300000000000001 104.84 167.473 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.1 tp -116.11 111.57 20.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.749 -2.315 . . . . 9.9600000000000009 104.749 -179.639 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -103.46 140.87 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 127.3 2.24 . . . . 9.7599999999999998 106.275 -179.994 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mt -93.87 136.06 34.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.357 3.063 . . . . 19.57 106.079 176.873 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.254 49.9 ttp180 -74.54 132.92 42.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.295 1.861 . . . . 35.079999999999998 114.765 174.648 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.8 tp -88.04 -67.15 0.85 Allowed 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.369 -1.741 . . . . 32.310000000000002 111.195 176.345 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.287 32.4 ttp-105 -104.01 -109.41 0.26 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 116.658 -1.639 . . . . 42.75 112.209 -176.144 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.06 -158.01 10.42 Favored Glycine 0 N--CA 1.431 -1.696 1 CA-C-N 126.765 4.348 . . . . 36.310000000000002 115.069 167.323 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.751 1 O-C-N 115.47 -4.547 . . . . 36.270000000000003 107.348 -178.829 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 108.139 -1.059 . . . . 17.170000000000002 108.139 . . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -100.11 116.17 31.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.549 1.166 . . . . 21.890000000000001 112.442 -177.37 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.1 pt -97.4 151.92 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.192 -1.367 . . . . 10.83 113.996 148.554 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -107.67 149.46 28.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.434 2.958 . . . . 10.609999999999999 110.951 174.66 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 67' ' ' LEU . 47.3 t -126.43 133.99 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 106.224 -1.769 . . . . 9.1300000000000008 106.224 162.092 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -108.73 139.45 43.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.742 2.017 . . . . 20.550000000000001 113.62 174.591 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 p -88.07 -169.54 2.61 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 114.973 1.471 . . . . 11.779999999999999 114.973 -171.659 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.87 -59.08 4.6 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 120.163 1.347 . . . . 19.309999999999999 113.435 179.175 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -69.6 -30.06 67.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.023 -1.673 . . . . 23.140000000000001 110.689 179.714 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.2 54.3 0.27 Allowed Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 129.168 3.27 . . . . 19.739999999999998 108.422 152.083 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -82.67 116.09 21.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.238 2.019 . . . . 21.93 108.839 167.623 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -84.32 112.02 19.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.691 -2.576 . . . . 12.33 115.898 176.285 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.61 162.22 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 122.357 2.344 . . . . 17.079999999999998 108.232 -172.848 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.5 m -123.75 98.22 5.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.492 2.717 . . . . 16.300000000000001 113.83 -174.504 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 29' ' ' LYS . 73.0 mt -92.68 160.3 15.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.025 0.83 . . . . 15.880000000000001 111.554 -170.62 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -106.13 103.91 13.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.372 1.442 . . . . 28.899999999999999 113.757 175.044 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.74 165.02 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.7 2.4 . . . . 12.050000000000001 108.347 -174.771 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.15 170.9 7.89 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-O 115.75 -2.071 . . . . 18.170000000000002 109.621 162.513 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.291 0.0 OUTLIER -66.7 -9.51 24.75 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 N-CA-C 120.205 3.117 . . . . 8.1600000000000001 120.205 179.83 . . . . . . . . 3 3 . 1 . 109 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -82.52 -21.58 35.36 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.207 -2.33 . . . . 11.130000000000001 113.927 176.474 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -57.75 146.29 31.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 119.745 3.239 . . . . 18.030000000000001 119.745 172.93 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.4 p -105.08 159.95 15.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.256 -3.403 . . . . 10.220000000000001 108.087 -178.013 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.62 -40.66 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 112.917 -1.947 . . . . 12.300000000000001 112.781 178.111 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -49.63 -41.88 43.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.509 1.924 . . . . 36.509999999999998 112.975 165.092 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -80.63 -21.31 41.59 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.565 -3.834 . . . . 25.66 116.942 176.14 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 t -59.91 -50.08 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.471 -2.643 . . . . 8.1199999999999992 107.782 165.375 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -59.56 -39.8 85.22 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.687 1.708 . . . . 15.470000000000001 113.013 -179.305 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.323 . . -71.58 -28.99 64.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.621 -1.627 . . . . 11.449999999999999 112.653 -176.996 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.486 ' HB3' HD21 ' A' ' 15' ' ' LEU . 55.8 mttm -69.0 -31.29 70.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.086 3.355 . . . . 24.98 111.899 171.803 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.2 mt -79.51 -37.6 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.853 0.835 . . . . 9.4600000000000009 111.921 173.401 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -61.94 -38.64 89.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.157 1.932 . . . . 14.76 114.129 168.808 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.7 -55.62 25.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.794 1.405 . . . . 26.289999999999999 114.794 172.069 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -67.78 -58.01 5.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.664 -3.147 . . . . 30.059999999999999 115.807 -174.812 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -95.52 -52.29 4.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.28 2.238 . . . . 25.190000000000001 115.533 -168.202 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.59 38.18 0.86 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 116.58 -2.724 . . . . 7.4100000000000001 114.402 174.091 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.2 mt -114.56 120.86 37.0 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-O 111.936 -3.888 . . . . 9.4900000000000002 103.609 -176.007 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -72.46 157.82 52.3 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 125.124 2.866 . . . . 11.42 112.508 -173.992 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -73.8 -32.34 7.47 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 122.813 2.041 . . . . 12.0 110.674 -162.518 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -59.73 -41.87 91.89 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.006 1.854 . . . . 35.549999999999997 116.006 -178.058 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -65.64 -27.75 68.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.095 2.258 . . . . 20.52 117.095 179.258 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -74.97 155.32 37.51 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.236 3.05 . . . . 7.1299999999999999 119.236 177.849 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -143.71 97.16 3.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.084 2.153 . . . . 36.390000000000001 113.779 177.549 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.6 mt -91.69 129.49 37.66 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.666 2.65 . . . . 9.5500000000000007 116.104 -167.201 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -120.1 128.71 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 2 O-C-N 115.692 -4.38 . . . . 13.9 115.532 -169.048 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -118.06 119.57 35.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.902 -2.374 . . . . 6.8600000000000003 104.94 176.916 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.51 -96.6 0.05 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.774 3.23 . . . . 11.15 109.825 -168.622 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.94 21.31 4.43 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 126.727 2.108 . . . . 13.93 114.099 176.594 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -134.85 145.27 48.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.465 -1.609 . . . . 23.920000000000002 108.091 -170.164 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -95.73 139.38 32.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.443 2.339 . . . . 23.23 114.456 -168.955 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.2 mt -87.31 136.13 33.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.124 2.392 . . . . 9.1099999999999994 112.14 -166.846 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -96.3 147.96 23.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.374 -2.704 . . . . 33.439999999999998 112.65 176.036 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -62.25 -43.49 98.71 Favored 'General case' 0 N--CA 1.431 -1.413 1 CA-C-O 128.821 4.153 . . . . 28.370000000000001 117.607 -160.394 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.76 -23.39 75.66 Favored Glycine 0 N--CA 1.43 -1.727 0 O-C-N 117.939 -2.976 . . . . 15.0 112.766 -173.375 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 mmm-85 -84.39 151.35 24.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.517 2.658 . . . . 25.5 107.913 -158.856 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -81.13 171.92 14.31 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.457 -6.402 . . . . 11.949999999999999 114.208 175.721 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.2 mt -69.82 -24.72 63.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.371 -2.706 . . . . 10.17 115.061 166.102 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -56.82 -43.93 81.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.802 2.89 . . . . 13.59 118.802 167.722 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -57.72 -56.23 24.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 110.812 -2.904 . . . . 11.699999999999999 110.371 -176.562 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -75.38 -21.52 58.22 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.504 -2.134 . . . . 12.949999999999999 115.358 -177.028 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 62.15 55.37 2.47 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.969 3.307 . . . . 25.449999999999999 107.878 -171.787 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 mt -88.34 112.52 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 116.079 -1.915 . . . . 14.6 106.675 161.371 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -108.93 -158.37 0.65 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.118 2.266 . . . . 33.229999999999997 117.118 -179.195 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -61.47 124.95 22.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.287 3.435 . . . . 25.969999999999999 114.549 168.17 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.307 38.5 mt-10 78.14 2.99 2.81 Favored 'General case' 0 N--CA 1.43 -1.434 1 N-CA-C 122.164 4.135 . . . . 32.609999999999999 122.164 -169.47 . . . . . . . . 3 2 . 1 . 109 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -75.24 122.59 23.91 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.105 -4.122 . . . . 10.56 113.547 -175.752 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -102.22 118.02 36.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.419 1.918 . . . . 5.3300000000000001 113.673 177.854 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.483 ' HB2' HG22 ' A' ' 5' ' ' VAL . 85.7 mt -88.18 159.4 18.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.684 -1.969 . . . . 11.66 105.684 -178.204 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -110.3 136.92 48.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.086 -2.259 . . . . 16.300000000000001 106.977 173.787 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -105.72 140.49 38.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.519 -1.988 . . . . 9.9600000000000009 107.41 170.506 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.273 28.4 t -114.6 140.17 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 128.003 2.521 . . . . 9.7599999999999998 106.737 167.998 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.9 mt -118.31 131.51 56.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.181 2.192 . . . . 19.57 108.707 178.986 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -81.42 170.43 15.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 127.452 2.97 . . . . 35.079999999999998 109.697 169.373 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.1 tp -109.42 -40.58 4.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.376 1.47 . . . . 32.310000000000002 110.372 -175.943 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -157.98 -100.04 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 115.229 -2.32 . . . . 42.75 109.548 -171.897 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.71 142.46 16.06 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 125.535 3.788 . . . . 36.310000000000002 111.401 -173.924 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.771 0 N-CA-C 105.691 -2.963 . . . . 36.270000000000003 105.691 151.929 . . . . . . . . 0 0 . 1 . 110 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 11.2 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 117.94 2.57 . . . . 17.170000000000002 117.94 . . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.266 31.1 mt-30 -71.96 131.15 42.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.655 -3.153 . . . . 21.890000000000001 112.098 -178.813 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 pt -135.96 155.06 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 101.324 -3.584 . . . . 10.83 101.324 -169.795 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.29 118.66 37.31 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.826 2.05 . . . . 10.609999999999999 114.508 175.683 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -114.67 104.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 104.762 -2.31 . . . . 9.1300000000000008 104.762 -177.063 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -89.89 123.3 33.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.813 2.845 . . . . 20.550000000000001 112.66 -175.904 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -78.33 166.58 22.51 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.87 1.319 . . . . 11.779999999999999 113.619 -172.36 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 71' ' ' LEU . 32.5 tp -58.43 -47.64 83.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.405 -3.934 . . . . 19.309999999999999 115.03 175.112 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -63.02 -69.82 0.24 Allowed 'General case' 0 N--CA 1.43 -1.471 2 CA-C-O 111.163 -4.255 . . . . 23.140000000000001 108.804 176.26 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.66 45.27 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 O-C-N 126.706 2.504 . . . . 19.739999999999998 116.129 179.438 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -127.24 142.23 51.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.712 -1.464 . . . . 21.93 107.105 -172.766 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.5 m -112.44 131.75 55.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.391 1.567 . . . . 12.33 107.644 175.203 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 pt -122.56 145.4 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.654 -2.529 . . . . 17.079999999999998 105.38 171.149 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m -113.21 110.44 20.4 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.772 -3.705 . . . . 16.300000000000001 107.66 -166.991 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 mt -115.49 152.02 33.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 118.026 -0.988 . . . . 15.880000000000001 112.256 -170.52 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -97.86 125.63 42.83 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 127.088 3.327 . . . . 28.899999999999999 117.672 162.935 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.0 175.36 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 111.307 -2.679 . . . . 12.050000000000001 111.511 167.425 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -102.04 178.42 1.22 Allowed Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.647 -2.121 . . . . 18.170000000000002 107.628 168.012 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -71.84 -26.54 18.88 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 C-N-CA 122.297 1.998 . . . . 8.1600000000000001 115.235 163.966 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -83.14 -8.97 59.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.782 2.882 . . . . 11.130000000000001 118.782 177.133 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -69.11 155.34 40.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.934 2.198 . . . . 18.030000000000001 116.934 171.853 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.8 p -106.35 -172.83 2.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.651 -1.28 . . . . 10.220000000000001 107.731 -176.258 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.543 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 43.3 mm -81.38 -25.99 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 125.139 2.4 . . . . 12.300000000000001 111.895 -178.746 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -53.23 -43.3 67.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.192 -3.442 . . . . 36.509999999999998 112.705 164.139 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -75.33 -45.25 40.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.736 -2.477 . . . . 25.66 111.775 -178.443 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.1 t -50.37 -56.93 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 124.874 1.269 . . . . 8.1199999999999992 111.402 166.593 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -58.63 -32.33 68.94 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 119.84 3.274 . . . . 15.470000000000001 119.84 179.26 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.32 -49.09 59.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.87 -3.019 . . . . 11.449999999999999 109.718 173.051 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -46.64 -47.48 20.14 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.17 -2.831 . . . . 24.98 116.7 172.197 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.7 mt -54.94 -44.4 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.353 2.661 . . . . 9.4600000000000009 113.412 171.903 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -67.0 -50.64 61.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.738 2.415 . . . . 14.76 111.751 173.595 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.7 -56.83 17.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.228 -2.795 . . . . 26.289999999999999 113.909 173.307 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.262 35.4 tptt -57.93 -80.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.31 2.005 . . . . 30.059999999999999 116.043 174.334 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -68.25 -56.86 7.18 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 126.79 3.186 . . . . 25.190000000000001 112.787 -170.632 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.75 13.77 0.93 Allowed Glycine 0 N--CA 1.431 -1.666 1 O-C-N 115.361 -4.587 . . . . 7.4100000000000001 110.096 169.535 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.68 134.07 27.01 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 116.334 -1.793 . . . . 9.4900000000000002 112.713 -169.04 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -76.22 150.44 33.08 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 121.603 1.608 . . . . 11.42 109.487 177.041 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 89.3 Cg_endo -78.3 -9.56 16.34 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 123.799 3.0 . . . . 12.0 111.692 -170.384 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -65.13 -22.6 66.95 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 127.315 3.436 . . . . 35.549999999999997 111.348 165.442 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -90.78 -23.28 20.67 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.723 -4.36 . . . . 20.52 113.372 -173.969 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -89.06 131.29 35.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.025 -2.922 . . . . 7.1299999999999999 114.144 -166.053 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -121.84 126.85 49.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.013 -1.847 . . . . 36.390000000000001 106.013 156.995 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.6 tp -106.96 127.05 53.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.119 1.367 . . . . 9.5500000000000007 112.778 178.974 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -129.25 138.17 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 126.9 2.08 . . . . 13.9 111.998 -165.988 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -120.62 122.04 39.66 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 114.914 -4.867 . . . . 6.8600000000000003 102.39 166.851 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.27 -85.51 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.067 2.147 . . . . 11.15 111.82 -174.927 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.59 23.08 1.34 Allowed Glycine 0 N--CA 1.429 -1.787 0 O-C-N 118.935 -2.353 . . . . 13.93 109.687 171.631 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -95.12 116.9 29.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.073 2.149 . . . . 23.920000000000002 114.136 168.196 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -70.36 119.22 14.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 118.817 2.895 . . . . 23.23 118.817 169.571 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.83 134.79 33.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.425 -3.297 . . . . 9.1099999999999994 116.899 -167.958 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -103.6 143.25 33.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.485 1.948 . . . . 33.439999999999998 115.426 -172.592 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.543 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 9.0 m-20 -50.46 -37.74 39.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.702 3.201 . . . . 28.370000000000001 119.272 -161.784 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.74 35.3 4.57 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 115.218 -2.99 . . . . 15.0 111.473 -178.425 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.44 HH21 ' CG ' ' A' ' 58' ' ' ASP . 21.1 mmm180 -110.77 153.91 24.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 122.566 3.183 . . . . 25.5 106.151 166.448 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.307 10.9 p -86.25 162.03 18.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.153 2.581 . . . . 11.949999999999999 107.1 -176.348 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.07 -32.63 73.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.287 -2.133 . . . . 10.17 115.37 169.014 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.1 t -60.08 -40.37 89.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.688 2.395 . . . . 13.59 112.762 167.199 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' CG ' HH21 ' A' ' 54' ' ' ARG . 11.5 t70 -59.5 -48.63 80.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.716 -2.49 . . . . 11.699999999999999 115.583 169.173 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 54' ' ' ARG 0.273 10.5 m-85 -82.46 4.88 22.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.752 1.39 . . . . 12.949999999999999 114.752 -179.979 . . . . . . . . 3 3 . 1 . 110 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 59.37 28.31 17.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 114.805 -2.521 . . . . 25.449999999999999 114.79 -176.588 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.9 mt -76.18 126.58 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 124.21 3.186 . . . . 14.6 111.944 166.408 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -102.73 -179.29 3.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.221 2.439 . . . . 33.229999999999997 116.317 178.834 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -78.33 136.34 37.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 112.838 -1.983 . . . . 25.969999999999999 110.253 179.684 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.26 11.5 tt0 75.12 30.64 0.87 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.424 2.379 . . . . 32.609999999999999 117.424 -177.083 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -113.54 160.0 18.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.466 -2.021 . . . . 10.56 110.324 -175.965 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -109.39 115.25 29.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.203 2.601 . . . . 5.3300000000000001 113.869 -173.068 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.54 156.91 18.31 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 111.662 -2.517 . . . . 11.66 113.611 170.869 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -116.33 109.46 17.41 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 112.415 -2.175 . . . . 16.300000000000001 107.838 -176.03 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.8 tp -89.31 114.33 25.71 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.583 -3.198 . . . . 9.9600000000000009 103.674 179.177 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.3 t -114.51 132.27 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 118.07 -2.894 . . . . 9.7599999999999998 108.129 -178.697 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.461 ' H ' HD22 ' A' ' 8' ' ' LEU . 11.4 mt -113.01 156.5 22.95 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.419 2.056 . . . . 19.57 106.005 -165.332 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.273 30.5 ptt180 -81.93 143.77 31.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.296 -1.775 . . . . 35.079999999999998 112.275 -177.162 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 tp -84.01 -45.4 13.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.826 1.954 . . . . 32.310000000000002 110.144 167.726 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.9 140.78 12.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.155 -2.84 . . . . 42.75 106.477 -178.278 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 -73.67 2.42 Favored Glycine 0 N--CA 1.429 -1.78 0 O-C-N 118.043 -2.911 . . . . 36.310000000000002 115.786 173.182 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.744 0 CA-C-O 114.654 -3.303 . . . . 36.270000000000003 117.12 -170.03 . . . . . . . . 0 0 . 1 . 111 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 121.102 0.477 . . . . 17.170000000000002 110.039 . . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -89.5 134.37 34.14 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.911 -1.743 . . . . 21.890000000000001 113.079 -171.302 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -115.18 139.2 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.072 -2.893 . . . . 10.83 112.062 160.595 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.285 12.3 m-85 -109.89 88.91 2.86 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.55 -5.094 . . . . 10.609999999999999 107.972 -169.248 . . . . . . . . 3 2 . 1 . 111 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.13 100.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 CA-C-O 129.184 4.326 . . . . 9.1300000000000008 113.522 173.353 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.28 46.7 mttt -83.31 148.57 27.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.15 -3.469 . . . . 20.550000000000001 113.752 178.536 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -104.27 -179.35 3.92 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.164 -2.21 . . . . 11.779999999999999 110.678 -168.322 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.325 1.9 tp -66.34 -41.18 89.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.996 1.48 . . . . 19.309999999999999 114.996 171.833 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.31 16.2 p -71.55 -66.22 0.66 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.589 2.614 . . . . 23.140000000000001 117.348 177.797 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.09 22.49 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 125.205 2.559 . . . . 19.739999999999998 119.451 -166.483 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -106.12 147.59 28.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.412 -2.394 . . . . 21.93 108.98 179.182 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -124.22 106.28 10.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.375 -2.454 . . . . 12.33 104.375 178.827 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -90.59 102.85 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 105.247 -2.131 . . . . 17.079999999999998 105.247 -177.933 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.2 m -81.14 121.65 26.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.081 -2.563 . . . . 16.300000000000001 104.081 -177.015 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.4 mt -112.37 133.97 54.17 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.38 2.363 . . . . 15.880000000000001 117.38 175.411 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.338 32.7 mt-10 -87.47 97.89 11.08 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.943 -4.223 . . . . 28.899999999999999 107.521 -177.677 . . . . . . . . 3 2 . 1 . 111 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -123.56 177.24 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.24 -1.538 . . . . 12.050000000000001 113.328 178.234 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -128.17 171.18 8.91 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.208 -1.853 . . . . 18.170000000000002 111.852 168.685 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -70.0 -16.37 36.54 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 C-N-CA 125.512 4.141 . . . . 8.1600000000000001 113.829 -174.312 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.2 m -92.96 -3.62 54.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.849 2.86 . . . . 11.130000000000001 110.919 179.476 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.54 154.72 40.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.368 -2.707 . . . . 18.030000000000001 115.348 176.507 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 4.8 p -93.65 156.5 16.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.286 -2.487 . . . . 10.220000000000001 104.286 -179.807 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -51.85 -36.5 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.637 -3.789 . . . . 12.300000000000001 113.52 167.561 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.67 -39.42 88.33 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.276 -2.765 . . . . 36.509999999999998 112.186 174.801 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -62.01 -47.17 85.98 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.764 -2.065 . . . . 25.66 113.049 170.421 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.5 t -44.83 -56.13 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 1 C-N-CA 131.915 4.086 . . . . 8.1199999999999992 111.068 172.213 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.95 -34.25 76.23 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.329 -3.357 . . . . 15.470000000000001 113.338 -174.024 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.55 85.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 114.68 1.363 . . . . 11.449999999999999 114.68 165.482 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -65.28 -32.2 73.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.072 -2.893 . . . . 24.98 113.012 173.669 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.5 mt -70.96 -44.75 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.147 -1.596 . . . . 9.4600000000000009 109.189 176.527 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -57.44 -52.4 65.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.861 -2.399 . . . . 14.76 110.906 169.076 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -48.62 -53.23 19.33 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.899 3.296 . . . . 26.289999999999999 119.899 171.622 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -82.67 -57.88 3.14 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.191 -4.068 . . . . 30.059999999999999 118.38 179.63 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -86.75 -25.47 24.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.893 1.442 . . . . 25.190000000000001 114.893 -172.563 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.44 23.0 38.31 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 126.703 2.502 . . . . 7.4100000000000001 119.004 -176.585 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.6 mt -96.95 127.23 39.71 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 113.016 -3.374 . . . . 9.4900000000000002 106.466 -175.223 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.3 153.97 18.67 Favored 'Trans proline' 0 C--N 1.299 -2.034 2 C-N-CA 126.941 5.094 . . . . 11.42 112.736 179.038 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.58 -18.19 29.33 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 124.679 3.586 . . . . 12.0 108.469 -159.982 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.261 41.4 m-20 -73.96 -22.97 59.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.1 2.125 . . . . 35.549999999999997 113.206 179.341 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -91.03 -3.57 57.11 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.68 2.487 . . . . 20.52 110.993 179.122 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -94.36 102.66 14.65 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.364 2.347 . . . . 7.1299999999999999 115.77 -166.256 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -90.83 100.6 13.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.392 -3.318 . . . . 36.390000000000001 107.38 158.405 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.0 tp -95.14 106.89 18.94 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.119 -1.855 . . . . 9.5500000000000007 109.659 174.435 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.11 127.24 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 127.619 2.367 . . . . 13.9 109.921 -168.681 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -118.77 111.82 18.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.481 -1.387 . . . . 6.8600000000000003 110.663 173.869 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.01 -103.14 0.11 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.264 2.626 . . . . 11.15 111.666 -165.663 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.42 20.53 3.71 Favored Glycine 0 N--CA 1.431 -1.697 0 O-C-N 118.314 -2.741 . . . . 13.93 107.239 166.469 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -85.93 133.77 33.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.987 2.327 . . . . 23.920000000000002 114.28 165.069 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -93.01 125.91 37.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.628 -1.624 . . . . 23.23 107.628 178.614 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -98.89 144.39 28.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.135 2.772 . . . . 9.1099999999999994 111.593 -174.389 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -113.01 149.51 33.23 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.216 1.96 . . . . 33.439999999999998 110.416 -175.655 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.32 -48.86 79.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.894 2.183 . . . . 28.370000000000001 116.894 -160.917 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.96 7.53 78.85 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 118.761 2.264 . . . . 15.0 118.761 -175.39 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -88.37 149.91 23.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.307 -0.946 . . . . 25.5 109.556 170.775 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 64.8 p -84.86 168.45 15.07 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.38 -2.075 . . . . 11.949999999999999 115.296 176.7 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.0 mt -73.13 -39.23 65.9 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 127.804 2.441 . . . . 10.17 110.605 178.451 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -68.54 -39.27 81.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.874 2.07 . . . . 13.59 112.651 178.383 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.56 -32.86 71.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 121.568 1.985 . . . . 11.699999999999999 109.506 175.739 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.27 -13.04 53.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 122.181 2.264 . . . . 12.949999999999999 106.331 176.358 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.327 59.7 m-20 80.66 28.0 0.23 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.968 2.507 . . . . 25.449999999999999 113.098 -178.471 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.46 HG23 HD13 ' A' ' 61' ' ' ILE . 75.9 mt -81.66 109.33 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.517 -2.614 . . . . 14.6 110.196 -174.555 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -90.71 -178.97 5.41 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.831 2.453 . . . . 33.229999999999997 109.5 -177.282 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.412 ' HA ' ' SD ' ' A' ' 1' ' ' MET 0.258 20.2 pttp -64.78 151.69 44.63 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.077 1.88 . . . . 25.969999999999999 116.077 173.174 . . . . . . . . 3 3 . 1 . 111 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 69.01 19.62 8.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.254 3.421 . . . . 32.609999999999999 117.877 177.03 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -76.39 125.81 29.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.971 2.908 . . . . 10.56 111.654 -176.619 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.6 m -77.66 113.41 15.48 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.065 2.728 . . . . 5.3300000000000001 112.556 177.582 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.91 161.22 14.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.381 1.473 . . . . 11.66 113.62 167.315 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -106.35 132.92 51.82 Favored 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 131.727 4.011 . . . . 16.300000000000001 109.654 164.692 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -116.28 101.62 8.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.229 2.919 . . . . 9.9600000000000009 109.55 171.694 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -99.93 143.65 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 118.89 -2.381 . . . . 9.7599999999999998 108.618 170.704 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.2 mt -101.96 145.5 29.18 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 114.878 -4.889 . . . . 19.57 109.241 -178.012 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -123.07 -158.21 0.78 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 126.246 2.216 . . . . 35.079999999999998 106.02 173.348 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tt -108.37 -55.79 2.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 124.327 3.24 . . . . 32.310000000000002 110.889 168.611 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtt-85 -155.25 -175.13 5.28 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 102.981 -2.97 . . . . 42.75 102.981 178.303 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.81 -117.52 4.9 Favored Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.806 -1.184 . . . . 36.310000000000002 111.603 177.204 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.774 1 N-CA-C 102.41 -4.276 . . . . 36.270000000000003 102.41 -173.548 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptt? . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 113.642 0.979 . . . . 17.170000000000002 113.642 . . . . . . . . . 0 0 . 1 . 112 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -103.59 121.71 43.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.08 2.371 . . . . 21.890000000000001 110.142 176.206 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -111.1 146.41 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.986 -2.321 . . . . 10.83 113.052 168.73 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -108.01 142.74 37.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.22 -1.809 . . . . 10.609999999999999 114.643 -176.876 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.425 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 48.4 t -131.41 119.47 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.847 -3.02 . . . . 9.1300000000000008 102.847 -172.957 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -118.31 115.82 25.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 112.896 -3.431 . . . . 20.550000000000001 110.304 -165.793 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -63.19 175.77 0.88 Allowed 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 129.917 4.51 . . . . 11.779999999999999 112.863 174.992 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.9 tp -67.82 -36.71 80.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.608 -0.724 . . . . 19.309999999999999 112.501 -179.677 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -86.17 -47.87 9.09 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.162 1.785 . . . . 23.140000000000001 107.182 -168.896 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.24 40.69 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 CA-C-O 123.165 1.425 . . . . 19.739999999999998 112.026 168.73 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -90.81 123.83 34.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.211 1.957 . . . . 21.93 111.305 163.101 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -99.54 106.73 18.76 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 111.946 -2.388 . . . . 12.33 108.868 -176.472 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 46.8 mt -96.32 118.53 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.548 -1.345 . . . . 17.079999999999998 109.668 -177.949 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 m -100.19 121.93 42.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.395 -3.316 . . . . 16.300000000000001 105.033 -173.023 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.4 mt -122.42 141.16 51.9 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.421 1.888 . . . . 15.880000000000001 108.357 -176.951 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -100.43 132.87 45.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 127.99 3.757 . . . . 28.899999999999999 107.702 174.24 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -137.23 174.51 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.328 -3.357 . . . . 12.050000000000001 109.456 -175.447 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -122.54 157.11 60.14 Favored Pre-proline 0 N--CA 1.43 -1.464 0 C-N-CA 123.928 0.891 . . . . 18.170000000000002 109.015 151.123 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.5 -25.17 75.69 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.363 2.709 . . . . 8.1600000000000001 113.703 -171.087 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -86.41 7.45 25.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.645 1.566 . . . . 11.130000000000001 112.471 -171.515 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -87.35 147.39 25.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.215 -2.178 . . . . 18.030000000000001 105.62 -172.145 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.4 p -82.77 151.63 26.05 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.301 -2.125 . . . . 10.220000000000001 112.685 -177.658 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -51.94 -43.22 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 130.607 3.563 . . . . 12.300000000000001 109.149 176.84 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.76 -37.74 79.86 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 125.96 2.037 . . . . 36.509999999999998 114.449 178.325 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.254 71.9 m-80 -72.83 -32.91 65.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.662 -2.524 . . . . 25.66 114.803 176.786 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.77 -36.03 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 127.127 2.171 . . . . 8.1199999999999992 110.771 167.188 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -70.69 -26.93 63.65 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.399 -2.688 . . . . 15.470000000000001 115.809 169.05 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.41 72.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.294 1.861 . . . . 11.449999999999999 109.999 167.923 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -63.87 -33.04 74.81 Favored 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 115.694 -4.378 . . . . 24.98 115.24 178.905 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 mt -69.77 -32.3 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.847 -2.408 . . . . 9.4600000000000009 108.682 172.651 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -69.98 -44.88 68.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.927 -3.608 . . . . 14.76 109.188 173.479 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -61.17 -46.03 92.17 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.736 2.208 . . . . 26.289999999999999 116.335 179.286 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -79.01 -60.82 2.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.742 -3.724 . . . . 30.059999999999999 116.647 -174.106 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -86.59 -53.86 4.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 126.182 2.176 . . . . 25.190000000000001 111.443 177.21 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.08 33.58 2.75 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 115.958 -2.579 . . . . 7.4100000000000001 113.958 -172.796 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.52 127.82 36.6 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 130.185 3.394 . . . . 9.4900000000000002 103.826 166.366 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -77.75 161.67 30.39 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-O 112.905 -3.04 . . . . 11.42 115.271 -177.498 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -66.84 -24.7 46.27 Favored 'Trans proline' 0 N--CA 1.434 -1.999 1 CA-C-N 129.772 4.526 . . . . 12.0 116.693 -172.079 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.06 -31.94 72.41 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.491 2.369 . . . . 35.549999999999997 113.418 -174.222 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.402 45.0 mt-30 -72.95 -16.91 61.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 119.427 3.121 . . . . 20.52 119.427 -179.53 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -102.68 110.16 22.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.105 -3.497 . . . . 7.1299999999999999 114.268 -155.521 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -94.14 103.94 15.97 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.178 -2.527 . . . . 36.390000000000001 104.178 169.178 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.08 118.46 31.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.086 2.374 . . . . 9.5500000000000007 110.114 174.773 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.1 mt -113.6 136.72 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 110.563 -3.017 . . . . 13.9 107.584 -179.393 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -120.36 113.35 20.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 101.494 -3.521 . . . . 6.8600000000000003 101.494 172.368 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.74 -117.14 0.47 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.085 -2.26 . . . . 11.15 111.314 -176.125 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.37 25.29 13.97 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 117.911 -2.993 . . . . 13.93 116.656 175.234 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -131.35 142.6 50.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.51 2.576 . . . . 23.920000000000002 109.305 -173.3 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -110.29 141.78 42.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.394 -2.691 . . . . 23.23 111.82 -177.284 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mt -95.2 140.54 29.96 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.134 2.397 . . . . 9.1099999999999994 110.606 -166.646 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -109.61 136.54 48.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.936 -1.938 . . . . 33.439999999999998 111.67 -172.359 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.7 -60.26 2.1 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.532 1.678 . . . . 28.370000000000001 115.532 -170.944 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.82 -4.03 61.04 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 118.797 -2.439 . . . . 15.0 117.805 -173.905 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -83.63 178.78 7.82 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 118.634 1.217 . . . . 25.5 110.689 170.883 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 76.6 p -106.09 178.44 4.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.333 -1.479 . . . . 11.949999999999999 109.958 177.058 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.9 mt -74.18 -33.89 63.6 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.591 1.156 . . . . 10.17 108.29 179.897 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -78.06 -27.35 48.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.389 3.076 . . . . 13.59 111.219 -175.007 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.02 -34.92 79.09 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 116.81 -1.567 . . . . 11.699999999999999 110.005 179.993 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -88.33 1.87 53.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.922 3.289 . . . . 12.949999999999999 114.103 167.521 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m120 58.31 49.07 11.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.25 1.204 . . . . 25.449999999999999 114.25 -178.098 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mm -79.18 113.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.22 -2.175 . . . . 14.6 106.767 170.436 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -87.62 -177.68 5.92 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.924 2.015 . . . . 33.229999999999997 112.42 174.087 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -64.03 134.42 54.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.667 -3.145 . . . . 25.969999999999999 115.408 164.508 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 69.84 31.22 3.53 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.757 2.217 . . . . 32.609999999999999 111.425 173.719 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.267 45.6 t -83.69 134.27 34.77 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.932 1.693 . . . . 10.56 108.54 166.499 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 m -103.96 122.84 46.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.716 -1.24 . . . . 5.3300000000000001 108.377 -179.573 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -81.99 138.71 34.85 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 115.135 -2.364 . . . . 11.66 116.073 165.185 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -88.5 114.61 25.29 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.172 2.17 . . . . 16.300000000000001 107.352 175.281 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.268 9.5 tp -92.55 106.45 18.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 117.672 -1.611 . . . . 9.9600000000000009 112.216 176.092 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.61 138.68 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.836 2.455 . . . . 9.7599999999999998 105.37 179.267 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 mt -103.13 139.93 37.99 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.485 2.032 . . . . 19.57 116.485 -171.897 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -123.18 173.92 7.59 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.855 1.057 . . . . 35.079999999999998 113.855 171.908 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.45 -75.51 0.19 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 117.655 -1.618 . . . . 32.310000000000002 111.92 175.522 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -134.06 -172.23 2.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.285 2.469 . . . . 42.75 105.441 170.267 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.51 -113.13 3.96 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-O 127.471 3.817 . . . . 36.310000000000002 111.416 166.733 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.759 0 O-C-N 118.276 -2.896 . . . . 36.270000000000003 116.414 -166.286 . . . . . . . . 0 0 . 1 . 113 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.283 -0.636 . . . . 17.170000000000002 109.283 . . . . . . . . . 0 0 . 1 . 113 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -89.88 120.97 31.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.185 -0.672 . . . . 21.890000000000001 109.185 165.744 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -117.01 167.88 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 118.499 -2.626 . . . . 10.83 108.129 157.043 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.1 133.96 55.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.847 -2.408 . . . . 10.609999999999999 115.529 -176.163 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -112.62 117.76 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 123.875 1.798 . . . . 9.1300000000000008 110.661 175.323 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -96.58 151.86 19.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 112.278 -3.725 . . . . 20.550000000000001 110.771 177.142 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.6 p -85.21 -176.07 6.0 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 121.675 2.034 . . . . 11.779999999999999 113.327 159.88 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.252 36.5 mt -86.15 -17.93 33.62 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.407 1.003 . . . . 19.309999999999999 113.595 169.329 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 p -77.97 -69.56 0.54 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.575 2.35 . . . . 23.140000000000001 113.196 175.985 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.9 28.25 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.719 1 O-C-N 115.117 -4.739 . . . . 19.739999999999998 111.022 -177.504 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -109.06 130.65 55.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.116 -1.226 . . . . 21.93 111.085 179.091 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -111.17 115.99 30.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.015 -3.553 . . . . 12.33 108.151 173.577 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 pt -105.15 155.39 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 117.261 -1.776 . . . . 17.079999999999998 108.537 171.625 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.1 m -111.91 131.95 55.05 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.917 -2.623 . . . . 16.300000000000001 103.917 -177.287 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.3 tp -144.87 125.94 14.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.679 -2.513 . . . . 15.880000000000001 109.047 -164.885 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.82 103.47 15.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.045 -2.284 . . . . 28.899999999999999 110.996 -172.833 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -131.95 155.45 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 115.379 -0.828 . . . . 12.050000000000001 110.483 176.891 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -85.79 146.41 43.6 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 117.517 -1.23 . . . . 18.170000000000002 110.035 178.153 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.03 -10.69 21.53 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 N-CA-C 118.197 2.345 . . . . 8.1600000000000001 118.197 177.288 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 p -90.83 -7.19 53.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.363 2.665 . . . . 11.130000000000001 114.746 175.927 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -69.56 149.27 48.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.741 -1.224 . . . . 18.030000000000001 110.415 176.402 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -79.78 170.13 16.96 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 117.026 -1.464 . . . . 10.220000000000001 110.492 175.931 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -72.24 -29.04 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 127.062 2.145 . . . . 12.300000000000001 110.761 178.392 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -59.44 -47.39 85.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.369 -2.707 . . . . 36.509999999999998 113.246 163.483 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -62.63 -40.17 96.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.052 2.206 . . . . 25.66 115.163 170.499 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -56.59 -50.91 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 121.499 1.954 . . . . 8.1199999999999992 112.98 171.471 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -68.52 -30.19 68.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.256 -2.778 . . . . 15.470000000000001 112.892 -176.507 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.29 77.53 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.216 1.806 . . . . 11.449999999999999 109.844 174.088 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -80.48 -39.77 27.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.207 1.479 . . . . 24.98 109.882 -176.454 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.4 mt -56.32 -39.26 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.408 -3.932 . . . . 9.4600000000000009 113.665 162.746 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.351 17.6 tt0 -56.31 -51.65 67.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.131 2.972 . . . . 14.76 108.334 167.374 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.62 -37.75 76.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 121.711 2.051 . . . . 26.289999999999999 112.318 -168.181 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -83.01 -66.0 0.94 Allowed 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 129.212 4.07 . . . . 30.059999999999999 116.77 -178.399 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -93.48 -26.16 17.3 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.671 1.188 . . . . 25.190000000000001 112.748 -169.995 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.62 37.88 8.48 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.389 1.471 . . . . 7.4100000000000001 114.427 178.526 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.402 HD12 HD23 ' A' ' 71' ' ' LEU . 4.7 mt -88.9 128.86 50.54 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 118.739 -1.184 . . . . 9.4900000000000002 113.105 160.862 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.39 158.2 36.79 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 123.288 2.659 . . . . 11.42 111.815 170.186 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -90.31 0.28 5.35 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 116.808 -2.259 . . . . 12.0 109.916 -159.931 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -77.09 -29.73 55.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.665 -2.522 . . . . 35.549999999999997 110.755 169.626 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -71.23 -37.77 72.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.089 -2.257 . . . . 20.52 109.174 175.433 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -76.99 116.89 18.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.023 2.231 . . . . 7.1299999999999999 117.023 -164.909 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -115.59 120.31 39.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.1 1.905 . . . . 36.390000000000001 108.482 166.75 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -111.77 112.97 25.03 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.245 -4.034 . . . . 9.5500000000000007 110.442 -169.447 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.6 mm -102.89 137.84 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.479 -2.013 . . . . 13.9 110.026 -177.93 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -106.46 111.58 24.22 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.747 -5.596 . . . . 6.8600000000000003 108.079 153.786 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.44 -99.17 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.192 2.597 . . . . 11.15 115.615 -174.534 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -122.53 8.62 9.46 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 118.985 -2.322 . . . . 13.93 115.018 161.174 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -89.27 124.89 34.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.033 1.333 . . . . 23.920000000000002 114.546 172.475 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -85.47 131.51 34.37 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.145 -2.539 . . . . 23.23 104.145 -179.341 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -93.37 126.76 38.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.379 1.472 . . . . 9.1099999999999994 110.17 -175.653 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -121.0 150.45 41.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.911 2.141 . . . . 33.439999999999998 113.011 -164.77 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.365 67.2 m-20 -18.02 -74.7 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.432 1 C-N-CA 132.285 4.234 . . . . 28.370000000000001 120.039 -168.968 . . . . . . . . 3 2 . 1 . 113 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.38 34.34 5.19 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.713 -2.492 . . . . 15.0 116.339 -164.802 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -133.55 171.34 14.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.862 -1.964 . . . . 25.5 111.949 175.989 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -95.54 167.21 11.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.664 2.029 . . . . 11.949999999999999 112.889 -167.519 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.53 -34.25 76.54 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.53 -2.606 . . . . 10.17 112.908 166.828 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -38.22 79.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.426 1.269 . . . . 13.59 114.426 178.129 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -56.4 -50.38 71.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.596 -3.815 . . . . 11.699999999999999 114.044 177.914 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -77.78 8.42 4.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 127.576 3.048 . . . . 12.949999999999999 113.631 178.163 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 2.0 m120 54.4 40.33 31.69 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 131.748 4.019 . . . . 25.449999999999999 117.222 -179.519 . . . . . . . . 3 2 . 1 . 113 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.346 10.1 mt -77.77 115.72 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.407 -1.433 . . . . 14.6 109.307 178.962 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -91.85 176.06 6.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.207 -3.433 . . . . 33.229999999999997 108.473 176.361 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -69.38 146.91 51.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.346 -2.721 . . . . 25.969999999999999 114.023 176.817 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 71.35 18.59 5.55 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 129.652 3.181 . . . . 32.609999999999999 112.561 -179.102 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.8 m -76.69 148.95 36.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.199 -2.813 . . . . 10.56 112.507 178.949 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.4 m -90.96 106.09 18.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.472 2.309 . . . . 5.3300000000000001 115.735 170.507 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -91.44 152.24 20.46 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.422 2.289 . . . . 11.66 114.311 166.164 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -119.77 125.84 49.57 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.184 -2.822 . . . . 16.300000000000001 103.956 -169.76 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -102.2 123.53 46.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.723 2.409 . . . . 9.9600000000000009 108.053 177.915 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.76 130.6 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 113.41 -1.723 . . . . 9.7599999999999998 114.089 162.292 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.402 HD23 HD12 ' A' ' 36' ' ' ILE . 10.8 mt -98.71 140.89 32.24 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.486 3.114 . . . . 19.57 117.926 176.531 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.266 38.3 ttt180 -73.38 138.53 45.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 115.535 1.68 . . . . 35.079999999999998 115.535 179.188 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.264 76.1 mt -104.68 170.43 7.89 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.028 -1.841 . . . . 32.310000000000002 106.028 176.413 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -75.86 159.69 30.71 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.197 -0.939 . . . . 42.75 112.643 176.493 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 38.18 74.34 0.12 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 117.907 1.923 . . . . 36.310000000000002 117.907 -171.086 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.726 0 CA-C-N 109.112 -3.544 . . . . 36.270000000000003 112.7 -175.218 . . . . . . . . 0 0 . 1 . 114 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ptt? . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 118.514 2.783 . . . . 17.170000000000002 118.514 . . . . . . . . . 0 0 . 1 . 114 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.371 36.7 mt-30 -69.01 128.48 36.85 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.253 -2.129 . . . . 21.890000000000001 105.253 170.569 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 pt -123.4 151.8 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.677 -2.056 . . . . 10.83 110.972 161.983 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -96.37 130.01 43.58 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.738 -0.785 . . . . 10.609999999999999 111.402 174.778 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 76.3 t -119.26 125.14 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 103.126 -2.916 . . . . 9.1300000000000008 103.126 160.966 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -119.48 132.22 55.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 109.983 -3.28 . . . . 20.550000000000001 105.985 -175.942 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.481 HG22 HD21 ' A' ' 69' ' ' LEU . 10.5 p -75.34 157.58 34.07 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.794 -3.066 . . . . 11.779999999999999 109.109 174.552 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.5 mt -61.59 -39.76 92.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.514 -3.241 . . . . 19.309999999999999 114.43 159.283 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -48.02 -34.57 9.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.001 2.12 . . . . 23.140000000000001 112.794 172.141 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.04 -62.88 0.32 Allowed Glycine 0 N--CA 1.43 -1.725 1 O-C-N 114.156 -5.34 . . . . 19.739999999999998 119.801 -178.638 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -80.78 160.76 24.78 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 115.296 -2.561 . . . . 21.93 117.084 -158.251 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.69 131.29 48.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.427 -1.42 . . . . 12.33 109.493 166.641 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 pt -112.9 144.54 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 129.216 3.006 . . . . 17.079999999999998 109.017 157.219 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -106.34 128.22 53.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.129 2.571 . . . . 16.300000000000001 104.97 179.231 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.471 HD13 HG12 ' A' ' 30' ' ' ILE . 0.4 OUTLIER -107.15 129.33 54.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.577 1.551 . . . . 15.880000000000001 110.978 172.902 . . . . . . . . 3 3 . 1 . 114 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -79.73 101.84 8.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 120.318 1.417 . . . . 28.899999999999999 113.451 159.899 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -111.22 166.76 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.624 -3.173 . . . . 12.050000000000001 115.221 173.996 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -95.76 154.96 38.97 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.926 -1.879 . . . . 18.170000000000002 105.926 167.838 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.252 14.1 Cg_exo -63.0 -21.56 73.3 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 N-CA-C 116.008 1.503 . . . . 8.1600000000000001 116.008 170.26 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.5 p -80.96 -2.48 47.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.878 1.671 . . . . 11.130000000000001 115.475 175.351 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.77 148.72 28.76 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.94 3.296 . . . . 18.030000000000001 106.533 -171.017 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.9 p -91.18 164.12 14.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.256 -2.247 . . . . 10.220000000000001 105.551 -179.392 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.414 HG23 ' CD2' ' A' ' 43' ' ' LEU . 41.1 mm -72.48 -30.9 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 116.948 -1.501 . . . . 12.300000000000001 107.124 174.592 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -51.53 -50.96 59.0 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 125.47 3.759 . . . . 36.509999999999998 114.503 168.777 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -60.39 -28.28 68.1 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.388 2.366 . . . . 25.66 117.388 174.087 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.5 t -65.66 -47.86 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 129.251 3.02 . . . . 8.1199999999999992 110.825 172.018 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -70.48 -30.05 66.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.166 2.412 . . . . 15.470000000000001 109.794 178.402 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.62 74.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.365 -3.959 . . . . 11.449999999999999 109.783 -179.133 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -70.48 -27.81 64.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.302 -2.124 . . . . 24.98 108.601 -177.189 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.471 HG12 HD13 ' A' ' 15' ' ' LEU . 89.5 mt -78.17 -24.63 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 114.017 1.117 . . . . 9.4600000000000009 114.017 170.879 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -62.45 -46.12 89.94 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 115.649 -4.407 . . . . 14.76 110.878 169.081 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.5 -42.01 99.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.627 -1.296 . . . . 26.289999999999999 112.953 174.627 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -73.99 -67.81 0.57 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.521 -1.362 . . . . 30.059999999999999 110.711 -171.017 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -90.57 -29.69 17.68 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 113.74 -5.6 . . . . 25.190000000000001 113.191 -177.215 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.0 40.73 1.78 Allowed Glycine 0 N--CA 1.43 -1.752 0 O-C-N 120.082 -1.636 . . . . 7.4100000000000001 111.601 -177.085 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.7 mt -115.4 119.54 37.99 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 119.031 -2.452 . . . . 9.4900000000000002 111.539 -171.786 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.466 ' HB2' ' HG3' ' A' ' 40' ' ' GLN . 8.2 Cg_exo -58.8 140.6 95.8 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.567 2.178 . . . . 11.42 113.313 177.69 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.36 -17.79 42.13 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 124.901 3.734 . . . . 12.0 118.441 179.458 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.8 -37.21 56.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.799 1.407 . . . . 35.549999999999997 114.799 179.386 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' A' ' 37' ' ' PRO . 13.2 mt-30 -61.4 -21.74 64.35 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 121.711 3.967 . . . . 20.52 121.711 167.193 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -88.6 101.73 14.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.482 2.401 . . . . 7.1299999999999999 117.482 -171.378 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -100.74 107.36 18.93 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 125.288 2.471 . . . . 36.390000000000001 110.982 177.072 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' CD2' HG23 ' A' ' 23' ' ' ILE . 8.7 tp -105.99 118.7 37.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.432 -2.667 . . . . 9.5500000000000007 107.375 -161.469 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 36.3 mm -111.99 124.48 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 128.969 2.908 . . . . 13.9 115.988 -166.351 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -112.87 87.13 2.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.651 -3.155 . . . . 6.8600000000000003 108.473 -179.314 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.283 . . 62.52 -93.16 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 114.39 -5.193 . . . . 11.15 110.291 -177.122 . . . . . . . . 3 2 . 1 . 114 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.43 -10.99 22.65 Favored Glycine 0 N--CA 1.43 -1.712 0 O-C-N 126.244 2.215 . . . . 13.93 111.253 176.653 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -88.6 137.27 32.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.417 3.087 . . . . 23.920000000000002 108.395 -172.779 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -107.3 117.93 35.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.354 2.026 . . . . 23.23 107.791 177.322 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -80.66 163.41 23.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.023 -1.673 . . . . 9.1099999999999994 111.989 -170.925 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -106.94 165.39 11.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.284 3.034 . . . . 33.439999999999998 105.447 179.443 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.337 23.7 m-20 -84.12 -54.39 4.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.03 2.348 . . . . 28.370000000000001 117.069 -168.549 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.87 50.79 2.26 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.682 -1.599 . . . . 15.0 116.056 177.749 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -133.39 156.05 48.37 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 100.11 -4.033 . . . . 25.5 100.11 175.811 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 30.2 p -86.04 158.54 19.81 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.258 1.98 . . . . 11.949999999999999 113.242 -170.218 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.28 -36.65 80.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.097 -2.252 . . . . 10.17 116.782 167.239 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.4 t -65.8 -38.14 88.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.341 1.856 . . . . 13.59 111.963 -179.519 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -63.36 -54.37 37.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.387 2.275 . . . . 11.699999999999999 112.129 178.721 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -64.14 -17.99 64.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 120.025 3.343 . . . . 12.949999999999999 120.025 170.588 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 69.9 43.4 0.93 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.399 2.37 . . . . 25.449999999999999 117.399 -172.742 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.01 112.47 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.339 -2.21 . . . . 14.6 112.132 165.416 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -83.31 -179.29 7.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.568 1.651 . . . . 33.229999999999997 108.706 -172.91 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.96 152.45 44.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.414 -1.429 . . . . 25.969999999999999 114.787 162.223 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 57.36 21.69 7.08 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.191 1.922 . . . . 32.609999999999999 116.191 -172.23 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 t -90.47 141.14 29.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.795 1.035 . . . . 10.56 113.795 -179.932 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 m -96.94 93.77 6.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.603 2.816 . . . . 5.3300000000000001 118.603 -174.682 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.6 mt -79.02 161.57 26.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.107 -0.995 . . . . 11.66 109.221 174.893 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 79.0 m-70 -104.37 137.22 42.58 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.44 -2.059 . . . . 16.300000000000001 105.44 173.646 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.481 HD21 HG22 ' A' ' 7' ' ' THR . 62.1 tp -95.02 119.49 33.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 127.491 2.994 . . . . 9.9600000000000009 112.655 160.231 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 t -104.25 120.56 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 106.226 -1.768 . . . . 9.7599999999999998 106.226 174.664 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.0 mt -92.41 178.05 5.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 129.699 3.2 . . . . 19.57 113.577 -171.155 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -160.19 175.93 12.34 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.488 -0.93 . . . . 35.079999999999998 108.488 167.86 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 mt -98.63 -169.98 1.87 Allowed 'General case' 0 N--CA 1.43 -1.455 1 C-N-CA 132.053 4.141 . . . . 32.310000000000002 105.108 163.179 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.254 88.4 mtt-85 -83.48 -64.76 1.11 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.998 -2.314 . . . . 42.75 110.261 -179.946 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.28 76.99 0.66 Allowed Glycine 0 N--CA 1.431 -1.662 0 O-C-N 128.693 3.746 . . . . 36.310000000000002 110.34 -167.483 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.776 1 O-C-N 130.334 4.196 . . . . 36.270000000000003 108.052 -174.526 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptt? . . . . . 0 CA--C 1.49 -1.33 0 CA-C-O 117.706 -1.14 . . . . 17.170000000000002 113.719 . . . . . . . . . 0 0 . 1 . 115 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.22 144.17 45.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.621 2.153 . . . . 21.890000000000001 115.243 167.729 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.8 pt -127.32 163.29 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.529 -1.669 . . . . 10.83 107.861 175.03 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -123.18 130.13 52.34 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 115.28 -2.295 . . . . 10.609999999999999 111.147 -171.037 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.54 112.13 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 CA-C-N 126.331 4.151 . . . . 9.1300000000000008 102.718 -167.511 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -81.94 144.0 31.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.494 1.517 . . . . 20.550000000000001 113.967 -176.849 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.302 81.8 p -98.91 -140.86 0.32 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.722 -2.486 . . . . 11.779999999999999 112.731 -178.45 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.8 -44.97 1.92 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 100.741 -3.8 . . . . 19.309999999999999 100.741 174.003 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -92.24 -74.45 0.51 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.552 1.541 . . . . 23.140000000000001 112.649 -169.692 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.94 -137.04 3.76 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 108.319 -1.913 . . . . 19.739999999999998 108.319 -157.99 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -91.7 160.45 15.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.651 2.167 . . . . 21.93 112.062 -172.512 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.6 m -77.01 116.72 17.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.651 -3.78 . . . . 12.33 109.691 172.098 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.3 pt -79.37 160.39 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.79 -2.444 . . . . 17.079999999999998 112.356 179.403 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -124.79 132.96 53.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.504 -2.622 . . . . 16.300000000000001 107.422 -175.893 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 mt -121.8 142.39 50.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.261 -0.644 . . . . 15.880000000000001 109.261 177.565 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -99.82 110.57 22.94 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.206 -2.184 . . . . 28.899999999999999 109.217 168.227 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.5 164.84 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 131.252 3.821 . . . . 12.050000000000001 109.915 -170.532 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.272 52.0 mm-40 -110.42 155.14 42.51 Favored Pre-proline 0 N--CA 1.43 -1.453 1 O-C-N 116.011 -4.181 . . . . 18.170000000000002 102.558 172.896 . . . . . . . . 3 2 . 1 . 115 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -66.07 -19.62 57.28 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 127.876 3.849 . . . . 8.1600000000000001 114.654 176.47 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 p -75.99 -5.63 47.2 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.751 2.021 . . . . 11.130000000000001 115.292 179.526 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -78.2 142.45 37.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.1 -1.0 . . . . 18.030000000000001 110.161 171.903 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 40.8 p -81.66 169.19 17.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.1 2.381 . . . . 10.220000000000001 113.501 177.359 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.38 -29.11 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.693 -2.504 . . . . 12.300000000000001 107.942 -178.438 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.18 -34.91 66.26 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.785 1.634 . . . . 36.509999999999998 113.627 175.886 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.6 -40.22 78.62 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.385 -2.721 . . . . 25.66 116.578 161.424 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.65 -38.26 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 123.143 1.449 . . . . 8.1199999999999992 108.369 176.468 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 89.6 mttt -57.29 -36.02 70.53 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 115.336 -4.603 . . . . 15.470000000000001 114.618 171.871 . . . . . . . . 3 3 . 1 . 115 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.91 94.06 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 130.376 4.797 . . . . 11.449999999999999 110.685 176.124 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.284 56.2 mttm -61.4 -42.41 98.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.771 1.623 . . . . 24.98 114.943 167.987 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 27' ' ' LYS . 63.8 mt -60.55 -32.71 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.733 -3.105 . . . . 9.4600000000000009 117.34 176.358 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -58.86 -48.94 79.61 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.979 -2.95 . . . . 14.76 115.475 167.497 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.54 -62.79 1.42 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.142 -3.474 . . . . 26.289999999999999 114.224 162.386 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -64.87 -42.03 95.18 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.673 2.101 . . . . 30.059999999999999 116.673 -170.528 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -106.59 -50.55 3.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.264 -1.522 . . . . 25.190000000000001 113.258 174.143 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.37 5.18 6.16 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 125.029 2.461 . . . . 7.4100000000000001 116.524 -178.039 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.1 mt -82.86 133.69 48.3 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 119.741 -2.035 . . . . 9.4900000000000002 109.655 -177.502 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -64.12 146.35 90.58 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 125.771 4.314 . . . . 11.42 118.021 174.278 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.485 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 72.4 Cg_exo -61.54 -20.71 69.75 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 124.273 2.562 . . . . 12.0 116.736 -173.057 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -82.44 -18.17 42.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.523 1.139 . . . . 35.549999999999997 112.922 -179.874 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -100.06 -4.44 29.88 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 117.592 -1.194 . . . . 20.52 113.709 -176.256 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.05 135.23 33.71 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.106 3.362 . . . . 7.1299999999999999 114.999 175.6 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -129.57 118.38 21.93 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.943 -1.723 . . . . 36.390000000000001 107.946 176.336 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mt -101.5 137.29 40.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.421 1.581 . . . . 9.5500000000000007 109.529 -177.338 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.9 mm -137.36 130.93 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 100.268 -3.975 . . . . 13.9 100.268 -173.191 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -119.94 121.18 38.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 113.377 -3.202 . . . . 6.8600000000000003 109.105 170.705 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.33 -116.26 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.931 2.605 . . . . 11.15 107.599 -174.664 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.5 34.41 4.55 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 118.739 -2.476 . . . . 13.93 113.091 164.375 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -113.36 123.98 51.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.644 -2.092 . . . . 23.920000000000002 108.681 -179.882 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -77.21 119.38 20.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.647 -2.533 . . . . 23.23 111.625 171.743 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.6 mt -90.52 136.16 33.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.995 -2.315 . . . . 9.1099999999999994 115.466 -174.89 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -96.45 128.67 43.59 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.111 -1.618 . . . . 33.439999999999998 114.082 178.855 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -31.72 -52.93 0.25 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.94 3.696 . . . . 28.370000000000001 117.037 -177.627 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.57 0.46 82.97 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 119.012 -2.305 . . . . 15.0 110.322 -165.161 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -91.33 168.35 11.64 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 118.145 0.972 . . . . 25.5 112.212 170.756 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 66.4 p -109.37 178.82 4.33 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.4 -3.312 . . . . 11.949999999999999 108.118 -176.11 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -75.32 -33.81 61.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.422 2.535 . . . . 10.17 111.003 179.579 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -35.89 77.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.445 -3.909 . . . . 13.59 109.242 168.383 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.27 -36.64 71.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 122.42 2.373 . . . . 11.699999999999999 112.798 -176.336 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -83.16 3.43 30.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.277 2.231 . . . . 12.949999999999999 109.794 -177.706 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 49.59 51.52 16.29 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 115.069 1.507 . . . . 25.449999999999999 115.069 -169.766 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mt -102.81 113.86 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 127.161 2.788 . . . . 14.6 113.092 -179.784 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -97.31 -175.25 3.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.778 3.18 . . . . 33.229999999999997 109.535 -174.377 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -73.3 154.5 40.12 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.426 -3.296 . . . . 25.969999999999999 112.889 -175.156 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 76.33 13.68 2.49 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.022 2.129 . . . . 32.609999999999999 109.303 170.499 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 m -87.41 141.77 28.38 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 127.214 2.821 . . . . 10.56 109.703 -172.901 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.1 m -83.94 115.55 22.36 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 123.528 1.632 . . . . 5.3300000000000001 112.804 176.116 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.4 mt -87.29 147.65 25.43 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.923 1.344 . . . . 11.66 110.906 162.674 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -105.36 131.06 53.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.97 -3.582 . . . . 16.300000000000001 109.661 172.85 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 tp -112.39 117.66 33.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.255 3.407 . . . . 9.9600000000000009 107.721 179.929 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.37 151.9 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 101.366 -3.568 . . . . 9.7599999999999998 101.366 -168.15 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.68 139.96 38.23 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.702 -3.124 . . . . 19.57 109.431 -171.669 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -140.01 156.39 46.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.727 1.727 . . . . 35.079999999999998 110.897 173.05 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.05 -171.16 2.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.583 3.563 . . . . 32.310000000000002 105.01 -175.658 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -82.87 -49.3 9.81 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.114 -4.741 . . . . 42.75 109.632 178.464 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.92 71.65 2.72 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.245 -1.535 . . . . 36.310000000000002 111.971 -177.551 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.737 0 N-CA-C 106.819 -2.512 . . . . 36.270000000000003 106.819 -158.288 . . . . . . . . 0 0 . 1 . 116 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 118.71 2.856 . . . . 17.170000000000002 118.71 . . . . . . . . . 0 0 . 1 . 116 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -93.24 124.66 37.37 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.241 -4.037 . . . . 21.890000000000001 106.225 -174.043 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.327 0.9 OUTLIER -110.31 166.69 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 119.784 -1.822 . . . . 10.83 109.578 167.341 . . . . . . . . 3 3 . 1 . 116 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -117.56 120.74 39.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.636 2.16 . . . . 10.609999999999999 116.534 176.241 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -99.17 105.78 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.222 -2.799 . . . . 9.1300000000000008 114.941 176.766 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -102.94 133.89 47.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.802 -3.061 . . . . 20.550000000000001 109.39 -171.74 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.316 17.1 p -93.29 -177.71 4.53 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.119 -4.113 . . . . 11.779999999999999 110.559 -172.77 . . . . . . . . 3 2 . 1 . 116 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.8 mt -74.42 -67.13 0.65 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.233 2.613 . . . . 19.309999999999999 105.322 175.947 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -125.76 129.42 49.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.309 2.256 . . . . 23.140000000000001 106.645 176.166 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.81 -114.06 0.73 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.506 -2.621 . . . . 19.739999999999998 108.492 176.994 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -158.43 163.54 37.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 126.948 3.261 . . . . 21.93 103.581 -178.01 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.7 m -92.38 135.17 34.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.195 -2.191 . . . . 12.33 112.669 178.31 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 pt -110.12 139.47 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.453 -3.28 . . . . 17.079999999999998 111.025 -174.517 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.4 m -101.5 121.11 41.36 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.033 -2.58 . . . . 16.300000000000001 104.033 -175.572 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 mt -119.95 172.42 7.74 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.169 -2.207 . . . . 15.880000000000001 111.504 179.995 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -120.42 120.43 35.91 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.264 -2.772 . . . . 28.899999999999999 114.085 178.062 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -138.2 167.65 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 126.763 2.539 . . . . 12.050000000000001 109.558 -177.756 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -122.96 158.34 57.7 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 121.05 1.75 . . . . 18.170000000000002 108.168 176.902 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.16 -19.58 66.22 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 O-C-N 113.932 -3.772 . . . . 8.1600000000000001 118.278 -179.838 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -82.9 -1.83 53.22 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 118.937 2.94 . . . . 11.130000000000001 118.937 177.577 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -78.78 144.69 34.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.703 -0.623 . . . . 18.030000000000001 109.4 173.719 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 p -76.42 173.84 10.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.206 -2.184 . . . . 10.220000000000001 114.97 165.012 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.6 mm -63.33 -42.99 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.869 1.795 . . . . 12.300000000000001 112.572 174.414 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -49.43 -39.29 32.41 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 131.006 3.723 . . . . 36.509999999999998 113.511 175.583 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -75.45 -17.02 60.26 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.664 -2.522 . . . . 25.66 115.374 172.271 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.54 -44.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.139 -1.601 . . . . 8.1199999999999992 114.234 167.463 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -51.71 -22.89 3.85 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.227 1.936 . . . . 15.470000000000001 116.227 175.659 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.01 -27.3 23.3 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.209 0.913 . . . . 11.449999999999999 109.073 -174.847 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.26 -26.06 65.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.883 2.873 . . . . 24.98 113.428 167.352 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 11.2 mt -89.35 -31.75 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.522 -1.986 . . . . 9.4600000000000009 111.261 175.1 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -57.26 -37.45 72.35 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.769 -4.332 . . . . 14.76 114.307 168.461 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -64.68 -55.64 18.83 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.289 -1.815 . . . . 26.289999999999999 112.205 168.191 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -75.97 -51.53 12.2 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.708 1.88 . . . . 30.059999999999999 114.592 -161.171 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -94.59 -42.92 8.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.008 2.813 . . . . 25.190000000000001 116.659 179.578 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.38 33.14 2.57 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 109.94 -3.3 . . . . 7.4100000000000001 113.563 161.388 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.6 mt -91.22 137.88 26.04 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 114.626 -2.607 . . . . 9.4900000000000002 109.399 -179.071 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -61.9 137.56 68.34 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 124.759 3.639 . . . . 11.42 114.087 178.985 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.42 -26.54 62.96 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 127.126 3.581 . . . . 12.0 118.241 -168.564 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -63.03 -31.41 72.54 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.26 2.224 . . . . 35.549999999999997 113.405 171.552 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -86.55 -25.78 24.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.229 2.212 . . . . 20.52 112.964 -179.909 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -73.54 118.0 15.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.674 -2.516 . . . . 7.1299999999999999 112.228 178.328 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -110.15 118.39 36.26 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.411 1.46 . . . . 36.390000000000001 111.45 166.418 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.3 mt -98.9 124.52 43.88 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.097 -2.186 . . . . 9.5500000000000007 105.097 178.719 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.402 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 51.4 mm -105.21 120.06 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 126.621 1.969 . . . . 13.9 110.9 173.126 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.73 111.32 22.42 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.37 2.51 . . . . 6.8600000000000003 105.277 167.853 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.342 . . 55.37 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.17 2.188 . . . . 11.15 116.189 -167.763 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.81 -23.5 6.47 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 116.33 1.292 . . . . 13.93 116.33 -177.294 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.44 167.8 9.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.938 -2.131 . . . . 23.920000000000002 114.393 -172.832 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -92.42 148.98 21.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.536 -2.12 . . . . 23.23 108.851 176.691 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -102.5 121.5 42.48 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.942 -2.349 . . . . 9.1099999999999994 111.517 177.317 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.276 35.2 mt-10 -103.56 139.99 38.13 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.189 -1.569 . . . . 33.439999999999998 114.494 -166.498 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -29.37 -67.43 0.08 Allowed 'General case' 0 N--CA 1.43 -1.453 1 N-CA-C 122.068 4.099 . . . . 28.370000000000001 122.068 -161.466 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.97 24.99 28.88 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.7 -1.875 . . . . 15.0 115.814 -175.658 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -99.58 146.73 26.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.586 3.168 . . . . 25.5 109.966 166.23 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -85.95 167.26 15.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.857 1.663 . . . . 11.949999999999999 110.24 -162.46 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.19 -12.33 59.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.039 -1.467 . . . . 10.17 107.039 176.729 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -68.47 -50.91 48.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.146 1.378 . . . . 13.59 111.037 175.991 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -56.48 -49.35 74.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.848 3.259 . . . . 11.699999999999999 108.738 176.287 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -71.18 -20.15 62.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.16 1.541 . . . . 12.949999999999999 115.16 -178.851 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.346 32.5 t30 51.05 68.63 0.76 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.308 -2.12 . . . . 25.449999999999999 109.891 -172.335 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.68 138.2 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 100.929 -3.73 . . . . 14.6 100.929 167.215 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -123.77 -173.29 2.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.621 -1.925 . . . . 33.229999999999997 111.014 -176.455 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -75.35 146.65 40.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.045 -2.284 . . . . 25.969999999999999 109.128 -177.369 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 65.12 22.79 12.33 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 128.118 2.567 . . . . 32.609999999999999 112.408 166.901 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 t -101.09 159.78 14.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.985 2.326 . . . . 10.56 112.031 -175.56 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.8 m -111.36 109.34 19.28 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.261 -4.649 . . . . 5.3300000000000001 111.168 -166.088 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.0 mt -84.86 146.86 27.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.177 -1.577 . . . . 11.66 110.445 162.565 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 14.7 m170 -106.9 125.69 51.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.068 -3.52 . . . . 16.300000000000001 107.433 179.841 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.256 47.3 tp -103.93 111.43 23.96 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 123.83 3.014 . . . . 9.9600000000000009 102.927 -172.832 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.3 t -107.34 152.46 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 104.849 -2.278 . . . . 9.7599999999999998 104.849 -176.526 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.4 136.53 33.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.8 -2.296 . . . . 19.57 104.8 165.809 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -95.03 133.11 39.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.363 -1.46 . . . . 35.079999999999998 110.255 163.707 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.0 tp -104.49 -164.07 1.02 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.14 -1.429 . . . . 32.310000000000002 107.14 176.173 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -68.04 150.55 48.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.327 -2.108 . . . . 42.75 115.448 178.251 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.23 -71.48 0.3 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.243 -1.536 . . . . 36.310000000000002 116.161 176.287 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.78 0 N-CA-C 105.68 -2.968 . . . . 36.270000000000003 105.68 -173.73 . . . . . . . . 0 0 . 1 . 117 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 CA--C 1.49 -1.362 0 CA-C-O 125.934 2.778 . . . . 17.170000000000002 114.697 . . . . . . . . . 0 0 . 1 . 117 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.51 119.11 11.77 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 121.361 3.837 . . . . 21.890000000000001 121.361 168.191 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.443 HG13 ' HB2' ' A' ' 15' ' ' LEU 0.417 29.7 pt -111.31 130.08 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 103.652 -2.721 . . . . 10.83 103.652 169.693 . . . . . . . . 3 3 . 1 . 117 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -91.05 121.66 33.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.794 0.807 . . . . 10.609999999999999 111.986 171.92 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -116.75 106.61 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 O-C-N 114.882 -4.887 . . . . 9.1300000000000008 108.871 176.27 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 12' ' ' THR . 76.4 tttt -84.94 112.44 20.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 118.27 2.692 . . . . 20.550000000000001 118.27 169.753 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 m -76.84 134.88 38.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.034 -3.541 . . . . 11.779999999999999 107.398 163.971 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.93 -48.79 33.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.807 -3.058 . . . . 19.309999999999999 112.179 -175.23 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 m -93.48 98.26 11.08 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.186 -2.821 . . . . 23.140000000000001 107.546 161.879 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.57 -126.19 2.16 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 106.268 -2.733 . . . . 19.739999999999998 106.268 -175.973 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -156.77 170.44 22.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.793 -2.592 . . . . 21.93 109.879 173.641 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 41.6 m -79.97 104.61 10.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.024 2.345 . . . . 12.33 114.662 167.233 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.8 pt -90.42 165.6 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 124.321 2.01 . . . . 17.079999999999998 108.379 171.077 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 13.1 m -118.65 125.28 49.38 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.287 3.035 . . . . 16.300000000000001 107.431 179.064 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.443 ' HB2' HG13 ' A' ' 3' ' ' ILE . 59.6 mt -116.24 127.26 54.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.135 1.921 . . . . 15.880000000000001 107.658 -178.779 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -89.57 95.05 10.1 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.256 -4.653 . . . . 28.899999999999999 116.628 175.267 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.89 160.68 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.541 -1.974 . . . . 12.050000000000001 110.253 -171.575 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -97.82 147.41 33.0 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 118.968 -2.332 . . . . 18.170000000000002 108.526 163.176 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.3 -13.21 31.14 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 N-CA-C 120.779 3.338 . . . . 8.1600000000000001 120.779 -175.437 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 m -99.91 -7.95 24.62 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.369 -1.457 . . . . 11.130000000000001 113.752 -168.526 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.58 172.63 13.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.79 -2.444 . . . . 18.030000000000001 111.492 178.964 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -92.14 161.83 14.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.322 1.601 . . . . 10.220000000000001 115.322 178.07 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -65.63 -30.13 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.891 3.276 . . . . 12.300000000000001 111.482 -172.654 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -70.23 -22.7 62.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.97 1.708 . . . . 36.509999999999998 113.318 176.481 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -82.64 -18.48 40.95 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.65 2.38 . . . . 25.66 110.902 170.744 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.46 -43.42 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 121.034 1.743 . . . . 8.1199999999999992 107.709 176.966 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -54.86 -24.55 23.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 121.486 3.884 . . . . 15.470000000000001 121.486 173.441 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.271 . . -70.87 -29.44 65.54 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.659 2.783 . . . . 11.449999999999999 114.04 177.738 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -85.94 -35.12 20.67 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.968 -2.957 . . . . 24.98 107.132 -177.192 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 mt -54.29 -52.23 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 129.399 3.08 . . . . 9.4600000000000009 113.138 168.397 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -53.18 -49.29 66.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 131.13 3.772 . . . . 14.76 118.307 167.355 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -53.8 -57.95 9.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 121.85 2.114 . . . . 26.289999999999999 111.142 164.25 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -77.73 -54.9 5.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.957 -2.339 . . . . 30.059999999999999 116.291 -162.071 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -92.15 -35.9 13.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.19 -1.569 . . . . 25.190000000000001 112.82 178.782 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.53 69.86 1.15 Allowed Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 109.524 -1.43 . . . . 7.4100000000000001 109.524 -178.118 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.5 mt -138.12 123.41 12.36 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 102.352 -3.203 . . . . 9.4900000000000002 102.352 171.481 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -72.43 164.11 36.61 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 124.504 3.47 . . . . 11.42 111.807 179.366 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.14 -1.34 9.82 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 C-N-CA 123.042 2.495 . . . . 12.0 114.583 -163.319 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -93.94 -19.99 20.42 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.004 2.522 . . . . 35.549999999999997 109.732 173.757 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -84.62 -33.79 23.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 126.479 3.038 . . . . 20.52 112.727 175.833 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.36 143.44 51.94 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 126.366 2.984 . . . . 7.1299999999999999 117.815 177.983 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -154.13 123.88 6.7 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 114.111 -5.368 . . . . 36.390000000000001 100.41 179.813 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.87 126.84 50.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.6 3.16 . . . . 9.5500000000000007 107.428 -172.827 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.9 mm -118.41 132.98 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.451 -1.685 . . . . 13.9 106.451 -174.362 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -106.11 93.81 4.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 105.222 -2.14 . . . . 6.8600000000000003 105.222 178.151 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.98 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.535 2.334 . . . . 11.15 114.812 -171.813 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.14 -1.44 7.35 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 118.093 -2.88 . . . . 13.93 112.336 -179.578 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -90.65 147.8 23.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 115.807 -2.044 . . . . 23.920000000000002 116.075 170.547 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -98.94 138.74 35.62 Favored 'General case' 0 N--CA 1.43 -1.462 1 CA-C-O 129.351 4.405 . . . . 23.23 105.214 171.094 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.4 mt -88.62 151.96 22.13 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.434 -3.916 . . . . 9.1099999999999994 114.133 171.197 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -116.14 157.49 24.7 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.943 1.402 . . . . 33.439999999999998 110.806 178.098 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -63.51 -50.71 68.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.504 2.779 . . . . 28.370000000000001 118.504 -163.027 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.99 -2.05 90.46 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 118.402 2.121 . . . . 15.0 118.402 -161.127 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 65.5 mtp180 -101.8 158.85 15.82 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.521 2.105 . . . . 25.5 107.617 -169.979 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.301 45.0 p -83.74 159.1 21.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.3 -2.75 . . . . 11.949999999999999 111.029 -169.766 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.75 -43.97 69.57 Favored 'General case' 0 N--CA 1.43 -1.473 2 CA-C-O 129.674 4.559 . . . . 10.17 119.353 169.014 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 p -51.64 -42.87 62.36 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.603 -3.185 . . . . 13.59 117.543 166.684 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -56.7 -50.14 73.05 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.598 -3.189 . . . . 11.699999999999999 116.682 -179.942 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -65.43 -29.1 69.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 111.832 -2.44 . . . . 12.949999999999999 117.077 169.604 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 m120 83.49 55.5 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 129.041 3.963 . . . . 25.449999999999999 112.125 174.722 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.334 72.7 mt -84.92 149.17 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.529 -1.982 . . . . 14.6 107.941 177.507 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -147.99 -162.44 1.55 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.702 -3.124 . . . . 33.229999999999997 108.022 -173.172 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -76.42 132.79 39.88 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.734 -1.229 . . . . 25.969999999999999 108.024 -170.268 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 74.42 10.26 4.25 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 131.346 3.858 . . . . 32.609999999999999 110.84 167.095 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -58.97 141.04 54.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.631 1.105 . . . . 10.56 112.799 170.139 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.0 m -112.3 102.52 10.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.72 -2.696 . . . . 5.3300000000000001 103.72 -168.345 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.17 148.86 22.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.845 3.658 . . . . 11.66 105.004 179.223 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -115.54 127.9 55.59 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.377 -1.452 . . . . 16.300000000000001 109.06 176.897 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.2 tp -95.27 116.05 28.24 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.336 2.493 . . . . 9.9600000000000009 107.213 -178.706 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.71 141.36 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 100.295 -3.965 . . . . 9.7599999999999998 100.295 -171.505 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.8 mt -87.64 119.29 27.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.892 -2.38 . . . . 19.57 113.906 174.962 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -105.57 141.54 36.86 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.512 -3.242 . . . . 35.079999999999998 112.4 -176.692 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.8 tp -96.17 -122.27 0.12 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 114.934 -2.46 . . . . 32.310000000000002 106.954 173.621 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -136.24 152.69 51.01 Favored 'General case' 0 N--CA 1.43 -1.457 1 CA-C-N 126.007 4.003 . . . . 42.75 103.868 178.535 . . . . . . . . 2 2 . 1 . 117 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.55 -55.07 4.16 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 113.822 -1.535 . . . . 36.310000000000002 110.643 -177.688 . . . . . . . . 1 1 . 1 . 117 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.781 0 O-C-N 118.496 -2.767 . . . . 36.270000000000003 109.237 -175.61 . . . . . . . . 0 0 . 1 . 118 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 108.375 -0.972 . . . . 17.170000000000002 108.375 . . . . . . . . . 0 0 . 1 . 118 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -83.03 115.2 21.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.788 2.435 . . . . 21.890000000000001 110.424 -173.081 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pp -120.27 155.71 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.152 -2.536 . . . . 10.83 104.152 175.959 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -100.85 134.55 43.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.312 -3.367 . . . . 10.609999999999999 106.607 -176.338 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.88 117.69 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 121.111 -0.993 . . . . 9.1300000000000008 108.971 160.87 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -98.66 117.22 32.63 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.748 0.819 . . . . 20.550000000000001 111.694 -178.093 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 m -79.02 127.7 32.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.23 -2.169 . . . . 11.779999999999999 113.135 161.098 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.61 -59.79 2.57 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.207 -2.145 . . . . 19.309999999999999 105.207 -174.968 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.259 8.2 m -87.54 71.43 9.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 112.888 0.699 . . . . 23.140000000000001 112.888 168.346 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.11 -128.48 1.42 Allowed Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 109.627 -1.389 . . . . 19.739999999999998 109.627 -175.342 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.258 20.6 pttm -132.45 179.45 6.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 131.107 3.763 . . . . 21.93 117.157 173.465 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -105.52 119.16 38.4 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.167 -4.083 . . . . 12.33 108.709 178.098 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 pt -104.02 143.02 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 117.314 -3.366 . . . . 17.079999999999998 110.462 173.847 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -96.9 134.33 40.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.626 2.632 . . . . 16.300000000000001 107.129 170.811 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.7 mt -121.86 140.89 51.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.197 -2.274 . . . . 15.880000000000001 111.118 175.474 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -103.95 90.39 3.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.155 2.883 . . . . 28.899999999999999 111.968 177.596 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.56 176.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 C-N-CA 132.07 4.148 . . . . 12.050000000000001 111.504 -170.204 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.259 37.5 tt0 -134.34 144.06 49.54 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 117.703 -1.142 . . . . 18.170000000000002 112.862 167.551 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -65.69 -16.92 55.37 Favored 'Trans proline' 0 C--N 1.3 -2.025 1 C-N-CA 126.876 5.051 . . . . 8.1600000000000001 115.184 -169.912 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -66.83 -20.92 66.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.112 3.765 . . . . 11.130000000000001 117.245 166.165 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -73.04 159.65 33.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.141 1.924 . . . . 18.030000000000001 113.029 179.878 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.6 p -86.9 154.16 21.06 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.552 1.541 . . . . 10.220000000000001 109.225 166.062 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 mm -56.58 -51.15 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 125.016 1.448 . . . . 12.300000000000001 108.597 167.334 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.279 37.8 tp10 -37.25 -35.54 0.11 Allowed 'General case' 0 N--CA 1.43 -1.436 1 N-CA-C 123.37 4.582 . . . . 36.509999999999998 123.37 166.823 . . . . . . . . 3 2 . 1 . 118 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -74.84 -33.72 62.18 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 111.733 -6.854 . . . . 25.66 118.535 167.756 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -67.86 -45.22 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 128.36 2.664 . . . . 8.1199999999999992 106.623 175.678 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -55.47 -40.99 72.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.898 3.237 . . . . 15.470000000000001 111.107 176.358 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.33 -17.39 60.84 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 111.586 -6.946 . . . . 11.449999999999999 120.652 176.49 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -75.36 -34.54 61.17 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.098 -2.876 . . . . 24.98 112.708 173.198 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.3 mt -63.82 -43.23 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 119.601 -1.937 . . . . 9.4600000000000009 113.736 173.004 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -50.93 -51.05 56.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.805 2.566 . . . . 14.76 116.527 167.399 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.63 -42.7 70.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.619 1.967 . . . . 26.289999999999999 112.513 -169.281 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -76.32 -47.44 23.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.386 -1.768 . . . . 30.059999999999999 114.717 -178.682 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -102.78 -53.64 2.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 116.12 -1.895 . . . . 25.190000000000001 107.913 -169.267 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.91 -31.69 1.33 Allowed Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 122.549 2.431 . . . . 7.4100000000000001 112.08 -175.962 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 19.8 mt -61.32 115.9 16.96 Favored Pre-proline 0 N--CA 1.431 -1.403 1 O-C-N 131.579 4.929 . . . . 9.4900000000000002 117.089 -164.287 . . . . . . . . 3 2 . 1 . 118 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -82.16 148.89 15.19 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 CA-C-N 129.263 4.344 . . . . 11.42 108.448 -169.825 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.5 -12.61 25.17 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 124.652 3.568 . . . . 12.0 119.642 -170.094 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -79.84 -33.51 40.14 Favored 'General case' 0 N--CA 1.43 -1.459 1 CA-C-O 131.789 5.566 . . . . 35.549999999999997 110.778 179.123 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -76.94 -20.41 56.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 110.019 -3.264 . . . . 20.52 112.671 -176.92 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -76.34 149.34 37.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.53 2.586 . . . . 7.1299999999999999 108.268 -178.795 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -145.29 95.89 2.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.739 -2.476 . . . . 36.390000000000001 111.741 161.549 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.2 mt -84.37 121.41 27.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.035 -0.984 . . . . 9.5500000000000007 113.296 -175.753 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.1 mm -107.2 136.47 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 122.886 1.327 . . . . 13.9 110.239 171.284 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -116.3 114.84 24.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.562 -2.014 . . . . 6.8600000000000003 105.562 167.674 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.82 -112.28 0.5 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.855 1.262 . . . . 11.15 113.431 -164.405 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.5 -4.49 43.3 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 126.211 2.195 . . . . 13.93 112.992 -174.398 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -93.89 121.64 35.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.076 2.551 . . . . 23.920000000000002 105.544 -175.912 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -83.81 102.45 12.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.67 1.988 . . . . 23.23 107.335 169.238 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -51.81 132.57 31.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.104 3.002 . . . . 9.1099999999999994 119.104 -173.511 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -109.23 139.89 43.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.618 2.628 . . . . 33.439999999999998 111.325 179.943 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -64.24 -43.23 95.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 109.893 -3.321 . . . . 28.370000000000001 116.065 -148.322 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.52 -6.15 88.86 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 127.652 2.549 . . . . 15.0 110.752 -171.787 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -86.9 158.45 19.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.405 3.002 . . . . 25.5 109.78 -177.464 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.9 p -89.81 158.65 17.39 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.627 -3.171 . . . . 11.949999999999999 110.45 179.658 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.5 mt -59.16 -45.0 92.13 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.797 -1.547 . . . . 10.17 113.951 175.056 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.377 71.5 p -43.57 -43.55 5.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.348 2.659 . . . . 13.59 114.509 165.7 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -63.25 -40.91 98.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.53 1.633 . . . . 11.699999999999999 115.198 179.829 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -82.58 -18.79 40.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.842 2.057 . . . . 12.949999999999999 110.564 -176.673 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.382 12.5 m120 80.8 32.41 0.15 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.145 2.178 . . . . 25.449999999999999 111.513 -179.09 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.4 mt -91.57 106.18 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 128.072 2.549 . . . . 14.6 109.165 179.177 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -103.18 -173.58 2.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.744 3.217 . . . . 33.229999999999997 110.755 -169.354 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -68.22 158.33 33.52 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.072 2.669 . . . . 25.969999999999999 114.248 178.022 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 41.1 mt-10 72.75 5.02 5.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.438 1.895 . . . . 32.609999999999999 108.528 169.004 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -70.01 149.69 47.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.659 -1.901 . . . . 10.56 115.854 169.507 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.6 m -120.08 121.7 39.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.124 2.392 . . . . 5.3300000000000001 105.265 -168.942 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.54 128.04 43.1 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.297 -4.627 . . . . 11.66 109.052 172.978 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.326 35.1 m80 -97.7 132.78 43.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.644 2.474 . . . . 16.300000000000001 113.699 175.465 . . . . . . . . 2 2 . 1 . 118 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tt -108.45 112.63 25.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.21 1.481 . . . . 9.9600000000000009 109.482 -169.558 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 t -92.45 129.28 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 116.401 -1.762 . . . . 9.7599999999999998 110.491 164.46 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt -89.56 121.8 32.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.527 2.331 . . . . 19.57 106.821 177.063 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -113.61 168.76 9.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.151 3.019 . . . . 35.079999999999998 119.151 -172.462 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.8 mt -105.73 -174.25 2.49 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 116.439 -1.743 . . . . 32.310000000000002 106.373 174.825 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -92.8 171.56 8.9 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.746 2.212 . . . . 42.75 116.621 177.693 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.11 28.4 1.85 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 112.692 -2.049 . . . . 36.310000000000002 113.757 -178.61 . . . . . . . . 1 1 . 1 . 118 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.741 0 C-N-CA 114.214 -3.851 . . . . 36.270000000000003 112.941 174.804 . . . . . . . . 0 0 . 1 . 119 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 114.839 1.422 . . . . 17.170000000000002 114.839 . . . . . . . . . 0 0 . 1 . 119 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.53 135.32 39.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.588 -3.82 . . . . 21.890000000000001 112.833 168.352 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.2 pt -127.63 160.0 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.43 3.014 . . . . 10.83 106.397 159.956 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -103.07 148.48 25.67 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 109.355 -3.566 . . . . 10.609999999999999 112.67 -178.473 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -125.03 119.58 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 121.086 1.766 . . . . 9.1300000000000008 108.616 167.465 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -95.43 85.67 4.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 125.261 1.601 . . . . 20.550000000000001 114.819 -176.977 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.5 m -83.32 141.47 31.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.45 -0.945 . . . . 11.779999999999999 108.45 171.962 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.1 mt -86.2 -54.1 4.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.965 1.306 . . . . 19.309999999999999 112.56 179.706 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -89.43 63.77 6.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.746 2.213 . . . . 23.140000000000001 107.054 -176.385 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.74 -135.15 3.71 Favored Glycine 0 N--CA 1.429 -1.77 1 CA-C-N 107.994 -4.184 . . . . 19.739999999999998 103.774 -174.035 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -143.45 174.2 10.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.363 2.357 . . . . 21.93 117.363 -178.148 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -92.31 117.65 30.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.952 2.575 . . . . 12.33 117.952 176.884 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 pt -102.95 156.32 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 128.824 2.85 . . . . 17.079999999999998 116.809 -172.536 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -127.72 104.02 7.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.939 -1.101 . . . . 16.300000000000001 110.89 -168.746 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.1 mt -104.02 138.11 41.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.241 1.817 . . . . 15.880000000000001 111.962 -165.645 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -108.0 86.99 2.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 128.122 3.82 . . . . 28.899999999999999 110.804 -170.247 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -101.73 172.98 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 111.971 -2.377 . . . . 12.050000000000001 114.437 -175.71 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.86 146.87 63.12 Favored Pre-proline 0 N--CA 1.431 -1.416 0 O-C-N 125.56 1.788 . . . . 18.170000000000002 108.452 171.339 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.3 -4.56 13.17 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 115.955 -1.769 . . . . 8.1600000000000001 116.406 -150.097 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 m -90.91 6.22 45.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.732 2.06 . . . . 11.130000000000001 111.172 172.598 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.91 154.68 20.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.5 2.778 . . . . 18.030000000000001 118.5 -176.252 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -91.45 163.05 14.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.062 -2.899 . . . . 10.220000000000001 111.669 -164.338 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mm -64.51 -34.89 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 117.342 -1.313 . . . . 12.300000000000001 108.315 -178.188 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -51.0 -49.32 60.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 114.294 1.22 . . . . 36.509999999999998 114.294 169.646 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.08 -25.07 62.46 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.915 2.931 . . . . 25.66 118.915 176.393 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 86.7 t -62.99 -44.79 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 116.249 -1.834 . . . . 8.1199999999999992 109.098 167.637 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -52.35 -48.97 65.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.823 3.638 . . . . 15.470000000000001 120.823 171.504 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.09 67.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.937 3.695 . . . . 11.449999999999999 114.975 170.594 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.98 -43.72 98.01 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.748 1.758 . . . . 24.98 115.748 170.455 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.6 -54.29 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.774 -1.829 . . . . 9.4600000000000009 112.931 174.505 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.41 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 56.2 tt0 -41.7 -46.03 3.64 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.42 2.288 . . . . 14.76 113.045 172.573 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -76.03 -46.59 28.57 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.049 1.74 . . . . 26.289999999999999 111.586 -178.118 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -68.2 -62.43 1.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.321 -1.487 . . . . 30.059999999999999 113.852 -172.65 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -92.53 -49.57 6.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.573 -0.899 . . . . 25.190000000000001 108.573 -173.642 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 117.85 28.24 2.32 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 122.568 1.093 . . . . 7.4100000000000001 112.672 177.825 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mt -87.18 119.75 71.07 Favored Pre-proline 0 N--CA 1.431 -1.413 0 O-C-N 117.985 -3.068 . . . . 9.4900000000000002 104.075 -171.757 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -64.77 133.63 37.2 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 N-CA-C 121.633 3.666 . . . . 11.42 121.633 -176.068 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -78.9 -10.8 15.34 Favored 'Trans proline' 0 N--CA 1.433 -2.05 1 C-N-CA 128.698 6.266 . . . . 12.0 113.947 -159.039 . . . . . . . . 3 3 . 1 . 119 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -76.87 -36.07 57.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.01 1.732 . . . . 35.549999999999997 113.175 168.808 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -74.55 -27.45 60.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.533 3.933 . . . . 20.52 112.63 -178.982 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 76.7 mt-30 -74.49 119.33 18.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.338 -2.101 . . . . 7.1299999999999999 110.466 172.968 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.325 40.5 ttm180 -114.65 108.8 17.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.048 2.539 . . . . 36.390000000000001 104.857 159.681 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.19 130.55 35.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.321 3.452 . . . . 9.5500000000000007 120.321 166.876 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.9 mm -117.83 131.61 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.018 2.127 . . . . 13.9 111.168 -174.538 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -128.17 123.63 34.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.639 -3.788 . . . . 6.8600000000000003 106.314 170.965 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.19 -99.65 0.1 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.705 -1.588 . . . . 11.15 112.727 -163.198 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.17 22.3 2.76 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 104.359 -3.496 . . . . 13.93 104.359 -176.736 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -107.47 135.27 49.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.403 3.481 . . . . 23.920000000000002 101.952 -177.282 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -97.98 118.6 34.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.463 -2.648 . . . . 23.23 109.623 177.297 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.3 mt -88.67 135.81 33.31 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.215 -2.803 . . . . 9.1099999999999994 109.246 -160.719 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -80.11 159.08 26.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.124 2.569 . . . . 33.439999999999998 111.924 179.286 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -75.75 -47.7 24.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 124.982 1.426 . . . . 28.370000000000001 111.973 -172.936 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.29 29.62 11.51 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 124.639 1.212 . . . . 15.0 113.046 -166.396 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 58' ' ' ASP . 77.7 mtp180 -117.47 157.06 26.91 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 126.186 1.794 . . . . 25.5 108.818 177.727 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -96.2 162.38 13.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.096 2.628 . . . . 11.949999999999999 118.096 -169.705 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.6 mt -63.09 -33.4 75.36 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.919 -2.363 . . . . 10.17 113.75 170.367 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 p -66.61 -39.52 88.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.51 -3.869 . . . . 13.59 114.403 171.148 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' CG ' HH21 ' A' ' 54' ' ' ARG . 66.2 t0 -64.34 -54.53 31.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.246 2.618 . . . . 11.699999999999999 107.671 179.801 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -73.09 -15.32 61.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 115.313 -2.555 . . . . 12.949999999999999 108.887 -178.933 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.271 35.1 m120 85.91 37.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 127.255 3.407 . . . . 25.449999999999999 113.368 176.251 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.7 mt -95.78 79.85 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.478 1 O-C-N 116.243 -4.036 . . . . 14.6 110.413 -172.166 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -59.33 174.17 0.43 Allowed 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.435 2.754 . . . . 33.229999999999997 118.435 172.719 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -62.57 141.02 58.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.111 1.522 . . . . 25.969999999999999 115.111 174.733 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 22.3 tt0 67.88 27.02 7.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.613 3.165 . . . . 32.609999999999999 114.672 -176.196 . . . . . . . . 2 2 . 1 . 119 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -91.49 139.79 30.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.899 -3.625 . . . . 10.56 112.014 174.634 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -113.78 118.94 35.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.309 -1.357 . . . . 5.3300000000000001 111.883 -172.099 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -97.35 141.48 30.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 103.87 -2.641 . . . . 11.66 103.87 -176.109 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -108.49 135.1 50.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.254 -2.499 . . . . 16.300000000000001 104.254 -176.36 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.91 108.52 20.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.64 -1.985 . . . . 9.9600000000000009 105.64 -172.013 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.9 t -76.95 130.43 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 125.3 1.625 . . . . 9.7599999999999998 113.985 162.633 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.7 mt -95.19 112.77 24.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.325 2.488 . . . . 19.57 105.137 174.652 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -95.24 157.28 15.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 112.472 -2.149 . . . . 35.079999999999998 113.325 -156.024 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.4 mt -94.21 155.37 17.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 113.067 -1.879 . . . . 32.310000000000002 113.207 172.605 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -83.26 -169.58 2.61 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 121.84 2.109 . . . . 42.75 110.419 -165.096 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.23 59.8 3.78 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 117.862 -3.024 . . . . 36.310000000000002 114.034 172.565 . . . . . . . . 1 1 . 1 . 119 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.787 0 CA-C-O 114.725 -3.264 . . . . 36.270000000000003 111.55 175.336 . . . . . . . . 0 0 . 1 . 120 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptt? . . . . . 0 CA--C 1.489 -1.367 0 CA-C-O 123.587 1.66 . . . . 17.170000000000002 110.316 . . . . . . . . . 0 0 . 1 . 120 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -96.83 140.33 31.55 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.413 -2.055 . . . . 21.890000000000001 106.872 -179.195 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 pt -136.79 157.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 124.007 0.923 . . . . 10.83 108.793 177.467 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -112.61 133.94 54.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.55 -2.759 . . . . 10.609999999999999 103.55 -178.498 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.16 121.23 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 1 O-C-N 115.359 -4.588 . . . . 9.1300000000000008 106.859 165.713 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -105.66 115.9 31.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.084 2.115 . . . . 20.550000000000001 107.856 -167.569 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.486 HG23 HD22 ' A' ' 69' ' ' LEU 0.335 0.2 OUTLIER -101.27 126.92 48.06 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.738 -1.949 . . . . 11.779999999999999 105.738 -168.471 . . . . . . . . 4 4 . 1 . 120 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.72 -49.65 8.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.157 -1.59 . . . . 19.309999999999999 107.468 -178.142 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 m -95.03 75.52 3.5 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.931 2.3 . . . . 23.140000000000001 112.71 172.556 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.47 -111.3 0.46 Allowed Glycine 0 N--CA 1.431 -1.695 0 O-C-N 119.394 -2.066 . . . . 19.739999999999998 110.329 -166.721 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 9.3 pttm -175.32 177.97 1.76 Allowed 'General case' 0 N--CA 1.43 -1.459 1 CA-C-N 124.497 4.148 . . . . 21.93 106.122 178.932 . . . . . . . . 3 3 . 1 . 120 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -97.23 122.33 40.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.402 -2.061 . . . . 12.33 106.67 -176.771 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 pt -106.63 148.66 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 122.94 1.352 . . . . 17.079999999999998 108.329 -178.869 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.9 m -111.3 112.44 24.21 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.916 -2.253 . . . . 16.300000000000001 104.916 -175.357 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -111.33 142.7 43.21 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.501 2.096 . . . . 15.880000000000001 112.478 179.924 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -97.78 117.39 31.98 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.563 -3.211 . . . . 28.899999999999999 109.711 172.977 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.46 153.66 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.613 -3.179 . . . . 12.050000000000001 108.146 -171.797 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -105.54 137.97 19.45 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 112.491 -3.623 . . . . 18.170000000000002 107.281 173.428 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -75.25 -9.88 20.59 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 123.67 2.346 . . . . 8.1600000000000001 113.045 -158.588 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.8 m -84.1 -20.44 32.57 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 126.935 2.647 . . . . 11.130000000000001 113.947 -176.418 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -85.12 159.67 20.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.184 -2.198 . . . . 18.030000000000001 109.053 -169.284 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -78.86 163.58 25.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.18 -2.825 . . . . 10.220000000000001 109.935 -167.385 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.6 mm -64.46 -38.45 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.613 -1.929 . . . . 12.300000000000001 109.875 174.667 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -44.77 -36.57 3.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.017 2.927 . . . . 36.509999999999998 115.012 164.405 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -71.97 -44.56 63.36 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.971 1.708 . . . . 25.66 110.14 173.138 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 t -55.92 -43.24 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.614 2.366 . . . . 8.1199999999999992 112.497 173.055 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -62.98 -26.22 68.74 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.561 -3.212 . . . . 15.470000000000001 113.902 173.085 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.02 -36.04 59.29 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.983 -2.323 . . . . 11.449999999999999 107.605 177.517 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -73.26 -36.67 66.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.209 -1.557 . . . . 24.98 114.097 -178.241 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 mt -65.55 -34.62 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.713 1.605 . . . . 9.4600000000000009 113.569 168.237 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -61.59 -52.22 65.32 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.227 1.489 . . . . 14.76 112.741 170.859 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.74 -46.67 88.42 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.367 2.267 . . . . 26.289999999999999 112.102 -179.652 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -65.58 -59.29 4.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.15 1.537 . . . . 30.059999999999999 115.15 178.309 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.424 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS 0.378 65.9 mm-40 -87.98 -43.69 11.56 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.203 2.201 . . . . 25.190000000000001 111.84 -165.927 . . . . . . . . 3 3 . 1 . 120 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.78 29.64 5.49 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-O 117.562 -1.688 . . . . 7.4100000000000001 109.878 -174.775 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.2 mt -104.49 99.83 19.75 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 130.189 3.396 . . . . 9.4900000000000002 109.203 175.886 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -58.77 160.62 17.26 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 115.628 -2.88 . . . . 11.42 115.628 173.406 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -102.15 12.1 0.39 Allowed 'Trans proline' 0 N--CA 1.434 -1.997 0 N-CA-C 121.517 3.622 . . . . 12.0 121.517 -163.811 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.11 -13.55 55.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 125.647 1.842 . . . . 35.549999999999997 114.669 151.044 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -90.86 -3.05 57.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.993 -2.317 . . . . 20.52 107.744 178.273 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -95.34 131.68 41.19 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.589 -2.569 . . . . 7.1299999999999999 113.179 -175.995 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -119.48 103.38 9.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.459 -2.422 . . . . 36.390000000000001 104.459 166.2 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.72 109.43 21.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.915 -2.99 . . . . 9.5500000000000007 107.057 -165.764 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.08 135.56 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 123.714 1.721 . . . . 13.9 107.581 -159.011 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -124.11 115.3 20.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.197 -2.814 . . . . 6.8600000000000003 103.846 176.816 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.282 . . 63.2 -103.14 0.11 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.414 1.886 . . . . 11.15 113.305 -169.17 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.69 40.84 1.54 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 118.406 -2.684 . . . . 13.93 113.016 168.704 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -147.37 137.46 23.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.542 2.337 . . . . 23.920000000000002 106.153 -178.103 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -76.44 158.51 31.27 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.798 -3.689 . . . . 23.23 111.377 -171.498 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.4 mt -97.07 147.36 24.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 113.346 0.869 . . . . 9.1099999999999994 113.346 165.224 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -95.38 167.92 11.04 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 123.614 0.571 . . . . 33.439999999999998 111.72 177.421 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.09 -46.21 13.07 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.054 -2.904 . . . . 28.370000000000001 114.538 -163.284 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.23 27.57 13.06 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.121 -2.862 . . . . 15.0 112.291 -176.33 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -106.43 166.63 10.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 115.621 -2.133 . . . . 25.5 111.486 173.097 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -104.1 176.87 5.01 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 121.763 2.074 . . . . 11.949999999999999 111.575 -175.288 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.38 -40.52 73.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.412 2.529 . . . . 10.17 106.511 173.251 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.3 p -78.79 -8.11 58.46 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.065 -2.272 . . . . 13.59 111.245 -171.966 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -75.26 -51.17 13.91 Favored 'General case' 0 N--CA 1.431 -1.406 2 O-C-N 115.315 -4.616 . . . . 11.699999999999999 104.477 174.422 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -82.22 -10.26 59.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.792 -2.442 . . . . 12.949999999999999 113.574 179.435 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 71.51 58.96 0.17 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.132 1.373 . . . . 25.449999999999999 109.962 -177.656 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mt -80.71 111.44 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.184 2.594 . . . . 14.6 110.567 159.925 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -97.53 175.04 6.36 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.397 -2.183 . . . . 33.229999999999997 110.17 174.401 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -58.79 143.07 48.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.702 3.201 . . . . 25.969999999999999 106.811 -178.679 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.317 3.2 mp0 60.96 20.2 10.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.829 2.159 . . . . 32.609999999999999 116.829 -178.871 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 m -72.37 147.23 46.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.242 2.312 . . . . 10.56 117.242 167.131 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.4 m -95.11 126.56 40.52 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.086 2.155 . . . . 5.3300000000000001 109.071 165.521 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.59 152.26 20.63 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.141 -2.17 . . . . 11.66 105.141 164.623 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -105.78 128.43 53.71 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.08 -5.388 . . . . 16.300000000000001 108.675 179.164 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.486 HD22 HG23 ' A' ' 7' ' ' THR . 16.9 tp -97.05 131.66 43.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 116.074 -2.25 . . . . 9.9600000000000009 108.717 179.53 . . . . . . . . 2 2 . 1 . 120 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.5 t -107.84 129.38 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.789 -3.069 . . . . 9.7599999999999998 107.67 172.288 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.6 mt -104.59 137.95 41.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.514 -1.221 . . . . 19.57 110.261 176.239 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -120.95 174.3 6.71 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 123.276 1.512 . . . . 35.079999999999998 115.03 -163.105 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 mt -69.0 128.97 38.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.015 3.326 . . . . 32.310000000000002 107.035 162.005 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.51 162.71 24.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.372 -1.344 . . . . 42.75 107.372 -162.11 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.03 119.4 0.64 Allowed Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 129.114 3.245 . . . . 36.310000000000002 115.134 168.55 . . . . . . . . 1 1 . 1 . 120 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 N-CA-C 106.619 -2.592 . . . . 36.270000000000003 106.619 169.605 . . . . . . . . 0 0 . 1 . 121 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.349 0 CA-C-O 117.293 -1.336 . . . . 17.170000000000002 112.388 . . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -96.88 137.49 35.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.946 2.654 . . . . 21.890000000000001 111.169 176.956 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.29 172.02 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 126.919 2.088 . . . . 10.83 112.711 176.952 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -123.66 115.7 21.87 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.614 -2.735 . . . . 10.609999999999999 103.614 -167.89 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.72 115.35 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 102.623 -3.103 . . . . 9.1300000000000008 102.623 170.445 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -86.67 131.21 34.21 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.235 -3.416 . . . . 20.550000000000001 112.183 167.397 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -87.18 162.39 17.52 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.746 1.279 . . . . 11.779999999999999 114.231 172.104 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.9 tp -69.13 -28.42 66.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.419 2.687 . . . . 19.309999999999999 111.599 -174.935 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 53.3 m -59.1 -47.54 84.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.818 -2.515 . . . . 23.140000000000001 114.961 167.39 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.44 49.06 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 105.691 -2.964 . . . . 19.739999999999998 105.691 167.269 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.307 41.7 mttt -138.69 145.33 40.23 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.621 -5.047 . . . . 21.93 104.266 178.592 . . . . . . . . 3 2 . 1 . 121 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -99.85 116.01 30.93 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.494 -2.594 . . . . 12.33 106.394 168.722 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 pt -106.27 133.28 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 105.15 -2.166 . . . . 17.079999999999998 105.15 176.337 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 m -93.78 117.81 30.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 126.869 2.605 . . . . 16.300000000000001 110.082 -177.127 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.274 95.8 mt -119.15 141.76 48.54 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.978 -2.23 . . . . 15.880000000000001 104.978 -177.296 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -104.38 111.48 24.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.318 3.047 . . . . 28.899999999999999 112.955 172.346 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.5 169.15 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 124.719 2.199 . . . . 12.050000000000001 111.805 -178.132 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -92.13 154.88 43.25 Favored Pre-proline 0 N--CA 1.43 -1.446 0 O-C-N 117.283 -3.385 . . . . 18.170000000000002 107.163 167.308 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.01 -3.89 12.98 Favored 'Trans proline' 0 C--N 1.3 -1.99 1 CA-C-N 129.355 4.377 . . . . 8.1600000000000001 111.974 175.019 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -76.2 -22.19 55.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.311 -2.743 . . . . 11.130000000000001 114.325 169.614 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -67.76 151.25 47.52 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.618 2.152 . . . . 18.030000000000001 111.054 173.167 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.4 p -99.43 -170.93 1.98 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.469 2.557 . . . . 10.220000000000001 110.781 -173.86 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.7 mm -86.92 -17.43 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 O-C-N 115.975 -4.203 . . . . 12.300000000000001 108.662 -173.171 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.57 -26.56 55.22 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.613 -4.429 . . . . 36.509999999999998 110.501 174.142 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -73.06 -33.89 65.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.334 -0.947 . . . . 25.66 108.719 176.455 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.353 65.6 t -65.53 -47.43 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 124.622 1.169 . . . . 8.1199999999999992 113.695 178.034 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -55.36 -43.19 74.84 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.675 1.99 . . . . 15.470000000000001 113.869 171.944 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.5 90.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 120.732 3.604 . . . . 11.449999999999999 120.732 168.193 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -70.26 -38.87 75.19 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.589 -1.944 . . . . 24.98 111.701 174.968 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -66.66 -35.5 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 127.277 2.231 . . . . 9.4600000000000009 108.999 177.429 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -64.75 -39.4 93.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.725 -3.109 . . . . 14.76 107.834 174.929 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -72.85 -60.19 2.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.179 2.895 . . . . 26.289999999999999 111.094 -173.866 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -61.8 -49.72 75.21 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 120.677 3.584 . . . . 30.059999999999999 120.677 177.176 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -108.8 -18.29 13.73 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.208 -1.557 . . . . 25.190000000000001 111.9 -174.935 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.89 27.25 29.41 Favored Glycine 0 N--CA 1.429 -1.772 1 O-C-N 114.919 -4.863 . . . . 7.4100000000000001 113.657 170.972 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -91.65 133.56 30.78 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 118.52 -2.753 . . . . 9.4900000000000002 111.439 175.499 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.54 153.87 65.05 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 O-C-N 115.784 -2.798 . . . . 11.42 117.741 -179.292 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -75.31 -29.0 8.19 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 CA-C-N 122.863 2.058 . . . . 12.0 116.206 -166.477 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.99 -14.72 60.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.178 -2.826 . . . . 35.549999999999997 107.992 -169.733 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -109.55 3.2 20.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.385 -3.322 . . . . 20.52 111.828 -172.15 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -87.59 134.96 33.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.71 3.604 . . . . 7.1299999999999999 105.172 168.607 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -129.55 125.3 35.94 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 101.719 -3.438 . . . . 36.390000000000001 101.719 178.651 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.2 mt -126.1 132.91 51.79 Favored 'General case' 0 N--CA 1.43 -1.427 2 O-C-N 115.597 -4.439 . . . . 9.5500000000000007 99.45 -167.995 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 mm -119.31 134.75 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 109.74 -3.391 . . . . 13.9 111.824 -178.042 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -128.77 124.02 34.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 117.077 -1.44 . . . . 6.8600000000000003 112.244 163.18 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.61 -101.64 0.11 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.319 2.248 . . . . 11.15 106.773 -168.693 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.05 17.46 5.41 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 119.961 -1.712 . . . . 13.93 115.781 170.829 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -103.92 141.19 36.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.138 -1.801 . . . . 23.920000000000002 106.138 -172.906 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -83.18 124.29 30.38 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.605 2.362 . . . . 23.23 114.0 166.684 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.19 111.56 23.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.236 3.05 . . . . 9.1099999999999994 119.236 -174.647 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.83 140.17 58.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 120.519 3.526 . . . . 33.439999999999998 120.519 -178.714 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -49.24 -51.33 33.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.623 3.169 . . . . 28.370000000000001 118.289 -163.83 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.37 18.5 56.83 Favored Glycine 0 N--CA 1.43 -1.706 0 O-C-N 117.844 -3.035 . . . . 15.0 116.024 -178.154 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -97.62 148.02 23.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 122.83 3.315 . . . . 25.5 108.015 -177.196 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -78.56 151.15 32.59 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 115.785 -4.322 . . . . 11.949999999999999 110.32 179.908 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.0 mt -65.62 -30.81 71.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.571 -2.581 . . . . 10.17 112.809 179.38 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -59.42 -44.37 92.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.321 3.448 . . . . 13.59 112.083 170.952 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.72 -40.99 89.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.304 -3.372 . . . . 11.699999999999999 117.378 172.841 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -77.37 -21.24 53.56 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.534 -1.979 . . . . 12.949999999999999 111.505 175.496 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.5 t30 56.71 53.15 8.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.929 3.292 . . . . 25.449999999999999 117.009 -175.043 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.1 mm -64.38 121.8 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 118.671 -2.518 . . . . 14.6 112.266 164.387 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -96.67 167.5 11.08 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.632 2.634 . . . . 33.229999999999997 111.451 179.221 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -72.28 145.52 47.82 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 112.796 -6.19 . . . . 25.969999999999999 120.52 174.787 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 63.17 19.95 11.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.0 2.52 . . . . 32.609999999999999 115.688 -175.287 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.49 143.3 27.28 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.071 -2.786 . . . . 10.56 118.446 170.041 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.2 m -92.05 117.01 29.43 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.402 3.112 . . . . 5.3300000000000001 119.402 -179.756 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.83 143.51 26.27 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.554 1.524 . . . . 11.66 108.126 171.743 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -93.53 134.85 35.38 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.841 -2.412 . . . . 16.300000000000001 109.858 167.785 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 tt -106.24 132.5 52.22 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.399 -2.815 . . . . 9.9600000000000009 103.399 166.357 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -120.34 174.18 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 129.731 3.212 . . . . 9.7599999999999998 106.044 160.351 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.1 mt -103.55 140.2 37.85 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.245 -5.284 . . . . 19.57 111.881 -173.265 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -95.51 128.39 42.33 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 114.629 -5.044 . . . . 35.079999999999998 106.343 177.02 . . . . . . . . 2 2 . 1 . 121 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.8 mt -96.42 152.66 18.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.806 2.717 . . . . 32.310000000000002 108.484 172.38 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -64.74 117.48 7.54 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 117.477 2.399 . . . . 42.75 117.477 170.298 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.75 -30.87 1.92 Allowed Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 125.425 1.488 . . . . 36.310000000000002 114.118 -162.552 . . . . . . . . 1 1 . 1 . 121 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.786 0 O-C-N 120.352 -1.675 . . . . 36.270000000000003 111.992 179.145 . . . . . . . . 0 0 . 1 . 122 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 13.4 ptt? . . . . . 0 CA--C 1.489 -1.368 0 CA-C-O 121.471 0.653 . . . . 17.170000000000002 110.859 . . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -106.1 129.83 54.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.576 -1.647 . . . . 21.890000000000001 115.36 175.319 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -123.46 169.39 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.621 -2.55 . . . . 10.83 105.475 170.784 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.68 140.81 52.62 Favored 'General case' 0 N--CA 1.429 -1.485 1 N-CA-C 99.994 -4.076 . . . . 10.609999999999999 99.994 -169.403 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 t -129.99 126.27 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 105.622 -1.992 . . . . 9.1300000000000008 105.622 175.227 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -102.35 125.82 49.17 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 124.9 1.375 . . . . 20.550000000000001 108.232 177.816 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -89.63 -166.26 1.55 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.521 -2.612 . . . . 11.779999999999999 112.656 -162.079 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.5 tp -73.44 -60.23 2.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.143 2.247 . . . . 19.309999999999999 112.449 -176.919 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 m -48.45 -49.6 34.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 110.218 -3.174 . . . . 23.140000000000001 110.08 174.332 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.36 64.15 0.16 Allowed Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 117.893 -1.504 . . . . 19.739999999999998 113.187 176.842 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 40.4 mtpt -123.23 137.11 54.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.739 -1.578 . . . . 21.93 106.739 176.691 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -100.38 103.88 15.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.969 2.168 . . . . 12.33 111.737 176.394 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.438 16.9 pt -93.1 147.24 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 124.204 1.954 . . . . 17.079999999999998 109.806 -176.314 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 m -101.0 123.03 44.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.134 -2.229 . . . . 16.300000000000001 106.115 175.846 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -116.21 152.71 33.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.632 2.373 . . . . 15.880000000000001 111.582 176.261 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -111.76 114.03 26.76 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.189 -2.278 . . . . 28.899999999999999 108.278 177.145 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.62 173.77 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 113.417 -1.719 . . . . 12.050000000000001 110.521 -178.867 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -123.07 142.16 37.57 Favored Pre-proline 0 N--CA 1.43 -1.431 0 N-CA-C 107.889 -1.152 . . . . 18.170000000000002 107.889 175.481 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -68.84 -9.12 25.35 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 O-C-N 114.434 -3.508 . . . . 8.1600000000000001 116.228 -169.011 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -83.82 -19.86 34.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.649 2.022 . . . . 11.130000000000001 110.362 179.184 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -69.86 144.83 52.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.265 2.226 . . . . 18.030000000000001 112.392 172.871 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 27.1 p -82.75 172.04 13.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.597 -3.189 . . . . 10.220000000000001 115.768 -175.402 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mm -61.17 -41.97 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 117.653 2.464 . . . . 12.300000000000001 117.653 173.657 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -31.57 -61.4 0.22 Allowed 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.586 -3.196 . . . . 36.509999999999998 118.486 152.578 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -50.94 -39.58 55.2 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.698 2.11 . . . . 25.66 116.698 171.287 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 t -68.57 -43.83 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 118.516 -2.615 . . . . 8.1199999999999992 113.471 178.016 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.18 -34.67 76.87 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.479 2.029 . . . . 15.470000000000001 116.479 168.473 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.31 -32.86 63.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.079 -2.263 . . . . 11.449999999999999 110.767 178.017 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.253 66.6 mttt -64.65 -29.52 70.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.841 -2.412 . . . . 24.98 115.644 168.166 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.8 mt -67.97 -36.42 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.647 1.567 . . . . 9.4600000000000009 113.248 170.348 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -61.15 -42.16 98.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.448 -2.032 . . . . 14.76 113.728 169.027 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.63 -53.06 17.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.082 1.896 . . . . 26.289999999999999 107.702 -174.802 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -56.8 -62.8 1.49 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 116.164 -4.085 . . . . 30.059999999999999 114.35 173.573 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 10.5 mm-40 -92.33 -41.88 10.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 119.236 3.05 . . . . 25.190000000000001 119.236 -173.669 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.58 46.65 2.1 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 116.536 -2.258 . . . . 7.4100000000000001 112.706 -171.894 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.4 mt -109.99 116.37 53.73 Favored Pre-proline 0 N--CA 1.429 -1.479 0 C-N-CA 130.098 3.359 . . . . 9.4900000000000002 110.892 173.698 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.02 149.29 92.01 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 127.279 3.635 . . . . 11.42 115.223 -178.876 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -76.36 -24.81 10.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 120.336 1.156 . . . . 12.0 114.475 -164.114 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.28 -22.42 52.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.336 1.454 . . . . 35.549999999999997 110.618 -169.562 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.33 3.78 51.03 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 121.771 2.078 . . . . 20.52 108.94 176.184 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -86.38 135.13 33.62 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.949 -2.969 . . . . 7.1299999999999999 111.289 172.755 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.2 ttm105 -127.5 125.43 40.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.622 -1.924 . . . . 36.390000000000001 110.51 153.51 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.88 135.0 33.59 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 124.909 2.29 . . . . 9.5500000000000007 113.678 178.654 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.31 146.92 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 103.424 -2.806 . . . . 13.9 103.424 -178.954 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -122.47 125.91 46.79 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 114.595 -5.065 . . . . 6.8600000000000003 101.499 157.47 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.65 -94.46 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.487 1.613 . . . . 11.15 112.895 -178.186 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.22 22.42 1.4 Allowed Glycine 0 N--CA 1.43 -1.751 0 O-C-N 117.43 -3.294 . . . . 13.93 113.723 166.719 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -87.18 120.75 28.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.615 2.766 . . . . 23.920000000000002 112.123 167.32 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -78.44 129.29 34.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.23 -3.419 . . . . 23.23 113.543 176.98 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.1 mt -108.3 124.86 50.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.62 -2.55 . . . . 9.1099999999999994 105.494 -154.524 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -93.25 138.55 31.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.291 -2.756 . . . . 33.439999999999998 111.971 -175.187 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -43.73 -43.74 6.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.919 3.287 . . . . 28.370000000000001 119.67 -179.099 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.56 18.0 45.29 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.49 -2.631 . . . . 15.0 113.932 -169.855 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -95.38 149.22 21.61 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.288 1.518 . . . . 25.5 110.128 163.519 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 p -71.52 146.49 48.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 111.958 -2.383 . . . . 11.949999999999999 108.093 171.349 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -49.19 -49.35 43.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.947 1.832 . . . . 10.17 115.947 161.332 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 p -49.48 -35.27 19.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 119.014 2.968 . . . . 13.59 119.014 166.29 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.83 -26.73 54.68 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 127.639 3.59 . . . . 11.699999999999999 114.646 -178.452 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -87.51 1.52 53.28 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.699 2.481 . . . . 12.949999999999999 117.699 168.297 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 72.68 31.92 1.58 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.215 2.822 . . . . 25.449999999999999 112.127 172.411 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mm -89.1 118.78 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 121.326 -0.859 . . . . 14.6 109.698 -169.919 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -106.28 172.72 6.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.354 -1.466 . . . . 33.229999999999997 107.155 -179.416 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 53.4 pttt -70.3 160.86 31.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 118.437 -1.305 . . . . 25.969999999999999 113.563 -175.703 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.253 52.5 mt-10 65.69 9.09 5.67 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.569 2.433 . . . . 32.609999999999999 117.569 -168.622 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.0 m -69.48 135.2 49.85 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 112.445 -2.161 . . . . 10.56 113.179 171.939 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.8 m -110.97 122.03 46.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.768 -3.083 . . . . 5.3300000000000001 106.466 -174.593 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.29 164.92 11.4 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 100.793 -3.78 . . . . 11.66 100.793 -172.508 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -123.45 130.59 52.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.139 -1.886 . . . . 16.300000000000001 109.912 -179.691 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -84.69 134.19 34.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.569 2.062 . . . . 9.9600000000000009 116.569 169.719 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.52 164.66 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.68 -1.887 . . . . 9.7599999999999998 107.668 169.881 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.268 24.1 tp -94.27 132.59 38.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.981 -2.949 . . . . 19.57 104.806 -172.059 . . . . . . . . 2 2 . 1 . 122 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -101.37 137.22 40.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.364 2.265 . . . . 35.079999999999998 113.196 166.828 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.8 mt -114.91 -159.12 0.69 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 131.388 3.875 . . . . 32.310000000000002 101.902 -178.05 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -99.4 128.76 45.54 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.767 2.222 . . . . 42.75 114.732 -176.572 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.85 3.49 4.96 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 116.205 -2.441 . . . . 36.310000000000002 112.292 156.168 . . . . . . . . 1 1 . 1 . 122 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.723 0 CA-C-N 122.334 3.067 . . . . 36.270000000000003 115.431 -173.641 . . . . . . . . 0 0 . 1 . 123 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 117.614 2.45 . . . . 17.170000000000002 117.614 . . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -93.41 123.53 36.77 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 118.167 -0.92 . . . . 21.890000000000001 110.274 -163.945 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 pt -92.48 171.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 127.084 3.326 . . . . 10.83 109.394 165.567 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 26.1 m-85 -115.13 112.48 22.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.794 2.837 . . . . 10.609999999999999 107.688 169.545 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.5 t -105.71 118.43 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.858 -2.402 . . . . 9.1300000000000008 105.13 172.08 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -97.57 113.12 24.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.843 2.857 . . . . 20.550000000000001 112.826 175.218 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.456 26.7 p -66.45 161.52 22.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 119.65 3.204 . . . . 11.779999999999999 119.65 174.979 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 tp -70.12 -34.06 72.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.26 -3.4 . . . . 19.309999999999999 107.31 -178.267 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -68.63 -61.84 1.65 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.184 0.993 . . . . 23.140000000000001 110.174 170.826 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.71 46.45 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 117.26 -3.4 . . . . 19.739999999999998 114.369 -170.436 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 41.7 mtpt -126.1 135.96 52.34 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.981 -2.482 . . . . 21.93 112.678 162.868 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.4 m -105.85 114.04 27.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.692 -3.755 . . . . 12.33 106.291 -179.678 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -97.78 129.01 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 130.954 3.702 . . . . 17.079999999999998 109.278 -177.844 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -98.22 102.92 14.8 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.426 2.536 . . . . 16.300000000000001 105.409 -178.725 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.88 124.04 45.07 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.212 -2.18 . . . . 15.880000000000001 110.521 -155.216 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.73 113.49 18.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.83 -2.441 . . . . 28.899999999999999 114.922 -176.413 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.57 156.03 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 125.191 2.424 . . . . 12.050000000000001 111.469 178.33 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -91.97 158.32 39.84 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 116.041 -1.933 . . . . 18.170000000000002 108.988 174.704 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -83.32 -22.13 4.11 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 126.379 3.314 . . . . 8.1600000000000001 118.027 -179.331 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 m -86.43 14.25 7.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 125.047 1.467 . . . . 11.130000000000001 114.483 -175.535 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -110.79 151.91 27.24 Favored 'General case' 0 N--CA 1.43 -1.449 1 C-N-CA 133.438 4.695 . . . . 18.030000000000001 111.334 -177.643 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -75.37 157.55 34.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 127.74 3.638 . . . . 10.220000000000001 113.046 -177.648 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.37 -28.24 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 126.03 2.824 . . . . 12.300000000000001 109.832 -179.137 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -69.24 -24.29 63.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.373 -3.954 . . . . 36.509999999999998 108.498 176.455 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -83.08 -38.98 21.76 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.192 2.997 . . . . 25.66 108.631 -179.077 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.8 t -55.84 -47.99 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 123.78 1.752 . . . . 8.1199999999999992 112.711 162.483 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -60.69 -39.04 87.04 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.717 -4.364 . . . . 15.470000000000001 114.997 177.052 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.15 -43.14 66.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.31 3.078 . . . . 11.449999999999999 119.31 164.57 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -65.18 -41.41 94.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.791 -1.818 . . . . 24.98 111.629 177.114 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -60.38 -44.02 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 126.55 1.94 . . . . 9.4600000000000009 113.151 172.482 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -51.12 -37.13 44.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.725 3.21 . . . . 14.76 113.988 167.615 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -83.76 -38.01 21.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.077 -1.639 . . . . 26.289999999999999 108.37 -176.921 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -63.93 -58.9 5.36 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.124 1.898 . . . . 30.059999999999999 116.124 177.4 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 14.3 mm-40 -100.14 -69.32 0.77 Allowed 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 124.724 2.202 . . . . 25.190000000000001 110.641 -171.351 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.49 46.07 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.766 0 O-C-N 117.418 -3.302 . . . . 7.4100000000000001 105.593 -175.34 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -106.32 130.9 22.24 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 116.932 -1.509 . . . . 9.4900000000000002 110.298 167.821 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -76.21 154.66 37.04 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 119.79 2.958 . . . . 11.42 119.79 177.858 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -70.5 -17.82 33.95 Favored 'Trans proline' 0 N--CA 1.434 -1.993 1 C-N-CA 126.142 4.561 . . . . 12.0 112.207 -169.229 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -84.55 -21.01 30.62 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 115.267 -4.646 . . . . 35.549999999999997 114.408 176.451 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.95 -16.06 30.7 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.987 -1.695 . . . . 20.52 111.109 -175.549 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -86.1 153.13 22.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 118.834 -1.146 . . . . 7.1299999999999999 112.842 -174.613 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.2 ttm180 -140.98 125.57 17.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 102.362 -3.199 . . . . 36.390000000000001 102.362 169.35 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.3 mt -105.63 125.68 51.27 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.03 1.395 . . . . 9.5500000000000007 109.473 175.014 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mm -106.57 128.2 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 121.16 -0.963 . . . . 13.9 111.03 177.307 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -112.97 115.51 28.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 118.859 -1.136 . . . . 6.8600000000000003 109.476 160.8 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.307 . . 64.31 -101.28 0.09 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.859 2.463 . . . . 11.15 111.613 -170.911 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.63 2.19 23.31 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 130.057 3.694 . . . . 13.93 114.158 172.11 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.258 14.3 tppt? -102.7 132.86 48.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 119.916 1.858 . . . . 23.920000000000002 111.019 -177.97 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -91.6 138.16 31.79 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.902 -1.954 . . . . 23.23 110.88 176.819 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.287 3.3 mt -106.59 114.24 28.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.974 3.273 . . . . 9.1099999999999994 110.255 -166.018 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.37 130.27 35.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.271 -2.768 . . . . 33.439999999999998 114.063 -167.789 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -31.35 -67.35 0.1 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 121.245 3.795 . . . . 28.370000000000001 121.245 -164.336 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.56 21.9 43.15 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 115.177 -3.392 . . . . 15.0 111.334 -168.233 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -91.63 153.98 19.33 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.183 -4.716 . . . . 25.5 112.333 166.832 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.9 p -76.01 166.5 23.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.739 -2.476 . . . . 11.949999999999999 116.668 179.248 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 124.977 2.322 . . . . 10.17 116.758 163.526 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -60.94 -24.93 66.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 112.329 -3.701 . . . . 13.59 117.981 177.978 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -71.82 -38.55 70.16 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.497 2.408 . . . . 11.699999999999999 115.356 167.448 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -77.78 -2.99 39.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.673 -2.517 . . . . 12.949999999999999 114.709 170.645 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 2.6 m-80 52.62 49.05 21.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.58 3.086 . . . . 25.449999999999999 115.644 177.093 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.66 112.7 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 109.645 -3.434 . . . . 14.6 110.124 176.629 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -96.49 166.57 11.62 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.559 -2.588 . . . . 33.229999999999997 107.215 179.566 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -52.55 146.86 9.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.08 2.552 . . . . 25.969999999999999 114.704 171.507 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 57.81 38.69 27.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.856 3.693 . . . . 32.609999999999999 115.534 -178.516 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.254 72.5 m -102.35 131.21 49.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.833 -3.042 . . . . 10.56 110.206 -173.544 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 96.3 m -102.9 101.0 11.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.766 1.746 . . . . 5.3300000000000001 108.787 -164.309 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 mt -81.75 134.34 35.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.913 -3.617 . . . . 11.66 113.353 172.47 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -89.28 101.19 13.86 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 113.424 -3.179 . . . . 16.300000000000001 105.406 -179.521 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -71.2 114.76 9.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 124.458 3.299 . . . . 9.9600000000000009 114.489 169.602 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.95 -174.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.35 2.976 . . . . 9.7599999999999998 107.622 -176.024 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 tp -94.38 127.57 40.35 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 113.467 -5.771 . . . . 19.57 115.779 176.808 . . . . . . . . 2 2 . 1 . 123 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -94.05 119.49 32.99 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.188 2.899 . . . . 35.079999999999998 110.674 167.23 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.9 mt -103.17 152.09 21.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.708 2.803 . . . . 32.310000000000002 110.674 162.069 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -73.53 154.14 39.99 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.508 2.723 . . . . 42.75 111.641 176.524 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.69 30.15 21.97 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 116.485 1.354 . . . . 36.310000000000002 116.485 -167.953 . . . . . . . . 1 1 . 1 . 123 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.767 0 N-CA-C 107.771 -2.132 . . . . 36.270000000000003 107.771 172.074 . . . . . . . . 0 0 . 1 . 124 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.341 9.5 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 113.954 -2.927 . . . . 17.170000000000002 117.243 . . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -74.93 124.97 27.89 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 131.799 4.039 . . . . 21.890000000000001 113.684 165.054 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.4 pt -120.16 162.08 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 103.36 -2.83 . . . . 10.83 103.36 159.675 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -114.93 135.44 54.21 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.024 -1.843 . . . . 10.609999999999999 106.024 -179.371 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.39 106.34 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 1 O-C-N 113.024 -6.047 . . . . 9.1300000000000008 111.369 179.7 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -84.51 138.64 32.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.517 2.579 . . . . 20.550000000000001 112.947 179.957 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -106.9 174.79 5.73 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.31 -2.118 . . . . 11.779999999999999 106.872 -178.16 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -74.69 -50.11 18.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.202 2.201 . . . . 19.309999999999999 108.225 -169.396 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 p -71.43 -73.36 0.18 Allowed 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.131 1.9 . . . . 23.140000000000001 116.131 176.591 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.37 68.98 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.699 1 O-C-N 112.348 -6.47 . . . . 19.739999999999998 115.729 168.528 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -132.83 146.05 51.49 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.578 -1.542 . . . . 21.93 109.109 163.398 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.2 m -119.48 129.22 54.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.283 -1.767 . . . . 12.33 107.975 166.428 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.07 127.88 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 113.118 -1.855 . . . . 17.079999999999998 107.253 -177.209 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -86.39 128.87 34.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.22 -2.881 . . . . 16.300000000000001 103.22 169.007 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 tp -128.2 139.2 52.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.06 -1.427 . . . . 15.880000000000001 111.687 173.258 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -86.81 118.45 26.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.541 -1.35 . . . . 28.899999999999999 113.945 171.574 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -129.05 157.01 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.027 1.862 . . . . 12.050000000000001 116.027 173.266 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -103.78 140.05 20.69 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 125.572 1.549 . . . . 18.170000000000002 108.011 171.439 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -70.18 -18.13 35.23 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 122.356 1.877 . . . . 8.1600000000000001 111.884 -170.407 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.39 -8.81 58.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.771 2.429 . . . . 11.130000000000001 116.031 178.361 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.26 164.41 25.75 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.985 -4.197 . . . . 18.030000000000001 111.625 171.558 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 59.1 p -79.88 170.65 16.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.623 -2.548 . . . . 10.220000000000001 115.654 156.431 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -73.95 -26.19 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.707 2.003 . . . . 12.300000000000001 111.37 175.234 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -57.91 -39.2 77.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 116.598 -3.814 . . . . 36.509999999999998 114.237 166.68 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -76.35 -31.06 57.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.846 -3.659 . . . . 25.66 112.042 -175.334 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.72 -42.07 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.245 1.818 . . . . 8.1199999999999992 112.06 172.274 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -69.16 -23.8 63.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 119.708 3.225 . . . . 15.470000000000001 119.708 172.472 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.43 -23.45 67.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.77 2.428 . . . . 11.449999999999999 116.916 159.412 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -94.57 -19.21 20.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.444 1.592 . . . . 24.98 111.274 175.431 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.72 -34.97 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-O 116.314 -1.803 . . . . 9.4600000000000009 106.451 175.868 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -67.63 -29.09 68.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.625 1.679 . . . . 14.76 111.943 174.957 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.81 -47.71 51.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.729 -2.482 . . . . 26.289999999999999 115.79 172.928 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -78.81 -47.82 15.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.332 1.975 . . . . 30.059999999999999 116.332 -177.257 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -105.2 -17.28 14.52 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.996 -2.94 . . . . 25.190000000000001 116.612 -178.88 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.17 61.4 5.19 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 127.077 2.275 . . . . 7.4100000000000001 112.052 172.978 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -121.93 142.14 35.66 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 100.274 -3.972 . . . . 9.4900000000000002 100.274 170.834 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -65.49 157.71 56.81 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 124.834 2.762 . . . . 11.42 110.531 -177.389 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -64.41 -27.05 62.79 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 123.867 3.044 . . . . 12.0 114.697 -178.982 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.5 -31.7 65.57 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 115.953 -4.217 . . . . 35.549999999999997 108.748 -176.154 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -81.71 -23.17 36.93 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.113 -2.867 . . . . 20.52 113.74 -179.815 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -71.0 120.29 16.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.413 2.285 . . . . 7.1299999999999999 113.272 171.224 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -121.71 126.37 48.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 118.062 -0.97 . . . . 36.390000000000001 108.592 159.555 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.27 136.75 43.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.759 2.695 . . . . 9.5500000000000007 108.536 -179.077 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.7 mm -120.31 146.78 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.649 -2.532 . . . . 13.9 105.779 -178.064 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -127.02 127.26 44.5 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 100.427 -3.916 . . . . 6.8600000000000003 100.427 164.604 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.526 . . 59.34 -88.64 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 120.789 3.625 . . . . 11.15 120.789 -172.884 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.13 19.39 1.56 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 123.659 0.599 . . . . 13.93 112.029 153.025 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -77.38 132.99 38.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.732 0.777 . . . . 23.920000000000002 112.017 160.751 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -79.01 124.1 27.93 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.87 -3.644 . . . . 23.23 113.597 173.728 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -99.48 120.82 40.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.091 -2.255 . . . . 9.1099999999999994 107.987 -178.91 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -102.79 153.12 20.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.426 2.953 . . . . 33.439999999999998 110.42 -178.146 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.09 -51.59 30.75 Favored 'General case' 0 N--CA 1.43 -1.441 1 N-CA-C 122.677 4.325 . . . . 28.370000000000001 122.677 -166.545 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.44 -5.07 85.46 Favored Glycine 0 N--CA 1.43 -1.753 0 O-C-N 124.955 1.41 . . . . 15.0 114.945 -176.624 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -78.53 150.11 32.93 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.427 1.108 . . . . 25.5 110.214 168.102 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.5 p -88.31 179.06 6.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.176 -1.829 . . . . 11.949999999999999 113.029 169.044 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.6 mt -76.34 -45.03 33.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.944 -1.502 . . . . 10.17 106.944 -174.544 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 p -50.57 -41.63 54.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.938 2.895 . . . . 13.59 114.408 176.147 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.6 -38.35 90.77 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.198 1.799 . . . . 11.699999999999999 111.125 -174.277 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -96.15 17.0 16.57 Favored 'General case' 0 N--CA 1.43 -1.468 2 O-C-N 115.145 -4.722 . . . . 12.949999999999999 111.788 169.718 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 47.36 55.32 8.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 127.693 3.616 . . . . 25.449999999999999 118.756 -172.558 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.4 mm -82.42 119.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 111.117 -2.765 . . . . 14.6 113.843 171.57 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -97.84 170.36 9.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.573 2.421 . . . . 33.229999999999997 110.191 -176.039 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -76.39 155.65 33.88 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 115.647 -2.12 . . . . 25.969999999999999 108.062 -179.482 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.354 46.7 mt-10 58.2 39.35 25.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.685 1.994 . . . . 32.609999999999999 116.089 177.94 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -124.14 136.36 54.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.921 -1.881 . . . . 10.56 105.921 -173.458 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.9 m -85.1 121.42 27.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.924 -1.988 . . . . 5.3300000000000001 109.692 -171.834 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.62 158.65 15.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.402 2.681 . . . . 11.66 108.88 174.118 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -111.88 113.26 25.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.063 1.301 . . . . 16.300000000000001 110.185 -179.55 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.9 tp -81.34 119.16 23.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.547 -1.216 . . . . 9.9600000000000009 111.063 173.355 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.77 166.73 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 118.75 -1.18 . . . . 9.7599999999999998 110.971 173.304 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 tp -85.12 119.97 26.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.609 -2.557 . . . . 19.57 110.781 176.527 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -97.53 134.45 40.74 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.275 1.03 . . . . 35.079999999999998 111.563 166.921 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.29 99.0 mt -94.65 174.54 7.06 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.824 -1.173 . . . . 32.310000000000002 111.5 172.148 . . . . . . . . 2 2 . 1 . 124 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -74.39 158.81 33.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.678 -3.139 . . . . 42.75 112.222 166.534 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.27 -83.26 0.15 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 130.212 3.768 . . . . 36.310000000000002 112.604 175.271 . . . . . . . . 1 1 . 1 . 124 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 CA-C-O 117.817 -1.546 . . . . 36.270000000000003 109.747 176.461 . . . . . . . . 0 0 . 1 . 125 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 CA--C 1.489 -1.366 0 N-CA-C 108.08 -1.081 . . . . 17.170000000000002 108.08 . . . . . . . . . 0 0 . 1 . 125 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -88.67 145.47 25.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.887 -2.383 . . . . 21.890000000000001 110.656 178.558 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.0 pt -133.17 164.69 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 104.785 -2.302 . . . . 10.83 104.785 166.677 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -121.44 142.6 49.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 128.372 3.545 . . . . 10.609999999999999 108.344 -175.195 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -118.31 116.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 111.652 -2.522 . . . . 9.1300000000000008 107.843 177.16 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -101.89 138.51 38.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.218 -2.176 . . . . 20.550000000000001 111.126 179.819 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.9 p -98.81 170.35 8.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.688 -2.051 . . . . 11.779999999999999 108.421 -172.487 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.3 tp -49.59 -60.63 2.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.738 2.496 . . . . 19.309999999999999 117.738 177.688 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.275 17.7 p -74.26 -32.81 63.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 111.587 -2.552 . . . . 23.140000000000001 112.144 -178.781 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.17 69.85 0.26 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 118.694 -2.504 . . . . 19.739999999999998 114.256 159.919 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -107.92 143.5 36.47 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.795 -0.826 . . . . 21.93 112.982 164.511 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -94.0 98.53 11.08 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.038 1.866 . . . . 12.33 116.038 167.874 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.5 mt -86.06 92.59 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 116.164 -4.085 . . . . 17.079999999999998 106.577 176.873 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 m -61.57 127.46 31.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 117.089 -1.434 . . . . 16.300000000000001 113.185 164.902 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.431 HD13 HG11 ' A' ' 26' ' ' VAL . 30.8 mt -110.34 150.3 28.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.953 2.901 . . . . 15.880000000000001 115.669 163.756 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -104.83 125.19 50.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.6 -3.188 . . . . 28.899999999999999 103.824 170.485 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -139.53 156.18 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.57 -2.581 . . . . 12.050000000000001 116.489 -171.195 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -105.43 149.3 37.63 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 117.973 -2.954 . . . . 18.170000000000002 111.242 168.054 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.68 -25.53 75.75 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 123.947 3.098 . . . . 8.1600000000000001 113.882 172.776 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 p -81.58 -5.76 58.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.844 1.258 . . . . 11.130000000000001 111.777 -175.537 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -74.66 145.93 42.79 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 118.334 2.716 . . . . 18.030000000000001 118.334 179.674 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -88.66 154.4 20.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.917 -2.364 . . . . 10.220000000000001 108.901 177.451 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 mm -63.29 -27.81 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.843 2.735 . . . . 12.300000000000001 112.786 179.511 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -54.06 -54.42 39.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.313 -3.992 . . . . 36.509999999999998 112.048 168.075 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.63 -41.34 98.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.583 1.698 . . . . 25.66 115.583 174.562 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 15' ' ' LEU . 72.8 t -61.42 -46.14 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 119.597 -1.939 . . . . 8.1199999999999992 111.937 176.045 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -67.68 -20.67 65.32 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.254 -3.404 . . . . 15.470000000000001 114.47 177.986 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.4 -27.85 66.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.579 1.325 . . . . 11.449999999999999 114.579 174.361 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -83.75 -29.05 27.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.503 1.127 . . . . 24.98 110.906 175.658 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.95 -29.87 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 120.746 1.612 . . . . 9.4600000000000009 111.511 165.897 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -76.81 -45.19 29.65 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.47 1.655 . . . . 14.76 115.47 176.649 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.378 20.7 t70 -41.5 -54.97 2.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.521 2.328 . . . . 26.289999999999999 112.171 163.058 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -79.32 -61.88 1.87 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 121.377 3.843 . . . . 30.059999999999999 121.377 -177.145 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.63 -36.48 16.24 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 115.525 -4.485 . . . . 25.190000000000001 105.994 -171.226 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.22 81.15 0.46 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 118.932 -2.355 . . . . 7.4100000000000001 112.743 -171.112 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.3 mt -135.34 131.01 19.36 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 100.686 -3.82 . . . . 9.4900000000000002 100.686 170.58 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -69.29 149.43 69.91 Favored 'Trans proline' 0 N--CA 1.434 -2.022 1 CA-C-N 128.604 4.108 . . . . 11.42 115.213 -178.543 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -93.88 4.45 2.92 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 C-N-CA 115.992 -2.205 . . . . 12.0 112.651 -154.102 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.44 -38.97 21.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.523 3.129 . . . . 35.549999999999997 105.827 176.236 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -67.67 -37.72 82.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.064 2.946 . . . . 20.52 109.52 174.003 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.36 69.0 mt-30 -83.93 132.55 34.76 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 128.059 3.79 . . . . 7.1299999999999999 110.189 -176.163 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.599 ' HB3' HG21 ' A' ' 70' ' ' VAL . 45.0 ttt180 -127.31 133.77 50.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 110.786 -2.915 . . . . 36.390000000000001 108.997 175.229 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.3 mt -103.92 139.41 39.12 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-O 131.272 5.32 . . . . 9.5500000000000007 108.507 178.512 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.612 HD12 ' HG2' ' A' ' 49' ' ' GLN . 10.7 mm -123.06 137.22 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 1 O-C-N 115.974 -4.204 . . . . 13.9 111.762 172.449 . . . . . . . . 3 3 . 1 . 125 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -127.01 124.92 40.52 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.933 -4.229 . . . . 6.8600000000000003 102.629 165.363 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.9 -98.5 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 134.392 5.077 . . . . 11.15 117.717 -173.62 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.04 -18.61 36.37 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 124.71 1.148 . . . . 13.93 114.238 -174.564 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -128.96 133.03 47.67 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.991 2.219 . . . . 23.920000000000002 116.991 -166.761 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.612 ' HG2' HD12 ' A' ' 44' ' ' ILE . 33.1 mt-30 -83.04 134.33 35.04 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.08 -1.822 . . . . 23.23 106.08 -170.585 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.0 mt -92.39 132.21 36.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.24 -1.345 . . . . 9.1099999999999994 111.262 -166.417 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.37 164.76 11.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.872 -3.017 . . . . 33.439999999999998 108.163 -176.558 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.75 -57.2 12.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.703 -2.044 . . . . 28.370000000000001 115.339 -161.742 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.82 18.94 36.27 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 117.273 -1.849 . . . . 15.0 115.324 -174.711 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.4 mtt-85 -104.5 150.76 24.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.698 1.749 . . . . 25.5 108.615 -178.478 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 p -91.56 153.43 19.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.682 -2.511 . . . . 11.949999999999999 110.583 -164.432 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.1 mt -53.68 -35.68 61.35 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.257 2.623 . . . . 10.17 112.797 167.991 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.0 p -70.72 -37.99 73.57 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.662 1.696 . . . . 13.59 115.274 178.652 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -78.93 -29.68 44.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.23 -2.169 . . . . 11.699999999999999 109.502 173.45 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -77.79 -2.45 36.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 123.816 3.007 . . . . 12.949999999999999 116.882 166.133 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 61.38 34.74 18.18 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 126.039 2.828 . . . . 25.449999999999999 114.753 177.884 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.93 116.28 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 113.507 -1.679 . . . . 14.6 114.986 174.543 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -98.29 174.61 6.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.318 -2.845 . . . . 33.229999999999997 103.318 -175.234 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -65.5 147.23 53.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.49 1.293 . . . . 25.969999999999999 114.49 173.387 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 8.5 mt-10 55.3 25.74 7.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.803 -2.436 . . . . 32.609999999999999 113.252 179.73 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -93.96 151.55 19.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.174 -2.346 . . . . 10.56 110.859 169.908 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.5 m -114.09 125.44 53.97 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.138 2.149 . . . . 5.3300000000000001 108.731 -169.72 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -92.11 151.26 20.5 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 116.895 -3.628 . . . . 11.66 112.983 165.705 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -91.51 135.28 33.97 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.152 -2.536 . . . . 16.300000000000001 104.152 172.158 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.5 tp -84.86 125.95 33.06 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.638 -1.914 . . . . 9.9600000000000009 113.846 154.909 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 42' ' ' ARG . 24.9 m -114.17 165.58 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 127.597 2.359 . . . . 9.7599999999999998 112.036 168.476 . . . . . . . . 2 2 . 1 . 125 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.0 tp -84.16 149.18 26.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.904 -2.372 . . . . 19.57 114.319 170.943 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -114.04 126.03 54.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 113.496 0.924 . . . . 35.079999999999998 113.496 169.011 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 mt -86.67 153.68 21.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.022 -1.674 . . . . 32.310000000000002 106.63 179.807 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -86.87 100.5 12.6 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 117.681 -3.137 . . . . 42.75 111.197 173.04 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.52 38.79 1.86 Allowed Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 109.701 -3.408 . . . . 36.310000000000002 108.622 173.686 . . . . . . . . 1 1 . 1 . 125 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.809 0 CA-C-O 116.14 -2.478 . . . . 36.270000000000003 110.759 -171.902 . . . . . . . . 0 0 . 1 . 126 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 CA--C 1.49 -1.35 0 N-CA-C 117.855 2.539 . . . . 17.170000000000002 117.855 . . . . . . . . . 0 0 . 1 . 126 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -82.05 131.68 35.25 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.059 -1.924 . . . . 21.890000000000001 108.536 177.017 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -117.13 176.0 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 123.435 2.834 . . . . 10.83 107.719 160.071 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -135.89 109.79 8.18 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.862 -3.024 . . . . 10.609999999999999 111.654 179.659 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.73 128.95 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 120.171 1.351 . . . . 9.1300000000000008 111.271 -177.629 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -90.68 134.46 34.39 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.296 -1.503 . . . . 20.550000000000001 113.0 173.657 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.7 p -88.09 172.08 9.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.273 3.029 . . . . 11.779999999999999 113.09 -178.281 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.73 -36.96 79.07 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.204 -4.06 . . . . 19.309999999999999 116.772 177.14 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -70.81 -58.5 3.56 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 114.992 -4.817 . . . . 23.140000000000001 109.673 172.548 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.96 46.76 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 123.973 1.874 . . . . 19.739999999999998 112.241 -176.668 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.434 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU . 45.7 mtpt -96.46 160.09 14.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 105.137 -2.171 . . . . 21.93 105.137 162.309 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.8 m -117.94 121.93 41.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.033 -1.667 . . . . 12.33 110.032 157.003 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.431 HD13 ' HG3' ' A' ' 34' ' ' GLU . 21.1 mt -105.79 120.07 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.021 -1.844 . . . . 17.079999999999998 106.021 -168.371 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m -84.44 94.72 8.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.534 -1.212 . . . . 16.300000000000001 109.189 -179.145 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.9 mt -95.43 132.66 40.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 115.161 -2.352 . . . . 15.880000000000001 108.485 -175.941 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.273 26.0 tt0 -89.5 102.67 15.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.291 2.314 . . . . 28.899999999999999 114.295 173.692 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 m -115.5 155.19 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.493 1.951 . . . . 12.050000000000001 111.399 -166.999 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.18 152.8 39.83 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 115.72 -2.086 . . . . 18.170000000000002 107.671 170.511 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -85.88 -10.08 7.31 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 129.123 4.294 . . . . 8.1600000000000001 110.14 -164.513 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 p -85.77 -1.75 57.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 118.827 -1.149 . . . . 11.130000000000001 112.776 174.616 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -69.6 151.01 46.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.759 -3.713 . . . . 18.030000000000001 114.713 -178.878 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 10.2 p -77.26 161.76 27.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.044 -1.836 . . . . 10.220000000000001 106.044 177.356 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mm -57.94 -41.32 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 117.071 -3.518 . . . . 12.300000000000001 110.946 165.513 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.281 22.6 tt0 -42.42 -44.12 3.87 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.709 2.404 . . . . 36.509999999999998 115.215 164.254 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -65.86 -48.4 71.7 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.708 -3.12 . . . . 25.66 114.223 170.68 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.1 t -49.98 -38.77 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.291 -1.506 . . . . 8.1199999999999992 112.769 177.928 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -76.16 -21.63 56.32 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.417 2.006 . . . . 15.470000000000001 116.417 179.522 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.02 -23.82 62.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.921 2.888 . . . . 11.449999999999999 113.708 178.357 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -81.99 -33.32 30.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 126.644 3.116 . . . . 24.98 113.763 171.778 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.4 mt -68.72 -43.86 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.612 -1.93 . . . . 9.4600000000000009 112.529 165.083 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -45.23 -47.48 12.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.275 2.324 . . . . 14.76 117.275 165.188 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -75.85 -54.43 6.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.485 2.714 . . . . 26.289999999999999 114.775 -173.012 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -81.12 -70.43 0.53 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.185 1.394 . . . . 30.059999999999999 110.951 -169.57 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 75.3 mm-40 -58.83 -43.35 90.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.002 2.223 . . . . 25.190000000000001 117.002 175.085 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.25 13.05 50.18 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 126.38 3.211 . . . . 7.4100000000000001 120.145 -168.001 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.7 mt -76.72 125.29 87.39 Favored Pre-proline 0 N--CA 1.43 -1.439 1 O-C-N 116.381 -4.011 . . . . 9.4900000000000002 114.019 174.443 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -78.06 158.82 30.53 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-O 113.999 -2.584 . . . . 11.42 113.545 -164.477 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -71.12 -23.85 24.29 Favored 'Trans proline' 0 C--N 1.3 -2.026 1 CA-C-N 128.988 4.246 . . . . 12.0 111.149 -170.519 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.46 0.27 30.18 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.509 3.152 . . . . 35.549999999999997 119.509 174.805 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.306 60.2 mt-30 -84.24 -25.42 29.43 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.141 -5.35 . . . . 20.52 108.346 169.687 . . . . . . . . 3 2 . 1 . 126 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -92.83 129.44 38.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.684 2.105 . . . . 7.1299999999999999 116.684 -152.205 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -142.03 120.82 12.68 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 115.689 -2.101 . . . . 36.390000000000001 108.803 168.953 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -104.43 138.55 40.66 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 122.593 2.451 . . . . 9.5500000000000007 110.988 -177.629 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mm -116.14 136.22 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 125.969 1.707 . . . . 13.9 110.75 -177.317 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -108.94 102.9 11.87 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 114.738 -4.976 . . . . 6.8600000000000003 106.453 161.663 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.2 -77.62 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.784 3.253 . . . . 11.15 119.784 -168.614 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.62 20.87 2.02 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.108 -1.597 . . . . 13.93 109.108 175.906 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -117.19 129.91 56.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.549 -2.736 . . . . 23.920000000000002 104.184 -179.588 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -76.48 143.59 40.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.069 -1.878 . . . . 23.23 112.575 179.515 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.2 mt -103.57 111.52 24.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 116.982 -1.485 . . . . 9.1099999999999994 107.936 -178.389 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -93.88 150.57 20.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.921 2.013 . . . . 33.439999999999998 111.733 -177.128 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -39.63 -63.4 0.58 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.635 3.084 . . . . 28.370000000000001 115.482 -169.727 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.38 -25.9 64.79 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.815 -1.803 . . . . 15.0 113.702 -159.022 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -83.93 164.35 19.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 114.582 -2.847 . . . . 25.5 112.866 -178.088 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 61.0 p -97.36 169.07 10.01 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.754 1.264 . . . . 11.949999999999999 113.836 -171.431 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.2 mt -63.51 -41.92 98.49 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.193 1.397 . . . . 10.17 112.305 172.903 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 p -55.35 -43.82 75.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.898 2.136 . . . . 13.59 114.561 165.893 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.38 -35.91 76.29 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.245 -3.409 . . . . 11.699999999999999 111.676 -174.044 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.332 2.3 m-85 -91.55 6.23 46.48 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 127.975 3.297 . . . . 12.949999999999999 111.814 179.974 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.292 8.0 m120 58.87 40.78 22.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.163 2.653 . . . . 25.449999999999999 118.163 175.268 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 mm -75.06 131.59 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 104.928 -2.249 . . . . 14.6 104.928 178.361 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -92.21 175.48 6.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.247 -2.783 . . . . 33.229999999999997 113.452 169.159 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -63.64 124.0 20.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 131.629 3.972 . . . . 25.969999999999999 112.123 169.541 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 68.12 34.54 3.98 Favored 'General case' 0 N--CA 1.43 -1.461 2 O-C-N 112.188 -6.57 . . . . 32.609999999999999 107.317 175.907 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.356 61.7 m -90.86 143.72 26.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.783 2.083 . . . . 10.56 108.727 179.308 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 m -84.73 124.35 31.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.109 -2.869 . . . . 5.3300000000000001 111.754 -176.15 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.76 151.7 29.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.671 -1.893 . . . . 11.66 107.958 179.643 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.296 63.3 m170 -115.49 129.94 56.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.666 2.03 . . . . 16.300000000000001 113.546 170.307 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.6 tp -94.09 122.74 36.92 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.353 1.861 . . . . 9.9600000000000009 113.969 176.467 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 m -114.38 167.03 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 122.955 2.616 . . . . 9.7599999999999998 111.751 -175.666 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.47 ' HG ' HD21 ' A' ' 73' ' ' LEU . 36.7 tp -85.77 113.63 22.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 124.626 1.204 . . . . 19.57 109.517 176.514 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -75.59 110.22 9.8 Favored 'General case' 0 N--CA 1.43 -1.453 2 C-N-CA 133.071 4.548 . . . . 35.079999999999998 108.765 -178.098 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.47 HD21 ' HG ' ' A' ' 71' ' ' LEU 0.314 16.8 mt -112.67 114.47 27.09 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.485 -3.26 . . . . 32.310000000000002 106.185 178.528 . . . . . . . . 3 3 . 1 . 126 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.544 ' HE ' ' C ' ' A' ' 76' ' ' GLY . 49.4 ttt180 -125.28 128.02 47.6 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.091 -1.818 . . . . 42.75 106.091 179.689 . . . . . . . . 2 2 . 1 . 126 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.69 -40.36 9.76 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 119.326 -1.416 . . . . 36.310000000000002 110.78 176.038 . . . . . . . . 1 1 . 1 . 126 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.544 ' C ' ' HE ' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.26 1.756 0 N-CA-C 109.173 -1.571 . . . . 36.270000000000003 109.173 -173.0 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.49 -1.36 0 N-CA-C 114.273 1.212 . . . . 17.170000000000002 114.273 . . . . . . . . . 0 0 . 1 . 127 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -86.5 151.59 23.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.032 -2.211 . . . . 21.890000000000001 105.032 -175.288 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 pt -134.86 171.62 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 115.678 -4.389 . . . . 10.83 106.267 152.355 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -112.82 132.91 55.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.233 1.813 . . . . 10.609999999999999 107.417 -177.553 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.01 102.21 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.202 -2.518 . . . . 9.1300000000000008 104.202 176.429 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -87.02 127.26 35.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 128.355 3.931 . . . . 20.550000000000001 114.462 -178.967 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.9 p -81.04 170.8 15.76 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 116.043 -4.161 . . . . 11.779999999999999 119.149 -178.097 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.5 mt -57.69 -34.85 69.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.107 1.763 . . . . 19.309999999999999 114.199 171.012 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.8 p -69.26 -23.55 63.86 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.465 -3.272 . . . . 23.140000000000001 112.634 172.554 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.63 -5.18 40.27 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 118.036 -2.915 . . . . 19.739999999999998 117.529 -161.167 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -76.3 154.06 35.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 120.232 -0.587 . . . . 21.93 111.969 -177.334 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 m -113.1 126.39 55.42 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.559 -3.213 . . . . 12.33 108.868 175.239 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 mt -114.38 112.73 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 102.091 -3.3 . . . . 17.079999999999998 102.091 176.355 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.6 m -95.85 107.24 19.47 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 116.782 -3.699 . . . . 16.300000000000001 110.497 -174.706 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.3 mt -112.41 151.36 29.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.022 2.344 . . . . 15.880000000000001 115.751 -173.539 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.7 104.81 14.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.592 -1.317 . . . . 28.899999999999999 109.611 -177.511 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.28 172.22 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 112.862 0.69 . . . . 12.050000000000001 112.862 171.145 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -106.06 174.45 2.6 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 107.833 -1.173 . . . . 18.170000000000002 107.833 166.577 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -72.8 -17.73 25.44 Favored 'Trans proline' 0 C--N 1.299 -2.048 0 CA-C-O 116.527 -1.53 . . . . 8.1600000000000001 110.515 175.156 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 m -90.69 9.24 30.63 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 120.877 1.671 . . . . 11.130000000000001 112.161 -174.405 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -94.28 154.33 17.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.401 2.048 . . . . 18.030000000000001 107.821 -179.103 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -92.59 164.26 13.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 114.695 1.369 . . . . 10.220000000000001 114.695 -177.314 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.276 22.1 mm -56.07 -41.05 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 127.842 2.457 . . . . 12.300000000000001 112.487 175.296 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.08 -39.94 69.82 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.427 2.291 . . . . 36.509999999999998 115.172 173.285 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -57.46 -38.44 74.5 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 130.962 3.705 . . . . 25.66 115.516 165.622 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.76 -45.46 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 123.998 3.09 . . . . 8.1199999999999992 108.317 -175.146 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.329 17.9 mtmt -55.7 -36.26 66.98 Favored 'General case' 0 N--CA 1.43 -1.456 1 C-N-CA 132.498 4.319 . . . . 15.470000000000001 116.619 171.338 . . . . . . . . 3 2 . 1 . 127 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.35 -38.22 83.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.158 3.021 . . . . 11.449999999999999 119.158 167.693 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -76.24 -24.61 54.58 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 115.082 1.512 . . . . 24.98 115.082 176.162 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -79.24 -33.45 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 119.043 -2.286 . . . . 9.4600000000000009 111.184 178.57 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -62.07 -39.91 94.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.297 -1.32 . . . . 14.76 108.562 168.706 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.7 -40.63 79.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.582 2.438 . . . . 26.289999999999999 117.582 -176.696 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -82.31 -59.3 2.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 114.816 -2.516 . . . . 30.059999999999999 109.129 176.299 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -87.94 -46.28 9.52 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.333 2.271 . . . . 25.190000000000001 109.505 -160.495 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.72 45.12 4.99 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 107.815 -2.114 . . . . 7.4100000000000001 107.815 175.823 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.259 68.3 mt -98.86 121.22 56.68 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 103.993 -2.595 . . . . 9.4900000000000002 103.993 173.172 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.327 1.1 Cg_exo -71.79 166.21 30.2 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 127.599 3.75 . . . . 11.42 118.491 -171.007 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.48 -6.09 4.49 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 CA-C-N 124.47 2.632 . . . . 12.0 112.667 -157.398 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -82.71 -29.53 29.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.28 1.613 . . . . 35.549999999999997 108.445 172.099 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -80.75 -26.44 37.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.095 1.358 . . . . 20.52 112.744 -175.177 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -83.61 128.93 34.9 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.055 -0.975 . . . . 7.1299999999999999 112.263 175.906 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -126.1 131.2 52.15 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.971 -1.122 . . . . 36.390000000000001 107.971 167.663 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.62 137.9 34.04 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.424 3.49 . . . . 9.5500000000000007 105.742 176.978 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mt -134.2 136.37 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.102 2.561 . . . . 13.9 110.818 179.698 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -120.86 95.09 4.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.323 -1.732 . . . . 6.8600000000000003 106.323 -174.393 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.64 -82.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.739 2.415 . . . . 11.15 111.994 -163.223 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.39 -1.49 6.11 Favored Glycine 0 N--CA 1.429 -1.794 0 O-C-N 116.959 -3.588 . . . . 13.93 112.5 171.172 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -83.74 113.25 20.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.708 -2.642 . . . . 23.920000000000002 113.488 176.51 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -70.38 142.03 52.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.387 -3.321 . . . . 23.23 109.974 171.794 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -107.55 110.66 22.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.963 -1.495 . . . . 9.1099999999999994 106.963 -166.323 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -87.77 153.74 21.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.129 -2.857 . . . . 33.439999999999998 114.479 -175.906 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.366 1.7 m-20 -48.73 -58.92 4.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.781 2.511 . . . . 28.370000000000001 117.781 -160.621 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.96 51.86 0.7 Allowed Glycine 0 N--CA 1.43 -1.756 0 CA-C-O 127.514 3.841 . . . . 15.0 114.73 -171.515 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -128.18 158.78 37.13 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.66 -4.435 . . . . 25.5 109.63 174.459 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.7 p -88.16 159.47 18.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.483 2.087 . . . . 11.949999999999999 106.869 -171.184 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.63 -30.33 69.79 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 116.064 -4.147 . . . . 10.17 113.354 169.167 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.2 p -64.91 -20.1 66.27 Favored 'General case' 0 N--CA 1.43 -1.47 1 C-N-CA 135.493 5.517 . . . . 13.59 116.294 176.237 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -82.73 -39.04 22.45 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.466 1.907 . . . . 11.699999999999999 112.536 172.31 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -79.69 -19.7 48.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.414 -2.679 . . . . 12.949999999999999 117.849 163.079 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.496 32.3 m120 75.26 57.28 0.06 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.745 2.212 . . . . 25.449999999999999 113.782 174.187 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mm -85.64 126.79 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 129.048 2.939 . . . . 14.6 106.727 -178.7 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -104.18 167.89 9.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.532 -1.655 . . . . 33.229999999999997 106.532 172.981 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -60.5 148.64 37.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.658 2.783 . . . . 25.969999999999999 110.816 -175.494 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 60.25 28.48 18.08 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 116.041 1.867 . . . . 32.609999999999999 116.041 176.879 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 m -77.09 150.28 35.67 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.18 -1.045 . . . . 10.56 108.18 174.191 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.6 m -98.62 104.16 16.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.799 -2.297 . . . . 5.3300000000000001 104.799 168.143 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -85.88 133.77 33.94 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.178 -2.283 . . . . 11.66 105.043 168.746 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.262 47.5 p-80 -106.13 145.34 31.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.796 2.713 . . . . 16.300000000000001 112.917 176.826 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -104.36 127.47 52.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.687 -2.508 . . . . 9.9600000000000009 109.8 -171.063 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.75 164.27 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 124.018 3.099 . . . . 9.7599999999999998 109.52 177.6 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.9 tp -89.62 142.89 27.26 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.205 -1.816 . . . . 19.57 108.319 -171.294 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -70.61 136.14 48.96 Favored 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 122.081 4.104 . . . . 35.079999999999998 122.081 174.975 . . . . . . . . 2 2 . 1 . 127 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.3 mt -68.46 -51.22 45.88 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 128.456 2.702 . . . . 32.310000000000002 116.51 -175.417 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ptt-85 -80.72 164.08 23.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 124.92 2.295 . . . . 42.75 111.836 166.92 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.96 63.86 0.55 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.876 -3.015 . . . . 36.310000000000002 110.462 175.563 . . . . . . . . 1 1 . 1 . 127 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.76 0 N-CA-C 108.166 -1.974 . . . . 36.270000000000003 108.166 165.257 . . . . . . . . 0 0 . 1 . 128 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.489 -1.37 0 N-CA-C 106.501 -1.666 . . . . 17.170000000000002 106.501 . . . . . . . . . 0 0 . 1 . 128 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -114.04 121.16 43.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.401 3.08 . . . . 21.890000000000001 104.636 -175.644 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -120.23 162.6 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 126.891 2.619 . . . . 10.83 106.023 165.048 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -124.94 130.06 51.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.006 -2.961 . . . . 10.609999999999999 103.006 -169.608 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.2 111.8 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 116.423 -2.111 . . . . 9.1300000000000008 108.435 172.798 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -78.41 124.32 27.99 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 124.598 3.363 . . . . 20.550000000000001 112.077 174.646 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -69.31 164.28 23.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.397 -2.69 . . . . 11.779999999999999 117.768 169.503 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.33 -19.37 65.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.373 1.99 . . . . 19.309999999999999 116.373 172.241 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -93.15 -20.68 20.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.823 1.786 . . . . 23.140000000000001 115.823 179.488 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.73 34.38 2.64 Favored Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 116.421 1.329 . . . . 19.739999999999998 116.421 175.374 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -99.62 129.52 45.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.758 1.623 . . . . 21.93 110.187 164.072 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -91.67 119.99 32.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.34 -2.1 . . . . 12.33 105.542 167.915 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 30' ' ' ILE 0.3 7.8 mt -86.11 104.89 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 126.994 2.118 . . . . 17.079999999999998 110.353 172.873 . . . . . . . . 3 3 . 1 . 128 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.0 m -84.7 106.77 16.5 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.991 -1.484 . . . . 16.300000000000001 108.599 177.433 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.6 mt -110.34 139.84 45.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.913 -1.117 . . . . 15.880000000000001 110.01 -178.765 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -96.41 128.62 43.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.254 1.978 . . . . 28.899999999999999 106.464 174.215 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -137.11 155.15 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.378 -2.076 . . . . 12.050000000000001 108.333 -173.232 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -101.61 129.68 26.24 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 113.703 -3.046 . . . . 18.170000000000002 105.851 178.008 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.52 -16.17 46.02 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 CA-C-N 123.834 2.405 . . . . 8.1600000000000001 114.621 -168.825 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.6 p -94.55 -3.53 49.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 123.083 2.674 . . . . 11.130000000000001 110.668 -171.555 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.14 153.3 34.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 127.035 3.302 . . . . 18.030000000000001 115.93 175.883 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.7 p -75.36 162.88 28.01 Favored 'General case' 0 N--CA 1.43 -1.469 1 C-N-CA 131.787 4.035 . . . . 10.220000000000001 110.982 -178.456 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.293 6.3 mm -71.29 -34.74 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 1 O-C-N 115.392 -4.568 . . . . 12.300000000000001 112.546 178.754 . . . . . . . . 3 2 . 1 . 128 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -53.05 -43.27 66.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.241 1.817 . . . . 36.509999999999998 112.643 169.006 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -71.08 -22.66 62.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.898 2.184 . . . . 25.66 116.898 170.995 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.9 t -66.07 -43.76 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 1 CA-C-N 126.873 4.397 . . . . 8.1199999999999992 114.016 166.817 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -59.78 -39.12 83.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.963 2.105 . . . . 15.470000000000001 110.275 179.409 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.52 66.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.407 -3.308 . . . . 11.449999999999999 119.656 177.954 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -74.9 -33.45 62.04 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.834 2.454 . . . . 24.98 110.877 173.672 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.458 HG23 HD13 ' A' ' 13' ' ' ILE 0.253 6.8 mt -75.19 -40.71 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.004 -2.935 . . . . 9.4600000000000009 110.289 175.322 . . . . . . . . 3 3 . 1 . 128 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.48 -48.82 56.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.499 -2.625 . . . . 14.76 114.6 160.219 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -66.0 -42.85 89.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.588 1.995 . . . . 26.289999999999999 114.661 176.827 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -72.85 -69.58 0.4 Allowed 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.016 -2.303 . . . . 30.059999999999999 111.959 178.169 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -97.92 -2.01 41.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.523 1.929 . . . . 25.190000000000001 114.518 -164.428 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.51 21.43 79.5 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 118.579 2.191 . . . . 7.4100000000000001 118.579 174.526 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 98.0 mt -98.91 130.12 28.26 Favored Pre-proline 0 N--CA 1.431 -1.421 0 O-C-N 116.794 -3.768 . . . . 9.4900000000000002 102.623 -169.153 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -76.92 154.81 33.91 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 117.928 -1.67 . . . . 11.42 110.021 -172.105 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.344 9.7 Cg_endo -63.96 -30.16 66.94 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 123.463 2.775 . . . . 12.0 115.25 -169.525 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -63.63 -31.84 73.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.558 3.54 . . . . 35.549999999999997 120.558 -179.206 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -70.06 -34.53 73.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.853 -2.404 . . . . 20.52 114.39 166.777 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -64.25 103.79 0.67 Allowed 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.337 -4.602 . . . . 7.1299999999999999 121.327 178.743 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -102.77 125.25 49.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.556 -2.59 . . . . 36.390000000000001 110.897 163.332 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.7 mt -96.61 139.17 33.08 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.649 1.214 . . . . 9.5500000000000007 111.872 170.329 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.45 HG21 ' HE1' ' A' ' 68' ' ' HIS . 7.9 mt -133.13 122.26 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 129.337 3.055 . . . . 13.9 109.534 173.035 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -93.44 112.58 24.53 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.981 2.912 . . . . 6.8600000000000003 108.696 164.106 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.27 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 127.877 2.471 . . . . 11.15 114.128 -177.51 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 27.86 2.5 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 127.711 2.576 . . . . 13.93 111.757 166.431 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -104.95 137.09 43.24 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.975 2.91 . . . . 23.920000000000002 111.949 172.662 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -99.46 124.14 44.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.535 1.516 . . . . 23.23 112.415 -172.535 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.9 mt -97.59 137.35 36.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.575 -2.578 . . . . 9.1099999999999994 110.666 -171.307 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -118.69 135.17 54.62 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 127.128 3.346 . . . . 33.439999999999998 104.122 -166.193 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -43.53 -37.33 2.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 113.793 -3.003 . . . . 28.370000000000001 118.82 -166.502 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.6 11.66 27.95 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 107.001 -2.439 . . . . 15.0 107.001 -167.935 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -91.0 160.29 15.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.521 -3.929 . . . . 25.5 103.549 168.399 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.2 p -103.88 170.09 8.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.75 -1.843 . . . . 11.949999999999999 108.983 -170.329 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -57.64 -42.23 83.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 124.001 1.857 . . . . 10.17 114.226 168.751 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.3 p -62.89 -18.46 63.01 Favored 'General case' 0 N--CA 1.43 -1.459 1 N-CA-C 122.661 4.319 . . . . 13.59 122.661 173.303 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -77.96 -41.43 36.18 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.289 -4.632 . . . . 11.699999999999999 112.656 -173.667 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -86.08 -10.68 54.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.655 -1.612 . . . . 12.949999999999999 111.802 179.078 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.316 71.9 m-20 71.11 54.88 0.23 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.89 3.276 . . . . 25.449999999999999 113.232 -176.517 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.285 59.6 mt -89.28 108.6 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 127.933 3.27 . . . . 14.6 113.623 -179.352 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -89.34 176.24 7.01 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.515 3.526 . . . . 33.229999999999997 113.396 -166.404 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -69.14 139.32 54.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.474 2.027 . . . . 25.969999999999999 116.474 172.173 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 50.59 68.71 0.73 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.689 1.868 . . . . 32.609999999999999 112.771 -171.793 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -125.24 156.97 37.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.898 2.879 . . . . 10.56 103.536 176.485 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.0 m -126.37 124.81 41.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 124.413 1.071 . . . . 5.3300000000000001 109.292 -178.086 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.04 167.39 10.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.223 3.009 . . . . 11.66 109.332 -179.583 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.45 ' HE1' HG21 ' A' ' 44' ' ' ILE . 7.4 p-80 -135.73 158.81 43.47 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.475 2.559 . . . . 16.300000000000001 112.184 179.056 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -118.04 136.82 53.31 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.162 -4.087 . . . . 9.9600000000000009 103.382 -168.597 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.81 172.95 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.295 -1.743 . . . . 9.7599999999999998 106.295 -175.522 . . . . . . . . 2 2 . 1 . 128 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mt -74.01 150.51 40.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 115.845 -2.342 . . . . 19.57 111.773 176.787 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 ttp85 -104.35 116.29 31.89 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 130.064 3.346 . . . . 35.079999999999998 111.209 175.589 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 65.6 tp -78.0 -43.07 30.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 116.894 2.183 . . . . 32.310000000000002 116.894 -175.433 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -81.4 140.35 34.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.25 2.22 . . . . 42.75 113.871 -172.056 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.07 2.61 59.84 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 120.413 2.925 . . . . 36.310000000000002 120.413 -172.618 . . . . . . . . 1 1 . 1 . 128 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.741 0 N-CA-C 107.797 -2.121 . . . . 36.270000000000003 107.797 176.669 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 124.209 1.957 . . . . 17.17 109.691 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -98.41 145.96 26.21 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 113.94 -5.475 . . . . 21.89 115.352 -176.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 pt -127.52 -176.49 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.414 -3.18 . . . . 10.83 102.414 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -121.61 130.47 53.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.901 -1.954 . . . . 10.61 116.084 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.75 132.66 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 122.371 2.35 . . . . 9.13 107.289 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -117.89 128.32 54.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.618 -1.623 . . . . 20.55 106.618 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.8 p -74.35 179.64 4.46 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.256 1.947 . . . . 11.78 116.256 170.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.03 -58.46 8.07 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.388 2.518 . . . . 19.31 117.571 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.94 -38.97 93.16 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 126.537 3.065 . . . . 23.14 114.55 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.27 49.57 0.27 Allowed Glycine 0 N--CA 1.431 -1.699 0 CA-C-N 111.589 -2.55 . . . . 19.74 115.667 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -89.74 129.55 36.13 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.613 -4.463 . . . . 21.93 109.235 160.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.2 m -92.01 126.7 37.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 117.316 -1.754 . . . . 12.33 114.243 169.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 94.8 mt -102.91 103.53 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 C-N-CA 132.39 4.276 . . . . 17.08 105.505 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.9 m -74.66 131.52 40.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.264 -2.773 . . . . 16.3 106.787 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 tp -143.3 128.62 18.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 115.979 -1.962 . . . . 15.88 115.735 -166.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -103.4 142.95 33.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.222 1.963 . . . . 28.9 114.383 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.414 HG11 HG22 ' A' ' 26' ' ' VAL . 6.8 m -157.72 165.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.167 1.937 . . . . 12.05 111.128 -158.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.47 124.35 25.07 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.673 -2.584 . . . . 18.17 111.819 -172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.29 -20.85 9.5 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 C-N-CA 124.267 3.311 . . . . 8.16 116.677 -154.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.1 p -95.66 7.23 46.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.412 1.885 . . . . 11.13 113.687 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.94 177.29 5.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 105.129 -2.174 . . . . 18.03 105.129 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.7 p -104.31 173.23 6.39 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.596 2.141 . . . . 10.22 111.215 -158.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.38 26.1 mm -65.33 -29.48 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 127.825 3.679 . . . . 12.3 113.737 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -55.8 -40.66 73.02 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 115.276 -4.64 . . . . 36.51 114.526 164.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.98 -26.8 66.99 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.883 -1.127 . . . . 25.66 113.46 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.414 HG22 HG11 ' A' ' 17' ' ' VAL . 4.4 t -71.79 -43.22 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 115.145 -2.622 . . . . 8.12 110.577 175.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -63.41 -33.62 75.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.534 -2.604 . . . . 15.47 117.2 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -14.92 58.62 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.798 3.259 . . . . 11.45 119.798 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -84.97 -39.12 18.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.056 -2.278 . . . . 24.98 114.162 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 mt -63.3 -40.94 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 130.066 3.347 . . . . 9.46 112.666 170.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -68.03 -31.47 71.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.343 1.457 . . . . 14.76 114.07 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.257 43.2 t0 -71.1 -59.75 2.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.574 -3.204 . . . . 26.29 108.278 172.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.301 3.6 tppp? -51.08 -67.34 0.26 Allowed 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 121.251 3.797 . . . . 30.06 121.251 -176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -89.51 -48.0 7.6 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.7 1.37 . . . . 25.19 114.7 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.52 71.77 1.09 Allowed Glycine 0 N--CA 1.43 -1.755 0 O-C-N 127.381 2.926 . . . . 7.41 114.883 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mt -128.75 132.37 24.32 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 103.676 -2.713 . . . . 9.49 103.676 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -82.96 158.31 15.62 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 CA-C-N 124.931 2.797 . . . . 11.42 112.9 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -73.85 -20.94 19.21 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 123.373 2.715 . . . . 12.0 110.86 -153.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -65.64 -41.31 92.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.306 2.243 . . . . 35.55 112.755 167.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.61 -34.53 53.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.68 -1.263 . . . . 20.52 112.406 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.13 124.17 19.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 121.123 3.749 . . . . 7.13 121.123 165.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -127.35 120.2 27.98 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.612 1.195 . . . . 36.39 109.169 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.484 ' O ' HD22 ' A' ' 50' ' ' LEU . 83.3 mt -111.7 120.17 41.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.082 -2.261 . . . . 9.55 106.68 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.68 112.29 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 129.768 3.227 . . . . 13.9 112.944 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -99.2 120.85 40.19 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.939 2.304 . . . . 6.86 106.403 165.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 65.29 -102.08 0.08 Allowed 'General case' 0 N--CA 1.431 -1.422 1 CA-C-O 129.27 4.367 . . . . 11.15 116.146 -177.591 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.34 55.18 0.59 Allowed Glycine 0 N--CA 1.43 -1.752 1 O-C-N 114.782 -4.949 . . . . 13.93 109.047 160.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.254 31.9 ttmt -135.08 139.23 44.57 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.9 1.68 . . . . 23.92 106.688 163.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -82.51 133.95 35.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.052 -1.03 . . . . 23.23 110.934 165.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.484 HD22 ' O ' ' A' ' 43' ' ' LEU . 1.2 mm? -77.79 131.01 37.41 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.073 1.879 . . . . 9.11 116.073 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -75.68 160.02 30.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.813 2.72 . . . . 33.44 108.458 -175.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.81 -52.95 20.66 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.665 -4.397 . . . . 28.37 110.042 -167.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.37 23.65 35.07 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 129.649 3.5 . . . . 15.0 112.588 -160.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.1 mtt-85 -116.65 160.7 20.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.808 2.122 . . . . 25.5 106.811 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 p -95.0 177.81 5.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.427 2.537 . . . . 11.95 113.438 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.17 -29.95 48.83 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.718 -3.114 . . . . 10.17 112.647 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 m -62.13 -19.56 63.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.347 1.61 . . . . 13.59 115.347 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.6 -46.27 22.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.525 -1.657 . . . . 11.7 106.525 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -73.5 -31.47 63.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.389 -1.732 . . . . 12.95 113.33 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 87.1 53.16 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.486 3.514 . . . . 25.45 107.52 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.1 mt -101.34 132.3 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.412 -3.181 . . . . 14.6 102.412 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -128.27 177.11 7.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.001 2.52 . . . . 33.23 113.008 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -51.31 128.08 21.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.011 2.339 . . . . 25.97 116.807 172.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 63.72 52.24 2.25 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.361 2.029 . . . . 32.61 116.277 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.7 m -113.45 146.04 40.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.084 2.954 . . . . 10.56 106.031 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.3 m -101.3 118.66 37.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.23 1.967 . . . . 5.33 115.769 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.9 145.8 34.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.395 -3.316 . . . . 11.66 105.78 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -109.27 128.47 55.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 125.385 2.517 . . . . 16.3 113.659 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.3 tp -102.6 111.47 23.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.592 2.357 . . . . 9.96 106.787 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.22 174.35 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 102.87 -3.011 . . . . 9.76 102.87 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.43 -1.455 0 CA-C-O 123.225 1.488 . . . . 19.57 113.687 -169.18 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.213 -0.662 . . . . 17.17 109.213 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -113.58 143.33 44.74 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 100.366 -3.938 . . . . 21.89 100.366 -170.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -119.32 164.91 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.447 -2.033 . . . . 10.83 108.352 170.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 65.9 m-85 -98.83 122.41 42.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.117 -2.92 . . . . 10.61 103.117 170.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.7 113.53 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.564 -2.585 . . . . 9.13 108.36 154.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -84.61 134.58 34.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.842 -2.411 . . . . 20.55 113.309 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 18.6 p -89.56 179.73 5.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.297 -3.377 . . . . 11.78 106.377 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -71.83 -44.53 63.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 128.171 3.843 . . . . 19.31 111.91 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.1 p -79.97 -78.52 0.16 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 109.382 -3.554 . . . . 23.14 115.642 -168.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.24 50.1 0.21 Allowed Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 119.575 1.079 . . . . 19.74 113.377 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 tttt -139.98 137.15 34.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.77 -1.429 . . . . 21.93 111.627 163.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -119.7 103.18 9.16 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.592 2.615 . . . . 12.33 110.535 171.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 83.8 mt -79.59 120.42 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 114.506 -2.664 . . . . 17.08 107.704 -165.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 p -105.12 94.04 5.02 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 123.364 2.802 . . . . 16.3 108.74 -172.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.67 116.17 31.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.934 2.493 . . . . 15.88 109.031 -158.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.406 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 7.1 pt-20 -73.41 119.32 17.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.123 1.369 . . . . 28.9 111.846 173.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.79 178.6 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 113.888 -1.505 . . . . 12.05 108.802 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.17 158.33 44.67 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 126.524 2.39 . . . . 18.17 106.394 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -70.02 -3.76 12.84 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 N-CA-C 118.666 2.525 . . . . 8.16 118.666 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 p -90.84 -0.51 57.74 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.121 4.168 . . . . 11.13 109.834 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.66 147.18 35.64 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.446 1.93 . . . . 18.03 112.06 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 23' ' ' ILE . 41.5 p -92.0 -165.94 1.45 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.809 -2.432 . . . . 10.22 111.804 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.403 ' H ' ' HB ' ' A' ' 22' ' ' THR . 37.3 mm -85.76 -39.24 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.278 2.631 . . . . 12.3 105.611 175.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.4 -33.24 69.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.265 -3.397 . . . . 36.51 116.65 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.02 -56.65 15.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.925 1.345 . . . . 25.66 110.8 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -53.17 -47.19 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.199 -1.563 . . . . 8.12 113.7 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -54.53 -39.21 67.44 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.783 -3.073 . . . . 15.47 114.761 171.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -32.92 71.13 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.241 -3.412 . . . . 11.45 114.73 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -81.14 -23.6 38.2 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.396 1.093 . . . . 24.98 109.45 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.36 -25.73 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 117.307 -3.371 . . . . 9.46 113.184 169.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -75.49 -30.2 59.8 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.941 2.496 . . . . 14.76 109.675 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.7 -55.95 19.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.477 -2.014 . . . . 26.29 108.482 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -79.83 -43.31 22.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 116.545 -1.693 . . . . 30.06 112.333 -161.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -104.35 -44.05 5.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.462 1.028 . . . . 25.19 108.603 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.34 37.99 4.14 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 121.109 -0.995 . . . . 7.41 111.449 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.7 mt -101.58 135.74 19.74 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 108.036 -1.098 . . . . 9.49 108.036 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -65.36 137.94 53.33 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 C-N-CA 123.258 2.639 . . . . 11.42 113.567 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -68.31 -19.54 43.8 Favored 'Trans proline' 0 C--N 1.3 -1.988 1 C-N-CA 126.065 4.51 . . . . 12.0 118.178 -172.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -87.74 -27.28 22.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.948 1.699 . . . . 35.55 112.769 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.07 -40.37 82.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.106 2.162 . . . . 20.52 109.471 165.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.91 129.75 43.37 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.699 2.852 . . . . 7.13 118.699 167.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -130.44 129.16 42.65 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.94 -4.225 . . . . 36.39 110.823 168.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.2 mt -112.93 129.08 56.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.856 1.262 . . . . 9.55 110.145 -173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -130.5 140.09 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.988 1.852 . . . . 13.9 107.17 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.57 -75.83 0.51 Allowed 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 114.738 -2.785 . . . . 6.86 112.187 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.61 -66.06 1.01 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.319 -2.845 . . . . 11.15 103.319 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.85 10.11 2.09 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 127.068 2.271 . . . . 13.93 115.523 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -112.26 142.1 45.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.287 1.042 . . . . 23.92 109.451 170.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -86.23 145.88 26.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.24 1.416 . . . . 23.23 107.784 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.03 130.12 45.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.067 -3.521 . . . . 9.11 110.324 -171.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -103.89 151.32 23.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 118.31 -1.356 . . . . 33.44 109.979 -171.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -47.78 -53.53 15.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.733 2.864 . . . . 28.37 118.733 -152.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.94 50.82 0.74 Allowed Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 126.644 2.068 . . . . 15.0 114.465 -166.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -127.21 160.04 32.49 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.423 1.889 . . . . 25.5 109.899 154.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.341 48.0 p -79.24 164.17 24.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.041 2.536 . . . . 11.95 111.269 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.86 -31.22 72.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.829 1.776 . . . . 10.17 111.875 165.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -68.15 -31.09 70.4 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.7 -2.5 . . . . 13.59 114.919 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -71.99 -48.2 46.55 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.335 1.854 . . . . 11.7 106.596 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -74.15 -11.3 60.26 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.67 2.841 . . . . 12.95 118.67 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m120 69.24 49.01 0.63 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.753 2.021 . . . . 25.45 113.896 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.4 mt -105.24 108.01 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.333 -2.839 . . . . 14.6 103.333 173.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -101.5 -172.81 2.22 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.638 3.589 . . . . 33.23 109.859 -166.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp -61.59 126.75 28.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.208 -3.432 . . . . 25.97 113.898 169.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 41.7 mt-10 64.78 27.8 12.96 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.403 2.742 . . . . 32.61 118.403 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.2 m -90.67 154.44 19.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.056 2.836 . . . . 10.56 105.073 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 10.9 m -98.76 126.98 44.54 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.361 -2.2 . . . . 5.33 105.249 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.4 mt -102.48 149.66 24.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.44 -2.037 . . . . 11.66 113.259 153.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -93.71 129.09 40.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.081 2.219 . . . . 16.3 112.246 172.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 10.4 tp -96.31 126.3 41.42 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.153 2.981 . . . . 9.96 109.466 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.71 126.21 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 113.713 -1.585 . . . . 9.76 108.602 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 N--CA 1.43 -1.437 0 O-C-N 125.795 1.934 . . . . 19.57 110.865 -179.549 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 122.143 0.973 . . . . 17.17 113.216 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -80.12 109.78 14.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.969 -2.332 . . . . 21.89 111.863 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -96.67 154.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 116.106 -1.902 . . . . 10.83 113.984 165.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.283 21.2 m-85 -101.79 113.56 26.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.252 1.842 . . . . 10.61 111.398 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.2 t -111.67 95.77 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 101.01 -3.7 . . . . 9.13 101.01 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 12' ' ' THR 0.284 55.5 tttt -87.5 126.97 35.23 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.169 -1.832 . . . . 20.55 114.492 -167.04 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.1 p -83.46 158.04 22.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.265 1.983 . . . . 11.78 113.554 -173.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -74.1 -27.66 60.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.101 -3.5 . . . . 19.31 107.996 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -62.25 -60.24 3.86 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.873 -4.267 . . . . 23.14 113.77 175.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.12 41.98 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.755 0 O-C-N 117.109 -3.494 . . . . 19.74 114.566 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -140.21 163.11 33.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.868 2.834 . . . . 21.93 105.784 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 8.1 m -128.53 123.05 32.52 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.955 2.659 . . . . 12.33 106.073 174.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -83.49 119.84 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.991 -1.693 . . . . 17.08 113.96 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 p -81.47 90.72 6.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.657 -2.527 . . . . 16.3 114.996 165.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 tp -94.39 118.9 32.33 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.387 2.275 . . . . 15.88 108.184 -167.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -81.51 109.4 15.93 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.544 -1.348 . . . . 28.9 112.456 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.07 171.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 127.76 2.424 . . . . 12.05 110.243 167.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -108.27 173.94 2.74 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 126.673 1.989 . . . . 18.17 107.273 158.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -71.32 -3.09 12.28 Favored 'Trans proline' 0 N--CA 1.434 -2.015 1 C-N-CA 125.601 4.201 . . . . 8.16 113.136 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -88.7 -25.42 22.35 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 111.634 -2.53 . . . . 11.13 111.276 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.8 138.64 46.53 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.594 2.14 . . . . 18.03 113.121 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -91.2 177.7 6.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.267 -1.788 . . . . 10.22 108.309 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -82.26 -22.09 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.084 -1.01 . . . . 12.3 109.318 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -61.26 -37.74 84.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.665 1.986 . . . . 36.51 114.483 161.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -68.5 -25.8 65.14 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 118.931 -2.356 . . . . 25.66 115.452 167.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.1 t -64.79 -56.68 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 128.493 2.717 . . . . 8.12 111.115 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -56.46 -30.1 62.48 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 117.336 2.347 . . . . 15.47 117.336 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.67 -45.53 64.91 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.308 2.243 . . . . 11.45 111.84 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -69.74 -34.91 74.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.797 2.439 . . . . 24.98 112.454 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.9 mt -73.02 -27.24 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 113.489 0.922 . . . . 9.46 113.489 166.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.256 16.6 tt0 -66.9 -33.04 74.71 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.662 -5.649 . . . . 14.76 111.504 170.327 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.56 -58.46 4.25 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.45 2.7 . . . . 26.29 115.281 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -63.67 -71.97 0.15 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 114.808 1.411 . . . . 30.06 114.808 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -96.66 -22.39 17.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.326 -2.734 . . . . 25.19 113.222 -169.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.58 31.76 8.6 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.487 -1.383 . . . . 7.41 114.484 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.6 mt -97.03 126.17 43.39 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 114.65 -2.595 . . . . 9.49 106.606 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.26 0.1 OUTLIER -68.2 160.35 49.2 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 124.599 1.842 . . . . 11.42 114.969 -176.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -74.9 -11.76 21.7 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 123.321 2.222 . . . . 12.0 113.905 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -77.51 -7.84 56.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.987 -2.946 . . . . 35.55 112.969 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -110.22 -18.94 13.18 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.398 -2.064 . . . . 20.52 110.045 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -80.61 108.87 14.61 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 121.034 3.716 . . . . 7.13 121.034 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -104.7 153.21 21.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.583 -1.189 . . . . 36.39 110.351 160.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -127.46 141.99 51.52 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.444 -2.035 . . . . 9.55 112.665 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 pt -130.09 164.66 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 106.976 -1.491 . . . . 13.9 106.976 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.88 -88.77 0.17 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.325 2.266 . . . . 6.86 111.345 167.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.98 -61.79 1.39 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.261 -3.399 . . . . 11.15 104.542 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.37 -37.84 0.9 Allowed Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 118.696 2.238 . . . . 13.93 118.696 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -71.38 128.98 37.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.312 2.338 . . . . 23.92 117.312 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -75.29 118.17 17.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.515 -2.616 . . . . 23.23 112.005 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.7 mt -72.52 132.61 44.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.142 2.401 . . . . 9.11 111.144 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.272 28.7 mt-10 -97.09 155.66 16.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.427 -2.064 . . . . 33.44 105.427 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.81 -62.1 1.62 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.56 3.144 . . . . 28.37 112.392 -166.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.38 21.72 30.55 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 124.906 3.503 . . . . 15.0 115.249 -157.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.503 HH21 ' CG ' ' A' ' 58' ' ' ASP . 72.2 mtp180 -115.97 156.22 26.65 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 121.106 2.453 . . . . 25.5 108.375 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.9 p -84.73 163.65 19.03 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.007 -2.933 . . . . 11.95 111.206 -169.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.8 mt -73.34 -13.6 61.14 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.965 -4.834 . . . . 10.17 114.869 170.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 t -70.19 -39.14 75.39 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.499 -3.251 . . . . 13.59 108.665 167.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.503 ' CG ' HH21 ' A' ' 54' ' ' ARG . 16.7 t0 -63.29 -40.34 97.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.983 1.845 . . . . 11.7 115.983 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -79.4 -31.3 42.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 117.3 -1.333 . . . . 12.95 111.833 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.274 68.7 m-80 72.77 54.02 0.14 Allowed 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.365 4.266 . . . . 25.45 106.829 -176.835 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.3 mt -98.51 106.95 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.217 3.007 . . . . 14.6 107.704 169.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -102.94 -166.5 1.28 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.368 -2.083 . . . . 33.23 111.567 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -66.33 135.62 54.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.425 1.49 . . . . 25.97 110.063 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.359 51.4 mt-10 65.37 40.91 4.52 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.229 1.566 . . . . 32.61 115.229 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 t -109.13 149.48 29.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.565 -3.834 . . . . 10.56 111.055 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.295 78.2 m -97.66 109.55 22.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.814 1.646 . . . . 5.33 110.1 -170.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.1 mt -108.13 155.11 20.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.745 -1.946 . . . . 11.66 105.745 171.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -120.3 137.34 54.31 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.143 -1.598 . . . . 16.3 113.569 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.1 tp -91.75 110.35 21.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.193 -1.367 . . . . 9.96 111.611 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.97 144.79 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 127.846 2.459 . . . . 9.76 112.162 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.429 -1.477 1 O-C-N 115.205 -4.685 . . . . 19.57 110.483 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.57 ' HB2' ' HG3' ' A' ' 63' ' ' LYS 0.25 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.331 0 N-CA-C 115.738 1.755 . . . . 17.17 115.738 . . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.34 29.9 mt-30 -103.16 145.2 30.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.159 3.022 . . . . 21.89 119.159 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.32 29.3 pt -123.36 155.12 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 122.483 2.401 . . . . 10.83 106.679 166.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -112.12 137.43 50.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.396 -2.184 . . . . 10.61 108.505 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.22 123.07 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 123.023 1.392 . . . . 9.13 111.253 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -100.14 125.79 46.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.001 -1.952 . . . . 20.55 113.434 -170.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.3 p -83.48 173.85 11.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.28 1.215 . . . . 11.78 114.28 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.7 tp -71.84 -43.06 66.18 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.836 1.779 . . . . 19.31 112.878 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -67.56 -23.05 65.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.003 -1.061 . . . . 23.14 109.603 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.53 10.9 8.29 Favored Glycine 0 N--CA 1.429 -1.786 1 N-CA-C 123.781 4.272 . . . . 19.74 123.781 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -86.49 146.35 26.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.112 -2.551 . . . . 21.93 104.112 -171.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 m -110.16 104.62 13.49 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.588 0.709 . . . . 12.33 112.736 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -84.04 129.23 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.69 2.796 . . . . 17.08 112.401 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -106.19 116.56 32.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.982 -2.324 . . . . 16.3 113.196 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.271 0.6 OUTLIER -118.77 131.4 56.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.642 1.839 . . . . 15.88 106.177 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -94.49 122.09 36.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.197 -2.815 . . . . 28.9 108.46 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.18 174.38 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.059 -1.428 . . . . 12.05 113.462 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -103.05 -173.97 0.32 Allowed Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 103.829 -2.656 . . . . 18.17 103.829 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -74.41 -29.5 9.25 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 C-N-CA 127.309 5.34 . . . . 8.16 110.184 160.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 94.7 p -68.25 -28.55 67.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.797 2.888 . . . . 11.13 118.797 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -71.86 162.35 29.58 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.728 1.251 . . . . 18.03 112.94 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.6 p -104.61 175.25 5.55 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.83 -3.669 . . . . 10.22 112.389 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -65.24 -25.39 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.652 -2.53 . . . . 12.3 113.122 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.13 -37.76 88.47 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 117.726 2.491 . . . . 36.51 117.726 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.414 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 28.2 m120 -62.84 -43.4 98.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.363 1.246 . . . . 25.66 114.363 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -54.44 -38.2 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 126.095 1.758 . . . . 8.12 107.506 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -75.72 -26.66 57.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.409 -1.432 . . . . 15.47 113.16 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.11 74.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.964 -2.96 . . . . 11.45 109.073 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 50.4 mttm -72.23 -43.24 64.72 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.801 3.641 . . . . 24.98 114.424 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 91.2 mt -55.25 -40.04 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 128.224 3.869 . . . . 9.46 117.503 164.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -63.37 -44.28 95.24 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 110.904 -7.372 . . . . 14.76 114.584 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.14 -50.99 68.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.395 2.739 . . . . 26.29 118.395 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -67.49 -56.4 9.7 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.714 2.005 . . . . 30.06 115.582 -175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -98.58 -22.78 15.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.688 1.595 . . . . 25.19 113.525 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.59 23.39 31.16 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 125.601 2.778 . . . . 7.41 116.464 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 mt -102.7 120.11 53.78 Favored Pre-proline 0 N--CA 1.43 -1.441 1 O-C-N 115.553 -4.498 . . . . 9.49 104.21 -168.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -66.6 150.39 83.87 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 CA-C-N 126.784 3.459 . . . . 11.42 116.95 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -85.98 -4.75 8.82 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 CA-C-O 115.513 -1.953 . . . . 12.0 114.244 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -70.48 -36.37 73.82 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.38 1.9 . . . . 35.55 110.27 165.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -70.07 -28.43 65.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.053 2.541 . . . . 20.52 112.817 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -83.38 130.77 35.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 126.24 2.924 . . . . 7.13 116.229 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -122.14 135.8 54.83 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 103.692 -2.707 . . . . 36.39 103.692 170.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.2 mt -113.67 137.33 51.76 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 124.253 0.97 . . . . 9.55 109.643 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 pt -123.4 169.44 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 117.305 -1.758 . . . . 13.9 110.893 171.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.414 ' HB3' ' H ' ' A' ' 46' ' ' ALA . 17.5 t80 -85.61 -90.46 0.1 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 117.217 -1.793 . . . . 6.86 106.681 161.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' H ' ' HB3' ' A' ' 45' ' ' PHE . . . -111.8 -16.55 13.15 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.023 1.86 . . . . 11.15 116.023 171.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.55 -32.63 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 O-C-N 117.782 -3.074 . . . . 13.93 115.931 172.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -76.99 135.24 38.68 Favored 'General case' 0 N--CA 1.43 -1.465 1 CA-C-O 129.406 4.431 . . . . 23.92 109.482 174.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -75.83 152.48 37.25 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 114.584 -5.073 . . . . 23.23 117.866 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.0 mt -118.31 117.71 29.82 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.457 -2.027 . . . . 9.11 106.19 -171.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -108.2 151.6 25.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.579 3.085 . . . . 33.44 114.73 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.335 2.1 m-20 -37.06 -70.48 0.09 Allowed 'General case' 0 N--CA 1.429 -1.484 1 C-N-CA 134.754 5.222 . . . . 28.37 113.827 -166.47 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.37 23.15 33.29 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 116.958 -2.544 . . . . 15.0 117.04 -156.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -105.71 161.32 14.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.206 1.503 . . . . 25.5 111.477 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.3 p -91.03 170.18 10.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.678 -3.139 . . . . 11.95 112.465 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.64 -38.78 84.33 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 117.92 -2.987 . . . . 10.17 113.675 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.59 -39.21 16.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.438 -3.289 . . . . 13.59 112.153 162.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -82.69 -32.57 27.99 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 119.7 -1.875 . . . . 11.7 112.281 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.287 77.0 m-85 -88.72 -7.78 55.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.676 1.58 . . . . 12.95 111.438 170.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 m120 81.23 29.83 0.16 Allowed 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 131.721 4.009 . . . . 25.45 108.415 166.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mt -75.99 132.54 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 117.72 -3.113 . . . . 14.6 104.099 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -96.43 -177.51 3.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.199 -1.819 . . . . 33.23 113.117 -171.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.57 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 19.8 ttpp -69.51 131.08 44.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.653 -1.905 . . . . 25.97 106.551 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 53.29 59.34 4.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.208 1.403 . . . . 32.61 108.145 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 t -98.84 147.42 24.95 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.799 -1.186 . . . . 10.56 107.799 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -90.6 114.52 26.8 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.869 1.356 . . . . 5.33 108.306 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 mt -100.76 154.63 18.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.927 -1.733 . . . . 11.66 109.473 167.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -108.7 132.21 54.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.254 2.454 . . . . 16.3 111.016 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 tp -102.0 128.39 48.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.53 -3.231 . . . . 9.96 109.221 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.8 98.47 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 112.492 -2.14 . . . . 9.76 107.031 -167.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 117.486 2.402 . . . . 19.57 117.486 -178.386 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 116.606 -1.664 . . . . 17.17 112.437 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.86 138.77 31.29 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 125.809 1.943 . . . . 21.89 109.868 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.5 pt -119.97 148.52 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 129.797 3.239 . . . . 10.83 104.664 158.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -100.41 118.9 37.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.367 1.467 . . . . 10.61 112.944 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.81 122.52 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 116.891 -3.631 . . . . 9.13 112.114 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -102.3 141.94 34.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.187 -1.005 . . . . 20.55 109.76 -173.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.6 p -84.66 176.15 8.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.089 -2.257 . . . . 11.78 110.8 171.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -60.74 -49.95 75.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.495 -2.628 . . . . 19.31 114.427 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 66.2 p -62.53 -57.36 11.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.901 3.68 . . . . 23.14 109.257 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.0 49.43 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 126.797 2.141 . . . . 19.74 110.767 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -93.17 143.73 25.97 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.794 -3.18 . . . . 21.93 112.01 161.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.272 25.1 m -108.85 107.28 17.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 126.285 2.945 . . . . 12.33 113.801 -176.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -86.09 117.37 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 110.151 -3.204 . . . . 17.08 109.287 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.461 ' O ' HD13 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -102.47 131.2 49.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.921 -1.737 . . . . 16.3 109.333 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 14' ' ' THR . 1.6 mm? -123.55 134.37 53.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.892 -1.151 . . . . 15.88 107.892 176.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -109.7 114.57 28.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.772 -1.936 . . . . 28.9 105.772 -170.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.9 177.59 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 104.784 -2.302 . . . . 12.05 104.784 -152.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -111.42 171.1 4.6 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 126.828 2.051 . . . . 18.17 107.453 168.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -79.53 -14.15 13.04 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 123.142 2.158 . . . . 8.16 107.647 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -93.54 9.74 35.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.541 1.682 . . . . 11.13 115.541 -175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -80.62 139.41 36.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.288 1.835 . . . . 18.03 114.522 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -90.49 170.34 10.29 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.442 -3.911 . . . . 10.22 107.901 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.7 mm -71.38 -29.0 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 116.845 -3.659 . . . . 12.3 108.235 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -51.81 -51.51 55.97 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.284 3.033 . . . . 36.51 112.902 164.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -54.44 -43.34 71.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.729 2.862 . . . . 25.66 118.729 172.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.17 -43.15 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 117.88 -1.057 . . . . 8.12 109.039 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -57.96 -36.04 72.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.267 1.951 . . . . 15.47 116.267 166.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.22 -35.84 65.34 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.117 2.567 . . . . 11.45 115.741 170.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -81.26 -29.99 34.2 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 127.398 2.936 . . . . 24.98 109.446 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.7 mt -65.42 -43.3 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 121.256 1.844 . . . . 9.46 115.951 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -53.95 -39.61 66.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.154 -2.355 . . . . 14.76 114.521 167.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.258 21.2 t70 -68.33 -53.44 24.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.386 2.357 . . . . 26.29 115.159 164.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -63.02 -43.8 97.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 120.191 3.404 . . . . 30.06 120.191 -169.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -100.28 -30.19 12.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.961 -2.337 . . . . 25.19 108.874 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.4 37.46 12.23 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 112.715 -2.039 . . . . 7.41 110.188 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mt -102.68 128.47 27.91 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 118.627 -2.69 . . . . 9.49 111.919 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -67.85 146.15 71.08 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 124.914 3.743 . . . . 11.42 108.299 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -81.15 2.28 8.69 Favored 'Trans proline' 0 C--N 1.3 -2.005 1 C-N-CA 127.345 5.364 . . . . 12.0 114.533 -165.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.43 -47.56 6.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.67 -1.894 . . . . 35.55 107.818 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -52.05 -29.44 21.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.967 1.84 . . . . 20.52 115.967 162.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -71.84 136.21 46.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.771 2.829 . . . . 7.13 116.731 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -118.09 105.98 12.4 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.851 -1.537 . . . . 36.39 106.851 161.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.3 tp -102.11 120.75 40.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.546 -3.222 . . . . 9.55 105.995 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 pt -127.24 170.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 125.323 1.449 . . . . 13.9 107.132 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -96.6 -55.57 2.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.058 1.743 . . . . 6.86 113.364 169.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.44 -80.71 0.4 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.074 1.35 . . . . 11.15 113.75 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.47 -12.81 2.98 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.545 -1.347 . . . . 13.93 115.578 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -97.18 124.94 41.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 114.604 -2.617 . . . . 23.92 113.673 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -52.25 119.36 4.31 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.962 1.71 . . . . 23.23 111.965 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.505 HD22 ' CE1' ' A' ' 59' ' ' TYR . 35.2 mt -81.76 142.72 32.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.836 2.732 . . . . 9.11 114.364 -176.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -80.56 124.69 29.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.502 2.721 . . . . 33.44 107.288 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.319 36.4 m-20 -45.29 -56.28 5.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.323 3.083 . . . . 28.37 119.323 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.59 10.84 65.77 Favored Glycine 0 N--CA 1.43 -1.735 0 CA-C-O 117.024 -1.987 . . . . 15.0 116.631 -157.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.41 HH21 ' CG ' ' A' ' 58' ' ' ASP . 83.3 mtp180 -98.87 152.07 20.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 118.155 0.978 . . . . 25.5 108.864 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.5 p -80.55 161.54 24.73 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.684 2.105 . . . . 11.95 116.684 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 HD12 ' A' ' 61' ' ' ILE . 7.6 mt -76.07 -29.71 58.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.084 -2.562 . . . . 10.17 104.084 -171.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.2 t -60.99 -46.88 88.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.119 2.137 . . . . 13.59 112.928 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CG ' HH21 ' A' ' 54' ' ' ARG . 20.6 t0 -58.32 -47.96 82.04 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.596 2.758 . . . . 11.7 111.085 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CE1' HD22 ' A' ' 50' ' ' LEU . 9.6 m-85 -61.98 -34.23 75.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 131.391 3.876 . . . . 12.95 114.332 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.481 10.3 m120 92.49 29.53 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.038 2.086 . . . . 25.45 113.051 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.482 HD12 HD23 ' A' ' 56' ' ' LEU . 22.7 mt -89.11 108.64 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 127.542 2.337 . . . . 14.6 111.409 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -87.55 179.26 6.58 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.04 -4.162 . . . . 33.23 114.978 -169.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -63.31 126.19 26.61 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.497 3.046 . . . . 25.97 114.888 167.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.394 68.4 mt-10 75.43 42.8 0.22 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.881 3.273 . . . . 32.61 110.27 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -109.93 141.78 42.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.688 1.995 . . . . 10.56 107.969 -173.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.1 m -90.74 129.04 36.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.281 1.956 . . . . 5.33 116.281 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.49 171.85 7.24 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.054 -1.462 . . . . 11.66 107.054 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -135.39 127.41 29.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.937 2.78 . . . . 16.3 105.285 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.7 tp -96.84 114.63 26.27 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.138 2.399 . . . . 9.96 108.285 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.252 37.6 t -101.25 151.58 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 101.543 -3.503 . . . . 9.76 101.543 170.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 107.429 -1.323 . . . . 19.57 107.429 173.924 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.268 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 118.151 2.649 . . . . 17.17 118.151 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -80.61 134.15 35.86 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.22 1.933 . . . . 21.89 116.22 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.6 pt -124.45 149.34 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 112.833 -1.985 . . . . 10.83 109.195 166.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.47 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 59.9 m-85 -103.96 132.68 49.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 102.567 -3.123 . . . . 10.61 102.567 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.45 109.25 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 126.224 1.81 . . . . 9.13 106.729 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -95.58 132.35 40.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.045 3.307 . . . . 20.55 108.693 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -91.29 175.91 6.76 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.316 -3.365 . . . . 11.78 114.287 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.638 HD11 ' H ' ' A' ' 71' ' ' LEU . 84.5 mt -75.47 -28.19 59.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.536 -1.211 . . . . 19.31 113.775 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.354 82.5 p -83.63 -24.33 31.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 120.496 1.498 . . . . 23.14 107.968 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.29 52.12 0.22 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.397 -2.689 . . . . 19.74 107.861 161.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -131.01 135.26 47.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.296 -4.061 . . . . 21.93 103.738 -175.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.7 m -106.65 107.45 18.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.309 2.48 . . . . 12.33 108.29 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -98.99 133.02 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 128.416 2.687 . . . . 17.08 110.329 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.4 m -98.42 112.63 24.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.673 -1.232 . . . . 16.3 107.673 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -102.35 164.48 11.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.372 2.511 . . . . 15.88 107.338 172.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.67 106.28 9.61 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 115.302 -4.624 . . . . 28.9 102.326 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -109.44 175.66 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 123.445 1.593 . . . . 12.05 109.726 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -115.89 143.48 30.87 Favored Pre-proline 0 N--CA 1.43 -1.46 1 CA-C-O 109.792 -4.909 . . . . 18.17 105.795 162.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -60.13 -11.12 14.62 Favored 'Trans proline' 0 N--CA 1.434 -2.023 2 CA-C-N 130.774 4.883 . . . . 8.16 117.737 176.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.8 m -74.0 -19.09 60.76 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.252 2.221 . . . . 11.13 116.183 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.13 156.28 38.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.542 2.337 . . . . 18.03 111.039 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 p -107.95 163.61 12.99 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.775 -1.557 . . . . 10.22 115.072 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -63.24 -26.02 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 114.319 -2.753 . . . . 12.3 109.952 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.89 -44.96 93.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.586 1.803 . . . . 36.51 108.777 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -63.95 -47.53 80.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.819 -3.05 . . . . 25.66 111.776 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 26' ' ' VAL . 1.5 t -60.8 -43.39 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 120.938 1.699 . . . . 8.12 113.098 173.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -59.46 -32.16 69.98 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 115.682 -2.104 . . . . 15.47 114.657 170.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.09 -51.15 65.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.204 1.82 . . . . 11.45 110.881 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.05 -36.09 78.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.953 2.205 . . . . 24.98 116.953 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 mt -70.1 -39.66 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 124.822 2.249 . . . . 9.46 111.531 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.4 -36.93 76.74 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 111.811 -6.806 . . . . 14.76 113.791 168.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -75.18 -29.92 60.52 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 116.227 -4.046 . . . . 26.29 109.754 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -75.91 -47.12 26.52 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 117.837 2.532 . . . . 30.06 117.837 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -100.34 -27.1 13.65 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.71 -1.132 . . . . 25.19 113.406 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.92 6.4 54.19 Favored Glycine 0 N--CA 1.431 -1.668 0 O-C-N 116.77 -3.706 . . . . 7.41 117.415 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.9 mm -99.05 137.04 20.4 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-N 120.657 2.229 . . . . 9.49 106.206 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -65.71 154.21 74.84 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 N-CA-C 119.094 2.69 . . . . 11.42 119.094 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -88.46 -7.49 5.74 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-N 125.953 3.162 . . . . 12.0 107.396 -155.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -82.39 -18.29 42.48 Favored 'General case' 0 N--CA 1.429 -1.483 1 C-N-CA 131.789 4.036 . . . . 35.55 112.248 167.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -85.81 -24.84 26.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.644 -1.91 . . . . 20.52 113.313 165.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -83.84 138.3 33.27 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.615 2.366 . . . . 7.13 113.759 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -142.61 122.28 13.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.864 -1.902 . . . . 36.39 105.864 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -101.23 125.96 47.91 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.363 1.865 . . . . 9.55 108.533 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 68' ' ' HIS . 5.8 pt -127.56 154.27 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.149 -2.908 . . . . 13.9 103.149 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.43 -63.31 1.22 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.889 -1.757 . . . . 6.86 113.382 173.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.58 -36.39 0.78 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.904 -2.373 . . . . 11.15 106.64 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.06 -14.72 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.109 1.814 . . . . 13.93 116.253 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -103.12 148.66 25.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.622 -2.031 . . . . 23.92 106.708 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -81.97 110.37 17.17 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 127.784 6.216 . . . . 23.23 127.784 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.8 mt -87.32 112.87 22.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.9 -2.375 . . . . 9.11 107.191 -169.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -110.11 148.49 31.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.542 2.591 . . . . 33.44 107.447 -159.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -44.07 -61.82 1.35 Allowed 'General case' 0 N--CA 1.431 -1.424 1 C-N-CA 131.815 4.046 . . . . 28.37 118.365 -169.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.37 -22.21 72.8 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 128.422 2.915 . . . . 15.0 110.326 -155.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -100.27 159.65 14.95 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.773 1.229 . . . . 25.5 112.814 -167.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -74.69 156.33 36.76 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 114.432 -2.699 . . . . 11.95 117.425 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.272 14.8 mt -54.39 -37.11 64.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 120.031 3.345 . . . . 10.17 120.031 160.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -64.1 -25.9 68.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.751 2.13 . . . . 13.59 116.751 171.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -73.02 -22.28 60.68 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.033 -1.937 . . . . 11.7 110.117 169.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -96.75 -12.5 23.63 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.534 1.97 . . . . 12.95 114.257 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.29 14.4 m120 59.5 46.0 12.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.666 3.986 . . . . 25.45 114.589 -172.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 61' ' ' ILE . 69.1 mt -81.48 108.86 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.067 -2.896 . . . . 14.6 112.154 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -88.07 178.72 6.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.318 2.34 . . . . 33.23 117.318 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -61.96 138.34 58.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 127.453 3.501 . . . . 25.97 113.103 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 60.52 31.03 20.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.705 3.202 . . . . 32.61 115.276 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.4 m -70.69 144.91 50.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.417 -1.719 . . . . 10.56 108.752 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 23.0 m -95.66 122.53 38.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.007 -2.59 . . . . 5.33 104.007 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.3 mt -116.71 152.61 33.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.246 -2.501 . . . . 11.66 104.246 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.404 ' HB2' HG13 ' A' ' 44' ' ' ILE . 73.2 m80 -111.89 122.04 46.69 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-O 128.67 4.081 . . . . 16.3 107.748 -175.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.0 tp -85.51 135.62 33.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.827 -3.046 . . . . 9.96 105.466 171.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.2 t -130.76 151.91 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 102.761 -3.052 . . . . 9.76 102.761 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.638 ' H ' HD11 ' A' ' 8' ' ' LEU . 54.5 mt . . . . . 0 N--CA 1.431 -1.417 0 O-C-N 120.24 -1.538 . . . . 19.57 110.952 170.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.607 1.336 . . . . 17.17 114.607 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -95.15 142.47 27.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.168 0.987 . . . . 21.89 111.595 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.29 168.57 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.346 -2.094 . . . . 10.83 105.346 159.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -118.34 158.04 25.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.862 1.792 . . . . 10.61 114.321 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.467 HG21 HD11 ' A' ' 30' ' ' ILE . 59.6 t -124.4 121.25 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.389 3.476 . . . . 9.13 106.866 167.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -106.48 127.58 53.41 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 124.018 1.866 . . . . 20.55 107.772 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 p -88.84 166.24 14.12 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.678 1.704 . . . . 11.78 106.642 -173.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.2 mt -65.95 -45.35 82.11 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 129.703 3.201 . . . . 19.31 110.53 169.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.0 p -64.31 -29.67 70.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.901 2.481 . . . . 23.14 117.576 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.39 29.46 1.92 Allowed Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 114.157 -1.383 . . . . 19.74 109.916 167.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -92.66 133.44 35.99 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.798 -3.766 . . . . 21.93 112.714 164.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.3 m -100.63 119.02 37.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.935 -1.876 . . . . 12.33 105.935 167.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.7 mt -113.3 115.5 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 117.99 -2.943 . . . . 17.08 105.94 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.3 m -83.78 124.78 31.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 112.846 -3.454 . . . . 16.3 108.307 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.16 145.03 30.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 123.901 3.046 . . . . 15.88 111.211 167.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -98.87 131.74 44.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 118.816 -1.154 . . . . 28.9 112.225 167.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.08 171.94 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.889 1.676 . . . . 12.05 110.029 -166.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -118.6 171.79 4.88 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-N 122.105 2.23 . . . . 18.17 109.21 156.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.2 -30.57 72.05 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 N-CA-C 119.5 2.846 . . . . 8.16 119.5 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.7 m -92.58 14.64 16.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.805 -3.059 . . . . 11.13 112.474 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.47 138.08 41.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.052 -3.53 . . . . 18.03 115.944 171.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 p -85.05 164.1 18.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 112.592 -2.095 . . . . 10.22 109.822 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 23' ' ' ILE 0.351 3.9 mm -78.62 -17.6 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 117.876 -3.015 . . . . 12.3 111.29 -175.358 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -62.26 -51.73 66.56 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.902 2.881 . . . . 36.51 110.678 164.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -66.63 -25.29 66.52 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.411 -1.431 . . . . 25.66 110.693 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.67 -56.2 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.595 2.072 . . . . 8.12 116.595 167.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -50.6 -30.55 13.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.271 3.434 . . . . 15.47 120.271 164.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.83 -42.76 97.54 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.253 2.316 . . . . 11.45 117.253 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -61.78 -31.53 71.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.3 1.963 . . . . 24.98 116.3 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.467 HD11 HG21 ' A' ' 5' ' ' VAL . 63.2 mt -85.0 -40.52 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.092 1.757 . . . . 9.46 111.143 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -48.24 -51.34 25.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.595 2.758 . . . . 14.76 116.915 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.58 -39.78 74.09 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.776 2.83 . . . . 26.29 112.662 166.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -87.42 -70.99 0.59 Allowed 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.051 -4.156 . . . . 30.06 109.209 -168.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -89.96 -26.47 20.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.117 -3.489 . . . . 25.19 117.802 -171.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.81 43.45 4.48 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 117.22 -1.878 . . . . 7.41 115.75 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mm -90.82 124.39 62.29 Favored Pre-proline 0 N--CA 1.43 -1.468 1 CA-C-O 110.872 -4.394 . . . . 9.49 107.397 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -77.04 147.25 26.42 Favored 'Trans proline' 0 C--N 1.3 -2.022 1 CA-C-N 129.741 4.515 . . . . 11.42 112.033 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.08 -21.03 32.59 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-O 117.3 -1.208 . . . . 12.0 114.153 -159.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -71.45 -27.86 63.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 123.563 2.892 . . . . 35.55 111.994 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.277 88.4 mm-40 -77.24 -23.42 51.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.422 1.889 . . . . 20.52 111.096 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -77.28 107.37 9.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 113.812 1.041 . . . . 7.13 113.812 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -112.78 114.23 26.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.346 2.022 . . . . 36.39 109.921 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.7 mt -100.2 117.85 35.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.892 -1.755 . . . . 9.55 109.839 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 68' ' ' HIS . 36.5 pt -98.19 156.64 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.415 2.286 . . . . 13.9 112.797 166.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -79.86 -68.87 0.63 Allowed 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 123.396 1.569 . . . . 6.86 107.929 162.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.54 -60.79 0.98 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.051 -2.203 . . . . 11.15 105.051 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.16 -25.18 1.71 Allowed Glycine 0 N--CA 1.43 -1.731 1 C-N-CA 134.965 6.031 . . . . 13.93 114.451 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 139.72 33.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.012 -3.052 . . . . 23.92 109.482 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -90.29 147.82 23.27 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.162 0.982 . . . . 23.23 112.661 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mt -99.71 118.72 36.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.118 1.767 . . . . 9.11 110.391 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -95.21 147.85 23.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.939 -1.105 . . . . 33.44 111.002 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.04 -47.62 8.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.435 3.094 . . . . 28.37 116.094 -166.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.19 31.61 7.81 Favored Glycine 0 N--CA 1.431 -1.694 1 CA-C-O 112.914 -4.27 . . . . 15.0 115.746 -165.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -129.42 171.63 12.33 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.797 3.299 . . . . 25.5 105.588 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.4 p -99.97 169.0 9.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.942 2.155 . . . . 11.95 112.223 -174.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.6 -40.03 68.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.311 1.226 . . . . 10.17 114.311 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.9 t -63.83 -49.92 70.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 131.495 3.918 . . . . 13.59 112.384 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 38.6 m-20 -43.83 -58.0 2.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.665 3.186 . . . . 11.7 110.892 168.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.269 32.6 m-85 -54.58 -21.11 9.38 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 120.574 3.546 . . . . 12.95 120.574 171.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 m120 53.86 56.39 7.2 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.024 1.729 . . . . 25.45 112.234 -162.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -93.74 132.07 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.77 -3.081 . . . . 14.6 110.024 165.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -105.6 -165.56 1.12 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 119.76 -0.776 . . . . 33.23 111.506 -166.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -79.12 125.44 29.43 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 117.395 -1.722 . . . . 25.97 112.521 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.3 34.6 mt-10 68.22 27.43 6.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.115 2.166 . . . . 32.61 114.348 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -74.7 153.99 38.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.905 -3.622 . . . . 10.56 116.503 163.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.1 m -93.27 125.7 38.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.375 2.297 . . . . 5.33 111.447 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -93.33 154.91 17.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.004 -2.591 . . . . 11.66 104.004 169.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.531 ' HB2' HG13 ' A' ' 44' ' ' ILE . 75.5 m80 -122.46 107.26 11.83 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 108.912 -0.773 . . . . 16.3 108.912 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -78.24 120.71 23.41 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 122.876 1.322 . . . . 9.96 109.545 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.39 -179.65 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.737 2.415 . . . . 9.76 107.421 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.9 mt . . . . . 0 N--CA 1.43 -1.438 0 CA-C-O 123.504 1.621 . . . . 19.57 112.789 178.663 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptt? . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 109.027 -0.731 . . . . 17.17 109.027 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -100.09 125.4 46.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.929 -2.357 . . . . 21.89 105.251 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -123.37 159.12 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.62 -3.175 . . . . 10.83 105.898 159.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -111.91 137.03 50.45 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.846 -3.034 . . . . 10.61 112.021 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.07 125.41 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 111.504 -2.589 . . . . 9.13 109.572 169.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -107.11 124.62 49.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.567 -3.208 . . . . 20.55 110.535 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p -89.88 163.61 14.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.76 1.743 . . . . 11.78 111.438 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.04 -39.95 94.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.628 1.571 . . . . 19.31 113.987 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -73.59 -33.04 64.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.376 3.07 . . . . 23.14 105.915 -175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.42 48.33 0.47 Allowed Glycine 0 N--CA 1.431 -1.696 0 CA-C-O 122.622 1.124 . . . . 19.74 115.651 160.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.23 125.84 52.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.053 -3.027 . . . . 21.93 108.241 168.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.6 m -93.21 95.06 9.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.084 2.554 . . . . 12.33 112.309 169.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.4 mt -102.9 125.47 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 131.064 3.746 . . . . 17.08 106.677 -159.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -81.55 119.84 24.28 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.285 -3.384 . . . . 16.3 114.308 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.2 142.71 36.5 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.884 -4.26 . . . . 15.88 109.465 174.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -110.28 105.52 14.59 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.4 3.88 . . . . 28.9 111.333 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.73 157.77 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 111.571 -2.559 . . . . 12.05 108.281 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.1 mm-40 -88.9 168.11 16.52 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 124.547 1.154 . . . . 18.17 113.247 159.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 73.1 Cg_endo -70.56 -24.24 26.22 Favored 'Trans proline' 0 C--N 1.299 -2.036 1 O-C-N 112.537 -4.507 . . . . 8.16 113.485 177.026 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -97.33 16.47 19.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.45 2.344 . . . . 11.13 116.106 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -67.89 136.76 54.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.712 2.805 . . . . 18.03 108.164 163.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.342 60.9 p -80.27 168.14 19.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.035 2.534 . . . . 10.22 107.145 -176.088 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 mm -75.9 -35.11 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 105.034 -2.21 . . . . 12.3 105.034 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -44.17 -46.28 8.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.795 2.146 . . . . 36.51 116.795 161.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.269 11.4 m120 -69.24 -32.48 71.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.65 -3.781 . . . . 25.66 111.843 173.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.12 -38.67 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 116.215 1.931 . . . . 8.12 116.215 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -71.19 -22.34 62.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.065 -2.897 . . . . 15.47 116.085 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.86 72.91 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.029 -1.669 . . . . 11.45 114.333 171.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -70.97 -40.95 71.65 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.067 2.988 . . . . 24.98 119.067 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.96 -32.28 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.622 -1.923 . . . . 9.46 112.038 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -66.15 -43.1 88.0 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.674 2.39 . . . . 14.76 115.437 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -78.49 -28.31 46.38 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.553 1.979 . . . . 26.29 115.747 168.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.24 -68.35 0.5 Allowed 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.095 -4.128 . . . . 30.06 110.101 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -81.97 -49.08 10.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.653 2.933 . . . . 25.19 110.352 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.66 7.85 13.02 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.645 -2.534 . . . . 7.41 111.711 -170.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mm -82.88 127.82 68.16 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 116.25 1.945 . . . . 9.49 116.25 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -64.14 150.49 88.24 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 CA-C-O 115.515 -1.952 . . . . 11.42 116.915 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -71.89 -20.82 25.39 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 123.98 2.457 . . . . 12.0 114.488 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -64.35 -39.36 93.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.458 -2.211 . . . . 35.55 115.645 165.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -78.03 -24.74 47.71 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 127.204 2.815 . . . . 20.52 110.657 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -70.6 119.17 14.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.522 2.329 . . . . 7.13 112.358 168.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -130.94 103.1 6.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.421 -2.807 . . . . 36.39 103.421 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -92.13 118.27 30.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.144 -2.222 . . . . 9.55 108.789 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 pt -90.21 -179.22 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 113.821 1.045 . . . . 13.9 113.821 159.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -111.68 -77.68 0.59 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.061 -2.2 . . . . 6.86 105.061 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.73 -50.63 2.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.29 2.236 . . . . 11.15 112.489 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.55 -24.17 0.85 Allowed Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 126.782 2.134 . . . . 13.93 112.356 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -113.78 146.27 40.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.733 -2.039 . . . . 23.92 114.697 -167.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -78.12 152.4 32.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.305 3.431 . . . . 23.23 115.928 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.1 mt -114.5 136.25 53.22 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 102.928 -2.989 . . . . 9.11 102.928 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -104.77 139.12 40.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.628 -2.545 . . . . 33.44 108.85 -173.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -28.2 -55.36 0.11 Allowed 'General case' 0 N--CA 1.429 -1.482 1 N-CA-C 123.444 4.609 . . . . 28.37 123.444 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.93 -1.75 81.96 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.765 -2.459 . . . . 15.0 117.922 -164.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -93.35 167.61 11.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.879 3.271 . . . . 25.5 107.949 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -101.37 168.49 9.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.831 2.052 . . . . 11.95 111.811 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.26 -25.87 68.25 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 131.713 4.005 . . . . 10.17 111.677 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -59.6 -46.45 88.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.363 -3.336 . . . . 13.59 114.744 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.8 -40.0 87.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.675 -2.057 . . . . 11.7 110.363 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.444 ' HB2' HD12 ' A' ' 61' ' ' ILE . 25.9 m-85 -85.05 -2.38 57.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.789 0.804 . . . . 12.95 109.486 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m120 65.09 46.7 2.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.274 2.464 . . . . 25.45 112.724 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 59' ' ' TYR . 10.0 mt -90.02 114.12 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.985 -2.322 . . . . 14.6 110.175 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -97.16 166.18 11.7 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.194 2.998 . . . . 33.23 112.188 -175.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -55.63 134.11 50.95 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.88 1.808 . . . . 25.97 115.88 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 55.55 58.12 4.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.179 -1.828 . . . . 32.61 111.78 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 t -115.74 142.82 46.24 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.25 1.42 . . . . 10.56 108.972 173.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -98.5 124.18 43.08 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.66 1.695 . . . . 5.33 115.47 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.79 156.59 17.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.152 3.381 . . . . 11.66 107.681 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -129.07 122.21 29.47 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.44 -2.059 . . . . 16.3 105.44 -172.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.43 105.76 17.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 112.886 -1.961 . . . . 9.96 111.32 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 m -104.95 178.15 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 127.74 2.416 . . . . 9.76 112.507 168.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt . . . . . 0 N--CA 1.43 -1.449 0 CA-C-O 124.877 2.275 . . . . 19.57 115.711 176.201 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 ttp . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 122.407 1.098 . . . . 17.17 108.85 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -82.65 135.95 34.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.065 -1.647 . . . . 21.89 108.184 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.77 166.46 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 124.789 1.236 . . . . 10.83 109.296 165.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -125.61 104.05 8.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.563 -2.014 . . . . 10.61 105.563 -167.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.43 105.12 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.515 -2.031 . . . . 9.13 105.515 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -108.68 126.15 52.67 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.474 0.654 . . . . 20.55 110.125 -174.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -80.69 -179.35 7.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.504 1.668 . . . . 11.78 115.504 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.06 -43.32 78.9 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.004 -4.185 . . . . 19.31 112.056 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -84.99 -21.22 29.59 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.271 -1.786 . . . . 23.14 108.927 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.28 70.82 0.93 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-O 124.928 2.404 . . . . 19.74 115.957 166.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -116.66 118.48 32.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 110.398 -2.901 . . . . 21.93 106.724 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -90.39 103.7 16.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 127.245 2.841 . . . . 12.33 110.383 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.2 mt -94.42 98.79 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.746 2.418 . . . . 17.08 113.075 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -73.47 122.42 22.11 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 119.991 1.268 . . . . 16.3 113.068 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.95 147.87 37.82 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.765 -3.709 . . . . 15.88 102.816 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -105.32 134.92 47.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.819 1.771 . . . . 28.9 108.209 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -148.87 -174.52 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.57 3.148 . . . . 12.05 105.968 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -141.6 162.77 45.08 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 114.75 -2.548 . . . . 18.17 108.227 170.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -23.23 76.64 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 C-N-CA 127.014 5.142 . . . . 8.16 118.024 -169.15 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 5.3 p -94.28 -6.05 45.36 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.559 2.344 . . . . 11.13 110.683 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -74.93 167.09 22.58 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.495 -3.878 . . . . 18.03 115.201 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 2.4 p -89.42 170.13 10.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.283 2.697 . . . . 10.22 118.283 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mt -87.63 -13.15 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 117.53 -1.668 . . . . 12.3 108.527 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -59.31 -47.51 85.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.01 1.324 . . . . 36.51 113.556 160.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -55.83 -40.67 73.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.134 -2.854 . . . . 25.66 116.104 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.9 t -52.63 -54.93 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 117.145 -3.472 . . . . 8.12 113.213 167.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -61.22 -30.12 70.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.791 1.636 . . . . 15.47 114.955 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -30.24 70.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.528 3.531 . . . . 11.45 113.997 166.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -92.78 -14.4 27.9 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 116.742 -1.983 . . . . 24.98 112.174 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.27 67.8 mt -64.2 -36.18 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.398 1.57 . . . . 9.46 114.418 158.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -67.76 -21.52 65.26 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.748 -3.095 . . . . 14.76 116.112 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.48 -58.63 2.66 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.085 -2.561 . . . . 26.29 104.085 -175.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -64.83 -62.06 1.8 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.112 2.565 . . . . 30.06 115.89 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -81.16 -58.15 3.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.302 1.864 . . . . 25.19 111.734 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.25 17.35 3.67 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.111 -1.596 . . . . 7.41 109.111 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.1 mt -90.58 131.21 38.65 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-O 115.445 -2.217 . . . . 9.49 109.085 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -66.18 156.59 64.08 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 125.497 2.999 . . . . 11.42 116.606 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -68.73 -23.03 36.4 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 124.374 3.383 . . . . 12.0 112.319 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.252 10.1 p-10 -77.85 -28.46 50.09 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.248 3.019 . . . . 35.55 107.801 -170.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -69.38 -35.4 75.78 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.192 -1.568 . . . . 20.52 110.841 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -96.39 133.56 40.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.237 -0.887 . . . . 7.13 111.606 -151.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -111.61 131.87 54.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 103.274 -2.861 . . . . 36.39 103.274 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -116.91 125.06 50.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.24 1.495 . . . . 9.55 110.724 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 23.2 mm -95.11 132.32 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.288 2.235 . . . . 13.9 114.298 170.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -123.17 115.94 22.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.481 -2.637 . . . . 6.86 109.013 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.84 -102.56 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.364 -0.835 . . . . 11.15 110.007 -172.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.42 34.2 2.39 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 118.822 -2.424 . . . . 13.93 113.017 164.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.345 21.2 ttmm -120.16 144.11 47.85 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 112.735 -1.732 . . . . 23.92 115.145 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -81.42 135.49 35.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.763 1.744 . . . . 23.23 113.372 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.8 mt -89.26 145.74 25.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.069 -2.197 . . . . 9.11 105.069 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -87.12 160.78 18.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.013 -2.422 . . . . 33.44 114.41 159.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.95 -41.55 13.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.888 2.551 . . . . 28.37 117.888 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.58 17.87 58.5 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 116.7 -2.667 . . . . 15.0 108.473 -170.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -90.18 165.92 13.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.163 -3.551 . . . . 25.5 109.817 161.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.9 p -102.13 174.26 6.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.849 3.214 . . . . 11.95 104.111 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.14 -37.5 83.91 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.691 2.796 . . . . 10.17 109.783 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.254 67.7 m -61.5 -42.67 99.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 113.241 0.83 . . . . 13.59 113.241 176.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -53.0 -44.45 67.26 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 121.057 3.725 . . . . 11.7 121.057 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -79.33 -15.76 57.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 125.715 1.884 . . . . 12.95 115.865 165.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 68.56 71.57 0.29 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.357 2.663 . . . . 25.45 110.303 -169.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.274 82.4 mt -109.15 114.51 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 113.332 -3.347 . . . . 14.6 110.004 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -100.13 -166.39 1.32 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.9 2.185 . . . . 33.23 116.9 -171.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 137.62 55.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.63 1.681 . . . . 25.97 112.197 -171.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.47 80.4 mt-10 72.74 12.12 5.35 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 116.703 -3.748 . . . . 32.61 118.091 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.1 t -86.46 137.66 32.37 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 125.763 1.914 . . . . 10.56 108.704 -165.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 m -87.25 115.34 24.59 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.234 -1.803 . . . . 5.33 112.147 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.1 mt -93.13 149.69 21.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.402 -1.436 . . . . 11.66 109.368 167.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.572 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 77.7 m-70 -99.72 109.75 22.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 125.871 1.982 . . . . 16.3 109.972 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.1 tp -96.41 117.68 31.38 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.292 2.473 . . . . 9.96 110.303 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.4 t -92.65 130.88 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 128.607 2.763 . . . . 9.76 106.339 164.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.5 mt . . . . . 0 N--CA 1.43 -1.451 0 N-CA-C 107.115 -1.439 . . . . 19.57 107.115 161.704 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.4 ttp . . . . . 0 CA--C 1.49 -1.342 0 CA-C-O 121.162 0.506 . . . . 17.17 109.732 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -84.82 125.29 32.47 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.723 -2.486 . . . . 21.89 114.667 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.264 8.7 pt -114.04 165.25 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 124.109 3.14 . . . . 10.83 104.415 167.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -106.47 138.43 42.66 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 111.0 -2.818 . . . . 10.61 111.96 166.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.0 t -118.67 103.41 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.657 3.122 . . . . 9.13 105.77 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -88.42 134.92 33.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.544 -2.598 . . . . 20.55 111.101 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.563 HG22 HD23 ' A' ' 69' ' ' LEU . 71.4 p -81.56 -170.51 2.83 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 123.791 2.996 . . . . 11.78 114.46 169.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.7 tp -100.74 -27.72 13.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.399 2.047 . . . . 19.31 112.907 -171.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 p -69.33 -41.79 76.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.529 -3.232 . . . . 23.14 107.598 160.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.68 72.1 0.67 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 117.959 -2.963 . . . . 19.74 116.045 173.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -123.97 133.63 53.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.074 -1.917 . . . . 21.93 109.476 160.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.4 m -93.57 105.01 17.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.277 2.86 . . . . 12.33 109.313 -170.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.413 HG23 ' HD2' ' A' ' 33' ' ' LYS . 3.5 mt -95.34 118.86 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 CA-C-O 129.507 4.479 . . . . 17.08 110.267 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.42 102.77 14.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.017 -3.552 . . . . 16.3 112.609 -175.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.56 129.44 36.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.282 -2.136 . . . . 15.88 110.65 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -98.04 92.09 5.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 127.145 3.355 . . . . 28.9 106.667 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -102.81 174.25 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 130.979 3.712 . . . . 12.05 110.063 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.349 73.6 mm-40 -115.36 141.53 27.34 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 112.594 -3.574 . . . . 18.17 105.51 163.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -56.25 -16.16 16.71 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 N-CA-C 119.879 2.992 . . . . 8.16 119.879 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -82.15 -10.86 59.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.971 1.843 . . . . 11.13 111.922 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -74.0 142.94 45.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.58 -3.825 . . . . 18.03 118.028 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -92.0 152.52 19.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.635 1.683 . . . . 10.22 108.25 -171.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.2 mm -57.68 -27.1 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 116.287 1.958 . . . . 12.3 116.287 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.318 37.0 tt0 -64.23 -45.21 89.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.616 1.674 . . . . 36.51 115.415 166.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -73.04 -29.2 62.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.506 -3.871 . . . . 25.66 113.05 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.94 -46.85 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.244 -2.785 . . . . 8.12 107.026 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -60.19 -18.19 46.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.991 1.716 . . . . 15.47 114.96 171.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.16 -24.09 40.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.556 -2.59 . . . . 11.45 112.17 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttt -78.81 -36.02 43.29 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.757 -4.34 . . . . 24.98 107.666 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -69.72 -37.45 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 125.994 2.059 . . . . 9.46 109.82 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -54.64 -53.52 53.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.713 1.597 . . . . 14.76 114.468 157.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.77 -30.29 71.29 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 123.128 2.695 . . . . 26.29 116.688 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HD2' HG23 ' A' ' 13' ' ' ILE . 15.0 mttm -61.24 -67.1 0.44 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 126.289 2.947 . . . . 30.06 113.857 168.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -95.83 -48.47 5.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.872 -2.392 . . . . 25.19 113.123 -160.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.45 12.57 10.52 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 113.744 -1.571 . . . . 7.41 114.108 -172.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -97.0 113.48 63.06 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 107.881 -1.155 . . . . 9.49 107.881 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 13.7 Cg_exo -76.91 164.1 30.3 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 125.445 2.98 . . . . 11.42 109.813 -169.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 37' ' ' PRO 0.256 68.0 Cg_exo -63.33 -31.16 73.48 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 N-CA-C 120.827 3.357 . . . . 12.0 120.827 -166.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -97.95 9.0 43.84 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 118.331 -1.347 . . . . 35.55 111.38 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -78.86 -24.49 44.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.361 2.346 . . . . 20.52 111.889 156.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -83.5 144.79 29.31 Favored 'General case' 0 N--CA 1.429 -1.481 1 N-CA-C 121.811 4.004 . . . . 7.13 121.811 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -136.19 111.4 9.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 103.965 -2.606 . . . . 36.39 103.965 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 mt -97.85 120.39 38.16 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 117.655 -1.618 . . . . 9.55 115.282 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -99.85 133.62 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 128.001 3.762 . . . . 13.9 109.924 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -125.69 114.88 19.25 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.025 -4.797 . . . . 6.86 105.625 157.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.65 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 131.803 4.041 . . . . 11.15 109.17 -170.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.91 7.17 3.52 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 128.384 2.897 . . . . 13.93 112.332 172.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.307 24.5 ttmm -98.7 137.72 36.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 122.113 2.957 . . . . 23.92 108.483 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -96.53 127.95 43.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.428 -2.045 . . . . 23.23 107.398 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.2 mt -83.71 152.02 24.94 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 112.742 -2.026 . . . . 9.11 106.69 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -99.07 141.46 31.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.961 3.304 . . . . 33.44 117.355 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.14 -43.96 98.08 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 121.612 3.93 . . . . 28.37 121.612 -171.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.22 35.37 5.06 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 125.421 1.486 . . . . 15.0 110.028 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -117.65 157.41 26.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.845 0.683 . . . . 25.5 112.845 161.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.3 p -101.54 164.97 11.49 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.068 2.842 . . . . 11.95 113.494 -169.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.0 mt -56.26 -41.95 76.6 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.144 -4.722 . . . . 10.17 115.467 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 t -63.77 -33.12 74.95 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 130.305 3.442 . . . . 13.59 114.884 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.22 -50.13 56.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.926 2.89 . . . . 11.7 107.583 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -76.93 -1.84 30.64 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.217 -2.177 . . . . 12.95 113.514 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.9 t30 54.28 68.46 0.85 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.762 3.625 . . . . 25.45 110.11 -170.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -108.89 102.61 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 127.473 2.309 . . . . 14.6 108.17 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -90.74 -174.05 3.93 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 114.052 1.131 . . . . 33.23 114.052 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -59.02 154.88 14.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.605 -3.184 . . . . 25.97 115.218 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 64.97 25.57 12.71 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.535 4.334 . . . . 32.61 113.256 169.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -82.48 130.99 35.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.306 1.043 . . . . 10.56 109.647 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.6 m -83.11 113.04 20.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.178 -1.045 . . . . 5.33 108.178 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.52 149.57 24.26 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.758 -1.941 . . . . 11.66 105.758 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -113.99 116.69 29.61 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.531 -1.356 . . . . 16.3 111.714 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.563 HD23 HG22 ' A' ' 7' ' ' THR . 44.7 tp -84.6 125.76 32.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.02 2.819 . . . . 9.96 111.11 171.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -118.81 123.54 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 130.382 3.473 . . . . 9.76 111.849 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.486 HD21 HD21 ' A' ' 69' ' ' LEU . 75.8 mt . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 123.745 1.736 . . . . 19.57 107.48 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 120.912 0.387 . . . . 17.17 111.451 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.263 52.5 mt-30 -114.8 138.61 50.55 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.485 1.291 . . . . 21.89 114.485 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.413 HG13 ' HB2' ' A' ' 15' ' ' LEU . 10.9 pt -116.19 140.47 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 119.825 -1.797 . . . . 10.83 110.337 174.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -99.81 115.47 29.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.261 1.505 . . . . 10.61 111.069 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -100.36 107.42 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 115.123 -2.37 . . . . 9.13 107.98 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.264 19.5 ttmm -90.64 124.34 34.99 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 126.398 2.311 . . . . 20.55 110.943 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -74.65 164.27 26.77 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 121.241 1.837 . . . . 11.78 109.595 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.1 tp -71.59 -22.57 61.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.64 1.348 . . . . 19.31 114.64 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.253 27.4 p -72.42 -78.55 0.08 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.602 2.761 . . . . 23.14 111.235 173.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.06 43.64 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.707 1 C-N-CA 132.117 4.675 . . . . 19.74 114.801 170.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -117.16 143.57 45.69 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 102.927 -2.99 . . . . 21.93 102.927 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.4 m -123.24 115.5 21.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.299 -1.741 . . . . 12.33 106.299 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.73 132.64 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.084 -2.26 . . . . 17.08 109.396 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 m -101.85 100.54 10.87 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.736 -1.95 . . . . 16.3 105.736 -172.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.413 ' HB2' HG13 ' A' ' 3' ' ' ILE 0.277 62.0 mt -97.89 137.03 37.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.955 2.788 . . . . 15.88 104.108 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -85.95 118.68 25.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.686 -3.134 . . . . 28.9 112.007 168.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 56' ' ' LEU . 31.6 m -131.02 158.46 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.738 -2.69 . . . . 12.05 103.738 -169.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -92.95 146.91 32.92 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 113.467 -3.158 . . . . 18.17 114.001 158.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.74 -7.92 22.09 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 CA-C-N 124.617 2.685 . . . . 8.16 114.069 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -90.92 -7.4 52.24 Favored 'General case' 0 N--CA 1.43 -1.457 1 C-N-CA 132.969 4.508 . . . . 11.13 113.654 174.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.78 153.11 44.37 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.231 -2.793 . . . . 18.03 114.666 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -106.42 163.15 13.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.169 -1.049 . . . . 10.22 108.169 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 mm -65.9 -28.69 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 121.011 -1.055 . . . . 12.3 110.827 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -44.49 -41.31 6.27 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.78 3.622 . . . . 36.51 120.78 157.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -80.33 -29.22 38.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.009 -3.557 . . . . 25.66 113.499 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.97 -38.77 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 105.09 -2.189 . . . . 8.12 105.09 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -70.91 -42.26 70.16 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.248 1.819 . . . . 15.47 113.543 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.8 -43.64 27.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.444 2.069 . . . . 11.45 111.789 169.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -77.3 -31.66 54.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.79 -3.069 . . . . 24.98 109.032 -173.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.6 mt -70.61 -40.79 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.188 -3.445 . . . . 9.46 115.834 171.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -50.26 -47.69 55.1 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 133.055 4.542 . . . . 14.76 109.435 172.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -60.28 -56.55 20.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.212 1.482 . . . . 26.29 113.744 171.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -74.15 -37.89 63.89 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.384 3.476 . . . . 30.06 120.384 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -107.83 -40.13 5.36 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.401 1.909 . . . . 25.19 114.233 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.2 44.23 4.45 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 120.598 1.545 . . . . 7.41 112.963 -169.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 mt -111.68 126.6 28.24 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 100.314 -3.958 . . . . 9.49 100.314 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -67.35 153.41 77.04 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 C-N-CA 126.335 4.69 . . . . 11.42 115.765 -174.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -78.27 -18.89 12.29 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 126.412 3.326 . . . . 12.0 112.998 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.9 -11.76 60.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 114.885 -2.483 . . . . 35.55 115.69 165.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -97.07 -16.73 20.39 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 121.901 2.137 . . . . 20.52 112.763 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 76.7 mt-30 -92.04 118.07 30.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.747 3.154 . . . . 7.13 111.098 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -116.37 111.02 19.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.933 -1.877 . . . . 36.39 105.933 170.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -86.75 113.94 23.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.879 2.752 . . . . 9.55 110.638 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.2 mm -99.43 142.12 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.243 -2.786 . . . . 13.9 105.878 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.48 ' HB2' HD11 ' A' ' 50' ' ' LEU . 25.5 t80 -128.65 112.24 14.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.69 -1.881 . . . . 6.86 108.08 171.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.33 . . 68.86 -91.65 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.343 -3.973 . . . . 11.15 117.354 -162.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.68 34.68 0.95 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 118.842 -1.646 . . . . 13.93 111.804 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -149.98 144.83 26.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 129.513 3.714 . . . . 23.92 113.709 173.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -73.43 134.41 43.98 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 125.832 2.73 . . . . 23.23 115.125 -176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 45' ' ' PHE . 14.7 mt -86.51 151.1 23.78 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 110.727 -2.942 . . . . 9.11 109.925 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.36 133.31 46.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.216 -3.428 . . . . 33.44 105.214 -158.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -40.45 -58.8 1.47 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 130.466 3.506 . . . . 28.37 117.789 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.7 14.16 43.6 Favored Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 121.055 1.752 . . . . 15.0 114.288 -169.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -113.44 159.68 19.23 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.671 -2.664 . . . . 25.5 108.626 -172.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 p -114.27 -178.12 3.29 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.476 -3.265 . . . . 11.95 112.571 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 17' ' ' VAL . 71.3 mt -74.51 -28.71 61.11 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 110.656 -2.975 . . . . 10.17 114.319 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.6 m -65.52 -31.11 72.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 119.167 3.025 . . . . 13.59 119.167 170.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -65.89 -45.63 81.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 127.62 3.075 . . . . 11.7 110.388 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -92.38 -8.41 44.97 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.695 -2.098 . . . . 12.95 109.51 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 60.35 54.24 4.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.508 3.051 . . . . 25.45 114.305 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mt -93.44 108.39 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 109.602 -3.454 . . . . 14.6 105.744 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -88.2 -179.09 6.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 124.769 2.223 . . . . 33.23 111.419 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.269 17.9 pttp -53.37 141.69 23.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.723 -3.111 . . . . 25.97 116.146 159.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 70.98 20.87 5.15 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.785 -3.072 . . . . 32.61 112.545 168.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -89.71 135.21 33.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.972 3.709 . . . . 10.56 114.786 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -95.0 117.71 30.6 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.869 2.914 . . . . 5.33 118.869 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mp -108.83 151.35 26.36 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.89 -2.263 . . . . 11.66 104.89 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -107.13 140.66 39.62 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.231 -1.766 . . . . 16.3 106.231 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -106.37 106.48 17.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.535 1.772 . . . . 9.96 111.952 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.3 t -94.42 134.33 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 126.948 2.655 . . . . 9.76 107.029 173.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 N--CA 1.43 -1.44 0 CA-C-N 115.417 -0.811 . . . . 19.57 110.314 166.256 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 112.505 0.558 . . . . 17.17 112.505 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -102.73 147.86 26.32 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.517 3.532 . . . . 21.89 112.94 170.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 pt -128.6 163.66 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 115.802 -4.311 . . . . 10.83 103.908 169.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.57 101.67 7.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 105.057 -2.201 . . . . 10.61 105.057 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.0 t -93.53 123.3 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 107.015 -1.476 . . . . 9.13 107.015 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -124.36 152.75 42.78 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.246 1.839 . . . . 20.55 111.004 -171.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -88.42 -178.37 5.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.614 1.709 . . . . 11.78 115.614 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.269 36.1 tp -67.77 -40.08 84.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.719 2.859 . . . . 19.31 118.719 158.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -56.55 7.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.899 -2.376 . . . . 23.14 111.74 -169.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.74 24.52 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 119.03 -2.294 . . . . 19.74 115.197 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -100.38 148.48 24.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.911 -3.111 . . . . 21.93 115.849 166.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.8 m -125.34 135.77 52.79 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.744 2.818 . . . . 12.33 104.883 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.6 mt -121.59 110.78 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 103.273 -2.862 . . . . 17.08 103.273 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -79.57 118.72 21.67 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.07 -1.644 . . . . 16.3 113.852 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -112.68 145.12 41.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.425 -3.297 . . . . 15.88 113.119 -174.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -100.61 98.25 8.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.496 -1.668 . . . . 28.9 106.496 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 m -104.42 174.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 124.883 1.364 . . . . 12.05 113.025 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -121.02 152.02 55.96 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 127.367 2.267 . . . . 18.17 106.213 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -68.35 -14.72 40.87 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 122.784 2.03 . . . . 8.16 115.224 -172.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.255 53.3 p -99.8 1.34 43.0 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.737 2.815 . . . . 11.13 114.596 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.264 11.3 m-20 -71.0 155.23 41.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.882 2.277 . . . . 18.03 110.638 161.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 p -85.36 161.68 19.37 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.04 2.829 . . . . 10.22 108.487 173.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mm -57.01 -29.12 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.161 -2.837 . . . . 12.3 115.068 163.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -62.68 -46.65 87.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.021 -3.55 . . . . 36.51 109.538 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -52.85 -52.75 56.07 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.892 1.277 . . . . 25.66 113.325 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -45.12 -50.35 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.911 1.684 . . . . 8.12 113.409 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.19 -36.21 77.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.038 1.875 . . . . 15.47 115.011 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.97 82.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.641 -2.537 . . . . 11.45 116.408 170.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -63.92 -40.03 95.54 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.795 1.776 . . . . 24.98 115.795 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -60.05 -45.2 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 C-N-CA 135.097 5.359 . . . . 9.46 110.693 168.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -54.54 -48.23 72.25 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.991 1.717 . . . . 14.76 113.386 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.21 -35.57 80.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.535 2.05 . . . . 26.29 116.535 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -87.37 -46.31 9.77 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.637 1.684 . . . . 30.06 114.694 -172.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -78.63 -55.61 5.06 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 114.225 -1.352 . . . . 25.19 114.51 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.1 44.84 1.97 Allowed Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 110.066 -1.213 . . . . 7.41 110.066 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.413 HG22 ' HB3' ' A' ' 40' ' ' GLN . 6.8 mt -125.38 127.24 25.0 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 104.806 -2.294 . . . . 9.49 104.806 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 41.9 Cg_exo -67.22 160.36 47.92 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-O 115.998 -1.751 . . . . 11.42 116.052 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.6 Cg_exo -70.29 -27.34 24.05 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 124.74 3.626 . . . . 12.0 110.993 -169.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -77.64 -37.2 50.49 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 117.92 -1.038 . . . . 35.55 109.457 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HB3' HG22 ' A' ' 36' ' ' ILE . 7.1 tp-100 -59.96 -33.08 71.45 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.559 2.344 . . . . 20.52 115.498 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -98.93 145.32 27.15 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.346 2.022 . . . . 7.13 116.418 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -115.03 153.71 30.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.692 2.797 . . . . 36.39 107.683 165.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 tp -133.93 114.89 13.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.413 1.085 . . . . 9.55 108.966 -171.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.4 mm -103.71 128.57 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 117.26 -3.4 . . . . 13.9 112.452 -171.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -109.87 128.62 55.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.02 1.328 . . . . 6.86 108.674 160.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.42 -108.25 0.42 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.81 -2.432 . . . . 11.15 112.262 -168.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.67 31.55 3.53 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 109.212 -1.555 . . . . 13.93 109.212 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -121.8 124.18 43.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.269 1.428 . . . . 23.92 111.054 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -76.31 107.41 8.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.217 1.807 . . . . 23.23 110.682 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.82 136.63 34.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.247 1.019 . . . . 9.11 111.696 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -93.24 159.1 15.42 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.483 2.087 . . . . 33.44 111.101 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -73.15 -42.07 63.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.226 -2.796 . . . . 28.37 108.764 -156.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.84 41.5 2.13 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 117.217 -3.427 . . . . 15.0 113.01 -165.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -122.37 159.71 26.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.158 2.328 . . . . 25.5 108.842 166.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.9 p -85.99 167.92 14.62 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.964 2.106 . . . . 11.95 116.396 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -68.36 -26.66 65.7 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.794 -1.191 . . . . 10.17 111.416 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 t -76.37 -40.76 50.24 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 118.431 2.752 . . . . 13.59 118.431 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -43.16 -48.11 6.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.922 -2.361 . . . . 11.7 117.251 158.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -78.85 -6.99 57.49 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 120.575 3.546 . . . . 12.95 120.575 170.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 t30 53.75 40.06 31.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.064 2.616 . . . . 25.45 118.064 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.8 mt -81.47 118.91 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 105.044 -2.206 . . . . 14.6 105.044 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -81.31 -173.07 4.13 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.878 2.751 . . . . 33.23 113.79 -176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -74.42 146.06 43.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.009 -2.932 . . . . 25.97 112.605 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 65.57 30.16 10.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.364 1.665 . . . . 32.61 114.821 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -79.45 152.53 30.24 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 103.763 -2.68 . . . . 10.56 103.763 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.6 m -103.51 124.16 48.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.103 2.961 . . . . 5.33 108.309 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.282 4.9 mp -117.11 162.13 18.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.106 1.762 . . . . 11.66 107.894 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.27 127.08 52.9 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.705 -2.497 . . . . 16.3 111.182 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.72 107.73 18.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.414 2.686 . . . . 9.96 114.739 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -122.12 121.34 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 108.057 -1.09 . . . . 9.76 108.057 -171.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.402 HD11 HD13 ' A' ' 36' ' ' ILE . 7.9 mp . . . . . 0 N--CA 1.431 -1.409 0 C-N-CA 117.092 -1.843 . . . . 19.57 110.151 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 112.747 0.647 . . . . 17.17 112.747 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -95.95 121.8 38.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.907 -1.886 . . . . 21.89 105.907 -176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 pt -109.62 164.85 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 107.268 -1.382 . . . . 10.83 107.268 170.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -114.83 105.79 13.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.432 -2.433 . . . . 10.61 104.432 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.4 t -86.57 124.84 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 126.931 3.253 . . . . 9.13 109.483 166.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -106.4 134.62 49.25 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.431 -2.668 . . . . 20.55 107.684 -173.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.253 47.5 p -75.79 161.14 29.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.775 2.03 . . . . 11.78 112.042 170.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.5 tp -59.28 -37.93 78.88 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.378 -3.326 . . . . 19.31 115.613 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -68.1 -64.58 0.83 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.651 2.167 . . . . 23.14 115.085 169.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.51 71.55 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 O-C-N 117.113 -3.492 . . . . 19.74 107.826 174.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -104.02 160.14 15.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.549 1.174 . . . . 21.93 113.885 147.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.1 m -90.96 118.98 30.78 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 115.824 -4.298 . . . . 12.33 105.92 168.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.71 119.17 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 123.914 1.816 . . . . 17.08 107.737 156.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 84.7 m -98.96 108.65 21.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 111.595 -2.548 . . . . 16.3 106.723 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.447 ' CD1' HG13 ' A' ' 26' ' ' VAL . 87.7 mt -107.2 116.87 32.69 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.598 2.359 . . . . 15.88 115.719 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.31 112.42 15.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.531 -1.668 . . . . 28.9 110.211 167.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.29 158.32 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 123.284 0.634 . . . . 12.05 109.949 167.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 56.7 mt-10 -115.79 151.73 46.65 Favored Pre-proline 0 N--CA 1.429 -1.478 0 N-CA-C 102.834 -3.024 . . . . 18.17 102.834 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 22.1 Cg_exo -76.03 -16.4 18.02 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 CA-C-O 114.889 -2.213 . . . . 8.16 113.456 -159.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -70.51 -14.83 62.68 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-N 127.26 4.573 . . . . 11.13 112.931 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 18.3 m-20 -78.32 146.8 34.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.703 -3.748 . . . . 18.03 106.19 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.7 p -78.77 167.89 20.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.336 -3.978 . . . . 10.22 116.489 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.95 -39.88 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 117.427 -1.273 . . . . 12.3 110.234 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -51.1 -39.51 56.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 123.422 2.828 . . . . 36.51 113.233 170.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -57.57 -38.67 75.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.565 -1.335 . . . . 25.66 112.811 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.447 HG13 ' CD1' ' A' ' 15' ' ' LEU . 58.5 t -56.77 -54.42 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 125.925 2.774 . . . . 8.12 111.183 176.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -56.57 -37.38 70.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.981 3.326 . . . . 15.47 119.981 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.23 -32.08 69.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.231 1.491 . . . . 11.45 112.475 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -80.22 -27.89 38.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 118.585 -1.246 . . . . 24.98 108.461 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.9 mt -58.65 -42.21 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 114.749 1.389 . . . . 9.46 114.749 159.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -65.05 -24.91 67.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.867 -2.395 . . . . 14.76 115.96 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.23 -59.82 3.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.442 -3.287 . . . . 26.29 109.445 166.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -73.1 -56.83 4.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.331 2.715 . . . . 30.06 118.331 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -93.95 -53.3 4.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.751 1.621 . . . . 25.19 115.094 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.52 2.9 6.21 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 125.173 2.54 . . . . 7.41 115.995 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.5 mt -68.18 127.55 93.27 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 113.691 -3.052 . . . . 9.49 112.767 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -70.63 155.57 62.82 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 126.974 3.527 . . . . 11.42 115.337 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -62.45 -39.45 45.78 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 CA-C-N 124.552 2.661 . . . . 12.0 110.636 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.73 -8.7 11.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.65 2.833 . . . . 35.55 118.65 170.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -94.68 -32.26 13.45 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.785 -2.447 . . . . 20.52 110.402 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 16.1 pt20 -107.96 154.33 21.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.737 1.384 . . . . 7.13 114.737 -172.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 mtt85 -134.55 164.34 27.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 117.823 -1.084 . . . . 36.39 108.222 157.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -113.31 136.62 52.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.059 3.344 . . . . 9.55 107.15 -174.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -115.76 122.72 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.131 -1.433 . . . . 13.9 107.131 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -113.63 111.14 21.35 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.968 -2.975 . . . . 6.86 102.968 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.08 -75.83 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.446 -2.034 . . . . 11.15 114.972 -164.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.59 9.09 2.61 Favored Glycine 0 N--CA 1.429 -1.807 0 CA-C-N 121.021 1.737 . . . . 13.93 116.463 169.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -107.62 123.76 48.96 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.719 2.2 . . . . 23.92 108.249 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -82.19 121.34 26.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 110.362 -3.108 . . . . 23.23 111.721 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 mt -86.27 156.17 20.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 115.749 -2.072 . . . . 9.11 110.547 -165.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -109.25 142.42 40.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 123.034 2.652 . . . . 33.44 111.265 -173.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.61 -48.75 79.93 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.374 2.67 . . . . 28.37 115.564 -163.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.29 -3.69 71.24 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 118.163 2.025 . . . . 15.0 118.163 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.8 mtt-85 -98.0 170.25 9.06 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.889 1.328 . . . . 25.5 110.286 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -106.43 162.04 14.05 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.927 -1.733 . . . . 11.95 112.521 -170.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.437 HD23 HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -63.58 -25.37 68.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.884 -2.385 . . . . 10.17 114.611 175.178 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.96 -30.19 55.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.664 2.386 . . . . 13.59 112.493 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -63.73 -42.23 97.93 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.542 -3.223 . . . . 11.7 111.246 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -88.99 5.68 43.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.033 2.975 . . . . 12.95 119.033 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 55.36 59.64 3.82 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.833 2.453 . . . . 25.45 111.994 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.437 HD12 HD23 ' A' ' 56' ' ' LEU . 60.6 mt -96.38 122.94 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.125 -1.805 . . . . 14.6 106.125 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -102.34 -174.73 2.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.646 1.688 . . . . 33.23 111.978 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -56.03 149.33 15.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.148 -3.47 . . . . 25.97 115.919 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 39.2 mt-10 66.98 31.04 7.23 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.367 -2.708 . . . . 32.61 113.434 171.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.3 m -93.29 132.21 37.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.798 -2.001 . . . . 10.56 113.375 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.1 m -90.74 124.64 35.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.452 -2.655 . . . . 5.33 108.09 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.322 11.2 mp -109.61 140.02 43.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.997 1.719 . . . . 11.66 111.838 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -98.48 135.36 40.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.135 2.243 . . . . 16.3 115.505 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.5 tp -98.14 125.43 43.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.44 1.59 . . . . 9.96 110.189 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -133.37 148.08 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 121.032 -1.042 . . . . 9.76 110.187 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 105.079 -2.193 . . . . 19.57 105.079 -170.078 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 122.931 1.348 . . . . 17.17 114.554 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -107.77 155.98 19.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 120.036 3.347 . . . . 21.89 120.036 172.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -138.73 154.54 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 106.817 -1.549 . . . . 10.83 106.817 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -106.83 126.73 52.69 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.401 -2.074 . . . . 10.61 105.401 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.01 108.83 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 120.09 1.314 . . . . 9.13 109.581 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -96.97 135.66 38.65 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.735 -1.121 . . . . 20.55 109.568 -167.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -77.61 171.11 15.42 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.412 1.695 . . . . 11.78 112.007 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -51.5 -56.39 13.63 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 117.093 2.257 . . . . 19.31 117.093 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -85.93 -72.95 0.47 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.442 -2.036 . . . . 23.14 109.324 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.41 48.0 0.17 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 118.658 2.223 . . . . 19.74 118.658 -162.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -110.85 156.27 21.38 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 116.304 -4.056 . . . . 21.93 110.299 157.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.9 m -129.14 135.82 49.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 103.148 -2.908 . . . . 12.33 103.148 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 mt -121.54 112.97 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 114.5 -1.227 . . . . 17.08 108.989 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.7 m -88.19 107.17 18.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.995 0.903 . . . . 16.3 111.479 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.92 112.35 24.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 120.233 3.42 . . . . 15.88 120.233 -173.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -83.59 117.74 23.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.723 -3.735 . . . . 28.9 111.892 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.62 177.84 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.547 -1.971 . . . . 12.05 109.377 -166.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -117.46 160.13 39.13 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 118.488 -2.633 . . . . 18.17 109.951 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -79.48 -6.78 14.72 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 125.253 3.969 . . . . 8.16 110.091 -166.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 m -88.58 -7.22 56.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.711 2.804 . . . . 11.13 115.064 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.49 169.74 11.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 118.703 0.683 . . . . 18.03 112.79 -175.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.5 p -107.9 164.91 11.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.421 2.288 . . . . 10.22 109.029 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 mm -55.83 -47.01 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 126.499 1.92 . . . . 12.3 112.37 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -60.99 -32.7 72.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.21 2.604 . . . . 36.51 115.642 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -67.04 -43.2 83.36 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 122.714 2.507 . . . . 25.66 115.38 162.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.89 -29.24 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 118.435 -2.666 . . . . 8.12 113.004 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -72.68 -34.68 67.35 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.968 2.507 . . . . 15.47 110.476 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -34.92 73.56 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.788 2.835 . . . . 11.45 115.771 169.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -57.87 -52.14 66.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.939 2.896 . . . . 24.98 117.069 162.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.2 mt -60.6 -40.3 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 117.794 -3.066 . . . . 9.46 113.404 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -50.45 -49.0 56.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.513 2.578 . . . . 14.76 112.006 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -46.47 80.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.359 -3.963 . . . . 26.29 116.941 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -63.22 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.063 -2.335 . . . . 30.06 114.954 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -58.97 -64.65 0.86 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.166 2.186 . . . . 25.19 113.663 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.54 62.24 0.33 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 108.476 -1.849 . . . . 7.41 108.476 -171.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.42 HD13 HD11 ' A' ' 71' ' ' LEU . 36.0 mt -127.84 114.05 20.58 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.326 -2.75 . . . . 9.49 113.89 177.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -73.77 150.8 45.16 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 124.809 2.753 . . . . 11.42 113.737 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -57.97 -35.07 99.01 Favored 'Trans proline' 0 N--CA 1.434 -2.003 2 C-N-CA 129.514 6.81 . . . . 12.0 117.451 -166.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.299 38.7 m-20 -74.21 -21.65 59.71 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.603 1.161 . . . . 35.55 111.15 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -78.23 -31.86 49.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.355 3.455 . . . . 20.52 114.097 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -109.65 140.24 43.73 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 113.287 -5.883 . . . . 7.13 111.203 -175.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -123.17 171.74 9.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.747 -1.945 . . . . 36.39 105.747 163.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.25 35.3 mt -123.32 143.32 50.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 125.773 1.92 . . . . 9.55 107.519 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.88 138.68 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.431 2.062 . . . . 13.9 106.38 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -114.07 102.19 9.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.318 -2.739 . . . . 6.86 107.882 171.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.297 . . 58.58 -98.33 0.08 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.735 1.754 . . . . 11.15 115.735 -166.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.47 -6.89 24.95 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 120.704 1.593 . . . . 13.93 109.195 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.8 120.32 30.09 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 113.382 0.882 . . . . 23.92 113.382 -171.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -87.61 116.97 26.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.235 -3.416 . . . . 23.23 111.386 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.0 mt -84.58 126.86 33.7 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.331 -1.481 . . . . 9.11 112.315 -169.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -78.0 134.91 37.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.359 2.664 . . . . 33.44 114.084 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.52 -46.03 91.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.332 1.853 . . . . 28.37 112.657 -155.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.23 -8.02 86.95 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 125.818 1.675 . . . . 15.0 117.247 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.8 mtt-85 -76.64 148.18 37.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.035 -2.45 . . . . 25.5 112.122 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.2 p -81.66 166.41 20.18 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.729 -4.357 . . . . 11.95 110.034 -176.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.74 -19.28 63.54 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.957 1.836 . . . . 10.17 115.957 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 t -91.05 -18.21 24.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.753 2.821 . . . . 13.59 108.563 -172.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -66.78 -21.88 66.04 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.444 -4.535 . . . . 11.7 114.082 163.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -104.24 -20.68 13.71 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.66 -1.154 . . . . 12.95 111.582 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 66.44 61.03 0.58 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.419 1.888 . . . . 25.45 112.083 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -101.29 103.46 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.241 1.816 . . . . 14.6 108.789 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -83.49 -163.42 0.75 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.348 1.61 . . . . 33.23 115.348 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -71.75 159.02 35.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.424 1.89 . . . . 25.97 112.756 170.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 54.04 22.14 3.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.749 2.82 . . . . 32.61 110.206 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -66.22 140.64 58.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.587 1.955 . . . . 10.56 116.08 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -90.75 116.99 29.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.677 3.991 . . . . 5.33 106.498 171.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -112.2 166.53 11.18 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 127.023 2.702 . . . . 11.66 110.498 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -122.86 135.54 54.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 117.81 -1.091 . . . . 16.3 111.269 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 tp -94.16 133.4 37.7 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.974 1.369 . . . . 9.96 107.411 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.9 152.79 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 O-C-N 114.605 -5.059 . . . . 9.76 106.735 161.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 36' ' ' ILE . 7.3 mp . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 115.057 -2.402 . . . . 19.57 110.493 171.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 114.464 1.283 . . . . 17.17 114.464 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -113.78 135.0 54.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.549 1.643 . . . . 21.89 109.123 -178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.6 pt -124.19 158.09 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 112.463 -2.153 . . . . 10.83 105.513 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -104.07 114.29 28.43 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.623 1.169 . . . . 10.61 113.38 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.23 116.0 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 116.724 -3.735 . . . . 9.13 102.588 166.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -107.99 133.74 51.88 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.703 3.601 . . . . 20.55 109.97 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.392 17.6 p -79.88 -173.39 3.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.002 1.853 . . . . 11.78 116.002 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.5 tp -79.37 -42.41 25.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.889 2.757 . . . . 19.31 111.817 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p -68.49 -70.2 0.28 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.343 4.257 . . . . 23.14 110.129 174.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.44 55.98 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 104.089 -3.604 . . . . 19.74 104.089 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -117.33 146.19 43.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 120.728 2.264 . . . . 21.93 108.76 159.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -114.48 117.58 31.38 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.286 -2.759 . . . . 12.33 110.392 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 13' ' ' ILE 0.27 0.3 OUTLIER -104.45 104.32 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 103.154 -2.906 . . . . 17.08 103.154 175.178 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.4 m -88.88 111.72 22.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.711 1.204 . . . . 16.3 110.796 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.4 mt -114.26 148.92 36.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 122.853 2.57 . . . . 15.88 107.875 -160.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -106.34 118.93 37.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.382 -1.449 . . . . 28.9 114.697 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.56 170.66 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 124.061 1.886 . . . . 12.05 112.425 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -107.99 164.24 15.21 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.07 -2.894 . . . . 18.17 109.445 167.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -71.06 -24.85 23.32 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.263 1.975 . . . . 8.16 112.447 -172.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.9 m -73.45 -8.08 54.43 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.727 2.811 . . . . 11.13 116.552 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -84.28 142.59 30.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.077 -1.874 . . . . 18.03 112.428 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.7 p -80.04 165.05 22.92 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.288 2.47 . . . . 10.22 113.807 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.455 HD12 HD13 ' A' ' 50' ' ' LEU . 35.6 mm -69.73 -32.31 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 119.535 -1.978 . . . . 12.3 109.448 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -51.66 -35.89 44.16 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.777 1.769 . . . . 36.51 115.777 159.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.69 -35.91 65.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.405 2.526 . . . . 25.66 109.845 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.05 -43.77 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 1 O-C-N 115.841 -4.287 . . . . 8.12 109.785 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -56.64 -33.64 66.5 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.164 2.653 . . . . 15.47 118.164 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.77 -29.21 64.24 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.544 2.592 . . . . 11.45 109.281 -167.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -78.47 -34.08 47.85 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.794 2.037 . . . . 24.98 111.251 174.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.33 -33.57 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 123.859 1.79 . . . . 9.46 110.769 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -59.4 -44.22 92.84 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.418 -2.676 . . . . 14.76 110.607 166.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.94 -41.47 91.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.446 1.098 . . . . 26.29 110.242 -172.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -78.96 -63.94 1.3 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 119.026 0.83 . . . . 30.06 110.041 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -89.72 -20.88 23.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.561 2.06 . . . . 25.19 116.561 -158.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.39 34.24 23.51 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 118.632 2.213 . . . . 7.41 118.632 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -107.99 124.0 36.04 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 119.157 -0.449 . . . . 9.49 111.598 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -66.0 148.02 85.25 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.636 2.224 . . . . 11.42 115.641 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.08 -21.48 12.09 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.162 2.575 . . . . 12.0 109.983 -148.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -70.28 -28.12 64.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.858 1.799 . . . . 35.55 115.858 173.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -81.81 -26.74 34.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.448 -2.033 . . . . 20.52 115.813 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -96.03 152.25 18.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.221 1.408 . . . . 7.13 108.533 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -135.51 168.2 19.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 117.205 -1.378 . . . . 36.39 109.685 167.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 43' ' ' LEU . 35.2 mt -131.71 130.75 42.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 125.388 3.722 . . . . 9.55 110.714 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mt -110.77 116.59 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 112.124 -2.307 . . . . 13.9 110.657 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -96.73 102.07 13.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.107 3.363 . . . . 6.86 109.905 169.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.1 -95.84 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.746 2.018 . . . . 11.15 114.714 -165.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.03 -12.91 26.47 Favored Glycine 0 N--CA 1.43 -1.703 1 C-N-CA 131.204 4.24 . . . . 13.93 112.694 -175.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -104.25 150.14 24.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.705 -2.644 . . . . 23.92 115.354 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -109.79 149.33 29.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.151 2.405 . . . . 23.23 109.752 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.455 HD13 HD12 ' A' ' 23' ' ' ILE . 23.4 mt -90.03 118.84 29.89 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.878 2.071 . . . . 9.11 113.234 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -79.04 150.68 31.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.993 1.378 . . . . 33.44 110.475 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.97 -24.66 55.43 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 115.474 -4.517 . . . . 28.37 112.284 -157.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.18 27.2 10.37 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 121.145 3.218 . . . . 15.0 121.145 -171.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -110.79 174.91 5.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.309 1.843 . . . . 25.5 111.278 162.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.2 p -95.88 167.32 11.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 113.661 0.986 . . . . 11.95 113.661 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.4 -33.66 74.05 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 114.637 1.347 . . . . 10.17 114.637 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.39 -39.65 84.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.698 1.599 . . . . 13.59 114.681 171.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.287 72.5 m-20 -57.57 -37.25 72.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.802 2.041 . . . . 11.7 114.976 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -110.41 4.92 21.04 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.822 -1.547 . . . . 12.95 106.822 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 t30 72.34 45.03 0.39 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.147 -2.22 . . . . 25.45 109.75 162.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.6 mt -94.59 119.89 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 128.11 3.814 . . . . 14.6 111.227 168.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -99.35 175.29 5.92 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.885 -4.259 . . . . 33.23 108.043 169.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -40.77 145.56 0.19 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.347 -3.346 . . . . 25.97 117.446 165.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 70.76 9.5 6.85 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.155 3.382 . . . . 32.61 116.759 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.8 m -78.11 145.58 35.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.398 3.079 . . . . 10.56 108.824 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.3 m -100.69 121.22 41.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.202 1.401 . . . . 5.33 109.145 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.7 mt -104.8 149.36 25.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.317 -0.994 . . . . 11.66 108.317 164.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -99.86 108.42 20.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.577 2.351 . . . . 16.3 110.142 169.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tp -84.54 98.12 9.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.716 -1.865 . . . . 9.96 109.347 171.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.2 156.18 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 119.332 -2.105 . . . . 9.76 107.429 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 N--CA 1.43 -1.436 0 CA-C-O 125.741 2.686 . . . . 19.57 107.63 172.835 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.338 18.0 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 119.101 3.0 . . . . 17.17 119.101 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -102.04 128.72 48.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 119.314 -0.954 . . . . 21.89 112.414 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.321 31.1 pt -118.42 169.33 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.377 1.471 . . . . 10.83 112.649 171.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -132.88 131.6 41.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.46 -2.65 . . . . 10.61 111.953 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.4 t -106.01 114.5 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 103.822 -2.659 . . . . 9.13 103.822 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -79.72 142.43 35.47 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.027 2.822 . . . . 20.55 109.548 167.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.276 17.0 p -93.67 -176.82 4.18 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.686 -2.509 . . . . 11.78 112.167 176.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.66 -25.92 24.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 120.472 1.487 . . . . 19.31 113.169 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -69.7 -55.45 9.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.02 2.343 . . . . 23.14 109.34 161.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.37 58.02 0.18 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.381 -1.45 . . . . 19.74 112.999 164.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.254 42.1 pttt -101.83 149.33 24.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.47 1.108 . . . . 21.93 113.878 172.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.1 m -74.83 114.01 12.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.105 -2.872 . . . . 12.33 118.149 164.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.8 mt -96.52 123.62 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 122.104 0.954 . . . . 17.08 109.052 160.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.5 m -110.5 121.15 44.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 102.508 -3.145 . . . . 16.3 102.508 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.4 mt -115.07 146.49 41.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.742 -2.474 . . . . 15.88 113.074 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -113.35 103.74 11.61 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.701 2.801 . . . . 28.9 104.506 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.2 169.37 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 115.523 -2.179 . . . . 12.05 108.57 -167.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -114.75 158.71 39.73 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 128.491 2.717 . . . . 18.17 104.21 161.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -91.22 -4.83 4.25 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 115.615 -2.457 . . . . 8.16 108.364 -167.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.287 33.1 m -72.67 -11.31 60.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.582 2.438 . . . . 11.13 117.582 164.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -84.22 159.57 20.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 121.451 1.932 . . . . 18.03 112.185 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.2 p -95.63 155.5 16.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.238 -2.164 . . . . 10.22 107.964 -169.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.24 -31.78 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 O-C-N 115.487 -4.508 . . . . 12.3 106.708 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -52.34 -38.89 59.82 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.652 -4.405 . . . . 36.51 112.051 166.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -75.41 -33.01 60.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.651 -2.53 . . . . 25.66 112.514 170.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -72.92 -41.43 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.133 -3.479 . . . . 8.12 111.68 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.32 -23.47 65.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.876 2.917 . . . . 15.47 118.876 166.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.76 -32.2 65.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.603 1.547 . . . . 11.45 114.485 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.254 37.0 mttm -59.3 -40.41 86.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.034 1.734 . . . . 24.98 113.694 163.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.351 55.6 mt -54.27 -43.24 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.773 -3.08 . . . . 9.46 116.629 165.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -66.78 -42.56 85.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.939 1.696 . . . . 14.76 107.031 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -61.53 -59.44 5.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.898 -1.752 . . . . 26.29 113.206 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -61.09 -72.27 0.12 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.806 2.842 . . . . 30.06 112.121 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -77.25 -44.26 30.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 113.473 0.916 . . . . 25.19 113.473 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.92 43.0 2.71 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 129.61 3.481 . . . . 7.41 116.96 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 mt -111.25 117.82 48.86 Favored Pre-proline 0 N--CA 1.43 -1.427 0 O-C-N 121.394 -1.062 . . . . 9.49 111.195 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.66 160.2 31.49 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-O 124.828 1.928 . . . . 11.42 114.784 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HA ' ' HG3' ' A' ' 41' ' ' GLN . 69.7 Cg_endo -86.57 -2.23 8.36 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 114.827 -3.302 . . . . 12.0 111.152 -155.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -88.63 -1.63 58.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 124.428 3.286 . . . . 35.55 112.142 164.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -99.22 -31.07 11.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.334 2.716 . . . . 20.52 118.334 169.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 5.4 pt20 -109.2 152.49 25.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.334 1.854 . . . . 7.13 111.893 -176.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -148.45 154.25 39.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.822 -1.547 . . . . 36.39 106.822 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.7 mt -119.3 148.95 42.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.251 -1.759 . . . . 9.55 106.251 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -127.06 136.64 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 114.161 -1.381 . . . . 13.9 107.537 171.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -114.46 107.94 16.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.766 1.746 . . . . 6.86 107.769 169.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.289 . . 61.89 -68.01 0.06 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.159 3.384 . . . . 11.15 111.155 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -148.53 -16.56 0.11 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 105.961 -2.856 . . . . 13.93 105.961 -172.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' H ' ' H ' ' A' ' 47' ' ' GLY . 51.3 mtpt -88.08 131.26 34.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 126.334 2.968 . . . . 23.92 115.349 174.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -88.6 120.86 30.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.422 -3.923 . . . . 23.23 108.483 -172.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.4 mt -82.72 145.02 29.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.051 2.241 . . . . 9.11 117.051 -167.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -110.54 139.17 46.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.229 2.918 . . . . 33.44 106.388 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.22 -41.2 64.02 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.039 -1.891 . . . . 28.37 112.46 -159.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.11 31.74 4.94 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 121.476 1.944 . . . . 15.0 115.584 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -106.67 -175.33 2.76 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 128.043 2.849 . . . . 25.5 116.257 155.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.7 p -113.27 177.47 4.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.56 1.544 . . . . 11.95 111.311 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.84 -22.65 45.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.066 1.136 . . . . 10.17 114.066 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -74.93 -25.61 59.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.698 -3.126 . . . . 13.59 111.637 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -67.85 -53.77 24.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.092 -2.255 . . . . 11.7 114.481 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -81.56 -17.11 49.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 118.726 -0.654 . . . . 12.95 110.487 -174.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 0.3 OUTLIER 81.51 55.69 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.208 2.432 . . . . 25.45 106.214 -173.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -90.87 101.4 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 1 O-C-N 116.263 -4.023 . . . . 14.6 108.914 171.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 62' ' ' GLN 0.322 12.9 pt20 -90.99 176.0 6.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.247 0.967 . . . . 33.23 112.001 -171.156 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -70.69 148.08 48.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 120.944 3.683 . . . . 25.97 120.944 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.425 24.1 mt-10 51.59 32.64 9.34 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.107 2.861 . . . . 32.61 117.193 -171.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 166.55 10.39 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.365 1.866 . . . . 10.56 108.58 -174.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.0 m -115.99 132.66 56.59 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 112.625 -2.08 . . . . 5.33 110.362 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.45 150.0 28.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 131.148 3.779 . . . . 11.66 107.315 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -105.54 114.75 29.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.771 -1.104 . . . . 16.3 111.246 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 tp -78.18 130.8 36.76 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.202 -2.811 . . . . 9.96 108.732 169.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.3 167.45 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 112.703 -2.044 . . . . 9.76 111.251 156.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 105.457 -2.053 . . . . 19.57 105.457 -175.973 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.289 0.8 OUTLIER . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 113.715 1.006 . . . . 17.17 113.715 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -79.01 135.87 37.02 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.087 -4.758 . . . . 21.89 113.134 169.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -120.57 155.54 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.845 -2.409 . . . . 10.83 104.746 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -107.96 123.79 49.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.728 1.611 . . . . 10.61 114.594 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.6 t -109.37 114.9 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 126.087 2.117 . . . . 9.13 111.554 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -101.18 122.61 43.93 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.379 -2.075 . . . . 20.55 111.38 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -79.08 168.95 18.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.389 2.276 . . . . 11.78 114.016 -175.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.43 -16.35 57.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 118.866 2.913 . . . . 19.31 118.866 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 p -76.71 -50.68 13.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.647 -1.615 . . . . 23.14 112.393 166.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.94 39.87 0.19 Allowed Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 125.259 2.589 . . . . 19.74 118.911 162.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -99.27 124.85 44.68 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.692 2.397 . . . . 21.93 112.642 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.277 7.1 m -82.85 97.7 8.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.065 -2.272 . . . . 12.33 110.553 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.7 mt -72.89 123.18 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 106.527 -1.657 . . . . 17.08 106.527 170.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 p -101.21 110.66 22.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.228 2.211 . . . . 16.3 111.427 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.4 mt -118.51 143.82 46.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.697 -1.877 . . . . 15.88 106.913 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -109.85 121.61 45.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.859 2.464 . . . . 28.9 106.891 170.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.94 172.73 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.141 0.972 . . . . 12.05 111.331 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -111.5 160.57 28.9 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 118.727 -2.483 . . . . 18.17 113.27 171.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -86.46 3.31 6.88 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 CA-C-N 125.996 3.177 . . . . 8.16 116.611 -162.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 m -92.98 4.65 53.61 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.274 2.23 . . . . 11.13 109.689 167.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -70.46 131.42 44.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.363 2.801 . . . . 18.03 117.262 161.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.1 p -74.3 158.94 33.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.358 -3.339 . . . . 10.22 114.542 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.508 ' HA ' HD13 ' A' ' 23' ' ' ILE . 30.1 mm -57.2 -28.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 112.178 0.436 . . . . 12.3 112.178 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -55.93 -46.26 78.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.83 2.728 . . . . 36.51 111.424 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -63.95 -45.22 90.13 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.307 -2.745 . . . . 25.66 112.399 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.4 t -57.63 -44.91 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.038 -1.664 . . . . 8.12 114.426 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -60.11 -32.29 70.85 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 119.246 3.054 . . . . 15.47 119.246 165.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.42 82.55 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.05 -4.156 . . . . 11.45 114.661 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -66.03 -21.54 66.39 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 120.02 3.341 . . . . 24.98 120.02 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -74.72 -41.61 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 120.235 -1.541 . . . . 9.46 112.252 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -52.91 -59.64 4.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.605 1.962 . . . . 14.76 114.405 167.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -42.7 -44.73 4.44 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 119.301 3.075 . . . . 26.29 119.301 161.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -76.78 -49.12 16.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.866 -1.771 . . . . 30.06 110.374 -173.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -114.01 -17.61 11.92 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 115.9 1.815 . . . . 25.19 115.9 -160.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.29 29.38 19.84 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 124.726 1.155 . . . . 7.41 115.016 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.7 mt -110.86 115.92 52.65 Favored Pre-proline 0 N--CA 1.43 -1.443 0 C-N-CA 129.067 2.947 . . . . 9.49 109.603 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.512 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.7 Cg_exo -62.53 141.68 87.26 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 N-CA-C 121.672 3.682 . . . . 11.42 121.672 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.1 Cg_exo -74.95 -5.11 16.38 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 127.306 3.645 . . . . 12.0 116.89 -162.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -96.99 -21.06 17.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.016 -2.302 . . . . 35.55 109.762 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -69.75 -41.58 75.04 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 127.127 2.767 . . . . 20.52 110.873 168.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -60.57 141.71 56.3 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 114.976 1.473 . . . . 7.13 114.976 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -132.42 151.65 51.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.375 -2.824 . . . . 36.39 103.375 150.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.1 mt -110.96 141.92 43.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 111.503 -2.59 . . . . 9.55 111.407 166.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 mt -109.53 142.87 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 126.577 1.951 . . . . 13.9 109.194 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -131.5 129.68 41.41 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 123.503 2.865 . . . . 6.86 111.762 157.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.12 44.38 5.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.351 -2.093 . . . . 11.15 109.118 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.81 -30.46 4.62 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 130.49 3.9 . . . . 13.93 114.372 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -94.9 132.73 39.4 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.421 2.058 . . . . 23.92 112.522 -167.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -76.29 137.72 40.08 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.896 -3.002 . . . . 23.23 109.262 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.9 mt -94.42 133.76 37.66 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.022 -2.298 . . . . 9.11 112.658 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.95 173.59 8.14 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 124.9 3.5 . . . . 33.44 111.254 170.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.77 -51.87 10.59 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 124.947 1.404 . . . . 28.37 113.099 -159.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.72 -28.76 73.75 Favored Glycine 0 N--CA 1.43 -1.75 1 O-C-N 131.946 5.779 . . . . 15.0 120.041 -162.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.0 mtt180 -105.66 169.96 8.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 121.421 2.61 . . . . 25.5 111.329 -163.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 27.0 p -83.69 169.73 14.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.634 2.635 . . . . 11.95 114.865 -174.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.2 mt -73.24 -34.03 65.64 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.026 -1.671 . . . . 10.17 110.857 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 t -57.74 -40.02 78.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.472 2.027 . . . . 13.59 116.472 163.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -64.27 -49.89 70.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.518 1.673 . . . . 11.7 115.518 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -57.71 -41.18 81.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.557 1.543 . . . . 12.95 111.194 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 81.96 60.5 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.46 3.504 . . . . 25.45 111.41 -172.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.5 mt -103.0 103.74 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 128.823 2.849 . . . . 14.6 108.878 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -84.88 -179.36 7.07 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.587 2.137 . . . . 33.23 112.075 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -65.39 158.19 27.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.863 -3.648 . . . . 25.97 117.05 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 36.9 mt-10 55.19 27.51 9.75 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 129.473 3.109 . . . . 32.61 114.622 176.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.335 21.8 m -83.22 157.08 22.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 125.427 1.705 . . . . 10.56 114.516 164.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -110.67 95.3 5.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.702 -1.874 . . . . 5.33 113.427 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.17 141.61 35.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.425 1.89 . . . . 11.66 112.316 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -116.4 114.02 23.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.505 -1.372 . . . . 16.3 114.192 -167.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -86.86 115.69 24.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.166 1.913 . . . . 9.96 116.166 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.297 12.3 m -107.92 156.36 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 129.786 3.234 . . . . 9.76 107.386 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 127.729 3.633 . . . . 19.57 106.821 -179.186 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 124.375 2.036 . . . . 17.17 110.69 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -94.03 135.97 34.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.198 -2.519 . . . . 21.89 104.198 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.2 pt -125.31 135.0 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 116.23 -1.843 . . . . 10.83 108.168 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.1 133.29 34.02 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.528 2.047 . . . . 10.61 116.528 166.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 t -126.9 109.14 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.55 -0.907 . . . . 9.13 108.55 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -89.81 133.58 34.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.768 2.427 . . . . 20.55 113.644 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.6 p -89.54 -167.59 1.9 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.596 -1.184 . . . . 11.78 108.142 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mt -70.47 -66.49 0.59 Allowed 'General case' 0 N--CA 1.43 -1.435 1 C-N-CA 135.113 5.365 . . . . 19.31 114.845 166.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -63.74 -81.96 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.563 -2.585 . . . . 23.14 117.265 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.94 46.86 0.29 Allowed Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 117.908 -1.495 . . . . 19.74 110.798 -166.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -140.46 147.62 39.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 118.906 1.353 . . . . 21.93 110.758 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.4 m -129.51 137.03 50.57 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.203 2.43 . . . . 12.33 107.308 166.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.3 mt -105.62 121.7 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 118.821 -2.425 . . . . 17.08 106.009 -175.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.7 m -90.33 120.74 31.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 116.454 -1.736 . . . . 16.3 109.451 172.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.17 134.33 55.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.357 -1.782 . . . . 15.88 109.839 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -88.44 132.03 34.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 114.938 -2.458 . . . . 28.9 107.379 163.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.27 173.32 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 C-N-CA 133.288 4.635 . . . . 12.05 110.702 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -123.53 143.53 41.78 Favored Pre-proline 0 N--CA 1.43 -1.429 1 O-C-N 116.082 -4.136 . . . . 18.17 110.694 174.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -63.71 -28.66 68.75 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 123.761 2.379 . . . . 8.16 117.558 -159.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.2 p -87.34 4.83 41.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 125.836 1.96 . . . . 11.13 110.489 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -72.88 151.81 41.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.856 3.025 . . . . 18.03 110.079 170.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -82.93 158.18 22.72 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 111.706 -2.497 . . . . 10.22 111.009 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.6 -29.02 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 O-C-N 121.07 -1.019 . . . . 12.3 110.641 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -48.99 -39.57 27.2 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.137 4.175 . . . . 36.51 116.834 158.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -89.32 -16.99 29.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.402 -3.936 . . . . 25.66 109.996 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -78.36 -35.28 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 O-C-N 115.51 -4.494 . . . . 8.12 105.521 173.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -69.23 -29.58 67.54 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.675 2.655 . . . . 15.47 112.47 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.13 -34.19 69.98 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.012 -3.555 . . . . 11.45 114.932 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -84.17 -19.41 34.15 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.482 -2.145 . . . . 24.98 115.102 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mt -80.11 -35.02 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 116.048 -4.157 . . . . 9.46 112.86 167.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.278 0.8 OUTLIER -54.11 -52.52 60.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.944 -2.348 . . . . 14.76 113.039 161.093 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -71.99 -27.17 62.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.835 2.107 . . . . 26.29 114.977 -174.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -74.4 -57.74 3.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.65 -3.156 . . . . 30.06 111.431 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.303 33.6 mm-40 -112.4 -29.08 7.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.676 -1.89 . . . . 25.19 110.926 -168.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.01 28.19 42.49 Favored Glycine 0 N--CA 1.429 -1.771 0 O-C-N 118.035 -2.916 . . . . 7.41 117.314 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.427 HD13 HD21 ' A' ' 71' ' ' LEU . 43.4 mt -80.37 119.51 76.62 Favored Pre-proline 0 N--CA 1.43 -1.47 0 CA-C-O 115.318 -2.277 . . . . 9.49 110.718 162.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -65.1 156.71 61.29 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 122.44 1.907 . . . . 11.42 114.003 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -11.96 33.74 Favored 'Trans proline' 0 N--CA 1.434 -2.021 1 C-N-CA 125.844 4.362 . . . . 12.0 120.671 -174.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -77.54 -38.22 49.17 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 125.206 2.431 . . . . 35.55 116.233 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -61.74 -32.31 72.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.141 2.645 . . . . 20.52 118.141 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -70.95 123.27 21.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.716 2.006 . . . . 7.13 115.118 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -132.38 117.09 17.66 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.241 1.837 . . . . 36.39 109.738 165.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.74 115.89 27.43 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.006 1.322 . . . . 9.55 111.988 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.6 mm -96.42 136.01 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 118.25 -0.881 . . . . 13.9 109.209 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -115.4 117.19 29.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.565 2.439 . . . . 6.86 104.844 162.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.91 -93.08 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.075 2.95 . . . . 11.15 108.142 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.48 4.54 7.15 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 126.564 2.031 . . . . 13.93 109.051 171.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.39 144.1 31.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 121.653 2.727 . . . . 23.92 113.969 -171.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -69.46 137.99 53.09 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.399 2.37 . . . . 23.23 117.399 171.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -106.74 118.28 36.26 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.306 -3.996 . . . . 9.11 108.62 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -85.41 151.04 24.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.017 1.865 . . . . 33.44 113.279 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.01 -49.12 72.33 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 118.038 2.607 . . . . 28.37 118.038 -170.162 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.75 77.54 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 119.792 2.677 . . . . 15.0 119.792 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 36.0 mmt180 -76.33 170.56 16.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.75 -3.206 . . . . 25.5 113.104 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.252 69.8 p -100.0 167.36 10.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.678 2.18 . . . . 11.95 113.174 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mt -54.45 -45.87 73.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.338 2.255 . . . . 10.17 111.909 164.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -76.24 -22.18 55.48 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.841 -1.527 . . . . 13.59 112.689 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -67.43 -48.3 67.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.933 2.093 . . . . 11.7 109.152 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 55.5 m-85 -85.08 4.7 32.87 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.995 2.591 . . . . 12.95 117.995 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.9 m120 65.96 45.61 2.42 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.458 2.303 . . . . 25.45 110.079 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.2 mt -98.18 108.62 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 127.034 2.134 . . . . 14.6 107.91 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -107.93 -172.87 2.15 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.923 2.297 . . . . 33.23 106.619 -168.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -73.84 134.5 43.32 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.418 -5.176 . . . . 25.97 109.895 -173.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.326 88.8 mt-10 68.96 30.22 4.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.522 3.014 . . . . 32.61 113.536 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -56.31 149.05 17.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 122.172 2.26 . . . . 10.56 110.56 167.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.0 m -106.71 110.94 23.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.536 2.397 . . . . 5.33 104.794 159.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.8 mt -99.53 145.29 27.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.325 -2.734 . . . . 11.66 107.886 170.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -104.61 116.78 32.66 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.351 -1.468 . . . . 16.3 110.509 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.4 tp -95.62 115.26 27.17 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.497 1.498 . . . . 9.96 107.8 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.5 m -109.04 143.92 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.761 1.743 . . . . 9.76 109.278 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.427 HD21 HD13 ' A' ' 36' ' ' ILE . 46.9 mt . . . . . 0 N--CA 1.429 -1.489 0 CA-C-N 113.699 -1.591 . . . . 19.57 114.701 -168.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptt? . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 120.436 0.16 . . . . 17.17 111.175 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -94.04 131.32 39.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.766 1.765 . . . . 21.89 115.766 170.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -103.13 152.55 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 103.741 -2.688 . . . . 10.83 103.741 163.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -101.82 146.82 27.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.861 2.743 . . . . 10.61 110.239 162.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.15 113.67 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 110.121 -3.218 . . . . 9.13 104.489 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.272 9.2 ttmt -107.12 127.32 53.39 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.472 -3.268 . . . . 20.55 110.852 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -95.97 170.38 9.33 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.93 -2.981 . . . . 11.78 109.736 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -68.27 -31.83 71.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.447 2.017 . . . . 19.31 116.447 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -53.62 -64.63 0.76 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.704 -3.123 . . . . 23.14 111.823 166.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.87 76.1 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 106.57 -2.612 . . . . 19.74 106.57 170.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -140.74 153.89 46.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 113.351 -3.339 . . . . 21.93 104.036 163.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -108.75 87.79 2.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.048 2.718 . . . . 12.33 109.811 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.22 124.11 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 124.208 1.956 . . . . 17.08 112.305 168.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.5 m -99.71 111.1 23.47 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.019 -2.355 . . . . 16.3 111.826 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.19 133.86 51.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.186 -2.34 . . . . 15.88 110.239 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -96.1 106.68 18.89 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 116.667 -1.635 . . . . 28.9 110.727 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.48 158.82 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 128.187 3.429 . . . . 12.05 107.063 -174.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -108.94 157.85 35.79 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 107.139 -1.43 . . . . 18.17 107.139 173.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.82 -8.86 16.93 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 O-C-N 116.008 -2.68 . . . . 8.16 114.239 -168.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.4 p -82.81 1.75 37.56 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 118.432 2.752 . . . . 11.13 118.432 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -83.52 156.88 22.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.726 -3.109 . . . . 18.03 111.116 169.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -93.83 164.23 13.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.471 -3.893 . . . . 10.22 115.048 -174.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.67 -39.09 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 119.782 -1.824 . . . . 12.3 109.917 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.39 -43.78 23.73 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.214 2.672 . . . . 36.51 118.214 165.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -67.08 -43.19 83.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.628 2.085 . . . . 25.66 116.628 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -53.24 -52.99 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.029 1.732 . . . . 8.12 110.469 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -70.79 -19.99 62.64 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.81 -3.681 . . . . 15.47 116.832 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.08 65.69 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.872 -4.267 . . . . 11.45 115.056 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -84.51 -28.02 27.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.033 2.933 . . . . 24.98 114.513 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.7 mt -72.89 -44.91 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.168 -1.378 . . . . 9.46 111.229 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -52.14 -50.13 62.35 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.862 2.912 . . . . 14.76 118.862 165.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -49.59 -48.47 48.73 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.974 1.842 . . . . 26.29 115.974 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -78.67 -71.76 0.42 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.088 3.328 . . . . 30.06 115.488 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -74.15 -35.26 64.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.513 -3.867 . . . . 25.19 116.799 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.47 42.73 7.72 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 127.676 3.931 . . . . 7.41 113.433 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.4 mt -104.44 137.72 19.31 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 102.822 -3.029 . . . . 9.49 102.822 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -82.48 146.78 13.83 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 CA-C-N 124.813 2.755 . . . . 11.42 108.821 -174.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -70.78 -3.37 12.55 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 124.265 2.559 . . . . 12.0 115.806 -162.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.42 -22.15 19.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.769 -2.457 . . . . 35.55 110.667 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -80.16 -25.86 39.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.456 3.102 . . . . 20.52 109.794 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HB3' HD11 ' A' ' 69' ' ' LEU . 76.8 mt-30 -71.7 121.73 19.37 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.786 2.034 . . . . 7.13 112.071 170.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -123.1 116.7 23.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.953 1.835 . . . . 36.39 111.268 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.1 tp -102.61 116.41 32.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.953 -1.476 . . . . 9.55 111.976 -166.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mm -103.79 117.17 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 125.92 1.688 . . . . 13.9 109.022 -172.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -97.03 114.44 26.07 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 120.919 1.69 . . . . 6.86 108.93 161.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.89 -98.09 0.06 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 123.892 0.877 . . . . 11.15 111.397 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.85 12.06 8.25 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 127.321 2.391 . . . . 13.93 113.863 166.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -102.19 126.05 49.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.561 -3.905 . . . . 23.92 105.837 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -85.43 126.81 34.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 125.157 1.535 . . . . 23.23 108.059 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.8 mt -90.14 144.86 25.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.44 2.543 . . . . 9.11 116.003 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -100.91 146.76 26.94 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.666 -4.396 . . . . 33.44 110.077 -168.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -45.17 -54.45 6.87 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 129.114 2.965 . . . . 28.37 118.373 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.54 24.56 8.34 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 129.324 3.345 . . . . 15.0 114.593 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -115.63 171.75 7.55 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.849 -1.537 . . . . 25.5 106.849 172.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.8 p -104.86 -177.45 3.37 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.311 -0.859 . . . . 11.95 112.195 172.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.8 mt -80.31 -28.01 38.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.309 -1.769 . . . . 10.17 110.541 169.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -65.95 -43.18 88.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.72 -3.113 . . . . 13.59 116.437 170.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.298 10.8 m-20 -49.75 -39.84 38.98 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.241 2.682 . . . . 11.7 118.241 165.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -94.29 -18.72 21.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.549 -2.594 . . . . 12.95 116.88 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 73.57 54.52 0.11 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.418 2.949 . . . . 25.45 110.104 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mt -93.83 120.7 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 113.73 -1.577 . . . . 14.6 109.487 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -89.48 168.76 11.94 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.992 1.853 . . . . 33.23 108.406 -167.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -64.12 153.95 36.11 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.815 -3.678 . . . . 25.97 109.764 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 41.23 35.11 0.37 Allowed 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 113.808 -5.557 . . . . 32.61 118.621 -169.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -91.88 129.24 37.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.572 -3.205 . . . . 10.56 108.341 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -87.77 122.54 31.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.832 1.049 . . . . 5.33 113.832 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.341 1.5 mt -101.63 149.8 23.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.086 -2.259 . . . . 11.66 110.255 170.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -98.22 130.93 44.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.491 -1.38 . . . . 16.3 107.539 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 41' ' ' GLN . 40.5 tp -114.46 115.58 27.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.47 -2.789 . . . . 9.96 103.47 -171.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.11 164.98 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.518 -2.03 . . . . 9.76 105.518 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.6 mt . . . . . 0 N--CA 1.431 -1.415 0 CA-C-O 123.941 1.829 . . . . 19.57 109.787 177.855 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 108.957 -0.757 . . . . 17.17 108.957 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -103.34 144.7 31.01 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 116.223 -4.048 . . . . 21.89 111.849 -176.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.83 160.69 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 109.095 -3.684 . . . . 10.83 107.901 164.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -125.19 112.56 16.59 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.088 2.743 . . . . 10.61 105.558 -166.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 67' ' ' LEU . 48.2 t -104.94 125.42 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.817 -1.179 . . . . 9.13 107.817 -174.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.445 ' HG2' HG23 ' A' ' 12' ' ' THR . 79.6 mttt -121.3 127.18 51.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.419 2.372 . . . . 20.55 111.621 -167.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.439 HG22 HD23 ' A' ' 69' ' ' LEU . 30.3 p -70.67 169.86 13.52 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 112.642 -2.072 . . . . 11.78 111.047 168.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.3 mt -81.59 -12.69 58.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.921 -2.987 . . . . 19.31 112.55 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -91.27 -37.32 13.37 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 124.199 1.952 . . . . 23.14 110.431 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.39 38.05 0.35 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 116.53 -2.261 . . . . 19.74 111.871 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -98.99 138.74 35.66 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.741 -2.688 . . . . 21.93 103.741 172.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.445 HG23 ' HG2' ' A' ' 6' ' ' LYS . 76.1 m -114.97 122.81 47.41 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.603 -1.31 . . . . 12.33 108.572 -172.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -101.47 128.76 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 101.721 -3.437 . . . . 17.08 101.721 -170.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.6 m -112.59 112.76 24.51 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.461 2.076 . . . . 16.3 111.999 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.264 73.0 mt -116.25 158.91 22.61 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 111.839 -2.437 . . . . 15.88 112.685 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -113.39 117.52 31.99 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.77 -2.678 . . . . 28.9 103.77 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.23 154.87 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 115.447 -0.797 . . . . 12.05 108.874 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -94.66 147.46 33.23 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 117.517 -1.23 . . . . 18.17 109.173 170.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -66.15 -8.66 20.9 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 127.629 3.76 . . . . 8.16 118.994 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -100.18 12.5 36.85 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 129.642 4.339 . . . . 11.13 120.847 164.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.55 163.99 26.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.141 -1.424 . . . . 18.03 111.47 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.0 p -104.25 164.45 11.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.624 2.083 . . . . 10.22 116.624 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.1 mm -63.57 -36.09 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.943 2.497 . . . . 12.3 111.814 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -53.52 -45.08 69.62 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.48 1.659 . . . . 36.51 115.48 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.17 -41.52 94.58 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.822 2.849 . . . . 25.66 114.729 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.56 -52.99 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 118.682 -2.511 . . . . 8.12 105.635 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -58.69 -35.37 72.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.579 2.609 . . . . 15.47 116.014 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.28 94.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.776 -1.827 . . . . 11.45 114.447 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -74.28 -26.59 60.29 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 115.637 -2.125 . . . . 24.98 108.775 -174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.9 mt -66.92 -29.75 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 124.895 2.283 . . . . 9.46 110.599 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -66.91 -48.3 69.13 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.96 -4.212 . . . . 14.76 114.463 175.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -62.36 -48.39 79.99 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.397 1.999 . . . . 26.29 116.397 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -69.95 -67.15 0.51 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.445 2.069 . . . . 30.06 109.707 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.04 -22.12 31.38 Favored 'General case' 0 N--CA 1.43 -1.425 1 O-C-N 115.838 -4.289 . . . . 25.19 118.75 -165.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.08 27.9 14.92 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 126.106 1.813 . . . . 7.41 111.874 171.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 36' ' ' ILE . 11.1 mt -104.82 125.06 34.82 Favored Pre-proline 0 N--CA 1.43 -1.45 0 C-N-CA 125.908 1.683 . . . . 9.49 109.35 -173.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.65 146.33 30.31 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 122.91 2.075 . . . . 11.42 114.748 -176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.98 -7.27 12.24 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 124.908 2.788 . . . . 12.0 111.269 -162.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.74 -19.04 64.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.024 2.93 . . . . 35.55 114.166 169.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -104.91 -10.32 17.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.558 2.743 . . . . 20.52 109.102 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -94.65 137.12 34.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.468 -2.02 . . . . 7.13 106.068 -173.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -121.81 140.98 51.69 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.704 -1.591 . . . . 36.39 106.704 162.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.26 136.64 54.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.922 -1.111 . . . . 9.55 108.004 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.8 mm -118.34 129.46 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.058 2.143 . . . . 13.9 110.904 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -128.46 117.23 20.98 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.835 -3.666 . . . . 6.86 108.328 169.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.34 . . 58.37 -91.56 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.416 1.887 . . . . 11.15 114.338 -166.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.18 26.08 2.33 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.256 -2.153 . . . . 13.93 112.309 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -115.12 155.33 27.29 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.119 2.568 . . . . 23.92 104.177 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -114.14 137.09 52.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.145 -2.847 . . . . 23.23 106.163 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.521 HD22 ' CE2' ' A' ' 59' ' ' TYR . 30.1 mt -81.77 154.26 26.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.848 2.166 . . . . 9.11 116.848 -167.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -102.11 157.31 16.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.994 2.33 . . . . 33.44 111.541 172.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -76.75 -52.34 9.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 118.789 2.885 . . . . 28.37 118.789 -161.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.82 24.49 5.15 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 116.908 -2.568 . . . . 15.0 118.384 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -90.23 167.29 12.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.952 2.876 . . . . 25.5 111.125 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.1 p -90.24 166.85 13.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.694 -2.504 . . . . 11.95 116.083 171.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.483 HD22 ' H ' ' A' ' 56' ' ' LEU . 2.8 mm? -54.15 -31.94 53.95 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.658 -1.901 . . . . 10.17 114.346 158.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -74.72 -42.08 58.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.006 -1.077 . . . . 13.59 109.619 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -47.95 -34.37 9.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 114.979 -2.438 . . . . 11.7 115.03 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.521 ' CE2' HD22 ' A' ' 50' ' ' LEU . 93.3 m-85 -104.89 -0.87 26.64 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 121.96 2.164 . . . . 12.95 107.273 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.5 m120 71.6 46.25 0.41 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.738 2.815 . . . . 25.45 105.579 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mt -82.6 106.67 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 O-C-N 117.998 -2.939 . . . . 14.6 108.792 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -96.07 -175.11 3.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.148 1.53 . . . . 33.23 111.02 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -65.76 141.91 58.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 124.674 3.397 . . . . 25.97 112.851 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.362 15.3 tt0 80.19 21.08 0.52 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.202 2.601 . . . . 32.61 113.993 174.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.6 m -80.69 144.76 32.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.243 3.417 . . . . 10.56 113.243 -174.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -98.78 101.97 13.55 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.212 2.605 . . . . 5.33 115.009 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.6 mp -99.94 130.8 46.15 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.119 -3.488 . . . . 11.66 109.233 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.261 17.2 m-70 -101.01 142.91 31.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.786 -2.446 . . . . 16.3 108.755 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.439 HD23 HG22 ' A' ' 7' ' ' THR . 19.1 tp -119.86 101.86 8.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.522 -0.763 . . . . 9.96 109.929 -171.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.0 t -96.2 119.0 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 126.493 3.044 . . . . 9.76 108.387 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.43 -1.472 0 O-C-N 119.036 -2.29 . . . . 19.57 105.551 176.973 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 122.937 1.351 . . . . 17.17 112.899 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -94.25 145.93 24.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 127.646 3.593 . . . . 21.89 108.254 177.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -130.88 167.5 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 103.777 -2.675 . . . . 10.83 103.777 172.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -126.81 137.18 53.16 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 102.841 -3.022 . . . . 10.61 102.841 -174.142 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.75 135.44 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.2 -1.778 . . . . 9.13 106.2 171.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -135.38 135.46 40.69 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.486 2.403 . . . . 20.55 112.769 173.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.515 HG22 HD23 ' A' ' 69' ' ' LEU . 68.2 p -77.87 173.07 12.53 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 113.601 -1.636 . . . . 11.78 113.573 173.048 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.73 -28.23 62.52 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.124 -2.86 . . . . 19.31 112.524 -172.541 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.6 p -75.11 -36.5 61.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.357 -3.339 . . . . 23.14 109.953 166.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.12 42.25 0.37 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 120.972 3.149 . . . . 19.74 120.972 170.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -88.98 115.51 26.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.844 1.794 . . . . 21.93 115.844 176.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 m -92.18 114.24 26.73 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.162 2.585 . . . . 12.33 108.343 -165.27 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.0 mt -105.07 102.83 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 106.343 -1.725 . . . . 17.08 106.343 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -87.42 115.52 24.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 116.062 1.875 . . . . 16.3 116.062 175.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.7 mt -123.95 151.44 43.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.246 -1.835 . . . . 15.88 115.396 -174.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.5 138.55 31.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.388 1.055 . . . . 28.9 109.651 176.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.305 0.1 OUTLIER -144.84 161.43 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.85 -1.907 . . . . 12.05 105.85 170.235 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -103.23 165.84 12.88 Favored Pre-proline 0 N--CA 1.429 -1.477 0 CA-C-O 115.685 -2.103 . . . . 18.17 106.721 164.155 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.39 -9.64 14.94 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 124.829 2.76 . . . . 8.16 115.342 -178.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 p -84.13 -19.02 34.91 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 129.766 4.416 . . . . 11.13 109.263 169.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -61.17 149.84 36.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 118.44 -1.304 . . . . 18.03 114.395 167.257 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.292 35.5 p -78.17 174.8 10.79 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.068 -3.52 . . . . 10.22 116.06 171.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 50' ' ' LEU . 28.7 mt -93.59 -17.42 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 117.224 -3.423 . . . . 12.3 107.743 -176.166 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -72.46 -40.57 66.89 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 131.751 4.02 . . . . 36.51 107.298 172.599 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -51.41 -49.82 60.86 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 130.969 3.708 . . . . 25.66 112.457 169.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.18 -52.25 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 124.371 1.044 . . . . 8.12 113.075 173.02 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.73 -29.55 70.08 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 126.45 1.9 . . . . 15.47 111.066 -178.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.77 -27.24 62.82 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 115.221 -2.591 . . . . 11.45 116.56 175.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -72.41 -18.65 61.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.531 1.678 . . . . 24.98 115.531 168.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.3 mt -75.38 -27.96 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 112.494 0.553 . . . . 9.46 112.494 170.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.341 18.1 tt0 -52.31 -42.85 64.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.314 1.968 . . . . 14.76 116.314 160.427 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -78.11 -49.01 14.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.551 1.54 . . . . 26.29 110.116 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -79.63 -58.8 3.01 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.917 2.932 . . . . 30.06 118.917 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.313 6.6 mm-40 -74.53 -44.05 52.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 113.478 0.918 . . . . 25.19 113.478 -177.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.76 53.96 3.05 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 128.369 2.89 . . . . 7.41 107.372 -171.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -118.18 120.1 32.68 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 102.384 -3.191 . . . . 9.49 102.384 174.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -72.85 154.48 53.62 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 CA-C-N 122.825 2.045 . . . . 11.42 114.094 176.375 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -62.48 -16.47 52.27 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 N-CA-C 118.666 2.525 . . . . 12.0 118.666 -173.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -76.24 -31.32 58.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 117.607 -1.187 . . . . 35.55 111.948 -174.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -78.4 -18.07 55.53 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 127.4 2.937 . . . . 20.52 114.447 170.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -82.02 122.57 27.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.919 -1.738 . . . . 7.13 114.577 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -111.29 120.8 43.46 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.412 -2.44 . . . . 36.39 104.412 166.121 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.7 mt -96.32 106.96 19.25 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.339 -2.1 . . . . 9.55 112.26 164.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -89.53 145.28 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 O-C-N 125.619 1.825 . . . . 13.9 108.059 173.066 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -122.83 107.78 12.26 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.086 -1.82 . . . . 6.86 106.086 170.203 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.0 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.4 3.48 . . . . 11.15 111.817 -160.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.74 1.08 9.33 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 116.629 -3.795 . . . . 13.93 114.937 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -102.45 126.88 49.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.717 -2.637 . . . . 23.92 113.349 177.095 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -72.59 125.3 27.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.205 1.821 . . . . 23.23 111.168 171.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.506 HD22 ' CD2' ' A' ' 59' ' ' TYR . 63.4 mt -81.92 166.3 20.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.54 1.064 . . . . 9.11 110.479 -174.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -98.65 158.18 15.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.868 -1.77 . . . . 33.44 113.02 167.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.58 -56.25 6.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.286 2.234 . . . . 28.37 112.163 -174.145 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.45 13.93 31.93 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 118.272 -2.768 . . . . 15.0 118.852 -175.154 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -106.79 159.15 16.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.619 2.368 . . . . 25.5 107.401 172.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -103.37 170.89 7.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 111.385 -2.643 . . . . 11.95 112.874 -173.005 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.411 HD22 ' H ' ' A' ' 56' ' ' LEU . 1.3 mm? -58.35 -43.14 88.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 126.18 2.175 . . . . 10.17 111.654 174.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -53.84 -35.2 61.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.686 2.794 . . . . 13.59 115.994 174.65 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 14.9 m-20 -80.91 -25.25 37.66 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 112.763 -3.494 . . . . 11.7 114.51 -171.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.506 ' CD2' HD22 ' A' ' 50' ' ' LEU . 80.4 m-85 -95.8 -10.32 29.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 128.879 3.862 . . . . 12.95 110.538 171.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.2 m120 77.72 45.64 0.07 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.542 3.537 . . . . 25.45 113.583 173.496 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -74.56 140.23 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 127.788 2.435 . . . . 14.6 109.141 170.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -97.79 175.98 5.97 Favored 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 132.926 4.49 . . . . 33.23 108.759 178.321 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -68.35 156.11 38.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.094 1.887 . . . . 25.97 116.094 162.077 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 56.62 17.58 3.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.12 1.438 . . . . 32.61 114.1 -178.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -85.03 154.05 22.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.915 -2.991 . . . . 10.56 110.262 177.635 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -99.73 109.96 22.38 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 111.979 -2.373 . . . . 5.33 114.517 -178.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -86.1 156.38 20.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 128.773 3.795 . . . . 11.66 110.111 171.262 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -112.07 140.57 46.64 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 116.915 -3.616 . . . . 16.3 109.014 178.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.515 HD23 HG22 ' A' ' 7' ' ' THR . 48.8 tp -110.53 119.55 39.54 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.854 -1.975 . . . . 9.96 110.484 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.45 135.18 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 101.855 -3.387 . . . . 9.76 101.855 -178.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.429 -1.487 0 N-CA-C 104.555 -2.387 . . . . 19.57 104.555 -179.016 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 114.851 -2.5 . . . . 17.17 116.933 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -90.62 132.57 35.68 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.964 -1.493 . . . . 21.89 107.101 -179.267 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -119.64 153.28 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.938 -1.875 . . . . 10.83 105.938 162.718 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -115.18 135.22 54.42 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.409 -2.682 . . . . 10.61 110.628 177.369 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -100.8 123.78 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.369 -2.707 . . . . 9.13 107.487 176.193 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -108.8 128.28 54.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.458 1.099 . . . . 20.55 108.117 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.3 p -81.17 173.76 12.22 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 117.603 2.446 . . . . 11.78 117.603 -177.334 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.6 mt -67.56 -27.46 66.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.42 -2.05 . . . . 19.31 114.772 166.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -74.08 -48.78 27.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.501 2.32 . . . . 23.14 114.907 175.108 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 68.06 0.32 Allowed Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.483 -1.447 . . . . 19.74 109.483 178.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -139.63 160.35 40.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.927 -1.511 . . . . 21.93 111.259 164.101 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -124.27 109.61 13.59 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.008 2.068 . . . . 12.33 112.54 -166.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mp -96.96 132.01 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.477 -2.416 . . . . 17.08 104.477 -173.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.302 31.6 m -88.53 96.11 10.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.232 0.958 . . . . 16.3 112.891 -178.031 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.39 119.64 39.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.839 -1.944 . . . . 15.88 110.55 -169.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.79 123.01 32.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.958 -2.339 . . . . 28.9 114.772 169.059 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.34 154.06 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.744 2.818 . . . . 12.05 115.088 -172.412 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -107.57 158.33 33.54 Favored Pre-proline 0 N--CA 1.43 -1.435 0 CA-C-O 115.771 -2.061 . . . . 18.17 112.063 173.927 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.51 -21.45 40.07 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 123.314 2.219 . . . . 8.16 117.216 -175.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -67.88 -11.84 59.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.692 3.597 . . . . 11.13 114.291 172.033 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -79.61 133.6 36.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.683 2.793 . . . . 18.03 113.592 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.8 p -74.2 154.43 39.04 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.881 1.672 . . . . 10.22 110.019 168.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 54' ' ' ARG . 4.3 mp -76.28 -9.24 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.528 -3.233 . . . . 12.3 114.778 174.12 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.01 -35.83 61.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 112.983 -3.389 . . . . 36.51 112.264 162.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -58.95 -42.28 89.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.17 2.414 . . . . 25.66 113.665 173.262 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -66.65 -34.38 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 113.472 -1.695 . . . . 8.12 112.461 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -71.07 -30.5 66.65 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.971 2.319 . . . . 15.47 111.759 -179.617 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.09 -25.94 63.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.472 2.309 . . . . 11.45 114.917 174.5 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -88.22 -29.84 20.16 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.633 2.159 . . . . 24.98 109.1 -176.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.6 mt -74.65 -37.31 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 118.502 -2.624 . . . . 9.46 116.048 169.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -47.42 -38.33 13.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 119.436 3.125 . . . . 14.76 119.436 159.214 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.273 10.9 t70 -71.77 -53.73 12.45 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 114.816 -2.516 . . . . 26.29 107.137 -176.14 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -71.75 -57.7 4.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.447 2.299 . . . . 30.06 112.483 -172.638 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -92.83 -38.5 11.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.567 -0.901 . . . . 25.19 108.567 -166.406 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.26 37.54 5.34 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 120.619 3.008 . . . . 7.41 120.619 -173.167 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -98.61 127.6 35.32 Favored Pre-proline 0 N--CA 1.429 -1.476 0 O-C-N 119.619 -2.106 . . . . 9.49 108.594 171.477 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.13 139.21 54.81 Favored 'Trans proline' 0 C--N 1.3 -1.997 1 CA-C-O 110.134 -4.194 . . . . 11.42 110.816 175.266 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -82.5 -7.44 11.7 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 CA-C-N 127.836 3.834 . . . . 12.0 117.129 -161.299 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -67.36 -32.68 73.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.165 3.786 . . . . 35.55 113.412 169.603 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -68.7 -50.45 50.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 111.41 -2.632 . . . . 20.52 116.251 168.092 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -59.69 145.07 46.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 118.891 2.923 . . . . 7.13 118.891 -168.006 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -123.65 120.95 34.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 124.434 3.288 . . . . 36.39 109.523 167.181 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 43' ' ' LEU . 35.6 mt -103.97 121.45 43.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.633 -1.988 . . . . 9.55 105.633 -178.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -118.13 129.26 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 102.436 -3.172 . . . . 13.9 102.436 -169.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -104.62 106.15 16.53 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.532 -3.855 . . . . 6.86 106.77 170.09 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 72.5 -91.09 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 125.255 2.455 . . . . 11.15 116.748 -171.398 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.64 -19.24 4.18 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 111.716 -2.493 . . . . 13.93 111.966 168.482 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -88.67 121.42 31.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.181 -3.541 . . . . 23.92 111.375 -166.136 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -80.12 122.22 26.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.323 -3.986 . . . . 23.23 109.191 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.52 134.92 46.84 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 128.35 3.531 . . . . 9.11 115.593 175.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -95.56 130.18 42.5 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.542 3.137 . . . . 33.44 111.583 -178.003 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.12 -42.41 69.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 110.944 -2.844 . . . . 28.37 111.703 -165.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.6 4.84 85.18 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 118.762 -2.461 . . . . 15.0 114.888 -176.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.49 ' O ' HD12 ' A' ' 23' ' ' ILE 0.27 95.0 mtt180 -95.0 163.65 13.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.005 2.402 . . . . 25.5 106.554 176.679 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.0 p -95.15 166.35 11.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.9 1.815 . . . . 11.95 115.9 168.24 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -64.18 -29.68 70.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.578 2.351 . . . . 10.17 111.835 168.006 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.251 8.5 t -67.73 -42.07 82.48 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.96 -4.213 . . . . 13.59 112.433 178.484 . . . . . . . . 3 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -58.16 -42.84 86.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 117.19 2.293 . . . . 11.7 117.19 174.196 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -82.69 4.92 23.03 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 116.485 2.031 . . . . 12.95 116.485 170.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 m120 48.16 55.03 9.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.456 -2.653 . . . . 25.45 113.744 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.83 111.35 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 125.349 1.655 . . . . 14.6 106.744 -177.419 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -81.33 166.4 20.51 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.502 1.521 . . . . 33.23 111.343 174.059 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -63.06 158.87 18.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.553 1.541 . . . . 25.97 114.378 -171.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.289 38.5 mt-10 58.86 24.66 12.68 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.575 2.131 . . . . 32.61 116.534 -177.375 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m -77.71 125.63 29.63 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.113 -1.617 . . . . 10.56 113.687 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.9 m -80.06 126.48 31.12 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.593 1.557 . . . . 5.33 112.002 174.601 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.405 HD13 HD22 ' A' ' 43' ' ' LEU . 80.3 mt -103.69 150.2 24.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.569 1.148 . . . . 11.66 108.527 169.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -101.43 124.38 47.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.318 -1.734 . . . . 16.3 106.318 170.051 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.8 tp -96.86 128.09 43.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.282 -1.747 . . . . 9.96 106.282 171.172 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.63 155.23 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.735 -2.32 . . . . 9.76 104.735 168.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 43.5 mt . . . . . 0 N--CA 1.43 -1.462 0 O-C-N 121.027 -1.045 . . . . 19.57 109.418 175.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 122.88 1.324 . . . . 17.17 111.403 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.76 110.65 21.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.134 -1.604 . . . . 21.89 108.132 -175.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -84.81 145.96 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.195 -1.566 . . . . 10.83 110.841 153.667 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -123.15 89.21 3.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.489 -2.782 . . . . 10.61 103.489 -172.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 62.0 t -80.7 123.17 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.181 -1.414 . . . . 9.13 107.181 179.309 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -114.21 119.26 36.43 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.497 3.522 . . . . 20.55 110.977 -172.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.7 p -77.91 161.56 27.48 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.082 -4.761 . . . . 11.78 113.004 -176.948 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.6 mt -78.83 -21.78 47.15 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 117.34 -1.744 . . . . 19.31 109.657 -175.101 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.0 p -70.55 -43.71 68.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.083 -2.886 . . . . 23.14 114.16 173.081 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.66 -2.26 0.21 Allowed Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 118.173 2.029 . . . . 19.74 118.173 178.025 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -91.49 145.49 24.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.756 -1.222 . . . . 21.93 110.955 -167.649 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.6 m -115.63 115.35 26.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.873 -2.269 . . . . 12.33 104.873 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.8 mt -96.52 105.51 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.735 2.414 . . . . 17.08 107.318 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -74.59 119.92 19.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.563 1.649 . . . . 16.3 110.655 169.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.322 97.8 mt -130.46 134.62 47.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.333 2.968 . . . . 15.88 103.922 168.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.361 2.2 mt-10 -84.86 107.65 17.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 127.511 3.529 . . . . 28.9 113.678 169.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -116.87 171.34 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.031 -2.293 . . . . 12.05 108.978 177.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -114.72 160.29 33.94 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 127.895 2.478 . . . . 18.17 108.03 176.145 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -68.3 -24.5 37.36 Favored 'Trans proline' 0 N--CA 1.434 -1.978 0 O-C-N 116.216 -2.57 . . . . 8.16 112.726 -170.354 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.391 7.1 m -88.12 -2.52 58.65 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.917 -1.739 . . . . 11.13 114.686 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -72.96 158.14 36.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 128.328 3.918 . . . . 18.03 114.84 174.024 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.414 43.1 p -95.47 149.62 21.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.296 -2.229 . . . . 10.22 114.804 -176.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mp -66.06 -37.3 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.513 -1.291 . . . . 12.3 107.513 173.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -50.27 -45.46 54.31 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.296 -2.128 . . . . 36.51 113.906 169.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -84.63 7.21 21.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 123.766 2.984 . . . . 25.66 112.797 177.036 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.269 23.5 t -77.42 -60.04 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 O-C-N 116.746 -3.721 . . . . 8.12 107.255 159.316 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -43.65 -40.66 4.26 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.968 2.581 . . . . 15.47 117.968 175.465 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.315 . . -50.05 -47.47 53.38 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 128.079 2.552 . . . . 11.45 116.697 171.301 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -76.99 -30.94 56.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.102 -2.249 . . . . 24.98 108.252 -175.272 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.84 -31.75 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 O-C-N 115.967 -4.208 . . . . 9.46 112.86 174.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -69.01 -33.34 73.49 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.161 -1.587 . . . . 14.76 109.611 176.038 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -76.16 -51.92 11.17 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.728 1.611 . . . . 26.29 115.109 177.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -76.91 -42.34 39.92 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 119.669 3.211 . . . . 30.06 119.669 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 48.2 mm-40 -106.4 -25.6 11.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.391 1.682 . . . . 25.19 110.69 -178.252 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.4 18.82 51.74 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 120.305 2.882 . . . . 7.41 120.305 175.39 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.2 mt -91.12 126.85 53.72 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 101.32 -3.585 . . . . 9.49 101.32 -175.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -56.06 151.56 41.74 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 N-CA-C 120.639 3.284 . . . . 11.42 120.639 171.515 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -86.02 -22.22 2.36 Favored 'Trans proline' 0 C--N 1.3 -2.014 1 CA-C-N 130.077 4.635 . . . . 12.0 116.128 -161.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -84.12 -23.09 30.87 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.37 2.033 . . . . 35.55 110.821 -174.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -61.52 -28.15 69.11 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.201 2.6 . . . . 20.52 114.385 162.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -87.8 122.93 32.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 116.716 -1.612 . . . . 7.13 112.34 -170.179 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -113.97 131.24 56.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 122.363 2.347 . . . . 36.39 112.181 166.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.53 122.25 39.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.207 -3.433 . . . . 9.55 114.698 171.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.7 mt -106.95 118.58 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.88 -2.267 . . . . 13.9 104.88 172.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' A' ' 50' ' ' LEU . 33.6 t80 -106.04 121.81 44.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.603 1.668 . . . . 6.86 107.978 167.247 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.318 . . 52.55 -99.2 0.08 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.098 1.888 . . . . 11.15 116.098 -174.761 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.26 -17.82 13.18 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 117.554 1.782 . . . . 13.93 117.554 -173.826 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -109.6 133.08 53.52 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.513 2.725 . . . . 23.92 111.236 -165.586 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -79.63 128.25 33.17 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.655 -1.278 . . . . 23.23 108.719 173.622 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 45' ' ' PHE . 23.2 mt -95.05 126.52 40.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.782 2.083 . . . . 9.11 115.856 -165.793 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 54' ' ' ARG . 34.2 tt0 -82.28 139.38 34.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.786 2.232 . . . . 33.44 111.308 171.14 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.24 -50.16 61.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.157 2.583 . . . . 28.37 113.471 -160.168 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.03 3.93 86.53 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 127.385 2.421 . . . . 15.0 113.34 -162.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 51' ' ' GLU 0.284 22.6 mtt180 -85.5 162.52 18.9 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.988 2.115 . . . . 25.5 111.689 172.925 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -88.91 168.4 12.43 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 116.563 -2.055 . . . . 11.95 110.562 178.379 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.94 -25.25 60.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.994 -1.912 . . . . 10.17 111.655 169.275 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.8 t -63.77 -41.61 97.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.652 2.093 . . . . 13.59 116.652 172.041 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -47.31 -46.93 25.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.626 2.631 . . . . 11.7 116.259 175.086 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -86.14 1.24 51.3 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.122 -2.236 . . . . 12.95 115.601 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.37 17.3 m-20 75.98 32.45 0.64 Allowed 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.734 2.683 . . . . 25.45 113.501 169.013 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.56 113.85 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.35 -2.719 . . . . 14.6 109.129 -170.528 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -111.29 -171.11 1.77 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.284 1.992 . . . . 33.23 109.182 -174.017 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -71.36 148.13 47.32 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 115.142 -2.361 . . . . 25.97 112.773 -168.202 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 49.65 29.48 3.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 119.728 3.233 . . . . 32.61 119.728 -165.41 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -68.66 148.26 50.69 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 116.091 1.885 . . . . 10.56 116.091 170.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -104.08 117.63 34.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 121.235 0.541 . . . . 5.33 110.805 171.159 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.37 151.04 25.4 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.364 -3.335 . . . . 11.66 108.343 175.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -93.77 130.03 39.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.35 1.656 . . . . 16.3 115.038 178.11 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.5 tp -109.69 95.12 5.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.315 2.007 . . . . 9.96 112.611 178.666 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -97.24 126.37 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 128.13 2.572 . . . . 9.76 111.807 176.14 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.43 -1.454 0 O-C-N 120.281 -1.512 . . . . 19.57 112.085 177.906 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 107.733 -1.21 . . . . 17.17 107.733 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -112.61 147.18 37.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.206 -1.559 . . . . 21.89 112.09 174.034 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.98 170.77 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.851 -1.907 . . . . 10.83 105.851 164.133 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -131.71 126.1 33.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.432 -3.292 . . . . 10.61 107.825 -175.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.0 t -97.77 118.76 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.983 -2.323 . . . . 9.13 110.138 168.08 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -103.56 137.23 41.91 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.452 -2.795 . . . . 20.55 103.452 -176.175 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 11' ' ' LYS . 48.9 p -97.84 179.79 4.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.504 -0.748 . . . . 11.78 111.685 -168.33 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.94 -33.78 75.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.358 -2.714 . . . . 19.31 113.705 177.142 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.1 p -76.49 -32.13 58.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.176 -2.821 . . . . 23.14 105.643 175.235 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.54 30.03 4.81 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-O 124.096 1.942 . . . . 19.74 116.994 -166.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 7' ' ' THR . 58.8 tttm -84.97 138.92 32.18 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 114.427 -5.16 . . . . 21.93 107.525 160.996 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -109.14 129.11 55.48 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 129.1 2.96 . . . . 12.33 110.923 177.528 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.94 115.01 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.423 1.889 . . . . 17.08 109.183 -174.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.9 m -79.86 124.74 28.92 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.835 -2.416 . . . . 16.3 113.628 175.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.669 HD22 ' HB3' ' A' ' 29' ' ' LYS . 85.5 mt -128.26 134.07 48.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.324 -1.732 . . . . 15.88 106.324 -173.415 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -101.89 111.8 24.19 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.186 1.921 . . . . 28.9 116.186 -173.617 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.24 170.66 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.433 -1.417 . . . . 12.05 111.904 -165.541 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -120.95 162.54 34.62 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 113.696 -3.049 . . . . 18.17 107.584 177.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.32 51.1 Cg_exo -51.77 -21.58 11.79 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 N-CA-C 121.685 3.687 . . . . 8.16 121.685 173.068 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 t -106.81 4.02 27.07 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.01 1.724 . . . . 11.13 113.466 -171.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -75.74 161.69 28.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.385 1.254 . . . . 18.03 114.385 159.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.1 p -103.96 175.41 5.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.565 -1.198 . . . . 10.22 113.797 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.4 mp -71.88 -31.63 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.181 -2.199 . . . . 12.3 109.713 -178.635 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -44.93 -41.69 7.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.547 2.425 . . . . 36.51 117.547 164.616 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -68.9 -26.91 65.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.979 -1.918 . . . . 25.66 114.713 177.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.16 -42.52 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 126.693 1.997 . . . . 8.12 109.729 176.123 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -53.88 -44.27 70.31 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.334 1.605 . . . . 15.47 115.334 171.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.26 -38.48 41.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.145 2.646 . . . . 11.45 118.145 170.211 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.669 ' HB3' HD22 ' A' ' 15' ' ' LEU . 45.9 mttm -75.63 -29.0 59.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 124.598 1.186 . . . . 24.98 111.693 -177.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.94 -33.56 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 122.591 1.186 . . . . 9.46 109.033 175.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -64.26 -53.06 54.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.245 -1.798 . . . . 14.76 115.583 178.38 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -54.0 -53.06 58.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.147 -2.751 . . . . 26.29 115.039 165.774 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -78.43 -71.49 0.43 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.119 1.438 . . . . 30.06 111.732 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -79.18 -25.04 42.83 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 115.692 -4.38 . . . . 25.19 114.94 -167.22 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.61 46.96 4.43 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 128.87 3.128 . . . . 7.41 115.666 -178.543 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.58 132.99 22.85 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 118.793 1.297 . . . . 9.49 113.271 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -67.35 147.77 78.5 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 CA-C-O 110.233 -4.153 . . . . 11.42 118.532 -178.763 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -64.78 -18.95 64.01 Favored 'Trans proline' 0 C--N 1.299 -2.027 2 C-N-CA 130.096 7.197 . . . . 12.0 108.429 -172.146 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.362 7.5 t70 -102.55 -33.39 9.5 Favored 'General case' 0 N--CA 1.429 -1.477 1 CA-C-N 126.383 4.174 . . . . 35.55 108.976 -169.105 . . . . . . . . 3 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -46.89 -41.36 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.809 2.444 . . . . 20.52 113.452 165.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB2' HD11 ' A' ' 69' ' ' LEU . 4.4 pt20 -97.96 148.21 23.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.616 2.627 . . . . 7.13 113.86 178.493 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -136.06 137.51 41.18 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.38 -4.575 . . . . 36.39 108.408 173.588 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.93 143.43 38.18 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.107 -4.121 . . . . 9.55 109.357 -172.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mt -122.52 147.82 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 129.186 2.994 . . . . 13.9 109.342 -177.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -137.59 116.09 12.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 100.257 -3.979 . . . . 6.86 100.257 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.29 -104.01 0.13 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.246 -1.797 . . . . 11.15 113.072 -164.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.06 16.53 5.24 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 107.312 -2.315 . . . . 13.93 107.312 171.063 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -100.89 143.43 31.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 120.878 2.339 . . . . 23.92 107.633 170.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -91.91 133.15 35.94 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.372 3.469 . . . . 23.23 113.447 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.16 157.64 16.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.443 3.021 . . . . 9.11 117.957 -175.294 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -90.83 154.23 19.65 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.846 2.26 . . . . 33.44 111.104 161.76 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -77.05 -47.95 19.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.299 -2.228 . . . . 28.37 108.219 -163.096 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.84 11.46 62.55 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.439 -1.413 . . . . 15.0 114.578 -159.23 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -101.95 146.91 27.19 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.371 2.268 . . . . 25.5 105.361 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 8.4 p -82.07 156.98 24.3 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.24 2.448 . . . . 11.95 113.959 -169.558 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.56 -35.23 72.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.523 -3.236 . . . . 10.17 105.456 -177.105 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.5 t -69.04 -29.24 67.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.816 2.553 . . . . 13.59 113.884 174.139 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -59.44 -56.6 19.95 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.838 -4.289 . . . . 11.7 111.86 176.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -79.96 0.39 31.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.149 0.98 . . . . 12.95 112.677 -177.584 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.428 72.2 m-80 65.9 49.18 1.69 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.843 2.905 . . . . 25.45 118.843 -176.178 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mt -93.34 110.27 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.122 2.569 . . . . 14.6 108.304 179.409 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -96.14 -168.03 1.68 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.602 -1.635 . . . . 33.23 110.407 -172.04 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -72.26 146.05 47.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.891 -1.049 . . . . 25.97 109.389 176.18 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 28.6 mt-10 73.3 30.01 1.59 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.737 -1.208 . . . . 32.61 107.737 170.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 m -90.18 116.89 28.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.567 2.127 . . . . 10.56 108.221 -170.271 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.8 m -72.21 108.08 5.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.486 -3.258 . . . . 5.33 113.73 165.244 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -98.69 166.03 11.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.998 3.319 . . . . 11.66 102.884 173.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -121.19 138.77 54.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.049 -1.657 . . . . 16.3 113.506 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 41' ' ' GLN . 29.6 tp -103.04 121.76 43.23 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.157 -1.423 . . . . 9.96 107.157 -179.249 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.91 131.36 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.995 -2.224 . . . . 9.76 104.995 170.62 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.431 -1.415 0 CA-C-O 122.31 1.052 . . . . 19.57 109.259 -177.932 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 114.604 1.335 . . . . 17.17 114.604 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.25 138.01 52.25 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 118.236 -1.386 . . . . 21.89 109.996 -173.169 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 3' ' ' ILE . 42.3 pt -123.22 151.87 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 123.318 0.647 . . . . 10.83 111.886 170.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -106.71 134.74 49.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.153 -2.217 . . . . 10.61 106.684 -168.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.84 108.62 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 126.785 3.183 . . . . 9.13 107.849 -175.35 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -91.65 129.76 37.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.283 -3.386 . . . . 20.55 116.895 -173.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.65 156.85 16.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.725 -1.954 . . . . 11.78 105.725 173.626 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.76 -49.3 40.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.471 -3.268 . . . . 19.31 113.148 -164.619 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.364 29.8 p -49.69 -79.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.908 2.483 . . . . 23.14 115.176 166.232 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.93 161.34 29.54 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 116.869 -3.645 . . . . 19.74 105.243 -177.629 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HE2' HG22 ' A' ' 13' ' ' ILE . 75.8 tttt 86.23 126.9 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.97 2.508 . . . . 21.93 115.585 166.642 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.7 m -120.22 105.67 11.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.57 2.348 . . . . 12.33 106.897 -175.766 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.417 HG22 ' HE2' ' A' ' 11' ' ' LYS . 12.0 pt -88.02 152.03 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.059 -1.65 . . . . 17.08 112.955 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -111.5 113.06 25.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 113.225 -1.807 . . . . 16.3 110.145 -173.454 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 15' ' ' LEU . 1.3 mm? -108.62 139.38 43.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.951 2.786 . . . . 15.88 107.409 176.595 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -84.3 125.8 32.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.781 -3.075 . . . . 28.9 108.589 172.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -149.82 175.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 117.488 -3.257 . . . . 12.05 110.768 -176.913 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -115.34 148.92 41.88 Favored Pre-proline 0 N--CA 1.429 -1.493 1 O-C-N 116.277 -4.015 . . . . 18.17 109.279 176.583 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -64.6 -8.48 17.49 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 125.735 4.29 . . . . 8.16 115.74 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.8 m -105.76 16.52 25.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.541 -2.022 . . . . 11.13 105.541 177.611 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.84 153.51 25.13 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.523 -2.611 . . . . 18.03 111.921 168.405 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.8 p -87.01 164.61 16.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.517 2.58 . . . . 10.22 105.249 -176.645 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -75.6 -21.9 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 116.708 -3.745 . . . . 12.3 109.796 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.29 -32.6 66.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.731 2.412 . . . . 36.51 113.057 163.672 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -88.37 -21.84 24.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.892 -1.049 . . . . 25.66 110.715 -177.692 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -73.92 -49.56 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 118.104 -2.873 . . . . 8.12 107.023 169.55 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -46.57 -45.18 18.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.45 1.9 . . . . 15.47 112.071 170.403 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.14 95.68 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.634 2.774 . . . . 11.45 111.746 -175.007 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -62.5 -43.22 99.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.223 1.809 . . . . 24.98 113.638 169.186 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 mt -63.19 -38.83 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 116.879 2.177 . . . . 9.46 116.879 171.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.1 -29.24 70.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.317 2.247 . . . . 14.76 111.102 177.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -79.93 -56.59 4.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.904 -2.372 . . . . 26.29 116.412 166.168 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -78.13 -48.43 15.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.622 -1.251 . . . . 30.06 107.622 -156.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 6.1 mm-40 -85.89 -45.66 11.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.931 1.086 . . . . 25.19 113.931 169.745 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.44 66.36 1.65 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 121.789 0.66 . . . . 7.41 111.73 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.7 mt -112.36 118.99 44.68 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 102.066 -3.309 . . . . 9.49 102.066 166.544 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.53 154.64 63.28 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 CA-C-N 124.767 2.738 . . . . 11.42 113.784 -178.244 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -73.52 -13.15 25.01 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 O-C-N 112.611 -4.468 . . . . 12.0 117.906 -165.259 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -92.91 -10.13 37.63 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 125.06 1.475 . . . . 35.55 112.069 175.839 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -84.14 -7.23 59.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.23 -1.544 . . . . 20.52 114.21 168.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -95.64 123.68 39.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 113.937 -2.935 . . . . 7.13 108.663 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.436 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 65.6 ttt180 -105.51 102.21 11.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.167 3.417 . . . . 36.39 106.877 165.404 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.8 mt -90.9 99.17 12.25 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 123.376 2.807 . . . . 9.55 110.693 -177.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.4 mt -104.49 116.71 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 129.369 3.068 . . . . 13.9 109.608 -176.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -93.09 113.74 26.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.944 -2.613 . . . . 6.86 103.944 165.257 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.12 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.527 2.584 . . . . 11.15 116.695 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.02 18.3 1.21 Allowed Glycine 0 N--CA 1.429 -1.775 1 O-C-N 116.049 -4.157 . . . . 13.93 117.054 176.067 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -135.18 142.8 46.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 101.139 -3.652 . . . . 23.92 101.139 171.023 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -96.35 165.89 11.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.613 -3.179 . . . . 23.23 113.528 173.439 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.08 156.96 17.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 127.156 2.785 . . . . 9.11 112.329 -162.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.261 40.2 mt-10 -99.51 141.09 32.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.009 2.338 . . . . 33.44 112.14 -173.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -70.31 -51.26 31.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.668 -3.145 . . . . 28.37 115.615 -154.239 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.46 15.3 41.37 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 123.03 3.972 . . . . 15.0 123.03 171.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -101.44 162.72 12.69 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.47 2.308 . . . . 25.5 109.302 168.327 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.0 p -107.31 172.35 6.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 114.692 1.367 . . . . 11.95 114.692 -169.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 56' ' ' LEU . 93.8 mt -64.39 -35.41 80.81 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.081 -2.262 . . . . 10.17 114.917 166.169 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -54.25 -46.69 72.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.881 2.178 . . . . 13.59 116.881 161.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -59.07 -37.03 76.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 124.23 3.195 . . . . 11.7 115.447 176.086 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -90.55 12.7 17.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.363 -2.711 . . . . 12.95 115.385 173.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.52 6.5 t30 46.61 42.36 11.17 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.95 2.574 . . . . 25.45 117.95 -172.262 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -93.07 99.07 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 118.437 -2.665 . . . . 14.6 108.119 -178.579 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -79.93 176.13 10.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.225 2.61 . . . . 33.23 109.682 172.248 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -71.48 151.61 43.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.248 -2.782 . . . . 25.97 116.549 -174.264 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.29 45.2 mt-10 75.17 11.68 3.47 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.733 2.52 . . . . 32.61 114.687 -173.442 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.309 70.9 m -73.76 145.93 44.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.896 1.331 . . . . 10.56 112.199 -176.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -96.73 123.06 40.31 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.388 -2.695 . . . . 5.33 113.288 173.758 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.305 65.7 tp -126.16 150.08 48.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.137 -2.852 . . . . 11.66 105.974 175.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -111.59 122.47 47.91 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.658 -2.526 . . . . 16.3 112.623 -167.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -98.56 103.17 15.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.223 -2.88 . . . . 9.96 103.223 -178.18 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 42' ' ' ARG 0.257 15.3 t -100.14 168.26 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 110.316 -3.129 . . . . 9.76 111.496 170.998 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tp . . . . . 0 N--CA 1.431 -1.423 0 N-CA-C 107.746 -1.205 . . . . 19.57 107.746 176.264 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptt? . . . . . 0 CA--C 1.489 -1.367 0 CA-C-O 123.058 1.409 . . . . 17.17 111.717 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -96.66 137.29 35.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.978 2.799 . . . . 21.89 112.339 167.03 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.6 pt -119.5 162.29 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 117.349 -3.345 . . . . 10.83 105.87 175.408 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -119.73 136.39 54.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.219 2.208 . . . . 10.61 109.176 -177.088 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.35 103.02 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 102.524 -3.139 . . . . 9.13 102.524 -173.028 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -86.4 118.41 25.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.411 -2.056 . . . . 20.55 108.584 -176.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -84.07 -170.96 3.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.289 1.618 . . . . 11.78 109.267 -173.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.0 -25.37 19.74 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.753 -4.342 . . . . 19.31 109.329 -171.417 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.7 p -90.43 -72.14 0.59 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.232 2.208 . . . . 23.14 115.695 -173.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.8 35.9 0.18 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-O 117.065 -1.964 . . . . 19.74 111.876 177.162 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -122.84 151.58 41.55 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.534 -2.025 . . . . 21.93 105.534 175.923 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.7 m -125.71 121.9 34.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.374 -2.084 . . . . 12.33 105.374 169.299 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.572 HD11 HG23 ' A' ' 30' ' ' ILE 0.305 48.5 pt -103.39 141.56 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.503 -2.623 . . . . 17.08 113.065 -178.61 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -104.08 116.03 31.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.969 -2.234 . . . . 16.3 104.969 -173.148 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.91 133.07 56.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.262 1.392 . . . . 15.88 111.256 175.227 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -106.95 118.21 36.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.459 2.552 . . . . 28.9 108.678 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 m -139.71 145.3 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 131.469 3.908 . . . . 12.05 107.501 -152.704 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.2 147.85 34.55 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 125.305 1.442 . . . . 18.17 107.906 166.769 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.92 -26.3 22.3 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 123.746 2.964 . . . . 8.16 114.565 -177.039 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.0 m -70.12 0.24 6.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.525 2.417 . . . . 11.13 117.525 161.054 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -70.72 142.3 51.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.704 -3.123 . . . . 18.03 117.674 163.834 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.269 7.3 p -73.9 158.61 34.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.644 2.778 . . . . 10.22 109.759 178.601 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 50' ' ' LEU 0.284 26.9 mm -67.07 -34.45 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 119.283 0.947 . . . . 12.3 111.884 173.38 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -47.94 -42.7 28.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.623 -2.548 . . . . 36.51 115.306 162.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -71.91 -27.36 62.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.546 -3.846 . . . . 25.66 112.456 -178.335 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -68.38 -49.0 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 130.55 3.54 . . . . 8.12 110.639 172.114 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -55.16 -38.62 68.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.569 2.063 . . . . 15.47 116.569 173.243 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.46 -35.71 53.11 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.13 -1.606 . . . . 11.45 114.974 173.245 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -76.9 -31.5 56.77 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 117.276 2.324 . . . . 24.98 117.276 176.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.572 HG23 HD11 ' A' ' 13' ' ' ILE . 1.2 mt -70.23 -32.63 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.58 1.552 . . . . 9.46 109.282 172.295 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -74.14 -36.0 64.11 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.36 -1.462 . . . . 14.76 109.802 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.99 -51.28 62.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.068 1.413 . . . . 26.29 112.476 177.508 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -80.62 -55.37 4.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.256 -3.403 . . . . 30.06 112.132 -168.662 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.403 ' HB2' HG13 ' A' ' 36' ' ' ILE . 69.3 mm-40 -94.73 -34.36 12.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.316 0.962 . . . . 25.19 111.485 -167.618 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.72 54.06 1.99 Allowed Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 127.114 2.292 . . . . 7.41 113.276 -177.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.456 HD13 HG21 ' A' ' 36' ' ' ILE . 14.0 mt -113.37 103.45 55.5 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 113.671 -3.061 . . . . 9.49 104.121 -175.601 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -57.56 141.45 95.24 Favored 'Trans proline' 0 C--N 1.3 -1.999 1 CA-C-N 131.862 5.272 . . . . 11.42 116.688 -178.522 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.267 19.7 Cg_endo -70.72 -18.82 32.23 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 125.018 3.812 . . . . 12.0 114.177 -159.785 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.26 -32.07 58.65 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.195 2.902 . . . . 35.55 108.552 -178.387 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -73.35 -5.73 41.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.493 -2.629 . . . . 20.52 116.322 172.156 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -105.39 139.86 39.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.709 1.243 . . . . 7.13 108.682 -177.6 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -138.58 118.04 12.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.703 -3.123 . . . . 36.39 109.276 162.497 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.2 mt -86.38 129.67 34.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 113.975 1.102 . . . . 9.55 113.975 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mt -120.12 135.59 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 117.829 -1.082 . . . . 13.9 113.706 177.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -106.22 103.18 12.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.841 -2.281 . . . . 6.86 104.841 172.803 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.359 . . 62.9 -110.89 0.35 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.242 1.817 . . . . 11.15 113.646 -170.901 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.19 -8.31 78.62 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 121.19 3.236 . . . . 13.93 121.19 169.625 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -115.47 115.65 26.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.745 1.26 . . . . 23.92 110.502 -165.037 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -71.73 133.93 45.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.714 2.406 . . . . 23.23 108.904 170.542 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -95.38 137.53 34.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.423 -2.227 . . . . 9.11 112.332 -177.618 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HB3' ' HG3' ' A' ' 54' ' ' ARG . 38.7 tt0 -88.06 139.8 30.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 123.503 2.865 . . . . 33.44 109.14 174.502 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -32.39 -74.52 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 136.12 5.768 . . . . 28.37 113.407 172.478 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.03 43.13 3.14 Favored Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 117.853 -2.118 . . . . 15.0 113.738 -171.403 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.402 ' HG3' ' HB3' ' A' ' 51' ' ' GLU . 18.4 mtt180 -130.49 157.25 43.17 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.861 2.064 . . . . 25.5 107.779 174.047 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.0 p -87.33 176.32 7.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 124.089 3.131 . . . . 11.95 113.243 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.21 -43.03 92.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 130.064 3.346 . . . . 10.17 106.848 161.244 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -64.67 -31.95 73.4 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 115.2 1.555 . . . . 13.59 115.2 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -60.78 -55.22 35.72 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.0 -2.313 . . . . 11.7 112.995 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -71.61 15.32 0.14 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 114.489 -2.672 . . . . 12.95 116.816 166.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 41.39 40.0 1.15 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.98 2.627 . . . . 25.45 116.939 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -82.15 116.35 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.011 -1.848 . . . . 14.6 106.011 -178.924 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.454 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 55.8 mt-30 -98.2 -150.59 0.36 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.841 -2.412 . . . . 33.23 108.883 -175.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 62' ' ' GLN . 12.5 pttp -76.73 156.02 32.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.956 -1.474 . . . . 25.97 111.087 -167.413 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 16.8 mt-10 65.3 9.1 5.39 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.029 1.732 . . . . 32.61 112.843 164.025 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -65.29 132.79 49.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.135 -3.478 . . . . 10.56 117.96 177.353 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.291 85.3 m -82.97 113.55 20.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.132 1.901 . . . . 5.33 116.132 169.161 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.79 156.0 18.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.147 2.403 . . . . 11.66 108.824 171.658 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -107.46 126.99 53.19 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.385 -2.45 . . . . 16.3 104.385 -171.622 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.6 tp -103.82 124.66 49.34 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 116.119 -4.113 . . . . 9.96 110.26 178.119 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.267 46.0 t -111.92 147.86 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 101.968 -3.345 . . . . 9.76 101.968 -171.916 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.43 -1.461 0 CA-C-O 119.719 -0.181 . . . . 19.57 111.056 170.522 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.48 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 14.1 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 113.616 0.969 . . . . 17.17 113.616 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.286 14.5 pt20 -90.53 134.15 34.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 121.558 1.981 . . . . 21.89 114.911 172.66 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.8 pt -132.06 166.61 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.671 -1.603 . . . . 10.83 106.671 177.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -107.3 131.73 53.89 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.401 -3.937 . . . . 10.61 112.484 177.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.0 t -116.57 109.32 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.258 -1.377 . . . . 9.13 110.171 170.075 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -99.16 117.62 34.04 Favored 'General case' 0 N--CA 1.429 -1.481 1 CA-C-O 130.117 4.77 . . . . 20.55 110.098 -172.734 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 30.7 p -75.16 164.66 26.26 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 110.738 -7.477 . . . . 11.78 114.455 -171.94 . . . . . . . . 3 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 70' ' ' VAL . 4.8 tp -53.16 -52.08 59.93 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.177 2.191 . . . . 19.31 115.603 174.701 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -59.0 -70.4 0.15 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 128.783 3.802 . . . . 23.14 114.599 169.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.49 59.01 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.774 0 O-C-N 118.988 -2.32 . . . . 19.74 113.834 156.448 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.33 85.7 tttt -108.06 134.18 51.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.398 -2.236 . . . . 21.93 106.737 173.503 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.2 m -97.45 111.67 23.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.439 -1.71 . . . . 12.33 108.35 173.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 13' ' ' ILE . 29.5 pt -108.75 127.33 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.312 -1.492 . . . . 17.08 113.178 172.491 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.3 m -86.33 122.51 30.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.572 1.549 . . . . 16.3 110.506 -178.365 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -110.53 123.04 49.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.251 3.021 . . . . 15.88 111.05 -172.723 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -102.89 117.4 34.54 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.638 3.113 . . . . 28.9 107.087 171.666 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.72 167.34 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 110.404 -3.089 . . . . 12.05 110.341 -174.795 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -110.81 164.88 13.81 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 113.885 -2.96 . . . . 18.17 115.782 165.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.283 60.7 Cg_endo -69.83 -24.91 28.82 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 CA-C-N 127.813 3.826 . . . . 8.16 113.279 -171.408 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.256 3.9 m -82.99 -5.57 59.15 Favored 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 133.819 4.847 . . . . 11.13 114.464 -176.363 . . . . . . . . 3 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -59.67 126.41 27.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.377 2.271 . . . . 18.03 114.104 167.05 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.4 p -77.3 158.15 30.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.056 -2.277 . . . . 10.22 111.59 170.609 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.544 HG23 HD12 ' A' ' 43' ' ' LEU 0.295 35.8 mm -60.91 -34.55 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.829 -1.169 . . . . 12.3 113.732 176.662 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -33.96 -60.69 0.38 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.99 -3.569 . . . . 36.51 117.775 157.689 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -70.67 -31.86 68.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 110.75 -2.932 . . . . 25.66 111.024 -177.615 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 22' ' ' THR . 90.9 t -66.21 -43.85 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.093 -1.629 . . . . 8.12 112.435 -178.121 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -57.46 -42.79 83.23 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.149 2.18 . . . . 15.47 113.771 176.037 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.329 . . -64.45 -35.43 80.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.851 -2.406 . . . . 11.45 114.374 175.269 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -59.67 -35.02 73.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.274 2.94 . . . . 24.98 115.968 170.442 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -75.74 -36.92 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.617 -2.552 . . . . 9.46 109.281 172.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -56.32 -32.61 64.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.423 2.059 . . . . 14.76 113.326 174.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.64 -36.09 67.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 128.215 3.864 . . . . 26.29 111.463 -177.71 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -65.13 -51.4 61.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.063 -2.79 . . . . 30.06 115.196 171.803 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -110.67 -59.02 2.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.519 2.104 . . . . 25.19 112.018 -168.132 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.15 49.29 0.88 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 126.942 2.211 . . . . 7.41 110.509 -176.358 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -100.25 130.55 25.72 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 114.299 -2.762 . . . . 9.49 107.732 169.363 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -71.25 148.98 56.69 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 124.417 2.613 . . . . 11.42 113.364 179.444 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -68.99 -17.96 40.82 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 CA-C-N 125.55 3.018 . . . . 12.0 117.768 -172.843 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.262 1.1 m-20 -69.41 -20.64 63.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.926 2.775 . . . . 35.55 117.028 172.902 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -94.6 -23.26 17.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.225 2.917 . . . . 20.52 108.5 -177.639 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -84.17 119.67 25.28 Favored 'General case' 0 N--CA 1.431 -1.418 1 O-C-N 115.767 -4.333 . . . . 7.13 116.791 178.114 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -113.57 106.59 14.72 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.068 2.947 . . . . 36.39 111.066 177.721 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.544 HD12 HG23 ' A' ' 23' ' ' ILE . 92.3 mt -88.3 124.27 33.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.096 -1.816 . . . . 9.55 106.096 -175.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -116.99 106.71 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 122.576 2.444 . . . . 13.9 108.534 176.825 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -95.66 108.94 21.27 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 125.628 2.632 . . . . 6.86 111.876 170.565 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.426 . . 70.57 -96.95 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.465 -2.647 . . . . 11.15 116.692 -178.754 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.76 -2.36 19.08 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.508 -1.37 . . . . 13.93 112.57 170.189 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -109.06 126.54 53.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.501 1.143 . . . . 23.92 111.261 -166.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -93.31 130.73 38.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 112.487 -2.142 . . . . 23.23 109.109 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -96.46 149.95 21.15 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.762 2.134 . . . . 9.11 116.762 -164.416 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -111.22 148.65 32.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.741 2.21 . . . . 33.44 111.041 -176.385 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -60.15 -47.28 86.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.276 2.695 . . . . 28.37 118.276 -166.748 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.83 26.67 8.08 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 117.995 -2.05 . . . . 15.0 112.982 -166.406 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -113.68 154.35 27.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 131.136 3.775 . . . . 25.5 106.24 -176.186 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -90.29 168.41 11.92 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.594 1.701 . . . . 11.95 115.594 168.436 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.0 mt -73.28 -36.14 66.26 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 118.031 -0.985 . . . . 10.17 112.406 177.25 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -45.89 -53.33 9.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.602 3.064 . . . . 13.59 115.837 160.961 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -49.76 -44.07 48.43 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.251 -4.656 . . . . 11.7 117.205 179.78 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -79.35 -18.95 51.41 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.431 -2.043 . . . . 12.95 108.265 -173.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 66.07 71.83 0.4 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.316 2.246 . . . . 25.45 110.238 -170.694 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -115.82 117.94 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 102.855 -3.017 . . . . 14.6 102.855 178.401 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -100.41 174.44 6.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.447 3.499 . . . . 33.23 112.239 174.386 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 13.3 pttp -53.69 161.88 0.99 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.829 -4.92 . . . . 25.97 115.293 165.243 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 50.96 46.57 26.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.292 3.037 . . . . 32.61 109.461 174.083 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -130.53 155.9 45.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.767 -3.083 . . . . 10.56 102.694 179.414 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.6 m -119.16 118.65 31.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.043 -1.435 . . . . 5.33 108.818 -155.14 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 mt -100.55 147.36 26.01 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.546 -2.391 . . . . 11.66 104.546 -173.773 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -108.8 133.89 52.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.625 -2.43 . . . . 16.3 111.41 167.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -106.34 97.79 7.55 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.682 1.734 . . . . 9.96 115.682 -175.419 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HA ' HD13 ' A' ' 8' ' ' LEU . 88.6 t -95.13 150.31 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 101.493 -3.521 . . . . 9.76 101.493 -171.383 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt . . . . . 0 N--CA 1.43 -1.442 1 CA-C-O 128.51 4.005 . . . . 19.57 106.772 173.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 118.366 -0.826 . . . . 17.17 113.012 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -98.75 142.0 30.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.478 2.361 . . . . 21.89 114.147 161.428 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.04 153.94 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.14 -1.43 . . . . 10.83 107.14 176.049 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -100.2 105.31 16.88 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 117.586 2.439 . . . . 10.61 117.586 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 70.9 t -88.44 117.58 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 119.635 1.107 . . . . 9.13 110.619 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -93.23 129.36 39.3 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.992 2.917 . . . . 20.55 110.39 174.81 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -98.01 170.53 8.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.169 -1.378 . . . . 11.78 108.164 178.005 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.02 -49.72 75.9 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.705 1.742 . . . . 19.31 115.705 173.348 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 p -74.78 -73.21 0.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.261 2.458 . . . . 23.14 111.507 -172.582 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.27 32.89 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 117.331 -3.355 . . . . 19.74 116.854 167.699 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -84.39 154.91 22.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.384 2.516 . . . . 21.93 110.054 167.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.9 m -112.18 113.52 25.82 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.117 -1.856 . . . . 12.33 106.376 163.246 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 12.6 mt -102.2 129.17 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 118.602 -2.561 . . . . 17.08 105.137 177.345 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.9 m -107.57 115.47 30.2 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.854 -2.404 . . . . 16.3 106.582 -169.807 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 tp -118.74 125.1 48.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.5 -2.625 . . . . 15.88 109.388 -156.615 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -95.34 119.53 33.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.468 -2.645 . . . . 28.9 114.873 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.7 158.18 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 106.903 -1.517 . . . . 12.05 106.903 -167.56 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -81.09 146.85 59.71 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 126.717 2.007 . . . . 18.17 109.9 175.452 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -82.87 -3.49 11.16 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 119.599 0.893 . . . . 8.16 113.434 -165.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 t -113.59 7.91 17.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.937 2.153 . . . . 11.13 112.396 171.755 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -88.89 177.22 6.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.364 2.357 . . . . 18.03 117.364 -172.695 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.447 HG22 HG22 ' A' ' 55' ' ' THR . 48.1 p -92.8 159.94 15.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 118.293 2.701 . . . . 10.22 118.293 -167.658 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -67.17 -36.24 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 127.132 2.173 . . . . 12.3 107.741 179.638 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -54.73 -44.87 73.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.606 1.963 . . . . 36.51 112.967 172.12 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -69.63 -31.14 69.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.835 2.161 . . . . 25.66 116.835 170.553 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.1 -48.11 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 122.091 2.223 . . . . 8.12 113.71 164.056 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -60.79 -31.35 70.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.978 1.711 . . . . 15.47 113.529 173.618 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.269 . . -79.24 -28.7 42.47 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 115.654 1.724 . . . . 11.45 115.654 177.716 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -63.43 -45.71 89.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.841 -1.527 . . . . 24.98 114.496 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.3 mt -70.0 -35.48 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.42 -2.173 . . . . 9.46 110.589 172.948 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -56.85 -29.68 63.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 125.974 3.988 . . . . 14.76 110.377 168.616 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.93 -50.73 7.76 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 114.857 -4.902 . . . . 26.29 111.439 -174.699 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -65.54 -52.27 53.73 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.661 -2.525 . . . . 30.06 113.417 175.589 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -107.82 -39.65 5.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.504 -0.924 . . . . 25.19 108.504 -162.109 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.99 37.6 5.97 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 106.587 -2.605 . . . . 7.41 106.587 176.338 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.74 123.66 37.93 Favored Pre-proline 0 N--CA 1.43 -1.446 1 N-CA-C 97.13 -5.137 . . . . 9.49 97.13 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -90.52 166.97 4.2 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 CA-C-N 125.278 2.921 . . . . 11.42 107.757 -168.564 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.26 36.4 Cg_endo -65.58 -24.83 55.45 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 122.793 2.328 . . . . 12.0 116.307 -169.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.282 18.0 m-20 -82.29 -22.33 35.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 114.516 -2.874 . . . . 35.55 111.476 178.906 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -91.56 -12.14 35.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 124.412 3.278 . . . . 20.52 112.77 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -75.46 99.93 4.34 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.74 2.416 . . . . 7.13 113.64 171.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -84.99 113.05 21.14 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 101.051 -3.685 . . . . 36.39 101.051 168.12 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.0 mt -101.31 115.24 30.05 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.405 -2.059 . . . . 9.55 110.343 165.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 44' ' ' ILE . 5.5 mt -112.53 137.6 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 C-N-CA 131.717 4.007 . . . . 13.9 109.234 178.576 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -133.75 99.37 4.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.738 2.015 . . . . 6.86 106.262 -171.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.394 . . 66.46 -108.65 0.13 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.954 -1.716 . . . . 11.15 113.471 -158.658 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.59 17.53 11.11 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 126.522 2.01 . . . . 13.93 112.106 172.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -107.06 119.74 40.18 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.661 3.23 . . . . 23.92 110.826 174.948 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -70.06 124.5 24.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.994 -2.941 . . . . 23.23 112.946 160.431 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.529 HD22 ' CD2' ' A' ' 59' ' ' TYR . 29.1 mt -79.41 162.74 25.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.352 1.461 . . . . 9.11 112.106 -178.187 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.28 141.47 52.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 126.748 3.166 . . . . 33.44 104.105 -177.955 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.67 -48.29 72.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.331 2.252 . . . . 28.37 114.848 -152.52 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.32 0.96 88.45 Favored Glycine 0 N--CA 1.43 -1.706 0 O-C-N 119.094 -2.254 . . . . 15.0 116.827 -178.305 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.252 23.3 mmt180 -74.9 161.43 29.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.105 3.336 . . . . 25.5 111.458 170.329 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.447 HG22 HG22 ' A' ' 22' ' ' THR 0.343 31.0 p -87.75 163.62 16.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.503 -2.623 . . . . 11.95 112.624 178.121 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.9 mt -60.15 -32.03 70.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.021 1.86 . . . . 10.17 116.021 163.315 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -56.55 -38.26 71.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.243 2.449 . . . . 13.59 114.426 166.408 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.79 -32.51 74.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.35 -2.719 . . . . 11.7 116.472 -169.123 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.529 ' CD2' HD22 ' A' ' 50' ' ' LEU . 34.2 m-85 -104.39 1.88 30.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.029 -2.919 . . . . 12.95 112.596 175.369 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.252 81.0 m-20 70.99 48.96 0.36 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.379 2.363 . . . . 25.45 117.379 -177.271 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.1 mt -92.41 124.79 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 114.545 -2.862 . . . . 14.6 110.614 -174.396 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -108.87 169.95 8.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 123.941 0.775 . . . . 33.23 110.635 -169.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 143.87 57.24 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.694 2.797 . . . . 25.97 110.262 -170.033 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 57.67 23.42 9.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.646 -3.784 . . . . 32.61 115.957 -174.392 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.0 t -92.93 160.36 14.93 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.269 3.414 . . . . 10.56 110.151 -178.622 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 m -92.52 126.16 37.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.599 -3.188 . . . . 5.33 114.749 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.44 155.63 31.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.524 -2.399 . . . . 11.66 104.524 173.842 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -130.61 111.03 11.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 119.024 0.829 . . . . 16.3 111.329 -173.3 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -87.16 108.56 18.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 131.0 3.72 . . . . 9.96 114.406 175.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -111.22 141.31 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 129.681 3.192 . . . . 9.76 102.7 -173.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.43 -1.454 0 C-N-CA 127.746 2.418 . . . . 19.57 109.187 -170.906 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 CA--C 1.49 -1.365 0 CA-C-O 116.449 -1.739 . . . . 17.17 109.209 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -88.38 140.59 29.32 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 123.247 2.749 . . . . 21.89 116.81 171.478 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.1 pt -110.41 167.83 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 102.628 -3.101 . . . . 10.83 102.628 173.082 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -109.03 139.2 44.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.403 -2.814 . . . . 10.61 103.403 167.652 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -122.85 123.17 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.435 -2.041 . . . . 9.13 109.677 165.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -96.91 134.89 39.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.127 -0.942 . . . . 20.55 112.508 172.361 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.401 HG22 HD23 ' A' ' 69' ' ' LEU . 42.9 p -91.77 -173.97 3.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.37 2.986 . . . . 11.78 113.207 177.769 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 tp -65.49 -52.95 49.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.635 -3.791 . . . . 19.31 116.661 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -61.8 -40.5 95.45 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.325 -2.11 . . . . 23.14 110.204 171.075 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.01 37.15 0.44 Allowed Glycine 0 N--CA 1.43 -1.738 0 CA-C-O 115.186 -3.008 . . . . 19.74 116.837 177.209 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -86.17 141.05 29.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.483 3.641 . . . . 21.93 111.079 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 m -92.74 101.75 14.15 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 119.954 1.252 . . . . 12.33 108.995 175.711 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.6 mt -93.05 118.43 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 125.072 1.349 . . . . 17.08 111.149 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -86.66 105.58 17.01 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.471 1.908 . . . . 16.3 112.338 175.128 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 tp -120.57 116.24 24.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.73 -1.856 . . . . 15.88 110.329 -160.61 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -78.76 100.51 7.14 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.562 4.345 . . . . 28.9 120.351 178.898 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 m -122.93 148.46 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-O 125.452 2.549 . . . . 12.05 109.138 -171.666 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -94.64 141.73 23.8 Favored Pre-proline 0 N--CA 1.43 -1.474 1 O-C-N 116.277 -4.015 . . . . 18.17 106.01 162.542 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.49 -14.51 45.26 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-O 114.086 -2.548 . . . . 8.16 111.091 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.7 p -67.83 -9.88 48.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 120.931 3.678 . . . . 11.13 120.931 160.759 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -71.06 134.92 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.55 -3.843 . . . . 18.03 111.679 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.3 p -82.48 153.14 25.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 117.332 -1.318 . . . . 10.22 111.974 177.82 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.0 mm -51.61 -37.73 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 113.907 -2.949 . . . . 12.3 113.795 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -49.64 -43.56 46.9 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.959 3.704 . . . . 36.51 113.86 168.214 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -90.54 -25.56 20.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.693 3.197 . . . . 25.66 110.295 -176.848 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.46 -51.84 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.238 1.495 . . . . 8.12 110.736 164.634 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -51.74 -31.92 28.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.66 -3.775 . . . . 15.47 115.183 170.639 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.05 -39.38 86.92 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.808 1.643 . . . . 11.45 113.018 171.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -69.19 -35.08 75.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.473 1.13 . . . . 24.98 108.4 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.5 mt -79.51 -35.59 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.833 -2.417 . . . . 9.46 110.77 -173.032 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -49.41 -50.54 40.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.542 2.423 . . . . 14.76 117.542 158.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.56 -33.44 69.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.266 3.027 . . . . 26.29 113.91 170.773 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -73.69 -69.83 0.41 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.925 2.565 . . . . 30.06 117.925 173.378 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -90.42 -37.89 13.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 111.189 -2.732 . . . . 25.19 115.215 -172.146 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.35 46.39 1.85 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 120.743 1.61 . . . . 7.41 110.784 176.452 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.41 105.32 48.64 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 113.195 -3.288 . . . . 9.49 105.031 -178.324 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -58.36 159.01 20.66 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.497 3.356 . . . . 11.42 113.62 -175.463 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -76.39 -20.4 14.23 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 122.826 2.045 . . . . 12.0 115.227 -161.828 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.33 -40.01 67.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.649 -1.907 . . . . 35.55 110.005 178.439 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.99 -29.8 69.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.812 -1.805 . . . . 20.52 111.697 172.075 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -78.98 140.9 37.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 117.865 -3.022 . . . . 7.13 109.952 -177.697 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -123.12 124.43 43.06 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.563 -3.21 . . . . 36.39 107.393 158.078 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.2 mt -106.4 129.79 54.33 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 123.957 0.786 . . . . 9.55 112.609 176.69 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.1 109.82 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 125.991 1.716 . . . . 13.9 112.004 -171.462 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -94.09 129.52 40.6 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.346 -3.346 . . . . 6.86 107.33 163.278 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.52 -97.92 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.019 2.97 . . . . 11.15 119.019 -169.054 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.84 27.82 3.81 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.44 -2.037 . . . . 13.93 113.819 -179.413 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -138.93 128.39 24.4 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.903 -1.888 . . . . 23.92 105.903 -176.824 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -84.34 127.34 33.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 111.799 -2.455 . . . . 23.23 113.664 171.954 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.4 mt -87.02 137.16 32.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.074 -1.875 . . . . 9.11 108.353 -161.206 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -106.26 140.41 39.25 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.31 -0.869 . . . . 33.44 111.936 -160.155 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -46.17 -54.03 9.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 121.3 3.815 . . . . 28.37 121.3 -162.302 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.11 -0.44 74.17 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-O 117.906 -1.497 . . . . 15.0 112.706 -178.417 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -75.4 158.47 32.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.106 1.953 . . . . 25.5 114.308 169.644 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 p -93.68 173.46 7.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.746 2.212 . . . . 11.95 110.452 174.469 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.5 mt -66.39 -29.84 70.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.331 -3.356 . . . . 10.17 113.965 166.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.6 t -66.05 -39.73 90.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.856 -3.028 . . . . 13.59 110.892 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -61.2 -33.64 73.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.911 -1.743 . . . . 11.7 113.634 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.83 -20.44 30.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.187 0.81 . . . . 12.95 113.187 174.314 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 m120 72.47 51.78 0.18 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.604 3.962 . . . . 25.45 112.539 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.259 60.0 mt -80.79 121.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 110.192 -3.185 . . . . 14.6 110.026 -178.288 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -106.54 -175.2 2.73 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 118.704 -1.198 . . . . 33.23 112.228 -175.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.427 0.0 OUTLIER -66.46 150.85 48.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.234 2.309 . . . . 25.97 117.234 173.219 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 48.24 39.0 11.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.047 2.832 . . . . 32.61 116.408 -168.697 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.373 63.9 m -94.29 137.21 33.72 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.013 -4.804 . . . . 10.56 107.826 173.841 . . . . . . . . 3 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -103.52 113.92 27.79 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.563 1.529 . . . . 5.33 111.665 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -84.78 146.54 27.32 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.238 2.215 . . . . 11.66 111.63 169.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -110.93 129.49 55.86 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.603 -1.936 . . . . 16.3 114.41 172.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.401 HD23 HG22 ' A' ' 7' ' ' THR . 17.7 tp -87.78 124.82 34.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.32 -2.474 . . . . 9.96 104.32 170.313 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.12 146.03 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 112.816 -1.993 . . . . 9.76 109.34 163.489 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.257 14.2 mt . . . . . 0 N--CA 1.431 -1.418 1 O-C-N 115.578 -4.451 . . . . 19.57 111.452 -176.253 . . . . . . . . 2 1 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.348 0 CA-C-O 119.242 -0.409 . . . . 17.17 111.932 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.29 133.99 39.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 119.324 0.965 . . . . 21.89 113.157 -178.572 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 pt -114.63 171.24 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.703 -1.873 . . . . 10.83 111.024 168.125 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -107.82 135.95 48.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.563 1.649 . . . . 10.61 111.876 173.132 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 69' ' ' LEU . 88.1 t -119.25 128.62 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 117.523 -3.235 . . . . 9.13 102.288 175.025 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -120.89 121.74 38.73 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.068 1.413 . . . . 20.55 111.143 -178.741 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.458 HG22 HD23 ' A' ' 69' ' ' LEU . 12.5 p -69.79 164.06 24.42 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.539 2.336 . . . . 11.78 109.632 -174.245 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.4 tp -61.76 -44.19 97.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.092 1.901 . . . . 19.31 111.154 174.155 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 p -67.32 -51.57 50.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.765 -1.835 . . . . 23.14 113.045 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.56 59.9 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 119.439 2.536 . . . . 19.74 119.439 162.803 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -116.42 138.5 51.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.522 -0.918 . . . . 21.93 108.522 172.494 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.2 m -90.15 113.86 25.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 118.37 -0.824 . . . . 12.33 109.164 178.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mt -96.39 137.57 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.694 -3.129 . . . . 17.08 106.872 -177.27 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.3 m -97.28 121.43 39.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 114.821 -2.514 . . . . 16.3 104.301 171.572 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 tp -121.97 138.37 54.44 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.648 2.166 . . . . 15.88 115.895 178.38 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.294 71.6 tt0 -100.1 111.16 23.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.339 -3.976 . . . . 28.9 109.1 -172.858 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.2 152.99 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 1 O-C-N 113.29 -5.881 . . . . 12.05 117.937 -172.55 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -117.36 161.03 35.32 Favored Pre-proline 0 N--CA 1.43 -1.446 1 O-C-N 116.154 -4.091 . . . . 18.17 119.327 170.467 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -66.59 -17.63 53.15 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 CA-C-N 129.859 4.557 . . . . 8.16 117.468 -175.117 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.4 m -76.74 -17.19 59.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.403 1.91 . . . . 11.13 114.414 177.46 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -67.98 151.78 46.55 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.925 2.774 . . . . 18.03 111.094 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -97.82 158.77 15.33 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.778 -1.826 . . . . 10.22 112.012 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.269 4.7 mm -61.34 -31.52 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 CA-C-O 128.941 4.21 . . . . 12.3 116.294 -178.648 . . . . . . . . 3 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -50.21 -43.42 52.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.051 -3.531 . . . . 36.51 114.76 162.812 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -73.16 -19.37 61.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.643 -2.535 . . . . 25.66 117.2 173.797 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.263 94.5 t -66.36 -37.87 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 117.723 -3.11 . . . . 8.12 111.813 176.802 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -68.67 -40.63 80.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.414 3.086 . . . . 15.47 112.56 176.136 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.11 -52.87 59.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 121.184 3.772 . . . . 11.45 121.184 167.752 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -56.86 -41.15 77.43 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.674 2.034 . . . . 24.98 115.797 165.321 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -64.57 -36.8 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 125.202 2.43 . . . . 9.46 110.585 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.463 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 3.6 tt0 -53.92 -55.0 30.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.851 1.786 . . . . 14.76 113.285 171.135 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.259 29.4 t70 -57.89 -56.13 25.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.587 -2.571 . . . . 26.29 116.22 179.316 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -69.67 -65.35 0.73 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 125.865 2.745 . . . . 30.06 113.928 -176.11 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -86.39 -46.24 10.44 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.596 -4.44 . . . . 25.19 118.439 177.34 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 102.28 28.72 6.31 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.107 -1.997 . . . . 7.41 108.107 168.219 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.0 mt -83.35 118.97 73.15 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.005 -1.95 . . . . 9.49 108.641 169.813 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -73.63 157.25 48.72 Favored 'Trans proline' 0 N--CA 1.433 -2.036 1 CA-C-N 128.467 4.06 . . . . 11.42 114.412 -166.375 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.42 -23.72 64.79 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 123.02 2.48 . . . . 12.0 116.659 -168.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.88 -28.53 39.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.317 1.969 . . . . 35.55 116.317 177.262 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -18.03 59.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.792 2.515 . . . . 20.52 117.792 170.481 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -79.98 138.41 37.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.063 -2.273 . . . . 7.13 116.735 177.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -137.94 129.26 27.71 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 125.666 2.651 . . . . 36.39 106.423 164.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mt -110.91 117.42 33.32 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 111.522 -2.581 . . . . 9.55 112.584 -173.787 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.15 131.19 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.984 2.114 . . . . 13.9 109.532 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.587 ' HB3' HD21 ' A' ' 50' ' ' LEU . 11.5 t80 -122.75 107.4 11.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.826 -2.287 . . . . 6.86 104.826 178.642 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.315 . . 69.93 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 125.572 1.795 . . . . 11.15 113.971 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.9 -29.87 3.66 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-O 118.419 -1.211 . . . . 13.93 112.796 175.557 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -94.79 127.95 41.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 126.248 1.793 . . . . 23.92 115.116 -162.301 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -77.13 132.72 38.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.378 2.037 . . . . 23.23 115.533 166.631 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 45' ' ' PHE 0.26 7.6 mt -91.07 133.29 35.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.263 -2.773 . . . . 9.11 113.125 -163.692 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -88.86 121.85 31.65 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.227 -1.545 . . . . 33.44 114.07 -176.153 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -29.49 -57.75 0.16 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.032 3.733 . . . . 28.37 115.941 -178.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.87 25.35 25.59 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 119.278 -2.139 . . . . 15.0 116.188 -168.901 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.1 mtt-85 -108.91 155.33 20.96 Favored 'General case' 0 N--CA 1.43 -1.463 1 C-N-CA 132.081 4.153 . . . . 25.5 113.216 170.123 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.44 23.9 p -80.69 158.93 25.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 128.292 3.901 . . . . 11.95 115.045 177.615 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mp -68.86 -8.36 43.1 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.782 -5.574 . . . . 10.17 116.358 166.371 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.33 -42.85 18.21 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 112.686 -3.53 . . . . 13.59 103.294 177.52 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -62.47 -28.56 69.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 123.27 2.759 . . . . 11.7 114.466 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -94.32 -4.68 48.2 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.483 2.313 . . . . 12.95 112.088 175.192 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 m120 63.52 44.22 5.42 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.734 3.214 . . . . 25.45 110.007 169.303 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.7 mt -80.22 113.58 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 119.89 -1.756 . . . . 14.6 111.41 -178.256 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.261 14.6 mm100 -71.4 -179.56 2.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 124.644 2.164 . . . . 33.23 109.455 173.841 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -79.21 144.57 34.28 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-O 128.752 4.12 . . . . 25.97 109.95 165.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.366 65.8 mt-10 71.09 32.99 2.15 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.334 -2.666 . . . . 32.61 110.26 174.371 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.269 2.9 m -98.55 144.93 27.34 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 116.559 -3.838 . . . . 10.56 107.269 175.617 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -94.82 115.36 27.4 Favored 'General case' 0 N--CA 1.431 -1.423 1 C-N-CA 132.147 4.179 . . . . 5.33 110.267 176.809 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.69 129.83 34.72 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.62 -1.622 . . . . 11.66 106.62 170.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -81.1 105.91 12.68 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.932 -2.355 . . . . 16.3 108.413 168.563 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.458 HD23 HG22 ' A' ' 7' ' ' THR . 34.3 tp -84.93 108.72 17.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.226 2.61 . . . . 9.96 109.893 168.154 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 m -113.74 168.59 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.237 2.215 . . . . 9.76 106.264 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.9 tp . . . . . 0 N--CA 1.43 -1.465 0 O-C-N 127.748 3.155 . . . . 19.57 108.886 -167.491 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.335 0 N-CA-C 104.455 -2.424 . . . . 17.17 104.455 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -114.3 160.12 19.44 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.938 -1.726 . . . . 21.89 115.459 173.942 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.4 pt -133.7 154.17 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 1 CA-C-O 129.434 4.445 . . . . 10.83 105.32 169.842 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -106.96 105.03 14.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.026 3.298 . . . . 10.61 102.872 177.073 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.32 105.19 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.009 -2.307 . . . . 9.13 112.838 171.173 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -95.64 128.04 42.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.258 1.98 . . . . 20.55 111.499 -175.498 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -82.29 -179.16 7.31 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.939 -3.601 . . . . 11.78 113.845 -172.603 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.0 tp -75.22 -48.52 23.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.467 -3.896 . . . . 19.31 112.114 -176.701 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.0 p -70.22 -24.0 63.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.93 2.776 . . . . 23.14 116.647 -178.632 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.36 75.88 0.52 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 118.657 -2.527 . . . . 19.74 110.517 170.916 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -142.16 139.38 32.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.882 -3.007 . . . . 21.93 102.882 170.141 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.3 m -106.52 104.19 13.82 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.296 1.438 . . . . 12.33 110.626 176.112 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 mt -92.31 118.21 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 118.468 -0.777 . . . . 17.08 109.636 176.817 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.5 m -95.83 122.72 38.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.229 -3.248 . . . . 16.3 102.229 179.005 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 tp -127.85 147.53 50.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.364 -0.835 . . . . 15.88 112.386 -176.216 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -95.87 122.73 38.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.284 -1.817 . . . . 28.9 108.787 178.915 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.23 168.06 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.196 2.599 . . . . 12.05 109.187 177.686 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -107.12 153.41 41.04 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 116.756 -3.715 . . . . 18.17 101.264 163.644 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.43 -12.96 32.49 Favored 'Trans proline' 0 N--CA 1.433 -2.036 2 C-N-CA 128.323 6.016 . . . . 8.16 105.122 179.699 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p -83.97 12.44 6.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.017 2.927 . . . . 11.13 114.387 171.538 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -93.34 146.12 23.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.599 -2.0 . . . . 18.03 105.599 176.82 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.9 p -89.1 168.58 12.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.852 -1.536 . . . . 10.22 106.852 -175.456 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -82.24 -28.08 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 116.151 1.908 . . . . 12.3 116.151 -173.671 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -48.27 -50.31 30.29 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.745 -2.48 . . . . 36.51 112.078 155.349 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -59.0 -53.03 63.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.239 2.681 . . . . 25.66 118.239 168.021 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 t -50.22 -37.99 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 116.552 2.056 . . . . 8.12 116.552 171.087 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -68.33 -41.55 80.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 117.725 -1.131 . . . . 15.47 113.984 173.598 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.69 70.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.907 3.299 . . . . 11.45 119.907 174.197 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -61.89 -47.42 85.04 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.976 2.911 . . . . 24.98 113.002 170.17 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.51 -35.0 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.982 -1.698 . . . . 9.46 108.595 -176.814 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -62.02 -46.79 87.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.428 -3.295 . . . . 14.76 113.876 170.29 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -49.27 -58.97 4.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.458 2.762 . . . . 26.29 118.458 163.711 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -71.04 -67.41 0.51 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.237 -2.789 . . . . 30.06 116.203 -178.58 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -85.33 -24.87 27.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.916 1.817 . . . . 25.19 114.077 -171.891 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.82 38.89 14.8 Favored Glycine 0 N--CA 1.43 -1.727 0 O-C-N 119.611 -1.931 . . . . 7.41 115.235 -178.614 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.1 mt -102.98 109.91 62.42 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 114.3 -2.762 . . . . 9.49 109.013 -179.168 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.7 142.23 82.98 Favored 'Trans proline' 0 N--CA 1.434 -1.987 2 C-N-CA 127.181 5.254 . . . . 11.42 114.321 -171.649 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.47 -17.97 6.08 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 123.026 2.116 . . . . 12.0 109.946 -159.807 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.269 37.0 m-20 -60.49 -23.67 64.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 126.551 2.407 . . . . 35.55 116.486 161.954 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -84.3 -33.04 24.04 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 117.261 -3.399 . . . . 20.52 115.263 176.595 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -67.41 138.03 56.37 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.026 3.343 . . . . 7.13 120.026 -179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -136.71 132.09 34.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 105.181 -2.155 . . . . 36.39 105.181 161.441 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.253 11.4 mt -111.91 124.89 53.33 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 129.279 4.112 . . . . 9.55 107.702 -174.621 . . . . . . . . 3 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.3 mt -117.79 117.84 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.704 2.402 . . . . 13.9 111.2 -173.165 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -94.55 102.97 14.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.567 -1.958 . . . . 6.86 110.96 168.917 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.99 -81.35 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.767 2.136 . . . . 11.15 116.767 -163.976 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.85 16.91 2.39 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 104.666 -3.374 . . . . 13.93 104.666 172.773 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -95.73 111.49 23.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 119.255 1.528 . . . . 23.92 114.671 171.519 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -76.73 116.55 17.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.836 -1.529 . . . . 23.23 111.721 -179.503 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.0 mt -87.26 138.64 31.31 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.457 -3.277 . . . . 9.11 112.806 -164.909 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -97.21 161.23 13.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.428 2.01 . . . . 33.44 116.428 -175.894 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.269 7.8 m-20 -46.4 -68.78 0.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 119.829 3.27 . . . . 28.37 119.829 -166.844 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.14 8.4 70.85 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 118.013 1.965 . . . . 15.0 118.013 -165.977 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -94.92 158.88 15.29 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 126.866 3.222 . . . . 25.5 112.092 -176.844 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.95 164.03 12.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.089 2.376 . . . . 11.95 109.229 -179.335 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.69 -18.92 62.14 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 112.762 -3.494 . . . . 10.17 113.207 171.482 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -71.22 -31.86 68.09 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 126.046 2.091 . . . . 13.59 112.464 169.587 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -66.41 -53.1 39.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.55 -3.219 . . . . 11.7 109.269 179.012 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -66.42 -19.76 65.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.704 -3.122 . . . . 12.95 110.683 -179.454 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 m120 73.64 47.54 0.17 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.616 1.71 . . . . 25.45 115.616 -178.947 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.72 111.65 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.179 2.419 . . . . 14.6 110.003 -177.021 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -71.03 174.5 6.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 112.327 -2.215 . . . . 33.23 111.681 -176.17 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -52.46 133.22 35.48 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.561 3.171 . . . . 25.97 119.561 168.68 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 60.53 50.71 5.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.666 -3.146 . . . . 32.61 113.392 175.523 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 m -107.35 154.6 21.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.875 -1.511 . . . . 10.56 110.74 -179.426 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -102.08 126.68 49.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.377 3.548 . . . . 5.33 107.244 -168.294 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.23 145.9 39.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 117.524 -1.227 . . . . 11.66 109.243 178.339 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -101.59 123.84 46.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.495 -1.668 . . . . 16.3 106.495 177.942 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 tp -100.4 117.88 35.49 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.613 2.365 . . . . 9.96 107.62 174.895 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -115.46 -165.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.602 2.075 . . . . 9.76 116.602 171.903 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 N--CA 1.43 -1.437 0 O-C-N 120.043 -1.661 . . . . 19.57 113.327 168.293 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 39.7 ttm . . . . . 0 CA--C 1.49 -1.365 0 N-CA-C 110.297 -0.26 . . . . 17.17 110.297 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -87.82 134.12 33.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.741 -1.85 . . . . 21.89 112.454 171.06 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -122.09 171.22 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 119.162 0.892 . . . . 10.83 110.675 162.497 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -116.09 121.65 42.8 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.133 -2.854 . . . . 10.61 109.319 174.39 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.3 t -106.2 104.49 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 124.971 2.319 . . . . 9.13 111.483 173.11 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -82.74 134.37 35.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.906 -3.621 . . . . 20.55 113.822 -177.804 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.7 p -87.12 176.22 7.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.364 1.665 . . . . 11.78 110.963 -174.376 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.64 -44.4 64.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.75 1.22 . . . . 19.31 109.636 177.707 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -69.55 -63.7 1.02 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.47 1.508 . . . . 23.14 114.231 -177.426 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.23 21.82 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 115.589 -3.196 . . . . 19.74 115.42 176.178 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -105.28 138.58 41.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.318 -1.364 . . . . 21.93 107.318 -173.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -105.43 118.45 36.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.717 -2.489 . . . . 12.33 107.182 168.713 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.39 126.68 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 114.102 -2.856 . . . . 17.08 107.211 -173.553 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.3 m -101.37 125.69 48.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 102.888 -3.004 . . . . 16.3 102.888 -171.782 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 15' ' ' LEU . 15.6 tp -141.05 131.0 24.48 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.721 -2.696 . . . . 15.88 103.721 -154.91 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -114.85 107.13 15.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.025 -2.954 . . . . 28.9 103.025 -168.082 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.409 HG11 HG22 ' A' ' 26' ' ' VAL . 16.8 m -116.6 155.76 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 128.541 2.737 . . . . 12.05 112.727 -177.412 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -89.47 143.86 31.28 Favored Pre-proline 0 N--CA 1.43 -1.443 1 CA-C-O 111.465 -4.112 . . . . 18.17 108.494 171.152 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 56' ' ' LEU . 27.9 Cg_endo -87.47 -5.77 7.21 Favored 'Trans proline' 0 N--CA 1.433 -2.043 2 CA-C-N 129.132 4.297 . . . . 8.16 105.628 -173.767 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.267 65.9 m -84.11 -6.51 59.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.014 -1.074 . . . . 11.13 113.726 171.817 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -107.91 161.14 15.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 128.16 3.838 . . . . 18.03 108.843 -179.132 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -77.23 166.9 22.61 Favored 'General case' 0 N--CA 1.43 -1.446 1 N-CA-C 121.849 4.018 . . . . 10.22 121.849 -176.006 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -63.25 -32.85 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.039 1.335 . . . . 12.3 111.64 174.587 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -53.61 -44.15 69.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.109 -1.619 . . . . 36.51 112.032 172.537 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -79.84 -14.3 58.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.3 -3.375 . . . . 25.66 114.309 178.004 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.409 HG22 HG11 ' A' ' 17' ' ' VAL . 65.0 t -69.22 -47.62 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.251 -2.156 . . . . 8.12 109.866 165.522 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.25 90.7 mttt -69.68 -28.39 65.81 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.07 1.748 . . . . 15.47 111.527 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.271 . . -65.8 -38.04 87.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.832 2.053 . . . . 11.45 106.885 175.502 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -73.32 -31.69 64.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.004 2.638 . . . . 24.98 116.55 178.199 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.25 70.8 mt -72.34 -42.21 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.081 2.372 . . . . 9.46 111.317 172.108 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -49.93 -35.63 24.72 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.475 2.028 . . . . 14.76 116.475 169.71 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -85.59 -55.28 4.07 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.814 -1.921 . . . . 26.29 105.814 -173.822 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -71.85 -44.46 63.8 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.507 -1.371 . . . . 30.06 112.774 -169.419 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -106.89 -33.09 7.64 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.529 -1.357 . . . . 25.19 109.589 -162.054 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.4 46.69 4.88 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 128.124 2.774 . . . . 7.41 113.81 170.289 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.0 mt -106.93 128.6 25.79 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 101.364 -3.569 . . . . 9.49 101.364 176.355 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -82.86 162.95 16.06 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 O-C-N 117.029 -2.143 . . . . 11.42 110.857 179.409 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.15 -23.23 4.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 N-CA-C 121.386 3.571 . . . . 12.0 121.386 166.087 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -68.08 -23.65 64.96 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.608 -2.557 . . . . 35.55 106.936 178.258 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -108.73 -12.94 14.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 127.266 3.412 . . . . 20.52 116.267 -179.304 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -86.84 115.46 24.27 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 115.678 -4.389 . . . . 7.13 113.46 -177.384 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -111.89 117.24 32.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.297 -1.001 . . . . 36.39 108.297 163.969 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -98.98 131.44 45.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.889 1.676 . . . . 9.55 106.716 178.813 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.421 HD13 HG21 ' A' ' 44' ' ' ILE . 63.8 mt -131.2 140.51 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 119.487 -2.008 . . . . 13.9 107.062 177.397 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -101.28 100.92 11.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.228 3.811 . . . . 6.86 108.678 161.674 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.09 -91.48 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.532 2.333 . . . . 11.15 116.704 -169.366 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.84 14.49 6.69 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 116.928 -2.04 . . . . 13.93 111.241 175.724 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -98.46 108.81 21.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 126.514 1.949 . . . . 23.92 106.785 173.899 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -79.74 102.28 8.93 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 119.963 3.32 . . . . 23.23 119.963 171.096 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.12 146.18 55.32 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 124.737 2.208 . . . . 9.11 114.729 -155.967 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -107.06 143.87 34.54 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.119 -4.113 . . . . 33.44 112.835 178.805 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.96 -38.95 20.35 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 114.571 -2.633 . . . . 28.37 114.313 -153.379 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.88 45.78 3.57 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 124.024 3.102 . . . . 15.0 113.818 163.901 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -131.46 162.51 30.04 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.119 -4.754 . . . . 25.5 105.252 170.622 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -108.26 172.86 6.6 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 117.591 -3.193 . . . . 11.95 114.82 -175.669 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 19' ' ' PRO . 11.2 mt -64.81 -37.87 89.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.16 1.457 . . . . 10.17 108.191 169.006 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.356 1.2 m -56.2 -36.95 68.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.468 3.507 . . . . 13.59 120.468 167.626 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -58.75 -42.67 89.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.351 -2.718 . . . . 11.7 114.009 165.527 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -81.07 -7.39 59.55 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.731 -1.855 . . . . 12.95 111.426 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.256 60.8 m-80 55.78 48.42 18.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.321 2.249 . . . . 25.45 116.023 -171.872 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -84.32 140.47 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.009 1.723 . . . . 14.6 113.014 175.625 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -109.1 -175.06 2.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.122 1.769 . . . . 33.23 106.879 -170.247 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HG2' ' HG3' ' A' ' 1' ' ' MET 0.299 18.3 mtmm -72.63 147.53 45.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.662 -1.899 . . . . 25.97 112.532 174.97 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 78.51 20.85 0.83 Allowed 'General case' 0 N--CA 1.43 -1.441 1 C-N-CA 132.027 4.131 . . . . 32.61 106.863 166.341 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -88.48 159.97 17.72 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 116.08 -4.137 . . . . 10.56 109.779 -163.934 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 m -103.84 134.98 46.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 124.328 2.013 . . . . 5.33 112.473 -175.832 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -114.71 169.24 9.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 130.447 3.499 . . . . 11.66 108.302 165.222 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -123.62 136.5 54.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 114.775 -2.536 . . . . 16.3 107.753 174.002 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tp -97.04 113.95 25.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.542 2.428 . . . . 9.96 113.96 159.572 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -116.96 -166.01 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 116.764 -3.71 . . . . 9.76 108.542 162.515 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.43 -1.452 0 C-N-CA 127.345 2.258 . . . . 19.57 109.668 -172.359 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 CA--C 1.49 -1.346 0 N-CA-C 115.65 1.722 . . . . 17.17 115.65 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -86.75 133.62 33.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.967 3.707 . . . . 21.89 110.941 171.557 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.39 158.83 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 119.569 1.077 . . . . 10.83 108.376 172.243 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.93 145.09 31.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.324 1.059 . . . . 10.61 109.935 168.85 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 67' ' ' LEU . 85.7 t -122.3 139.08 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 101.22 -3.622 . . . . 9.13 101.22 168.994 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -117.6 124.5 48.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.162 -0.926 . . . . 20.55 112.843 177.245 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -79.69 166.84 21.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.073 -1.876 . . . . 11.78 115.563 -177.957 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.9 tt -74.5 -43.61 55.16 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.687 -4.383 . . . . 19.31 108.912 -172.948 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -60.06 -44.06 94.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.575 -3.203 . . . . 23.14 110.024 173.464 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.21 59.87 0.21 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 126.233 2.208 . . . . 19.74 111.123 177.37 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -107.53 127.16 53.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.453 1.101 . . . . 21.93 109.553 161.561 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -101.07 112.2 24.61 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.124 -0.985 . . . . 12.33 108.892 174.588 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 pt -109.94 134.98 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 125.963 2.792 . . . . 17.08 111.01 -172.397 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.2 m -89.25 115.22 26.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.512 -1.992 . . . . 16.3 109.142 -174.769 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 mt -104.0 167.23 9.9 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.373 -2.079 . . . . 15.88 114.629 170.015 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.321 9.2 tt0 -130.47 113.69 14.6 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.565 1.546 . . . . 28.9 115.169 168.45 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.76 145.28 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.957 1.703 . . . . 12.05 110.363 -173.176 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.84 148.17 94.59 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 117.267 -3.396 . . . . 18.17 113.018 158.596 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -65.97 -21.68 56.45 Favored 'Trans proline' 0 C--N 1.3 -2.019 3 C-N-CA 126.214 4.609 . . . . 8.16 113.414 172.096 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.8 m -84.61 8.11 17.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.681 1.705 . . . . 11.13 115.483 173.756 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -87.82 157.98 18.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.546 -2.596 . . . . 18.03 109.248 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 55' ' ' THR . 23.6 p -95.1 167.7 11.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.091 2.957 . . . . 10.22 115.061 -176.975 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -67.26 -26.35 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.211 1.93 . . . . 12.3 116.211 172.321 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -63.41 -47.52 81.64 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.073 -2.267 . . . . 36.51 112.03 175.264 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.91 -23.36 65.98 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.001 2.52 . . . . 25.66 113.738 176.096 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.31 -58.16 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.955 2.902 . . . . 8.12 107.87 167.831 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -70.56 -17.99 62.92 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 115.353 -4.592 . . . . 15.47 116.495 -173.896 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.55 -28.26 65.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.061 -1.65 . . . . 11.45 109.315 167.171 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -77.93 -33.36 51.76 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.497 1.499 . . . . 24.98 111.05 -177.036 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.1 -34.74 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 128.368 2.667 . . . . 9.46 110.213 178.529 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -56.75 -47.53 79.85 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 117.959 -1.02 . . . . 14.76 113.057 165.756 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -65.78 -57.95 6.8 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.059 2.614 . . . . 26.29 118.059 171.798 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -59.28 -52.16 66.87 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.46 3.133 . . . . 30.06 119.46 -173.359 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -107.09 -43.64 4.57 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 122.079 0.943 . . . . 25.19 109.681 176.418 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.32 47.43 2.02 Favored Glycine 0 N--CA 1.43 -1.741 0 O-C-N 118.264 -2.772 . . . . 7.41 110.733 -173.957 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 mt -104.55 114.61 63.9 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 101.516 -3.513 . . . . 9.49 101.516 168.249 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -83.62 163.41 14.4 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 CA-C-O 111.719 -3.534 . . . . 11.42 116.55 -171.061 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -81.6 -3.61 11.96 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 130.279 4.707 . . . . 12.0 111.281 -162.265 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.51 -26.4 45.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.001 1.273 . . . . 35.55 112.945 176.215 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -69.24 -51.24 39.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.912 3.671 . . . . 20.52 120.912 158.062 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -68.45 116.5 9.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.787 2.708 . . . . 7.13 115.858 -168.892 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -111.83 113.84 26.44 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.216 -4.678 . . . . 36.39 105.961 168.992 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 mt -83.61 127.65 33.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.155 1.798 . . . . 9.55 110.88 -179.919 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.6 mm -121.45 139.81 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 125.947 1.699 . . . . 13.9 108.282 177.774 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -135.25 139.99 44.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 104.206 -2.516 . . . . 6.86 104.206 157.207 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.266 . . 47.92 -98.86 0.05 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.504 2.721 . . . . 11.15 112.052 -164.899 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.91 31.05 1.35 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 114.376 -3.773 . . . . 13.93 110.252 167.568 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -95.18 147.34 23.56 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.242 1.417 . . . . 23.92 108.11 166.689 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -99.62 139.46 35.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.927 -1.511 . . . . 23.23 110.692 170.595 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.258 0.4 OUTLIER -113.74 131.75 56.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.092 1.495 . . . . 9.11 107.574 -163.756 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -101.08 157.36 16.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 125.333 1.646 . . . . 33.44 115.075 -162.71 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.259 33.6 m-20 -59.8 -53.72 54.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 121.447 3.869 . . . . 28.37 121.447 -165.283 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.86 33.93 5.24 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-N 121.109 1.777 . . . . 15.0 115.695 -179.408 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -113.92 150.34 33.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.18 -2.953 . . . . 25.5 105.092 169.712 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 22' ' ' THR . 16.0 p -90.16 171.48 9.49 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.939 2.78 . . . . 11.95 111.653 -170.21 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.63 -30.49 26.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.978 -3.576 . . . . 10.17 108.722 -176.789 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -59.05 -39.83 83.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.792 2.837 . . . . 13.59 108.233 170.816 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -58.03 -59.92 4.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.631 -3.793 . . . . 11.7 111.247 179.496 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -70.74 -11.96 61.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 130.099 3.359 . . . . 12.95 112.056 -170.97 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 65.71 60.04 0.72 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.92 -2.988 . . . . 25.45 112.851 -179.193 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mm -90.69 137.05 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.319 -2.738 . . . . 14.6 110.646 179.556 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -101.06 -175.8 2.98 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.507 -1.995 . . . . 33.23 114.883 -171.876 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -78.17 142.12 38.21 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.124 1.157 . . . . 25.97 114.124 178.661 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 61.11 30.84 19.65 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.214 2.206 . . . . 32.61 112.401 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.1 t -81.35 158.44 24.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 117.053 2.242 . . . . 10.56 117.053 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.3 m -121.37 103.76 9.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.145 -2.222 . . . . 5.33 107.805 -166.678 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB2' HG22 ' A' ' 5' ' ' VAL 0.273 91.6 mt -88.48 147.35 24.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.142 2.977 . . . . 11.66 107.438 175.542 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -100.84 137.72 38.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.303 2.252 . . . . 16.3 110.093 -178.625 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 mt -106.07 141.22 37.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.908 -1.745 . . . . 9.96 111.778 165.122 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.85 -169.85 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.62 2.368 . . . . 9.76 108.517 169.969 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.43 -1.448 0 C-N-CA 131.369 3.868 . . . . 19.57 116.06 -173.103 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 CA--C 1.49 -1.361 0 CA-C-O 121.447 0.642 . . . . 17.17 110.874 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -89.39 152.07 21.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.239 1.971 . . . . 21.89 109.987 170.549 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 pt -126.33 168.71 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.668 2.787 . . . . 10.83 109.401 154.811 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -119.15 145.75 45.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.775 1.75 . . . . 10.61 110.927 164.255 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.9 123.53 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 116.618 -3.801 . . . . 9.13 107.897 169.305 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -93.09 121.14 34.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.884 3.23 . . . . 20.55 109.72 176.227 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 p -78.18 -176.88 4.83 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.098 -4.751 . . . . 11.78 111.663 -174.138 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.3 tp -81.9 -34.36 30.02 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 111.823 -6.798 . . . . 19.31 113.337 -175.666 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.1 p -88.15 -26.29 22.52 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.12 -2.238 . . . . 23.14 107.06 -173.18 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.41 0.21 Allowed Glycine 0 N--CA 1.43 -1.738 0 CA-C-N 118.968 0.804 . . . . 19.74 113.161 166.121 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -112.1 145.62 39.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.367 -1.666 . . . . 21.93 108.043 169.552 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -111.15 123.78 50.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.991 2.057 . . . . 12.33 106.743 176.08 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.6 pt -110.7 141.99 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.76 -1.212 . . . . 17.08 113.856 177.232 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.7 m -110.57 112.85 25.03 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 115.491 -4.506 . . . . 16.3 111.047 -174.782 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 30' ' ' ILE . 45.6 mt -106.35 124.13 49.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.443 2.068 . . . . 15.88 108.967 -173.953 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -97.6 105.43 17.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.865 -3.022 . . . . 28.9 111.987 176.698 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -131.47 149.25 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.921 2.088 . . . . 12.05 107.677 -159.617 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -85.5 151.83 56.59 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 112.592 -3.575 . . . . 18.17 113.182 176.334 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -84.71 -6.06 9.8 Favored 'Trans proline' 0 N--CA 1.434 -2.028 1 CA-C-N 132.554 5.519 . . . . 8.16 109.072 -168.866 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -98.64 5.68 47.57 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.559 -3.213 . . . . 11.13 110.117 176.91 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -75.76 157.73 33.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.79 3.186 . . . . 18.03 108.677 173.394 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 p -96.37 164.26 12.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.812 -3.68 . . . . 10.22 108.29 -175.972 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mm -76.96 -16.6 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 119.516 -1.99 . . . . 12.3 111.692 -176.326 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -64.27 -46.88 81.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.343 -1.725 . . . . 36.51 106.343 172.865 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.77 -30.95 71.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.617 -2.552 . . . . 25.66 113.48 -178.296 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.77 -44.07 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 126.707 3.146 . . . . 8.12 108.265 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -62.78 -39.25 93.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 120.67 3.581 . . . . 15.47 120.67 172.756 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.76 -41.1 77.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.741 2.817 . . . . 11.45 113.76 175.045 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -57.13 -32.47 66.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.847 1.259 . . . . 24.98 110.4 178.82 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 15' ' ' LEU . 8.5 mt -82.41 -37.71 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.977 1.846 . . . . 9.46 109.194 -173.075 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -62.1 -39.53 92.79 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.143 -1.598 . . . . 14.76 112.602 168.509 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.5 -55.16 30.13 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 115.621 -2.133 . . . . 26.29 113.052 175.236 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -78.52 -54.9 5.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.964 3.32 . . . . 30.06 119.964 -171.98 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -92.87 -36.13 12.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.548 -2.595 . . . . 25.19 112.115 176.991 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.84 55.98 2.56 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 117.763 -3.086 . . . . 7.41 115.425 -174.849 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.0 mt -108.93 135.87 20.1 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 116.111 -1.899 . . . . 9.49 105.982 172.945 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -71.53 146.58 49.98 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-O 112.397 -3.251 . . . . 11.42 119.591 -170.149 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -91.53 8.57 3.1 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 CA-C-N 128.163 3.951 . . . . 12.0 112.96 -165.729 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.42 -44.19 10.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.799 2.839 . . . . 35.55 109.142 165.393 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.31 -42.11 65.81 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 113.826 -2.988 . . . . 20.52 111.555 175.253 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.268 72.6 mt-30 -66.45 108.97 2.57 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 126.616 3.103 . . . . 7.13 115.67 -174.169 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -106.51 110.02 22.11 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.114 4.165 . . . . 36.39 105.278 -174.223 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HG ' HD12 ' A' ' 50' ' ' LEU . 25.8 tp -100.27 108.87 21.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 126.037 2.827 . . . . 9.55 108.182 -162.735 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -106.66 145.82 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.141 -3.475 . . . . 13.9 113.09 -173.54 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -129.99 100.17 5.35 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.624 2.631 . . . . 6.86 106.642 172.736 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.88 -75.51 0.07 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.638 -2.539 . . . . 11.15 115.63 -176.352 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.58 1.2 1.33 Allowed Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 126.527 2.013 . . . . 13.93 113.621 171.532 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -99.13 146.55 26.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.201 -2.352 . . . . 23.92 110.079 173.659 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.296 10.0 tt0 -91.1 117.29 29.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.045 2.609 . . . . 23.23 118.045 164.119 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.444 HD12 ' HG ' ' A' ' 43' ' ' LEU . 19.4 mt -65.85 131.92 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 1 C-N-CA 133.177 4.591 . . . . 9.11 113.581 170.841 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.9 146.33 44.01 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.811 -1.181 . . . . 33.44 107.811 -169.084 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.65 -27.45 68.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.19 -2.277 . . . . 28.37 115.563 -158.65 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.04 24.43 30.53 Favored Glycine 0 N--CA 1.43 -1.729 1 O-C-N 114.526 -5.109 . . . . 15.0 117.353 -166.335 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -129.22 166.46 19.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.479 -0.934 . . . . 25.5 108.479 -176.137 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.295 22.2 p -92.93 157.91 16.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.251 1.501 . . . . 11.95 111.052 -173.708 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.2 mt -55.76 -34.04 64.87 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.449 1.595 . . . . 10.17 113.463 168.77 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 t -78.42 -25.43 46.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.895 3.278 . . . . 13.59 118.869 170.751 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -61.77 -47.58 84.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.734 -2.479 . . . . 11.7 113.044 166.871 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -81.76 -16.63 50.43 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.456 3.102 . . . . 12.95 111.271 -179.205 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 56.51 51.46 11.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.125 2.97 . . . . 25.45 109.39 -178.583 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.39 120.19 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 110.851 -2.886 . . . . 14.6 108.679 163.24 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -83.49 176.82 8.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.451 1.9 . . . . 33.23 110.365 -176.564 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.274 47.7 mttp -81.98 134.39 35.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.141 2.576 . . . . 25.97 109.55 179.81 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 56.83 34.03 24.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.787 2.835 . . . . 32.61 116.141 -175.961 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -72.14 127.44 32.55 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 127.591 3.567 . . . . 10.56 111.67 166.007 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.6 m -95.65 109.12 21.43 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 112.16 -2.291 . . . . 5.33 112.499 179.297 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 mt -96.36 175.26 6.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.815 -1.178 . . . . 11.66 109.899 -172.945 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -128.65 136.13 50.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.827 -1.171 . . . . 16.3 112.432 -175.478 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 tp -120.6 129.77 53.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.552 -1.967 . . . . 9.96 108.004 -176.063 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.53 163.43 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.366 1.066 . . . . 9.76 109.727 170.186 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.43 -1.447 0 O-C-N 120.182 -1.574 . . . . 19.57 109.548 -169.172 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.366 0 CA-C-O 123.144 1.449 . . . . 17.17 108.774 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -108.29 138.06 45.22 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.202 -4.061 . . . . 21.89 108.74 -172.576 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -133.78 148.85 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.609 -2.557 . . . . 10.83 107.361 -179.842 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.68 110.88 22.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.729 2.122 . . . . 10.61 116.729 177.311 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 t -101.14 122.7 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 120.918 1.69 . . . . 9.13 108.863 175.635 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HG2' HG23 ' A' ' 12' ' ' THR . 49.0 mttt -90.32 111.32 22.48 Favored 'General case' 0 N--CA 1.429 -1.495 1 C-N-CA 131.881 4.072 . . . . 20.55 113.247 175.249 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -76.93 159.49 29.94 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.253 1.945 . . . . 11.78 116.253 176.942 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 tp -53.52 -49.69 67.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.239 2.215 . . . . 19.31 110.981 -178.605 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.4 p -65.85 -38.1 87.95 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.533 3.533 . . . . 23.14 113.751 178.37 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.66 51.07 0.26 Allowed Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 127.785 2.612 . . . . 19.74 116.496 -178.195 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -121.53 128.92 52.54 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.961 -1.905 . . . . 21.93 108.764 165.645 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.415 HG23 ' HG2' ' A' ' 6' ' ' LYS . 85.6 m -99.59 108.22 20.57 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.697 -3.752 . . . . 12.33 105.9 171.199 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pt -105.15 140.79 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 130.25 3.42 . . . . 17.08 104.536 -171.818 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -109.14 131.22 55.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.143 -2.848 . . . . 16.3 108.624 -170.239 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.0 mt -113.3 140.55 47.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.89 -1.893 . . . . 15.88 105.89 -179.147 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -100.24 128.25 46.35 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.585 -1.265 . . . . 28.9 107.585 171.127 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.05 152.15 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.193 -2.817 . . . . 12.05 117.188 -168.847 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.26 32.5 mt-10 -97.03 148.78 34.89 Favored Pre-proline 0 N--CA 1.43 -1.456 1 O-C-N 115.795 -4.316 . . . . 18.17 105.863 172.246 . . . . . . . . 3 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -82.31 -8.57 11.7 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.687 1.888 . . . . 8.16 111.899 -169.544 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -81.06 -12.47 59.31 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.944 2.097 . . . . 11.13 109.976 -179.086 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -90.7 154.36 19.61 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 126.457 3.027 . . . . 18.03 109.259 -176.582 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.9 p -83.11 175.83 9.69 Favored 'General case' 0 N--CA 1.43 -1.43 2 O-C-N 114.63 -5.043 . . . . 10.22 117.758 -170.386 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.0 mm -79.65 -25.79 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 1 O-C-N 113.432 -5.792 . . . . 12.3 111.862 178.647 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -47.58 -40.71 19.89 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.97 2.211 . . . . 36.51 116.97 165.978 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -70.29 -42.33 72.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.274 2.629 . . . . 25.66 111.855 176.711 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.443 HG21 HD21 ' A' ' 56' ' ' LEU . 68.4 t -67.86 -34.14 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 117.37 -3.331 . . . . 8.12 110.592 178.309 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.256 35.5 mtmt -65.4 -37.19 86.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.977 2.111 . . . . 15.47 112.541 166.792 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.88 -24.34 64.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.083 2.114 . . . . 11.45 112.559 -174.516 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -71.22 -37.89 72.02 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 133.599 4.76 . . . . 24.98 109.096 175.215 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' CG2' HD12 ' A' ' 36' ' ' ILE . 52.6 mt -80.51 -31.02 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.322 -1.487 . . . . 9.46 107.575 -174.535 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.06 -31.33 68.89 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.24 1.416 . . . . 14.76 112.971 177.201 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -82.28 -52.3 7.07 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.283 2.327 . . . . 26.29 117.283 -175.471 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -86.06 -54.55 4.41 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.269 1.985 . . . . 30.06 116.046 -177.657 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -72.32 -39.89 67.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.315 -1.491 . . . . 25.19 114.484 177.291 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.89 51.78 2.94 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 116.449 -3.907 . . . . 7.41 115.9 174.064 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.403 HD12 ' CG2' ' A' ' 30' ' ' ILE . 63.9 mt -113.18 129.21 24.78 Favored Pre-proline 0 N--CA 1.431 -1.421 0 C-N-CA 127.304 2.242 . . . . 9.49 107.909 -176.516 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -77.39 148.95 27.15 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 114.568 -3.438 . . . . 11.42 110.01 -164.682 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -71.3 -24.39 23.06 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.805 2.337 . . . . 12.0 113.919 -156.596 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.292 5.2 p-10 -63.61 -53.23 54.8 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.687 -2.508 . . . . 35.55 110.124 173.751 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -57.43 -13.81 4.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.522 -2.611 . . . . 20.52 117.376 -177.98 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -93.63 95.61 9.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.351 1.46 . . . . 7.13 109.311 -178.737 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -89.89 142.79 27.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 118.448 -1.301 . . . . 36.39 109.927 156.49 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 43' ' ' LEU . 12.0 mt -120.29 135.67 54.93 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.36 -0.978 . . . . 9.55 108.36 -177.19 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 49' ' ' GLN . 11.1 mm -120.31 138.22 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.667 2.787 . . . . 13.9 106.22 -179.685 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.431 ' HB2' HD11 ' A' ' 50' ' ' LEU . 25.4 t80 -112.76 114.72 27.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.995 2.918 . . . . 6.86 106.439 165.632 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.62 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.912 2.19 . . . . 11.15 116.912 -173.649 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.51 8.01 2.04 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 129.115 3.245 . . . . 13.93 106.525 -175.571 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -125.4 144.95 50.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.196 2.498 . . . . 23.92 111.927 -173.539 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.401 ' HA ' HD13 ' A' ' 44' ' ' ILE . 22.1 tt0 -103.13 134.5 46.45 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.884 1.326 . . . . 23.23 111.127 -161.682 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 45' ' ' PHE . 50.1 mt -84.68 143.89 28.91 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 115.882 -2.008 . . . . 9.11 110.674 -176.105 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -135.11 156.37 49.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 126.529 2.393 . . . . 33.44 111.134 -173.059 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.79 -50.55 19.99 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 118.807 2.892 . . . . 28.37 118.807 -147.407 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.65 2.07 18.38 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 121.078 3.191 . . . . 15.0 121.078 -177.964 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -106.92 148.89 28.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.269 1.509 . . . . 25.5 109.613 -174.415 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -90.85 159.26 16.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.027 2.531 . . . . 11.95 111.17 -162.023 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 26' ' ' VAL . 8.4 mt -58.23 -45.23 88.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.809 2.844 . . . . 10.17 108.378 172.111 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -57.58 -50.14 74.08 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.798 2.09 . . . . 13.59 114.505 178.325 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -60.53 -35.89 77.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.524 -1.36 . . . . 11.7 113.509 174.61 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -79.11 2.31 21.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.361 -3.337 . . . . 12.95 116.554 177.941 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.376 4.2 m120 71.39 34.52 1.7 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.213 -1.554 . . . . 25.45 111.932 -179.602 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.8 98.63 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 105.826 -1.916 . . . . 14.6 105.826 -165.84 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -107.13 -152.89 0.49 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.347 2.022 . . . . 33.23 112.16 -174.729 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -73.87 116.96 15.09 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.882 2.549 . . . . 25.97 117.882 -170.314 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 81.38 50.2 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.287 2.635 . . . . 32.61 106.468 163.601 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 152.66 25.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.983 1.713 . . . . 10.56 112.554 -169.859 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -94.58 115.91 28.13 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.483 3.513 . . . . 5.33 112.754 -164.416 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -116.07 147.51 41.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.024 -3.548 . . . . 11.66 111.261 173.993 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -121.2 127.69 51.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.916 -2.253 . . . . 16.3 104.916 -175.618 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 tp -91.11 109.94 21.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.533 2.42 . . . . 9.96 117.533 178.473 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.87 156.09 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.199 2.599 . . . . 9.76 106.458 -172.763 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.7 tp . . . . . 0 N--CA 1.43 -1.45 0 O-C-N 119.162 -2.211 . . . . 19.57 112.524 173.289 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 115.061 1.504 . . . . 17.17 115.061 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -113.2 145.49 40.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.165 -2.21 . . . . 21.89 110.467 -174.654 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 pt -127.35 154.42 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.311 -1.737 . . . . 10.83 106.311 173.042 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -119.43 115.5 24.2 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.274 2.306 . . . . 10.61 106.987 -176.656 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.97 106.85 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.292 -1.505 . . . . 9.13 113.471 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -83.56 110.2 18.03 Favored 'General case' 0 N--CA 1.43 -1.466 1 CA-C-O 128.648 4.07 . . . . 20.55 110.855 175.845 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.258 15.1 p -74.04 176.85 6.11 Favored 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 131.914 4.086 . . . . 11.78 113.238 -171.269 . . . . . . . . 3 2 . 1 . 036 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.66 -46.93 62.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.843 2.259 . . . . 19.31 114.743 -170.844 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.3 p -74.88 -91.24 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.216 3.006 . . . . 23.14 109.339 179.355 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.18 33.55 0.34 Allowed Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 121.59 1.995 . . . . 19.74 113.454 -174.675 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -122.64 141.99 51.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.136 -3.567 . . . . 21.93 115.089 178.108 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -109.54 123.56 49.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.768 -1.832 . . . . 12.33 111.461 170.477 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.0 pt -101.0 144.9 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 117.554 -1.212 . . . . 17.08 110.556 178.86 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.8 m -104.55 114.45 28.69 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.186 -2.34 . . . . 16.3 107.86 176.309 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.547 ' CD1' HG13 ' A' ' 26' ' ' VAL 0.313 96.5 mt -106.76 158.31 17.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.144 2.878 . . . . 15.88 105.234 176.021 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.323 27.0 tt0 -104.64 121.19 43.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 113.165 -1.834 . . . . 28.9 108.914 173.206 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -141.39 154.71 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 120.064 -1.647 . . . . 12.05 107.501 -179.517 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -87.87 158.37 50.53 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 119.603 -1.936 . . . . 18.17 106.907 167.229 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.12 -1.6 11.75 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 CA-C-N 122.169 1.81 . . . . 8.16 115.664 174.117 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.5 m -86.25 -16.57 37.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.834 3.272 . . . . 11.13 119.834 173.75 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -84.26 170.25 13.9 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.872 2.869 . . . . 18.03 109.196 -174.766 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.5 p -90.92 -176.77 4.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.463 -3.273 . . . . 10.22 116.615 -173.084 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -83.16 -19.3 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 116.419 -3.926 . . . . 12.3 108.703 173.986 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -73.0 -42.51 63.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.055 -2.903 . . . . 36.51 107.309 178.216 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -54.82 -26.67 36.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.203 -1.856 . . . . 25.66 111.337 174.34 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.547 HG13 ' CD1' ' A' ' 15' ' ' LEU . 20.0 t -67.24 -54.85 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 117.795 2.517 . . . . 8.12 117.795 167.703 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -62.48 -30.55 71.34 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 118.306 -2.746 . . . . 15.47 116.092 -177.981 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.68 -49.79 56.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.827 3.651 . . . . 11.45 116.153 164.074 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -63.89 -35.89 82.14 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.381 2.672 . . . . 24.98 109.845 178.04 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.49 -43.39 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.806 1.288 . . . . 9.46 112.372 177.521 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -72.43 -37.89 68.49 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 113.899 -2.953 . . . . 14.76 109.586 -179.479 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.68 -45.79 42.2 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.408 2.822 . . . . 26.29 111.18 179.398 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -88.49 -55.29 3.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.202 -0.999 . . . . 30.06 112.703 -168.926 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -75.62 -63.28 1.33 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.094 1.426 . . . . 25.19 110.774 -176.214 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.11 40.3 0.45 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 125.376 1.465 . . . . 7.41 115.099 173.804 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -104.07 118.46 57.0 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-O 116.581 -1.676 . . . . 9.49 108.443 175.255 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -64.21 156.89 56.86 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 124.752 3.635 . . . . 11.42 112.11 -170.595 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.6 -18.78 25.24 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 115.57 1.335 . . . . 12.0 115.57 -161.171 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.59 -13.23 32.33 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 127.132 3.349 . . . . 35.55 107.013 -165.269 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.99 -6.65 58.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 112.171 -2.286 . . . . 20.52 115.778 175.193 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -102.35 107.28 18.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.735 2.124 . . . . 7.13 116.735 -162.723 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -117.77 125.3 50.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.693 -1.254 . . . . 36.39 107.9 172.754 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 mt -102.12 128.22 48.7 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.971 -2.33 . . . . 9.55 111.302 179.43 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.8 mt -110.01 141.72 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.608 2.363 . . . . 13.9 108.246 169.811 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.431 ' HB3' HD21 ' A' ' 50' ' ' LEU . 21.0 t80 -136.09 131.35 34.71 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.233 -2.136 . . . . 6.86 105.233 174.148 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.15 -97.54 0.07 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.303 1.841 . . . . 11.15 112.354 -167.633 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.66 5.15 7.06 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 119.914 -1.741 . . . . 13.93 115.901 171.61 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -111.71 143.88 41.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.947 3.699 . . . . 23.92 112.146 -175.817 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -90.41 132.83 35.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 114.641 1.349 . . . . 23.23 114.641 176.643 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.4 mt -87.86 139.74 30.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.756 2.422 . . . . 9.11 113.855 -172.891 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.03 -176.25 6.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.028 2.531 . . . . 33.44 110.76 168.978 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -83.02 -69.54 0.62 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 116.397 -3.939 . . . . 28.37 113.743 -176.557 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.9 56.35 4.36 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 120.387 -1.445 . . . . 15.0 116.007 -167.852 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -148.5 138.78 22.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 114.584 -2.627 . . . . 25.5 106.438 -172.669 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 44.3 p -79.68 163.87 24.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.309 2.956 . . . . 11.95 112.043 -167.926 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.51 -45.98 91.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 110.488 -3.051 . . . . 10.17 108.347 172.119 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 m -54.85 -39.47 68.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 125.56 1.787 . . . . 13.59 115.017 174.312 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -63.36 -53.5 51.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.306 -2.121 . . . . 11.7 113.213 176.199 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -70.25 -5.56 28.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.857 -1.065 . . . . 12.95 113.734 178.017 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 66.61 52.28 1.02 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.93 2.492 . . . . 25.45 110.595 179.237 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.9 119.13 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.041 -2.207 . . . . 14.6 105.041 175.758 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -120.05 -172.47 2.36 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.163 2.585 . . . . 33.23 108.72 -163.93 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -64.24 115.93 5.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 112.926 -3.416 . . . . 25.97 116.246 -174.368 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 76.93 18.7 1.5 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.986 3.314 . . . . 32.61 114.181 -176.164 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.0 m -61.12 145.27 51.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.643 -3.161 . . . . 10.56 115.68 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -94.42 126.29 39.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.705 -2.497 . . . . 5.33 115.899 171.457 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 45' ' ' PHE 0.251 22.0 mt -108.31 152.81 24.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.727 1.01 . . . . 11.66 113.727 172.62 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -114.45 131.59 56.55 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.919 -3.613 . . . . 16.3 111.656 -177.928 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.6 tp -109.56 122.6 47.79 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 118.457 -0.782 . . . . 9.96 109.705 -178.85 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.86 -168.77 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.413 -1.699 . . . . 9.76 106.413 -170.522 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.0 tp . . . . . 0 N--CA 1.43 -1.446 0 N-CA-C 105.405 -2.072 . . . . 19.57 105.405 -169.742 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 119.589 3.181 . . . . 17.17 119.589 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -65.37 140.33 58.64 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 117.049 2.241 . . . . 21.89 117.049 163.354 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.4 pt -124.6 159.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.517 -1.99 . . . . 10.83 111.45 166.262 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -110.41 122.12 46.95 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 115.679 -2.105 . . . . 10.61 115.555 170.478 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.6 t -110.43 110.1 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 101.827 -3.397 . . . . 9.13 101.827 -179.096 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -75.72 134.86 40.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.187 2.195 . . . . 20.55 114.124 175.684 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -98.42 -169.14 1.75 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.944 -1.132 . . . . 11.78 107.944 -172.963 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.6 tp -91.01 -38.33 12.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.254 -1.758 . . . . 19.31 106.254 -168.353 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.328 62.1 p -71.67 -69.77 0.36 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.067 1.877 . . . . 23.14 116.067 171.858 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.5 42.36 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 O-C-N 116.977 -3.577 . . . . 19.74 119.417 177.895 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -112.48 129.42 56.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 114.317 -2.754 . . . . 21.93 104.96 -172.517 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -88.71 105.72 17.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.726 2.679 . . . . 12.33 109.862 165.266 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.0 mt -86.12 110.91 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 116.616 -3.802 . . . . 17.08 111.427 175.253 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -100.55 113.75 26.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.274 1.852 . . . . 16.3 114.712 -172.925 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -116.26 139.39 50.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.359 0.982 . . . . 15.88 111.886 -167.014 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -96.73 109.13 21.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.434 -2.042 . . . . 28.9 110.808 -179.164 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.42 156.13 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 118.266 -2.771 . . . . 12.05 108.645 -174.629 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -107.55 136.79 19.59 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.243 -1.536 . . . . 18.17 110.172 170.576 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.11 -5.45 14.46 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 122.578 2.185 . . . . 8.16 113.275 -155.425 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -93.12 -8.81 41.59 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 112.187 -3.768 . . . . 11.13 110.876 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -77.71 177.57 8.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 128.628 3.705 . . . . 18.03 115.204 166.415 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.2 p -115.62 -178.23 3.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.383 -2.698 . . . . 10.22 109.615 -169.401 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.485 HD12 HD13 ' A' ' 50' ' ' LEU 0.308 11.9 mm -63.09 -35.53 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 116.939 -3.601 . . . . 12.3 113.09 175.725 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.2 -33.17 51.62 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.157 -4.089 . . . . 36.51 114.629 174.953 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -64.97 -39.24 93.18 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.294 -2.129 . . . . 25.66 111.832 174.857 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.6 t -73.91 -45.63 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.843 -1.785 . . . . 8.12 107.27 -174.228 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.288 38.9 ttmt -63.9 -30.63 71.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.709 -3.744 . . . . 15.47 111.478 -178.766 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.03 89.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.696 2.799 . . . . 11.45 117.328 171.021 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -71.97 -21.86 61.52 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.527 2.417 . . . . 24.98 117.527 174.127 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.2 mt -75.24 -30.84 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 127.675 3.607 . . . . 9.46 114.077 164.217 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.92 -47.53 82.87 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.529 -4.482 . . . . 14.76 111.798 168.08 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.94 -47.24 21.51 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.321 -1.487 . . . . 26.29 111.678 -172.711 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -74.18 -76.84 0.12 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 116.825 -1.559 . . . . 30.06 112.373 -176.332 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -80.26 -38.34 31.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.829 3.251 . . . . 25.19 108.099 -161.564 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.01 50.83 3.36 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-O 123.952 1.862 . . . . 7.41 111.669 -176.144 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.1 mt -101.66 120.01 55.58 Favored Pre-proline 0 N--CA 1.43 -1.468 1 O-C-N 114.703 -4.998 . . . . 9.49 109.605 165.216 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.9 158.66 56.35 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 126.883 3.494 . . . . 11.42 114.671 -174.27 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.85 -7.83 5.24 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 CA-C-N 128.995 4.248 . . . . 12.0 110.977 -157.618 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -70.83 -32.26 69.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.767 2.827 . . . . 35.55 106.626 175.521 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -88.02 -11.79 46.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.981 -2.949 . . . . 20.52 113.755 177.994 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -84.74 122.51 29.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.853 2.861 . . . . 7.13 112.818 176.577 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -129.95 146.96 51.66 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.147 -2.221 . . . . 36.39 105.014 154.061 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.85 122.19 44.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.16 1.457 . . . . 9.55 107.72 -173.371 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -110.22 131.69 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 128.298 2.639 . . . . 13.9 111.907 -179.412 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -126.02 118.75 26.0 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 114.417 -5.177 . . . . 6.86 103.763 176.386 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.395 . . 65.8 -98.8 0.06 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.483 2.031 . . . . 11.15 116.483 -164.944 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.13 13.82 4.35 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 127.759 2.599 . . . . 13.93 109.951 -173.861 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -132.02 147.28 52.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.217 -2.343 . . . . 23.92 113.025 -177.408 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -85.76 146.34 26.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.293 2.473 . . . . 23.23 110.533 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.485 HD13 HD12 ' A' ' 23' ' ' ILE . 94.1 mt -93.55 148.4 22.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.673 -2.517 . . . . 9.11 110.987 178.049 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.305 10.0 pt-20 -80.69 -168.86 1.91 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.572 1.949 . . . . 33.44 110.111 175.969 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -105.77 -47.39 3.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.111 3.338 . . . . 28.37 113.186 174.985 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.93 59.92 1.01 Allowed Glycine 0 N--CA 1.43 -1.715 1 O-C-N 115.394 -4.566 . . . . 15.0 115.088 -173.022 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -139.42 139.29 37.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.387 -1.338 . . . . 25.5 107.387 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 50.1 p -80.07 163.75 23.92 Favored 'General case' 0 N--CA 1.43 -1.45 1 CA-C-O 128.903 4.192 . . . . 11.95 111.351 -166.887 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -67.3 -37.52 83.53 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.619 -4.425 . . . . 10.17 114.342 -179.761 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -72.53 -27.13 62.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.802 1.641 . . . . 13.59 115.064 176.187 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -73.13 -39.16 65.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.073 -3.517 . . . . 11.7 107.019 172.483 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.06 -0.07 23.28 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.453 1.101 . . . . 12.95 111.779 178.801 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 51.09 60.12 4.11 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.363 -2.711 . . . . 25.45 114.685 179.355 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.0 mm -104.28 132.9 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 127.971 2.509 . . . . 14.6 109.191 170.592 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -111.1 -179.82 3.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.007 1.861 . . . . 33.23 114.362 -179.07 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -59.33 118.7 6.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.087 -1.87 . . . . 25.97 114.902 172.55 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.321 55.7 mt-10 76.27 35.0 0.48 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.437 -3.914 . . . . 32.61 112.874 173.464 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -90.63 141.92 28.28 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.094 1.757 . . . . 10.56 109.818 -175.553 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -87.55 128.14 35.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 113.878 -1.51 . . . . 5.33 113.528 176.239 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.57 149.35 42.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.144 2.978 . . . . 11.66 104.693 174.357 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -119.78 135.41 54.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.088 -1.008 . . . . 16.3 111.598 176.304 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.75 110.98 23.47 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.051 1.405 . . . . 9.96 112.609 177.584 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -99.18 -174.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.207 2.432 . . . . 9.76 108.837 -178.653 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 tp . . . . . 0 N--CA 1.43 -1.448 1 O-C-N 115.796 -4.315 . . . . 19.57 106.706 -177.437 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 117.057 2.243 . . . . 17.17 117.057 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 81.9 mt-30 -80.92 135.63 35.93 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 116.084 -4.135 . . . . 21.89 111.73 -176.107 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.71 153.24 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.177 -2.527 . . . . 10.83 104.177 161.049 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.279 50.2 m-85 -115.06 121.86 44.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 126.798 2.561 . . . . 10.61 111.634 -174.085 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.07 112.69 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 116.501 -3.875 . . . . 9.13 110.504 -173.288 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -95.45 147.28 23.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.919 2.295 . . . . 20.55 106.36 -176.437 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.3 p -89.06 -178.14 5.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.785 -3.072 . . . . 11.78 106.635 174.109 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.2 tp -63.37 -47.8 80.59 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 117.912 -1.042 . . . . 19.31 112.87 168.576 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -55.63 -50.16 70.93 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.103 2.561 . . . . 23.14 111.16 171.319 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.9 49.78 0.3 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 118.887 -2.383 . . . . 19.74 109.311 169.391 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -90.42 124.48 34.99 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 103.179 -2.897 . . . . 21.93 103.179 176.918 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -97.67 115.13 27.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.345 2.498 . . . . 12.33 109.068 -175.672 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.5 mt -105.81 113.88 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.29 -2.232 . . . . 17.08 106.249 178.419 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -88.49 133.69 34.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.604 -3.185 . . . . 16.3 111.342 173.298 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 58.0 mt -120.6 172.25 7.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.986 2.054 . . . . 15.88 108.937 -175.101 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -128.26 114.65 17.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.094 -1.628 . . . . 28.9 108.748 170.182 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.37 152.53 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 125.801 1.938 . . . . 12.05 108.366 -177.812 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.26 140.22 28.67 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-O 114.21 -2.805 . . . . 18.17 113.799 157.641 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 73.3 Cg_endo -81.7 -4.69 12.25 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 123.987 2.46 . . . . 8.16 111.258 -169.722 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 m -82.68 4.09 26.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.85 2.907 . . . . 11.13 118.85 163.553 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -99.94 176.86 5.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.015 2.189 . . . . 18.03 106.572 173.876 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.369 11.0 p -89.3 -169.92 2.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.48 -1.236 . . . . 10.22 113.827 -166.404 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 mm -81.05 -18.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.672 2.389 . . . . 12.3 115.258 161.478 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -71.32 -29.64 65.27 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 123.88 0.872 . . . . 36.51 109.08 173.659 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -60.57 -45.67 93.05 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.047 1.739 . . . . 25.66 110.819 169.29 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -65.29 -35.56 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 119.16 0.891 . . . . 8.12 109.198 -175.496 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -65.15 -37.59 87.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.857 1.429 . . . . 15.47 114.857 168.889 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.274 . . -70.0 -33.02 71.5 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.299 2.703 . . . . 11.45 118.299 172.469 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -65.93 -33.04 74.9 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.358 -3.964 . . . . 24.98 110.775 173.729 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.5 mt -65.98 -44.87 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 117.051 -3.53 . . . . 9.46 108.386 167.122 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.76 -38.65 82.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.959 1.709 . . . . 14.76 112.344 176.099 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.99 -46.87 49.79 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.304 -0.872 . . . . 26.29 110.871 179.316 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -77.01 -57.78 3.65 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 116.498 -2.081 . . . . 30.06 113.059 -173.362 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -91.5 -52.14 4.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.908 1.337 . . . . 25.19 109.267 -167.934 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.22 30.02 3.05 Favored Glycine 0 N--CA 1.43 -1.708 1 C-N-CA 132.061 4.648 . . . . 7.41 115.037 173.534 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.5 mt -81.34 135.15 50.64 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 119.068 -2.431 . . . . 9.49 106.055 175.071 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -68.88 137.67 38.71 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-O 114.203 -2.499 . . . . 11.42 116.354 177.819 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.39 -12.14 22.81 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 124.158 3.239 . . . . 12.0 113.933 -175.532 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -74.56 -26.82 60.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.583 1.992 . . . . 35.55 113.826 167.655 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -95.37 3.81 54.01 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.008 2.523 . . . . 20.52 113.138 178.25 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' HG2' HD11 ' A' ' 69' ' ' LEU . 72.8 mt-30 -99.06 133.66 43.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.264 -2.148 . . . . 7.13 114.751 178.201 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -113.4 121.0 43.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.187 2.595 . . . . 36.39 109.947 158.63 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 mt -100.67 140.85 34.36 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.269 -2.77 . . . . 9.55 109.829 174.945 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mt -141.73 138.62 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 105.013 -2.217 . . . . 13.9 105.013 -169.36 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -123.46 117.99 26.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.07 -1.019 . . . . 6.86 111.027 172.871 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.299 . . 74.63 -108.01 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.525 -2.398 . . . . 11.15 104.525 176.002 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.34 6.18 5.63 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 119.031 -2.293 . . . . 13.93 113.629 168.699 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.283 38.3 pttt -81.12 135.52 35.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.671 2.1 . . . . 23.92 116.671 159.79 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -82.76 162.31 21.77 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.462 -3.899 . . . . 23.23 107.908 172.985 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.6 mt -110.42 133.5 53.22 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.23 1.967 . . . . 9.11 115.044 175.104 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.79 153.08 19.09 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.739 2.126 . . . . 33.44 116.739 163.856 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.23 -30.63 60.62 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 131.306 3.842 . . . . 28.37 116.819 -160.213 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.94 34.48 4.64 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 126.244 2.215 . . . . 15.0 117.665 177.312 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -140.2 146.86 39.25 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 118.547 1.173 . . . . 25.5 109.109 -170.874 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 68.4 p -89.66 164.18 14.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.537 1.517 . . . . 11.95 114.537 -173.088 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 11.9 mt -55.19 -46.28 75.85 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.522 3.529 . . . . 10.17 110.878 166.372 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 m -58.53 -52.12 67.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.621 1.568 . . . . 13.59 109.717 173.481 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.93 -32.82 30.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.493 2.406 . . . . 11.7 109.965 -168.96 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -61.88 -34.5 76.12 Favored 'General case' 0 N--CA 1.43 -1.45 1 N-CA-C 122.269 4.174 . . . . 12.95 122.269 161.873 . . . . . . . . 4 4 . 1 . 038 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 66.8 m-80 90.35 59.86 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.108 2.163 . . . . 25.45 109.781 177.415 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mm -107.53 108.84 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 113.253 -1.794 . . . . 14.6 106.621 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.313 10.0 pt20 -83.84 176.65 8.76 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.108 -2.87 . . . . 33.23 117.858 -178.223 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -68.73 125.08 25.46 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 130.487 3.515 . . . . 25.97 110.533 168.574 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 64.63 39.28 6.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 130.516 3.526 . . . . 32.61 115.922 -171.216 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.8 m -78.18 165.03 24.43 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 113.308 0.855 . . . . 10.56 113.308 172.165 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m -106.01 139.04 41.16 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 126.534 1.933 . . . . 5.33 106.855 170.52 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.38 156.78 41.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.86 -3.025 . . . . 11.66 107.707 171.235 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -112.69 117.7 32.96 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.173 -3.455 . . . . 16.3 107.436 -175.887 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.419 HD11 ' HG2' ' A' ' 41' ' ' GLN 0.257 12.4 tp -101.37 121.39 41.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.524 -2.61 . . . . 9.96 114.97 169.206 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.307 10.7 m -121.4 158.52 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 130.425 3.49 . . . . 9.76 102.83 177.945 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tp . . . . . 0 N--CA 1.43 -1.471 0 CA-C-N 114.672 -1.149 . . . . 19.57 113.881 166.641 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.491 -1.32 0 CA-C-O 118.34 -0.838 . . . . 17.17 112.882 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.09 150.07 23.62 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.537 -3.852 . . . . 21.89 109.156 177.202 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.282 32.0 pt -131.45 159.03 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 128.59 2.756 . . . . 10.83 109.815 169.345 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -110.95 141.87 43.81 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.696 -1.965 . . . . 10.61 105.696 173.41 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 30' ' ' ILE . 4.9 t -108.47 120.02 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 120.457 1.48 . . . . 9.13 108.851 161.205 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -103.03 125.18 49.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.557 2.343 . . . . 20.55 110.851 -179.135 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -88.01 148.23 24.62 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.215 1.006 . . . . 11.78 112.751 177.889 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.338 14.5 tp -51.16 -40.2 58.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.659 2.384 . . . . 19.31 110.825 162.995 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.5 m -64.58 -50.77 65.95 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 121.105 1.775 . . . . 23.14 112.481 -179.19 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.0 19.34 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 123.787 1.771 . . . . 19.74 116.675 169.351 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -103.37 138.42 40.14 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.243 -3.504 . . . . 21.93 112.417 177.864 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.9 m -99.59 124.73 45.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.244 -2.16 . . . . 12.33 108.796 162.894 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 13' ' ' ILE . 42.8 mt -119.75 119.38 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 126.41 1.884 . . . . 17.08 110.093 -171.053 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -82.76 119.08 23.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.08 -3.512 . . . . 16.3 106.446 -169.047 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 mt -106.27 159.39 16.15 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 116.226 -4.046 . . . . 15.88 111.352 169.378 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -99.45 134.92 41.62 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 121.605 2.002 . . . . 28.9 109.5 154.735 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.69 156.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 125.416 2.532 . . . . 12.05 106.589 175.727 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -96.94 153.18 38.65 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 112.354 -2.203 . . . . 18.17 110.633 173.922 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.11 -24.16 28.37 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 127.251 3.625 . . . . 8.16 111.319 178.997 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 p -81.21 -13.88 58.11 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.404 3.002 . . . . 11.13 111.49 -171.736 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -67.19 151.23 47.92 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.729 -4.982 . . . . 18.03 113.809 176.785 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.275 22.3 p -80.66 153.36 27.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 120.282 3.438 . . . . 10.22 120.282 162.973 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.3 mm -64.75 -26.61 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 125.772 2.701 . . . . 12.3 112.123 -179.218 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.257 20.4 tt0 -44.37 -46.63 9.48 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.855 -4.278 . . . . 36.51 116.345 162.663 . . . . . . . . 3 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -69.32 -37.82 77.92 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.012 2.925 . . . . 25.66 111.329 172.097 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.256 58.5 t -63.44 -47.36 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 119.398 0.999 . . . . 8.12 113.167 170.99 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -49.24 -43.24 42.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.167 2.284 . . . . 15.47 117.167 168.315 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.37 -28.6 69.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 117.915 2.561 . . . . 11.45 117.915 173.496 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -83.32 -29.09 28.57 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.603 1.334 . . . . 24.98 114.603 175.304 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.426 HD11 HG21 ' A' ' 5' ' ' VAL . 69.4 mt -70.68 -36.3 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.837 -1.074 . . . . 9.46 108.202 169.61 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.12 -37.75 88.46 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.547 -1.692 . . . . 14.76 115.337 171.025 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.16 -43.62 67.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.703 2.047 . . . . 26.29 111.334 179.619 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -70.7 -76.16 0.11 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.032 2.133 . . . . 30.06 115.347 177.81 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -81.44 -28.75 34.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.16 2.584 . . . . 25.19 108.974 -169.725 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.63 43.57 6.08 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 116.437 -2.313 . . . . 7.41 113.64 -176.231 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 mt -105.25 121.63 45.69 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 115.966 -1.968 . . . . 9.49 114.671 176.18 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.5 149.8 74.78 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 126.436 3.334 . . . . 11.42 115.292 -175.288 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -73.67 -18.4 22.36 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 127.075 3.562 . . . . 12.0 118.291 -168.378 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -71.06 -32.64 69.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.409 -2.682 . . . . 35.55 111.672 179.194 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -91.92 2.76 56.33 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 117.211 -1.376 . . . . 20.52 111.856 -179.693 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -89.17 119.72 29.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.698 3.199 . . . . 7.13 116.164 177.619 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -138.7 119.62 14.34 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 123.865 0.866 . . . . 36.39 108.957 171.701 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -101.12 136.7 40.55 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.953 1.835 . . . . 9.55 113.822 -177.557 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mt -114.61 127.81 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 C-N-CA 134.338 5.055 . . . . 13.9 107.213 -179.46 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -116.32 106.04 13.21 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.56 -1.274 . . . . 6.86 107.56 166.551 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.05 -71.97 0.07 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 116.364 1.987 . . . . 11.15 116.364 -170.298 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.32 -14.0 0.97 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 128.571 2.986 . . . . 13.93 116.33 174.458 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -101.74 144.63 30.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.019 2.91 . . . . 23.92 111.028 -167.382 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.265 15.2 pt20 -65.49 123.12 18.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.744 2.818 . . . . 23.23 113.539 167.067 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.9 mt -94.42 139.32 31.28 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 101.325 -3.583 . . . . 9.11 101.325 -174.853 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.88 176.61 8.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.328 2.251 . . . . 33.44 111.213 168.241 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.31 -53.41 3.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.36 -2.712 . . . . 28.37 112.619 -172.251 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 53.05 4.82 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 118.035 -2.915 . . . . 15.0 119.118 175.222 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -132.03 139.3 48.53 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 119.44 1.62 . . . . 25.5 110.123 166.951 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.286 56.9 p -75.33 150.77 38.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.757 -1.839 . . . . 11.95 112.977 -172.098 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.1 mt -51.44 -33.41 30.63 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.289 2.636 . . . . 10.17 114.601 165.443 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.309 22.7 t -59.9 -50.05 75.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.479 3.511 . . . . 13.59 110.216 168.328 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -86.1 -32.63 21.24 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.363 -2.088 . . . . 11.7 105.363 -163.618 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -60.16 -25.42 65.52 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.172 -2.83 . . . . 12.95 113.341 167.093 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 68.65 54.56 0.5 Allowed 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 131.679 3.992 . . . . 25.45 113.027 -179.058 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.03 131.39 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.596 -2.001 . . . . 14.6 105.596 174.307 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -108.01 -171.66 1.91 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.579 1.326 . . . . 33.23 114.579 178.099 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -76.83 134.82 38.94 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.009 2.596 . . . . 25.97 118.009 -174.943 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 53.12 45.43 28.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 116.937 2.199 . . . . 32.61 116.937 -166.835 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.357 49.3 m -94.85 139.59 31.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 100.303 -3.962 . . . . 10.56 100.303 -175.356 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -98.83 122.47 42.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.092 0.86 . . . . 5.33 108.952 179.465 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mp -98.03 147.39 24.57 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.576 -1.327 . . . . 11.66 111.393 167.118 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -103.92 127.43 51.45 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.243 -3.41 . . . . 16.3 119.215 172.366 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.09 132.54 35.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.402 -2.061 . . . . 9.96 113.883 175.163 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.28 -176.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 125.383 1.473 . . . . 9.76 109.437 168.418 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 N--CA 1.431 -1.416 0 O-C-N 116.402 -3.936 . . . . 19.57 110.986 175.403 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 118.551 2.797 . . . . 17.17 118.551 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -93.3 113.15 25.27 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 101.864 -3.384 . . . . 21.89 101.864 178.467 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -120.1 149.74 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 104.331 -2.47 . . . . 10.83 104.331 170.936 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -107.05 121.28 44.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.189 1.471 . . . . 10.61 109.629 -172.103 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -100.12 117.46 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 O-C-N 115.15 -4.719 . . . . 9.13 102.129 175.312 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -100.56 123.95 45.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.654 -2.529 . . . . 20.55 111.127 176.902 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -86.5 -176.54 5.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.422 -2.674 . . . . 11.78 109.28 -174.12 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 tp -70.55 -50.08 41.24 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.225 2.21 . . . . 19.31 110.075 178.633 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.4 p -72.93 -29.57 63.21 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.261 -1.755 . . . . 23.14 106.261 -178.065 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.2 54.03 0.31 Allowed Glycine 0 N--CA 1.43 -1.753 0 O-C-N 118.692 -2.505 . . . . 19.74 107.67 162.626 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -107.54 135.7 48.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.536 2.112 . . . . 21.93 109.608 171.473 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -96.42 109.61 22.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.629 -1.919 . . . . 12.33 106.046 -173.803 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 mt -102.22 96.26 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 126.424 3.011 . . . . 17.08 105.512 178.816 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.9 m -88.83 117.43 27.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.345 -3.347 . . . . 16.3 108.989 -172.969 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 mt -109.71 137.49 47.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.903 -2.373 . . . . 15.88 112.259 -167.549 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -106.66 101.44 10.89 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.696 -1.878 . . . . 28.9 109.47 177.311 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.26 163.01 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 118.802 -2.436 . . . . 12.05 109.396 -175.318 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -85.55 164.9 38.31 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 118.44 -2.663 . . . . 18.17 109.493 173.4 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.82 -4.45 3.33 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 C-N-CA 123.223 2.616 . . . . 8.16 111.573 -174.463 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -87.85 -6.45 58.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.006 2.923 . . . . 11.13 111.838 175.665 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.48 159.03 18.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.273 -3.392 . . . . 18.03 114.443 -179.323 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -90.44 165.67 13.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.394 1.569 . . . . 10.22 111.985 -173.964 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -69.17 -20.42 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 127.415 3.483 . . . . 12.3 113.636 171.905 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.11 -43.34 87.47 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.047 -5.408 . . . . 36.51 112.759 174.037 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -70.93 -32.53 69.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.061 -1.447 . . . . 25.66 113.717 178.362 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.2 t -61.08 -38.61 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 131.231 3.813 . . . . 8.12 111.927 169.866 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -67.01 -42.44 84.95 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.742 -1.599 . . . . 15.47 114.43 165.401 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.02 -37.28 74.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 117.56 2.429 . . . . 11.45 117.56 172.098 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.281 57.5 mmtt -46.26 -35.91 5.69 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 126.073 2.844 . . . . 24.98 117.712 165.398 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.2 mt -93.95 -34.47 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 117.776 -3.077 . . . . 9.46 111.429 -172.695 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -48.01 81.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.76 0.824 . . . . 14.76 111.961 160.842 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.279 12.5 t70 -53.52 -57.76 9.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.149 1.928 . . . . 26.29 114.246 169.942 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -81.16 -51.64 8.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.659 -1.275 . . . . 30.06 112.364 -170.506 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -96.43 -42.09 8.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 116.814 -3.679 . . . . 25.19 101.791 -163.257 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.88 42.9 3.7 Favored Glycine 0 N--CA 1.43 -1.744 1 O-C-N 115.935 -4.228 . . . . 7.41 115.852 -170.502 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 90.6 mt -111.12 120.36 43.39 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 113.393 -3.194 . . . . 9.49 107.94 177.077 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -66.96 148.89 82.72 Favored 'Trans proline' 0 N--CA 1.434 -1.975 0 CA-C-N 125.778 3.099 . . . . 11.42 114.425 -178.093 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -74.05 -18.86 20.92 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 123.645 2.338 . . . . 12.0 117.868 -161.815 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -60.63 -18.86 55.94 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.815 2.524 . . . . 35.55 117.815 173.962 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -97.33 -12.57 22.68 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.03 2.132 . . . . 20.52 114.002 -175.139 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -98.91 141.07 32.16 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.48 -2.013 . . . . 7.13 111.713 -169.356 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -143.73 108.1 4.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 114.015 -2.897 . . . . 36.39 107.472 -177.89 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 mt -91.78 144.96 24.96 Favored 'General case' 0 N--CA 1.43 -1.426 1 CA-C-N 126.2 4.091 . . . . 9.55 112.837 -175.67 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 mt -128.24 138.84 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.628 1.971 . . . . 13.9 109.886 -176.935 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' A' ' 50' ' ' LEU . 70.3 t80 -122.19 112.74 18.55 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 115.082 -4.761 . . . . 6.86 100.446 175.055 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.34 -74.96 0.07 Allowed 'General case' 0 N--CA 1.431 -1.41 1 CA-C-O 111.436 -4.126 . . . . 11.15 113.967 177.758 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.76 21.62 0.32 Allowed Glycine 0 N--CA 1.43 -1.729 1 O-C-N 130.178 4.674 . . . . 13.93 114.342 167.685 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -115.45 131.03 57.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.396 -1.705 . . . . 23.92 106.396 174.955 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -71.48 147.51 47.72 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.327 1.421 . . . . 23.23 114.593 173.924 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 45' ' ' PHE . 21.3 mt -101.13 109.16 21.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.376 1.87 . . . . 9.11 112.821 170.95 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -95.77 142.84 27.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 113.493 0.923 . . . . 33.44 113.493 179.186 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -22.01 -68.05 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 134.421 5.088 . . . . 28.37 118.893 179.255 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.69 62.58 4.58 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 122.54 2.427 . . . . 15.0 115.676 -174.778 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -160.91 156.59 25.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.525 -2.162 . . . . 25.5 107.834 164.156 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.316 82.8 p -82.08 150.82 27.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.39 -3.319 . . . . 11.95 114.355 -172.56 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mt -65.51 -46.21 80.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.799 -1.188 . . . . 10.17 112.882 -173.002 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -58.11 -43.64 87.3 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.279 0.987 . . . . 13.59 111.829 171.075 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -69.01 -17.11 63.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.714 -3.741 . . . . 11.7 111.186 -172.899 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.49 -17.75 38.04 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.929 2.892 . . . . 12.95 114.956 169.523 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.354 16.5 m120 87.61 39.02 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 129.311 3.045 . . . . 25.45 112.267 177.437 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -107.9 105.97 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.59 2.138 . . . . 14.6 105.932 -172.717 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.51 -162.96 0.83 Allowed 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 116.127 -4.108 . . . . 33.23 112.288 -174.861 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.252 37.9 tttp -64.37 120.93 13.16 Favored 'General case' 0 N--CA 1.431 -1.424 2 O-C-N 114.976 -4.827 . . . . 25.97 112.39 -173.741 . . . . . . . . 3 2 . 1 . 040 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 20.6 mt-10 65.23 51.79 1.56 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.494 1.918 . . . . 32.61 108.857 -174.143 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.285 63.0 m -95.45 155.44 16.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.766 2.076 . . . . 10.56 107.75 168.948 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.4 m -119.68 128.94 54.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 126.092 2.12 . . . . 5.33 106.388 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.3 mt -113.44 116.36 29.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.27 1.828 . . . . 11.66 111.519 -177.41 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -93.17 125.13 37.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.489 2.404 . . . . 16.3 113.103 -175.829 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -101.33 123.58 45.65 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.804 2.042 . . . . 9.96 111.062 -169.842 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.23 -178.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 126.15 2.881 . . . . 9.76 112.747 173.76 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.7 tp . . . . . 0 N--CA 1.43 -1.429 0 O-C-N 116.539 -3.851 . . . . 19.57 119.369 175.863 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 10.8 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 113.433 0.901 . . . . 17.17 113.433 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -94.92 125.52 39.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 113.826 1.047 . . . . 21.89 113.826 178.963 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -124.3 162.88 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.148 1.379 . . . . 10.83 112.627 167.76 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -118.62 139.81 50.9 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.82 -3.05 . . . . 10.61 107.178 176.393 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.66 118.7 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.381 1.873 . . . . 9.13 106.152 172.086 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -116.93 143.6 45.52 Favored 'General case' 0 N--CA 1.43 -1.438 1 CA-C-O 128.74 4.114 . . . . 20.55 114.07 -171.896 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -81.88 172.78 12.91 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 114.743 -4.973 . . . . 11.78 111.472 179.767 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.2 -33.69 70.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.555 2.057 . . . . 19.31 116.555 176.787 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -72.19 -69.53 0.39 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.966 1.099 . . . . 23.14 113.966 171.547 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.14 31.8 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 118.319 -1.896 . . . . 19.74 114.305 -175.797 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -106.86 121.98 45.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.162 1.458 . . . . 21.93 112.686 176.728 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.1 m -97.37 127.94 43.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.516 -1.99 . . . . 12.33 108.841 176.951 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.75 116.8 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 102.437 -3.172 . . . . 17.08 102.437 172.757 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 m -93.38 131.73 38.28 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.913 -1.742 . . . . 16.3 109.502 173.361 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -125.61 143.26 51.1 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.833 -1.792 . . . . 15.88 109.427 -179.59 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 1' ' ' MET . 42.9 mt-10 -99.13 77.71 2.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.546 3.138 . . . . 28.9 116.342 165.183 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -104.83 147.72 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 126.72 3.152 . . . . 12.05 106.987 -177.995 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -83.82 149.1 55.96 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 117.748 -3.095 . . . . 18.17 108.712 178.391 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -88.42 -6.29 6.17 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 127.172 3.597 . . . . 8.16 109.543 -157.38 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.7 m -84.6 -14.06 49.84 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.624 3.106 . . . . 11.13 114.49 -179.492 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -80.12 163.67 23.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.859 2.54 . . . . 18.03 117.859 -167.982 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.322 22.1 p -79.34 158.19 27.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.618 2.367 . . . . 10.22 111.621 -172.16 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.67 -36.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.224 -1.353 . . . . 12.3 107.772 178.631 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -45.16 -45.84 11.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 117.504 2.409 . . . . 36.51 117.504 160.01 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.23 -14.32 59.49 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.808 -4.307 . . . . 25.66 116.163 173.472 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.6 t -62.8 -48.94 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 124.607 2.146 . . . . 8.12 112.377 162.334 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -63.7 -32.45 73.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.107 2.86 . . . . 15.47 112.04 178.287 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.54 -13.27 61.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.863 -2.398 . . . . 11.45 117.472 -177.007 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -79.1 -36.43 40.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.324 2.265 . . . . 24.98 115.13 166.33 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 mt -69.72 -26.26 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 121.149 -0.969 . . . . 9.46 113.405 176.162 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -65.48 -39.83 92.4 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 112.437 -2.165 . . . . 14.76 110.539 173.366 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -70.93 -46.26 62.78 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.85 2.167 . . . . 26.29 116.85 171.394 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -76.73 -67.2 0.72 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.09 -2.256 . . . . 30.06 108.918 -171.536 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -94.17 -20.5 19.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 123.839 3.018 . . . . 25.19 107.14 -164.363 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.42 34.83 9.99 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 126.753 2.121 . . . . 7.41 114.445 173.867 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 mt -110.91 130.62 22.75 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 118.342 -2.858 . . . . 9.49 104.181 -169.206 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -85.15 153.26 10.94 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 112.509 -4.528 . . . . 11.42 114.485 -167.418 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -71.05 -14.48 32.05 Favored 'Trans proline' 0 N--CA 1.433 -2.045 1 C-N-CA 125.308 4.005 . . . . 12.0 113.444 -162.56 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.69 -39.12 73.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.442 0.904 . . . . 35.55 113.442 168.851 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -77.97 -26.32 48.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.79 2.885 . . . . 20.52 118.79 175.171 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -72.15 118.95 15.67 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.739 1.216 . . . . 7.13 111.502 -177.261 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -102.97 121.43 42.52 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.455 -3.278 . . . . 36.39 105.807 169.532 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 mt -106.11 123.06 47.41 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.674 3.59 . . . . 9.55 115.24 170.02 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -123.21 110.31 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 128.954 2.902 . . . . 13.9 114.893 -174.646 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -94.8 117.88 30.86 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.222 -1.399 . . . . 6.86 107.222 169.977 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.36 -84.3 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.42 1 C-N-CA 132.35 4.26 . . . . 11.15 110.507 -169.704 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.44 31.05 1.28 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-O 124.078 1.932 . . . . 13.93 112.239 169.952 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -99.13 142.11 31.03 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.968 -3.078 . . . . 23.92 109.539 174.706 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -88.08 108.74 19.39 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 116.577 2.066 . . . . 23.23 116.577 173.405 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.339 85.4 mt -71.47 118.26 14.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.078 -2.889 . . . . 9.11 116.907 -162.171 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -74.31 114.94 13.25 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.72 2.408 . . . . 33.44 109.271 178.423 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.32 -33.93 76.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.405 1.882 . . . . 28.37 114.472 -162.895 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.05 15.49 60.85 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 127.031 2.253 . . . . 15.0 113.37 -175.849 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -99.25 171.02 8.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 126.693 3.139 . . . . 25.5 108.961 160.928 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.9 p -102.72 -178.92 3.82 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.105 -4.122 . . . . 11.95 114.231 174.805 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.1 mt -80.64 -17.7 50.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.937 -2.977 . . . . 10.17 110.073 178.989 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t -69.48 -42.36 74.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.065 -2.272 . . . . 13.59 109.672 177.319 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -54.68 -45.22 73.89 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.87 2.468 . . . . 11.7 114.412 178.849 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -92.58 0.6 57.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.756 -2.465 . . . . 12.95 109.48 -174.616 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 50.27 51.23 17.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.973 3.709 . . . . 25.45 112.134 -171.177 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mt -98.38 114.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 120.418 1.463 . . . . 14.6 107.722 179.429 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -99.54 -173.14 2.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.391 3.076 . . . . 33.23 110.785 -169.424 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -70.05 147.39 50.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.601 1.191 . . . . 25.97 109.892 -174.182 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.377 86.7 mt-10 70.89 16.41 6.58 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.187 1.795 . . . . 32.61 113.668 174.047 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.16 136.75 34.33 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 116.631 -1.652 . . . . 10.56 111.657 179.23 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.2 m -92.81 130.48 38.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 115.373 -2.251 . . . . 5.33 110.655 -178.358 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.97 172.07 6.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.806 2.443 . . . . 11.66 110.628 166.941 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -111.99 145.16 40.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.799 2.714 . . . . 16.3 111.421 171.842 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 tp -120.11 132.97 55.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.435 -3.916 . . . . 9.96 109.069 176.12 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.56 131.03 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.905 1.682 . . . . 9.76 108.993 -172.87 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 N--CA 1.43 -1.459 0 O-C-N 119.815 -1.803 . . . . 19.57 109.002 166.878 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 125.768 2.699 . . . . 17.17 113.851 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -114.54 137.32 52.01 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 112.983 -6.073 . . . . 21.89 110.738 -177.7 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.591 HD12 HD13 ' A' ' 67' ' ' LEU . 37.3 pt -129.07 178.21 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 118.018 -2.926 . . . . 10.83 109.239 164.942 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -125.55 137.86 53.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.299 2.952 . . . . 10.61 107.91 -179.66 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.27 116.11 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 105.054 -2.202 . . . . 9.13 105.054 167.983 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -102.97 126.31 50.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.079 2.152 . . . . 20.55 113.911 176.372 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.526 15.7 p -67.99 175.15 3.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.312 1.845 . . . . 11.78 115.43 -178.201 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.44 -45.57 45.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.276 -2.765 . . . . 19.31 114.306 177.053 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -63.85 -56.31 16.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.768 2.699 . . . . 23.14 117.065 175.56 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 54.21 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 117.963 -2.065 . . . . 19.74 115.352 172.854 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -114.08 140.8 48.18 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.426 -1.75 . . . . 21.93 110.806 165.005 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -103.67 129.91 51.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.032 2.708 . . . . 12.33 110.092 165.69 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -96.73 104.93 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 128.335 2.654 . . . . 17.08 106.223 169.431 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.2 m -79.97 114.91 19.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 120.48 1.491 . . . . 16.3 114.7 170.783 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 15' ' ' LEU . 18.0 tp -121.78 133.21 54.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.647 -1.615 . . . . 15.88 113.547 -166.623 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -90.94 112.86 24.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.345 1.858 . . . . 28.9 114.612 -175.602 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.8 m -128.59 178.84 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.121 -2.862 . . . . 12.05 107.318 -168.968 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -123.94 168.14 13.5 Favored Pre-proline 0 N--CA 1.431 -1.416 0 CA-C-O 114.598 -2.62 . . . . 18.17 104.549 168.654 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.73 -14.89 43.12 Favored 'Trans proline' 0 C--N 1.3 -2.01 2 CA-C-N 129.076 4.277 . . . . 8.16 108.853 173.311 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -93.05 -3.56 54.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.782 2.083 . . . . 11.13 115.084 -169.725 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -72.68 141.86 48.25 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.354 1.462 . . . . 18.03 108.759 -179.909 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -86.93 160.66 18.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.264 2.626 . . . . 10.22 104.525 178.722 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.592 HD12 HD13 ' A' ' 50' ' ' LEU . 24.8 mm -69.29 -30.06 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 122.593 1.187 . . . . 12.3 112.849 177.675 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -65.94 -41.83 90.81 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.52 2.728 . . . . 36.51 110.532 177.539 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -66.52 -43.28 85.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.712 -1.959 . . . . 25.66 105.712 -179.918 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.79 -45.77 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 125.876 1.67 . . . . 8.12 114.004 -178.051 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -57.6 -33.19 67.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.622 2.153 . . . . 15.47 113.09 172.532 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.46 -26.89 60.32 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.674 1.731 . . . . 11.45 115.674 179.355 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.315 52.6 mttp -75.07 -31.74 61.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.84 -2.344 . . . . 24.98 112.277 171.944 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.1 mt -63.71 -34.51 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 124.898 2.285 . . . . 9.46 116.554 175.326 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -62.19 -41.81 98.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.135 -1.848 . . . . 14.76 113.419 165.592 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.49 -48.3 41.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.087 -1.633 . . . . 26.29 112.969 -179.263 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -60.83 -66.82 0.47 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.121 -2.237 . . . . 30.06 114.022 174.146 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -87.37 -26.69 23.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.809 -3.057 . . . . 25.19 111.243 -162.499 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.29 11.35 48.86 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 119.341 -1.409 . . . . 7.41 114.086 -178.672 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.2 mt -80.79 130.7 62.92 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 117.461 -3.376 . . . . 9.49 111.596 -168.421 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -74.02 147.75 39.04 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 128.126 3.938 . . . . 11.42 113.066 -167.383 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.48 -16.59 24.27 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 CA-C-N 122.903 2.073 . . . . 12.0 113.4 -174.935 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.63 -30.53 70.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.622 -3.799 . . . . 35.55 118.285 163.647 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -75.46 -21.6 57.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.3 1.409 . . . . 20.52 113.392 177.819 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -83.43 114.9 21.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 115.947 -1.978 . . . . 7.13 111.634 -160.58 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -119.37 108.1 14.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.401 2.524 . . . . 36.39 114.227 164.893 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mt -88.54 129.81 35.38 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.762 2.22 . . . . 9.55 109.363 179.218 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 mt -116.83 139.71 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 119.182 -2.199 . . . . 13.9 106.027 177.052 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -126.53 112.14 15.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.013 -1.477 . . . . 6.86 107.013 172.814 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.271 . . 81.29 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.938 1.695 . . . . 11.15 111.194 -174.537 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.12 43.39 0.23 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.304 -1.498 . . . . 13.93 116.181 173.993 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.28 155.09 46.98 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.148 2.579 . . . . 23.92 111.42 164.58 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.262 9.3 tt0 -79.93 129.58 34.61 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.3 -2.125 . . . . 23.23 111.953 -176.727 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.592 HD13 HD12 ' A' ' 23' ' ' ILE 0.252 98.4 mt -83.71 121.51 27.38 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.685 -1.884 . . . . 9.11 109.916 172.704 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -99.14 154.51 18.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.437 -1.69 . . . . 33.44 106.437 -168.534 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.09 -32.04 71.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.281 2.326 . . . . 28.37 117.281 -162.438 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.95 21.66 43.75 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 120.788 1.631 . . . . 15.0 112.065 -169.673 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -118.36 -179.48 3.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.369 -1.665 . . . . 25.5 113.858 164.225 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.7 p -108.91 176.27 5.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.897 2.76 . . . . 11.95 118.332 178.01 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.6 mt -71.03 -35.02 71.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 113.775 -1.557 . . . . 10.17 113.223 176.026 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -57.3 -45.93 83.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.668 1.987 . . . . 13.59 113.667 165.756 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -61.99 -35.33 78.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.495 2.718 . . . . 11.7 114.757 175.056 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.4 -4.19 42.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 114.666 -2.587 . . . . 12.95 111.976 -174.638 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.2 m120 72.79 43.4 0.43 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 123.539 2.882 . . . . 25.45 110.396 173.831 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -102.99 115.62 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.383 -2.073 . . . . 14.6 111.349 179.936 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -95.82 -177.89 4.19 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.161 1.934 . . . . 33.23 111.79 175.207 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.258 21.7 ptmt -53.75 138.15 36.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 131.163 3.785 . . . . 25.97 116.686 175.747 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 71.89 24.53 3.31 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 123.118 1.437 . . . . 32.61 113.243 171.897 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -92.89 142.5 27.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.983 -1.073 . . . . 10.56 112.071 -178.774 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -101.89 97.91 8.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.244 2.618 . . . . 5.33 112.713 -172.973 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.591 HD13 HD12 ' A' ' 3' ' ' ILE . 9.6 mp -84.48 145.55 28.07 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.73 2.519 . . . . 11.66 110.478 174.924 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -109.02 134.03 52.2 Favored 'General case' 0 N--CA 1.43 -1.425 1 O-C-N 115.646 -4.408 . . . . 16.3 100.537 -169.768 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.78 125.75 51.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.607 1.194 . . . . 9.96 109.729 170.979 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.6 t -113.79 152.3 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 126.738 3.161 . . . . 9.76 106.329 179.947 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 N--CA 1.43 -1.434 0 O-C-N 118.678 -2.514 . . . . 19.57 110.97 -179.306 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 127.171 3.367 . . . . 17.17 104.451 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -93.22 123.7 36.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.234 -2.257 . . . . 21.89 105.241 177.924 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -117.59 166.96 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 118.322 -2.736 . . . . 10.83 106.414 170.149 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.86 100.94 7.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.411 -3.306 . . . . 10.61 115.01 -176.049 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.44 105.89 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 118.89 -2.381 . . . . 9.13 109.394 -163.265 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -99.45 132.69 44.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.612 -1.176 . . . . 20.55 111.042 -172.345 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 p -98.11 -177.88 3.88 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.226 2.21 . . . . 11.78 113.194 -178.555 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 mt -83.6 -33.52 25.33 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.838 -2.414 . . . . 19.31 111.637 -164.304 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 p -88.49 -66.79 0.88 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.73 2.012 . . . . 23.14 112.523 -177.038 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.24 48.76 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 117.505 -2.283 . . . . 19.74 109.665 -174.031 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -136.07 119.37 16.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.012 2.339 . . . . 21.93 105.506 176.379 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -92.23 106.87 18.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.376 2.989 . . . . 12.33 111.832 163.666 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 mt -88.46 114.89 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.661 -2.063 . . . . 17.08 106.308 -179.717 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -94.18 125.14 38.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.698 -0.482 . . . . 16.3 109.698 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 tp -153.8 135.86 14.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.965 -2.959 . . . . 15.88 115.212 -157.232 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.9 97.32 11.11 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 132.398 4.279 . . . . 28.9 117.021 -177.287 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.69 150.57 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.674 2.39 . . . . 12.05 111.714 179.158 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -87.04 152.77 53.77 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 112.867 -3.444 . . . . 18.17 109.394 176.671 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -71.99 -23.49 21.76 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 CA-C-N 123.321 2.222 . . . . 8.16 112.949 173.682 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -81.44 2.27 29.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.97 3.919 . . . . 11.13 113.821 168.22 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -72.05 148.48 45.78 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 124.529 3.332 . . . . 18.03 110.887 165.08 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 73.4 p -84.54 173.25 10.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.767 -1.833 . . . . 10.22 109.522 177.344 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -63.43 -23.18 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 124.525 2.107 . . . . 12.3 112.263 168.407 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -80.88 -37.93 28.92 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.031 -4.168 . . . . 36.51 109.749 176.433 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 28' ' ' ALA 0.321 17.1 m120 -73.68 -35.12 65.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.62 -1.3 . . . . 25.66 112.26 179.773 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.604 HG21 HD11 ' A' ' 56' ' ' LEU 0.489 81.4 t -45.83 -59.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 129.937 3.295 . . . . 8.12 113.619 163.106 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt -60.67 -30.53 69.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.177 3.391 . . . . 15.47 113.051 174.144 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.7 -42.59 88.99 Favored 'General case' 0 N--CA 1.429 -1.48 1 CA-C-O 131.011 5.196 . . . . 11.45 118.047 163.297 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -75.5 -35.97 60.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.72 -3.737 . . . . 24.98 111.764 -179.065 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mt -64.57 -41.87 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 125.381 1.675 . . . . 9.46 114.53 168.46 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -50.16 -57.88 6.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.66 2.171 . . . . 14.76 115.421 174.545 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -47.81 -60.96 2.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.546 3.538 . . . . 26.29 114.627 167.962 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -65.73 -58.4 5.76 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.252 1.025 . . . . 30.06 109.975 -168.737 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -83.93 -48.81 9.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.807 2.151 . . . . 25.19 116.807 179.988 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.08 9.86 5.94 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 129.683 3.516 . . . . 7.41 112.617 179.424 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mt -85.81 128.93 56.5 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-N 121.356 2.578 . . . . 9.49 108.115 -162.799 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.83 153.86 29.75 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 CA-C-O 109.941 -4.275 . . . . 11.42 114.439 -166.732 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.6 -24.1 26.22 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 124.13 3.22 . . . . 12.0 117.671 -168.881 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -80.63 -6.68 58.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.338 3.055 . . . . 35.55 112.733 171.843 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -93.46 -36.79 12.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.298 -2.126 . . . . 20.52 111.412 169.565 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -72.51 144.78 47.88 Favored 'General case' 0 N--CA 1.429 -1.48 1 N-CA-C 123.509 4.633 . . . . 7.13 123.509 179.975 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -160.74 135.41 7.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.776 -0.824 . . . . 36.39 108.776 175.465 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.526 HD21 HD13 ' A' ' 69' ' ' LEU . 49.7 mt -117.51 116.44 27.14 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.149 1.928 . . . . 9.55 108.6 -170.372 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.582 HD12 HG21 ' A' ' 70' ' ' VAL . 33.9 mt -110.52 133.54 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 126.767 2.027 . . . . 13.9 111.066 175.117 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -118.37 118.95 33.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 102.269 -3.234 . . . . 6.86 102.269 177.854 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.92 -62.69 0.07 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.263 3.425 . . . . 11.15 118.32 -176.551 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.99 7.89 0.79 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 115.895 1.118 . . . . 13.93 115.895 178.684 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -153.81 154.89 34.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.741 2.686 . . . . 23.92 105.76 177.84 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -66.76 150.04 49.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.377 3.471 . . . . 23.23 113.648 -179.227 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 mt -112.61 134.47 54.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.481 2.312 . . . . 9.11 105.519 -173.986 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -97.55 130.67 44.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.835 2.731 . . . . 33.44 111.248 -171.524 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -34.2 -42.95 0.14 Allowed 'General case' 0 N--CA 1.43 -1.445 1 N-CA-C 122.704 4.335 . . . . 28.37 122.704 178.365 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.95 -15.84 69.05 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.237 -1.539 . . . . 15.0 113.664 -168.485 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -87.73 147.18 25.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.36 2.664 . . . . 25.5 109.845 178.175 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 37.6 p -81.88 163.77 22.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.303 2.241 . . . . 11.95 110.088 173.017 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.604 HD11 HG21 ' A' ' 26' ' ' VAL . 39.2 mt -61.29 -37.31 82.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.674 1.702 . . . . 10.17 115.43 171.798 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.9 m -45.77 -46.17 15.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.36 -3.338 . . . . 13.59 118.448 161.888 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -55.98 -13.6 2.01 Favored 'General case' 0 N--CA 1.43 -1.463 2 O-C-N 114.084 -5.385 . . . . 11.7 118.058 166.044 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -121.17 -7.73 9.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 115.894 -2.003 . . . . 12.95 107.134 -174.352 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.4 m120 74.58 34.68 0.74 Allowed 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 135.935 5.694 . . . . 25.45 107.955 176.664 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -82.6 106.42 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.42 -1.696 . . . . 14.6 106.42 -175.827 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -92.01 -175.39 4.08 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.468 2.707 . . . . 33.23 113.725 174.944 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -58.65 153.13 17.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.276 -3.39 . . . . 25.97 115.023 179.6 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 74.66 -1.16 3.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 125.996 2.06 . . . . 32.61 115.332 171.356 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.3 m -61.51 141.94 57.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 120.517 3.525 . . . . 10.56 120.517 178.05 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.3 m -98.63 109.76 22.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.085 2.116 . . . . 5.33 107.628 -170.604 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mt -110.25 141.29 43.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.173 -2.158 . . . . 11.66 105.173 -173.278 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -104.91 118.83 37.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.06 1.41 . . . . 16.3 109.967 -177.539 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.526 HD13 HD21 ' A' ' 43' ' ' LEU . 19.8 tp -95.55 99.24 11.14 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.814 2.446 . . . . 9.96 108.273 176.572 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 44' ' ' ILE . 61.7 t -87.1 110.26 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.986 3.315 . . . . 9.76 111.06 174.124 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.43 -1.446 0 N-CA-C 103.592 -2.744 . . . . 19.57 103.592 -178.137 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 111.202 0.075 . . . . 17.17 111.202 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -104.44 141.48 36.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.043 -2.286 . . . . 21.89 109.741 178.158 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 pt -119.56 159.84 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 131.295 3.838 . . . . 10.83 108.694 170.984 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -114.58 92.06 3.83 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.094 2.158 . . . . 10.61 107.123 -175.139 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.0 t -93.74 108.61 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.112 -2.242 . . . . 9.13 106.952 175.765 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -102.96 145.09 30.38 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 122.729 1.252 . . . . 20.55 113.697 -171.706 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.8 p -90.94 171.89 8.97 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.744 -2.074 . . . . 11.78 110.81 177.145 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.95 -51.66 68.33 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 129.116 4.01 . . . . 19.31 115.16 171.351 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.251 78.9 p -46.33 -48.98 18.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 125.274 3.67 . . . . 23.14 113.186 161.24 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.19 52.62 0.56 Allowed Glycine 0 N--CA 1.43 -1.72 1 C-N-CA 132.526 4.869 . . . . 19.74 108.909 176.138 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -84.98 132.18 34.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.618 -2.033 . . . . 21.93 106.512 161.826 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -103.65 110.06 21.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 128.342 3.925 . . . . 12.33 109.733 -178.468 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.467 HG22 ' HB2' ' A' ' 15' ' ' LEU . 61.8 mt -81.54 109.31 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 O-C-N 112.222 -6.549 . . . . 17.08 105.751 177.651 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 p -83.14 66.27 8.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.958 2.103 . . . . 16.3 108.532 -178.23 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.467 ' HB2' HG22 ' A' ' 13' ' ' ILE . 12.8 tp -94.29 127.12 39.95 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.764 -3.085 . . . . 15.88 116.744 -164.313 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -103.51 102.46 12.36 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.595 -4.44 . . . . 28.9 115.663 -163.72 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -125.0 167.96 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.734 1.255 . . . . 12.05 109.455 -172.106 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.289 27.8 mt-10 -98.15 170.6 6.84 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 118.369 -2.707 . . . . 18.17 108.898 161.568 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.15 -4.35 9.56 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 O-C-N 117.288 -2.006 . . . . 8.16 108.673 -175.038 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 m -95.03 18.69 11.62 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.112 -1.44 . . . . 11.13 107.112 178.908 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -93.7 139.42 30.83 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.52 -1.987 . . . . 18.03 108.779 175.143 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 14.6 p -84.72 165.77 17.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.05 1.295 . . . . 10.22 114.198 173.809 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 43.5 mm -71.95 -27.38 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.904 2.082 . . . . 12.3 106.869 -167.346 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -58.73 -50.09 75.22 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.929 2.892 . . . . 36.51 116.848 167.354 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -69.78 -22.11 63.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.584 2.809 . . . . 25.66 118.584 169.608 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.307 21.1 t -66.0 -55.93 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 C-N-CA 132.041 4.136 . . . . 8.12 107.522 166.791 . . . . . . . . 3 2 . 1 . 044 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 51.5 mtmt -61.88 -44.29 97.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.441 2.385 . . . . 15.47 117.441 173.059 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.57 -32.05 64.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.602 -2.561 . . . . 11.45 113.676 174.093 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -66.68 -38.78 87.5 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.445 3.022 . . . . 24.98 110.677 176.206 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -70.36 -33.87 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.998 -2.939 . . . . 9.46 113.877 177.963 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.291 27.3 tt0 -52.81 -49.82 64.89 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.845 3.212 . . . . 14.76 113.83 171.915 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.66 -53.44 47.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.891 2.876 . . . . 26.29 112.92 174.039 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -68.27 -76.09 0.09 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.063 2.945 . . . . 30.06 112.185 -179.224 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.95 -51.4 67.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 124.625 3.375 . . . . 25.19 118.356 175.041 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.01 28.92 9.46 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.221 -1.549 . . . . 7.41 113.63 -174.741 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mt -96.67 117.54 65.89 Favored Pre-proline 0 N--CA 1.429 -1.513 0 C-N-CA 131.537 3.935 . . . . 9.49 105.205 177.114 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -69.04 158.34 58.28 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 CA-C-N 125.503 3.001 . . . . 11.42 112.45 -171.731 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.36 -24.12 8.11 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 122.485 2.123 . . . . 12.0 112.017 -149.649 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.98 -17.0 64.39 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.294 2.638 . . . . 35.55 113.295 -173.905 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -92.61 -26.0 18.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.63 1.972 . . . . 20.52 115.108 -172.905 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -70.88 86.74 0.7 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 121.063 3.727 . . . . 7.13 121.063 -179.243 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 20.6 ttt180 -79.17 112.17 16.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.839 -3.663 . . . . 36.39 117.439 167.146 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.16 109.44 20.84 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 116.007 -4.183 . . . . 9.55 112.013 -173.932 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mm -103.67 125.95 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 118.764 -2.46 . . . . 13.9 110.047 176.732 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -102.65 117.86 35.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.644 -2.071 . . . . 6.86 106.121 166.714 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.7 -110.93 0.53 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.935 -2.353 . . . . 11.15 113.01 178.14 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.95 17.12 25.12 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 118.984 -1.579 . . . . 13.93 113.498 168.187 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -119.83 139.3 52.57 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.27 3.428 . . . . 23.92 108.519 -161.588 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -104.71 128.03 52.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.418 -2.808 . . . . 23.23 103.418 -166.487 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.65 128.75 35.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.097 -2.877 . . . . 9.11 111.749 -176.844 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.256 43.1 mt-10 -107.28 158.66 16.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 117.479 -1.688 . . . . 33.44 111.092 -176.716 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -58.54 -53.46 58.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.468 3.507 . . . . 28.37 113.956 -155.264 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.81 -2.91 71.45 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 113.548 -1.66 . . . . 15.0 111.887 -161.936 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -88.28 155.26 19.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 113.889 -2.958 . . . . 25.5 113.583 166.383 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 82.0 p -92.72 173.05 7.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.565 2.346 . . . . 11.95 114.198 178.923 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.52 -46.0 47.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.782 2.512 . . . . 10.17 117.782 160.216 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -54.86 -46.38 74.67 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.739 2.816 . . . . 13.59 117.291 170.912 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -48.2 -63.94 0.93 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.566 1.946 . . . . 11.7 109.56 172.438 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -73.36 3.96 5.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.215 -2.326 . . . . 12.95 116.015 179.726 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.468 66.8 t30 67.72 54.0 0.67 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.555 3.034 . . . . 25.45 112.42 171.114 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.71 103.47 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 127.051 2.14 . . . . 14.6 111.636 -174.647 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -68.25 168.58 12.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.224 3.81 . . . . 33.23 106.561 174.293 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.34 154.2 14.01 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.424 1.639 . . . . 25.97 115.424 172.293 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 56.75 41.1 28.68 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.808 2.567 . . . . 32.61 114.873 176.802 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.263 47.2 m -86.78 126.9 34.91 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.489 1.916 . . . . 10.56 108.607 173.326 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -72.52 127.15 31.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 117.088 -1.845 . . . . 5.33 115.212 163.748 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mt -114.62 164.86 13.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.702 3.62 . . . . 11.66 111.851 159.627 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -120.45 121.31 38.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.875 -2.639 . . . . 16.3 103.875 -172.886 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -91.47 108.74 20.1 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.247 -2.131 . . . . 9.96 105.247 173.201 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 19.3 t -96.61 144.28 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.056 2.836 . . . . 9.76 107.224 168.931 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 71' ' ' LEU . 80.0 mt . . . . . 0 N--CA 1.431 -1.414 0 O-C-N 116.514 -3.866 . . . . 19.57 111.333 -179.087 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptt? . . . . . 0 CA--C 1.491 -1.323 0 CA-C-O 124.233 1.968 . . . . 17.17 108.446 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -98.47 140.8 32.17 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.011 -2.931 . . . . 21.89 109.778 176.838 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.471 HD13 HD12 ' A' ' 67' ' ' LEU . 2.2 pp -131.16 166.4 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 112.22 -2.264 . . . . 10.83 109.403 168.02 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.3 145.79 42.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.786 -3.071 . . . . 10.61 108.692 177.659 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.43 118.55 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.358 2.663 . . . . 9.13 112.724 163.935 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -111.68 110.9 21.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.391 2.996 . . . . 20.55 112.488 179.271 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.8 p -76.72 171.26 15.0 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.647 -4.408 . . . . 11.78 113.102 -170.179 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mt -52.8 -54.26 36.66 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.898 -1.049 . . . . 19.31 111.506 174.778 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.4 p -56.93 -31.5 65.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.575 2.35 . . . . 23.14 116.86 167.989 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.91 27.28 4.36 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 120.006 -1.684 . . . . 19.74 113.685 168.219 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -80.24 131.84 35.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 121.05 2.425 . . . . 21.93 105.074 175.978 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -85.42 109.5 18.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.082 2.153 . . . . 12.33 112.452 163.85 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -103.06 123.43 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 114.806 -1.088 . . . . 17.08 108.786 171.949 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -84.74 121.82 28.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 117.24 -1.362 . . . . 16.3 112.341 173.852 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 tp -129.91 121.17 26.11 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.126 1.37 . . . . 15.88 110.7 -172.959 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -87.5 122.76 31.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.768 1.747 . . . . 28.9 108.873 173.204 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.44 149.68 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 129.707 3.203 . . . . 12.05 108.782 -179.491 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.2 mt-10 -87.0 149.01 46.72 Favored Pre-proline 0 N--CA 1.43 -1.426 0 C-N-CA 127.253 2.221 . . . . 18.17 106.248 166.683 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 61.4 Cg_exo -73.55 -15.03 24.8 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 115.847 -2.302 . . . . 8.16 111.44 -173.983 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -87.73 3.65 47.21 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 116.028 -4.17 . . . . 11.13 118.02 172.831 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.3 150.8 35.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.346 -1.471 . . . . 18.03 113.092 167.654 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 24.8 p -96.01 177.67 5.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.395 1.685 . . . . 10.22 109.438 -172.729 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.48 -23.73 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 121.424 1.92 . . . . 12.3 113.344 -177.019 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -52.5 -48.51 65.94 Favored 'General case' 0 N--CA 1.431 -1.394 1 C-N-CA 133.101 4.561 . . . . 36.51 111.021 158.071 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 40.5 m-20 -72.01 -27.39 62.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.65 2.093 . . . . 25.66 116.65 179.661 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -73.2 -41.06 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 128.081 2.552 . . . . 8.12 112.563 175.958 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -59.63 -31.01 69.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 117.25 -1.357 . . . . 15.47 111.886 165.085 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -71.85 -41.84 67.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.931 1.395 . . . . 11.45 109.669 -177.822 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.285 21.1 mmtp -63.38 -28.12 69.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.814 3.246 . . . . 24.98 113.059 173.96 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.7 mt -87.48 -41.71 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 1 O-C-N 113.91 -5.494 . . . . 9.46 112.726 178.973 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -46.22 -47.14 17.94 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.847 -2.408 . . . . 14.76 114.806 159.126 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.31 -25.51 61.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.015 1.857 . . . . 26.29 116.015 -178.437 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -87.73 -52.81 5.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 116.914 2.19 . . . . 30.06 116.914 178.837 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -98.77 -25.28 14.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.085 1.354 . . . . 25.19 112.011 -168.832 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.01 17.11 28.56 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 118.262 -1.299 . . . . 7.41 115.267 168.276 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.2 mt -94.77 126.5 47.05 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 130.715 3.606 . . . . 9.49 108.254 -168.855 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.51 139.68 54.59 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 124.322 3.348 . . . . 11.42 113.349 -179.504 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.04 -2.63 12.79 Favored 'Trans proline' 0 C--N 1.3 -2.019 1 C-N-CA 126.415 4.743 . . . . 12.0 114.108 -166.538 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.273 9.5 p-10 -84.61 -31.98 23.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 122.678 2.49 . . . . 35.55 111.182 174.178 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.91 -13.17 60.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.041 2.088 . . . . 20.52 114.183 -179.274 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -88.98 121.62 31.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 111.504 -2.589 . . . . 7.13 114.677 177.924 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -111.95 118.09 34.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 115.544 -2.169 . . . . 36.39 113.66 166.034 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.7 mt -109.93 123.48 49.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.335 1.647 . . . . 9.55 108.142 -174.376 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.14 127.09 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.946 2.098 . . . . 13.9 106.731 -174.813 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -103.77 114.11 28.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.58 -1.637 . . . . 6.86 106.58 169.061 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.01 -96.98 0.05 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.92 2.488 . . . . 11.15 110.338 178.115 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.82 -7.71 17.07 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 125.37 1.462 . . . . 13.93 115.781 173.865 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -90.89 130.62 36.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 128.426 3.965 . . . . 23.92 108.429 -171.131 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -98.52 157.96 15.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 111.285 -2.689 . . . . 23.23 104.812 166.947 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.3 mt -122.01 166.48 14.42 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.619 -1.628 . . . . 9.11 111.533 -155.9 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.27 176.94 5.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.141 -1.429 . . . . 33.44 107.141 166.569 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -102.44 -53.14 2.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.372 1.469 . . . . 28.37 111.043 -168.135 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.04 16.38 7.23 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 118.791 2.276 . . . . 15.0 118.791 -170.139 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -116.62 153.55 32.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.514 1.925 . . . . 25.5 110.938 -173.142 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 20.3 p -88.57 170.67 10.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 113.851 1.056 . . . . 11.95 113.851 -173.328 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.52 -31.25 71.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.774 1.749 . . . . 10.17 108.418 177.69 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -70.48 -43.2 70.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.101 1.76 . . . . 13.59 111.78 -175.928 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -59.39 -28.11 66.6 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 128.467 3.984 . . . . 11.7 118.24 176.884 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -82.06 -27.11 33.15 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 113.558 -5.714 . . . . 12.95 121.078 169.784 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 t30 71.95 48.66 0.27 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.508 2.575 . . . . 25.45 117.372 -157.503 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mt -94.75 99.66 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 118.452 -2.655 . . . . 14.6 104.995 174.35 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.45 -175.73 2.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.701 -1.874 . . . . 33.23 107.134 -165.121 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.305 20.3 pttm -67.13 148.38 51.91 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 120.295 1.407 . . . . 25.97 112.247 -178.396 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 76.57 7.22 3.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.557 2.343 . . . . 32.61 114.451 178.962 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 t -63.96 140.68 58.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.689 1.366 . . . . 10.56 114.689 -177.488 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 m -93.9 104.21 16.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.517 -3.239 . . . . 5.33 113.117 170.949 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 3' ' ' ILE . 35.7 mt -84.45 128.18 34.44 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 114.531 -5.106 . . . . 11.66 110.131 169.718 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -106.22 125.27 50.79 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.374 -2.079 . . . . 16.3 111.668 -172.183 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.25 12.1 tp -92.22 134.16 35.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.764 -1.569 . . . . 9.96 106.764 -177.961 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.1 t -116.31 112.04 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 126.709 3.147 . . . . 9.76 109.153 162.407 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.0 tp . . . . . 0 N--CA 1.43 -1.465 0 O-C-N 118.811 -2.431 . . . . 19.57 114.022 -167.382 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 123.624 1.678 . . . . 17.17 112.04 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -101.79 131.09 48.3 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.583 -4.448 . . . . 21.89 109.057 -171.584 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -116.81 156.78 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.469 -3.269 . . . . 10.83 105.089 162.686 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -120.28 126.32 50.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.94 2.781 . . . . 10.61 108.629 -178.513 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.49 105.86 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 119.17 -2.206 . . . . 9.13 112.826 -179.32 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -92.42 151.12 20.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.56 -1.338 . . . . 20.55 112.289 -176.264 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -104.18 -166.57 1.26 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.098 1.759 . . . . 11.78 113.383 -178.003 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.35 -62.48 1.38 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 115.57 -2.157 . . . . 19.31 114.1 172.23 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.2 p -63.19 -35.14 79.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.319 2.647 . . . . 23.14 111.576 177.898 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.49 53.87 0.67 Allowed Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 127.029 3.572 . . . . 19.74 111.769 167.209 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -89.44 139.58 30.37 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.563 -4.492 . . . . 21.93 102.121 162.216 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.1 m -83.48 110.68 18.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 115.813 -2.042 . . . . 12.33 113.457 161.399 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -88.04 123.99 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 126.197 2.185 . . . . 17.08 107.238 169.858 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.7 m -94.45 115.43 27.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.751 -1.203 . . . . 16.3 107.751 177.883 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -109.37 134.42 51.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.592 -3.817 . . . . 15.88 115.71 168.782 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.69 109.12 20.93 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.599 -2.0 . . . . 28.9 105.599 175.217 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -121.6 152.06 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 C-N-CA 133.583 4.753 . . . . 12.05 112.388 -177.015 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -90.4 146.25 34.16 Favored Pre-proline 0 N--CA 1.429 -1.495 0 O-C-N 117.805 -3.059 . . . . 18.17 108.288 164.546 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.3 -18.4 62.4 Favored 'Trans proline' 0 C--N 1.299 -2.06 1 C-N-CA 128.245 5.964 . . . . 8.16 111.788 172.758 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.7 p -83.9 -7.42 59.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.791 1.636 . . . . 11.13 110.113 174.607 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -81.01 165.88 21.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.078 2.672 . . . . 18.03 111.606 178.448 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 p -85.36 164.24 18.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.948 2.899 . . . . 10.22 113.365 168.395 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.0 mm -67.28 -35.61 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.355 1.862 . . . . 12.3 110.199 178.914 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -50.91 -48.95 60.44 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.16 -2.213 . . . . 36.51 115.998 168.11 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.98 -32.79 71.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.941 -3.6 . . . . 25.66 118.203 169.281 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.91 -54.31 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 124.966 1.306 . . . . 8.12 108.273 169.654 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -56.95 -36.72 70.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.006 2.225 . . . . 15.47 117.006 178.349 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.29 -24.12 64.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.05 2.982 . . . . 11.45 119.05 173.078 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -69.99 -56.99 5.54 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.514 -1.991 . . . . 24.98 113.096 173.516 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -51.42 -46.85 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 127.228 2.211 . . . . 9.46 110.517 169.394 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -49.49 -41.93 42.08 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.427 2.01 . . . . 14.76 116.427 171.894 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -81.01 -77.53 0.2 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.905 3.241 . . . . 26.29 106.352 -178.893 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -64.4 -42.01 96.33 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.519 -5.113 . . . . 30.06 114.148 -162.574 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -94.61 -43.04 8.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.169 -3.457 . . . . 25.19 115.316 178.897 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.18 41.62 3.69 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.018 -2.301 . . . . 7.41 114.863 176.609 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -109.55 113.15 58.34 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 103.952 -2.61 . . . . 9.49 103.952 168.351 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_exo -57.7 159.3 17.51 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 C-N-CA 126.424 4.749 . . . . 11.42 112.953 -173.726 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -86.42 -1.34 8.39 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 124.8 3.667 . . . . 12.0 112.22 -169.916 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -87.39 -26.86 23.11 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.397 2.936 . . . . 35.55 111.747 169.319 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.03 -31.05 71.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.352 1.612 . . . . 20.52 115.352 175.03 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -83.44 136.23 34.39 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.441 2.015 . . . . 7.13 116.441 -173.726 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -132.07 143.36 49.97 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 115.198 -2.601 . . . . 36.39 110.143 140.763 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.7 mt -94.05 128.31 40.34 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.792 -2.004 . . . . 9.55 111.824 -178.51 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mm -113.4 138.47 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 107.367 -1.346 . . . . 13.9 107.367 -176.596 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -114.89 100.99 8.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.274 2.464 . . . . 6.86 109.797 171.251 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.501 . . 82.34 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.626 -3.796 . . . . 11.15 110.646 172.919 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.04 3.47 6.86 Favored Glycine 0 N--CA 1.429 -1.768 0 CA-C-N 113.262 -1.79 . . . . 13.93 112.745 159.367 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -89.03 124.88 34.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 120.727 2.264 . . . . 23.92 113.193 178.798 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -89.82 118.88 29.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.245 -2.159 . . . . 23.23 110.616 179.817 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.98 159.37 31.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.109 2.385 . . . . 9.11 110.117 -164.843 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.42 142.19 50.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.742 -1.572 . . . . 33.44 113.98 175.942 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.04 -45.31 95.31 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 122.535 4.272 . . . . 28.37 122.535 -162.678 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.24 -4.78 31.27 Favored Glycine 0 N--CA 1.43 -1.721 1 N-CA-C 124.44 4.536 . . . . 15.0 124.44 172.71 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -100.37 171.75 7.57 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.36 2.029 . . . . 25.5 111.164 -176.819 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.27 30.8 p -94.4 157.35 16.06 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.524 -2.61 . . . . 11.95 114.167 179.82 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.88 -46.83 60.59 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 117.571 2.434 . . . . 10.17 117.571 163.074 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -56.4 -33.45 65.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 120.382 3.475 . . . . 13.59 120.382 169.003 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -58.88 -37.64 77.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.187 -2.82 . . . . 11.7 113.656 172.746 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -88.78 -13.17 40.09 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.935 -4.228 . . . . 12.95 110.112 177.35 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.439 40.8 t30 62.03 72.42 0.5 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 129.055 2.942 . . . . 25.45 114.379 -165.231 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -111.16 106.17 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 N-CA-C 99.478 -4.267 . . . . 14.6 99.478 -179.785 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -100.33 -173.98 2.55 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.586 -0.697 . . . . 33.23 110.675 -178.848 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.262 25.1 pttt -55.25 131.74 46.15 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.771 2.428 . . . . 25.97 113.981 179.656 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 58.99 45.54 14.76 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 127.215 3.388 . . . . 32.61 115.232 -176.313 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 t -110.28 137.18 48.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.884 -2.385 . . . . 10.56 107.798 179.208 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 m -105.16 129.47 53.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.932 2.093 . . . . 5.33 107.614 -159.396 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -118.48 150.42 39.63 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 128.086 3.803 . . . . 11.66 106.271 179.12 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -112.03 124.37 52.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.149 -2.219 . . . . 16.3 105.201 -178.643 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -90.45 124.78 35.25 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 129.148 4.03 . . . . 9.96 108.629 -178.496 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.6 m -99.1 151.62 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.992 2.517 . . . . 9.76 109.065 167.192 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 mt . . . . . 0 N--CA 1.43 -1.461 0 O-C-N 118.508 -2.62 . . . . 19.57 109.487 163.13 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 123.46 1.6 . . . . 17.17 114.12 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -82.39 138.06 34.56 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.422 -4.549 . . . . 21.89 107.75 168.556 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 17' ' ' VAL . 6.9 pt -118.95 177.48 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 124.849 1.26 . . . . 10.83 109.69 157.904 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -134.89 112.02 10.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.429 2.011 . . . . 10.61 116.429 -173.915 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.96 115.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 125.87 2.748 . . . . 9.13 110.493 177.547 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.263 28.2 tttp -107.32 140.56 40.04 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.977 -4.202 . . . . 20.55 113.588 -179.866 . . . . . . . . 3 2 . 1 . 047 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.5 p -102.09 172.7 6.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.983 -2.323 . . . . 11.78 109.797 -179.429 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.9 -46.75 88.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.501 3.12 . . . . 19.31 111.853 172.081 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -69.38 -26.86 64.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.905 -2.372 . . . . 23.14 114.185 171.77 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.4 62.29 0.95 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 116.717 1.447 . . . . 19.74 116.717 162.97 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -103.13 175.18 5.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.929 2.092 . . . . 21.93 107.905 155.389 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 m -128.46 134.12 48.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.3 -3.375 . . . . 12.33 105.792 172.817 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -114.57 117.4 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 107.896 -1.15 . . . . 17.08 107.896 174.566 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 m -85.36 107.79 17.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.227 -2.26 . . . . 16.3 105.955 -175.581 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.0 mt -102.67 135.93 43.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.088 2.375 . . . . 15.88 115.185 172.668 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -99.7 129.34 45.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.779 -3.701 . . . . 28.9 110.63 173.248 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 3' ' ' ILE . 4.2 m -151.09 159.63 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.842 1.657 . . . . 12.05 109.458 -167.628 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 62.2 mm-40 -107.08 159.63 29.3 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 120.554 -1.341 . . . . 18.17 110.328 163.132 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -72.7 -6.58 19.29 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 124.856 3.704 . . . . 8.16 112.374 -176.66 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.8 p -72.64 -26.0 61.49 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 125.355 1.66 . . . . 11.13 114.338 171.779 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -64.82 157.75 26.87 Favored 'General case' 0 N--CA 1.43 -1.456 1 N-CA-C 124.425 4.972 . . . . 18.03 124.425 174.687 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 62.5 p -101.29 167.64 10.06 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 114.074 -2.869 . . . . 10.22 113.899 -173.49 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.317 7.0 mm -64.65 -35.41 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 125.392 1.682 . . . . 12.3 109.65 172.001 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -44.55 -48.82 10.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.683 3.586 . . . . 36.51 120.683 160.049 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -62.79 -40.72 98.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.122 1.514 . . . . 25.66 109.255 174.375 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.299 57.6 t -55.07 -59.76 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 116.721 -1.609 . . . . 8.12 113.652 171.371 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.79 -27.48 68.78 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.073 1.76 . . . . 15.47 112.735 176.875 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.48 -32.53 62.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 122.549 2.431 . . . . 11.45 115.148 175.923 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -70.04 -26.65 64.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.303 -3.373 . . . . 24.98 109.375 176.189 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 30' ' ' ILE . 17.4 mm -70.48 -37.87 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.224 1.409 . . . . 9.46 110.988 168.723 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -43.84 78.37 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.301 -2.124 . . . . 14.76 111.612 -178.033 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.35 -69.09 0.12 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 126.948 2.655 . . . . 26.29 110.984 170.443 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -69.73 -52.32 26.52 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.835 -3.041 . . . . 30.06 118.485 -171.093 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -84.53 -65.51 1.0 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.877 -1.764 . . . . 25.19 107.589 -178.272 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.01 17.79 1.0 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 122.64 2.473 . . . . 7.41 113.884 -175.048 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.8 mt -97.3 131.19 27.85 Favored Pre-proline 0 N--CA 1.431 -1.41 0 N-CA-C 116.07 1.878 . . . . 9.49 116.07 -175.61 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.86 154.79 70.4 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 CA-C-N 124.157 2.521 . . . . 11.42 109.549 -178.946 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 -17.69 13.6 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 N-CA-C 117.221 1.97 . . . . 12.0 117.221 -170.716 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.26 -15.64 57.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.216 1.484 . . . . 35.55 110.704 178.111 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -86.96 -33.18 19.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.74 2.816 . . . . 20.52 113.036 176.462 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -71.03 139.02 50.33 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.231 1.937 . . . . 7.13 116.231 171.013 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -131.67 131.7 43.35 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.015 2.341 . . . . 36.39 114.497 160.008 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.1 mt -109.37 125.95 52.9 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.154 -4.716 . . . . 9.55 110.881 -170.993 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.7 mm -116.45 112.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.531 -1.355 . . . . 13.9 110.132 -176.038 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -102.06 116.38 32.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.879 2.276 . . . . 6.86 112.348 163.578 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.447 . . 63.1 -81.81 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.91 1.818 . . . . 11.15 115.91 -167.252 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.95 15.94 1.18 Allowed Glycine 0 N--CA 1.431 -1.687 0 CA-C-O 125.204 2.558 . . . . 13.93 112.569 174.517 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -101.09 131.39 47.03 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.607 -1.525 . . . . 23.92 110.976 -175.004 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -75.97 120.82 21.83 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.658 -1.155 . . . . 23.23 112.955 170.308 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 mt -89.56 121.29 31.62 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.179 -1.576 . . . . 9.11 111.49 -172.893 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -80.95 143.55 32.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.248 1.573 . . . . 33.44 115.248 172.407 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.78 -42.19 99.59 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.04 4.136 . . . . 28.37 110.538 -171.812 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.76 -7.69 88.3 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 127.238 2.352 . . . . 15.0 114.012 -170.476 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -101.6 155.68 17.94 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.742 1.617 . . . . 25.5 109.62 -169.875 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.4 p -95.11 167.06 11.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.04 -2.288 . . . . 11.95 110.256 -174.487 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 mt -57.69 -56.34 23.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.52 3.128 . . . . 10.17 111.886 174.306 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.406 6.6 t -36.13 -37.88 0.13 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.673 3.589 . . . . 13.59 118.822 156.283 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -72.3 -46.66 54.73 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.829 -4.919 . . . . 11.7 110.829 -176.828 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -67.96 -3.44 9.97 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 120.028 3.344 . . . . 12.95 120.028 167.26 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.0 m120 64.69 27.45 13.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.461 1.504 . . . . 25.45 114.381 -175.71 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -85.27 116.29 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.215 1.483 . . . . 14.6 109.059 -174.277 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -97.8 -165.21 1.22 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.902 3.239 . . . . 33.23 110.598 -176.733 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -76.35 150.11 36.9 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.436 -4.54 . . . . 25.97 112.979 -174.356 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 50.6 mt-10 54.6 35.64 24.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 125.344 1.652 . . . . 32.61 113.411 -174.763 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -86.71 133.97 33.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.053 1.882 . . . . 10.56 108.731 -174.668 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m -95.38 118.4 32.05 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.911 -2.368 . . . . 5.33 107.725 -177.498 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -109.31 144.58 37.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 100.827 -3.768 . . . . 11.66 100.827 -178.802 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -117.36 126.86 53.39 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.307 -3.996 . . . . 16.3 104.945 -177.164 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.4 tp -100.11 119.8 38.87 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.567 1.547 . . . . 9.96 108.044 -176.446 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.7 m -117.99 159.14 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.051 -1.656 . . . . 9.76 113.384 169.368 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 N--CA 1.429 -1.481 0 N-CA-C 106.705 -1.591 . . . . 19.57 106.705 -179.276 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 117.601 2.445 . . . . 17.17 117.601 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -98.85 134.52 41.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 115.785 -2.055 . . . . 21.89 113.459 170.308 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -130.77 155.53 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 125.546 2.594 . . . . 10.83 107.18 172.078 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -119.29 105.16 11.05 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.577 -3.827 . . . . 10.61 107.489 -161.221 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.68 100.15 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 1 O-C-N 129.64 4.338 . . . . 9.13 107.705 177.177 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -92.03 120.27 32.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.834 -1.53 . . . . 20.55 109.975 -177.455 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -74.18 -174.01 1.82 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.872 2.069 . . . . 11.78 113.739 -178.967 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.2 tp -77.76 -32.25 52.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.932 2.197 . . . . 19.31 116.932 177.334 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.8 p -70.67 -31.15 67.95 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.542 2.337 . . . . 23.14 114.637 170.75 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.8 20.15 8.23 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 117.758 -1.579 . . . . 19.74 114.538 179.849 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.292 44.4 pttt -89.07 142.96 27.19 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 124.733 1.213 . . . . 21.93 111.747 169.357 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.7 m -98.29 130.89 44.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.817 -1.802 . . . . 12.33 108.669 178.0 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.9 mt -106.56 104.64 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 1 N-CA-C 99.737 -4.171 . . . . 17.08 99.737 171.508 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -73.89 119.52 18.21 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.284 -1.51 . . . . 16.3 111.702 173.559 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.553 ' CD1' HG13 ' A' ' 26' ' ' VAL . 67.5 mt -100.17 126.07 46.39 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 114.964 -4.835 . . . . 15.88 114.13 170.588 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -78.93 92.83 4.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 125.797 1.936 . . . . 28.9 113.349 174.805 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.286 16.3 m -132.8 165.26 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 121.903 2.138 . . . . 12.05 111.325 -175.701 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -97.07 165.31 16.03 Favored Pre-proline 0 N--CA 1.429 -1.483 0 O-C-N 116.36 -3.963 . . . . 18.17 109.461 174.409 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.85 -23.66 73.16 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.811 3.111 . . . . 8.16 119.539 164.833 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -63.38 -22.39 66.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.04 2.536 . . . . 11.13 112.823 174.748 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.18 148.69 39.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.315 -2.74 . . . . 18.03 109.492 -172.174 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 7.8 p -86.91 171.77 10.56 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.46 2.076 . . . . 10.22 109.425 179.145 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mm -76.93 -22.93 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.064 -2.897 . . . . 12.3 107.204 176.407 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.82 -46.79 74.59 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.737 -1.852 . . . . 36.51 110.828 171.132 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 72.4 m-20 -70.64 -21.49 62.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.238 2.615 . . . . 25.66 115.784 -179.612 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.553 HG13 ' CD1' ' A' ' 15' ' ' LEU . 7.8 t -83.72 -57.22 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 112.413 -2.176 . . . . 8.12 107.113 174.191 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -45.19 -39.73 6.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.121 -2.862 . . . . 15.47 117.024 169.714 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.35 89.86 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.722 3.23 . . . . 11.45 119.722 173.047 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.31 -36.0 80.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.113 1.894 . . . . 24.98 116.113 169.127 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mm -69.43 -31.32 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.924 -1.735 . . . . 9.46 107.624 -179.11 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -72.17 -44.67 62.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.417 -2.677 . . . . 14.76 113.182 169.709 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -54.64 -45.36 73.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.102 2.561 . . . . 26.29 114.57 177.511 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -91.46 -56.93 2.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.455 -2.028 . . . . 30.06 114.061 -177.994 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.269 52.6 mm-40 -85.81 -31.07 22.51 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.564 -4.46 . . . . 25.19 114.53 -175.156 . . . . . . . . 3 2 . 1 . 048 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.76 7.55 59.99 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 119.568 -1.958 . . . . 7.41 112.902 173.702 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.2 116.95 59.22 Favored Pre-proline 0 N--CA 1.429 -1.485 0 CA-C-O 114.856 -2.497 . . . . 9.49 113.819 177.415 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -63.94 150.74 87.72 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 125.227 3.952 . . . . 11.42 114.08 -172.074 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -73.95 -20.69 19.25 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 O-C-N 114.941 -3.241 . . . . 12.0 113.843 -166.964 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -80.61 -18.73 47.3 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.685 -1.969 . . . . 35.55 105.685 178.596 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -89.93 -18.34 26.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.753 -1.842 . . . . 20.52 113.478 176.744 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -72.95 137.33 45.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.71 -2.494 . . . . 7.13 109.163 -177.485 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.517 ' HB3' HG23 ' A' ' 70' ' ' VAL . 28.0 ttt180 -130.89 129.54 42.38 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.668 1.576 . . . . 36.39 109.837 168.878 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 50' ' ' LEU . 22.9 mt -118.95 124.32 46.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.704 -1.135 . . . . 9.55 111.33 -173.928 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 21.7 mm -118.01 134.38 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.171 2.588 . . . . 13.9 106.647 -171.071 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.409 ' HB2' HD11 ' A' ' 50' ' ' LEU . 82.2 t80 -121.24 113.32 19.79 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.324 2.342 . . . . 6.86 117.324 161.245 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.86 -98.44 0.08 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.786 1.402 . . . . 11.15 114.786 -164.725 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.21 4.04 9.62 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 124.762 1.172 . . . . 13.93 113.875 166.116 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -90.98 139.24 30.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.294 1.521 . . . . 23.92 109.56 177.809 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -87.73 117.07 26.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.204 2.202 . . . . 23.23 110.386 178.721 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 43' ' ' LEU . 83.2 mt -83.61 129.27 34.96 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.962 2.905 . . . . 9.11 107.898 -178.553 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -111.74 154.43 25.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.224 -1.807 . . . . 33.44 109.245 -173.995 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.38 -48.57 67.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.49 1.614 . . . . 28.37 110.876 -158.404 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.58 15.75 44.58 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.972 1.749 . . . . 15.0 114.605 177.279 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -100.36 167.8 10.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.79 -1.93 . . . . 25.5 105.79 171.005 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 11.4 p -105.04 176.86 5.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.514 -1.991 . . . . 11.95 107.955 -177.865 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.78 -43.55 88.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.957 2.661 . . . . 10.17 115.272 164.856 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.2 t -51.85 -43.74 63.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.414 2.686 . . . . 13.59 113.663 173.717 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -67.17 -29.24 68.88 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 117.147 2.277 . . . . 11.7 117.147 -173.914 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.07 -10.23 50.83 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 119.441 3.126 . . . . 12.95 119.441 171.296 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.4 m120 85.06 56.69 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.471 1 C-N-CA 133.679 4.791 . . . . 25.45 107.244 172.466 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.7 mt -104.92 101.38 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 N-CA-C 99.375 -4.305 . . . . 14.6 99.375 -172.844 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -91.07 -177.48 4.92 Favored 'General case' 0 N--CA 1.43 -1.433 2 C-N-CA 134.561 5.144 . . . . 33.23 107.265 179.973 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -66.57 145.57 55.46 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.001 1.32 . . . . 25.97 114.37 -179.311 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.381 17.0 mt-10 66.64 52.56 0.99 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 126.715 3.15 . . . . 32.61 117.337 176.866 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.1 t -131.76 134.01 45.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.689 -3.132 . . . . 10.56 113.166 -153.227 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.2 m -77.25 117.08 18.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.745 2.528 . . . . 5.33 115.16 -179.231 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -115.05 138.37 50.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 115.388 -2.244 . . . . 11.66 108.305 165.39 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.5 m-70 -100.49 122.64 43.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.766 1.166 . . . . 16.3 111.288 -177.329 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.69 117.46 31.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.099 2.381 . . . . 9.96 110.197 172.575 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -126.85 176.7 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 130.596 3.558 . . . . 9.76 109.266 172.772 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.43 -1.434 0 O-C-N 119.688 -1.882 . . . . 19.57 115.858 175.441 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 104.832 -2.284 . . . . 17.17 104.832 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -116.3 130.51 56.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.815 -2.291 . . . . 21.89 104.815 -175.6 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -117.68 154.45 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.785 -2.302 . . . . 10.83 104.785 161.161 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.314 98.1 m-85 -116.14 152.06 34.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.603 -3.186 . . . . 10.61 106.121 176.801 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -125.41 113.18 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 106.746 -1.575 . . . . 9.13 106.746 177.942 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -122.4 150.95 41.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.699 1.249 . . . . 20.55 113.234 -169.357 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -89.7 176.2 6.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.242 1.817 . . . . 11.78 108.246 176.65 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 mt -68.79 -38.82 80.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.124 -2.235 . . . . 19.31 107.064 -175.4 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -83.83 -61.84 1.72 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.771 -2.456 . . . . 23.14 114.268 -172.832 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.55 68.69 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 117.737 -2.173 . . . . 19.74 109.402 177.42 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tmmm? -120.09 121.25 38.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.112 -2.922 . . . . 21.93 103.112 155.407 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.0 m -111.88 112.03 23.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.709 -2.495 . . . . 12.33 108.093 -173.73 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.26 136.73 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 105.468 -2.049 . . . . 17.08 105.468 173.654 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.2 m -101.78 119.8 39.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.721 -1.214 . . . . 16.3 107.721 -171.283 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.6 mt -103.84 134.91 46.35 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 119.279 3.066 . . . . 15.88 119.279 178.943 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.18 109.49 21.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.205 -1.56 . . . . 28.9 108.686 178.691 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -130.1 148.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 116.765 -3.709 . . . . 12.05 112.291 -169.884 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -97.44 146.68 31.81 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 118.997 -2.315 . . . . 18.17 109.312 171.34 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.8 -17.74 17.6 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-O 112.393 -3.253 . . . . 8.16 107.602 -172.651 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -85.29 7.37 22.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 123.896 3.044 . . . . 11.13 112.042 177.035 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -92.71 171.81 8.76 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.213 -2.804 . . . . 18.03 107.217 -174.717 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -112.48 153.45 27.41 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.046 -1.659 . . . . 10.22 109.975 -169.12 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 3.0 mt -74.21 -20.74 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.209 2.604 . . . . 12.3 106.383 -174.311 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.94 -44.87 91.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.283 1.033 . . . . 36.51 112.101 169.614 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -66.37 -34.96 79.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.293 3.437 . . . . 25.66 109.66 174.439 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 97.6 t -62.84 -49.77 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 119.852 -1.78 . . . . 8.12 111.948 177.703 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -65.7 -27.63 68.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.468 2.355 . . . . 15.47 110.429 -172.802 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.81 -28.35 67.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.562 2.345 . . . . 11.45 110.02 177.932 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -93.04 -28.94 16.07 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 121.719 2.054 . . . . 24.98 108.26 -178.253 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 mt -65.1 -42.13 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 118.687 -2.508 . . . . 9.46 111.377 164.763 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -59.36 -51.84 68.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.109 -3.495 . . . . 14.76 117.691 168.087 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -46.24 -50.08 16.39 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 122.268 2.303 . . . . 26.29 115.018 174.324 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -68.68 -63.76 1.0 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.496 2.719 . . . . 30.06 117.109 174.16 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -88.24 -29.82 20.16 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.64 2.089 . . . . 25.19 116.64 -174.092 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.13 14.83 59.94 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 119.058 2.383 . . . . 7.41 119.058 -178.44 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 tt -103.15 115.31 64.2 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 114.903 -2.475 . . . . 9.49 106.536 -178.275 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -60.27 170.03 4.47 Favored 'Trans proline' 0 N--CA 1.434 -1.988 2 C-N-CA 131.058 7.839 . . . . 11.42 116.256 -168.977 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.88 -21.09 7.17 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 125.365 2.952 . . . . 12.0 108.126 -164.307 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -75.43 -33.92 60.95 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.445 -2.66 . . . . 35.55 113.005 175.946 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -73.59 -37.52 65.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.516 -3.24 . . . . 20.52 113.929 176.265 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -54.74 124.55 16.8 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.967 -2.333 . . . . 7.13 114.269 173.952 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -124.32 99.34 6.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.369 1.44 . . . . 36.39 108.43 -178.123 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.3 mt -96.93 107.33 19.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.384 1.874 . . . . 9.55 110.705 -173.131 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.421 HG13 HG21 ' A' ' 70' ' ' VAL . 17.2 mm -110.37 120.41 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 128.471 2.708 . . . . 13.9 105.67 -175.406 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -107.95 115.93 31.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.734 -2.03 . . . . 6.86 108.022 169.132 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.29 -94.04 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 112.32 -2.218 . . . . 11.15 113.306 -164.168 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.72 12.56 4.53 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 129.361 3.362 . . . . 13.93 113.149 169.997 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -117.91 148.79 41.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.757 2.279 . . . . 23.92 108.843 -179.82 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -110.77 114.71 28.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.217 -1.031 . . . . 23.23 108.217 -169.115 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.771 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -68.55 157.67 35.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.94 -2.35 . . . . 9.11 115.108 -171.947 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -100.21 154.95 18.04 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.775 -1.194 . . . . 33.44 107.775 178.465 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -75.87 -50.0 16.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.013 -2.899 . . . . 28.37 116.309 -160.23 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.9 52.93 2.94 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 123.197 2.726 . . . . 15.0 111.855 179.726 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.259 6.7 mmt180 -121.41 160.3 24.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 103.874 -2.639 . . . . 25.5 103.874 171.207 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.303 66.2 p -86.62 151.85 23.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.33 1.452 . . . . 11.95 111.971 175.937 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.252 33.3 mt -47.51 -50.78 22.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.677 1.191 . . . . 10.17 111.699 165.545 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 p -54.12 -26.73 28.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.328 1.973 . . . . 13.59 116.328 176.866 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.35 -43.45 98.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.396 -2.69 . . . . 11.7 110.505 173.455 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.23 -16.01 28.32 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 126.601 2.438 . . . . 12.95 115.724 176.532 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 70.63 36.95 1.51 Allowed 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.601 1.561 . . . . 25.45 113.381 -172.226 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -68.63 101.43 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.49 -2.006 . . . . 14.6 116.121 170.901 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -76.52 163.43 26.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.82 2.896 . . . . 33.23 118.82 -175.829 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -61.35 147.85 43.41 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.605 2.817 . . . . 25.97 118.605 169.593 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.333 26.2 mt-10 68.74 23.98 6.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.07 1.89 . . . . 32.61 112.773 179.916 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -84.79 152.39 23.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.275 3.417 . . . . 10.56 107.945 -179.997 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -110.41 97.81 7.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 110.766 -2.925 . . . . 5.33 107.887 175.825 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -80.81 152.26 28.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.267 3.027 . . . . 11.66 112.119 165.446 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -104.41 140.15 38.33 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.253 -2.78 . . . . 16.3 106.376 -178.136 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 tp -102.73 104.27 14.57 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.994 2.33 . . . . 9.96 110.225 156.939 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG21 HG13 ' A' ' 44' ' ' ILE . 3.4 t -91.53 138.21 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 117.357 -3.34 . . . . 9.76 108.047 -176.62 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 N--CA 1.43 -1.453 0 O-C-N 118.79 -2.444 . . . . 19.57 105.769 172.632 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 125.08 2.372 . . . . 17.17 114.308 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -104.92 131.1 52.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.539 -3.851 . . . . 21.89 111.92 166.162 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.297 2.3 pp -124.08 162.52 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 1 O-C-N 114.61 -5.056 . . . . 10.83 105.283 169.679 . . . . . . . . 3 2 . 1 . 050 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -107.04 128.39 54.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.484 3.113 . . . . 10.61 106.607 -175.189 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.59 104.89 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 100.319 -3.956 . . . . 9.13 100.319 -177.859 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 tttt -89.4 162.22 15.89 Favored 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 131.913 4.085 . . . . 20.55 108.661 175.008 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.484 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 17.8 p -101.99 -151.72 0.42 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.818 -2.426 . . . . 11.78 105.899 173.703 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.484 ' H ' ' HB ' ' A' ' 7' ' ' THR . 51.3 mt -91.58 -42.39 10.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.004 1.275 . . . . 19.31 111.459 170.07 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -66.53 -36.66 83.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.875 -1.766 . . . . 23.14 113.182 174.455 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.01 22.13 1.28 Allowed Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 120.057 2.783 . . . . 19.74 120.057 158.053 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -72.99 106.02 4.7 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.216 2.206 . . . . 21.93 116.438 168.261 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -81.13 130.33 34.97 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.818 -1.083 . . . . 12.33 109.69 173.511 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -107.38 157.25 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 119.912 -1.743 . . . . 17.08 106.871 158.79 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.7 m -125.57 106.59 9.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.315 -1.735 . . . . 16.3 106.315 -169.147 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.261 86.5 mt -125.24 144.95 50.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.829 -0.545 . . . . 15.88 112.047 -168.345 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -97.1 105.69 17.88 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.375 2.731 . . . . 28.9 118.375 -171.005 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 m -125.61 161.33 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.375 2.27 . . . . 12.05 108.146 -168.476 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -103.92 169.58 7.13 Favored Pre-proline 0 N--CA 1.429 -1.476 1 O-C-N 113.232 -5.917 . . . . 18.17 106.653 167.72 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -77.96 -17.25 13.83 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 116.301 -2.526 . . . . 8.16 107.74 174.639 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -75.85 -6.44 50.76 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 117.788 -3.07 . . . . 11.13 112.654 173.02 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -77.26 145.01 37.77 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.98 -3.575 . . . . 18.03 108.935 174.76 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.324 20.1 p -77.76 151.75 33.93 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 133.175 4.59 . . . . 10.22 110.655 176.458 . . . . . . . . 3 2 . 1 . 050 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 50' ' ' LEU . 65.0 mt -63.5 -38.96 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 120.264 -1.523 . . . . 12.3 113.031 175.431 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -46.13 -45.37 16.47 Favored 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 132.463 4.305 . . . . 36.51 113.72 168.591 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -74.57 -23.12 58.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.721 -3.737 . . . . 25.66 114.26 174.738 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.36 -44.93 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.503 -1.998 . . . . 8.12 110.576 174.28 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.17 -40.24 73.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.485 1.514 . . . . 15.47 114.008 173.426 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.06 -42.11 65.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.232 2.308 . . . . 11.45 117.232 167.648 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -79.54 -14.26 58.98 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 116.151 -4.093 . . . . 24.98 116.259 179.037 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -88.1 -26.29 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.892 -1.755 . . . . 9.46 110.17 168.119 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -63.97 -48.9 74.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.642 -3.161 . . . . 14.76 115.933 162.876 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -42.4 -51.42 4.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.0 3.333 . . . . 26.29 120.0 157.209 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -90.67 -68.11 0.81 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.347 -0.845 . . . . 30.06 111.326 -166.474 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -86.78 -34.43 19.58 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.303 1.441 . . . . 25.19 112.648 -176.249 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.55 67.27 1.57 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 115.997 1.159 . . . . 7.41 115.997 173.797 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.58 HD11 HD13 ' A' ' 71' ' ' LEU . 10.5 tt -126.9 133.55 25.15 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-N 110.138 -3.031 . . . . 9.49 110.97 164.864 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 10.7 Cg_endo -74.44 157.36 45.18 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 123.924 3.083 . . . . 11.42 113.368 -172.435 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 84.1 Cg_exo -72.85 -15.5 26.53 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 CA-C-O 112.567 -3.181 . . . . 12.0 114.171 -153.775 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.49 -17.63 29.93 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 128.639 3.712 . . . . 35.55 106.068 -176.216 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -89.11 -27.17 20.94 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.781 -3.074 . . . . 20.52 104.832 -178.711 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -78.62 109.61 12.99 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.006 -3.559 . . . . 7.13 111.541 -175.538 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -100.44 104.52 15.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.107 -2.553 . . . . 36.39 104.107 174.587 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -96.45 140.56 30.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.855 -2.403 . . . . 9.55 109.16 179.014 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -134.88 146.58 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.722 1.725 . . . . 13.9 107.815 -173.073 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -121.84 104.5 9.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.702 2.001 . . . . 6.86 106.482 166.376 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.36 -102.64 0.16 Allowed 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 116.064 -4.147 . . . . 11.15 113.975 173.147 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.11 -25.05 27.72 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 124.461 3.3 . . . . 13.93 113.233 171.526 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -83.8 136.81 34.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.95 1.357 . . . . 23.92 113.364 -173.021 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -78.67 147.52 33.51 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.644 -3.16 . . . . 23.23 111.146 163.056 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.429 ' HB3' HD13 ' A' ' 23' ' ' ILE . 9.8 mt -110.42 110.45 21.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 114.662 -2.59 . . . . 9.11 104.914 -172.282 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.296 20.8 mt-10 -81.08 145.41 31.11 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.714 3.606 . . . . 33.44 113.47 177.427 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.59 -49.56 74.74 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 119.847 3.277 . . . . 28.37 119.847 -158.429 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.17 15.32 56.48 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.589 -3.819 . . . . 15.0 116.345 -174.045 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.2 mtt-85 -93.87 161.21 14.4 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.627 1.204 . . . . 25.5 109.147 169.292 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.1 p -91.52 173.77 7.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.101 1.905 . . . . 11.95 111.211 177.183 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.5 -24.82 53.75 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.38 -1.45 . . . . 10.17 109.434 173.133 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.5 t -72.5 -36.32 68.35 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.805 -1.809 . . . . 13.59 113.132 -177.196 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -59.01 -39.93 83.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.318 2.261 . . . . 11.7 114.724 173.762 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -84.73 2.08 43.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.761 -3.087 . . . . 12.95 113.551 -179.874 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.292 29.3 m120 54.47 51.49 14.03 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.061 2.615 . . . . 25.45 118.061 -168.829 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -99.11 112.53 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 122.741 2.518 . . . . 14.6 107.752 -179.808 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -103.24 176.94 4.98 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.889 1.676 . . . . 33.23 108.527 -173.975 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 pttp -73.79 148.76 42.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.021 -2.299 . . . . 25.97 112.897 -173.674 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.81 19.75 10.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 111.367 -2.651 . . . . 32.61 110.802 -173.456 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -82.39 160.66 22.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.217 -2.142 . . . . 10.56 105.217 179.31 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -116.68 120.55 38.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 126.185 2.898 . . . . 5.33 104.766 -171.994 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.41 64.2 mt -100.37 155.55 17.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.489 -2.141 . . . . 11.66 108.508 169.207 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -107.52 131.51 54.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.562 1.69 . . . . 16.3 115.562 173.482 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.0 107.61 19.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.433 1.893 . . . . 9.96 106.096 178.915 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.82 152.75 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.049 -1.657 . . . . 9.76 107.47 172.629 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.58 HD13 HD11 ' A' ' 36' ' ' ILE . 10.0 tp . . . . . 0 N--CA 1.43 -1.453 0 O-C-N 119.165 -2.209 . . . . 19.57 105.164 172.679 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 114.518 1.303 . . . . 17.17 114.518 . . . . . . . . . 0 0 . 1 . 051 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -79.55 127.04 31.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.094 -1.432 . . . . 21.89 114.475 178.36 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -119.25 159.65 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 122.161 2.255 . . . . 10.83 113.943 159.011 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.64 135.6 53.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 104.479 -2.415 . . . . 10.61 104.479 -172.052 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.63 119.03 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 105.408 -2.071 . . . . 9.13 105.408 174.743 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.494 ' HG2' HG23 ' A' ' 12' ' ' THR . 61.0 mttt -107.38 136.49 47.09 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.15 -2.167 . . . . 20.55 105.15 -171.523 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.272 72.0 p -97.62 172.95 7.39 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.371 2.986 . . . . 11.78 107.52 -172.02 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mt -77.78 -35.72 51.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.096 -1.866 . . . . 19.31 115.845 176.875 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -65.42 -69.78 0.27 Allowed 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 121.697 2.044 . . . . 23.14 106.243 170.405 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.84 68.81 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 113.418 -1.719 . . . . 19.74 113.556 178.623 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -132.75 150.07 52.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.776 -3.046 . . . . 21.93 102.776 170.346 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 6' ' ' LYS . 34.6 m -127.33 90.98 3.22 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 116.573 -1.68 . . . . 12.33 107.211 -178.219 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 pt -77.07 125.37 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 128.377 2.671 . . . . 17.08 110.964 -179.784 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.7 m -97.47 117.11 30.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.126 1.516 . . . . 16.3 113.047 177.008 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -99.12 144.41 28.29 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.037 -1.097 . . . . 15.88 108.037 178.618 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -87.08 112.69 22.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.669 -3.144 . . . . 28.9 113.873 165.427 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.68 -176.25 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.416 1 O-C-N 115.917 -4.24 . . . . 12.05 114.374 176.438 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -132.06 141.47 41.58 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 116.849 -3.657 . . . . 18.17 111.717 169.696 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.87 -18.19 41.41 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 119.296 2.768 . . . . 8.16 119.296 -170.79 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -76.65 -10.31 59.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.223 1.934 . . . . 11.13 116.223 173.535 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.271 10.9 t0 -94.43 164.77 12.87 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.496 -2.003 . . . . 18.03 114.173 -175.76 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -75.49 161.41 29.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.819 -2.425 . . . . 10.22 114.828 -170.197 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 50' ' ' LEU . 22.0 mt -77.83 -31.21 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.891 -3.006 . . . . 12.3 112.389 177.855 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -49.3 -48.0 46.51 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.384 2.274 . . . . 36.51 112.385 167.404 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -74.1 -13.66 60.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.372 1.869 . . . . 25.66 113.066 179.657 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.95 -49.27 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 116.553 -3.842 . . . . 8.12 108.034 165.368 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -62.96 -33.22 74.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.376 2.67 . . . . 15.47 110.601 -179.236 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.63 -44.78 85.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.491 3.043 . . . . 11.45 107.953 -177.087 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.277 65.9 mttm -63.66 -35.06 79.29 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 120.503 3.52 . . . . 24.98 120.503 173.391 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.93 -28.06 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.54 3.067 . . . . 9.46 111.15 178.911 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -70.88 -50.36 35.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.499 -3.25 . . . . 14.76 106.056 177.992 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -48.38 -46.64 37.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.703 3.62 . . . . 26.29 114.895 178.159 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -82.49 -56.96 3.57 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.034 -2.348 . . . . 30.06 109.517 -165.614 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -100.1 -22.82 15.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.598 3.184 . . . . 25.19 119.598 -174.841 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.31 27.64 8.04 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 117.228 -3.42 . . . . 7.41 115.238 170.204 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 tt -111.98 135.14 21.26 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-O 113.686 -3.054 . . . . 9.49 107.073 -168.426 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.55 167.21 27.05 Favored 'Trans proline' 0 C--N 1.299 -2.045 1 CA-C-O 109.448 -4.48 . . . . 11.42 113.307 -174.383 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.18 -11.12 7.6 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 126.026 3.188 . . . . 12.0 111.833 -179.924 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -71.93 -18.66 62.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.611 -2.556 . . . . 35.55 110.796 173.036 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -92.03 -17.77 24.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 116.562 -1.685 . . . . 20.52 110.43 172.724 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -89.02 128.25 35.71 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.81 1.29 . . . . 7.13 112.768 -168.516 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -140.66 143.94 35.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 112.562 -2.108 . . . . 36.39 107.324 152.274 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.4 mt -110.23 136.31 49.64 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.712 2.405 . . . . 9.55 106.092 -171.92 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -128.13 136.02 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 116.658 -3.776 . . . . 13.9 105.874 -170.314 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -120.9 108.01 13.39 Favored 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 98.938 -4.467 . . . . 6.86 98.938 -177.076 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.53 -64.91 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 131.41 3.884 . . . . 11.15 115.056 178.181 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.64 -0.81 1.73 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 116.906 1.522 . . . . 13.93 116.906 169.208 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -119.11 153.28 35.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 120.552 2.176 . . . . 23.92 107.575 -169.603 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -84.52 137.28 33.42 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.56 1.171 . . . . 23.23 113.676 177.256 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HB3' HD13 ' A' ' 23' ' ' ILE . 27.1 mt -94.15 120.55 34.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.152 1.381 . . . . 9.11 107.31 -178.547 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -78.85 141.26 37.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.009 1.861 . . . . 33.44 113.894 177.499 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.7 -63.5 1.07 Allowed 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 132.157 4.183 . . . . 28.37 115.386 -179.588 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.15 4.32 6.21 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 128.103 2.763 . . . . 15.0 119.569 -179.003 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -105.89 165.82 10.92 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 125.165 2.412 . . . . 25.5 106.439 -177.882 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.6 p -94.38 177.2 6.02 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.11 -2.869 . . . . 11.95 117.64 172.048 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.38 -25.96 38.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.606 1.962 . . . . 10.17 108.849 179.242 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 m -76.2 -24.86 54.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 121.293 1.86 . . . . 13.59 112.962 172.259 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -54.61 -38.95 67.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.712 1.745 . . . . 11.7 115.712 171.595 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -99.19 -11.99 20.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.37 2.668 . . . . 12.95 111.428 -175.359 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.12 60.07 3.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.625 1.97 . . . . 25.45 114.68 -162.499 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -92.31 118.43 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 126.899 2.08 . . . . 14.6 106.336 173.679 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -103.75 -174.76 2.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.166 1.543 . . . . 33.23 115.166 178.486 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -69.54 155.77 39.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.041 -2.287 . . . . 25.97 108.948 176.193 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 53.9 40.01 31.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.88 2.472 . . . . 32.61 112.021 -178.283 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -92.93 136.43 33.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 129.156 2.983 . . . . 10.56 106.23 176.715 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.4 m -81.13 110.47 16.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.707 -2.331 . . . . 5.33 104.707 171.027 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.99 148.85 25.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.489 2.859 . . . . 11.66 108.451 165.989 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -111.24 138.6 47.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.024 -2.213 . . . . 16.3 105.024 -179.733 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tp -116.45 122.25 44.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.17 -2.529 . . . . 9.96 104.17 -179.39 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -108.52 171.47 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 124.811 1.32 . . . . 9.76 110.759 -179.617 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 tp . . . . . 0 N--CA 1.43 -1.473 0 O-C-N 118.084 -2.885 . . . . 19.57 113.287 167.335 . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 CA--C 1.489 -1.377 0 N-CA-C 120.027 3.343 . . . . 17.17 120.027 . . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -92.03 132.9 36.2 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 116.017 -4.177 . . . . 21.89 109.216 -176.908 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 pt -135.68 150.66 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 116.646 -3.784 . . . . 10.83 105.795 174.836 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.3 134.46 52.87 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.36 -1.291 . . . . 10.61 109.498 -177.102 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -115.02 120.25 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 119.478 -2.014 . . . . 9.13 109.901 173.695 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -89.98 128.48 36.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.711 2.672 . . . . 20.55 114.46 167.151 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -80.48 -167.51 1.37 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.125 -2.234 . . . . 11.78 109.711 -165.731 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.2 -55.65 31.14 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.554 2.742 . . . . 19.31 112.682 169.409 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -91.04 -34.65 15.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.077 1.751 . . . . 23.14 110.785 -164.341 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.26 79.02 0.2 Allowed Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 128.776 3.084 . . . . 19.74 111.223 170.023 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -141.76 137.59 31.71 Favored 'General case' 0 N--CA 1.43 -1.451 1 N-CA-C 97.533 -4.988 . . . . 21.93 97.533 177.682 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -109.38 101.23 10.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.846 -1.168 . . . . 12.33 107.846 174.803 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.42 153.91 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 130.242 3.417 . . . . 17.08 110.283 164.251 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.3 m -120.03 139.87 51.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.41 -1.7 . . . . 16.3 106.41 -176.17 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.302 96.0 mt -134.63 152.2 51.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 121.436 1.925 . . . . 15.88 112.294 173.362 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -102.48 117.58 35.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.132 1.333 . . . . 28.9 112.761 176.838 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.68 172.3 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 121.704 2.047 . . . . 12.05 112.769 -178.892 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -111.99 155.64 43.03 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 104.969 -2.234 . . . . 18.17 104.969 170.252 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.271 21.6 Cg_exo -71.22 -12.08 29.58 Favored 'Trans proline' 0 N--CA 1.433 -2.033 1 C-N-CA 126.115 4.543 . . . . 8.16 111.631 -175.273 . . . . . . . . 3 2 . 1 . 052 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 p -92.42 -1.88 56.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 127.646 3.091 . . . . 11.13 108.379 179.401 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -71.79 143.48 49.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 127.846 3.689 . . . . 18.03 113.948 170.071 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -86.53 169.42 12.81 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 109.631 -3.44 . . . . 10.22 110.598 -169.649 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -69.73 -37.48 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.434 -1.321 . . . . 12.3 107.434 175.619 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -54.3 -50.68 66.75 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.503 -1.998 . . . . 36.51 113.653 171.3 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -61.09 -34.1 74.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 122.843 2.565 . . . . 25.66 115.472 173.196 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.388 75.9 t -54.02 -54.53 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 124.597 1.186 . . . . 8.12 113.553 169.124 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -53.3 -24.25 11.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.968 3.307 . . . . 15.47 119.507 170.266 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.72 -38.78 58.26 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.695 3.617 . . . . 11.45 111.033 176.489 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -68.29 -33.08 73.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.071 -3.518 . . . . 24.98 115.471 174.361 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -75.02 -47.25 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.782 2.033 . . . . 9.46 107.412 175.462 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -46.06 -48.43 16.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 114.704 -2.569 . . . . 14.76 113.37 169.46 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.65 -48.12 60.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 120.398 1.453 . . . . 26.29 114.39 -176.472 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -71.88 -52.8 15.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.956 -1.497 . . . . 30.06 113.324 -172.948 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -91.67 -41.61 10.63 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 126.502 2.376 . . . . 25.19 113.989 -167.271 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.71 40.61 1.56 Allowed Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 119.11 -0.828 . . . . 7.41 113.551 173.54 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 tt -113.49 139.86 23.8 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-O 114.826 -2.511 . . . . 9.49 106.271 -179.511 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -68.77 153.04 73.79 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 126.964 3.523 . . . . 11.42 109.582 177.624 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.01 -22.82 70.81 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 127.894 5.729 . . . . 12.0 119.356 176.814 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.84 -24.59 48.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.762 -2.681 . . . . 35.55 103.762 -171.381 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.15 -25.02 25.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.424 -1.423 . . . . 20.52 114.114 -171.225 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -74.95 117.9 17.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.504 -1.998 . . . . 7.13 116.101 179.742 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -108.71 110.6 22.05 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.564 2.345 . . . . 36.39 111.223 167.598 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.69 135.58 33.62 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.141 3.015 . . . . 9.55 119.141 173.955 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 mm -121.13 137.15 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 124.107 1.908 . . . . 13.9 110.626 176.202 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -117.08 130.0 56.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.293 -2.754 . . . . 6.86 105.67 164.417 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 48.25 -94.62 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.902 1.816 . . . . 11.15 115.902 -176.028 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.03 15.14 7.4 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 118.578 -2.576 . . . . 13.93 114.365 165.307 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -103.4 138.33 40.28 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.695 -3.238 . . . . 23.92 108.916 -174.553 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -91.27 114.19 26.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.422 2.289 . . . . 23.23 112.688 173.075 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 mt -74.99 129.47 37.71 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 124.527 1.142 . . . . 9.11 111.576 -171.469 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -71.81 143.34 49.53 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.179 2.659 . . . . 33.44 118.179 172.72 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -53.78 -54.49 37.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.543 3.137 . . . . 28.37 113.302 -169.347 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.86 18.8 55.38 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-O 116.479 -2.29 . . . . 15.0 116.498 -172.321 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -92.92 168.84 10.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.134 1.967 . . . . 25.5 112.206 169.345 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 p -100.81 166.01 11.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 113.974 1.101 . . . . 11.95 113.974 170.488 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.59 -25.31 62.13 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 114.411 -2.709 . . . . 10.17 112.66 -177.044 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -70.07 -31.17 68.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.852 3.261 . . . . 13.59 110.887 176.224 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -67.84 -33.51 74.91 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.154 1.797 . . . . 11.7 111.337 175.962 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.16 13.38 17.17 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.775 -6.203 . . . . 12.95 115.343 166.116 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.73 27.52 14.5 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 114.904 -4.873 . . . . 25.45 114.693 179.334 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.6 121.98 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.973 -3.579 . . . . 14.6 107.127 -174.15 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -109.92 179.08 4.22 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.21 2.604 . . . . 33.23 108.302 -169.653 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -48.76 145.32 3.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.734 1.613 . . . . 25.97 110.733 172.551 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.257 54.0 mt-10 67.64 30.62 6.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.008 -1.906 . . . . 32.61 115.121 165.039 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -108.28 141.48 40.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.234 1.969 . . . . 10.56 110.335 -175.015 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 m -89.13 105.82 18.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.746 -2.024 . . . . 5.33 107.093 -174.789 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.11 148.42 34.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.147 3.379 . . . . 11.66 108.361 158.213 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -115.3 134.5 55.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.933 -1.73 . . . . 16.3 110.209 170.753 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.7 tp -106.67 116.97 32.85 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.96 1.413 . . . . 9.96 109.674 -176.127 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.6 m -127.26 -173.14 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.542 -2.762 . . . . 9.76 103.542 175.699 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.2 mt . . . . . 0 N--CA 1.43 -1.464 0 O-C-N 119.859 -1.775 . . . . 19.57 109.996 -173.532 . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 114.407 1.262 . . . . 17.17 114.407 . . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -109.66 149.51 29.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.086 1.884 . . . . 21.89 116.086 178.84 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -133.08 157.28 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.331 -3.356 . . . . 10.83 112.205 163.6 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -109.29 131.7 54.82 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 128.293 3.496 . . . . 10.61 106.425 179.669 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -135.75 131.81 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 117.071 -3.518 . . . . 9.13 106.986 -176.37 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -103.41 147.13 27.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.126 -2.234 . . . . 20.55 109.738 -179.283 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.6 p -85.48 -178.19 6.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.24 1.495 . . . . 11.78 108.394 172.297 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.06 -47.45 85.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.049 1.74 . . . . 19.31 113.485 172.936 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -93.29 -79.42 0.4 Allowed 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 118.226 -2.796 . . . . 23.14 112.718 -172.408 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.19 63.62 0.32 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 127.157 2.313 . . . . 19.74 115.111 -177.362 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -140.87 129.54 22.84 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.056 1.884 . . . . 21.93 110.825 172.265 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -110.79 109.89 20.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.259 -3.401 . . . . 12.33 103.908 178.41 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 30' ' ' ILE . 1.8 pt -98.88 142.79 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 127.097 2.159 . . . . 17.08 111.692 178.531 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.9 m -115.31 112.47 22.45 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.222 -2.174 . . . . 16.3 110.709 -178.61 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -103.64 155.11 18.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.01 1.862 . . . . 15.88 106.952 -172.278 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.56 121.67 42.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.021 2.343 . . . . 28.9 111.667 165.425 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.462 HG12 ' HE3' ' A' ' 29' ' ' LYS . 5.6 m -134.73 164.88 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 103.082 -2.933 . . . . 12.05 103.082 -175.838 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -120.8 153.42 57.02 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 115.798 -2.049 . . . . 18.17 109.196 165.103 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -67.61 -13.76 39.94 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 124.859 3.706 . . . . 8.16 115.759 -172.612 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 75.2 m -79.73 -2.33 42.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.976 2.91 . . . . 11.13 116.375 166.501 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -74.21 132.93 42.63 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.567 -3.123 . . . . 18.03 102.567 172.734 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.6 p -78.06 154.36 31.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.379 3.072 . . . . 10.22 106.463 165.026 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -69.07 -28.15 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 118.507 -0.759 . . . . 12.3 110.024 178.531 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -51.06 -43.09 60.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 121.523 1.965 . . . . 36.51 113.883 163.529 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -70.48 -33.64 71.48 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.816 1.643 . . . . 25.66 113.132 173.118 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.24 -40.37 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 123.203 1.478 . . . . 8.12 109.477 176.19 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -69.61 -35.27 75.12 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.129 -3.482 . . . . 15.47 114.065 179.257 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.69 -33.66 76.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.02 -2.925 . . . . 11.45 112.541 171.121 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HE3' HG12 ' A' ' 17' ' ' VAL . 35.2 mttm -70.62 -39.49 73.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.357 2.027 . . . . 24.98 108.452 -179.224 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.441 HG12 HD11 ' A' ' 13' ' ' ILE . 45.7 mt -65.68 -38.24 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.263 -1.523 . . . . 9.46 111.105 176.203 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -51.27 -48.95 62.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.99 -3.569 . . . . 14.76 117.098 165.195 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -68.67 -42.04 78.41 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.178 1.808 . . . . 26.29 111.174 178.309 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -68.26 -57.16 6.4 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 123.652 2.933 . . . . 30.06 113.052 -179.947 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -103.46 -19.69 14.32 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.434 2.013 . . . . 25.19 116.434 -161.624 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.63 58.23 3.6 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 128.453 2.93 . . . . 7.41 112.858 176.042 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.2 tt -127.65 136.41 28.92 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 127.353 2.261 . . . . 9.49 108.451 -179.596 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -83.41 161.46 14.93 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 122.922 2.079 . . . . 11.42 107.321 -166.672 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.06 -18.35 10.12 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 CA-C-O 114.264 -2.473 . . . . 12.0 115.546 -170.757 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.259 16.3 t0 -66.41 -42.4 87.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.343 3.857 . . . . 35.55 108.179 176.851 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -65.36 -30.32 71.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.484 -2.635 . . . . 20.52 116.022 174.973 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -82.95 121.52 27.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.621 1.555 . . . . 7.13 113.785 -168.88 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -117.7 101.99 8.78 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 102.99 -2.967 . . . . 36.39 102.99 167.905 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -80.11 113.38 18.23 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.859 1.314 . . . . 9.55 113.745 171.271 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -93.93 127.89 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 118.335 -2.728 . . . . 13.9 111.711 171.555 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -105.54 114.25 28.31 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.276 2.235 . . . . 6.86 107.792 162.793 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.54 -106.51 0.09 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.037 -2.914 . . . . 11.15 110.502 178.38 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.31 20.34 8.44 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 128.67 3.732 . . . . 13.93 116.554 170.957 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -115.52 139.0 50.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 102.348 -3.204 . . . . 23.92 102.348 -173.502 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -89.25 133.46 34.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 111.234 -2.712 . . . . 23.23 110.405 170.633 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.55 133.61 54.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.703 1.601 . . . . 9.11 109.012 -168.278 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -111.08 170.89 7.8 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.73 2.059 . . . . 33.44 113.434 -176.589 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.75 -43.21 38.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.919 2.488 . . . . 28.37 112.399 -156.725 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.84 -2.32 51.01 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 118.81 2.284 . . . . 15.0 118.81 179.149 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -121.12 170.64 9.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.782 -2.599 . . . . 25.5 113.677 -175.91 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -101.74 -172.46 2.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 105.879 -1.897 . . . . 11.95 105.879 -161.228 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.4 ' H ' ' HB ' ' A' ' 55' ' ' THR . 12.4 mt -79.32 -37.5 37.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.118 -1.401 . . . . 10.17 110.782 172.276 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p -61.4 -31.61 71.53 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.787 2.884 . . . . 13.59 118.787 172.173 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.76 -39.05 93.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.319 2.248 . . . . 11.7 109.551 -179.613 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -92.31 -0.17 57.41 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 131.143 3.777 . . . . 12.95 113.785 178.509 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 m120 72.99 35.6 0.95 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.478 2.311 . . . . 25.45 108.761 173.733 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -95.32 114.61 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 125.349 2.499 . . . . 14.6 109.036 -178.079 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -113.44 -179.43 3.64 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 112.357 -6.464 . . . . 33.23 109.307 178.61 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -47.67 147.03 1.99 Allowed 'General case' 0 N--CA 1.43 -1.474 1 N-CA-C 123.952 4.797 . . . . 25.97 123.952 179.339 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 55.88 29.34 13.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.542 -3.849 . . . . 32.61 116.383 -177.091 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -82.38 139.98 33.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.864 -2.017 . . . . 10.56 111.626 174.565 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.9 m -83.49 122.41 28.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.996 2.06 . . . . 5.33 112.605 166.754 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.31 157.1 25.51 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.022 -1.844 . . . . 11.66 106.022 172.132 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -129.45 127.04 40.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.23 1.196 . . . . 16.3 114.23 177.777 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 mt -77.06 120.38 22.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.779 -3.701 . . . . 9.96 112.356 163.893 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.79 -178.85 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 104.87 -2.27 . . . . 9.76 104.87 -170.126 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 N--CA 1.43 -1.444 0 O-C-N 126.189 2.18 . . . . 19.57 113.815 172.935 . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 108.651 -0.87 . . . . 17.17 108.651 . . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.262 29.7 mt-30 -94.22 130.26 40.52 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.579 -1.201 . . . . 21.89 113.745 177.742 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -120.35 150.21 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.97 1.708 . . . . 10.83 106.722 170.526 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -106.01 141.73 36.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.713 -2.492 . . . . 10.61 106.681 -172.69 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.49 128.57 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 117.21 -1.796 . . . . 9.13 107.864 -179.462 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -105.62 110.87 23.35 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.719 -4.363 . . . . 20.55 103.631 -173.992 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.1 p -72.41 166.85 21.76 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.132 1.773 . . . . 11.78 107.964 -175.044 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.9 tp -75.43 -41.01 56.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.05 -2.281 . . . . 19.31 113.293 -172.257 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -56.92 -57.82 10.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.373 1.559 . . . . 23.14 112.401 168.194 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.24 68.0 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.834 1.797 . . . . 19.74 114.372 171.765 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -127.79 129.96 47.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.595 -2.709 . . . . 21.93 108.681 165.349 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -81.44 96.29 7.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.141 -0.974 . . . . 12.33 112.366 173.283 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 pt -92.43 142.2 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.583 -1.948 . . . . 17.08 113.793 -178.019 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.4 m -96.08 128.54 43.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.188 -1.57 . . . . 16.3 113.686 178.307 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.3 mt -124.12 133.13 53.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.99 -2.944 . . . . 15.88 107.578 -178.739 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.361 13.7 mt-10 -84.41 113.58 21.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.796 3.238 . . . . 28.9 113.093 162.816 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.83 155.72 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 1 N-CA-C 99.556 -4.239 . . . . 12.05 99.556 175.572 . . . . . . . . 3 3 . 1 . 054 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.46 144.65 32.45 Favored Pre-proline 0 N--CA 1.429 -1.492 1 O-C-N 116.229 -4.044 . . . . 18.17 105.482 163.764 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -78.16 4.67 6.01 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-O 113.662 -2.724 . . . . 8.16 117.022 -175.97 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.1 m -91.52 -9.61 43.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.594 3.361 . . . . 11.13 110.958 171.411 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -80.19 171.0 15.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 125.262 3.664 . . . . 18.03 109.353 -179.318 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.7 p -80.75 159.03 25.31 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 133.274 4.629 . . . . 10.22 113.526 173.445 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.275 31.0 mm -67.13 -17.02 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 125.007 2.337 . . . . 12.3 111.031 -179.409 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -55.22 -37.26 66.92 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 116.146 -4.096 . . . . 36.51 117.495 171.711 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -67.43 -41.61 84.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.189 2.996 . . . . 25.66 112.435 169.644 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.41 -43.73 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.274 -2.766 . . . . 8.12 111.188 174.224 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.258 79.8 mttt -62.89 -39.03 93.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.78 -2.45 . . . . 15.47 111.277 172.84 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.13 86.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.628 1.971 . . . . 11.45 111.309 -178.768 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -61.78 -37.59 84.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.739 2.126 . . . . 24.98 116.739 169.203 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mt -72.84 -32.16 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 118.939 -1.104 . . . . 9.46 109.568 170.615 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -58.95 -48.41 81.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 116.388 -3.945 . . . . 14.76 113.389 172.136 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.48 -39.43 90.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 131.307 3.843 . . . . 26.29 110.713 -177.376 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -75.9 -55.1 5.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.617 3.191 . . . . 30.06 119.617 174.994 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -104.68 -37.87 6.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 114.129 -2.843 . . . . 25.19 111.066 -167.254 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.28 10.68 31.16 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 122.684 2.493 . . . . 7.41 110.205 173.858 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.477 HD13 HD21 ' A' ' 69' ' ' LEU 0.368 14.1 tt -75.47 115.38 45.06 Favored Pre-proline 0 N--CA 1.429 -1.501 0 C-N-CA 130.683 3.593 . . . . 9.49 116.834 169.839 . . . . . . . . 3 3 . 1 . 054 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.66 159.26 21.93 Favored 'Trans proline' 0 N--CA 1.434 -2.027 2 CA-C-N 130.411 4.754 . . . . 11.42 110.351 -172.378 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -62.12 -22.61 74.5 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 124.954 3.769 . . . . 12.0 114.715 -168.827 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.83 -36.26 82.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.334 1.453 . . . . 35.55 111.937 -175.805 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -91.57 -15.63 28.37 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.68 3.133 . . . . 20.52 110.493 -171.525 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -77.85 131.24 37.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.215 -2.803 . . . . 7.13 116.451 170.756 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -120.8 122.4 40.25 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.386 -3.321 . . . . 36.39 108.701 162.518 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.9 mt -114.03 105.44 13.22 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.796 -2.44 . . . . 9.55 111.85 -171.728 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -90.27 136.51 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 127.773 2.429 . . . . 13.9 112.194 179.639 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -122.83 94.01 4.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.415 2.286 . . . . 6.86 106.657 -178.951 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.297 . . 73.44 -77.75 0.05 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.565 -2.584 . . . . 11.15 111.23 -172.517 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.29 16.76 0.59 Allowed Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 114.214 -1.357 . . . . 13.93 111.889 -177.757 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -120.98 164.67 16.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.442 3.097 . . . . 23.92 113.391 170.845 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -119.29 120.53 37.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 122.183 -0.323 . . . . 23.23 110.699 -167.441 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.59 147.86 28.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.511 2.1 . . . . 9.11 110.897 -167.535 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -110.8 167.12 10.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.647 -2.533 . . . . 33.44 104.749 -168.17 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.16 -66.72 0.69 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 122.989 1.376 . . . . 28.37 113.682 -169.038 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.63 18.64 2.22 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 116.394 1.318 . . . . 15.0 116.394 -170.472 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -115.94 154.95 28.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.938 -2.615 . . . . 25.5 103.938 -176.151 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -87.67 146.28 25.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.605 3.557 . . . . 11.95 120.605 -179.456 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.04 -43.72 74.01 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 118.712 2.856 . . . . 10.17 118.712 173.717 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 p -66.26 -33.45 75.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.996 2.591 . . . . 13.59 117.996 170.052 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.77 -36.46 80.54 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 122.607 2.458 . . . . 11.7 112.663 177.038 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -69.62 -18.03 63.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.808 3.243 . . . . 12.95 113.817 174.808 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 65.09 51.69 1.63 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.51 1.524 . . . . 25.45 111.822 -174.801 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -94.7 111.41 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-O 123.62 1.676 . . . . 14.6 108.392 174.92 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -101.72 165.62 11.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 111.5 -2.591 . . . . 33.23 108.98 -162.775 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -61.73 133.85 56.05 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.628 -2.545 . . . . 25.97 116.298 178.729 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 49.9 mt-10 71.59 25.41 3.34 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.289 2.329 . . . . 32.61 117.289 -177.539 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -94.29 146.29 24.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.676 2.472 . . . . 10.56 117.676 174.94 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -104.32 116.93 33.02 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.996 -4.19 . . . . 5.33 108.931 -163.737 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.37 132.59 36.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.867 2.467 . . . . 11.66 110.088 167.636 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -81.93 127.79 33.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.16 -3.462 . . . . 16.3 116.173 159.747 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 36' ' ' ILE . 60.7 tp -94.79 103.03 14.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 125.129 1.518 . . . . 9.96 110.695 159.013 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.38 -177.05 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 117.819 -1.552 . . . . 9.76 107.252 -179.676 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.4 tp . . . . . 0 N--CA 1.43 -1.44 0 CA-C-N 110.798 -2.91 . . . . 19.57 107.282 170.73 . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.49 -1.344 0 CA-C-O 122.832 1.301 . . . . 17.17 107.949 . . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -87.67 135.83 33.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.929 2.196 . . . . 21.89 116.929 160.752 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -125.99 142.41 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 128.739 2.815 . . . . 10.83 105.694 -175.223 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -102.45 143.09 32.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.897 1.808 . . . . 10.61 106.713 175.917 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.8 t -124.46 130.94 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.311 -1.768 . . . . 9.13 110.777 162.811 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -96.2 126.19 41.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.791 1.632 . . . . 20.55 111.261 168.099 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 69' ' ' LEU 0.259 72.2 p -89.73 176.26 6.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.67 3.188 . . . . 11.78 114.36 -171.168 . . . . . . . . 3 3 . 1 . 055 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.423 HD22 HD21 ' A' ' 71' ' ' LEU . 51.0 tp -79.48 -54.93 5.43 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.264 -2.148 . . . . 19.31 112.613 -178.174 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -38.06 -72.34 0.06 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.312 2.708 . . . . 23.14 118.312 161.418 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.84 45.79 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.232 -3.418 . . . . 19.74 112.944 167.771 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -119.08 149.25 42.0 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.485 -1.302 . . . . 21.93 107.485 179.717 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.2 m -110.26 101.15 9.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.254 -2.499 . . . . 12.33 104.254 171.405 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.411 HD11 HG12 ' A' ' 30' ' ' ILE . 28.6 pt -94.86 126.3 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 127.256 3.408 . . . . 17.08 112.193 -176.389 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.275 3.2 m -74.91 114.4 13.32 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.332 -3.355 . . . . 16.3 117.369 161.994 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.42 149.16 44.21 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 116.014 -4.179 . . . . 15.88 106.623 174.475 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -102.4 125.75 49.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.509 2.576 . . . . 28.9 108.621 -178.291 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.536 HG11 HG22 ' A' ' 26' ' ' VAL . 8.9 m -147.77 165.1 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 118.492 -2.63 . . . . 12.05 106.945 -178.118 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -102.28 170.84 5.88 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 125.675 2.655 . . . . 18.17 110.093 161.852 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -56.89 -41.68 72.7 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 114.801 -3.315 . . . . 8.16 117.374 166.46 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.2 p -70.68 -3.51 18.84 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.591 2.757 . . . . 11.13 115.223 176.239 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -83.88 153.54 23.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.32 -2.113 . . . . 18.03 113.894 167.552 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.6 p -95.16 176.53 6.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.689 -3.757 . . . . 10.22 115.846 -172.493 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mm -66.55 -43.55 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.86 -2.4 . . . . 12.3 107.607 173.923 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -47.82 -46.09 30.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.795 2.517 . . . . 36.51 117.795 168.535 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -75.75 -28.72 58.58 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.99 -1.068 . . . . 25.66 110.26 -178.685 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.536 HG22 HG11 ' A' ' 17' ' ' VAL . 83.9 t -59.65 -54.54 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.666 -3.146 . . . . 8.12 110.881 169.867 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -58.74 -24.32 61.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.545 -1.972 . . . . 15.47 115.951 179.159 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.253 . . -76.4 -28.29 56.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.321 -0.862 . . . . 11.45 111.29 -177.738 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -68.83 -49.25 60.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.186 2.595 . . . . 24.98 105.346 176.901 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 13' ' ' ILE . 39.9 mt -61.42 -39.32 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 127.89 3.709 . . . . 9.46 114.261 -178.533 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.4 -39.7 80.39 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.124 -4.11 . . . . 14.76 115.647 171.517 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -67.31 -70.41 0.25 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.436 -1.69 . . . . 26.29 106.436 178.149 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -77.8 -33.87 52.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.708 2.114 . . . . 30.06 116.708 -161.277 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -99.22 -63.13 1.15 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 120.991 1.723 . . . . 25.19 109.248 179.203 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.94 89.02 1.22 Allowed Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.505 -1.997 . . . . 7.41 111.61 174.501 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.418 ' CD1' HD21 ' A' ' 69' ' ' LEU . 38.5 mt -146.18 128.45 7.81 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 115.856 -2.021 . . . . 9.49 106.898 179.669 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -61.49 145.5 97.88 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 125.132 2.869 . . . . 11.42 117.998 176.681 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -79.26 -15.34 12.78 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 123.568 2.845 . . . . 12.0 116.252 -166.506 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.35 -35.07 25.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.113 1.911 . . . . 35.55 108.748 174.545 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -72.86 -30.06 63.69 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.576 -3.828 . . . . 20.52 108.896 -179.737 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -64.57 134.95 55.42 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.225 -2.797 . . . . 7.13 115.953 173.787 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -129.08 114.8 16.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.775 2.226 . . . . 36.39 112.299 167.907 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.87 119.8 33.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.453 -3.067 . . . . 9.55 112.643 179.709 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.9 130.74 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 123.575 1.655 . . . . 13.9 108.597 -179.816 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -111.19 104.96 13.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.534 2.587 . . . . 6.86 113.204 166.051 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.292 . . 71.6 -83.82 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.219 -3.425 . . . . 11.15 109.575 -168.489 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.59 28.82 0.85 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 107.847 -2.101 . . . . 13.93 107.847 166.624 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -107.53 111.89 24.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.366 -2.457 . . . . 23.92 104.366 175.911 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -70.32 130.39 41.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.687 2.184 . . . . 23.23 109.359 176.852 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -91.7 123.86 35.41 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.369 -1.287 . . . . 9.11 114.155 -171.391 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -74.79 136.85 41.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 116.467 2.025 . . . . 33.44 116.467 173.198 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -39.29 -60.83 0.86 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.351 2.723 . . . . 28.37 118.351 175.38 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.52 -10.19 47.8 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 117.057 -3.527 . . . . 15.0 121.2 -177.936 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -96.1 165.02 12.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 120.53 2.165 . . . . 25.5 114.803 -172.298 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.5 p -88.57 158.51 18.26 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.929 -4.232 . . . . 11.95 109.271 -172.073 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.518 HD21 HG21 ' A' ' 26' ' ' VAL . 1.6 mt -62.74 -40.45 97.25 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.61 -0.723 . . . . 10.17 111.978 171.101 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 p -47.85 -36.72 12.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.735 -2.478 . . . . 13.59 116.755 168.981 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.3 -42.08 65.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.825 1.65 . . . . 11.7 108.532 -166.679 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -84.15 0.52 48.27 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.904 -1.747 . . . . 12.95 111.533 179.937 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.8 m120 73.03 41.68 0.49 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.043 0.937 . . . . 25.45 108.908 174.142 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.5 mt -85.85 122.18 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 116.877 -1.535 . . . . 14.6 113.392 177.577 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -112.75 175.31 5.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 119.429 1.013 . . . . 33.23 111.86 -175.125 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.295 19.2 pttp -66.3 151.33 47.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.523 3.058 . . . . 25.97 108.916 175.763 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 63.35 4.58 1.73 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 120.09 3.367 . . . . 32.61 120.09 -172.22 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -72.08 162.21 29.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.297 -1.774 . . . . 10.56 107.265 172.601 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.8 m -130.64 121.34 25.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.844 -1.551 . . . . 5.33 108.994 -177.074 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.1 mt -92.51 150.33 20.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.739 2.685 . . . . 11.66 112.422 172.62 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -108.46 127.68 54.13 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.845 -3.659 . . . . 16.3 110.149 -178.088 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' A' ' 36' ' ' ILE . 53.6 tp -94.2 103.81 15.84 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.181 -0.918 . . . . 9.96 112.309 -171.963 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.317 18.4 m -116.98 -169.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 106.369 -1.715 . . . . 9.76 106.369 -174.981 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.423 HD21 HD22 ' A' ' 8' ' ' LEU . 8.7 mt . . . . . 0 N--CA 1.43 -1.446 0 C-N-CA 125.97 1.708 . . . . 19.57 110.285 -168.46 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.512 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 4.9 ptm . . . . . 0 CA--C 1.49 -1.336 0 N-CA-C 118.434 2.753 . . . . 17.17 118.434 . . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -87.47 125.62 34.41 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.744 -1.848 . . . . 21.89 107.089 -174.897 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.0 pt -115.91 163.69 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 112.069 -2.332 . . . . 10.83 107.168 174.034 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -124.72 132.94 53.34 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.147 2.579 . . . . 10.61 106.532 -177.354 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.24 117.63 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 121.142 -0.974 . . . . 9.13 109.57 176.661 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -109.94 141.22 43.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.341 -2.724 . . . . 20.55 115.745 -179.62 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.4 p -83.59 -171.87 3.83 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.295 1.22 . . . . 11.78 114.295 179.744 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 tp -72.62 -35.07 67.74 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.729 -3.107 . . . . 19.31 109.802 -178.34 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 p -87.15 -49.16 7.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 104.247 -2.501 . . . . 23.14 104.247 -178.083 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.98 59.48 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 117.403 -1.776 . . . . 19.74 116.599 166.156 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -96.51 125.41 40.98 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.706 -3.442 . . . . 21.93 101.706 166.687 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -105.23 122.37 45.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.976 -2.601 . . . . 12.33 103.976 -175.853 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 pt -108.49 130.76 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 125.808 2.718 . . . . 17.08 116.06 168.759 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -86.34 116.45 24.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.664 -3.772 . . . . 16.3 107.915 179.513 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.0 mt -121.39 156.38 32.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.906 -2.371 . . . . 15.88 109.319 -179.341 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -130.98 129.99 42.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.097 -2.557 . . . . 28.9 104.097 179.995 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -148.57 179.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.882 1.673 . . . . 12.05 108.652 177.009 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 17.9 mm-40 -107.58 169.14 7.01 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 119.677 -1.889 . . . . 18.17 107.533 174.953 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 43.7 Cg_endo -83.67 -2.24 10.33 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 124.712 3.608 . . . . 8.16 113.021 -173.103 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.273 73.4 m -101.68 -0.44 34.6 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 126.266 2.229 . . . . 11.13 110.499 174.14 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.4 145.15 49.52 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.396 -3.315 . . . . 18.03 110.099 173.029 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -79.63 164.51 23.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.066 -2.271 . . . . 10.22 113.848 173.038 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -57.21 -38.52 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 126.668 1.987 . . . . 12.3 109.604 171.08 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.65 -51.97 19.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.001 1.721 . . . . 36.51 114.066 167.943 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -72.65 -12.38 61.01 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.458 1.503 . . . . 25.66 114.288 176.565 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.4 t -80.03 -50.05 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 104.165 -2.531 . . . . 8.12 104.165 172.668 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.298 62.7 mttt -47.78 -38.65 16.12 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.415 2.686 . . . . 15.47 113.875 170.039 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.56 -44.34 93.31 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.672 2.789 . . . . 11.45 115.136 -178.271 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -69.89 -40.4 75.68 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.814 2.846 . . . . 24.98 107.731 178.307 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.45 -33.58 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 124.454 1.096 . . . . 9.46 109.153 179.484 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.42 -44.03 92.95 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.153 -2.217 . . . . 14.76 114.139 172.708 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -59.7 -61.21 2.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.572 1.949 . . . . 26.29 113.855 171.727 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.99 -52.02 67.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 121.059 3.725 . . . . 30.06 121.059 -179.991 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -108.97 -29.87 8.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.584 1.327 . . . . 25.19 114.584 -157.584 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.19 41.21 8.11 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.201 -1.16 . . . . 7.41 110.201 177.244 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.1 mt -102.73 120.06 53.89 Favored Pre-proline 0 N--CA 1.431 -1.424 0 CA-C-O 115.461 -2.209 . . . . 9.49 111.678 169.055 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 95.1 Cg_exo -59.14 146.25 95.06 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 CA-C-N 126.305 3.287 . . . . 11.42 114.227 172.424 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -59.24 -29.53 90.59 Favored 'Trans proline' 0 C--N 1.299 -2.027 1 C-N-CA 125.333 4.022 . . . . 12.0 116.438 179.93 . . . . . . . . 4 4 . 1 . 056 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.9 -42.37 94.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.988 -3.57 . . . . 35.55 113.266 168.851 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.403 ' HG2' HD22 ' A' ' 71' ' ' LEU 0.287 12.7 tt0 -64.95 -35.17 80.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.748 2.019 . . . . 20.52 112.618 173.092 . . . . . . . . 3 3 . 1 . 056 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -81.14 136.81 35.94 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.418 -2.676 . . . . 7.13 115.647 -177.462 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -128.94 117.46 21.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 128.062 3.351 . . . . 36.39 110.031 167.077 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.8 mt -91.68 121.91 33.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.493 -1.717 . . . . 9.55 109.24 179.599 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mt -111.05 133.27 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 124.525 3.329 . . . . 13.9 108.262 178.041 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -115.38 107.59 15.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.148 2.979 . . . . 6.86 107.147 172.196 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 63.38 -96.07 0.05 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.331 2.652 . . . . 11.15 111.823 -166.545 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.71 -5.5 9.11 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.675 1.708 . . . . 13.93 109.541 -178.372 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -98.75 126.55 44.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.49 -3.947 . . . . 23.92 105.985 -166.832 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -90.61 141.31 28.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 127.712 3.625 . . . . 23.23 106.344 176.071 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.365 97.1 mt -104.52 133.77 48.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.748 -3.72 . . . . 9.11 114.312 -168.827 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -74.63 154.83 38.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.687 2.395 . . . . 33.44 112.231 174.881 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -73.16 -55.57 6.29 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 130.053 3.341 . . . . 28.37 112.346 -167.131 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.73 18.47 30.09 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 119.136 2.415 . . . . 15.0 119.136 -172.766 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -114.01 146.6 39.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.606 2.146 . . . . 25.5 109.897 169.763 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.264 73.3 p -75.99 162.82 27.74 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 128.937 2.895 . . . . 11.95 116.866 -179.105 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.9 mt -58.43 -49.57 76.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 128.807 3.817 . . . . 10.17 109.92 174.873 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.357 88.9 p -57.54 -43.96 84.77 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.795 3.238 . . . . 13.59 119.487 178.698 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -53.81 -53.42 52.58 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 121.588 3.921 . . . . 11.7 121.588 162.924 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -62.44 -21.01 65.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.66 2.467 . . . . 12.95 117.66 169.325 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.347 58.2 t30 60.04 67.64 0.85 Allowed 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.508 2.04 . . . . 25.45 116.508 -161.556 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -118.5 117.39 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.5 -2.778 . . . . 14.6 103.5 170.198 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.35 -163.15 1.01 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.48 2.562 . . . . 33.23 112.685 -175.536 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 38.1 pttt -76.0 156.71 33.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.213 -3.43 . . . . 25.97 115.427 168.548 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.85 23.33 13.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.31 2.244 . . . . 32.61 110.741 176.663 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -85.36 122.53 29.65 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.071 1.748 . . . . 10.56 113.335 175.631 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.9 m -88.52 98.9 11.91 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 116.132 -1.89 . . . . 5.33 112.498 170.667 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.96 140.04 29.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.704 2.002 . . . . 11.66 109.015 -179.966 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -98.64 107.61 20.1 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.428 -1.42 . . . . 16.3 113.49 -173.267 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -82.88 109.78 17.31 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 129.156 2.982 . . . . 9.96 112.368 -177.172 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.9 m -121.58 161.76 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 116.726 -3.733 . . . . 9.76 106.912 177.981 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.403 HD22 ' HG2' ' A' ' 40' ' ' GLN . 29.8 mt . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 107.591 -1.263 . . . . 19.57 107.591 -173.087 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.454 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 13.6 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 106.484 -1.672 . . . . 17.17 106.484 . . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.273 4.2 pt20 -113.28 127.69 56.23 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.712 -2.493 . . . . 21.89 112.773 176.189 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -120.34 174.48 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 125.293 2.473 . . . . 10.83 108.102 171.883 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -120.96 145.9 47.23 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 112.744 -2.026 . . . . 10.61 109.802 -176.78 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.99 122.53 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 107.402 -1.333 . . . . 9.13 107.402 173.218 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -136.05 142.21 44.37 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.394 -3.941 . . . . 20.55 115.338 -164.33 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.278 80.7 p -80.85 -171.5 3.2 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 126.533 3.064 . . . . 11.78 110.03 -170.612 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.89 -40.5 60.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 131.556 3.943 . . . . 19.31 114.266 166.945 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.18 -47.6 49.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.544 -3.223 . . . . 23.14 111.031 173.606 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.91 35.91 0.23 Allowed Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 114.637 -3.313 . . . . 19.74 115.593 172.782 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -88.03 121.58 30.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 113.746 -3.026 . . . . 21.93 110.701 178.784 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -108.19 137.57 45.94 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 121.695 2.043 . . . . 12.33 114.037 -172.331 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.1 pt -124.6 136.78 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 118.532 -1.267 . . . . 17.08 107.804 172.776 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.3 m -82.81 120.89 26.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.176 3.39 . . . . 16.3 108.564 168.862 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -115.17 132.73 56.51 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.966 -2.334 . . . . 15.88 107.123 174.504 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -107.82 115.09 29.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.191 -2.818 . . . . 28.9 108.762 -178.681 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.31 162.04 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 124.559 1.162 . . . . 12.05 109.473 -166.928 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -90.7 155.08 45.89 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 120.374 -1.454 . . . . 18.17 107.444 159.512 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -60.95 -23.39 77.17 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 122.722 2.282 . . . . 8.16 112.674 168.536 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 m -69.39 -18.32 63.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.003 2.638 . . . . 11.13 113.498 173.427 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -65.53 147.15 53.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.525 2.875 . . . . 18.03 108.574 179.162 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -85.08 172.91 10.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.933 1.827 . . . . 10.22 115.933 179.061 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 13.1 mm -78.15 -27.11 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 124.053 0.846 . . . . 12.3 109.326 178.432 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -50.81 -59.54 4.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.386 -2.188 . . . . 36.51 114.143 167.634 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.468 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 7.3 t-20 -55.14 -45.77 75.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.98 3.712 . . . . 25.66 109.984 176.082 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -60.4 -50.32 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.363 -2.086 . . . . 8.12 113.156 -176.508 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -63.39 -37.19 86.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.014 1.864 . . . . 15.47 110.354 176.584 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.38 -13.12 36.05 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.324 -4.61 . . . . 11.45 114.206 174.726 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 13.7 mtpt -80.04 -49.24 12.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.909 -2.994 . . . . 24.98 117.487 169.189 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.9 mt -60.23 -30.26 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 126.096 2.855 . . . . 9.46 112.523 171.944 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -70.7 -43.35 69.17 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.346 -3.971 . . . . 14.76 117.143 172.969 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.33 -49.53 74.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.793 2.516 . . . . 26.29 117.793 159.313 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -79.94 -74.73 0.29 Allowed 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 116.266 -4.021 . . . . 30.06 111.274 -176.606 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -64.94 -43.3 93.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 120.322 1.419 . . . . 25.19 113.824 -173.509 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.69 68.83 1.19 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 107.06 -2.416 . . . . 7.41 107.06 179.53 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.8 128.44 23.87 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-N 113.393 -1.403 . . . . 9.49 108.644 176.643 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -66.69 143.53 68.3 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-O 114.342 -2.441 . . . . 11.42 115.015 -174.596 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.81 -14.69 42.34 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 122.841 2.361 . . . . 12.0 113.027 -163.68 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -95.96 -22.31 17.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 123.021 2.646 . . . . 35.55 110.318 -179.66 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.378 32.9 mt-30 -71.47 -22.6 61.8 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 117.645 -1.169 . . . . 20.52 112.87 164.355 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -79.33 124.58 28.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.955 -2.609 . . . . 7.13 103.955 175.601 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 52.6 mtp180 -110.89 122.13 47.09 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.978 3.311 . . . . 36.39 109.685 156.217 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.3 mt -113.78 133.23 55.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.368 2.509 . . . . 9.55 105.435 178.101 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 mm -130.39 119.4 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 111.033 -2.803 . . . . 13.9 103.733 -163.244 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -93.98 108.88 20.65 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.453 1.501 . . . . 6.86 110.773 158.194 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.53 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.48 -2.637 . . . . 11.15 112.118 179.825 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.88 36.72 1.21 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 126.192 1.853 . . . . 13.93 110.756 165.965 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -108.28 123.74 49.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.5 -2.177 . . . . 23.92 113.68 162.581 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -81.57 136.07 35.57 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.186 -3.446 . . . . 23.23 109.386 166.246 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.73 127.98 35.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.776 1.231 . . . . 9.11 111.071 179.595 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -78.43 133.14 37.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.954 2.576 . . . . 33.44 117.954 -178.214 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 47.1 m-20 -49.14 -45.37 43.6 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.363 -3.335 . . . . 28.37 116.288 -168.129 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.73 4.49 75.8 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-N 119.981 1.264 . . . . 15.0 112.586 -169.107 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.3 40.0 mtt180 -95.19 166.17 12.04 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.069 -3.607 . . . . 25.5 109.262 -178.495 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.8 p -92.66 156.24 17.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.161 -2.212 . . . . 11.95 106.475 -178.516 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.4 mt -51.14 -45.25 61.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.971 -3.581 . . . . 10.17 113.726 164.7 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.4 t -57.12 -36.6 70.85 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.826 2.051 . . . . 13.59 108.316 -177.391 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -64.59 -30.9 71.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.289 -2.132 . . . . 11.7 113.512 -167.486 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -87.27 0.61 55.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.165 -1.38 . . . . 12.95 113.044 178.423 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 62.23 49.21 4.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.837 1.655 . . . . 25.45 112.605 -178.742 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.94 112.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.895 2.478 . . . . 14.6 109.85 172.037 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -84.68 -162.57 0.7 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.375 2.036 . . . . 33.23 112.222 178.087 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 22.5 pttp -88.06 164.86 15.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.779 -3.7 . . . . 25.97 111.141 172.815 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.381 37.3 mt-10 73.54 1.1 3.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.683 1.593 . . . . 32.61 112.439 173.7 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.346 8.7 t -88.06 140.13 29.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.363 -2.71 . . . . 10.56 112.277 -168.581 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.0 m -100.68 113.93 27.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 126.059 2.837 . . . . 5.33 108.826 -178.507 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.1 mt -87.6 144.99 26.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.515 2.783 . . . . 11.66 118.515 165.519 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -96.39 120.59 36.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.318 -3.989 . . . . 16.3 112.501 179.522 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 tp -94.08 120.99 35.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.167 -2.288 . . . . 9.96 110.43 -177.325 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 44.1 t -118.27 138.22 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 129.735 3.214 . . . . 9.76 111.254 -173.56 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.3 tp . . . . . 0 N--CA 1.43 -1.436 0 O-C-N 126.867 2.604 . . . . 19.57 106.535 176.615 . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.491 -1.325 0 CA-C-O 121.382 0.61 . . . . 17.17 109.687 . . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.92 133.76 35.78 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.139 -3.475 . . . . 21.89 112.836 171.012 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -118.94 147.89 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 128.599 4.047 . . . . 10.83 116.021 164.664 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -97.17 128.16 43.81 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.893 -3.63 . . . . 10.61 108.323 176.391 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -118.58 131.61 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.153 -2.536 . . . . 9.13 104.153 173.214 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -105.82 157.17 17.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.331 -3.355 . . . . 20.55 109.607 173.749 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 56.1 p -99.79 178.32 4.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.742 3.217 . . . . 11.78 109.403 175.517 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.4 tp -77.2 -36.9 54.46 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.517 -2.614 . . . . 19.31 110.84 178.744 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -38.18 72.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.96 -1.713 . . . . 23.14 111.991 160.662 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.51 33.72 2.23 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 117.382 1.713 . . . . 19.74 117.382 171.529 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -80.8 119.44 23.38 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.919 2.487 . . . . 21.93 105.807 -179.775 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -81.34 104.51 11.84 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.693 3.121 . . . . 12.33 116.578 169.833 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 pt -100.83 147.4 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 124.622 1.169 . . . . 17.08 112.583 174.587 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 m -111.28 99.47 8.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.816 -2.291 . . . . 16.3 104.816 -172.248 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.7 mt -97.33 118.67 34.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.799 -3.688 . . . . 15.88 110.412 179.288 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -80.82 128.37 33.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.734 -1.229 . . . . 28.9 108.142 165.302 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 m -147.72 164.35 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 103.794 -2.669 . . . . 12.05 103.794 -178.48 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -105.81 140.72 21.49 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 116.44 -1.743 . . . . 18.17 109.103 171.91 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.44 -5.71 11.79 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 124.767 2.738 . . . . 8.16 113.036 -167.046 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.4 p -69.28 -26.2 64.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.744 0.818 . . . . 11.13 112.483 169.522 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -75.73 178.28 6.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.522 2.415 . . . . 18.03 117.522 174.935 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 9.2 p -106.76 178.8 4.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.719 -3.113 . . . . 10.22 111.617 -165.71 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 11.3 mm -69.81 -35.47 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 116.854 -3.654 . . . . 12.3 114.261 168.479 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -52.31 -44.59 65.16 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 117.124 -1.417 . . . . 36.51 114.431 167.051 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -52.49 -49.36 64.89 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 114.947 -2.454 . . . . 25.66 114.612 163.477 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.18 -43.34 97.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 122.091 2.223 . . . . 8.12 109.37 -177.084 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.66 -35.54 70.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.161 2.282 . . . . 15.47 117.161 172.883 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' ASP . . . -70.21 -25.65 63.51 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 126.898 3.237 . . . . 11.45 116.968 170.662 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -75.2 -27.35 59.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.792 -2.458 . . . . 24.98 111.786 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -80.47 -37.51 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 118.057 -2.902 . . . . 9.46 107.923 178.851 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.11 -52.49 62.4 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 115.205 -2.331 . . . . 14.76 107.769 -178.773 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 2.2 t0 -52.99 -45.52 67.88 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.981 2.912 . . . . 26.29 113.495 173.362 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -74.33 -95.84 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.277 4.231 . . . . 30.06 112.643 176.879 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -71.36 -9.41 58.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.122 2.237 . . . . 25.19 111.449 -162.608 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.46 52.66 5.92 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.51 -1.994 . . . . 7.41 117.105 179.975 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.68 110.62 22.69 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.086 -2.864 . . . . 9.49 106.321 -170.876 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.06 147.03 92.24 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 128.782 4.172 . . . . 11.42 111.531 -177.58 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -75.12 -8.19 19.72 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 121.397 1.398 . . . . 12.0 112.925 -161.943 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -74.81 -39.86 61.43 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.201 1.953 . . . . 35.55 115.167 -174.299 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -66.95 -28.05 67.96 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 132.691 4.397 . . . . 20.52 114.913 173.12 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.4 117.54 12.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.955 2.788 . . . . 7.13 114.489 -169.969 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -111.55 98.37 7.4 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.512 -3.243 . . . . 36.39 107.499 176.727 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.05 122.3 33.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 111.779 -2.464 . . . . 9.55 111.59 176.466 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mm -112.26 144.37 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 124.119 1.914 . . . . 13.9 110.424 -177.887 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -123.31 114.17 19.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.854 2.74 . . . . 6.86 107.962 161.394 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.306 . . 70.6 -88.05 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.677 -2.514 . . . . 11.15 115.889 -177.046 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.22 8.28 2.13 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 126.4 1.952 . . . . 13.93 110.291 165.073 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -88.29 149.96 23.51 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 114.704 -4.998 . . . . 23.92 108.173 168.5 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -109.96 146.99 34.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.961 -3.348 . . . . 23.23 101.961 -179.02 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.9 mt -104.25 137.87 41.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.589 1.699 . . . . 9.11 115.589 -171.819 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 19.4 tp10 -97.4 155.46 16.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 120.524 1.511 . . . . 33.44 112.735 -169.661 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 22' ' ' THR . 15.0 m-20 -69.52 -61.39 1.81 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.374 1.25 . . . . 28.37 114.374 -162.448 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.16 42.46 2.74 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 117.08 1.592 . . . . 15.0 117.08 -179.962 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -131.59 154.93 48.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 119.141 1.47 . . . . 25.5 107.44 175.393 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -88.67 146.22 25.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 121.325 3.824 . . . . 11.95 121.325 -176.913 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.7 mt -54.74 -38.19 66.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.078 1.751 . . . . 10.17 114.984 171.854 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -51.62 -55.19 20.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.486 3.143 . . . . 13.59 119.486 166.861 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.74 -49.12 73.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.796 2.438 . . . . 11.7 115.093 176.923 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -71.53 -6.55 41.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.339 3.456 . . . . 12.95 112.825 173.72 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 54.32 44.21 29.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.949 2.203 . . . . 25.45 116.949 -179.961 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.0 120.55 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 129.593 3.157 . . . . 14.6 105.179 171.763 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -103.68 170.38 7.97 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.955 -1.716 . . . . 33.23 109.555 -178.205 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -47.06 141.12 4.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.506 2.378 . . . . 25.97 110.863 167.355 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 66.6 mt-10 51.9 20.37 1.19 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.818 2.896 . . . . 32.61 118.818 -175.674 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 t -75.18 165.21 25.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.078 2.551 . . . . 10.56 110.815 171.901 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.5 m -122.47 101.77 7.69 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 112.877 -3.44 . . . . 5.33 108.021 -164.496 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.94 156.98 19.59 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 125.661 1.851 . . . . 11.66 110.506 163.313 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -118.73 119.9 35.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.019 -2.301 . . . . 16.3 112.817 -177.452 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.39 98.45 11.49 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.505 -2.622 . . . . 9.96 111.42 -175.969 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.48 156.84 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 125.386 1.679 . . . . 9.76 110.198 167.652 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 N--CA 1.43 -1.45 0 O-C-N 119.321 -2.112 . . . . 19.57 111.645 -172.871 . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.49 -1.332 0 N-CA-C 115.445 1.646 . . . . 17.17 115.445 . . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.51 132.78 46.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.649 -2.532 . . . . 21.89 105.738 171.842 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 pt -110.2 156.77 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 113.752 -1.567 . . . . 10.83 109.851 170.005 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -98.0 135.76 39.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 118.292 -0.861 . . . . 10.61 109.706 177.727 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.36 121.67 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 N-CA-C 99.337 -4.32 . . . . 9.13 99.337 171.197 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -102.81 128.83 49.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 126.791 2.557 . . . . 20.55 109.072 177.063 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 69' ' ' LEU . 77.7 p -96.09 176.59 6.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.497 -2.627 . . . . 11.78 112.511 -170.563 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.1 tp -80.61 -30.32 36.8 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.644 -5.035 . . . . 19.31 111.116 -173.658 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.7 p -68.33 -69.74 0.31 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.42 2.748 . . . . 23.14 118.42 162.538 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.98 38.39 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.712 0 O-C-N 119.891 -1.756 . . . . 19.74 112.144 174.226 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -99.6 132.33 45.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 119.388 1.594 . . . . 21.93 110.856 171.646 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.2 m -111.74 111.28 22.15 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.612 -2.736 . . . . 12.33 103.612 172.862 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -96.35 145.46 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 112.934 -1.939 . . . . 17.08 110.11 -178.736 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.7 m -106.33 112.22 25.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.964 -1.085 . . . . 16.3 113.593 178.613 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -111.54 130.12 55.84 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.366 1.467 . . . . 15.88 109.196 -175.132 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -97.58 132.33 43.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.316 -1.49 . . . . 28.9 109.621 173.898 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -155.88 162.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 119.389 -2.07 . . . . 12.05 113.191 -168.396 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -93.72 153.94 41.06 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 126.113 1.765 . . . . 18.17 109.026 177.378 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -60.83 -26.1 82.45 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 O-C-N 116.343 -2.503 . . . . 8.16 115.941 171.667 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.0 p -82.16 -16.44 49.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.18 1.792 . . . . 11.13 114.78 -177.625 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.77 143.01 55.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.705 1.241 . . . . 18.03 113.273 170.185 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -97.84 158.78 15.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.053 -2.279 . . . . 10.22 109.587 -175.79 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.0 mm -53.19 -46.44 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 128.558 2.743 . . . . 12.3 111.722 171.501 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -45.82 -55.54 6.49 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.362 1.615 . . . . 36.51 115.362 161.962 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -54.65 -34.53 62.3 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.102 3.761 . . . . 25.66 112.851 173.643 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.34 -33.39 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.199 -2.188 . . . . 8.12 110.028 177.79 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -67.28 -35.78 80.19 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.84 0.856 . . . . 15.47 111.81 179.898 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.1 82.43 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 132.212 4.205 . . . . 11.45 118.102 166.319 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.422 -3.924 . . . . 24.98 111.417 169.935 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 mt -53.06 -48.23 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 113.112 -3.328 . . . . 9.46 110.927 170.103 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -37.45 78.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 124.903 3.501 . . . . 14.76 116.363 176.996 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -77.34 -38.46 50.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.057 -2.277 . . . . 26.29 111.734 -177.661 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -81.25 -42.44 20.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.279 2.309 . . . . 30.06 110.96 -176.194 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -99.57 -44.2 6.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.012 1.863 . . . . 25.19 114.899 -169.179 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.74 45.46 4.56 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 118.424 -2.673 . . . . 7.41 108.91 -177.489 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.7 mt -102.7 133.6 20.35 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 107.021 -1.474 . . . . 9.49 107.021 161.714 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 3.2 Cg_exo -78.77 157.06 27.75 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 121.697 1.642 . . . . 11.42 113.464 175.83 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 81.8 Cg_exo -68.67 -24.01 35.68 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.969 3.112 . . . . 12.0 118.406 -169.127 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.73 -24.76 65.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.034 -2.348 . . . . 35.55 111.36 172.918 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -75.77 -31.82 59.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.288 -3.382 . . . . 20.52 111.132 175.521 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -94.72 89.2 5.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.104 -1.623 . . . . 7.13 111.037 -145.257 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -88.34 115.2 25.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.994 -3.566 . . . . 36.39 106.284 171.527 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.6 mt -91.26 121.83 33.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.471 -2.789 . . . . 9.55 103.471 177.157 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.65 132.24 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 124.501 2.096 . . . . 13.9 110.61 176.208 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -107.21 105.48 15.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.459 -3.276 . . . . 6.86 107.866 166.754 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.309 . . 60.49 -76.42 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.617 2.367 . . . . 11.15 115.838 -168.554 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.03 -20.0 3.48 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 126.689 2.09 . . . . 13.93 117.413 173.347 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.278 50.3 pttt -109.42 142.03 40.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.378 3.089 . . . . 23.92 105.118 -160.919 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -79.82 140.09 36.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.439 1.114 . . . . 23.23 109.782 -176.767 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 mt -84.3 128.7 34.73 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.617 -3.802 . . . . 9.11 112.847 177.432 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -83.6 136.83 34.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.117 2.967 . . . . 33.44 108.635 -174.68 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.277 0.9 OUTLIER -42.84 -63.53 0.77 Allowed 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 122.332 4.197 . . . . 28.37 122.332 -174.063 . . . . . . . . 4 3 . 1 . 059 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.97 37.11 2.34 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 128.974 3.178 . . . . 15.0 115.191 -171.517 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -132.06 148.25 52.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.984 2.216 . . . . 25.5 116.984 178.338 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.7 p -88.62 157.54 18.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 123.512 1.625 . . . . 11.95 113.126 -172.236 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.9 mt -71.69 -28.36 63.66 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.513 3.53 . . . . 10.17 110.685 -174.46 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.6 t -68.05 -44.42 76.44 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 118.042 -2.911 . . . . 13.59 113.004 173.386 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -56.35 -40.51 74.62 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.364 1.866 . . . . 11.7 111.79 177.179 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -85.34 -17.83 35.61 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.849 1.425 . . . . 12.95 114.849 175.632 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.508 12.9 m120 83.89 44.41 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.929 -2.357 . . . . 25.45 112.772 172.799 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.7 mm -79.24 117.12 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 113.965 -1.47 . . . . 14.6 112.685 174.837 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -91.72 178.47 5.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.069 -3.519 . . . . 33.23 108.351 -178.821 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -65.57 154.8 37.67 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 115.492 -2.483 . . . . 25.97 112.005 172.874 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.47 36.42 11.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.115 -2.241 . . . . 32.61 110.645 172.075 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 t -109.1 142.27 40.08 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.828 1.955 . . . . 10.56 112.437 -174.708 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -97.62 115.97 28.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 116.011 -1.947 . . . . 5.33 113.158 -170.883 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.31 141.43 28.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.022 1.451 . . . . 11.66 107.389 167.376 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.2 113.22 25.73 Favored 'General case' 0 N--CA 1.43 -1.433 1 CA-C-O 129.145 4.307 . . . . 16.3 107.803 -170.546 . . . . . . . . 3 3 . 1 . 059 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 7' ' ' THR . 58.9 tp -81.84 105.53 13.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 117.287 -3.383 . . . . 9.96 110.843 -178.016 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.19 113.52 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 123.329 1.538 . . . . 9.76 112.615 174.064 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 N--CA 1.43 -1.463 0 O-C-N 118.229 -2.794 . . . . 19.57 115.467 -178.333 . . . . . . . . 0 0 . 1 . 060 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptt? . . . . . 0 CA--C 1.49 -1.328 0 N-CA-C 116.686 2.106 . . . . 17.17 116.686 . . . . . . . . . 0 0 . 1 . 060 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.77 147.09 37.62 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 117.124 -1.417 . . . . 21.89 110.268 178.478 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.93 156.23 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.638 -2.727 . . . . 10.83 103.638 160.727 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -99.11 117.25 33.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 112.001 -2.363 . . . . 10.61 115.196 169.233 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.8 t -107.05 111.43 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.108 -3.495 . . . . 9.13 109.291 179.796 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -90.23 113.48 25.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.63 -1.623 . . . . 20.55 111.479 -171.727 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.391 9.0 p -70.72 172.55 8.54 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.533 -2.605 . . . . 11.78 115.302 173.672 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.1 tp -98.23 3.85 48.88 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.901 3.239 . . . . 19.31 109.48 177.763 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -85.59 -71.22 0.54 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.663 -3.773 . . . . 23.14 106.34 168.937 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.36 13.67 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.725 0 O-C-N 126.452 2.345 . . . . 19.74 114.499 -174.502 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -98.37 132.48 43.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.533 -3.333 . . . . 21.93 108.208 179.68 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -104.91 103.1 12.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.483 -3.885 . . . . 12.33 115.294 165.485 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -80.36 136.82 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.538 -2.601 . . . . 17.08 111.091 179.206 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 m -107.76 135.84 48.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.286 3.422 . . . . 16.3 106.13 175.733 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -132.47 157.15 45.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.386 -2.696 . . . . 15.88 107.163 -176.691 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -112.21 111.28 22.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.265 2.226 . . . . 28.9 108.195 -176.341 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.22 155.78 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 124.248 1.975 . . . . 12.05 110.466 -168.23 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.94 165.67 16.57 Favored Pre-proline 0 N--CA 1.43 -1.429 1 O-C-N 115.36 -4.587 . . . . 18.17 106.179 165.814 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -62.8 -22.56 73.98 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 123.155 2.57 . . . . 8.16 115.528 168.394 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.9 m -87.07 3.51 45.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.021 3.296 . . . . 11.13 115.147 -178.429 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -77.87 145.59 36.15 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.179 -5.326 . . . . 18.03 109.32 171.533 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -78.14 170.89 15.86 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.2 1.926 . . . . 10.22 116.2 173.172 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -61.85 -35.61 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 125.316 1.446 . . . . 12.3 112.228 161.76 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.12 -43.63 97.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.803 -2.435 . . . . 36.51 111.92 174.368 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -61.02 -32.59 72.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.169 2.285 . . . . 25.66 117.169 170.741 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.333 95.6 t -60.2 -53.66 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.366 3.066 . . . . 8.12 113.626 167.584 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -55.68 -44.53 77.4 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 121.924 4.046 . . . . 15.47 121.924 169.886 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.51 -34.26 64.49 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 125.942 2.782 . . . . 11.45 117.57 175.93 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -82.12 -27.35 32.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.199 -2.148 . . . . 24.98 105.199 -171.796 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.67 -29.94 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 103.416 -2.809 . . . . 9.46 103.416 -176.127 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.13 -51.3 68.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.221 3.009 . . . . 14.76 110.608 170.393 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -55.43 -43.35 75.29 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.191 1.922 . . . . 26.29 116.191 173.069 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -84.04 -71.86 0.49 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.094 -1.866 . . . . 30.06 108.312 -169.138 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -74.28 -54.09 8.4 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.791 2.71 . . . . 25.19 115.526 -170.893 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.11 -24.78 1.27 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.136 -2.227 . . . . 7.41 112.158 -177.975 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.548 HD13 HD21 ' A' ' 71' ' ' LEU . 3.7 mt -69.87 122.97 87.68 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 116.658 -1.639 . . . . 9.49 112.801 -160.802 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.44 153.39 65.83 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 C-N-CA 126.326 4.684 . . . . 11.42 110.979 176.378 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.95 -21.95 49.16 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 C-N-CA 124.627 3.552 . . . . 12.0 118.743 -168.702 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -65.58 -37.37 86.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.361 3.464 . . . . 35.55 111.127 178.695 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.26 65.7 mt-30 -76.49 -16.7 59.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.553 2.341 . . . . 20.52 113.917 -177.37 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -97.85 124.5 42.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.403 -3.311 . . . . 7.13 110.715 -165.783 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.401 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 59.4 mtp180 -101.97 126.98 49.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.513 -3.867 . . . . 36.39 105.969 160.121 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mt -115.48 132.0 56.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.578 -1.326 . . . . 9.55 107.697 177.504 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.57 134.24 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 126.554 1.941 . . . . 13.9 109.681 -159.266 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -140.68 116.48 10.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.733 1.73 . . . . 6.86 107.938 179.848 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.71 -93.92 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.739 3.216 . . . . 11.15 110.223 -178.027 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.86 11.11 7.43 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.683 -2.511 . . . . 13.93 116.625 178.591 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -128.92 153.02 47.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.222 -2.929 . . . . 23.92 112.46 -178.01 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -89.15 138.81 31.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.173 -2.529 . . . . 23.23 104.173 169.319 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.68 126.11 33.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.378 -2.646 . . . . 9.11 115.499 -176.997 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.56 140.97 31.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 121.343 1.883 . . . . 33.44 109.967 -173.355 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.39 -62.43 1.78 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.798 3.639 . . . . 28.37 115.493 -158.377 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.83 28.04 3.69 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 118.568 -2.582 . . . . 15.0 111.965 -177.078 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -103.95 154.07 20.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.828 -2.572 . . . . 25.5 107.134 174.72 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -97.0 177.59 5.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.709 3.147 . . . . 11.95 103.769 -170.559 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.78 -34.16 73.37 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 112.567 -6.333 . . . . 10.17 117.764 172.894 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 m -64.15 -21.43 66.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.592 -1.67 . . . . 13.59 112.588 174.237 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.16 -39.64 54.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.388 1.475 . . . . 11.7 111.698 177.72 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -90.15 3.15 54.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.845 2.906 . . . . 12.95 118.845 171.239 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.379 17.9 m120 73.18 25.49 2.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.739 2.416 . . . . 25.45 116.11 171.304 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.3 mt -83.83 127.74 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 128.855 2.862 . . . . 14.6 109.304 -176.692 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -126.37 -155.59 0.69 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.178 0.924 . . . . 33.23 110.157 179.451 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -83.33 144.87 29.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.598 -1.939 . . . . 25.97 112.412 179.673 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 87.0 6.93 0.26 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.289 3.836 . . . . 32.61 108.23 176.625 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -84.5 151.6 24.49 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 115.894 -4.254 . . . . 10.56 109.768 -167.657 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.452 5.2 m -93.24 112.56 24.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.345 2.658 . . . . 5.33 116.258 172.87 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -90.52 168.28 11.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.375 -3.328 . . . . 11.66 107.324 168.336 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -130.43 133.02 46.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.73 -2.481 . . . . 16.3 104.316 177.078 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -102.03 133.34 47.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.02 1.728 . . . . 9.96 113.405 177.887 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.458 HG12 ' N ' ' A' ' 71' ' ' LEU . 88.3 t -131.71 161.17 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.867 -2.271 . . . . 9.76 104.867 174.066 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.548 HD21 HD13 ' A' ' 36' ' ' ILE . 64.2 mt . . . . . 0 N--CA 1.429 -1.483 0 CA-C-N 121.848 2.113 . . . . 19.57 110.594 178.981 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 106.795 -1.557 . . . . 17.17 106.795 . . . . . . . . . 0 0 . 1 . 061 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.85 151.6 25.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.871 -1.899 . . . . 21.89 105.871 -178.278 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -134.5 167.42 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.593 2.139 . . . . 10.83 108.595 169.663 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -121.14 130.69 53.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.191 -2.818 . . . . 10.61 109.738 177.657 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -110.62 124.49 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 1 O-C-N 113.774 -5.579 . . . . 9.13 105.848 161.041 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.252 77.8 tttt -109.15 134.0 52.29 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.386 -2.696 . . . . 20.55 115.752 -179.39 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -71.0 170.29 13.11 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.966 2.794 . . . . 11.78 110.678 178.745 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.4 tp -78.11 -29.82 49.11 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.33 -2.668 . . . . 19.31 114.956 177.801 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -58.6 -56.01 27.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 122.198 2.272 . . . . 23.14 112.547 165.35 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.41 38.16 0.11 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 128.709 3.052 . . . . 19.74 113.799 163.302 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -92.79 132.11 37.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 126.837 2.139 . . . . 21.93 106.42 -179.421 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -105.89 126.58 52.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.03 2.348 . . . . 12.33 110.572 -175.692 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -97.06 118.86 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 111.291 -2.686 . . . . 17.08 105.905 174.864 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.7 m -82.54 128.9 34.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.817 -1.802 . . . . 16.3 115.137 166.523 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 mt -123.55 148.91 45.88 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.695 -1.224 . . . . 15.88 107.695 -179.895 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -118.77 116.89 27.48 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.616 2.366 . . . . 28.9 106.485 177.799 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.293 34.1 m -141.29 -179.22 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 126.394 2.309 . . . . 12.05 106.443 -177.329 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -117.13 157.86 45.76 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 118.502 -2.624 . . . . 18.17 108.582 171.418 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -64.3 -8.85 17.85 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-N 126.161 3.236 . . . . 8.16 118.029 178.818 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.1 m -88.99 -1.94 58.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.741 1.616 . . . . 11.13 113.976 -178.149 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -89.35 164.9 14.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.357 1.075 . . . . 18.03 108.976 176.831 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -87.96 168.07 13.18 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.826 2.45 . . . . 10.22 114.846 -179.624 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 22.3 mm -75.1 -26.35 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 115.393 1.627 . . . . 12.3 115.393 172.65 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -61.77 -43.35 99.03 Favored 'General case' 0 N--CA 1.43 -1.452 2 C-N-CA 133.994 4.918 . . . . 36.51 106.999 166.113 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -65.07 -33.92 77.18 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.017 2.599 . . . . 25.66 118.017 169.647 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -60.19 -44.42 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.668 -1.27 . . . . 8.12 111.501 171.38 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -75.25 -39.79 59.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.368 -3.332 . . . . 15.47 111.433 -175.691 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.53 -23.5 64.53 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.274 -2.141 . . . . 11.45 116.737 172.972 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -63.99 -45.22 90.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 125.095 3.588 . . . . 24.98 107.672 169.625 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.566 ' HB ' HE22 ' A' ' 41' ' ' GLN . 92.6 mt -67.09 -30.74 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.468 -2.645 . . . . 9.46 109.952 177.36 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -60.45 -41.32 93.86 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.805 2.842 . . . . 14.76 113.963 171.777 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -68.3 -59.7 3.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.084 1.883 . . . . 26.29 116.084 163.294 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 mttm -63.57 -58.38 7.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 120.122 3.379 . . . . 30.06 120.122 -171.802 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -88.72 -55.26 3.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.718 2.007 . . . . 25.19 113.429 -174.565 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.37 20.89 2.6 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 112.077 -2.329 . . . . 7.41 117.202 -178.152 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.0 mt -100.34 117.25 63.37 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 119.007 -2.467 . . . . 9.49 110.829 178.641 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 6.6 Cg_endo -73.43 154.7 50.77 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-N 127.732 3.797 . . . . 11.42 112.774 -175.694 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 94.4 Cg_exo -69.85 -22.58 31.46 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 CA-C-O 117.682 -1.049 . . . . 12.0 113.217 -167.287 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -54.09 -41.23 68.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.649 -2.596 . . . . 35.55 117.092 175.302 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -77.38 -36.03 53.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.024 2.703 . . . . 20.52 111.854 170.221 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.566 HE22 ' HB ' ' A' ' 30' ' ' ILE . 69.8 mt-30 -69.32 115.07 8.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.16 2.652 . . . . 7.13 118.16 -176.476 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 59.7 mtp180 -102.87 121.66 42.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.952 -1.499 . . . . 36.39 107.335 161.083 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 mt -99.15 132.43 44.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.382 1.901 . . . . 9.55 109.382 175.971 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -125.56 122.74 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.739 2.416 . . . . 13.9 109.523 -170.001 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -104.3 120.0 40.21 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.185 1.357 . . . . 6.86 109.19 168.76 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.49 . . 62.98 -102.59 0.11 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.941 -1.1 . . . . 11.15 113.457 -167.717 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.75 16.85 5.3 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 117.424 -3.298 . . . . 13.93 107.497 171.306 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -95.52 131.64 41.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.778 2.831 . . . . 23.92 109.335 177.209 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -87.99 133.0 34.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 124.872 1.358 . . . . 23.23 110.355 178.665 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 mt -93.13 120.47 33.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.662 1.185 . . . . 9.11 110.998 -175.116 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -78.55 139.0 38.66 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.607 1.563 . . . . 33.44 113.576 169.024 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 5.8 m-20 -64.75 -40.23 94.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.372 2.269 . . . . 28.37 113.33 -165.575 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.53 29.14 5.0 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 116.725 1.45 . . . . 15.0 116.725 177.23 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -109.75 164.09 12.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.903 -2.528 . . . . 25.5 107.27 162.873 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -93.31 165.17 12.92 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.772 1.748 . . . . 11.95 114.06 173.581 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -59.48 -35.24 73.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.748 -1.845 . . . . 10.17 112.669 174.473 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 t -66.55 -32.01 73.08 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 119.807 3.262 . . . . 13.59 119.807 174.085 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -63.37 -39.22 93.92 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 123.615 1.674 . . . . 11.7 110.638 175.571 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -88.14 -4.53 58.74 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.351 2.26 . . . . 12.95 112.376 178.727 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.8 m120 50.96 56.05 8.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.666 1.986 . . . . 25.45 114.504 -168.43 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.0 mt -103.16 103.57 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 101.204 -3.628 . . . . 14.6 101.204 178.278 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -89.74 -171.85 3.33 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.501 2.72 . . . . 33.23 111.288 -177.444 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -69.06 143.77 54.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 105.461 -2.051 . . . . 25.97 105.461 -170.831 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 25.3 mt-10 64.67 26.43 13.15 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.951 2.204 . . . . 32.61 116.951 172.673 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 t -93.34 144.5 25.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 104.383 -2.451 . . . . 10.56 104.383 -173.535 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.6 m -110.78 124.15 51.45 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 114.277 -1.329 . . . . 5.33 110.737 -171.951 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mt -95.22 140.94 29.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.114 3.365 . . . . 11.66 108.136 174.603 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -89.03 143.26 26.97 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.142 1.449 . . . . 16.3 108.952 165.894 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -119.51 119.82 34.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.167 -2.16 . . . . 9.96 105.167 -171.989 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 71.1 t -109.76 132.42 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 114.563 -1.199 . . . . 9.76 110.568 -179.778 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 N--CA 1.43 -1.431 0 O-C-N 118.231 -2.793 . . . . 19.57 113.569 174.716 . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 116.845 2.165 . . . . 17.17 116.845 . . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.64 128.46 33.64 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.496 -2.628 . . . . 21.89 108.77 172.221 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -124.01 173.33 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.935 -2.978 . . . . 10.83 103.548 163.901 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.269 77.5 m-85 -128.18 136.3 50.91 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.782 -0.821 . . . . 10.61 108.782 -176.31 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -113.62 117.16 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 125.971 2.796 . . . . 9.13 106.768 175.401 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 19.9 ttpt -95.91 136.77 35.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.343 -1.753 . . . . 20.55 111.117 174.666 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -88.89 -169.29 2.47 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 128.15 3.833 . . . . 11.78 111.51 -175.34 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.3 tp -80.57 -44.15 19.47 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.691 -3.755 . . . . 19.31 110.543 -176.71 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -62.28 1.93 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.417 1.887 . . . . 23.14 110.006 168.562 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.84 41.34 0.11 Allowed Glycine 0 N--CA 1.431 -1.687 0 O-C-N 119.139 -2.226 . . . . 19.74 111.593 169.63 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 21.1 tptm -84.29 142.9 29.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 128.94 3.377 . . . . 21.93 113.833 166.489 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.5 m -106.94 112.21 25.07 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.593 1.663 . . . . 12.33 109.466 -176.254 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.483 HD13 ' HG3' ' A' ' 34' ' ' GLU . 34.3 mt -104.27 108.91 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 119.562 -1.961 . . . . 17.08 110.358 -174.974 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -87.82 123.09 32.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.489 -1.382 . . . . 16.3 108.564 -174.164 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.3 mt -120.17 158.26 27.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.087 2.155 . . . . 15.88 116.29 179.636 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -120.77 89.33 3.11 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.556 3.074 . . . . 28.9 114.893 177.377 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -109.55 164.39 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 119.86 -1.775 . . . . 12.05 114.473 -178.624 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -98.26 159.69 30.04 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 116.551 -2.059 . . . . 18.17 106.444 167.793 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 79.5 Cg_endo -73.53 -17.68 23.37 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 O-C-N 116.012 -2.678 . . . . 8.16 110.066 174.904 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -59.78 -20.25 55.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.005 2.522 . . . . 11.13 116.19 164.785 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -71.57 142.3 50.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.562 2.601 . . . . 18.03 112.0 175.964 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.7 p -79.94 165.64 22.43 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.09 -4.131 . . . . 10.22 107.932 167.233 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 mm -66.18 -24.69 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.589 1.955 . . . . 12.3 108.558 177.637 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.29 35.0 tt0 -65.73 -39.85 91.57 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 118.19 -0.91 . . . . 36.51 108.596 174.19 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -72.25 -24.31 61.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.895 2.134 . . . . 25.66 114.237 179.109 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t -72.77 -42.06 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.385 -2.697 . . . . 8.12 110.834 175.189 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.274 93.0 mttt -51.57 -36.88 47.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 117.581 2.438 . . . . 15.47 117.581 163.512 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.76 61.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.504 -1.372 . . . . 11.45 111.265 -177.232 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -58.67 -47.98 82.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.164 2.986 . . . . 24.98 113.814 175.487 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -69.92 -34.16 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.553 -1.658 . . . . 9.46 109.147 175.401 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -60.59 -46.71 89.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.144 2.247 . . . . 14.76 110.794 172.978 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.26 -58.7 6.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.759 -1.838 . . . . 26.29 111.305 -177.308 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -75.61 -55.43 5.67 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 132.805 4.442 . . . . 30.06 111.264 -168.068 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HG3' HD13 ' A' ' 13' ' ' ILE . 27.1 mm-40 -89.43 -31.8 17.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.968 -2.333 . . . . 25.19 115.241 -179.016 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.01 11.42 20.57 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 121.269 3.268 . . . . 7.41 121.269 179.536 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.307 71.5 mt -109.5 135.16 20.35 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 102.447 -3.168 . . . . 9.49 102.447 -153.502 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -61.44 158.03 38.22 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 124.079 3.186 . . . . 11.42 117.481 179.605 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -78.53 -13.35 14.93 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 127.847 3.838 . . . . 12.0 118.066 179.932 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.92 -17.8 64.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.996 -1.457 . . . . 35.55 114.93 -178.634 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -86.2 -22.38 26.98 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 124.07 1.89 . . . . 20.52 111.24 178.025 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -89.07 108.01 19.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.819 2.525 . . . . 7.13 117.819 -163.303 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -104.49 100.15 9.84 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.994 -1.113 . . . . 36.39 107.994 171.517 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.482 ' HB3' HD12 ' A' ' 50' ' ' LEU . 13.6 mt -81.81 130.33 35.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.182 -2.824 . . . . 9.55 112.884 178.33 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mm -128.8 136.06 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 104.148 -2.538 . . . . 13.9 104.148 -167.739 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -135.08 133.5 39.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.843 -1.539 . . . . 6.86 106.843 176.604 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.262 . . 49.98 -111.34 0.49 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.844 2.535 . . . . 11.15 117.844 -164.163 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.36 2.53 37.27 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 119.007 -0.885 . . . . 13.93 114.405 169.341 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -105.7 126.33 52.03 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.237 3.015 . . . . 23.92 111.024 -161.508 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -80.54 130.41 35.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.523 -1.217 . . . . 23.23 110.49 171.712 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 43' ' ' LEU . 34.3 mt -86.47 166.01 15.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.61 -1.186 . . . . 9.11 113.756 -167.908 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -132.48 128.91 38.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 114.791 -2.528 . . . . 33.44 109.085 -170.4 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.05 -44.49 78.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 127.157 2.785 . . . . 28.37 115.573 -162.954 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.55 -8.72 14.89 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 128.546 2.974 . . . . 15.0 118.634 -179.394 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -95.8 150.92 19.87 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 116.234 -4.098 . . . . 25.5 110.851 178.583 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.7 p -78.53 161.68 26.86 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.298 2.475 . . . . 11.95 112.144 168.041 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 19.9 mt -65.29 -42.88 92.64 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.0 -5.438 . . . . 10.17 111.904 172.348 . . . . . . . . 3 3 . 1 . 062 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -42.14 -40.27 2.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.626 2.824 . . . . 13.59 118.626 160.685 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.34 -22.82 67.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.193 -2.192 . . . . 11.7 116.531 172.677 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -101.82 3.59 39.52 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.023 -1.673 . . . . 12.95 111.276 -178.75 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.478 26.9 m120 63.37 32.12 14.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.127 2.87 . . . . 25.45 118.191 -174.204 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.6 mt -95.51 123.06 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.026 -2.296 . . . . 14.6 106.38 -171.493 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -124.78 -171.17 2.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.093 2.557 . . . . 33.23 107.305 -168.673 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -76.33 150.68 36.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.512 -1.992 . . . . 25.97 115.949 -169.001 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 63.15 15.34 8.46 Favored 'General case' 0 N--CA 1.43 -1.464 1 CA-C-O 128.535 4.017 . . . . 32.61 118.894 -169.711 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.37 147.34 40.13 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 112.884 -6.135 . . . . 10.56 113.981 172.47 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.8 m -108.15 123.37 48.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.612 1.565 . . . . 5.33 114.486 -176.823 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.25 166.51 10.91 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.666 0.746 . . . . 11.66 110.163 174.313 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -126.27 144.96 50.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.076 -2.89 . . . . 16.3 108.295 -175.769 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.3 tp -121.55 102.47 8.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.965 1.306 . . . . 9.96 108.747 -165.026 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 t -87.9 128.84 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 123.105 0.562 . . . . 9.76 110.226 176.265 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 103.425 -2.805 . . . . 19.57 103.425 -169.637 . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 CA--C 1.49 -1.338 0 CA-C-O 123.909 1.814 . . . . 17.17 114.597 . . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -74.92 125.29 28.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.386 -3.321 . . . . 21.89 114.092 168.465 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 pt -120.88 161.95 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 112.965 -1.925 . . . . 10.83 112.064 170.048 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -119.76 125.34 48.37 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.573 1.654 . . . . 10.61 111.615 -177.259 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.1 111.84 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 121.118 -0.988 . . . . 9.13 110.237 174.632 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -88.37 138.52 31.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.608 -3.182 . . . . 20.55 118.261 179.088 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.264 28.2 p -87.25 175.79 7.87 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.301 2.334 . . . . 11.78 117.301 178.672 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -75.39 -38.21 60.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.729 -2.082 . . . . 19.31 115.095 173.978 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 63.0 p -70.64 -52.77 19.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.486 -2.673 . . . . 23.14 116.688 161.036 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.7 58.17 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 124.927 3.512 . . . . 19.74 110.899 158.494 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -97.14 147.11 24.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.29 -1.712 . . . . 21.93 110.485 165.411 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 m -93.62 108.41 20.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.208 1.004 . . . . 12.33 109.632 167.175 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 mt -75.93 127.7 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 117.738 -3.101 . . . . 17.08 107.605 166.185 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.6 p -114.15 127.46 55.92 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.742 -3.099 . . . . 16.3 111.97 177.573 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -127.81 133.19 49.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 128.172 3.42 . . . . 15.88 113.759 -171.567 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -95.75 91.7 6.21 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 132.242 4.217 . . . . 28.9 109.42 -179.516 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -126.52 167.47 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.513 -1.662 . . . . 12.05 106.513 178.927 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -102.44 154.19 37.61 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 117.39 -3.319 . . . . 18.17 105.838 174.255 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -68.99 -5.33 15.46 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 124.079 2.493 . . . . 8.16 117.631 -173.494 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -98.37 4.38 48.56 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 124.442 1.089 . . . . 11.13 108.298 174.963 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.49 147.3 53.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.902 2.186 . . . . 18.03 116.902 162.052 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 7.5 p -89.67 158.84 17.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.318 -1.765 . . . . 10.22 106.681 -173.665 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -64.7 -32.69 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.385 -2.697 . . . . 12.3 114.486 -178.766 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -44.21 -50.81 8.63 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.206 3.002 . . . . 36.51 109.783 162.238 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -74.12 -21.24 59.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.936 -2.977 . . . . 25.66 117.128 178.333 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 56' ' ' LEU . 55.8 t -71.63 -43.61 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 123.25 1.5 . . . . 8.12 109.838 172.909 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -61.51 -30.65 70.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.087 2.995 . . . . 15.47 119.087 168.66 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.37 -34.65 61.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.88 -3.013 . . . . 11.45 112.922 171.204 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -49.04 76.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 127.063 3.316 . . . . 24.98 116.103 167.953 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.6 mt -57.79 -42.23 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 117.645 -3.16 . . . . 9.46 113.528 166.54 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -63.2 -39.55 94.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.426 -3.921 . . . . 14.76 116.176 172.977 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -68.05 -50.56 54.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.12 0.887 . . . . 26.29 113.121 176.126 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -70.14 -66.02 0.65 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.112 1.152 . . . . 30.06 114.112 176.889 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -76.96 -35.28 57.36 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.856 2.909 . . . . 25.19 118.856 -170.221 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.01 60.16 1.79 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 119.827 -1.796 . . . . 7.41 111.246 -173.169 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.99 119.54 15.82 Favored Pre-proline 0 N--CA 1.43 -1.439 0 C-N-CA 125.151 1.38 . . . . 9.49 108.091 178.255 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.49 154.41 45.1 Favored 'Trans proline' 0 N--CA 1.433 -2.059 1 C-N-CA 125.893 4.395 . . . . 11.42 111.716 -172.218 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.299 52.3 Cg_endo -64.27 -14.3 43.09 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 O-C-N 123.891 1.469 . . . . 12.0 111.507 174.726 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -67.29 -34.34 77.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.361 2.505 . . . . 35.55 113.779 176.605 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -96.58 -37.74 10.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.012 -2.305 . . . . 20.52 108.639 -164.684 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -75.21 136.89 40.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 117.067 2.247 . . . . 7.13 117.067 -176.345 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HB3' HG23 ' A' ' 70' ' ' VAL . 37.3 ttm180 -120.06 133.25 55.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.197 -3.26 . . . . 36.39 102.197 161.339 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.7 mt -108.53 141.93 39.7 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.386 -2.071 . . . . 9.55 106.389 179.903 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.1 mt -126.83 138.54 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.214 3.406 . . . . 13.9 103.367 -170.476 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -121.03 121.24 37.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.974 1.369 . . . . 6.86 111.471 161.185 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.61 -78.58 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.719 -2.488 . . . . 11.15 114.843 -174.613 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.25 -4.94 0.24 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 123.882 3.037 . . . . 13.93 110.638 -177.998 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -113.07 146.03 39.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.747 2.419 . . . . 23.92 112.689 -173.391 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -89.52 156.07 18.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.597 1.959 . . . . 23.23 110.288 -171.773 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -118.86 127.24 53.32 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 129.455 4.222 . . . . 9.11 107.8 -170.413 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -103.14 165.07 11.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.837 -3.04 . . . . 33.44 112.384 -172.118 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -69.91 -58.13 4.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.477 -2.639 . . . . 28.37 113.848 -157.645 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.35 31.03 5.95 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 117.919 -1.489 . . . . 15.0 115.523 -167.714 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -107.96 162.09 14.34 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.94 1.696 . . . . 25.5 114.202 159.831 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 29.2 p -92.72 173.48 7.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.305 1.526 . . . . 11.95 107.626 -171.65 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 26' ' ' VAL . 12.5 mt -65.67 -44.26 86.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.026 -0.988 . . . . 10.17 110.469 171.729 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.1 m -63.89 -32.21 73.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.198 2.295 . . . . 13.59 117.198 178.704 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -58.21 -42.81 87.03 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.267 3.432 . . . . 11.7 120.267 173.54 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -70.5 -13.89 62.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 117.46 -1.257 . . . . 12.95 114.275 163.849 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 30.2 m120 68.68 38.59 2.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.474 2.71 . . . . 25.45 114.265 -171.61 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.16 129.16 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.053 2.095 . . . . 14.6 110.339 164.557 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.44 -173.77 3.26 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.128 2.971 . . . . 33.23 108.944 -164.217 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -65.26 136.22 56.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.57 -3.831 . . . . 25.97 111.14 172.629 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 55.42 53.19 10.16 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-N 108.039 -4.164 . . . . 32.61 113.442 -170.889 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -96.37 150.67 20.33 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.057 -4.152 . . . . 10.56 110.121 -178.136 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.5 m -103.46 111.1 23.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 127.4 2.937 . . . . 5.33 108.444 -174.9 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -100.07 162.09 13.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.293 -1.002 . . . . 11.66 108.293 176.215 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -122.75 128.06 50.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.35 -1.469 . . . . 16.3 111.347 170.422 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -93.92 121.9 35.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.737 1.014 . . . . 9.96 113.737 176.638 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 42' ' ' ARG . 18.7 m -121.68 155.87 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.778 -1.934 . . . . 9.76 105.778 174.445 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.2 mt . . . . . 0 N--CA 1.43 -1.451 0 O-C-N 118.872 -2.393 . . . . 19.57 109.787 172.056 . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 111.932 0.345 . . . . 17.17 111.932 . . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -89.74 115.26 26.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.569 1.548 . . . . 21.89 113.084 -175.662 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.48 18.0 pt -107.29 155.27 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 126.076 1.75 . . . . 10.83 115.593 168.874 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -121.2 116.57 25.16 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.333 2.653 . . . . 10.61 105.681 -178.006 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.32 109.36 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 118.064 -2.897 . . . . 9.13 108.26 172.074 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -101.29 132.67 46.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.281 1.515 . . . . 20.55 107.12 -173.798 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -87.12 171.56 10.6 Favored 'General case' 0 N--CA 1.429 -1.486 1 O-C-N 115.732 -4.355 . . . . 11.78 113.495 177.708 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.4 tp -70.23 -42.2 72.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 127.047 3.308 . . . . 19.31 109.495 177.699 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 p -56.81 -31.69 64.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.751 -3.093 . . . . 23.14 116.928 167.889 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.62 37.29 2.09 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 122.632 2.469 . . . . 19.74 113.137 173.235 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -99.55 152.9 19.5 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.451 -2.796 . . . . 21.93 103.451 167.446 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -110.97 106.23 15.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 114.06 1.133 . . . . 12.33 114.06 160.246 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.5 mt -81.27 108.25 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.876 -1.765 . . . . 17.08 108.571 169.973 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.9 p -78.39 137.8 38.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.49 -2.006 . . . . 16.3 111.039 172.34 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.2 139.32 44.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 125.197 1.561 . . . . 15.88 110.366 -177.166 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -95.46 111.6 23.46 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.298 2.639 . . . . 28.9 109.784 164.579 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.252 29.0 m -135.51 162.26 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 1 O-C-N 114.446 -5.159 . . . . 12.05 107.344 175.133 . . . . . . . . 3 2 . 1 . 064 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -97.95 166.05 14.23 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 120.239 -1.538 . . . . 18.17 107.967 179.682 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.74 -19.9 48.59 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 123.721 2.365 . . . . 8.16 118.1 174.184 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -98.5 12.94 33.53 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 125.032 1.458 . . . . 11.13 112.066 -172.182 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.34 131.16 34.73 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.429 -2.044 . . . . 18.03 108.87 176.952 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 52' ' ' ASP 0.314 65.1 p -59.26 163.55 3.77 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.913 1.82 . . . . 10.22 115.913 164.889 . . . . . . . . 3 3 . 1 . 064 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 37.2 mm -76.05 -17.1 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 O-C-N 116.291 -4.005 . . . . 12.3 106.335 -179.72 . . . . . . . . 3 3 . 1 . 064 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 36.7 tt0 -69.12 -47.24 65.64 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.074 -1.642 . . . . 36.51 107.538 172.127 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.273 70.4 m-80 -66.49 -29.43 69.54 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.508 3.151 . . . . 25.66 119.508 175.677 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.269 60.2 t -51.4 -51.56 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 114.155 1.168 . . . . 8.12 114.155 163.621 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -71.61 -40.48 69.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.556 1.942 . . . . 15.47 110.618 -174.995 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.264 . . -52.34 -49.34 64.5 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.336 3.054 . . . . 11.45 109.809 170.051 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -62.51 -36.72 83.45 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.556 -3.215 . . . . 24.98 116.812 172.836 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -58.91 -47.25 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.763 -3.086 . . . . 9.46 111.538 167.455 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -55.86 -35.78 66.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.231 2.678 . . . . 14.76 118.231 173.931 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.9 -43.06 69.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.992 -1.485 . . . . 26.29 106.992 -179.894 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -79.03 -57.47 3.72 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.785 -1.822 . . . . 30.06 115.31 -173.935 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -85.74 -49.7 7.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.779 -2.01 . . . . 25.19 111.572 -173.947 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.6 28.66 5.91 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 116.396 -3.94 . . . . 7.41 110.885 -169.436 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.23 122.9 41.4 Favored Pre-proline 0 N--CA 1.429 -1.5 1 CA-C-O 111.541 -4.076 . . . . 9.49 105.997 176.161 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -87.63 159.77 7.83 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-O 114.543 -2.357 . . . . 11.42 112.199 -165.369 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -64.26 -9.48 20.01 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 122.912 2.408 . . . . 12.0 116.227 -175.626 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -82.36 -34.61 28.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 124.165 3.166 . . . . 35.55 109.907 -169.568 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -83.19 -19.45 36.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.539 1.536 . . . . 20.52 108.467 -174.775 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -90.95 127.96 36.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.054 2.983 . . . . 7.13 119.054 -166.839 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -120.4 123.61 43.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 128.273 3.892 . . . . 36.39 111.174 168.674 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.0 mt -112.42 141.37 46.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.538 -2.601 . . . . 9.55 112.541 177.923 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.91 134.91 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.484 -1.673 . . . . 13.9 106.484 -164.796 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -117.46 112.43 20.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.959 -2.978 . . . . 6.86 102.959 171.608 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.321 . . 60.48 -108.29 0.35 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.068 1.889 . . . . 11.15 113.537 -167.748 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.17 -12.2 22.4 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 113.08 -1.873 . . . . 13.93 109.97 170.141 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -74.17 107.97 6.68 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.387 3.593 . . . . 23.92 112.835 179.618 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.8 122.36 22.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.239 -4.663 . . . . 23.23 110.897 176.528 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.274 6.5 mt -90.67 127.28 36.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.861 2.911 . . . . 9.11 118.861 -165.244 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -83.55 143.58 30.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.35 -2.094 . . . . 33.44 114.926 173.005 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 36.0 m-20 -65.31 -41.44 94.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.755 2.217 . . . . 28.37 114.985 -163.977 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.51 21.46 38.32 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 118.614 -2.554 . . . . 15.0 113.58 -174.411 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -106.23 165.29 11.35 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.391 -1.337 . . . . 25.5 107.391 162.892 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -104.49 178.15 4.64 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.086 2.155 . . . . 11.95 111.54 -173.333 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.2 mt -80.1 -36.84 34.82 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.546 3.138 . . . . 10.17 106.445 173.945 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -51.77 -38.91 57.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.934 2.152 . . . . 13.59 114.931 163.509 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -70.96 -54.73 10.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.6 3.56 . . . . 11.7 109.234 -179.179 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -77.19 0.03 23.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.59 1.181 . . . . 12.95 113.213 -178.979 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 48.97 46.43 22.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.537 2.589 . . . . 25.45 117.034 -176.902 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mt -84.88 120.05 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 111.962 -2.381 . . . . 14.6 108.577 176.909 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -107.69 172.84 6.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.972 1.844 . . . . 33.23 113.831 177.96 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -60.14 141.73 55.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.423 -2.673 . . . . 25.97 113.038 179.462 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.313 12.2 mt-10 71.29 20.68 4.93 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 126.238 2.923 . . . . 32.61 117.876 177.863 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -87.63 124.72 33.82 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.448 -2.033 . . . . 10.56 109.958 173.833 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 m -74.26 100.93 3.86 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.383 2.04 . . . . 5.33 112.157 177.698 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.75 141.95 30.18 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 117.659 -3.15 . . . . 11.66 113.508 167.144 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -107.16 128.2 54.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.264 1.983 . . . . 16.3 109.754 -178.808 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.7 tp -97.58 128.44 44.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.207 -3.433 . . . . 9.96 109.2 173.367 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.07 136.52 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.303 2.954 . . . . 9.76 105.084 171.015 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 N--CA 1.43 -1.448 0 O-C-N 117.975 -2.953 . . . . 19.57 109.572 179.054 . . . . . . . . 0 0 . 1 . 065 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' HG23 ' A' ' 17' ' ' VAL . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 117.795 -1.098 . . . . 17.17 111.997 . . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.336 2.8 pt20 -95.87 145.29 25.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.794 2.088 . . . . 21.89 115.928 166.472 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.1 pt -138.39 167.26 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 103.361 -2.829 . . . . 10.83 103.361 174.865 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -122.22 145.28 48.36 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.891 -2.413 . . . . 10.61 108.272 179.177 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 30' ' ' ILE . 78.5 t -128.66 111.12 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 103.457 -2.794 . . . . 9.13 103.457 176.937 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -107.26 137.49 45.21 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.676 2.655 . . . . 20.55 112.293 179.415 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.418 HG22 HD23 ' A' ' 69' ' ' LEU . 44.9 p -79.38 -166.45 0.96 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.916 -2.365 . . . . 11.78 105.541 -173.489 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.5 tp -81.59 -47.13 13.45 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.653 -1.904 . . . . 19.31 109.277 173.129 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 -31.2 61.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.711 2.804 . . . . 23.14 109.07 -170.059 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.43 42.17 0.47 Allowed Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 125.579 3.809 . . . . 19.74 115.226 174.326 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -108.27 133.98 51.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 102.27 -3.233 . . . . 21.93 102.27 168.358 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -104.54 113.17 26.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 124.888 1.368 . . . . 12.33 108.64 168.934 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -87.6 100.45 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.331 1.852 . . . . 17.08 112.562 166.618 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.9 m -77.23 136.51 38.54 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 118.143 -0.932 . . . . 16.3 108.879 177.778 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.296 32.0 mt -134.64 128.08 32.4 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.901 2.137 . . . . 15.88 105.519 178.548 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -88.26 132.33 34.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.367 -3.333 . . . . 28.9 107.676 161.296 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.525 HG23 ' HG3' ' A' ' 1' ' ' MET . 18.2 m -133.27 171.32 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 1 C-N-CA 132.194 4.198 . . . . 12.05 113.118 -164.146 . . . . . . . . 3 3 . 1 . 065 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -108.0 148.06 36.7 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 129.109 2.964 . . . . 18.17 112.604 161.753 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.6 -23.12 69.99 Favored 'Trans proline' 0 N--CA 1.434 -2.017 1 C-N-CA 126.162 4.575 . . . . 8.16 115.364 173.086 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -86.58 -7.16 58.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.145 1.535 . . . . 11.13 115.145 -179.101 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -73.61 146.53 44.59 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.039 -2.913 . . . . 18.03 110.452 179.33 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.8 p -99.28 -176.81 3.41 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 104.331 -2.47 . . . . 10.22 104.331 -172.507 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -70.45 -34.61 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 127.353 2.261 . . . . 12.3 109.569 -177.638 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -55.23 -43.33 74.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.695 2.798 . . . . 36.51 110.822 172.209 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -70.68 -34.92 72.49 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.755 2.502 . . . . 25.66 117.755 174.346 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.3 t -55.24 -48.81 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 132.031 4.133 . . . . 8.12 108.058 174.002 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -63.81 -27.86 69.47 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.036 2.934 . . . . 15.47 115.066 177.488 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.34 -31.06 54.24 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.542 1.974 . . . . 11.45 110.997 177.374 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -65.04 -44.88 87.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.64 -2.538 . . . . 24.98 109.414 178.734 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 HG11 ' A' ' 5' ' ' VAL . 15.6 mt -65.59 -24.11 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.729 2.122 . . . . 9.46 116.729 173.189 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -64.89 -57.42 8.85 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.798 -3.689 . . . . 14.76 114.342 162.276 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -52.24 -60.62 3.0 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.517 3.527 . . . . 26.29 114.729 175.757 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -79.5 -39.73 31.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.913 2.085 . . . . 30.06 112.612 -166.432 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -106.87 -42.2 5.0 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.029 1.732 . . . . 25.19 110.009 -163.287 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.63 7.09 30.22 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 117.709 -2.186 . . . . 7.41 117.85 -173.118 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.6 mm -90.97 126.91 53.82 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-N 122.25 3.025 . . . . 9.49 108.917 -170.314 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -68.51 152.97 74.69 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 122.261 1.843 . . . . 11.42 111.867 -178.617 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -92.98 -10.53 1.9 Allowed 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-O 113.241 -2.9 . . . . 12.0 111.797 -151.995 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -85.85 -28.43 24.44 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 128.671 3.732 . . . . 35.55 111.356 174.872 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.17 -17.35 37.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 118.884 -0.579 . . . . 20.52 111.625 -171.807 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -66.85 115.66 6.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.593 2.757 . . . . 7.13 111.049 171.866 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -114.64 124.11 51.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.317 2.008 . . . . 36.39 108.772 171.967 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mt -103.35 134.9 45.96 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.041 -2.287 . . . . 9.55 107.221 -177.854 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 7.5 mm -112.38 122.62 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 130.522 3.529 . . . . 13.9 115.144 171.053 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -108.8 118.81 37.77 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.755 -1.202 . . . . 6.86 107.755 170.965 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.55 -78.37 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 131.134 3.774 . . . . 11.15 113.611 -170.545 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.47 40.41 0.28 Allowed Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 107.193 -2.363 . . . . 13.93 107.193 -179.808 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -137.2 139.33 41.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.525 -2.75 . . . . 23.92 111.473 159.7 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -67.79 167.52 13.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 117.518 2.414 . . . . 23.23 117.518 175.361 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.49 149.83 35.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.679 2.392 . . . . 9.11 107.508 178.41 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.9 146.92 48.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 123.528 0.518 . . . . 33.44 109.786 -177.665 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.74 -47.27 41.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 120.577 3.547 . . . . 28.37 120.577 -158.651 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.56 53.7 0.63 Allowed Glycine 0 N--CA 1.429 -1.77 0 O-C-N 117.068 -3.52 . . . . 15.0 111.131 -170.338 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -120.62 159.27 25.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 117.574 -1.65 . . . . 25.5 106.997 155.969 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -85.12 165.38 17.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.969 2.508 . . . . 11.95 112.348 -169.914 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.6 mt -72.09 -38.04 69.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.685 -1.885 . . . . 10.17 110.012 -176.639 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -54.09 -49.15 69.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 114.891 -2.48 . . . . 13.59 113.105 169.706 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -44.53 -50.05 9.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 124.989 3.54 . . . . 11.7 113.787 174.702 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -76.93 -7.63 55.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.669 -2.519 . . . . 12.95 116.839 -178.981 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 69.19 37.47 2.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.966 3.307 . . . . 25.45 115.258 -179.42 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.2 mt -85.01 109.19 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 130.878 3.671 . . . . 14.6 105.677 -172.867 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -91.07 165.26 13.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.826 2.727 . . . . 33.23 113.035 -179.751 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 147.25 12.83 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.798 -3.689 . . . . 25.97 115.532 168.308 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 58.37 32.23 21.84 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.046 2.61 . . . . 32.61 118.046 -170.762 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -98.74 142.63 30.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.495 1.747 . . . . 10.56 108.796 177.071 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.2 m -93.24 102.91 15.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.137 3.775 . . . . 5.33 115.636 169.473 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.25 153.58 23.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.842 -2.281 . . . . 11.66 104.842 168.602 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.424 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 89.2 m-70 -92.04 152.96 19.72 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.735 1.383 . . . . 16.3 114.735 168.191 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.418 HD23 HG22 ' A' ' 7' ' ' THR . 22.2 tp -120.01 108.78 14.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.977 2.111 . . . . 9.96 110.998 169.082 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.327 16.0 m -119.65 168.74 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 126.922 2.639 . . . . 9.76 112.505 171.495 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.2 mt . . . . . 0 N--CA 1.431 -1.411 0 CA-C-O 125.534 2.588 . . . . 19.57 106.591 179.053 . . . . . . . . 0 0 . 1 . 066 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 108.119 -1.067 . . . . 17.17 108.119 . . . . . . . . . 0 0 . 1 . 066 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -83.15 132.93 35.06 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.919 -2.363 . . . . 21.89 114.764 175.734 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -131.84 163.14 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 124.716 1.26 . . . . 10.83 110.039 172.489 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -124.67 166.27 16.44 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 102.282 -3.229 . . . . 10.61 102.282 -174.949 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -150.18 143.17 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 100.877 -3.749 . . . . 9.13 100.877 179.464 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -119.2 139.05 52.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.467 1.939 . . . . 20.55 106.271 -178.649 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.0 p -81.81 167.84 18.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.744 1.903 . . . . 11.78 107.565 178.654 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 tp -56.17 -54.8 40.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.014 3.326 . . . . 19.31 113.132 -178.946 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.3 p -62.62 -53.76 49.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.891 2.476 . . . . 23.14 110.57 175.727 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.18 70.61 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 CA-C-O 117.601 -1.666 . . . . 19.74 112.768 169.587 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -125.78 124.42 40.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.909 1.855 . . . . 21.93 109.665 176.858 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -79.57 106.03 11.31 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.383 -5.198 . . . . 12.33 111.177 177.387 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.7 mt -81.35 115.07 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 123.259 1.504 . . . . 17.08 107.139 171.934 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -94.47 104.11 16.08 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 114.344 -5.222 . . . . 16.3 114.818 171.518 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -97.35 162.29 13.4 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.436 -4.54 . . . . 15.88 112.244 179.378 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -116.22 118.99 34.34 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 102.913 -2.995 . . . . 28.9 102.913 174.322 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.27 165.55 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 121.844 2.111 . . . . 12.05 112.707 173.653 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -104.57 161.78 21.79 Favored Pre-proline 0 N--CA 1.43 -1.46 0 N-CA-C 105.658 -1.979 . . . . 18.17 105.658 164.169 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.17 -6.29 12.96 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 123.978 3.119 . . . . 8.16 109.311 -169.412 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -88.22 2.97 51.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 131.54 3.936 . . . . 11.13 113.379 168.0 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -87.15 152.71 22.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.21 -3.431 . . . . 18.03 109.91 -178.859 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p -94.86 164.05 13.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.149 2.704 . . . . 10.22 110.7 -167.042 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.5 mm -69.37 -34.87 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 O-C-N 115.489 -4.507 . . . . 12.3 109.164 -179.864 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.24 -42.78 77.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.737 2.866 . . . . 36.51 118.737 168.045 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -71.21 -32.43 68.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.02 2.128 . . . . 25.66 110.403 175.643 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.359 44.4 t -52.06 -61.27 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 118.98 -2.325 . . . . 8.12 111.094 165.396 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -52.59 -35.43 54.11 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 127.109 2.164 . . . . 15.47 114.479 177.772 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.37 70.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.296 -2.753 . . . . 11.45 109.481 -178.302 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -62.27 -41.65 98.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.145 -0.972 . . . . 24.98 112.925 171.846 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.7 mt -63.71 -36.34 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 127.459 2.974 . . . . 9.46 114.348 179.428 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -53.91 -33.19 55.92 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.509 3.924 . . . . 14.76 117.834 166.643 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.68 -51.48 9.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 124.12 1.914 . . . . 26.29 108.841 178.053 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -56.46 -63.15 1.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.274 1.987 . . . . 30.06 114.991 -176.771 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -110.91 -13.51 14.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.693 -3.129 . . . . 25.19 114.28 -172.765 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.78 43.86 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 119.524 2.57 . . . . 7.41 119.524 -172.623 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.6 115.9 65.85 Favored Pre-proline 0 N--CA 1.43 -1.425 0 CA-C-O 115.154 -2.355 . . . . 9.49 105.903 169.575 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -66.32 152.43 81.03 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 CA-C-N 126.906 3.502 . . . . 11.42 113.57 -177.856 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.14 -0.26 10.6 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.06 2.506 . . . . 12.0 112.92 -166.109 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -90.66 -54.79 3.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.836 3.207 . . . . 35.55 109.123 -173.897 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -84.28 -8.56 58.99 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.252 2.315 . . . . 20.52 117.252 -174.616 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -88.85 157.33 18.49 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.942 -2.974 . . . . 7.13 109.923 171.52 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -143.46 144.69 32.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.018 -1.676 . . . . 36.39 107.593 168.637 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.8 mt -97.59 140.07 32.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.017 1.327 . . . . 9.55 113.673 -175.983 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mm -134.52 139.35 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 104.009 -2.589 . . . . 13.9 104.009 -173.707 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' HB2' HD11 ' A' ' 50' ' ' LEU . 5.2 t80 -111.93 108.36 17.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.559 2.344 . . . . 6.86 107.834 173.389 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.41 -88.6 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.362 2.289 . . . . 11.15 112.781 -169.99 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.42 -8.48 4.89 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 117.012 -3.555 . . . . 13.93 109.953 175.841 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -81.56 141.07 34.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 118.032 0.916 . . . . 23.92 111.32 -177.345 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -94.61 120.84 35.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.272 1.429 . . . . 23.23 108.168 -178.168 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 45' ' ' PHE . 14.7 mt -91.84 133.25 35.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.593 1.957 . . . . 9.11 110.588 -165.138 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -94.84 136.25 35.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.772 -2.455 . . . . 33.44 114.92 179.098 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.82 -38.23 64.62 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.205 2.298 . . . . 28.37 117.205 -143.214 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.85 11.95 4.16 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 120.904 3.121 . . . . 15.0 120.904 164.66 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -106.18 172.88 6.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.39 2.595 . . . . 25.5 112.586 172.367 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -98.69 171.45 8.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.478 2.085 . . . . 11.95 115.436 176.128 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.01 -40.35 95.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.434 2.294 . . . . 10.17 109.391 173.394 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -60.41 -33.68 72.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 118.856 2.91 . . . . 13.59 118.856 173.17 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.286 28.5 m-20 -68.06 -44.78 75.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.629 1.715 . . . . 11.7 115.629 174.046 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -76.02 -32.55 59.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.424 1.489 . . . . 12.95 114.57 175.897 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t30 83.08 67.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 1 C-N-CA 131.884 4.073 . . . . 25.45 108.978 177.951 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.4 mt -101.49 118.15 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 127.485 2.314 . . . . 14.6 107.985 -177.916 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -89.25 177.92 6.48 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.097 -1.041 . . . . 33.23 110.518 -171.314 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -70.61 149.76 46.73 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.138 1.335 . . . . 25.97 110.882 175.916 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 70.03 51.41 0.41 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.778 3.231 . . . . 32.61 107.508 170.374 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -126.38 132.26 51.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.798 3.239 . . . . 10.56 115.398 -169.045 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.361 6.8 m -103.02 106.15 16.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.895 1.68 . . . . 5.33 115.48 -172.751 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 mt -83.67 156.13 22.81 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.346 3.451 . . . . 11.66 107.523 177.854 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -111.39 157.8 19.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.028 -3.545 . . . . 16.3 106.979 -174.971 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -126.85 106.86 9.63 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.923 1.344 . . . . 9.96 109.853 -169.696 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -118.88 171.49 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 100.896 -3.742 . . . . 9.76 100.896 -166.99 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 N--CA 1.43 -1.462 0 O-C-N 116.606 -3.809 . . . . 19.57 101.851 -177.54 . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 118.873 -0.585 . . . . 17.17 111.193 . . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -96.57 138.76 33.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.001 -2.312 . . . . 21.89 113.455 170.324 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.8 pt -115.04 154.15 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 127.231 2.212 . . . . 10.83 105.249 165.803 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -113.18 114.31 26.58 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.839 -1.788 . . . . 10.61 107.17 -176.991 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.8 105.93 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 105.504 -2.036 . . . . 9.13 105.504 177.784 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -101.03 152.43 20.6 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.827 -2.657 . . . . 20.55 103.827 -172.73 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -97.11 172.19 7.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.135 -0.978 . . . . 11.78 110.803 178.348 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.5 tp -45.72 -57.17 4.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.424 2.009 . . . . 19.31 116.424 170.191 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.06 -42.78 77.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 131.562 3.945 . . . . 23.14 111.235 175.13 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.1 55.86 0.47 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 126.811 3.451 . . . . 19.74 109.653 172.407 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -115.2 135.82 53.76 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.231 -2.334 . . . . 21.93 107.815 175.058 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -106.79 119.5 39.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.214 -3.429 . . . . 12.33 117.102 -164.544 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.2 mt -104.14 102.69 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 119.047 -2.283 . . . . 17.08 111.283 -172.567 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -84.76 118.27 24.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.967 1.707 . . . . 16.3 106.812 -176.714 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.415 HD11 HG13 ' A' ' 30' ' ' ILE . 58.3 mt -115.52 131.32 56.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.611 -2.556 . . . . 15.88 106.952 -173.919 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -100.06 91.04 4.6 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.727 1.751 . . . . 28.9 115.727 179.824 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.77 163.88 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 128.053 3.787 . . . . 12.05 112.208 -171.44 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -92.45 157.12 40.78 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.791 -2.443 . . . . 18.17 106.478 167.799 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.54 -3.61 14.01 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 114.748 -3.343 . . . . 8.16 111.39 176.749 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 p -87.59 -7.55 57.36 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 118.732 -2.48 . . . . 11.13 111.007 175.33 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.74 137.57 54.18 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.147 1.379 . . . . 18.03 109.531 176.127 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 p -85.28 164.11 18.22 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.341 2.256 . . . . 10.22 109.136 -173.131 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.605 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 35.8 mm -62.29 -37.83 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 O-C-N 114.669 -5.02 . . . . 12.3 110.559 178.299 . . . . . . . . 3 3 . 1 . 067 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.27 19.1 tt0 -52.54 -54.05 37.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.49 1.916 . . . . 36.51 115.421 169.463 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 15.2 t-20 -55.68 -45.76 77.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.422 1.889 . . . . 25.66 112.568 170.889 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.39 -42.95 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.294 1.438 . . . . 8.12 112.747 175.16 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -68.41 -33.45 74.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.658 2.481 . . . . 15.47 108.609 179.8 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.2 -30.75 71.67 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 116.124 1.898 . . . . 11.45 116.124 178.773 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -70.28 -33.59 71.75 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 117.234 -1.365 . . . . 24.98 112.047 173.454 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.415 HG13 HD11 ' A' ' 15' ' ' LEU . 25.6 mt -71.26 -45.62 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 119.56 1.073 . . . . 9.46 112.717 169.372 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.309 36.5 tt0 -44.04 -52.93 6.73 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.79 1.636 . . . . 14.76 115.239 166.617 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -55.7 -39.49 71.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.623 -1.923 . . . . 26.29 115.123 173.56 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -88.81 -67.74 0.82 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.338 2.018 . . . . 30.06 114.932 -165.518 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -88.78 -43.49 11.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.35 2.5 . . . . 25.19 109.552 -168.119 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.24 19.83 3.45 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.032 -1.895 . . . . 7.41 110.283 168.424 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.2 mt -90.31 120.19 69.12 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-N 121.616 2.708 . . . . 9.49 104.219 -167.501 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 23.3 Cg_endo -81.16 162.66 20.21 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 CA-C-N 123.152 2.161 . . . . 11.42 115.27 -179.88 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 19.4 Cg_endo -84.57 -8.34 9.47 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 N-CA-C 116.286 1.61 . . . . 12.0 116.286 -161.452 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -79.03 -20.88 47.86 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.101 3.137 . . . . 35.55 114.791 164.972 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -79.71 -37.66 35.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.695 2.188 . . . . 20.52 112.961 -178.306 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -102.61 136.44 42.44 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.961 -4.212 . . . . 7.13 110.211 -172.834 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -115.44 148.67 39.12 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.199 1.399 . . . . 36.39 110.346 164.826 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.9 mt -114.8 125.43 53.68 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.664 -1.607 . . . . 9.55 111.578 -178.021 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -103.8 139.14 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 125.931 2.019 . . . . 13.9 106.624 174.241 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -122.17 138.12 54.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.335 -1.793 . . . . 6.86 113.482 162.668 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.325 . . 52.26 -99.17 0.08 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.368 1.895 . . . . 11.15 112.955 -174.707 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.13 51.71 0.58 Allowed Glycine 0 N--CA 1.43 -1.748 1 O-C-N 115.468 -4.52 . . . . 13.93 108.484 169.78 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -153.83 165.26 36.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 127.408 2.475 . . . . 23.92 115.485 177.039 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -91.7 127.97 37.35 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.071 2.948 . . . . 23.23 115.7 -174.47 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.9 mt -90.79 123.9 34.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.025 -2.297 . . . . 9.11 114.453 175.099 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -97.93 131.83 44.04 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.801 2.04 . . . . 33.44 112.818 -171.793 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.605 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 1.9 m-20 -32.36 -50.04 0.22 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.382 3.873 . . . . 28.37 118.369 176.942 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.98 -12.44 76.89 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 119.133 2.413 . . . . 15.0 119.133 -174.14 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -91.23 167.78 12.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.428 -2.219 . . . . 25.5 111.35 -178.418 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 p -88.13 160.68 17.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 127.313 2.883 . . . . 11.95 112.301 173.081 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -68.01 -30.7 70.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.999 2.592 . . . . 10.17 117.999 169.031 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 29.4 m -56.19 -41.73 75.99 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 131.02 3.728 . . . . 13.59 110.062 168.352 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.95 -32.49 74.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.303 -2.123 . . . . 11.7 114.95 -176.347 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -82.8 -31.76 28.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.221 2.608 . . . . 12.95 109.448 178.7 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.6 m120 74.03 58.96 0.09 Allowed 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 129.216 4.073 . . . . 25.45 115.498 -166.845 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.7 mt -104.6 135.47 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 117.813 -3.055 . . . . 14.6 106.571 -176.748 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -117.49 -168.28 1.46 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.124 1.37 . . . . 33.23 113.348 -155.354 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -83.34 134.59 34.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.184 -2.197 . . . . 25.97 109.947 168.488 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 69.21 38.09 1.97 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.917 2.77 . . . . 32.61 113.938 -176.781 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 m -98.33 133.71 42.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.034 1.873 . . . . 10.56 107.682 -173.918 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.6 m -95.73 123.47 39.31 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.064 -1.648 . . . . 5.33 111.212 -174.236 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.5 132.93 53.68 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 130.637 3.575 . . . . 11.66 108.611 -179.339 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -104.18 105.87 16.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.298 1.863 . . . . 16.3 112.067 -175.225 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 tt -79.36 120.97 24.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.346 2.658 . . . . 9.96 111.39 -179.466 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -126.49 173.73 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.447 3.023 . . . . 9.76 104.08 -173.503 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 N--CA 1.43 -1.438 0 O-C-N 118.703 -2.498 . . . . 19.57 110.342 174.291 . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 117.505 2.409 . . . . 17.17 117.505 . . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -130.41 145.74 51.86 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.589 -0.893 . . . . 21.89 108.589 174.629 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.8 pt -139.68 162.43 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 117.64 -3.162 . . . . 10.83 107.601 174.523 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -121.09 127.21 51.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.674 -0.861 . . . . 10.61 108.674 -178.536 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.502 HG11 HD12 ' A' ' 69' ' ' LEU . 60.5 t -96.32 120.33 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 128.181 3.425 . . . . 9.13 107.959 170.231 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -125.46 145.27 50.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.524 3.059 . . . . 20.55 108.743 178.734 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 41.7 p -94.55 -161.53 0.86 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 112.405 -2.18 . . . . 11.78 113.88 174.941 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.401 ' H ' ' HB ' ' A' ' 7' ' ' THR . 9.6 tt -77.64 -47.58 18.91 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 115.555 -2.164 . . . . 19.31 109.56 -170.292 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.4 p -71.08 -47.59 57.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.347 2.022 . . . . 23.14 111.194 175.848 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.54 63.09 0.17 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.505 -2.622 . . . . 19.74 109.156 176.213 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -91.51 116.26 28.71 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.957 2.903 . . . . 21.93 111.153 167.985 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -88.29 106.82 18.47 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.083 1.765 . . . . 12.33 114.567 -173.389 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 mt -104.99 104.86 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 125.663 1.585 . . . . 17.08 107.495 -178.435 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -90.88 125.06 35.63 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 114.97 -4.831 . . . . 16.3 108.701 -172.357 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.266 87.6 mt -127.84 147.64 50.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 120.474 3.509 . . . . 15.88 120.474 -179.589 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -107.18 117.06 33.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.15 -1.426 . . . . 28.9 107.15 -166.972 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.72 158.24 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 131.414 3.886 . . . . 12.05 112.297 -170.944 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -121.11 160.36 45.61 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 114.821 -2.514 . . . . 18.17 105.773 172.73 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -72.19 -19.85 25.51 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 CA-C-N 128.496 4.07 . . . . 8.16 111.195 -159.253 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 m -84.58 3.18 38.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.885 -3.009 . . . . 11.13 112.561 -177.197 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.88 144.32 41.24 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 117.323 -1.751 . . . . 18.03 115.225 175.138 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 69.2 p -82.45 159.4 22.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.754 2.692 . . . . 10.22 113.794 -173.153 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.45 -35.89 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.896 -3.003 . . . . 12.3 113.103 176.409 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.278 54.9 tt0 -37.72 -65.07 0.35 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.119 2.568 . . . . 36.51 112.221 160.88 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -57.81 -34.91 70.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.194 2.197 . . . . 25.66 114.521 -177.642 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 t -62.63 -52.94 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.05 2.094 . . . . 8.12 110.129 179.664 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -64.31 -30.55 71.6 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.605 3.098 . . . . 15.47 113.398 -177.287 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.35 -40.28 74.23 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.575 -4.453 . . . . 11.45 113.949 179.266 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -62.56 -47.93 81.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.181 1.792 . . . . 24.98 111.079 169.516 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.444 ' HB ' HE22 ' A' ' 41' ' ' GLN . 70.9 mt -63.88 -41.55 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 127.011 2.124 . . . . 9.46 112.384 -176.094 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -62.33 -56.91 13.86 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.156 -2.215 . . . . 14.76 114.948 168.625 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.67 -40.66 92.63 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 116.274 -4.017 . . . . 26.29 116.32 -176.027 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -89.25 -64.29 1.16 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.607 -3.808 . . . . 30.06 110.407 -172.184 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -83.75 -29.6 27.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.848 -3.657 . . . . 25.19 109.286 -173.302 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.92 46.17 2.12 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 123.367 2.803 . . . . 7.41 108.724 159.779 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.2 mt -114.96 113.94 44.0 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.462 -2.051 . . . . 9.49 105.462 -176.374 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.98 156.52 34.33 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.111 2.541 . . . . 11.42 112.581 -158.957 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -80.28 -8.49 13.97 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 123.907 3.071 . . . . 12.0 108.984 -161.88 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.341 4.0 p30 -79.39 -25.47 42.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.263 1.506 . . . . 35.55 109.503 175.889 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -95.06 -38.51 10.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.208 1.48 . . . . 20.52 111.707 -166.946 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.444 HE22 ' HB ' ' A' ' 30' ' ' ILE . 26.4 pt20 -83.57 147.2 27.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.488 -2.007 . . . . 7.13 114.038 178.034 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -144.55 145.18 31.69 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 99.998 -4.075 . . . . 36.39 99.998 166.055 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.97 130.61 55.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.739 -1.226 . . . . 9.55 113.696 179.645 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.5 138.86 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 103.264 -2.865 . . . . 13.9 103.264 173.148 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.437 ' HB2' HD11 ' A' ' 50' ' ' LEU . 86.3 t80 -126.53 119.05 26.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.931 -1.486 . . . . 6.86 109.099 169.964 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.11 -54.13 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 132.614 4.365 . . . . 11.15 116.108 -163.558 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.99 19.56 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 127.953 2.692 . . . . 13.93 112.08 177.417 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -104.36 146.16 29.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.051 -2.203 . . . . 23.92 105.051 164.012 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.257 10.8 tt0 -87.45 125.09 34.08 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.281 1.832 . . . . 23.23 111.969 176.241 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 45' ' ' PHE . 64.2 mt -97.08 107.29 19.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.53 2.048 . . . . 9.11 116.53 -170.619 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -69.49 141.75 53.87 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.055 2.097 . . . . 33.44 113.92 -173.904 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -24.34 -75.95 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 1 N-CA-C 123.682 4.697 . . . . 28.37 123.682 176.251 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.91 28.54 14.01 Favored Glycine 0 N--CA 1.43 -1.737 1 O-C-N 114.817 -4.927 . . . . 15.0 113.003 -157.186 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -107.79 153.79 22.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.015 1.388 . . . . 25.5 113.366 177.566 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -90.39 161.07 15.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 115.504 -2.479 . . . . 11.95 109.242 -172.21 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.42 -31.45 69.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.996 2.119 . . . . 10.17 113.045 170.311 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.27 8.6 t -55.34 -59.2 5.12 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 131.05 3.74 . . . . 13.59 116.744 167.489 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.8 -33.72 74.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.386 3.106 . . . . 11.7 119.386 172.531 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -82.77 3.62 28.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.718 -3.114 . . . . 12.95 114.506 174.577 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 65.84 30.21 10.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.864 3.666 . . . . 25.45 114.965 172.668 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -91.05 104.88 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.485 -2.634 . . . . 14.6 115.657 -173.517 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -101.6 -178.16 3.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.084 1.897 . . . . 33.23 112.757 -169.462 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.329 15.1 pttp -54.38 146.92 14.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.893 1.812 . . . . 25.97 115.893 -172.113 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 39.79 45.57 1.5 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.368 2.267 . . . . 32.61 116.933 -166.407 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 m -84.05 138.3 33.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.584 3.564 . . . . 10.56 108.051 178.265 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 m -84.46 111.09 19.16 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 110.649 -2.978 . . . . 5.33 109.37 176.356 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.401 9.2 mp -94.65 119.73 33.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.166 -3.459 . . . . 11.66 118.467 172.12 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -93.53 99.26 11.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.195 2.902 . . . . 16.3 105.964 -172.411 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.502 HD12 HG11 ' A' ' 5' ' ' VAL . 7.8 tt -82.65 116.83 22.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.559 -2.564 . . . . 9.96 109.929 174.516 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.272 2.7 m -114.89 166.04 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 124.65 2.167 . . . . 9.76 112.997 -167.169 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 N--CA 1.431 -1.425 0 O-C-N 118.018 -2.926 . . . . 19.57 115.156 173.313 . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 122.77 1.271 . . . . 17.17 114.182 . . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -105.78 124.0 48.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.353 3.461 . . . . 21.89 108.068 -163.333 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.301 13.1 pt -118.18 163.55 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 128.723 2.809 . . . . 10.83 114.606 179.311 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -133.73 117.6 17.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.206 -2.809 . . . . 10.61 112.274 -164.572 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.78 114.31 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 124.546 2.117 . . . . 9.13 106.932 -174.127 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -94.71 136.77 34.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.071 -1.643 . . . . 20.55 109.112 177.37 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.262 7.8 p -80.24 -169.62 2.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.613 1.965 . . . . 11.78 112.917 -177.82 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.29 -56.88 4.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.213 1.006 . . . . 19.31 113.238 166.029 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.3 p -61.45 -62.44 1.82 Allowed 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 115.416 1.636 . . . . 23.14 115.416 -173.458 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.89 40.66 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 122.935 1.297 . . . . 19.74 116.152 -170.692 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -118.11 140.72 49.36 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.241 -1.741 . . . . 21.93 112.024 172.069 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.8 m -117.12 115.05 24.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.532 -1.655 . . . . 12.33 106.532 -178.409 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -98.1 126.43 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 124.983 1.427 . . . . 17.08 109.564 -170.98 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -96.82 135.43 38.8 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.667 -2.521 . . . . 16.3 105.903 178.474 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.489 HD11 HG13 ' A' ' 30' ' ' ILE . 11.7 mt -125.67 155.77 40.32 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 103.918 -2.623 . . . . 15.88 103.918 173.706 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -118.62 132.38 56.18 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.853 -1.536 . . . . 28.9 106.853 167.961 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -148.73 165.03 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 126.322 2.263 . . . . 12.05 105.336 -162.563 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -117.93 145.37 36.57 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 127.72 2.408 . . . . 18.17 106.224 173.872 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.5 -24.1 31.24 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 124.944 3.763 . . . . 8.16 115.288 -165.562 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -77.91 -0.51 27.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.926 2.641 . . . . 11.13 117.027 173.326 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -90.55 152.31 20.96 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.675 -1.89 . . . . 18.03 112.082 177.924 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.9 p -82.22 174.85 10.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.175 2.287 . . . . 10.22 117.175 -177.992 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mm -69.17 -32.26 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.695 2.798 . . . . 12.3 103.647 175.962 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.83 -31.19 66.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 124.396 3.271 . . . . 36.51 119.288 174.557 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -76.62 -30.4 56.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.178 2.191 . . . . 25.66 109.156 179.757 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.496 HG21 HD21 ' A' ' 56' ' ' LEU . 59.8 t -76.46 -38.59 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 115.651 -2.118 . . . . 8.12 108.316 177.222 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -60.77 -57.49 12.46 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 125.17 1.543 . . . . 15.47 110.81 175.564 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.22 -48.02 17.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.984 2.914 . . . . 11.45 115.089 169.923 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HB3' HD22 ' A' ' 15' ' ' LEU . 38.1 mttt -75.16 -30.28 60.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 121.265 1.848 . . . . 24.98 114.304 -179.27 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.489 HG13 HD11 ' A' ' 15' ' ' LEU . 44.1 mt -55.84 -56.36 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 114.103 1.149 . . . . 9.46 114.103 161.209 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -45.49 -45.55 13.26 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.179 2.592 . . . . 14.76 112.11 179.328 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -59.29 -34.95 72.91 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.454 2.761 . . . . 26.29 118.454 173.233 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -71.93 -72.61 0.22 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.074 1.879 . . . . 30.06 116.074 166.846 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -87.89 -30.65 19.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 119.877 3.288 . . . . 25.19 119.877 -176.432 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.66 73.44 0.98 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 123.926 1.848 . . . . 7.41 115.1 -173.226 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.507 HD13 HG21 ' A' ' 36' ' ' ILE . 94.3 mt -124.91 127.73 25.04 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-O 112.36 -3.686 . . . . 9.49 105.51 178.515 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -63.94 146.94 92.0 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 127.782 3.815 . . . . 11.42 114.98 -166.714 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.29 -20.98 36.33 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 119.718 2.93 . . . . 12.0 119.718 179.058 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -81.3 -30.13 34.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.854 3.216 . . . . 35.55 113.05 172.999 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -71.97 -47.6 50.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.897 -3.627 . . . . 20.52 113.041 175.396 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -72.54 161.56 30.63 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 116.079 -4.138 . . . . 7.13 116.818 -179.808 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -147.22 136.93 22.97 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.136 2.174 . . . . 36.39 111.988 170.864 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 mt -105.33 122.38 45.83 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 116.333 -1.794 . . . . 9.55 114.505 178.822 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mm -93.6 140.74 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 131.607 3.963 . . . . 13.9 111.026 167.753 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -134.71 117.22 15.8 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.118 2.967 . . . . 6.86 112.503 167.158 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.84 -105.74 0.23 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.134 2.574 . . . . 11.15 111.531 -159.853 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.81 27.24 5.47 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.838 -1.164 . . . . 13.93 114.65 -172.337 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -153.69 141.87 20.45 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 126.535 3.064 . . . . 23.92 110.64 -179.706 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.45 165.06 23.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 112.469 -2.151 . . . . 23.23 112.605 172.879 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.363 12.0 mt -110.1 161.78 15.21 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.766 -1.834 . . . . 9.11 110.049 -172.665 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -108.47 132.5 53.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.38 2.3 . . . . 33.44 109.971 179.228 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -45.48 -50.49 12.66 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 122.379 4.214 . . . . 28.37 122.379 -169.022 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.51 14.52 45.99 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 111.701 -2.5 . . . . 15.0 113.848 -175.664 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -99.37 155.15 17.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 116.902 -1.523 . . . . 25.5 111.747 174.744 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.9 p -87.34 161.46 17.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.129 1.518 . . . . 11.95 109.63 -177.119 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.496 HD21 HG21 ' A' ' 26' ' ' VAL . 14.7 mt -57.38 -44.38 84.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.961 2.791 . . . . 10.17 112.897 169.592 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -64.76 -15.45 61.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.303 -3.998 . . . . 13.59 115.486 -179.663 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -79.96 -44.7 19.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.57 -2.581 . . . . 11.7 110.583 179.951 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -85.6 -4.18 59.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.056 1.408 . . . . 12.95 112.64 174.746 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.435 22.9 m120 82.62 36.32 0.06 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.091 -3.505 . . . . 25.45 108.97 171.127 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.3 mt -89.44 98.12 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 119.601 -1.937 . . . . 14.6 109.277 -176.482 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -86.68 -172.25 3.92 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 117.341 2.348 . . . . 33.23 117.341 -171.044 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -73.26 138.74 45.7 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.941 0.877 . . . . 25.97 112.149 176.697 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 62.86 12.51 5.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.801 -2.437 . . . . 32.61 116.793 -171.977 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m -78.04 134.88 37.7 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 119.8 3.259 . . . . 10.56 119.8 169.019 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -87.16 123.84 32.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.676 1.58 . . . . 5.33 109.549 -177.061 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -93.49 163.36 13.6 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.339 -2.1 . . . . 11.66 114.518 153.755 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -123.62 119.23 29.25 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.778 -1.556 . . . . 16.3 114.556 177.583 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.82 128.97 35.66 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 117.956 -1.021 . . . . 9.96 111.373 177.517 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 m -127.43 -167.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 127.648 3.092 . . . . 9.76 107.281 179.707 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 tp . . . . . 0 N--CA 1.43 -1.475 0 N-CA-C 105.744 -1.947 . . . . 19.57 105.744 -172.665 . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttm . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 107.315 -1.365 . . . . 17.17 107.315 . . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -100.19 161.17 13.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.891 -3.63 . . . . 21.89 111.506 169.734 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 65' ' ' SER . 12.4 pt -152.96 157.7 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 129.083 2.953 . . . . 10.83 110.401 172.587 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.29 108.46 16.59 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 114.917 -4.864 . . . . 10.61 113.148 -172.557 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.3 t -103.13 114.59 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.596 -2.565 . . . . 9.13 109.705 -176.667 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -98.06 146.02 25.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.625 1.678 . . . . 20.55 114.163 -173.863 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.311 81.4 p -86.56 -176.84 5.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.75 1.262 . . . . 11.78 109.41 172.678 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.4 tp -68.32 -62.37 1.43 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.692 2.797 . . . . 19.31 110.49 168.114 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -60.79 -68.77 0.27 Allowed 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.857 -3.652 . . . . 23.14 119.409 176.418 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.4 46.28 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 O-C-N 116.549 -3.844 . . . . 19.74 109.611 -173.552 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -118.88 141.15 48.91 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.673 -0.898 . . . . 21.93 110.415 157.95 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -110.41 124.9 52.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.612 -1.625 . . . . 12.33 106.612 169.077 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mt -84.39 108.6 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 128.437 2.695 . . . . 17.08 107.994 169.188 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.4 m -96.64 97.94 9.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.128 -2.858 . . . . 16.3 111.95 -176.405 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.18 147.18 25.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.149 -2.844 . . . . 15.88 112.053 -169.125 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -111.16 133.05 53.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.485 1.612 . . . . 28.9 111.992 162.07 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.04 158.08 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 2 CA-C-N 107.04 -4.618 . . . . 12.05 111.592 -167.441 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -95.71 160.86 29.37 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 123.925 0.766 . . . . 18.17 112.035 159.145 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -87.85 -2.35 7.29 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 124.498 2.642 . . . . 8.16 108.689 -175.561 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -81.8 -18.38 44.24 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.396 3.078 . . . . 11.13 111.709 170.208 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.24 153.08 34.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.019 1.489 . . . . 18.03 115.019 177.327 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.7 p -89.69 172.76 8.71 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.532 1.133 . . . . 10.22 110.468 -173.967 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -70.24 -24.32 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 118.526 -1.27 . . . . 12.3 111.597 171.26 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.53 -39.7 85.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.76 1.267 . . . . 36.51 113.414 171.336 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -65.53 -37.28 86.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.359 -3.963 . . . . 25.66 114.035 167.735 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 22' ' ' THR . 79.0 t -73.85 -34.18 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 122.716 2.507 . . . . 8.12 108.746 -171.679 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -67.88 -41.26 83.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.147 3.779 . . . . 15.47 108.557 172.837 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.54 -33.52 66.9 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.713 2.405 . . . . 11.45 112.403 -177.666 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -61.97 -33.73 74.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.715 -3.116 . . . . 24.98 114.597 166.887 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.4 mt -73.0 -41.69 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 117.034 -1.46 . . . . 9.46 110.333 173.157 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -56.98 -42.12 79.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.606 2.362 . . . . 14.76 113.797 178.407 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.01 -43.46 82.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 112.974 -3.393 . . . . 26.29 110.825 179.806 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -100.79 -43.13 6.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 124.395 3.27 . . . . 30.06 118.33 -173.209 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -91.75 -38.06 12.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 123.461 0.705 . . . . 25.19 109.429 -175.977 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.27 21.84 9.12 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 120.373 -1.454 . . . . 7.41 114.61 170.847 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -91.73 122.44 65.53 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 113.392 -3.194 . . . . 9.49 109.263 -175.718 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.87 147.72 85.45 Favored 'Trans proline' 0 N--CA 1.434 -2.014 1 CA-C-N 129.786 4.531 . . . . 11.42 114.501 -179.972 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -79.58 -8.42 14.8 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 122.395 2.063 . . . . 12.0 112.792 -162.61 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -83.84 -34.65 24.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.999 -3.563 . . . . 35.55 109.065 179.045 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -83.87 -28.41 28.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 131.072 3.749 . . . . 20.52 112.04 -167.696 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -92.05 155.5 18.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.584 2.611 . . . . 7.13 112.793 166.3 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -142.16 142.45 32.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.052 -2.28 . . . . 36.39 109.998 167.708 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.5 mt -101.1 111.14 23.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 116.561 2.06 . . . . 9.55 116.561 176.904 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.7 mm -95.71 132.1 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 126.432 2.332 . . . . 13.9 111.705 172.148 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -111.86 123.0 49.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.818 2.723 . . . . 6.86 105.949 169.677 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.451 . . 59.61 -99.36 0.09 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 116.255 -1.831 . . . . 11.15 115.66 -170.338 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.98 18.39 4.5 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 106.426 -2.669 . . . . 13.93 106.426 179.67 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -124.21 130.42 52.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.236 2.214 . . . . 23.92 110.301 -173.636 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -91.3 125.72 36.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.342 -2.096 . . . . 23.23 105.342 -169.977 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.533 HD22 ' CD2' ' A' ' 59' ' ' TYR . 92.9 mt -86.28 148.5 25.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.095 0.958 . . . . 9.11 112.275 -179.296 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -123.42 148.76 45.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.182 -2.824 . . . . 33.44 116.87 -171.171 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -19.15 -76.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 133.491 4.716 . . . . 28.37 121.387 178.691 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.49 16.22 61.19 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 117.458 1.743 . . . . 15.0 117.458 -168.474 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -99.11 160.99 13.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.955 -2.497 . . . . 25.5 110.32 167.351 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -103.76 168.26 9.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 104.792 -2.299 . . . . 11.95 104.792 -178.829 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -55.88 -36.59 67.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.617 -2.083 . . . . 10.17 115.994 167.768 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 t -61.63 -43.69 98.38 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.123 -2.861 . . . . 13.59 117.114 167.35 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -64.64 -26.64 68.48 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.095 1.887 . . . . 11.7 116.095 -177.182 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.533 ' CD2' HD22 ' A' ' 50' ' ' LEU . 66.9 m-85 -83.94 -32.34 25.12 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 116.912 -3.618 . . . . 12.95 111.043 170.717 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.301 26.2 m120 96.25 51.83 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.98 2.112 . . . . 25.45 114.379 -175.271 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.78 125.63 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 125.067 1.48 . . . . 14.6 113.96 177.837 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -110.03 177.27 4.76 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.972 1.841 . . . . 33.23 115.972 -176.957 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -60.41 145.75 46.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 124.404 3.275 . . . . 25.97 119.066 -174.54 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 67.74 32.19 5.52 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 132.129 4.171 . . . . 32.61 111.466 178.558 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.468 ' H ' HG22 ' A' ' 3' ' ' ILE . 22.7 t -89.35 151.7 21.93 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.685 -3.134 . . . . 10.56 110.145 -174.95 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -92.2 120.81 33.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.88 2.072 . . . . 5.33 112.584 -172.32 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -117.77 159.99 22.11 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.222 2.915 . . . . 11.66 105.582 172.758 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -116.99 117.51 29.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.45 -3.281 . . . . 16.3 113.577 177.503 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -91.72 116.46 28.9 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.168 -1.583 . . . . 9.96 111.191 174.487 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.6 m -112.27 134.15 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 127.819 2.448 . . . . 9.76 106.193 178.551 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 124.309 2.004 . . . . 19.57 106.481 -175.783 . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 117.454 2.39 . . . . 17.17 117.454 . . . . . . . . . 0 0 . 1 . 071 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -90.36 133.49 34.95 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.07 -4.769 . . . . 21.89 106.708 -179.462 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.8 pt -118.04 164.89 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 104.456 -2.424 . . . . 10.83 104.456 163.369 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -119.29 127.29 53.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.885 -2.416 . . . . 10.61 105.038 -174.561 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.5 139.13 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.159 -2.534 . . . . 9.13 104.159 176.202 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -125.23 133.63 52.64 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.325 -3.36 . . . . 20.55 116.029 178.742 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.2 p -77.98 171.79 14.47 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 127.128 3.347 . . . . 11.78 111.277 175.558 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -79.35 -24.05 42.98 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.514 -2.13 . . . . 19.31 110.95 -172.993 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -77.21 -69.16 0.55 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.902 1.334 . . . . 23.14 108.338 170.181 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.23 66.19 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 O-C-N 119.143 -2.223 . . . . 19.74 112.018 169.303 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -99.76 134.26 42.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.54 1.536 . . . . 21.93 114.041 155.686 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.7 m -80.06 119.91 23.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.357 -1.464 . . . . 12.33 113.124 164.597 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.49 95.67 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 128.519 2.727 . . . . 17.08 107.53 -171.844 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.0 m -89.82 99.23 12.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.206 -1.035 . . . . 16.3 108.206 -165.137 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.295 47.0 mt -104.49 149.12 25.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.602 -3.186 . . . . 15.88 110.653 -170.788 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -108.0 123.33 48.49 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 121.66 2.027 . . . . 28.9 113.664 173.356 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -135.27 162.53 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.582 -1.948 . . . . 12.05 107.262 -164.839 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -101.69 165.31 14.24 Favored Pre-proline 0 N--CA 1.429 -1.486 0 O-C-N 118.421 -2.674 . . . . 18.17 108.334 165.299 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -64.06 -23.71 67.13 Favored 'Trans proline' 0 C--N 1.3 -2.012 2 C-N-CA 125.721 4.281 . . . . 8.16 112.597 174.053 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 m -87.68 3.15 48.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.987 -1.695 . . . . 11.13 109.907 -174.627 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -88.89 148.02 24.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.331 1.062 . . . . 18.03 109.286 -178.286 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 p -91.76 169.47 10.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.01 -1.904 . . . . 10.22 110.048 -175.828 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -46.65 -49.83 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.972 2.509 . . . . 12.3 114.46 160.513 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.301 23.8 tt0 -42.53 -43.21 3.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 117.03 2.233 . . . . 36.51 117.03 165.577 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -69.22 -30.32 68.46 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.402 1.91 . . . . 25.66 112.637 172.78 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.1 -56.2 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.568 -3.833 . . . . 8.12 113.585 175.909 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -49.15 -46.13 44.75 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 130.439 3.496 . . . . 15.47 112.292 171.592 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.8 -36.95 76.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.339 -3.35 . . . . 11.45 114.828 -178.419 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -68.63 -33.8 74.64 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.986 1.476 . . . . 24.98 114.986 173.507 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.5 mt -70.39 -42.77 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.662 -4.399 . . . . 9.46 111.167 175.528 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -55.75 -43.24 76.47 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.97 -1.706 . . . . 14.76 110.001 170.358 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.263 21.5 t70 -48.95 -67.31 0.28 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.075 3.35 . . . . 26.29 114.683 177.751 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -93.99 -46.66 7.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.061 2.986 . . . . 30.06 119.061 178.847 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.98 -33.08 70.08 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 116.283 -1.818 . . . . 25.19 111.294 -171.591 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.74 18.68 46.99 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 116.446 -2.308 . . . . 7.41 115.213 -179.164 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.4 mt -99.71 121.38 54.69 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 119.737 1.768 . . . . 9.49 108.879 175.158 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -68.36 157.07 63.38 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 122.982 2.455 . . . . 11.42 117.958 178.328 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.02 -28.53 10.97 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 122.417 2.078 . . . . 12.0 111.675 -170.083 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.64 -31.43 68.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 126.108 2.13 . . . . 35.55 110.427 173.41 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -72.64 -15.95 61.71 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.363 -2.711 . . . . 20.52 115.413 -175.488 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -118.15 161.08 20.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.695 2.497 . . . . 7.13 112.563 -168.999 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -138.09 133.66 33.74 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.772 -1.566 . . . . 36.39 106.772 164.223 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.29 129.72 43.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.932 -2.355 . . . . 9.55 107.306 178.666 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.7 mm -116.04 133.58 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.366 -1.459 . . . . 13.9 109.898 -178.579 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -114.26 115.31 27.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.088 -3.508 . . . . 6.86 108.143 165.032 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.25 -83.46 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.273 2.323 . . . . 11.15 117.273 -176.385 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.25 -36.7 5.6 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 116.981 -3.574 . . . . 13.93 111.444 -178.328 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -105.42 148.49 27.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.62 1.341 . . . . 23.92 114.62 -162.599 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 49' ' ' GLN . 23.4 pt20 -92.95 131.15 38.21 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.126 -4.734 . . . . 23.23 108.592 173.403 . . . . . . . . 3 3 . 1 . 071 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.9 mt -74.25 143.3 45.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.531 1.678 . . . . 9.11 115.531 -176.584 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.56 133.49 55.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.231 -1.543 . . . . 33.44 108.043 -168.739 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -30.72 -53.58 0.19 Allowed 'General case' 0 N--CA 1.429 -1.476 1 N-CA-C 124.261 4.912 . . . . 28.37 124.261 -173.014 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.98 17.41 44.94 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 121.305 1.866 . . . . 15.0 116.23 -160.443 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -115.71 145.15 43.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.869 -2.491 . . . . 25.5 113.449 -173.341 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.352 5.8 p -82.5 165.91 19.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 122.486 2.403 . . . . 11.95 114.354 -171.855 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.6 mt -78.14 -22.11 49.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.158 -2.214 . . . . 10.17 112.69 177.947 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.267 3.7 t -70.31 -37.84 74.83 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 127.937 3.732 . . . . 13.59 114.983 175.32 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -55.97 -43.78 77.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.891 2.876 . . . . 11.7 111.205 164.605 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -86.62 -3.22 59.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.484 1.661 . . . . 12.95 115.484 -176.736 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 m120 54.96 51.61 13.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.529 2.732 . . . . 25.45 112.12 -178.298 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.6 mt -103.28 116.6 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 116.92 -3.612 . . . . 14.6 106.566 173.223 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -94.44 -160.32 0.77 Allowed 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.581 -2.574 . . . . 33.23 109.214 178.944 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -83.11 161.61 21.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.12 -1.067 . . . . 25.97 108.12 -173.143 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.357 27.9 mt-10 55.42 28.65 11.89 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.752 2.421 . . . . 32.61 112.97 178.336 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.1 t -87.93 154.6 20.38 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.662 1.985 . . . . 10.56 113.191 172.27 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.306 1.3 m -121.45 90.34 3.3 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 125.481 1.738 . . . . 5.33 113.603 -160.342 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -92.53 150.78 20.54 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.815 2.245 . . . . 11.66 107.604 176.65 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -116.67 139.31 50.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.001 2.81 . . . . 16.3 108.271 -176.964 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.25 113.87 27.32 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.301 -2.227 . . . . 9.96 113.373 170.449 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 m -110.14 171.44 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 113.086 -1.87 . . . . 9.76 106.443 175.194 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt . . . . . 0 N--CA 1.43 -1.433 0 O-C-N 119.393 -2.067 . . . . 19.57 112.431 172.227 . . . . . . . . 0 0 . 1 . 072 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 105.93 -1.878 . . . . 17.17 105.93 . . . . . . . . . 0 0 . 1 . 072 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -108.46 158.8 17.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.041 -2.577 . . . . 21.89 104.041 168.088 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -125.78 172.04 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.097 2.959 . . . . 10.83 105.511 171.585 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -123.9 146.78 48.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.71 -1.869 . . . . 10.61 109.808 167.906 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.3 125.88 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.587 1.955 . . . . 9.13 106.153 175.71 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -105.67 140.66 38.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.187 1.47 . . . . 20.55 107.326 177.51 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -81.89 -164.07 0.75 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.034 2.35 . . . . 11.78 112.429 172.364 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.3 tp -82.93 -48.47 10.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.364 -3.335 . . . . 19.31 114.613 177.121 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.7 p -65.86 -40.94 92.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.325 -1.484 . . . . 23.14 113.288 171.033 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.07 62.57 0.26 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 117.768 1.867 . . . . 19.74 117.768 175.41 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -112.48 145.97 39.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.096 -1.816 . . . . 21.93 106.096 167.495 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.2 m -112.73 106.62 15.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 101.908 -3.367 . . . . 12.33 101.908 -166.315 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.8 mt -92.1 117.62 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 101.186 -3.635 . . . . 17.08 101.186 -172.317 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.9 m -94.05 130.11 40.33 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 116.795 -1.962 . . . . 16.3 109.976 174.628 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -129.9 142.63 50.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 124.649 1.218 . . . . 15.88 111.058 178.301 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -97.1 128.25 43.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.4 -2.687 . . . . 28.9 114.811 179.673 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.481 HG21 HD13 ' A' ' 56' ' ' LEU 0.263 6.9 m -149.22 176.85 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.123 -1.611 . . . . 12.05 111.424 -174.068 . . . . . . . . 3 3 . 1 . 072 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -110.74 179.64 0.78 Allowed Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.845 1.202 . . . . 18.17 111.663 168.123 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -71.2 -22.56 25.55 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-N 123.274 2.205 . . . . 8.16 109.019 173.886 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 m -95.36 1.75 54.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.04 1.4 . . . . 11.13 110.534 -165.052 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.19 139.6 31.55 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.227 -4.671 . . . . 18.03 108.705 -176.419 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 79.6 p -76.4 166.58 23.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.129 1.159 . . . . 10.22 114.129 173.021 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.1 mm -70.5 -18.86 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 119.345 -0.942 . . . . 12.3 108.785 -179.127 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -69.54 -31.16 69.19 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.39 -2.694 . . . . 36.51 115.245 172.635 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -66.1 -42.13 89.7 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.788 2.835 . . . . 25.66 109.461 167.676 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.63 -51.2 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 125.546 1.779 . . . . 8.12 110.835 176.237 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.63 -19.97 64.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.789 1.774 . . . . 15.47 115.789 -174.697 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.78 -27.54 66.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.48 1.912 . . . . 11.45 114.764 172.488 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -93.4 -20.52 20.26 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.321 -1.733 . . . . 24.98 106.321 -176.269 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 30' ' ' ILE . 75.3 mt -75.12 -44.43 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 119.927 -1.733 . . . . 9.46 113.557 167.307 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -56.91 -30.6 64.1 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.253 -2.78 . . . . 14.76 114.428 167.31 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.4 -52.88 14.05 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.627 -4.421 . . . . 26.29 108.523 178.53 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -66.13 -59.76 3.46 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.519 2.415 . . . . 30.06 117.519 172.23 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -97.53 -11.97 23.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 119.142 3.016 . . . . 25.19 119.142 -169.215 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.87 27.05 65.45 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 118.198 -2.814 . . . . 7.41 115.489 -176.442 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -103.23 109.38 61.55 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 108.207 -1.035 . . . . 9.49 108.207 -174.613 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -76.73 166.79 26.52 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.669 1.989 . . . . 11.42 116.14 -167.253 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.02 -20.86 16.41 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 123.126 2.152 . . . . 12.0 114.77 -156.277 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -83.61 -17.49 41.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.817 3.198 . . . . 35.55 114.795 178.686 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.423 ' HG2' HD22 ' A' ' 71' ' ' LEU . 49.4 tt0 -79.1 -31.72 44.37 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.844 2.59 . . . . 20.52 105.39 -179.53 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -111.41 176.01 5.19 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.589 1.995 . . . . 7.13 115.285 -170.426 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -131.8 146.09 51.94 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 113.02 -3.371 . . . . 36.39 109.649 169.887 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 43' ' ' LEU . 8.1 mt -109.16 134.5 51.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.723 1.889 . . . . 9.55 106.649 172.449 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mm -121.23 143.17 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.697 -2.705 . . . . 13.9 103.697 -169.576 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -130.31 100.79 5.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.491 2.716 . . . . 6.86 113.519 163.748 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.52 -107.28 0.19 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.997 1.719 . . . . 11.15 110.768 -165.708 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.29 -20.96 10.38 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-O 115.958 -2.579 . . . . 13.93 111.042 177.044 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -77.54 122.1 24.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.31 3.433 . . . . 23.92 104.772 -170.293 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -89.02 138.22 31.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.629 -3.169 . . . . 23.23 107.004 178.605 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.7 mt -106.03 127.68 53.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.112 -3.492 . . . . 9.11 112.673 -161.236 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -77.37 146.14 36.84 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.187 2.595 . . . . 33.44 105.74 -175.111 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -65.74 -45.51 82.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.302 -2.124 . . . . 28.37 112.684 -171.667 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.82 41.85 2.98 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 117.496 -1.724 . . . . 15.0 114.354 177.883 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -124.75 157.5 35.56 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 119.884 1.842 . . . . 25.5 108.584 168.315 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 44.0 p -91.16 164.16 14.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.028 -3.545 . . . . 11.95 117.085 -177.204 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.481 HD13 HG21 ' A' ' 17' ' ' VAL . 24.9 mt -54.36 -43.57 71.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.505 -1.68 . . . . 10.17 112.677 163.77 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -55.39 -42.29 73.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.286 -3.384 . . . . 13.59 118.271 167.596 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -56.97 -39.28 74.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.865 -1.772 . . . . 11.7 113.712 179.237 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -83.65 -13.58 53.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.599 1.333 . . . . 12.95 114.599 175.446 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.55 52.34 4.64 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.084 1.883 . . . . 25.45 116.084 -167.384 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.296 11.8 mt -87.64 123.78 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 102.276 -3.231 . . . . 14.6 102.276 176.733 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.273 23.1 mt-30 -100.92 179.76 4.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.621 -1.924 . . . . 33.23 114.709 179.427 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -64.3 147.17 53.09 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.585 -2.572 . . . . 25.97 110.691 -174.097 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 48.76 37.51 9.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.156 2.583 . . . . 32.61 116.883 179.899 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 t -108.19 151.36 26.03 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.487 1.915 . . . . 10.56 108.621 -169.366 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.324 41.1 p -102.23 115.52 30.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.642 -2.536 . . . . 5.33 111.099 -165.587 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.51 149.52 21.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.419 3.088 . . . . 11.66 103.429 172.39 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -114.6 130.8 56.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.695 -1.253 . . . . 16.3 108.94 178.366 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tt -105.18 120.93 42.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.004 1.722 . . . . 9.96 110.249 -178.437 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 147.53 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 101.74 -3.43 . . . . 9.76 101.74 -177.212 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.423 HD22 ' HG2' ' A' ' 40' ' ' GLN . 16.5 mt . . . . . 0 N--CA 1.43 -1.432 0 CA-C-O 123.87 1.795 . . . . 19.57 109.101 177.892 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttp . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 124.829 2.252 . . . . 17.17 113.606 . . . . . . . . . 0 0 . 1 . 073 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -89.46 126.28 35.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 126.29 2.948 . . . . 21.89 111.897 178.834 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -128.31 147.22 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 116.83 -3.669 . . . . 10.83 109.199 176.364 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 53.0 m-85 -100.79 137.86 38.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.34 3.856 . . . . 10.61 105.87 175.669 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.45 110.46 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 117.076 -1.44 . . . . 9.13 111.106 170.743 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -93.61 143.22 26.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 116.813 -1.565 . . . . 20.55 111.122 -176.167 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.526 HG22 HD23 ' A' ' 69' ' ' LEU . 42.6 p -96.53 174.16 6.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.807 1.64 . . . . 11.78 107.1 -175.488 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.84 -51.3 70.32 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.744 -2.472 . . . . 19.31 114.617 177.582 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.1 p -67.32 -40.25 85.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.584 1.953 . . . . 23.14 115.841 172.351 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.15 59.89 0.3 Allowed Glycine 0 N--CA 1.43 -1.748 0 O-C-N 127.309 2.88 . . . . 19.74 114.315 151.449 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -95.17 126.27 40.38 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 115.625 -2.131 . . . . 21.93 108.638 163.667 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.7 m -95.8 113.22 24.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 116.916 -1.914 . . . . 12.33 107.025 179.271 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.1 pt -91.59 141.29 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.997 1.719 . . . . 17.08 107.374 178.276 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.1 m -107.3 124.97 50.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.749 -1.22 . . . . 16.3 111.529 178.821 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.25 141.87 51.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.725 -2.484 . . . . 15.88 106.445 177.876 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -108.47 107.76 18.42 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.885 2.474 . . . . 28.9 107.172 179.246 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.87 -177.52 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.733 -2.321 . . . . 12.05 104.733 -173.006 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -104.96 159.2 30.15 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 129.759 3.224 . . . . 18.17 108.475 170.49 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -81.04 -10.11 12.71 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 123.409 2.74 . . . . 8.16 110.989 -172.051 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -94.68 2.2 55.57 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.227 2.829 . . . . 11.13 111.965 175.685 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -75.83 161.61 28.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 123.749 2.977 . . . . 18.03 111.945 178.415 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.6 p -87.31 164.64 16.16 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.398 -2.689 . . . . 10.22 116.633 179.479 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.15 -39.6 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 120.194 1.361 . . . . 12.3 109.005 174.473 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -53.43 -45.08 69.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.429 -2.045 . . . . 36.51 111.684 174.304 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -58.31 -42.64 87.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.863 2.542 . . . . 25.66 117.863 170.489 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.8 -54.22 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.301 -2.75 . . . . 8.12 109.011 171.434 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HA ' HD12 ' A' ' 30' ' ' ILE . 34.7 mtmt -58.87 -28.18 65.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 116.768 -3.707 . . . . 15.47 118.449 -177.153 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.16 94.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.498 2.719 . . . . 11.45 113.471 168.211 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -71.43 -39.34 71.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.526 -2.609 . . . . 24.98 111.661 -178.663 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 27' ' ' LYS . 21.3 mt -60.52 -36.87 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.228 2.611 . . . . 9.46 109.1 173.771 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -66.85 -52.08 47.84 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.923 1.344 . . . . 14.76 113.432 175.882 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -50.53 -45.31 56.69 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.932 -2.98 . . . . 26.29 115.889 170.177 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -79.95 -51.61 8.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.777 -3.077 . . . . 30.06 115.404 -165.891 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -102.02 -30.9 10.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.428 1.091 . . . . 25.19 110.673 -175.107 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.55 34.08 5.92 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 127.977 2.703 . . . . 7.41 110.182 164.805 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.0 mt -91.64 125.15 58.59 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 127.194 2.197 . . . . 9.49 106.021 -174.809 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.65 171.57 4.43 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 126.233 3.262 . . . . 11.42 115.511 -179.234 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -76.41 -27.17 8.04 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 124.209 3.273 . . . . 12.0 114.059 -173.678 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -81.6 -20.32 40.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.951 -3.593 . . . . 35.55 114.618 -173.504 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -86.0 -45.93 11.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.505 1.922 . . . . 20.52 110.613 179.913 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -51.23 113.32 0.91 Allowed 'General case' 0 N--CA 1.43 -1.452 1 N-CA-C 123.674 4.694 . . . . 7.13 123.674 163.153 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -117.0 119.58 35.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.562 -2.586 . . . . 36.39 109.198 157.494 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.38 128.34 39.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.196 -2.275 . . . . 9.55 109.565 -177.441 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 44' ' ' ILE 0.29 23.8 mm -118.58 148.99 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.942 2.897 . . . . 13.9 105.637 -177.684 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.401 ' HB3' ' H ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -85.19 -83.58 0.16 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.1 0.864 . . . . 6.86 112.459 177.252 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 45' ' ' PHE . . . -98.93 -71.16 0.7 Allowed 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 106.651 -1.611 . . . . 11.15 106.651 166.668 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.2 -4.52 5.45 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 119.983 2.753 . . . . 13.93 119.983 172.652 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -101.69 160.18 14.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 112.485 -1.858 . . . . 23.92 115.435 171.918 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -87.66 170.77 10.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.828 -2.42 . . . . 23.23 115.999 -171.269 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.3 mt -131.23 105.81 7.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.995 1.379 . . . . 9.11 108.683 176.086 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -72.76 140.51 47.81 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 121.711 3.967 . . . . 33.44 121.711 166.153 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -36.93 -66.3 0.24 Allowed 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 135.199 5.4 . . . . 28.37 119.958 -170.462 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.88 13.25 9.08 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 129.841 3.591 . . . . 15.0 116.857 -165.458 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -117.61 141.95 47.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.33 1.452 . . . . 25.5 111.989 -168.064 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.0 p -87.22 161.51 17.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.643 2.639 . . . . 11.95 111.03 -179.937 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 61' ' ' ILE . 1.1 mt -49.09 -50.52 36.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.923 3.289 . . . . 10.17 113.565 176.126 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 t -50.58 -48.71 57.55 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 129.544 4.277 . . . . 13.59 115.585 172.416 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -61.06 -38.56 86.63 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.514 1.926 . . . . 11.7 112.219 177.276 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -85.8 -2.04 57.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.92 2.563 . . . . 12.95 117.92 171.483 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m120 65.82 48.47 1.86 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 127.278 2.861 . . . . 25.45 113.055 176.31 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 56' ' ' LEU . 82.4 mt -94.57 108.0 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.942 3.297 . . . . 14.6 103.555 177.133 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -101.6 176.88 5.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.069 2.366 . . . . 33.23 110.871 177.568 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -60.61 146.18 46.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.713 -3.117 . . . . 25.97 117.124 -173.18 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.306 35.5 mt-10 71.94 -1.26 2.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 127.025 2.703 . . . . 32.61 117.25 174.09 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.316 56.0 m -48.39 138.56 9.95 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.37 2.668 . . . . 10.56 116.833 162.549 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.479 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 24.4 m -103.13 124.96 49.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.124 -1.61 . . . . 5.33 111.007 167.253 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.73 169.28 8.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.858 -2.645 . . . . 11.66 103.858 -177.955 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -139.37 132.44 29.58 Favored 'General case' 0 N--CA 1.43 -1.444 1 CA-C-O 130.053 4.74 . . . . 16.3 113.324 -169.868 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.526 HD23 HG22 ' A' ' 7' ' ' THR . 34.8 tp -115.81 107.74 15.43 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.387 -2.696 . . . . 9.96 107.385 -168.187 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.6 172.09 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 2 C-N-CA 132.415 4.286 . . . . 9.76 112.012 -171.011 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 N--CA 1.429 -1.481 0 CA-C-O 123.016 1.388 . . . . 19.57 112.463 -178.73 . . . . . . . . 0 0 . 1 . 074 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 CA--C 1.49 -1.346 0 CA-C-O 125.05 2.357 . . . . 17.17 110.327 . . . . . . . . . 0 0 . 1 . 074 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -92.13 150.84 20.71 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.566 -2.753 . . . . 21.89 103.566 -177.821 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -127.37 155.32 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.797 1.239 . . . . 10.83 109.848 159.736 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -105.82 158.05 17.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.649 -1.282 . . . . 10.61 109.174 174.649 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -148.32 120.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 N-CA-C 99.302 -4.333 . . . . 9.13 99.302 -178.213 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -108.82 121.78 45.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.41 2.284 . . . . 20.55 116.978 -178.512 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -73.21 -178.41 2.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.222 1.963 . . . . 11.78 113.68 -169.074 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.257 15.1 tp -51.88 -57.04 10.54 Favored 'General case' 0 N--CA 1.431 -1.401 1 C-N-CA 134.109 4.964 . . . . 19.31 108.942 178.356 . . . . . . . . 3 2 . 1 . 074 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -73.28 -54.11 9.19 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.44 -4.537 . . . . 23.14 112.444 175.595 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.11 45.61 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 114.245 -3.531 . . . . 19.74 113.104 177.983 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -96.01 100.54 12.2 Favored 'General case' 0 N--CA 1.43 -1.472 2 C-N-CA 132.072 4.149 . . . . 21.93 103.536 178.097 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -82.87 102.21 11.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.7 2.0 . . . . 12.33 106.186 -177.975 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.255 3.5 pt -90.28 170.09 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 128.492 2.717 . . . . 17.08 106.327 178.584 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 m -121.53 149.91 42.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.085 3.354 . . . . 16.3 105.981 177.061 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.7 mt -143.38 145.09 32.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.013 -2.304 . . . . 15.88 105.18 171.954 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -106.11 104.84 14.64 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.142 1.925 . . . . 28.9 111.723 -177.936 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.251 20.9 m -120.38 128.67 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.171 -1.58 . . . . 12.05 114.57 -162.041 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -88.62 134.93 33.07 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 104.515 -2.402 . . . . 18.17 104.515 171.89 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.87 -0.52 10.01 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 120.864 1.344 . . . . 8.16 114.241 -171.087 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 m -70.07 -26.36 63.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.252 3.056 . . . . 11.13 119.252 169.308 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -81.79 176.36 9.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.761 1.393 . . . . 18.03 114.761 179.347 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -76.38 157.14 32.63 Favored 'General case' 0 N--CA 1.43 -1.455 1 N-CA-C 123.324 4.564 . . . . 10.22 123.324 173.371 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -73.66 -28.08 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 117.746 -3.096 . . . . 12.3 113.307 173.614 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -52.08 -36.48 50.83 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 116.742 -3.724 . . . . 36.51 113.551 163.583 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -80.02 -22.08 42.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.803 1.641 . . . . 25.66 115.17 -177.811 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.47 -49.78 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 119.96 3.319 . . . . 8.12 119.96 153.673 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.251 55.9 mtmt -70.98 -30.37 66.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.299 1.039 . . . . 15.47 113.199 -175.773 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.81 78.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.117 -1.615 . . . . 11.45 112.296 175.796 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 35.3 tptt -77.69 -21.52 51.9 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.548 1.139 . . . . 24.98 112.423 -175.766 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.7 mt -74.06 -40.75 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 128.061 2.545 . . . . 9.46 109.013 170.389 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -65.86 -32.72 74.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.188 1.555 . . . . 14.76 111.999 177.71 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.35 -58.16 4.05 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.19 -2.194 . . . . 26.29 112.28 172.59 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -57.72 -60.82 3.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 119.883 3.29 . . . . 30.06 119.883 -177.975 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -101.8 -48.34 4.31 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.575 3.15 . . . . 25.19 108.311 -171.248 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.11 24.59 5.66 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 127.375 2.417 . . . . 7.41 118.593 177.554 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.0 mt -92.04 103.94 9.44 Favored Pre-proline 0 N--CA 1.43 -1.453 1 CA-C-O 111.516 -4.088 . . . . 9.49 108.476 -170.711 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.51 154.16 72.27 Favored 'Trans proline' 0 N--CA 1.434 -2.002 1 CA-C-N 130.542 4.801 . . . . 11.42 116.481 -168.31 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.32 -19.88 60.11 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 N-CA-C 119.048 2.672 . . . . 12.0 119.048 -174.344 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.35 -21.03 53.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 122.221 2.282 . . . . 35.55 115.106 173.04 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -83.27 -13.01 56.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.379 1.992 . . . . 20.52 116.379 168.865 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 75.6 mt-30 -96.17 119.15 34.14 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.199 -4.063 . . . . 7.13 111.225 -173.638 . . . . . . . . 3 2 . 1 . 074 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -90.95 116.86 29.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 101.639 -3.467 . . . . 36.39 101.639 164.584 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 tp -105.58 113.91 27.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.623 2.011 . . . . 9.55 110.946 -179.799 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -116.2 152.54 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 125.572 2.606 . . . . 13.9 104.625 -164.748 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -82.41 -80.49 0.16 Allowed 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.199 -4.063 . . . . 6.86 112.789 162.871 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.3 -72.71 0.7 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.193 2.197 . . . . 11.15 109.001 172.105 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.97 -27.32 4.91 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 125.951 2.973 . . . . 13.93 117.144 174.085 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -106.64 150.83 25.82 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.366 -2.255 . . . . 23.92 109.786 -165.76 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -102.19 144.77 30.31 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.018 -2.926 . . . . 23.23 106.629 -170.197 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.1 mt -77.84 145.65 36.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.462 -2.608 . . . . 9.11 111.19 179.764 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.55 151.59 27.41 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.105 1.362 . . . . 33.44 110.211 -175.256 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.36 -59.51 4.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.541 2.736 . . . . 28.37 112.24 -161.422 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.08 33.12 5.8 Favored Glycine 0 N--CA 1.43 -1.741 0 O-C-N 116.635 -3.791 . . . . 15.0 116.442 -168.912 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -121.76 160.47 24.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.518 -1.66 . . . . 25.5 106.518 174.363 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.4 p -104.56 173.47 6.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.95 2.786 . . . . 11.95 117.194 -174.32 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.6 -25.56 41.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.073 -2.267 . . . . 10.17 114.046 -177.926 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.7 m -59.58 -59.14 5.91 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.661 1.696 . . . . 13.59 110.789 168.523 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -67.0 -32.56 73.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.347 -2.096 . . . . 11.7 114.494 -173.186 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -69.43 -19.36 63.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.257 1.823 . . . . 12.95 113.019 171.902 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.299 42.5 m-80 58.98 50.36 8.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.514 1.926 . . . . 25.45 114.962 -173.232 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 mt -95.43 125.76 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.296 -1.372 . . . . 14.6 107.296 174.516 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -85.48 174.0 9.82 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.481 -3.887 . . . . 33.23 109.998 177.393 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -72.53 152.5 41.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 125.125 2.393 . . . . 25.97 113.881 174.016 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.52 41.48 30.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.664 3.586 . . . . 32.61 111.232 -171.564 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.5 t -107.73 142.05 38.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 127.22 3.39 . . . . 10.56 103.048 -179.062 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.9 m -98.94 123.56 43.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 110.632 -2.985 . . . . 5.33 114.175 -179.119 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.6 mt -95.9 144.12 26.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.041 2.829 . . . . 11.66 108.045 174.838 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -111.14 124.89 53.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.414 -2.679 . . . . 16.3 114.449 -169.44 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.9 mt -100.78 126.86 47.38 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.123 1.44 . . . . 9.96 110.441 -179.584 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.04 177.82 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.411 -1.329 . . . . 9.76 107.411 162.539 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp . . . . . 0 N--CA 1.43 -1.44 0 O-C-N 119.463 -2.023 . . . . 19.57 106.827 175.123 . . . . . . . . 0 0 . 1 . 075 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.329 4.1 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 122.438 1.113 . . . . 17.17 109.809 . . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -113.83 145.32 41.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.283 1.516 . . . . 21.89 107.237 177.684 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -123.75 -175.1 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 119.793 -1.817 . . . . 10.83 107.423 160.224 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.294 0.7 OUTLIER -129.59 140.21 51.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 127.013 2.695 . . . . 10.61 109.051 171.146 . . . . . . . . 3 3 . 1 . 075 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.58 137.52 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 1 O-C-N 114.382 -5.199 . . . . 9.13 111.819 169.353 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -100.66 115.29 29.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 124.215 3.189 . . . . 20.55 109.783 162.352 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 p -67.41 -164.7 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 127.459 2.975 . . . . 11.78 116.692 -169.458 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.32 -56.54 17.45 Favored 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 131.922 4.089 . . . . 19.31 110.232 -179.487 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 p -76.35 -41.89 46.7 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.776 2.227 . . . . 23.14 111.601 -176.53 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.28 72.78 0.39 Allowed Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 127.405 2.431 . . . . 19.74 114.417 -174.419 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.33 80.1 tttt -135.34 124.4 24.31 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.421 1.088 . . . . 21.93 108.107 170.785 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -88.11 118.12 27.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.95 -2.968 . . . . 12.33 112.125 -179.21 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.5 pt -111.69 148.02 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 O-C-N 115.788 -4.32 . . . . 17.08 109.53 -173.829 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -98.21 137.55 36.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.839 -1.541 . . . . 16.3 106.839 -177.363 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -124.57 159.01 31.61 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.476 2.31 . . . . 15.88 107.185 178.994 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -123.06 126.85 47.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.508 -2.034 . . . . 28.9 105.508 173.986 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.07 169.18 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.032 -2.581 . . . . 12.05 104.032 -174.269 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -109.16 156.95 38.38 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 125.338 1.455 . . . . 18.17 107.938 165.077 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.19 -16.03 31.77 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 116.711 -1.726 . . . . 8.16 114.106 176.942 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -72.7 -15.54 61.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.437 -1.32 . . . . 11.13 107.437 179.586 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -76.83 141.27 40.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.354 -2.716 . . . . 18.03 115.466 -170.961 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -70.58 168.51 16.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 121.67 3.952 . . . . 10.22 121.67 170.685 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.37 5.7 mm -62.43 -40.45 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.444 -1.41 . . . . 12.3 111.816 174.173 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -51.02 -31.84 19.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.48 2.03 . . . . 36.51 116.48 168.051 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -81.81 -29.42 32.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.024 -1.048 . . . . 25.66 111.097 176.665 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.27 4.0 t -62.1 -54.1 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 124.754 1.221 . . . . 8.12 109.529 174.613 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -56.38 -37.45 70.12 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.824 2.157 . . . . 15.47 116.824 176.565 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.72 81.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.83 2.159 . . . . 11.45 116.83 175.284 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -71.71 -29.01 64.08 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 117.076 2.25 . . . . 24.98 117.076 168.888 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.342 48.5 mt -73.11 -43.25 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.191 -1.781 . . . . 9.46 106.191 172.734 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -67.77 -26.67 66.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.734 2.124 . . . . 14.76 116.734 178.72 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.99 -51.53 25.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.484 -1.689 . . . . 26.29 114.117 169.381 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -64.99 -66.08 0.59 Allowed 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 131.78 4.032 . . . . 30.06 115.64 -179.896 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -95.71 -25.97 15.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.515 1.672 . . . . 25.19 115.515 -172.872 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.07 -27.51 8.56 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 120.75 -1.219 . . . . 7.41 115.385 -178.967 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.3 mt -52.38 125.59 35.48 Favored Pre-proline 0 N--CA 1.43 -1.451 1 C-N-CA 131.807 4.043 . . . . 9.49 109.237 -172.512 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.65 164.33 24.3 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-O 115.324 -2.032 . . . . 11.42 115.18 -178.44 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -80.98 -16.98 9.7 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 126.245 3.266 . . . . 12.0 114.239 -177.219 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -86.3 -5.1 59.25 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.876 -2.39 . . . . 35.55 106.865 -175.259 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.62 -28.19 22.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.046 -2.284 . . . . 20.52 112.278 171.676 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -88.05 123.13 32.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.961 1.097 . . . . 7.13 113.961 -165.182 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -114.92 117.19 29.97 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.045 2.138 . . . . 36.39 115.365 160.86 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.17 112.89 24.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.565 1.65 . . . . 9.55 109.31 -169.079 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -100.43 143.85 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 O-C-N 115.828 -4.295 . . . . 13.9 107.297 175.841 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -81.06 -92.07 0.06 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.106 1.763 . . . . 6.86 112.35 169.848 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.28 -48.97 3.85 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 121.199 1.818 . . . . 11.15 109.51 162.017 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.9 9.12 0.73 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 119.792 -1.818 . . . . 13.93 115.607 -177.419 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -112.17 134.89 53.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.806 -1.924 . . . . 23.92 105.806 175.613 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -74.49 148.32 41.1 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.815 -1.803 . . . . 23.23 112.125 168.765 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 mt -91.83 127.0 37.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.016 -2.303 . . . . 9.11 105.865 -177.486 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -79.46 131.89 36.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.412 1.885 . . . . 33.44 113.734 177.878 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -51.7 -51.91 52.39 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.343 2.257 . . . . 28.37 111.77 -162.189 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.94 9.56 59.82 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 119.741 -1.849 . . . . 15.0 116.927 -174.862 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -101.57 158.62 15.95 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.453 -3.969 . . . . 25.5 112.545 177.334 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -84.15 158.1 21.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.365 1.866 . . . . 11.95 112.402 -178.09 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -62.41 -32.14 72.94 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.676 -4.39 . . . . 10.17 111.294 164.749 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -57.86 -45.72 85.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.592 2.357 . . . . 13.59 116.648 174.252 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.98 -35.56 76.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.81 -1.541 . . . . 11.7 114.447 -178.444 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -79.79 2.9 21.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.263 -1.523 . . . . 12.95 111.839 169.698 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.7 t30 40.79 40.93 1.06 Allowed 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.582 2.353 . . . . 25.45 116.006 -168.761 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.8 mt -74.74 126.08 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 104.324 -2.473 . . . . 14.6 104.324 175.452 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -115.21 165.75 12.59 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 132.636 4.374 . . . . 33.23 114.191 179.881 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.345 45.8 pttt -55.25 157.67 3.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.498 3.519 . . . . 25.97 115.213 -172.829 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 75.01 0.22 3.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.98 2.112 . . . . 32.61 113.977 168.63 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t -91.61 157.44 16.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.72 -2.488 . . . . 10.56 110.771 -173.287 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -99.55 116.83 32.59 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 127.043 2.715 . . . . 5.33 109.416 178.459 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.7 mt -99.98 152.61 19.99 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.073 1.749 . . . . 11.66 107.817 174.297 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -116.03 142.68 46.48 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.614 -1.624 . . . . 16.3 106.614 -166.659 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tp -111.41 112.16 23.72 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 115.832 -4.293 . . . . 9.96 111.383 -175.541 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.86 139.03 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.67 -2.345 . . . . 9.76 104.67 -173.701 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 tp . . . . . 0 N--CA 1.43 -1.433 0 O-C-N 118.558 -2.589 . . . . 19.57 114.217 177.53 . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 109.464 -0.569 . . . . 17.17 109.464 . . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -75.43 126.4 30.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.709 -1.244 . . . . 21.89 112.736 -179.06 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -107.73 141.27 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 125.277 2.465 . . . . 10.83 104.902 151.552 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 43.3 m-85 -101.06 144.48 29.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.876 -2.39 . . . . 10.61 107.007 165.665 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.287 58.1 t -106.54 124.0 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 116.735 -1.602 . . . . 9.13 111.772 169.484 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -102.41 113.92 27.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 119.701 1.137 . . . . 20.55 111.825 -178.181 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.374 3.1 p -63.5 -174.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.135 2.642 . . . . 11.78 118.135 176.509 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.4 mt -81.54 -60.28 2.32 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.236 -2.79 . . . . 19.31 110.819 175.944 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.297 62.2 p -71.89 -64.45 0.93 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 116.062 -1.923 . . . . 23.14 114.566 -174.188 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.18 54.72 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.765 1 CA-C-N 126.13 4.059 . . . . 19.74 114.639 -175.584 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -135.49 138.46 43.15 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 128.057 2.857 . . . . 21.93 107.847 -176.192 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.288 72.9 m -139.79 107.58 5.66 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.225 -2.139 . . . . 12.33 105.225 -179.874 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 17.9 pt -112.36 161.06 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 124.254 1.978 . . . . 17.08 108.345 -166.692 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 m -117.38 126.78 53.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.726 -1.859 . . . . 16.3 111.885 -174.54 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -111.06 163.11 14.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.988 -1.07 . . . . 15.88 110.992 172.543 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -116.4 110.15 18.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.859 -2.275 . . . . 28.9 104.859 179.395 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.46 154.08 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.047 -2.283 . . . . 12.05 113.437 -176.833 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -97.34 153.08 38.53 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 114.862 -2.494 . . . . 18.17 113.973 167.142 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -59.96 -22.04 67.26 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-N 125.728 3.081 . . . . 8.16 116.856 -179.834 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -76.72 -9.04 58.39 Favored 'General case' 0 N--CA 1.43 -1.457 1 C-N-CA 132.073 4.149 . . . . 11.13 116.875 170.758 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.72 127.5 33.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.77 -3.706 . . . . 18.03 114.971 175.583 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.291 45.1 p -68.53 159.09 32.51 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.257 2.623 . . . . 10.22 112.719 179.045 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.259 45.2 mm -57.25 -35.33 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.27 1.828 . . . . 12.3 112.461 168.021 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -60.79 -52.9 63.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.206 1.821 . . . . 36.51 115.337 173.46 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.271 33.0 m-80 -60.65 -36.05 77.72 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 115.34 -2.267 . . . . 25.66 113.328 174.497 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.421 50.1 t -46.81 -48.02 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 131.262 3.825 . . . . 8.12 113.905 167.781 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -76.01 -20.72 57.59 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.79 -1.55 . . . . 15.47 110.868 -169.887 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.77 -28.75 55.82 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 112.631 0.604 . . . . 11.45 112.631 174.293 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -70.03 -32.45 70.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.471 0.915 . . . . 24.98 113.471 173.181 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -69.95 -35.0 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 123.936 1.827 . . . . 9.46 109.594 172.33 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -69.63 -29.11 66.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.878 -2.389 . . . . 14.76 113.508 174.205 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.5 -54.3 21.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.289 -2.132 . . . . 26.29 112.604 168.575 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -64.38 -63.35 1.16 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 117.229 -1.367 . . . . 30.06 109.599 -175.955 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.74 -48.53 7.79 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.298 2.333 . . . . 25.19 117.298 177.916 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.46 52.02 1.63 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 117.474 -3.266 . . . . 7.41 115.585 -171.915 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.0 mt -113.99 127.72 26.53 Favored Pre-proline 0 N--CA 1.43 -1.44 1 N-CA-C 99.132 -4.396 . . . . 9.49 99.132 -169.399 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -72.7 157.86 51.47 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 O-C-N 117.053 -2.13 . . . . 11.42 109.075 -170.335 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -77.38 -29.1 5.07 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 C-N-CA 125.027 3.818 . . . . 12.0 111.639 -153.001 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.16 -26.79 42.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 130.579 3.552 . . . . 35.55 108.3 175.367 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -80.19 -26.99 38.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.477 -3.89 . . . . 20.52 111.596 -176.078 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -71.48 138.55 49.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.386 2.041 . . . . 7.13 110.314 174.685 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -142.16 137.42 30.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.881 -2.387 . . . . 36.39 110.676 161.519 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -104.34 135.19 46.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.434 2.54 . . . . 9.55 111.933 178.654 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mm -111.25 138.92 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.408 -1.724 . . . . 13.9 110.957 163.823 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.31 5.6 t80 -70.09 -87.82 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.892 1.677 . . . . 6.86 109.742 167.762 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.23 -62.94 1.41 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 121.179 -0.951 . . . . 11.15 108.867 165.873 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.86 -24.87 2.21 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.033 1.778 . . . . 13.93 110.333 177.311 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.269 0.1 OUTLIER -74.36 123.52 24.78 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.147 -1.427 . . . . 23.92 107.147 -178.047 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.269 16.2 pt20 -70.39 122.09 18.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.786 2.554 . . . . 23.23 111.137 164.292 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.3 mt -95.37 150.45 20.26 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 118.343 -2.723 . . . . 9.11 111.282 -171.354 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -120.14 141.37 49.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.801 3.191 . . . . 33.44 116.019 -169.263 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.01 -52.97 56.71 Favored 'General case' 0 N--CA 1.43 -1.451 2 O-C-N 115.653 -4.404 . . . . 28.37 112.943 -156.988 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.88 29.59 7.85 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 124.216 3.189 . . . . 15.0 115.034 -169.862 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 -114.88 147.3 40.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.2 2.2 . . . . 25.5 109.332 177.359 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 p -94.19 173.04 7.84 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 129.584 3.154 . . . . 11.95 112.229 179.37 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.5 mt -86.28 -18.17 32.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 104.498 -2.408 . . . . 10.17 104.498 -173.259 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.18 -41.47 77.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.397 -2.064 . . . . 13.59 110.137 168.617 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.71 -41.43 92.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.95 2.1 . . . . 11.7 112.676 -177.585 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -78.44 -28.72 46.73 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 115.575 -2.45 . . . . 12.95 116.563 173.142 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.288 29.8 t30 74.5 56.36 0.08 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.63 3.172 . . . . 25.45 112.544 -168.242 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.562 HD13 HD21 ' A' ' 67' ' ' LEU . 31.4 mt -99.9 101.94 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 104.435 -2.432 . . . . 14.6 104.435 170.898 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -100.35 -156.28 0.55 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.522 2.329 . . . . 33.23 108.084 -172.113 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -61.41 157.6 16.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.905 -3.622 . . . . 25.97 119.336 174.799 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 71.78 15.98 5.73 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.016 -1.053 . . . . 32.61 112.603 163.623 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -101.22 142.78 32.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.742 2.526 . . . . 10.56 108.371 -156.999 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.3 m -111.58 129.26 56.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.8 -3.687 . . . . 5.33 107.09 -178.3 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.562 HD21 HD13 ' A' ' 61' ' ' ILE . 66.8 mt -103.61 164.09 11.89 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.31 -1.366 . . . . 11.66 107.31 168.715 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -122.13 124.16 43.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.729 2.412 . . . . 16.3 110.966 -177.936 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.1 tp -106.01 110.78 23.16 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.598 -1.939 . . . . 9.96 109.379 -172.032 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 m -114.53 174.38 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 117.966 -2.959 . . . . 9.76 107.207 -174.743 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 123.621 1.677 . . . . 19.57 111.007 168.151 . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 ttp . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 115.505 1.669 . . . . 17.17 115.505 . . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -93.47 133.33 36.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.057 2.208 . . . . 21.89 107.923 -175.522 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.85 150.83 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.655 -2.528 . . . . 10.83 111.106 175.126 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.433 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 21.2 m-85 -112.31 100.68 8.99 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.61 2.364 . . . . 10.61 116.896 176.867 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.3 t -92.63 114.86 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 120.294 -0.562 . . . . 9.13 111.227 179.731 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -98.88 125.03 44.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.067 -2.896 . . . . 20.55 112.662 177.269 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.539 HG22 HD23 ' A' ' 69' ' ' LEU . 82.3 p -84.24 -179.07 7.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.488 -1.233 . . . . 11.78 113.481 -179.373 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 tt -50.72 -47.94 59.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.045 3.338 . . . . 19.31 112.573 179.405 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -93.15 -66.8 0.9 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.049 2.139 . . . . 23.14 107.287 -165.752 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.56 75.57 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 104.062 -3.615 . . . . 19.74 104.062 161.9 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -115.15 116.97 29.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.839 -0.8 . . . . 21.93 108.839 164.001 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.285 28.1 m -83.87 93.94 8.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.098 2.559 . . . . 12.33 109.689 173.907 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 mt -85.78 105.45 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 123.769 1.747 . . . . 17.08 107.394 -174.922 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -87.07 110.4 20.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.054 -4.154 . . . . 16.3 108.37 179.98 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.05 140.62 47.69 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.944 -1.873 . . . . 15.88 105.944 176.272 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -104.23 131.2 51.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.32 1.057 . . . . 28.9 111.812 167.781 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.24 178.94 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 115.142 -0.936 . . . . 12.05 109.529 -178.612 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -85.1 163.15 46.82 Favored Pre-proline 0 N--CA 1.429 -1.479 0 O-C-N 118.426 -2.671 . . . . 18.17 110.949 163.98 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.257 0.1 OUTLIER -76.24 -12.35 19.16 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 125.148 2.874 . . . . 8.16 114.169 179.812 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -102.89 2.53 35.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.421 2.325 . . . . 11.13 108.063 -168.617 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -76.33 154.62 34.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.017 1.858 . . . . 18.03 116.017 169.298 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -93.06 169.65 10.25 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.823 2.527 . . . . 10.22 117.823 -179.316 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.54 -42.72 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 126.026 2.079 . . . . 12.3 116.185 -178.627 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 5.7 mm-40 -29.47 -50.3 0.1 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.9 2.48 . . . . 36.51 114.791 158.446 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.41 -37.91 63.23 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.161 -2.212 . . . . 25.66 108.092 -175.899 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.74 -43.46 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 124.379 2.038 . . . . 8.12 111.613 176.083 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 50.0 mtpt -62.78 -36.79 84.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.276 -2.14 . . . . 15.47 115.392 173.659 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.46 89.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.994 2.518 . . . . 11.45 113.176 175.473 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -71.45 -30.3 65.87 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 124.391 1.076 . . . . 24.98 110.083 -178.095 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.5 mt -71.39 -39.15 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.327 -1.306 . . . . 9.46 111.274 174.092 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -62.92 -40.59 98.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.887 -2.383 . . . . 14.76 109.35 170.476 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.19 -43.82 63.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 115.952 -1.975 . . . . 26.29 110.681 -171.664 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' HB3' ' HG2' ' A' ' 34' ' ' GLU 0.303 28.8 tptt -69.25 -51.14 40.53 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.554 1.645 . . . . 30.06 113.516 -176.785 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HB3' ' A' ' 33' ' ' LYS . 76.8 mm-40 -106.02 -32.7 8.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.268 3.027 . . . . 25.19 113.833 -157.818 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.42 56.71 4.17 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 128.429 2.919 . . . . 7.41 113.329 -175.072 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mt -110.87 124.19 33.58 Favored Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 103.824 -2.658 . . . . 9.49 103.824 -178.456 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.98 139.62 85.71 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 124.071 3.181 . . . . 11.42 117.085 175.589 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.95 -14.84 45.69 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 C-N-CA 127.422 5.415 . . . . 12.0 111.474 -174.757 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.401 2.5 p30 -81.37 -24.73 36.84 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.119 2.266 . . . . 35.55 117.119 178.351 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -75.72 -25.15 56.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 126.248 2.217 . . . . 20.52 116.83 167.142 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -79.51 121.72 25.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.638 2.459 . . . . 7.13 117.638 -179.043 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -128.4 151.6 49.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.438 -2.664 . . . . 36.39 107.137 157.493 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.6 mt -131.12 143.57 50.74 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.332 2.015 . . . . 9.55 111.089 -169.943 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.4 mm -120.65 140.74 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.401 3.08 . . . . 13.9 105.476 -176.28 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -104.16 -55.02 2.44 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 124.404 2.049 . . . . 6.86 108.93 155.643 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.66 107.62 3.22 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.488 -2.008 . . . . 11.15 107.716 -176.661 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.81 -69.96 0.75 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 126.634 2.064 . . . . 13.93 116.619 175.853 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -96.3 166.95 11.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 119.138 1.469 . . . . 23.92 114.254 -175.727 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -60.39 139.11 57.84 Favored 'General case' 0 N--CA 1.43 -1.47 1 N-CA-C 123.489 4.626 . . . . 23.23 123.489 172.887 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.2 mt -83.4 120.42 25.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.825 1.65 . . . . 9.11 114.759 173.642 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -89.25 155.09 19.61 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.682 -2.511 . . . . 33.44 110.075 -174.803 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.09 -53.72 49.22 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.165 1.786 . . . . 28.37 112.999 -158.433 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.15 36.23 4.54 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 117.673 -1.626 . . . . 15.0 114.273 -173.71 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -107.2 147.39 30.2 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.401 -2.074 . . . . 25.5 105.401 174.171 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.315 32.2 p -77.89 169.74 17.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.179 1.55 . . . . 11.95 112.272 -178.48 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.08 -30.99 55.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 113.953 -1.476 . . . . 10.17 109.17 178.999 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -66.49 -49.87 65.16 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 131.039 3.736 . . . . 13.59 110.233 179.155 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 33.1 t70 -56.63 -43.3 80.12 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.137 -2.227 . . . . 11.7 116.553 174.796 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -69.72 -27.61 65.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 124.952 1.408 . . . . 12.95 110.176 176.778 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 70.69 46.6 0.51 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 129.045 2.938 . . . . 25.45 107.795 -175.509 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.15 119.9 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 112.249 -2.25 . . . . 14.6 106.58 162.578 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -107.64 -176.15 2.98 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.802 2.441 . . . . 33.23 111.205 -174.987 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.276 54.7 pttt -69.92 135.03 49.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.661 -1.899 . . . . 25.97 115.099 -172.024 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 73.46 38.62 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.109 2.164 . . . . 32.61 109.809 179.9 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.6 m -94.21 150.76 20.01 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 112.865 -6.147 . . . . 10.56 110.15 -169.95 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.433 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 99.0 m -98.63 123.35 42.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.33 -2.731 . . . . 5.33 105.244 -175.717 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.27 4.8 mp -116.03 148.21 40.42 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.676 -3.14 . . . . 11.66 109.746 168.9 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -95.05 121.87 37.12 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.157 1.932 . . . . 16.3 114.716 173.185 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.539 HD23 HG22 ' A' ' 7' ' ' THR 0.274 44.5 tp -81.62 114.89 20.61 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.489 -4.507 . . . . 9.96 113.385 171.27 . . . . . . . . 4 3 . 1 . 077 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.86 157.09 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.695 2.043 . . . . 9.76 113.951 -178.529 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.1 tp . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 112.942 0.719 . . . . 19.57 112.942 177.148 . . . . . . . . 0 0 . 1 . 078 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 120.007 3.336 . . . . 17.17 120.007 . . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -94.08 136.48 34.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.675 -1.972 . . . . 21.89 105.675 -164.98 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 15' ' ' LEU . 7.0 pt -132.09 162.19 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 128.161 2.585 . . . . 10.83 110.731 168.666 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -113.58 143.29 44.81 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 124.346 2.022 . . . . 10.61 109.221 175.457 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -133.62 115.47 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.175 -4.703 . . . . 9.13 104.881 175.832 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -94.01 126.89 39.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.911 -1.885 . . . . 20.55 105.911 179.013 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 69' ' ' LEU . 2.1 p -72.56 168.52 18.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.603 -1.936 . . . . 11.78 115.175 171.911 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.0 tp -66.82 -47.49 71.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.275 -1.515 . . . . 19.31 110.837 -175.463 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -73.58 -50.1 22.93 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.286 1.835 . . . . 23.14 115.068 -179.055 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.53 49.75 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 114.924 -3.513 . . . . 19.74 115.403 -169.906 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -138.71 137.17 36.54 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 116.945 -1.902 . . . . 21.93 110.698 165.047 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -95.82 103.24 15.11 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 125.224 1.577 . . . . 12.33 108.588 172.529 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.98 120.05 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.974 -2.954 . . . . 17.08 111.786 177.641 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -99.28 120.55 39.73 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.915 -3.616 . . . . 16.3 102.396 -176.069 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.425 ' HB2' HG13 ' A' ' 3' ' ' ILE . 14.4 mt -122.77 168.95 11.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.376 3.071 . . . . 15.88 110.883 -170.538 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -135.58 120.42 18.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.635 1.574 . . . . 28.9 107.5 179.859 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.82 168.81 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.302 -2.481 . . . . 12.05 104.302 -172.972 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.266 32.4 mt-10 -106.14 170.83 5.37 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 117.822 -3.048 . . . . 18.17 110.188 162.045 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 68.9 Cg_endo -81.11 5.04 6.5 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 CA-C-N 121.983 1.744 . . . . 8.16 112.101 -179.325 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -93.95 -16.03 24.35 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.133 2.573 . . . . 11.13 108.797 -179.089 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -80.5 142.24 34.4 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.88 1.218 . . . . 18.03 113.497 -173.078 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -74.79 159.03 32.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.684 -1.885 . . . . 10.22 111.3 176.489 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mm -49.35 -40.72 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 119.425 -2.047 . . . . 12.3 115.042 170.059 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -47.82 -50.02 27.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 115.227 -2.321 . . . . 36.51 115.782 167.529 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -68.28 -29.68 68.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 123.496 2.862 . . . . 25.66 115.337 177.013 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.87 -37.62 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 115.734 -0.666 . . . . 8.12 111.487 177.059 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -58.95 -34.77 72.15 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 120.045 3.35 . . . . 15.47 120.045 163.273 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.42 -37.32 65.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.042 -2.911 . . . . 11.45 110.887 -178.133 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -52.99 -45.02 67.66 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.17 2.188 . . . . 24.98 116.502 159.937 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.59 -48.09 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 1 O-C-N 115.813 -4.305 . . . . 9.46 108.625 179.236 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -49.57 -50.44 42.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.007 1.854 . . . . 14.76 116.007 169.605 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -54.07 -49.05 69.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.535 1.68 . . . . 26.29 115.535 174.044 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -67.66 -57.65 6.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.007 -1.451 . . . . 30.06 113.433 -179.676 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -95.81 -36.82 11.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.582 2.753 . . . . 25.19 112.493 -161.763 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.23 0.3 50.85 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 116.938 -2.034 . . . . 7.41 116.572 -178.116 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.3 mt -72.56 124.77 91.19 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 128.69 2.796 . . . . 9.49 108.588 179.948 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.48 160.42 9.52 Favored 'Trans proline' 0 C--N 1.3 -2.013 1 C-N-CA 126.294 4.662 . . . . 11.42 116.28 -178.555 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.19 -7.25 18.83 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 123.668 2.912 . . . . 12.0 113.964 -161.715 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -76.65 -57.23 3.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 131.069 3.748 . . . . 35.55 106.469 -179.847 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -56.98 -45.3 83.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.361 1.986 . . . . 20.52 116.361 168.82 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -62.03 110.52 1.6 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.402 -3.311 . . . . 7.13 116.715 175.451 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -110.18 130.56 55.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.119 1.437 . . . . 36.39 107.326 163.458 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.0 mt -110.83 128.77 55.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.819 2.247 . . . . 9.55 106.828 179.906 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.65 152.74 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.323 -3.36 . . . . 13.9 103.857 173.413 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -96.04 -66.96 0.87 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.806 -2.434 . . . . 6.86 104.923 162.26 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.283 . . -156.33 130.56 8.68 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 104.486 -2.413 . . . . 11.15 104.486 173.766 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.59 -49.94 1.17 Allowed Glycine 0 N--CA 1.43 -1.753 0 CA-C-O 116.863 -2.076 . . . . 13.93 112.953 154.011 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -145.13 172.55 12.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.62 2.71 . . . . 23.92 107.378 -172.476 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.256 5.4 pm0 -83.66 135.23 34.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.229 -2.17 . . . . 23.23 115.553 -175.847 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.4 mt -77.27 151.41 35.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.485 -3.259 . . . . 9.11 111.924 175.885 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB2' ' CG ' ' A' ' 54' ' ' ARG . 40.7 mt-10 -79.4 155.46 28.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.927 -2.983 . . . . 33.44 111.706 175.791 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -77.9 -43.09 31.07 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 120.83 1.65 . . . . 28.37 113.406 -173.564 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.16 29.4 11.9 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 118.462 0.574 . . . . 15.0 112.115 -175.873 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.427 ' CG ' ' HB2' ' A' ' 51' ' ' GLU . 38.0 mmt180 -114.51 149.19 36.78 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.425 -2.065 . . . . 25.5 105.425 178.025 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.286 30.1 p -100.1 176.39 5.42 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 111.568 -2.56 . . . . 11.95 117.547 -164.372 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 26.7 mt -73.8 -8.25 55.3 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.268 -3.395 . . . . 10.17 114.1 168.181 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.0 m -94.9 -28.61 15.11 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.551 -3.843 . . . . 13.59 102.332 -172.796 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -62.43 -51.71 66.43 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 131.673 3.989 . . . . 11.7 116.553 169.574 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -90.17 -6.4 55.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.361 -2.199 . . . . 12.95 111.707 -177.829 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.326 35.2 m120 72.13 36.3 1.13 Allowed 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 116.001 -4.187 . . . . 25.45 113.264 174.25 . . . . . . . . 3 2 . 1 . 078 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.77 109.19 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.72 2.408 . . . . 14.6 107.867 -172.612 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.12 -178.37 3.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.564 2.602 . . . . 33.23 111.213 -179.772 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -49.89 148.89 2.89 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 118.853 -2.404 . . . . 25.97 116.685 175.972 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 35.1 mt-10 53.48 36.97 24.57 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.302 -3.374 . . . . 32.61 118.616 -172.637 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -97.57 144.39 27.3 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.171 -2.159 . . . . 10.56 105.171 178.752 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -101.22 105.86 17.02 Favored 'General case' 0 N--CA 1.43 -1.442 1 CA-C-O 128.844 4.164 . . . . 5.33 110.583 175.595 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.57 150.3 21.79 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.542 -2.599 . . . . 11.66 111.832 173.777 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -103.36 127.5 50.7 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.825 -1.172 . . . . 16.3 112.128 178.274 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 7' ' ' THR . 15.2 tp -105.26 116.52 32.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.41 3.481 . . . . 9.96 109.347 169.947 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.76 174.16 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 112.781 -2.009 . . . . 9.76 110.996 -179.114 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.9 tp . . . . . 0 N--CA 1.43 -1.442 0 C-N-CA 127.788 2.435 . . . . 19.57 111.386 -175.748 . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 116.746 2.128 . . . . 17.17 116.746 . . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.251 85.8 mt-30 -85.05 122.23 28.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.096 1.903 . . . . 21.89 113.331 177.168 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -113.09 159.92 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.12 -2.548 . . . . 10.83 104.12 175.916 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -111.87 127.15 55.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 123.586 1.66 . . . . 10.61 109.298 -177.756 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.7 t -122.85 109.6 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.204 1.954 . . . . 9.13 110.93 179.528 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -90.48 144.2 26.02 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 113.235 -5.916 . . . . 20.55 115.914 176.054 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -85.61 164.25 17.84 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.148 2.979 . . . . 11.78 113.653 175.582 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.94 -26.23 68.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.311 -2.743 . . . . 19.31 114.795 168.401 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 38.9 p -75.38 -44.06 46.87 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.455 1.934 . . . . 23.14 112.339 178.632 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.8 38.6 0.23 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-N 115.08 -0.964 . . . . 19.74 112.291 169.458 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -103.08 125.79 49.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.188 -1.042 . . . . 21.93 108.188 172.353 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.4 m -91.66 128.05 37.35 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 102.339 -3.208 . . . . 12.33 102.339 168.965 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.254 28.7 mt -102.06 136.22 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 117.828 -3.045 . . . . 17.08 105.309 178.295 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.7 m -105.99 100.17 9.73 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 100.607 -3.849 . . . . 16.3 100.607 -175.095 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 mt -96.14 119.74 35.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.907 1.683 . . . . 15.88 110.334 -177.939 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -93.97 96.72 9.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.063 -2.569 . . . . 28.9 104.063 178.837 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.71 168.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.733 2.013 . . . . 12.05 108.831 179.178 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -116.22 154.27 48.68 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-N 120.011 1.278 . . . . 18.17 108.98 -169.98 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.79 -4.32 14.49 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 CA-C-N 122.56 1.95 . . . . 8.16 115.185 -173.127 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.4 m -88.59 -12.39 42.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 125.238 1.586 . . . . 11.13 113.987 172.431 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.67 149.78 48.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.034 -2.916 . . . . 18.03 114.511 -179.462 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.284 37.2 p -90.55 175.34 7.09 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 111.245 -2.707 . . . . 10.22 107.699 -179.105 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 mm -73.55 -27.36 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 119.456 -2.027 . . . . 12.3 109.791 171.992 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.73 -52.16 65.39 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.509 -2.619 . . . . 36.51 108.532 170.333 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -47.58 -39.86 17.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.654 2.381 . . . . 25.66 115.807 172.87 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.66 -46.63 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 127.1 3.333 . . . . 8.12 114.657 -171.572 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.46 -27.63 66.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.934 -2.979 . . . . 15.47 115.19 160.636 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.88 -19.84 60.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.369 2.35 . . . . 11.45 111.211 178.073 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -69.34 -30.53 68.58 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 112.739 -6.225 . . . . 24.98 112.373 165.449 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -87.76 -18.03 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 126.005 2.812 . . . . 9.46 113.068 174.593 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -69.67 -33.24 72.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.52 -3.863 . . . . 14.76 110.558 167.662 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.85 -54.11 12.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.202 -2.811 . . . . 26.29 110.767 178.481 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -71.31 -62.94 1.22 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.178 -1.576 . . . . 30.06 113.432 -176.774 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -91.5 -33.37 15.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.435 2.541 . . . . 25.19 110.779 -174.051 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.73 59.28 2.24 Favored Glycine 0 N--CA 1.43 -1.751 2 O-C-N 114.577 -5.077 . . . . 7.41 109.371 179.55 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 mt -118.48 146.48 39.78 Favored Pre-proline 0 N--CA 1.43 -1.459 0 N-CA-C 103.236 -2.876 . . . . 9.49 103.236 -177.127 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.266 53.1 Cg_exo -75.1 138.79 23.24 Favored 'Trans proline' 0 C--N 1.3 -1.996 2 C-N-CA 128.48 6.12 . . . . 11.42 112.064 -176.295 . . . . . . . . 3 2 . 1 . 079 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.88 -29.18 89.49 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 C-N-CA 122.748 2.299 . . . . 12.0 112.711 175.425 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.31 7.8 p-10 -70.87 -38.28 73.09 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.523 1.965 . . . . 35.55 112.084 175.825 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -73.44 -35.41 65.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.6 2.36 . . . . 20.52 110.379 -176.469 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -69.12 116.93 10.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.54 2.736 . . . . 7.13 110.781 169.319 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -110.76 129.12 55.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 128.612 3.695 . . . . 36.39 111.692 165.628 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 tp -116.45 133.37 56.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.408 -1.433 . . . . 9.55 109.843 -172.691 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.5 mt -127.08 130.13 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 116.664 -3.772 . . . . 13.9 109.383 -175.108 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -89.87 -58.59 2.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 123.121 2.691 . . . . 6.86 115.492 172.634 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.4 -73.94 0.63 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.19 1.396 . . . . 11.15 107.684 -178.608 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.25 -64.16 0.26 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 117.206 -2.426 . . . . 13.93 111.108 -173.569 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.275 17.6 ptmt -67.04 168.0 10.84 Favored 'General case' 0 N--CA 1.429 -1.491 2 CA-C-O 128.924 4.202 . . . . 23.92 113.496 171.961 . . . . . . . . 3 2 . 1 . 079 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -86.12 145.68 26.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.175 -2.739 . . . . 23.23 113.692 172.922 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -80.74 137.97 36.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.093 -1.629 . . . . 9.11 107.793 -178.054 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -102.6 145.84 29.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.081 2.953 . . . . 33.44 107.884 -170.525 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -39.36 -73.97 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 119.77 3.248 . . . . 28.37 119.77 -174.692 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.02 17.52 41.28 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 129.073 3.225 . . . . 15.0 111.808 -164.16 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -96.4 163.66 12.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.687 -2.066 . . . . 25.5 105.46 173.395 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -101.55 163.89 12.04 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.42 -2.437 . . . . 11.95 104.42 -179.577 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.37 -26.46 66.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.358 -1.292 . . . . 10.17 114.424 162.592 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -65.93 -35.62 81.12 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 123.49 0.716 . . . . 13.59 111.895 168.421 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.8 -34.09 73.97 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 116.045 -4.159 . . . . 11.7 120.201 175.168 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -92.37 -22.26 19.78 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.476 -3.265 . . . . 12.95 105.79 -178.267 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.8 m120 71.89 75.44 0.17 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.5 2.72 . . . . 25.45 108.91 -177.563 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.2 mt -115.56 126.8 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 125.557 1.786 . . . . 14.6 106.637 -175.34 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.94 -178.79 4.54 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.398 -1.439 . . . . 33.23 109.323 179.848 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -66.61 156.06 36.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.948 2.309 . . . . 25.97 115.768 -168.231 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.291 46.7 mt-10 58.21 42.22 22.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.435 2.754 . . . . 32.61 118.435 -171.202 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 m -116.84 132.82 56.6 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.069 -1.826 . . . . 10.56 106.069 -175.759 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.6 m -84.09 140.41 31.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.984 -2.947 . . . . 5.33 114.183 173.262 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -125.04 165.57 17.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.135 2.574 . . . . 11.66 110.096 174.344 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -110.27 104.4 13.2 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.271 1.952 . . . . 16.3 116.271 176.294 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.6 tp -73.06 118.74 16.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 123.876 0.735 . . . . 9.96 110.236 165.817 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 m -129.64 155.53 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 105.592 -2.003 . . . . 9.76 105.592 176.254 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 71' ' ' LEU . 17.9 mt . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 103.539 -2.763 . . . . 19.57 103.539 -166.558 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ptt? . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 124.582 2.134 . . . . 17.17 108.851 . . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -99.03 132.7 44.15 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 116.585 -3.822 . . . . 21.89 113.089 -169.551 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 pt -120.46 154.5 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.08 -1.013 . . . . 10.83 110.331 175.661 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -124.52 125.01 43.51 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.073 -1.642 . . . . 10.61 106.706 -174.315 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.476 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 22.7 t -109.54 102.56 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 124.46 2.076 . . . . 9.13 110.335 -178.229 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -83.61 126.28 32.68 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 127.284 3.421 . . . . 20.55 116.311 172.725 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.6 p -78.96 174.31 11.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.928 2.299 . . . . 11.78 112.612 -175.745 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.48 HD13 HG12 ' A' ' 70' ' ' VAL . 12.5 tp -75.6 -36.23 60.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.61 -2.556 . . . . 19.31 109.889 -177.018 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -61.68 -37.63 84.82 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.076 -3.515 . . . . 23.14 116.678 170.519 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.36 43.28 0.6 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 120.227 1.376 . . . . 19.74 111.066 174.546 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -111.18 151.17 28.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.611 1.708 . . . . 21.93 115.611 161.911 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -97.36 115.51 27.85 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.214 -1.554 . . . . 12.33 113.568 171.577 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.476 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 10.0 mt -93.04 92.18 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 126.366 2.984 . . . . 17.08 111.165 170.699 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.3 m -82.91 105.22 13.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.551 -2.113 . . . . 16.3 113.122 -173.956 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.86 158.38 17.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.738 -2.69 . . . . 15.88 103.738 -169.938 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -110.97 133.29 53.5 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.395 -2.69 . . . . 28.9 108.437 164.146 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.92 169.15 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.006 -2.961 . . . . 12.05 103.006 -171.502 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.48 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 73.7 mm-40 -100.88 174.15 3.16 Favored Pre-proline 0 N--CA 1.429 -1.485 1 O-C-N 114.432 -5.168 . . . . 18.17 104.14 165.882 . . . . . . . . 3 3 . 1 . 080 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 69.2 Cg_endo -78.29 -15.3 14.34 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 CA-C-N 123.239 2.192 . . . . 8.16 116.133 168.937 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.7 p -77.91 -5.46 51.16 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.57 2.348 . . . . 11.13 114.688 176.366 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -70.84 148.25 48.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.588 -3.82 . . . . 18.03 112.456 178.428 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.9 p -93.0 148.01 22.35 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 129.477 4.236 . . . . 10.22 108.644 178.134 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.8 mm -52.21 -32.49 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 125.781 2.705 . . . . 12.3 116.144 173.144 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -67.61 -39.18 84.74 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.617 -3.802 . . . . 36.51 113.106 174.742 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -78.64 -6.76 56.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 114.483 -2.887 . . . . 25.66 110.548 -179.665 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.3 t -86.56 -43.59 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 130.762 3.625 . . . . 8.12 110.026 171.806 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -51.25 -33.27 27.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.36 -3.338 . . . . 15.47 119.093 161.4 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.7 -19.04 63.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.327 -2.108 . . . . 11.45 114.407 177.849 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -78.89 -39.98 33.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.364 -1.347 . . . . 24.98 107.364 174.117 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 mt -74.36 -40.48 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.742 -1.849 . . . . 9.46 107.965 -176.652 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -54.1 -45.44 71.82 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.99 -2.944 . . . . 14.76 110.714 173.014 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -64.81 -52.64 55.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.749 -1.844 . . . . 26.29 111.081 -176.65 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.58 -66.96 0.54 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.102 2.26 . . . . 30.06 117.102 -176.393 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -67.47 -49.73 62.25 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.507 2.379 . . . . 25.19 113.334 -172.174 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.85 13.34 16.39 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-N 113.22 -1.809 . . . . 7.41 115.387 178.49 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.1 mt -89.08 127.15 56.62 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 126.926 2.091 . . . . 9.49 108.801 -171.559 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -67.71 139.37 48.02 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-O 116.192 -1.67 . . . . 11.42 113.397 -177.878 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -73.34 -14.57 25.37 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 124.253 2.554 . . . . 12.0 118.301 -166.371 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -35.94 63.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 120.374 1.443 . . . . 35.55 111.299 172.172 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.55 -41.13 89.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 117.061 2.245 . . . . 20.52 117.061 166.688 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -63.65 117.53 6.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.904 3.282 . . . . 7.13 109.375 -176.031 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.414 ' HB3' HG23 ' A' ' 70' ' ' VAL . 27.3 ttm180 -116.88 101.25 8.37 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.054 -2.904 . . . . 36.39 104.649 176.429 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.6 tp -96.43 115.33 27.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.749 3.219 . . . . 9.55 108.95 -172.32 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -114.97 154.38 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.928 2.891 . . . . 13.9 110.761 -171.391 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.89 -91.4 0.24 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 116.58 -1.676 . . . . 6.86 106.622 174.264 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.54 -75.46 0.6 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.183 2.177 . . . . 11.15 106.019 178.786 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.95 -32.57 3.77 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 109.347 -3.57 . . . . 13.93 117.407 -175.062 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 8.2 ptpt -99.08 152.08 20.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.758 3.17 . . . . 23.92 116.869 173.083 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -88.89 133.5 34.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.852 -2.405 . . . . 23.23 113.014 171.557 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.8 mt -89.82 123.71 34.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.343 -1.473 . . . . 9.11 110.973 -176.485 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -95.62 138.48 33.23 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.302 2.241 . . . . 33.44 107.562 -169.174 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -34.27 -49.89 0.39 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.843 3.657 . . . . 28.37 120.668 -168.869 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.55 -8.46 59.63 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 119.899 -1.751 . . . . 15.0 115.657 -164.453 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -83.59 154.38 23.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.864 -2.551 . . . . 25.5 108.43 -175.903 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -89.27 166.77 13.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.839 1.781 . . . . 11.95 115.312 176.759 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.47 -31.6 71.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 118.976 2.954 . . . . 10.17 118.976 169.71 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -61.12 -30.71 70.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.032 2.133 . . . . 13.59 115.33 163.325 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -72.02 -42.86 65.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.865 1.793 . . . . 11.7 110.82 174.41 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -83.31 -17.04 43.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.796 2.517 . . . . 12.95 117.796 -174.612 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 28.0 m120 78.52 45.96 0.06 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 131.0 3.72 . . . . 25.45 109.941 -179.005 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -83.06 123.91 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.413 -2.679 . . . . 14.6 105.78 167.605 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -112.42 -157.07 0.61 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.861 -2.274 . . . . 33.23 104.861 -179.382 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -85.32 153.23 22.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.097 1.147 . . . . 25.97 114.097 -178.826 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 57.03 34.11 24.41 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.526 -3.234 . . . . 32.61 111.749 -176.747 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -77.88 138.85 39.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.077 -1.083 . . . . 10.56 108.077 -178.288 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 m -98.93 118.79 36.5 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.437 -1.32 . . . . 5.33 107.437 167.801 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.7 mt -106.36 176.41 5.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 123.386 0.674 . . . . 11.66 109.992 169.994 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -136.55 135.91 38.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 103.577 -2.749 . . . . 16.3 103.577 -168.444 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.4 tp -117.17 119.97 36.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.967 -3.583 . . . . 9.96 108.42 173.28 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.48 HG12 HD13 ' A' ' 8' ' ' LEU . 27.9 m -116.9 166.97 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.734 2.207 . . . . 9.76 110.055 163.091 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.429 -1.481 0 O-C-N 120.211 -1.556 . . . . 19.57 108.992 179.673 . . . . . . . . 0 0 . 1 . 081 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.458 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 121.271 0.558 . . . . 17.17 111.406 . . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -77.69 126.47 30.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.593 -3.817 . . . . 21.89 112.39 -173.614 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -115.19 139.45 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 119.369 0.986 . . . . 10.83 110.569 168.601 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -99.91 109.13 21.51 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.568 2.604 . . . . 10.61 111.555 179.282 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.8 t -92.03 105.82 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 119.576 -1.953 . . . . 9.13 106.195 175.411 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.281 71.8 mttt -86.3 138.08 32.11 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.974 1.102 . . . . 20.55 113.974 -179.867 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.273 8.7 p -99.93 176.05 5.56 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.516 -3.24 . . . . 11.78 112.702 -167.89 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.278 27.7 tp -71.58 -55.6 7.47 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.424 3.489 . . . . 19.31 115.158 -174.453 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.414 67.6 p -56.53 -63.3 1.24 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.059 -1.65 . . . . 23.14 113.727 165.142 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.64 60.49 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 122.502 3.761 . . . . 19.74 122.502 -177.979 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.15 166.51 13.85 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.753 -3.204 . . . . 21.93 105.882 175.543 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -117.51 130.24 56.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.036 2.236 . . . . 12.33 117.036 158.678 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.8 mt -101.37 112.05 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 117.373 -1.731 . . . . 17.08 110.027 175.214 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.272 90.6 m -93.57 115.36 27.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.891 -3.631 . . . . 16.3 110.99 177.768 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.28 50.9 mt -119.42 134.37 55.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.737 -1.579 . . . . 15.88 106.737 -173.455 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -96.94 94.68 7.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.918 3.287 . . . . 28.9 109.038 -179.53 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.9 m -119.45 159.2 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 118.01 -2.931 . . . . 12.05 105.477 -169.133 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -113.87 155.85 44.64 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 116.556 -3.84 . . . . 18.17 106.959 171.351 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.306 69.2 Cg_endo -65.54 -9.61 23.16 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 125.153 3.902 . . . . 8.16 121.387 -164.203 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -94.61 -11.37 29.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.359 -1.463 . . . . 11.13 113.676 -179.612 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -64.22 143.52 57.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.158 2.183 . . . . 18.03 113.902 171.743 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -93.49 165.12 12.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.523 -1.361 . . . . 10.22 110.266 -166.464 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -66.91 -31.57 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 115.878 1.807 . . . . 12.3 115.878 171.235 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -49.51 -48.02 48.41 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.111 1.507 . . . . 36.51 113.39 166.766 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -81.11 -16.26 53.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.283 -1.326 . . . . 25.66 109.177 -178.375 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.81 -47.01 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 123.358 2.799 . . . . 8.12 109.924 173.722 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -50.68 -38.52 47.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.289 2.235 . . . . 15.47 114.375 174.365 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.309 . . -62.53 -37.17 85.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.253 -2.308 . . . . 11.45 112.757 173.325 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -67.9 -49.06 64.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.382 1.446 . . . . 24.98 112.662 175.443 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.99 -36.86 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 O-C-N 115.978 -4.201 . . . . 9.46 107.99 -179.096 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.43 -38.34 86.81 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.151 -3.468 . . . . 14.76 115.569 174.305 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -72.95 -43.51 62.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.242 1.942 . . . . 26.29 116.242 178.655 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -64.41 -69.86 0.26 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 120.847 3.647 . . . . 30.06 120.847 175.512 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -94.28 -2.56 52.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.068 -1.645 . . . . 25.19 111.966 -175.845 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.99 41.65 87.05 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 122.411 2.369 . . . . 7.41 118.215 -178.302 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 mm -106.28 107.87 60.69 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 114.416 -2.707 . . . . 9.49 108.972 -178.053 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.18 144.98 78.93 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 123.466 2.273 . . . . 11.42 117.319 177.165 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.34 -13.19 32.96 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 123.67 2.913 . . . . 12.0 112.0 -166.875 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -85.87 -9.38 57.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.839 3.255 . . . . 35.55 107.863 179.016 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -107.07 -15.45 14.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.53 -1.356 . . . . 20.52 114.413 171.088 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -81.47 99.26 8.66 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.613 -3.179 . . . . 7.13 113.867 -179.258 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -91.88 107.1 18.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.685 -3.135 . . . . 36.39 107.011 170.56 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.9 134.47 41.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.742 -1.947 . . . . 9.55 105.742 -177.685 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -123.39 132.91 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 130.257 3.423 . . . . 13.9 110.458 -179.522 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -107.98 112.06 24.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.536 -2.602 . . . . 6.86 106.62 158.372 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.35 -86.84 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 131.927 4.091 . . . . 11.15 109.276 178.712 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.14 16.67 3.42 Favored Glycine 0 N--CA 1.43 -1.742 1 O-C-N 115.396 -4.565 . . . . 13.93 111.801 162.441 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.255 88.7 mttt -87.17 122.53 31.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.848 2.324 . . . . 23.92 111.105 172.988 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -84.86 106.48 16.42 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 121.099 1.772 . . . . 23.23 108.165 178.377 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.35 139.48 58.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.52 2.328 . . . . 9.11 109.732 -174.015 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -100.35 140.74 34.16 Favored 'General case' 0 N--CA 1.43 -1.474 1 C-N-CA 131.735 4.014 . . . . 33.44 111.907 -175.785 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -54.88 -54.01 48.07 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.133 2.573 . . . . 28.37 113.661 -168.49 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.32 7.12 61.66 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 129.86 3.6 . . . . 15.0 114.978 -173.73 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -107.82 170.46 7.97 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.823 -1.177 . . . . 25.5 107.823 176.603 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.0 p -110.07 172.37 6.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.772 2.701 . . . . 11.95 115.877 -174.672 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 14.1 mt -59.2 -48.43 81.63 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.985 -2.947 . . . . 10.17 112.988 162.791 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.6 p -58.49 -23.18 57.22 Favored 'General case' 0 N--CA 1.43 -1.451 1 N-CA-C 123.196 4.517 . . . . 13.59 123.196 173.17 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.313 15.6 t70 -74.16 -50.47 19.19 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.741 -2.475 . . . . 11.7 110.989 177.106 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -73.62 -21.62 60.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.188 1.921 . . . . 12.95 116.188 177.92 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 67.8 m-20 80.78 47.93 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 127.958 3.742 . . . . 25.45 114.071 -176.604 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.7 mt -77.88 134.97 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.29 -2.756 . . . . 14.6 108.37 168.976 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -121.14 -158.11 0.75 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.296 1.622 . . . . 33.23 108.57 176.525 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 7.2 ptmm? -77.67 158.72 29.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.984 3.278 . . . . 25.97 113.334 170.814 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 64.91 24.69 12.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.032 -2.293 . . . . 32.61 109.333 168.658 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -91.35 148.51 22.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.031 -2.293 . . . . 10.56 109.62 -170.02 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -102.86 120.83 41.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.986 -1.696 . . . . 5.33 109.156 173.921 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.28 160.27 16.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 102.932 -2.988 . . . . 11.66 102.932 174.025 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -122.54 134.18 54.55 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.026 -4.171 . . . . 16.3 105.332 179.395 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tp -100.52 129.93 46.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 128.613 3.696 . . . . 9.96 105.663 167.788 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.66 168.32 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 101.833 -3.395 . . . . 9.76 101.833 175.575 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.8 tp . . . . . 0 N--CA 1.431 -1.417 0 N-CA-C 117.403 2.371 . . . . 19.57 117.403 -176.151 . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 CA--C 1.489 -1.387 0 CA-C-O 124.832 2.254 . . . . 17.17 113.517 . . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -105.46 148.39 27.24 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.649 -3.157 . . . . 21.89 106.38 179.405 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.1 pt -130.27 153.84 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.286 -2.487 . . . . 10.83 104.286 172.64 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -109.21 113.77 26.9 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.881 -1.509 . . . . 10.61 110.75 173.574 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -95.5 110.83 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.294 -1.002 . . . . 9.13 108.294 170.599 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -102.57 142.71 33.3 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.46 1.124 . . . . 20.55 113.06 -176.334 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 p -87.43 174.65 8.39 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 110.779 -2.919 . . . . 11.78 114.816 175.522 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.32 -49.75 62.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.538 -2.601 . . . . 19.31 115.027 167.957 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.8 p -69.89 -46.09 66.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.769 1.622 . . . . 23.14 112.41 176.914 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.36 54.25 0.13 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 119.7 -1.875 . . . . 19.74 108.523 173.589 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.26 132.41 54.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.497 1.519 . . . . 21.93 112.059 159.023 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -99.25 112.71 24.81 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 121.12 1.782 . . . . 12.33 111.842 178.378 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 mt -85.98 109.22 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.269 -2.863 . . . . 17.08 103.269 176.314 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.2 m -104.08 101.02 10.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.016 -1.476 . . . . 16.3 107.016 -175.185 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.0 mt -97.93 131.59 44.25 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.719 1.748 . . . . 15.88 115.719 173.412 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -75.75 124.35 27.12 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.578 2.132 . . . . 28.9 105.997 160.999 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.1 169.33 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 104.701 -2.333 . . . . 12.05 104.701 -179.988 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -104.49 152.3 39.33 Favored Pre-proline 0 N--CA 1.43 -1.444 0 C-N-CA 124.093 0.957 . . . . 18.17 112.67 155.009 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -63.74 -9.95 20.52 Favored 'Trans proline' 0 N--CA 1.434 -2.005 1 C-N-CA 127.248 5.299 . . . . 8.16 113.124 -179.378 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.5 m -90.93 -7.76 51.22 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.645 1.72 . . . . 11.13 115.645 170.429 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -67.31 159.79 28.53 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.709 1.719 . . . . 18.03 114.328 174.011 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.326 71.1 p -86.83 168.9 13.04 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.869 -1.144 . . . . 10.22 114.035 -177.398 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.426 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 29.1 mm -60.61 -36.29 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 119.219 -2.176 . . . . 12.3 115.504 158.311 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -57.47 -33.75 68.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 126.837 3.208 . . . . 36.51 114.61 171.961 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -79.76 -23.98 41.84 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.537 -5.727 . . . . 25.66 111.154 179.547 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 55.2 t -69.11 -51.46 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 115.485 -0.779 . . . . 8.12 112.736 168.458 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -56.62 -31.76 64.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.92 1.688 . . . . 15.47 112.815 178.448 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.47 75.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.901 2.137 . . . . 11.45 114.457 176.9 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -80.09 -31.12 39.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.747 2.689 . . . . 24.98 112.485 178.321 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.28 -38.11 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 1 O-C-N 115.538 -4.477 . . . . 9.46 110.59 171.399 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -69.7 -29.94 67.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.585 -3.197 . . . . 14.76 119.152 171.268 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -76.24 -57.6 3.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.401 1.572 . . . . 26.29 113.286 171.336 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -78.1 -66.96 0.78 Allowed 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 115.114 -4.742 . . . . 30.06 109.567 -167.155 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -72.03 -38.71 69.5 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.981 2.8 . . . . 25.19 116.848 -175.084 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.04 43.12 2.28 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.968 -2.333 . . . . 7.41 114.952 178.796 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mm -98.66 117.25 64.8 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 112.786 -3.483 . . . . 9.49 111.073 -179.792 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -68.27 165.11 29.82 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 CA-C-N 125.207 2.895 . . . . 11.42 114.8 -177.553 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -79.34 -28.17 3.83 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 121.791 1.675 . . . . 12.0 112.737 -153.84 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -79.55 -30.65 41.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 127.513 3.008 . . . . 35.55 107.251 177.191 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -74.0 -16.65 61.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.238 -3.414 . . . . 20.52 112.222 -178.314 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -86.68 118.6 26.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.145 2.402 . . . . 7.13 112.815 176.714 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -108.22 125.81 52.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.515 -3.143 . . . . 36.39 102.515 160.665 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -102.03 123.82 46.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 110.999 -2.818 . . . . 9.55 106.391 168.035 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.6 mm -121.62 140.83 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 100.975 -3.713 . . . . 13.9 100.975 -173.266 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -126.72 122.77 35.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 116.323 -1.799 . . . . 6.86 106.773 165.053 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.67 -92.28 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.785 1.63 . . . . 11.15 112.383 -164.478 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.67 -7.28 5.73 Favored Glycine 0 N--CA 1.431 -1.678 0 C-N-CA 127.659 2.552 . . . . 13.93 109.394 -179.305 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -103.52 119.79 39.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 118.497 2.777 . . . . 23.92 118.497 -166.874 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -69.43 112.19 5.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.668 1.359 . . . . 23.23 114.668 -178.621 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.2 mt -80.46 112.14 17.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.562 0.696 . . . . 9.11 112.017 -179.862 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -85.94 168.48 14.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.409 2.684 . . . . 33.44 109.83 -170.808 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.62 -46.86 62.54 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 113.359 -5.838 . . . . 28.37 115.351 -165.441 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.63 32.0 6.68 Favored Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 126.922 2.201 . . . . 15.0 116.418 -168.607 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.8 mtt-85 -130.68 159.09 38.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.594 -3.484 . . . . 25.5 101.594 -177.771 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 p -87.8 156.79 19.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 131.511 3.925 . . . . 11.95 111.815 174.046 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.86 -28.78 68.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.016 -1.447 . . . . 10.17 111.612 178.843 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.291 68.8 p -59.28 -36.58 75.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.03 2.233 . . . . 13.59 117.03 165.972 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -81.93 -29.3 32.35 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.686 -4.384 . . . . 11.7 106.158 -170.816 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -72.86 -20.79 61.05 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 121.187 3.773 . . . . 12.95 121.187 160.874 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.389 15.6 m120 70.86 34.65 1.91 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.386 -2.071 . . . . 25.45 112.892 -174.479 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -88.46 132.21 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 101.42 -3.548 . . . . 14.6 101.42 171.859 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.271 81.9 mt-30 -98.53 175.22 6.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 109.864 -3.335 . . . . 33.23 114.869 174.211 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -45.71 137.73 5.14 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.549 2.74 . . . . 25.97 111.963 160.467 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 60.04 24.34 13.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.915 2.561 . . . . 32.61 117.915 177.466 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -78.08 154.22 31.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.215 -2.178 . . . . 10.56 106.408 -168.049 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.4 m -98.0 108.71 21.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 117.246 -1.359 . . . . 5.33 111.975 173.277 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.07 158.2 16.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 125.114 1.509 . . . . 11.66 109.457 175.781 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -121.71 130.86 53.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.115 -2.241 . . . . 16.3 113.079 -178.167 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -87.55 100.8 13.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.314 3.046 . . . . 9.96 110.928 169.402 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 t -96.94 120.26 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.99 -1.694 . . . . 9.76 113.031 174.05 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 tp . . . . . 0 N--CA 1.43 -1.459 0 O-C-N 116.541 -3.849 . . . . 19.57 108.655 -175.797 . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 117.664 2.468 . . . . 17.17 117.664 . . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -91.71 134.75 34.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 126.243 2.925 . . . . 21.89 113.688 179.971 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.4 pt -121.69 161.86 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 117.422 -3.299 . . . . 10.83 112.83 172.763 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -111.33 116.59 31.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 123.694 0.621 . . . . 10.61 111.589 179.806 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.6 HG21 HD12 ' A' ' 15' ' ' LEU . 15.5 t -103.56 108.6 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 118.728 -2.482 . . . . 9.13 107.924 -175.383 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -97.5 119.96 37.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.41 2.052 . . . . 20.55 110.689 -172.108 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 2.2 p -76.66 175.35 9.41 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.568 -1.197 . . . . 11.78 111.931 -173.803 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.04 -40.52 75.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 124.219 1.961 . . . . 19.31 112.869 175.796 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 p -76.91 -21.14 55.34 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.483 2.313 . . . . 23.14 114.538 177.33 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.51 26.81 2.77 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 118.956 -1.592 . . . . 19.74 110.069 153.403 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -83.6 139.06 33.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 116.831 -1.556 . . . . 21.93 111.487 178.329 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -93.34 105.34 17.42 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.339 2.336 . . . . 12.33 109.837 168.161 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.18 119.94 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 125.013 2.339 . . . . 17.08 106.886 176.249 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.7 m -81.14 115.71 20.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.845 -2.409 . . . . 16.3 109.216 169.683 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.6 HD12 HG21 ' A' ' 5' ' ' VAL . 64.9 mt -123.41 144.65 49.35 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 113.186 -5.946 . . . . 15.88 106.922 177.361 . . . . . . . . 3 3 . 1 . 083 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -89.99 108.78 19.93 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.051 1.74 . . . . 28.9 115.136 167.835 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.85 155.92 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 114.655 -1.157 . . . . 12.05 108.915 -179.412 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -109.06 152.4 42.47 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 101.081 -3.674 . . . . 18.17 101.081 163.148 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -65.83 -23.39 55.34 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 C-N-CA 126.271 4.647 . . . . 8.16 112.34 -172.991 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.5 m -90.61 1.73 56.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.795 -3.066 . . . . 11.13 110.731 179.179 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -78.96 161.22 26.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 123.572 2.897 . . . . 18.03 104.177 175.374 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.0 p -108.03 167.36 10.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.803 -1.925 . . . . 10.22 105.803 -168.062 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.4 mm -74.62 -34.51 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 C-N-CA 128.921 2.888 . . . . 12.3 104.662 -171.587 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.87 -38.55 72.91 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.846 -4.284 . . . . 36.51 119.428 169.933 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -70.6 -19.3 62.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.006 -1.906 . . . . 25.66 114.839 169.916 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -79.14 -37.31 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 118.048 -1.461 . . . . 8.12 110.948 175.884 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -67.96 -30.31 69.57 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 130.575 3.55 . . . . 15.47 111.033 176.568 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.69 -41.84 36.63 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.874 -2.391 . . . . 11.45 111.771 -175.755 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -61.21 -34.23 74.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.102 -2.874 . . . . 24.98 113.546 170.304 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.299 65.9 mt -65.17 -39.8 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 125.532 1.77 . . . . 9.46 115.701 169.531 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -57.64 -53.41 58.51 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.728 -3.733 . . . . 14.76 112.541 173.78 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -67.83 -44.82 76.33 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.112 -2.313 . . . . 26.29 115.68 -177.6 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -83.02 -50.22 8.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.088 -1.434 . . . . 30.06 113.985 -178.678 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -94.76 -55.64 3.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.134 2.397 . . . . 25.19 111.438 -176.655 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.64 40.74 2.47 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 118.559 -1.781 . . . . 7.41 117.141 -176.512 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.1 mm -90.04 131.17 39.87 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 118.275 -2.897 . . . . 9.49 109.006 167.778 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -67.93 144.21 63.61 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 128.101 3.929 . . . . 11.42 118.298 -174.58 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -81.61 -3.59 11.96 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 124.082 3.188 . . . . 12.0 114.639 -163.502 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.83 -23.57 45.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.066 -1.646 . . . . 35.55 115.428 165.661 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -89.53 -24.18 21.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.35 1.86 . . . . 20.52 111.234 -179.754 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -78.8 96.63 5.67 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.195 -2.191 . . . . 7.13 109.951 -173.177 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -109.28 127.05 53.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.408 -2.441 . . . . 36.39 104.408 171.706 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.571 ' HB3' HD12 ' A' ' 50' ' ' LEU . 14.8 mt -107.28 127.26 53.39 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 116.871 -1.538 . . . . 9.55 108.672 -168.368 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 51.7 mm -117.92 137.79 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 125.323 1.639 . . . . 13.9 109.14 179.404 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -131.42 127.59 37.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 125.211 3.642 . . . . 6.86 106.736 155.951 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.75 -106.89 0.35 Allowed 'General case' 0 N--CA 1.429 -1.482 1 C-N-CA 132.203 4.201 . . . . 11.15 113.649 -171.759 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.32 6.2 19.13 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.118 -2.239 . . . . 13.93 109.267 -177.761 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -122.4 142.1 50.89 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 116.068 -4.196 . . . . 23.92 107.989 -174.194 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -76.26 137.55 40.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.22 -1.355 . . . . 23.23 110.594 175.093 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.571 HD12 ' HB3' ' A' ' 43' ' ' LEU . 40.5 mt -86.04 112.85 21.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.0 -1.0 . . . . 9.11 111.01 179.845 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -88.3 137.57 32.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 128.127 3.822 . . . . 33.44 109.907 -178.442 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.32 -62.44 1.48 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 110.023 -3.262 . . . . 28.37 116.372 -164.054 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.7 19.4 37.33 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 117.735 -3.103 . . . . 15.0 114.077 -171.73 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -92.38 171.08 9.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.452 2.019 . . . . 25.5 116.452 166.348 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 p -98.38 161.23 13.79 Favored 'General case' 0 N--CA 1.43 -1.459 1 CA-C-O 128.569 4.033 . . . . 11.95 110.269 178.856 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.325 5.5 mp -68.8 -36.99 78.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 111.362 -2.654 . . . . 10.17 110.604 172.377 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 p -50.92 -39.57 54.88 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.132 2.271 . . . . 13.59 117.132 162.865 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.9 -29.37 67.63 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.127 1.899 . . . . 11.7 116.127 -177.369 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -94.58 0.73 55.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.783 2.433 . . . . 12.95 115.382 178.002 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m120 68.05 33.0 4.73 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.299 -1.319 . . . . 25.45 113.701 -179.733 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.255 86.5 mt -78.47 116.4 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 124.848 1.259 . . . . 14.6 109.099 -174.065 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -93.05 173.35 7.78 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.117 -2.864 . . . . 33.23 109.974 -174.126 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -75.8 150.25 37.75 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.642 -3.161 . . . . 25.97 113.237 175.127 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.311 88.4 mt-10 64.83 39.97 5.78 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 131.568 3.947 . . . . 32.61 109.985 176.813 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.1 m -103.09 145.85 29.28 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.358 3.063 . . . . 10.56 112.064 -179.725 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -96.43 116.35 28.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 118.17 -1.412 . . . . 5.33 112.828 -178.073 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.02 157.3 20.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.767 1.765 . . . . 11.66 115.767 165.364 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 10.9 m-70 -105.52 112.23 25.24 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.01 -2.931 . . . . 16.3 116.108 172.086 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 15.5 tp -96.21 104.86 16.85 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 119.857 -0.737 . . . . 9.96 111.391 175.886 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.02 155.86 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 125.466 1.506 . . . . 9.76 114.304 -166.259 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.3 tp . . . . . 0 N--CA 1.43 -1.436 0 O-C-N 118.662 -2.523 . . . . 19.57 115.384 -179.548 . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 118.112 -0.947 . . . . 17.17 110.291 . . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -101.58 159.22 15.48 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.033 1.873 . . . . 21.89 113.826 165.719 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -135.8 157.29 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 126.227 1.811 . . . . 10.83 106.452 -179.696 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -112.07 117.46 32.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.874 -3.016 . . . . 10.61 112.809 175.613 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.7 t -99.15 122.26 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 102.919 -2.993 . . . . 9.13 102.919 -175.435 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -122.87 120.87 34.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.136 -1.602 . . . . 20.55 112.071 -171.021 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -92.86 176.87 6.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.889 1.675 . . . . 11.78 109.626 -169.672 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -79.59 -31.8 41.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.863 -1.971 . . . . 19.31 113.027 -171.446 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.15 -62.88 1.36 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.047 1.739 . . . . 23.14 108.573 174.904 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.9 37.56 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.66 1 C-N-CA 113.35 -4.262 . . . . 19.74 106.365 156.921 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -88.77 130.33 35.38 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.105 -2.409 . . . . 21.93 109.646 -176.846 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -103.26 101.8 11.74 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.746 -1.575 . . . . 12.33 106.746 -178.11 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mt -93.19 131.82 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.892 -1.892 . . . . 17.08 105.892 -175.027 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 m -80.78 114.72 19.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.126 -1.805 . . . . 16.3 106.126 166.074 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 tp -127.89 125.28 39.34 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.954 2.101 . . . . 15.88 106.721 -177.946 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -103.26 133.63 48.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.945 -2.972 . . . . 28.9 110.937 -176.415 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -162.05 164.37 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 104.886 -2.264 . . . . 12.05 104.886 -160.252 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -126.64 141.25 39.68 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 117.594 -1.193 . . . . 18.17 111.244 177.953 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -67.17 -15.41 46.23 Favored 'Trans proline' 0 C--N 1.3 -1.98 1 C-N-CA 127.05 5.167 . . . . 8.16 113.389 -166.739 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -89.49 -13.62 37.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 123.226 2.739 . . . . 11.13 112.27 -172.774 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.75 170.35 9.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.831 2.729 . . . . 18.03 108.019 -177.177 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -89.49 172.1 9.24 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.901 -2.999 . . . . 10.22 110.617 -164.496 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -70.83 -30.21 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.142 -2.224 . . . . 12.3 109.474 175.486 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -49.09 -39.06 26.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.513 -3.242 . . . . 36.51 115.702 161.711 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -64.63 -48.72 73.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.58 -1.95 . . . . 25.66 111.512 171.408 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.7 -44.51 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 117.899 2.555 . . . . 8.12 117.899 173.322 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' NZ ' ' OD1' ' A' ' 52' ' ' ASP . 26.0 ttmt -53.69 -35.64 61.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.286 -2.759 . . . . 15.47 116.922 168.49 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.56 -21.65 61.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.02 2.6 . . . . 11.45 118.02 -177.98 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -86.52 -32.63 20.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 130.61 3.564 . . . . 24.98 108.432 -175.992 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.2 mt -76.81 -33.07 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 119.768 1.167 . . . . 9.46 109.28 175.036 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -54.1 -36.53 63.31 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.509 2.04 . . . . 14.76 116.509 167.641 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.54 -54.9 4.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.475 1.287 . . . . 26.29 114.475 -178.658 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -71.15 -73.86 0.16 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.805 1.941 . . . . 30.06 112.107 -174.951 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.44 -37.18 82.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.015 2.228 . . . . 25.19 117.015 173.49 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.0 30.11 11.68 Favored Glycine 0 N--CA 1.43 -1.718 1 O-C-N 115.624 -4.423 . . . . 7.41 115.611 -176.493 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mm -87.12 125.59 65.67 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-O 115.911 -1.995 . . . . 9.49 116.221 169.692 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -83.87 161.91 13.99 Favored 'Trans proline' 0 C--N 1.3 -2.002 1 CA-C-N 129.345 4.373 . . . . 11.42 114.91 -172.799 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -86.02 -11.8 6.33 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 123.465 2.273 . . . . 12.0 114.333 -142.658 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.52 -4.5 59.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.873 3.669 . . . . 35.55 114.971 168.059 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.27 57.9 mt-30 -106.54 6.0 29.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.34 -1.475 . . . . 20.52 110.964 176.471 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -99.57 101.16 12.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.813 2.097 . . . . 7.13 113.126 -177.002 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -99.15 109.81 22.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.355 1.074 . . . . 36.39 112.229 174.423 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 mt -103.92 136.22 43.98 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.642 -1.163 . . . . 9.55 113.729 177.914 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.33 131.91 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.955 2.034 . . . . 13.9 106.267 -179.92 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.436 ' HB3' HD21 ' A' ' 50' ' ' LEU . 82.6 t80 -116.62 125.66 52.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.111 -1.44 . . . . 6.86 107.111 163.884 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.346 . . 59.18 -106.09 0.28 Allowed 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.613 2.149 . . . . 11.15 116.112 -171.107 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.88 57.14 0.71 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 120.074 -1.641 . . . . 13.93 114.435 159.92 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -145.45 146.2 31.4 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.704 2.802 . . . . 23.92 108.803 178.817 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -93.48 130.65 39.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.864 2.603 . . . . 23.23 110.618 175.405 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 45' ' ' PHE . 43.3 mt -87.26 114.47 23.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.573 -3.204 . . . . 9.11 110.73 -170.817 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.21 153.36 18.66 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.318 2.485 . . . . 33.44 109.331 -169.979 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 28.2 m-20 -52.61 -49.26 65.42 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 117.01 -3.556 . . . . 28.37 116.756 -159.036 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.18 4.52 77.65 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 119.74 -1.85 . . . . 15.0 114.709 -171.376 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -83.71 163.88 19.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.302 -2.881 . . . . 25.5 106.896 -178.373 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -102.66 173.55 6.28 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.424 2.009 . . . . 11.95 116.424 170.949 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 mt -79.39 -29.46 42.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.455 -1.403 . . . . 10.17 108.327 177.378 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.9 p -65.51 -27.84 68.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.434 -1.27 . . . . 13.59 111.953 177.715 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.28 -56.48 21.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.825 2.05 . . . . 11.7 110.143 177.62 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.433 ' HB2' HG13 ' A' ' 61' ' ' ILE . 49.7 m-85 -83.11 3.42 30.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.479 -1.237 . . . . 12.95 113.327 -173.443 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 m120 49.05 61.56 3.06 Favored 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 134.361 5.064 . . . . 25.45 112.343 -169.274 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 59' ' ' TYR . 74.9 mt -89.88 116.26 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 103.267 -2.864 . . . . 14.6 103.267 -177.604 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -99.19 -167.85 1.54 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.041 3.782 . . . . 33.23 110.816 -171.368 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -75.8 148.3 38.54 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 113.718 -5.614 . . . . 25.97 110.213 -177.411 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 35.17 63.55 0.49 Allowed 'General case' 0 N--CA 1.43 -1.459 2 C-N-CA 134.846 5.258 . . . . 32.61 115.463 -172.992 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.9 t -120.33 146.45 46.12 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 129.461 3.105 . . . . 10.56 108.602 -172.639 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.7 m -77.98 119.05 20.88 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.642 2.464 . . . . 5.33 107.543 -175.266 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.96 132.0 53.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.029 -1.045 . . . . 11.66 108.2 158.128 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -85.58 141.23 29.99 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.987 -4.196 . . . . 16.3 110.71 174.802 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.2 tp -119.28 127.51 53.29 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.273 2.694 . . . . 9.96 118.273 175.094 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.31 -160.73 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 123.463 1.601 . . . . 9.76 108.548 -178.601 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp . . . . . 0 N--CA 1.429 -1.503 0 CA-C-N 112.535 -2.12 . . . . 19.57 114.161 -174.494 . . . . . . . . 0 0 . 1 . 085 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.36 0.3 OUTLIER . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 122.441 1.115 . . . . 17.17 110.066 . . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -88.65 115.67 26.34 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.451 3.1 . . . . 21.89 113.344 179.923 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.81 171.05 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 118.88 -2.388 . . . . 10.83 104.998 166.565 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -121.6 147.56 45.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.71 2.804 . . . . 10.61 106.24 173.615 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -128.68 120.92 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 104.009 -2.589 . . . . 9.13 104.009 172.671 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -102.29 127.8 49.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.602 2.361 . . . . 20.55 110.994 -171.355 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.9 p -89.6 169.09 11.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.195 2.426 . . . . 11.78 109.223 -173.941 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.7 mt -51.55 -40.53 59.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.347 2.259 . . . . 19.31 115.488 164.384 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.8 p -94.54 -71.69 0.65 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 125.336 1.648 . . . . 23.14 111.861 -165.507 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.97 48.67 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 120.611 -1.306 . . . . 19.74 115.94 178.053 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -119.09 140.68 49.69 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.218 1.562 . . . . 21.93 115.218 170.077 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.5 m -104.8 105.85 16.1 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.074 -4.766 . . . . 12.33 108.817 174.181 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.5 mt -91.4 105.43 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 O-C-N 114.552 -5.093 . . . . 17.08 107.747 -171.539 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -82.52 122.8 28.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.674 1.731 . . . . 16.3 115.674 178.19 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.5 tp -123.86 154.92 38.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.101 2.228 . . . . 15.88 113.966 -167.221 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -112.35 129.14 56.4 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.203 1.954 . . . . 28.9 110.848 165.181 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -148.46 170.34 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 130.292 3.437 . . . . 12.05 107.781 -179.237 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -120.95 165.18 19.6 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 107.035 -1.468 . . . . 18.17 107.035 166.564 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -69.9 -21.44 32.82 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-O 127.374 2.989 . . . . 8.16 117.789 -172.325 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 m -78.83 -4.91 51.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 111.374 -2.648 . . . . 11.13 113.279 177.411 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.291 69.3 m-20 -78.35 143.04 37.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.34 2.019 . . . . 18.03 114.12 173.888 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 2.3 p -89.05 156.59 18.75 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.003 -2.311 . . . . 10.22 111.524 -168.894 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.7 mm -61.86 -33.92 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 118.55 2.796 . . . . 12.3 118.55 -179.072 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -44.79 -45.86 10.27 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 120.124 3.379 . . . . 36.51 120.124 161.623 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -72.63 -44.76 61.5 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.675 2.39 . . . . 25.66 111.097 -177.991 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.92 -48.48 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 114.849 1.426 . . . . 8.12 114.849 177.735 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -54.44 -44.34 72.4 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.719 2.008 . . . . 15.47 115.412 171.439 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.309 . . -48.21 -46.25 34.88 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 120.117 3.377 . . . . 11.45 120.117 160.663 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -68.7 -35.36 77.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.883 -3.011 . . . . 24.98 114.946 175.066 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.302 63.2 mt -51.62 -49.57 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 110.74 -2.936 . . . . 9.46 111.227 172.641 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -64.52 -24.57 67.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.79 3.236 . . . . 14.76 114.704 -179.776 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.48 -30.76 69.68 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.198 -4.064 . . . . 26.29 111.799 168.882 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -79.3 -66.65 0.84 Allowed 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 116.169 -4.082 . . . . 30.06 107.588 -173.711 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -121.71 145.57 47.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 103.133 -2.914 . . . . 25.19 103.133 -173.705 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.64 64.56 4.27 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 117.444 -1.753 . . . . 7.41 112.824 -169.84 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.9 mm -110.97 109.7 57.19 Favored Pre-proline 0 N--CA 1.43 -1.473 1 CA-C-O 109.491 -5.052 . . . . 9.49 108.443 -173.658 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.12 135.56 69.39 Favored 'Trans proline' 0 C--N 1.299 -2.034 1 C-N-CA 125.445 4.096 . . . . 11.42 115.276 -173.954 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.89 -19.32 65.31 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 CA-C-N 125.3 2.929 . . . . 12.0 116.442 -177.313 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.16 -16.46 49.72 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.271 -1.518 . . . . 35.55 112.053 175.191 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -99.36 -15.18 18.88 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.162 -2.211 . . . . 20.52 106.447 -177.112 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -77.71 121.76 24.44 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.91 -2.369 . . . . 7.13 111.884 -175.987 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -121.31 110.45 16.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.295 -3.378 . . . . 36.39 104.93 175.055 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.7 mt -94.22 105.48 17.46 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 103.644 -2.724 . . . . 9.55 103.644 -174.831 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mm -88.22 133.98 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 126.945 2.098 . . . . 13.9 108.874 167.777 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.458 ' CE2' HG12 ' A' ' 61' ' ' ILE . 70.6 t80 -137.51 109.09 6.98 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 101.444 -3.539 . . . . 6.86 101.444 -175.495 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.43 -108.0 0.22 Allowed 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 114.236 -1.347 . . . . 11.15 113.9 -164.784 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.67 -16.71 25.74 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-O 115.774 -2.681 . . . . 13.93 112.584 177.837 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -113.59 147.25 38.39 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.965 2.383 . . . . 23.92 112.947 -163.001 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -73.95 127.73 33.64 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 127.506 3.527 . . . . 23.23 113.899 159.389 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.32 83.7 mt -78.4 132.99 37.57 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.556 -1.965 . . . . 9.11 107.278 170.787 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -106.37 151.27 25.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.628 2.156 . . . . 33.44 115.473 -170.164 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.35 3.6 m-20 -46.99 -55.05 8.82 Favored 'General case' 0 N--CA 1.43 -1.469 1 N-CA-C 123.673 4.694 . . . . 28.37 123.673 -164.766 . . . . . . . . 3 2 . 1 . 085 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 5.35 78.52 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 122.128 0.849 . . . . 15.0 113.016 -170.812 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -105.11 152.77 22.38 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.532 1.933 . . . . 25.5 111.626 -172.384 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 56.3 p -89.47 174.25 7.89 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 118.907 -0.568 . . . . 11.95 109.666 179.582 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.71 -34.91 60.39 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.021 0.915 . . . . 10.17 110.078 174.603 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.7 p -57.57 -40.93 80.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.507 3.523 . . . . 13.59 110.342 173.416 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.11 -44.92 32.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.654 -3.154 . . . . 11.7 115.904 174.952 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.313 98.3 m-85 -92.37 2.23 56.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.06 -2.9 . . . . 12.95 115.338 172.101 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.285 18.0 m120 65.38 38.99 5.45 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 117.724 2.491 . . . . 25.45 117.724 176.267 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.458 HG12 ' CE2' ' A' ' 45' ' ' PHE . 57.2 mt -74.19 138.67 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.665 2.386 . . . . 14.6 108.015 172.934 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -129.66 -167.07 1.75 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.83 -2.419 . . . . 33.23 108.125 -176.3 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -76.77 158.56 30.81 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.863 -3.023 . . . . 25.97 113.318 -173.836 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 68.05 20.32 9.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.967 -2.958 . . . . 32.61 113.306 177.043 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.8 t -106.56 143.49 34.6 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.106 2.962 . . . . 10.56 116.857 -172.682 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -100.97 129.44 46.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.696 0.998 . . . . 5.33 113.696 -173.993 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -104.12 152.56 21.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.474 -1.676 . . . . 11.66 106.474 173.171 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -115.74 124.53 51.02 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 116.863 -3.648 . . . . 16.3 108.677 -176.726 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tp -103.66 107.69 18.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.13 -1.606 . . . . 9.96 108.851 -170.075 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.89 158.81 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 124.874 1.359 . . . . 9.76 109.739 -179.265 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.7 tp . . . . . 0 N--CA 1.43 -1.446 0 CA-C-O 124.557 2.123 . . . . 19.57 112.394 -178.925 . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 121.559 0.695 . . . . 17.17 111.82 . . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -113.77 145.05 41.97 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.199 -4.688 . . . . 21.89 111.435 -172.196 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.26 161.55 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.339 -2.725 . . . . 10.83 109.15 169.799 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -105.11 145.33 30.68 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.259 2.624 . . . . 10.61 110.753 167.923 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -123.2 125.05 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.064 -1.648 . . . . 9.13 107.854 171.996 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -97.92 143.09 28.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.352 -2.717 . . . . 20.55 111.481 176.549 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.2 p -97.2 -177.28 3.79 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 122.407 2.367 . . . . 11.78 109.236 -173.611 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tt -76.68 -45.34 30.07 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 117.626 -1.178 . . . . 19.31 110.666 177.466 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -66.97 -54.55 20.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.264 1.393 . . . . 23.14 112.939 174.805 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.83 84.48 0.13 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 129.394 3.378 . . . . 19.74 114.18 168.328 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -132.83 152.71 51.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.845 -2.177 . . . . 21.93 106.976 171.843 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.291 26.2 m -108.83 108.61 19.47 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.465 -1.698 . . . . 12.33 112.407 171.986 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 mt -91.81 137.18 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 104.668 -2.345 . . . . 17.08 104.668 174.695 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 m -116.65 120.58 39.1 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.964 1.705 . . . . 16.3 111.629 175.533 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 29' ' ' LYS . 22.7 mt -114.13 146.64 40.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.551 -3.218 . . . . 15.88 107.601 179.968 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.68 137.85 32.03 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 116.012 -2.275 . . . . 28.9 114.573 148.915 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 m -140.73 157.84 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.314 2.646 . . . . 12.05 104.719 -171.286 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.54 145.75 31.29 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 101.893 -3.373 . . . . 18.17 101.893 165.703 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -78.19 -7.6 16.2 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 N-CA-C 118.389 2.419 . . . . 8.16 118.389 -174.453 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -100.46 14.64 30.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.957 -1.496 . . . . 11.13 110.614 178.566 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -107.9 160.47 15.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.912 2.142 . . . . 18.03 108.058 166.292 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -88.04 173.46 8.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 126.326 2.267 . . . . 10.22 112.748 -162.604 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mm -73.47 -26.8 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.26 -3.4 . . . . 12.3 110.027 -177.18 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.56 -21.95 66.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.45 -3.281 . . . . 36.51 117.159 169.914 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.29 -41.24 20.4 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 117.581 -1.2 . . . . 25.66 112.841 168.765 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.1 t -57.57 -40.94 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 127.547 3.03 . . . . 8.12 116.936 173.944 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -63.73 -41.58 98.03 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 131.781 4.033 . . . . 15.47 113.183 170.694 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.71 -25.42 65.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.319 2.009 . . . . 11.45 113.495 176.458 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB3' HD22 ' A' ' 15' ' ' LEU . 48.3 mttm -79.17 -31.23 43.85 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.257 -1.527 . . . . 24.98 112.783 173.66 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.41 -34.87 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 125.401 2.524 . . . . 9.46 112.504 170.249 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -60.0 -46.77 88.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.754 3.222 . . . . 14.76 115.849 166.671 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -54.07 -56.75 15.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.617 -3.177 . . . . 26.29 115.116 168.844 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -66.48 -80.29 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.402 -3.311 . . . . 30.06 116.829 171.703 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.89 -30.19 50.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 114.338 -5.226 . . . . 25.19 117.125 -178.126 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.18 5.17 50.06 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 125.011 3.55 . . . . 7.41 117.148 179.524 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mm -69.92 128.83 91.5 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 114.684 1.364 . . . . 9.49 114.684 -177.76 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -67.9 149.93 78.07 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 O-C-N 115.103 -3.157 . . . . 11.42 111.92 -170.428 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -73.68 -18.56 22.19 Favored 'Trans proline' 0 N--CA 1.433 -2.043 2 C-N-CA 127.794 5.663 . . . . 12.0 116.286 -175.853 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -68.86 -26.31 65.07 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.198 3.399 . . . . 35.55 115.258 168.797 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -95.08 -23.08 17.49 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.553 -1.658 . . . . 20.52 114.896 -172.598 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -85.75 118.43 25.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.678 -0.86 . . . . 7.13 108.678 -171.895 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -108.79 116.14 31.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.612 1.965 . . . . 36.39 106.983 171.476 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.56 111.58 23.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.87 1.356 . . . . 9.55 109.768 -176.788 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.93 125.09 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.062 -1.649 . . . . 13.9 106.789 179.562 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -117.71 127.16 53.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.381 2.991 . . . . 6.86 108.84 168.39 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.31 -98.11 0.08 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.425 -3.922 . . . . 11.15 113.466 -153.503 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.07 33.96 1.69 Allowed Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 127.426 2.441 . . . . 13.93 110.432 -179.523 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -145.05 143.15 30.3 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.515 1.626 . . . . 23.92 109.437 173.273 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -80.37 124.91 29.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.575 1.655 . . . . 23.23 114.194 -178.419 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -66.24 131.59 46.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.545 2.116 . . . . 9.11 109.184 172.813 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -82.71 158.85 22.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.633 -3.167 . . . . 33.44 113.107 178.158 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.22 -45.3 81.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.109 1.909 . . . . 28.37 115.304 -162.186 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.9 4.67 85.6 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 113.39 -1.732 . . . . 15.0 115.21 -178.434 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 -92.53 159.99 15.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 122.358 3.079 . . . . 25.5 108.735 178.969 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.4 p -86.57 171.19 11.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.72 1.248 . . . . 11.95 112.229 171.945 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.73 -33.76 66.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.334 -1.728 . . . . 10.17 106.334 172.222 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.5 p -65.7 -7.85 17.69 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 121.226 3.788 . . . . 13.59 121.226 174.179 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.11 -42.58 15.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.118 2.866 . . . . 11.7 109.518 -176.493 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -77.88 -13.56 59.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.678 2.391 . . . . 12.95 112.419 177.084 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 64.87 51.28 1.81 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.768 1.627 . . . . 25.45 112.956 -172.958 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -84.94 137.92 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.788 -2.301 . . . . 14.6 104.788 179.778 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -110.57 168.83 9.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.849 -2.407 . . . . 33.23 113.126 -175.369 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -66.81 155.41 38.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.511 -0.743 . . . . 25.97 111.569 174.221 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 50.2 mt-10 53.22 25.72 4.56 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.147 2.277 . . . . 32.61 117.147 -170.381 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 t -91.32 152.02 20.63 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.384 0.612 . . . . 10.56 110.765 169.695 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -107.98 121.37 44.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.45 3.9 . . . . 5.33 113.145 179.664 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -97.38 163.69 12.77 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.22 1.962 . . . . 11.66 107.034 174.896 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -119.34 129.36 54.81 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.503 -4.498 . . . . 16.3 109.141 175.603 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.3 tp -105.61 119.95 40.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.293 2.637 . . . . 9.96 112.013 179.928 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.458 ' HB ' ' H ' ' A' ' 71' ' ' LEU . 26.8 m -130.29 -160.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.412 1 CA-C-O 128.979 4.228 . . . . 9.76 111.05 168.903 . . . . . . . . 3 3 . 1 . 086 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.458 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 16.5 tp . . . . . 0 N--CA 1.43 -1.451 1 O-C-N 113.997 -5.439 . . . . 19.57 112.579 -168.842 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 123.704 1.716 . . . . 17.17 112.1 . . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -97.77 130.81 44.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.066 -2.896 . . . . 21.89 110.624 177.498 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.365 9.9 pt -129.67 157.67 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 124.752 1.221 . . . . 10.83 110.941 174.389 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -111.32 143.63 41.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.163 -1.791 . . . . 10.61 106.163 -177.134 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.68 127.5 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.482 -1.235 . . . . 9.13 107.993 167.82 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -106.13 129.4 54.22 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.533 1.635 . . . . 20.55 113.862 170.448 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -82.37 -175.15 5.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.414 1.635 . . . . 11.78 115.414 179.65 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.348 5.9 tp -67.02 -40.03 87.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.87 2.174 . . . . 19.31 116.87 177.635 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -73.05 -22.12 60.67 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.08 2.552 . . . . 23.14 112.238 -171.244 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.68 40.59 3.83 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 127.67 2.557 . . . . 19.74 109.757 -174.961 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -104.64 126.98 52.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.517 -2.073 . . . . 21.93 108.557 164.395 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -94.0 116.37 28.8 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.714 2.006 . . . . 12.33 113.412 173.827 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 pt -113.15 148.33 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.365 -2.709 . . . . 17.08 106.882 -179.291 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.436 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 15.7 m -98.81 129.37 45.21 Favored 'General case' 0 N--CA 1.43 -1.475 1 C-N-CA 134.003 4.921 . . . . 16.3 113.615 -178.21 . . . . . . . . 3 3 . 1 . 087 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.73 128.99 40.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.78 -3.075 . . . . 15.88 102.993 -177.494 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -87.16 93.97 9.52 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.721 2.808 . . . . 28.9 109.825 164.724 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.441 HG12 ' HD2' ' A' ' 29' ' ' LYS . 5.3 m -121.14 154.59 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 123.531 2.878 . . . . 12.05 109.494 175.973 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.88 140.09 37.43 Favored Pre-proline 0 N--CA 1.43 -1.426 0 C-N-CA 129.434 3.094 . . . . 18.17 110.841 -178.717 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -79.87 -3.56 12.86 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 124.518 2.649 . . . . 8.16 109.432 -167.746 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -83.95 -26.02 29.61 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 114.929 -2.462 . . . . 11.13 113.368 -176.093 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -84.2 163.02 19.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.79 2.036 . . . . 18.03 114.25 -174.424 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -70.11 158.12 36.32 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.27 1.581 . . . . 10.22 115.27 -177.225 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mm -63.52 -19.94 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 125.762 2.696 . . . . 12.3 116.954 166.382 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -74.89 -27.37 60.2 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.83 -3.044 . . . . 36.51 113.878 179.869 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -70.11 -34.05 72.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.521 2.328 . . . . 25.66 112.912 175.049 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.49 -56.93 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 CA-C-O 129.166 4.317 . . . . 8.12 110.717 175.967 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.14 -27.13 61.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.845 -3.034 . . . . 15.47 114.604 -171.854 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.19 83.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.72 2.2 . . . . 11.45 109.286 -178.898 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HD2' HG12 ' A' ' 17' ' ' VAL . 50.5 mttm -78.35 -35.65 47.17 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.285 -1.51 . . . . 24.98 108.576 -174.261 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mt -67.87 -32.26 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 125.796 2.712 . . . . 9.46 108.233 177.183 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -69.04 -56.28 8.23 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 116.165 -4.084 . . . . 14.76 110.039 174.553 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -58.73 -24.07 60.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.061 1.744 . . . . 26.29 114.329 -178.871 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 14' ' ' THR . 50.6 mttm -78.13 -80.66 0.11 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.484 -2.01 . . . . 30.06 112.778 165.536 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -99.06 10.69 40.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.11 -3.494 . . . . 25.19 115.826 -161.124 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.87 3.5 90.46 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 117.995 -2.941 . . . . 7.41 116.6 -175.736 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.6 mt -77.59 115.69 51.81 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 118.906 1.353 . . . . 9.49 111.202 -169.599 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 40.4 Cg_exo -67.95 142.31 56.42 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 O-C-N 114.313 -3.572 . . . . 11.42 112.342 -179.355 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 65.3 Cg_exo -62.87 -21.68 73.29 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 N-CA-C 119.772 2.951 . . . . 12.0 119.772 -173.167 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -56.69 -39.06 73.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.665 1.586 . . . . 35.55 113.594 171.25 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -80.17 7.36 9.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.199 2.296 . . . . 20.52 117.199 -173.923 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -113.89 117.98 32.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 114.79 -2.529 . . . . 7.13 110.642 -160.344 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -128.62 115.78 18.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.681 3.738 . . . . 36.39 113.011 170.985 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.9 mt -92.89 125.89 37.71 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 116.276 -4.015 . . . . 9.55 111.81 -173.844 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -105.37 126.08 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.618 1.967 . . . . 13.9 109.518 172.132 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -110.22 120.0 41.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.896 3.236 . . . . 6.86 105.401 171.886 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.409 . . 59.77 -91.07 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.548 -3.845 . . . . 11.15 118.394 -164.818 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.23 13.01 5.75 Favored Glycine 0 N--CA 1.43 -1.729 1 CA-C-O 111.115 -5.269 . . . . 13.93 109.957 160.847 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -93.31 135.86 34.13 Favored 'General case' 0 N--CA 1.43 -1.433 1 CA-C-N 124.549 4.175 . . . . 23.92 110.963 -176.918 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -75.07 99.92 4.06 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 113.938 -5.477 . . . . 23.23 113.324 167.354 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.6 mt -69.77 136.94 51.48 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.253 -3.404 . . . . 9.11 113.912 178.265 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.48 136.18 38.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.286 -1.325 . . . . 33.44 113.475 -177.938 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.75 -30.79 68.47 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 115.055 1.502 . . . . 28.37 115.055 -156.27 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.5 23.54 12.27 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 115.716 -2.713 . . . . 15.0 115.316 179.727 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -125.42 174.48 8.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.085 2.943 . . . . 25.5 106.841 175.56 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -96.04 167.41 11.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.728 1.728 . . . . 11.95 114.875 179.949 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.575 ' H ' HD12 ' A' ' 56' ' ' LEU . 5.3 mp -56.39 -43.72 79.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.111 2.862 . . . . 10.17 114.383 162.535 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.3 p -61.1 -19.44 61.46 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 114.374 -5.204 . . . . 13.59 119.243 170.831 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -58.7 -52.38 65.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.308 2.336 . . . . 11.7 117.308 167.304 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -88.36 -13.33 40.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.596 3.558 . . . . 12.95 115.002 177.884 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 m120 73.92 58.08 0.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.332 -1.729 . . . . 25.45 106.332 167.749 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -85.73 121.61 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.861 2.267 . . . . 14.6 107.055 166.571 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -107.03 175.09 5.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 109.548 -3.478 . . . . 33.23 107.306 -174.913 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -58.61 137.08 57.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.005 -2.309 . . . . 25.97 116.862 -176.318 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 84.47 7.39 0.54 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.679 3.992 . . . . 32.61 113.96 170.18 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 t -72.46 134.38 45.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.131 -1.395 . . . . 10.56 110.678 -175.496 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.5 m -102.26 103.08 13.54 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.706 -3.746 . . . . 5.33 113.418 -171.785 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.63 159.55 14.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.231 -3.248 . . . . 11.66 102.231 -165.085 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -101.73 140.85 35.46 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 118.181 -2.824 . . . . 16.3 108.92 170.897 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.5 tp -102.22 136.66 41.66 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 102.138 -3.282 . . . . 9.96 102.138 169.369 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 m -134.71 175.01 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.615 2.366 . . . . 9.76 105.991 173.576 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.6 tp . . . . . 0 N--CA 1.43 -1.447 0 CA-C-N 112.235 -2.257 . . . . 19.57 116.685 -171.341 . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ptt? . . . . . 0 CA--C 1.491 -1.309 0 CA-C-O 125.056 2.36 . . . . 17.17 109.477 . . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -104.57 138.93 40.19 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.796 -2.456 . . . . 21.89 110.883 -172.822 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.284 44.0 pt -136.21 144.84 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 102.505 -3.146 . . . . 10.83 102.505 165.785 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -107.97 139.05 43.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.52 0.728 . . . . 10.61 109.647 173.903 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.7 t -121.58 114.38 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.657 -2.349 . . . . 9.13 104.657 179.027 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -83.89 124.79 31.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.115 2.388 . . . . 20.55 105.405 166.283 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.323 17.7 p -77.85 178.24 7.57 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.962 2.315 . . . . 11.78 110.2 -174.886 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 tp -78.38 -32.7 49.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.274 -3.391 . . . . 19.31 111.705 171.947 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -74.79 -33.19 62.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.966 -2.333 . . . . 23.14 113.44 170.576 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.42 60.26 0.52 Allowed Glycine 0 N--CA 1.429 -1.77 0 CA-C-O 123.197 1.443 . . . . 19.74 115.124 169.436 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -118.54 152.5 35.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.563 1.945 . . . . 21.93 113.585 162.099 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -105.72 96.89 6.81 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.248 1.975 . . . . 12.33 108.813 174.084 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.286 3.4 pt -89.45 150.24 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.407 -3.308 . . . . 17.08 109.943 -179.98 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -111.22 124.4 52.14 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.819 -0.752 . . . . 16.3 110.573 -176.046 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.66 147.11 29.93 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.865 1.317 . . . . 15.88 108.045 176.897 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -105.35 90.36 3.4 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 130.051 3.34 . . . . 28.9 111.599 166.327 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.95 162.1 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 125.975 2.797 . . . . 12.05 112.528 175.979 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.43 147.83 33.55 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 119.461 -2.024 . . . . 18.17 106.601 173.738 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.37 -9.47 23.08 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-O 115.99 -1.754 . . . . 8.16 111.939 -177.54 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.5 p -88.62 -3.92 58.68 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.258 2.623 . . . . 11.13 114.238 173.078 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -68.84 148.6 50.02 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.374 -2.454 . . . . 18.03 104.374 178.897 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.8 p -87.9 155.13 20.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.62 -1.173 . . . . 10.22 109.789 172.096 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.6 mm -52.08 -37.57 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 128.461 2.704 . . . . 12.3 110.69 176.605 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.83 -42.53 99.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.685 3.194 . . . . 36.51 114.978 174.924 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -67.06 -36.28 81.67 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.751 -2.022 . . . . 25.66 115.171 173.186 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.72 -37.33 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 114.569 1.322 . . . . 8.12 114.569 177.663 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -57.51 -42.02 81.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.206 -2.809 . . . . 15.47 117.898 171.966 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.16 -31.68 61.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.128 2.269 . . . . 11.45 117.128 170.889 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -67.76 -36.2 80.08 Favored 'General case' 0 N--CA 1.43 -1.44 1 N-CA-C 122.081 4.104 . . . . 24.98 122.081 165.094 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.5 mt -57.71 -40.58 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 116.17 1.915 . . . . 9.46 116.17 159.821 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -56.89 -40.68 76.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 113.617 -3.087 . . . . 14.76 117.224 162.481 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -65.77 -38.07 88.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.622 3.076 . . . . 26.29 111.694 177.717 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -73.88 -70.39 0.38 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.697 1.999 . . . . 30.06 115.191 178.226 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -92.4 -9.28 42.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.495 3.517 . . . . 25.19 120.495 -172.335 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.52 53.27 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 117.678 -3.139 . . . . 7.41 109.777 177.535 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.6 mt -107.45 123.28 38.58 Favored Pre-proline 0 N--CA 1.43 -1.469 0 O-C-N 125.331 1.254 . . . . 9.49 109.879 -178.518 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.02 127.72 27.23 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 124.098 3.199 . . . . 11.42 115.084 177.903 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -63.75 -7.61 13.43 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 125.059 3.839 . . . . 12.0 116.762 171.586 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -68.83 -28.62 66.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.716 2.487 . . . . 35.55 117.716 164.263 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -101.99 4.37 39.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.025 -3.547 . . . . 20.52 111.182 -172.324 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.436 ' HG2' HD11 ' A' ' 69' ' ' LEU . 70.7 mt-30 -95.02 134.32 37.83 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.285 1.993 . . . . 7.13 113.04 -173.804 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.307 40.1 ttm180 -133.07 107.38 8.19 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.172 -1.831 . . . . 36.39 111.309 168.725 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.48 116.87 12.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 114.319 -2.753 . . . . 9.55 112.867 170.979 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 49' ' ' GLN . 34.3 mm -109.07 135.95 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 123.151 2.705 . . . . 13.9 113.346 171.186 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -112.99 114.48 26.97 Favored 'General case' 0 N--CA 1.429 -1.475 2 O-C-N 113.141 -5.975 . . . . 6.86 110.074 173.802 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.365 . . 68.18 -87.58 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.176 -3.452 . . . . 11.15 113.879 -170.012 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.64 5.03 6.2 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 126.253 1.882 . . . . 13.93 111.643 163.394 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -92.38 120.82 33.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 118.558 1.179 . . . . 23.92 113.638 -171.099 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HA ' HD13 ' A' ' 44' ' ' ILE . 32.6 tt0 -82.17 111.87 18.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.373 3.464 . . . . 23.23 112.88 173.058 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -69.53 139.74 53.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.209 -2.807 . . . . 9.11 110.007 -173.232 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -81.54 156.73 25.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.832 -1.556 . . . . 33.44 109.593 169.156 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -84.03 -47.27 11.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.027 1.739 . . . . 28.37 111.847 -167.695 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.98 37.91 2.36 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 116.514 -3.866 . . . . 15.0 117.658 176.957 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HD2' ' CE2' ' A' ' 59' ' ' TYR . 77.6 mtt-85 -113.2 178.12 4.39 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.575 -2.72 . . . . 25.5 110.736 164.361 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.8 p -101.55 173.81 6.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.338 -1.476 . . . . 11.95 111.62 168.695 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 61' ' ' ILE . 35.6 mt -67.79 -26.92 66.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.344 1.069 . . . . 10.17 112.175 171.597 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.5 p -82.36 -25.14 34.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.096 1.358 . . . . 13.59 111.738 -175.992 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -58.05 -39.9 79.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 123.193 2.724 . . . . 11.7 116.453 162.339 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CE2' ' HD2' ' A' ' 54' ' ' ARG 0.297 24.3 m-85 -89.93 3.7 52.27 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.552 2.427 . . . . 12.95 117.552 175.843 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 73.4 m-20 67.82 38.73 2.81 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.475 1.51 . . . . 25.45 112.133 171.161 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.417 HD12 HD23 ' A' ' 56' ' ' LEU . 69.9 mt -89.71 108.84 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.167 -2.16 . . . . 14.6 105.167 178.847 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -83.67 174.85 10.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 128.069 3.795 . . . . 33.23 110.31 174.249 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -66.68 158.52 29.86 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.258 -3.401 . . . . 25.97 112.846 176.568 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.316 10.5 mt-10 57.28 20.76 6.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.357 2.263 . . . . 32.61 116.638 -179.919 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 m -80.57 129.8 34.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.227 2.611 . . . . 10.56 115.96 172.808 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 m -90.45 116.86 28.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.788 -3.07 . . . . 5.33 111.354 172.836 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -91.6 155.61 18.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.403 -2.073 . . . . 11.66 105.403 174.123 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -106.23 152.23 23.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 114.325 -2.95 . . . . 16.3 110.39 169.088 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.436 HD11 ' HG2' ' A' ' 41' ' ' GLN . 28.4 tp -121.95 113.32 19.44 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.918 3.886 . . . . 9.96 109.533 174.685 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 m -121.47 -172.43 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 128.617 2.767 . . . . 9.76 104.897 178.17 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 124.901 2.286 . . . . 19.57 110.123 -164.834 . . . . . . . . 0 0 . 1 . 089 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.573 1.323 . . . . 17.17 114.573 . . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.68 129.73 38.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 126.911 3.243 . . . . 21.89 107.673 -167.98 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.301 24.9 pt -124.21 154.21 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 O-C-N 117.023 -3.548 . . . . 10.83 110.077 171.831 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -114.21 136.32 53.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.532 1.933 . . . . 10.61 114.092 -178.858 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.6 t -117.31 103.39 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 100.322 -3.955 . . . . 9.13 100.322 178.309 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -94.42 152.78 18.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.104 -3.497 . . . . 20.55 110.105 -177.713 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.269 58.4 p -106.71 175.77 5.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 118.005 2.595 . . . . 11.78 118.005 -163.743 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.4 tp -77.52 -51.79 10.14 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.621 -1.172 . . . . 19.31 113.25 167.92 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 81.7 p -64.47 -59.71 4.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.197 -3.439 . . . . 23.14 115.252 174.773 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.77 -35.98 0.21 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 114.933 -3.148 . . . . 19.74 118.931 179.078 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -82.96 98.98 9.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 125.905 1.591 . . . . 21.93 110.107 -168.193 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -50.92 133.54 26.7 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.783 1.401 . . . . 12.33 114.783 178.441 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 mt -93.4 129.92 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 129.488 3.115 . . . . 17.08 106.891 176.426 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.3 m -119.6 111.43 18.06 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.854 -3.654 . . . . 16.3 108.493 -170.177 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.7 mt -113.8 149.62 34.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.499 -2.625 . . . . 15.88 111.82 178.22 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -104.67 136.34 44.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.329 -1.482 . . . . 28.9 110.65 163.172 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 m -132.82 172.64 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.021 -1.675 . . . . 12.05 107.641 -173.142 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -113.28 150.37 42.96 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 102.31 -3.218 . . . . 18.17 102.31 166.797 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.87 -2.97 13.21 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 CA-C-N 122.943 2.087 . . . . 8.16 116.468 -175.547 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -70.82 -25.49 62.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 128.284 3.49 . . . . 11.13 117.078 159.037 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -67.81 150.45 48.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 129.407 3.083 . . . . 18.03 110.79 179.646 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -98.1 160.45 14.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.035 -2.888 . . . . 10.22 114.41 -173.865 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.7 mm -52.44 -32.53 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 121.668 2.031 . . . . 12.3 113.065 166.441 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.32 1.5 tt0 -51.78 -51.27 57.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 117.873 2.546 . . . . 36.51 117.873 160.761 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -63.71 -33.31 75.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 124.531 3.332 . . . . 25.66 111.036 177.344 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.12 -37.65 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.639 -1.913 . . . . 8.12 109.564 177.595 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.794 1.775 . . . . 15.47 115.794 173.486 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.39 -19.25 62.29 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.736 1.614 . . . . 11.45 114.595 -179.079 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -91.21 -19.82 22.63 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.735 -3.103 . . . . 24.98 108.179 176.535 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.9 mt -76.71 -34.15 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 117.803 -3.061 . . . . 9.46 108.476 167.098 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -52.86 -49.05 66.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.646 2.165 . . . . 14.76 110.962 169.823 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.04 -52.96 44.31 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.946 1.699 . . . . 26.29 110.427 -178.204 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -67.43 -69.23 0.33 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.196 -1.565 . . . . 30.06 115.052 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -87.81 -53.99 4.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.418 -2.676 . . . . 25.19 113.389 -175.518 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.05 54.21 0.39 Allowed Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 117.632 1.813 . . . . 7.41 117.632 -165.601 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.43 123.61 27.56 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 128.377 3.046 . . . . 9.49 104.859 176.022 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.69 125.25 18.41 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 124.837 3.691 . . . . 11.42 113.44 168.224 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.74 -28.17 55.84 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 121.336 3.552 . . . . 12.0 121.336 174.192 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.25 17.1 p-10 -51.73 -37.22 50.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.242 2.312 . . . . 35.55 117.242 167.174 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -86.91 -7.79 57.86 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.918 1.451 . . . . 20.52 114.918 -175.892 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -89.06 141.36 28.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.059 2.361 . . . . 7.13 114.284 177.92 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -132.66 140.78 48.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.902 3.239 . . . . 36.39 106.155 164.018 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -118.81 130.59 55.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.674 -3.766 . . . . 9.55 105.668 -177.683 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.7 tt -122.92 133.14 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.149 -3.47 . . . . 13.9 110.129 174.154 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -82.76 -66.75 0.85 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.193 1.949 . . . . 6.86 109.458 174.389 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.81 -75.4 0.58 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.152 3.381 . . . . 11.15 115.547 -178.847 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.89 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.081 -0.963 . . . . 13.93 115.403 -174.306 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -83.51 138.06 33.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.596 1.665 . . . . 23.92 110.373 -172.938 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.21 133.87 36.06 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 118.484 2.772 . . . . 23.23 118.484 -169.757 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.3 mt -90.36 151.15 21.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.438 2.695 . . . . 9.11 113.927 -169.724 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -100.59 137.31 39.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.409 3.083 . . . . 33.44 109.873 177.892 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -72.32 -50.35 27.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.439 -2.663 . . . . 28.37 104.969 -157.537 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.4 37.75 3.32 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 118.123 -2.861 . . . . 15.0 110.874 -169.623 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -93.14 152.51 19.2 Favored 'General case' 0 N--CA 1.431 -1.413 1 C-N-CA 132.929 4.491 . . . . 25.5 111.756 158.594 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.1 p -97.96 171.55 8.2 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.957 1.837 . . . . 11.95 106.416 -172.24 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.14 -47.42 68.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.558 1.647 . . . . 10.17 112.571 173.276 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -84.96 -11.35 55.71 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.477 3.111 . . . . 13.59 113.932 -173.17 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.1 -47.99 77.87 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.705 1.717 . . . . 11.7 108.657 164.277 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -93.0 12.45 23.94 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 114.837 -4.914 . . . . 12.95 112.214 -176.464 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 59.92 31.07 20.53 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.279 2.232 . . . . 25.45 111.205 171.954 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.3 mt -82.45 120.75 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 124.204 1.001 . . . . 14.6 108.535 177.384 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -100.7 -172.31 2.17 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.962 1.363 . . . . 33.23 113.284 179.419 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -69.15 151.15 46.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.403 -3.31 . . . . 25.97 115.829 177.342 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 28.4 mt-10 66.66 20.28 10.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.429 2.692 . . . . 32.61 112.214 177.711 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -88.07 144.08 26.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.431 1.892 . . . . 10.56 112.87 179.833 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -97.79 122.33 40.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.395 -1.729 . . . . 5.33 107.371 -174.363 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mp -97.19 166.41 11.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.796 3.238 . . . . 11.66 108.418 159.238 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -137.57 132.17 32.73 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.496 -2.628 . . . . 16.3 111.656 174.411 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.6 tp -87.98 121.6 30.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.14 2.576 . . . . 9.96 106.6 -171.069 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.9 t -113.69 113.2 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 128.266 2.626 . . . . 9.76 112.312 175.42 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 N--CA 1.431 -1.423 1 O-C-N 115.819 -4.301 . . . . 19.57 112.128 -171.26 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 CA--C 1.489 -1.374 0 CA-C-O 120.865 0.364 . . . . 17.17 111.1 . . . . . . . . . 0 0 . 1 . 090 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -94.51 112.17 23.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.546 2.117 . . . . 21.89 111.099 -176.065 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 pt -120.31 150.99 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 116.379 -3.951 . . . . 10.83 111.833 174.039 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -116.27 150.52 37.46 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.606 -1.998 . . . . 10.61 105.606 -174.248 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.2 t -132.18 135.42 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 100.423 -3.917 . . . . 9.13 100.423 -176.539 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -119.81 143.49 47.84 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.735 3.159 . . . . 20.55 107.17 175.36 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.2 p -83.85 -175.43 5.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.082 -3.511 . . . . 11.78 114.212 172.82 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.1 tp -66.57 -51.53 55.41 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.826 -0.435 . . . . 19.31 109.826 -176.9 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -75.07 -31.96 61.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.252 -1.356 . . . . 23.14 109.004 -177.567 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.11 71.62 0.6 Allowed Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 122.95 2.613 . . . . 19.74 116.206 174.012 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -118.81 147.9 43.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 100.471 -3.9 . . . . 21.93 100.471 159.915 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 m -104.06 116.15 31.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.316 1.446 . . . . 12.33 108.439 -179.488 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -81.07 128.92 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.793 -2.299 . . . . 17.08 104.793 166.122 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.0 m -104.74 135.02 46.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.645 0.657 . . . . 16.3 109.846 173.288 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.4 mt -122.43 119.67 31.67 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 118.572 2.805 . . . . 15.88 118.572 179.984 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -86.79 103.33 15.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.912 1.233 . . . . 28.9 108.715 167.509 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 m -110.23 169.59 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 129.574 3.15 . . . . 12.05 109.698 179.447 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -108.03 145.67 31.9 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 117.488 -1.244 . . . . 18.17 110.044 177.227 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.335 42.4 Cg_exo -47.51 -36.03 23.32 Favored 'Trans proline' 0 C--N 1.3 -2.02 1 N-CA-C 123.002 4.193 . . . . 8.16 123.002 -175.238 . . . . . . . . 3 2 . 1 . 090 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.18 5.37 34.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.11 2.164 . . . . 11.13 114.567 176.947 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -62.1 132.38 52.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.082 -2.886 . . . . 18.03 116.212 176.623 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.266 8.0 p -67.14 161.84 23.74 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.857 -4.277 . . . . 10.22 107.591 171.915 . . . . . . . . 3 2 . 1 . 090 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -61.55 -41.29 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.007 -2.308 . . . . 12.3 115.498 171.064 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -64.2 -27.53 69.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.814 2.552 . . . . 36.51 112.725 172.665 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -70.14 -34.94 73.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.956 -1.715 . . . . 25.66 112.735 169.411 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.52 -41.89 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 1 O-C-N 115.419 -4.551 . . . . 8.12 116.914 169.493 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -54.95 -29.46 56.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.532 2.733 . . . . 15.47 115.713 166.024 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.19 -32.47 66.85 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 118.431 -0.795 . . . . 11.45 110.991 -177.111 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -70.25 -20.33 63.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.959 1.838 . . . . 24.98 114.965 170.3 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -86.19 -28.47 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 O-C-N 115.537 -4.477 . . . . 9.46 111.531 177.111 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -64.57 -40.35 95.4 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.744 4.018 . . . . 14.76 109.484 174.358 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.6 -50.49 15.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.107 -0.996 . . . . 26.29 111.064 173.922 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -73.15 -70.05 0.38 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.521 1.674 . . . . 30.06 115.521 -175.956 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.69 -50.88 55.35 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.853 0.751 . . . . 25.19 112.658 -177.64 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.54 21.72 10.29 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 118.332 2.093 . . . . 7.41 118.332 -176.37 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 71' ' ' LEU . 17.1 mt -82.85 126.59 72.52 Favored Pre-proline 0 N--CA 1.43 -1.471 0 C-N-CA 127.082 2.153 . . . . 9.49 108.9 168.743 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -72.63 167.96 25.72 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-O 117.187 -1.255 . . . . 11.42 110.195 -172.455 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 12.2 Cg_endo -86.08 -15.86 4.45 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 CA-C-N 124.557 2.663 . . . . 12.0 112.676 -169.302 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -73.14 -32.82 65.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.32 1.533 . . . . 35.55 115.059 171.258 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -76.32 -36.04 58.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.526 1.631 . . . . 20.52 114.779 -177.943 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.254 72.0 mt-30 -64.15 135.42 56.32 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.526 3.536 . . . . 7.13 113.36 170.532 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -131.97 116.16 16.78 Favored 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 132.001 4.12 . . . . 36.39 108.893 169.784 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -97.24 144.22 27.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.558 1.786 . . . . 9.55 109.51 176.569 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 tp -139.72 137.16 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 119.168 -2.208 . . . . 13.9 113.49 171.388 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.338 76.7 t80 -88.18 -62.06 1.57 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.266 -0.896 . . . . 6.86 113.347 171.772 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.8 -89.17 0.28 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.881 -1.525 . . . . 11.15 106.881 -177.763 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.76 9.01 2.56 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-O 116.303 -2.387 . . . . 13.93 116.815 175.964 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -82.64 131.98 35.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 121.311 2.556 . . . . 23.92 110.121 162.798 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -75.13 114.0 13.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.364 2.03 . . . . 23.23 111.189 -177.928 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.335 10.2 mt -73.08 101.57 3.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 130.06 3.344 . . . . 9.11 111.716 -177.924 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HB2' ' HG3' ' A' ' 54' ' ' ARG . 45.2 mt-10 -67.81 -172.92 0.3 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.908 -2.995 . . . . 33.44 116.475 170.172 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.58 -63.49 1.32 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.993 -4.192 . . . . 28.37 113.973 -176.143 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.96 40.32 2.85 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 125.574 1.559 . . . . 15.0 115.842 -170.625 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 51' ' ' GLU . 21.6 mmt180 -124.46 145.2 49.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.67 -1.974 . . . . 25.5 105.67 -174.061 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.528 1.1 p -89.36 157.15 18.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.747 3.641 . . . . 11.95 116.347 -169.032 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.7 mt -63.02 -36.33 83.19 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 116.041 -4.162 . . . . 10.17 110.346 174.418 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 t -65.39 -42.01 93.1 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.27 3.028 . . . . 13.59 112.077 -177.546 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.41 -14.43 57.14 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.602 2.144 . . . . 11.7 110.744 -171.262 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -103.27 4.64 36.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.708 -3.745 . . . . 12.95 103.93 176.919 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 50.51 47.2 24.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.576 2.751 . . . . 25.45 117.521 -176.461 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.0 mt -84.39 106.55 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 112.664 -2.062 . . . . 14.6 109.23 172.328 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -104.96 -174.17 2.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.083 -2.326 . . . . 33.23 110.958 -167.646 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -83.97 136.08 34.21 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.536 1.516 . . . . 25.97 112.399 -161.761 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.298 18.2 mt-10 81.38 20.75 0.37 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.296 1.838 . . . . 32.61 115.909 -169.368 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -70.54 131.82 44.58 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 116.679 -1.629 . . . . 10.56 111.972 172.081 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.4 m -103.57 125.82 50.34 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.246 -1.391 . . . . 5.33 107.246 -179.536 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -109.52 164.16 12.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.397 -2.689 . . . . 11.66 106.562 -173.262 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -117.12 139.6 50.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.566 -3.209 . . . . 16.3 110.198 176.811 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -106.23 104.04 13.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.713 2.805 . . . . 9.96 111.475 -178.222 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -97.05 140.4 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.345 -1.752 . . . . 9.76 111.54 174.236 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.442 HD21 HG21 ' A' ' 36' ' ' ILE . 37.6 mt . . . . . 0 N--CA 1.43 -1.451 0 CA-C-N 119.718 1.145 . . . . 19.57 112.744 162.314 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 ttp . . . . . 0 CA--C 1.489 -1.374 0 CA-C-O 121.746 0.784 . . . . 17.17 112.989 . . . . . . . . . 0 0 . 1 . 091 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -84.77 121.35 27.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.396 -2.69 . . . . 21.89 110.293 -175.451 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -127.7 168.88 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 123.191 2.723 . . . . 10.83 110.974 160.187 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -120.47 147.69 44.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 125.064 1.477 . . . . 10.61 110.929 -176.635 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -117.08 118.93 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 C-N-CA 131.782 4.033 . . . . 9.13 112.365 163.774 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -103.46 124.89 49.58 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.859 -2.401 . . . . 20.55 111.563 176.701 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.305 34.7 p -77.79 175.56 9.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.105 1.431 . . . . 11.78 113.44 -174.594 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.499 ' HA ' ' HE1' ' A' ' 68' ' ' HIS . 52.1 tp -65.07 -55.27 19.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.358 2.663 . . . . 19.31 115.378 -178.788 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.3 p -60.73 -62.75 1.63 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.881 1.219 . . . . 23.14 110.633 165.253 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.24 64.14 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 122.417 2.371 . . . . 19.74 115.092 176.875 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -118.7 128.26 54.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 114.019 -2.896 . . . . 21.93 106.885 178.197 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -109.46 115.37 29.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 125.471 3.76 . . . . 12.33 101.681 -173.866 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.27 132.07 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 119.002 -2.312 . . . . 17.08 109.888 178.102 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.9 m -98.38 119.65 37.43 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.109 -4.12 . . . . 16.3 111.196 179.361 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.9 mt -106.39 162.55 13.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.966 2.506 . . . . 15.88 109.928 -175.477 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -135.22 97.68 3.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 101.689 -3.449 . . . . 28.9 101.689 178.734 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 m -105.66 163.15 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 117.416 2.376 . . . . 12.05 117.416 -174.666 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.256 2.9 mp0 -73.46 138.57 77.86 Favored Pre-proline 0 N--CA 1.431 -1.422 0 CA-C-O 114.749 -2.548 . . . . 18.17 108.285 162.35 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -58.97 -24.53 73.6 Favored 'Trans proline' 0 C--N 1.299 -2.04 1 C-N-CA 128.073 5.848 . . . . 8.16 119.442 -179.868 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -117.41 28.63 8.35 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 122.454 4.242 . . . . 11.13 122.454 173.437 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -77.18 170.7 16.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.402 -2.061 . . . . 18.03 113.802 -179.289 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.328 69.0 p -90.48 154.39 19.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.418 2.007 . . . . 10.22 116.418 -174.982 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.4 -19.84 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 119.447 1.021 . . . . 12.3 112.237 178.003 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -62.77 -39.43 94.16 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.138 -4.101 . . . . 36.51 106.359 166.435 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -82.01 -29.55 31.97 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.213 2.279 . . . . 25.66 112.457 -174.398 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.36 40.5 t -46.22 -62.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 118.012 -2.93 . . . . 8.12 114.544 154.252 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -54.21 -39.67 66.93 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.039 2.237 . . . . 15.47 117.039 172.039 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.29 92.5 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.641 -4.412 . . . . 11.45 111.852 173.919 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -61.36 -38.82 88.38 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.417 2.377 . . . . 24.98 117.417 163.063 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.267 72.5 mt -63.35 -41.53 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 122.145 2.248 . . . . 9.46 116.132 172.497 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.75 -40.49 92.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.067 1.747 . . . . 14.76 115.324 173.689 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.02 -50.18 74.76 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 125.828 2.728 . . . . 26.29 115.629 173.107 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -75.31 -68.27 0.57 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 109.405 -3.543 . . . . 30.06 115.377 -175.121 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -87.82 -16.3 34.45 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.743 3.617 . . . . 25.19 111.445 -170.729 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.39 13.15 83.56 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 120.534 2.974 . . . . 7.41 120.534 -178.942 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -76.03 115.67 48.74 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 116.521 -1.704 . . . . 9.49 110.622 176.84 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.07 155.43 45.04 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 C-N-CA 123.673 2.915 . . . . 11.42 109.805 -172.797 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.41 -25.66 17.97 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 124.071 2.49 . . . . 12.0 112.376 -167.782 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.84 -40.55 88.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.305 -3.372 . . . . 35.55 108.864 -175.087 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.432 ' OE1' HD23 ' A' ' 71' ' ' LEU . 7.2 tt0 -63.33 -23.75 67.55 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.519 -1.673 . . . . 20.52 114.446 -177.974 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -87.91 131.7 34.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 126.417 3.008 . . . . 7.13 118.295 -173.628 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -120.06 106.16 11.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.126 -2.859 . . . . 36.39 110.23 166.629 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.52 132.75 36.07 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 115.56 -4.463 . . . . 9.55 113.299 175.698 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.5 mt -106.88 141.92 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.516 2.327 . . . . 13.9 107.931 176.815 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -91.5 -83.03 0.29 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.328 2.489 . . . . 6.86 107.792 163.04 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.05 -71.43 0.74 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.473 1.909 . . . . 11.15 115.887 176.459 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.74 -41.66 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 124.083 1.935 . . . . 13.93 114.207 -166.886 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -103.38 155.36 18.54 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 121.493 -1.004 . . . . 23.92 112.94 -169.594 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -86.59 132.08 33.99 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.016 2.599 . . . . 23.23 118.016 -156.396 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -92.84 146.2 23.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.395 2.309 . . . . 9.11 109.93 -174.398 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.98 153.45 17.9 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.145 -3.472 . . . . 33.44 106.573 177.767 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.66 -63.17 1.3 Allowed 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.066 -4.772 . . . . 28.37 114.315 -178.906 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.06 35.55 3.4 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 119.229 -1.462 . . . . 15.0 110.451 -172.225 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -106.55 161.18 14.84 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.367 -5.196 . . . . 25.5 111.478 164.813 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -97.89 171.96 7.96 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 114.284 -5.26 . . . . 11.95 111.878 -166.842 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.79 -37.09 78.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 112.863 -1.971 . . . . 10.17 109.027 169.338 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 t -81.71 -10.7 59.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 123.881 0.872 . . . . 13.59 112.71 -169.012 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.13 -50.29 12.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.504 3.526 . . . . 11.7 114.815 173.694 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -82.8 -20.71 35.22 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.949 -4.845 . . . . 12.95 112.164 179.849 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 23.2 m-80 72.63 65.94 0.12 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.233 3.049 . . . . 25.45 119.233 179.862 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.7 mt -106.13 93.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 109.157 -3.656 . . . . 14.6 105.104 -178.894 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -85.3 -166.19 1.43 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.033 -3.542 . . . . 33.23 114.381 179.223 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.368 14.8 pttp -62.43 134.85 57.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.36 -3.338 . . . . 25.97 114.271 -177.068 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.322 21.5 mt-10 70.05 15.87 7.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.527 2.047 . . . . 32.61 116.527 169.23 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.7 m -61.45 140.32 58.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.068 3.347 . . . . 10.56 112.457 159.427 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -110.54 111.03 21.99 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 119.865 1.212 . . . . 5.33 113.515 175.24 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.6 mt -78.86 153.46 30.56 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.276 -2.14 . . . . 11.66 108.605 173.589 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.499 ' HE1' ' HA ' ' A' ' 8' ' ' LEU . 11.9 t60 -121.79 137.56 54.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.323 2.011 . . . . 16.3 107.619 175.935 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.3 tp -116.19 124.91 51.46 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.454 -2.029 . . . . 9.96 109.019 -174.668 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.8 t -112.08 139.68 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 125.039 1.336 . . . . 9.76 110.068 -179.53 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.432 HD23 ' OE1' ' A' ' 40' ' ' GLN . 7.8 mp . . . . . 0 N--CA 1.43 -1.431 0 C-N-CA 115.861 -2.336 . . . . 19.57 113.942 -176.682 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 CA--C 1.491 -1.326 0 N-CA-C 114.308 1.225 . . . . 17.17 114.308 . . . . . . . . . 0 0 . 1 . 092 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -93.13 118.29 31.05 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 116.525 -1.702 . . . . 21.89 107.345 -174.228 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.295 19.4 pt -120.22 151.78 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 126.446 2.341 . . . . 10.83 108.51 169.926 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -118.55 149.18 41.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.244 -2.873 . . . . 10.61 103.244 178.073 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -111.03 140.6 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 110.376 -3.102 . . . . 9.13 117.019 162.653 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -123.28 128.31 49.78 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.779 -4.325 . . . . 20.55 110.835 -178.363 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.264 39.7 p -91.33 174.1 7.56 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.518 -1.989 . . . . 11.78 112.247 -176.229 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.264 12.8 tp -63.94 -52.82 58.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.785 -2.462 . . . . 19.31 115.192 171.369 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.4 -58.69 3.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.995 -2.316 . . . . 23.14 115.85 -175.804 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.44 53.92 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 120.571 1.532 . . . . 19.74 111.909 167.745 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -112.74 136.65 52.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.121 -1.811 . . . . 21.93 109.473 163.599 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -104.23 110.86 23.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 128.334 3.521 . . . . 12.33 101.864 170.488 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.6 mt -102.42 129.96 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 101.142 -3.651 . . . . 17.08 101.142 -176.013 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 m -97.77 128.27 44.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.046 1.738 . . . . 16.3 107.462 177.089 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.455 HD22 ' HG2' ' A' ' 29' ' ' LYS . 58.2 mt -118.72 158.2 26.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.353 2.342 . . . . 15.88 110.993 170.735 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -102.6 122.18 43.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.144 -2.909 . . . . 28.9 103.144 165.092 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 m -137.46 177.62 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 117.989 -1.484 . . . . 12.05 110.147 176.451 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.26 157.82 34.59 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 105.863 -1.902 . . . . 18.17 105.863 173.904 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.307 18.5 Cg_endo -66.82 -15.02 46.03 Favored 'Trans proline' 0 C--N 1.3 -1.996 1 C-N-CA 126.829 5.019 . . . . 8.16 110.502 168.273 . . . . . . . . 3 2 . 1 . 092 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.2 m -94.69 0.12 54.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.577 -2.577 . . . . 11.13 115.67 -175.888 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -78.18 145.32 35.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.724 -2.485 . . . . 18.03 114.224 178.116 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 p -81.12 148.88 29.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.38 -2.7 . . . . 10.22 104.201 176.589 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.7 mt -76.37 -26.61 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 121.261 -0.899 . . . . 12.3 111.06 -173.402 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.296 17.0 pt-20 -51.8 -35.69 45.09 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 117.104 -1.426 . . . . 36.51 114.68 161.488 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -77.7 -39.85 43.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 117.167 -1.397 . . . . 25.66 113.73 176.128 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.4 t -57.91 -40.32 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 121.086 1.766 . . . . 8.12 109.472 176.875 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 55.8 mtmt -73.57 -35.67 65.48 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.499 1.12 . . . . 15.47 112.755 177.985 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.13 83.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 118.476 -1.289 . . . . 11.45 113.647 171.574 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' HD22 ' A' ' 15' ' ' LEU 0.347 29.8 ttmt -48.09 -40.38 23.14 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.219 -3.426 . . . . 24.98 112.022 161.382 . . . . . . . . 3 3 . 1 . 092 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.1 -35.94 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 120.706 1.594 . . . . 9.46 111.296 177.865 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -49.9 -47.85 51.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 115.607 -2.14 . . . . 14.76 114.188 163.424 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -63.33 -38.43 91.11 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.315 1.871 . . . . 26.29 113.951 177.65 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -72.48 -67.21 0.57 Allowed 'General case' 0 N--CA 1.429 -1.486 1 C-N-CA 131.868 4.067 . . . . 30.06 110.238 -178.686 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -97.84 -72.83 0.63 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.473 -2.017 . . . . 25.19 110.56 -166.859 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.47 64.73 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 118.427 2.131 . . . . 7.41 118.427 169.714 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.6 mt -133.56 116.18 13.83 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 128.151 2.58 . . . . 9.49 104.244 -168.359 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.39 156.34 26.45 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 123.731 2.368 . . . . 11.42 116.007 -172.325 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -78.66 -15.29 13.73 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 CA-C-N 124.39 2.604 . . . . 12.0 112.51 -172.596 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -75.08 -42.4 56.81 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.792 0.806 . . . . 35.55 110.753 175.268 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -68.56 -26.59 65.48 Favored 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 134.126 4.971 . . . . 20.52 111.784 -175.239 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.53 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 69.6 mt-30 -86.84 135.68 33.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.925 -2.36 . . . . 7.13 110.213 178.239 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -121.35 118.63 29.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.42 -2.067 . . . . 36.39 105.42 166.684 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 50' ' ' LEU . 62.3 mt -93.46 120.97 34.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.482 3.113 . . . . 9.55 111.849 177.86 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mt -109.29 134.07 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 117.119 -3.488 . . . . 13.9 107.488 173.957 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -91.27 -73.09 0.55 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 123.764 2.984 . . . . 6.86 103.56 163.909 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.32 -140.19 0.2 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.475 2.083 . . . . 11.15 107.122 -172.387 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.03 -23.65 69.7 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 122.609 3.803 . . . . 13.93 122.609 -176.191 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -76.81 162.7 27.44 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.989 -4.242 . . . . 23.92 118.149 174.491 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.282 81.6 mm-40 -84.87 133.93 34.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.719 -1.238 . . . . 23.23 111.806 167.456 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 43' ' ' LEU . 60.4 mt -93.25 132.78 37.12 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.384 -0.822 . . . . 9.11 110.733 177.328 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -93.27 122.34 35.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.012 2.125 . . . . 33.44 107.897 168.78 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.06 -25.12 65.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.459 1.904 . . . . 28.37 114.149 -168.794 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.78 -2.69 86.45 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 126.253 1.882 . . . . 15.0 117.723 -179.573 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -104.9 -176.61 3.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.908 1.337 . . . . 25.5 107.984 172.63 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.4 p -100.43 178.07 4.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.724 1.75 . . . . 11.95 115.724 -173.557 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.95 -35.95 81.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.97 3.308 . . . . 10.17 112.408 167.79 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 t -72.77 -36.71 67.7 Favored 'General case' 0 N--CA 1.431 -1.387 1 O-C-N 113.947 -5.471 . . . . 13.59 112.485 -179.052 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -66.98 -38.34 85.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.854 3.261 . . . . 11.7 110.938 176.11 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -88.57 -4.13 58.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.659 -1.9 . . . . 12.95 110.738 176.301 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 m120 57.68 58.85 3.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 131.508 3.923 . . . . 25.45 111.677 178.083 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mm -102.28 108.81 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.309 -2.108 . . . . 14.6 105.309 -178.113 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -108.79 169.23 8.8 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 127.361 2.913 . . . . 33.23 109.335 -171.577 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -44.68 138.69 3.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.587 2.613 . . . . 25.97 112.343 -176.345 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.281 18.1 mt-10 60.16 6.16 0.94 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.119 3.368 . . . . 32.61 115.296 175.702 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.6 m -62.73 140.83 58.75 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.183 -4.073 . . . . 10.56 113.354 160.838 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -103.91 122.32 44.94 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.493 3.517 . . . . 5.33 110.557 -175.407 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -86.24 156.35 20.32 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.089 2.743 . . . . 11.66 113.608 170.85 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -121.46 120.32 34.6 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 123.089 2.677 . . . . 16.3 111.223 168.365 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.6 tp -84.46 124.08 30.96 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 126.582 2.426 . . . . 9.96 116.702 173.962 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.3 127.8 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 103.433 -2.803 . . . . 9.76 103.433 179.423 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.286 1.3 mm? . . . . . 0 N--CA 1.43 -1.427 0 O-C-N 119.867 -1.77 . . . . 19.57 115.212 175.43 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 113.766 1.024 . . . . 17.17 113.766 . . . . . . . . . 0 0 . 1 . 093 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -90.49 121.44 32.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.412 1.577 . . . . 21.89 113.795 -178.643 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.9 pt -123.54 151.92 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 O-C-N 114.145 -5.347 . . . . 10.83 108.653 168.449 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -115.93 137.01 52.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 119.484 1.038 . . . . 10.61 111.447 -179.451 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -109.82 130.23 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 130.134 3.374 . . . . 9.13 109.028 168.049 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -122.84 137.61 54.88 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.586 -2.552 . . . . 20.55 107.097 -173.251 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.329 55.2 p -100.88 -173.38 2.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 119.696 1.134 . . . . 11.78 110.881 -170.085 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.4 mt -74.01 -41.27 62.13 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.855 -3.028 . . . . 19.31 111.982 177.62 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.95 -57.56 9.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.237 -1.54 . . . . 23.14 108.135 165.768 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.25 6.86 0.17 Allowed Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 117.618 -2.229 . . . . 19.74 115.436 177.55 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -77.29 149.46 35.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 122.661 3.231 . . . . 21.93 110.715 -161.786 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -113.72 110.73 20.64 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.974 -3.579 . . . . 12.33 105.939 -174.601 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.04 121.66 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 111.212 -2.722 . . . . 17.08 112.289 169.392 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.3 m -103.66 114.07 28.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 128.003 3.314 . . . . 16.3 106.832 -174.37 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -104.14 141.7 35.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.147 -1.596 . . . . 15.88 112.295 178.651 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -84.13 100.81 11.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.406 1.883 . . . . 28.9 107.87 164.592 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.93 151.34 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.295 -1.002 . . . . 12.05 108.295 179.103 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -91.23 164.08 26.4 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 116.906 -1.918 . . . . 18.17 106.394 171.263 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -82.76 -8.06 11.31 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.515 2.144 . . . . 8.16 108.872 -177.635 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -86.67 -4.54 59.19 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.795 1.759 . . . . 11.13 115.717 171.722 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -83.13 137.74 33.95 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.499 -2.001 . . . . 18.03 107.282 -168.284 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 p -74.21 157.84 35.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.631 3.11 . . . . 10.22 112.57 174.169 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.8 mt -69.19 -21.4 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 1 O-C-N 115.907 -4.246 . . . . 12.3 110.499 175.6 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.06 -48.18 82.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.02 2.343 . . . . 36.51 115.328 161.752 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.76 -41.03 94.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.38 3.072 . . . . 25.66 114.566 173.037 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.44 -55.68 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 129.191 2.997 . . . . 8.12 114.986 164.23 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -46.58 -44.89 18.49 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 114.683 -5.011 . . . . 15.47 118.73 164.964 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.96 -36.71 75.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 124.725 2.202 . . . . 11.45 115.768 -177.854 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -69.83 -34.9 74.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.269 -2.242 . . . . 24.98 110.951 178.602 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -59.36 -43.61 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 125.861 1.665 . . . . 9.46 109.892 171.403 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -68.05 -42.93 79.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.072 -1.642 . . . . 14.76 108.752 -174.882 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.36 -46.92 87.31 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.399 2.28 . . . . 26.29 112.602 176.598 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -79.31 -57.25 3.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.703 2.112 . . . . 30.06 116.703 179.561 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -85.31 -54.64 4.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.708 -3.745 . . . . 25.19 116.003 -179.78 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.05 54.26 0.98 Allowed Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 124.509 1.052 . . . . 7.41 115.161 -176.012 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.7 mt -119.48 125.57 27.44 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 104.585 -2.376 . . . . 9.49 104.585 165.614 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 43.0 Cg_endo -75.32 159.17 40.48 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 123.721 2.948 . . . . 11.42 113.276 -176.672 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 41.8 Cg_exo -61.65 -11.41 20.27 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 124.952 3.768 . . . . 12.0 115.651 -179.765 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -85.7 -28.72 24.48 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 121.488 1.949 . . . . 35.55 106.414 -173.935 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -85.43 -28.66 24.94 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 115.365 -4.584 . . . . 20.52 110.222 -178.191 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -74.29 130.42 39.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.978 2.323 . . . . 7.13 114.443 -177.858 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -132.89 126.86 33.11 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 112.81 -1.996 . . . . 36.39 111.172 164.584 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.2 mt -108.25 114.88 29.09 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 109.286 -3.597 . . . . 9.55 113.89 -163.646 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.57 135.19 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 118.685 -2.51 . . . . 13.9 106.132 -172.217 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -96.02 -54.89 3.15 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.185 1.945 . . . . 6.86 110.701 173.308 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.28 -126.35 0.27 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 108.899 -3.773 . . . . 11.15 108.026 -176.064 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.5 6.51 12.69 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 127.755 2.598 . . . . 13.93 107.55 -170.732 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -110.16 145.11 37.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.352 1.612 . . . . 23.92 115.352 -175.553 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -75.1 121.59 22.28 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.239 1.816 . . . . 23.23 111.919 -174.515 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.5 mt -94.68 120.7 35.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.393 2.677 . . . . 9.11 110.496 176.61 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.74 143.26 28.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.81 -3.057 . . . . 33.44 107.641 -177.53 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -65.38 -39.48 92.3 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.027 -1.442 . . . . 28.37 112.076 -162.45 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.35 -11.77 81.6 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 120.289 2.875 . . . . 15.0 120.289 -168.672 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -91.26 173.57 7.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.657 -2.084 . . . . 25.5 105.765 -178.209 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.2 p -113.83 174.36 5.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.72 2.2 . . . . 11.95 108.142 -166.91 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.06 -31.11 72.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.444 -2.035 . . . . 10.17 113.989 173.164 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -67.77 -31.99 72.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.781 2.141 . . . . 13.59 116.781 175.716 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -61.92 -50.29 72.75 Favored 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.342 4.257 . . . . 11.7 110.214 176.811 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -89.87 -20.93 22.83 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 124.172 1.939 . . . . 12.95 115.198 -178.533 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.339 16.1 m120 85.65 41.73 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 127.346 2.258 . . . . 25.45 111.88 175.193 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.3 mm -79.31 115.52 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 124.323 2.011 . . . . 14.6 109.002 169.148 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -95.04 -174.16 3.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.405 -1.27 . . . . 33.23 111.941 -177.559 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -66.82 146.27 54.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.689 1.596 . . . . 25.97 112.583 175.853 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.461 65.3 mt-10 76.43 11.73 2.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.979 2.214 . . . . 32.61 116.979 -179.417 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.254 56.2 m -84.42 141.69 30.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.318 1.97 . . . . 10.56 116.318 -169.579 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.4 m -107.7 98.0 7.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.24 -2.162 . . . . 5.33 109.843 -166.769 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -88.93 151.57 22.24 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.517 1.927 . . . . 11.66 107.594 -177.036 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.84 123.32 39.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.64 2.638 . . . . 16.3 108.228 -171.874 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -94.41 112.29 24.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.81 -2.45 . . . . 9.96 110.591 -176.624 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.254 38.5 t -103.88 131.57 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 105.594 -2.002 . . . . 9.76 105.594 -171.925 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.429 -1.481 0 O-C-N 117.789 -3.069 . . . . 19.57 112.7 -171.401 . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.49 -1.344 0 N-CA-C 116.607 2.077 . . . . 17.17 116.607 . . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -90.87 144.2 25.93 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.97 -4.206 . . . . 21.89 112.444 -175.122 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.4 pt -122.09 155.16 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 126.023 2.82 . . . . 10.83 103.946 165.543 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -114.95 111.11 20.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.034 -3.542 . . . . 10.61 103.597 -172.302 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 67' ' ' LEU . 46.1 t -101.19 135.44 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 116.699 -3.751 . . . . 9.13 107.736 179.648 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -115.15 122.79 47.16 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 125.715 1.606 . . . . 20.55 112.813 -172.491 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -77.02 172.69 12.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.19 -2.819 . . . . 11.78 115.112 177.675 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.518 HD23 ' CE1' ' A' ' 68' ' ' HIS . 40.8 mt -76.58 -23.74 53.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.274 2.694 . . . . 19.31 118.274 170.498 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -83.66 -24.8 31.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 115.805 -2.045 . . . . 23.14 113.501 166.613 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.33 49.8 0.35 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 113.636 -3.869 . . . . 19.74 113.786 161.388 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -114.69 140.16 49.08 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.665 2.038 . . . . 21.93 107.511 175.499 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -84.4 117.13 23.43 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 116.13 -4.106 . . . . 12.33 108.431 160.856 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -86.2 116.21 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.658 -2.349 . . . . 17.08 104.658 162.984 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.2 m -106.21 97.39 7.21 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 124.834 2.254 . . . . 16.3 108.808 -172.415 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 mt -103.45 116.08 31.73 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.892 -1.958 . . . . 15.88 112.224 -162.428 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.93 119.16 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.727 -1.579 . . . . 28.9 112.893 170.869 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.78 177.55 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.226 2.441 . . . . 12.05 109.387 -179.514 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.88 167.3 14.81 Favored Pre-proline 0 N--CA 1.43 -1.471 0 O-C-N 117.176 -3.452 . . . . 18.17 103.781 172.784 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -76.61 -19.35 14.68 Favored 'Trans proline' 0 C--N 1.3 -2.021 1 C-N-CA 125.595 4.196 . . . . 8.16 114.985 179.713 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -79.89 -14.55 58.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.196 2.665 . . . . 11.13 118.196 171.755 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -72.58 144.83 47.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.303 -2.748 . . . . 18.03 106.263 -168.87 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.5 p -82.69 157.13 23.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.567 -1.253 . . . . 10.22 111.854 177.338 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.29 -21.54 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 CA-C-O 128.868 4.175 . . . . 12.3 114.979 -172.822 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -58.62 -53.77 54.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.488 -3.258 . . . . 36.51 114.612 157.899 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -50.73 -32.83 20.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.583 -3.823 . . . . 25.66 115.934 173.974 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.11 -53.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 128.496 2.718 . . . . 8.12 108.971 173.092 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -65.28 -35.49 81.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.606 1.548 . . . . 15.47 112.849 -179.887 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.53 92.47 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.254 1.022 . . . . 11.45 112.318 169.88 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -53.0 -43.35 66.41 Favored 'General case' 0 N--CA 1.43 -1.458 2 O-C-N 113.938 -5.476 . . . . 24.98 113.802 169.866 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -64.88 -29.55 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 127.894 2.478 . . . . 9.46 112.807 172.67 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -72.92 -45.79 56.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 123.48 2.854 . . . . 14.76 109.21 167.897 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -59.81 -37.04 78.05 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.165 -2.209 . . . . 26.29 114.997 177.551 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -85.69 -51.1 6.68 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.563 2.801 . . . . 30.06 118.563 171.107 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -102.91 -8.14 20.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.155 3.02 . . . . 25.19 119.155 -178.658 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.29 51.42 58.25 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 117.811 -3.055 . . . . 7.41 114.768 -175.512 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.8 mt -111.02 106.25 57.45 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 128.337 2.655 . . . . 9.49 108.625 165.775 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 74.6 Cg_exo -72.59 157.45 52.5 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 N-CA-C 118.134 2.321 . . . . 11.42 118.134 -172.048 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -71.84 -15.97 29.65 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-N 126.47 3.346 . . . . 12.0 119.467 -163.78 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.8 -24.43 67.55 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 120.713 3.597 . . . . 35.55 120.713 160.274 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.406 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 25.8 mt-30 -72.07 -28.93 63.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.903 2.592 . . . . 20.52 114.257 170.594 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -86.85 133.27 33.64 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.54 -3.225 . . . . 7.13 115.534 -159.321 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -125.95 108.27 11.25 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.965 1.841 . . . . 36.39 108.516 167.317 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 43' ' ' LEU . 75.8 mt -87.39 113.94 23.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.444 -1.707 . . . . 9.55 108.572 -179.021 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -116.85 134.82 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 1 O-C-N 115.844 -4.285 . . . . 13.9 103.137 175.614 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -103.79 -63.62 1.17 Allowed 'General case' 0 N--CA 1.431 -1.419 1 O-C-N 115.061 -4.774 . . . . 6.86 109.952 166.832 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.95 -66.47 0.93 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.797 -3.69 . . . . 11.15 109.122 -168.453 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.11 -53.75 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 O-C-N 116.854 -3.654 . . . . 13.93 118.931 -174.065 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -71.91 169.19 16.36 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.725 2.12 . . . . 23.92 116.725 -170.035 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -88.46 129.28 35.48 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 114.77 -4.956 . . . . 23.23 106.177 -178.686 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.5 mt -84.47 127.2 33.89 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 111.891 -2.413 . . . . 9.11 112.647 175.767 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.29 163.89 26.07 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 129.221 4.075 . . . . 33.44 111.709 166.493 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -91.07 -63.39 1.27 Allowed 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 115.539 -4.475 . . . . 28.37 108.936 -172.473 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.25 -5.87 9.1 Favored Glycine 0 N--CA 1.431 -1.667 1 C-N-CA 130.873 4.082 . . . . 15.0 113.561 -178.484 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -91.34 168.43 11.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.119 3.46 . . . . 25.5 110.759 174.763 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 29.6 p -94.72 170.02 9.75 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.237 4.215 . . . . 11.95 111.334 179.466 . . . . . . . . 3 2 . 1 . 094 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.61 -26.04 62.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.393 -3.942 . . . . 10.17 115.753 172.823 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -63.99 -49.75 71.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 111.447 -2.615 . . . . 13.59 111.119 172.762 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -45.14 -44.48 10.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.767 2.506 . . . . 11.7 117.767 169.533 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -88.54 3.66 49.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 116.622 -1.656 . . . . 12.95 114.647 179.257 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.336 3.7 m-80 57.01 52.93 8.55 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.747 3.24 . . . . 25.45 119.747 -175.227 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mt -115.19 122.8 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 113.926 -1.488 . . . . 14.6 108.214 -177.785 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -112.24 -150.55 0.47 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.37 -2.706 . . . . 33.23 113.252 175.417 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 64' ' ' GLU . 19.4 pttp -76.59 165.88 24.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.699 2.045 . . . . 25.97 111.996 -173.252 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.418 ' OE2' ' NZ ' ' A' ' 63' ' ' LYS . 51.4 mt-10 57.23 25.45 11.06 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 133.012 4.525 . . . . 32.61 109.668 174.528 . . . . . . . . 3 3 . 1 . 094 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.286 52.6 m -76.29 121.94 23.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 129.507 3.123 . . . . 10.56 107.979 -176.709 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.4 m -90.8 116.75 28.88 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 124.697 1.248 . . . . 5.33 111.313 175.885 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' A' ' 5' ' ' VAL . 5.8 mp -107.35 158.37 17.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.111 2.164 . . . . 11.66 107.502 178.889 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.518 ' CE1' HD23 ' A' ' 8' ' ' LEU . 5.9 t60 -114.84 131.79 56.72 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.446 1.593 . . . . 16.3 110.505 172.661 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.65 103.88 14.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 127.715 3.626 . . . . 9.96 104.387 172.176 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 t -95.15 133.82 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 1 C-N-CA 135.459 5.504 . . . . 9.76 109.94 171.824 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 N--CA 1.431 -1.408 0 N-CA-C 116.102 1.89 . . . . 19.57 116.102 -171.688 . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 113.614 0.968 . . . . 17.17 113.614 . . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -91.98 132.5 36.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.746 1.387 . . . . 21.89 114.746 -170.772 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 pt -131.21 150.24 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 119.118 -2.239 . . . . 10.83 113.257 167.745 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -99.48 123.61 43.9 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 125.685 1.865 . . . . 10.61 108.529 -176.796 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.7 t -104.22 121.98 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 117.178 -1.809 . . . . 9.13 107.786 171.835 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -103.21 105.98 16.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.112 2.965 . . . . 20.55 110.958 -170.026 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -69.96 177.39 3.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.832 1.419 . . . . 11.78 114.832 178.673 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.1 mt -66.29 -43.71 85.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 114.989 -2.434 . . . . 19.31 111.739 -170.295 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -67.48 -47.83 68.91 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 132.594 6.184 . . . . 23.14 106.708 172.928 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.32 41.77 0.62 Allowed Glycine 0 N--CA 1.43 -1.708 0 O-C-N 117.669 -3.145 . . . . 19.74 115.333 -176.879 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -83.38 135.23 34.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 101.889 -3.374 . . . . 21.93 101.889 175.356 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -90.11 101.93 14.64 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 122.183 2.265 . . . . 12.33 106.105 -177.934 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 mt -85.34 109.26 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.445 -0.784 . . . . 17.08 109.392 172.708 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -92.0 116.8 29.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.317 2.961 . . . . 16.3 111.302 -178.673 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.2 mt -116.13 137.04 52.47 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.818 -4.301 . . . . 15.88 111.475 -174.082 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -111.19 108.65 18.38 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.476 -2.64 . . . . 28.9 106.521 -175.331 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.86 164.62 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 125.116 1.51 . . . . 12.05 112.786 -172.448 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.33 154.79 37.93 Favored Pre-proline 0 N--CA 1.43 -1.464 0 O-C-N 116.952 -3.592 . . . . 18.17 110.663 165.419 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -60.55 -24.51 78.38 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 125.101 3.867 . . . . 8.16 110.789 179.125 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -98.33 26.01 5.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.211 -1.556 . . . . 11.13 109.44 -179.408 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -94.86 158.91 15.28 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.998 -2.939 . . . . 18.03 112.247 161.951 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -105.09 169.8 8.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.447 1.594 . . . . 10.22 109.578 -170.775 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.11 -40.21 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.666 -2.521 . . . . 12.3 113.558 178.383 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -43.04 -41.62 3.56 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 121.082 3.734 . . . . 36.51 121.082 160.653 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -63.19 -60.7 3.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.397 -3.314 . . . . 25.66 111.948 174.913 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 t -46.94 -41.36 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 116.313 -3.992 . . . . 8.12 117.182 170.939 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -56.3 -35.67 67.79 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.354 -1.466 . . . . 15.47 111.091 177.696 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.1 -24.23 60.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.922 -3.611 . . . . 11.45 114.341 -179.13 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -65.03 -30.1 71.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.416 2.747 . . . . 24.98 118.416 166.028 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.8 mt -78.24 -33.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 124.291 1.996 . . . . 9.46 110.492 178.544 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -66.18 -31.33 72.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.87 -1.768 . . . . 14.76 115.073 169.093 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -62.41 -60.8 3.03 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.442 3.097 . . . . 26.29 109.218 173.251 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -79.87 -63.7 1.35 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 115.059 1.503 . . . . 30.06 115.059 -174.142 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 45.2 mm-40 -82.53 -28.88 30.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.239 3.051 . . . . 25.19 119.239 -177.28 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.98 7.79 49.45 Favored Glycine 0 N--CA 1.43 -1.75 1 O-C-N 116.056 -4.153 . . . . 7.41 120.956 173.25 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.67 129.65 51.95 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 118.656 -2.673 . . . . 9.49 111.815 -179.529 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -66.66 146.61 79.63 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 N-CA-C 118.411 2.427 . . . . 11.42 118.411 174.979 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -16.95 57.51 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 120.125 3.087 . . . . 12.0 120.125 -169.335 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.67 -19.85 34.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.587 -1.946 . . . . 35.55 110.738 176.766 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -91.6 -24.12 19.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.064 2.364 . . . . 20.52 107.843 -169.22 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -73.45 155.56 39.16 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.191 -3.443 . . . . 7.13 111.391 175.171 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.291 51.5 ttt180 -139.5 120.0 14.03 Favored 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 132.471 4.308 . . . . 36.39 113.672 167.604 . . . . . . . . 3 2 . 1 . 095 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.84 132.77 49.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.809 -1.807 . . . . 9.55 109.698 -179.471 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 3.6 mt -120.61 130.61 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.007 -1.108 . . . . 13.9 108.007 179.215 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -86.45 -77.5 0.31 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.43 -2.044 . . . . 6.86 110.135 163.002 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.07 -73.37 0.67 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.053 1.341 . . . . 11.15 107.864 173.973 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.46 1.2 0.42 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 113.699 -3.834 . . . . 13.93 115.129 -171.733 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -105.54 166.83 10.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 123.875 3.838 . . . . 23.92 107.832 -167.176 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -97.31 139.94 32.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.818 1.645 . . . . 23.23 111.365 177.729 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -101.61 141.95 33.7 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.308 -0.86 . . . . 9.11 108.881 -174.661 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.253 43.6 mt-10 -97.93 149.25 22.61 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.127 -2.233 . . . . 33.44 107.397 174.182 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.03 -31.21 71.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.303 2.241 . . . . 28.37 112.436 -175.299 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.71 36.26 4.52 Favored Glycine 0 N--CA 1.43 -1.728 1 N-CA-C 125.189 4.835 . . . . 15.0 125.189 -177.179 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -126.35 162.15 26.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.161 -2.376 . . . . 25.5 107.179 170.871 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.255 29.9 p -88.24 166.49 14.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.146 -2.846 . . . . 11.95 111.432 -175.479 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.57 -41.67 90.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.495 2.569 . . . . 10.17 111.301 164.789 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -58.51 -39.17 79.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.482 -3.261 . . . . 13.59 114.539 175.064 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -67.43 -36.71 81.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.228 1.966 . . . . 11.7 111.66 -174.256 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -85.32 -0.61 55.28 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.869 -3.019 . . . . 12.95 108.716 176.1 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.301 3.3 m120 56.67 36.87 28.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.884 2.179 . . . . 25.45 116.884 -179.329 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.5 mt -99.02 111.07 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 117.182 -1.39 . . . . 14.6 108.848 177.816 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.307 28.8 mm100 -96.0 -167.04 1.52 Allowed 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.927 3.267 . . . . 33.23 107.134 -167.294 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -57.33 159.92 4.34 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 117.161 2.282 . . . . 25.97 117.161 167.089 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 65.24 14.37 9.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.542 1.937 . . . . 32.61 113.546 -178.045 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -81.04 133.7 35.53 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.566 1.691 . . . . 10.56 115.566 -171.248 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.4 m -93.25 112.11 23.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.472 -1.694 . . . . 5.33 108.737 -173.232 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.9 mt -98.06 133.48 42.45 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.379 -3.326 . . . . 11.66 106.163 176.248 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 15.3 t60 -94.75 119.09 32.8 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 126.67 1.988 . . . . 16.3 112.819 167.918 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.9 tp -103.81 121.51 43.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 126.153 2.882 . . . . 9.96 114.418 -179.981 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.72 176.98 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 1 O-C-N 114.668 -5.02 . . . . 9.76 103.104 -177.243 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 N--CA 1.43 -1.443 1 O-C-N 114.212 -5.305 . . . . 19.57 115.282 -179.049 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 116.981 -1.485 . . . . 17.17 112.864 . . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -101.67 149.42 24.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 114.51 -2.876 . . . . 21.89 113.934 -173.836 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.74 174.98 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 119.636 -1.915 . . . . 10.83 109.034 160.145 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -126.18 149.5 48.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 115.349 -2.54 . . . . 10.61 108.098 -175.319 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.8 t -112.94 127.59 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 104.659 -2.349 . . . . 9.13 104.659 168.051 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -105.85 117.69 34.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.853 2.168 . . . . 20.55 116.853 164.58 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -92.05 169.54 10.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.723 3.154 . . . . 11.78 109.068 -168.966 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 mt -62.93 -38.36 90.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.499 -2.625 . . . . 19.31 111.668 166.501 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 m -61.37 -61.32 2.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.48 3.512 . . . . 23.14 112.718 -178.982 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.52 52.42 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 118.567 -1.778 . . . . 19.74 111.373 177.869 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -123.87 167.37 14.18 Favored 'General case' 0 N--CA 1.43 -1.454 1 CA-C-O 129.648 4.546 . . . . 21.93 108.18 179.759 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.2 m -131.06 108.28 9.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 110.368 -3.105 . . . . 12.33 103.155 166.771 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.8 mt -101.28 131.52 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 111.953 -3.88 . . . . 17.08 107.123 175.545 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.6 m -104.59 114.88 29.39 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 123.996 3.089 . . . . 16.3 106.551 173.846 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.3 mt -104.1 129.03 51.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.145 1.778 . . . . 15.88 111.824 174.074 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -87.03 106.3 17.75 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.657 3.122 . . . . 28.9 105.081 -178.545 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.19 155.7 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.031 -2.918 . . . . 12.05 110.418 -171.266 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -109.89 137.42 20.45 Favored Pre-proline 0 N--CA 1.43 -1.432 0 O-C-N 116.723 -3.735 . . . . 18.17 107.759 164.881 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.69 -10.25 13.11 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 124.828 3.686 . . . . 8.16 113.074 -164.077 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -89.22 -12.98 39.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.024 2.345 . . . . 11.13 110.958 174.511 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -81.88 157.9 24.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.105 -1.407 . . . . 18.03 111.749 176.007 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -87.51 170.33 11.43 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.54 -2.6 . . . . 10.22 116.007 -150.895 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.0 mt -80.95 -27.3 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 118.3 -2.75 . . . . 12.3 110.892 -175.471 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -62.21 -45.14 94.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.767 -2.063 . . . . 36.51 112.619 166.98 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -64.25 -20.43 66.04 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 117.516 -1.23 . . . . 25.66 112.238 178.055 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.1 t -73.06 -40.4 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 122.16 2.255 . . . . 8.12 111.82 168.473 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -66.94 -38.45 86.18 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.491 2.994 . . . . 15.47 113.989 176.807 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -64.44 -11.07 29.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.617 2.821 . . . . 11.45 118.617 169.564 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -84.04 -38.88 20.3 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.506 1.622 . . . . 24.98 113.506 166.35 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.7 -40.51 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 117.561 -3.212 . . . . 9.46 115.545 160.618 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 22.4 tt0 -55.01 -35.34 64.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.15 -2.844 . . . . 14.76 114.438 170.289 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.4 -57.07 11.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.892 -1.755 . . . . 26.29 115.344 166.452 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -66.27 -65.11 0.72 Allowed 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 133.415 4.686 . . . . 30.06 109.714 -168.452 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -93.32 -26.53 17.26 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.903 1.811 . . . . 25.19 114.454 -173.471 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.8 28.6 9.32 Favored Glycine 0 N--CA 1.43 -1.709 1 O-C-N 114.152 -5.342 . . . . 7.41 116.358 177.126 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 90.2 mt -120.12 118.54 31.41 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 116.256 -1.83 . . . . 9.49 108.263 -162.62 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -73.05 162.0 41.99 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.867 3.488 . . . . 11.42 114.961 -164.004 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.63 -15.53 19.35 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 125.616 3.041 . . . . 12.0 114.338 -174.016 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.4 -29.78 42.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.599 2.454 . . . . 35.55 114.078 176.351 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -78.11 -23.63 47.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.653 1.981 . . . . 20.52 115.38 171.866 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -71.79 139.48 49.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.266 3.062 . . . . 7.13 119.266 170.562 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.488 ' HB3' HG23 ' A' ' 70' ' ' VAL . 72.6 ttt180 -119.71 147.46 44.55 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.488 -2.007 . . . . 36.39 113.949 158.604 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -127.64 112.52 14.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.858 -2.401 . . . . 9.55 111.047 179.419 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.6 mt -95.71 125.35 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.124 -3.485 . . . . 13.9 107.044 -175.663 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -98.1 -62.51 1.23 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.909 -3.62 . . . . 6.86 105.952 178.107 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.69 -128.5 0.1 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.135 2.574 . . . . 11.15 104.497 177.976 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.04 7.07 32.81 Favored Glycine 0 N--CA 1.431 -1.699 0 O-C-N 121.043 -1.036 . . . . 13.93 114.609 -172.482 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -111.98 117.36 32.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.206 1.558 . . . . 23.92 115.206 169.661 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -68.6 129.3 39.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.319 2.009 . . . . 23.23 111.191 -170.345 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.37 153.3 35.89 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.61 -3.181 . . . . 9.11 113.891 -176.687 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -101.65 150.41 23.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.107 0.956 . . . . 33.44 111.676 162.253 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -67.02 -43.99 81.42 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 120.44 3.496 . . . . 28.37 120.44 -178.145 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.73 48.04 1.85 Allowed Glycine 0 N--CA 1.43 -1.709 0 CA-C-O 123.777 1.765 . . . . 15.0 111.873 -178.449 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -127.39 162.22 26.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.8 -2.296 . . . . 25.5 104.8 174.544 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.2 p -91.09 169.42 10.87 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.77 -3.081 . . . . 11.95 108.605 178.097 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.7 -34.28 71.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.345 -3.347 . . . . 10.17 114.319 171.442 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 t -65.81 -34.69 78.75 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 128.358 3.536 . . . . 13.59 116.008 -178.482 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -56.58 -43.33 79.95 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.83 -1.794 . . . . 11.7 113.323 177.834 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -95.11 8.82 41.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 122.354 2.343 . . . . 12.95 113.437 -178.882 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.493 10.6 m120 66.0 41.23 3.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.847 2.059 . . . . 25.45 113.274 175.96 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.3 mt -91.05 138.09 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 106.632 -1.618 . . . . 14.6 106.632 -178.233 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -128.98 -177.28 4.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.943 -2.973 . . . . 33.23 112.426 -168.746 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.327 19.9 pttp -60.93 149.6 35.93 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 120.862 3.653 . . . . 25.97 120.862 168.916 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 48.1 27.49 1.26 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.965 3.306 . . . . 32.61 116.802 -171.905 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.334 54.5 m -92.99 144.94 24.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.409 -3.307 . . . . 10.56 114.986 177.277 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.5 m -99.91 120.99 40.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.057 -1.925 . . . . 5.33 115.937 -171.761 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -103.51 137.92 40.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.11 -1.441 . . . . 11.66 107.11 174.567 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -93.6 114.44 26.78 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 114.445 1.276 . . . . 16.3 114.445 177.08 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.253 49.6 tp -83.4 115.2 21.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 124.288 0.992 . . . . 9.96 110.353 -179.595 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 42' ' ' ARG . 3.3 m -119.57 -175.05 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 115.068 -0.969 . . . . 9.76 110.102 166.92 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.43 -1.432 0 CA-C-O 122.606 1.193 . . . . 19.57 113.147 172.334 . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 116.08 -1.914 . . . . 17.17 113.758 . . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -104.24 131.58 51.4 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.267 2.23 . . . . 21.89 110.383 -179.08 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.38 152.51 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.182 -2.525 . . . . 10.83 104.182 -178.696 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -107.31 125.08 50.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.269 2.228 . . . . 10.61 111.289 -176.69 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 t -110.84 115.63 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.23 -2.794 . . . . 9.13 109.221 176.513 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.262 31.3 tttt -97.79 130.59 44.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.741 0.781 . . . . 20.55 109.626 -171.535 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.271 13.9 p -74.92 166.25 23.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.841 -3.662 . . . . 11.78 115.12 -179.001 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.263 1.6 tp -54.96 -43.33 73.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.618 3.567 . . . . 19.31 106.288 171.607 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 p -89.49 -50.25 6.21 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.177 -3.452 . . . . 23.14 115.64 179.529 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.75 67.61 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.763 0 O-C-N 117.533 -3.23 . . . . 19.74 111.34 163.475 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -137.24 139.83 41.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.503 -2.763 . . . . 21.93 106.545 173.784 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -104.57 112.9 26.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.799 1.64 . . . . 12.33 107.655 -166.816 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 60.1 mt -91.03 144.22 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 118.17 -2.831 . . . . 17.08 107.348 179.328 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.1 m -108.5 121.01 44.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 122.799 2.545 . . . . 16.3 112.779 164.867 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 15' ' ' LEU . 91.4 mt -110.66 130.7 55.5 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.688 2.795 . . . . 15.88 111.715 -179.997 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -90.54 114.83 27.13 Favored 'General case' 0 N--CA 1.43 -1.453 1 CA-C-O 128.596 4.046 . . . . 28.9 108.81 173.687 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.61 171.63 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.56 -3.212 . . . . 12.05 110.89 -173.621 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.36 147.94 36.63 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 102.387 -3.19 . . . . 18.17 102.387 166.663 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -65.11 -14.07 43.19 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 121.695 1.597 . . . . 8.16 113.938 171.671 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.34 -4.95 50.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.936 2.303 . . . . 11.13 116.142 171.895 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -81.18 146.47 30.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 114.596 -2.621 . . . . 18.03 109.753 178.919 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.0 p -79.75 166.71 21.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 125.717 3.871 . . . . 10.22 114.111 167.627 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.7 mm -49.77 -43.36 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 111.624 -2.534 . . . . 12.3 113.738 169.234 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.254 36.0 tt0 -54.11 -24.83 19.08 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.663 -2.113 . . . . 36.51 115.632 176.632 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -86.9 -34.71 19.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.156 2.408 . . . . 25.66 111.043 178.206 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.22 -48.4 88.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.457 2.075 . . . . 8.12 108.521 178.677 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -61.31 -27.04 68.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 119.134 3.012 . . . . 15.47 119.134 175.278 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.258 . . -74.2 -29.51 61.78 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.83 -3.044 . . . . 11.45 109.827 -175.959 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HB3' HD22 ' A' ' 15' ' ' LEU . 68.7 mmtt -64.52 -36.75 85.22 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.399 2.523 . . . . 24.98 115.904 169.254 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.344 39.1 mt -65.08 -42.05 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 O-C-N 116.198 -4.063 . . . . 9.46 110.701 171.766 . . . . . . . . 3 2 . 1 . 097 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.07 -29.83 68.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.914 -3.616 . . . . 14.76 118.367 168.211 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.65 -48.67 16.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 126.42 2.325 . . . . 26.29 111.194 -179.023 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -83.03 -57.48 3.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 126.21 2.194 . . . . 30.06 112.005 -169.883 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -78.32 -45.8 21.73 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.62 2.768 . . . . 25.19 111.537 177.757 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.2 50.15 5.59 Favored Glycine 0 N--CA 1.43 -1.763 0 O-C-N 119.407 -2.058 . . . . 7.41 113.25 -169.126 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mt -113.31 140.81 24.81 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.114 -2.18 . . . . 9.49 105.114 170.38 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -72.75 148.88 47.39 Favored 'Trans proline' 0 N--CA 1.433 -2.032 1 C-N-CA 125.885 4.39 . . . . 11.42 111.164 -176.837 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.8 -30.16 9.68 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 N-CA-C 116.44 1.669 . . . . 12.0 116.44 -165.3 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -66.23 -26.21 67.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 120.333 3.457 . . . . 35.55 120.333 172.356 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -78.09 -29.7 49.18 Favored 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 132.327 4.251 . . . . 20.52 108.528 -178.163 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.262 56.6 mt-30 -67.74 91.44 0.31 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.693 3.197 . . . . 7.13 110.283 170.799 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -93.77 98.54 11.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 126.74 3.162 . . . . 36.39 109.51 171.417 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -98.22 130.52 44.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.08 2.848 . . . . 9.55 104.496 -170.374 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mt -123.08 134.27 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.544 -3.847 . . . . 13.9 107.095 -173.72 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -115.54 103.36 10.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 102.491 -3.151 . . . . 6.86 102.491 175.794 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.69 -97.48 0.06 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.407 2.283 . . . . 11.15 111.368 -172.679 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.58 16.23 9.05 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-O 124.083 1.935 . . . . 13.93 117.353 161.679 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -84.33 115.0 22.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.659 -3.26 . . . . 23.92 106.833 174.963 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -74.13 123.58 24.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 117.142 -1.409 . . . . 23.23 110.916 166.82 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.07 132.66 39.71 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 116.618 -2.033 . . . . 9.11 108.648 -160.301 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -78.37 151.0 33.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.496 -3.877 . . . . 33.44 107.325 174.929 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.16 -36.85 75.0 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.485 2.088 . . . . 28.37 111.843 -169.572 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.03 25.15 27.23 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-O 125.415 2.675 . . . . 15.0 113.043 -160.754 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -115.56 142.19 47.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 124.288 1.994 . . . . 25.5 108.414 -174.231 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -76.31 153.89 35.51 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.166 2.412 . . . . 11.95 112.73 178.959 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.9 mt -70.9 -32.27 69.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.552 -3.217 . . . . 10.17 111.88 178.586 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.5 p -70.93 -17.58 62.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.347 -1.471 . . . . 13.59 114.844 168.843 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -77.73 -44.86 26.47 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 119.059 -2.275 . . . . 11.7 110.37 178.769 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -70.03 -25.44 63.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.799 -3.688 . . . . 12.95 115.76 173.975 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.501 20.3 t30 81.6 43.8 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 131.399 3.879 . . . . 25.45 115.905 -170.553 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.9 mt -94.13 94.25 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 105.68 -1.97 . . . . 14.6 105.68 174.009 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -93.07 -177.45 4.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.784 -1.553 . . . . 33.23 114.94 176.067 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -55.96 139.03 47.73 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.241 2.311 . . . . 25.97 117.241 -174.19 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 80.0 mt-10 68.98 12.27 8.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 128.634 3.709 . . . . 32.61 114.015 -179.854 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.275 16.1 m -64.69 144.05 57.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.392 1.477 . . . . 10.56 112.876 170.0 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 m -102.06 116.25 32.28 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 102.076 -3.305 . . . . 5.33 102.076 -176.602 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.36 134.72 42.88 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.191 -1.568 . . . . 11.66 111.455 168.245 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -109.5 120.75 43.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 113.317 -3.23 . . . . 16.3 112.115 -163.993 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.7 tp -94.43 117.88 30.79 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.686 1.866 . . . . 9.96 108.51 -170.292 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.55 149.3 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.293 -1.504 . . . . 9.76 107.625 167.283 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.264 80.2 mt . . . . . 0 N--CA 1.43 -1.43 0 O-C-N 120.481 -1.387 . . . . 19.57 113.589 -179.06 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 114.311 1.226 . . . . 17.17 114.311 . . . . . . . . . 0 0 . 1 . 098 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.259 61.8 mt-30 -98.4 135.58 39.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.183 1.793 . . . . 21.89 107.28 171.306 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.313 18.3 pt -131.23 150.64 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.416 -2.053 . . . . 10.83 110.14 166.947 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.255 17.5 m-85 -115.78 111.57 20.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.108 2.163 . . . . 10.61 112.713 -172.675 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.4 t -96.92 121.51 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.65 -1.281 . . . . 9.13 107.943 177.459 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.29 38.6 ttmt -114.27 133.68 55.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.144 -1.408 . . . . 20.55 113.107 -170.844 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.8 p -83.9 173.54 11.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 127.982 3.302 . . . . 11.78 114.429 178.248 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 mt -75.93 -29.48 58.39 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.642 2.46 . . . . 19.31 117.642 -178.686 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -68.07 -64.53 0.84 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.072 2.549 . . . . 23.14 107.367 169.846 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.26 51.72 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 104.656 -3.378 . . . . 19.74 104.656 170.016 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -97.13 125.64 41.76 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.161 2.984 . . . . 21.93 108.757 161.019 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -99.19 127.68 45.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.063 -2.273 . . . . 12.33 106.0 176.662 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.55 115.77 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 128.741 2.816 . . . . 17.08 111.297 161.576 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.3 m -84.8 124.74 31.91 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 119.327 0.967 . . . . 16.3 112.005 165.037 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.18 128.43 56.36 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 126.969 2.668 . . . . 15.88 104.733 -175.645 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -99.77 110.92 23.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.577 -2.749 . . . . 28.9 103.577 178.843 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.4 155.55 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 117.863 -1.065 . . . . 12.05 110.264 -169.477 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -104.08 139.23 19.9 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 115.933 -1.984 . . . . 18.17 112.153 171.166 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.66 -15.56 21.58 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 126.165 3.237 . . . . 8.16 111.369 -158.484 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.3 p -82.45 -1.8 51.3 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 121.121 3.749 . . . . 11.13 121.121 -177.414 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -89.1 174.2 8.01 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.922 3.689 . . . . 18.03 110.384 -179.036 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.4 p -91.51 157.43 17.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.482 -3.261 . . . . 10.22 113.843 -173.671 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mt -73.89 -31.21 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.056 -2.572 . . . . 12.3 104.056 172.96 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -40.23 -48.74 2.63 Favored 'General case' 0 N--CA 1.43 -1.429 2 O-C-N 114.13 -5.356 . . . . 36.51 110.656 164.982 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.306 8.8 t-20 -61.73 -41.82 98.15 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.026 2.93 . . . . 25.66 112.956 177.744 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -59.35 -45.19 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 125.436 1.495 . . . . 8.12 111.352 174.976 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -68.91 -40.63 78.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.686 3.194 . . . . 15.47 109.315 -179.087 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.32 -26.3 68.42 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.508 3.123 . . . . 11.45 111.886 176.493 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -72.18 -37.68 69.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.269 1.85 . . . . 24.98 111.594 172.496 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mt -76.49 -29.03 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 125.809 1.644 . . . . 9.46 109.879 178.43 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.27 -50.34 74.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.885 -3.01 . . . . 14.76 110.641 165.873 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.09 -68.27 0.26 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 129.158 2.983 . . . . 26.29 112.712 179.974 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -71.68 -62.87 1.26 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 114.719 -2.562 . . . . 30.06 115.197 -176.541 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -72.1 -51.18 22.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.403 2.049 . . . . 25.19 113.549 -175.079 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.74 38.83 1.52 Allowed Glycine 0 N--CA 1.43 -1.718 0 O-C-N 116.716 -3.74 . . . . 7.41 113.934 -179.509 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.272 78.9 mt -124.92 124.51 25.47 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 103.311 -2.848 . . . . 9.49 103.311 -174.249 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -76.84 175.82 10.9 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-O 114.904 -2.207 . . . . 11.42 110.789 -171.38 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HA ' ' HG2' ' A' ' 41' ' ' GLN . 49.0 Cg_endo -74.85 -32.84 5.29 Favored 'Trans proline' 0 C--N 1.299 -2.027 1 C-N-CA 126.53 4.82 . . . . 12.0 110.759 171.925 . . . . . . . . 3 3 . 1 . 098 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.272 11.6 t70 -58.26 -42.55 86.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.401 1.08 . . . . 35.55 113.809 176.322 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -79.54 -38.71 33.59 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.248 2.219 . . . . 20.52 112.314 -178.66 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 38' ' ' PRO . 5.6 pt20 -80.08 167.28 20.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 127.342 3.448 . . . . 7.13 118.71 -175.31 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -131.43 121.8 25.18 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.612 -3.18 . . . . 36.39 111.975 162.086 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.3 tp -108.66 119.0 38.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.24 -1.393 . . . . 9.55 107.24 -170.469 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 44' ' ' ILE . 56.1 mt -118.31 135.67 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.959 -2.963 . . . . 13.9 113.128 -169.68 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -118.7 109.54 16.22 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.879 -3.013 . . . . 6.86 106.323 167.798 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.4 -92.85 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.385 3.074 . . . . 11.15 113.566 -172.371 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.04 -37.89 8.16 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 119.486 -2.009 . . . . 13.93 116.611 175.545 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -107.71 146.56 31.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 124.794 0.938 . . . . 23.92 112.546 -159.742 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -81.02 138.37 36.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.43 2.538 . . . . 23.23 112.699 171.9 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.2 mt -89.78 114.83 26.61 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.757 -3.715 . . . . 9.11 112.306 -175.914 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.85 143.98 27.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.26 -2.15 . . . . 33.44 114.578 -173.084 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.8 -49.86 72.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.61 3.164 . . . . 28.37 112.447 -165.875 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.12 -4.63 77.78 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 118.325 2.09 . . . . 15.0 118.325 -163.303 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -84.06 178.94 7.64 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.776 3.179 . . . . 25.5 113.854 166.105 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.5 p -110.83 175.84 5.27 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.732 -3.105 . . . . 11.95 104.651 -177.667 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.49 -26.9 32.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.152 2.181 . . . . 10.17 105.374 -178.589 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.1 p -65.99 -36.33 83.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 131.461 3.905 . . . . 13.59 113.147 174.264 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.4 -52.84 63.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 126.972 2.67 . . . . 11.7 116.001 171.048 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -67.56 -17.49 64.66 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.767 1.627 . . . . 12.95 111.357 176.822 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 59.51 55.08 4.27 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.545 2.338 . . . . 25.45 111.754 -170.405 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 61' ' ' ILE . 57.0 mt -86.79 116.96 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 104.038 -2.579 . . . . 14.6 104.038 -178.417 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -98.3 159.69 14.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 126.925 2.641 . . . . 33.23 110.011 -178.212 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -52.18 131.98 32.97 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.878 2.071 . . . . 25.97 112.909 -178.051 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 73.09 32.57 1.29 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.716 -2.947 . . . . 32.61 111.938 176.666 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -75.66 141.49 42.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.843 1.783 . . . . 10.56 110.636 169.48 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -86.54 120.48 27.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.505 -2.035 . . . . 5.33 105.505 171.63 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.86 146.73 38.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.754 1.622 . . . . 11.66 106.827 175.959 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -117.73 140.57 49.49 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.422 2.058 . . . . 16.3 108.134 -172.177 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 tp -119.68 135.69 54.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.024 -2.954 . . . . 9.96 103.024 -174.534 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 71' ' ' LEU . 2.3 t -135.03 -176.6 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.381 2.672 . . . . 9.76 105.283 174.805 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.568 ' H ' HG12 ' A' ' 70' ' ' VAL . 7.2 mt . . . . . 0 N--CA 1.431 -1.414 0 C-N-CA 126.792 2.037 . . . . 19.57 108.973 169.111 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tmm? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 112.485 0.55 . . . . 17.17 112.485 . . . . . . . . . 0 0 . 1 . 099 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -85.83 123.47 31.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.206 1.402 . . . . 21.89 108.066 -178.659 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.496 HD12 HD22 ' A' ' 67' ' ' LEU . 39.6 pt -106.29 161.01 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.871 -2.393 . . . . 10.83 109.769 151.855 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -114.23 131.81 56.35 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.851 -3.389 . . . . 10.61 101.851 -178.765 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.95 102.83 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 101.867 -3.383 . . . . 9.13 101.867 -178.079 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -94.89 128.5 41.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.174 2.19 . . . . 20.55 116.403 -173.206 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.267 18.9 p -89.41 173.17 8.51 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.121 -2.862 . . . . 11.78 116.407 -177.012 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.95 -48.56 15.99 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.118 -2.239 . . . . 19.31 109.004 174.502 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -67.69 -46.98 70.72 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.929 3.291 . . . . 23.14 107.188 -168.54 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.63 24.58 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 116.074 -2.514 . . . . 19.74 118.799 173.083 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -110.89 124.91 53.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 120.082 1.941 . . . . 21.93 107.243 -174.489 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 m -105.53 114.1 28.06 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.729 -1.857 . . . . 12.33 109.846 171.745 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -95.34 122.1 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 103.698 -2.705 . . . . 17.08 103.698 -165.735 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -91.48 110.92 22.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.985 -2.969 . . . . 16.3 102.985 175.244 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.5 mt -106.26 136.77 45.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.986 1.314 . . . . 15.88 108.404 169.126 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -93.58 116.02 28.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.342 2.02 . . . . 28.9 108.938 169.275 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.85 167.57 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.529 3.132 . . . . 12.05 110.694 175.487 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -105.64 158.44 32.31 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 114.485 -2.674 . . . . 18.17 110.878 157.68 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -74.38 -25.12 13.54 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 126.174 3.241 . . . . 8.16 117.478 -172.453 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -75.24 -11.4 60.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 131.223 3.809 . . . . 11.13 115.788 163.629 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -72.46 158.24 36.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.998 2.333 . . . . 18.03 113.522 178.382 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -92.98 161.41 14.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.244 -3.41 . . . . 10.22 112.478 -173.926 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.7 mt -82.82 -8.75 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 126.661 2.476 . . . . 12.3 111.224 -179.398 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -57.7 -54.91 41.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.941 -2.349 . . . . 36.51 111.313 166.421 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -61.27 -16.08 41.85 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 116.291 -4.005 . . . . 25.66 115.012 168.776 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -74.64 -43.93 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 CA-C-N 126.381 4.173 . . . . 8.12 108.302 167.906 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -67.15 -32.29 73.3 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.311 1.869 . . . . 15.47 114.79 175.51 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.98 -25.14 58.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.108 1.892 . . . . 11.45 116.108 172.176 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -74.08 -30.58 62.44 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.493 1.497 . . . . 24.98 107.052 178.233 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.402 HG22 ' HB ' ' A' ' 36' ' ' ILE . 37.9 mm -69.9 -34.67 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 118.368 -0.825 . . . . 9.46 111.857 173.639 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -65.13 -43.49 91.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.802 2.841 . . . . 14.76 109.741 173.466 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.02 -56.77 14.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 117.49 2.404 . . . . 26.29 117.49 176.311 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 14.7 mmtm -56.53 -65.16 0.66 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.875 3.27 . . . . 30.06 112.235 173.322 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -101.17 -36.03 9.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.682 -1.145 . . . . 25.19 113.133 -159.673 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.08 4.72 31.08 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 118.231 -2.793 . . . . 7.41 114.078 -177.402 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.402 ' HB ' HG22 ' A' ' 30' ' ' ILE . 9.6 mt -88.34 112.25 48.6 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-O 116.831 -1.557 . . . . 9.49 109.121 -173.02 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -81.74 -176.7 3.17 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 122.568 1.953 . . . . 11.42 114.472 -171.819 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -74.4 -16.31 21.91 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 122.412 2.074 . . . . 12.0 115.764 -178.924 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.42 -24.08 42.77 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.88 2.752 . . . . 35.55 116.614 -175.904 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -98.33 -35.52 10.29 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.501 -2.136 . . . . 20.52 110.057 -168.587 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -91.89 166.26 12.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.635 -1.29 . . . . 7.13 108.515 -172.333 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.2 139.02 37.39 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 131.778 4.031 . . . . 36.39 104.102 165.632 . . . . . . . . 3 3 . 1 . 099 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.1 mt -104.2 132.9 49.96 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.647 1.979 . . . . 9.55 106.401 178.069 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.02 142.07 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.809 -1.807 . . . . 13.9 107.846 177.514 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -148.83 108.54 4.02 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.308 -2.12 . . . . 6.86 108.484 -175.066 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 57.05 -114.31 0.81 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 120.541 3.534 . . . . 11.15 120.541 -158.54 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.34 -36.53 20.39 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.605 -1.31 . . . . 13.93 114.607 -178.901 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -116.06 170.49 8.46 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 120.729 2.264 . . . . 23.92 114.499 -162.54 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.19 146.54 24.99 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 102.799 -3.037 . . . . 23.23 102.799 -176.676 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.8 mt -99.86 128.79 45.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.489 -2.782 . . . . 9.11 103.489 -166.397 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -75.3 153.81 37.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.736 1.614 . . . . 33.44 113.868 168.76 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.55 -61.69 1.73 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.782 -3.699 . . . . 28.37 108.56 -162.671 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.93 59.2 3.21 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 122.297 2.317 . . . . 15.0 111.147 -169.438 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -140.72 153.07 45.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.472 2.309 . . . . 25.5 106.987 -177.354 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.25 46.7 p -82.94 154.53 24.5 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.674 -2.516 . . . . 11.95 113.174 -173.151 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.631 HD23 HD12 ' A' ' 61' ' ' ILE . 17.5 mt -63.88 -39.52 94.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.933 -2.354 . . . . 10.17 111.642 165.503 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 p -54.59 -37.5 65.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.408 2.744 . . . . 13.59 118.408 172.578 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.37 -50.35 53.76 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.287 -5.258 . . . . 11.7 113.941 174.745 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -69.88 -14.09 62.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.295 2.638 . . . . 12.95 114.03 -177.909 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.492 27.6 m-20 75.23 41.15 0.3 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 116.963 2.209 . . . . 25.45 116.963 -176.289 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.631 HD12 HD23 ' A' ' 56' ' ' LEU . 71.7 mt -83.0 116.12 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 118.21 -2.806 . . . . 14.6 107.77 177.522 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -97.95 167.46 10.9 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.615 -0.721 . . . . 33.23 110.012 -176.65 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -70.23 144.65 51.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 120.874 1.67 . . . . 25.97 112.605 -174.86 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 67.16 21.5 10.04 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.661 3.6 . . . . 32.61 112.134 176.81 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 t -97.67 151.61 19.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.896 -2.378 . . . . 10.56 108.682 -178.081 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.8 m -101.47 111.3 23.5 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.244 2.618 . . . . 5.33 113.07 -168.502 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.496 HD22 HD12 ' A' ' 3' ' ' ILE . 9.2 mp -90.88 145.89 24.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.293 2.637 . . . . 11.66 106.206 164.065 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -97.26 132.46 42.98 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 119.824 -0.75 . . . . 16.3 112.583 171.48 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 tp -95.03 121.01 36.22 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.432 -1.692 . . . . 9.96 106.432 166.732 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.76 153.77 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 114.959 -2.448 . . . . 9.76 105.596 178.699 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.6 mt . . . . . 0 N--CA 1.43 -1.465 0 CA-C-N 124.692 3.406 . . . . 19.57 107.465 175.541 . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttp . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 123.704 1.716 . . . . 17.17 107.499 . . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -99.98 116.61 32.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.613 2.765 . . . . 21.89 111.036 175.776 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -124.83 167.69 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 106.79 -1.559 . . . . 10.83 106.79 178.884 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -122.48 115.82 22.88 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.663 -1.273 . . . . 10.61 110.823 -169.364 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.05 123.48 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 121.295 -0.878 . . . . 9.13 109.128 171.351 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HD2' HG21 ' A' ' 66' ' ' THR . 85.2 mttt -117.38 137.17 52.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.171 1.788 . . . . 20.55 108.846 -175.907 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -102.94 -176.77 3.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.488 1.742 . . . . 11.78 109.035 -175.16 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.266 95.9 mt -69.93 -27.1 64.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.805 2.442 . . . . 19.31 116.698 -172.091 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -96.2 -89.08 0.26 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.451 2.3 . . . . 23.14 111.079 -177.679 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.74 36.85 0.47 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.811 -3.681 . . . . 19.74 111.321 168.765 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -97.04 137.96 35.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 116.732 -1.987 . . . . 21.93 109.721 179.423 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.3 m -123.26 121.97 37.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.36 1.552 . . . . 12.33 107.103 171.144 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.9 mt -101.38 119.35 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 103.382 -2.822 . . . . 17.08 103.382 179.96 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -89.36 105.34 17.73 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.237 1.494 . . . . 16.3 108.874 165.241 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.7 mt -92.13 146.12 23.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.602 3.572 . . . . 15.88 106.076 -178.32 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -95.2 108.56 20.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.284 -2.689 . . . . 28.9 112.33 171.272 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.86 -177.28 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.439 -1.689 . . . . 12.05 106.439 -176.183 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -132.63 159.9 70.58 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 119.157 -2.215 . . . . 18.17 107.279 164.547 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -77.48 -16.03 15.33 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 O-C-N 116.417 -2.464 . . . . 8.16 114.691 -168.131 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 m -90.11 9.09 29.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 116.425 -2.11 . . . . 11.13 114.665 177.605 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -86.9 162.54 17.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.755 2.693 . . . . 18.03 113.703 165.048 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 69.2 p -99.56 169.79 9.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.84 2.733 . . . . 10.22 112.622 -170.7 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.372 36.8 mm -52.89 -32.72 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 116.164 1.913 . . . . 12.3 116.164 171.78 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.24 -28.65 69.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.933 -3.604 . . . . 36.51 116.263 170.769 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -75.79 -20.21 58.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.995 -2.315 . . . . 25.66 113.825 171.423 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.7 t -83.6 -45.33 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 116.694 -1.622 . . . . 8.12 107.392 -179.491 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -63.58 -31.58 72.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.656 2.383 . . . . 15.47 110.94 173.682 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.6 -25.05 68.05 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 117.525 -1.67 . . . . 11.45 114.251 175.181 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -90.29 -15.24 31.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 116.702 -3.749 . . . . 24.98 115.768 173.3 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mm -80.44 -24.6 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 126.159 2.162 . . . . 9.46 110.59 167.88 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -81.82 -26.77 34.06 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.524 1.93 . . . . 14.76 108.478 -177.537 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.89 -68.9 0.38 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.566 -3.208 . . . . 26.29 111.497 164.542 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -73.64 -49.36 26.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.11 1.893 . . . . 30.06 116.11 -169.375 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -86.81 -47.82 8.74 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.666 2.03 . . . . 25.19 113.396 178.95 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.06 59.11 1.51 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.288 3.804 . . . . 7.41 107.152 169.33 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 40' ' ' GLN . 15.9 mm -102.41 140.0 20.74 Favored Pre-proline 0 N--CA 1.43 -1.469 0 O-C-N 129.099 3.47 . . . . 9.49 104.004 177.79 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -62.07 161.22 26.99 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 O-C-N 114.304 -3.577 . . . . 11.42 115.953 173.582 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -72.66 -27.49 15.14 Favored 'Trans proline' 0 N--CA 1.434 -1.987 1 CA-C-N 128.85 4.196 . . . . 12.0 110.682 -168.408 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -87.13 -24.08 24.64 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.669 2.84 . . . . 35.55 118.669 179.425 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.408 ' HB3' HG22 ' A' ' 36' ' ' ILE . 11.0 tt0 -66.9 -42.06 86.08 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.828 2.529 . . . . 20.52 117.828 172.624 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -72.64 131.74 42.82 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.117 3.377 . . . . 7.13 120.117 176.155 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -131.9 104.96 7.14 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.685 1.994 . . . . 36.39 108.624 -170.082 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.1 mt -83.84 112.43 20.11 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 115.22 -4.675 . . . . 9.55 114.293 174.84 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.7 mt -99.89 115.81 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 114.041 -1.436 . . . . 13.9 111.585 175.402 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -108.21 120.65 42.96 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.06 -1.65 . . . . 6.86 106.55 163.436 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.52 . . 69.21 -111.16 0.09 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.627 -2.546 . . . . 11.15 111.65 -176.77 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.69 6.15 12.6 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 116.507 -2.758 . . . . 13.93 108.58 172.027 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -86.39 139.22 31.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.468 -2.783 . . . . 23.92 111.702 -158.15 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -89.41 125.16 35.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 102.998 -2.964 . . . . 23.23 102.998 166.132 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 mt -94.33 144.18 25.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.544 2.116 . . . . 9.11 110.447 -167.806 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -90.68 130.46 36.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.622 -2.549 . . . . 33.44 116.402 172.686 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -36.54 -51.1 0.82 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.992 4.517 . . . . 28.37 119.612 176.074 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.29 20.9 36.58 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 114.23 -1.35 . . . . 15.0 113.773 -169.341 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mtt-85 -93.3 163.91 13.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.146 -2.973 . . . . 25.5 110.468 160.872 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 38.0 p -104.74 158.16 16.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.037 -1.664 . . . . 11.95 108.276 -173.978 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -56.06 -35.88 67.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.728 2.68 . . . . 10.17 115.522 -179.648 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.7 p -63.04 -48.2 79.75 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 136.82 6.048 . . . . 13.59 113.653 169.663 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -60.35 -44.78 95.24 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.579 1.952 . . . . 11.7 112.896 176.803 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -74.7 -10.41 59.49 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 116.239 -4.038 . . . . 12.95 114.323 173.96 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.394 60.5 m-80 71.33 36.08 1.41 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.93 2.492 . . . . 25.45 112.313 178.803 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.9 mt -87.87 86.18 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 125.604 1.815 . . . . 14.6 109.52 -175.776 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -77.04 -178.1 4.81 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 125.708 1.88 . . . . 33.23 114.5 -173.408 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -72.29 135.72 46.05 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.797 1.639 . . . . 25.97 110.463 -178.69 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.306 47.6 mt-10 61.91 35.21 16.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.241 1.02 . . . . 32.61 112.377 -176.304 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.288 0.2 OUTLIER -105.47 147.23 28.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.466 -2.152 . . . . 10.56 109.587 172.224 . . . . . . . . 3 3 . 1 . 100 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.439 HG21 ' HD2' ' A' ' 6' ' ' LYS . 61.9 m -122.65 120.42 33.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.728 2.204 . . . . 5.33 112.586 -157.198 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -101.89 130.23 48.33 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 130.337 3.455 . . . . 11.66 109.959 -177.393 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -102.7 104.23 14.54 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.348 -3.97 . . . . 16.3 104.953 -174.208 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.5 tp -80.05 119.37 22.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.479 -2.045 . . . . 9.96 105.479 172.957 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.06 141.01 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 126.223 2.202 . . . . 9.76 108.361 170.739 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 112.99 0.737 . . . . 19.57 112.99 177.395 . . . . . . . . 0 0 . 1 . 101 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 115.456 1.65 . . . . 17.17 115.456 . . . . . . . . . 0 0 . 1 . 101 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -80.55 118.88 22.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.881 -3.012 . . . . 21.89 118.336 -179.924 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 pt -100.8 165.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 126.957 2.103 . . . . 10.83 111.819 168.937 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.294 15.8 m-30 -123.15 112.6 17.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.838 -2.414 . . . . 10.61 112.656 -176.016 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.3 t -90.91 105.38 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 117.972 -2.955 . . . . 9.13 117.206 170.46 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -88.99 137.11 32.62 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 124.208 1.956 . . . . 20.55 115.343 -175.591 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.1 p -87.15 178.41 6.9 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 113.314 -5.866 . . . . 11.78 110.648 -176.183 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tp -58.63 -50.02 75.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.473 -3.892 . . . . 19.31 114.681 173.006 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -77.78 -38.63 46.25 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 116.211 -4.056 . . . . 23.14 112.99 -177.412 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.76 52.18 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.999 -1.688 . . . . 19.74 115.485 169.589 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -111.3 126.74 55.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.906 1.336 . . . . 21.93 107.924 179.331 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -86.06 116.08 24.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.573 -2.58 . . . . 12.33 111.789 169.936 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.4 mt -92.97 117.27 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 112.969 0.729 . . . . 17.08 112.969 168.254 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.0 m -88.11 122.26 31.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 119.118 -2.238 . . . . 16.3 109.936 177.865 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.8 mt -115.36 131.13 57.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.602 2.62 . . . . 15.88 111.52 172.553 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -87.75 103.25 15.44 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.504 2.722 . . . . 28.9 105.146 -177.068 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.405 HG12 ' HE3' ' A' ' 29' ' ' LYS . 28.4 m -119.33 167.8 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 105.662 -1.977 . . . . 12.05 105.662 -178.321 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -123.56 147.05 51.81 Favored Pre-proline 0 N--CA 1.431 -1.402 0 C-N-CA 126.471 1.908 . . . . 18.17 106.407 176.609 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -67.52 -22.5 44.71 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 O-C-N 115.796 -2.791 . . . . 8.16 117.245 -158.094 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 m -94.53 33.85 1.38 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 123.934 3.061 . . . . 11.13 113.612 171.34 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -84.92 139.14 32.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 127.193 3.378 . . . . 18.03 113.243 162.665 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 p -80.05 163.07 24.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.651 -2.068 . . . . 10.22 112.614 176.275 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.91 -26.04 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.712 -1.868 . . . . 12.3 112.321 -179.624 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.398 15.2 pt-20 -60.58 -28.38 68.43 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.687 2.106 . . . . 36.51 116.687 168.959 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.293 5.7 t-20 -72.83 -37.92 67.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.955 3.302 . . . . 25.66 111.152 173.719 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 39.6 t -52.34 -53.93 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 129.213 3.005 . . . . 8.12 111.59 173.55 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -69.76 -11.01 60.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.728 3.211 . . . . 15.47 112.184 -179.303 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.44 -44.7 70.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 121.423 1.919 . . . . 11.45 107.623 174.074 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HE3' HG12 ' A' ' 17' ' ' VAL . 64.0 mttm -76.0 -37.81 58.07 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.346 2.659 . . . . 24.98 106.023 -168.247 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.315 8.8 mm -57.37 -35.51 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 118.594 2.813 . . . . 9.46 118.594 171.233 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -71.46 -40.4 70.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.473 2.709 . . . . 14.76 114.895 167.339 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -60.3 -67.26 0.41 Allowed 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 128.23 3.871 . . . . 26.29 111.495 169.687 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -72.62 -50.97 21.69 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 110.502 -7.624 . . . . 30.06 112.48 -160.629 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -97.1 -71.64 0.67 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.112 1.911 . . . . 25.19 111.479 175.104 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.41 26.01 0.5 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 116.276 -2.869 . . . . 7.41 120.178 -175.662 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.53 133.5 28.09 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 115.323 -2.275 . . . . 9.49 107.72 -178.519 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -73.49 160.09 45.07 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 126.566 3.381 . . . . 11.42 114.639 179.525 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.5 -16.06 9.53 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 123.552 2.835 . . . . 12.0 110.521 -162.266 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -82.03 -37.61 26.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 125.056 3.571 . . . . 35.55 114.474 -179.899 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -69.49 -27.57 65.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.636 2.458 . . . . 20.52 117.636 -178.139 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -87.65 139.24 30.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.33 -1.359 . . . . 7.13 107.33 -174.318 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -106.63 142.59 36.03 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 105.007 -2.22 . . . . 36.39 105.007 165.526 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.4 mt -118.96 108.85 15.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.704 -3.122 . . . . 9.55 112.879 171.119 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mt -92.82 137.86 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.441 -1.689 . . . . 13.9 106.441 -177.363 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -110.38 118.95 37.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.304 2.241 . . . . 6.86 105.576 167.125 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.18 -96.63 0.05 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.919 1.288 . . . . 11.15 111.899 -167.277 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.86 5.55 6.13 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 117.36 -3.337 . . . . 13.93 112.065 172.769 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -82.03 152.65 26.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.609 -2.701 . . . . 23.92 110.487 -168.079 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -92.02 124.62 36.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.94 -1.505 . . . . 23.23 112.361 169.098 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.2 mt -104.72 168.7 8.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.693 1.246 . . . . 9.11 112.467 -175.173 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -132.06 166.44 21.74 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.643 1.977 . . . . 33.44 107.374 -178.403 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -93.9 -42.86 8.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.913 -1.742 . . . . 28.37 111.104 -149.305 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.83 44.96 1.44 Allowed Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 118.462 -1.828 . . . . 15.0 115.193 -179.042 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -120.82 159.12 26.12 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.486 2.314 . . . . 25.5 107.748 173.293 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -97.98 160.31 14.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.384 1.564 . . . . 11.95 114.506 -169.461 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.52 -38.83 82.03 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.902 -1.749 . . . . 10.17 112.496 168.179 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 p -52.73 -45.6 67.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 118.498 2.777 . . . . 13.59 118.498 171.281 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.47 -41.68 96.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 114.549 -2.644 . . . . 11.7 114.92 176.436 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -78.91 -10.13 59.72 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.41 2.368 . . . . 12.95 115.13 172.966 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.422 1.0 OUTLIER 71.82 42.7 0.61 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.776 1.769 . . . . 25.45 115.776 -178.832 . . . . . . . . 3 3 . 1 . 101 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.5 mt -88.11 111.84 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 1 O-C-N 129.418 4.199 . . . . 14.6 108.756 -177.4 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.319 40.1 mt-30 -93.1 -175.55 3.89 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.876 -3.64 . . . . 33.23 110.671 -177.938 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttt -69.69 147.36 50.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.053 -1.655 . . . . 25.97 112.722 171.571 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 56.26 41.57 29.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.652 2.381 . . . . 32.61 116.786 -168.122 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.6 m -104.34 145.61 30.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 125.023 1.452 . . . . 10.56 107.441 178.82 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -105.81 124.02 48.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.593 2.14 . . . . 5.33 106.221 -165.578 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.3 mt -104.34 143.03 33.53 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.108 -3.495 . . . . 11.66 106.751 168.499 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -98.84 111.33 23.75 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.264 1.95 . . . . 16.3 116.264 -179.524 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.88 108.36 5.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.251 -3.406 . . . . 9.96 109.249 179.747 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 t -117.04 149.32 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 104.818 -2.29 . . . . 9.76 104.818 177.206 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 tp . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 116.833 2.16 . . . . 19.57 116.833 171.212 . . . . . . . . 0 0 . 1 . 102 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 124.191 1.948 . . . . 17.17 111.683 . . . . . . . . . 0 0 . 1 . 102 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -76.85 119.51 20.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.397 -2.69 . . . . 21.89 110.334 -178.775 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.4 pt -112.06 154.66 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.614 -1.254 . . . . 10.83 107.614 169.548 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.24 133.02 52.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 126.568 3.08 . . . . 10.61 108.643 175.152 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -110.91 117.81 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 126.812 2.045 . . . . 9.13 111.17 165.437 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.22 135.57 55.11 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.557 -1.339 . . . . 20.55 108.289 -170.752 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.8 p -95.32 179.81 5.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.803 1.287 . . . . 11.78 109.421 -163.501 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 tp -71.99 -46.46 57.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.111 1.91 . . . . 19.31 114.851 173.618 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -73.21 -40.14 64.98 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.259 -2.15 . . . . 23.14 115.546 175.842 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.17 64.65 0.15 Allowed Glycine 0 N--CA 1.431 -1.691 0 CA-C-O 122.897 1.276 . . . . 19.74 111.715 176.254 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -123.99 136.48 54.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.708 2.194 . . . . 21.93 108.016 159.263 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -105.01 108.22 19.62 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.973 -2.329 . . . . 12.33 112.69 168.451 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.02 126.21 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.041 -1.662 . . . . 17.08 109.054 178.64 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -96.91 111.63 23.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.875 1.065 . . . . 16.3 113.875 179.465 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.3 mt -96.59 138.57 33.97 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.119 -2.863 . . . . 15.88 110.498 -176.025 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -107.28 73.35 0.92 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.389 2.995 . . . . 28.9 110.915 -175.394 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -102.46 169.47 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 O-C-N 115.792 -4.318 . . . . 12.05 106.798 -175.143 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -95.87 159.09 33.13 Favored Pre-proline 0 N--CA 1.43 -1.453 1 O-C-N 130.002 4.564 . . . . 18.17 106.871 174.647 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.25 -26.68 20.64 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 O-C-N 126.268 2.72 . . . . 8.16 110.964 172.645 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 p -72.64 -7.09 48.56 Favored 'General case' 0 N--CA 1.43 -1.453 1 CA-C-N 127.237 4.562 . . . . 11.13 112.742 175.915 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -77.67 154.14 32.43 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 123.196 2.725 . . . . 18.03 112.724 -175.19 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 64.4 p -89.34 151.33 22.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.302 3.041 . . . . 10.22 110.95 178.976 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.25 39.7 mm -56.97 -30.26 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.308 2.643 . . . . 12.3 114.198 178.691 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -49.25 -45.56 44.9 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.974 -2.954 . . . . 36.51 113.733 166.303 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -68.91 -37.0 78.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 124.249 0.968 . . . . 25.66 111.266 177.987 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.62 -40.31 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 113.741 1.015 . . . . 8.12 113.741 -179.678 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.26 49.8 mtpt -59.1 -48.88 79.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.544 2.737 . . . . 15.47 112.823 174.521 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.87 -32.33 63.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.867 3.267 . . . . 11.45 111.094 172.581 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -74.27 -39.82 62.72 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 124.005 3.093 . . . . 24.98 109.455 -177.374 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD13 HD22 ' A' ' 69' ' ' LEU 0.326 81.8 mt -59.36 -37.52 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 129.991 3.317 . . . . 9.46 112.732 173.928 . . . . . . . . 3 3 . 1 . 102 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -59.91 -54.36 47.08 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.555 1.525 . . . . 14.76 112.9 167.039 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.23 -51.41 68.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.702 1.239 . . . . 26.29 112.123 -173.723 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -78.17 -69.54 0.55 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.364 2.666 . . . . 30.06 114.351 179.398 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -87.29 -11.24 50.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.087 2.254 . . . . 25.19 117.087 -170.34 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.68 20.52 34.09 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 128.151 2.786 . . . . 7.41 116.253 160.895 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mm -113.32 125.45 29.65 Favored Pre-proline 0 N--CA 1.43 -1.459 0 O-C-N 120.493 -1.592 . . . . 9.49 110.036 -173.164 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.309 53.9 Cg_exo -76.55 167.58 25.29 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-O 115.423 -1.991 . . . . 11.42 116.61 -173.968 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -63.9 -23.5 68.29 Favored 'Trans proline' 0 C--N 1.3 -2.019 1 C-N-CA 126.533 4.822 . . . . 12.0 115.907 -170.445 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -89.89 -21.81 22.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 124.008 3.095 . . . . 35.55 112.258 177.277 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -75.72 -9.54 58.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.627 -2.606 . . . . 20.52 116.1 -176.893 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -112.1 150.54 30.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.102 2.751 . . . . 7.13 114.656 -167.502 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -127.22 93.25 3.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.851 -1.781 . . . . 36.39 109.357 -176.518 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.9 mt -82.17 91.59 6.74 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 113.831 1.049 . . . . 9.55 113.831 172.24 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.4 mt -91.07 135.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 118.764 -0.636 . . . . 13.9 110.202 -177.816 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -122.66 112.7 18.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.603 -2.369 . . . . 6.86 104.603 179.65 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.86 -108.53 0.44 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.187 -2.196 . . . . 11.15 113.004 -169.721 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.91 -19.66 39.31 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 115.536 -2.813 . . . . 13.93 117.041 167.43 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -105.34 134.08 49.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.791 1.795 . . . . 23.92 114.414 -165.564 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.45 138.4 47.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.303 2.002 . . . . 23.23 112.327 167.636 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.86 141.78 31.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.222 2.209 . . . . 9.11 111.185 -169.099 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -119.62 135.88 54.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.467 1.603 . . . . 33.44 112.791 -166.453 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -48.86 -58.95 4.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.883 2.873 . . . . 28.37 111.882 -160.376 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.57 -10.18 75.28 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 122.85 3.9 . . . . 15.0 122.85 -173.843 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 54' ' ' ARG . 16.4 mmt180 -79.66 156.59 27.52 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.548 1.969 . . . . 25.5 114.95 174.586 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.9 p -93.88 168.81 10.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.748 3.166 . . . . 11.95 108.663 -176.001 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mt -72.64 -40.04 66.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.685 -2.052 . . . . 10.17 106.615 -176.198 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -63.79 -28.66 70.02 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 127.853 3.22 . . . . 13.59 116.139 174.114 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.76 -50.38 69.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.177 3.791 . . . . 11.7 113.406 170.805 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -64.95 -30.73 71.74 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.917 1.821 . . . . 12.95 115.917 167.144 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 49.4 m-80 82.11 41.27 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.43 1 C-N-CA 131.939 4.096 . . . . 25.45 110.921 176.908 . . . . . . . . 3 2 . 1 . 102 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -78.82 92.53 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 CA-C-O 129.469 4.461 . . . . 14.6 108.935 170.919 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -84.66 175.65 9.08 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 113.202 -5.936 . . . . 33.23 111.168 179.707 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -54.03 127.76 27.79 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.278 1.99 . . . . 25.97 116.173 172.201 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 78.37 29.29 0.44 Allowed 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 132.744 4.418 . . . . 32.61 117.016 176.877 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.3 m -81.49 149.03 28.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.955 -1.498 . . . . 10.56 106.955 -169.693 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.7 m -94.43 118.01 31.0 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.701 -2.5 . . . . 5.33 112.492 177.45 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.0 137.6 40.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.508 -3.245 . . . . 11.66 106.039 168.565 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -98.25 109.97 22.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.067 2.247 . . . . 16.3 117.067 169.868 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.422 HD22 HD13 ' A' ' 30' ' ' ILE . 14.2 tp -91.43 105.32 17.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.342 1.857 . . . . 9.96 115.713 -179.944 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -109.32 162.68 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 101.81 -3.404 . . . . 9.76 101.81 178.412 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 N--CA 1.429 -1.483 0 C-N-CA 127.267 2.227 . . . . 19.57 112.411 168.78 . . . . . . . . 0 0 . 1 . 103 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 123.628 1.68 . . . . 17.17 108.738 . . . . . . . . . 0 0 . 1 . 103 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -88.66 126.85 35.49 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 111.47 -2.604 . . . . 21.89 111.401 -179.68 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 3' ' ' ILE 0.256 20.8 pt -130.9 159.29 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 107.221 -1.4 . . . . 10.83 107.221 168.721 . . . . . . . . 3 3 . 1 . 103 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -106.89 132.92 52.3 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 118.433 -0.794 . . . . 10.61 109.481 179.414 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.4 t -101.19 112.89 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.219 2.438 . . . . 9.13 111.704 160.325 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -95.73 127.17 41.53 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 113.129 -5.982 . . . . 20.55 112.99 177.274 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -76.87 -177.26 4.28 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.492 -4.505 . . . . 11.78 118.146 178.494 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 tp -79.53 -21.74 44.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.484 2.564 . . . . 19.31 113.658 178.849 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.372 0.1 OUTLIER -75.32 -48.23 24.09 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 116.055 -4.153 . . . . 23.14 108.72 174.219 . . . . . . . . 4 3 . 1 . 103 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.15 20.92 1.11 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 112.749 -2.023 . . . . 19.74 109.593 172.246 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -78.62 117.83 20.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.354 2.502 . . . . 21.93 110.751 173.581 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -88.26 110.96 21.15 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.693 -3.129 . . . . 12.33 114.241 -178.9 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 mt -99.61 107.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.901 2.08 . . . . 17.08 110.983 -172.268 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.2 m -71.97 127.29 32.09 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.101 -1.624 . . . . 16.3 112.835 173.524 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 mt -111.63 151.34 28.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.532 -1.355 . . . . 15.88 114.313 167.303 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -108.96 99.05 8.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.808 2.043 . . . . 28.9 111.253 177.325 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.15 166.13 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.188 -3.445 . . . . 12.05 103.882 -171.801 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -120.0 161.88 36.18 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 118.959 -2.338 . . . . 18.17 106.348 177.656 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.68 -8.54 8.21 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 127.501 3.715 . . . . 8.16 107.73 -155.901 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -76.17 -9.63 58.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 130.153 3.381 . . . . 11.13 109.136 172.168 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -81.99 141.34 33.34 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.58 2.352 . . . . 18.03 112.67 -175.316 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.6 p -88.14 163.15 16.33 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.901 -1.749 . . . . 10.22 108.59 -171.576 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mm -76.42 -17.6 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 125.936 2.023 . . . . 12.3 109.081 -172.595 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -64.26 -30.19 71.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.562 -1.961 . . . . 36.51 116.243 162.259 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -76.17 -36.1 58.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.175 1.39 . . . . 25.66 109.696 -179.887 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.45 -48.74 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 128.865 2.866 . . . . 8.12 115.959 172.752 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.02 -35.9 78.08 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.256 -1.831 . . . . 15.47 114.069 164.728 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.66 -39.25 80.09 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.752 2.978 . . . . 11.45 115.138 173.671 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -57.28 -42.78 82.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 124.371 3.259 . . . . 24.98 115.814 169.205 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.18 -29.79 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 O-C-N 114.18 -5.325 . . . . 9.46 112.625 176.447 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -66.26 -52.7 44.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.603 -2.561 . . . . 14.76 108.504 167.804 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.337 34.1 t70 -51.81 -42.3 62.38 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 114.869 -2.491 . . . . 26.29 115.053 176.349 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -80.99 -86.06 0.09 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 128.944 3.903 . . . . 30.06 112.052 -178.151 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -72.51 -33.68 67.08 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.237 1.94 . . . . 25.19 116.237 -175.275 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.15 39.46 4.53 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.089 -3.507 . . . . 7.41 114.218 -175.945 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mm -100.03 113.4 65.21 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 117.391 -3.417 . . . . 9.49 110.601 175.849 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -64.85 151.56 85.33 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 124.811 3.674 . . . . 11.42 114.075 -176.49 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.23 -9.87 16.39 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-N 127.013 3.54 . . . . 12.0 114.836 -165.605 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.06 -28.56 61.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.216 2.436 . . . . 35.55 107.577 178.406 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -84.62 -20.34 31.53 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.198 -2.189 . . . . 20.52 112.018 -174.764 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -93.53 149.52 21.16 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.17 2.891 . . . . 7.13 114.094 -172.873 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -141.64 126.31 17.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.324 -3.36 . . . . 36.39 108.175 167.146 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.83 121.06 43.98 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 110.048 -3.251 . . . . 9.55 106.864 -175.556 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.7 mt -113.83 135.19 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 1 N-CA-C 98.916 -4.476 . . . . 13.9 98.916 -171.185 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -115.64 103.41 10.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 127.429 2.292 . . . . 6.86 106.479 170.212 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.29 -105.16 0.07 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.154 1.782 . . . . 11.15 114.034 -174.7 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.14 27.29 9.16 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 115.54 -2.811 . . . . 13.93 116.289 170.561 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -147.49 158.97 44.21 Favored 'General case' 0 N--CA 1.43 -1.458 1 CA-C-N 124.363 4.082 . . . . 23.92 111.872 171.822 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.259 15.8 pt20 -85.31 137.81 32.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.501 1.52 . . . . 23.23 110.784 -175.84 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -83.67 131.05 34.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.218 -1.771 . . . . 9.11 106.218 175.043 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -93.97 134.25 36.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.534 1.679 . . . . 33.44 115.534 -179.081 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.66 -46.52 49.81 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 132.073 4.149 . . . . 28.37 111.665 -168.859 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.78 -8.79 87.57 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 129.96 3.648 . . . . 15.0 112.148 -167.761 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -102.7 167.19 10.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.99 -4.241 . . . . 25.5 111.914 -179.522 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.9 p -89.67 170.95 10.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.903 -1.748 . . . . 11.95 108.296 176.327 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.0 mt -72.53 -30.92 64.89 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.629 3.172 . . . . 10.17 110.662 169.3 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 p -65.8 -30.87 71.57 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 132.488 4.315 . . . . 13.59 112.435 179.393 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.87 -44.58 96.54 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.558 -4.464 . . . . 11.7 111.261 175.757 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -78.03 -12.62 60.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.43 2.292 . . . . 12.95 113.017 -177.784 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.439 35.8 m120 65.69 31.53 9.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.64 2.376 . . . . 25.45 116.659 -166.078 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -79.69 125.89 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 1 O-C-N 116.252 -4.03 . . . . 14.6 103.888 -169.483 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -104.78 -173.94 2.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.269 3.427 . . . . 33.23 113.283 -169.447 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -67.74 137.46 55.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.961 3.304 . . . . 25.97 109.895 174.687 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 52.5 33.56 13.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.093 2.957 . . . . 32.61 111.288 179.373 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -76.21 151.52 36.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 114.204 -2.808 . . . . 10.56 110.422 163.909 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.9 m -110.17 112.54 24.58 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 133.046 6.466 . . . . 5.33 110.166 179.555 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.1 mt -97.62 159.06 15.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 110.654 -2.976 . . . . 11.66 106.566 170.704 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -124.82 123.71 40.55 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 115.992 -1.956 . . . . 16.3 106.76 -169.266 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -112.33 125.18 53.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.937 2.153 . . . . 9.96 109.315 -172.303 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.298 16.5 m -127.01 150.89 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 124.432 2.063 . . . . 9.76 109.119 169.63 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 N--CA 1.43 -1.441 0 CA-C-N 113.023 -1.899 . . . . 19.57 110.86 -167.174 . . . . . . . . 0 0 . 1 . 104 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 107.668 -1.234 . . . . 17.17 107.668 . . . . . . . . . 0 0 . 1 . 104 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -112.08 140.58 46.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.802 -2.295 . . . . 21.89 104.802 -175.817 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -128.62 154.48 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 123.422 1.582 . . . . 10.83 111.083 167.764 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -113.37 107.84 16.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.48 -2.012 . . . . 10.61 110.823 -173.517 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t -102.04 106.26 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.473 -1.392 . . . . 9.13 109.671 178.251 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -89.39 128.89 35.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.489 1.662 . . . . 20.55 115.489 179.557 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -78.63 164.45 24.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.86 -1.775 . . . . 11.78 110.572 171.103 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.0 mt -77.5 -22.41 51.28 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.485 -4.509 . . . . 19.31 110.833 -172.76 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -92.74 -67.84 0.83 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.425 -1.324 . . . . 23.14 107.425 176.583 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.12 76.75 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 114.521 -3.377 . . . . 19.74 121.496 -178.701 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -156.91 131.67 8.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.609 2.704 . . . . 21.93 106.577 171.556 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.0 m -105.76 108.17 19.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.52 1.629 . . . . 12.33 107.248 172.843 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 mt -86.71 117.03 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 105.509 -2.034 . . . . 17.08 105.509 176.311 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -93.88 127.31 39.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.408 1.693 . . . . 16.3 112.232 171.479 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -117.7 132.91 56.41 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.898 2.079 . . . . 15.88 112.816 -177.74 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -92.09 107.07 18.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.511 -1.663 . . . . 28.9 106.511 172.601 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.85 166.97 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 104.628 -2.36 . . . . 12.05 104.628 179.482 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -118.17 138.37 25.49 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 126.698 1.999 . . . . 18.17 109.069 168.872 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.652 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 38.0 Cg_endo -67.54 -10.0 27.26 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 124.579 3.519 . . . . 8.16 117.965 -171.721 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -76.64 -14.32 59.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.984 1.846 . . . . 11.13 115.984 170.399 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -85.06 172.65 11.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.531 1.514 . . . . 18.03 108.455 -178.767 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 70.8 p -103.54 157.08 17.29 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 117.229 -1.367 . . . . 10.22 113.296 -176.731 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.427 HD12 HD13 ' A' ' 50' ' ' LEU . 13.6 mm -53.65 -36.59 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 122.065 2.211 . . . . 12.3 113.842 177.61 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -53.47 -25.55 16.75 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.095 -2.253 . . . . 36.51 116.191 169.525 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -87.62 -18.82 28.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 117.666 -1.159 . . . . 25.66 113.025 173.334 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -75.38 -44.03 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 122.136 2.244 . . . . 8.12 112.486 176.196 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -62.84 -37.52 87.12 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 110.559 -3.019 . . . . 15.47 109.195 173.381 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.28 -19.43 61.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.387 -1.768 . . . . 11.45 114.084 173.309 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -77.2 -29.4 54.26 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.924 2.602 . . . . 24.98 110.628 171.313 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.7 mt -64.58 -45.6 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 116.615 -1.659 . . . . 9.46 114.924 167.695 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -48.03 -49.95 29.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 121.292 3.812 . . . . 14.76 121.292 167.995 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -59.52 -65.56 0.65 Allowed 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 127.7 2.4 . . . . 26.29 115.484 170.849 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -74.62 -71.53 0.34 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.544 -3.847 . . . . 30.06 112.388 -177.725 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -71.51 -31.11 66.71 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.676 -6.265 . . . . 25.19 113.616 -170.132 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.08 52.16 4.42 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.353 2.882 . . . . 7.41 110.704 178.56 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.85 143.02 28.26 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-N 119.959 1.88 . . . . 9.49 106.18 168.125 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -72.5 168.33 24.63 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 125.266 2.917 . . . . 11.42 113.16 -173.34 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -81.91 -11.95 11.05 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.547 3.017 . . . . 12.0 112.546 177.699 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.94 -33.39 75.47 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.135 -2.228 . . . . 35.55 113.281 172.135 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.261 46.5 mt-30 -95.38 -8.85 34.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.044 2.831 . . . . 20.52 110.756 -167.731 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -87.05 122.01 30.29 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 111.902 -6.749 . . . . 7.13 115.418 175.33 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -122.05 121.05 36.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.244 -2.16 . . . . 36.39 107.13 165.431 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.0 mt -105.98 139.04 41.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.677 -1.63 . . . . 9.55 110.115 -177.58 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 44' ' ' ILE . 75.5 mt -117.21 141.98 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 100.433 -3.914 . . . . 13.9 100.433 -175.474 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -136.85 104.23 5.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.15 -2.167 . . . . 6.86 105.15 172.7 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.266 . . 65.99 -127.83 0.27 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.758 -1.839 . . . . 11.15 111.927 -177.06 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.8 24.04 30.05 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 119.753 2.661 . . . . 13.93 119.753 -178.468 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.5 157.74 40.26 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 110.818 -2.691 . . . . 23.92 112.085 -168.018 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -105.88 152.56 23.12 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.155 -1.794 . . . . 23.23 106.155 -176.188 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.427 HD13 HD12 ' A' ' 23' ' ' ILE . 78.3 mt -88.59 146.76 24.94 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.767 2.222 . . . . 9.11 111.014 -177.03 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.52 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 17.5 tt0 -100.77 139.36 36.56 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 126.545 1.938 . . . . 33.44 107.217 -176.706 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.44 -55.54 32.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.153 2.581 . . . . 28.37 111.992 -168.937 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.97 31.47 7.92 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 113.45 -1.705 . . . . 15.0 110.878 -162.667 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.52 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 29.6 mtt180 -103.89 170.06 8.14 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.689 -3.83 . . . . 25.5 104.004 169.57 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.4 p -85.93 158.68 19.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.012 2.925 . . . . 11.95 105.908 -179.196 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.652 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 1.2 mt -69.41 -32.36 71.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.757 -3.089 . . . . 10.17 116.215 171.385 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.6 p -53.41 -40.33 65.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.404 3.082 . . . . 13.59 115.98 167.643 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.93 -20.47 61.75 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.2 -2.812 . . . . 11.7 117.073 -176.597 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -91.64 -1.12 57.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.325 1.85 . . . . 12.95 110.844 174.037 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 44.05 63.32 1.65 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.53 -2.123 . . . . 25.45 115.171 -161.497 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.69 127.17 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.825 -1.546 . . . . 14.6 106.825 168.539 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -124.35 179.74 4.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.188 2.595 . . . . 33.23 106.28 -168.16 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -67.54 145.92 54.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.886 -3.634 . . . . 25.97 111.537 -172.315 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 51.46 26.53 3.23 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.447 2.018 . . . . 32.61 116.447 -175.847 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 m -56.18 145.79 25.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.937 -1.727 . . . . 10.56 113.201 167.628 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -98.58 120.56 39.21 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.142 -2.224 . . . . 5.33 114.192 167.974 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -110.27 160.41 16.55 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.344 0.974 . . . . 11.66 110.547 169.669 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -112.87 133.4 54.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 102.424 -3.176 . . . . 16.3 102.424 176.271 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -103.12 117.48 34.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.437 1.895 . . . . 9.96 113.313 166.633 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.0 t -116.62 123.21 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.931 -2.248 . . . . 9.76 104.931 -173.567 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 N--CA 1.43 -1.436 0 O-C-N 119.677 -1.889 . . . . 19.57 113.75 -173.95 . . . . . . . . 0 0 . 1 . 105 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.26 7.9 ptt? . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 117.756 2.502 . . . . 17.17 117.756 . . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -113.29 130.64 56.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 105.844 -1.91 . . . . 21.89 105.844 -177.421 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 pt -131.29 160.02 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 100.569 -3.863 . . . . 10.83 100.569 -177.673 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -112.41 151.59 29.66 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.527 2.584 . . . . 10.61 106.785 -177.739 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.33 124.56 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 117.456 -3.277 . . . . 9.13 109.66 166.745 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -136.66 135.7 38.48 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.772 -1.558 . . . . 20.55 109.934 -170.366 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -80.83 -174.25 4.67 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.448 2.547 . . . . 11.78 111.271 175.985 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.16 -43.42 74.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.027 -2.296 . . . . 19.31 111.47 177.077 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -76.62 -34.8 58.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.361 -2.257 . . . . 23.14 108.07 179.658 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.15 70.2 0.63 Allowed Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 126.523 2.011 . . . . 19.74 114.162 173.72 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -96.55 103.07 14.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 131.051 3.74 . . . . 21.93 106.877 160.491 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -100.08 135.81 40.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.21 2.433 . . . . 12.33 110.445 -178.866 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 pt -139.99 162.33 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.445 2.698 . . . . 17.08 111.79 175.054 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 m -126.81 119.47 26.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.794 1.309 . . . . 16.3 110.145 -172.218 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.42 134.13 48.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.218 -1.81 . . . . 15.88 107.83 -178.321 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -98.86 115.49 28.96 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.352 -2.833 . . . . 28.9 103.352 178.689 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.37 177.86 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.818 -1.549 . . . . 12.05 106.818 177.183 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -116.89 160.17 37.89 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 104.497 -2.408 . . . . 18.17 104.497 179.228 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -76.67 2.53 7.34 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 115.837 -2.309 . . . . 8.16 116.427 -175.099 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.0 p -77.47 -13.8 59.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 124.871 1.357 . . . . 11.13 112.175 169.557 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.89 137.57 33.6 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 122.728 1.251 . . . . 18.03 111.805 -170.766 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -76.13 158.12 32.08 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 109.283 -3.599 . . . . 10.22 112.266 -169.781 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mm -52.93 -45.62 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 1 O-C-N 115.377 -4.577 . . . . 12.3 110.242 168.376 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -59.97 -32.09 70.51 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.278 -2.764 . . . . 36.51 118.176 168.887 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -63.84 -38.74 92.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.924 -2.985 . . . . 25.66 111.555 168.871 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.84 -47.18 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.014 1.326 . . . . 8.12 108.771 171.9 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -58.81 -39.82 82.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.864 -1.772 . . . . 15.47 112.954 178.436 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.43 61.79 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.499 3.148 . . . . 11.45 119.499 171.326 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.26 4.6 tppt? -66.84 -44.07 82.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.151 2.881 . . . . 24.98 117.127 167.854 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -74.01 -43.12 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.659 2.384 . . . . 9.46 107.416 179.144 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -48.27 -45.09 34.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.75 2.5 . . . . 14.76 117.75 169.67 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.03 -57.18 8.32 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.279 2.696 . . . . 26.29 118.279 169.502 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -64.67 -58.06 7.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.637 2.458 . . . . 30.06 117.637 173.32 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.45 -67.93 0.61 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.353 -1.467 . . . . 25.19 112.775 -176.475 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.82 27.01 2.88 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 122.53 1.072 . . . . 7.41 111.731 -176.863 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.7 mt -88.23 125.79 62.78 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 114.063 -2.875 . . . . 9.49 111.95 174.764 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.0 Cg_exo -71.13 154.81 62.06 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 CA-C-N 126.698 3.428 . . . . 11.42 112.827 -174.89 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 84.9 Cg_exo -70.18 -15.24 35.45 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.22 1.946 . . . . 12.0 110.068 -170.703 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -87.14 -16.58 35.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.828 1.775 . . . . 35.55 115.54 177.486 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -94.79 -34.86 12.33 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.06 -1.65 . . . . 20.52 108.687 -178.838 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.39 135.27 55.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.083 0.944 . . . . 7.13 111.877 174.811 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.258 21.6 tpp180 -139.27 130.59 26.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.012 -2.93 . . . . 36.39 106.566 160.906 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.5 mt -94.33 135.66 35.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.95 2.5 . . . . 9.55 112.779 -179.629 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.525 HG12 ' HG2' ' A' ' 49' ' ' GLN . 11.8 mt -127.09 132.09 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 1 N-CA-C 97.688 -4.931 . . . . 13.9 97.688 -172.28 . . . . . . . . 3 3 . 1 . 105 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -116.19 130.84 56.99 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.025 -2.297 . . . . 6.86 107.368 166.563 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.83 -109.85 0.51 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.694 -2.504 . . . . 11.15 117.388 -172.059 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.17 -7.46 56.12 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 130.663 3.983 . . . . 13.93 114.636 174.844 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -127.05 144.86 50.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.588 3.194 . . . . 23.92 112.999 -159.532 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.525 ' HG2' HG12 ' A' ' 44' ' ' ILE . 65.1 mt-30 -98.44 124.19 43.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.476 -1.693 . . . . 23.23 106.643 -176.2 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.408 ' H ' HD22 ' A' ' 50' ' ' LEU . 1.1 mm? -88.69 143.29 27.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.953 -1.092 . . . . 9.11 112.372 -167.552 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.256 74.1 mm-40 -85.62 149.87 25.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.408 2.744 . . . . 33.44 118.408 -178.435 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -40.75 -64.08 0.58 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 131.031 3.733 . . . . 28.37 118.798 -173.034 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.59 51.51 0.76 Allowed Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 123.284 1.491 . . . . 15.0 111.153 -171.081 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.273 13.7 mmt85 -123.83 173.35 8.23 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.743 -4.386 . . . . 25.5 108.775 173.693 . . . . . . . . 3 2 . 1 . 105 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 p -112.39 175.1 5.57 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.424 2.375 . . . . 11.95 113.525 175.201 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.3 mt -58.81 -41.08 85.94 Favored 'General case' 0 N--CA 1.43 -1.449 2 CA-C-N 106.801 -4.727 . . . . 10.17 113.648 169.322 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -70.52 -35.53 73.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.751 -1.218 . . . . 13.59 113.769 177.778 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -62.14 -48.56 79.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.407 -2.058 . . . . 11.7 114.261 178.979 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -72.86 -25.83 61.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.801 -3.687 . . . . 12.95 115.86 174.575 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.288 9.0 m120 83.16 67.2 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.013 2.125 . . . . 25.45 109.007 -173.424 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.49 117.12 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 101.81 -3.404 . . . . 14.6 101.81 172.208 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -102.55 -164.53 1.09 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.51 -2.619 . . . . 33.23 109.225 -179.893 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -72.72 131.32 42.21 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 131.601 3.961 . . . . 25.97 111.132 -172.171 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 60.71 24.66 14.48 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.785 1.63 . . . . 32.61 113.385 179.526 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.8 m -89.58 153.62 20.63 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 101.21 -3.626 . . . . 10.56 101.21 171.723 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -116.46 109.68 17.62 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.039 1.735 . . . . 5.33 107.33 -167.142 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mp -90.88 131.74 36.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 120.0 1.273 . . . . 11.66 110.082 178.418 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -80.38 132.0 35.7 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 127.066 3.317 . . . . 16.3 107.796 -176.076 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.256 5.1 tp -102.03 116.63 33.11 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 115.353 -4.592 . . . . 9.96 109.804 173.261 . . . . . . . . 3 2 . 1 . 105 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.0 t -106.09 109.96 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 127.574 2.35 . . . . 9.76 114.924 168.883 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.431 -1.416 0 N-CA-C 102.836 -3.024 . . . . 19.57 102.836 -171.648 . . . . . . . . 0 0 . 1 . 106 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 121.011 0.434 . . . . 17.17 109.877 . . . . . . . . . 0 0 . 1 . 106 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -107.78 153.36 23.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.489 -2.141 . . . . 21.89 114.473 173.577 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -126.78 147.19 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 102.669 -3.086 . . . . 10.83 102.669 171.374 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.55 135.85 45.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.8 2.148 . . . . 10.61 116.8 156.768 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.57 141.97 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.603 1.961 . . . . 9.13 107.081 174.241 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -140.02 130.97 26.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.57 2.348 . . . . 20.55 112.543 -163.719 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -91.36 -176.7 4.63 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.642 -1.911 . . . . 11.78 107.153 -176.334 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.98 -48.4 74.13 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.416 -2.678 . . . . 19.31 111.562 175.874 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.1 p -79.83 -62.57 1.64 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.385 -3.322 . . . . 23.14 110.585 -174.851 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.71 41.25 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 116.999 -2.524 . . . . 19.74 114.348 175.409 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.3 19.7 tptm -88.54 109.06 19.76 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.035 -1.469 . . . . 21.93 107.035 165.313 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -104.14 108.91 20.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.316 -1.49 . . . . 12.33 108.08 -179.619 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.264 36.6 pt -97.03 134.22 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 116.412 -1.756 . . . . 17.08 110.312 175.156 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 3.6 m -109.66 112.13 24.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.977 2.911 . . . . 16.3 107.745 -179.893 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -106.61 160.07 15.72 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.823 -3.048 . . . . 15.88 110.553 -176.084 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -115.44 132.26 56.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.756 -2.465 . . . . 28.9 109.296 176.024 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.52 167.24 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.294 2.237 . . . . 12.05 114.608 -167.756 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -90.97 140.5 26.1 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 119.087 -2.258 . . . . 18.17 115.623 155.762 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.65 -10.86 30.28 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 122.55 1.946 . . . . 8.16 117.048 174.868 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.337 83.7 p -74.8 -14.55 60.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.736 2.865 . . . . 11.13 118.736 166.817 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -81.06 165.97 21.17 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.125 1.516 . . . . 18.03 114.936 -164.63 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 45.7 p -87.77 157.52 19.01 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.349 2.5 . . . . 10.22 112.31 -172.092 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.4 mm -68.91 -28.62 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.638 -3.164 . . . . 12.3 111.679 -178.057 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -48.71 -48.98 39.98 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.274 2.23 . . . . 36.51 115.528 153.116 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -75.09 1.62 12.71 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.79 -4.319 . . . . 25.66 119.687 175.012 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.6 t -82.91 -39.56 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.189 -2.152 . . . . 8.12 105.189 160.545 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -63.97 -25.56 68.19 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.303 -3.998 . . . . 15.47 113.633 -179.109 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.33 92.06 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.434 -2.666 . . . . 11.45 114.926 170.74 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -72.78 -27.76 62.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.7 -3.125 . . . . 24.98 111.639 -177.285 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.44 -44.04 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 115.051 1.5 . . . . 9.46 115.051 170.021 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -60.52 -45.18 94.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.782 1.401 . . . . 14.76 114.782 167.799 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -65.31 -43.92 89.53 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.656 2.48 . . . . 26.29 111.698 178.926 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -75.38 -67.16 0.69 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.858 2.17 . . . . 30.06 116.858 -179.027 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -82.69 -43.07 17.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.003 -2.311 . . . . 25.19 115.194 179.905 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.7 52.32 2.84 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-O 124.548 2.193 . . . . 7.41 117.521 177.861 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.5 mt -111.97 125.74 29.7 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 102.145 -3.28 . . . . 9.49 102.145 -178.386 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 64.8 Cg_endo -80.44 160.5 22.59 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 127.754 3.805 . . . . 11.42 113.098 -173.393 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 1.3 Cg_exo -77.04 -17.24 15.38 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 CA-C-N 127.949 3.874 . . . . 12.0 111.045 -148.168 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.54 -24.27 45.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.76 -3.088 . . . . 35.55 110.647 -171.721 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -90.01 -0.67 57.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.697 2.399 . . . . 20.52 110.764 -173.714 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -100.05 129.6 46.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.233 2.213 . . . . 7.13 115.803 -177.728 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -130.76 114.48 15.4 Favored 'General case' 0 N--CA 1.431 -1.404 1 O-C-N 115.918 -4.238 . . . . 36.39 110.602 167.317 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.7 mt -103.54 137.87 41.02 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 116.576 -1.678 . . . . 9.55 114.455 -174.666 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 mt -125.53 133.95 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 101.079 -3.675 . . . . 13.9 101.079 -164.703 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -118.12 96.15 5.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 101.441 -3.541 . . . . 6.86 101.441 172.956 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.91 -93.96 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.653 -2.067 . . . . 11.15 113.262 -170.667 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.48 -16.64 45.43 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 116.812 -2.105 . . . . 13.93 116.525 174.389 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -105.57 126.35 52.04 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 126.323 1.837 . . . . 23.92 113.032 -157.72 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -98.39 123.83 42.73 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 125.379 1.674 . . . . 23.23 113.13 -167.023 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.24 125.65 36.99 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.827 -1.082 . . . . 9.11 110.578 -158.378 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -87.63 152.21 22.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 131.608 3.963 . . . . 33.44 116.511 171.238 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -75.02 -49.12 20.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.382 2.515 . . . . 28.37 108.405 -152.227 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.69 34.76 4.08 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 117.548 -3.22 . . . . 15.0 114.342 -171.791 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -123.23 161.94 23.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 100.426 -3.916 . . . . 25.5 100.426 176.231 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.3 p -99.8 164.38 12.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.106 -1.621 . . . . 11.95 114.822 -179.809 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mt -48.06 -37.71 15.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.342 -3.349 . . . . 10.17 119.247 167.505 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -76.02 -14.92 60.21 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.539 -1.664 . . . . 13.59 113.025 174.963 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -74.92 -38.38 61.82 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 123.798 2.999 . . . . 11.7 110.552 172.205 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -91.82 2.13 56.71 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.396 -1.335 . . . . 12.95 107.396 -172.603 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m120 60.33 45.33 11.31 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.927 2.566 . . . . 25.45 117.927 179.98 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.4 mt -86.91 135.49 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 126.594 3.092 . . . . 14.6 106.399 -178.884 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -113.72 167.3 10.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.309 -2.119 . . . . 33.23 109.558 -163.864 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -55.22 114.37 1.76 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.531 1.634 . . . . 25.97 111.774 166.14 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 63.12 37.96 11.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 110.453 -3.067 . . . . 32.61 113.254 -175.383 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -72.18 148.62 45.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.464 1.484 . . . . 10.56 113.815 159.497 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.4 m -109.32 128.53 55.16 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.566 -3.209 . . . . 5.33 110.16 179.77 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -101.85 140.3 36.33 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 116.214 1.931 . . . . 11.66 116.214 177.12 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -100.36 110.72 22.94 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 125.175 2.416 . . . . 16.3 111.704 -179.511 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -94.6 127.61 40.67 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.792 -2.443 . . . . 9.96 110.49 -175.243 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.7 123.13 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.256 3.023 . . . . 9.76 113.755 163.563 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 128.325 3.917 . . . . 19.57 108.751 173.935 . . . . . . . . 0 0 . 1 . 107 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptt? . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 110.752 -0.092 . . . . 17.17 110.752 . . . . . . . . . 0 0 . 1 . 107 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -90.04 148.27 23.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 123.664 0.786 . . . . 21.89 111.232 177.464 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.31 141.61 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.701 -2.333 . . . . 10.83 104.701 -179.118 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -97.0 143.05 28.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.935 1.457 . . . . 10.61 114.935 170.169 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -128.86 112.04 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.232 2.92 . . . . 9.13 107.165 177.841 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -109.2 130.66 55.49 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.594 -3.816 . . . . 20.55 115.164 -172.753 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 p -82.09 162.55 22.48 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.398 -5.813 . . . . 11.78 107.851 179.532 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mt -59.17 -39.03 81.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.293 -2.755 . . . . 19.31 115.274 169.019 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 p -65.58 -58.64 5.27 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.344 2.497 . . . . 23.14 112.662 -178.151 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.03 64.14 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 O-C-N 118.129 -2.857 . . . . 19.74 113.555 164.935 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -129.88 134.8 47.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 119.712 1.756 . . . . 21.93 107.606 157.408 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -105.57 121.35 43.78 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.84 1.781 . . . . 12.33 108.898 175.302 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.6 pt -111.23 144.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 118.082 -2.886 . . . . 17.08 105.837 -179.569 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -107.39 123.09 47.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.686 1.241 . . . . 16.3 110.627 -177.197 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -119.98 162.79 18.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.023 -1.103 . . . . 15.88 108.023 -177.027 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -106.35 133.41 51.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.197 1.799 . . . . 28.9 111.3 172.726 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.444 HG11 HG22 ' A' ' 26' ' ' VAL 0.262 16.1 m -147.96 162.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 119.448 -2.032 . . . . 12.05 106.365 167.344 . . . . . . . . 3 3 . 1 . 107 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -82.24 170.43 14.91 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 105.21 -2.144 . . . . 18.17 105.21 161.151 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.287 1.1 Cg_exo -69.84 -24.93 28.73 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 120.79 1.318 . . . . 8.16 111.704 170.438 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -78.7 8.13 5.85 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 115.347 -2.264 . . . . 11.13 111.075 -174.265 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.255 75.2 m-20 -108.31 162.07 14.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 123.198 2.727 . . . . 18.03 107.33 -176.669 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.9 p -92.21 163.72 13.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.846 -3.034 . . . . 10.22 114.204 -171.556 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -69.44 -24.65 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 118.814 -2.429 . . . . 12.3 112.121 176.753 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -53.69 -48.77 69.2 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.69 -4.381 . . . . 36.51 114.303 162.458 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -62.97 -30.74 71.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.311 2.337 . . . . 25.66 117.311 169.661 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.444 HG22 HG11 ' A' ' 17' ' ' VAL . 37.2 t -65.68 -49.41 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 121.767 2.076 . . . . 8.12 113.435 166.319 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HA ' HD12 ' A' ' 30' ' ' ILE . 49.6 mtmt -61.82 -31.53 71.77 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.709 1.604 . . . . 15.47 113.451 178.839 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -67.72 -35.33 78.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.145 2.578 . . . . 11.45 106.678 169.94 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -75.67 -21.26 57.81 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.862 -4.274 . . . . 24.98 116.901 177.05 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 27' ' ' LYS . 11.0 mt -69.44 -45.85 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.39 -2.069 . . . . 9.46 110.316 164.599 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 66.0 tt0 -49.75 -39.98 39.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.583 2.611 . . . . 14.76 111.44 171.862 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.71 -64.16 1.06 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.233 -3.417 . . . . 26.29 110.464 -179.99 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -80.66 -27.47 37.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.45 -3.906 . . . . 30.06 114.359 -163.167 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -103.89 -56.05 2.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 113.946 1.091 . . . . 25.19 113.946 -177.728 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.28 26.79 2.59 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 126.963 2.221 . . . . 7.41 116.89 172.841 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -94.42 135.36 24.29 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 108.127 -1.064 . . . . 9.49 108.127 -176.438 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.48 157.4 61.91 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 115.221 -3.094 . . . . 11.42 112.885 -177.65 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -84.83 -11.32 7.89 Favored 'Trans proline' 0 C--N 1.299 -2.029 1 C-N-CA 128.157 5.905 . . . . 12.0 112.779 -175.198 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.82 -43.47 58.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.358 0.981 . . . . 35.55 111.567 173.392 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -72.12 12.01 0.48 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.785 -2.447 . . . . 20.52 114.588 -179.051 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -116.89 128.42 55.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.625 1.202 . . . . 7.13 114.082 -164.613 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -129.13 130.06 45.96 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.793 -1.817 . . . . 36.39 106.184 171.763 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.5 mt -102.47 143.56 32.03 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 120.357 -0.537 . . . . 9.55 111.546 171.617 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -124.82 127.95 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 128.036 2.534 . . . . 13.9 104.798 177.726 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -112.67 107.9 16.75 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.116 -2.865 . . . . 6.86 104.504 177.201 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.388 . . 60.29 -91.45 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.188 -1.57 . . . . 11.15 115.017 -169.08 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.0 5.58 7.35 Favored Glycine 0 N--CA 1.43 -1.703 1 C-N-CA 131.064 4.173 . . . . 13.93 119.074 171.745 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -113.96 156.91 23.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.921 1.343 . . . . 23.92 108.319 175.384 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -84.11 151.8 24.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.385 -1.279 . . . . 23.23 111.937 175.742 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.2 mt -110.24 128.34 55.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.458 1.935 . . . . 9.11 111.777 178.773 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -92.18 163.62 13.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.063 3.316 . . . . 33.44 105.983 179.096 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -63.26 -61.1 2.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 109.402 -3.544 . . . . 28.37 118.939 -171.938 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.54 15.55 13.13 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 119.476 2.55 . . . . 15.0 119.476 -171.849 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -101.45 156.85 17.22 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.398 -1.648 . . . . 25.5 110.116 173.46 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 35.5 p -94.37 167.43 11.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.406 -1.331 . . . . 11.95 107.406 -175.636 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mp -67.96 -25.94 65.69 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.348 2.259 . . . . 10.17 108.752 165.713 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.3 t -71.62 -43.29 66.45 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.653 2.381 . . . . 13.59 110.243 175.526 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -59.28 -44.74 92.44 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.945 -4.222 . . . . 11.7 116.768 175.316 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -79.89 -11.64 59.79 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.642 2.83 . . . . 12.95 118.642 169.734 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.315 31.0 m120 75.75 34.86 0.55 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.644 -3.16 . . . . 25.45 115.002 174.434 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 mt -73.47 118.91 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.347 -1.297 . . . . 14.6 110.757 167.619 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' SER . 45.5 mt-30 -90.75 169.91 10.57 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 124.155 1.931 . . . . 33.23 113.609 174.219 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -61.94 146.88 48.64 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.742 -4.349 . . . . 25.97 108.064 -174.32 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 85.7 mt-10 62.48 46.88 5.4 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.889 1.804 . . . . 32.61 113.167 174.273 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' GLN . 9.2 t -111.09 131.94 54.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.355 2.662 . . . . 10.56 103.994 -168.531 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -89.59 109.95 20.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.385 2.517 . . . . 5.33 108.562 177.233 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.7 mt -89.74 150.58 22.23 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.776 2.03 . . . . 11.66 107.95 172.626 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -106.23 113.39 26.9 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 114.965 1.469 . . . . 16.3 114.965 -178.283 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.7 tp -89.93 120.2 30.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.276 1.988 . . . . 9.96 114.493 177.152 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.81 145.58 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 112.651 -2.068 . . . . 9.76 105.829 172.964 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.9 mt . . . . . 0 N--CA 1.43 -1.451 0 CA-C-O 123.372 1.558 . . . . 19.57 111.331 -176.258 . . . . . . . . 0 0 . 1 . 108 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 106.413 -1.699 . . . . 17.17 106.413 . . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -106.38 140.08 39.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.707 2.114 . . . . 21.89 116.707 -176.671 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.6 pt -119.17 143.88 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 129.036 2.934 . . . . 10.83 114.324 169.979 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -104.92 126.1 51.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.05 -2.906 . . . . 10.61 107.827 -179.409 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.38 109.75 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 127.67 3.605 . . . . 9.13 105.94 -176.773 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -117.93 138.79 51.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 125.897 2.761 . . . . 20.55 108.969 -167.665 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 9.8 p -72.68 -179.09 2.92 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.956 -2.34 . . . . 11.78 117.051 163.805 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.404 ' H ' ' HB ' ' A' ' 7' ' ' THR . 63.4 tp -76.14 -39.83 54.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 131.118 3.767 . . . . 19.31 110.431 -160.66 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -73.17 -56.6 4.87 Favored 'General case' 0 N--CA 1.429 -1.488 1 C-N-CA 133.94 4.896 . . . . 23.14 105.93 175.67 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.04 30.98 0.34 Allowed Glycine 0 N--CA 1.43 -1.741 0 O-C-N 125.873 1.983 . . . . 19.74 115.003 173.204 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -79.32 109.77 13.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.287 2.043 . . . . 21.93 109.779 168.664 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -95.79 126.43 41.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.007 -2.308 . . . . 12.33 112.684 -176.387 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.313 28.4 pt -109.47 152.93 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.433 2.063 . . . . 17.08 108.241 165.863 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -122.53 125.6 46.07 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.321 -2.737 . . . . 16.3 110.672 -175.78 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.284 52.4 mt -119.1 144.16 46.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.315 2.339 . . . . 15.88 117.315 179.442 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -101.16 101.86 12.67 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.705 2.002 . . . . 28.9 112.17 -179.161 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.18 165.1 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 C-N-CA 134.028 4.931 . . . . 12.05 108.284 -165.301 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 9.0 mt-10 -112.67 173.37 2.89 Favored Pre-proline 0 N--CA 1.429 -1.486 0 N-CA-C 114.836 1.421 . . . . 18.17 114.836 162.305 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -74.07 -14.12 23.57 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 115.963 -2.704 . . . . 8.16 112.763 -179.111 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -95.11 0.9 54.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.159 0.912 . . . . 11.13 110.311 177.688 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.267 35.2 m-20 -85.98 152.23 23.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.877 -3.639 . . . . 18.03 109.812 -173.308 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 71.0 p -100.63 160.76 14.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.334 2.492 . . . . 10.22 107.859 -160.714 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 mm -64.48 -40.22 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 124.65 2.167 . . . . 12.3 108.624 -174.419 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -56.24 -35.47 67.41 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.03 -2.919 . . . . 36.51 117.021 168.121 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -72.14 -31.49 66.04 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 113.362 -5.836 . . . . 25.66 112.613 167.55 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.79 -43.55 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.724 -1.584 . . . . 8.12 106.724 -177.021 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.25 -35.96 72.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.763 1.625 . . . . 15.47 113.361 174.907 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.99 -42.29 76.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.221 -2.174 . . . . 11.45 116.0 175.824 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -75.17 -32.03 61.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.649 3.179 . . . . 24.98 112.89 -176.989 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -60.88 -48.1 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.529 2.585 . . . . 9.46 113.029 174.253 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -52.53 -45.88 66.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 113.15 -3.31 . . . . 14.76 117.037 166.386 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.53 -62.93 1.18 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.721 3.138 . . . . 26.29 110.032 179.291 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -53.71 -57.16 11.85 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.412 -3.305 . . . . 30.06 112.093 -176.757 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -93.96 -64.63 1.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.534 2.05 . . . . 25.19 116.534 -173.64 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.79 23.71 0.86 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 120.9 3.12 . . . . 7.41 120.9 -176.939 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.69 118.14 60.27 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 114.723 -2.56 . . . . 9.49 106.945 -169.191 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 36.2 Cg_exo -51.89 147.16 26.35 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 121.238 3.515 . . . . 11.42 121.238 178.318 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 21.0 Cg_exo -68.69 -35.68 16.0 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 123.793 2.39 . . . . 12.0 113.261 -160.378 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -78.21 -27.34 47.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.904 -2.372 . . . . 35.55 113.971 -177.462 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -62.89 -39.16 93.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.173 2.189 . . . . 20.52 115.365 170.776 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -65.9 140.17 58.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.342 2.349 . . . . 7.13 117.342 173.585 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -128.32 99.61 5.49 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.855 -2.403 . . . . 36.39 114.192 169.866 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -86.06 131.43 34.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.065 -2.334 . . . . 9.55 109.629 -177.728 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 70' ' ' VAL . 31.6 mt -130.47 136.59 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 126.282 2.944 . . . . 13.9 103.253 -179.846 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -113.5 114.98 27.29 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 115.055 -4.778 . . . . 6.86 107.897 164.393 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.277 . . 72.31 -86.33 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.738 2.815 . . . . 11.15 111.331 -179.221 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.38 22.71 1.71 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 109.121 -1.591 . . . . 13.93 109.121 165.42 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.259 81.6 mttt -103.69 124.57 49.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.473 -3.369 . . . . 23.92 105.365 176.282 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -91.72 132.9 36.06 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 123.295 1.521 . . . . 23.23 108.941 -179.929 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.4 mt -94.15 128.86 40.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 115.715 -2.394 . . . . 9.11 109.794 -151.377 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -78.32 139.73 38.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 119.038 2.977 . . . . 33.44 119.038 172.166 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.57 -50.14 70.85 Favored 'General case' 0 N--CA 1.431 -1.394 1 N-CA-C 122.654 4.316 . . . . 28.37 122.654 -162.62 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.49 0.72 89.24 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.232 -2.793 . . . . 15.0 115.775 175.333 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -81.78 165.33 21.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.835 -1.979 . . . . 25.5 108.143 171.382 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.3 p -104.97 -178.2 3.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 116.447 -3.908 . . . . 11.95 111.353 -172.98 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.3 mt -81.48 -29.31 33.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.699 -1.593 . . . . 10.17 106.699 178.712 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.9 t -66.08 -38.12 87.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.409 -2.057 . . . . 13.59 111.355 -176.589 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -54.95 -40.89 70.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.347 3.059 . . . . 11.7 113.788 176.924 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -93.49 1.16 56.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.322 2.342 . . . . 12.95 117.322 174.995 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.459 3.7 m120 79.52 18.83 0.73 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.263 1.579 . . . . 25.45 115.263 174.494 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.9 mt -87.01 99.4 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 118.446 -2.659 . . . . 14.6 105.014 -174.477 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.36 10.4 mt-30 -112.39 -165.11 0.96 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.324 2.249 . . . . 33.23 112.02 -169.874 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -61.55 106.8 0.7 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.103 2.961 . . . . 25.97 113.4 -170.061 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 82.76 41.92 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.011 2.525 . . . . 32.61 111.749 172.003 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.6 m -92.27 142.69 27.19 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.582 1.953 . . . . 10.56 111.376 179.388 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 m -102.41 121.18 41.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.334 -2.104 . . . . 5.33 112.365 178.387 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -85.26 160.09 19.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 117.403 -1.284 . . . . 11.66 110.228 167.814 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -105.41 136.03 45.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 127.5 3.0 . . . . 16.3 104.84 167.473 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.1 tp -116.11 111.57 20.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.749 -2.315 . . . . 9.96 104.749 -179.639 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.605 HG21 HD12 ' A' ' 44' ' ' ILE . 1.9 t -103.46 140.87 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 127.3 2.24 . . . . 9.76 106.275 -179.994 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 N--CA 1.43 -1.456 0 C-N-CA 129.357 3.063 . . . . 19.57 106.079 176.873 . . . . . . . . 0 0 . 1 . 109 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 108.139 -1.059 . . . . 17.17 108.139 . . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -100.11 116.17 31.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.549 1.166 . . . . 21.89 112.442 -177.37 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.1 pt -97.4 151.92 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.192 -1.367 . . . . 10.83 113.996 148.554 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.432 ' HB2' HG23 ' A' ' 66' ' ' THR . 77.8 m-85 -107.67 149.46 28.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.434 2.958 . . . . 10.61 110.951 174.66 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 30' ' ' ILE . 47.3 t -126.43 133.99 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 106.224 -1.769 . . . . 9.13 106.224 162.092 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -108.73 139.45 43.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.742 2.017 . . . . 20.55 113.62 174.591 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 p -88.07 -169.54 2.61 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 114.973 1.471 . . . . 11.78 114.973 -171.659 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.87 -59.08 4.6 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 120.163 1.347 . . . . 19.31 113.435 179.175 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -69.6 -30.06 67.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.023 -1.673 . . . . 23.14 110.689 179.714 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.2 54.3 0.27 Allowed Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 129.168 3.27 . . . . 19.74 108.422 152.083 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -82.67 116.09 21.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.238 2.019 . . . . 21.93 108.839 167.623 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -84.32 112.02 19.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.691 -2.576 . . . . 12.33 115.898 176.285 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.61 162.22 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 122.357 2.344 . . . . 17.08 108.232 -172.848 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.5 m -123.75 98.22 5.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.492 2.717 . . . . 16.3 113.83 -174.504 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 29' ' ' LYS . 73.0 mt -92.68 160.3 15.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.025 0.83 . . . . 15.88 111.554 -170.62 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -106.13 103.91 13.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.372 1.442 . . . . 28.9 113.757 175.044 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.74 165.02 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.7 2.4 . . . . 12.05 108.347 -174.771 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.15 170.9 7.89 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-O 115.75 -2.071 . . . . 18.17 109.621 162.513 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.291 0.0 OUTLIER -66.7 -9.51 24.75 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 N-CA-C 120.205 3.117 . . . . 8.16 120.205 179.83 . . . . . . . . 3 3 . 1 . 109 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -82.52 -21.58 35.36 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.207 -2.33 . . . . 11.13 113.927 176.474 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -57.75 146.29 31.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 119.745 3.239 . . . . 18.03 119.745 172.93 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.4 p -105.08 159.95 15.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.256 -3.403 . . . . 10.22 108.087 -178.013 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.62 -40.66 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 112.917 -1.947 . . . . 12.3 112.781 178.111 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -49.63 -41.88 43.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.509 1.924 . . . . 36.51 112.975 165.092 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -80.63 -21.31 41.59 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.565 -3.834 . . . . 25.66 116.942 176.14 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 t -59.91 -50.08 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.471 -2.643 . . . . 8.12 107.782 165.375 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -59.56 -39.8 85.22 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.687 1.708 . . . . 15.47 113.013 -179.305 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.323 . . -71.58 -28.99 64.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.621 -1.627 . . . . 11.45 112.653 -176.996 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HB3' HD22 ' A' ' 15' ' ' LEU . 55.8 mttm -69.0 -31.29 70.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.086 3.355 . . . . 24.98 111.899 171.803 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.545 HD11 HG21 ' A' ' 5' ' ' VAL . 79.2 mt -79.51 -37.6 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.853 0.835 . . . . 9.46 111.921 173.401 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -61.94 -38.64 89.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.157 1.932 . . . . 14.76 114.129 168.808 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.7 -55.62 25.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.794 1.405 . . . . 26.29 114.794 172.069 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -67.78 -58.01 5.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.664 -3.147 . . . . 30.06 115.807 -174.812 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -95.52 -52.29 4.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.28 2.238 . . . . 25.19 115.533 -168.202 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.59 38.18 0.86 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 116.58 -2.724 . . . . 7.41 114.402 174.091 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.56 HG21 HD21 ' A' ' 71' ' ' LEU . 54.2 mt -114.56 120.86 37.0 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-O 111.936 -3.888 . . . . 9.49 103.609 -176.007 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -72.46 157.82 52.3 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 125.124 2.866 . . . . 11.42 112.508 -173.992 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -73.8 -32.34 7.47 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 122.813 2.041 . . . . 12.0 110.674 -162.518 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -59.73 -41.87 91.89 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.006 1.854 . . . . 35.55 116.006 -178.058 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -65.64 -27.75 68.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.095 2.258 . . . . 20.52 117.095 179.258 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -74.97 155.32 37.51 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.236 3.05 . . . . 7.13 119.236 177.849 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -143.71 97.16 3.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.084 2.153 . . . . 36.39 113.779 177.549 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.6 mt -91.69 129.49 37.66 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.666 2.65 . . . . 9.55 116.104 -167.201 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -120.1 128.71 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 2 O-C-N 115.692 -4.38 . . . . 13.9 115.532 -169.048 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -118.06 119.57 35.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.902 -2.374 . . . . 6.86 104.94 176.916 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.51 -96.6 0.05 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.774 3.23 . . . . 11.15 109.825 -168.622 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.94 21.31 4.43 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 126.727 2.108 . . . . 13.93 114.099 176.594 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -134.85 145.27 48.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.465 -1.609 . . . . 23.92 108.091 -170.164 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -95.73 139.38 32.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.443 2.339 . . . . 23.23 114.456 -168.955 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.2 mt -87.31 136.13 33.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.124 2.392 . . . . 9.11 112.14 -166.846 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -96.3 147.96 23.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.374 -2.704 . . . . 33.44 112.65 176.036 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -62.25 -43.49 98.71 Favored 'General case' 0 N--CA 1.431 -1.413 1 CA-C-O 128.821 4.153 . . . . 28.37 117.607 -160.394 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.76 -23.39 75.66 Favored Glycine 0 N--CA 1.43 -1.727 0 O-C-N 117.939 -2.976 . . . . 15.0 112.766 -173.375 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 mmm-85 -84.39 151.35 24.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.517 2.658 . . . . 25.5 107.913 -158.856 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -81.13 171.92 14.31 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.457 -6.402 . . . . 11.95 114.208 175.721 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.2 mt -69.82 -24.72 63.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.371 -2.706 . . . . 10.17 115.061 166.102 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -56.82 -43.93 81.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.802 2.89 . . . . 13.59 118.802 167.722 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -57.72 -56.23 24.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 110.812 -2.904 . . . . 11.7 110.371 -176.562 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -75.38 -21.52 58.22 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.504 -2.134 . . . . 12.95 115.358 -177.028 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 62.15 55.37 2.47 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.969 3.307 . . . . 25.45 107.878 -171.787 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 mt -88.34 112.52 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 116.079 -1.915 . . . . 14.6 106.675 161.371 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -108.93 -158.37 0.65 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.118 2.266 . . . . 33.23 117.118 -179.195 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -61.47 124.95 22.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.287 3.435 . . . . 25.97 114.549 168.17 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.307 38.5 mt-10 78.14 2.99 2.81 Favored 'General case' 0 N--CA 1.43 -1.434 1 N-CA-C 122.164 4.135 . . . . 32.61 122.164 -169.47 . . . . . . . . 3 2 . 1 . 109 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -75.24 122.59 23.91 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.105 -4.122 . . . . 10.56 113.547 -175.752 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 4' ' ' PHE . 6.0 m -102.22 118.02 36.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.419 1.918 . . . . 5.33 113.673 177.854 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.45 HD12 HG22 ' A' ' 5' ' ' VAL . 85.7 mt -88.18 159.4 18.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.684 -1.969 . . . . 11.66 105.684 -178.204 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -110.3 136.92 48.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.086 -2.259 . . . . 16.3 106.977 173.787 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -105.72 140.49 38.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.519 -1.988 . . . . 9.96 107.41 170.506 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.273 28.4 t -114.6 140.17 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 128.003 2.521 . . . . 9.76 106.737 167.998 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.56 HD21 HG21 ' A' ' 36' ' ' ILE . 64.9 mt . . . . . 0 N--CA 1.43 -1.465 0 C-N-CA 127.181 2.192 . . . . 19.57 108.707 178.986 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 11.2 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 117.94 2.57 . . . . 17.17 117.94 . . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.266 31.1 mt-30 -71.96 131.15 42.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.655 -3.153 . . . . 21.89 112.098 -178.813 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 pt -135.96 155.06 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 101.324 -3.584 . . . . 10.83 101.324 -169.795 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.29 118.66 37.31 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.826 2.05 . . . . 10.61 114.508 175.683 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -114.67 104.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 104.762 -2.31 . . . . 9.13 104.762 -177.063 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -89.89 123.3 33.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.813 2.845 . . . . 20.55 112.66 -175.904 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -78.33 166.58 22.51 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.87 1.319 . . . . 11.78 113.619 -172.36 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.464 HD22 ' H ' ' A' ' 71' ' ' LEU . 32.5 tp -58.43 -47.64 83.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.405 -3.934 . . . . 19.31 115.03 175.112 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -63.02 -69.82 0.24 Allowed 'General case' 0 N--CA 1.43 -1.471 2 CA-C-O 111.163 -4.255 . . . . 23.14 108.804 176.26 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.66 45.27 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 O-C-N 126.706 2.504 . . . . 19.74 116.129 179.438 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -127.24 142.23 51.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.712 -1.464 . . . . 21.93 107.105 -172.766 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.5 m -112.44 131.75 55.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.391 1.567 . . . . 12.33 107.644 175.203 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 pt -122.56 145.4 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.654 -2.529 . . . . 17.08 105.38 171.149 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m -113.21 110.44 20.4 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.772 -3.705 . . . . 16.3 107.66 -166.991 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 mt -115.49 152.02 33.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 118.026 -0.988 . . . . 15.88 112.256 -170.52 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -97.86 125.63 42.83 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 127.088 3.327 . . . . 28.9 117.672 162.935 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.0 175.36 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 111.307 -2.679 . . . . 12.05 111.511 167.425 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -102.04 178.42 1.22 Allowed Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.647 -2.121 . . . . 18.17 107.628 168.012 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -71.84 -26.54 18.88 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 C-N-CA 122.297 1.998 . . . . 8.16 115.235 163.966 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -83.14 -8.97 59.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.782 2.882 . . . . 11.13 118.782 177.133 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -69.11 155.34 40.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.934 2.198 . . . . 18.03 116.934 171.853 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.8 p -106.35 -172.83 2.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.651 -1.28 . . . . 10.22 107.731 -176.258 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.734 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 43.3 mm -81.38 -25.99 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 125.139 2.4 . . . . 12.3 111.895 -178.746 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -53.23 -43.3 67.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.192 -3.442 . . . . 36.51 112.705 164.139 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -75.33 -45.25 40.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.736 -2.477 . . . . 25.66 111.775 -178.443 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.1 t -50.37 -56.93 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 124.874 1.269 . . . . 8.12 111.402 166.593 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -58.63 -32.33 68.94 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 119.84 3.274 . . . . 15.47 119.84 179.26 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.32 -49.09 59.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.87 -3.019 . . . . 11.45 109.718 173.051 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -46.64 -47.48 20.14 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.17 -2.831 . . . . 24.98 116.7 172.197 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.469 HD13 HD13 ' A' ' 69' ' ' LEU . 94.7 mt -54.94 -44.4 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.353 2.661 . . . . 9.46 113.412 171.903 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -67.0 -50.64 61.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.738 2.415 . . . . 14.76 111.751 173.595 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.7 -56.83 17.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.228 -2.795 . . . . 26.29 113.909 173.307 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.262 35.4 tptt -57.93 -80.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.31 2.005 . . . . 30.06 116.043 174.334 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -68.25 -56.86 7.18 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 126.79 3.186 . . . . 25.19 112.787 -170.632 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.75 13.77 0.93 Allowed Glycine 0 N--CA 1.431 -1.666 1 O-C-N 115.361 -4.587 . . . . 7.41 110.096 169.535 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.68 134.07 27.01 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 116.334 -1.793 . . . . 9.49 112.713 -169.04 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -76.22 150.44 33.08 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 121.603 1.608 . . . . 11.42 109.487 177.041 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 89.3 Cg_endo -78.3 -9.56 16.34 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 123.799 3.0 . . . . 12.0 111.692 -170.384 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -65.13 -22.6 66.95 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 127.315 3.436 . . . . 35.55 111.348 165.442 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -90.78 -23.28 20.67 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.723 -4.36 . . . . 20.52 113.372 -173.969 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -89.06 131.29 35.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.025 -2.922 . . . . 7.13 114.144 -166.053 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -121.84 126.85 49.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.013 -1.847 . . . . 36.39 106.013 156.995 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 43' ' ' LEU . 26.6 tp -106.96 127.05 53.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.119 1.367 . . . . 9.55 112.778 178.974 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -129.25 138.17 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 126.9 2.08 . . . . 13.9 111.998 -165.988 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -120.62 122.04 39.66 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 114.914 -4.867 . . . . 6.86 102.39 166.851 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.27 -85.51 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.067 2.147 . . . . 11.15 111.82 -174.927 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.59 23.08 1.34 Allowed Glycine 0 N--CA 1.429 -1.787 0 O-C-N 118.935 -2.353 . . . . 13.93 109.687 171.631 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -95.12 116.9 29.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.073 2.149 . . . . 23.92 114.136 168.196 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -70.36 119.22 14.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 118.817 2.895 . . . . 23.23 118.817 169.571 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.83 134.79 33.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.425 -3.297 . . . . 9.11 116.899 -167.958 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -103.6 143.25 33.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.485 1.948 . . . . 33.44 115.426 -172.592 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.734 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 9.0 m-20 -50.46 -37.74 39.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.702 3.201 . . . . 28.37 119.272 -161.784 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.74 35.3 4.57 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 115.218 -2.99 . . . . 15.0 111.473 -178.425 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -110.77 153.91 24.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 122.566 3.183 . . . . 25.5 106.151 166.448 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.307 10.9 p -86.25 162.03 18.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.153 2.581 . . . . 11.95 107.1 -176.348 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.07 -32.63 73.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.287 -2.133 . . . . 10.17 115.37 169.014 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.1 t -60.08 -40.37 89.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.688 2.395 . . . . 13.59 112.762 167.199 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.5 -48.63 80.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.716 -2.49 . . . . 11.7 115.583 169.173 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.273 10.5 m-85 -82.46 4.88 22.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.752 1.39 . . . . 12.95 114.752 -179.979 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 59.37 28.31 17.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 114.805 -2.521 . . . . 25.45 114.79 -176.588 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.9 mt -76.18 126.58 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 124.21 3.186 . . . . 14.6 111.944 166.408 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -102.73 -179.29 3.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.221 2.439 . . . . 33.23 116.317 178.834 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -78.33 136.34 37.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 112.838 -1.983 . . . . 25.97 110.253 179.684 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.26 11.5 tt0 75.12 30.64 0.87 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.424 2.379 . . . . 32.61 117.424 -177.083 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -113.54 160.0 18.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.466 -2.021 . . . . 10.56 110.324 -175.965 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -109.39 115.25 29.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.203 2.601 . . . . 5.33 113.869 -173.068 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.54 156.91 18.31 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 111.662 -2.517 . . . . 11.66 113.611 170.869 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -116.33 109.46 17.41 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 112.415 -2.175 . . . . 16.3 107.838 -176.03 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.469 HD13 HD13 ' A' ' 30' ' ' ILE . 10.8 tp -89.31 114.33 25.71 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.583 -3.198 . . . . 9.96 103.674 179.177 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.3 t -114.51 132.27 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 118.07 -2.894 . . . . 9.76 108.129 -178.697 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.464 ' H ' HD22 ' A' ' 8' ' ' LEU . 11.4 mt . . . . . 0 N--CA 1.43 -1.457 0 CA-C-O 124.419 2.056 . . . . 19.57 106.005 -165.332 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.457 ' SD ' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 121.102 0.477 . . . . 17.17 110.039 . . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -89.5 134.37 34.14 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.911 -1.743 . . . . 21.89 113.079 -171.302 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -115.18 139.2 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.072 -2.893 . . . . 10.83 112.062 160.595 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.285 12.3 m-85 -109.89 88.91 2.86 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.55 -5.094 . . . . 10.61 107.972 -169.248 . . . . . . . . 3 2 . 1 . 111 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.13 100.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 CA-C-O 129.184 4.326 . . . . 9.13 113.522 173.353 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.28 46.7 mttt -83.31 148.57 27.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.15 -3.469 . . . . 20.55 113.752 178.536 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -104.27 -179.35 3.92 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.164 -2.21 . . . . 11.78 110.678 -168.322 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.325 1.9 tp -66.34 -41.18 89.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.996 1.48 . . . . 19.31 114.996 171.833 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.31 16.2 p -71.55 -66.22 0.66 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.589 2.614 . . . . 23.14 117.348 177.797 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.09 22.49 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 125.205 2.559 . . . . 19.74 119.451 -166.483 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -106.12 147.59 28.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.412 -2.394 . . . . 21.93 108.98 179.182 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -124.22 106.28 10.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.375 -2.454 . . . . 12.33 104.375 178.827 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -90.59 102.85 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 105.247 -2.131 . . . . 17.08 105.247 -177.933 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.2 m -81.14 121.65 26.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.081 -2.563 . . . . 16.3 104.081 -177.015 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.443 HD11 ' CG1' ' A' ' 30' ' ' ILE . 92.4 mt -112.37 133.97 54.17 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.38 2.363 . . . . 15.88 117.38 175.411 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.338 32.7 mt-10 -87.47 97.89 11.08 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.943 -4.223 . . . . 28.9 107.521 -177.677 . . . . . . . . 3 2 . 1 . 111 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -123.56 177.24 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.24 -1.538 . . . . 12.05 113.328 178.234 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -128.17 171.18 8.91 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.208 -1.853 . . . . 18.17 111.852 168.685 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -70.0 -16.37 36.54 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 C-N-CA 125.512 4.141 . . . . 8.16 113.829 -174.312 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.2 m -92.96 -3.62 54.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.849 2.86 . . . . 11.13 110.919 179.476 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.54 154.72 40.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.368 -2.707 . . . . 18.03 115.348 176.507 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.8 p -93.65 156.5 16.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.286 -2.487 . . . . 10.22 104.286 -179.807 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -51.85 -36.5 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.637 -3.789 . . . . 12.3 113.52 167.561 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.67 -39.42 88.33 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.276 -2.765 . . . . 36.51 112.186 174.801 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -62.01 -47.17 85.98 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.764 -2.065 . . . . 25.66 113.049 170.421 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.5 t -44.83 -56.13 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 1 C-N-CA 131.915 4.086 . . . . 8.12 111.068 172.213 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.95 -34.25 76.23 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.329 -3.357 . . . . 15.47 113.338 -174.024 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.55 85.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 114.68 1.363 . . . . 11.45 114.68 165.482 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -65.28 -32.2 73.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.072 -2.893 . . . . 24.98 113.012 173.669 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' CG1' HD11 ' A' ' 15' ' ' LEU . 87.5 mt -70.96 -44.75 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.147 -1.596 . . . . 9.46 109.189 176.527 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -57.44 -52.4 65.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.861 -2.399 . . . . 14.76 110.906 169.076 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -48.62 -53.23 19.33 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.899 3.296 . . . . 26.29 119.899 171.622 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -82.67 -57.88 3.14 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.191 -4.068 . . . . 30.06 118.38 179.63 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -86.75 -25.47 24.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.893 1.442 . . . . 25.19 114.893 -172.563 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.44 23.0 38.31 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 126.703 2.502 . . . . 7.41 119.004 -176.585 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.6 mt -96.95 127.23 39.71 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 113.016 -3.374 . . . . 9.49 106.466 -175.223 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 94.9 Cg_endo -81.3 153.97 18.67 Favored 'Trans proline' 0 C--N 1.299 -2.034 2 C-N-CA 126.941 5.094 . . . . 11.42 112.736 179.038 . . . . . . . . 3 3 . 1 . 111 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 45.1 Cg_endo -71.58 -18.19 29.33 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 124.679 3.586 . . . . 12.0 108.469 -159.982 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.261 41.4 m-20 -73.96 -22.97 59.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.1 2.125 . . . . 35.55 113.206 179.341 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -91.03 -3.57 57.11 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.68 2.487 . . . . 20.52 110.993 179.122 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -94.36 102.66 14.65 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.364 2.347 . . . . 7.13 115.77 -166.256 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -90.83 100.6 13.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.392 -3.318 . . . . 36.39 107.38 158.405 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.0 tp -95.14 106.89 18.94 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.119 -1.855 . . . . 9.55 109.659 174.435 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.11 127.24 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 127.619 2.367 . . . . 13.9 109.921 -168.681 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -118.77 111.82 18.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.481 -1.387 . . . . 6.86 110.663 173.869 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.01 -103.14 0.11 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.264 2.626 . . . . 11.15 111.666 -165.663 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.42 20.53 3.71 Favored Glycine 0 N--CA 1.431 -1.697 0 O-C-N 118.314 -2.741 . . . . 13.93 107.239 166.469 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -85.93 133.77 33.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.987 2.327 . . . . 23.92 114.28 165.069 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -93.01 125.91 37.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.628 -1.624 . . . . 23.23 107.628 178.614 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -98.89 144.39 28.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.135 2.772 . . . . 9.11 111.593 -174.389 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -113.01 149.51 33.23 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.216 1.96 . . . . 33.44 110.416 -175.655 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.32 -48.86 79.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.894 2.183 . . . . 28.37 116.894 -160.917 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.96 7.53 78.85 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 118.761 2.264 . . . . 15.0 118.761 -175.39 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -88.37 149.91 23.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.307 -0.946 . . . . 25.5 109.556 170.775 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -84.86 168.45 15.07 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.38 -2.075 . . . . 11.95 115.296 176.7 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.0 mt -73.13 -39.23 65.9 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 127.804 2.441 . . . . 10.17 110.605 178.451 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -68.54 -39.27 81.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.874 2.07 . . . . 13.59 112.651 178.383 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.56 -32.86 71.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 121.568 1.985 . . . . 11.7 109.506 175.739 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.27 -13.04 53.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 122.181 2.264 . . . . 12.95 106.331 176.358 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.327 59.7 m-20 80.66 28.0 0.23 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.968 2.507 . . . . 25.45 113.098 -178.471 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -81.66 109.33 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.517 -2.614 . . . . 14.6 110.196 -174.555 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -90.71 -178.97 5.41 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.831 2.453 . . . . 33.23 109.5 -177.282 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HA ' ' SD ' ' A' ' 1' ' ' MET 0.258 20.2 pttp -64.78 151.69 44.63 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.077 1.88 . . . . 25.97 116.077 173.174 . . . . . . . . 3 3 . 1 . 111 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 69.01 19.62 8.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.254 3.421 . . . . 32.61 117.877 177.03 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -76.39 125.81 29.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.971 2.908 . . . . 10.56 111.654 -176.619 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.6 m -77.66 113.41 15.48 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.065 2.728 . . . . 5.33 112.556 177.582 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.91 161.22 14.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.381 1.473 . . . . 11.66 113.62 167.315 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -106.35 132.92 51.82 Favored 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 131.727 4.011 . . . . 16.3 109.654 164.692 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -116.28 101.62 8.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.229 2.919 . . . . 9.96 109.55 171.694 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -99.93 143.65 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 118.89 -2.381 . . . . 9.76 108.618 170.704 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.43 -1.446 1 O-C-N 114.878 -4.889 . . . . 19.57 109.241 -178.012 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptt? . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 113.642 0.979 . . . . 17.17 113.642 . . . . . . . . . 0 0 . 1 . 112 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -103.59 121.71 43.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.08 2.371 . . . . 21.89 110.142 176.206 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -111.1 146.41 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.986 -2.321 . . . . 10.83 113.052 168.73 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -108.01 142.74 37.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.22 -1.809 . . . . 10.61 114.643 -176.876 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -131.41 119.47 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.847 -3.02 . . . . 9.13 102.847 -172.957 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -118.31 115.82 25.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 112.896 -3.431 . . . . 20.55 110.304 -165.793 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -63.19 175.77 0.88 Allowed 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 129.917 4.51 . . . . 11.78 112.863 174.992 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.9 tp -67.82 -36.71 80.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.608 -0.724 . . . . 19.31 112.501 -179.677 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -86.17 -47.87 9.09 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.162 1.785 . . . . 23.14 107.182 -168.896 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.24 40.69 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 CA-C-O 123.165 1.425 . . . . 19.74 112.026 168.73 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -90.81 123.83 34.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.211 1.957 . . . . 21.93 111.305 163.101 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -99.54 106.73 18.76 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 111.946 -2.388 . . . . 12.33 108.868 -176.472 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.32 118.53 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.548 -1.345 . . . . 17.08 109.668 -177.949 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 m -100.19 121.93 42.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.395 -3.316 . . . . 16.3 105.033 -173.023 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 15' ' ' LEU . 23.4 mt -122.42 141.16 51.9 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.421 1.888 . . . . 15.88 108.357 -176.951 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -100.43 132.87 45.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 127.99 3.757 . . . . 28.9 107.702 174.24 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -137.23 174.51 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.328 -3.357 . . . . 12.05 109.456 -175.447 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -122.54 157.11 60.14 Favored Pre-proline 0 N--CA 1.43 -1.464 0 C-N-CA 123.928 0.891 . . . . 18.17 109.015 151.123 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.5 -25.17 75.69 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.363 2.709 . . . . 8.16 113.703 -171.087 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -86.41 7.45 25.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.645 1.566 . . . . 11.13 112.471 -171.515 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -87.35 147.39 25.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.215 -2.178 . . . . 18.03 105.62 -172.145 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.4 p -82.77 151.63 26.05 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.301 -2.125 . . . . 10.22 112.685 -177.658 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -51.94 -43.22 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 130.607 3.563 . . . . 12.3 109.149 176.84 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.76 -37.74 79.86 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 125.96 2.037 . . . . 36.51 114.449 178.325 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.254 71.9 m-80 -72.83 -32.91 65.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.662 -2.524 . . . . 25.66 114.803 176.786 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.77 -36.03 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 127.127 2.171 . . . . 8.12 110.771 167.188 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -70.69 -26.93 63.65 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.399 -2.688 . . . . 15.47 115.809 169.05 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.41 72.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.294 1.861 . . . . 11.45 109.999 167.923 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -63.87 -33.04 74.81 Favored 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 115.694 -4.378 . . . . 24.98 115.24 178.905 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 mt -69.77 -32.3 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.847 -2.408 . . . . 9.46 108.682 172.651 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -69.98 -44.88 68.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.927 -3.608 . . . . 14.76 109.188 173.479 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -61.17 -46.03 92.17 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.736 2.208 . . . . 26.29 116.335 179.286 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -79.01 -60.82 2.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.742 -3.724 . . . . 30.06 116.647 -174.106 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -86.59 -53.86 4.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 126.182 2.176 . . . . 25.19 111.443 177.21 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.08 33.58 2.75 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 115.958 -2.579 . . . . 7.41 113.958 -172.796 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.52 127.82 36.6 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 130.185 3.394 . . . . 9.49 103.826 166.366 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -77.75 161.67 30.39 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-O 112.905 -3.04 . . . . 11.42 115.271 -177.498 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -66.84 -24.7 46.27 Favored 'Trans proline' 0 N--CA 1.434 -1.999 1 CA-C-N 129.772 4.526 . . . . 12.0 116.693 -172.079 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.06 -31.94 72.41 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.491 2.369 . . . . 35.55 113.418 -174.222 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.402 45.0 mt-30 -72.95 -16.91 61.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 119.427 3.121 . . . . 20.52 119.427 -179.53 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -102.68 110.16 22.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.105 -3.497 . . . . 7.13 114.268 -155.521 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -94.14 103.94 15.97 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.178 -2.527 . . . . 36.39 104.178 169.178 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.08 118.46 31.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.086 2.374 . . . . 9.55 110.114 174.773 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.1 mt -113.6 136.72 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 110.563 -3.017 . . . . 13.9 107.584 -179.393 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -120.36 113.35 20.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 101.494 -3.521 . . . . 6.86 101.494 172.368 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.74 -117.14 0.47 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.085 -2.26 . . . . 11.15 111.314 -176.125 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.37 25.29 13.97 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 117.911 -2.993 . . . . 13.93 116.656 175.234 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -131.35 142.6 50.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.51 2.576 . . . . 23.92 109.305 -173.3 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -110.29 141.78 42.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.394 -2.691 . . . . 23.23 111.82 -177.284 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mt -95.2 140.54 29.96 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.134 2.397 . . . . 9.11 110.606 -166.646 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -109.61 136.54 48.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.936 -1.938 . . . . 33.44 111.67 -172.359 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.7 -60.26 2.1 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.532 1.678 . . . . 28.37 115.532 -170.944 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.82 -4.03 61.04 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 118.797 -2.439 . . . . 15.0 117.805 -173.905 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -83.63 178.78 7.82 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 118.634 1.217 . . . . 25.5 110.689 170.883 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 76.6 p -106.09 178.44 4.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.333 -1.479 . . . . 11.95 109.958 177.058 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.9 mt -74.18 -33.89 63.6 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.591 1.156 . . . . 10.17 108.29 179.897 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -78.06 -27.35 48.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.389 3.076 . . . . 13.59 111.219 -175.007 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.02 -34.92 79.09 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 116.81 -1.567 . . . . 11.7 110.005 179.993 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -88.33 1.87 53.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.922 3.289 . . . . 12.95 114.103 167.521 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m120 58.31 49.07 11.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.25 1.204 . . . . 25.45 114.25 -178.098 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mm -79.18 113.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.22 -2.175 . . . . 14.6 106.767 170.436 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -87.62 -177.68 5.92 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.924 2.015 . . . . 33.23 112.42 174.087 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -64.03 134.42 54.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.667 -3.145 . . . . 25.97 115.408 164.508 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 69.84 31.22 3.53 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.757 2.217 . . . . 32.61 111.425 173.719 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.267 45.6 t -83.69 134.27 34.77 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.932 1.693 . . . . 10.56 108.54 166.499 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 m -103.96 122.84 46.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.716 -1.24 . . . . 5.33 108.377 -179.573 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -81.99 138.71 34.85 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 115.135 -2.364 . . . . 11.66 116.073 165.185 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -88.5 114.61 25.29 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.172 2.17 . . . . 16.3 107.352 175.281 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.268 9.5 tp -92.55 106.45 18.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 117.672 -1.611 . . . . 9.96 112.216 176.092 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.61 138.68 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.836 2.455 . . . . 9.76 105.37 179.267 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 mt . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 116.485 2.032 . . . . 19.57 116.485 -171.897 . . . . . . . . 0 0 . 1 . 113 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.283 -0.636 . . . . 17.17 109.283 . . . . . . . . . 0 0 . 1 . 113 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -89.88 120.97 31.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.185 -0.672 . . . . 21.89 109.185 165.744 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -117.01 167.88 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 118.499 -2.626 . . . . 10.83 108.129 157.043 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.1 133.96 55.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.847 -2.408 . . . . 10.61 115.529 -176.163 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -112.62 117.76 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 123.875 1.798 . . . . 9.13 110.661 175.323 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -96.58 151.86 19.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 112.278 -3.725 . . . . 20.55 110.771 177.142 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.6 p -85.21 -176.07 6.0 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 121.675 2.034 . . . . 11.78 113.327 159.88 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.252 36.5 mt -86.15 -17.93 33.62 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.407 1.003 . . . . 19.31 113.595 169.329 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 p -77.97 -69.56 0.54 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.575 2.35 . . . . 23.14 113.196 175.985 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.9 28.25 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.719 1 O-C-N 115.117 -4.739 . . . . 19.74 111.022 -177.504 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -109.06 130.65 55.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.116 -1.226 . . . . 21.93 111.085 179.091 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -111.17 115.99 30.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.015 -3.553 . . . . 12.33 108.151 173.577 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 pt -105.15 155.39 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 117.261 -1.776 . . . . 17.08 108.537 171.625 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.1 m -111.91 131.95 55.05 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.917 -2.623 . . . . 16.3 103.917 -177.287 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.3 tp -144.87 125.94 14.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.679 -2.513 . . . . 15.88 109.047 -164.885 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.82 103.47 15.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.045 -2.284 . . . . 28.9 110.996 -172.833 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -131.95 155.45 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 115.379 -0.828 . . . . 12.05 110.483 176.891 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -85.79 146.41 43.6 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 117.517 -1.23 . . . . 18.17 110.035 178.153 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.03 -10.69 21.53 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 N-CA-C 118.197 2.345 . . . . 8.16 118.197 177.288 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 p -90.83 -7.19 53.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.363 2.665 . . . . 11.13 114.746 175.927 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -69.56 149.27 48.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.741 -1.224 . . . . 18.03 110.415 176.402 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -79.78 170.13 16.96 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 117.026 -1.464 . . . . 10.22 110.492 175.931 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -72.24 -29.04 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 127.062 2.145 . . . . 12.3 110.761 178.392 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -59.44 -47.39 85.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.369 -2.707 . . . . 36.51 113.246 163.483 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -62.63 -40.17 96.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.052 2.206 . . . . 25.66 115.163 170.499 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -56.59 -50.91 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 121.499 1.954 . . . . 8.12 112.98 171.471 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -68.52 -30.19 68.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.256 -2.778 . . . . 15.47 112.892 -176.507 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.29 77.53 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.216 1.806 . . . . 11.45 109.844 174.088 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -80.48 -39.77 27.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.207 1.479 . . . . 24.98 109.882 -176.454 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.4 mt -56.32 -39.26 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.408 -3.932 . . . . 9.46 113.665 162.746 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.351 17.6 tt0 -56.31 -51.65 67.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.131 2.972 . . . . 14.76 108.334 167.374 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.62 -37.75 76.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 121.711 2.051 . . . . 26.29 112.318 -168.181 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -83.01 -66.0 0.94 Allowed 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 129.212 4.07 . . . . 30.06 116.77 -178.399 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -93.48 -26.16 17.3 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.671 1.188 . . . . 25.19 112.748 -169.995 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.62 37.88 8.48 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.389 1.471 . . . . 7.41 114.427 178.526 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.591 HD13 HD21 ' A' ' 71' ' ' LEU . 4.7 mt -88.9 128.86 50.54 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 118.739 -1.184 . . . . 9.49 113.105 160.862 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.39 158.2 36.79 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 123.288 2.659 . . . . 11.42 111.815 170.186 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -90.31 0.28 5.35 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 116.808 -2.259 . . . . 12.0 109.916 -159.931 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -77.09 -29.73 55.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.665 -2.522 . . . . 35.55 110.755 169.626 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -71.23 -37.77 72.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.089 -2.257 . . . . 20.52 109.174 175.433 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -76.99 116.89 18.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.023 2.231 . . . . 7.13 117.023 -164.909 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -115.59 120.31 39.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.1 1.905 . . . . 36.39 108.482 166.75 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -111.77 112.97 25.03 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.245 -4.034 . . . . 9.55 110.442 -169.447 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.6 mm -102.89 137.84 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.479 -2.013 . . . . 13.9 110.026 -177.93 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -106.46 111.58 24.22 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.747 -5.596 . . . . 6.86 108.079 153.786 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.44 -99.17 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.192 2.597 . . . . 11.15 115.615 -174.534 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -122.53 8.62 9.46 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 118.985 -2.322 . . . . 13.93 115.018 161.174 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -89.27 124.89 34.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.033 1.333 . . . . 23.92 114.546 172.475 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -85.47 131.51 34.37 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.145 -2.539 . . . . 23.23 104.145 -179.341 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -93.37 126.76 38.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.379 1.472 . . . . 9.11 110.17 -175.653 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -121.0 150.45 41.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.911 2.141 . . . . 33.44 113.011 -164.77 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.365 67.2 m-20 -18.02 -74.7 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.432 1 C-N-CA 132.285 4.234 . . . . 28.37 120.039 -168.968 . . . . . . . . 3 2 . 1 . 113 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.38 34.34 5.19 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.713 -2.492 . . . . 15.0 116.339 -164.802 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -133.55 171.34 14.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.862 -1.964 . . . . 25.5 111.949 175.989 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -95.54 167.21 11.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.664 2.029 . . . . 11.95 112.889 -167.519 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.53 -34.25 76.54 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.53 -2.606 . . . . 10.17 112.908 166.828 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -38.22 79.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.426 1.269 . . . . 13.59 114.426 178.129 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -56.4 -50.38 71.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.596 -3.815 . . . . 11.7 114.044 177.914 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -77.78 8.42 4.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 127.576 3.048 . . . . 12.95 113.631 178.163 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 2.0 m120 54.4 40.33 31.69 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 131.748 4.019 . . . . 25.45 117.222 -179.519 . . . . . . . . 3 2 . 1 . 113 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.346 10.1 mt -77.77 115.72 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.407 -1.433 . . . . 14.6 109.307 178.962 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -91.85 176.06 6.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.207 -3.433 . . . . 33.23 108.473 176.361 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -69.38 146.91 51.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.346 -2.721 . . . . 25.97 114.023 176.817 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 71.35 18.59 5.55 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 129.652 3.181 . . . . 32.61 112.561 -179.102 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.8 m -76.69 148.95 36.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.199 -2.813 . . . . 10.56 112.507 178.949 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.4 m -90.96 106.09 18.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.472 2.309 . . . . 5.33 115.735 170.507 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -91.44 152.24 20.46 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.422 2.289 . . . . 11.66 114.311 166.164 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -119.77 125.84 49.57 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.184 -2.822 . . . . 16.3 103.956 -169.76 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -102.2 123.53 46.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.723 2.409 . . . . 9.96 108.053 177.915 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.76 130.6 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 113.41 -1.723 . . . . 9.76 114.089 162.292 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.591 HD21 HD13 ' A' ' 36' ' ' ILE . 10.8 mt . . . . . 0 N--CA 1.43 -1.455 0 C-N-CA 129.486 3.114 . . . . 19.57 117.926 176.531 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ptt? . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 118.514 2.783 . . . . 17.17 118.514 . . . . . . . . . 0 0 . 1 . 114 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.371 36.7 mt-30 -69.01 128.48 36.85 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.253 -2.129 . . . . 21.89 105.253 170.569 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 pt -123.4 151.8 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.677 -2.056 . . . . 10.83 110.972 161.983 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -96.37 130.01 43.58 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.738 -0.785 . . . . 10.61 111.402 174.778 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 67' ' ' LEU . 76.3 t -119.26 125.14 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 103.126 -2.916 . . . . 9.13 103.126 160.966 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -119.48 132.22 55.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 109.983 -3.28 . . . . 20.55 105.985 -175.942 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 69' ' ' LEU . 10.5 p -75.34 157.58 34.07 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.794 -3.066 . . . . 11.78 109.109 174.552 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.5 mt -61.59 -39.76 92.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.514 -3.241 . . . . 19.31 114.43 159.283 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -48.02 -34.57 9.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.001 2.12 . . . . 23.14 112.794 172.141 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.04 -62.88 0.32 Allowed Glycine 0 N--CA 1.43 -1.725 1 O-C-N 114.156 -5.34 . . . . 19.74 119.801 -178.638 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -80.78 160.76 24.78 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 115.296 -2.561 . . . . 21.93 117.084 -158.251 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.69 131.29 48.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.427 -1.42 . . . . 12.33 109.493 166.641 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 pt -112.9 144.54 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 129.216 3.006 . . . . 17.08 109.017 157.219 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -106.34 128.22 53.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.129 2.571 . . . . 16.3 104.97 179.231 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.15 129.33 54.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.577 1.551 . . . . 15.88 110.978 172.902 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -79.73 101.84 8.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 120.318 1.417 . . . . 28.9 113.451 159.899 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -111.22 166.76 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.624 -3.173 . . . . 12.05 115.221 173.996 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -95.76 154.96 38.97 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.926 -1.879 . . . . 18.17 105.926 167.838 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.252 14.1 Cg_exo -63.0 -21.56 73.3 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 N-CA-C 116.008 1.503 . . . . 8.16 116.008 170.26 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.5 p -80.96 -2.48 47.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.878 1.671 . . . . 11.13 115.475 175.351 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.77 148.72 28.76 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.94 3.296 . . . . 18.03 106.533 -171.017 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 26' ' ' VAL . 57.9 p -91.18 164.12 14.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.256 -2.247 . . . . 10.22 105.551 -179.392 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.659 HG23 HD23 ' A' ' 43' ' ' LEU . 41.1 mm -72.48 -30.9 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 116.948 -1.501 . . . . 12.3 107.124 174.592 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -51.53 -50.96 59.0 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 125.47 3.759 . . . . 36.51 114.503 168.777 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -60.39 -28.28 68.1 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.388 2.366 . . . . 25.66 117.388 174.087 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 22' ' ' THR . 88.5 t -65.66 -47.86 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 129.251 3.02 . . . . 8.12 110.825 172.018 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -70.48 -30.05 66.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.166 2.412 . . . . 15.47 109.794 178.402 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.62 74.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.365 -3.959 . . . . 11.45 109.783 -179.133 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -70.48 -27.81 64.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.302 -2.124 . . . . 24.98 108.601 -177.189 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.5 mt -78.17 -24.63 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 114.017 1.117 . . . . 9.46 114.017 170.879 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 15.4 tt0 -62.45 -46.12 89.94 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 115.649 -4.407 . . . . 14.76 110.878 169.081 . . . . . . . . 3 3 . 1 . 114 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.5 -42.01 99.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.627 -1.296 . . . . 26.29 112.953 174.627 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -73.99 -67.81 0.57 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.521 -1.362 . . . . 30.06 110.711 -171.017 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -90.57 -29.69 17.68 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 113.74 -5.6 . . . . 25.19 113.191 -177.215 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.0 40.73 1.78 Allowed Glycine 0 N--CA 1.43 -1.752 0 O-C-N 120.082 -1.636 . . . . 7.41 111.601 -177.085 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.455 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 2.7 mt -115.4 119.54 37.99 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 119.031 -2.452 . . . . 9.49 111.539 -171.786 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -58.8 140.6 95.8 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.567 2.178 . . . . 11.42 113.313 177.69 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.36 -17.79 42.13 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 124.901 3.734 . . . . 12.0 118.441 179.458 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.8 -37.21 56.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.799 1.407 . . . . 35.55 114.799 179.386 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -61.4 -21.74 64.35 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 121.711 3.967 . . . . 20.52 121.711 167.193 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -88.6 101.73 14.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.482 2.401 . . . . 7.13 117.482 -171.378 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -100.74 107.36 18.93 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 125.288 2.471 . . . . 36.39 110.982 177.072 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.659 HD23 HG23 ' A' ' 23' ' ' ILE . 8.7 tp -105.99 118.7 37.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.432 -2.667 . . . . 9.55 107.375 -161.469 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 36.3 mm -111.99 124.48 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 128.969 2.908 . . . . 13.9 115.988 -166.351 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -112.87 87.13 2.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.651 -3.155 . . . . 6.86 108.473 -179.314 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.283 . . 62.52 -93.16 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 114.39 -5.193 . . . . 11.15 110.291 -177.122 . . . . . . . . 3 2 . 1 . 114 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.43 -10.99 22.65 Favored Glycine 0 N--CA 1.43 -1.712 0 O-C-N 126.244 2.215 . . . . 13.93 111.253 176.653 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -88.6 137.27 32.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.417 3.087 . . . . 23.92 108.395 -172.779 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -107.3 117.93 35.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.354 2.026 . . . . 23.23 107.791 177.322 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -80.66 163.41 23.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.023 -1.673 . . . . 9.11 111.989 -170.925 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -106.94 165.39 11.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.284 3.034 . . . . 33.44 105.447 179.443 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.337 23.7 m-20 -84.12 -54.39 4.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.03 2.348 . . . . 28.37 117.069 -168.549 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.87 50.79 2.26 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.682 -1.599 . . . . 15.0 116.056 177.749 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -133.39 156.05 48.37 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 100.11 -4.033 . . . . 25.5 100.11 175.811 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 30.2 p -86.04 158.54 19.81 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.258 1.98 . . . . 11.95 113.242 -170.218 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.28 -36.65 80.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.097 -2.252 . . . . 10.17 116.782 167.239 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.4 t -65.8 -38.14 88.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.341 1.856 . . . . 13.59 111.963 -179.519 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -63.36 -54.37 37.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.387 2.275 . . . . 11.7 112.129 178.721 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -64.14 -17.99 64.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 120.025 3.343 . . . . 12.95 120.025 170.588 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 69.9 43.4 0.93 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.399 2.37 . . . . 25.45 117.399 -172.742 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.01 112.47 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.339 -2.21 . . . . 14.6 112.132 165.416 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -83.31 -179.29 7.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.568 1.651 . . . . 33.23 108.706 -172.91 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.96 152.45 44.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.414 -1.429 . . . . 25.97 114.787 162.223 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 57.36 21.69 7.08 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.191 1.922 . . . . 32.61 116.191 -172.23 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 t -90.47 141.14 29.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.795 1.035 . . . . 10.56 113.795 -179.932 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 m -96.94 93.77 6.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.603 2.816 . . . . 5.33 118.603 -174.682 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 5' ' ' VAL . 64.6 mt -79.02 161.57 26.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.107 -0.995 . . . . 11.66 109.221 174.893 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.486 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 79.0 m-70 -104.37 137.22 42.58 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.44 -2.059 . . . . 16.3 105.44 173.646 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 7' ' ' THR . 62.1 tp -95.02 119.49 33.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 127.491 2.994 . . . . 9.96 112.655 160.231 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 t -104.25 120.56 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 106.226 -1.768 . . . . 9.76 106.226 174.664 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 N--CA 1.429 -1.485 0 C-N-CA 129.699 3.2 . . . . 19.57 113.577 -171.155 . . . . . . . . 0 0 . 1 . 115 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptt? . . . . . 0 CA--C 1.49 -1.33 0 CA-C-O 117.706 -1.14 . . . . 17.17 113.719 . . . . . . . . . 0 0 . 1 . 115 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.22 144.17 45.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.621 2.153 . . . . 21.89 115.243 167.729 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.8 pt -127.32 163.29 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.529 -1.669 . . . . 10.83 107.861 175.03 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -123.18 130.13 52.34 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 115.28 -2.295 . . . . 10.61 111.147 -171.037 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.515 HG22 ' HB2' ' A' ' 67' ' ' LEU . 86.0 t -130.54 112.13 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 CA-C-N 126.331 4.151 . . . . 9.13 102.718 -167.511 . . . . . . . . 3 3 . 1 . 115 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -81.94 144.0 31.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.494 1.517 . . . . 20.55 113.967 -176.849 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.302 81.8 p -98.91 -140.86 0.32 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.722 -2.486 . . . . 11.78 112.731 -178.45 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.8 -44.97 1.92 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 100.741 -3.8 . . . . 19.31 100.741 174.003 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -92.24 -74.45 0.51 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.552 1.541 . . . . 23.14 112.649 -169.692 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.94 -137.04 3.76 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 108.319 -1.913 . . . . 19.74 108.319 -157.99 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -91.7 160.45 15.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.651 2.167 . . . . 21.93 112.062 -172.512 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.6 m -77.01 116.72 17.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.651 -3.78 . . . . 12.33 109.691 172.098 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.3 pt -79.37 160.39 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.79 -2.444 . . . . 17.08 112.356 179.403 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -124.79 132.96 53.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.504 -2.622 . . . . 16.3 107.422 -175.893 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 mt -121.8 142.39 50.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.261 -0.644 . . . . 15.88 109.261 177.565 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -99.82 110.57 22.94 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.206 -2.184 . . . . 28.9 109.217 168.227 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.5 164.84 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 131.252 3.821 . . . . 12.05 109.915 -170.532 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.272 52.0 mm-40 -110.42 155.14 42.51 Favored Pre-proline 0 N--CA 1.43 -1.453 1 O-C-N 116.011 -4.181 . . . . 18.17 102.558 172.896 . . . . . . . . 3 2 . 1 . 115 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -66.07 -19.62 57.28 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 127.876 3.849 . . . . 8.16 114.654 176.47 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 p -75.99 -5.63 47.2 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.751 2.021 . . . . 11.13 115.292 179.526 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -78.2 142.45 37.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.1 -1.0 . . . . 18.03 110.161 171.903 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 40.8 p -81.66 169.19 17.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.1 2.381 . . . . 10.22 113.501 177.359 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.38 -29.11 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.693 -2.504 . . . . 12.3 107.942 -178.438 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.18 -34.91 66.26 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.785 1.634 . . . . 36.51 113.627 175.886 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.6 -40.22 78.62 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.385 -2.721 . . . . 25.66 116.578 161.424 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.65 -38.26 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 123.143 1.449 . . . . 8.12 108.369 176.468 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 89.6 mttt -57.29 -36.02 70.53 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 115.336 -4.603 . . . . 15.47 114.618 171.871 . . . . . . . . 3 3 . 1 . 115 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.91 94.06 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 130.376 4.797 . . . . 11.45 110.685 176.124 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.284 56.2 mttm -61.4 -42.41 98.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.771 1.623 . . . . 24.98 114.943 167.987 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 27' ' ' LYS . 63.8 mt -60.55 -32.71 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.733 -3.105 . . . . 9.46 117.34 176.358 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -58.86 -48.94 79.61 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.979 -2.95 . . . . 14.76 115.475 167.497 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.54 -62.79 1.42 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.142 -3.474 . . . . 26.29 114.224 162.386 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -64.87 -42.03 95.18 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.673 2.101 . . . . 30.06 116.673 -170.528 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -106.59 -50.55 3.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.264 -1.522 . . . . 25.19 113.258 174.143 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.37 5.18 6.16 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 125.029 2.461 . . . . 7.41 116.524 -178.039 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.1 mt -82.86 133.69 48.3 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 119.741 -2.035 . . . . 9.49 109.655 -177.502 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -64.12 146.35 90.58 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 125.771 4.314 . . . . 11.42 118.021 174.278 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.525 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 72.4 Cg_exo -61.54 -20.71 69.75 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 124.273 2.562 . . . . 12.0 116.736 -173.057 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -82.44 -18.17 42.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.523 1.139 . . . . 35.55 112.922 -179.874 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -100.06 -4.44 29.88 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 117.592 -1.194 . . . . 20.52 113.709 -176.256 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.05 135.23 33.71 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.106 3.362 . . . . 7.13 114.999 175.6 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -129.57 118.38 21.93 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.943 -1.723 . . . . 36.39 107.946 176.336 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mt -101.5 137.29 40.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.421 1.581 . . . . 9.55 109.529 -177.338 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.9 mm -137.36 130.93 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 100.268 -3.975 . . . . 13.9 100.268 -173.191 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -119.94 121.18 38.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 113.377 -3.202 . . . . 6.86 109.105 170.705 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.33 -116.26 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.931 2.605 . . . . 11.15 107.599 -174.664 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.5 34.41 4.55 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 118.739 -2.476 . . . . 13.93 113.091 164.375 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -113.36 123.98 51.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.644 -2.092 . . . . 23.92 108.681 -179.882 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -77.21 119.38 20.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.647 -2.533 . . . . 23.23 111.625 171.743 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.6 mt -90.52 136.16 33.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.995 -2.315 . . . . 9.11 115.466 -174.89 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -96.45 128.67 43.59 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.111 -1.618 . . . . 33.44 114.082 178.855 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -31.72 -52.93 0.25 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.94 3.696 . . . . 28.37 117.037 -177.627 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.57 0.46 82.97 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 119.012 -2.305 . . . . 15.0 110.322 -165.161 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -91.33 168.35 11.64 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 118.145 0.972 . . . . 25.5 112.212 170.756 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 66.4 p -109.37 178.82 4.33 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.4 -3.312 . . . . 11.95 108.118 -176.11 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -75.32 -33.81 61.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.422 2.535 . . . . 10.17 111.003 179.579 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -35.89 77.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.445 -3.909 . . . . 13.59 109.242 168.383 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.27 -36.64 71.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 122.42 2.373 . . . . 11.7 112.798 -176.336 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -83.16 3.43 30.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.277 2.231 . . . . 12.95 109.794 -177.706 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 49.59 51.52 16.29 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 115.069 1.507 . . . . 25.45 115.069 -169.766 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mt -102.81 113.86 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 127.161 2.788 . . . . 14.6 113.092 -179.784 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -97.31 -175.25 3.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.778 3.18 . . . . 33.23 109.535 -174.377 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -73.3 154.5 40.12 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.426 -3.296 . . . . 25.97 112.889 -175.156 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 76.33 13.68 2.49 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.022 2.129 . . . . 32.61 109.303 170.499 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 m -87.41 141.77 28.38 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 127.214 2.821 . . . . 10.56 109.703 -172.901 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.1 m -83.94 115.55 22.36 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 123.528 1.632 . . . . 5.33 112.804 176.116 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.515 ' HB2' HG22 ' A' ' 5' ' ' VAL . 63.4 mt -87.29 147.65 25.43 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.923 1.344 . . . . 11.66 110.906 162.674 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -105.36 131.06 53.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.97 -3.582 . . . . 16.3 109.661 172.85 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 tp -112.39 117.66 33.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.255 3.407 . . . . 9.96 107.721 179.929 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.37 151.9 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 101.366 -3.568 . . . . 9.76 101.366 -168.15 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 N--CA 1.43 -1.438 0 O-C-N 117.702 -3.124 . . . . 19.57 109.431 -171.669 . . . . . . . . 0 0 . 1 . 116 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 118.71 2.856 . . . . 17.17 118.71 . . . . . . . . . 0 0 . 1 . 116 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -93.24 124.66 37.37 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.241 -4.037 . . . . 21.89 106.225 -174.043 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.327 0.9 OUTLIER -110.31 166.69 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 119.784 -1.822 . . . . 10.83 109.578 167.341 . . . . . . . . 3 3 . 1 . 116 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -117.56 120.74 39.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.636 2.16 . . . . 10.61 116.534 176.241 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -99.17 105.78 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.222 -2.799 . . . . 9.13 114.941 176.766 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -102.94 133.89 47.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.802 -3.061 . . . . 20.55 109.39 -171.74 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.763 HG22 HD23 ' A' ' 69' ' ' LEU 0.316 17.1 p -93.29 -177.71 4.53 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.119 -4.113 . . . . 11.78 110.559 -172.77 . . . . . . . . 4 3 . 1 . 116 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.8 mt -74.42 -67.13 0.65 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.233 2.613 . . . . 19.31 105.322 175.947 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -125.76 129.42 49.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.309 2.256 . . . . 23.14 106.645 176.166 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.81 -114.06 0.73 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.506 -2.621 . . . . 19.74 108.492 176.994 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -158.43 163.54 37.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 126.948 3.261 . . . . 21.93 103.581 -178.01 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.7 m -92.38 135.17 34.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.195 -2.191 . . . . 12.33 112.669 178.31 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 pt -110.12 139.47 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.453 -3.28 . . . . 17.08 111.025 -174.517 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.4 m -101.5 121.11 41.36 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.033 -2.58 . . . . 16.3 104.033 -175.572 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 mt -119.95 172.42 7.74 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.169 -2.207 . . . . 15.88 111.504 179.995 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -120.42 120.43 35.91 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.264 -2.772 . . . . 28.9 114.085 178.062 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -138.2 167.65 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 126.763 2.539 . . . . 12.05 109.558 -177.756 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -122.96 158.34 57.7 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 121.05 1.75 . . . . 18.17 108.168 176.902 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.16 -19.58 66.22 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 O-C-N 113.932 -3.772 . . . . 8.16 118.278 -179.838 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -82.9 -1.83 53.22 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 118.937 2.94 . . . . 11.13 118.937 177.577 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -78.78 144.69 34.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.703 -0.623 . . . . 18.03 109.4 173.719 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 p -76.42 173.84 10.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.206 -2.184 . . . . 10.22 114.97 165.012 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.6 mm -63.33 -42.99 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.869 1.795 . . . . 12.3 112.572 174.414 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -49.43 -39.29 32.41 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 131.006 3.723 . . . . 36.51 113.511 175.583 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -75.45 -17.02 60.26 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.664 -2.522 . . . . 25.66 115.374 172.271 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.54 -44.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.139 -1.601 . . . . 8.12 114.234 167.463 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HA ' HD12 ' A' ' 30' ' ' ILE . 79.7 mttt -51.71 -22.89 3.85 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.227 1.936 . . . . 15.47 116.227 175.659 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.01 -27.3 23.3 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.209 0.913 . . . . 11.45 109.073 -174.847 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.26 -26.06 65.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.883 2.873 . . . . 24.98 113.428 167.352 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 27' ' ' LYS . 11.2 mt -89.35 -31.75 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.522 -1.986 . . . . 9.46 111.261 175.1 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -57.26 -37.45 72.35 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.769 -4.332 . . . . 14.76 114.307 168.461 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -64.68 -55.64 18.83 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.289 -1.815 . . . . 26.29 112.205 168.191 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -75.97 -51.53 12.2 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.708 1.88 . . . . 30.06 114.592 -161.171 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -94.59 -42.92 8.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.008 2.813 . . . . 25.19 116.659 179.578 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.38 33.14 2.57 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 109.94 -3.3 . . . . 7.41 113.563 161.388 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.465 HD12 HD21 ' A' ' 69' ' ' LEU . 87.6 mt -91.22 137.88 26.04 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 114.626 -2.607 . . . . 9.49 109.399 -179.071 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -61.9 137.56 68.34 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 124.759 3.639 . . . . 11.42 114.087 178.985 . . . . . . . . 3 3 . 1 . 116 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.2 Cg_exo -64.42 -26.54 62.96 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 127.126 3.581 . . . . 12.0 118.241 -168.564 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -63.03 -31.41 72.54 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.26 2.224 . . . . 35.55 113.405 171.552 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -86.55 -25.78 24.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.229 2.212 . . . . 20.52 112.964 -179.909 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -73.54 118.0 15.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.674 -2.516 . . . . 7.13 112.228 178.328 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.475 ' HD3' HD11 ' A' ' 44' ' ' ILE . 26.3 ttm180 -110.15 118.39 36.26 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.411 1.46 . . . . 36.39 111.45 166.418 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.3 mt -98.9 124.52 43.88 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.097 -2.186 . . . . 9.55 105.097 178.719 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.475 HD11 ' HD3' ' A' ' 42' ' ' ARG . 51.4 mm -105.21 120.06 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 126.621 1.969 . . . . 13.9 110.9 173.126 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.73 111.32 22.42 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.37 2.51 . . . . 6.86 105.277 167.853 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.342 . . 55.37 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.17 2.188 . . . . 11.15 116.189 -167.763 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.81 -23.5 6.47 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 116.33 1.292 . . . . 13.93 116.33 -177.294 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.44 167.8 9.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.938 -2.131 . . . . 23.92 114.393 -172.832 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -92.42 148.98 21.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.536 -2.12 . . . . 23.23 108.851 176.691 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -102.5 121.5 42.48 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.942 -2.349 . . . . 9.11 111.517 177.317 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.276 35.2 mt-10 -103.56 139.99 38.13 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.189 -1.569 . . . . 33.44 114.494 -166.498 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -29.37 -67.43 0.08 Allowed 'General case' 0 N--CA 1.43 -1.453 1 N-CA-C 122.068 4.099 . . . . 28.37 122.068 -161.466 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.97 24.99 28.88 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.7 -1.875 . . . . 15.0 115.814 -175.658 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -99.58 146.73 26.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.586 3.168 . . . . 25.5 109.966 166.23 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -85.95 167.26 15.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.857 1.663 . . . . 11.95 110.24 -162.46 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.19 -12.33 59.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.039 -1.467 . . . . 10.17 107.039 176.729 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -68.47 -50.91 48.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.146 1.378 . . . . 13.59 111.037 175.991 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -56.48 -49.35 74.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.848 3.259 . . . . 11.7 108.738 176.287 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -71.18 -20.15 62.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.16 1.541 . . . . 12.95 115.16 -178.851 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.346 32.5 t30 51.05 68.63 0.76 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.308 -2.12 . . . . 25.45 109.891 -172.335 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.68 138.2 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 100.929 -3.73 . . . . 14.6 100.929 167.215 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -123.77 -173.29 2.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.621 -1.925 . . . . 33.23 111.014 -176.455 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -75.35 146.65 40.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.045 -2.284 . . . . 25.97 109.128 -177.369 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 65.12 22.79 12.33 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 128.118 2.567 . . . . 32.61 112.408 166.901 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 t -101.09 159.78 14.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.985 2.326 . . . . 10.56 112.031 -175.56 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.8 m -111.36 109.34 19.28 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.261 -4.649 . . . . 5.33 111.168 -166.088 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.0 mt -84.86 146.86 27.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.177 -1.577 . . . . 11.66 110.445 162.565 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 14.7 m170 -106.9 125.69 51.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.068 -3.52 . . . . 16.3 107.433 179.841 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.763 HD23 HG22 ' A' ' 7' ' ' THR 0.256 47.3 tp -103.93 111.43 23.96 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 123.83 3.014 . . . . 9.96 102.927 -172.832 . . . . . . . . 3 3 . 1 . 116 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.3 t -107.34 152.46 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 104.849 -2.278 . . . . 9.76 104.849 -176.526 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 104.8 -2.296 . . . . 19.57 104.8 165.809 . . . . . . . . 0 0 . 1 . 117 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 CA--C 1.49 -1.362 0 CA-C-O 125.934 2.778 . . . . 17.17 114.697 . . . . . . . . . 0 0 . 1 . 117 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.51 119.11 11.77 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 121.361 3.837 . . . . 21.89 121.361 168.191 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.417 29.7 pt -111.31 130.08 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 103.652 -2.721 . . . . 10.83 103.652 169.693 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -91.05 121.66 33.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.794 0.807 . . . . 10.61 111.986 171.92 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -116.75 106.61 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 O-C-N 114.882 -4.887 . . . . 9.13 108.871 176.27 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 12' ' ' THR . 76.4 tttt -84.94 112.44 20.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 118.27 2.692 . . . . 20.55 118.27 169.753 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 m -76.84 134.88 38.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.034 -3.541 . . . . 11.78 107.398 163.971 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.93 -48.79 33.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.807 -3.058 . . . . 19.31 112.179 -175.23 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 m -93.48 98.26 11.08 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.186 -2.821 . . . . 23.14 107.546 161.879 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.57 -126.19 2.16 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 106.268 -2.733 . . . . 19.74 106.268 -175.973 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -156.77 170.44 22.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.793 -2.592 . . . . 21.93 109.879 173.641 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 41.6 m -79.97 104.61 10.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.024 2.345 . . . . 12.33 114.662 167.233 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.8 pt -90.42 165.6 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 124.321 2.01 . . . . 17.08 108.379 171.077 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 13.1 m -118.65 125.28 49.38 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.287 3.035 . . . . 16.3 107.431 179.064 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 mt -116.24 127.26 54.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.135 1.921 . . . . 15.88 107.658 -178.779 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -89.57 95.05 10.1 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.256 -4.653 . . . . 28.9 116.628 175.267 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.89 160.68 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.541 -1.974 . . . . 12.05 110.253 -171.575 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -97.82 147.41 33.0 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 118.968 -2.332 . . . . 18.17 108.526 163.176 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.3 -13.21 31.14 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 N-CA-C 120.779 3.338 . . . . 8.16 120.779 -175.437 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 m -99.91 -7.95 24.62 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.369 -1.457 . . . . 11.13 113.752 -168.526 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.58 172.63 13.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.79 -2.444 . . . . 18.03 111.492 178.964 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -92.14 161.83 14.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.322 1.601 . . . . 10.22 115.322 178.07 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -65.63 -30.13 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.891 3.276 . . . . 12.3 111.482 -172.654 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -70.23 -22.7 62.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.97 1.708 . . . . 36.51 113.318 176.481 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -82.64 -18.48 40.95 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.65 2.38 . . . . 25.66 110.902 170.744 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.46 -43.42 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 121.034 1.743 . . . . 8.12 107.709 176.966 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -54.86 -24.55 23.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 121.486 3.884 . . . . 15.47 121.486 173.441 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.271 . . -70.87 -29.44 65.54 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.659 2.783 . . . . 11.45 114.04 177.738 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -85.94 -35.12 20.67 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.968 -2.957 . . . . 24.98 107.132 -177.192 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 mt -54.29 -52.23 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 129.399 3.08 . . . . 9.46 113.138 168.397 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -53.18 -49.29 66.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 131.13 3.772 . . . . 14.76 118.307 167.355 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -53.8 -57.95 9.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 121.85 2.114 . . . . 26.29 111.142 164.25 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -77.73 -54.9 5.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.957 -2.339 . . . . 30.06 116.291 -162.071 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -92.15 -35.9 13.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.19 -1.569 . . . . 25.19 112.82 178.782 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.53 69.86 1.15 Allowed Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 109.524 -1.43 . . . . 7.41 109.524 -178.118 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.5 mt -138.12 123.41 12.36 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 102.352 -3.203 . . . . 9.49 102.352 171.481 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -72.43 164.11 36.61 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 124.504 3.47 . . . . 11.42 111.807 179.366 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.14 -1.34 9.82 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 C-N-CA 123.042 2.495 . . . . 12.0 114.583 -163.319 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -93.94 -19.99 20.42 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.004 2.522 . . . . 35.55 109.732 173.757 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -84.62 -33.79 23.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 126.479 3.038 . . . . 20.52 112.727 175.833 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.36 143.44 51.94 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 126.366 2.984 . . . . 7.13 117.815 177.983 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -154.13 123.88 6.7 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 114.111 -5.368 . . . . 36.39 100.41 179.813 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.87 126.84 50.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.6 3.16 . . . . 9.55 107.428 -172.827 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.9 mm -118.41 132.98 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.451 -1.685 . . . . 13.9 106.451 -174.362 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -106.11 93.81 4.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 105.222 -2.14 . . . . 6.86 105.222 178.151 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.98 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.535 2.334 . . . . 11.15 114.812 -171.813 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.14 -1.44 7.35 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 118.093 -2.88 . . . . 13.93 112.336 -179.578 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -90.65 147.8 23.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 115.807 -2.044 . . . . 23.92 116.075 170.547 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -98.94 138.74 35.62 Favored 'General case' 0 N--CA 1.43 -1.462 1 CA-C-O 129.351 4.405 . . . . 23.23 105.214 171.094 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.4 mt -88.62 151.96 22.13 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.434 -3.916 . . . . 9.11 114.133 171.197 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -116.14 157.49 24.7 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.943 1.402 . . . . 33.44 110.806 178.098 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -63.51 -50.71 68.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.504 2.779 . . . . 28.37 118.504 -163.027 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.99 -2.05 90.46 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 118.402 2.121 . . . . 15.0 118.402 -161.127 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 65.5 mtp180 -101.8 158.85 15.82 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.521 2.105 . . . . 25.5 107.617 -169.979 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.301 45.0 p -83.74 159.1 21.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.3 -2.75 . . . . 11.95 111.029 -169.766 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.75 -43.97 69.57 Favored 'General case' 0 N--CA 1.43 -1.473 2 CA-C-O 129.674 4.559 . . . . 10.17 119.353 169.014 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 p -51.64 -42.87 62.36 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.603 -3.185 . . . . 13.59 117.543 166.684 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -56.7 -50.14 73.05 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.598 -3.189 . . . . 11.7 116.682 -179.942 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 47.9 m-85 -65.43 -29.1 69.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 111.832 -2.44 . . . . 12.95 117.077 169.604 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 m120 83.49 55.5 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 129.041 3.963 . . . . 25.45 112.125 174.722 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.334 72.7 mt -84.92 149.17 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.529 -1.982 . . . . 14.6 107.941 177.507 . . . . . . . . 2 2 . 1 . 117 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -147.99 -162.44 1.55 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.702 -3.124 . . . . 33.23 108.022 -173.172 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -76.42 132.79 39.88 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.734 -1.229 . . . . 25.97 108.024 -170.268 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 74.42 10.26 4.25 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 131.346 3.858 . . . . 32.61 110.84 167.095 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -58.97 141.04 54.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.631 1.105 . . . . 10.56 112.799 170.139 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.0 m -112.3 102.52 10.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.72 -2.696 . . . . 5.33 103.72 -168.345 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.17 148.86 22.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.845 3.658 . . . . 11.66 105.004 179.223 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -115.54 127.9 55.59 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.377 -1.452 . . . . 16.3 109.06 176.897 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.2 tp -95.27 116.05 28.24 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.336 2.493 . . . . 9.96 107.213 -178.706 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.71 141.36 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 100.295 -3.965 . . . . 9.76 100.295 -171.505 . . . . . . . . 1 1 . 1 . 117 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.429 -1.477 0 O-C-N 118.892 -2.38 . . . . 19.57 113.906 174.962 . . . . . . . . 0 0 . 1 . 118 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 108.375 -0.972 . . . . 17.17 108.375 . . . . . . . . . 0 0 . 1 . 118 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -83.03 115.2 21.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.788 2.435 . . . . 21.89 110.424 -173.081 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pp -120.27 155.71 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.152 -2.536 . . . . 10.83 104.152 175.959 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -100.85 134.55 43.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.312 -3.367 . . . . 10.61 106.607 -176.338 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.88 117.69 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 121.111 -0.993 . . . . 9.13 108.971 160.87 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -98.66 117.22 32.63 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.748 0.819 . . . . 20.55 111.694 -178.093 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 m -79.02 127.7 32.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.23 -2.169 . . . . 11.78 113.135 161.098 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.61 -59.79 2.57 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.207 -2.145 . . . . 19.31 105.207 -174.968 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.259 8.2 m -87.54 71.43 9.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 112.888 0.699 . . . . 23.14 112.888 168.346 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.11 -128.48 1.42 Allowed Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 109.627 -1.389 . . . . 19.74 109.627 -175.342 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU 0.258 20.6 pttm -132.45 179.45 6.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 131.107 3.763 . . . . 21.93 117.157 173.465 . . . . . . . . 3 3 . 1 . 118 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -105.52 119.16 38.4 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.167 -4.083 . . . . 12.33 108.709 178.098 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 pt -104.02 143.02 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 117.314 -3.366 . . . . 17.08 110.462 173.847 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -96.9 134.33 40.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.626 2.632 . . . . 16.3 107.129 170.811 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.7 mt -121.86 140.89 51.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.197 -2.274 . . . . 15.88 111.118 175.474 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -103.95 90.39 3.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.155 2.883 . . . . 28.9 111.968 177.596 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.56 176.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 C-N-CA 132.07 4.148 . . . . 12.05 111.504 -170.204 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.259 37.5 tt0 -134.34 144.06 49.54 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 117.703 -1.142 . . . . 18.17 112.862 167.551 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 88.9 Cg_endo -65.69 -16.92 55.37 Favored 'Trans proline' 0 C--N 1.3 -2.025 1 C-N-CA 126.876 5.051 . . . . 8.16 115.184 -169.912 . . . . . . . . 3 3 . 1 . 118 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -66.83 -20.92 66.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.112 3.765 . . . . 11.13 117.245 166.165 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -73.04 159.65 33.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.141 1.924 . . . . 18.03 113.029 179.878 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.6 p -86.9 154.16 21.06 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.552 1.541 . . . . 10.22 109.225 166.062 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 mm -56.58 -51.15 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 125.016 1.448 . . . . 12.3 108.597 167.334 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.279 37.8 tp10 -37.25 -35.54 0.11 Allowed 'General case' 0 N--CA 1.43 -1.436 1 N-CA-C 123.37 4.582 . . . . 36.51 123.37 166.823 . . . . . . . . 3 2 . 1 . 118 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -74.84 -33.72 62.18 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 111.733 -6.854 . . . . 25.66 118.535 167.756 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -67.86 -45.22 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 128.36 2.664 . . . . 8.12 106.623 175.678 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -55.47 -40.99 72.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.898 3.237 . . . . 15.47 111.107 176.358 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.33 -17.39 60.84 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 111.586 -6.946 . . . . 11.45 120.652 176.49 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -75.36 -34.54 61.17 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.098 -2.876 . . . . 24.98 112.708 173.198 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.3 mt -63.82 -43.23 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 119.601 -1.937 . . . . 9.46 113.736 173.004 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -50.93 -51.05 56.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.805 2.566 . . . . 14.76 116.527 167.399 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.63 -42.7 70.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.619 1.967 . . . . 26.29 112.513 -169.281 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -76.32 -47.44 23.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.386 -1.768 . . . . 30.06 114.717 -178.682 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.424 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS . 59.3 mm-40 -102.78 -53.64 2.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 116.12 -1.895 . . . . 25.19 107.913 -169.267 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.91 -31.69 1.33 Allowed Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 122.549 2.431 . . . . 7.41 112.08 -175.962 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 19.8 mt -61.32 115.9 16.96 Favored Pre-proline 0 N--CA 1.431 -1.403 1 O-C-N 131.579 4.929 . . . . 9.49 117.089 -164.287 . . . . . . . . 3 2 . 1 . 118 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 38.0 Cg_endo -82.16 148.89 15.19 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 CA-C-N 129.263 4.344 . . . . 11.42 108.448 -169.825 . . . . . . . . 3 3 . 1 . 118 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 32.3 Cg_exo -61.5 -12.61 25.17 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 124.652 3.568 . . . . 12.0 119.642 -170.094 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -79.84 -33.51 40.14 Favored 'General case' 0 N--CA 1.43 -1.459 1 CA-C-O 131.789 5.566 . . . . 35.55 110.778 179.123 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -76.94 -20.41 56.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 110.019 -3.264 . . . . 20.52 112.671 -176.92 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -76.34 149.34 37.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.53 2.586 . . . . 7.13 108.268 -178.795 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -145.29 95.89 2.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.739 -2.476 . . . . 36.39 111.741 161.549 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.2 mt -84.37 121.41 27.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.035 -0.984 . . . . 9.55 113.296 -175.753 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.1 mm -107.2 136.47 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 122.886 1.327 . . . . 13.9 110.239 171.284 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB2' HD11 ' A' ' 50' ' ' LEU . 33.1 t80 -116.3 114.84 24.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.562 -2.014 . . . . 6.86 105.562 167.674 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.82 -112.28 0.5 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.855 1.262 . . . . 11.15 113.431 -164.405 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.5 -4.49 43.3 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 126.211 2.195 . . . . 13.93 112.992 -174.398 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -93.89 121.64 35.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.076 2.551 . . . . 23.92 105.544 -175.912 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -83.81 102.45 12.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.67 1.988 . . . . 23.23 107.335 169.238 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 45' ' ' PHE . 23.8 mt -51.81 132.57 31.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.104 3.002 . . . . 9.11 119.104 -173.511 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -109.23 139.89 43.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.618 2.628 . . . . 33.44 111.325 179.943 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -64.24 -43.23 95.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 109.893 -3.321 . . . . 28.37 116.065 -148.322 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.52 -6.15 88.86 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 127.652 2.549 . . . . 15.0 110.752 -171.787 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -86.9 158.45 19.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.405 3.002 . . . . 25.5 109.78 -177.464 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.9 p -89.81 158.65 17.39 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.627 -3.171 . . . . 11.95 110.45 179.658 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 30.5 mt -59.16 -45.0 92.13 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.797 -1.547 . . . . 10.17 113.951 175.056 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.377 71.5 p -43.57 -43.55 5.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.348 2.659 . . . . 13.59 114.509 165.7 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -63.25 -40.91 98.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.53 1.633 . . . . 11.7 115.198 179.829 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HB3' HG13 ' A' ' 61' ' ' ILE . 6.4 m-85 -82.58 -18.79 40.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.842 2.057 . . . . 12.95 110.564 -176.673 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.382 12.5 m120 80.8 32.41 0.15 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.145 2.178 . . . . 25.45 111.513 -179.09 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.406 HG13 ' HB3' ' A' ' 59' ' ' TYR . 66.4 mt -91.57 106.18 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 128.072 2.549 . . . . 14.6 109.165 179.177 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -103.18 -173.58 2.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.744 3.217 . . . . 33.23 110.755 -169.354 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -68.22 158.33 33.52 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.072 2.669 . . . . 25.97 114.248 178.022 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 41.1 mt-10 72.75 5.02 5.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.438 1.895 . . . . 32.61 108.528 169.004 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -70.01 149.69 47.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.659 -1.901 . . . . 10.56 115.854 169.507 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.6 m -120.08 121.7 39.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.124 2.392 . . . . 5.33 105.265 -168.942 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.54 128.04 43.1 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.297 -4.627 . . . . 11.66 109.052 172.978 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.326 35.1 m80 -97.7 132.78 43.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.644 2.474 . . . . 16.3 113.699 175.465 . . . . . . . . 2 2 . 1 . 118 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tt -108.45 112.63 25.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.21 1.481 . . . . 9.96 109.482 -169.558 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 t -92.45 129.28 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 116.401 -1.762 . . . . 9.76 110.491 164.46 . . . . . . . . 1 1 . 1 . 118 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.43 -1.43 0 C-N-CA 127.527 2.331 . . . . 19.57 106.821 177.063 . . . . . . . . 0 0 . 1 . 119 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 114.839 1.422 . . . . 17.17 114.839 . . . . . . . . . 0 0 . 1 . 119 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.53 135.32 39.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.588 -3.82 . . . . 21.89 112.833 168.352 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.443 HD12 HD13 ' A' ' 67' ' ' LEU . 17.2 pt -127.63 160.0 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.43 3.014 . . . . 10.83 106.397 159.956 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -103.07 148.48 25.67 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 109.355 -3.566 . . . . 10.61 112.67 -178.473 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -125.03 119.58 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 121.086 1.766 . . . . 9.13 108.616 167.465 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -95.43 85.67 4.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 125.261 1.601 . . . . 20.55 114.819 -176.977 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.5 m -83.32 141.47 31.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.45 -0.945 . . . . 11.78 108.45 171.962 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.1 mt -86.2 -54.1 4.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.965 1.306 . . . . 19.31 112.56 179.706 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -89.43 63.77 6.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.746 2.213 . . . . 23.14 107.054 -176.385 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.74 -135.15 3.71 Favored Glycine 0 N--CA 1.429 -1.77 1 CA-C-N 107.994 -4.184 . . . . 19.74 103.774 -174.035 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -143.45 174.2 10.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.363 2.357 . . . . 21.93 117.363 -178.148 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -92.31 117.65 30.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.952 2.575 . . . . 12.33 117.952 176.884 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 pt -102.95 156.32 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 128.824 2.85 . . . . 17.08 116.809 -172.536 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -127.72 104.02 7.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.939 -1.101 . . . . 16.3 110.89 -168.746 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.1 mt -104.02 138.11 41.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.241 1.817 . . . . 15.88 111.962 -165.645 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -108.0 86.99 2.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 128.122 3.82 . . . . 28.9 110.804 -170.247 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -101.73 172.98 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 111.971 -2.377 . . . . 12.05 114.437 -175.71 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.86 146.87 63.12 Favored Pre-proline 0 N--CA 1.431 -1.416 0 O-C-N 125.56 1.788 . . . . 18.17 108.452 171.339 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.3 -4.56 13.17 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 115.955 -1.769 . . . . 8.16 116.406 -150.097 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 m -90.91 6.22 45.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.732 2.06 . . . . 11.13 111.172 172.598 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.91 154.68 20.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.5 2.778 . . . . 18.03 118.5 -176.252 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -91.45 163.05 14.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.062 -2.899 . . . . 10.22 111.669 -164.338 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mm -64.51 -34.89 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 117.342 -1.313 . . . . 12.3 108.315 -178.188 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -51.0 -49.32 60.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 114.294 1.22 . . . . 36.51 114.294 169.646 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.08 -25.07 62.46 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.915 2.931 . . . . 25.66 118.915 176.393 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.509 HG21 HD21 ' A' ' 56' ' ' LEU . 86.7 t -62.99 -44.79 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 116.249 -1.834 . . . . 8.12 109.098 167.637 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -52.35 -48.97 65.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.823 3.638 . . . . 15.47 120.823 171.504 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.09 67.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.937 3.695 . . . . 11.45 114.975 170.594 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.98 -43.72 98.01 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.748 1.758 . . . . 24.98 115.748 170.455 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.6 -54.29 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.774 -1.829 . . . . 9.46 112.931 174.505 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -41.7 -46.03 3.64 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.42 2.288 . . . . 14.76 113.045 172.573 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -76.03 -46.59 28.57 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.049 1.74 . . . . 26.29 111.586 -178.118 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -68.2 -62.43 1.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.321 -1.487 . . . . 30.06 113.852 -172.65 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -92.53 -49.57 6.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.573 -0.899 . . . . 25.19 108.573 -173.642 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.85 28.24 2.32 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 122.568 1.093 . . . . 7.41 112.672 177.825 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mt -87.18 119.75 71.07 Favored Pre-proline 0 N--CA 1.431 -1.413 0 O-C-N 117.985 -3.068 . . . . 9.49 104.075 -171.757 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -64.77 133.63 37.2 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 N-CA-C 121.633 3.666 . . . . 11.42 121.633 -176.068 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -78.9 -10.8 15.34 Favored 'Trans proline' 0 N--CA 1.433 -2.05 1 C-N-CA 128.698 6.266 . . . . 12.0 113.947 -159.039 . . . . . . . . 3 3 . 1 . 119 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -76.87 -36.07 57.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.01 1.732 . . . . 35.55 113.175 168.808 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -74.55 -27.45 60.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.533 3.933 . . . . 20.52 112.63 -178.982 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 76.7 mt-30 -74.49 119.33 18.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.338 -2.101 . . . . 7.13 110.466 172.968 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.325 40.5 ttm180 -114.65 108.8 17.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.048 2.539 . . . . 36.39 104.857 159.681 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.19 130.55 35.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.321 3.452 . . . . 9.55 120.321 166.876 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.9 mm -117.83 131.61 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.018 2.127 . . . . 13.9 111.168 -174.538 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -128.17 123.63 34.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.639 -3.788 . . . . 6.86 106.314 170.965 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.19 -99.65 0.1 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.705 -1.588 . . . . 11.15 112.727 -163.198 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.17 22.3 2.76 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 104.359 -3.496 . . . . 13.93 104.359 -176.736 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -107.47 135.27 49.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.403 3.481 . . . . 23.92 101.952 -177.282 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -97.98 118.6 34.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.463 -2.648 . . . . 23.23 109.623 177.297 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.3 mt -88.67 135.81 33.31 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.215 -2.803 . . . . 9.11 109.246 -160.719 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -80.11 159.08 26.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.124 2.569 . . . . 33.44 111.924 179.286 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -75.75 -47.7 24.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 124.982 1.426 . . . . 28.37 111.973 -172.936 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.29 29.62 11.51 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 124.639 1.212 . . . . 15.0 113.046 -166.396 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.441 HH21 ' CG ' ' A' ' 58' ' ' ASP . 77.7 mtp180 -117.47 157.06 26.91 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 126.186 1.794 . . . . 25.5 108.818 177.727 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -96.2 162.38 13.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.096 2.628 . . . . 11.95 118.096 -169.705 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.509 HD21 HG21 ' A' ' 26' ' ' VAL . 42.6 mt -63.09 -33.4 75.36 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.919 -2.363 . . . . 10.17 113.75 170.367 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 p -66.61 -39.52 88.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.51 -3.869 . . . . 13.59 114.403 171.148 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' CG ' HH21 ' A' ' 54' ' ' ARG . 66.2 t0 -64.34 -54.53 31.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.246 2.618 . . . . 11.7 107.671 179.801 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -73.09 -15.32 61.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 115.313 -2.555 . . . . 12.95 108.887 -178.933 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.271 35.1 m120 85.91 37.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 127.255 3.407 . . . . 25.45 113.368 176.251 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.491 HG21 HD11 ' A' ' 67' ' ' LEU . 53.7 mt -95.78 79.85 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.478 1 O-C-N 116.243 -4.036 . . . . 14.6 110.413 -172.166 . . . . . . . . 3 3 . 1 . 119 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -59.33 174.17 0.43 Allowed 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.435 2.754 . . . . 33.23 118.435 172.719 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -62.57 141.02 58.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.111 1.522 . . . . 25.97 115.111 174.733 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 22.3 tt0 67.88 27.02 7.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.613 3.165 . . . . 32.61 114.672 -176.196 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -91.49 139.79 30.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.899 -3.625 . . . . 10.56 112.014 174.634 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -113.78 118.94 35.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.309 -1.357 . . . . 5.33 111.883 -172.099 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 61' ' ' ILE . 5.5 mp -97.35 141.48 30.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 103.87 -2.641 . . . . 11.66 103.87 -176.109 . . . . . . . . 2 2 . 1 . 119 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -108.49 135.1 50.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.254 -2.499 . . . . 16.3 104.254 -176.36 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.91 108.52 20.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.64 -1.985 . . . . 9.96 105.64 -172.013 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.9 t -76.95 130.43 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 125.3 1.625 . . . . 9.76 113.985 162.633 . . . . . . . . 1 1 . 1 . 119 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 N--CA 1.429 -1.479 0 CA-C-O 125.325 2.488 . . . . 19.57 105.137 174.652 . . . . . . . . 0 0 . 1 . 120 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptt? . . . . . 0 CA--C 1.489 -1.367 0 CA-C-O 123.587 1.66 . . . . 17.17 110.316 . . . . . . . . . 0 0 . 1 . 120 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -96.83 140.33 31.55 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.413 -2.055 . . . . 21.89 106.872 -179.195 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 pt -136.79 157.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 124.007 0.923 . . . . 10.83 108.793 177.467 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -112.61 133.94 54.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.55 -2.759 . . . . 10.61 103.55 -178.498 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.16 121.23 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 1 O-C-N 115.359 -4.588 . . . . 9.13 106.859 165.713 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -105.66 115.9 31.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.084 2.115 . . . . 20.55 107.856 -167.569 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.335 0.2 OUTLIER -101.27 126.92 48.06 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.738 -1.949 . . . . 11.78 105.738 -168.471 . . . . . . . . 3 3 . 1 . 120 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.72 -49.65 8.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.157 -1.59 . . . . 19.31 107.468 -178.142 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 m -95.03 75.52 3.5 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.931 2.3 . . . . 23.14 112.71 172.556 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.47 -111.3 0.46 Allowed Glycine 0 N--CA 1.431 -1.695 0 O-C-N 119.394 -2.066 . . . . 19.74 110.329 -166.721 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -175.32 177.97 1.76 Allowed 'General case' 0 N--CA 1.43 -1.459 1 CA-C-N 124.497 4.148 . . . . 21.93 106.122 178.932 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -97.23 122.33 40.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.402 -2.061 . . . . 12.33 106.67 -176.771 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 pt -106.63 148.66 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 122.94 1.352 . . . . 17.08 108.329 -178.869 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.9 m -111.3 112.44 24.21 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.916 -2.253 . . . . 16.3 104.916 -175.357 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -111.33 142.7 43.21 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.501 2.096 . . . . 15.88 112.478 179.924 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -97.78 117.39 31.98 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.563 -3.211 . . . . 28.9 109.711 172.977 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.46 153.66 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.613 -3.179 . . . . 12.05 108.146 -171.797 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -105.54 137.97 19.45 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 112.491 -3.623 . . . . 18.17 107.281 173.428 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -75.25 -9.88 20.59 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 123.67 2.346 . . . . 8.16 113.045 -158.588 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.8 m -84.1 -20.44 32.57 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 126.935 2.647 . . . . 11.13 113.947 -176.418 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -85.12 159.67 20.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.184 -2.198 . . . . 18.03 109.053 -169.284 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -78.86 163.58 25.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.18 -2.825 . . . . 10.22 109.935 -167.385 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.6 mm -64.46 -38.45 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.613 -1.929 . . . . 12.3 109.875 174.667 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -44.77 -36.57 3.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.017 2.927 . . . . 36.51 115.012 164.405 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -71.97 -44.56 63.36 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.971 1.708 . . . . 25.66 110.14 173.138 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 t -55.92 -43.24 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.614 2.366 . . . . 8.12 112.497 173.055 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -62.98 -26.22 68.74 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.561 -3.212 . . . . 15.47 113.902 173.085 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -76.02 -36.04 59.29 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.983 -2.323 . . . . 11.45 107.605 177.517 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -73.26 -36.67 66.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.209 -1.557 . . . . 24.98 114.097 -178.241 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 mt -65.55 -34.62 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.713 1.605 . . . . 9.46 113.569 168.237 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 58.9 tt0 -61.59 -52.22 65.32 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.227 1.489 . . . . 14.76 112.741 170.859 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.74 -46.67 88.42 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.367 2.267 . . . . 26.29 112.102 -179.652 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -65.58 -59.29 4.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.15 1.537 . . . . 30.06 115.15 178.309 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.378 65.9 mm-40 -87.98 -43.69 11.56 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.203 2.201 . . . . 25.19 111.84 -165.927 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.78 29.64 5.49 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-O 117.562 -1.688 . . . . 7.41 109.878 -174.775 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.2 mt -104.49 99.83 19.75 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 130.189 3.396 . . . . 9.49 109.203 175.886 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -58.77 160.62 17.26 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 115.628 -2.88 . . . . 11.42 115.628 173.406 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -102.15 12.1 0.39 Allowed 'Trans proline' 0 N--CA 1.434 -1.997 0 N-CA-C 121.517 3.622 . . . . 12.0 121.517 -163.811 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.11 -13.55 55.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 125.647 1.842 . . . . 35.55 114.669 151.044 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -90.86 -3.05 57.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.993 -2.317 . . . . 20.52 107.744 178.273 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -95.34 131.68 41.19 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.589 -2.569 . . . . 7.13 113.179 -175.995 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -119.48 103.38 9.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.459 -2.422 . . . . 36.39 104.459 166.2 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.72 109.43 21.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.915 -2.99 . . . . 9.55 107.057 -165.764 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.08 135.56 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 123.714 1.721 . . . . 13.9 107.581 -159.011 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -124.11 115.3 20.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.197 -2.814 . . . . 6.86 103.846 176.816 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.282 . . 63.2 -103.14 0.11 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.414 1.886 . . . . 11.15 113.305 -169.17 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.69 40.84 1.54 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 118.406 -2.684 . . . . 13.93 113.016 168.704 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -147.37 137.46 23.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.542 2.337 . . . . 23.92 106.153 -178.103 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -76.44 158.51 31.27 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.798 -3.689 . . . . 23.23 111.377 -171.498 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD11 HD23 ' A' ' 67' ' ' LEU . 5.4 mt -97.07 147.36 24.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 113.346 0.869 . . . . 9.11 113.346 165.224 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -95.38 167.92 11.04 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 123.614 0.571 . . . . 33.44 111.72 177.421 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.09 -46.21 13.07 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.054 -2.904 . . . . 28.37 114.538 -163.284 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.23 27.57 13.06 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.121 -2.862 . . . . 15.0 112.291 -176.33 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -106.43 166.63 10.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 115.621 -2.133 . . . . 25.5 111.486 173.097 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -104.1 176.87 5.01 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 121.763 2.074 . . . . 11.95 111.575 -175.288 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.38 -40.52 73.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.412 2.529 . . . . 10.17 106.511 173.251 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.3 p -78.79 -8.11 58.46 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.065 -2.272 . . . . 13.59 111.245 -171.966 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -75.26 -51.17 13.91 Favored 'General case' 0 N--CA 1.431 -1.406 2 O-C-N 115.315 -4.616 . . . . 11.7 104.477 174.422 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -82.22 -10.26 59.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.792 -2.442 . . . . 12.95 113.574 179.435 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 71.51 58.96 0.17 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.132 1.373 . . . . 25.45 109.962 -177.656 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mt -80.71 111.44 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.184 2.594 . . . . 14.6 110.567 159.925 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -97.53 175.04 6.36 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.397 -2.183 . . . . 33.23 110.17 174.401 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -58.79 143.07 48.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.702 3.201 . . . . 25.97 106.811 -178.679 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.317 3.2 mp0 60.96 20.2 10.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.829 2.159 . . . . 32.61 116.829 -178.871 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 m -72.37 147.23 46.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.242 2.312 . . . . 10.56 117.242 167.131 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.4 m -95.11 126.56 40.52 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.086 2.155 . . . . 5.33 109.071 165.521 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.483 HD23 HD11 ' A' ' 50' ' ' LEU . 6.6 mp -100.59 152.26 20.63 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.141 -2.17 . . . . 11.66 105.141 164.623 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -105.78 128.43 53.71 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.08 -5.388 . . . . 16.3 108.675 179.164 . . . . . . . . 2 2 . 1 . 120 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 tp -97.05 131.66 43.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 116.074 -2.25 . . . . 9.96 108.717 179.53 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.5 t -107.84 129.38 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.789 -3.069 . . . . 9.76 107.67 172.288 . . . . . . . . 1 1 . 1 . 120 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.43 -1.447 0 CA-C-N 114.514 -1.221 . . . . 19.57 110.261 176.239 . . . . . . . . 0 0 . 1 . 121 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.349 0 CA-C-O 117.293 -1.336 . . . . 17.17 112.388 . . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -96.88 137.49 35.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.946 2.654 . . . . 21.89 111.169 176.956 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.29 172.02 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 126.919 2.088 . . . . 10.83 112.711 176.952 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -123.66 115.7 21.87 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.614 -2.735 . . . . 10.61 103.614 -167.89 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.72 115.35 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 102.623 -3.103 . . . . 9.13 102.623 170.445 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -86.67 131.21 34.21 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.235 -3.416 . . . . 20.55 112.183 167.397 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -87.18 162.39 17.52 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.746 1.279 . . . . 11.78 114.231 172.104 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.9 tp -69.13 -28.42 66.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.419 2.687 . . . . 19.31 111.599 -174.935 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 53.3 m -59.1 -47.54 84.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.818 -2.515 . . . . 23.14 114.961 167.39 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.44 49.06 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 105.691 -2.964 . . . . 19.74 105.691 167.269 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.307 41.7 mttt -138.69 145.33 40.23 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.621 -5.047 . . . . 21.93 104.266 178.592 . . . . . . . . 3 2 . 1 . 121 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -99.85 116.01 30.93 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.494 -2.594 . . . . 12.33 106.394 168.722 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 pt -106.27 133.28 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 105.15 -2.166 . . . . 17.08 105.15 176.337 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 m -93.78 117.81 30.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 126.869 2.605 . . . . 16.3 110.082 -177.127 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.274 95.8 mt -119.15 141.76 48.54 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.978 -2.23 . . . . 15.88 104.978 -177.296 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -104.38 111.48 24.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.318 3.047 . . . . 28.9 112.955 172.346 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.5 169.15 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 124.719 2.199 . . . . 12.05 111.805 -178.132 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -92.13 154.88 43.25 Favored Pre-proline 0 N--CA 1.43 -1.446 0 O-C-N 117.283 -3.385 . . . . 18.17 107.163 167.308 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.01 -3.89 12.98 Favored 'Trans proline' 0 C--N 1.3 -1.99 1 CA-C-N 129.355 4.377 . . . . 8.16 111.974 175.019 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -76.2 -22.19 55.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.311 -2.743 . . . . 11.13 114.325 169.614 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -67.76 151.25 47.52 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.618 2.152 . . . . 18.03 111.054 173.167 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.4 p -99.43 -170.93 1.98 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.469 2.557 . . . . 10.22 110.781 -173.86 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.7 mm -86.92 -17.43 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 O-C-N 115.975 -4.203 . . . . 12.3 108.662 -173.171 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.57 -26.56 55.22 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.613 -4.429 . . . . 36.51 110.501 174.142 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -73.06 -33.89 65.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.334 -0.947 . . . . 25.66 108.719 176.455 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.353 65.6 t -65.53 -47.43 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 124.622 1.169 . . . . 8.12 113.695 178.034 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -55.36 -43.19 74.84 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.675 1.99 . . . . 15.47 113.869 171.944 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.5 90.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 120.732 3.604 . . . . 11.45 120.732 168.193 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -70.26 -38.87 75.19 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.589 -1.944 . . . . 24.98 111.701 174.968 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -66.66 -35.5 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 127.277 2.231 . . . . 9.46 108.999 177.429 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -64.75 -39.4 93.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.725 -3.109 . . . . 14.76 107.834 174.929 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -72.85 -60.19 2.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.179 2.895 . . . . 26.29 111.094 -173.866 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -61.8 -49.72 75.21 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 120.677 3.584 . . . . 30.06 120.677 177.176 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -108.8 -18.29 13.73 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.208 -1.557 . . . . 25.19 111.9 -174.935 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.89 27.25 29.41 Favored Glycine 0 N--CA 1.429 -1.772 1 O-C-N 114.919 -4.863 . . . . 7.41 113.657 170.972 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -91.65 133.56 30.78 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 118.52 -2.753 . . . . 9.49 111.439 175.499 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.9 Cg_exo -70.54 153.87 65.05 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 O-C-N 115.784 -2.798 . . . . 11.42 117.741 -179.292 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 12.5 Cg_exo -75.31 -29.0 8.19 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 CA-C-N 122.863 2.058 . . . . 12.0 116.206 -166.477 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.99 -14.72 60.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.178 -2.826 . . . . 35.55 107.992 -169.733 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -109.55 3.2 20.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.385 -3.322 . . . . 20.52 111.828 -172.15 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -87.59 134.96 33.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.71 3.604 . . . . 7.13 105.172 168.607 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -129.55 125.3 35.94 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 101.719 -3.438 . . . . 36.39 101.719 178.651 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.2 mt -126.1 132.91 51.79 Favored 'General case' 0 N--CA 1.43 -1.427 2 O-C-N 115.597 -4.439 . . . . 9.55 99.45 -167.995 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 mm -119.31 134.75 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 109.74 -3.391 . . . . 13.9 111.824 -178.042 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -128.77 124.02 34.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 117.077 -1.44 . . . . 6.86 112.244 163.18 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.61 -101.64 0.11 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.319 2.248 . . . . 11.15 106.773 -168.693 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.05 17.46 5.41 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 119.961 -1.712 . . . . 13.93 115.781 170.829 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -103.92 141.19 36.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.138 -1.801 . . . . 23.92 106.138 -172.906 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -83.18 124.29 30.38 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.605 2.362 . . . . 23.23 114.0 166.684 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.19 111.56 23.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.236 3.05 . . . . 9.11 119.236 -174.647 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.83 140.17 58.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 120.519 3.526 . . . . 33.44 120.519 -178.714 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -49.24 -51.33 33.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.623 3.169 . . . . 28.37 118.289 -163.83 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.37 18.5 56.83 Favored Glycine 0 N--CA 1.43 -1.706 0 O-C-N 117.844 -3.035 . . . . 15.0 116.024 -178.154 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -97.62 148.02 23.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 122.83 3.315 . . . . 25.5 108.015 -177.196 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -78.56 151.15 32.59 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 115.785 -4.322 . . . . 11.95 110.32 179.908 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.0 mt -65.62 -30.81 71.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.571 -2.581 . . . . 10.17 112.809 179.38 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -59.42 -44.37 92.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.321 3.448 . . . . 13.59 112.083 170.952 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.72 -40.99 89.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.304 -3.372 . . . . 11.7 117.378 172.841 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -77.37 -21.24 53.56 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.534 -1.979 . . . . 12.95 111.505 175.496 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.5 t30 56.71 53.15 8.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.929 3.292 . . . . 25.45 117.009 -175.043 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.1 mm -64.38 121.8 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 118.671 -2.518 . . . . 14.6 112.266 164.387 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -96.67 167.5 11.08 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.632 2.634 . . . . 33.23 111.451 179.221 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -72.28 145.52 47.82 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 112.796 -6.19 . . . . 25.97 120.52 174.787 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 63.17 19.95 11.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.0 2.52 . . . . 32.61 115.688 -175.287 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.49 143.3 27.28 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.071 -2.786 . . . . 10.56 118.446 170.041 . . . . . . . . 2 2 . 1 . 121 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.2 m -92.05 117.01 29.43 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.402 3.112 . . . . 5.33 119.402 -179.756 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.83 143.51 26.27 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.554 1.524 . . . . 11.66 108.126 171.743 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -93.53 134.85 35.38 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.841 -2.412 . . . . 16.3 109.858 167.785 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 tt -106.24 132.5 52.22 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.399 -2.815 . . . . 9.96 103.399 166.357 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -120.34 174.18 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 129.731 3.212 . . . . 9.76 106.044 160.351 . . . . . . . . 1 1 . 1 . 121 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 N--CA 1.43 -1.467 1 O-C-N 114.245 -5.284 . . . . 19.57 111.881 -173.265 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 CA--C 1.489 -1.368 0 CA-C-O 121.471 0.653 . . . . 17.17 110.859 . . . . . . . . . 0 0 . 1 . 122 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -106.1 129.83 54.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.576 -1.647 . . . . 21.89 115.36 175.319 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -123.46 169.39 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.621 -2.55 . . . . 10.83 105.475 170.784 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.68 140.81 52.62 Favored 'General case' 0 N--CA 1.429 -1.485 1 N-CA-C 99.994 -4.076 . . . . 10.61 99.994 -169.403 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 t -129.99 126.27 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 105.622 -1.992 . . . . 9.13 105.622 175.227 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -102.35 125.82 49.17 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 124.9 1.375 . . . . 20.55 108.232 177.816 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -89.63 -166.26 1.55 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.521 -2.612 . . . . 11.78 112.656 -162.079 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.5 tp -73.44 -60.23 2.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.143 2.247 . . . . 19.31 112.449 -176.919 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 m -48.45 -49.6 34.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 110.218 -3.174 . . . . 23.14 110.08 174.332 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.36 64.15 0.16 Allowed Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 117.893 -1.504 . . . . 19.74 113.187 176.842 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -123.23 137.11 54.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.739 -1.578 . . . . 21.93 106.739 176.691 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -100.38 103.88 15.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.969 2.168 . . . . 12.33 111.737 176.394 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.438 16.9 pt -93.1 147.24 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 124.204 1.954 . . . . 17.08 109.806 -176.314 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 m -101.0 123.03 44.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.134 -2.229 . . . . 16.3 106.115 175.846 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -116.21 152.71 33.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.632 2.373 . . . . 15.88 111.582 176.261 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -111.76 114.03 26.76 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.189 -2.278 . . . . 28.9 108.278 177.145 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.62 173.77 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 113.417 -1.719 . . . . 12.05 110.521 -178.867 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -123.07 142.16 37.57 Favored Pre-proline 0 N--CA 1.43 -1.431 0 N-CA-C 107.889 -1.152 . . . . 18.17 107.889 175.481 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -68.84 -9.12 25.35 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 O-C-N 114.434 -3.508 . . . . 8.16 116.228 -169.011 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -83.82 -19.86 34.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.649 2.022 . . . . 11.13 110.362 179.184 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -69.86 144.83 52.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.265 2.226 . . . . 18.03 112.392 172.871 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 27.1 p -82.75 172.04 13.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.597 -3.189 . . . . 10.22 115.768 -175.402 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mm -61.17 -41.97 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 117.653 2.464 . . . . 12.3 117.653 173.657 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -31.57 -61.4 0.22 Allowed 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.586 -3.196 . . . . 36.51 118.486 152.578 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -50.94 -39.58 55.2 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.698 2.11 . . . . 25.66 116.698 171.287 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 t -68.57 -43.83 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 118.516 -2.615 . . . . 8.12 113.471 178.016 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.18 -34.67 76.87 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.479 2.029 . . . . 15.47 116.479 168.473 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.31 -32.86 63.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.079 -2.263 . . . . 11.45 110.767 178.017 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.253 66.6 mttt -64.65 -29.52 70.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.841 -2.412 . . . . 24.98 115.644 168.166 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.8 mt -67.97 -36.42 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.647 1.567 . . . . 9.46 113.248 170.348 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -61.15 -42.16 98.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.448 -2.032 . . . . 14.76 113.728 169.027 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.63 -53.06 17.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.082 1.896 . . . . 26.29 107.702 -174.802 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -56.8 -62.8 1.49 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 116.164 -4.085 . . . . 30.06 114.35 173.573 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -92.33 -41.88 10.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 119.236 3.05 . . . . 25.19 119.236 -173.669 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.58 46.65 2.1 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 116.536 -2.258 . . . . 7.41 112.706 -171.894 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.4 mt -109.99 116.37 53.73 Favored Pre-proline 0 N--CA 1.429 -1.479 0 C-N-CA 130.098 3.359 . . . . 9.49 110.892 173.698 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.02 149.29 92.01 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 127.279 3.635 . . . . 11.42 115.223 -178.876 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -76.36 -24.81 10.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 120.336 1.156 . . . . 12.0 114.475 -164.114 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.28 -22.42 52.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.336 1.454 . . . . 35.55 110.618 -169.562 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.33 3.78 51.03 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 121.771 2.078 . . . . 20.52 108.94 176.184 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -86.38 135.13 33.62 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.949 -2.969 . . . . 7.13 111.289 172.755 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.2 ttm105 -127.5 125.43 40.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.622 -1.924 . . . . 36.39 110.51 153.51 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.88 135.0 33.59 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 124.909 2.29 . . . . 9.55 113.678 178.654 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.31 146.92 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 103.424 -2.806 . . . . 13.9 103.424 -178.954 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -122.47 125.91 46.79 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 114.595 -5.065 . . . . 6.86 101.499 157.47 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.65 -94.46 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.487 1.613 . . . . 11.15 112.895 -178.186 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.22 22.42 1.4 Allowed Glycine 0 N--CA 1.43 -1.751 0 O-C-N 117.43 -3.294 . . . . 13.93 113.723 166.719 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -87.18 120.75 28.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.615 2.766 . . . . 23.92 112.123 167.32 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -78.44 129.29 34.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.23 -3.419 . . . . 23.23 113.543 176.98 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.1 mt -108.3 124.86 50.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.62 -2.55 . . . . 9.11 105.494 -154.524 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -93.25 138.55 31.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.291 -2.756 . . . . 33.44 111.971 -175.187 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -43.73 -43.74 6.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.919 3.287 . . . . 28.37 119.67 -179.099 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.56 18.0 45.29 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.49 -2.631 . . . . 15.0 113.932 -169.855 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -95.38 149.22 21.61 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.288 1.518 . . . . 25.5 110.128 163.519 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 p -71.52 146.49 48.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 111.958 -2.383 . . . . 11.95 108.093 171.349 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -49.19 -49.35 43.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.947 1.832 . . . . 10.17 115.947 161.332 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 p -49.48 -35.27 19.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 119.014 2.968 . . . . 13.59 119.014 166.29 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.83 -26.73 54.68 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 127.639 3.59 . . . . 11.7 114.646 -178.452 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -87.51 1.52 53.28 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.699 2.481 . . . . 12.95 117.699 168.297 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 72.68 31.92 1.58 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.215 2.822 . . . . 25.45 112.127 172.411 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mm -89.1 118.78 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 121.326 -0.859 . . . . 14.6 109.698 -169.919 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -106.28 172.72 6.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.354 -1.466 . . . . 33.23 107.155 -179.416 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -70.3 160.86 31.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 118.437 -1.305 . . . . 25.97 113.563 -175.703 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.253 52.5 mt-10 65.69 9.09 5.67 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.569 2.433 . . . . 32.61 117.569 -168.622 . . . . . . . . 2 2 . 1 . 122 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.0 m -69.48 135.2 49.85 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 112.445 -2.161 . . . . 10.56 113.179 171.939 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.8 m -110.97 122.03 46.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.768 -3.083 . . . . 5.33 106.466 -174.593 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.29 164.92 11.4 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 100.793 -3.78 . . . . 11.66 100.793 -172.508 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -123.45 130.59 52.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.139 -1.886 . . . . 16.3 109.912 -179.691 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -84.69 134.19 34.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.569 2.062 . . . . 9.96 116.569 169.719 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.52 164.66 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.68 -1.887 . . . . 9.76 107.668 169.881 . . . . . . . . 1 1 . 1 . 122 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.268 24.1 tp . . . . . 0 N--CA 1.429 -1.476 0 O-C-N 117.981 -2.949 . . . . 19.57 104.806 -172.059 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 117.614 2.45 . . . . 17.17 117.614 . . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -93.41 123.53 36.77 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 118.167 -0.92 . . . . 21.89 110.274 -163.945 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 pt -92.48 171.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 127.084 3.326 . . . . 10.83 109.394 165.567 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.556 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 26.1 m-85 -115.13 112.48 22.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.794 2.837 . . . . 10.61 107.688 169.545 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.5 t -105.71 118.43 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.858 -2.402 . . . . 9.13 105.13 172.08 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -97.57 113.12 24.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.843 2.857 . . . . 20.55 112.826 175.218 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.456 26.7 p -66.45 161.52 22.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 119.65 3.204 . . . . 11.78 119.65 174.979 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 tp -70.12 -34.06 72.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.26 -3.4 . . . . 19.31 107.31 -178.267 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -68.63 -61.84 1.65 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.184 0.993 . . . . 23.14 110.174 170.826 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.71 46.45 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 117.26 -3.4 . . . . 19.74 114.369 -170.436 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -126.1 135.96 52.34 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.981 -2.482 . . . . 21.93 112.678 162.868 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.4 m -105.85 114.04 27.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.692 -3.755 . . . . 12.33 106.291 -179.678 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -97.78 129.01 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 130.954 3.702 . . . . 17.08 109.278 -177.844 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -98.22 102.92 14.8 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.426 2.536 . . . . 16.3 105.409 -178.725 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.88 124.04 45.07 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.212 -2.18 . . . . 15.88 110.521 -155.216 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.73 113.49 18.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.83 -2.441 . . . . 28.9 114.922 -176.413 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.57 156.03 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 125.191 2.424 . . . . 12.05 111.469 178.33 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -91.97 158.32 39.84 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 116.041 -1.933 . . . . 18.17 108.988 174.704 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -83.32 -22.13 4.11 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 126.379 3.314 . . . . 8.16 118.027 -179.331 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 m -86.43 14.25 7.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 125.047 1.467 . . . . 11.13 114.483 -175.535 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -110.79 151.91 27.24 Favored 'General case' 0 N--CA 1.43 -1.449 1 C-N-CA 133.438 4.695 . . . . 18.03 111.334 -177.643 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 55.9 p -75.37 157.55 34.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 127.74 3.638 . . . . 10.22 113.046 -177.648 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.37 -28.24 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 126.03 2.824 . . . . 12.3 109.832 -179.137 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -69.24 -24.29 63.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.373 -3.954 . . . . 36.51 108.498 176.455 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -83.08 -38.98 21.76 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.192 2.997 . . . . 25.66 108.631 -179.077 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.8 t -55.84 -47.99 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 123.78 1.752 . . . . 8.12 112.711 162.483 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -60.69 -39.04 87.04 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.717 -4.364 . . . . 15.47 114.997 177.052 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.15 -43.14 66.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.31 3.078 . . . . 11.45 119.31 164.57 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -65.18 -41.41 94.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.791 -1.818 . . . . 24.98 111.629 177.114 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -60.38 -44.02 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 126.55 1.94 . . . . 9.46 113.151 172.482 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -51.12 -37.13 44.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.725 3.21 . . . . 14.76 113.988 167.615 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -83.76 -38.01 21.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.077 -1.639 . . . . 26.29 108.37 -176.921 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -63.93 -58.9 5.36 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.124 1.898 . . . . 30.06 116.124 177.4 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -100.14 -69.32 0.77 Allowed 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 124.724 2.202 . . . . 25.19 110.641 -171.351 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.49 46.07 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.766 0 O-C-N 117.418 -3.302 . . . . 7.41 105.593 -175.34 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -106.32 130.9 22.24 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 116.932 -1.509 . . . . 9.49 110.298 167.821 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 80.2 Cg_exo -76.21 154.66 37.04 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 119.79 2.958 . . . . 11.42 119.79 177.858 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 62.4 Cg_exo -70.5 -17.82 33.95 Favored 'Trans proline' 0 N--CA 1.434 -1.993 1 C-N-CA 126.142 4.561 . . . . 12.0 112.207 -169.229 . . . . . . . . 3 3 . 1 . 123 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -84.55 -21.01 30.62 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 115.267 -4.646 . . . . 35.55 114.408 176.451 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.95 -16.06 30.7 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.987 -1.695 . . . . 20.52 111.109 -175.549 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -86.1 153.13 22.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 118.834 -1.146 . . . . 7.13 112.842 -174.613 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.458 ' HB3' HG23 ' A' ' 70' ' ' VAL . 21.2 ttm180 -140.98 125.57 17.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 102.362 -3.199 . . . . 36.39 102.362 169.35 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.3 mt -105.63 125.68 51.27 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.03 1.395 . . . . 9.55 109.473 175.014 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mm -106.57 128.2 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 121.16 -0.963 . . . . 13.9 111.03 177.307 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -112.97 115.51 28.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 118.859 -1.136 . . . . 6.86 109.476 160.8 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.307 . . 64.31 -101.28 0.09 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.859 2.463 . . . . 11.15 111.613 -170.911 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.63 2.19 23.31 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 130.057 3.694 . . . . 13.93 114.158 172.11 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.258 14.3 tppt? -102.7 132.86 48.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 119.916 1.858 . . . . 23.92 111.019 -177.97 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -91.6 138.16 31.79 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.902 -1.954 . . . . 23.23 110.88 176.819 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.287 3.3 mt -106.59 114.24 28.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.974 3.273 . . . . 9.11 110.255 -166.018 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.37 130.27 35.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.271 -2.768 . . . . 33.44 114.063 -167.789 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -31.35 -67.35 0.1 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 121.245 3.795 . . . . 28.37 121.245 -164.336 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.56 21.9 43.15 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 115.177 -3.392 . . . . 15.0 111.334 -168.233 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -91.63 153.98 19.33 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.183 -4.716 . . . . 25.5 112.333 166.832 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 64.9 p -76.01 166.5 23.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.739 -2.476 . . . . 11.95 116.668 179.248 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 124.977 2.322 . . . . 10.17 116.758 163.526 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -60.94 -24.93 66.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 112.329 -3.701 . . . . 13.59 117.981 177.978 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -71.82 -38.55 70.16 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.497 2.408 . . . . 11.7 115.356 167.448 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -77.78 -2.99 39.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.673 -2.517 . . . . 12.95 114.709 170.645 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 2.6 m-80 52.62 49.05 21.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.58 3.086 . . . . 25.45 115.644 177.093 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.66 112.7 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 109.645 -3.434 . . . . 14.6 110.124 176.629 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -96.49 166.57 11.62 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.559 -2.588 . . . . 33.23 107.215 179.566 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -52.55 146.86 9.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.08 2.552 . . . . 25.97 114.704 171.507 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 57.81 38.69 27.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.856 3.693 . . . . 32.61 115.534 -178.516 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.254 72.5 m -102.35 131.21 49.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.833 -3.042 . . . . 10.56 110.206 -173.544 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 96.3 m -102.9 101.0 11.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.766 1.746 . . . . 5.33 108.787 -164.309 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 mt -81.75 134.34 35.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.913 -3.617 . . . . 11.66 113.353 172.47 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -89.28 101.19 13.86 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 113.424 -3.179 . . . . 16.3 105.406 -179.521 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -71.2 114.76 9.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 124.458 3.299 . . . . 9.96 114.489 169.602 . . . . . . . . 1 1 . 1 . 123 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 42' ' ' ARG . 15.7 m -121.95 -174.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.35 2.976 . . . . 9.76 107.622 -176.024 . . . . . . . . 2 2 . 1 . 123 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 tp . . . . . 0 N--CA 1.431 -1.424 1 O-C-N 113.467 -5.771 . . . . 19.57 115.779 176.808 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.341 9.5 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 113.954 -2.927 . . . . 17.17 117.243 . . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -74.93 124.97 27.89 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 131.799 4.039 . . . . 21.89 113.684 165.054 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.4 pt -120.16 162.08 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 103.36 -2.83 . . . . 10.83 103.36 159.675 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -114.93 135.44 54.21 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.024 -1.843 . . . . 10.61 106.024 -179.371 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.39 106.34 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 1 O-C-N 113.024 -6.047 . . . . 9.13 111.369 179.7 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -84.51 138.64 32.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.517 2.579 . . . . 20.55 112.947 179.957 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -106.9 174.79 5.73 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.31 -2.118 . . . . 11.78 106.872 -178.16 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -74.69 -50.11 18.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.202 2.201 . . . . 19.31 108.225 -169.396 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 p -71.43 -73.36 0.18 Allowed 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.131 1.9 . . . . 23.14 116.131 176.591 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.37 68.98 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.699 1 O-C-N 112.348 -6.47 . . . . 19.74 115.729 168.528 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -132.83 146.05 51.49 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.578 -1.542 . . . . 21.93 109.109 163.398 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.2 m -119.48 129.22 54.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.283 -1.767 . . . . 12.33 107.975 166.428 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.07 127.88 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 113.118 -1.855 . . . . 17.08 107.253 -177.209 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -86.39 128.87 34.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.22 -2.881 . . . . 16.3 103.22 169.007 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 tp -128.2 139.2 52.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.06 -1.427 . . . . 15.88 111.687 173.258 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -86.81 118.45 26.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.541 -1.35 . . . . 28.9 113.945 171.574 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -129.05 157.01 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.027 1.862 . . . . 12.05 116.027 173.266 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -103.78 140.05 20.69 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 125.572 1.549 . . . . 18.17 108.011 171.439 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -70.18 -18.13 35.23 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 122.356 1.877 . . . . 8.16 111.884 -170.407 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.39 -8.81 58.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.771 2.429 . . . . 11.13 116.031 178.361 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.26 164.41 25.75 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.985 -4.197 . . . . 18.03 111.625 171.558 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 59.1 p -79.88 170.65 16.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.623 -2.548 . . . . 10.22 115.654 156.431 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -73.95 -26.19 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.707 2.003 . . . . 12.3 111.37 175.234 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -57.91 -39.2 77.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 116.598 -3.814 . . . . 36.51 114.237 166.68 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -76.35 -31.06 57.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.846 -3.659 . . . . 25.66 112.042 -175.334 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.72 -42.07 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.245 1.818 . . . . 8.12 112.06 172.274 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -69.16 -23.8 63.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 119.708 3.225 . . . . 15.47 119.708 172.472 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.43 -23.45 67.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.77 2.428 . . . . 11.45 116.916 159.412 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -94.57 -19.21 20.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.444 1.592 . . . . 24.98 111.274 175.431 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.72 -34.97 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-O 116.314 -1.803 . . . . 9.46 106.451 175.868 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -67.63 -29.09 68.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.625 1.679 . . . . 14.76 111.943 174.957 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.81 -47.71 51.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.729 -2.482 . . . . 26.29 115.79 172.928 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -78.81 -47.82 15.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.332 1.975 . . . . 30.06 116.332 -177.257 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -105.2 -17.28 14.52 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.996 -2.94 . . . . 25.19 116.612 -178.88 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.17 61.4 5.19 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 127.077 2.275 . . . . 7.41 112.052 172.978 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -121.93 142.14 35.66 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 100.274 -3.972 . . . . 9.49 100.274 170.834 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -65.49 157.71 56.81 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 124.834 2.762 . . . . 11.42 110.531 -177.389 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -64.41 -27.05 62.79 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 123.867 3.044 . . . . 12.0 114.697 -178.982 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.5 -31.7 65.57 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 115.953 -4.217 . . . . 35.55 108.748 -176.154 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -81.71 -23.17 36.93 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.113 -2.867 . . . . 20.52 113.74 -179.815 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -71.0 120.29 16.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.413 2.285 . . . . 7.13 113.272 171.224 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -121.71 126.37 48.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 118.062 -0.97 . . . . 36.39 108.592 159.555 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.27 136.75 43.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.759 2.695 . . . . 9.55 108.536 -179.077 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.7 mm -120.31 146.78 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.649 -2.532 . . . . 13.9 105.779 -178.064 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -127.02 127.26 44.5 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 100.427 -3.916 . . . . 6.86 100.427 164.604 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.526 . . 59.34 -88.64 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 120.789 3.625 . . . . 11.15 120.789 -172.884 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.13 19.39 1.56 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 123.659 0.599 . . . . 13.93 112.029 153.025 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -77.38 132.99 38.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.732 0.777 . . . . 23.92 112.017 160.751 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -79.01 124.1 27.93 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.87 -3.644 . . . . 23.23 113.597 173.728 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.432 HD22 ' CD2' ' A' ' 59' ' ' TYR . 48.4 mt -99.48 120.82 40.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.091 -2.255 . . . . 9.11 107.987 -178.91 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -102.79 153.12 20.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.426 2.953 . . . . 33.44 110.42 -178.146 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.09 -51.59 30.75 Favored 'General case' 0 N--CA 1.43 -1.441 1 N-CA-C 122.677 4.325 . . . . 28.37 122.677 -166.545 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.44 -5.07 85.46 Favored Glycine 0 N--CA 1.43 -1.753 0 O-C-N 124.955 1.41 . . . . 15.0 114.945 -176.624 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -78.53 150.11 32.93 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.427 1.108 . . . . 25.5 110.214 168.102 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.5 p -88.31 179.06 6.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.176 -1.829 . . . . 11.95 113.029 169.044 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 56' ' ' LEU . 94.6 mt -76.34 -45.03 33.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.944 -1.502 . . . . 10.17 106.944 -174.544 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 p -50.57 -41.63 54.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.938 2.895 . . . . 13.59 114.408 176.147 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.6 -38.35 90.77 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.198 1.799 . . . . 11.7 111.125 -174.277 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CD2' HD22 ' A' ' 50' ' ' LEU . 76.2 m-85 -96.15 17.0 16.57 Favored 'General case' 0 N--CA 1.43 -1.468 2 O-C-N 115.145 -4.722 . . . . 12.95 111.788 169.718 . . . . . . . . 3 3 . 1 . 124 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 47.36 55.32 8.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 127.693 3.616 . . . . 25.45 118.756 -172.558 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.4 mm -82.42 119.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 111.117 -2.765 . . . . 14.6 113.843 171.57 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -97.84 170.36 9.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.573 2.421 . . . . 33.23 110.191 -176.039 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -76.39 155.65 33.88 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 115.647 -2.12 . . . . 25.97 108.062 -179.482 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.354 46.7 mt-10 58.2 39.35 25.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.685 1.994 . . . . 32.61 116.089 177.94 . . . . . . . . 2 2 . 1 . 124 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -124.14 136.36 54.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.921 -1.881 . . . . 10.56 105.921 -173.458 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.9 m -85.1 121.42 27.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.924 -1.988 . . . . 5.33 109.692 -171.834 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.62 158.65 15.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.402 2.681 . . . . 11.66 108.88 174.118 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -111.88 113.26 25.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.063 1.301 . . . . 16.3 110.185 -179.55 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.9 tp -81.34 119.16 23.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.547 -1.216 . . . . 9.96 111.063 173.355 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.77 166.73 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 118.75 -1.18 . . . . 9.76 110.971 173.304 . . . . . . . . 1 1 . 1 . 124 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 N--CA 1.43 -1.453 0 O-C-N 118.609 -2.557 . . . . 19.57 110.781 176.527 . . . . . . . . 0 0 . 1 . 125 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 CA--C 1.489 -1.366 0 N-CA-C 108.08 -1.081 . . . . 17.17 108.08 . . . . . . . . . 0 0 . 1 . 125 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -88.67 145.47 25.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.887 -2.383 . . . . 21.89 110.656 178.558 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.0 pt -133.17 164.69 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 104.785 -2.302 . . . . 10.83 104.785 166.677 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -121.44 142.6 49.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 128.372 3.545 . . . . 10.61 108.344 -175.195 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -118.31 116.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 111.652 -2.522 . . . . 9.13 107.843 177.16 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -101.89 138.51 38.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.218 -2.176 . . . . 20.55 111.126 179.819 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.9 p -98.81 170.35 8.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.688 -2.051 . . . . 11.78 108.421 -172.487 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.3 tp -49.59 -60.63 2.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.738 2.496 . . . . 19.31 117.738 177.688 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.275 17.7 p -74.26 -32.81 63.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 111.587 -2.552 . . . . 23.14 112.144 -178.781 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.17 69.85 0.26 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 118.694 -2.504 . . . . 19.74 114.256 159.919 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -107.92 143.5 36.47 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.795 -0.826 . . . . 21.93 112.982 164.511 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -94.0 98.53 11.08 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.038 1.866 . . . . 12.33 116.038 167.874 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.5 mt -86.06 92.59 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 116.164 -4.085 . . . . 17.08 106.577 176.873 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 m -61.57 127.46 31.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 117.089 -1.434 . . . . 16.3 113.185 164.902 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.403 HD13 HG13 ' A' ' 26' ' ' VAL . 30.8 mt -110.34 150.3 28.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.953 2.901 . . . . 15.88 115.669 163.756 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -104.83 125.19 50.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.6 -3.188 . . . . 28.9 103.824 170.485 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -139.53 156.18 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.57 -2.581 . . . . 12.05 116.489 -171.195 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -105.43 149.3 37.63 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 117.973 -2.954 . . . . 18.17 111.242 168.054 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.68 -25.53 75.75 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 123.947 3.098 . . . . 8.16 113.882 172.776 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 p -81.58 -5.76 58.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.844 1.258 . . . . 11.13 111.777 -175.537 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -74.66 145.93 42.79 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 118.334 2.716 . . . . 18.03 118.334 179.674 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -88.66 154.4 20.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.917 -2.364 . . . . 10.22 108.901 177.451 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 mm -63.29 -27.81 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.843 2.735 . . . . 12.3 112.786 179.511 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -54.06 -54.42 39.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.313 -3.992 . . . . 36.51 112.048 168.075 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.63 -41.34 98.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.583 1.698 . . . . 25.66 115.583 174.562 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 HD13 ' A' ' 15' ' ' LEU . 72.8 t -61.42 -46.14 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 119.597 -1.939 . . . . 8.12 111.937 176.045 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -67.68 -20.67 65.32 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.254 -3.404 . . . . 15.47 114.47 177.986 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.4 -27.85 66.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.579 1.325 . . . . 11.45 114.579 174.361 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -83.75 -29.05 27.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.503 1.127 . . . . 24.98 110.906 175.658 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.95 -29.87 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 120.746 1.612 . . . . 9.46 111.511 165.897 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -76.81 -45.19 29.65 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.47 1.655 . . . . 14.76 115.47 176.649 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.378 20.7 t70 -41.5 -54.97 2.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.521 2.328 . . . . 26.29 112.171 163.058 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -79.32 -61.88 1.87 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 121.377 3.843 . . . . 30.06 121.377 -177.145 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.63 -36.48 16.24 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 115.525 -4.485 . . . . 25.19 105.994 -171.226 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.22 81.15 0.46 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 118.932 -2.355 . . . . 7.41 112.743 -171.112 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.3 mt -135.34 131.01 19.36 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 100.686 -3.82 . . . . 9.49 100.686 170.58 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -69.29 149.43 69.91 Favored 'Trans proline' 0 N--CA 1.434 -2.022 1 CA-C-N 128.604 4.108 . . . . 11.42 115.213 -178.543 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -93.88 4.45 2.92 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 C-N-CA 115.992 -2.205 . . . . 12.0 112.651 -154.102 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.44 -38.97 21.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.523 3.129 . . . . 35.55 105.827 176.236 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -67.67 -37.72 82.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.064 2.946 . . . . 20.52 109.52 174.003 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.36 69.0 mt-30 -83.93 132.55 34.76 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 128.059 3.79 . . . . 7.13 110.189 -176.163 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.416 ' HB3' HG23 ' A' ' 70' ' ' VAL . 45.0 ttt180 -127.31 133.77 50.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 110.786 -2.915 . . . . 36.39 108.997 175.229 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.3 mt -103.92 139.41 39.12 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-O 131.272 5.32 . . . . 9.55 108.507 178.512 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.62 HD12 ' HG2' ' A' ' 49' ' ' GLN . 10.7 mm -123.06 137.22 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 1 O-C-N 115.974 -4.204 . . . . 13.9 111.762 172.449 . . . . . . . . 3 3 . 1 . 125 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -127.01 124.92 40.52 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.933 -4.229 . . . . 6.86 102.629 165.363 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.9 -98.5 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 134.392 5.077 . . . . 11.15 117.717 -173.62 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.04 -18.61 36.37 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 124.71 1.148 . . . . 13.93 114.238 -174.564 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -128.96 133.03 47.67 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.991 2.219 . . . . 23.92 116.991 -166.761 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.62 ' HG2' HD12 ' A' ' 44' ' ' ILE . 33.1 mt-30 -83.04 134.33 35.04 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.08 -1.822 . . . . 23.23 106.08 -170.585 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.0 mt -92.39 132.21 36.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.24 -1.345 . . . . 9.11 111.262 -166.417 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.37 164.76 11.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.872 -3.017 . . . . 33.44 108.163 -176.558 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.75 -57.2 12.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.703 -2.044 . . . . 28.37 115.339 -161.742 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.82 18.94 36.27 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 117.273 -1.849 . . . . 15.0 115.324 -174.711 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.4 mtt-85 -104.5 150.76 24.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.698 1.749 . . . . 25.5 108.615 -178.478 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 p -91.56 153.43 19.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.682 -2.511 . . . . 11.95 110.583 -164.432 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.1 mt -53.68 -35.68 61.35 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.257 2.623 . . . . 10.17 112.797 167.991 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.0 p -70.72 -37.99 73.57 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.662 1.696 . . . . 13.59 115.274 178.652 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -78.93 -29.68 44.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.23 -2.169 . . . . 11.7 109.502 173.45 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -77.79 -2.45 36.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 123.816 3.007 . . . . 12.95 116.882 166.133 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 61.38 34.74 18.18 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 126.039 2.828 . . . . 25.45 114.753 177.884 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.93 116.28 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 113.507 -1.679 . . . . 14.6 114.986 174.543 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -98.29 174.61 6.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.318 -2.845 . . . . 33.23 103.318 -175.234 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -65.5 147.23 53.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.49 1.293 . . . . 25.97 114.49 173.387 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 8.5 mt-10 55.3 25.74 7.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.803 -2.436 . . . . 32.61 113.252 179.73 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -93.96 151.55 19.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.174 -2.346 . . . . 10.56 110.859 169.908 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.5 m -114.09 125.44 53.97 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.138 2.149 . . . . 5.33 108.731 -169.72 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -92.11 151.26 20.5 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 116.895 -3.628 . . . . 11.66 112.983 165.705 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -91.51 135.28 33.97 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.152 -2.536 . . . . 16.3 104.152 172.158 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.5 tp -84.86 125.95 33.06 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.638 -1.914 . . . . 9.96 113.846 154.909 . . . . . . . . 1 1 . 1 . 125 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 42' ' ' ARG . 24.9 m -114.17 165.58 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 127.597 2.359 . . . . 9.76 112.036 168.476 . . . . . . . . 2 2 . 1 . 125 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.0 tp . . . . . 0 N--CA 1.43 -1.454 0 O-C-N 118.904 -2.372 . . . . 19.57 114.319 170.943 . . . . . . . . 0 0 . 1 . 126 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 CA--C 1.49 -1.35 0 N-CA-C 117.855 2.539 . . . . 17.17 117.855 . . . . . . . . . 0 0 . 1 . 126 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -82.05 131.68 35.25 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.059 -1.924 . . . . 21.89 108.536 177.017 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -117.13 176.0 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 123.435 2.834 . . . . 10.83 107.719 160.071 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -135.89 109.79 8.18 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.862 -3.024 . . . . 10.61 111.654 179.659 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.73 128.95 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 120.171 1.351 . . . . 9.13 111.271 -177.629 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -90.68 134.46 34.39 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.296 -1.503 . . . . 20.55 113.0 173.657 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.7 p -88.09 172.08 9.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.273 3.029 . . . . 11.78 113.09 -178.281 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.73 -36.96 79.07 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.204 -4.06 . . . . 19.31 116.772 177.14 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -70.81 -58.5 3.56 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 114.992 -4.817 . . . . 23.14 109.673 172.548 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.96 46.76 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 123.973 1.874 . . . . 19.74 112.241 -176.668 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -96.46 160.09 14.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 105.137 -2.171 . . . . 21.93 105.137 162.309 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.8 m -117.94 121.93 41.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.033 -1.667 . . . . 12.33 110.032 157.003 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.423 HD13 ' HG3' ' A' ' 34' ' ' GLU . 21.1 mt -105.79 120.07 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.021 -1.844 . . . . 17.08 106.021 -168.371 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m -84.44 94.72 8.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.534 -1.212 . . . . 16.3 109.189 -179.145 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 15' ' ' LEU . 96.9 mt -95.43 132.66 40.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 115.161 -2.352 . . . . 15.88 108.485 -175.941 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.273 26.0 tt0 -89.5 102.67 15.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.291 2.314 . . . . 28.9 114.295 173.692 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.411 HG21 HD13 ' A' ' 56' ' ' LEU . 4.1 m -115.5 155.19 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.493 1.951 . . . . 12.05 111.399 -166.999 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.18 152.8 39.83 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 115.72 -2.086 . . . . 18.17 107.671 170.511 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -85.88 -10.08 7.31 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 129.123 4.294 . . . . 8.16 110.14 -164.513 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 p -85.77 -1.75 57.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 118.827 -1.149 . . . . 11.13 112.776 174.616 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -69.6 151.01 46.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.759 -3.713 . . . . 18.03 114.713 -178.878 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 10.2 p -77.26 161.76 27.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.044 -1.836 . . . . 10.22 106.044 177.356 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mm -57.94 -41.32 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 117.071 -3.518 . . . . 12.3 110.946 165.513 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.281 22.6 tt0 -42.42 -44.12 3.87 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.709 2.404 . . . . 36.51 115.215 164.254 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -65.86 -48.4 71.7 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.708 -3.12 . . . . 25.66 114.223 170.68 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.1 t -49.98 -38.77 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.291 -1.506 . . . . 8.12 112.769 177.928 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -76.16 -21.63 56.32 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.417 2.006 . . . . 15.47 116.417 179.522 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.02 -23.82 62.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.921 2.888 . . . . 11.45 113.708 178.357 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -81.99 -33.32 30.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 126.644 3.116 . . . . 24.98 113.763 171.778 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.4 mt -68.72 -43.86 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.612 -1.93 . . . . 9.46 112.529 165.083 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -45.23 -47.48 12.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.275 2.324 . . . . 14.76 117.275 165.188 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -75.85 -54.43 6.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.485 2.714 . . . . 26.29 114.775 -173.012 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -81.12 -70.43 0.53 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.185 1.394 . . . . 30.06 110.951 -169.57 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HG3' HD13 ' A' ' 13' ' ' ILE . 75.3 mm-40 -58.83 -43.35 90.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.002 2.223 . . . . 25.19 117.002 175.085 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.25 13.05 50.18 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 126.38 3.211 . . . . 7.41 120.145 -168.001 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 56.7 mt -76.72 125.29 87.39 Favored Pre-proline 0 N--CA 1.43 -1.439 1 O-C-N 116.381 -4.011 . . . . 9.49 114.019 174.443 . . . . . . . . 3 3 . 1 . 126 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 40.4 Cg_exo -78.06 158.82 30.53 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-O 113.999 -2.584 . . . . 11.42 113.545 -164.477 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -71.12 -23.85 24.29 Favored 'Trans proline' 0 C--N 1.3 -2.026 1 CA-C-N 128.988 4.246 . . . . 12.0 111.149 -170.519 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.46 0.27 30.18 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.509 3.152 . . . . 35.55 119.509 174.805 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.306 60.2 mt-30 -84.24 -25.42 29.43 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.141 -5.35 . . . . 20.52 108.346 169.687 . . . . . . . . 3 2 . 1 . 126 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -92.83 129.44 38.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.684 2.105 . . . . 7.13 116.684 -152.205 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -142.03 120.82 12.68 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 115.689 -2.101 . . . . 36.39 108.803 168.953 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -104.43 138.55 40.66 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 122.593 2.451 . . . . 9.55 110.988 -177.629 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mm -116.14 136.22 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 125.969 1.707 . . . . 13.9 110.75 -177.317 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -108.94 102.9 11.87 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 114.738 -4.976 . . . . 6.86 106.453 161.663 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.2 -77.62 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.784 3.253 . . . . 11.15 119.784 -168.614 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.62 20.87 2.02 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.108 -1.597 . . . . 13.93 109.108 175.906 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -117.19 129.91 56.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.549 -2.736 . . . . 23.92 104.184 -179.588 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -76.48 143.59 40.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.069 -1.878 . . . . 23.23 112.575 179.515 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.2 mt -103.57 111.52 24.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 116.982 -1.485 . . . . 9.11 107.936 -178.389 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -93.88 150.57 20.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.921 2.013 . . . . 33.44 111.733 -177.128 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -39.63 -63.4 0.58 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.635 3.084 . . . . 28.37 115.482 -169.727 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.38 -25.9 64.79 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.815 -1.803 . . . . 15.0 113.702 -159.022 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -83.93 164.35 19.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 114.582 -2.847 . . . . 25.5 112.866 -178.088 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 61.0 p -97.36 169.07 10.01 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.754 1.264 . . . . 11.95 113.836 -171.431 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 17' ' ' VAL . 48.2 mt -63.51 -41.92 98.49 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.193 1.397 . . . . 10.17 112.305 172.903 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 p -55.35 -43.82 75.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.898 2.136 . . . . 13.59 114.561 165.893 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.38 -35.91 76.29 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.245 -3.409 . . . . 11.7 111.676 -174.044 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.332 2.3 m-85 -91.55 6.23 46.48 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 127.975 3.297 . . . . 12.95 111.814 179.974 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.292 8.0 m120 58.87 40.78 22.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.163 2.653 . . . . 25.45 118.163 175.268 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 mm -75.06 131.59 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 104.928 -2.249 . . . . 14.6 104.928 178.361 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -92.21 175.48 6.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.247 -2.783 . . . . 33.23 113.452 169.159 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -63.64 124.0 20.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 131.629 3.972 . . . . 25.97 112.123 169.541 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 68.12 34.54 3.98 Favored 'General case' 0 N--CA 1.43 -1.461 2 O-C-N 112.188 -6.57 . . . . 32.61 107.317 175.907 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.356 61.7 m -90.86 143.72 26.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.783 2.083 . . . . 10.56 108.727 179.308 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 m -84.73 124.35 31.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.109 -2.869 . . . . 5.33 111.754 -176.15 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.76 151.7 29.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.671 -1.893 . . . . 11.66 107.958 179.643 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.296 63.3 m170 -115.49 129.94 56.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.666 2.03 . . . . 16.3 113.546 170.307 . . . . . . . . 2 2 . 1 . 126 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.6 tp -94.09 122.74 36.92 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.353 1.861 . . . . 9.96 113.969 176.467 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 m -114.38 167.03 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 122.955 2.616 . . . . 9.76 111.751 -175.666 . . . . . . . . 1 1 . 1 . 126 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.7 tp . . . . . 0 N--CA 1.43 -1.463 0 O-C-N 124.626 1.204 . . . . 19.57 109.517 176.514 . . . . . . . . 0 0 . 1 . 127 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.49 -1.36 0 N-CA-C 114.273 1.212 . . . . 17.17 114.273 . . . . . . . . . 0 0 . 1 . 127 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -86.5 151.59 23.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.032 -2.211 . . . . 21.89 105.032 -175.288 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 pt -134.86 171.62 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 115.678 -4.389 . . . . 10.83 106.267 152.355 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -112.82 132.91 55.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.233 1.813 . . . . 10.61 107.417 -177.553 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.01 102.21 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.202 -2.518 . . . . 9.13 104.202 176.429 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -87.02 127.26 35.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 128.355 3.931 . . . . 20.55 114.462 -178.967 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.9 p -81.04 170.8 15.76 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 116.043 -4.161 . . . . 11.78 119.149 -178.097 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.5 mt -57.69 -34.85 69.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.107 1.763 . . . . 19.31 114.199 171.012 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.8 p -69.26 -23.55 63.86 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.465 -3.272 . . . . 23.14 112.634 172.554 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.63 -5.18 40.27 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 118.036 -2.915 . . . . 19.74 117.529 -161.167 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -76.3 154.06 35.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 120.232 -0.587 . . . . 21.93 111.969 -177.334 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 m -113.1 126.39 55.42 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.559 -3.213 . . . . 12.33 108.868 175.239 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 mt -114.38 112.73 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 102.091 -3.3 . . . . 17.08 102.091 176.355 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.6 m -95.85 107.24 19.47 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 116.782 -3.699 . . . . 16.3 110.497 -174.706 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.3 mt -112.41 151.36 29.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.022 2.344 . . . . 15.88 115.751 -173.539 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.7 104.81 14.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.592 -1.317 . . . . 28.9 109.611 -177.511 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.28 172.22 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 112.862 0.69 . . . . 12.05 112.862 171.145 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -106.06 174.45 2.6 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 107.833 -1.173 . . . . 18.17 107.833 166.577 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -72.8 -17.73 25.44 Favored 'Trans proline' 0 C--N 1.299 -2.048 0 CA-C-O 116.527 -1.53 . . . . 8.16 110.515 175.156 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 m -90.69 9.24 30.63 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 120.877 1.671 . . . . 11.13 112.161 -174.405 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -94.28 154.33 17.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.401 2.048 . . . . 18.03 107.821 -179.103 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -92.59 164.26 13.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 114.695 1.369 . . . . 10.22 114.695 -177.314 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.276 22.1 mm -56.07 -41.05 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 127.842 2.457 . . . . 12.3 112.487 175.296 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.08 -39.94 69.82 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.427 2.291 . . . . 36.51 115.172 173.285 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -57.46 -38.44 74.5 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 130.962 3.705 . . . . 25.66 115.516 165.622 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.76 -45.46 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 123.998 3.09 . . . . 8.12 108.317 -175.146 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.329 17.9 mtmt -55.7 -36.26 66.98 Favored 'General case' 0 N--CA 1.43 -1.456 1 C-N-CA 132.498 4.319 . . . . 15.47 116.619 171.338 . . . . . . . . 3 2 . 1 . 127 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.35 -38.22 83.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.158 3.021 . . . . 11.45 119.158 167.693 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -76.24 -24.61 54.58 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 115.082 1.512 . . . . 24.98 115.082 176.162 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -79.24 -33.45 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 119.043 -2.286 . . . . 9.46 111.184 178.57 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -62.07 -39.91 94.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.297 -1.32 . . . . 14.76 108.562 168.706 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.7 -40.63 79.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.582 2.438 . . . . 26.29 117.582 -176.696 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -82.31 -59.3 2.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 114.816 -2.516 . . . . 30.06 109.129 176.299 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -87.94 -46.28 9.52 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.333 2.271 . . . . 25.19 109.505 -160.495 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.72 45.12 4.99 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 107.815 -2.114 . . . . 7.41 107.815 175.823 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.259 68.3 mt -98.86 121.22 56.68 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 103.993 -2.595 . . . . 9.49 103.993 173.172 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.327 1.1 Cg_exo -71.79 166.21 30.2 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 127.599 3.75 . . . . 11.42 118.491 -171.007 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.48 -6.09 4.49 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 CA-C-N 124.47 2.632 . . . . 12.0 112.667 -157.398 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -82.71 -29.53 29.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.28 1.613 . . . . 35.55 108.445 172.099 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -80.75 -26.44 37.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.095 1.358 . . . . 20.52 112.744 -175.177 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -83.61 128.93 34.9 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.055 -0.975 . . . . 7.13 112.263 175.906 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -126.1 131.2 52.15 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.971 -1.122 . . . . 36.39 107.971 167.663 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.62 137.9 34.04 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.424 3.49 . . . . 9.55 105.742 176.978 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mt -134.2 136.37 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.102 2.561 . . . . 13.9 110.818 179.698 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -120.86 95.09 4.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.323 -1.732 . . . . 6.86 106.323 -174.393 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.64 -82.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.739 2.415 . . . . 11.15 111.994 -163.223 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.39 -1.49 6.11 Favored Glycine 0 N--CA 1.429 -1.794 0 O-C-N 116.959 -3.588 . . . . 13.93 112.5 171.172 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -83.74 113.25 20.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.708 -2.642 . . . . 23.92 113.488 176.51 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -70.38 142.03 52.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.387 -3.321 . . . . 23.23 109.974 171.794 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -107.55 110.66 22.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.963 -1.495 . . . . 9.11 106.963 -166.323 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -87.77 153.74 21.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.129 -2.857 . . . . 33.44 114.479 -175.906 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.366 1.7 m-20 -48.73 -58.92 4.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.781 2.511 . . . . 28.37 117.781 -160.621 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.96 51.86 0.7 Allowed Glycine 0 N--CA 1.43 -1.756 0 CA-C-O 127.514 3.841 . . . . 15.0 114.73 -171.515 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -128.18 158.78 37.13 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.66 -4.435 . . . . 25.5 109.63 174.459 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.7 p -88.16 159.47 18.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.483 2.087 . . . . 11.95 106.869 -171.184 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.63 -30.33 69.79 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 116.064 -4.147 . . . . 10.17 113.354 169.167 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.2 p -64.91 -20.1 66.27 Favored 'General case' 0 N--CA 1.43 -1.47 1 C-N-CA 135.493 5.517 . . . . 13.59 116.294 176.237 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -82.73 -39.04 22.45 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.466 1.907 . . . . 11.7 112.536 172.31 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -79.69 -19.7 48.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.414 -2.679 . . . . 12.95 117.849 163.079 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.496 32.3 m120 75.26 57.28 0.06 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.745 2.212 . . . . 25.45 113.782 174.187 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mm -85.64 126.79 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 129.048 2.939 . . . . 14.6 106.727 -178.7 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -104.18 167.89 9.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.532 -1.655 . . . . 33.23 106.532 172.981 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -60.5 148.64 37.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.658 2.783 . . . . 25.97 110.816 -175.494 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 60.25 28.48 18.08 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 116.041 1.867 . . . . 32.61 116.041 176.879 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 m -77.09 150.28 35.67 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.18 -1.045 . . . . 10.56 108.18 174.191 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.6 m -98.62 104.16 16.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.799 -2.297 . . . . 5.33 104.799 168.143 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -85.88 133.77 33.94 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.178 -2.283 . . . . 11.66 105.043 168.746 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.262 47.5 p-80 -106.13 145.34 31.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.796 2.713 . . . . 16.3 112.917 176.826 . . . . . . . . 2 2 . 1 . 127 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -104.36 127.47 52.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.687 -2.508 . . . . 9.96 109.8 -171.063 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.75 164.27 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 124.018 3.099 . . . . 9.76 109.52 177.6 . . . . . . . . 1 1 . 1 . 127 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 71' ' ' LEU . 46.9 tp . . . . . 0 N--CA 1.429 -1.485 0 CA-C-N 113.205 -1.816 . . . . 19.57 108.319 -171.294 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.489 -1.37 0 N-CA-C 106.501 -1.666 . . . . 17.17 106.501 . . . . . . . . . 0 0 . 1 . 128 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -114.04 121.16 43.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.401 3.08 . . . . 21.89 104.636 -175.644 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -120.23 162.6 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 126.891 2.619 . . . . 10.83 106.023 165.048 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -124.94 130.06 51.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.006 -2.961 . . . . 10.61 103.006 -169.608 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.2 111.8 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 116.423 -2.111 . . . . 9.13 108.435 172.798 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -78.41 124.32 27.99 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 124.598 3.363 . . . . 20.55 112.077 174.646 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -69.31 164.28 23.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.397 -2.69 . . . . 11.78 117.768 169.503 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.33 -19.37 65.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.373 1.99 . . . . 19.31 116.373 172.241 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -93.15 -20.68 20.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.823 1.786 . . . . 23.14 115.823 179.488 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.73 34.38 2.64 Favored Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 116.421 1.329 . . . . 19.74 116.421 175.374 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -99.62 129.52 45.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.758 1.623 . . . . 21.93 110.187 164.072 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -91.67 119.99 32.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.34 -2.1 . . . . 12.33 105.542 167.915 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.3 7.8 mt -86.11 104.89 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 126.994 2.118 . . . . 17.08 110.353 172.873 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.0 m -84.7 106.77 16.5 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.991 -1.484 . . . . 16.3 108.599 177.433 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.6 mt -110.34 139.84 45.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.913 -1.117 . . . . 15.88 110.01 -178.765 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -96.41 128.62 43.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.254 1.978 . . . . 28.9 106.464 174.215 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -137.11 155.15 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.378 -2.076 . . . . 12.05 108.333 -173.232 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -101.61 129.68 26.24 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 113.703 -3.046 . . . . 18.17 105.851 178.008 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.52 -16.17 46.02 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 CA-C-N 123.834 2.405 . . . . 8.16 114.621 -168.825 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.6 p -94.55 -3.53 49.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 123.083 2.674 . . . . 11.13 110.668 -171.555 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.14 153.3 34.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 127.035 3.302 . . . . 18.03 115.93 175.883 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.7 p -75.36 162.88 28.01 Favored 'General case' 0 N--CA 1.43 -1.469 1 C-N-CA 131.787 4.035 . . . . 10.22 110.982 -178.456 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.293 6.3 mm -71.29 -34.74 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 1 O-C-N 115.392 -4.568 . . . . 12.3 112.546 178.754 . . . . . . . . 3 2 . 1 . 128 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -53.05 -43.27 66.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.241 1.817 . . . . 36.51 112.643 169.006 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -71.08 -22.66 62.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.898 2.184 . . . . 25.66 116.898 170.995 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.9 t -66.07 -43.76 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 1 CA-C-N 126.873 4.397 . . . . 8.12 114.016 166.817 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -59.78 -39.12 83.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.963 2.105 . . . . 15.47 110.275 179.409 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.52 66.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.407 -3.308 . . . . 11.45 119.656 177.954 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -74.9 -33.45 62.04 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.834 2.454 . . . . 24.98 110.877 173.672 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 6.8 mt -75.19 -40.71 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.004 -2.935 . . . . 9.46 110.289 175.322 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.48 -48.82 56.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.499 -2.625 . . . . 14.76 114.6 160.219 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -66.0 -42.85 89.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.588 1.995 . . . . 26.29 114.661 176.827 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -72.85 -69.58 0.4 Allowed 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.016 -2.303 . . . . 30.06 111.959 178.169 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -97.92 -2.01 41.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.523 1.929 . . . . 25.19 114.518 -164.428 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.51 21.43 79.5 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 118.579 2.191 . . . . 7.41 118.579 174.526 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 98.0 mt -98.91 130.12 28.26 Favored Pre-proline 0 N--CA 1.431 -1.421 0 O-C-N 116.794 -3.768 . . . . 9.49 102.623 -169.153 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -76.92 154.81 33.91 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 117.928 -1.67 . . . . 11.42 110.021 -172.105 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.344 9.7 Cg_endo -63.96 -30.16 66.94 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 123.463 2.775 . . . . 12.0 115.25 -169.525 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -63.63 -31.84 73.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.558 3.54 . . . . 35.55 120.558 -179.206 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -70.06 -34.53 73.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.853 -2.404 . . . . 20.52 114.39 166.777 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -64.25 103.79 0.67 Allowed 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.337 -4.602 . . . . 7.13 121.327 178.743 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -102.77 125.25 49.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.556 -2.59 . . . . 36.39 110.897 163.332 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.7 mt -96.61 139.17 33.08 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.649 1.214 . . . . 9.55 111.872 170.329 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.9 mt -133.13 122.26 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 129.337 3.055 . . . . 13.9 109.534 173.035 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -93.44 112.58 24.53 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.981 2.912 . . . . 6.86 108.696 164.106 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.27 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 127.877 2.471 . . . . 11.15 114.128 -177.51 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 27.86 2.5 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 127.711 2.576 . . . . 13.93 111.757 166.431 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -104.95 137.09 43.24 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.975 2.91 . . . . 23.92 111.949 172.662 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -99.46 124.14 44.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.535 1.516 . . . . 23.23 112.415 -172.535 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.9 mt -97.59 137.35 36.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.575 -2.578 . . . . 9.11 110.666 -171.307 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -118.69 135.17 54.62 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 127.128 3.346 . . . . 33.44 104.122 -166.193 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -43.53 -37.33 2.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 113.793 -3.003 . . . . 28.37 118.82 -166.502 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.6 11.66 27.95 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 107.001 -2.439 . . . . 15.0 107.001 -167.935 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -91.0 160.29 15.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.521 -3.929 . . . . 25.5 103.549 168.399 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.2 p -103.88 170.09 8.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.75 -1.843 . . . . 11.95 108.983 -170.329 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -57.64 -42.23 83.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 124.001 1.857 . . . . 10.17 114.226 168.751 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.3 p -62.89 -18.46 63.01 Favored 'General case' 0 N--CA 1.43 -1.459 1 N-CA-C 122.661 4.319 . . . . 13.59 122.661 173.303 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -77.96 -41.43 36.18 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.289 -4.632 . . . . 11.7 112.656 -173.667 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -86.08 -10.68 54.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.655 -1.612 . . . . 12.95 111.802 179.078 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.316 71.9 m-20 71.11 54.88 0.23 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.89 3.276 . . . . 25.45 113.232 -176.517 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.285 59.6 mt -89.28 108.6 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 127.933 3.27 . . . . 14.6 113.623 -179.352 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -89.34 176.24 7.01 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.515 3.526 . . . . 33.23 113.396 -166.404 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -69.14 139.32 54.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.474 2.027 . . . . 25.97 116.474 172.173 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 50.59 68.71 0.73 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.689 1.868 . . . . 32.61 112.771 -171.793 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -125.24 156.97 37.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.898 2.879 . . . . 10.56 103.536 176.485 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.0 m -126.37 124.81 41.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 124.413 1.071 . . . . 5.33 109.292 -178.086 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.04 167.39 10.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.223 3.009 . . . . 11.66 109.332 -179.583 . . . . . . . . 1 1 . 1 . 128 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.73 158.81 43.47 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.475 2.559 . . . . 16.3 112.184 179.056 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -118.04 136.82 53.31 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.162 -4.087 . . . . 9.96 103.382 -168.597 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.81 172.95 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.295 -1.743 . . . . 9.76 106.295 -175.522 . . . . . . . . 2 2 . 1 . 128 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.431 -1.416 0 C-N-CA 115.845 -2.342 . . . . 19.57 111.773 176.787 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 124.209 1.957 . . . . 17.17 109.691 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -98.41 145.96 26.21 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 113.94 -5.475 . . . . 21.89 115.352 -176.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 pt -127.52 -176.49 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.414 -3.18 . . . . 10.83 102.414 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -121.61 130.47 53.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.901 -1.954 . . . . 10.61 116.084 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.75 132.66 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 122.371 2.35 . . . . 9.13 107.289 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -117.89 128.32 54.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.618 -1.623 . . . . 20.55 106.618 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.8 p -74.35 179.64 4.46 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.256 1.947 . . . . 11.78 116.256 170.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.03 -58.46 8.07 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.388 2.518 . . . . 19.31 117.571 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.94 -38.97 93.16 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 126.537 3.065 . . . . 23.14 114.55 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.27 49.57 0.27 Allowed Glycine 0 N--CA 1.431 -1.699 0 CA-C-N 111.589 -2.55 . . . . 19.74 115.667 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -89.74 129.55 36.13 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.613 -4.463 . . . . 21.93 109.235 160.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.2 m -92.01 126.7 37.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 117.316 -1.754 . . . . 12.33 114.243 169.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 94.8 mt -102.91 103.53 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 C-N-CA 132.39 4.276 . . . . 17.08 105.505 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.9 m -74.66 131.52 40.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.264 -2.773 . . . . 16.3 106.787 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 tp -143.3 128.62 18.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 115.979 -1.962 . . . . 15.88 115.735 -166.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -103.4 142.95 33.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.222 1.963 . . . . 28.9 114.383 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.414 HG11 HG22 ' A' ' 26' ' ' VAL . 6.8 m -157.72 165.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.167 1.937 . . . . 12.05 111.128 -158.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.47 124.35 25.07 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.673 -2.584 . . . . 18.17 111.819 -172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.29 -20.85 9.5 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 C-N-CA 124.267 3.311 . . . . 8.16 116.677 -154.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.1 p -95.66 7.23 46.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.412 1.885 . . . . 11.13 113.687 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.94 177.29 5.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 105.129 -2.174 . . . . 18.03 105.129 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.7 p -104.31 173.23 6.39 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.596 2.141 . . . . 10.22 111.215 -158.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.38 26.1 mm -65.33 -29.48 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 127.825 3.679 . . . . 12.3 113.737 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -55.8 -40.66 73.02 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 115.276 -4.64 . . . . 36.51 114.526 164.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.98 -26.8 66.99 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.883 -1.127 . . . . 25.66 113.46 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.414 HG22 HG11 ' A' ' 17' ' ' VAL . 4.4 t -71.79 -43.22 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 115.145 -2.622 . . . . 8.12 110.577 175.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -63.41 -33.62 75.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.534 -2.604 . . . . 15.47 117.2 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -14.92 58.62 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.798 3.259 . . . . 11.45 119.798 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -84.97 -39.12 18.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.056 -2.278 . . . . 24.98 114.162 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 mt -63.3 -40.94 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 130.066 3.347 . . . . 9.46 112.666 170.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -68.03 -31.47 71.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.343 1.457 . . . . 14.76 114.07 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.257 43.2 t0 -71.1 -59.75 2.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.574 -3.204 . . . . 26.29 108.278 172.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.301 3.6 tppp? -51.08 -67.34 0.26 Allowed 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 121.251 3.797 . . . . 30.06 121.251 -176.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -89.51 -48.0 7.6 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.7 1.37 . . . . 25.19 114.7 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.52 71.77 1.09 Allowed Glycine 0 N--CA 1.43 -1.755 0 O-C-N 127.381 2.926 . . . . 7.41 114.883 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mt -128.75 132.37 24.32 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 103.676 -2.713 . . . . 9.49 103.676 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -82.96 158.31 15.62 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 CA-C-N 124.931 2.797 . . . . 11.42 112.9 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -73.85 -20.94 19.21 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 123.373 2.715 . . . . 12.0 110.86 -153.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -65.64 -41.31 92.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.306 2.243 . . . . 35.55 112.755 167.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.61 -34.53 53.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.68 -1.263 . . . . 20.52 112.406 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.13 124.17 19.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 121.123 3.749 . . . . 7.13 121.123 165.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -127.35 120.2 27.98 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.612 1.195 . . . . 36.39 109.169 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.484 ' O ' HD22 ' A' ' 50' ' ' LEU . 83.3 mt -111.7 120.17 41.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.082 -2.261 . . . . 9.55 106.68 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.68 112.29 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 129.768 3.227 . . . . 13.9 112.944 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -99.2 120.85 40.19 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.939 2.304 . . . . 6.86 106.403 165.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 65.29 -102.08 0.08 Allowed 'General case' 0 N--CA 1.431 -1.422 1 CA-C-O 129.27 4.367 . . . . 11.15 116.146 -177.591 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.34 55.18 0.59 Allowed Glycine 0 N--CA 1.43 -1.752 1 O-C-N 114.782 -4.949 . . . . 13.93 109.047 160.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.254 31.9 ttmt -135.08 139.23 44.57 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.9 1.68 . . . . 23.92 106.688 163.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -82.51 133.95 35.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.052 -1.03 . . . . 23.23 110.934 165.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.484 HD22 ' O ' ' A' ' 43' ' ' LEU . 1.2 mm? -77.79 131.01 37.41 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.073 1.879 . . . . 9.11 116.073 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -75.68 160.02 30.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.813 2.72 . . . . 33.44 108.458 -175.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.81 -52.95 20.66 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.665 -4.397 . . . . 28.37 110.042 -167.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.37 23.65 35.07 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 129.649 3.5 . . . . 15.0 112.588 -160.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.1 mtt-85 -116.65 160.7 20.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.808 2.122 . . . . 25.5 106.811 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 p -95.0 177.81 5.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.427 2.537 . . . . 11.95 113.438 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.17 -29.95 48.83 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.718 -3.114 . . . . 10.17 112.647 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 m -62.13 -19.56 63.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.347 1.61 . . . . 13.59 115.347 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.6 -46.27 22.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.525 -1.657 . . . . 11.7 106.525 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -73.5 -31.47 63.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.389 -1.732 . . . . 12.95 113.33 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 87.1 53.16 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.486 3.514 . . . . 25.45 107.52 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.1 mt -101.34 132.3 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.412 -3.181 . . . . 14.6 102.412 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -128.27 177.11 7.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.001 2.52 . . . . 33.23 113.008 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -51.31 128.08 21.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.011 2.339 . . . . 25.97 116.807 172.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 63.72 52.24 2.25 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.361 2.029 . . . . 32.61 116.277 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.7 m -113.45 146.04 40.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.084 2.954 . . . . 10.56 106.031 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.3 m -101.3 118.66 37.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.23 1.967 . . . . 5.33 115.769 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.9 145.8 34.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.395 -3.316 . . . . 11.66 105.78 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -109.27 128.47 55.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 125.385 2.517 . . . . 16.3 113.659 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.3 tp -102.6 111.47 23.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.592 2.357 . . . . 9.96 106.787 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.22 174.35 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 102.87 -3.011 . . . . 9.76 102.87 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 mt -105.46 171.87 7.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.225 1.488 . . . . 19.57 113.687 -169.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -119.51 111.07 17.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.284 3.421 . . . . 35.08 107.403 167.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.8 mt -99.15 -139.5 0.31 Allowed 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 112.782 -6.199 . . . . 32.31 107.186 165.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.42 -69.81 0.68 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.463 -2.648 . . . . 42.75 110.393 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.73 174.31 54.81 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.019 -1.676 . . . . 36.31 112.642 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.772 0 N-CA-C 108.428 -1.869 . . . . 36.27 108.428 178.374 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.213 -0.662 . . . . 17.17 109.213 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -113.58 143.33 44.74 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 100.366 -3.938 . . . . 21.89 100.366 -170.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -119.32 164.91 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.447 -2.033 . . . . 10.83 108.352 170.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 65.9 m-85 -98.83 122.41 42.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.117 -2.92 . . . . 10.61 103.117 170.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.7 113.53 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.564 -2.585 . . . . 9.13 108.36 154.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -84.61 134.58 34.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.842 -2.411 . . . . 20.55 113.309 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 18.6 p -89.56 179.73 5.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.297 -3.377 . . . . 11.78 106.377 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -71.83 -44.53 63.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 128.171 3.843 . . . . 19.31 111.91 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.1 p -79.97 -78.52 0.16 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 109.382 -3.554 . . . . 23.14 115.642 -168.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.24 50.1 0.21 Allowed Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 119.575 1.079 . . . . 19.74 113.377 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 tttt -139.98 137.15 34.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.77 -1.429 . . . . 21.93 111.627 163.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -119.7 103.18 9.16 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.592 2.615 . . . . 12.33 110.535 171.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 83.8 mt -79.59 120.42 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 114.506 -2.664 . . . . 17.08 107.704 -165.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 p -105.12 94.04 5.02 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 123.364 2.802 . . . . 16.3 108.74 -172.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.67 116.17 31.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.934 2.493 . . . . 15.88 109.031 -158.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.406 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 7.1 pt-20 -73.41 119.32 17.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.123 1.369 . . . . 28.9 111.846 173.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.79 178.6 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 113.888 -1.505 . . . . 12.05 108.802 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.17 158.33 44.67 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 126.524 2.39 . . . . 18.17 106.394 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -70.02 -3.76 12.84 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 N-CA-C 118.666 2.525 . . . . 8.16 118.666 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 p -90.84 -0.51 57.74 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.121 4.168 . . . . 11.13 109.834 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.66 147.18 35.64 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.446 1.93 . . . . 18.03 112.06 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 23' ' ' ILE . 41.5 p -92.0 -165.94 1.45 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.809 -2.432 . . . . 10.22 111.804 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.403 ' H ' ' HB ' ' A' ' 22' ' ' THR . 37.3 mm -85.76 -39.24 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.278 2.631 . . . . 12.3 105.611 175.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.4 -33.24 69.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.265 -3.397 . . . . 36.51 116.65 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.02 -56.65 15.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.925 1.345 . . . . 25.66 110.8 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -53.17 -47.19 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.199 -1.563 . . . . 8.12 113.7 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -54.53 -39.21 67.44 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.783 -3.073 . . . . 15.47 114.761 171.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -32.92 71.13 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.241 -3.412 . . . . 11.45 114.73 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -81.14 -23.6 38.2 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.396 1.093 . . . . 24.98 109.45 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.36 -25.73 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 117.307 -3.371 . . . . 9.46 113.184 169.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -75.49 -30.2 59.8 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.941 2.496 . . . . 14.76 109.675 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.7 -55.95 19.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.477 -2.014 . . . . 26.29 108.482 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -79.83 -43.31 22.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 116.545 -1.693 . . . . 30.06 112.333 -161.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -104.35 -44.05 5.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.462 1.028 . . . . 25.19 108.603 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.34 37.99 4.14 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 121.109 -0.995 . . . . 7.41 111.449 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.7 mt -101.58 135.74 19.74 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 108.036 -1.098 . . . . 9.49 108.036 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -65.36 137.94 53.33 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 C-N-CA 123.258 2.639 . . . . 11.42 113.567 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -68.31 -19.54 43.8 Favored 'Trans proline' 0 C--N 1.3 -1.988 1 C-N-CA 126.065 4.51 . . . . 12.0 118.178 -172.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -87.74 -27.28 22.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.948 1.699 . . . . 35.55 112.769 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.07 -40.37 82.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.106 2.162 . . . . 20.52 109.471 165.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.91 129.75 43.37 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.699 2.852 . . . . 7.13 118.699 167.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -130.44 129.16 42.65 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.94 -4.225 . . . . 36.39 110.823 168.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.2 mt -112.93 129.08 56.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.856 1.262 . . . . 9.55 110.145 -173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -130.5 140.09 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.988 1.852 . . . . 13.9 107.17 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.57 -75.83 0.51 Allowed 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 114.738 -2.785 . . . . 6.86 112.187 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.61 -66.06 1.01 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.319 -2.845 . . . . 11.15 103.319 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.85 10.11 2.09 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 127.068 2.271 . . . . 13.93 115.523 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -112.26 142.1 45.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.287 1.042 . . . . 23.92 109.451 170.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -86.23 145.88 26.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.24 1.416 . . . . 23.23 107.784 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.03 130.12 45.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.067 -3.521 . . . . 9.11 110.324 -171.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -103.89 151.32 23.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 118.31 -1.356 . . . . 33.44 109.979 -171.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -47.78 -53.53 15.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.733 2.864 . . . . 28.37 118.733 -152.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.94 50.82 0.74 Allowed Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 126.644 2.068 . . . . 15.0 114.465 -166.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -127.21 160.04 32.49 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.423 1.889 . . . . 25.5 109.899 154.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.341 48.0 p -79.24 164.17 24.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.041 2.536 . . . . 11.95 111.269 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.86 -31.22 72.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.829 1.776 . . . . 10.17 111.875 165.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -68.15 -31.09 70.4 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.7 -2.5 . . . . 13.59 114.919 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -71.99 -48.2 46.55 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.335 1.854 . . . . 11.7 106.596 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -74.15 -11.3 60.26 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.67 2.841 . . . . 12.95 118.67 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m120 69.24 49.01 0.63 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.753 2.021 . . . . 25.45 113.896 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.4 mt -105.24 108.01 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.333 -2.839 . . . . 14.6 103.333 173.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -101.5 -172.81 2.22 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.638 3.589 . . . . 33.23 109.859 -166.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp -61.59 126.75 28.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.208 -3.432 . . . . 25.97 113.898 169.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 41.7 mt-10 64.78 27.8 12.96 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.403 2.742 . . . . 32.61 118.403 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.2 m -90.67 154.44 19.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.056 2.836 . . . . 10.56 105.073 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 10.9 m -98.76 126.98 44.54 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.361 -2.2 . . . . 5.33 105.249 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.4 mt -102.48 149.66 24.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.44 -2.037 . . . . 11.66 113.259 153.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -93.71 129.09 40.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.081 2.219 . . . . 16.3 112.246 172.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 10.4 tp -96.31 126.3 41.42 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.153 2.981 . . . . 9.96 109.466 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.71 126.21 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 113.713 -1.585 . . . . 9.76 108.602 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.7 mt -106.97 -178.75 3.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.795 1.934 . . . . 19.57 110.865 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -82.24 111.61 18.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.593 -3.192 . . . . 35.08 110.792 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.36 -52.11 3.32 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.445 -3.539 . . . . 32.31 101.445 172.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -101.99 -73.19 0.66 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 116.402 -3.936 . . . . 42.75 114.242 -175.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.31 140.62 3.36 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-O 117.194 -1.892 . . . . 36.31 110.253 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.76 0 CA-C-N 120.235 2.018 . . . . 36.27 116.515 -169.438 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 122.143 0.973 . . . . 17.17 113.216 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -80.12 109.78 14.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.969 -2.332 . . . . 21.89 111.863 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -96.67 154.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 116.106 -1.902 . . . . 10.83 113.984 165.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.283 21.2 m-85 -101.79 113.56 26.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.252 1.842 . . . . 10.61 111.398 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.2 t -111.67 95.77 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 101.01 -3.7 . . . . 9.13 101.01 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 12' ' ' THR 0.284 55.5 tttt -87.5 126.97 35.23 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.169 -1.832 . . . . 20.55 114.492 -167.04 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.1 p -83.46 158.04 22.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.265 1.983 . . . . 11.78 113.554 -173.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -74.1 -27.66 60.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.101 -3.5 . . . . 19.31 107.996 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -62.25 -60.24 3.86 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.873 -4.267 . . . . 23.14 113.77 175.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.12 41.98 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.755 0 O-C-N 117.109 -3.494 . . . . 19.74 114.566 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -140.21 163.11 33.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.868 2.834 . . . . 21.93 105.784 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 8.1 m -128.53 123.05 32.52 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.955 2.659 . . . . 12.33 106.073 174.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -83.49 119.84 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.991 -1.693 . . . . 17.08 113.96 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 p -81.47 90.72 6.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.657 -2.527 . . . . 16.3 114.996 165.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 tp -94.39 118.9 32.33 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.387 2.275 . . . . 15.88 108.184 -167.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -81.51 109.4 15.93 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.544 -1.348 . . . . 28.9 112.456 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.07 171.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 127.76 2.424 . . . . 12.05 110.243 167.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -108.27 173.94 2.74 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 126.673 1.989 . . . . 18.17 107.273 158.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -71.32 -3.09 12.28 Favored 'Trans proline' 0 N--CA 1.434 -2.015 1 C-N-CA 125.601 4.201 . . . . 8.16 113.136 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -88.7 -25.42 22.35 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 111.634 -2.53 . . . . 11.13 111.276 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.8 138.64 46.53 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.594 2.14 . . . . 18.03 113.121 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -91.2 177.7 6.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.267 -1.788 . . . . 10.22 108.309 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -82.26 -22.09 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.084 -1.01 . . . . 12.3 109.318 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -61.26 -37.74 84.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.665 1.986 . . . . 36.51 114.483 161.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -68.5 -25.8 65.14 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 118.931 -2.356 . . . . 25.66 115.452 167.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.1 t -64.79 -56.68 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 128.493 2.717 . . . . 8.12 111.115 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -56.46 -30.1 62.48 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 117.336 2.347 . . . . 15.47 117.336 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.67 -45.53 64.91 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.308 2.243 . . . . 11.45 111.84 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -69.74 -34.91 74.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.797 2.439 . . . . 24.98 112.454 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.9 mt -73.02 -27.24 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 113.489 0.922 . . . . 9.46 113.489 166.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.256 16.6 tt0 -66.9 -33.04 74.71 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.662 -5.649 . . . . 14.76 111.504 170.327 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.56 -58.46 4.25 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.45 2.7 . . . . 26.29 115.281 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -63.67 -71.97 0.15 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 114.808 1.411 . . . . 30.06 114.808 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -96.66 -22.39 17.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.326 -2.734 . . . . 25.19 113.222 -169.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.58 31.76 8.6 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.487 -1.383 . . . . 7.41 114.484 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.6 mt -97.03 126.17 43.39 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 114.65 -2.595 . . . . 9.49 106.606 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.26 0.1 OUTLIER -68.2 160.35 49.2 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 124.599 1.842 . . . . 11.42 114.969 -176.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -74.9 -11.76 21.7 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 123.321 2.222 . . . . 12.0 113.905 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -77.51 -7.84 56.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.987 -2.946 . . . . 35.55 112.969 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -110.22 -18.94 13.18 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.398 -2.064 . . . . 20.52 110.045 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -80.61 108.87 14.61 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 121.034 3.716 . . . . 7.13 121.034 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -104.7 153.21 21.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.583 -1.189 . . . . 36.39 110.351 160.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -127.46 141.99 51.52 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.444 -2.035 . . . . 9.55 112.665 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 pt -130.09 164.66 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 106.976 -1.491 . . . . 13.9 106.976 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.88 -88.77 0.17 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.325 2.266 . . . . 6.86 111.345 167.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.98 -61.79 1.39 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.261 -3.399 . . . . 11.15 104.542 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.37 -37.84 0.9 Allowed Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 118.696 2.238 . . . . 13.93 118.696 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -71.38 128.98 37.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.312 2.338 . . . . 23.92 117.312 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -75.29 118.17 17.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.515 -2.616 . . . . 23.23 112.005 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.7 mt -72.52 132.61 44.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.142 2.401 . . . . 9.11 111.144 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.272 28.7 mt-10 -97.09 155.66 16.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.427 -2.064 . . . . 33.44 105.427 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.81 -62.1 1.62 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.56 3.144 . . . . 28.37 112.392 -166.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.38 21.72 30.55 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 124.906 3.503 . . . . 15.0 115.249 -157.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.503 HH21 ' CG ' ' A' ' 58' ' ' ASP . 72.2 mtp180 -115.97 156.22 26.65 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 121.106 2.453 . . . . 25.5 108.375 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.9 p -84.73 163.65 19.03 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.007 -2.933 . . . . 11.95 111.206 -169.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.8 mt -73.34 -13.6 61.14 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.965 -4.834 . . . . 10.17 114.869 170.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 t -70.19 -39.14 75.39 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.499 -3.251 . . . . 13.59 108.665 167.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.503 ' CG ' HH21 ' A' ' 54' ' ' ARG . 16.7 t0 -63.29 -40.34 97.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.983 1.845 . . . . 11.7 115.983 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -79.4 -31.3 42.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 117.3 -1.333 . . . . 12.95 111.833 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.274 68.7 m-80 72.77 54.02 0.14 Allowed 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.365 4.266 . . . . 25.45 106.829 -176.835 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.3 mt -98.51 106.95 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.217 3.007 . . . . 14.6 107.704 169.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -102.94 -166.5 1.28 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.368 -2.083 . . . . 33.23 111.567 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -66.33 135.62 54.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.425 1.49 . . . . 25.97 110.063 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.359 51.4 mt-10 65.37 40.91 4.52 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.229 1.566 . . . . 32.61 115.229 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 t -109.13 149.48 29.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.565 -3.834 . . . . 10.56 111.055 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.295 78.2 m -97.66 109.55 22.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.814 1.646 . . . . 5.33 110.1 -170.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.1 mt -108.13 155.11 20.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.745 -1.946 . . . . 11.66 105.745 171.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -120.3 137.34 54.31 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.143 -1.598 . . . . 16.3 113.569 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.1 tp -91.75 110.35 21.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.193 -1.367 . . . . 9.96 111.611 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.97 144.79 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 127.846 2.459 . . . . 9.76 112.162 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -107.16 170.64 7.83 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 115.205 -4.685 . . . . 19.57 110.483 -175.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -109.26 164.66 12.26 Favored 'General case' 0 N--CA 1.43 -1.434 1 N-CA-C 99.791 -4.152 . . . . 35.08 99.791 -175.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.2 tp -89.36 -61.44 1.7 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.383 -2.08 . . . . 32.31 105.383 163.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 75' ' ' GLY . 16.4 tpp180 -167.44 -91.77 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.79 -3.693 . . . . 42.75 110.694 -166.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' A' ' 74' ' ' ARG . . . -108.26 120.16 5.91 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 106.58 -2.608 . . . . 36.31 106.58 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.792 0 CA-C-O 113.971 -3.683 . . . . 36.27 107.32 -178.549 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.57 ' HB2' ' HG3' ' A' ' 63' ' ' LYS 0.25 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.331 0 N-CA-C 115.738 1.755 . . . . 17.17 115.738 . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.34 29.9 mt-30 -103.16 145.2 30.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.159 3.022 . . . . 21.89 119.159 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.32 29.3 pt -123.36 155.12 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 122.483 2.401 . . . . 10.83 106.679 166.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -112.12 137.43 50.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.396 -2.184 . . . . 10.61 108.505 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.22 123.07 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 123.023 1.392 . . . . 9.13 111.253 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -100.14 125.79 46.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.001 -1.952 . . . . 20.55 113.434 -170.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.3 p -83.48 173.85 11.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.28 1.215 . . . . 11.78 114.28 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.7 tp -71.84 -43.06 66.18 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.836 1.779 . . . . 19.31 112.878 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -67.56 -23.05 65.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.003 -1.061 . . . . 23.14 109.603 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.53 10.9 8.29 Favored Glycine 0 N--CA 1.429 -1.786 1 N-CA-C 123.781 4.272 . . . . 19.74 123.781 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -86.49 146.35 26.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.112 -2.551 . . . . 21.93 104.112 -171.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 m -110.16 104.62 13.49 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.588 0.709 . . . . 12.33 112.736 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -84.04 129.23 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.69 2.796 . . . . 17.08 112.401 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -106.19 116.56 32.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.982 -2.324 . . . . 16.3 113.196 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.271 0.6 OUTLIER -118.77 131.4 56.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.642 1.839 . . . . 15.88 106.177 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -94.49 122.09 36.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.197 -2.815 . . . . 28.9 108.46 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.18 174.38 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.059 -1.428 . . . . 12.05 113.462 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -103.05 -173.97 0.32 Allowed Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 103.829 -2.656 . . . . 18.17 103.829 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -74.41 -29.5 9.25 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 C-N-CA 127.309 5.34 . . . . 8.16 110.184 160.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 94.7 p -68.25 -28.55 67.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.797 2.888 . . . . 11.13 118.797 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -71.86 162.35 29.58 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.728 1.251 . . . . 18.03 112.94 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.6 p -104.61 175.25 5.55 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.83 -3.669 . . . . 10.22 112.389 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -65.24 -25.39 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.652 -2.53 . . . . 12.3 113.122 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.13 -37.76 88.47 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 117.726 2.491 . . . . 36.51 117.726 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 28.2 m120 -62.84 -43.4 98.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.363 1.246 . . . . 25.66 114.363 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -54.44 -38.2 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 126.095 1.758 . . . . 8.12 107.506 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -75.72 -26.66 57.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.409 -1.432 . . . . 15.47 113.16 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.11 74.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.964 -2.96 . . . . 11.45 109.073 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 50.4 mttm -72.23 -43.24 64.72 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.801 3.641 . . . . 24.98 114.424 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 91.2 mt -55.25 -40.04 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 128.224 3.869 . . . . 9.46 117.503 164.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -63.37 -44.28 95.24 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 110.904 -7.372 . . . . 14.76 114.584 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.14 -50.99 68.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.395 2.739 . . . . 26.29 118.395 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -67.49 -56.4 9.7 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.714 2.005 . . . . 30.06 115.582 -175.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -98.58 -22.78 15.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.688 1.595 . . . . 25.19 113.525 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.59 23.39 31.16 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 125.601 2.778 . . . . 7.41 116.464 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 mt -102.7 120.11 53.78 Favored Pre-proline 0 N--CA 1.43 -1.441 1 O-C-N 115.553 -4.498 . . . . 9.49 104.21 -168.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -66.6 150.39 83.87 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 CA-C-N 126.784 3.459 . . . . 11.42 116.95 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -85.98 -4.75 8.82 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 CA-C-O 115.513 -1.953 . . . . 12.0 114.244 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -70.48 -36.37 73.82 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.38 1.9 . . . . 35.55 110.27 165.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -70.07 -28.43 65.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.053 2.541 . . . . 20.52 112.817 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -83.38 130.77 35.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 126.24 2.924 . . . . 7.13 116.229 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -122.14 135.8 54.83 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 103.692 -2.707 . . . . 36.39 103.692 170.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.2 mt -113.67 137.33 51.76 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 124.253 0.97 . . . . 9.55 109.643 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 pt -123.4 169.44 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 117.305 -1.758 . . . . 13.9 110.893 171.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.414 ' HB3' ' H ' ' A' ' 46' ' ' ALA . 17.5 t80 -85.61 -90.46 0.1 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 117.217 -1.793 . . . . 6.86 106.681 161.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' H ' ' HB3' ' A' ' 45' ' ' PHE . . . -111.8 -16.55 13.15 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.023 1.86 . . . . 11.15 116.023 171.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.55 -32.63 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 O-C-N 117.782 -3.074 . . . . 13.93 115.931 172.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -76.99 135.24 38.68 Favored 'General case' 0 N--CA 1.43 -1.465 1 CA-C-O 129.406 4.431 . . . . 23.92 109.482 174.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -75.83 152.48 37.25 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 114.584 -5.073 . . . . 23.23 117.866 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.0 mt -118.31 117.71 29.82 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.457 -2.027 . . . . 9.11 106.19 -171.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -108.2 151.6 25.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.579 3.085 . . . . 33.44 114.73 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.335 2.1 m-20 -37.06 -70.48 0.09 Allowed 'General case' 0 N--CA 1.429 -1.484 1 C-N-CA 134.754 5.222 . . . . 28.37 113.827 -166.47 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.37 23.15 33.29 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 116.958 -2.544 . . . . 15.0 117.04 -156.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -105.71 161.32 14.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.206 1.503 . . . . 25.5 111.477 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.3 p -91.03 170.18 10.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.678 -3.139 . . . . 11.95 112.465 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.64 -38.78 84.33 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 117.92 -2.987 . . . . 10.17 113.675 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.59 -39.21 16.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.438 -3.289 . . . . 13.59 112.153 162.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -82.69 -32.57 27.99 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 119.7 -1.875 . . . . 11.7 112.281 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.287 77.0 m-85 -88.72 -7.78 55.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.676 1.58 . . . . 12.95 111.438 170.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 m120 81.23 29.83 0.16 Allowed 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 131.721 4.009 . . . . 25.45 108.415 166.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mt -75.99 132.54 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 117.72 -3.113 . . . . 14.6 104.099 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -96.43 -177.51 3.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.199 -1.819 . . . . 33.23 113.117 -171.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.57 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 19.8 ttpp -69.51 131.08 44.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.653 -1.905 . . . . 25.97 106.551 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 53.29 59.34 4.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.208 1.403 . . . . 32.61 108.145 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 t -98.84 147.42 24.95 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.799 -1.186 . . . . 10.56 107.799 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -90.6 114.52 26.8 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.869 1.356 . . . . 5.33 108.306 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 mt -100.76 154.63 18.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.927 -1.733 . . . . 11.66 109.473 167.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -108.7 132.21 54.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.254 2.454 . . . . 16.3 111.016 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 tp -102.0 128.39 48.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.53 -3.231 . . . . 9.96 109.221 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.8 98.47 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 112.492 -2.14 . . . . 9.76 107.031 -167.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.33 -159.3 0.3 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.486 2.402 . . . . 19.57 117.486 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -101.49 100.92 11.42 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 116.385 -3.947 . . . . 35.08 110.651 173.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 tp -102.73 -62.35 1.29 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.677 1.126 . . . . 32.31 111.541 -171.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.32 -83.46 0.15 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 101.858 -3.386 . . . . 42.75 101.858 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.3 150.09 21.58 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 122.871 2.578 . . . . 36.31 115.57 168.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 O-C-N 116.955 -3.674 . . . . 36.27 111.445 173.617 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 116.606 -1.664 . . . . 17.17 112.437 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.86 138.77 31.29 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 125.809 1.943 . . . . 21.89 109.868 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.5 pt -119.97 148.52 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 129.797 3.239 . . . . 10.83 104.664 158.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -100.41 118.9 37.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.367 1.467 . . . . 10.61 112.944 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.81 122.52 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 116.891 -3.631 . . . . 9.13 112.114 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -102.3 141.94 34.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.187 -1.005 . . . . 20.55 109.76 -173.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.6 p -84.66 176.15 8.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.089 -2.257 . . . . 11.78 110.8 171.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -60.74 -49.95 75.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.495 -2.628 . . . . 19.31 114.427 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 66.2 p -62.53 -57.36 11.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.901 3.68 . . . . 23.14 109.257 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.0 49.43 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 126.797 2.141 . . . . 19.74 110.767 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -93.17 143.73 25.97 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.794 -3.18 . . . . 21.93 112.01 161.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.272 25.1 m -108.85 107.28 17.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 126.285 2.945 . . . . 12.33 113.801 -176.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -86.09 117.37 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 110.151 -3.204 . . . . 17.08 109.287 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.461 ' O ' HD13 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -102.47 131.2 49.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.921 -1.737 . . . . 16.3 109.333 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 14' ' ' THR . 1.6 mm? -123.55 134.37 53.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.892 -1.151 . . . . 15.88 107.892 176.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -109.7 114.57 28.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.772 -1.936 . . . . 28.9 105.772 -170.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.9 177.59 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 104.784 -2.302 . . . . 12.05 104.784 -152.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -111.42 171.1 4.6 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 126.828 2.051 . . . . 18.17 107.453 168.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -79.53 -14.15 13.04 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 123.142 2.158 . . . . 8.16 107.647 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -93.54 9.74 35.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.541 1.682 . . . . 11.13 115.541 -175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -80.62 139.41 36.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.288 1.835 . . . . 18.03 114.522 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -90.49 170.34 10.29 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.442 -3.911 . . . . 10.22 107.901 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.7 mm -71.38 -29.0 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 116.845 -3.659 . . . . 12.3 108.235 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -51.81 -51.51 55.97 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.284 3.033 . . . . 36.51 112.902 164.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -54.44 -43.34 71.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.729 2.862 . . . . 25.66 118.729 172.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.17 -43.15 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 117.88 -1.057 . . . . 8.12 109.039 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -57.96 -36.04 72.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.267 1.951 . . . . 15.47 116.267 166.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.22 -35.84 65.34 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.117 2.567 . . . . 11.45 115.741 170.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -81.26 -29.99 34.2 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 127.398 2.936 . . . . 24.98 109.446 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.7 mt -65.42 -43.3 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 121.256 1.844 . . . . 9.46 115.951 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -53.95 -39.61 66.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.154 -2.355 . . . . 14.76 114.521 167.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.258 21.2 t70 -68.33 -53.44 24.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.386 2.357 . . . . 26.29 115.159 164.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -63.02 -43.8 97.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 120.191 3.404 . . . . 30.06 120.191 -169.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -100.28 -30.19 12.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.961 -2.337 . . . . 25.19 108.874 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.4 37.46 12.23 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 112.715 -2.039 . . . . 7.41 110.188 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mt -102.68 128.47 27.91 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 118.627 -2.69 . . . . 9.49 111.919 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -67.85 146.15 71.08 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 124.914 3.743 . . . . 11.42 108.299 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -81.15 2.28 8.69 Favored 'Trans proline' 0 C--N 1.3 -2.005 1 C-N-CA 127.345 5.364 . . . . 12.0 114.533 -165.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.43 -47.56 6.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.67 -1.894 . . . . 35.55 107.818 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -52.05 -29.44 21.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.967 1.84 . . . . 20.52 115.967 162.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -71.84 136.21 46.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.771 2.829 . . . . 7.13 116.731 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -118.09 105.98 12.4 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.851 -1.537 . . . . 36.39 106.851 161.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.3 tp -102.11 120.75 40.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.546 -3.222 . . . . 9.55 105.995 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 pt -127.24 170.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 125.323 1.449 . . . . 13.9 107.132 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -96.6 -55.57 2.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.058 1.743 . . . . 6.86 113.364 169.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.44 -80.71 0.4 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.074 1.35 . . . . 11.15 113.75 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.47 -12.81 2.98 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.545 -1.347 . . . . 13.93 115.578 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -97.18 124.94 41.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 114.604 -2.617 . . . . 23.92 113.673 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -52.25 119.36 4.31 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.962 1.71 . . . . 23.23 111.965 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.505 HD22 ' CE1' ' A' ' 59' ' ' TYR . 35.2 mt -81.76 142.72 32.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.836 2.732 . . . . 9.11 114.364 -176.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -80.56 124.69 29.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.502 2.721 . . . . 33.44 107.288 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.319 36.4 m-20 -45.29 -56.28 5.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.323 3.083 . . . . 28.37 119.323 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.59 10.84 65.77 Favored Glycine 0 N--CA 1.43 -1.735 0 CA-C-O 117.024 -1.987 . . . . 15.0 116.631 -157.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.41 HH21 ' CG ' ' A' ' 58' ' ' ASP . 83.3 mtp180 -98.87 152.07 20.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 118.155 0.978 . . . . 25.5 108.864 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.5 p -80.55 161.54 24.73 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.684 2.105 . . . . 11.95 116.684 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 HD12 ' A' ' 61' ' ' ILE . 7.6 mt -76.07 -29.71 58.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.084 -2.562 . . . . 10.17 104.084 -171.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.2 t -60.99 -46.88 88.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.119 2.137 . . . . 13.59 112.928 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CG ' HH21 ' A' ' 54' ' ' ARG . 20.6 t0 -58.32 -47.96 82.04 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.596 2.758 . . . . 11.7 111.085 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CE1' HD22 ' A' ' 50' ' ' LEU . 9.6 m-85 -61.98 -34.23 75.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 131.391 3.876 . . . . 12.95 114.332 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.481 10.3 m120 92.49 29.53 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.038 2.086 . . . . 25.45 113.051 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.482 HD12 HD23 ' A' ' 56' ' ' LEU . 22.7 mt -89.11 108.64 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 127.542 2.337 . . . . 14.6 111.409 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -87.55 179.26 6.58 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.04 -4.162 . . . . 33.23 114.978 -169.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -63.31 126.19 26.61 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.497 3.046 . . . . 25.97 114.888 167.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.394 68.4 mt-10 75.43 42.8 0.22 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.881 3.273 . . . . 32.61 110.27 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -109.93 141.78 42.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.688 1.995 . . . . 10.56 107.969 -173.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.1 m -90.74 129.04 36.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.281 1.956 . . . . 5.33 116.281 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.49 171.85 7.24 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.054 -1.462 . . . . 11.66 107.054 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -135.39 127.41 29.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.937 2.78 . . . . 16.3 105.285 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.7 tp -96.84 114.63 26.27 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.138 2.399 . . . . 9.96 108.285 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.252 37.6 t -101.25 151.58 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 101.543 -3.503 . . . . 9.76 101.543 170.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.7 mt -100.49 -172.83 2.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.429 -1.323 . . . . 19.57 107.429 173.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -87.74 -46.38 9.52 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.533 2.587 . . . . 35.08 115.657 -168.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.8 tp -83.72 -75.2 0.34 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.31 -3.994 . . . . 32.31 113.83 -171.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -94.92 141.94 28.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.189 -0.914 . . . . 42.75 111.499 -172.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.77 -161.79 11.02 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 108.515 -1.834 . . . . 36.31 108.515 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 CA-C-O 116.245 -2.419 . . . . 36.27 113.315 178.068 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.268 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 118.151 2.649 . . . . 17.17 118.151 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -80.61 134.15 35.86 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.22 1.933 . . . . 21.89 116.22 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.6 pt -124.45 149.34 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 112.833 -1.985 . . . . 10.83 109.195 166.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.47 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 59.9 m-85 -103.96 132.68 49.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 102.567 -3.123 . . . . 10.61 102.567 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.45 109.25 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 126.224 1.81 . . . . 9.13 106.729 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -95.58 132.35 40.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.045 3.307 . . . . 20.55 108.693 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -91.29 175.91 6.76 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.316 -3.365 . . . . 11.78 114.287 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.638 HD11 ' H ' ' A' ' 71' ' ' LEU . 84.5 mt -75.47 -28.19 59.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.536 -1.211 . . . . 19.31 113.775 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.354 82.5 p -83.63 -24.33 31.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 120.496 1.498 . . . . 23.14 107.968 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.29 52.12 0.22 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.397 -2.689 . . . . 19.74 107.861 161.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -131.01 135.26 47.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.296 -4.061 . . . . 21.93 103.738 -175.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.7 m -106.65 107.45 18.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.309 2.48 . . . . 12.33 108.29 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -98.99 133.02 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 128.416 2.687 . . . . 17.08 110.329 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.4 m -98.42 112.63 24.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.673 -1.232 . . . . 16.3 107.673 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -102.35 164.48 11.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.372 2.511 . . . . 15.88 107.338 172.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.67 106.28 9.61 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 115.302 -4.624 . . . . 28.9 102.326 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -109.44 175.66 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 123.445 1.593 . . . . 12.05 109.726 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -115.89 143.48 30.87 Favored Pre-proline 0 N--CA 1.43 -1.46 1 CA-C-O 109.792 -4.909 . . . . 18.17 105.795 162.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -60.13 -11.12 14.62 Favored 'Trans proline' 0 N--CA 1.434 -2.023 2 CA-C-N 130.774 4.883 . . . . 8.16 117.737 176.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.8 m -74.0 -19.09 60.76 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.252 2.221 . . . . 11.13 116.183 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.13 156.28 38.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.542 2.337 . . . . 18.03 111.039 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 p -107.95 163.61 12.99 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.775 -1.557 . . . . 10.22 115.072 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -63.24 -26.02 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 114.319 -2.753 . . . . 12.3 109.952 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.89 -44.96 93.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.586 1.803 . . . . 36.51 108.777 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -63.95 -47.53 80.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.819 -3.05 . . . . 25.66 111.776 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' H ' HG23 ' A' ' 26' ' ' VAL . 1.5 t -60.8 -43.39 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 120.938 1.699 . . . . 8.12 113.098 173.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -59.46 -32.16 69.98 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 115.682 -2.104 . . . . 15.47 114.657 170.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.09 -51.15 65.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.204 1.82 . . . . 11.45 110.881 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.05 -36.09 78.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.953 2.205 . . . . 24.98 116.953 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 mt -70.1 -39.66 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 124.822 2.249 . . . . 9.46 111.531 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.4 -36.93 76.74 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 111.811 -6.806 . . . . 14.76 113.791 168.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -75.18 -29.92 60.52 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 116.227 -4.046 . . . . 26.29 109.754 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -75.91 -47.12 26.52 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 117.837 2.532 . . . . 30.06 117.837 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -100.34 -27.1 13.65 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.71 -1.132 . . . . 25.19 113.406 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.92 6.4 54.19 Favored Glycine 0 N--CA 1.431 -1.668 0 O-C-N 116.77 -3.706 . . . . 7.41 117.415 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.9 mm -99.05 137.04 20.4 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-N 120.657 2.229 . . . . 9.49 106.206 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -65.71 154.21 74.84 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 N-CA-C 119.094 2.69 . . . . 11.42 119.094 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -88.46 -7.49 5.74 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-N 125.953 3.162 . . . . 12.0 107.396 -155.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -82.39 -18.29 42.48 Favored 'General case' 0 N--CA 1.429 -1.483 1 C-N-CA 131.789 4.036 . . . . 35.55 112.248 167.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -85.81 -24.84 26.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.644 -1.91 . . . . 20.52 113.313 165.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -83.84 138.3 33.27 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.615 2.366 . . . . 7.13 113.759 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -142.61 122.28 13.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.864 -1.902 . . . . 36.39 105.864 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -101.23 125.96 47.91 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.363 1.865 . . . . 9.55 108.533 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 68' ' ' HIS . 5.8 pt -127.56 154.27 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.149 -2.908 . . . . 13.9 103.149 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.43 -63.31 1.22 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.889 -1.757 . . . . 6.86 113.382 173.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.58 -36.39 0.78 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.904 -2.373 . . . . 11.15 106.64 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.06 -14.72 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.109 1.814 . . . . 13.93 116.253 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -103.12 148.66 25.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.622 -2.031 . . . . 23.92 106.708 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -81.97 110.37 17.17 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 127.784 6.216 . . . . 23.23 127.784 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.8 mt -87.32 112.87 22.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.9 -2.375 . . . . 9.11 107.191 -169.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -110.11 148.49 31.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.542 2.591 . . . . 33.44 107.447 -159.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -44.07 -61.82 1.35 Allowed 'General case' 0 N--CA 1.431 -1.424 1 C-N-CA 131.815 4.046 . . . . 28.37 118.365 -169.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.37 -22.21 72.8 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 128.422 2.915 . . . . 15.0 110.326 -155.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -100.27 159.65 14.95 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.773 1.229 . . . . 25.5 112.814 -167.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -74.69 156.33 36.76 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 114.432 -2.699 . . . . 11.95 117.425 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.272 14.8 mt -54.39 -37.11 64.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 120.031 3.345 . . . . 10.17 120.031 160.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -64.1 -25.9 68.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.751 2.13 . . . . 13.59 116.751 171.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -73.02 -22.28 60.68 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.033 -1.937 . . . . 11.7 110.117 169.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -96.75 -12.5 23.63 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.534 1.97 . . . . 12.95 114.257 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.29 14.4 m120 59.5 46.0 12.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.666 3.986 . . . . 25.45 114.589 -172.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 61' ' ' ILE . 69.1 mt -81.48 108.86 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.067 -2.896 . . . . 14.6 112.154 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -88.07 178.72 6.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.318 2.34 . . . . 33.23 117.318 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -61.96 138.34 58.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 127.453 3.501 . . . . 25.97 113.103 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 60.52 31.03 20.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.705 3.202 . . . . 32.61 115.276 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.4 m -70.69 144.91 50.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.417 -1.719 . . . . 10.56 108.752 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 23.0 m -95.66 122.53 38.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.007 -2.59 . . . . 5.33 104.007 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.3 mt -116.71 152.61 33.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.246 -2.501 . . . . 11.66 104.246 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.404 ' HB2' HG13 ' A' ' 44' ' ' ILE . 73.2 m80 -111.89 122.04 46.69 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-O 128.67 4.081 . . . . 16.3 107.748 -175.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.0 tp -85.51 135.62 33.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.827 -3.046 . . . . 9.96 105.466 171.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.2 t -130.76 151.91 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 102.761 -3.052 . . . . 9.76 102.761 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.638 ' H ' HD11 ' A' ' 8' ' ' LEU . 54.5 mt -114.23 157.39 22.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.24 -1.538 . . . . 19.57 110.952 170.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -63.29 -63.13 1.28 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.572 2.42 . . . . 35.08 109.84 -165.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.85 -50.23 6.0 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.387 1.875 . . . . 32.31 114.899 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -79.77 75.8 6.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.985 1.476 . . . . 42.75 114.985 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.98 161.7 16.27 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 119.561 2.584 . . . . 36.31 119.561 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.755 0 O-C-N 121.422 -1.046 . . . . 36.27 115.481 176.423 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.607 1.336 . . . . 17.17 114.607 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -95.15 142.47 27.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.168 0.987 . . . . 21.89 111.595 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.29 168.57 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.346 -2.094 . . . . 10.83 105.346 159.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -118.34 158.04 25.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.862 1.792 . . . . 10.61 114.321 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.467 HG21 HD11 ' A' ' 30' ' ' ILE . 59.6 t -124.4 121.25 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.389 3.476 . . . . 9.13 106.866 167.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -106.48 127.58 53.41 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 124.018 1.866 . . . . 20.55 107.772 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 p -88.84 166.24 14.12 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.678 1.704 . . . . 11.78 106.642 -173.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.2 mt -65.95 -45.35 82.11 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 129.703 3.201 . . . . 19.31 110.53 169.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.0 p -64.31 -29.67 70.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.901 2.481 . . . . 23.14 117.576 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.39 29.46 1.92 Allowed Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 114.157 -1.383 . . . . 19.74 109.916 167.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -92.66 133.44 35.99 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.798 -3.766 . . . . 21.93 112.714 164.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.3 m -100.63 119.02 37.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.935 -1.876 . . . . 12.33 105.935 167.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.7 mt -113.3 115.5 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 117.99 -2.943 . . . . 17.08 105.94 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.3 m -83.78 124.78 31.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 112.846 -3.454 . . . . 16.3 108.307 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.16 145.03 30.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 123.901 3.046 . . . . 15.88 111.211 167.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -98.87 131.74 44.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 118.816 -1.154 . . . . 28.9 112.225 167.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.08 171.94 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.889 1.676 . . . . 12.05 110.029 -166.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -118.6 171.79 4.88 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-N 122.105 2.23 . . . . 18.17 109.21 156.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.2 -30.57 72.05 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 N-CA-C 119.5 2.846 . . . . 8.16 119.5 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.7 m -92.58 14.64 16.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.805 -3.059 . . . . 11.13 112.474 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.47 138.08 41.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.052 -3.53 . . . . 18.03 115.944 171.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 p -85.05 164.1 18.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 112.592 -2.095 . . . . 10.22 109.822 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 23' ' ' ILE 0.351 3.9 mm -78.62 -17.6 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 117.876 -3.015 . . . . 12.3 111.29 -175.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -62.26 -51.73 66.56 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.902 2.881 . . . . 36.51 110.678 164.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -66.63 -25.29 66.52 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.411 -1.431 . . . . 25.66 110.693 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.67 -56.2 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.595 2.072 . . . . 8.12 116.595 167.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -50.6 -30.55 13.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.271 3.434 . . . . 15.47 120.271 164.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.83 -42.76 97.54 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.253 2.316 . . . . 11.45 117.253 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -61.78 -31.53 71.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.3 1.963 . . . . 24.98 116.3 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.467 HD11 HG21 ' A' ' 5' ' ' VAL . 63.2 mt -85.0 -40.52 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.092 1.757 . . . . 9.46 111.143 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -48.24 -51.34 25.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.595 2.758 . . . . 14.76 116.915 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.58 -39.78 74.09 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.776 2.83 . . . . 26.29 112.662 166.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -87.42 -70.99 0.59 Allowed 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.051 -4.156 . . . . 30.06 109.209 -168.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -89.96 -26.47 20.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.117 -3.489 . . . . 25.19 117.802 -171.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.81 43.45 4.48 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 117.22 -1.878 . . . . 7.41 115.75 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mm -90.82 124.39 62.29 Favored Pre-proline 0 N--CA 1.43 -1.468 1 CA-C-O 110.872 -4.394 . . . . 9.49 107.397 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -77.04 147.25 26.42 Favored 'Trans proline' 0 C--N 1.3 -2.022 1 CA-C-N 129.741 4.515 . . . . 11.42 112.033 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.08 -21.03 32.59 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-O 117.3 -1.208 . . . . 12.0 114.153 -159.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -71.45 -27.86 63.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 123.563 2.892 . . . . 35.55 111.994 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.277 88.4 mm-40 -77.24 -23.42 51.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.422 1.889 . . . . 20.52 111.096 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -77.28 107.37 9.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 113.812 1.041 . . . . 7.13 113.812 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -112.78 114.23 26.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.346 2.022 . . . . 36.39 109.921 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.7 mt -100.2 117.85 35.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.892 -1.755 . . . . 9.55 109.839 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 68' ' ' HIS . 36.5 pt -98.19 156.64 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.415 2.286 . . . . 13.9 112.797 166.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -79.86 -68.87 0.63 Allowed 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 123.396 1.569 . . . . 6.86 107.929 162.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.54 -60.79 0.98 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.051 -2.203 . . . . 11.15 105.051 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.16 -25.18 1.71 Allowed Glycine 0 N--CA 1.43 -1.731 1 C-N-CA 134.965 6.031 . . . . 13.93 114.451 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 139.72 33.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.012 -3.052 . . . . 23.92 109.482 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -90.29 147.82 23.27 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.162 0.982 . . . . 23.23 112.661 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mt -99.71 118.72 36.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.118 1.767 . . . . 9.11 110.391 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -95.21 147.85 23.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.939 -1.105 . . . . 33.44 111.002 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.04 -47.62 8.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.435 3.094 . . . . 28.37 116.094 -166.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.19 31.61 7.81 Favored Glycine 0 N--CA 1.431 -1.694 1 CA-C-O 112.914 -4.27 . . . . 15.0 115.746 -165.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -129.42 171.63 12.33 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.797 3.299 . . . . 25.5 105.588 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.4 p -99.97 169.0 9.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.942 2.155 . . . . 11.95 112.223 -174.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.6 -40.03 68.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.311 1.226 . . . . 10.17 114.311 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.9 t -63.83 -49.92 70.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 131.495 3.918 . . . . 13.59 112.384 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 38.6 m-20 -43.83 -58.0 2.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.665 3.186 . . . . 11.7 110.892 168.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.269 32.6 m-85 -54.58 -21.11 9.38 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 120.574 3.546 . . . . 12.95 120.574 171.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 m120 53.86 56.39 7.2 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.024 1.729 . . . . 25.45 112.234 -162.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -93.74 132.07 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.77 -3.081 . . . . 14.6 110.024 165.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -105.6 -165.56 1.12 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 119.76 -0.776 . . . . 33.23 111.506 -166.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -79.12 125.44 29.43 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 117.395 -1.722 . . . . 25.97 112.521 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.3 34.6 mt-10 68.22 27.43 6.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.115 2.166 . . . . 32.61 114.348 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -74.7 153.99 38.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.905 -3.622 . . . . 10.56 116.503 163.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.1 m -93.27 125.7 38.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.375 2.297 . . . . 5.33 111.447 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -93.33 154.91 17.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.004 -2.591 . . . . 11.66 104.004 169.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.531 ' HB2' HG13 ' A' ' 44' ' ' ILE . 75.5 m80 -122.46 107.26 11.83 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 108.912 -0.773 . . . . 16.3 108.912 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -78.24 120.71 23.41 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 122.876 1.322 . . . . 9.96 109.545 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.39 -179.65 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.737 2.415 . . . . 9.76 107.421 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.9 mt -98.52 171.79 7.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.504 1.621 . . . . 19.57 112.789 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -83.74 -43.91 14.99 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.191 2.293 . . . . 35.08 117.191 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.53 -55.28 3.2 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.058 1.503 . . . . 32.31 115.058 173.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 mtm105 -86.57 152.6 22.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.539 0.94 . . . . 42.75 113.539 -170.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.99 88.32 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.72 1 CA-C-O 128.175 4.208 . . . . 36.31 112.789 -175.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.754 0 C-N-CA 128.925 3.155 . . . . 36.27 109.773 -174.257 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptt? . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 109.027 -0.731 . . . . 17.17 109.027 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -100.09 125.4 46.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.929 -2.357 . . . . 21.89 105.251 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -123.37 159.12 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.62 -3.175 . . . . 10.83 105.898 159.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -111.91 137.03 50.45 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.846 -3.034 . . . . 10.61 112.021 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.07 125.41 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 111.504 -2.589 . . . . 9.13 109.572 169.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -107.11 124.62 49.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.567 -3.208 . . . . 20.55 110.535 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p -89.88 163.61 14.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.76 1.743 . . . . 11.78 111.438 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.04 -39.95 94.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.628 1.571 . . . . 19.31 113.987 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -73.59 -33.04 64.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.376 3.07 . . . . 23.14 105.915 -175.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.42 48.33 0.47 Allowed Glycine 0 N--CA 1.431 -1.696 0 CA-C-O 122.622 1.124 . . . . 19.74 115.651 160.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.23 125.84 52.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.053 -3.027 . . . . 21.93 108.241 168.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.6 m -93.21 95.06 9.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.084 2.554 . . . . 12.33 112.309 169.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.4 mt -102.9 125.47 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 131.064 3.746 . . . . 17.08 106.677 -159.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -81.55 119.84 24.28 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.285 -3.384 . . . . 16.3 114.308 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.2 142.71 36.5 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.884 -4.26 . . . . 15.88 109.465 174.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -110.28 105.52 14.59 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.4 3.88 . . . . 28.9 111.333 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.73 157.77 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 111.571 -2.559 . . . . 12.05 108.281 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.1 mm-40 -88.9 168.11 16.52 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 124.547 1.154 . . . . 18.17 113.247 159.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 73.1 Cg_endo -70.56 -24.24 26.22 Favored 'Trans proline' 0 C--N 1.299 -2.036 1 O-C-N 112.537 -4.507 . . . . 8.16 113.485 177.026 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -97.33 16.47 19.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.45 2.344 . . . . 11.13 116.106 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -67.89 136.76 54.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.712 2.805 . . . . 18.03 108.164 163.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.342 60.9 p -80.27 168.14 19.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.035 2.534 . . . . 10.22 107.145 -176.088 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 mm -75.9 -35.11 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 105.034 -2.21 . . . . 12.3 105.034 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -44.17 -46.28 8.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.795 2.146 . . . . 36.51 116.795 161.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.269 11.4 m120 -69.24 -32.48 71.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.65 -3.781 . . . . 25.66 111.843 173.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.12 -38.67 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 116.215 1.931 . . . . 8.12 116.215 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -71.19 -22.34 62.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.065 -2.897 . . . . 15.47 116.085 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.86 72.91 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.029 -1.669 . . . . 11.45 114.333 171.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -70.97 -40.95 71.65 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.067 2.988 . . . . 24.98 119.067 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.96 -32.28 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.622 -1.923 . . . . 9.46 112.038 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -66.15 -43.1 88.0 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.674 2.39 . . . . 14.76 115.437 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -78.49 -28.31 46.38 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.553 1.979 . . . . 26.29 115.747 168.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.24 -68.35 0.5 Allowed 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.095 -4.128 . . . . 30.06 110.101 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -81.97 -49.08 10.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.653 2.933 . . . . 25.19 110.352 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.66 7.85 13.02 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.645 -2.534 . . . . 7.41 111.711 -170.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mm -82.88 127.82 68.16 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 116.25 1.945 . . . . 9.49 116.25 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -64.14 150.49 88.24 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 CA-C-O 115.515 -1.952 . . . . 11.42 116.915 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -71.89 -20.82 25.39 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 123.98 2.457 . . . . 12.0 114.488 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -64.35 -39.36 93.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.458 -2.211 . . . . 35.55 115.645 165.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -78.03 -24.74 47.71 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 127.204 2.815 . . . . 20.52 110.657 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -70.6 119.17 14.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.522 2.329 . . . . 7.13 112.358 168.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -130.94 103.1 6.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.421 -2.807 . . . . 36.39 103.421 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -92.13 118.27 30.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.144 -2.222 . . . . 9.55 108.789 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 pt -90.21 -179.22 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 113.821 1.045 . . . . 13.9 113.821 159.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -111.68 -77.68 0.59 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.061 -2.2 . . . . 6.86 105.061 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.73 -50.63 2.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.29 2.236 . . . . 11.15 112.489 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.55 -24.17 0.85 Allowed Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 126.782 2.134 . . . . 13.93 112.356 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -113.78 146.27 40.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.733 -2.039 . . . . 23.92 114.697 -167.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -78.12 152.4 32.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.305 3.431 . . . . 23.23 115.928 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.1 mt -114.5 136.25 53.22 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 102.928 -2.989 . . . . 9.11 102.928 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -104.77 139.12 40.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.628 -2.545 . . . . 33.44 108.85 -173.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -28.2 -55.36 0.11 Allowed 'General case' 0 N--CA 1.429 -1.482 1 N-CA-C 123.444 4.609 . . . . 28.37 123.444 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.93 -1.75 81.96 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.765 -2.459 . . . . 15.0 117.922 -164.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -93.35 167.61 11.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.879 3.271 . . . . 25.5 107.949 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -101.37 168.49 9.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.831 2.052 . . . . 11.95 111.811 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.26 -25.87 68.25 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 131.713 4.005 . . . . 10.17 111.677 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -59.6 -46.45 88.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.363 -3.336 . . . . 13.59 114.744 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.8 -40.0 87.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.675 -2.057 . . . . 11.7 110.363 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.444 ' HB2' HD12 ' A' ' 61' ' ' ILE . 25.9 m-85 -85.05 -2.38 57.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.789 0.804 . . . . 12.95 109.486 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m120 65.09 46.7 2.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.274 2.464 . . . . 25.45 112.724 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 59' ' ' TYR . 10.0 mt -90.02 114.12 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.985 -2.322 . . . . 14.6 110.175 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -97.16 166.18 11.7 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.194 2.998 . . . . 33.23 112.188 -175.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -55.63 134.11 50.95 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.88 1.808 . . . . 25.97 115.88 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 55.55 58.12 4.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.179 -1.828 . . . . 32.61 111.78 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 t -115.74 142.82 46.24 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.25 1.42 . . . . 10.56 108.972 173.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -98.5 124.18 43.08 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.66 1.695 . . . . 5.33 115.47 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.79 156.59 17.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.152 3.381 . . . . 11.66 107.681 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -129.07 122.21 29.47 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.44 -2.059 . . . . 16.3 105.44 -172.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.43 105.76 17.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 112.886 -1.961 . . . . 9.96 111.32 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 m -104.95 178.15 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 127.74 2.416 . . . . 9.76 112.507 168.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -75.93 174.18 10.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.877 2.275 . . . . 19.57 115.711 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -59.04 -65.4 0.67 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.668 -3.145 . . . . 35.08 112.907 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.6 tp -89.9 -61.26 1.73 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 116.021 -0.536 . . . . 32.31 111.118 -172.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -87.47 142.35 27.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.666 2.469 . . . . 42.75 117.666 -168.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.38 156.78 28.52 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 119.235 -1.459 . . . . 36.31 112.627 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.764 0 CA-C-O 124.058 1.921 . . . . 36.27 116.181 176.308 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 ttp . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 122.407 1.098 . . . . 17.17 108.85 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -82.65 135.95 34.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.065 -1.647 . . . . 21.89 108.184 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.77 166.46 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 124.789 1.236 . . . . 10.83 109.296 165.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -125.61 104.05 8.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.563 -2.014 . . . . 10.61 105.563 -167.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.43 105.12 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.515 -2.031 . . . . 9.13 105.515 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -108.68 126.15 52.67 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.474 0.654 . . . . 20.55 110.125 -174.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -80.69 -179.35 7.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.504 1.668 . . . . 11.78 115.504 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.06 -43.32 78.9 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.004 -4.185 . . . . 19.31 112.056 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -84.99 -21.22 29.59 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.271 -1.786 . . . . 23.14 108.927 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.28 70.82 0.93 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-O 124.928 2.404 . . . . 19.74 115.957 166.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -116.66 118.48 32.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 110.398 -2.901 . . . . 21.93 106.724 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -90.39 103.7 16.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 127.245 2.841 . . . . 12.33 110.383 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.2 mt -94.42 98.79 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.746 2.418 . . . . 17.08 113.075 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -73.47 122.42 22.11 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 119.991 1.268 . . . . 16.3 113.068 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.95 147.87 37.82 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.765 -3.709 . . . . 15.88 102.816 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -105.32 134.92 47.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.819 1.771 . . . . 28.9 108.209 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -148.87 -174.52 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.57 3.148 . . . . 12.05 105.968 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -141.6 162.77 45.08 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 114.75 -2.548 . . . . 18.17 108.227 170.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -23.23 76.64 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 C-N-CA 127.014 5.142 . . . . 8.16 118.024 -169.15 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 5.3 p -94.28 -6.05 45.36 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.559 2.344 . . . . 11.13 110.683 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -74.93 167.09 22.58 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.495 -3.878 . . . . 18.03 115.201 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 2.4 p -89.42 170.13 10.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.283 2.697 . . . . 10.22 118.283 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mt -87.63 -13.15 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 117.53 -1.668 . . . . 12.3 108.527 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -59.31 -47.51 85.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.01 1.324 . . . . 36.51 113.556 160.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -55.83 -40.67 73.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.134 -2.854 . . . . 25.66 116.104 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.9 t -52.63 -54.93 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 117.145 -3.472 . . . . 8.12 113.213 167.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -61.22 -30.12 70.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.791 1.636 . . . . 15.47 114.955 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -30.24 70.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.528 3.531 . . . . 11.45 113.997 166.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -92.78 -14.4 27.9 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 116.742 -1.983 . . . . 24.98 112.174 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.27 67.8 mt -64.2 -36.18 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.398 1.57 . . . . 9.46 114.418 158.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -67.76 -21.52 65.26 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.748 -3.095 . . . . 14.76 116.112 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.48 -58.63 2.66 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.085 -2.561 . . . . 26.29 104.085 -175.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -64.83 -62.06 1.8 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.112 2.565 . . . . 30.06 115.89 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -81.16 -58.15 3.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.302 1.864 . . . . 25.19 111.734 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.25 17.35 3.67 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.111 -1.596 . . . . 7.41 109.111 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.1 mt -90.58 131.21 38.65 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-O 115.445 -2.217 . . . . 9.49 109.085 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -66.18 156.59 64.08 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 125.497 2.999 . . . . 11.42 116.606 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -68.73 -23.03 36.4 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 124.374 3.383 . . . . 12.0 112.319 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.252 10.1 p-10 -77.85 -28.46 50.09 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.248 3.019 . . . . 35.55 107.801 -170.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -69.38 -35.4 75.78 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.192 -1.568 . . . . 20.52 110.841 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -96.39 133.56 40.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.237 -0.887 . . . . 7.13 111.606 -151.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -111.61 131.87 54.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 103.274 -2.861 . . . . 36.39 103.274 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -116.91 125.06 50.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.24 1.495 . . . . 9.55 110.724 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 23.2 mm -95.11 132.32 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.288 2.235 . . . . 13.9 114.298 170.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -123.17 115.94 22.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.481 -2.637 . . . . 6.86 109.013 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.84 -102.56 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.364 -0.835 . . . . 11.15 110.007 -172.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.42 34.2 2.39 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 118.822 -2.424 . . . . 13.93 113.017 164.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.345 21.2 ttmm -120.16 144.11 47.85 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 112.735 -1.732 . . . . 23.92 115.145 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -81.42 135.49 35.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.763 1.744 . . . . 23.23 113.372 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.8 mt -89.26 145.74 25.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.069 -2.197 . . . . 9.11 105.069 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -87.12 160.78 18.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.013 -2.422 . . . . 33.44 114.41 159.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.95 -41.55 13.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.888 2.551 . . . . 28.37 117.888 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.58 17.87 58.5 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 116.7 -2.667 . . . . 15.0 108.473 -170.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -90.18 165.92 13.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.163 -3.551 . . . . 25.5 109.817 161.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.9 p -102.13 174.26 6.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.849 3.214 . . . . 11.95 104.111 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.14 -37.5 83.91 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.691 2.796 . . . . 10.17 109.783 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.254 67.7 m -61.5 -42.67 99.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 113.241 0.83 . . . . 13.59 113.241 176.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -53.0 -44.45 67.26 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 121.057 3.725 . . . . 11.7 121.057 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -79.33 -15.76 57.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 125.715 1.884 . . . . 12.95 115.865 165.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 68.56 71.57 0.29 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.357 2.663 . . . . 25.45 110.303 -169.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.274 82.4 mt -109.15 114.51 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 113.332 -3.347 . . . . 14.6 110.004 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -100.13 -166.39 1.32 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.9 2.185 . . . . 33.23 116.9 -171.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 137.62 55.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.63 1.681 . . . . 25.97 112.197 -171.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.47 80.4 mt-10 72.74 12.12 5.35 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 116.703 -3.748 . . . . 32.61 118.091 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.1 t -86.46 137.66 32.37 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 125.763 1.914 . . . . 10.56 108.704 -165.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 m -87.25 115.34 24.59 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.234 -1.803 . . . . 5.33 112.147 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.1 mt -93.13 149.69 21.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.402 -1.436 . . . . 11.66 109.368 167.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.572 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 77.7 m-70 -99.72 109.75 22.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 125.871 1.982 . . . . 16.3 109.972 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.1 tp -96.41 117.68 31.38 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.292 2.473 . . . . 9.96 110.303 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.4 t -92.65 130.88 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 128.607 2.763 . . . . 9.76 106.339 164.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.5 mt -118.54 139.71 51.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.115 -1.439 . . . . 19.57 107.115 161.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -92.12 -54.09 3.98 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.615 2.366 . . . . 35.08 108.793 -159.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.2 mt -88.73 -68.4 0.77 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.801 2.715 . . . . 32.31 113.245 -168.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -86.25 -64.54 1.13 Allowed 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.15 -4.719 . . . . 42.75 116.977 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.37 -147.09 17.54 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.877 -0.889 . . . . 36.31 110.877 -161.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.761 0 O-C-N 121.298 -1.119 . . . . 36.27 114.487 176.237 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.4 ttp . . . . . 0 CA--C 1.49 -1.342 0 CA-C-O 121.162 0.506 . . . . 17.17 109.732 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -84.82 125.29 32.47 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.723 -2.486 . . . . 21.89 114.667 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.264 8.7 pt -114.04 165.25 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 124.109 3.14 . . . . 10.83 104.415 167.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -106.47 138.43 42.66 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 111.0 -2.818 . . . . 10.61 111.96 166.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.0 t -118.67 103.41 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.657 3.122 . . . . 9.13 105.77 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -88.42 134.92 33.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.544 -2.598 . . . . 20.55 111.101 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.563 HG22 HD23 ' A' ' 69' ' ' LEU . 71.4 p -81.56 -170.51 2.83 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 123.791 2.996 . . . . 11.78 114.46 169.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.7 tp -100.74 -27.72 13.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.399 2.047 . . . . 19.31 112.907 -171.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 p -69.33 -41.79 76.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.529 -3.232 . . . . 23.14 107.598 160.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.68 72.1 0.67 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 117.959 -2.963 . . . . 19.74 116.045 173.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -123.97 133.63 53.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.074 -1.917 . . . . 21.93 109.476 160.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.4 m -93.57 105.01 17.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.277 2.86 . . . . 12.33 109.313 -170.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.413 HG23 ' HD2' ' A' ' 33' ' ' LYS . 3.5 mt -95.34 118.86 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 CA-C-O 129.507 4.479 . . . . 17.08 110.267 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.42 102.77 14.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.017 -3.552 . . . . 16.3 112.609 -175.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.56 129.44 36.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.282 -2.136 . . . . 15.88 110.65 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -98.04 92.09 5.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 127.145 3.355 . . . . 28.9 106.667 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -102.81 174.25 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 130.979 3.712 . . . . 12.05 110.063 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.349 73.6 mm-40 -115.36 141.53 27.34 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 112.594 -3.574 . . . . 18.17 105.51 163.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -56.25 -16.16 16.71 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 N-CA-C 119.879 2.992 . . . . 8.16 119.879 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -82.15 -10.86 59.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.971 1.843 . . . . 11.13 111.922 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -74.0 142.94 45.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.58 -3.825 . . . . 18.03 118.028 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -92.0 152.52 19.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.635 1.683 . . . . 10.22 108.25 -171.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.2 mm -57.68 -27.1 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 116.287 1.958 . . . . 12.3 116.287 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.318 37.0 tt0 -64.23 -45.21 89.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.616 1.674 . . . . 36.51 115.415 166.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -73.04 -29.2 62.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.506 -3.871 . . . . 25.66 113.05 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.94 -46.85 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.244 -2.785 . . . . 8.12 107.026 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -60.19 -18.19 46.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.991 1.716 . . . . 15.47 114.96 171.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.16 -24.09 40.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.556 -2.59 . . . . 11.45 112.17 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttt -78.81 -36.02 43.29 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.757 -4.34 . . . . 24.98 107.666 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -69.72 -37.45 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 125.994 2.059 . . . . 9.46 109.82 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -54.64 -53.52 53.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.713 1.597 . . . . 14.76 114.468 157.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.77 -30.29 71.29 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 123.128 2.695 . . . . 26.29 116.688 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HD2' HG23 ' A' ' 13' ' ' ILE . 15.0 mttm -61.24 -67.1 0.44 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 126.289 2.947 . . . . 30.06 113.857 168.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -95.83 -48.47 5.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.872 -2.392 . . . . 25.19 113.123 -160.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.45 12.57 10.52 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 113.744 -1.571 . . . . 7.41 114.108 -172.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -97.0 113.48 63.06 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 107.881 -1.155 . . . . 9.49 107.881 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 13.7 Cg_exo -76.91 164.1 30.3 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 125.445 2.98 . . . . 11.42 109.813 -169.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 37' ' ' PRO 0.256 68.0 Cg_exo -63.33 -31.16 73.48 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 N-CA-C 120.827 3.357 . . . . 12.0 120.827 -166.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -97.95 9.0 43.84 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 118.331 -1.347 . . . . 35.55 111.38 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -78.86 -24.49 44.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.361 2.346 . . . . 20.52 111.889 156.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -83.5 144.79 29.31 Favored 'General case' 0 N--CA 1.429 -1.481 1 N-CA-C 121.811 4.004 . . . . 7.13 121.811 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -136.19 111.4 9.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 103.965 -2.606 . . . . 36.39 103.965 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 mt -97.85 120.39 38.16 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 117.655 -1.618 . . . . 9.55 115.282 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -99.85 133.62 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 128.001 3.762 . . . . 13.9 109.924 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -125.69 114.88 19.25 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.025 -4.797 . . . . 6.86 105.625 157.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.65 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 131.803 4.041 . . . . 11.15 109.17 -170.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.91 7.17 3.52 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 128.384 2.897 . . . . 13.93 112.332 172.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.307 24.5 ttmm -98.7 137.72 36.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 122.113 2.957 . . . . 23.92 108.483 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -96.53 127.95 43.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.428 -2.045 . . . . 23.23 107.398 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.2 mt -83.71 152.02 24.94 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 112.742 -2.026 . . . . 9.11 106.69 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -99.07 141.46 31.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.961 3.304 . . . . 33.44 117.355 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.14 -43.96 98.08 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 121.612 3.93 . . . . 28.37 121.612 -171.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.22 35.37 5.06 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 125.421 1.486 . . . . 15.0 110.028 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -117.65 157.41 26.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.845 0.683 . . . . 25.5 112.845 161.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.3 p -101.54 164.97 11.49 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.068 2.842 . . . . 11.95 113.494 -169.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.0 mt -56.26 -41.95 76.6 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.144 -4.722 . . . . 10.17 115.467 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 t -63.77 -33.12 74.95 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 130.305 3.442 . . . . 13.59 114.884 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.22 -50.13 56.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.926 2.89 . . . . 11.7 107.583 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -76.93 -1.84 30.64 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.217 -2.177 . . . . 12.95 113.514 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.9 t30 54.28 68.46 0.85 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.762 3.625 . . . . 25.45 110.11 -170.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -108.89 102.61 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 127.473 2.309 . . . . 14.6 108.17 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -90.74 -174.05 3.93 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 114.052 1.131 . . . . 33.23 114.052 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -59.02 154.88 14.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.605 -3.184 . . . . 25.97 115.218 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 64.97 25.57 12.71 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.535 4.334 . . . . 32.61 113.256 169.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -82.48 130.99 35.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.306 1.043 . . . . 10.56 109.647 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.6 m -83.11 113.04 20.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.178 -1.045 . . . . 5.33 108.178 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.52 149.57 24.26 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.758 -1.941 . . . . 11.66 105.758 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -113.99 116.69 29.61 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.531 -1.356 . . . . 16.3 111.714 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.563 HD23 HG22 ' A' ' 7' ' ' THR . 44.7 tp -84.6 125.76 32.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.02 2.819 . . . . 9.96 111.11 171.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -118.81 123.54 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 130.382 3.473 . . . . 9.76 111.849 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.486 HD21 HD21 ' A' ' 69' ' ' LEU . 75.8 mt -95.6 146.34 24.55 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.745 1.736 . . . . 19.57 107.48 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -78.29 -62.22 1.75 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.783 2.23 . . . . 35.08 105.47 -164.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.8 mt -87.47 -44.5 11.27 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 118.627 2.825 . . . . 32.31 118.627 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -83.48 102.84 12.37 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.478 2.085 . . . . 42.75 116.195 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.1 37.75 3.32 Favored Glycine 0 N--CA 1.43 -1.739 1 C-N-CA 130.983 4.135 . . . . 36.31 109.029 -173.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.725 0 N-CA-C 108.708 -1.757 . . . . 36.27 108.708 174.06 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 120.912 0.387 . . . . 17.17 111.451 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.263 52.5 mt-30 -114.8 138.61 50.55 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.485 1.291 . . . . 21.89 114.485 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.413 HG13 ' HB2' ' A' ' 15' ' ' LEU . 10.9 pt -116.19 140.47 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 119.825 -1.797 . . . . 10.83 110.337 174.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -99.81 115.47 29.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.261 1.505 . . . . 10.61 111.069 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -100.36 107.42 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 115.123 -2.37 . . . . 9.13 107.98 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.264 19.5 ttmm -90.64 124.34 34.99 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 126.398 2.311 . . . . 20.55 110.943 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -74.65 164.27 26.77 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 121.241 1.837 . . . . 11.78 109.595 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.1 tp -71.59 -22.57 61.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.64 1.348 . . . . 19.31 114.64 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.253 27.4 p -72.42 -78.55 0.08 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.602 2.761 . . . . 23.14 111.235 173.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.06 43.64 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.707 1 C-N-CA 132.117 4.675 . . . . 19.74 114.801 170.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -117.16 143.57 45.69 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 102.927 -2.99 . . . . 21.93 102.927 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.4 m -123.24 115.5 21.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.299 -1.741 . . . . 12.33 106.299 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.73 132.64 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.084 -2.26 . . . . 17.08 109.396 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 m -101.85 100.54 10.87 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.736 -1.95 . . . . 16.3 105.736 -172.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.413 ' HB2' HG13 ' A' ' 3' ' ' ILE 0.277 62.0 mt -97.89 137.03 37.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.955 2.788 . . . . 15.88 104.108 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -85.95 118.68 25.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.686 -3.134 . . . . 28.9 112.007 168.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 56' ' ' LEU . 31.6 m -131.02 158.46 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.738 -2.69 . . . . 12.05 103.738 -169.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -92.95 146.91 32.92 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 113.467 -3.158 . . . . 18.17 114.001 158.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.74 -7.92 22.09 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 CA-C-N 124.617 2.685 . . . . 8.16 114.069 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -90.92 -7.4 52.24 Favored 'General case' 0 N--CA 1.43 -1.457 1 C-N-CA 132.969 4.508 . . . . 11.13 113.654 174.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.78 153.11 44.37 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.231 -2.793 . . . . 18.03 114.666 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -106.42 163.15 13.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.169 -1.049 . . . . 10.22 108.169 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 mm -65.9 -28.69 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 121.011 -1.055 . . . . 12.3 110.827 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -44.49 -41.31 6.27 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.78 3.622 . . . . 36.51 120.78 157.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -80.33 -29.22 38.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.009 -3.557 . . . . 25.66 113.499 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.97 -38.77 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 105.09 -2.189 . . . . 8.12 105.09 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -70.91 -42.26 70.16 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.248 1.819 . . . . 15.47 113.543 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.8 -43.64 27.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.444 2.069 . . . . 11.45 111.789 169.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -77.3 -31.66 54.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.79 -3.069 . . . . 24.98 109.032 -173.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.6 mt -70.61 -40.79 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.188 -3.445 . . . . 9.46 115.834 171.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -50.26 -47.69 55.1 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 133.055 4.542 . . . . 14.76 109.435 172.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -60.28 -56.55 20.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.212 1.482 . . . . 26.29 113.744 171.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -74.15 -37.89 63.89 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.384 3.476 . . . . 30.06 120.384 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -107.83 -40.13 5.36 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.401 1.909 . . . . 25.19 114.233 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.2 44.23 4.45 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 120.598 1.545 . . . . 7.41 112.963 -169.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 mt -111.68 126.6 28.24 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 100.314 -3.958 . . . . 9.49 100.314 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -67.35 153.41 77.04 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 C-N-CA 126.335 4.69 . . . . 11.42 115.765 -174.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -78.27 -18.89 12.29 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 126.412 3.326 . . . . 12.0 112.998 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.9 -11.76 60.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 114.885 -2.483 . . . . 35.55 115.69 165.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -97.07 -16.73 20.39 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 121.901 2.137 . . . . 20.52 112.763 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 76.7 mt-30 -92.04 118.07 30.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.747 3.154 . . . . 7.13 111.098 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -116.37 111.02 19.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.933 -1.877 . . . . 36.39 105.933 170.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -86.75 113.94 23.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.879 2.752 . . . . 9.55 110.638 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.2 mm -99.43 142.12 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.243 -2.786 . . . . 13.9 105.878 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.48 ' HB2' HD11 ' A' ' 50' ' ' LEU . 25.5 t80 -128.65 112.24 14.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.69 -1.881 . . . . 6.86 108.08 171.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.33 . . 68.86 -91.65 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.343 -3.973 . . . . 11.15 117.354 -162.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.68 34.68 0.95 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 118.842 -1.646 . . . . 13.93 111.804 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -149.98 144.83 26.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 129.513 3.714 . . . . 23.92 113.709 173.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -73.43 134.41 43.98 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 125.832 2.73 . . . . 23.23 115.125 -176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 45' ' ' PHE . 14.7 mt -86.51 151.1 23.78 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 110.727 -2.942 . . . . 9.11 109.925 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.36 133.31 46.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.216 -3.428 . . . . 33.44 105.214 -158.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -40.45 -58.8 1.47 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 130.466 3.506 . . . . 28.37 117.789 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.7 14.16 43.6 Favored Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 121.055 1.752 . . . . 15.0 114.288 -169.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -113.44 159.68 19.23 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.671 -2.664 . . . . 25.5 108.626 -172.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 p -114.27 -178.12 3.29 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.476 -3.265 . . . . 11.95 112.571 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 17' ' ' VAL . 71.3 mt -74.51 -28.71 61.11 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 110.656 -2.975 . . . . 10.17 114.319 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.6 m -65.52 -31.11 72.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 119.167 3.025 . . . . 13.59 119.167 170.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -65.89 -45.63 81.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 127.62 3.075 . . . . 11.7 110.388 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -92.38 -8.41 44.97 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.695 -2.098 . . . . 12.95 109.51 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 60.35 54.24 4.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.508 3.051 . . . . 25.45 114.305 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mt -93.44 108.39 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 109.602 -3.454 . . . . 14.6 105.744 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -88.2 -179.09 6.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 124.769 2.223 . . . . 33.23 111.419 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.269 17.9 pttp -53.37 141.69 23.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.723 -3.111 . . . . 25.97 116.146 159.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 70.98 20.87 5.15 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.785 -3.072 . . . . 32.61 112.545 168.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -89.71 135.21 33.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.972 3.709 . . . . 10.56 114.786 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -95.0 117.71 30.6 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.869 2.914 . . . . 5.33 118.869 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mp -108.83 151.35 26.36 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.89 -2.263 . . . . 11.66 104.89 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -107.13 140.66 39.62 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.231 -1.766 . . . . 16.3 106.231 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -106.37 106.48 17.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.535 1.772 . . . . 9.96 111.952 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.3 t -94.42 134.33 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 126.948 2.655 . . . . 9.76 107.029 173.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 mt -77.06 126.88 31.69 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.417 -0.811 . . . . 19.57 110.314 166.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -68.86 -82.31 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.286 2.946 . . . . 35.08 117.162 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.8 tp -77.64 -42.42 34.9 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 112.528 -2.124 . . . . 32.31 109.813 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -68.81 143.08 54.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.409 2.683 . . . . 42.75 115.645 169.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.62 -53.64 4.57 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 128.984 3.183 . . . . 36.31 113.306 159.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.738 0 CA-C-O 116.067 -2.518 . . . . 36.27 108.106 -169.088 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 112.505 0.558 . . . . 17.17 112.505 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -102.73 147.86 26.32 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.517 3.532 . . . . 21.89 112.94 170.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 pt -128.6 163.66 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 115.802 -4.311 . . . . 10.83 103.908 169.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.57 101.67 7.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 105.057 -2.201 . . . . 10.61 105.057 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.0 t -93.53 123.3 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 107.015 -1.476 . . . . 9.13 107.015 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -124.36 152.75 42.78 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.246 1.839 . . . . 20.55 111.004 -171.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -88.42 -178.37 5.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.614 1.709 . . . . 11.78 115.614 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.269 36.1 tp -67.77 -40.08 84.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.719 2.859 . . . . 19.31 118.719 158.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -56.55 7.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.899 -2.376 . . . . 23.14 111.74 -169.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.74 24.52 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 119.03 -2.294 . . . . 19.74 115.197 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -100.38 148.48 24.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.911 -3.111 . . . . 21.93 115.849 166.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.8 m -125.34 135.77 52.79 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.744 2.818 . . . . 12.33 104.883 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.6 mt -121.59 110.78 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 103.273 -2.862 . . . . 17.08 103.273 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -79.57 118.72 21.67 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.07 -1.644 . . . . 16.3 113.852 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -112.68 145.12 41.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.425 -3.297 . . . . 15.88 113.119 -174.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -100.61 98.25 8.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.496 -1.668 . . . . 28.9 106.496 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 m -104.42 174.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 124.883 1.364 . . . . 12.05 113.025 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -121.02 152.02 55.96 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 127.367 2.267 . . . . 18.17 106.213 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -68.35 -14.72 40.87 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 122.784 2.03 . . . . 8.16 115.224 -172.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.255 53.3 p -99.8 1.34 43.0 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.737 2.815 . . . . 11.13 114.596 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.264 11.3 m-20 -71.0 155.23 41.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.882 2.277 . . . . 18.03 110.638 161.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 p -85.36 161.68 19.37 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.04 2.829 . . . . 10.22 108.487 173.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mm -57.01 -29.12 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.161 -2.837 . . . . 12.3 115.068 163.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -62.68 -46.65 87.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.021 -3.55 . . . . 36.51 109.538 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -52.85 -52.75 56.07 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.892 1.277 . . . . 25.66 113.325 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -45.12 -50.35 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.911 1.684 . . . . 8.12 113.409 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.19 -36.21 77.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.038 1.875 . . . . 15.47 115.011 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.97 82.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.641 -2.537 . . . . 11.45 116.408 170.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -63.92 -40.03 95.54 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.795 1.776 . . . . 24.98 115.795 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -60.05 -45.2 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 C-N-CA 135.097 5.359 . . . . 9.46 110.693 168.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -54.54 -48.23 72.25 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.991 1.717 . . . . 14.76 113.386 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.21 -35.57 80.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.535 2.05 . . . . 26.29 116.535 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -87.37 -46.31 9.77 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.637 1.684 . . . . 30.06 114.694 -172.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -78.63 -55.61 5.06 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 114.225 -1.352 . . . . 25.19 114.51 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.1 44.84 1.97 Allowed Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 110.066 -1.213 . . . . 7.41 110.066 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.413 HG22 ' HB3' ' A' ' 40' ' ' GLN . 6.8 mt -125.38 127.24 25.0 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 104.806 -2.294 . . . . 9.49 104.806 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 41.9 Cg_exo -67.22 160.36 47.92 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-O 115.998 -1.751 . . . . 11.42 116.052 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.6 Cg_exo -70.29 -27.34 24.05 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 124.74 3.626 . . . . 12.0 110.993 -169.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -77.64 -37.2 50.49 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 117.92 -1.038 . . . . 35.55 109.457 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HB3' HG22 ' A' ' 36' ' ' ILE . 7.1 tp-100 -59.96 -33.08 71.45 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.559 2.344 . . . . 20.52 115.498 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -98.93 145.32 27.15 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.346 2.022 . . . . 7.13 116.418 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -115.03 153.71 30.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.692 2.797 . . . . 36.39 107.683 165.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 tp -133.93 114.89 13.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.413 1.085 . . . . 9.55 108.966 -171.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.4 mm -103.71 128.57 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 117.26 -3.4 . . . . 13.9 112.452 -171.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -109.87 128.62 55.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.02 1.328 . . . . 6.86 108.674 160.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.42 -108.25 0.42 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.81 -2.432 . . . . 11.15 112.262 -168.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.67 31.55 3.53 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 109.212 -1.555 . . . . 13.93 109.212 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -121.8 124.18 43.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.269 1.428 . . . . 23.92 111.054 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -76.31 107.41 8.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.217 1.807 . . . . 23.23 110.682 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.82 136.63 34.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.247 1.019 . . . . 9.11 111.696 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -93.24 159.1 15.42 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.483 2.087 . . . . 33.44 111.101 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -73.15 -42.07 63.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.226 -2.796 . . . . 28.37 108.764 -156.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.84 41.5 2.13 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 117.217 -3.427 . . . . 15.0 113.01 -165.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -122.37 159.71 26.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.158 2.328 . . . . 25.5 108.842 166.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.9 p -85.99 167.92 14.62 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.964 2.106 . . . . 11.95 116.396 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -68.36 -26.66 65.7 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.794 -1.191 . . . . 10.17 111.416 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 t -76.37 -40.76 50.24 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 118.431 2.752 . . . . 13.59 118.431 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -43.16 -48.11 6.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.922 -2.361 . . . . 11.7 117.251 158.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -78.85 -6.99 57.49 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 120.575 3.546 . . . . 12.95 120.575 170.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 t30 53.75 40.06 31.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.064 2.616 . . . . 25.45 118.064 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.8 mt -81.47 118.91 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 105.044 -2.206 . . . . 14.6 105.044 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -81.31 -173.07 4.13 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.878 2.751 . . . . 33.23 113.79 -176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -74.42 146.06 43.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.009 -2.932 . . . . 25.97 112.605 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 65.57 30.16 10.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.364 1.665 . . . . 32.61 114.821 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -79.45 152.53 30.24 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 103.763 -2.68 . . . . 10.56 103.763 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.6 m -103.51 124.16 48.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.103 2.961 . . . . 5.33 108.309 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.282 4.9 mp -117.11 162.13 18.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.106 1.762 . . . . 11.66 107.894 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.27 127.08 52.9 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.705 -2.497 . . . . 16.3 111.182 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.72 107.73 18.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.414 2.686 . . . . 9.96 114.739 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -122.12 121.34 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 108.057 -1.09 . . . . 9.76 108.057 -171.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.402 HD11 HD13 ' A' ' 36' ' ' ILE . 7.9 mp -107.35 138.24 43.91 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 117.092 -1.843 . . . . 19.57 110.151 -177.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -65.48 -87.8 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.288 1.588 . . . . 35.08 115.288 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 tp -82.37 -63.52 1.36 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.561 -1.685 . . . . 32.31 113.181 -172.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -92.57 150.55 20.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.692 -2.336 . . . . 42.75 104.692 -171.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.02 62.57 0.53 Allowed Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 105.908 -2.877 . . . . 36.31 105.908 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.749 0 C-N-CA 125.63 1.586 . . . . 36.27 111.918 -171.71 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 112.747 0.647 . . . . 17.17 112.747 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -95.95 121.8 38.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.907 -1.886 . . . . 21.89 105.907 -176.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 pt -109.62 164.85 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 107.268 -1.382 . . . . 10.83 107.268 170.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -114.83 105.79 13.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.432 -2.433 . . . . 10.61 104.432 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.4 t -86.57 124.84 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 126.931 3.253 . . . . 9.13 109.483 166.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -106.4 134.62 49.25 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.431 -2.668 . . . . 20.55 107.684 -173.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.253 47.5 p -75.79 161.14 29.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.775 2.03 . . . . 11.78 112.042 170.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.5 tp -59.28 -37.93 78.88 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.378 -3.326 . . . . 19.31 115.613 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -68.1 -64.58 0.83 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.651 2.167 . . . . 23.14 115.085 169.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.51 71.55 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 O-C-N 117.113 -3.492 . . . . 19.74 107.826 174.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -104.02 160.14 15.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.549 1.174 . . . . 21.93 113.885 147.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.1 m -90.96 118.98 30.78 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 115.824 -4.298 . . . . 12.33 105.92 168.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.71 119.17 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 123.914 1.816 . . . . 17.08 107.737 156.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 84.7 m -98.96 108.65 21.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 111.595 -2.548 . . . . 16.3 106.723 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.447 ' CD1' HG13 ' A' ' 26' ' ' VAL . 87.7 mt -107.2 116.87 32.69 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.598 2.359 . . . . 15.88 115.719 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.31 112.42 15.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.531 -1.668 . . . . 28.9 110.211 167.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.29 158.32 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 123.284 0.634 . . . . 12.05 109.949 167.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 56.7 mt-10 -115.79 151.73 46.65 Favored Pre-proline 0 N--CA 1.429 -1.478 0 N-CA-C 102.834 -3.024 . . . . 18.17 102.834 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 22.1 Cg_exo -76.03 -16.4 18.02 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 CA-C-O 114.889 -2.213 . . . . 8.16 113.456 -159.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -70.51 -14.83 62.68 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-N 127.26 4.573 . . . . 11.13 112.931 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 18.3 m-20 -78.32 146.8 34.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.703 -3.748 . . . . 18.03 106.19 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.7 p -78.77 167.89 20.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.336 -3.978 . . . . 10.22 116.489 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.95 -39.88 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 117.427 -1.273 . . . . 12.3 110.234 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -51.1 -39.51 56.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 123.422 2.828 . . . . 36.51 113.233 170.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -57.57 -38.67 75.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.565 -1.335 . . . . 25.66 112.811 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.447 HG13 ' CD1' ' A' ' 15' ' ' LEU . 58.5 t -56.77 -54.42 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 125.925 2.774 . . . . 8.12 111.183 176.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -56.57 -37.38 70.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.981 3.326 . . . . 15.47 119.981 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.23 -32.08 69.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.231 1.491 . . . . 11.45 112.475 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -80.22 -27.89 38.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 118.585 -1.246 . . . . 24.98 108.461 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.9 mt -58.65 -42.21 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 114.749 1.389 . . . . 9.46 114.749 159.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -65.05 -24.91 67.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.867 -2.395 . . . . 14.76 115.96 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.23 -59.82 3.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.442 -3.287 . . . . 26.29 109.445 166.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -73.1 -56.83 4.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.331 2.715 . . . . 30.06 118.331 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -93.95 -53.3 4.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.751 1.621 . . . . 25.19 115.094 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.52 2.9 6.21 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 125.173 2.54 . . . . 7.41 115.995 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.5 mt -68.18 127.55 93.27 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 113.691 -3.052 . . . . 9.49 112.767 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -70.63 155.57 62.82 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 126.974 3.527 . . . . 11.42 115.337 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -62.45 -39.45 45.78 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 CA-C-N 124.552 2.661 . . . . 12.0 110.636 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.73 -8.7 11.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.65 2.833 . . . . 35.55 118.65 170.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -94.68 -32.26 13.45 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.785 -2.447 . . . . 20.52 110.402 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 16.1 pt20 -107.96 154.33 21.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.737 1.384 . . . . 7.13 114.737 -172.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 mtt85 -134.55 164.34 27.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 117.823 -1.084 . . . . 36.39 108.222 157.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -113.31 136.62 52.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.059 3.344 . . . . 9.55 107.15 -174.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -115.76 122.72 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.131 -1.433 . . . . 13.9 107.131 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -113.63 111.14 21.35 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.968 -2.975 . . . . 6.86 102.968 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.08 -75.83 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.446 -2.034 . . . . 11.15 114.972 -164.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.59 9.09 2.61 Favored Glycine 0 N--CA 1.429 -1.807 0 CA-C-N 121.021 1.737 . . . . 13.93 116.463 169.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -107.62 123.76 48.96 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.719 2.2 . . . . 23.92 108.249 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -82.19 121.34 26.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 110.362 -3.108 . . . . 23.23 111.721 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 mt -86.27 156.17 20.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 115.749 -2.072 . . . . 9.11 110.547 -165.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -109.25 142.42 40.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 123.034 2.652 . . . . 33.44 111.265 -173.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.61 -48.75 79.93 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.374 2.67 . . . . 28.37 115.564 -163.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.29 -3.69 71.24 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 118.163 2.025 . . . . 15.0 118.163 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.8 mtt-85 -98.0 170.25 9.06 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.889 1.328 . . . . 25.5 110.286 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -106.43 162.04 14.05 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.927 -1.733 . . . . 11.95 112.521 -170.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.437 HD23 HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -63.58 -25.37 68.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.884 -2.385 . . . . 10.17 114.611 175.178 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.96 -30.19 55.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.664 2.386 . . . . 13.59 112.493 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -63.73 -42.23 97.93 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.542 -3.223 . . . . 11.7 111.246 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -88.99 5.68 43.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.033 2.975 . . . . 12.95 119.033 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 55.36 59.64 3.82 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.833 2.453 . . . . 25.45 111.994 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.437 HD12 HD23 ' A' ' 56' ' ' LEU . 60.6 mt -96.38 122.94 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.125 -1.805 . . . . 14.6 106.125 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -102.34 -174.73 2.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.646 1.688 . . . . 33.23 111.978 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -56.03 149.33 15.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.148 -3.47 . . . . 25.97 115.919 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 39.2 mt-10 66.98 31.04 7.23 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.367 -2.708 . . . . 32.61 113.434 171.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.3 m -93.29 132.21 37.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.798 -2.001 . . . . 10.56 113.375 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.1 m -90.74 124.64 35.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.452 -2.655 . . . . 5.33 108.09 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.322 11.2 mp -109.61 140.02 43.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.997 1.719 . . . . 11.66 111.838 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -98.48 135.36 40.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.135 2.243 . . . . 16.3 115.505 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.5 tp -98.14 125.43 43.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.44 1.59 . . . . 9.96 110.189 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -133.37 148.08 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 121.032 -1.042 . . . . 9.76 110.187 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp -132.49 152.52 51.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.079 -2.193 . . . . 19.57 105.079 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -90.38 -82.87 0.27 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.56 1.544 . . . . 35.08 111.761 -161.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.8 tp -88.11 -35.01 17.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 125.158 2.408 . . . . 32.31 115.573 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -110.65 168.81 9.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.121 -2.237 . . . . 42.75 111.82 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.09 98.54 0.12 Allowed Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 119.491 1.042 . . . . 36.31 111.119 162.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.734 0 N-CA-C 103.768 -3.733 . . . . 36.27 103.768 -164.075 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 122.931 1.348 . . . . 17.17 114.554 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -107.77 155.98 19.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 120.036 3.347 . . . . 21.89 120.036 172.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -138.73 154.54 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 106.817 -1.549 . . . . 10.83 106.817 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -106.83 126.73 52.69 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.401 -2.074 . . . . 10.61 105.401 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.01 108.83 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 120.09 1.314 . . . . 9.13 109.581 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -96.97 135.66 38.65 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.735 -1.121 . . . . 20.55 109.568 -167.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -77.61 171.11 15.42 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.412 1.695 . . . . 11.78 112.007 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -51.5 -56.39 13.63 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 117.093 2.257 . . . . 19.31 117.093 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -85.93 -72.95 0.47 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.442 -2.036 . . . . 23.14 109.324 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.41 48.0 0.17 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 118.658 2.223 . . . . 19.74 118.658 -162.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -110.85 156.27 21.38 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 116.304 -4.056 . . . . 21.93 110.299 157.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.9 m -129.14 135.82 49.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 103.148 -2.908 . . . . 12.33 103.148 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 mt -121.54 112.97 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 114.5 -1.227 . . . . 17.08 108.989 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.7 m -88.19 107.17 18.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.995 0.903 . . . . 16.3 111.479 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.92 112.35 24.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 120.233 3.42 . . . . 15.88 120.233 -173.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -83.59 117.74 23.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.723 -3.735 . . . . 28.9 111.892 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.62 177.84 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.547 -1.971 . . . . 12.05 109.377 -166.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -117.46 160.13 39.13 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 118.488 -2.633 . . . . 18.17 109.951 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -79.48 -6.78 14.72 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 125.253 3.969 . . . . 8.16 110.091 -166.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 m -88.58 -7.22 56.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.711 2.804 . . . . 11.13 115.064 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.49 169.74 11.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 118.703 0.683 . . . . 18.03 112.79 -175.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.5 p -107.9 164.91 11.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.421 2.288 . . . . 10.22 109.029 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 mm -55.83 -47.01 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 126.499 1.92 . . . . 12.3 112.37 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -60.99 -32.7 72.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.21 2.604 . . . . 36.51 115.642 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -67.04 -43.2 83.36 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 122.714 2.507 . . . . 25.66 115.38 162.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.89 -29.24 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 118.435 -2.666 . . . . 8.12 113.004 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -72.68 -34.68 67.35 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.968 2.507 . . . . 15.47 110.476 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -34.92 73.56 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.788 2.835 . . . . 11.45 115.771 169.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -57.87 -52.14 66.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.939 2.896 . . . . 24.98 117.069 162.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.2 mt -60.6 -40.3 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 117.794 -3.066 . . . . 9.46 113.404 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -50.45 -49.0 56.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.513 2.578 . . . . 14.76 112.006 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -46.47 80.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.359 -3.963 . . . . 26.29 116.941 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -63.22 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.063 -2.335 . . . . 30.06 114.954 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -58.97 -64.65 0.86 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.166 2.186 . . . . 25.19 113.663 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.54 62.24 0.33 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 108.476 -1.849 . . . . 7.41 108.476 -171.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.42 HD13 HD11 ' A' ' 71' ' ' LEU . 36.0 mt -127.84 114.05 20.58 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.326 -2.75 . . . . 9.49 113.89 177.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -73.77 150.8 45.16 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 124.809 2.753 . . . . 11.42 113.737 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -57.97 -35.07 99.01 Favored 'Trans proline' 0 N--CA 1.434 -2.003 2 C-N-CA 129.514 6.81 . . . . 12.0 117.451 -166.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.299 38.7 m-20 -74.21 -21.65 59.71 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.603 1.161 . . . . 35.55 111.15 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -78.23 -31.86 49.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.355 3.455 . . . . 20.52 114.097 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -109.65 140.24 43.73 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 113.287 -5.883 . . . . 7.13 111.203 -175.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -123.17 171.74 9.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.747 -1.945 . . . . 36.39 105.747 163.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.25 35.3 mt -123.32 143.32 50.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 125.773 1.92 . . . . 9.55 107.519 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.88 138.68 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.431 2.062 . . . . 13.9 106.38 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -114.07 102.19 9.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.318 -2.739 . . . . 6.86 107.882 171.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.297 . . 58.58 -98.33 0.08 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.735 1.754 . . . . 11.15 115.735 -166.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.47 -6.89 24.95 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 120.704 1.593 . . . . 13.93 109.195 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.8 120.32 30.09 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 113.382 0.882 . . . . 23.92 113.382 -171.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -87.61 116.97 26.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.235 -3.416 . . . . 23.23 111.386 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.0 mt -84.58 126.86 33.7 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.331 -1.481 . . . . 9.11 112.315 -169.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -78.0 134.91 37.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.359 2.664 . . . . 33.44 114.084 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.52 -46.03 91.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.332 1.853 . . . . 28.37 112.657 -155.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.23 -8.02 86.95 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 125.818 1.675 . . . . 15.0 117.247 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.8 mtt-85 -76.64 148.18 37.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.035 -2.45 . . . . 25.5 112.122 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.2 p -81.66 166.41 20.18 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.729 -4.357 . . . . 11.95 110.034 -176.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.74 -19.28 63.54 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.957 1.836 . . . . 10.17 115.957 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 t -91.05 -18.21 24.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.753 2.821 . . . . 13.59 108.563 -172.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -66.78 -21.88 66.04 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.444 -4.535 . . . . 11.7 114.082 163.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -104.24 -20.68 13.71 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.66 -1.154 . . . . 12.95 111.582 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 66.44 61.03 0.58 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.419 1.888 . . . . 25.45 112.083 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -101.29 103.46 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.241 1.816 . . . . 14.6 108.789 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -83.49 -163.42 0.75 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.348 1.61 . . . . 33.23 115.348 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -71.75 159.02 35.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.424 1.89 . . . . 25.97 112.756 170.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 54.04 22.14 3.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.749 2.82 . . . . 32.61 110.206 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -66.22 140.64 58.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.587 1.955 . . . . 10.56 116.08 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -90.75 116.99 29.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.677 3.991 . . . . 5.33 106.498 171.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -112.2 166.53 11.18 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 127.023 2.702 . . . . 11.66 110.498 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -122.86 135.54 54.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 117.81 -1.091 . . . . 16.3 111.269 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 tp -94.16 133.4 37.7 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.974 1.369 . . . . 9.96 107.411 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.9 152.79 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 O-C-N 114.605 -5.059 . . . . 9.76 106.735 161.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 36' ' ' ILE . 7.3 mp -109.92 151.6 26.87 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 115.057 -2.402 . . . . 19.57 110.493 171.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -86.93 -80.43 0.25 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.572 1.987 . . . . 35.08 110.307 -164.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.269 65.4 mt -86.71 -44.44 11.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.431 -2.043 . . . . 32.31 113.476 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -73.67 -164.83 0.23 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.069 2.366 . . . . 42.75 116.683 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.28 123.81 0.67 Allowed Glycine 0 N--CA 1.429 -1.774 0 O-C-N 117.638 -3.164 . . . . 36.31 108.746 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.758 0 C-N-CA 117.239 -2.41 . . . . 36.27 111.88 -176.37 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 114.464 1.283 . . . . 17.17 114.464 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -113.78 135.0 54.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.549 1.643 . . . . 21.89 109.123 -178.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.6 pt -124.19 158.09 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 112.463 -2.153 . . . . 10.83 105.513 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -104.07 114.29 28.43 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.623 1.169 . . . . 10.61 113.38 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.23 116.0 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 116.724 -3.735 . . . . 9.13 102.588 166.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -107.99 133.74 51.88 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.703 3.601 . . . . 20.55 109.97 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.392 17.6 p -79.88 -173.39 3.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.002 1.853 . . . . 11.78 116.002 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.5 tp -79.37 -42.41 25.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.889 2.757 . . . . 19.31 111.817 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p -68.49 -70.2 0.28 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.343 4.257 . . . . 23.14 110.129 174.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.44 55.98 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 104.089 -3.604 . . . . 19.74 104.089 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -117.33 146.19 43.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 120.728 2.264 . . . . 21.93 108.76 159.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -114.48 117.58 31.38 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.286 -2.759 . . . . 12.33 110.392 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 13' ' ' ILE 0.27 0.3 OUTLIER -104.45 104.32 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 103.154 -2.906 . . . . 17.08 103.154 175.178 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.4 m -88.88 111.72 22.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.711 1.204 . . . . 16.3 110.796 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.4 mt -114.26 148.92 36.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 122.853 2.57 . . . . 15.88 107.875 -160.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -106.34 118.93 37.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.382 -1.449 . . . . 28.9 114.697 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.56 170.66 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 124.061 1.886 . . . . 12.05 112.425 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -107.99 164.24 15.21 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.07 -2.894 . . . . 18.17 109.445 167.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -71.06 -24.85 23.32 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.263 1.975 . . . . 8.16 112.447 -172.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.9 m -73.45 -8.08 54.43 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.727 2.811 . . . . 11.13 116.552 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -84.28 142.59 30.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.077 -1.874 . . . . 18.03 112.428 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.7 p -80.04 165.05 22.92 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.288 2.47 . . . . 10.22 113.807 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.455 HD12 HD13 ' A' ' 50' ' ' LEU . 35.6 mm -69.73 -32.31 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 119.535 -1.978 . . . . 12.3 109.448 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -51.66 -35.89 44.16 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.777 1.769 . . . . 36.51 115.777 159.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.69 -35.91 65.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.405 2.526 . . . . 25.66 109.845 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.05 -43.77 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 1 O-C-N 115.841 -4.287 . . . . 8.12 109.785 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -56.64 -33.64 66.5 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.164 2.653 . . . . 15.47 118.164 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.77 -29.21 64.24 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.544 2.592 . . . . 11.45 109.281 -167.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -78.47 -34.08 47.85 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.794 2.037 . . . . 24.98 111.251 174.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.33 -33.57 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 123.859 1.79 . . . . 9.46 110.769 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -59.4 -44.22 92.84 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.418 -2.676 . . . . 14.76 110.607 166.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.94 -41.47 91.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.446 1.098 . . . . 26.29 110.242 -172.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -78.96 -63.94 1.3 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 119.026 0.83 . . . . 30.06 110.041 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -89.72 -20.88 23.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.561 2.06 . . . . 25.19 116.561 -158.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.39 34.24 23.51 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 118.632 2.213 . . . . 7.41 118.632 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -107.99 124.0 36.04 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 119.157 -0.449 . . . . 9.49 111.598 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -66.0 148.02 85.25 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.636 2.224 . . . . 11.42 115.641 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.08 -21.48 12.09 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.162 2.575 . . . . 12.0 109.983 -148.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -70.28 -28.12 64.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.858 1.799 . . . . 35.55 115.858 173.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -81.81 -26.74 34.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.448 -2.033 . . . . 20.52 115.813 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -96.03 152.25 18.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.221 1.408 . . . . 7.13 108.533 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -135.51 168.2 19.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 117.205 -1.378 . . . . 36.39 109.685 167.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 43' ' ' LEU . 35.2 mt -131.71 130.75 42.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 125.388 3.722 . . . . 9.55 110.714 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mt -110.77 116.59 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 112.124 -2.307 . . . . 13.9 110.657 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -96.73 102.07 13.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.107 3.363 . . . . 6.86 109.905 169.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.1 -95.84 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.746 2.018 . . . . 11.15 114.714 -165.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.03 -12.91 26.47 Favored Glycine 0 N--CA 1.43 -1.703 1 C-N-CA 131.204 4.24 . . . . 13.93 112.694 -175.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -104.25 150.14 24.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.705 -2.644 . . . . 23.92 115.354 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -109.79 149.33 29.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.151 2.405 . . . . 23.23 109.752 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.455 HD13 HD12 ' A' ' 23' ' ' ILE . 23.4 mt -90.03 118.84 29.89 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.878 2.071 . . . . 9.11 113.234 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -79.04 150.68 31.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.993 1.378 . . . . 33.44 110.475 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.97 -24.66 55.43 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 115.474 -4.517 . . . . 28.37 112.284 -157.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.18 27.2 10.37 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 121.145 3.218 . . . . 15.0 121.145 -171.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -110.79 174.91 5.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.309 1.843 . . . . 25.5 111.278 162.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.2 p -95.88 167.32 11.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 113.661 0.986 . . . . 11.95 113.661 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.4 -33.66 74.05 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 114.637 1.347 . . . . 10.17 114.637 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.39 -39.65 84.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.698 1.599 . . . . 13.59 114.681 171.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.287 72.5 m-20 -57.57 -37.25 72.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.802 2.041 . . . . 11.7 114.976 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -110.41 4.92 21.04 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.822 -1.547 . . . . 12.95 106.822 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 t30 72.34 45.03 0.39 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.147 -2.22 . . . . 25.45 109.75 162.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.6 mt -94.59 119.89 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 128.11 3.814 . . . . 14.6 111.227 168.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -99.35 175.29 5.92 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.885 -4.259 . . . . 33.23 108.043 169.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -40.77 145.56 0.19 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.347 -3.346 . . . . 25.97 117.446 165.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 70.76 9.5 6.85 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.155 3.382 . . . . 32.61 116.759 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.8 m -78.11 145.58 35.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.398 3.079 . . . . 10.56 108.824 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.3 m -100.69 121.22 41.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.202 1.401 . . . . 5.33 109.145 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.7 mt -104.8 149.36 25.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.317 -0.994 . . . . 11.66 108.317 164.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -99.86 108.42 20.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.577 2.351 . . . . 16.3 110.142 169.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tp -84.54 98.12 9.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.716 -1.865 . . . . 9.96 109.347 171.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.2 156.18 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 119.332 -2.105 . . . . 9.76 107.429 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp -112.09 155.25 24.18 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.741 2.686 . . . . 19.57 107.63 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -76.42 -51.1 12.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.711 3.226 . . . . 35.08 119.711 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.6 mt -143.54 -56.32 0.39 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.079 -2.934 . . . . 32.31 103.079 -161.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -76.43 156.22 33.3 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 114.132 -1.395 . . . . 42.75 112.997 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.87 135.45 1.86 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.383 -1.487 . . . . 36.31 109.383 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.777 0 N-CA-C 103.523 -3.831 . . . . 36.27 103.523 -178.179 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.338 18.0 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 119.101 3.0 . . . . 17.17 119.101 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -102.04 128.72 48.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 119.314 -0.954 . . . . 21.89 112.414 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.321 31.1 pt -118.42 169.33 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.377 1.471 . . . . 10.83 112.649 171.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -132.88 131.6 41.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.46 -2.65 . . . . 10.61 111.953 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.4 t -106.01 114.5 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 103.822 -2.659 . . . . 9.13 103.822 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -79.72 142.43 35.47 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.027 2.822 . . . . 20.55 109.548 167.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.276 17.0 p -93.67 -176.82 4.18 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.686 -2.509 . . . . 11.78 112.167 176.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.66 -25.92 24.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 120.472 1.487 . . . . 19.31 113.169 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -69.7 -55.45 9.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.02 2.343 . . . . 23.14 109.34 161.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.37 58.02 0.18 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.381 -1.45 . . . . 19.74 112.999 164.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.254 42.1 pttt -101.83 149.33 24.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.47 1.108 . . . . 21.93 113.878 172.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.1 m -74.83 114.01 12.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.105 -2.872 . . . . 12.33 118.149 164.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.8 mt -96.52 123.62 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 122.104 0.954 . . . . 17.08 109.052 160.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.5 m -110.5 121.15 44.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 102.508 -3.145 . . . . 16.3 102.508 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.4 mt -115.07 146.49 41.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.742 -2.474 . . . . 15.88 113.074 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -113.35 103.74 11.61 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.701 2.801 . . . . 28.9 104.506 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.2 169.37 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 115.523 -2.179 . . . . 12.05 108.57 -167.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -114.75 158.71 39.73 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 128.491 2.717 . . . . 18.17 104.21 161.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -91.22 -4.83 4.25 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 115.615 -2.457 . . . . 8.16 108.364 -167.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.287 33.1 m -72.67 -11.31 60.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.582 2.438 . . . . 11.13 117.582 164.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -84.22 159.57 20.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 121.451 1.932 . . . . 18.03 112.185 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.2 p -95.63 155.5 16.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.238 -2.164 . . . . 10.22 107.964 -169.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.24 -31.78 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 O-C-N 115.487 -4.508 . . . . 12.3 106.708 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -52.34 -38.89 59.82 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.652 -4.405 . . . . 36.51 112.051 166.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -75.41 -33.01 60.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.651 -2.53 . . . . 25.66 112.514 170.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -72.92 -41.43 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.133 -3.479 . . . . 8.12 111.68 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.32 -23.47 65.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.876 2.917 . . . . 15.47 118.876 166.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.76 -32.2 65.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.603 1.547 . . . . 11.45 114.485 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.254 37.0 mttm -59.3 -40.41 86.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.034 1.734 . . . . 24.98 113.694 163.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.351 55.6 mt -54.27 -43.24 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.773 -3.08 . . . . 9.46 116.629 165.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -66.78 -42.56 85.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.939 1.696 . . . . 14.76 107.031 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -61.53 -59.44 5.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.898 -1.752 . . . . 26.29 113.206 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -61.09 -72.27 0.12 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.806 2.842 . . . . 30.06 112.121 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -77.25 -44.26 30.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 113.473 0.916 . . . . 25.19 113.473 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.92 43.0 2.71 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 129.61 3.481 . . . . 7.41 116.96 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 mt -111.25 117.82 48.86 Favored Pre-proline 0 N--CA 1.43 -1.427 0 O-C-N 121.394 -1.062 . . . . 9.49 111.195 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.66 160.2 31.49 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-O 124.828 1.928 . . . . 11.42 114.784 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HA ' ' HG3' ' A' ' 41' ' ' GLN . 69.7 Cg_endo -86.57 -2.23 8.36 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 114.827 -3.302 . . . . 12.0 111.152 -155.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -88.63 -1.63 58.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 124.428 3.286 . . . . 35.55 112.142 164.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -99.22 -31.07 11.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.334 2.716 . . . . 20.52 118.334 169.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 5.4 pt20 -109.2 152.49 25.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.334 1.854 . . . . 7.13 111.893 -176.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -148.45 154.25 39.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.822 -1.547 . . . . 36.39 106.822 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.7 mt -119.3 148.95 42.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.251 -1.759 . . . . 9.55 106.251 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -127.06 136.64 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 114.161 -1.381 . . . . 13.9 107.537 171.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -114.46 107.94 16.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.766 1.746 . . . . 6.86 107.769 169.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.289 . . 61.89 -68.01 0.06 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.159 3.384 . . . . 11.15 111.155 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -148.53 -16.56 0.11 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 105.961 -2.856 . . . . 13.93 105.961 -172.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' H ' ' H ' ' A' ' 47' ' ' GLY . 51.3 mtpt -88.08 131.26 34.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 126.334 2.968 . . . . 23.92 115.349 174.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -88.6 120.86 30.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.422 -3.923 . . . . 23.23 108.483 -172.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.4 mt -82.72 145.02 29.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.051 2.241 . . . . 9.11 117.051 -167.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -110.54 139.17 46.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.229 2.918 . . . . 33.44 106.388 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.22 -41.2 64.02 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.039 -1.891 . . . . 28.37 112.46 -159.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.11 31.74 4.94 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 121.476 1.944 . . . . 15.0 115.584 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -106.67 -175.33 2.76 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 128.043 2.849 . . . . 25.5 116.257 155.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.7 p -113.27 177.47 4.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.56 1.544 . . . . 11.95 111.311 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.84 -22.65 45.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.066 1.136 . . . . 10.17 114.066 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -74.93 -25.61 59.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.698 -3.126 . . . . 13.59 111.637 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -67.85 -53.77 24.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.092 -2.255 . . . . 11.7 114.481 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -81.56 -17.11 49.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 118.726 -0.654 . . . . 12.95 110.487 -174.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 0.3 OUTLIER 81.51 55.69 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.208 2.432 . . . . 25.45 106.214 -173.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -90.87 101.4 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 1 O-C-N 116.263 -4.023 . . . . 14.6 108.914 171.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 62' ' ' GLN 0.322 12.9 pt20 -90.99 176.0 6.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.247 0.967 . . . . 33.23 112.001 -171.156 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -70.69 148.08 48.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 120.944 3.683 . . . . 25.97 120.944 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.425 24.1 mt-10 51.59 32.64 9.34 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.107 2.861 . . . . 32.61 117.193 -171.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 166.55 10.39 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.365 1.866 . . . . 10.56 108.58 -174.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.0 m -115.99 132.66 56.59 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 112.625 -2.08 . . . . 5.33 110.362 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.45 150.0 28.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 131.148 3.779 . . . . 11.66 107.315 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -105.54 114.75 29.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.771 -1.104 . . . . 16.3 111.246 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 tp -78.18 130.8 36.76 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.202 -2.811 . . . . 9.96 108.732 169.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.3 167.45 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 112.703 -2.044 . . . . 9.76 111.251 156.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.52 178.72 5.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.457 -2.053 . . . . 19.57 105.457 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -114.3 -63.11 1.5 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 117.798 -1.561 . . . . 35.08 111.666 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.7 mt -122.07 -69.71 0.82 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.792 2.037 . . . . 32.31 106.63 -164.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -89.23 149.91 22.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.028 -2.295 . . . . 42.75 114.216 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.62 -28.9 7.67 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 109.239 -3.619 . . . . 36.31 112.598 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.728 0 CA-C-O 116.752 -2.138 . . . . 36.27 111.363 -173.458 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.289 0.8 OUTLIER . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 113.715 1.006 . . . . 17.17 113.715 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -79.01 135.87 37.02 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.087 -4.758 . . . . 21.89 113.134 169.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -120.57 155.54 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.845 -2.409 . . . . 10.83 104.746 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -107.96 123.79 49.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.728 1.611 . . . . 10.61 114.594 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.6 t -109.37 114.9 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 126.087 2.117 . . . . 9.13 111.554 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -101.18 122.61 43.93 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.379 -2.075 . . . . 20.55 111.38 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -79.08 168.95 18.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.389 2.276 . . . . 11.78 114.016 -175.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.43 -16.35 57.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 118.866 2.913 . . . . 19.31 118.866 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 p -76.71 -50.68 13.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.647 -1.615 . . . . 23.14 112.393 166.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.94 39.87 0.19 Allowed Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 125.259 2.589 . . . . 19.74 118.911 162.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -99.27 124.85 44.68 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.692 2.397 . . . . 21.93 112.642 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.277 7.1 m -82.85 97.7 8.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.065 -2.272 . . . . 12.33 110.553 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.7 mt -72.89 123.18 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 106.527 -1.657 . . . . 17.08 106.527 170.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 p -101.21 110.66 22.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.228 2.211 . . . . 16.3 111.427 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.4 mt -118.51 143.82 46.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.697 -1.877 . . . . 15.88 106.913 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -109.85 121.61 45.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.859 2.464 . . . . 28.9 106.891 170.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.94 172.73 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.141 0.972 . . . . 12.05 111.331 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -111.5 160.57 28.9 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 118.727 -2.483 . . . . 18.17 113.27 171.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -86.46 3.31 6.88 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 CA-C-N 125.996 3.177 . . . . 8.16 116.611 -162.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 m -92.98 4.65 53.61 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.274 2.23 . . . . 11.13 109.689 167.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -70.46 131.42 44.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.363 2.801 . . . . 18.03 117.262 161.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.1 p -74.3 158.94 33.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.358 -3.339 . . . . 10.22 114.542 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.508 ' HA ' HD13 ' A' ' 23' ' ' ILE . 30.1 mm -57.2 -28.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 112.178 0.436 . . . . 12.3 112.178 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -55.93 -46.26 78.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.83 2.728 . . . . 36.51 111.424 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -63.95 -45.22 90.13 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.307 -2.745 . . . . 25.66 112.399 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.4 t -57.63 -44.91 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.038 -1.664 . . . . 8.12 114.426 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -60.11 -32.29 70.85 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 119.246 3.054 . . . . 15.47 119.246 165.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.42 82.55 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.05 -4.156 . . . . 11.45 114.661 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -66.03 -21.54 66.39 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 120.02 3.341 . . . . 24.98 120.02 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -74.72 -41.61 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 120.235 -1.541 . . . . 9.46 112.252 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -52.91 -59.64 4.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.605 1.962 . . . . 14.76 114.405 167.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -42.7 -44.73 4.44 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 119.301 3.075 . . . . 26.29 119.301 161.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -76.78 -49.12 16.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.866 -1.771 . . . . 30.06 110.374 -173.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -114.01 -17.61 11.92 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 115.9 1.815 . . . . 25.19 115.9 -160.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.29 29.38 19.84 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 124.726 1.155 . . . . 7.41 115.016 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.7 mt -110.86 115.92 52.65 Favored Pre-proline 0 N--CA 1.43 -1.443 0 C-N-CA 129.067 2.947 . . . . 9.49 109.603 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.512 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.7 Cg_exo -62.53 141.68 87.26 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 N-CA-C 121.672 3.682 . . . . 11.42 121.672 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.1 Cg_exo -74.95 -5.11 16.38 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 127.306 3.645 . . . . 12.0 116.89 -162.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -96.99 -21.06 17.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.016 -2.302 . . . . 35.55 109.762 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -69.75 -41.58 75.04 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 127.127 2.767 . . . . 20.52 110.873 168.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -60.57 141.71 56.3 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 114.976 1.473 . . . . 7.13 114.976 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -132.42 151.65 51.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.375 -2.824 . . . . 36.39 103.375 150.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.1 mt -110.96 141.92 43.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 111.503 -2.59 . . . . 9.55 111.407 166.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 mt -109.53 142.87 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 126.577 1.951 . . . . 13.9 109.194 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -131.5 129.68 41.41 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 123.503 2.865 . . . . 6.86 111.762 157.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.12 44.38 5.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.351 -2.093 . . . . 11.15 109.118 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.81 -30.46 4.62 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 130.49 3.9 . . . . 13.93 114.372 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -94.9 132.73 39.4 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.421 2.058 . . . . 23.92 112.522 -167.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -76.29 137.72 40.08 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.896 -3.002 . . . . 23.23 109.262 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.9 mt -94.42 133.76 37.66 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.022 -2.298 . . . . 9.11 112.658 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.95 173.59 8.14 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 124.9 3.5 . . . . 33.44 111.254 170.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.77 -51.87 10.59 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 124.947 1.404 . . . . 28.37 113.099 -159.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.72 -28.76 73.75 Favored Glycine 0 N--CA 1.43 -1.75 1 O-C-N 131.946 5.779 . . . . 15.0 120.041 -162.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.0 mtt180 -105.66 169.96 8.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 121.421 2.61 . . . . 25.5 111.329 -163.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 27.0 p -83.69 169.73 14.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.634 2.635 . . . . 11.95 114.865 -174.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.2 mt -73.24 -34.03 65.64 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.026 -1.671 . . . . 10.17 110.857 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 t -57.74 -40.02 78.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.472 2.027 . . . . 13.59 116.472 163.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -64.27 -49.89 70.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.518 1.673 . . . . 11.7 115.518 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -57.71 -41.18 81.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.557 1.543 . . . . 12.95 111.194 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 81.96 60.5 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.46 3.504 . . . . 25.45 111.41 -172.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.5 mt -103.0 103.74 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 128.823 2.849 . . . . 14.6 108.878 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -84.88 -179.36 7.07 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.587 2.137 . . . . 33.23 112.075 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -65.39 158.19 27.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.863 -3.648 . . . . 25.97 117.05 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 36.9 mt-10 55.19 27.51 9.75 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 129.473 3.109 . . . . 32.61 114.622 176.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.335 21.8 m -83.22 157.08 22.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 125.427 1.705 . . . . 10.56 114.516 164.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -110.67 95.3 5.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.702 -1.874 . . . . 5.33 113.427 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.17 141.61 35.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.425 1.89 . . . . 11.66 112.316 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -116.4 114.02 23.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.505 -1.372 . . . . 16.3 114.192 -167.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -86.86 115.69 24.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.166 1.913 . . . . 9.96 116.166 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.297 12.3 m -107.92 156.36 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 129.786 3.234 . . . . 9.76 107.386 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.456 ' HB3' ' H ' ' A' ' 72' ' ' ARG . 96.1 mt -120.23 -165.46 1.19 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.729 3.633 . . . . 19.57 106.821 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.456 ' H ' ' HB3' ' A' ' 71' ' ' LEU . 53.9 ttp180 -132.63 139.78 47.9 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 109.983 -3.28 . . . . 35.08 107.561 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.6 tp -65.45 115.02 5.26 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.889 -1.505 . . . . 32.31 112.563 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -100.96 -44.52 5.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.999 -1.852 . . . . 42.75 105.999 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.32 -91.1 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.761 1 C-N-CA 131.248 4.261 . . . . 36.31 108.146 176.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.744 0 N-CA-C 105.672 -2.971 . . . . 36.27 105.672 -176.287 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 124.375 2.036 . . . . 17.17 110.69 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -94.03 135.97 34.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.198 -2.519 . . . . 21.89 104.198 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.2 pt -125.31 135.0 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 116.23 -1.843 . . . . 10.83 108.168 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.1 133.29 34.02 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.528 2.047 . . . . 10.61 116.528 166.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 t -126.9 109.14 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.55 -0.907 . . . . 9.13 108.55 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -89.81 133.58 34.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.768 2.427 . . . . 20.55 113.644 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.6 p -89.54 -167.59 1.9 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.596 -1.184 . . . . 11.78 108.142 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mt -70.47 -66.49 0.59 Allowed 'General case' 0 N--CA 1.43 -1.435 1 C-N-CA 135.113 5.365 . . . . 19.31 114.845 166.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -63.74 -81.96 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.563 -2.585 . . . . 23.14 117.265 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.94 46.86 0.29 Allowed Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 117.908 -1.495 . . . . 19.74 110.798 -166.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -140.46 147.62 39.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 118.906 1.353 . . . . 21.93 110.758 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.4 m -129.51 137.03 50.57 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.203 2.43 . . . . 12.33 107.308 166.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.3 mt -105.62 121.7 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 118.821 -2.425 . . . . 17.08 106.009 -175.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.7 m -90.33 120.74 31.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 116.454 -1.736 . . . . 16.3 109.451 172.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.17 134.33 55.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.357 -1.782 . . . . 15.88 109.839 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -88.44 132.03 34.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 114.938 -2.458 . . . . 28.9 107.379 163.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.27 173.32 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 C-N-CA 133.288 4.635 . . . . 12.05 110.702 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -123.53 143.53 41.78 Favored Pre-proline 0 N--CA 1.43 -1.429 1 O-C-N 116.082 -4.136 . . . . 18.17 110.694 174.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -63.71 -28.66 68.75 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 123.761 2.379 . . . . 8.16 117.558 -159.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.2 p -87.34 4.83 41.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 125.836 1.96 . . . . 11.13 110.489 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -72.88 151.81 41.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.856 3.025 . . . . 18.03 110.079 170.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -82.93 158.18 22.72 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 111.706 -2.497 . . . . 10.22 111.009 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.6 -29.02 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 O-C-N 121.07 -1.019 . . . . 12.3 110.641 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -48.99 -39.57 27.2 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.137 4.175 . . . . 36.51 116.834 158.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -89.32 -16.99 29.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.402 -3.936 . . . . 25.66 109.996 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -78.36 -35.28 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 O-C-N 115.51 -4.494 . . . . 8.12 105.521 173.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -69.23 -29.58 67.54 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.675 2.655 . . . . 15.47 112.47 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.13 -34.19 69.98 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.012 -3.555 . . . . 11.45 114.932 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -84.17 -19.41 34.15 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.482 -2.145 . . . . 24.98 115.102 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mt -80.11 -35.02 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 116.048 -4.157 . . . . 9.46 112.86 167.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.278 0.8 OUTLIER -54.11 -52.52 60.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.944 -2.348 . . . . 14.76 113.039 161.093 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -71.99 -27.17 62.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.835 2.107 . . . . 26.29 114.977 -174.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -74.4 -57.74 3.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.65 -3.156 . . . . 30.06 111.431 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.303 33.6 mm-40 -112.4 -29.08 7.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.676 -1.89 . . . . 25.19 110.926 -168.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.01 28.19 42.49 Favored Glycine 0 N--CA 1.429 -1.771 0 O-C-N 118.035 -2.916 . . . . 7.41 117.314 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.427 HD13 HD21 ' A' ' 71' ' ' LEU . 43.4 mt -80.37 119.51 76.62 Favored Pre-proline 0 N--CA 1.43 -1.47 0 CA-C-O 115.318 -2.277 . . . . 9.49 110.718 162.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -65.1 156.71 61.29 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 122.44 1.907 . . . . 11.42 114.003 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -11.96 33.74 Favored 'Trans proline' 0 N--CA 1.434 -2.021 1 C-N-CA 125.844 4.362 . . . . 12.0 120.671 -174.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -77.54 -38.22 49.17 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 125.206 2.431 . . . . 35.55 116.233 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -61.74 -32.31 72.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.141 2.645 . . . . 20.52 118.141 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -70.95 123.27 21.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.716 2.006 . . . . 7.13 115.118 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -132.38 117.09 17.66 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.241 1.837 . . . . 36.39 109.738 165.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.74 115.89 27.43 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.006 1.322 . . . . 9.55 111.988 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.6 mm -96.42 136.01 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 118.25 -0.881 . . . . 13.9 109.209 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -115.4 117.19 29.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.565 2.439 . . . . 6.86 104.844 162.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.91 -93.08 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.075 2.95 . . . . 11.15 108.142 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.48 4.54 7.15 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 126.564 2.031 . . . . 13.93 109.051 171.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.39 144.1 31.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 121.653 2.727 . . . . 23.92 113.969 -171.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -69.46 137.99 53.09 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.399 2.37 . . . . 23.23 117.399 171.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -106.74 118.28 36.26 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.306 -3.996 . . . . 9.11 108.62 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -85.41 151.04 24.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.017 1.865 . . . . 33.44 113.279 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.01 -49.12 72.33 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 118.038 2.607 . . . . 28.37 118.038 -170.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.75 77.54 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 119.792 2.677 . . . . 15.0 119.792 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 36.0 mmt180 -76.33 170.56 16.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.75 -3.206 . . . . 25.5 113.104 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.252 69.8 p -100.0 167.36 10.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.678 2.18 . . . . 11.95 113.174 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mt -54.45 -45.87 73.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.338 2.255 . . . . 10.17 111.909 164.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -76.24 -22.18 55.48 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.841 -1.527 . . . . 13.59 112.689 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -67.43 -48.3 67.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.933 2.093 . . . . 11.7 109.152 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 55.5 m-85 -85.08 4.7 32.87 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.995 2.591 . . . . 12.95 117.995 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.9 m120 65.96 45.61 2.42 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.458 2.303 . . . . 25.45 110.079 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.2 mt -98.18 108.62 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 127.034 2.134 . . . . 14.6 107.91 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -107.93 -172.87 2.15 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.923 2.297 . . . . 33.23 106.619 -168.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -73.84 134.5 43.32 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.418 -5.176 . . . . 25.97 109.895 -173.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.326 88.8 mt-10 68.96 30.22 4.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.522 3.014 . . . . 32.61 113.536 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -56.31 149.05 17.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 122.172 2.26 . . . . 10.56 110.56 167.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.0 m -106.71 110.94 23.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.536 2.397 . . . . 5.33 104.794 159.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.8 mt -99.53 145.29 27.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.325 -2.734 . . . . 11.66 107.886 170.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -104.61 116.78 32.66 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.351 -1.468 . . . . 16.3 110.509 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.4 tp -95.62 115.26 27.17 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.497 1.498 . . . . 9.96 107.8 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.5 m -109.04 143.92 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.761 1.743 . . . . 9.76 109.278 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.427 HD21 HD13 ' A' ' 36' ' ' ILE . 46.9 mt -124.25 147.81 47.81 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.699 -1.591 . . . . 19.57 114.701 -168.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -84.03 139.56 32.43 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.826 -2.657 . . . . 35.08 103.826 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 tp -74.91 124.89 27.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.305 2.478 . . . . 32.31 113.605 -167.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -122.42 -38.65 2.64 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.925 1.69 . . . . 42.75 110.649 171.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.38 -59.51 0.18 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 116.421 -2.799 . . . . 36.31 119.402 170.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.777 1 O-C-N 115.664 -4.433 . . . . 36.27 105.364 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptt? . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 120.436 0.16 . . . . 17.17 111.175 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -94.04 131.32 39.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.766 1.765 . . . . 21.89 115.766 170.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -103.13 152.55 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 103.741 -2.688 . . . . 10.83 103.741 163.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -101.82 146.82 27.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.861 2.743 . . . . 10.61 110.239 162.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.15 113.67 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 110.121 -3.218 . . . . 9.13 104.489 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.272 9.2 ttmt -107.12 127.32 53.39 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.472 -3.268 . . . . 20.55 110.852 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -95.97 170.38 9.33 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.93 -2.981 . . . . 11.78 109.736 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -68.27 -31.83 71.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.447 2.017 . . . . 19.31 116.447 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -53.62 -64.63 0.76 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.704 -3.123 . . . . 23.14 111.823 166.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.87 76.1 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 106.57 -2.612 . . . . 19.74 106.57 170.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -140.74 153.89 46.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 113.351 -3.339 . . . . 21.93 104.036 163.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -108.75 87.79 2.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.048 2.718 . . . . 12.33 109.811 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.22 124.11 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 124.208 1.956 . . . . 17.08 112.305 168.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.5 m -99.71 111.1 23.47 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.019 -2.355 . . . . 16.3 111.826 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.19 133.86 51.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.186 -2.34 . . . . 15.88 110.239 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -96.1 106.68 18.89 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 116.667 -1.635 . . . . 28.9 110.727 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.48 158.82 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 128.187 3.429 . . . . 12.05 107.063 -174.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -108.94 157.85 35.79 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 107.139 -1.43 . . . . 18.17 107.139 173.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.82 -8.86 16.93 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 O-C-N 116.008 -2.68 . . . . 8.16 114.239 -168.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.4 p -82.81 1.75 37.56 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 118.432 2.752 . . . . 11.13 118.432 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -83.52 156.88 22.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.726 -3.109 . . . . 18.03 111.116 169.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -93.83 164.23 13.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.471 -3.893 . . . . 10.22 115.048 -174.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.67 -39.09 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 119.782 -1.824 . . . . 12.3 109.917 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.39 -43.78 23.73 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.214 2.672 . . . . 36.51 118.214 165.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -67.08 -43.19 83.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.628 2.085 . . . . 25.66 116.628 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -53.24 -52.99 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.029 1.732 . . . . 8.12 110.469 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -70.79 -19.99 62.64 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.81 -3.681 . . . . 15.47 116.832 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.08 65.69 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.872 -4.267 . . . . 11.45 115.056 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -84.51 -28.02 27.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.033 2.933 . . . . 24.98 114.513 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.7 mt -72.89 -44.91 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.168 -1.378 . . . . 9.46 111.229 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -52.14 -50.13 62.35 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.862 2.912 . . . . 14.76 118.862 165.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -49.59 -48.47 48.73 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.974 1.842 . . . . 26.29 115.974 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -78.67 -71.76 0.42 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.088 3.328 . . . . 30.06 115.488 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -74.15 -35.26 64.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.513 -3.867 . . . . 25.19 116.799 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.47 42.73 7.72 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 127.676 3.931 . . . . 7.41 113.433 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.4 mt -104.44 137.72 19.31 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 102.822 -3.029 . . . . 9.49 102.822 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -82.48 146.78 13.83 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 CA-C-N 124.813 2.755 . . . . 11.42 108.821 -174.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -70.78 -3.37 12.55 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 124.265 2.559 . . . . 12.0 115.806 -162.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.42 -22.15 19.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.769 -2.457 . . . . 35.55 110.667 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -80.16 -25.86 39.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.456 3.102 . . . . 20.52 109.794 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HB3' HD11 ' A' ' 69' ' ' LEU . 76.8 mt-30 -71.7 121.73 19.37 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.786 2.034 . . . . 7.13 112.071 170.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -123.1 116.7 23.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.953 1.835 . . . . 36.39 111.268 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.1 tp -102.61 116.41 32.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.953 -1.476 . . . . 9.55 111.976 -166.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mm -103.79 117.17 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 125.92 1.688 . . . . 13.9 109.022 -172.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -97.03 114.44 26.07 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 120.919 1.69 . . . . 6.86 108.93 161.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.89 -98.09 0.06 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 123.892 0.877 . . . . 11.15 111.397 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.85 12.06 8.25 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 127.321 2.391 . . . . 13.93 113.863 166.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -102.19 126.05 49.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.561 -3.905 . . . . 23.92 105.837 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -85.43 126.81 34.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 125.157 1.535 . . . . 23.23 108.059 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.8 mt -90.14 144.86 25.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.44 2.543 . . . . 9.11 116.003 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -100.91 146.76 26.94 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.666 -4.396 . . . . 33.44 110.077 -168.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -45.17 -54.45 6.87 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 129.114 2.965 . . . . 28.37 118.373 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.54 24.56 8.34 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 129.324 3.345 . . . . 15.0 114.593 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -115.63 171.75 7.55 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.849 -1.537 . . . . 25.5 106.849 172.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.8 p -104.86 -177.45 3.37 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.311 -0.859 . . . . 11.95 112.195 172.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.8 mt -80.31 -28.01 38.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.309 -1.769 . . . . 10.17 110.541 169.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -65.95 -43.18 88.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.72 -3.113 . . . . 13.59 116.437 170.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.298 10.8 m-20 -49.75 -39.84 38.98 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.241 2.682 . . . . 11.7 118.241 165.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -94.29 -18.72 21.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.549 -2.594 . . . . 12.95 116.88 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 73.57 54.52 0.11 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.418 2.949 . . . . 25.45 110.104 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mt -93.83 120.7 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 113.73 -1.577 . . . . 14.6 109.487 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -89.48 168.76 11.94 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.992 1.853 . . . . 33.23 108.406 -167.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -64.12 153.95 36.11 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.815 -3.678 . . . . 25.97 109.764 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 41.23 35.11 0.37 Allowed 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 113.808 -5.557 . . . . 32.61 118.621 -169.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -91.88 129.24 37.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.572 -3.205 . . . . 10.56 108.341 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -87.77 122.54 31.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.832 1.049 . . . . 5.33 113.832 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.341 1.5 mt -101.63 149.8 23.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.086 -2.259 . . . . 11.66 110.255 170.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -98.22 130.93 44.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.491 -1.38 . . . . 16.3 107.539 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 41' ' ' GLN . 40.5 tp -114.46 115.58 27.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.47 -2.789 . . . . 9.96 103.47 -171.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.11 164.98 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.518 -2.03 . . . . 9.76 105.518 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.6 mt -105.81 151.68 24.19 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 123.941 1.829 . . . . 19.57 109.787 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -62.6 132.59 52.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.414 2.005 . . . . 35.08 116.414 161.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 tp -97.91 130.23 44.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 115.143 1.535 . . . . 32.31 115.143 174.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -138.42 -111.38 0.17 Allowed 'General case' 0 N--CA 1.43 -1.431 1 C-N-CA 132.426 4.291 . . . . 42.75 105.135 169.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.86 122.87 1.22 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 116.43 -3.919 . . . . 36.31 114.91 165.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.79 0 CA-C-O 115.927 -2.596 . . . . 36.27 116.225 -161.837 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 108.957 -0.757 . . . . 17.17 108.957 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -103.34 144.7 31.01 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 116.223 -4.048 . . . . 21.89 111.849 -176.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.83 160.69 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 109.095 -3.684 . . . . 10.83 107.901 164.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -125.19 112.56 16.59 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.088 2.743 . . . . 10.61 105.558 -166.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 67' ' ' LEU . 48.2 t -104.94 125.42 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.817 -1.179 . . . . 9.13 107.817 -174.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' HG2' HG23 ' A' ' 12' ' ' THR . 79.6 mttt -121.3 127.18 51.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.419 2.372 . . . . 20.55 111.621 -167.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.439 HG22 HD23 ' A' ' 69' ' ' LEU . 30.3 p -70.67 169.86 13.52 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 112.642 -2.072 . . . . 11.78 111.047 168.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.3 mt -81.59 -12.69 58.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.921 -2.987 . . . . 19.31 112.55 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -91.27 -37.32 13.37 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 124.199 1.952 . . . . 23.14 110.431 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.39 38.05 0.35 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 116.53 -2.261 . . . . 19.74 111.871 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -98.99 138.74 35.66 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.741 -2.688 . . . . 21.93 103.741 172.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.445 HG23 ' HG2' ' A' ' 6' ' ' LYS . 76.1 m -114.97 122.81 47.41 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.603 -1.31 . . . . 12.33 108.572 -172.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -101.47 128.76 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 101.721 -3.437 . . . . 17.08 101.721 -170.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.6 m -112.59 112.76 24.51 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.461 2.076 . . . . 16.3 111.999 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.264 73.0 mt -116.25 158.91 22.61 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 111.839 -2.437 . . . . 15.88 112.685 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -113.39 117.52 31.99 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.77 -2.678 . . . . 28.9 103.77 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.23 154.87 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 115.447 -0.797 . . . . 12.05 108.874 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -94.66 147.46 33.23 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 117.517 -1.23 . . . . 18.17 109.173 170.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -66.15 -8.66 20.9 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 127.629 3.76 . . . . 8.16 118.994 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -100.18 12.5 36.85 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 129.642 4.339 . . . . 11.13 120.847 164.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.55 163.99 26.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.141 -1.424 . . . . 18.03 111.47 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.0 p -104.25 164.45 11.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.624 2.083 . . . . 10.22 116.624 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.1 mm -63.57 -36.09 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.943 2.497 . . . . 12.3 111.814 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -53.52 -45.08 69.62 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.48 1.659 . . . . 36.51 115.48 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.17 -41.52 94.58 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.822 2.849 . . . . 25.66 114.729 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.56 -52.99 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 118.682 -2.511 . . . . 8.12 105.635 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -58.69 -35.37 72.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.579 2.609 . . . . 15.47 116.014 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.28 94.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.776 -1.827 . . . . 11.45 114.447 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -74.28 -26.59 60.29 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 115.637 -2.125 . . . . 24.98 108.775 -174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.9 mt -66.92 -29.75 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 124.895 2.283 . . . . 9.46 110.599 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -66.91 -48.3 69.13 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.96 -4.212 . . . . 14.76 114.463 175.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -62.36 -48.39 79.99 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.397 1.999 . . . . 26.29 116.397 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -69.95 -67.15 0.51 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.445 2.069 . . . . 30.06 109.707 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.04 -22.12 31.38 Favored 'General case' 0 N--CA 1.43 -1.425 1 O-C-N 115.838 -4.289 . . . . 25.19 118.75 -165.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.08 27.9 14.92 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 126.106 1.813 . . . . 7.41 111.874 171.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 36' ' ' ILE . 11.1 mt -104.82 125.06 34.82 Favored Pre-proline 0 N--CA 1.43 -1.45 0 C-N-CA 125.908 1.683 . . . . 9.49 109.35 -173.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.65 146.33 30.31 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 122.91 2.075 . . . . 11.42 114.748 -176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.98 -7.27 12.24 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 124.908 2.788 . . . . 12.0 111.269 -162.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.74 -19.04 64.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.024 2.93 . . . . 35.55 114.166 169.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -104.91 -10.32 17.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.558 2.743 . . . . 20.52 109.102 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -94.65 137.12 34.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.468 -2.02 . . . . 7.13 106.068 -173.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -121.81 140.98 51.69 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.704 -1.591 . . . . 36.39 106.704 162.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.26 136.64 54.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.922 -1.111 . . . . 9.55 108.004 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.8 mm -118.34 129.46 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.058 2.143 . . . . 13.9 110.904 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -128.46 117.23 20.98 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.835 -3.666 . . . . 6.86 108.328 169.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.34 . . 58.37 -91.56 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.416 1.887 . . . . 11.15 114.338 -166.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.18 26.08 2.33 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.256 -2.153 . . . . 13.93 112.309 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -115.12 155.33 27.29 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.119 2.568 . . . . 23.92 104.177 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -114.14 137.09 52.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.145 -2.847 . . . . 23.23 106.163 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.521 HD22 ' CE2' ' A' ' 59' ' ' TYR . 30.1 mt -81.77 154.26 26.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.848 2.166 . . . . 9.11 116.848 -167.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -102.11 157.31 16.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.994 2.33 . . . . 33.44 111.541 172.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -76.75 -52.34 9.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 118.789 2.885 . . . . 28.37 118.789 -161.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.82 24.49 5.15 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 116.908 -2.568 . . . . 15.0 118.384 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -90.23 167.29 12.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.952 2.876 . . . . 25.5 111.125 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.1 p -90.24 166.85 13.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.694 -2.504 . . . . 11.95 116.083 171.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.483 HD22 ' H ' ' A' ' 56' ' ' LEU . 2.8 mm? -54.15 -31.94 53.95 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.658 -1.901 . . . . 10.17 114.346 158.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -74.72 -42.08 58.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.006 -1.077 . . . . 13.59 109.619 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -47.95 -34.37 9.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 114.979 -2.438 . . . . 11.7 115.03 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.521 ' CE2' HD22 ' A' ' 50' ' ' LEU . 93.3 m-85 -104.89 -0.87 26.64 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 121.96 2.164 . . . . 12.95 107.273 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.5 m120 71.6 46.25 0.41 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.738 2.815 . . . . 25.45 105.579 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mt -82.6 106.67 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 O-C-N 117.998 -2.939 . . . . 14.6 108.792 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -96.07 -175.11 3.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.148 1.53 . . . . 33.23 111.02 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -65.76 141.91 58.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 124.674 3.397 . . . . 25.97 112.851 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.362 15.3 tt0 80.19 21.08 0.52 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.202 2.601 . . . . 32.61 113.993 174.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.6 m -80.69 144.76 32.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.243 3.417 . . . . 10.56 113.243 -174.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -98.78 101.97 13.55 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.212 2.605 . . . . 5.33 115.009 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.6 mp -99.94 130.8 46.15 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.119 -3.488 . . . . 11.66 109.233 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.261 17.2 m-70 -101.01 142.91 31.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.786 -2.446 . . . . 16.3 108.755 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.439 HD23 HG22 ' A' ' 7' ' ' THR . 19.1 tp -119.86 101.86 8.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.522 -0.763 . . . . 9.96 109.929 -171.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.0 t -96.2 119.0 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 126.493 3.044 . . . . 9.76 108.387 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 mt -84.52 130.44 34.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.036 -2.29 . . . . 19.57 105.551 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -61.56 116.7 4.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 122.875 0.47 . . . . 35.08 111.659 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.71 122.82 27.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.896 -2.378 . . . . 32.31 110.611 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -109.31 -55.03 2.47 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.918 2.087 . . . . 42.75 113.474 159.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.45 -53.13 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.687 0 CA-C-O 125.768 2.871 . . . . 36.31 109.058 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 N-CA-C 106.697 -2.561 . . . . 36.27 106.697 -171.051 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 122.937 1.351 . . . . 17.17 112.899 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -94.25 145.93 24.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 127.646 3.593 . . . . 21.89 108.254 177.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -130.88 167.5 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 103.777 -2.675 . . . . 10.83 103.777 172.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -126.81 137.18 53.16 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 102.841 -3.022 . . . . 10.61 102.841 -174.142 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.75 135.44 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.2 -1.778 . . . . 9.13 106.2 171.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -135.38 135.46 40.69 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.486 2.403 . . . . 20.55 112.769 173.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.515 HG22 HD23 ' A' ' 69' ' ' LEU . 68.2 p -77.87 173.07 12.53 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 113.601 -1.636 . . . . 11.78 113.573 173.048 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.73 -28.23 62.52 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.124 -2.86 . . . . 19.31 112.524 -172.541 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.6 p -75.11 -36.5 61.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.357 -3.339 . . . . 23.14 109.953 166.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.12 42.25 0.37 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 120.972 3.149 . . . . 19.74 120.972 170.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -88.98 115.51 26.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.844 1.794 . . . . 21.93 115.844 176.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 m -92.18 114.24 26.73 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.162 2.585 . . . . 12.33 108.343 -165.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.0 mt -105.07 102.83 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 106.343 -1.725 . . . . 17.08 106.343 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -87.42 115.52 24.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 116.062 1.875 . . . . 16.3 116.062 175.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.7 mt -123.95 151.44 43.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.246 -1.835 . . . . 15.88 115.396 -174.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.5 138.55 31.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.388 1.055 . . . . 28.9 109.651 176.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.305 0.1 OUTLIER -144.84 161.43 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.85 -1.907 . . . . 12.05 105.85 170.235 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -103.23 165.84 12.88 Favored Pre-proline 0 N--CA 1.429 -1.477 0 CA-C-O 115.685 -2.103 . . . . 18.17 106.721 164.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.39 -9.64 14.94 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 124.829 2.76 . . . . 8.16 115.342 -178.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 p -84.13 -19.02 34.91 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 129.766 4.416 . . . . 11.13 109.263 169.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -61.17 149.84 36.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 118.44 -1.304 . . . . 18.03 114.395 167.257 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.292 35.5 p -78.17 174.8 10.79 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.068 -3.52 . . . . 10.22 116.06 171.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 50' ' ' LEU . 28.7 mt -93.59 -17.42 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 117.224 -3.423 . . . . 12.3 107.743 -176.166 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -72.46 -40.57 66.89 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 131.751 4.02 . . . . 36.51 107.298 172.599 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -51.41 -49.82 60.86 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 130.969 3.708 . . . . 25.66 112.457 169.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.18 -52.25 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 124.371 1.044 . . . . 8.12 113.075 173.02 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.73 -29.55 70.08 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 126.45 1.9 . . . . 15.47 111.066 -178.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.77 -27.24 62.82 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 115.221 -2.591 . . . . 11.45 116.56 175.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -72.41 -18.65 61.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.531 1.678 . . . . 24.98 115.531 168.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.3 mt -75.38 -27.96 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 112.494 0.553 . . . . 9.46 112.494 170.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.341 18.1 tt0 -52.31 -42.85 64.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.314 1.968 . . . . 14.76 116.314 160.427 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -78.11 -49.01 14.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.551 1.54 . . . . 26.29 110.116 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -79.63 -58.8 3.01 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.917 2.932 . . . . 30.06 118.917 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.313 6.6 mm-40 -74.53 -44.05 52.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 113.478 0.918 . . . . 25.19 113.478 -177.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.76 53.96 3.05 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 128.369 2.89 . . . . 7.41 107.372 -171.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -118.18 120.1 32.68 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 102.384 -3.191 . . . . 9.49 102.384 174.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -72.85 154.48 53.62 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 CA-C-N 122.825 2.045 . . . . 11.42 114.094 176.375 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -62.48 -16.47 52.27 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 N-CA-C 118.666 2.525 . . . . 12.0 118.666 -173.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.429 ' CG ' HH12 ' A' ' 72' ' ' ARG . 37.5 t70 -76.24 -31.32 58.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 117.607 -1.187 . . . . 35.55 111.948 -174.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -78.4 -18.07 55.53 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 127.4 2.937 . . . . 20.52 114.447 170.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -82.02 122.57 27.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.919 -1.738 . . . . 7.13 114.577 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -111.29 120.8 43.46 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.412 -2.44 . . . . 36.39 104.412 166.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.7 mt -96.32 106.96 19.25 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.339 -2.1 . . . . 9.55 112.26 164.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -89.53 145.28 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 O-C-N 125.619 1.825 . . . . 13.9 108.059 173.066 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -122.83 107.78 12.26 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.086 -1.82 . . . . 6.86 106.086 170.203 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.0 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.4 3.48 . . . . 11.15 111.817 -160.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.74 1.08 9.33 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 116.629 -3.795 . . . . 13.93 114.937 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -102.45 126.88 49.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.717 -2.637 . . . . 23.92 113.349 177.095 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -72.59 125.3 27.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.205 1.821 . . . . 23.23 111.168 171.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.506 HD22 ' CD2' ' A' ' 59' ' ' TYR . 63.4 mt -81.92 166.3 20.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.54 1.064 . . . . 9.11 110.479 -174.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -98.65 158.18 15.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.868 -1.77 . . . . 33.44 113.02 167.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.58 -56.25 6.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.286 2.234 . . . . 28.37 112.163 -174.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.45 13.93 31.93 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 118.272 -2.768 . . . . 15.0 118.852 -175.154 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -106.79 159.15 16.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.619 2.368 . . . . 25.5 107.401 172.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -103.37 170.89 7.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 111.385 -2.643 . . . . 11.95 112.874 -173.005 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.411 HD22 ' H ' ' A' ' 56' ' ' LEU . 1.3 mm? -58.35 -43.14 88.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 126.18 2.175 . . . . 10.17 111.654 174.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -53.84 -35.2 61.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.686 2.794 . . . . 13.59 115.994 174.65 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 14.9 m-20 -80.91 -25.25 37.66 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 112.763 -3.494 . . . . 11.7 114.51 -171.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.506 ' CD2' HD22 ' A' ' 50' ' ' LEU . 80.4 m-85 -95.8 -10.32 29.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 128.879 3.862 . . . . 12.95 110.538 171.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.2 m120 77.72 45.64 0.07 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.542 3.537 . . . . 25.45 113.583 173.496 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -74.56 140.23 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 127.788 2.435 . . . . 14.6 109.141 170.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -97.79 175.98 5.97 Favored 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 132.926 4.49 . . . . 33.23 108.759 178.321 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -68.35 156.11 38.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.094 1.887 . . . . 25.97 116.094 162.077 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 56.62 17.58 3.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.12 1.438 . . . . 32.61 114.1 -178.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -85.03 154.05 22.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.915 -2.991 . . . . 10.56 110.262 177.635 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -99.73 109.96 22.38 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 111.979 -2.373 . . . . 5.33 114.517 -178.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -86.1 156.38 20.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 128.773 3.795 . . . . 11.66 110.111 171.262 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -112.07 140.57 46.64 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 116.915 -3.616 . . . . 16.3 109.014 178.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.515 HD23 HG22 ' A' ' 7' ' ' THR . 48.8 tp -110.53 119.55 39.54 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.854 -1.975 . . . . 9.96 110.484 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.45 135.18 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 101.855 -3.387 . . . . 9.76 101.855 -178.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mt -93.28 153.41 18.59 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.555 -2.387 . . . . 19.57 104.555 -179.016 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.429 HH12 ' CG ' ' A' ' 39' ' ' ASP . 52.2 ttp180 -79.43 119.57 22.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.042 1.877 . . . . 35.08 111.306 166.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.3 mt -92.18 91.79 7.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.426 -2.671 . . . . 32.31 112.023 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -86.06 -56.82 3.28 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.54 -1.35 . . . . 42.75 110.269 166.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.82 116.38 0.59 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 107.373 -2.291 . . . . 36.31 107.373 163.389 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.759 0 CA-C-O 123.42 1.567 . . . . 36.27 113.46 -165.081 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 114.851 -2.5 . . . . 17.17 116.933 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -90.62 132.57 35.68 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.964 -1.493 . . . . 21.89 107.101 -179.267 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -119.64 153.28 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.938 -1.875 . . . . 10.83 105.938 162.718 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -115.18 135.22 54.42 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.409 -2.682 . . . . 10.61 110.628 177.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -100.8 123.78 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.369 -2.707 . . . . 9.13 107.487 176.193 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -108.8 128.28 54.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.458 1.099 . . . . 20.55 108.117 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.3 p -81.17 173.76 12.22 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 117.603 2.446 . . . . 11.78 117.603 -177.334 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.6 mt -67.56 -27.46 66.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.42 -2.05 . . . . 19.31 114.772 166.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -74.08 -48.78 27.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.501 2.32 . . . . 23.14 114.907 175.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 68.06 0.32 Allowed Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.483 -1.447 . . . . 19.74 109.483 178.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -139.63 160.35 40.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.927 -1.511 . . . . 21.93 111.259 164.101 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -124.27 109.61 13.59 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.008 2.068 . . . . 12.33 112.54 -166.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mp -96.96 132.01 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.477 -2.416 . . . . 17.08 104.477 -173.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.302 31.6 m -88.53 96.11 10.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.232 0.958 . . . . 16.3 112.891 -178.031 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.39 119.64 39.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.839 -1.944 . . . . 15.88 110.55 -169.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.79 123.01 32.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.958 -2.339 . . . . 28.9 114.772 169.059 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.34 154.06 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.744 2.818 . . . . 12.05 115.088 -172.412 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -107.57 158.33 33.54 Favored Pre-proline 0 N--CA 1.43 -1.435 0 CA-C-O 115.771 -2.061 . . . . 18.17 112.063 173.927 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.51 -21.45 40.07 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 123.314 2.219 . . . . 8.16 117.216 -175.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -67.88 -11.84 59.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.692 3.597 . . . . 11.13 114.291 172.033 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -79.61 133.6 36.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.683 2.793 . . . . 18.03 113.592 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.8 p -74.2 154.43 39.04 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.881 1.672 . . . . 10.22 110.019 168.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 54' ' ' ARG . 4.3 mp -76.28 -9.24 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.528 -3.233 . . . . 12.3 114.778 174.12 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.01 -35.83 61.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 112.983 -3.389 . . . . 36.51 112.264 162.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -58.95 -42.28 89.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.17 2.414 . . . . 25.66 113.665 173.262 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -66.65 -34.38 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 113.472 -1.695 . . . . 8.12 112.461 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -71.07 -30.5 66.65 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.971 2.319 . . . . 15.47 111.759 -179.617 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.09 -25.94 63.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.472 2.309 . . . . 11.45 114.917 174.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -88.22 -29.84 20.16 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.633 2.159 . . . . 24.98 109.1 -176.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.6 mt -74.65 -37.31 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 118.502 -2.624 . . . . 9.46 116.048 169.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -47.42 -38.33 13.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 119.436 3.125 . . . . 14.76 119.436 159.214 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.273 10.9 t70 -71.77 -53.73 12.45 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 114.816 -2.516 . . . . 26.29 107.137 -176.14 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -71.75 -57.7 4.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.447 2.299 . . . . 30.06 112.483 -172.638 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -92.83 -38.5 11.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.567 -0.901 . . . . 25.19 108.567 -166.406 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.26 37.54 5.34 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 120.619 3.008 . . . . 7.41 120.619 -173.167 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -98.61 127.6 35.32 Favored Pre-proline 0 N--CA 1.429 -1.476 0 O-C-N 119.619 -2.106 . . . . 9.49 108.594 171.477 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.13 139.21 54.81 Favored 'Trans proline' 0 C--N 1.3 -1.997 1 CA-C-O 110.134 -4.194 . . . . 11.42 110.816 175.266 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -82.5 -7.44 11.7 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 CA-C-N 127.836 3.834 . . . . 12.0 117.129 -161.299 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -67.36 -32.68 73.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.165 3.786 . . . . 35.55 113.412 169.603 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -68.7 -50.45 50.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 111.41 -2.632 . . . . 20.52 116.251 168.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -59.69 145.07 46.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 118.891 2.923 . . . . 7.13 118.891 -168.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -123.65 120.95 34.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 124.434 3.288 . . . . 36.39 109.523 167.181 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 43' ' ' LEU . 35.6 mt -103.97 121.45 43.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.633 -1.988 . . . . 9.55 105.633 -178.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -118.13 129.26 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 102.436 -3.172 . . . . 13.9 102.436 -169.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -104.62 106.15 16.53 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.532 -3.855 . . . . 6.86 106.77 170.09 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 72.5 -91.09 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 125.255 2.455 . . . . 11.15 116.748 -171.398 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.64 -19.24 4.18 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 111.716 -2.493 . . . . 13.93 111.966 168.482 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -88.67 121.42 31.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.181 -3.541 . . . . 23.92 111.375 -166.136 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -80.12 122.22 26.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.323 -3.986 . . . . 23.23 109.191 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.52 134.92 46.84 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 128.35 3.531 . . . . 9.11 115.593 175.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -95.56 130.18 42.5 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.542 3.137 . . . . 33.44 111.583 -178.003 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.12 -42.41 69.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 110.944 -2.844 . . . . 28.37 111.703 -165.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.6 4.84 85.18 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 118.762 -2.461 . . . . 15.0 114.888 -176.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.49 ' O ' HD12 ' A' ' 23' ' ' ILE 0.27 95.0 mtt180 -95.0 163.65 13.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.005 2.402 . . . . 25.5 106.554 176.679 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.0 p -95.15 166.35 11.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.9 1.815 . . . . 11.95 115.9 168.24 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -64.18 -29.68 70.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.578 2.351 . . . . 10.17 111.835 168.006 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.251 8.5 t -67.73 -42.07 82.48 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.96 -4.213 . . . . 13.59 112.433 178.484 . . . . . . . . 3 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -58.16 -42.84 86.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 117.19 2.293 . . . . 11.7 117.19 174.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -82.69 4.92 23.03 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 116.485 2.031 . . . . 12.95 116.485 170.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 m120 48.16 55.03 9.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.456 -2.653 . . . . 25.45 113.744 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.83 111.35 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 125.349 1.655 . . . . 14.6 106.744 -177.419 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -81.33 166.4 20.51 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.502 1.521 . . . . 33.23 111.343 174.059 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -63.06 158.87 18.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.553 1.541 . . . . 25.97 114.378 -171.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.289 38.5 mt-10 58.86 24.66 12.68 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.575 2.131 . . . . 32.61 116.534 -177.375 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m -77.71 125.63 29.63 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.113 -1.617 . . . . 10.56 113.687 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.9 m -80.06 126.48 31.12 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.593 1.557 . . . . 5.33 112.002 174.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.405 HD13 HD22 ' A' ' 43' ' ' LEU . 80.3 mt -103.69 150.2 24.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.569 1.148 . . . . 11.66 108.527 169.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -101.43 124.38 47.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.318 -1.734 . . . . 16.3 106.318 170.051 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.8 tp -96.86 128.09 43.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.282 -1.747 . . . . 9.96 106.282 171.172 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.63 155.23 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.735 -2.32 . . . . 9.76 104.735 168.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 43.5 mt -104.2 177.54 4.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 121.027 -1.045 . . . . 19.57 109.418 175.476 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -105.16 118.02 35.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.589 1.956 . . . . 35.08 112.75 -164.401 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.7 tp -100.84 112.16 24.53 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.993 1.479 . . . . 32.31 114.993 -175.523 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.95 -55.01 1.05 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.254 2.221 . . . . 42.75 109.941 169.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.42 98.09 0.12 Allowed Glycine 0 N--CA 1.43 -1.763 1 C-N-CA 131.599 4.428 . . . . 36.31 109.468 169.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.762 1 CA-C-O 112.974 -4.237 . . . . 36.27 122.044 175.433 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 122.88 1.324 . . . . 17.17 111.403 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.76 110.65 21.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.134 -1.604 . . . . 21.89 108.132 -175.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -84.81 145.96 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.195 -1.566 . . . . 10.83 110.841 153.667 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -123.15 89.21 3.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.489 -2.782 . . . . 10.61 103.489 -172.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 62.0 t -80.7 123.17 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.181 -1.414 . . . . 9.13 107.181 179.309 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -114.21 119.26 36.43 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.497 3.522 . . . . 20.55 110.977 -172.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.7 p -77.91 161.56 27.48 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.082 -4.761 . . . . 11.78 113.004 -176.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.6 mt -78.83 -21.78 47.15 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 117.34 -1.744 . . . . 19.31 109.657 -175.101 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.0 p -70.55 -43.71 68.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.083 -2.886 . . . . 23.14 114.16 173.081 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.66 -2.26 0.21 Allowed Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 118.173 2.029 . . . . 19.74 118.173 178.025 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -91.49 145.49 24.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.756 -1.222 . . . . 21.93 110.955 -167.649 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.6 m -115.63 115.35 26.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.873 -2.269 . . . . 12.33 104.873 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.8 mt -96.52 105.51 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.735 2.414 . . . . 17.08 107.318 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -74.59 119.92 19.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.563 1.649 . . . . 16.3 110.655 169.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.322 97.8 mt -130.46 134.62 47.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.333 2.968 . . . . 15.88 103.922 168.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.361 2.2 mt-10 -84.86 107.65 17.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 127.511 3.529 . . . . 28.9 113.678 169.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -116.87 171.34 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.031 -2.293 . . . . 12.05 108.978 177.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -114.72 160.29 33.94 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 127.895 2.478 . . . . 18.17 108.03 176.145 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -68.3 -24.5 37.36 Favored 'Trans proline' 0 N--CA 1.434 -1.978 0 O-C-N 116.216 -2.57 . . . . 8.16 112.726 -170.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.391 7.1 m -88.12 -2.52 58.65 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.917 -1.739 . . . . 11.13 114.686 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -72.96 158.14 36.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 128.328 3.918 . . . . 18.03 114.84 174.024 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.414 43.1 p -95.47 149.62 21.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.296 -2.229 . . . . 10.22 114.804 -176.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mp -66.06 -37.3 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.513 -1.291 . . . . 12.3 107.513 173.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -50.27 -45.46 54.31 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.296 -2.128 . . . . 36.51 113.906 169.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -84.63 7.21 21.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 123.766 2.984 . . . . 25.66 112.797 177.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.269 23.5 t -77.42 -60.04 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 O-C-N 116.746 -3.721 . . . . 8.12 107.255 159.316 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -43.65 -40.66 4.26 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.968 2.581 . . . . 15.47 117.968 175.465 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.315 . . -50.05 -47.47 53.38 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 128.079 2.552 . . . . 11.45 116.697 171.301 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -76.99 -30.94 56.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.102 -2.249 . . . . 24.98 108.252 -175.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.84 -31.75 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 O-C-N 115.967 -4.208 . . . . 9.46 112.86 174.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -69.01 -33.34 73.49 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.161 -1.587 . . . . 14.76 109.611 176.038 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -76.16 -51.92 11.17 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.728 1.611 . . . . 26.29 115.109 177.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -76.91 -42.34 39.92 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 119.669 3.211 . . . . 30.06 119.669 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 48.2 mm-40 -106.4 -25.6 11.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.391 1.682 . . . . 25.19 110.69 -178.252 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.4 18.82 51.74 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 120.305 2.882 . . . . 7.41 120.305 175.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.2 mt -91.12 126.85 53.72 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 101.32 -3.585 . . . . 9.49 101.32 -175.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -56.06 151.56 41.74 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 N-CA-C 120.639 3.284 . . . . 11.42 120.639 171.515 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -86.02 -22.22 2.36 Favored 'Trans proline' 0 C--N 1.3 -2.014 1 CA-C-N 130.077 4.635 . . . . 12.0 116.128 -161.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -84.12 -23.09 30.87 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.37 2.033 . . . . 35.55 110.821 -174.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -61.52 -28.15 69.11 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.201 2.6 . . . . 20.52 114.385 162.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -87.8 122.93 32.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 116.716 -1.612 . . . . 7.13 112.34 -170.179 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -113.97 131.24 56.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 122.363 2.347 . . . . 36.39 112.181 166.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.53 122.25 39.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.207 -3.433 . . . . 9.55 114.698 171.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.7 mt -106.95 118.58 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.88 -2.267 . . . . 13.9 104.88 172.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' A' ' 50' ' ' LEU . 33.6 t80 -106.04 121.81 44.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.603 1.668 . . . . 6.86 107.978 167.247 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.318 . . 52.55 -99.2 0.08 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.098 1.888 . . . . 11.15 116.098 -174.761 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.26 -17.82 13.18 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 117.554 1.782 . . . . 13.93 117.554 -173.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -109.6 133.08 53.52 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.513 2.725 . . . . 23.92 111.236 -165.586 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -79.63 128.25 33.17 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.655 -1.278 . . . . 23.23 108.719 173.622 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 45' ' ' PHE . 23.2 mt -95.05 126.52 40.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.782 2.083 . . . . 9.11 115.856 -165.793 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 54' ' ' ARG . 34.2 tt0 -82.28 139.38 34.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.786 2.232 . . . . 33.44 111.308 171.14 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.24 -50.16 61.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.157 2.583 . . . . 28.37 113.471 -160.168 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.03 3.93 86.53 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 127.385 2.421 . . . . 15.0 113.34 -162.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 51' ' ' GLU 0.284 22.6 mtt180 -85.5 162.52 18.9 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.988 2.115 . . . . 25.5 111.689 172.925 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -88.91 168.4 12.43 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 116.563 -2.055 . . . . 11.95 110.562 178.379 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.94 -25.25 60.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.994 -1.912 . . . . 10.17 111.655 169.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.8 t -63.77 -41.61 97.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.652 2.093 . . . . 13.59 116.652 172.041 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -47.31 -46.93 25.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.626 2.631 . . . . 11.7 116.259 175.086 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -86.14 1.24 51.3 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.122 -2.236 . . . . 12.95 115.601 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.37 17.3 m-20 75.98 32.45 0.64 Allowed 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.734 2.683 . . . . 25.45 113.501 169.013 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.56 113.85 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.35 -2.719 . . . . 14.6 109.129 -170.528 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -111.29 -171.11 1.77 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.284 1.992 . . . . 33.23 109.182 -174.017 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -71.36 148.13 47.32 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 115.142 -2.361 . . . . 25.97 112.773 -168.202 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 49.65 29.48 3.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 119.728 3.233 . . . . 32.61 119.728 -165.41 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -68.66 148.26 50.69 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 116.091 1.885 . . . . 10.56 116.091 170.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -104.08 117.63 34.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 121.235 0.541 . . . . 5.33 110.805 171.159 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.37 151.04 25.4 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.364 -3.335 . . . . 11.66 108.343 175.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -93.77 130.03 39.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.35 1.656 . . . . 16.3 115.038 178.11 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.5 tp -109.69 95.12 5.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.315 2.007 . . . . 9.96 112.611 178.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -97.24 126.37 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 128.13 2.572 . . . . 9.76 111.807 176.14 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.3 mt -93.19 162.85 13.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.281 -1.512 . . . . 19.57 112.085 177.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -90.4 131.81 35.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.876 -2.39 . . . . 35.08 113.147 -178.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.313 84.5 mt -97.32 94.52 7.13 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 121.382 -0.824 . . . . 32.31 111.469 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -114.71 -67.49 0.99 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.408 2.283 . . . . 42.75 113.043 -176.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.14 62.55 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.718 0 O-C-N 127.259 2.849 . . . . 36.31 108.387 -175.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.716 0 O-C-N 119.22 -2.341 . . . . 36.27 116.631 179.447 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 107.733 -1.21 . . . . 17.17 107.733 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -112.61 147.18 37.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.206 -1.559 . . . . 21.89 112.09 174.034 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.98 170.77 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.851 -1.907 . . . . 10.83 105.851 164.133 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -131.71 126.1 33.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.432 -3.292 . . . . 10.61 107.825 -175.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.0 t -97.77 118.76 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.983 -2.323 . . . . 9.13 110.138 168.08 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -103.56 137.23 41.91 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.452 -2.795 . . . . 20.55 103.452 -176.175 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 11' ' ' LYS . 48.9 p -97.84 179.79 4.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.504 -0.748 . . . . 11.78 111.685 -168.33 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.94 -33.78 75.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.358 -2.714 . . . . 19.31 113.705 177.142 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.1 p -76.49 -32.13 58.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.176 -2.821 . . . . 23.14 105.643 175.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.54 30.03 4.81 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-O 124.096 1.942 . . . . 19.74 116.994 -166.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 7' ' ' THR . 58.8 tttm -84.97 138.92 32.18 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 114.427 -5.16 . . . . 21.93 107.525 160.996 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -109.14 129.11 55.48 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 129.1 2.96 . . . . 12.33 110.923 177.528 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.94 115.01 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.423 1.889 . . . . 17.08 109.183 -174.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.9 m -79.86 124.74 28.92 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.835 -2.416 . . . . 16.3 113.628 175.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.669 HD22 ' HB3' ' A' ' 29' ' ' LYS . 85.5 mt -128.26 134.07 48.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.324 -1.732 . . . . 15.88 106.324 -173.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -101.89 111.8 24.19 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.186 1.921 . . . . 28.9 116.186 -173.617 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.24 170.66 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.433 -1.417 . . . . 12.05 111.904 -165.541 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -120.95 162.54 34.62 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 113.696 -3.049 . . . . 18.17 107.584 177.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.32 51.1 Cg_exo -51.77 -21.58 11.79 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 N-CA-C 121.685 3.687 . . . . 8.16 121.685 173.068 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 t -106.81 4.02 27.07 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.01 1.724 . . . . 11.13 113.466 -171.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -75.74 161.69 28.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.385 1.254 . . . . 18.03 114.385 159.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.1 p -103.96 175.41 5.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.565 -1.198 . . . . 10.22 113.797 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.439 ' N ' HD12 ' A' ' 23' ' ' ILE . 2.4 mp -71.88 -31.63 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.181 -2.199 . . . . 12.3 109.713 -178.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -44.93 -41.69 7.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.547 2.425 . . . . 36.51 117.547 164.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -68.9 -26.91 65.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.979 -1.918 . . . . 25.66 114.713 177.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.16 -42.52 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 126.693 1.997 . . . . 8.12 109.729 176.123 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -53.88 -44.27 70.31 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.334 1.605 . . . . 15.47 115.334 171.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.26 -38.48 41.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.145 2.646 . . . . 11.45 118.145 170.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.669 ' HB3' HD22 ' A' ' 15' ' ' LEU . 45.9 mttm -75.63 -29.0 59.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 124.598 1.186 . . . . 24.98 111.693 -177.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.94 -33.56 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 122.591 1.186 . . . . 9.46 109.033 175.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -64.26 -53.06 54.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.245 -1.798 . . . . 14.76 115.583 178.38 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -54.0 -53.06 58.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.147 -2.751 . . . . 26.29 115.039 165.774 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -78.43 -71.49 0.43 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.119 1.438 . . . . 30.06 111.732 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -79.18 -25.04 42.83 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 115.692 -4.38 . . . . 25.19 114.94 -167.22 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.61 46.96 4.43 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 128.87 3.128 . . . . 7.41 115.666 -178.543 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.58 132.99 22.85 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 118.793 1.297 . . . . 9.49 113.271 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -67.35 147.77 78.5 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 CA-C-O 110.233 -4.153 . . . . 11.42 118.532 -178.763 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -64.78 -18.95 64.01 Favored 'Trans proline' 0 C--N 1.299 -2.027 2 C-N-CA 130.096 7.197 . . . . 12.0 108.429 -172.146 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.362 7.5 t70 -102.55 -33.39 9.5 Favored 'General case' 0 N--CA 1.429 -1.477 1 CA-C-N 126.383 4.174 . . . . 35.55 108.976 -169.105 . . . . . . . . 3 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -46.89 -41.36 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.809 2.444 . . . . 20.52 113.452 165.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB2' HD11 ' A' ' 69' ' ' LEU . 4.4 pt20 -97.96 148.21 23.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.616 2.627 . . . . 7.13 113.86 178.493 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -136.06 137.51 41.18 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.38 -4.575 . . . . 36.39 108.408 173.588 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.93 143.43 38.18 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.107 -4.121 . . . . 9.55 109.357 -172.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mt -122.52 147.82 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 129.186 2.994 . . . . 13.9 109.342 -177.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -137.59 116.09 12.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 100.257 -3.979 . . . . 6.86 100.257 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.29 -104.01 0.13 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.246 -1.797 . . . . 11.15 113.072 -164.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.06 16.53 5.24 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 107.312 -2.315 . . . . 13.93 107.312 171.063 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -100.89 143.43 31.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 120.878 2.339 . . . . 23.92 107.633 170.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -91.91 133.15 35.94 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.372 3.469 . . . . 23.23 113.447 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.16 157.64 16.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.443 3.021 . . . . 9.11 117.957 -175.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -90.83 154.23 19.65 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.846 2.26 . . . . 33.44 111.104 161.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -77.05 -47.95 19.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.299 -2.228 . . . . 28.37 108.219 -163.096 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.84 11.46 62.55 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.439 -1.413 . . . . 15.0 114.578 -159.23 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -101.95 146.91 27.19 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.371 2.268 . . . . 25.5 105.361 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 8.4 p -82.07 156.98 24.3 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.24 2.448 . . . . 11.95 113.959 -169.558 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.56 -35.23 72.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.523 -3.236 . . . . 10.17 105.456 -177.105 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.5 t -69.04 -29.24 67.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.816 2.553 . . . . 13.59 113.884 174.139 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -59.44 -56.6 19.95 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.838 -4.289 . . . . 11.7 111.86 176.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -79.96 0.39 31.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.149 0.98 . . . . 12.95 112.677 -177.584 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.428 72.2 m-80 65.9 49.18 1.69 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.843 2.905 . . . . 25.45 118.843 -176.178 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mt -93.34 110.27 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.122 2.569 . . . . 14.6 108.304 179.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -96.14 -168.03 1.68 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.602 -1.635 . . . . 33.23 110.407 -172.04 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -72.26 146.05 47.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.891 -1.049 . . . . 25.97 109.389 176.18 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 28.6 mt-10 73.3 30.01 1.59 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.737 -1.208 . . . . 32.61 107.737 170.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 m -90.18 116.89 28.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.567 2.127 . . . . 10.56 108.221 -170.271 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.8 m -72.21 108.08 5.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.486 -3.258 . . . . 5.33 113.73 165.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -98.69 166.03 11.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.998 3.319 . . . . 11.66 102.884 173.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -121.19 138.77 54.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.049 -1.657 . . . . 16.3 113.506 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 41' ' ' GLN . 29.6 tp -103.04 121.76 43.23 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.157 -1.423 . . . . 9.96 107.157 -179.249 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.91 131.36 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.995 -2.224 . . . . 9.76 104.995 170.62 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -104.61 144.64 31.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 122.31 1.052 . . . . 19.57 109.259 -177.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -79.51 143.13 35.16 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.341 1.056 . . . . 35.08 113.773 176.02 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 tp -83.08 87.62 6.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.982 3.313 . . . . 32.31 108.74 170.446 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -130.3 -76.51 0.54 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.242 2.448 . . . . 42.75 105.592 165.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 166.02 16.35 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 120.762 3.065 . . . . 36.31 120.762 -175.463 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.781 0 CA-C-O 115.709 -2.717 . . . . 36.27 111.642 -175.522 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 114.604 1.335 . . . . 17.17 114.604 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.25 138.01 52.25 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 118.236 -1.386 . . . . 21.89 109.996 -173.169 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 3' ' ' ILE . 42.3 pt -123.22 151.87 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 123.318 0.647 . . . . 10.83 111.886 170.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -106.71 134.74 49.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.153 -2.217 . . . . 10.61 106.684 -168.618 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.84 108.62 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 126.785 3.183 . . . . 9.13 107.849 -175.35 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -91.65 129.76 37.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.283 -3.386 . . . . 20.55 116.895 -173.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.65 156.85 16.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.725 -1.954 . . . . 11.78 105.725 173.626 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.76 -49.3 40.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.471 -3.268 . . . . 19.31 113.148 -164.619 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.364 29.8 p -49.69 -79.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.908 2.483 . . . . 23.14 115.176 166.232 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.93 161.34 29.54 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 116.869 -3.645 . . . . 19.74 105.243 -177.629 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HE2' HG22 ' A' ' 13' ' ' ILE . 75.8 tttt 86.23 126.9 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.97 2.508 . . . . 21.93 115.585 166.642 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.7 m -120.22 105.67 11.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.57 2.348 . . . . 12.33 106.897 -175.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.417 HG22 ' HE2' ' A' ' 11' ' ' LYS . 12.0 pt -88.02 152.03 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.059 -1.65 . . . . 17.08 112.955 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -111.5 113.06 25.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 113.225 -1.807 . . . . 16.3 110.145 -173.454 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 15' ' ' LEU . 1.3 mm? -108.62 139.38 43.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.951 2.786 . . . . 15.88 107.409 176.595 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -84.3 125.8 32.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.781 -3.075 . . . . 28.9 108.589 172.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -149.82 175.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 117.488 -3.257 . . . . 12.05 110.768 -176.913 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -115.34 148.92 41.88 Favored Pre-proline 0 N--CA 1.429 -1.493 1 O-C-N 116.277 -4.015 . . . . 18.17 109.279 176.583 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -64.6 -8.48 17.49 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 125.735 4.29 . . . . 8.16 115.74 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.8 m -105.76 16.52 25.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.541 -2.022 . . . . 11.13 105.541 177.611 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.84 153.51 25.13 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.523 -2.611 . . . . 18.03 111.921 168.405 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.8 p -87.01 164.61 16.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.517 2.58 . . . . 10.22 105.249 -176.645 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -75.6 -21.9 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 116.708 -3.745 . . . . 12.3 109.796 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.29 -32.6 66.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.731 2.412 . . . . 36.51 113.057 163.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -88.37 -21.84 24.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.892 -1.049 . . . . 25.66 110.715 -177.692 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -73.92 -49.56 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 118.104 -2.873 . . . . 8.12 107.023 169.55 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -46.57 -45.18 18.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.45 1.9 . . . . 15.47 112.071 170.403 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.14 95.68 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.634 2.774 . . . . 11.45 111.746 -175.007 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -62.5 -43.22 99.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.223 1.809 . . . . 24.98 113.638 169.186 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 mt -63.19 -38.83 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 116.879 2.177 . . . . 9.46 116.879 171.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.1 -29.24 70.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.317 2.247 . . . . 14.76 111.102 177.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -79.93 -56.59 4.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.904 -2.372 . . . . 26.29 116.412 166.168 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -78.13 -48.43 15.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.622 -1.251 . . . . 30.06 107.622 -156.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 6.1 mm-40 -85.89 -45.66 11.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.931 1.086 . . . . 25.19 113.931 169.745 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.44 66.36 1.65 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 121.789 0.66 . . . . 7.41 111.73 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.7 mt -112.36 118.99 44.68 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 102.066 -3.309 . . . . 9.49 102.066 166.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.53 154.64 63.28 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 CA-C-N 124.767 2.738 . . . . 11.42 113.784 -178.244 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -73.52 -13.15 25.01 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 O-C-N 112.611 -4.468 . . . . 12.0 117.906 -165.259 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -92.91 -10.13 37.63 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 125.06 1.475 . . . . 35.55 112.069 175.839 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -84.14 -7.23 59.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.23 -1.544 . . . . 20.52 114.21 168.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -95.64 123.68 39.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 113.937 -2.935 . . . . 7.13 108.663 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.436 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 65.6 ttt180 -105.51 102.21 11.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.167 3.417 . . . . 36.39 106.877 165.404 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.8 mt -90.9 99.17 12.25 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 123.376 2.807 . . . . 9.55 110.693 -177.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.4 mt -104.49 116.71 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 129.369 3.068 . . . . 13.9 109.608 -176.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -93.09 113.74 26.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.944 -2.613 . . . . 6.86 103.944 165.257 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.12 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.527 2.584 . . . . 11.15 116.695 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.02 18.3 1.21 Allowed Glycine 0 N--CA 1.429 -1.775 1 O-C-N 116.049 -4.157 . . . . 13.93 117.054 176.067 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -135.18 142.8 46.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 101.139 -3.652 . . . . 23.92 101.139 171.023 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -96.35 165.89 11.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.613 -3.179 . . . . 23.23 113.528 173.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.08 156.96 17.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 127.156 2.785 . . . . 9.11 112.329 -162.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.261 40.2 mt-10 -99.51 141.09 32.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.009 2.338 . . . . 33.44 112.14 -173.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -70.31 -51.26 31.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.668 -3.145 . . . . 28.37 115.615 -154.239 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.46 15.3 41.37 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 123.03 3.972 . . . . 15.0 123.03 171.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -101.44 162.72 12.69 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.47 2.308 . . . . 25.5 109.302 168.327 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.0 p -107.31 172.35 6.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 114.692 1.367 . . . . 11.95 114.692 -169.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 56' ' ' LEU . 93.8 mt -64.39 -35.41 80.81 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.081 -2.262 . . . . 10.17 114.917 166.169 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -54.25 -46.69 72.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.881 2.178 . . . . 13.59 116.881 161.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -59.07 -37.03 76.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 124.23 3.195 . . . . 11.7 115.447 176.086 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -90.55 12.7 17.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.363 -2.711 . . . . 12.95 115.385 173.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.52 6.5 t30 46.61 42.36 11.17 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.95 2.574 . . . . 25.45 117.95 -172.262 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -93.07 99.07 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 118.437 -2.665 . . . . 14.6 108.119 -178.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -79.93 176.13 10.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.225 2.61 . . . . 33.23 109.682 172.248 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -71.48 151.61 43.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.248 -2.782 . . . . 25.97 116.549 -174.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.29 45.2 mt-10 75.17 11.68 3.47 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.733 2.52 . . . . 32.61 114.687 -173.442 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.309 70.9 m -73.76 145.93 44.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.896 1.331 . . . . 10.56 112.199 -176.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -96.73 123.06 40.31 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.388 -2.695 . . . . 5.33 113.288 173.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.305 65.7 tp -126.16 150.08 48.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.137 -2.852 . . . . 11.66 105.974 175.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -111.59 122.47 47.91 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.658 -2.526 . . . . 16.3 112.623 -167.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -98.56 103.17 15.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.223 -2.88 . . . . 9.96 103.223 -178.18 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 42' ' ' ARG 0.257 15.3 t -100.14 168.26 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 110.316 -3.129 . . . . 9.76 111.496 170.998 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tp -78.77 138.37 38.18 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.746 -1.205 . . . . 19.57 107.746 176.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -106.25 128.1 53.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 127.056 3.312 . . . . 35.08 113.458 166.054 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.5 mt -93.9 154.87 17.48 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.138 -5.351 . . . . 32.31 111.533 173.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -82.32 122.64 28.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 127.011 3.291 . . . . 42.75 112.239 177.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.13 57.55 0.15 Allowed Glycine 0 N--CA 1.43 -1.742 1 N-CA-C 102.362 -4.295 . . . . 36.31 102.362 -171.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.749 0 CA-C-O 116.272 -2.404 . . . . 36.27 114.666 -170.392 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptt? . . . . . 0 CA--C 1.489 -1.367 0 CA-C-O 123.058 1.409 . . . . 17.17 111.717 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -96.66 137.29 35.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.978 2.799 . . . . 21.89 112.339 167.03 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.6 pt -119.5 162.29 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 117.349 -3.345 . . . . 10.83 105.87 175.408 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -119.73 136.39 54.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.219 2.208 . . . . 10.61 109.176 -177.088 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.35 103.02 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 102.524 -3.139 . . . . 9.13 102.524 -173.028 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -86.4 118.41 25.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.411 -2.056 . . . . 20.55 108.584 -176.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -84.07 -170.96 3.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.289 1.618 . . . . 11.78 109.267 -173.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.0 -25.37 19.74 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.753 -4.342 . . . . 19.31 109.329 -171.417 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.7 p -90.43 -72.14 0.59 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.232 2.208 . . . . 23.14 115.695 -173.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.8 35.9 0.18 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-O 117.065 -1.964 . . . . 19.74 111.876 177.162 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -122.84 151.58 41.55 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.534 -2.025 . . . . 21.93 105.534 175.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.7 m -125.71 121.9 34.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.374 -2.084 . . . . 12.33 105.374 169.299 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.572 HD11 HG23 ' A' ' 30' ' ' ILE 0.305 48.5 pt -103.39 141.56 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.503 -2.623 . . . . 17.08 113.065 -178.61 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -104.08 116.03 31.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.969 -2.234 . . . . 16.3 104.969 -173.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.91 133.07 56.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.262 1.392 . . . . 15.88 111.256 175.227 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -106.95 118.21 36.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.459 2.552 . . . . 28.9 108.678 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 m -139.71 145.3 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 131.469 3.908 . . . . 12.05 107.501 -152.704 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.2 147.85 34.55 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 125.305 1.442 . . . . 18.17 107.906 166.769 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.92 -26.3 22.3 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 123.746 2.964 . . . . 8.16 114.565 -177.039 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.0 m -70.12 0.24 6.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.525 2.417 . . . . 11.13 117.525 161.054 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -70.72 142.3 51.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.704 -3.123 . . . . 18.03 117.674 163.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.269 7.3 p -73.9 158.61 34.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.644 2.778 . . . . 10.22 109.759 178.601 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 50' ' ' LEU 0.284 26.9 mm -67.07 -34.45 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 119.283 0.947 . . . . 12.3 111.884 173.38 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -47.94 -42.7 28.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.623 -2.548 . . . . 36.51 115.306 162.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -71.91 -27.36 62.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.546 -3.846 . . . . 25.66 112.456 -178.335 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -68.38 -49.0 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 130.55 3.54 . . . . 8.12 110.639 172.114 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -55.16 -38.62 68.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.569 2.063 . . . . 15.47 116.569 173.243 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.46 -35.71 53.11 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.13 -1.606 . . . . 11.45 114.974 173.245 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -76.9 -31.5 56.77 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 117.276 2.324 . . . . 24.98 117.276 176.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.572 HG23 HD11 ' A' ' 13' ' ' ILE . 1.2 mt -70.23 -32.63 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.58 1.552 . . . . 9.46 109.282 172.295 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -74.14 -36.0 64.11 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.36 -1.462 . . . . 14.76 109.802 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.99 -51.28 62.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.068 1.413 . . . . 26.29 112.476 177.508 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -80.62 -55.37 4.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.256 -3.403 . . . . 30.06 112.132 -168.662 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.403 ' HB2' HG13 ' A' ' 36' ' ' ILE . 69.3 mm-40 -94.73 -34.36 12.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.316 0.962 . . . . 25.19 111.485 -167.618 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.72 54.06 1.99 Allowed Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 127.114 2.292 . . . . 7.41 113.276 -177.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.456 HD13 HG21 ' A' ' 36' ' ' ILE . 14.0 mt -113.37 103.45 55.5 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 113.671 -3.061 . . . . 9.49 104.121 -175.601 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -57.56 141.45 95.24 Favored 'Trans proline' 0 C--N 1.3 -1.999 1 CA-C-N 131.862 5.272 . . . . 11.42 116.688 -178.522 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.267 19.7 Cg_endo -70.72 -18.82 32.23 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 125.018 3.812 . . . . 12.0 114.177 -159.785 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.26 -32.07 58.65 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.195 2.902 . . . . 35.55 108.552 -178.387 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -73.35 -5.73 41.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.493 -2.629 . . . . 20.52 116.322 172.156 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -105.39 139.86 39.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.709 1.243 . . . . 7.13 108.682 -177.6 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -138.58 118.04 12.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.703 -3.123 . . . . 36.39 109.276 162.497 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.2 mt -86.38 129.67 34.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 113.975 1.102 . . . . 9.55 113.975 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mt -120.12 135.59 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 117.829 -1.082 . . . . 13.9 113.706 177.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -106.22 103.18 12.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.841 -2.281 . . . . 6.86 104.841 172.803 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.359 . . 62.9 -110.89 0.35 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.242 1.817 . . . . 11.15 113.646 -170.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.19 -8.31 78.62 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 121.19 3.236 . . . . 13.93 121.19 169.625 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -115.47 115.65 26.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.745 1.26 . . . . 23.92 110.502 -165.037 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -71.73 133.93 45.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.714 2.406 . . . . 23.23 108.904 170.542 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -95.38 137.53 34.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.423 -2.227 . . . . 9.11 112.332 -177.618 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HB3' ' HG3' ' A' ' 54' ' ' ARG . 38.7 tt0 -88.06 139.8 30.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 123.503 2.865 . . . . 33.44 109.14 174.502 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -32.39 -74.52 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 136.12 5.768 . . . . 28.37 113.407 172.478 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.03 43.13 3.14 Favored Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 117.853 -2.118 . . . . 15.0 113.738 -171.403 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.402 ' HG3' ' HB3' ' A' ' 51' ' ' GLU . 18.4 mtt180 -130.49 157.25 43.17 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.861 2.064 . . . . 25.5 107.779 174.047 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.0 p -87.33 176.32 7.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 124.089 3.131 . . . . 11.95 113.243 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.21 -43.03 92.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 130.064 3.346 . . . . 10.17 106.848 161.244 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -64.67 -31.95 73.4 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 115.2 1.555 . . . . 13.59 115.2 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -60.78 -55.22 35.72 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.0 -2.313 . . . . 11.7 112.995 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -71.61 15.32 0.14 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 114.489 -2.672 . . . . 12.95 116.816 166.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 41.39 40.0 1.15 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.98 2.627 . . . . 25.45 116.939 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -82.15 116.35 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.011 -1.848 . . . . 14.6 106.011 -178.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.454 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 55.8 mt-30 -98.2 -150.59 0.36 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.841 -2.412 . . . . 33.23 108.883 -175.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 62' ' ' GLN . 12.5 pttp -76.73 156.02 32.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.956 -1.474 . . . . 25.97 111.087 -167.413 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 16.8 mt-10 65.3 9.1 5.39 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.029 1.732 . . . . 32.61 112.843 164.025 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -65.29 132.79 49.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.135 -3.478 . . . . 10.56 117.96 177.353 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.291 85.3 m -82.97 113.55 20.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.132 1.901 . . . . 5.33 116.132 169.161 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.79 156.0 18.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.147 2.403 . . . . 11.66 108.824 171.658 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -107.46 126.99 53.19 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.385 -2.45 . . . . 16.3 104.385 -171.622 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.6 tp -103.82 124.66 49.34 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 116.119 -4.113 . . . . 9.96 110.26 178.119 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.267 46.0 t -111.92 147.86 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 101.968 -3.345 . . . . 9.76 101.968 -171.916 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.2 mt -89.82 131.74 35.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 119.719 -0.181 . . . . 19.57 111.056 170.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -109.46 131.99 54.55 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 123.936 0.772 . . . . 35.08 112.321 -171.354 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.3 mt -93.34 161.81 14.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.857 -3.027 . . . . 32.31 107.175 178.459 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -73.45 157.95 35.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.358 -2.714 . . . . 42.75 109.398 177.305 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.16 51.67 3.67 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 125.302 1.429 . . . . 36.31 110.176 175.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.756 0 O-C-N 127.42 2.482 . . . . 36.27 113.482 179.44 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.48 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 14.1 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 113.616 0.969 . . . . 17.17 113.616 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.286 14.5 pt20 -90.53 134.15 34.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 121.558 1.981 . . . . 21.89 114.911 172.66 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.8 pt -132.06 166.61 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.671 -1.603 . . . . 10.83 106.671 177.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -107.3 131.73 53.89 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.401 -3.937 . . . . 10.61 112.484 177.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.0 t -116.57 109.32 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.258 -1.377 . . . . 9.13 110.171 170.075 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -99.16 117.62 34.04 Favored 'General case' 0 N--CA 1.429 -1.481 1 CA-C-O 130.117 4.77 . . . . 20.55 110.098 -172.734 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 30.7 p -75.16 164.66 26.26 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 110.738 -7.477 . . . . 11.78 114.455 -171.94 . . . . . . . . 3 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 70' ' ' VAL . 4.8 tp -53.16 -52.08 59.93 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.177 2.191 . . . . 19.31 115.603 174.701 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -59.0 -70.4 0.15 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 128.783 3.802 . . . . 23.14 114.599 169.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.49 59.01 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.774 0 O-C-N 118.988 -2.32 . . . . 19.74 113.834 156.448 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.33 85.7 tttt -108.06 134.18 51.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.398 -2.236 . . . . 21.93 106.737 173.503 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.2 m -97.45 111.67 23.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.439 -1.71 . . . . 12.33 108.35 173.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 13' ' ' ILE . 29.5 pt -108.75 127.33 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.312 -1.492 . . . . 17.08 113.178 172.491 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.3 m -86.33 122.51 30.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.572 1.549 . . . . 16.3 110.506 -178.365 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -110.53 123.04 49.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.251 3.021 . . . . 15.88 111.05 -172.723 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -102.89 117.4 34.54 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.638 3.113 . . . . 28.9 107.087 171.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.72 167.34 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 110.404 -3.089 . . . . 12.05 110.341 -174.795 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -110.81 164.88 13.81 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 113.885 -2.96 . . . . 18.17 115.782 165.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.283 60.7 Cg_endo -69.83 -24.91 28.82 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 CA-C-N 127.813 3.826 . . . . 8.16 113.279 -171.408 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.256 3.9 m -82.99 -5.57 59.15 Favored 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 133.819 4.847 . . . . 11.13 114.464 -176.363 . . . . . . . . 3 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -59.67 126.41 27.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.377 2.271 . . . . 18.03 114.104 167.05 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.4 p -77.3 158.15 30.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.056 -2.277 . . . . 10.22 111.59 170.609 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.544 HG23 HD12 ' A' ' 43' ' ' LEU 0.295 35.8 mm -60.91 -34.55 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.829 -1.169 . . . . 12.3 113.732 176.662 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -33.96 -60.69 0.38 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.99 -3.569 . . . . 36.51 117.775 157.689 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -70.67 -31.86 68.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 110.75 -2.932 . . . . 25.66 111.024 -177.615 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 22' ' ' THR . 90.9 t -66.21 -43.85 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.093 -1.629 . . . . 8.12 112.435 -178.121 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -57.46 -42.79 83.23 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.149 2.18 . . . . 15.47 113.771 176.037 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.329 . . -64.45 -35.43 80.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.851 -2.406 . . . . 11.45 114.374 175.269 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -59.67 -35.02 73.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.274 2.94 . . . . 24.98 115.968 170.442 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -75.74 -36.92 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.617 -2.552 . . . . 9.46 109.281 172.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -56.32 -32.61 64.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.423 2.059 . . . . 14.76 113.326 174.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.64 -36.09 67.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 128.215 3.864 . . . . 26.29 111.463 -177.71 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -65.13 -51.4 61.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.063 -2.79 . . . . 30.06 115.196 171.803 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -110.67 -59.02 2.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.519 2.104 . . . . 25.19 112.018 -168.132 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.15 49.29 0.88 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 126.942 2.211 . . . . 7.41 110.509 -176.358 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -100.25 130.55 25.72 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 114.299 -2.762 . . . . 9.49 107.732 169.363 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -71.25 148.98 56.69 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 124.417 2.613 . . . . 11.42 113.364 179.444 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -68.99 -17.96 40.82 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 CA-C-N 125.55 3.018 . . . . 12.0 117.768 -172.843 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.262 1.1 m-20 -69.41 -20.64 63.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.926 2.775 . . . . 35.55 117.028 172.902 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -94.6 -23.26 17.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.225 2.917 . . . . 20.52 108.5 -177.639 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -84.17 119.67 25.28 Favored 'General case' 0 N--CA 1.431 -1.418 1 O-C-N 115.767 -4.333 . . . . 7.13 116.791 178.114 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -113.57 106.59 14.72 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.068 2.947 . . . . 36.39 111.066 177.721 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.544 HD12 HG23 ' A' ' 23' ' ' ILE . 92.3 mt -88.3 124.27 33.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.096 -1.816 . . . . 9.55 106.096 -175.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -116.99 106.71 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 122.576 2.444 . . . . 13.9 108.534 176.825 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -95.66 108.94 21.27 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 125.628 2.632 . . . . 6.86 111.876 170.565 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.426 . . 70.57 -96.95 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.465 -2.647 . . . . 11.15 116.692 -178.754 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.76 -2.36 19.08 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.508 -1.37 . . . . 13.93 112.57 170.189 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -109.06 126.54 53.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.501 1.143 . . . . 23.92 111.261 -166.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -93.31 130.73 38.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 112.487 -2.142 . . . . 23.23 109.109 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -96.46 149.95 21.15 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.762 2.134 . . . . 9.11 116.762 -164.416 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -111.22 148.65 32.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.741 2.21 . . . . 33.44 111.041 -176.385 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -60.15 -47.28 86.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.276 2.695 . . . . 28.37 118.276 -166.748 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.83 26.67 8.08 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 117.995 -2.05 . . . . 15.0 112.982 -166.406 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -113.68 154.35 27.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 131.136 3.775 . . . . 25.5 106.24 -176.186 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -90.29 168.41 11.92 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.594 1.701 . . . . 11.95 115.594 168.436 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.0 mt -73.28 -36.14 66.26 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 118.031 -0.985 . . . . 10.17 112.406 177.25 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -45.89 -53.33 9.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.602 3.064 . . . . 13.59 115.837 160.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -49.76 -44.07 48.43 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.251 -4.656 . . . . 11.7 117.205 179.78 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -79.35 -18.95 51.41 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.431 -2.043 . . . . 12.95 108.265 -173.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 66.07 71.83 0.4 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.316 2.246 . . . . 25.45 110.238 -170.694 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -115.82 117.94 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 102.855 -3.017 . . . . 14.6 102.855 178.401 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -100.41 174.44 6.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.447 3.499 . . . . 33.23 112.239 174.386 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 13.3 pttp -53.69 161.88 0.99 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.829 -4.92 . . . . 25.97 115.293 165.243 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 50.96 46.57 26.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.292 3.037 . . . . 32.61 109.461 174.083 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -130.53 155.9 45.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.767 -3.083 . . . . 10.56 102.694 179.414 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.6 m -119.16 118.65 31.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.043 -1.435 . . . . 5.33 108.818 -155.14 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 mt -100.55 147.36 26.01 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.546 -2.391 . . . . 11.66 104.546 -173.773 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -108.8 133.89 52.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.625 -2.43 . . . . 16.3 111.41 167.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -106.34 97.79 7.55 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.682 1.734 . . . . 9.96 115.682 -175.419 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HA ' HD13 ' A' ' 8' ' ' LEU . 88.6 t -95.13 150.31 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 101.493 -3.521 . . . . 9.76 101.493 -171.383 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt -104.19 141.44 36.27 Favored 'General case' 0 N--CA 1.43 -1.442 1 CA-C-O 128.51 4.005 . . . . 19.57 106.772 173.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -77.58 135.79 38.2 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.555 -3.84 . . . . 35.08 115.705 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.1 mt -122.67 131.49 53.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.326 -1.306 . . . . 32.31 109.583 161.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -76.69 125.41 29.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.72 -1.863 . . . . 42.75 110.218 -153.327 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.7 -93.02 0.12 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 106.555 -2.618 . . . . 36.31 106.555 -175.787 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.767 0 CA-C-N 119.139 1.47 . . . . 36.27 113.1 171.714 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 118.366 -0.826 . . . . 17.17 113.012 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -98.75 142.0 30.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.478 2.361 . . . . 21.89 114.147 161.428 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.04 153.94 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.14 -1.43 . . . . 10.83 107.14 176.049 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -100.2 105.31 16.88 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 117.586 2.439 . . . . 10.61 117.586 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 70.9 t -88.44 117.58 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 119.635 1.107 . . . . 9.13 110.619 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -93.23 129.36 39.3 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.992 2.917 . . . . 20.55 110.39 174.81 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -98.01 170.53 8.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.169 -1.378 . . . . 11.78 108.164 178.005 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.02 -49.72 75.9 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.705 1.742 . . . . 19.31 115.705 173.348 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 p -74.78 -73.21 0.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.261 2.458 . . . . 23.14 111.507 -172.582 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.27 32.89 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 117.331 -3.355 . . . . 19.74 116.854 167.699 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -84.39 154.91 22.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.384 2.516 . . . . 21.93 110.054 167.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.9 m -112.18 113.52 25.82 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.117 -1.856 . . . . 12.33 106.376 163.246 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 12.6 mt -102.2 129.17 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 118.602 -2.561 . . . . 17.08 105.137 177.345 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.9 m -107.57 115.47 30.2 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.854 -2.404 . . . . 16.3 106.582 -169.807 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 tp -118.74 125.1 48.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.5 -2.625 . . . . 15.88 109.388 -156.615 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -95.34 119.53 33.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.468 -2.645 . . . . 28.9 114.873 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.7 158.18 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 106.903 -1.517 . . . . 12.05 106.903 -167.56 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -81.09 146.85 59.71 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 126.717 2.007 . . . . 18.17 109.9 175.452 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -82.87 -3.49 11.16 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 119.599 0.893 . . . . 8.16 113.434 -165.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 t -113.59 7.91 17.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.937 2.153 . . . . 11.13 112.396 171.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -88.89 177.22 6.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.364 2.357 . . . . 18.03 117.364 -172.695 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.447 HG22 HG22 ' A' ' 55' ' ' THR . 48.1 p -92.8 159.94 15.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 118.293 2.701 . . . . 10.22 118.293 -167.658 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -67.17 -36.24 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 127.132 2.173 . . . . 12.3 107.741 179.638 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -54.73 -44.87 73.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.606 1.963 . . . . 36.51 112.967 172.12 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -69.63 -31.14 69.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.835 2.161 . . . . 25.66 116.835 170.553 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.1 -48.11 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 122.091 2.223 . . . . 8.12 113.71 164.056 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -60.79 -31.35 70.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.978 1.711 . . . . 15.47 113.529 173.618 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.269 . . -79.24 -28.7 42.47 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 115.654 1.724 . . . . 11.45 115.654 177.716 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -63.43 -45.71 89.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.841 -1.527 . . . . 24.98 114.496 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.3 mt -70.0 -35.48 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.42 -2.173 . . . . 9.46 110.589 172.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -56.85 -29.68 63.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 125.974 3.988 . . . . 14.76 110.377 168.616 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.93 -50.73 7.76 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 114.857 -4.902 . . . . 26.29 111.439 -174.699 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -65.54 -52.27 53.73 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.661 -2.525 . . . . 30.06 113.417 175.589 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -107.82 -39.65 5.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.504 -0.924 . . . . 25.19 108.504 -162.109 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.99 37.6 5.97 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 106.587 -2.605 . . . . 7.41 106.587 176.338 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.74 123.66 37.93 Favored Pre-proline 0 N--CA 1.43 -1.446 1 N-CA-C 97.13 -5.137 . . . . 9.49 97.13 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -90.52 166.97 4.2 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 CA-C-N 125.278 2.921 . . . . 11.42 107.757 -168.564 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.26 36.4 Cg_endo -65.58 -24.83 55.45 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 122.793 2.328 . . . . 12.0 116.307 -169.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.282 18.0 m-20 -82.29 -22.33 35.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 114.516 -2.874 . . . . 35.55 111.476 178.906 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -91.56 -12.14 35.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 124.412 3.278 . . . . 20.52 112.77 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -75.46 99.93 4.34 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.74 2.416 . . . . 7.13 113.64 171.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -84.99 113.05 21.14 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 101.051 -3.685 . . . . 36.39 101.051 168.12 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.0 mt -101.31 115.24 30.05 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.405 -2.059 . . . . 9.55 110.343 165.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 44' ' ' ILE . 5.5 mt -112.53 137.6 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 C-N-CA 131.717 4.007 . . . . 13.9 109.234 178.576 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -133.75 99.37 4.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.738 2.015 . . . . 6.86 106.262 -171.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.394 . . 66.46 -108.65 0.13 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.954 -1.716 . . . . 11.15 113.471 -158.658 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.59 17.53 11.11 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 126.522 2.01 . . . . 13.93 112.106 172.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -107.06 119.74 40.18 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.661 3.23 . . . . 23.92 110.826 174.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -70.06 124.5 24.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.994 -2.941 . . . . 23.23 112.946 160.431 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.529 HD22 ' CD2' ' A' ' 59' ' ' TYR . 29.1 mt -79.41 162.74 25.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.352 1.461 . . . . 9.11 112.106 -178.187 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.28 141.47 52.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 126.748 3.166 . . . . 33.44 104.105 -177.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.67 -48.29 72.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.331 2.252 . . . . 28.37 114.848 -152.52 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.32 0.96 88.45 Favored Glycine 0 N--CA 1.43 -1.706 0 O-C-N 119.094 -2.254 . . . . 15.0 116.827 -178.305 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.252 23.3 mmt180 -74.9 161.43 29.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.105 3.336 . . . . 25.5 111.458 170.329 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.447 HG22 HG22 ' A' ' 22' ' ' THR 0.343 31.0 p -87.75 163.62 16.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.503 -2.623 . . . . 11.95 112.624 178.121 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.9 mt -60.15 -32.03 70.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.021 1.86 . . . . 10.17 116.021 163.315 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -56.55 -38.26 71.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.243 2.449 . . . . 13.59 114.426 166.408 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.79 -32.51 74.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.35 -2.719 . . . . 11.7 116.472 -169.123 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.529 ' CD2' HD22 ' A' ' 50' ' ' LEU . 34.2 m-85 -104.39 1.88 30.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.029 -2.919 . . . . 12.95 112.596 175.369 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.252 81.0 m-20 70.99 48.96 0.36 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.379 2.363 . . . . 25.45 117.379 -177.271 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.1 mt -92.41 124.79 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 114.545 -2.862 . . . . 14.6 110.614 -174.396 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -108.87 169.95 8.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 123.941 0.775 . . . . 33.23 110.635 -169.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 143.87 57.24 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.694 2.797 . . . . 25.97 110.262 -170.033 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 57.67 23.42 9.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.646 -3.784 . . . . 32.61 115.957 -174.392 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.0 t -92.93 160.36 14.93 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.269 3.414 . . . . 10.56 110.151 -178.622 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 m -92.52 126.16 37.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.599 -3.188 . . . . 5.33 114.749 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.44 155.63 31.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.524 -2.399 . . . . 11.66 104.524 173.842 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -130.61 111.03 11.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 119.024 0.829 . . . . 16.3 111.329 -173.3 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -87.16 108.56 18.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 131.0 3.72 . . . . 9.96 114.406 175.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -111.22 141.31 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 129.681 3.192 . . . . 9.76 102.7 -173.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt -94.6 118.25 31.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.746 2.418 . . . . 19.57 109.187 -170.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -91.64 157.89 16.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.197 0.999 . . . . 35.08 110.445 167.843 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.7 mt -70.71 162.85 28.32 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.521 2.415 . . . . 32.31 117.521 168.01 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -95.32 96.67 9.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.112 2.565 . . . . 42.75 106.411 162.713 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.45 72.28 0.99 Allowed Glycine 0 N--CA 1.43 -1.736 0 O-C-N 124.941 1.401 . . . . 36.31 114.658 -166.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.785 2 CA-C-N 124.922 4.361 . . . . 36.27 105.12 -174.183 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 CA--C 1.49 -1.365 0 CA-C-O 116.449 -1.739 . . . . 17.17 109.209 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -88.38 140.59 29.32 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 123.247 2.749 . . . . 21.89 116.81 171.478 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.1 pt -110.41 167.83 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 102.628 -3.101 . . . . 10.83 102.628 173.082 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -109.03 139.2 44.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.403 -2.814 . . . . 10.61 103.403 167.652 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -122.85 123.17 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.435 -2.041 . . . . 9.13 109.677 165.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -96.91 134.89 39.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.127 -0.942 . . . . 20.55 112.508 172.361 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.401 HG22 HD23 ' A' ' 69' ' ' LEU . 42.9 p -91.77 -173.97 3.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.37 2.986 . . . . 11.78 113.207 177.769 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 tp -65.49 -52.95 49.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.635 -3.791 . . . . 19.31 116.661 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -61.8 -40.5 95.45 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.325 -2.11 . . . . 23.14 110.204 171.075 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.01 37.15 0.44 Allowed Glycine 0 N--CA 1.43 -1.738 0 CA-C-O 115.186 -3.008 . . . . 19.74 116.837 177.209 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -86.17 141.05 29.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.483 3.641 . . . . 21.93 111.079 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 m -92.74 101.75 14.15 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 119.954 1.252 . . . . 12.33 108.995 175.711 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.6 mt -93.05 118.43 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 125.072 1.349 . . . . 17.08 111.149 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -86.66 105.58 17.01 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.471 1.908 . . . . 16.3 112.338 175.128 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 tp -120.57 116.24 24.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.73 -1.856 . . . . 15.88 110.329 -160.61 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -78.76 100.51 7.14 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.562 4.345 . . . . 28.9 120.351 178.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 m -122.93 148.46 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-O 125.452 2.549 . . . . 12.05 109.138 -171.666 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -94.64 141.73 23.8 Favored Pre-proline 0 N--CA 1.43 -1.474 1 O-C-N 116.277 -4.015 . . . . 18.17 106.01 162.542 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.49 -14.51 45.26 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-O 114.086 -2.548 . . . . 8.16 111.091 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.7 p -67.83 -9.88 48.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 120.931 3.678 . . . . 11.13 120.931 160.759 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -71.06 134.92 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.55 -3.843 . . . . 18.03 111.679 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.3 p -82.48 153.14 25.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 117.332 -1.318 . . . . 10.22 111.974 177.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.0 mm -51.61 -37.73 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 113.907 -2.949 . . . . 12.3 113.795 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -49.64 -43.56 46.9 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.959 3.704 . . . . 36.51 113.86 168.214 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -90.54 -25.56 20.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.693 3.197 . . . . 25.66 110.295 -176.848 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.46 -51.84 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.238 1.495 . . . . 8.12 110.736 164.634 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -51.74 -31.92 28.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.66 -3.775 . . . . 15.47 115.183 170.639 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.05 -39.38 86.92 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.808 1.643 . . . . 11.45 113.018 171.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -69.19 -35.08 75.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.473 1.13 . . . . 24.98 108.4 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.5 mt -79.51 -35.59 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.833 -2.417 . . . . 9.46 110.77 -173.032 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -49.41 -50.54 40.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.542 2.423 . . . . 14.76 117.542 158.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.56 -33.44 69.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.266 3.027 . . . . 26.29 113.91 170.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -73.69 -69.83 0.41 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.925 2.565 . . . . 30.06 117.925 173.378 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -90.42 -37.89 13.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 111.189 -2.732 . . . . 25.19 115.215 -172.146 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.35 46.39 1.85 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 120.743 1.61 . . . . 7.41 110.784 176.452 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.41 105.32 48.64 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 113.195 -3.288 . . . . 9.49 105.031 -178.324 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -58.36 159.01 20.66 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.497 3.356 . . . . 11.42 113.62 -175.463 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -76.39 -20.4 14.23 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 122.826 2.045 . . . . 12.0 115.227 -161.828 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.33 -40.01 67.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.649 -1.907 . . . . 35.55 110.005 178.439 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.99 -29.8 69.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.812 -1.805 . . . . 20.52 111.697 172.075 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -78.98 140.9 37.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 117.865 -3.022 . . . . 7.13 109.952 -177.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 72' ' ' ARG . 51.0 mtp180 -123.12 124.43 43.06 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.563 -3.21 . . . . 36.39 107.393 158.078 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.2 mt -106.4 129.79 54.33 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 123.957 0.786 . . . . 9.55 112.609 176.69 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.1 109.82 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 125.991 1.716 . . . . 13.9 112.004 -171.462 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -94.09 129.52 40.6 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.346 -3.346 . . . . 6.86 107.33 163.278 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.52 -97.92 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.019 2.97 . . . . 11.15 119.019 -169.054 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.84 27.82 3.81 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.44 -2.037 . . . . 13.93 113.819 -179.413 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -138.93 128.39 24.4 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.903 -1.888 . . . . 23.92 105.903 -176.824 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -84.34 127.34 33.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 111.799 -2.455 . . . . 23.23 113.664 171.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.4 mt -87.02 137.16 32.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.074 -1.875 . . . . 9.11 108.353 -161.206 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -106.26 140.41 39.25 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.31 -0.869 . . . . 33.44 111.936 -160.155 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -46.17 -54.03 9.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 121.3 3.815 . . . . 28.37 121.3 -162.302 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.11 -0.44 74.17 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-O 117.906 -1.497 . . . . 15.0 112.706 -178.417 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -75.4 158.47 32.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.106 1.953 . . . . 25.5 114.308 169.644 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 p -93.68 173.46 7.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.746 2.212 . . . . 11.95 110.452 174.469 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.5 mt -66.39 -29.84 70.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.331 -3.356 . . . . 10.17 113.965 166.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.6 t -66.05 -39.73 90.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.856 -3.028 . . . . 13.59 110.892 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -61.2 -33.64 73.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.911 -1.743 . . . . 11.7 113.634 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.83 -20.44 30.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.187 0.81 . . . . 12.95 113.187 174.314 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 m120 72.47 51.78 0.18 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.604 3.962 . . . . 25.45 112.539 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.259 60.0 mt -80.79 121.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 110.192 -3.185 . . . . 14.6 110.026 -178.288 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -106.54 -175.2 2.73 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 118.704 -1.198 . . . . 33.23 112.228 -175.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.427 0.0 OUTLIER -66.46 150.85 48.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.234 2.309 . . . . 25.97 117.234 173.219 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 48.24 39.0 11.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.047 2.832 . . . . 32.61 116.408 -168.697 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.373 63.9 m -94.29 137.21 33.72 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.013 -4.804 . . . . 10.56 107.826 173.841 . . . . . . . . 3 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -103.52 113.92 27.79 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.563 1.529 . . . . 5.33 111.665 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -84.78 146.54 27.32 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.238 2.215 . . . . 11.66 111.63 169.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -110.93 129.49 55.86 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.603 -1.936 . . . . 16.3 114.41 172.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.401 HD23 HG22 ' A' ' 7' ' ' THR . 17.7 tp -87.78 124.82 34.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.32 -2.474 . . . . 9.96 104.32 170.313 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.12 146.03 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 112.816 -1.993 . . . . 9.76 109.34 163.489 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.257 14.2 mt -91.75 148.39 22.28 Favored 'General case' 0 N--CA 1.431 -1.418 1 O-C-N 115.578 -4.451 . . . . 19.57 111.452 -176.253 . . . . . . . . 3 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.432 ' HB2' ' HG3' ' A' ' 42' ' ' ARG . 43.3 ttt180 -105.87 137.59 43.49 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.089 -2.882 . . . . 35.08 107.166 171.833 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mp -87.09 176.6 7.53 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.407 -2.235 . . . . 32.31 109.94 178.019 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -101.28 114.86 29.22 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.523 1.675 . . . . 42.75 115.523 -178.174 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.24 -9.72 22.53 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 123.892 1.829 . . . . 36.31 116.635 -175.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.784 0 C-N-CA 127.339 2.399 . . . . 36.27 112.903 -178.838 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.348 0 CA-C-O 119.242 -0.409 . . . . 17.17 111.932 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.29 133.99 39.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 119.324 0.965 . . . . 21.89 113.157 -178.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 pt -114.63 171.24 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.703 -1.873 . . . . 10.83 111.024 168.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -107.82 135.95 48.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.563 1.649 . . . . 10.61 111.876 173.132 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 69' ' ' LEU . 88.1 t -119.25 128.62 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 117.523 -3.235 . . . . 9.13 102.288 175.025 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -120.89 121.74 38.73 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.068 1.413 . . . . 20.55 111.143 -178.741 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.458 HG22 HD23 ' A' ' 69' ' ' LEU . 12.5 p -69.79 164.06 24.42 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.539 2.336 . . . . 11.78 109.632 -174.245 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.4 tp -61.76 -44.19 97.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.092 1.901 . . . . 19.31 111.154 174.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 p -67.32 -51.57 50.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.765 -1.835 . . . . 23.14 113.045 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.56 59.9 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 119.439 2.536 . . . . 19.74 119.439 162.803 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -116.42 138.5 51.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.522 -0.918 . . . . 21.93 108.522 172.494 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.2 m -90.15 113.86 25.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 118.37 -0.824 . . . . 12.33 109.164 178.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mt -96.39 137.57 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.694 -3.129 . . . . 17.08 106.872 -177.27 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.3 m -97.28 121.43 39.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 114.821 -2.514 . . . . 16.3 104.301 171.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 tp -121.97 138.37 54.44 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.648 2.166 . . . . 15.88 115.895 178.38 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.294 71.6 tt0 -100.1 111.16 23.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.339 -3.976 . . . . 28.9 109.1 -172.858 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.2 152.99 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 1 O-C-N 113.29 -5.881 . . . . 12.05 117.937 -172.55 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -117.36 161.03 35.32 Favored Pre-proline 0 N--CA 1.43 -1.446 1 O-C-N 116.154 -4.091 . . . . 18.17 119.327 170.467 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -66.59 -17.63 53.15 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 CA-C-N 129.859 4.557 . . . . 8.16 117.468 -175.117 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.4 m -76.74 -17.19 59.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.403 1.91 . . . . 11.13 114.414 177.46 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -67.98 151.78 46.55 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.925 2.774 . . . . 18.03 111.094 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -97.82 158.77 15.33 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.778 -1.826 . . . . 10.22 112.012 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.269 4.7 mm -61.34 -31.52 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 CA-C-O 128.941 4.21 . . . . 12.3 116.294 -178.648 . . . . . . . . 3 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -50.21 -43.42 52.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.051 -3.531 . . . . 36.51 114.76 162.812 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -73.16 -19.37 61.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.643 -2.535 . . . . 25.66 117.2 173.797 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.263 94.5 t -66.36 -37.87 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 117.723 -3.11 . . . . 8.12 111.813 176.802 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -68.67 -40.63 80.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.414 3.086 . . . . 15.47 112.56 176.136 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.11 -52.87 59.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 121.184 3.772 . . . . 11.45 121.184 167.752 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -56.86 -41.15 77.43 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.674 2.034 . . . . 24.98 115.797 165.321 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -64.57 -36.8 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 125.202 2.43 . . . . 9.46 110.585 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 3.6 tt0 -53.92 -55.0 30.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.851 1.786 . . . . 14.76 113.285 171.135 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.259 29.4 t70 -57.89 -56.13 25.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.587 -2.571 . . . . 26.29 116.22 179.316 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -69.67 -65.35 0.73 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 125.865 2.745 . . . . 30.06 113.928 -176.11 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -86.39 -46.24 10.44 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.596 -4.44 . . . . 25.19 118.439 177.34 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 102.28 28.72 6.31 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.107 -1.997 . . . . 7.41 108.107 168.219 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.0 mt -83.35 118.97 73.15 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.005 -1.95 . . . . 9.49 108.641 169.813 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -73.63 157.25 48.72 Favored 'Trans proline' 0 N--CA 1.433 -2.036 1 CA-C-N 128.467 4.06 . . . . 11.42 114.412 -166.375 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.42 -23.72 64.79 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 123.02 2.48 . . . . 12.0 116.659 -168.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.88 -28.53 39.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.317 1.969 . . . . 35.55 116.317 177.262 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -18.03 59.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.792 2.515 . . . . 20.52 117.792 170.481 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -79.98 138.41 37.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.063 -2.273 . . . . 7.13 116.735 177.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -137.94 129.26 27.71 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 125.666 2.651 . . . . 36.39 106.423 164.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mt -110.91 117.42 33.32 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 111.522 -2.581 . . . . 9.55 112.584 -173.787 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.15 131.19 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.984 2.114 . . . . 13.9 109.532 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.587 ' HB3' HD21 ' A' ' 50' ' ' LEU . 11.5 t80 -122.75 107.4 11.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.826 -2.287 . . . . 6.86 104.826 178.642 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.315 . . 69.93 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 125.572 1.795 . . . . 11.15 113.971 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.9 -29.87 3.66 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-O 118.419 -1.211 . . . . 13.93 112.796 175.557 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -94.79 127.95 41.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 126.248 1.793 . . . . 23.92 115.116 -162.301 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -77.13 132.72 38.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.378 2.037 . . . . 23.23 115.533 166.631 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 45' ' ' PHE 0.26 7.6 mt -91.07 133.29 35.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.263 -2.773 . . . . 9.11 113.125 -163.692 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -88.86 121.85 31.65 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.227 -1.545 . . . . 33.44 114.07 -176.153 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -29.49 -57.75 0.16 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.032 3.733 . . . . 28.37 115.941 -178.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.87 25.35 25.59 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 119.278 -2.139 . . . . 15.0 116.188 -168.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.1 mtt-85 -108.91 155.33 20.96 Favored 'General case' 0 N--CA 1.43 -1.463 1 C-N-CA 132.081 4.153 . . . . 25.5 113.216 170.123 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.44 23.9 p -80.69 158.93 25.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 128.292 3.901 . . . . 11.95 115.045 177.615 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mp -68.86 -8.36 43.1 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.782 -5.574 . . . . 10.17 116.358 166.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.33 -42.85 18.21 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 112.686 -3.53 . . . . 13.59 103.294 177.52 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -62.47 -28.56 69.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 123.27 2.759 . . . . 11.7 114.466 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -94.32 -4.68 48.2 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.483 2.313 . . . . 12.95 112.088 175.192 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 m120 63.52 44.22 5.42 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.734 3.214 . . . . 25.45 110.007 169.303 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.7 mt -80.22 113.58 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 119.89 -1.756 . . . . 14.6 111.41 -178.256 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.261 14.6 mm100 -71.4 -179.56 2.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 124.644 2.164 . . . . 33.23 109.455 173.841 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -79.21 144.57 34.28 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-O 128.752 4.12 . . . . 25.97 109.95 165.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.366 65.8 mt-10 71.09 32.99 2.15 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.334 -2.666 . . . . 32.61 110.26 174.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.269 2.9 m -98.55 144.93 27.34 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 116.559 -3.838 . . . . 10.56 107.269 175.617 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -94.82 115.36 27.4 Favored 'General case' 0 N--CA 1.431 -1.423 1 C-N-CA 132.147 4.179 . . . . 5.33 110.267 176.809 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.69 129.83 34.72 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.62 -1.622 . . . . 11.66 106.62 170.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -81.1 105.91 12.68 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.932 -2.355 . . . . 16.3 108.413 168.563 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.458 HD23 HG22 ' A' ' 7' ' ' THR . 34.3 tp -84.93 108.72 17.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.226 2.61 . . . . 9.96 109.893 168.154 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 m -113.74 168.59 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.237 2.215 . . . . 9.76 106.264 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.9 tp -86.97 123.71 32.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 127.748 3.155 . . . . 19.57 108.886 -167.491 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -92.91 115.05 27.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.492 1.615 . . . . 35.08 108.544 173.368 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.58 163.61 19.22 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.106 -1.406 . . . . 32.31 111.855 175.252 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -65.64 140.33 58.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.946 2.308 . . . . 42.75 113.396 172.239 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.58 78.47 1.22 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-O 116.184 -2.453 . . . . 36.31 114.725 -175.328 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.734 0 CA-C-O 115.717 -2.713 . . . . 36.27 111.833 -167.933 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.335 0 N-CA-C 104.455 -2.424 . . . . 17.17 104.455 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -114.3 160.12 19.44 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.938 -1.726 . . . . 21.89 115.459 173.942 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.4 pt -133.7 154.17 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 1 CA-C-O 129.434 4.445 . . . . 10.83 105.32 169.842 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -106.96 105.03 14.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.026 3.298 . . . . 10.61 102.872 177.073 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.32 105.19 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.009 -2.307 . . . . 9.13 112.838 171.173 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -95.64 128.04 42.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.258 1.98 . . . . 20.55 111.499 -175.498 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -82.29 -179.16 7.31 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.939 -3.601 . . . . 11.78 113.845 -172.603 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.0 tp -75.22 -48.52 23.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.467 -3.896 . . . . 19.31 112.114 -176.701 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.0 p -70.22 -24.0 63.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.93 2.776 . . . . 23.14 116.647 -178.632 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.36 75.88 0.52 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 118.657 -2.527 . . . . 19.74 110.517 170.916 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -142.16 139.38 32.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.882 -3.007 . . . . 21.93 102.882 170.141 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.3 m -106.52 104.19 13.82 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.296 1.438 . . . . 12.33 110.626 176.112 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 mt -92.31 118.21 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 118.468 -0.777 . . . . 17.08 109.636 176.817 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.5 m -95.83 122.72 38.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.229 -3.248 . . . . 16.3 102.229 179.005 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 tp -127.85 147.53 50.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.364 -0.835 . . . . 15.88 112.386 -176.216 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -95.87 122.73 38.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.284 -1.817 . . . . 28.9 108.787 178.915 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.23 168.06 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.196 2.599 . . . . 12.05 109.187 177.686 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -107.12 153.41 41.04 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 116.756 -3.715 . . . . 18.17 101.264 163.644 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.43 -12.96 32.49 Favored 'Trans proline' 0 N--CA 1.433 -2.036 2 C-N-CA 128.323 6.016 . . . . 8.16 105.122 179.699 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p -83.97 12.44 6.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.017 2.927 . . . . 11.13 114.387 171.538 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -93.34 146.12 23.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.599 -2.0 . . . . 18.03 105.599 176.82 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.9 p -89.1 168.58 12.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.852 -1.536 . . . . 10.22 106.852 -175.456 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -82.24 -28.08 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 116.151 1.908 . . . . 12.3 116.151 -173.671 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -48.27 -50.31 30.29 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.745 -2.48 . . . . 36.51 112.078 155.349 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -59.0 -53.03 63.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.239 2.681 . . . . 25.66 118.239 168.021 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 t -50.22 -37.99 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 116.552 2.056 . . . . 8.12 116.552 171.087 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -68.33 -41.55 80.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 117.725 -1.131 . . . . 15.47 113.984 173.598 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.69 70.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.907 3.299 . . . . 11.45 119.907 174.197 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -61.89 -47.42 85.04 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.976 2.911 . . . . 24.98 113.002 170.17 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.51 -35.0 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.982 -1.698 . . . . 9.46 108.595 -176.814 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -62.02 -46.79 87.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.428 -3.295 . . . . 14.76 113.876 170.29 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -49.27 -58.97 4.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.458 2.762 . . . . 26.29 118.458 163.711 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -71.04 -67.41 0.51 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.237 -2.789 . . . . 30.06 116.203 -178.58 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -85.33 -24.87 27.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.916 1.817 . . . . 25.19 114.077 -171.891 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.82 38.89 14.8 Favored Glycine 0 N--CA 1.43 -1.727 0 O-C-N 119.611 -1.931 . . . . 7.41 115.235 -178.614 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.1 mt -102.98 109.91 62.42 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 114.3 -2.762 . . . . 9.49 109.013 -179.168 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.7 142.23 82.98 Favored 'Trans proline' 0 N--CA 1.434 -1.987 2 C-N-CA 127.181 5.254 . . . . 11.42 114.321 -171.649 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.47 -17.97 6.08 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 123.026 2.116 . . . . 12.0 109.946 -159.807 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.269 37.0 m-20 -60.49 -23.67 64.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 126.551 2.407 . . . . 35.55 116.486 161.954 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -84.3 -33.04 24.04 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 117.261 -3.399 . . . . 20.52 115.263 176.595 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -67.41 138.03 56.37 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.026 3.343 . . . . 7.13 120.026 -179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -136.71 132.09 34.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 105.181 -2.155 . . . . 36.39 105.181 161.441 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.253 11.4 mt -111.91 124.89 53.33 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 129.279 4.112 . . . . 9.55 107.702 -174.621 . . . . . . . . 3 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.3 mt -117.79 117.84 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.704 2.402 . . . . 13.9 111.2 -173.165 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -94.55 102.97 14.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.567 -1.958 . . . . 6.86 110.96 168.917 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.99 -81.35 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.767 2.136 . . . . 11.15 116.767 -163.976 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.85 16.91 2.39 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 104.666 -3.374 . . . . 13.93 104.666 172.773 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -95.73 111.49 23.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 119.255 1.528 . . . . 23.92 114.671 171.519 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -76.73 116.55 17.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.836 -1.529 . . . . 23.23 111.721 -179.503 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.0 mt -87.26 138.64 31.31 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.457 -3.277 . . . . 9.11 112.806 -164.909 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -97.21 161.23 13.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.428 2.01 . . . . 33.44 116.428 -175.894 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.269 7.8 m-20 -46.4 -68.78 0.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 119.829 3.27 . . . . 28.37 119.829 -166.844 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.14 8.4 70.85 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 118.013 1.965 . . . . 15.0 118.013 -165.977 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -94.92 158.88 15.29 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 126.866 3.222 . . . . 25.5 112.092 -176.844 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.95 164.03 12.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.089 2.376 . . . . 11.95 109.229 -179.335 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.69 -18.92 62.14 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 112.762 -3.494 . . . . 10.17 113.207 171.482 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -71.22 -31.86 68.09 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 126.046 2.091 . . . . 13.59 112.464 169.587 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -66.41 -53.1 39.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.55 -3.219 . . . . 11.7 109.269 179.012 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -66.42 -19.76 65.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.704 -3.122 . . . . 12.95 110.683 -179.454 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 m120 73.64 47.54 0.17 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.616 1.71 . . . . 25.45 115.616 -178.947 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.72 111.65 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.179 2.419 . . . . 14.6 110.003 -177.021 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -71.03 174.5 6.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 112.327 -2.215 . . . . 33.23 111.681 -176.17 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -52.46 133.22 35.48 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.561 3.171 . . . . 25.97 119.561 168.68 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 60.53 50.71 5.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.666 -3.146 . . . . 32.61 113.392 175.523 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 m -107.35 154.6 21.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.875 -1.511 . . . . 10.56 110.74 -179.426 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -102.08 126.68 49.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.377 3.548 . . . . 5.33 107.244 -168.294 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.23 145.9 39.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 117.524 -1.227 . . . . 11.66 109.243 178.339 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -101.59 123.84 46.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.495 -1.668 . . . . 16.3 106.495 177.942 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 tp -100.4 117.88 35.49 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.613 2.365 . . . . 9.96 107.62 174.895 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -115.46 -165.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.602 2.075 . . . . 9.76 116.602 171.903 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 tp -88.68 123.89 33.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.043 -1.661 . . . . 19.57 113.327 168.293 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -82.16 117.17 22.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.371 1.557 . . . . 35.08 108.439 174.637 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.1 mt -101.02 -174.16 2.55 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.027 -2.295 . . . . 32.31 107.98 172.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -126.19 156.73 39.73 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.225 -2.172 . . . . 42.75 108.246 -172.789 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.73 21.19 64.26 Favored Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 115.233 -2.982 . . . . 36.31 112.713 -162.512 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.761 0 CA-C-N 123.006 3.403 . . . . 36.27 121.026 177.174 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 39.7 ttm . . . . . 0 CA--C 1.49 -1.365 0 N-CA-C 110.297 -0.26 . . . . 17.17 110.297 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -87.82 134.12 33.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.741 -1.85 . . . . 21.89 112.454 171.06 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -122.09 171.22 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 119.162 0.892 . . . . 10.83 110.675 162.497 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -116.09 121.65 42.8 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.133 -2.854 . . . . 10.61 109.319 174.39 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.3 t -106.2 104.49 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 124.971 2.319 . . . . 9.13 111.483 173.11 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -82.74 134.37 35.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.906 -3.621 . . . . 20.55 113.822 -177.804 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.7 p -87.12 176.22 7.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.364 1.665 . . . . 11.78 110.963 -174.376 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.64 -44.4 64.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.75 1.22 . . . . 19.31 109.636 177.707 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -69.55 -63.7 1.02 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.47 1.508 . . . . 23.14 114.231 -177.426 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.23 21.82 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 115.589 -3.196 . . . . 19.74 115.42 176.178 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -105.28 138.58 41.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.318 -1.364 . . . . 21.93 107.318 -173.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -105.43 118.45 36.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.717 -2.489 . . . . 12.33 107.182 168.713 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.39 126.68 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 114.102 -2.856 . . . . 17.08 107.211 -173.553 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.3 m -101.37 125.69 48.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 102.888 -3.004 . . . . 16.3 102.888 -171.782 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 15' ' ' LEU . 15.6 tp -141.05 131.0 24.48 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.721 -2.696 . . . . 15.88 103.721 -154.91 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -114.85 107.13 15.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.025 -2.954 . . . . 28.9 103.025 -168.082 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.409 HG11 HG22 ' A' ' 26' ' ' VAL . 16.8 m -116.6 155.76 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 128.541 2.737 . . . . 12.05 112.727 -177.412 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -89.47 143.86 31.28 Favored Pre-proline 0 N--CA 1.43 -1.443 1 CA-C-O 111.465 -4.112 . . . . 18.17 108.494 171.152 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 56' ' ' LEU . 27.9 Cg_endo -87.47 -5.77 7.21 Favored 'Trans proline' 0 N--CA 1.433 -2.043 2 CA-C-N 129.132 4.297 . . . . 8.16 105.628 -173.767 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.267 65.9 m -84.11 -6.51 59.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.014 -1.074 . . . . 11.13 113.726 171.817 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -107.91 161.14 15.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 128.16 3.838 . . . . 18.03 108.843 -179.132 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -77.23 166.9 22.61 Favored 'General case' 0 N--CA 1.43 -1.446 1 N-CA-C 121.849 4.018 . . . . 10.22 121.849 -176.006 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -63.25 -32.85 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.039 1.335 . . . . 12.3 111.64 174.587 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -53.61 -44.15 69.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.109 -1.619 . . . . 36.51 112.032 172.537 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -79.84 -14.3 58.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.3 -3.375 . . . . 25.66 114.309 178.004 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.409 HG22 HG11 ' A' ' 17' ' ' VAL . 65.0 t -69.22 -47.62 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.251 -2.156 . . . . 8.12 109.866 165.522 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.25 90.7 mttt -69.68 -28.39 65.81 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.07 1.748 . . . . 15.47 111.527 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.271 . . -65.8 -38.04 87.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.832 2.053 . . . . 11.45 106.885 175.502 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -73.32 -31.69 64.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.004 2.638 . . . . 24.98 116.55 178.199 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.25 70.8 mt -72.34 -42.21 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.081 2.372 . . . . 9.46 111.317 172.108 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -49.93 -35.63 24.72 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.475 2.028 . . . . 14.76 116.475 169.71 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -85.59 -55.28 4.07 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.814 -1.921 . . . . 26.29 105.814 -173.822 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -71.85 -44.46 63.8 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.507 -1.371 . . . . 30.06 112.774 -169.419 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -106.89 -33.09 7.64 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.529 -1.357 . . . . 25.19 109.589 -162.054 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.4 46.69 4.88 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 128.124 2.774 . . . . 7.41 113.81 170.289 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.0 mt -106.93 128.6 25.79 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 101.364 -3.569 . . . . 9.49 101.364 176.355 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -82.86 162.95 16.06 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 O-C-N 117.029 -2.143 . . . . 11.42 110.857 179.409 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.15 -23.23 4.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 N-CA-C 121.386 3.571 . . . . 12.0 121.386 166.087 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -68.08 -23.65 64.96 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.608 -2.557 . . . . 35.55 106.936 178.258 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -108.73 -12.94 14.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 127.266 3.412 . . . . 20.52 116.267 -179.304 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -86.84 115.46 24.27 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 115.678 -4.389 . . . . 7.13 113.46 -177.384 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -111.89 117.24 32.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.297 -1.001 . . . . 36.39 108.297 163.969 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -98.98 131.44 45.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.889 1.676 . . . . 9.55 106.716 178.813 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.421 HD13 HG21 ' A' ' 44' ' ' ILE . 63.8 mt -131.2 140.51 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 119.487 -2.008 . . . . 13.9 107.062 177.397 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -101.28 100.92 11.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.228 3.811 . . . . 6.86 108.678 161.674 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.09 -91.48 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.532 2.333 . . . . 11.15 116.704 -169.366 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.84 14.49 6.69 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 116.928 -2.04 . . . . 13.93 111.241 175.724 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -98.46 108.81 21.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 126.514 1.949 . . . . 23.92 106.785 173.899 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -79.74 102.28 8.93 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 119.963 3.32 . . . . 23.23 119.963 171.096 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.12 146.18 55.32 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 124.737 2.208 . . . . 9.11 114.729 -155.967 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -107.06 143.87 34.54 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.119 -4.113 . . . . 33.44 112.835 178.805 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.96 -38.95 20.35 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 114.571 -2.633 . . . . 28.37 114.313 -153.379 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.88 45.78 3.57 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 124.024 3.102 . . . . 15.0 113.818 163.901 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -131.46 162.51 30.04 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.119 -4.754 . . . . 25.5 105.252 170.622 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -108.26 172.86 6.6 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 117.591 -3.193 . . . . 11.95 114.82 -175.669 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 19' ' ' PRO . 11.2 mt -64.81 -37.87 89.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.16 1.457 . . . . 10.17 108.191 169.006 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.356 1.2 m -56.2 -36.95 68.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.468 3.507 . . . . 13.59 120.468 167.626 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -58.75 -42.67 89.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.351 -2.718 . . . . 11.7 114.009 165.527 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -81.07 -7.39 59.55 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.731 -1.855 . . . . 12.95 111.426 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.256 60.8 m-80 55.78 48.42 18.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.321 2.249 . . . . 25.45 116.023 -171.872 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -84.32 140.47 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.009 1.723 . . . . 14.6 113.014 175.625 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -109.1 -175.06 2.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.122 1.769 . . . . 33.23 106.879 -170.247 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HG2' ' HG3' ' A' ' 1' ' ' MET 0.299 18.3 mtmm -72.63 147.53 45.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.662 -1.899 . . . . 25.97 112.532 174.97 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 78.51 20.85 0.83 Allowed 'General case' 0 N--CA 1.43 -1.441 1 C-N-CA 132.027 4.131 . . . . 32.61 106.863 166.341 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -88.48 159.97 17.72 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 116.08 -4.137 . . . . 10.56 109.779 -163.934 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 m -103.84 134.98 46.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 124.328 2.013 . . . . 5.33 112.473 -175.832 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -114.71 169.24 9.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 130.447 3.499 . . . . 11.66 108.302 165.222 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -123.62 136.5 54.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 114.775 -2.536 . . . . 16.3 107.753 174.002 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tp -97.04 113.95 25.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.542 2.428 . . . . 9.96 113.96 159.572 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -116.96 -166.01 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 116.764 -3.71 . . . . 9.76 108.542 162.515 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 71' ' ' LEU . 0.9 OUTLIER -84.85 145.16 27.97 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.345 2.258 . . . . 19.57 109.668 -172.359 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -103.29 124.16 48.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.388 -2.07 . . . . 35.08 106.115 -178.077 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.1 mt -124.58 136.1 53.68 Favored 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 133.039 4.535 . . . . 32.31 106.465 177.632 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -52.47 -52.31 54.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.695 2.48 . . . . 42.75 117.695 -175.545 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.35 68.57 0.54 Allowed Glycine 0 N--CA 1.43 -1.743 0 O-C-N 117.977 -2.952 . . . . 36.31 108.749 152.985 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.744 0 CA-C-O 124.779 2.322 . . . . 36.27 112.164 163.667 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 CA--C 1.49 -1.346 0 N-CA-C 115.65 1.722 . . . . 17.17 115.65 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -86.75 133.62 33.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.967 3.707 . . . . 21.89 110.941 171.557 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.39 158.83 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 119.569 1.077 . . . . 10.83 108.376 172.243 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.93 145.09 31.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.324 1.059 . . . . 10.61 109.935 168.85 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 67' ' ' LEU . 85.7 t -122.3 139.08 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 101.22 -3.622 . . . . 9.13 101.22 168.994 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -117.6 124.5 48.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.162 -0.926 . . . . 20.55 112.843 177.245 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -79.69 166.84 21.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.073 -1.876 . . . . 11.78 115.563 -177.957 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.9 tt -74.5 -43.61 55.16 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.687 -4.383 . . . . 19.31 108.912 -172.948 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -60.06 -44.06 94.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.575 -3.203 . . . . 23.14 110.024 173.464 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.21 59.87 0.21 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 126.233 2.208 . . . . 19.74 111.123 177.37 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -107.53 127.16 53.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.453 1.101 . . . . 21.93 109.553 161.561 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -101.07 112.2 24.61 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.124 -0.985 . . . . 12.33 108.892 174.588 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 pt -109.94 134.98 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 125.963 2.792 . . . . 17.08 111.01 -172.397 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.2 m -89.25 115.22 26.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.512 -1.992 . . . . 16.3 109.142 -174.769 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 mt -104.0 167.23 9.9 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.373 -2.079 . . . . 15.88 114.629 170.015 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.321 9.2 tt0 -130.47 113.69 14.6 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.565 1.546 . . . . 28.9 115.169 168.45 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.76 145.28 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.957 1.703 . . . . 12.05 110.363 -173.176 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.84 148.17 94.59 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 117.267 -3.396 . . . . 18.17 113.018 158.596 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -65.97 -21.68 56.45 Favored 'Trans proline' 0 C--N 1.3 -2.019 3 C-N-CA 126.214 4.609 . . . . 8.16 113.414 172.096 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.8 m -84.61 8.11 17.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.681 1.705 . . . . 11.13 115.483 173.756 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -87.82 157.98 18.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.546 -2.596 . . . . 18.03 109.248 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 55' ' ' THR . 23.6 p -95.1 167.7 11.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.091 2.957 . . . . 10.22 115.061 -176.975 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -67.26 -26.35 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.211 1.93 . . . . 12.3 116.211 172.321 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -63.41 -47.52 81.64 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.073 -2.267 . . . . 36.51 112.03 175.264 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.91 -23.36 65.98 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.001 2.52 . . . . 25.66 113.738 176.096 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.31 -58.16 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.955 2.902 . . . . 8.12 107.87 167.831 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -70.56 -17.99 62.92 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 115.353 -4.592 . . . . 15.47 116.495 -173.896 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.55 -28.26 65.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.061 -1.65 . . . . 11.45 109.315 167.171 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -77.93 -33.36 51.76 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.497 1.499 . . . . 24.98 111.05 -177.036 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.1 -34.74 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 128.368 2.667 . . . . 9.46 110.213 178.529 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -56.75 -47.53 79.85 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 117.959 -1.02 . . . . 14.76 113.057 165.756 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -65.78 -57.95 6.8 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.059 2.614 . . . . 26.29 118.059 171.798 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -59.28 -52.16 66.87 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.46 3.133 . . . . 30.06 119.46 -173.359 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -107.09 -43.64 4.57 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 122.079 0.943 . . . . 25.19 109.681 176.418 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.32 47.43 2.02 Favored Glycine 0 N--CA 1.43 -1.741 0 O-C-N 118.264 -2.772 . . . . 7.41 110.733 -173.957 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 mt -104.55 114.61 63.9 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 101.516 -3.513 . . . . 9.49 101.516 168.249 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -83.62 163.41 14.4 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 CA-C-O 111.719 -3.534 . . . . 11.42 116.55 -171.061 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -81.6 -3.61 11.96 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 130.279 4.707 . . . . 12.0 111.281 -162.265 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.51 -26.4 45.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.001 1.273 . . . . 35.55 112.945 176.215 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -69.24 -51.24 39.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.912 3.671 . . . . 20.52 120.912 158.062 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -68.45 116.5 9.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.787 2.708 . . . . 7.13 115.858 -168.892 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -111.83 113.84 26.44 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.216 -4.678 . . . . 36.39 105.961 168.992 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 mt -83.61 127.65 33.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.155 1.798 . . . . 9.55 110.88 -179.919 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.6 mm -121.45 139.81 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 125.947 1.699 . . . . 13.9 108.282 177.774 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -135.25 139.99 44.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 104.206 -2.516 . . . . 6.86 104.206 157.207 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.266 . . 47.92 -98.86 0.05 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.504 2.721 . . . . 11.15 112.052 -164.899 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.91 31.05 1.35 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 114.376 -3.773 . . . . 13.93 110.252 167.568 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -95.18 147.34 23.56 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.242 1.417 . . . . 23.92 108.11 166.689 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -99.62 139.46 35.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.927 -1.511 . . . . 23.23 110.692 170.595 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.258 0.4 OUTLIER -113.74 131.75 56.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.092 1.495 . . . . 9.11 107.574 -163.756 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -101.08 157.36 16.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 125.333 1.646 . . . . 33.44 115.075 -162.71 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.259 33.6 m-20 -59.8 -53.72 54.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 121.447 3.869 . . . . 28.37 121.447 -165.283 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.86 33.93 5.24 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-N 121.109 1.777 . . . . 15.0 115.695 -179.408 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -113.92 150.34 33.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.18 -2.953 . . . . 25.5 105.092 169.712 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 22' ' ' THR . 16.0 p -90.16 171.48 9.49 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.939 2.78 . . . . 11.95 111.653 -170.21 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.63 -30.49 26.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.978 -3.576 . . . . 10.17 108.722 -176.789 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -59.05 -39.83 83.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.792 2.837 . . . . 13.59 108.233 170.816 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -58.03 -59.92 4.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.631 -3.793 . . . . 11.7 111.247 179.496 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -70.74 -11.96 61.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 130.099 3.359 . . . . 12.95 112.056 -170.97 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 65.71 60.04 0.72 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.92 -2.988 . . . . 25.45 112.851 -179.193 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mm -90.69 137.05 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.319 -2.738 . . . . 14.6 110.646 179.556 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -101.06 -175.8 2.98 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.507 -1.995 . . . . 33.23 114.883 -171.876 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -78.17 142.12 38.21 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.124 1.157 . . . . 25.97 114.124 178.661 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 61.11 30.84 19.65 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.214 2.206 . . . . 32.61 112.401 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.1 t -81.35 158.44 24.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 117.053 2.242 . . . . 10.56 117.053 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.3 m -121.37 103.76 9.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.145 -2.222 . . . . 5.33 107.805 -166.678 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB2' HG22 ' A' ' 5' ' ' VAL 0.273 91.6 mt -88.48 147.35 24.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.142 2.977 . . . . 11.66 107.438 175.542 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -100.84 137.72 38.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.303 2.252 . . . . 16.3 110.093 -178.625 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 mt -106.07 141.22 37.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.908 -1.745 . . . . 9.96 111.778 165.122 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.85 -169.85 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.62 2.368 . . . . 9.76 108.517 169.969 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.6 mt -94.79 126.08 39.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.369 3.868 . . . . 19.57 116.06 -173.103 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -104.31 148.86 25.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.852 -1.78 . . . . 35.08 112.764 170.313 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.56 -64.45 0.9 Allowed 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 127.082 2.153 . . . . 32.31 110.055 173.639 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.312 29.7 ttt180 -155.67 -79.45 0.09 Allowed 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.922 -3.611 . . . . 42.75 112.661 173.755 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.83 50.88 0.85 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 109.473 -1.451 . . . . 36.31 109.473 -173.599 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 O-C-N 119.811 -1.994 . . . . 36.27 109.448 -170.21 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 CA--C 1.49 -1.361 0 CA-C-O 121.447 0.642 . . . . 17.17 110.874 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -89.39 152.07 21.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.239 1.971 . . . . 21.89 109.987 170.549 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 pt -126.33 168.71 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.668 2.787 . . . . 10.83 109.401 154.811 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -119.15 145.75 45.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.775 1.75 . . . . 10.61 110.927 164.255 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.9 123.53 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 116.618 -3.801 . . . . 9.13 107.897 169.305 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -93.09 121.14 34.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.884 3.23 . . . . 20.55 109.72 176.227 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 p -78.18 -176.88 4.83 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.098 -4.751 . . . . 11.78 111.663 -174.138 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.3 tp -81.9 -34.36 30.02 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 111.823 -6.798 . . . . 19.31 113.337 -175.666 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.1 p -88.15 -26.29 22.52 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.12 -2.238 . . . . 23.14 107.06 -173.18 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.41 0.21 Allowed Glycine 0 N--CA 1.43 -1.738 0 CA-C-N 118.968 0.804 . . . . 19.74 113.161 166.121 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -112.1 145.62 39.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.367 -1.666 . . . . 21.93 108.043 169.552 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -111.15 123.78 50.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.991 2.057 . . . . 12.33 106.743 176.08 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.6 pt -110.7 141.99 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.76 -1.212 . . . . 17.08 113.856 177.232 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.7 m -110.57 112.85 25.03 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 115.491 -4.506 . . . . 16.3 111.047 -174.782 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 30' ' ' ILE . 45.6 mt -106.35 124.13 49.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.443 2.068 . . . . 15.88 108.967 -173.953 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -97.6 105.43 17.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.865 -3.022 . . . . 28.9 111.987 176.698 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -131.47 149.25 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.921 2.088 . . . . 12.05 107.677 -159.617 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -85.5 151.83 56.59 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 112.592 -3.575 . . . . 18.17 113.182 176.334 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -84.71 -6.06 9.8 Favored 'Trans proline' 0 N--CA 1.434 -2.028 1 CA-C-N 132.554 5.519 . . . . 8.16 109.072 -168.866 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -98.64 5.68 47.57 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.559 -3.213 . . . . 11.13 110.117 176.91 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -75.76 157.73 33.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.79 3.186 . . . . 18.03 108.677 173.394 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 p -96.37 164.26 12.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.812 -3.68 . . . . 10.22 108.29 -175.972 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mm -76.96 -16.6 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 119.516 -1.99 . . . . 12.3 111.692 -176.326 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -64.27 -46.88 81.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.343 -1.725 . . . . 36.51 106.343 172.865 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.77 -30.95 71.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.617 -2.552 . . . . 25.66 113.48 -178.296 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.77 -44.07 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 126.707 3.146 . . . . 8.12 108.265 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -62.78 -39.25 93.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 120.67 3.581 . . . . 15.47 120.67 172.756 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.76 -41.1 77.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.741 2.817 . . . . 11.45 113.76 175.045 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -57.13 -32.47 66.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.847 1.259 . . . . 24.98 110.4 178.82 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 15' ' ' LEU . 8.5 mt -82.41 -37.71 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.977 1.846 . . . . 9.46 109.194 -173.075 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -62.1 -39.53 92.79 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.143 -1.598 . . . . 14.76 112.602 168.509 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.5 -55.16 30.13 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 115.621 -2.133 . . . . 26.29 113.052 175.236 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -78.52 -54.9 5.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.964 3.32 . . . . 30.06 119.964 -171.98 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -92.87 -36.13 12.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.548 -2.595 . . . . 25.19 112.115 176.991 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.84 55.98 2.56 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 117.763 -3.086 . . . . 7.41 115.425 -174.849 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.0 mt -108.93 135.87 20.1 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 116.111 -1.899 . . . . 9.49 105.982 172.945 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -71.53 146.58 49.98 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-O 112.397 -3.251 . . . . 11.42 119.591 -170.149 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -91.53 8.57 3.1 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 CA-C-N 128.163 3.951 . . . . 12.0 112.96 -165.729 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.42 -44.19 10.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.799 2.839 . . . . 35.55 109.142 165.393 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.31 -42.11 65.81 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 113.826 -2.988 . . . . 20.52 111.555 175.253 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.268 72.6 mt-30 -66.45 108.97 2.57 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 126.616 3.103 . . . . 7.13 115.67 -174.169 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -106.51 110.02 22.11 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.114 4.165 . . . . 36.39 105.278 -174.223 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HG ' HD12 ' A' ' 50' ' ' LEU . 25.8 tp -100.27 108.87 21.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 126.037 2.827 . . . . 9.55 108.182 -162.735 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -106.66 145.82 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.141 -3.475 . . . . 13.9 113.09 -173.54 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -129.99 100.17 5.35 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.624 2.631 . . . . 6.86 106.642 172.736 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.88 -75.51 0.07 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.638 -2.539 . . . . 11.15 115.63 -176.352 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.58 1.2 1.33 Allowed Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 126.527 2.013 . . . . 13.93 113.621 171.532 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -99.13 146.55 26.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.201 -2.352 . . . . 23.92 110.079 173.659 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.296 10.0 tt0 -91.1 117.29 29.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.045 2.609 . . . . 23.23 118.045 164.119 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.444 HD12 ' HG ' ' A' ' 43' ' ' LEU . 19.4 mt -65.85 131.92 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 1 C-N-CA 133.177 4.591 . . . . 9.11 113.581 170.841 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.9 146.33 44.01 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.811 -1.181 . . . . 33.44 107.811 -169.084 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.65 -27.45 68.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.19 -2.277 . . . . 28.37 115.563 -158.65 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.04 24.43 30.53 Favored Glycine 0 N--CA 1.43 -1.729 1 O-C-N 114.526 -5.109 . . . . 15.0 117.353 -166.335 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -129.22 166.46 19.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.479 -0.934 . . . . 25.5 108.479 -176.137 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.295 22.2 p -92.93 157.91 16.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.251 1.501 . . . . 11.95 111.052 -173.708 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.2 mt -55.76 -34.04 64.87 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.449 1.595 . . . . 10.17 113.463 168.77 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 t -78.42 -25.43 46.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.895 3.278 . . . . 13.59 118.869 170.751 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -61.77 -47.58 84.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.734 -2.479 . . . . 11.7 113.044 166.871 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -81.76 -16.63 50.43 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.456 3.102 . . . . 12.95 111.271 -179.205 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 56.51 51.46 11.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.125 2.97 . . . . 25.45 109.39 -178.583 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.39 120.19 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 110.851 -2.886 . . . . 14.6 108.679 163.24 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -83.49 176.82 8.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.451 1.9 . . . . 33.23 110.365 -176.564 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.274 47.7 mttp -81.98 134.39 35.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.141 2.576 . . . . 25.97 109.55 179.81 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 56.83 34.03 24.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.787 2.835 . . . . 32.61 116.141 -175.961 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -72.14 127.44 32.55 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 127.591 3.567 . . . . 10.56 111.67 166.007 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.6 m -95.65 109.12 21.43 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 112.16 -2.291 . . . . 5.33 112.499 179.297 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 mt -96.36 175.26 6.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.815 -1.178 . . . . 11.66 109.899 -172.945 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -128.65 136.13 50.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.827 -1.171 . . . . 16.3 112.432 -175.478 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 tp -120.6 129.77 53.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.552 -1.967 . . . . 9.96 108.004 -176.063 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.53 163.43 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.366 1.066 . . . . 9.76 109.727 170.186 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.8 mt -102.43 155.21 18.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.182 -1.574 . . . . 19.57 109.548 -169.172 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.421 HH21 ' C ' ' A' ' 76' ' ' GLY . 26.7 ttt180 -149.72 164.42 35.29 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.673 1.989 . . . . 35.08 106.504 -171.627 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.9 mt -103.3 -164.97 1.12 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.869 -1.514 . . . . 32.31 111.245 164.166 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -94.37 -39.36 10.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.237 -3.414 . . . . 42.75 115.349 -164.263 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.71 69.5 0.22 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 126.578 2.037 . . . . 36.31 115.292 179.072 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.421 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 N--CA 1.43 -1.732 0 N-CA-C 108.274 -1.93 . . . . 36.27 108.274 162.51 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.366 0 CA-C-O 123.144 1.449 . . . . 17.17 108.774 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -108.29 138.06 45.22 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.202 -4.061 . . . . 21.89 108.74 -172.576 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -133.78 148.85 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.609 -2.557 . . . . 10.83 107.361 -179.842 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.68 110.88 22.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.729 2.122 . . . . 10.61 116.729 177.311 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 t -101.14 122.7 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 120.918 1.69 . . . . 9.13 108.863 175.635 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HG2' HG23 ' A' ' 12' ' ' THR . 49.0 mttt -90.32 111.32 22.48 Favored 'General case' 0 N--CA 1.429 -1.495 1 C-N-CA 131.881 4.072 . . . . 20.55 113.247 175.249 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -76.93 159.49 29.94 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.253 1.945 . . . . 11.78 116.253 176.942 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 tp -53.52 -49.69 67.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.239 2.215 . . . . 19.31 110.981 -178.605 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.4 p -65.85 -38.1 87.95 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.533 3.533 . . . . 23.14 113.751 178.37 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.66 51.07 0.26 Allowed Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 127.785 2.612 . . . . 19.74 116.496 -178.195 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -121.53 128.92 52.54 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.961 -1.905 . . . . 21.93 108.764 165.645 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.415 HG23 ' HG2' ' A' ' 6' ' ' LYS . 85.6 m -99.59 108.22 20.57 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.697 -3.752 . . . . 12.33 105.9 171.199 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pt -105.15 140.79 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 130.25 3.42 . . . . 17.08 104.536 -171.818 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -109.14 131.22 55.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.143 -2.848 . . . . 16.3 108.624 -170.239 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.0 mt -113.3 140.55 47.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.89 -1.893 . . . . 15.88 105.89 -179.147 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -100.24 128.25 46.35 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.585 -1.265 . . . . 28.9 107.585 171.127 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.05 152.15 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.193 -2.817 . . . . 12.05 117.188 -168.847 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.26 32.5 mt-10 -97.03 148.78 34.89 Favored Pre-proline 0 N--CA 1.43 -1.456 1 O-C-N 115.795 -4.316 . . . . 18.17 105.863 172.246 . . . . . . . . 3 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -82.31 -8.57 11.7 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.687 1.888 . . . . 8.16 111.899 -169.544 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -81.06 -12.47 59.31 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.944 2.097 . . . . 11.13 109.976 -179.086 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -90.7 154.36 19.61 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 126.457 3.027 . . . . 18.03 109.259 -176.582 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.9 p -83.11 175.83 9.69 Favored 'General case' 0 N--CA 1.43 -1.43 2 O-C-N 114.63 -5.043 . . . . 10.22 117.758 -170.386 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.0 mm -79.65 -25.79 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 1 O-C-N 113.432 -5.792 . . . . 12.3 111.862 178.647 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -47.58 -40.71 19.89 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.97 2.211 . . . . 36.51 116.97 165.978 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -70.29 -42.33 72.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.274 2.629 . . . . 25.66 111.855 176.711 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.443 HG21 HD21 ' A' ' 56' ' ' LEU . 68.4 t -67.86 -34.14 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 117.37 -3.331 . . . . 8.12 110.592 178.309 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.256 35.5 mtmt -65.4 -37.19 86.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.977 2.111 . . . . 15.47 112.541 166.792 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.88 -24.34 64.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.083 2.114 . . . . 11.45 112.559 -174.516 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -71.22 -37.89 72.02 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 133.599 4.76 . . . . 24.98 109.096 175.215 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' CG2' HD12 ' A' ' 36' ' ' ILE . 52.6 mt -80.51 -31.02 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.322 -1.487 . . . . 9.46 107.575 -174.535 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.06 -31.33 68.89 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.24 1.416 . . . . 14.76 112.971 177.201 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -82.28 -52.3 7.07 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.283 2.327 . . . . 26.29 117.283 -175.471 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -86.06 -54.55 4.41 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.269 1.985 . . . . 30.06 116.046 -177.657 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -72.32 -39.89 67.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.315 -1.491 . . . . 25.19 114.484 177.291 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.89 51.78 2.94 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 116.449 -3.907 . . . . 7.41 115.9 174.064 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.403 HD12 ' CG2' ' A' ' 30' ' ' ILE . 63.9 mt -113.18 129.21 24.78 Favored Pre-proline 0 N--CA 1.431 -1.421 0 C-N-CA 127.304 2.242 . . . . 9.49 107.909 -176.516 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -77.39 148.95 27.15 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 114.568 -3.438 . . . . 11.42 110.01 -164.682 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -71.3 -24.39 23.06 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.805 2.337 . . . . 12.0 113.919 -156.596 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.292 5.2 p-10 -63.61 -53.23 54.8 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.687 -2.508 . . . . 35.55 110.124 173.751 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -57.43 -13.81 4.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.522 -2.611 . . . . 20.52 117.376 -177.98 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -93.63 95.61 9.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.351 1.46 . . . . 7.13 109.311 -178.737 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -89.89 142.79 27.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 118.448 -1.301 . . . . 36.39 109.927 156.49 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 43' ' ' LEU . 12.0 mt -120.29 135.67 54.93 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.36 -0.978 . . . . 9.55 108.36 -177.19 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 49' ' ' GLN . 11.1 mm -120.31 138.22 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.667 2.787 . . . . 13.9 106.22 -179.685 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.431 ' HB2' HD11 ' A' ' 50' ' ' LEU . 25.4 t80 -112.76 114.72 27.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.995 2.918 . . . . 6.86 106.439 165.632 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.62 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.912 2.19 . . . . 11.15 116.912 -173.649 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.51 8.01 2.04 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 129.115 3.245 . . . . 13.93 106.525 -175.571 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -125.4 144.95 50.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.196 2.498 . . . . 23.92 111.927 -173.539 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.401 ' HA ' HD13 ' A' ' 44' ' ' ILE . 22.1 tt0 -103.13 134.5 46.45 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.884 1.326 . . . . 23.23 111.127 -161.682 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 45' ' ' PHE . 50.1 mt -84.68 143.89 28.91 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 115.882 -2.008 . . . . 9.11 110.674 -176.105 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -135.11 156.37 49.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 126.529 2.393 . . . . 33.44 111.134 -173.059 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.79 -50.55 19.99 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 118.807 2.892 . . . . 28.37 118.807 -147.407 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.65 2.07 18.38 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 121.078 3.191 . . . . 15.0 121.078 -177.964 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -106.92 148.89 28.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.269 1.509 . . . . 25.5 109.613 -174.415 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -90.85 159.26 16.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.027 2.531 . . . . 11.95 111.17 -162.023 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 26' ' ' VAL . 8.4 mt -58.23 -45.23 88.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.809 2.844 . . . . 10.17 108.378 172.111 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -57.58 -50.14 74.08 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.798 2.09 . . . . 13.59 114.505 178.325 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -60.53 -35.89 77.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.524 -1.36 . . . . 11.7 113.509 174.61 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -79.11 2.31 21.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.361 -3.337 . . . . 12.95 116.554 177.941 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.376 4.2 m120 71.39 34.52 1.7 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.213 -1.554 . . . . 25.45 111.932 -179.602 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.8 98.63 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 105.826 -1.916 . . . . 14.6 105.826 -165.84 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -107.13 -152.89 0.49 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.347 2.022 . . . . 33.23 112.16 -174.729 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -73.87 116.96 15.09 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.882 2.549 . . . . 25.97 117.882 -170.314 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 81.38 50.2 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.287 2.635 . . . . 32.61 106.468 163.601 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 152.66 25.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.983 1.713 . . . . 10.56 112.554 -169.859 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -94.58 115.91 28.13 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.483 3.513 . . . . 5.33 112.754 -164.416 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -116.07 147.51 41.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.024 -3.548 . . . . 11.66 111.261 173.993 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -121.2 127.69 51.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.916 -2.253 . . . . 16.3 104.916 -175.618 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 tp -91.11 109.94 21.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.533 2.42 . . . . 9.96 117.533 178.473 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.87 156.09 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.199 2.599 . . . . 9.76 106.458 -172.763 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.7 tp -89.22 111.41 22.2 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.162 -2.211 . . . . 19.57 112.524 173.289 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -90.12 116.92 28.5 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.206 -0.934 . . . . 35.08 110.141 -175.055 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.89 148.42 49.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 131.51 3.924 . . . . 32.31 112.111 169.492 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -83.81 118.37 23.89 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.729 -3.107 . . . . 42.75 118.419 177.072 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.21 79.62 0.55 Allowed Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 127.226 2.346 . . . . 36.31 114.344 -177.329 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 N-CA-C 107.102 -2.399 . . . . 36.27 107.102 178.324 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 115.061 1.504 . . . . 17.17 115.061 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -113.2 145.49 40.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.165 -2.21 . . . . 21.89 110.467 -174.654 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 pt -127.35 154.42 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.311 -1.737 . . . . 10.83 106.311 173.042 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -119.43 115.5 24.2 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.274 2.306 . . . . 10.61 106.987 -176.656 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.97 106.85 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.292 -1.505 . . . . 9.13 113.471 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -83.56 110.2 18.03 Favored 'General case' 0 N--CA 1.43 -1.466 1 CA-C-O 128.648 4.07 . . . . 20.55 110.855 175.845 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.258 15.1 p -74.04 176.85 6.11 Favored 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 131.914 4.086 . . . . 11.78 113.238 -171.269 . . . . . . . . 3 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.66 -46.93 62.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.843 2.259 . . . . 19.31 114.743 -170.844 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.3 p -74.88 -91.24 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.216 3.006 . . . . 23.14 109.339 179.355 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.18 33.55 0.34 Allowed Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 121.59 1.995 . . . . 19.74 113.454 -174.675 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -122.64 141.99 51.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.136 -3.567 . . . . 21.93 115.089 178.108 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -109.54 123.56 49.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.768 -1.832 . . . . 12.33 111.461 170.477 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.0 pt -101.0 144.9 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 117.554 -1.212 . . . . 17.08 110.556 178.86 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.8 m -104.55 114.45 28.69 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.186 -2.34 . . . . 16.3 107.86 176.309 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.547 ' CD1' HG13 ' A' ' 26' ' ' VAL 0.313 96.5 mt -106.76 158.31 17.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.144 2.878 . . . . 15.88 105.234 176.021 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.323 27.0 tt0 -104.64 121.19 43.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 113.165 -1.834 . . . . 28.9 108.914 173.206 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -141.39 154.71 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 120.064 -1.647 . . . . 12.05 107.501 -179.517 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -87.87 158.37 50.53 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 119.603 -1.936 . . . . 18.17 106.907 167.229 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.12 -1.6 11.75 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 CA-C-N 122.169 1.81 . . . . 8.16 115.664 174.117 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.5 m -86.25 -16.57 37.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.834 3.272 . . . . 11.13 119.834 173.75 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -84.26 170.25 13.9 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.872 2.869 . . . . 18.03 109.196 -174.766 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.5 p -90.92 -176.77 4.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.463 -3.273 . . . . 10.22 116.615 -173.084 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -83.16 -19.3 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 116.419 -3.926 . . . . 12.3 108.703 173.986 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -73.0 -42.51 63.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.055 -2.903 . . . . 36.51 107.309 178.216 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -54.82 -26.67 36.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.203 -1.856 . . . . 25.66 111.337 174.34 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.547 HG13 ' CD1' ' A' ' 15' ' ' LEU . 20.0 t -67.24 -54.85 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 117.795 2.517 . . . . 8.12 117.795 167.703 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -62.48 -30.55 71.34 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 118.306 -2.746 . . . . 15.47 116.092 -177.981 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.68 -49.79 56.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.827 3.651 . . . . 11.45 116.153 164.074 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -63.89 -35.89 82.14 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.381 2.672 . . . . 24.98 109.845 178.04 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.49 -43.39 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.806 1.288 . . . . 9.46 112.372 177.521 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -72.43 -37.89 68.49 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 113.899 -2.953 . . . . 14.76 109.586 -179.479 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.68 -45.79 42.2 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.408 2.822 . . . . 26.29 111.18 179.398 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -88.49 -55.29 3.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.202 -0.999 . . . . 30.06 112.703 -168.926 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -75.62 -63.28 1.33 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.094 1.426 . . . . 25.19 110.774 -176.214 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.11 40.3 0.45 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 125.376 1.465 . . . . 7.41 115.099 173.804 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -104.07 118.46 57.0 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-O 116.581 -1.676 . . . . 9.49 108.443 175.255 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -64.21 156.89 56.86 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 124.752 3.635 . . . . 11.42 112.11 -170.595 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.6 -18.78 25.24 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 115.57 1.335 . . . . 12.0 115.57 -161.171 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.59 -13.23 32.33 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 127.132 3.349 . . . . 35.55 107.013 -165.269 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.99 -6.65 58.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 112.171 -2.286 . . . . 20.52 115.778 175.193 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -102.35 107.28 18.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.735 2.124 . . . . 7.13 116.735 -162.723 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -117.77 125.3 50.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.693 -1.254 . . . . 36.39 107.9 172.754 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 mt -102.12 128.22 48.7 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.971 -2.33 . . . . 9.55 111.302 179.43 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.8 mt -110.01 141.72 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.608 2.363 . . . . 13.9 108.246 169.811 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.431 ' HB3' HD21 ' A' ' 50' ' ' LEU . 21.0 t80 -136.09 131.35 34.71 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.233 -2.136 . . . . 6.86 105.233 174.148 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.15 -97.54 0.07 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.303 1.841 . . . . 11.15 112.354 -167.633 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.66 5.15 7.06 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 119.914 -1.741 . . . . 13.93 115.901 171.61 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -111.71 143.88 41.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.947 3.699 . . . . 23.92 112.146 -175.817 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -90.41 132.83 35.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 114.641 1.349 . . . . 23.23 114.641 176.643 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.4 mt -87.86 139.74 30.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.756 2.422 . . . . 9.11 113.855 -172.891 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.03 -176.25 6.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.028 2.531 . . . . 33.44 110.76 168.978 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -83.02 -69.54 0.62 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 116.397 -3.939 . . . . 28.37 113.743 -176.557 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.9 56.35 4.36 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 120.387 -1.445 . . . . 15.0 116.007 -167.852 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -148.5 138.78 22.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 114.584 -2.627 . . . . 25.5 106.438 -172.669 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 44.3 p -79.68 163.87 24.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.309 2.956 . . . . 11.95 112.043 -167.926 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.51 -45.98 91.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 110.488 -3.051 . . . . 10.17 108.347 172.119 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 m -54.85 -39.47 68.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 125.56 1.787 . . . . 13.59 115.017 174.312 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -63.36 -53.5 51.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.306 -2.121 . . . . 11.7 113.213 176.199 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -70.25 -5.56 28.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.857 -1.065 . . . . 12.95 113.734 178.017 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 66.61 52.28 1.02 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.93 2.492 . . . . 25.45 110.595 179.237 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.9 119.13 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.041 -2.207 . . . . 14.6 105.041 175.758 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -120.05 -172.47 2.36 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.163 2.585 . . . . 33.23 108.72 -163.93 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -64.24 115.93 5.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 112.926 -3.416 . . . . 25.97 116.246 -174.368 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 76.93 18.7 1.5 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.986 3.314 . . . . 32.61 114.181 -176.164 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.0 m -61.12 145.27 51.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.643 -3.161 . . . . 10.56 115.68 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -94.42 126.29 39.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.705 -2.497 . . . . 5.33 115.899 171.457 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 45' ' ' PHE 0.251 22.0 mt -108.31 152.81 24.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.727 1.01 . . . . 11.66 113.727 172.62 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -114.45 131.59 56.55 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.919 -3.613 . . . . 16.3 111.656 -177.928 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.6 tp -109.56 122.6 47.79 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 118.457 -0.782 . . . . 9.96 109.705 -178.85 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.86 -168.77 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.413 -1.699 . . . . 9.76 106.413 -170.522 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.0 tp -90.25 129.82 36.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.405 -2.072 . . . . 19.57 105.405 -169.742 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -90.95 120.21 31.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.19 -2.204 . . . . 35.08 111.348 157.384 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mt -101.99 145.07 29.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 110.409 -3.087 . . . . 32.31 105.661 179.197 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -55.53 111.4 0.88 Allowed 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.292 -4.005 . . . . 42.75 114.499 -178.975 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.78 69.91 0.34 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 121.146 3.218 . . . . 36.31 121.146 -170.667 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 O-C-N 129.068 3.451 . . . . 36.27 112.492 -167.849 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 119.589 3.181 . . . . 17.17 119.589 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -65.37 140.33 58.64 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 117.049 2.241 . . . . 21.89 117.049 163.354 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.4 pt -124.6 159.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.517 -1.99 . . . . 10.83 111.45 166.262 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -110.41 122.12 46.95 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 115.679 -2.105 . . . . 10.61 115.555 170.478 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.6 t -110.43 110.1 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 101.827 -3.397 . . . . 9.13 101.827 -179.096 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -75.72 134.86 40.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.187 2.195 . . . . 20.55 114.124 175.684 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -98.42 -169.14 1.75 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.944 -1.132 . . . . 11.78 107.944 -172.963 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.6 tp -91.01 -38.33 12.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.254 -1.758 . . . . 19.31 106.254 -168.353 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.328 62.1 p -71.67 -69.77 0.36 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.067 1.877 . . . . 23.14 116.067 171.858 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.5 42.36 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 O-C-N 116.977 -3.577 . . . . 19.74 119.417 177.895 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -112.48 129.42 56.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 114.317 -2.754 . . . . 21.93 104.96 -172.517 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -88.71 105.72 17.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.726 2.679 . . . . 12.33 109.862 165.266 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.0 mt -86.12 110.91 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 116.616 -3.802 . . . . 17.08 111.427 175.253 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -100.55 113.75 26.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.274 1.852 . . . . 16.3 114.712 -172.925 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -116.26 139.39 50.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.359 0.982 . . . . 15.88 111.886 -167.014 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -96.73 109.13 21.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.434 -2.042 . . . . 28.9 110.808 -179.164 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.42 156.13 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 118.266 -2.771 . . . . 12.05 108.645 -174.629 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -107.55 136.79 19.59 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.243 -1.536 . . . . 18.17 110.172 170.576 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.11 -5.45 14.46 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 122.578 2.185 . . . . 8.16 113.275 -155.425 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -93.12 -8.81 41.59 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 112.187 -3.768 . . . . 11.13 110.876 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -77.71 177.57 8.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 128.628 3.705 . . . . 18.03 115.204 166.415 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.2 p -115.62 -178.23 3.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.383 -2.698 . . . . 10.22 109.615 -169.401 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.485 HD12 HD13 ' A' ' 50' ' ' LEU 0.308 11.9 mm -63.09 -35.53 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 116.939 -3.601 . . . . 12.3 113.09 175.725 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.2 -33.17 51.62 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.157 -4.089 . . . . 36.51 114.629 174.953 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -64.97 -39.24 93.18 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.294 -2.129 . . . . 25.66 111.832 174.857 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.6 t -73.91 -45.63 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.843 -1.785 . . . . 8.12 107.27 -174.228 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.288 38.9 ttmt -63.9 -30.63 71.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.709 -3.744 . . . . 15.47 111.478 -178.766 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.03 89.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.696 2.799 . . . . 11.45 117.328 171.021 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -71.97 -21.86 61.52 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.527 2.417 . . . . 24.98 117.527 174.127 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.2 mt -75.24 -30.84 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 127.675 3.607 . . . . 9.46 114.077 164.217 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.92 -47.53 82.87 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.529 -4.482 . . . . 14.76 111.798 168.08 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.94 -47.24 21.51 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.321 -1.487 . . . . 26.29 111.678 -172.711 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -74.18 -76.84 0.12 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 116.825 -1.559 . . . . 30.06 112.373 -176.332 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -80.26 -38.34 31.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.829 3.251 . . . . 25.19 108.099 -161.564 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.01 50.83 3.36 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-O 123.952 1.862 . . . . 7.41 111.669 -176.144 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.1 mt -101.66 120.01 55.58 Favored Pre-proline 0 N--CA 1.43 -1.468 1 O-C-N 114.703 -4.998 . . . . 9.49 109.605 165.216 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.9 158.66 56.35 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 126.883 3.494 . . . . 11.42 114.671 -174.27 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.85 -7.83 5.24 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 CA-C-N 128.995 4.248 . . . . 12.0 110.977 -157.618 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -70.83 -32.26 69.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.767 2.827 . . . . 35.55 106.626 175.521 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -88.02 -11.79 46.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.981 -2.949 . . . . 20.52 113.755 177.994 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -84.74 122.51 29.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.853 2.861 . . . . 7.13 112.818 176.577 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -129.95 146.96 51.66 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.147 -2.221 . . . . 36.39 105.014 154.061 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.85 122.19 44.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.16 1.457 . . . . 9.55 107.72 -173.371 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -110.22 131.69 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 128.298 2.639 . . . . 13.9 111.907 -179.412 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -126.02 118.75 26.0 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 114.417 -5.177 . . . . 6.86 103.763 176.386 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.395 . . 65.8 -98.8 0.06 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.483 2.031 . . . . 11.15 116.483 -164.944 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.13 13.82 4.35 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 127.759 2.599 . . . . 13.93 109.951 -173.861 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -132.02 147.28 52.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.217 -2.343 . . . . 23.92 113.025 -177.408 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -85.76 146.34 26.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.293 2.473 . . . . 23.23 110.533 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.485 HD13 HD12 ' A' ' 23' ' ' ILE . 94.1 mt -93.55 148.4 22.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.673 -2.517 . . . . 9.11 110.987 178.049 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.305 10.0 pt-20 -80.69 -168.86 1.91 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.572 1.949 . . . . 33.44 110.111 175.969 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -105.77 -47.39 3.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.111 3.338 . . . . 28.37 113.186 174.985 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.93 59.92 1.01 Allowed Glycine 0 N--CA 1.43 -1.715 1 O-C-N 115.394 -4.566 . . . . 15.0 115.088 -173.022 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -139.42 139.29 37.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.387 -1.338 . . . . 25.5 107.387 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 50.1 p -80.07 163.75 23.92 Favored 'General case' 0 N--CA 1.43 -1.45 1 CA-C-O 128.903 4.192 . . . . 11.95 111.351 -166.887 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -67.3 -37.52 83.53 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.619 -4.425 . . . . 10.17 114.342 -179.761 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -72.53 -27.13 62.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.802 1.641 . . . . 13.59 115.064 176.187 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -73.13 -39.16 65.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.073 -3.517 . . . . 11.7 107.019 172.483 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.06 -0.07 23.28 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.453 1.101 . . . . 12.95 111.779 178.801 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 51.09 60.12 4.11 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.363 -2.711 . . . . 25.45 114.685 179.355 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.0 mm -104.28 132.9 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 127.971 2.509 . . . . 14.6 109.191 170.592 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -111.1 -179.82 3.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.007 1.861 . . . . 33.23 114.362 -179.07 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -59.33 118.7 6.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.087 -1.87 . . . . 25.97 114.902 172.55 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.321 55.7 mt-10 76.27 35.0 0.48 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.437 -3.914 . . . . 32.61 112.874 173.464 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -90.63 141.92 28.28 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.094 1.757 . . . . 10.56 109.818 -175.553 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -87.55 128.14 35.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 113.878 -1.51 . . . . 5.33 113.528 176.239 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.57 149.35 42.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.144 2.978 . . . . 11.66 104.693 174.357 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -119.78 135.41 54.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.088 -1.008 . . . . 16.3 111.598 176.304 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.75 110.98 23.47 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.051 1.405 . . . . 9.96 112.609 177.584 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -99.18 -174.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.207 2.432 . . . . 9.76 108.837 -178.653 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 tp -101.12 110.83 22.91 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 115.796 -4.315 . . . . 19.57 106.706 -177.437 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.253 58.0 ttt180 -78.05 133.63 37.9 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.433 2.693 . . . . 35.08 111.127 172.63 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -101.62 -163.64 1.03 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.645 -1.284 . . . . 32.31 107.757 -174.356 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -86.35 135.37 33.54 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.128 1.529 . . . . 42.75 115.128 169.546 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.24 -82.7 0.33 Allowed Glycine 0 N--CA 1.43 -1.765 0 CA-C-O 122.016 0.787 . . . . 36.31 113.522 -174.713 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.735 0 N-CA-C 118.54 2.176 . . . . 36.27 118.54 -170.358 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 117.057 2.243 . . . . 17.17 117.057 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 81.9 mt-30 -80.92 135.63 35.93 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 116.084 -4.135 . . . . 21.89 111.73 -176.107 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.71 153.24 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.177 -2.527 . . . . 10.83 104.177 161.049 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.279 50.2 m-85 -115.06 121.86 44.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 126.798 2.561 . . . . 10.61 111.634 -174.085 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.07 112.69 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 116.501 -3.875 . . . . 9.13 110.504 -173.288 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -95.45 147.28 23.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.919 2.295 . . . . 20.55 106.36 -176.437 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.3 p -89.06 -178.14 5.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.785 -3.072 . . . . 11.78 106.635 174.109 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.2 tp -63.37 -47.8 80.59 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 117.912 -1.042 . . . . 19.31 112.87 168.576 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -55.63 -50.16 70.93 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.103 2.561 . . . . 23.14 111.16 171.319 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.9 49.78 0.3 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 118.887 -2.383 . . . . 19.74 109.311 169.391 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -90.42 124.48 34.99 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 103.179 -2.897 . . . . 21.93 103.179 176.918 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -97.67 115.13 27.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.345 2.498 . . . . 12.33 109.068 -175.672 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.5 mt -105.81 113.88 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.29 -2.232 . . . . 17.08 106.249 178.419 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -88.49 133.69 34.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.604 -3.185 . . . . 16.3 111.342 173.298 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 58.0 mt -120.6 172.25 7.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.986 2.054 . . . . 15.88 108.937 -175.101 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -128.26 114.65 17.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.094 -1.628 . . . . 28.9 108.748 170.182 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.37 152.53 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 125.801 1.938 . . . . 12.05 108.366 -177.812 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.26 140.22 28.67 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-O 114.21 -2.805 . . . . 18.17 113.799 157.641 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 73.3 Cg_endo -81.7 -4.69 12.25 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 123.987 2.46 . . . . 8.16 111.258 -169.722 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 m -82.68 4.09 26.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.85 2.907 . . . . 11.13 118.85 163.553 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -99.94 176.86 5.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.015 2.189 . . . . 18.03 106.572 173.876 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.369 11.0 p -89.3 -169.92 2.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.48 -1.236 . . . . 10.22 113.827 -166.404 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 mm -81.05 -18.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.672 2.389 . . . . 12.3 115.258 161.478 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -71.32 -29.64 65.27 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 123.88 0.872 . . . . 36.51 109.08 173.659 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -60.57 -45.67 93.05 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.047 1.739 . . . . 25.66 110.819 169.29 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -65.29 -35.56 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 119.16 0.891 . . . . 8.12 109.198 -175.496 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -65.15 -37.59 87.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.857 1.429 . . . . 15.47 114.857 168.889 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.274 . . -70.0 -33.02 71.5 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.299 2.703 . . . . 11.45 118.299 172.469 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -65.93 -33.04 74.9 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.358 -3.964 . . . . 24.98 110.775 173.729 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.5 mt -65.98 -44.87 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 117.051 -3.53 . . . . 9.46 108.386 167.122 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.76 -38.65 82.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.959 1.709 . . . . 14.76 112.344 176.099 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.99 -46.87 49.79 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.304 -0.872 . . . . 26.29 110.871 179.316 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -77.01 -57.78 3.65 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 116.498 -2.081 . . . . 30.06 113.059 -173.362 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -91.5 -52.14 4.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.908 1.337 . . . . 25.19 109.267 -167.934 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.22 30.02 3.05 Favored Glycine 0 N--CA 1.43 -1.708 1 C-N-CA 132.061 4.648 . . . . 7.41 115.037 173.534 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.5 mt -81.34 135.15 50.64 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 119.068 -2.431 . . . . 9.49 106.055 175.071 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -68.88 137.67 38.71 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-O 114.203 -2.499 . . . . 11.42 116.354 177.819 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.39 -12.14 22.81 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 124.158 3.239 . . . . 12.0 113.933 -175.532 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -74.56 -26.82 60.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.583 1.992 . . . . 35.55 113.826 167.655 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -95.37 3.81 54.01 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.008 2.523 . . . . 20.52 113.138 178.25 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' HG2' HD11 ' A' ' 69' ' ' LEU . 72.8 mt-30 -99.06 133.66 43.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.264 -2.148 . . . . 7.13 114.751 178.201 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -113.4 121.0 43.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.187 2.595 . . . . 36.39 109.947 158.63 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 mt -100.67 140.85 34.36 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.269 -2.77 . . . . 9.55 109.829 174.945 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mt -141.73 138.62 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 105.013 -2.217 . . . . 13.9 105.013 -169.36 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -123.46 117.99 26.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.07 -1.019 . . . . 6.86 111.027 172.871 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.299 . . 74.63 -108.01 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.525 -2.398 . . . . 11.15 104.525 176.002 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.34 6.18 5.63 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 119.031 -2.293 . . . . 13.93 113.629 168.699 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.283 38.3 pttt -81.12 135.52 35.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.671 2.1 . . . . 23.92 116.671 159.79 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -82.76 162.31 21.77 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.462 -3.899 . . . . 23.23 107.908 172.985 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.6 mt -110.42 133.5 53.22 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.23 1.967 . . . . 9.11 115.044 175.104 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.79 153.08 19.09 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.739 2.126 . . . . 33.44 116.739 163.856 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.23 -30.63 60.62 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 131.306 3.842 . . . . 28.37 116.819 -160.213 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.94 34.48 4.64 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 126.244 2.215 . . . . 15.0 117.665 177.312 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -140.2 146.86 39.25 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 118.547 1.173 . . . . 25.5 109.109 -170.874 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 68.4 p -89.66 164.18 14.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.537 1.517 . . . . 11.95 114.537 -173.088 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 11.9 mt -55.19 -46.28 75.85 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.522 3.529 . . . . 10.17 110.878 166.372 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 m -58.53 -52.12 67.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.621 1.568 . . . . 13.59 109.717 173.481 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.93 -32.82 30.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.493 2.406 . . . . 11.7 109.965 -168.96 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -61.88 -34.5 76.12 Favored 'General case' 0 N--CA 1.43 -1.45 1 N-CA-C 122.269 4.174 . . . . 12.95 122.269 161.873 . . . . . . . . 4 4 . 1 . 038 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 66.8 m-80 90.35 59.86 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.108 2.163 . . . . 25.45 109.781 177.415 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mm -107.53 108.84 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 113.253 -1.794 . . . . 14.6 106.621 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.313 10.0 pt20 -83.84 176.65 8.76 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.108 -2.87 . . . . 33.23 117.858 -178.223 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -68.73 125.08 25.46 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 130.487 3.515 . . . . 25.97 110.533 168.574 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 64.63 39.28 6.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 130.516 3.526 . . . . 32.61 115.922 -171.216 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.8 m -78.18 165.03 24.43 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 113.308 0.855 . . . . 10.56 113.308 172.165 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m -106.01 139.04 41.16 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 126.534 1.933 . . . . 5.33 106.855 170.52 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.38 156.78 41.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.86 -3.025 . . . . 11.66 107.707 171.235 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -112.69 117.7 32.96 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.173 -3.455 . . . . 16.3 107.436 -175.887 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.419 HD11 ' HG2' ' A' ' 41' ' ' GLN 0.257 12.4 tp -101.37 121.39 41.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.524 -2.61 . . . . 9.96 114.97 169.206 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.307 10.7 m -121.4 158.52 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 130.425 3.49 . . . . 9.76 102.83 177.945 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tp -64.01 139.52 58.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.672 -1.149 . . . . 19.57 113.881 166.641 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.343 63.2 ttt180 -76.56 127.22 32.4 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.063 2.616 . . . . 35.08 118.063 173.284 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.3 mt -113.4 165.44 12.45 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 122.455 2.389 . . . . 32.31 107.576 -175.796 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -66.24 105.23 1.36 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.527 1.531 . . . . 42.75 113.096 168.272 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.59 87.4 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 113.881 -1.509 . . . . 36.31 113.753 -178.576 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.758 0 O-C-N 125.077 1.104 . . . . 36.27 111.988 -166.401 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.491 -1.32 0 CA-C-O 118.34 -0.838 . . . . 17.17 112.882 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.09 150.07 23.62 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.537 -3.852 . . . . 21.89 109.156 177.202 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.282 32.0 pt -131.45 159.03 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 128.59 2.756 . . . . 10.83 109.815 169.345 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -110.95 141.87 43.81 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.696 -1.965 . . . . 10.61 105.696 173.41 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 30' ' ' ILE . 4.9 t -108.47 120.02 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 120.457 1.48 . . . . 9.13 108.851 161.205 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -103.03 125.18 49.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.557 2.343 . . . . 20.55 110.851 -179.135 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -88.01 148.23 24.62 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.215 1.006 . . . . 11.78 112.751 177.889 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.338 14.5 tp -51.16 -40.2 58.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.659 2.384 . . . . 19.31 110.825 162.995 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.5 m -64.58 -50.77 65.95 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 121.105 1.775 . . . . 23.14 112.481 -179.19 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.0 19.34 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 123.787 1.771 . . . . 19.74 116.675 169.351 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -103.37 138.42 40.14 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.243 -3.504 . . . . 21.93 112.417 177.864 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.9 m -99.59 124.73 45.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.244 -2.16 . . . . 12.33 108.796 162.894 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 13' ' ' ILE . 42.8 mt -119.75 119.38 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 126.41 1.884 . . . . 17.08 110.093 -171.053 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -82.76 119.08 23.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.08 -3.512 . . . . 16.3 106.446 -169.047 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 mt -106.27 159.39 16.15 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 116.226 -4.046 . . . . 15.88 111.352 169.378 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -99.45 134.92 41.62 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 121.605 2.002 . . . . 28.9 109.5 154.735 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.69 156.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 125.416 2.532 . . . . 12.05 106.589 175.727 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -96.94 153.18 38.65 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 112.354 -2.203 . . . . 18.17 110.633 173.922 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.11 -24.16 28.37 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 127.251 3.625 . . . . 8.16 111.319 178.997 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 p -81.21 -13.88 58.11 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.404 3.002 . . . . 11.13 111.49 -171.736 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -67.19 151.23 47.92 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.729 -4.982 . . . . 18.03 113.809 176.785 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.275 22.3 p -80.66 153.36 27.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 120.282 3.438 . . . . 10.22 120.282 162.973 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.3 mm -64.75 -26.61 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 125.772 2.701 . . . . 12.3 112.123 -179.218 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.257 20.4 tt0 -44.37 -46.63 9.48 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.855 -4.278 . . . . 36.51 116.345 162.663 . . . . . . . . 3 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -69.32 -37.82 77.92 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.012 2.925 . . . . 25.66 111.329 172.097 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.256 58.5 t -63.44 -47.36 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 119.398 0.999 . . . . 8.12 113.167 170.99 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -49.24 -43.24 42.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.167 2.284 . . . . 15.47 117.167 168.315 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.37 -28.6 69.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 117.915 2.561 . . . . 11.45 117.915 173.496 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -83.32 -29.09 28.57 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.603 1.334 . . . . 24.98 114.603 175.304 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.426 HD11 HG21 ' A' ' 5' ' ' VAL . 69.4 mt -70.68 -36.3 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.837 -1.074 . . . . 9.46 108.202 169.61 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.12 -37.75 88.46 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.547 -1.692 . . . . 14.76 115.337 171.025 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.16 -43.62 67.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.703 2.047 . . . . 26.29 111.334 179.619 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -70.7 -76.16 0.11 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.032 2.133 . . . . 30.06 115.347 177.81 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -81.44 -28.75 34.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.16 2.584 . . . . 25.19 108.974 -169.725 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.63 43.57 6.08 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 116.437 -2.313 . . . . 7.41 113.64 -176.231 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 mt -105.25 121.63 45.69 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 115.966 -1.968 . . . . 9.49 114.671 176.18 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.5 149.8 74.78 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 126.436 3.334 . . . . 11.42 115.292 -175.288 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -73.67 -18.4 22.36 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 127.075 3.562 . . . . 12.0 118.291 -168.378 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -71.06 -32.64 69.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.409 -2.682 . . . . 35.55 111.672 179.194 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -91.92 2.76 56.33 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 117.211 -1.376 . . . . 20.52 111.856 -179.693 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -89.17 119.72 29.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.698 3.199 . . . . 7.13 116.164 177.619 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -138.7 119.62 14.34 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 123.865 0.866 . . . . 36.39 108.957 171.701 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -101.12 136.7 40.55 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.953 1.835 . . . . 9.55 113.822 -177.557 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mt -114.61 127.81 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 C-N-CA 134.338 5.055 . . . . 13.9 107.213 -179.46 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -116.32 106.04 13.21 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.56 -1.274 . . . . 6.86 107.56 166.551 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.05 -71.97 0.07 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 116.364 1.987 . . . . 11.15 116.364 -170.298 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.32 -14.0 0.97 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 128.571 2.986 . . . . 13.93 116.33 174.458 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -101.74 144.63 30.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.019 2.91 . . . . 23.92 111.028 -167.382 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.265 15.2 pt20 -65.49 123.12 18.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.744 2.818 . . . . 23.23 113.539 167.067 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.9 mt -94.42 139.32 31.28 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 101.325 -3.583 . . . . 9.11 101.325 -174.853 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.88 176.61 8.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.328 2.251 . . . . 33.44 111.213 168.241 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.31 -53.41 3.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.36 -2.712 . . . . 28.37 112.619 -172.251 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 53.05 4.82 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 118.035 -2.915 . . . . 15.0 119.118 175.222 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -132.03 139.3 48.53 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 119.44 1.62 . . . . 25.5 110.123 166.951 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.286 56.9 p -75.33 150.77 38.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.757 -1.839 . . . . 11.95 112.977 -172.098 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.1 mt -51.44 -33.41 30.63 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.289 2.636 . . . . 10.17 114.601 165.443 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.309 22.7 t -59.9 -50.05 75.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.479 3.511 . . . . 13.59 110.216 168.328 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -86.1 -32.63 21.24 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.363 -2.088 . . . . 11.7 105.363 -163.618 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -60.16 -25.42 65.52 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.172 -2.83 . . . . 12.95 113.341 167.093 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 68.65 54.56 0.5 Allowed 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 131.679 3.992 . . . . 25.45 113.027 -179.058 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.03 131.39 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.596 -2.001 . . . . 14.6 105.596 174.307 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -108.01 -171.66 1.91 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.579 1.326 . . . . 33.23 114.579 178.099 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -76.83 134.82 38.94 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.009 2.596 . . . . 25.97 118.009 -174.943 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 53.12 45.43 28.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 116.937 2.199 . . . . 32.61 116.937 -166.835 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.357 49.3 m -94.85 139.59 31.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 100.303 -3.962 . . . . 10.56 100.303 -175.356 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -98.83 122.47 42.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.092 0.86 . . . . 5.33 108.952 179.465 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mp -98.03 147.39 24.57 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.576 -1.327 . . . . 11.66 111.393 167.118 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -103.92 127.43 51.45 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.243 -3.41 . . . . 16.3 119.215 172.366 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.09 132.54 35.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.402 -2.061 . . . . 9.96 113.883 175.163 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.28 -176.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 125.383 1.473 . . . . 9.76 109.437 168.418 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.3 tp -86.73 135.18 33.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 116.402 -3.936 . . . . 19.57 110.986 175.403 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -89.64 116.19 27.58 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 125.206 1.566 . . . . 35.08 109.55 172.076 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -97.57 167.16 11.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.592 -2.744 . . . . 32.31 103.592 -174.693 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -87.29 131.27 34.3 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.079 -1.638 . . . . 42.75 110.209 -178.542 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.62 -37.94 1.02 Allowed Glycine 0 N--CA 1.431 -1.661 1 O-C-N 129.191 4.057 . . . . 36.31 107.729 -174.26 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.738 0 C-N-CA 124.715 1.15 . . . . 36.27 115.142 176.096 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 118.551 2.797 . . . . 17.17 118.551 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -93.3 113.15 25.27 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 101.864 -3.384 . . . . 21.89 101.864 178.467 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -120.1 149.74 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 104.331 -2.47 . . . . 10.83 104.331 170.936 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -107.05 121.28 44.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.189 1.471 . . . . 10.61 109.629 -172.103 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -100.12 117.46 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 O-C-N 115.15 -4.719 . . . . 9.13 102.129 175.312 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -100.56 123.95 45.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.654 -2.529 . . . . 20.55 111.127 176.902 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -86.5 -176.54 5.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.422 -2.674 . . . . 11.78 109.28 -174.12 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 tp -70.55 -50.08 41.24 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.225 2.21 . . . . 19.31 110.075 178.633 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.4 p -72.93 -29.57 63.21 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.261 -1.755 . . . . 23.14 106.261 -178.065 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.2 54.03 0.31 Allowed Glycine 0 N--CA 1.43 -1.753 0 O-C-N 118.692 -2.505 . . . . 19.74 107.67 162.626 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -107.54 135.7 48.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.536 2.112 . . . . 21.93 109.608 171.473 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -96.42 109.61 22.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.629 -1.919 . . . . 12.33 106.046 -173.803 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 mt -102.22 96.26 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 126.424 3.011 . . . . 17.08 105.512 178.816 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.9 m -88.83 117.43 27.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.345 -3.347 . . . . 16.3 108.989 -172.969 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 mt -109.71 137.49 47.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.903 -2.373 . . . . 15.88 112.259 -167.549 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -106.66 101.44 10.89 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.696 -1.878 . . . . 28.9 109.47 177.311 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.26 163.01 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 118.802 -2.436 . . . . 12.05 109.396 -175.318 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -85.55 164.9 38.31 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 118.44 -2.663 . . . . 18.17 109.493 173.4 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.82 -4.45 3.33 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 C-N-CA 123.223 2.616 . . . . 8.16 111.573 -174.463 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -87.85 -6.45 58.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.006 2.923 . . . . 11.13 111.838 175.665 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.48 159.03 18.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.273 -3.392 . . . . 18.03 114.443 -179.323 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -90.44 165.67 13.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.394 1.569 . . . . 10.22 111.985 -173.964 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -69.17 -20.42 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 127.415 3.483 . . . . 12.3 113.636 171.905 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.11 -43.34 87.47 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.047 -5.408 . . . . 36.51 112.759 174.037 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -70.93 -32.53 69.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.061 -1.447 . . . . 25.66 113.717 178.362 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.2 t -61.08 -38.61 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 131.231 3.813 . . . . 8.12 111.927 169.866 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -67.01 -42.44 84.95 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.742 -1.599 . . . . 15.47 114.43 165.401 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.02 -37.28 74.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 117.56 2.429 . . . . 11.45 117.56 172.098 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.281 57.5 mmtt -46.26 -35.91 5.69 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 126.073 2.844 . . . . 24.98 117.712 165.398 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.2 mt -93.95 -34.47 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 117.776 -3.077 . . . . 9.46 111.429 -172.695 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -48.01 81.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.76 0.824 . . . . 14.76 111.961 160.842 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.279 12.5 t70 -53.52 -57.76 9.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.149 1.928 . . . . 26.29 114.246 169.942 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -81.16 -51.64 8.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.659 -1.275 . . . . 30.06 112.364 -170.506 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -96.43 -42.09 8.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 116.814 -3.679 . . . . 25.19 101.791 -163.257 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.88 42.9 3.7 Favored Glycine 0 N--CA 1.43 -1.744 1 O-C-N 115.935 -4.228 . . . . 7.41 115.852 -170.502 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 90.6 mt -111.12 120.36 43.39 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 113.393 -3.194 . . . . 9.49 107.94 177.077 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -66.96 148.89 82.72 Favored 'Trans proline' 0 N--CA 1.434 -1.975 0 CA-C-N 125.778 3.099 . . . . 11.42 114.425 -178.093 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -74.05 -18.86 20.92 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 123.645 2.338 . . . . 12.0 117.868 -161.815 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -60.63 -18.86 55.94 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.815 2.524 . . . . 35.55 117.815 173.962 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -97.33 -12.57 22.68 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.03 2.132 . . . . 20.52 114.002 -175.139 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -98.91 141.07 32.16 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.48 -2.013 . . . . 7.13 111.713 -169.356 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -143.73 108.1 4.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 114.015 -2.897 . . . . 36.39 107.472 -177.89 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 mt -91.78 144.96 24.96 Favored 'General case' 0 N--CA 1.43 -1.426 1 CA-C-N 126.2 4.091 . . . . 9.55 112.837 -175.67 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 mt -128.24 138.84 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.628 1.971 . . . . 13.9 109.886 -176.935 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' A' ' 50' ' ' LEU . 70.3 t80 -122.19 112.74 18.55 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 115.082 -4.761 . . . . 6.86 100.446 175.055 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.34 -74.96 0.07 Allowed 'General case' 0 N--CA 1.431 -1.41 1 CA-C-O 111.436 -4.126 . . . . 11.15 113.967 177.758 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.76 21.62 0.32 Allowed Glycine 0 N--CA 1.43 -1.729 1 O-C-N 130.178 4.674 . . . . 13.93 114.342 167.685 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -115.45 131.03 57.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.396 -1.705 . . . . 23.92 106.396 174.955 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -71.48 147.51 47.72 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.327 1.421 . . . . 23.23 114.593 173.924 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 45' ' ' PHE . 21.3 mt -101.13 109.16 21.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.376 1.87 . . . . 9.11 112.821 170.95 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -95.77 142.84 27.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 113.493 0.923 . . . . 33.44 113.493 179.186 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -22.01 -68.05 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 134.421 5.088 . . . . 28.37 118.893 179.255 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.69 62.58 4.58 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 122.54 2.427 . . . . 15.0 115.676 -174.778 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -160.91 156.59 25.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.525 -2.162 . . . . 25.5 107.834 164.156 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.316 82.8 p -82.08 150.82 27.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.39 -3.319 . . . . 11.95 114.355 -172.56 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mt -65.51 -46.21 80.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.799 -1.188 . . . . 10.17 112.882 -173.002 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -58.11 -43.64 87.3 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.279 0.987 . . . . 13.59 111.829 171.075 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -69.01 -17.11 63.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.714 -3.741 . . . . 11.7 111.186 -172.899 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.49 -17.75 38.04 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.929 2.892 . . . . 12.95 114.956 169.523 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.354 16.5 m120 87.61 39.02 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 129.311 3.045 . . . . 25.45 112.267 177.437 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -107.9 105.97 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.59 2.138 . . . . 14.6 105.932 -172.717 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.51 -162.96 0.83 Allowed 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 116.127 -4.108 . . . . 33.23 112.288 -174.861 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.252 37.9 tttp -64.37 120.93 13.16 Favored 'General case' 0 N--CA 1.431 -1.424 2 O-C-N 114.976 -4.827 . . . . 25.97 112.39 -173.741 . . . . . . . . 3 2 . 1 . 040 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 20.6 mt-10 65.23 51.79 1.56 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.494 1.918 . . . . 32.61 108.857 -174.143 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.285 63.0 m -95.45 155.44 16.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.766 2.076 . . . . 10.56 107.75 168.948 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.4 m -119.68 128.94 54.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 126.092 2.12 . . . . 5.33 106.388 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.3 mt -113.44 116.36 29.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.27 1.828 . . . . 11.66 111.519 -177.41 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -93.17 125.13 37.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.489 2.404 . . . . 16.3 113.103 -175.829 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -101.33 123.58 45.65 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.804 2.042 . . . . 9.96 111.062 -169.842 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.23 -178.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 126.15 2.881 . . . . 9.76 112.747 173.76 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.7 tp -92.15 124.18 36.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.539 -3.851 . . . . 19.57 119.369 175.863 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -75.84 110.23 10.11 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 129.248 3.019 . . . . 35.08 114.217 175.298 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.272 40.3 mt -96.92 174.18 6.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.573 -2.38 . . . . 32.31 104.573 -174.444 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -92.03 46.48 1.27 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.707 -1.87 . . . . 42.75 112.686 -179.443 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.43 66.23 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.732 0 O-C-N 119.121 -2.237 . . . . 36.31 116.466 178.489 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.752 0 C-N-CA 126.606 2.051 . . . . 36.27 112.825 177.032 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 10.8 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 113.433 0.901 . . . . 17.17 113.433 . . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -94.92 125.52 39.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 113.826 1.047 . . . . 21.89 113.826 178.963 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -124.3 162.88 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.148 1.379 . . . . 10.83 112.627 167.76 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -118.62 139.81 50.9 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.82 -3.05 . . . . 10.61 107.178 176.393 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.66 118.7 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.381 1.873 . . . . 9.13 106.152 172.086 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -116.93 143.6 45.52 Favored 'General case' 0 N--CA 1.43 -1.438 1 CA-C-O 128.74 4.114 . . . . 20.55 114.07 -171.896 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -81.88 172.78 12.91 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 114.743 -4.973 . . . . 11.78 111.472 179.767 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.2 -33.69 70.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.555 2.057 . . . . 19.31 116.555 176.787 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -72.19 -69.53 0.39 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.966 1.099 . . . . 23.14 113.966 171.547 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.14 31.8 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 118.319 -1.896 . . . . 19.74 114.305 -175.797 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -106.86 121.98 45.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.162 1.458 . . . . 21.93 112.686 176.728 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.1 m -97.37 127.94 43.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.516 -1.99 . . . . 12.33 108.841 176.951 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.75 116.8 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 102.437 -3.172 . . . . 17.08 102.437 172.757 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 m -93.38 131.73 38.28 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.913 -1.742 . . . . 16.3 109.502 173.361 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -125.61 143.26 51.1 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.833 -1.792 . . . . 15.88 109.427 -179.59 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 1' ' ' MET . 42.9 mt-10 -99.13 77.71 2.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.546 3.138 . . . . 28.9 116.342 165.183 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -104.83 147.72 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 126.72 3.152 . . . . 12.05 106.987 -177.995 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -83.82 149.1 55.96 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 117.748 -3.095 . . . . 18.17 108.712 178.391 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -88.42 -6.29 6.17 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 127.172 3.597 . . . . 8.16 109.543 -157.38 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.7 m -84.6 -14.06 49.84 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.624 3.106 . . . . 11.13 114.49 -179.492 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -80.12 163.67 23.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.859 2.54 . . . . 18.03 117.859 -167.982 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.322 22.1 p -79.34 158.19 27.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.618 2.367 . . . . 10.22 111.621 -172.16 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.67 -36.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.224 -1.353 . . . . 12.3 107.772 178.631 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -45.16 -45.84 11.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 117.504 2.409 . . . . 36.51 117.504 160.01 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.23 -14.32 59.49 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.808 -4.307 . . . . 25.66 116.163 173.472 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.6 t -62.8 -48.94 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 124.607 2.146 . . . . 8.12 112.377 162.334 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -63.7 -32.45 73.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.107 2.86 . . . . 15.47 112.04 178.287 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.54 -13.27 61.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.863 -2.398 . . . . 11.45 117.472 -177.007 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -79.1 -36.43 40.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.324 2.265 . . . . 24.98 115.13 166.33 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 mt -69.72 -26.26 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 121.149 -0.969 . . . . 9.46 113.405 176.162 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -65.48 -39.83 92.4 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 112.437 -2.165 . . . . 14.76 110.539 173.366 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -70.93 -46.26 62.78 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.85 2.167 . . . . 26.29 116.85 171.394 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -76.73 -67.2 0.72 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.09 -2.256 . . . . 30.06 108.918 -171.536 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -94.17 -20.5 19.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 123.839 3.018 . . . . 25.19 107.14 -164.363 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.42 34.83 9.99 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 126.753 2.121 . . . . 7.41 114.445 173.867 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 mt -110.91 130.62 22.75 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 118.342 -2.858 . . . . 9.49 104.181 -169.206 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -85.15 153.26 10.94 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 112.509 -4.528 . . . . 11.42 114.485 -167.418 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -71.05 -14.48 32.05 Favored 'Trans proline' 0 N--CA 1.433 -2.045 1 C-N-CA 125.308 4.005 . . . . 12.0 113.444 -162.56 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.69 -39.12 73.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.442 0.904 . . . . 35.55 113.442 168.851 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -77.97 -26.32 48.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.79 2.885 . . . . 20.52 118.79 175.171 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -72.15 118.95 15.67 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.739 1.216 . . . . 7.13 111.502 -177.261 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -102.97 121.43 42.52 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.455 -3.278 . . . . 36.39 105.807 169.532 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 mt -106.11 123.06 47.41 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.674 3.59 . . . . 9.55 115.24 170.02 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -123.21 110.31 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 128.954 2.902 . . . . 13.9 114.893 -174.646 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -94.8 117.88 30.86 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.222 -1.399 . . . . 6.86 107.222 169.977 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.36 -84.3 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.42 1 C-N-CA 132.35 4.26 . . . . 11.15 110.507 -169.704 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.44 31.05 1.28 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-O 124.078 1.932 . . . . 13.93 112.239 169.952 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -99.13 142.11 31.03 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.968 -3.078 . . . . 23.92 109.539 174.706 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -88.08 108.74 19.39 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 116.577 2.066 . . . . 23.23 116.577 173.405 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.339 85.4 mt -71.47 118.26 14.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.078 -2.889 . . . . 9.11 116.907 -162.171 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -74.31 114.94 13.25 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.72 2.408 . . . . 33.44 109.271 178.423 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.32 -33.93 76.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.405 1.882 . . . . 28.37 114.472 -162.895 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.05 15.49 60.85 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 127.031 2.253 . . . . 15.0 113.37 -175.849 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -99.25 171.02 8.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 126.693 3.139 . . . . 25.5 108.961 160.928 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.9 p -102.72 -178.92 3.82 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.105 -4.122 . . . . 11.95 114.231 174.805 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.1 mt -80.64 -17.7 50.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.937 -2.977 . . . . 10.17 110.073 178.989 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t -69.48 -42.36 74.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.065 -2.272 . . . . 13.59 109.672 177.319 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -54.68 -45.22 73.89 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.87 2.468 . . . . 11.7 114.412 178.849 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -92.58 0.6 57.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.756 -2.465 . . . . 12.95 109.48 -174.616 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 50.27 51.23 17.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.973 3.709 . . . . 25.45 112.134 -171.177 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mt -98.38 114.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 120.418 1.463 . . . . 14.6 107.722 179.429 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -99.54 -173.14 2.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.391 3.076 . . . . 33.23 110.785 -169.424 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -70.05 147.39 50.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.601 1.191 . . . . 25.97 109.892 -174.182 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.377 86.7 mt-10 70.89 16.41 6.58 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.187 1.795 . . . . 32.61 113.668 174.047 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.16 136.75 34.33 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 116.631 -1.652 . . . . 10.56 111.657 179.23 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.2 m -92.81 130.48 38.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 115.373 -2.251 . . . . 5.33 110.655 -178.358 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.97 172.07 6.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.806 2.443 . . . . 11.66 110.628 166.941 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -111.99 145.16 40.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.799 2.714 . . . . 16.3 111.421 171.842 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 tp -120.11 132.97 55.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.435 -3.916 . . . . 9.96 109.069 176.12 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.56 131.03 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.905 1.682 . . . . 9.76 108.993 -172.87 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.6 mt -73.17 116.31 13.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.815 -1.803 . . . . 19.57 109.002 166.878 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -90.84 168.9 11.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.155 -2.355 . . . . 35.08 111.414 177.956 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.3 mt -94.9 151.42 19.22 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.678 2.486 . . . . 32.31 107.031 159.975 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.256 67.2 mtp180 -108.51 162.13 14.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.466 2.555 . . . . 42.75 110.382 179.599 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.36 62.48 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 106.275 -2.73 . . . . 36.31 106.275 -175.261 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.751 0 C-N-CA 116.807 -2.616 . . . . 36.27 110.685 169.061 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 125.768 2.699 . . . . 17.17 113.851 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -114.54 137.32 52.01 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 112.983 -6.073 . . . . 21.89 110.738 -177.7 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.591 HD12 HD13 ' A' ' 67' ' ' LEU . 37.3 pt -129.07 178.21 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 118.018 -2.926 . . . . 10.83 109.239 164.942 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -125.55 137.86 53.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.299 2.952 . . . . 10.61 107.91 -179.66 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.27 116.11 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 105.054 -2.202 . . . . 9.13 105.054 167.983 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -102.97 126.31 50.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.079 2.152 . . . . 20.55 113.911 176.372 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.526 15.7 p -67.99 175.15 3.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.312 1.845 . . . . 11.78 115.43 -178.201 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.44 -45.57 45.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.276 -2.765 . . . . 19.31 114.306 177.053 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -63.85 -56.31 16.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.768 2.699 . . . . 23.14 117.065 175.56 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 54.21 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 117.963 -2.065 . . . . 19.74 115.352 172.854 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -114.08 140.8 48.18 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.426 -1.75 . . . . 21.93 110.806 165.005 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -103.67 129.91 51.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.032 2.708 . . . . 12.33 110.092 165.69 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -96.73 104.93 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 128.335 2.654 . . . . 17.08 106.223 169.431 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.2 m -79.97 114.91 19.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 120.48 1.491 . . . . 16.3 114.7 170.783 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 15' ' ' LEU . 18.0 tp -121.78 133.21 54.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.647 -1.615 . . . . 15.88 113.547 -166.623 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -90.94 112.86 24.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.345 1.858 . . . . 28.9 114.612 -175.602 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.8 m -128.59 178.84 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.121 -2.862 . . . . 12.05 107.318 -168.968 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -123.94 168.14 13.5 Favored Pre-proline 0 N--CA 1.431 -1.416 0 CA-C-O 114.598 -2.62 . . . . 18.17 104.549 168.654 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.73 -14.89 43.12 Favored 'Trans proline' 0 C--N 1.3 -2.01 2 CA-C-N 129.076 4.277 . . . . 8.16 108.853 173.311 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -93.05 -3.56 54.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.782 2.083 . . . . 11.13 115.084 -169.725 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -72.68 141.86 48.25 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.354 1.462 . . . . 18.03 108.759 -179.909 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -86.93 160.66 18.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.264 2.626 . . . . 10.22 104.525 178.722 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.592 HD12 HD13 ' A' ' 50' ' ' LEU . 24.8 mm -69.29 -30.06 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 122.593 1.187 . . . . 12.3 112.849 177.675 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -65.94 -41.83 90.81 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.52 2.728 . . . . 36.51 110.532 177.539 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -66.52 -43.28 85.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.712 -1.959 . . . . 25.66 105.712 -179.918 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.79 -45.77 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 125.876 1.67 . . . . 8.12 114.004 -178.051 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -57.6 -33.19 67.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.622 2.153 . . . . 15.47 113.09 172.532 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.46 -26.89 60.32 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.674 1.731 . . . . 11.45 115.674 179.355 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.315 52.6 mttp -75.07 -31.74 61.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.84 -2.344 . . . . 24.98 112.277 171.944 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.1 mt -63.71 -34.51 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 124.898 2.285 . . . . 9.46 116.554 175.326 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -62.19 -41.81 98.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.135 -1.848 . . . . 14.76 113.419 165.592 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.49 -48.3 41.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.087 -1.633 . . . . 26.29 112.969 -179.263 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -60.83 -66.82 0.47 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.121 -2.237 . . . . 30.06 114.022 174.146 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -87.37 -26.69 23.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.809 -3.057 . . . . 25.19 111.243 -162.499 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.29 11.35 48.86 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 119.341 -1.409 . . . . 7.41 114.086 -178.672 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.2 mt -80.79 130.7 62.92 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 117.461 -3.376 . . . . 9.49 111.596 -168.421 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -74.02 147.75 39.04 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 128.126 3.938 . . . . 11.42 113.066 -167.383 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.48 -16.59 24.27 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 CA-C-N 122.903 2.073 . . . . 12.0 113.4 -174.935 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.63 -30.53 70.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.622 -3.799 . . . . 35.55 118.285 163.647 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -75.46 -21.6 57.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.3 1.409 . . . . 20.52 113.392 177.819 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -83.43 114.9 21.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 115.947 -1.978 . . . . 7.13 111.634 -160.58 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -119.37 108.1 14.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.401 2.524 . . . . 36.39 114.227 164.893 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mt -88.54 129.81 35.38 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.762 2.22 . . . . 9.55 109.363 179.218 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 mt -116.83 139.71 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 119.182 -2.199 . . . . 13.9 106.027 177.052 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -126.53 112.14 15.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.013 -1.477 . . . . 6.86 107.013 172.814 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.271 . . 81.29 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.938 1.695 . . . . 11.15 111.194 -174.537 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.12 43.39 0.23 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.304 -1.498 . . . . 13.93 116.181 173.993 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.28 155.09 46.98 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.148 2.579 . . . . 23.92 111.42 164.58 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.262 9.3 tt0 -79.93 129.58 34.61 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.3 -2.125 . . . . 23.23 111.953 -176.727 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.592 HD13 HD12 ' A' ' 23' ' ' ILE 0.252 98.4 mt -83.71 121.51 27.38 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.685 -1.884 . . . . 9.11 109.916 172.704 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -99.14 154.51 18.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.437 -1.69 . . . . 33.44 106.437 -168.534 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.09 -32.04 71.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.281 2.326 . . . . 28.37 117.281 -162.438 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.95 21.66 43.75 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 120.788 1.631 . . . . 15.0 112.065 -169.673 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -118.36 -179.48 3.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.369 -1.665 . . . . 25.5 113.858 164.225 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.7 p -108.91 176.27 5.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.897 2.76 . . . . 11.95 118.332 178.01 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.6 mt -71.03 -35.02 71.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 113.775 -1.557 . . . . 10.17 113.223 176.026 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -57.3 -45.93 83.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.668 1.987 . . . . 13.59 113.667 165.756 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -61.99 -35.33 78.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.495 2.718 . . . . 11.7 114.757 175.056 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.4 -4.19 42.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 114.666 -2.587 . . . . 12.95 111.976 -174.638 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.2 m120 72.79 43.4 0.43 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 123.539 2.882 . . . . 25.45 110.396 173.831 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -102.99 115.62 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.383 -2.073 . . . . 14.6 111.349 179.936 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -95.82 -177.89 4.19 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.161 1.934 . . . . 33.23 111.79 175.207 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.258 21.7 ptmt -53.75 138.15 36.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 131.163 3.785 . . . . 25.97 116.686 175.747 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 71.89 24.53 3.31 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 123.118 1.437 . . . . 32.61 113.243 171.897 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -92.89 142.5 27.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.983 -1.073 . . . . 10.56 112.071 -178.774 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -101.89 97.91 8.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.244 2.618 . . . . 5.33 112.713 -172.973 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.591 HD13 HD12 ' A' ' 3' ' ' ILE . 9.6 mp -84.48 145.55 28.07 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.73 2.519 . . . . 11.66 110.478 174.924 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -109.02 134.03 52.2 Favored 'General case' 0 N--CA 1.43 -1.425 1 O-C-N 115.646 -4.408 . . . . 16.3 100.537 -169.768 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.78 125.75 51.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.607 1.194 . . . . 9.96 109.729 170.979 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.6 t -113.79 152.3 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 126.738 3.161 . . . . 9.76 106.329 179.947 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.1 mt -121.47 111.56 17.44 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.678 -2.514 . . . . 19.57 110.97 -179.306 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.18 161.7 18.56 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.115 3.366 . . . . 35.08 111.026 -172.498 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.2 mt -80.36 159.15 25.84 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.615 -4.428 . . . . 32.31 109.823 171.28 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -84.42 132.74 34.54 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.357 -3.34 . . . . 42.75 117.698 -164.3 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.5 -105.42 0.19 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 126.653 3.363 . . . . 36.31 118.29 -172.068 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.783 0 CA-C-O 114.64 -3.311 . . . . 36.27 111.23 -173.092 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 127.171 3.367 . . . . 17.17 104.451 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -93.22 123.7 36.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.234 -2.257 . . . . 21.89 105.241 177.924 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -117.59 166.96 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 118.322 -2.736 . . . . 10.83 106.414 170.149 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.86 100.94 7.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.411 -3.306 . . . . 10.61 115.01 -176.049 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.44 105.89 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 118.89 -2.381 . . . . 9.13 109.394 -163.265 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -99.45 132.69 44.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.612 -1.176 . . . . 20.55 111.042 -172.345 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 p -98.11 -177.88 3.88 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.226 2.21 . . . . 11.78 113.194 -178.555 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 mt -83.6 -33.52 25.33 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.838 -2.414 . . . . 19.31 111.637 -164.304 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 p -88.49 -66.79 0.88 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.73 2.012 . . . . 23.14 112.523 -177.038 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.24 48.76 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 117.505 -2.283 . . . . 19.74 109.665 -174.031 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -136.07 119.37 16.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.012 2.339 . . . . 21.93 105.506 176.379 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -92.23 106.87 18.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.376 2.989 . . . . 12.33 111.832 163.666 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 mt -88.46 114.89 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.661 -2.063 . . . . 17.08 106.308 -179.717 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -94.18 125.14 38.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.698 -0.482 . . . . 16.3 109.698 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 tp -153.8 135.86 14.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.965 -2.959 . . . . 15.88 115.212 -157.232 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.9 97.32 11.11 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 132.398 4.279 . . . . 28.9 117.021 -177.287 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.69 150.57 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.674 2.39 . . . . 12.05 111.714 179.158 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -87.04 152.77 53.77 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 112.867 -3.444 . . . . 18.17 109.394 176.671 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -71.99 -23.49 21.76 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 CA-C-N 123.321 2.222 . . . . 8.16 112.949 173.682 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -81.44 2.27 29.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.97 3.919 . . . . 11.13 113.821 168.22 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -72.05 148.48 45.78 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 124.529 3.332 . . . . 18.03 110.887 165.08 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 73.4 p -84.54 173.25 10.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.767 -1.833 . . . . 10.22 109.522 177.344 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -63.43 -23.18 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 124.525 2.107 . . . . 12.3 112.263 168.407 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -80.88 -37.93 28.92 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.031 -4.168 . . . . 36.51 109.749 176.433 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 28' ' ' ALA 0.321 17.1 m120 -73.68 -35.12 65.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.62 -1.3 . . . . 25.66 112.26 179.773 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.604 HG21 HD11 ' A' ' 56' ' ' LEU 0.489 81.4 t -45.83 -59.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 129.937 3.295 . . . . 8.12 113.619 163.106 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt -60.67 -30.53 69.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.177 3.391 . . . . 15.47 113.051 174.144 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.7 -42.59 88.99 Favored 'General case' 0 N--CA 1.429 -1.48 1 CA-C-O 131.011 5.196 . . . . 11.45 118.047 163.297 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -75.5 -35.97 60.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.72 -3.737 . . . . 24.98 111.764 -179.065 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mt -64.57 -41.87 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 125.381 1.675 . . . . 9.46 114.53 168.46 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -50.16 -57.88 6.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.66 2.171 . . . . 14.76 115.421 174.545 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -47.81 -60.96 2.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.546 3.538 . . . . 26.29 114.627 167.962 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -65.73 -58.4 5.76 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.252 1.025 . . . . 30.06 109.975 -168.737 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -83.93 -48.81 9.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.807 2.151 . . . . 25.19 116.807 179.988 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.08 9.86 5.94 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 129.683 3.516 . . . . 7.41 112.617 179.424 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mt -85.81 128.93 56.5 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-N 121.356 2.578 . . . . 9.49 108.115 -162.799 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.83 153.86 29.75 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 CA-C-O 109.941 -4.275 . . . . 11.42 114.439 -166.732 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.6 -24.1 26.22 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 124.13 3.22 . . . . 12.0 117.671 -168.881 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.475 ' HB2' ' HD2' ' A' ' 74' ' ' ARG . 12.2 p-10 -80.63 -6.68 58.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.338 3.055 . . . . 35.55 112.733 171.843 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -93.46 -36.79 12.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.298 -2.126 . . . . 20.52 111.412 169.565 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -72.51 144.78 47.88 Favored 'General case' 0 N--CA 1.429 -1.48 1 N-CA-C 123.509 4.633 . . . . 7.13 123.509 179.975 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -160.74 135.41 7.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.776 -0.824 . . . . 36.39 108.776 175.465 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.526 HD21 HD13 ' A' ' 69' ' ' LEU . 49.7 mt -117.51 116.44 27.14 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.149 1.928 . . . . 9.55 108.6 -170.372 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.582 HD12 HG21 ' A' ' 70' ' ' VAL . 33.9 mt -110.52 133.54 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 126.767 2.027 . . . . 13.9 111.066 175.117 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -118.37 118.95 33.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 102.269 -3.234 . . . . 6.86 102.269 177.854 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.92 -62.69 0.07 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.263 3.425 . . . . 11.15 118.32 -176.551 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.99 7.89 0.79 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 115.895 1.118 . . . . 13.93 115.895 178.684 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -153.81 154.89 34.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.741 2.686 . . . . 23.92 105.76 177.84 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -66.76 150.04 49.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.377 3.471 . . . . 23.23 113.648 -179.227 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 mt -112.61 134.47 54.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.481 2.312 . . . . 9.11 105.519 -173.986 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -97.55 130.67 44.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.835 2.731 . . . . 33.44 111.248 -171.524 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -34.2 -42.95 0.14 Allowed 'General case' 0 N--CA 1.43 -1.445 1 N-CA-C 122.704 4.335 . . . . 28.37 122.704 178.365 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.95 -15.84 69.05 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.237 -1.539 . . . . 15.0 113.664 -168.485 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -87.73 147.18 25.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.36 2.664 . . . . 25.5 109.845 178.175 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 37.6 p -81.88 163.77 22.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.303 2.241 . . . . 11.95 110.088 173.017 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.604 HD11 HG21 ' A' ' 26' ' ' VAL . 39.2 mt -61.29 -37.31 82.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.674 1.702 . . . . 10.17 115.43 171.798 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.9 m -45.77 -46.17 15.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.36 -3.338 . . . . 13.59 118.448 161.888 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -55.98 -13.6 2.01 Favored 'General case' 0 N--CA 1.43 -1.463 2 O-C-N 114.084 -5.385 . . . . 11.7 118.058 166.044 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -121.17 -7.73 9.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 115.894 -2.003 . . . . 12.95 107.134 -174.352 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.4 m120 74.58 34.68 0.74 Allowed 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 135.935 5.694 . . . . 25.45 107.955 176.664 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -82.6 106.42 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.42 -1.696 . . . . 14.6 106.42 -175.827 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -92.01 -175.39 4.08 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.468 2.707 . . . . 33.23 113.725 174.944 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -58.65 153.13 17.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.276 -3.39 . . . . 25.97 115.023 179.6 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 74.66 -1.16 3.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 125.996 2.06 . . . . 32.61 115.332 171.356 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.3 m -61.51 141.94 57.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 120.517 3.525 . . . . 10.56 120.517 178.05 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.3 m -98.63 109.76 22.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.085 2.116 . . . . 5.33 107.628 -170.604 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mt -110.25 141.29 43.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.173 -2.158 . . . . 11.66 105.173 -173.278 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -104.91 118.83 37.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.06 1.41 . . . . 16.3 109.967 -177.539 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.526 HD13 HD21 ' A' ' 43' ' ' LEU . 19.8 tp -95.55 99.24 11.14 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.814 2.446 . . . . 9.96 108.273 176.572 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 44' ' ' ILE . 61.7 t -87.1 110.26 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.986 3.315 . . . . 9.76 111.06 174.124 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.77 112.94 20.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.592 -2.744 . . . . 19.57 103.592 -178.137 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -129.1 168.4 16.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.859 1.429 . . . . 35.08 114.859 -172.324 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.258 78.5 mt -90.52 156.18 18.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.408 -1.758 . . . . 32.31 111.072 173.672 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.475 ' HD2' ' HB2' ' A' ' 39' ' ' ASP . 60.4 ttt180 -82.09 109.47 16.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.528 3.018 . . . . 42.75 115.138 -171.841 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.25 -70.22 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 O-C-N 117.935 -2.978 . . . . 36.31 110.409 177.64 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.77 0 N-CA-C 105.869 -2.893 . . . . 36.27 105.869 -174.561 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 111.202 0.075 . . . . 17.17 111.202 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -104.44 141.48 36.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.043 -2.286 . . . . 21.89 109.741 178.158 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 pt -119.56 159.84 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 131.295 3.838 . . . . 10.83 108.694 170.984 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -114.58 92.06 3.83 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.094 2.158 . . . . 10.61 107.123 -175.139 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.0 t -93.74 108.61 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.112 -2.242 . . . . 9.13 106.952 175.765 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -102.96 145.09 30.38 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 122.729 1.252 . . . . 20.55 113.697 -171.706 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.8 p -90.94 171.89 8.97 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.744 -2.074 . . . . 11.78 110.81 177.145 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.95 -51.66 68.33 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 129.116 4.01 . . . . 19.31 115.16 171.351 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.251 78.9 p -46.33 -48.98 18.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 125.274 3.67 . . . . 23.14 113.186 161.24 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.19 52.62 0.56 Allowed Glycine 0 N--CA 1.43 -1.72 1 C-N-CA 132.526 4.869 . . . . 19.74 108.909 176.138 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -84.98 132.18 34.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.618 -2.033 . . . . 21.93 106.512 161.826 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -103.65 110.06 21.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 128.342 3.925 . . . . 12.33 109.733 -178.468 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.467 HG22 ' HB2' ' A' ' 15' ' ' LEU . 61.8 mt -81.54 109.31 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 O-C-N 112.222 -6.549 . . . . 17.08 105.751 177.651 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 p -83.14 66.27 8.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.958 2.103 . . . . 16.3 108.532 -178.23 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.467 ' HB2' HG22 ' A' ' 13' ' ' ILE . 12.8 tp -94.29 127.12 39.95 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.764 -3.085 . . . . 15.88 116.744 -164.313 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -103.51 102.46 12.36 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.595 -4.44 . . . . 28.9 115.663 -163.72 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -125.0 167.96 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.734 1.255 . . . . 12.05 109.455 -172.106 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.289 27.8 mt-10 -98.15 170.6 6.84 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 118.369 -2.707 . . . . 18.17 108.898 161.568 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.15 -4.35 9.56 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 O-C-N 117.288 -2.006 . . . . 8.16 108.673 -175.038 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 m -95.03 18.69 11.62 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.112 -1.44 . . . . 11.13 107.112 178.908 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -93.7 139.42 30.83 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.52 -1.987 . . . . 18.03 108.779 175.143 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 14.6 p -84.72 165.77 17.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.05 1.295 . . . . 10.22 114.198 173.809 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 43.5 mm -71.95 -27.38 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.904 2.082 . . . . 12.3 106.869 -167.346 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -58.73 -50.09 75.22 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.929 2.892 . . . . 36.51 116.848 167.354 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -69.78 -22.11 63.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.584 2.809 . . . . 25.66 118.584 169.608 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.307 21.1 t -66.0 -55.93 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 C-N-CA 132.041 4.136 . . . . 8.12 107.522 166.791 . . . . . . . . 3 2 . 1 . 044 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 51.5 mtmt -61.88 -44.29 97.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.441 2.385 . . . . 15.47 117.441 173.059 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.57 -32.05 64.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.602 -2.561 . . . . 11.45 113.676 174.093 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -66.68 -38.78 87.5 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.445 3.022 . . . . 24.98 110.677 176.206 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -70.36 -33.87 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.998 -2.939 . . . . 9.46 113.877 177.963 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.291 27.3 tt0 -52.81 -49.82 64.89 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.845 3.212 . . . . 14.76 113.83 171.915 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.66 -53.44 47.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.891 2.876 . . . . 26.29 112.92 174.039 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -68.27 -76.09 0.09 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.063 2.945 . . . . 30.06 112.185 -179.224 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.95 -51.4 67.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 124.625 3.375 . . . . 25.19 118.356 175.041 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.01 28.92 9.46 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.221 -1.549 . . . . 7.41 113.63 -174.741 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mt -96.67 117.54 65.89 Favored Pre-proline 0 N--CA 1.429 -1.513 0 C-N-CA 131.537 3.935 . . . . 9.49 105.205 177.114 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -69.04 158.34 58.28 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 CA-C-N 125.503 3.001 . . . . 11.42 112.45 -171.731 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.36 -24.12 8.11 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 122.485 2.123 . . . . 12.0 112.017 -149.649 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.98 -17.0 64.39 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.294 2.638 . . . . 35.55 113.295 -173.905 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -92.61 -26.0 18.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.63 1.972 . . . . 20.52 115.108 -172.905 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -70.88 86.74 0.7 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 121.063 3.727 . . . . 7.13 121.063 -179.243 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 20.6 ttt180 -79.17 112.17 16.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.839 -3.663 . . . . 36.39 117.439 167.146 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.16 109.44 20.84 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 116.007 -4.183 . . . . 9.55 112.013 -173.932 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mm -103.67 125.95 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 118.764 -2.46 . . . . 13.9 110.047 176.732 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -102.65 117.86 35.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.644 -2.071 . . . . 6.86 106.121 166.714 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.7 -110.93 0.53 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.935 -2.353 . . . . 11.15 113.01 178.14 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.95 17.12 25.12 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 118.984 -1.579 . . . . 13.93 113.498 168.187 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -119.83 139.3 52.57 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.27 3.428 . . . . 23.92 108.519 -161.588 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -104.71 128.03 52.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.418 -2.808 . . . . 23.23 103.418 -166.487 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.65 128.75 35.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.097 -2.877 . . . . 9.11 111.749 -176.844 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.256 43.1 mt-10 -107.28 158.66 16.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 117.479 -1.688 . . . . 33.44 111.092 -176.716 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -58.54 -53.46 58.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.468 3.507 . . . . 28.37 113.956 -155.264 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.81 -2.91 71.45 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 113.548 -1.66 . . . . 15.0 111.887 -161.936 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -88.28 155.26 19.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 113.889 -2.958 . . . . 25.5 113.583 166.383 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 82.0 p -92.72 173.05 7.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.565 2.346 . . . . 11.95 114.198 178.923 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.52 -46.0 47.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.782 2.512 . . . . 10.17 117.782 160.216 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -54.86 -46.38 74.67 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.739 2.816 . . . . 13.59 117.291 170.912 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -48.2 -63.94 0.93 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.566 1.946 . . . . 11.7 109.56 172.438 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -73.36 3.96 5.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.215 -2.326 . . . . 12.95 116.015 179.726 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.468 66.8 t30 67.72 54.0 0.67 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.555 3.034 . . . . 25.45 112.42 171.114 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.71 103.47 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 127.051 2.14 . . . . 14.6 111.636 -174.647 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -68.25 168.58 12.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.224 3.81 . . . . 33.23 106.561 174.293 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.34 154.2 14.01 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.424 1.639 . . . . 25.97 115.424 172.293 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 56.75 41.1 28.68 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.808 2.567 . . . . 32.61 114.873 176.802 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.263 47.2 m -86.78 126.9 34.91 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.489 1.916 . . . . 10.56 108.607 173.326 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -72.52 127.15 31.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 117.088 -1.845 . . . . 5.33 115.212 163.748 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mt -114.62 164.86 13.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.702 3.62 . . . . 11.66 111.851 159.627 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -120.45 121.31 38.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.875 -2.639 . . . . 16.3 103.875 -172.886 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -91.47 108.74 20.1 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.247 -2.131 . . . . 9.96 105.247 173.201 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 19.3 t -96.61 144.28 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.056 2.836 . . . . 9.76 107.224 168.931 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 71' ' ' LEU . 80.0 mt -115.8 115.78 26.87 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.514 -3.866 . . . . 19.57 111.333 -179.087 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -121.87 -178.68 3.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.762 -1.563 . . . . 35.08 107.296 -177.126 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 mt -107.56 171.92 7.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.806 2.717 . . . . 32.31 103.739 164.978 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -76.12 138.19 40.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 112.296 -2.229 . . . . 42.75 111.766 -173.5 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.6 -119.99 0.69 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 106.896 -2.482 . . . . 36.31 106.896 -179.193 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.77 1 CA-C-O 108.926 -6.486 . . . . 36.27 108.461 -165.677 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptt? . . . . . 0 CA--C 1.491 -1.323 0 CA-C-O 124.233 1.968 . . . . 17.17 108.446 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -98.47 140.8 32.17 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.011 -2.931 . . . . 21.89 109.778 176.838 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.471 HD13 HD12 ' A' ' 67' ' ' LEU . 2.2 pp -131.16 166.4 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 112.22 -2.264 . . . . 10.83 109.403 168.02 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.3 145.79 42.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.786 -3.071 . . . . 10.61 108.692 177.659 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.43 118.55 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.358 2.663 . . . . 9.13 112.724 163.935 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -111.68 110.9 21.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.391 2.996 . . . . 20.55 112.488 179.271 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.8 p -76.72 171.26 15.0 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.647 -4.408 . . . . 11.78 113.102 -170.179 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mt -52.8 -54.26 36.66 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.898 -1.049 . . . . 19.31 111.506 174.778 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.4 p -56.93 -31.5 65.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.575 2.35 . . . . 23.14 116.86 167.989 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.91 27.28 4.36 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 120.006 -1.684 . . . . 19.74 113.685 168.219 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -80.24 131.84 35.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 121.05 2.425 . . . . 21.93 105.074 175.978 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -85.42 109.5 18.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.082 2.153 . . . . 12.33 112.452 163.85 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -103.06 123.43 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 114.806 -1.088 . . . . 17.08 108.786 171.949 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -84.74 121.82 28.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 117.24 -1.362 . . . . 16.3 112.341 173.852 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 tp -129.91 121.17 26.11 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.126 1.37 . . . . 15.88 110.7 -172.959 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -87.5 122.76 31.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.768 1.747 . . . . 28.9 108.873 173.204 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.44 149.68 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 129.707 3.203 . . . . 12.05 108.782 -179.491 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.2 mt-10 -87.0 149.01 46.72 Favored Pre-proline 0 N--CA 1.43 -1.426 0 C-N-CA 127.253 2.221 . . . . 18.17 106.248 166.683 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 61.4 Cg_exo -73.55 -15.03 24.8 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 115.847 -2.302 . . . . 8.16 111.44 -173.983 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -87.73 3.65 47.21 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 116.028 -4.17 . . . . 11.13 118.02 172.831 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.3 150.8 35.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.346 -1.471 . . . . 18.03 113.092 167.654 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 24.8 p -96.01 177.67 5.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.395 1.685 . . . . 10.22 109.438 -172.729 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.48 -23.73 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 121.424 1.92 . . . . 12.3 113.344 -177.019 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -52.5 -48.51 65.94 Favored 'General case' 0 N--CA 1.431 -1.394 1 C-N-CA 133.101 4.561 . . . . 36.51 111.021 158.071 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 40.5 m-20 -72.01 -27.39 62.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.65 2.093 . . . . 25.66 116.65 179.661 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -73.2 -41.06 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 128.081 2.552 . . . . 8.12 112.563 175.958 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -59.63 -31.01 69.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 117.25 -1.357 . . . . 15.47 111.886 165.085 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -71.85 -41.84 67.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.931 1.395 . . . . 11.45 109.669 -177.822 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.285 21.1 mmtp -63.38 -28.12 69.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.814 3.246 . . . . 24.98 113.059 173.96 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.7 mt -87.48 -41.71 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 1 O-C-N 113.91 -5.494 . . . . 9.46 112.726 178.973 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -46.22 -47.14 17.94 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.847 -2.408 . . . . 14.76 114.806 159.126 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.31 -25.51 61.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.015 1.857 . . . . 26.29 116.015 -178.437 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -87.73 -52.81 5.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 116.914 2.19 . . . . 30.06 116.914 178.837 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -98.77 -25.28 14.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.085 1.354 . . . . 25.19 112.011 -168.832 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.01 17.11 28.56 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 118.262 -1.299 . . . . 7.41 115.267 168.276 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.2 mt -94.77 126.5 47.05 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 130.715 3.606 . . . . 9.49 108.254 -168.855 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.51 139.68 54.59 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 124.322 3.348 . . . . 11.42 113.349 -179.504 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.04 -2.63 12.79 Favored 'Trans proline' 0 C--N 1.3 -2.019 1 C-N-CA 126.415 4.743 . . . . 12.0 114.108 -166.538 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.273 9.5 p-10 -84.61 -31.98 23.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 122.678 2.49 . . . . 35.55 111.182 174.178 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.91 -13.17 60.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.041 2.088 . . . . 20.52 114.183 -179.274 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -88.98 121.62 31.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 111.504 -2.589 . . . . 7.13 114.677 177.924 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -111.95 118.09 34.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 115.544 -2.169 . . . . 36.39 113.66 166.034 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.7 mt -109.93 123.48 49.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.335 1.647 . . . . 9.55 108.142 -174.376 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.14 127.09 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.946 2.098 . . . . 13.9 106.731 -174.813 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -103.77 114.11 28.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.58 -1.637 . . . . 6.86 106.58 169.061 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.01 -96.98 0.05 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.92 2.488 . . . . 11.15 110.338 178.115 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.82 -7.71 17.07 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 125.37 1.462 . . . . 13.93 115.781 173.865 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -90.89 130.62 36.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 128.426 3.965 . . . . 23.92 108.429 -171.131 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -98.52 157.96 15.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 111.285 -2.689 . . . . 23.23 104.812 166.947 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.3 mt -122.01 166.48 14.42 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.619 -1.628 . . . . 9.11 111.533 -155.9 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.27 176.94 5.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.141 -1.429 . . . . 33.44 107.141 166.569 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -102.44 -53.14 2.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.372 1.469 . . . . 28.37 111.043 -168.135 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.04 16.38 7.23 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 118.791 2.276 . . . . 15.0 118.791 -170.139 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -116.62 153.55 32.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.514 1.925 . . . . 25.5 110.938 -173.142 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 20.3 p -88.57 170.67 10.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 113.851 1.056 . . . . 11.95 113.851 -173.328 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.52 -31.25 71.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.774 1.749 . . . . 10.17 108.418 177.69 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -70.48 -43.2 70.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.101 1.76 . . . . 13.59 111.78 -175.928 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -59.39 -28.11 66.6 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 128.467 3.984 . . . . 11.7 118.24 176.884 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -82.06 -27.11 33.15 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 113.558 -5.714 . . . . 12.95 121.078 169.784 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 t30 71.95 48.66 0.27 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.508 2.575 . . . . 25.45 117.372 -157.503 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mt -94.75 99.66 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 118.452 -2.655 . . . . 14.6 104.995 174.35 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.45 -175.73 2.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.701 -1.874 . . . . 33.23 107.134 -165.121 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.305 20.3 pttm -67.13 148.38 51.91 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 120.295 1.407 . . . . 25.97 112.247 -178.396 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 76.57 7.22 3.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.557 2.343 . . . . 32.61 114.451 178.962 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 t -63.96 140.68 58.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.689 1.366 . . . . 10.56 114.689 -177.488 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 m -93.9 104.21 16.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.517 -3.239 . . . . 5.33 113.117 170.949 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 3' ' ' ILE . 35.7 mt -84.45 128.18 34.44 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 114.531 -5.106 . . . . 11.66 110.131 169.718 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -106.22 125.27 50.79 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.374 -2.079 . . . . 16.3 111.668 -172.183 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.25 12.1 tp -92.22 134.16 35.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.764 -1.569 . . . . 9.96 106.764 -177.961 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.1 t -116.31 112.04 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 126.709 3.147 . . . . 9.76 109.153 162.407 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.0 tp -97.57 112.68 24.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.811 -2.431 . . . . 19.57 114.022 -167.382 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -156.27 -161.58 1.15 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.408 -2.683 . . . . 35.08 106.013 -158.548 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.3 mt -110.69 166.05 11.33 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.892 -4.88 . . . . 32.31 110.582 171.296 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -57.79 131.95 51.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.123 2.268 . . . . 42.75 117.123 -176.603 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.38 -114.29 1.38 Allowed Glycine 0 N--CA 1.43 -1.753 0 CA-C-O 125.982 2.99 . . . . 36.31 107.453 -173.385 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.729 0 CA-C-N 111.195 -2.503 . . . . 36.27 113.022 -179.981 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 123.624 1.678 . . . . 17.17 112.04 . . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -101.79 131.09 48.3 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.583 -4.448 . . . . 21.89 109.057 -171.584 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -116.81 156.78 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.469 -3.269 . . . . 10.83 105.089 162.686 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -120.28 126.32 50.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.94 2.781 . . . . 10.61 108.629 -178.513 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.49 105.86 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 119.17 -2.206 . . . . 9.13 112.826 -179.32 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -92.42 151.12 20.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.56 -1.338 . . . . 20.55 112.289 -176.264 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -104.18 -166.57 1.26 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.098 1.759 . . . . 11.78 113.383 -178.003 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.35 -62.48 1.38 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 115.57 -2.157 . . . . 19.31 114.1 172.23 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.2 p -63.19 -35.14 79.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.319 2.647 . . . . 23.14 111.576 177.898 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.49 53.87 0.67 Allowed Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 127.029 3.572 . . . . 19.74 111.769 167.209 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -89.44 139.58 30.37 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.563 -4.492 . . . . 21.93 102.121 162.216 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.1 m -83.48 110.68 18.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 115.813 -2.042 . . . . 12.33 113.457 161.399 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -88.04 123.99 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 126.197 2.185 . . . . 17.08 107.238 169.858 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.7 m -94.45 115.43 27.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.751 -1.203 . . . . 16.3 107.751 177.883 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -109.37 134.42 51.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.592 -3.817 . . . . 15.88 115.71 168.782 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.69 109.12 20.93 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.599 -2.0 . . . . 28.9 105.599 175.217 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -121.6 152.06 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 C-N-CA 133.583 4.753 . . . . 12.05 112.388 -177.015 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -90.4 146.25 34.16 Favored Pre-proline 0 N--CA 1.429 -1.495 0 O-C-N 117.805 -3.059 . . . . 18.17 108.288 164.546 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.3 -18.4 62.4 Favored 'Trans proline' 0 C--N 1.299 -2.06 1 C-N-CA 128.245 5.964 . . . . 8.16 111.788 172.758 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.7 p -83.9 -7.42 59.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.791 1.636 . . . . 11.13 110.113 174.607 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -81.01 165.88 21.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.078 2.672 . . . . 18.03 111.606 178.448 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 p -85.36 164.24 18.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.948 2.899 . . . . 10.22 113.365 168.395 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.0 mm -67.28 -35.61 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.355 1.862 . . . . 12.3 110.199 178.914 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -50.91 -48.95 60.44 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.16 -2.213 . . . . 36.51 115.998 168.11 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.98 -32.79 71.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.941 -3.6 . . . . 25.66 118.203 169.281 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.91 -54.31 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 124.966 1.306 . . . . 8.12 108.273 169.654 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -56.95 -36.72 70.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.006 2.225 . . . . 15.47 117.006 178.349 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.29 -24.12 64.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.05 2.982 . . . . 11.45 119.05 173.078 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -69.99 -56.99 5.54 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.514 -1.991 . . . . 24.98 113.096 173.516 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -51.42 -46.85 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 127.228 2.211 . . . . 9.46 110.517 169.394 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -49.49 -41.93 42.08 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.427 2.01 . . . . 14.76 116.427 171.894 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -81.01 -77.53 0.2 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.905 3.241 . . . . 26.29 106.352 -178.893 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -64.4 -42.01 96.33 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.519 -5.113 . . . . 30.06 114.148 -162.574 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -94.61 -43.04 8.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.169 -3.457 . . . . 25.19 115.316 178.897 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.18 41.62 3.69 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.018 -2.301 . . . . 7.41 114.863 176.609 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -109.55 113.15 58.34 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 103.952 -2.61 . . . . 9.49 103.952 168.351 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_exo -57.7 159.3 17.51 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 C-N-CA 126.424 4.749 . . . . 11.42 112.953 -173.726 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -86.42 -1.34 8.39 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 124.8 3.667 . . . . 12.0 112.22 -169.916 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -87.39 -26.86 23.11 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.397 2.936 . . . . 35.55 111.747 169.319 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.03 -31.05 71.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.352 1.612 . . . . 20.52 115.352 175.03 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -83.44 136.23 34.39 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.441 2.015 . . . . 7.13 116.441 -173.726 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -132.07 143.36 49.97 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 115.198 -2.601 . . . . 36.39 110.143 140.763 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.7 mt -94.05 128.31 40.34 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.792 -2.004 . . . . 9.55 111.824 -178.51 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mm -113.4 138.47 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 107.367 -1.346 . . . . 13.9 107.367 -176.596 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -114.89 100.99 8.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.274 2.464 . . . . 6.86 109.797 171.251 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.501 . . 82.34 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.626 -3.796 . . . . 11.15 110.646 172.919 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.04 3.47 6.86 Favored Glycine 0 N--CA 1.429 -1.768 0 CA-C-N 113.262 -1.79 . . . . 13.93 112.745 159.367 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -89.03 124.88 34.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 120.727 2.264 . . . . 23.92 113.193 178.798 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -89.82 118.88 29.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.245 -2.159 . . . . 23.23 110.616 179.817 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.98 159.37 31.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.109 2.385 . . . . 9.11 110.117 -164.843 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.42 142.19 50.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.742 -1.572 . . . . 33.44 113.98 175.942 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.04 -45.31 95.31 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 122.535 4.272 . . . . 28.37 122.535 -162.678 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.24 -4.78 31.27 Favored Glycine 0 N--CA 1.43 -1.721 1 N-CA-C 124.44 4.536 . . . . 15.0 124.44 172.71 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -100.37 171.75 7.57 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.36 2.029 . . . . 25.5 111.164 -176.819 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.27 30.8 p -94.4 157.35 16.06 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.524 -2.61 . . . . 11.95 114.167 179.82 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.88 -46.83 60.59 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 117.571 2.434 . . . . 10.17 117.571 163.074 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -56.4 -33.45 65.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 120.382 3.475 . . . . 13.59 120.382 169.003 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -58.88 -37.64 77.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.187 -2.82 . . . . 11.7 113.656 172.746 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -88.78 -13.17 40.09 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.935 -4.228 . . . . 12.95 110.112 177.35 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.439 40.8 t30 62.03 72.42 0.5 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 129.055 2.942 . . . . 25.45 114.379 -165.231 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -111.16 106.17 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 N-CA-C 99.478 -4.267 . . . . 14.6 99.478 -179.785 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -100.33 -173.98 2.55 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.586 -0.697 . . . . 33.23 110.675 -178.848 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.262 25.1 pttt -55.25 131.74 46.15 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.771 2.428 . . . . 25.97 113.981 179.656 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 58.99 45.54 14.76 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 127.215 3.388 . . . . 32.61 115.232 -176.313 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 t -110.28 137.18 48.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.884 -2.385 . . . . 10.56 107.798 179.208 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 m -105.16 129.47 53.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.932 2.093 . . . . 5.33 107.614 -159.396 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -118.48 150.42 39.63 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 128.086 3.803 . . . . 11.66 106.271 179.12 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -112.03 124.37 52.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.149 -2.219 . . . . 16.3 105.201 -178.643 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -90.45 124.78 35.25 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 129.148 4.03 . . . . 9.96 108.629 -178.496 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.6 m -99.1 151.62 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.992 2.517 . . . . 9.76 109.065 167.192 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.76 151.93 22.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.508 -2.62 . . . . 19.57 109.487 163.13 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -135.42 177.49 7.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.527 -1.358 . . . . 35.08 109.174 175.69 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.7 mt -77.33 142.64 39.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.457 -2.027 . . . . 32.31 109.131 -173.961 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -81.77 163.02 22.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.417 2.006 . . . . 42.75 116.417 -168.055 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.29 -82.35 0.35 Allowed Glycine 0 N--CA 1.43 -1.701 0 O-C-N 118.229 -2.794 . . . . 36.31 115.161 -172.939 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.735 0 O-C-N 118.98 -2.482 . . . . 36.27 108.333 -174.208 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 123.46 1.6 . . . . 17.17 114.12 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -82.39 138.06 34.56 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.422 -4.549 . . . . 21.89 107.75 168.556 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 17' ' ' VAL . 6.9 pt -118.95 177.48 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 124.849 1.26 . . . . 10.83 109.69 157.904 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -134.89 112.02 10.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.429 2.011 . . . . 10.61 116.429 -173.915 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.96 115.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 125.87 2.748 . . . . 9.13 110.493 177.547 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.263 28.2 tttp -107.32 140.56 40.04 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.977 -4.202 . . . . 20.55 113.588 -179.866 . . . . . . . . 3 2 . 1 . 047 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.5 p -102.09 172.7 6.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.983 -2.323 . . . . 11.78 109.797 -179.429 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.9 -46.75 88.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.501 3.12 . . . . 19.31 111.853 172.081 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -69.38 -26.86 64.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.905 -2.372 . . . . 23.14 114.185 171.77 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.4 62.29 0.95 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 116.717 1.447 . . . . 19.74 116.717 162.97 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -103.13 175.18 5.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.929 2.092 . . . . 21.93 107.905 155.389 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 m -128.46 134.12 48.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.3 -3.375 . . . . 12.33 105.792 172.817 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -114.57 117.4 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 107.896 -1.15 . . . . 17.08 107.896 174.566 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 m -85.36 107.79 17.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.227 -2.26 . . . . 16.3 105.955 -175.581 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.0 mt -102.67 135.93 43.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.088 2.375 . . . . 15.88 115.185 172.668 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -99.7 129.34 45.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.779 -3.701 . . . . 28.9 110.63 173.248 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 3' ' ' ILE . 4.2 m -151.09 159.63 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.842 1.657 . . . . 12.05 109.458 -167.628 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 62.2 mm-40 -107.08 159.63 29.3 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 120.554 -1.341 . . . . 18.17 110.328 163.132 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -72.7 -6.58 19.29 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 124.856 3.704 . . . . 8.16 112.374 -176.66 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.8 p -72.64 -26.0 61.49 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 125.355 1.66 . . . . 11.13 114.338 171.779 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -64.82 157.75 26.87 Favored 'General case' 0 N--CA 1.43 -1.456 1 N-CA-C 124.425 4.972 . . . . 18.03 124.425 174.687 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 62.5 p -101.29 167.64 10.06 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 114.074 -2.869 . . . . 10.22 113.899 -173.49 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.317 7.0 mm -64.65 -35.41 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 125.392 1.682 . . . . 12.3 109.65 172.001 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -44.55 -48.82 10.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.683 3.586 . . . . 36.51 120.683 160.049 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -62.79 -40.72 98.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.122 1.514 . . . . 25.66 109.255 174.375 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.299 57.6 t -55.07 -59.76 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 116.721 -1.609 . . . . 8.12 113.652 171.371 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.79 -27.48 68.78 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.073 1.76 . . . . 15.47 112.735 176.875 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.48 -32.53 62.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 122.549 2.431 . . . . 11.45 115.148 175.923 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -70.04 -26.65 64.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.303 -3.373 . . . . 24.98 109.375 176.189 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 30' ' ' ILE . 17.4 mm -70.48 -37.87 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.224 1.409 . . . . 9.46 110.988 168.723 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -43.84 78.37 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.301 -2.124 . . . . 14.76 111.612 -178.033 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.35 -69.09 0.12 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 126.948 2.655 . . . . 26.29 110.984 170.443 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -69.73 -52.32 26.52 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.835 -3.041 . . . . 30.06 118.485 -171.093 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -84.53 -65.51 1.0 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.877 -1.764 . . . . 25.19 107.589 -178.272 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.01 17.79 1.0 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 122.64 2.473 . . . . 7.41 113.884 -175.048 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.8 mt -97.3 131.19 27.85 Favored Pre-proline 0 N--CA 1.431 -1.41 0 N-CA-C 116.07 1.878 . . . . 9.49 116.07 -175.61 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.86 154.79 70.4 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 CA-C-N 124.157 2.521 . . . . 11.42 109.549 -178.946 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 -17.69 13.6 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 N-CA-C 117.221 1.97 . . . . 12.0 117.221 -170.716 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.26 -15.64 57.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.216 1.484 . . . . 35.55 110.704 178.111 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -86.96 -33.18 19.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.74 2.816 . . . . 20.52 113.036 176.462 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -71.03 139.02 50.33 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.231 1.937 . . . . 7.13 116.231 171.013 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -131.67 131.7 43.35 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.015 2.341 . . . . 36.39 114.497 160.008 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.1 mt -109.37 125.95 52.9 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.154 -4.716 . . . . 9.55 110.881 -170.993 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.7 mm -116.45 112.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.531 -1.355 . . . . 13.9 110.132 -176.038 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -102.06 116.38 32.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.879 2.276 . . . . 6.86 112.348 163.578 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.447 . . 63.1 -81.81 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.91 1.818 . . . . 11.15 115.91 -167.252 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.95 15.94 1.18 Allowed Glycine 0 N--CA 1.431 -1.687 0 CA-C-O 125.204 2.558 . . . . 13.93 112.569 174.517 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -101.09 131.39 47.03 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.607 -1.525 . . . . 23.92 110.976 -175.004 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -75.97 120.82 21.83 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.658 -1.155 . . . . 23.23 112.955 170.308 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 mt -89.56 121.29 31.62 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.179 -1.576 . . . . 9.11 111.49 -172.893 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -80.95 143.55 32.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.248 1.573 . . . . 33.44 115.248 172.407 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.78 -42.19 99.59 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.04 4.136 . . . . 28.37 110.538 -171.812 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.76 -7.69 88.3 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 127.238 2.352 . . . . 15.0 114.012 -170.476 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -101.6 155.68 17.94 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.742 1.617 . . . . 25.5 109.62 -169.875 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.4 p -95.11 167.06 11.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.04 -2.288 . . . . 11.95 110.256 -174.487 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 mt -57.69 -56.34 23.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.52 3.128 . . . . 10.17 111.886 174.306 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.406 6.6 t -36.13 -37.88 0.13 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.673 3.589 . . . . 13.59 118.822 156.283 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -72.3 -46.66 54.73 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.829 -4.919 . . . . 11.7 110.829 -176.828 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -67.96 -3.44 9.97 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 120.028 3.344 . . . . 12.95 120.028 167.26 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.0 m120 64.69 27.45 13.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.461 1.504 . . . . 25.45 114.381 -175.71 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -85.27 116.29 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.215 1.483 . . . . 14.6 109.059 -174.277 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -97.8 -165.21 1.22 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.902 3.239 . . . . 33.23 110.598 -176.733 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -76.35 150.11 36.9 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.436 -4.54 . . . . 25.97 112.979 -174.356 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 50.6 mt-10 54.6 35.64 24.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 125.344 1.652 . . . . 32.61 113.411 -174.763 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -86.71 133.97 33.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.053 1.882 . . . . 10.56 108.731 -174.668 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m -95.38 118.4 32.05 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.911 -2.368 . . . . 5.33 107.725 -177.498 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -109.31 144.58 37.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 100.827 -3.768 . . . . 11.66 100.827 -178.802 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -117.36 126.86 53.39 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.307 -3.996 . . . . 16.3 104.945 -177.164 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.4 tp -100.11 119.8 38.87 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.567 1.547 . . . . 9.96 108.044 -176.446 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.7 m -117.99 159.14 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.051 -1.656 . . . . 9.76 113.384 169.368 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.7 mt -92.34 112.77 24.84 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.705 -1.591 . . . . 19.57 106.705 -179.276 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -99.92 -179.8 4.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.423 -2.673 . . . . 35.08 114.271 170.396 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.288 96.0 mt -74.43 159.71 31.94 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.678 1.228 . . . . 32.31 108.548 166.059 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -80.47 122.72 27.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.422 -2.049 . . . . 42.75 113.489 -172.372 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.5 147.06 8.3 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 124.839 1.337 . . . . 36.31 110.16 169.883 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.778 0 C-N-CA 125.123 1.344 . . . . 36.27 110.024 -173.442 . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 117.601 2.445 . . . . 17.17 117.601 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -98.85 134.52 41.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 115.785 -2.055 . . . . 21.89 113.459 170.308 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -130.77 155.53 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 125.546 2.594 . . . . 10.83 107.18 172.078 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -119.29 105.16 11.05 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.577 -3.827 . . . . 10.61 107.489 -161.221 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.68 100.15 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 1 O-C-N 129.64 4.338 . . . . 9.13 107.705 177.177 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -92.03 120.27 32.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.834 -1.53 . . . . 20.55 109.975 -177.455 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -74.18 -174.01 1.82 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.872 2.069 . . . . 11.78 113.739 -178.967 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.2 tp -77.76 -32.25 52.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.932 2.197 . . . . 19.31 116.932 177.334 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.8 p -70.67 -31.15 67.95 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.542 2.337 . . . . 23.14 114.637 170.75 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.8 20.15 8.23 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 117.758 -1.579 . . . . 19.74 114.538 179.849 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.292 44.4 pttt -89.07 142.96 27.19 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 124.733 1.213 . . . . 21.93 111.747 169.357 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.7 m -98.29 130.89 44.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.817 -1.802 . . . . 12.33 108.669 178.0 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.9 mt -106.56 104.64 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 1 N-CA-C 99.737 -4.171 . . . . 17.08 99.737 171.508 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -73.89 119.52 18.21 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.284 -1.51 . . . . 16.3 111.702 173.559 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.553 ' CD1' HG13 ' A' ' 26' ' ' VAL . 67.5 mt -100.17 126.07 46.39 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 114.964 -4.835 . . . . 15.88 114.13 170.588 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -78.93 92.83 4.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 125.797 1.936 . . . . 28.9 113.349 174.805 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.286 16.3 m -132.8 165.26 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 121.903 2.138 . . . . 12.05 111.325 -175.701 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -97.07 165.31 16.03 Favored Pre-proline 0 N--CA 1.429 -1.483 0 O-C-N 116.36 -3.963 . . . . 18.17 109.461 174.409 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.85 -23.66 73.16 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.811 3.111 . . . . 8.16 119.539 164.833 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -63.38 -22.39 66.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.04 2.536 . . . . 11.13 112.823 174.748 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.18 148.69 39.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.315 -2.74 . . . . 18.03 109.492 -172.174 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 7.8 p -86.91 171.77 10.56 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.46 2.076 . . . . 10.22 109.425 179.145 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mm -76.93 -22.93 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.064 -2.897 . . . . 12.3 107.204 176.407 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.82 -46.79 74.59 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.737 -1.852 . . . . 36.51 110.828 171.132 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 72.4 m-20 -70.64 -21.49 62.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.238 2.615 . . . . 25.66 115.784 -179.612 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.553 HG13 ' CD1' ' A' ' 15' ' ' LEU . 7.8 t -83.72 -57.22 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 112.413 -2.176 . . . . 8.12 107.113 174.191 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -45.19 -39.73 6.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.121 -2.862 . . . . 15.47 117.024 169.714 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.35 89.86 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.722 3.23 . . . . 11.45 119.722 173.047 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.31 -36.0 80.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.113 1.894 . . . . 24.98 116.113 169.127 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mm -69.43 -31.32 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.924 -1.735 . . . . 9.46 107.624 -179.11 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -72.17 -44.67 62.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.417 -2.677 . . . . 14.76 113.182 169.709 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -54.64 -45.36 73.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.102 2.561 . . . . 26.29 114.57 177.511 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -91.46 -56.93 2.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.455 -2.028 . . . . 30.06 114.061 -177.994 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.269 52.6 mm-40 -85.81 -31.07 22.51 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.564 -4.46 . . . . 25.19 114.53 -175.156 . . . . . . . . 3 2 . 1 . 048 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.76 7.55 59.99 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 119.568 -1.958 . . . . 7.41 112.902 173.702 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.2 116.95 59.22 Favored Pre-proline 0 N--CA 1.429 -1.485 0 CA-C-O 114.856 -2.497 . . . . 9.49 113.819 177.415 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -63.94 150.74 87.72 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 125.227 3.952 . . . . 11.42 114.08 -172.074 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -73.95 -20.69 19.25 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 O-C-N 114.941 -3.241 . . . . 12.0 113.843 -166.964 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -80.61 -18.73 47.3 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.685 -1.969 . . . . 35.55 105.685 178.596 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -89.93 -18.34 26.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.753 -1.842 . . . . 20.52 113.478 176.744 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -72.95 137.33 45.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.71 -2.494 . . . . 7.13 109.163 -177.485 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.517 ' HB3' HG23 ' A' ' 70' ' ' VAL . 28.0 ttt180 -130.89 129.54 42.38 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.668 1.576 . . . . 36.39 109.837 168.878 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 50' ' ' LEU . 22.9 mt -118.95 124.32 46.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.704 -1.135 . . . . 9.55 111.33 -173.928 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 21.7 mm -118.01 134.38 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.171 2.588 . . . . 13.9 106.647 -171.071 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.409 ' HB2' HD11 ' A' ' 50' ' ' LEU . 82.2 t80 -121.24 113.32 19.79 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.324 2.342 . . . . 6.86 117.324 161.245 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.86 -98.44 0.08 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.786 1.402 . . . . 11.15 114.786 -164.725 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.21 4.04 9.62 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 124.762 1.172 . . . . 13.93 113.875 166.116 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -90.98 139.24 30.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.294 1.521 . . . . 23.92 109.56 177.809 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -87.73 117.07 26.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.204 2.202 . . . . 23.23 110.386 178.721 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 43' ' ' LEU . 83.2 mt -83.61 129.27 34.96 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.962 2.905 . . . . 9.11 107.898 -178.553 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -111.74 154.43 25.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.224 -1.807 . . . . 33.44 109.245 -173.995 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.38 -48.57 67.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.49 1.614 . . . . 28.37 110.876 -158.404 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.58 15.75 44.58 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.972 1.749 . . . . 15.0 114.605 177.279 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -100.36 167.8 10.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.79 -1.93 . . . . 25.5 105.79 171.005 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 11.4 p -105.04 176.86 5.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.514 -1.991 . . . . 11.95 107.955 -177.865 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.78 -43.55 88.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.957 2.661 . . . . 10.17 115.272 164.856 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.2 t -51.85 -43.74 63.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.414 2.686 . . . . 13.59 113.663 173.717 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -67.17 -29.24 68.88 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 117.147 2.277 . . . . 11.7 117.147 -173.914 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.07 -10.23 50.83 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 119.441 3.126 . . . . 12.95 119.441 171.296 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.4 m120 85.06 56.69 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.471 1 C-N-CA 133.679 4.791 . . . . 25.45 107.244 172.466 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.7 mt -104.92 101.38 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 N-CA-C 99.375 -4.305 . . . . 14.6 99.375 -172.844 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -91.07 -177.48 4.92 Favored 'General case' 0 N--CA 1.43 -1.433 2 C-N-CA 134.561 5.144 . . . . 33.23 107.265 179.973 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -66.57 145.57 55.46 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.001 1.32 . . . . 25.97 114.37 -179.311 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.381 17.0 mt-10 66.64 52.56 0.99 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 126.715 3.15 . . . . 32.61 117.337 176.866 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.1 t -131.76 134.01 45.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.689 -3.132 . . . . 10.56 113.166 -153.227 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.2 m -77.25 117.08 18.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.745 2.528 . . . . 5.33 115.16 -179.231 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -115.05 138.37 50.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 115.388 -2.244 . . . . 11.66 108.305 165.39 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.5 m-70 -100.49 122.64 43.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.766 1.166 . . . . 16.3 111.288 -177.329 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.69 117.46 31.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.099 2.381 . . . . 9.96 110.197 172.575 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -126.85 176.7 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 130.596 3.558 . . . . 9.76 109.266 172.772 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 mp -122.43 144.1 49.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.688 -1.882 . . . . 19.57 115.858 175.441 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -118.84 -177.87 3.42 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.529 2.585 . . . . 35.08 106.649 177.579 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.1 mt -81.26 155.93 25.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.552 3.072 . . . . 32.31 111.741 172.497 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -79.32 155.37 28.5 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 113.523 -5.736 . . . . 42.75 117.303 -169.054 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.41 -81.58 0.09 OUTLIER Glycine 0 N--CA 1.431 -1.695 0 O-C-N 128.016 3.323 . . . . 36.31 113.393 168.465 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.771 0 CA-C-O 126.348 3.193 . . . . 36.27 110.757 -173.039 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 104.832 -2.284 . . . . 17.17 104.832 . . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -116.3 130.51 56.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.815 -2.291 . . . . 21.89 104.815 -175.6 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -117.68 154.45 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.785 -2.302 . . . . 10.83 104.785 161.161 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.314 98.1 m-85 -116.14 152.06 34.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.603 -3.186 . . . . 10.61 106.121 176.801 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -125.41 113.18 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 106.746 -1.575 . . . . 9.13 106.746 177.942 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -122.4 150.95 41.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.699 1.249 . . . . 20.55 113.234 -169.357 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -89.7 176.2 6.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.242 1.817 . . . . 11.78 108.246 176.65 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 mt -68.79 -38.82 80.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.124 -2.235 . . . . 19.31 107.064 -175.4 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -83.83 -61.84 1.72 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.771 -2.456 . . . . 23.14 114.268 -172.832 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.55 68.69 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 117.737 -2.173 . . . . 19.74 109.402 177.42 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tmmm? -120.09 121.25 38.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.112 -2.922 . . . . 21.93 103.112 155.407 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.0 m -111.88 112.03 23.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.709 -2.495 . . . . 12.33 108.093 -173.73 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.26 136.73 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 105.468 -2.049 . . . . 17.08 105.468 173.654 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.2 m -101.78 119.8 39.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.721 -1.214 . . . . 16.3 107.721 -171.283 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.6 mt -103.84 134.91 46.35 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 119.279 3.066 . . . . 15.88 119.279 178.943 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.18 109.49 21.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.205 -1.56 . . . . 28.9 108.686 178.691 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -130.1 148.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 116.765 -3.709 . . . . 12.05 112.291 -169.884 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -97.44 146.68 31.81 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 118.997 -2.315 . . . . 18.17 109.312 171.34 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.8 -17.74 17.6 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-O 112.393 -3.253 . . . . 8.16 107.602 -172.651 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -85.29 7.37 22.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 123.896 3.044 . . . . 11.13 112.042 177.035 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -92.71 171.81 8.76 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.213 -2.804 . . . . 18.03 107.217 -174.717 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -112.48 153.45 27.41 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.046 -1.659 . . . . 10.22 109.975 -169.12 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 3.0 mt -74.21 -20.74 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.209 2.604 . . . . 12.3 106.383 -174.311 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.94 -44.87 91.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.283 1.033 . . . . 36.51 112.101 169.614 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -66.37 -34.96 79.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.293 3.437 . . . . 25.66 109.66 174.439 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 97.6 t -62.84 -49.77 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 119.852 -1.78 . . . . 8.12 111.948 177.703 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -65.7 -27.63 68.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.468 2.355 . . . . 15.47 110.429 -172.802 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.81 -28.35 67.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.562 2.345 . . . . 11.45 110.02 177.932 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -93.04 -28.94 16.07 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 121.719 2.054 . . . . 24.98 108.26 -178.253 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 mt -65.1 -42.13 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 118.687 -2.508 . . . . 9.46 111.377 164.763 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -59.36 -51.84 68.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.109 -3.495 . . . . 14.76 117.691 168.087 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -46.24 -50.08 16.39 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 122.268 2.303 . . . . 26.29 115.018 174.324 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -68.68 -63.76 1.0 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.496 2.719 . . . . 30.06 117.109 174.16 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -88.24 -29.82 20.16 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.64 2.089 . . . . 25.19 116.64 -174.092 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.13 14.83 59.94 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 119.058 2.383 . . . . 7.41 119.058 -178.44 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 tt -103.15 115.31 64.2 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 114.903 -2.475 . . . . 9.49 106.536 -178.275 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -60.27 170.03 4.47 Favored 'Trans proline' 0 N--CA 1.434 -1.988 2 C-N-CA 131.058 7.839 . . . . 11.42 116.256 -168.977 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.88 -21.09 7.17 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 125.365 2.952 . . . . 12.0 108.126 -164.307 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -75.43 -33.92 60.95 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.445 -2.66 . . . . 35.55 113.005 175.946 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -73.59 -37.52 65.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.516 -3.24 . . . . 20.52 113.929 176.265 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -54.74 124.55 16.8 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.967 -2.333 . . . . 7.13 114.269 173.952 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -124.32 99.34 6.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.369 1.44 . . . . 36.39 108.43 -178.123 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.3 mt -96.93 107.33 19.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.384 1.874 . . . . 9.55 110.705 -173.131 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.421 HG13 HG21 ' A' ' 70' ' ' VAL . 17.2 mm -110.37 120.41 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 128.471 2.708 . . . . 13.9 105.67 -175.406 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -107.95 115.93 31.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.734 -2.03 . . . . 6.86 108.022 169.132 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.29 -94.04 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 112.32 -2.218 . . . . 11.15 113.306 -164.168 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.72 12.56 4.53 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 129.361 3.362 . . . . 13.93 113.149 169.997 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -117.91 148.79 41.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.757 2.279 . . . . 23.92 108.843 -179.82 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -110.77 114.71 28.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.217 -1.031 . . . . 23.23 108.217 -169.115 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.771 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -68.55 157.67 35.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.94 -2.35 . . . . 9.11 115.108 -171.947 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -100.21 154.95 18.04 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.775 -1.194 . . . . 33.44 107.775 178.465 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -75.87 -50.0 16.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.013 -2.899 . . . . 28.37 116.309 -160.23 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.9 52.93 2.94 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 123.197 2.726 . . . . 15.0 111.855 179.726 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.259 6.7 mmt180 -121.41 160.3 24.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 103.874 -2.639 . . . . 25.5 103.874 171.207 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.303 66.2 p -86.62 151.85 23.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.33 1.452 . . . . 11.95 111.971 175.937 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.252 33.3 mt -47.51 -50.78 22.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.677 1.191 . . . . 10.17 111.699 165.545 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 p -54.12 -26.73 28.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.328 1.973 . . . . 13.59 116.328 176.866 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.35 -43.45 98.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.396 -2.69 . . . . 11.7 110.505 173.455 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.23 -16.01 28.32 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 126.601 2.438 . . . . 12.95 115.724 176.532 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 70.63 36.95 1.51 Allowed 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.601 1.561 . . . . 25.45 113.381 -172.226 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -68.63 101.43 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.49 -2.006 . . . . 14.6 116.121 170.901 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -76.52 163.43 26.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.82 2.896 . . . . 33.23 118.82 -175.829 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -61.35 147.85 43.41 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.605 2.817 . . . . 25.97 118.605 169.593 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.333 26.2 mt-10 68.74 23.98 6.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.07 1.89 . . . . 32.61 112.773 179.916 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -84.79 152.39 23.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.275 3.417 . . . . 10.56 107.945 -179.997 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -110.41 97.81 7.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 110.766 -2.925 . . . . 5.33 107.887 175.825 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -80.81 152.26 28.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.267 3.027 . . . . 11.66 112.119 165.446 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -104.41 140.15 38.33 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.253 -2.78 . . . . 16.3 106.376 -178.136 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 tp -102.73 104.27 14.57 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.994 2.33 . . . . 9.96 110.225 156.939 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.421 HG21 HG13 ' A' ' 44' ' ' ILE . 3.4 t -91.53 138.21 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 117.357 -3.34 . . . . 9.76 108.047 -176.62 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.6 tp -87.38 127.14 35.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.79 -2.444 . . . . 19.57 105.769 172.632 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -126.94 148.78 50.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 128.162 3.414 . . . . 35.08 113.133 164.752 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 mt -76.54 140.16 41.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.779 -2.45 . . . . 32.31 110.386 -179.496 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -79.35 127.9 32.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.541 1.936 . . . . 42.75 108.267 -175.926 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.31 -58.56 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.746 0 O-C-N 121.101 -0.999 . . . . 36.31 113.279 -162.182 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 CA-C-O 117.218 -1.879 . . . . 36.27 109.756 169.008 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 125.08 2.372 . . . . 17.17 114.308 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -104.92 131.1 52.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.539 -3.851 . . . . 21.89 111.92 166.162 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.297 2.3 pp -124.08 162.52 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 1 O-C-N 114.61 -5.056 . . . . 10.83 105.283 169.679 . . . . . . . . 3 2 . 1 . 050 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -107.04 128.39 54.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.484 3.113 . . . . 10.61 106.607 -175.189 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.59 104.89 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 100.319 -3.956 . . . . 9.13 100.319 -177.859 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 tttt -89.4 162.22 15.89 Favored 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 131.913 4.085 . . . . 20.55 108.661 175.008 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.484 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 17.8 p -101.99 -151.72 0.42 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.818 -2.426 . . . . 11.78 105.899 173.703 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.484 ' H ' ' HB ' ' A' ' 7' ' ' THR . 51.3 mt -91.58 -42.39 10.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.004 1.275 . . . . 19.31 111.459 170.07 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -66.53 -36.66 83.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.875 -1.766 . . . . 23.14 113.182 174.455 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.01 22.13 1.28 Allowed Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 120.057 2.783 . . . . 19.74 120.057 158.053 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -72.99 106.02 4.7 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.216 2.206 . . . . 21.93 116.438 168.261 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -81.13 130.33 34.97 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.818 -1.083 . . . . 12.33 109.69 173.511 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -107.38 157.25 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 119.912 -1.743 . . . . 17.08 106.871 158.79 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.7 m -125.57 106.59 9.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.315 -1.735 . . . . 16.3 106.315 -169.147 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.261 86.5 mt -125.24 144.95 50.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.829 -0.545 . . . . 15.88 112.047 -168.345 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -97.1 105.69 17.88 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.375 2.731 . . . . 28.9 118.375 -171.005 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 m -125.61 161.33 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.375 2.27 . . . . 12.05 108.146 -168.476 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -103.92 169.58 7.13 Favored Pre-proline 0 N--CA 1.429 -1.476 1 O-C-N 113.232 -5.917 . . . . 18.17 106.653 167.72 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -77.96 -17.25 13.83 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 116.301 -2.526 . . . . 8.16 107.74 174.639 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -75.85 -6.44 50.76 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 117.788 -3.07 . . . . 11.13 112.654 173.02 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -77.26 145.01 37.77 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.98 -3.575 . . . . 18.03 108.935 174.76 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.324 20.1 p -77.76 151.75 33.93 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 133.175 4.59 . . . . 10.22 110.655 176.458 . . . . . . . . 3 2 . 1 . 050 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 50' ' ' LEU . 65.0 mt -63.5 -38.96 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 120.264 -1.523 . . . . 12.3 113.031 175.431 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -46.13 -45.37 16.47 Favored 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 132.463 4.305 . . . . 36.51 113.72 168.591 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -74.57 -23.12 58.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.721 -3.737 . . . . 25.66 114.26 174.738 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.36 -44.93 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.503 -1.998 . . . . 8.12 110.576 174.28 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.17 -40.24 73.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.485 1.514 . . . . 15.47 114.008 173.426 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.06 -42.11 65.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.232 2.308 . . . . 11.45 117.232 167.648 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -79.54 -14.26 58.98 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 116.151 -4.093 . . . . 24.98 116.259 179.037 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -88.1 -26.29 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.892 -1.755 . . . . 9.46 110.17 168.119 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -63.97 -48.9 74.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.642 -3.161 . . . . 14.76 115.933 162.876 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -42.4 -51.42 4.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.0 3.333 . . . . 26.29 120.0 157.209 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -90.67 -68.11 0.81 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.347 -0.845 . . . . 30.06 111.326 -166.474 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -86.78 -34.43 19.58 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.303 1.441 . . . . 25.19 112.648 -176.249 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.55 67.27 1.57 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 115.997 1.159 . . . . 7.41 115.997 173.797 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.58 HD11 HD13 ' A' ' 71' ' ' LEU . 10.5 tt -126.9 133.55 25.15 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-N 110.138 -3.031 . . . . 9.49 110.97 164.864 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 10.7 Cg_endo -74.44 157.36 45.18 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 123.924 3.083 . . . . 11.42 113.368 -172.435 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 84.1 Cg_exo -72.85 -15.5 26.53 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 CA-C-O 112.567 -3.181 . . . . 12.0 114.171 -153.775 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.49 -17.63 29.93 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 128.639 3.712 . . . . 35.55 106.068 -176.216 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -89.11 -27.17 20.94 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.781 -3.074 . . . . 20.52 104.832 -178.711 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -78.62 109.61 12.99 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.006 -3.559 . . . . 7.13 111.541 -175.538 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -100.44 104.52 15.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.107 -2.553 . . . . 36.39 104.107 174.587 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -96.45 140.56 30.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.855 -2.403 . . . . 9.55 109.16 179.014 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -134.88 146.58 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.722 1.725 . . . . 13.9 107.815 -173.073 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -121.84 104.5 9.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.702 2.001 . . . . 6.86 106.482 166.376 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.36 -102.64 0.16 Allowed 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 116.064 -4.147 . . . . 11.15 113.975 173.147 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.11 -25.05 27.72 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 124.461 3.3 . . . . 13.93 113.233 171.526 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -83.8 136.81 34.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.95 1.357 . . . . 23.92 113.364 -173.021 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -78.67 147.52 33.51 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.644 -3.16 . . . . 23.23 111.146 163.056 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.429 ' HB3' HD13 ' A' ' 23' ' ' ILE . 9.8 mt -110.42 110.45 21.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 114.662 -2.59 . . . . 9.11 104.914 -172.282 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.296 20.8 mt-10 -81.08 145.41 31.11 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.714 3.606 . . . . 33.44 113.47 177.427 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.59 -49.56 74.74 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 119.847 3.277 . . . . 28.37 119.847 -158.429 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.17 15.32 56.48 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.589 -3.819 . . . . 15.0 116.345 -174.045 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.2 mtt-85 -93.87 161.21 14.4 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.627 1.204 . . . . 25.5 109.147 169.292 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.1 p -91.52 173.77 7.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.101 1.905 . . . . 11.95 111.211 177.183 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.5 -24.82 53.75 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.38 -1.45 . . . . 10.17 109.434 173.133 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.5 t -72.5 -36.32 68.35 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.805 -1.809 . . . . 13.59 113.132 -177.196 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -59.01 -39.93 83.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.318 2.261 . . . . 11.7 114.724 173.762 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -84.73 2.08 43.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.761 -3.087 . . . . 12.95 113.551 -179.874 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.292 29.3 m120 54.47 51.49 14.03 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.061 2.615 . . . . 25.45 118.061 -168.829 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -99.11 112.53 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 122.741 2.518 . . . . 14.6 107.752 -179.808 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -103.24 176.94 4.98 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.889 1.676 . . . . 33.23 108.527 -173.975 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 pttp -73.79 148.76 42.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.021 -2.299 . . . . 25.97 112.897 -173.674 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.81 19.75 10.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 111.367 -2.651 . . . . 32.61 110.802 -173.456 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -82.39 160.66 22.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.217 -2.142 . . . . 10.56 105.217 179.31 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -116.68 120.55 38.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 126.185 2.898 . . . . 5.33 104.766 -171.994 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.41 64.2 mt -100.37 155.55 17.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.489 -2.141 . . . . 11.66 108.508 169.207 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -107.52 131.51 54.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.562 1.69 . . . . 16.3 115.562 173.482 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.0 107.61 19.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.433 1.893 . . . . 9.96 106.096 178.915 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.82 152.75 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.049 -1.657 . . . . 9.76 107.47 172.629 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.58 HD13 HD11 ' A' ' 36' ' ' ILE . 10.0 tp -101.55 125.89 48.27 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.165 -2.209 . . . . 19.57 105.164 172.679 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -130.8 132.73 45.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 128.343 3.925 . . . . 35.08 107.35 170.626 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.8 mt -73.57 -155.28 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.321 -3.987 . . . . 32.31 112.628 178.666 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -92.68 145.18 24.62 Favored 'General case' 0 N--CA 1.429 -1.487 1 CA-C-O 129.253 4.359 . . . . 42.75 115.396 -178.995 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.14 -103.18 0.18 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 117.979 -2.951 . . . . 36.31 115.24 177.954 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.777 0 N-CA-C 104.048 -3.621 . . . . 36.27 104.048 -171.555 . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 114.518 1.303 . . . . 17.17 114.518 . . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -79.55 127.04 31.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.094 -1.432 . . . . 21.89 114.475 178.36 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -119.25 159.65 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 122.161 2.255 . . . . 10.83 113.943 159.011 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.64 135.6 53.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 104.479 -2.415 . . . . 10.61 104.479 -172.052 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.63 119.03 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 105.408 -2.071 . . . . 9.13 105.408 174.743 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.494 ' HG2' HG23 ' A' ' 12' ' ' THR . 61.0 mttt -107.38 136.49 47.09 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.15 -2.167 . . . . 20.55 105.15 -171.523 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.272 72.0 p -97.62 172.95 7.39 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.371 2.986 . . . . 11.78 107.52 -172.02 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mt -77.78 -35.72 51.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.096 -1.866 . . . . 19.31 115.845 176.875 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -65.42 -69.78 0.27 Allowed 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 121.697 2.044 . . . . 23.14 106.243 170.405 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.84 68.81 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 113.418 -1.719 . . . . 19.74 113.556 178.623 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -132.75 150.07 52.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.776 -3.046 . . . . 21.93 102.776 170.346 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 6' ' ' LYS . 34.6 m -127.33 90.98 3.22 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 116.573 -1.68 . . . . 12.33 107.211 -178.219 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 pt -77.07 125.37 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 128.377 2.671 . . . . 17.08 110.964 -179.784 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.7 m -97.47 117.11 30.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.126 1.516 . . . . 16.3 113.047 177.008 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -99.12 144.41 28.29 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.037 -1.097 . . . . 15.88 108.037 178.618 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -87.08 112.69 22.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.669 -3.144 . . . . 28.9 113.873 165.427 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.68 -176.25 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.416 1 O-C-N 115.917 -4.24 . . . . 12.05 114.374 176.438 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -132.06 141.47 41.58 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 116.849 -3.657 . . . . 18.17 111.717 169.696 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.87 -18.19 41.41 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 119.296 2.768 . . . . 8.16 119.296 -170.79 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -76.65 -10.31 59.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.223 1.934 . . . . 11.13 116.223 173.535 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.271 10.9 t0 -94.43 164.77 12.87 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.496 -2.003 . . . . 18.03 114.173 -175.76 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -75.49 161.41 29.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.819 -2.425 . . . . 10.22 114.828 -170.197 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 50' ' ' LEU . 22.0 mt -77.83 -31.21 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.891 -3.006 . . . . 12.3 112.389 177.855 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -49.3 -48.0 46.51 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.384 2.274 . . . . 36.51 112.385 167.404 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -74.1 -13.66 60.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.372 1.869 . . . . 25.66 113.066 179.657 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.95 -49.27 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 116.553 -3.842 . . . . 8.12 108.034 165.368 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -62.96 -33.22 74.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.376 2.67 . . . . 15.47 110.601 -179.236 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.63 -44.78 85.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.491 3.043 . . . . 11.45 107.953 -177.087 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.277 65.9 mttm -63.66 -35.06 79.29 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 120.503 3.52 . . . . 24.98 120.503 173.391 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.93 -28.06 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.54 3.067 . . . . 9.46 111.15 178.911 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -70.88 -50.36 35.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.499 -3.25 . . . . 14.76 106.056 177.992 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -48.38 -46.64 37.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.703 3.62 . . . . 26.29 114.895 178.159 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -82.49 -56.96 3.57 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.034 -2.348 . . . . 30.06 109.517 -165.614 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -100.1 -22.82 15.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.598 3.184 . . . . 25.19 119.598 -174.841 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.31 27.64 8.04 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 117.228 -3.42 . . . . 7.41 115.238 170.204 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 tt -111.98 135.14 21.26 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-O 113.686 -3.054 . . . . 9.49 107.073 -168.426 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.55 167.21 27.05 Favored 'Trans proline' 0 C--N 1.299 -2.045 1 CA-C-O 109.448 -4.48 . . . . 11.42 113.307 -174.383 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.18 -11.12 7.6 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 126.026 3.188 . . . . 12.0 111.833 -179.924 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -71.93 -18.66 62.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.611 -2.556 . . . . 35.55 110.796 173.036 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -92.03 -17.77 24.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 116.562 -1.685 . . . . 20.52 110.43 172.724 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -89.02 128.25 35.71 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.81 1.29 . . . . 7.13 112.768 -168.516 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -140.66 143.94 35.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 112.562 -2.108 . . . . 36.39 107.324 152.274 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.4 mt -110.23 136.31 49.64 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.712 2.405 . . . . 9.55 106.092 -171.92 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -128.13 136.02 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 116.658 -3.776 . . . . 13.9 105.874 -170.314 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -120.9 108.01 13.39 Favored 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 98.938 -4.467 . . . . 6.86 98.938 -177.076 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.53 -64.91 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 131.41 3.884 . . . . 11.15 115.056 178.181 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.64 -0.81 1.73 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 116.906 1.522 . . . . 13.93 116.906 169.208 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -119.11 153.28 35.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 120.552 2.176 . . . . 23.92 107.575 -169.603 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -84.52 137.28 33.42 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.56 1.171 . . . . 23.23 113.676 177.256 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HB3' HD13 ' A' ' 23' ' ' ILE . 27.1 mt -94.15 120.55 34.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.152 1.381 . . . . 9.11 107.31 -178.547 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -78.85 141.26 37.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.009 1.861 . . . . 33.44 113.894 177.499 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.7 -63.5 1.07 Allowed 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 132.157 4.183 . . . . 28.37 115.386 -179.588 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.15 4.32 6.21 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 128.103 2.763 . . . . 15.0 119.569 -179.003 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -105.89 165.82 10.92 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 125.165 2.412 . . . . 25.5 106.439 -177.882 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.6 p -94.38 177.2 6.02 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.11 -2.869 . . . . 11.95 117.64 172.048 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.38 -25.96 38.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.606 1.962 . . . . 10.17 108.849 179.242 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 m -76.2 -24.86 54.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 121.293 1.86 . . . . 13.59 112.962 172.259 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -54.61 -38.95 67.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.712 1.745 . . . . 11.7 115.712 171.595 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -99.19 -11.99 20.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.37 2.668 . . . . 12.95 111.428 -175.359 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.12 60.07 3.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.625 1.97 . . . . 25.45 114.68 -162.499 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -92.31 118.43 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 126.899 2.08 . . . . 14.6 106.336 173.679 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -103.75 -174.76 2.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.166 1.543 . . . . 33.23 115.166 178.486 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -69.54 155.77 39.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.041 -2.287 . . . . 25.97 108.948 176.193 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 53.9 40.01 31.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.88 2.472 . . . . 32.61 112.021 -178.283 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -92.93 136.43 33.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 129.156 2.983 . . . . 10.56 106.23 176.715 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.4 m -81.13 110.47 16.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.707 -2.331 . . . . 5.33 104.707 171.027 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.99 148.85 25.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.489 2.859 . . . . 11.66 108.451 165.989 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -111.24 138.6 47.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.024 -2.213 . . . . 16.3 105.024 -179.733 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tp -116.45 122.25 44.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.17 -2.529 . . . . 9.96 104.17 -179.39 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -108.52 171.47 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 124.811 1.32 . . . . 9.76 110.759 -179.617 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 tp -83.49 133.61 34.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.084 -2.885 . . . . 19.57 113.287 167.335 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -91.32 112.14 23.93 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.31 2.005 . . . . 35.08 112.175 -178.501 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.9 mt -79.43 149.03 31.72 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 112.176 -6.578 . . . . 32.31 109.159 169.894 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -85.55 125.89 33.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.036 -2.29 . . . . 42.75 113.811 -168.014 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.54 -75.58 0.14 Allowed Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 107.058 -2.417 . . . . 36.31 107.058 -172.336 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.745 0 N-CA-C 104.108 -3.597 . . . . 36.27 104.108 167.771 . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 CA--C 1.489 -1.377 0 N-CA-C 120.027 3.343 . . . . 17.17 120.027 . . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -92.03 132.9 36.2 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 116.017 -4.177 . . . . 21.89 109.216 -176.908 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 pt -135.68 150.66 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 116.646 -3.784 . . . . 10.83 105.795 174.836 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.3 134.46 52.87 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.36 -1.291 . . . . 10.61 109.498 -177.102 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -115.02 120.25 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 119.478 -2.014 . . . . 9.13 109.901 173.695 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -89.98 128.48 36.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.711 2.672 . . . . 20.55 114.46 167.151 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -80.48 -167.51 1.37 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.125 -2.234 . . . . 11.78 109.711 -165.731 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.2 -55.65 31.14 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.554 2.742 . . . . 19.31 112.682 169.409 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -91.04 -34.65 15.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.077 1.751 . . . . 23.14 110.785 -164.341 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.26 79.02 0.2 Allowed Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 128.776 3.084 . . . . 19.74 111.223 170.023 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -141.76 137.59 31.71 Favored 'General case' 0 N--CA 1.43 -1.451 1 N-CA-C 97.533 -4.988 . . . . 21.93 97.533 177.682 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -109.38 101.23 10.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.846 -1.168 . . . . 12.33 107.846 174.803 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.42 153.91 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 130.242 3.417 . . . . 17.08 110.283 164.251 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.3 m -120.03 139.87 51.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.41 -1.7 . . . . 16.3 106.41 -176.17 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.302 96.0 mt -134.63 152.2 51.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 121.436 1.925 . . . . 15.88 112.294 173.362 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -102.48 117.58 35.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.132 1.333 . . . . 28.9 112.761 176.838 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.68 172.3 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 121.704 2.047 . . . . 12.05 112.769 -178.892 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -111.99 155.64 43.03 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 104.969 -2.234 . . . . 18.17 104.969 170.252 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.271 21.6 Cg_exo -71.22 -12.08 29.58 Favored 'Trans proline' 0 N--CA 1.433 -2.033 1 C-N-CA 126.115 4.543 . . . . 8.16 111.631 -175.273 . . . . . . . . 3 2 . 1 . 052 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 p -92.42 -1.88 56.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 127.646 3.091 . . . . 11.13 108.379 179.401 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -71.79 143.48 49.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 127.846 3.689 . . . . 18.03 113.948 170.071 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -86.53 169.42 12.81 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 109.631 -3.44 . . . . 10.22 110.598 -169.649 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -69.73 -37.48 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.434 -1.321 . . . . 12.3 107.434 175.619 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -54.3 -50.68 66.75 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.503 -1.998 . . . . 36.51 113.653 171.3 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -61.09 -34.1 74.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 122.843 2.565 . . . . 25.66 115.472 173.196 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.388 75.9 t -54.02 -54.53 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 124.597 1.186 . . . . 8.12 113.553 169.124 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -53.3 -24.25 11.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.968 3.307 . . . . 15.47 119.507 170.266 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.72 -38.78 58.26 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.695 3.617 . . . . 11.45 111.033 176.489 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -68.29 -33.08 73.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.071 -3.518 . . . . 24.98 115.471 174.361 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -75.02 -47.25 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.782 2.033 . . . . 9.46 107.412 175.462 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -46.06 -48.43 16.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 114.704 -2.569 . . . . 14.76 113.37 169.46 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.65 -48.12 60.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 120.398 1.453 . . . . 26.29 114.39 -176.472 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -71.88 -52.8 15.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.956 -1.497 . . . . 30.06 113.324 -172.948 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -91.67 -41.61 10.63 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 126.502 2.376 . . . . 25.19 113.989 -167.271 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.71 40.61 1.56 Allowed Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 119.11 -0.828 . . . . 7.41 113.551 173.54 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 tt -113.49 139.86 23.8 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-O 114.826 -2.511 . . . . 9.49 106.271 -179.511 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -68.77 153.04 73.79 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 126.964 3.523 . . . . 11.42 109.582 177.624 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.01 -22.82 70.81 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 127.894 5.729 . . . . 12.0 119.356 176.814 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.84 -24.59 48.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.762 -2.681 . . . . 35.55 103.762 -171.381 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.15 -25.02 25.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.424 -1.423 . . . . 20.52 114.114 -171.225 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -74.95 117.9 17.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.504 -1.998 . . . . 7.13 116.101 179.742 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -108.71 110.6 22.05 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.564 2.345 . . . . 36.39 111.223 167.598 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.69 135.58 33.62 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.141 3.015 . . . . 9.55 119.141 173.955 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 mm -121.13 137.15 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 124.107 1.908 . . . . 13.9 110.626 176.202 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -117.08 130.0 56.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.293 -2.754 . . . . 6.86 105.67 164.417 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 48.25 -94.62 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.902 1.816 . . . . 11.15 115.902 -176.028 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.03 15.14 7.4 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 118.578 -2.576 . . . . 13.93 114.365 165.307 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -103.4 138.33 40.28 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.695 -3.238 . . . . 23.92 108.916 -174.553 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -91.27 114.19 26.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.422 2.289 . . . . 23.23 112.688 173.075 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 mt -74.99 129.47 37.71 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 124.527 1.142 . . . . 9.11 111.576 -171.469 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -71.81 143.34 49.53 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.179 2.659 . . . . 33.44 118.179 172.72 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.416 ' CG ' HH12 ' A' ' 72' ' ' ARG . 61.7 m-20 -53.78 -54.49 37.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.543 3.137 . . . . 28.37 113.302 -169.347 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.86 18.8 55.38 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-O 116.479 -2.29 . . . . 15.0 116.498 -172.321 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -92.92 168.84 10.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.134 1.967 . . . . 25.5 112.206 169.345 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 p -100.81 166.01 11.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 113.974 1.101 . . . . 11.95 113.974 170.488 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.59 -25.31 62.13 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 114.411 -2.709 . . . . 10.17 112.66 -177.044 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -70.07 -31.17 68.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.852 3.261 . . . . 13.59 110.887 176.224 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -67.84 -33.51 74.91 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.154 1.797 . . . . 11.7 111.337 175.962 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.16 13.38 17.17 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.775 -6.203 . . . . 12.95 115.343 166.116 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.73 27.52 14.5 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 114.904 -4.873 . . . . 25.45 114.693 179.334 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.6 121.98 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.973 -3.579 . . . . 14.6 107.127 -174.15 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -109.92 179.08 4.22 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.21 2.604 . . . . 33.23 108.302 -169.653 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -48.76 145.32 3.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.734 1.613 . . . . 25.97 110.733 172.551 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.257 54.0 mt-10 67.64 30.62 6.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.008 -1.906 . . . . 32.61 115.121 165.039 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -108.28 141.48 40.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.234 1.969 . . . . 10.56 110.335 -175.015 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 m -89.13 105.82 18.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.746 -2.024 . . . . 5.33 107.093 -174.789 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.11 148.42 34.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.147 3.379 . . . . 11.66 108.361 158.213 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -115.3 134.5 55.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.933 -1.73 . . . . 16.3 110.209 170.753 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.7 tp -106.67 116.97 32.85 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.96 1.413 . . . . 9.96 109.674 -176.127 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.6 m -127.26 -173.14 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.542 -2.762 . . . . 9.76 103.542 175.699 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.2 mt -100.53 138.24 37.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.859 -1.775 . . . . 19.57 109.996 -173.532 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.416 HH12 ' CG ' ' A' ' 52' ' ' ASP . 59.5 ttt180 -88.7 135.06 33.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.257 2.317 . . . . 35.08 117.257 178.484 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.45 155.46 18.9 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 128.461 2.704 . . . . 32.31 109.263 174.999 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -77.12 143.52 39.11 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.403 -0.591 . . . . 42.75 109.403 154.689 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.62 -67.72 3.68 Favored Glycine 0 N--CA 1.43 -1.745 1 C-N-CA 131.088 4.185 . . . . 36.31 116.424 -174.935 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.762 0 CA-C-N 113.388 -1.406 . . . . 36.27 112.741 -166.361 . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 114.407 1.262 . . . . 17.17 114.407 . . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -109.66 149.51 29.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.086 1.884 . . . . 21.89 116.086 178.84 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -133.08 157.28 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.331 -3.356 . . . . 10.83 112.205 163.6 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -109.29 131.7 54.82 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 128.293 3.496 . . . . 10.61 106.425 179.669 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -135.75 131.81 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 117.071 -3.518 . . . . 9.13 106.986 -176.37 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -103.41 147.13 27.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.126 -2.234 . . . . 20.55 109.738 -179.283 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.6 p -85.48 -178.19 6.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.24 1.495 . . . . 11.78 108.394 172.297 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.06 -47.45 85.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.049 1.74 . . . . 19.31 113.485 172.936 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -93.29 -79.42 0.4 Allowed 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 118.226 -2.796 . . . . 23.14 112.718 -172.408 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.19 63.62 0.32 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 127.157 2.313 . . . . 19.74 115.111 -177.362 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -140.87 129.54 22.84 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.056 1.884 . . . . 21.93 110.825 172.265 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -110.79 109.89 20.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.259 -3.401 . . . . 12.33 103.908 178.41 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 30' ' ' ILE . 1.8 pt -98.88 142.79 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 127.097 2.159 . . . . 17.08 111.692 178.531 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.9 m -115.31 112.47 22.45 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.222 -2.174 . . . . 16.3 110.709 -178.61 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -103.64 155.11 18.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.01 1.862 . . . . 15.88 106.952 -172.278 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.56 121.67 42.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.021 2.343 . . . . 28.9 111.667 165.425 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.462 HG12 ' HE3' ' A' ' 29' ' ' LYS . 5.6 m -134.73 164.88 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 103.082 -2.933 . . . . 12.05 103.082 -175.838 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -120.8 153.42 57.02 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 115.798 -2.049 . . . . 18.17 109.196 165.103 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -67.61 -13.76 39.94 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 124.859 3.706 . . . . 8.16 115.759 -172.612 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 75.2 m -79.73 -2.33 42.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.976 2.91 . . . . 11.13 116.375 166.501 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -74.21 132.93 42.63 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.567 -3.123 . . . . 18.03 102.567 172.734 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.6 p -78.06 154.36 31.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.379 3.072 . . . . 10.22 106.463 165.026 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -69.07 -28.15 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 118.507 -0.759 . . . . 12.3 110.024 178.531 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -51.06 -43.09 60.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 121.523 1.965 . . . . 36.51 113.883 163.529 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -70.48 -33.64 71.48 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.816 1.643 . . . . 25.66 113.132 173.118 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.24 -40.37 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 123.203 1.478 . . . . 8.12 109.477 176.19 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -69.61 -35.27 75.12 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.129 -3.482 . . . . 15.47 114.065 179.257 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.69 -33.66 76.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.02 -2.925 . . . . 11.45 112.541 171.121 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HE3' HG12 ' A' ' 17' ' ' VAL . 35.2 mttm -70.62 -39.49 73.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.357 2.027 . . . . 24.98 108.452 -179.224 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.441 HG12 HD11 ' A' ' 13' ' ' ILE . 45.7 mt -65.68 -38.24 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.263 -1.523 . . . . 9.46 111.105 176.203 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -51.27 -48.95 62.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.99 -3.569 . . . . 14.76 117.098 165.195 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -68.67 -42.04 78.41 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.178 1.808 . . . . 26.29 111.174 178.309 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -68.26 -57.16 6.4 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 123.652 2.933 . . . . 30.06 113.052 -179.947 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -103.46 -19.69 14.32 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.434 2.013 . . . . 25.19 116.434 -161.624 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.63 58.23 3.6 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 128.453 2.93 . . . . 7.41 112.858 176.042 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.2 tt -127.65 136.41 28.92 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 127.353 2.261 . . . . 9.49 108.451 -179.596 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -83.41 161.46 14.93 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 122.922 2.079 . . . . 11.42 107.321 -166.672 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.06 -18.35 10.12 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 CA-C-O 114.264 -2.473 . . . . 12.0 115.546 -170.757 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.259 16.3 t0 -66.41 -42.4 87.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.343 3.857 . . . . 35.55 108.179 176.851 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -65.36 -30.32 71.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.484 -2.635 . . . . 20.52 116.022 174.973 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -82.95 121.52 27.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.621 1.555 . . . . 7.13 113.785 -168.88 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -117.7 101.99 8.78 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 102.99 -2.967 . . . . 36.39 102.99 167.905 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -80.11 113.38 18.23 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.859 1.314 . . . . 9.55 113.745 171.271 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -93.93 127.89 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 118.335 -2.728 . . . . 13.9 111.711 171.555 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -105.54 114.25 28.31 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.276 2.235 . . . . 6.86 107.792 162.793 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.54 -106.51 0.09 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.037 -2.914 . . . . 11.15 110.502 178.38 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.31 20.34 8.44 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 128.67 3.732 . . . . 13.93 116.554 170.957 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -115.52 139.0 50.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 102.348 -3.204 . . . . 23.92 102.348 -173.502 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -89.25 133.46 34.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 111.234 -2.712 . . . . 23.23 110.405 170.633 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.55 133.61 54.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.703 1.601 . . . . 9.11 109.012 -168.278 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -111.08 170.89 7.8 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.73 2.059 . . . . 33.44 113.434 -176.589 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.75 -43.21 38.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.919 2.488 . . . . 28.37 112.399 -156.725 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.84 -2.32 51.01 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 118.81 2.284 . . . . 15.0 118.81 179.149 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -121.12 170.64 9.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.782 -2.599 . . . . 25.5 113.677 -175.91 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -101.74 -172.46 2.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 105.879 -1.897 . . . . 11.95 105.879 -161.228 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.4 ' H ' ' HB ' ' A' ' 55' ' ' THR . 12.4 mt -79.32 -37.5 37.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.118 -1.401 . . . . 10.17 110.782 172.276 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p -61.4 -31.61 71.53 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.787 2.884 . . . . 13.59 118.787 172.173 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.76 -39.05 93.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.319 2.248 . . . . 11.7 109.551 -179.613 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -92.31 -0.17 57.41 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 131.143 3.777 . . . . 12.95 113.785 178.509 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 m120 72.99 35.6 0.95 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.478 2.311 . . . . 25.45 108.761 173.733 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -95.32 114.61 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 125.349 2.499 . . . . 14.6 109.036 -178.079 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -113.44 -179.43 3.64 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 112.357 -6.464 . . . . 33.23 109.307 178.61 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -47.67 147.03 1.99 Allowed 'General case' 0 N--CA 1.43 -1.474 1 N-CA-C 123.952 4.797 . . . . 25.97 123.952 179.339 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 55.88 29.34 13.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.542 -3.849 . . . . 32.61 116.383 -177.091 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -82.38 139.98 33.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.864 -2.017 . . . . 10.56 111.626 174.565 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.9 m -83.49 122.41 28.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.996 2.06 . . . . 5.33 112.605 166.754 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.31 157.1 25.51 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.022 -1.844 . . . . 11.66 106.022 172.132 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -129.45 127.04 40.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.23 1.196 . . . . 16.3 114.23 177.777 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 mt -77.06 120.38 22.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.779 -3.701 . . . . 9.96 112.356 163.893 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.79 -178.85 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 104.87 -2.27 . . . . 9.76 104.87 -170.126 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.8 tp -86.41 119.79 27.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.189 2.18 . . . . 19.57 113.815 172.935 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -98.75 114.21 26.65 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.815 1.783 . . . . 35.08 115.815 177.436 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.8 tp -92.45 139.2 30.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.047 2.939 . . . . 32.31 107.603 167.411 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -81.65 132.63 35.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.681 -1.887 . . . . 42.75 112.841 177.29 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.9 53.14 0.19 Allowed Glycine 0 N--CA 1.43 -1.734 1 C-N-CA 131.021 4.153 . . . . 36.31 108.313 -172.303 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.741 0 C-N-CA 124.749 1.166 . . . . 36.27 111.497 -178.678 . . . . . . . . 0 0 . 1 . 054 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 108.651 -0.87 . . . . 17.17 108.651 . . . . . . . . . 0 0 . 1 . 054 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.262 29.7 mt-30 -94.22 130.26 40.52 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.579 -1.201 . . . . 21.89 113.745 177.742 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -120.35 150.21 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.97 1.708 . . . . 10.83 106.722 170.526 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -106.01 141.73 36.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.713 -2.492 . . . . 10.61 106.681 -172.69 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.49 128.57 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 117.21 -1.796 . . . . 9.13 107.864 -179.462 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -105.62 110.87 23.35 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.719 -4.363 . . . . 20.55 103.631 -173.992 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.1 p -72.41 166.85 21.76 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.132 1.773 . . . . 11.78 107.964 -175.044 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.9 tp -75.43 -41.01 56.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.05 -2.281 . . . . 19.31 113.293 -172.257 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -56.92 -57.82 10.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.373 1.559 . . . . 23.14 112.401 168.194 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.24 68.0 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.834 1.797 . . . . 19.74 114.372 171.765 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -127.79 129.96 47.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.595 -2.709 . . . . 21.93 108.681 165.349 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -81.44 96.29 7.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.141 -0.974 . . . . 12.33 112.366 173.283 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 pt -92.43 142.2 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.583 -1.948 . . . . 17.08 113.793 -178.019 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.4 m -96.08 128.54 43.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.188 -1.57 . . . . 16.3 113.686 178.307 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.3 mt -124.12 133.13 53.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.99 -2.944 . . . . 15.88 107.578 -178.739 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.361 13.7 mt-10 -84.41 113.58 21.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.796 3.238 . . . . 28.9 113.093 162.816 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.83 155.72 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 1 N-CA-C 99.556 -4.239 . . . . 12.05 99.556 175.572 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.46 144.65 32.45 Favored Pre-proline 0 N--CA 1.429 -1.492 1 O-C-N 116.229 -4.044 . . . . 18.17 105.482 163.764 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -78.16 4.67 6.01 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-O 113.662 -2.724 . . . . 8.16 117.022 -175.97 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.1 m -91.52 -9.61 43.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.594 3.361 . . . . 11.13 110.958 171.411 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -80.19 171.0 15.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 125.262 3.664 . . . . 18.03 109.353 -179.318 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.7 p -80.75 159.03 25.31 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 133.274 4.629 . . . . 10.22 113.526 173.445 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.275 31.0 mm -67.13 -17.02 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 125.007 2.337 . . . . 12.3 111.031 -179.409 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -55.22 -37.26 66.92 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 116.146 -4.096 . . . . 36.51 117.495 171.711 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -67.43 -41.61 84.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.189 2.996 . . . . 25.66 112.435 169.644 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.41 -43.73 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.274 -2.766 . . . . 8.12 111.188 174.224 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.258 79.8 mttt -62.89 -39.03 93.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.78 -2.45 . . . . 15.47 111.277 172.84 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.13 86.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.628 1.971 . . . . 11.45 111.309 -178.768 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -61.78 -37.59 84.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.739 2.126 . . . . 24.98 116.739 169.203 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mt -72.84 -32.16 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 118.939 -1.104 . . . . 9.46 109.568 170.615 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -58.95 -48.41 81.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 116.388 -3.945 . . . . 14.76 113.389 172.136 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.48 -39.43 90.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 131.307 3.843 . . . . 26.29 110.713 -177.376 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -75.9 -55.1 5.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.617 3.191 . . . . 30.06 119.617 174.994 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -104.68 -37.87 6.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 114.129 -2.843 . . . . 25.19 111.066 -167.254 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.28 10.68 31.16 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 122.684 2.493 . . . . 7.41 110.205 173.858 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.477 HD13 HD21 ' A' ' 69' ' ' LEU 0.368 14.1 tt -75.47 115.38 45.06 Favored Pre-proline 0 N--CA 1.429 -1.501 0 C-N-CA 130.683 3.593 . . . . 9.49 116.834 169.839 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.66 159.26 21.93 Favored 'Trans proline' 0 N--CA 1.434 -2.027 2 CA-C-N 130.411 4.754 . . . . 11.42 110.351 -172.378 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -62.12 -22.61 74.5 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 124.954 3.769 . . . . 12.0 114.715 -168.827 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.5 ' CG ' HH22 ' A' ' 74' ' ' ARG . 27.7 t70 -65.83 -36.26 82.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.334 1.453 . . . . 35.55 111.937 -175.805 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -91.57 -15.63 28.37 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.68 3.133 . . . . 20.52 110.493 -171.525 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -77.85 131.24 37.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.215 -2.803 . . . . 7.13 116.451 170.756 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -120.8 122.4 40.25 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.386 -3.321 . . . . 36.39 108.701 162.518 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.9 mt -114.03 105.44 13.22 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.796 -2.44 . . . . 9.55 111.85 -171.728 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -90.27 136.51 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 127.773 2.429 . . . . 13.9 112.194 179.639 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -122.83 94.01 4.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.415 2.286 . . . . 6.86 106.657 -178.951 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.297 . . 73.44 -77.75 0.05 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.565 -2.584 . . . . 11.15 111.23 -172.517 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.29 16.76 0.59 Allowed Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 114.214 -1.357 . . . . 13.93 111.889 -177.757 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -120.98 164.67 16.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.442 3.097 . . . . 23.92 113.391 170.845 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -119.29 120.53 37.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 122.183 -0.323 . . . . 23.23 110.699 -167.441 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.59 147.86 28.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.511 2.1 . . . . 9.11 110.897 -167.535 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -110.8 167.12 10.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.647 -2.533 . . . . 33.44 104.749 -168.17 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.16 -66.72 0.69 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 122.989 1.376 . . . . 28.37 113.682 -169.038 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.63 18.64 2.22 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 116.394 1.318 . . . . 15.0 116.394 -170.472 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -115.94 154.95 28.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.938 -2.615 . . . . 25.5 103.938 -176.151 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -87.67 146.28 25.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.605 3.557 . . . . 11.95 120.605 -179.456 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.04 -43.72 74.01 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 118.712 2.856 . . . . 10.17 118.712 173.717 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 p -66.26 -33.45 75.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.996 2.591 . . . . 13.59 117.996 170.052 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.77 -36.46 80.54 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 122.607 2.458 . . . . 11.7 112.663 177.038 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -69.62 -18.03 63.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.808 3.243 . . . . 12.95 113.817 174.808 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 65.09 51.69 1.63 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.51 1.524 . . . . 25.45 111.822 -174.801 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -94.7 111.41 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-O 123.62 1.676 . . . . 14.6 108.392 174.92 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -101.72 165.62 11.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 111.5 -2.591 . . . . 33.23 108.98 -162.775 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -61.73 133.85 56.05 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.628 -2.545 . . . . 25.97 116.298 178.729 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 49.9 mt-10 71.59 25.41 3.34 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.289 2.329 . . . . 32.61 117.289 -177.539 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -94.29 146.29 24.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.676 2.472 . . . . 10.56 117.676 174.94 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -104.32 116.93 33.02 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.996 -4.19 . . . . 5.33 108.931 -163.737 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.37 132.59 36.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.867 2.467 . . . . 11.66 110.088 167.636 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -81.93 127.79 33.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.16 -3.462 . . . . 16.3 116.173 159.747 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 36' ' ' ILE . 60.7 tp -94.79 103.03 14.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 125.129 1.518 . . . . 9.96 110.695 159.013 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.38 -177.05 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 117.819 -1.552 . . . . 9.76 107.252 -179.676 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.4 tp -76.68 138.04 39.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 110.798 -2.91 . . . . 19.57 107.282 170.73 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -92.97 125.36 37.53 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.746 -3.096 . . . . 35.08 112.335 173.141 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.3 mt -104.5 132.34 50.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.298 -2.126 . . . . 32.31 107.801 166.137 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.5 HH22 ' CG ' ' A' ' 39' ' ' ASP . 21.8 mmt180 -80.41 139.46 36.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.276 3.43 . . . . 42.75 107.331 -176.452 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.77 -75.51 0.26 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 118.184 -2.823 . . . . 36.31 106.19 -166.357 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.778 1 C-N-CA 134.18 5.657 . . . . 36.27 111.66 -178.79 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.49 -1.344 0 CA-C-O 122.832 1.301 . . . . 17.17 107.949 . . . . . . . . . 0 0 . 1 . 055 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -87.67 135.83 33.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.929 2.196 . . . . 21.89 116.929 160.752 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -125.99 142.41 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 128.739 2.815 . . . . 10.83 105.694 -175.223 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -102.45 143.09 32.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.897 1.808 . . . . 10.61 106.713 175.917 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.8 t -124.46 130.94 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.311 -1.768 . . . . 9.13 110.777 162.811 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -96.2 126.19 41.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.791 1.632 . . . . 20.55 111.261 168.099 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 69' ' ' LEU 0.259 72.2 p -89.73 176.26 6.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.67 3.188 . . . . 11.78 114.36 -171.168 . . . . . . . . 3 3 . 1 . 055 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.423 HD22 HD21 ' A' ' 71' ' ' LEU . 51.0 tp -79.48 -54.93 5.43 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.264 -2.148 . . . . 19.31 112.613 -178.174 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -38.06 -72.34 0.06 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.312 2.708 . . . . 23.14 118.312 161.418 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.84 45.79 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.232 -3.418 . . . . 19.74 112.944 167.771 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -119.08 149.25 42.0 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.485 -1.302 . . . . 21.93 107.485 179.717 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.2 m -110.26 101.15 9.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.254 -2.499 . . . . 12.33 104.254 171.405 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.411 HD11 HG12 ' A' ' 30' ' ' ILE . 28.6 pt -94.86 126.3 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 127.256 3.408 . . . . 17.08 112.193 -176.389 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.275 3.2 m -74.91 114.4 13.32 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.332 -3.355 . . . . 16.3 117.369 161.994 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.42 149.16 44.21 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 116.014 -4.179 . . . . 15.88 106.623 174.475 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -102.4 125.75 49.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.509 2.576 . . . . 28.9 108.621 -178.291 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.536 HG11 HG22 ' A' ' 26' ' ' VAL . 8.9 m -147.77 165.1 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 118.492 -2.63 . . . . 12.05 106.945 -178.118 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -102.28 170.84 5.88 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 125.675 2.655 . . . . 18.17 110.093 161.852 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -56.89 -41.68 72.7 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 114.801 -3.315 . . . . 8.16 117.374 166.46 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.2 p -70.68 -3.51 18.84 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.591 2.757 . . . . 11.13 115.223 176.239 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -83.88 153.54 23.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.32 -2.113 . . . . 18.03 113.894 167.552 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.6 p -95.16 176.53 6.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.689 -3.757 . . . . 10.22 115.846 -172.493 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mm -66.55 -43.55 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.86 -2.4 . . . . 12.3 107.607 173.923 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -47.82 -46.09 30.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.795 2.517 . . . . 36.51 117.795 168.535 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -75.75 -28.72 58.58 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.99 -1.068 . . . . 25.66 110.26 -178.685 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.536 HG22 HG11 ' A' ' 17' ' ' VAL . 83.9 t -59.65 -54.54 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.666 -3.146 . . . . 8.12 110.881 169.867 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -58.74 -24.32 61.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.545 -1.972 . . . . 15.47 115.951 179.159 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.253 . . -76.4 -28.29 56.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.321 -0.862 . . . . 11.45 111.29 -177.738 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -68.83 -49.25 60.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.186 2.595 . . . . 24.98 105.346 176.901 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 13' ' ' ILE . 39.9 mt -61.42 -39.32 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 127.89 3.709 . . . . 9.46 114.261 -178.533 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.4 -39.7 80.39 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.124 -4.11 . . . . 14.76 115.647 171.517 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -67.31 -70.41 0.25 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.436 -1.69 . . . . 26.29 106.436 178.149 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -77.8 -33.87 52.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.708 2.114 . . . . 30.06 116.708 -161.277 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -99.22 -63.13 1.15 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 120.991 1.723 . . . . 25.19 109.248 179.203 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.94 89.02 1.22 Allowed Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.505 -1.997 . . . . 7.41 111.61 174.501 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.418 ' CD1' HD21 ' A' ' 69' ' ' LEU . 38.5 mt -146.18 128.45 7.81 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 115.856 -2.021 . . . . 9.49 106.898 179.669 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -61.49 145.5 97.88 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 125.132 2.869 . . . . 11.42 117.998 176.681 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -79.26 -15.34 12.78 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 123.568 2.845 . . . . 12.0 116.252 -166.506 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.35 -35.07 25.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.113 1.911 . . . . 35.55 108.748 174.545 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -72.86 -30.06 63.69 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.576 -3.828 . . . . 20.52 108.896 -179.737 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -64.57 134.95 55.42 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.225 -2.797 . . . . 7.13 115.953 173.787 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -129.08 114.8 16.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.775 2.226 . . . . 36.39 112.299 167.907 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.87 119.8 33.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.453 -3.067 . . . . 9.55 112.643 179.709 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.9 130.74 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 123.575 1.655 . . . . 13.9 108.597 -179.816 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -111.19 104.96 13.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.534 2.587 . . . . 6.86 113.204 166.051 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.292 . . 71.6 -83.82 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.219 -3.425 . . . . 11.15 109.575 -168.489 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.59 28.82 0.85 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 107.847 -2.101 . . . . 13.93 107.847 166.624 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -107.53 111.89 24.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.366 -2.457 . . . . 23.92 104.366 175.911 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -70.32 130.39 41.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.687 2.184 . . . . 23.23 109.359 176.852 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -91.7 123.86 35.41 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.369 -1.287 . . . . 9.11 114.155 -171.391 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -74.79 136.85 41.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 116.467 2.025 . . . . 33.44 116.467 173.198 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -39.29 -60.83 0.86 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.351 2.723 . . . . 28.37 118.351 175.38 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.52 -10.19 47.8 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 117.057 -3.527 . . . . 15.0 121.2 -177.936 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -96.1 165.02 12.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 120.53 2.165 . . . . 25.5 114.803 -172.298 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.5 p -88.57 158.51 18.26 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.929 -4.232 . . . . 11.95 109.271 -172.073 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.518 HD21 HG21 ' A' ' 26' ' ' VAL . 1.6 mt -62.74 -40.45 97.25 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.61 -0.723 . . . . 10.17 111.978 171.101 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 p -47.85 -36.72 12.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.735 -2.478 . . . . 13.59 116.755 168.981 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.3 -42.08 65.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.825 1.65 . . . . 11.7 108.532 -166.679 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -84.15 0.52 48.27 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.904 -1.747 . . . . 12.95 111.533 179.937 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.8 m120 73.03 41.68 0.49 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.043 0.937 . . . . 25.45 108.908 174.142 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.5 mt -85.85 122.18 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 116.877 -1.535 . . . . 14.6 113.392 177.577 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -112.75 175.31 5.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 119.429 1.013 . . . . 33.23 111.86 -175.125 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.295 19.2 pttp -66.3 151.33 47.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.523 3.058 . . . . 25.97 108.916 175.763 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 63.35 4.58 1.73 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 120.09 3.367 . . . . 32.61 120.09 -172.22 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -72.08 162.21 29.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.297 -1.774 . . . . 10.56 107.265 172.601 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.8 m -130.64 121.34 25.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.844 -1.551 . . . . 5.33 108.994 -177.074 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.1 mt -92.51 150.33 20.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.739 2.685 . . . . 11.66 112.422 172.62 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -108.46 127.68 54.13 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.845 -3.659 . . . . 16.3 110.149 -178.088 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' A' ' 36' ' ' ILE . 53.6 tp -94.2 103.81 15.84 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.181 -0.918 . . . . 9.96 112.309 -171.963 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.317 18.4 m -116.98 -169.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 106.369 -1.715 . . . . 9.76 106.369 -174.981 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.423 HD21 HD22 ' A' ' 8' ' ' LEU . 8.7 mt -112.83 147.56 36.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.97 1.708 . . . . 19.57 110.285 -168.46 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -98.54 123.27 42.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.571 -1.33 . . . . 35.08 111.23 176.507 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.8 mt -111.07 166.29 11.18 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 127.787 2.435 . . . . 32.31 106.852 175.235 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.469 68.8 mtt-85 -70.99 155.94 40.23 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 126.013 2.071 . . . . 42.75 115.639 -168.831 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.14 -72.5 0.25 Allowed Glycine 0 N--CA 1.43 -1.767 0 CA-C-N 122.522 2.419 . . . . 36.31 113.023 178.868 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.706 0 CA-C-O 124.735 2.297 . . . . 36.27 112.969 -168.614 . . . . . . . . 0 0 . 1 . 056 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.512 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 4.9 ptm . . . . . 0 CA--C 1.49 -1.336 0 N-CA-C 118.434 2.753 . . . . 17.17 118.434 . . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -87.47 125.62 34.41 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.744 -1.848 . . . . 21.89 107.089 -174.897 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.0 pt -115.91 163.69 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 112.069 -2.332 . . . . 10.83 107.168 174.034 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -124.72 132.94 53.34 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.147 2.579 . . . . 10.61 106.532 -177.354 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.24 117.63 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 121.142 -0.974 . . . . 9.13 109.57 176.661 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -109.94 141.22 43.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.341 -2.724 . . . . 20.55 115.745 -179.62 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.4 p -83.59 -171.87 3.83 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.295 1.22 . . . . 11.78 114.295 179.744 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 tp -72.62 -35.07 67.74 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.729 -3.107 . . . . 19.31 109.802 -178.34 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 p -87.15 -49.16 7.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 104.247 -2.501 . . . . 23.14 104.247 -178.083 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.98 59.48 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 117.403 -1.776 . . . . 19.74 116.599 166.156 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -96.51 125.41 40.98 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.706 -3.442 . . . . 21.93 101.706 166.687 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -105.23 122.37 45.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.976 -2.601 . . . . 12.33 103.976 -175.853 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 pt -108.49 130.76 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 125.808 2.718 . . . . 17.08 116.06 168.759 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -86.34 116.45 24.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.664 -3.772 . . . . 16.3 107.915 179.513 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.0 mt -121.39 156.38 32.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.906 -2.371 . . . . 15.88 109.319 -179.341 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -130.98 129.99 42.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.097 -2.557 . . . . 28.9 104.097 179.995 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -148.57 179.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.882 1.673 . . . . 12.05 108.652 177.009 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 17.9 mm-40 -107.58 169.14 7.01 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 119.677 -1.889 . . . . 18.17 107.533 174.953 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 43.7 Cg_endo -83.67 -2.24 10.33 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 124.712 3.608 . . . . 8.16 113.021 -173.103 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.273 73.4 m -101.68 -0.44 34.6 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 126.266 2.229 . . . . 11.13 110.499 174.14 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.4 145.15 49.52 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.396 -3.315 . . . . 18.03 110.099 173.029 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -79.63 164.51 23.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.066 -2.271 . . . . 10.22 113.848 173.038 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -57.21 -38.52 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 126.668 1.987 . . . . 12.3 109.604 171.08 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.65 -51.97 19.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.001 1.721 . . . . 36.51 114.066 167.943 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -72.65 -12.38 61.01 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.458 1.503 . . . . 25.66 114.288 176.565 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.4 t -80.03 -50.05 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 104.165 -2.531 . . . . 8.12 104.165 172.668 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.298 62.7 mttt -47.78 -38.65 16.12 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.415 2.686 . . . . 15.47 113.875 170.039 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.56 -44.34 93.31 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.672 2.789 . . . . 11.45 115.136 -178.271 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -69.89 -40.4 75.68 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.814 2.846 . . . . 24.98 107.731 178.307 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.45 -33.58 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 124.454 1.096 . . . . 9.46 109.153 179.484 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.42 -44.03 92.95 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.153 -2.217 . . . . 14.76 114.139 172.708 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -59.7 -61.21 2.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.572 1.949 . . . . 26.29 113.855 171.727 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.99 -52.02 67.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 121.059 3.725 . . . . 30.06 121.059 -179.991 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -108.97 -29.87 8.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.584 1.327 . . . . 25.19 114.584 -157.584 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.19 41.21 8.11 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.201 -1.16 . . . . 7.41 110.201 177.244 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.1 mt -102.73 120.06 53.89 Favored Pre-proline 0 N--CA 1.431 -1.424 0 CA-C-O 115.461 -2.209 . . . . 9.49 111.678 169.055 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 95.1 Cg_exo -59.14 146.25 95.06 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 CA-C-N 126.305 3.287 . . . . 11.42 114.227 172.424 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -59.24 -29.53 90.59 Favored 'Trans proline' 0 C--N 1.299 -2.027 1 C-N-CA 125.333 4.022 . . . . 12.0 116.438 179.93 . . . . . . . . 4 4 . 1 . 056 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.9 -42.37 94.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.988 -3.57 . . . . 35.55 113.266 168.851 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.403 ' HG2' HD22 ' A' ' 71' ' ' LEU 0.287 12.7 tt0 -64.95 -35.17 80.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.748 2.019 . . . . 20.52 112.618 173.092 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -81.14 136.81 35.94 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.418 -2.676 . . . . 7.13 115.647 -177.462 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -128.94 117.46 21.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 128.062 3.351 . . . . 36.39 110.031 167.077 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.8 mt -91.68 121.91 33.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.493 -1.717 . . . . 9.55 109.24 179.599 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mt -111.05 133.27 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 124.525 3.329 . . . . 13.9 108.262 178.041 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -115.38 107.59 15.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.148 2.979 . . . . 6.86 107.147 172.196 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 63.38 -96.07 0.05 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.331 2.652 . . . . 11.15 111.823 -166.545 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.71 -5.5 9.11 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.675 1.708 . . . . 13.93 109.541 -178.372 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -98.75 126.55 44.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.49 -3.947 . . . . 23.92 105.985 -166.832 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -90.61 141.31 28.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 127.712 3.625 . . . . 23.23 106.344 176.071 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.365 97.1 mt -104.52 133.77 48.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.748 -3.72 . . . . 9.11 114.312 -168.827 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -74.63 154.83 38.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.687 2.395 . . . . 33.44 112.231 174.881 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -73.16 -55.57 6.29 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 130.053 3.341 . . . . 28.37 112.346 -167.131 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.73 18.47 30.09 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 119.136 2.415 . . . . 15.0 119.136 -172.766 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -114.01 146.6 39.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.606 2.146 . . . . 25.5 109.897 169.763 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.264 73.3 p -75.99 162.82 27.74 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 128.937 2.895 . . . . 11.95 116.866 -179.105 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.9 mt -58.43 -49.57 76.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 128.807 3.817 . . . . 10.17 109.92 174.873 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.357 88.9 p -57.54 -43.96 84.77 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.795 3.238 . . . . 13.59 119.487 178.698 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -53.81 -53.42 52.58 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 121.588 3.921 . . . . 11.7 121.588 162.924 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -62.44 -21.01 65.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.66 2.467 . . . . 12.95 117.66 169.325 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.347 58.2 t30 60.04 67.64 0.85 Allowed 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.508 2.04 . . . . 25.45 116.508 -161.556 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -118.5 117.39 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.5 -2.778 . . . . 14.6 103.5 170.198 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.35 -163.15 1.01 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.48 2.562 . . . . 33.23 112.685 -175.536 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 38.1 pttt -76.0 156.71 33.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.213 -3.43 . . . . 25.97 115.427 168.548 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.85 23.33 13.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.31 2.244 . . . . 32.61 110.741 176.663 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -85.36 122.53 29.65 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.071 1.748 . . . . 10.56 113.335 175.631 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.9 m -88.52 98.9 11.91 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 116.132 -1.89 . . . . 5.33 112.498 170.667 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.96 140.04 29.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.704 2.002 . . . . 11.66 109.015 -179.966 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -98.64 107.61 20.1 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.428 -1.42 . . . . 16.3 113.49 -173.267 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -82.88 109.78 17.31 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 129.156 2.982 . . . . 9.96 112.368 -177.172 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.9 m -121.58 161.76 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 116.726 -3.733 . . . . 9.76 106.912 177.981 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.403 HD22 ' HG2' ' A' ' 40' ' ' GLN . 29.8 mt -81.28 138.67 35.71 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.591 -1.263 . . . . 19.57 107.591 -173.087 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -109.78 107.38 17.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.579 2.751 . . . . 35.08 104.525 171.048 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.404 ' HB3' ' H ' ' A' ' 74' ' ' ARG . 1.2 mm? -91.35 -142.68 0.18 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.303 -3.998 . . . . 32.31 108.778 168.951 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.404 ' H ' ' HB3' ' A' ' 73' ' ' LEU . 32.6 mmt180 -96.11 171.93 8.3 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.202 1.953 . . . . 42.75 108.379 174.03 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.4 -62.74 4.04 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 111.496 -2.593 . . . . 36.31 115.428 -170.876 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 C-N-CA 115.121 -3.418 . . . . 36.27 110.618 -176.13 . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 13.6 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 106.484 -1.672 . . . . 17.17 106.484 . . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.273 4.2 pt20 -113.28 127.69 56.23 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.712 -2.493 . . . . 21.89 112.773 176.189 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -120.34 174.48 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 125.293 2.473 . . . . 10.83 108.102 171.883 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -120.96 145.9 47.23 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 112.744 -2.026 . . . . 10.61 109.802 -176.78 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.99 122.53 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 107.402 -1.333 . . . . 9.13 107.402 173.218 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -136.05 142.21 44.37 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.394 -3.941 . . . . 20.55 115.338 -164.33 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.278 80.7 p -80.85 -171.5 3.2 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 126.533 3.064 . . . . 11.78 110.03 -170.612 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.89 -40.5 60.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 131.556 3.943 . . . . 19.31 114.266 166.945 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.18 -47.6 49.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.544 -3.223 . . . . 23.14 111.031 173.606 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.91 35.91 0.23 Allowed Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 114.637 -3.313 . . . . 19.74 115.593 172.782 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -88.03 121.58 30.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 113.746 -3.026 . . . . 21.93 110.701 178.784 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -108.19 137.57 45.94 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 121.695 2.043 . . . . 12.33 114.037 -172.331 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.1 pt -124.6 136.78 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 118.532 -1.267 . . . . 17.08 107.804 172.776 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.3 m -82.81 120.89 26.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.176 3.39 . . . . 16.3 108.564 168.862 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -115.17 132.73 56.51 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.966 -2.334 . . . . 15.88 107.123 174.504 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -107.82 115.09 29.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.191 -2.818 . . . . 28.9 108.762 -178.681 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.31 162.04 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 124.559 1.162 . . . . 12.05 109.473 -166.928 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -90.7 155.08 45.89 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 120.374 -1.454 . . . . 18.17 107.444 159.512 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -60.95 -23.39 77.17 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 122.722 2.282 . . . . 8.16 112.674 168.536 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 m -69.39 -18.32 63.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.003 2.638 . . . . 11.13 113.498 173.427 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -65.53 147.15 53.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.525 2.875 . . . . 18.03 108.574 179.162 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -85.08 172.91 10.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.933 1.827 . . . . 10.22 115.933 179.061 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 13.1 mm -78.15 -27.11 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 124.053 0.846 . . . . 12.3 109.326 178.432 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -50.81 -59.54 4.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.386 -2.188 . . . . 36.51 114.143 167.634 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.468 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 7.3 t-20 -55.14 -45.77 75.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.98 3.712 . . . . 25.66 109.984 176.082 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -60.4 -50.32 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.363 -2.086 . . . . 8.12 113.156 -176.508 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -63.39 -37.19 86.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.014 1.864 . . . . 15.47 110.354 176.584 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.38 -13.12 36.05 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.324 -4.61 . . . . 11.45 114.206 174.726 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 13.7 mtpt -80.04 -49.24 12.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.909 -2.994 . . . . 24.98 117.487 169.189 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.9 mt -60.23 -30.26 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 126.096 2.855 . . . . 9.46 112.523 171.944 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -70.7 -43.35 69.17 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.346 -3.971 . . . . 14.76 117.143 172.969 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.33 -49.53 74.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.793 2.516 . . . . 26.29 117.793 159.313 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -79.94 -74.73 0.29 Allowed 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 116.266 -4.021 . . . . 30.06 111.274 -176.606 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -64.94 -43.3 93.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 120.322 1.419 . . . . 25.19 113.824 -173.509 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.69 68.83 1.19 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 107.06 -2.416 . . . . 7.41 107.06 179.53 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.8 128.44 23.87 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-N 113.393 -1.403 . . . . 9.49 108.644 176.643 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -66.69 143.53 68.3 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-O 114.342 -2.441 . . . . 11.42 115.015 -174.596 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.81 -14.69 42.34 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 122.841 2.361 . . . . 12.0 113.027 -163.68 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -95.96 -22.31 17.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 123.021 2.646 . . . . 35.55 110.318 -179.66 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.378 32.9 mt-30 -71.47 -22.6 61.8 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 117.645 -1.169 . . . . 20.52 112.87 164.355 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -79.33 124.58 28.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.955 -2.609 . . . . 7.13 103.955 175.601 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 52.6 mtp180 -110.89 122.13 47.09 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.978 3.311 . . . . 36.39 109.685 156.217 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.3 mt -113.78 133.23 55.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.368 2.509 . . . . 9.55 105.435 178.101 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 mm -130.39 119.4 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 111.033 -2.803 . . . . 13.9 103.733 -163.244 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -93.98 108.88 20.65 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.453 1.501 . . . . 6.86 110.773 158.194 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.53 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.48 -2.637 . . . . 11.15 112.118 179.825 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.88 36.72 1.21 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 126.192 1.853 . . . . 13.93 110.756 165.965 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -108.28 123.74 49.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.5 -2.177 . . . . 23.92 113.68 162.581 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -81.57 136.07 35.57 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.186 -3.446 . . . . 23.23 109.386 166.246 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.73 127.98 35.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.776 1.231 . . . . 9.11 111.071 179.595 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -78.43 133.14 37.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.954 2.576 . . . . 33.44 117.954 -178.214 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 47.1 m-20 -49.14 -45.37 43.6 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.363 -3.335 . . . . 28.37 116.288 -168.129 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.73 4.49 75.8 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-N 119.981 1.264 . . . . 15.0 112.586 -169.107 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.3 40.0 mtt180 -95.19 166.17 12.04 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.069 -3.607 . . . . 25.5 109.262 -178.495 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.8 p -92.66 156.24 17.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.161 -2.212 . . . . 11.95 106.475 -178.516 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.4 mt -51.14 -45.25 61.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.971 -3.581 . . . . 10.17 113.726 164.7 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.4 t -57.12 -36.6 70.85 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.826 2.051 . . . . 13.59 108.316 -177.391 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -64.59 -30.9 71.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.289 -2.132 . . . . 11.7 113.512 -167.486 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -87.27 0.61 55.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.165 -1.38 . . . . 12.95 113.044 178.423 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 62.23 49.21 4.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.837 1.655 . . . . 25.45 112.605 -178.742 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.94 112.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.895 2.478 . . . . 14.6 109.85 172.037 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -84.68 -162.57 0.7 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.375 2.036 . . . . 33.23 112.222 178.087 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 22.5 pttp -88.06 164.86 15.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.779 -3.7 . . . . 25.97 111.141 172.815 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.381 37.3 mt-10 73.54 1.1 3.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.683 1.593 . . . . 32.61 112.439 173.7 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.346 8.7 t -88.06 140.13 29.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.363 -2.71 . . . . 10.56 112.277 -168.581 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.0 m -100.68 113.93 27.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 126.059 2.837 . . . . 5.33 108.826 -178.507 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.1 mt -87.6 144.99 26.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.515 2.783 . . . . 11.66 118.515 165.519 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -96.39 120.59 36.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.318 -3.989 . . . . 16.3 112.501 179.522 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 tp -94.08 120.99 35.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.167 -2.288 . . . . 9.96 110.43 -177.325 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 44.1 t -118.27 138.22 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 129.735 3.214 . . . . 9.76 111.254 -173.56 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.3 tp -96.35 151.29 19.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.867 2.604 . . . . 19.57 106.535 176.615 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -118.14 139.94 50.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 117.657 -1.164 . . . . 35.08 108.418 148.583 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.264 77.7 mt -73.38 167.74 20.63 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.407 2.942 . . . . 32.31 115.434 173.071 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -78.38 143.61 36.69 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.765 1.745 . . . . 42.75 110.299 172.398 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.5 84.85 1.83 Allowed Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 106.718 -2.553 . . . . 36.31 106.718 -178.693 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 CA-C-N 113.086 -1.557 . . . . 36.27 110.96 177.518 . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.491 -1.325 0 CA-C-O 121.382 0.61 . . . . 17.17 109.687 . . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.92 133.76 35.78 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.139 -3.475 . . . . 21.89 112.836 171.012 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -118.94 147.89 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 128.599 4.047 . . . . 10.83 116.021 164.664 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -97.17 128.16 43.81 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.893 -3.63 . . . . 10.61 108.323 176.391 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -118.58 131.61 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.153 -2.536 . . . . 9.13 104.153 173.214 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -105.82 157.17 17.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.331 -3.355 . . . . 20.55 109.607 173.749 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 56.1 p -99.79 178.32 4.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.742 3.217 . . . . 11.78 109.403 175.517 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.4 tp -77.2 -36.9 54.46 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.517 -2.614 . . . . 19.31 110.84 178.744 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -38.18 72.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.96 -1.713 . . . . 23.14 111.991 160.662 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.51 33.72 2.23 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 117.382 1.713 . . . . 19.74 117.382 171.529 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -80.8 119.44 23.38 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.919 2.487 . . . . 21.93 105.807 -179.775 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -81.34 104.51 11.84 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.693 3.121 . . . . 12.33 116.578 169.833 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 pt -100.83 147.4 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 124.622 1.169 . . . . 17.08 112.583 174.587 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 m -111.28 99.47 8.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.816 -2.291 . . . . 16.3 104.816 -172.248 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.7 mt -97.33 118.67 34.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.799 -3.688 . . . . 15.88 110.412 179.288 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -80.82 128.37 33.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.734 -1.229 . . . . 28.9 108.142 165.302 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 m -147.72 164.35 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 103.794 -2.669 . . . . 12.05 103.794 -178.48 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -105.81 140.72 21.49 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 116.44 -1.743 . . . . 18.17 109.103 171.91 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.44 -5.71 11.79 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 124.767 2.738 . . . . 8.16 113.036 -167.046 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.4 p -69.28 -26.2 64.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.744 0.818 . . . . 11.13 112.483 169.522 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -75.73 178.28 6.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.522 2.415 . . . . 18.03 117.522 174.935 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 9.2 p -106.76 178.8 4.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.719 -3.113 . . . . 10.22 111.617 -165.71 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 11.3 mm -69.81 -35.47 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 116.854 -3.654 . . . . 12.3 114.261 168.479 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -52.31 -44.59 65.16 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 117.124 -1.417 . . . . 36.51 114.431 167.051 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -52.49 -49.36 64.89 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 114.947 -2.454 . . . . 25.66 114.612 163.477 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.18 -43.34 97.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 122.091 2.223 . . . . 8.12 109.37 -177.084 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.66 -35.54 70.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.161 2.282 . . . . 15.47 117.161 172.883 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' ASP . . . -70.21 -25.65 63.51 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 126.898 3.237 . . . . 11.45 116.968 170.662 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -75.2 -27.35 59.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.792 -2.458 . . . . 24.98 111.786 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -80.47 -37.51 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 118.057 -2.902 . . . . 9.46 107.923 178.851 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.11 -52.49 62.4 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 115.205 -2.331 . . . . 14.76 107.769 -178.773 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 2.2 t0 -52.99 -45.52 67.88 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.981 2.912 . . . . 26.29 113.495 173.362 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -74.33 -95.84 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.277 4.231 . . . . 30.06 112.643 176.879 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -71.36 -9.41 58.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.122 2.237 . . . . 25.19 111.449 -162.608 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.46 52.66 5.92 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.51 -1.994 . . . . 7.41 117.105 179.975 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.68 110.62 22.69 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.086 -2.864 . . . . 9.49 106.321 -170.876 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.06 147.03 92.24 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 128.782 4.172 . . . . 11.42 111.531 -177.58 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -75.12 -8.19 19.72 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 121.397 1.398 . . . . 12.0 112.925 -161.943 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -74.81 -39.86 61.43 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.201 1.953 . . . . 35.55 115.167 -174.299 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -66.95 -28.05 67.96 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 132.691 4.397 . . . . 20.52 114.913 173.12 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.4 117.54 12.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.955 2.788 . . . . 7.13 114.489 -169.969 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -111.55 98.37 7.4 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.512 -3.243 . . . . 36.39 107.499 176.727 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.05 122.3 33.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 111.779 -2.464 . . . . 9.55 111.59 176.466 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mm -112.26 144.37 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 124.119 1.914 . . . . 13.9 110.424 -177.887 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -123.31 114.17 19.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.854 2.74 . . . . 6.86 107.962 161.394 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.306 . . 70.6 -88.05 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.677 -2.514 . . . . 11.15 115.889 -177.046 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.22 8.28 2.13 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 126.4 1.952 . . . . 13.93 110.291 165.073 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -88.29 149.96 23.51 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 114.704 -4.998 . . . . 23.92 108.173 168.5 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -109.96 146.99 34.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.961 -3.348 . . . . 23.23 101.961 -179.02 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.9 mt -104.25 137.87 41.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.589 1.699 . . . . 9.11 115.589 -171.819 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 19.4 tp10 -97.4 155.46 16.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 120.524 1.511 . . . . 33.44 112.735 -169.661 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 22' ' ' THR . 15.0 m-20 -69.52 -61.39 1.81 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.374 1.25 . . . . 28.37 114.374 -162.448 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.16 42.46 2.74 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 117.08 1.592 . . . . 15.0 117.08 -179.962 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -131.59 154.93 48.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 119.141 1.47 . . . . 25.5 107.44 175.393 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -88.67 146.22 25.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 121.325 3.824 . . . . 11.95 121.325 -176.913 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.7 mt -54.74 -38.19 66.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.078 1.751 . . . . 10.17 114.984 171.854 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -51.62 -55.19 20.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.486 3.143 . . . . 13.59 119.486 166.861 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.74 -49.12 73.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.796 2.438 . . . . 11.7 115.093 176.923 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -71.53 -6.55 41.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.339 3.456 . . . . 12.95 112.825 173.72 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 54.32 44.21 29.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.949 2.203 . . . . 25.45 116.949 -179.961 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.0 120.55 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 129.593 3.157 . . . . 14.6 105.179 171.763 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -103.68 170.38 7.97 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.955 -1.716 . . . . 33.23 109.555 -178.205 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -47.06 141.12 4.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.506 2.378 . . . . 25.97 110.863 167.355 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 66.6 mt-10 51.9 20.37 1.19 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.818 2.896 . . . . 32.61 118.818 -175.674 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 t -75.18 165.21 25.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.078 2.551 . . . . 10.56 110.815 171.901 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.5 m -122.47 101.77 7.69 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 112.877 -3.44 . . . . 5.33 108.021 -164.496 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.94 156.98 19.59 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 125.661 1.851 . . . . 11.66 110.506 163.313 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -118.73 119.9 35.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.019 -2.301 . . . . 16.3 112.817 -177.452 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.39 98.45 11.49 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.505 -2.622 . . . . 9.96 111.42 -175.969 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.48 156.84 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 125.386 1.679 . . . . 9.76 110.198 167.652 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.2 mt -136.26 139.86 43.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.321 -2.112 . . . . 19.57 111.645 -172.871 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -112.42 176.94 4.81 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.905 4.082 . . . . 35.08 115.985 165.723 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.9 mt -108.05 -161.99 0.8 Allowed 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 124.206 1.955 . . . . 32.31 106.394 -171.188 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -94.15 152.62 18.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.295 1.998 . . . . 42.75 109.717 173.991 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.14 -45.3 1.16 Allowed Glycine 0 N--CA 1.431 -1.672 0 O-C-N 120.284 -1.51 . . . . 36.31 111.616 175.348 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 N-CA-C 105.294 -3.122 . . . . 36.27 105.294 -172.323 . . . . . . . . 0 0 . 1 . 059 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.49 -1.332 0 N-CA-C 115.445 1.646 . . . . 17.17 115.445 . . . . . . . . . 0 0 . 1 . 059 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.51 132.78 46.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.649 -2.532 . . . . 21.89 105.738 171.842 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 pt -110.2 156.77 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 113.752 -1.567 . . . . 10.83 109.851 170.005 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -98.0 135.76 39.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 118.292 -0.861 . . . . 10.61 109.706 177.727 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.36 121.67 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 N-CA-C 99.337 -4.32 . . . . 9.13 99.337 171.197 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -102.81 128.83 49.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 126.791 2.557 . . . . 20.55 109.072 177.063 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 69' ' ' LEU . 77.7 p -96.09 176.59 6.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.497 -2.627 . . . . 11.78 112.511 -170.563 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.1 tp -80.61 -30.32 36.8 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.644 -5.035 . . . . 19.31 111.116 -173.658 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.7 p -68.33 -69.74 0.31 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.42 2.748 . . . . 23.14 118.42 162.538 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.98 38.39 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.712 0 O-C-N 119.891 -1.756 . . . . 19.74 112.144 174.226 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -99.6 132.33 45.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 119.388 1.594 . . . . 21.93 110.856 171.646 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.2 m -111.74 111.28 22.15 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.612 -2.736 . . . . 12.33 103.612 172.862 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -96.35 145.46 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 112.934 -1.939 . . . . 17.08 110.11 -178.736 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.7 m -106.33 112.22 25.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.964 -1.085 . . . . 16.3 113.593 178.613 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -111.54 130.12 55.84 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.366 1.467 . . . . 15.88 109.196 -175.132 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -97.58 132.33 43.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.316 -1.49 . . . . 28.9 109.621 173.898 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -155.88 162.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 119.389 -2.07 . . . . 12.05 113.191 -168.396 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -93.72 153.94 41.06 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 126.113 1.765 . . . . 18.17 109.026 177.378 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -60.83 -26.1 82.45 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 O-C-N 116.343 -2.503 . . . . 8.16 115.941 171.667 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.0 p -82.16 -16.44 49.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.18 1.792 . . . . 11.13 114.78 -177.625 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.77 143.01 55.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.705 1.241 . . . . 18.03 113.273 170.185 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -97.84 158.78 15.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.053 -2.279 . . . . 10.22 109.587 -175.79 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.0 mm -53.19 -46.44 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 128.558 2.743 . . . . 12.3 111.722 171.501 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -45.82 -55.54 6.49 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.362 1.615 . . . . 36.51 115.362 161.962 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -54.65 -34.53 62.3 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.102 3.761 . . . . 25.66 112.851 173.643 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.34 -33.39 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.199 -2.188 . . . . 8.12 110.028 177.79 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -67.28 -35.78 80.19 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.84 0.856 . . . . 15.47 111.81 179.898 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.1 82.43 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 132.212 4.205 . . . . 11.45 118.102 166.319 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.422 -3.924 . . . . 24.98 111.417 169.935 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 mt -53.06 -48.23 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 113.112 -3.328 . . . . 9.46 110.927 170.103 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -37.45 78.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 124.903 3.501 . . . . 14.76 116.363 176.996 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -77.34 -38.46 50.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.057 -2.277 . . . . 26.29 111.734 -177.661 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -81.25 -42.44 20.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.279 2.309 . . . . 30.06 110.96 -176.194 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -99.57 -44.2 6.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.012 1.863 . . . . 25.19 114.899 -169.179 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.74 45.46 4.56 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 118.424 -2.673 . . . . 7.41 108.91 -177.489 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.7 mt -102.7 133.6 20.35 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 107.021 -1.474 . . . . 9.49 107.021 161.714 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 3.2 Cg_exo -78.77 157.06 27.75 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 121.697 1.642 . . . . 11.42 113.464 175.83 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 81.8 Cg_exo -68.67 -24.01 35.68 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.969 3.112 . . . . 12.0 118.406 -169.127 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.73 -24.76 65.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.034 -2.348 . . . . 35.55 111.36 172.918 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -75.77 -31.82 59.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.288 -3.382 . . . . 20.52 111.132 175.521 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -94.72 89.2 5.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.104 -1.623 . . . . 7.13 111.037 -145.257 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -88.34 115.2 25.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.994 -3.566 . . . . 36.39 106.284 171.527 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.6 mt -91.26 121.83 33.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.471 -2.789 . . . . 9.55 103.471 177.157 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.65 132.24 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 124.501 2.096 . . . . 13.9 110.61 176.208 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -107.21 105.48 15.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.459 -3.276 . . . . 6.86 107.866 166.754 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.309 . . 60.49 -76.42 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.617 2.367 . . . . 11.15 115.838 -168.554 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.03 -20.0 3.48 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 126.689 2.09 . . . . 13.93 117.413 173.347 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.278 50.3 pttt -109.42 142.03 40.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.378 3.089 . . . . 23.92 105.118 -160.919 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -79.82 140.09 36.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.439 1.114 . . . . 23.23 109.782 -176.767 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 mt -84.3 128.7 34.73 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.617 -3.802 . . . . 9.11 112.847 177.432 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -83.6 136.83 34.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.117 2.967 . . . . 33.44 108.635 -174.68 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.277 0.9 OUTLIER -42.84 -63.53 0.77 Allowed 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 122.332 4.197 . . . . 28.37 122.332 -174.063 . . . . . . . . 4 3 . 1 . 059 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.97 37.11 2.34 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 128.974 3.178 . . . . 15.0 115.191 -171.517 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -132.06 148.25 52.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.984 2.216 . . . . 25.5 116.984 178.338 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.7 p -88.62 157.54 18.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 123.512 1.625 . . . . 11.95 113.126 -172.236 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.9 mt -71.69 -28.36 63.66 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.513 3.53 . . . . 10.17 110.685 -174.46 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.6 t -68.05 -44.42 76.44 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 118.042 -2.911 . . . . 13.59 113.004 173.386 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -56.35 -40.51 74.62 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.364 1.866 . . . . 11.7 111.79 177.179 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -85.34 -17.83 35.61 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.849 1.425 . . . . 12.95 114.849 175.632 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.508 12.9 m120 83.89 44.41 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.929 -2.357 . . . . 25.45 112.772 172.799 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.7 mm -79.24 117.12 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 113.965 -1.47 . . . . 14.6 112.685 174.837 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -91.72 178.47 5.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.069 -3.519 . . . . 33.23 108.351 -178.821 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -65.57 154.8 37.67 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 115.492 -2.483 . . . . 25.97 112.005 172.874 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.47 36.42 11.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.115 -2.241 . . . . 32.61 110.645 172.075 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 t -109.1 142.27 40.08 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.828 1.955 . . . . 10.56 112.437 -174.708 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -97.62 115.97 28.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 116.011 -1.947 . . . . 5.33 113.158 -170.883 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.31 141.43 28.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.022 1.451 . . . . 11.66 107.389 167.376 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.2 113.22 25.73 Favored 'General case' 0 N--CA 1.43 -1.433 1 CA-C-O 129.145 4.307 . . . . 16.3 107.803 -170.546 . . . . . . . . 3 3 . 1 . 059 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 7' ' ' THR . 58.9 tp -81.84 105.53 13.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 117.287 -3.383 . . . . 9.96 110.843 -178.016 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.19 113.52 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 123.329 1.538 . . . . 9.76 112.615 174.064 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.5 mt -89.5 143.55 26.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.229 -2.794 . . . . 19.57 115.467 -178.333 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -108.18 154.36 21.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.599 2.142 . . . . 35.08 107.624 178.133 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 mt -78.56 145.26 34.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.683 -3.136 . . . . 32.31 105.355 -179.319 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -64.29 120.62 12.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.035 1.494 . . . . 42.75 115.035 -167.259 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.45 29.84 8.56 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 126.473 2.358 . . . . 36.31 114.688 171.216 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.735 0 O-C-N 125.861 1.565 . . . . 36.27 114.299 -170.244 . . . . . . . . 0 0 . 1 . 060 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptt? . . . . . 0 CA--C 1.49 -1.328 0 N-CA-C 116.686 2.106 . . . . 17.17 116.686 . . . . . . . . . 0 0 . 1 . 060 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.77 147.09 37.62 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 117.124 -1.417 . . . . 21.89 110.268 178.478 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.93 156.23 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.638 -2.727 . . . . 10.83 103.638 160.727 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -99.11 117.25 33.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 112.001 -2.363 . . . . 10.61 115.196 169.233 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.8 t -107.05 111.43 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.108 -3.495 . . . . 9.13 109.291 179.796 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -90.23 113.48 25.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.63 -1.623 . . . . 20.55 111.479 -171.727 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.391 9.0 p -70.72 172.55 8.54 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.533 -2.605 . . . . 11.78 115.302 173.672 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.1 tp -98.23 3.85 48.88 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.901 3.239 . . . . 19.31 109.48 177.763 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -85.59 -71.22 0.54 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.663 -3.773 . . . . 23.14 106.34 168.937 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.36 13.67 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.725 0 O-C-N 126.452 2.345 . . . . 19.74 114.499 -174.502 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -98.37 132.48 43.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.533 -3.333 . . . . 21.93 108.208 179.68 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -104.91 103.1 12.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.483 -3.885 . . . . 12.33 115.294 165.485 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -80.36 136.82 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.538 -2.601 . . . . 17.08 111.091 179.206 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 m -107.76 135.84 48.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.286 3.422 . . . . 16.3 106.13 175.733 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -132.47 157.15 45.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.386 -2.696 . . . . 15.88 107.163 -176.691 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -112.21 111.28 22.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.265 2.226 . . . . 28.9 108.195 -176.341 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.22 155.78 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 124.248 1.975 . . . . 12.05 110.466 -168.23 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.94 165.67 16.57 Favored Pre-proline 0 N--CA 1.43 -1.429 1 O-C-N 115.36 -4.587 . . . . 18.17 106.179 165.814 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -62.8 -22.56 73.98 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 123.155 2.57 . . . . 8.16 115.528 168.394 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.9 m -87.07 3.51 45.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.021 3.296 . . . . 11.13 115.147 -178.429 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -77.87 145.59 36.15 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.179 -5.326 . . . . 18.03 109.32 171.533 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -78.14 170.89 15.86 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.2 1.926 . . . . 10.22 116.2 173.172 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -61.85 -35.61 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 125.316 1.446 . . . . 12.3 112.228 161.76 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.12 -43.63 97.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.803 -2.435 . . . . 36.51 111.92 174.368 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -61.02 -32.59 72.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.169 2.285 . . . . 25.66 117.169 170.741 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.333 95.6 t -60.2 -53.66 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.366 3.066 . . . . 8.12 113.626 167.584 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -55.68 -44.53 77.4 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 121.924 4.046 . . . . 15.47 121.924 169.886 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.51 -34.26 64.49 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 125.942 2.782 . . . . 11.45 117.57 175.93 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -82.12 -27.35 32.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.199 -2.148 . . . . 24.98 105.199 -171.796 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.67 -29.94 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 103.416 -2.809 . . . . 9.46 103.416 -176.127 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.13 -51.3 68.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.221 3.009 . . . . 14.76 110.608 170.393 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -55.43 -43.35 75.29 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.191 1.922 . . . . 26.29 116.191 173.069 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -84.04 -71.86 0.49 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.094 -1.866 . . . . 30.06 108.312 -169.138 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -74.28 -54.09 8.4 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.791 2.71 . . . . 25.19 115.526 -170.893 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.11 -24.78 1.27 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.136 -2.227 . . . . 7.41 112.158 -177.975 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.548 HD13 HD21 ' A' ' 71' ' ' LEU . 3.7 mt -69.87 122.97 87.68 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 116.658 -1.639 . . . . 9.49 112.801 -160.802 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.44 153.39 65.83 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 C-N-CA 126.326 4.684 . . . . 11.42 110.979 176.378 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.95 -21.95 49.16 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 C-N-CA 124.627 3.552 . . . . 12.0 118.743 -168.702 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -65.58 -37.37 86.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.361 3.464 . . . . 35.55 111.127 178.695 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.26 65.7 mt-30 -76.49 -16.7 59.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.553 2.341 . . . . 20.52 113.917 -177.37 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -97.85 124.5 42.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.403 -3.311 . . . . 7.13 110.715 -165.783 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.401 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 59.4 mtp180 -101.97 126.98 49.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.513 -3.867 . . . . 36.39 105.969 160.121 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mt -115.48 132.0 56.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.578 -1.326 . . . . 9.55 107.697 177.504 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.57 134.24 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 126.554 1.941 . . . . 13.9 109.681 -159.266 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -140.68 116.48 10.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.733 1.73 . . . . 6.86 107.938 179.848 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.71 -93.92 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.739 3.216 . . . . 11.15 110.223 -178.027 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.86 11.11 7.43 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.683 -2.511 . . . . 13.93 116.625 178.591 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -128.92 153.02 47.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.222 -2.929 . . . . 23.92 112.46 -178.01 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -89.15 138.81 31.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.173 -2.529 . . . . 23.23 104.173 169.319 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.68 126.11 33.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.378 -2.646 . . . . 9.11 115.499 -176.997 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.56 140.97 31.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 121.343 1.883 . . . . 33.44 109.967 -173.355 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.39 -62.43 1.78 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.798 3.639 . . . . 28.37 115.493 -158.377 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.83 28.04 3.69 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 118.568 -2.582 . . . . 15.0 111.965 -177.078 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -103.95 154.07 20.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.828 -2.572 . . . . 25.5 107.134 174.72 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -97.0 177.59 5.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.709 3.147 . . . . 11.95 103.769 -170.559 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.78 -34.16 73.37 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 112.567 -6.333 . . . . 10.17 117.764 172.894 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 m -64.15 -21.43 66.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.592 -1.67 . . . . 13.59 112.588 174.237 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.16 -39.64 54.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.388 1.475 . . . . 11.7 111.698 177.72 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -90.15 3.15 54.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.845 2.906 . . . . 12.95 118.845 171.239 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.379 17.9 m120 73.18 25.49 2.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.739 2.416 . . . . 25.45 116.11 171.304 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.3 mt -83.83 127.74 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 128.855 2.862 . . . . 14.6 109.304 -176.692 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -126.37 -155.59 0.69 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.178 0.924 . . . . 33.23 110.157 179.451 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -83.33 144.87 29.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.598 -1.939 . . . . 25.97 112.412 179.673 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 87.0 6.93 0.26 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.289 3.836 . . . . 32.61 108.23 176.625 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -84.5 151.6 24.49 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 115.894 -4.254 . . . . 10.56 109.768 -167.657 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.452 5.2 m -93.24 112.56 24.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.345 2.658 . . . . 5.33 116.258 172.87 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -90.52 168.28 11.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.375 -3.328 . . . . 11.66 107.324 168.336 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -130.43 133.02 46.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.73 -2.481 . . . . 16.3 104.316 177.078 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -102.03 133.34 47.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.02 1.728 . . . . 9.96 113.405 177.887 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.458 HG12 ' N ' ' A' ' 71' ' ' LEU . 88.3 t -131.71 161.17 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.867 -2.271 . . . . 9.76 104.867 174.066 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.548 HD21 HD13 ' A' ' 36' ' ' ILE . 64.2 mt -113.85 159.82 19.41 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.848 2.113 . . . . 19.57 110.594 178.981 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -135.41 168.25 19.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 129.734 3.214 . . . . 35.08 106.83 176.119 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 tp -94.8 -51.35 4.74 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.157 2.884 . . . . 32.31 107.049 -174.957 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -142.1 151.77 42.64 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.627 -4.421 . . . . 42.75 110.219 174.154 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.66 160.05 27.89 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 119.319 -1.419 . . . . 36.31 111.047 -177.751 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.747 0 N-CA-C 110.696 -0.961 . . . . 36.27 110.696 -168.735 . . . . . . . . 0 0 . 1 . 061 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 106.795 -1.557 . . . . 17.17 106.795 . . . . . . . . . 0 0 . 1 . 061 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.85 151.6 25.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.871 -1.899 . . . . 21.89 105.871 -178.278 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -134.5 167.42 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.593 2.139 . . . . 10.83 108.595 169.663 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -121.14 130.69 53.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.191 -2.818 . . . . 10.61 109.738 177.657 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -110.62 124.49 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 1 O-C-N 113.774 -5.579 . . . . 9.13 105.848 161.041 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.252 77.8 tttt -109.15 134.0 52.29 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.386 -2.696 . . . . 20.55 115.752 -179.39 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -71.0 170.29 13.11 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.966 2.794 . . . . 11.78 110.678 178.745 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.4 tp -78.11 -29.82 49.11 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.33 -2.668 . . . . 19.31 114.956 177.801 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -58.6 -56.01 27.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 122.198 2.272 . . . . 23.14 112.547 165.35 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.41 38.16 0.11 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 128.709 3.052 . . . . 19.74 113.799 163.302 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -92.79 132.11 37.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 126.837 2.139 . . . . 21.93 106.42 -179.421 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -105.89 126.58 52.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.03 2.348 . . . . 12.33 110.572 -175.692 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -97.06 118.86 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 111.291 -2.686 . . . . 17.08 105.905 174.864 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.7 m -82.54 128.9 34.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.817 -1.802 . . . . 16.3 115.137 166.523 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 mt -123.55 148.91 45.88 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.695 -1.224 . . . . 15.88 107.695 -179.895 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -118.77 116.89 27.48 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.616 2.366 . . . . 28.9 106.485 177.799 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.293 34.1 m -141.29 -179.22 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 126.394 2.309 . . . . 12.05 106.443 -177.329 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -117.13 157.86 45.76 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 118.502 -2.624 . . . . 18.17 108.582 171.418 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -64.3 -8.85 17.85 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-N 126.161 3.236 . . . . 8.16 118.029 178.818 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.1 m -88.99 -1.94 58.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.741 1.616 . . . . 11.13 113.976 -178.149 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -89.35 164.9 14.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.357 1.075 . . . . 18.03 108.976 176.831 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -87.96 168.07 13.18 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.826 2.45 . . . . 10.22 114.846 -179.624 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 22.3 mm -75.1 -26.35 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 115.393 1.627 . . . . 12.3 115.393 172.65 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -61.77 -43.35 99.03 Favored 'General case' 0 N--CA 1.43 -1.452 2 C-N-CA 133.994 4.918 . . . . 36.51 106.999 166.113 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -65.07 -33.92 77.18 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.017 2.599 . . . . 25.66 118.017 169.647 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -60.19 -44.42 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.668 -1.27 . . . . 8.12 111.501 171.38 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -75.25 -39.79 59.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.368 -3.332 . . . . 15.47 111.433 -175.691 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.53 -23.5 64.53 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.274 -2.141 . . . . 11.45 116.737 172.972 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -63.99 -45.22 90.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 125.095 3.588 . . . . 24.98 107.672 169.625 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.566 ' HB ' HE22 ' A' ' 41' ' ' GLN . 92.6 mt -67.09 -30.74 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.468 -2.645 . . . . 9.46 109.952 177.36 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -60.45 -41.32 93.86 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.805 2.842 . . . . 14.76 113.963 171.777 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -68.3 -59.7 3.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.084 1.883 . . . . 26.29 116.084 163.294 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 mttm -63.57 -58.38 7.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 120.122 3.379 . . . . 30.06 120.122 -171.802 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -88.72 -55.26 3.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.718 2.007 . . . . 25.19 113.429 -174.565 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.37 20.89 2.6 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 112.077 -2.329 . . . . 7.41 117.202 -178.152 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.0 mt -100.34 117.25 63.37 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 119.007 -2.467 . . . . 9.49 110.829 178.641 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 6.6 Cg_endo -73.43 154.7 50.77 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-N 127.732 3.797 . . . . 11.42 112.774 -175.694 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 94.4 Cg_exo -69.85 -22.58 31.46 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 CA-C-O 117.682 -1.049 . . . . 12.0 113.217 -167.287 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -54.09 -41.23 68.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.649 -2.596 . . . . 35.55 117.092 175.302 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -77.38 -36.03 53.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.024 2.703 . . . . 20.52 111.854 170.221 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.566 HE22 ' HB ' ' A' ' 30' ' ' ILE . 69.8 mt-30 -69.32 115.07 8.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.16 2.652 . . . . 7.13 118.16 -176.476 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 59.7 mtp180 -102.87 121.66 42.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.952 -1.499 . . . . 36.39 107.335 161.083 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 mt -99.15 132.43 44.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.382 1.901 . . . . 9.55 109.382 175.971 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -125.56 122.74 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.739 2.416 . . . . 13.9 109.523 -170.001 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -104.3 120.0 40.21 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.185 1.357 . . . . 6.86 109.19 168.76 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.49 . . 62.98 -102.59 0.11 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.941 -1.1 . . . . 11.15 113.457 -167.717 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.75 16.85 5.3 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 117.424 -3.298 . . . . 13.93 107.497 171.306 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -95.52 131.64 41.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.778 2.831 . . . . 23.92 109.335 177.209 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -87.99 133.0 34.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 124.872 1.358 . . . . 23.23 110.355 178.665 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 mt -93.13 120.47 33.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.662 1.185 . . . . 9.11 110.998 -175.116 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -78.55 139.0 38.66 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.607 1.563 . . . . 33.44 113.576 169.024 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 5.8 m-20 -64.75 -40.23 94.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.372 2.269 . . . . 28.37 113.33 -165.575 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.53 29.14 5.0 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 116.725 1.45 . . . . 15.0 116.725 177.23 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -109.75 164.09 12.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.903 -2.528 . . . . 25.5 107.27 162.873 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -93.31 165.17 12.92 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.772 1.748 . . . . 11.95 114.06 173.581 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -59.48 -35.24 73.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.748 -1.845 . . . . 10.17 112.669 174.473 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 t -66.55 -32.01 73.08 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 119.807 3.262 . . . . 13.59 119.807 174.085 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -63.37 -39.22 93.92 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 123.615 1.674 . . . . 11.7 110.638 175.571 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -88.14 -4.53 58.74 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.351 2.26 . . . . 12.95 112.376 178.727 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.8 m120 50.96 56.05 8.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.666 1.986 . . . . 25.45 114.504 -168.43 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.0 mt -103.16 103.57 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 101.204 -3.628 . . . . 14.6 101.204 178.278 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -89.74 -171.85 3.33 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.501 2.72 . . . . 33.23 111.288 -177.444 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -69.06 143.77 54.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 105.461 -2.051 . . . . 25.97 105.461 -170.831 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 25.3 mt-10 64.67 26.43 13.15 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.951 2.204 . . . . 32.61 116.951 172.673 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 t -93.34 144.5 25.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 104.383 -2.451 . . . . 10.56 104.383 -173.535 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.6 m -110.78 124.15 51.45 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 114.277 -1.329 . . . . 5.33 110.737 -171.951 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mt -95.22 140.94 29.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.114 3.365 . . . . 11.66 108.136 174.603 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -89.03 143.26 26.97 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.142 1.449 . . . . 16.3 108.952 165.894 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -119.51 119.82 34.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.167 -2.16 . . . . 9.96 105.167 -171.989 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 71.1 t -109.76 132.42 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 114.563 -1.199 . . . . 9.76 110.568 -179.778 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.1 mt -98.13 118.59 35.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.231 -2.793 . . . . 19.57 113.569 174.716 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.498 HH12 ' C ' ' A' ' 76' ' ' GLY . 30.3 ptt180 -92.87 170.03 10.0 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.673 -1.232 . . . . 35.08 107.673 163.585 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.1 tp -79.63 -85.62 0.08 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 116.242 1.942 . . . . 32.31 116.242 173.776 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -153.41 141.88 20.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.005 1.73 . . . . 42.75 110.165 167.814 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.59 -82.58 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 CA-C-O 125.21 2.561 . . . . 36.31 114.931 176.064 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.498 ' C ' HH12 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.261 1.783 0 CA-C-N 111.542 -2.329 . . . . 36.27 112.937 168.984 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 116.845 2.165 . . . . 17.17 116.845 . . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.64 128.46 33.64 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.496 -2.628 . . . . 21.89 108.77 172.221 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -124.01 173.33 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.935 -2.978 . . . . 10.83 103.548 163.901 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.269 77.5 m-85 -128.18 136.3 50.91 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.782 -0.821 . . . . 10.61 108.782 -176.31 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -113.62 117.16 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 125.971 2.796 . . . . 9.13 106.768 175.401 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 19.9 ttpt -95.91 136.77 35.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.343 -1.753 . . . . 20.55 111.117 174.666 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -88.89 -169.29 2.47 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 128.15 3.833 . . . . 11.78 111.51 -175.34 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.3 tp -80.57 -44.15 19.47 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.691 -3.755 . . . . 19.31 110.543 -176.71 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -62.28 1.93 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.417 1.887 . . . . 23.14 110.006 168.562 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.84 41.34 0.11 Allowed Glycine 0 N--CA 1.431 -1.687 0 O-C-N 119.139 -2.226 . . . . 19.74 111.593 169.63 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 21.1 tptm -84.29 142.9 29.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 128.94 3.377 . . . . 21.93 113.833 166.489 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.5 m -106.94 112.21 25.07 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.593 1.663 . . . . 12.33 109.466 -176.254 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.483 HD13 ' HG3' ' A' ' 34' ' ' GLU . 34.3 mt -104.27 108.91 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 119.562 -1.961 . . . . 17.08 110.358 -174.974 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -87.82 123.09 32.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.489 -1.382 . . . . 16.3 108.564 -174.164 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.3 mt -120.17 158.26 27.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.087 2.155 . . . . 15.88 116.29 179.636 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -120.77 89.33 3.11 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.556 3.074 . . . . 28.9 114.893 177.377 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -109.55 164.39 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 119.86 -1.775 . . . . 12.05 114.473 -178.624 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -98.26 159.69 30.04 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 116.551 -2.059 . . . . 18.17 106.444 167.793 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 79.5 Cg_endo -73.53 -17.68 23.37 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 O-C-N 116.012 -2.678 . . . . 8.16 110.066 174.904 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -59.78 -20.25 55.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.005 2.522 . . . . 11.13 116.19 164.785 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -71.57 142.3 50.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.562 2.601 . . . . 18.03 112.0 175.964 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.7 p -79.94 165.64 22.43 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.09 -4.131 . . . . 10.22 107.932 167.233 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 mm -66.18 -24.69 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.589 1.955 . . . . 12.3 108.558 177.637 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.29 35.0 tt0 -65.73 -39.85 91.57 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 118.19 -0.91 . . . . 36.51 108.596 174.19 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -72.25 -24.31 61.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.895 2.134 . . . . 25.66 114.237 179.109 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t -72.77 -42.06 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.385 -2.697 . . . . 8.12 110.834 175.189 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.274 93.0 mttt -51.57 -36.88 47.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 117.581 2.438 . . . . 15.47 117.581 163.512 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.76 61.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.504 -1.372 . . . . 11.45 111.265 -177.232 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -58.67 -47.98 82.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.164 2.986 . . . . 24.98 113.814 175.487 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -69.92 -34.16 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.553 -1.658 . . . . 9.46 109.147 175.401 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -60.59 -46.71 89.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.144 2.247 . . . . 14.76 110.794 172.978 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.26 -58.7 6.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.759 -1.838 . . . . 26.29 111.305 -177.308 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -75.61 -55.43 5.67 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 132.805 4.442 . . . . 30.06 111.264 -168.068 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HG3' HD13 ' A' ' 13' ' ' ILE . 27.1 mm-40 -89.43 -31.8 17.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.968 -2.333 . . . . 25.19 115.241 -179.016 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.01 11.42 20.57 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 121.269 3.268 . . . . 7.41 121.269 179.536 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.307 71.5 mt -109.5 135.16 20.35 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 102.447 -3.168 . . . . 9.49 102.447 -153.502 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -61.44 158.03 38.22 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 124.079 3.186 . . . . 11.42 117.481 179.605 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -78.53 -13.35 14.93 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 127.847 3.838 . . . . 12.0 118.066 179.932 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.92 -17.8 64.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.996 -1.457 . . . . 35.55 114.93 -178.634 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -86.2 -22.38 26.98 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 124.07 1.89 . . . . 20.52 111.24 178.025 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -89.07 108.01 19.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.819 2.525 . . . . 7.13 117.819 -163.303 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -104.49 100.15 9.84 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.994 -1.113 . . . . 36.39 107.994 171.517 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.482 ' HB3' HD12 ' A' ' 50' ' ' LEU . 13.6 mt -81.81 130.33 35.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.182 -2.824 . . . . 9.55 112.884 178.33 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mm -128.8 136.06 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 104.148 -2.538 . . . . 13.9 104.148 -167.739 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -135.08 133.5 39.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.843 -1.539 . . . . 6.86 106.843 176.604 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.262 . . 49.98 -111.34 0.49 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.844 2.535 . . . . 11.15 117.844 -164.163 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.36 2.53 37.27 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 119.007 -0.885 . . . . 13.93 114.405 169.341 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -105.7 126.33 52.03 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.237 3.015 . . . . 23.92 111.024 -161.508 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -80.54 130.41 35.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.523 -1.217 . . . . 23.23 110.49 171.712 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 43' ' ' LEU . 34.3 mt -86.47 166.01 15.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.61 -1.186 . . . . 9.11 113.756 -167.908 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -132.48 128.91 38.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 114.791 -2.528 . . . . 33.44 109.085 -170.4 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.05 -44.49 78.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 127.157 2.785 . . . . 28.37 115.573 -162.954 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.55 -8.72 14.89 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 128.546 2.974 . . . . 15.0 118.634 -179.394 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -95.8 150.92 19.87 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 116.234 -4.098 . . . . 25.5 110.851 178.583 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.7 p -78.53 161.68 26.86 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.298 2.475 . . . . 11.95 112.144 168.041 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 19.9 mt -65.29 -42.88 92.64 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.0 -5.438 . . . . 10.17 111.904 172.348 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -42.14 -40.27 2.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.626 2.824 . . . . 13.59 118.626 160.685 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.34 -22.82 67.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.193 -2.192 . . . . 11.7 116.531 172.677 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -101.82 3.59 39.52 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.023 -1.673 . . . . 12.95 111.276 -178.75 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.478 26.9 m120 63.37 32.12 14.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.127 2.87 . . . . 25.45 118.191 -174.204 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.6 mt -95.51 123.06 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.026 -2.296 . . . . 14.6 106.38 -171.493 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -124.78 -171.17 2.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.093 2.557 . . . . 33.23 107.305 -168.673 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -76.33 150.68 36.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.512 -1.992 . . . . 25.97 115.949 -169.001 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 63.15 15.34 8.46 Favored 'General case' 0 N--CA 1.43 -1.464 1 CA-C-O 128.535 4.017 . . . . 32.61 118.894 -169.711 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.37 147.34 40.13 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 112.884 -6.135 . . . . 10.56 113.981 172.47 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.8 m -108.15 123.37 48.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.612 1.565 . . . . 5.33 114.486 -176.823 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.25 166.51 10.91 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.666 0.746 . . . . 11.66 110.163 174.313 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -126.27 144.96 50.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.076 -2.89 . . . . 16.3 108.295 -175.769 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.3 tp -121.55 102.47 8.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.965 1.306 . . . . 9.96 108.747 -165.026 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 t -87.9 128.84 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 123.105 0.562 . . . . 9.76 110.226 176.265 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -105.07 161.77 13.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.425 -2.805 . . . . 19.57 103.425 -169.637 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -166.39 179.14 5.74 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.842 -1.072 . . . . 35.08 109.73 -178.735 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.8 mt -109.0 149.88 28.58 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.925 1.69 . . . . 32.31 113.899 179.163 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -56.39 126.02 24.53 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.643 2.46 . . . . 42.75 117.643 -173.461 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.0 -54.64 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 116.992 1.557 . . . . 36.31 116.992 177.369 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.743 0 CA-C-O 114.317 -3.491 . . . . 36.27 106.104 169.258 . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 CA--C 1.49 -1.338 0 CA-C-O 123.909 1.814 . . . . 17.17 114.597 . . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -74.92 125.29 28.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.386 -3.321 . . . . 21.89 114.092 168.465 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 pt -120.88 161.95 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 112.965 -1.925 . . . . 10.83 112.064 170.048 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -119.76 125.34 48.37 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.573 1.654 . . . . 10.61 111.615 -177.259 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.1 111.84 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 121.118 -0.988 . . . . 9.13 110.237 174.632 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -88.37 138.52 31.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.608 -3.182 . . . . 20.55 118.261 179.088 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.264 28.2 p -87.25 175.79 7.87 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.301 2.334 . . . . 11.78 117.301 178.672 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -75.39 -38.21 60.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.729 -2.082 . . . . 19.31 115.095 173.978 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 63.0 p -70.64 -52.77 19.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.486 -2.673 . . . . 23.14 116.688 161.036 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.7 58.17 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 124.927 3.512 . . . . 19.74 110.899 158.494 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -97.14 147.11 24.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.29 -1.712 . . . . 21.93 110.485 165.411 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 m -93.62 108.41 20.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.208 1.004 . . . . 12.33 109.632 167.175 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 mt -75.93 127.7 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 117.738 -3.101 . . . . 17.08 107.605 166.185 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.6 p -114.15 127.46 55.92 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.742 -3.099 . . . . 16.3 111.97 177.573 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -127.81 133.19 49.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 128.172 3.42 . . . . 15.88 113.759 -171.567 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -95.75 91.7 6.21 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 132.242 4.217 . . . . 28.9 109.42 -179.516 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -126.52 167.47 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.513 -1.662 . . . . 12.05 106.513 178.927 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -102.44 154.19 37.61 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 117.39 -3.319 . . . . 18.17 105.838 174.255 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -68.99 -5.33 15.46 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 124.079 2.493 . . . . 8.16 117.631 -173.494 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -98.37 4.38 48.56 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 124.442 1.089 . . . . 11.13 108.298 174.963 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.49 147.3 53.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.902 2.186 . . . . 18.03 116.902 162.052 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 7.5 p -89.67 158.84 17.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.318 -1.765 . . . . 10.22 106.681 -173.665 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -64.7 -32.69 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.385 -2.697 . . . . 12.3 114.486 -178.766 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -44.21 -50.81 8.63 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.206 3.002 . . . . 36.51 109.783 162.238 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -74.12 -21.24 59.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.936 -2.977 . . . . 25.66 117.128 178.333 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 56' ' ' LEU . 55.8 t -71.63 -43.61 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 123.25 1.5 . . . . 8.12 109.838 172.909 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -61.51 -30.65 70.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.087 2.995 . . . . 15.47 119.087 168.66 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.37 -34.65 61.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.88 -3.013 . . . . 11.45 112.922 171.204 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -49.04 76.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 127.063 3.316 . . . . 24.98 116.103 167.953 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.6 mt -57.79 -42.23 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 117.645 -3.16 . . . . 9.46 113.528 166.54 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -63.2 -39.55 94.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.426 -3.921 . . . . 14.76 116.176 172.977 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -68.05 -50.56 54.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.12 0.887 . . . . 26.29 113.121 176.126 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -70.14 -66.02 0.65 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.112 1.152 . . . . 30.06 114.112 176.889 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -76.96 -35.28 57.36 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.856 2.909 . . . . 25.19 118.856 -170.221 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.01 60.16 1.79 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 119.827 -1.796 . . . . 7.41 111.246 -173.169 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.99 119.54 15.82 Favored Pre-proline 0 N--CA 1.43 -1.439 0 C-N-CA 125.151 1.38 . . . . 9.49 108.091 178.255 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.49 154.41 45.1 Favored 'Trans proline' 0 N--CA 1.433 -2.059 1 C-N-CA 125.893 4.395 . . . . 11.42 111.716 -172.218 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.299 52.3 Cg_endo -64.27 -14.3 43.09 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 O-C-N 123.891 1.469 . . . . 12.0 111.507 174.726 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -67.29 -34.34 77.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.361 2.505 . . . . 35.55 113.779 176.605 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -96.58 -37.74 10.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.012 -2.305 . . . . 20.52 108.639 -164.684 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -75.21 136.89 40.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 117.067 2.247 . . . . 7.13 117.067 -176.345 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HB3' HG23 ' A' ' 70' ' ' VAL . 37.3 ttm180 -120.06 133.25 55.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.197 -3.26 . . . . 36.39 102.197 161.339 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.7 mt -108.53 141.93 39.7 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.386 -2.071 . . . . 9.55 106.389 179.903 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.1 mt -126.83 138.54 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.214 3.406 . . . . 13.9 103.367 -170.476 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -121.03 121.24 37.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.974 1.369 . . . . 6.86 111.471 161.185 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.61 -78.58 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.719 -2.488 . . . . 11.15 114.843 -174.613 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.25 -4.94 0.24 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 123.882 3.037 . . . . 13.93 110.638 -177.998 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -113.07 146.03 39.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.747 2.419 . . . . 23.92 112.689 -173.391 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -89.52 156.07 18.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.597 1.959 . . . . 23.23 110.288 -171.773 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -118.86 127.24 53.32 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 129.455 4.222 . . . . 9.11 107.8 -170.413 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -103.14 165.07 11.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.837 -3.04 . . . . 33.44 112.384 -172.118 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -69.91 -58.13 4.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.477 -2.639 . . . . 28.37 113.848 -157.645 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.35 31.03 5.95 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 117.919 -1.489 . . . . 15.0 115.523 -167.714 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -107.96 162.09 14.34 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.94 1.696 . . . . 25.5 114.202 159.831 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 29.2 p -92.72 173.48 7.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.305 1.526 . . . . 11.95 107.626 -171.65 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 26' ' ' VAL . 12.5 mt -65.67 -44.26 86.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.026 -0.988 . . . . 10.17 110.469 171.729 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.1 m -63.89 -32.21 73.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.198 2.295 . . . . 13.59 117.198 178.704 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -58.21 -42.81 87.03 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.267 3.432 . . . . 11.7 120.267 173.54 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -70.5 -13.89 62.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 117.46 -1.257 . . . . 12.95 114.275 163.849 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 30.2 m120 68.68 38.59 2.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.474 2.71 . . . . 25.45 114.265 -171.61 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.16 129.16 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.053 2.095 . . . . 14.6 110.339 164.557 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.44 -173.77 3.26 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.128 2.971 . . . . 33.23 108.944 -164.217 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -65.26 136.22 56.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.57 -3.831 . . . . 25.97 111.14 172.629 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 55.42 53.19 10.16 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-N 108.039 -4.164 . . . . 32.61 113.442 -170.889 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -96.37 150.67 20.33 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.057 -4.152 . . . . 10.56 110.121 -178.136 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.5 m -103.46 111.1 23.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 127.4 2.937 . . . . 5.33 108.444 -174.9 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -100.07 162.09 13.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.293 -1.002 . . . . 11.66 108.293 176.215 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -122.75 128.06 50.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.35 -1.469 . . . . 16.3 111.347 170.422 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -93.92 121.9 35.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.737 1.014 . . . . 9.96 113.737 176.638 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 42' ' ' ARG . 18.7 m -121.68 155.87 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.778 -1.934 . . . . 9.76 105.778 174.445 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.2 mt -101.17 117.64 35.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.872 -2.393 . . . . 19.57 109.787 172.056 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -92.13 177.71 6.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.918 2.487 . . . . 35.08 109.673 178.876 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.6 mt -112.01 176.94 4.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.442 1.497 . . . . 32.31 108.844 158.253 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.8 ttt85 -67.63 136.16 53.97 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 119.664 1.12 . . . . 42.75 112.139 -172.477 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.3 -120.42 0.96 Allowed Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 116.722 -2.154 . . . . 36.31 108.575 -169.371 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 CA-C-N 118.961 1.381 . . . . 36.27 110.455 179.964 . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 111.932 0.345 . . . . 17.17 111.932 . . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -89.74 115.26 26.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.569 1.548 . . . . 21.89 113.084 -175.662 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.48 18.0 pt -107.29 155.27 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 126.076 1.75 . . . . 10.83 115.593 168.874 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -121.2 116.57 25.16 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.333 2.653 . . . . 10.61 105.681 -178.006 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.32 109.36 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 118.064 -2.897 . . . . 9.13 108.26 172.074 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -101.29 132.67 46.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.281 1.515 . . . . 20.55 107.12 -173.798 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -87.12 171.56 10.6 Favored 'General case' 0 N--CA 1.429 -1.486 1 O-C-N 115.732 -4.355 . . . . 11.78 113.495 177.708 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.4 tp -70.23 -42.2 72.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 127.047 3.308 . . . . 19.31 109.495 177.699 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 p -56.81 -31.69 64.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.751 -3.093 . . . . 23.14 116.928 167.889 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.62 37.29 2.09 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 122.632 2.469 . . . . 19.74 113.137 173.235 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -99.55 152.9 19.5 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.451 -2.796 . . . . 21.93 103.451 167.446 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -110.97 106.23 15.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 114.06 1.133 . . . . 12.33 114.06 160.246 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.5 mt -81.27 108.25 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.876 -1.765 . . . . 17.08 108.571 169.973 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.9 p -78.39 137.8 38.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.49 -2.006 . . . . 16.3 111.039 172.34 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.2 139.32 44.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 125.197 1.561 . . . . 15.88 110.366 -177.166 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -95.46 111.6 23.46 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.298 2.639 . . . . 28.9 109.784 164.579 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.252 29.0 m -135.51 162.26 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 1 O-C-N 114.446 -5.159 . . . . 12.05 107.344 175.133 . . . . . . . . 3 2 . 1 . 064 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -97.95 166.05 14.23 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 120.239 -1.538 . . . . 18.17 107.967 179.682 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.74 -19.9 48.59 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 123.721 2.365 . . . . 8.16 118.1 174.184 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -98.5 12.94 33.53 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 125.032 1.458 . . . . 11.13 112.066 -172.182 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.34 131.16 34.73 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.429 -2.044 . . . . 18.03 108.87 176.952 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 52' ' ' ASP 0.314 65.1 p -59.26 163.55 3.77 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.913 1.82 . . . . 10.22 115.913 164.889 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 37.2 mm -76.05 -17.1 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 O-C-N 116.291 -4.005 . . . . 12.3 106.335 -179.72 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 36.7 tt0 -69.12 -47.24 65.64 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.074 -1.642 . . . . 36.51 107.538 172.127 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.273 70.4 m-80 -66.49 -29.43 69.54 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.508 3.151 . . . . 25.66 119.508 175.677 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.269 60.2 t -51.4 -51.56 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 114.155 1.168 . . . . 8.12 114.155 163.621 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -71.61 -40.48 69.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.556 1.942 . . . . 15.47 110.618 -174.995 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.264 . . -52.34 -49.34 64.5 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.336 3.054 . . . . 11.45 109.809 170.051 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -62.51 -36.72 83.45 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.556 -3.215 . . . . 24.98 116.812 172.836 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -58.91 -47.25 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.763 -3.086 . . . . 9.46 111.538 167.455 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -55.86 -35.78 66.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.231 2.678 . . . . 14.76 118.231 173.931 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.9 -43.06 69.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.992 -1.485 . . . . 26.29 106.992 -179.894 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -79.03 -57.47 3.72 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.785 -1.822 . . . . 30.06 115.31 -173.935 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -85.74 -49.7 7.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.779 -2.01 . . . . 25.19 111.572 -173.947 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.6 28.66 5.91 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 116.396 -3.94 . . . . 7.41 110.885 -169.436 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.23 122.9 41.4 Favored Pre-proline 0 N--CA 1.429 -1.5 1 CA-C-O 111.541 -4.076 . . . . 9.49 105.997 176.161 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -87.63 159.77 7.83 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-O 114.543 -2.357 . . . . 11.42 112.199 -165.369 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -64.26 -9.48 20.01 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 122.912 2.408 . . . . 12.0 116.227 -175.626 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -82.36 -34.61 28.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 124.165 3.166 . . . . 35.55 109.907 -169.568 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -83.19 -19.45 36.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.539 1.536 . . . . 20.52 108.467 -174.775 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -90.95 127.96 36.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.054 2.983 . . . . 7.13 119.054 -166.839 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -120.4 123.61 43.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 128.273 3.892 . . . . 36.39 111.174 168.674 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.0 mt -112.42 141.37 46.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.538 -2.601 . . . . 9.55 112.541 177.923 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.91 134.91 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.484 -1.673 . . . . 13.9 106.484 -164.796 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -117.46 112.43 20.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.959 -2.978 . . . . 6.86 102.959 171.608 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.321 . . 60.48 -108.29 0.35 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.068 1.889 . . . . 11.15 113.537 -167.748 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.17 -12.2 22.4 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 113.08 -1.873 . . . . 13.93 109.97 170.141 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -74.17 107.97 6.68 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.387 3.593 . . . . 23.92 112.835 179.618 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.8 122.36 22.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.239 -4.663 . . . . 23.23 110.897 176.528 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.274 6.5 mt -90.67 127.28 36.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.861 2.911 . . . . 9.11 118.861 -165.244 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -83.55 143.58 30.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.35 -2.094 . . . . 33.44 114.926 173.005 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 36.0 m-20 -65.31 -41.44 94.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.755 2.217 . . . . 28.37 114.985 -163.977 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.51 21.46 38.32 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 118.614 -2.554 . . . . 15.0 113.58 -174.411 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -106.23 165.29 11.35 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.391 -1.337 . . . . 25.5 107.391 162.892 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -104.49 178.15 4.64 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.086 2.155 . . . . 11.95 111.54 -173.333 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.2 mt -80.1 -36.84 34.82 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.546 3.138 . . . . 10.17 106.445 173.945 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -51.77 -38.91 57.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.934 2.152 . . . . 13.59 114.931 163.509 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -70.96 -54.73 10.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.6 3.56 . . . . 11.7 109.234 -179.179 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -77.19 0.03 23.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.59 1.181 . . . . 12.95 113.213 -178.979 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 48.97 46.43 22.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.537 2.589 . . . . 25.45 117.034 -176.902 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mt -84.88 120.05 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 111.962 -2.381 . . . . 14.6 108.577 176.909 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -107.69 172.84 6.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.972 1.844 . . . . 33.23 113.831 177.96 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -60.14 141.73 55.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.423 -2.673 . . . . 25.97 113.038 179.462 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.313 12.2 mt-10 71.29 20.68 4.93 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 126.238 2.923 . . . . 32.61 117.876 177.863 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -87.63 124.72 33.82 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.448 -2.033 . . . . 10.56 109.958 173.833 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 m -74.26 100.93 3.86 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.383 2.04 . . . . 5.33 112.157 177.698 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.75 141.95 30.18 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 117.659 -3.15 . . . . 11.66 113.508 167.144 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -107.16 128.2 54.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.264 1.983 . . . . 16.3 109.754 -178.808 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.7 tp -97.58 128.44 44.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.207 -3.433 . . . . 9.96 109.2 173.367 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.07 136.52 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.303 2.954 . . . . 9.76 105.084 171.015 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt -102.03 115.08 29.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.975 -2.953 . . . . 19.57 109.572 179.054 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -85.82 -176.95 6.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.673 -2.517 . . . . 35.08 112.751 -170.237 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.5 mt -107.29 160.41 15.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 115.936 -2.306 . . . . 32.31 108.688 149.198 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.291 0.5 OUTLIER -67.46 90.1 0.24 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.574 2.35 . . . . 42.75 111.202 -167.879 . . . . . . . . 3 3 . 1 . 064 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.94 106.75 0.22 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 119.382 -1.389 . . . . 36.31 111.049 -174.308 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.752 0 CA-C-O 117.062 -1.966 . . . . 36.27 110.025 -168.932 . . . . . . . . 0 0 . 1 . 065 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' HG23 ' A' ' 17' ' ' VAL . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 117.795 -1.098 . . . . 17.17 111.997 . . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.336 2.8 pt20 -95.87 145.29 25.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.794 2.088 . . . . 21.89 115.928 166.472 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.1 pt -138.39 167.26 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 103.361 -2.829 . . . . 10.83 103.361 174.865 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -122.22 145.28 48.36 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.891 -2.413 . . . . 10.61 108.272 179.177 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 30' ' ' ILE . 78.5 t -128.66 111.12 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 103.457 -2.794 . . . . 9.13 103.457 176.937 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -107.26 137.49 45.21 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.676 2.655 . . . . 20.55 112.293 179.415 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.418 HG22 HD23 ' A' ' 69' ' ' LEU . 44.9 p -79.38 -166.45 0.96 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.916 -2.365 . . . . 11.78 105.541 -173.489 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.5 tp -81.59 -47.13 13.45 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.653 -1.904 . . . . 19.31 109.277 173.129 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 -31.2 61.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.711 2.804 . . . . 23.14 109.07 -170.059 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.43 42.17 0.47 Allowed Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 125.579 3.809 . . . . 19.74 115.226 174.326 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -108.27 133.98 51.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 102.27 -3.233 . . . . 21.93 102.27 168.358 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -104.54 113.17 26.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 124.888 1.368 . . . . 12.33 108.64 168.934 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -87.6 100.45 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.331 1.852 . . . . 17.08 112.562 166.618 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.9 m -77.23 136.51 38.54 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 118.143 -0.932 . . . . 16.3 108.879 177.778 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.296 32.0 mt -134.64 128.08 32.4 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.901 2.137 . . . . 15.88 105.519 178.548 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -88.26 132.33 34.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.367 -3.333 . . . . 28.9 107.676 161.296 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.525 HG23 ' HG3' ' A' ' 1' ' ' MET . 18.2 m -133.27 171.32 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 1 C-N-CA 132.194 4.198 . . . . 12.05 113.118 -164.146 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -108.0 148.06 36.7 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 129.109 2.964 . . . . 18.17 112.604 161.753 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.6 -23.12 69.99 Favored 'Trans proline' 0 N--CA 1.434 -2.017 1 C-N-CA 126.162 4.575 . . . . 8.16 115.364 173.086 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -86.58 -7.16 58.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.145 1.535 . . . . 11.13 115.145 -179.101 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -73.61 146.53 44.59 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.039 -2.913 . . . . 18.03 110.452 179.33 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.8 p -99.28 -176.81 3.41 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 104.331 -2.47 . . . . 10.22 104.331 -172.507 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -70.45 -34.61 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 127.353 2.261 . . . . 12.3 109.569 -177.638 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -55.23 -43.33 74.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.695 2.798 . . . . 36.51 110.822 172.209 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -70.68 -34.92 72.49 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.755 2.502 . . . . 25.66 117.755 174.346 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.3 t -55.24 -48.81 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 132.031 4.133 . . . . 8.12 108.058 174.002 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -63.81 -27.86 69.47 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.036 2.934 . . . . 15.47 115.066 177.488 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.34 -31.06 54.24 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.542 1.974 . . . . 11.45 110.997 177.374 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -65.04 -44.88 87.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.64 -2.538 . . . . 24.98 109.414 178.734 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 HG11 ' A' ' 5' ' ' VAL . 15.6 mt -65.59 -24.11 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.729 2.122 . . . . 9.46 116.729 173.189 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -64.89 -57.42 8.85 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.798 -3.689 . . . . 14.76 114.342 162.276 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -52.24 -60.62 3.0 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.517 3.527 . . . . 26.29 114.729 175.757 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -79.5 -39.73 31.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.913 2.085 . . . . 30.06 112.612 -166.432 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -106.87 -42.2 5.0 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.029 1.732 . . . . 25.19 110.009 -163.287 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.63 7.09 30.22 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 117.709 -2.186 . . . . 7.41 117.85 -173.118 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.6 mm -90.97 126.91 53.82 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-N 122.25 3.025 . . . . 9.49 108.917 -170.314 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -68.51 152.97 74.69 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 122.261 1.843 . . . . 11.42 111.867 -178.617 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -92.98 -10.53 1.9 Allowed 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-O 113.241 -2.9 . . . . 12.0 111.797 -151.995 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -85.85 -28.43 24.44 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 128.671 3.732 . . . . 35.55 111.356 174.872 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.17 -17.35 37.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 118.884 -0.579 . . . . 20.52 111.625 -171.807 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -66.85 115.66 6.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.593 2.757 . . . . 7.13 111.049 171.866 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -114.64 124.11 51.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.317 2.008 . . . . 36.39 108.772 171.967 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mt -103.35 134.9 45.96 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.041 -2.287 . . . . 9.55 107.221 -177.854 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 7.5 mm -112.38 122.62 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 130.522 3.529 . . . . 13.9 115.144 171.053 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -108.8 118.81 37.77 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.755 -1.202 . . . . 6.86 107.755 170.965 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.55 -78.37 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 131.134 3.774 . . . . 11.15 113.611 -170.545 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.47 40.41 0.28 Allowed Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 107.193 -2.363 . . . . 13.93 107.193 -179.808 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -137.2 139.33 41.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.525 -2.75 . . . . 23.92 111.473 159.7 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -67.79 167.52 13.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 117.518 2.414 . . . . 23.23 117.518 175.361 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.49 149.83 35.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.679 2.392 . . . . 9.11 107.508 178.41 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.9 146.92 48.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 123.528 0.518 . . . . 33.44 109.786 -177.665 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.74 -47.27 41.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 120.577 3.547 . . . . 28.37 120.577 -158.651 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.56 53.7 0.63 Allowed Glycine 0 N--CA 1.429 -1.77 0 O-C-N 117.068 -3.52 . . . . 15.0 111.131 -170.338 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -120.62 159.27 25.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 117.574 -1.65 . . . . 25.5 106.997 155.969 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -85.12 165.38 17.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.969 2.508 . . . . 11.95 112.348 -169.914 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.6 mt -72.09 -38.04 69.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.685 -1.885 . . . . 10.17 110.012 -176.639 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -54.09 -49.15 69.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 114.891 -2.48 . . . . 13.59 113.105 169.706 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -44.53 -50.05 9.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 124.989 3.54 . . . . 11.7 113.787 174.702 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -76.93 -7.63 55.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.669 -2.519 . . . . 12.95 116.839 -178.981 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 69.19 37.47 2.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.966 3.307 . . . . 25.45 115.258 -179.42 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.2 mt -85.01 109.19 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 130.878 3.671 . . . . 14.6 105.677 -172.867 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -91.07 165.26 13.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.826 2.727 . . . . 33.23 113.035 -179.751 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 147.25 12.83 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.798 -3.689 . . . . 25.97 115.532 168.308 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 58.37 32.23 21.84 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.046 2.61 . . . . 32.61 118.046 -170.762 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -98.74 142.63 30.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.495 1.747 . . . . 10.56 108.796 177.071 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.2 m -93.24 102.91 15.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.137 3.775 . . . . 5.33 115.636 169.473 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.25 153.58 23.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.842 -2.281 . . . . 11.66 104.842 168.602 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.424 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 89.2 m-70 -92.04 152.96 19.72 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.735 1.383 . . . . 16.3 114.735 168.191 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.418 HD23 HG22 ' A' ' 7' ' ' THR . 22.2 tp -120.01 108.78 14.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.977 2.111 . . . . 9.96 110.998 169.082 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.327 16.0 m -119.65 168.74 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 126.922 2.639 . . . . 9.76 112.505 171.495 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.2 mt -98.32 147.46 24.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 125.534 2.588 . . . . 19.57 106.591 179.053 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -85.15 112.75 20.97 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.951 -1.931 . . . . 35.08 112.951 176.654 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.2 mt -91.69 178.2 5.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.341 -3.349 . . . . 32.31 112.26 -178.117 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.4 tpp180 -82.01 83.66 7.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.351 1.432 . . . . 42.75 114.759 -162.548 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.82 -84.5 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 117.206 -2.426 . . . . 36.31 110.827 176.025 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.746 0 N-CA-C 106.818 -2.513 . . . . 36.27 106.818 156.757 . . . . . . . . 0 0 . 1 . 066 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 108.119 -1.067 . . . . 17.17 108.119 . . . . . . . . . 0 0 . 1 . 066 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -83.15 132.93 35.06 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.919 -2.363 . . . . 21.89 114.764 175.734 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -131.84 163.14 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 124.716 1.26 . . . . 10.83 110.039 172.489 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -124.67 166.27 16.44 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 102.282 -3.229 . . . . 10.61 102.282 -174.949 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -150.18 143.17 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 100.877 -3.749 . . . . 9.13 100.877 179.464 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -119.2 139.05 52.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.467 1.939 . . . . 20.55 106.271 -178.649 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.0 p -81.81 167.84 18.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.744 1.903 . . . . 11.78 107.565 178.654 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 tp -56.17 -54.8 40.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.014 3.326 . . . . 19.31 113.132 -178.946 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.3 p -62.62 -53.76 49.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.891 2.476 . . . . 23.14 110.57 175.727 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.18 70.61 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 CA-C-O 117.601 -1.666 . . . . 19.74 112.768 169.587 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -125.78 124.42 40.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.909 1.855 . . . . 21.93 109.665 176.858 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -79.57 106.03 11.31 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.383 -5.198 . . . . 12.33 111.177 177.387 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.7 mt -81.35 115.07 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 123.259 1.504 . . . . 17.08 107.139 171.934 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -94.47 104.11 16.08 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 114.344 -5.222 . . . . 16.3 114.818 171.518 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -97.35 162.29 13.4 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.436 -4.54 . . . . 15.88 112.244 179.378 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -116.22 118.99 34.34 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 102.913 -2.995 . . . . 28.9 102.913 174.322 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.27 165.55 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 121.844 2.111 . . . . 12.05 112.707 173.653 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -104.57 161.78 21.79 Favored Pre-proline 0 N--CA 1.43 -1.46 0 N-CA-C 105.658 -1.979 . . . . 18.17 105.658 164.169 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.17 -6.29 12.96 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 123.978 3.119 . . . . 8.16 109.311 -169.412 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -88.22 2.97 51.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 131.54 3.936 . . . . 11.13 113.379 168.0 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -87.15 152.71 22.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.21 -3.431 . . . . 18.03 109.91 -178.859 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p -94.86 164.05 13.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.149 2.704 . . . . 10.22 110.7 -167.042 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.5 mm -69.37 -34.87 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 O-C-N 115.489 -4.507 . . . . 12.3 109.164 -179.864 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.24 -42.78 77.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.737 2.866 . . . . 36.51 118.737 168.045 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -71.21 -32.43 68.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.02 2.128 . . . . 25.66 110.403 175.643 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.359 44.4 t -52.06 -61.27 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 118.98 -2.325 . . . . 8.12 111.094 165.396 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -52.59 -35.43 54.11 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 127.109 2.164 . . . . 15.47 114.479 177.772 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.37 70.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.296 -2.753 . . . . 11.45 109.481 -178.302 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -62.27 -41.65 98.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.145 -0.972 . . . . 24.98 112.925 171.846 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.7 mt -63.71 -36.34 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 127.459 2.974 . . . . 9.46 114.348 179.428 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -53.91 -33.19 55.92 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.509 3.924 . . . . 14.76 117.834 166.643 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.68 -51.48 9.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 124.12 1.914 . . . . 26.29 108.841 178.053 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -56.46 -63.15 1.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.274 1.987 . . . . 30.06 114.991 -176.771 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -110.91 -13.51 14.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.693 -3.129 . . . . 25.19 114.28 -172.765 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.78 43.86 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 119.524 2.57 . . . . 7.41 119.524 -172.623 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.6 115.9 65.85 Favored Pre-proline 0 N--CA 1.43 -1.425 0 CA-C-O 115.154 -2.355 . . . . 9.49 105.903 169.575 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -66.32 152.43 81.03 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 CA-C-N 126.906 3.502 . . . . 11.42 113.57 -177.856 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.14 -0.26 10.6 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.06 2.506 . . . . 12.0 112.92 -166.109 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -90.66 -54.79 3.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.836 3.207 . . . . 35.55 109.123 -173.897 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -84.28 -8.56 58.99 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.252 2.315 . . . . 20.52 117.252 -174.616 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -88.85 157.33 18.49 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.942 -2.974 . . . . 7.13 109.923 171.52 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -143.46 144.69 32.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.018 -1.676 . . . . 36.39 107.593 168.637 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.8 mt -97.59 140.07 32.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.017 1.327 . . . . 9.55 113.673 -175.983 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mm -134.52 139.35 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 104.009 -2.589 . . . . 13.9 104.009 -173.707 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' HB2' HD11 ' A' ' 50' ' ' LEU . 5.2 t80 -111.93 108.36 17.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.559 2.344 . . . . 6.86 107.834 173.389 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.41 -88.6 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.362 2.289 . . . . 11.15 112.781 -169.99 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.42 -8.48 4.89 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 117.012 -3.555 . . . . 13.93 109.953 175.841 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -81.56 141.07 34.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 118.032 0.916 . . . . 23.92 111.32 -177.345 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -94.61 120.84 35.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.272 1.429 . . . . 23.23 108.168 -178.168 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 45' ' ' PHE . 14.7 mt -91.84 133.25 35.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.593 1.957 . . . . 9.11 110.588 -165.138 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -94.84 136.25 35.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.772 -2.455 . . . . 33.44 114.92 179.098 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.82 -38.23 64.62 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.205 2.298 . . . . 28.37 117.205 -143.214 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.85 11.95 4.16 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 120.904 3.121 . . . . 15.0 120.904 164.66 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -106.18 172.88 6.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.39 2.595 . . . . 25.5 112.586 172.367 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -98.69 171.45 8.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.478 2.085 . . . . 11.95 115.436 176.128 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.01 -40.35 95.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.434 2.294 . . . . 10.17 109.391 173.394 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -60.41 -33.68 72.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 118.856 2.91 . . . . 13.59 118.856 173.17 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.286 28.5 m-20 -68.06 -44.78 75.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.629 1.715 . . . . 11.7 115.629 174.046 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -76.02 -32.55 59.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.424 1.489 . . . . 12.95 114.57 175.897 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t30 83.08 67.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 1 C-N-CA 131.884 4.073 . . . . 25.45 108.978 177.951 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.4 mt -101.49 118.15 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 127.485 2.314 . . . . 14.6 107.985 -177.916 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -89.25 177.92 6.48 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.097 -1.041 . . . . 33.23 110.518 -171.314 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -70.61 149.76 46.73 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.138 1.335 . . . . 25.97 110.882 175.916 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 70.03 51.41 0.41 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.778 3.231 . . . . 32.61 107.508 170.374 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -126.38 132.26 51.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.798 3.239 . . . . 10.56 115.398 -169.045 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.361 6.8 m -103.02 106.15 16.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.895 1.68 . . . . 5.33 115.48 -172.751 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 mt -83.67 156.13 22.81 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.346 3.451 . . . . 11.66 107.523 177.854 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -111.39 157.8 19.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.028 -3.545 . . . . 16.3 106.979 -174.971 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -126.85 106.86 9.63 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.923 1.344 . . . . 9.96 109.853 -169.696 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -118.88 171.49 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 100.896 -3.742 . . . . 9.76 100.896 -166.99 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt -97.1 147.1 24.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.606 -3.809 . . . . 19.57 101.851 -177.54 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -97.59 119.69 36.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.622 -3.174 . . . . 35.08 112.316 175.956 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 mt -91.41 164.66 13.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 116.12 1.896 . . . . 32.31 116.12 168.472 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -74.98 134.24 41.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.428 2.061 . . . . 42.75 114.401 -179.052 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.71 -74.08 0.25 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 113.359 -1.746 . . . . 36.31 114.367 171.419 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.794 0 O-C-N 120.48 -1.6 . . . . 36.27 111.327 170.864 . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 118.873 -0.585 . . . . 17.17 111.193 . . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -96.57 138.76 33.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.001 -2.312 . . . . 21.89 113.455 170.324 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.8 pt -115.04 154.15 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 127.231 2.212 . . . . 10.83 105.249 165.803 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -113.18 114.31 26.58 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.839 -1.788 . . . . 10.61 107.17 -176.991 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.8 105.93 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 105.504 -2.036 . . . . 9.13 105.504 177.784 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -101.03 152.43 20.6 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.827 -2.657 . . . . 20.55 103.827 -172.73 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -97.11 172.19 7.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.135 -0.978 . . . . 11.78 110.803 178.348 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.5 tp -45.72 -57.17 4.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.424 2.009 . . . . 19.31 116.424 170.191 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.06 -42.78 77.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 131.562 3.945 . . . . 23.14 111.235 175.13 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.1 55.86 0.47 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 126.811 3.451 . . . . 19.74 109.653 172.407 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -115.2 135.82 53.76 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.231 -2.334 . . . . 21.93 107.815 175.058 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -106.79 119.5 39.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.214 -3.429 . . . . 12.33 117.102 -164.544 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.2 mt -104.14 102.69 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 119.047 -2.283 . . . . 17.08 111.283 -172.567 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -84.76 118.27 24.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.967 1.707 . . . . 16.3 106.812 -176.714 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.415 HD11 HG13 ' A' ' 30' ' ' ILE . 58.3 mt -115.52 131.32 56.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.611 -2.556 . . . . 15.88 106.952 -173.919 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -100.06 91.04 4.6 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.727 1.751 . . . . 28.9 115.727 179.824 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.77 163.88 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 128.053 3.787 . . . . 12.05 112.208 -171.44 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -92.45 157.12 40.78 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.791 -2.443 . . . . 18.17 106.478 167.799 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.54 -3.61 14.01 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 114.748 -3.343 . . . . 8.16 111.39 176.749 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 p -87.59 -7.55 57.36 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 118.732 -2.48 . . . . 11.13 111.007 175.33 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.74 137.57 54.18 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.147 1.379 . . . . 18.03 109.531 176.127 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 p -85.28 164.11 18.22 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.341 2.256 . . . . 10.22 109.136 -173.131 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.605 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 35.8 mm -62.29 -37.83 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 O-C-N 114.669 -5.02 . . . . 12.3 110.559 178.299 . . . . . . . . 3 3 . 1 . 067 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.27 19.1 tt0 -52.54 -54.05 37.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.49 1.916 . . . . 36.51 115.421 169.463 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 15.2 t-20 -55.68 -45.76 77.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.422 1.889 . . . . 25.66 112.568 170.889 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.39 -42.95 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.294 1.438 . . . . 8.12 112.747 175.16 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -68.41 -33.45 74.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.658 2.481 . . . . 15.47 108.609 179.8 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.2 -30.75 71.67 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 116.124 1.898 . . . . 11.45 116.124 178.773 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -70.28 -33.59 71.75 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 117.234 -1.365 . . . . 24.98 112.047 173.454 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.415 HG13 HD11 ' A' ' 15' ' ' LEU . 25.6 mt -71.26 -45.62 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 119.56 1.073 . . . . 9.46 112.717 169.372 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.309 36.5 tt0 -44.04 -52.93 6.73 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.79 1.636 . . . . 14.76 115.239 166.617 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -55.7 -39.49 71.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.623 -1.923 . . . . 26.29 115.123 173.56 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -88.81 -67.74 0.82 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.338 2.018 . . . . 30.06 114.932 -165.518 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -88.78 -43.49 11.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.35 2.5 . . . . 25.19 109.552 -168.119 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.24 19.83 3.45 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.032 -1.895 . . . . 7.41 110.283 168.424 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.2 mt -90.31 120.19 69.12 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-N 121.616 2.708 . . . . 9.49 104.219 -167.501 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 23.3 Cg_endo -81.16 162.66 20.21 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 CA-C-N 123.152 2.161 . . . . 11.42 115.27 -179.88 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 19.4 Cg_endo -84.57 -8.34 9.47 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 N-CA-C 116.286 1.61 . . . . 12.0 116.286 -161.452 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -79.03 -20.88 47.86 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.101 3.137 . . . . 35.55 114.791 164.972 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -79.71 -37.66 35.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.695 2.188 . . . . 20.52 112.961 -178.306 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -102.61 136.44 42.44 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.961 -4.212 . . . . 7.13 110.211 -172.834 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -115.44 148.67 39.12 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.199 1.399 . . . . 36.39 110.346 164.826 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.9 mt -114.8 125.43 53.68 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.664 -1.607 . . . . 9.55 111.578 -178.021 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -103.8 139.14 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 125.931 2.019 . . . . 13.9 106.624 174.241 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -122.17 138.12 54.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.335 -1.793 . . . . 6.86 113.482 162.668 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.325 . . 52.26 -99.17 0.08 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.368 1.895 . . . . 11.15 112.955 -174.707 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.13 51.71 0.58 Allowed Glycine 0 N--CA 1.43 -1.748 1 O-C-N 115.468 -4.52 . . . . 13.93 108.484 169.78 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -153.83 165.26 36.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 127.408 2.475 . . . . 23.92 115.485 177.039 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -91.7 127.97 37.35 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.071 2.948 . . . . 23.23 115.7 -174.47 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.9 mt -90.79 123.9 34.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.025 -2.297 . . . . 9.11 114.453 175.099 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -97.93 131.83 44.04 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.801 2.04 . . . . 33.44 112.818 -171.793 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.605 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 1.9 m-20 -32.36 -50.04 0.22 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.382 3.873 . . . . 28.37 118.369 176.942 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.98 -12.44 76.89 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 119.133 2.413 . . . . 15.0 119.133 -174.14 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -91.23 167.78 12.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.428 -2.219 . . . . 25.5 111.35 -178.418 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 p -88.13 160.68 17.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 127.313 2.883 . . . . 11.95 112.301 173.081 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -68.01 -30.7 70.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.999 2.592 . . . . 10.17 117.999 169.031 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 29.4 m -56.19 -41.73 75.99 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 131.02 3.728 . . . . 13.59 110.062 168.352 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.95 -32.49 74.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.303 -2.123 . . . . 11.7 114.95 -176.347 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -82.8 -31.76 28.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.221 2.608 . . . . 12.95 109.448 178.7 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.6 m120 74.03 58.96 0.09 Allowed 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 129.216 4.073 . . . . 25.45 115.498 -166.845 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.7 mt -104.6 135.47 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 117.813 -3.055 . . . . 14.6 106.571 -176.748 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -117.49 -168.28 1.46 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.124 1.37 . . . . 33.23 113.348 -155.354 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -83.34 134.59 34.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.184 -2.197 . . . . 25.97 109.947 168.488 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 69.21 38.09 1.97 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.917 2.77 . . . . 32.61 113.938 -176.781 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 m -98.33 133.71 42.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.034 1.873 . . . . 10.56 107.682 -173.918 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.6 m -95.73 123.47 39.31 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.064 -1.648 . . . . 5.33 111.212 -174.236 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.5 132.93 53.68 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 130.637 3.575 . . . . 11.66 108.611 -179.339 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -104.18 105.87 16.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.298 1.863 . . . . 16.3 112.067 -175.225 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 tt -79.36 120.97 24.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.346 2.658 . . . . 9.96 111.39 -179.466 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -126.49 173.73 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.447 3.023 . . . . 9.76 104.08 -173.503 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -85.48 129.45 34.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.703 -2.498 . . . . 19.57 110.342 174.291 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -86.4 129.77 34.74 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 122.953 1.358 . . . . 35.08 108.029 165.21 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.0 mt -104.38 -179.04 3.83 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.243 -1.391 . . . . 32.31 107.243 170.32 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -78.31 141.94 38.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.343 -1.313 . . . . 42.75 111.181 161.929 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.35 -94.8 0.17 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 117.267 -2.397 . . . . 36.31 108.793 178.638 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.732 0 N-CA-C 110.579 -1.009 . . . . 36.27 110.579 179.881 . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 117.505 2.409 . . . . 17.17 117.505 . . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -130.41 145.74 51.86 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.589 -0.893 . . . . 21.89 108.589 174.629 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.8 pt -139.68 162.43 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 117.64 -3.162 . . . . 10.83 107.601 174.523 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -121.09 127.21 51.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.674 -0.861 . . . . 10.61 108.674 -178.536 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.502 HG11 HD12 ' A' ' 69' ' ' LEU . 60.5 t -96.32 120.33 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 128.181 3.425 . . . . 9.13 107.959 170.231 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -125.46 145.27 50.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.524 3.059 . . . . 20.55 108.743 178.734 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 41.7 p -94.55 -161.53 0.86 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 112.405 -2.18 . . . . 11.78 113.88 174.941 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' H ' ' HB ' ' A' ' 7' ' ' THR . 9.6 tt -77.64 -47.58 18.91 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 115.555 -2.164 . . . . 19.31 109.56 -170.292 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.4 p -71.08 -47.59 57.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.347 2.022 . . . . 23.14 111.194 175.848 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.54 63.09 0.17 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.505 -2.622 . . . . 19.74 109.156 176.213 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -91.51 116.26 28.71 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.957 2.903 . . . . 21.93 111.153 167.985 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -88.29 106.82 18.47 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.083 1.765 . . . . 12.33 114.567 -173.389 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 mt -104.99 104.86 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 125.663 1.585 . . . . 17.08 107.495 -178.435 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -90.88 125.06 35.63 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 114.97 -4.831 . . . . 16.3 108.701 -172.357 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.266 87.6 mt -127.84 147.64 50.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 120.474 3.509 . . . . 15.88 120.474 -179.589 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -107.18 117.06 33.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.15 -1.426 . . . . 28.9 107.15 -166.972 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.72 158.24 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 131.414 3.886 . . . . 12.05 112.297 -170.944 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -121.11 160.36 45.61 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 114.821 -2.514 . . . . 18.17 105.773 172.73 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -72.19 -19.85 25.51 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 CA-C-N 128.496 4.07 . . . . 8.16 111.195 -159.253 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 m -84.58 3.18 38.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.885 -3.009 . . . . 11.13 112.561 -177.197 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.88 144.32 41.24 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 117.323 -1.751 . . . . 18.03 115.225 175.138 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 69.2 p -82.45 159.4 22.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.754 2.692 . . . . 10.22 113.794 -173.153 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.45 -35.89 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.896 -3.003 . . . . 12.3 113.103 176.409 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.278 54.9 tt0 -37.72 -65.07 0.35 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.119 2.568 . . . . 36.51 112.221 160.88 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -57.81 -34.91 70.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.194 2.197 . . . . 25.66 114.521 -177.642 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 t -62.63 -52.94 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.05 2.094 . . . . 8.12 110.129 179.664 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -64.31 -30.55 71.6 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.605 3.098 . . . . 15.47 113.398 -177.287 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.35 -40.28 74.23 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.575 -4.453 . . . . 11.45 113.949 179.266 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -62.56 -47.93 81.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.181 1.792 . . . . 24.98 111.079 169.516 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.444 ' HB ' HE22 ' A' ' 41' ' ' GLN . 70.9 mt -63.88 -41.55 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 127.011 2.124 . . . . 9.46 112.384 -176.094 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -62.33 -56.91 13.86 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.156 -2.215 . . . . 14.76 114.948 168.625 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.67 -40.66 92.63 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 116.274 -4.017 . . . . 26.29 116.32 -176.027 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -89.25 -64.29 1.16 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.607 -3.808 . . . . 30.06 110.407 -172.184 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -83.75 -29.6 27.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.848 -3.657 . . . . 25.19 109.286 -173.302 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.92 46.17 2.12 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 123.367 2.803 . . . . 7.41 108.724 159.779 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.2 mt -114.96 113.94 44.0 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.462 -2.051 . . . . 9.49 105.462 -176.374 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.98 156.52 34.33 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.111 2.541 . . . . 11.42 112.581 -158.957 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -80.28 -8.49 13.97 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 123.907 3.071 . . . . 12.0 108.984 -161.88 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.341 4.0 p30 -79.39 -25.47 42.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.263 1.506 . . . . 35.55 109.503 175.889 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -95.06 -38.51 10.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.208 1.48 . . . . 20.52 111.707 -166.946 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.444 HE22 ' HB ' ' A' ' 30' ' ' ILE . 26.4 pt20 -83.57 147.2 27.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.488 -2.007 . . . . 7.13 114.038 178.034 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -144.55 145.18 31.69 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 99.998 -4.075 . . . . 36.39 99.998 166.055 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.97 130.61 55.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.739 -1.226 . . . . 9.55 113.696 179.645 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.5 138.86 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 103.264 -2.865 . . . . 13.9 103.264 173.148 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.437 ' HB2' HD11 ' A' ' 50' ' ' LEU . 86.3 t80 -126.53 119.05 26.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.931 -1.486 . . . . 6.86 109.099 169.964 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.11 -54.13 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 132.614 4.365 . . . . 11.15 116.108 -163.558 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.99 19.56 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 127.953 2.692 . . . . 13.93 112.08 177.417 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -104.36 146.16 29.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.051 -2.203 . . . . 23.92 105.051 164.012 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.257 10.8 tt0 -87.45 125.09 34.08 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.281 1.832 . . . . 23.23 111.969 176.241 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 45' ' ' PHE . 64.2 mt -97.08 107.29 19.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.53 2.048 . . . . 9.11 116.53 -170.619 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -69.49 141.75 53.87 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.055 2.097 . . . . 33.44 113.92 -173.904 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -24.34 -75.95 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 1 N-CA-C 123.682 4.697 . . . . 28.37 123.682 176.251 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.91 28.54 14.01 Favored Glycine 0 N--CA 1.43 -1.737 1 O-C-N 114.817 -4.927 . . . . 15.0 113.003 -157.186 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -107.79 153.79 22.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.015 1.388 . . . . 25.5 113.366 177.566 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -90.39 161.07 15.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 115.504 -2.479 . . . . 11.95 109.242 -172.21 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.42 -31.45 69.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.996 2.119 . . . . 10.17 113.045 170.311 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.27 8.6 t -55.34 -59.2 5.12 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 131.05 3.74 . . . . 13.59 116.744 167.489 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.8 -33.72 74.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.386 3.106 . . . . 11.7 119.386 172.531 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -82.77 3.62 28.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.718 -3.114 . . . . 12.95 114.506 174.577 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 65.84 30.21 10.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.864 3.666 . . . . 25.45 114.965 172.668 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -91.05 104.88 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.485 -2.634 . . . . 14.6 115.657 -173.517 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -101.6 -178.16 3.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.084 1.897 . . . . 33.23 112.757 -169.462 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.329 15.1 pttp -54.38 146.92 14.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.893 1.812 . . . . 25.97 115.893 -172.113 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 39.79 45.57 1.5 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.368 2.267 . . . . 32.61 116.933 -166.407 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 m -84.05 138.3 33.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.584 3.564 . . . . 10.56 108.051 178.265 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 m -84.46 111.09 19.16 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 110.649 -2.978 . . . . 5.33 109.37 176.356 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.401 9.2 mp -94.65 119.73 33.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.166 -3.459 . . . . 11.66 118.467 172.12 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -93.53 99.26 11.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.195 2.902 . . . . 16.3 105.964 -172.411 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.502 HD12 HG11 ' A' ' 5' ' ' VAL . 7.8 tt -82.65 116.83 22.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.559 -2.564 . . . . 9.96 109.929 174.516 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.272 2.7 m -114.89 166.04 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 124.65 2.167 . . . . 9.76 112.997 -167.169 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 tp -71.22 123.71 22.83 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.018 -2.926 . . . . 19.57 115.156 173.313 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -101.44 131.43 47.55 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.077 -3.515 . . . . 35.08 114.601 -176.653 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.92 162.71 26.92 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.117 -1.401 . . . . 32.31 109.51 -172.609 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -67.02 148.29 52.13 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.424 2.379 . . . . 42.75 117.424 -176.52 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.09 -53.37 0.81 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 127.185 2.326 . . . . 36.31 112.992 178.261 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.781 0 N-CA-C 110.982 -0.847 . . . . 36.27 110.982 176.707 . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 122.77 1.271 . . . . 17.17 114.182 . . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -105.78 124.0 48.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.353 3.461 . . . . 21.89 108.068 -163.333 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.301 13.1 pt -118.18 163.55 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 128.723 2.809 . . . . 10.83 114.606 179.311 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -133.73 117.6 17.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.206 -2.809 . . . . 10.61 112.274 -164.572 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.78 114.31 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 124.546 2.117 . . . . 9.13 106.932 -174.127 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -94.71 136.77 34.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.071 -1.643 . . . . 20.55 109.112 177.37 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.262 7.8 p -80.24 -169.62 2.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.613 1.965 . . . . 11.78 112.917 -177.82 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.29 -56.88 4.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.213 1.006 . . . . 19.31 113.238 166.029 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.3 p -61.45 -62.44 1.82 Allowed 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 115.416 1.636 . . . . 23.14 115.416 -173.458 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.89 40.66 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 122.935 1.297 . . . . 19.74 116.152 -170.692 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -118.11 140.72 49.36 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.241 -1.741 . . . . 21.93 112.024 172.069 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.8 m -117.12 115.05 24.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.532 -1.655 . . . . 12.33 106.532 -178.409 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -98.1 126.43 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 124.983 1.427 . . . . 17.08 109.564 -170.98 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -96.82 135.43 38.8 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.667 -2.521 . . . . 16.3 105.903 178.474 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.489 HD11 HG13 ' A' ' 30' ' ' ILE . 11.7 mt -125.67 155.77 40.32 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 103.918 -2.623 . . . . 15.88 103.918 173.706 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -118.62 132.38 56.18 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.853 -1.536 . . . . 28.9 106.853 167.961 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -148.73 165.03 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 126.322 2.263 . . . . 12.05 105.336 -162.563 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -117.93 145.37 36.57 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 127.72 2.408 . . . . 18.17 106.224 173.872 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.5 -24.1 31.24 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 124.944 3.763 . . . . 8.16 115.288 -165.562 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -77.91 -0.51 27.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.926 2.641 . . . . 11.13 117.027 173.326 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -90.55 152.31 20.96 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.675 -1.89 . . . . 18.03 112.082 177.924 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.9 p -82.22 174.85 10.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.175 2.287 . . . . 10.22 117.175 -177.992 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mm -69.17 -32.26 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.695 2.798 . . . . 12.3 103.647 175.962 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.83 -31.19 66.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 124.396 3.271 . . . . 36.51 119.288 174.557 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -76.62 -30.4 56.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.178 2.191 . . . . 25.66 109.156 179.757 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.496 HG21 HD21 ' A' ' 56' ' ' LEU . 59.8 t -76.46 -38.59 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 115.651 -2.118 . . . . 8.12 108.316 177.222 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -60.77 -57.49 12.46 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 125.17 1.543 . . . . 15.47 110.81 175.564 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.22 -48.02 17.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.984 2.914 . . . . 11.45 115.089 169.923 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HB3' HD22 ' A' ' 15' ' ' LEU . 38.1 mttt -75.16 -30.28 60.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 121.265 1.848 . . . . 24.98 114.304 -179.27 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.489 HG13 HD11 ' A' ' 15' ' ' LEU . 44.1 mt -55.84 -56.36 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 114.103 1.149 . . . . 9.46 114.103 161.209 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -45.49 -45.55 13.26 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.179 2.592 . . . . 14.76 112.11 179.328 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -59.29 -34.95 72.91 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.454 2.761 . . . . 26.29 118.454 173.233 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -71.93 -72.61 0.22 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.074 1.879 . . . . 30.06 116.074 166.846 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -87.89 -30.65 19.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 119.877 3.288 . . . . 25.19 119.877 -176.432 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.66 73.44 0.98 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 123.926 1.848 . . . . 7.41 115.1 -173.226 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.507 HD13 HG21 ' A' ' 36' ' ' ILE . 94.3 mt -124.91 127.73 25.04 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-O 112.36 -3.686 . . . . 9.49 105.51 178.515 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -63.94 146.94 92.0 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 127.782 3.815 . . . . 11.42 114.98 -166.714 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.29 -20.98 36.33 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 119.718 2.93 . . . . 12.0 119.718 179.058 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -81.3 -30.13 34.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.854 3.216 . . . . 35.55 113.05 172.999 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -71.97 -47.6 50.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.897 -3.627 . . . . 20.52 113.041 175.396 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -72.54 161.56 30.63 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 116.079 -4.138 . . . . 7.13 116.818 -179.808 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -147.22 136.93 22.97 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.136 2.174 . . . . 36.39 111.988 170.864 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 mt -105.33 122.38 45.83 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 116.333 -1.794 . . . . 9.55 114.505 178.822 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mm -93.6 140.74 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 131.607 3.963 . . . . 13.9 111.026 167.753 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -134.71 117.22 15.8 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.118 2.967 . . . . 6.86 112.503 167.158 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.84 -105.74 0.23 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.134 2.574 . . . . 11.15 111.531 -159.853 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.81 27.24 5.47 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.838 -1.164 . . . . 13.93 114.65 -172.337 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -153.69 141.87 20.45 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 126.535 3.064 . . . . 23.92 110.64 -179.706 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.45 165.06 23.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 112.469 -2.151 . . . . 23.23 112.605 172.879 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.363 12.0 mt -110.1 161.78 15.21 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.766 -1.834 . . . . 9.11 110.049 -172.665 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -108.47 132.5 53.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.38 2.3 . . . . 33.44 109.971 179.228 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -45.48 -50.49 12.66 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 122.379 4.214 . . . . 28.37 122.379 -169.022 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.51 14.52 45.99 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 111.701 -2.5 . . . . 15.0 113.848 -175.664 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -99.37 155.15 17.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 116.902 -1.523 . . . . 25.5 111.747 174.744 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.9 p -87.34 161.46 17.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.129 1.518 . . . . 11.95 109.63 -177.119 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.496 HD21 HG21 ' A' ' 26' ' ' VAL . 14.7 mt -57.38 -44.38 84.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.961 2.791 . . . . 10.17 112.897 169.592 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -64.76 -15.45 61.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.303 -3.998 . . . . 13.59 115.486 -179.663 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -79.96 -44.7 19.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.57 -2.581 . . . . 11.7 110.583 179.951 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -85.6 -4.18 59.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.056 1.408 . . . . 12.95 112.64 174.746 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.435 22.9 m120 82.62 36.32 0.06 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.091 -3.505 . . . . 25.45 108.97 171.127 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.3 mt -89.44 98.12 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 119.601 -1.937 . . . . 14.6 109.277 -176.482 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -86.68 -172.25 3.92 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 117.341 2.348 . . . . 33.23 117.341 -171.044 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -73.26 138.74 45.7 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.941 0.877 . . . . 25.97 112.149 176.697 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 62.86 12.51 5.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.801 -2.437 . . . . 32.61 116.793 -171.977 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m -78.04 134.88 37.7 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 119.8 3.259 . . . . 10.56 119.8 169.019 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -87.16 123.84 32.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.676 1.58 . . . . 5.33 109.549 -177.061 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -93.49 163.36 13.6 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.339 -2.1 . . . . 11.66 114.518 153.755 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -123.62 119.23 29.25 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.778 -1.556 . . . . 16.3 114.556 177.583 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.82 128.97 35.66 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 117.956 -1.021 . . . . 9.96 111.373 177.517 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 m -127.43 -167.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 127.648 3.092 . . . . 9.76 107.281 179.707 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 tp -111.81 142.32 44.31 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 105.744 -1.947 . . . . 19.57 105.744 -172.665 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -97.07 117.39 31.15 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.485 -1.234 . . . . 35.08 107.776 179.571 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.8 mt -107.65 134.52 50.52 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.423 -2.048 . . . . 32.31 113.137 159.46 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.281 3.8 tpp180 -72.96 115.51 12.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.135 -1.603 . . . . 42.75 110.482 -173.937 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.82 -51.16 0.43 Allowed Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 109.685 -1.366 . . . . 36.31 109.685 -173.091 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.814 0 CA-C-O 124.17 1.983 . . . . 36.27 109.528 171.957 . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttm . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 107.315 -1.365 . . . . 17.17 107.315 . . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -100.19 161.17 13.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.891 -3.63 . . . . 21.89 111.506 169.734 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 65' ' ' SER . 12.4 pt -152.96 157.7 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 129.083 2.953 . . . . 10.83 110.401 172.587 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.29 108.46 16.59 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 114.917 -4.864 . . . . 10.61 113.148 -172.557 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.3 t -103.13 114.59 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.596 -2.565 . . . . 9.13 109.705 -176.667 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -98.06 146.02 25.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.625 1.678 . . . . 20.55 114.163 -173.863 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.311 81.4 p -86.56 -176.84 5.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.75 1.262 . . . . 11.78 109.41 172.678 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.4 tp -68.32 -62.37 1.43 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.692 2.797 . . . . 19.31 110.49 168.114 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -60.79 -68.77 0.27 Allowed 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.857 -3.652 . . . . 23.14 119.409 176.418 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.4 46.28 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 O-C-N 116.549 -3.844 . . . . 19.74 109.611 -173.552 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -118.88 141.15 48.91 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.673 -0.898 . . . . 21.93 110.415 157.95 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -110.41 124.9 52.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.612 -1.625 . . . . 12.33 106.612 169.077 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mt -84.39 108.6 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 128.437 2.695 . . . . 17.08 107.994 169.188 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.4 m -96.64 97.94 9.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.128 -2.858 . . . . 16.3 111.95 -176.405 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.18 147.18 25.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.149 -2.844 . . . . 15.88 112.053 -169.125 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -111.16 133.05 53.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.485 1.612 . . . . 28.9 111.992 162.07 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.04 158.08 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 2 CA-C-N 107.04 -4.618 . . . . 12.05 111.592 -167.441 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -95.71 160.86 29.37 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 123.925 0.766 . . . . 18.17 112.035 159.145 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -87.85 -2.35 7.29 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 124.498 2.642 . . . . 8.16 108.689 -175.561 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -81.8 -18.38 44.24 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.396 3.078 . . . . 11.13 111.709 170.208 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.24 153.08 34.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.019 1.489 . . . . 18.03 115.019 177.327 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.7 p -89.69 172.76 8.71 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.532 1.133 . . . . 10.22 110.468 -173.967 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -70.24 -24.32 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 118.526 -1.27 . . . . 12.3 111.597 171.26 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.53 -39.7 85.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.76 1.267 . . . . 36.51 113.414 171.336 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -65.53 -37.28 86.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.359 -3.963 . . . . 25.66 114.035 167.735 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 22' ' ' THR . 79.0 t -73.85 -34.18 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 122.716 2.507 . . . . 8.12 108.746 -171.679 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -67.88 -41.26 83.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.147 3.779 . . . . 15.47 108.557 172.837 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.54 -33.52 66.9 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.713 2.405 . . . . 11.45 112.403 -177.666 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -61.97 -33.73 74.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.715 -3.116 . . . . 24.98 114.597 166.887 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.4 mt -73.0 -41.69 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 117.034 -1.46 . . . . 9.46 110.333 173.157 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -56.98 -42.12 79.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.606 2.362 . . . . 14.76 113.797 178.407 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.01 -43.46 82.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 112.974 -3.393 . . . . 26.29 110.825 179.806 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -100.79 -43.13 6.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 124.395 3.27 . . . . 30.06 118.33 -173.209 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -91.75 -38.06 12.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 123.461 0.705 . . . . 25.19 109.429 -175.977 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.27 21.84 9.12 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 120.373 -1.454 . . . . 7.41 114.61 170.847 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -91.73 122.44 65.53 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 113.392 -3.194 . . . . 9.49 109.263 -175.718 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.87 147.72 85.45 Favored 'Trans proline' 0 N--CA 1.434 -2.014 1 CA-C-N 129.786 4.531 . . . . 11.42 114.501 -179.972 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -79.58 -8.42 14.8 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 122.395 2.063 . . . . 12.0 112.792 -162.61 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -83.84 -34.65 24.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.999 -3.563 . . . . 35.55 109.065 179.045 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -83.87 -28.41 28.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 131.072 3.749 . . . . 20.52 112.04 -167.696 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -92.05 155.5 18.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.584 2.611 . . . . 7.13 112.793 166.3 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -142.16 142.45 32.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.052 -2.28 . . . . 36.39 109.998 167.708 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.5 mt -101.1 111.14 23.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 116.561 2.06 . . . . 9.55 116.561 176.904 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.7 mm -95.71 132.1 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 126.432 2.332 . . . . 13.9 111.705 172.148 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -111.86 123.0 49.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.818 2.723 . . . . 6.86 105.949 169.677 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.451 . . 59.61 -99.36 0.09 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 116.255 -1.831 . . . . 11.15 115.66 -170.338 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.98 18.39 4.5 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 106.426 -2.669 . . . . 13.93 106.426 179.67 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -124.21 130.42 52.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.236 2.214 . . . . 23.92 110.301 -173.636 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -91.3 125.72 36.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.342 -2.096 . . . . 23.23 105.342 -169.977 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.533 HD22 ' CD2' ' A' ' 59' ' ' TYR . 92.9 mt -86.28 148.5 25.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.095 0.958 . . . . 9.11 112.275 -179.296 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -123.42 148.76 45.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.182 -2.824 . . . . 33.44 116.87 -171.171 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -19.15 -76.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 133.491 4.716 . . . . 28.37 121.387 178.691 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.49 16.22 61.19 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 117.458 1.743 . . . . 15.0 117.458 -168.474 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -99.11 160.99 13.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.955 -2.497 . . . . 25.5 110.32 167.351 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -103.76 168.26 9.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 104.792 -2.299 . . . . 11.95 104.792 -178.829 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -55.88 -36.59 67.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.617 -2.083 . . . . 10.17 115.994 167.768 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 t -61.63 -43.69 98.38 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.123 -2.861 . . . . 13.59 117.114 167.35 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -64.64 -26.64 68.48 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.095 1.887 . . . . 11.7 116.095 -177.182 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.533 ' CD2' HD22 ' A' ' 50' ' ' LEU . 66.9 m-85 -83.94 -32.34 25.12 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 116.912 -3.618 . . . . 12.95 111.043 170.717 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.301 26.2 m120 96.25 51.83 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.98 2.112 . . . . 25.45 114.379 -175.271 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.78 125.63 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 125.067 1.48 . . . . 14.6 113.96 177.837 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -110.03 177.27 4.76 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.972 1.841 . . . . 33.23 115.972 -176.957 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -60.41 145.75 46.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 124.404 3.275 . . . . 25.97 119.066 -174.54 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 67.74 32.19 5.52 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 132.129 4.171 . . . . 32.61 111.466 178.558 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.468 ' H ' HG22 ' A' ' 3' ' ' ILE . 22.7 t -89.35 151.7 21.93 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.685 -3.134 . . . . 10.56 110.145 -174.95 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -92.2 120.81 33.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.88 2.072 . . . . 5.33 112.584 -172.32 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -117.77 159.99 22.11 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.222 2.915 . . . . 11.66 105.582 172.758 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -116.99 117.51 29.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.45 -3.281 . . . . 16.3 113.577 177.503 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -91.72 116.46 28.9 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.168 -1.583 . . . . 9.96 111.191 174.487 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.6 m -112.27 134.15 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 127.819 2.448 . . . . 9.76 106.193 178.551 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.55 144.31 30.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.309 2.004 . . . . 19.57 106.481 -175.783 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -79.64 116.15 19.66 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.579 2.437 . . . . 35.08 117.579 -172.783 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.1 mt -108.85 169.04 8.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.754 2.822 . . . . 32.31 108.355 -179.856 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -80.2 -44.21 20.15 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.267 -1.333 . . . . 42.75 113.943 -167.2 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.36 50.36 0.8 Allowed Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 130.459 3.885 . . . . 36.31 107.673 -174.793 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.739 0 CA-C-N 119.241 1.521 . . . . 36.27 110.399 176.332 . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 117.454 2.39 . . . . 17.17 117.454 . . . . . . . . . 0 0 . 1 . 071 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -90.36 133.49 34.95 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.07 -4.769 . . . . 21.89 106.708 -179.462 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.8 pt -118.04 164.89 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 104.456 -2.424 . . . . 10.83 104.456 163.369 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -119.29 127.29 53.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.885 -2.416 . . . . 10.61 105.038 -174.561 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.5 139.13 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.159 -2.534 . . . . 9.13 104.159 176.202 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -125.23 133.63 52.64 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.325 -3.36 . . . . 20.55 116.029 178.742 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.2 p -77.98 171.79 14.47 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 127.128 3.347 . . . . 11.78 111.277 175.558 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -79.35 -24.05 42.98 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.514 -2.13 . . . . 19.31 110.95 -172.993 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -77.21 -69.16 0.55 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.902 1.334 . . . . 23.14 108.338 170.181 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.23 66.19 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 O-C-N 119.143 -2.223 . . . . 19.74 112.018 169.303 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -99.76 134.26 42.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.54 1.536 . . . . 21.93 114.041 155.686 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.7 m -80.06 119.91 23.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.357 -1.464 . . . . 12.33 113.124 164.597 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.49 95.67 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 128.519 2.727 . . . . 17.08 107.53 -171.844 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.0 m -89.82 99.23 12.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.206 -1.035 . . . . 16.3 108.206 -165.137 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.295 47.0 mt -104.49 149.12 25.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.602 -3.186 . . . . 15.88 110.653 -170.788 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -108.0 123.33 48.49 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 121.66 2.027 . . . . 28.9 113.664 173.356 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -135.27 162.53 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.582 -1.948 . . . . 12.05 107.262 -164.839 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -101.69 165.31 14.24 Favored Pre-proline 0 N--CA 1.429 -1.486 0 O-C-N 118.421 -2.674 . . . . 18.17 108.334 165.299 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -64.06 -23.71 67.13 Favored 'Trans proline' 0 C--N 1.3 -2.012 2 C-N-CA 125.721 4.281 . . . . 8.16 112.597 174.053 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 m -87.68 3.15 48.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.987 -1.695 . . . . 11.13 109.907 -174.627 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -88.89 148.02 24.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.331 1.062 . . . . 18.03 109.286 -178.286 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 p -91.76 169.47 10.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.01 -1.904 . . . . 10.22 110.048 -175.828 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -46.65 -49.83 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.972 2.509 . . . . 12.3 114.46 160.513 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.301 23.8 tt0 -42.53 -43.21 3.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 117.03 2.233 . . . . 36.51 117.03 165.577 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -69.22 -30.32 68.46 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.402 1.91 . . . . 25.66 112.637 172.78 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.1 -56.2 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.568 -3.833 . . . . 8.12 113.585 175.909 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -49.15 -46.13 44.75 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 130.439 3.496 . . . . 15.47 112.292 171.592 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.8 -36.95 76.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.339 -3.35 . . . . 11.45 114.828 -178.419 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -68.63 -33.8 74.64 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.986 1.476 . . . . 24.98 114.986 173.507 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.5 mt -70.39 -42.77 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.662 -4.399 . . . . 9.46 111.167 175.528 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -55.75 -43.24 76.47 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.97 -1.706 . . . . 14.76 110.001 170.358 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.263 21.5 t70 -48.95 -67.31 0.28 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.075 3.35 . . . . 26.29 114.683 177.751 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -93.99 -46.66 7.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.061 2.986 . . . . 30.06 119.061 178.847 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.98 -33.08 70.08 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 116.283 -1.818 . . . . 25.19 111.294 -171.591 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.74 18.68 46.99 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 116.446 -2.308 . . . . 7.41 115.213 -179.164 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.4 mt -99.71 121.38 54.69 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 119.737 1.768 . . . . 9.49 108.879 175.158 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -68.36 157.07 63.38 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 122.982 2.455 . . . . 11.42 117.958 178.328 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.02 -28.53 10.97 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 122.417 2.078 . . . . 12.0 111.675 -170.083 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.64 -31.43 68.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 126.108 2.13 . . . . 35.55 110.427 173.41 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -72.64 -15.95 61.71 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.363 -2.711 . . . . 20.52 115.413 -175.488 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -118.15 161.08 20.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.695 2.497 . . . . 7.13 112.563 -168.999 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -138.09 133.66 33.74 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.772 -1.566 . . . . 36.39 106.772 164.223 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.29 129.72 43.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.932 -2.355 . . . . 9.55 107.306 178.666 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.7 mm -116.04 133.58 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.366 -1.459 . . . . 13.9 109.898 -178.579 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -114.26 115.31 27.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.088 -3.508 . . . . 6.86 108.143 165.032 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.25 -83.46 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.273 2.323 . . . . 11.15 117.273 -176.385 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.25 -36.7 5.6 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 116.981 -3.574 . . . . 13.93 111.444 -178.328 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -105.42 148.49 27.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.62 1.341 . . . . 23.92 114.62 -162.599 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 49' ' ' GLN . 23.4 pt20 -92.95 131.15 38.21 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.126 -4.734 . . . . 23.23 108.592 173.403 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.9 mt -74.25 143.3 45.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.531 1.678 . . . . 9.11 115.531 -176.584 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.56 133.49 55.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.231 -1.543 . . . . 33.44 108.043 -168.739 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -30.72 -53.58 0.19 Allowed 'General case' 0 N--CA 1.429 -1.476 1 N-CA-C 124.261 4.912 . . . . 28.37 124.261 -173.014 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.98 17.41 44.94 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 121.305 1.866 . . . . 15.0 116.23 -160.443 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -115.71 145.15 43.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.869 -2.491 . . . . 25.5 113.449 -173.341 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.352 5.8 p -82.5 165.91 19.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 122.486 2.403 . . . . 11.95 114.354 -171.855 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.6 mt -78.14 -22.11 49.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.158 -2.214 . . . . 10.17 112.69 177.947 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.267 3.7 t -70.31 -37.84 74.83 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 127.937 3.732 . . . . 13.59 114.983 175.32 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -55.97 -43.78 77.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.891 2.876 . . . . 11.7 111.205 164.605 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -86.62 -3.22 59.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.484 1.661 . . . . 12.95 115.484 -176.736 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 m120 54.96 51.61 13.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.529 2.732 . . . . 25.45 112.12 -178.298 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.6 mt -103.28 116.6 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 116.92 -3.612 . . . . 14.6 106.566 173.223 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -94.44 -160.32 0.77 Allowed 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.581 -2.574 . . . . 33.23 109.214 178.944 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -83.11 161.61 21.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.12 -1.067 . . . . 25.97 108.12 -173.143 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.357 27.9 mt-10 55.42 28.65 11.89 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.752 2.421 . . . . 32.61 112.97 178.336 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.1 t -87.93 154.6 20.38 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.662 1.985 . . . . 10.56 113.191 172.27 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.306 1.3 m -121.45 90.34 3.3 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 125.481 1.738 . . . . 5.33 113.603 -160.342 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -92.53 150.78 20.54 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.815 2.245 . . . . 11.66 107.604 176.65 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -116.67 139.31 50.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.001 2.81 . . . . 16.3 108.271 -176.964 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.25 113.87 27.32 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.301 -2.227 . . . . 9.96 113.373 170.449 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 m -110.14 171.44 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 113.086 -1.87 . . . . 9.76 106.443 175.194 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt -83.08 154.68 24.26 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.393 -2.067 . . . . 19.57 112.431 172.227 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -112.27 122.98 49.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.161 -1.587 . . . . 35.08 109.094 176.981 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.07 168.09 12.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.12 -2.862 . . . . 32.31 109.739 -178.477 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -75.95 -60.15 2.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.949 -1.719 . . . . 42.75 111.772 165.625 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.46 79.35 0.8 Allowed Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 128.008 2.718 . . . . 36.31 113.456 168.1 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.785 0 C-N-CA 127.882 2.658 . . . . 36.27 114.41 -177.093 . . . . . . . . 0 0 . 1 . 072 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 105.93 -1.878 . . . . 17.17 105.93 . . . . . . . . . 0 0 . 1 . 072 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -108.46 158.8 17.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.041 -2.577 . . . . 21.89 104.041 168.088 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -125.78 172.04 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.097 2.959 . . . . 10.83 105.511 171.585 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -123.9 146.78 48.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.71 -1.869 . . . . 10.61 109.808 167.906 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.3 125.88 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.587 1.955 . . . . 9.13 106.153 175.71 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -105.67 140.66 38.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.187 1.47 . . . . 20.55 107.326 177.51 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -81.89 -164.07 0.75 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.034 2.35 . . . . 11.78 112.429 172.364 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.3 tp -82.93 -48.47 10.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.364 -3.335 . . . . 19.31 114.613 177.121 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.7 p -65.86 -40.94 92.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.325 -1.484 . . . . 23.14 113.288 171.033 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.07 62.57 0.26 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 117.768 1.867 . . . . 19.74 117.768 175.41 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -112.48 145.97 39.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.096 -1.816 . . . . 21.93 106.096 167.495 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.2 m -112.73 106.62 15.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 101.908 -3.367 . . . . 12.33 101.908 -166.315 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.8 mt -92.1 117.62 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 101.186 -3.635 . . . . 17.08 101.186 -172.317 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.9 m -94.05 130.11 40.33 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 116.795 -1.962 . . . . 16.3 109.976 174.628 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -129.9 142.63 50.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 124.649 1.218 . . . . 15.88 111.058 178.301 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -97.1 128.25 43.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.4 -2.687 . . . . 28.9 114.811 179.673 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.481 HG21 HD13 ' A' ' 56' ' ' LEU 0.263 6.9 m -149.22 176.85 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.123 -1.611 . . . . 12.05 111.424 -174.068 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -110.74 179.64 0.78 Allowed Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.845 1.202 . . . . 18.17 111.663 168.123 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -71.2 -22.56 25.55 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-N 123.274 2.205 . . . . 8.16 109.019 173.886 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 m -95.36 1.75 54.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.04 1.4 . . . . 11.13 110.534 -165.052 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.19 139.6 31.55 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.227 -4.671 . . . . 18.03 108.705 -176.419 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 79.6 p -76.4 166.58 23.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.129 1.159 . . . . 10.22 114.129 173.021 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.1 mm -70.5 -18.86 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 119.345 -0.942 . . . . 12.3 108.785 -179.127 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -69.54 -31.16 69.19 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.39 -2.694 . . . . 36.51 115.245 172.635 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -66.1 -42.13 89.7 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.788 2.835 . . . . 25.66 109.461 167.676 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.63 -51.2 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 125.546 1.779 . . . . 8.12 110.835 176.237 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.63 -19.97 64.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.789 1.774 . . . . 15.47 115.789 -174.697 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.78 -27.54 66.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.48 1.912 . . . . 11.45 114.764 172.488 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -93.4 -20.52 20.26 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.321 -1.733 . . . . 24.98 106.321 -176.269 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 30' ' ' ILE . 75.3 mt -75.12 -44.43 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 119.927 -1.733 . . . . 9.46 113.557 167.307 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -56.91 -30.6 64.1 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.253 -2.78 . . . . 14.76 114.428 167.31 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.4 -52.88 14.05 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.627 -4.421 . . . . 26.29 108.523 178.53 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -66.13 -59.76 3.46 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.519 2.415 . . . . 30.06 117.519 172.23 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -97.53 -11.97 23.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 119.142 3.016 . . . . 25.19 119.142 -169.215 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.87 27.05 65.45 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 118.198 -2.814 . . . . 7.41 115.489 -176.442 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -103.23 109.38 61.55 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 108.207 -1.035 . . . . 9.49 108.207 -174.613 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -76.73 166.79 26.52 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.669 1.989 . . . . 11.42 116.14 -167.253 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.02 -20.86 16.41 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 123.126 2.152 . . . . 12.0 114.77 -156.277 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -83.61 -17.49 41.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.817 3.198 . . . . 35.55 114.795 178.686 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.423 ' HG2' HD22 ' A' ' 71' ' ' LEU . 49.4 tt0 -79.1 -31.72 44.37 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.844 2.59 . . . . 20.52 105.39 -179.53 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -111.41 176.01 5.19 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.589 1.995 . . . . 7.13 115.285 -170.426 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 42.7 mtp180 -131.8 146.09 51.94 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 113.02 -3.371 . . . . 36.39 109.649 169.887 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 43' ' ' LEU . 8.1 mt -109.16 134.5 51.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.723 1.889 . . . . 9.55 106.649 172.449 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mm -121.23 143.17 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.697 -2.705 . . . . 13.9 103.697 -169.576 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -130.31 100.79 5.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.491 2.716 . . . . 6.86 113.519 163.748 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.52 -107.28 0.19 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.997 1.719 . . . . 11.15 110.768 -165.708 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.29 -20.96 10.38 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-O 115.958 -2.579 . . . . 13.93 111.042 177.044 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -77.54 122.1 24.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.31 3.433 . . . . 23.92 104.772 -170.293 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -89.02 138.22 31.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.629 -3.169 . . . . 23.23 107.004 178.605 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.7 mt -106.03 127.68 53.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.112 -3.492 . . . . 9.11 112.673 -161.236 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -77.37 146.14 36.84 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.187 2.595 . . . . 33.44 105.74 -175.111 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -65.74 -45.51 82.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.302 -2.124 . . . . 28.37 112.684 -171.667 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.82 41.85 2.98 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 117.496 -1.724 . . . . 15.0 114.354 177.883 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -124.75 157.5 35.56 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 119.884 1.842 . . . . 25.5 108.584 168.315 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 44.0 p -91.16 164.16 14.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.028 -3.545 . . . . 11.95 117.085 -177.204 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.481 HD13 HG21 ' A' ' 17' ' ' VAL . 24.9 mt -54.36 -43.57 71.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.505 -1.68 . . . . 10.17 112.677 163.77 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -55.39 -42.29 73.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.286 -3.384 . . . . 13.59 118.271 167.596 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -56.97 -39.28 74.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.865 -1.772 . . . . 11.7 113.712 179.237 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -83.65 -13.58 53.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.599 1.333 . . . . 12.95 114.599 175.446 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.55 52.34 4.64 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.084 1.883 . . . . 25.45 116.084 -167.384 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.296 11.8 mt -87.64 123.78 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 102.276 -3.231 . . . . 14.6 102.276 176.733 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.273 23.1 mt-30 -100.92 179.76 4.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.621 -1.924 . . . . 33.23 114.709 179.427 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -64.3 147.17 53.09 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.585 -2.572 . . . . 25.97 110.691 -174.097 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 48.76 37.51 9.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.156 2.583 . . . . 32.61 116.883 179.899 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 t -108.19 151.36 26.03 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.487 1.915 . . . . 10.56 108.621 -169.366 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.324 41.1 p -102.23 115.52 30.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.642 -2.536 . . . . 5.33 111.099 -165.587 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.51 149.52 21.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.419 3.088 . . . . 11.66 103.429 172.39 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -114.6 130.8 56.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.695 -1.253 . . . . 16.3 108.94 178.366 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tt -105.18 120.93 42.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.004 1.722 . . . . 9.96 110.249 -178.437 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 147.53 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 101.74 -3.43 . . . . 9.76 101.74 -177.212 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.423 HD22 ' HG2' ' A' ' 40' ' ' GLN . 16.5 mt -81.81 152.88 26.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.87 1.795 . . . . 19.57 109.101 177.892 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HG3' ' HD2' ' A' ' 42' ' ' ARG . 74.8 ttt180 -79.39 122.42 26.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 116.051 -1.928 . . . . 35.08 108.899 -167.993 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.1 mt -93.04 162.24 14.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 113.518 -3.134 . . . . 32.31 111.56 179.883 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -93.01 116.12 28.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.41 2.368 . . . . 42.75 109.218 -166.432 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.5 67.96 0.52 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.9 -1.68 . . . . 36.31 108.9 -167.996 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.7 2 O-C-N 131.923 5.131 . . . . 36.27 105.145 155.653 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttp . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 124.829 2.252 . . . . 17.17 113.606 . . . . . . . . . 0 0 . 1 . 073 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -89.46 126.28 35.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 126.29 2.948 . . . . 21.89 111.897 178.834 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -128.31 147.22 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 116.83 -3.669 . . . . 10.83 109.199 176.364 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 53.0 m-85 -100.79 137.86 38.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.34 3.856 . . . . 10.61 105.87 175.669 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.45 110.46 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 117.076 -1.44 . . . . 9.13 111.106 170.743 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -93.61 143.22 26.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 116.813 -1.565 . . . . 20.55 111.122 -176.167 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.526 HG22 HD23 ' A' ' 69' ' ' LEU . 42.6 p -96.53 174.16 6.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.807 1.64 . . . . 11.78 107.1 -175.488 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.84 -51.3 70.32 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.744 -2.472 . . . . 19.31 114.617 177.582 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.1 p -67.32 -40.25 85.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.584 1.953 . . . . 23.14 115.841 172.351 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.15 59.89 0.3 Allowed Glycine 0 N--CA 1.43 -1.748 0 O-C-N 127.309 2.88 . . . . 19.74 114.315 151.449 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -95.17 126.27 40.38 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 115.625 -2.131 . . . . 21.93 108.638 163.667 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.7 m -95.8 113.22 24.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 116.916 -1.914 . . . . 12.33 107.025 179.271 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.1 pt -91.59 141.29 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.997 1.719 . . . . 17.08 107.374 178.276 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.1 m -107.3 124.97 50.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.749 -1.22 . . . . 16.3 111.529 178.821 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.25 141.87 51.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.725 -2.484 . . . . 15.88 106.445 177.876 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -108.47 107.76 18.42 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.885 2.474 . . . . 28.9 107.172 179.246 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.87 -177.52 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.733 -2.321 . . . . 12.05 104.733 -173.006 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -104.96 159.2 30.15 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 129.759 3.224 . . . . 18.17 108.475 170.49 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -81.04 -10.11 12.71 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 123.409 2.74 . . . . 8.16 110.989 -172.051 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -94.68 2.2 55.57 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.227 2.829 . . . . 11.13 111.965 175.685 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -75.83 161.61 28.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 123.749 2.977 . . . . 18.03 111.945 178.415 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.6 p -87.31 164.64 16.16 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.398 -2.689 . . . . 10.22 116.633 179.479 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.15 -39.6 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 120.194 1.361 . . . . 12.3 109.005 174.473 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -53.43 -45.08 69.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.429 -2.045 . . . . 36.51 111.684 174.304 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -58.31 -42.64 87.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.863 2.542 . . . . 25.66 117.863 170.489 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.8 -54.22 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.301 -2.75 . . . . 8.12 109.011 171.434 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HA ' HD12 ' A' ' 30' ' ' ILE . 34.7 mtmt -58.87 -28.18 65.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 116.768 -3.707 . . . . 15.47 118.449 -177.153 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.16 94.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.498 2.719 . . . . 11.45 113.471 168.211 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -71.43 -39.34 71.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.526 -2.609 . . . . 24.98 111.661 -178.663 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 27' ' ' LYS . 21.3 mt -60.52 -36.87 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.228 2.611 . . . . 9.46 109.1 173.771 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -66.85 -52.08 47.84 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.923 1.344 . . . . 14.76 113.432 175.882 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -50.53 -45.31 56.69 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.932 -2.98 . . . . 26.29 115.889 170.177 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -79.95 -51.61 8.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.777 -3.077 . . . . 30.06 115.404 -165.891 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -102.02 -30.9 10.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.428 1.091 . . . . 25.19 110.673 -175.107 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.55 34.08 5.92 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 127.977 2.703 . . . . 7.41 110.182 164.805 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.0 mt -91.64 125.15 58.59 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 127.194 2.197 . . . . 9.49 106.021 -174.809 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.65 171.57 4.43 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 126.233 3.262 . . . . 11.42 115.511 -179.234 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -76.41 -27.17 8.04 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 124.209 3.273 . . . . 12.0 114.059 -173.678 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -81.6 -20.32 40.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.951 -3.593 . . . . 35.55 114.618 -173.504 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -86.0 -45.93 11.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.505 1.922 . . . . 20.52 110.613 179.913 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -51.23 113.32 0.91 Allowed 'General case' 0 N--CA 1.43 -1.452 1 N-CA-C 123.674 4.694 . . . . 7.13 123.674 163.153 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -117.0 119.58 35.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.562 -2.586 . . . . 36.39 109.198 157.494 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.38 128.34 39.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.196 -2.275 . . . . 9.55 109.565 -177.441 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 44' ' ' ILE 0.29 23.8 mm -118.58 148.99 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.942 2.897 . . . . 13.9 105.637 -177.684 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.401 ' HB3' ' H ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -85.19 -83.58 0.16 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.1 0.864 . . . . 6.86 112.459 177.252 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 45' ' ' PHE . . . -98.93 -71.16 0.7 Allowed 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 106.651 -1.611 . . . . 11.15 106.651 166.668 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.2 -4.52 5.45 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 119.983 2.753 . . . . 13.93 119.983 172.652 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -101.69 160.18 14.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 112.485 -1.858 . . . . 23.92 115.435 171.918 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -87.66 170.77 10.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.828 -2.42 . . . . 23.23 115.999 -171.269 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.3 mt -131.23 105.81 7.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.995 1.379 . . . . 9.11 108.683 176.086 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -72.76 140.51 47.81 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 121.711 3.967 . . . . 33.44 121.711 166.153 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -36.93 -66.3 0.24 Allowed 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 135.199 5.4 . . . . 28.37 119.958 -170.462 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.88 13.25 9.08 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 129.841 3.591 . . . . 15.0 116.857 -165.458 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -117.61 141.95 47.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.33 1.452 . . . . 25.5 111.989 -168.064 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.0 p -87.22 161.51 17.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.643 2.639 . . . . 11.95 111.03 -179.937 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 61' ' ' ILE . 1.1 mt -49.09 -50.52 36.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.923 3.289 . . . . 10.17 113.565 176.126 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 t -50.58 -48.71 57.55 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 129.544 4.277 . . . . 13.59 115.585 172.416 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -61.06 -38.56 86.63 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.514 1.926 . . . . 11.7 112.219 177.276 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -85.8 -2.04 57.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.92 2.563 . . . . 12.95 117.92 171.483 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m120 65.82 48.47 1.86 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 127.278 2.861 . . . . 25.45 113.055 176.31 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 56' ' ' LEU . 82.4 mt -94.57 108.0 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.942 3.297 . . . . 14.6 103.555 177.133 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -101.6 176.88 5.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.069 2.366 . . . . 33.23 110.871 177.568 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -60.61 146.18 46.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.713 -3.117 . . . . 25.97 117.124 -173.18 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.306 35.5 mt-10 71.94 -1.26 2.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 127.025 2.703 . . . . 32.61 117.25 174.09 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.316 56.0 m -48.39 138.56 9.95 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.37 2.668 . . . . 10.56 116.833 162.549 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.479 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 24.4 m -103.13 124.96 49.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.124 -1.61 . . . . 5.33 111.007 167.253 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.73 169.28 8.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.858 -2.645 . . . . 11.66 103.858 -177.955 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -139.37 132.44 29.58 Favored 'General case' 0 N--CA 1.43 -1.444 1 CA-C-O 130.053 4.74 . . . . 16.3 113.324 -169.868 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.526 HD23 HG22 ' A' ' 7' ' ' THR . 34.8 tp -115.81 107.74 15.43 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.387 -2.696 . . . . 9.96 107.385 -168.187 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.6 172.09 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 2 C-N-CA 132.415 4.286 . . . . 9.76 112.012 -171.011 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.8 tp -84.66 148.11 26.59 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.016 1.388 . . . . 19.57 112.463 -178.73 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -92.86 135.3 34.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.745 -3.097 . . . . 35.08 112.996 176.033 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.4 tt -123.5 113.45 18.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.249 1.976 . . . . 32.31 107.605 153.081 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -76.65 -53.72 7.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.461 -2.649 . . . . 42.75 116.023 -164.941 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.04 -83.6 1.19 Allowed Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 120.105 1.32 . . . . 36.31 114.753 172.893 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.752 0 C-N-CA 127.375 2.417 . . . . 36.27 112.745 -173.969 . . . . . . . . 0 0 . 1 . 074 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 CA--C 1.49 -1.346 0 CA-C-O 125.05 2.357 . . . . 17.17 110.327 . . . . . . . . . 0 0 . 1 . 074 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -92.13 150.84 20.71 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.566 -2.753 . . . . 21.89 103.566 -177.821 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -127.37 155.32 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.797 1.239 . . . . 10.83 109.848 159.736 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -105.82 158.05 17.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.649 -1.282 . . . . 10.61 109.174 174.649 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -148.32 120.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 N-CA-C 99.302 -4.333 . . . . 9.13 99.302 -178.213 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -108.82 121.78 45.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.41 2.284 . . . . 20.55 116.978 -178.512 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -73.21 -178.41 2.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.222 1.963 . . . . 11.78 113.68 -169.074 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.257 15.1 tp -51.88 -57.04 10.54 Favored 'General case' 0 N--CA 1.431 -1.401 1 C-N-CA 134.109 4.964 . . . . 19.31 108.942 178.356 . . . . . . . . 3 2 . 1 . 074 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -73.28 -54.11 9.19 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.44 -4.537 . . . . 23.14 112.444 175.595 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.11 45.61 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 114.245 -3.531 . . . . 19.74 113.104 177.983 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -96.01 100.54 12.2 Favored 'General case' 0 N--CA 1.43 -1.472 2 C-N-CA 132.072 4.149 . . . . 21.93 103.536 178.097 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -82.87 102.21 11.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.7 2.0 . . . . 12.33 106.186 -177.975 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.255 3.5 pt -90.28 170.09 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 128.492 2.717 . . . . 17.08 106.327 178.584 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 m -121.53 149.91 42.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.085 3.354 . . . . 16.3 105.981 177.061 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.7 mt -143.38 145.09 32.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.013 -2.304 . . . . 15.88 105.18 171.954 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -106.11 104.84 14.64 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.142 1.925 . . . . 28.9 111.723 -177.936 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.251 20.9 m -120.38 128.67 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.171 -1.58 . . . . 12.05 114.57 -162.041 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -88.62 134.93 33.07 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 104.515 -2.402 . . . . 18.17 104.515 171.89 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.87 -0.52 10.01 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 120.864 1.344 . . . . 8.16 114.241 -171.087 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 m -70.07 -26.36 63.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.252 3.056 . . . . 11.13 119.252 169.308 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -81.79 176.36 9.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.761 1.393 . . . . 18.03 114.761 179.347 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -76.38 157.14 32.63 Favored 'General case' 0 N--CA 1.43 -1.455 1 N-CA-C 123.324 4.564 . . . . 10.22 123.324 173.371 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -73.66 -28.08 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 117.746 -3.096 . . . . 12.3 113.307 173.614 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -52.08 -36.48 50.83 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 116.742 -3.724 . . . . 36.51 113.551 163.583 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -80.02 -22.08 42.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.803 1.641 . . . . 25.66 115.17 -177.811 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.47 -49.78 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 119.96 3.319 . . . . 8.12 119.96 153.673 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.251 55.9 mtmt -70.98 -30.37 66.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.299 1.039 . . . . 15.47 113.199 -175.773 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.81 78.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.117 -1.615 . . . . 11.45 112.296 175.796 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 35.3 tptt -77.69 -21.52 51.9 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.548 1.139 . . . . 24.98 112.423 -175.766 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.7 mt -74.06 -40.75 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 128.061 2.545 . . . . 9.46 109.013 170.389 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -65.86 -32.72 74.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.188 1.555 . . . . 14.76 111.999 177.71 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.35 -58.16 4.05 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.19 -2.194 . . . . 26.29 112.28 172.59 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -57.72 -60.82 3.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 119.883 3.29 . . . . 30.06 119.883 -177.975 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -101.8 -48.34 4.31 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.575 3.15 . . . . 25.19 108.311 -171.248 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.11 24.59 5.66 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 127.375 2.417 . . . . 7.41 118.593 177.554 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.0 mt -92.04 103.94 9.44 Favored Pre-proline 0 N--CA 1.43 -1.453 1 CA-C-O 111.516 -4.088 . . . . 9.49 108.476 -170.711 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.51 154.16 72.27 Favored 'Trans proline' 0 N--CA 1.434 -2.002 1 CA-C-N 130.542 4.801 . . . . 11.42 116.481 -168.31 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.32 -19.88 60.11 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 N-CA-C 119.048 2.672 . . . . 12.0 119.048 -174.344 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.35 -21.03 53.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 122.221 2.282 . . . . 35.55 115.106 173.04 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -83.27 -13.01 56.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.379 1.992 . . . . 20.52 116.379 168.865 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 75.6 mt-30 -96.17 119.15 34.14 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.199 -4.063 . . . . 7.13 111.225 -173.638 . . . . . . . . 3 2 . 1 . 074 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -90.95 116.86 29.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 101.639 -3.467 . . . . 36.39 101.639 164.584 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 tp -105.58 113.91 27.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.623 2.011 . . . . 9.55 110.946 -179.799 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -116.2 152.54 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 125.572 2.606 . . . . 13.9 104.625 -164.748 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -82.41 -80.49 0.16 Allowed 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.199 -4.063 . . . . 6.86 112.789 162.871 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.3 -72.71 0.7 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.193 2.197 . . . . 11.15 109.001 172.105 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.97 -27.32 4.91 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 125.951 2.973 . . . . 13.93 117.144 174.085 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -106.64 150.83 25.82 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.366 -2.255 . . . . 23.92 109.786 -165.76 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -102.19 144.77 30.31 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.018 -2.926 . . . . 23.23 106.629 -170.197 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.1 mt -77.84 145.65 36.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.462 -2.608 . . . . 9.11 111.19 179.764 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.55 151.59 27.41 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.105 1.362 . . . . 33.44 110.211 -175.256 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.36 -59.51 4.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.541 2.736 . . . . 28.37 112.24 -161.422 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.08 33.12 5.8 Favored Glycine 0 N--CA 1.43 -1.741 0 O-C-N 116.635 -3.791 . . . . 15.0 116.442 -168.912 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -121.76 160.47 24.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.518 -1.66 . . . . 25.5 106.518 174.363 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.4 p -104.56 173.47 6.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.95 2.786 . . . . 11.95 117.194 -174.32 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.6 -25.56 41.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.073 -2.267 . . . . 10.17 114.046 -177.926 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.7 m -59.58 -59.14 5.91 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.661 1.696 . . . . 13.59 110.789 168.523 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -67.0 -32.56 73.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.347 -2.096 . . . . 11.7 114.494 -173.186 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -69.43 -19.36 63.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.257 1.823 . . . . 12.95 113.019 171.902 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.299 42.5 m-80 58.98 50.36 8.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.514 1.926 . . . . 25.45 114.962 -173.232 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 mt -95.43 125.76 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.296 -1.372 . . . . 14.6 107.296 174.516 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -85.48 174.0 9.82 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.481 -3.887 . . . . 33.23 109.998 177.393 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -72.53 152.5 41.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 125.125 2.393 . . . . 25.97 113.881 174.016 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.52 41.48 30.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.664 3.586 . . . . 32.61 111.232 -171.564 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.5 t -107.73 142.05 38.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 127.22 3.39 . . . . 10.56 103.048 -179.062 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.9 m -98.94 123.56 43.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 110.632 -2.985 . . . . 5.33 114.175 -179.119 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.6 mt -95.9 144.12 26.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.041 2.829 . . . . 11.66 108.045 174.838 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -111.14 124.89 53.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.414 -2.679 . . . . 16.3 114.449 -169.44 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.9 mt -100.78 126.86 47.38 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.123 1.44 . . . . 9.96 110.441 -179.584 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.04 177.82 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.411 -1.329 . . . . 9.76 107.411 162.539 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -85.05 122.97 30.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.463 -2.023 . . . . 19.57 106.827 175.123 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -93.89 148.29 22.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.026 3.33 . . . . 35.08 110.112 171.774 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 mt -85.81 172.56 10.68 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.401 -2.062 . . . . 32.31 111.876 172.252 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -75.37 -65.21 0.92 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.638 -1.289 . . . . 42.75 111.596 -167.506 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.82 -82.81 0.6 Allowed Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 124.974 1.274 . . . . 36.31 112.096 -165.259 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.752 1 CA-C-O 112.21 -4.661 . . . . 36.27 107.882 -178.371 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.329 4.1 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 122.438 1.113 . . . . 17.17 109.809 . . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -113.83 145.32 41.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.283 1.516 . . . . 21.89 107.237 177.684 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -123.75 -175.1 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 119.793 -1.817 . . . . 10.83 107.423 160.224 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.294 0.7 OUTLIER -129.59 140.21 51.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 127.013 2.695 . . . . 10.61 109.051 171.146 . . . . . . . . 3 3 . 1 . 075 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.58 137.52 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 1 O-C-N 114.382 -5.199 . . . . 9.13 111.819 169.353 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -100.66 115.29 29.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 124.215 3.189 . . . . 20.55 109.783 162.352 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 p -67.41 -164.7 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 127.459 2.975 . . . . 11.78 116.692 -169.458 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.32 -56.54 17.45 Favored 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 131.922 4.089 . . . . 19.31 110.232 -179.487 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 p -76.35 -41.89 46.7 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.776 2.227 . . . . 23.14 111.601 -176.53 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.28 72.78 0.39 Allowed Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 127.405 2.431 . . . . 19.74 114.417 -174.419 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.33 80.1 tttt -135.34 124.4 24.31 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.421 1.088 . . . . 21.93 108.107 170.785 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -88.11 118.12 27.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.95 -2.968 . . . . 12.33 112.125 -179.21 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.5 pt -111.69 148.02 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 O-C-N 115.788 -4.32 . . . . 17.08 109.53 -173.829 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -98.21 137.55 36.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.839 -1.541 . . . . 16.3 106.839 -177.363 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -124.57 159.01 31.61 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.476 2.31 . . . . 15.88 107.185 178.994 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -123.06 126.85 47.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.508 -2.034 . . . . 28.9 105.508 173.986 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.07 169.18 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.032 -2.581 . . . . 12.05 104.032 -174.269 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -109.16 156.95 38.38 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 125.338 1.455 . . . . 18.17 107.938 165.077 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.19 -16.03 31.77 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 116.711 -1.726 . . . . 8.16 114.106 176.942 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -72.7 -15.54 61.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.437 -1.32 . . . . 11.13 107.437 179.586 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -76.83 141.27 40.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.354 -2.716 . . . . 18.03 115.466 -170.961 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -70.58 168.51 16.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 121.67 3.952 . . . . 10.22 121.67 170.685 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.37 5.7 mm -62.43 -40.45 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.444 -1.41 . . . . 12.3 111.816 174.173 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -51.02 -31.84 19.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.48 2.03 . . . . 36.51 116.48 168.051 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -81.81 -29.42 32.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.024 -1.048 . . . . 25.66 111.097 176.665 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.27 4.0 t -62.1 -54.1 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 124.754 1.221 . . . . 8.12 109.529 174.613 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -56.38 -37.45 70.12 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.824 2.157 . . . . 15.47 116.824 176.565 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.72 81.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.83 2.159 . . . . 11.45 116.83 175.284 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -71.71 -29.01 64.08 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 117.076 2.25 . . . . 24.98 117.076 168.888 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.342 48.5 mt -73.11 -43.25 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.191 -1.781 . . . . 9.46 106.191 172.734 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -67.77 -26.67 66.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.734 2.124 . . . . 14.76 116.734 178.72 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.99 -51.53 25.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.484 -1.689 . . . . 26.29 114.117 169.381 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -64.99 -66.08 0.59 Allowed 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 131.78 4.032 . . . . 30.06 115.64 -179.896 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -95.71 -25.97 15.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.515 1.672 . . . . 25.19 115.515 -172.872 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.07 -27.51 8.56 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 120.75 -1.219 . . . . 7.41 115.385 -178.967 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.3 mt -52.38 125.59 35.48 Favored Pre-proline 0 N--CA 1.43 -1.451 1 C-N-CA 131.807 4.043 . . . . 9.49 109.237 -172.512 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.65 164.33 24.3 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-O 115.324 -2.032 . . . . 11.42 115.18 -178.44 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -80.98 -16.98 9.7 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 126.245 3.266 . . . . 12.0 114.239 -177.219 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -86.3 -5.1 59.25 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.876 -2.39 . . . . 35.55 106.865 -175.259 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.62 -28.19 22.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.046 -2.284 . . . . 20.52 112.278 171.676 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -88.05 123.13 32.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.961 1.097 . . . . 7.13 113.961 -165.182 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -114.92 117.19 29.97 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.045 2.138 . . . . 36.39 115.365 160.86 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.17 112.89 24.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.565 1.65 . . . . 9.55 109.31 -169.079 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -100.43 143.85 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 O-C-N 115.828 -4.295 . . . . 13.9 107.297 175.841 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -81.06 -92.07 0.06 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.106 1.763 . . . . 6.86 112.35 169.848 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.28 -48.97 3.85 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 121.199 1.818 . . . . 11.15 109.51 162.017 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.9 9.12 0.73 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 119.792 -1.818 . . . . 13.93 115.607 -177.419 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -112.17 134.89 53.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.806 -1.924 . . . . 23.92 105.806 175.613 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -74.49 148.32 41.1 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.815 -1.803 . . . . 23.23 112.125 168.765 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 mt -91.83 127.0 37.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.016 -2.303 . . . . 9.11 105.865 -177.486 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -79.46 131.89 36.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.412 1.885 . . . . 33.44 113.734 177.878 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -51.7 -51.91 52.39 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.343 2.257 . . . . 28.37 111.77 -162.189 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.94 9.56 59.82 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 119.741 -1.849 . . . . 15.0 116.927 -174.862 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -101.57 158.62 15.95 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.453 -3.969 . . . . 25.5 112.545 177.334 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -84.15 158.1 21.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.365 1.866 . . . . 11.95 112.402 -178.09 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -62.41 -32.14 72.94 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.676 -4.39 . . . . 10.17 111.294 164.749 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -57.86 -45.72 85.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.592 2.357 . . . . 13.59 116.648 174.252 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.98 -35.56 76.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.81 -1.541 . . . . 11.7 114.447 -178.444 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -79.79 2.9 21.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.263 -1.523 . . . . 12.95 111.839 169.698 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.7 t30 40.79 40.93 1.06 Allowed 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.582 2.353 . . . . 25.45 116.006 -168.761 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.8 mt -74.74 126.08 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 104.324 -2.473 . . . . 14.6 104.324 175.452 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -115.21 165.75 12.59 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 132.636 4.374 . . . . 33.23 114.191 179.881 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.345 45.8 pttt -55.25 157.67 3.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.498 3.519 . . . . 25.97 115.213 -172.829 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 75.01 0.22 3.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.98 2.112 . . . . 32.61 113.977 168.63 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t -91.61 157.44 16.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.72 -2.488 . . . . 10.56 110.771 -173.287 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -99.55 116.83 32.59 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 127.043 2.715 . . . . 5.33 109.416 178.459 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.7 mt -99.98 152.61 19.99 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.073 1.749 . . . . 11.66 107.817 174.297 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -116.03 142.68 46.48 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.614 -1.624 . . . . 16.3 106.614 -166.659 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tp -111.41 112.16 23.72 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 115.832 -4.293 . . . . 9.96 111.383 -175.541 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.86 139.03 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.67 -2.345 . . . . 9.76 104.67 -173.701 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 tp -66.52 127.94 34.29 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.558 -2.589 . . . . 19.57 114.217 177.53 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -93.57 126.67 38.85 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.615 -1.928 . . . . 35.08 108.158 -170.961 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.276 26.5 mt -79.09 -75.06 0.25 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 121.777 2.08 . . . . 32.31 115.111 176.313 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -103.04 -50.22 3.56 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.88 2.472 . . . . 42.75 107.687 -158.24 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.31 -178.37 43.71 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 122.929 1.294 . . . . 36.31 112.182 -177.263 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 C-N-CA 129.598 3.475 . . . . 36.27 112.962 165.25 . . . . . . . . 0 0 . 1 . 076 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 109.464 -0.569 . . . . 17.17 109.464 . . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -75.43 126.4 30.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.709 -1.244 . . . . 21.89 112.736 -179.06 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -107.73 141.27 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 125.277 2.465 . . . . 10.83 104.902 151.552 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 43.3 m-85 -101.06 144.48 29.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.876 -2.39 . . . . 10.61 107.007 165.665 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.287 58.1 t -106.54 124.0 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 116.735 -1.602 . . . . 9.13 111.772 169.484 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -102.41 113.92 27.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 119.701 1.137 . . . . 20.55 111.825 -178.181 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.374 3.1 p -63.5 -174.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.135 2.642 . . . . 11.78 118.135 176.509 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.4 mt -81.54 -60.28 2.32 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.236 -2.79 . . . . 19.31 110.819 175.944 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.297 62.2 p -71.89 -64.45 0.93 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 116.062 -1.923 . . . . 23.14 114.566 -174.188 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.18 54.72 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.765 1 CA-C-N 126.13 4.059 . . . . 19.74 114.639 -175.584 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -135.49 138.46 43.15 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 128.057 2.857 . . . . 21.93 107.847 -176.192 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.288 72.9 m -139.79 107.58 5.66 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.225 -2.139 . . . . 12.33 105.225 -179.874 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 17.9 pt -112.36 161.06 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 124.254 1.978 . . . . 17.08 108.345 -166.692 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 m -117.38 126.78 53.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.726 -1.859 . . . . 16.3 111.885 -174.54 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -111.06 163.11 14.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.988 -1.07 . . . . 15.88 110.992 172.543 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -116.4 110.15 18.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.859 -2.275 . . . . 28.9 104.859 179.395 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.46 154.08 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.047 -2.283 . . . . 12.05 113.437 -176.833 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -97.34 153.08 38.53 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 114.862 -2.494 . . . . 18.17 113.973 167.142 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -59.96 -22.04 67.26 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-N 125.728 3.081 . . . . 8.16 116.856 -179.834 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -76.72 -9.04 58.39 Favored 'General case' 0 N--CA 1.43 -1.457 1 C-N-CA 132.073 4.149 . . . . 11.13 116.875 170.758 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.72 127.5 33.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.77 -3.706 . . . . 18.03 114.971 175.583 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.291 45.1 p -68.53 159.09 32.51 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.257 2.623 . . . . 10.22 112.719 179.045 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.259 45.2 mm -57.25 -35.33 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.27 1.828 . . . . 12.3 112.461 168.021 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -60.79 -52.9 63.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.206 1.821 . . . . 36.51 115.337 173.46 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.271 33.0 m-80 -60.65 -36.05 77.72 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 115.34 -2.267 . . . . 25.66 113.328 174.497 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.421 50.1 t -46.81 -48.02 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 131.262 3.825 . . . . 8.12 113.905 167.781 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -76.01 -20.72 57.59 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.79 -1.55 . . . . 15.47 110.868 -169.887 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.77 -28.75 55.82 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 112.631 0.604 . . . . 11.45 112.631 174.293 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -70.03 -32.45 70.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.471 0.915 . . . . 24.98 113.471 173.181 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -69.95 -35.0 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 123.936 1.827 . . . . 9.46 109.594 172.33 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -69.63 -29.11 66.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.878 -2.389 . . . . 14.76 113.508 174.205 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.5 -54.3 21.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.289 -2.132 . . . . 26.29 112.604 168.575 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -64.38 -63.35 1.16 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 117.229 -1.367 . . . . 30.06 109.599 -175.955 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.74 -48.53 7.79 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.298 2.333 . . . . 25.19 117.298 177.916 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.46 52.02 1.63 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 117.474 -3.266 . . . . 7.41 115.585 -171.915 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.0 mt -113.99 127.72 26.53 Favored Pre-proline 0 N--CA 1.43 -1.44 1 N-CA-C 99.132 -4.396 . . . . 9.49 99.132 -169.399 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -72.7 157.86 51.47 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 O-C-N 117.053 -2.13 . . . . 11.42 109.075 -170.335 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -77.38 -29.1 5.07 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 C-N-CA 125.027 3.818 . . . . 12.0 111.639 -153.001 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.16 -26.79 42.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 130.579 3.552 . . . . 35.55 108.3 175.367 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -80.19 -26.99 38.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.477 -3.89 . . . . 20.52 111.596 -176.078 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -71.48 138.55 49.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.386 2.041 . . . . 7.13 110.314 174.685 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -142.16 137.42 30.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.881 -2.387 . . . . 36.39 110.676 161.519 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -104.34 135.19 46.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.434 2.54 . . . . 9.55 111.933 178.654 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mm -111.25 138.92 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.408 -1.724 . . . . 13.9 110.957 163.823 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.31 5.6 t80 -70.09 -87.82 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.892 1.677 . . . . 6.86 109.742 167.762 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.23 -62.94 1.41 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 121.179 -0.951 . . . . 11.15 108.867 165.873 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.86 -24.87 2.21 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.033 1.778 . . . . 13.93 110.333 177.311 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.269 0.1 OUTLIER -74.36 123.52 24.78 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.147 -1.427 . . . . 23.92 107.147 -178.047 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.269 16.2 pt20 -70.39 122.09 18.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.786 2.554 . . . . 23.23 111.137 164.292 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.3 mt -95.37 150.45 20.26 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 118.343 -2.723 . . . . 9.11 111.282 -171.354 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -120.14 141.37 49.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.801 3.191 . . . . 33.44 116.019 -169.263 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.01 -52.97 56.71 Favored 'General case' 0 N--CA 1.43 -1.451 2 O-C-N 115.653 -4.404 . . . . 28.37 112.943 -156.988 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.88 29.59 7.85 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 124.216 3.189 . . . . 15.0 115.034 -169.862 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 -114.88 147.3 40.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.2 2.2 . . . . 25.5 109.332 177.359 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 p -94.19 173.04 7.84 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 129.584 3.154 . . . . 11.95 112.229 179.37 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.5 mt -86.28 -18.17 32.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 104.498 -2.408 . . . . 10.17 104.498 -173.259 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.18 -41.47 77.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.397 -2.064 . . . . 13.59 110.137 168.617 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.71 -41.43 92.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.95 2.1 . . . . 11.7 112.676 -177.585 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -78.44 -28.72 46.73 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 115.575 -2.45 . . . . 12.95 116.563 173.142 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.288 29.8 t30 74.5 56.36 0.08 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.63 3.172 . . . . 25.45 112.544 -168.242 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.562 HD13 HD21 ' A' ' 67' ' ' LEU . 31.4 mt -99.9 101.94 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 104.435 -2.432 . . . . 14.6 104.435 170.898 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -100.35 -156.28 0.55 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.522 2.329 . . . . 33.23 108.084 -172.113 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -61.41 157.6 16.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.905 -3.622 . . . . 25.97 119.336 174.799 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 71.78 15.98 5.73 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.016 -1.053 . . . . 32.61 112.603 163.623 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -101.22 142.78 32.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.742 2.526 . . . . 10.56 108.371 -156.999 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.3 m -111.58 129.26 56.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.8 -3.687 . . . . 5.33 107.09 -178.3 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.562 HD21 HD13 ' A' ' 61' ' ' ILE . 66.8 mt -103.61 164.09 11.89 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.31 -1.366 . . . . 11.66 107.31 168.715 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -122.13 124.16 43.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.729 2.412 . . . . 16.3 110.966 -177.936 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.1 tp -106.01 110.78 23.16 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.598 -1.939 . . . . 9.96 109.379 -172.032 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 m -114.53 174.38 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 117.966 -2.959 . . . . 9.76 107.207 -174.743 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.6 mt -81.95 141.96 32.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.621 1.677 . . . . 19.57 111.007 168.151 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -75.89 103.31 5.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.06 -2.275 . . . . 35.08 111.695 159.814 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.7 mt -99.68 92.98 5.59 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.546 2.338 . . . . 32.31 114.6 171.604 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -123.37 -74.58 0.61 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.486 -1.384 . . . . 42.75 110.145 179.634 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.33 49.16 1.34 Allowed Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 125.505 2.725 . . . . 36.31 113.775 -170.18 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.812 0 CA-C-N 111.404 -2.398 . . . . 36.27 112.232 -165.12 . . . . . . . . 0 0 . 1 . 077 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 ttp . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 115.505 1.669 . . . . 17.17 115.505 . . . . . . . . . 0 0 . 1 . 077 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -93.47 133.33 36.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.057 2.208 . . . . 21.89 107.923 -175.522 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.85 150.83 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.655 -2.528 . . . . 10.83 111.106 175.126 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.433 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 21.2 m-85 -112.31 100.68 8.99 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.61 2.364 . . . . 10.61 116.896 176.867 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.3 t -92.63 114.86 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 120.294 -0.562 . . . . 9.13 111.227 179.731 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -98.88 125.03 44.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.067 -2.896 . . . . 20.55 112.662 177.269 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.539 HG22 HD23 ' A' ' 69' ' ' LEU . 82.3 p -84.24 -179.07 7.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.488 -1.233 . . . . 11.78 113.481 -179.373 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 tt -50.72 -47.94 59.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.045 3.338 . . . . 19.31 112.573 179.405 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -93.15 -66.8 0.9 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.049 2.139 . . . . 23.14 107.287 -165.752 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.56 75.57 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 104.062 -3.615 . . . . 19.74 104.062 161.9 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -115.15 116.97 29.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.839 -0.8 . . . . 21.93 108.839 164.001 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.285 28.1 m -83.87 93.94 8.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.098 2.559 . . . . 12.33 109.689 173.907 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 mt -85.78 105.45 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 123.769 1.747 . . . . 17.08 107.394 -174.922 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -87.07 110.4 20.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.054 -4.154 . . . . 16.3 108.37 179.98 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.05 140.62 47.69 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.944 -1.873 . . . . 15.88 105.944 176.272 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -104.23 131.2 51.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.32 1.057 . . . . 28.9 111.812 167.781 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.24 178.94 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 115.142 -0.936 . . . . 12.05 109.529 -178.612 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -85.1 163.15 46.82 Favored Pre-proline 0 N--CA 1.429 -1.479 0 O-C-N 118.426 -2.671 . . . . 18.17 110.949 163.98 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.257 0.1 OUTLIER -76.24 -12.35 19.16 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 125.148 2.874 . . . . 8.16 114.169 179.812 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -102.89 2.53 35.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.421 2.325 . . . . 11.13 108.063 -168.617 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -76.33 154.62 34.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.017 1.858 . . . . 18.03 116.017 169.298 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -93.06 169.65 10.25 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.823 2.527 . . . . 10.22 117.823 -179.316 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.54 -42.72 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 126.026 2.079 . . . . 12.3 116.185 -178.627 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 5.7 mm-40 -29.47 -50.3 0.1 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.9 2.48 . . . . 36.51 114.791 158.446 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.41 -37.91 63.23 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.161 -2.212 . . . . 25.66 108.092 -175.899 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.74 -43.46 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 124.379 2.038 . . . . 8.12 111.613 176.083 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 50.0 mtpt -62.78 -36.79 84.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.276 -2.14 . . . . 15.47 115.392 173.659 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.46 89.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.994 2.518 . . . . 11.45 113.176 175.473 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -71.45 -30.3 65.87 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 124.391 1.076 . . . . 24.98 110.083 -178.095 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.5 mt -71.39 -39.15 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.327 -1.306 . . . . 9.46 111.274 174.092 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -62.92 -40.59 98.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.887 -2.383 . . . . 14.76 109.35 170.476 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.19 -43.82 63.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 115.952 -1.975 . . . . 26.29 110.681 -171.664 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' HB3' ' HG2' ' A' ' 34' ' ' GLU 0.303 28.8 tptt -69.25 -51.14 40.53 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.554 1.645 . . . . 30.06 113.516 -176.785 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HB3' ' A' ' 33' ' ' LYS . 76.8 mm-40 -106.02 -32.7 8.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.268 3.027 . . . . 25.19 113.833 -157.818 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.42 56.71 4.17 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 128.429 2.919 . . . . 7.41 113.329 -175.072 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mt -110.87 124.19 33.58 Favored Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 103.824 -2.658 . . . . 9.49 103.824 -178.456 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.98 139.62 85.71 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 124.071 3.181 . . . . 11.42 117.085 175.589 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.95 -14.84 45.69 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 C-N-CA 127.422 5.415 . . . . 12.0 111.474 -174.757 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.401 2.5 p30 -81.37 -24.73 36.84 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.119 2.266 . . . . 35.55 117.119 178.351 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -75.72 -25.15 56.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 126.248 2.217 . . . . 20.52 116.83 167.142 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -79.51 121.72 25.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.638 2.459 . . . . 7.13 117.638 -179.043 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -128.4 151.6 49.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.438 -2.664 . . . . 36.39 107.137 157.493 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.6 mt -131.12 143.57 50.74 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.332 2.015 . . . . 9.55 111.089 -169.943 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.4 mm -120.65 140.74 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.401 3.08 . . . . 13.9 105.476 -176.28 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -104.16 -55.02 2.44 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 124.404 2.049 . . . . 6.86 108.93 155.643 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.66 107.62 3.22 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.488 -2.008 . . . . 11.15 107.716 -176.661 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.81 -69.96 0.75 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 126.634 2.064 . . . . 13.93 116.619 175.853 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -96.3 166.95 11.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 119.138 1.469 . . . . 23.92 114.254 -175.727 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -60.39 139.11 57.84 Favored 'General case' 0 N--CA 1.43 -1.47 1 N-CA-C 123.489 4.626 . . . . 23.23 123.489 172.887 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.2 mt -83.4 120.42 25.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.825 1.65 . . . . 9.11 114.759 173.642 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -89.25 155.09 19.61 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.682 -2.511 . . . . 33.44 110.075 -174.803 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.09 -53.72 49.22 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.165 1.786 . . . . 28.37 112.999 -158.433 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.15 36.23 4.54 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 117.673 -1.626 . . . . 15.0 114.273 -173.71 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -107.2 147.39 30.2 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.401 -2.074 . . . . 25.5 105.401 174.171 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.315 32.2 p -77.89 169.74 17.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.179 1.55 . . . . 11.95 112.272 -178.48 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.08 -30.99 55.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 113.953 -1.476 . . . . 10.17 109.17 178.999 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -66.49 -49.87 65.16 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 131.039 3.736 . . . . 13.59 110.233 179.155 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 33.1 t70 -56.63 -43.3 80.12 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.137 -2.227 . . . . 11.7 116.553 174.796 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -69.72 -27.61 65.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 124.952 1.408 . . . . 12.95 110.176 176.778 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 70.69 46.6 0.51 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 129.045 2.938 . . . . 25.45 107.795 -175.509 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.15 119.9 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 112.249 -2.25 . . . . 14.6 106.58 162.578 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -107.64 -176.15 2.98 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.802 2.441 . . . . 33.23 111.205 -174.987 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.276 54.7 pttt -69.92 135.03 49.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.661 -1.899 . . . . 25.97 115.099 -172.024 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 73.46 38.62 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.109 2.164 . . . . 32.61 109.809 179.9 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.6 m -94.21 150.76 20.01 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 112.865 -6.147 . . . . 10.56 110.15 -169.95 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.433 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 99.0 m -98.63 123.35 42.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.33 -2.731 . . . . 5.33 105.244 -175.717 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.27 4.8 mp -116.03 148.21 40.42 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.676 -3.14 . . . . 11.66 109.746 168.9 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -95.05 121.87 37.12 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.157 1.932 . . . . 16.3 114.716 173.185 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.539 HD23 HG22 ' A' ' 7' ' ' THR 0.274 44.5 tp -81.62 114.89 20.61 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.489 -4.507 . . . . 9.96 113.385 171.27 . . . . . . . . 4 3 . 1 . 077 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.86 157.09 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.695 2.043 . . . . 9.76 113.951 -178.529 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.1 tp -73.29 122.41 21.93 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 112.942 0.719 . . . . 19.57 112.942 177.148 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -78.21 115.1 17.69 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.565 1.946 . . . . 35.08 114.32 170.201 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -113.72 79.01 1.19 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.218 1.961 . . . . 32.31 109.403 179.65 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -130.12 171.43 12.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.031 -1.895 . . . . 42.75 110.473 177.468 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.48 77.71 0.29 Allowed Glycine 0 N--CA 1.43 -1.715 0 CA-C-O 124.001 1.889 . . . . 36.31 115.698 175.256 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.762 0 N-CA-C 107.049 -2.42 . . . . 36.27 107.049 -165.767 . . . . . . . . 0 0 . 1 . 078 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 120.007 3.336 . . . . 17.17 120.007 . . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -94.08 136.48 34.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.675 -1.972 . . . . 21.89 105.675 -164.98 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 15' ' ' LEU . 7.0 pt -132.09 162.19 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 128.161 2.585 . . . . 10.83 110.731 168.666 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -113.58 143.29 44.81 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 124.346 2.022 . . . . 10.61 109.221 175.457 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -133.62 115.47 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.175 -4.703 . . . . 9.13 104.881 175.832 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -94.01 126.89 39.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.911 -1.885 . . . . 20.55 105.911 179.013 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 69' ' ' LEU . 2.1 p -72.56 168.52 18.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.603 -1.936 . . . . 11.78 115.175 171.911 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.0 tp -66.82 -47.49 71.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.275 -1.515 . . . . 19.31 110.837 -175.463 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -73.58 -50.1 22.93 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.286 1.835 . . . . 23.14 115.068 -179.055 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.53 49.75 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 114.924 -3.513 . . . . 19.74 115.403 -169.906 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -138.71 137.17 36.54 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 116.945 -1.902 . . . . 21.93 110.698 165.047 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -95.82 103.24 15.11 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 125.224 1.577 . . . . 12.33 108.588 172.529 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.98 120.05 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.974 -2.954 . . . . 17.08 111.786 177.641 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -99.28 120.55 39.73 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.915 -3.616 . . . . 16.3 102.396 -176.069 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.425 ' HB2' HG13 ' A' ' 3' ' ' ILE . 14.4 mt -122.77 168.95 11.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.376 3.071 . . . . 15.88 110.883 -170.538 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -135.58 120.42 18.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.635 1.574 . . . . 28.9 107.5 179.859 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.82 168.81 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.302 -2.481 . . . . 12.05 104.302 -172.972 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.266 32.4 mt-10 -106.14 170.83 5.37 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 117.822 -3.048 . . . . 18.17 110.188 162.045 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 68.9 Cg_endo -81.11 5.04 6.5 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 CA-C-N 121.983 1.744 . . . . 8.16 112.101 -179.325 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -93.95 -16.03 24.35 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.133 2.573 . . . . 11.13 108.797 -179.089 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -80.5 142.24 34.4 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.88 1.218 . . . . 18.03 113.497 -173.078 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -74.79 159.03 32.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.684 -1.885 . . . . 10.22 111.3 176.489 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mm -49.35 -40.72 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 119.425 -2.047 . . . . 12.3 115.042 170.059 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -47.82 -50.02 27.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 115.227 -2.321 . . . . 36.51 115.782 167.529 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -68.28 -29.68 68.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 123.496 2.862 . . . . 25.66 115.337 177.013 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.87 -37.62 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 115.734 -0.666 . . . . 8.12 111.487 177.059 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -58.95 -34.77 72.15 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 120.045 3.35 . . . . 15.47 120.045 163.273 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.42 -37.32 65.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.042 -2.911 . . . . 11.45 110.887 -178.133 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -52.99 -45.02 67.66 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.17 2.188 . . . . 24.98 116.502 159.937 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.59 -48.09 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 1 O-C-N 115.813 -4.305 . . . . 9.46 108.625 179.236 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -49.57 -50.44 42.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.007 1.854 . . . . 14.76 116.007 169.605 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -54.07 -49.05 69.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.535 1.68 . . . . 26.29 115.535 174.044 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -67.66 -57.65 6.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.007 -1.451 . . . . 30.06 113.433 -179.676 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -95.81 -36.82 11.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.582 2.753 . . . . 25.19 112.493 -161.763 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.23 0.3 50.85 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 116.938 -2.034 . . . . 7.41 116.572 -178.116 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.3 mt -72.56 124.77 91.19 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 128.69 2.796 . . . . 9.49 108.588 179.948 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.48 160.42 9.52 Favored 'Trans proline' 0 C--N 1.3 -2.013 1 C-N-CA 126.294 4.662 . . . . 11.42 116.28 -178.555 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.19 -7.25 18.83 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 123.668 2.912 . . . . 12.0 113.964 -161.715 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -76.65 -57.23 3.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 131.069 3.748 . . . . 35.55 106.469 -179.847 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -56.98 -45.3 83.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.361 1.986 . . . . 20.52 116.361 168.82 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -62.03 110.52 1.6 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.402 -3.311 . . . . 7.13 116.715 175.451 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -110.18 130.56 55.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.119 1.437 . . . . 36.39 107.326 163.458 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.0 mt -110.83 128.77 55.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.819 2.247 . . . . 9.55 106.828 179.906 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.65 152.74 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.323 -3.36 . . . . 13.9 103.857 173.413 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -96.04 -66.96 0.87 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.806 -2.434 . . . . 6.86 104.923 162.26 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.283 . . -156.33 130.56 8.68 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 104.486 -2.413 . . . . 11.15 104.486 173.766 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.59 -49.94 1.17 Allowed Glycine 0 N--CA 1.43 -1.753 0 CA-C-O 116.863 -2.076 . . . . 13.93 112.953 154.011 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -145.13 172.55 12.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.62 2.71 . . . . 23.92 107.378 -172.476 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.256 5.4 pm0 -83.66 135.23 34.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.229 -2.17 . . . . 23.23 115.553 -175.847 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.4 mt -77.27 151.41 35.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.485 -3.259 . . . . 9.11 111.924 175.885 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB2' ' CG ' ' A' ' 54' ' ' ARG . 40.7 mt-10 -79.4 155.46 28.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.927 -2.983 . . . . 33.44 111.706 175.791 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -77.9 -43.09 31.07 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 120.83 1.65 . . . . 28.37 113.406 -173.564 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.16 29.4 11.9 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 118.462 0.574 . . . . 15.0 112.115 -175.873 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.427 ' CG ' ' HB2' ' A' ' 51' ' ' GLU . 38.0 mmt180 -114.51 149.19 36.78 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.425 -2.065 . . . . 25.5 105.425 178.025 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.286 30.1 p -100.1 176.39 5.42 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 111.568 -2.56 . . . . 11.95 117.547 -164.372 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 26.7 mt -73.8 -8.25 55.3 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.268 -3.395 . . . . 10.17 114.1 168.181 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.0 m -94.9 -28.61 15.11 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.551 -3.843 . . . . 13.59 102.332 -172.796 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -62.43 -51.71 66.43 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 131.673 3.989 . . . . 11.7 116.553 169.574 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -90.17 -6.4 55.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.361 -2.199 . . . . 12.95 111.707 -177.829 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.326 35.2 m120 72.13 36.3 1.13 Allowed 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 116.001 -4.187 . . . . 25.45 113.264 174.25 . . . . . . . . 3 2 . 1 . 078 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.77 109.19 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.72 2.408 . . . . 14.6 107.867 -172.612 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.12 -178.37 3.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.564 2.602 . . . . 33.23 111.213 -179.772 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -49.89 148.89 2.89 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 118.853 -2.404 . . . . 25.97 116.685 175.972 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 35.1 mt-10 53.48 36.97 24.57 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.302 -3.374 . . . . 32.61 118.616 -172.637 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -97.57 144.39 27.3 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.171 -2.159 . . . . 10.56 105.171 178.752 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -101.22 105.86 17.02 Favored 'General case' 0 N--CA 1.43 -1.442 1 CA-C-O 128.844 4.164 . . . . 5.33 110.583 175.595 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.57 150.3 21.79 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.542 -2.599 . . . . 11.66 111.832 173.777 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -103.36 127.5 50.7 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.825 -1.172 . . . . 16.3 112.128 178.274 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 7' ' ' THR . 15.2 tp -105.26 116.52 32.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.41 3.481 . . . . 9.96 109.347 169.947 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.76 174.16 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 112.781 -2.009 . . . . 9.76 110.996 -179.114 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.9 tp -96.47 123.81 40.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.788 2.435 . . . . 19.57 111.386 -175.748 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -73.8 139.71 45.35 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.2 -1.562 . . . . 35.08 114.634 -176.091 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.6 mt -86.38 -53.49 4.97 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.081 -4.762 . . . . 32.31 108.29 -176.04 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.3 mtm-85 -119.49 -80.3 0.61 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.364 -3.335 . . . . 42.75 111.265 -167.115 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.08 -57.27 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.734 0 O-C-N 126.377 2.298 . . . . 36.31 110.459 -175.58 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.733 0 C-N-CA 125.679 1.609 . . . . 36.27 112.737 -178.434 . . . . . . . . 0 0 . 1 . 079 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 116.746 2.128 . . . . 17.17 116.746 . . . . . . . . . 0 0 . 1 . 079 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.251 85.8 mt-30 -85.05 122.23 28.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.096 1.903 . . . . 21.89 113.331 177.168 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -113.09 159.92 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.12 -2.548 . . . . 10.83 104.12 175.916 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -111.87 127.15 55.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 123.586 1.66 . . . . 10.61 109.298 -177.756 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.7 t -122.85 109.6 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.204 1.954 . . . . 9.13 110.93 179.528 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -90.48 144.2 26.02 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 113.235 -5.916 . . . . 20.55 115.914 176.054 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -85.61 164.25 17.84 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.148 2.979 . . . . 11.78 113.653 175.582 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.94 -26.23 68.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.311 -2.743 . . . . 19.31 114.795 168.401 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 38.9 p -75.38 -44.06 46.87 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.455 1.934 . . . . 23.14 112.339 178.632 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.8 38.6 0.23 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-N 115.08 -0.964 . . . . 19.74 112.291 169.458 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -103.08 125.79 49.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.188 -1.042 . . . . 21.93 108.188 172.353 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.4 m -91.66 128.05 37.35 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 102.339 -3.208 . . . . 12.33 102.339 168.965 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.254 28.7 mt -102.06 136.22 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 117.828 -3.045 . . . . 17.08 105.309 178.295 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.7 m -105.99 100.17 9.73 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 100.607 -3.849 . . . . 16.3 100.607 -175.095 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 mt -96.14 119.74 35.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.907 1.683 . . . . 15.88 110.334 -177.939 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -93.97 96.72 9.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.063 -2.569 . . . . 28.9 104.063 178.837 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.71 168.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.733 2.013 . . . . 12.05 108.831 179.178 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -116.22 154.27 48.68 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-N 120.011 1.278 . . . . 18.17 108.98 -169.98 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.79 -4.32 14.49 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 CA-C-N 122.56 1.95 . . . . 8.16 115.185 -173.127 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.4 m -88.59 -12.39 42.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 125.238 1.586 . . . . 11.13 113.987 172.431 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.67 149.78 48.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.034 -2.916 . . . . 18.03 114.511 -179.462 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.284 37.2 p -90.55 175.34 7.09 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 111.245 -2.707 . . . . 10.22 107.699 -179.105 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 mm -73.55 -27.36 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 119.456 -2.027 . . . . 12.3 109.791 171.992 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.73 -52.16 65.39 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.509 -2.619 . . . . 36.51 108.532 170.333 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -47.58 -39.86 17.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.654 2.381 . . . . 25.66 115.807 172.87 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.66 -46.63 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 127.1 3.333 . . . . 8.12 114.657 -171.572 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.46 -27.63 66.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.934 -2.979 . . . . 15.47 115.19 160.636 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.88 -19.84 60.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.369 2.35 . . . . 11.45 111.211 178.073 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -69.34 -30.53 68.58 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 112.739 -6.225 . . . . 24.98 112.373 165.449 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -87.76 -18.03 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 126.005 2.812 . . . . 9.46 113.068 174.593 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -69.67 -33.24 72.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.52 -3.863 . . . . 14.76 110.558 167.662 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.85 -54.11 12.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.202 -2.811 . . . . 26.29 110.767 178.481 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -71.31 -62.94 1.22 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.178 -1.576 . . . . 30.06 113.432 -176.774 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -91.5 -33.37 15.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.435 2.541 . . . . 25.19 110.779 -174.051 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.73 59.28 2.24 Favored Glycine 0 N--CA 1.43 -1.751 2 O-C-N 114.577 -5.077 . . . . 7.41 109.371 179.55 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 mt -118.48 146.48 39.78 Favored Pre-proline 0 N--CA 1.43 -1.459 0 N-CA-C 103.236 -2.876 . . . . 9.49 103.236 -177.127 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.266 53.1 Cg_exo -75.1 138.79 23.24 Favored 'Trans proline' 0 C--N 1.3 -1.996 2 C-N-CA 128.48 6.12 . . . . 11.42 112.064 -176.295 . . . . . . . . 3 2 . 1 . 079 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.88 -29.18 89.49 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 C-N-CA 122.748 2.299 . . . . 12.0 112.711 175.425 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.31 7.8 p-10 -70.87 -38.28 73.09 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.523 1.965 . . . . 35.55 112.084 175.825 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -73.44 -35.41 65.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.6 2.36 . . . . 20.52 110.379 -176.469 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -69.12 116.93 10.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.54 2.736 . . . . 7.13 110.781 169.319 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -110.76 129.12 55.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 128.612 3.695 . . . . 36.39 111.692 165.628 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 tp -116.45 133.37 56.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.408 -1.433 . . . . 9.55 109.843 -172.691 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.5 mt -127.08 130.13 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 116.664 -3.772 . . . . 13.9 109.383 -175.108 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -89.87 -58.59 2.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 123.121 2.691 . . . . 6.86 115.492 172.634 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.4 -73.94 0.63 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.19 1.396 . . . . 11.15 107.684 -178.608 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.25 -64.16 0.26 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 117.206 -2.426 . . . . 13.93 111.108 -173.569 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.275 17.6 ptmt -67.04 168.0 10.84 Favored 'General case' 0 N--CA 1.429 -1.491 2 CA-C-O 128.924 4.202 . . . . 23.92 113.496 171.961 . . . . . . . . 3 2 . 1 . 079 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -86.12 145.68 26.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.175 -2.739 . . . . 23.23 113.692 172.922 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -80.74 137.97 36.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.093 -1.629 . . . . 9.11 107.793 -178.054 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -102.6 145.84 29.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.081 2.953 . . . . 33.44 107.884 -170.525 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -39.36 -73.97 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 119.77 3.248 . . . . 28.37 119.77 -174.692 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.02 17.52 41.28 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 129.073 3.225 . . . . 15.0 111.808 -164.16 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -96.4 163.66 12.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.687 -2.066 . . . . 25.5 105.46 173.395 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -101.55 163.89 12.04 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.42 -2.437 . . . . 11.95 104.42 -179.577 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.37 -26.46 66.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.358 -1.292 . . . . 10.17 114.424 162.592 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -65.93 -35.62 81.12 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 123.49 0.716 . . . . 13.59 111.895 168.421 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.8 -34.09 73.97 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 116.045 -4.159 . . . . 11.7 120.201 175.168 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -92.37 -22.26 19.78 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.476 -3.265 . . . . 12.95 105.79 -178.267 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.8 m120 71.89 75.44 0.17 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.5 2.72 . . . . 25.45 108.91 -177.563 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.2 mt -115.56 126.8 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 125.557 1.786 . . . . 14.6 106.637 -175.34 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.94 -178.79 4.54 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.398 -1.439 . . . . 33.23 109.323 179.848 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -66.61 156.06 36.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.948 2.309 . . . . 25.97 115.768 -168.231 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.291 46.7 mt-10 58.21 42.22 22.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.435 2.754 . . . . 32.61 118.435 -171.202 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 m -116.84 132.82 56.6 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.069 -1.826 . . . . 10.56 106.069 -175.759 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.6 m -84.09 140.41 31.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.984 -2.947 . . . . 5.33 114.183 173.262 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -125.04 165.57 17.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.135 2.574 . . . . 11.66 110.096 174.344 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -110.27 104.4 13.2 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.271 1.952 . . . . 16.3 116.271 176.294 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.6 tp -73.06 118.74 16.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 123.876 0.735 . . . . 9.96 110.236 165.817 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 m -129.64 155.53 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 105.592 -2.003 . . . . 9.76 105.592 176.254 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 71' ' ' LEU . 17.9 mt -112.0 169.31 8.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.539 -2.763 . . . . 19.57 103.539 -166.558 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -84.1 123.55 30.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.335 -1.302 . . . . 35.08 114.073 -178.9 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mt -93.86 -72.48 0.61 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 101.16 -3.644 . . . . 32.31 101.16 -175.858 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -121.13 -51.56 2.1 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.267 1.984 . . . . 42.75 109.235 170.351 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.42 151.3 5.45 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 105.362 -3.095 . . . . 36.31 105.362 174.569 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 C-N-CA 118.595 -1.764 . . . . 36.27 111.51 174.787 . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ptt? . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 124.582 2.134 . . . . 17.17 108.851 . . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -99.03 132.7 44.15 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 116.585 -3.822 . . . . 21.89 113.089 -169.551 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 pt -120.46 154.5 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.08 -1.013 . . . . 10.83 110.331 175.661 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -124.52 125.01 43.51 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.073 -1.642 . . . . 10.61 106.706 -174.315 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.476 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 22.7 t -109.54 102.56 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 124.46 2.076 . . . . 9.13 110.335 -178.229 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -83.61 126.28 32.68 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 127.284 3.421 . . . . 20.55 116.311 172.725 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.6 p -78.96 174.31 11.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.928 2.299 . . . . 11.78 112.612 -175.745 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.48 HD13 HG12 ' A' ' 70' ' ' VAL . 12.5 tp -75.6 -36.23 60.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.61 -2.556 . . . . 19.31 109.889 -177.018 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -61.68 -37.63 84.82 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.076 -3.515 . . . . 23.14 116.678 170.519 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.36 43.28 0.6 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 120.227 1.376 . . . . 19.74 111.066 174.546 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -111.18 151.17 28.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.611 1.708 . . . . 21.93 115.611 161.911 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -97.36 115.51 27.85 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.214 -1.554 . . . . 12.33 113.568 171.577 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.476 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 10.0 mt -93.04 92.18 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 126.366 2.984 . . . . 17.08 111.165 170.699 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.3 m -82.91 105.22 13.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.551 -2.113 . . . . 16.3 113.122 -173.956 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.86 158.38 17.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.738 -2.69 . . . . 15.88 103.738 -169.938 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -110.97 133.29 53.5 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.395 -2.69 . . . . 28.9 108.437 164.146 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.92 169.15 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.006 -2.961 . . . . 12.05 103.006 -171.502 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.48 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 73.7 mm-40 -100.88 174.15 3.16 Favored Pre-proline 0 N--CA 1.429 -1.485 1 O-C-N 114.432 -5.168 . . . . 18.17 104.14 165.882 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 69.2 Cg_endo -78.29 -15.3 14.34 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 CA-C-N 123.239 2.192 . . . . 8.16 116.133 168.937 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.7 p -77.91 -5.46 51.16 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.57 2.348 . . . . 11.13 114.688 176.366 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -70.84 148.25 48.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.588 -3.82 . . . . 18.03 112.456 178.428 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.9 p -93.0 148.01 22.35 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 129.477 4.236 . . . . 10.22 108.644 178.134 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.8 mm -52.21 -32.49 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 125.781 2.705 . . . . 12.3 116.144 173.144 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -67.61 -39.18 84.74 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.617 -3.802 . . . . 36.51 113.106 174.742 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -78.64 -6.76 56.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 114.483 -2.887 . . . . 25.66 110.548 -179.665 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.3 t -86.56 -43.59 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 130.762 3.625 . . . . 8.12 110.026 171.806 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -51.25 -33.27 27.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.36 -3.338 . . . . 15.47 119.093 161.4 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.7 -19.04 63.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.327 -2.108 . . . . 11.45 114.407 177.849 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -78.89 -39.98 33.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.364 -1.347 . . . . 24.98 107.364 174.117 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 mt -74.36 -40.48 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.742 -1.849 . . . . 9.46 107.965 -176.652 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -54.1 -45.44 71.82 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.99 -2.944 . . . . 14.76 110.714 173.014 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -64.81 -52.64 55.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.749 -1.844 . . . . 26.29 111.081 -176.65 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.58 -66.96 0.54 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.102 2.26 . . . . 30.06 117.102 -176.393 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -67.47 -49.73 62.25 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.507 2.379 . . . . 25.19 113.334 -172.174 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.85 13.34 16.39 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-N 113.22 -1.809 . . . . 7.41 115.387 178.49 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.1 mt -89.08 127.15 56.62 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 126.926 2.091 . . . . 9.49 108.801 -171.559 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -67.71 139.37 48.02 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-O 116.192 -1.67 . . . . 11.42 113.397 -177.878 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -73.34 -14.57 25.37 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 124.253 2.554 . . . . 12.0 118.301 -166.371 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -35.94 63.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 120.374 1.443 . . . . 35.55 111.299 172.172 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.55 -41.13 89.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 117.061 2.245 . . . . 20.52 117.061 166.688 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -63.65 117.53 6.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.904 3.282 . . . . 7.13 109.375 -176.031 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.414 ' HB3' HG23 ' A' ' 70' ' ' VAL . 27.3 ttm180 -116.88 101.25 8.37 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.054 -2.904 . . . . 36.39 104.649 176.429 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.6 tp -96.43 115.33 27.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.749 3.219 . . . . 9.55 108.95 -172.32 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -114.97 154.38 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.928 2.891 . . . . 13.9 110.761 -171.391 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.89 -91.4 0.24 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 116.58 -1.676 . . . . 6.86 106.622 174.264 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.54 -75.46 0.6 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.183 2.177 . . . . 11.15 106.019 178.786 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.95 -32.57 3.77 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 109.347 -3.57 . . . . 13.93 117.407 -175.062 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 8.2 ptpt -99.08 152.08 20.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.758 3.17 . . . . 23.92 116.869 173.083 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -88.89 133.5 34.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.852 -2.405 . . . . 23.23 113.014 171.557 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.8 mt -89.82 123.71 34.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.343 -1.473 . . . . 9.11 110.973 -176.485 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -95.62 138.48 33.23 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.302 2.241 . . . . 33.44 107.562 -169.174 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -34.27 -49.89 0.39 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.843 3.657 . . . . 28.37 120.668 -168.869 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.55 -8.46 59.63 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 119.899 -1.751 . . . . 15.0 115.657 -164.453 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -83.59 154.38 23.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.864 -2.551 . . . . 25.5 108.43 -175.903 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -89.27 166.77 13.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.839 1.781 . . . . 11.95 115.312 176.759 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.47 -31.6 71.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 118.976 2.954 . . . . 10.17 118.976 169.71 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -61.12 -30.71 70.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.032 2.133 . . . . 13.59 115.33 163.325 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -72.02 -42.86 65.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.865 1.793 . . . . 11.7 110.82 174.41 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -83.31 -17.04 43.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.796 2.517 . . . . 12.95 117.796 -174.612 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 28.0 m120 78.52 45.96 0.06 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 131.0 3.72 . . . . 25.45 109.941 -179.005 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -83.06 123.91 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.413 -2.679 . . . . 14.6 105.78 167.605 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -112.42 -157.07 0.61 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.861 -2.274 . . . . 33.23 104.861 -179.382 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -85.32 153.23 22.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.097 1.147 . . . . 25.97 114.097 -178.826 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 57.03 34.11 24.41 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.526 -3.234 . . . . 32.61 111.749 -176.747 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -77.88 138.85 39.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.077 -1.083 . . . . 10.56 108.077 -178.288 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 m -98.93 118.79 36.5 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.437 -1.32 . . . . 5.33 107.437 167.801 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.7 mt -106.36 176.41 5.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 123.386 0.674 . . . . 11.66 109.992 169.994 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -136.55 135.91 38.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 103.577 -2.749 . . . . 16.3 103.577 -168.444 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.4 tp -117.17 119.97 36.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.967 -3.583 . . . . 9.96 108.42 173.28 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.48 HG12 HD13 ' A' ' 8' ' ' LEU . 27.9 m -116.9 166.97 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.734 2.207 . . . . 9.76 110.055 163.091 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt -106.72 124.5 49.7 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.211 -1.556 . . . . 19.57 108.992 179.673 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -58.2 108.34 0.59 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.841 1.793 . . . . 35.08 115.841 178.908 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 mt -86.02 -145.75 0.11 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.275 -2.141 . . . . 32.31 111.68 167.074 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -124.31 96.77 5.04 Favored 'General case' 0 N--CA 1.43 -1.442 1 C-N-CA 133.614 4.766 . . . . 42.75 108.376 -167.547 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.22 -121.73 0.71 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 105.074 -3.21 . . . . 36.31 105.074 -168.33 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.751 0 CA-C-O 115.672 -2.738 . . . . 36.27 114.904 179.47 . . . . . . . . 0 0 . 1 . 081 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 121.271 0.558 . . . . 17.17 111.406 . . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -77.69 126.47 30.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.593 -3.817 . . . . 21.89 112.39 -173.614 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -115.19 139.45 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 119.369 0.986 . . . . 10.83 110.569 168.601 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -99.91 109.13 21.51 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.568 2.604 . . . . 10.61 111.555 179.282 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.8 t -92.03 105.82 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 119.576 -1.953 . . . . 9.13 106.195 175.411 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.281 71.8 mttt -86.3 138.08 32.11 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.974 1.102 . . . . 20.55 113.974 -179.867 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.273 8.7 p -99.93 176.05 5.56 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.516 -3.24 . . . . 11.78 112.702 -167.89 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.278 27.7 tp -71.58 -55.6 7.47 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.424 3.489 . . . . 19.31 115.158 -174.453 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.414 67.6 p -56.53 -63.3 1.24 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.059 -1.65 . . . . 23.14 113.727 165.142 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.64 60.49 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 122.502 3.761 . . . . 19.74 122.502 -177.979 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.15 166.51 13.85 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.753 -3.204 . . . . 21.93 105.882 175.543 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -117.51 130.24 56.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.036 2.236 . . . . 12.33 117.036 158.678 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.8 mt -101.37 112.05 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 117.373 -1.731 . . . . 17.08 110.027 175.214 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.272 90.6 m -93.57 115.36 27.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.891 -3.631 . . . . 16.3 110.99 177.768 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.28 50.9 mt -119.42 134.37 55.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.737 -1.579 . . . . 15.88 106.737 -173.455 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -96.94 94.68 7.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.918 3.287 . . . . 28.9 109.038 -179.53 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.9 m -119.45 159.2 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 118.01 -2.931 . . . . 12.05 105.477 -169.133 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -113.87 155.85 44.64 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 116.556 -3.84 . . . . 18.17 106.959 171.351 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.306 69.2 Cg_endo -65.54 -9.61 23.16 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 125.153 3.902 . . . . 8.16 121.387 -164.203 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -94.61 -11.37 29.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.359 -1.463 . . . . 11.13 113.676 -179.612 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -64.22 143.52 57.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.158 2.183 . . . . 18.03 113.902 171.743 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -93.49 165.12 12.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.523 -1.361 . . . . 10.22 110.266 -166.464 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -66.91 -31.57 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 115.878 1.807 . . . . 12.3 115.878 171.235 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -49.51 -48.02 48.41 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.111 1.507 . . . . 36.51 113.39 166.766 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -81.11 -16.26 53.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.283 -1.326 . . . . 25.66 109.177 -178.375 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.81 -47.01 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 123.358 2.799 . . . . 8.12 109.924 173.722 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -50.68 -38.52 47.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.289 2.235 . . . . 15.47 114.375 174.365 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.309 . . -62.53 -37.17 85.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.253 -2.308 . . . . 11.45 112.757 173.325 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -67.9 -49.06 64.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.382 1.446 . . . . 24.98 112.662 175.443 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.99 -36.86 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 O-C-N 115.978 -4.201 . . . . 9.46 107.99 -179.096 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.43 -38.34 86.81 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.151 -3.468 . . . . 14.76 115.569 174.305 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -72.95 -43.51 62.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.242 1.942 . . . . 26.29 116.242 178.655 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -64.41 -69.86 0.26 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 120.847 3.647 . . . . 30.06 120.847 175.512 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -94.28 -2.56 52.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.068 -1.645 . . . . 25.19 111.966 -175.845 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.99 41.65 87.05 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 122.411 2.369 . . . . 7.41 118.215 -178.302 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 mm -106.28 107.87 60.69 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 114.416 -2.707 . . . . 9.49 108.972 -178.053 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.18 144.98 78.93 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 123.466 2.273 . . . . 11.42 117.319 177.165 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.34 -13.19 32.96 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 123.67 2.913 . . . . 12.0 112.0 -166.875 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -85.87 -9.38 57.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.839 3.255 . . . . 35.55 107.863 179.016 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -107.07 -15.45 14.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.53 -1.356 . . . . 20.52 114.413 171.088 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -81.47 99.26 8.66 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.613 -3.179 . . . . 7.13 113.867 -179.258 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 44.5 ttt-85 -91.88 107.1 18.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.685 -3.135 . . . . 36.39 107.011 170.56 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.9 134.47 41.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.742 -1.947 . . . . 9.55 105.742 -177.685 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -123.39 132.91 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 130.257 3.423 . . . . 13.9 110.458 -179.522 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -107.98 112.06 24.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.536 -2.602 . . . . 6.86 106.62 158.372 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.35 -86.84 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 131.927 4.091 . . . . 11.15 109.276 178.712 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.14 16.67 3.42 Favored Glycine 0 N--CA 1.43 -1.742 1 O-C-N 115.396 -4.565 . . . . 13.93 111.801 162.441 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.255 88.7 mttt -87.17 122.53 31.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.848 2.324 . . . . 23.92 111.105 172.988 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -84.86 106.48 16.42 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 121.099 1.772 . . . . 23.23 108.165 178.377 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.35 139.48 58.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.52 2.328 . . . . 9.11 109.732 -174.015 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -100.35 140.74 34.16 Favored 'General case' 0 N--CA 1.43 -1.474 1 C-N-CA 131.735 4.014 . . . . 33.44 111.907 -175.785 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -54.88 -54.01 48.07 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.133 2.573 . . . . 28.37 113.661 -168.49 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.32 7.12 61.66 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 129.86 3.6 . . . . 15.0 114.978 -173.73 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -107.82 170.46 7.97 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.823 -1.177 . . . . 25.5 107.823 176.603 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.0 p -110.07 172.37 6.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.772 2.701 . . . . 11.95 115.877 -174.672 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 14.1 mt -59.2 -48.43 81.63 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.985 -2.947 . . . . 10.17 112.988 162.791 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.6 p -58.49 -23.18 57.22 Favored 'General case' 0 N--CA 1.43 -1.451 1 N-CA-C 123.196 4.517 . . . . 13.59 123.196 173.17 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.313 15.6 t70 -74.16 -50.47 19.19 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.741 -2.475 . . . . 11.7 110.989 177.106 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -73.62 -21.62 60.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.188 1.921 . . . . 12.95 116.188 177.92 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 67.8 m-20 80.78 47.93 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 127.958 3.742 . . . . 25.45 114.071 -176.604 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.7 mt -77.88 134.97 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.29 -2.756 . . . . 14.6 108.37 168.976 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -121.14 -158.11 0.75 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.296 1.622 . . . . 33.23 108.57 176.525 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 7.2 ptmm? -77.67 158.72 29.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.984 3.278 . . . . 25.97 113.334 170.814 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 64.91 24.69 12.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.032 -2.293 . . . . 32.61 109.333 168.658 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -91.35 148.51 22.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.031 -2.293 . . . . 10.56 109.62 -170.02 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -102.86 120.83 41.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.986 -1.696 . . . . 5.33 109.156 173.921 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.28 160.27 16.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 102.932 -2.988 . . . . 11.66 102.932 174.025 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -122.54 134.18 54.55 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.026 -4.171 . . . . 16.3 105.332 179.395 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tp -100.52 129.93 46.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 128.613 3.696 . . . . 9.96 105.663 167.788 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.66 168.32 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 101.833 -3.395 . . . . 9.76 101.833 175.575 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.8 tp -88.8 126.21 35.25 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.403 2.371 . . . . 19.57 117.403 -176.151 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 42' ' ' ARG . 53.5 ttt180 -87.6 136.35 32.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 113.573 0.953 . . . . 35.08 113.573 -171.132 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.3 mt -110.86 134.32 52.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.38 2.672 . . . . 32.31 106.106 174.996 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -82.8 164.06 20.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.699 2.19 . . . . 42.75 116.109 173.441 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.29 -86.53 0.22 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 110.364 -3.107 . . . . 36.31 107.505 -151.879 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.756 0 N-CA-C 108.213 -1.955 . . . . 36.27 108.213 177.291 . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 CA--C 1.489 -1.387 0 CA-C-O 124.832 2.254 . . . . 17.17 113.517 . . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -105.46 148.39 27.24 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.649 -3.157 . . . . 21.89 106.38 179.405 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.1 pt -130.27 153.84 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.286 -2.487 . . . . 10.83 104.286 172.64 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -109.21 113.77 26.9 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.881 -1.509 . . . . 10.61 110.75 173.574 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -95.5 110.83 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.294 -1.002 . . . . 9.13 108.294 170.599 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -102.57 142.71 33.3 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.46 1.124 . . . . 20.55 113.06 -176.334 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 p -87.43 174.65 8.39 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 110.779 -2.919 . . . . 11.78 114.816 175.522 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.32 -49.75 62.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.538 -2.601 . . . . 19.31 115.027 167.957 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.8 p -69.89 -46.09 66.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.769 1.622 . . . . 23.14 112.41 176.914 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.36 54.25 0.13 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 119.7 -1.875 . . . . 19.74 108.523 173.589 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.26 132.41 54.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.497 1.519 . . . . 21.93 112.059 159.023 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -99.25 112.71 24.81 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 121.12 1.782 . . . . 12.33 111.842 178.378 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 mt -85.98 109.22 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.269 -2.863 . . . . 17.08 103.269 176.314 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.2 m -104.08 101.02 10.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.016 -1.476 . . . . 16.3 107.016 -175.185 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.0 mt -97.93 131.59 44.25 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.719 1.748 . . . . 15.88 115.719 173.412 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -75.75 124.35 27.12 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.578 2.132 . . . . 28.9 105.997 160.999 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.1 169.33 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 104.701 -2.333 . . . . 12.05 104.701 -179.988 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -104.49 152.3 39.33 Favored Pre-proline 0 N--CA 1.43 -1.444 0 C-N-CA 124.093 0.957 . . . . 18.17 112.67 155.009 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -63.74 -9.95 20.52 Favored 'Trans proline' 0 N--CA 1.434 -2.005 1 C-N-CA 127.248 5.299 . . . . 8.16 113.124 -179.378 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.5 m -90.93 -7.76 51.22 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.645 1.72 . . . . 11.13 115.645 170.429 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -67.31 159.79 28.53 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.709 1.719 . . . . 18.03 114.328 174.011 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.326 71.1 p -86.83 168.9 13.04 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.869 -1.144 . . . . 10.22 114.035 -177.398 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.426 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 29.1 mm -60.61 -36.29 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 119.219 -2.176 . . . . 12.3 115.504 158.311 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -57.47 -33.75 68.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 126.837 3.208 . . . . 36.51 114.61 171.961 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -79.76 -23.98 41.84 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.537 -5.727 . . . . 25.66 111.154 179.547 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 55.2 t -69.11 -51.46 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 115.485 -0.779 . . . . 8.12 112.736 168.458 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -56.62 -31.76 64.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.92 1.688 . . . . 15.47 112.815 178.448 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.47 75.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.901 2.137 . . . . 11.45 114.457 176.9 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -80.09 -31.12 39.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.747 2.689 . . . . 24.98 112.485 178.321 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.28 -38.11 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 1 O-C-N 115.538 -4.477 . . . . 9.46 110.59 171.399 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -69.7 -29.94 67.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.585 -3.197 . . . . 14.76 119.152 171.268 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -76.24 -57.6 3.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.401 1.572 . . . . 26.29 113.286 171.336 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -78.1 -66.96 0.78 Allowed 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 115.114 -4.742 . . . . 30.06 109.567 -167.155 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -72.03 -38.71 69.5 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.981 2.8 . . . . 25.19 116.848 -175.084 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.04 43.12 2.28 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.968 -2.333 . . . . 7.41 114.952 178.796 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mm -98.66 117.25 64.8 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 112.786 -3.483 . . . . 9.49 111.073 -179.792 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -68.27 165.11 29.82 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 CA-C-N 125.207 2.895 . . . . 11.42 114.8 -177.553 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -79.34 -28.17 3.83 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 121.791 1.675 . . . . 12.0 112.737 -153.84 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -79.55 -30.65 41.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 127.513 3.008 . . . . 35.55 107.251 177.191 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -74.0 -16.65 61.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.238 -3.414 . . . . 20.52 112.222 -178.314 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -86.68 118.6 26.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.145 2.402 . . . . 7.13 112.815 176.714 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -108.22 125.81 52.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.515 -3.143 . . . . 36.39 102.515 160.665 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -102.03 123.82 46.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 110.999 -2.818 . . . . 9.55 106.391 168.035 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.6 mm -121.62 140.83 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 100.975 -3.713 . . . . 13.9 100.975 -173.266 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -126.72 122.77 35.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 116.323 -1.799 . . . . 6.86 106.773 165.053 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.67 -92.28 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.785 1.63 . . . . 11.15 112.383 -164.478 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.67 -7.28 5.73 Favored Glycine 0 N--CA 1.431 -1.678 0 C-N-CA 127.659 2.552 . . . . 13.93 109.394 -179.305 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -103.52 119.79 39.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 118.497 2.777 . . . . 23.92 118.497 -166.874 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -69.43 112.19 5.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.668 1.359 . . . . 23.23 114.668 -178.621 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.2 mt -80.46 112.14 17.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.562 0.696 . . . . 9.11 112.017 -179.862 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -85.94 168.48 14.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.409 2.684 . . . . 33.44 109.83 -170.808 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.62 -46.86 62.54 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 113.359 -5.838 . . . . 28.37 115.351 -165.441 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.63 32.0 6.68 Favored Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 126.922 2.201 . . . . 15.0 116.418 -168.607 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.8 mtt-85 -130.68 159.09 38.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.594 -3.484 . . . . 25.5 101.594 -177.771 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 p -87.8 156.79 19.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 131.511 3.925 . . . . 11.95 111.815 174.046 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.86 -28.78 68.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.016 -1.447 . . . . 10.17 111.612 178.843 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.291 68.8 p -59.28 -36.58 75.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.03 2.233 . . . . 13.59 117.03 165.972 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -81.93 -29.3 32.35 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.686 -4.384 . . . . 11.7 106.158 -170.816 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -72.86 -20.79 61.05 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 121.187 3.773 . . . . 12.95 121.187 160.874 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.389 15.6 m120 70.86 34.65 1.91 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.386 -2.071 . . . . 25.45 112.892 -174.479 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -88.46 132.21 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 101.42 -3.548 . . . . 14.6 101.42 171.859 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.271 81.9 mt-30 -98.53 175.22 6.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 109.864 -3.335 . . . . 33.23 114.869 174.211 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -45.71 137.73 5.14 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.549 2.74 . . . . 25.97 111.963 160.467 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 60.04 24.34 13.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.915 2.561 . . . . 32.61 117.915 177.466 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -78.08 154.22 31.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.215 -2.178 . . . . 10.56 106.408 -168.049 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.4 m -98.0 108.71 21.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 117.246 -1.359 . . . . 5.33 111.975 173.277 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.07 158.2 16.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 125.114 1.509 . . . . 11.66 109.457 175.781 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -121.71 130.86 53.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.115 -2.241 . . . . 16.3 113.079 -178.167 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -87.55 100.8 13.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.314 3.046 . . . . 9.96 110.928 169.402 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 t -96.94 120.26 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.99 -1.694 . . . . 9.76 113.031 174.05 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 tp -75.57 116.13 15.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.541 -3.849 . . . . 19.57 108.655 -175.797 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.274 9.2 ttt180 -101.58 152.58 20.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.82 2.048 . . . . 35.08 112.515 -174.281 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.276 7.6 tp -89.64 163.39 15.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.27 2.628 . . . . 32.31 116.203 173.385 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -88.54 141.72 28.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.807 -1.808 . . . . 42.75 110.958 167.815 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.52 57.74 3.79 Favored Glycine 0 N--CA 1.429 -1.801 0 O-C-N 119.87 -1.769 . . . . 36.31 113.081 -165.585 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.78 0 O-C-N 121.231 -1.158 . . . . 36.27 114.687 -168.924 . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 117.664 2.468 . . . . 17.17 117.664 . . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -91.71 134.75 34.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 126.243 2.925 . . . . 21.89 113.688 179.971 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.4 pt -121.69 161.86 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 117.422 -3.299 . . . . 10.83 112.83 172.763 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -111.33 116.59 31.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 123.694 0.621 . . . . 10.61 111.589 179.806 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.6 HG21 HD12 ' A' ' 15' ' ' LEU . 15.5 t -103.56 108.6 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 118.728 -2.482 . . . . 9.13 107.924 -175.383 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -97.5 119.96 37.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.41 2.052 . . . . 20.55 110.689 -172.108 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 2.2 p -76.66 175.35 9.41 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.568 -1.197 . . . . 11.78 111.931 -173.803 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.04 -40.52 75.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 124.219 1.961 . . . . 19.31 112.869 175.796 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 p -76.91 -21.14 55.34 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.483 2.313 . . . . 23.14 114.538 177.33 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.51 26.81 2.77 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 118.956 -1.592 . . . . 19.74 110.069 153.403 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -83.6 139.06 33.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 116.831 -1.556 . . . . 21.93 111.487 178.329 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -93.34 105.34 17.42 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.339 2.336 . . . . 12.33 109.837 168.161 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.18 119.94 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 125.013 2.339 . . . . 17.08 106.886 176.249 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.7 m -81.14 115.71 20.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.845 -2.409 . . . . 16.3 109.216 169.683 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.6 HD12 HG21 ' A' ' 5' ' ' VAL . 64.9 mt -123.41 144.65 49.35 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 113.186 -5.946 . . . . 15.88 106.922 177.361 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -89.99 108.78 19.93 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.051 1.74 . . . . 28.9 115.136 167.835 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.85 155.92 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 114.655 -1.157 . . . . 12.05 108.915 -179.412 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -109.06 152.4 42.47 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 101.081 -3.674 . . . . 18.17 101.081 163.148 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -65.83 -23.39 55.34 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 C-N-CA 126.271 4.647 . . . . 8.16 112.34 -172.991 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.5 m -90.61 1.73 56.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.795 -3.066 . . . . 11.13 110.731 179.179 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -78.96 161.22 26.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 123.572 2.897 . . . . 18.03 104.177 175.374 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.0 p -108.03 167.36 10.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.803 -1.925 . . . . 10.22 105.803 -168.062 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.4 mm -74.62 -34.51 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 C-N-CA 128.921 2.888 . . . . 12.3 104.662 -171.587 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.87 -38.55 72.91 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.846 -4.284 . . . . 36.51 119.428 169.933 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -70.6 -19.3 62.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.006 -1.906 . . . . 25.66 114.839 169.916 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -79.14 -37.31 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 118.048 -1.461 . . . . 8.12 110.948 175.884 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -67.96 -30.31 69.57 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 130.575 3.55 . . . . 15.47 111.033 176.568 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.69 -41.84 36.63 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.874 -2.391 . . . . 11.45 111.771 -175.755 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -61.21 -34.23 74.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.102 -2.874 . . . . 24.98 113.546 170.304 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.299 65.9 mt -65.17 -39.8 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 125.532 1.77 . . . . 9.46 115.701 169.531 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -57.64 -53.41 58.51 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.728 -3.733 . . . . 14.76 112.541 173.78 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -67.83 -44.82 76.33 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.112 -2.313 . . . . 26.29 115.68 -177.6 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -83.02 -50.22 8.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.088 -1.434 . . . . 30.06 113.985 -178.678 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -94.76 -55.64 3.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.134 2.397 . . . . 25.19 111.438 -176.655 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.64 40.74 2.47 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 118.559 -1.781 . . . . 7.41 117.141 -176.512 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.1 mm -90.04 131.17 39.87 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 118.275 -2.897 . . . . 9.49 109.006 167.778 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -67.93 144.21 63.61 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 128.101 3.929 . . . . 11.42 118.298 -174.58 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -81.61 -3.59 11.96 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 124.082 3.188 . . . . 12.0 114.639 -163.502 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.83 -23.57 45.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.066 -1.646 . . . . 35.55 115.428 165.661 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -89.53 -24.18 21.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.35 1.86 . . . . 20.52 111.234 -179.754 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -78.8 96.63 5.67 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.195 -2.191 . . . . 7.13 109.951 -173.177 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -109.28 127.05 53.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.408 -2.441 . . . . 36.39 104.408 171.706 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.571 ' HB3' HD12 ' A' ' 50' ' ' LEU . 14.8 mt -107.28 127.26 53.39 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 116.871 -1.538 . . . . 9.55 108.672 -168.368 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 51.7 mm -117.92 137.79 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 125.323 1.639 . . . . 13.9 109.14 179.404 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -131.42 127.59 37.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 125.211 3.642 . . . . 6.86 106.736 155.951 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.75 -106.89 0.35 Allowed 'General case' 0 N--CA 1.429 -1.482 1 C-N-CA 132.203 4.201 . . . . 11.15 113.649 -171.759 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.32 6.2 19.13 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.118 -2.239 . . . . 13.93 109.267 -177.761 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -122.4 142.1 50.89 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 116.068 -4.196 . . . . 23.92 107.989 -174.194 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -76.26 137.55 40.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.22 -1.355 . . . . 23.23 110.594 175.093 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.571 HD12 ' HB3' ' A' ' 43' ' ' LEU . 40.5 mt -86.04 112.85 21.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.0 -1.0 . . . . 9.11 111.01 179.845 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -88.3 137.57 32.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 128.127 3.822 . . . . 33.44 109.907 -178.442 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.32 -62.44 1.48 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 110.023 -3.262 . . . . 28.37 116.372 -164.054 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.7 19.4 37.33 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 117.735 -3.103 . . . . 15.0 114.077 -171.73 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -92.38 171.08 9.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.452 2.019 . . . . 25.5 116.452 166.348 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 p -98.38 161.23 13.79 Favored 'General case' 0 N--CA 1.43 -1.459 1 CA-C-O 128.569 4.033 . . . . 11.95 110.269 178.856 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.325 5.5 mp -68.8 -36.99 78.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 111.362 -2.654 . . . . 10.17 110.604 172.377 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 p -50.92 -39.57 54.88 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.132 2.271 . . . . 13.59 117.132 162.865 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.9 -29.37 67.63 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.127 1.899 . . . . 11.7 116.127 -177.369 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -94.58 0.73 55.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.783 2.433 . . . . 12.95 115.382 178.002 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m120 68.05 33.0 4.73 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.299 -1.319 . . . . 25.45 113.701 -179.733 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.255 86.5 mt -78.47 116.4 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 124.848 1.259 . . . . 14.6 109.099 -174.065 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -93.05 173.35 7.78 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.117 -2.864 . . . . 33.23 109.974 -174.126 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -75.8 150.25 37.75 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.642 -3.161 . . . . 25.97 113.237 175.127 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.311 88.4 mt-10 64.83 39.97 5.78 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 131.568 3.947 . . . . 32.61 109.985 176.813 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.1 m -103.09 145.85 29.28 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.358 3.063 . . . . 10.56 112.064 -179.725 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -96.43 116.35 28.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 118.17 -1.412 . . . . 5.33 112.828 -178.073 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.02 157.3 20.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.767 1.765 . . . . 11.66 115.767 165.364 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 10.9 m-70 -105.52 112.23 25.24 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.01 -2.931 . . . . 16.3 116.108 172.086 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 15.5 tp -96.21 104.86 16.85 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 119.857 -0.737 . . . . 9.96 111.391 175.886 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.02 155.86 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 125.466 1.506 . . . . 9.76 114.304 -166.259 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.3 tp -71.42 102.45 2.65 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.662 -2.523 . . . . 19.57 115.384 -179.548 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.4 ttt180 -63.82 129.75 41.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.683 1.706 . . . . 35.08 115.292 177.876 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.9 tp -105.76 130.76 53.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 100.329 -3.952 . . . . 32.31 100.329 170.827 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -62.12 151.91 34.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.188 1.921 . . . . 42.75 116.188 -176.396 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.66 -129.1 1.59 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.887 -2.085 . . . . 36.31 107.887 177.338 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 1 CA-C-O 111.36 -5.134 . . . . 36.27 106.685 -178.355 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 118.112 -0.947 . . . . 17.17 110.291 . . . . . . . . . 0 0 . 1 . 084 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -101.58 159.22 15.48 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.033 1.873 . . . . 21.89 113.826 165.719 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -135.8 157.29 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 126.227 1.811 . . . . 10.83 106.452 -179.696 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -112.07 117.46 32.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.874 -3.016 . . . . 10.61 112.809 175.613 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.7 t -99.15 122.26 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 102.919 -2.993 . . . . 9.13 102.919 -175.435 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -122.87 120.87 34.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.136 -1.602 . . . . 20.55 112.071 -171.021 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -92.86 176.87 6.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.889 1.675 . . . . 11.78 109.626 -169.672 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -79.59 -31.8 41.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.863 -1.971 . . . . 19.31 113.027 -171.446 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.15 -62.88 1.36 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.047 1.739 . . . . 23.14 108.573 174.904 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.9 37.56 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.66 1 C-N-CA 113.35 -4.262 . . . . 19.74 106.365 156.921 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -88.77 130.33 35.38 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.105 -2.409 . . . . 21.93 109.646 -176.846 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -103.26 101.8 11.74 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.746 -1.575 . . . . 12.33 106.746 -178.11 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mt -93.19 131.82 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.892 -1.892 . . . . 17.08 105.892 -175.027 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 m -80.78 114.72 19.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.126 -1.805 . . . . 16.3 106.126 166.074 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 tp -127.89 125.28 39.34 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.954 2.101 . . . . 15.88 106.721 -177.946 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -103.26 133.63 48.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.945 -2.972 . . . . 28.9 110.937 -176.415 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -162.05 164.37 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 104.886 -2.264 . . . . 12.05 104.886 -160.252 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -126.64 141.25 39.68 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 117.594 -1.193 . . . . 18.17 111.244 177.953 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -67.17 -15.41 46.23 Favored 'Trans proline' 0 C--N 1.3 -1.98 1 C-N-CA 127.05 5.167 . . . . 8.16 113.389 -166.739 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -89.49 -13.62 37.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 123.226 2.739 . . . . 11.13 112.27 -172.774 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.75 170.35 9.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.831 2.729 . . . . 18.03 108.019 -177.177 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -89.49 172.1 9.24 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.901 -2.999 . . . . 10.22 110.617 -164.496 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -70.83 -30.21 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.142 -2.224 . . . . 12.3 109.474 175.486 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -49.09 -39.06 26.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.513 -3.242 . . . . 36.51 115.702 161.711 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -64.63 -48.72 73.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.58 -1.95 . . . . 25.66 111.512 171.408 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.7 -44.51 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 117.899 2.555 . . . . 8.12 117.899 173.322 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' NZ ' ' OD1' ' A' ' 52' ' ' ASP . 26.0 ttmt -53.69 -35.64 61.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.286 -2.759 . . . . 15.47 116.922 168.49 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.56 -21.65 61.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.02 2.6 . . . . 11.45 118.02 -177.98 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -86.52 -32.63 20.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 130.61 3.564 . . . . 24.98 108.432 -175.992 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.2 mt -76.81 -33.07 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 119.768 1.167 . . . . 9.46 109.28 175.036 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -54.1 -36.53 63.31 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.509 2.04 . . . . 14.76 116.509 167.641 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.54 -54.9 4.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.475 1.287 . . . . 26.29 114.475 -178.658 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -71.15 -73.86 0.16 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.805 1.941 . . . . 30.06 112.107 -174.951 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.44 -37.18 82.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.015 2.228 . . . . 25.19 117.015 173.49 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.0 30.11 11.68 Favored Glycine 0 N--CA 1.43 -1.718 1 O-C-N 115.624 -4.423 . . . . 7.41 115.611 -176.493 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mm -87.12 125.59 65.67 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-O 115.911 -1.995 . . . . 9.49 116.221 169.692 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -83.87 161.91 13.99 Favored 'Trans proline' 0 C--N 1.3 -2.002 1 CA-C-N 129.345 4.373 . . . . 11.42 114.91 -172.799 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -86.02 -11.8 6.33 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 123.465 2.273 . . . . 12.0 114.333 -142.658 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.478 ' CG ' HH21 ' A' ' 74' ' ' ARG . 5.4 p-10 -86.52 -4.5 59.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.873 3.669 . . . . 35.55 114.971 168.059 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.27 57.9 mt-30 -106.54 6.0 29.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.34 -1.475 . . . . 20.52 110.964 176.471 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -99.57 101.16 12.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.813 2.097 . . . . 7.13 113.126 -177.002 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -99.15 109.81 22.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.355 1.074 . . . . 36.39 112.229 174.423 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 mt -103.92 136.22 43.98 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.642 -1.163 . . . . 9.55 113.729 177.914 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.33 131.91 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.955 2.034 . . . . 13.9 106.267 -179.92 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.436 ' HB3' HD21 ' A' ' 50' ' ' LEU . 82.6 t80 -116.62 125.66 52.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.111 -1.44 . . . . 6.86 107.111 163.884 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.346 . . 59.18 -106.09 0.28 Allowed 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.613 2.149 . . . . 11.15 116.112 -171.107 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.88 57.14 0.71 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 120.074 -1.641 . . . . 13.93 114.435 159.92 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -145.45 146.2 31.4 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.704 2.802 . . . . 23.92 108.803 178.817 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -93.48 130.65 39.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.864 2.603 . . . . 23.23 110.618 175.405 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 45' ' ' PHE . 43.3 mt -87.26 114.47 23.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.573 -3.204 . . . . 9.11 110.73 -170.817 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.21 153.36 18.66 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.318 2.485 . . . . 33.44 109.331 -169.979 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 28.2 m-20 -52.61 -49.26 65.42 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 117.01 -3.556 . . . . 28.37 116.756 -159.036 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.18 4.52 77.65 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 119.74 -1.85 . . . . 15.0 114.709 -171.376 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -83.71 163.88 19.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.302 -2.881 . . . . 25.5 106.896 -178.373 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -102.66 173.55 6.28 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.424 2.009 . . . . 11.95 116.424 170.949 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 mt -79.39 -29.46 42.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.455 -1.403 . . . . 10.17 108.327 177.378 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.9 p -65.51 -27.84 68.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.434 -1.27 . . . . 13.59 111.953 177.715 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.28 -56.48 21.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.825 2.05 . . . . 11.7 110.143 177.62 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.433 ' HB2' HG13 ' A' ' 61' ' ' ILE . 49.7 m-85 -83.11 3.42 30.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.479 -1.237 . . . . 12.95 113.327 -173.443 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 m120 49.05 61.56 3.06 Favored 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 134.361 5.064 . . . . 25.45 112.343 -169.274 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 59' ' ' TYR . 74.9 mt -89.88 116.26 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 103.267 -2.864 . . . . 14.6 103.267 -177.604 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -99.19 -167.85 1.54 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.041 3.782 . . . . 33.23 110.816 -171.368 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -75.8 148.3 38.54 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 113.718 -5.614 . . . . 25.97 110.213 -177.411 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 35.17 63.55 0.49 Allowed 'General case' 0 N--CA 1.43 -1.459 2 C-N-CA 134.846 5.258 . . . . 32.61 115.463 -172.992 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.9 t -120.33 146.45 46.12 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 129.461 3.105 . . . . 10.56 108.602 -172.639 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.7 m -77.98 119.05 20.88 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.642 2.464 . . . . 5.33 107.543 -175.266 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.96 132.0 53.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.029 -1.045 . . . . 11.66 108.2 158.128 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -85.58 141.23 29.99 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.987 -4.196 . . . . 16.3 110.71 174.802 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.2 tp -119.28 127.51 53.29 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.273 2.694 . . . . 9.96 118.273 175.094 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.31 -160.73 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 123.463 1.601 . . . . 9.76 108.548 -178.601 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp -98.27 126.97 43.98 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 112.535 -2.12 . . . . 19.57 114.161 -174.494 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -99.5 142.41 31.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.25 -2.156 . . . . 35.08 106.264 176.852 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mp -101.21 153.26 19.76 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.195 -2.191 . . . . 32.31 105.396 170.007 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.478 HH21 ' CG ' ' A' ' 39' ' ' ASP . 7.6 ptp180 -88.14 156.18 19.39 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 115.841 -2.344 . . . . 42.75 113.238 -175.258 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.52 50.53 1.19 Allowed Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 122.898 1.277 . . . . 36.31 112.895 -177.299 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.752 0 CA-C-O 115.199 -3.001 . . . . 36.27 105.687 -168.705 . . . . . . . . 0 0 . 1 . 085 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.36 0.3 OUTLIER . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 122.441 1.115 . . . . 17.17 110.066 . . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -88.65 115.67 26.34 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.451 3.1 . . . . 21.89 113.344 179.923 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.81 171.05 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 118.88 -2.388 . . . . 10.83 104.998 166.565 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -121.6 147.56 45.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.71 2.804 . . . . 10.61 106.24 173.615 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -128.68 120.92 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 104.009 -2.589 . . . . 9.13 104.009 172.671 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -102.29 127.8 49.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.602 2.361 . . . . 20.55 110.994 -171.355 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.9 p -89.6 169.09 11.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.195 2.426 . . . . 11.78 109.223 -173.941 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.7 mt -51.55 -40.53 59.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.347 2.259 . . . . 19.31 115.488 164.384 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.8 p -94.54 -71.69 0.65 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 125.336 1.648 . . . . 23.14 111.861 -165.507 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.97 48.67 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 120.611 -1.306 . . . . 19.74 115.94 178.053 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -119.09 140.68 49.69 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.218 1.562 . . . . 21.93 115.218 170.077 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.5 m -104.8 105.85 16.1 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.074 -4.766 . . . . 12.33 108.817 174.181 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.5 mt -91.4 105.43 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 O-C-N 114.552 -5.093 . . . . 17.08 107.747 -171.539 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -82.52 122.8 28.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.674 1.731 . . . . 16.3 115.674 178.19 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.5 tp -123.86 154.92 38.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.101 2.228 . . . . 15.88 113.966 -167.221 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -112.35 129.14 56.4 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.203 1.954 . . . . 28.9 110.848 165.181 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -148.46 170.34 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 130.292 3.437 . . . . 12.05 107.781 -179.237 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -120.95 165.18 19.6 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 107.035 -1.468 . . . . 18.17 107.035 166.564 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -69.9 -21.44 32.82 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-O 127.374 2.989 . . . . 8.16 117.789 -172.325 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 m -78.83 -4.91 51.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 111.374 -2.648 . . . . 11.13 113.279 177.411 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.291 69.3 m-20 -78.35 143.04 37.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.34 2.019 . . . . 18.03 114.12 173.888 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 2.3 p -89.05 156.59 18.75 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.003 -2.311 . . . . 10.22 111.524 -168.894 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.7 mm -61.86 -33.92 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 118.55 2.796 . . . . 12.3 118.55 -179.072 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -44.79 -45.86 10.27 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 120.124 3.379 . . . . 36.51 120.124 161.623 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -72.63 -44.76 61.5 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.675 2.39 . . . . 25.66 111.097 -177.991 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.92 -48.48 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 114.849 1.426 . . . . 8.12 114.849 177.735 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -54.44 -44.34 72.4 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.719 2.008 . . . . 15.47 115.412 171.439 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.309 . . -48.21 -46.25 34.88 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 120.117 3.377 . . . . 11.45 120.117 160.663 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -68.7 -35.36 77.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.883 -3.011 . . . . 24.98 114.946 175.066 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.302 63.2 mt -51.62 -49.57 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 110.74 -2.936 . . . . 9.46 111.227 172.641 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -64.52 -24.57 67.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.79 3.236 . . . . 14.76 114.704 -179.776 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.48 -30.76 69.68 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.198 -4.064 . . . . 26.29 111.799 168.882 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -79.3 -66.65 0.84 Allowed 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 116.169 -4.082 . . . . 30.06 107.588 -173.711 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -121.71 145.57 47.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 103.133 -2.914 . . . . 25.19 103.133 -173.705 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.64 64.56 4.27 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 117.444 -1.753 . . . . 7.41 112.824 -169.84 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.9 mm -110.97 109.7 57.19 Favored Pre-proline 0 N--CA 1.43 -1.473 1 CA-C-O 109.491 -5.052 . . . . 9.49 108.443 -173.658 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.12 135.56 69.39 Favored 'Trans proline' 0 C--N 1.299 -2.034 1 C-N-CA 125.445 4.096 . . . . 11.42 115.276 -173.954 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.89 -19.32 65.31 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 CA-C-N 125.3 2.929 . . . . 12.0 116.442 -177.313 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.16 -16.46 49.72 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.271 -1.518 . . . . 35.55 112.053 175.191 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -99.36 -15.18 18.88 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.162 -2.211 . . . . 20.52 106.447 -177.112 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -77.71 121.76 24.44 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.91 -2.369 . . . . 7.13 111.884 -175.987 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -121.31 110.45 16.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.295 -3.378 . . . . 36.39 104.93 175.055 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.7 mt -94.22 105.48 17.46 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 103.644 -2.724 . . . . 9.55 103.644 -174.831 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mm -88.22 133.98 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 126.945 2.098 . . . . 13.9 108.874 167.777 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.458 ' CE2' HG12 ' A' ' 61' ' ' ILE . 70.6 t80 -137.51 109.09 6.98 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 101.444 -3.539 . . . . 6.86 101.444 -175.495 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.43 -108.0 0.22 Allowed 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 114.236 -1.347 . . . . 11.15 113.9 -164.784 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.67 -16.71 25.74 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-O 115.774 -2.681 . . . . 13.93 112.584 177.837 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -113.59 147.25 38.39 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.965 2.383 . . . . 23.92 112.947 -163.001 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -73.95 127.73 33.64 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 127.506 3.527 . . . . 23.23 113.899 159.389 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.32 83.7 mt -78.4 132.99 37.57 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.556 -1.965 . . . . 9.11 107.278 170.787 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -106.37 151.27 25.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.628 2.156 . . . . 33.44 115.473 -170.164 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.35 3.6 m-20 -46.99 -55.05 8.82 Favored 'General case' 0 N--CA 1.43 -1.469 1 N-CA-C 123.673 4.694 . . . . 28.37 123.673 -164.766 . . . . . . . . 3 2 . 1 . 085 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 5.35 78.52 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 122.128 0.849 . . . . 15.0 113.016 -170.812 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -105.11 152.77 22.38 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.532 1.933 . . . . 25.5 111.626 -172.384 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 56.3 p -89.47 174.25 7.89 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 118.907 -0.568 . . . . 11.95 109.666 179.582 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.71 -34.91 60.39 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.021 0.915 . . . . 10.17 110.078 174.603 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.7 p -57.57 -40.93 80.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.507 3.523 . . . . 13.59 110.342 173.416 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.11 -44.92 32.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.654 -3.154 . . . . 11.7 115.904 174.952 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.313 98.3 m-85 -92.37 2.23 56.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.06 -2.9 . . . . 12.95 115.338 172.101 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.285 18.0 m120 65.38 38.99 5.45 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 117.724 2.491 . . . . 25.45 117.724 176.267 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.458 HG12 ' CE2' ' A' ' 45' ' ' PHE . 57.2 mt -74.19 138.67 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.665 2.386 . . . . 14.6 108.015 172.934 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -129.66 -167.07 1.75 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.83 -2.419 . . . . 33.23 108.125 -176.3 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -76.77 158.56 30.81 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.863 -3.023 . . . . 25.97 113.318 -173.836 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 68.05 20.32 9.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.967 -2.958 . . . . 32.61 113.306 177.043 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.8 t -106.56 143.49 34.6 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.106 2.962 . . . . 10.56 116.857 -172.682 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -100.97 129.44 46.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.696 0.998 . . . . 5.33 113.696 -173.993 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -104.12 152.56 21.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.474 -1.676 . . . . 11.66 106.474 173.171 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -115.74 124.53 51.02 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 116.863 -3.648 . . . . 16.3 108.677 -176.726 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tp -103.66 107.69 18.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.13 -1.606 . . . . 9.96 108.851 -170.075 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.89 158.81 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 124.874 1.359 . . . . 9.76 109.739 -179.265 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.7 tp -81.24 113.38 19.33 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.557 2.123 . . . . 19.57 112.394 -178.925 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -59.55 140.02 56.66 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.516 2.579 . . . . 35.08 113.389 170.003 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.4 tp -97.25 142.78 28.73 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 130.285 3.434 . . . . 32.31 105.769 173.769 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -80.93 161.56 24.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.509 -1.994 . . . . 42.75 110.436 -179.718 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.46 -61.79 0.64 Allowed Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 107.544 -2.223 . . . . 36.31 107.544 -172.916 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.77 0 O-C-N 126.026 1.662 . . . . 36.27 111.217 173.832 . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 121.559 0.695 . . . . 17.17 111.82 . . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -113.77 145.05 41.97 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.199 -4.688 . . . . 21.89 111.435 -172.196 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.26 161.55 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.339 -2.725 . . . . 10.83 109.15 169.799 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -105.11 145.33 30.68 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.259 2.624 . . . . 10.61 110.753 167.923 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -123.2 125.05 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.064 -1.648 . . . . 9.13 107.854 171.996 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -97.92 143.09 28.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.352 -2.717 . . . . 20.55 111.481 176.549 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.2 p -97.2 -177.28 3.79 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 122.407 2.367 . . . . 11.78 109.236 -173.611 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tt -76.68 -45.34 30.07 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 117.626 -1.178 . . . . 19.31 110.666 177.466 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -66.97 -54.55 20.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.264 1.393 . . . . 23.14 112.939 174.805 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.83 84.48 0.13 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 129.394 3.378 . . . . 19.74 114.18 168.328 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -132.83 152.71 51.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.845 -2.177 . . . . 21.93 106.976 171.843 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.291 26.2 m -108.83 108.61 19.47 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.465 -1.698 . . . . 12.33 112.407 171.986 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 mt -91.81 137.18 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 104.668 -2.345 . . . . 17.08 104.668 174.695 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 m -116.65 120.58 39.1 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.964 1.705 . . . . 16.3 111.629 175.533 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 29' ' ' LYS . 22.7 mt -114.13 146.64 40.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.551 -3.218 . . . . 15.88 107.601 179.968 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.68 137.85 32.03 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 116.012 -2.275 . . . . 28.9 114.573 148.915 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 m -140.73 157.84 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.314 2.646 . . . . 12.05 104.719 -171.286 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.54 145.75 31.29 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 101.893 -3.373 . . . . 18.17 101.893 165.703 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -78.19 -7.6 16.2 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 N-CA-C 118.389 2.419 . . . . 8.16 118.389 -174.453 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -100.46 14.64 30.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.957 -1.496 . . . . 11.13 110.614 178.566 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -107.9 160.47 15.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.912 2.142 . . . . 18.03 108.058 166.292 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -88.04 173.46 8.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 126.326 2.267 . . . . 10.22 112.748 -162.604 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mm -73.47 -26.8 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.26 -3.4 . . . . 12.3 110.027 -177.18 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.56 -21.95 66.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.45 -3.281 . . . . 36.51 117.159 169.914 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.29 -41.24 20.4 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 117.581 -1.2 . . . . 25.66 112.841 168.765 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.1 t -57.57 -40.94 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 127.547 3.03 . . . . 8.12 116.936 173.944 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -63.73 -41.58 98.03 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 131.781 4.033 . . . . 15.47 113.183 170.694 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.71 -25.42 65.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.319 2.009 . . . . 11.45 113.495 176.458 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB3' HD22 ' A' ' 15' ' ' LEU . 48.3 mttm -79.17 -31.23 43.85 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.257 -1.527 . . . . 24.98 112.783 173.66 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.41 -34.87 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 125.401 2.524 . . . . 9.46 112.504 170.249 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -60.0 -46.77 88.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.754 3.222 . . . . 14.76 115.849 166.671 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -54.07 -56.75 15.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.617 -3.177 . . . . 26.29 115.116 168.844 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -66.48 -80.29 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.402 -3.311 . . . . 30.06 116.829 171.703 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.89 -30.19 50.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 114.338 -5.226 . . . . 25.19 117.125 -178.126 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.18 5.17 50.06 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 125.011 3.55 . . . . 7.41 117.148 179.524 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mm -69.92 128.83 91.5 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 114.684 1.364 . . . . 9.49 114.684 -177.76 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -67.9 149.93 78.07 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 O-C-N 115.103 -3.157 . . . . 11.42 111.92 -170.428 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -73.68 -18.56 22.19 Favored 'Trans proline' 0 N--CA 1.433 -2.043 2 C-N-CA 127.794 5.663 . . . . 12.0 116.286 -175.853 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -68.86 -26.31 65.07 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.198 3.399 . . . . 35.55 115.258 168.797 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -95.08 -23.08 17.49 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.553 -1.658 . . . . 20.52 114.896 -172.598 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -85.75 118.43 25.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.678 -0.86 . . . . 7.13 108.678 -171.895 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -108.79 116.14 31.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.612 1.965 . . . . 36.39 106.983 171.476 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.56 111.58 23.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.87 1.356 . . . . 9.55 109.768 -176.788 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.93 125.09 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.062 -1.649 . . . . 13.9 106.789 179.562 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -117.71 127.16 53.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.381 2.991 . . . . 6.86 108.84 168.39 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.31 -98.11 0.08 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.425 -3.922 . . . . 11.15 113.466 -153.503 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.07 33.96 1.69 Allowed Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 127.426 2.441 . . . . 13.93 110.432 -179.523 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -145.05 143.15 30.3 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.515 1.626 . . . . 23.92 109.437 173.273 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -80.37 124.91 29.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.575 1.655 . . . . 23.23 114.194 -178.419 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -66.24 131.59 46.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.545 2.116 . . . . 9.11 109.184 172.813 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -82.71 158.85 22.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.633 -3.167 . . . . 33.44 113.107 178.158 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.22 -45.3 81.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.109 1.909 . . . . 28.37 115.304 -162.186 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.9 4.67 85.6 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 113.39 -1.732 . . . . 15.0 115.21 -178.434 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 -92.53 159.99 15.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 122.358 3.079 . . . . 25.5 108.735 178.969 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.4 p -86.57 171.19 11.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.72 1.248 . . . . 11.95 112.229 171.945 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.73 -33.76 66.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.334 -1.728 . . . . 10.17 106.334 172.222 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.5 p -65.7 -7.85 17.69 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 121.226 3.788 . . . . 13.59 121.226 174.179 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.11 -42.58 15.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.118 2.866 . . . . 11.7 109.518 -176.493 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -77.88 -13.56 59.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.678 2.391 . . . . 12.95 112.419 177.084 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 64.87 51.28 1.81 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.768 1.627 . . . . 25.45 112.956 -172.958 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -84.94 137.92 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.788 -2.301 . . . . 14.6 104.788 179.778 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -110.57 168.83 9.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.849 -2.407 . . . . 33.23 113.126 -175.369 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -66.81 155.41 38.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.511 -0.743 . . . . 25.97 111.569 174.221 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 50.2 mt-10 53.22 25.72 4.56 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.147 2.277 . . . . 32.61 117.147 -170.381 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 t -91.32 152.02 20.63 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.384 0.612 . . . . 10.56 110.765 169.695 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -107.98 121.37 44.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.45 3.9 . . . . 5.33 113.145 179.664 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -97.38 163.69 12.77 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.22 1.962 . . . . 11.66 107.034 174.896 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -119.34 129.36 54.81 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.503 -4.498 . . . . 16.3 109.141 175.603 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.3 tp -105.61 119.95 40.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.293 2.637 . . . . 9.96 112.013 179.928 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.458 ' HB ' ' H ' ' A' ' 71' ' ' LEU . 26.8 m -130.29 -160.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.412 1 CA-C-O 128.979 4.228 . . . . 9.76 111.05 168.903 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.458 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 16.5 tp -91.44 142.21 27.91 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 113.997 -5.439 . . . . 19.57 112.579 -168.842 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.409 HH21 ' C ' ' A' ' 76' ' ' GLY . 44.5 ttt180 -110.71 135.14 51.76 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.23 1.581 . . . . 35.08 114.439 174.575 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 mt -90.59 143.18 26.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.032 2.133 . . . . 32.31 110.991 161.898 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -77.73 125.93 30.09 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.065 -2.272 . . . . 42.75 108.396 -171.956 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.51 -29.36 0.3 Allowed Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 114.377 -3.773 . . . . 36.31 112.686 174.809 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.409 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.731 0 N-CA-C 106.419 -2.672 . . . . 36.27 106.419 177.062 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 123.704 1.716 . . . . 17.17 112.1 . . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -97.77 130.81 44.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.066 -2.896 . . . . 21.89 110.624 177.498 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.365 9.9 pt -129.67 157.67 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 124.752 1.221 . . . . 10.83 110.941 174.389 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -111.32 143.63 41.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.163 -1.791 . . . . 10.61 106.163 -177.134 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.68 127.5 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.482 -1.235 . . . . 9.13 107.993 167.82 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -106.13 129.4 54.22 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.533 1.635 . . . . 20.55 113.862 170.448 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -82.37 -175.15 5.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.414 1.635 . . . . 11.78 115.414 179.65 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.348 5.9 tp -67.02 -40.03 87.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.87 2.174 . . . . 19.31 116.87 177.635 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -73.05 -22.12 60.67 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.08 2.552 . . . . 23.14 112.238 -171.244 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.68 40.59 3.83 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 127.67 2.557 . . . . 19.74 109.757 -174.961 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -104.64 126.98 52.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.517 -2.073 . . . . 21.93 108.557 164.395 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -94.0 116.37 28.8 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.714 2.006 . . . . 12.33 113.412 173.827 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 pt -113.15 148.33 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.365 -2.709 . . . . 17.08 106.882 -179.291 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.436 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 15.7 m -98.81 129.37 45.21 Favored 'General case' 0 N--CA 1.43 -1.475 1 C-N-CA 134.003 4.921 . . . . 16.3 113.615 -178.21 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.73 128.99 40.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.78 -3.075 . . . . 15.88 102.993 -177.494 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -87.16 93.97 9.52 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.721 2.808 . . . . 28.9 109.825 164.724 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.441 HG12 ' HD2' ' A' ' 29' ' ' LYS . 5.3 m -121.14 154.59 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 123.531 2.878 . . . . 12.05 109.494 175.973 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.88 140.09 37.43 Favored Pre-proline 0 N--CA 1.43 -1.426 0 C-N-CA 129.434 3.094 . . . . 18.17 110.841 -178.717 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -79.87 -3.56 12.86 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 124.518 2.649 . . . . 8.16 109.432 -167.746 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -83.95 -26.02 29.61 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 114.929 -2.462 . . . . 11.13 113.368 -176.093 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -84.2 163.02 19.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.79 2.036 . . . . 18.03 114.25 -174.424 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -70.11 158.12 36.32 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.27 1.581 . . . . 10.22 115.27 -177.225 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mm -63.52 -19.94 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 125.762 2.696 . . . . 12.3 116.954 166.382 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -74.89 -27.37 60.2 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.83 -3.044 . . . . 36.51 113.878 179.869 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -70.11 -34.05 72.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.521 2.328 . . . . 25.66 112.912 175.049 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.49 -56.93 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 CA-C-O 129.166 4.317 . . . . 8.12 110.717 175.967 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.14 -27.13 61.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.845 -3.034 . . . . 15.47 114.604 -171.854 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.19 83.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.72 2.2 . . . . 11.45 109.286 -178.898 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HD2' HG12 ' A' ' 17' ' ' VAL . 50.5 mttm -78.35 -35.65 47.17 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.285 -1.51 . . . . 24.98 108.576 -174.261 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mt -67.87 -32.26 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 125.796 2.712 . . . . 9.46 108.233 177.183 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -69.04 -56.28 8.23 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 116.165 -4.084 . . . . 14.76 110.039 174.553 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -58.73 -24.07 60.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.061 1.744 . . . . 26.29 114.329 -178.871 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 14' ' ' THR . 50.6 mttm -78.13 -80.66 0.11 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.484 -2.01 . . . . 30.06 112.778 165.536 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -99.06 10.69 40.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.11 -3.494 . . . . 25.19 115.826 -161.124 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.87 3.5 90.46 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 117.995 -2.941 . . . . 7.41 116.6 -175.736 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.6 mt -77.59 115.69 51.81 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 118.906 1.353 . . . . 9.49 111.202 -169.599 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 40.4 Cg_exo -67.95 142.31 56.42 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 O-C-N 114.313 -3.572 . . . . 11.42 112.342 -179.355 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 65.3 Cg_exo -62.87 -21.68 73.29 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 N-CA-C 119.772 2.951 . . . . 12.0 119.772 -173.167 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.434 ' CG ' HH22 ' A' ' 74' ' ' ARG . 9.7 m-20 -56.69 -39.06 73.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.665 1.586 . . . . 35.55 113.594 171.25 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -80.17 7.36 9.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.199 2.296 . . . . 20.52 117.199 -173.923 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -113.89 117.98 32.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 114.79 -2.529 . . . . 7.13 110.642 -160.344 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -128.62 115.78 18.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.681 3.738 . . . . 36.39 113.011 170.985 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.9 mt -92.89 125.89 37.71 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 116.276 -4.015 . . . . 9.55 111.81 -173.844 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -105.37 126.08 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.618 1.967 . . . . 13.9 109.518 172.132 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -110.22 120.0 41.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.896 3.236 . . . . 6.86 105.401 171.886 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.409 . . 59.77 -91.07 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.548 -3.845 . . . . 11.15 118.394 -164.818 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.23 13.01 5.75 Favored Glycine 0 N--CA 1.43 -1.729 1 CA-C-O 111.115 -5.269 . . . . 13.93 109.957 160.847 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -93.31 135.86 34.13 Favored 'General case' 0 N--CA 1.43 -1.433 1 CA-C-N 124.549 4.175 . . . . 23.92 110.963 -176.918 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -75.07 99.92 4.06 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 113.938 -5.477 . . . . 23.23 113.324 167.354 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.6 mt -69.77 136.94 51.48 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.253 -3.404 . . . . 9.11 113.912 178.265 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.48 136.18 38.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.286 -1.325 . . . . 33.44 113.475 -177.938 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.75 -30.79 68.47 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 115.055 1.502 . . . . 28.37 115.055 -156.27 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.5 23.54 12.27 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 115.716 -2.713 . . . . 15.0 115.316 179.727 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -125.42 174.48 8.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.085 2.943 . . . . 25.5 106.841 175.56 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -96.04 167.41 11.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.728 1.728 . . . . 11.95 114.875 179.949 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.575 ' H ' HD12 ' A' ' 56' ' ' LEU . 5.3 mp -56.39 -43.72 79.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.111 2.862 . . . . 10.17 114.383 162.535 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.3 p -61.1 -19.44 61.46 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 114.374 -5.204 . . . . 13.59 119.243 170.831 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -58.7 -52.38 65.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.308 2.336 . . . . 11.7 117.308 167.304 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -88.36 -13.33 40.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.596 3.558 . . . . 12.95 115.002 177.884 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 m120 73.92 58.08 0.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.332 -1.729 . . . . 25.45 106.332 167.749 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -85.73 121.61 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.861 2.267 . . . . 14.6 107.055 166.571 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -107.03 175.09 5.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 109.548 -3.478 . . . . 33.23 107.306 -174.913 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -58.61 137.08 57.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.005 -2.309 . . . . 25.97 116.862 -176.318 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 84.47 7.39 0.54 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.679 3.992 . . . . 32.61 113.96 170.18 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 t -72.46 134.38 45.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.131 -1.395 . . . . 10.56 110.678 -175.496 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.5 m -102.26 103.08 13.54 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.706 -3.746 . . . . 5.33 113.418 -171.785 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.63 159.55 14.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.231 -3.248 . . . . 11.66 102.231 -165.085 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -101.73 140.85 35.46 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 118.181 -2.824 . . . . 16.3 108.92 170.897 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.5 tp -102.22 136.66 41.66 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 102.138 -3.282 . . . . 9.96 102.138 169.369 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 m -134.71 175.01 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.615 2.366 . . . . 9.76 105.991 173.576 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.6 tp -82.31 127.82 33.6 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.235 -2.257 . . . . 19.57 116.685 -171.341 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -89.74 126.89 35.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.937 -2.977 . . . . 35.08 108.355 169.211 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.4 mt -91.64 155.94 17.97 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.815 2.446 . . . . 32.31 111.126 170.229 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.434 HH22 ' CG ' ' A' ' 39' ' ' ASP 0.358 50.4 ttm-85 -82.75 117.94 23.02 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.027 -4.795 . . . . 42.75 107.652 -174.299 . . . . . . . . 4 3 . 1 . 087 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.88 50.17 0.01 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 O-C-N 126.588 2.43 . . . . 36.31 115.419 169.5 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.755 1 C-N-CA 130.712 4.006 . . . . 36.27 105.149 176.859 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ptt? . . . . . 0 CA--C 1.491 -1.309 0 CA-C-O 125.056 2.36 . . . . 17.17 109.477 . . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -104.57 138.93 40.19 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.796 -2.456 . . . . 21.89 110.883 -172.822 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.284 44.0 pt -136.21 144.84 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 102.505 -3.146 . . . . 10.83 102.505 165.785 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -107.97 139.05 43.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.52 0.728 . . . . 10.61 109.647 173.903 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.7 t -121.58 114.38 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.657 -2.349 . . . . 9.13 104.657 179.027 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -83.89 124.79 31.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.115 2.388 . . . . 20.55 105.405 166.283 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.323 17.7 p -77.85 178.24 7.57 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.962 2.315 . . . . 11.78 110.2 -174.886 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 tp -78.38 -32.7 49.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.274 -3.391 . . . . 19.31 111.705 171.947 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -74.79 -33.19 62.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.966 -2.333 . . . . 23.14 113.44 170.576 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.42 60.26 0.52 Allowed Glycine 0 N--CA 1.429 -1.77 0 CA-C-O 123.197 1.443 . . . . 19.74 115.124 169.436 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -118.54 152.5 35.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.563 1.945 . . . . 21.93 113.585 162.099 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -105.72 96.89 6.81 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.248 1.975 . . . . 12.33 108.813 174.084 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.286 3.4 pt -89.45 150.24 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.407 -3.308 . . . . 17.08 109.943 -179.98 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -111.22 124.4 52.14 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.819 -0.752 . . . . 16.3 110.573 -176.046 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.66 147.11 29.93 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.865 1.317 . . . . 15.88 108.045 176.897 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -105.35 90.36 3.4 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 130.051 3.34 . . . . 28.9 111.599 166.327 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.95 162.1 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 125.975 2.797 . . . . 12.05 112.528 175.979 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.43 147.83 33.55 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 119.461 -2.024 . . . . 18.17 106.601 173.738 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.37 -9.47 23.08 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-O 115.99 -1.754 . . . . 8.16 111.939 -177.54 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.5 p -88.62 -3.92 58.68 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.258 2.623 . . . . 11.13 114.238 173.078 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -68.84 148.6 50.02 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.374 -2.454 . . . . 18.03 104.374 178.897 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.8 p -87.9 155.13 20.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.62 -1.173 . . . . 10.22 109.789 172.096 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.6 mm -52.08 -37.57 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 128.461 2.704 . . . . 12.3 110.69 176.605 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.83 -42.53 99.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.685 3.194 . . . . 36.51 114.978 174.924 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -67.06 -36.28 81.67 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.751 -2.022 . . . . 25.66 115.171 173.186 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.72 -37.33 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 114.569 1.322 . . . . 8.12 114.569 177.663 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -57.51 -42.02 81.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.206 -2.809 . . . . 15.47 117.898 171.966 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.16 -31.68 61.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.128 2.269 . . . . 11.45 117.128 170.889 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -67.76 -36.2 80.08 Favored 'General case' 0 N--CA 1.43 -1.44 1 N-CA-C 122.081 4.104 . . . . 24.98 122.081 165.094 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.5 mt -57.71 -40.58 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 116.17 1.915 . . . . 9.46 116.17 159.821 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -56.89 -40.68 76.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 113.617 -3.087 . . . . 14.76 117.224 162.481 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -65.77 -38.07 88.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.622 3.076 . . . . 26.29 111.694 177.717 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -73.88 -70.39 0.38 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.697 1.999 . . . . 30.06 115.191 178.226 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -92.4 -9.28 42.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.495 3.517 . . . . 25.19 120.495 -172.335 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.52 53.27 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 117.678 -3.139 . . . . 7.41 109.777 177.535 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.6 mt -107.45 123.28 38.58 Favored Pre-proline 0 N--CA 1.43 -1.469 0 O-C-N 125.331 1.254 . . . . 9.49 109.879 -178.518 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.02 127.72 27.23 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 124.098 3.199 . . . . 11.42 115.084 177.903 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -63.75 -7.61 13.43 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 125.059 3.839 . . . . 12.0 116.762 171.586 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -68.83 -28.62 66.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.716 2.487 . . . . 35.55 117.716 164.263 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -101.99 4.37 39.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.025 -3.547 . . . . 20.52 111.182 -172.324 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.436 ' HG2' HD11 ' A' ' 69' ' ' LEU . 70.7 mt-30 -95.02 134.32 37.83 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.285 1.993 . . . . 7.13 113.04 -173.804 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.307 40.1 ttm180 -133.07 107.38 8.19 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.172 -1.831 . . . . 36.39 111.309 168.725 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.48 116.87 12.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 114.319 -2.753 . . . . 9.55 112.867 170.979 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 49' ' ' GLN . 34.3 mm -109.07 135.95 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 123.151 2.705 . . . . 13.9 113.346 171.186 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -112.99 114.48 26.97 Favored 'General case' 0 N--CA 1.429 -1.475 2 O-C-N 113.141 -5.975 . . . . 6.86 110.074 173.802 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.365 . . 68.18 -87.58 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.176 -3.452 . . . . 11.15 113.879 -170.012 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.64 5.03 6.2 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 126.253 1.882 . . . . 13.93 111.643 163.394 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -92.38 120.82 33.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 118.558 1.179 . . . . 23.92 113.638 -171.099 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HA ' HD13 ' A' ' 44' ' ' ILE . 32.6 tt0 -82.17 111.87 18.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.373 3.464 . . . . 23.23 112.88 173.058 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -69.53 139.74 53.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.209 -2.807 . . . . 9.11 110.007 -173.232 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -81.54 156.73 25.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.832 -1.556 . . . . 33.44 109.593 169.156 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -84.03 -47.27 11.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.027 1.739 . . . . 28.37 111.847 -167.695 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.98 37.91 2.36 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 116.514 -3.866 . . . . 15.0 117.658 176.957 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HD2' ' CE2' ' A' ' 59' ' ' TYR . 77.6 mtt-85 -113.2 178.12 4.39 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.575 -2.72 . . . . 25.5 110.736 164.361 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.8 p -101.55 173.81 6.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.338 -1.476 . . . . 11.95 111.62 168.695 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 61' ' ' ILE . 35.6 mt -67.79 -26.92 66.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.344 1.069 . . . . 10.17 112.175 171.597 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.5 p -82.36 -25.14 34.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.096 1.358 . . . . 13.59 111.738 -175.992 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -58.05 -39.9 79.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 123.193 2.724 . . . . 11.7 116.453 162.339 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CE2' ' HD2' ' A' ' 54' ' ' ARG 0.297 24.3 m-85 -89.93 3.7 52.27 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.552 2.427 . . . . 12.95 117.552 175.843 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 73.4 m-20 67.82 38.73 2.81 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.475 1.51 . . . . 25.45 112.133 171.161 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.417 HD12 HD23 ' A' ' 56' ' ' LEU . 69.9 mt -89.71 108.84 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.167 -2.16 . . . . 14.6 105.167 178.847 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -83.67 174.85 10.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 128.069 3.795 . . . . 33.23 110.31 174.249 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -66.68 158.52 29.86 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.258 -3.401 . . . . 25.97 112.846 176.568 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.316 10.5 mt-10 57.28 20.76 6.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.357 2.263 . . . . 32.61 116.638 -179.919 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 m -80.57 129.8 34.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.227 2.611 . . . . 10.56 115.96 172.808 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 m -90.45 116.86 28.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.788 -3.07 . . . . 5.33 111.354 172.836 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -91.6 155.61 18.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.403 -2.073 . . . . 11.66 105.403 174.123 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -106.23 152.23 23.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 114.325 -2.95 . . . . 16.3 110.39 169.088 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.436 HD11 ' HG2' ' A' ' 41' ' ' GLN . 28.4 tp -121.95 113.32 19.44 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.918 3.886 . . . . 9.96 109.533 174.685 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 m -121.47 -172.43 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 128.617 2.767 . . . . 9.76 104.897 178.17 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -104.68 146.47 28.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.901 2.286 . . . . 19.57 110.123 -164.834 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -113.73 140.67 48.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.495 1.918 . . . . 35.08 107.752 176.404 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.9 mt -101.78 155.37 18.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.828 -1.795 . . . . 32.31 109.683 170.354 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -58.19 111.85 1.34 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.317 -2.739 . . . . 42.75 111.968 172.934 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.13 -46.08 0.23 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 114.141 -1.39 . . . . 36.31 112.988 174.068 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.759 0 C-N-CA 124.86 1.219 . . . . 36.27 110.839 176.474 . . . . . . . . 0 0 . 1 . 089 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.573 1.323 . . . . 17.17 114.573 . . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.68 129.73 38.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 126.911 3.243 . . . . 21.89 107.673 -167.98 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.301 24.9 pt -124.21 154.21 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 O-C-N 117.023 -3.548 . . . . 10.83 110.077 171.831 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -114.21 136.32 53.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.532 1.933 . . . . 10.61 114.092 -178.858 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.6 t -117.31 103.39 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 100.322 -3.955 . . . . 9.13 100.322 178.309 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -94.42 152.78 18.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.104 -3.497 . . . . 20.55 110.105 -177.713 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.269 58.4 p -106.71 175.77 5.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 118.005 2.595 . . . . 11.78 118.005 -163.743 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.4 tp -77.52 -51.79 10.14 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.621 -1.172 . . . . 19.31 113.25 167.92 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 81.7 p -64.47 -59.71 4.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.197 -3.439 . . . . 23.14 115.252 174.773 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.77 -35.98 0.21 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 114.933 -3.148 . . . . 19.74 118.931 179.078 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -82.96 98.98 9.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 125.905 1.591 . . . . 21.93 110.107 -168.193 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -50.92 133.54 26.7 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.783 1.401 . . . . 12.33 114.783 178.441 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 mt -93.4 129.92 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 129.488 3.115 . . . . 17.08 106.891 176.426 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.3 m -119.6 111.43 18.06 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.854 -3.654 . . . . 16.3 108.493 -170.177 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.7 mt -113.8 149.62 34.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.499 -2.625 . . . . 15.88 111.82 178.22 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -104.67 136.34 44.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.329 -1.482 . . . . 28.9 110.65 163.172 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 m -132.82 172.64 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.021 -1.675 . . . . 12.05 107.641 -173.142 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -113.28 150.37 42.96 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 102.31 -3.218 . . . . 18.17 102.31 166.797 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.87 -2.97 13.21 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 CA-C-N 122.943 2.087 . . . . 8.16 116.468 -175.547 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -70.82 -25.49 62.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 128.284 3.49 . . . . 11.13 117.078 159.037 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -67.81 150.45 48.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 129.407 3.083 . . . . 18.03 110.79 179.646 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -98.1 160.45 14.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.035 -2.888 . . . . 10.22 114.41 -173.865 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.7 mm -52.44 -32.53 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 121.668 2.031 . . . . 12.3 113.065 166.441 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.32 1.5 tt0 -51.78 -51.27 57.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 117.873 2.546 . . . . 36.51 117.873 160.761 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -63.71 -33.31 75.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 124.531 3.332 . . . . 25.66 111.036 177.344 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.12 -37.65 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.639 -1.913 . . . . 8.12 109.564 177.595 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.794 1.775 . . . . 15.47 115.794 173.486 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.39 -19.25 62.29 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.736 1.614 . . . . 11.45 114.595 -179.079 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -91.21 -19.82 22.63 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.735 -3.103 . . . . 24.98 108.179 176.535 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.9 mt -76.71 -34.15 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 117.803 -3.061 . . . . 9.46 108.476 167.098 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -52.86 -49.05 66.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.646 2.165 . . . . 14.76 110.962 169.823 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.04 -52.96 44.31 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.946 1.699 . . . . 26.29 110.427 -178.204 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -67.43 -69.23 0.33 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.196 -1.565 . . . . 30.06 115.052 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -87.81 -53.99 4.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.418 -2.676 . . . . 25.19 113.389 -175.518 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.05 54.21 0.39 Allowed Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 117.632 1.813 . . . . 7.41 117.632 -165.601 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.43 123.61 27.56 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 128.377 3.046 . . . . 9.49 104.859 176.022 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.69 125.25 18.41 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 124.837 3.691 . . . . 11.42 113.44 168.224 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.74 -28.17 55.84 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 121.336 3.552 . . . . 12.0 121.336 174.192 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.25 17.1 p-10 -51.73 -37.22 50.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.242 2.312 . . . . 35.55 117.242 167.174 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -86.91 -7.79 57.86 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.918 1.451 . . . . 20.52 114.918 -175.892 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -89.06 141.36 28.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.059 2.361 . . . . 7.13 114.284 177.92 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -132.66 140.78 48.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.902 3.239 . . . . 36.39 106.155 164.018 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -118.81 130.59 55.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.674 -3.766 . . . . 9.55 105.668 -177.683 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.7 tt -122.92 133.14 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.149 -3.47 . . . . 13.9 110.129 174.154 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -82.76 -66.75 0.85 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.193 1.949 . . . . 6.86 109.458 174.389 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.81 -75.4 0.58 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.152 3.381 . . . . 11.15 115.547 -178.847 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.89 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.081 -0.963 . . . . 13.93 115.403 -174.306 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -83.51 138.06 33.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.596 1.665 . . . . 23.92 110.373 -172.938 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.21 133.87 36.06 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 118.484 2.772 . . . . 23.23 118.484 -169.757 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.3 mt -90.36 151.15 21.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.438 2.695 . . . . 9.11 113.927 -169.724 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -100.59 137.31 39.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.409 3.083 . . . . 33.44 109.873 177.892 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -72.32 -50.35 27.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.439 -2.663 . . . . 28.37 104.969 -157.537 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.4 37.75 3.32 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 118.123 -2.861 . . . . 15.0 110.874 -169.623 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -93.14 152.51 19.2 Favored 'General case' 0 N--CA 1.431 -1.413 1 C-N-CA 132.929 4.491 . . . . 25.5 111.756 158.594 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.1 p -97.96 171.55 8.2 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.957 1.837 . . . . 11.95 106.416 -172.24 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.14 -47.42 68.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.558 1.647 . . . . 10.17 112.571 173.276 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -84.96 -11.35 55.71 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.477 3.111 . . . . 13.59 113.932 -173.17 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.1 -47.99 77.87 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.705 1.717 . . . . 11.7 108.657 164.277 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -93.0 12.45 23.94 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 114.837 -4.914 . . . . 12.95 112.214 -176.464 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 59.92 31.07 20.53 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.279 2.232 . . . . 25.45 111.205 171.954 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.3 mt -82.45 120.75 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 124.204 1.001 . . . . 14.6 108.535 177.384 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -100.7 -172.31 2.17 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.962 1.363 . . . . 33.23 113.284 179.419 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -69.15 151.15 46.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.403 -3.31 . . . . 25.97 115.829 177.342 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 28.4 mt-10 66.66 20.28 10.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.429 2.692 . . . . 32.61 112.214 177.711 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -88.07 144.08 26.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.431 1.892 . . . . 10.56 112.87 179.833 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -97.79 122.33 40.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.395 -1.729 . . . . 5.33 107.371 -174.363 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mp -97.19 166.41 11.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.796 3.238 . . . . 11.66 108.418 159.238 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -137.57 132.17 32.73 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.496 -2.628 . . . . 16.3 111.656 174.411 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.6 tp -87.98 121.6 30.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.14 2.576 . . . . 9.96 106.6 -171.069 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.9 t -113.69 113.2 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 128.266 2.626 . . . . 9.76 112.312 175.42 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.6 tp -83.23 119.53 24.67 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 115.819 -4.301 . . . . 19.57 112.128 -171.26 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -111.21 150.35 29.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.389 2.676 . . . . 35.08 112.309 177.811 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.6 tp -83.26 -64.3 1.2 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.293 2.237 . . . . 32.31 115.683 176.283 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -152.32 154.49 35.79 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.172 -1.788 . . . . 42.75 106.172 173.521 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.07 -177.45 46.31 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.24 -2.787 . . . . 36.31 111.434 171.658 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.796 0 C-N-CA 125.582 1.563 . . . . 36.27 115.477 -171.75 . . . . . . . . 0 0 . 1 . 090 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 CA--C 1.489 -1.374 0 CA-C-O 120.865 0.364 . . . . 17.17 111.1 . . . . . . . . . 0 0 . 1 . 090 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -94.51 112.17 23.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.546 2.117 . . . . 21.89 111.099 -176.065 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 pt -120.31 150.99 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 116.379 -3.951 . . . . 10.83 111.833 174.039 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -116.27 150.52 37.46 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.606 -1.998 . . . . 10.61 105.606 -174.248 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.2 t -132.18 135.42 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 100.423 -3.917 . . . . 9.13 100.423 -176.539 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -119.81 143.49 47.84 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.735 3.159 . . . . 20.55 107.17 175.36 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.2 p -83.85 -175.43 5.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.082 -3.511 . . . . 11.78 114.212 172.82 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.1 tp -66.57 -51.53 55.41 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.826 -0.435 . . . . 19.31 109.826 -176.9 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -75.07 -31.96 61.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.252 -1.356 . . . . 23.14 109.004 -177.567 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.11 71.62 0.6 Allowed Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 122.95 2.613 . . . . 19.74 116.206 174.012 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -118.81 147.9 43.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 100.471 -3.9 . . . . 21.93 100.471 159.915 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 m -104.06 116.15 31.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.316 1.446 . . . . 12.33 108.439 -179.488 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -81.07 128.92 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.793 -2.299 . . . . 17.08 104.793 166.122 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.0 m -104.74 135.02 46.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.645 0.657 . . . . 16.3 109.846 173.288 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.4 mt -122.43 119.67 31.67 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 118.572 2.805 . . . . 15.88 118.572 179.984 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -86.79 103.33 15.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.912 1.233 . . . . 28.9 108.715 167.509 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 m -110.23 169.59 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 129.574 3.15 . . . . 12.05 109.698 179.447 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -108.03 145.67 31.9 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 117.488 -1.244 . . . . 18.17 110.044 177.227 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.335 42.4 Cg_exo -47.51 -36.03 23.32 Favored 'Trans proline' 0 C--N 1.3 -2.02 1 N-CA-C 123.002 4.193 . . . . 8.16 123.002 -175.238 . . . . . . . . 3 2 . 1 . 090 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.18 5.37 34.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.11 2.164 . . . . 11.13 114.567 176.947 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -62.1 132.38 52.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.082 -2.886 . . . . 18.03 116.212 176.623 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.266 8.0 p -67.14 161.84 23.74 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.857 -4.277 . . . . 10.22 107.591 171.915 . . . . . . . . 3 2 . 1 . 090 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -61.55 -41.29 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.007 -2.308 . . . . 12.3 115.498 171.064 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -64.2 -27.53 69.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.814 2.552 . . . . 36.51 112.725 172.665 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -70.14 -34.94 73.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.956 -1.715 . . . . 25.66 112.735 169.411 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.52 -41.89 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 1 O-C-N 115.419 -4.551 . . . . 8.12 116.914 169.493 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -54.95 -29.46 56.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.532 2.733 . . . . 15.47 115.713 166.024 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.19 -32.47 66.85 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 118.431 -0.795 . . . . 11.45 110.991 -177.111 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -70.25 -20.33 63.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.959 1.838 . . . . 24.98 114.965 170.3 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -86.19 -28.47 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 O-C-N 115.537 -4.477 . . . . 9.46 111.531 177.111 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -64.57 -40.35 95.4 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.744 4.018 . . . . 14.76 109.484 174.358 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.6 -50.49 15.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.107 -0.996 . . . . 26.29 111.064 173.922 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -73.15 -70.05 0.38 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.521 1.674 . . . . 30.06 115.521 -175.956 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.69 -50.88 55.35 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.853 0.751 . . . . 25.19 112.658 -177.64 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.54 21.72 10.29 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 118.332 2.093 . . . . 7.41 118.332 -176.37 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 71' ' ' LEU . 17.1 mt -82.85 126.59 72.52 Favored Pre-proline 0 N--CA 1.43 -1.471 0 C-N-CA 127.082 2.153 . . . . 9.49 108.9 168.743 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -72.63 167.96 25.72 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-O 117.187 -1.255 . . . . 11.42 110.195 -172.455 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 12.2 Cg_endo -86.08 -15.86 4.45 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 CA-C-N 124.557 2.663 . . . . 12.0 112.676 -169.302 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -73.14 -32.82 65.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.32 1.533 . . . . 35.55 115.059 171.258 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -76.32 -36.04 58.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.526 1.631 . . . . 20.52 114.779 -177.943 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.254 72.0 mt-30 -64.15 135.42 56.32 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.526 3.536 . . . . 7.13 113.36 170.532 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -131.97 116.16 16.78 Favored 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 132.001 4.12 . . . . 36.39 108.893 169.784 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -97.24 144.22 27.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.558 1.786 . . . . 9.55 109.51 176.569 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 tp -139.72 137.16 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 119.168 -2.208 . . . . 13.9 113.49 171.388 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.338 76.7 t80 -88.18 -62.06 1.57 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.266 -0.896 . . . . 6.86 113.347 171.772 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.8 -89.17 0.28 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.881 -1.525 . . . . 11.15 106.881 -177.763 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.76 9.01 2.56 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-O 116.303 -2.387 . . . . 13.93 116.815 175.964 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -82.64 131.98 35.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 121.311 2.556 . . . . 23.92 110.121 162.798 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -75.13 114.0 13.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.364 2.03 . . . . 23.23 111.189 -177.928 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.335 10.2 mt -73.08 101.57 3.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 130.06 3.344 . . . . 9.11 111.716 -177.924 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HB2' ' HG3' ' A' ' 54' ' ' ARG . 45.2 mt-10 -67.81 -172.92 0.3 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.908 -2.995 . . . . 33.44 116.475 170.172 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.58 -63.49 1.32 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.993 -4.192 . . . . 28.37 113.973 -176.143 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.96 40.32 2.85 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 125.574 1.559 . . . . 15.0 115.842 -170.625 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 51' ' ' GLU . 21.6 mmt180 -124.46 145.2 49.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.67 -1.974 . . . . 25.5 105.67 -174.061 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.528 1.1 p -89.36 157.15 18.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.747 3.641 . . . . 11.95 116.347 -169.032 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.7 mt -63.02 -36.33 83.19 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 116.041 -4.162 . . . . 10.17 110.346 174.418 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 t -65.39 -42.01 93.1 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.27 3.028 . . . . 13.59 112.077 -177.546 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.41 -14.43 57.14 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.602 2.144 . . . . 11.7 110.744 -171.262 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -103.27 4.64 36.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.708 -3.745 . . . . 12.95 103.93 176.919 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 50.51 47.2 24.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.576 2.751 . . . . 25.45 117.521 -176.461 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.0 mt -84.39 106.55 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 112.664 -2.062 . . . . 14.6 109.23 172.328 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -104.96 -174.17 2.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.083 -2.326 . . . . 33.23 110.958 -167.646 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -83.97 136.08 34.21 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.536 1.516 . . . . 25.97 112.399 -161.761 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.298 18.2 mt-10 81.38 20.75 0.37 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.296 1.838 . . . . 32.61 115.909 -169.368 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -70.54 131.82 44.58 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 116.679 -1.629 . . . . 10.56 111.972 172.081 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.4 m -103.57 125.82 50.34 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.246 -1.391 . . . . 5.33 107.246 -179.536 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -109.52 164.16 12.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.397 -2.689 . . . . 11.66 106.562 -173.262 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -117.12 139.6 50.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.566 -3.209 . . . . 16.3 110.198 176.811 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -106.23 104.04 13.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.713 2.805 . . . . 9.96 111.475 -178.222 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -97.05 140.4 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.345 -1.752 . . . . 9.76 111.54 174.236 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.442 HD21 HG21 ' A' ' 36' ' ' ILE . 37.6 mt -101.8 150.94 22.64 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.718 1.145 . . . . 19.57 112.744 162.314 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.292 43.4 ttp180 -113.71 134.39 54.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.414 -0.812 . . . . 35.08 109.186 -175.811 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.1 tp -93.02 -80.9 0.37 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.895 -2.378 . . . . 32.31 110.913 174.281 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -163.35 130.73 3.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.379 -2.452 . . . . 42.75 104.379 -176.602 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.75 -120.87 0.61 Allowed Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 117.078 -1.957 . . . . 36.31 110.697 177.635 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.761 0 CA-C-O 116.072 -2.516 . . . . 36.27 114.506 175.677 . . . . . . . . 0 0 . 1 . 091 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 ttp . . . . . 0 CA--C 1.489 -1.374 0 CA-C-O 121.746 0.784 . . . . 17.17 112.989 . . . . . . . . . 0 0 . 1 . 091 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -84.77 121.35 27.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.396 -2.69 . . . . 21.89 110.293 -175.451 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -127.7 168.88 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 123.191 2.723 . . . . 10.83 110.974 160.187 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -120.47 147.69 44.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 125.064 1.477 . . . . 10.61 110.929 -176.635 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -117.08 118.93 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 C-N-CA 131.782 4.033 . . . . 9.13 112.365 163.774 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -103.46 124.89 49.58 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.859 -2.401 . . . . 20.55 111.563 176.701 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.305 34.7 p -77.79 175.56 9.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.105 1.431 . . . . 11.78 113.44 -174.594 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.499 ' HA ' ' HE1' ' A' ' 68' ' ' HIS . 52.1 tp -65.07 -55.27 19.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.358 2.663 . . . . 19.31 115.378 -178.788 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.3 p -60.73 -62.75 1.63 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.881 1.219 . . . . 23.14 110.633 165.253 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.24 64.14 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 122.417 2.371 . . . . 19.74 115.092 176.875 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -118.7 128.26 54.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 114.019 -2.896 . . . . 21.93 106.885 178.197 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -109.46 115.37 29.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 125.471 3.76 . . . . 12.33 101.681 -173.866 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.27 132.07 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 119.002 -2.312 . . . . 17.08 109.888 178.102 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.9 m -98.38 119.65 37.43 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.109 -4.12 . . . . 16.3 111.196 179.361 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.9 mt -106.39 162.55 13.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.966 2.506 . . . . 15.88 109.928 -175.477 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -135.22 97.68 3.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 101.689 -3.449 . . . . 28.9 101.689 178.734 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 m -105.66 163.15 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 117.416 2.376 . . . . 12.05 117.416 -174.666 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.256 2.9 mp0 -73.46 138.57 77.86 Favored Pre-proline 0 N--CA 1.431 -1.422 0 CA-C-O 114.749 -2.548 . . . . 18.17 108.285 162.35 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -58.97 -24.53 73.6 Favored 'Trans proline' 0 C--N 1.299 -2.04 1 C-N-CA 128.073 5.848 . . . . 8.16 119.442 -179.868 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -117.41 28.63 8.35 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 122.454 4.242 . . . . 11.13 122.454 173.437 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -77.18 170.7 16.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.402 -2.061 . . . . 18.03 113.802 -179.289 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.328 69.0 p -90.48 154.39 19.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.418 2.007 . . . . 10.22 116.418 -174.982 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.4 -19.84 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 119.447 1.021 . . . . 12.3 112.237 178.003 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -62.77 -39.43 94.16 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.138 -4.101 . . . . 36.51 106.359 166.435 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -82.01 -29.55 31.97 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.213 2.279 . . . . 25.66 112.457 -174.398 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.36 40.5 t -46.22 -62.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 118.012 -2.93 . . . . 8.12 114.544 154.252 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -54.21 -39.67 66.93 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.039 2.237 . . . . 15.47 117.039 172.039 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.29 92.5 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.641 -4.412 . . . . 11.45 111.852 173.919 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -61.36 -38.82 88.38 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.417 2.377 . . . . 24.98 117.417 163.063 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.267 72.5 mt -63.35 -41.53 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 122.145 2.248 . . . . 9.46 116.132 172.497 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.75 -40.49 92.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.067 1.747 . . . . 14.76 115.324 173.689 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.02 -50.18 74.76 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 125.828 2.728 . . . . 26.29 115.629 173.107 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -75.31 -68.27 0.57 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 109.405 -3.543 . . . . 30.06 115.377 -175.121 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -87.82 -16.3 34.45 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.743 3.617 . . . . 25.19 111.445 -170.729 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.39 13.15 83.56 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 120.534 2.974 . . . . 7.41 120.534 -178.942 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -76.03 115.67 48.74 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 116.521 -1.704 . . . . 9.49 110.622 176.84 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.07 155.43 45.04 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 C-N-CA 123.673 2.915 . . . . 11.42 109.805 -172.797 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.41 -25.66 17.97 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 124.071 2.49 . . . . 12.0 112.376 -167.782 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.84 -40.55 88.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.305 -3.372 . . . . 35.55 108.864 -175.087 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.432 ' OE1' HD23 ' A' ' 71' ' ' LEU . 7.2 tt0 -63.33 -23.75 67.55 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.519 -1.673 . . . . 20.52 114.446 -177.974 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -87.91 131.7 34.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 126.417 3.008 . . . . 7.13 118.295 -173.628 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -120.06 106.16 11.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.126 -2.859 . . . . 36.39 110.23 166.629 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.52 132.75 36.07 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 115.56 -4.463 . . . . 9.55 113.299 175.698 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.5 mt -106.88 141.92 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.516 2.327 . . . . 13.9 107.931 176.815 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -91.5 -83.03 0.29 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.328 2.489 . . . . 6.86 107.792 163.04 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.05 -71.43 0.74 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.473 1.909 . . . . 11.15 115.887 176.459 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.74 -41.66 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 124.083 1.935 . . . . 13.93 114.207 -166.886 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -103.38 155.36 18.54 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 121.493 -1.004 . . . . 23.92 112.94 -169.594 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -86.59 132.08 33.99 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.016 2.599 . . . . 23.23 118.016 -156.396 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -92.84 146.2 23.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.395 2.309 . . . . 9.11 109.93 -174.398 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.98 153.45 17.9 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.145 -3.472 . . . . 33.44 106.573 177.767 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.66 -63.17 1.3 Allowed 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.066 -4.772 . . . . 28.37 114.315 -178.906 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.06 35.55 3.4 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 119.229 -1.462 . . . . 15.0 110.451 -172.225 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -106.55 161.18 14.84 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.367 -5.196 . . . . 25.5 111.478 164.813 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -97.89 171.96 7.96 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 114.284 -5.26 . . . . 11.95 111.878 -166.842 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.79 -37.09 78.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 112.863 -1.971 . . . . 10.17 109.027 169.338 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 t -81.71 -10.7 59.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 123.881 0.872 . . . . 13.59 112.71 -169.012 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.13 -50.29 12.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.504 3.526 . . . . 11.7 114.815 173.694 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -82.8 -20.71 35.22 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.949 -4.845 . . . . 12.95 112.164 179.849 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 23.2 m-80 72.63 65.94 0.12 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.233 3.049 . . . . 25.45 119.233 179.862 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.7 mt -106.13 93.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 109.157 -3.656 . . . . 14.6 105.104 -178.894 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -85.3 -166.19 1.43 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.033 -3.542 . . . . 33.23 114.381 179.223 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.368 14.8 pttp -62.43 134.85 57.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.36 -3.338 . . . . 25.97 114.271 -177.068 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.322 21.5 mt-10 70.05 15.87 7.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.527 2.047 . . . . 32.61 116.527 169.23 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.7 m -61.45 140.32 58.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.068 3.347 . . . . 10.56 112.457 159.427 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -110.54 111.03 21.99 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 119.865 1.212 . . . . 5.33 113.515 175.24 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.6 mt -78.86 153.46 30.56 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.276 -2.14 . . . . 11.66 108.605 173.589 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.499 ' HE1' ' HA ' ' A' ' 8' ' ' LEU . 11.9 t60 -121.79 137.56 54.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.323 2.011 . . . . 16.3 107.619 175.935 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.3 tp -116.19 124.91 51.46 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.454 -2.029 . . . . 9.96 109.019 -174.668 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.8 t -112.08 139.68 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 125.039 1.336 . . . . 9.76 110.068 -179.53 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.432 HD23 ' OE1' ' A' ' 40' ' ' GLN . 7.8 mp -95.05 139.0 32.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 115.861 -2.336 . . . . 19.57 113.942 -176.682 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -119.67 157.03 29.33 Favored 'General case' 0 N--CA 1.431 -1.423 1 N-CA-C 100.046 -4.057 . . . . 35.08 100.046 -162.928 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.3 tp -113.79 -54.27 2.61 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 125.979 2.8 . . . . 32.31 105.042 177.237 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -159.63 123.61 3.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.846 -1.979 . . . . 42.75 111.04 177.627 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.47 25.2 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 118.44 -1.838 . . . . 36.31 117.448 171.012 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.79 0 C-N-CA 118.029 -2.034 . . . . 36.27 109.45 164.476 . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 CA--C 1.491 -1.326 0 N-CA-C 114.308 1.225 . . . . 17.17 114.308 . . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -93.13 118.29 31.05 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 116.525 -1.702 . . . . 21.89 107.345 -174.228 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.295 19.4 pt -120.22 151.78 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 126.446 2.341 . . . . 10.83 108.51 169.926 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -118.55 149.18 41.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.244 -2.873 . . . . 10.61 103.244 178.073 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -111.03 140.6 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 110.376 -3.102 . . . . 9.13 117.019 162.653 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -123.28 128.31 49.78 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.779 -4.325 . . . . 20.55 110.835 -178.363 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.264 39.7 p -91.33 174.1 7.56 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.518 -1.989 . . . . 11.78 112.247 -176.229 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.264 12.8 tp -63.94 -52.82 58.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.785 -2.462 . . . . 19.31 115.192 171.369 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.4 -58.69 3.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.995 -2.316 . . . . 23.14 115.85 -175.804 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.44 53.92 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 120.571 1.532 . . . . 19.74 111.909 167.745 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -112.74 136.65 52.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.121 -1.811 . . . . 21.93 109.473 163.599 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -104.23 110.86 23.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 128.334 3.521 . . . . 12.33 101.864 170.488 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.6 mt -102.42 129.96 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 101.142 -3.651 . . . . 17.08 101.142 -176.013 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 m -97.77 128.27 44.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.046 1.738 . . . . 16.3 107.462 177.089 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.455 HD22 ' HG2' ' A' ' 29' ' ' LYS . 58.2 mt -118.72 158.2 26.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.353 2.342 . . . . 15.88 110.993 170.735 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -102.6 122.18 43.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.144 -2.909 . . . . 28.9 103.144 165.092 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 m -137.46 177.62 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 117.989 -1.484 . . . . 12.05 110.147 176.451 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.26 157.82 34.59 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 105.863 -1.902 . . . . 18.17 105.863 173.904 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.307 18.5 Cg_endo -66.82 -15.02 46.03 Favored 'Trans proline' 0 C--N 1.3 -1.996 1 C-N-CA 126.829 5.019 . . . . 8.16 110.502 168.273 . . . . . . . . 3 2 . 1 . 092 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.2 m -94.69 0.12 54.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.577 -2.577 . . . . 11.13 115.67 -175.888 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -78.18 145.32 35.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.724 -2.485 . . . . 18.03 114.224 178.116 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 p -81.12 148.88 29.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.38 -2.7 . . . . 10.22 104.201 176.589 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.7 mt -76.37 -26.61 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 121.261 -0.899 . . . . 12.3 111.06 -173.402 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.296 17.0 pt-20 -51.8 -35.69 45.09 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 117.104 -1.426 . . . . 36.51 114.68 161.488 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -77.7 -39.85 43.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 117.167 -1.397 . . . . 25.66 113.73 176.128 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.4 t -57.91 -40.32 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 121.086 1.766 . . . . 8.12 109.472 176.875 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 55.8 mtmt -73.57 -35.67 65.48 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.499 1.12 . . . . 15.47 112.755 177.985 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.13 83.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 118.476 -1.289 . . . . 11.45 113.647 171.574 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' HD22 ' A' ' 15' ' ' LEU 0.347 29.8 ttmt -48.09 -40.38 23.14 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.219 -3.426 . . . . 24.98 112.022 161.382 . . . . . . . . 3 3 . 1 . 092 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.1 -35.94 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 120.706 1.594 . . . . 9.46 111.296 177.865 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -49.9 -47.85 51.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 115.607 -2.14 . . . . 14.76 114.188 163.424 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -63.33 -38.43 91.11 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.315 1.871 . . . . 26.29 113.951 177.65 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -72.48 -67.21 0.57 Allowed 'General case' 0 N--CA 1.429 -1.486 1 C-N-CA 131.868 4.067 . . . . 30.06 110.238 -178.686 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -97.84 -72.83 0.63 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.473 -2.017 . . . . 25.19 110.56 -166.859 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.47 64.73 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 118.427 2.131 . . . . 7.41 118.427 169.714 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.6 mt -133.56 116.18 13.83 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 128.151 2.58 . . . . 9.49 104.244 -168.359 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.39 156.34 26.45 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 123.731 2.368 . . . . 11.42 116.007 -172.325 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -78.66 -15.29 13.73 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 CA-C-N 124.39 2.604 . . . . 12.0 112.51 -172.596 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -75.08 -42.4 56.81 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.792 0.806 . . . . 35.55 110.753 175.268 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -68.56 -26.59 65.48 Favored 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 134.126 4.971 . . . . 20.52 111.784 -175.239 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.53 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 69.6 mt-30 -86.84 135.68 33.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.925 -2.36 . . . . 7.13 110.213 178.239 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -121.35 118.63 29.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.42 -2.067 . . . . 36.39 105.42 166.684 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 50' ' ' LEU . 62.3 mt -93.46 120.97 34.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.482 3.113 . . . . 9.55 111.849 177.86 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mt -109.29 134.07 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 117.119 -3.488 . . . . 13.9 107.488 173.957 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -91.27 -73.09 0.55 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 123.764 2.984 . . . . 6.86 103.56 163.909 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.32 -140.19 0.2 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.475 2.083 . . . . 11.15 107.122 -172.387 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.03 -23.65 69.7 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 122.609 3.803 . . . . 13.93 122.609 -176.191 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -76.81 162.7 27.44 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.989 -4.242 . . . . 23.92 118.149 174.491 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.282 81.6 mm-40 -84.87 133.93 34.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.719 -1.238 . . . . 23.23 111.806 167.456 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 43' ' ' LEU . 60.4 mt -93.25 132.78 37.12 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.384 -0.822 . . . . 9.11 110.733 177.328 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -93.27 122.34 35.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.012 2.125 . . . . 33.44 107.897 168.78 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.06 -25.12 65.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.459 1.904 . . . . 28.37 114.149 -168.794 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.78 -2.69 86.45 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 126.253 1.882 . . . . 15.0 117.723 -179.573 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -104.9 -176.61 3.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.908 1.337 . . . . 25.5 107.984 172.63 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.4 p -100.43 178.07 4.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.724 1.75 . . . . 11.95 115.724 -173.557 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.95 -35.95 81.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.97 3.308 . . . . 10.17 112.408 167.79 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 t -72.77 -36.71 67.7 Favored 'General case' 0 N--CA 1.431 -1.387 1 O-C-N 113.947 -5.471 . . . . 13.59 112.485 -179.052 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -66.98 -38.34 85.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.854 3.261 . . . . 11.7 110.938 176.11 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -88.57 -4.13 58.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.659 -1.9 . . . . 12.95 110.738 176.301 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 m120 57.68 58.85 3.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 131.508 3.923 . . . . 25.45 111.677 178.083 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mm -102.28 108.81 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.309 -2.108 . . . . 14.6 105.309 -178.113 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -108.79 169.23 8.8 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 127.361 2.913 . . . . 33.23 109.335 -171.577 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -44.68 138.69 3.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.587 2.613 . . . . 25.97 112.343 -176.345 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.281 18.1 mt-10 60.16 6.16 0.94 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.119 3.368 . . . . 32.61 115.296 175.702 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.6 m -62.73 140.83 58.75 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.183 -4.073 . . . . 10.56 113.354 160.838 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -103.91 122.32 44.94 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.493 3.517 . . . . 5.33 110.557 -175.407 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -86.24 156.35 20.32 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.089 2.743 . . . . 11.66 113.608 170.85 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -121.46 120.32 34.6 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 123.089 2.677 . . . . 16.3 111.223 168.365 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.6 tp -84.46 124.08 30.96 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 126.582 2.426 . . . . 9.96 116.702 173.962 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.3 127.8 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 103.433 -2.803 . . . . 9.76 103.433 179.423 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.286 1.3 mm? -65.36 136.53 56.64 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.867 -1.77 . . . . 19.57 115.212 175.43 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -119.36 150.61 39.88 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.035 2.826 . . . . 35.08 111.473 -178.341 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.323 28.9 mt -84.66 -67.69 0.78 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.64 -5.037 . . . . 32.31 111.828 169.463 . . . . . . . . 3 2 . 1 . 092 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -153.03 144.65 23.44 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.866 -3.022 . . . . 42.75 108.519 -176.915 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.57 -73.78 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.726 0 O-C-N 117.462 -3.273 . . . . 36.31 119.339 175.298 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.759 0 N-CA-C 109.648 -1.381 . . . . 36.27 109.648 -161.671 . . . . . . . . 0 0 . 1 . 093 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 113.766 1.024 . . . . 17.17 113.766 . . . . . . . . . 0 0 . 1 . 093 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -90.49 121.44 32.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.412 1.577 . . . . 21.89 113.795 -178.643 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.9 pt -123.54 151.92 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 O-C-N 114.145 -5.347 . . . . 10.83 108.653 168.449 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -115.93 137.01 52.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 119.484 1.038 . . . . 10.61 111.447 -179.451 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -109.82 130.23 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 130.134 3.374 . . . . 9.13 109.028 168.049 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -122.84 137.61 54.88 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.586 -2.552 . . . . 20.55 107.097 -173.251 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.329 55.2 p -100.88 -173.38 2.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 119.696 1.134 . . . . 11.78 110.881 -170.085 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.4 mt -74.01 -41.27 62.13 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.855 -3.028 . . . . 19.31 111.982 177.62 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.95 -57.56 9.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.237 -1.54 . . . . 23.14 108.135 165.768 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.25 6.86 0.17 Allowed Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 117.618 -2.229 . . . . 19.74 115.436 177.55 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -77.29 149.46 35.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 122.661 3.231 . . . . 21.93 110.715 -161.786 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -113.72 110.73 20.64 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.974 -3.579 . . . . 12.33 105.939 -174.601 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.04 121.66 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 111.212 -2.722 . . . . 17.08 112.289 169.392 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.3 m -103.66 114.07 28.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 128.003 3.314 . . . . 16.3 106.832 -174.37 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -104.14 141.7 35.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.147 -1.596 . . . . 15.88 112.295 178.651 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -84.13 100.81 11.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.406 1.883 . . . . 28.9 107.87 164.592 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.93 151.34 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.295 -1.002 . . . . 12.05 108.295 179.103 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -91.23 164.08 26.4 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 116.906 -1.918 . . . . 18.17 106.394 171.263 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -82.76 -8.06 11.31 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.515 2.144 . . . . 8.16 108.872 -177.635 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -86.67 -4.54 59.19 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.795 1.759 . . . . 11.13 115.717 171.722 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -83.13 137.74 33.95 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.499 -2.001 . . . . 18.03 107.282 -168.284 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 p -74.21 157.84 35.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.631 3.11 . . . . 10.22 112.57 174.169 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.8 mt -69.19 -21.4 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 1 O-C-N 115.907 -4.246 . . . . 12.3 110.499 175.6 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.06 -48.18 82.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.02 2.343 . . . . 36.51 115.328 161.752 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.76 -41.03 94.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.38 3.072 . . . . 25.66 114.566 173.037 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.44 -55.68 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 129.191 2.997 . . . . 8.12 114.986 164.23 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -46.58 -44.89 18.49 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 114.683 -5.011 . . . . 15.47 118.73 164.964 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.96 -36.71 75.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 124.725 2.202 . . . . 11.45 115.768 -177.854 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -69.83 -34.9 74.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.269 -2.242 . . . . 24.98 110.951 178.602 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -59.36 -43.61 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 125.861 1.665 . . . . 9.46 109.892 171.403 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -68.05 -42.93 79.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.072 -1.642 . . . . 14.76 108.752 -174.882 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.36 -46.92 87.31 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.399 2.28 . . . . 26.29 112.602 176.598 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -79.31 -57.25 3.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.703 2.112 . . . . 30.06 116.703 179.561 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -85.31 -54.64 4.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.708 -3.745 . . . . 25.19 116.003 -179.78 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.05 54.26 0.98 Allowed Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 124.509 1.052 . . . . 7.41 115.161 -176.012 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.7 mt -119.48 125.57 27.44 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 104.585 -2.376 . . . . 9.49 104.585 165.614 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 43.0 Cg_endo -75.32 159.17 40.48 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 123.721 2.948 . . . . 11.42 113.276 -176.672 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 41.8 Cg_exo -61.65 -11.41 20.27 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 124.952 3.768 . . . . 12.0 115.651 -179.765 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -85.7 -28.72 24.48 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 121.488 1.949 . . . . 35.55 106.414 -173.935 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -85.43 -28.66 24.94 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 115.365 -4.584 . . . . 20.52 110.222 -178.191 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -74.29 130.42 39.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.978 2.323 . . . . 7.13 114.443 -177.858 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -132.89 126.86 33.11 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 112.81 -1.996 . . . . 36.39 111.172 164.584 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.2 mt -108.25 114.88 29.09 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 109.286 -3.597 . . . . 9.55 113.89 -163.646 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.57 135.19 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 118.685 -2.51 . . . . 13.9 106.132 -172.217 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -96.02 -54.89 3.15 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.185 1.945 . . . . 6.86 110.701 173.308 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.28 -126.35 0.27 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 108.899 -3.773 . . . . 11.15 108.026 -176.064 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.5 6.51 12.69 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 127.755 2.598 . . . . 13.93 107.55 -170.732 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -110.16 145.11 37.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.352 1.612 . . . . 23.92 115.352 -175.553 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -75.1 121.59 22.28 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.239 1.816 . . . . 23.23 111.919 -174.515 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.5 mt -94.68 120.7 35.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.393 2.677 . . . . 9.11 110.496 176.61 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.74 143.26 28.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.81 -3.057 . . . . 33.44 107.641 -177.53 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -65.38 -39.48 92.3 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.027 -1.442 . . . . 28.37 112.076 -162.45 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.35 -11.77 81.6 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 120.289 2.875 . . . . 15.0 120.289 -168.672 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -91.26 173.57 7.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.657 -2.084 . . . . 25.5 105.765 -178.209 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.2 p -113.83 174.36 5.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.72 2.2 . . . . 11.95 108.142 -166.91 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.06 -31.11 72.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.444 -2.035 . . . . 10.17 113.989 173.164 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -67.77 -31.99 72.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.781 2.141 . . . . 13.59 116.781 175.716 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -61.92 -50.29 72.75 Favored 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.342 4.257 . . . . 11.7 110.214 176.811 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -89.87 -20.93 22.83 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 124.172 1.939 . . . . 12.95 115.198 -178.533 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.339 16.1 m120 85.65 41.73 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 127.346 2.258 . . . . 25.45 111.88 175.193 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.3 mm -79.31 115.52 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 124.323 2.011 . . . . 14.6 109.002 169.148 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -95.04 -174.16 3.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.405 -1.27 . . . . 33.23 111.941 -177.559 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -66.82 146.27 54.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.689 1.596 . . . . 25.97 112.583 175.853 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.461 65.3 mt-10 76.43 11.73 2.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.979 2.214 . . . . 32.61 116.979 -179.417 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.254 56.2 m -84.42 141.69 30.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.318 1.97 . . . . 10.56 116.318 -169.579 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.4 m -107.7 98.0 7.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.24 -2.162 . . . . 5.33 109.843 -166.769 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -88.93 151.57 22.24 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.517 1.927 . . . . 11.66 107.594 -177.036 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.84 123.32 39.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.64 2.638 . . . . 16.3 108.228 -171.874 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -94.41 112.29 24.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.81 -2.45 . . . . 9.96 110.591 -176.624 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.254 38.5 t -103.88 131.57 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 105.594 -2.002 . . . . 9.76 105.594 -171.925 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -99.57 115.23 28.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.789 -3.069 . . . . 19.57 112.7 -171.401 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -75.86 153.44 36.78 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 110.582 -3.008 . . . . 35.08 117.714 -160.227 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.9 mt -81.66 -99.33 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.008 -3.558 . . . . 32.31 112.812 158.551 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -135.26 155.94 49.8 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.939 -1.028 . . . . 42.75 109.739 173.95 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.75 177.17 37.79 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 125.344 1.652 . . . . 36.31 110.538 175.998 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.759 0 C-N-CA 126.039 1.781 . . . . 36.27 111.228 -179.461 . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.49 -1.344 0 N-CA-C 116.607 2.077 . . . . 17.17 116.607 . . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -90.87 144.2 25.93 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.97 -4.206 . . . . 21.89 112.444 -175.122 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.4 pt -122.09 155.16 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 126.023 2.82 . . . . 10.83 103.946 165.543 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -114.95 111.11 20.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.034 -3.542 . . . . 10.61 103.597 -172.302 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 67' ' ' LEU . 46.1 t -101.19 135.44 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 116.699 -3.751 . . . . 9.13 107.736 179.648 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -115.15 122.79 47.16 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 125.715 1.606 . . . . 20.55 112.813 -172.491 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -77.02 172.69 12.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.19 -2.819 . . . . 11.78 115.112 177.675 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.518 HD23 ' CE1' ' A' ' 68' ' ' HIS . 40.8 mt -76.58 -23.74 53.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.274 2.694 . . . . 19.31 118.274 170.498 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -83.66 -24.8 31.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 115.805 -2.045 . . . . 23.14 113.501 166.613 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.33 49.8 0.35 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 113.636 -3.869 . . . . 19.74 113.786 161.388 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -114.69 140.16 49.08 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.665 2.038 . . . . 21.93 107.511 175.499 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -84.4 117.13 23.43 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 116.13 -4.106 . . . . 12.33 108.431 160.856 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -86.2 116.21 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.658 -2.349 . . . . 17.08 104.658 162.984 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.2 m -106.21 97.39 7.21 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 124.834 2.254 . . . . 16.3 108.808 -172.415 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 mt -103.45 116.08 31.73 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.892 -1.958 . . . . 15.88 112.224 -162.428 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.93 119.16 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.727 -1.579 . . . . 28.9 112.893 170.869 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.78 177.55 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.226 2.441 . . . . 12.05 109.387 -179.514 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.88 167.3 14.81 Favored Pre-proline 0 N--CA 1.43 -1.471 0 O-C-N 117.176 -3.452 . . . . 18.17 103.781 172.784 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -76.61 -19.35 14.68 Favored 'Trans proline' 0 C--N 1.3 -2.021 1 C-N-CA 125.595 4.196 . . . . 8.16 114.985 179.713 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -79.89 -14.55 58.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.196 2.665 . . . . 11.13 118.196 171.755 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -72.58 144.83 47.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.303 -2.748 . . . . 18.03 106.263 -168.87 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.5 p -82.69 157.13 23.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.567 -1.253 . . . . 10.22 111.854 177.338 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.29 -21.54 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 CA-C-O 128.868 4.175 . . . . 12.3 114.979 -172.822 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -58.62 -53.77 54.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.488 -3.258 . . . . 36.51 114.612 157.899 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -50.73 -32.83 20.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.583 -3.823 . . . . 25.66 115.934 173.974 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.11 -53.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 128.496 2.718 . . . . 8.12 108.971 173.092 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -65.28 -35.49 81.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.606 1.548 . . . . 15.47 112.849 -179.887 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.53 92.47 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.254 1.022 . . . . 11.45 112.318 169.88 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -53.0 -43.35 66.41 Favored 'General case' 0 N--CA 1.43 -1.458 2 O-C-N 113.938 -5.476 . . . . 24.98 113.802 169.866 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -64.88 -29.55 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 127.894 2.478 . . . . 9.46 112.807 172.67 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -72.92 -45.79 56.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 123.48 2.854 . . . . 14.76 109.21 167.897 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -59.81 -37.04 78.05 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.165 -2.209 . . . . 26.29 114.997 177.551 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -85.69 -51.1 6.68 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.563 2.801 . . . . 30.06 118.563 171.107 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -102.91 -8.14 20.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.155 3.02 . . . . 25.19 119.155 -178.658 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.29 51.42 58.25 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 117.811 -3.055 . . . . 7.41 114.768 -175.512 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.8 mt -111.02 106.25 57.45 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 128.337 2.655 . . . . 9.49 108.625 165.775 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 74.6 Cg_exo -72.59 157.45 52.5 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 N-CA-C 118.134 2.321 . . . . 11.42 118.134 -172.048 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -71.84 -15.97 29.65 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-N 126.47 3.346 . . . . 12.0 119.467 -163.78 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.8 -24.43 67.55 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 120.713 3.597 . . . . 35.55 120.713 160.274 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.406 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 25.8 mt-30 -72.07 -28.93 63.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.903 2.592 . . . . 20.52 114.257 170.594 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -86.85 133.27 33.64 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.54 -3.225 . . . . 7.13 115.534 -159.321 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -125.95 108.27 11.25 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.965 1.841 . . . . 36.39 108.516 167.317 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 43' ' ' LEU . 75.8 mt -87.39 113.94 23.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.444 -1.707 . . . . 9.55 108.572 -179.021 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -116.85 134.82 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 1 O-C-N 115.844 -4.285 . . . . 13.9 103.137 175.614 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -103.79 -63.62 1.17 Allowed 'General case' 0 N--CA 1.431 -1.419 1 O-C-N 115.061 -4.774 . . . . 6.86 109.952 166.832 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.95 -66.47 0.93 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.797 -3.69 . . . . 11.15 109.122 -168.453 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.11 -53.75 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 O-C-N 116.854 -3.654 . . . . 13.93 118.931 -174.065 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -71.91 169.19 16.36 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.725 2.12 . . . . 23.92 116.725 -170.035 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -88.46 129.28 35.48 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 114.77 -4.956 . . . . 23.23 106.177 -178.686 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.5 mt -84.47 127.2 33.89 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 111.891 -2.413 . . . . 9.11 112.647 175.767 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.29 163.89 26.07 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 129.221 4.075 . . . . 33.44 111.709 166.493 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -91.07 -63.39 1.27 Allowed 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 115.539 -4.475 . . . . 28.37 108.936 -172.473 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.25 -5.87 9.1 Favored Glycine 0 N--CA 1.431 -1.667 1 C-N-CA 130.873 4.082 . . . . 15.0 113.561 -178.484 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -91.34 168.43 11.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.119 3.46 . . . . 25.5 110.759 174.763 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 29.6 p -94.72 170.02 9.75 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.237 4.215 . . . . 11.95 111.334 179.466 . . . . . . . . 3 2 . 1 . 094 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.61 -26.04 62.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.393 -3.942 . . . . 10.17 115.753 172.823 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -63.99 -49.75 71.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 111.447 -2.615 . . . . 13.59 111.119 172.762 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -45.14 -44.48 10.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.767 2.506 . . . . 11.7 117.767 169.533 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -88.54 3.66 49.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 116.622 -1.656 . . . . 12.95 114.647 179.257 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.336 3.7 m-80 57.01 52.93 8.55 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.747 3.24 . . . . 25.45 119.747 -175.227 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mt -115.19 122.8 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 113.926 -1.488 . . . . 14.6 108.214 -177.785 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -112.24 -150.55 0.47 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.37 -2.706 . . . . 33.23 113.252 175.417 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 64' ' ' GLU . 19.4 pttp -76.59 165.88 24.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.699 2.045 . . . . 25.97 111.996 -173.252 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.418 ' OE2' ' NZ ' ' A' ' 63' ' ' LYS . 51.4 mt-10 57.23 25.45 11.06 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 133.012 4.525 . . . . 32.61 109.668 174.528 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.286 52.6 m -76.29 121.94 23.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 129.507 3.123 . . . . 10.56 107.979 -176.709 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.4 m -90.8 116.75 28.88 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 124.697 1.248 . . . . 5.33 111.313 175.885 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' A' ' 5' ' ' VAL . 5.8 mp -107.35 158.37 17.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.111 2.164 . . . . 11.66 107.502 178.889 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.518 ' CE1' HD23 ' A' ' 8' ' ' LEU . 5.9 t60 -114.84 131.79 56.72 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.446 1.593 . . . . 16.3 110.505 172.661 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.65 103.88 14.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 127.715 3.626 . . . . 9.96 104.387 172.176 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 t -95.15 133.82 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 1 C-N-CA 135.459 5.504 . . . . 9.76 109.94 171.824 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.08 113.58 25.5 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 116.102 1.89 . . . . 19.57 116.102 -171.688 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.254 27.7 ttp85 -83.08 160.0 22.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.243 3.017 . . . . 35.08 113.24 -157.106 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.38 133.01 33.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.019 -1.901 . . . . 32.31 106.887 177.148 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -74.43 139.4 43.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.369 1.248 . . . . 42.75 114.369 -174.85 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.79 85.07 0.84 Allowed Glycine 0 N--CA 1.43 -1.746 1 C-N-CA 130.959 4.123 . . . . 36.31 105.0 165.11 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.801 0 O-C-N 129.415 3.656 . . . . 36.27 111.052 178.963 . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 113.614 0.968 . . . . 17.17 113.614 . . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -91.98 132.5 36.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.746 1.387 . . . . 21.89 114.746 -170.772 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 pt -131.21 150.24 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 119.118 -2.239 . . . . 10.83 113.257 167.745 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -99.48 123.61 43.9 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 125.685 1.865 . . . . 10.61 108.529 -176.796 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.7 t -104.22 121.98 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 117.178 -1.809 . . . . 9.13 107.786 171.835 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -103.21 105.98 16.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.112 2.965 . . . . 20.55 110.958 -170.026 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -69.96 177.39 3.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.832 1.419 . . . . 11.78 114.832 178.673 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.1 mt -66.29 -43.71 85.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 114.989 -2.434 . . . . 19.31 111.739 -170.295 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -67.48 -47.83 68.91 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 132.594 6.184 . . . . 23.14 106.708 172.928 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.32 41.77 0.62 Allowed Glycine 0 N--CA 1.43 -1.708 0 O-C-N 117.669 -3.145 . . . . 19.74 115.333 -176.879 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -83.38 135.23 34.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 101.889 -3.374 . . . . 21.93 101.889 175.356 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -90.11 101.93 14.64 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 122.183 2.265 . . . . 12.33 106.105 -177.934 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 mt -85.34 109.26 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.445 -0.784 . . . . 17.08 109.392 172.708 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -92.0 116.8 29.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.317 2.961 . . . . 16.3 111.302 -178.673 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.2 mt -116.13 137.04 52.47 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.818 -4.301 . . . . 15.88 111.475 -174.082 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -111.19 108.65 18.38 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.476 -2.64 . . . . 28.9 106.521 -175.331 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.86 164.62 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 125.116 1.51 . . . . 12.05 112.786 -172.448 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.33 154.79 37.93 Favored Pre-proline 0 N--CA 1.43 -1.464 0 O-C-N 116.952 -3.592 . . . . 18.17 110.663 165.419 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -60.55 -24.51 78.38 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 125.101 3.867 . . . . 8.16 110.789 179.125 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -98.33 26.01 5.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.211 -1.556 . . . . 11.13 109.44 -179.408 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -94.86 158.91 15.28 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.998 -2.939 . . . . 18.03 112.247 161.951 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -105.09 169.8 8.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.447 1.594 . . . . 10.22 109.578 -170.775 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.11 -40.21 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.666 -2.521 . . . . 12.3 113.558 178.383 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -43.04 -41.62 3.56 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 121.082 3.734 . . . . 36.51 121.082 160.653 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -63.19 -60.7 3.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.397 -3.314 . . . . 25.66 111.948 174.913 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 t -46.94 -41.36 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 116.313 -3.992 . . . . 8.12 117.182 170.939 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -56.3 -35.67 67.79 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.354 -1.466 . . . . 15.47 111.091 177.696 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.1 -24.23 60.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.922 -3.611 . . . . 11.45 114.341 -179.13 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -65.03 -30.1 71.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.416 2.747 . . . . 24.98 118.416 166.028 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.8 mt -78.24 -33.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 124.291 1.996 . . . . 9.46 110.492 178.544 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -66.18 -31.33 72.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.87 -1.768 . . . . 14.76 115.073 169.093 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -62.41 -60.8 3.03 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.442 3.097 . . . . 26.29 109.218 173.251 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -79.87 -63.7 1.35 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 115.059 1.503 . . . . 30.06 115.059 -174.142 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 45.2 mm-40 -82.53 -28.88 30.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.239 3.051 . . . . 25.19 119.239 -177.28 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.98 7.79 49.45 Favored Glycine 0 N--CA 1.43 -1.75 1 O-C-N 116.056 -4.153 . . . . 7.41 120.956 173.25 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.67 129.65 51.95 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 118.656 -2.673 . . . . 9.49 111.815 -179.529 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -66.66 146.61 79.63 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 N-CA-C 118.411 2.427 . . . . 11.42 118.411 174.979 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -16.95 57.51 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 120.125 3.087 . . . . 12.0 120.125 -169.335 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.67 -19.85 34.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.587 -1.946 . . . . 35.55 110.738 176.766 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -91.6 -24.12 19.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.064 2.364 . . . . 20.52 107.843 -169.22 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -73.45 155.56 39.16 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.191 -3.443 . . . . 7.13 111.391 175.171 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.291 51.5 ttt180 -139.5 120.0 14.03 Favored 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 132.471 4.308 . . . . 36.39 113.672 167.604 . . . . . . . . 3 2 . 1 . 095 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.84 132.77 49.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.809 -1.807 . . . . 9.55 109.698 -179.471 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 3.6 mt -120.61 130.61 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.007 -1.108 . . . . 13.9 108.007 179.215 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -86.45 -77.5 0.31 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.43 -2.044 . . . . 6.86 110.135 163.002 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.07 -73.37 0.67 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.053 1.341 . . . . 11.15 107.864 173.973 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.46 1.2 0.42 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 113.699 -3.834 . . . . 13.93 115.129 -171.733 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -105.54 166.83 10.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 123.875 3.838 . . . . 23.92 107.832 -167.176 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -97.31 139.94 32.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.818 1.645 . . . . 23.23 111.365 177.729 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -101.61 141.95 33.7 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.308 -0.86 . . . . 9.11 108.881 -174.661 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.253 43.6 mt-10 -97.93 149.25 22.61 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.127 -2.233 . . . . 33.44 107.397 174.182 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.03 -31.21 71.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.303 2.241 . . . . 28.37 112.436 -175.299 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.71 36.26 4.52 Favored Glycine 0 N--CA 1.43 -1.728 1 N-CA-C 125.189 4.835 . . . . 15.0 125.189 -177.179 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -126.35 162.15 26.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.161 -2.376 . . . . 25.5 107.179 170.871 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.255 29.9 p -88.24 166.49 14.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.146 -2.846 . . . . 11.95 111.432 -175.479 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.57 -41.67 90.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.495 2.569 . . . . 10.17 111.301 164.789 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -58.51 -39.17 79.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.482 -3.261 . . . . 13.59 114.539 175.064 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -67.43 -36.71 81.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.228 1.966 . . . . 11.7 111.66 -174.256 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -85.32 -0.61 55.28 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.869 -3.019 . . . . 12.95 108.716 176.1 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.301 3.3 m120 56.67 36.87 28.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.884 2.179 . . . . 25.45 116.884 -179.329 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.5 mt -99.02 111.07 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 117.182 -1.39 . . . . 14.6 108.848 177.816 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.307 28.8 mm100 -96.0 -167.04 1.52 Allowed 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.927 3.267 . . . . 33.23 107.134 -167.294 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -57.33 159.92 4.34 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 117.161 2.282 . . . . 25.97 117.161 167.089 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 65.24 14.37 9.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.542 1.937 . . . . 32.61 113.546 -178.045 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -81.04 133.7 35.53 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.566 1.691 . . . . 10.56 115.566 -171.248 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.4 m -93.25 112.11 23.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.472 -1.694 . . . . 5.33 108.737 -173.232 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.9 mt -98.06 133.48 42.45 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.379 -3.326 . . . . 11.66 106.163 176.248 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 15.3 t60 -94.75 119.09 32.8 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 126.67 1.988 . . . . 16.3 112.819 167.918 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.9 tp -103.81 121.51 43.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 126.153 2.882 . . . . 9.96 114.418 -179.981 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.72 176.98 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 1 O-C-N 114.668 -5.02 . . . . 9.76 103.104 -177.243 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.3 mp -98.18 157.19 16.3 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.212 -5.305 . . . . 19.57 115.282 -179.049 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.8 ttp85 -90.58 149.18 22.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.478 1.659 . . . . 35.08 115.478 170.768 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.2 mt -105.2 121.1 43.14 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.365 2.031 . . . . 32.31 107.705 174.274 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 -111.67 162.43 15.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.017 2.927 . . . . 42.75 118.213 -162.923 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.89 -73.68 0.21 Allowed Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 126.605 2.05 . . . . 36.31 109.79 -177.995 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 CA-C-O 114.812 -3.216 . . . . 36.27 113.173 174.952 . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 116.981 -1.485 . . . . 17.17 112.864 . . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -101.67 149.42 24.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 114.51 -2.876 . . . . 21.89 113.934 -173.836 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.74 174.98 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 119.636 -1.915 . . . . 10.83 109.034 160.145 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -126.18 149.5 48.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 115.349 -2.54 . . . . 10.61 108.098 -175.319 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.8 t -112.94 127.59 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 104.659 -2.349 . . . . 9.13 104.659 168.051 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -105.85 117.69 34.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.853 2.168 . . . . 20.55 116.853 164.58 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -92.05 169.54 10.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.723 3.154 . . . . 11.78 109.068 -168.966 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 mt -62.93 -38.36 90.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.499 -2.625 . . . . 19.31 111.668 166.501 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 m -61.37 -61.32 2.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.48 3.512 . . . . 23.14 112.718 -178.982 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.52 52.42 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 118.567 -1.778 . . . . 19.74 111.373 177.869 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -123.87 167.37 14.18 Favored 'General case' 0 N--CA 1.43 -1.454 1 CA-C-O 129.648 4.546 . . . . 21.93 108.18 179.759 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.2 m -131.06 108.28 9.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 110.368 -3.105 . . . . 12.33 103.155 166.771 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.8 mt -101.28 131.52 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 111.953 -3.88 . . . . 17.08 107.123 175.545 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.6 m -104.59 114.88 29.39 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 123.996 3.089 . . . . 16.3 106.551 173.846 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.3 mt -104.1 129.03 51.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.145 1.778 . . . . 15.88 111.824 174.074 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -87.03 106.3 17.75 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.657 3.122 . . . . 28.9 105.081 -178.545 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.19 155.7 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.031 -2.918 . . . . 12.05 110.418 -171.266 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -109.89 137.42 20.45 Favored Pre-proline 0 N--CA 1.43 -1.432 0 O-C-N 116.723 -3.735 . . . . 18.17 107.759 164.881 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.69 -10.25 13.11 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 124.828 3.686 . . . . 8.16 113.074 -164.077 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -89.22 -12.98 39.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.024 2.345 . . . . 11.13 110.958 174.511 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -81.88 157.9 24.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.105 -1.407 . . . . 18.03 111.749 176.007 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -87.51 170.33 11.43 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.54 -2.6 . . . . 10.22 116.007 -150.895 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.0 mt -80.95 -27.3 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 118.3 -2.75 . . . . 12.3 110.892 -175.471 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -62.21 -45.14 94.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.767 -2.063 . . . . 36.51 112.619 166.98 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -64.25 -20.43 66.04 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 117.516 -1.23 . . . . 25.66 112.238 178.055 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.1 t -73.06 -40.4 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 122.16 2.255 . . . . 8.12 111.82 168.473 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -66.94 -38.45 86.18 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.491 2.994 . . . . 15.47 113.989 176.807 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -64.44 -11.07 29.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.617 2.821 . . . . 11.45 118.617 169.564 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -84.04 -38.88 20.3 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.506 1.622 . . . . 24.98 113.506 166.35 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.7 -40.51 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 117.561 -3.212 . . . . 9.46 115.545 160.618 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 22.4 tt0 -55.01 -35.34 64.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.15 -2.844 . . . . 14.76 114.438 170.289 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.4 -57.07 11.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.892 -1.755 . . . . 26.29 115.344 166.452 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -66.27 -65.11 0.72 Allowed 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 133.415 4.686 . . . . 30.06 109.714 -168.452 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -93.32 -26.53 17.26 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.903 1.811 . . . . 25.19 114.454 -173.471 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.8 28.6 9.32 Favored Glycine 0 N--CA 1.43 -1.709 1 O-C-N 114.152 -5.342 . . . . 7.41 116.358 177.126 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 90.2 mt -120.12 118.54 31.41 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 116.256 -1.83 . . . . 9.49 108.263 -162.62 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -73.05 162.0 41.99 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.867 3.488 . . . . 11.42 114.961 -164.004 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.63 -15.53 19.35 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 125.616 3.041 . . . . 12.0 114.338 -174.016 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.4 -29.78 42.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.599 2.454 . . . . 35.55 114.078 176.351 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -78.11 -23.63 47.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.653 1.981 . . . . 20.52 115.38 171.866 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -71.79 139.48 49.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.266 3.062 . . . . 7.13 119.266 170.562 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.488 ' HB3' HG23 ' A' ' 70' ' ' VAL . 72.6 ttt180 -119.71 147.46 44.55 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.488 -2.007 . . . . 36.39 113.949 158.604 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -127.64 112.52 14.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.858 -2.401 . . . . 9.55 111.047 179.419 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.6 mt -95.71 125.35 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.124 -3.485 . . . . 13.9 107.044 -175.663 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -98.1 -62.51 1.23 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.909 -3.62 . . . . 6.86 105.952 178.107 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.69 -128.5 0.1 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.135 2.574 . . . . 11.15 104.497 177.976 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.04 7.07 32.81 Favored Glycine 0 N--CA 1.431 -1.699 0 O-C-N 121.043 -1.036 . . . . 13.93 114.609 -172.482 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -111.98 117.36 32.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.206 1.558 . . . . 23.92 115.206 169.661 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -68.6 129.3 39.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.319 2.009 . . . . 23.23 111.191 -170.345 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.37 153.3 35.89 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.61 -3.181 . . . . 9.11 113.891 -176.687 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -101.65 150.41 23.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.107 0.956 . . . . 33.44 111.676 162.253 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -67.02 -43.99 81.42 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 120.44 3.496 . . . . 28.37 120.44 -178.145 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.73 48.04 1.85 Allowed Glycine 0 N--CA 1.43 -1.709 0 CA-C-O 123.777 1.765 . . . . 15.0 111.873 -178.449 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -127.39 162.22 26.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.8 -2.296 . . . . 25.5 104.8 174.544 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.2 p -91.09 169.42 10.87 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.77 -3.081 . . . . 11.95 108.605 178.097 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.7 -34.28 71.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.345 -3.347 . . . . 10.17 114.319 171.442 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 t -65.81 -34.69 78.75 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 128.358 3.536 . . . . 13.59 116.008 -178.482 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -56.58 -43.33 79.95 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.83 -1.794 . . . . 11.7 113.323 177.834 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -95.11 8.82 41.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 122.354 2.343 . . . . 12.95 113.437 -178.882 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.493 10.6 m120 66.0 41.23 3.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.847 2.059 . . . . 25.45 113.274 175.96 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.3 mt -91.05 138.09 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 106.632 -1.618 . . . . 14.6 106.632 -178.233 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -128.98 -177.28 4.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.943 -2.973 . . . . 33.23 112.426 -168.746 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.327 19.9 pttp -60.93 149.6 35.93 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 120.862 3.653 . . . . 25.97 120.862 168.916 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 48.1 27.49 1.26 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.965 3.306 . . . . 32.61 116.802 -171.905 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.334 54.5 m -92.99 144.94 24.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.409 -3.307 . . . . 10.56 114.986 177.277 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.5 m -99.91 120.99 40.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.057 -1.925 . . . . 5.33 115.937 -171.761 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -103.51 137.92 40.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.11 -1.441 . . . . 11.66 107.11 174.567 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -93.6 114.44 26.78 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 114.445 1.276 . . . . 16.3 114.445 177.08 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.253 49.6 tp -83.4 115.2 21.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 124.288 0.992 . . . . 9.96 110.353 -179.595 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 42' ' ' ARG . 3.3 m -119.57 -175.05 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 115.068 -0.969 . . . . 9.76 110.102 166.92 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 mt -94.73 154.1 17.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.606 1.193 . . . . 19.57 113.147 172.334 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -88.25 130.4 35.1 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.964 2.209 . . . . 35.08 116.964 170.968 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.6 tp -86.56 109.37 19.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.969 -2.234 . . . . 32.31 104.969 -178.745 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -92.68 150.42 20.7 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 124.088 1.899 . . . . 42.75 115.224 -170.473 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.35 95.0 1.98 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.762 -1.211 . . . . 36.31 110.542 173.402 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.773 0 C-N-CA 125.429 1.49 . . . . 36.27 110.97 171.798 . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 116.08 -1.914 . . . . 17.17 113.758 . . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -104.24 131.58 51.4 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.267 2.23 . . . . 21.89 110.383 -179.08 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.38 152.51 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.182 -2.525 . . . . 10.83 104.182 -178.696 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -107.31 125.08 50.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.269 2.228 . . . . 10.61 111.289 -176.69 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 t -110.84 115.63 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.23 -2.794 . . . . 9.13 109.221 176.513 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.262 31.3 tttt -97.79 130.59 44.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.741 0.781 . . . . 20.55 109.626 -171.535 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.271 13.9 p -74.92 166.25 23.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.841 -3.662 . . . . 11.78 115.12 -179.001 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.263 1.6 tp -54.96 -43.33 73.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.618 3.567 . . . . 19.31 106.288 171.607 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 p -89.49 -50.25 6.21 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.177 -3.452 . . . . 23.14 115.64 179.529 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.75 67.61 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.763 0 O-C-N 117.533 -3.23 . . . . 19.74 111.34 163.475 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -137.24 139.83 41.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.503 -2.763 . . . . 21.93 106.545 173.784 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -104.57 112.9 26.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.799 1.64 . . . . 12.33 107.655 -166.816 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 60.1 mt -91.03 144.22 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 118.17 -2.831 . . . . 17.08 107.348 179.328 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.1 m -108.5 121.01 44.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 122.799 2.545 . . . . 16.3 112.779 164.867 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 15' ' ' LEU . 91.4 mt -110.66 130.7 55.5 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.688 2.795 . . . . 15.88 111.715 -179.997 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -90.54 114.83 27.13 Favored 'General case' 0 N--CA 1.43 -1.453 1 CA-C-O 128.596 4.046 . . . . 28.9 108.81 173.687 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.61 171.63 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.56 -3.212 . . . . 12.05 110.89 -173.621 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.36 147.94 36.63 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 102.387 -3.19 . . . . 18.17 102.387 166.663 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -65.11 -14.07 43.19 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 121.695 1.597 . . . . 8.16 113.938 171.671 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.34 -4.95 50.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.936 2.303 . . . . 11.13 116.142 171.895 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -81.18 146.47 30.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 114.596 -2.621 . . . . 18.03 109.753 178.919 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.0 p -79.75 166.71 21.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 125.717 3.871 . . . . 10.22 114.111 167.627 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.7 mm -49.77 -43.36 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 111.624 -2.534 . . . . 12.3 113.738 169.234 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.254 36.0 tt0 -54.11 -24.83 19.08 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.663 -2.113 . . . . 36.51 115.632 176.632 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -86.9 -34.71 19.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.156 2.408 . . . . 25.66 111.043 178.206 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.22 -48.4 88.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.457 2.075 . . . . 8.12 108.521 178.677 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -61.31 -27.04 68.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 119.134 3.012 . . . . 15.47 119.134 175.278 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.258 . . -74.2 -29.51 61.78 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.83 -3.044 . . . . 11.45 109.827 -175.959 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HB3' HD22 ' A' ' 15' ' ' LEU . 68.7 mmtt -64.52 -36.75 85.22 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.399 2.523 . . . . 24.98 115.904 169.254 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.344 39.1 mt -65.08 -42.05 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 O-C-N 116.198 -4.063 . . . . 9.46 110.701 171.766 . . . . . . . . 3 2 . 1 . 097 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.07 -29.83 68.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.914 -3.616 . . . . 14.76 118.367 168.211 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.65 -48.67 16.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 126.42 2.325 . . . . 26.29 111.194 -179.023 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -83.03 -57.48 3.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 126.21 2.194 . . . . 30.06 112.005 -169.883 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -78.32 -45.8 21.73 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.62 2.768 . . . . 25.19 111.537 177.757 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.2 50.15 5.59 Favored Glycine 0 N--CA 1.43 -1.763 0 O-C-N 119.407 -2.058 . . . . 7.41 113.25 -169.126 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mt -113.31 140.81 24.81 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.114 -2.18 . . . . 9.49 105.114 170.38 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -72.75 148.88 47.39 Favored 'Trans proline' 0 N--CA 1.433 -2.032 1 C-N-CA 125.885 4.39 . . . . 11.42 111.164 -176.837 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.8 -30.16 9.68 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 N-CA-C 116.44 1.669 . . . . 12.0 116.44 -165.3 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -66.23 -26.21 67.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 120.333 3.457 . . . . 35.55 120.333 172.356 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -78.09 -29.7 49.18 Favored 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 132.327 4.251 . . . . 20.52 108.528 -178.163 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.262 56.6 mt-30 -67.74 91.44 0.31 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.693 3.197 . . . . 7.13 110.283 170.799 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -93.77 98.54 11.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 126.74 3.162 . . . . 36.39 109.51 171.417 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -98.22 130.52 44.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.08 2.848 . . . . 9.55 104.496 -170.374 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mt -123.08 134.27 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.544 -3.847 . . . . 13.9 107.095 -173.72 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -115.54 103.36 10.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 102.491 -3.151 . . . . 6.86 102.491 175.794 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.69 -97.48 0.06 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.407 2.283 . . . . 11.15 111.368 -172.679 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.58 16.23 9.05 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-O 124.083 1.935 . . . . 13.93 117.353 161.679 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -84.33 115.0 22.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.659 -3.26 . . . . 23.92 106.833 174.963 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -74.13 123.58 24.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 117.142 -1.409 . . . . 23.23 110.916 166.82 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.07 132.66 39.71 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 116.618 -2.033 . . . . 9.11 108.648 -160.301 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -78.37 151.0 33.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.496 -3.877 . . . . 33.44 107.325 174.929 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.16 -36.85 75.0 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.485 2.088 . . . . 28.37 111.843 -169.572 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.03 25.15 27.23 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-O 125.415 2.675 . . . . 15.0 113.043 -160.754 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -115.56 142.19 47.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 124.288 1.994 . . . . 25.5 108.414 -174.231 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -76.31 153.89 35.51 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.166 2.412 . . . . 11.95 112.73 178.959 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.9 mt -70.9 -32.27 69.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.552 -3.217 . . . . 10.17 111.88 178.586 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.5 p -70.93 -17.58 62.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.347 -1.471 . . . . 13.59 114.844 168.843 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -77.73 -44.86 26.47 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 119.059 -2.275 . . . . 11.7 110.37 178.769 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -70.03 -25.44 63.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.799 -3.688 . . . . 12.95 115.76 173.975 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.501 20.3 t30 81.6 43.8 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 131.399 3.879 . . . . 25.45 115.905 -170.553 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.9 mt -94.13 94.25 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 105.68 -1.97 . . . . 14.6 105.68 174.009 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -93.07 -177.45 4.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.784 -1.553 . . . . 33.23 114.94 176.067 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -55.96 139.03 47.73 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.241 2.311 . . . . 25.97 117.241 -174.19 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 80.0 mt-10 68.98 12.27 8.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 128.634 3.709 . . . . 32.61 114.015 -179.854 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.275 16.1 m -64.69 144.05 57.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.392 1.477 . . . . 10.56 112.876 170.0 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 m -102.06 116.25 32.28 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 102.076 -3.305 . . . . 5.33 102.076 -176.602 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.36 134.72 42.88 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.191 -1.568 . . . . 11.66 111.455 168.245 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -109.5 120.75 43.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 113.317 -3.23 . . . . 16.3 112.115 -163.993 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.7 tp -94.43 117.88 30.79 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.686 1.866 . . . . 9.96 108.51 -170.292 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.55 149.3 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.293 -1.504 . . . . 9.76 107.625 167.283 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.264 80.2 mt -97.8 151.07 20.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.481 -1.387 . . . . 19.57 113.589 -179.06 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -137.52 172.03 13.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.866 -1.771 . . . . 35.08 107.906 164.005 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.34 41.7 mt -96.77 -82.66 0.4 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.303 -1.498 . . . . 32.31 114.041 174.253 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -107.99 -42.54 4.65 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.703 -2.498 . . . . 42.75 113.14 -171.612 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.18 169.4 38.29 Favored Glycine 0 N--CA 1.429 -1.767 0 C-N-CA 118.85 -1.643 . . . . 36.31 109.349 -176.546 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 0 CA-C-O 117.633 -1.648 . . . . 36.27 110.843 179.246 . . . . . . . . 0 0 . 1 . 098 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 114.311 1.226 . . . . 17.17 114.311 . . . . . . . . . 0 0 . 1 . 098 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.259 61.8 mt-30 -98.4 135.58 39.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.183 1.793 . . . . 21.89 107.28 171.306 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.313 18.3 pt -131.23 150.64 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.416 -2.053 . . . . 10.83 110.14 166.947 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.255 17.5 m-85 -115.78 111.57 20.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.108 2.163 . . . . 10.61 112.713 -172.675 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.4 t -96.92 121.51 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.65 -1.281 . . . . 9.13 107.943 177.459 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.29 38.6 ttmt -114.27 133.68 55.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.144 -1.408 . . . . 20.55 113.107 -170.844 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.8 p -83.9 173.54 11.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 127.982 3.302 . . . . 11.78 114.429 178.248 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 mt -75.93 -29.48 58.39 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.642 2.46 . . . . 19.31 117.642 -178.686 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -68.07 -64.53 0.84 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.072 2.549 . . . . 23.14 107.367 169.846 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.26 51.72 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 104.656 -3.378 . . . . 19.74 104.656 170.016 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -97.13 125.64 41.76 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.161 2.984 . . . . 21.93 108.757 161.019 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -99.19 127.68 45.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.063 -2.273 . . . . 12.33 106.0 176.662 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.55 115.77 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 128.741 2.816 . . . . 17.08 111.297 161.576 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.3 m -84.8 124.74 31.91 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 119.327 0.967 . . . . 16.3 112.005 165.037 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.18 128.43 56.36 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 126.969 2.668 . . . . 15.88 104.733 -175.645 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -99.77 110.92 23.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.577 -2.749 . . . . 28.9 103.577 178.843 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.4 155.55 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 117.863 -1.065 . . . . 12.05 110.264 -169.477 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -104.08 139.23 19.9 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 115.933 -1.984 . . . . 18.17 112.153 171.166 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.66 -15.56 21.58 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 126.165 3.237 . . . . 8.16 111.369 -158.484 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.3 p -82.45 -1.8 51.3 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 121.121 3.749 . . . . 11.13 121.121 -177.414 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -89.1 174.2 8.01 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.922 3.689 . . . . 18.03 110.384 -179.036 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.4 p -91.51 157.43 17.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.482 -3.261 . . . . 10.22 113.843 -173.671 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mt -73.89 -31.21 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.056 -2.572 . . . . 12.3 104.056 172.96 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -40.23 -48.74 2.63 Favored 'General case' 0 N--CA 1.43 -1.429 2 O-C-N 114.13 -5.356 . . . . 36.51 110.656 164.982 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.306 8.8 t-20 -61.73 -41.82 98.15 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.026 2.93 . . . . 25.66 112.956 177.744 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -59.35 -45.19 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 125.436 1.495 . . . . 8.12 111.352 174.976 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -68.91 -40.63 78.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.686 3.194 . . . . 15.47 109.315 -179.087 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.32 -26.3 68.42 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.508 3.123 . . . . 11.45 111.886 176.493 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -72.18 -37.68 69.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.269 1.85 . . . . 24.98 111.594 172.496 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mt -76.49 -29.03 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 125.809 1.644 . . . . 9.46 109.879 178.43 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.27 -50.34 74.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.885 -3.01 . . . . 14.76 110.641 165.873 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.09 -68.27 0.26 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 129.158 2.983 . . . . 26.29 112.712 179.974 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -71.68 -62.87 1.26 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 114.719 -2.562 . . . . 30.06 115.197 -176.541 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -72.1 -51.18 22.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.403 2.049 . . . . 25.19 113.549 -175.079 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.74 38.83 1.52 Allowed Glycine 0 N--CA 1.43 -1.718 0 O-C-N 116.716 -3.74 . . . . 7.41 113.934 -179.509 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.272 78.9 mt -124.92 124.51 25.47 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 103.311 -2.848 . . . . 9.49 103.311 -174.249 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -76.84 175.82 10.9 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-O 114.904 -2.207 . . . . 11.42 110.789 -171.38 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HA ' ' HG2' ' A' ' 41' ' ' GLN . 49.0 Cg_endo -74.85 -32.84 5.29 Favored 'Trans proline' 0 C--N 1.299 -2.027 1 C-N-CA 126.53 4.82 . . . . 12.0 110.759 171.925 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.272 11.6 t70 -58.26 -42.55 86.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.401 1.08 . . . . 35.55 113.809 176.322 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -79.54 -38.71 33.59 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.248 2.219 . . . . 20.52 112.314 -178.66 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 38' ' ' PRO . 5.6 pt20 -80.08 167.28 20.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 127.342 3.448 . . . . 7.13 118.71 -175.31 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -131.43 121.8 25.18 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.612 -3.18 . . . . 36.39 111.975 162.086 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.3 tp -108.66 119.0 38.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.24 -1.393 . . . . 9.55 107.24 -170.469 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 44' ' ' ILE . 56.1 mt -118.31 135.67 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.959 -2.963 . . . . 13.9 113.128 -169.68 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -118.7 109.54 16.22 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.879 -3.013 . . . . 6.86 106.323 167.798 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.4 -92.85 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.385 3.074 . . . . 11.15 113.566 -172.371 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.04 -37.89 8.16 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 119.486 -2.009 . . . . 13.93 116.611 175.545 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -107.71 146.56 31.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 124.794 0.938 . . . . 23.92 112.546 -159.742 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -81.02 138.37 36.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.43 2.538 . . . . 23.23 112.699 171.9 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.2 mt -89.78 114.83 26.61 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.757 -3.715 . . . . 9.11 112.306 -175.914 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.85 143.98 27.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.26 -2.15 . . . . 33.44 114.578 -173.084 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.8 -49.86 72.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.61 3.164 . . . . 28.37 112.447 -165.875 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.12 -4.63 77.78 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 118.325 2.09 . . . . 15.0 118.325 -163.303 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -84.06 178.94 7.64 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.776 3.179 . . . . 25.5 113.854 166.105 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.5 p -110.83 175.84 5.27 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.732 -3.105 . . . . 11.95 104.651 -177.667 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.49 -26.9 32.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.152 2.181 . . . . 10.17 105.374 -178.589 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.1 p -65.99 -36.33 83.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 131.461 3.905 . . . . 13.59 113.147 174.264 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.4 -52.84 63.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 126.972 2.67 . . . . 11.7 116.001 171.048 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -67.56 -17.49 64.66 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.767 1.627 . . . . 12.95 111.357 176.822 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 59.51 55.08 4.27 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.545 2.338 . . . . 25.45 111.754 -170.405 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 61' ' ' ILE . 57.0 mt -86.79 116.96 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 104.038 -2.579 . . . . 14.6 104.038 -178.417 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -98.3 159.69 14.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 126.925 2.641 . . . . 33.23 110.011 -178.212 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -52.18 131.98 32.97 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.878 2.071 . . . . 25.97 112.909 -178.051 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 73.09 32.57 1.29 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.716 -2.947 . . . . 32.61 111.938 176.666 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -75.66 141.49 42.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.843 1.783 . . . . 10.56 110.636 169.48 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -86.54 120.48 27.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.505 -2.035 . . . . 5.33 105.505 171.63 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.86 146.73 38.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.754 1.622 . . . . 11.66 106.827 175.959 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -117.73 140.57 49.49 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.422 2.058 . . . . 16.3 108.134 -172.177 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 tp -119.68 135.69 54.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.024 -2.954 . . . . 9.96 103.024 -174.534 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 71' ' ' LEU . 2.3 t -135.03 -176.6 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.381 2.672 . . . . 9.76 105.283 174.805 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.568 ' H ' HG12 ' A' ' 70' ' ' VAL . 7.2 mt -92.11 167.49 12.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.792 2.037 . . . . 19.57 108.973 169.111 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -105.2 115.08 29.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.699 1.714 . . . . 35.08 108.716 171.108 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.4 tp -67.02 -61.31 2.0 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.508 -2.187 . . . . 32.31 112.44 178.9 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -146.84 -104.13 0.09 Allowed 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 122.825 2.557 . . . . 42.75 108.182 172.313 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.05 157.81 28.34 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 108.952 -1.659 . . . . 36.31 108.952 171.544 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.729 0 CA-C-O 117.179 -1.901 . . . . 36.27 112.833 -169.624 . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tmm? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 112.485 0.55 . . . . 17.17 112.485 . . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -85.83 123.47 31.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.206 1.402 . . . . 21.89 108.066 -178.659 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.496 HD12 HD22 ' A' ' 67' ' ' LEU . 39.6 pt -106.29 161.01 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.871 -2.393 . . . . 10.83 109.769 151.855 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -114.23 131.81 56.35 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.851 -3.389 . . . . 10.61 101.851 -178.765 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.95 102.83 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 101.867 -3.383 . . . . 9.13 101.867 -178.079 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -94.89 128.5 41.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.174 2.19 . . . . 20.55 116.403 -173.206 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.267 18.9 p -89.41 173.17 8.51 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.121 -2.862 . . . . 11.78 116.407 -177.012 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.95 -48.56 15.99 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.118 -2.239 . . . . 19.31 109.004 174.502 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -67.69 -46.98 70.72 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.929 3.291 . . . . 23.14 107.188 -168.54 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.63 24.58 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 116.074 -2.514 . . . . 19.74 118.799 173.083 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -110.89 124.91 53.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 120.082 1.941 . . . . 21.93 107.243 -174.489 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 m -105.53 114.1 28.06 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.729 -1.857 . . . . 12.33 109.846 171.745 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -95.34 122.1 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 103.698 -2.705 . . . . 17.08 103.698 -165.735 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -91.48 110.92 22.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.985 -2.969 . . . . 16.3 102.985 175.244 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.5 mt -106.26 136.77 45.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.986 1.314 . . . . 15.88 108.404 169.126 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -93.58 116.02 28.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.342 2.02 . . . . 28.9 108.938 169.275 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.85 167.57 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.529 3.132 . . . . 12.05 110.694 175.487 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -105.64 158.44 32.31 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 114.485 -2.674 . . . . 18.17 110.878 157.68 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -74.38 -25.12 13.54 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 126.174 3.241 . . . . 8.16 117.478 -172.453 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -75.24 -11.4 60.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 131.223 3.809 . . . . 11.13 115.788 163.629 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -72.46 158.24 36.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.998 2.333 . . . . 18.03 113.522 178.382 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -92.98 161.41 14.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.244 -3.41 . . . . 10.22 112.478 -173.926 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.7 mt -82.82 -8.75 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 126.661 2.476 . . . . 12.3 111.224 -179.398 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -57.7 -54.91 41.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.941 -2.349 . . . . 36.51 111.313 166.421 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -61.27 -16.08 41.85 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 116.291 -4.005 . . . . 25.66 115.012 168.776 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -74.64 -43.93 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 CA-C-N 126.381 4.173 . . . . 8.12 108.302 167.906 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -67.15 -32.29 73.3 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.311 1.869 . . . . 15.47 114.79 175.51 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.98 -25.14 58.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.108 1.892 . . . . 11.45 116.108 172.176 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -74.08 -30.58 62.44 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.493 1.497 . . . . 24.98 107.052 178.233 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.402 HG22 ' HB ' ' A' ' 36' ' ' ILE . 37.9 mm -69.9 -34.67 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 118.368 -0.825 . . . . 9.46 111.857 173.639 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -65.13 -43.49 91.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.802 2.841 . . . . 14.76 109.741 173.466 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.02 -56.77 14.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 117.49 2.404 . . . . 26.29 117.49 176.311 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 14.7 mmtm -56.53 -65.16 0.66 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.875 3.27 . . . . 30.06 112.235 173.322 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -101.17 -36.03 9.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.682 -1.145 . . . . 25.19 113.133 -159.673 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.08 4.72 31.08 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 118.231 -2.793 . . . . 7.41 114.078 -177.402 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.402 ' HB ' HG22 ' A' ' 30' ' ' ILE . 9.6 mt -88.34 112.25 48.6 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-O 116.831 -1.557 . . . . 9.49 109.121 -173.02 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -81.74 -176.7 3.17 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 122.568 1.953 . . . . 11.42 114.472 -171.819 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -74.4 -16.31 21.91 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 122.412 2.074 . . . . 12.0 115.764 -178.924 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.42 -24.08 42.77 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.88 2.752 . . . . 35.55 116.614 -175.904 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -98.33 -35.52 10.29 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.501 -2.136 . . . . 20.52 110.057 -168.587 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -91.89 166.26 12.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.635 -1.29 . . . . 7.13 108.515 -172.333 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.2 139.02 37.39 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 131.778 4.031 . . . . 36.39 104.102 165.632 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.1 mt -104.2 132.9 49.96 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.647 1.979 . . . . 9.55 106.401 178.069 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.02 142.07 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.809 -1.807 . . . . 13.9 107.846 177.514 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -148.83 108.54 4.02 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.308 -2.12 . . . . 6.86 108.484 -175.066 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 57.05 -114.31 0.81 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 120.541 3.534 . . . . 11.15 120.541 -158.54 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.34 -36.53 20.39 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.605 -1.31 . . . . 13.93 114.607 -178.901 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -116.06 170.49 8.46 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 120.729 2.264 . . . . 23.92 114.499 -162.54 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.19 146.54 24.99 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 102.799 -3.037 . . . . 23.23 102.799 -176.676 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.8 mt -99.86 128.79 45.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.489 -2.782 . . . . 9.11 103.489 -166.397 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -75.3 153.81 37.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.736 1.614 . . . . 33.44 113.868 168.76 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.55 -61.69 1.73 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.782 -3.699 . . . . 28.37 108.56 -162.671 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.93 59.2 3.21 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 122.297 2.317 . . . . 15.0 111.147 -169.438 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -140.72 153.07 45.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.472 2.309 . . . . 25.5 106.987 -177.354 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.25 46.7 p -82.94 154.53 24.5 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.674 -2.516 . . . . 11.95 113.174 -173.151 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.631 HD23 HD12 ' A' ' 61' ' ' ILE . 17.5 mt -63.88 -39.52 94.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.933 -2.354 . . . . 10.17 111.642 165.503 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 p -54.59 -37.5 65.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.408 2.744 . . . . 13.59 118.408 172.578 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.37 -50.35 53.76 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.287 -5.258 . . . . 11.7 113.941 174.745 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -69.88 -14.09 62.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.295 2.638 . . . . 12.95 114.03 -177.909 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.492 27.6 m-20 75.23 41.15 0.3 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 116.963 2.209 . . . . 25.45 116.963 -176.289 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.631 HD12 HD23 ' A' ' 56' ' ' LEU . 71.7 mt -83.0 116.12 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 118.21 -2.806 . . . . 14.6 107.77 177.522 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -97.95 167.46 10.9 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.615 -0.721 . . . . 33.23 110.012 -176.65 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -70.23 144.65 51.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 120.874 1.67 . . . . 25.97 112.605 -174.86 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 67.16 21.5 10.04 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.661 3.6 . . . . 32.61 112.134 176.81 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 t -97.67 151.61 19.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.896 -2.378 . . . . 10.56 108.682 -178.081 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.8 m -101.47 111.3 23.5 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.244 2.618 . . . . 5.33 113.07 -168.502 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.496 HD22 HD12 ' A' ' 3' ' ' ILE . 9.2 mp -90.88 145.89 24.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.293 2.637 . . . . 11.66 106.206 164.065 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -97.26 132.46 42.98 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 119.824 -0.75 . . . . 16.3 112.583 171.48 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 tp -95.03 121.01 36.22 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.432 -1.692 . . . . 9.96 106.432 166.732 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.76 153.77 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 114.959 -2.448 . . . . 9.76 105.596 178.699 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.6 mt -112.18 176.05 5.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 124.692 3.406 . . . . 19.57 107.465 175.541 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -107.93 143.12 37.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.909 2.929 . . . . 35.08 118.909 -174.398 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.1 tp -84.15 -60.88 1.96 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 117.042 -1.863 . . . . 32.31 108.267 -173.854 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -96.61 -38.39 9.97 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.757 1.223 . . . . 42.75 109.191 -171.181 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.87 -51.13 0.51 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 106.522 -2.631 . . . . 36.31 106.522 -179.448 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.781 0 O-C-N 119.118 -2.401 . . . . 36.27 108.94 -175.358 . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttp . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 123.704 1.716 . . . . 17.17 107.499 . . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -99.98 116.61 32.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.613 2.765 . . . . 21.89 111.036 175.776 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -124.83 167.69 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 106.79 -1.559 . . . . 10.83 106.79 178.884 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -122.48 115.82 22.88 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.663 -1.273 . . . . 10.61 110.823 -169.364 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.05 123.48 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 121.295 -0.878 . . . . 9.13 109.128 171.351 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HD2' HG21 ' A' ' 66' ' ' THR . 85.2 mttt -117.38 137.17 52.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.171 1.788 . . . . 20.55 108.846 -175.907 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -102.94 -176.77 3.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.488 1.742 . . . . 11.78 109.035 -175.16 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.266 95.9 mt -69.93 -27.1 64.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.805 2.442 . . . . 19.31 116.698 -172.091 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -96.2 -89.08 0.26 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.451 2.3 . . . . 23.14 111.079 -177.679 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.74 36.85 0.47 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.811 -3.681 . . . . 19.74 111.321 168.765 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -97.04 137.96 35.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 116.732 -1.987 . . . . 21.93 109.721 179.423 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.3 m -123.26 121.97 37.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.36 1.552 . . . . 12.33 107.103 171.144 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.9 mt -101.38 119.35 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 103.382 -2.822 . . . . 17.08 103.382 179.96 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -89.36 105.34 17.73 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.237 1.494 . . . . 16.3 108.874 165.241 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.7 mt -92.13 146.12 23.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.602 3.572 . . . . 15.88 106.076 -178.32 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -95.2 108.56 20.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.284 -2.689 . . . . 28.9 112.33 171.272 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.86 -177.28 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.439 -1.689 . . . . 12.05 106.439 -176.183 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -132.63 159.9 70.58 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 119.157 -2.215 . . . . 18.17 107.279 164.547 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -77.48 -16.03 15.33 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 O-C-N 116.417 -2.464 . . . . 8.16 114.691 -168.131 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 m -90.11 9.09 29.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 116.425 -2.11 . . . . 11.13 114.665 177.605 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -86.9 162.54 17.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.755 2.693 . . . . 18.03 113.703 165.048 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 69.2 p -99.56 169.79 9.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.84 2.733 . . . . 10.22 112.622 -170.7 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.372 36.8 mm -52.89 -32.72 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 116.164 1.913 . . . . 12.3 116.164 171.78 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.24 -28.65 69.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.933 -3.604 . . . . 36.51 116.263 170.769 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -75.79 -20.21 58.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.995 -2.315 . . . . 25.66 113.825 171.423 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.7 t -83.6 -45.33 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 116.694 -1.622 . . . . 8.12 107.392 -179.491 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -63.58 -31.58 72.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.656 2.383 . . . . 15.47 110.94 173.682 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.6 -25.05 68.05 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 117.525 -1.67 . . . . 11.45 114.251 175.181 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -90.29 -15.24 31.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 116.702 -3.749 . . . . 24.98 115.768 173.3 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mm -80.44 -24.6 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 126.159 2.162 . . . . 9.46 110.59 167.88 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -81.82 -26.77 34.06 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.524 1.93 . . . . 14.76 108.478 -177.537 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.89 -68.9 0.38 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.566 -3.208 . . . . 26.29 111.497 164.542 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -73.64 -49.36 26.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.11 1.893 . . . . 30.06 116.11 -169.375 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -86.81 -47.82 8.74 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.666 2.03 . . . . 25.19 113.396 178.95 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.06 59.11 1.51 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.288 3.804 . . . . 7.41 107.152 169.33 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 40' ' ' GLN . 15.9 mm -102.41 140.0 20.74 Favored Pre-proline 0 N--CA 1.43 -1.469 0 O-C-N 129.099 3.47 . . . . 9.49 104.004 177.79 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -62.07 161.22 26.99 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 O-C-N 114.304 -3.577 . . . . 11.42 115.953 173.582 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -72.66 -27.49 15.14 Favored 'Trans proline' 0 N--CA 1.434 -1.987 1 CA-C-N 128.85 4.196 . . . . 12.0 110.682 -168.408 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -87.13 -24.08 24.64 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.669 2.84 . . . . 35.55 118.669 179.425 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.408 ' HB3' HG22 ' A' ' 36' ' ' ILE . 11.0 tt0 -66.9 -42.06 86.08 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.828 2.529 . . . . 20.52 117.828 172.624 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -72.64 131.74 42.82 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.117 3.377 . . . . 7.13 120.117 176.155 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -131.9 104.96 7.14 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.685 1.994 . . . . 36.39 108.624 -170.082 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.1 mt -83.84 112.43 20.11 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 115.22 -4.675 . . . . 9.55 114.293 174.84 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.7 mt -99.89 115.81 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 114.041 -1.436 . . . . 13.9 111.585 175.402 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -108.21 120.65 42.96 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.06 -1.65 . . . . 6.86 106.55 163.436 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.52 . . 69.21 -111.16 0.09 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.627 -2.546 . . . . 11.15 111.65 -176.77 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.69 6.15 12.6 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 116.507 -2.758 . . . . 13.93 108.58 172.027 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -86.39 139.22 31.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.468 -2.783 . . . . 23.92 111.702 -158.15 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -89.41 125.16 35.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 102.998 -2.964 . . . . 23.23 102.998 166.132 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 mt -94.33 144.18 25.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.544 2.116 . . . . 9.11 110.447 -167.806 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -90.68 130.46 36.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.622 -2.549 . . . . 33.44 116.402 172.686 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -36.54 -51.1 0.82 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.992 4.517 . . . . 28.37 119.612 176.074 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.29 20.9 36.58 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 114.23 -1.35 . . . . 15.0 113.773 -169.341 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mtt-85 -93.3 163.91 13.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.146 -2.973 . . . . 25.5 110.468 160.872 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 38.0 p -104.74 158.16 16.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.037 -1.664 . . . . 11.95 108.276 -173.978 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -56.06 -35.88 67.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.728 2.68 . . . . 10.17 115.522 -179.648 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.7 p -63.04 -48.2 79.75 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 136.82 6.048 . . . . 13.59 113.653 169.663 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -60.35 -44.78 95.24 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.579 1.952 . . . . 11.7 112.896 176.803 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -74.7 -10.41 59.49 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 116.239 -4.038 . . . . 12.95 114.323 173.96 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.394 60.5 m-80 71.33 36.08 1.41 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.93 2.492 . . . . 25.45 112.313 178.803 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.9 mt -87.87 86.18 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 125.604 1.815 . . . . 14.6 109.52 -175.776 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -77.04 -178.1 4.81 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 125.708 1.88 . . . . 33.23 114.5 -173.408 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -72.29 135.72 46.05 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.797 1.639 . . . . 25.97 110.463 -178.69 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.306 47.6 mt-10 61.91 35.21 16.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.241 1.02 . . . . 32.61 112.377 -176.304 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.288 0.2 OUTLIER -105.47 147.23 28.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.466 -2.152 . . . . 10.56 109.587 172.224 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.439 HG21 ' HD2' ' A' ' 6' ' ' LYS . 61.9 m -122.65 120.42 33.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.728 2.204 . . . . 5.33 112.586 -157.198 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -101.89 130.23 48.33 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 130.337 3.455 . . . . 11.66 109.959 -177.393 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -102.7 104.23 14.54 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.348 -3.97 . . . . 16.3 104.953 -174.208 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.5 tp -80.05 119.37 22.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.479 -2.045 . . . . 9.96 105.479 172.957 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.06 141.01 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 126.223 2.202 . . . . 9.76 108.361 170.739 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.5 mt -95.72 146.8 24.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 112.99 0.737 . . . . 19.57 112.99 177.395 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -97.25 158.01 15.67 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.706 -1.59 . . . . 35.08 106.706 179.174 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 mt -67.96 -61.94 1.64 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.916 -2.99 . . . . 32.31 115.807 166.535 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.8 ttt-85 -83.25 -36.94 24.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.904 -1.748 . . . . 42.75 114.682 -169.973 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.48 51.44 3.29 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 119.541 -1.975 . . . . 36.31 117.089 -177.694 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.715 0 C-N-CA 117.364 -2.351 . . . . 36.27 112.36 -176.876 . . . . . . . . 0 0 . 1 . 101 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 115.456 1.65 . . . . 17.17 115.456 . . . . . . . . . 0 0 . 1 . 101 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -80.55 118.88 22.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.881 -3.012 . . . . 21.89 118.336 -179.924 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 pt -100.8 165.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 126.957 2.103 . . . . 10.83 111.819 168.937 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.294 15.8 m-30 -123.15 112.6 17.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.838 -2.414 . . . . 10.61 112.656 -176.016 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.3 t -90.91 105.38 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 117.972 -2.955 . . . . 9.13 117.206 170.46 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -88.99 137.11 32.62 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 124.208 1.956 . . . . 20.55 115.343 -175.591 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.1 p -87.15 178.41 6.9 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 113.314 -5.866 . . . . 11.78 110.648 -176.183 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tp -58.63 -50.02 75.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.473 -3.892 . . . . 19.31 114.681 173.006 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -77.78 -38.63 46.25 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 116.211 -4.056 . . . . 23.14 112.99 -177.412 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.76 52.18 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.999 -1.688 . . . . 19.74 115.485 169.589 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -111.3 126.74 55.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.906 1.336 . . . . 21.93 107.924 179.331 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -86.06 116.08 24.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.573 -2.58 . . . . 12.33 111.789 169.936 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.4 mt -92.97 117.27 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 112.969 0.729 . . . . 17.08 112.969 168.254 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.0 m -88.11 122.26 31.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 119.118 -2.238 . . . . 16.3 109.936 177.865 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.8 mt -115.36 131.13 57.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.602 2.62 . . . . 15.88 111.52 172.553 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -87.75 103.25 15.44 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.504 2.722 . . . . 28.9 105.146 -177.068 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.405 HG12 ' HE3' ' A' ' 29' ' ' LYS . 28.4 m -119.33 167.8 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 105.662 -1.977 . . . . 12.05 105.662 -178.321 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -123.56 147.05 51.81 Favored Pre-proline 0 N--CA 1.431 -1.402 0 C-N-CA 126.471 1.908 . . . . 18.17 106.407 176.609 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -67.52 -22.5 44.71 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 O-C-N 115.796 -2.791 . . . . 8.16 117.245 -158.094 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 m -94.53 33.85 1.38 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 123.934 3.061 . . . . 11.13 113.612 171.34 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -84.92 139.14 32.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 127.193 3.378 . . . . 18.03 113.243 162.665 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 p -80.05 163.07 24.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.651 -2.068 . . . . 10.22 112.614 176.275 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.91 -26.04 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.712 -1.868 . . . . 12.3 112.321 -179.624 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.398 15.2 pt-20 -60.58 -28.38 68.43 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.687 2.106 . . . . 36.51 116.687 168.959 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.293 5.7 t-20 -72.83 -37.92 67.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.955 3.302 . . . . 25.66 111.152 173.719 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 39.6 t -52.34 -53.93 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 129.213 3.005 . . . . 8.12 111.59 173.55 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -69.76 -11.01 60.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.728 3.211 . . . . 15.47 112.184 -179.303 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.44 -44.7 70.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 121.423 1.919 . . . . 11.45 107.623 174.074 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HE3' HG12 ' A' ' 17' ' ' VAL . 64.0 mttm -76.0 -37.81 58.07 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.346 2.659 . . . . 24.98 106.023 -168.247 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.315 8.8 mm -57.37 -35.51 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 118.594 2.813 . . . . 9.46 118.594 171.233 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -71.46 -40.4 70.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.473 2.709 . . . . 14.76 114.895 167.339 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -60.3 -67.26 0.41 Allowed 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 128.23 3.871 . . . . 26.29 111.495 169.687 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -72.62 -50.97 21.69 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 110.502 -7.624 . . . . 30.06 112.48 -160.629 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -97.1 -71.64 0.67 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.112 1.911 . . . . 25.19 111.479 175.104 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.41 26.01 0.5 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 116.276 -2.869 . . . . 7.41 120.178 -175.662 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.53 133.5 28.09 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 115.323 -2.275 . . . . 9.49 107.72 -178.519 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -73.49 160.09 45.07 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 126.566 3.381 . . . . 11.42 114.639 179.525 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.5 -16.06 9.53 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 123.552 2.835 . . . . 12.0 110.521 -162.266 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -82.03 -37.61 26.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 125.056 3.571 . . . . 35.55 114.474 -179.899 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -69.49 -27.57 65.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.636 2.458 . . . . 20.52 117.636 -178.139 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -87.65 139.24 30.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.33 -1.359 . . . . 7.13 107.33 -174.318 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -106.63 142.59 36.03 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 105.007 -2.22 . . . . 36.39 105.007 165.526 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.4 mt -118.96 108.85 15.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.704 -3.122 . . . . 9.55 112.879 171.119 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mt -92.82 137.86 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.441 -1.689 . . . . 13.9 106.441 -177.363 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -110.38 118.95 37.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.304 2.241 . . . . 6.86 105.576 167.125 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.18 -96.63 0.05 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.919 1.288 . . . . 11.15 111.899 -167.277 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.86 5.55 6.13 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 117.36 -3.337 . . . . 13.93 112.065 172.769 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -82.03 152.65 26.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.609 -2.701 . . . . 23.92 110.487 -168.079 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -92.02 124.62 36.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.94 -1.505 . . . . 23.23 112.361 169.098 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.2 mt -104.72 168.7 8.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.693 1.246 . . . . 9.11 112.467 -175.173 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -132.06 166.44 21.74 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.643 1.977 . . . . 33.44 107.374 -178.403 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -93.9 -42.86 8.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.913 -1.742 . . . . 28.37 111.104 -149.305 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.83 44.96 1.44 Allowed Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 118.462 -1.828 . . . . 15.0 115.193 -179.042 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -120.82 159.12 26.12 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.486 2.314 . . . . 25.5 107.748 173.293 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -97.98 160.31 14.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.384 1.564 . . . . 11.95 114.506 -169.461 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.52 -38.83 82.03 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.902 -1.749 . . . . 10.17 112.496 168.179 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 p -52.73 -45.6 67.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 118.498 2.777 . . . . 13.59 118.498 171.281 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.47 -41.68 96.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 114.549 -2.644 . . . . 11.7 114.92 176.436 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -78.91 -10.13 59.72 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.41 2.368 . . . . 12.95 115.13 172.966 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.422 1.0 OUTLIER 71.82 42.7 0.61 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.776 1.769 . . . . 25.45 115.776 -178.832 . . . . . . . . 3 3 . 1 . 101 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.5 mt -88.11 111.84 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 1 O-C-N 129.418 4.199 . . . . 14.6 108.756 -177.4 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.319 40.1 mt-30 -93.1 -175.55 3.89 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.876 -3.64 . . . . 33.23 110.671 -177.938 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttt -69.69 147.36 50.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.053 -1.655 . . . . 25.97 112.722 171.571 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 56.26 41.57 29.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.652 2.381 . . . . 32.61 116.786 -168.122 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.6 m -104.34 145.61 30.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 125.023 1.452 . . . . 10.56 107.441 178.82 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -105.81 124.02 48.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.593 2.14 . . . . 5.33 106.221 -165.578 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.3 mt -104.34 143.03 33.53 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.108 -3.495 . . . . 11.66 106.751 168.499 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -98.84 111.33 23.75 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.264 1.95 . . . . 16.3 116.264 -179.524 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.88 108.36 5.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.251 -3.406 . . . . 9.96 109.249 179.747 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 t -117.04 149.32 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 104.818 -2.29 . . . . 9.76 104.818 177.206 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 tp -95.83 135.23 37.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.833 2.16 . . . . 19.57 116.833 171.212 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -87.65 155.58 19.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.732 3.145 . . . . 35.08 109.433 -179.707 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.8 tp -86.81 -62.47 1.5 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.566 2.439 . . . . 32.31 111.716 -176.163 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -77.32 -43.85 31.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.513 1.052 . . . . 42.75 112.054 177.338 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.79 17.91 59.07 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-O 116.936 -2.036 . . . . 36.31 115.685 -175.496 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.775 0 CA-C-N 123.226 3.513 . . . . 36.27 104.872 177.737 . . . . . . . . 0 0 . 1 . 102 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 124.191 1.948 . . . . 17.17 111.683 . . . . . . . . . 0 0 . 1 . 102 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -76.85 119.51 20.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.397 -2.69 . . . . 21.89 110.334 -178.775 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.4 pt -112.06 154.66 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.614 -1.254 . . . . 10.83 107.614 169.548 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.24 133.02 52.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 126.568 3.08 . . . . 10.61 108.643 175.152 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -110.91 117.81 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 126.812 2.045 . . . . 9.13 111.17 165.437 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.22 135.57 55.11 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.557 -1.339 . . . . 20.55 108.289 -170.752 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.8 p -95.32 179.81 5.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.803 1.287 . . . . 11.78 109.421 -163.501 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 tp -71.99 -46.46 57.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.111 1.91 . . . . 19.31 114.851 173.618 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -73.21 -40.14 64.98 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.259 -2.15 . . . . 23.14 115.546 175.842 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.17 64.65 0.15 Allowed Glycine 0 N--CA 1.431 -1.691 0 CA-C-O 122.897 1.276 . . . . 19.74 111.715 176.254 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -123.99 136.48 54.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.708 2.194 . . . . 21.93 108.016 159.263 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -105.01 108.22 19.62 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.973 -2.329 . . . . 12.33 112.69 168.451 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.02 126.21 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.041 -1.662 . . . . 17.08 109.054 178.64 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -96.91 111.63 23.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.875 1.065 . . . . 16.3 113.875 179.465 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.3 mt -96.59 138.57 33.97 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.119 -2.863 . . . . 15.88 110.498 -176.025 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -107.28 73.35 0.92 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.389 2.995 . . . . 28.9 110.915 -175.394 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -102.46 169.47 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 O-C-N 115.792 -4.318 . . . . 12.05 106.798 -175.143 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -95.87 159.09 33.13 Favored Pre-proline 0 N--CA 1.43 -1.453 1 O-C-N 130.002 4.564 . . . . 18.17 106.871 174.647 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.25 -26.68 20.64 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 O-C-N 126.268 2.72 . . . . 8.16 110.964 172.645 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 p -72.64 -7.09 48.56 Favored 'General case' 0 N--CA 1.43 -1.453 1 CA-C-N 127.237 4.562 . . . . 11.13 112.742 175.915 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -77.67 154.14 32.43 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 123.196 2.725 . . . . 18.03 112.724 -175.19 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 64.4 p -89.34 151.33 22.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.302 3.041 . . . . 10.22 110.95 178.976 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.25 39.7 mm -56.97 -30.26 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.308 2.643 . . . . 12.3 114.198 178.691 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -49.25 -45.56 44.9 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.974 -2.954 . . . . 36.51 113.733 166.303 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -68.91 -37.0 78.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 124.249 0.968 . . . . 25.66 111.266 177.987 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.62 -40.31 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 113.741 1.015 . . . . 8.12 113.741 -179.678 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.26 49.8 mtpt -59.1 -48.88 79.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.544 2.737 . . . . 15.47 112.823 174.521 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.87 -32.33 63.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.867 3.267 . . . . 11.45 111.094 172.581 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -74.27 -39.82 62.72 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 124.005 3.093 . . . . 24.98 109.455 -177.374 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD13 HD22 ' A' ' 69' ' ' LEU 0.326 81.8 mt -59.36 -37.52 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 129.991 3.317 . . . . 9.46 112.732 173.928 . . . . . . . . 3 3 . 1 . 102 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -59.91 -54.36 47.08 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.555 1.525 . . . . 14.76 112.9 167.039 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.23 -51.41 68.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.702 1.239 . . . . 26.29 112.123 -173.723 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -78.17 -69.54 0.55 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.364 2.666 . . . . 30.06 114.351 179.398 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -87.29 -11.24 50.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.087 2.254 . . . . 25.19 117.087 -170.34 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.68 20.52 34.09 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 128.151 2.786 . . . . 7.41 116.253 160.895 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mm -113.32 125.45 29.65 Favored Pre-proline 0 N--CA 1.43 -1.459 0 O-C-N 120.493 -1.592 . . . . 9.49 110.036 -173.164 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.309 53.9 Cg_exo -76.55 167.58 25.29 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-O 115.423 -1.991 . . . . 11.42 116.61 -173.968 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -63.9 -23.5 68.29 Favored 'Trans proline' 0 C--N 1.3 -2.019 1 C-N-CA 126.533 4.822 . . . . 12.0 115.907 -170.445 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -89.89 -21.81 22.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 124.008 3.095 . . . . 35.55 112.258 177.277 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -75.72 -9.54 58.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.627 -2.606 . . . . 20.52 116.1 -176.893 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -112.1 150.54 30.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.102 2.751 . . . . 7.13 114.656 -167.502 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -127.22 93.25 3.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.851 -1.781 . . . . 36.39 109.357 -176.518 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.9 mt -82.17 91.59 6.74 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 113.831 1.049 . . . . 9.55 113.831 172.24 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.4 mt -91.07 135.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 118.764 -0.636 . . . . 13.9 110.202 -177.816 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -122.66 112.7 18.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.603 -2.369 . . . . 6.86 104.603 179.65 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.86 -108.53 0.44 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.187 -2.196 . . . . 11.15 113.004 -169.721 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.91 -19.66 39.31 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 115.536 -2.813 . . . . 13.93 117.041 167.43 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -105.34 134.08 49.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.791 1.795 . . . . 23.92 114.414 -165.564 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.45 138.4 47.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.303 2.002 . . . . 23.23 112.327 167.636 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.86 141.78 31.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.222 2.209 . . . . 9.11 111.185 -169.099 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -119.62 135.88 54.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.467 1.603 . . . . 33.44 112.791 -166.453 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -48.86 -58.95 4.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.883 2.873 . . . . 28.37 111.882 -160.376 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.57 -10.18 75.28 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 122.85 3.9 . . . . 15.0 122.85 -173.843 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 54' ' ' ARG . 16.4 mmt180 -79.66 156.59 27.52 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.548 1.969 . . . . 25.5 114.95 174.586 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.9 p -93.88 168.81 10.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.748 3.166 . . . . 11.95 108.663 -176.001 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mt -72.64 -40.04 66.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.685 -2.052 . . . . 10.17 106.615 -176.198 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -63.79 -28.66 70.02 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 127.853 3.22 . . . . 13.59 116.139 174.114 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.76 -50.38 69.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.177 3.791 . . . . 11.7 113.406 170.805 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -64.95 -30.73 71.74 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.917 1.821 . . . . 12.95 115.917 167.144 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 49.4 m-80 82.11 41.27 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.43 1 C-N-CA 131.939 4.096 . . . . 25.45 110.921 176.908 . . . . . . . . 3 2 . 1 . 102 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -78.82 92.53 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 CA-C-O 129.469 4.461 . . . . 14.6 108.935 170.919 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -84.66 175.65 9.08 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 113.202 -5.936 . . . . 33.23 111.168 179.707 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -54.03 127.76 27.79 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.278 1.99 . . . . 25.97 116.173 172.201 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 78.37 29.29 0.44 Allowed 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 132.744 4.418 . . . . 32.61 117.016 176.877 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.3 m -81.49 149.03 28.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.955 -1.498 . . . . 10.56 106.955 -169.693 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.7 m -94.43 118.01 31.0 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.701 -2.5 . . . . 5.33 112.492 177.45 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.0 137.6 40.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.508 -3.245 . . . . 11.66 106.039 168.565 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -98.25 109.97 22.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.067 2.247 . . . . 16.3 117.067 169.868 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.422 HD22 HD13 ' A' ' 30' ' ' ILE . 14.2 tp -91.43 105.32 17.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.342 1.857 . . . . 9.96 115.713 -179.944 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -109.32 162.68 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 101.81 -3.404 . . . . 9.76 101.81 178.412 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -116.39 145.68 43.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.267 2.227 . . . . 19.57 112.411 168.78 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -68.34 127.56 33.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.63 2.085 . . . . 35.08 116.63 159.804 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.52 -50.44 67.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.53 -1.981 . . . . 32.31 111.049 171.822 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 -70.45 0.8 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.353 1.061 . . . . 42.75 109.135 -176.547 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.91 -144.34 4.13 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 105.513 -3.035 . . . . 36.31 105.513 -178.232 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.74 0 O-C-N 118.533 -2.745 . . . . 36.27 111.819 -162.825 . . . . . . . . 0 0 . 1 . 103 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 123.628 1.68 . . . . 17.17 108.738 . . . . . . . . . 0 0 . 1 . 103 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -88.66 126.85 35.49 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 111.47 -2.604 . . . . 21.89 111.401 -179.68 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 3' ' ' ILE 0.256 20.8 pt -130.9 159.29 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 107.221 -1.4 . . . . 10.83 107.221 168.721 . . . . . . . . 3 3 . 1 . 103 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -106.89 132.92 52.3 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 118.433 -0.794 . . . . 10.61 109.481 179.414 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.4 t -101.19 112.89 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.219 2.438 . . . . 9.13 111.704 160.325 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -95.73 127.17 41.53 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 113.129 -5.982 . . . . 20.55 112.99 177.274 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -76.87 -177.26 4.28 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.492 -4.505 . . . . 11.78 118.146 178.494 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 tp -79.53 -21.74 44.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.484 2.564 . . . . 19.31 113.658 178.849 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.372 0.1 OUTLIER -75.32 -48.23 24.09 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 116.055 -4.153 . . . . 23.14 108.72 174.219 . . . . . . . . 4 3 . 1 . 103 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.15 20.92 1.11 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 112.749 -2.023 . . . . 19.74 109.593 172.246 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -78.62 117.83 20.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.354 2.502 . . . . 21.93 110.751 173.581 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -88.26 110.96 21.15 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.693 -3.129 . . . . 12.33 114.241 -178.9 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 mt -99.61 107.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.901 2.08 . . . . 17.08 110.983 -172.268 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.2 m -71.97 127.29 32.09 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.101 -1.624 . . . . 16.3 112.835 173.524 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 mt -111.63 151.34 28.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.532 -1.355 . . . . 15.88 114.313 167.303 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -108.96 99.05 8.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.808 2.043 . . . . 28.9 111.253 177.325 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.15 166.13 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.188 -3.445 . . . . 12.05 103.882 -171.801 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -120.0 161.88 36.18 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 118.959 -2.338 . . . . 18.17 106.348 177.656 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.68 -8.54 8.21 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 127.501 3.715 . . . . 8.16 107.73 -155.901 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -76.17 -9.63 58.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 130.153 3.381 . . . . 11.13 109.136 172.168 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -81.99 141.34 33.34 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.58 2.352 . . . . 18.03 112.67 -175.316 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.6 p -88.14 163.15 16.33 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.901 -1.749 . . . . 10.22 108.59 -171.576 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mm -76.42 -17.6 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 125.936 2.023 . . . . 12.3 109.081 -172.595 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -64.26 -30.19 71.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.562 -1.961 . . . . 36.51 116.243 162.259 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -76.17 -36.1 58.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.175 1.39 . . . . 25.66 109.696 -179.887 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.45 -48.74 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 128.865 2.866 . . . . 8.12 115.959 172.752 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.02 -35.9 78.08 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.256 -1.831 . . . . 15.47 114.069 164.728 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.66 -39.25 80.09 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.752 2.978 . . . . 11.45 115.138 173.671 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -57.28 -42.78 82.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 124.371 3.259 . . . . 24.98 115.814 169.205 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.18 -29.79 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 O-C-N 114.18 -5.325 . . . . 9.46 112.625 176.447 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -66.26 -52.7 44.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.603 -2.561 . . . . 14.76 108.504 167.804 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.337 34.1 t70 -51.81 -42.3 62.38 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 114.869 -2.491 . . . . 26.29 115.053 176.349 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -80.99 -86.06 0.09 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 128.944 3.903 . . . . 30.06 112.052 -178.151 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -72.51 -33.68 67.08 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.237 1.94 . . . . 25.19 116.237 -175.275 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.15 39.46 4.53 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.089 -3.507 . . . . 7.41 114.218 -175.945 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mm -100.03 113.4 65.21 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 117.391 -3.417 . . . . 9.49 110.601 175.849 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -64.85 151.56 85.33 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 124.811 3.674 . . . . 11.42 114.075 -176.49 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.23 -9.87 16.39 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-N 127.013 3.54 . . . . 12.0 114.836 -165.605 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.06 -28.56 61.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.216 2.436 . . . . 35.55 107.577 178.406 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -84.62 -20.34 31.53 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.198 -2.189 . . . . 20.52 112.018 -174.764 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -93.53 149.52 21.16 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.17 2.891 . . . . 7.13 114.094 -172.873 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -141.64 126.31 17.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.324 -3.36 . . . . 36.39 108.175 167.146 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.83 121.06 43.98 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 110.048 -3.251 . . . . 9.55 106.864 -175.556 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.7 mt -113.83 135.19 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 1 N-CA-C 98.916 -4.476 . . . . 13.9 98.916 -171.185 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -115.64 103.41 10.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 127.429 2.292 . . . . 6.86 106.479 170.212 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.29 -105.16 0.07 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.154 1.782 . . . . 11.15 114.034 -174.7 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.14 27.29 9.16 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 115.54 -2.811 . . . . 13.93 116.289 170.561 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -147.49 158.97 44.21 Favored 'General case' 0 N--CA 1.43 -1.458 1 CA-C-N 124.363 4.082 . . . . 23.92 111.872 171.822 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.259 15.8 pt20 -85.31 137.81 32.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.501 1.52 . . . . 23.23 110.784 -175.84 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -83.67 131.05 34.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.218 -1.771 . . . . 9.11 106.218 175.043 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -93.97 134.25 36.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.534 1.679 . . . . 33.44 115.534 -179.081 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.66 -46.52 49.81 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 132.073 4.149 . . . . 28.37 111.665 -168.859 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.78 -8.79 87.57 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 129.96 3.648 . . . . 15.0 112.148 -167.761 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -102.7 167.19 10.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.99 -4.241 . . . . 25.5 111.914 -179.522 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.9 p -89.67 170.95 10.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.903 -1.748 . . . . 11.95 108.296 176.327 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.0 mt -72.53 -30.92 64.89 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.629 3.172 . . . . 10.17 110.662 169.3 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 p -65.8 -30.87 71.57 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 132.488 4.315 . . . . 13.59 112.435 179.393 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.87 -44.58 96.54 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.558 -4.464 . . . . 11.7 111.261 175.757 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -78.03 -12.62 60.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.43 2.292 . . . . 12.95 113.017 -177.784 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.439 35.8 m120 65.69 31.53 9.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.64 2.376 . . . . 25.45 116.659 -166.078 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -79.69 125.89 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 1 O-C-N 116.252 -4.03 . . . . 14.6 103.888 -169.483 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -104.78 -173.94 2.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.269 3.427 . . . . 33.23 113.283 -169.447 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -67.74 137.46 55.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.961 3.304 . . . . 25.97 109.895 174.687 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 52.5 33.56 13.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.093 2.957 . . . . 32.61 111.288 179.373 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -76.21 151.52 36.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 114.204 -2.808 . . . . 10.56 110.422 163.909 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.9 m -110.17 112.54 24.58 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 133.046 6.466 . . . . 5.33 110.166 179.555 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.1 mt -97.62 159.06 15.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 110.654 -2.976 . . . . 11.66 106.566 170.704 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -124.82 123.71 40.55 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 115.992 -1.956 . . . . 16.3 106.76 -169.266 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -112.33 125.18 53.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.937 2.153 . . . . 9.96 109.315 -172.303 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.298 16.5 m -127.01 150.89 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 124.432 2.063 . . . . 9.76 109.119 169.63 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.5 mt -110.63 167.81 9.94 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.023 -1.899 . . . . 19.57 110.86 -167.174 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.482 HH12 ' C ' ' A' ' 76' ' ' GLY . 73.6 mtp180 -126.34 177.84 6.19 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.052 -2.905 . . . . 35.08 107.04 -172.924 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 tp -70.21 -62.88 1.22 Allowed 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.752 2.501 . . . . 32.31 117.752 171.256 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -132.56 -51.98 0.93 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.123 -2.236 . . . . 42.75 112.941 175.396 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.97 178.88 27.12 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 122.405 2.366 . . . . 36.31 109.948 -177.511 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.482 ' C ' HH12 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.755 0 O-C-N 118.702 -2.646 . . . . 36.27 107.66 -172.893 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 107.668 -1.234 . . . . 17.17 107.668 . . . . . . . . . 0 0 . 1 . 104 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -112.08 140.58 46.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.802 -2.295 . . . . 21.89 104.802 -175.817 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -128.62 154.48 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 123.422 1.582 . . . . 10.83 111.083 167.764 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -113.37 107.84 16.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.48 -2.012 . . . . 10.61 110.823 -173.517 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t -102.04 106.26 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.473 -1.392 . . . . 9.13 109.671 178.251 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -89.39 128.89 35.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.489 1.662 . . . . 20.55 115.489 179.557 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -78.63 164.45 24.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.86 -1.775 . . . . 11.78 110.572 171.103 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.0 mt -77.5 -22.41 51.28 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.485 -4.509 . . . . 19.31 110.833 -172.76 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -92.74 -67.84 0.83 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.425 -1.324 . . . . 23.14 107.425 176.583 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.12 76.75 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 114.521 -3.377 . . . . 19.74 121.496 -178.701 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -156.91 131.67 8.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.609 2.704 . . . . 21.93 106.577 171.556 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.0 m -105.76 108.17 19.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.52 1.629 . . . . 12.33 107.248 172.843 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 mt -86.71 117.03 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 105.509 -2.034 . . . . 17.08 105.509 176.311 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -93.88 127.31 39.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.408 1.693 . . . . 16.3 112.232 171.479 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -117.7 132.91 56.41 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.898 2.079 . . . . 15.88 112.816 -177.74 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -92.09 107.07 18.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.511 -1.663 . . . . 28.9 106.511 172.601 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.85 166.97 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 104.628 -2.36 . . . . 12.05 104.628 179.482 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -118.17 138.37 25.49 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 126.698 1.999 . . . . 18.17 109.069 168.872 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.652 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 38.0 Cg_endo -67.54 -10.0 27.26 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 124.579 3.519 . . . . 8.16 117.965 -171.721 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -76.64 -14.32 59.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.984 1.846 . . . . 11.13 115.984 170.399 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -85.06 172.65 11.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.531 1.514 . . . . 18.03 108.455 -178.767 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 70.8 p -103.54 157.08 17.29 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 117.229 -1.367 . . . . 10.22 113.296 -176.731 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.427 HD12 HD13 ' A' ' 50' ' ' LEU . 13.6 mm -53.65 -36.59 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 122.065 2.211 . . . . 12.3 113.842 177.61 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -53.47 -25.55 16.75 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.095 -2.253 . . . . 36.51 116.191 169.525 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -87.62 -18.82 28.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 117.666 -1.159 . . . . 25.66 113.025 173.334 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -75.38 -44.03 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 122.136 2.244 . . . . 8.12 112.486 176.196 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -62.84 -37.52 87.12 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 110.559 -3.019 . . . . 15.47 109.195 173.381 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.28 -19.43 61.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.387 -1.768 . . . . 11.45 114.084 173.309 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -77.2 -29.4 54.26 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.924 2.602 . . . . 24.98 110.628 171.313 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.7 mt -64.58 -45.6 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 116.615 -1.659 . . . . 9.46 114.924 167.695 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -48.03 -49.95 29.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 121.292 3.812 . . . . 14.76 121.292 167.995 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -59.52 -65.56 0.65 Allowed 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 127.7 2.4 . . . . 26.29 115.484 170.849 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -74.62 -71.53 0.34 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.544 -3.847 . . . . 30.06 112.388 -177.725 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -71.51 -31.11 66.71 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.676 -6.265 . . . . 25.19 113.616 -170.132 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.08 52.16 4.42 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.353 2.882 . . . . 7.41 110.704 178.56 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.85 143.02 28.26 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-N 119.959 1.88 . . . . 9.49 106.18 168.125 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -72.5 168.33 24.63 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 125.266 2.917 . . . . 11.42 113.16 -173.34 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -81.91 -11.95 11.05 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.547 3.017 . . . . 12.0 112.546 177.699 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.94 -33.39 75.47 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.135 -2.228 . . . . 35.55 113.281 172.135 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.261 46.5 mt-30 -95.38 -8.85 34.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.044 2.831 . . . . 20.52 110.756 -167.731 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -87.05 122.01 30.29 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 111.902 -6.749 . . . . 7.13 115.418 175.33 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -122.05 121.05 36.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.244 -2.16 . . . . 36.39 107.13 165.431 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.0 mt -105.98 139.04 41.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.677 -1.63 . . . . 9.55 110.115 -177.58 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 44' ' ' ILE . 75.5 mt -117.21 141.98 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 100.433 -3.914 . . . . 13.9 100.433 -175.474 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -136.85 104.23 5.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.15 -2.167 . . . . 6.86 105.15 172.7 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.266 . . 65.99 -127.83 0.27 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.758 -1.839 . . . . 11.15 111.927 -177.06 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.8 24.04 30.05 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 119.753 2.661 . . . . 13.93 119.753 -178.468 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.5 157.74 40.26 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 110.818 -2.691 . . . . 23.92 112.085 -168.018 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -105.88 152.56 23.12 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.155 -1.794 . . . . 23.23 106.155 -176.188 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.427 HD13 HD12 ' A' ' 23' ' ' ILE . 78.3 mt -88.59 146.76 24.94 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.767 2.222 . . . . 9.11 111.014 -177.03 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.52 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 17.5 tt0 -100.77 139.36 36.56 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 126.545 1.938 . . . . 33.44 107.217 -176.706 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.44 -55.54 32.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.153 2.581 . . . . 28.37 111.992 -168.937 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.97 31.47 7.92 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 113.45 -1.705 . . . . 15.0 110.878 -162.667 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.52 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 29.6 mtt180 -103.89 170.06 8.14 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.689 -3.83 . . . . 25.5 104.004 169.57 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.4 p -85.93 158.68 19.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.012 2.925 . . . . 11.95 105.908 -179.196 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.652 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 1.2 mt -69.41 -32.36 71.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.757 -3.089 . . . . 10.17 116.215 171.385 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.6 p -53.41 -40.33 65.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.404 3.082 . . . . 13.59 115.98 167.643 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.93 -20.47 61.75 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.2 -2.812 . . . . 11.7 117.073 -176.597 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -91.64 -1.12 57.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.325 1.85 . . . . 12.95 110.844 174.037 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 44.05 63.32 1.65 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.53 -2.123 . . . . 25.45 115.171 -161.497 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.69 127.17 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.825 -1.546 . . . . 14.6 106.825 168.539 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -124.35 179.74 4.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.188 2.595 . . . . 33.23 106.28 -168.16 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -67.54 145.92 54.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.886 -3.634 . . . . 25.97 111.537 -172.315 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 51.46 26.53 3.23 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.447 2.018 . . . . 32.61 116.447 -175.847 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 m -56.18 145.79 25.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.937 -1.727 . . . . 10.56 113.201 167.628 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -98.58 120.56 39.21 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.142 -2.224 . . . . 5.33 114.192 167.974 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -110.27 160.41 16.55 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.344 0.974 . . . . 11.66 110.547 169.669 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -112.87 133.4 54.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 102.424 -3.176 . . . . 16.3 102.424 176.271 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -103.12 117.48 34.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.437 1.895 . . . . 9.96 113.313 166.633 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.0 t -116.62 123.21 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.931 -2.248 . . . . 9.76 104.931 -173.567 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt -98.65 132.46 44.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.677 -1.889 . . . . 19.57 113.75 -173.95 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.55 HH12 ' C ' ' A' ' 76' ' ' GLY . 43.4 mtp180 -112.47 -177.4 3.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.172 2.26 . . . . 35.08 114.211 -175.11 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.54 -178.57 7.01 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 114.535 -5.103 . . . . 32.31 107.524 178.465 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -92.61 82.13 4.8 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.455 -3.278 . . . . 42.75 110.671 173.098 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.63 -67.36 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.608 -3.807 . . . . 36.31 112.545 -173.635 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.55 ' C ' HH12 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.741 0 CA-C-N 121.93 2.865 . . . . 36.27 112.23 -171.804 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.26 7.9 ptt? . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 117.756 2.502 . . . . 17.17 117.756 . . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -113.29 130.64 56.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 105.844 -1.91 . . . . 21.89 105.844 -177.421 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 pt -131.29 160.02 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 100.569 -3.863 . . . . 10.83 100.569 -177.673 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -112.41 151.59 29.66 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.527 2.584 . . . . 10.61 106.785 -177.739 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.33 124.56 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 117.456 -3.277 . . . . 9.13 109.66 166.745 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -136.66 135.7 38.48 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.772 -1.558 . . . . 20.55 109.934 -170.366 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -80.83 -174.25 4.67 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.448 2.547 . . . . 11.78 111.271 175.985 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.16 -43.42 74.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.027 -2.296 . . . . 19.31 111.47 177.077 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -76.62 -34.8 58.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.361 -2.257 . . . . 23.14 108.07 179.658 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.15 70.2 0.63 Allowed Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 126.523 2.011 . . . . 19.74 114.162 173.72 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -96.55 103.07 14.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 131.051 3.74 . . . . 21.93 106.877 160.491 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -100.08 135.81 40.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.21 2.433 . . . . 12.33 110.445 -178.866 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 pt -139.99 162.33 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.445 2.698 . . . . 17.08 111.79 175.054 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 m -126.81 119.47 26.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.794 1.309 . . . . 16.3 110.145 -172.218 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.42 134.13 48.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.218 -1.81 . . . . 15.88 107.83 -178.321 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -98.86 115.49 28.96 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.352 -2.833 . . . . 28.9 103.352 178.689 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.37 177.86 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.818 -1.549 . . . . 12.05 106.818 177.183 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -116.89 160.17 37.89 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 104.497 -2.408 . . . . 18.17 104.497 179.228 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -76.67 2.53 7.34 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 115.837 -2.309 . . . . 8.16 116.427 -175.099 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.0 p -77.47 -13.8 59.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 124.871 1.357 . . . . 11.13 112.175 169.557 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.89 137.57 33.6 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 122.728 1.251 . . . . 18.03 111.805 -170.766 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -76.13 158.12 32.08 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 109.283 -3.599 . . . . 10.22 112.266 -169.781 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mm -52.93 -45.62 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 1 O-C-N 115.377 -4.577 . . . . 12.3 110.242 168.376 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -59.97 -32.09 70.51 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.278 -2.764 . . . . 36.51 118.176 168.887 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -63.84 -38.74 92.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.924 -2.985 . . . . 25.66 111.555 168.871 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.84 -47.18 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.014 1.326 . . . . 8.12 108.771 171.9 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -58.81 -39.82 82.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.864 -1.772 . . . . 15.47 112.954 178.436 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.43 61.79 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.499 3.148 . . . . 11.45 119.499 171.326 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.26 4.6 tppt? -66.84 -44.07 82.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.151 2.881 . . . . 24.98 117.127 167.854 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -74.01 -43.12 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.659 2.384 . . . . 9.46 107.416 179.144 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -48.27 -45.09 34.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.75 2.5 . . . . 14.76 117.75 169.67 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.03 -57.18 8.32 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.279 2.696 . . . . 26.29 118.279 169.502 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -64.67 -58.06 7.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.637 2.458 . . . . 30.06 117.637 173.32 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.45 -67.93 0.61 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.353 -1.467 . . . . 25.19 112.775 -176.475 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.82 27.01 2.88 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 122.53 1.072 . . . . 7.41 111.731 -176.863 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.7 mt -88.23 125.79 62.78 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 114.063 -2.875 . . . . 9.49 111.95 174.764 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.0 Cg_exo -71.13 154.81 62.06 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 CA-C-N 126.698 3.428 . . . . 11.42 112.827 -174.89 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 84.9 Cg_exo -70.18 -15.24 35.45 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.22 1.946 . . . . 12.0 110.068 -170.703 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -87.14 -16.58 35.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.828 1.775 . . . . 35.55 115.54 177.486 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -94.79 -34.86 12.33 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.06 -1.65 . . . . 20.52 108.687 -178.838 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.39 135.27 55.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.083 0.944 . . . . 7.13 111.877 174.811 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.258 21.6 tpp180 -139.27 130.59 26.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.012 -2.93 . . . . 36.39 106.566 160.906 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.5 mt -94.33 135.66 35.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.95 2.5 . . . . 9.55 112.779 -179.629 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.525 HG12 ' HG2' ' A' ' 49' ' ' GLN . 11.8 mt -127.09 132.09 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 1 N-CA-C 97.688 -4.931 . . . . 13.9 97.688 -172.28 . . . . . . . . 3 3 . 1 . 105 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -116.19 130.84 56.99 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.025 -2.297 . . . . 6.86 107.368 166.563 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.83 -109.85 0.51 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.694 -2.504 . . . . 11.15 117.388 -172.059 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.17 -7.46 56.12 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 130.663 3.983 . . . . 13.93 114.636 174.844 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -127.05 144.86 50.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.588 3.194 . . . . 23.92 112.999 -159.532 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.525 ' HG2' HG12 ' A' ' 44' ' ' ILE . 65.1 mt-30 -98.44 124.19 43.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.476 -1.693 . . . . 23.23 106.643 -176.2 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.408 ' H ' HD22 ' A' ' 50' ' ' LEU . 1.1 mm? -88.69 143.29 27.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.953 -1.092 . . . . 9.11 112.372 -167.552 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.256 74.1 mm-40 -85.62 149.87 25.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.408 2.744 . . . . 33.44 118.408 -178.435 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -40.75 -64.08 0.58 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 131.031 3.733 . . . . 28.37 118.798 -173.034 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.59 51.51 0.76 Allowed Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 123.284 1.491 . . . . 15.0 111.153 -171.081 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.273 13.7 mmt85 -123.83 173.35 8.23 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.743 -4.386 . . . . 25.5 108.775 173.693 . . . . . . . . 3 2 . 1 . 105 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 p -112.39 175.1 5.57 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.424 2.375 . . . . 11.95 113.525 175.201 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.3 mt -58.81 -41.08 85.94 Favored 'General case' 0 N--CA 1.43 -1.449 2 CA-C-N 106.801 -4.727 . . . . 10.17 113.648 169.322 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -70.52 -35.53 73.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.751 -1.218 . . . . 13.59 113.769 177.778 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -62.14 -48.56 79.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.407 -2.058 . . . . 11.7 114.261 178.979 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -72.86 -25.83 61.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.801 -3.687 . . . . 12.95 115.86 174.575 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.288 9.0 m120 83.16 67.2 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.013 2.125 . . . . 25.45 109.007 -173.424 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.49 117.12 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 101.81 -3.404 . . . . 14.6 101.81 172.208 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -102.55 -164.53 1.09 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.51 -2.619 . . . . 33.23 109.225 -179.893 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -72.72 131.32 42.21 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 131.601 3.961 . . . . 25.97 111.132 -172.171 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 60.71 24.66 14.48 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.785 1.63 . . . . 32.61 113.385 179.526 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.8 m -89.58 153.62 20.63 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 101.21 -3.626 . . . . 10.56 101.21 171.723 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -116.46 109.68 17.62 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.039 1.735 . . . . 5.33 107.33 -167.142 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mp -90.88 131.74 36.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 120.0 1.273 . . . . 11.66 110.082 178.418 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -80.38 132.0 35.7 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 127.066 3.317 . . . . 16.3 107.796 -176.076 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.256 5.1 tp -102.03 116.63 33.11 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 115.353 -4.592 . . . . 9.96 109.804 173.261 . . . . . . . . 3 2 . 1 . 105 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.0 t -106.09 109.96 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 127.574 2.35 . . . . 9.76 114.924 168.883 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -93.42 121.89 35.28 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.836 -3.024 . . . . 19.57 102.836 -171.648 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -63.35 139.46 58.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.798 2.147 . . . . 35.08 116.798 179.986 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.9 tp -91.4 -42.4 10.34 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.729 -4.357 . . . . 32.31 110.96 179.407 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpp180 -158.72 -50.54 0.06 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.266 -2.146 . . . . 42.75 111.287 164.157 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.04 134.14 2.25 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 118.513 -2.617 . . . . 36.31 112.256 -174.708 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.768 0 C-N-CA 127.033 2.254 . . . . 36.27 113.62 175.049 . . . . . . . . 0 0 . 1 . 106 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 121.011 0.434 . . . . 17.17 109.877 . . . . . . . . . 0 0 . 1 . 106 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -107.78 153.36 23.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.489 -2.141 . . . . 21.89 114.473 173.577 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -126.78 147.19 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 102.669 -3.086 . . . . 10.83 102.669 171.374 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.55 135.85 45.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.8 2.148 . . . . 10.61 116.8 156.768 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.57 141.97 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.603 1.961 . . . . 9.13 107.081 174.241 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -140.02 130.97 26.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.57 2.348 . . . . 20.55 112.543 -163.719 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -91.36 -176.7 4.63 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.642 -1.911 . . . . 11.78 107.153 -176.334 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.98 -48.4 74.13 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.416 -2.678 . . . . 19.31 111.562 175.874 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.1 p -79.83 -62.57 1.64 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.385 -3.322 . . . . 23.14 110.585 -174.851 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.71 41.25 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 116.999 -2.524 . . . . 19.74 114.348 175.409 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.3 19.7 tptm -88.54 109.06 19.76 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.035 -1.469 . . . . 21.93 107.035 165.313 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -104.14 108.91 20.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.316 -1.49 . . . . 12.33 108.08 -179.619 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.264 36.6 pt -97.03 134.22 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 116.412 -1.756 . . . . 17.08 110.312 175.156 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 3.6 m -109.66 112.13 24.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.977 2.911 . . . . 16.3 107.745 -179.893 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -106.61 160.07 15.72 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.823 -3.048 . . . . 15.88 110.553 -176.084 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -115.44 132.26 56.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.756 -2.465 . . . . 28.9 109.296 176.024 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.52 167.24 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.294 2.237 . . . . 12.05 114.608 -167.756 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -90.97 140.5 26.1 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 119.087 -2.258 . . . . 18.17 115.623 155.762 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.65 -10.86 30.28 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 122.55 1.946 . . . . 8.16 117.048 174.868 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.337 83.7 p -74.8 -14.55 60.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.736 2.865 . . . . 11.13 118.736 166.817 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -81.06 165.97 21.17 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.125 1.516 . . . . 18.03 114.936 -164.63 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 45.7 p -87.77 157.52 19.01 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.349 2.5 . . . . 10.22 112.31 -172.092 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.4 mm -68.91 -28.62 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.638 -3.164 . . . . 12.3 111.679 -178.057 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -48.71 -48.98 39.98 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.274 2.23 . . . . 36.51 115.528 153.116 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -75.09 1.62 12.71 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.79 -4.319 . . . . 25.66 119.687 175.012 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.6 t -82.91 -39.56 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.189 -2.152 . . . . 8.12 105.189 160.545 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -63.97 -25.56 68.19 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.303 -3.998 . . . . 15.47 113.633 -179.109 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.33 92.06 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.434 -2.666 . . . . 11.45 114.926 170.74 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -72.78 -27.76 62.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.7 -3.125 . . . . 24.98 111.639 -177.285 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.44 -44.04 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 115.051 1.5 . . . . 9.46 115.051 170.021 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -60.52 -45.18 94.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.782 1.401 . . . . 14.76 114.782 167.799 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -65.31 -43.92 89.53 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.656 2.48 . . . . 26.29 111.698 178.926 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -75.38 -67.16 0.69 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.858 2.17 . . . . 30.06 116.858 -179.027 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -82.69 -43.07 17.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.003 -2.311 . . . . 25.19 115.194 179.905 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.7 52.32 2.84 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-O 124.548 2.193 . . . . 7.41 117.521 177.861 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.5 mt -111.97 125.74 29.7 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 102.145 -3.28 . . . . 9.49 102.145 -178.386 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 64.8 Cg_endo -80.44 160.5 22.59 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 127.754 3.805 . . . . 11.42 113.098 -173.393 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 1.3 Cg_exo -77.04 -17.24 15.38 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 CA-C-N 127.949 3.874 . . . . 12.0 111.045 -148.168 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.54 -24.27 45.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.76 -3.088 . . . . 35.55 110.647 -171.721 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -90.01 -0.67 57.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.697 2.399 . . . . 20.52 110.764 -173.714 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -100.05 129.6 46.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.233 2.213 . . . . 7.13 115.803 -177.728 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -130.76 114.48 15.4 Favored 'General case' 0 N--CA 1.431 -1.404 1 O-C-N 115.918 -4.238 . . . . 36.39 110.602 167.317 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.7 mt -103.54 137.87 41.02 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 116.576 -1.678 . . . . 9.55 114.455 -174.666 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 mt -125.53 133.95 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 101.079 -3.675 . . . . 13.9 101.079 -164.703 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -118.12 96.15 5.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 101.441 -3.541 . . . . 6.86 101.441 172.956 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.91 -93.96 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.653 -2.067 . . . . 11.15 113.262 -170.667 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.48 -16.64 45.43 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 116.812 -2.105 . . . . 13.93 116.525 174.389 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -105.57 126.35 52.04 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 126.323 1.837 . . . . 23.92 113.032 -157.72 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -98.39 123.83 42.73 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 125.379 1.674 . . . . 23.23 113.13 -167.023 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.24 125.65 36.99 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.827 -1.082 . . . . 9.11 110.578 -158.378 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -87.63 152.21 22.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 131.608 3.963 . . . . 33.44 116.511 171.238 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -75.02 -49.12 20.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.382 2.515 . . . . 28.37 108.405 -152.227 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.69 34.76 4.08 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 117.548 -3.22 . . . . 15.0 114.342 -171.791 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -123.23 161.94 23.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 100.426 -3.916 . . . . 25.5 100.426 176.231 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.3 p -99.8 164.38 12.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.106 -1.621 . . . . 11.95 114.822 -179.809 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mt -48.06 -37.71 15.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.342 -3.349 . . . . 10.17 119.247 167.505 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -76.02 -14.92 60.21 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.539 -1.664 . . . . 13.59 113.025 174.963 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -74.92 -38.38 61.82 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 123.798 2.999 . . . . 11.7 110.552 172.205 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -91.82 2.13 56.71 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.396 -1.335 . . . . 12.95 107.396 -172.603 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m120 60.33 45.33 11.31 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.927 2.566 . . . . 25.45 117.927 179.98 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.4 mt -86.91 135.49 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 126.594 3.092 . . . . 14.6 106.399 -178.884 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -113.72 167.3 10.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.309 -2.119 . . . . 33.23 109.558 -163.864 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -55.22 114.37 1.76 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.531 1.634 . . . . 25.97 111.774 166.14 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 63.12 37.96 11.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 110.453 -3.067 . . . . 32.61 113.254 -175.383 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -72.18 148.62 45.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.464 1.484 . . . . 10.56 113.815 159.497 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.4 m -109.32 128.53 55.16 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.566 -3.209 . . . . 5.33 110.16 179.77 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -101.85 140.3 36.33 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 116.214 1.931 . . . . 11.66 116.214 177.12 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -100.36 110.72 22.94 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 125.175 2.416 . . . . 16.3 111.704 -179.511 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -94.6 127.61 40.67 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.792 -2.443 . . . . 9.96 110.49 -175.243 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.7 123.13 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.256 3.023 . . . . 9.76 113.755 163.563 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.23 129.28 34.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 128.325 3.917 . . . . 19.57 108.751 173.935 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -77.19 133.57 38.89 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.657 -3.152 . . . . 35.08 106.26 179.943 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.1 tp -121.82 -59.4 1.68 Allowed 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.184 1.468 . . . . 32.31 109.233 172.734 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -98.77 -63.67 1.1 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.925 -1.943 . . . . 42.75 112.39 177.907 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.54 161.21 31.18 Favored Glycine 0 N--CA 1.43 -1.726 1 N-CA-C 102.094 -4.402 . . . . 36.31 102.094 171.067 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 0 C-N-CA 114.935 -3.507 . . . . 36.27 114.27 169.316 . . . . . . . . 0 0 . 1 . 107 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptt? . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 110.752 -0.092 . . . . 17.17 110.752 . . . . . . . . . 0 0 . 1 . 107 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -90.04 148.27 23.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 123.664 0.786 . . . . 21.89 111.232 177.464 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.31 141.61 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.701 -2.333 . . . . 10.83 104.701 -179.118 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -97.0 143.05 28.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.935 1.457 . . . . 10.61 114.935 170.169 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -128.86 112.04 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.232 2.92 . . . . 9.13 107.165 177.841 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -109.2 130.66 55.49 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.594 -3.816 . . . . 20.55 115.164 -172.753 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 p -82.09 162.55 22.48 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.398 -5.813 . . . . 11.78 107.851 179.532 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mt -59.17 -39.03 81.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.293 -2.755 . . . . 19.31 115.274 169.019 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 p -65.58 -58.64 5.27 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.344 2.497 . . . . 23.14 112.662 -178.151 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.03 64.14 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 O-C-N 118.129 -2.857 . . . . 19.74 113.555 164.935 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -129.88 134.8 47.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 119.712 1.756 . . . . 21.93 107.606 157.408 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -105.57 121.35 43.78 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.84 1.781 . . . . 12.33 108.898 175.302 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.6 pt -111.23 144.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 118.082 -2.886 . . . . 17.08 105.837 -179.569 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -107.39 123.09 47.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.686 1.241 . . . . 16.3 110.627 -177.197 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -119.98 162.79 18.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.023 -1.103 . . . . 15.88 108.023 -177.027 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -106.35 133.41 51.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.197 1.799 . . . . 28.9 111.3 172.726 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.444 HG11 HG22 ' A' ' 26' ' ' VAL 0.262 16.1 m -147.96 162.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 119.448 -2.032 . . . . 12.05 106.365 167.344 . . . . . . . . 3 3 . 1 . 107 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -82.24 170.43 14.91 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 105.21 -2.144 . . . . 18.17 105.21 161.151 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.287 1.1 Cg_exo -69.84 -24.93 28.73 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 120.79 1.318 . . . . 8.16 111.704 170.438 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -78.7 8.13 5.85 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 115.347 -2.264 . . . . 11.13 111.075 -174.265 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.255 75.2 m-20 -108.31 162.07 14.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 123.198 2.727 . . . . 18.03 107.33 -176.669 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.9 p -92.21 163.72 13.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.846 -3.034 . . . . 10.22 114.204 -171.556 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -69.44 -24.65 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 118.814 -2.429 . . . . 12.3 112.121 176.753 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -53.69 -48.77 69.2 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.69 -4.381 . . . . 36.51 114.303 162.458 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -62.97 -30.74 71.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.311 2.337 . . . . 25.66 117.311 169.661 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.444 HG22 HG11 ' A' ' 17' ' ' VAL . 37.2 t -65.68 -49.41 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 121.767 2.076 . . . . 8.12 113.435 166.319 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HA ' HD12 ' A' ' 30' ' ' ILE . 49.6 mtmt -61.82 -31.53 71.77 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.709 1.604 . . . . 15.47 113.451 178.839 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -67.72 -35.33 78.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.145 2.578 . . . . 11.45 106.678 169.94 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -75.67 -21.26 57.81 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.862 -4.274 . . . . 24.98 116.901 177.05 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 27' ' ' LYS . 11.0 mt -69.44 -45.85 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.39 -2.069 . . . . 9.46 110.316 164.599 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 66.0 tt0 -49.75 -39.98 39.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.583 2.611 . . . . 14.76 111.44 171.862 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.71 -64.16 1.06 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.233 -3.417 . . . . 26.29 110.464 -179.99 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -80.66 -27.47 37.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.45 -3.906 . . . . 30.06 114.359 -163.167 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -103.89 -56.05 2.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 113.946 1.091 . . . . 25.19 113.946 -177.728 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.28 26.79 2.59 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 126.963 2.221 . . . . 7.41 116.89 172.841 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -94.42 135.36 24.29 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 108.127 -1.064 . . . . 9.49 108.127 -176.438 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.48 157.4 61.91 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 115.221 -3.094 . . . . 11.42 112.885 -177.65 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -84.83 -11.32 7.89 Favored 'Trans proline' 0 C--N 1.299 -2.029 1 C-N-CA 128.157 5.905 . . . . 12.0 112.779 -175.198 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.82 -43.47 58.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.358 0.981 . . . . 35.55 111.567 173.392 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.468 ' HG2' ' H ' ' A' ' 72' ' ' ARG . 7.2 tt0 -72.12 12.01 0.48 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.785 -2.447 . . . . 20.52 114.588 -179.051 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -116.89 128.42 55.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.625 1.202 . . . . 7.13 114.082 -164.613 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -129.13 130.06 45.96 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.793 -1.817 . . . . 36.39 106.184 171.763 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.5 mt -102.47 143.56 32.03 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 120.357 -0.537 . . . . 9.55 111.546 171.617 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -124.82 127.95 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 128.036 2.534 . . . . 13.9 104.798 177.726 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -112.67 107.9 16.75 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.116 -2.865 . . . . 6.86 104.504 177.201 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.388 . . 60.29 -91.45 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.188 -1.57 . . . . 11.15 115.017 -169.08 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.0 5.58 7.35 Favored Glycine 0 N--CA 1.43 -1.703 1 C-N-CA 131.064 4.173 . . . . 13.93 119.074 171.745 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -113.96 156.91 23.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.921 1.343 . . . . 23.92 108.319 175.384 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -84.11 151.8 24.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.385 -1.279 . . . . 23.23 111.937 175.742 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.2 mt -110.24 128.34 55.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.458 1.935 . . . . 9.11 111.777 178.773 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -92.18 163.62 13.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.063 3.316 . . . . 33.44 105.983 179.096 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -63.26 -61.1 2.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 109.402 -3.544 . . . . 28.37 118.939 -171.938 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.54 15.55 13.13 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 119.476 2.55 . . . . 15.0 119.476 -171.849 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -101.45 156.85 17.22 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.398 -1.648 . . . . 25.5 110.116 173.46 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 35.5 p -94.37 167.43 11.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.406 -1.331 . . . . 11.95 107.406 -175.636 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mp -67.96 -25.94 65.69 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.348 2.259 . . . . 10.17 108.752 165.713 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.3 t -71.62 -43.29 66.45 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.653 2.381 . . . . 13.59 110.243 175.526 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -59.28 -44.74 92.44 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.945 -4.222 . . . . 11.7 116.768 175.316 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -79.89 -11.64 59.79 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.642 2.83 . . . . 12.95 118.642 169.734 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.315 31.0 m120 75.75 34.86 0.55 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.644 -3.16 . . . . 25.45 115.002 174.434 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 mt -73.47 118.91 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.347 -1.297 . . . . 14.6 110.757 167.619 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' SER . 45.5 mt-30 -90.75 169.91 10.57 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 124.155 1.931 . . . . 33.23 113.609 174.219 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -61.94 146.88 48.64 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.742 -4.349 . . . . 25.97 108.064 -174.32 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 85.7 mt-10 62.48 46.88 5.4 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.889 1.804 . . . . 32.61 113.167 174.273 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' GLN . 9.2 t -111.09 131.94 54.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.355 2.662 . . . . 10.56 103.994 -168.531 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -89.59 109.95 20.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.385 2.517 . . . . 5.33 108.562 177.233 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.7 mt -89.74 150.58 22.23 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.776 2.03 . . . . 11.66 107.95 172.626 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -106.23 113.39 26.9 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 114.965 1.469 . . . . 16.3 114.965 -178.283 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.7 tp -89.93 120.2 30.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.276 1.988 . . . . 9.96 114.493 177.152 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.81 145.58 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 112.651 -2.068 . . . . 9.76 105.829 172.964 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.9 mt -125.23 137.36 54.11 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.372 1.558 . . . . 19.57 111.331 -176.258 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.468 ' H ' ' HG2' ' A' ' 40' ' ' GLN . 51.8 ttp180 -84.92 146.34 27.31 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.905 -2.997 . . . . 35.08 115.803 -166.357 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.8 tp -82.92 -84.72 0.12 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.291 1.836 . . . . 32.31 108.277 -172.506 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -91.41 -48.82 6.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.727 -2.483 . . . . 42.75 113.118 -165.154 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.81 169.35 37.33 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 118.277 -2.765 . . . . 36.31 110.309 178.929 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.791 1 N-CA-C 102.033 -4.427 . . . . 36.27 102.033 158.714 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 106.413 -1.699 . . . . 17.17 106.413 . . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -106.38 140.08 39.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.707 2.114 . . . . 21.89 116.707 -176.671 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.6 pt -119.17 143.88 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 129.036 2.934 . . . . 10.83 114.324 169.979 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -104.92 126.1 51.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.05 -2.906 . . . . 10.61 107.827 -179.409 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.38 109.75 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 127.67 3.605 . . . . 9.13 105.94 -176.773 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -117.93 138.79 51.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 125.897 2.761 . . . . 20.55 108.969 -167.665 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 9.8 p -72.68 -179.09 2.92 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.956 -2.34 . . . . 11.78 117.051 163.805 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.404 ' H ' ' HB ' ' A' ' 7' ' ' THR . 63.4 tp -76.14 -39.83 54.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 131.118 3.767 . . . . 19.31 110.431 -160.66 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -73.17 -56.6 4.87 Favored 'General case' 0 N--CA 1.429 -1.488 1 C-N-CA 133.94 4.896 . . . . 23.14 105.93 175.67 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.04 30.98 0.34 Allowed Glycine 0 N--CA 1.43 -1.741 0 O-C-N 125.873 1.983 . . . . 19.74 115.003 173.204 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -79.32 109.77 13.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.287 2.043 . . . . 21.93 109.779 168.664 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -95.79 126.43 41.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.007 -2.308 . . . . 12.33 112.684 -176.387 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.313 28.4 pt -109.47 152.93 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.433 2.063 . . . . 17.08 108.241 165.863 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -122.53 125.6 46.07 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.321 -2.737 . . . . 16.3 110.672 -175.78 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.284 52.4 mt -119.1 144.16 46.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.315 2.339 . . . . 15.88 117.315 179.442 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -101.16 101.86 12.67 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.705 2.002 . . . . 28.9 112.17 -179.161 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.18 165.1 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 C-N-CA 134.028 4.931 . . . . 12.05 108.284 -165.301 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 9.0 mt-10 -112.67 173.37 2.89 Favored Pre-proline 0 N--CA 1.429 -1.486 0 N-CA-C 114.836 1.421 . . . . 18.17 114.836 162.305 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -74.07 -14.12 23.57 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 115.963 -2.704 . . . . 8.16 112.763 -179.111 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -95.11 0.9 54.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.159 0.912 . . . . 11.13 110.311 177.688 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.267 35.2 m-20 -85.98 152.23 23.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.877 -3.639 . . . . 18.03 109.812 -173.308 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 71.0 p -100.63 160.76 14.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.334 2.492 . . . . 10.22 107.859 -160.714 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 mm -64.48 -40.22 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 124.65 2.167 . . . . 12.3 108.624 -174.419 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -56.24 -35.47 67.41 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.03 -2.919 . . . . 36.51 117.021 168.121 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -72.14 -31.49 66.04 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 113.362 -5.836 . . . . 25.66 112.613 167.55 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.79 -43.55 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.724 -1.584 . . . . 8.12 106.724 -177.021 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.25 -35.96 72.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.763 1.625 . . . . 15.47 113.361 174.907 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.99 -42.29 76.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.221 -2.174 . . . . 11.45 116.0 175.824 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -75.17 -32.03 61.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.649 3.179 . . . . 24.98 112.89 -176.989 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -60.88 -48.1 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.529 2.585 . . . . 9.46 113.029 174.253 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -52.53 -45.88 66.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 113.15 -3.31 . . . . 14.76 117.037 166.386 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.53 -62.93 1.18 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.721 3.138 . . . . 26.29 110.032 179.291 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -53.71 -57.16 11.85 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.412 -3.305 . . . . 30.06 112.093 -176.757 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -93.96 -64.63 1.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.534 2.05 . . . . 25.19 116.534 -173.64 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.79 23.71 0.86 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 120.9 3.12 . . . . 7.41 120.9 -176.939 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.69 118.14 60.27 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 114.723 -2.56 . . . . 9.49 106.945 -169.191 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 36.2 Cg_exo -51.89 147.16 26.35 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 121.238 3.515 . . . . 11.42 121.238 178.318 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 21.0 Cg_exo -68.69 -35.68 16.0 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 123.793 2.39 . . . . 12.0 113.261 -160.378 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -78.21 -27.34 47.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.904 -2.372 . . . . 35.55 113.971 -177.462 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -62.89 -39.16 93.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.173 2.189 . . . . 20.52 115.365 170.776 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -65.9 140.17 58.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.342 2.349 . . . . 7.13 117.342 173.585 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -128.32 99.61 5.49 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.855 -2.403 . . . . 36.39 114.192 169.866 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -86.06 131.43 34.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.065 -2.334 . . . . 9.55 109.629 -177.728 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 70' ' ' VAL . 31.6 mt -130.47 136.59 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 126.282 2.944 . . . . 13.9 103.253 -179.846 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -113.5 114.98 27.29 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 115.055 -4.778 . . . . 6.86 107.897 164.393 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.277 . . 72.31 -86.33 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.738 2.815 . . . . 11.15 111.331 -179.221 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.38 22.71 1.71 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 109.121 -1.591 . . . . 13.93 109.121 165.42 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.259 81.6 mttt -103.69 124.57 49.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.473 -3.369 . . . . 23.92 105.365 176.282 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -91.72 132.9 36.06 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 123.295 1.521 . . . . 23.23 108.941 -179.929 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.4 mt -94.15 128.86 40.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 115.715 -2.394 . . . . 9.11 109.794 -151.377 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -78.32 139.73 38.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 119.038 2.977 . . . . 33.44 119.038 172.166 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.57 -50.14 70.85 Favored 'General case' 0 N--CA 1.431 -1.394 1 N-CA-C 122.654 4.316 . . . . 28.37 122.654 -162.62 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.49 0.72 89.24 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.232 -2.793 . . . . 15.0 115.775 175.333 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -81.78 165.33 21.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.835 -1.979 . . . . 25.5 108.143 171.382 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.3 p -104.97 -178.2 3.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 116.447 -3.908 . . . . 11.95 111.353 -172.98 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.3 mt -81.48 -29.31 33.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.699 -1.593 . . . . 10.17 106.699 178.712 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.9 t -66.08 -38.12 87.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.409 -2.057 . . . . 13.59 111.355 -176.589 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -54.95 -40.89 70.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.347 3.059 . . . . 11.7 113.788 176.924 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -93.49 1.16 56.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.322 2.342 . . . . 12.95 117.322 174.995 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.459 3.7 m120 79.52 18.83 0.73 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.263 1.579 . . . . 25.45 115.263 174.494 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.9 mt -87.01 99.4 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 118.446 -2.659 . . . . 14.6 105.014 -174.477 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.36 10.4 mt-30 -112.39 -165.11 0.96 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.324 2.249 . . . . 33.23 112.02 -169.874 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -61.55 106.8 0.7 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.103 2.961 . . . . 25.97 113.4 -170.061 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 82.76 41.92 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.011 2.525 . . . . 32.61 111.749 172.003 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.6 m -92.27 142.69 27.19 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.582 1.953 . . . . 10.56 111.376 179.388 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 m -102.41 121.18 41.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.334 -2.104 . . . . 5.33 112.365 178.387 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -85.26 160.09 19.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 117.403 -1.284 . . . . 11.66 110.228 167.814 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -105.41 136.03 45.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 127.5 3.0 . . . . 16.3 104.84 167.473 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.1 tp -116.11 111.57 20.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.749 -2.315 . . . . 9.96 104.749 -179.639 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.605 HG21 HD12 ' A' ' 44' ' ' ILE . 1.9 t -103.46 140.87 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 127.3 2.24 . . . . 9.76 106.275 -179.994 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mt -93.87 136.06 34.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.357 3.063 . . . . 19.57 106.079 176.873 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.254 49.9 ttp180 -74.54 132.92 42.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.295 1.861 . . . . 35.08 114.765 174.648 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.8 tp -88.04 -67.15 0.85 Allowed 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.369 -1.741 . . . . 32.31 111.195 176.345 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.287 32.4 ttp-105 -104.01 -109.41 0.26 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 116.658 -1.639 . . . . 42.75 112.209 -176.144 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.06 -158.01 10.42 Favored Glycine 0 N--CA 1.431 -1.696 1 CA-C-N 126.765 4.348 . . . . 36.31 115.069 167.323 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.751 1 O-C-N 115.47 -4.547 . . . . 36.27 107.348 -178.829 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 108.139 -1.059 . . . . 17.17 108.139 . . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -100.11 116.17 31.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.549 1.166 . . . . 21.89 112.442 -177.37 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.1 pt -97.4 151.92 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.192 -1.367 . . . . 10.83 113.996 148.554 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.432 ' HB2' HG23 ' A' ' 66' ' ' THR . 77.8 m-85 -107.67 149.46 28.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.434 2.958 . . . . 10.61 110.951 174.66 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 30' ' ' ILE . 47.3 t -126.43 133.99 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 106.224 -1.769 . . . . 9.13 106.224 162.092 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -108.73 139.45 43.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.742 2.017 . . . . 20.55 113.62 174.591 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 p -88.07 -169.54 2.61 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 114.973 1.471 . . . . 11.78 114.973 -171.659 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.87 -59.08 4.6 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 120.163 1.347 . . . . 19.31 113.435 179.175 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -69.6 -30.06 67.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.023 -1.673 . . . . 23.14 110.689 179.714 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.2 54.3 0.27 Allowed Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 129.168 3.27 . . . . 19.74 108.422 152.083 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -82.67 116.09 21.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.238 2.019 . . . . 21.93 108.839 167.623 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -84.32 112.02 19.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.691 -2.576 . . . . 12.33 115.898 176.285 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.61 162.22 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 122.357 2.344 . . . . 17.08 108.232 -172.848 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.5 m -123.75 98.22 5.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.492 2.717 . . . . 16.3 113.83 -174.504 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 29' ' ' LYS . 73.0 mt -92.68 160.3 15.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.025 0.83 . . . . 15.88 111.554 -170.62 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -106.13 103.91 13.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.372 1.442 . . . . 28.9 113.757 175.044 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.74 165.02 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.7 2.4 . . . . 12.05 108.347 -174.771 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.15 170.9 7.89 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-O 115.75 -2.071 . . . . 18.17 109.621 162.513 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.291 0.0 OUTLIER -66.7 -9.51 24.75 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 N-CA-C 120.205 3.117 . . . . 8.16 120.205 179.83 . . . . . . . . 3 3 . 1 . 109 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -82.52 -21.58 35.36 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.207 -2.33 . . . . 11.13 113.927 176.474 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -57.75 146.29 31.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 119.745 3.239 . . . . 18.03 119.745 172.93 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.4 p -105.08 159.95 15.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.256 -3.403 . . . . 10.22 108.087 -178.013 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.62 -40.66 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 112.917 -1.947 . . . . 12.3 112.781 178.111 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -49.63 -41.88 43.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.509 1.924 . . . . 36.51 112.975 165.092 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -80.63 -21.31 41.59 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.565 -3.834 . . . . 25.66 116.942 176.14 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 t -59.91 -50.08 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.471 -2.643 . . . . 8.12 107.782 165.375 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -59.56 -39.8 85.22 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.687 1.708 . . . . 15.47 113.013 -179.305 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.323 . . -71.58 -28.99 64.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.621 -1.627 . . . . 11.45 112.653 -176.996 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HB3' HD22 ' A' ' 15' ' ' LEU . 55.8 mttm -69.0 -31.29 70.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.086 3.355 . . . . 24.98 111.899 171.803 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.545 HD11 HG21 ' A' ' 5' ' ' VAL . 79.2 mt -79.51 -37.6 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.853 0.835 . . . . 9.46 111.921 173.401 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -61.94 -38.64 89.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.157 1.932 . . . . 14.76 114.129 168.808 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.7 -55.62 25.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.794 1.405 . . . . 26.29 114.794 172.069 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -67.78 -58.01 5.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.664 -3.147 . . . . 30.06 115.807 -174.812 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -95.52 -52.29 4.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.28 2.238 . . . . 25.19 115.533 -168.202 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.59 38.18 0.86 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 116.58 -2.724 . . . . 7.41 114.402 174.091 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.56 HG21 HD21 ' A' ' 71' ' ' LEU . 54.2 mt -114.56 120.86 37.0 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-O 111.936 -3.888 . . . . 9.49 103.609 -176.007 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -72.46 157.82 52.3 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 125.124 2.866 . . . . 11.42 112.508 -173.992 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -73.8 -32.34 7.47 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 122.813 2.041 . . . . 12.0 110.674 -162.518 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -59.73 -41.87 91.89 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.006 1.854 . . . . 35.55 116.006 -178.058 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -65.64 -27.75 68.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.095 2.258 . . . . 20.52 117.095 179.258 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -74.97 155.32 37.51 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.236 3.05 . . . . 7.13 119.236 177.849 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -143.71 97.16 3.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.084 2.153 . . . . 36.39 113.779 177.549 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.6 mt -91.69 129.49 37.66 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.666 2.65 . . . . 9.55 116.104 -167.201 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -120.1 128.71 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 2 O-C-N 115.692 -4.38 . . . . 13.9 115.532 -169.048 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -118.06 119.57 35.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.902 -2.374 . . . . 6.86 104.94 176.916 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.51 -96.6 0.05 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.774 3.23 . . . . 11.15 109.825 -168.622 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.94 21.31 4.43 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 126.727 2.108 . . . . 13.93 114.099 176.594 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -134.85 145.27 48.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.465 -1.609 . . . . 23.92 108.091 -170.164 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -95.73 139.38 32.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.443 2.339 . . . . 23.23 114.456 -168.955 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.2 mt -87.31 136.13 33.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.124 2.392 . . . . 9.11 112.14 -166.846 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -96.3 147.96 23.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.374 -2.704 . . . . 33.44 112.65 176.036 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -62.25 -43.49 98.71 Favored 'General case' 0 N--CA 1.431 -1.413 1 CA-C-O 128.821 4.153 . . . . 28.37 117.607 -160.394 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.76 -23.39 75.66 Favored Glycine 0 N--CA 1.43 -1.727 0 O-C-N 117.939 -2.976 . . . . 15.0 112.766 -173.375 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 mmm-85 -84.39 151.35 24.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.517 2.658 . . . . 25.5 107.913 -158.856 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -81.13 171.92 14.31 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.457 -6.402 . . . . 11.95 114.208 175.721 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.2 mt -69.82 -24.72 63.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.371 -2.706 . . . . 10.17 115.061 166.102 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -56.82 -43.93 81.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.802 2.89 . . . . 13.59 118.802 167.722 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -57.72 -56.23 24.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 110.812 -2.904 . . . . 11.7 110.371 -176.562 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -75.38 -21.52 58.22 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.504 -2.134 . . . . 12.95 115.358 -177.028 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 62.15 55.37 2.47 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.969 3.307 . . . . 25.45 107.878 -171.787 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 mt -88.34 112.52 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 116.079 -1.915 . . . . 14.6 106.675 161.371 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -108.93 -158.37 0.65 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.118 2.266 . . . . 33.23 117.118 -179.195 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -61.47 124.95 22.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.287 3.435 . . . . 25.97 114.549 168.17 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.307 38.5 mt-10 78.14 2.99 2.81 Favored 'General case' 0 N--CA 1.43 -1.434 1 N-CA-C 122.164 4.135 . . . . 32.61 122.164 -169.47 . . . . . . . . 3 2 . 1 . 109 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -75.24 122.59 23.91 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.105 -4.122 . . . . 10.56 113.547 -175.752 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 4' ' ' PHE . 6.0 m -102.22 118.02 36.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.419 1.918 . . . . 5.33 113.673 177.854 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.45 HD12 HG22 ' A' ' 5' ' ' VAL . 85.7 mt -88.18 159.4 18.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.684 -1.969 . . . . 11.66 105.684 -178.204 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -110.3 136.92 48.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.086 -2.259 . . . . 16.3 106.977 173.787 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -105.72 140.49 38.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.519 -1.988 . . . . 9.96 107.41 170.506 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.273 28.4 t -114.6 140.17 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 128.003 2.521 . . . . 9.76 106.737 167.998 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.56 HD21 HG21 ' A' ' 36' ' ' ILE . 64.9 mt -118.31 131.51 56.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.181 2.192 . . . . 19.57 108.707 178.986 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -81.42 170.43 15.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 127.452 2.97 . . . . 35.08 109.697 169.373 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.1 tp -109.42 -40.58 4.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.376 1.47 . . . . 32.31 110.372 -175.943 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -157.98 -100.04 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 115.229 -2.32 . . . . 42.75 109.548 -171.897 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.71 142.46 16.06 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 125.535 3.788 . . . . 36.31 111.401 -173.924 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.771 0 N-CA-C 105.691 -2.963 . . . . 36.27 105.691 151.929 . . . . . . . . 0 0 . 1 . 110 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 11.2 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 117.94 2.57 . . . . 17.17 117.94 . . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.266 31.1 mt-30 -71.96 131.15 42.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.655 -3.153 . . . . 21.89 112.098 -178.813 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 pt -135.96 155.06 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 101.324 -3.584 . . . . 10.83 101.324 -169.795 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.29 118.66 37.31 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.826 2.05 . . . . 10.61 114.508 175.683 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -114.67 104.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 104.762 -2.31 . . . . 9.13 104.762 -177.063 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -89.89 123.3 33.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.813 2.845 . . . . 20.55 112.66 -175.904 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -78.33 166.58 22.51 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.87 1.319 . . . . 11.78 113.619 -172.36 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.464 HD22 ' H ' ' A' ' 71' ' ' LEU . 32.5 tp -58.43 -47.64 83.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.405 -3.934 . . . . 19.31 115.03 175.112 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -63.02 -69.82 0.24 Allowed 'General case' 0 N--CA 1.43 -1.471 2 CA-C-O 111.163 -4.255 . . . . 23.14 108.804 176.26 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.66 45.27 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 O-C-N 126.706 2.504 . . . . 19.74 116.129 179.438 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -127.24 142.23 51.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.712 -1.464 . . . . 21.93 107.105 -172.766 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.5 m -112.44 131.75 55.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.391 1.567 . . . . 12.33 107.644 175.203 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 pt -122.56 145.4 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.654 -2.529 . . . . 17.08 105.38 171.149 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m -113.21 110.44 20.4 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.772 -3.705 . . . . 16.3 107.66 -166.991 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 mt -115.49 152.02 33.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 118.026 -0.988 . . . . 15.88 112.256 -170.52 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -97.86 125.63 42.83 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 127.088 3.327 . . . . 28.9 117.672 162.935 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.0 175.36 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 111.307 -2.679 . . . . 12.05 111.511 167.425 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -102.04 178.42 1.22 Allowed Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.647 -2.121 . . . . 18.17 107.628 168.012 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -71.84 -26.54 18.88 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 C-N-CA 122.297 1.998 . . . . 8.16 115.235 163.966 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -83.14 -8.97 59.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.782 2.882 . . . . 11.13 118.782 177.133 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -69.11 155.34 40.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.934 2.198 . . . . 18.03 116.934 171.853 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.8 p -106.35 -172.83 2.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.651 -1.28 . . . . 10.22 107.731 -176.258 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.734 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 43.3 mm -81.38 -25.99 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 125.139 2.4 . . . . 12.3 111.895 -178.746 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -53.23 -43.3 67.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.192 -3.442 . . . . 36.51 112.705 164.139 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -75.33 -45.25 40.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.736 -2.477 . . . . 25.66 111.775 -178.443 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.1 t -50.37 -56.93 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 124.874 1.269 . . . . 8.12 111.402 166.593 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -58.63 -32.33 68.94 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 119.84 3.274 . . . . 15.47 119.84 179.26 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.32 -49.09 59.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.87 -3.019 . . . . 11.45 109.718 173.051 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -46.64 -47.48 20.14 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.17 -2.831 . . . . 24.98 116.7 172.197 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.469 HD13 HD13 ' A' ' 69' ' ' LEU . 94.7 mt -54.94 -44.4 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.353 2.661 . . . . 9.46 113.412 171.903 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -67.0 -50.64 61.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.738 2.415 . . . . 14.76 111.751 173.595 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.7 -56.83 17.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.228 -2.795 . . . . 26.29 113.909 173.307 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.262 35.4 tptt -57.93 -80.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.31 2.005 . . . . 30.06 116.043 174.334 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -68.25 -56.86 7.18 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 126.79 3.186 . . . . 25.19 112.787 -170.632 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.75 13.77 0.93 Allowed Glycine 0 N--CA 1.431 -1.666 1 O-C-N 115.361 -4.587 . . . . 7.41 110.096 169.535 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.68 134.07 27.01 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 116.334 -1.793 . . . . 9.49 112.713 -169.04 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -76.22 150.44 33.08 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 121.603 1.608 . . . . 11.42 109.487 177.041 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 89.3 Cg_endo -78.3 -9.56 16.34 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 123.799 3.0 . . . . 12.0 111.692 -170.384 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -65.13 -22.6 66.95 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 127.315 3.436 . . . . 35.55 111.348 165.442 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -90.78 -23.28 20.67 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.723 -4.36 . . . . 20.52 113.372 -173.969 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -89.06 131.29 35.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.025 -2.922 . . . . 7.13 114.144 -166.053 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -121.84 126.85 49.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.013 -1.847 . . . . 36.39 106.013 156.995 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 43' ' ' LEU . 26.6 tp -106.96 127.05 53.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.119 1.367 . . . . 9.55 112.778 178.974 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -129.25 138.17 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 126.9 2.08 . . . . 13.9 111.998 -165.988 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -120.62 122.04 39.66 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 114.914 -4.867 . . . . 6.86 102.39 166.851 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.27 -85.51 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.067 2.147 . . . . 11.15 111.82 -174.927 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.59 23.08 1.34 Allowed Glycine 0 N--CA 1.429 -1.787 0 O-C-N 118.935 -2.353 . . . . 13.93 109.687 171.631 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -95.12 116.9 29.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.073 2.149 . . . . 23.92 114.136 168.196 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -70.36 119.22 14.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 118.817 2.895 . . . . 23.23 118.817 169.571 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.83 134.79 33.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.425 -3.297 . . . . 9.11 116.899 -167.958 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -103.6 143.25 33.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.485 1.948 . . . . 33.44 115.426 -172.592 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.734 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 9.0 m-20 -50.46 -37.74 39.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.702 3.201 . . . . 28.37 119.272 -161.784 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.74 35.3 4.57 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 115.218 -2.99 . . . . 15.0 111.473 -178.425 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -110.77 153.91 24.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 122.566 3.183 . . . . 25.5 106.151 166.448 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.307 10.9 p -86.25 162.03 18.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.153 2.581 . . . . 11.95 107.1 -176.348 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.07 -32.63 73.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.287 -2.133 . . . . 10.17 115.37 169.014 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.1 t -60.08 -40.37 89.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.688 2.395 . . . . 13.59 112.762 167.199 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.5 -48.63 80.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.716 -2.49 . . . . 11.7 115.583 169.173 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.273 10.5 m-85 -82.46 4.88 22.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.752 1.39 . . . . 12.95 114.752 -179.979 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 59.37 28.31 17.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 114.805 -2.521 . . . . 25.45 114.79 -176.588 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.9 mt -76.18 126.58 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 124.21 3.186 . . . . 14.6 111.944 166.408 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -102.73 -179.29 3.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.221 2.439 . . . . 33.23 116.317 178.834 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -78.33 136.34 37.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 112.838 -1.983 . . . . 25.97 110.253 179.684 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.26 11.5 tt0 75.12 30.64 0.87 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.424 2.379 . . . . 32.61 117.424 -177.083 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -113.54 160.0 18.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.466 -2.021 . . . . 10.56 110.324 -175.965 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -109.39 115.25 29.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.203 2.601 . . . . 5.33 113.869 -173.068 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.54 156.91 18.31 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 111.662 -2.517 . . . . 11.66 113.611 170.869 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -116.33 109.46 17.41 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 112.415 -2.175 . . . . 16.3 107.838 -176.03 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.469 HD13 HD13 ' A' ' 30' ' ' ILE . 10.8 tp -89.31 114.33 25.71 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.583 -3.198 . . . . 9.96 103.674 179.177 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.3 t -114.51 132.27 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 118.07 -2.894 . . . . 9.76 108.129 -178.697 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.464 ' H ' HD22 ' A' ' 8' ' ' LEU . 11.4 mt -113.01 156.5 22.95 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.419 2.056 . . . . 19.57 106.005 -165.332 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.273 30.5 ptt180 -81.93 143.77 31.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.296 -1.775 . . . . 35.08 112.275 -177.162 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 tp -84.01 -45.4 13.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.826 1.954 . . . . 32.31 110.144 167.726 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.592 ' HE ' ' HA ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -159.9 140.78 12.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.155 -2.84 . . . . 42.75 106.477 -178.278 . . . . . . . . 3 3 . 1 . 110 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 -73.67 2.42 Favored Glycine 0 N--CA 1.429 -1.78 0 O-C-N 118.043 -2.911 . . . . 36.31 115.786 173.182 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.744 0 CA-C-O 114.654 -3.303 . . . . 36.27 117.12 -170.03 . . . . . . . . 0 0 . 1 . 111 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.457 ' SD ' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 121.102 0.477 . . . . 17.17 110.039 . . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -89.5 134.37 34.14 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.911 -1.743 . . . . 21.89 113.079 -171.302 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -115.18 139.2 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.072 -2.893 . . . . 10.83 112.062 160.595 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.285 12.3 m-85 -109.89 88.91 2.86 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.55 -5.094 . . . . 10.61 107.972 -169.248 . . . . . . . . 3 2 . 1 . 111 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.13 100.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 CA-C-O 129.184 4.326 . . . . 9.13 113.522 173.353 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.28 46.7 mttt -83.31 148.57 27.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.15 -3.469 . . . . 20.55 113.752 178.536 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -104.27 -179.35 3.92 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.164 -2.21 . . . . 11.78 110.678 -168.322 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.325 1.9 tp -66.34 -41.18 89.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.996 1.48 . . . . 19.31 114.996 171.833 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.31 16.2 p -71.55 -66.22 0.66 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.589 2.614 . . . . 23.14 117.348 177.797 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.09 22.49 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 125.205 2.559 . . . . 19.74 119.451 -166.483 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -106.12 147.59 28.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.412 -2.394 . . . . 21.93 108.98 179.182 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -124.22 106.28 10.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.375 -2.454 . . . . 12.33 104.375 178.827 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -90.59 102.85 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 105.247 -2.131 . . . . 17.08 105.247 -177.933 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.2 m -81.14 121.65 26.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.081 -2.563 . . . . 16.3 104.081 -177.015 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.443 HD11 ' CG1' ' A' ' 30' ' ' ILE . 92.4 mt -112.37 133.97 54.17 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.38 2.363 . . . . 15.88 117.38 175.411 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.338 32.7 mt-10 -87.47 97.89 11.08 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.943 -4.223 . . . . 28.9 107.521 -177.677 . . . . . . . . 3 2 . 1 . 111 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -123.56 177.24 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.24 -1.538 . . . . 12.05 113.328 178.234 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -128.17 171.18 8.91 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.208 -1.853 . . . . 18.17 111.852 168.685 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -70.0 -16.37 36.54 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 C-N-CA 125.512 4.141 . . . . 8.16 113.829 -174.312 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.2 m -92.96 -3.62 54.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.849 2.86 . . . . 11.13 110.919 179.476 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.54 154.72 40.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.368 -2.707 . . . . 18.03 115.348 176.507 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.8 p -93.65 156.5 16.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.286 -2.487 . . . . 10.22 104.286 -179.807 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -51.85 -36.5 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.637 -3.789 . . . . 12.3 113.52 167.561 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.67 -39.42 88.33 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.276 -2.765 . . . . 36.51 112.186 174.801 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -62.01 -47.17 85.98 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.764 -2.065 . . . . 25.66 113.049 170.421 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.5 t -44.83 -56.13 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 1 C-N-CA 131.915 4.086 . . . . 8.12 111.068 172.213 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.95 -34.25 76.23 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.329 -3.357 . . . . 15.47 113.338 -174.024 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.55 85.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 114.68 1.363 . . . . 11.45 114.68 165.482 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -65.28 -32.2 73.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.072 -2.893 . . . . 24.98 113.012 173.669 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' CG1' HD11 ' A' ' 15' ' ' LEU . 87.5 mt -70.96 -44.75 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.147 -1.596 . . . . 9.46 109.189 176.527 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -57.44 -52.4 65.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.861 -2.399 . . . . 14.76 110.906 169.076 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -48.62 -53.23 19.33 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.899 3.296 . . . . 26.29 119.899 171.622 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -82.67 -57.88 3.14 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.191 -4.068 . . . . 30.06 118.38 179.63 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -86.75 -25.47 24.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.893 1.442 . . . . 25.19 114.893 -172.563 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.44 23.0 38.31 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 126.703 2.502 . . . . 7.41 119.004 -176.585 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.6 mt -96.95 127.23 39.71 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 113.016 -3.374 . . . . 9.49 106.466 -175.223 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 94.9 Cg_endo -81.3 153.97 18.67 Favored 'Trans proline' 0 C--N 1.299 -2.034 2 C-N-CA 126.941 5.094 . . . . 11.42 112.736 179.038 . . . . . . . . 3 3 . 1 . 111 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 45.1 Cg_endo -71.58 -18.19 29.33 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 124.679 3.586 . . . . 12.0 108.469 -159.982 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.261 41.4 m-20 -73.96 -22.97 59.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.1 2.125 . . . . 35.55 113.206 179.341 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -91.03 -3.57 57.11 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.68 2.487 . . . . 20.52 110.993 179.122 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -94.36 102.66 14.65 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.364 2.347 . . . . 7.13 115.77 -166.256 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -90.83 100.6 13.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.392 -3.318 . . . . 36.39 107.38 158.405 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.0 tp -95.14 106.89 18.94 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.119 -1.855 . . . . 9.55 109.659 174.435 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.11 127.24 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 127.619 2.367 . . . . 13.9 109.921 -168.681 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -118.77 111.82 18.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.481 -1.387 . . . . 6.86 110.663 173.869 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.01 -103.14 0.11 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.264 2.626 . . . . 11.15 111.666 -165.663 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.42 20.53 3.71 Favored Glycine 0 N--CA 1.431 -1.697 0 O-C-N 118.314 -2.741 . . . . 13.93 107.239 166.469 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -85.93 133.77 33.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.987 2.327 . . . . 23.92 114.28 165.069 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -93.01 125.91 37.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.628 -1.624 . . . . 23.23 107.628 178.614 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -98.89 144.39 28.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.135 2.772 . . . . 9.11 111.593 -174.389 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -113.01 149.51 33.23 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.216 1.96 . . . . 33.44 110.416 -175.655 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.32 -48.86 79.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.894 2.183 . . . . 28.37 116.894 -160.917 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.96 7.53 78.85 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 118.761 2.264 . . . . 15.0 118.761 -175.39 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -88.37 149.91 23.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.307 -0.946 . . . . 25.5 109.556 170.775 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -84.86 168.45 15.07 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.38 -2.075 . . . . 11.95 115.296 176.7 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.0 mt -73.13 -39.23 65.9 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 127.804 2.441 . . . . 10.17 110.605 178.451 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -68.54 -39.27 81.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.874 2.07 . . . . 13.59 112.651 178.383 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.56 -32.86 71.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 121.568 1.985 . . . . 11.7 109.506 175.739 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.27 -13.04 53.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 122.181 2.264 . . . . 12.95 106.331 176.358 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.327 59.7 m-20 80.66 28.0 0.23 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.968 2.507 . . . . 25.45 113.098 -178.471 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -81.66 109.33 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.517 -2.614 . . . . 14.6 110.196 -174.555 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -90.71 -178.97 5.41 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.831 2.453 . . . . 33.23 109.5 -177.282 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HA ' ' SD ' ' A' ' 1' ' ' MET 0.258 20.2 pttp -64.78 151.69 44.63 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.077 1.88 . . . . 25.97 116.077 173.174 . . . . . . . . 3 3 . 1 . 111 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 69.01 19.62 8.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.254 3.421 . . . . 32.61 117.877 177.03 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -76.39 125.81 29.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.971 2.908 . . . . 10.56 111.654 -176.619 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.6 m -77.66 113.41 15.48 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.065 2.728 . . . . 5.33 112.556 177.582 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.91 161.22 14.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.381 1.473 . . . . 11.66 113.62 167.315 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -106.35 132.92 51.82 Favored 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 131.727 4.011 . . . . 16.3 109.654 164.692 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -116.28 101.62 8.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.229 2.919 . . . . 9.96 109.55 171.694 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -99.93 143.65 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 118.89 -2.381 . . . . 9.76 108.618 170.704 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.2 mt -101.96 145.5 29.18 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 114.878 -4.889 . . . . 19.57 109.241 -178.012 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -123.07 -158.21 0.78 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 126.246 2.216 . . . . 35.08 106.02 173.348 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tt -108.37 -55.79 2.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 124.327 3.24 . . . . 32.31 110.889 168.611 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtt-85 -155.25 -175.13 5.28 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 102.981 -2.97 . . . . 42.75 102.981 178.303 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.81 -117.52 4.9 Favored Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.806 -1.184 . . . . 36.31 111.603 177.204 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.774 1 N-CA-C 102.41 -4.276 . . . . 36.27 102.41 -173.548 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptt? . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 113.642 0.979 . . . . 17.17 113.642 . . . . . . . . . 0 0 . 1 . 112 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -103.59 121.71 43.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.08 2.371 . . . . 21.89 110.142 176.206 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -111.1 146.41 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.986 -2.321 . . . . 10.83 113.052 168.73 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -108.01 142.74 37.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.22 -1.809 . . . . 10.61 114.643 -176.876 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -131.41 119.47 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.847 -3.02 . . . . 9.13 102.847 -172.957 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -118.31 115.82 25.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 112.896 -3.431 . . . . 20.55 110.304 -165.793 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -63.19 175.77 0.88 Allowed 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 129.917 4.51 . . . . 11.78 112.863 174.992 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.9 tp -67.82 -36.71 80.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.608 -0.724 . . . . 19.31 112.501 -179.677 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -86.17 -47.87 9.09 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.162 1.785 . . . . 23.14 107.182 -168.896 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.24 40.69 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 CA-C-O 123.165 1.425 . . . . 19.74 112.026 168.73 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -90.81 123.83 34.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.211 1.957 . . . . 21.93 111.305 163.101 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -99.54 106.73 18.76 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 111.946 -2.388 . . . . 12.33 108.868 -176.472 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.32 118.53 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.548 -1.345 . . . . 17.08 109.668 -177.949 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 m -100.19 121.93 42.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.395 -3.316 . . . . 16.3 105.033 -173.023 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 15' ' ' LEU . 23.4 mt -122.42 141.16 51.9 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.421 1.888 . . . . 15.88 108.357 -176.951 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -100.43 132.87 45.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 127.99 3.757 . . . . 28.9 107.702 174.24 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -137.23 174.51 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.328 -3.357 . . . . 12.05 109.456 -175.447 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -122.54 157.11 60.14 Favored Pre-proline 0 N--CA 1.43 -1.464 0 C-N-CA 123.928 0.891 . . . . 18.17 109.015 151.123 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.5 -25.17 75.69 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.363 2.709 . . . . 8.16 113.703 -171.087 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -86.41 7.45 25.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.645 1.566 . . . . 11.13 112.471 -171.515 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -87.35 147.39 25.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.215 -2.178 . . . . 18.03 105.62 -172.145 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.4 p -82.77 151.63 26.05 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.301 -2.125 . . . . 10.22 112.685 -177.658 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -51.94 -43.22 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 130.607 3.563 . . . . 12.3 109.149 176.84 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.76 -37.74 79.86 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 125.96 2.037 . . . . 36.51 114.449 178.325 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.254 71.9 m-80 -72.83 -32.91 65.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.662 -2.524 . . . . 25.66 114.803 176.786 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.77 -36.03 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 127.127 2.171 . . . . 8.12 110.771 167.188 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -70.69 -26.93 63.65 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.399 -2.688 . . . . 15.47 115.809 169.05 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.41 72.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.294 1.861 . . . . 11.45 109.999 167.923 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -63.87 -33.04 74.81 Favored 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 115.694 -4.378 . . . . 24.98 115.24 178.905 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 mt -69.77 -32.3 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.847 -2.408 . . . . 9.46 108.682 172.651 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -69.98 -44.88 68.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.927 -3.608 . . . . 14.76 109.188 173.479 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -61.17 -46.03 92.17 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.736 2.208 . . . . 26.29 116.335 179.286 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -79.01 -60.82 2.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.742 -3.724 . . . . 30.06 116.647 -174.106 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -86.59 -53.86 4.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 126.182 2.176 . . . . 25.19 111.443 177.21 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.08 33.58 2.75 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 115.958 -2.579 . . . . 7.41 113.958 -172.796 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.52 127.82 36.6 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 130.185 3.394 . . . . 9.49 103.826 166.366 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -77.75 161.67 30.39 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-O 112.905 -3.04 . . . . 11.42 115.271 -177.498 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -66.84 -24.7 46.27 Favored 'Trans proline' 0 N--CA 1.434 -1.999 1 CA-C-N 129.772 4.526 . . . . 12.0 116.693 -172.079 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.06 -31.94 72.41 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.491 2.369 . . . . 35.55 113.418 -174.222 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.402 45.0 mt-30 -72.95 -16.91 61.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 119.427 3.121 . . . . 20.52 119.427 -179.53 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -102.68 110.16 22.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.105 -3.497 . . . . 7.13 114.268 -155.521 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -94.14 103.94 15.97 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.178 -2.527 . . . . 36.39 104.178 169.178 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.08 118.46 31.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.086 2.374 . . . . 9.55 110.114 174.773 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.1 mt -113.6 136.72 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 110.563 -3.017 . . . . 13.9 107.584 -179.393 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -120.36 113.35 20.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 101.494 -3.521 . . . . 6.86 101.494 172.368 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.74 -117.14 0.47 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.085 -2.26 . . . . 11.15 111.314 -176.125 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.37 25.29 13.97 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 117.911 -2.993 . . . . 13.93 116.656 175.234 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -131.35 142.6 50.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.51 2.576 . . . . 23.92 109.305 -173.3 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -110.29 141.78 42.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.394 -2.691 . . . . 23.23 111.82 -177.284 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mt -95.2 140.54 29.96 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.134 2.397 . . . . 9.11 110.606 -166.646 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -109.61 136.54 48.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.936 -1.938 . . . . 33.44 111.67 -172.359 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.7 -60.26 2.1 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.532 1.678 . . . . 28.37 115.532 -170.944 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.82 -4.03 61.04 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 118.797 -2.439 . . . . 15.0 117.805 -173.905 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -83.63 178.78 7.82 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 118.634 1.217 . . . . 25.5 110.689 170.883 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 76.6 p -106.09 178.44 4.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.333 -1.479 . . . . 11.95 109.958 177.058 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.9 mt -74.18 -33.89 63.6 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.591 1.156 . . . . 10.17 108.29 179.897 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -78.06 -27.35 48.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.389 3.076 . . . . 13.59 111.219 -175.007 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.02 -34.92 79.09 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 116.81 -1.567 . . . . 11.7 110.005 179.993 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -88.33 1.87 53.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.922 3.289 . . . . 12.95 114.103 167.521 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m120 58.31 49.07 11.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.25 1.204 . . . . 25.45 114.25 -178.098 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mm -79.18 113.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.22 -2.175 . . . . 14.6 106.767 170.436 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -87.62 -177.68 5.92 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.924 2.015 . . . . 33.23 112.42 174.087 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -64.03 134.42 54.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.667 -3.145 . . . . 25.97 115.408 164.508 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 69.84 31.22 3.53 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.757 2.217 . . . . 32.61 111.425 173.719 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.267 45.6 t -83.69 134.27 34.77 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.932 1.693 . . . . 10.56 108.54 166.499 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 m -103.96 122.84 46.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.716 -1.24 . . . . 5.33 108.377 -179.573 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -81.99 138.71 34.85 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 115.135 -2.364 . . . . 11.66 116.073 165.185 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -88.5 114.61 25.29 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.172 2.17 . . . . 16.3 107.352 175.281 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.268 9.5 tp -92.55 106.45 18.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 117.672 -1.611 . . . . 9.96 112.216 176.092 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.61 138.68 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.836 2.455 . . . . 9.76 105.37 179.267 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 mt -103.13 139.93 37.99 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.485 2.032 . . . . 19.57 116.485 -171.897 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -123.18 173.92 7.59 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.855 1.057 . . . . 35.08 113.855 171.908 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.45 -75.51 0.19 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 117.655 -1.618 . . . . 32.31 111.92 175.522 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -134.06 -172.23 2.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.285 2.469 . . . . 42.75 105.441 170.267 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.51 -113.13 3.96 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-O 127.471 3.817 . . . . 36.31 111.416 166.733 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.759 0 O-C-N 118.276 -2.896 . . . . 36.27 116.414 -166.286 . . . . . . . . 0 0 . 1 . 113 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.283 -0.636 . . . . 17.17 109.283 . . . . . . . . . 0 0 . 1 . 113 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -89.88 120.97 31.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.185 -0.672 . . . . 21.89 109.185 165.744 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -117.01 167.88 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 118.499 -2.626 . . . . 10.83 108.129 157.043 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.1 133.96 55.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.847 -2.408 . . . . 10.61 115.529 -176.163 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -112.62 117.76 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 123.875 1.798 . . . . 9.13 110.661 175.323 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -96.58 151.86 19.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 112.278 -3.725 . . . . 20.55 110.771 177.142 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.6 p -85.21 -176.07 6.0 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 121.675 2.034 . . . . 11.78 113.327 159.88 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.252 36.5 mt -86.15 -17.93 33.62 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.407 1.003 . . . . 19.31 113.595 169.329 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 p -77.97 -69.56 0.54 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.575 2.35 . . . . 23.14 113.196 175.985 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.9 28.25 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.719 1 O-C-N 115.117 -4.739 . . . . 19.74 111.022 -177.504 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -109.06 130.65 55.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.116 -1.226 . . . . 21.93 111.085 179.091 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -111.17 115.99 30.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.015 -3.553 . . . . 12.33 108.151 173.577 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 pt -105.15 155.39 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 117.261 -1.776 . . . . 17.08 108.537 171.625 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.1 m -111.91 131.95 55.05 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.917 -2.623 . . . . 16.3 103.917 -177.287 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.3 tp -144.87 125.94 14.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.679 -2.513 . . . . 15.88 109.047 -164.885 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.82 103.47 15.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.045 -2.284 . . . . 28.9 110.996 -172.833 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -131.95 155.45 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 115.379 -0.828 . . . . 12.05 110.483 176.891 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -85.79 146.41 43.6 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 117.517 -1.23 . . . . 18.17 110.035 178.153 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.03 -10.69 21.53 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 N-CA-C 118.197 2.345 . . . . 8.16 118.197 177.288 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 p -90.83 -7.19 53.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.363 2.665 . . . . 11.13 114.746 175.927 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -69.56 149.27 48.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.741 -1.224 . . . . 18.03 110.415 176.402 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -79.78 170.13 16.96 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 117.026 -1.464 . . . . 10.22 110.492 175.931 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -72.24 -29.04 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 127.062 2.145 . . . . 12.3 110.761 178.392 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -59.44 -47.39 85.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.369 -2.707 . . . . 36.51 113.246 163.483 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -62.63 -40.17 96.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.052 2.206 . . . . 25.66 115.163 170.499 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -56.59 -50.91 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 121.499 1.954 . . . . 8.12 112.98 171.471 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -68.52 -30.19 68.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.256 -2.778 . . . . 15.47 112.892 -176.507 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.29 77.53 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.216 1.806 . . . . 11.45 109.844 174.088 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -80.48 -39.77 27.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.207 1.479 . . . . 24.98 109.882 -176.454 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.4 mt -56.32 -39.26 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.408 -3.932 . . . . 9.46 113.665 162.746 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.351 17.6 tt0 -56.31 -51.65 67.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.131 2.972 . . . . 14.76 108.334 167.374 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.62 -37.75 76.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 121.711 2.051 . . . . 26.29 112.318 -168.181 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -83.01 -66.0 0.94 Allowed 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 129.212 4.07 . . . . 30.06 116.77 -178.399 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -93.48 -26.16 17.3 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.671 1.188 . . . . 25.19 112.748 -169.995 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.62 37.88 8.48 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.389 1.471 . . . . 7.41 114.427 178.526 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.591 HD13 HD21 ' A' ' 71' ' ' LEU . 4.7 mt -88.9 128.86 50.54 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 118.739 -1.184 . . . . 9.49 113.105 160.862 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.39 158.2 36.79 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 123.288 2.659 . . . . 11.42 111.815 170.186 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -90.31 0.28 5.35 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 116.808 -2.259 . . . . 12.0 109.916 -159.931 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -77.09 -29.73 55.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.665 -2.522 . . . . 35.55 110.755 169.626 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -71.23 -37.77 72.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.089 -2.257 . . . . 20.52 109.174 175.433 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -76.99 116.89 18.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.023 2.231 . . . . 7.13 117.023 -164.909 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -115.59 120.31 39.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.1 1.905 . . . . 36.39 108.482 166.75 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -111.77 112.97 25.03 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.245 -4.034 . . . . 9.55 110.442 -169.447 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.6 mm -102.89 137.84 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.479 -2.013 . . . . 13.9 110.026 -177.93 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -106.46 111.58 24.22 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.747 -5.596 . . . . 6.86 108.079 153.786 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.44 -99.17 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.192 2.597 . . . . 11.15 115.615 -174.534 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -122.53 8.62 9.46 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 118.985 -2.322 . . . . 13.93 115.018 161.174 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -89.27 124.89 34.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.033 1.333 . . . . 23.92 114.546 172.475 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -85.47 131.51 34.37 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.145 -2.539 . . . . 23.23 104.145 -179.341 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -93.37 126.76 38.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.379 1.472 . . . . 9.11 110.17 -175.653 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -121.0 150.45 41.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.911 2.141 . . . . 33.44 113.011 -164.77 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.365 67.2 m-20 -18.02 -74.7 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.432 1 C-N-CA 132.285 4.234 . . . . 28.37 120.039 -168.968 . . . . . . . . 3 2 . 1 . 113 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.38 34.34 5.19 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.713 -2.492 . . . . 15.0 116.339 -164.802 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -133.55 171.34 14.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.862 -1.964 . . . . 25.5 111.949 175.989 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -95.54 167.21 11.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.664 2.029 . . . . 11.95 112.889 -167.519 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.53 -34.25 76.54 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.53 -2.606 . . . . 10.17 112.908 166.828 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -38.22 79.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.426 1.269 . . . . 13.59 114.426 178.129 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -56.4 -50.38 71.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.596 -3.815 . . . . 11.7 114.044 177.914 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -77.78 8.42 4.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 127.576 3.048 . . . . 12.95 113.631 178.163 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 2.0 m120 54.4 40.33 31.69 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 131.748 4.019 . . . . 25.45 117.222 -179.519 . . . . . . . . 3 2 . 1 . 113 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.346 10.1 mt -77.77 115.72 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.407 -1.433 . . . . 14.6 109.307 178.962 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -91.85 176.06 6.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.207 -3.433 . . . . 33.23 108.473 176.361 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -69.38 146.91 51.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.346 -2.721 . . . . 25.97 114.023 176.817 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 71.35 18.59 5.55 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 129.652 3.181 . . . . 32.61 112.561 -179.102 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.8 m -76.69 148.95 36.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.199 -2.813 . . . . 10.56 112.507 178.949 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.4 m -90.96 106.09 18.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.472 2.309 . . . . 5.33 115.735 170.507 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -91.44 152.24 20.46 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.422 2.289 . . . . 11.66 114.311 166.164 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -119.77 125.84 49.57 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.184 -2.822 . . . . 16.3 103.956 -169.76 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -102.2 123.53 46.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.723 2.409 . . . . 9.96 108.053 177.915 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.76 130.6 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 113.41 -1.723 . . . . 9.76 114.089 162.292 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.591 HD21 HD13 ' A' ' 36' ' ' ILE . 10.8 mt -98.71 140.89 32.24 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.486 3.114 . . . . 19.57 117.926 176.531 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.266 38.3 ttt180 -73.38 138.53 45.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 115.535 1.68 . . . . 35.08 115.535 179.188 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.264 76.1 mt -104.68 170.43 7.89 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.028 -1.841 . . . . 32.31 106.028 176.413 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -75.86 159.69 30.71 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.197 -0.939 . . . . 42.75 112.643 176.493 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 38.18 74.34 0.12 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 117.907 1.923 . . . . 36.31 117.907 -171.086 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.726 0 CA-C-N 109.112 -3.544 . . . . 36.27 112.7 -175.218 . . . . . . . . 0 0 . 1 . 114 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ptt? . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 118.514 2.783 . . . . 17.17 118.514 . . . . . . . . . 0 0 . 1 . 114 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.371 36.7 mt-30 -69.01 128.48 36.85 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.253 -2.129 . . . . 21.89 105.253 170.569 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 pt -123.4 151.8 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.677 -2.056 . . . . 10.83 110.972 161.983 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -96.37 130.01 43.58 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.738 -0.785 . . . . 10.61 111.402 174.778 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 67' ' ' LEU . 76.3 t -119.26 125.14 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 103.126 -2.916 . . . . 9.13 103.126 160.966 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -119.48 132.22 55.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 109.983 -3.28 . . . . 20.55 105.985 -175.942 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 69' ' ' LEU . 10.5 p -75.34 157.58 34.07 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.794 -3.066 . . . . 11.78 109.109 174.552 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.5 mt -61.59 -39.76 92.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.514 -3.241 . . . . 19.31 114.43 159.283 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -48.02 -34.57 9.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.001 2.12 . . . . 23.14 112.794 172.141 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.04 -62.88 0.32 Allowed Glycine 0 N--CA 1.43 -1.725 1 O-C-N 114.156 -5.34 . . . . 19.74 119.801 -178.638 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -80.78 160.76 24.78 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 115.296 -2.561 . . . . 21.93 117.084 -158.251 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.69 131.29 48.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.427 -1.42 . . . . 12.33 109.493 166.641 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 pt -112.9 144.54 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 129.216 3.006 . . . . 17.08 109.017 157.219 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -106.34 128.22 53.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.129 2.571 . . . . 16.3 104.97 179.231 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.15 129.33 54.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.577 1.551 . . . . 15.88 110.978 172.902 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -79.73 101.84 8.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 120.318 1.417 . . . . 28.9 113.451 159.899 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -111.22 166.76 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.624 -3.173 . . . . 12.05 115.221 173.996 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -95.76 154.96 38.97 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.926 -1.879 . . . . 18.17 105.926 167.838 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.252 14.1 Cg_exo -63.0 -21.56 73.3 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 N-CA-C 116.008 1.503 . . . . 8.16 116.008 170.26 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.5 p -80.96 -2.48 47.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.878 1.671 . . . . 11.13 115.475 175.351 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.77 148.72 28.76 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.94 3.296 . . . . 18.03 106.533 -171.017 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 26' ' ' VAL . 57.9 p -91.18 164.12 14.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.256 -2.247 . . . . 10.22 105.551 -179.392 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.659 HG23 HD23 ' A' ' 43' ' ' LEU . 41.1 mm -72.48 -30.9 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 116.948 -1.501 . . . . 12.3 107.124 174.592 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -51.53 -50.96 59.0 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 125.47 3.759 . . . . 36.51 114.503 168.777 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -60.39 -28.28 68.1 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.388 2.366 . . . . 25.66 117.388 174.087 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 22' ' ' THR . 88.5 t -65.66 -47.86 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 129.251 3.02 . . . . 8.12 110.825 172.018 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -70.48 -30.05 66.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.166 2.412 . . . . 15.47 109.794 178.402 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.62 74.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.365 -3.959 . . . . 11.45 109.783 -179.133 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -70.48 -27.81 64.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.302 -2.124 . . . . 24.98 108.601 -177.189 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.5 mt -78.17 -24.63 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 114.017 1.117 . . . . 9.46 114.017 170.879 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 15.4 tt0 -62.45 -46.12 89.94 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 115.649 -4.407 . . . . 14.76 110.878 169.081 . . . . . . . . 3 3 . 1 . 114 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.5 -42.01 99.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.627 -1.296 . . . . 26.29 112.953 174.627 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -73.99 -67.81 0.57 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.521 -1.362 . . . . 30.06 110.711 -171.017 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -90.57 -29.69 17.68 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 113.74 -5.6 . . . . 25.19 113.191 -177.215 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.0 40.73 1.78 Allowed Glycine 0 N--CA 1.43 -1.752 0 O-C-N 120.082 -1.636 . . . . 7.41 111.601 -177.085 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.455 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 2.7 mt -115.4 119.54 37.99 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 119.031 -2.452 . . . . 9.49 111.539 -171.786 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -58.8 140.6 95.8 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.567 2.178 . . . . 11.42 113.313 177.69 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.36 -17.79 42.13 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 124.901 3.734 . . . . 12.0 118.441 179.458 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.8 -37.21 56.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.799 1.407 . . . . 35.55 114.799 179.386 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -61.4 -21.74 64.35 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 121.711 3.967 . . . . 20.52 121.711 167.193 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -88.6 101.73 14.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.482 2.401 . . . . 7.13 117.482 -171.378 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -100.74 107.36 18.93 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 125.288 2.471 . . . . 36.39 110.982 177.072 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.659 HD23 HG23 ' A' ' 23' ' ' ILE . 8.7 tp -105.99 118.7 37.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.432 -2.667 . . . . 9.55 107.375 -161.469 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 36.3 mm -111.99 124.48 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 128.969 2.908 . . . . 13.9 115.988 -166.351 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -112.87 87.13 2.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.651 -3.155 . . . . 6.86 108.473 -179.314 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.283 . . 62.52 -93.16 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 114.39 -5.193 . . . . 11.15 110.291 -177.122 . . . . . . . . 3 2 . 1 . 114 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.43 -10.99 22.65 Favored Glycine 0 N--CA 1.43 -1.712 0 O-C-N 126.244 2.215 . . . . 13.93 111.253 176.653 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -88.6 137.27 32.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.417 3.087 . . . . 23.92 108.395 -172.779 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -107.3 117.93 35.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.354 2.026 . . . . 23.23 107.791 177.322 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -80.66 163.41 23.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.023 -1.673 . . . . 9.11 111.989 -170.925 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -106.94 165.39 11.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.284 3.034 . . . . 33.44 105.447 179.443 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.337 23.7 m-20 -84.12 -54.39 4.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.03 2.348 . . . . 28.37 117.069 -168.549 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.87 50.79 2.26 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.682 -1.599 . . . . 15.0 116.056 177.749 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -133.39 156.05 48.37 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 100.11 -4.033 . . . . 25.5 100.11 175.811 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 30.2 p -86.04 158.54 19.81 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.258 1.98 . . . . 11.95 113.242 -170.218 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.28 -36.65 80.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.097 -2.252 . . . . 10.17 116.782 167.239 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.4 t -65.8 -38.14 88.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.341 1.856 . . . . 13.59 111.963 -179.519 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -63.36 -54.37 37.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.387 2.275 . . . . 11.7 112.129 178.721 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -64.14 -17.99 64.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 120.025 3.343 . . . . 12.95 120.025 170.588 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 69.9 43.4 0.93 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.399 2.37 . . . . 25.45 117.399 -172.742 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.01 112.47 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.339 -2.21 . . . . 14.6 112.132 165.416 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -83.31 -179.29 7.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.568 1.651 . . . . 33.23 108.706 -172.91 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.96 152.45 44.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.414 -1.429 . . . . 25.97 114.787 162.223 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 57.36 21.69 7.08 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.191 1.922 . . . . 32.61 116.191 -172.23 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 t -90.47 141.14 29.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.795 1.035 . . . . 10.56 113.795 -179.932 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 m -96.94 93.77 6.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.603 2.816 . . . . 5.33 118.603 -174.682 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 5' ' ' VAL . 64.6 mt -79.02 161.57 26.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.107 -0.995 . . . . 11.66 109.221 174.893 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.486 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 79.0 m-70 -104.37 137.22 42.58 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.44 -2.059 . . . . 16.3 105.44 173.646 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 7' ' ' THR . 62.1 tp -95.02 119.49 33.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 127.491 2.994 . . . . 9.96 112.655 160.231 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 t -104.25 120.56 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 106.226 -1.768 . . . . 9.76 106.226 174.664 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.0 mt -92.41 178.05 5.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 129.699 3.2 . . . . 19.57 113.577 -171.155 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -160.19 175.93 12.34 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.488 -0.93 . . . . 35.08 108.488 167.86 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 mt -98.63 -169.98 1.87 Allowed 'General case' 0 N--CA 1.43 -1.455 1 C-N-CA 132.053 4.141 . . . . 32.31 105.108 163.179 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.254 88.4 mtt-85 -83.48 -64.76 1.11 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.998 -2.314 . . . . 42.75 110.261 -179.946 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.28 76.99 0.66 Allowed Glycine 0 N--CA 1.431 -1.662 0 O-C-N 128.693 3.746 . . . . 36.31 110.34 -167.483 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.776 1 O-C-N 130.334 4.196 . . . . 36.27 108.052 -174.526 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptt? . . . . . 0 CA--C 1.49 -1.33 0 CA-C-O 117.706 -1.14 . . . . 17.17 113.719 . . . . . . . . . 0 0 . 1 . 115 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.22 144.17 45.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.621 2.153 . . . . 21.89 115.243 167.729 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.8 pt -127.32 163.29 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.529 -1.669 . . . . 10.83 107.861 175.03 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -123.18 130.13 52.34 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 115.28 -2.295 . . . . 10.61 111.147 -171.037 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.515 HG22 ' HB2' ' A' ' 67' ' ' LEU . 86.0 t -130.54 112.13 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 CA-C-N 126.331 4.151 . . . . 9.13 102.718 -167.511 . . . . . . . . 3 3 . 1 . 115 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -81.94 144.0 31.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.494 1.517 . . . . 20.55 113.967 -176.849 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.302 81.8 p -98.91 -140.86 0.32 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.722 -2.486 . . . . 11.78 112.731 -178.45 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.8 -44.97 1.92 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 100.741 -3.8 . . . . 19.31 100.741 174.003 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -92.24 -74.45 0.51 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.552 1.541 . . . . 23.14 112.649 -169.692 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.94 -137.04 3.76 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 108.319 -1.913 . . . . 19.74 108.319 -157.99 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -91.7 160.45 15.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.651 2.167 . . . . 21.93 112.062 -172.512 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.6 m -77.01 116.72 17.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.651 -3.78 . . . . 12.33 109.691 172.098 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.3 pt -79.37 160.39 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.79 -2.444 . . . . 17.08 112.356 179.403 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -124.79 132.96 53.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.504 -2.622 . . . . 16.3 107.422 -175.893 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 mt -121.8 142.39 50.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.261 -0.644 . . . . 15.88 109.261 177.565 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -99.82 110.57 22.94 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.206 -2.184 . . . . 28.9 109.217 168.227 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.5 164.84 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 131.252 3.821 . . . . 12.05 109.915 -170.532 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.272 52.0 mm-40 -110.42 155.14 42.51 Favored Pre-proline 0 N--CA 1.43 -1.453 1 O-C-N 116.011 -4.181 . . . . 18.17 102.558 172.896 . . . . . . . . 3 2 . 1 . 115 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -66.07 -19.62 57.28 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 127.876 3.849 . . . . 8.16 114.654 176.47 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 p -75.99 -5.63 47.2 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.751 2.021 . . . . 11.13 115.292 179.526 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -78.2 142.45 37.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.1 -1.0 . . . . 18.03 110.161 171.903 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 40.8 p -81.66 169.19 17.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.1 2.381 . . . . 10.22 113.501 177.359 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.38 -29.11 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.693 -2.504 . . . . 12.3 107.942 -178.438 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.18 -34.91 66.26 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.785 1.634 . . . . 36.51 113.627 175.886 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.6 -40.22 78.62 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.385 -2.721 . . . . 25.66 116.578 161.424 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.65 -38.26 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 123.143 1.449 . . . . 8.12 108.369 176.468 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 89.6 mttt -57.29 -36.02 70.53 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 115.336 -4.603 . . . . 15.47 114.618 171.871 . . . . . . . . 3 3 . 1 . 115 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.91 94.06 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 130.376 4.797 . . . . 11.45 110.685 176.124 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.284 56.2 mttm -61.4 -42.41 98.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.771 1.623 . . . . 24.98 114.943 167.987 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 27' ' ' LYS . 63.8 mt -60.55 -32.71 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.733 -3.105 . . . . 9.46 117.34 176.358 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -58.86 -48.94 79.61 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.979 -2.95 . . . . 14.76 115.475 167.497 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.54 -62.79 1.42 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.142 -3.474 . . . . 26.29 114.224 162.386 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -64.87 -42.03 95.18 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.673 2.101 . . . . 30.06 116.673 -170.528 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -106.59 -50.55 3.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.264 -1.522 . . . . 25.19 113.258 174.143 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.37 5.18 6.16 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 125.029 2.461 . . . . 7.41 116.524 -178.039 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.1 mt -82.86 133.69 48.3 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 119.741 -2.035 . . . . 9.49 109.655 -177.502 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -64.12 146.35 90.58 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 125.771 4.314 . . . . 11.42 118.021 174.278 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.525 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 72.4 Cg_exo -61.54 -20.71 69.75 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 124.273 2.562 . . . . 12.0 116.736 -173.057 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -82.44 -18.17 42.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.523 1.139 . . . . 35.55 112.922 -179.874 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -100.06 -4.44 29.88 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 117.592 -1.194 . . . . 20.52 113.709 -176.256 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.05 135.23 33.71 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.106 3.362 . . . . 7.13 114.999 175.6 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -129.57 118.38 21.93 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.943 -1.723 . . . . 36.39 107.946 176.336 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mt -101.5 137.29 40.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.421 1.581 . . . . 9.55 109.529 -177.338 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.9 mm -137.36 130.93 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 100.268 -3.975 . . . . 13.9 100.268 -173.191 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -119.94 121.18 38.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 113.377 -3.202 . . . . 6.86 109.105 170.705 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.33 -116.26 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.931 2.605 . . . . 11.15 107.599 -174.664 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.5 34.41 4.55 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 118.739 -2.476 . . . . 13.93 113.091 164.375 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -113.36 123.98 51.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.644 -2.092 . . . . 23.92 108.681 -179.882 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -77.21 119.38 20.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.647 -2.533 . . . . 23.23 111.625 171.743 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.6 mt -90.52 136.16 33.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.995 -2.315 . . . . 9.11 115.466 -174.89 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -96.45 128.67 43.59 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.111 -1.618 . . . . 33.44 114.082 178.855 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -31.72 -52.93 0.25 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.94 3.696 . . . . 28.37 117.037 -177.627 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.57 0.46 82.97 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 119.012 -2.305 . . . . 15.0 110.322 -165.161 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -91.33 168.35 11.64 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 118.145 0.972 . . . . 25.5 112.212 170.756 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 66.4 p -109.37 178.82 4.33 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.4 -3.312 . . . . 11.95 108.118 -176.11 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -75.32 -33.81 61.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.422 2.535 . . . . 10.17 111.003 179.579 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -35.89 77.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.445 -3.909 . . . . 13.59 109.242 168.383 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.27 -36.64 71.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 122.42 2.373 . . . . 11.7 112.798 -176.336 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -83.16 3.43 30.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.277 2.231 . . . . 12.95 109.794 -177.706 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 49.59 51.52 16.29 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 115.069 1.507 . . . . 25.45 115.069 -169.766 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mt -102.81 113.86 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 127.161 2.788 . . . . 14.6 113.092 -179.784 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -97.31 -175.25 3.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.778 3.18 . . . . 33.23 109.535 -174.377 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -73.3 154.5 40.12 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.426 -3.296 . . . . 25.97 112.889 -175.156 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 76.33 13.68 2.49 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.022 2.129 . . . . 32.61 109.303 170.499 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 m -87.41 141.77 28.38 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 127.214 2.821 . . . . 10.56 109.703 -172.901 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.1 m -83.94 115.55 22.36 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 123.528 1.632 . . . . 5.33 112.804 176.116 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.515 ' HB2' HG22 ' A' ' 5' ' ' VAL . 63.4 mt -87.29 147.65 25.43 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.923 1.344 . . . . 11.66 110.906 162.674 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -105.36 131.06 53.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.97 -3.582 . . . . 16.3 109.661 172.85 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 tp -112.39 117.66 33.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.255 3.407 . . . . 9.96 107.721 179.929 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.37 151.9 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 101.366 -3.568 . . . . 9.76 101.366 -168.15 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.68 139.96 38.23 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.702 -3.124 . . . . 19.57 109.431 -171.669 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -140.01 156.39 46.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.727 1.727 . . . . 35.08 110.897 173.05 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.05 -171.16 2.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.583 3.563 . . . . 32.31 105.01 -175.658 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -82.87 -49.3 9.81 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.114 -4.741 . . . . 42.75 109.632 178.464 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.92 71.65 2.72 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.245 -1.535 . . . . 36.31 111.971 -177.551 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.737 0 N-CA-C 106.819 -2.512 . . . . 36.27 106.819 -158.288 . . . . . . . . 0 0 . 1 . 116 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 118.71 2.856 . . . . 17.17 118.71 . . . . . . . . . 0 0 . 1 . 116 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -93.24 124.66 37.37 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.241 -4.037 . . . . 21.89 106.225 -174.043 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.327 0.9 OUTLIER -110.31 166.69 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 119.784 -1.822 . . . . 10.83 109.578 167.341 . . . . . . . . 3 3 . 1 . 116 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -117.56 120.74 39.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.636 2.16 . . . . 10.61 116.534 176.241 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -99.17 105.78 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.222 -2.799 . . . . 9.13 114.941 176.766 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -102.94 133.89 47.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.802 -3.061 . . . . 20.55 109.39 -171.74 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.763 HG22 HD23 ' A' ' 69' ' ' LEU 0.316 17.1 p -93.29 -177.71 4.53 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.119 -4.113 . . . . 11.78 110.559 -172.77 . . . . . . . . 4 3 . 1 . 116 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.8 mt -74.42 -67.13 0.65 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.233 2.613 . . . . 19.31 105.322 175.947 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -125.76 129.42 49.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.309 2.256 . . . . 23.14 106.645 176.166 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.81 -114.06 0.73 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.506 -2.621 . . . . 19.74 108.492 176.994 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -158.43 163.54 37.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 126.948 3.261 . . . . 21.93 103.581 -178.01 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.7 m -92.38 135.17 34.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.195 -2.191 . . . . 12.33 112.669 178.31 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 pt -110.12 139.47 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.453 -3.28 . . . . 17.08 111.025 -174.517 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.4 m -101.5 121.11 41.36 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.033 -2.58 . . . . 16.3 104.033 -175.572 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 mt -119.95 172.42 7.74 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.169 -2.207 . . . . 15.88 111.504 179.995 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -120.42 120.43 35.91 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.264 -2.772 . . . . 28.9 114.085 178.062 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -138.2 167.65 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 126.763 2.539 . . . . 12.05 109.558 -177.756 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -122.96 158.34 57.7 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 121.05 1.75 . . . . 18.17 108.168 176.902 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.16 -19.58 66.22 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 O-C-N 113.932 -3.772 . . . . 8.16 118.278 -179.838 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -82.9 -1.83 53.22 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 118.937 2.94 . . . . 11.13 118.937 177.577 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -78.78 144.69 34.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.703 -0.623 . . . . 18.03 109.4 173.719 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 p -76.42 173.84 10.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.206 -2.184 . . . . 10.22 114.97 165.012 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.6 mm -63.33 -42.99 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.869 1.795 . . . . 12.3 112.572 174.414 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -49.43 -39.29 32.41 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 131.006 3.723 . . . . 36.51 113.511 175.583 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -75.45 -17.02 60.26 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.664 -2.522 . . . . 25.66 115.374 172.271 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.54 -44.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.139 -1.601 . . . . 8.12 114.234 167.463 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HA ' HD12 ' A' ' 30' ' ' ILE . 79.7 mttt -51.71 -22.89 3.85 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.227 1.936 . . . . 15.47 116.227 175.659 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.01 -27.3 23.3 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.209 0.913 . . . . 11.45 109.073 -174.847 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.26 -26.06 65.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.883 2.873 . . . . 24.98 113.428 167.352 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 27' ' ' LYS . 11.2 mt -89.35 -31.75 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.522 -1.986 . . . . 9.46 111.261 175.1 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -57.26 -37.45 72.35 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.769 -4.332 . . . . 14.76 114.307 168.461 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -64.68 -55.64 18.83 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.289 -1.815 . . . . 26.29 112.205 168.191 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -75.97 -51.53 12.2 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.708 1.88 . . . . 30.06 114.592 -161.171 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -94.59 -42.92 8.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.008 2.813 . . . . 25.19 116.659 179.578 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.38 33.14 2.57 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 109.94 -3.3 . . . . 7.41 113.563 161.388 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.465 HD12 HD21 ' A' ' 69' ' ' LEU . 87.6 mt -91.22 137.88 26.04 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 114.626 -2.607 . . . . 9.49 109.399 -179.071 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -61.9 137.56 68.34 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 124.759 3.639 . . . . 11.42 114.087 178.985 . . . . . . . . 3 3 . 1 . 116 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.2 Cg_exo -64.42 -26.54 62.96 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 127.126 3.581 . . . . 12.0 118.241 -168.564 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -63.03 -31.41 72.54 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.26 2.224 . . . . 35.55 113.405 171.552 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -86.55 -25.78 24.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.229 2.212 . . . . 20.52 112.964 -179.909 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -73.54 118.0 15.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.674 -2.516 . . . . 7.13 112.228 178.328 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.475 ' HD3' HD11 ' A' ' 44' ' ' ILE . 26.3 ttm180 -110.15 118.39 36.26 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.411 1.46 . . . . 36.39 111.45 166.418 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.3 mt -98.9 124.52 43.88 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.097 -2.186 . . . . 9.55 105.097 178.719 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.475 HD11 ' HD3' ' A' ' 42' ' ' ARG . 51.4 mm -105.21 120.06 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 126.621 1.969 . . . . 13.9 110.9 173.126 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.73 111.32 22.42 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.37 2.51 . . . . 6.86 105.277 167.853 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.342 . . 55.37 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.17 2.188 . . . . 11.15 116.189 -167.763 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.81 -23.5 6.47 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 116.33 1.292 . . . . 13.93 116.33 -177.294 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.44 167.8 9.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.938 -2.131 . . . . 23.92 114.393 -172.832 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -92.42 148.98 21.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.536 -2.12 . . . . 23.23 108.851 176.691 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -102.5 121.5 42.48 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.942 -2.349 . . . . 9.11 111.517 177.317 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.276 35.2 mt-10 -103.56 139.99 38.13 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.189 -1.569 . . . . 33.44 114.494 -166.498 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -29.37 -67.43 0.08 Allowed 'General case' 0 N--CA 1.43 -1.453 1 N-CA-C 122.068 4.099 . . . . 28.37 122.068 -161.466 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.97 24.99 28.88 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.7 -1.875 . . . . 15.0 115.814 -175.658 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -99.58 146.73 26.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.586 3.168 . . . . 25.5 109.966 166.23 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -85.95 167.26 15.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.857 1.663 . . . . 11.95 110.24 -162.46 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.19 -12.33 59.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.039 -1.467 . . . . 10.17 107.039 176.729 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -68.47 -50.91 48.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.146 1.378 . . . . 13.59 111.037 175.991 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -56.48 -49.35 74.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.848 3.259 . . . . 11.7 108.738 176.287 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -71.18 -20.15 62.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.16 1.541 . . . . 12.95 115.16 -178.851 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.346 32.5 t30 51.05 68.63 0.76 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.308 -2.12 . . . . 25.45 109.891 -172.335 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.68 138.2 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 100.929 -3.73 . . . . 14.6 100.929 167.215 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -123.77 -173.29 2.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.621 -1.925 . . . . 33.23 111.014 -176.455 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -75.35 146.65 40.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.045 -2.284 . . . . 25.97 109.128 -177.369 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 65.12 22.79 12.33 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 128.118 2.567 . . . . 32.61 112.408 166.901 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 t -101.09 159.78 14.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.985 2.326 . . . . 10.56 112.031 -175.56 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.8 m -111.36 109.34 19.28 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.261 -4.649 . . . . 5.33 111.168 -166.088 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.0 mt -84.86 146.86 27.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.177 -1.577 . . . . 11.66 110.445 162.565 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 14.7 m170 -106.9 125.69 51.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.068 -3.52 . . . . 16.3 107.433 179.841 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.763 HD23 HG22 ' A' ' 7' ' ' THR 0.256 47.3 tp -103.93 111.43 23.96 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 123.83 3.014 . . . . 9.96 102.927 -172.832 . . . . . . . . 3 3 . 1 . 116 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.3 t -107.34 152.46 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 104.849 -2.278 . . . . 9.76 104.849 -176.526 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.4 136.53 33.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.8 -2.296 . . . . 19.57 104.8 165.809 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -95.03 133.11 39.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.363 -1.46 . . . . 35.08 110.255 163.707 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 74' ' ' ARG . 5.0 tp -104.49 -164.07 1.02 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.14 -1.429 . . . . 32.31 107.14 176.173 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.431 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 40.4 mmt180 -68.04 150.55 48.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.327 -2.108 . . . . 42.75 115.448 178.251 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.23 -71.48 0.3 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.243 -1.536 . . . . 36.31 116.161 176.287 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.455 ' C ' HH22 ' A' ' 42' ' ' ARG . . . . . . . . 0 C--O 1.26 1.78 0 N-CA-C 105.68 -2.968 . . . . 36.27 105.68 -173.73 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 CA--C 1.49 -1.362 0 CA-C-O 125.934 2.778 . . . . 17.17 114.697 . . . . . . . . . 0 0 . 1 . 117 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.51 119.11 11.77 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 121.361 3.837 . . . . 21.89 121.361 168.191 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.417 29.7 pt -111.31 130.08 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 103.652 -2.721 . . . . 10.83 103.652 169.693 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -91.05 121.66 33.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.794 0.807 . . . . 10.61 111.986 171.92 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -116.75 106.61 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 O-C-N 114.882 -4.887 . . . . 9.13 108.871 176.27 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 12' ' ' THR . 76.4 tttt -84.94 112.44 20.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 118.27 2.692 . . . . 20.55 118.27 169.753 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 m -76.84 134.88 38.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.034 -3.541 . . . . 11.78 107.398 163.971 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.93 -48.79 33.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.807 -3.058 . . . . 19.31 112.179 -175.23 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 m -93.48 98.26 11.08 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.186 -2.821 . . . . 23.14 107.546 161.879 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.57 -126.19 2.16 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 106.268 -2.733 . . . . 19.74 106.268 -175.973 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -156.77 170.44 22.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.793 -2.592 . . . . 21.93 109.879 173.641 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 41.6 m -79.97 104.61 10.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.024 2.345 . . . . 12.33 114.662 167.233 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.8 pt -90.42 165.6 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 124.321 2.01 . . . . 17.08 108.379 171.077 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 13.1 m -118.65 125.28 49.38 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.287 3.035 . . . . 16.3 107.431 179.064 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 mt -116.24 127.26 54.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.135 1.921 . . . . 15.88 107.658 -178.779 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -89.57 95.05 10.1 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.256 -4.653 . . . . 28.9 116.628 175.267 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.89 160.68 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.541 -1.974 . . . . 12.05 110.253 -171.575 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -97.82 147.41 33.0 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 118.968 -2.332 . . . . 18.17 108.526 163.176 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.3 -13.21 31.14 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 N-CA-C 120.779 3.338 . . . . 8.16 120.779 -175.437 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 m -99.91 -7.95 24.62 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.369 -1.457 . . . . 11.13 113.752 -168.526 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.58 172.63 13.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.79 -2.444 . . . . 18.03 111.492 178.964 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -92.14 161.83 14.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.322 1.601 . . . . 10.22 115.322 178.07 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -65.63 -30.13 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.891 3.276 . . . . 12.3 111.482 -172.654 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -70.23 -22.7 62.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.97 1.708 . . . . 36.51 113.318 176.481 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -82.64 -18.48 40.95 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.65 2.38 . . . . 25.66 110.902 170.744 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.46 -43.42 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 121.034 1.743 . . . . 8.12 107.709 176.966 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -54.86 -24.55 23.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 121.486 3.884 . . . . 15.47 121.486 173.441 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.271 . . -70.87 -29.44 65.54 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.659 2.783 . . . . 11.45 114.04 177.738 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -85.94 -35.12 20.67 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.968 -2.957 . . . . 24.98 107.132 -177.192 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 mt -54.29 -52.23 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 129.399 3.08 . . . . 9.46 113.138 168.397 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -53.18 -49.29 66.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 131.13 3.772 . . . . 14.76 118.307 167.355 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -53.8 -57.95 9.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 121.85 2.114 . . . . 26.29 111.142 164.25 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -77.73 -54.9 5.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.957 -2.339 . . . . 30.06 116.291 -162.071 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -92.15 -35.9 13.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.19 -1.569 . . . . 25.19 112.82 178.782 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.53 69.86 1.15 Allowed Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 109.524 -1.43 . . . . 7.41 109.524 -178.118 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.5 mt -138.12 123.41 12.36 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 102.352 -3.203 . . . . 9.49 102.352 171.481 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -72.43 164.11 36.61 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 124.504 3.47 . . . . 11.42 111.807 179.366 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.14 -1.34 9.82 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 C-N-CA 123.042 2.495 . . . . 12.0 114.583 -163.319 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -93.94 -19.99 20.42 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.004 2.522 . . . . 35.55 109.732 173.757 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -84.62 -33.79 23.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 126.479 3.038 . . . . 20.52 112.727 175.833 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.36 143.44 51.94 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 126.366 2.984 . . . . 7.13 117.815 177.983 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -154.13 123.88 6.7 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 114.111 -5.368 . . . . 36.39 100.41 179.813 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.87 126.84 50.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.6 3.16 . . . . 9.55 107.428 -172.827 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.9 mm -118.41 132.98 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.451 -1.685 . . . . 13.9 106.451 -174.362 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -106.11 93.81 4.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 105.222 -2.14 . . . . 6.86 105.222 178.151 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.98 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.535 2.334 . . . . 11.15 114.812 -171.813 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.14 -1.44 7.35 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 118.093 -2.88 . . . . 13.93 112.336 -179.578 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -90.65 147.8 23.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 115.807 -2.044 . . . . 23.92 116.075 170.547 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -98.94 138.74 35.62 Favored 'General case' 0 N--CA 1.43 -1.462 1 CA-C-O 129.351 4.405 . . . . 23.23 105.214 171.094 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.4 mt -88.62 151.96 22.13 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.434 -3.916 . . . . 9.11 114.133 171.197 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -116.14 157.49 24.7 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.943 1.402 . . . . 33.44 110.806 178.098 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -63.51 -50.71 68.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.504 2.779 . . . . 28.37 118.504 -163.027 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.99 -2.05 90.46 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 118.402 2.121 . . . . 15.0 118.402 -161.127 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 65.5 mtp180 -101.8 158.85 15.82 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.521 2.105 . . . . 25.5 107.617 -169.979 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.301 45.0 p -83.74 159.1 21.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.3 -2.75 . . . . 11.95 111.029 -169.766 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.75 -43.97 69.57 Favored 'General case' 0 N--CA 1.43 -1.473 2 CA-C-O 129.674 4.559 . . . . 10.17 119.353 169.014 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 p -51.64 -42.87 62.36 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.603 -3.185 . . . . 13.59 117.543 166.684 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -56.7 -50.14 73.05 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.598 -3.189 . . . . 11.7 116.682 -179.942 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 47.9 m-85 -65.43 -29.1 69.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 111.832 -2.44 . . . . 12.95 117.077 169.604 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 m120 83.49 55.5 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 129.041 3.963 . . . . 25.45 112.125 174.722 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.334 72.7 mt -84.92 149.17 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.529 -1.982 . . . . 14.6 107.941 177.507 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -147.99 -162.44 1.55 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.702 -3.124 . . . . 33.23 108.022 -173.172 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -76.42 132.79 39.88 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.734 -1.229 . . . . 25.97 108.024 -170.268 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 74.42 10.26 4.25 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 131.346 3.858 . . . . 32.61 110.84 167.095 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -58.97 141.04 54.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.631 1.105 . . . . 10.56 112.799 170.139 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.0 m -112.3 102.52 10.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.72 -2.696 . . . . 5.33 103.72 -168.345 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.17 148.86 22.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.845 3.658 . . . . 11.66 105.004 179.223 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -115.54 127.9 55.59 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.377 -1.452 . . . . 16.3 109.06 176.897 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.2 tp -95.27 116.05 28.24 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.336 2.493 . . . . 9.96 107.213 -178.706 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.71 141.36 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 100.295 -3.965 . . . . 9.76 100.295 -171.505 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.8 mt -87.64 119.29 27.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.892 -2.38 . . . . 19.57 113.906 174.962 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -105.57 141.54 36.86 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.512 -3.242 . . . . 35.08 112.4 -176.692 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.8 tp -96.17 -122.27 0.12 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 114.934 -2.46 . . . . 32.31 106.954 173.621 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -136.24 152.69 51.01 Favored 'General case' 0 N--CA 1.43 -1.457 1 CA-C-N 126.007 4.003 . . . . 42.75 103.868 178.535 . . . . . . . . 2 2 . 1 . 117 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.55 -55.07 4.16 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 113.822 -1.535 . . . . 36.31 110.643 -177.688 . . . . . . . . 1 1 . 1 . 117 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.781 0 O-C-N 118.496 -2.767 . . . . 36.27 109.237 -175.61 . . . . . . . . 0 0 . 1 . 118 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 108.375 -0.972 . . . . 17.17 108.375 . . . . . . . . . 0 0 . 1 . 118 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -83.03 115.2 21.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.788 2.435 . . . . 21.89 110.424 -173.081 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pp -120.27 155.71 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.152 -2.536 . . . . 10.83 104.152 175.959 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -100.85 134.55 43.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.312 -3.367 . . . . 10.61 106.607 -176.338 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.88 117.69 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 121.111 -0.993 . . . . 9.13 108.971 160.87 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -98.66 117.22 32.63 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.748 0.819 . . . . 20.55 111.694 -178.093 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 m -79.02 127.7 32.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.23 -2.169 . . . . 11.78 113.135 161.098 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.61 -59.79 2.57 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.207 -2.145 . . . . 19.31 105.207 -174.968 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.259 8.2 m -87.54 71.43 9.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 112.888 0.699 . . . . 23.14 112.888 168.346 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.11 -128.48 1.42 Allowed Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 109.627 -1.389 . . . . 19.74 109.627 -175.342 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU 0.258 20.6 pttm -132.45 179.45 6.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 131.107 3.763 . . . . 21.93 117.157 173.465 . . . . . . . . 3 3 . 1 . 118 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -105.52 119.16 38.4 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.167 -4.083 . . . . 12.33 108.709 178.098 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 pt -104.02 143.02 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 117.314 -3.366 . . . . 17.08 110.462 173.847 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -96.9 134.33 40.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.626 2.632 . . . . 16.3 107.129 170.811 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.7 mt -121.86 140.89 51.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.197 -2.274 . . . . 15.88 111.118 175.474 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -103.95 90.39 3.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.155 2.883 . . . . 28.9 111.968 177.596 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.56 176.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 C-N-CA 132.07 4.148 . . . . 12.05 111.504 -170.204 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.259 37.5 tt0 -134.34 144.06 49.54 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 117.703 -1.142 . . . . 18.17 112.862 167.551 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 88.9 Cg_endo -65.69 -16.92 55.37 Favored 'Trans proline' 0 C--N 1.3 -2.025 1 C-N-CA 126.876 5.051 . . . . 8.16 115.184 -169.912 . . . . . . . . 3 3 . 1 . 118 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -66.83 -20.92 66.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.112 3.765 . . . . 11.13 117.245 166.165 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -73.04 159.65 33.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.141 1.924 . . . . 18.03 113.029 179.878 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.6 p -86.9 154.16 21.06 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.552 1.541 . . . . 10.22 109.225 166.062 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 mm -56.58 -51.15 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 125.016 1.448 . . . . 12.3 108.597 167.334 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.279 37.8 tp10 -37.25 -35.54 0.11 Allowed 'General case' 0 N--CA 1.43 -1.436 1 N-CA-C 123.37 4.582 . . . . 36.51 123.37 166.823 . . . . . . . . 3 2 . 1 . 118 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -74.84 -33.72 62.18 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 111.733 -6.854 . . . . 25.66 118.535 167.756 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -67.86 -45.22 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 128.36 2.664 . . . . 8.12 106.623 175.678 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -55.47 -40.99 72.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.898 3.237 . . . . 15.47 111.107 176.358 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.33 -17.39 60.84 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 111.586 -6.946 . . . . 11.45 120.652 176.49 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -75.36 -34.54 61.17 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.098 -2.876 . . . . 24.98 112.708 173.198 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.3 mt -63.82 -43.23 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 119.601 -1.937 . . . . 9.46 113.736 173.004 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -50.93 -51.05 56.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.805 2.566 . . . . 14.76 116.527 167.399 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.63 -42.7 70.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.619 1.967 . . . . 26.29 112.513 -169.281 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -76.32 -47.44 23.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.386 -1.768 . . . . 30.06 114.717 -178.682 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.424 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS . 59.3 mm-40 -102.78 -53.64 2.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 116.12 -1.895 . . . . 25.19 107.913 -169.267 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.91 -31.69 1.33 Allowed Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 122.549 2.431 . . . . 7.41 112.08 -175.962 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 19.8 mt -61.32 115.9 16.96 Favored Pre-proline 0 N--CA 1.431 -1.403 1 O-C-N 131.579 4.929 . . . . 9.49 117.089 -164.287 . . . . . . . . 3 2 . 1 . 118 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 38.0 Cg_endo -82.16 148.89 15.19 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 CA-C-N 129.263 4.344 . . . . 11.42 108.448 -169.825 . . . . . . . . 3 3 . 1 . 118 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 32.3 Cg_exo -61.5 -12.61 25.17 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 124.652 3.568 . . . . 12.0 119.642 -170.094 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -79.84 -33.51 40.14 Favored 'General case' 0 N--CA 1.43 -1.459 1 CA-C-O 131.789 5.566 . . . . 35.55 110.778 179.123 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -76.94 -20.41 56.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 110.019 -3.264 . . . . 20.52 112.671 -176.92 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -76.34 149.34 37.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.53 2.586 . . . . 7.13 108.268 -178.795 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -145.29 95.89 2.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.739 -2.476 . . . . 36.39 111.741 161.549 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.2 mt -84.37 121.41 27.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.035 -0.984 . . . . 9.55 113.296 -175.753 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.1 mm -107.2 136.47 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 122.886 1.327 . . . . 13.9 110.239 171.284 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB2' HD11 ' A' ' 50' ' ' LEU . 33.1 t80 -116.3 114.84 24.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.562 -2.014 . . . . 6.86 105.562 167.674 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.82 -112.28 0.5 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.855 1.262 . . . . 11.15 113.431 -164.405 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.5 -4.49 43.3 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 126.211 2.195 . . . . 13.93 112.992 -174.398 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -93.89 121.64 35.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.076 2.551 . . . . 23.92 105.544 -175.912 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -83.81 102.45 12.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.67 1.988 . . . . 23.23 107.335 169.238 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 45' ' ' PHE . 23.8 mt -51.81 132.57 31.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.104 3.002 . . . . 9.11 119.104 -173.511 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -109.23 139.89 43.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.618 2.628 . . . . 33.44 111.325 179.943 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -64.24 -43.23 95.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 109.893 -3.321 . . . . 28.37 116.065 -148.322 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.52 -6.15 88.86 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 127.652 2.549 . . . . 15.0 110.752 -171.787 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -86.9 158.45 19.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.405 3.002 . . . . 25.5 109.78 -177.464 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.9 p -89.81 158.65 17.39 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.627 -3.171 . . . . 11.95 110.45 179.658 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 30.5 mt -59.16 -45.0 92.13 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.797 -1.547 . . . . 10.17 113.951 175.056 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.377 71.5 p -43.57 -43.55 5.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.348 2.659 . . . . 13.59 114.509 165.7 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -63.25 -40.91 98.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.53 1.633 . . . . 11.7 115.198 179.829 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HB3' HG13 ' A' ' 61' ' ' ILE . 6.4 m-85 -82.58 -18.79 40.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.842 2.057 . . . . 12.95 110.564 -176.673 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.382 12.5 m120 80.8 32.41 0.15 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.145 2.178 . . . . 25.45 111.513 -179.09 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG13 ' HB3' ' A' ' 59' ' ' TYR . 66.4 mt -91.57 106.18 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 128.072 2.549 . . . . 14.6 109.165 179.177 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -103.18 -173.58 2.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.744 3.217 . . . . 33.23 110.755 -169.354 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -68.22 158.33 33.52 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.072 2.669 . . . . 25.97 114.248 178.022 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 41.1 mt-10 72.75 5.02 5.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.438 1.895 . . . . 32.61 108.528 169.004 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -70.01 149.69 47.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.659 -1.901 . . . . 10.56 115.854 169.507 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.6 m -120.08 121.7 39.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.124 2.392 . . . . 5.33 105.265 -168.942 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.54 128.04 43.1 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.297 -4.627 . . . . 11.66 109.052 172.978 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.326 35.1 m80 -97.7 132.78 43.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.644 2.474 . . . . 16.3 113.699 175.465 . . . . . . . . 2 2 . 1 . 118 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tt -108.45 112.63 25.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.21 1.481 . . . . 9.96 109.482 -169.558 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 t -92.45 129.28 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 116.401 -1.762 . . . . 9.76 110.491 164.46 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt -89.56 121.8 32.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.527 2.331 . . . . 19.57 106.821 177.063 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -113.61 168.76 9.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.151 3.019 . . . . 35.08 119.151 -172.462 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.8 mt -105.73 -174.25 2.49 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 116.439 -1.743 . . . . 32.31 106.373 174.825 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -92.8 171.56 8.9 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.746 2.212 . . . . 42.75 116.621 177.693 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.11 28.4 1.85 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 112.692 -2.049 . . . . 36.31 113.757 -178.61 . . . . . . . . 1 1 . 1 . 118 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.741 0 C-N-CA 114.214 -3.851 . . . . 36.27 112.941 174.804 . . . . . . . . 0 0 . 1 . 119 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 114.839 1.422 . . . . 17.17 114.839 . . . . . . . . . 0 0 . 1 . 119 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.53 135.32 39.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.588 -3.82 . . . . 21.89 112.833 168.352 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.443 HD12 HD13 ' A' ' 67' ' ' LEU . 17.2 pt -127.63 160.0 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.43 3.014 . . . . 10.83 106.397 159.956 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -103.07 148.48 25.67 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 109.355 -3.566 . . . . 10.61 112.67 -178.473 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -125.03 119.58 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 121.086 1.766 . . . . 9.13 108.616 167.465 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -95.43 85.67 4.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 125.261 1.601 . . . . 20.55 114.819 -176.977 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.5 m -83.32 141.47 31.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.45 -0.945 . . . . 11.78 108.45 171.962 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.1 mt -86.2 -54.1 4.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.965 1.306 . . . . 19.31 112.56 179.706 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -89.43 63.77 6.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.746 2.213 . . . . 23.14 107.054 -176.385 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.74 -135.15 3.71 Favored Glycine 0 N--CA 1.429 -1.77 1 CA-C-N 107.994 -4.184 . . . . 19.74 103.774 -174.035 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -143.45 174.2 10.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.363 2.357 . . . . 21.93 117.363 -178.148 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -92.31 117.65 30.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.952 2.575 . . . . 12.33 117.952 176.884 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 pt -102.95 156.32 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 128.824 2.85 . . . . 17.08 116.809 -172.536 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -127.72 104.02 7.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.939 -1.101 . . . . 16.3 110.89 -168.746 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.1 mt -104.02 138.11 41.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.241 1.817 . . . . 15.88 111.962 -165.645 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -108.0 86.99 2.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 128.122 3.82 . . . . 28.9 110.804 -170.247 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -101.73 172.98 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 111.971 -2.377 . . . . 12.05 114.437 -175.71 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.86 146.87 63.12 Favored Pre-proline 0 N--CA 1.431 -1.416 0 O-C-N 125.56 1.788 . . . . 18.17 108.452 171.339 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.3 -4.56 13.17 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 115.955 -1.769 . . . . 8.16 116.406 -150.097 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 m -90.91 6.22 45.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.732 2.06 . . . . 11.13 111.172 172.598 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.91 154.68 20.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.5 2.778 . . . . 18.03 118.5 -176.252 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -91.45 163.05 14.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.062 -2.899 . . . . 10.22 111.669 -164.338 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mm -64.51 -34.89 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 117.342 -1.313 . . . . 12.3 108.315 -178.188 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -51.0 -49.32 60.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 114.294 1.22 . . . . 36.51 114.294 169.646 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.08 -25.07 62.46 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.915 2.931 . . . . 25.66 118.915 176.393 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.509 HG21 HD21 ' A' ' 56' ' ' LEU . 86.7 t -62.99 -44.79 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 116.249 -1.834 . . . . 8.12 109.098 167.637 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -52.35 -48.97 65.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.823 3.638 . . . . 15.47 120.823 171.504 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.09 67.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.937 3.695 . . . . 11.45 114.975 170.594 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.98 -43.72 98.01 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.748 1.758 . . . . 24.98 115.748 170.455 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.6 -54.29 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.774 -1.829 . . . . 9.46 112.931 174.505 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -41.7 -46.03 3.64 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.42 2.288 . . . . 14.76 113.045 172.573 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -76.03 -46.59 28.57 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.049 1.74 . . . . 26.29 111.586 -178.118 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -68.2 -62.43 1.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.321 -1.487 . . . . 30.06 113.852 -172.65 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -92.53 -49.57 6.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.573 -0.899 . . . . 25.19 108.573 -173.642 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.85 28.24 2.32 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 122.568 1.093 . . . . 7.41 112.672 177.825 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mt -87.18 119.75 71.07 Favored Pre-proline 0 N--CA 1.431 -1.413 0 O-C-N 117.985 -3.068 . . . . 9.49 104.075 -171.757 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -64.77 133.63 37.2 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 N-CA-C 121.633 3.666 . . . . 11.42 121.633 -176.068 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -78.9 -10.8 15.34 Favored 'Trans proline' 0 N--CA 1.433 -2.05 1 C-N-CA 128.698 6.266 . . . . 12.0 113.947 -159.039 . . . . . . . . 3 3 . 1 . 119 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -76.87 -36.07 57.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.01 1.732 . . . . 35.55 113.175 168.808 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -74.55 -27.45 60.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.533 3.933 . . . . 20.52 112.63 -178.982 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 76.7 mt-30 -74.49 119.33 18.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.338 -2.101 . . . . 7.13 110.466 172.968 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.325 40.5 ttm180 -114.65 108.8 17.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.048 2.539 . . . . 36.39 104.857 159.681 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.19 130.55 35.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.321 3.452 . . . . 9.55 120.321 166.876 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.9 mm -117.83 131.61 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.018 2.127 . . . . 13.9 111.168 -174.538 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -128.17 123.63 34.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.639 -3.788 . . . . 6.86 106.314 170.965 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.19 -99.65 0.1 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.705 -1.588 . . . . 11.15 112.727 -163.198 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.17 22.3 2.76 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 104.359 -3.496 . . . . 13.93 104.359 -176.736 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -107.47 135.27 49.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.403 3.481 . . . . 23.92 101.952 -177.282 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -97.98 118.6 34.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.463 -2.648 . . . . 23.23 109.623 177.297 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.3 mt -88.67 135.81 33.31 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.215 -2.803 . . . . 9.11 109.246 -160.719 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -80.11 159.08 26.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.124 2.569 . . . . 33.44 111.924 179.286 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -75.75 -47.7 24.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 124.982 1.426 . . . . 28.37 111.973 -172.936 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.29 29.62 11.51 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 124.639 1.212 . . . . 15.0 113.046 -166.396 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.441 HH21 ' CG ' ' A' ' 58' ' ' ASP . 77.7 mtp180 -117.47 157.06 26.91 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 126.186 1.794 . . . . 25.5 108.818 177.727 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -96.2 162.38 13.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.096 2.628 . . . . 11.95 118.096 -169.705 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.509 HD21 HG21 ' A' ' 26' ' ' VAL . 42.6 mt -63.09 -33.4 75.36 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.919 -2.363 . . . . 10.17 113.75 170.367 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 p -66.61 -39.52 88.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.51 -3.869 . . . . 13.59 114.403 171.148 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' CG ' HH21 ' A' ' 54' ' ' ARG . 66.2 t0 -64.34 -54.53 31.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.246 2.618 . . . . 11.7 107.671 179.801 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -73.09 -15.32 61.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 115.313 -2.555 . . . . 12.95 108.887 -178.933 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.271 35.1 m120 85.91 37.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 127.255 3.407 . . . . 25.45 113.368 176.251 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.491 HG21 HD11 ' A' ' 67' ' ' LEU . 53.7 mt -95.78 79.85 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.478 1 O-C-N 116.243 -4.036 . . . . 14.6 110.413 -172.166 . . . . . . . . 3 3 . 1 . 119 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -59.33 174.17 0.43 Allowed 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.435 2.754 . . . . 33.23 118.435 172.719 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -62.57 141.02 58.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.111 1.522 . . . . 25.97 115.111 174.733 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 22.3 tt0 67.88 27.02 7.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.613 3.165 . . . . 32.61 114.672 -176.196 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -91.49 139.79 30.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.899 -3.625 . . . . 10.56 112.014 174.634 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -113.78 118.94 35.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.309 -1.357 . . . . 5.33 111.883 -172.099 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 61' ' ' ILE . 5.5 mp -97.35 141.48 30.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 103.87 -2.641 . . . . 11.66 103.87 -176.109 . . . . . . . . 2 2 . 1 . 119 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -108.49 135.1 50.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.254 -2.499 . . . . 16.3 104.254 -176.36 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.91 108.52 20.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.64 -1.985 . . . . 9.96 105.64 -172.013 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.9 t -76.95 130.43 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 125.3 1.625 . . . . 9.76 113.985 162.633 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.7 mt -95.19 112.77 24.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.325 2.488 . . . . 19.57 105.137 174.652 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -95.24 157.28 15.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 112.472 -2.149 . . . . 35.08 113.325 -156.024 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.4 mt -94.21 155.37 17.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 113.067 -1.879 . . . . 32.31 113.207 172.605 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -83.26 -169.58 2.61 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 121.84 2.109 . . . . 42.75 110.419 -165.096 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.23 59.8 3.78 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 117.862 -3.024 . . . . 36.31 114.034 172.565 . . . . . . . . 1 1 . 1 . 119 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.787 0 CA-C-O 114.725 -3.264 . . . . 36.27 111.55 175.336 . . . . . . . . 0 0 . 1 . 120 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptt? . . . . . 0 CA--C 1.489 -1.367 0 CA-C-O 123.587 1.66 . . . . 17.17 110.316 . . . . . . . . . 0 0 . 1 . 120 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -96.83 140.33 31.55 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.413 -2.055 . . . . 21.89 106.872 -179.195 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 pt -136.79 157.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 124.007 0.923 . . . . 10.83 108.793 177.467 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -112.61 133.94 54.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.55 -2.759 . . . . 10.61 103.55 -178.498 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.16 121.23 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 1 O-C-N 115.359 -4.588 . . . . 9.13 106.859 165.713 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -105.66 115.9 31.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.084 2.115 . . . . 20.55 107.856 -167.569 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.335 0.2 OUTLIER -101.27 126.92 48.06 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.738 -1.949 . . . . 11.78 105.738 -168.471 . . . . . . . . 3 3 . 1 . 120 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.72 -49.65 8.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.157 -1.59 . . . . 19.31 107.468 -178.142 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 m -95.03 75.52 3.5 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.931 2.3 . . . . 23.14 112.71 172.556 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.47 -111.3 0.46 Allowed Glycine 0 N--CA 1.431 -1.695 0 O-C-N 119.394 -2.066 . . . . 19.74 110.329 -166.721 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -175.32 177.97 1.76 Allowed 'General case' 0 N--CA 1.43 -1.459 1 CA-C-N 124.497 4.148 . . . . 21.93 106.122 178.932 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -97.23 122.33 40.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.402 -2.061 . . . . 12.33 106.67 -176.771 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 pt -106.63 148.66 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 122.94 1.352 . . . . 17.08 108.329 -178.869 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.9 m -111.3 112.44 24.21 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.916 -2.253 . . . . 16.3 104.916 -175.357 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -111.33 142.7 43.21 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.501 2.096 . . . . 15.88 112.478 179.924 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -97.78 117.39 31.98 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.563 -3.211 . . . . 28.9 109.711 172.977 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.46 153.66 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.613 -3.179 . . . . 12.05 108.146 -171.797 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -105.54 137.97 19.45 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 112.491 -3.623 . . . . 18.17 107.281 173.428 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -75.25 -9.88 20.59 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 123.67 2.346 . . . . 8.16 113.045 -158.588 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.8 m -84.1 -20.44 32.57 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 126.935 2.647 . . . . 11.13 113.947 -176.418 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -85.12 159.67 20.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.184 -2.198 . . . . 18.03 109.053 -169.284 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -78.86 163.58 25.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.18 -2.825 . . . . 10.22 109.935 -167.385 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.6 mm -64.46 -38.45 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.613 -1.929 . . . . 12.3 109.875 174.667 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -44.77 -36.57 3.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.017 2.927 . . . . 36.51 115.012 164.405 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -71.97 -44.56 63.36 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.971 1.708 . . . . 25.66 110.14 173.138 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 t -55.92 -43.24 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.614 2.366 . . . . 8.12 112.497 173.055 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -62.98 -26.22 68.74 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.561 -3.212 . . . . 15.47 113.902 173.085 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -76.02 -36.04 59.29 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.983 -2.323 . . . . 11.45 107.605 177.517 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -73.26 -36.67 66.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.209 -1.557 . . . . 24.98 114.097 -178.241 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 mt -65.55 -34.62 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.713 1.605 . . . . 9.46 113.569 168.237 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 58.9 tt0 -61.59 -52.22 65.32 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.227 1.489 . . . . 14.76 112.741 170.859 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.74 -46.67 88.42 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.367 2.267 . . . . 26.29 112.102 -179.652 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -65.58 -59.29 4.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.15 1.537 . . . . 30.06 115.15 178.309 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.378 65.9 mm-40 -87.98 -43.69 11.56 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.203 2.201 . . . . 25.19 111.84 -165.927 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.78 29.64 5.49 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-O 117.562 -1.688 . . . . 7.41 109.878 -174.775 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.2 mt -104.49 99.83 19.75 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 130.189 3.396 . . . . 9.49 109.203 175.886 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -58.77 160.62 17.26 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 115.628 -2.88 . . . . 11.42 115.628 173.406 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -102.15 12.1 0.39 Allowed 'Trans proline' 0 N--CA 1.434 -1.997 0 N-CA-C 121.517 3.622 . . . . 12.0 121.517 -163.811 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.11 -13.55 55.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 125.647 1.842 . . . . 35.55 114.669 151.044 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -90.86 -3.05 57.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.993 -2.317 . . . . 20.52 107.744 178.273 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -95.34 131.68 41.19 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.589 -2.569 . . . . 7.13 113.179 -175.995 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -119.48 103.38 9.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.459 -2.422 . . . . 36.39 104.459 166.2 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.72 109.43 21.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.915 -2.99 . . . . 9.55 107.057 -165.764 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.08 135.56 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 123.714 1.721 . . . . 13.9 107.581 -159.011 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -124.11 115.3 20.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.197 -2.814 . . . . 6.86 103.846 176.816 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.282 . . 63.2 -103.14 0.11 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.414 1.886 . . . . 11.15 113.305 -169.17 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.69 40.84 1.54 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 118.406 -2.684 . . . . 13.93 113.016 168.704 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -147.37 137.46 23.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.542 2.337 . . . . 23.92 106.153 -178.103 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -76.44 158.51 31.27 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.798 -3.689 . . . . 23.23 111.377 -171.498 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD11 HD23 ' A' ' 67' ' ' LEU . 5.4 mt -97.07 147.36 24.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 113.346 0.869 . . . . 9.11 113.346 165.224 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -95.38 167.92 11.04 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 123.614 0.571 . . . . 33.44 111.72 177.421 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.09 -46.21 13.07 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.054 -2.904 . . . . 28.37 114.538 -163.284 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.23 27.57 13.06 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.121 -2.862 . . . . 15.0 112.291 -176.33 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -106.43 166.63 10.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 115.621 -2.133 . . . . 25.5 111.486 173.097 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -104.1 176.87 5.01 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 121.763 2.074 . . . . 11.95 111.575 -175.288 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.38 -40.52 73.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.412 2.529 . . . . 10.17 106.511 173.251 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.3 p -78.79 -8.11 58.46 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.065 -2.272 . . . . 13.59 111.245 -171.966 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -75.26 -51.17 13.91 Favored 'General case' 0 N--CA 1.431 -1.406 2 O-C-N 115.315 -4.616 . . . . 11.7 104.477 174.422 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -82.22 -10.26 59.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.792 -2.442 . . . . 12.95 113.574 179.435 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 71.51 58.96 0.17 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.132 1.373 . . . . 25.45 109.962 -177.656 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mt -80.71 111.44 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.184 2.594 . . . . 14.6 110.567 159.925 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -97.53 175.04 6.36 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.397 -2.183 . . . . 33.23 110.17 174.401 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -58.79 143.07 48.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.702 3.201 . . . . 25.97 106.811 -178.679 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.317 3.2 mp0 60.96 20.2 10.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.829 2.159 . . . . 32.61 116.829 -178.871 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 m -72.37 147.23 46.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.242 2.312 . . . . 10.56 117.242 167.131 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.4 m -95.11 126.56 40.52 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.086 2.155 . . . . 5.33 109.071 165.521 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.483 HD23 HD11 ' A' ' 50' ' ' LEU . 6.6 mp -100.59 152.26 20.63 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.141 -2.17 . . . . 11.66 105.141 164.623 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -105.78 128.43 53.71 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.08 -5.388 . . . . 16.3 108.675 179.164 . . . . . . . . 2 2 . 1 . 120 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 tp -97.05 131.66 43.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 116.074 -2.25 . . . . 9.96 108.717 179.53 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.5 t -107.84 129.38 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.789 -3.069 . . . . 9.76 107.67 172.288 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.6 mt -104.59 137.95 41.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.514 -1.221 . . . . 19.57 110.261 176.239 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -120.95 174.3 6.71 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 123.276 1.512 . . . . 35.08 115.03 -163.105 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 mt -69.0 128.97 38.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.015 3.326 . . . . 32.31 107.035 162.005 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.51 162.71 24.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.372 -1.344 . . . . 42.75 107.372 -162.11 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.03 119.4 0.64 Allowed Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 129.114 3.245 . . . . 36.31 115.134 168.55 . . . . . . . . 1 1 . 1 . 120 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 N-CA-C 106.619 -2.592 . . . . 36.27 106.619 169.605 . . . . . . . . 0 0 . 1 . 121 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.349 0 CA-C-O 117.293 -1.336 . . . . 17.17 112.388 . . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -96.88 137.49 35.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.946 2.654 . . . . 21.89 111.169 176.956 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.29 172.02 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 126.919 2.088 . . . . 10.83 112.711 176.952 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -123.66 115.7 21.87 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.614 -2.735 . . . . 10.61 103.614 -167.89 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.72 115.35 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 102.623 -3.103 . . . . 9.13 102.623 170.445 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -86.67 131.21 34.21 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.235 -3.416 . . . . 20.55 112.183 167.397 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -87.18 162.39 17.52 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.746 1.279 . . . . 11.78 114.231 172.104 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.9 tp -69.13 -28.42 66.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.419 2.687 . . . . 19.31 111.599 -174.935 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 53.3 m -59.1 -47.54 84.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.818 -2.515 . . . . 23.14 114.961 167.39 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.44 49.06 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 105.691 -2.964 . . . . 19.74 105.691 167.269 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.307 41.7 mttt -138.69 145.33 40.23 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.621 -5.047 . . . . 21.93 104.266 178.592 . . . . . . . . 3 2 . 1 . 121 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -99.85 116.01 30.93 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.494 -2.594 . . . . 12.33 106.394 168.722 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 pt -106.27 133.28 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 105.15 -2.166 . . . . 17.08 105.15 176.337 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 m -93.78 117.81 30.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 126.869 2.605 . . . . 16.3 110.082 -177.127 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.274 95.8 mt -119.15 141.76 48.54 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.978 -2.23 . . . . 15.88 104.978 -177.296 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -104.38 111.48 24.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.318 3.047 . . . . 28.9 112.955 172.346 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.5 169.15 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 124.719 2.199 . . . . 12.05 111.805 -178.132 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -92.13 154.88 43.25 Favored Pre-proline 0 N--CA 1.43 -1.446 0 O-C-N 117.283 -3.385 . . . . 18.17 107.163 167.308 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.01 -3.89 12.98 Favored 'Trans proline' 0 C--N 1.3 -1.99 1 CA-C-N 129.355 4.377 . . . . 8.16 111.974 175.019 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -76.2 -22.19 55.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.311 -2.743 . . . . 11.13 114.325 169.614 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -67.76 151.25 47.52 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.618 2.152 . . . . 18.03 111.054 173.167 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.4 p -99.43 -170.93 1.98 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.469 2.557 . . . . 10.22 110.781 -173.86 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.7 mm -86.92 -17.43 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 O-C-N 115.975 -4.203 . . . . 12.3 108.662 -173.171 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.57 -26.56 55.22 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.613 -4.429 . . . . 36.51 110.501 174.142 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -73.06 -33.89 65.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.334 -0.947 . . . . 25.66 108.719 176.455 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.353 65.6 t -65.53 -47.43 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 124.622 1.169 . . . . 8.12 113.695 178.034 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -55.36 -43.19 74.84 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.675 1.99 . . . . 15.47 113.869 171.944 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.5 90.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 120.732 3.604 . . . . 11.45 120.732 168.193 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -70.26 -38.87 75.19 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.589 -1.944 . . . . 24.98 111.701 174.968 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -66.66 -35.5 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 127.277 2.231 . . . . 9.46 108.999 177.429 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -64.75 -39.4 93.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.725 -3.109 . . . . 14.76 107.834 174.929 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -72.85 -60.19 2.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.179 2.895 . . . . 26.29 111.094 -173.866 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -61.8 -49.72 75.21 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 120.677 3.584 . . . . 30.06 120.677 177.176 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -108.8 -18.29 13.73 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.208 -1.557 . . . . 25.19 111.9 -174.935 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.89 27.25 29.41 Favored Glycine 0 N--CA 1.429 -1.772 1 O-C-N 114.919 -4.863 . . . . 7.41 113.657 170.972 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -91.65 133.56 30.78 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 118.52 -2.753 . . . . 9.49 111.439 175.499 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.9 Cg_exo -70.54 153.87 65.05 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 O-C-N 115.784 -2.798 . . . . 11.42 117.741 -179.292 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 12.5 Cg_exo -75.31 -29.0 8.19 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 CA-C-N 122.863 2.058 . . . . 12.0 116.206 -166.477 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.99 -14.72 60.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.178 -2.826 . . . . 35.55 107.992 -169.733 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -109.55 3.2 20.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.385 -3.322 . . . . 20.52 111.828 -172.15 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -87.59 134.96 33.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.71 3.604 . . . . 7.13 105.172 168.607 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -129.55 125.3 35.94 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 101.719 -3.438 . . . . 36.39 101.719 178.651 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.2 mt -126.1 132.91 51.79 Favored 'General case' 0 N--CA 1.43 -1.427 2 O-C-N 115.597 -4.439 . . . . 9.55 99.45 -167.995 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 mm -119.31 134.75 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 109.74 -3.391 . . . . 13.9 111.824 -178.042 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -128.77 124.02 34.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 117.077 -1.44 . . . . 6.86 112.244 163.18 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.61 -101.64 0.11 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.319 2.248 . . . . 11.15 106.773 -168.693 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.05 17.46 5.41 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 119.961 -1.712 . . . . 13.93 115.781 170.829 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -103.92 141.19 36.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.138 -1.801 . . . . 23.92 106.138 -172.906 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -83.18 124.29 30.38 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.605 2.362 . . . . 23.23 114.0 166.684 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.19 111.56 23.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.236 3.05 . . . . 9.11 119.236 -174.647 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.83 140.17 58.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 120.519 3.526 . . . . 33.44 120.519 -178.714 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -49.24 -51.33 33.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.623 3.169 . . . . 28.37 118.289 -163.83 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.37 18.5 56.83 Favored Glycine 0 N--CA 1.43 -1.706 0 O-C-N 117.844 -3.035 . . . . 15.0 116.024 -178.154 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -97.62 148.02 23.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 122.83 3.315 . . . . 25.5 108.015 -177.196 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -78.56 151.15 32.59 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 115.785 -4.322 . . . . 11.95 110.32 179.908 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.0 mt -65.62 -30.81 71.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.571 -2.581 . . . . 10.17 112.809 179.38 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -59.42 -44.37 92.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.321 3.448 . . . . 13.59 112.083 170.952 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.72 -40.99 89.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.304 -3.372 . . . . 11.7 117.378 172.841 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -77.37 -21.24 53.56 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.534 -1.979 . . . . 12.95 111.505 175.496 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.5 t30 56.71 53.15 8.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.929 3.292 . . . . 25.45 117.009 -175.043 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.1 mm -64.38 121.8 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 118.671 -2.518 . . . . 14.6 112.266 164.387 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -96.67 167.5 11.08 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.632 2.634 . . . . 33.23 111.451 179.221 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -72.28 145.52 47.82 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 112.796 -6.19 . . . . 25.97 120.52 174.787 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 63.17 19.95 11.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.0 2.52 . . . . 32.61 115.688 -175.287 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.49 143.3 27.28 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.071 -2.786 . . . . 10.56 118.446 170.041 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.2 m -92.05 117.01 29.43 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.402 3.112 . . . . 5.33 119.402 -179.756 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.83 143.51 26.27 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.554 1.524 . . . . 11.66 108.126 171.743 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -93.53 134.85 35.38 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.841 -2.412 . . . . 16.3 109.858 167.785 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 tt -106.24 132.5 52.22 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.399 -2.815 . . . . 9.96 103.399 166.357 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -120.34 174.18 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 129.731 3.212 . . . . 9.76 106.044 160.351 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.1 mt -103.55 140.2 37.85 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.245 -5.284 . . . . 19.57 111.881 -173.265 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -95.51 128.39 42.33 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 114.629 -5.044 . . . . 35.08 106.343 177.02 . . . . . . . . 2 2 . 1 . 121 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.8 mt -96.42 152.66 18.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.806 2.717 . . . . 32.31 108.484 172.38 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -64.74 117.48 7.54 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 117.477 2.399 . . . . 42.75 117.477 170.298 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.75 -30.87 1.92 Allowed Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 125.425 1.488 . . . . 36.31 114.118 -162.552 . . . . . . . . 1 1 . 1 . 121 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.786 0 O-C-N 120.352 -1.675 . . . . 36.27 111.992 179.145 . . . . . . . . 0 0 . 1 . 122 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 CA--C 1.489 -1.368 0 CA-C-O 121.471 0.653 . . . . 17.17 110.859 . . . . . . . . . 0 0 . 1 . 122 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -106.1 129.83 54.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.576 -1.647 . . . . 21.89 115.36 175.319 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -123.46 169.39 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.621 -2.55 . . . . 10.83 105.475 170.784 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.68 140.81 52.62 Favored 'General case' 0 N--CA 1.429 -1.485 1 N-CA-C 99.994 -4.076 . . . . 10.61 99.994 -169.403 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 t -129.99 126.27 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 105.622 -1.992 . . . . 9.13 105.622 175.227 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -102.35 125.82 49.17 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 124.9 1.375 . . . . 20.55 108.232 177.816 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -89.63 -166.26 1.55 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.521 -2.612 . . . . 11.78 112.656 -162.079 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.5 tp -73.44 -60.23 2.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.143 2.247 . . . . 19.31 112.449 -176.919 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 m -48.45 -49.6 34.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 110.218 -3.174 . . . . 23.14 110.08 174.332 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.36 64.15 0.16 Allowed Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 117.893 -1.504 . . . . 19.74 113.187 176.842 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -123.23 137.11 54.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.739 -1.578 . . . . 21.93 106.739 176.691 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -100.38 103.88 15.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.969 2.168 . . . . 12.33 111.737 176.394 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.438 16.9 pt -93.1 147.24 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 124.204 1.954 . . . . 17.08 109.806 -176.314 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 m -101.0 123.03 44.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.134 -2.229 . . . . 16.3 106.115 175.846 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -116.21 152.71 33.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.632 2.373 . . . . 15.88 111.582 176.261 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -111.76 114.03 26.76 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.189 -2.278 . . . . 28.9 108.278 177.145 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.62 173.77 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 113.417 -1.719 . . . . 12.05 110.521 -178.867 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -123.07 142.16 37.57 Favored Pre-proline 0 N--CA 1.43 -1.431 0 N-CA-C 107.889 -1.152 . . . . 18.17 107.889 175.481 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -68.84 -9.12 25.35 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 O-C-N 114.434 -3.508 . . . . 8.16 116.228 -169.011 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -83.82 -19.86 34.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.649 2.022 . . . . 11.13 110.362 179.184 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -69.86 144.83 52.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.265 2.226 . . . . 18.03 112.392 172.871 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 27.1 p -82.75 172.04 13.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.597 -3.189 . . . . 10.22 115.768 -175.402 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mm -61.17 -41.97 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 117.653 2.464 . . . . 12.3 117.653 173.657 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -31.57 -61.4 0.22 Allowed 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.586 -3.196 . . . . 36.51 118.486 152.578 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -50.94 -39.58 55.2 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.698 2.11 . . . . 25.66 116.698 171.287 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 t -68.57 -43.83 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 118.516 -2.615 . . . . 8.12 113.471 178.016 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.18 -34.67 76.87 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.479 2.029 . . . . 15.47 116.479 168.473 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.31 -32.86 63.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.079 -2.263 . . . . 11.45 110.767 178.017 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.253 66.6 mttt -64.65 -29.52 70.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.841 -2.412 . . . . 24.98 115.644 168.166 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.8 mt -67.97 -36.42 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.647 1.567 . . . . 9.46 113.248 170.348 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -61.15 -42.16 98.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.448 -2.032 . . . . 14.76 113.728 169.027 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.63 -53.06 17.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.082 1.896 . . . . 26.29 107.702 -174.802 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -56.8 -62.8 1.49 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 116.164 -4.085 . . . . 30.06 114.35 173.573 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -92.33 -41.88 10.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 119.236 3.05 . . . . 25.19 119.236 -173.669 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.58 46.65 2.1 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 116.536 -2.258 . . . . 7.41 112.706 -171.894 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.4 mt -109.99 116.37 53.73 Favored Pre-proline 0 N--CA 1.429 -1.479 0 C-N-CA 130.098 3.359 . . . . 9.49 110.892 173.698 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.02 149.29 92.01 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 127.279 3.635 . . . . 11.42 115.223 -178.876 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -76.36 -24.81 10.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 120.336 1.156 . . . . 12.0 114.475 -164.114 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.28 -22.42 52.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.336 1.454 . . . . 35.55 110.618 -169.562 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.33 3.78 51.03 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 121.771 2.078 . . . . 20.52 108.94 176.184 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -86.38 135.13 33.62 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.949 -2.969 . . . . 7.13 111.289 172.755 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.2 ttm105 -127.5 125.43 40.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.622 -1.924 . . . . 36.39 110.51 153.51 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.88 135.0 33.59 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 124.909 2.29 . . . . 9.55 113.678 178.654 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.31 146.92 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 103.424 -2.806 . . . . 13.9 103.424 -178.954 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -122.47 125.91 46.79 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 114.595 -5.065 . . . . 6.86 101.499 157.47 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.65 -94.46 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.487 1.613 . . . . 11.15 112.895 -178.186 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.22 22.42 1.4 Allowed Glycine 0 N--CA 1.43 -1.751 0 O-C-N 117.43 -3.294 . . . . 13.93 113.723 166.719 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -87.18 120.75 28.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.615 2.766 . . . . 23.92 112.123 167.32 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -78.44 129.29 34.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.23 -3.419 . . . . 23.23 113.543 176.98 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.1 mt -108.3 124.86 50.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.62 -2.55 . . . . 9.11 105.494 -154.524 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -93.25 138.55 31.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.291 -2.756 . . . . 33.44 111.971 -175.187 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -43.73 -43.74 6.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.919 3.287 . . . . 28.37 119.67 -179.099 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.56 18.0 45.29 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.49 -2.631 . . . . 15.0 113.932 -169.855 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -95.38 149.22 21.61 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.288 1.518 . . . . 25.5 110.128 163.519 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 p -71.52 146.49 48.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 111.958 -2.383 . . . . 11.95 108.093 171.349 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -49.19 -49.35 43.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.947 1.832 . . . . 10.17 115.947 161.332 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 p -49.48 -35.27 19.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 119.014 2.968 . . . . 13.59 119.014 166.29 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.83 -26.73 54.68 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 127.639 3.59 . . . . 11.7 114.646 -178.452 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -87.51 1.52 53.28 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.699 2.481 . . . . 12.95 117.699 168.297 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 72.68 31.92 1.58 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.215 2.822 . . . . 25.45 112.127 172.411 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mm -89.1 118.78 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 121.326 -0.859 . . . . 14.6 109.698 -169.919 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -106.28 172.72 6.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.354 -1.466 . . . . 33.23 107.155 -179.416 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -70.3 160.86 31.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 118.437 -1.305 . . . . 25.97 113.563 -175.703 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.253 52.5 mt-10 65.69 9.09 5.67 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.569 2.433 . . . . 32.61 117.569 -168.622 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.0 m -69.48 135.2 49.85 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 112.445 -2.161 . . . . 10.56 113.179 171.939 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.8 m -110.97 122.03 46.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.768 -3.083 . . . . 5.33 106.466 -174.593 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.29 164.92 11.4 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 100.793 -3.78 . . . . 11.66 100.793 -172.508 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -123.45 130.59 52.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.139 -1.886 . . . . 16.3 109.912 -179.691 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -84.69 134.19 34.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.569 2.062 . . . . 9.96 116.569 169.719 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.52 164.66 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.68 -1.887 . . . . 9.76 107.668 169.881 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.268 24.1 tp -94.27 132.59 38.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.981 -2.949 . . . . 19.57 104.806 -172.059 . . . . . . . . 2 2 . 1 . 122 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -101.37 137.22 40.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.364 2.265 . . . . 35.08 113.196 166.828 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.8 mt -114.91 -159.12 0.69 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 131.388 3.875 . . . . 32.31 101.902 -178.05 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -99.4 128.76 45.54 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.767 2.222 . . . . 42.75 114.732 -176.572 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.85 3.49 4.96 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 116.205 -2.441 . . . . 36.31 112.292 156.168 . . . . . . . . 1 1 . 1 . 122 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.723 0 CA-C-N 122.334 3.067 . . . . 36.27 115.431 -173.641 . . . . . . . . 0 0 . 1 . 123 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 117.614 2.45 . . . . 17.17 117.614 . . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -93.41 123.53 36.77 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 118.167 -0.92 . . . . 21.89 110.274 -163.945 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 pt -92.48 171.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 127.084 3.326 . . . . 10.83 109.394 165.567 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.556 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 26.1 m-85 -115.13 112.48 22.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.794 2.837 . . . . 10.61 107.688 169.545 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.5 t -105.71 118.43 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.858 -2.402 . . . . 9.13 105.13 172.08 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -97.57 113.12 24.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.843 2.857 . . . . 20.55 112.826 175.218 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.456 26.7 p -66.45 161.52 22.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 119.65 3.204 . . . . 11.78 119.65 174.979 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 tp -70.12 -34.06 72.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.26 -3.4 . . . . 19.31 107.31 -178.267 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -68.63 -61.84 1.65 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.184 0.993 . . . . 23.14 110.174 170.826 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.71 46.45 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 117.26 -3.4 . . . . 19.74 114.369 -170.436 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -126.1 135.96 52.34 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.981 -2.482 . . . . 21.93 112.678 162.868 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.4 m -105.85 114.04 27.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.692 -3.755 . . . . 12.33 106.291 -179.678 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -97.78 129.01 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 130.954 3.702 . . . . 17.08 109.278 -177.844 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -98.22 102.92 14.8 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.426 2.536 . . . . 16.3 105.409 -178.725 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.88 124.04 45.07 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.212 -2.18 . . . . 15.88 110.521 -155.216 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.73 113.49 18.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.83 -2.441 . . . . 28.9 114.922 -176.413 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.57 156.03 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 125.191 2.424 . . . . 12.05 111.469 178.33 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -91.97 158.32 39.84 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 116.041 -1.933 . . . . 18.17 108.988 174.704 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -83.32 -22.13 4.11 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 126.379 3.314 . . . . 8.16 118.027 -179.331 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 m -86.43 14.25 7.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 125.047 1.467 . . . . 11.13 114.483 -175.535 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -110.79 151.91 27.24 Favored 'General case' 0 N--CA 1.43 -1.449 1 C-N-CA 133.438 4.695 . . . . 18.03 111.334 -177.643 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 55.9 p -75.37 157.55 34.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 127.74 3.638 . . . . 10.22 113.046 -177.648 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.37 -28.24 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 126.03 2.824 . . . . 12.3 109.832 -179.137 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -69.24 -24.29 63.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.373 -3.954 . . . . 36.51 108.498 176.455 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -83.08 -38.98 21.76 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.192 2.997 . . . . 25.66 108.631 -179.077 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.8 t -55.84 -47.99 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 123.78 1.752 . . . . 8.12 112.711 162.483 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -60.69 -39.04 87.04 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.717 -4.364 . . . . 15.47 114.997 177.052 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.15 -43.14 66.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.31 3.078 . . . . 11.45 119.31 164.57 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -65.18 -41.41 94.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.791 -1.818 . . . . 24.98 111.629 177.114 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -60.38 -44.02 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 126.55 1.94 . . . . 9.46 113.151 172.482 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -51.12 -37.13 44.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.725 3.21 . . . . 14.76 113.988 167.615 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -83.76 -38.01 21.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.077 -1.639 . . . . 26.29 108.37 -176.921 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -63.93 -58.9 5.36 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.124 1.898 . . . . 30.06 116.124 177.4 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -100.14 -69.32 0.77 Allowed 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 124.724 2.202 . . . . 25.19 110.641 -171.351 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.49 46.07 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.766 0 O-C-N 117.418 -3.302 . . . . 7.41 105.593 -175.34 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -106.32 130.9 22.24 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 116.932 -1.509 . . . . 9.49 110.298 167.821 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 80.2 Cg_exo -76.21 154.66 37.04 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 119.79 2.958 . . . . 11.42 119.79 177.858 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 62.4 Cg_exo -70.5 -17.82 33.95 Favored 'Trans proline' 0 N--CA 1.434 -1.993 1 C-N-CA 126.142 4.561 . . . . 12.0 112.207 -169.229 . . . . . . . . 3 3 . 1 . 123 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -84.55 -21.01 30.62 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 115.267 -4.646 . . . . 35.55 114.408 176.451 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.95 -16.06 30.7 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.987 -1.695 . . . . 20.52 111.109 -175.549 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -86.1 153.13 22.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 118.834 -1.146 . . . . 7.13 112.842 -174.613 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.458 ' HB3' HG23 ' A' ' 70' ' ' VAL . 21.2 ttm180 -140.98 125.57 17.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 102.362 -3.199 . . . . 36.39 102.362 169.35 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.3 mt -105.63 125.68 51.27 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.03 1.395 . . . . 9.55 109.473 175.014 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mm -106.57 128.2 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 121.16 -0.963 . . . . 13.9 111.03 177.307 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -112.97 115.51 28.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 118.859 -1.136 . . . . 6.86 109.476 160.8 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.307 . . 64.31 -101.28 0.09 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.859 2.463 . . . . 11.15 111.613 -170.911 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.63 2.19 23.31 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 130.057 3.694 . . . . 13.93 114.158 172.11 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.258 14.3 tppt? -102.7 132.86 48.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 119.916 1.858 . . . . 23.92 111.019 -177.97 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -91.6 138.16 31.79 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.902 -1.954 . . . . 23.23 110.88 176.819 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.287 3.3 mt -106.59 114.24 28.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.974 3.273 . . . . 9.11 110.255 -166.018 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.37 130.27 35.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.271 -2.768 . . . . 33.44 114.063 -167.789 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -31.35 -67.35 0.1 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 121.245 3.795 . . . . 28.37 121.245 -164.336 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.56 21.9 43.15 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 115.177 -3.392 . . . . 15.0 111.334 -168.233 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -91.63 153.98 19.33 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.183 -4.716 . . . . 25.5 112.333 166.832 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 64.9 p -76.01 166.5 23.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.739 -2.476 . . . . 11.95 116.668 179.248 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 124.977 2.322 . . . . 10.17 116.758 163.526 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -60.94 -24.93 66.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 112.329 -3.701 . . . . 13.59 117.981 177.978 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -71.82 -38.55 70.16 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.497 2.408 . . . . 11.7 115.356 167.448 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -77.78 -2.99 39.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.673 -2.517 . . . . 12.95 114.709 170.645 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 2.6 m-80 52.62 49.05 21.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.58 3.086 . . . . 25.45 115.644 177.093 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.66 112.7 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 109.645 -3.434 . . . . 14.6 110.124 176.629 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -96.49 166.57 11.62 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.559 -2.588 . . . . 33.23 107.215 179.566 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -52.55 146.86 9.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.08 2.552 . . . . 25.97 114.704 171.507 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 57.81 38.69 27.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.856 3.693 . . . . 32.61 115.534 -178.516 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.254 72.5 m -102.35 131.21 49.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.833 -3.042 . . . . 10.56 110.206 -173.544 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 96.3 m -102.9 101.0 11.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.766 1.746 . . . . 5.33 108.787 -164.309 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 mt -81.75 134.34 35.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.913 -3.617 . . . . 11.66 113.353 172.47 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -89.28 101.19 13.86 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 113.424 -3.179 . . . . 16.3 105.406 -179.521 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -71.2 114.76 9.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 124.458 3.299 . . . . 9.96 114.489 169.602 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 42' ' ' ARG . 15.7 m -121.95 -174.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.35 2.976 . . . . 9.76 107.622 -176.024 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 tp -94.38 127.57 40.35 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 113.467 -5.771 . . . . 19.57 115.779 176.808 . . . . . . . . 2 2 . 1 . 123 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -94.05 119.49 32.99 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.188 2.899 . . . . 35.08 110.674 167.23 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.9 mt -103.17 152.09 21.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.708 2.803 . . . . 32.31 110.674 162.069 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -73.53 154.14 39.99 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.508 2.723 . . . . 42.75 111.641 176.524 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.69 30.15 21.97 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 116.485 1.354 . . . . 36.31 116.485 -167.953 . . . . . . . . 1 1 . 1 . 123 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.767 0 N-CA-C 107.771 -2.132 . . . . 36.27 107.771 172.074 . . . . . . . . 0 0 . 1 . 124 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.341 9.5 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 113.954 -2.927 . . . . 17.17 117.243 . . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -74.93 124.97 27.89 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 131.799 4.039 . . . . 21.89 113.684 165.054 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.4 pt -120.16 162.08 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 103.36 -2.83 . . . . 10.83 103.36 159.675 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -114.93 135.44 54.21 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.024 -1.843 . . . . 10.61 106.024 -179.371 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.39 106.34 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 1 O-C-N 113.024 -6.047 . . . . 9.13 111.369 179.7 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -84.51 138.64 32.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.517 2.579 . . . . 20.55 112.947 179.957 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -106.9 174.79 5.73 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.31 -2.118 . . . . 11.78 106.872 -178.16 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -74.69 -50.11 18.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.202 2.201 . . . . 19.31 108.225 -169.396 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 p -71.43 -73.36 0.18 Allowed 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.131 1.9 . . . . 23.14 116.131 176.591 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.37 68.98 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.699 1 O-C-N 112.348 -6.47 . . . . 19.74 115.729 168.528 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -132.83 146.05 51.49 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.578 -1.542 . . . . 21.93 109.109 163.398 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.2 m -119.48 129.22 54.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.283 -1.767 . . . . 12.33 107.975 166.428 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.07 127.88 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 113.118 -1.855 . . . . 17.08 107.253 -177.209 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -86.39 128.87 34.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.22 -2.881 . . . . 16.3 103.22 169.007 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 tp -128.2 139.2 52.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.06 -1.427 . . . . 15.88 111.687 173.258 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -86.81 118.45 26.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.541 -1.35 . . . . 28.9 113.945 171.574 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -129.05 157.01 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.027 1.862 . . . . 12.05 116.027 173.266 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -103.78 140.05 20.69 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 125.572 1.549 . . . . 18.17 108.011 171.439 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -70.18 -18.13 35.23 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 122.356 1.877 . . . . 8.16 111.884 -170.407 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.39 -8.81 58.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.771 2.429 . . . . 11.13 116.031 178.361 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.26 164.41 25.75 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.985 -4.197 . . . . 18.03 111.625 171.558 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 59.1 p -79.88 170.65 16.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.623 -2.548 . . . . 10.22 115.654 156.431 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -73.95 -26.19 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.707 2.003 . . . . 12.3 111.37 175.234 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -57.91 -39.2 77.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 116.598 -3.814 . . . . 36.51 114.237 166.68 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -76.35 -31.06 57.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.846 -3.659 . . . . 25.66 112.042 -175.334 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.72 -42.07 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.245 1.818 . . . . 8.12 112.06 172.274 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -69.16 -23.8 63.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 119.708 3.225 . . . . 15.47 119.708 172.472 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.43 -23.45 67.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.77 2.428 . . . . 11.45 116.916 159.412 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -94.57 -19.21 20.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.444 1.592 . . . . 24.98 111.274 175.431 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.72 -34.97 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-O 116.314 -1.803 . . . . 9.46 106.451 175.868 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -67.63 -29.09 68.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.625 1.679 . . . . 14.76 111.943 174.957 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.81 -47.71 51.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.729 -2.482 . . . . 26.29 115.79 172.928 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -78.81 -47.82 15.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.332 1.975 . . . . 30.06 116.332 -177.257 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -105.2 -17.28 14.52 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.996 -2.94 . . . . 25.19 116.612 -178.88 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.17 61.4 5.19 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 127.077 2.275 . . . . 7.41 112.052 172.978 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -121.93 142.14 35.66 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 100.274 -3.972 . . . . 9.49 100.274 170.834 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -65.49 157.71 56.81 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 124.834 2.762 . . . . 11.42 110.531 -177.389 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -64.41 -27.05 62.79 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 123.867 3.044 . . . . 12.0 114.697 -178.982 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.5 -31.7 65.57 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 115.953 -4.217 . . . . 35.55 108.748 -176.154 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -81.71 -23.17 36.93 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.113 -2.867 . . . . 20.52 113.74 -179.815 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -71.0 120.29 16.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.413 2.285 . . . . 7.13 113.272 171.224 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -121.71 126.37 48.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 118.062 -0.97 . . . . 36.39 108.592 159.555 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.27 136.75 43.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.759 2.695 . . . . 9.55 108.536 -179.077 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.7 mm -120.31 146.78 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.649 -2.532 . . . . 13.9 105.779 -178.064 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -127.02 127.26 44.5 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 100.427 -3.916 . . . . 6.86 100.427 164.604 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.526 . . 59.34 -88.64 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 120.789 3.625 . . . . 11.15 120.789 -172.884 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.13 19.39 1.56 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 123.659 0.599 . . . . 13.93 112.029 153.025 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -77.38 132.99 38.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.732 0.777 . . . . 23.92 112.017 160.751 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -79.01 124.1 27.93 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.87 -3.644 . . . . 23.23 113.597 173.728 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.432 HD22 ' CD2' ' A' ' 59' ' ' TYR . 48.4 mt -99.48 120.82 40.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.091 -2.255 . . . . 9.11 107.987 -178.91 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -102.79 153.12 20.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.426 2.953 . . . . 33.44 110.42 -178.146 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.09 -51.59 30.75 Favored 'General case' 0 N--CA 1.43 -1.441 1 N-CA-C 122.677 4.325 . . . . 28.37 122.677 -166.545 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.44 -5.07 85.46 Favored Glycine 0 N--CA 1.43 -1.753 0 O-C-N 124.955 1.41 . . . . 15.0 114.945 -176.624 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -78.53 150.11 32.93 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.427 1.108 . . . . 25.5 110.214 168.102 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.5 p -88.31 179.06 6.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.176 -1.829 . . . . 11.95 113.029 169.044 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.466 ' HA ' HD23 ' A' ' 56' ' ' LEU . 94.6 mt -76.34 -45.03 33.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.944 -1.502 . . . . 10.17 106.944 -174.544 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 p -50.57 -41.63 54.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.938 2.895 . . . . 13.59 114.408 176.147 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.6 -38.35 90.77 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.198 1.799 . . . . 11.7 111.125 -174.277 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CD2' HD22 ' A' ' 50' ' ' LEU . 76.2 m-85 -96.15 17.0 16.57 Favored 'General case' 0 N--CA 1.43 -1.468 2 O-C-N 115.145 -4.722 . . . . 12.95 111.788 169.718 . . . . . . . . 3 3 . 1 . 124 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 47.36 55.32 8.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 127.693 3.616 . . . . 25.45 118.756 -172.558 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.4 mm -82.42 119.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 111.117 -2.765 . . . . 14.6 113.843 171.57 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -97.84 170.36 9.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.573 2.421 . . . . 33.23 110.191 -176.039 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -76.39 155.65 33.88 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 115.647 -2.12 . . . . 25.97 108.062 -179.482 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.354 46.7 mt-10 58.2 39.35 25.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.685 1.994 . . . . 32.61 116.089 177.94 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -124.14 136.36 54.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.921 -1.881 . . . . 10.56 105.921 -173.458 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.9 m -85.1 121.42 27.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.924 -1.988 . . . . 5.33 109.692 -171.834 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.62 158.65 15.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.402 2.681 . . . . 11.66 108.88 174.118 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -111.88 113.26 25.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.063 1.301 . . . . 16.3 110.185 -179.55 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.9 tp -81.34 119.16 23.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.547 -1.216 . . . . 9.96 111.063 173.355 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.77 166.73 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 118.75 -1.18 . . . . 9.76 110.971 173.304 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 tp -85.12 119.97 26.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.609 -2.557 . . . . 19.57 110.781 176.527 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -97.53 134.45 40.74 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.275 1.03 . . . . 35.08 111.563 166.921 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.29 99.0 mt -94.65 174.54 7.06 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.824 -1.173 . . . . 32.31 111.5 172.148 . . . . . . . . 2 2 . 1 . 124 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -74.39 158.81 33.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.678 -3.139 . . . . 42.75 112.222 166.534 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.27 -83.26 0.15 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 130.212 3.768 . . . . 36.31 112.604 175.271 . . . . . . . . 1 1 . 1 . 124 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 CA-C-O 117.817 -1.546 . . . . 36.27 109.747 176.461 . . . . . . . . 0 0 . 1 . 125 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 CA--C 1.489 -1.366 0 N-CA-C 108.08 -1.081 . . . . 17.17 108.08 . . . . . . . . . 0 0 . 1 . 125 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -88.67 145.47 25.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.887 -2.383 . . . . 21.89 110.656 178.558 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.0 pt -133.17 164.69 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 104.785 -2.302 . . . . 10.83 104.785 166.677 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -121.44 142.6 49.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 128.372 3.545 . . . . 10.61 108.344 -175.195 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -118.31 116.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 111.652 -2.522 . . . . 9.13 107.843 177.16 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -101.89 138.51 38.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.218 -2.176 . . . . 20.55 111.126 179.819 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.9 p -98.81 170.35 8.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.688 -2.051 . . . . 11.78 108.421 -172.487 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.3 tp -49.59 -60.63 2.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.738 2.496 . . . . 19.31 117.738 177.688 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.275 17.7 p -74.26 -32.81 63.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 111.587 -2.552 . . . . 23.14 112.144 -178.781 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.17 69.85 0.26 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 118.694 -2.504 . . . . 19.74 114.256 159.919 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -107.92 143.5 36.47 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.795 -0.826 . . . . 21.93 112.982 164.511 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -94.0 98.53 11.08 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.038 1.866 . . . . 12.33 116.038 167.874 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.5 mt -86.06 92.59 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 116.164 -4.085 . . . . 17.08 106.577 176.873 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 m -61.57 127.46 31.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 117.089 -1.434 . . . . 16.3 113.185 164.902 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.403 HD13 HG13 ' A' ' 26' ' ' VAL . 30.8 mt -110.34 150.3 28.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.953 2.901 . . . . 15.88 115.669 163.756 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -104.83 125.19 50.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.6 -3.188 . . . . 28.9 103.824 170.485 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -139.53 156.18 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.57 -2.581 . . . . 12.05 116.489 -171.195 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -105.43 149.3 37.63 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 117.973 -2.954 . . . . 18.17 111.242 168.054 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.68 -25.53 75.75 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 123.947 3.098 . . . . 8.16 113.882 172.776 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 p -81.58 -5.76 58.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.844 1.258 . . . . 11.13 111.777 -175.537 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -74.66 145.93 42.79 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 118.334 2.716 . . . . 18.03 118.334 179.674 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -88.66 154.4 20.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.917 -2.364 . . . . 10.22 108.901 177.451 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 mm -63.29 -27.81 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.843 2.735 . . . . 12.3 112.786 179.511 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -54.06 -54.42 39.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.313 -3.992 . . . . 36.51 112.048 168.075 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.63 -41.34 98.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.583 1.698 . . . . 25.66 115.583 174.562 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 HD13 ' A' ' 15' ' ' LEU . 72.8 t -61.42 -46.14 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 119.597 -1.939 . . . . 8.12 111.937 176.045 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -67.68 -20.67 65.32 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.254 -3.404 . . . . 15.47 114.47 177.986 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.4 -27.85 66.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.579 1.325 . . . . 11.45 114.579 174.361 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -83.75 -29.05 27.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.503 1.127 . . . . 24.98 110.906 175.658 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.95 -29.87 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 120.746 1.612 . . . . 9.46 111.511 165.897 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -76.81 -45.19 29.65 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.47 1.655 . . . . 14.76 115.47 176.649 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.378 20.7 t70 -41.5 -54.97 2.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.521 2.328 . . . . 26.29 112.171 163.058 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -79.32 -61.88 1.87 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 121.377 3.843 . . . . 30.06 121.377 -177.145 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.63 -36.48 16.24 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 115.525 -4.485 . . . . 25.19 105.994 -171.226 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.22 81.15 0.46 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 118.932 -2.355 . . . . 7.41 112.743 -171.112 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.3 mt -135.34 131.01 19.36 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 100.686 -3.82 . . . . 9.49 100.686 170.58 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -69.29 149.43 69.91 Favored 'Trans proline' 0 N--CA 1.434 -2.022 1 CA-C-N 128.604 4.108 . . . . 11.42 115.213 -178.543 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -93.88 4.45 2.92 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 C-N-CA 115.992 -2.205 . . . . 12.0 112.651 -154.102 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.44 -38.97 21.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.523 3.129 . . . . 35.55 105.827 176.236 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -67.67 -37.72 82.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.064 2.946 . . . . 20.52 109.52 174.003 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.36 69.0 mt-30 -83.93 132.55 34.76 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 128.059 3.79 . . . . 7.13 110.189 -176.163 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.416 ' HB3' HG23 ' A' ' 70' ' ' VAL . 45.0 ttt180 -127.31 133.77 50.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 110.786 -2.915 . . . . 36.39 108.997 175.229 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.3 mt -103.92 139.41 39.12 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-O 131.272 5.32 . . . . 9.55 108.507 178.512 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.62 HD12 ' HG2' ' A' ' 49' ' ' GLN . 10.7 mm -123.06 137.22 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 1 O-C-N 115.974 -4.204 . . . . 13.9 111.762 172.449 . . . . . . . . 3 3 . 1 . 125 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -127.01 124.92 40.52 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.933 -4.229 . . . . 6.86 102.629 165.363 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.9 -98.5 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 134.392 5.077 . . . . 11.15 117.717 -173.62 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.04 -18.61 36.37 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 124.71 1.148 . . . . 13.93 114.238 -174.564 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -128.96 133.03 47.67 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.991 2.219 . . . . 23.92 116.991 -166.761 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.62 ' HG2' HD12 ' A' ' 44' ' ' ILE . 33.1 mt-30 -83.04 134.33 35.04 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.08 -1.822 . . . . 23.23 106.08 -170.585 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.0 mt -92.39 132.21 36.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.24 -1.345 . . . . 9.11 111.262 -166.417 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.37 164.76 11.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.872 -3.017 . . . . 33.44 108.163 -176.558 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.75 -57.2 12.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.703 -2.044 . . . . 28.37 115.339 -161.742 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.82 18.94 36.27 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 117.273 -1.849 . . . . 15.0 115.324 -174.711 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.4 mtt-85 -104.5 150.76 24.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.698 1.749 . . . . 25.5 108.615 -178.478 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 p -91.56 153.43 19.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.682 -2.511 . . . . 11.95 110.583 -164.432 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.1 mt -53.68 -35.68 61.35 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.257 2.623 . . . . 10.17 112.797 167.991 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.0 p -70.72 -37.99 73.57 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.662 1.696 . . . . 13.59 115.274 178.652 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -78.93 -29.68 44.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.23 -2.169 . . . . 11.7 109.502 173.45 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -77.79 -2.45 36.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 123.816 3.007 . . . . 12.95 116.882 166.133 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 61.38 34.74 18.18 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 126.039 2.828 . . . . 25.45 114.753 177.884 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.93 116.28 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 113.507 -1.679 . . . . 14.6 114.986 174.543 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -98.29 174.61 6.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.318 -2.845 . . . . 33.23 103.318 -175.234 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -65.5 147.23 53.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.49 1.293 . . . . 25.97 114.49 173.387 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 8.5 mt-10 55.3 25.74 7.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.803 -2.436 . . . . 32.61 113.252 179.73 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -93.96 151.55 19.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.174 -2.346 . . . . 10.56 110.859 169.908 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.5 m -114.09 125.44 53.97 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.138 2.149 . . . . 5.33 108.731 -169.72 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -92.11 151.26 20.5 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 116.895 -3.628 . . . . 11.66 112.983 165.705 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -91.51 135.28 33.97 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.152 -2.536 . . . . 16.3 104.152 172.158 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.5 tp -84.86 125.95 33.06 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.638 -1.914 . . . . 9.96 113.846 154.909 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 42' ' ' ARG . 24.9 m -114.17 165.58 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 127.597 2.359 . . . . 9.76 112.036 168.476 . . . . . . . . 2 2 . 1 . 125 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.0 tp -84.16 149.18 26.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.904 -2.372 . . . . 19.57 114.319 170.943 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -114.04 126.03 54.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 113.496 0.924 . . . . 35.08 113.496 169.011 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 mt -86.67 153.68 21.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.022 -1.674 . . . . 32.31 106.63 179.807 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -86.87 100.5 12.6 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 117.681 -3.137 . . . . 42.75 111.197 173.04 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.52 38.79 1.86 Allowed Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 109.701 -3.408 . . . . 36.31 108.622 173.686 . . . . . . . . 1 1 . 1 . 125 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.809 0 CA-C-O 116.14 -2.478 . . . . 36.27 110.759 -171.902 . . . . . . . . 0 0 . 1 . 126 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 CA--C 1.49 -1.35 0 N-CA-C 117.855 2.539 . . . . 17.17 117.855 . . . . . . . . . 0 0 . 1 . 126 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -82.05 131.68 35.25 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.059 -1.924 . . . . 21.89 108.536 177.017 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -117.13 176.0 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 123.435 2.834 . . . . 10.83 107.719 160.071 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -135.89 109.79 8.18 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.862 -3.024 . . . . 10.61 111.654 179.659 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.73 128.95 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 120.171 1.351 . . . . 9.13 111.271 -177.629 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -90.68 134.46 34.39 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.296 -1.503 . . . . 20.55 113.0 173.657 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.7 p -88.09 172.08 9.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.273 3.029 . . . . 11.78 113.09 -178.281 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.73 -36.96 79.07 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.204 -4.06 . . . . 19.31 116.772 177.14 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -70.81 -58.5 3.56 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 114.992 -4.817 . . . . 23.14 109.673 172.548 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.96 46.76 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 123.973 1.874 . . . . 19.74 112.241 -176.668 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -96.46 160.09 14.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 105.137 -2.171 . . . . 21.93 105.137 162.309 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.8 m -117.94 121.93 41.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.033 -1.667 . . . . 12.33 110.032 157.003 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.423 HD13 ' HG3' ' A' ' 34' ' ' GLU . 21.1 mt -105.79 120.07 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.021 -1.844 . . . . 17.08 106.021 -168.371 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m -84.44 94.72 8.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.534 -1.212 . . . . 16.3 109.189 -179.145 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 15' ' ' LEU . 96.9 mt -95.43 132.66 40.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 115.161 -2.352 . . . . 15.88 108.485 -175.941 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.273 26.0 tt0 -89.5 102.67 15.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.291 2.314 . . . . 28.9 114.295 173.692 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.411 HG21 HD13 ' A' ' 56' ' ' LEU . 4.1 m -115.5 155.19 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.493 1.951 . . . . 12.05 111.399 -166.999 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.18 152.8 39.83 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 115.72 -2.086 . . . . 18.17 107.671 170.511 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -85.88 -10.08 7.31 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 129.123 4.294 . . . . 8.16 110.14 -164.513 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 p -85.77 -1.75 57.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 118.827 -1.149 . . . . 11.13 112.776 174.616 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -69.6 151.01 46.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.759 -3.713 . . . . 18.03 114.713 -178.878 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 10.2 p -77.26 161.76 27.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.044 -1.836 . . . . 10.22 106.044 177.356 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mm -57.94 -41.32 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 117.071 -3.518 . . . . 12.3 110.946 165.513 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.281 22.6 tt0 -42.42 -44.12 3.87 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.709 2.404 . . . . 36.51 115.215 164.254 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -65.86 -48.4 71.7 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.708 -3.12 . . . . 25.66 114.223 170.68 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.1 t -49.98 -38.77 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.291 -1.506 . . . . 8.12 112.769 177.928 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -76.16 -21.63 56.32 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.417 2.006 . . . . 15.47 116.417 179.522 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.02 -23.82 62.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.921 2.888 . . . . 11.45 113.708 178.357 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -81.99 -33.32 30.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 126.644 3.116 . . . . 24.98 113.763 171.778 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.4 mt -68.72 -43.86 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.612 -1.93 . . . . 9.46 112.529 165.083 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -45.23 -47.48 12.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.275 2.324 . . . . 14.76 117.275 165.188 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -75.85 -54.43 6.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.485 2.714 . . . . 26.29 114.775 -173.012 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -81.12 -70.43 0.53 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.185 1.394 . . . . 30.06 110.951 -169.57 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HG3' HD13 ' A' ' 13' ' ' ILE . 75.3 mm-40 -58.83 -43.35 90.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.002 2.223 . . . . 25.19 117.002 175.085 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.25 13.05 50.18 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 126.38 3.211 . . . . 7.41 120.145 -168.001 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 56.7 mt -76.72 125.29 87.39 Favored Pre-proline 0 N--CA 1.43 -1.439 1 O-C-N 116.381 -4.011 . . . . 9.49 114.019 174.443 . . . . . . . . 3 3 . 1 . 126 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 40.4 Cg_exo -78.06 158.82 30.53 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-O 113.999 -2.584 . . . . 11.42 113.545 -164.477 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -71.12 -23.85 24.29 Favored 'Trans proline' 0 C--N 1.3 -2.026 1 CA-C-N 128.988 4.246 . . . . 12.0 111.149 -170.519 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.46 0.27 30.18 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.509 3.152 . . . . 35.55 119.509 174.805 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.306 60.2 mt-30 -84.24 -25.42 29.43 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.141 -5.35 . . . . 20.52 108.346 169.687 . . . . . . . . 3 2 . 1 . 126 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -92.83 129.44 38.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.684 2.105 . . . . 7.13 116.684 -152.205 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -142.03 120.82 12.68 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 115.689 -2.101 . . . . 36.39 108.803 168.953 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -104.43 138.55 40.66 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 122.593 2.451 . . . . 9.55 110.988 -177.629 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mm -116.14 136.22 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 125.969 1.707 . . . . 13.9 110.75 -177.317 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -108.94 102.9 11.87 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 114.738 -4.976 . . . . 6.86 106.453 161.663 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.2 -77.62 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.784 3.253 . . . . 11.15 119.784 -168.614 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.62 20.87 2.02 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.108 -1.597 . . . . 13.93 109.108 175.906 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -117.19 129.91 56.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.549 -2.736 . . . . 23.92 104.184 -179.588 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -76.48 143.59 40.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.069 -1.878 . . . . 23.23 112.575 179.515 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.2 mt -103.57 111.52 24.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 116.982 -1.485 . . . . 9.11 107.936 -178.389 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -93.88 150.57 20.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.921 2.013 . . . . 33.44 111.733 -177.128 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -39.63 -63.4 0.58 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.635 3.084 . . . . 28.37 115.482 -169.727 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.38 -25.9 64.79 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.815 -1.803 . . . . 15.0 113.702 -159.022 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -83.93 164.35 19.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 114.582 -2.847 . . . . 25.5 112.866 -178.088 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 61.0 p -97.36 169.07 10.01 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.754 1.264 . . . . 11.95 113.836 -171.431 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 17' ' ' VAL . 48.2 mt -63.51 -41.92 98.49 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.193 1.397 . . . . 10.17 112.305 172.903 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 p -55.35 -43.82 75.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.898 2.136 . . . . 13.59 114.561 165.893 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.38 -35.91 76.29 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.245 -3.409 . . . . 11.7 111.676 -174.044 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.332 2.3 m-85 -91.55 6.23 46.48 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 127.975 3.297 . . . . 12.95 111.814 179.974 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.292 8.0 m120 58.87 40.78 22.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.163 2.653 . . . . 25.45 118.163 175.268 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 mm -75.06 131.59 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 104.928 -2.249 . . . . 14.6 104.928 178.361 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -92.21 175.48 6.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.247 -2.783 . . . . 33.23 113.452 169.159 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -63.64 124.0 20.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 131.629 3.972 . . . . 25.97 112.123 169.541 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 68.12 34.54 3.98 Favored 'General case' 0 N--CA 1.43 -1.461 2 O-C-N 112.188 -6.57 . . . . 32.61 107.317 175.907 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.356 61.7 m -90.86 143.72 26.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.783 2.083 . . . . 10.56 108.727 179.308 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 m -84.73 124.35 31.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.109 -2.869 . . . . 5.33 111.754 -176.15 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.76 151.7 29.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.671 -1.893 . . . . 11.66 107.958 179.643 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.296 63.3 m170 -115.49 129.94 56.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.666 2.03 . . . . 16.3 113.546 170.307 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.6 tp -94.09 122.74 36.92 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.353 1.861 . . . . 9.96 113.969 176.467 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 m -114.38 167.03 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 122.955 2.616 . . . . 9.76 111.751 -175.666 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.7 tp -85.77 113.63 22.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 124.626 1.204 . . . . 19.57 109.517 176.514 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -75.59 110.22 9.8 Favored 'General case' 0 N--CA 1.43 -1.453 2 C-N-CA 133.071 4.548 . . . . 35.08 108.765 -178.098 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.314 16.8 mt -112.67 114.47 27.09 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.485 -3.26 . . . . 32.31 106.185 178.528 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.49 ' HE ' ' C ' ' A' ' 76' ' ' GLY . 49.4 ttt180 -125.28 128.02 47.6 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.091 -1.818 . . . . 42.75 106.091 179.689 . . . . . . . . 2 2 . 1 . 126 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.69 -40.36 9.76 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 119.326 -1.416 . . . . 36.31 110.78 176.038 . . . . . . . . 1 1 . 1 . 126 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.49 ' C ' ' HE ' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.26 1.756 0 N-CA-C 109.173 -1.571 . . . . 36.27 109.173 -173.0 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.49 -1.36 0 N-CA-C 114.273 1.212 . . . . 17.17 114.273 . . . . . . . . . 0 0 . 1 . 127 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -86.5 151.59 23.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.032 -2.211 . . . . 21.89 105.032 -175.288 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 pt -134.86 171.62 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 115.678 -4.389 . . . . 10.83 106.267 152.355 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -112.82 132.91 55.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.233 1.813 . . . . 10.61 107.417 -177.553 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.01 102.21 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.202 -2.518 . . . . 9.13 104.202 176.429 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -87.02 127.26 35.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 128.355 3.931 . . . . 20.55 114.462 -178.967 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.9 p -81.04 170.8 15.76 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 116.043 -4.161 . . . . 11.78 119.149 -178.097 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.5 mt -57.69 -34.85 69.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.107 1.763 . . . . 19.31 114.199 171.012 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.8 p -69.26 -23.55 63.86 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.465 -3.272 . . . . 23.14 112.634 172.554 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.63 -5.18 40.27 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 118.036 -2.915 . . . . 19.74 117.529 -161.167 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -76.3 154.06 35.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 120.232 -0.587 . . . . 21.93 111.969 -177.334 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 m -113.1 126.39 55.42 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.559 -3.213 . . . . 12.33 108.868 175.239 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 mt -114.38 112.73 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 102.091 -3.3 . . . . 17.08 102.091 176.355 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.6 m -95.85 107.24 19.47 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 116.782 -3.699 . . . . 16.3 110.497 -174.706 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.3 mt -112.41 151.36 29.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.022 2.344 . . . . 15.88 115.751 -173.539 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.7 104.81 14.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.592 -1.317 . . . . 28.9 109.611 -177.511 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.28 172.22 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 112.862 0.69 . . . . 12.05 112.862 171.145 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -106.06 174.45 2.6 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 107.833 -1.173 . . . . 18.17 107.833 166.577 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -72.8 -17.73 25.44 Favored 'Trans proline' 0 C--N 1.299 -2.048 0 CA-C-O 116.527 -1.53 . . . . 8.16 110.515 175.156 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 m -90.69 9.24 30.63 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 120.877 1.671 . . . . 11.13 112.161 -174.405 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -94.28 154.33 17.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.401 2.048 . . . . 18.03 107.821 -179.103 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -92.59 164.26 13.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 114.695 1.369 . . . . 10.22 114.695 -177.314 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.276 22.1 mm -56.07 -41.05 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 127.842 2.457 . . . . 12.3 112.487 175.296 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.08 -39.94 69.82 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.427 2.291 . . . . 36.51 115.172 173.285 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -57.46 -38.44 74.5 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 130.962 3.705 . . . . 25.66 115.516 165.622 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.76 -45.46 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 123.998 3.09 . . . . 8.12 108.317 -175.146 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.329 17.9 mtmt -55.7 -36.26 66.98 Favored 'General case' 0 N--CA 1.43 -1.456 1 C-N-CA 132.498 4.319 . . . . 15.47 116.619 171.338 . . . . . . . . 3 2 . 1 . 127 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.35 -38.22 83.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.158 3.021 . . . . 11.45 119.158 167.693 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -76.24 -24.61 54.58 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 115.082 1.512 . . . . 24.98 115.082 176.162 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -79.24 -33.45 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 119.043 -2.286 . . . . 9.46 111.184 178.57 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -62.07 -39.91 94.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.297 -1.32 . . . . 14.76 108.562 168.706 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.7 -40.63 79.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.582 2.438 . . . . 26.29 117.582 -176.696 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -82.31 -59.3 2.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 114.816 -2.516 . . . . 30.06 109.129 176.299 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -87.94 -46.28 9.52 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.333 2.271 . . . . 25.19 109.505 -160.495 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.72 45.12 4.99 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 107.815 -2.114 . . . . 7.41 107.815 175.823 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.259 68.3 mt -98.86 121.22 56.68 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 103.993 -2.595 . . . . 9.49 103.993 173.172 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.327 1.1 Cg_exo -71.79 166.21 30.2 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 127.599 3.75 . . . . 11.42 118.491 -171.007 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.48 -6.09 4.49 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 CA-C-N 124.47 2.632 . . . . 12.0 112.667 -157.398 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -82.71 -29.53 29.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.28 1.613 . . . . 35.55 108.445 172.099 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -80.75 -26.44 37.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.095 1.358 . . . . 20.52 112.744 -175.177 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -83.61 128.93 34.9 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.055 -0.975 . . . . 7.13 112.263 175.906 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -126.1 131.2 52.15 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.971 -1.122 . . . . 36.39 107.971 167.663 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.62 137.9 34.04 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.424 3.49 . . . . 9.55 105.742 176.978 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mt -134.2 136.37 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.102 2.561 . . . . 13.9 110.818 179.698 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -120.86 95.09 4.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.323 -1.732 . . . . 6.86 106.323 -174.393 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.64 -82.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.739 2.415 . . . . 11.15 111.994 -163.223 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.39 -1.49 6.11 Favored Glycine 0 N--CA 1.429 -1.794 0 O-C-N 116.959 -3.588 . . . . 13.93 112.5 171.172 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -83.74 113.25 20.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.708 -2.642 . . . . 23.92 113.488 176.51 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -70.38 142.03 52.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.387 -3.321 . . . . 23.23 109.974 171.794 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -107.55 110.66 22.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.963 -1.495 . . . . 9.11 106.963 -166.323 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -87.77 153.74 21.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.129 -2.857 . . . . 33.44 114.479 -175.906 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.366 1.7 m-20 -48.73 -58.92 4.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.781 2.511 . . . . 28.37 117.781 -160.621 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.96 51.86 0.7 Allowed Glycine 0 N--CA 1.43 -1.756 0 CA-C-O 127.514 3.841 . . . . 15.0 114.73 -171.515 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -128.18 158.78 37.13 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.66 -4.435 . . . . 25.5 109.63 174.459 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.7 p -88.16 159.47 18.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.483 2.087 . . . . 11.95 106.869 -171.184 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.63 -30.33 69.79 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 116.064 -4.147 . . . . 10.17 113.354 169.167 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.2 p -64.91 -20.1 66.27 Favored 'General case' 0 N--CA 1.43 -1.47 1 C-N-CA 135.493 5.517 . . . . 13.59 116.294 176.237 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -82.73 -39.04 22.45 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.466 1.907 . . . . 11.7 112.536 172.31 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -79.69 -19.7 48.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.414 -2.679 . . . . 12.95 117.849 163.079 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.496 32.3 m120 75.26 57.28 0.06 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.745 2.212 . . . . 25.45 113.782 174.187 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mm -85.64 126.79 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 129.048 2.939 . . . . 14.6 106.727 -178.7 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -104.18 167.89 9.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.532 -1.655 . . . . 33.23 106.532 172.981 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -60.5 148.64 37.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.658 2.783 . . . . 25.97 110.816 -175.494 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 60.25 28.48 18.08 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 116.041 1.867 . . . . 32.61 116.041 176.879 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 m -77.09 150.28 35.67 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.18 -1.045 . . . . 10.56 108.18 174.191 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.6 m -98.62 104.16 16.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.799 -2.297 . . . . 5.33 104.799 168.143 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -85.88 133.77 33.94 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.178 -2.283 . . . . 11.66 105.043 168.746 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.262 47.5 p-80 -106.13 145.34 31.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.796 2.713 . . . . 16.3 112.917 176.826 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -104.36 127.47 52.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.687 -2.508 . . . . 9.96 109.8 -171.063 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.75 164.27 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 124.018 3.099 . . . . 9.76 109.52 177.6 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 71' ' ' LEU . 46.9 tp -89.62 142.89 27.26 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.205 -1.816 . . . . 19.57 108.319 -171.294 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -70.61 136.14 48.96 Favored 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 122.081 4.104 . . . . 35.08 122.081 174.975 . . . . . . . . 2 2 . 1 . 127 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.3 mt -68.46 -51.22 45.88 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 128.456 2.702 . . . . 32.31 116.51 -175.417 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ptt-85 -80.72 164.08 23.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 124.92 2.295 . . . . 42.75 111.836 166.92 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.96 63.86 0.55 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.876 -3.015 . . . . 36.31 110.462 175.563 . . . . . . . . 1 1 . 1 . 127 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.76 0 N-CA-C 108.166 -1.974 . . . . 36.27 108.166 165.257 . . . . . . . . 0 0 . 1 . 128 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.489 -1.37 0 N-CA-C 106.501 -1.666 . . . . 17.17 106.501 . . . . . . . . . 0 0 . 1 . 128 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -114.04 121.16 43.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.401 3.08 . . . . 21.89 104.636 -175.644 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -120.23 162.6 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 126.891 2.619 . . . . 10.83 106.023 165.048 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -124.94 130.06 51.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.006 -2.961 . . . . 10.61 103.006 -169.608 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.2 111.8 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 116.423 -2.111 . . . . 9.13 108.435 172.798 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -78.41 124.32 27.99 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 124.598 3.363 . . . . 20.55 112.077 174.646 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -69.31 164.28 23.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.397 -2.69 . . . . 11.78 117.768 169.503 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.33 -19.37 65.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.373 1.99 . . . . 19.31 116.373 172.241 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -93.15 -20.68 20.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.823 1.786 . . . . 23.14 115.823 179.488 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.73 34.38 2.64 Favored Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 116.421 1.329 . . . . 19.74 116.421 175.374 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -99.62 129.52 45.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.758 1.623 . . . . 21.93 110.187 164.072 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -91.67 119.99 32.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.34 -2.1 . . . . 12.33 105.542 167.915 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.3 7.8 mt -86.11 104.89 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 126.994 2.118 . . . . 17.08 110.353 172.873 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.0 m -84.7 106.77 16.5 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.991 -1.484 . . . . 16.3 108.599 177.433 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.6 mt -110.34 139.84 45.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.913 -1.117 . . . . 15.88 110.01 -178.765 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -96.41 128.62 43.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.254 1.978 . . . . 28.9 106.464 174.215 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -137.11 155.15 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.378 -2.076 . . . . 12.05 108.333 -173.232 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -101.61 129.68 26.24 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 113.703 -3.046 . . . . 18.17 105.851 178.008 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.52 -16.17 46.02 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 CA-C-N 123.834 2.405 . . . . 8.16 114.621 -168.825 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.6 p -94.55 -3.53 49.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 123.083 2.674 . . . . 11.13 110.668 -171.555 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.14 153.3 34.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 127.035 3.302 . . . . 18.03 115.93 175.883 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.7 p -75.36 162.88 28.01 Favored 'General case' 0 N--CA 1.43 -1.469 1 C-N-CA 131.787 4.035 . . . . 10.22 110.982 -178.456 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.293 6.3 mm -71.29 -34.74 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 1 O-C-N 115.392 -4.568 . . . . 12.3 112.546 178.754 . . . . . . . . 3 2 . 1 . 128 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -53.05 -43.27 66.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.241 1.817 . . . . 36.51 112.643 169.006 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -71.08 -22.66 62.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.898 2.184 . . . . 25.66 116.898 170.995 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.9 t -66.07 -43.76 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 1 CA-C-N 126.873 4.397 . . . . 8.12 114.016 166.817 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -59.78 -39.12 83.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.963 2.105 . . . . 15.47 110.275 179.409 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.52 66.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.407 -3.308 . . . . 11.45 119.656 177.954 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -74.9 -33.45 62.04 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.834 2.454 . . . . 24.98 110.877 173.672 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 6.8 mt -75.19 -40.71 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.004 -2.935 . . . . 9.46 110.289 175.322 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.48 -48.82 56.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.499 -2.625 . . . . 14.76 114.6 160.219 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -66.0 -42.85 89.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.588 1.995 . . . . 26.29 114.661 176.827 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -72.85 -69.58 0.4 Allowed 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.016 -2.303 . . . . 30.06 111.959 178.169 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -97.92 -2.01 41.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.523 1.929 . . . . 25.19 114.518 -164.428 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.51 21.43 79.5 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 118.579 2.191 . . . . 7.41 118.579 174.526 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 98.0 mt -98.91 130.12 28.26 Favored Pre-proline 0 N--CA 1.431 -1.421 0 O-C-N 116.794 -3.768 . . . . 9.49 102.623 -169.153 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -76.92 154.81 33.91 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 117.928 -1.67 . . . . 11.42 110.021 -172.105 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.344 9.7 Cg_endo -63.96 -30.16 66.94 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 123.463 2.775 . . . . 12.0 115.25 -169.525 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -63.63 -31.84 73.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.558 3.54 . . . . 35.55 120.558 -179.206 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -70.06 -34.53 73.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.853 -2.404 . . . . 20.52 114.39 166.777 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -64.25 103.79 0.67 Allowed 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.337 -4.602 . . . . 7.13 121.327 178.743 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -102.77 125.25 49.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.556 -2.59 . . . . 36.39 110.897 163.332 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.7 mt -96.61 139.17 33.08 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.649 1.214 . . . . 9.55 111.872 170.329 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.9 mt -133.13 122.26 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 129.337 3.055 . . . . 13.9 109.534 173.035 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -93.44 112.58 24.53 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.981 2.912 . . . . 6.86 108.696 164.106 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.27 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 127.877 2.471 . . . . 11.15 114.128 -177.51 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 27.86 2.5 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 127.711 2.576 . . . . 13.93 111.757 166.431 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -104.95 137.09 43.24 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.975 2.91 . . . . 23.92 111.949 172.662 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -99.46 124.14 44.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.535 1.516 . . . . 23.23 112.415 -172.535 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.9 mt -97.59 137.35 36.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.575 -2.578 . . . . 9.11 110.666 -171.307 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -118.69 135.17 54.62 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 127.128 3.346 . . . . 33.44 104.122 -166.193 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -43.53 -37.33 2.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 113.793 -3.003 . . . . 28.37 118.82 -166.502 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.6 11.66 27.95 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 107.001 -2.439 . . . . 15.0 107.001 -167.935 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -91.0 160.29 15.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.521 -3.929 . . . . 25.5 103.549 168.399 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.2 p -103.88 170.09 8.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.75 -1.843 . . . . 11.95 108.983 -170.329 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -57.64 -42.23 83.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 124.001 1.857 . . . . 10.17 114.226 168.751 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.3 p -62.89 -18.46 63.01 Favored 'General case' 0 N--CA 1.43 -1.459 1 N-CA-C 122.661 4.319 . . . . 13.59 122.661 173.303 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -77.96 -41.43 36.18 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.289 -4.632 . . . . 11.7 112.656 -173.667 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -86.08 -10.68 54.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.655 -1.612 . . . . 12.95 111.802 179.078 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.316 71.9 m-20 71.11 54.88 0.23 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.89 3.276 . . . . 25.45 113.232 -176.517 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.285 59.6 mt -89.28 108.6 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 127.933 3.27 . . . . 14.6 113.623 -179.352 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -89.34 176.24 7.01 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.515 3.526 . . . . 33.23 113.396 -166.404 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -69.14 139.32 54.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.474 2.027 . . . . 25.97 116.474 172.173 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 50.59 68.71 0.73 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.689 1.868 . . . . 32.61 112.771 -171.793 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -125.24 156.97 37.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.898 2.879 . . . . 10.56 103.536 176.485 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.0 m -126.37 124.81 41.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 124.413 1.071 . . . . 5.33 109.292 -178.086 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.04 167.39 10.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.223 3.009 . . . . 11.66 109.332 -179.583 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -135.73 158.81 43.47 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.475 2.559 . . . . 16.3 112.184 179.056 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -118.04 136.82 53.31 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.162 -4.087 . . . . 9.96 103.382 -168.597 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.81 172.95 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.295 -1.743 . . . . 9.76 106.295 -175.522 . . . . . . . . 2 2 . 1 . 128 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mt -74.01 150.51 40.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 115.845 -2.342 . . . . 19.57 111.773 176.787 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 ttp85 -104.35 116.29 31.89 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 130.064 3.346 . . . . 35.08 111.209 175.589 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 65.6 tp -78.0 -43.07 30.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 116.894 2.183 . . . . 32.31 116.894 -175.433 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -81.4 140.35 34.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.25 2.22 . . . . 42.75 113.871 -172.056 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.07 2.61 59.84 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 120.413 2.925 . . . . 36.31 120.413 -172.618 . . . . . . . . 1 1 . 1 . 128 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.741 0 N-CA-C 107.797 -2.121 . . . . 36.27 107.797 176.669 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 124.209 1.957 . . . . 17.170000000000002 109.691 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -98.41 145.96 26.21 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 113.94 -5.475 . . . . 21.890000000000001 115.352 -176.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 pt -127.52 -176.49 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.414 -3.18 . . . . 10.83 102.414 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -121.61 130.47 53.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.901 -1.954 . . . . 10.609999999999999 116.084 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.75 132.66 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 122.371 2.35 . . . . 9.1300000000000008 107.289 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -117.89 128.32 54.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.618 -1.623 . . . . 20.550000000000001 106.618 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.8 p -74.35 179.64 4.46 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.256 1.947 . . . . 11.779999999999999 116.256 170.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.03 -58.46 8.07 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.388 2.518 . . . . 19.309999999999999 117.571 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.94 -38.97 93.16 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 126.537 3.065 . . . . 23.140000000000001 114.55 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.27 49.57 0.27 Allowed Glycine 0 N--CA 1.431 -1.699 0 CA-C-N 111.589 -2.55 . . . . 19.739999999999998 115.667 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -89.74 129.55 36.13 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.613 -4.463 . . . . 21.93 109.235 160.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.2 m -92.01 126.7 37.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 117.316 -1.754 . . . . 12.33 114.243 169.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 94.8 mt -102.91 103.53 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 C-N-CA 132.39 4.276 . . . . 17.079999999999998 105.505 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.9 m -74.66 131.52 40.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.264 -2.773 . . . . 16.300000000000001 106.787 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 tp -143.3 128.62 18.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 115.979 -1.962 . . . . 15.880000000000001 115.735 -166.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -103.4 142.95 33.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.222 1.963 . . . . 28.899999999999999 114.383 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.414 HG11 HG22 ' A' ' 26' ' ' VAL . 6.8 m -157.72 165.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.167 1.937 . . . . 12.050000000000001 111.128 -158.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.47 124.35 25.07 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.673 -2.584 . . . . 18.170000000000002 111.819 -172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.29 -20.85 9.5 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 C-N-CA 124.267 3.311 . . . . 8.1600000000000001 116.677 -154.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.1 p -95.66 7.23 46.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.412 1.885 . . . . 11.130000000000001 113.687 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.94 177.29 5.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 105.129 -2.174 . . . . 18.030000000000001 105.129 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.7 p -104.31 173.23 6.39 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.596 2.141 . . . . 10.220000000000001 111.215 -158.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.38 26.1 mm -65.33 -29.48 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 127.825 3.679 . . . . 12.300000000000001 113.737 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -55.8 -40.66 73.02 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 115.276 -4.64 . . . . 36.509999999999998 114.526 164.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.98 -26.8 66.99 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.883 -1.127 . . . . 25.66 113.46 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.414 HG22 HG11 ' A' ' 17' ' ' VAL . 4.4 t -71.79 -43.22 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 115.145 -2.622 . . . . 8.1199999999999992 110.577 175.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -63.41 -33.62 75.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.534 -2.604 . . . . 15.470000000000001 117.2 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -14.92 58.62 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.798 3.259 . . . . 11.449999999999999 119.798 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -84.97 -39.12 18.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.056 -2.278 . . . . 24.98 114.162 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 mt -63.3 -40.94 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 130.066 3.347 . . . . 9.4600000000000009 112.666 170.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -68.03 -31.47 71.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.343 1.457 . . . . 14.76 114.07 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.257 43.2 t0 -71.1 -59.75 2.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.574 -3.204 . . . . 26.289999999999999 108.278 172.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.301 3.6 tppp? -51.08 -67.34 0.26 Allowed 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 121.251 3.797 . . . . 30.059999999999999 121.251 -176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -89.51 -48.0 7.6 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.7 1.37 . . . . 25.190000000000001 114.7 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.52 71.77 1.09 Allowed Glycine 0 N--CA 1.43 -1.755 0 O-C-N 127.381 2.926 . . . . 7.4100000000000001 114.883 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mt -128.75 132.37 24.32 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 103.676 -2.713 . . . . 9.4900000000000002 103.676 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -82.96 158.31 15.62 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 CA-C-N 124.931 2.797 . . . . 11.42 112.9 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -73.85 -20.94 19.21 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 123.373 2.715 . . . . 12.0 110.86 -153.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -65.64 -41.31 92.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.306 2.243 . . . . 35.549999999999997 112.755 167.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.61 -34.53 53.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.68 -1.263 . . . . 20.52 112.406 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.13 124.17 19.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 121.123 3.749 . . . . 7.1299999999999999 121.123 165.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -127.35 120.2 27.98 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.612 1.195 . . . . 36.390000000000001 109.169 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.484 ' O ' HD22 ' A' ' 50' ' ' LEU . 83.3 mt -111.7 120.17 41.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.082 -2.261 . . . . 9.5500000000000007 106.68 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.68 112.29 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 129.768 3.227 . . . . 13.9 112.944 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -99.2 120.85 40.19 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.939 2.304 . . . . 6.8600000000000003 106.403 165.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 65.29 -102.08 0.08 Allowed 'General case' 0 N--CA 1.431 -1.422 1 CA-C-O 129.27 4.367 . . . . 11.15 116.146 -177.591 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.34 55.18 0.59 Allowed Glycine 0 N--CA 1.43 -1.752 1 O-C-N 114.782 -4.949 . . . . 13.93 109.047 160.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.254 31.9 ttmt -135.08 139.23 44.57 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.9 1.68 . . . . 23.920000000000002 106.688 163.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -82.51 133.95 35.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.052 -1.03 . . . . 23.23 110.934 165.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.484 HD22 ' O ' ' A' ' 43' ' ' LEU . 1.2 mm? -77.79 131.01 37.41 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.073 1.879 . . . . 9.1099999999999994 116.073 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -75.68 160.02 30.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.813 2.72 . . . . 33.439999999999998 108.458 -175.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.81 -52.95 20.66 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.665 -4.397 . . . . 28.370000000000001 110.042 -167.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.37 23.65 35.07 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 129.649 3.5 . . . . 15.0 112.588 -160.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.1 mtt-85 -116.65 160.7 20.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.808 2.122 . . . . 25.5 106.811 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 p -95.0 177.81 5.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.427 2.537 . . . . 11.949999999999999 113.438 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.17 -29.95 48.83 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.718 -3.114 . . . . 10.17 112.647 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 m -62.13 -19.56 63.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.347 1.61 . . . . 13.59 115.347 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.6 -46.27 22.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.525 -1.657 . . . . 11.699999999999999 106.525 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -73.5 -31.47 63.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.389 -1.732 . . . . 12.949999999999999 113.33 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 87.1 53.16 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.486 3.514 . . . . 25.449999999999999 107.52 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.1 mt -101.34 132.3 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.412 -3.181 . . . . 14.6 102.412 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -128.27 177.11 7.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.001 2.52 . . . . 33.229999999999997 113.008 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -51.31 128.08 21.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.011 2.339 . . . . 25.969999999999999 116.807 172.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 63.72 52.24 2.25 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.361 2.029 . . . . 32.609999999999999 116.277 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.7 m -113.45 146.04 40.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.084 2.954 . . . . 10.56 106.031 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.3 m -101.3 118.66 37.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.23 1.967 . . . . 5.3300000000000001 115.769 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.9 145.8 34.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.395 -3.316 . . . . 11.66 105.78 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -109.27 128.47 55.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 125.385 2.517 . . . . 16.300000000000001 113.659 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.3 tp -102.6 111.47 23.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.592 2.357 . . . . 9.9600000000000009 106.787 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.22 174.35 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 102.87 -3.011 . . . . 9.7599999999999998 102.87 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 mt . . . . . 0 N--CA 1.43 -1.455 0 CA-C-O 123.225 1.488 . . . . 19.57 113.687 -169.18 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.213 -0.662 . . . . 17.170000000000002 109.213 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -113.58 143.33 44.74 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 100.366 -3.938 . . . . 21.890000000000001 100.366 -170.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -119.32 164.91 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.447 -2.033 . . . . 10.83 108.352 170.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 65.9 m-85 -98.83 122.41 42.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.117 -2.92 . . . . 10.609999999999999 103.117 170.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.7 113.53 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.564 -2.585 . . . . 9.1300000000000008 108.36 154.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -84.61 134.58 34.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.842 -2.411 . . . . 20.550000000000001 113.309 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 18.6 p -89.56 179.73 5.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.297 -3.377 . . . . 11.779999999999999 106.377 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -71.83 -44.53 63.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 128.171 3.843 . . . . 19.309999999999999 111.91 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.1 p -79.97 -78.52 0.16 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 109.382 -3.554 . . . . 23.140000000000001 115.642 -168.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.24 50.1 0.21 Allowed Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 119.575 1.079 . . . . 19.739999999999998 113.377 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 tttt -139.98 137.15 34.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.77 -1.429 . . . . 21.93 111.627 163.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -119.7 103.18 9.16 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.592 2.615 . . . . 12.33 110.535 171.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 83.8 mt -79.59 120.42 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 114.506 -2.664 . . . . 17.079999999999998 107.704 -165.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 p -105.12 94.04 5.02 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 123.364 2.802 . . . . 16.300000000000001 108.74 -172.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.67 116.17 31.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.934 2.493 . . . . 15.880000000000001 109.031 -158.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.406 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 7.1 pt-20 -73.41 119.32 17.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.123 1.369 . . . . 28.899999999999999 111.846 173.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.79 178.6 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 113.888 -1.505 . . . . 12.050000000000001 108.802 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.17 158.33 44.67 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 126.524 2.39 . . . . 18.170000000000002 106.394 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -70.02 -3.76 12.84 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 N-CA-C 118.666 2.525 . . . . 8.1600000000000001 118.666 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 p -90.84 -0.51 57.74 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.121 4.168 . . . . 11.130000000000001 109.834 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.66 147.18 35.64 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.446 1.93 . . . . 18.030000000000001 112.06 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 23' ' ' ILE . 41.5 p -92.0 -165.94 1.45 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.809 -2.432 . . . . 10.220000000000001 111.804 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.403 ' H ' ' HB ' ' A' ' 22' ' ' THR . 37.3 mm -85.76 -39.24 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.278 2.631 . . . . 12.300000000000001 105.611 175.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.4 -33.24 69.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.265 -3.397 . . . . 36.509999999999998 116.65 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.02 -56.65 15.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.925 1.345 . . . . 25.66 110.8 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -53.17 -47.19 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.199 -1.563 . . . . 8.1199999999999992 113.7 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -54.53 -39.21 67.44 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.783 -3.073 . . . . 15.470000000000001 114.761 171.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -32.92 71.13 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.241 -3.412 . . . . 11.449999999999999 114.73 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -81.14 -23.6 38.2 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.396 1.093 . . . . 24.98 109.45 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.36 -25.73 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 117.307 -3.371 . . . . 9.4600000000000009 113.184 169.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -75.49 -30.2 59.8 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.941 2.496 . . . . 14.76 109.675 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.7 -55.95 19.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.477 -2.014 . . . . 26.289999999999999 108.482 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -79.83 -43.31 22.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 116.545 -1.693 . . . . 30.059999999999999 112.333 -161.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -104.35 -44.05 5.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.462 1.028 . . . . 25.190000000000001 108.603 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.34 37.99 4.14 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 121.109 -0.995 . . . . 7.4100000000000001 111.449 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.7 mt -101.58 135.74 19.74 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 108.036 -1.098 . . . . 9.4900000000000002 108.036 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -65.36 137.94 53.33 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 C-N-CA 123.258 2.639 . . . . 11.42 113.567 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -68.31 -19.54 43.8 Favored 'Trans proline' 0 C--N 1.3 -1.988 1 C-N-CA 126.065 4.51 . . . . 12.0 118.178 -172.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -87.74 -27.28 22.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.948 1.699 . . . . 35.549999999999997 112.769 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.07 -40.37 82.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.106 2.162 . . . . 20.52 109.471 165.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.91 129.75 43.37 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.699 2.852 . . . . 7.1299999999999999 118.699 167.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -130.44 129.16 42.65 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.94 -4.225 . . . . 36.390000000000001 110.823 168.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.2 mt -112.93 129.08 56.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.856 1.262 . . . . 9.5500000000000007 110.145 -173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -130.5 140.09 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.988 1.852 . . . . 13.9 107.17 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.57 -75.83 0.51 Allowed 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 114.738 -2.785 . . . . 6.8600000000000003 112.187 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.61 -66.06 1.01 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.319 -2.845 . . . . 11.15 103.319 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.85 10.11 2.09 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 127.068 2.271 . . . . 13.93 115.523 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -112.26 142.1 45.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.287 1.042 . . . . 23.920000000000002 109.451 170.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -86.23 145.88 26.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.24 1.416 . . . . 23.23 107.784 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.03 130.12 45.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.067 -3.521 . . . . 9.1099999999999994 110.324 -171.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -103.89 151.32 23.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 118.31 -1.356 . . . . 33.439999999999998 109.979 -171.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -47.78 -53.53 15.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.733 2.864 . . . . 28.370000000000001 118.733 -152.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.94 50.82 0.74 Allowed Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 126.644 2.068 . . . . 15.0 114.465 -166.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -127.21 160.04 32.49 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.423 1.889 . . . . 25.5 109.899 154.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.341 48.0 p -79.24 164.17 24.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.041 2.536 . . . . 11.949999999999999 111.269 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.86 -31.22 72.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.829 1.776 . . . . 10.17 111.875 165.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -68.15 -31.09 70.4 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.7 -2.5 . . . . 13.59 114.919 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -71.99 -48.2 46.55 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.335 1.854 . . . . 11.699999999999999 106.596 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -74.15 -11.3 60.26 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.67 2.841 . . . . 12.949999999999999 118.67 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m120 69.24 49.01 0.63 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.753 2.021 . . . . 25.449999999999999 113.896 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.4 mt -105.24 108.01 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.333 -2.839 . . . . 14.6 103.333 173.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -101.5 -172.81 2.22 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.638 3.589 . . . . 33.229999999999997 109.859 -166.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp -61.59 126.75 28.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.208 -3.432 . . . . 25.969999999999999 113.898 169.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 41.7 mt-10 64.78 27.8 12.96 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.403 2.742 . . . . 32.609999999999999 118.403 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.2 m -90.67 154.44 19.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.056 2.836 . . . . 10.56 105.073 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 10.9 m -98.76 126.98 44.54 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.361 -2.2 . . . . 5.3300000000000001 105.249 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.4 mt -102.48 149.66 24.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.44 -2.037 . . . . 11.66 113.259 153.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -93.71 129.09 40.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.081 2.219 . . . . 16.300000000000001 112.246 172.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 10.4 tp -96.31 126.3 41.42 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.153 2.981 . . . . 9.9600000000000009 109.466 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.71 126.21 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 113.713 -1.585 . . . . 9.7599999999999998 108.602 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.7 mt . . . . . 0 N--CA 1.43 -1.437 0 O-C-N 125.795 1.934 . . . . 19.57 110.865 -179.549 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 122.143 0.973 . . . . 17.170000000000002 113.216 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -80.12 109.78 14.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.969 -2.332 . . . . 21.890000000000001 111.863 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -96.67 154.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 116.106 -1.902 . . . . 10.83 113.984 165.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.283 21.2 m-85 -101.79 113.56 26.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.252 1.842 . . . . 10.609999999999999 111.398 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.2 t -111.67 95.77 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 101.01 -3.7 . . . . 9.1300000000000008 101.01 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 12' ' ' THR 0.284 55.5 tttt -87.5 126.97 35.23 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.169 -1.832 . . . . 20.550000000000001 114.492 -167.04 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.1 p -83.46 158.04 22.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.265 1.983 . . . . 11.779999999999999 113.554 -173.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -74.1 -27.66 60.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.101 -3.5 . . . . 19.309999999999999 107.996 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -62.25 -60.24 3.86 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.873 -4.267 . . . . 23.140000000000001 113.77 175.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.12 41.98 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.755 0 O-C-N 117.109 -3.494 . . . . 19.739999999999998 114.566 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -140.21 163.11 33.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.868 2.834 . . . . 21.93 105.784 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 8.1 m -128.53 123.05 32.52 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.955 2.659 . . . . 12.33 106.073 174.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -83.49 119.84 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.991 -1.693 . . . . 17.079999999999998 113.96 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 p -81.47 90.72 6.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.657 -2.527 . . . . 16.300000000000001 114.996 165.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 tp -94.39 118.9 32.33 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.387 2.275 . . . . 15.880000000000001 108.184 -167.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -81.51 109.4 15.93 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.544 -1.348 . . . . 28.899999999999999 112.456 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.07 171.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 127.76 2.424 . . . . 12.050000000000001 110.243 167.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -108.27 173.94 2.74 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 126.673 1.989 . . . . 18.170000000000002 107.273 158.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -71.32 -3.09 12.28 Favored 'Trans proline' 0 N--CA 1.434 -2.015 1 C-N-CA 125.601 4.201 . . . . 8.1600000000000001 113.136 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -88.7 -25.42 22.35 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 111.634 -2.53 . . . . 11.130000000000001 111.276 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.8 138.64 46.53 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.594 2.14 . . . . 18.030000000000001 113.121 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -91.2 177.7 6.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.267 -1.788 . . . . 10.220000000000001 108.309 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -82.26 -22.09 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.084 -1.01 . . . . 12.300000000000001 109.318 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -61.26 -37.74 84.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.665 1.986 . . . . 36.509999999999998 114.483 161.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -68.5 -25.8 65.14 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 118.931 -2.356 . . . . 25.66 115.452 167.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.1 t -64.79 -56.68 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 128.493 2.717 . . . . 8.1199999999999992 111.115 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -56.46 -30.1 62.48 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 117.336 2.347 . . . . 15.470000000000001 117.336 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.67 -45.53 64.91 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.308 2.243 . . . . 11.449999999999999 111.84 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -69.74 -34.91 74.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.797 2.439 . . . . 24.98 112.454 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.9 mt -73.02 -27.24 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 113.489 0.922 . . . . 9.4600000000000009 113.489 166.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.256 16.6 tt0 -66.9 -33.04 74.71 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.662 -5.649 . . . . 14.76 111.504 170.327 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.56 -58.46 4.25 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.45 2.7 . . . . 26.289999999999999 115.281 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -63.67 -71.97 0.15 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 114.808 1.411 . . . . 30.059999999999999 114.808 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -96.66 -22.39 17.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.326 -2.734 . . . . 25.190000000000001 113.222 -169.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.58 31.76 8.6 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.487 -1.383 . . . . 7.4100000000000001 114.484 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.6 mt -97.03 126.17 43.39 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 114.65 -2.595 . . . . 9.4900000000000002 106.606 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.26 0.1 OUTLIER -68.2 160.35 49.2 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 124.599 1.842 . . . . 11.42 114.969 -176.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -74.9 -11.76 21.7 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 123.321 2.222 . . . . 12.0 113.905 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -77.51 -7.84 56.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.987 -2.946 . . . . 35.549999999999997 112.969 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -110.22 -18.94 13.18 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.398 -2.064 . . . . 20.52 110.045 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -80.61 108.87 14.61 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 121.034 3.716 . . . . 7.1299999999999999 121.034 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -104.7 153.21 21.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.583 -1.189 . . . . 36.390000000000001 110.351 160.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -127.46 141.99 51.52 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.444 -2.035 . . . . 9.5500000000000007 112.665 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 pt -130.09 164.66 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 106.976 -1.491 . . . . 13.9 106.976 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.88 -88.77 0.17 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.325 2.266 . . . . 6.8600000000000003 111.345 167.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.98 -61.79 1.39 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.261 -3.399 . . . . 11.15 104.542 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.37 -37.84 0.9 Allowed Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 118.696 2.238 . . . . 13.93 118.696 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -71.38 128.98 37.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.312 2.338 . . . . 23.920000000000002 117.312 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -75.29 118.17 17.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.515 -2.616 . . . . 23.23 112.005 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.7 mt -72.52 132.61 44.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.142 2.401 . . . . 9.1099999999999994 111.144 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.272 28.7 mt-10 -97.09 155.66 16.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.427 -2.064 . . . . 33.439999999999998 105.427 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.81 -62.1 1.62 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.56 3.144 . . . . 28.370000000000001 112.392 -166.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.38 21.72 30.55 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 124.906 3.503 . . . . 15.0 115.249 -157.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.503 HH21 ' CG ' ' A' ' 58' ' ' ASP . 72.2 mtp180 -115.97 156.22 26.65 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 121.106 2.453 . . . . 25.5 108.375 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.9 p -84.73 163.65 19.03 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.007 -2.933 . . . . 11.949999999999999 111.206 -169.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.8 mt -73.34 -13.6 61.14 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.965 -4.834 . . . . 10.17 114.869 170.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 t -70.19 -39.14 75.39 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.499 -3.251 . . . . 13.59 108.665 167.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.503 ' CG ' HH21 ' A' ' 54' ' ' ARG . 16.7 t0 -63.29 -40.34 97.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.983 1.845 . . . . 11.699999999999999 115.983 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -79.4 -31.3 42.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 117.3 -1.333 . . . . 12.949999999999999 111.833 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.274 68.7 m-80 72.77 54.02 0.14 Allowed 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.365 4.266 . . . . 25.449999999999999 106.829 -176.835 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.3 mt -98.51 106.95 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.217 3.007 . . . . 14.6 107.704 169.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -102.94 -166.5 1.28 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.368 -2.083 . . . . 33.229999999999997 111.567 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -66.33 135.62 54.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.425 1.49 . . . . 25.969999999999999 110.063 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.359 51.4 mt-10 65.37 40.91 4.52 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.229 1.566 . . . . 32.609999999999999 115.229 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 t -109.13 149.48 29.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.565 -3.834 . . . . 10.56 111.055 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.295 78.2 m -97.66 109.55 22.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.814 1.646 . . . . 5.3300000000000001 110.1 -170.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.1 mt -108.13 155.11 20.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.745 -1.946 . . . . 11.66 105.745 171.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -120.3 137.34 54.31 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.143 -1.598 . . . . 16.300000000000001 113.569 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.1 tp -91.75 110.35 21.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.193 -1.367 . . . . 9.9600000000000009 111.611 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.97 144.79 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 127.846 2.459 . . . . 9.7599999999999998 112.162 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.429 -1.477 1 O-C-N 115.205 -4.685 . . . . 19.57 110.483 -175.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.57 ' HB2' ' HG3' ' A' ' 63' ' ' LYS 0.25 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.331 0 N-CA-C 115.738 1.755 . . . . 17.170000000000002 115.738 . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.34 29.9 mt-30 -103.16 145.2 30.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.159 3.022 . . . . 21.890000000000001 119.159 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.32 29.3 pt -123.36 155.12 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 122.483 2.401 . . . . 10.83 106.679 166.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -112.12 137.43 50.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.396 -2.184 . . . . 10.609999999999999 108.505 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.22 123.07 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 123.023 1.392 . . . . 9.1300000000000008 111.253 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -100.14 125.79 46.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.001 -1.952 . . . . 20.550000000000001 113.434 -170.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.3 p -83.48 173.85 11.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.28 1.215 . . . . 11.779999999999999 114.28 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.7 tp -71.84 -43.06 66.18 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.836 1.779 . . . . 19.309999999999999 112.878 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -67.56 -23.05 65.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.003 -1.061 . . . . 23.140000000000001 109.603 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.53 10.9 8.29 Favored Glycine 0 N--CA 1.429 -1.786 1 N-CA-C 123.781 4.272 . . . . 19.739999999999998 123.781 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -86.49 146.35 26.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.112 -2.551 . . . . 21.93 104.112 -171.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 m -110.16 104.62 13.49 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.588 0.709 . . . . 12.33 112.736 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -84.04 129.23 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.69 2.796 . . . . 17.079999999999998 112.401 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -106.19 116.56 32.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.982 -2.324 . . . . 16.300000000000001 113.196 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.271 0.6 OUTLIER -118.77 131.4 56.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.642 1.839 . . . . 15.880000000000001 106.177 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -94.49 122.09 36.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.197 -2.815 . . . . 28.899999999999999 108.46 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.18 174.38 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.059 -1.428 . . . . 12.050000000000001 113.462 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -103.05 -173.97 0.32 Allowed Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 103.829 -2.656 . . . . 18.170000000000002 103.829 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -74.41 -29.5 9.25 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 C-N-CA 127.309 5.34 . . . . 8.1600000000000001 110.184 160.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 94.7 p -68.25 -28.55 67.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.797 2.888 . . . . 11.130000000000001 118.797 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -71.86 162.35 29.58 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.728 1.251 . . . . 18.030000000000001 112.94 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.6 p -104.61 175.25 5.55 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.83 -3.669 . . . . 10.220000000000001 112.389 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -65.24 -25.39 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.652 -2.53 . . . . 12.300000000000001 113.122 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.13 -37.76 88.47 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 117.726 2.491 . . . . 36.509999999999998 117.726 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.414 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 28.2 m120 -62.84 -43.4 98.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.363 1.246 . . . . 25.66 114.363 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -54.44 -38.2 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 126.095 1.758 . . . . 8.1199999999999992 107.506 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -75.72 -26.66 57.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.409 -1.432 . . . . 15.470000000000001 113.16 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.11 74.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.964 -2.96 . . . . 11.449999999999999 109.073 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 50.4 mttm -72.23 -43.24 64.72 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.801 3.641 . . . . 24.98 114.424 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 91.2 mt -55.25 -40.04 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 128.224 3.869 . . . . 9.4600000000000009 117.503 164.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -63.37 -44.28 95.24 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 110.904 -7.372 . . . . 14.76 114.584 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.14 -50.99 68.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.395 2.739 . . . . 26.289999999999999 118.395 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -67.49 -56.4 9.7 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.714 2.005 . . . . 30.059999999999999 115.582 -175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -98.58 -22.78 15.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.688 1.595 . . . . 25.190000000000001 113.525 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.59 23.39 31.16 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 125.601 2.778 . . . . 7.4100000000000001 116.464 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 mt -102.7 120.11 53.78 Favored Pre-proline 0 N--CA 1.43 -1.441 1 O-C-N 115.553 -4.498 . . . . 9.4900000000000002 104.21 -168.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -66.6 150.39 83.87 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 CA-C-N 126.784 3.459 . . . . 11.42 116.95 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -85.98 -4.75 8.82 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 CA-C-O 115.513 -1.953 . . . . 12.0 114.244 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -70.48 -36.37 73.82 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.38 1.9 . . . . 35.549999999999997 110.27 165.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -70.07 -28.43 65.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.053 2.541 . . . . 20.52 112.817 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -83.38 130.77 35.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 126.24 2.924 . . . . 7.1299999999999999 116.229 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -122.14 135.8 54.83 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 103.692 -2.707 . . . . 36.390000000000001 103.692 170.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.2 mt -113.67 137.33 51.76 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 124.253 0.97 . . . . 9.5500000000000007 109.643 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 pt -123.4 169.44 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 117.305 -1.758 . . . . 13.9 110.893 171.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.414 ' HB3' ' H ' ' A' ' 46' ' ' ALA . 17.5 t80 -85.61 -90.46 0.1 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 117.217 -1.793 . . . . 6.8600000000000003 106.681 161.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.414 ' H ' ' HB3' ' A' ' 45' ' ' PHE . . . -111.8 -16.55 13.15 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.023 1.86 . . . . 11.15 116.023 171.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.55 -32.63 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 O-C-N 117.782 -3.074 . . . . 13.93 115.931 172.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -76.99 135.24 38.68 Favored 'General case' 0 N--CA 1.43 -1.465 1 CA-C-O 129.406 4.431 . . . . 23.920000000000002 109.482 174.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -75.83 152.48 37.25 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 114.584 -5.073 . . . . 23.23 117.866 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.0 mt -118.31 117.71 29.82 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.457 -2.027 . . . . 9.1099999999999994 106.19 -171.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -108.2 151.6 25.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.579 3.085 . . . . 33.439999999999998 114.73 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.335 2.1 m-20 -37.06 -70.48 0.09 Allowed 'General case' 0 N--CA 1.429 -1.484 1 C-N-CA 134.754 5.222 . . . . 28.370000000000001 113.827 -166.47 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.37 23.15 33.29 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 116.958 -2.544 . . . . 15.0 117.04 -156.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -105.71 161.32 14.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.206 1.503 . . . . 25.5 111.477 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.3 p -91.03 170.18 10.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.678 -3.139 . . . . 11.949999999999999 112.465 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.64 -38.78 84.33 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 117.92 -2.987 . . . . 10.17 113.675 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.59 -39.21 16.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.438 -3.289 . . . . 13.59 112.153 162.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -82.69 -32.57 27.99 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 119.7 -1.875 . . . . 11.699999999999999 112.281 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.287 77.0 m-85 -88.72 -7.78 55.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.676 1.58 . . . . 12.949999999999999 111.438 170.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 m120 81.23 29.83 0.16 Allowed 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 131.721 4.009 . . . . 25.449999999999999 108.415 166.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mt -75.99 132.54 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 117.72 -3.113 . . . . 14.6 104.099 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -96.43 -177.51 3.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.199 -1.819 . . . . 33.229999999999997 113.117 -171.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.57 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 19.8 ttpp -69.51 131.08 44.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.653 -1.905 . . . . 25.969999999999999 106.551 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 53.29 59.34 4.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.208 1.403 . . . . 32.609999999999999 108.145 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 t -98.84 147.42 24.95 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.799 -1.186 . . . . 10.56 107.799 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -90.6 114.52 26.8 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.869 1.356 . . . . 5.3300000000000001 108.306 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 mt -100.76 154.63 18.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.927 -1.733 . . . . 11.66 109.473 167.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -108.7 132.21 54.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.254 2.454 . . . . 16.300000000000001 111.016 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 tp -102.0 128.39 48.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.53 -3.231 . . . . 9.9600000000000009 109.221 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.8 98.47 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 112.492 -2.14 . . . . 9.7599999999999998 107.031 -167.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 117.486 2.402 . . . . 19.57 117.486 -178.386 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 116.606 -1.664 . . . . 17.170000000000002 112.437 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.86 138.77 31.29 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 125.809 1.943 . . . . 21.890000000000001 109.868 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.5 pt -119.97 148.52 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 129.797 3.239 . . . . 10.83 104.664 158.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -100.41 118.9 37.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.367 1.467 . . . . 10.609999999999999 112.944 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.81 122.52 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 116.891 -3.631 . . . . 9.1300000000000008 112.114 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -102.3 141.94 34.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.187 -1.005 . . . . 20.550000000000001 109.76 -173.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.6 p -84.66 176.15 8.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.089 -2.257 . . . . 11.779999999999999 110.8 171.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -60.74 -49.95 75.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.495 -2.628 . . . . 19.309999999999999 114.427 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 66.2 p -62.53 -57.36 11.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.901 3.68 . . . . 23.140000000000001 109.257 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.0 49.43 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 126.797 2.141 . . . . 19.739999999999998 110.767 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -93.17 143.73 25.97 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.794 -3.18 . . . . 21.93 112.01 161.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.272 25.1 m -108.85 107.28 17.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 126.285 2.945 . . . . 12.33 113.801 -176.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -86.09 117.37 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 110.151 -3.204 . . . . 17.079999999999998 109.287 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.461 ' O ' HD13 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -102.47 131.2 49.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.921 -1.737 . . . . 16.300000000000001 109.333 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 14' ' ' THR . 1.6 mm? -123.55 134.37 53.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.892 -1.151 . . . . 15.880000000000001 107.892 176.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -109.7 114.57 28.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.772 -1.936 . . . . 28.899999999999999 105.772 -170.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.9 177.59 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 104.784 -2.302 . . . . 12.050000000000001 104.784 -152.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -111.42 171.1 4.6 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 126.828 2.051 . . . . 18.170000000000002 107.453 168.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -79.53 -14.15 13.04 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 123.142 2.158 . . . . 8.1600000000000001 107.647 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -93.54 9.74 35.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.541 1.682 . . . . 11.130000000000001 115.541 -175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -80.62 139.41 36.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.288 1.835 . . . . 18.030000000000001 114.522 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -90.49 170.34 10.29 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.442 -3.911 . . . . 10.220000000000001 107.901 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.7 mm -71.38 -29.0 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 116.845 -3.659 . . . . 12.300000000000001 108.235 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -51.81 -51.51 55.97 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.284 3.033 . . . . 36.509999999999998 112.902 164.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -54.44 -43.34 71.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.729 2.862 . . . . 25.66 118.729 172.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.17 -43.15 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 117.88 -1.057 . . . . 8.1199999999999992 109.039 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -57.96 -36.04 72.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.267 1.951 . . . . 15.470000000000001 116.267 166.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.22 -35.84 65.34 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.117 2.567 . . . . 11.449999999999999 115.741 170.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -81.26 -29.99 34.2 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 127.398 2.936 . . . . 24.98 109.446 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.7 mt -65.42 -43.3 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 121.256 1.844 . . . . 9.4600000000000009 115.951 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -53.95 -39.61 66.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.154 -2.355 . . . . 14.76 114.521 167.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.258 21.2 t70 -68.33 -53.44 24.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.386 2.357 . . . . 26.289999999999999 115.159 164.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -63.02 -43.8 97.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 120.191 3.404 . . . . 30.059999999999999 120.191 -169.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -100.28 -30.19 12.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.961 -2.337 . . . . 25.190000000000001 108.874 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.4 37.46 12.23 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 112.715 -2.039 . . . . 7.4100000000000001 110.188 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mt -102.68 128.47 27.91 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 118.627 -2.69 . . . . 9.4900000000000002 111.919 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -67.85 146.15 71.08 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 124.914 3.743 . . . . 11.42 108.299 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -81.15 2.28 8.69 Favored 'Trans proline' 0 C--N 1.3 -2.005 1 C-N-CA 127.345 5.364 . . . . 12.0 114.533 -165.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.43 -47.56 6.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.67 -1.894 . . . . 35.549999999999997 107.818 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -52.05 -29.44 21.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.967 1.84 . . . . 20.52 115.967 162.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -71.84 136.21 46.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.771 2.829 . . . . 7.1299999999999999 116.731 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -118.09 105.98 12.4 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.851 -1.537 . . . . 36.390000000000001 106.851 161.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.3 tp -102.11 120.75 40.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.546 -3.222 . . . . 9.5500000000000007 105.995 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 pt -127.24 170.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 125.323 1.449 . . . . 13.9 107.132 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -96.6 -55.57 2.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.058 1.743 . . . . 6.8600000000000003 113.364 169.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.44 -80.71 0.4 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.074 1.35 . . . . 11.15 113.75 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.47 -12.81 2.98 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.545 -1.347 . . . . 13.93 115.578 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -97.18 124.94 41.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 114.604 -2.617 . . . . 23.920000000000002 113.673 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -52.25 119.36 4.31 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.962 1.71 . . . . 23.23 111.965 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.505 HD22 ' CE1' ' A' ' 59' ' ' TYR . 35.2 mt -81.76 142.72 32.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.836 2.732 . . . . 9.1099999999999994 114.364 -176.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -80.56 124.69 29.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.502 2.721 . . . . 33.439999999999998 107.288 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.319 36.4 m-20 -45.29 -56.28 5.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.323 3.083 . . . . 28.370000000000001 119.323 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.59 10.84 65.77 Favored Glycine 0 N--CA 1.43 -1.735 0 CA-C-O 117.024 -1.987 . . . . 15.0 116.631 -157.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.41 HH21 ' CG ' ' A' ' 58' ' ' ASP . 83.3 mtp180 -98.87 152.07 20.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 118.155 0.978 . . . . 25.5 108.864 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.5 p -80.55 161.54 24.73 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.684 2.105 . . . . 11.949999999999999 116.684 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 HD12 ' A' ' 61' ' ' ILE . 7.6 mt -76.07 -29.71 58.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.084 -2.562 . . . . 10.17 104.084 -171.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.2 t -60.99 -46.88 88.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.119 2.137 . . . . 13.59 112.928 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CG ' HH21 ' A' ' 54' ' ' ARG . 20.6 t0 -58.32 -47.96 82.04 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.596 2.758 . . . . 11.699999999999999 111.085 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CE1' HD22 ' A' ' 50' ' ' LEU . 9.6 m-85 -61.98 -34.23 75.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 131.391 3.876 . . . . 12.949999999999999 114.332 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.481 10.3 m120 92.49 29.53 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.038 2.086 . . . . 25.449999999999999 113.051 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.482 HD12 HD23 ' A' ' 56' ' ' LEU . 22.7 mt -89.11 108.64 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 127.542 2.337 . . . . 14.6 111.409 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -87.55 179.26 6.58 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.04 -4.162 . . . . 33.229999999999997 114.978 -169.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -63.31 126.19 26.61 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.497 3.046 . . . . 25.969999999999999 114.888 167.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.394 68.4 mt-10 75.43 42.8 0.22 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.881 3.273 . . . . 32.609999999999999 110.27 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -109.93 141.78 42.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.688 1.995 . . . . 10.56 107.969 -173.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.1 m -90.74 129.04 36.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.281 1.956 . . . . 5.3300000000000001 116.281 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.49 171.85 7.24 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.054 -1.462 . . . . 11.66 107.054 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -135.39 127.41 29.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.937 2.78 . . . . 16.300000000000001 105.285 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.7 tp -96.84 114.63 26.27 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.138 2.399 . . . . 9.9600000000000009 108.285 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.252 37.6 t -101.25 151.58 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 101.543 -3.503 . . . . 9.7599999999999998 101.543 170.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 N--CA 1.43 -1.448 0 N-CA-C 107.429 -1.323 . . . . 19.57 107.429 173.924 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.268 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 118.151 2.649 . . . . 17.170000000000002 118.151 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -80.61 134.15 35.86 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.22 1.933 . . . . 21.890000000000001 116.22 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.6 pt -124.45 149.34 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 112.833 -1.985 . . . . 10.83 109.195 166.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.47 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 59.9 m-85 -103.96 132.68 49.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 102.567 -3.123 . . . . 10.609999999999999 102.567 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.45 109.25 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 126.224 1.81 . . . . 9.1300000000000008 106.729 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -95.58 132.35 40.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.045 3.307 . . . . 20.550000000000001 108.693 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -91.29 175.91 6.76 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.316 -3.365 . . . . 11.779999999999999 114.287 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.638 HD11 ' H ' ' A' ' 71' ' ' LEU . 84.5 mt -75.47 -28.19 59.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.536 -1.211 . . . . 19.309999999999999 113.775 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.354 82.5 p -83.63 -24.33 31.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 120.496 1.498 . . . . 23.140000000000001 107.968 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.29 52.12 0.22 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.397 -2.689 . . . . 19.739999999999998 107.861 161.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -131.01 135.26 47.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.296 -4.061 . . . . 21.93 103.738 -175.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.7 m -106.65 107.45 18.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.309 2.48 . . . . 12.33 108.29 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -98.99 133.02 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 128.416 2.687 . . . . 17.079999999999998 110.329 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.4 m -98.42 112.63 24.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.673 -1.232 . . . . 16.300000000000001 107.673 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -102.35 164.48 11.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.372 2.511 . . . . 15.880000000000001 107.338 172.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.67 106.28 9.61 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 115.302 -4.624 . . . . 28.899999999999999 102.326 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -109.44 175.66 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 123.445 1.593 . . . . 12.050000000000001 109.726 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -115.89 143.48 30.87 Favored Pre-proline 0 N--CA 1.43 -1.46 1 CA-C-O 109.792 -4.909 . . . . 18.170000000000002 105.795 162.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -60.13 -11.12 14.62 Favored 'Trans proline' 0 N--CA 1.434 -2.023 2 CA-C-N 130.774 4.883 . . . . 8.1600000000000001 117.737 176.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.8 m -74.0 -19.09 60.76 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.252 2.221 . . . . 11.130000000000001 116.183 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.13 156.28 38.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.542 2.337 . . . . 18.030000000000001 111.039 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 p -107.95 163.61 12.99 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.775 -1.557 . . . . 10.220000000000001 115.072 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -63.24 -26.02 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 114.319 -2.753 . . . . 12.300000000000001 109.952 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.89 -44.96 93.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.586 1.803 . . . . 36.509999999999998 108.777 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -63.95 -47.53 80.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.819 -3.05 . . . . 25.66 111.776 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 26' ' ' VAL . 1.5 t -60.8 -43.39 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 120.938 1.699 . . . . 8.1199999999999992 113.098 173.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -59.46 -32.16 69.98 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 115.682 -2.104 . . . . 15.470000000000001 114.657 170.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.09 -51.15 65.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.204 1.82 . . . . 11.449999999999999 110.881 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.05 -36.09 78.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.953 2.205 . . . . 24.98 116.953 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 mt -70.1 -39.66 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 124.822 2.249 . . . . 9.4600000000000009 111.531 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.4 -36.93 76.74 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 111.811 -6.806 . . . . 14.76 113.791 168.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -75.18 -29.92 60.52 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 116.227 -4.046 . . . . 26.289999999999999 109.754 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -75.91 -47.12 26.52 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 117.837 2.532 . . . . 30.059999999999999 117.837 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -100.34 -27.1 13.65 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.71 -1.132 . . . . 25.190000000000001 113.406 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.92 6.4 54.19 Favored Glycine 0 N--CA 1.431 -1.668 0 O-C-N 116.77 -3.706 . . . . 7.4100000000000001 117.415 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.9 mm -99.05 137.04 20.4 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-N 120.657 2.229 . . . . 9.4900000000000002 106.206 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -65.71 154.21 74.84 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 N-CA-C 119.094 2.69 . . . . 11.42 119.094 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -88.46 -7.49 5.74 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-N 125.953 3.162 . . . . 12.0 107.396 -155.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -82.39 -18.29 42.48 Favored 'General case' 0 N--CA 1.429 -1.483 1 C-N-CA 131.789 4.036 . . . . 35.549999999999997 112.248 167.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -85.81 -24.84 26.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.644 -1.91 . . . . 20.52 113.313 165.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -83.84 138.3 33.27 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.615 2.366 . . . . 7.1299999999999999 113.759 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -142.61 122.28 13.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.864 -1.902 . . . . 36.390000000000001 105.864 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -101.23 125.96 47.91 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.363 1.865 . . . . 9.5500000000000007 108.533 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 68' ' ' HIS . 5.8 pt -127.56 154.27 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.149 -2.908 . . . . 13.9 103.149 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.43 -63.31 1.22 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.889 -1.757 . . . . 6.8600000000000003 113.382 173.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.58 -36.39 0.78 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.904 -2.373 . . . . 11.15 106.64 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.06 -14.72 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.109 1.814 . . . . 13.93 116.253 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -103.12 148.66 25.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.622 -2.031 . . . . 23.920000000000002 106.708 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -81.97 110.37 17.17 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 127.784 6.216 . . . . 23.23 127.784 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.8 mt -87.32 112.87 22.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.9 -2.375 . . . . 9.1099999999999994 107.191 -169.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -110.11 148.49 31.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.542 2.591 . . . . 33.439999999999998 107.447 -159.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -44.07 -61.82 1.35 Allowed 'General case' 0 N--CA 1.431 -1.424 1 C-N-CA 131.815 4.046 . . . . 28.370000000000001 118.365 -169.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.37 -22.21 72.8 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 128.422 2.915 . . . . 15.0 110.326 -155.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -100.27 159.65 14.95 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.773 1.229 . . . . 25.5 112.814 -167.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -74.69 156.33 36.76 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 114.432 -2.699 . . . . 11.949999999999999 117.425 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.272 14.8 mt -54.39 -37.11 64.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 120.031 3.345 . . . . 10.17 120.031 160.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -64.1 -25.9 68.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.751 2.13 . . . . 13.59 116.751 171.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -73.02 -22.28 60.68 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.033 -1.937 . . . . 11.699999999999999 110.117 169.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -96.75 -12.5 23.63 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.534 1.97 . . . . 12.949999999999999 114.257 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.29 14.4 m120 59.5 46.0 12.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.666 3.986 . . . . 25.449999999999999 114.589 -172.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 61' ' ' ILE . 69.1 mt -81.48 108.86 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.067 -2.896 . . . . 14.6 112.154 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -88.07 178.72 6.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.318 2.34 . . . . 33.229999999999997 117.318 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -61.96 138.34 58.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 127.453 3.501 . . . . 25.969999999999999 113.103 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 60.52 31.03 20.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.705 3.202 . . . . 32.609999999999999 115.276 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.4 m -70.69 144.91 50.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.417 -1.719 . . . . 10.56 108.752 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 23.0 m -95.66 122.53 38.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.007 -2.59 . . . . 5.3300000000000001 104.007 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.3 mt -116.71 152.61 33.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.246 -2.501 . . . . 11.66 104.246 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.404 ' HB2' HG13 ' A' ' 44' ' ' ILE . 73.2 m80 -111.89 122.04 46.69 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-O 128.67 4.081 . . . . 16.300000000000001 107.748 -175.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.0 tp -85.51 135.62 33.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.827 -3.046 . . . . 9.9600000000000009 105.466 171.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.2 t -130.76 151.91 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 102.761 -3.052 . . . . 9.7599999999999998 102.761 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.638 ' H ' HD11 ' A' ' 8' ' ' LEU . 54.5 mt . . . . . 0 N--CA 1.431 -1.417 0 O-C-N 120.24 -1.538 . . . . 19.57 110.952 170.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.607 1.336 . . . . 17.170000000000002 114.607 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -95.15 142.47 27.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.168 0.987 . . . . 21.890000000000001 111.595 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.29 168.57 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.346 -2.094 . . . . 10.83 105.346 159.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -118.34 158.04 25.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.862 1.792 . . . . 10.609999999999999 114.321 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.467 HG21 HD11 ' A' ' 30' ' ' ILE . 59.6 t -124.4 121.25 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.389 3.476 . . . . 9.1300000000000008 106.866 167.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -106.48 127.58 53.41 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 124.018 1.866 . . . . 20.550000000000001 107.772 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 p -88.84 166.24 14.12 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.678 1.704 . . . . 11.779999999999999 106.642 -173.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.2 mt -65.95 -45.35 82.11 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 129.703 3.201 . . . . 19.309999999999999 110.53 169.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.0 p -64.31 -29.67 70.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.901 2.481 . . . . 23.140000000000001 117.576 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.39 29.46 1.92 Allowed Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 114.157 -1.383 . . . . 19.739999999999998 109.916 167.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -92.66 133.44 35.99 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.798 -3.766 . . . . 21.93 112.714 164.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.3 m -100.63 119.02 37.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.935 -1.876 . . . . 12.33 105.935 167.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.7 mt -113.3 115.5 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 117.99 -2.943 . . . . 17.079999999999998 105.94 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.3 m -83.78 124.78 31.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 112.846 -3.454 . . . . 16.300000000000001 108.307 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.16 145.03 30.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 123.901 3.046 . . . . 15.880000000000001 111.211 167.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -98.87 131.74 44.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 118.816 -1.154 . . . . 28.899999999999999 112.225 167.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.08 171.94 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.889 1.676 . . . . 12.050000000000001 110.029 -166.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -118.6 171.79 4.88 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-N 122.105 2.23 . . . . 18.170000000000002 109.21 156.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.2 -30.57 72.05 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 N-CA-C 119.5 2.846 . . . . 8.1600000000000001 119.5 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.7 m -92.58 14.64 16.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.805 -3.059 . . . . 11.130000000000001 112.474 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.47 138.08 41.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.052 -3.53 . . . . 18.030000000000001 115.944 171.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 p -85.05 164.1 18.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 112.592 -2.095 . . . . 10.220000000000001 109.822 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 23' ' ' ILE 0.351 3.9 mm -78.62 -17.6 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 117.876 -3.015 . . . . 12.300000000000001 111.29 -175.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -62.26 -51.73 66.56 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.902 2.881 . . . . 36.509999999999998 110.678 164.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -66.63 -25.29 66.52 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.411 -1.431 . . . . 25.66 110.693 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.67 -56.2 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.595 2.072 . . . . 8.1199999999999992 116.595 167.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -50.6 -30.55 13.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.271 3.434 . . . . 15.470000000000001 120.271 164.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.83 -42.76 97.54 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.253 2.316 . . . . 11.449999999999999 117.253 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -61.78 -31.53 71.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.3 1.963 . . . . 24.98 116.3 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.467 HD11 HG21 ' A' ' 5' ' ' VAL . 63.2 mt -85.0 -40.52 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.092 1.757 . . . . 9.4600000000000009 111.143 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -48.24 -51.34 25.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.595 2.758 . . . . 14.76 116.915 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.58 -39.78 74.09 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.776 2.83 . . . . 26.289999999999999 112.662 166.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -87.42 -70.99 0.59 Allowed 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.051 -4.156 . . . . 30.059999999999999 109.209 -168.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -89.96 -26.47 20.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.117 -3.489 . . . . 25.190000000000001 117.802 -171.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.81 43.45 4.48 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 117.22 -1.878 . . . . 7.4100000000000001 115.75 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mm -90.82 124.39 62.29 Favored Pre-proline 0 N--CA 1.43 -1.468 1 CA-C-O 110.872 -4.394 . . . . 9.4900000000000002 107.397 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -77.04 147.25 26.42 Favored 'Trans proline' 0 C--N 1.3 -2.022 1 CA-C-N 129.741 4.515 . . . . 11.42 112.033 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.08 -21.03 32.59 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-O 117.3 -1.208 . . . . 12.0 114.153 -159.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -71.45 -27.86 63.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 123.563 2.892 . . . . 35.549999999999997 111.994 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.277 88.4 mm-40 -77.24 -23.42 51.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.422 1.889 . . . . 20.52 111.096 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -77.28 107.37 9.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 113.812 1.041 . . . . 7.1299999999999999 113.812 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -112.78 114.23 26.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.346 2.022 . . . . 36.390000000000001 109.921 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.7 mt -100.2 117.85 35.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.892 -1.755 . . . . 9.5500000000000007 109.839 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 68' ' ' HIS . 36.5 pt -98.19 156.64 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.415 2.286 . . . . 13.9 112.797 166.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -79.86 -68.87 0.63 Allowed 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 123.396 1.569 . . . . 6.8600000000000003 107.929 162.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.54 -60.79 0.98 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.051 -2.203 . . . . 11.15 105.051 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.16 -25.18 1.71 Allowed Glycine 0 N--CA 1.43 -1.731 1 C-N-CA 134.965 6.031 . . . . 13.93 114.451 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 139.72 33.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.012 -3.052 . . . . 23.920000000000002 109.482 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -90.29 147.82 23.27 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.162 0.982 . . . . 23.23 112.661 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mt -99.71 118.72 36.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.118 1.767 . . . . 9.1099999999999994 110.391 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -95.21 147.85 23.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.939 -1.105 . . . . 33.439999999999998 111.002 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.04 -47.62 8.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.435 3.094 . . . . 28.370000000000001 116.094 -166.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.19 31.61 7.81 Favored Glycine 0 N--CA 1.431 -1.694 1 CA-C-O 112.914 -4.27 . . . . 15.0 115.746 -165.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -129.42 171.63 12.33 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.797 3.299 . . . . 25.5 105.588 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.4 p -99.97 169.0 9.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.942 2.155 . . . . 11.949999999999999 112.223 -174.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.6 -40.03 68.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.311 1.226 . . . . 10.17 114.311 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.9 t -63.83 -49.92 70.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 131.495 3.918 . . . . 13.59 112.384 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 38.6 m-20 -43.83 -58.0 2.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.665 3.186 . . . . 11.699999999999999 110.892 168.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.269 32.6 m-85 -54.58 -21.11 9.38 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 120.574 3.546 . . . . 12.949999999999999 120.574 171.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 m120 53.86 56.39 7.2 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.024 1.729 . . . . 25.449999999999999 112.234 -162.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -93.74 132.07 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.77 -3.081 . . . . 14.6 110.024 165.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -105.6 -165.56 1.12 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 119.76 -0.776 . . . . 33.229999999999997 111.506 -166.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -79.12 125.44 29.43 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 117.395 -1.722 . . . . 25.969999999999999 112.521 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.3 34.6 mt-10 68.22 27.43 6.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.115 2.166 . . . . 32.609999999999999 114.348 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -74.7 153.99 38.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.905 -3.622 . . . . 10.56 116.503 163.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.1 m -93.27 125.7 38.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.375 2.297 . . . . 5.3300000000000001 111.447 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -93.33 154.91 17.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.004 -2.591 . . . . 11.66 104.004 169.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.531 ' HB2' HG13 ' A' ' 44' ' ' ILE . 75.5 m80 -122.46 107.26 11.83 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 108.912 -0.773 . . . . 16.300000000000001 108.912 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -78.24 120.71 23.41 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 122.876 1.322 . . . . 9.9600000000000009 109.545 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.39 -179.65 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.737 2.415 . . . . 9.7599999999999998 107.421 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.9 mt . . . . . 0 N--CA 1.43 -1.438 0 CA-C-O 123.504 1.621 . . . . 19.57 112.789 178.663 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptt? . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 109.027 -0.731 . . . . 17.170000000000002 109.027 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -100.09 125.4 46.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.929 -2.357 . . . . 21.890000000000001 105.251 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -123.37 159.12 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.62 -3.175 . . . . 10.83 105.898 159.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -111.91 137.03 50.45 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.846 -3.034 . . . . 10.609999999999999 112.021 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.07 125.41 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 111.504 -2.589 . . . . 9.1300000000000008 109.572 169.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -107.11 124.62 49.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.567 -3.208 . . . . 20.550000000000001 110.535 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p -89.88 163.61 14.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.76 1.743 . . . . 11.779999999999999 111.438 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.04 -39.95 94.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.628 1.571 . . . . 19.309999999999999 113.987 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -73.59 -33.04 64.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.376 3.07 . . . . 23.140000000000001 105.915 -175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.42 48.33 0.47 Allowed Glycine 0 N--CA 1.431 -1.696 0 CA-C-O 122.622 1.124 . . . . 19.739999999999998 115.651 160.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.23 125.84 52.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.053 -3.027 . . . . 21.93 108.241 168.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.6 m -93.21 95.06 9.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.084 2.554 . . . . 12.33 112.309 169.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.4 mt -102.9 125.47 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 131.064 3.746 . . . . 17.079999999999998 106.677 -159.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -81.55 119.84 24.28 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.285 -3.384 . . . . 16.300000000000001 114.308 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.2 142.71 36.5 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.884 -4.26 . . . . 15.880000000000001 109.465 174.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -110.28 105.52 14.59 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.4 3.88 . . . . 28.899999999999999 111.333 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.73 157.77 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 111.571 -2.559 . . . . 12.050000000000001 108.281 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.1 mm-40 -88.9 168.11 16.52 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 124.547 1.154 . . . . 18.170000000000002 113.247 159.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 73.1 Cg_endo -70.56 -24.24 26.22 Favored 'Trans proline' 0 C--N 1.299 -2.036 1 O-C-N 112.537 -4.507 . . . . 8.1600000000000001 113.485 177.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -97.33 16.47 19.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.45 2.344 . . . . 11.130000000000001 116.106 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -67.89 136.76 54.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.712 2.805 . . . . 18.030000000000001 108.164 163.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.342 60.9 p -80.27 168.14 19.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.035 2.534 . . . . 10.220000000000001 107.145 -176.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 mm -75.9 -35.11 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 105.034 -2.21 . . . . 12.300000000000001 105.034 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -44.17 -46.28 8.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.795 2.146 . . . . 36.509999999999998 116.795 161.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.269 11.4 m120 -69.24 -32.48 71.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.65 -3.781 . . . . 25.66 111.843 173.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.12 -38.67 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 116.215 1.931 . . . . 8.1199999999999992 116.215 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -71.19 -22.34 62.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.065 -2.897 . . . . 15.470000000000001 116.085 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.86 72.91 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.029 -1.669 . . . . 11.449999999999999 114.333 171.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -70.97 -40.95 71.65 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.067 2.988 . . . . 24.98 119.067 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.96 -32.28 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.622 -1.923 . . . . 9.4600000000000009 112.038 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -66.15 -43.1 88.0 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.674 2.39 . . . . 14.76 115.437 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -78.49 -28.31 46.38 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.553 1.979 . . . . 26.289999999999999 115.747 168.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.24 -68.35 0.5 Allowed 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.095 -4.128 . . . . 30.059999999999999 110.101 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -81.97 -49.08 10.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.653 2.933 . . . . 25.190000000000001 110.352 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.66 7.85 13.02 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.645 -2.534 . . . . 7.4100000000000001 111.711 -170.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mm -82.88 127.82 68.16 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 116.25 1.945 . . . . 9.4900000000000002 116.25 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -64.14 150.49 88.24 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 CA-C-O 115.515 -1.952 . . . . 11.42 116.915 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -71.89 -20.82 25.39 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 123.98 2.457 . . . . 12.0 114.488 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -64.35 -39.36 93.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.458 -2.211 . . . . 35.549999999999997 115.645 165.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -78.03 -24.74 47.71 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 127.204 2.815 . . . . 20.52 110.657 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -70.6 119.17 14.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.522 2.329 . . . . 7.1299999999999999 112.358 168.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -130.94 103.1 6.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.421 -2.807 . . . . 36.390000000000001 103.421 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -92.13 118.27 30.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.144 -2.222 . . . . 9.5500000000000007 108.789 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 pt -90.21 -179.22 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 113.821 1.045 . . . . 13.9 113.821 159.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -111.68 -77.68 0.59 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.061 -2.2 . . . . 6.8600000000000003 105.061 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.73 -50.63 2.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.29 2.236 . . . . 11.15 112.489 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.55 -24.17 0.85 Allowed Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 126.782 2.134 . . . . 13.93 112.356 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -113.78 146.27 40.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.733 -2.039 . . . . 23.920000000000002 114.697 -167.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -78.12 152.4 32.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.305 3.431 . . . . 23.23 115.928 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.1 mt -114.5 136.25 53.22 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 102.928 -2.989 . . . . 9.1099999999999994 102.928 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -104.77 139.12 40.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.628 -2.545 . . . . 33.439999999999998 108.85 -173.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -28.2 -55.36 0.11 Allowed 'General case' 0 N--CA 1.429 -1.482 1 N-CA-C 123.444 4.609 . . . . 28.370000000000001 123.444 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.93 -1.75 81.96 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.765 -2.459 . . . . 15.0 117.922 -164.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -93.35 167.61 11.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.879 3.271 . . . . 25.5 107.949 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -101.37 168.49 9.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.831 2.052 . . . . 11.949999999999999 111.811 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.26 -25.87 68.25 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 131.713 4.005 . . . . 10.17 111.677 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -59.6 -46.45 88.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.363 -3.336 . . . . 13.59 114.744 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.8 -40.0 87.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.675 -2.057 . . . . 11.699999999999999 110.363 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.444 ' HB2' HD12 ' A' ' 61' ' ' ILE . 25.9 m-85 -85.05 -2.38 57.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.789 0.804 . . . . 12.949999999999999 109.486 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m120 65.09 46.7 2.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.274 2.464 . . . . 25.449999999999999 112.724 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 59' ' ' TYR . 10.0 mt -90.02 114.12 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.985 -2.322 . . . . 14.6 110.175 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -97.16 166.18 11.7 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.194 2.998 . . . . 33.229999999999997 112.188 -175.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -55.63 134.11 50.95 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.88 1.808 . . . . 25.969999999999999 115.88 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 55.55 58.12 4.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.179 -1.828 . . . . 32.609999999999999 111.78 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 t -115.74 142.82 46.24 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.25 1.42 . . . . 10.56 108.972 173.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -98.5 124.18 43.08 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.66 1.695 . . . . 5.3300000000000001 115.47 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.79 156.59 17.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.152 3.381 . . . . 11.66 107.681 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -129.07 122.21 29.47 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.44 -2.059 . . . . 16.300000000000001 105.44 -172.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.43 105.76 17.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 112.886 -1.961 . . . . 9.9600000000000009 111.32 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 m -104.95 178.15 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 127.74 2.416 . . . . 9.7599999999999998 112.507 168.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt . . . . . 0 N--CA 1.43 -1.449 0 CA-C-O 124.877 2.275 . . . . 19.57 115.711 176.201 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 ttp . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 122.407 1.098 . . . . 17.170000000000002 108.85 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -82.65 135.95 34.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.065 -1.647 . . . . 21.890000000000001 108.184 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.77 166.46 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 124.789 1.236 . . . . 10.83 109.296 165.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -125.61 104.05 8.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.563 -2.014 . . . . 10.609999999999999 105.563 -167.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.43 105.12 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.515 -2.031 . . . . 9.1300000000000008 105.515 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -108.68 126.15 52.67 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.474 0.654 . . . . 20.550000000000001 110.125 -174.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -80.69 -179.35 7.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.504 1.668 . . . . 11.779999999999999 115.504 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.06 -43.32 78.9 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.004 -4.185 . . . . 19.309999999999999 112.056 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -84.99 -21.22 29.59 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.271 -1.786 . . . . 23.140000000000001 108.927 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.28 70.82 0.93 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-O 124.928 2.404 . . . . 19.739999999999998 115.957 166.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -116.66 118.48 32.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 110.398 -2.901 . . . . 21.93 106.724 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -90.39 103.7 16.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 127.245 2.841 . . . . 12.33 110.383 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.2 mt -94.42 98.79 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.746 2.418 . . . . 17.079999999999998 113.075 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -73.47 122.42 22.11 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 119.991 1.268 . . . . 16.300000000000001 113.068 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.95 147.87 37.82 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.765 -3.709 . . . . 15.880000000000001 102.816 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -105.32 134.92 47.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.819 1.771 . . . . 28.899999999999999 108.209 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -148.87 -174.52 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.57 3.148 . . . . 12.050000000000001 105.968 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -141.6 162.77 45.08 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 114.75 -2.548 . . . . 18.170000000000002 108.227 170.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -23.23 76.64 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 C-N-CA 127.014 5.142 . . . . 8.1600000000000001 118.024 -169.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 5.3 p -94.28 -6.05 45.36 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.559 2.344 . . . . 11.130000000000001 110.683 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -74.93 167.09 22.58 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.495 -3.878 . . . . 18.030000000000001 115.201 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 2.4 p -89.42 170.13 10.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.283 2.697 . . . . 10.220000000000001 118.283 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mt -87.63 -13.15 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 117.53 -1.668 . . . . 12.300000000000001 108.527 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -59.31 -47.51 85.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.01 1.324 . . . . 36.509999999999998 113.556 160.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -55.83 -40.67 73.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.134 -2.854 . . . . 25.66 116.104 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.9 t -52.63 -54.93 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 117.145 -3.472 . . . . 8.1199999999999992 113.213 167.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -61.22 -30.12 70.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.791 1.636 . . . . 15.470000000000001 114.955 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -30.24 70.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.528 3.531 . . . . 11.449999999999999 113.997 166.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -92.78 -14.4 27.9 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 116.742 -1.983 . . . . 24.98 112.174 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.27 67.8 mt -64.2 -36.18 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.398 1.57 . . . . 9.4600000000000009 114.418 158.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -67.76 -21.52 65.26 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.748 -3.095 . . . . 14.76 116.112 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.48 -58.63 2.66 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.085 -2.561 . . . . 26.289999999999999 104.085 -175.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -64.83 -62.06 1.8 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.112 2.565 . . . . 30.059999999999999 115.89 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -81.16 -58.15 3.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.302 1.864 . . . . 25.190000000000001 111.734 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.25 17.35 3.67 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.111 -1.596 . . . . 7.4100000000000001 109.111 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.1 mt -90.58 131.21 38.65 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-O 115.445 -2.217 . . . . 9.4900000000000002 109.085 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -66.18 156.59 64.08 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 125.497 2.999 . . . . 11.42 116.606 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -68.73 -23.03 36.4 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 124.374 3.383 . . . . 12.0 112.319 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.252 10.1 p-10 -77.85 -28.46 50.09 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.248 3.019 . . . . 35.549999999999997 107.801 -170.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -69.38 -35.4 75.78 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.192 -1.568 . . . . 20.52 110.841 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -96.39 133.56 40.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.237 -0.887 . . . . 7.1299999999999999 111.606 -151.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -111.61 131.87 54.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 103.274 -2.861 . . . . 36.390000000000001 103.274 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -116.91 125.06 50.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.24 1.495 . . . . 9.5500000000000007 110.724 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 23.2 mm -95.11 132.32 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.288 2.235 . . . . 13.9 114.298 170.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -123.17 115.94 22.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.481 -2.637 . . . . 6.8600000000000003 109.013 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.84 -102.56 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.364 -0.835 . . . . 11.15 110.007 -172.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.42 34.2 2.39 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 118.822 -2.424 . . . . 13.93 113.017 164.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.345 21.2 ttmm -120.16 144.11 47.85 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 112.735 -1.732 . . . . 23.920000000000002 115.145 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -81.42 135.49 35.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.763 1.744 . . . . 23.23 113.372 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.8 mt -89.26 145.74 25.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.069 -2.197 . . . . 9.1099999999999994 105.069 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -87.12 160.78 18.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.013 -2.422 . . . . 33.439999999999998 114.41 159.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.95 -41.55 13.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.888 2.551 . . . . 28.370000000000001 117.888 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.58 17.87 58.5 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 116.7 -2.667 . . . . 15.0 108.473 -170.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -90.18 165.92 13.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.163 -3.551 . . . . 25.5 109.817 161.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.9 p -102.13 174.26 6.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.849 3.214 . . . . 11.949999999999999 104.111 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.14 -37.5 83.91 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.691 2.796 . . . . 10.17 109.783 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.254 67.7 m -61.5 -42.67 99.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 113.241 0.83 . . . . 13.59 113.241 176.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -53.0 -44.45 67.26 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 121.057 3.725 . . . . 11.699999999999999 121.057 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -79.33 -15.76 57.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 125.715 1.884 . . . . 12.949999999999999 115.865 165.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 68.56 71.57 0.29 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.357 2.663 . . . . 25.449999999999999 110.303 -169.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.274 82.4 mt -109.15 114.51 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 113.332 -3.347 . . . . 14.6 110.004 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -100.13 -166.39 1.32 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.9 2.185 . . . . 33.229999999999997 116.9 -171.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 137.62 55.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.63 1.681 . . . . 25.969999999999999 112.197 -171.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.47 80.4 mt-10 72.74 12.12 5.35 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 116.703 -3.748 . . . . 32.609999999999999 118.091 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.1 t -86.46 137.66 32.37 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 125.763 1.914 . . . . 10.56 108.704 -165.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 m -87.25 115.34 24.59 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.234 -1.803 . . . . 5.3300000000000001 112.147 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.1 mt -93.13 149.69 21.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.402 -1.436 . . . . 11.66 109.368 167.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.572 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 77.7 m-70 -99.72 109.75 22.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 125.871 1.982 . . . . 16.300000000000001 109.972 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.1 tp -96.41 117.68 31.38 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.292 2.473 . . . . 9.9600000000000009 110.303 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.4 t -92.65 130.88 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 128.607 2.763 . . . . 9.7599999999999998 106.339 164.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.5 mt . . . . . 0 N--CA 1.43 -1.451 0 N-CA-C 107.115 -1.439 . . . . 19.57 107.115 161.704 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.4 ttp . . . . . 0 CA--C 1.49 -1.342 0 CA-C-O 121.162 0.506 . . . . 17.170000000000002 109.732 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -84.82 125.29 32.47 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.723 -2.486 . . . . 21.890000000000001 114.667 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.264 8.7 pt -114.04 165.25 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 124.109 3.14 . . . . 10.83 104.415 167.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -106.47 138.43 42.66 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 111.0 -2.818 . . . . 10.609999999999999 111.96 166.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.0 t -118.67 103.41 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.657 3.122 . . . . 9.1300000000000008 105.77 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -88.42 134.92 33.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.544 -2.598 . . . . 20.550000000000001 111.101 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.563 HG22 HD23 ' A' ' 69' ' ' LEU . 71.4 p -81.56 -170.51 2.83 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 123.791 2.996 . . . . 11.779999999999999 114.46 169.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.7 tp -100.74 -27.72 13.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.399 2.047 . . . . 19.309999999999999 112.907 -171.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 p -69.33 -41.79 76.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.529 -3.232 . . . . 23.140000000000001 107.598 160.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.68 72.1 0.67 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 117.959 -2.963 . . . . 19.739999999999998 116.045 173.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -123.97 133.63 53.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.074 -1.917 . . . . 21.93 109.476 160.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.4 m -93.57 105.01 17.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.277 2.86 . . . . 12.33 109.313 -170.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.413 HG23 ' HD2' ' A' ' 33' ' ' LYS . 3.5 mt -95.34 118.86 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 CA-C-O 129.507 4.479 . . . . 17.079999999999998 110.267 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.42 102.77 14.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.017 -3.552 . . . . 16.300000000000001 112.609 -175.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.56 129.44 36.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.282 -2.136 . . . . 15.880000000000001 110.65 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -98.04 92.09 5.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 127.145 3.355 . . . . 28.899999999999999 106.667 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -102.81 174.25 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 130.979 3.712 . . . . 12.050000000000001 110.063 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.349 73.6 mm-40 -115.36 141.53 27.34 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 112.594 -3.574 . . . . 18.170000000000002 105.51 163.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -56.25 -16.16 16.71 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 N-CA-C 119.879 2.992 . . . . 8.1600000000000001 119.879 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -82.15 -10.86 59.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.971 1.843 . . . . 11.130000000000001 111.922 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -74.0 142.94 45.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.58 -3.825 . . . . 18.030000000000001 118.028 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -92.0 152.52 19.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.635 1.683 . . . . 10.220000000000001 108.25 -171.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.2 mm -57.68 -27.1 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 116.287 1.958 . . . . 12.300000000000001 116.287 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.318 37.0 tt0 -64.23 -45.21 89.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.616 1.674 . . . . 36.509999999999998 115.415 166.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -73.04 -29.2 62.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.506 -3.871 . . . . 25.66 113.05 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.94 -46.85 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.244 -2.785 . . . . 8.1199999999999992 107.026 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -60.19 -18.19 46.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.991 1.716 . . . . 15.470000000000001 114.96 171.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.16 -24.09 40.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.556 -2.59 . . . . 11.449999999999999 112.17 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttt -78.81 -36.02 43.29 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.757 -4.34 . . . . 24.98 107.666 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -69.72 -37.45 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 125.994 2.059 . . . . 9.4600000000000009 109.82 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -54.64 -53.52 53.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.713 1.597 . . . . 14.76 114.468 157.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.77 -30.29 71.29 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 123.128 2.695 . . . . 26.289999999999999 116.688 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HD2' HG23 ' A' ' 13' ' ' ILE . 15.0 mttm -61.24 -67.1 0.44 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 126.289 2.947 . . . . 30.059999999999999 113.857 168.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -95.83 -48.47 5.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.872 -2.392 . . . . 25.190000000000001 113.123 -160.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.45 12.57 10.52 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 113.744 -1.571 . . . . 7.4100000000000001 114.108 -172.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -97.0 113.48 63.06 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 107.881 -1.155 . . . . 9.4900000000000002 107.881 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 13.7 Cg_exo -76.91 164.1 30.3 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 125.445 2.98 . . . . 11.42 109.813 -169.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 37' ' ' PRO 0.256 68.0 Cg_exo -63.33 -31.16 73.48 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 N-CA-C 120.827 3.357 . . . . 12.0 120.827 -166.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -97.95 9.0 43.84 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 118.331 -1.347 . . . . 35.549999999999997 111.38 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -78.86 -24.49 44.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.361 2.346 . . . . 20.52 111.889 156.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -83.5 144.79 29.31 Favored 'General case' 0 N--CA 1.429 -1.481 1 N-CA-C 121.811 4.004 . . . . 7.1299999999999999 121.811 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -136.19 111.4 9.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 103.965 -2.606 . . . . 36.390000000000001 103.965 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 mt -97.85 120.39 38.16 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 117.655 -1.618 . . . . 9.5500000000000007 115.282 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -99.85 133.62 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 128.001 3.762 . . . . 13.9 109.924 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -125.69 114.88 19.25 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.025 -4.797 . . . . 6.8600000000000003 105.625 157.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.65 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 131.803 4.041 . . . . 11.15 109.17 -170.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.91 7.17 3.52 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 128.384 2.897 . . . . 13.93 112.332 172.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.307 24.5 ttmm -98.7 137.72 36.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 122.113 2.957 . . . . 23.920000000000002 108.483 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -96.53 127.95 43.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.428 -2.045 . . . . 23.23 107.398 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.2 mt -83.71 152.02 24.94 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 112.742 -2.026 . . . . 9.1099999999999994 106.69 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -99.07 141.46 31.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.961 3.304 . . . . 33.439999999999998 117.355 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.14 -43.96 98.08 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 121.612 3.93 . . . . 28.370000000000001 121.612 -171.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.22 35.37 5.06 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 125.421 1.486 . . . . 15.0 110.028 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -117.65 157.41 26.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.845 0.683 . . . . 25.5 112.845 161.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.3 p -101.54 164.97 11.49 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.068 2.842 . . . . 11.949999999999999 113.494 -169.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.0 mt -56.26 -41.95 76.6 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.144 -4.722 . . . . 10.17 115.467 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 t -63.77 -33.12 74.95 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 130.305 3.442 . . . . 13.59 114.884 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.22 -50.13 56.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.926 2.89 . . . . 11.699999999999999 107.583 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -76.93 -1.84 30.64 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.217 -2.177 . . . . 12.949999999999999 113.514 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.9 t30 54.28 68.46 0.85 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.762 3.625 . . . . 25.449999999999999 110.11 -170.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -108.89 102.61 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 127.473 2.309 . . . . 14.6 108.17 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -90.74 -174.05 3.93 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 114.052 1.131 . . . . 33.229999999999997 114.052 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -59.02 154.88 14.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.605 -3.184 . . . . 25.969999999999999 115.218 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 64.97 25.57 12.71 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.535 4.334 . . . . 32.609999999999999 113.256 169.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -82.48 130.99 35.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.306 1.043 . . . . 10.56 109.647 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.6 m -83.11 113.04 20.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.178 -1.045 . . . . 5.3300000000000001 108.178 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.52 149.57 24.26 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.758 -1.941 . . . . 11.66 105.758 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -113.99 116.69 29.61 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.531 -1.356 . . . . 16.300000000000001 111.714 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.563 HD23 HG22 ' A' ' 7' ' ' THR . 44.7 tp -84.6 125.76 32.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.02 2.819 . . . . 9.9600000000000009 111.11 171.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -118.81 123.54 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 130.382 3.473 . . . . 9.7599999999999998 111.849 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.486 HD21 HD21 ' A' ' 69' ' ' LEU . 75.8 mt . . . . . 0 N--CA 1.43 -1.465 0 CA-C-O 123.745 1.736 . . . . 19.57 107.48 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 120.912 0.387 . . . . 17.170000000000002 111.451 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.263 52.5 mt-30 -114.8 138.61 50.55 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.485 1.291 . . . . 21.890000000000001 114.485 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.413 HG13 ' HB2' ' A' ' 15' ' ' LEU . 10.9 pt -116.19 140.47 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 119.825 -1.797 . . . . 10.83 110.337 174.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -99.81 115.47 29.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.261 1.505 . . . . 10.609999999999999 111.069 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -100.36 107.42 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 115.123 -2.37 . . . . 9.1300000000000008 107.98 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.264 19.5 ttmm -90.64 124.34 34.99 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 126.398 2.311 . . . . 20.550000000000001 110.943 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -74.65 164.27 26.77 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 121.241 1.837 . . . . 11.779999999999999 109.595 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.1 tp -71.59 -22.57 61.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.64 1.348 . . . . 19.309999999999999 114.64 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.253 27.4 p -72.42 -78.55 0.08 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.602 2.761 . . . . 23.140000000000001 111.235 173.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.06 43.64 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.707 1 C-N-CA 132.117 4.675 . . . . 19.739999999999998 114.801 170.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -117.16 143.57 45.69 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 102.927 -2.99 . . . . 21.93 102.927 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.4 m -123.24 115.5 21.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.299 -1.741 . . . . 12.33 106.299 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.73 132.64 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.084 -2.26 . . . . 17.079999999999998 109.396 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 m -101.85 100.54 10.87 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.736 -1.95 . . . . 16.300000000000001 105.736 -172.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.413 ' HB2' HG13 ' A' ' 3' ' ' ILE 0.277 62.0 mt -97.89 137.03 37.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.955 2.788 . . . . 15.880000000000001 104.108 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -85.95 118.68 25.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.686 -3.134 . . . . 28.899999999999999 112.007 168.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 56' ' ' LEU . 31.6 m -131.02 158.46 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.738 -2.69 . . . . 12.050000000000001 103.738 -169.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -92.95 146.91 32.92 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 113.467 -3.158 . . . . 18.170000000000002 114.001 158.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.74 -7.92 22.09 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 CA-C-N 124.617 2.685 . . . . 8.1600000000000001 114.069 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -90.92 -7.4 52.24 Favored 'General case' 0 N--CA 1.43 -1.457 1 C-N-CA 132.969 4.508 . . . . 11.130000000000001 113.654 174.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.78 153.11 44.37 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.231 -2.793 . . . . 18.030000000000001 114.666 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -106.42 163.15 13.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.169 -1.049 . . . . 10.220000000000001 108.169 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 mm -65.9 -28.69 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 121.011 -1.055 . . . . 12.300000000000001 110.827 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -44.49 -41.31 6.27 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.78 3.622 . . . . 36.509999999999998 120.78 157.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -80.33 -29.22 38.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.009 -3.557 . . . . 25.66 113.499 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.97 -38.77 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 105.09 -2.189 . . . . 8.1199999999999992 105.09 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -70.91 -42.26 70.16 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.248 1.819 . . . . 15.470000000000001 113.543 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.8 -43.64 27.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.444 2.069 . . . . 11.449999999999999 111.789 169.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -77.3 -31.66 54.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.79 -3.069 . . . . 24.98 109.032 -173.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.6 mt -70.61 -40.79 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.188 -3.445 . . . . 9.4600000000000009 115.834 171.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -50.26 -47.69 55.1 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 133.055 4.542 . . . . 14.76 109.435 172.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -60.28 -56.55 20.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.212 1.482 . . . . 26.289999999999999 113.744 171.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -74.15 -37.89 63.89 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.384 3.476 . . . . 30.059999999999999 120.384 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -107.83 -40.13 5.36 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.401 1.909 . . . . 25.190000000000001 114.233 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.2 44.23 4.45 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 120.598 1.545 . . . . 7.4100000000000001 112.963 -169.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 mt -111.68 126.6 28.24 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 100.314 -3.958 . . . . 9.4900000000000002 100.314 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -67.35 153.41 77.04 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 C-N-CA 126.335 4.69 . . . . 11.42 115.765 -174.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -78.27 -18.89 12.29 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 126.412 3.326 . . . . 12.0 112.998 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.9 -11.76 60.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 114.885 -2.483 . . . . 35.549999999999997 115.69 165.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -97.07 -16.73 20.39 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 121.901 2.137 . . . . 20.52 112.763 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 76.7 mt-30 -92.04 118.07 30.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.747 3.154 . . . . 7.1299999999999999 111.098 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -116.37 111.02 19.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.933 -1.877 . . . . 36.390000000000001 105.933 170.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -86.75 113.94 23.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.879 2.752 . . . . 9.5500000000000007 110.638 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.2 mm -99.43 142.12 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.243 -2.786 . . . . 13.9 105.878 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.48 ' HB2' HD11 ' A' ' 50' ' ' LEU . 25.5 t80 -128.65 112.24 14.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.69 -1.881 . . . . 6.8600000000000003 108.08 171.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.33 . . 68.86 -91.65 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.343 -3.973 . . . . 11.15 117.354 -162.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.68 34.68 0.95 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 118.842 -1.646 . . . . 13.93 111.804 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -149.98 144.83 26.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 129.513 3.714 . . . . 23.920000000000002 113.709 173.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -73.43 134.41 43.98 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 125.832 2.73 . . . . 23.23 115.125 -176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 45' ' ' PHE . 14.7 mt -86.51 151.1 23.78 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 110.727 -2.942 . . . . 9.1099999999999994 109.925 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.36 133.31 46.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.216 -3.428 . . . . 33.439999999999998 105.214 -158.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -40.45 -58.8 1.47 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 130.466 3.506 . . . . 28.370000000000001 117.789 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.7 14.16 43.6 Favored Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 121.055 1.752 . . . . 15.0 114.288 -169.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -113.44 159.68 19.23 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.671 -2.664 . . . . 25.5 108.626 -172.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 p -114.27 -178.12 3.29 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.476 -3.265 . . . . 11.949999999999999 112.571 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 17' ' ' VAL . 71.3 mt -74.51 -28.71 61.11 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 110.656 -2.975 . . . . 10.17 114.319 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.6 m -65.52 -31.11 72.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 119.167 3.025 . . . . 13.59 119.167 170.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -65.89 -45.63 81.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 127.62 3.075 . . . . 11.699999999999999 110.388 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -92.38 -8.41 44.97 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.695 -2.098 . . . . 12.949999999999999 109.51 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 60.35 54.24 4.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.508 3.051 . . . . 25.449999999999999 114.305 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mt -93.44 108.39 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 109.602 -3.454 . . . . 14.6 105.744 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -88.2 -179.09 6.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 124.769 2.223 . . . . 33.229999999999997 111.419 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.269 17.9 pttp -53.37 141.69 23.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.723 -3.111 . . . . 25.969999999999999 116.146 159.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 70.98 20.87 5.15 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.785 -3.072 . . . . 32.609999999999999 112.545 168.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -89.71 135.21 33.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.972 3.709 . . . . 10.56 114.786 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -95.0 117.71 30.6 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.869 2.914 . . . . 5.3300000000000001 118.869 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mp -108.83 151.35 26.36 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.89 -2.263 . . . . 11.66 104.89 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -107.13 140.66 39.62 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.231 -1.766 . . . . 16.300000000000001 106.231 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -106.37 106.48 17.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.535 1.772 . . . . 9.9600000000000009 111.952 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.3 t -94.42 134.33 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 126.948 2.655 . . . . 9.7599999999999998 107.029 173.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 N--CA 1.43 -1.44 0 CA-C-N 115.417 -0.811 . . . . 19.57 110.314 166.256 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 112.505 0.558 . . . . 17.170000000000002 112.505 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -102.73 147.86 26.32 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.517 3.532 . . . . 21.890000000000001 112.94 170.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 pt -128.6 163.66 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 115.802 -4.311 . . . . 10.83 103.908 169.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.57 101.67 7.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 105.057 -2.201 . . . . 10.609999999999999 105.057 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.0 t -93.53 123.3 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 107.015 -1.476 . . . . 9.1300000000000008 107.015 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -124.36 152.75 42.78 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.246 1.839 . . . . 20.550000000000001 111.004 -171.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -88.42 -178.37 5.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.614 1.709 . . . . 11.779999999999999 115.614 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.269 36.1 tp -67.77 -40.08 84.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.719 2.859 . . . . 19.309999999999999 118.719 158.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -56.55 7.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.899 -2.376 . . . . 23.140000000000001 111.74 -169.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.74 24.52 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 119.03 -2.294 . . . . 19.739999999999998 115.197 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -100.38 148.48 24.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.911 -3.111 . . . . 21.93 115.849 166.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.8 m -125.34 135.77 52.79 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.744 2.818 . . . . 12.33 104.883 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.6 mt -121.59 110.78 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 103.273 -2.862 . . . . 17.079999999999998 103.273 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -79.57 118.72 21.67 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.07 -1.644 . . . . 16.300000000000001 113.852 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -112.68 145.12 41.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.425 -3.297 . . . . 15.880000000000001 113.119 -174.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -100.61 98.25 8.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.496 -1.668 . . . . 28.899999999999999 106.496 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 m -104.42 174.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 124.883 1.364 . . . . 12.050000000000001 113.025 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -121.02 152.02 55.96 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 127.367 2.267 . . . . 18.170000000000002 106.213 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -68.35 -14.72 40.87 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 122.784 2.03 . . . . 8.1600000000000001 115.224 -172.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.255 53.3 p -99.8 1.34 43.0 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.737 2.815 . . . . 11.130000000000001 114.596 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.264 11.3 m-20 -71.0 155.23 41.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.882 2.277 . . . . 18.030000000000001 110.638 161.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 p -85.36 161.68 19.37 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.04 2.829 . . . . 10.220000000000001 108.487 173.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mm -57.01 -29.12 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.161 -2.837 . . . . 12.300000000000001 115.068 163.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -62.68 -46.65 87.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.021 -3.55 . . . . 36.509999999999998 109.538 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -52.85 -52.75 56.07 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.892 1.277 . . . . 25.66 113.325 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -45.12 -50.35 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.911 1.684 . . . . 8.1199999999999992 113.409 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.19 -36.21 77.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.038 1.875 . . . . 15.470000000000001 115.011 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.97 82.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.641 -2.537 . . . . 11.449999999999999 116.408 170.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -63.92 -40.03 95.54 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.795 1.776 . . . . 24.98 115.795 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -60.05 -45.2 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 C-N-CA 135.097 5.359 . . . . 9.4600000000000009 110.693 168.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -54.54 -48.23 72.25 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.991 1.717 . . . . 14.76 113.386 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.21 -35.57 80.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.535 2.05 . . . . 26.289999999999999 116.535 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -87.37 -46.31 9.77 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.637 1.684 . . . . 30.059999999999999 114.694 -172.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -78.63 -55.61 5.06 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 114.225 -1.352 . . . . 25.190000000000001 114.51 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.1 44.84 1.97 Allowed Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 110.066 -1.213 . . . . 7.4100000000000001 110.066 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.413 HG22 ' HB3' ' A' ' 40' ' ' GLN . 6.8 mt -125.38 127.24 25.0 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 104.806 -2.294 . . . . 9.4900000000000002 104.806 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 41.9 Cg_exo -67.22 160.36 47.92 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-O 115.998 -1.751 . . . . 11.42 116.052 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.6 Cg_exo -70.29 -27.34 24.05 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 124.74 3.626 . . . . 12.0 110.993 -169.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -77.64 -37.2 50.49 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 117.92 -1.038 . . . . 35.549999999999997 109.457 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HB3' HG22 ' A' ' 36' ' ' ILE . 7.1 tp-100 -59.96 -33.08 71.45 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.559 2.344 . . . . 20.52 115.498 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -98.93 145.32 27.15 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.346 2.022 . . . . 7.1299999999999999 116.418 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -115.03 153.71 30.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.692 2.797 . . . . 36.390000000000001 107.683 165.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 tp -133.93 114.89 13.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.413 1.085 . . . . 9.5500000000000007 108.966 -171.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.4 mm -103.71 128.57 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 117.26 -3.4 . . . . 13.9 112.452 -171.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -109.87 128.62 55.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.02 1.328 . . . . 6.8600000000000003 108.674 160.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.42 -108.25 0.42 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.81 -2.432 . . . . 11.15 112.262 -168.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.67 31.55 3.53 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 109.212 -1.555 . . . . 13.93 109.212 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -121.8 124.18 43.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.269 1.428 . . . . 23.920000000000002 111.054 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -76.31 107.41 8.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.217 1.807 . . . . 23.23 110.682 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.82 136.63 34.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.247 1.019 . . . . 9.1099999999999994 111.696 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -93.24 159.1 15.42 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.483 2.087 . . . . 33.439999999999998 111.101 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -73.15 -42.07 63.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.226 -2.796 . . . . 28.370000000000001 108.764 -156.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.84 41.5 2.13 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 117.217 -3.427 . . . . 15.0 113.01 -165.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -122.37 159.71 26.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.158 2.328 . . . . 25.5 108.842 166.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.9 p -85.99 167.92 14.62 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.964 2.106 . . . . 11.949999999999999 116.396 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -68.36 -26.66 65.7 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.794 -1.191 . . . . 10.17 111.416 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 t -76.37 -40.76 50.24 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 118.431 2.752 . . . . 13.59 118.431 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -43.16 -48.11 6.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.922 -2.361 . . . . 11.699999999999999 117.251 158.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -78.85 -6.99 57.49 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 120.575 3.546 . . . . 12.949999999999999 120.575 170.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 t30 53.75 40.06 31.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.064 2.616 . . . . 25.449999999999999 118.064 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.8 mt -81.47 118.91 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 105.044 -2.206 . . . . 14.6 105.044 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -81.31 -173.07 4.13 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.878 2.751 . . . . 33.229999999999997 113.79 -176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -74.42 146.06 43.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.009 -2.932 . . . . 25.969999999999999 112.605 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 65.57 30.16 10.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.364 1.665 . . . . 32.609999999999999 114.821 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -79.45 152.53 30.24 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 103.763 -2.68 . . . . 10.56 103.763 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.6 m -103.51 124.16 48.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.103 2.961 . . . . 5.3300000000000001 108.309 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.282 4.9 mp -117.11 162.13 18.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.106 1.762 . . . . 11.66 107.894 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.27 127.08 52.9 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.705 -2.497 . . . . 16.300000000000001 111.182 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.72 107.73 18.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.414 2.686 . . . . 9.9600000000000009 114.739 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -122.12 121.34 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 108.057 -1.09 . . . . 9.7599999999999998 108.057 -171.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.402 HD11 HD13 ' A' ' 36' ' ' ILE . 7.9 mp . . . . . 0 N--CA 1.431 -1.409 0 C-N-CA 117.092 -1.843 . . . . 19.57 110.151 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 112.747 0.647 . . . . 17.170000000000002 112.747 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -95.95 121.8 38.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.907 -1.886 . . . . 21.890000000000001 105.907 -176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 pt -109.62 164.85 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 107.268 -1.382 . . . . 10.83 107.268 170.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -114.83 105.79 13.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.432 -2.433 . . . . 10.609999999999999 104.432 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.4 t -86.57 124.84 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 126.931 3.253 . . . . 9.1300000000000008 109.483 166.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -106.4 134.62 49.25 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.431 -2.668 . . . . 20.550000000000001 107.684 -173.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.253 47.5 p -75.79 161.14 29.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.775 2.03 . . . . 11.779999999999999 112.042 170.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.5 tp -59.28 -37.93 78.88 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.378 -3.326 . . . . 19.309999999999999 115.613 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -68.1 -64.58 0.83 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.651 2.167 . . . . 23.140000000000001 115.085 169.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.51 71.55 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 O-C-N 117.113 -3.492 . . . . 19.739999999999998 107.826 174.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -104.02 160.14 15.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.549 1.174 . . . . 21.93 113.885 147.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.1 m -90.96 118.98 30.78 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 115.824 -4.298 . . . . 12.33 105.92 168.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.71 119.17 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 123.914 1.816 . . . . 17.079999999999998 107.737 156.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 84.7 m -98.96 108.65 21.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 111.595 -2.548 . . . . 16.300000000000001 106.723 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.447 ' CD1' HG13 ' A' ' 26' ' ' VAL . 87.7 mt -107.2 116.87 32.69 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.598 2.359 . . . . 15.880000000000001 115.719 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.31 112.42 15.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.531 -1.668 . . . . 28.899999999999999 110.211 167.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.29 158.32 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 123.284 0.634 . . . . 12.050000000000001 109.949 167.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 56.7 mt-10 -115.79 151.73 46.65 Favored Pre-proline 0 N--CA 1.429 -1.478 0 N-CA-C 102.834 -3.024 . . . . 18.170000000000002 102.834 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 22.1 Cg_exo -76.03 -16.4 18.02 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 CA-C-O 114.889 -2.213 . . . . 8.1600000000000001 113.456 -159.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -70.51 -14.83 62.68 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-N 127.26 4.573 . . . . 11.130000000000001 112.931 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 18.3 m-20 -78.32 146.8 34.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.703 -3.748 . . . . 18.030000000000001 106.19 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.7 p -78.77 167.89 20.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.336 -3.978 . . . . 10.220000000000001 116.489 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.95 -39.88 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 117.427 -1.273 . . . . 12.300000000000001 110.234 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -51.1 -39.51 56.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 123.422 2.828 . . . . 36.509999999999998 113.233 170.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -57.57 -38.67 75.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.565 -1.335 . . . . 25.66 112.811 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.447 HG13 ' CD1' ' A' ' 15' ' ' LEU . 58.5 t -56.77 -54.42 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 125.925 2.774 . . . . 8.1199999999999992 111.183 176.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -56.57 -37.38 70.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.981 3.326 . . . . 15.470000000000001 119.981 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.23 -32.08 69.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.231 1.491 . . . . 11.449999999999999 112.475 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -80.22 -27.89 38.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 118.585 -1.246 . . . . 24.98 108.461 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.9 mt -58.65 -42.21 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 114.749 1.389 . . . . 9.4600000000000009 114.749 159.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -65.05 -24.91 67.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.867 -2.395 . . . . 14.76 115.96 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.23 -59.82 3.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.442 -3.287 . . . . 26.289999999999999 109.445 166.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -73.1 -56.83 4.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.331 2.715 . . . . 30.059999999999999 118.331 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -93.95 -53.3 4.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.751 1.621 . . . . 25.190000000000001 115.094 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.52 2.9 6.21 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 125.173 2.54 . . . . 7.4100000000000001 115.995 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.5 mt -68.18 127.55 93.27 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 113.691 -3.052 . . . . 9.4900000000000002 112.767 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -70.63 155.57 62.82 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 126.974 3.527 . . . . 11.42 115.337 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -62.45 -39.45 45.78 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 CA-C-N 124.552 2.661 . . . . 12.0 110.636 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.73 -8.7 11.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.65 2.833 . . . . 35.549999999999997 118.65 170.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -94.68 -32.26 13.45 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.785 -2.447 . . . . 20.52 110.402 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 16.1 pt20 -107.96 154.33 21.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.737 1.384 . . . . 7.1299999999999999 114.737 -172.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 mtt85 -134.55 164.34 27.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 117.823 -1.084 . . . . 36.390000000000001 108.222 157.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -113.31 136.62 52.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.059 3.344 . . . . 9.5500000000000007 107.15 -174.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -115.76 122.72 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.131 -1.433 . . . . 13.9 107.131 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -113.63 111.14 21.35 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.968 -2.975 . . . . 6.8600000000000003 102.968 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.08 -75.83 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.446 -2.034 . . . . 11.15 114.972 -164.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.59 9.09 2.61 Favored Glycine 0 N--CA 1.429 -1.807 0 CA-C-N 121.021 1.737 . . . . 13.93 116.463 169.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -107.62 123.76 48.96 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.719 2.2 . . . . 23.920000000000002 108.249 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -82.19 121.34 26.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 110.362 -3.108 . . . . 23.23 111.721 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 mt -86.27 156.17 20.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 115.749 -2.072 . . . . 9.1099999999999994 110.547 -165.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -109.25 142.42 40.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 123.034 2.652 . . . . 33.439999999999998 111.265 -173.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.61 -48.75 79.93 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.374 2.67 . . . . 28.370000000000001 115.564 -163.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.29 -3.69 71.24 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 118.163 2.025 . . . . 15.0 118.163 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.8 mtt-85 -98.0 170.25 9.06 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.889 1.328 . . . . 25.5 110.286 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -106.43 162.04 14.05 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.927 -1.733 . . . . 11.949999999999999 112.521 -170.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.437 HD23 HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -63.58 -25.37 68.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.884 -2.385 . . . . 10.17 114.611 175.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.96 -30.19 55.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.664 2.386 . . . . 13.59 112.493 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -63.73 -42.23 97.93 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.542 -3.223 . . . . 11.699999999999999 111.246 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -88.99 5.68 43.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.033 2.975 . . . . 12.949999999999999 119.033 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 55.36 59.64 3.82 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.833 2.453 . . . . 25.449999999999999 111.994 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.437 HD12 HD23 ' A' ' 56' ' ' LEU . 60.6 mt -96.38 122.94 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.125 -1.805 . . . . 14.6 106.125 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -102.34 -174.73 2.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.646 1.688 . . . . 33.229999999999997 111.978 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -56.03 149.33 15.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.148 -3.47 . . . . 25.969999999999999 115.919 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 39.2 mt-10 66.98 31.04 7.23 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.367 -2.708 . . . . 32.609999999999999 113.434 171.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.3 m -93.29 132.21 37.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.798 -2.001 . . . . 10.56 113.375 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.1 m -90.74 124.64 35.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.452 -2.655 . . . . 5.3300000000000001 108.09 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.322 11.2 mp -109.61 140.02 43.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.997 1.719 . . . . 11.66 111.838 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -98.48 135.36 40.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.135 2.243 . . . . 16.300000000000001 115.505 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.5 tp -98.14 125.43 43.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.44 1.59 . . . . 9.9600000000000009 110.189 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -133.37 148.08 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 121.032 -1.042 . . . . 9.7599999999999998 110.187 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 105.079 -2.193 . . . . 19.57 105.079 -170.078 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 122.931 1.348 . . . . 17.170000000000002 114.554 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -107.77 155.98 19.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 120.036 3.347 . . . . 21.890000000000001 120.036 172.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -138.73 154.54 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 106.817 -1.549 . . . . 10.83 106.817 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -106.83 126.73 52.69 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.401 -2.074 . . . . 10.609999999999999 105.401 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.01 108.83 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 120.09 1.314 . . . . 9.1300000000000008 109.581 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -96.97 135.66 38.65 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.735 -1.121 . . . . 20.550000000000001 109.568 -167.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -77.61 171.11 15.42 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.412 1.695 . . . . 11.779999999999999 112.007 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -51.5 -56.39 13.63 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 117.093 2.257 . . . . 19.309999999999999 117.093 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -85.93 -72.95 0.47 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.442 -2.036 . . . . 23.140000000000001 109.324 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.41 48.0 0.17 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 118.658 2.223 . . . . 19.739999999999998 118.658 -162.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -110.85 156.27 21.38 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 116.304 -4.056 . . . . 21.93 110.299 157.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.9 m -129.14 135.82 49.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 103.148 -2.908 . . . . 12.33 103.148 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 mt -121.54 112.97 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 114.5 -1.227 . . . . 17.079999999999998 108.989 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.7 m -88.19 107.17 18.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.995 0.903 . . . . 16.300000000000001 111.479 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.92 112.35 24.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 120.233 3.42 . . . . 15.880000000000001 120.233 -173.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -83.59 117.74 23.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.723 -3.735 . . . . 28.899999999999999 111.892 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.62 177.84 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.547 -1.971 . . . . 12.050000000000001 109.377 -166.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -117.46 160.13 39.13 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 118.488 -2.633 . . . . 18.170000000000002 109.951 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -79.48 -6.78 14.72 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 125.253 3.969 . . . . 8.1600000000000001 110.091 -166.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 m -88.58 -7.22 56.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.711 2.804 . . . . 11.130000000000001 115.064 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.49 169.74 11.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 118.703 0.683 . . . . 18.030000000000001 112.79 -175.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.5 p -107.9 164.91 11.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.421 2.288 . . . . 10.220000000000001 109.029 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 mm -55.83 -47.01 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 126.499 1.92 . . . . 12.300000000000001 112.37 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -60.99 -32.7 72.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.21 2.604 . . . . 36.509999999999998 115.642 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -67.04 -43.2 83.36 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 122.714 2.507 . . . . 25.66 115.38 162.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.89 -29.24 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 118.435 -2.666 . . . . 8.1199999999999992 113.004 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -72.68 -34.68 67.35 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.968 2.507 . . . . 15.470000000000001 110.476 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -34.92 73.56 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.788 2.835 . . . . 11.449999999999999 115.771 169.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -57.87 -52.14 66.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.939 2.896 . . . . 24.98 117.069 162.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.2 mt -60.6 -40.3 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 117.794 -3.066 . . . . 9.4600000000000009 113.404 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -50.45 -49.0 56.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.513 2.578 . . . . 14.76 112.006 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -46.47 80.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.359 -3.963 . . . . 26.289999999999999 116.941 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -63.22 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.063 -2.335 . . . . 30.059999999999999 114.954 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -58.97 -64.65 0.86 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.166 2.186 . . . . 25.190000000000001 113.663 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.54 62.24 0.33 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 108.476 -1.849 . . . . 7.4100000000000001 108.476 -171.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.42 HD13 HD11 ' A' ' 71' ' ' LEU . 36.0 mt -127.84 114.05 20.58 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.326 -2.75 . . . . 9.4900000000000002 113.89 177.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -73.77 150.8 45.16 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 124.809 2.753 . . . . 11.42 113.737 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -57.97 -35.07 99.01 Favored 'Trans proline' 0 N--CA 1.434 -2.003 2 C-N-CA 129.514 6.81 . . . . 12.0 117.451 -166.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.299 38.7 m-20 -74.21 -21.65 59.71 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.603 1.161 . . . . 35.549999999999997 111.15 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -78.23 -31.86 49.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.355 3.455 . . . . 20.52 114.097 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -109.65 140.24 43.73 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 113.287 -5.883 . . . . 7.1299999999999999 111.203 -175.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -123.17 171.74 9.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.747 -1.945 . . . . 36.390000000000001 105.747 163.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.25 35.3 mt -123.32 143.32 50.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 125.773 1.92 . . . . 9.5500000000000007 107.519 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.88 138.68 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.431 2.062 . . . . 13.9 106.38 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -114.07 102.19 9.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.318 -2.739 . . . . 6.8600000000000003 107.882 171.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.297 . . 58.58 -98.33 0.08 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.735 1.754 . . . . 11.15 115.735 -166.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.47 -6.89 24.95 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 120.704 1.593 . . . . 13.93 109.195 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.8 120.32 30.09 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 113.382 0.882 . . . . 23.920000000000002 113.382 -171.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -87.61 116.97 26.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.235 -3.416 . . . . 23.23 111.386 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.0 mt -84.58 126.86 33.7 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.331 -1.481 . . . . 9.1099999999999994 112.315 -169.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -78.0 134.91 37.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.359 2.664 . . . . 33.439999999999998 114.084 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.52 -46.03 91.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.332 1.853 . . . . 28.370000000000001 112.657 -155.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.23 -8.02 86.95 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 125.818 1.675 . . . . 15.0 117.247 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.8 mtt-85 -76.64 148.18 37.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.035 -2.45 . . . . 25.5 112.122 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.2 p -81.66 166.41 20.18 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.729 -4.357 . . . . 11.949999999999999 110.034 -176.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.74 -19.28 63.54 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.957 1.836 . . . . 10.17 115.957 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 t -91.05 -18.21 24.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.753 2.821 . . . . 13.59 108.563 -172.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -66.78 -21.88 66.04 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.444 -4.535 . . . . 11.699999999999999 114.082 163.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -104.24 -20.68 13.71 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.66 -1.154 . . . . 12.949999999999999 111.582 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 66.44 61.03 0.58 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.419 1.888 . . . . 25.449999999999999 112.083 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -101.29 103.46 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.241 1.816 . . . . 14.6 108.789 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -83.49 -163.42 0.75 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.348 1.61 . . . . 33.229999999999997 115.348 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -71.75 159.02 35.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.424 1.89 . . . . 25.969999999999999 112.756 170.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 54.04 22.14 3.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.749 2.82 . . . . 32.609999999999999 110.206 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -66.22 140.64 58.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.587 1.955 . . . . 10.56 116.08 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -90.75 116.99 29.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.677 3.991 . . . . 5.3300000000000001 106.498 171.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -112.2 166.53 11.18 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 127.023 2.702 . . . . 11.66 110.498 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -122.86 135.54 54.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 117.81 -1.091 . . . . 16.300000000000001 111.269 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 tp -94.16 133.4 37.7 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.974 1.369 . . . . 9.9600000000000009 107.411 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.9 152.79 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 O-C-N 114.605 -5.059 . . . . 9.7599999999999998 106.735 161.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 36' ' ' ILE . 7.3 mp . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 115.057 -2.402 . . . . 19.57 110.493 171.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 114.464 1.283 . . . . 17.170000000000002 114.464 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -113.78 135.0 54.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.549 1.643 . . . . 21.890000000000001 109.123 -178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.6 pt -124.19 158.09 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 112.463 -2.153 . . . . 10.83 105.513 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -104.07 114.29 28.43 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.623 1.169 . . . . 10.609999999999999 113.38 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.23 116.0 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 116.724 -3.735 . . . . 9.1300000000000008 102.588 166.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -107.99 133.74 51.88 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.703 3.601 . . . . 20.550000000000001 109.97 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.392 17.6 p -79.88 -173.39 3.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.002 1.853 . . . . 11.779999999999999 116.002 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.5 tp -79.37 -42.41 25.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.889 2.757 . . . . 19.309999999999999 111.817 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p -68.49 -70.2 0.28 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.343 4.257 . . . . 23.140000000000001 110.129 174.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.44 55.98 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 104.089 -3.604 . . . . 19.739999999999998 104.089 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -117.33 146.19 43.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 120.728 2.264 . . . . 21.93 108.76 159.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -114.48 117.58 31.38 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.286 -2.759 . . . . 12.33 110.392 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 13' ' ' ILE 0.27 0.3 OUTLIER -104.45 104.32 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 103.154 -2.906 . . . . 17.079999999999998 103.154 175.178 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.4 m -88.88 111.72 22.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.711 1.204 . . . . 16.300000000000001 110.796 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.4 mt -114.26 148.92 36.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 122.853 2.57 . . . . 15.880000000000001 107.875 -160.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -106.34 118.93 37.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.382 -1.449 . . . . 28.899999999999999 114.697 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.56 170.66 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 124.061 1.886 . . . . 12.050000000000001 112.425 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -107.99 164.24 15.21 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.07 -2.894 . . . . 18.170000000000002 109.445 167.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -71.06 -24.85 23.32 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.263 1.975 . . . . 8.1600000000000001 112.447 -172.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.9 m -73.45 -8.08 54.43 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.727 2.811 . . . . 11.130000000000001 116.552 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -84.28 142.59 30.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.077 -1.874 . . . . 18.030000000000001 112.428 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.7 p -80.04 165.05 22.92 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.288 2.47 . . . . 10.220000000000001 113.807 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.455 HD12 HD13 ' A' ' 50' ' ' LEU . 35.6 mm -69.73 -32.31 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 119.535 -1.978 . . . . 12.300000000000001 109.448 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -51.66 -35.89 44.16 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.777 1.769 . . . . 36.509999999999998 115.777 159.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.69 -35.91 65.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.405 2.526 . . . . 25.66 109.845 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.05 -43.77 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 1 O-C-N 115.841 -4.287 . . . . 8.1199999999999992 109.785 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -56.64 -33.64 66.5 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.164 2.653 . . . . 15.470000000000001 118.164 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.77 -29.21 64.24 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.544 2.592 . . . . 11.449999999999999 109.281 -167.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -78.47 -34.08 47.85 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.794 2.037 . . . . 24.98 111.251 174.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.33 -33.57 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 123.859 1.79 . . . . 9.4600000000000009 110.769 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -59.4 -44.22 92.84 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.418 -2.676 . . . . 14.76 110.607 166.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.94 -41.47 91.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.446 1.098 . . . . 26.289999999999999 110.242 -172.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -78.96 -63.94 1.3 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 119.026 0.83 . . . . 30.059999999999999 110.041 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -89.72 -20.88 23.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.561 2.06 . . . . 25.190000000000001 116.561 -158.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.39 34.24 23.51 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 118.632 2.213 . . . . 7.4100000000000001 118.632 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -107.99 124.0 36.04 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 119.157 -0.449 . . . . 9.4900000000000002 111.598 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -66.0 148.02 85.25 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.636 2.224 . . . . 11.42 115.641 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.08 -21.48 12.09 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.162 2.575 . . . . 12.0 109.983 -148.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -70.28 -28.12 64.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.858 1.799 . . . . 35.549999999999997 115.858 173.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -81.81 -26.74 34.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.448 -2.033 . . . . 20.52 115.813 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -96.03 152.25 18.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.221 1.408 . . . . 7.1299999999999999 108.533 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -135.51 168.2 19.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 117.205 -1.378 . . . . 36.390000000000001 109.685 167.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 43' ' ' LEU . 35.2 mt -131.71 130.75 42.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 125.388 3.722 . . . . 9.5500000000000007 110.714 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mt -110.77 116.59 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 112.124 -2.307 . . . . 13.9 110.657 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -96.73 102.07 13.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.107 3.363 . . . . 6.8600000000000003 109.905 169.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.1 -95.84 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.746 2.018 . . . . 11.15 114.714 -165.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.03 -12.91 26.47 Favored Glycine 0 N--CA 1.43 -1.703 1 C-N-CA 131.204 4.24 . . . . 13.93 112.694 -175.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -104.25 150.14 24.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.705 -2.644 . . . . 23.920000000000002 115.354 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -109.79 149.33 29.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.151 2.405 . . . . 23.23 109.752 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.455 HD13 HD12 ' A' ' 23' ' ' ILE . 23.4 mt -90.03 118.84 29.89 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.878 2.071 . . . . 9.1099999999999994 113.234 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -79.04 150.68 31.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.993 1.378 . . . . 33.439999999999998 110.475 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.97 -24.66 55.43 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 115.474 -4.517 . . . . 28.370000000000001 112.284 -157.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.18 27.2 10.37 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 121.145 3.218 . . . . 15.0 121.145 -171.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -110.79 174.91 5.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.309 1.843 . . . . 25.5 111.278 162.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.2 p -95.88 167.32 11.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 113.661 0.986 . . . . 11.949999999999999 113.661 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.4 -33.66 74.05 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 114.637 1.347 . . . . 10.17 114.637 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.39 -39.65 84.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.698 1.599 . . . . 13.59 114.681 171.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.287 72.5 m-20 -57.57 -37.25 72.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.802 2.041 . . . . 11.699999999999999 114.976 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -110.41 4.92 21.04 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.822 -1.547 . . . . 12.949999999999999 106.822 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 t30 72.34 45.03 0.39 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.147 -2.22 . . . . 25.449999999999999 109.75 162.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.6 mt -94.59 119.89 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 128.11 3.814 . . . . 14.6 111.227 168.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -99.35 175.29 5.92 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.885 -4.259 . . . . 33.229999999999997 108.043 169.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -40.77 145.56 0.19 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.347 -3.346 . . . . 25.969999999999999 117.446 165.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 70.76 9.5 6.85 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.155 3.382 . . . . 32.609999999999999 116.759 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.8 m -78.11 145.58 35.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.398 3.079 . . . . 10.56 108.824 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.3 m -100.69 121.22 41.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.202 1.401 . . . . 5.3300000000000001 109.145 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.7 mt -104.8 149.36 25.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.317 -0.994 . . . . 11.66 108.317 164.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -99.86 108.42 20.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.577 2.351 . . . . 16.300000000000001 110.142 169.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tp -84.54 98.12 9.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.716 -1.865 . . . . 9.9600000000000009 109.347 171.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.2 156.18 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 119.332 -2.105 . . . . 9.7599999999999998 107.429 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp . . . . . 0 N--CA 1.43 -1.436 0 CA-C-O 125.741 2.686 . . . . 19.57 107.63 172.835 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.338 18.0 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 119.101 3.0 . . . . 17.170000000000002 119.101 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -102.04 128.72 48.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 119.314 -0.954 . . . . 21.890000000000001 112.414 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.321 31.1 pt -118.42 169.33 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.377 1.471 . . . . 10.83 112.649 171.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -132.88 131.6 41.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.46 -2.65 . . . . 10.609999999999999 111.953 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.4 t -106.01 114.5 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 103.822 -2.659 . . . . 9.1300000000000008 103.822 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -79.72 142.43 35.47 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.027 2.822 . . . . 20.550000000000001 109.548 167.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.276 17.0 p -93.67 -176.82 4.18 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.686 -2.509 . . . . 11.779999999999999 112.167 176.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.66 -25.92 24.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 120.472 1.487 . . . . 19.309999999999999 113.169 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -69.7 -55.45 9.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.02 2.343 . . . . 23.140000000000001 109.34 161.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.37 58.02 0.18 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.381 -1.45 . . . . 19.739999999999998 112.999 164.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.254 42.1 pttt -101.83 149.33 24.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.47 1.108 . . . . 21.93 113.878 172.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.1 m -74.83 114.01 12.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.105 -2.872 . . . . 12.33 118.149 164.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.8 mt -96.52 123.62 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 122.104 0.954 . . . . 17.079999999999998 109.052 160.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.5 m -110.5 121.15 44.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 102.508 -3.145 . . . . 16.300000000000001 102.508 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.4 mt -115.07 146.49 41.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.742 -2.474 . . . . 15.880000000000001 113.074 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -113.35 103.74 11.61 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.701 2.801 . . . . 28.899999999999999 104.506 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.2 169.37 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 115.523 -2.179 . . . . 12.050000000000001 108.57 -167.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -114.75 158.71 39.73 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 128.491 2.717 . . . . 18.170000000000002 104.21 161.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -91.22 -4.83 4.25 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 115.615 -2.457 . . . . 8.1600000000000001 108.364 -167.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.287 33.1 m -72.67 -11.31 60.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.582 2.438 . . . . 11.130000000000001 117.582 164.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -84.22 159.57 20.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 121.451 1.932 . . . . 18.030000000000001 112.185 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.2 p -95.63 155.5 16.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.238 -2.164 . . . . 10.220000000000001 107.964 -169.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.24 -31.78 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 O-C-N 115.487 -4.508 . . . . 12.300000000000001 106.708 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -52.34 -38.89 59.82 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.652 -4.405 . . . . 36.509999999999998 112.051 166.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -75.41 -33.01 60.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.651 -2.53 . . . . 25.66 112.514 170.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -72.92 -41.43 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.133 -3.479 . . . . 8.1199999999999992 111.68 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.32 -23.47 65.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.876 2.917 . . . . 15.470000000000001 118.876 166.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.76 -32.2 65.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.603 1.547 . . . . 11.449999999999999 114.485 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.254 37.0 mttm -59.3 -40.41 86.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.034 1.734 . . . . 24.98 113.694 163.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.351 55.6 mt -54.27 -43.24 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.773 -3.08 . . . . 9.4600000000000009 116.629 165.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -66.78 -42.56 85.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.939 1.696 . . . . 14.76 107.031 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -61.53 -59.44 5.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.898 -1.752 . . . . 26.289999999999999 113.206 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -61.09 -72.27 0.12 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.806 2.842 . . . . 30.059999999999999 112.121 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -77.25 -44.26 30.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 113.473 0.916 . . . . 25.190000000000001 113.473 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.92 43.0 2.71 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 129.61 3.481 . . . . 7.4100000000000001 116.96 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 mt -111.25 117.82 48.86 Favored Pre-proline 0 N--CA 1.43 -1.427 0 O-C-N 121.394 -1.062 . . . . 9.4900000000000002 111.195 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.66 160.2 31.49 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-O 124.828 1.928 . . . . 11.42 114.784 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HA ' ' HG3' ' A' ' 41' ' ' GLN . 69.7 Cg_endo -86.57 -2.23 8.36 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 114.827 -3.302 . . . . 12.0 111.152 -155.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -88.63 -1.63 58.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 124.428 3.286 . . . . 35.549999999999997 112.142 164.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -99.22 -31.07 11.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.334 2.716 . . . . 20.52 118.334 169.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 5.4 pt20 -109.2 152.49 25.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.334 1.854 . . . . 7.1299999999999999 111.893 -176.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -148.45 154.25 39.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.822 -1.547 . . . . 36.390000000000001 106.822 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.7 mt -119.3 148.95 42.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.251 -1.759 . . . . 9.5500000000000007 106.251 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -127.06 136.64 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 114.161 -1.381 . . . . 13.9 107.537 171.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -114.46 107.94 16.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.766 1.746 . . . . 6.8600000000000003 107.769 169.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.289 . . 61.89 -68.01 0.06 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.159 3.384 . . . . 11.15 111.155 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -148.53 -16.56 0.11 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 105.961 -2.856 . . . . 13.93 105.961 -172.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' H ' ' H ' ' A' ' 47' ' ' GLY . 51.3 mtpt -88.08 131.26 34.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 126.334 2.968 . . . . 23.920000000000002 115.349 174.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -88.6 120.86 30.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.422 -3.923 . . . . 23.23 108.483 -172.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.4 mt -82.72 145.02 29.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.051 2.241 . . . . 9.1099999999999994 117.051 -167.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -110.54 139.17 46.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.229 2.918 . . . . 33.439999999999998 106.388 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.22 -41.2 64.02 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.039 -1.891 . . . . 28.370000000000001 112.46 -159.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.11 31.74 4.94 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 121.476 1.944 . . . . 15.0 115.584 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -106.67 -175.33 2.76 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 128.043 2.849 . . . . 25.5 116.257 155.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.7 p -113.27 177.47 4.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.56 1.544 . . . . 11.949999999999999 111.311 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.84 -22.65 45.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.066 1.136 . . . . 10.17 114.066 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -74.93 -25.61 59.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.698 -3.126 . . . . 13.59 111.637 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -67.85 -53.77 24.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.092 -2.255 . . . . 11.699999999999999 114.481 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -81.56 -17.11 49.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 118.726 -0.654 . . . . 12.949999999999999 110.487 -174.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 0.3 OUTLIER 81.51 55.69 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.208 2.432 . . . . 25.449999999999999 106.214 -173.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -90.87 101.4 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 1 O-C-N 116.263 -4.023 . . . . 14.6 108.914 171.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 62' ' ' GLN 0.322 12.9 pt20 -90.99 176.0 6.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.247 0.967 . . . . 33.229999999999997 112.001 -171.156 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -70.69 148.08 48.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 120.944 3.683 . . . . 25.969999999999999 120.944 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.425 24.1 mt-10 51.59 32.64 9.34 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.107 2.861 . . . . 32.609999999999999 117.193 -171.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 166.55 10.39 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.365 1.866 . . . . 10.56 108.58 -174.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.0 m -115.99 132.66 56.59 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 112.625 -2.08 . . . . 5.3300000000000001 110.362 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.45 150.0 28.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 131.148 3.779 . . . . 11.66 107.315 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -105.54 114.75 29.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.771 -1.104 . . . . 16.300000000000001 111.246 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 tp -78.18 130.8 36.76 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.202 -2.811 . . . . 9.9600000000000009 108.732 169.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.3 167.45 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 112.703 -2.044 . . . . 9.7599999999999998 111.251 156.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 105.457 -2.053 . . . . 19.57 105.457 -175.973 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.289 0.8 OUTLIER . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 113.715 1.006 . . . . 17.170000000000002 113.715 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -79.01 135.87 37.02 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.087 -4.758 . . . . 21.890000000000001 113.134 169.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -120.57 155.54 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.845 -2.409 . . . . 10.83 104.746 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -107.96 123.79 49.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.728 1.611 . . . . 10.609999999999999 114.594 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.6 t -109.37 114.9 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 126.087 2.117 . . . . 9.1300000000000008 111.554 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -101.18 122.61 43.93 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.379 -2.075 . . . . 20.550000000000001 111.38 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -79.08 168.95 18.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.389 2.276 . . . . 11.779999999999999 114.016 -175.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.43 -16.35 57.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 118.866 2.913 . . . . 19.309999999999999 118.866 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 p -76.71 -50.68 13.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.647 -1.615 . . . . 23.140000000000001 112.393 166.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.94 39.87 0.19 Allowed Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 125.259 2.589 . . . . 19.739999999999998 118.911 162.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -99.27 124.85 44.68 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.692 2.397 . . . . 21.93 112.642 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.277 7.1 m -82.85 97.7 8.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.065 -2.272 . . . . 12.33 110.553 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.7 mt -72.89 123.18 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 106.527 -1.657 . . . . 17.079999999999998 106.527 170.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 p -101.21 110.66 22.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.228 2.211 . . . . 16.300000000000001 111.427 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.4 mt -118.51 143.82 46.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.697 -1.877 . . . . 15.880000000000001 106.913 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -109.85 121.61 45.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.859 2.464 . . . . 28.899999999999999 106.891 170.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.94 172.73 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.141 0.972 . . . . 12.050000000000001 111.331 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -111.5 160.57 28.9 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 118.727 -2.483 . . . . 18.170000000000002 113.27 171.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -86.46 3.31 6.88 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 CA-C-N 125.996 3.177 . . . . 8.1600000000000001 116.611 -162.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 m -92.98 4.65 53.61 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.274 2.23 . . . . 11.130000000000001 109.689 167.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -70.46 131.42 44.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.363 2.801 . . . . 18.030000000000001 117.262 161.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.1 p -74.3 158.94 33.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.358 -3.339 . . . . 10.220000000000001 114.542 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.508 ' HA ' HD13 ' A' ' 23' ' ' ILE . 30.1 mm -57.2 -28.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 112.178 0.436 . . . . 12.300000000000001 112.178 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -55.93 -46.26 78.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.83 2.728 . . . . 36.509999999999998 111.424 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -63.95 -45.22 90.13 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.307 -2.745 . . . . 25.66 112.399 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.4 t -57.63 -44.91 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.038 -1.664 . . . . 8.1199999999999992 114.426 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -60.11 -32.29 70.85 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 119.246 3.054 . . . . 15.470000000000001 119.246 165.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.42 82.55 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.05 -4.156 . . . . 11.449999999999999 114.661 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -66.03 -21.54 66.39 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 120.02 3.341 . . . . 24.98 120.02 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -74.72 -41.61 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 120.235 -1.541 . . . . 9.4600000000000009 112.252 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -52.91 -59.64 4.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.605 1.962 . . . . 14.76 114.405 167.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -42.7 -44.73 4.44 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 119.301 3.075 . . . . 26.289999999999999 119.301 161.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -76.78 -49.12 16.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.866 -1.771 . . . . 30.059999999999999 110.374 -173.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -114.01 -17.61 11.92 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 115.9 1.815 . . . . 25.190000000000001 115.9 -160.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.29 29.38 19.84 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 124.726 1.155 . . . . 7.4100000000000001 115.016 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.7 mt -110.86 115.92 52.65 Favored Pre-proline 0 N--CA 1.43 -1.443 0 C-N-CA 129.067 2.947 . . . . 9.4900000000000002 109.603 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.512 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.7 Cg_exo -62.53 141.68 87.26 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 N-CA-C 121.672 3.682 . . . . 11.42 121.672 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.1 Cg_exo -74.95 -5.11 16.38 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 127.306 3.645 . . . . 12.0 116.89 -162.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -96.99 -21.06 17.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.016 -2.302 . . . . 35.549999999999997 109.762 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -69.75 -41.58 75.04 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 127.127 2.767 . . . . 20.52 110.873 168.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -60.57 141.71 56.3 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 114.976 1.473 . . . . 7.1299999999999999 114.976 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -132.42 151.65 51.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.375 -2.824 . . . . 36.390000000000001 103.375 150.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.1 mt -110.96 141.92 43.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 111.503 -2.59 . . . . 9.5500000000000007 111.407 166.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 mt -109.53 142.87 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 126.577 1.951 . . . . 13.9 109.194 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -131.5 129.68 41.41 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 123.503 2.865 . . . . 6.8600000000000003 111.762 157.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.12 44.38 5.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.351 -2.093 . . . . 11.15 109.118 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.81 -30.46 4.62 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 130.49 3.9 . . . . 13.93 114.372 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -94.9 132.73 39.4 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.421 2.058 . . . . 23.920000000000002 112.522 -167.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -76.29 137.72 40.08 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.896 -3.002 . . . . 23.23 109.262 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.9 mt -94.42 133.76 37.66 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.022 -2.298 . . . . 9.1099999999999994 112.658 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.95 173.59 8.14 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 124.9 3.5 . . . . 33.439999999999998 111.254 170.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.77 -51.87 10.59 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 124.947 1.404 . . . . 28.370000000000001 113.099 -159.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.72 -28.76 73.75 Favored Glycine 0 N--CA 1.43 -1.75 1 O-C-N 131.946 5.779 . . . . 15.0 120.041 -162.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.0 mtt180 -105.66 169.96 8.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 121.421 2.61 . . . . 25.5 111.329 -163.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 27.0 p -83.69 169.73 14.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.634 2.635 . . . . 11.949999999999999 114.865 -174.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.2 mt -73.24 -34.03 65.64 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.026 -1.671 . . . . 10.17 110.857 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 t -57.74 -40.02 78.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.472 2.027 . . . . 13.59 116.472 163.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -64.27 -49.89 70.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.518 1.673 . . . . 11.699999999999999 115.518 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -57.71 -41.18 81.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.557 1.543 . . . . 12.949999999999999 111.194 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 81.96 60.5 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.46 3.504 . . . . 25.449999999999999 111.41 -172.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.5 mt -103.0 103.74 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 128.823 2.849 . . . . 14.6 108.878 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -84.88 -179.36 7.07 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.587 2.137 . . . . 33.229999999999997 112.075 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -65.39 158.19 27.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.863 -3.648 . . . . 25.969999999999999 117.05 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 36.9 mt-10 55.19 27.51 9.75 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 129.473 3.109 . . . . 32.609999999999999 114.622 176.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.335 21.8 m -83.22 157.08 22.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 125.427 1.705 . . . . 10.56 114.516 164.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -110.67 95.3 5.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.702 -1.874 . . . . 5.3300000000000001 113.427 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.17 141.61 35.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.425 1.89 . . . . 11.66 112.316 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -116.4 114.02 23.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.505 -1.372 . . . . 16.300000000000001 114.192 -167.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -86.86 115.69 24.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.166 1.913 . . . . 9.9600000000000009 116.166 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.297 12.3 m -107.92 156.36 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 129.786 3.234 . . . . 9.7599999999999998 107.386 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.43 -1.458 0 CA-C-O 127.729 3.633 . . . . 19.57 106.821 -179.186 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 124.375 2.036 . . . . 17.170000000000002 110.69 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -94.03 135.97 34.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.198 -2.519 . . . . 21.890000000000001 104.198 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.2 pt -125.31 135.0 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 116.23 -1.843 . . . . 10.83 108.168 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.1 133.29 34.02 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.528 2.047 . . . . 10.609999999999999 116.528 166.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 t -126.9 109.14 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.55 -0.907 . . . . 9.1300000000000008 108.55 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -89.81 133.58 34.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.768 2.427 . . . . 20.550000000000001 113.644 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.6 p -89.54 -167.59 1.9 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.596 -1.184 . . . . 11.779999999999999 108.142 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mt -70.47 -66.49 0.59 Allowed 'General case' 0 N--CA 1.43 -1.435 1 C-N-CA 135.113 5.365 . . . . 19.309999999999999 114.845 166.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -63.74 -81.96 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.563 -2.585 . . . . 23.140000000000001 117.265 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.94 46.86 0.29 Allowed Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 117.908 -1.495 . . . . 19.739999999999998 110.798 -166.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -140.46 147.62 39.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 118.906 1.353 . . . . 21.93 110.758 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.4 m -129.51 137.03 50.57 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.203 2.43 . . . . 12.33 107.308 166.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.3 mt -105.62 121.7 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 118.821 -2.425 . . . . 17.079999999999998 106.009 -175.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.7 m -90.33 120.74 31.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 116.454 -1.736 . . . . 16.300000000000001 109.451 172.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.17 134.33 55.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.357 -1.782 . . . . 15.880000000000001 109.839 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -88.44 132.03 34.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 114.938 -2.458 . . . . 28.899999999999999 107.379 163.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.27 173.32 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 C-N-CA 133.288 4.635 . . . . 12.050000000000001 110.702 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -123.53 143.53 41.78 Favored Pre-proline 0 N--CA 1.43 -1.429 1 O-C-N 116.082 -4.136 . . . . 18.170000000000002 110.694 174.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -63.71 -28.66 68.75 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 123.761 2.379 . . . . 8.1600000000000001 117.558 -159.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.2 p -87.34 4.83 41.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 125.836 1.96 . . . . 11.130000000000001 110.489 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -72.88 151.81 41.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.856 3.025 . . . . 18.030000000000001 110.079 170.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -82.93 158.18 22.72 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 111.706 -2.497 . . . . 10.220000000000001 111.009 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.6 -29.02 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 O-C-N 121.07 -1.019 . . . . 12.300000000000001 110.641 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -48.99 -39.57 27.2 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.137 4.175 . . . . 36.509999999999998 116.834 158.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -89.32 -16.99 29.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.402 -3.936 . . . . 25.66 109.996 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -78.36 -35.28 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 O-C-N 115.51 -4.494 . . . . 8.1199999999999992 105.521 173.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -69.23 -29.58 67.54 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.675 2.655 . . . . 15.470000000000001 112.47 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.13 -34.19 69.98 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.012 -3.555 . . . . 11.449999999999999 114.932 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -84.17 -19.41 34.15 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.482 -2.145 . . . . 24.98 115.102 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mt -80.11 -35.02 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 116.048 -4.157 . . . . 9.4600000000000009 112.86 167.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.278 0.8 OUTLIER -54.11 -52.52 60.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.944 -2.348 . . . . 14.76 113.039 161.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -71.99 -27.17 62.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.835 2.107 . . . . 26.289999999999999 114.977 -174.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -74.4 -57.74 3.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.65 -3.156 . . . . 30.059999999999999 111.431 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.303 33.6 mm-40 -112.4 -29.08 7.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.676 -1.89 . . . . 25.190000000000001 110.926 -168.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.01 28.19 42.49 Favored Glycine 0 N--CA 1.429 -1.771 0 O-C-N 118.035 -2.916 . . . . 7.4100000000000001 117.314 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.427 HD13 HD21 ' A' ' 71' ' ' LEU . 43.4 mt -80.37 119.51 76.62 Favored Pre-proline 0 N--CA 1.43 -1.47 0 CA-C-O 115.318 -2.277 . . . . 9.4900000000000002 110.718 162.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -65.1 156.71 61.29 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 122.44 1.907 . . . . 11.42 114.003 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -11.96 33.74 Favored 'Trans proline' 0 N--CA 1.434 -2.021 1 C-N-CA 125.844 4.362 . . . . 12.0 120.671 -174.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -77.54 -38.22 49.17 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 125.206 2.431 . . . . 35.549999999999997 116.233 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -61.74 -32.31 72.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.141 2.645 . . . . 20.52 118.141 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -70.95 123.27 21.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.716 2.006 . . . . 7.1299999999999999 115.118 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -132.38 117.09 17.66 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.241 1.837 . . . . 36.390000000000001 109.738 165.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.74 115.89 27.43 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.006 1.322 . . . . 9.5500000000000007 111.988 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.6 mm -96.42 136.01 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 118.25 -0.881 . . . . 13.9 109.209 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -115.4 117.19 29.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.565 2.439 . . . . 6.8600000000000003 104.844 162.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.91 -93.08 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.075 2.95 . . . . 11.15 108.142 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.48 4.54 7.15 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 126.564 2.031 . . . . 13.93 109.051 171.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.39 144.1 31.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 121.653 2.727 . . . . 23.920000000000002 113.969 -171.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -69.46 137.99 53.09 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.399 2.37 . . . . 23.23 117.399 171.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -106.74 118.28 36.26 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.306 -3.996 . . . . 9.1099999999999994 108.62 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -85.41 151.04 24.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.017 1.865 . . . . 33.439999999999998 113.279 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.01 -49.12 72.33 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 118.038 2.607 . . . . 28.370000000000001 118.038 -170.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.75 77.54 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 119.792 2.677 . . . . 15.0 119.792 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 36.0 mmt180 -76.33 170.56 16.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.75 -3.206 . . . . 25.5 113.104 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.252 69.8 p -100.0 167.36 10.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.678 2.18 . . . . 11.949999999999999 113.174 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mt -54.45 -45.87 73.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.338 2.255 . . . . 10.17 111.909 164.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -76.24 -22.18 55.48 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.841 -1.527 . . . . 13.59 112.689 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -67.43 -48.3 67.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.933 2.093 . . . . 11.699999999999999 109.152 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 55.5 m-85 -85.08 4.7 32.87 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.995 2.591 . . . . 12.949999999999999 117.995 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.9 m120 65.96 45.61 2.42 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.458 2.303 . . . . 25.449999999999999 110.079 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.2 mt -98.18 108.62 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 127.034 2.134 . . . . 14.6 107.91 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -107.93 -172.87 2.15 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.923 2.297 . . . . 33.229999999999997 106.619 -168.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -73.84 134.5 43.32 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.418 -5.176 . . . . 25.969999999999999 109.895 -173.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.326 88.8 mt-10 68.96 30.22 4.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.522 3.014 . . . . 32.609999999999999 113.536 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -56.31 149.05 17.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 122.172 2.26 . . . . 10.56 110.56 167.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.0 m -106.71 110.94 23.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.536 2.397 . . . . 5.3300000000000001 104.794 159.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.8 mt -99.53 145.29 27.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.325 -2.734 . . . . 11.66 107.886 170.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -104.61 116.78 32.66 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.351 -1.468 . . . . 16.300000000000001 110.509 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.4 tp -95.62 115.26 27.17 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.497 1.498 . . . . 9.9600000000000009 107.8 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.5 m -109.04 143.92 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.761 1.743 . . . . 9.7599999999999998 109.278 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.427 HD21 HD13 ' A' ' 36' ' ' ILE . 46.9 mt . . . . . 0 N--CA 1.429 -1.489 0 CA-C-N 113.699 -1.591 . . . . 19.57 114.701 -168.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptt? . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 120.436 0.16 . . . . 17.170000000000002 111.175 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -94.04 131.32 39.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.766 1.765 . . . . 21.890000000000001 115.766 170.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -103.13 152.55 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 103.741 -2.688 . . . . 10.83 103.741 163.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -101.82 146.82 27.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.861 2.743 . . . . 10.609999999999999 110.239 162.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.15 113.67 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 110.121 -3.218 . . . . 9.1300000000000008 104.489 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.272 9.2 ttmt -107.12 127.32 53.39 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.472 -3.268 . . . . 20.550000000000001 110.852 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -95.97 170.38 9.33 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.93 -2.981 . . . . 11.779999999999999 109.736 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -68.27 -31.83 71.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.447 2.017 . . . . 19.309999999999999 116.447 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -53.62 -64.63 0.76 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.704 -3.123 . . . . 23.140000000000001 111.823 166.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.87 76.1 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 106.57 -2.612 . . . . 19.739999999999998 106.57 170.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -140.74 153.89 46.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 113.351 -3.339 . . . . 21.93 104.036 163.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -108.75 87.79 2.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.048 2.718 . . . . 12.33 109.811 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.22 124.11 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 124.208 1.956 . . . . 17.079999999999998 112.305 168.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.5 m -99.71 111.1 23.47 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.019 -2.355 . . . . 16.300000000000001 111.826 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.19 133.86 51.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.186 -2.34 . . . . 15.880000000000001 110.239 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -96.1 106.68 18.89 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 116.667 -1.635 . . . . 28.899999999999999 110.727 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.48 158.82 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 128.187 3.429 . . . . 12.050000000000001 107.063 -174.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -108.94 157.85 35.79 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 107.139 -1.43 . . . . 18.170000000000002 107.139 173.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.82 -8.86 16.93 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 O-C-N 116.008 -2.68 . . . . 8.1600000000000001 114.239 -168.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.4 p -82.81 1.75 37.56 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 118.432 2.752 . . . . 11.130000000000001 118.432 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -83.52 156.88 22.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.726 -3.109 . . . . 18.030000000000001 111.116 169.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -93.83 164.23 13.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.471 -3.893 . . . . 10.220000000000001 115.048 -174.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.67 -39.09 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 119.782 -1.824 . . . . 12.300000000000001 109.917 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.39 -43.78 23.73 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.214 2.672 . . . . 36.509999999999998 118.214 165.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -67.08 -43.19 83.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.628 2.085 . . . . 25.66 116.628 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -53.24 -52.99 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.029 1.732 . . . . 8.1199999999999992 110.469 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -70.79 -19.99 62.64 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.81 -3.681 . . . . 15.470000000000001 116.832 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.08 65.69 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.872 -4.267 . . . . 11.449999999999999 115.056 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -84.51 -28.02 27.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.033 2.933 . . . . 24.98 114.513 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.7 mt -72.89 -44.91 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.168 -1.378 . . . . 9.4600000000000009 111.229 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -52.14 -50.13 62.35 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.862 2.912 . . . . 14.76 118.862 165.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -49.59 -48.47 48.73 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.974 1.842 . . . . 26.289999999999999 115.974 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -78.67 -71.76 0.42 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.088 3.328 . . . . 30.059999999999999 115.488 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -74.15 -35.26 64.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.513 -3.867 . . . . 25.190000000000001 116.799 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.47 42.73 7.72 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 127.676 3.931 . . . . 7.4100000000000001 113.433 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.4 mt -104.44 137.72 19.31 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 102.822 -3.029 . . . . 9.4900000000000002 102.822 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -82.48 146.78 13.83 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 CA-C-N 124.813 2.755 . . . . 11.42 108.821 -174.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -70.78 -3.37 12.55 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 124.265 2.559 . . . . 12.0 115.806 -162.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.42 -22.15 19.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.769 -2.457 . . . . 35.549999999999997 110.667 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -80.16 -25.86 39.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.456 3.102 . . . . 20.52 109.794 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HB3' HD11 ' A' ' 69' ' ' LEU . 76.8 mt-30 -71.7 121.73 19.37 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.786 2.034 . . . . 7.1299999999999999 112.071 170.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -123.1 116.7 23.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.953 1.835 . . . . 36.390000000000001 111.268 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.1 tp -102.61 116.41 32.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.953 -1.476 . . . . 9.5500000000000007 111.976 -166.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mm -103.79 117.17 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 125.92 1.688 . . . . 13.9 109.022 -172.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -97.03 114.44 26.07 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 120.919 1.69 . . . . 6.8600000000000003 108.93 161.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.89 -98.09 0.06 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 123.892 0.877 . . . . 11.15 111.397 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.85 12.06 8.25 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 127.321 2.391 . . . . 13.93 113.863 166.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -102.19 126.05 49.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.561 -3.905 . . . . 23.920000000000002 105.837 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -85.43 126.81 34.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 125.157 1.535 . . . . 23.23 108.059 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.8 mt -90.14 144.86 25.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.44 2.543 . . . . 9.1099999999999994 116.003 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -100.91 146.76 26.94 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.666 -4.396 . . . . 33.439999999999998 110.077 -168.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -45.17 -54.45 6.87 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 129.114 2.965 . . . . 28.370000000000001 118.373 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.54 24.56 8.34 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 129.324 3.345 . . . . 15.0 114.593 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -115.63 171.75 7.55 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.849 -1.537 . . . . 25.5 106.849 172.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.8 p -104.86 -177.45 3.37 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.311 -0.859 . . . . 11.949999999999999 112.195 172.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.8 mt -80.31 -28.01 38.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.309 -1.769 . . . . 10.17 110.541 169.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -65.95 -43.18 88.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.72 -3.113 . . . . 13.59 116.437 170.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.298 10.8 m-20 -49.75 -39.84 38.98 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.241 2.682 . . . . 11.699999999999999 118.241 165.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -94.29 -18.72 21.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.549 -2.594 . . . . 12.949999999999999 116.88 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 73.57 54.52 0.11 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.418 2.949 . . . . 25.449999999999999 110.104 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mt -93.83 120.7 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 113.73 -1.577 . . . . 14.6 109.487 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -89.48 168.76 11.94 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.992 1.853 . . . . 33.229999999999997 108.406 -167.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -64.12 153.95 36.11 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.815 -3.678 . . . . 25.969999999999999 109.764 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 41.23 35.11 0.37 Allowed 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 113.808 -5.557 . . . . 32.609999999999999 118.621 -169.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -91.88 129.24 37.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.572 -3.205 . . . . 10.56 108.341 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -87.77 122.54 31.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.832 1.049 . . . . 5.3300000000000001 113.832 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.341 1.5 mt -101.63 149.8 23.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.086 -2.259 . . . . 11.66 110.255 170.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -98.22 130.93 44.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.491 -1.38 . . . . 16.300000000000001 107.539 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 41' ' ' GLN . 40.5 tp -114.46 115.58 27.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.47 -2.789 . . . . 9.9600000000000009 103.47 -171.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.11 164.98 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.518 -2.03 . . . . 9.7599999999999998 105.518 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.6 mt . . . . . 0 N--CA 1.431 -1.415 0 CA-C-O 123.941 1.829 . . . . 19.57 109.787 177.855 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 108.957 -0.757 . . . . 17.170000000000002 108.957 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -103.34 144.7 31.01 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 116.223 -4.048 . . . . 21.890000000000001 111.849 -176.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.83 160.69 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 109.095 -3.684 . . . . 10.83 107.901 164.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -125.19 112.56 16.59 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.088 2.743 . . . . 10.609999999999999 105.558 -166.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 67' ' ' LEU . 48.2 t -104.94 125.42 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.817 -1.179 . . . . 9.1300000000000008 107.817 -174.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.445 ' HG2' HG23 ' A' ' 12' ' ' THR . 79.6 mttt -121.3 127.18 51.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.419 2.372 . . . . 20.550000000000001 111.621 -167.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.439 HG22 HD23 ' A' ' 69' ' ' LEU . 30.3 p -70.67 169.86 13.52 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 112.642 -2.072 . . . . 11.779999999999999 111.047 168.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.3 mt -81.59 -12.69 58.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.921 -2.987 . . . . 19.309999999999999 112.55 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -91.27 -37.32 13.37 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 124.199 1.952 . . . . 23.140000000000001 110.431 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.39 38.05 0.35 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 116.53 -2.261 . . . . 19.739999999999998 111.871 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -98.99 138.74 35.66 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.741 -2.688 . . . . 21.93 103.741 172.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.445 HG23 ' HG2' ' A' ' 6' ' ' LYS . 76.1 m -114.97 122.81 47.41 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.603 -1.31 . . . . 12.33 108.572 -172.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -101.47 128.76 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 101.721 -3.437 . . . . 17.079999999999998 101.721 -170.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.6 m -112.59 112.76 24.51 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.461 2.076 . . . . 16.300000000000001 111.999 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.264 73.0 mt -116.25 158.91 22.61 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 111.839 -2.437 . . . . 15.880000000000001 112.685 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -113.39 117.52 31.99 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.77 -2.678 . . . . 28.899999999999999 103.77 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.23 154.87 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 115.447 -0.797 . . . . 12.050000000000001 108.874 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -94.66 147.46 33.23 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 117.517 -1.23 . . . . 18.170000000000002 109.173 170.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -66.15 -8.66 20.9 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 127.629 3.76 . . . . 8.1600000000000001 118.994 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -100.18 12.5 36.85 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 129.642 4.339 . . . . 11.130000000000001 120.847 164.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.55 163.99 26.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.141 -1.424 . . . . 18.030000000000001 111.47 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.0 p -104.25 164.45 11.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.624 2.083 . . . . 10.220000000000001 116.624 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.1 mm -63.57 -36.09 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.943 2.497 . . . . 12.300000000000001 111.814 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -53.52 -45.08 69.62 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.48 1.659 . . . . 36.509999999999998 115.48 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.17 -41.52 94.58 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.822 2.849 . . . . 25.66 114.729 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.56 -52.99 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 118.682 -2.511 . . . . 8.1199999999999992 105.635 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -58.69 -35.37 72.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.579 2.609 . . . . 15.470000000000001 116.014 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.28 94.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.776 -1.827 . . . . 11.449999999999999 114.447 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -74.28 -26.59 60.29 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 115.637 -2.125 . . . . 24.98 108.775 -174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.9 mt -66.92 -29.75 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 124.895 2.283 . . . . 9.4600000000000009 110.599 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -66.91 -48.3 69.13 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.96 -4.212 . . . . 14.76 114.463 175.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -62.36 -48.39 79.99 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.397 1.999 . . . . 26.289999999999999 116.397 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -69.95 -67.15 0.51 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.445 2.069 . . . . 30.059999999999999 109.707 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.04 -22.12 31.38 Favored 'General case' 0 N--CA 1.43 -1.425 1 O-C-N 115.838 -4.289 . . . . 25.190000000000001 118.75 -165.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.08 27.9 14.92 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 126.106 1.813 . . . . 7.4100000000000001 111.874 171.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 36' ' ' ILE . 11.1 mt -104.82 125.06 34.82 Favored Pre-proline 0 N--CA 1.43 -1.45 0 C-N-CA 125.908 1.683 . . . . 9.4900000000000002 109.35 -173.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.65 146.33 30.31 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 122.91 2.075 . . . . 11.42 114.748 -176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.98 -7.27 12.24 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 124.908 2.788 . . . . 12.0 111.269 -162.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.74 -19.04 64.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.024 2.93 . . . . 35.549999999999997 114.166 169.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -104.91 -10.32 17.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.558 2.743 . . . . 20.52 109.102 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -94.65 137.12 34.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.468 -2.02 . . . . 7.1299999999999999 106.068 -173.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -121.81 140.98 51.69 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.704 -1.591 . . . . 36.390000000000001 106.704 162.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.26 136.64 54.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.922 -1.111 . . . . 9.5500000000000007 108.004 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.8 mm -118.34 129.46 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.058 2.143 . . . . 13.9 110.904 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -128.46 117.23 20.98 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.835 -3.666 . . . . 6.8600000000000003 108.328 169.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.34 . . 58.37 -91.56 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.416 1.887 . . . . 11.15 114.338 -166.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.18 26.08 2.33 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.256 -2.153 . . . . 13.93 112.309 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -115.12 155.33 27.29 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.119 2.568 . . . . 23.920000000000002 104.177 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -114.14 137.09 52.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.145 -2.847 . . . . 23.23 106.163 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.521 HD22 ' CE2' ' A' ' 59' ' ' TYR . 30.1 mt -81.77 154.26 26.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.848 2.166 . . . . 9.1099999999999994 116.848 -167.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -102.11 157.31 16.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.994 2.33 . . . . 33.439999999999998 111.541 172.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -76.75 -52.34 9.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 118.789 2.885 . . . . 28.370000000000001 118.789 -161.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.82 24.49 5.15 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 116.908 -2.568 . . . . 15.0 118.384 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -90.23 167.29 12.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.952 2.876 . . . . 25.5 111.125 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.1 p -90.24 166.85 13.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.694 -2.504 . . . . 11.949999999999999 116.083 171.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.483 HD22 ' H ' ' A' ' 56' ' ' LEU . 2.8 mm? -54.15 -31.94 53.95 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.658 -1.901 . . . . 10.17 114.346 158.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -74.72 -42.08 58.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.006 -1.077 . . . . 13.59 109.619 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -47.95 -34.37 9.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 114.979 -2.438 . . . . 11.699999999999999 115.03 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.521 ' CE2' HD22 ' A' ' 50' ' ' LEU . 93.3 m-85 -104.89 -0.87 26.64 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 121.96 2.164 . . . . 12.949999999999999 107.273 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.5 m120 71.6 46.25 0.41 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.738 2.815 . . . . 25.449999999999999 105.579 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mt -82.6 106.67 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 O-C-N 117.998 -2.939 . . . . 14.6 108.792 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -96.07 -175.11 3.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.148 1.53 . . . . 33.229999999999997 111.02 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -65.76 141.91 58.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 124.674 3.397 . . . . 25.969999999999999 112.851 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.362 15.3 tt0 80.19 21.08 0.52 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.202 2.601 . . . . 32.609999999999999 113.993 174.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.6 m -80.69 144.76 32.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.243 3.417 . . . . 10.56 113.243 -174.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -98.78 101.97 13.55 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.212 2.605 . . . . 5.3300000000000001 115.009 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.6 mp -99.94 130.8 46.15 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.119 -3.488 . . . . 11.66 109.233 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.261 17.2 m-70 -101.01 142.91 31.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.786 -2.446 . . . . 16.300000000000001 108.755 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.439 HD23 HG22 ' A' ' 7' ' ' THR . 19.1 tp -119.86 101.86 8.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.522 -0.763 . . . . 9.9600000000000009 109.929 -171.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.0 t -96.2 119.0 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 126.493 3.044 . . . . 9.7599999999999998 108.387 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.43 -1.472 0 O-C-N 119.036 -2.29 . . . . 19.57 105.551 176.973 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 122.937 1.351 . . . . 17.170000000000002 112.899 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -94.25 145.93 24.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 127.646 3.593 . . . . 21.890000000000001 108.254 177.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -130.88 167.5 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 103.777 -2.675 . . . . 10.83 103.777 172.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -126.81 137.18 53.16 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 102.841 -3.022 . . . . 10.609999999999999 102.841 -174.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.75 135.44 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.2 -1.778 . . . . 9.1300000000000008 106.2 171.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -135.38 135.46 40.69 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.486 2.403 . . . . 20.550000000000001 112.769 173.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.515 HG22 HD23 ' A' ' 69' ' ' LEU . 68.2 p -77.87 173.07 12.53 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 113.601 -1.636 . . . . 11.779999999999999 113.573 173.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.73 -28.23 62.52 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.124 -2.86 . . . . 19.309999999999999 112.524 -172.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.6 p -75.11 -36.5 61.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.357 -3.339 . . . . 23.140000000000001 109.953 166.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.12 42.25 0.37 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 120.972 3.149 . . . . 19.739999999999998 120.972 170.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -88.98 115.51 26.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.844 1.794 . . . . 21.93 115.844 176.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 m -92.18 114.24 26.73 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.162 2.585 . . . . 12.33 108.343 -165.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.0 mt -105.07 102.83 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 106.343 -1.725 . . . . 17.079999999999998 106.343 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -87.42 115.52 24.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 116.062 1.875 . . . . 16.300000000000001 116.062 175.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.7 mt -123.95 151.44 43.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.246 -1.835 . . . . 15.880000000000001 115.396 -174.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.5 138.55 31.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.388 1.055 . . . . 28.899999999999999 109.651 176.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.305 0.1 OUTLIER -144.84 161.43 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.85 -1.907 . . . . 12.050000000000001 105.85 170.235 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -103.23 165.84 12.88 Favored Pre-proline 0 N--CA 1.429 -1.477 0 CA-C-O 115.685 -2.103 . . . . 18.170000000000002 106.721 164.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.39 -9.64 14.94 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 124.829 2.76 . . . . 8.1600000000000001 115.342 -178.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 p -84.13 -19.02 34.91 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 129.766 4.416 . . . . 11.130000000000001 109.263 169.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -61.17 149.84 36.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 118.44 -1.304 . . . . 18.030000000000001 114.395 167.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.292 35.5 p -78.17 174.8 10.79 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.068 -3.52 . . . . 10.220000000000001 116.06 171.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 50' ' ' LEU . 28.7 mt -93.59 -17.42 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 117.224 -3.423 . . . . 12.300000000000001 107.743 -176.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -72.46 -40.57 66.89 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 131.751 4.02 . . . . 36.509999999999998 107.298 172.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -51.41 -49.82 60.86 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 130.969 3.708 . . . . 25.66 112.457 169.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.18 -52.25 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 124.371 1.044 . . . . 8.1199999999999992 113.075 173.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.73 -29.55 70.08 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 126.45 1.9 . . . . 15.470000000000001 111.066 -178.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.77 -27.24 62.82 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 115.221 -2.591 . . . . 11.449999999999999 116.56 175.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -72.41 -18.65 61.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.531 1.678 . . . . 24.98 115.531 168.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.3 mt -75.38 -27.96 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 112.494 0.553 . . . . 9.4600000000000009 112.494 170.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.341 18.1 tt0 -52.31 -42.85 64.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.314 1.968 . . . . 14.76 116.314 160.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -78.11 -49.01 14.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.551 1.54 . . . . 26.289999999999999 110.116 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -79.63 -58.8 3.01 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.917 2.932 . . . . 30.059999999999999 118.917 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.313 6.6 mm-40 -74.53 -44.05 52.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 113.478 0.918 . . . . 25.190000000000001 113.478 -177.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.76 53.96 3.05 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 128.369 2.89 . . . . 7.4100000000000001 107.372 -171.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -118.18 120.1 32.68 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 102.384 -3.191 . . . . 9.4900000000000002 102.384 174.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -72.85 154.48 53.62 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 CA-C-N 122.825 2.045 . . . . 11.42 114.094 176.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -62.48 -16.47 52.27 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 N-CA-C 118.666 2.525 . . . . 12.0 118.666 -173.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -76.24 -31.32 58.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 117.607 -1.187 . . . . 35.549999999999997 111.948 -174.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -78.4 -18.07 55.53 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 127.4 2.937 . . . . 20.52 114.447 170.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -82.02 122.57 27.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.919 -1.738 . . . . 7.1299999999999999 114.577 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -111.29 120.8 43.46 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.412 -2.44 . . . . 36.390000000000001 104.412 166.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.7 mt -96.32 106.96 19.25 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.339 -2.1 . . . . 9.5500000000000007 112.26 164.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -89.53 145.28 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 O-C-N 125.619 1.825 . . . . 13.9 108.059 173.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -122.83 107.78 12.26 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.086 -1.82 . . . . 6.8600000000000003 106.086 170.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.0 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.4 3.48 . . . . 11.15 111.817 -160.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.74 1.08 9.33 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 116.629 -3.795 . . . . 13.93 114.937 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -102.45 126.88 49.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.717 -2.637 . . . . 23.920000000000002 113.349 177.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -72.59 125.3 27.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.205 1.821 . . . . 23.23 111.168 171.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.506 HD22 ' CD2' ' A' ' 59' ' ' TYR . 63.4 mt -81.92 166.3 20.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.54 1.064 . . . . 9.1099999999999994 110.479 -174.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -98.65 158.18 15.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.868 -1.77 . . . . 33.439999999999998 113.02 167.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.58 -56.25 6.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.286 2.234 . . . . 28.370000000000001 112.163 -174.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.45 13.93 31.93 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 118.272 -2.768 . . . . 15.0 118.852 -175.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -106.79 159.15 16.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.619 2.368 . . . . 25.5 107.401 172.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -103.37 170.89 7.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 111.385 -2.643 . . . . 11.949999999999999 112.874 -173.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.411 HD22 ' H ' ' A' ' 56' ' ' LEU . 1.3 mm? -58.35 -43.14 88.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 126.18 2.175 . . . . 10.17 111.654 174.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -53.84 -35.2 61.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.686 2.794 . . . . 13.59 115.994 174.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 14.9 m-20 -80.91 -25.25 37.66 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 112.763 -3.494 . . . . 11.699999999999999 114.51 -171.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.506 ' CD2' HD22 ' A' ' 50' ' ' LEU . 80.4 m-85 -95.8 -10.32 29.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 128.879 3.862 . . . . 12.949999999999999 110.538 171.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.2 m120 77.72 45.64 0.07 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.542 3.537 . . . . 25.449999999999999 113.583 173.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -74.56 140.23 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 127.788 2.435 . . . . 14.6 109.141 170.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -97.79 175.98 5.97 Favored 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 132.926 4.49 . . . . 33.229999999999997 108.759 178.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -68.35 156.11 38.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.094 1.887 . . . . 25.969999999999999 116.094 162.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 56.62 17.58 3.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.12 1.438 . . . . 32.609999999999999 114.1 -178.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -85.03 154.05 22.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.915 -2.991 . . . . 10.56 110.262 177.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -99.73 109.96 22.38 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 111.979 -2.373 . . . . 5.3300000000000001 114.517 -178.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -86.1 156.38 20.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 128.773 3.795 . . . . 11.66 110.111 171.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -112.07 140.57 46.64 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 116.915 -3.616 . . . . 16.300000000000001 109.014 178.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.515 HD23 HG22 ' A' ' 7' ' ' THR . 48.8 tp -110.53 119.55 39.54 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.854 -1.975 . . . . 9.9600000000000009 110.484 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.45 135.18 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 101.855 -3.387 . . . . 9.7599999999999998 101.855 -178.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mt . . . . . 0 N--CA 1.429 -1.487 0 N-CA-C 104.555 -2.387 . . . . 19.57 104.555 -179.016 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 114.851 -2.5 . . . . 17.170000000000002 116.933 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -90.62 132.57 35.68 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.964 -1.493 . . . . 21.890000000000001 107.101 -179.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -119.64 153.28 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.938 -1.875 . . . . 10.83 105.938 162.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -115.18 135.22 54.42 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.409 -2.682 . . . . 10.609999999999999 110.628 177.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -100.8 123.78 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.369 -2.707 . . . . 9.1300000000000008 107.487 176.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -108.8 128.28 54.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.458 1.099 . . . . 20.550000000000001 108.117 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.3 p -81.17 173.76 12.22 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 117.603 2.446 . . . . 11.779999999999999 117.603 -177.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.6 mt -67.56 -27.46 66.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.42 -2.05 . . . . 19.309999999999999 114.772 166.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -74.08 -48.78 27.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.501 2.32 . . . . 23.140000000000001 114.907 175.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 68.06 0.32 Allowed Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.483 -1.447 . . . . 19.739999999999998 109.483 178.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -139.63 160.35 40.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.927 -1.511 . . . . 21.93 111.259 164.101 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -124.27 109.61 13.59 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.008 2.068 . . . . 12.33 112.54 -166.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mp -96.96 132.01 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.477 -2.416 . . . . 17.079999999999998 104.477 -173.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.302 31.6 m -88.53 96.11 10.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.232 0.958 . . . . 16.300000000000001 112.891 -178.031 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.39 119.64 39.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.839 -1.944 . . . . 15.880000000000001 110.55 -169.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.79 123.01 32.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.958 -2.339 . . . . 28.899999999999999 114.772 169.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.34 154.06 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.744 2.818 . . . . 12.050000000000001 115.088 -172.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -107.57 158.33 33.54 Favored Pre-proline 0 N--CA 1.43 -1.435 0 CA-C-O 115.771 -2.061 . . . . 18.170000000000002 112.063 173.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.51 -21.45 40.07 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 123.314 2.219 . . . . 8.1600000000000001 117.216 -175.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -67.88 -11.84 59.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.692 3.597 . . . . 11.130000000000001 114.291 172.033 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -79.61 133.6 36.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.683 2.793 . . . . 18.030000000000001 113.592 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.8 p -74.2 154.43 39.04 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.881 1.672 . . . . 10.220000000000001 110.019 168.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 54' ' ' ARG . 4.3 mp -76.28 -9.24 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.528 -3.233 . . . . 12.300000000000001 114.778 174.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.01 -35.83 61.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 112.983 -3.389 . . . . 36.509999999999998 112.264 162.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -58.95 -42.28 89.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.17 2.414 . . . . 25.66 113.665 173.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -66.65 -34.38 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 113.472 -1.695 . . . . 8.1199999999999992 112.461 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -71.07 -30.5 66.65 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.971 2.319 . . . . 15.470000000000001 111.759 -179.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.09 -25.94 63.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.472 2.309 . . . . 11.449999999999999 114.917 174.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -88.22 -29.84 20.16 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.633 2.159 . . . . 24.98 109.1 -176.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.6 mt -74.65 -37.31 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 118.502 -2.624 . . . . 9.4600000000000009 116.048 169.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -47.42 -38.33 13.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 119.436 3.125 . . . . 14.76 119.436 159.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.273 10.9 t70 -71.77 -53.73 12.45 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 114.816 -2.516 . . . . 26.289999999999999 107.137 -176.14 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -71.75 -57.7 4.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.447 2.299 . . . . 30.059999999999999 112.483 -172.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -92.83 -38.5 11.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.567 -0.901 . . . . 25.190000000000001 108.567 -166.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.26 37.54 5.34 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 120.619 3.008 . . . . 7.4100000000000001 120.619 -173.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -98.61 127.6 35.32 Favored Pre-proline 0 N--CA 1.429 -1.476 0 O-C-N 119.619 -2.106 . . . . 9.4900000000000002 108.594 171.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.13 139.21 54.81 Favored 'Trans proline' 0 C--N 1.3 -1.997 1 CA-C-O 110.134 -4.194 . . . . 11.42 110.816 175.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -82.5 -7.44 11.7 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 CA-C-N 127.836 3.834 . . . . 12.0 117.129 -161.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -67.36 -32.68 73.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.165 3.786 . . . . 35.549999999999997 113.412 169.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -68.7 -50.45 50.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 111.41 -2.632 . . . . 20.52 116.251 168.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -59.69 145.07 46.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 118.891 2.923 . . . . 7.1299999999999999 118.891 -168.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -123.65 120.95 34.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 124.434 3.288 . . . . 36.390000000000001 109.523 167.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 43' ' ' LEU . 35.6 mt -103.97 121.45 43.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.633 -1.988 . . . . 9.5500000000000007 105.633 -178.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -118.13 129.26 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 102.436 -3.172 . . . . 13.9 102.436 -169.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -104.62 106.15 16.53 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.532 -3.855 . . . . 6.8600000000000003 106.77 170.09 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 72.5 -91.09 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 125.255 2.455 . . . . 11.15 116.748 -171.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.64 -19.24 4.18 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 111.716 -2.493 . . . . 13.93 111.966 168.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -88.67 121.42 31.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.181 -3.541 . . . . 23.920000000000002 111.375 -166.136 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -80.12 122.22 26.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.323 -3.986 . . . . 23.23 109.191 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.52 134.92 46.84 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 128.35 3.531 . . . . 9.1099999999999994 115.593 175.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -95.56 130.18 42.5 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.542 3.137 . . . . 33.439999999999998 111.583 -178.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.12 -42.41 69.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 110.944 -2.844 . . . . 28.370000000000001 111.703 -165.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.6 4.84 85.18 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 118.762 -2.461 . . . . 15.0 114.888 -176.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.49 ' O ' HD12 ' A' ' 23' ' ' ILE 0.27 95.0 mtt180 -95.0 163.65 13.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.005 2.402 . . . . 25.5 106.554 176.679 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.0 p -95.15 166.35 11.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.9 1.815 . . . . 11.949999999999999 115.9 168.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -64.18 -29.68 70.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.578 2.351 . . . . 10.17 111.835 168.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.251 8.5 t -67.73 -42.07 82.48 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.96 -4.213 . . . . 13.59 112.433 178.484 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -58.16 -42.84 86.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 117.19 2.293 . . . . 11.699999999999999 117.19 174.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -82.69 4.92 23.03 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 116.485 2.031 . . . . 12.949999999999999 116.485 170.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 m120 48.16 55.03 9.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.456 -2.653 . . . . 25.449999999999999 113.744 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.83 111.35 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 125.349 1.655 . . . . 14.6 106.744 -177.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -81.33 166.4 20.51 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.502 1.521 . . . . 33.229999999999997 111.343 174.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -63.06 158.87 18.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.553 1.541 . . . . 25.969999999999999 114.378 -171.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.289 38.5 mt-10 58.86 24.66 12.68 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.575 2.131 . . . . 32.609999999999999 116.534 -177.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m -77.71 125.63 29.63 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.113 -1.617 . . . . 10.56 113.687 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.9 m -80.06 126.48 31.12 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.593 1.557 . . . . 5.3300000000000001 112.002 174.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.405 HD13 HD22 ' A' ' 43' ' ' LEU . 80.3 mt -103.69 150.2 24.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.569 1.148 . . . . 11.66 108.527 169.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -101.43 124.38 47.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.318 -1.734 . . . . 16.300000000000001 106.318 170.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.8 tp -96.86 128.09 43.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.282 -1.747 . . . . 9.9600000000000009 106.282 171.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.63 155.23 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.735 -2.32 . . . . 9.7599999999999998 104.735 168.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 43.5 mt . . . . . 0 N--CA 1.43 -1.462 0 O-C-N 121.027 -1.045 . . . . 19.57 109.418 175.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 122.88 1.324 . . . . 17.170000000000002 111.403 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.76 110.65 21.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.134 -1.604 . . . . 21.890000000000001 108.132 -175.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -84.81 145.96 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.195 -1.566 . . . . 10.83 110.841 153.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -123.15 89.21 3.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.489 -2.782 . . . . 10.609999999999999 103.489 -172.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 62.0 t -80.7 123.17 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.181 -1.414 . . . . 9.1300000000000008 107.181 179.309 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -114.21 119.26 36.43 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.497 3.522 . . . . 20.550000000000001 110.977 -172.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.7 p -77.91 161.56 27.48 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.082 -4.761 . . . . 11.779999999999999 113.004 -176.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.6 mt -78.83 -21.78 47.15 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 117.34 -1.744 . . . . 19.309999999999999 109.657 -175.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.0 p -70.55 -43.71 68.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.083 -2.886 . . . . 23.140000000000001 114.16 173.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.66 -2.26 0.21 Allowed Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 118.173 2.029 . . . . 19.739999999999998 118.173 178.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -91.49 145.49 24.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.756 -1.222 . . . . 21.93 110.955 -167.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.6 m -115.63 115.35 26.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.873 -2.269 . . . . 12.33 104.873 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.8 mt -96.52 105.51 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.735 2.414 . . . . 17.079999999999998 107.318 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -74.59 119.92 19.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.563 1.649 . . . . 16.300000000000001 110.655 169.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.322 97.8 mt -130.46 134.62 47.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.333 2.968 . . . . 15.880000000000001 103.922 168.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.361 2.2 mt-10 -84.86 107.65 17.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 127.511 3.529 . . . . 28.899999999999999 113.678 169.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -116.87 171.34 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.031 -2.293 . . . . 12.050000000000001 108.978 177.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -114.72 160.29 33.94 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 127.895 2.478 . . . . 18.170000000000002 108.03 176.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -68.3 -24.5 37.36 Favored 'Trans proline' 0 N--CA 1.434 -1.978 0 O-C-N 116.216 -2.57 . . . . 8.1600000000000001 112.726 -170.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.391 7.1 m -88.12 -2.52 58.65 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.917 -1.739 . . . . 11.130000000000001 114.686 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -72.96 158.14 36.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 128.328 3.918 . . . . 18.030000000000001 114.84 174.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.414 43.1 p -95.47 149.62 21.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.296 -2.229 . . . . 10.220000000000001 114.804 -176.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mp -66.06 -37.3 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.513 -1.291 . . . . 12.300000000000001 107.513 173.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -50.27 -45.46 54.31 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.296 -2.128 . . . . 36.509999999999998 113.906 169.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -84.63 7.21 21.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 123.766 2.984 . . . . 25.66 112.797 177.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.269 23.5 t -77.42 -60.04 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 O-C-N 116.746 -3.721 . . . . 8.1199999999999992 107.255 159.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -43.65 -40.66 4.26 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.968 2.581 . . . . 15.470000000000001 117.968 175.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.315 . . -50.05 -47.47 53.38 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 128.079 2.552 . . . . 11.449999999999999 116.697 171.301 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -76.99 -30.94 56.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.102 -2.249 . . . . 24.98 108.252 -175.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.84 -31.75 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 O-C-N 115.967 -4.208 . . . . 9.4600000000000009 112.86 174.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -69.01 -33.34 73.49 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.161 -1.587 . . . . 14.76 109.611 176.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -76.16 -51.92 11.17 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.728 1.611 . . . . 26.289999999999999 115.109 177.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -76.91 -42.34 39.92 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 119.669 3.211 . . . . 30.059999999999999 119.669 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 48.2 mm-40 -106.4 -25.6 11.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.391 1.682 . . . . 25.190000000000001 110.69 -178.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.4 18.82 51.74 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 120.305 2.882 . . . . 7.4100000000000001 120.305 175.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.2 mt -91.12 126.85 53.72 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 101.32 -3.585 . . . . 9.4900000000000002 101.32 -175.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -56.06 151.56 41.74 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 N-CA-C 120.639 3.284 . . . . 11.42 120.639 171.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -86.02 -22.22 2.36 Favored 'Trans proline' 0 C--N 1.3 -2.014 1 CA-C-N 130.077 4.635 . . . . 12.0 116.128 -161.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -84.12 -23.09 30.87 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.37 2.033 . . . . 35.549999999999997 110.821 -174.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -61.52 -28.15 69.11 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.201 2.6 . . . . 20.52 114.385 162.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -87.8 122.93 32.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 116.716 -1.612 . . . . 7.1299999999999999 112.34 -170.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -113.97 131.24 56.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 122.363 2.347 . . . . 36.390000000000001 112.181 166.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.53 122.25 39.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.207 -3.433 . . . . 9.5500000000000007 114.698 171.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.7 mt -106.95 118.58 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.88 -2.267 . . . . 13.9 104.88 172.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' A' ' 50' ' ' LEU . 33.6 t80 -106.04 121.81 44.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.603 1.668 . . . . 6.8600000000000003 107.978 167.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.318 . . 52.55 -99.2 0.08 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.098 1.888 . . . . 11.15 116.098 -174.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.26 -17.82 13.18 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 117.554 1.782 . . . . 13.93 117.554 -173.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -109.6 133.08 53.52 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.513 2.725 . . . . 23.920000000000002 111.236 -165.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -79.63 128.25 33.17 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.655 -1.278 . . . . 23.23 108.719 173.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 45' ' ' PHE . 23.2 mt -95.05 126.52 40.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.782 2.083 . . . . 9.1099999999999994 115.856 -165.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 54' ' ' ARG . 34.2 tt0 -82.28 139.38 34.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.786 2.232 . . . . 33.439999999999998 111.308 171.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.24 -50.16 61.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.157 2.583 . . . . 28.370000000000001 113.471 -160.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.03 3.93 86.53 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 127.385 2.421 . . . . 15.0 113.34 -162.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 51' ' ' GLU 0.284 22.6 mtt180 -85.5 162.52 18.9 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.988 2.115 . . . . 25.5 111.689 172.925 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -88.91 168.4 12.43 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 116.563 -2.055 . . . . 11.949999999999999 110.562 178.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.94 -25.25 60.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.994 -1.912 . . . . 10.17 111.655 169.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.8 t -63.77 -41.61 97.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.652 2.093 . . . . 13.59 116.652 172.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -47.31 -46.93 25.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.626 2.631 . . . . 11.699999999999999 116.259 175.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -86.14 1.24 51.3 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.122 -2.236 . . . . 12.949999999999999 115.601 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.37 17.3 m-20 75.98 32.45 0.64 Allowed 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.734 2.683 . . . . 25.449999999999999 113.501 169.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.56 113.85 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.35 -2.719 . . . . 14.6 109.129 -170.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -111.29 -171.11 1.77 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.284 1.992 . . . . 33.229999999999997 109.182 -174.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -71.36 148.13 47.32 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 115.142 -2.361 . . . . 25.969999999999999 112.773 -168.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 49.65 29.48 3.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 119.728 3.233 . . . . 32.609999999999999 119.728 -165.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -68.66 148.26 50.69 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 116.091 1.885 . . . . 10.56 116.091 170.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -104.08 117.63 34.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 121.235 0.541 . . . . 5.3300000000000001 110.805 171.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.37 151.04 25.4 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.364 -3.335 . . . . 11.66 108.343 175.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -93.77 130.03 39.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.35 1.656 . . . . 16.300000000000001 115.038 178.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.5 tp -109.69 95.12 5.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.315 2.007 . . . . 9.9600000000000009 112.611 178.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -97.24 126.37 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 128.13 2.572 . . . . 9.7599999999999998 111.807 176.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.43 -1.454 0 O-C-N 120.281 -1.512 . . . . 19.57 112.085 177.906 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 107.733 -1.21 . . . . 17.170000000000002 107.733 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -112.61 147.18 37.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.206 -1.559 . . . . 21.890000000000001 112.09 174.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.98 170.77 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.851 -1.907 . . . . 10.83 105.851 164.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -131.71 126.1 33.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.432 -3.292 . . . . 10.609999999999999 107.825 -175.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.0 t -97.77 118.76 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.983 -2.323 . . . . 9.1300000000000008 110.138 168.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -103.56 137.23 41.91 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.452 -2.795 . . . . 20.550000000000001 103.452 -176.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 11' ' ' LYS . 48.9 p -97.84 179.79 4.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.504 -0.748 . . . . 11.779999999999999 111.685 -168.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.94 -33.78 75.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.358 -2.714 . . . . 19.309999999999999 113.705 177.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.1 p -76.49 -32.13 58.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.176 -2.821 . . . . 23.140000000000001 105.643 175.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.54 30.03 4.81 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-O 124.096 1.942 . . . . 19.739999999999998 116.994 -166.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 7' ' ' THR . 58.8 tttm -84.97 138.92 32.18 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 114.427 -5.16 . . . . 21.93 107.525 160.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -109.14 129.11 55.48 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 129.1 2.96 . . . . 12.33 110.923 177.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.94 115.01 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.423 1.889 . . . . 17.079999999999998 109.183 -174.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.9 m -79.86 124.74 28.92 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.835 -2.416 . . . . 16.300000000000001 113.628 175.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.669 HD22 ' HB3' ' A' ' 29' ' ' LYS . 85.5 mt -128.26 134.07 48.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.324 -1.732 . . . . 15.880000000000001 106.324 -173.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -101.89 111.8 24.19 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.186 1.921 . . . . 28.899999999999999 116.186 -173.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.24 170.66 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.433 -1.417 . . . . 12.050000000000001 111.904 -165.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -120.95 162.54 34.62 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 113.696 -3.049 . . . . 18.170000000000002 107.584 177.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.32 51.1 Cg_exo -51.77 -21.58 11.79 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 N-CA-C 121.685 3.687 . . . . 8.1600000000000001 121.685 173.068 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 t -106.81 4.02 27.07 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.01 1.724 . . . . 11.130000000000001 113.466 -171.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -75.74 161.69 28.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.385 1.254 . . . . 18.030000000000001 114.385 159.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.1 p -103.96 175.41 5.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.565 -1.198 . . . . 10.220000000000001 113.797 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.4 mp -71.88 -31.63 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.181 -2.199 . . . . 12.300000000000001 109.713 -178.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -44.93 -41.69 7.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.547 2.425 . . . . 36.509999999999998 117.547 164.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -68.9 -26.91 65.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.979 -1.918 . . . . 25.66 114.713 177.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.16 -42.52 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 126.693 1.997 . . . . 8.1199999999999992 109.729 176.123 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -53.88 -44.27 70.31 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.334 1.605 . . . . 15.470000000000001 115.334 171.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.26 -38.48 41.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.145 2.646 . . . . 11.449999999999999 118.145 170.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.669 ' HB3' HD22 ' A' ' 15' ' ' LEU . 45.9 mttm -75.63 -29.0 59.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 124.598 1.186 . . . . 24.98 111.693 -177.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.94 -33.56 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 122.591 1.186 . . . . 9.4600000000000009 109.033 175.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -64.26 -53.06 54.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.245 -1.798 . . . . 14.76 115.583 178.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -54.0 -53.06 58.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.147 -2.751 . . . . 26.289999999999999 115.039 165.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -78.43 -71.49 0.43 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.119 1.438 . . . . 30.059999999999999 111.732 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -79.18 -25.04 42.83 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 115.692 -4.38 . . . . 25.190000000000001 114.94 -167.22 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.61 46.96 4.43 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 128.87 3.128 . . . . 7.4100000000000001 115.666 -178.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.58 132.99 22.85 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 118.793 1.297 . . . . 9.4900000000000002 113.271 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -67.35 147.77 78.5 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 CA-C-O 110.233 -4.153 . . . . 11.42 118.532 -178.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -64.78 -18.95 64.01 Favored 'Trans proline' 0 C--N 1.299 -2.027 2 C-N-CA 130.096 7.197 . . . . 12.0 108.429 -172.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.362 7.5 t70 -102.55 -33.39 9.5 Favored 'General case' 0 N--CA 1.429 -1.477 1 CA-C-N 126.383 4.174 . . . . 35.549999999999997 108.976 -169.105 . . . . . . . . 3 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -46.89 -41.36 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.809 2.444 . . . . 20.52 113.452 165.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB2' HD11 ' A' ' 69' ' ' LEU . 4.4 pt20 -97.96 148.21 23.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.616 2.627 . . . . 7.1299999999999999 113.86 178.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -136.06 137.51 41.18 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.38 -4.575 . . . . 36.390000000000001 108.408 173.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.93 143.43 38.18 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.107 -4.121 . . . . 9.5500000000000007 109.357 -172.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mt -122.52 147.82 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 129.186 2.994 . . . . 13.9 109.342 -177.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -137.59 116.09 12.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 100.257 -3.979 . . . . 6.8600000000000003 100.257 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.29 -104.01 0.13 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.246 -1.797 . . . . 11.15 113.072 -164.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.06 16.53 5.24 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 107.312 -2.315 . . . . 13.93 107.312 171.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -100.89 143.43 31.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 120.878 2.339 . . . . 23.920000000000002 107.633 170.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -91.91 133.15 35.94 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.372 3.469 . . . . 23.23 113.447 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.16 157.64 16.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.443 3.021 . . . . 9.1099999999999994 117.957 -175.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -90.83 154.23 19.65 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.846 2.26 . . . . 33.439999999999998 111.104 161.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -77.05 -47.95 19.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.299 -2.228 . . . . 28.370000000000001 108.219 -163.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.84 11.46 62.55 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.439 -1.413 . . . . 15.0 114.578 -159.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -101.95 146.91 27.19 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.371 2.268 . . . . 25.5 105.361 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 8.4 p -82.07 156.98 24.3 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.24 2.448 . . . . 11.949999999999999 113.959 -169.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.56 -35.23 72.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.523 -3.236 . . . . 10.17 105.456 -177.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.5 t -69.04 -29.24 67.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.816 2.553 . . . . 13.59 113.884 174.139 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -59.44 -56.6 19.95 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.838 -4.289 . . . . 11.699999999999999 111.86 176.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -79.96 0.39 31.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.149 0.98 . . . . 12.949999999999999 112.677 -177.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.428 72.2 m-80 65.9 49.18 1.69 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.843 2.905 . . . . 25.449999999999999 118.843 -176.178 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mt -93.34 110.27 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.122 2.569 . . . . 14.6 108.304 179.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -96.14 -168.03 1.68 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.602 -1.635 . . . . 33.229999999999997 110.407 -172.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -72.26 146.05 47.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.891 -1.049 . . . . 25.969999999999999 109.389 176.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 28.6 mt-10 73.3 30.01 1.59 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.737 -1.208 . . . . 32.609999999999999 107.737 170.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 m -90.18 116.89 28.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.567 2.127 . . . . 10.56 108.221 -170.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.8 m -72.21 108.08 5.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.486 -3.258 . . . . 5.3300000000000001 113.73 165.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -98.69 166.03 11.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.998 3.319 . . . . 11.66 102.884 173.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -121.19 138.77 54.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.049 -1.657 . . . . 16.300000000000001 113.506 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 41' ' ' GLN . 29.6 tp -103.04 121.76 43.23 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.157 -1.423 . . . . 9.9600000000000009 107.157 -179.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.91 131.36 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.995 -2.224 . . . . 9.7599999999999998 104.995 170.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.431 -1.415 0 CA-C-O 122.31 1.052 . . . . 19.57 109.259 -177.932 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 114.604 1.335 . . . . 17.170000000000002 114.604 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.25 138.01 52.25 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 118.236 -1.386 . . . . 21.890000000000001 109.996 -173.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 3' ' ' ILE . 42.3 pt -123.22 151.87 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 123.318 0.647 . . . . 10.83 111.886 170.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -106.71 134.74 49.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.153 -2.217 . . . . 10.609999999999999 106.684 -168.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.84 108.62 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 126.785 3.183 . . . . 9.1300000000000008 107.849 -175.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -91.65 129.76 37.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.283 -3.386 . . . . 20.550000000000001 116.895 -173.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.65 156.85 16.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.725 -1.954 . . . . 11.779999999999999 105.725 173.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.76 -49.3 40.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.471 -3.268 . . . . 19.309999999999999 113.148 -164.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.364 29.8 p -49.69 -79.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.908 2.483 . . . . 23.140000000000001 115.176 166.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.93 161.34 29.54 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 116.869 -3.645 . . . . 19.739999999999998 105.243 -177.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HE2' HG22 ' A' ' 13' ' ' ILE . 75.8 tttt 86.23 126.9 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.97 2.508 . . . . 21.93 115.585 166.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.7 m -120.22 105.67 11.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.57 2.348 . . . . 12.33 106.897 -175.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.417 HG22 ' HE2' ' A' ' 11' ' ' LYS . 12.0 pt -88.02 152.03 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.059 -1.65 . . . . 17.079999999999998 112.955 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -111.5 113.06 25.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 113.225 -1.807 . . . . 16.300000000000001 110.145 -173.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 15' ' ' LEU . 1.3 mm? -108.62 139.38 43.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.951 2.786 . . . . 15.880000000000001 107.409 176.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -84.3 125.8 32.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.781 -3.075 . . . . 28.899999999999999 108.589 172.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -149.82 175.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 117.488 -3.257 . . . . 12.050000000000001 110.768 -176.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -115.34 148.92 41.88 Favored Pre-proline 0 N--CA 1.429 -1.493 1 O-C-N 116.277 -4.015 . . . . 18.170000000000002 109.279 176.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -64.6 -8.48 17.49 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 125.735 4.29 . . . . 8.1600000000000001 115.74 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.8 m -105.76 16.52 25.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.541 -2.022 . . . . 11.130000000000001 105.541 177.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.84 153.51 25.13 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.523 -2.611 . . . . 18.030000000000001 111.921 168.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.8 p -87.01 164.61 16.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.517 2.58 . . . . 10.220000000000001 105.249 -176.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -75.6 -21.9 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 116.708 -3.745 . . . . 12.300000000000001 109.796 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.29 -32.6 66.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.731 2.412 . . . . 36.509999999999998 113.057 163.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -88.37 -21.84 24.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.892 -1.049 . . . . 25.66 110.715 -177.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -73.92 -49.56 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 118.104 -2.873 . . . . 8.1199999999999992 107.023 169.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -46.57 -45.18 18.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.45 1.9 . . . . 15.470000000000001 112.071 170.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.14 95.68 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.634 2.774 . . . . 11.449999999999999 111.746 -175.007 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -62.5 -43.22 99.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.223 1.809 . . . . 24.98 113.638 169.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 mt -63.19 -38.83 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 116.879 2.177 . . . . 9.4600000000000009 116.879 171.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.1 -29.24 70.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.317 2.247 . . . . 14.76 111.102 177.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -79.93 -56.59 4.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.904 -2.372 . . . . 26.289999999999999 116.412 166.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -78.13 -48.43 15.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.622 -1.251 . . . . 30.059999999999999 107.622 -156.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 6.1 mm-40 -85.89 -45.66 11.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.931 1.086 . . . . 25.190000000000001 113.931 169.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.44 66.36 1.65 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 121.789 0.66 . . . . 7.4100000000000001 111.73 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.7 mt -112.36 118.99 44.68 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 102.066 -3.309 . . . . 9.4900000000000002 102.066 166.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.53 154.64 63.28 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 CA-C-N 124.767 2.738 . . . . 11.42 113.784 -178.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -73.52 -13.15 25.01 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 O-C-N 112.611 -4.468 . . . . 12.0 117.906 -165.259 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -92.91 -10.13 37.63 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 125.06 1.475 . . . . 35.549999999999997 112.069 175.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -84.14 -7.23 59.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.23 -1.544 . . . . 20.52 114.21 168.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -95.64 123.68 39.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 113.937 -2.935 . . . . 7.1299999999999999 108.663 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.436 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 65.6 ttt180 -105.51 102.21 11.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.167 3.417 . . . . 36.390000000000001 106.877 165.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.8 mt -90.9 99.17 12.25 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 123.376 2.807 . . . . 9.5500000000000007 110.693 -177.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.4 mt -104.49 116.71 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 129.369 3.068 . . . . 13.9 109.608 -176.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -93.09 113.74 26.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.944 -2.613 . . . . 6.8600000000000003 103.944 165.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.12 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.527 2.584 . . . . 11.15 116.695 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.02 18.3 1.21 Allowed Glycine 0 N--CA 1.429 -1.775 1 O-C-N 116.049 -4.157 . . . . 13.93 117.054 176.067 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -135.18 142.8 46.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 101.139 -3.652 . . . . 23.920000000000002 101.139 171.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -96.35 165.89 11.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.613 -3.179 . . . . 23.23 113.528 173.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.08 156.96 17.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 127.156 2.785 . . . . 9.1099999999999994 112.329 -162.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.261 40.2 mt-10 -99.51 141.09 32.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.009 2.338 . . . . 33.439999999999998 112.14 -173.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -70.31 -51.26 31.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.668 -3.145 . . . . 28.370000000000001 115.615 -154.239 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.46 15.3 41.37 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 123.03 3.972 . . . . 15.0 123.03 171.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -101.44 162.72 12.69 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.47 2.308 . . . . 25.5 109.302 168.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.0 p -107.31 172.35 6.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 114.692 1.367 . . . . 11.949999999999999 114.692 -169.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 56' ' ' LEU . 93.8 mt -64.39 -35.41 80.81 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.081 -2.262 . . . . 10.17 114.917 166.169 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -54.25 -46.69 72.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.881 2.178 . . . . 13.59 116.881 161.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -59.07 -37.03 76.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 124.23 3.195 . . . . 11.699999999999999 115.447 176.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -90.55 12.7 17.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.363 -2.711 . . . . 12.949999999999999 115.385 173.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.52 6.5 t30 46.61 42.36 11.17 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.95 2.574 . . . . 25.449999999999999 117.95 -172.262 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -93.07 99.07 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 118.437 -2.665 . . . . 14.6 108.119 -178.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -79.93 176.13 10.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.225 2.61 . . . . 33.229999999999997 109.682 172.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -71.48 151.61 43.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.248 -2.782 . . . . 25.969999999999999 116.549 -174.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.29 45.2 mt-10 75.17 11.68 3.47 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.733 2.52 . . . . 32.609999999999999 114.687 -173.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.309 70.9 m -73.76 145.93 44.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.896 1.331 . . . . 10.56 112.199 -176.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -96.73 123.06 40.31 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.388 -2.695 . . . . 5.3300000000000001 113.288 173.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.305 65.7 tp -126.16 150.08 48.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.137 -2.852 . . . . 11.66 105.974 175.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -111.59 122.47 47.91 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.658 -2.526 . . . . 16.300000000000001 112.623 -167.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -98.56 103.17 15.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.223 -2.88 . . . . 9.9600000000000009 103.223 -178.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 42' ' ' ARG 0.257 15.3 t -100.14 168.26 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 110.316 -3.129 . . . . 9.7599999999999998 111.496 170.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tp . . . . . 0 N--CA 1.431 -1.423 0 N-CA-C 107.746 -1.205 . . . . 19.57 107.746 176.264 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptt? . . . . . 0 CA--C 1.489 -1.367 0 CA-C-O 123.058 1.409 . . . . 17.170000000000002 111.717 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -96.66 137.29 35.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.978 2.799 . . . . 21.890000000000001 112.339 167.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.6 pt -119.5 162.29 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 117.349 -3.345 . . . . 10.83 105.87 175.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -119.73 136.39 54.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.219 2.208 . . . . 10.609999999999999 109.176 -177.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.35 103.02 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 102.524 -3.139 . . . . 9.1300000000000008 102.524 -173.028 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -86.4 118.41 25.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.411 -2.056 . . . . 20.550000000000001 108.584 -176.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -84.07 -170.96 3.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.289 1.618 . . . . 11.779999999999999 109.267 -173.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.0 -25.37 19.74 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.753 -4.342 . . . . 19.309999999999999 109.329 -171.417 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.7 p -90.43 -72.14 0.59 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.232 2.208 . . . . 23.140000000000001 115.695 -173.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.8 35.9 0.18 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-O 117.065 -1.964 . . . . 19.739999999999998 111.876 177.162 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -122.84 151.58 41.55 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.534 -2.025 . . . . 21.93 105.534 175.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.7 m -125.71 121.9 34.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.374 -2.084 . . . . 12.33 105.374 169.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.572 HD11 HG23 ' A' ' 30' ' ' ILE 0.305 48.5 pt -103.39 141.56 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.503 -2.623 . . . . 17.079999999999998 113.065 -178.61 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -104.08 116.03 31.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.969 -2.234 . . . . 16.300000000000001 104.969 -173.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.91 133.07 56.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.262 1.392 . . . . 15.880000000000001 111.256 175.227 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -106.95 118.21 36.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.459 2.552 . . . . 28.899999999999999 108.678 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 m -139.71 145.3 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 131.469 3.908 . . . . 12.050000000000001 107.501 -152.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.2 147.85 34.55 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 125.305 1.442 . . . . 18.170000000000002 107.906 166.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.92 -26.3 22.3 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 123.746 2.964 . . . . 8.1600000000000001 114.565 -177.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.0 m -70.12 0.24 6.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.525 2.417 . . . . 11.130000000000001 117.525 161.054 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -70.72 142.3 51.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.704 -3.123 . . . . 18.030000000000001 117.674 163.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.269 7.3 p -73.9 158.61 34.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.644 2.778 . . . . 10.220000000000001 109.759 178.601 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 50' ' ' LEU 0.284 26.9 mm -67.07 -34.45 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 119.283 0.947 . . . . 12.300000000000001 111.884 173.38 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -47.94 -42.7 28.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.623 -2.548 . . . . 36.509999999999998 115.306 162.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -71.91 -27.36 62.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.546 -3.846 . . . . 25.66 112.456 -178.335 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -68.38 -49.0 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 130.55 3.54 . . . . 8.1199999999999992 110.639 172.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -55.16 -38.62 68.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.569 2.063 . . . . 15.470000000000001 116.569 173.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.46 -35.71 53.11 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.13 -1.606 . . . . 11.449999999999999 114.974 173.245 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -76.9 -31.5 56.77 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 117.276 2.324 . . . . 24.98 117.276 176.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.572 HG23 HD11 ' A' ' 13' ' ' ILE . 1.2 mt -70.23 -32.63 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.58 1.552 . . . . 9.4600000000000009 109.282 172.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -74.14 -36.0 64.11 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.36 -1.462 . . . . 14.76 109.802 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.99 -51.28 62.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.068 1.413 . . . . 26.289999999999999 112.476 177.508 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -80.62 -55.37 4.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.256 -3.403 . . . . 30.059999999999999 112.132 -168.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.403 ' HB2' HG13 ' A' ' 36' ' ' ILE . 69.3 mm-40 -94.73 -34.36 12.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.316 0.962 . . . . 25.190000000000001 111.485 -167.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.72 54.06 1.99 Allowed Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 127.114 2.292 . . . . 7.4100000000000001 113.276 -177.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.456 HD13 HG21 ' A' ' 36' ' ' ILE . 14.0 mt -113.37 103.45 55.5 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 113.671 -3.061 . . . . 9.4900000000000002 104.121 -175.601 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -57.56 141.45 95.24 Favored 'Trans proline' 0 C--N 1.3 -1.999 1 CA-C-N 131.862 5.272 . . . . 11.42 116.688 -178.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.267 19.7 Cg_endo -70.72 -18.82 32.23 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 125.018 3.812 . . . . 12.0 114.177 -159.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.26 -32.07 58.65 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.195 2.902 . . . . 35.549999999999997 108.552 -178.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -73.35 -5.73 41.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.493 -2.629 . . . . 20.52 116.322 172.156 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -105.39 139.86 39.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.709 1.243 . . . . 7.1299999999999999 108.682 -177.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -138.58 118.04 12.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.703 -3.123 . . . . 36.390000000000001 109.276 162.497 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.2 mt -86.38 129.67 34.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 113.975 1.102 . . . . 9.5500000000000007 113.975 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mt -120.12 135.59 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 117.829 -1.082 . . . . 13.9 113.706 177.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -106.22 103.18 12.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.841 -2.281 . . . . 6.8600000000000003 104.841 172.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.359 . . 62.9 -110.89 0.35 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.242 1.817 . . . . 11.15 113.646 -170.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.19 -8.31 78.62 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 121.19 3.236 . . . . 13.93 121.19 169.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -115.47 115.65 26.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.745 1.26 . . . . 23.920000000000002 110.502 -165.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -71.73 133.93 45.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.714 2.406 . . . . 23.23 108.904 170.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -95.38 137.53 34.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.423 -2.227 . . . . 9.1099999999999994 112.332 -177.618 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HB3' ' HG3' ' A' ' 54' ' ' ARG . 38.7 tt0 -88.06 139.8 30.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 123.503 2.865 . . . . 33.439999999999998 109.14 174.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -32.39 -74.52 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 136.12 5.768 . . . . 28.370000000000001 113.407 172.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.03 43.13 3.14 Favored Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 117.853 -2.118 . . . . 15.0 113.738 -171.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.402 ' HG3' ' HB3' ' A' ' 51' ' ' GLU . 18.4 mtt180 -130.49 157.25 43.17 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.861 2.064 . . . . 25.5 107.779 174.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.0 p -87.33 176.32 7.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 124.089 3.131 . . . . 11.949999999999999 113.243 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.21 -43.03 92.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 130.064 3.346 . . . . 10.17 106.848 161.244 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -64.67 -31.95 73.4 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 115.2 1.555 . . . . 13.59 115.2 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -60.78 -55.22 35.72 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.0 -2.313 . . . . 11.699999999999999 112.995 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -71.61 15.32 0.14 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 114.489 -2.672 . . . . 12.949999999999999 116.816 166.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 41.39 40.0 1.15 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.98 2.627 . . . . 25.449999999999999 116.939 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -82.15 116.35 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.011 -1.848 . . . . 14.6 106.011 -178.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.454 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 55.8 mt-30 -98.2 -150.59 0.36 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.841 -2.412 . . . . 33.229999999999997 108.883 -175.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 62' ' ' GLN . 12.5 pttp -76.73 156.02 32.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.956 -1.474 . . . . 25.969999999999999 111.087 -167.413 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 16.8 mt-10 65.3 9.1 5.39 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.029 1.732 . . . . 32.609999999999999 112.843 164.025 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -65.29 132.79 49.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.135 -3.478 . . . . 10.56 117.96 177.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.291 85.3 m -82.97 113.55 20.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.132 1.901 . . . . 5.3300000000000001 116.132 169.161 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.79 156.0 18.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.147 2.403 . . . . 11.66 108.824 171.658 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -107.46 126.99 53.19 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.385 -2.45 . . . . 16.300000000000001 104.385 -171.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.6 tp -103.82 124.66 49.34 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 116.119 -4.113 . . . . 9.9600000000000009 110.26 178.119 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.267 46.0 t -111.92 147.86 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 101.968 -3.345 . . . . 9.7599999999999998 101.968 -171.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.43 -1.461 0 CA-C-O 119.719 -0.181 . . . . 19.57 111.056 170.522 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.48 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 14.1 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 113.616 0.969 . . . . 17.170000000000002 113.616 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.286 14.5 pt20 -90.53 134.15 34.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 121.558 1.981 . . . . 21.890000000000001 114.911 172.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.8 pt -132.06 166.61 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.671 -1.603 . . . . 10.83 106.671 177.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -107.3 131.73 53.89 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.401 -3.937 . . . . 10.609999999999999 112.484 177.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.0 t -116.57 109.32 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.258 -1.377 . . . . 9.1300000000000008 110.171 170.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -99.16 117.62 34.04 Favored 'General case' 0 N--CA 1.429 -1.481 1 CA-C-O 130.117 4.77 . . . . 20.550000000000001 110.098 -172.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 30.7 p -75.16 164.66 26.26 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 110.738 -7.477 . . . . 11.779999999999999 114.455 -171.94 . . . . . . . . 3 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 70' ' ' VAL . 4.8 tp -53.16 -52.08 59.93 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.177 2.191 . . . . 19.309999999999999 115.603 174.701 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -59.0 -70.4 0.15 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 128.783 3.802 . . . . 23.140000000000001 114.599 169.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.49 59.01 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.774 0 O-C-N 118.988 -2.32 . . . . 19.739999999999998 113.834 156.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.33 85.7 tttt -108.06 134.18 51.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.398 -2.236 . . . . 21.93 106.737 173.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.2 m -97.45 111.67 23.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.439 -1.71 . . . . 12.33 108.35 173.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 13' ' ' ILE . 29.5 pt -108.75 127.33 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.312 -1.492 . . . . 17.079999999999998 113.178 172.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.3 m -86.33 122.51 30.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.572 1.549 . . . . 16.300000000000001 110.506 -178.365 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -110.53 123.04 49.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.251 3.021 . . . . 15.880000000000001 111.05 -172.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -102.89 117.4 34.54 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.638 3.113 . . . . 28.899999999999999 107.087 171.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.72 167.34 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 110.404 -3.089 . . . . 12.050000000000001 110.341 -174.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -110.81 164.88 13.81 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 113.885 -2.96 . . . . 18.170000000000002 115.782 165.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.283 60.7 Cg_endo -69.83 -24.91 28.82 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 CA-C-N 127.813 3.826 . . . . 8.1600000000000001 113.279 -171.408 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.256 3.9 m -82.99 -5.57 59.15 Favored 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 133.819 4.847 . . . . 11.130000000000001 114.464 -176.363 . . . . . . . . 3 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -59.67 126.41 27.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.377 2.271 . . . . 18.030000000000001 114.104 167.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.4 p -77.3 158.15 30.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.056 -2.277 . . . . 10.220000000000001 111.59 170.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.544 HG23 HD12 ' A' ' 43' ' ' LEU 0.295 35.8 mm -60.91 -34.55 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.829 -1.169 . . . . 12.300000000000001 113.732 176.662 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -33.96 -60.69 0.38 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.99 -3.569 . . . . 36.509999999999998 117.775 157.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -70.67 -31.86 68.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 110.75 -2.932 . . . . 25.66 111.024 -177.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 22' ' ' THR . 90.9 t -66.21 -43.85 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.093 -1.629 . . . . 8.1199999999999992 112.435 -178.121 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -57.46 -42.79 83.23 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.149 2.18 . . . . 15.470000000000001 113.771 176.037 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.329 . . -64.45 -35.43 80.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.851 -2.406 . . . . 11.449999999999999 114.374 175.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -59.67 -35.02 73.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.274 2.94 . . . . 24.98 115.968 170.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -75.74 -36.92 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.617 -2.552 . . . . 9.4600000000000009 109.281 172.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -56.32 -32.61 64.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.423 2.059 . . . . 14.76 113.326 174.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.64 -36.09 67.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 128.215 3.864 . . . . 26.289999999999999 111.463 -177.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -65.13 -51.4 61.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.063 -2.79 . . . . 30.059999999999999 115.196 171.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -110.67 -59.02 2.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.519 2.104 . . . . 25.190000000000001 112.018 -168.132 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.15 49.29 0.88 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 126.942 2.211 . . . . 7.4100000000000001 110.509 -176.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -100.25 130.55 25.72 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 114.299 -2.762 . . . . 9.4900000000000002 107.732 169.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -71.25 148.98 56.69 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 124.417 2.613 . . . . 11.42 113.364 179.444 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -68.99 -17.96 40.82 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 CA-C-N 125.55 3.018 . . . . 12.0 117.768 -172.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.262 1.1 m-20 -69.41 -20.64 63.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.926 2.775 . . . . 35.549999999999997 117.028 172.902 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -94.6 -23.26 17.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.225 2.917 . . . . 20.52 108.5 -177.639 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -84.17 119.67 25.28 Favored 'General case' 0 N--CA 1.431 -1.418 1 O-C-N 115.767 -4.333 . . . . 7.1299999999999999 116.791 178.114 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -113.57 106.59 14.72 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.068 2.947 . . . . 36.390000000000001 111.066 177.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.544 HD12 HG23 ' A' ' 23' ' ' ILE . 92.3 mt -88.3 124.27 33.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.096 -1.816 . . . . 9.5500000000000007 106.096 -175.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -116.99 106.71 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 122.576 2.444 . . . . 13.9 108.534 176.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -95.66 108.94 21.27 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 125.628 2.632 . . . . 6.8600000000000003 111.876 170.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.426 . . 70.57 -96.95 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.465 -2.647 . . . . 11.15 116.692 -178.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.76 -2.36 19.08 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.508 -1.37 . . . . 13.93 112.57 170.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -109.06 126.54 53.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.501 1.143 . . . . 23.920000000000002 111.261 -166.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -93.31 130.73 38.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 112.487 -2.142 . . . . 23.23 109.109 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -96.46 149.95 21.15 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.762 2.134 . . . . 9.1099999999999994 116.762 -164.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -111.22 148.65 32.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.741 2.21 . . . . 33.439999999999998 111.041 -176.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -60.15 -47.28 86.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.276 2.695 . . . . 28.370000000000001 118.276 -166.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.83 26.67 8.08 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 117.995 -2.05 . . . . 15.0 112.982 -166.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -113.68 154.35 27.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 131.136 3.775 . . . . 25.5 106.24 -176.186 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -90.29 168.41 11.92 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.594 1.701 . . . . 11.949999999999999 115.594 168.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.0 mt -73.28 -36.14 66.26 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 118.031 -0.985 . . . . 10.17 112.406 177.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -45.89 -53.33 9.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.602 3.064 . . . . 13.59 115.837 160.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -49.76 -44.07 48.43 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.251 -4.656 . . . . 11.699999999999999 117.205 179.78 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -79.35 -18.95 51.41 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.431 -2.043 . . . . 12.949999999999999 108.265 -173.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 66.07 71.83 0.4 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.316 2.246 . . . . 25.449999999999999 110.238 -170.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -115.82 117.94 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 102.855 -3.017 . . . . 14.6 102.855 178.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -100.41 174.44 6.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.447 3.499 . . . . 33.229999999999997 112.239 174.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 13.3 pttp -53.69 161.88 0.99 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.829 -4.92 . . . . 25.969999999999999 115.293 165.243 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 50.96 46.57 26.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.292 3.037 . . . . 32.609999999999999 109.461 174.083 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -130.53 155.9 45.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.767 -3.083 . . . . 10.56 102.694 179.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.6 m -119.16 118.65 31.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.043 -1.435 . . . . 5.3300000000000001 108.818 -155.14 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 mt -100.55 147.36 26.01 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.546 -2.391 . . . . 11.66 104.546 -173.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -108.8 133.89 52.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.625 -2.43 . . . . 16.300000000000001 111.41 167.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -106.34 97.79 7.55 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.682 1.734 . . . . 9.9600000000000009 115.682 -175.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HA ' HD13 ' A' ' 8' ' ' LEU . 88.6 t -95.13 150.31 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 101.493 -3.521 . . . . 9.7599999999999998 101.493 -171.383 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt . . . . . 0 N--CA 1.43 -1.442 1 CA-C-O 128.51 4.005 . . . . 19.57 106.772 173.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 118.366 -0.826 . . . . 17.170000000000002 113.012 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -98.75 142.0 30.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.478 2.361 . . . . 21.890000000000001 114.147 161.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.04 153.94 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.14 -1.43 . . . . 10.83 107.14 176.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -100.2 105.31 16.88 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 117.586 2.439 . . . . 10.609999999999999 117.586 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 70.9 t -88.44 117.58 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 119.635 1.107 . . . . 9.1300000000000008 110.619 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -93.23 129.36 39.3 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.992 2.917 . . . . 20.550000000000001 110.39 174.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -98.01 170.53 8.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.169 -1.378 . . . . 11.779999999999999 108.164 178.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.02 -49.72 75.9 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.705 1.742 . . . . 19.309999999999999 115.705 173.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 p -74.78 -73.21 0.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.261 2.458 . . . . 23.140000000000001 111.507 -172.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.27 32.89 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 117.331 -3.355 . . . . 19.739999999999998 116.854 167.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -84.39 154.91 22.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.384 2.516 . . . . 21.93 110.054 167.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.9 m -112.18 113.52 25.82 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.117 -1.856 . . . . 12.33 106.376 163.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 12.6 mt -102.2 129.17 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 118.602 -2.561 . . . . 17.079999999999998 105.137 177.345 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.9 m -107.57 115.47 30.2 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.854 -2.404 . . . . 16.300000000000001 106.582 -169.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 tp -118.74 125.1 48.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.5 -2.625 . . . . 15.880000000000001 109.388 -156.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -95.34 119.53 33.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.468 -2.645 . . . . 28.899999999999999 114.873 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.7 158.18 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 106.903 -1.517 . . . . 12.050000000000001 106.903 -167.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -81.09 146.85 59.71 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 126.717 2.007 . . . . 18.170000000000002 109.9 175.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -82.87 -3.49 11.16 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 119.599 0.893 . . . . 8.1600000000000001 113.434 -165.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 t -113.59 7.91 17.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.937 2.153 . . . . 11.130000000000001 112.396 171.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -88.89 177.22 6.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.364 2.357 . . . . 18.030000000000001 117.364 -172.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.447 HG22 HG22 ' A' ' 55' ' ' THR . 48.1 p -92.8 159.94 15.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 118.293 2.701 . . . . 10.220000000000001 118.293 -167.658 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -67.17 -36.24 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 127.132 2.173 . . . . 12.300000000000001 107.741 179.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -54.73 -44.87 73.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.606 1.963 . . . . 36.509999999999998 112.967 172.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -69.63 -31.14 69.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.835 2.161 . . . . 25.66 116.835 170.553 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.1 -48.11 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 122.091 2.223 . . . . 8.1199999999999992 113.71 164.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -60.79 -31.35 70.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.978 1.711 . . . . 15.470000000000001 113.529 173.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.269 . . -79.24 -28.7 42.47 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 115.654 1.724 . . . . 11.449999999999999 115.654 177.716 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -63.43 -45.71 89.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.841 -1.527 . . . . 24.98 114.496 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.3 mt -70.0 -35.48 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.42 -2.173 . . . . 9.4600000000000009 110.589 172.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -56.85 -29.68 63.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 125.974 3.988 . . . . 14.76 110.377 168.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.93 -50.73 7.76 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 114.857 -4.902 . . . . 26.289999999999999 111.439 -174.699 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -65.54 -52.27 53.73 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.661 -2.525 . . . . 30.059999999999999 113.417 175.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -107.82 -39.65 5.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.504 -0.924 . . . . 25.190000000000001 108.504 -162.109 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.99 37.6 5.97 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 106.587 -2.605 . . . . 7.4100000000000001 106.587 176.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.74 123.66 37.93 Favored Pre-proline 0 N--CA 1.43 -1.446 1 N-CA-C 97.13 -5.137 . . . . 9.4900000000000002 97.13 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -90.52 166.97 4.2 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 CA-C-N 125.278 2.921 . . . . 11.42 107.757 -168.564 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.26 36.4 Cg_endo -65.58 -24.83 55.45 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 122.793 2.328 . . . . 12.0 116.307 -169.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.282 18.0 m-20 -82.29 -22.33 35.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 114.516 -2.874 . . . . 35.549999999999997 111.476 178.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -91.56 -12.14 35.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 124.412 3.278 . . . . 20.52 112.77 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -75.46 99.93 4.34 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.74 2.416 . . . . 7.1299999999999999 113.64 171.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -84.99 113.05 21.14 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 101.051 -3.685 . . . . 36.390000000000001 101.051 168.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.0 mt -101.31 115.24 30.05 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.405 -2.059 . . . . 9.5500000000000007 110.343 165.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 44' ' ' ILE . 5.5 mt -112.53 137.6 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 C-N-CA 131.717 4.007 . . . . 13.9 109.234 178.576 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -133.75 99.37 4.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.738 2.015 . . . . 6.8600000000000003 106.262 -171.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.394 . . 66.46 -108.65 0.13 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.954 -1.716 . . . . 11.15 113.471 -158.658 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.59 17.53 11.11 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 126.522 2.01 . . . . 13.93 112.106 172.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -107.06 119.74 40.18 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.661 3.23 . . . . 23.920000000000002 110.826 174.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -70.06 124.5 24.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.994 -2.941 . . . . 23.23 112.946 160.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.529 HD22 ' CD2' ' A' ' 59' ' ' TYR . 29.1 mt -79.41 162.74 25.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.352 1.461 . . . . 9.1099999999999994 112.106 -178.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.28 141.47 52.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 126.748 3.166 . . . . 33.439999999999998 104.105 -177.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.67 -48.29 72.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.331 2.252 . . . . 28.370000000000001 114.848 -152.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.32 0.96 88.45 Favored Glycine 0 N--CA 1.43 -1.706 0 O-C-N 119.094 -2.254 . . . . 15.0 116.827 -178.305 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.252 23.3 mmt180 -74.9 161.43 29.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.105 3.336 . . . . 25.5 111.458 170.329 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.447 HG22 HG22 ' A' ' 22' ' ' THR 0.343 31.0 p -87.75 163.62 16.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.503 -2.623 . . . . 11.949999999999999 112.624 178.121 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.9 mt -60.15 -32.03 70.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.021 1.86 . . . . 10.17 116.021 163.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -56.55 -38.26 71.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.243 2.449 . . . . 13.59 114.426 166.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.79 -32.51 74.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.35 -2.719 . . . . 11.699999999999999 116.472 -169.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.529 ' CD2' HD22 ' A' ' 50' ' ' LEU . 34.2 m-85 -104.39 1.88 30.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.029 -2.919 . . . . 12.949999999999999 112.596 175.369 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.252 81.0 m-20 70.99 48.96 0.36 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.379 2.363 . . . . 25.449999999999999 117.379 -177.271 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.1 mt -92.41 124.79 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 114.545 -2.862 . . . . 14.6 110.614 -174.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -108.87 169.95 8.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 123.941 0.775 . . . . 33.229999999999997 110.635 -169.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 143.87 57.24 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.694 2.797 . . . . 25.969999999999999 110.262 -170.033 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 57.67 23.42 9.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.646 -3.784 . . . . 32.609999999999999 115.957 -174.392 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.0 t -92.93 160.36 14.93 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.269 3.414 . . . . 10.56 110.151 -178.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 m -92.52 126.16 37.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.599 -3.188 . . . . 5.3300000000000001 114.749 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.44 155.63 31.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.524 -2.399 . . . . 11.66 104.524 173.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -130.61 111.03 11.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 119.024 0.829 . . . . 16.300000000000001 111.329 -173.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -87.16 108.56 18.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 131.0 3.72 . . . . 9.9600000000000009 114.406 175.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -111.22 141.31 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 129.681 3.192 . . . . 9.7599999999999998 102.7 -173.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.43 -1.454 0 C-N-CA 127.746 2.418 . . . . 19.57 109.187 -170.906 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 CA--C 1.49 -1.365 0 CA-C-O 116.449 -1.739 . . . . 17.170000000000002 109.209 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -88.38 140.59 29.32 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 123.247 2.749 . . . . 21.890000000000001 116.81 171.478 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.1 pt -110.41 167.83 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 102.628 -3.101 . . . . 10.83 102.628 173.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -109.03 139.2 44.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.403 -2.814 . . . . 10.609999999999999 103.403 167.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -122.85 123.17 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.435 -2.041 . . . . 9.1300000000000008 109.677 165.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -96.91 134.89 39.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.127 -0.942 . . . . 20.550000000000001 112.508 172.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.401 HG22 HD23 ' A' ' 69' ' ' LEU . 42.9 p -91.77 -173.97 3.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.37 2.986 . . . . 11.779999999999999 113.207 177.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 tp -65.49 -52.95 49.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.635 -3.791 . . . . 19.309999999999999 116.661 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -61.8 -40.5 95.45 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.325 -2.11 . . . . 23.140000000000001 110.204 171.075 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.01 37.15 0.44 Allowed Glycine 0 N--CA 1.43 -1.738 0 CA-C-O 115.186 -3.008 . . . . 19.739999999999998 116.837 177.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -86.17 141.05 29.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.483 3.641 . . . . 21.93 111.079 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 m -92.74 101.75 14.15 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 119.954 1.252 . . . . 12.33 108.995 175.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.6 mt -93.05 118.43 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 125.072 1.349 . . . . 17.079999999999998 111.149 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -86.66 105.58 17.01 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.471 1.908 . . . . 16.300000000000001 112.338 175.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 tp -120.57 116.24 24.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.73 -1.856 . . . . 15.880000000000001 110.329 -160.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -78.76 100.51 7.14 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.562 4.345 . . . . 28.899999999999999 120.351 178.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 m -122.93 148.46 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-O 125.452 2.549 . . . . 12.050000000000001 109.138 -171.666 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -94.64 141.73 23.8 Favored Pre-proline 0 N--CA 1.43 -1.474 1 O-C-N 116.277 -4.015 . . . . 18.170000000000002 106.01 162.542 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.49 -14.51 45.26 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-O 114.086 -2.548 . . . . 8.1600000000000001 111.091 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.7 p -67.83 -9.88 48.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 120.931 3.678 . . . . 11.130000000000001 120.931 160.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -71.06 134.92 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.55 -3.843 . . . . 18.030000000000001 111.679 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.3 p -82.48 153.14 25.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 117.332 -1.318 . . . . 10.220000000000001 111.974 177.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.0 mm -51.61 -37.73 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 113.907 -2.949 . . . . 12.300000000000001 113.795 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -49.64 -43.56 46.9 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.959 3.704 . . . . 36.509999999999998 113.86 168.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -90.54 -25.56 20.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.693 3.197 . . . . 25.66 110.295 -176.848 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.46 -51.84 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.238 1.495 . . . . 8.1199999999999992 110.736 164.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -51.74 -31.92 28.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.66 -3.775 . . . . 15.470000000000001 115.183 170.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.05 -39.38 86.92 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.808 1.643 . . . . 11.449999999999999 113.018 171.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -69.19 -35.08 75.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.473 1.13 . . . . 24.98 108.4 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.5 mt -79.51 -35.59 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.833 -2.417 . . . . 9.4600000000000009 110.77 -173.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -49.41 -50.54 40.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.542 2.423 . . . . 14.76 117.542 158.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.56 -33.44 69.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.266 3.027 . . . . 26.289999999999999 113.91 170.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -73.69 -69.83 0.41 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.925 2.565 . . . . 30.059999999999999 117.925 173.378 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -90.42 -37.89 13.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 111.189 -2.732 . . . . 25.190000000000001 115.215 -172.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.35 46.39 1.85 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 120.743 1.61 . . . . 7.4100000000000001 110.784 176.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.41 105.32 48.64 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 113.195 -3.288 . . . . 9.4900000000000002 105.031 -178.324 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -58.36 159.01 20.66 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.497 3.356 . . . . 11.42 113.62 -175.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -76.39 -20.4 14.23 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 122.826 2.045 . . . . 12.0 115.227 -161.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.33 -40.01 67.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.649 -1.907 . . . . 35.549999999999997 110.005 178.439 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.99 -29.8 69.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.812 -1.805 . . . . 20.52 111.697 172.075 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -78.98 140.9 37.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 117.865 -3.022 . . . . 7.1299999999999999 109.952 -177.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.0 mtp180 -123.12 124.43 43.06 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.563 -3.21 . . . . 36.390000000000001 107.393 158.078 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.2 mt -106.4 129.79 54.33 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 123.957 0.786 . . . . 9.5500000000000007 112.609 176.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.1 109.82 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 125.991 1.716 . . . . 13.9 112.004 -171.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -94.09 129.52 40.6 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.346 -3.346 . . . . 6.8600000000000003 107.33 163.278 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.52 -97.92 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.019 2.97 . . . . 11.15 119.019 -169.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.84 27.82 3.81 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.44 -2.037 . . . . 13.93 113.819 -179.413 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -138.93 128.39 24.4 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.903 -1.888 . . . . 23.920000000000002 105.903 -176.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -84.34 127.34 33.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 111.799 -2.455 . . . . 23.23 113.664 171.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.4 mt -87.02 137.16 32.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.074 -1.875 . . . . 9.1099999999999994 108.353 -161.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -106.26 140.41 39.25 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.31 -0.869 . . . . 33.439999999999998 111.936 -160.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -46.17 -54.03 9.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 121.3 3.815 . . . . 28.370000000000001 121.3 -162.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.11 -0.44 74.17 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-O 117.906 -1.497 . . . . 15.0 112.706 -178.417 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -75.4 158.47 32.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.106 1.953 . . . . 25.5 114.308 169.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 p -93.68 173.46 7.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.746 2.212 . . . . 11.949999999999999 110.452 174.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.5 mt -66.39 -29.84 70.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.331 -3.356 . . . . 10.17 113.965 166.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.6 t -66.05 -39.73 90.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.856 -3.028 . . . . 13.59 110.892 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -61.2 -33.64 73.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.911 -1.743 . . . . 11.699999999999999 113.634 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.83 -20.44 30.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.187 0.81 . . . . 12.949999999999999 113.187 174.314 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 m120 72.47 51.78 0.18 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.604 3.962 . . . . 25.449999999999999 112.539 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.259 60.0 mt -80.79 121.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 110.192 -3.185 . . . . 14.6 110.026 -178.288 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -106.54 -175.2 2.73 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 118.704 -1.198 . . . . 33.229999999999997 112.228 -175.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.427 0.0 OUTLIER -66.46 150.85 48.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.234 2.309 . . . . 25.969999999999999 117.234 173.219 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 48.24 39.0 11.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.047 2.832 . . . . 32.609999999999999 116.408 -168.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.373 63.9 m -94.29 137.21 33.72 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.013 -4.804 . . . . 10.56 107.826 173.841 . . . . . . . . 3 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -103.52 113.92 27.79 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.563 1.529 . . . . 5.3300000000000001 111.665 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -84.78 146.54 27.32 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.238 2.215 . . . . 11.66 111.63 169.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -110.93 129.49 55.86 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.603 -1.936 . . . . 16.300000000000001 114.41 172.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.401 HD23 HG22 ' A' ' 7' ' ' THR . 17.7 tp -87.78 124.82 34.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.32 -2.474 . . . . 9.9600000000000009 104.32 170.313 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.12 146.03 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 112.816 -1.993 . . . . 9.7599999999999998 109.34 163.489 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.257 14.2 mt . . . . . 0 N--CA 1.431 -1.418 1 O-C-N 115.578 -4.451 . . . . 19.57 111.452 -176.253 . . . . . . . . 2 1 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.348 0 CA-C-O 119.242 -0.409 . . . . 17.170000000000002 111.932 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.29 133.99 39.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 119.324 0.965 . . . . 21.890000000000001 113.157 -178.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 pt -114.63 171.24 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.703 -1.873 . . . . 10.83 111.024 168.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -107.82 135.95 48.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.563 1.649 . . . . 10.609999999999999 111.876 173.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 69' ' ' LEU . 88.1 t -119.25 128.62 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 117.523 -3.235 . . . . 9.1300000000000008 102.288 175.025 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -120.89 121.74 38.73 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.068 1.413 . . . . 20.550000000000001 111.143 -178.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.458 HG22 HD23 ' A' ' 69' ' ' LEU . 12.5 p -69.79 164.06 24.42 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.539 2.336 . . . . 11.779999999999999 109.632 -174.245 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.4 tp -61.76 -44.19 97.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.092 1.901 . . . . 19.309999999999999 111.154 174.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 p -67.32 -51.57 50.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.765 -1.835 . . . . 23.140000000000001 113.045 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.56 59.9 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 119.439 2.536 . . . . 19.739999999999998 119.439 162.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -116.42 138.5 51.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.522 -0.918 . . . . 21.93 108.522 172.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.2 m -90.15 113.86 25.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 118.37 -0.824 . . . . 12.33 109.164 178.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mt -96.39 137.57 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.694 -3.129 . . . . 17.079999999999998 106.872 -177.27 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.3 m -97.28 121.43 39.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 114.821 -2.514 . . . . 16.300000000000001 104.301 171.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 tp -121.97 138.37 54.44 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.648 2.166 . . . . 15.880000000000001 115.895 178.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.294 71.6 tt0 -100.1 111.16 23.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.339 -3.976 . . . . 28.899999999999999 109.1 -172.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.2 152.99 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 1 O-C-N 113.29 -5.881 . . . . 12.050000000000001 117.937 -172.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -117.36 161.03 35.32 Favored Pre-proline 0 N--CA 1.43 -1.446 1 O-C-N 116.154 -4.091 . . . . 18.170000000000002 119.327 170.467 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -66.59 -17.63 53.15 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 CA-C-N 129.859 4.557 . . . . 8.1600000000000001 117.468 -175.117 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.4 m -76.74 -17.19 59.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.403 1.91 . . . . 11.130000000000001 114.414 177.46 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -67.98 151.78 46.55 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.925 2.774 . . . . 18.030000000000001 111.094 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -97.82 158.77 15.33 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.778 -1.826 . . . . 10.220000000000001 112.012 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.269 4.7 mm -61.34 -31.52 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 CA-C-O 128.941 4.21 . . . . 12.300000000000001 116.294 -178.648 . . . . . . . . 3 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -50.21 -43.42 52.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.051 -3.531 . . . . 36.509999999999998 114.76 162.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -73.16 -19.37 61.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.643 -2.535 . . . . 25.66 117.2 173.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.263 94.5 t -66.36 -37.87 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 117.723 -3.11 . . . . 8.1199999999999992 111.813 176.802 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -68.67 -40.63 80.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.414 3.086 . . . . 15.470000000000001 112.56 176.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.11 -52.87 59.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 121.184 3.772 . . . . 11.449999999999999 121.184 167.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -56.86 -41.15 77.43 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.674 2.034 . . . . 24.98 115.797 165.321 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -64.57 -36.8 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 125.202 2.43 . . . . 9.4600000000000009 110.585 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.463 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 3.6 tt0 -53.92 -55.0 30.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.851 1.786 . . . . 14.76 113.285 171.135 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.259 29.4 t70 -57.89 -56.13 25.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.587 -2.571 . . . . 26.289999999999999 116.22 179.316 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -69.67 -65.35 0.73 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 125.865 2.745 . . . . 30.059999999999999 113.928 -176.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -86.39 -46.24 10.44 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.596 -4.44 . . . . 25.190000000000001 118.439 177.34 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 102.28 28.72 6.31 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.107 -1.997 . . . . 7.4100000000000001 108.107 168.219 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.0 mt -83.35 118.97 73.15 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.005 -1.95 . . . . 9.4900000000000002 108.641 169.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -73.63 157.25 48.72 Favored 'Trans proline' 0 N--CA 1.433 -2.036 1 CA-C-N 128.467 4.06 . . . . 11.42 114.412 -166.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.42 -23.72 64.79 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 123.02 2.48 . . . . 12.0 116.659 -168.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.88 -28.53 39.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.317 1.969 . . . . 35.549999999999997 116.317 177.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -18.03 59.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.792 2.515 . . . . 20.52 117.792 170.481 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -79.98 138.41 37.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.063 -2.273 . . . . 7.1299999999999999 116.735 177.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -137.94 129.26 27.71 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 125.666 2.651 . . . . 36.390000000000001 106.423 164.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mt -110.91 117.42 33.32 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 111.522 -2.581 . . . . 9.5500000000000007 112.584 -173.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.15 131.19 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.984 2.114 . . . . 13.9 109.532 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.587 ' HB3' HD21 ' A' ' 50' ' ' LEU . 11.5 t80 -122.75 107.4 11.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.826 -2.287 . . . . 6.8600000000000003 104.826 178.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.315 . . 69.93 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 125.572 1.795 . . . . 11.15 113.971 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.9 -29.87 3.66 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-O 118.419 -1.211 . . . . 13.93 112.796 175.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -94.79 127.95 41.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 126.248 1.793 . . . . 23.920000000000002 115.116 -162.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -77.13 132.72 38.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.378 2.037 . . . . 23.23 115.533 166.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 45' ' ' PHE 0.26 7.6 mt -91.07 133.29 35.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.263 -2.773 . . . . 9.1099999999999994 113.125 -163.692 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -88.86 121.85 31.65 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.227 -1.545 . . . . 33.439999999999998 114.07 -176.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -29.49 -57.75 0.16 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.032 3.733 . . . . 28.370000000000001 115.941 -178.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.87 25.35 25.59 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 119.278 -2.139 . . . . 15.0 116.188 -168.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.1 mtt-85 -108.91 155.33 20.96 Favored 'General case' 0 N--CA 1.43 -1.463 1 C-N-CA 132.081 4.153 . . . . 25.5 113.216 170.123 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.44 23.9 p -80.69 158.93 25.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 128.292 3.901 . . . . 11.949999999999999 115.045 177.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mp -68.86 -8.36 43.1 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.782 -5.574 . . . . 10.17 116.358 166.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.33 -42.85 18.21 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 112.686 -3.53 . . . . 13.59 103.294 177.52 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -62.47 -28.56 69.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 123.27 2.759 . . . . 11.699999999999999 114.466 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -94.32 -4.68 48.2 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.483 2.313 . . . . 12.949999999999999 112.088 175.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 m120 63.52 44.22 5.42 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.734 3.214 . . . . 25.449999999999999 110.007 169.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.7 mt -80.22 113.58 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 119.89 -1.756 . . . . 14.6 111.41 -178.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.261 14.6 mm100 -71.4 -179.56 2.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 124.644 2.164 . . . . 33.229999999999997 109.455 173.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -79.21 144.57 34.28 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-O 128.752 4.12 . . . . 25.969999999999999 109.95 165.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.366 65.8 mt-10 71.09 32.99 2.15 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.334 -2.666 . . . . 32.609999999999999 110.26 174.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.269 2.9 m -98.55 144.93 27.34 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 116.559 -3.838 . . . . 10.56 107.269 175.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -94.82 115.36 27.4 Favored 'General case' 0 N--CA 1.431 -1.423 1 C-N-CA 132.147 4.179 . . . . 5.3300000000000001 110.267 176.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.69 129.83 34.72 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.62 -1.622 . . . . 11.66 106.62 170.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -81.1 105.91 12.68 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.932 -2.355 . . . . 16.300000000000001 108.413 168.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.458 HD23 HG22 ' A' ' 7' ' ' THR . 34.3 tp -84.93 108.72 17.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.226 2.61 . . . . 9.9600000000000009 109.893 168.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 m -113.74 168.59 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.237 2.215 . . . . 9.7599999999999998 106.264 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.9 tp . . . . . 0 N--CA 1.43 -1.465 0 O-C-N 127.748 3.155 . . . . 19.57 108.886 -167.491 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.335 0 N-CA-C 104.455 -2.424 . . . . 17.170000000000002 104.455 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -114.3 160.12 19.44 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.938 -1.726 . . . . 21.890000000000001 115.459 173.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.4 pt -133.7 154.17 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 1 CA-C-O 129.434 4.445 . . . . 10.83 105.32 169.842 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -106.96 105.03 14.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.026 3.298 . . . . 10.609999999999999 102.872 177.073 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.32 105.19 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.009 -2.307 . . . . 9.1300000000000008 112.838 171.173 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -95.64 128.04 42.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.258 1.98 . . . . 20.550000000000001 111.499 -175.498 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -82.29 -179.16 7.31 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.939 -3.601 . . . . 11.779999999999999 113.845 -172.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.0 tp -75.22 -48.52 23.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.467 -3.896 . . . . 19.309999999999999 112.114 -176.701 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.0 p -70.22 -24.0 63.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.93 2.776 . . . . 23.140000000000001 116.647 -178.632 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.36 75.88 0.52 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 118.657 -2.527 . . . . 19.739999999999998 110.517 170.916 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -142.16 139.38 32.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.882 -3.007 . . . . 21.93 102.882 170.141 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.3 m -106.52 104.19 13.82 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.296 1.438 . . . . 12.33 110.626 176.112 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 mt -92.31 118.21 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 118.468 -0.777 . . . . 17.079999999999998 109.636 176.817 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.5 m -95.83 122.72 38.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.229 -3.248 . . . . 16.300000000000001 102.229 179.005 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 tp -127.85 147.53 50.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.364 -0.835 . . . . 15.880000000000001 112.386 -176.216 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -95.87 122.73 38.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.284 -1.817 . . . . 28.899999999999999 108.787 178.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.23 168.06 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.196 2.599 . . . . 12.050000000000001 109.187 177.686 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -107.12 153.41 41.04 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 116.756 -3.715 . . . . 18.170000000000002 101.264 163.644 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.43 -12.96 32.49 Favored 'Trans proline' 0 N--CA 1.433 -2.036 2 C-N-CA 128.323 6.016 . . . . 8.1600000000000001 105.122 179.699 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p -83.97 12.44 6.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.017 2.927 . . . . 11.130000000000001 114.387 171.538 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -93.34 146.12 23.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.599 -2.0 . . . . 18.030000000000001 105.599 176.82 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.9 p -89.1 168.58 12.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.852 -1.536 . . . . 10.220000000000001 106.852 -175.456 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -82.24 -28.08 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 116.151 1.908 . . . . 12.300000000000001 116.151 -173.671 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -48.27 -50.31 30.29 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.745 -2.48 . . . . 36.509999999999998 112.078 155.349 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -59.0 -53.03 63.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.239 2.681 . . . . 25.66 118.239 168.021 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 t -50.22 -37.99 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 116.552 2.056 . . . . 8.1199999999999992 116.552 171.087 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -68.33 -41.55 80.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 117.725 -1.131 . . . . 15.470000000000001 113.984 173.598 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.69 70.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.907 3.299 . . . . 11.449999999999999 119.907 174.197 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -61.89 -47.42 85.04 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.976 2.911 . . . . 24.98 113.002 170.17 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.51 -35.0 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.982 -1.698 . . . . 9.4600000000000009 108.595 -176.814 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -62.02 -46.79 87.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.428 -3.295 . . . . 14.76 113.876 170.29 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -49.27 -58.97 4.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.458 2.762 . . . . 26.289999999999999 118.458 163.711 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -71.04 -67.41 0.51 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.237 -2.789 . . . . 30.059999999999999 116.203 -178.58 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -85.33 -24.87 27.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.916 1.817 . . . . 25.190000000000001 114.077 -171.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.82 38.89 14.8 Favored Glycine 0 N--CA 1.43 -1.727 0 O-C-N 119.611 -1.931 . . . . 7.4100000000000001 115.235 -178.614 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.1 mt -102.98 109.91 62.42 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 114.3 -2.762 . . . . 9.4900000000000002 109.013 -179.168 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.7 142.23 82.98 Favored 'Trans proline' 0 N--CA 1.434 -1.987 2 C-N-CA 127.181 5.254 . . . . 11.42 114.321 -171.649 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.47 -17.97 6.08 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 123.026 2.116 . . . . 12.0 109.946 -159.807 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.269 37.0 m-20 -60.49 -23.67 64.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 126.551 2.407 . . . . 35.549999999999997 116.486 161.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -84.3 -33.04 24.04 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 117.261 -3.399 . . . . 20.52 115.263 176.595 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -67.41 138.03 56.37 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.026 3.343 . . . . 7.1299999999999999 120.026 -179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -136.71 132.09 34.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 105.181 -2.155 . . . . 36.390000000000001 105.181 161.441 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.253 11.4 mt -111.91 124.89 53.33 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 129.279 4.112 . . . . 9.5500000000000007 107.702 -174.621 . . . . . . . . 3 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.3 mt -117.79 117.84 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.704 2.402 . . . . 13.9 111.2 -173.165 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -94.55 102.97 14.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.567 -1.958 . . . . 6.8600000000000003 110.96 168.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.99 -81.35 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.767 2.136 . . . . 11.15 116.767 -163.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.85 16.91 2.39 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 104.666 -3.374 . . . . 13.93 104.666 172.773 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -95.73 111.49 23.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 119.255 1.528 . . . . 23.920000000000002 114.671 171.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -76.73 116.55 17.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.836 -1.529 . . . . 23.23 111.721 -179.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.0 mt -87.26 138.64 31.31 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.457 -3.277 . . . . 9.1099999999999994 112.806 -164.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -97.21 161.23 13.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.428 2.01 . . . . 33.439999999999998 116.428 -175.894 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.269 7.8 m-20 -46.4 -68.78 0.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 119.829 3.27 . . . . 28.370000000000001 119.829 -166.844 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.14 8.4 70.85 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 118.013 1.965 . . . . 15.0 118.013 -165.977 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -94.92 158.88 15.29 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 126.866 3.222 . . . . 25.5 112.092 -176.844 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.95 164.03 12.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.089 2.376 . . . . 11.949999999999999 109.229 -179.335 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.69 -18.92 62.14 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 112.762 -3.494 . . . . 10.17 113.207 171.482 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -71.22 -31.86 68.09 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 126.046 2.091 . . . . 13.59 112.464 169.587 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -66.41 -53.1 39.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.55 -3.219 . . . . 11.699999999999999 109.269 179.012 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -66.42 -19.76 65.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.704 -3.122 . . . . 12.949999999999999 110.683 -179.454 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 m120 73.64 47.54 0.17 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.616 1.71 . . . . 25.449999999999999 115.616 -178.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.72 111.65 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.179 2.419 . . . . 14.6 110.003 -177.021 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -71.03 174.5 6.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 112.327 -2.215 . . . . 33.229999999999997 111.681 -176.17 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -52.46 133.22 35.48 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.561 3.171 . . . . 25.969999999999999 119.561 168.68 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 60.53 50.71 5.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.666 -3.146 . . . . 32.609999999999999 113.392 175.523 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 m -107.35 154.6 21.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.875 -1.511 . . . . 10.56 110.74 -179.426 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -102.08 126.68 49.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.377 3.548 . . . . 5.3300000000000001 107.244 -168.294 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.23 145.9 39.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 117.524 -1.227 . . . . 11.66 109.243 178.339 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -101.59 123.84 46.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.495 -1.668 . . . . 16.300000000000001 106.495 177.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 tp -100.4 117.88 35.49 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.613 2.365 . . . . 9.9600000000000009 107.62 174.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -115.46 -165.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.602 2.075 . . . . 9.7599999999999998 116.602 171.903 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 N--CA 1.43 -1.437 0 O-C-N 120.043 -1.661 . . . . 19.57 113.327 168.293 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 39.7 ttm . . . . . 0 CA--C 1.49 -1.365 0 N-CA-C 110.297 -0.26 . . . . 17.170000000000002 110.297 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -87.82 134.12 33.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.741 -1.85 . . . . 21.890000000000001 112.454 171.06 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -122.09 171.22 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 119.162 0.892 . . . . 10.83 110.675 162.497 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -116.09 121.65 42.8 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.133 -2.854 . . . . 10.609999999999999 109.319 174.39 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.3 t -106.2 104.49 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 124.971 2.319 . . . . 9.1300000000000008 111.483 173.11 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -82.74 134.37 35.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.906 -3.621 . . . . 20.550000000000001 113.822 -177.804 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.7 p -87.12 176.22 7.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.364 1.665 . . . . 11.779999999999999 110.963 -174.376 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.64 -44.4 64.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.75 1.22 . . . . 19.309999999999999 109.636 177.707 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -69.55 -63.7 1.02 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.47 1.508 . . . . 23.140000000000001 114.231 -177.426 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.23 21.82 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 115.589 -3.196 . . . . 19.739999999999998 115.42 176.178 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -105.28 138.58 41.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.318 -1.364 . . . . 21.93 107.318 -173.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -105.43 118.45 36.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.717 -2.489 . . . . 12.33 107.182 168.713 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.39 126.68 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 114.102 -2.856 . . . . 17.079999999999998 107.211 -173.553 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.3 m -101.37 125.69 48.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 102.888 -3.004 . . . . 16.300000000000001 102.888 -171.782 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 15' ' ' LEU . 15.6 tp -141.05 131.0 24.48 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.721 -2.696 . . . . 15.880000000000001 103.721 -154.91 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -114.85 107.13 15.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.025 -2.954 . . . . 28.899999999999999 103.025 -168.082 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.409 HG11 HG22 ' A' ' 26' ' ' VAL . 16.8 m -116.6 155.76 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 128.541 2.737 . . . . 12.050000000000001 112.727 -177.412 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -89.47 143.86 31.28 Favored Pre-proline 0 N--CA 1.43 -1.443 1 CA-C-O 111.465 -4.112 . . . . 18.170000000000002 108.494 171.152 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 56' ' ' LEU . 27.9 Cg_endo -87.47 -5.77 7.21 Favored 'Trans proline' 0 N--CA 1.433 -2.043 2 CA-C-N 129.132 4.297 . . . . 8.1600000000000001 105.628 -173.767 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.267 65.9 m -84.11 -6.51 59.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.014 -1.074 . . . . 11.130000000000001 113.726 171.817 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -107.91 161.14 15.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 128.16 3.838 . . . . 18.030000000000001 108.843 -179.132 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -77.23 166.9 22.61 Favored 'General case' 0 N--CA 1.43 -1.446 1 N-CA-C 121.849 4.018 . . . . 10.220000000000001 121.849 -176.006 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -63.25 -32.85 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.039 1.335 . . . . 12.300000000000001 111.64 174.587 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -53.61 -44.15 69.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.109 -1.619 . . . . 36.509999999999998 112.032 172.537 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -79.84 -14.3 58.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.3 -3.375 . . . . 25.66 114.309 178.004 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.409 HG22 HG11 ' A' ' 17' ' ' VAL . 65.0 t -69.22 -47.62 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.251 -2.156 . . . . 8.1199999999999992 109.866 165.522 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.25 90.7 mttt -69.68 -28.39 65.81 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.07 1.748 . . . . 15.470000000000001 111.527 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.271 . . -65.8 -38.04 87.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.832 2.053 . . . . 11.449999999999999 106.885 175.502 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -73.32 -31.69 64.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.004 2.638 . . . . 24.98 116.55 178.199 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.25 70.8 mt -72.34 -42.21 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.081 2.372 . . . . 9.4600000000000009 111.317 172.108 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -49.93 -35.63 24.72 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.475 2.028 . . . . 14.76 116.475 169.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -85.59 -55.28 4.07 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.814 -1.921 . . . . 26.289999999999999 105.814 -173.822 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -71.85 -44.46 63.8 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.507 -1.371 . . . . 30.059999999999999 112.774 -169.419 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -106.89 -33.09 7.64 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.529 -1.357 . . . . 25.190000000000001 109.589 -162.054 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.4 46.69 4.88 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 128.124 2.774 . . . . 7.4100000000000001 113.81 170.289 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.0 mt -106.93 128.6 25.79 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 101.364 -3.569 . . . . 9.4900000000000002 101.364 176.355 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -82.86 162.95 16.06 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 O-C-N 117.029 -2.143 . . . . 11.42 110.857 179.409 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.15 -23.23 4.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 N-CA-C 121.386 3.571 . . . . 12.0 121.386 166.087 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -68.08 -23.65 64.96 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.608 -2.557 . . . . 35.549999999999997 106.936 178.258 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -108.73 -12.94 14.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 127.266 3.412 . . . . 20.52 116.267 -179.304 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -86.84 115.46 24.27 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 115.678 -4.389 . . . . 7.1299999999999999 113.46 -177.384 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -111.89 117.24 32.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.297 -1.001 . . . . 36.390000000000001 108.297 163.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -98.98 131.44 45.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.889 1.676 . . . . 9.5500000000000007 106.716 178.813 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.421 HD13 HG21 ' A' ' 44' ' ' ILE . 63.8 mt -131.2 140.51 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 119.487 -2.008 . . . . 13.9 107.062 177.397 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -101.28 100.92 11.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.228 3.811 . . . . 6.8600000000000003 108.678 161.674 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.09 -91.48 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.532 2.333 . . . . 11.15 116.704 -169.366 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.84 14.49 6.69 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 116.928 -2.04 . . . . 13.93 111.241 175.724 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -98.46 108.81 21.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 126.514 1.949 . . . . 23.920000000000002 106.785 173.899 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -79.74 102.28 8.93 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 119.963 3.32 . . . . 23.23 119.963 171.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.12 146.18 55.32 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 124.737 2.208 . . . . 9.1099999999999994 114.729 -155.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -107.06 143.87 34.54 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.119 -4.113 . . . . 33.439999999999998 112.835 178.805 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.96 -38.95 20.35 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 114.571 -2.633 . . . . 28.370000000000001 114.313 -153.379 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.88 45.78 3.57 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 124.024 3.102 . . . . 15.0 113.818 163.901 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -131.46 162.51 30.04 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.119 -4.754 . . . . 25.5 105.252 170.622 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -108.26 172.86 6.6 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 117.591 -3.193 . . . . 11.949999999999999 114.82 -175.669 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 19' ' ' PRO . 11.2 mt -64.81 -37.87 89.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.16 1.457 . . . . 10.17 108.191 169.006 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.356 1.2 m -56.2 -36.95 68.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.468 3.507 . . . . 13.59 120.468 167.626 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -58.75 -42.67 89.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.351 -2.718 . . . . 11.699999999999999 114.009 165.527 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -81.07 -7.39 59.55 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.731 -1.855 . . . . 12.949999999999999 111.426 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.256 60.8 m-80 55.78 48.42 18.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.321 2.249 . . . . 25.449999999999999 116.023 -171.872 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -84.32 140.47 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.009 1.723 . . . . 14.6 113.014 175.625 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -109.1 -175.06 2.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.122 1.769 . . . . 33.229999999999997 106.879 -170.247 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HG2' ' HG3' ' A' ' 1' ' ' MET 0.299 18.3 mtmm -72.63 147.53 45.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.662 -1.899 . . . . 25.969999999999999 112.532 174.97 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 78.51 20.85 0.83 Allowed 'General case' 0 N--CA 1.43 -1.441 1 C-N-CA 132.027 4.131 . . . . 32.609999999999999 106.863 166.341 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -88.48 159.97 17.72 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 116.08 -4.137 . . . . 10.56 109.779 -163.934 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 m -103.84 134.98 46.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 124.328 2.013 . . . . 5.3300000000000001 112.473 -175.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -114.71 169.24 9.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 130.447 3.499 . . . . 11.66 108.302 165.222 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -123.62 136.5 54.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 114.775 -2.536 . . . . 16.300000000000001 107.753 174.002 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tp -97.04 113.95 25.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.542 2.428 . . . . 9.9600000000000009 113.96 159.572 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -116.96 -166.01 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 116.764 -3.71 . . . . 9.7599999999999998 108.542 162.515 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.559 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.43 -1.452 0 C-N-CA 127.345 2.258 . . . . 19.57 109.668 -172.359 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 CA--C 1.49 -1.346 0 N-CA-C 115.65 1.722 . . . . 17.170000000000002 115.65 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -86.75 133.62 33.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.967 3.707 . . . . 21.890000000000001 110.941 171.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.39 158.83 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 119.569 1.077 . . . . 10.83 108.376 172.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.93 145.09 31.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.324 1.059 . . . . 10.609999999999999 109.935 168.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 67' ' ' LEU . 85.7 t -122.3 139.08 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 101.22 -3.622 . . . . 9.1300000000000008 101.22 168.994 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -117.6 124.5 48.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.162 -0.926 . . . . 20.550000000000001 112.843 177.245 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -79.69 166.84 21.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.073 -1.876 . . . . 11.779999999999999 115.563 -177.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.9 tt -74.5 -43.61 55.16 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.687 -4.383 . . . . 19.309999999999999 108.912 -172.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -60.06 -44.06 94.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.575 -3.203 . . . . 23.140000000000001 110.024 173.464 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.21 59.87 0.21 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 126.233 2.208 . . . . 19.739999999999998 111.123 177.37 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -107.53 127.16 53.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.453 1.101 . . . . 21.93 109.553 161.561 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -101.07 112.2 24.61 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.124 -0.985 . . . . 12.33 108.892 174.588 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 pt -109.94 134.98 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 125.963 2.792 . . . . 17.079999999999998 111.01 -172.397 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.2 m -89.25 115.22 26.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.512 -1.992 . . . . 16.300000000000001 109.142 -174.769 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 mt -104.0 167.23 9.9 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.373 -2.079 . . . . 15.880000000000001 114.629 170.015 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.321 9.2 tt0 -130.47 113.69 14.6 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.565 1.546 . . . . 28.899999999999999 115.169 168.45 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.76 145.28 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.957 1.703 . . . . 12.050000000000001 110.363 -173.176 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.84 148.17 94.59 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 117.267 -3.396 . . . . 18.170000000000002 113.018 158.596 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -65.97 -21.68 56.45 Favored 'Trans proline' 0 C--N 1.3 -2.019 3 C-N-CA 126.214 4.609 . . . . 8.1600000000000001 113.414 172.096 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.8 m -84.61 8.11 17.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.681 1.705 . . . . 11.130000000000001 115.483 173.756 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -87.82 157.98 18.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.546 -2.596 . . . . 18.030000000000001 109.248 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 55' ' ' THR . 23.6 p -95.1 167.7 11.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.091 2.957 . . . . 10.220000000000001 115.061 -176.975 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -67.26 -26.35 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.211 1.93 . . . . 12.300000000000001 116.211 172.321 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -63.41 -47.52 81.64 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.073 -2.267 . . . . 36.509999999999998 112.03 175.264 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.91 -23.36 65.98 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.001 2.52 . . . . 25.66 113.738 176.096 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.31 -58.16 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.955 2.902 . . . . 8.1199999999999992 107.87 167.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -70.56 -17.99 62.92 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 115.353 -4.592 . . . . 15.470000000000001 116.495 -173.896 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.55 -28.26 65.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.061 -1.65 . . . . 11.449999999999999 109.315 167.171 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -77.93 -33.36 51.76 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.497 1.499 . . . . 24.98 111.05 -177.036 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.1 -34.74 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 128.368 2.667 . . . . 9.4600000000000009 110.213 178.529 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -56.75 -47.53 79.85 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 117.959 -1.02 . . . . 14.76 113.057 165.756 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -65.78 -57.95 6.8 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.059 2.614 . . . . 26.289999999999999 118.059 171.798 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -59.28 -52.16 66.87 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.46 3.133 . . . . 30.059999999999999 119.46 -173.359 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -107.09 -43.64 4.57 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 122.079 0.943 . . . . 25.190000000000001 109.681 176.418 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.32 47.43 2.02 Favored Glycine 0 N--CA 1.43 -1.741 0 O-C-N 118.264 -2.772 . . . . 7.4100000000000001 110.733 -173.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 mt -104.55 114.61 63.9 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 101.516 -3.513 . . . . 9.4900000000000002 101.516 168.249 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -83.62 163.41 14.4 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 CA-C-O 111.719 -3.534 . . . . 11.42 116.55 -171.061 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -81.6 -3.61 11.96 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 130.279 4.707 . . . . 12.0 111.281 -162.265 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.51 -26.4 45.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.001 1.273 . . . . 35.549999999999997 112.945 176.215 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -69.24 -51.24 39.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.912 3.671 . . . . 20.52 120.912 158.062 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -68.45 116.5 9.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.787 2.708 . . . . 7.1299999999999999 115.858 -168.892 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -111.83 113.84 26.44 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.216 -4.678 . . . . 36.390000000000001 105.961 168.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 mt -83.61 127.65 33.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.155 1.798 . . . . 9.5500000000000007 110.88 -179.919 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.6 mm -121.45 139.81 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 125.947 1.699 . . . . 13.9 108.282 177.774 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -135.25 139.99 44.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 104.206 -2.516 . . . . 6.8600000000000003 104.206 157.207 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.266 . . 47.92 -98.86 0.05 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.504 2.721 . . . . 11.15 112.052 -164.899 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.91 31.05 1.35 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 114.376 -3.773 . . . . 13.93 110.252 167.568 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -95.18 147.34 23.56 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.242 1.417 . . . . 23.920000000000002 108.11 166.689 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -99.62 139.46 35.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.927 -1.511 . . . . 23.23 110.692 170.595 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.258 0.4 OUTLIER -113.74 131.75 56.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.092 1.495 . . . . 9.1099999999999994 107.574 -163.756 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -101.08 157.36 16.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 125.333 1.646 . . . . 33.439999999999998 115.075 -162.71 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.259 33.6 m-20 -59.8 -53.72 54.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 121.447 3.869 . . . . 28.370000000000001 121.447 -165.283 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.86 33.93 5.24 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-N 121.109 1.777 . . . . 15.0 115.695 -179.408 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -113.92 150.34 33.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.18 -2.953 . . . . 25.5 105.092 169.712 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 22' ' ' THR . 16.0 p -90.16 171.48 9.49 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.939 2.78 . . . . 11.949999999999999 111.653 -170.21 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.63 -30.49 26.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.978 -3.576 . . . . 10.17 108.722 -176.789 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -59.05 -39.83 83.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.792 2.837 . . . . 13.59 108.233 170.816 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -58.03 -59.92 4.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.631 -3.793 . . . . 11.699999999999999 111.247 179.496 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -70.74 -11.96 61.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 130.099 3.359 . . . . 12.949999999999999 112.056 -170.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 65.71 60.04 0.72 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.92 -2.988 . . . . 25.449999999999999 112.851 -179.193 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mm -90.69 137.05 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.319 -2.738 . . . . 14.6 110.646 179.556 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -101.06 -175.8 2.98 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.507 -1.995 . . . . 33.229999999999997 114.883 -171.876 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -78.17 142.12 38.21 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.124 1.157 . . . . 25.969999999999999 114.124 178.661 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 61.11 30.84 19.65 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.214 2.206 . . . . 32.609999999999999 112.401 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.1 t -81.35 158.44 24.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 117.053 2.242 . . . . 10.56 117.053 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.3 m -121.37 103.76 9.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.145 -2.222 . . . . 5.3300000000000001 107.805 -166.678 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB2' HG22 ' A' ' 5' ' ' VAL 0.273 91.6 mt -88.48 147.35 24.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.142 2.977 . . . . 11.66 107.438 175.542 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -100.84 137.72 38.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.303 2.252 . . . . 16.300000000000001 110.093 -178.625 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 mt -106.07 141.22 37.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.908 -1.745 . . . . 9.9600000000000009 111.778 165.122 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.85 -169.85 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.62 2.368 . . . . 9.7599999999999998 108.517 169.969 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.43 -1.448 0 C-N-CA 131.369 3.868 . . . . 19.57 116.06 -173.103 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 CA--C 1.49 -1.361 0 CA-C-O 121.447 0.642 . . . . 17.170000000000002 110.874 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -89.39 152.07 21.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.239 1.971 . . . . 21.890000000000001 109.987 170.549 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 pt -126.33 168.71 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.668 2.787 . . . . 10.83 109.401 154.811 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -119.15 145.75 45.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.775 1.75 . . . . 10.609999999999999 110.927 164.255 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.9 123.53 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 116.618 -3.801 . . . . 9.1300000000000008 107.897 169.305 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -93.09 121.14 34.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.884 3.23 . . . . 20.550000000000001 109.72 176.227 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 p -78.18 -176.88 4.83 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.098 -4.751 . . . . 11.779999999999999 111.663 -174.138 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.3 tp -81.9 -34.36 30.02 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 111.823 -6.798 . . . . 19.309999999999999 113.337 -175.666 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.1 p -88.15 -26.29 22.52 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.12 -2.238 . . . . 23.140000000000001 107.06 -173.18 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.41 0.21 Allowed Glycine 0 N--CA 1.43 -1.738 0 CA-C-N 118.968 0.804 . . . . 19.739999999999998 113.161 166.121 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -112.1 145.62 39.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.367 -1.666 . . . . 21.93 108.043 169.552 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -111.15 123.78 50.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.991 2.057 . . . . 12.33 106.743 176.08 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.6 pt -110.7 141.99 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.76 -1.212 . . . . 17.079999999999998 113.856 177.232 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.7 m -110.57 112.85 25.03 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 115.491 -4.506 . . . . 16.300000000000001 111.047 -174.782 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 30' ' ' ILE . 45.6 mt -106.35 124.13 49.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.443 2.068 . . . . 15.880000000000001 108.967 -173.953 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -97.6 105.43 17.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.865 -3.022 . . . . 28.899999999999999 111.987 176.698 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -131.47 149.25 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.921 2.088 . . . . 12.050000000000001 107.677 -159.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -85.5 151.83 56.59 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 112.592 -3.575 . . . . 18.170000000000002 113.182 176.334 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -84.71 -6.06 9.8 Favored 'Trans proline' 0 N--CA 1.434 -2.028 1 CA-C-N 132.554 5.519 . . . . 8.1600000000000001 109.072 -168.866 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -98.64 5.68 47.57 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.559 -3.213 . . . . 11.130000000000001 110.117 176.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -75.76 157.73 33.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.79 3.186 . . . . 18.030000000000001 108.677 173.394 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 p -96.37 164.26 12.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.812 -3.68 . . . . 10.220000000000001 108.29 -175.972 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mm -76.96 -16.6 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 119.516 -1.99 . . . . 12.300000000000001 111.692 -176.326 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -64.27 -46.88 81.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.343 -1.725 . . . . 36.509999999999998 106.343 172.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.77 -30.95 71.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.617 -2.552 . . . . 25.66 113.48 -178.296 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.77 -44.07 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 126.707 3.146 . . . . 8.1199999999999992 108.265 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -62.78 -39.25 93.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 120.67 3.581 . . . . 15.470000000000001 120.67 172.756 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.76 -41.1 77.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.741 2.817 . . . . 11.449999999999999 113.76 175.045 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -57.13 -32.47 66.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.847 1.259 . . . . 24.98 110.4 178.82 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 15' ' ' LEU . 8.5 mt -82.41 -37.71 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.977 1.846 . . . . 9.4600000000000009 109.194 -173.075 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -62.1 -39.53 92.79 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.143 -1.598 . . . . 14.76 112.602 168.509 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.5 -55.16 30.13 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 115.621 -2.133 . . . . 26.289999999999999 113.052 175.236 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -78.52 -54.9 5.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.964 3.32 . . . . 30.059999999999999 119.964 -171.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -92.87 -36.13 12.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.548 -2.595 . . . . 25.190000000000001 112.115 176.991 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.84 55.98 2.56 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 117.763 -3.086 . . . . 7.4100000000000001 115.425 -174.849 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.0 mt -108.93 135.87 20.1 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 116.111 -1.899 . . . . 9.4900000000000002 105.982 172.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -71.53 146.58 49.98 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-O 112.397 -3.251 . . . . 11.42 119.591 -170.149 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -91.53 8.57 3.1 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 CA-C-N 128.163 3.951 . . . . 12.0 112.96 -165.729 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.42 -44.19 10.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.799 2.839 . . . . 35.549999999999997 109.142 165.393 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.31 -42.11 65.81 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 113.826 -2.988 . . . . 20.52 111.555 175.253 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.268 72.6 mt-30 -66.45 108.97 2.57 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 126.616 3.103 . . . . 7.1299999999999999 115.67 -174.169 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -106.51 110.02 22.11 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.114 4.165 . . . . 36.390000000000001 105.278 -174.223 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HG ' HD12 ' A' ' 50' ' ' LEU . 25.8 tp -100.27 108.87 21.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 126.037 2.827 . . . . 9.5500000000000007 108.182 -162.735 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -106.66 145.82 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.141 -3.475 . . . . 13.9 113.09 -173.54 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -129.99 100.17 5.35 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.624 2.631 . . . . 6.8600000000000003 106.642 172.736 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.88 -75.51 0.07 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.638 -2.539 . . . . 11.15 115.63 -176.352 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.58 1.2 1.33 Allowed Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 126.527 2.013 . . . . 13.93 113.621 171.532 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -99.13 146.55 26.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.201 -2.352 . . . . 23.920000000000002 110.079 173.659 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.296 10.0 tt0 -91.1 117.29 29.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.045 2.609 . . . . 23.23 118.045 164.119 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.444 HD12 ' HG ' ' A' ' 43' ' ' LEU . 19.4 mt -65.85 131.92 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 1 C-N-CA 133.177 4.591 . . . . 9.1099999999999994 113.581 170.841 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.9 146.33 44.01 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.811 -1.181 . . . . 33.439999999999998 107.811 -169.084 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.65 -27.45 68.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.19 -2.277 . . . . 28.370000000000001 115.563 -158.65 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.04 24.43 30.53 Favored Glycine 0 N--CA 1.43 -1.729 1 O-C-N 114.526 -5.109 . . . . 15.0 117.353 -166.335 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -129.22 166.46 19.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.479 -0.934 . . . . 25.5 108.479 -176.137 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.295 22.2 p -92.93 157.91 16.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.251 1.501 . . . . 11.949999999999999 111.052 -173.708 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.2 mt -55.76 -34.04 64.87 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.449 1.595 . . . . 10.17 113.463 168.77 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 t -78.42 -25.43 46.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.895 3.278 . . . . 13.59 118.869 170.751 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -61.77 -47.58 84.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.734 -2.479 . . . . 11.699999999999999 113.044 166.871 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -81.76 -16.63 50.43 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.456 3.102 . . . . 12.949999999999999 111.271 -179.205 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 56.51 51.46 11.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.125 2.97 . . . . 25.449999999999999 109.39 -178.583 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.39 120.19 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 110.851 -2.886 . . . . 14.6 108.679 163.24 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -83.49 176.82 8.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.451 1.9 . . . . 33.229999999999997 110.365 -176.564 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.274 47.7 mttp -81.98 134.39 35.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.141 2.576 . . . . 25.969999999999999 109.55 179.81 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 56.83 34.03 24.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.787 2.835 . . . . 32.609999999999999 116.141 -175.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -72.14 127.44 32.55 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 127.591 3.567 . . . . 10.56 111.67 166.007 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.6 m -95.65 109.12 21.43 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 112.16 -2.291 . . . . 5.3300000000000001 112.499 179.297 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 mt -96.36 175.26 6.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.815 -1.178 . . . . 11.66 109.899 -172.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -128.65 136.13 50.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.827 -1.171 . . . . 16.300000000000001 112.432 -175.478 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 tp -120.6 129.77 53.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.552 -1.967 . . . . 9.9600000000000009 108.004 -176.063 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.53 163.43 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.366 1.066 . . . . 9.7599999999999998 109.727 170.186 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.43 -1.447 0 O-C-N 120.182 -1.574 . . . . 19.57 109.548 -169.172 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.366 0 CA-C-O 123.144 1.449 . . . . 17.170000000000002 108.774 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -108.29 138.06 45.22 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.202 -4.061 . . . . 21.890000000000001 108.74 -172.576 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -133.78 148.85 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.609 -2.557 . . . . 10.83 107.361 -179.842 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.68 110.88 22.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.729 2.122 . . . . 10.609999999999999 116.729 177.311 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 t -101.14 122.7 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 120.918 1.69 . . . . 9.1300000000000008 108.863 175.635 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HG2' HG23 ' A' ' 12' ' ' THR . 49.0 mttt -90.32 111.32 22.48 Favored 'General case' 0 N--CA 1.429 -1.495 1 C-N-CA 131.881 4.072 . . . . 20.550000000000001 113.247 175.249 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -76.93 159.49 29.94 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.253 1.945 . . . . 11.779999999999999 116.253 176.942 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 tp -53.52 -49.69 67.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.239 2.215 . . . . 19.309999999999999 110.981 -178.605 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.4 p -65.85 -38.1 87.95 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.533 3.533 . . . . 23.140000000000001 113.751 178.37 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.66 51.07 0.26 Allowed Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 127.785 2.612 . . . . 19.739999999999998 116.496 -178.195 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -121.53 128.92 52.54 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.961 -1.905 . . . . 21.93 108.764 165.645 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.415 HG23 ' HG2' ' A' ' 6' ' ' LYS . 85.6 m -99.59 108.22 20.57 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.697 -3.752 . . . . 12.33 105.9 171.199 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pt -105.15 140.79 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 130.25 3.42 . . . . 17.079999999999998 104.536 -171.818 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -109.14 131.22 55.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.143 -2.848 . . . . 16.300000000000001 108.624 -170.239 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.0 mt -113.3 140.55 47.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.89 -1.893 . . . . 15.880000000000001 105.89 -179.147 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -100.24 128.25 46.35 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.585 -1.265 . . . . 28.899999999999999 107.585 171.127 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.05 152.15 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.193 -2.817 . . . . 12.050000000000001 117.188 -168.847 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.26 32.5 mt-10 -97.03 148.78 34.89 Favored Pre-proline 0 N--CA 1.43 -1.456 1 O-C-N 115.795 -4.316 . . . . 18.170000000000002 105.863 172.246 . . . . . . . . 3 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -82.31 -8.57 11.7 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.687 1.888 . . . . 8.1600000000000001 111.899 -169.544 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -81.06 -12.47 59.31 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.944 2.097 . . . . 11.130000000000001 109.976 -179.086 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -90.7 154.36 19.61 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 126.457 3.027 . . . . 18.030000000000001 109.259 -176.582 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.9 p -83.11 175.83 9.69 Favored 'General case' 0 N--CA 1.43 -1.43 2 O-C-N 114.63 -5.043 . . . . 10.220000000000001 117.758 -170.386 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.0 mm -79.65 -25.79 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 1 O-C-N 113.432 -5.792 . . . . 12.300000000000001 111.862 178.647 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -47.58 -40.71 19.89 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.97 2.211 . . . . 36.509999999999998 116.97 165.978 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -70.29 -42.33 72.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.274 2.629 . . . . 25.66 111.855 176.711 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.443 HG21 HD21 ' A' ' 56' ' ' LEU . 68.4 t -67.86 -34.14 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 117.37 -3.331 . . . . 8.1199999999999992 110.592 178.309 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.256 35.5 mtmt -65.4 -37.19 86.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.977 2.111 . . . . 15.470000000000001 112.541 166.792 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.88 -24.34 64.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.083 2.114 . . . . 11.449999999999999 112.559 -174.516 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -71.22 -37.89 72.02 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 133.599 4.76 . . . . 24.98 109.096 175.215 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.403 ' CG2' HD12 ' A' ' 36' ' ' ILE . 52.6 mt -80.51 -31.02 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.322 -1.487 . . . . 9.4600000000000009 107.575 -174.535 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.06 -31.33 68.89 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.24 1.416 . . . . 14.76 112.971 177.201 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -82.28 -52.3 7.07 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.283 2.327 . . . . 26.289999999999999 117.283 -175.471 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -86.06 -54.55 4.41 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.269 1.985 . . . . 30.059999999999999 116.046 -177.657 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -72.32 -39.89 67.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.315 -1.491 . . . . 25.190000000000001 114.484 177.291 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.89 51.78 2.94 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 116.449 -3.907 . . . . 7.4100000000000001 115.9 174.064 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.403 HD12 ' CG2' ' A' ' 30' ' ' ILE . 63.9 mt -113.18 129.21 24.78 Favored Pre-proline 0 N--CA 1.431 -1.421 0 C-N-CA 127.304 2.242 . . . . 9.4900000000000002 107.909 -176.516 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -77.39 148.95 27.15 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 114.568 -3.438 . . . . 11.42 110.01 -164.682 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -71.3 -24.39 23.06 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.805 2.337 . . . . 12.0 113.919 -156.596 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.292 5.2 p-10 -63.61 -53.23 54.8 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.687 -2.508 . . . . 35.549999999999997 110.124 173.751 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -57.43 -13.81 4.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.522 -2.611 . . . . 20.52 117.376 -177.98 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -93.63 95.61 9.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.351 1.46 . . . . 7.1299999999999999 109.311 -178.737 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -89.89 142.79 27.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 118.448 -1.301 . . . . 36.390000000000001 109.927 156.49 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 43' ' ' LEU . 12.0 mt -120.29 135.67 54.93 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.36 -0.978 . . . . 9.5500000000000007 108.36 -177.19 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 49' ' ' GLN . 11.1 mm -120.31 138.22 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.667 2.787 . . . . 13.9 106.22 -179.685 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.431 ' HB2' HD11 ' A' ' 50' ' ' LEU . 25.4 t80 -112.76 114.72 27.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.995 2.918 . . . . 6.8600000000000003 106.439 165.632 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.62 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.912 2.19 . . . . 11.15 116.912 -173.649 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.51 8.01 2.04 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 129.115 3.245 . . . . 13.93 106.525 -175.571 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -125.4 144.95 50.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.196 2.498 . . . . 23.920000000000002 111.927 -173.539 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.401 ' HA ' HD13 ' A' ' 44' ' ' ILE . 22.1 tt0 -103.13 134.5 46.45 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.884 1.326 . . . . 23.23 111.127 -161.682 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 45' ' ' PHE . 50.1 mt -84.68 143.89 28.91 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 115.882 -2.008 . . . . 9.1099999999999994 110.674 -176.105 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -135.11 156.37 49.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 126.529 2.393 . . . . 33.439999999999998 111.134 -173.059 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.79 -50.55 19.99 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 118.807 2.892 . . . . 28.370000000000001 118.807 -147.407 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.65 2.07 18.38 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 121.078 3.191 . . . . 15.0 121.078 -177.964 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -106.92 148.89 28.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.269 1.509 . . . . 25.5 109.613 -174.415 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -90.85 159.26 16.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.027 2.531 . . . . 11.949999999999999 111.17 -162.023 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 26' ' ' VAL . 8.4 mt -58.23 -45.23 88.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.809 2.844 . . . . 10.17 108.378 172.111 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -57.58 -50.14 74.08 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.798 2.09 . . . . 13.59 114.505 178.325 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -60.53 -35.89 77.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.524 -1.36 . . . . 11.699999999999999 113.509 174.61 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -79.11 2.31 21.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.361 -3.337 . . . . 12.949999999999999 116.554 177.941 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.376 4.2 m120 71.39 34.52 1.7 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.213 -1.554 . . . . 25.449999999999999 111.932 -179.602 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.8 98.63 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 105.826 -1.916 . . . . 14.6 105.826 -165.84 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -107.13 -152.89 0.49 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.347 2.022 . . . . 33.229999999999997 112.16 -174.729 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -73.87 116.96 15.09 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.882 2.549 . . . . 25.969999999999999 117.882 -170.314 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 81.38 50.2 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.287 2.635 . . . . 32.609999999999999 106.468 163.601 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 152.66 25.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.983 1.713 . . . . 10.56 112.554 -169.859 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -94.58 115.91 28.13 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.483 3.513 . . . . 5.3300000000000001 112.754 -164.416 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -116.07 147.51 41.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.024 -3.548 . . . . 11.66 111.261 173.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -121.2 127.69 51.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.916 -2.253 . . . . 16.300000000000001 104.916 -175.618 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 tp -91.11 109.94 21.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.533 2.42 . . . . 9.9600000000000009 117.533 178.473 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.87 156.09 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.199 2.599 . . . . 9.7599999999999998 106.458 -172.763 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.7 tp . . . . . 0 N--CA 1.43 -1.45 0 O-C-N 119.162 -2.211 . . . . 19.57 112.524 173.289 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 115.061 1.504 . . . . 17.170000000000002 115.061 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -113.2 145.49 40.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.165 -2.21 . . . . 21.890000000000001 110.467 -174.654 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 pt -127.35 154.42 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.311 -1.737 . . . . 10.83 106.311 173.042 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -119.43 115.5 24.2 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.274 2.306 . . . . 10.609999999999999 106.987 -176.656 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.97 106.85 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.292 -1.505 . . . . 9.1300000000000008 113.471 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -83.56 110.2 18.03 Favored 'General case' 0 N--CA 1.43 -1.466 1 CA-C-O 128.648 4.07 . . . . 20.550000000000001 110.855 175.845 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.258 15.1 p -74.04 176.85 6.11 Favored 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 131.914 4.086 . . . . 11.779999999999999 113.238 -171.269 . . . . . . . . 3 2 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.66 -46.93 62.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.843 2.259 . . . . 19.309999999999999 114.743 -170.844 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.3 p -74.88 -91.24 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.216 3.006 . . . . 23.140000000000001 109.339 179.355 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.18 33.55 0.34 Allowed Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 121.59 1.995 . . . . 19.739999999999998 113.454 -174.675 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -122.64 141.99 51.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.136 -3.567 . . . . 21.93 115.089 178.108 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -109.54 123.56 49.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.768 -1.832 . . . . 12.33 111.461 170.477 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.0 pt -101.0 144.9 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 117.554 -1.212 . . . . 17.079999999999998 110.556 178.86 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.8 m -104.55 114.45 28.69 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.186 -2.34 . . . . 16.300000000000001 107.86 176.309 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.547 ' CD1' HG13 ' A' ' 26' ' ' VAL 0.313 96.5 mt -106.76 158.31 17.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.144 2.878 . . . . 15.880000000000001 105.234 176.021 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.323 27.0 tt0 -104.64 121.19 43.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 113.165 -1.834 . . . . 28.899999999999999 108.914 173.206 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -141.39 154.71 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 120.064 -1.647 . . . . 12.050000000000001 107.501 -179.517 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -87.87 158.37 50.53 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 119.603 -1.936 . . . . 18.170000000000002 106.907 167.229 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.12 -1.6 11.75 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 CA-C-N 122.169 1.81 . . . . 8.1600000000000001 115.664 174.117 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.5 m -86.25 -16.57 37.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.834 3.272 . . . . 11.130000000000001 119.834 173.75 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -84.26 170.25 13.9 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.872 2.869 . . . . 18.030000000000001 109.196 -174.766 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.5 p -90.92 -176.77 4.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.463 -3.273 . . . . 10.220000000000001 116.615 -173.084 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -83.16 -19.3 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 116.419 -3.926 . . . . 12.300000000000001 108.703 173.986 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -73.0 -42.51 63.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.055 -2.903 . . . . 36.509999999999998 107.309 178.216 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -54.82 -26.67 36.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.203 -1.856 . . . . 25.66 111.337 174.34 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.547 HG13 ' CD1' ' A' ' 15' ' ' LEU . 20.0 t -67.24 -54.85 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 117.795 2.517 . . . . 8.1199999999999992 117.795 167.703 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -62.48 -30.55 71.34 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 118.306 -2.746 . . . . 15.470000000000001 116.092 -177.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.68 -49.79 56.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.827 3.651 . . . . 11.449999999999999 116.153 164.074 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -63.89 -35.89 82.14 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.381 2.672 . . . . 24.98 109.845 178.04 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.49 -43.39 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.806 1.288 . . . . 9.4600000000000009 112.372 177.521 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -72.43 -37.89 68.49 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 113.899 -2.953 . . . . 14.76 109.586 -179.479 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.68 -45.79 42.2 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.408 2.822 . . . . 26.289999999999999 111.18 179.398 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -88.49 -55.29 3.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.202 -0.999 . . . . 30.059999999999999 112.703 -168.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -75.62 -63.28 1.33 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.094 1.426 . . . . 25.190000000000001 110.774 -176.214 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.11 40.3 0.45 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 125.376 1.465 . . . . 7.4100000000000001 115.099 173.804 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -104.07 118.46 57.0 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-O 116.581 -1.676 . . . . 9.4900000000000002 108.443 175.255 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -64.21 156.89 56.86 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 124.752 3.635 . . . . 11.42 112.11 -170.595 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.6 -18.78 25.24 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 115.57 1.335 . . . . 12.0 115.57 -161.171 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.59 -13.23 32.33 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 127.132 3.349 . . . . 35.549999999999997 107.013 -165.269 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.99 -6.65 58.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 112.171 -2.286 . . . . 20.52 115.778 175.193 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -102.35 107.28 18.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.735 2.124 . . . . 7.1299999999999999 116.735 -162.723 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -117.77 125.3 50.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.693 -1.254 . . . . 36.390000000000001 107.9 172.754 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 mt -102.12 128.22 48.7 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.971 -2.33 . . . . 9.5500000000000007 111.302 179.43 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.8 mt -110.01 141.72 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.608 2.363 . . . . 13.9 108.246 169.811 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.431 ' HB3' HD21 ' A' ' 50' ' ' LEU . 21.0 t80 -136.09 131.35 34.71 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.233 -2.136 . . . . 6.8600000000000003 105.233 174.148 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.15 -97.54 0.07 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.303 1.841 . . . . 11.15 112.354 -167.633 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.66 5.15 7.06 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 119.914 -1.741 . . . . 13.93 115.901 171.61 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -111.71 143.88 41.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.947 3.699 . . . . 23.920000000000002 112.146 -175.817 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -90.41 132.83 35.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 114.641 1.349 . . . . 23.23 114.641 176.643 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.4 mt -87.86 139.74 30.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.756 2.422 . . . . 9.1099999999999994 113.855 -172.891 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.03 -176.25 6.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.028 2.531 . . . . 33.439999999999998 110.76 168.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -83.02 -69.54 0.62 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 116.397 -3.939 . . . . 28.370000000000001 113.743 -176.557 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.9 56.35 4.36 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 120.387 -1.445 . . . . 15.0 116.007 -167.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -148.5 138.78 22.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 114.584 -2.627 . . . . 25.5 106.438 -172.669 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 44.3 p -79.68 163.87 24.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.309 2.956 . . . . 11.949999999999999 112.043 -167.926 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.51 -45.98 91.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 110.488 -3.051 . . . . 10.17 108.347 172.119 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 m -54.85 -39.47 68.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 125.56 1.787 . . . . 13.59 115.017 174.312 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -63.36 -53.5 51.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.306 -2.121 . . . . 11.699999999999999 113.213 176.199 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -70.25 -5.56 28.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.857 -1.065 . . . . 12.949999999999999 113.734 178.017 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 66.61 52.28 1.02 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.93 2.492 . . . . 25.449999999999999 110.595 179.237 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.9 119.13 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.041 -2.207 . . . . 14.6 105.041 175.758 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -120.05 -172.47 2.36 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.163 2.585 . . . . 33.229999999999997 108.72 -163.93 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -64.24 115.93 5.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 112.926 -3.416 . . . . 25.969999999999999 116.246 -174.368 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 76.93 18.7 1.5 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.986 3.314 . . . . 32.609999999999999 114.181 -176.164 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.0 m -61.12 145.27 51.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.643 -3.161 . . . . 10.56 115.68 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -94.42 126.29 39.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.705 -2.497 . . . . 5.3300000000000001 115.899 171.457 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 45' ' ' PHE 0.251 22.0 mt -108.31 152.81 24.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.727 1.01 . . . . 11.66 113.727 172.62 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -114.45 131.59 56.55 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.919 -3.613 . . . . 16.300000000000001 111.656 -177.928 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.6 tp -109.56 122.6 47.79 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 118.457 -0.782 . . . . 9.9600000000000009 109.705 -178.85 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.86 -168.77 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.413 -1.699 . . . . 9.7599999999999998 106.413 -170.522 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.0 tp . . . . . 0 N--CA 1.43 -1.446 0 N-CA-C 105.405 -2.072 . . . . 19.57 105.405 -169.742 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 119.589 3.181 . . . . 17.170000000000002 119.589 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -65.37 140.33 58.64 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 117.049 2.241 . . . . 21.890000000000001 117.049 163.354 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.4 pt -124.6 159.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.517 -1.99 . . . . 10.83 111.45 166.262 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -110.41 122.12 46.95 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 115.679 -2.105 . . . . 10.609999999999999 115.555 170.478 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.6 t -110.43 110.1 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 101.827 -3.397 . . . . 9.1300000000000008 101.827 -179.096 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -75.72 134.86 40.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.187 2.195 . . . . 20.550000000000001 114.124 175.684 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -98.42 -169.14 1.75 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.944 -1.132 . . . . 11.779999999999999 107.944 -172.963 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.6 tp -91.01 -38.33 12.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.254 -1.758 . . . . 19.309999999999999 106.254 -168.353 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.328 62.1 p -71.67 -69.77 0.36 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.067 1.877 . . . . 23.140000000000001 116.067 171.858 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.5 42.36 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 O-C-N 116.977 -3.577 . . . . 19.739999999999998 119.417 177.895 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -112.48 129.42 56.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 114.317 -2.754 . . . . 21.93 104.96 -172.517 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -88.71 105.72 17.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.726 2.679 . . . . 12.33 109.862 165.266 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.0 mt -86.12 110.91 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 116.616 -3.802 . . . . 17.079999999999998 111.427 175.253 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -100.55 113.75 26.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.274 1.852 . . . . 16.300000000000001 114.712 -172.925 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -116.26 139.39 50.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.359 0.982 . . . . 15.880000000000001 111.886 -167.014 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -96.73 109.13 21.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.434 -2.042 . . . . 28.899999999999999 110.808 -179.164 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.42 156.13 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 118.266 -2.771 . . . . 12.050000000000001 108.645 -174.629 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -107.55 136.79 19.59 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.243 -1.536 . . . . 18.170000000000002 110.172 170.576 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.11 -5.45 14.46 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 122.578 2.185 . . . . 8.1600000000000001 113.275 -155.425 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -93.12 -8.81 41.59 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 112.187 -3.768 . . . . 11.130000000000001 110.876 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -77.71 177.57 8.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 128.628 3.705 . . . . 18.030000000000001 115.204 166.415 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.2 p -115.62 -178.23 3.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.383 -2.698 . . . . 10.220000000000001 109.615 -169.401 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.485 HD12 HD13 ' A' ' 50' ' ' LEU 0.308 11.9 mm -63.09 -35.53 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 116.939 -3.601 . . . . 12.300000000000001 113.09 175.725 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.2 -33.17 51.62 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.157 -4.089 . . . . 36.509999999999998 114.629 174.953 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -64.97 -39.24 93.18 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.294 -2.129 . . . . 25.66 111.832 174.857 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.6 t -73.91 -45.63 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.843 -1.785 . . . . 8.1199999999999992 107.27 -174.228 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.288 38.9 ttmt -63.9 -30.63 71.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.709 -3.744 . . . . 15.470000000000001 111.478 -178.766 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.03 89.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.696 2.799 . . . . 11.449999999999999 117.328 171.021 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -71.97 -21.86 61.52 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.527 2.417 . . . . 24.98 117.527 174.127 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.2 mt -75.24 -30.84 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 127.675 3.607 . . . . 9.4600000000000009 114.077 164.217 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.92 -47.53 82.87 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.529 -4.482 . . . . 14.76 111.798 168.08 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.94 -47.24 21.51 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.321 -1.487 . . . . 26.289999999999999 111.678 -172.711 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -74.18 -76.84 0.12 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 116.825 -1.559 . . . . 30.059999999999999 112.373 -176.332 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -80.26 -38.34 31.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.829 3.251 . . . . 25.190000000000001 108.099 -161.564 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.01 50.83 3.36 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-O 123.952 1.862 . . . . 7.4100000000000001 111.669 -176.144 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.1 mt -101.66 120.01 55.58 Favored Pre-proline 0 N--CA 1.43 -1.468 1 O-C-N 114.703 -4.998 . . . . 9.4900000000000002 109.605 165.216 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.9 158.66 56.35 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 126.883 3.494 . . . . 11.42 114.671 -174.27 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.85 -7.83 5.24 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 CA-C-N 128.995 4.248 . . . . 12.0 110.977 -157.618 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -70.83 -32.26 69.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.767 2.827 . . . . 35.549999999999997 106.626 175.521 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -88.02 -11.79 46.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.981 -2.949 . . . . 20.52 113.755 177.994 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -84.74 122.51 29.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.853 2.861 . . . . 7.1299999999999999 112.818 176.577 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -129.95 146.96 51.66 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.147 -2.221 . . . . 36.390000000000001 105.014 154.061 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.85 122.19 44.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.16 1.457 . . . . 9.5500000000000007 107.72 -173.371 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -110.22 131.69 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 128.298 2.639 . . . . 13.9 111.907 -179.412 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -126.02 118.75 26.0 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 114.417 -5.177 . . . . 6.8600000000000003 103.763 176.386 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.395 . . 65.8 -98.8 0.06 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.483 2.031 . . . . 11.15 116.483 -164.944 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.13 13.82 4.35 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 127.759 2.599 . . . . 13.93 109.951 -173.861 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -132.02 147.28 52.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.217 -2.343 . . . . 23.920000000000002 113.025 -177.408 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -85.76 146.34 26.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.293 2.473 . . . . 23.23 110.533 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.485 HD13 HD12 ' A' ' 23' ' ' ILE . 94.1 mt -93.55 148.4 22.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.673 -2.517 . . . . 9.1099999999999994 110.987 178.049 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.305 10.0 pt-20 -80.69 -168.86 1.91 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.572 1.949 . . . . 33.439999999999998 110.111 175.969 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -105.77 -47.39 3.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.111 3.338 . . . . 28.370000000000001 113.186 174.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.93 59.92 1.01 Allowed Glycine 0 N--CA 1.43 -1.715 1 O-C-N 115.394 -4.566 . . . . 15.0 115.088 -173.022 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -139.42 139.29 37.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.387 -1.338 . . . . 25.5 107.387 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 50.1 p -80.07 163.75 23.92 Favored 'General case' 0 N--CA 1.43 -1.45 1 CA-C-O 128.903 4.192 . . . . 11.949999999999999 111.351 -166.887 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -67.3 -37.52 83.53 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.619 -4.425 . . . . 10.17 114.342 -179.761 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -72.53 -27.13 62.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.802 1.641 . . . . 13.59 115.064 176.187 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -73.13 -39.16 65.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.073 -3.517 . . . . 11.699999999999999 107.019 172.483 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.06 -0.07 23.28 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.453 1.101 . . . . 12.949999999999999 111.779 178.801 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 51.09 60.12 4.11 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.363 -2.711 . . . . 25.449999999999999 114.685 179.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.0 mm -104.28 132.9 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 127.971 2.509 . . . . 14.6 109.191 170.592 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -111.1 -179.82 3.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.007 1.861 . . . . 33.229999999999997 114.362 -179.07 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -59.33 118.7 6.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.087 -1.87 . . . . 25.969999999999999 114.902 172.55 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.321 55.7 mt-10 76.27 35.0 0.48 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.437 -3.914 . . . . 32.609999999999999 112.874 173.464 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -90.63 141.92 28.28 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.094 1.757 . . . . 10.56 109.818 -175.553 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -87.55 128.14 35.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 113.878 -1.51 . . . . 5.3300000000000001 113.528 176.239 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.57 149.35 42.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.144 2.978 . . . . 11.66 104.693 174.357 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -119.78 135.41 54.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.088 -1.008 . . . . 16.300000000000001 111.598 176.304 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.75 110.98 23.47 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.051 1.405 . . . . 9.9600000000000009 112.609 177.584 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -99.18 -174.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.207 2.432 . . . . 9.7599999999999998 108.837 -178.653 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 tp . . . . . 0 N--CA 1.43 -1.448 1 O-C-N 115.796 -4.315 . . . . 19.57 106.706 -177.437 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 117.057 2.243 . . . . 17.170000000000002 117.057 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 81.9 mt-30 -80.92 135.63 35.93 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 116.084 -4.135 . . . . 21.890000000000001 111.73 -176.107 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.71 153.24 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.177 -2.527 . . . . 10.83 104.177 161.049 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.279 50.2 m-85 -115.06 121.86 44.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 126.798 2.561 . . . . 10.609999999999999 111.634 -174.085 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.07 112.69 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 116.501 -3.875 . . . . 9.1300000000000008 110.504 -173.288 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -95.45 147.28 23.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.919 2.295 . . . . 20.550000000000001 106.36 -176.437 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.3 p -89.06 -178.14 5.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.785 -3.072 . . . . 11.779999999999999 106.635 174.109 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.2 tp -63.37 -47.8 80.59 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 117.912 -1.042 . . . . 19.309999999999999 112.87 168.576 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -55.63 -50.16 70.93 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.103 2.561 . . . . 23.140000000000001 111.16 171.319 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.9 49.78 0.3 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 118.887 -2.383 . . . . 19.739999999999998 109.311 169.391 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -90.42 124.48 34.99 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 103.179 -2.897 . . . . 21.93 103.179 176.918 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -97.67 115.13 27.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.345 2.498 . . . . 12.33 109.068 -175.672 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.5 mt -105.81 113.88 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.29 -2.232 . . . . 17.079999999999998 106.249 178.419 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -88.49 133.69 34.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.604 -3.185 . . . . 16.300000000000001 111.342 173.298 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 58.0 mt -120.6 172.25 7.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.986 2.054 . . . . 15.880000000000001 108.937 -175.101 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -128.26 114.65 17.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.094 -1.628 . . . . 28.899999999999999 108.748 170.182 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.37 152.53 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 125.801 1.938 . . . . 12.050000000000001 108.366 -177.812 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.26 140.22 28.67 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-O 114.21 -2.805 . . . . 18.170000000000002 113.799 157.641 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 73.3 Cg_endo -81.7 -4.69 12.25 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 123.987 2.46 . . . . 8.1600000000000001 111.258 -169.722 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 m -82.68 4.09 26.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.85 2.907 . . . . 11.130000000000001 118.85 163.553 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -99.94 176.86 5.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.015 2.189 . . . . 18.030000000000001 106.572 173.876 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.369 11.0 p -89.3 -169.92 2.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.48 -1.236 . . . . 10.220000000000001 113.827 -166.404 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 mm -81.05 -18.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.672 2.389 . . . . 12.300000000000001 115.258 161.478 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -71.32 -29.64 65.27 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 123.88 0.872 . . . . 36.509999999999998 109.08 173.659 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -60.57 -45.67 93.05 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.047 1.739 . . . . 25.66 110.819 169.29 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -65.29 -35.56 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 119.16 0.891 . . . . 8.1199999999999992 109.198 -175.496 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -65.15 -37.59 87.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.857 1.429 . . . . 15.470000000000001 114.857 168.889 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.274 . . -70.0 -33.02 71.5 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.299 2.703 . . . . 11.449999999999999 118.299 172.469 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -65.93 -33.04 74.9 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.358 -3.964 . . . . 24.98 110.775 173.729 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.5 mt -65.98 -44.87 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 117.051 -3.53 . . . . 9.4600000000000009 108.386 167.122 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.76 -38.65 82.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.959 1.709 . . . . 14.76 112.344 176.099 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.99 -46.87 49.79 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.304 -0.872 . . . . 26.289999999999999 110.871 179.316 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -77.01 -57.78 3.65 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 116.498 -2.081 . . . . 30.059999999999999 113.059 -173.362 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -91.5 -52.14 4.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.908 1.337 . . . . 25.190000000000001 109.267 -167.934 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.22 30.02 3.05 Favored Glycine 0 N--CA 1.43 -1.708 1 C-N-CA 132.061 4.648 . . . . 7.4100000000000001 115.037 173.534 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.5 mt -81.34 135.15 50.64 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 119.068 -2.431 . . . . 9.4900000000000002 106.055 175.071 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -68.88 137.67 38.71 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-O 114.203 -2.499 . . . . 11.42 116.354 177.819 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.39 -12.14 22.81 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 124.158 3.239 . . . . 12.0 113.933 -175.532 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -74.56 -26.82 60.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.583 1.992 . . . . 35.549999999999997 113.826 167.655 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -95.37 3.81 54.01 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.008 2.523 . . . . 20.52 113.138 178.25 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' HG2' HD11 ' A' ' 69' ' ' LEU . 72.8 mt-30 -99.06 133.66 43.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.264 -2.148 . . . . 7.1299999999999999 114.751 178.201 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -113.4 121.0 43.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.187 2.595 . . . . 36.390000000000001 109.947 158.63 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 mt -100.67 140.85 34.36 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.269 -2.77 . . . . 9.5500000000000007 109.829 174.945 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mt -141.73 138.62 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 105.013 -2.217 . . . . 13.9 105.013 -169.36 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -123.46 117.99 26.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.07 -1.019 . . . . 6.8600000000000003 111.027 172.871 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.299 . . 74.63 -108.01 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.525 -2.398 . . . . 11.15 104.525 176.002 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.34 6.18 5.63 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 119.031 -2.293 . . . . 13.93 113.629 168.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.283 38.3 pttt -81.12 135.52 35.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.671 2.1 . . . . 23.920000000000002 116.671 159.79 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -82.76 162.31 21.77 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.462 -3.899 . . . . 23.23 107.908 172.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.6 mt -110.42 133.5 53.22 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.23 1.967 . . . . 9.1099999999999994 115.044 175.104 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.79 153.08 19.09 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.739 2.126 . . . . 33.439999999999998 116.739 163.856 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.23 -30.63 60.62 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 131.306 3.842 . . . . 28.370000000000001 116.819 -160.213 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.94 34.48 4.64 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 126.244 2.215 . . . . 15.0 117.665 177.312 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -140.2 146.86 39.25 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 118.547 1.173 . . . . 25.5 109.109 -170.874 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 68.4 p -89.66 164.18 14.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.537 1.517 . . . . 11.949999999999999 114.537 -173.088 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 11.9 mt -55.19 -46.28 75.85 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.522 3.529 . . . . 10.17 110.878 166.372 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 m -58.53 -52.12 67.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.621 1.568 . . . . 13.59 109.717 173.481 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.93 -32.82 30.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.493 2.406 . . . . 11.699999999999999 109.965 -168.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -61.88 -34.5 76.12 Favored 'General case' 0 N--CA 1.43 -1.45 1 N-CA-C 122.269 4.174 . . . . 12.949999999999999 122.269 161.873 . . . . . . . . 4 4 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 66.8 m-80 90.35 59.86 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.108 2.163 . . . . 25.449999999999999 109.781 177.415 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mm -107.53 108.84 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 113.253 -1.794 . . . . 14.6 106.621 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.313 10.0 pt20 -83.84 176.65 8.76 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.108 -2.87 . . . . 33.229999999999997 117.858 -178.223 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -68.73 125.08 25.46 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 130.487 3.515 . . . . 25.969999999999999 110.533 168.574 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 64.63 39.28 6.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 130.516 3.526 . . . . 32.609999999999999 115.922 -171.216 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.8 m -78.18 165.03 24.43 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 113.308 0.855 . . . . 10.56 113.308 172.165 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m -106.01 139.04 41.16 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 126.534 1.933 . . . . 5.3300000000000001 106.855 170.52 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.38 156.78 41.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.86 -3.025 . . . . 11.66 107.707 171.235 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -112.69 117.7 32.96 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.173 -3.455 . . . . 16.300000000000001 107.436 -175.887 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.419 HD11 ' HG2' ' A' ' 41' ' ' GLN 0.257 12.4 tp -101.37 121.39 41.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.524 -2.61 . . . . 9.9600000000000009 114.97 169.206 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.307 10.7 m -121.4 158.52 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 130.425 3.49 . . . . 9.7599999999999998 102.83 177.945 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tp . . . . . 0 N--CA 1.43 -1.471 0 CA-C-N 114.672 -1.149 . . . . 19.57 113.881 166.641 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.491 -1.32 0 CA-C-O 118.34 -0.838 . . . . 17.170000000000002 112.882 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.09 150.07 23.62 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.537 -3.852 . . . . 21.890000000000001 109.156 177.202 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.282 32.0 pt -131.45 159.03 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 128.59 2.756 . . . . 10.83 109.815 169.345 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -110.95 141.87 43.81 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.696 -1.965 . . . . 10.609999999999999 105.696 173.41 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 30' ' ' ILE . 4.9 t -108.47 120.02 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 120.457 1.48 . . . . 9.1300000000000008 108.851 161.205 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -103.03 125.18 49.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.557 2.343 . . . . 20.550000000000001 110.851 -179.135 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -88.01 148.23 24.62 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.215 1.006 . . . . 11.779999999999999 112.751 177.889 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.338 14.5 tp -51.16 -40.2 58.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.659 2.384 . . . . 19.309999999999999 110.825 162.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.5 m -64.58 -50.77 65.95 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 121.105 1.775 . . . . 23.140000000000001 112.481 -179.19 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.0 19.34 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 123.787 1.771 . . . . 19.739999999999998 116.675 169.351 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -103.37 138.42 40.14 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.243 -3.504 . . . . 21.93 112.417 177.864 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.9 m -99.59 124.73 45.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.244 -2.16 . . . . 12.33 108.796 162.894 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 13' ' ' ILE . 42.8 mt -119.75 119.38 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 126.41 1.884 . . . . 17.079999999999998 110.093 -171.053 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -82.76 119.08 23.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.08 -3.512 . . . . 16.300000000000001 106.446 -169.047 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 mt -106.27 159.39 16.15 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 116.226 -4.046 . . . . 15.880000000000001 111.352 169.378 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -99.45 134.92 41.62 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 121.605 2.002 . . . . 28.899999999999999 109.5 154.735 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.69 156.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 125.416 2.532 . . . . 12.050000000000001 106.589 175.727 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -96.94 153.18 38.65 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 112.354 -2.203 . . . . 18.170000000000002 110.633 173.922 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.11 -24.16 28.37 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 127.251 3.625 . . . . 8.1600000000000001 111.319 178.997 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 p -81.21 -13.88 58.11 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.404 3.002 . . . . 11.130000000000001 111.49 -171.736 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -67.19 151.23 47.92 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.729 -4.982 . . . . 18.030000000000001 113.809 176.785 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.275 22.3 p -80.66 153.36 27.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 120.282 3.438 . . . . 10.220000000000001 120.282 162.973 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.3 mm -64.75 -26.61 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 125.772 2.701 . . . . 12.300000000000001 112.123 -179.218 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.257 20.4 tt0 -44.37 -46.63 9.48 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.855 -4.278 . . . . 36.509999999999998 116.345 162.663 . . . . . . . . 3 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -69.32 -37.82 77.92 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.012 2.925 . . . . 25.66 111.329 172.097 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.256 58.5 t -63.44 -47.36 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 119.398 0.999 . . . . 8.1199999999999992 113.167 170.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -49.24 -43.24 42.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.167 2.284 . . . . 15.470000000000001 117.167 168.315 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.37 -28.6 69.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 117.915 2.561 . . . . 11.449999999999999 117.915 173.496 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -83.32 -29.09 28.57 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.603 1.334 . . . . 24.98 114.603 175.304 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.426 HD11 HG21 ' A' ' 5' ' ' VAL . 69.4 mt -70.68 -36.3 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.837 -1.074 . . . . 9.4600000000000009 108.202 169.61 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.12 -37.75 88.46 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.547 -1.692 . . . . 14.76 115.337 171.025 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.16 -43.62 67.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.703 2.047 . . . . 26.289999999999999 111.334 179.619 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -70.7 -76.16 0.11 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.032 2.133 . . . . 30.059999999999999 115.347 177.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -81.44 -28.75 34.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.16 2.584 . . . . 25.190000000000001 108.974 -169.725 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.63 43.57 6.08 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 116.437 -2.313 . . . . 7.4100000000000001 113.64 -176.231 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 mt -105.25 121.63 45.69 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 115.966 -1.968 . . . . 9.4900000000000002 114.671 176.18 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.5 149.8 74.78 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 126.436 3.334 . . . . 11.42 115.292 -175.288 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -73.67 -18.4 22.36 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 127.075 3.562 . . . . 12.0 118.291 -168.378 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -71.06 -32.64 69.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.409 -2.682 . . . . 35.549999999999997 111.672 179.194 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -91.92 2.76 56.33 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 117.211 -1.376 . . . . 20.52 111.856 -179.693 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -89.17 119.72 29.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.698 3.199 . . . . 7.1299999999999999 116.164 177.619 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -138.7 119.62 14.34 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 123.865 0.866 . . . . 36.390000000000001 108.957 171.701 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -101.12 136.7 40.55 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.953 1.835 . . . . 9.5500000000000007 113.822 -177.557 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mt -114.61 127.81 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 C-N-CA 134.338 5.055 . . . . 13.9 107.213 -179.46 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -116.32 106.04 13.21 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.56 -1.274 . . . . 6.8600000000000003 107.56 166.551 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.05 -71.97 0.07 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 116.364 1.987 . . . . 11.15 116.364 -170.298 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.32 -14.0 0.97 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 128.571 2.986 . . . . 13.93 116.33 174.458 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -101.74 144.63 30.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.019 2.91 . . . . 23.920000000000002 111.028 -167.382 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.265 15.2 pt20 -65.49 123.12 18.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.744 2.818 . . . . 23.23 113.539 167.067 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.9 mt -94.42 139.32 31.28 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 101.325 -3.583 . . . . 9.1099999999999994 101.325 -174.853 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.88 176.61 8.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.328 2.251 . . . . 33.439999999999998 111.213 168.241 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.31 -53.41 3.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.36 -2.712 . . . . 28.370000000000001 112.619 -172.251 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 53.05 4.82 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 118.035 -2.915 . . . . 15.0 119.118 175.222 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -132.03 139.3 48.53 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 119.44 1.62 . . . . 25.5 110.123 166.951 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.286 56.9 p -75.33 150.77 38.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.757 -1.839 . . . . 11.949999999999999 112.977 -172.098 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.1 mt -51.44 -33.41 30.63 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.289 2.636 . . . . 10.17 114.601 165.443 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.309 22.7 t -59.9 -50.05 75.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.479 3.511 . . . . 13.59 110.216 168.328 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -86.1 -32.63 21.24 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.363 -2.088 . . . . 11.699999999999999 105.363 -163.618 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -60.16 -25.42 65.52 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.172 -2.83 . . . . 12.949999999999999 113.341 167.093 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 68.65 54.56 0.5 Allowed 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 131.679 3.992 . . . . 25.449999999999999 113.027 -179.058 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.03 131.39 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.596 -2.001 . . . . 14.6 105.596 174.307 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -108.01 -171.66 1.91 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.579 1.326 . . . . 33.229999999999997 114.579 178.099 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -76.83 134.82 38.94 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.009 2.596 . . . . 25.969999999999999 118.009 -174.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 53.12 45.43 28.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 116.937 2.199 . . . . 32.609999999999999 116.937 -166.835 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.357 49.3 m -94.85 139.59 31.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 100.303 -3.962 . . . . 10.56 100.303 -175.356 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -98.83 122.47 42.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.092 0.86 . . . . 5.3300000000000001 108.952 179.465 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mp -98.03 147.39 24.57 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.576 -1.327 . . . . 11.66 111.393 167.118 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -103.92 127.43 51.45 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.243 -3.41 . . . . 16.300000000000001 119.215 172.366 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.09 132.54 35.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.402 -2.061 . . . . 9.9600000000000009 113.883 175.163 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.28 -176.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 125.383 1.473 . . . . 9.7599999999999998 109.437 168.418 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.3 tp . . . . . 0 N--CA 1.431 -1.416 0 O-C-N 116.402 -3.936 . . . . 19.57 110.986 175.403 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 118.551 2.797 . . . . 17.170000000000002 118.551 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -93.3 113.15 25.27 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 101.864 -3.384 . . . . 21.890000000000001 101.864 178.467 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -120.1 149.74 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 104.331 -2.47 . . . . 10.83 104.331 170.936 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -107.05 121.28 44.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.189 1.471 . . . . 10.609999999999999 109.629 -172.103 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -100.12 117.46 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 O-C-N 115.15 -4.719 . . . . 9.1300000000000008 102.129 175.312 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -100.56 123.95 45.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.654 -2.529 . . . . 20.550000000000001 111.127 176.902 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -86.5 -176.54 5.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.422 -2.674 . . . . 11.779999999999999 109.28 -174.12 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 tp -70.55 -50.08 41.24 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.225 2.21 . . . . 19.309999999999999 110.075 178.633 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.4 p -72.93 -29.57 63.21 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.261 -1.755 . . . . 23.140000000000001 106.261 -178.065 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.2 54.03 0.31 Allowed Glycine 0 N--CA 1.43 -1.753 0 O-C-N 118.692 -2.505 . . . . 19.739999999999998 107.67 162.626 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -107.54 135.7 48.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.536 2.112 . . . . 21.93 109.608 171.473 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -96.42 109.61 22.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.629 -1.919 . . . . 12.33 106.046 -173.803 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 mt -102.22 96.26 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 126.424 3.011 . . . . 17.079999999999998 105.512 178.816 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.9 m -88.83 117.43 27.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.345 -3.347 . . . . 16.300000000000001 108.989 -172.969 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 mt -109.71 137.49 47.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.903 -2.373 . . . . 15.880000000000001 112.259 -167.549 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -106.66 101.44 10.89 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.696 -1.878 . . . . 28.899999999999999 109.47 177.311 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.26 163.01 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 118.802 -2.436 . . . . 12.050000000000001 109.396 -175.318 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -85.55 164.9 38.31 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 118.44 -2.663 . . . . 18.170000000000002 109.493 173.4 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.82 -4.45 3.33 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 C-N-CA 123.223 2.616 . . . . 8.1600000000000001 111.573 -174.463 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -87.85 -6.45 58.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.006 2.923 . . . . 11.130000000000001 111.838 175.665 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.48 159.03 18.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.273 -3.392 . . . . 18.030000000000001 114.443 -179.323 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -90.44 165.67 13.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.394 1.569 . . . . 10.220000000000001 111.985 -173.964 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -69.17 -20.42 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 127.415 3.483 . . . . 12.300000000000001 113.636 171.905 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.11 -43.34 87.47 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.047 -5.408 . . . . 36.509999999999998 112.759 174.037 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -70.93 -32.53 69.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.061 -1.447 . . . . 25.66 113.717 178.362 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.2 t -61.08 -38.61 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 131.231 3.813 . . . . 8.1199999999999992 111.927 169.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -67.01 -42.44 84.95 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.742 -1.599 . . . . 15.470000000000001 114.43 165.401 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.02 -37.28 74.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 117.56 2.429 . . . . 11.449999999999999 117.56 172.098 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.281 57.5 mmtt -46.26 -35.91 5.69 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 126.073 2.844 . . . . 24.98 117.712 165.398 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.2 mt -93.95 -34.47 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 117.776 -3.077 . . . . 9.4600000000000009 111.429 -172.695 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -48.01 81.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.76 0.824 . . . . 14.76 111.961 160.842 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.279 12.5 t70 -53.52 -57.76 9.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.149 1.928 . . . . 26.289999999999999 114.246 169.942 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -81.16 -51.64 8.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.659 -1.275 . . . . 30.059999999999999 112.364 -170.506 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -96.43 -42.09 8.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 116.814 -3.679 . . . . 25.190000000000001 101.791 -163.257 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.88 42.9 3.7 Favored Glycine 0 N--CA 1.43 -1.744 1 O-C-N 115.935 -4.228 . . . . 7.4100000000000001 115.852 -170.502 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 90.6 mt -111.12 120.36 43.39 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 113.393 -3.194 . . . . 9.4900000000000002 107.94 177.077 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -66.96 148.89 82.72 Favored 'Trans proline' 0 N--CA 1.434 -1.975 0 CA-C-N 125.778 3.099 . . . . 11.42 114.425 -178.093 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -74.05 -18.86 20.92 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 123.645 2.338 . . . . 12.0 117.868 -161.815 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -60.63 -18.86 55.94 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.815 2.524 . . . . 35.549999999999997 117.815 173.962 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -97.33 -12.57 22.68 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.03 2.132 . . . . 20.52 114.002 -175.139 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -98.91 141.07 32.16 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.48 -2.013 . . . . 7.1299999999999999 111.713 -169.356 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -143.73 108.1 4.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 114.015 -2.897 . . . . 36.390000000000001 107.472 -177.89 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 mt -91.78 144.96 24.96 Favored 'General case' 0 N--CA 1.43 -1.426 1 CA-C-N 126.2 4.091 . . . . 9.5500000000000007 112.837 -175.67 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 mt -128.24 138.84 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.628 1.971 . . . . 13.9 109.886 -176.935 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' A' ' 50' ' ' LEU . 70.3 t80 -122.19 112.74 18.55 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 115.082 -4.761 . . . . 6.8600000000000003 100.446 175.055 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.34 -74.96 0.07 Allowed 'General case' 0 N--CA 1.431 -1.41 1 CA-C-O 111.436 -4.126 . . . . 11.15 113.967 177.758 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.76 21.62 0.32 Allowed Glycine 0 N--CA 1.43 -1.729 1 O-C-N 130.178 4.674 . . . . 13.93 114.342 167.685 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -115.45 131.03 57.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.396 -1.705 . . . . 23.920000000000002 106.396 174.955 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -71.48 147.51 47.72 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.327 1.421 . . . . 23.23 114.593 173.924 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 45' ' ' PHE . 21.3 mt -101.13 109.16 21.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.376 1.87 . . . . 9.1099999999999994 112.821 170.95 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -95.77 142.84 27.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 113.493 0.923 . . . . 33.439999999999998 113.493 179.186 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -22.01 -68.05 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 134.421 5.088 . . . . 28.370000000000001 118.893 179.255 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.69 62.58 4.58 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 122.54 2.427 . . . . 15.0 115.676 -174.778 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -160.91 156.59 25.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.525 -2.162 . . . . 25.5 107.834 164.156 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.316 82.8 p -82.08 150.82 27.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.39 -3.319 . . . . 11.949999999999999 114.355 -172.56 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mt -65.51 -46.21 80.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.799 -1.188 . . . . 10.17 112.882 -173.002 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -58.11 -43.64 87.3 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.279 0.987 . . . . 13.59 111.829 171.075 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -69.01 -17.11 63.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.714 -3.741 . . . . 11.699999999999999 111.186 -172.899 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.49 -17.75 38.04 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.929 2.892 . . . . 12.949999999999999 114.956 169.523 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.354 16.5 m120 87.61 39.02 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 129.311 3.045 . . . . 25.449999999999999 112.267 177.437 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -107.9 105.97 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.59 2.138 . . . . 14.6 105.932 -172.717 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.51 -162.96 0.83 Allowed 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 116.127 -4.108 . . . . 33.229999999999997 112.288 -174.861 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.252 37.9 tttp -64.37 120.93 13.16 Favored 'General case' 0 N--CA 1.431 -1.424 2 O-C-N 114.976 -4.827 . . . . 25.969999999999999 112.39 -173.741 . . . . . . . . 3 2 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 20.6 mt-10 65.23 51.79 1.56 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.494 1.918 . . . . 32.609999999999999 108.857 -174.143 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.285 63.0 m -95.45 155.44 16.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.766 2.076 . . . . 10.56 107.75 168.948 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.4 m -119.68 128.94 54.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 126.092 2.12 . . . . 5.3300000000000001 106.388 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.3 mt -113.44 116.36 29.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.27 1.828 . . . . 11.66 111.519 -177.41 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -93.17 125.13 37.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.489 2.404 . . . . 16.300000000000001 113.103 -175.829 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -101.33 123.58 45.65 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.804 2.042 . . . . 9.9600000000000009 111.062 -169.842 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.23 -178.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 126.15 2.881 . . . . 9.7599999999999998 112.747 173.76 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.7 tp . . . . . 0 N--CA 1.43 -1.429 0 O-C-N 116.539 -3.851 . . . . 19.57 119.369 175.863 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 10.8 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 113.433 0.901 . . . . 17.170000000000002 113.433 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -94.92 125.52 39.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 113.826 1.047 . . . . 21.890000000000001 113.826 178.963 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -124.3 162.88 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.148 1.379 . . . . 10.83 112.627 167.76 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -118.62 139.81 50.9 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.82 -3.05 . . . . 10.609999999999999 107.178 176.393 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.66 118.7 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.381 1.873 . . . . 9.1300000000000008 106.152 172.086 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -116.93 143.6 45.52 Favored 'General case' 0 N--CA 1.43 -1.438 1 CA-C-O 128.74 4.114 . . . . 20.550000000000001 114.07 -171.896 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -81.88 172.78 12.91 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 114.743 -4.973 . . . . 11.779999999999999 111.472 179.767 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.2 -33.69 70.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.555 2.057 . . . . 19.309999999999999 116.555 176.787 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -72.19 -69.53 0.39 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.966 1.099 . . . . 23.140000000000001 113.966 171.547 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.14 31.8 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 118.319 -1.896 . . . . 19.739999999999998 114.305 -175.797 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -106.86 121.98 45.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.162 1.458 . . . . 21.93 112.686 176.728 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.1 m -97.37 127.94 43.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.516 -1.99 . . . . 12.33 108.841 176.951 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.75 116.8 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 102.437 -3.172 . . . . 17.079999999999998 102.437 172.757 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 m -93.38 131.73 38.28 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.913 -1.742 . . . . 16.300000000000001 109.502 173.361 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -125.61 143.26 51.1 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.833 -1.792 . . . . 15.880000000000001 109.427 -179.59 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 1' ' ' MET . 42.9 mt-10 -99.13 77.71 2.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.546 3.138 . . . . 28.899999999999999 116.342 165.183 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -104.83 147.72 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 126.72 3.152 . . . . 12.050000000000001 106.987 -177.995 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -83.82 149.1 55.96 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 117.748 -3.095 . . . . 18.170000000000002 108.712 178.391 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -88.42 -6.29 6.17 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 127.172 3.597 . . . . 8.1600000000000001 109.543 -157.38 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.7 m -84.6 -14.06 49.84 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.624 3.106 . . . . 11.130000000000001 114.49 -179.492 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -80.12 163.67 23.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.859 2.54 . . . . 18.030000000000001 117.859 -167.982 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.322 22.1 p -79.34 158.19 27.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.618 2.367 . . . . 10.220000000000001 111.621 -172.16 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.67 -36.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.224 -1.353 . . . . 12.300000000000001 107.772 178.631 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -45.16 -45.84 11.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 117.504 2.409 . . . . 36.509999999999998 117.504 160.01 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.23 -14.32 59.49 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.808 -4.307 . . . . 25.66 116.163 173.472 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.6 t -62.8 -48.94 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 124.607 2.146 . . . . 8.1199999999999992 112.377 162.334 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -63.7 -32.45 73.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.107 2.86 . . . . 15.470000000000001 112.04 178.287 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.54 -13.27 61.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.863 -2.398 . . . . 11.449999999999999 117.472 -177.007 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -79.1 -36.43 40.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.324 2.265 . . . . 24.98 115.13 166.33 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 mt -69.72 -26.26 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 121.149 -0.969 . . . . 9.4600000000000009 113.405 176.162 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -65.48 -39.83 92.4 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 112.437 -2.165 . . . . 14.76 110.539 173.366 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -70.93 -46.26 62.78 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.85 2.167 . . . . 26.289999999999999 116.85 171.394 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -76.73 -67.2 0.72 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.09 -2.256 . . . . 30.059999999999999 108.918 -171.536 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -94.17 -20.5 19.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 123.839 3.018 . . . . 25.190000000000001 107.14 -164.363 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.42 34.83 9.99 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 126.753 2.121 . . . . 7.4100000000000001 114.445 173.867 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 mt -110.91 130.62 22.75 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 118.342 -2.858 . . . . 9.4900000000000002 104.181 -169.206 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -85.15 153.26 10.94 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 112.509 -4.528 . . . . 11.42 114.485 -167.418 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -71.05 -14.48 32.05 Favored 'Trans proline' 0 N--CA 1.433 -2.045 1 C-N-CA 125.308 4.005 . . . . 12.0 113.444 -162.56 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.69 -39.12 73.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.442 0.904 . . . . 35.549999999999997 113.442 168.851 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -77.97 -26.32 48.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.79 2.885 . . . . 20.52 118.79 175.171 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -72.15 118.95 15.67 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.739 1.216 . . . . 7.1299999999999999 111.502 -177.261 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -102.97 121.43 42.52 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.455 -3.278 . . . . 36.390000000000001 105.807 169.532 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 mt -106.11 123.06 47.41 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.674 3.59 . . . . 9.5500000000000007 115.24 170.02 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -123.21 110.31 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 128.954 2.902 . . . . 13.9 114.893 -174.646 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -94.8 117.88 30.86 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.222 -1.399 . . . . 6.8600000000000003 107.222 169.977 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.36 -84.3 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.42 1 C-N-CA 132.35 4.26 . . . . 11.15 110.507 -169.704 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.44 31.05 1.28 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-O 124.078 1.932 . . . . 13.93 112.239 169.952 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -99.13 142.11 31.03 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.968 -3.078 . . . . 23.920000000000002 109.539 174.706 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -88.08 108.74 19.39 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 116.577 2.066 . . . . 23.23 116.577 173.405 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.339 85.4 mt -71.47 118.26 14.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.078 -2.889 . . . . 9.1099999999999994 116.907 -162.171 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -74.31 114.94 13.25 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.72 2.408 . . . . 33.439999999999998 109.271 178.423 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.32 -33.93 76.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.405 1.882 . . . . 28.370000000000001 114.472 -162.895 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.05 15.49 60.85 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 127.031 2.253 . . . . 15.0 113.37 -175.849 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -99.25 171.02 8.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 126.693 3.139 . . . . 25.5 108.961 160.928 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.9 p -102.72 -178.92 3.82 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.105 -4.122 . . . . 11.949999999999999 114.231 174.805 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.1 mt -80.64 -17.7 50.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.937 -2.977 . . . . 10.17 110.073 178.989 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t -69.48 -42.36 74.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.065 -2.272 . . . . 13.59 109.672 177.319 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -54.68 -45.22 73.89 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.87 2.468 . . . . 11.699999999999999 114.412 178.849 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -92.58 0.6 57.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.756 -2.465 . . . . 12.949999999999999 109.48 -174.616 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 50.27 51.23 17.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.973 3.709 . . . . 25.449999999999999 112.134 -171.177 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mt -98.38 114.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 120.418 1.463 . . . . 14.6 107.722 179.429 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -99.54 -173.14 2.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.391 3.076 . . . . 33.229999999999997 110.785 -169.424 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -70.05 147.39 50.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.601 1.191 . . . . 25.969999999999999 109.892 -174.182 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.377 86.7 mt-10 70.89 16.41 6.58 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.187 1.795 . . . . 32.609999999999999 113.668 174.047 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.16 136.75 34.33 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 116.631 -1.652 . . . . 10.56 111.657 179.23 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.2 m -92.81 130.48 38.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 115.373 -2.251 . . . . 5.3300000000000001 110.655 -178.358 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.97 172.07 6.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.806 2.443 . . . . 11.66 110.628 166.941 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -111.99 145.16 40.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.799 2.714 . . . . 16.300000000000001 111.421 171.842 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 tp -120.11 132.97 55.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.435 -3.916 . . . . 9.9600000000000009 109.069 176.12 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.56 131.03 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.905 1.682 . . . . 9.7599999999999998 108.993 -172.87 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.6 mt . . . . . 0 N--CA 1.43 -1.459 0 O-C-N 119.815 -1.803 . . . . 19.57 109.002 166.878 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 125.768 2.699 . . . . 17.170000000000002 113.851 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -114.54 137.32 52.01 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 112.983 -6.073 . . . . 21.890000000000001 110.738 -177.7 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.591 HD12 HD13 ' A' ' 67' ' ' LEU . 37.3 pt -129.07 178.21 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 118.018 -2.926 . . . . 10.83 109.239 164.942 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -125.55 137.86 53.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.299 2.952 . . . . 10.609999999999999 107.91 -179.66 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.27 116.11 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 105.054 -2.202 . . . . 9.1300000000000008 105.054 167.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -102.97 126.31 50.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.079 2.152 . . . . 20.550000000000001 113.911 176.372 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.526 15.7 p -67.99 175.15 3.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.312 1.845 . . . . 11.779999999999999 115.43 -178.201 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.44 -45.57 45.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.276 -2.765 . . . . 19.309999999999999 114.306 177.053 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -63.85 -56.31 16.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.768 2.699 . . . . 23.140000000000001 117.065 175.56 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 54.21 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 117.963 -2.065 . . . . 19.739999999999998 115.352 172.854 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -114.08 140.8 48.18 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.426 -1.75 . . . . 21.93 110.806 165.005 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -103.67 129.91 51.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.032 2.708 . . . . 12.33 110.092 165.69 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -96.73 104.93 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 128.335 2.654 . . . . 17.079999999999998 106.223 169.431 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.2 m -79.97 114.91 19.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 120.48 1.491 . . . . 16.300000000000001 114.7 170.783 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 15' ' ' LEU . 18.0 tp -121.78 133.21 54.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.647 -1.615 . . . . 15.880000000000001 113.547 -166.623 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -90.94 112.86 24.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.345 1.858 . . . . 28.899999999999999 114.612 -175.602 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.8 m -128.59 178.84 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.121 -2.862 . . . . 12.050000000000001 107.318 -168.968 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -123.94 168.14 13.5 Favored Pre-proline 0 N--CA 1.431 -1.416 0 CA-C-O 114.598 -2.62 . . . . 18.170000000000002 104.549 168.654 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.73 -14.89 43.12 Favored 'Trans proline' 0 C--N 1.3 -2.01 2 CA-C-N 129.076 4.277 . . . . 8.1600000000000001 108.853 173.311 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -93.05 -3.56 54.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.782 2.083 . . . . 11.130000000000001 115.084 -169.725 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -72.68 141.86 48.25 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.354 1.462 . . . . 18.030000000000001 108.759 -179.909 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -86.93 160.66 18.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.264 2.626 . . . . 10.220000000000001 104.525 178.722 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.592 HD12 HD13 ' A' ' 50' ' ' LEU . 24.8 mm -69.29 -30.06 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 122.593 1.187 . . . . 12.300000000000001 112.849 177.675 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -65.94 -41.83 90.81 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.52 2.728 . . . . 36.509999999999998 110.532 177.539 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -66.52 -43.28 85.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.712 -1.959 . . . . 25.66 105.712 -179.918 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.79 -45.77 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 125.876 1.67 . . . . 8.1199999999999992 114.004 -178.051 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -57.6 -33.19 67.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.622 2.153 . . . . 15.470000000000001 113.09 172.532 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.46 -26.89 60.32 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.674 1.731 . . . . 11.449999999999999 115.674 179.355 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.315 52.6 mttp -75.07 -31.74 61.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.84 -2.344 . . . . 24.98 112.277 171.944 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.1 mt -63.71 -34.51 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 124.898 2.285 . . . . 9.4600000000000009 116.554 175.326 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -62.19 -41.81 98.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.135 -1.848 . . . . 14.76 113.419 165.592 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.49 -48.3 41.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.087 -1.633 . . . . 26.289999999999999 112.969 -179.263 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -60.83 -66.82 0.47 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.121 -2.237 . . . . 30.059999999999999 114.022 174.146 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -87.37 -26.69 23.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.809 -3.057 . . . . 25.190000000000001 111.243 -162.499 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.29 11.35 48.86 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 119.341 -1.409 . . . . 7.4100000000000001 114.086 -178.672 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.2 mt -80.79 130.7 62.92 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 117.461 -3.376 . . . . 9.4900000000000002 111.596 -168.421 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -74.02 147.75 39.04 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 128.126 3.938 . . . . 11.42 113.066 -167.383 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.48 -16.59 24.27 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 CA-C-N 122.903 2.073 . . . . 12.0 113.4 -174.935 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.63 -30.53 70.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.622 -3.799 . . . . 35.549999999999997 118.285 163.647 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -75.46 -21.6 57.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.3 1.409 . . . . 20.52 113.392 177.819 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -83.43 114.9 21.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 115.947 -1.978 . . . . 7.1299999999999999 111.634 -160.58 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -119.37 108.1 14.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.401 2.524 . . . . 36.390000000000001 114.227 164.893 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mt -88.54 129.81 35.38 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.762 2.22 . . . . 9.5500000000000007 109.363 179.218 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 mt -116.83 139.71 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 119.182 -2.199 . . . . 13.9 106.027 177.052 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -126.53 112.14 15.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.013 -1.477 . . . . 6.8600000000000003 107.013 172.814 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.271 . . 81.29 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.938 1.695 . . . . 11.15 111.194 -174.537 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.12 43.39 0.23 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.304 -1.498 . . . . 13.93 116.181 173.993 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.28 155.09 46.98 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.148 2.579 . . . . 23.920000000000002 111.42 164.58 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.262 9.3 tt0 -79.93 129.58 34.61 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.3 -2.125 . . . . 23.23 111.953 -176.727 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.592 HD13 HD12 ' A' ' 23' ' ' ILE 0.252 98.4 mt -83.71 121.51 27.38 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.685 -1.884 . . . . 9.1099999999999994 109.916 172.704 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -99.14 154.51 18.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.437 -1.69 . . . . 33.439999999999998 106.437 -168.534 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.09 -32.04 71.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.281 2.326 . . . . 28.370000000000001 117.281 -162.438 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.95 21.66 43.75 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 120.788 1.631 . . . . 15.0 112.065 -169.673 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -118.36 -179.48 3.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.369 -1.665 . . . . 25.5 113.858 164.225 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.7 p -108.91 176.27 5.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.897 2.76 . . . . 11.949999999999999 118.332 178.01 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.6 mt -71.03 -35.02 71.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 113.775 -1.557 . . . . 10.17 113.223 176.026 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -57.3 -45.93 83.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.668 1.987 . . . . 13.59 113.667 165.756 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -61.99 -35.33 78.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.495 2.718 . . . . 11.699999999999999 114.757 175.056 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.4 -4.19 42.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 114.666 -2.587 . . . . 12.949999999999999 111.976 -174.638 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.2 m120 72.79 43.4 0.43 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 123.539 2.882 . . . . 25.449999999999999 110.396 173.831 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -102.99 115.62 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.383 -2.073 . . . . 14.6 111.349 179.936 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -95.82 -177.89 4.19 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.161 1.934 . . . . 33.229999999999997 111.79 175.207 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.258 21.7 ptmt -53.75 138.15 36.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 131.163 3.785 . . . . 25.969999999999999 116.686 175.747 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 71.89 24.53 3.31 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 123.118 1.437 . . . . 32.609999999999999 113.243 171.897 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -92.89 142.5 27.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.983 -1.073 . . . . 10.56 112.071 -178.774 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -101.89 97.91 8.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.244 2.618 . . . . 5.3300000000000001 112.713 -172.973 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.591 HD13 HD12 ' A' ' 3' ' ' ILE . 9.6 mp -84.48 145.55 28.07 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.73 2.519 . . . . 11.66 110.478 174.924 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -109.02 134.03 52.2 Favored 'General case' 0 N--CA 1.43 -1.425 1 O-C-N 115.646 -4.408 . . . . 16.300000000000001 100.537 -169.768 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.78 125.75 51.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.607 1.194 . . . . 9.9600000000000009 109.729 170.979 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.6 t -113.79 152.3 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 126.738 3.161 . . . . 9.7599999999999998 106.329 179.947 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.1 mt . . . . . 0 N--CA 1.43 -1.434 0 O-C-N 118.678 -2.514 . . . . 19.57 110.97 -179.306 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 127.171 3.367 . . . . 17.170000000000002 104.451 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -93.22 123.7 36.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.234 -2.257 . . . . 21.890000000000001 105.241 177.924 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -117.59 166.96 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 118.322 -2.736 . . . . 10.83 106.414 170.149 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.86 100.94 7.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.411 -3.306 . . . . 10.609999999999999 115.01 -176.049 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.44 105.89 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 118.89 -2.381 . . . . 9.1300000000000008 109.394 -163.265 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -99.45 132.69 44.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.612 -1.176 . . . . 20.550000000000001 111.042 -172.345 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 p -98.11 -177.88 3.88 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.226 2.21 . . . . 11.779999999999999 113.194 -178.555 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 mt -83.6 -33.52 25.33 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.838 -2.414 . . . . 19.309999999999999 111.637 -164.304 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 p -88.49 -66.79 0.88 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.73 2.012 . . . . 23.140000000000001 112.523 -177.038 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.24 48.76 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 117.505 -2.283 . . . . 19.739999999999998 109.665 -174.031 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -136.07 119.37 16.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.012 2.339 . . . . 21.93 105.506 176.379 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -92.23 106.87 18.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.376 2.989 . . . . 12.33 111.832 163.666 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 mt -88.46 114.89 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.661 -2.063 . . . . 17.079999999999998 106.308 -179.717 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -94.18 125.14 38.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.698 -0.482 . . . . 16.300000000000001 109.698 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 tp -153.8 135.86 14.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.965 -2.959 . . . . 15.880000000000001 115.212 -157.232 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.9 97.32 11.11 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 132.398 4.279 . . . . 28.899999999999999 117.021 -177.287 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.69 150.57 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.674 2.39 . . . . 12.050000000000001 111.714 179.158 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -87.04 152.77 53.77 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 112.867 -3.444 . . . . 18.170000000000002 109.394 176.671 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -71.99 -23.49 21.76 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 CA-C-N 123.321 2.222 . . . . 8.1600000000000001 112.949 173.682 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -81.44 2.27 29.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.97 3.919 . . . . 11.130000000000001 113.821 168.22 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -72.05 148.48 45.78 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 124.529 3.332 . . . . 18.030000000000001 110.887 165.08 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 73.4 p -84.54 173.25 10.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.767 -1.833 . . . . 10.220000000000001 109.522 177.344 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -63.43 -23.18 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 124.525 2.107 . . . . 12.300000000000001 112.263 168.407 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -80.88 -37.93 28.92 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.031 -4.168 . . . . 36.509999999999998 109.749 176.433 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 28' ' ' ALA 0.321 17.1 m120 -73.68 -35.12 65.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.62 -1.3 . . . . 25.66 112.26 179.773 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.604 HG21 HD11 ' A' ' 56' ' ' LEU 0.489 81.4 t -45.83 -59.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 129.937 3.295 . . . . 8.1199999999999992 113.619 163.106 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt -60.67 -30.53 69.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.177 3.391 . . . . 15.470000000000001 113.051 174.144 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.7 -42.59 88.99 Favored 'General case' 0 N--CA 1.429 -1.48 1 CA-C-O 131.011 5.196 . . . . 11.449999999999999 118.047 163.297 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -75.5 -35.97 60.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.72 -3.737 . . . . 24.98 111.764 -179.065 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mt -64.57 -41.87 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 125.381 1.675 . . . . 9.4600000000000009 114.53 168.46 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -50.16 -57.88 6.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.66 2.171 . . . . 14.76 115.421 174.545 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -47.81 -60.96 2.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.546 3.538 . . . . 26.289999999999999 114.627 167.962 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -65.73 -58.4 5.76 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.252 1.025 . . . . 30.059999999999999 109.975 -168.737 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -83.93 -48.81 9.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.807 2.151 . . . . 25.190000000000001 116.807 179.988 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.08 9.86 5.94 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 129.683 3.516 . . . . 7.4100000000000001 112.617 179.424 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mt -85.81 128.93 56.5 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-N 121.356 2.578 . . . . 9.4900000000000002 108.115 -162.799 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.83 153.86 29.75 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 CA-C-O 109.941 -4.275 . . . . 11.42 114.439 -166.732 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.6 -24.1 26.22 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 124.13 3.22 . . . . 12.0 117.671 -168.881 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -80.63 -6.68 58.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.338 3.055 . . . . 35.549999999999997 112.733 171.843 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -93.46 -36.79 12.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.298 -2.126 . . . . 20.52 111.412 169.565 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -72.51 144.78 47.88 Favored 'General case' 0 N--CA 1.429 -1.48 1 N-CA-C 123.509 4.633 . . . . 7.1299999999999999 123.509 179.975 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -160.74 135.41 7.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.776 -0.824 . . . . 36.390000000000001 108.776 175.465 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.526 HD21 HD13 ' A' ' 69' ' ' LEU . 49.7 mt -117.51 116.44 27.14 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.149 1.928 . . . . 9.5500000000000007 108.6 -170.372 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.582 HD12 HG21 ' A' ' 70' ' ' VAL . 33.9 mt -110.52 133.54 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 126.767 2.027 . . . . 13.9 111.066 175.117 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -118.37 118.95 33.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 102.269 -3.234 . . . . 6.8600000000000003 102.269 177.854 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.92 -62.69 0.07 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.263 3.425 . . . . 11.15 118.32 -176.551 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.99 7.89 0.79 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 115.895 1.118 . . . . 13.93 115.895 178.684 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -153.81 154.89 34.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.741 2.686 . . . . 23.920000000000002 105.76 177.84 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -66.76 150.04 49.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.377 3.471 . . . . 23.23 113.648 -179.227 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 mt -112.61 134.47 54.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.481 2.312 . . . . 9.1099999999999994 105.519 -173.986 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -97.55 130.67 44.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.835 2.731 . . . . 33.439999999999998 111.248 -171.524 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -34.2 -42.95 0.14 Allowed 'General case' 0 N--CA 1.43 -1.445 1 N-CA-C 122.704 4.335 . . . . 28.370000000000001 122.704 178.365 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.95 -15.84 69.05 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.237 -1.539 . . . . 15.0 113.664 -168.485 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -87.73 147.18 25.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.36 2.664 . . . . 25.5 109.845 178.175 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 37.6 p -81.88 163.77 22.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.303 2.241 . . . . 11.949999999999999 110.088 173.017 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.604 HD11 HG21 ' A' ' 26' ' ' VAL . 39.2 mt -61.29 -37.31 82.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.674 1.702 . . . . 10.17 115.43 171.798 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.9 m -45.77 -46.17 15.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.36 -3.338 . . . . 13.59 118.448 161.888 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -55.98 -13.6 2.01 Favored 'General case' 0 N--CA 1.43 -1.463 2 O-C-N 114.084 -5.385 . . . . 11.699999999999999 118.058 166.044 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -121.17 -7.73 9.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 115.894 -2.003 . . . . 12.949999999999999 107.134 -174.352 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.4 m120 74.58 34.68 0.74 Allowed 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 135.935 5.694 . . . . 25.449999999999999 107.955 176.664 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -82.6 106.42 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.42 -1.696 . . . . 14.6 106.42 -175.827 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -92.01 -175.39 4.08 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.468 2.707 . . . . 33.229999999999997 113.725 174.944 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -58.65 153.13 17.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.276 -3.39 . . . . 25.969999999999999 115.023 179.6 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 74.66 -1.16 3.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 125.996 2.06 . . . . 32.609999999999999 115.332 171.356 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.3 m -61.51 141.94 57.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 120.517 3.525 . . . . 10.56 120.517 178.05 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.3 m -98.63 109.76 22.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.085 2.116 . . . . 5.3300000000000001 107.628 -170.604 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mt -110.25 141.29 43.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.173 -2.158 . . . . 11.66 105.173 -173.278 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -104.91 118.83 37.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.06 1.41 . . . . 16.300000000000001 109.967 -177.539 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.526 HD13 HD21 ' A' ' 43' ' ' LEU . 19.8 tp -95.55 99.24 11.14 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.814 2.446 . . . . 9.9600000000000009 108.273 176.572 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 44' ' ' ILE . 61.7 t -87.1 110.26 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.986 3.315 . . . . 9.7599999999999998 111.06 174.124 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp . . . . . 0 N--CA 1.43 -1.446 0 N-CA-C 103.592 -2.744 . . . . 19.57 103.592 -178.137 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 111.202 0.075 . . . . 17.170000000000002 111.202 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -104.44 141.48 36.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.043 -2.286 . . . . 21.890000000000001 109.741 178.158 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 pt -119.56 159.84 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 131.295 3.838 . . . . 10.83 108.694 170.984 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -114.58 92.06 3.83 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.094 2.158 . . . . 10.609999999999999 107.123 -175.139 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.0 t -93.74 108.61 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.112 -2.242 . . . . 9.1300000000000008 106.952 175.765 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -102.96 145.09 30.38 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 122.729 1.252 . . . . 20.550000000000001 113.697 -171.706 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.8 p -90.94 171.89 8.97 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.744 -2.074 . . . . 11.779999999999999 110.81 177.145 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.95 -51.66 68.33 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 129.116 4.01 . . . . 19.309999999999999 115.16 171.351 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.251 78.9 p -46.33 -48.98 18.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 125.274 3.67 . . . . 23.140000000000001 113.186 161.24 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.19 52.62 0.56 Allowed Glycine 0 N--CA 1.43 -1.72 1 C-N-CA 132.526 4.869 . . . . 19.739999999999998 108.909 176.138 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -84.98 132.18 34.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.618 -2.033 . . . . 21.93 106.512 161.826 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -103.65 110.06 21.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 128.342 3.925 . . . . 12.33 109.733 -178.468 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.467 HG22 ' HB2' ' A' ' 15' ' ' LEU . 61.8 mt -81.54 109.31 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 O-C-N 112.222 -6.549 . . . . 17.079999999999998 105.751 177.651 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 p -83.14 66.27 8.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.958 2.103 . . . . 16.300000000000001 108.532 -178.23 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.467 ' HB2' HG22 ' A' ' 13' ' ' ILE . 12.8 tp -94.29 127.12 39.95 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.764 -3.085 . . . . 15.880000000000001 116.744 -164.313 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -103.51 102.46 12.36 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.595 -4.44 . . . . 28.899999999999999 115.663 -163.72 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -125.0 167.96 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.734 1.255 . . . . 12.050000000000001 109.455 -172.106 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.289 27.8 mt-10 -98.15 170.6 6.84 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 118.369 -2.707 . . . . 18.170000000000002 108.898 161.568 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.15 -4.35 9.56 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 O-C-N 117.288 -2.006 . . . . 8.1600000000000001 108.673 -175.038 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 m -95.03 18.69 11.62 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.112 -1.44 . . . . 11.130000000000001 107.112 178.908 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -93.7 139.42 30.83 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.52 -1.987 . . . . 18.030000000000001 108.779 175.143 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 14.6 p -84.72 165.77 17.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.05 1.295 . . . . 10.220000000000001 114.198 173.809 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 43.5 mm -71.95 -27.38 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.904 2.082 . . . . 12.300000000000001 106.869 -167.346 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -58.73 -50.09 75.22 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.929 2.892 . . . . 36.509999999999998 116.848 167.354 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -69.78 -22.11 63.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.584 2.809 . . . . 25.66 118.584 169.608 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.307 21.1 t -66.0 -55.93 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 C-N-CA 132.041 4.136 . . . . 8.1199999999999992 107.522 166.791 . . . . . . . . 3 2 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 51.5 mtmt -61.88 -44.29 97.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.441 2.385 . . . . 15.470000000000001 117.441 173.059 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.57 -32.05 64.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.602 -2.561 . . . . 11.449999999999999 113.676 174.093 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -66.68 -38.78 87.5 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.445 3.022 . . . . 24.98 110.677 176.206 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -70.36 -33.87 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.998 -2.939 . . . . 9.4600000000000009 113.877 177.963 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.291 27.3 tt0 -52.81 -49.82 64.89 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.845 3.212 . . . . 14.76 113.83 171.915 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.66 -53.44 47.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.891 2.876 . . . . 26.289999999999999 112.92 174.039 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -68.27 -76.09 0.09 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.063 2.945 . . . . 30.059999999999999 112.185 -179.224 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.95 -51.4 67.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 124.625 3.375 . . . . 25.190000000000001 118.356 175.041 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.01 28.92 9.46 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.221 -1.549 . . . . 7.4100000000000001 113.63 -174.741 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mt -96.67 117.54 65.89 Favored Pre-proline 0 N--CA 1.429 -1.513 0 C-N-CA 131.537 3.935 . . . . 9.4900000000000002 105.205 177.114 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -69.04 158.34 58.28 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 CA-C-N 125.503 3.001 . . . . 11.42 112.45 -171.731 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.36 -24.12 8.11 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 122.485 2.123 . . . . 12.0 112.017 -149.649 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.98 -17.0 64.39 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.294 2.638 . . . . 35.549999999999997 113.295 -173.905 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -92.61 -26.0 18.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.63 1.972 . . . . 20.52 115.108 -172.905 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -70.88 86.74 0.7 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 121.063 3.727 . . . . 7.1299999999999999 121.063 -179.243 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 20.6 ttt180 -79.17 112.17 16.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.839 -3.663 . . . . 36.390000000000001 117.439 167.146 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.16 109.44 20.84 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 116.007 -4.183 . . . . 9.5500000000000007 112.013 -173.932 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mm -103.67 125.95 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 118.764 -2.46 . . . . 13.9 110.047 176.732 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -102.65 117.86 35.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.644 -2.071 . . . . 6.8600000000000003 106.121 166.714 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.7 -110.93 0.53 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.935 -2.353 . . . . 11.15 113.01 178.14 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.95 17.12 25.12 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 118.984 -1.579 . . . . 13.93 113.498 168.187 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -119.83 139.3 52.57 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.27 3.428 . . . . 23.920000000000002 108.519 -161.588 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -104.71 128.03 52.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.418 -2.808 . . . . 23.23 103.418 -166.487 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.65 128.75 35.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.097 -2.877 . . . . 9.1099999999999994 111.749 -176.844 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.256 43.1 mt-10 -107.28 158.66 16.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 117.479 -1.688 . . . . 33.439999999999998 111.092 -176.716 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -58.54 -53.46 58.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.468 3.507 . . . . 28.370000000000001 113.956 -155.264 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.81 -2.91 71.45 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 113.548 -1.66 . . . . 15.0 111.887 -161.936 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -88.28 155.26 19.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 113.889 -2.958 . . . . 25.5 113.583 166.383 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 82.0 p -92.72 173.05 7.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.565 2.346 . . . . 11.949999999999999 114.198 178.923 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.52 -46.0 47.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.782 2.512 . . . . 10.17 117.782 160.216 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -54.86 -46.38 74.67 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.739 2.816 . . . . 13.59 117.291 170.912 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -48.2 -63.94 0.93 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.566 1.946 . . . . 11.699999999999999 109.56 172.438 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -73.36 3.96 5.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.215 -2.326 . . . . 12.949999999999999 116.015 179.726 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.468 66.8 t30 67.72 54.0 0.67 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.555 3.034 . . . . 25.449999999999999 112.42 171.114 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.71 103.47 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 127.051 2.14 . . . . 14.6 111.636 -174.647 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -68.25 168.58 12.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.224 3.81 . . . . 33.229999999999997 106.561 174.293 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.34 154.2 14.01 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.424 1.639 . . . . 25.969999999999999 115.424 172.293 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 56.75 41.1 28.68 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.808 2.567 . . . . 32.609999999999999 114.873 176.802 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.263 47.2 m -86.78 126.9 34.91 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.489 1.916 . . . . 10.56 108.607 173.326 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -72.52 127.15 31.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 117.088 -1.845 . . . . 5.3300000000000001 115.212 163.748 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mt -114.62 164.86 13.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.702 3.62 . . . . 11.66 111.851 159.627 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -120.45 121.31 38.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.875 -2.639 . . . . 16.300000000000001 103.875 -172.886 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -91.47 108.74 20.1 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.247 -2.131 . . . . 9.9600000000000009 105.247 173.201 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 19.3 t -96.61 144.28 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.056 2.836 . . . . 9.7599999999999998 107.224 168.931 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 71' ' ' LEU . 80.0 mt . . . . . 0 N--CA 1.431 -1.414 0 O-C-N 116.514 -3.866 . . . . 19.57 111.333 -179.087 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptt? . . . . . 0 CA--C 1.491 -1.323 0 CA-C-O 124.233 1.968 . . . . 17.170000000000002 108.446 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -98.47 140.8 32.17 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.011 -2.931 . . . . 21.890000000000001 109.778 176.838 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.471 HD13 HD12 ' A' ' 67' ' ' LEU . 2.2 pp -131.16 166.4 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 112.22 -2.264 . . . . 10.83 109.403 168.02 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.3 145.79 42.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.786 -3.071 . . . . 10.609999999999999 108.692 177.659 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.43 118.55 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.358 2.663 . . . . 9.1300000000000008 112.724 163.935 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -111.68 110.9 21.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.391 2.996 . . . . 20.550000000000001 112.488 179.271 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.8 p -76.72 171.26 15.0 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.647 -4.408 . . . . 11.779999999999999 113.102 -170.179 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mt -52.8 -54.26 36.66 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.898 -1.049 . . . . 19.309999999999999 111.506 174.778 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.4 p -56.93 -31.5 65.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.575 2.35 . . . . 23.140000000000001 116.86 167.989 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.91 27.28 4.36 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 120.006 -1.684 . . . . 19.739999999999998 113.685 168.219 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -80.24 131.84 35.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 121.05 2.425 . . . . 21.93 105.074 175.978 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -85.42 109.5 18.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.082 2.153 . . . . 12.33 112.452 163.85 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -103.06 123.43 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 114.806 -1.088 . . . . 17.079999999999998 108.786 171.949 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -84.74 121.82 28.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 117.24 -1.362 . . . . 16.300000000000001 112.341 173.852 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 tp -129.91 121.17 26.11 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.126 1.37 . . . . 15.880000000000001 110.7 -172.959 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -87.5 122.76 31.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.768 1.747 . . . . 28.899999999999999 108.873 173.204 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.44 149.68 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 129.707 3.203 . . . . 12.050000000000001 108.782 -179.491 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.2 mt-10 -87.0 149.01 46.72 Favored Pre-proline 0 N--CA 1.43 -1.426 0 C-N-CA 127.253 2.221 . . . . 18.170000000000002 106.248 166.683 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 61.4 Cg_exo -73.55 -15.03 24.8 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 115.847 -2.302 . . . . 8.1600000000000001 111.44 -173.983 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -87.73 3.65 47.21 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 116.028 -4.17 . . . . 11.130000000000001 118.02 172.831 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.3 150.8 35.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.346 -1.471 . . . . 18.030000000000001 113.092 167.654 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 24.8 p -96.01 177.67 5.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.395 1.685 . . . . 10.220000000000001 109.438 -172.729 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.48 -23.73 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 121.424 1.92 . . . . 12.300000000000001 113.344 -177.019 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -52.5 -48.51 65.94 Favored 'General case' 0 N--CA 1.431 -1.394 1 C-N-CA 133.101 4.561 . . . . 36.509999999999998 111.021 158.071 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 40.5 m-20 -72.01 -27.39 62.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.65 2.093 . . . . 25.66 116.65 179.661 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -73.2 -41.06 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 128.081 2.552 . . . . 8.1199999999999992 112.563 175.958 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -59.63 -31.01 69.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 117.25 -1.357 . . . . 15.470000000000001 111.886 165.085 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -71.85 -41.84 67.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.931 1.395 . . . . 11.449999999999999 109.669 -177.822 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.285 21.1 mmtp -63.38 -28.12 69.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.814 3.246 . . . . 24.98 113.059 173.96 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.7 mt -87.48 -41.71 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 1 O-C-N 113.91 -5.494 . . . . 9.4600000000000009 112.726 178.973 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -46.22 -47.14 17.94 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.847 -2.408 . . . . 14.76 114.806 159.126 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.31 -25.51 61.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.015 1.857 . . . . 26.289999999999999 116.015 -178.437 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -87.73 -52.81 5.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 116.914 2.19 . . . . 30.059999999999999 116.914 178.837 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -98.77 -25.28 14.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.085 1.354 . . . . 25.190000000000001 112.011 -168.832 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.01 17.11 28.56 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 118.262 -1.299 . . . . 7.4100000000000001 115.267 168.276 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.2 mt -94.77 126.5 47.05 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 130.715 3.606 . . . . 9.4900000000000002 108.254 -168.855 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.51 139.68 54.59 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 124.322 3.348 . . . . 11.42 113.349 -179.504 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.04 -2.63 12.79 Favored 'Trans proline' 0 C--N 1.3 -2.019 1 C-N-CA 126.415 4.743 . . . . 12.0 114.108 -166.538 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.273 9.5 p-10 -84.61 -31.98 23.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 122.678 2.49 . . . . 35.549999999999997 111.182 174.178 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.91 -13.17 60.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.041 2.088 . . . . 20.52 114.183 -179.274 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -88.98 121.62 31.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 111.504 -2.589 . . . . 7.1299999999999999 114.677 177.924 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -111.95 118.09 34.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 115.544 -2.169 . . . . 36.390000000000001 113.66 166.034 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.7 mt -109.93 123.48 49.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.335 1.647 . . . . 9.5500000000000007 108.142 -174.376 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.14 127.09 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.946 2.098 . . . . 13.9 106.731 -174.813 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -103.77 114.11 28.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.58 -1.637 . . . . 6.8600000000000003 106.58 169.061 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.01 -96.98 0.05 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.92 2.488 . . . . 11.15 110.338 178.115 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.82 -7.71 17.07 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 125.37 1.462 . . . . 13.93 115.781 173.865 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -90.89 130.62 36.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 128.426 3.965 . . . . 23.920000000000002 108.429 -171.131 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -98.52 157.96 15.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 111.285 -2.689 . . . . 23.23 104.812 166.947 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.3 mt -122.01 166.48 14.42 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.619 -1.628 . . . . 9.1099999999999994 111.533 -155.9 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.27 176.94 5.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.141 -1.429 . . . . 33.439999999999998 107.141 166.569 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -102.44 -53.14 2.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.372 1.469 . . . . 28.370000000000001 111.043 -168.135 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.04 16.38 7.23 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 118.791 2.276 . . . . 15.0 118.791 -170.139 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -116.62 153.55 32.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.514 1.925 . . . . 25.5 110.938 -173.142 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 20.3 p -88.57 170.67 10.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 113.851 1.056 . . . . 11.949999999999999 113.851 -173.328 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.52 -31.25 71.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.774 1.749 . . . . 10.17 108.418 177.69 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -70.48 -43.2 70.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.101 1.76 . . . . 13.59 111.78 -175.928 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -59.39 -28.11 66.6 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 128.467 3.984 . . . . 11.699999999999999 118.24 176.884 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -82.06 -27.11 33.15 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 113.558 -5.714 . . . . 12.949999999999999 121.078 169.784 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 t30 71.95 48.66 0.27 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.508 2.575 . . . . 25.449999999999999 117.372 -157.503 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mt -94.75 99.66 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 118.452 -2.655 . . . . 14.6 104.995 174.35 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.45 -175.73 2.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.701 -1.874 . . . . 33.229999999999997 107.134 -165.121 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.305 20.3 pttm -67.13 148.38 51.91 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 120.295 1.407 . . . . 25.969999999999999 112.247 -178.396 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 76.57 7.22 3.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.557 2.343 . . . . 32.609999999999999 114.451 178.962 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 t -63.96 140.68 58.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.689 1.366 . . . . 10.56 114.689 -177.488 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 m -93.9 104.21 16.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.517 -3.239 . . . . 5.3300000000000001 113.117 170.949 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 3' ' ' ILE . 35.7 mt -84.45 128.18 34.44 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 114.531 -5.106 . . . . 11.66 110.131 169.718 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -106.22 125.27 50.79 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.374 -2.079 . . . . 16.300000000000001 111.668 -172.183 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.25 12.1 tp -92.22 134.16 35.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.764 -1.569 . . . . 9.9600000000000009 106.764 -177.961 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.1 t -116.31 112.04 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 126.709 3.147 . . . . 9.7599999999999998 109.153 162.407 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.0 tp . . . . . 0 N--CA 1.43 -1.465 0 O-C-N 118.811 -2.431 . . . . 19.57 114.022 -167.382 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 123.624 1.678 . . . . 17.170000000000002 112.04 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -101.79 131.09 48.3 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.583 -4.448 . . . . 21.890000000000001 109.057 -171.584 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -116.81 156.78 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.469 -3.269 . . . . 10.83 105.089 162.686 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -120.28 126.32 50.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.94 2.781 . . . . 10.609999999999999 108.629 -178.513 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.49 105.86 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 119.17 -2.206 . . . . 9.1300000000000008 112.826 -179.32 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -92.42 151.12 20.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.56 -1.338 . . . . 20.550000000000001 112.289 -176.264 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -104.18 -166.57 1.26 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.098 1.759 . . . . 11.779999999999999 113.383 -178.003 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.35 -62.48 1.38 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 115.57 -2.157 . . . . 19.309999999999999 114.1 172.23 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.2 p -63.19 -35.14 79.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.319 2.647 . . . . 23.140000000000001 111.576 177.898 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.49 53.87 0.67 Allowed Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 127.029 3.572 . . . . 19.739999999999998 111.769 167.209 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -89.44 139.58 30.37 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.563 -4.492 . . . . 21.93 102.121 162.216 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.1 m -83.48 110.68 18.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 115.813 -2.042 . . . . 12.33 113.457 161.399 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -88.04 123.99 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 126.197 2.185 . . . . 17.079999999999998 107.238 169.858 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.7 m -94.45 115.43 27.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.751 -1.203 . . . . 16.300000000000001 107.751 177.883 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -109.37 134.42 51.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.592 -3.817 . . . . 15.880000000000001 115.71 168.782 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.69 109.12 20.93 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.599 -2.0 . . . . 28.899999999999999 105.599 175.217 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -121.6 152.06 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 C-N-CA 133.583 4.753 . . . . 12.050000000000001 112.388 -177.015 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -90.4 146.25 34.16 Favored Pre-proline 0 N--CA 1.429 -1.495 0 O-C-N 117.805 -3.059 . . . . 18.170000000000002 108.288 164.546 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.3 -18.4 62.4 Favored 'Trans proline' 0 C--N 1.299 -2.06 1 C-N-CA 128.245 5.964 . . . . 8.1600000000000001 111.788 172.758 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.7 p -83.9 -7.42 59.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.791 1.636 . . . . 11.130000000000001 110.113 174.607 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -81.01 165.88 21.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.078 2.672 . . . . 18.030000000000001 111.606 178.448 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 p -85.36 164.24 18.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.948 2.899 . . . . 10.220000000000001 113.365 168.395 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.0 mm -67.28 -35.61 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.355 1.862 . . . . 12.300000000000001 110.199 178.914 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -50.91 -48.95 60.44 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.16 -2.213 . . . . 36.509999999999998 115.998 168.11 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.98 -32.79 71.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.941 -3.6 . . . . 25.66 118.203 169.281 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.91 -54.31 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 124.966 1.306 . . . . 8.1199999999999992 108.273 169.654 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -56.95 -36.72 70.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.006 2.225 . . . . 15.470000000000001 117.006 178.349 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.29 -24.12 64.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.05 2.982 . . . . 11.449999999999999 119.05 173.078 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -69.99 -56.99 5.54 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.514 -1.991 . . . . 24.98 113.096 173.516 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -51.42 -46.85 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 127.228 2.211 . . . . 9.4600000000000009 110.517 169.394 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -49.49 -41.93 42.08 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.427 2.01 . . . . 14.76 116.427 171.894 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -81.01 -77.53 0.2 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.905 3.241 . . . . 26.289999999999999 106.352 -178.893 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -64.4 -42.01 96.33 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.519 -5.113 . . . . 30.059999999999999 114.148 -162.574 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -94.61 -43.04 8.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.169 -3.457 . . . . 25.190000000000001 115.316 178.897 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.18 41.62 3.69 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.018 -2.301 . . . . 7.4100000000000001 114.863 176.609 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -109.55 113.15 58.34 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 103.952 -2.61 . . . . 9.4900000000000002 103.952 168.351 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_exo -57.7 159.3 17.51 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 C-N-CA 126.424 4.749 . . . . 11.42 112.953 -173.726 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -86.42 -1.34 8.39 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 124.8 3.667 . . . . 12.0 112.22 -169.916 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -87.39 -26.86 23.11 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.397 2.936 . . . . 35.549999999999997 111.747 169.319 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.03 -31.05 71.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.352 1.612 . . . . 20.52 115.352 175.03 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -83.44 136.23 34.39 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.441 2.015 . . . . 7.1299999999999999 116.441 -173.726 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -132.07 143.36 49.97 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 115.198 -2.601 . . . . 36.390000000000001 110.143 140.763 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.7 mt -94.05 128.31 40.34 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.792 -2.004 . . . . 9.5500000000000007 111.824 -178.51 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mm -113.4 138.47 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 107.367 -1.346 . . . . 13.9 107.367 -176.596 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -114.89 100.99 8.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.274 2.464 . . . . 6.8600000000000003 109.797 171.251 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.501 . . 82.34 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.626 -3.796 . . . . 11.15 110.646 172.919 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.04 3.47 6.86 Favored Glycine 0 N--CA 1.429 -1.768 0 CA-C-N 113.262 -1.79 . . . . 13.93 112.745 159.367 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -89.03 124.88 34.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 120.727 2.264 . . . . 23.920000000000002 113.193 178.798 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -89.82 118.88 29.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.245 -2.159 . . . . 23.23 110.616 179.817 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.98 159.37 31.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.109 2.385 . . . . 9.1099999999999994 110.117 -164.843 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.42 142.19 50.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.742 -1.572 . . . . 33.439999999999998 113.98 175.942 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.04 -45.31 95.31 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 122.535 4.272 . . . . 28.370000000000001 122.535 -162.678 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.24 -4.78 31.27 Favored Glycine 0 N--CA 1.43 -1.721 1 N-CA-C 124.44 4.536 . . . . 15.0 124.44 172.71 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -100.37 171.75 7.57 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.36 2.029 . . . . 25.5 111.164 -176.819 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.27 30.8 p -94.4 157.35 16.06 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.524 -2.61 . . . . 11.949999999999999 114.167 179.82 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.88 -46.83 60.59 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 117.571 2.434 . . . . 10.17 117.571 163.074 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -56.4 -33.45 65.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 120.382 3.475 . . . . 13.59 120.382 169.003 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -58.88 -37.64 77.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.187 -2.82 . . . . 11.699999999999999 113.656 172.746 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -88.78 -13.17 40.09 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.935 -4.228 . . . . 12.949999999999999 110.112 177.35 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.439 40.8 t30 62.03 72.42 0.5 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 129.055 2.942 . . . . 25.449999999999999 114.379 -165.231 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -111.16 106.17 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 N-CA-C 99.478 -4.267 . . . . 14.6 99.478 -179.785 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -100.33 -173.98 2.55 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.586 -0.697 . . . . 33.229999999999997 110.675 -178.848 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.262 25.1 pttt -55.25 131.74 46.15 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.771 2.428 . . . . 25.969999999999999 113.981 179.656 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 58.99 45.54 14.76 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 127.215 3.388 . . . . 32.609999999999999 115.232 -176.313 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 t -110.28 137.18 48.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.884 -2.385 . . . . 10.56 107.798 179.208 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 m -105.16 129.47 53.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.932 2.093 . . . . 5.3300000000000001 107.614 -159.396 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -118.48 150.42 39.63 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 128.086 3.803 . . . . 11.66 106.271 179.12 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -112.03 124.37 52.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.149 -2.219 . . . . 16.300000000000001 105.201 -178.643 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -90.45 124.78 35.25 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 129.148 4.03 . . . . 9.9600000000000009 108.629 -178.496 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.6 m -99.1 151.62 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.992 2.517 . . . . 9.7599999999999998 109.065 167.192 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 mt . . . . . 0 N--CA 1.43 -1.461 0 O-C-N 118.508 -2.62 . . . . 19.57 109.487 163.13 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 123.46 1.6 . . . . 17.170000000000002 114.12 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -82.39 138.06 34.56 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.422 -4.549 . . . . 21.890000000000001 107.75 168.556 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 17' ' ' VAL . 6.9 pt -118.95 177.48 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 124.849 1.26 . . . . 10.83 109.69 157.904 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -134.89 112.02 10.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.429 2.011 . . . . 10.609999999999999 116.429 -173.915 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.96 115.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 125.87 2.748 . . . . 9.1300000000000008 110.493 177.547 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.263 28.2 tttp -107.32 140.56 40.04 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.977 -4.202 . . . . 20.550000000000001 113.588 -179.866 . . . . . . . . 3 2 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.5 p -102.09 172.7 6.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.983 -2.323 . . . . 11.779999999999999 109.797 -179.429 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.9 -46.75 88.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.501 3.12 . . . . 19.309999999999999 111.853 172.081 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -69.38 -26.86 64.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.905 -2.372 . . . . 23.140000000000001 114.185 171.77 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.4 62.29 0.95 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 116.717 1.447 . . . . 19.739999999999998 116.717 162.97 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -103.13 175.18 5.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.929 2.092 . . . . 21.93 107.905 155.389 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 m -128.46 134.12 48.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.3 -3.375 . . . . 12.33 105.792 172.817 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -114.57 117.4 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 107.896 -1.15 . . . . 17.079999999999998 107.896 174.566 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 m -85.36 107.79 17.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.227 -2.26 . . . . 16.300000000000001 105.955 -175.581 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.0 mt -102.67 135.93 43.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.088 2.375 . . . . 15.880000000000001 115.185 172.668 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -99.7 129.34 45.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.779 -3.701 . . . . 28.899999999999999 110.63 173.248 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 3' ' ' ILE . 4.2 m -151.09 159.63 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.842 1.657 . . . . 12.050000000000001 109.458 -167.628 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 62.2 mm-40 -107.08 159.63 29.3 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 120.554 -1.341 . . . . 18.170000000000002 110.328 163.132 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -72.7 -6.58 19.29 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 124.856 3.704 . . . . 8.1600000000000001 112.374 -176.66 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.8 p -72.64 -26.0 61.49 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 125.355 1.66 . . . . 11.130000000000001 114.338 171.779 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -64.82 157.75 26.87 Favored 'General case' 0 N--CA 1.43 -1.456 1 N-CA-C 124.425 4.972 . . . . 18.030000000000001 124.425 174.687 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 62.5 p -101.29 167.64 10.06 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 114.074 -2.869 . . . . 10.220000000000001 113.899 -173.49 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.317 7.0 mm -64.65 -35.41 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 125.392 1.682 . . . . 12.300000000000001 109.65 172.001 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -44.55 -48.82 10.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.683 3.586 . . . . 36.509999999999998 120.683 160.049 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -62.79 -40.72 98.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.122 1.514 . . . . 25.66 109.255 174.375 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.299 57.6 t -55.07 -59.76 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 116.721 -1.609 . . . . 8.1199999999999992 113.652 171.371 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.79 -27.48 68.78 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.073 1.76 . . . . 15.470000000000001 112.735 176.875 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.48 -32.53 62.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 122.549 2.431 . . . . 11.449999999999999 115.148 175.923 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -70.04 -26.65 64.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.303 -3.373 . . . . 24.98 109.375 176.189 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 30' ' ' ILE . 17.4 mm -70.48 -37.87 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.224 1.409 . . . . 9.4600000000000009 110.988 168.723 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -43.84 78.37 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.301 -2.124 . . . . 14.76 111.612 -178.033 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.35 -69.09 0.12 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 126.948 2.655 . . . . 26.289999999999999 110.984 170.443 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -69.73 -52.32 26.52 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.835 -3.041 . . . . 30.059999999999999 118.485 -171.093 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -84.53 -65.51 1.0 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.877 -1.764 . . . . 25.190000000000001 107.589 -178.272 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.01 17.79 1.0 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 122.64 2.473 . . . . 7.4100000000000001 113.884 -175.048 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.8 mt -97.3 131.19 27.85 Favored Pre-proline 0 N--CA 1.431 -1.41 0 N-CA-C 116.07 1.878 . . . . 9.4900000000000002 116.07 -175.61 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.86 154.79 70.4 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 CA-C-N 124.157 2.521 . . . . 11.42 109.549 -178.946 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 -17.69 13.6 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 N-CA-C 117.221 1.97 . . . . 12.0 117.221 -170.716 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.26 -15.64 57.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.216 1.484 . . . . 35.549999999999997 110.704 178.111 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -86.96 -33.18 19.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.74 2.816 . . . . 20.52 113.036 176.462 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -71.03 139.02 50.33 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.231 1.937 . . . . 7.1299999999999999 116.231 171.013 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -131.67 131.7 43.35 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.015 2.341 . . . . 36.390000000000001 114.497 160.008 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.1 mt -109.37 125.95 52.9 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.154 -4.716 . . . . 9.5500000000000007 110.881 -170.993 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.7 mm -116.45 112.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.531 -1.355 . . . . 13.9 110.132 -176.038 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -102.06 116.38 32.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.879 2.276 . . . . 6.8600000000000003 112.348 163.578 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.447 . . 63.1 -81.81 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.91 1.818 . . . . 11.15 115.91 -167.252 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.95 15.94 1.18 Allowed Glycine 0 N--CA 1.431 -1.687 0 CA-C-O 125.204 2.558 . . . . 13.93 112.569 174.517 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -101.09 131.39 47.03 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.607 -1.525 . . . . 23.920000000000002 110.976 -175.004 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -75.97 120.82 21.83 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.658 -1.155 . . . . 23.23 112.955 170.308 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 mt -89.56 121.29 31.62 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.179 -1.576 . . . . 9.1099999999999994 111.49 -172.893 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -80.95 143.55 32.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.248 1.573 . . . . 33.439999999999998 115.248 172.407 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.78 -42.19 99.59 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.04 4.136 . . . . 28.370000000000001 110.538 -171.812 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.76 -7.69 88.3 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 127.238 2.352 . . . . 15.0 114.012 -170.476 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -101.6 155.68 17.94 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.742 1.617 . . . . 25.5 109.62 -169.875 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.4 p -95.11 167.06 11.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.04 -2.288 . . . . 11.949999999999999 110.256 -174.487 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 mt -57.69 -56.34 23.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.52 3.128 . . . . 10.17 111.886 174.306 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.406 6.6 t -36.13 -37.88 0.13 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.673 3.589 . . . . 13.59 118.822 156.283 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -72.3 -46.66 54.73 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.829 -4.919 . . . . 11.699999999999999 110.829 -176.828 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -67.96 -3.44 9.97 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 120.028 3.344 . . . . 12.949999999999999 120.028 167.26 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.0 m120 64.69 27.45 13.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.461 1.504 . . . . 25.449999999999999 114.381 -175.71 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -85.27 116.29 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.215 1.483 . . . . 14.6 109.059 -174.277 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -97.8 -165.21 1.22 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.902 3.239 . . . . 33.229999999999997 110.598 -176.733 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -76.35 150.11 36.9 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.436 -4.54 . . . . 25.969999999999999 112.979 -174.356 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 50.6 mt-10 54.6 35.64 24.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 125.344 1.652 . . . . 32.609999999999999 113.411 -174.763 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -86.71 133.97 33.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.053 1.882 . . . . 10.56 108.731 -174.668 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m -95.38 118.4 32.05 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.911 -2.368 . . . . 5.3300000000000001 107.725 -177.498 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -109.31 144.58 37.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 100.827 -3.768 . . . . 11.66 100.827 -178.802 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -117.36 126.86 53.39 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.307 -3.996 . . . . 16.300000000000001 104.945 -177.164 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.4 tp -100.11 119.8 38.87 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.567 1.547 . . . . 9.9600000000000009 108.044 -176.446 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.7 m -117.99 159.14 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.051 -1.656 . . . . 9.7599999999999998 113.384 169.368 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.7 mt . . . . . 0 N--CA 1.429 -1.481 0 N-CA-C 106.705 -1.591 . . . . 19.57 106.705 -179.276 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 117.601 2.445 . . . . 17.170000000000002 117.601 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -98.85 134.52 41.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 115.785 -2.055 . . . . 21.890000000000001 113.459 170.308 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -130.77 155.53 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 125.546 2.594 . . . . 10.83 107.18 172.078 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -119.29 105.16 11.05 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.577 -3.827 . . . . 10.609999999999999 107.489 -161.221 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.68 100.15 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 1 O-C-N 129.64 4.338 . . . . 9.1300000000000008 107.705 177.177 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -92.03 120.27 32.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.834 -1.53 . . . . 20.550000000000001 109.975 -177.455 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -74.18 -174.01 1.82 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.872 2.069 . . . . 11.779999999999999 113.739 -178.967 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.2 tp -77.76 -32.25 52.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.932 2.197 . . . . 19.309999999999999 116.932 177.334 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.8 p -70.67 -31.15 67.95 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.542 2.337 . . . . 23.140000000000001 114.637 170.75 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.8 20.15 8.23 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 117.758 -1.579 . . . . 19.739999999999998 114.538 179.849 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.292 44.4 pttt -89.07 142.96 27.19 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 124.733 1.213 . . . . 21.93 111.747 169.357 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.7 m -98.29 130.89 44.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.817 -1.802 . . . . 12.33 108.669 178.0 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.9 mt -106.56 104.64 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 1 N-CA-C 99.737 -4.171 . . . . 17.079999999999998 99.737 171.508 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -73.89 119.52 18.21 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.284 -1.51 . . . . 16.300000000000001 111.702 173.559 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.553 ' CD1' HG13 ' A' ' 26' ' ' VAL . 67.5 mt -100.17 126.07 46.39 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 114.964 -4.835 . . . . 15.880000000000001 114.13 170.588 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -78.93 92.83 4.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 125.797 1.936 . . . . 28.899999999999999 113.349 174.805 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.286 16.3 m -132.8 165.26 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 121.903 2.138 . . . . 12.050000000000001 111.325 -175.701 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -97.07 165.31 16.03 Favored Pre-proline 0 N--CA 1.429 -1.483 0 O-C-N 116.36 -3.963 . . . . 18.170000000000002 109.461 174.409 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.85 -23.66 73.16 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.811 3.111 . . . . 8.1600000000000001 119.539 164.833 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -63.38 -22.39 66.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.04 2.536 . . . . 11.130000000000001 112.823 174.748 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.18 148.69 39.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.315 -2.74 . . . . 18.030000000000001 109.492 -172.174 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 7.8 p -86.91 171.77 10.56 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.46 2.076 . . . . 10.220000000000001 109.425 179.145 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mm -76.93 -22.93 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.064 -2.897 . . . . 12.300000000000001 107.204 176.407 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.82 -46.79 74.59 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.737 -1.852 . . . . 36.509999999999998 110.828 171.132 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 72.4 m-20 -70.64 -21.49 62.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.238 2.615 . . . . 25.66 115.784 -179.612 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.553 HG13 ' CD1' ' A' ' 15' ' ' LEU . 7.8 t -83.72 -57.22 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 112.413 -2.176 . . . . 8.1199999999999992 107.113 174.191 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -45.19 -39.73 6.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.121 -2.862 . . . . 15.470000000000001 117.024 169.714 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.35 89.86 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.722 3.23 . . . . 11.449999999999999 119.722 173.047 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.31 -36.0 80.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.113 1.894 . . . . 24.98 116.113 169.127 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mm -69.43 -31.32 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.924 -1.735 . . . . 9.4600000000000009 107.624 -179.11 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -72.17 -44.67 62.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.417 -2.677 . . . . 14.76 113.182 169.709 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -54.64 -45.36 73.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.102 2.561 . . . . 26.289999999999999 114.57 177.511 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -91.46 -56.93 2.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.455 -2.028 . . . . 30.059999999999999 114.061 -177.994 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.269 52.6 mm-40 -85.81 -31.07 22.51 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.564 -4.46 . . . . 25.190000000000001 114.53 -175.156 . . . . . . . . 3 2 . 1 . 048 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.76 7.55 59.99 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 119.568 -1.958 . . . . 7.4100000000000001 112.902 173.702 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.2 116.95 59.22 Favored Pre-proline 0 N--CA 1.429 -1.485 0 CA-C-O 114.856 -2.497 . . . . 9.4900000000000002 113.819 177.415 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -63.94 150.74 87.72 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 125.227 3.952 . . . . 11.42 114.08 -172.074 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -73.95 -20.69 19.25 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 O-C-N 114.941 -3.241 . . . . 12.0 113.843 -166.964 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -80.61 -18.73 47.3 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.685 -1.969 . . . . 35.549999999999997 105.685 178.596 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -89.93 -18.34 26.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.753 -1.842 . . . . 20.52 113.478 176.744 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -72.95 137.33 45.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.71 -2.494 . . . . 7.1299999999999999 109.163 -177.485 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.517 ' HB3' HG23 ' A' ' 70' ' ' VAL . 28.0 ttt180 -130.89 129.54 42.38 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.668 1.576 . . . . 36.390000000000001 109.837 168.878 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 50' ' ' LEU . 22.9 mt -118.95 124.32 46.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.704 -1.135 . . . . 9.5500000000000007 111.33 -173.928 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 21.7 mm -118.01 134.38 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.171 2.588 . . . . 13.9 106.647 -171.071 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.409 ' HB2' HD11 ' A' ' 50' ' ' LEU . 82.2 t80 -121.24 113.32 19.79 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.324 2.342 . . . . 6.8600000000000003 117.324 161.245 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.86 -98.44 0.08 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.786 1.402 . . . . 11.15 114.786 -164.725 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.21 4.04 9.62 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 124.762 1.172 . . . . 13.93 113.875 166.116 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -90.98 139.24 30.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.294 1.521 . . . . 23.920000000000002 109.56 177.809 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -87.73 117.07 26.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.204 2.202 . . . . 23.23 110.386 178.721 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 43' ' ' LEU . 83.2 mt -83.61 129.27 34.96 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.962 2.905 . . . . 9.1099999999999994 107.898 -178.553 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -111.74 154.43 25.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.224 -1.807 . . . . 33.439999999999998 109.245 -173.995 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.38 -48.57 67.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.49 1.614 . . . . 28.370000000000001 110.876 -158.404 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.58 15.75 44.58 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.972 1.749 . . . . 15.0 114.605 177.279 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -100.36 167.8 10.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.79 -1.93 . . . . 25.5 105.79 171.005 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 11.4 p -105.04 176.86 5.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.514 -1.991 . . . . 11.949999999999999 107.955 -177.865 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.78 -43.55 88.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.957 2.661 . . . . 10.17 115.272 164.856 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.2 t -51.85 -43.74 63.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.414 2.686 . . . . 13.59 113.663 173.717 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -67.17 -29.24 68.88 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 117.147 2.277 . . . . 11.699999999999999 117.147 -173.914 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.07 -10.23 50.83 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 119.441 3.126 . . . . 12.949999999999999 119.441 171.296 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.4 m120 85.06 56.69 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.471 1 C-N-CA 133.679 4.791 . . . . 25.449999999999999 107.244 172.466 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.7 mt -104.92 101.38 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 N-CA-C 99.375 -4.305 . . . . 14.6 99.375 -172.844 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -91.07 -177.48 4.92 Favored 'General case' 0 N--CA 1.43 -1.433 2 C-N-CA 134.561 5.144 . . . . 33.229999999999997 107.265 179.973 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -66.57 145.57 55.46 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.001 1.32 . . . . 25.969999999999999 114.37 -179.311 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.381 17.0 mt-10 66.64 52.56 0.99 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 126.715 3.15 . . . . 32.609999999999999 117.337 176.866 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.1 t -131.76 134.01 45.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.689 -3.132 . . . . 10.56 113.166 -153.227 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.2 m -77.25 117.08 18.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.745 2.528 . . . . 5.3300000000000001 115.16 -179.231 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -115.05 138.37 50.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 115.388 -2.244 . . . . 11.66 108.305 165.39 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.5 m-70 -100.49 122.64 43.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.766 1.166 . . . . 16.300000000000001 111.288 -177.329 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.69 117.46 31.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.099 2.381 . . . . 9.9600000000000009 110.197 172.575 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -126.85 176.7 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 130.596 3.558 . . . . 9.7599999999999998 109.266 172.772 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.43 -1.434 0 O-C-N 119.688 -1.882 . . . . 19.57 115.858 175.441 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 104.832 -2.284 . . . . 17.170000000000002 104.832 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -116.3 130.51 56.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.815 -2.291 . . . . 21.890000000000001 104.815 -175.6 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -117.68 154.45 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.785 -2.302 . . . . 10.83 104.785 161.161 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.314 98.1 m-85 -116.14 152.06 34.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.603 -3.186 . . . . 10.609999999999999 106.121 176.801 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -125.41 113.18 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 106.746 -1.575 . . . . 9.1300000000000008 106.746 177.942 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -122.4 150.95 41.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.699 1.249 . . . . 20.550000000000001 113.234 -169.357 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -89.7 176.2 6.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.242 1.817 . . . . 11.779999999999999 108.246 176.65 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 mt -68.79 -38.82 80.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.124 -2.235 . . . . 19.309999999999999 107.064 -175.4 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -83.83 -61.84 1.72 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.771 -2.456 . . . . 23.140000000000001 114.268 -172.832 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.55 68.69 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 117.737 -2.173 . . . . 19.739999999999998 109.402 177.42 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tmmm? -120.09 121.25 38.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.112 -2.922 . . . . 21.93 103.112 155.407 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.0 m -111.88 112.03 23.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.709 -2.495 . . . . 12.33 108.093 -173.73 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.26 136.73 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 105.468 -2.049 . . . . 17.079999999999998 105.468 173.654 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.2 m -101.78 119.8 39.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.721 -1.214 . . . . 16.300000000000001 107.721 -171.283 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.6 mt -103.84 134.91 46.35 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 119.279 3.066 . . . . 15.880000000000001 119.279 178.943 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.18 109.49 21.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.205 -1.56 . . . . 28.899999999999999 108.686 178.691 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -130.1 148.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 116.765 -3.709 . . . . 12.050000000000001 112.291 -169.884 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -97.44 146.68 31.81 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 118.997 -2.315 . . . . 18.170000000000002 109.312 171.34 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.8 -17.74 17.6 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-O 112.393 -3.253 . . . . 8.1600000000000001 107.602 -172.651 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -85.29 7.37 22.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 123.896 3.044 . . . . 11.130000000000001 112.042 177.035 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -92.71 171.81 8.76 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.213 -2.804 . . . . 18.030000000000001 107.217 -174.717 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -112.48 153.45 27.41 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.046 -1.659 . . . . 10.220000000000001 109.975 -169.12 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 3.0 mt -74.21 -20.74 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.209 2.604 . . . . 12.300000000000001 106.383 -174.311 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.94 -44.87 91.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.283 1.033 . . . . 36.509999999999998 112.101 169.614 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -66.37 -34.96 79.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.293 3.437 . . . . 25.66 109.66 174.439 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 97.6 t -62.84 -49.77 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 119.852 -1.78 . . . . 8.1199999999999992 111.948 177.703 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -65.7 -27.63 68.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.468 2.355 . . . . 15.470000000000001 110.429 -172.802 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.81 -28.35 67.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.562 2.345 . . . . 11.449999999999999 110.02 177.932 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -93.04 -28.94 16.07 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 121.719 2.054 . . . . 24.98 108.26 -178.253 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 mt -65.1 -42.13 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 118.687 -2.508 . . . . 9.4600000000000009 111.377 164.763 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -59.36 -51.84 68.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.109 -3.495 . . . . 14.76 117.691 168.087 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -46.24 -50.08 16.39 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 122.268 2.303 . . . . 26.289999999999999 115.018 174.324 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -68.68 -63.76 1.0 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.496 2.719 . . . . 30.059999999999999 117.109 174.16 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -88.24 -29.82 20.16 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.64 2.089 . . . . 25.190000000000001 116.64 -174.092 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.13 14.83 59.94 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 119.058 2.383 . . . . 7.4100000000000001 119.058 -178.44 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 tt -103.15 115.31 64.2 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 114.903 -2.475 . . . . 9.4900000000000002 106.536 -178.275 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -60.27 170.03 4.47 Favored 'Trans proline' 0 N--CA 1.434 -1.988 2 C-N-CA 131.058 7.839 . . . . 11.42 116.256 -168.977 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.88 -21.09 7.17 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 125.365 2.952 . . . . 12.0 108.126 -164.307 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -75.43 -33.92 60.95 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.445 -2.66 . . . . 35.549999999999997 113.005 175.946 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -73.59 -37.52 65.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.516 -3.24 . . . . 20.52 113.929 176.265 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -54.74 124.55 16.8 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.967 -2.333 . . . . 7.1299999999999999 114.269 173.952 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -124.32 99.34 6.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.369 1.44 . . . . 36.390000000000001 108.43 -178.123 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.3 mt -96.93 107.33 19.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.384 1.874 . . . . 9.5500000000000007 110.705 -173.131 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.421 HG13 HG21 ' A' ' 70' ' ' VAL . 17.2 mm -110.37 120.41 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 128.471 2.708 . . . . 13.9 105.67 -175.406 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -107.95 115.93 31.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.734 -2.03 . . . . 6.8600000000000003 108.022 169.132 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.29 -94.04 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 112.32 -2.218 . . . . 11.15 113.306 -164.168 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.72 12.56 4.53 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 129.361 3.362 . . . . 13.93 113.149 169.997 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -117.91 148.79 41.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.757 2.279 . . . . 23.920000000000002 108.843 -179.82 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -110.77 114.71 28.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.217 -1.031 . . . . 23.23 108.217 -169.115 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.771 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -68.55 157.67 35.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.94 -2.35 . . . . 9.1099999999999994 115.108 -171.947 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -100.21 154.95 18.04 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.775 -1.194 . . . . 33.439999999999998 107.775 178.465 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -75.87 -50.0 16.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.013 -2.899 . . . . 28.370000000000001 116.309 -160.23 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.9 52.93 2.94 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 123.197 2.726 . . . . 15.0 111.855 179.726 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.259 6.7 mmt180 -121.41 160.3 24.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 103.874 -2.639 . . . . 25.5 103.874 171.207 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.303 66.2 p -86.62 151.85 23.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.33 1.452 . . . . 11.949999999999999 111.971 175.937 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.252 33.3 mt -47.51 -50.78 22.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.677 1.191 . . . . 10.17 111.699 165.545 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 p -54.12 -26.73 28.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.328 1.973 . . . . 13.59 116.328 176.866 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.35 -43.45 98.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.396 -2.69 . . . . 11.699999999999999 110.505 173.455 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.23 -16.01 28.32 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 126.601 2.438 . . . . 12.949999999999999 115.724 176.532 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 70.63 36.95 1.51 Allowed 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.601 1.561 . . . . 25.449999999999999 113.381 -172.226 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -68.63 101.43 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.49 -2.006 . . . . 14.6 116.121 170.901 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -76.52 163.43 26.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.82 2.896 . . . . 33.229999999999997 118.82 -175.829 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -61.35 147.85 43.41 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.605 2.817 . . . . 25.969999999999999 118.605 169.593 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.333 26.2 mt-10 68.74 23.98 6.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.07 1.89 . . . . 32.609999999999999 112.773 179.916 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -84.79 152.39 23.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.275 3.417 . . . . 10.56 107.945 -179.997 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -110.41 97.81 7.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 110.766 -2.925 . . . . 5.3300000000000001 107.887 175.825 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -80.81 152.26 28.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.267 3.027 . . . . 11.66 112.119 165.446 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -104.41 140.15 38.33 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.253 -2.78 . . . . 16.300000000000001 106.376 -178.136 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 tp -102.73 104.27 14.57 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.994 2.33 . . . . 9.9600000000000009 110.225 156.939 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.421 HG21 HG13 ' A' ' 44' ' ' ILE . 3.4 t -91.53 138.21 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 117.357 -3.34 . . . . 9.7599999999999998 108.047 -176.62 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 N--CA 1.43 -1.453 0 O-C-N 118.79 -2.444 . . . . 19.57 105.769 172.632 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 125.08 2.372 . . . . 17.170000000000002 114.308 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -104.92 131.1 52.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.539 -3.851 . . . . 21.890000000000001 111.92 166.162 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.297 2.3 pp -124.08 162.52 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 1 O-C-N 114.61 -5.056 . . . . 10.83 105.283 169.679 . . . . . . . . 3 2 . 1 . 050 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -107.04 128.39 54.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.484 3.113 . . . . 10.609999999999999 106.607 -175.189 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.59 104.89 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 100.319 -3.956 . . . . 9.1300000000000008 100.319 -177.859 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 tttt -89.4 162.22 15.89 Favored 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 131.913 4.085 . . . . 20.550000000000001 108.661 175.008 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.484 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 17.8 p -101.99 -151.72 0.42 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.818 -2.426 . . . . 11.779999999999999 105.899 173.703 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.484 ' H ' ' HB ' ' A' ' 7' ' ' THR . 51.3 mt -91.58 -42.39 10.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.004 1.275 . . . . 19.309999999999999 111.459 170.07 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -66.53 -36.66 83.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.875 -1.766 . . . . 23.140000000000001 113.182 174.455 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.01 22.13 1.28 Allowed Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 120.057 2.783 . . . . 19.739999999999998 120.057 158.053 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -72.99 106.02 4.7 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.216 2.206 . . . . 21.93 116.438 168.261 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -81.13 130.33 34.97 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.818 -1.083 . . . . 12.33 109.69 173.511 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -107.38 157.25 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 119.912 -1.743 . . . . 17.079999999999998 106.871 158.79 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.7 m -125.57 106.59 9.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.315 -1.735 . . . . 16.300000000000001 106.315 -169.147 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.261 86.5 mt -125.24 144.95 50.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.829 -0.545 . . . . 15.880000000000001 112.047 -168.345 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -97.1 105.69 17.88 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.375 2.731 . . . . 28.899999999999999 118.375 -171.005 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 m -125.61 161.33 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.375 2.27 . . . . 12.050000000000001 108.146 -168.476 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -103.92 169.58 7.13 Favored Pre-proline 0 N--CA 1.429 -1.476 1 O-C-N 113.232 -5.917 . . . . 18.170000000000002 106.653 167.72 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -77.96 -17.25 13.83 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 116.301 -2.526 . . . . 8.1600000000000001 107.74 174.639 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -75.85 -6.44 50.76 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 117.788 -3.07 . . . . 11.130000000000001 112.654 173.02 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -77.26 145.01 37.77 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.98 -3.575 . . . . 18.030000000000001 108.935 174.76 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.324 20.1 p -77.76 151.75 33.93 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 133.175 4.59 . . . . 10.220000000000001 110.655 176.458 . . . . . . . . 3 2 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 50' ' ' LEU . 65.0 mt -63.5 -38.96 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 120.264 -1.523 . . . . 12.300000000000001 113.031 175.431 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -46.13 -45.37 16.47 Favored 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 132.463 4.305 . . . . 36.509999999999998 113.72 168.591 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -74.57 -23.12 58.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.721 -3.737 . . . . 25.66 114.26 174.738 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.36 -44.93 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.503 -1.998 . . . . 8.1199999999999992 110.576 174.28 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.17 -40.24 73.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.485 1.514 . . . . 15.470000000000001 114.008 173.426 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.06 -42.11 65.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.232 2.308 . . . . 11.449999999999999 117.232 167.648 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -79.54 -14.26 58.98 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 116.151 -4.093 . . . . 24.98 116.259 179.037 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -88.1 -26.29 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.892 -1.755 . . . . 9.4600000000000009 110.17 168.119 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -63.97 -48.9 74.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.642 -3.161 . . . . 14.76 115.933 162.876 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -42.4 -51.42 4.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.0 3.333 . . . . 26.289999999999999 120.0 157.209 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -90.67 -68.11 0.81 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.347 -0.845 . . . . 30.059999999999999 111.326 -166.474 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -86.78 -34.43 19.58 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.303 1.441 . . . . 25.190000000000001 112.648 -176.249 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.55 67.27 1.57 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 115.997 1.159 . . . . 7.4100000000000001 115.997 173.797 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.58 HD11 HD13 ' A' ' 71' ' ' LEU . 10.5 tt -126.9 133.55 25.15 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-N 110.138 -3.031 . . . . 9.4900000000000002 110.97 164.864 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 10.7 Cg_endo -74.44 157.36 45.18 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 123.924 3.083 . . . . 11.42 113.368 -172.435 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 84.1 Cg_exo -72.85 -15.5 26.53 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 CA-C-O 112.567 -3.181 . . . . 12.0 114.171 -153.775 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.49 -17.63 29.93 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 128.639 3.712 . . . . 35.549999999999997 106.068 -176.216 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -89.11 -27.17 20.94 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.781 -3.074 . . . . 20.52 104.832 -178.711 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -78.62 109.61 12.99 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.006 -3.559 . . . . 7.1299999999999999 111.541 -175.538 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -100.44 104.52 15.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.107 -2.553 . . . . 36.390000000000001 104.107 174.587 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -96.45 140.56 30.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.855 -2.403 . . . . 9.5500000000000007 109.16 179.014 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -134.88 146.58 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.722 1.725 . . . . 13.9 107.815 -173.073 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -121.84 104.5 9.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.702 2.001 . . . . 6.8600000000000003 106.482 166.376 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.36 -102.64 0.16 Allowed 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 116.064 -4.147 . . . . 11.15 113.975 173.147 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.11 -25.05 27.72 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 124.461 3.3 . . . . 13.93 113.233 171.526 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -83.8 136.81 34.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.95 1.357 . . . . 23.920000000000002 113.364 -173.021 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -78.67 147.52 33.51 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.644 -3.16 . . . . 23.23 111.146 163.056 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.429 ' HB3' HD13 ' A' ' 23' ' ' ILE . 9.8 mt -110.42 110.45 21.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 114.662 -2.59 . . . . 9.1099999999999994 104.914 -172.282 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.296 20.8 mt-10 -81.08 145.41 31.11 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.714 3.606 . . . . 33.439999999999998 113.47 177.427 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.59 -49.56 74.74 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 119.847 3.277 . . . . 28.370000000000001 119.847 -158.429 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.17 15.32 56.48 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.589 -3.819 . . . . 15.0 116.345 -174.045 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.2 mtt-85 -93.87 161.21 14.4 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.627 1.204 . . . . 25.5 109.147 169.292 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.1 p -91.52 173.77 7.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.101 1.905 . . . . 11.949999999999999 111.211 177.183 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.5 -24.82 53.75 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.38 -1.45 . . . . 10.17 109.434 173.133 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.5 t -72.5 -36.32 68.35 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.805 -1.809 . . . . 13.59 113.132 -177.196 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -59.01 -39.93 83.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.318 2.261 . . . . 11.699999999999999 114.724 173.762 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -84.73 2.08 43.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.761 -3.087 . . . . 12.949999999999999 113.551 -179.874 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.292 29.3 m120 54.47 51.49 14.03 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.061 2.615 . . . . 25.449999999999999 118.061 -168.829 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -99.11 112.53 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 122.741 2.518 . . . . 14.6 107.752 -179.808 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -103.24 176.94 4.98 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.889 1.676 . . . . 33.229999999999997 108.527 -173.975 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 pttp -73.79 148.76 42.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.021 -2.299 . . . . 25.969999999999999 112.897 -173.674 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.81 19.75 10.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 111.367 -2.651 . . . . 32.609999999999999 110.802 -173.456 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -82.39 160.66 22.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.217 -2.142 . . . . 10.56 105.217 179.31 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -116.68 120.55 38.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 126.185 2.898 . . . . 5.3300000000000001 104.766 -171.994 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.41 64.2 mt -100.37 155.55 17.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.489 -2.141 . . . . 11.66 108.508 169.207 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -107.52 131.51 54.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.562 1.69 . . . . 16.300000000000001 115.562 173.482 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.0 107.61 19.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.433 1.893 . . . . 9.9600000000000009 106.096 178.915 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.82 152.75 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.049 -1.657 . . . . 9.7599999999999998 107.47 172.629 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.58 HD13 HD11 ' A' ' 36' ' ' ILE . 10.0 tp . . . . . 0 N--CA 1.43 -1.453 0 O-C-N 119.165 -2.209 . . . . 19.57 105.164 172.679 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 114.518 1.303 . . . . 17.170000000000002 114.518 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -79.55 127.04 31.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.094 -1.432 . . . . 21.890000000000001 114.475 178.36 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -119.25 159.65 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 122.161 2.255 . . . . 10.83 113.943 159.011 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.64 135.6 53.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 104.479 -2.415 . . . . 10.609999999999999 104.479 -172.052 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.63 119.03 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 105.408 -2.071 . . . . 9.1300000000000008 105.408 174.743 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.494 ' HG2' HG23 ' A' ' 12' ' ' THR . 61.0 mttt -107.38 136.49 47.09 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.15 -2.167 . . . . 20.550000000000001 105.15 -171.523 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.272 72.0 p -97.62 172.95 7.39 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.371 2.986 . . . . 11.779999999999999 107.52 -172.02 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mt -77.78 -35.72 51.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.096 -1.866 . . . . 19.309999999999999 115.845 176.875 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -65.42 -69.78 0.27 Allowed 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 121.697 2.044 . . . . 23.140000000000001 106.243 170.405 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.84 68.81 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 113.418 -1.719 . . . . 19.739999999999998 113.556 178.623 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -132.75 150.07 52.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.776 -3.046 . . . . 21.93 102.776 170.346 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 6' ' ' LYS . 34.6 m -127.33 90.98 3.22 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 116.573 -1.68 . . . . 12.33 107.211 -178.219 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 pt -77.07 125.37 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 128.377 2.671 . . . . 17.079999999999998 110.964 -179.784 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.7 m -97.47 117.11 30.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.126 1.516 . . . . 16.300000000000001 113.047 177.008 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -99.12 144.41 28.29 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.037 -1.097 . . . . 15.880000000000001 108.037 178.618 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -87.08 112.69 22.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.669 -3.144 . . . . 28.899999999999999 113.873 165.427 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.68 -176.25 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.416 1 O-C-N 115.917 -4.24 . . . . 12.050000000000001 114.374 176.438 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -132.06 141.47 41.58 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 116.849 -3.657 . . . . 18.170000000000002 111.717 169.696 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.87 -18.19 41.41 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 119.296 2.768 . . . . 8.1600000000000001 119.296 -170.79 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -76.65 -10.31 59.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.223 1.934 . . . . 11.130000000000001 116.223 173.535 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.271 10.9 t0 -94.43 164.77 12.87 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.496 -2.003 . . . . 18.030000000000001 114.173 -175.76 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -75.49 161.41 29.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.819 -2.425 . . . . 10.220000000000001 114.828 -170.197 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 50' ' ' LEU . 22.0 mt -77.83 -31.21 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.891 -3.006 . . . . 12.300000000000001 112.389 177.855 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -49.3 -48.0 46.51 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.384 2.274 . . . . 36.509999999999998 112.385 167.404 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -74.1 -13.66 60.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.372 1.869 . . . . 25.66 113.066 179.657 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.95 -49.27 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 116.553 -3.842 . . . . 8.1199999999999992 108.034 165.368 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -62.96 -33.22 74.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.376 2.67 . . . . 15.470000000000001 110.601 -179.236 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.63 -44.78 85.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.491 3.043 . . . . 11.449999999999999 107.953 -177.087 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.277 65.9 mttm -63.66 -35.06 79.29 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 120.503 3.52 . . . . 24.98 120.503 173.391 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.93 -28.06 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.54 3.067 . . . . 9.4600000000000009 111.15 178.911 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -70.88 -50.36 35.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.499 -3.25 . . . . 14.76 106.056 177.992 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -48.38 -46.64 37.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.703 3.62 . . . . 26.289999999999999 114.895 178.159 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -82.49 -56.96 3.57 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.034 -2.348 . . . . 30.059999999999999 109.517 -165.614 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -100.1 -22.82 15.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.598 3.184 . . . . 25.190000000000001 119.598 -174.841 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.31 27.64 8.04 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 117.228 -3.42 . . . . 7.4100000000000001 115.238 170.204 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 tt -111.98 135.14 21.26 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-O 113.686 -3.054 . . . . 9.4900000000000002 107.073 -168.426 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.55 167.21 27.05 Favored 'Trans proline' 0 C--N 1.299 -2.045 1 CA-C-O 109.448 -4.48 . . . . 11.42 113.307 -174.383 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.18 -11.12 7.6 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 126.026 3.188 . . . . 12.0 111.833 -179.924 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -71.93 -18.66 62.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.611 -2.556 . . . . 35.549999999999997 110.796 173.036 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -92.03 -17.77 24.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 116.562 -1.685 . . . . 20.52 110.43 172.724 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -89.02 128.25 35.71 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.81 1.29 . . . . 7.1299999999999999 112.768 -168.516 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -140.66 143.94 35.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 112.562 -2.108 . . . . 36.390000000000001 107.324 152.274 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.4 mt -110.23 136.31 49.64 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.712 2.405 . . . . 9.5500000000000007 106.092 -171.92 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -128.13 136.02 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 116.658 -3.776 . . . . 13.9 105.874 -170.314 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -120.9 108.01 13.39 Favored 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 98.938 -4.467 . . . . 6.8600000000000003 98.938 -177.076 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.53 -64.91 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 131.41 3.884 . . . . 11.15 115.056 178.181 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.64 -0.81 1.73 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 116.906 1.522 . . . . 13.93 116.906 169.208 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -119.11 153.28 35.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 120.552 2.176 . . . . 23.920000000000002 107.575 -169.603 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -84.52 137.28 33.42 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.56 1.171 . . . . 23.23 113.676 177.256 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HB3' HD13 ' A' ' 23' ' ' ILE . 27.1 mt -94.15 120.55 34.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.152 1.381 . . . . 9.1099999999999994 107.31 -178.547 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -78.85 141.26 37.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.009 1.861 . . . . 33.439999999999998 113.894 177.499 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.7 -63.5 1.07 Allowed 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 132.157 4.183 . . . . 28.370000000000001 115.386 -179.588 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.15 4.32 6.21 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 128.103 2.763 . . . . 15.0 119.569 -179.003 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -105.89 165.82 10.92 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 125.165 2.412 . . . . 25.5 106.439 -177.882 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.6 p -94.38 177.2 6.02 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.11 -2.869 . . . . 11.949999999999999 117.64 172.048 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.38 -25.96 38.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.606 1.962 . . . . 10.17 108.849 179.242 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 m -76.2 -24.86 54.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 121.293 1.86 . . . . 13.59 112.962 172.259 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -54.61 -38.95 67.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.712 1.745 . . . . 11.699999999999999 115.712 171.595 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -99.19 -11.99 20.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.37 2.668 . . . . 12.949999999999999 111.428 -175.359 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.12 60.07 3.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.625 1.97 . . . . 25.449999999999999 114.68 -162.499 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -92.31 118.43 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 126.899 2.08 . . . . 14.6 106.336 173.679 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -103.75 -174.76 2.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.166 1.543 . . . . 33.229999999999997 115.166 178.486 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -69.54 155.77 39.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.041 -2.287 . . . . 25.969999999999999 108.948 176.193 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 53.9 40.01 31.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.88 2.472 . . . . 32.609999999999999 112.021 -178.283 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -92.93 136.43 33.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 129.156 2.983 . . . . 10.56 106.23 176.715 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.4 m -81.13 110.47 16.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.707 -2.331 . . . . 5.3300000000000001 104.707 171.027 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.99 148.85 25.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.489 2.859 . . . . 11.66 108.451 165.989 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -111.24 138.6 47.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.024 -2.213 . . . . 16.300000000000001 105.024 -179.733 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tp -116.45 122.25 44.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.17 -2.529 . . . . 9.9600000000000009 104.17 -179.39 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -108.52 171.47 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 124.811 1.32 . . . . 9.7599999999999998 110.759 -179.617 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 tp . . . . . 0 N--CA 1.43 -1.473 0 O-C-N 118.084 -2.885 . . . . 19.57 113.287 167.335 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 CA--C 1.489 -1.377 0 N-CA-C 120.027 3.343 . . . . 17.170000000000002 120.027 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -92.03 132.9 36.2 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 116.017 -4.177 . . . . 21.890000000000001 109.216 -176.908 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 pt -135.68 150.66 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 116.646 -3.784 . . . . 10.83 105.795 174.836 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.3 134.46 52.87 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.36 -1.291 . . . . 10.609999999999999 109.498 -177.102 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -115.02 120.25 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 119.478 -2.014 . . . . 9.1300000000000008 109.901 173.695 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -89.98 128.48 36.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.711 2.672 . . . . 20.550000000000001 114.46 167.151 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -80.48 -167.51 1.37 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.125 -2.234 . . . . 11.779999999999999 109.711 -165.731 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.2 -55.65 31.14 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.554 2.742 . . . . 19.309999999999999 112.682 169.409 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -91.04 -34.65 15.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.077 1.751 . . . . 23.140000000000001 110.785 -164.341 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.26 79.02 0.2 Allowed Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 128.776 3.084 . . . . 19.739999999999998 111.223 170.023 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -141.76 137.59 31.71 Favored 'General case' 0 N--CA 1.43 -1.451 1 N-CA-C 97.533 -4.988 . . . . 21.93 97.533 177.682 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -109.38 101.23 10.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.846 -1.168 . . . . 12.33 107.846 174.803 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.42 153.91 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 130.242 3.417 . . . . 17.079999999999998 110.283 164.251 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.3 m -120.03 139.87 51.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.41 -1.7 . . . . 16.300000000000001 106.41 -176.17 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.302 96.0 mt -134.63 152.2 51.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 121.436 1.925 . . . . 15.880000000000001 112.294 173.362 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -102.48 117.58 35.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.132 1.333 . . . . 28.899999999999999 112.761 176.838 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.68 172.3 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 121.704 2.047 . . . . 12.050000000000001 112.769 -178.892 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -111.99 155.64 43.03 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 104.969 -2.234 . . . . 18.170000000000002 104.969 170.252 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.271 21.6 Cg_exo -71.22 -12.08 29.58 Favored 'Trans proline' 0 N--CA 1.433 -2.033 1 C-N-CA 126.115 4.543 . . . . 8.1600000000000001 111.631 -175.273 . . . . . . . . 3 2 . 1 . 052 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 p -92.42 -1.88 56.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 127.646 3.091 . . . . 11.130000000000001 108.379 179.401 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -71.79 143.48 49.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 127.846 3.689 . . . . 18.030000000000001 113.948 170.071 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -86.53 169.42 12.81 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 109.631 -3.44 . . . . 10.220000000000001 110.598 -169.649 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -69.73 -37.48 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.434 -1.321 . . . . 12.300000000000001 107.434 175.619 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -54.3 -50.68 66.75 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.503 -1.998 . . . . 36.509999999999998 113.653 171.3 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -61.09 -34.1 74.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 122.843 2.565 . . . . 25.66 115.472 173.196 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.388 75.9 t -54.02 -54.53 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 124.597 1.186 . . . . 8.1199999999999992 113.553 169.124 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -53.3 -24.25 11.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.968 3.307 . . . . 15.470000000000001 119.507 170.266 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.72 -38.78 58.26 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.695 3.617 . . . . 11.449999999999999 111.033 176.489 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -68.29 -33.08 73.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.071 -3.518 . . . . 24.98 115.471 174.361 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -75.02 -47.25 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.782 2.033 . . . . 9.4600000000000009 107.412 175.462 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -46.06 -48.43 16.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 114.704 -2.569 . . . . 14.76 113.37 169.46 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.65 -48.12 60.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 120.398 1.453 . . . . 26.289999999999999 114.39 -176.472 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -71.88 -52.8 15.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.956 -1.497 . . . . 30.059999999999999 113.324 -172.948 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -91.67 -41.61 10.63 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 126.502 2.376 . . . . 25.190000000000001 113.989 -167.271 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.71 40.61 1.56 Allowed Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 119.11 -0.828 . . . . 7.4100000000000001 113.551 173.54 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 tt -113.49 139.86 23.8 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-O 114.826 -2.511 . . . . 9.4900000000000002 106.271 -179.511 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -68.77 153.04 73.79 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 126.964 3.523 . . . . 11.42 109.582 177.624 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.01 -22.82 70.81 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 127.894 5.729 . . . . 12.0 119.356 176.814 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.84 -24.59 48.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.762 -2.681 . . . . 35.549999999999997 103.762 -171.381 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.15 -25.02 25.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.424 -1.423 . . . . 20.52 114.114 -171.225 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -74.95 117.9 17.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.504 -1.998 . . . . 7.1299999999999999 116.101 179.742 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -108.71 110.6 22.05 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.564 2.345 . . . . 36.390000000000001 111.223 167.598 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.69 135.58 33.62 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.141 3.015 . . . . 9.5500000000000007 119.141 173.955 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 mm -121.13 137.15 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 124.107 1.908 . . . . 13.9 110.626 176.202 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -117.08 130.0 56.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.293 -2.754 . . . . 6.8600000000000003 105.67 164.417 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 48.25 -94.62 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.902 1.816 . . . . 11.15 115.902 -176.028 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.03 15.14 7.4 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 118.578 -2.576 . . . . 13.93 114.365 165.307 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -103.4 138.33 40.28 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.695 -3.238 . . . . 23.920000000000002 108.916 -174.553 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -91.27 114.19 26.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.422 2.289 . . . . 23.23 112.688 173.075 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 mt -74.99 129.47 37.71 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 124.527 1.142 . . . . 9.1099999999999994 111.576 -171.469 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -71.81 143.34 49.53 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.179 2.659 . . . . 33.439999999999998 118.179 172.72 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -53.78 -54.49 37.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.543 3.137 . . . . 28.370000000000001 113.302 -169.347 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.86 18.8 55.38 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-O 116.479 -2.29 . . . . 15.0 116.498 -172.321 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -92.92 168.84 10.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.134 1.967 . . . . 25.5 112.206 169.345 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 p -100.81 166.01 11.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 113.974 1.101 . . . . 11.949999999999999 113.974 170.488 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.59 -25.31 62.13 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 114.411 -2.709 . . . . 10.17 112.66 -177.044 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -70.07 -31.17 68.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.852 3.261 . . . . 13.59 110.887 176.224 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -67.84 -33.51 74.91 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.154 1.797 . . . . 11.699999999999999 111.337 175.962 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.16 13.38 17.17 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.775 -6.203 . . . . 12.949999999999999 115.343 166.116 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.73 27.52 14.5 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 114.904 -4.873 . . . . 25.449999999999999 114.693 179.334 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.6 121.98 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.973 -3.579 . . . . 14.6 107.127 -174.15 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -109.92 179.08 4.22 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.21 2.604 . . . . 33.229999999999997 108.302 -169.653 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -48.76 145.32 3.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.734 1.613 . . . . 25.969999999999999 110.733 172.551 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.257 54.0 mt-10 67.64 30.62 6.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.008 -1.906 . . . . 32.609999999999999 115.121 165.039 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -108.28 141.48 40.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.234 1.969 . . . . 10.56 110.335 -175.015 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 m -89.13 105.82 18.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.746 -2.024 . . . . 5.3300000000000001 107.093 -174.789 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.11 148.42 34.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.147 3.379 . . . . 11.66 108.361 158.213 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -115.3 134.5 55.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.933 -1.73 . . . . 16.300000000000001 110.209 170.753 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.7 tp -106.67 116.97 32.85 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.96 1.413 . . . . 9.9600000000000009 109.674 -176.127 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.6 m -127.26 -173.14 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.542 -2.762 . . . . 9.7599999999999998 103.542 175.699 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.2 mt . . . . . 0 N--CA 1.43 -1.464 0 O-C-N 119.859 -1.775 . . . . 19.57 109.996 -173.532 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 114.407 1.262 . . . . 17.170000000000002 114.407 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -109.66 149.51 29.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.086 1.884 . . . . 21.890000000000001 116.086 178.84 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -133.08 157.28 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.331 -3.356 . . . . 10.83 112.205 163.6 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -109.29 131.7 54.82 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 128.293 3.496 . . . . 10.609999999999999 106.425 179.669 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -135.75 131.81 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 117.071 -3.518 . . . . 9.1300000000000008 106.986 -176.37 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -103.41 147.13 27.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.126 -2.234 . . . . 20.550000000000001 109.738 -179.283 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.6 p -85.48 -178.19 6.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.24 1.495 . . . . 11.779999999999999 108.394 172.297 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.06 -47.45 85.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.049 1.74 . . . . 19.309999999999999 113.485 172.936 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -93.29 -79.42 0.4 Allowed 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 118.226 -2.796 . . . . 23.140000000000001 112.718 -172.408 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.19 63.62 0.32 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 127.157 2.313 . . . . 19.739999999999998 115.111 -177.362 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -140.87 129.54 22.84 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.056 1.884 . . . . 21.93 110.825 172.265 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -110.79 109.89 20.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.259 -3.401 . . . . 12.33 103.908 178.41 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 30' ' ' ILE . 1.8 pt -98.88 142.79 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 127.097 2.159 . . . . 17.079999999999998 111.692 178.531 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.9 m -115.31 112.47 22.45 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.222 -2.174 . . . . 16.300000000000001 110.709 -178.61 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -103.64 155.11 18.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.01 1.862 . . . . 15.880000000000001 106.952 -172.278 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.56 121.67 42.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.021 2.343 . . . . 28.899999999999999 111.667 165.425 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.462 HG12 ' HE3' ' A' ' 29' ' ' LYS . 5.6 m -134.73 164.88 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 103.082 -2.933 . . . . 12.050000000000001 103.082 -175.838 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -120.8 153.42 57.02 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 115.798 -2.049 . . . . 18.170000000000002 109.196 165.103 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -67.61 -13.76 39.94 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 124.859 3.706 . . . . 8.1600000000000001 115.759 -172.612 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 75.2 m -79.73 -2.33 42.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.976 2.91 . . . . 11.130000000000001 116.375 166.501 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -74.21 132.93 42.63 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.567 -3.123 . . . . 18.030000000000001 102.567 172.734 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.6 p -78.06 154.36 31.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.379 3.072 . . . . 10.220000000000001 106.463 165.026 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -69.07 -28.15 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 118.507 -0.759 . . . . 12.300000000000001 110.024 178.531 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -51.06 -43.09 60.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 121.523 1.965 . . . . 36.509999999999998 113.883 163.529 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -70.48 -33.64 71.48 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.816 1.643 . . . . 25.66 113.132 173.118 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.24 -40.37 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 123.203 1.478 . . . . 8.1199999999999992 109.477 176.19 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -69.61 -35.27 75.12 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.129 -3.482 . . . . 15.470000000000001 114.065 179.257 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.69 -33.66 76.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.02 -2.925 . . . . 11.449999999999999 112.541 171.121 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HE3' HG12 ' A' ' 17' ' ' VAL . 35.2 mttm -70.62 -39.49 73.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.357 2.027 . . . . 24.98 108.452 -179.224 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.441 HG12 HD11 ' A' ' 13' ' ' ILE . 45.7 mt -65.68 -38.24 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.263 -1.523 . . . . 9.4600000000000009 111.105 176.203 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -51.27 -48.95 62.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.99 -3.569 . . . . 14.76 117.098 165.195 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -68.67 -42.04 78.41 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.178 1.808 . . . . 26.289999999999999 111.174 178.309 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -68.26 -57.16 6.4 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 123.652 2.933 . . . . 30.059999999999999 113.052 -179.947 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -103.46 -19.69 14.32 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.434 2.013 . . . . 25.190000000000001 116.434 -161.624 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.63 58.23 3.6 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 128.453 2.93 . . . . 7.4100000000000001 112.858 176.042 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.2 tt -127.65 136.41 28.92 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 127.353 2.261 . . . . 9.4900000000000002 108.451 -179.596 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -83.41 161.46 14.93 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 122.922 2.079 . . . . 11.42 107.321 -166.672 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.06 -18.35 10.12 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 CA-C-O 114.264 -2.473 . . . . 12.0 115.546 -170.757 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.259 16.3 t0 -66.41 -42.4 87.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.343 3.857 . . . . 35.549999999999997 108.179 176.851 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -65.36 -30.32 71.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.484 -2.635 . . . . 20.52 116.022 174.973 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -82.95 121.52 27.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.621 1.555 . . . . 7.1299999999999999 113.785 -168.88 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -117.7 101.99 8.78 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 102.99 -2.967 . . . . 36.390000000000001 102.99 167.905 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -80.11 113.38 18.23 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.859 1.314 . . . . 9.5500000000000007 113.745 171.271 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -93.93 127.89 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 118.335 -2.728 . . . . 13.9 111.711 171.555 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -105.54 114.25 28.31 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.276 2.235 . . . . 6.8600000000000003 107.792 162.793 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.54 -106.51 0.09 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.037 -2.914 . . . . 11.15 110.502 178.38 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.31 20.34 8.44 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 128.67 3.732 . . . . 13.93 116.554 170.957 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -115.52 139.0 50.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 102.348 -3.204 . . . . 23.920000000000002 102.348 -173.502 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -89.25 133.46 34.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 111.234 -2.712 . . . . 23.23 110.405 170.633 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.55 133.61 54.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.703 1.601 . . . . 9.1099999999999994 109.012 -168.278 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -111.08 170.89 7.8 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.73 2.059 . . . . 33.439999999999998 113.434 -176.589 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.75 -43.21 38.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.919 2.488 . . . . 28.370000000000001 112.399 -156.725 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.84 -2.32 51.01 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 118.81 2.284 . . . . 15.0 118.81 179.149 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -121.12 170.64 9.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.782 -2.599 . . . . 25.5 113.677 -175.91 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -101.74 -172.46 2.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 105.879 -1.897 . . . . 11.949999999999999 105.879 -161.228 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.4 ' H ' ' HB ' ' A' ' 55' ' ' THR . 12.4 mt -79.32 -37.5 37.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.118 -1.401 . . . . 10.17 110.782 172.276 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p -61.4 -31.61 71.53 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.787 2.884 . . . . 13.59 118.787 172.173 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.76 -39.05 93.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.319 2.248 . . . . 11.699999999999999 109.551 -179.613 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -92.31 -0.17 57.41 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 131.143 3.777 . . . . 12.949999999999999 113.785 178.509 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 m120 72.99 35.6 0.95 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.478 2.311 . . . . 25.449999999999999 108.761 173.733 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -95.32 114.61 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 125.349 2.499 . . . . 14.6 109.036 -178.079 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -113.44 -179.43 3.64 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 112.357 -6.464 . . . . 33.229999999999997 109.307 178.61 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -47.67 147.03 1.99 Allowed 'General case' 0 N--CA 1.43 -1.474 1 N-CA-C 123.952 4.797 . . . . 25.969999999999999 123.952 179.339 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 55.88 29.34 13.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.542 -3.849 . . . . 32.609999999999999 116.383 -177.091 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -82.38 139.98 33.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.864 -2.017 . . . . 10.56 111.626 174.565 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.9 m -83.49 122.41 28.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.996 2.06 . . . . 5.3300000000000001 112.605 166.754 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.31 157.1 25.51 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.022 -1.844 . . . . 11.66 106.022 172.132 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -129.45 127.04 40.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.23 1.196 . . . . 16.300000000000001 114.23 177.777 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 mt -77.06 120.38 22.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.779 -3.701 . . . . 9.9600000000000009 112.356 163.893 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.79 -178.85 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 104.87 -2.27 . . . . 9.7599999999999998 104.87 -170.126 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.8 tp . . . . . 0 N--CA 1.43 -1.444 0 O-C-N 126.189 2.18 . . . . 19.57 113.815 172.935 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 108.651 -0.87 . . . . 17.170000000000002 108.651 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.262 29.7 mt-30 -94.22 130.26 40.52 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.579 -1.201 . . . . 21.890000000000001 113.745 177.742 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -120.35 150.21 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.97 1.708 . . . . 10.83 106.722 170.526 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -106.01 141.73 36.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.713 -2.492 . . . . 10.609999999999999 106.681 -172.69 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.49 128.57 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 117.21 -1.796 . . . . 9.1300000000000008 107.864 -179.462 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -105.62 110.87 23.35 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.719 -4.363 . . . . 20.550000000000001 103.631 -173.992 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.1 p -72.41 166.85 21.76 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.132 1.773 . . . . 11.779999999999999 107.964 -175.044 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.9 tp -75.43 -41.01 56.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.05 -2.281 . . . . 19.309999999999999 113.293 -172.257 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -56.92 -57.82 10.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.373 1.559 . . . . 23.140000000000001 112.401 168.194 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.24 68.0 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.834 1.797 . . . . 19.739999999999998 114.372 171.765 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -127.79 129.96 47.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.595 -2.709 . . . . 21.93 108.681 165.349 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -81.44 96.29 7.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.141 -0.974 . . . . 12.33 112.366 173.283 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 pt -92.43 142.2 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.583 -1.948 . . . . 17.079999999999998 113.793 -178.019 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.4 m -96.08 128.54 43.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.188 -1.57 . . . . 16.300000000000001 113.686 178.307 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.3 mt -124.12 133.13 53.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.99 -2.944 . . . . 15.880000000000001 107.578 -178.739 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.361 13.7 mt-10 -84.41 113.58 21.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.796 3.238 . . . . 28.899999999999999 113.093 162.816 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.83 155.72 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 1 N-CA-C 99.556 -4.239 . . . . 12.050000000000001 99.556 175.572 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.46 144.65 32.45 Favored Pre-proline 0 N--CA 1.429 -1.492 1 O-C-N 116.229 -4.044 . . . . 18.170000000000002 105.482 163.764 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -78.16 4.67 6.01 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-O 113.662 -2.724 . . . . 8.1600000000000001 117.022 -175.97 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.1 m -91.52 -9.61 43.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.594 3.361 . . . . 11.130000000000001 110.958 171.411 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -80.19 171.0 15.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 125.262 3.664 . . . . 18.030000000000001 109.353 -179.318 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.7 p -80.75 159.03 25.31 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 133.274 4.629 . . . . 10.220000000000001 113.526 173.445 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.275 31.0 mm -67.13 -17.02 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 125.007 2.337 . . . . 12.300000000000001 111.031 -179.409 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -55.22 -37.26 66.92 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 116.146 -4.096 . . . . 36.509999999999998 117.495 171.711 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -67.43 -41.61 84.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.189 2.996 . . . . 25.66 112.435 169.644 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.41 -43.73 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.274 -2.766 . . . . 8.1199999999999992 111.188 174.224 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.258 79.8 mttt -62.89 -39.03 93.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.78 -2.45 . . . . 15.470000000000001 111.277 172.84 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.13 86.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.628 1.971 . . . . 11.449999999999999 111.309 -178.768 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -61.78 -37.59 84.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.739 2.126 . . . . 24.98 116.739 169.203 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mt -72.84 -32.16 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 118.939 -1.104 . . . . 9.4600000000000009 109.568 170.615 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -58.95 -48.41 81.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 116.388 -3.945 . . . . 14.76 113.389 172.136 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.48 -39.43 90.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 131.307 3.843 . . . . 26.289999999999999 110.713 -177.376 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -75.9 -55.1 5.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.617 3.191 . . . . 30.059999999999999 119.617 174.994 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -104.68 -37.87 6.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 114.129 -2.843 . . . . 25.190000000000001 111.066 -167.254 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.28 10.68 31.16 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 122.684 2.493 . . . . 7.4100000000000001 110.205 173.858 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.477 HD13 HD21 ' A' ' 69' ' ' LEU 0.368 14.1 tt -75.47 115.38 45.06 Favored Pre-proline 0 N--CA 1.429 -1.501 0 C-N-CA 130.683 3.593 . . . . 9.4900000000000002 116.834 169.839 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.66 159.26 21.93 Favored 'Trans proline' 0 N--CA 1.434 -2.027 2 CA-C-N 130.411 4.754 . . . . 11.42 110.351 -172.378 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -62.12 -22.61 74.5 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 124.954 3.769 . . . . 12.0 114.715 -168.827 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -65.83 -36.26 82.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.334 1.453 . . . . 35.549999999999997 111.937 -175.805 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -91.57 -15.63 28.37 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.68 3.133 . . . . 20.52 110.493 -171.525 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -77.85 131.24 37.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.215 -2.803 . . . . 7.1299999999999999 116.451 170.756 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -120.8 122.4 40.25 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.386 -3.321 . . . . 36.390000000000001 108.701 162.518 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.9 mt -114.03 105.44 13.22 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.796 -2.44 . . . . 9.5500000000000007 111.85 -171.728 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -90.27 136.51 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 127.773 2.429 . . . . 13.9 112.194 179.639 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -122.83 94.01 4.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.415 2.286 . . . . 6.8600000000000003 106.657 -178.951 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.297 . . 73.44 -77.75 0.05 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.565 -2.584 . . . . 11.15 111.23 -172.517 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.29 16.76 0.59 Allowed Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 114.214 -1.357 . . . . 13.93 111.889 -177.757 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -120.98 164.67 16.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.442 3.097 . . . . 23.920000000000002 113.391 170.845 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -119.29 120.53 37.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 122.183 -0.323 . . . . 23.23 110.699 -167.441 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.59 147.86 28.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.511 2.1 . . . . 9.1099999999999994 110.897 -167.535 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -110.8 167.12 10.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.647 -2.533 . . . . 33.439999999999998 104.749 -168.17 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.16 -66.72 0.69 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 122.989 1.376 . . . . 28.370000000000001 113.682 -169.038 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.63 18.64 2.22 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 116.394 1.318 . . . . 15.0 116.394 -170.472 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -115.94 154.95 28.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.938 -2.615 . . . . 25.5 103.938 -176.151 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -87.67 146.28 25.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.605 3.557 . . . . 11.949999999999999 120.605 -179.456 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.04 -43.72 74.01 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 118.712 2.856 . . . . 10.17 118.712 173.717 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 p -66.26 -33.45 75.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.996 2.591 . . . . 13.59 117.996 170.052 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.77 -36.46 80.54 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 122.607 2.458 . . . . 11.699999999999999 112.663 177.038 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -69.62 -18.03 63.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.808 3.243 . . . . 12.949999999999999 113.817 174.808 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 m120 65.09 51.69 1.63 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.51 1.524 . . . . 25.449999999999999 111.822 -174.801 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -94.7 111.41 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-O 123.62 1.676 . . . . 14.6 108.392 174.92 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -101.72 165.62 11.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 111.5 -2.591 . . . . 33.229999999999997 108.98 -162.775 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -61.73 133.85 56.05 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.628 -2.545 . . . . 25.969999999999999 116.298 178.729 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 49.9 mt-10 71.59 25.41 3.34 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.289 2.329 . . . . 32.609999999999999 117.289 -177.539 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -94.29 146.29 24.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.676 2.472 . . . . 10.56 117.676 174.94 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -104.32 116.93 33.02 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.996 -4.19 . . . . 5.3300000000000001 108.931 -163.737 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.37 132.59 36.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.867 2.467 . . . . 11.66 110.088 167.636 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -81.93 127.79 33.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.16 -3.462 . . . . 16.300000000000001 116.173 159.747 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 36' ' ' ILE . 60.7 tp -94.79 103.03 14.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 125.129 1.518 . . . . 9.9600000000000009 110.695 159.013 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.38 -177.05 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 117.819 -1.552 . . . . 9.7599999999999998 107.252 -179.676 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.4 tp . . . . . 0 N--CA 1.43 -1.44 0 CA-C-N 110.798 -2.91 . . . . 19.57 107.282 170.73 . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.49 -1.344 0 CA-C-O 122.832 1.301 . . . . 17.170000000000002 107.949 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -87.67 135.83 33.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.929 2.196 . . . . 21.890000000000001 116.929 160.752 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -125.99 142.41 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 128.739 2.815 . . . . 10.83 105.694 -175.223 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -102.45 143.09 32.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.897 1.808 . . . . 10.609999999999999 106.713 175.917 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.8 t -124.46 130.94 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.311 -1.768 . . . . 9.1300000000000008 110.777 162.811 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -96.2 126.19 41.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.791 1.632 . . . . 20.550000000000001 111.261 168.099 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 69' ' ' LEU 0.259 72.2 p -89.73 176.26 6.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.67 3.188 . . . . 11.779999999999999 114.36 -171.168 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.423 HD22 HD21 ' A' ' 71' ' ' LEU . 51.0 tp -79.48 -54.93 5.43 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.264 -2.148 . . . . 19.309999999999999 112.613 -178.174 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -38.06 -72.34 0.06 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.312 2.708 . . . . 23.140000000000001 118.312 161.418 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.84 45.79 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.232 -3.418 . . . . 19.739999999999998 112.944 167.771 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -119.08 149.25 42.0 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.485 -1.302 . . . . 21.93 107.485 179.717 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.2 m -110.26 101.15 9.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.254 -2.499 . . . . 12.33 104.254 171.405 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.411 HD11 HG12 ' A' ' 30' ' ' ILE . 28.6 pt -94.86 126.3 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 127.256 3.408 . . . . 17.079999999999998 112.193 -176.389 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.275 3.2 m -74.91 114.4 13.32 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.332 -3.355 . . . . 16.300000000000001 117.369 161.994 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.42 149.16 44.21 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 116.014 -4.179 . . . . 15.880000000000001 106.623 174.475 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -102.4 125.75 49.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.509 2.576 . . . . 28.899999999999999 108.621 -178.291 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.536 HG11 HG22 ' A' ' 26' ' ' VAL . 8.9 m -147.77 165.1 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 118.492 -2.63 . . . . 12.050000000000001 106.945 -178.118 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -102.28 170.84 5.88 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 125.675 2.655 . . . . 18.170000000000002 110.093 161.852 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -56.89 -41.68 72.7 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 114.801 -3.315 . . . . 8.1600000000000001 117.374 166.46 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.2 p -70.68 -3.51 18.84 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.591 2.757 . . . . 11.130000000000001 115.223 176.239 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -83.88 153.54 23.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.32 -2.113 . . . . 18.030000000000001 113.894 167.552 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.6 p -95.16 176.53 6.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.689 -3.757 . . . . 10.220000000000001 115.846 -172.493 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mm -66.55 -43.55 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.86 -2.4 . . . . 12.300000000000001 107.607 173.923 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -47.82 -46.09 30.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.795 2.517 . . . . 36.509999999999998 117.795 168.535 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -75.75 -28.72 58.58 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.99 -1.068 . . . . 25.66 110.26 -178.685 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.536 HG22 HG11 ' A' ' 17' ' ' VAL . 83.9 t -59.65 -54.54 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.666 -3.146 . . . . 8.1199999999999992 110.881 169.867 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -58.74 -24.32 61.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.545 -1.972 . . . . 15.470000000000001 115.951 179.159 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.253 . . -76.4 -28.29 56.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.321 -0.862 . . . . 11.449999999999999 111.29 -177.738 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -68.83 -49.25 60.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.186 2.595 . . . . 24.98 105.346 176.901 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 13' ' ' ILE . 39.9 mt -61.42 -39.32 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 127.89 3.709 . . . . 9.4600000000000009 114.261 -178.533 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.4 -39.7 80.39 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.124 -4.11 . . . . 14.76 115.647 171.517 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -67.31 -70.41 0.25 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.436 -1.69 . . . . 26.289999999999999 106.436 178.149 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -77.8 -33.87 52.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.708 2.114 . . . . 30.059999999999999 116.708 -161.277 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -99.22 -63.13 1.15 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 120.991 1.723 . . . . 25.190000000000001 109.248 179.203 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.94 89.02 1.22 Allowed Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.505 -1.997 . . . . 7.4100000000000001 111.61 174.501 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.418 ' CD1' HD21 ' A' ' 69' ' ' LEU . 38.5 mt -146.18 128.45 7.81 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 115.856 -2.021 . . . . 9.4900000000000002 106.898 179.669 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -61.49 145.5 97.88 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 125.132 2.869 . . . . 11.42 117.998 176.681 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -79.26 -15.34 12.78 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 123.568 2.845 . . . . 12.0 116.252 -166.506 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.35 -35.07 25.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.113 1.911 . . . . 35.549999999999997 108.748 174.545 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -72.86 -30.06 63.69 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.576 -3.828 . . . . 20.52 108.896 -179.737 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -64.57 134.95 55.42 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.225 -2.797 . . . . 7.1299999999999999 115.953 173.787 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -129.08 114.8 16.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.775 2.226 . . . . 36.390000000000001 112.299 167.907 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.87 119.8 33.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.453 -3.067 . . . . 9.5500000000000007 112.643 179.709 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.9 130.74 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 123.575 1.655 . . . . 13.9 108.597 -179.816 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -111.19 104.96 13.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.534 2.587 . . . . 6.8600000000000003 113.204 166.051 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.292 . . 71.6 -83.82 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.219 -3.425 . . . . 11.15 109.575 -168.489 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.59 28.82 0.85 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 107.847 -2.101 . . . . 13.93 107.847 166.624 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -107.53 111.89 24.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.366 -2.457 . . . . 23.920000000000002 104.366 175.911 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -70.32 130.39 41.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.687 2.184 . . . . 23.23 109.359 176.852 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -91.7 123.86 35.41 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.369 -1.287 . . . . 9.1099999999999994 114.155 -171.391 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -74.79 136.85 41.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 116.467 2.025 . . . . 33.439999999999998 116.467 173.198 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -39.29 -60.83 0.86 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.351 2.723 . . . . 28.370000000000001 118.351 175.38 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.52 -10.19 47.8 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 117.057 -3.527 . . . . 15.0 121.2 -177.936 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -96.1 165.02 12.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 120.53 2.165 . . . . 25.5 114.803 -172.298 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.5 p -88.57 158.51 18.26 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.929 -4.232 . . . . 11.949999999999999 109.271 -172.073 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.518 HD21 HG21 ' A' ' 26' ' ' VAL . 1.6 mt -62.74 -40.45 97.25 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.61 -0.723 . . . . 10.17 111.978 171.101 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 p -47.85 -36.72 12.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.735 -2.478 . . . . 13.59 116.755 168.981 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.3 -42.08 65.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.825 1.65 . . . . 11.699999999999999 108.532 -166.679 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -84.15 0.52 48.27 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.904 -1.747 . . . . 12.949999999999999 111.533 179.937 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.8 m120 73.03 41.68 0.49 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.043 0.937 . . . . 25.449999999999999 108.908 174.142 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.5 mt -85.85 122.18 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 116.877 -1.535 . . . . 14.6 113.392 177.577 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -112.75 175.31 5.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 119.429 1.013 . . . . 33.229999999999997 111.86 -175.125 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.295 19.2 pttp -66.3 151.33 47.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.523 3.058 . . . . 25.969999999999999 108.916 175.763 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 63.35 4.58 1.73 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 120.09 3.367 . . . . 32.609999999999999 120.09 -172.22 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -72.08 162.21 29.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.297 -1.774 . . . . 10.56 107.265 172.601 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.8 m -130.64 121.34 25.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.844 -1.551 . . . . 5.3300000000000001 108.994 -177.074 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.1 mt -92.51 150.33 20.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.739 2.685 . . . . 11.66 112.422 172.62 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -108.46 127.68 54.13 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.845 -3.659 . . . . 16.300000000000001 110.149 -178.088 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' A' ' 36' ' ' ILE . 53.6 tp -94.2 103.81 15.84 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.181 -0.918 . . . . 9.9600000000000009 112.309 -171.963 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.317 18.4 m -116.98 -169.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 106.369 -1.715 . . . . 9.7599999999999998 106.369 -174.981 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.423 HD21 HD22 ' A' ' 8' ' ' LEU . 8.7 mt . . . . . 0 N--CA 1.43 -1.446 0 C-N-CA 125.97 1.708 . . . . 19.57 110.285 -168.46 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.512 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 4.9 ptm . . . . . 0 CA--C 1.49 -1.336 0 N-CA-C 118.434 2.753 . . . . 17.170000000000002 118.434 . . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -87.47 125.62 34.41 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.744 -1.848 . . . . 21.890000000000001 107.089 -174.897 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.0 pt -115.91 163.69 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 112.069 -2.332 . . . . 10.83 107.168 174.034 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -124.72 132.94 53.34 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.147 2.579 . . . . 10.609999999999999 106.532 -177.354 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.24 117.63 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 121.142 -0.974 . . . . 9.1300000000000008 109.57 176.661 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -109.94 141.22 43.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.341 -2.724 . . . . 20.550000000000001 115.745 -179.62 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.4 p -83.59 -171.87 3.83 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.295 1.22 . . . . 11.779999999999999 114.295 179.744 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 tp -72.62 -35.07 67.74 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.729 -3.107 . . . . 19.309999999999999 109.802 -178.34 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 p -87.15 -49.16 7.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 104.247 -2.501 . . . . 23.140000000000001 104.247 -178.083 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.98 59.48 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 117.403 -1.776 . . . . 19.739999999999998 116.599 166.156 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -96.51 125.41 40.98 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.706 -3.442 . . . . 21.93 101.706 166.687 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -105.23 122.37 45.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.976 -2.601 . . . . 12.33 103.976 -175.853 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 pt -108.49 130.76 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 125.808 2.718 . . . . 17.079999999999998 116.06 168.759 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -86.34 116.45 24.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.664 -3.772 . . . . 16.300000000000001 107.915 179.513 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.0 mt -121.39 156.38 32.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.906 -2.371 . . . . 15.880000000000001 109.319 -179.341 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -130.98 129.99 42.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.097 -2.557 . . . . 28.899999999999999 104.097 179.995 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -148.57 179.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.882 1.673 . . . . 12.050000000000001 108.652 177.009 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 17.9 mm-40 -107.58 169.14 7.01 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 119.677 -1.889 . . . . 18.170000000000002 107.533 174.953 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 43.7 Cg_endo -83.67 -2.24 10.33 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 124.712 3.608 . . . . 8.1600000000000001 113.021 -173.103 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.273 73.4 m -101.68 -0.44 34.6 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 126.266 2.229 . . . . 11.130000000000001 110.499 174.14 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.4 145.15 49.52 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.396 -3.315 . . . . 18.030000000000001 110.099 173.029 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -79.63 164.51 23.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.066 -2.271 . . . . 10.220000000000001 113.848 173.038 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -57.21 -38.52 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 126.668 1.987 . . . . 12.300000000000001 109.604 171.08 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.65 -51.97 19.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.001 1.721 . . . . 36.509999999999998 114.066 167.943 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -72.65 -12.38 61.01 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.458 1.503 . . . . 25.66 114.288 176.565 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.4 t -80.03 -50.05 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 104.165 -2.531 . . . . 8.1199999999999992 104.165 172.668 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.298 62.7 mttt -47.78 -38.65 16.12 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.415 2.686 . . . . 15.470000000000001 113.875 170.039 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.56 -44.34 93.31 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.672 2.789 . . . . 11.449999999999999 115.136 -178.271 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -69.89 -40.4 75.68 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.814 2.846 . . . . 24.98 107.731 178.307 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.45 -33.58 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 124.454 1.096 . . . . 9.4600000000000009 109.153 179.484 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.42 -44.03 92.95 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.153 -2.217 . . . . 14.76 114.139 172.708 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -59.7 -61.21 2.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.572 1.949 . . . . 26.289999999999999 113.855 171.727 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.99 -52.02 67.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 121.059 3.725 . . . . 30.059999999999999 121.059 -179.991 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -108.97 -29.87 8.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.584 1.327 . . . . 25.190000000000001 114.584 -157.584 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.19 41.21 8.11 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.201 -1.16 . . . . 7.4100000000000001 110.201 177.244 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.1 mt -102.73 120.06 53.89 Favored Pre-proline 0 N--CA 1.431 -1.424 0 CA-C-O 115.461 -2.209 . . . . 9.4900000000000002 111.678 169.055 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 95.1 Cg_exo -59.14 146.25 95.06 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 CA-C-N 126.305 3.287 . . . . 11.42 114.227 172.424 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -59.24 -29.53 90.59 Favored 'Trans proline' 0 C--N 1.299 -2.027 1 C-N-CA 125.333 4.022 . . . . 12.0 116.438 179.93 . . . . . . . . 4 4 . 1 . 056 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.9 -42.37 94.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.988 -3.57 . . . . 35.549999999999997 113.266 168.851 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.403 ' HG2' HD22 ' A' ' 71' ' ' LEU 0.287 12.7 tt0 -64.95 -35.17 80.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.748 2.019 . . . . 20.52 112.618 173.092 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -81.14 136.81 35.94 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.418 -2.676 . . . . 7.1299999999999999 115.647 -177.462 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -128.94 117.46 21.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 128.062 3.351 . . . . 36.390000000000001 110.031 167.077 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.8 mt -91.68 121.91 33.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.493 -1.717 . . . . 9.5500000000000007 109.24 179.599 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mt -111.05 133.27 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 124.525 3.329 . . . . 13.9 108.262 178.041 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -115.38 107.59 15.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.148 2.979 . . . . 6.8600000000000003 107.147 172.196 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 63.38 -96.07 0.05 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.331 2.652 . . . . 11.15 111.823 -166.545 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.71 -5.5 9.11 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.675 1.708 . . . . 13.93 109.541 -178.372 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -98.75 126.55 44.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.49 -3.947 . . . . 23.920000000000002 105.985 -166.832 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -90.61 141.31 28.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 127.712 3.625 . . . . 23.23 106.344 176.071 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.365 97.1 mt -104.52 133.77 48.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.748 -3.72 . . . . 9.1099999999999994 114.312 -168.827 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -74.63 154.83 38.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.687 2.395 . . . . 33.439999999999998 112.231 174.881 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -73.16 -55.57 6.29 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 130.053 3.341 . . . . 28.370000000000001 112.346 -167.131 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.73 18.47 30.09 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 119.136 2.415 . . . . 15.0 119.136 -172.766 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -114.01 146.6 39.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.606 2.146 . . . . 25.5 109.897 169.763 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.264 73.3 p -75.99 162.82 27.74 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 128.937 2.895 . . . . 11.949999999999999 116.866 -179.105 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.9 mt -58.43 -49.57 76.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 128.807 3.817 . . . . 10.17 109.92 174.873 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.357 88.9 p -57.54 -43.96 84.77 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.795 3.238 . . . . 13.59 119.487 178.698 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -53.81 -53.42 52.58 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 121.588 3.921 . . . . 11.699999999999999 121.588 162.924 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -62.44 -21.01 65.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.66 2.467 . . . . 12.949999999999999 117.66 169.325 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.347 58.2 t30 60.04 67.64 0.85 Allowed 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.508 2.04 . . . . 25.449999999999999 116.508 -161.556 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -118.5 117.39 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.5 -2.778 . . . . 14.6 103.5 170.198 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.35 -163.15 1.01 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.48 2.562 . . . . 33.229999999999997 112.685 -175.536 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 38.1 pttt -76.0 156.71 33.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.213 -3.43 . . . . 25.969999999999999 115.427 168.548 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.85 23.33 13.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.31 2.244 . . . . 32.609999999999999 110.741 176.663 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -85.36 122.53 29.65 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.071 1.748 . . . . 10.56 113.335 175.631 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.9 m -88.52 98.9 11.91 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 116.132 -1.89 . . . . 5.3300000000000001 112.498 170.667 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.96 140.04 29.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.704 2.002 . . . . 11.66 109.015 -179.966 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -98.64 107.61 20.1 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.428 -1.42 . . . . 16.300000000000001 113.49 -173.267 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -82.88 109.78 17.31 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 129.156 2.982 . . . . 9.9600000000000009 112.368 -177.172 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.9 m -121.58 161.76 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 116.726 -3.733 . . . . 9.7599999999999998 106.912 177.981 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.403 HD22 ' HG2' ' A' ' 40' ' ' GLN . 29.8 mt . . . . . 0 N--CA 1.43 -1.468 0 N-CA-C 107.591 -1.263 . . . . 19.57 107.591 -173.087 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.454 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 13.6 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 106.484 -1.672 . . . . 17.170000000000002 106.484 . . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.273 4.2 pt20 -113.28 127.69 56.23 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.712 -2.493 . . . . 21.890000000000001 112.773 176.189 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -120.34 174.48 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 125.293 2.473 . . . . 10.83 108.102 171.883 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -120.96 145.9 47.23 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 112.744 -2.026 . . . . 10.609999999999999 109.802 -176.78 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.99 122.53 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 107.402 -1.333 . . . . 9.1300000000000008 107.402 173.218 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -136.05 142.21 44.37 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.394 -3.941 . . . . 20.550000000000001 115.338 -164.33 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.278 80.7 p -80.85 -171.5 3.2 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 126.533 3.064 . . . . 11.779999999999999 110.03 -170.612 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.89 -40.5 60.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 131.556 3.943 . . . . 19.309999999999999 114.266 166.945 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.18 -47.6 49.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.544 -3.223 . . . . 23.140000000000001 111.031 173.606 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.91 35.91 0.23 Allowed Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 114.637 -3.313 . . . . 19.739999999999998 115.593 172.782 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -88.03 121.58 30.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 113.746 -3.026 . . . . 21.93 110.701 178.784 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -108.19 137.57 45.94 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 121.695 2.043 . . . . 12.33 114.037 -172.331 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.1 pt -124.6 136.78 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 118.532 -1.267 . . . . 17.079999999999998 107.804 172.776 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.3 m -82.81 120.89 26.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.176 3.39 . . . . 16.300000000000001 108.564 168.862 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -115.17 132.73 56.51 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.966 -2.334 . . . . 15.880000000000001 107.123 174.504 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -107.82 115.09 29.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.191 -2.818 . . . . 28.899999999999999 108.762 -178.681 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.31 162.04 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 124.559 1.162 . . . . 12.050000000000001 109.473 -166.928 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -90.7 155.08 45.89 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 120.374 -1.454 . . . . 18.170000000000002 107.444 159.512 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -60.95 -23.39 77.17 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 122.722 2.282 . . . . 8.1600000000000001 112.674 168.536 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 m -69.39 -18.32 63.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.003 2.638 . . . . 11.130000000000001 113.498 173.427 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -65.53 147.15 53.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.525 2.875 . . . . 18.030000000000001 108.574 179.162 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -85.08 172.91 10.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.933 1.827 . . . . 10.220000000000001 115.933 179.061 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 13.1 mm -78.15 -27.11 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 124.053 0.846 . . . . 12.300000000000001 109.326 178.432 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -50.81 -59.54 4.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.386 -2.188 . . . . 36.509999999999998 114.143 167.634 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.468 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 7.3 t-20 -55.14 -45.77 75.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.98 3.712 . . . . 25.66 109.984 176.082 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -60.4 -50.32 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.363 -2.086 . . . . 8.1199999999999992 113.156 -176.508 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -63.39 -37.19 86.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.014 1.864 . . . . 15.470000000000001 110.354 176.584 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.38 -13.12 36.05 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.324 -4.61 . . . . 11.449999999999999 114.206 174.726 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 13.7 mtpt -80.04 -49.24 12.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.909 -2.994 . . . . 24.98 117.487 169.189 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.9 mt -60.23 -30.26 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 126.096 2.855 . . . . 9.4600000000000009 112.523 171.944 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -70.7 -43.35 69.17 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.346 -3.971 . . . . 14.76 117.143 172.969 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.33 -49.53 74.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.793 2.516 . . . . 26.289999999999999 117.793 159.313 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -79.94 -74.73 0.29 Allowed 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 116.266 -4.021 . . . . 30.059999999999999 111.274 -176.606 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -64.94 -43.3 93.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 120.322 1.419 . . . . 25.190000000000001 113.824 -173.509 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.69 68.83 1.19 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 107.06 -2.416 . . . . 7.4100000000000001 107.06 179.53 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.8 128.44 23.87 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-N 113.393 -1.403 . . . . 9.4900000000000002 108.644 176.643 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -66.69 143.53 68.3 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-O 114.342 -2.441 . . . . 11.42 115.015 -174.596 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.81 -14.69 42.34 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 122.841 2.361 . . . . 12.0 113.027 -163.68 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -95.96 -22.31 17.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 123.021 2.646 . . . . 35.549999999999997 110.318 -179.66 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.378 32.9 mt-30 -71.47 -22.6 61.8 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 117.645 -1.169 . . . . 20.52 112.87 164.355 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -79.33 124.58 28.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.955 -2.609 . . . . 7.1299999999999999 103.955 175.601 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 52.6 mtp180 -110.89 122.13 47.09 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.978 3.311 . . . . 36.390000000000001 109.685 156.217 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.3 mt -113.78 133.23 55.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.368 2.509 . . . . 9.5500000000000007 105.435 178.101 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 mm -130.39 119.4 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 111.033 -2.803 . . . . 13.9 103.733 -163.244 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -93.98 108.88 20.65 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.453 1.501 . . . . 6.8600000000000003 110.773 158.194 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.53 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.48 -2.637 . . . . 11.15 112.118 179.825 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.88 36.72 1.21 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 126.192 1.853 . . . . 13.93 110.756 165.965 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -108.28 123.74 49.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.5 -2.177 . . . . 23.920000000000002 113.68 162.581 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -81.57 136.07 35.57 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.186 -3.446 . . . . 23.23 109.386 166.246 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.73 127.98 35.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.776 1.231 . . . . 9.1099999999999994 111.071 179.595 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -78.43 133.14 37.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.954 2.576 . . . . 33.439999999999998 117.954 -178.214 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 47.1 m-20 -49.14 -45.37 43.6 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.363 -3.335 . . . . 28.370000000000001 116.288 -168.129 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.73 4.49 75.8 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-N 119.981 1.264 . . . . 15.0 112.586 -169.107 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.3 40.0 mtt180 -95.19 166.17 12.04 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.069 -3.607 . . . . 25.5 109.262 -178.495 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.8 p -92.66 156.24 17.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.161 -2.212 . . . . 11.949999999999999 106.475 -178.516 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.4 mt -51.14 -45.25 61.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.971 -3.581 . . . . 10.17 113.726 164.7 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.4 t -57.12 -36.6 70.85 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.826 2.051 . . . . 13.59 108.316 -177.391 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -64.59 -30.9 71.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.289 -2.132 . . . . 11.699999999999999 113.512 -167.486 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -87.27 0.61 55.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.165 -1.38 . . . . 12.949999999999999 113.044 178.423 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 62.23 49.21 4.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.837 1.655 . . . . 25.449999999999999 112.605 -178.742 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.94 112.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.895 2.478 . . . . 14.6 109.85 172.037 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -84.68 -162.57 0.7 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.375 2.036 . . . . 33.229999999999997 112.222 178.087 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 22.5 pttp -88.06 164.86 15.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.779 -3.7 . . . . 25.969999999999999 111.141 172.815 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.381 37.3 mt-10 73.54 1.1 3.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.683 1.593 . . . . 32.609999999999999 112.439 173.7 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.346 8.7 t -88.06 140.13 29.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.363 -2.71 . . . . 10.56 112.277 -168.581 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.0 m -100.68 113.93 27.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 126.059 2.837 . . . . 5.3300000000000001 108.826 -178.507 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.1 mt -87.6 144.99 26.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.515 2.783 . . . . 11.66 118.515 165.519 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -96.39 120.59 36.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.318 -3.989 . . . . 16.300000000000001 112.501 179.522 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 tp -94.08 120.99 35.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.167 -2.288 . . . . 9.9600000000000009 110.43 -177.325 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 44.1 t -118.27 138.22 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 129.735 3.214 . . . . 9.7599999999999998 111.254 -173.56 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.3 tp . . . . . 0 N--CA 1.43 -1.436 0 O-C-N 126.867 2.604 . . . . 19.57 106.535 176.615 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.491 -1.325 0 CA-C-O 121.382 0.61 . . . . 17.170000000000002 109.687 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.92 133.76 35.78 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.139 -3.475 . . . . 21.890000000000001 112.836 171.012 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -118.94 147.89 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 128.599 4.047 . . . . 10.83 116.021 164.664 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -97.17 128.16 43.81 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.893 -3.63 . . . . 10.609999999999999 108.323 176.391 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -118.58 131.61 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.153 -2.536 . . . . 9.1300000000000008 104.153 173.214 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -105.82 157.17 17.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.331 -3.355 . . . . 20.550000000000001 109.607 173.749 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 56.1 p -99.79 178.32 4.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.742 3.217 . . . . 11.779999999999999 109.403 175.517 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.4 tp -77.2 -36.9 54.46 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.517 -2.614 . . . . 19.309999999999999 110.84 178.744 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -38.18 72.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.96 -1.713 . . . . 23.140000000000001 111.991 160.662 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.51 33.72 2.23 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 117.382 1.713 . . . . 19.739999999999998 117.382 171.529 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -80.8 119.44 23.38 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.919 2.487 . . . . 21.93 105.807 -179.775 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -81.34 104.51 11.84 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.693 3.121 . . . . 12.33 116.578 169.833 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 pt -100.83 147.4 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 124.622 1.169 . . . . 17.079999999999998 112.583 174.587 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 m -111.28 99.47 8.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.816 -2.291 . . . . 16.300000000000001 104.816 -172.248 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.7 mt -97.33 118.67 34.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.799 -3.688 . . . . 15.880000000000001 110.412 179.288 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -80.82 128.37 33.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.734 -1.229 . . . . 28.899999999999999 108.142 165.302 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 m -147.72 164.35 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 103.794 -2.669 . . . . 12.050000000000001 103.794 -178.48 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -105.81 140.72 21.49 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 116.44 -1.743 . . . . 18.170000000000002 109.103 171.91 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.44 -5.71 11.79 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 124.767 2.738 . . . . 8.1600000000000001 113.036 -167.046 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.4 p -69.28 -26.2 64.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.744 0.818 . . . . 11.130000000000001 112.483 169.522 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -75.73 178.28 6.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.522 2.415 . . . . 18.030000000000001 117.522 174.935 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 9.2 p -106.76 178.8 4.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.719 -3.113 . . . . 10.220000000000001 111.617 -165.71 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 11.3 mm -69.81 -35.47 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 116.854 -3.654 . . . . 12.300000000000001 114.261 168.479 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -52.31 -44.59 65.16 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 117.124 -1.417 . . . . 36.509999999999998 114.431 167.051 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -52.49 -49.36 64.89 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 114.947 -2.454 . . . . 25.66 114.612 163.477 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.18 -43.34 97.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 122.091 2.223 . . . . 8.1199999999999992 109.37 -177.084 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.66 -35.54 70.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.161 2.282 . . . . 15.470000000000001 117.161 172.883 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' ASP . . . -70.21 -25.65 63.51 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 126.898 3.237 . . . . 11.449999999999999 116.968 170.662 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -75.2 -27.35 59.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.792 -2.458 . . . . 24.98 111.786 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -80.47 -37.51 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 118.057 -2.902 . . . . 9.4600000000000009 107.923 178.851 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.11 -52.49 62.4 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 115.205 -2.331 . . . . 14.76 107.769 -178.773 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 2.2 t0 -52.99 -45.52 67.88 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.981 2.912 . . . . 26.289999999999999 113.495 173.362 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -74.33 -95.84 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.277 4.231 . . . . 30.059999999999999 112.643 176.879 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -71.36 -9.41 58.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.122 2.237 . . . . 25.190000000000001 111.449 -162.608 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.46 52.66 5.92 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.51 -1.994 . . . . 7.4100000000000001 117.105 179.975 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.68 110.62 22.69 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.086 -2.864 . . . . 9.4900000000000002 106.321 -170.876 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.06 147.03 92.24 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 128.782 4.172 . . . . 11.42 111.531 -177.58 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -75.12 -8.19 19.72 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 121.397 1.398 . . . . 12.0 112.925 -161.943 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -74.81 -39.86 61.43 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.201 1.953 . . . . 35.549999999999997 115.167 -174.299 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -66.95 -28.05 67.96 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 132.691 4.397 . . . . 20.52 114.913 173.12 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.4 117.54 12.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.955 2.788 . . . . 7.1299999999999999 114.489 -169.969 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -111.55 98.37 7.4 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.512 -3.243 . . . . 36.390000000000001 107.499 176.727 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.05 122.3 33.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 111.779 -2.464 . . . . 9.5500000000000007 111.59 176.466 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mm -112.26 144.37 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 124.119 1.914 . . . . 13.9 110.424 -177.887 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -123.31 114.17 19.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.854 2.74 . . . . 6.8600000000000003 107.962 161.394 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.306 . . 70.6 -88.05 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.677 -2.514 . . . . 11.15 115.889 -177.046 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.22 8.28 2.13 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 126.4 1.952 . . . . 13.93 110.291 165.073 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -88.29 149.96 23.51 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 114.704 -4.998 . . . . 23.920000000000002 108.173 168.5 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -109.96 146.99 34.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.961 -3.348 . . . . 23.23 101.961 -179.02 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.9 mt -104.25 137.87 41.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.589 1.699 . . . . 9.1099999999999994 115.589 -171.819 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 19.4 tp10 -97.4 155.46 16.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 120.524 1.511 . . . . 33.439999999999998 112.735 -169.661 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 22' ' ' THR . 15.0 m-20 -69.52 -61.39 1.81 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.374 1.25 . . . . 28.370000000000001 114.374 -162.448 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.16 42.46 2.74 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 117.08 1.592 . . . . 15.0 117.08 -179.962 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -131.59 154.93 48.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 119.141 1.47 . . . . 25.5 107.44 175.393 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -88.67 146.22 25.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 121.325 3.824 . . . . 11.949999999999999 121.325 -176.913 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.7 mt -54.74 -38.19 66.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.078 1.751 . . . . 10.17 114.984 171.854 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -51.62 -55.19 20.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.486 3.143 . . . . 13.59 119.486 166.861 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.74 -49.12 73.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.796 2.438 . . . . 11.699999999999999 115.093 176.923 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -71.53 -6.55 41.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.339 3.456 . . . . 12.949999999999999 112.825 173.72 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 54.32 44.21 29.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.949 2.203 . . . . 25.449999999999999 116.949 -179.961 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.0 120.55 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 129.593 3.157 . . . . 14.6 105.179 171.763 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -103.68 170.38 7.97 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.955 -1.716 . . . . 33.229999999999997 109.555 -178.205 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -47.06 141.12 4.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.506 2.378 . . . . 25.969999999999999 110.863 167.355 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 66.6 mt-10 51.9 20.37 1.19 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.818 2.896 . . . . 32.609999999999999 118.818 -175.674 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 t -75.18 165.21 25.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.078 2.551 . . . . 10.56 110.815 171.901 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.5 m -122.47 101.77 7.69 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 112.877 -3.44 . . . . 5.3300000000000001 108.021 -164.496 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.94 156.98 19.59 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 125.661 1.851 . . . . 11.66 110.506 163.313 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -118.73 119.9 35.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.019 -2.301 . . . . 16.300000000000001 112.817 -177.452 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.39 98.45 11.49 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.505 -2.622 . . . . 9.9600000000000009 111.42 -175.969 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.48 156.84 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 125.386 1.679 . . . . 9.7599999999999998 110.198 167.652 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 N--CA 1.43 -1.45 0 O-C-N 119.321 -2.112 . . . . 19.57 111.645 -172.871 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.49 -1.332 0 N-CA-C 115.445 1.646 . . . . 17.170000000000002 115.445 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.51 132.78 46.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.649 -2.532 . . . . 21.890000000000001 105.738 171.842 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 pt -110.2 156.77 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 113.752 -1.567 . . . . 10.83 109.851 170.005 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -98.0 135.76 39.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 118.292 -0.861 . . . . 10.609999999999999 109.706 177.727 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.36 121.67 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 N-CA-C 99.337 -4.32 . . . . 9.1300000000000008 99.337 171.197 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -102.81 128.83 49.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 126.791 2.557 . . . . 20.550000000000001 109.072 177.063 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 69' ' ' LEU . 77.7 p -96.09 176.59 6.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.497 -2.627 . . . . 11.779999999999999 112.511 -170.563 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.1 tp -80.61 -30.32 36.8 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.644 -5.035 . . . . 19.309999999999999 111.116 -173.658 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.7 p -68.33 -69.74 0.31 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.42 2.748 . . . . 23.140000000000001 118.42 162.538 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.98 38.39 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.712 0 O-C-N 119.891 -1.756 . . . . 19.739999999999998 112.144 174.226 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -99.6 132.33 45.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 119.388 1.594 . . . . 21.93 110.856 171.646 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.2 m -111.74 111.28 22.15 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.612 -2.736 . . . . 12.33 103.612 172.862 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -96.35 145.46 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 112.934 -1.939 . . . . 17.079999999999998 110.11 -178.736 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.7 m -106.33 112.22 25.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.964 -1.085 . . . . 16.300000000000001 113.593 178.613 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -111.54 130.12 55.84 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.366 1.467 . . . . 15.880000000000001 109.196 -175.132 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -97.58 132.33 43.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.316 -1.49 . . . . 28.899999999999999 109.621 173.898 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -155.88 162.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 119.389 -2.07 . . . . 12.050000000000001 113.191 -168.396 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -93.72 153.94 41.06 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 126.113 1.765 . . . . 18.170000000000002 109.026 177.378 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -60.83 -26.1 82.45 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 O-C-N 116.343 -2.503 . . . . 8.1600000000000001 115.941 171.667 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.0 p -82.16 -16.44 49.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.18 1.792 . . . . 11.130000000000001 114.78 -177.625 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.77 143.01 55.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.705 1.241 . . . . 18.030000000000001 113.273 170.185 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -97.84 158.78 15.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.053 -2.279 . . . . 10.220000000000001 109.587 -175.79 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.0 mm -53.19 -46.44 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 128.558 2.743 . . . . 12.300000000000001 111.722 171.501 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -45.82 -55.54 6.49 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.362 1.615 . . . . 36.509999999999998 115.362 161.962 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -54.65 -34.53 62.3 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.102 3.761 . . . . 25.66 112.851 173.643 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.34 -33.39 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.199 -2.188 . . . . 8.1199999999999992 110.028 177.79 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -67.28 -35.78 80.19 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.84 0.856 . . . . 15.470000000000001 111.81 179.898 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.1 82.43 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 132.212 4.205 . . . . 11.449999999999999 118.102 166.319 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.422 -3.924 . . . . 24.98 111.417 169.935 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 mt -53.06 -48.23 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 113.112 -3.328 . . . . 9.4600000000000009 110.927 170.103 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -37.45 78.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 124.903 3.501 . . . . 14.76 116.363 176.996 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -77.34 -38.46 50.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.057 -2.277 . . . . 26.289999999999999 111.734 -177.661 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -81.25 -42.44 20.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.279 2.309 . . . . 30.059999999999999 110.96 -176.194 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -99.57 -44.2 6.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.012 1.863 . . . . 25.190000000000001 114.899 -169.179 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.74 45.46 4.56 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 118.424 -2.673 . . . . 7.4100000000000001 108.91 -177.489 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.7 mt -102.7 133.6 20.35 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 107.021 -1.474 . . . . 9.4900000000000002 107.021 161.714 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 3.2 Cg_exo -78.77 157.06 27.75 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 121.697 1.642 . . . . 11.42 113.464 175.83 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 81.8 Cg_exo -68.67 -24.01 35.68 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.969 3.112 . . . . 12.0 118.406 -169.127 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.73 -24.76 65.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.034 -2.348 . . . . 35.549999999999997 111.36 172.918 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -75.77 -31.82 59.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.288 -3.382 . . . . 20.52 111.132 175.521 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -94.72 89.2 5.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.104 -1.623 . . . . 7.1299999999999999 111.037 -145.257 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -88.34 115.2 25.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.994 -3.566 . . . . 36.390000000000001 106.284 171.527 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.6 mt -91.26 121.83 33.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.471 -2.789 . . . . 9.5500000000000007 103.471 177.157 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.65 132.24 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 124.501 2.096 . . . . 13.9 110.61 176.208 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -107.21 105.48 15.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.459 -3.276 . . . . 6.8600000000000003 107.866 166.754 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.309 . . 60.49 -76.42 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.617 2.367 . . . . 11.15 115.838 -168.554 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.03 -20.0 3.48 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 126.689 2.09 . . . . 13.93 117.413 173.347 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.278 50.3 pttt -109.42 142.03 40.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.378 3.089 . . . . 23.920000000000002 105.118 -160.919 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -79.82 140.09 36.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.439 1.114 . . . . 23.23 109.782 -176.767 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 mt -84.3 128.7 34.73 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.617 -3.802 . . . . 9.1099999999999994 112.847 177.432 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -83.6 136.83 34.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.117 2.967 . . . . 33.439999999999998 108.635 -174.68 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.277 0.9 OUTLIER -42.84 -63.53 0.77 Allowed 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 122.332 4.197 . . . . 28.370000000000001 122.332 -174.063 . . . . . . . . 4 3 . 1 . 059 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.97 37.11 2.34 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 128.974 3.178 . . . . 15.0 115.191 -171.517 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -132.06 148.25 52.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.984 2.216 . . . . 25.5 116.984 178.338 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.7 p -88.62 157.54 18.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 123.512 1.625 . . . . 11.949999999999999 113.126 -172.236 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.9 mt -71.69 -28.36 63.66 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.513 3.53 . . . . 10.17 110.685 -174.46 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.6 t -68.05 -44.42 76.44 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 118.042 -2.911 . . . . 13.59 113.004 173.386 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -56.35 -40.51 74.62 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.364 1.866 . . . . 11.699999999999999 111.79 177.179 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -85.34 -17.83 35.61 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.849 1.425 . . . . 12.949999999999999 114.849 175.632 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.508 12.9 m120 83.89 44.41 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.929 -2.357 . . . . 25.449999999999999 112.772 172.799 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.7 mm -79.24 117.12 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 113.965 -1.47 . . . . 14.6 112.685 174.837 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -91.72 178.47 5.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.069 -3.519 . . . . 33.229999999999997 108.351 -178.821 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -65.57 154.8 37.67 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 115.492 -2.483 . . . . 25.969999999999999 112.005 172.874 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.47 36.42 11.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.115 -2.241 . . . . 32.609999999999999 110.645 172.075 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 t -109.1 142.27 40.08 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.828 1.955 . . . . 10.56 112.437 -174.708 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -97.62 115.97 28.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 116.011 -1.947 . . . . 5.3300000000000001 113.158 -170.883 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.31 141.43 28.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.022 1.451 . . . . 11.66 107.389 167.376 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.2 113.22 25.73 Favored 'General case' 0 N--CA 1.43 -1.433 1 CA-C-O 129.145 4.307 . . . . 16.300000000000001 107.803 -170.546 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 7' ' ' THR . 58.9 tp -81.84 105.53 13.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 117.287 -3.383 . . . . 9.9600000000000009 110.843 -178.016 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.19 113.52 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 123.329 1.538 . . . . 9.7599999999999998 112.615 174.064 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 N--CA 1.43 -1.463 0 O-C-N 118.229 -2.794 . . . . 19.57 115.467 -178.333 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptt? . . . . . 0 CA--C 1.49 -1.328 0 N-CA-C 116.686 2.106 . . . . 17.170000000000002 116.686 . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.77 147.09 37.62 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 117.124 -1.417 . . . . 21.890000000000001 110.268 178.478 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.93 156.23 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.638 -2.727 . . . . 10.83 103.638 160.727 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -99.11 117.25 33.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 112.001 -2.363 . . . . 10.609999999999999 115.196 169.233 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.8 t -107.05 111.43 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.108 -3.495 . . . . 9.1300000000000008 109.291 179.796 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -90.23 113.48 25.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.63 -1.623 . . . . 20.550000000000001 111.479 -171.727 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.391 9.0 p -70.72 172.55 8.54 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.533 -2.605 . . . . 11.779999999999999 115.302 173.672 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.4 HD13 ' CE1' ' A' ' 68' ' ' HIS . 26.1 tp -98.23 3.85 48.88 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.901 3.239 . . . . 19.309999999999999 109.48 177.763 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -85.59 -71.22 0.54 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.663 -3.773 . . . . 23.140000000000001 106.34 168.937 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.36 13.67 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.725 0 O-C-N 126.452 2.345 . . . . 19.739999999999998 114.499 -174.502 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -98.37 132.48 43.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.533 -3.333 . . . . 21.93 108.208 179.68 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -104.91 103.1 12.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.483 -3.885 . . . . 12.33 115.294 165.485 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -80.36 136.82 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.538 -2.601 . . . . 17.079999999999998 111.091 179.206 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 m -107.76 135.84 48.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.286 3.422 . . . . 16.300000000000001 106.13 175.733 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -132.47 157.15 45.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.386 -2.696 . . . . 15.880000000000001 107.163 -176.691 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -112.21 111.28 22.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.265 2.226 . . . . 28.899999999999999 108.195 -176.341 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.22 155.78 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 124.248 1.975 . . . . 12.050000000000001 110.466 -168.23 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.94 165.67 16.57 Favored Pre-proline 0 N--CA 1.43 -1.429 1 O-C-N 115.36 -4.587 . . . . 18.170000000000002 106.179 165.814 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -62.8 -22.56 73.98 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 123.155 2.57 . . . . 8.1600000000000001 115.528 168.394 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.9 m -87.07 3.51 45.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.021 3.296 . . . . 11.130000000000001 115.147 -178.429 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -77.87 145.59 36.15 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.179 -5.326 . . . . 18.030000000000001 109.32 171.533 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -78.14 170.89 15.86 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.2 1.926 . . . . 10.220000000000001 116.2 173.172 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -61.85 -35.61 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 125.316 1.446 . . . . 12.300000000000001 112.228 161.76 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.12 -43.63 97.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.803 -2.435 . . . . 36.509999999999998 111.92 174.368 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -61.02 -32.59 72.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.169 2.285 . . . . 25.66 117.169 170.741 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.333 95.6 t -60.2 -53.66 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.366 3.066 . . . . 8.1199999999999992 113.626 167.584 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -55.68 -44.53 77.4 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 121.924 4.046 . . . . 15.470000000000001 121.924 169.886 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.51 -34.26 64.49 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 125.942 2.782 . . . . 11.449999999999999 117.57 175.93 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -82.12 -27.35 32.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.199 -2.148 . . . . 24.98 105.199 -171.796 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.67 -29.94 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 103.416 -2.809 . . . . 9.4600000000000009 103.416 -176.127 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.13 -51.3 68.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.221 3.009 . . . . 14.76 110.608 170.393 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -55.43 -43.35 75.29 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.191 1.922 . . . . 26.289999999999999 116.191 173.069 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -84.04 -71.86 0.49 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.094 -1.866 . . . . 30.059999999999999 108.312 -169.138 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -74.28 -54.09 8.4 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.791 2.71 . . . . 25.190000000000001 115.526 -170.893 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.11 -24.78 1.27 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.136 -2.227 . . . . 7.4100000000000001 112.158 -177.975 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.548 HD13 HD21 ' A' ' 71' ' ' LEU . 3.7 mt -69.87 122.97 87.68 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 116.658 -1.639 . . . . 9.4900000000000002 112.801 -160.802 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.44 153.39 65.83 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 C-N-CA 126.326 4.684 . . . . 11.42 110.979 176.378 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.95 -21.95 49.16 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 C-N-CA 124.627 3.552 . . . . 12.0 118.743 -168.702 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -65.58 -37.37 86.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.361 3.464 . . . . 35.549999999999997 111.127 178.695 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.26 65.7 mt-30 -76.49 -16.7 59.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.553 2.341 . . . . 20.52 113.917 -177.37 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -97.85 124.5 42.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.403 -3.311 . . . . 7.1299999999999999 110.715 -165.783 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.401 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 59.4 mtp180 -101.97 126.98 49.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.513 -3.867 . . . . 36.390000000000001 105.969 160.121 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mt -115.48 132.0 56.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.578 -1.326 . . . . 9.5500000000000007 107.697 177.504 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.57 134.24 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 126.554 1.941 . . . . 13.9 109.681 -159.266 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -140.68 116.48 10.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.733 1.73 . . . . 6.8600000000000003 107.938 179.848 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.71 -93.92 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.739 3.216 . . . . 11.15 110.223 -178.027 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.86 11.11 7.43 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.683 -2.511 . . . . 13.93 116.625 178.591 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -128.92 153.02 47.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.222 -2.929 . . . . 23.920000000000002 112.46 -178.01 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -89.15 138.81 31.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.173 -2.529 . . . . 23.23 104.173 169.319 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.68 126.11 33.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.378 -2.646 . . . . 9.1099999999999994 115.499 -176.997 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.56 140.97 31.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 121.343 1.883 . . . . 33.439999999999998 109.967 -173.355 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.39 -62.43 1.78 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.798 3.639 . . . . 28.370000000000001 115.493 -158.377 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.83 28.04 3.69 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 118.568 -2.582 . . . . 15.0 111.965 -177.078 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -103.95 154.07 20.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.828 -2.572 . . . . 25.5 107.134 174.72 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -97.0 177.59 5.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.709 3.147 . . . . 11.949999999999999 103.769 -170.559 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.78 -34.16 73.37 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 112.567 -6.333 . . . . 10.17 117.764 172.894 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 m -64.15 -21.43 66.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.592 -1.67 . . . . 13.59 112.588 174.237 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.16 -39.64 54.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.388 1.475 . . . . 11.699999999999999 111.698 177.72 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -90.15 3.15 54.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.845 2.906 . . . . 12.949999999999999 118.845 171.239 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.379 17.9 m120 73.18 25.49 2.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.739 2.416 . . . . 25.449999999999999 116.11 171.304 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.3 mt -83.83 127.74 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 128.855 2.862 . . . . 14.6 109.304 -176.692 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -126.37 -155.59 0.69 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.178 0.924 . . . . 33.229999999999997 110.157 179.451 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -83.33 144.87 29.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.598 -1.939 . . . . 25.969999999999999 112.412 179.673 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 87.0 6.93 0.26 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.289 3.836 . . . . 32.609999999999999 108.23 176.625 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -84.5 151.6 24.49 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 115.894 -4.254 . . . . 10.56 109.768 -167.657 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.452 5.2 m -93.24 112.56 24.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.345 2.658 . . . . 5.3300000000000001 116.258 172.87 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -90.52 168.28 11.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.375 -3.328 . . . . 11.66 107.324 168.336 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.4 ' CE1' HD13 ' A' ' 8' ' ' LEU . 9.6 t60 -130.43 133.02 46.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.73 -2.481 . . . . 16.300000000000001 104.316 177.078 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -102.03 133.34 47.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.02 1.728 . . . . 9.9600000000000009 113.405 177.887 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.458 HG12 ' N ' ' A' ' 71' ' ' LEU . 88.3 t -131.71 161.17 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.867 -2.271 . . . . 9.7599999999999998 104.867 174.066 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.548 HD21 HD13 ' A' ' 36' ' ' ILE . 64.2 mt . . . . . 0 N--CA 1.429 -1.483 0 CA-C-N 121.848 2.113 . . . . 19.57 110.594 178.981 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 106.795 -1.557 . . . . 17.170000000000002 106.795 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.85 151.6 25.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.871 -1.899 . . . . 21.890000000000001 105.871 -178.278 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -134.5 167.42 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.593 2.139 . . . . 10.83 108.595 169.663 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -121.14 130.69 53.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.191 -2.818 . . . . 10.609999999999999 109.738 177.657 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -110.62 124.49 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 1 O-C-N 113.774 -5.579 . . . . 9.1300000000000008 105.848 161.041 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.252 77.8 tttt -109.15 134.0 52.29 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.386 -2.696 . . . . 20.550000000000001 115.752 -179.39 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -71.0 170.29 13.11 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.966 2.794 . . . . 11.779999999999999 110.678 178.745 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.4 tp -78.11 -29.82 49.11 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.33 -2.668 . . . . 19.309999999999999 114.956 177.801 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -58.6 -56.01 27.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 122.198 2.272 . . . . 23.140000000000001 112.547 165.35 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.41 38.16 0.11 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 128.709 3.052 . . . . 19.739999999999998 113.799 163.302 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -92.79 132.11 37.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 126.837 2.139 . . . . 21.93 106.42 -179.421 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -105.89 126.58 52.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.03 2.348 . . . . 12.33 110.572 -175.692 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -97.06 118.86 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 111.291 -2.686 . . . . 17.079999999999998 105.905 174.864 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.7 m -82.54 128.9 34.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.817 -1.802 . . . . 16.300000000000001 115.137 166.523 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 mt -123.55 148.91 45.88 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.695 -1.224 . . . . 15.880000000000001 107.695 -179.895 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -118.77 116.89 27.48 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.616 2.366 . . . . 28.899999999999999 106.485 177.799 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.293 34.1 m -141.29 -179.22 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 126.394 2.309 . . . . 12.050000000000001 106.443 -177.329 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -117.13 157.86 45.76 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 118.502 -2.624 . . . . 18.170000000000002 108.582 171.418 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -64.3 -8.85 17.85 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-N 126.161 3.236 . . . . 8.1600000000000001 118.029 178.818 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.1 m -88.99 -1.94 58.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.741 1.616 . . . . 11.130000000000001 113.976 -178.149 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -89.35 164.9 14.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.357 1.075 . . . . 18.030000000000001 108.976 176.831 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -87.96 168.07 13.18 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.826 2.45 . . . . 10.220000000000001 114.846 -179.624 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 22.3 mm -75.1 -26.35 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 115.393 1.627 . . . . 12.300000000000001 115.393 172.65 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -61.77 -43.35 99.03 Favored 'General case' 0 N--CA 1.43 -1.452 2 C-N-CA 133.994 4.918 . . . . 36.509999999999998 106.999 166.113 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -65.07 -33.92 77.18 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.017 2.599 . . . . 25.66 118.017 169.647 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -60.19 -44.42 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.668 -1.27 . . . . 8.1199999999999992 111.501 171.38 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -75.25 -39.79 59.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.368 -3.332 . . . . 15.470000000000001 111.433 -175.691 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.53 -23.5 64.53 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.274 -2.141 . . . . 11.449999999999999 116.737 172.972 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -63.99 -45.22 90.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 125.095 3.588 . . . . 24.98 107.672 169.625 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.566 ' HB ' HE22 ' A' ' 41' ' ' GLN . 92.6 mt -67.09 -30.74 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.468 -2.645 . . . . 9.4600000000000009 109.952 177.36 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -60.45 -41.32 93.86 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.805 2.842 . . . . 14.76 113.963 171.777 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -68.3 -59.7 3.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.084 1.883 . . . . 26.289999999999999 116.084 163.294 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 mttm -63.57 -58.38 7.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 120.122 3.379 . . . . 30.059999999999999 120.122 -171.802 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -88.72 -55.26 3.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.718 2.007 . . . . 25.190000000000001 113.429 -174.565 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.37 20.89 2.6 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 112.077 -2.329 . . . . 7.4100000000000001 117.202 -178.152 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.0 mt -100.34 117.25 63.37 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 119.007 -2.467 . . . . 9.4900000000000002 110.829 178.641 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 6.6 Cg_endo -73.43 154.7 50.77 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-N 127.732 3.797 . . . . 11.42 112.774 -175.694 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 94.4 Cg_exo -69.85 -22.58 31.46 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 CA-C-O 117.682 -1.049 . . . . 12.0 113.217 -167.287 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -54.09 -41.23 68.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.649 -2.596 . . . . 35.549999999999997 117.092 175.302 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -77.38 -36.03 53.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.024 2.703 . . . . 20.52 111.854 170.221 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.566 HE22 ' HB ' ' A' ' 30' ' ' ILE . 69.8 mt-30 -69.32 115.07 8.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.16 2.652 . . . . 7.1299999999999999 118.16 -176.476 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 59.7 mtp180 -102.87 121.66 42.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.952 -1.499 . . . . 36.390000000000001 107.335 161.083 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 mt -99.15 132.43 44.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.382 1.901 . . . . 9.5500000000000007 109.382 175.971 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -125.56 122.74 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.739 2.416 . . . . 13.9 109.523 -170.001 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -104.3 120.0 40.21 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.185 1.357 . . . . 6.8600000000000003 109.19 168.76 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.49 . . 62.98 -102.59 0.11 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.941 -1.1 . . . . 11.15 113.457 -167.717 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.75 16.85 5.3 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 117.424 -3.298 . . . . 13.93 107.497 171.306 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -95.52 131.64 41.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.778 2.831 . . . . 23.920000000000002 109.335 177.209 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -87.99 133.0 34.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 124.872 1.358 . . . . 23.23 110.355 178.665 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 mt -93.13 120.47 33.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.662 1.185 . . . . 9.1099999999999994 110.998 -175.116 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -78.55 139.0 38.66 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.607 1.563 . . . . 33.439999999999998 113.576 169.024 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 5.8 m-20 -64.75 -40.23 94.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.372 2.269 . . . . 28.370000000000001 113.33 -165.575 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.53 29.14 5.0 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 116.725 1.45 . . . . 15.0 116.725 177.23 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -109.75 164.09 12.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.903 -2.528 . . . . 25.5 107.27 162.873 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -93.31 165.17 12.92 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.772 1.748 . . . . 11.949999999999999 114.06 173.581 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -59.48 -35.24 73.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.748 -1.845 . . . . 10.17 112.669 174.473 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 t -66.55 -32.01 73.08 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 119.807 3.262 . . . . 13.59 119.807 174.085 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -63.37 -39.22 93.92 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 123.615 1.674 . . . . 11.699999999999999 110.638 175.571 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -88.14 -4.53 58.74 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.351 2.26 . . . . 12.949999999999999 112.376 178.727 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.8 m120 50.96 56.05 8.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.666 1.986 . . . . 25.449999999999999 114.504 -168.43 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.0 mt -103.16 103.57 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 101.204 -3.628 . . . . 14.6 101.204 178.278 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -89.74 -171.85 3.33 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.501 2.72 . . . . 33.229999999999997 111.288 -177.444 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -69.06 143.77 54.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 105.461 -2.051 . . . . 25.969999999999999 105.461 -170.831 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 25.3 mt-10 64.67 26.43 13.15 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.951 2.204 . . . . 32.609999999999999 116.951 172.673 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 t -93.34 144.5 25.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 104.383 -2.451 . . . . 10.56 104.383 -173.535 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.6 m -110.78 124.15 51.45 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 114.277 -1.329 . . . . 5.3300000000000001 110.737 -171.951 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mt -95.22 140.94 29.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.114 3.365 . . . . 11.66 108.136 174.603 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -89.03 143.26 26.97 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.142 1.449 . . . . 16.300000000000001 108.952 165.894 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -119.51 119.82 34.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.167 -2.16 . . . . 9.9600000000000009 105.167 -171.989 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 71.1 t -109.76 132.42 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 114.563 -1.199 . . . . 9.7599999999999998 110.568 -179.778 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 N--CA 1.43 -1.431 0 O-C-N 118.231 -2.793 . . . . 19.57 113.569 174.716 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 116.845 2.165 . . . . 17.170000000000002 116.845 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.64 128.46 33.64 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.496 -2.628 . . . . 21.890000000000001 108.77 172.221 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -124.01 173.33 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.935 -2.978 . . . . 10.83 103.548 163.901 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.269 77.5 m-85 -128.18 136.3 50.91 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.782 -0.821 . . . . 10.609999999999999 108.782 -176.31 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -113.62 117.16 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 125.971 2.796 . . . . 9.1300000000000008 106.768 175.401 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 19.9 ttpt -95.91 136.77 35.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.343 -1.753 . . . . 20.550000000000001 111.117 174.666 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -88.89 -169.29 2.47 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 128.15 3.833 . . . . 11.779999999999999 111.51 -175.34 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.3 tp -80.57 -44.15 19.47 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.691 -3.755 . . . . 19.309999999999999 110.543 -176.71 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -62.28 1.93 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.417 1.887 . . . . 23.140000000000001 110.006 168.562 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.84 41.34 0.11 Allowed Glycine 0 N--CA 1.431 -1.687 0 O-C-N 119.139 -2.226 . . . . 19.739999999999998 111.593 169.63 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 21.1 tptm -84.29 142.9 29.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 128.94 3.377 . . . . 21.93 113.833 166.489 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.5 m -106.94 112.21 25.07 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.593 1.663 . . . . 12.33 109.466 -176.254 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.483 HD13 ' HG3' ' A' ' 34' ' ' GLU . 34.3 mt -104.27 108.91 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 119.562 -1.961 . . . . 17.079999999999998 110.358 -174.974 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -87.82 123.09 32.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.489 -1.382 . . . . 16.300000000000001 108.564 -174.164 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.3 mt -120.17 158.26 27.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.087 2.155 . . . . 15.880000000000001 116.29 179.636 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -120.77 89.33 3.11 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.556 3.074 . . . . 28.899999999999999 114.893 177.377 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -109.55 164.39 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 119.86 -1.775 . . . . 12.050000000000001 114.473 -178.624 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -98.26 159.69 30.04 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 116.551 -2.059 . . . . 18.170000000000002 106.444 167.793 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 79.5 Cg_endo -73.53 -17.68 23.37 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 O-C-N 116.012 -2.678 . . . . 8.1600000000000001 110.066 174.904 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -59.78 -20.25 55.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.005 2.522 . . . . 11.130000000000001 116.19 164.785 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -71.57 142.3 50.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.562 2.601 . . . . 18.030000000000001 112.0 175.964 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.7 p -79.94 165.64 22.43 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.09 -4.131 . . . . 10.220000000000001 107.932 167.233 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 mm -66.18 -24.69 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.589 1.955 . . . . 12.300000000000001 108.558 177.637 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.29 35.0 tt0 -65.73 -39.85 91.57 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 118.19 -0.91 . . . . 36.509999999999998 108.596 174.19 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -72.25 -24.31 61.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.895 2.134 . . . . 25.66 114.237 179.109 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t -72.77 -42.06 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.385 -2.697 . . . . 8.1199999999999992 110.834 175.189 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.274 93.0 mttt -51.57 -36.88 47.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 117.581 2.438 . . . . 15.470000000000001 117.581 163.512 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.76 61.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.504 -1.372 . . . . 11.449999999999999 111.265 -177.232 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -58.67 -47.98 82.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.164 2.986 . . . . 24.98 113.814 175.487 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -69.92 -34.16 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.553 -1.658 . . . . 9.4600000000000009 109.147 175.401 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -60.59 -46.71 89.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.144 2.247 . . . . 14.76 110.794 172.978 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.26 -58.7 6.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.759 -1.838 . . . . 26.289999999999999 111.305 -177.308 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -75.61 -55.43 5.67 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 132.805 4.442 . . . . 30.059999999999999 111.264 -168.068 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HG3' HD13 ' A' ' 13' ' ' ILE . 27.1 mm-40 -89.43 -31.8 17.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.968 -2.333 . . . . 25.190000000000001 115.241 -179.016 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.01 11.42 20.57 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 121.269 3.268 . . . . 7.4100000000000001 121.269 179.536 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.307 71.5 mt -109.5 135.16 20.35 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 102.447 -3.168 . . . . 9.4900000000000002 102.447 -153.502 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -61.44 158.03 38.22 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 124.079 3.186 . . . . 11.42 117.481 179.605 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -78.53 -13.35 14.93 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 127.847 3.838 . . . . 12.0 118.066 179.932 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.92 -17.8 64.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.996 -1.457 . . . . 35.549999999999997 114.93 -178.634 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -86.2 -22.38 26.98 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 124.07 1.89 . . . . 20.52 111.24 178.025 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -89.07 108.01 19.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.819 2.525 . . . . 7.1299999999999999 117.819 -163.303 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -104.49 100.15 9.84 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.994 -1.113 . . . . 36.390000000000001 107.994 171.517 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.482 ' HB3' HD12 ' A' ' 50' ' ' LEU . 13.6 mt -81.81 130.33 35.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.182 -2.824 . . . . 9.5500000000000007 112.884 178.33 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mm -128.8 136.06 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 104.148 -2.538 . . . . 13.9 104.148 -167.739 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -135.08 133.5 39.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.843 -1.539 . . . . 6.8600000000000003 106.843 176.604 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.262 . . 49.98 -111.34 0.49 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.844 2.535 . . . . 11.15 117.844 -164.163 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.36 2.53 37.27 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 119.007 -0.885 . . . . 13.93 114.405 169.341 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -105.7 126.33 52.03 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.237 3.015 . . . . 23.920000000000002 111.024 -161.508 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -80.54 130.41 35.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.523 -1.217 . . . . 23.23 110.49 171.712 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 43' ' ' LEU . 34.3 mt -86.47 166.01 15.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.61 -1.186 . . . . 9.1099999999999994 113.756 -167.908 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -132.48 128.91 38.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 114.791 -2.528 . . . . 33.439999999999998 109.085 -170.4 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.05 -44.49 78.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 127.157 2.785 . . . . 28.370000000000001 115.573 -162.954 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.55 -8.72 14.89 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 128.546 2.974 . . . . 15.0 118.634 -179.394 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -95.8 150.92 19.87 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 116.234 -4.098 . . . . 25.5 110.851 178.583 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.7 p -78.53 161.68 26.86 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.298 2.475 . . . . 11.949999999999999 112.144 168.041 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 19.9 mt -65.29 -42.88 92.64 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.0 -5.438 . . . . 10.17 111.904 172.348 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -42.14 -40.27 2.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.626 2.824 . . . . 13.59 118.626 160.685 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.34 -22.82 67.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.193 -2.192 . . . . 11.699999999999999 116.531 172.677 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -101.82 3.59 39.52 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.023 -1.673 . . . . 12.949999999999999 111.276 -178.75 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.478 26.9 m120 63.37 32.12 14.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.127 2.87 . . . . 25.449999999999999 118.191 -174.204 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.6 mt -95.51 123.06 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.026 -2.296 . . . . 14.6 106.38 -171.493 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -124.78 -171.17 2.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.093 2.557 . . . . 33.229999999999997 107.305 -168.673 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -76.33 150.68 36.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.512 -1.992 . . . . 25.969999999999999 115.949 -169.001 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 63.15 15.34 8.46 Favored 'General case' 0 N--CA 1.43 -1.464 1 CA-C-O 128.535 4.017 . . . . 32.609999999999999 118.894 -169.711 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.37 147.34 40.13 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 112.884 -6.135 . . . . 10.56 113.981 172.47 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.8 m -108.15 123.37 48.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.612 1.565 . . . . 5.3300000000000001 114.486 -176.823 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.25 166.51 10.91 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.666 0.746 . . . . 11.66 110.163 174.313 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -126.27 144.96 50.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.076 -2.89 . . . . 16.300000000000001 108.295 -175.769 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.3 tp -121.55 102.47 8.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.965 1.306 . . . . 9.9600000000000009 108.747 -165.026 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 t -87.9 128.84 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 123.105 0.562 . . . . 9.7599999999999998 110.226 176.265 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.43 -1.427 0 N-CA-C 103.425 -2.805 . . . . 19.57 103.425 -169.637 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 CA--C 1.49 -1.338 0 CA-C-O 123.909 1.814 . . . . 17.170000000000002 114.597 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -74.92 125.29 28.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.386 -3.321 . . . . 21.890000000000001 114.092 168.465 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 pt -120.88 161.95 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 112.965 -1.925 . . . . 10.83 112.064 170.048 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -119.76 125.34 48.37 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.573 1.654 . . . . 10.609999999999999 111.615 -177.259 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.1 111.84 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 121.118 -0.988 . . . . 9.1300000000000008 110.237 174.632 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -88.37 138.52 31.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.608 -3.182 . . . . 20.550000000000001 118.261 179.088 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.264 28.2 p -87.25 175.79 7.87 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.301 2.334 . . . . 11.779999999999999 117.301 178.672 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -75.39 -38.21 60.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.729 -2.082 . . . . 19.309999999999999 115.095 173.978 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 63.0 p -70.64 -52.77 19.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.486 -2.673 . . . . 23.140000000000001 116.688 161.036 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.7 58.17 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 124.927 3.512 . . . . 19.739999999999998 110.899 158.494 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -97.14 147.11 24.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.29 -1.712 . . . . 21.93 110.485 165.411 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 m -93.62 108.41 20.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.208 1.004 . . . . 12.33 109.632 167.175 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 mt -75.93 127.7 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 117.738 -3.101 . . . . 17.079999999999998 107.605 166.185 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.6 p -114.15 127.46 55.92 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.742 -3.099 . . . . 16.300000000000001 111.97 177.573 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -127.81 133.19 49.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 128.172 3.42 . . . . 15.880000000000001 113.759 -171.567 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -95.75 91.7 6.21 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 132.242 4.217 . . . . 28.899999999999999 109.42 -179.516 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -126.52 167.47 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.513 -1.662 . . . . 12.050000000000001 106.513 178.927 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -102.44 154.19 37.61 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 117.39 -3.319 . . . . 18.170000000000002 105.838 174.255 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -68.99 -5.33 15.46 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 124.079 2.493 . . . . 8.1600000000000001 117.631 -173.494 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -98.37 4.38 48.56 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 124.442 1.089 . . . . 11.130000000000001 108.298 174.963 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.49 147.3 53.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.902 2.186 . . . . 18.030000000000001 116.902 162.052 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 7.5 p -89.67 158.84 17.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.318 -1.765 . . . . 10.220000000000001 106.681 -173.665 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -64.7 -32.69 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.385 -2.697 . . . . 12.300000000000001 114.486 -178.766 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -44.21 -50.81 8.63 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.206 3.002 . . . . 36.509999999999998 109.783 162.238 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -74.12 -21.24 59.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.936 -2.977 . . . . 25.66 117.128 178.333 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 56' ' ' LEU . 55.8 t -71.63 -43.61 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 123.25 1.5 . . . . 8.1199999999999992 109.838 172.909 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -61.51 -30.65 70.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.087 2.995 . . . . 15.470000000000001 119.087 168.66 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.37 -34.65 61.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.88 -3.013 . . . . 11.449999999999999 112.922 171.204 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -49.04 76.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 127.063 3.316 . . . . 24.98 116.103 167.953 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.6 mt -57.79 -42.23 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 117.645 -3.16 . . . . 9.4600000000000009 113.528 166.54 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -63.2 -39.55 94.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.426 -3.921 . . . . 14.76 116.176 172.977 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -68.05 -50.56 54.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.12 0.887 . . . . 26.289999999999999 113.121 176.126 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -70.14 -66.02 0.65 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.112 1.152 . . . . 30.059999999999999 114.112 176.889 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -76.96 -35.28 57.36 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.856 2.909 . . . . 25.190000000000001 118.856 -170.221 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.01 60.16 1.79 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 119.827 -1.796 . . . . 7.4100000000000001 111.246 -173.169 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.99 119.54 15.82 Favored Pre-proline 0 N--CA 1.43 -1.439 0 C-N-CA 125.151 1.38 . . . . 9.4900000000000002 108.091 178.255 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.49 154.41 45.1 Favored 'Trans proline' 0 N--CA 1.433 -2.059 1 C-N-CA 125.893 4.395 . . . . 11.42 111.716 -172.218 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.299 52.3 Cg_endo -64.27 -14.3 43.09 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 O-C-N 123.891 1.469 . . . . 12.0 111.507 174.726 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -67.29 -34.34 77.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.361 2.505 . . . . 35.549999999999997 113.779 176.605 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -96.58 -37.74 10.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.012 -2.305 . . . . 20.52 108.639 -164.684 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -75.21 136.89 40.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 117.067 2.247 . . . . 7.1299999999999999 117.067 -176.345 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HB3' HG23 ' A' ' 70' ' ' VAL . 37.3 ttm180 -120.06 133.25 55.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.197 -3.26 . . . . 36.390000000000001 102.197 161.339 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.7 mt -108.53 141.93 39.7 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.386 -2.071 . . . . 9.5500000000000007 106.389 179.903 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.1 mt -126.83 138.54 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.214 3.406 . . . . 13.9 103.367 -170.476 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -121.03 121.24 37.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.974 1.369 . . . . 6.8600000000000003 111.471 161.185 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.61 -78.58 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.719 -2.488 . . . . 11.15 114.843 -174.613 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.25 -4.94 0.24 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 123.882 3.037 . . . . 13.93 110.638 -177.998 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -113.07 146.03 39.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.747 2.419 . . . . 23.920000000000002 112.689 -173.391 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -89.52 156.07 18.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.597 1.959 . . . . 23.23 110.288 -171.773 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -118.86 127.24 53.32 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 129.455 4.222 . . . . 9.1099999999999994 107.8 -170.413 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -103.14 165.07 11.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.837 -3.04 . . . . 33.439999999999998 112.384 -172.118 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -69.91 -58.13 4.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.477 -2.639 . . . . 28.370000000000001 113.848 -157.645 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.35 31.03 5.95 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 117.919 -1.489 . . . . 15.0 115.523 -167.714 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -107.96 162.09 14.34 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.94 1.696 . . . . 25.5 114.202 159.831 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 29.2 p -92.72 173.48 7.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.305 1.526 . . . . 11.949999999999999 107.626 -171.65 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 26' ' ' VAL . 12.5 mt -65.67 -44.26 86.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.026 -0.988 . . . . 10.17 110.469 171.729 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.1 m -63.89 -32.21 73.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.198 2.295 . . . . 13.59 117.198 178.704 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -58.21 -42.81 87.03 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.267 3.432 . . . . 11.699999999999999 120.267 173.54 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -70.5 -13.89 62.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 117.46 -1.257 . . . . 12.949999999999999 114.275 163.849 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 30.2 m120 68.68 38.59 2.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.474 2.71 . . . . 25.449999999999999 114.265 -171.61 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.16 129.16 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.053 2.095 . . . . 14.6 110.339 164.557 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.44 -173.77 3.26 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.128 2.971 . . . . 33.229999999999997 108.944 -164.217 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -65.26 136.22 56.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.57 -3.831 . . . . 25.969999999999999 111.14 172.629 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 55.42 53.19 10.16 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-N 108.039 -4.164 . . . . 32.609999999999999 113.442 -170.889 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -96.37 150.67 20.33 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.057 -4.152 . . . . 10.56 110.121 -178.136 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.5 m -103.46 111.1 23.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 127.4 2.937 . . . . 5.3300000000000001 108.444 -174.9 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -100.07 162.09 13.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.293 -1.002 . . . . 11.66 108.293 176.215 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -122.75 128.06 50.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.35 -1.469 . . . . 16.300000000000001 111.347 170.422 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -93.92 121.9 35.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.737 1.014 . . . . 9.9600000000000009 113.737 176.638 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 42' ' ' ARG . 18.7 m -121.68 155.87 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.778 -1.934 . . . . 9.7599999999999998 105.778 174.445 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.2 mt . . . . . 0 N--CA 1.43 -1.451 0 O-C-N 118.872 -2.393 . . . . 19.57 109.787 172.056 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 111.932 0.345 . . . . 17.170000000000002 111.932 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -89.74 115.26 26.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.569 1.548 . . . . 21.890000000000001 113.084 -175.662 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.48 18.0 pt -107.29 155.27 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 126.076 1.75 . . . . 10.83 115.593 168.874 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -121.2 116.57 25.16 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.333 2.653 . . . . 10.609999999999999 105.681 -178.006 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.32 109.36 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 118.064 -2.897 . . . . 9.1300000000000008 108.26 172.074 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -101.29 132.67 46.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.281 1.515 . . . . 20.550000000000001 107.12 -173.798 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -87.12 171.56 10.6 Favored 'General case' 0 N--CA 1.429 -1.486 1 O-C-N 115.732 -4.355 . . . . 11.779999999999999 113.495 177.708 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.4 tp -70.23 -42.2 72.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 127.047 3.308 . . . . 19.309999999999999 109.495 177.699 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 p -56.81 -31.69 64.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.751 -3.093 . . . . 23.140000000000001 116.928 167.889 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.62 37.29 2.09 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 122.632 2.469 . . . . 19.739999999999998 113.137 173.235 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -99.55 152.9 19.5 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.451 -2.796 . . . . 21.93 103.451 167.446 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -110.97 106.23 15.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 114.06 1.133 . . . . 12.33 114.06 160.246 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.5 mt -81.27 108.25 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.876 -1.765 . . . . 17.079999999999998 108.571 169.973 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.9 p -78.39 137.8 38.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.49 -2.006 . . . . 16.300000000000001 111.039 172.34 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.2 139.32 44.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 125.197 1.561 . . . . 15.880000000000001 110.366 -177.166 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -95.46 111.6 23.46 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.298 2.639 . . . . 28.899999999999999 109.784 164.579 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.252 29.0 m -135.51 162.26 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 1 O-C-N 114.446 -5.159 . . . . 12.050000000000001 107.344 175.133 . . . . . . . . 3 2 . 1 . 064 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -97.95 166.05 14.23 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 120.239 -1.538 . . . . 18.170000000000002 107.967 179.682 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.74 -19.9 48.59 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 123.721 2.365 . . . . 8.1600000000000001 118.1 174.184 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -98.5 12.94 33.53 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 125.032 1.458 . . . . 11.130000000000001 112.066 -172.182 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.34 131.16 34.73 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.429 -2.044 . . . . 18.030000000000001 108.87 176.952 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 52' ' ' ASP 0.314 65.1 p -59.26 163.55 3.77 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.913 1.82 . . . . 10.220000000000001 115.913 164.889 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 37.2 mm -76.05 -17.1 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 O-C-N 116.291 -4.005 . . . . 12.300000000000001 106.335 -179.72 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 36.7 tt0 -69.12 -47.24 65.64 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.074 -1.642 . . . . 36.509999999999998 107.538 172.127 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.273 70.4 m-80 -66.49 -29.43 69.54 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.508 3.151 . . . . 25.66 119.508 175.677 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.269 60.2 t -51.4 -51.56 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 114.155 1.168 . . . . 8.1199999999999992 114.155 163.621 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -71.61 -40.48 69.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.556 1.942 . . . . 15.470000000000001 110.618 -174.995 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.264 . . -52.34 -49.34 64.5 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.336 3.054 . . . . 11.449999999999999 109.809 170.051 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -62.51 -36.72 83.45 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.556 -3.215 . . . . 24.98 116.812 172.836 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -58.91 -47.25 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.763 -3.086 . . . . 9.4600000000000009 111.538 167.455 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -55.86 -35.78 66.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.231 2.678 . . . . 14.76 118.231 173.931 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.9 -43.06 69.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.992 -1.485 . . . . 26.289999999999999 106.992 -179.894 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -79.03 -57.47 3.72 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.785 -1.822 . . . . 30.059999999999999 115.31 -173.935 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -85.74 -49.7 7.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.779 -2.01 . . . . 25.190000000000001 111.572 -173.947 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.6 28.66 5.91 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 116.396 -3.94 . . . . 7.4100000000000001 110.885 -169.436 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.23 122.9 41.4 Favored Pre-proline 0 N--CA 1.429 -1.5 1 CA-C-O 111.541 -4.076 . . . . 9.4900000000000002 105.997 176.161 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -87.63 159.77 7.83 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-O 114.543 -2.357 . . . . 11.42 112.199 -165.369 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -64.26 -9.48 20.01 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 122.912 2.408 . . . . 12.0 116.227 -175.626 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -82.36 -34.61 28.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 124.165 3.166 . . . . 35.549999999999997 109.907 -169.568 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -83.19 -19.45 36.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.539 1.536 . . . . 20.52 108.467 -174.775 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -90.95 127.96 36.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.054 2.983 . . . . 7.1299999999999999 119.054 -166.839 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -120.4 123.61 43.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 128.273 3.892 . . . . 36.390000000000001 111.174 168.674 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.0 mt -112.42 141.37 46.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.538 -2.601 . . . . 9.5500000000000007 112.541 177.923 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.91 134.91 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.484 -1.673 . . . . 13.9 106.484 -164.796 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -117.46 112.43 20.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.959 -2.978 . . . . 6.8600000000000003 102.959 171.608 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.321 . . 60.48 -108.29 0.35 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.068 1.889 . . . . 11.15 113.537 -167.748 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.17 -12.2 22.4 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 113.08 -1.873 . . . . 13.93 109.97 170.141 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -74.17 107.97 6.68 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.387 3.593 . . . . 23.920000000000002 112.835 179.618 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.8 122.36 22.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.239 -4.663 . . . . 23.23 110.897 176.528 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.274 6.5 mt -90.67 127.28 36.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.861 2.911 . . . . 9.1099999999999994 118.861 -165.244 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -83.55 143.58 30.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.35 -2.094 . . . . 33.439999999999998 114.926 173.005 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 36.0 m-20 -65.31 -41.44 94.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.755 2.217 . . . . 28.370000000000001 114.985 -163.977 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.51 21.46 38.32 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 118.614 -2.554 . . . . 15.0 113.58 -174.411 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -106.23 165.29 11.35 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.391 -1.337 . . . . 25.5 107.391 162.892 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -104.49 178.15 4.64 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.086 2.155 . . . . 11.949999999999999 111.54 -173.333 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.2 mt -80.1 -36.84 34.82 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.546 3.138 . . . . 10.17 106.445 173.945 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -51.77 -38.91 57.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.934 2.152 . . . . 13.59 114.931 163.509 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -70.96 -54.73 10.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.6 3.56 . . . . 11.699999999999999 109.234 -179.179 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -77.19 0.03 23.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.59 1.181 . . . . 12.949999999999999 113.213 -178.979 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 48.97 46.43 22.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.537 2.589 . . . . 25.449999999999999 117.034 -176.902 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mt -84.88 120.05 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 111.962 -2.381 . . . . 14.6 108.577 176.909 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -107.69 172.84 6.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.972 1.844 . . . . 33.229999999999997 113.831 177.96 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -60.14 141.73 55.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.423 -2.673 . . . . 25.969999999999999 113.038 179.462 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.313 12.2 mt-10 71.29 20.68 4.93 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 126.238 2.923 . . . . 32.609999999999999 117.876 177.863 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -87.63 124.72 33.82 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.448 -2.033 . . . . 10.56 109.958 173.833 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 m -74.26 100.93 3.86 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.383 2.04 . . . . 5.3300000000000001 112.157 177.698 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.75 141.95 30.18 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 117.659 -3.15 . . . . 11.66 113.508 167.144 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -107.16 128.2 54.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.264 1.983 . . . . 16.300000000000001 109.754 -178.808 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.7 tp -97.58 128.44 44.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.207 -3.433 . . . . 9.9600000000000009 109.2 173.367 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.07 136.52 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.303 2.954 . . . . 9.7599999999999998 105.084 171.015 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 N--CA 1.43 -1.448 0 O-C-N 117.975 -2.953 . . . . 19.57 109.572 179.054 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' HG23 ' A' ' 17' ' ' VAL . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 117.795 -1.098 . . . . 17.170000000000002 111.997 . . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.336 2.8 pt20 -95.87 145.29 25.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.794 2.088 . . . . 21.890000000000001 115.928 166.472 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.1 pt -138.39 167.26 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 103.361 -2.829 . . . . 10.83 103.361 174.865 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -122.22 145.28 48.36 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.891 -2.413 . . . . 10.609999999999999 108.272 179.177 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 30' ' ' ILE . 78.5 t -128.66 111.12 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 103.457 -2.794 . . . . 9.1300000000000008 103.457 176.937 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -107.26 137.49 45.21 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.676 2.655 . . . . 20.550000000000001 112.293 179.415 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.418 HG22 HD23 ' A' ' 69' ' ' LEU . 44.9 p -79.38 -166.45 0.96 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.916 -2.365 . . . . 11.779999999999999 105.541 -173.489 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.5 tp -81.59 -47.13 13.45 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.653 -1.904 . . . . 19.309999999999999 109.277 173.129 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 -31.2 61.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.711 2.804 . . . . 23.140000000000001 109.07 -170.059 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.43 42.17 0.47 Allowed Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 125.579 3.809 . . . . 19.739999999999998 115.226 174.326 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -108.27 133.98 51.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 102.27 -3.233 . . . . 21.93 102.27 168.358 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -104.54 113.17 26.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 124.888 1.368 . . . . 12.33 108.64 168.934 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -87.6 100.45 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.331 1.852 . . . . 17.079999999999998 112.562 166.618 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.9 m -77.23 136.51 38.54 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 118.143 -0.932 . . . . 16.300000000000001 108.879 177.778 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.296 32.0 mt -134.64 128.08 32.4 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.901 2.137 . . . . 15.880000000000001 105.519 178.548 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -88.26 132.33 34.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.367 -3.333 . . . . 28.899999999999999 107.676 161.296 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.525 HG23 ' HG3' ' A' ' 1' ' ' MET . 18.2 m -133.27 171.32 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 1 C-N-CA 132.194 4.198 . . . . 12.050000000000001 113.118 -164.146 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -108.0 148.06 36.7 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 129.109 2.964 . . . . 18.170000000000002 112.604 161.753 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.6 -23.12 69.99 Favored 'Trans proline' 0 N--CA 1.434 -2.017 1 C-N-CA 126.162 4.575 . . . . 8.1600000000000001 115.364 173.086 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -86.58 -7.16 58.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.145 1.535 . . . . 11.130000000000001 115.145 -179.101 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -73.61 146.53 44.59 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.039 -2.913 . . . . 18.030000000000001 110.452 179.33 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.8 p -99.28 -176.81 3.41 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 104.331 -2.47 . . . . 10.220000000000001 104.331 -172.507 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -70.45 -34.61 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 127.353 2.261 . . . . 12.300000000000001 109.569 -177.638 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -55.23 -43.33 74.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.695 2.798 . . . . 36.509999999999998 110.822 172.209 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -70.68 -34.92 72.49 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.755 2.502 . . . . 25.66 117.755 174.346 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.3 t -55.24 -48.81 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 132.031 4.133 . . . . 8.1199999999999992 108.058 174.002 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -63.81 -27.86 69.47 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.036 2.934 . . . . 15.470000000000001 115.066 177.488 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.34 -31.06 54.24 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.542 1.974 . . . . 11.449999999999999 110.997 177.374 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -65.04 -44.88 87.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.64 -2.538 . . . . 24.98 109.414 178.734 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 HG11 ' A' ' 5' ' ' VAL . 15.6 mt -65.59 -24.11 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.729 2.122 . . . . 9.4600000000000009 116.729 173.189 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -64.89 -57.42 8.85 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.798 -3.689 . . . . 14.76 114.342 162.276 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -52.24 -60.62 3.0 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.517 3.527 . . . . 26.289999999999999 114.729 175.757 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -79.5 -39.73 31.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.913 2.085 . . . . 30.059999999999999 112.612 -166.432 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -106.87 -42.2 5.0 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.029 1.732 . . . . 25.190000000000001 110.009 -163.287 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.63 7.09 30.22 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 117.709 -2.186 . . . . 7.4100000000000001 117.85 -173.118 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.6 mm -90.97 126.91 53.82 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-N 122.25 3.025 . . . . 9.4900000000000002 108.917 -170.314 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -68.51 152.97 74.69 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 122.261 1.843 . . . . 11.42 111.867 -178.617 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -92.98 -10.53 1.9 Allowed 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-O 113.241 -2.9 . . . . 12.0 111.797 -151.995 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -85.85 -28.43 24.44 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 128.671 3.732 . . . . 35.549999999999997 111.356 174.872 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.17 -17.35 37.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 118.884 -0.579 . . . . 20.52 111.625 -171.807 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -66.85 115.66 6.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.593 2.757 . . . . 7.1299999999999999 111.049 171.866 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -114.64 124.11 51.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.317 2.008 . . . . 36.390000000000001 108.772 171.967 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mt -103.35 134.9 45.96 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.041 -2.287 . . . . 9.5500000000000007 107.221 -177.854 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 7.5 mm -112.38 122.62 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 130.522 3.529 . . . . 13.9 115.144 171.053 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -108.8 118.81 37.77 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.755 -1.202 . . . . 6.8600000000000003 107.755 170.965 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.55 -78.37 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 131.134 3.774 . . . . 11.15 113.611 -170.545 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.47 40.41 0.28 Allowed Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 107.193 -2.363 . . . . 13.93 107.193 -179.808 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -137.2 139.33 41.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.525 -2.75 . . . . 23.920000000000002 111.473 159.7 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -67.79 167.52 13.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 117.518 2.414 . . . . 23.23 117.518 175.361 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.49 149.83 35.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.679 2.392 . . . . 9.1099999999999994 107.508 178.41 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.9 146.92 48.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 123.528 0.518 . . . . 33.439999999999998 109.786 -177.665 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.74 -47.27 41.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 120.577 3.547 . . . . 28.370000000000001 120.577 -158.651 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.56 53.7 0.63 Allowed Glycine 0 N--CA 1.429 -1.77 0 O-C-N 117.068 -3.52 . . . . 15.0 111.131 -170.338 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -120.62 159.27 25.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 117.574 -1.65 . . . . 25.5 106.997 155.969 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -85.12 165.38 17.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.969 2.508 . . . . 11.949999999999999 112.348 -169.914 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.6 mt -72.09 -38.04 69.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.685 -1.885 . . . . 10.17 110.012 -176.639 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -54.09 -49.15 69.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 114.891 -2.48 . . . . 13.59 113.105 169.706 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -44.53 -50.05 9.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 124.989 3.54 . . . . 11.699999999999999 113.787 174.702 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -76.93 -7.63 55.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.669 -2.519 . . . . 12.949999999999999 116.839 -178.981 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 69.19 37.47 2.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.966 3.307 . . . . 25.449999999999999 115.258 -179.42 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.2 mt -85.01 109.19 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 130.878 3.671 . . . . 14.6 105.677 -172.867 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -91.07 165.26 13.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.826 2.727 . . . . 33.229999999999997 113.035 -179.751 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 147.25 12.83 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.798 -3.689 . . . . 25.969999999999999 115.532 168.308 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 58.37 32.23 21.84 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.046 2.61 . . . . 32.609999999999999 118.046 -170.762 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -98.74 142.63 30.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.495 1.747 . . . . 10.56 108.796 177.071 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.2 m -93.24 102.91 15.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.137 3.775 . . . . 5.3300000000000001 115.636 169.473 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.25 153.58 23.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.842 -2.281 . . . . 11.66 104.842 168.602 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.424 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 89.2 m-70 -92.04 152.96 19.72 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.735 1.383 . . . . 16.300000000000001 114.735 168.191 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.418 HD23 HG22 ' A' ' 7' ' ' THR . 22.2 tp -120.01 108.78 14.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.977 2.111 . . . . 9.9600000000000009 110.998 169.082 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.327 16.0 m -119.65 168.74 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 126.922 2.639 . . . . 9.7599999999999998 112.505 171.495 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.2 mt . . . . . 0 N--CA 1.431 -1.411 0 CA-C-O 125.534 2.588 . . . . 19.57 106.591 179.053 . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 108.119 -1.067 . . . . 17.170000000000002 108.119 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -83.15 132.93 35.06 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.919 -2.363 . . . . 21.890000000000001 114.764 175.734 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -131.84 163.14 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 124.716 1.26 . . . . 10.83 110.039 172.489 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -124.67 166.27 16.44 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 102.282 -3.229 . . . . 10.609999999999999 102.282 -174.949 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -150.18 143.17 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 100.877 -3.749 . . . . 9.1300000000000008 100.877 179.464 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -119.2 139.05 52.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.467 1.939 . . . . 20.550000000000001 106.271 -178.649 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.0 p -81.81 167.84 18.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.744 1.903 . . . . 11.779999999999999 107.565 178.654 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 tp -56.17 -54.8 40.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.014 3.326 . . . . 19.309999999999999 113.132 -178.946 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.3 p -62.62 -53.76 49.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.891 2.476 . . . . 23.140000000000001 110.57 175.727 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.18 70.61 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 CA-C-O 117.601 -1.666 . . . . 19.739999999999998 112.768 169.587 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -125.78 124.42 40.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.909 1.855 . . . . 21.93 109.665 176.858 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -79.57 106.03 11.31 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.383 -5.198 . . . . 12.33 111.177 177.387 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.7 mt -81.35 115.07 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 123.259 1.504 . . . . 17.079999999999998 107.139 171.934 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -94.47 104.11 16.08 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 114.344 -5.222 . . . . 16.300000000000001 114.818 171.518 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -97.35 162.29 13.4 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.436 -4.54 . . . . 15.880000000000001 112.244 179.378 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -116.22 118.99 34.34 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 102.913 -2.995 . . . . 28.899999999999999 102.913 174.322 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.27 165.55 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 121.844 2.111 . . . . 12.050000000000001 112.707 173.653 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -104.57 161.78 21.79 Favored Pre-proline 0 N--CA 1.43 -1.46 0 N-CA-C 105.658 -1.979 . . . . 18.170000000000002 105.658 164.169 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.17 -6.29 12.96 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 123.978 3.119 . . . . 8.1600000000000001 109.311 -169.412 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -88.22 2.97 51.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 131.54 3.936 . . . . 11.130000000000001 113.379 168.0 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -87.15 152.71 22.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.21 -3.431 . . . . 18.030000000000001 109.91 -178.859 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p -94.86 164.05 13.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.149 2.704 . . . . 10.220000000000001 110.7 -167.042 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.5 mm -69.37 -34.87 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 O-C-N 115.489 -4.507 . . . . 12.300000000000001 109.164 -179.864 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.24 -42.78 77.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.737 2.866 . . . . 36.509999999999998 118.737 168.045 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -71.21 -32.43 68.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.02 2.128 . . . . 25.66 110.403 175.643 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.359 44.4 t -52.06 -61.27 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 118.98 -2.325 . . . . 8.1199999999999992 111.094 165.396 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -52.59 -35.43 54.11 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 127.109 2.164 . . . . 15.470000000000001 114.479 177.772 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.37 70.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.296 -2.753 . . . . 11.449999999999999 109.481 -178.302 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -62.27 -41.65 98.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.145 -0.972 . . . . 24.98 112.925 171.846 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.7 mt -63.71 -36.34 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 127.459 2.974 . . . . 9.4600000000000009 114.348 179.428 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -53.91 -33.19 55.92 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.509 3.924 . . . . 14.76 117.834 166.643 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.68 -51.48 9.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 124.12 1.914 . . . . 26.289999999999999 108.841 178.053 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -56.46 -63.15 1.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.274 1.987 . . . . 30.059999999999999 114.991 -176.771 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -110.91 -13.51 14.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.693 -3.129 . . . . 25.190000000000001 114.28 -172.765 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.78 43.86 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 119.524 2.57 . . . . 7.4100000000000001 119.524 -172.623 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.6 115.9 65.85 Favored Pre-proline 0 N--CA 1.43 -1.425 0 CA-C-O 115.154 -2.355 . . . . 9.4900000000000002 105.903 169.575 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -66.32 152.43 81.03 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 CA-C-N 126.906 3.502 . . . . 11.42 113.57 -177.856 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.14 -0.26 10.6 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.06 2.506 . . . . 12.0 112.92 -166.109 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -90.66 -54.79 3.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.836 3.207 . . . . 35.549999999999997 109.123 -173.897 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -84.28 -8.56 58.99 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.252 2.315 . . . . 20.52 117.252 -174.616 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -88.85 157.33 18.49 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.942 -2.974 . . . . 7.1299999999999999 109.923 171.52 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -143.46 144.69 32.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.018 -1.676 . . . . 36.390000000000001 107.593 168.637 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.8 mt -97.59 140.07 32.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.017 1.327 . . . . 9.5500000000000007 113.673 -175.983 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mm -134.52 139.35 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 104.009 -2.589 . . . . 13.9 104.009 -173.707 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.445 ' HB2' HD11 ' A' ' 50' ' ' LEU . 5.2 t80 -111.93 108.36 17.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.559 2.344 . . . . 6.8600000000000003 107.834 173.389 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.41 -88.6 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.362 2.289 . . . . 11.15 112.781 -169.99 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.42 -8.48 4.89 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 117.012 -3.555 . . . . 13.93 109.953 175.841 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -81.56 141.07 34.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 118.032 0.916 . . . . 23.920000000000002 111.32 -177.345 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -94.61 120.84 35.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.272 1.429 . . . . 23.23 108.168 -178.168 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 45' ' ' PHE . 14.7 mt -91.84 133.25 35.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.593 1.957 . . . . 9.1099999999999994 110.588 -165.138 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -94.84 136.25 35.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.772 -2.455 . . . . 33.439999999999998 114.92 179.098 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.82 -38.23 64.62 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.205 2.298 . . . . 28.370000000000001 117.205 -143.214 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.85 11.95 4.16 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 120.904 3.121 . . . . 15.0 120.904 164.66 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -106.18 172.88 6.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.39 2.595 . . . . 25.5 112.586 172.367 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -98.69 171.45 8.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.478 2.085 . . . . 11.949999999999999 115.436 176.128 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.01 -40.35 95.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.434 2.294 . . . . 10.17 109.391 173.394 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -60.41 -33.68 72.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 118.856 2.91 . . . . 13.59 118.856 173.17 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.286 28.5 m-20 -68.06 -44.78 75.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.629 1.715 . . . . 11.699999999999999 115.629 174.046 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -76.02 -32.55 59.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.424 1.489 . . . . 12.949999999999999 114.57 175.897 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t30 83.08 67.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 1 C-N-CA 131.884 4.073 . . . . 25.449999999999999 108.978 177.951 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.4 mt -101.49 118.15 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 127.485 2.314 . . . . 14.6 107.985 -177.916 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -89.25 177.92 6.48 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.097 -1.041 . . . . 33.229999999999997 110.518 -171.314 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -70.61 149.76 46.73 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.138 1.335 . . . . 25.969999999999999 110.882 175.916 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 70.03 51.41 0.41 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.778 3.231 . . . . 32.609999999999999 107.508 170.374 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -126.38 132.26 51.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.798 3.239 . . . . 10.56 115.398 -169.045 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.361 6.8 m -103.02 106.15 16.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.895 1.68 . . . . 5.3300000000000001 115.48 -172.751 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 mt -83.67 156.13 22.81 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.346 3.451 . . . . 11.66 107.523 177.854 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -111.39 157.8 19.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.028 -3.545 . . . . 16.300000000000001 106.979 -174.971 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -126.85 106.86 9.63 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.923 1.344 . . . . 9.9600000000000009 109.853 -169.696 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -118.88 171.49 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 100.896 -3.742 . . . . 9.7599999999999998 100.896 -166.99 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt . . . . . 0 N--CA 1.43 -1.462 0 O-C-N 116.606 -3.809 . . . . 19.57 101.851 -177.54 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 118.873 -0.585 . . . . 17.170000000000002 111.193 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -96.57 138.76 33.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.001 -2.312 . . . . 21.890000000000001 113.455 170.324 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.8 pt -115.04 154.15 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 127.231 2.212 . . . . 10.83 105.249 165.803 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -113.18 114.31 26.58 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.839 -1.788 . . . . 10.609999999999999 107.17 -176.991 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.8 105.93 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 105.504 -2.036 . . . . 9.1300000000000008 105.504 177.784 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -101.03 152.43 20.6 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.827 -2.657 . . . . 20.550000000000001 103.827 -172.73 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -97.11 172.19 7.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.135 -0.978 . . . . 11.779999999999999 110.803 178.348 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.5 tp -45.72 -57.17 4.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.424 2.009 . . . . 19.309999999999999 116.424 170.191 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.06 -42.78 77.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 131.562 3.945 . . . . 23.140000000000001 111.235 175.13 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.1 55.86 0.47 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 126.811 3.451 . . . . 19.739999999999998 109.653 172.407 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -115.2 135.82 53.76 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.231 -2.334 . . . . 21.93 107.815 175.058 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -106.79 119.5 39.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.214 -3.429 . . . . 12.33 117.102 -164.544 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.2 mt -104.14 102.69 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 119.047 -2.283 . . . . 17.079999999999998 111.283 -172.567 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -84.76 118.27 24.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.967 1.707 . . . . 16.300000000000001 106.812 -176.714 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.415 HD11 HG13 ' A' ' 30' ' ' ILE . 58.3 mt -115.52 131.32 56.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.611 -2.556 . . . . 15.880000000000001 106.952 -173.919 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -100.06 91.04 4.6 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.727 1.751 . . . . 28.899999999999999 115.727 179.824 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.77 163.88 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 128.053 3.787 . . . . 12.050000000000001 112.208 -171.44 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -92.45 157.12 40.78 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.791 -2.443 . . . . 18.170000000000002 106.478 167.799 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.54 -3.61 14.01 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 114.748 -3.343 . . . . 8.1600000000000001 111.39 176.749 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 p -87.59 -7.55 57.36 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 118.732 -2.48 . . . . 11.130000000000001 111.007 175.33 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.74 137.57 54.18 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.147 1.379 . . . . 18.030000000000001 109.531 176.127 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 p -85.28 164.11 18.22 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.341 2.256 . . . . 10.220000000000001 109.136 -173.131 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.605 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 35.8 mm -62.29 -37.83 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 O-C-N 114.669 -5.02 . . . . 12.300000000000001 110.559 178.299 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.27 19.1 tt0 -52.54 -54.05 37.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.49 1.916 . . . . 36.509999999999998 115.421 169.463 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 15.2 t-20 -55.68 -45.76 77.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.422 1.889 . . . . 25.66 112.568 170.889 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.39 -42.95 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.294 1.438 . . . . 8.1199999999999992 112.747 175.16 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -68.41 -33.45 74.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.658 2.481 . . . . 15.470000000000001 108.609 179.8 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.2 -30.75 71.67 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 116.124 1.898 . . . . 11.449999999999999 116.124 178.773 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -70.28 -33.59 71.75 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 117.234 -1.365 . . . . 24.98 112.047 173.454 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.415 HG13 HD11 ' A' ' 15' ' ' LEU . 25.6 mt -71.26 -45.62 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 119.56 1.073 . . . . 9.4600000000000009 112.717 169.372 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.309 36.5 tt0 -44.04 -52.93 6.73 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.79 1.636 . . . . 14.76 115.239 166.617 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -55.7 -39.49 71.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.623 -1.923 . . . . 26.289999999999999 115.123 173.56 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -88.81 -67.74 0.82 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.338 2.018 . . . . 30.059999999999999 114.932 -165.518 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -88.78 -43.49 11.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.35 2.5 . . . . 25.190000000000001 109.552 -168.119 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.24 19.83 3.45 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.032 -1.895 . . . . 7.4100000000000001 110.283 168.424 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.2 mt -90.31 120.19 69.12 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-N 121.616 2.708 . . . . 9.4900000000000002 104.219 -167.501 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 23.3 Cg_endo -81.16 162.66 20.21 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 CA-C-N 123.152 2.161 . . . . 11.42 115.27 -179.88 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 19.4 Cg_endo -84.57 -8.34 9.47 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 N-CA-C 116.286 1.61 . . . . 12.0 116.286 -161.452 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -79.03 -20.88 47.86 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.101 3.137 . . . . 35.549999999999997 114.791 164.972 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -79.71 -37.66 35.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.695 2.188 . . . . 20.52 112.961 -178.306 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -102.61 136.44 42.44 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.961 -4.212 . . . . 7.1299999999999999 110.211 -172.834 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -115.44 148.67 39.12 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.199 1.399 . . . . 36.390000000000001 110.346 164.826 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.9 mt -114.8 125.43 53.68 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.664 -1.607 . . . . 9.5500000000000007 111.578 -178.021 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -103.8 139.14 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 125.931 2.019 . . . . 13.9 106.624 174.241 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -122.17 138.12 54.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.335 -1.793 . . . . 6.8600000000000003 113.482 162.668 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.325 . . 52.26 -99.17 0.08 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.368 1.895 . . . . 11.15 112.955 -174.707 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.13 51.71 0.58 Allowed Glycine 0 N--CA 1.43 -1.748 1 O-C-N 115.468 -4.52 . . . . 13.93 108.484 169.78 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -153.83 165.26 36.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 127.408 2.475 . . . . 23.920000000000002 115.485 177.039 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -91.7 127.97 37.35 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.071 2.948 . . . . 23.23 115.7 -174.47 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.9 mt -90.79 123.9 34.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.025 -2.297 . . . . 9.1099999999999994 114.453 175.099 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -97.93 131.83 44.04 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.801 2.04 . . . . 33.439999999999998 112.818 -171.793 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.605 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 1.9 m-20 -32.36 -50.04 0.22 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.382 3.873 . . . . 28.370000000000001 118.369 176.942 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.98 -12.44 76.89 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 119.133 2.413 . . . . 15.0 119.133 -174.14 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -91.23 167.78 12.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.428 -2.219 . . . . 25.5 111.35 -178.418 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 p -88.13 160.68 17.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 127.313 2.883 . . . . 11.949999999999999 112.301 173.081 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -68.01 -30.7 70.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.999 2.592 . . . . 10.17 117.999 169.031 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 29.4 m -56.19 -41.73 75.99 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 131.02 3.728 . . . . 13.59 110.062 168.352 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.95 -32.49 74.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.303 -2.123 . . . . 11.699999999999999 114.95 -176.347 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -82.8 -31.76 28.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.221 2.608 . . . . 12.949999999999999 109.448 178.7 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.6 m120 74.03 58.96 0.09 Allowed 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 129.216 4.073 . . . . 25.449999999999999 115.498 -166.845 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.7 mt -104.6 135.47 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 117.813 -3.055 . . . . 14.6 106.571 -176.748 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -117.49 -168.28 1.46 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.124 1.37 . . . . 33.229999999999997 113.348 -155.354 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -83.34 134.59 34.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.184 -2.197 . . . . 25.969999999999999 109.947 168.488 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 69.21 38.09 1.97 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.917 2.77 . . . . 32.609999999999999 113.938 -176.781 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 m -98.33 133.71 42.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.034 1.873 . . . . 10.56 107.682 -173.918 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.6 m -95.73 123.47 39.31 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.064 -1.648 . . . . 5.3300000000000001 111.212 -174.236 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.5 132.93 53.68 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 130.637 3.575 . . . . 11.66 108.611 -179.339 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -104.18 105.87 16.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.298 1.863 . . . . 16.300000000000001 112.067 -175.225 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 tt -79.36 120.97 24.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.346 2.658 . . . . 9.9600000000000009 111.39 -179.466 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -126.49 173.73 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.447 3.023 . . . . 9.7599999999999998 104.08 -173.503 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 N--CA 1.43 -1.438 0 O-C-N 118.703 -2.498 . . . . 19.57 110.342 174.291 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 117.505 2.409 . . . . 17.170000000000002 117.505 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -130.41 145.74 51.86 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.589 -0.893 . . . . 21.890000000000001 108.589 174.629 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.8 pt -139.68 162.43 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 117.64 -3.162 . . . . 10.83 107.601 174.523 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -121.09 127.21 51.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.674 -0.861 . . . . 10.609999999999999 108.674 -178.536 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.502 HG11 HD12 ' A' ' 69' ' ' LEU . 60.5 t -96.32 120.33 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 128.181 3.425 . . . . 9.1300000000000008 107.959 170.231 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -125.46 145.27 50.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.524 3.059 . . . . 20.550000000000001 108.743 178.734 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 41.7 p -94.55 -161.53 0.86 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 112.405 -2.18 . . . . 11.779999999999999 113.88 174.941 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.401 ' H ' ' HB ' ' A' ' 7' ' ' THR . 9.6 tt -77.64 -47.58 18.91 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 115.555 -2.164 . . . . 19.309999999999999 109.56 -170.292 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.4 p -71.08 -47.59 57.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.347 2.022 . . . . 23.140000000000001 111.194 175.848 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.54 63.09 0.17 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.505 -2.622 . . . . 19.739999999999998 109.156 176.213 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -91.51 116.26 28.71 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.957 2.903 . . . . 21.93 111.153 167.985 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -88.29 106.82 18.47 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.083 1.765 . . . . 12.33 114.567 -173.389 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 mt -104.99 104.86 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 125.663 1.585 . . . . 17.079999999999998 107.495 -178.435 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -90.88 125.06 35.63 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 114.97 -4.831 . . . . 16.300000000000001 108.701 -172.357 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.266 87.6 mt -127.84 147.64 50.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 120.474 3.509 . . . . 15.880000000000001 120.474 -179.589 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -107.18 117.06 33.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.15 -1.426 . . . . 28.899999999999999 107.15 -166.972 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.72 158.24 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 131.414 3.886 . . . . 12.050000000000001 112.297 -170.944 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -121.11 160.36 45.61 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 114.821 -2.514 . . . . 18.170000000000002 105.773 172.73 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -72.19 -19.85 25.51 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 CA-C-N 128.496 4.07 . . . . 8.1600000000000001 111.195 -159.253 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 m -84.58 3.18 38.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.885 -3.009 . . . . 11.130000000000001 112.561 -177.197 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.88 144.32 41.24 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 117.323 -1.751 . . . . 18.030000000000001 115.225 175.138 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 69.2 p -82.45 159.4 22.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.754 2.692 . . . . 10.220000000000001 113.794 -173.153 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.45 -35.89 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.896 -3.003 . . . . 12.300000000000001 113.103 176.409 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.278 54.9 tt0 -37.72 -65.07 0.35 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.119 2.568 . . . . 36.509999999999998 112.221 160.88 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -57.81 -34.91 70.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.194 2.197 . . . . 25.66 114.521 -177.642 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 t -62.63 -52.94 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.05 2.094 . . . . 8.1199999999999992 110.129 179.664 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -64.31 -30.55 71.6 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.605 3.098 . . . . 15.470000000000001 113.398 -177.287 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.35 -40.28 74.23 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.575 -4.453 . . . . 11.449999999999999 113.949 179.266 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -62.56 -47.93 81.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.181 1.792 . . . . 24.98 111.079 169.516 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.444 ' HB ' HE22 ' A' ' 41' ' ' GLN . 70.9 mt -63.88 -41.55 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 127.011 2.124 . . . . 9.4600000000000009 112.384 -176.094 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -62.33 -56.91 13.86 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.156 -2.215 . . . . 14.76 114.948 168.625 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.67 -40.66 92.63 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 116.274 -4.017 . . . . 26.289999999999999 116.32 -176.027 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -89.25 -64.29 1.16 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.607 -3.808 . . . . 30.059999999999999 110.407 -172.184 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -83.75 -29.6 27.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.848 -3.657 . . . . 25.190000000000001 109.286 -173.302 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.92 46.17 2.12 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 123.367 2.803 . . . . 7.4100000000000001 108.724 159.779 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.2 mt -114.96 113.94 44.0 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.462 -2.051 . . . . 9.4900000000000002 105.462 -176.374 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.98 156.52 34.33 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.111 2.541 . . . . 11.42 112.581 -158.957 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -80.28 -8.49 13.97 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 123.907 3.071 . . . . 12.0 108.984 -161.88 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.341 4.0 p30 -79.39 -25.47 42.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.263 1.506 . . . . 35.549999999999997 109.503 175.889 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -95.06 -38.51 10.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.208 1.48 . . . . 20.52 111.707 -166.946 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.444 HE22 ' HB ' ' A' ' 30' ' ' ILE . 26.4 pt20 -83.57 147.2 27.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.488 -2.007 . . . . 7.1299999999999999 114.038 178.034 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -144.55 145.18 31.69 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 99.998 -4.075 . . . . 36.390000000000001 99.998 166.055 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.97 130.61 55.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.739 -1.226 . . . . 9.5500000000000007 113.696 179.645 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.5 138.86 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 103.264 -2.865 . . . . 13.9 103.264 173.148 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.437 ' HB2' HD11 ' A' ' 50' ' ' LEU . 86.3 t80 -126.53 119.05 26.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.931 -1.486 . . . . 6.8600000000000003 109.099 169.964 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.11 -54.13 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 132.614 4.365 . . . . 11.15 116.108 -163.558 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.99 19.56 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 127.953 2.692 . . . . 13.93 112.08 177.417 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -104.36 146.16 29.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.051 -2.203 . . . . 23.920000000000002 105.051 164.012 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.257 10.8 tt0 -87.45 125.09 34.08 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.281 1.832 . . . . 23.23 111.969 176.241 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 45' ' ' PHE . 64.2 mt -97.08 107.29 19.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.53 2.048 . . . . 9.1099999999999994 116.53 -170.619 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -69.49 141.75 53.87 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.055 2.097 . . . . 33.439999999999998 113.92 -173.904 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -24.34 -75.95 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 1 N-CA-C 123.682 4.697 . . . . 28.370000000000001 123.682 176.251 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.91 28.54 14.01 Favored Glycine 0 N--CA 1.43 -1.737 1 O-C-N 114.817 -4.927 . . . . 15.0 113.003 -157.186 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -107.79 153.79 22.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.015 1.388 . . . . 25.5 113.366 177.566 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -90.39 161.07 15.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 115.504 -2.479 . . . . 11.949999999999999 109.242 -172.21 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.42 -31.45 69.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.996 2.119 . . . . 10.17 113.045 170.311 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.27 8.6 t -55.34 -59.2 5.12 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 131.05 3.74 . . . . 13.59 116.744 167.489 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.8 -33.72 74.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.386 3.106 . . . . 11.699999999999999 119.386 172.531 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -82.77 3.62 28.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.718 -3.114 . . . . 12.949999999999999 114.506 174.577 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 65.84 30.21 10.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.864 3.666 . . . . 25.449999999999999 114.965 172.668 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -91.05 104.88 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.485 -2.634 . . . . 14.6 115.657 -173.517 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -101.6 -178.16 3.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.084 1.897 . . . . 33.229999999999997 112.757 -169.462 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.329 15.1 pttp -54.38 146.92 14.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.893 1.812 . . . . 25.969999999999999 115.893 -172.113 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 39.79 45.57 1.5 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.368 2.267 . . . . 32.609999999999999 116.933 -166.407 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 m -84.05 138.3 33.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.584 3.564 . . . . 10.56 108.051 178.265 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 m -84.46 111.09 19.16 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 110.649 -2.978 . . . . 5.3300000000000001 109.37 176.356 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.401 9.2 mp -94.65 119.73 33.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.166 -3.459 . . . . 11.66 118.467 172.12 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -93.53 99.26 11.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.195 2.902 . . . . 16.300000000000001 105.964 -172.411 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.502 HD12 HG11 ' A' ' 5' ' ' VAL . 7.8 tt -82.65 116.83 22.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.559 -2.564 . . . . 9.9600000000000009 109.929 174.516 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.272 2.7 m -114.89 166.04 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 124.65 2.167 . . . . 9.7599999999999998 112.997 -167.169 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 tp . . . . . 0 N--CA 1.431 -1.425 0 O-C-N 118.018 -2.926 . . . . 19.57 115.156 173.313 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 122.77 1.271 . . . . 17.170000000000002 114.182 . . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -105.78 124.0 48.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.353 3.461 . . . . 21.890000000000001 108.068 -163.333 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.301 13.1 pt -118.18 163.55 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 128.723 2.809 . . . . 10.83 114.606 179.311 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -133.73 117.6 17.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.206 -2.809 . . . . 10.609999999999999 112.274 -164.572 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.78 114.31 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 124.546 2.117 . . . . 9.1300000000000008 106.932 -174.127 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -94.71 136.77 34.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.071 -1.643 . . . . 20.550000000000001 109.112 177.37 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.262 7.8 p -80.24 -169.62 2.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.613 1.965 . . . . 11.779999999999999 112.917 -177.82 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.29 -56.88 4.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.213 1.006 . . . . 19.309999999999999 113.238 166.029 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.3 p -61.45 -62.44 1.82 Allowed 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 115.416 1.636 . . . . 23.140000000000001 115.416 -173.458 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.89 40.66 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 122.935 1.297 . . . . 19.739999999999998 116.152 -170.692 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -118.11 140.72 49.36 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.241 -1.741 . . . . 21.93 112.024 172.069 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.8 m -117.12 115.05 24.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.532 -1.655 . . . . 12.33 106.532 -178.409 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -98.1 126.43 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 124.983 1.427 . . . . 17.079999999999998 109.564 -170.98 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -96.82 135.43 38.8 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.667 -2.521 . . . . 16.300000000000001 105.903 178.474 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.489 HD11 HG13 ' A' ' 30' ' ' ILE . 11.7 mt -125.67 155.77 40.32 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 103.918 -2.623 . . . . 15.880000000000001 103.918 173.706 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -118.62 132.38 56.18 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.853 -1.536 . . . . 28.899999999999999 106.853 167.961 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -148.73 165.03 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 126.322 2.263 . . . . 12.050000000000001 105.336 -162.563 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -117.93 145.37 36.57 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 127.72 2.408 . . . . 18.170000000000002 106.224 173.872 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.5 -24.1 31.24 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 124.944 3.763 . . . . 8.1600000000000001 115.288 -165.562 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -77.91 -0.51 27.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.926 2.641 . . . . 11.130000000000001 117.027 173.326 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -90.55 152.31 20.96 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.675 -1.89 . . . . 18.030000000000001 112.082 177.924 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.9 p -82.22 174.85 10.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.175 2.287 . . . . 10.220000000000001 117.175 -177.992 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mm -69.17 -32.26 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.695 2.798 . . . . 12.300000000000001 103.647 175.962 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.83 -31.19 66.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 124.396 3.271 . . . . 36.509999999999998 119.288 174.557 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -76.62 -30.4 56.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.178 2.191 . . . . 25.66 109.156 179.757 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.496 HG21 HD21 ' A' ' 56' ' ' LEU . 59.8 t -76.46 -38.59 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 115.651 -2.118 . . . . 8.1199999999999992 108.316 177.222 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -60.77 -57.49 12.46 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 125.17 1.543 . . . . 15.470000000000001 110.81 175.564 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.22 -48.02 17.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.984 2.914 . . . . 11.449999999999999 115.089 169.923 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HB3' HD22 ' A' ' 15' ' ' LEU . 38.1 mttt -75.16 -30.28 60.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 121.265 1.848 . . . . 24.98 114.304 -179.27 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.489 HG13 HD11 ' A' ' 15' ' ' LEU . 44.1 mt -55.84 -56.36 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 114.103 1.149 . . . . 9.4600000000000009 114.103 161.209 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -45.49 -45.55 13.26 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.179 2.592 . . . . 14.76 112.11 179.328 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -59.29 -34.95 72.91 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.454 2.761 . . . . 26.289999999999999 118.454 173.233 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -71.93 -72.61 0.22 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.074 1.879 . . . . 30.059999999999999 116.074 166.846 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -87.89 -30.65 19.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 119.877 3.288 . . . . 25.190000000000001 119.877 -176.432 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.66 73.44 0.98 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 123.926 1.848 . . . . 7.4100000000000001 115.1 -173.226 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.507 HD13 HG21 ' A' ' 36' ' ' ILE . 94.3 mt -124.91 127.73 25.04 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-O 112.36 -3.686 . . . . 9.4900000000000002 105.51 178.515 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -63.94 146.94 92.0 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 127.782 3.815 . . . . 11.42 114.98 -166.714 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.29 -20.98 36.33 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 119.718 2.93 . . . . 12.0 119.718 179.058 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -81.3 -30.13 34.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.854 3.216 . . . . 35.549999999999997 113.05 172.999 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -71.97 -47.6 50.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.897 -3.627 . . . . 20.52 113.041 175.396 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -72.54 161.56 30.63 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 116.079 -4.138 . . . . 7.1299999999999999 116.818 -179.808 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -147.22 136.93 22.97 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.136 2.174 . . . . 36.390000000000001 111.988 170.864 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 mt -105.33 122.38 45.83 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 116.333 -1.794 . . . . 9.5500000000000007 114.505 178.822 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mm -93.6 140.74 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 131.607 3.963 . . . . 13.9 111.026 167.753 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -134.71 117.22 15.8 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.118 2.967 . . . . 6.8600000000000003 112.503 167.158 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.84 -105.74 0.23 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.134 2.574 . . . . 11.15 111.531 -159.853 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.81 27.24 5.47 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.838 -1.164 . . . . 13.93 114.65 -172.337 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -153.69 141.87 20.45 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 126.535 3.064 . . . . 23.920000000000002 110.64 -179.706 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.45 165.06 23.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 112.469 -2.151 . . . . 23.23 112.605 172.879 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.363 12.0 mt -110.1 161.78 15.21 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.766 -1.834 . . . . 9.1099999999999994 110.049 -172.665 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -108.47 132.5 53.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.38 2.3 . . . . 33.439999999999998 109.971 179.228 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -45.48 -50.49 12.66 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 122.379 4.214 . . . . 28.370000000000001 122.379 -169.022 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.51 14.52 45.99 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 111.701 -2.5 . . . . 15.0 113.848 -175.664 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -99.37 155.15 17.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 116.902 -1.523 . . . . 25.5 111.747 174.744 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.9 p -87.34 161.46 17.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.129 1.518 . . . . 11.949999999999999 109.63 -177.119 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.496 HD21 HG21 ' A' ' 26' ' ' VAL . 14.7 mt -57.38 -44.38 84.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.961 2.791 . . . . 10.17 112.897 169.592 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -64.76 -15.45 61.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.303 -3.998 . . . . 13.59 115.486 -179.663 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -79.96 -44.7 19.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.57 -2.581 . . . . 11.699999999999999 110.583 179.951 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -85.6 -4.18 59.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.056 1.408 . . . . 12.949999999999999 112.64 174.746 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.435 22.9 m120 82.62 36.32 0.06 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.091 -3.505 . . . . 25.449999999999999 108.97 171.127 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.3 mt -89.44 98.12 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 119.601 -1.937 . . . . 14.6 109.277 -176.482 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -86.68 -172.25 3.92 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 117.341 2.348 . . . . 33.229999999999997 117.341 -171.044 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -73.26 138.74 45.7 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.941 0.877 . . . . 25.969999999999999 112.149 176.697 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 62.86 12.51 5.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.801 -2.437 . . . . 32.609999999999999 116.793 -171.977 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m -78.04 134.88 37.7 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 119.8 3.259 . . . . 10.56 119.8 169.019 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -87.16 123.84 32.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.676 1.58 . . . . 5.3300000000000001 109.549 -177.061 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -93.49 163.36 13.6 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.339 -2.1 . . . . 11.66 114.518 153.755 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -123.62 119.23 29.25 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.778 -1.556 . . . . 16.300000000000001 114.556 177.583 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.82 128.97 35.66 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 117.956 -1.021 . . . . 9.9600000000000009 111.373 177.517 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 m -127.43 -167.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 127.648 3.092 . . . . 9.7599999999999998 107.281 179.707 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 tp . . . . . 0 N--CA 1.43 -1.475 0 N-CA-C 105.744 -1.947 . . . . 19.57 105.744 -172.665 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttm . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 107.315 -1.365 . . . . 17.170000000000002 107.315 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -100.19 161.17 13.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.891 -3.63 . . . . 21.890000000000001 111.506 169.734 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 65' ' ' SER . 12.4 pt -152.96 157.7 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 129.083 2.953 . . . . 10.83 110.401 172.587 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.29 108.46 16.59 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 114.917 -4.864 . . . . 10.609999999999999 113.148 -172.557 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.3 t -103.13 114.59 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.596 -2.565 . . . . 9.1300000000000008 109.705 -176.667 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -98.06 146.02 25.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.625 1.678 . . . . 20.550000000000001 114.163 -173.863 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.311 81.4 p -86.56 -176.84 5.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.75 1.262 . . . . 11.779999999999999 109.41 172.678 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.4 tp -68.32 -62.37 1.43 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.692 2.797 . . . . 19.309999999999999 110.49 168.114 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -60.79 -68.77 0.27 Allowed 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.857 -3.652 . . . . 23.140000000000001 119.409 176.418 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.4 46.28 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 O-C-N 116.549 -3.844 . . . . 19.739999999999998 109.611 -173.552 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -118.88 141.15 48.91 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.673 -0.898 . . . . 21.93 110.415 157.95 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -110.41 124.9 52.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.612 -1.625 . . . . 12.33 106.612 169.077 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mt -84.39 108.6 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 128.437 2.695 . . . . 17.079999999999998 107.994 169.188 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.4 m -96.64 97.94 9.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.128 -2.858 . . . . 16.300000000000001 111.95 -176.405 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.18 147.18 25.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.149 -2.844 . . . . 15.880000000000001 112.053 -169.125 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -111.16 133.05 53.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.485 1.612 . . . . 28.899999999999999 111.992 162.07 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.04 158.08 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 2 CA-C-N 107.04 -4.618 . . . . 12.050000000000001 111.592 -167.441 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -95.71 160.86 29.37 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 123.925 0.766 . . . . 18.170000000000002 112.035 159.145 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -87.85 -2.35 7.29 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 124.498 2.642 . . . . 8.1600000000000001 108.689 -175.561 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -81.8 -18.38 44.24 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.396 3.078 . . . . 11.130000000000001 111.709 170.208 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.24 153.08 34.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.019 1.489 . . . . 18.030000000000001 115.019 177.327 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.7 p -89.69 172.76 8.71 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.532 1.133 . . . . 10.220000000000001 110.468 -173.967 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -70.24 -24.32 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 118.526 -1.27 . . . . 12.300000000000001 111.597 171.26 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.53 -39.7 85.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.76 1.267 . . . . 36.509999999999998 113.414 171.336 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -65.53 -37.28 86.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.359 -3.963 . . . . 25.66 114.035 167.735 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 22' ' ' THR . 79.0 t -73.85 -34.18 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 122.716 2.507 . . . . 8.1199999999999992 108.746 -171.679 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -67.88 -41.26 83.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.147 3.779 . . . . 15.470000000000001 108.557 172.837 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.54 -33.52 66.9 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.713 2.405 . . . . 11.449999999999999 112.403 -177.666 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -61.97 -33.73 74.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.715 -3.116 . . . . 24.98 114.597 166.887 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.4 mt -73.0 -41.69 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 117.034 -1.46 . . . . 9.4600000000000009 110.333 173.157 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -56.98 -42.12 79.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.606 2.362 . . . . 14.76 113.797 178.407 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.01 -43.46 82.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 112.974 -3.393 . . . . 26.289999999999999 110.825 179.806 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -100.79 -43.13 6.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 124.395 3.27 . . . . 30.059999999999999 118.33 -173.209 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -91.75 -38.06 12.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 123.461 0.705 . . . . 25.190000000000001 109.429 -175.977 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.27 21.84 9.12 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 120.373 -1.454 . . . . 7.4100000000000001 114.61 170.847 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -91.73 122.44 65.53 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 113.392 -3.194 . . . . 9.4900000000000002 109.263 -175.718 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.87 147.72 85.45 Favored 'Trans proline' 0 N--CA 1.434 -2.014 1 CA-C-N 129.786 4.531 . . . . 11.42 114.501 -179.972 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -79.58 -8.42 14.8 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 122.395 2.063 . . . . 12.0 112.792 -162.61 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -83.84 -34.65 24.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.999 -3.563 . . . . 35.549999999999997 109.065 179.045 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -83.87 -28.41 28.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 131.072 3.749 . . . . 20.52 112.04 -167.696 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -92.05 155.5 18.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.584 2.611 . . . . 7.1299999999999999 112.793 166.3 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -142.16 142.45 32.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.052 -2.28 . . . . 36.390000000000001 109.998 167.708 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.5 mt -101.1 111.14 23.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 116.561 2.06 . . . . 9.5500000000000007 116.561 176.904 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.7 mm -95.71 132.1 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 126.432 2.332 . . . . 13.9 111.705 172.148 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -111.86 123.0 49.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.818 2.723 . . . . 6.8600000000000003 105.949 169.677 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.451 . . 59.61 -99.36 0.09 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 116.255 -1.831 . . . . 11.15 115.66 -170.338 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.98 18.39 4.5 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 106.426 -2.669 . . . . 13.93 106.426 179.67 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -124.21 130.42 52.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.236 2.214 . . . . 23.920000000000002 110.301 -173.636 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -91.3 125.72 36.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.342 -2.096 . . . . 23.23 105.342 -169.977 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.533 HD22 ' CD2' ' A' ' 59' ' ' TYR . 92.9 mt -86.28 148.5 25.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.095 0.958 . . . . 9.1099999999999994 112.275 -179.296 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -123.42 148.76 45.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.182 -2.824 . . . . 33.439999999999998 116.87 -171.171 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -19.15 -76.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 133.491 4.716 . . . . 28.370000000000001 121.387 178.691 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.49 16.22 61.19 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 117.458 1.743 . . . . 15.0 117.458 -168.474 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -99.11 160.99 13.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.955 -2.497 . . . . 25.5 110.32 167.351 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -103.76 168.26 9.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 104.792 -2.299 . . . . 11.949999999999999 104.792 -178.829 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -55.88 -36.59 67.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.617 -2.083 . . . . 10.17 115.994 167.768 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 t -61.63 -43.69 98.38 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.123 -2.861 . . . . 13.59 117.114 167.35 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -64.64 -26.64 68.48 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.095 1.887 . . . . 11.699999999999999 116.095 -177.182 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.533 ' CD2' HD22 ' A' ' 50' ' ' LEU . 66.9 m-85 -83.94 -32.34 25.12 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 116.912 -3.618 . . . . 12.949999999999999 111.043 170.717 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.301 26.2 m120 96.25 51.83 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.98 2.112 . . . . 25.449999999999999 114.379 -175.271 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.78 125.63 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 125.067 1.48 . . . . 14.6 113.96 177.837 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -110.03 177.27 4.76 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.972 1.841 . . . . 33.229999999999997 115.972 -176.957 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -60.41 145.75 46.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 124.404 3.275 . . . . 25.969999999999999 119.066 -174.54 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 67.74 32.19 5.52 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 132.129 4.171 . . . . 32.609999999999999 111.466 178.558 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.468 ' H ' HG22 ' A' ' 3' ' ' ILE . 22.7 t -89.35 151.7 21.93 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.685 -3.134 . . . . 10.56 110.145 -174.95 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -92.2 120.81 33.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.88 2.072 . . . . 5.3300000000000001 112.584 -172.32 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -117.77 159.99 22.11 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.222 2.915 . . . . 11.66 105.582 172.758 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -116.99 117.51 29.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.45 -3.281 . . . . 16.300000000000001 113.577 177.503 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -91.72 116.46 28.9 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.168 -1.583 . . . . 9.9600000000000009 111.191 174.487 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.6 m -112.27 134.15 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 127.819 2.448 . . . . 9.7599999999999998 106.193 178.551 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.43 -1.46 0 CA-C-O 124.309 2.004 . . . . 19.57 106.481 -175.783 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 117.454 2.39 . . . . 17.170000000000002 117.454 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -90.36 133.49 34.95 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.07 -4.769 . . . . 21.890000000000001 106.708 -179.462 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.8 pt -118.04 164.89 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 104.456 -2.424 . . . . 10.83 104.456 163.369 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -119.29 127.29 53.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.885 -2.416 . . . . 10.609999999999999 105.038 -174.561 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.5 139.13 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.159 -2.534 . . . . 9.1300000000000008 104.159 176.202 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -125.23 133.63 52.64 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.325 -3.36 . . . . 20.550000000000001 116.029 178.742 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.2 p -77.98 171.79 14.47 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 127.128 3.347 . . . . 11.779999999999999 111.277 175.558 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -79.35 -24.05 42.98 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.514 -2.13 . . . . 19.309999999999999 110.95 -172.993 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -77.21 -69.16 0.55 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.902 1.334 . . . . 23.140000000000001 108.338 170.181 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.23 66.19 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 O-C-N 119.143 -2.223 . . . . 19.739999999999998 112.018 169.303 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -99.76 134.26 42.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.54 1.536 . . . . 21.93 114.041 155.686 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.7 m -80.06 119.91 23.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.357 -1.464 . . . . 12.33 113.124 164.597 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.49 95.67 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 128.519 2.727 . . . . 17.079999999999998 107.53 -171.844 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.0 m -89.82 99.23 12.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.206 -1.035 . . . . 16.300000000000001 108.206 -165.137 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.295 47.0 mt -104.49 149.12 25.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.602 -3.186 . . . . 15.880000000000001 110.653 -170.788 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -108.0 123.33 48.49 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 121.66 2.027 . . . . 28.899999999999999 113.664 173.356 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -135.27 162.53 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.582 -1.948 . . . . 12.050000000000001 107.262 -164.839 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -101.69 165.31 14.24 Favored Pre-proline 0 N--CA 1.429 -1.486 0 O-C-N 118.421 -2.674 . . . . 18.170000000000002 108.334 165.299 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -64.06 -23.71 67.13 Favored 'Trans proline' 0 C--N 1.3 -2.012 2 C-N-CA 125.721 4.281 . . . . 8.1600000000000001 112.597 174.053 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 m -87.68 3.15 48.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.987 -1.695 . . . . 11.130000000000001 109.907 -174.627 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -88.89 148.02 24.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.331 1.062 . . . . 18.030000000000001 109.286 -178.286 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 p -91.76 169.47 10.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.01 -1.904 . . . . 10.220000000000001 110.048 -175.828 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -46.65 -49.83 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.972 2.509 . . . . 12.300000000000001 114.46 160.513 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.301 23.8 tt0 -42.53 -43.21 3.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 117.03 2.233 . . . . 36.509999999999998 117.03 165.577 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -69.22 -30.32 68.46 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.402 1.91 . . . . 25.66 112.637 172.78 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.1 -56.2 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.568 -3.833 . . . . 8.1199999999999992 113.585 175.909 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -49.15 -46.13 44.75 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 130.439 3.496 . . . . 15.470000000000001 112.292 171.592 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.8 -36.95 76.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.339 -3.35 . . . . 11.449999999999999 114.828 -178.419 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -68.63 -33.8 74.64 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.986 1.476 . . . . 24.98 114.986 173.507 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.5 mt -70.39 -42.77 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.662 -4.399 . . . . 9.4600000000000009 111.167 175.528 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -55.75 -43.24 76.47 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.97 -1.706 . . . . 14.76 110.001 170.358 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.263 21.5 t70 -48.95 -67.31 0.28 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.075 3.35 . . . . 26.289999999999999 114.683 177.751 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -93.99 -46.66 7.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.061 2.986 . . . . 30.059999999999999 119.061 178.847 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.98 -33.08 70.08 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 116.283 -1.818 . . . . 25.190000000000001 111.294 -171.591 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.74 18.68 46.99 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 116.446 -2.308 . . . . 7.4100000000000001 115.213 -179.164 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.43 HG22 HE21 ' A' ' 41' ' ' GLN . 21.4 mt -99.71 121.38 54.69 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 119.737 1.768 . . . . 9.4900000000000002 108.879 175.158 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -68.36 157.07 63.38 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 122.982 2.455 . . . . 11.42 117.958 178.328 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.02 -28.53 10.97 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 122.417 2.078 . . . . 12.0 111.675 -170.083 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.64 -31.43 68.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 126.108 2.13 . . . . 35.549999999999997 110.427 173.41 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -72.64 -15.95 61.71 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.363 -2.711 . . . . 20.52 115.413 -175.488 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.43 HE21 HG22 ' A' ' 36' ' ' ILE . 6.2 pt20 -118.15 161.08 20.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.695 2.497 . . . . 7.1299999999999999 112.563 -168.999 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -138.09 133.66 33.74 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.772 -1.566 . . . . 36.390000000000001 106.772 164.223 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.29 129.72 43.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.932 -2.355 . . . . 9.5500000000000007 107.306 178.666 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.7 mm -116.04 133.58 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.366 -1.459 . . . . 13.9 109.898 -178.579 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -114.26 115.31 27.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.088 -3.508 . . . . 6.8600000000000003 108.143 165.032 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.25 -83.46 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.273 2.323 . . . . 11.15 117.273 -176.385 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.25 -36.7 5.6 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 116.981 -3.574 . . . . 13.93 111.444 -178.328 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -105.42 148.49 27.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.62 1.341 . . . . 23.920000000000002 114.62 -162.599 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 49' ' ' GLN . 23.4 pt20 -92.95 131.15 38.21 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.126 -4.734 . . . . 23.23 108.592 173.403 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.9 mt -74.25 143.3 45.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.531 1.678 . . . . 9.1099999999999994 115.531 -176.584 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.56 133.49 55.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.231 -1.543 . . . . 33.439999999999998 108.043 -168.739 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -30.72 -53.58 0.19 Allowed 'General case' 0 N--CA 1.429 -1.476 1 N-CA-C 124.261 4.912 . . . . 28.370000000000001 124.261 -173.014 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.98 17.41 44.94 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 121.305 1.866 . . . . 15.0 116.23 -160.443 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -115.71 145.15 43.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.869 -2.491 . . . . 25.5 113.449 -173.341 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.352 5.8 p -82.5 165.91 19.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 122.486 2.403 . . . . 11.949999999999999 114.354 -171.855 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.6 mt -78.14 -22.11 49.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.158 -2.214 . . . . 10.17 112.69 177.947 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.267 3.7 t -70.31 -37.84 74.83 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 127.937 3.732 . . . . 13.59 114.983 175.32 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -55.97 -43.78 77.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.891 2.876 . . . . 11.699999999999999 111.205 164.605 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -86.62 -3.22 59.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.484 1.661 . . . . 12.949999999999999 115.484 -176.736 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 m120 54.96 51.61 13.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.529 2.732 . . . . 25.449999999999999 112.12 -178.298 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.6 mt -103.28 116.6 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 116.92 -3.612 . . . . 14.6 106.566 173.223 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -94.44 -160.32 0.77 Allowed 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.581 -2.574 . . . . 33.229999999999997 109.214 178.944 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -83.11 161.61 21.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.12 -1.067 . . . . 25.969999999999999 108.12 -173.143 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.357 27.9 mt-10 55.42 28.65 11.89 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.752 2.421 . . . . 32.609999999999999 112.97 178.336 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.1 t -87.93 154.6 20.38 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.662 1.985 . . . . 10.56 113.191 172.27 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.306 1.3 m -121.45 90.34 3.3 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 125.481 1.738 . . . . 5.3300000000000001 113.603 -160.342 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -92.53 150.78 20.54 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.815 2.245 . . . . 11.66 107.604 176.65 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -116.67 139.31 50.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.001 2.81 . . . . 16.300000000000001 108.271 -176.964 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.25 113.87 27.32 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.301 -2.227 . . . . 9.9600000000000009 113.373 170.449 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 m -110.14 171.44 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 113.086 -1.87 . . . . 9.7599999999999998 106.443 175.194 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt . . . . . 0 N--CA 1.43 -1.433 0 O-C-N 119.393 -2.067 . . . . 19.57 112.431 172.227 . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 105.93 -1.878 . . . . 17.170000000000002 105.93 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -108.46 158.8 17.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.041 -2.577 . . . . 21.890000000000001 104.041 168.088 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -125.78 172.04 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.097 2.959 . . . . 10.83 105.511 171.585 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -123.9 146.78 48.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.71 -1.869 . . . . 10.609999999999999 109.808 167.906 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.3 125.88 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.587 1.955 . . . . 9.1300000000000008 106.153 175.71 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -105.67 140.66 38.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.187 1.47 . . . . 20.550000000000001 107.326 177.51 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -81.89 -164.07 0.75 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.034 2.35 . . . . 11.779999999999999 112.429 172.364 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.3 tp -82.93 -48.47 10.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.364 -3.335 . . . . 19.309999999999999 114.613 177.121 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.7 p -65.86 -40.94 92.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.325 -1.484 . . . . 23.140000000000001 113.288 171.033 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.07 62.57 0.26 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 117.768 1.867 . . . . 19.739999999999998 117.768 175.41 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -112.48 145.97 39.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.096 -1.816 . . . . 21.93 106.096 167.495 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.2 m -112.73 106.62 15.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 101.908 -3.367 . . . . 12.33 101.908 -166.315 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.8 mt -92.1 117.62 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 101.186 -3.635 . . . . 17.079999999999998 101.186 -172.317 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.9 m -94.05 130.11 40.33 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 116.795 -1.962 . . . . 16.300000000000001 109.976 174.628 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -129.9 142.63 50.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 124.649 1.218 . . . . 15.880000000000001 111.058 178.301 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -97.1 128.25 43.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.4 -2.687 . . . . 28.899999999999999 114.811 179.673 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.481 HG21 HD13 ' A' ' 56' ' ' LEU 0.263 6.9 m -149.22 176.85 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.123 -1.611 . . . . 12.050000000000001 111.424 -174.068 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -110.74 179.64 0.78 Allowed Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.845 1.202 . . . . 18.170000000000002 111.663 168.123 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -71.2 -22.56 25.55 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-N 123.274 2.205 . . . . 8.1600000000000001 109.019 173.886 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 m -95.36 1.75 54.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.04 1.4 . . . . 11.130000000000001 110.534 -165.052 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.19 139.6 31.55 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.227 -4.671 . . . . 18.030000000000001 108.705 -176.419 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 79.6 p -76.4 166.58 23.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.129 1.159 . . . . 10.220000000000001 114.129 173.021 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.1 mm -70.5 -18.86 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 119.345 -0.942 . . . . 12.300000000000001 108.785 -179.127 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -69.54 -31.16 69.19 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.39 -2.694 . . . . 36.509999999999998 115.245 172.635 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -66.1 -42.13 89.7 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.788 2.835 . . . . 25.66 109.461 167.676 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.63 -51.2 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 125.546 1.779 . . . . 8.1199999999999992 110.835 176.237 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.63 -19.97 64.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.789 1.774 . . . . 15.470000000000001 115.789 -174.697 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.78 -27.54 66.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.48 1.912 . . . . 11.449999999999999 114.764 172.488 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -93.4 -20.52 20.26 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.321 -1.733 . . . . 24.98 106.321 -176.269 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 30' ' ' ILE . 75.3 mt -75.12 -44.43 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 119.927 -1.733 . . . . 9.4600000000000009 113.557 167.307 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -56.91 -30.6 64.1 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.253 -2.78 . . . . 14.76 114.428 167.31 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.4 -52.88 14.05 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.627 -4.421 . . . . 26.289999999999999 108.523 178.53 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -66.13 -59.76 3.46 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.519 2.415 . . . . 30.059999999999999 117.519 172.23 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -97.53 -11.97 23.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 119.142 3.016 . . . . 25.190000000000001 119.142 -169.215 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.87 27.05 65.45 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 118.198 -2.814 . . . . 7.4100000000000001 115.489 -176.442 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.483 HG22 HE21 ' A' ' 41' ' ' GLN . 44.2 mt -103.23 109.38 61.55 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 108.207 -1.035 . . . . 9.4900000000000002 108.207 -174.613 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -76.73 166.79 26.52 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.669 1.989 . . . . 11.42 116.14 -167.253 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.02 -20.86 16.41 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 123.126 2.152 . . . . 12.0 114.77 -156.277 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -83.61 -17.49 41.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.817 3.198 . . . . 35.549999999999997 114.795 178.686 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.423 ' HG2' HD22 ' A' ' 71' ' ' LEU . 49.4 tt0 -79.1 -31.72 44.37 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.844 2.59 . . . . 20.52 105.39 -179.53 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.483 HE21 HG22 ' A' ' 36' ' ' ILE . 3.9 pt20 -111.41 176.01 5.19 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.589 1.995 . . . . 7.1299999999999999 115.285 -170.426 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.7 mtp180 -131.8 146.09 51.94 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 113.02 -3.371 . . . . 36.390000000000001 109.649 169.887 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 43' ' ' LEU . 8.1 mt -109.16 134.5 51.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.723 1.889 . . . . 9.5500000000000007 106.649 172.449 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mm -121.23 143.17 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.697 -2.705 . . . . 13.9 103.697 -169.576 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -130.31 100.79 5.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.491 2.716 . . . . 6.8600000000000003 113.519 163.748 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.52 -107.28 0.19 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.997 1.719 . . . . 11.15 110.768 -165.708 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.29 -20.96 10.38 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-O 115.958 -2.579 . . . . 13.93 111.042 177.044 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -77.54 122.1 24.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.31 3.433 . . . . 23.920000000000002 104.772 -170.293 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -89.02 138.22 31.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.629 -3.169 . . . . 23.23 107.004 178.605 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.7 mt -106.03 127.68 53.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.112 -3.492 . . . . 9.1099999999999994 112.673 -161.236 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -77.37 146.14 36.84 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.187 2.595 . . . . 33.439999999999998 105.74 -175.111 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -65.74 -45.51 82.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.302 -2.124 . . . . 28.370000000000001 112.684 -171.667 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.82 41.85 2.98 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 117.496 -1.724 . . . . 15.0 114.354 177.883 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -124.75 157.5 35.56 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 119.884 1.842 . . . . 25.5 108.584 168.315 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 44.0 p -91.16 164.16 14.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.028 -3.545 . . . . 11.949999999999999 117.085 -177.204 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.481 HD13 HG21 ' A' ' 17' ' ' VAL . 24.9 mt -54.36 -43.57 71.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.505 -1.68 . . . . 10.17 112.677 163.77 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -55.39 -42.29 73.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.286 -3.384 . . . . 13.59 118.271 167.596 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -56.97 -39.28 74.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.865 -1.772 . . . . 11.699999999999999 113.712 179.237 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -83.65 -13.58 53.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.599 1.333 . . . . 12.949999999999999 114.599 175.446 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.55 52.34 4.64 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.084 1.883 . . . . 25.449999999999999 116.084 -167.384 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.296 11.8 mt -87.64 123.78 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 102.276 -3.231 . . . . 14.6 102.276 176.733 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.273 23.1 mt-30 -100.92 179.76 4.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.621 -1.924 . . . . 33.229999999999997 114.709 179.427 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -64.3 147.17 53.09 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.585 -2.572 . . . . 25.969999999999999 110.691 -174.097 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 48.76 37.51 9.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.156 2.583 . . . . 32.609999999999999 116.883 179.899 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 t -108.19 151.36 26.03 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.487 1.915 . . . . 10.56 108.621 -169.366 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.324 41.1 p -102.23 115.52 30.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.642 -2.536 . . . . 5.3300000000000001 111.099 -165.587 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.51 149.52 21.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.419 3.088 . . . . 11.66 103.429 172.39 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -114.6 130.8 56.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.695 -1.253 . . . . 16.300000000000001 108.94 178.366 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tt -105.18 120.93 42.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.004 1.722 . . . . 9.9600000000000009 110.249 -178.437 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 147.53 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 101.74 -3.43 . . . . 9.7599999999999998 101.74 -177.212 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.423 HD22 ' HG2' ' A' ' 40' ' ' GLN . 16.5 mt . . . . . 0 N--CA 1.43 -1.432 0 CA-C-O 123.87 1.795 . . . . 19.57 109.101 177.892 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttp . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 124.829 2.252 . . . . 17.170000000000002 113.606 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -89.46 126.28 35.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 126.29 2.948 . . . . 21.890000000000001 111.897 178.834 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -128.31 147.22 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 116.83 -3.669 . . . . 10.83 109.199 176.364 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 53.0 m-85 -100.79 137.86 38.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.34 3.856 . . . . 10.609999999999999 105.87 175.669 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.45 110.46 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 117.076 -1.44 . . . . 9.1300000000000008 111.106 170.743 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -93.61 143.22 26.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 116.813 -1.565 . . . . 20.550000000000001 111.122 -176.167 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.526 HG22 HD23 ' A' ' 69' ' ' LEU . 42.6 p -96.53 174.16 6.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.807 1.64 . . . . 11.779999999999999 107.1 -175.488 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.84 -51.3 70.32 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.744 -2.472 . . . . 19.309999999999999 114.617 177.582 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.1 p -67.32 -40.25 85.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.584 1.953 . . . . 23.140000000000001 115.841 172.351 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.15 59.89 0.3 Allowed Glycine 0 N--CA 1.43 -1.748 0 O-C-N 127.309 2.88 . . . . 19.739999999999998 114.315 151.449 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -95.17 126.27 40.38 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 115.625 -2.131 . . . . 21.93 108.638 163.667 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.7 m -95.8 113.22 24.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 116.916 -1.914 . . . . 12.33 107.025 179.271 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.1 pt -91.59 141.29 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.997 1.719 . . . . 17.079999999999998 107.374 178.276 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.1 m -107.3 124.97 50.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.749 -1.22 . . . . 16.300000000000001 111.529 178.821 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.25 141.87 51.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.725 -2.484 . . . . 15.880000000000001 106.445 177.876 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -108.47 107.76 18.42 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.885 2.474 . . . . 28.899999999999999 107.172 179.246 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.87 -177.52 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.733 -2.321 . . . . 12.050000000000001 104.733 -173.006 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -104.96 159.2 30.15 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 129.759 3.224 . . . . 18.170000000000002 108.475 170.49 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -81.04 -10.11 12.71 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 123.409 2.74 . . . . 8.1600000000000001 110.989 -172.051 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -94.68 2.2 55.57 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.227 2.829 . . . . 11.130000000000001 111.965 175.685 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -75.83 161.61 28.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 123.749 2.977 . . . . 18.030000000000001 111.945 178.415 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.6 p -87.31 164.64 16.16 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.398 -2.689 . . . . 10.220000000000001 116.633 179.479 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.15 -39.6 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 120.194 1.361 . . . . 12.300000000000001 109.005 174.473 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -53.43 -45.08 69.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.429 -2.045 . . . . 36.509999999999998 111.684 174.304 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -58.31 -42.64 87.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.863 2.542 . . . . 25.66 117.863 170.489 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.8 -54.22 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.301 -2.75 . . . . 8.1199999999999992 109.011 171.434 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HA ' HD12 ' A' ' 30' ' ' ILE . 34.7 mtmt -58.87 -28.18 65.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 116.768 -3.707 . . . . 15.470000000000001 118.449 -177.153 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.16 94.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.498 2.719 . . . . 11.449999999999999 113.471 168.211 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -71.43 -39.34 71.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.526 -2.609 . . . . 24.98 111.661 -178.663 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 27' ' ' LYS . 21.3 mt -60.52 -36.87 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.228 2.611 . . . . 9.4600000000000009 109.1 173.771 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -66.85 -52.08 47.84 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.923 1.344 . . . . 14.76 113.432 175.882 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -50.53 -45.31 56.69 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.932 -2.98 . . . . 26.289999999999999 115.889 170.177 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -79.95 -51.61 8.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.777 -3.077 . . . . 30.059999999999999 115.404 -165.891 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -102.02 -30.9 10.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.428 1.091 . . . . 25.190000000000001 110.673 -175.107 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.55 34.08 5.92 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 127.977 2.703 . . . . 7.4100000000000001 110.182 164.805 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.0 mt -91.64 125.15 58.59 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 127.194 2.197 . . . . 9.4900000000000002 106.021 -174.809 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.65 171.57 4.43 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 126.233 3.262 . . . . 11.42 115.511 -179.234 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -76.41 -27.17 8.04 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 124.209 3.273 . . . . 12.0 114.059 -173.678 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -81.6 -20.32 40.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.951 -3.593 . . . . 35.549999999999997 114.618 -173.504 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -86.0 -45.93 11.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.505 1.922 . . . . 20.52 110.613 179.913 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -51.23 113.32 0.91 Allowed 'General case' 0 N--CA 1.43 -1.452 1 N-CA-C 123.674 4.694 . . . . 7.1299999999999999 123.674 163.153 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -117.0 119.58 35.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.562 -2.586 . . . . 36.390000000000001 109.198 157.494 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.38 128.34 39.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.196 -2.275 . . . . 9.5500000000000007 109.565 -177.441 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 44' ' ' ILE 0.29 23.8 mm -118.58 148.99 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.942 2.897 . . . . 13.9 105.637 -177.684 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.401 ' HB3' ' H ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -85.19 -83.58 0.16 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.1 0.864 . . . . 6.8600000000000003 112.459 177.252 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 45' ' ' PHE . . . -98.93 -71.16 0.7 Allowed 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 106.651 -1.611 . . . . 11.15 106.651 166.668 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.2 -4.52 5.45 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 119.983 2.753 . . . . 13.93 119.983 172.652 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -101.69 160.18 14.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 112.485 -1.858 . . . . 23.920000000000002 115.435 171.918 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -87.66 170.77 10.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.828 -2.42 . . . . 23.23 115.999 -171.269 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.3 mt -131.23 105.81 7.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.995 1.379 . . . . 9.1099999999999994 108.683 176.086 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -72.76 140.51 47.81 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 121.711 3.967 . . . . 33.439999999999998 121.711 166.153 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -36.93 -66.3 0.24 Allowed 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 135.199 5.4 . . . . 28.370000000000001 119.958 -170.462 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.88 13.25 9.08 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 129.841 3.591 . . . . 15.0 116.857 -165.458 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -117.61 141.95 47.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.33 1.452 . . . . 25.5 111.989 -168.064 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.0 p -87.22 161.51 17.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.643 2.639 . . . . 11.949999999999999 111.03 -179.937 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 61' ' ' ILE . 1.1 mt -49.09 -50.52 36.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.923 3.289 . . . . 10.17 113.565 176.126 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 t -50.58 -48.71 57.55 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 129.544 4.277 . . . . 13.59 115.585 172.416 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -61.06 -38.56 86.63 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.514 1.926 . . . . 11.699999999999999 112.219 177.276 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -85.8 -2.04 57.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.92 2.563 . . . . 12.949999999999999 117.92 171.483 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m120 65.82 48.47 1.86 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 127.278 2.861 . . . . 25.449999999999999 113.055 176.31 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 56' ' ' LEU . 82.4 mt -94.57 108.0 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.942 3.297 . . . . 14.6 103.555 177.133 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -101.6 176.88 5.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.069 2.366 . . . . 33.229999999999997 110.871 177.568 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -60.61 146.18 46.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.713 -3.117 . . . . 25.969999999999999 117.124 -173.18 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.306 35.5 mt-10 71.94 -1.26 2.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 127.025 2.703 . . . . 32.609999999999999 117.25 174.09 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.316 56.0 m -48.39 138.56 9.95 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.37 2.668 . . . . 10.56 116.833 162.549 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.479 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 24.4 m -103.13 124.96 49.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.124 -1.61 . . . . 5.3300000000000001 111.007 167.253 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.73 169.28 8.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.858 -2.645 . . . . 11.66 103.858 -177.955 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -139.37 132.44 29.58 Favored 'General case' 0 N--CA 1.43 -1.444 1 CA-C-O 130.053 4.74 . . . . 16.300000000000001 113.324 -169.868 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.526 HD23 HG22 ' A' ' 7' ' ' THR . 34.8 tp -115.81 107.74 15.43 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.387 -2.696 . . . . 9.9600000000000009 107.385 -168.187 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.6 172.09 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 2 C-N-CA 132.415 4.286 . . . . 9.7599999999999998 112.012 -171.011 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 N--CA 1.429 -1.481 0 CA-C-O 123.016 1.388 . . . . 19.57 112.463 -178.73 . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 CA--C 1.49 -1.346 0 CA-C-O 125.05 2.357 . . . . 17.170000000000002 110.327 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -92.13 150.84 20.71 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.566 -2.753 . . . . 21.890000000000001 103.566 -177.821 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -127.37 155.32 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.797 1.239 . . . . 10.83 109.848 159.736 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -105.82 158.05 17.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.649 -1.282 . . . . 10.609999999999999 109.174 174.649 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -148.32 120.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 N-CA-C 99.302 -4.333 . . . . 9.1300000000000008 99.302 -178.213 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -108.82 121.78 45.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.41 2.284 . . . . 20.550000000000001 116.978 -178.512 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -73.21 -178.41 2.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.222 1.963 . . . . 11.779999999999999 113.68 -169.074 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.257 15.1 tp -51.88 -57.04 10.54 Favored 'General case' 0 N--CA 1.431 -1.401 1 C-N-CA 134.109 4.964 . . . . 19.309999999999999 108.942 178.356 . . . . . . . . 3 2 . 1 . 074 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -73.28 -54.11 9.19 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.44 -4.537 . . . . 23.140000000000001 112.444 175.595 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.11 45.61 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 114.245 -3.531 . . . . 19.739999999999998 113.104 177.983 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -96.01 100.54 12.2 Favored 'General case' 0 N--CA 1.43 -1.472 2 C-N-CA 132.072 4.149 . . . . 21.93 103.536 178.097 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -82.87 102.21 11.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.7 2.0 . . . . 12.33 106.186 -177.975 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.255 3.5 pt -90.28 170.09 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 128.492 2.717 . . . . 17.079999999999998 106.327 178.584 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 m -121.53 149.91 42.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.085 3.354 . . . . 16.300000000000001 105.981 177.061 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.7 mt -143.38 145.09 32.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.013 -2.304 . . . . 15.880000000000001 105.18 171.954 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -106.11 104.84 14.64 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.142 1.925 . . . . 28.899999999999999 111.723 -177.936 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.251 20.9 m -120.38 128.67 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.171 -1.58 . . . . 12.050000000000001 114.57 -162.041 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -88.62 134.93 33.07 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 104.515 -2.402 . . . . 18.170000000000002 104.515 171.89 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.87 -0.52 10.01 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 120.864 1.344 . . . . 8.1600000000000001 114.241 -171.087 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 m -70.07 -26.36 63.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.252 3.056 . . . . 11.130000000000001 119.252 169.308 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -81.79 176.36 9.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.761 1.393 . . . . 18.030000000000001 114.761 179.347 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -76.38 157.14 32.63 Favored 'General case' 0 N--CA 1.43 -1.455 1 N-CA-C 123.324 4.564 . . . . 10.220000000000001 123.324 173.371 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -73.66 -28.08 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 117.746 -3.096 . . . . 12.300000000000001 113.307 173.614 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -52.08 -36.48 50.83 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 116.742 -3.724 . . . . 36.509999999999998 113.551 163.583 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -80.02 -22.08 42.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.803 1.641 . . . . 25.66 115.17 -177.811 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.47 -49.78 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 119.96 3.319 . . . . 8.1199999999999992 119.96 153.673 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.251 55.9 mtmt -70.98 -30.37 66.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.299 1.039 . . . . 15.470000000000001 113.199 -175.773 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.81 78.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.117 -1.615 . . . . 11.449999999999999 112.296 175.796 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 35.3 tptt -77.69 -21.52 51.9 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.548 1.139 . . . . 24.98 112.423 -175.766 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.7 mt -74.06 -40.75 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 128.061 2.545 . . . . 9.4600000000000009 109.013 170.389 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -65.86 -32.72 74.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.188 1.555 . . . . 14.76 111.999 177.71 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.35 -58.16 4.05 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.19 -2.194 . . . . 26.289999999999999 112.28 172.59 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -57.72 -60.82 3.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 119.883 3.29 . . . . 30.059999999999999 119.883 -177.975 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -101.8 -48.34 4.31 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.575 3.15 . . . . 25.190000000000001 108.311 -171.248 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.11 24.59 5.66 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 127.375 2.417 . . . . 7.4100000000000001 118.593 177.554 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.0 mt -92.04 103.94 9.44 Favored Pre-proline 0 N--CA 1.43 -1.453 1 CA-C-O 111.516 -4.088 . . . . 9.4900000000000002 108.476 -170.711 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.51 154.16 72.27 Favored 'Trans proline' 0 N--CA 1.434 -2.002 1 CA-C-N 130.542 4.801 . . . . 11.42 116.481 -168.31 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.32 -19.88 60.11 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 N-CA-C 119.048 2.672 . . . . 12.0 119.048 -174.344 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.35 -21.03 53.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 122.221 2.282 . . . . 35.549999999999997 115.106 173.04 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -83.27 -13.01 56.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.379 1.992 . . . . 20.52 116.379 168.865 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 75.6 mt-30 -96.17 119.15 34.14 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.199 -4.063 . . . . 7.1299999999999999 111.225 -173.638 . . . . . . . . 3 2 . 1 . 074 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -90.95 116.86 29.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 101.639 -3.467 . . . . 36.390000000000001 101.639 164.584 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 tp -105.58 113.91 27.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.623 2.011 . . . . 9.5500000000000007 110.946 -179.799 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -116.2 152.54 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 125.572 2.606 . . . . 13.9 104.625 -164.748 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -82.41 -80.49 0.16 Allowed 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.199 -4.063 . . . . 6.8600000000000003 112.789 162.871 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.3 -72.71 0.7 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.193 2.197 . . . . 11.15 109.001 172.105 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.97 -27.32 4.91 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 125.951 2.973 . . . . 13.93 117.144 174.085 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -106.64 150.83 25.82 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.366 -2.255 . . . . 23.920000000000002 109.786 -165.76 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -102.19 144.77 30.31 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.018 -2.926 . . . . 23.23 106.629 -170.197 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.1 mt -77.84 145.65 36.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.462 -2.608 . . . . 9.1099999999999994 111.19 179.764 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.55 151.59 27.41 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.105 1.362 . . . . 33.439999999999998 110.211 -175.256 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.36 -59.51 4.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.541 2.736 . . . . 28.370000000000001 112.24 -161.422 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.08 33.12 5.8 Favored Glycine 0 N--CA 1.43 -1.741 0 O-C-N 116.635 -3.791 . . . . 15.0 116.442 -168.912 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -121.76 160.47 24.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.518 -1.66 . . . . 25.5 106.518 174.363 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.4 p -104.56 173.47 6.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.95 2.786 . . . . 11.949999999999999 117.194 -174.32 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.6 -25.56 41.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.073 -2.267 . . . . 10.17 114.046 -177.926 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.7 m -59.58 -59.14 5.91 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.661 1.696 . . . . 13.59 110.789 168.523 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -67.0 -32.56 73.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.347 -2.096 . . . . 11.699999999999999 114.494 -173.186 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -69.43 -19.36 63.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.257 1.823 . . . . 12.949999999999999 113.019 171.902 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.299 42.5 m-80 58.98 50.36 8.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.514 1.926 . . . . 25.449999999999999 114.962 -173.232 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 mt -95.43 125.76 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.296 -1.372 . . . . 14.6 107.296 174.516 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -85.48 174.0 9.82 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.481 -3.887 . . . . 33.229999999999997 109.998 177.393 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -72.53 152.5 41.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 125.125 2.393 . . . . 25.969999999999999 113.881 174.016 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.52 41.48 30.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.664 3.586 . . . . 32.609999999999999 111.232 -171.564 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.5 t -107.73 142.05 38.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 127.22 3.39 . . . . 10.56 103.048 -179.062 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.9 m -98.94 123.56 43.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 110.632 -2.985 . . . . 5.3300000000000001 114.175 -179.119 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.6 mt -95.9 144.12 26.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.041 2.829 . . . . 11.66 108.045 174.838 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -111.14 124.89 53.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.414 -2.679 . . . . 16.300000000000001 114.449 -169.44 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.9 mt -100.78 126.86 47.38 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.123 1.44 . . . . 9.9600000000000009 110.441 -179.584 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.04 177.82 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.411 -1.329 . . . . 9.7599999999999998 107.411 162.539 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp . . . . . 0 N--CA 1.43 -1.44 0 O-C-N 119.463 -2.023 . . . . 19.57 106.827 175.123 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.329 4.1 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 122.438 1.113 . . . . 17.170000000000002 109.809 . . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -113.83 145.32 41.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.283 1.516 . . . . 21.890000000000001 107.237 177.684 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -123.75 -175.1 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 119.793 -1.817 . . . . 10.83 107.423 160.224 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.294 0.7 OUTLIER -129.59 140.21 51.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 127.013 2.695 . . . . 10.609999999999999 109.051 171.146 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.58 137.52 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 1 O-C-N 114.382 -5.199 . . . . 9.1300000000000008 111.819 169.353 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -100.66 115.29 29.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 124.215 3.189 . . . . 20.550000000000001 109.783 162.352 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 p -67.41 -164.7 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 127.459 2.975 . . . . 11.779999999999999 116.692 -169.458 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.32 -56.54 17.45 Favored 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 131.922 4.089 . . . . 19.309999999999999 110.232 -179.487 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 p -76.35 -41.89 46.7 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.776 2.227 . . . . 23.140000000000001 111.601 -176.53 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.28 72.78 0.39 Allowed Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 127.405 2.431 . . . . 19.739999999999998 114.417 -174.419 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.33 80.1 tttt -135.34 124.4 24.31 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.421 1.088 . . . . 21.93 108.107 170.785 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -88.11 118.12 27.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.95 -2.968 . . . . 12.33 112.125 -179.21 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.5 pt -111.69 148.02 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 O-C-N 115.788 -4.32 . . . . 17.079999999999998 109.53 -173.829 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -98.21 137.55 36.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.839 -1.541 . . . . 16.300000000000001 106.839 -177.363 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -124.57 159.01 31.61 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.476 2.31 . . . . 15.880000000000001 107.185 178.994 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -123.06 126.85 47.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.508 -2.034 . . . . 28.899999999999999 105.508 173.986 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.07 169.18 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.032 -2.581 . . . . 12.050000000000001 104.032 -174.269 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -109.16 156.95 38.38 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 125.338 1.455 . . . . 18.170000000000002 107.938 165.077 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.19 -16.03 31.77 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 116.711 -1.726 . . . . 8.1600000000000001 114.106 176.942 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -72.7 -15.54 61.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.437 -1.32 . . . . 11.130000000000001 107.437 179.586 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -76.83 141.27 40.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.354 -2.716 . . . . 18.030000000000001 115.466 -170.961 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -70.58 168.51 16.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 121.67 3.952 . . . . 10.220000000000001 121.67 170.685 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.37 5.7 mm -62.43 -40.45 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.444 -1.41 . . . . 12.300000000000001 111.816 174.173 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -51.02 -31.84 19.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.48 2.03 . . . . 36.509999999999998 116.48 168.051 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -81.81 -29.42 32.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.024 -1.048 . . . . 25.66 111.097 176.665 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.27 4.0 t -62.1 -54.1 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 124.754 1.221 . . . . 8.1199999999999992 109.529 174.613 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -56.38 -37.45 70.12 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.824 2.157 . . . . 15.470000000000001 116.824 176.565 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.72 81.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.83 2.159 . . . . 11.449999999999999 116.83 175.284 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -71.71 -29.01 64.08 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 117.076 2.25 . . . . 24.98 117.076 168.888 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.342 48.5 mt -73.11 -43.25 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.191 -1.781 . . . . 9.4600000000000009 106.191 172.734 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -67.77 -26.67 66.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.734 2.124 . . . . 14.76 116.734 178.72 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.99 -51.53 25.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.484 -1.689 . . . . 26.289999999999999 114.117 169.381 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -64.99 -66.08 0.59 Allowed 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 131.78 4.032 . . . . 30.059999999999999 115.64 -179.896 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -95.71 -25.97 15.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.515 1.672 . . . . 25.190000000000001 115.515 -172.872 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.07 -27.51 8.56 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 120.75 -1.219 . . . . 7.4100000000000001 115.385 -178.967 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.3 mt -52.38 125.59 35.48 Favored Pre-proline 0 N--CA 1.43 -1.451 1 C-N-CA 131.807 4.043 . . . . 9.4900000000000002 109.237 -172.512 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.65 164.33 24.3 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-O 115.324 -2.032 . . . . 11.42 115.18 -178.44 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -80.98 -16.98 9.7 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 126.245 3.266 . . . . 12.0 114.239 -177.219 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -86.3 -5.1 59.25 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.876 -2.39 . . . . 35.549999999999997 106.865 -175.259 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.62 -28.19 22.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.046 -2.284 . . . . 20.52 112.278 171.676 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -88.05 123.13 32.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.961 1.097 . . . . 7.1299999999999999 113.961 -165.182 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -114.92 117.19 29.97 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.045 2.138 . . . . 36.390000000000001 115.365 160.86 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.17 112.89 24.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.565 1.65 . . . . 9.5500000000000007 109.31 -169.079 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -100.43 143.85 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 O-C-N 115.828 -4.295 . . . . 13.9 107.297 175.841 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -81.06 -92.07 0.06 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.106 1.763 . . . . 6.8600000000000003 112.35 169.848 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.28 -48.97 3.85 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 121.199 1.818 . . . . 11.15 109.51 162.017 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.9 9.12 0.73 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 119.792 -1.818 . . . . 13.93 115.607 -177.419 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -112.17 134.89 53.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.806 -1.924 . . . . 23.920000000000002 105.806 175.613 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -74.49 148.32 41.1 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.815 -1.803 . . . . 23.23 112.125 168.765 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 mt -91.83 127.0 37.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.016 -2.303 . . . . 9.1099999999999994 105.865 -177.486 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -79.46 131.89 36.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.412 1.885 . . . . 33.439999999999998 113.734 177.878 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -51.7 -51.91 52.39 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.343 2.257 . . . . 28.370000000000001 111.77 -162.189 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.94 9.56 59.82 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 119.741 -1.849 . . . . 15.0 116.927 -174.862 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -101.57 158.62 15.95 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.453 -3.969 . . . . 25.5 112.545 177.334 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -84.15 158.1 21.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.365 1.866 . . . . 11.949999999999999 112.402 -178.09 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -62.41 -32.14 72.94 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.676 -4.39 . . . . 10.17 111.294 164.749 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -57.86 -45.72 85.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.592 2.357 . . . . 13.59 116.648 174.252 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.98 -35.56 76.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.81 -1.541 . . . . 11.699999999999999 114.447 -178.444 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -79.79 2.9 21.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.263 -1.523 . . . . 12.949999999999999 111.839 169.698 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.7 t30 40.79 40.93 1.06 Allowed 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.582 2.353 . . . . 25.449999999999999 116.006 -168.761 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.8 mt -74.74 126.08 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 104.324 -2.473 . . . . 14.6 104.324 175.452 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -115.21 165.75 12.59 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 132.636 4.374 . . . . 33.229999999999997 114.191 179.881 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.345 45.8 pttt -55.25 157.67 3.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.498 3.519 . . . . 25.969999999999999 115.213 -172.829 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 75.01 0.22 3.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.98 2.112 . . . . 32.609999999999999 113.977 168.63 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t -91.61 157.44 16.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.72 -2.488 . . . . 10.56 110.771 -173.287 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -99.55 116.83 32.59 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 127.043 2.715 . . . . 5.3300000000000001 109.416 178.459 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.7 mt -99.98 152.61 19.99 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.073 1.749 . . . . 11.66 107.817 174.297 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -116.03 142.68 46.48 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.614 -1.624 . . . . 16.300000000000001 106.614 -166.659 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tp -111.41 112.16 23.72 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 115.832 -4.293 . . . . 9.9600000000000009 111.383 -175.541 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.86 139.03 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.67 -2.345 . . . . 9.7599999999999998 104.67 -173.701 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 tp . . . . . 0 N--CA 1.43 -1.433 0 O-C-N 118.558 -2.589 . . . . 19.57 114.217 177.53 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 109.464 -0.569 . . . . 17.170000000000002 109.464 . . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -75.43 126.4 30.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.709 -1.244 . . . . 21.890000000000001 112.736 -179.06 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -107.73 141.27 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 125.277 2.465 . . . . 10.83 104.902 151.552 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 43.3 m-85 -101.06 144.48 29.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.876 -2.39 . . . . 10.609999999999999 107.007 165.665 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.287 58.1 t -106.54 124.0 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 116.735 -1.602 . . . . 9.1300000000000008 111.772 169.484 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -102.41 113.92 27.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 119.701 1.137 . . . . 20.550000000000001 111.825 -178.181 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.374 3.1 p -63.5 -174.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.135 2.642 . . . . 11.779999999999999 118.135 176.509 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.4 mt -81.54 -60.28 2.32 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.236 -2.79 . . . . 19.309999999999999 110.819 175.944 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.297 62.2 p -71.89 -64.45 0.93 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 116.062 -1.923 . . . . 23.140000000000001 114.566 -174.188 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.18 54.72 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.765 1 CA-C-N 126.13 4.059 . . . . 19.739999999999998 114.639 -175.584 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -135.49 138.46 43.15 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 128.057 2.857 . . . . 21.93 107.847 -176.192 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.288 72.9 m -139.79 107.58 5.66 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.225 -2.139 . . . . 12.33 105.225 -179.874 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 17.9 pt -112.36 161.06 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 124.254 1.978 . . . . 17.079999999999998 108.345 -166.692 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 m -117.38 126.78 53.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.726 -1.859 . . . . 16.300000000000001 111.885 -174.54 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -111.06 163.11 14.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.988 -1.07 . . . . 15.880000000000001 110.992 172.543 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -116.4 110.15 18.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.859 -2.275 . . . . 28.899999999999999 104.859 179.395 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.46 154.08 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.047 -2.283 . . . . 12.050000000000001 113.437 -176.833 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -97.34 153.08 38.53 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 114.862 -2.494 . . . . 18.170000000000002 113.973 167.142 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -59.96 -22.04 67.26 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-N 125.728 3.081 . . . . 8.1600000000000001 116.856 -179.834 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -76.72 -9.04 58.39 Favored 'General case' 0 N--CA 1.43 -1.457 1 C-N-CA 132.073 4.149 . . . . 11.130000000000001 116.875 170.758 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.72 127.5 33.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.77 -3.706 . . . . 18.030000000000001 114.971 175.583 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.291 45.1 p -68.53 159.09 32.51 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.257 2.623 . . . . 10.220000000000001 112.719 179.045 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.259 45.2 mm -57.25 -35.33 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.27 1.828 . . . . 12.300000000000001 112.461 168.021 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -60.79 -52.9 63.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.206 1.821 . . . . 36.509999999999998 115.337 173.46 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.271 33.0 m-80 -60.65 -36.05 77.72 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 115.34 -2.267 . . . . 25.66 113.328 174.497 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.421 50.1 t -46.81 -48.02 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 131.262 3.825 . . . . 8.1199999999999992 113.905 167.781 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -76.01 -20.72 57.59 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.79 -1.55 . . . . 15.470000000000001 110.868 -169.887 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.77 -28.75 55.82 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 112.631 0.604 . . . . 11.449999999999999 112.631 174.293 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -70.03 -32.45 70.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.471 0.915 . . . . 24.98 113.471 173.181 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -69.95 -35.0 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 123.936 1.827 . . . . 9.4600000000000009 109.594 172.33 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -69.63 -29.11 66.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.878 -2.389 . . . . 14.76 113.508 174.205 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.5 -54.3 21.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.289 -2.132 . . . . 26.289999999999999 112.604 168.575 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -64.38 -63.35 1.16 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 117.229 -1.367 . . . . 30.059999999999999 109.599 -175.955 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.74 -48.53 7.79 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.298 2.333 . . . . 25.190000000000001 117.298 177.916 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.46 52.02 1.63 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 117.474 -3.266 . . . . 7.4100000000000001 115.585 -171.915 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.0 mt -113.99 127.72 26.53 Favored Pre-proline 0 N--CA 1.43 -1.44 1 N-CA-C 99.132 -4.396 . . . . 9.4900000000000002 99.132 -169.399 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -72.7 157.86 51.47 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 O-C-N 117.053 -2.13 . . . . 11.42 109.075 -170.335 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -77.38 -29.1 5.07 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 C-N-CA 125.027 3.818 . . . . 12.0 111.639 -153.001 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.16 -26.79 42.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 130.579 3.552 . . . . 35.549999999999997 108.3 175.367 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -80.19 -26.99 38.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.477 -3.89 . . . . 20.52 111.596 -176.078 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -71.48 138.55 49.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.386 2.041 . . . . 7.1299999999999999 110.314 174.685 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -142.16 137.42 30.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.881 -2.387 . . . . 36.390000000000001 110.676 161.519 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -104.34 135.19 46.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.434 2.54 . . . . 9.5500000000000007 111.933 178.654 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mm -111.25 138.92 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.408 -1.724 . . . . 13.9 110.957 163.823 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.31 5.6 t80 -70.09 -87.82 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.892 1.677 . . . . 6.8600000000000003 109.742 167.762 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.23 -62.94 1.41 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 121.179 -0.951 . . . . 11.15 108.867 165.873 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.86 -24.87 2.21 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.033 1.778 . . . . 13.93 110.333 177.311 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.269 0.1 OUTLIER -74.36 123.52 24.78 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.147 -1.427 . . . . 23.920000000000002 107.147 -178.047 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.269 16.2 pt20 -70.39 122.09 18.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.786 2.554 . . . . 23.23 111.137 164.292 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.3 mt -95.37 150.45 20.26 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 118.343 -2.723 . . . . 9.1099999999999994 111.282 -171.354 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -120.14 141.37 49.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.801 3.191 . . . . 33.439999999999998 116.019 -169.263 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.01 -52.97 56.71 Favored 'General case' 0 N--CA 1.43 -1.451 2 O-C-N 115.653 -4.404 . . . . 28.370000000000001 112.943 -156.988 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.88 29.59 7.85 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 124.216 3.189 . . . . 15.0 115.034 -169.862 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 -114.88 147.3 40.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.2 2.2 . . . . 25.5 109.332 177.359 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 p -94.19 173.04 7.84 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 129.584 3.154 . . . . 11.949999999999999 112.229 179.37 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.5 mt -86.28 -18.17 32.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 104.498 -2.408 . . . . 10.17 104.498 -173.259 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.18 -41.47 77.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.397 -2.064 . . . . 13.59 110.137 168.617 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.71 -41.43 92.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.95 2.1 . . . . 11.699999999999999 112.676 -177.585 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -78.44 -28.72 46.73 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 115.575 -2.45 . . . . 12.949999999999999 116.563 173.142 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.288 29.8 t30 74.5 56.36 0.08 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.63 3.172 . . . . 25.449999999999999 112.544 -168.242 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.562 HD13 HD21 ' A' ' 67' ' ' LEU . 31.4 mt -99.9 101.94 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 104.435 -2.432 . . . . 14.6 104.435 170.898 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -100.35 -156.28 0.55 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.522 2.329 . . . . 33.229999999999997 108.084 -172.113 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -61.41 157.6 16.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.905 -3.622 . . . . 25.969999999999999 119.336 174.799 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 71.78 15.98 5.73 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.016 -1.053 . . . . 32.609999999999999 112.603 163.623 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -101.22 142.78 32.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.742 2.526 . . . . 10.56 108.371 -156.999 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.3 m -111.58 129.26 56.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.8 -3.687 . . . . 5.3300000000000001 107.09 -178.3 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.562 HD21 HD13 ' A' ' 61' ' ' ILE . 66.8 mt -103.61 164.09 11.89 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.31 -1.366 . . . . 11.66 107.31 168.715 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -122.13 124.16 43.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.729 2.412 . . . . 16.300000000000001 110.966 -177.936 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.1 tp -106.01 110.78 23.16 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.598 -1.939 . . . . 9.9600000000000009 109.379 -172.032 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 m -114.53 174.38 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 117.966 -2.959 . . . . 9.7599999999999998 107.207 -174.743 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.6 mt . . . . . 0 N--CA 1.43 -1.456 0 CA-C-O 123.621 1.677 . . . . 19.57 111.007 168.151 . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 ttp . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 115.505 1.669 . . . . 17.170000000000002 115.505 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -93.47 133.33 36.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.057 2.208 . . . . 21.890000000000001 107.923 -175.522 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.85 150.83 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.655 -2.528 . . . . 10.83 111.106 175.126 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.433 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 21.2 m-85 -112.31 100.68 8.99 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.61 2.364 . . . . 10.609999999999999 116.896 176.867 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.3 t -92.63 114.86 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 120.294 -0.562 . . . . 9.1300000000000008 111.227 179.731 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -98.88 125.03 44.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.067 -2.896 . . . . 20.550000000000001 112.662 177.269 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.539 HG22 HD23 ' A' ' 69' ' ' LEU . 82.3 p -84.24 -179.07 7.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.488 -1.233 . . . . 11.779999999999999 113.481 -179.373 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 tt -50.72 -47.94 59.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.045 3.338 . . . . 19.309999999999999 112.573 179.405 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -93.15 -66.8 0.9 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.049 2.139 . . . . 23.140000000000001 107.287 -165.752 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.56 75.57 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 104.062 -3.615 . . . . 19.739999999999998 104.062 161.9 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -115.15 116.97 29.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.839 -0.8 . . . . 21.93 108.839 164.001 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.285 28.1 m -83.87 93.94 8.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.098 2.559 . . . . 12.33 109.689 173.907 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 mt -85.78 105.45 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 123.769 1.747 . . . . 17.079999999999998 107.394 -174.922 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -87.07 110.4 20.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.054 -4.154 . . . . 16.300000000000001 108.37 179.98 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.05 140.62 47.69 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.944 -1.873 . . . . 15.880000000000001 105.944 176.272 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -104.23 131.2 51.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.32 1.057 . . . . 28.899999999999999 111.812 167.781 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.24 178.94 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 115.142 -0.936 . . . . 12.050000000000001 109.529 -178.612 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -85.1 163.15 46.82 Favored Pre-proline 0 N--CA 1.429 -1.479 0 O-C-N 118.426 -2.671 . . . . 18.170000000000002 110.949 163.98 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.257 0.1 OUTLIER -76.24 -12.35 19.16 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 125.148 2.874 . . . . 8.1600000000000001 114.169 179.812 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -102.89 2.53 35.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.421 2.325 . . . . 11.130000000000001 108.063 -168.617 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -76.33 154.62 34.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.017 1.858 . . . . 18.030000000000001 116.017 169.298 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -93.06 169.65 10.25 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.823 2.527 . . . . 10.220000000000001 117.823 -179.316 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.54 -42.72 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 126.026 2.079 . . . . 12.300000000000001 116.185 -178.627 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 5.7 mm-40 -29.47 -50.3 0.1 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.9 2.48 . . . . 36.509999999999998 114.791 158.446 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.41 -37.91 63.23 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.161 -2.212 . . . . 25.66 108.092 -175.899 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.74 -43.46 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 124.379 2.038 . . . . 8.1199999999999992 111.613 176.083 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 50.0 mtpt -62.78 -36.79 84.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.276 -2.14 . . . . 15.470000000000001 115.392 173.659 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.46 89.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.994 2.518 . . . . 11.449999999999999 113.176 175.473 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -71.45 -30.3 65.87 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 124.391 1.076 . . . . 24.98 110.083 -178.095 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.5 mt -71.39 -39.15 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.327 -1.306 . . . . 9.4600000000000009 111.274 174.092 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -62.92 -40.59 98.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.887 -2.383 . . . . 14.76 109.35 170.476 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.19 -43.82 63.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 115.952 -1.975 . . . . 26.289999999999999 110.681 -171.664 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.542 ' HB3' ' HG2' ' A' ' 34' ' ' GLU 0.303 28.8 tptt -69.25 -51.14 40.53 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.554 1.645 . . . . 30.059999999999999 113.516 -176.785 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HB3' ' A' ' 33' ' ' LYS . 76.8 mm-40 -106.02 -32.7 8.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.268 3.027 . . . . 25.190000000000001 113.833 -157.818 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.42 56.71 4.17 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 128.429 2.919 . . . . 7.4100000000000001 113.329 -175.072 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mt -110.87 124.19 33.58 Favored Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 103.824 -2.658 . . . . 9.4900000000000002 103.824 -178.456 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.98 139.62 85.71 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 124.071 3.181 . . . . 11.42 117.085 175.589 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.95 -14.84 45.69 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 C-N-CA 127.422 5.415 . . . . 12.0 111.474 -174.757 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.401 2.5 p30 -81.37 -24.73 36.84 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.119 2.266 . . . . 35.549999999999997 117.119 178.351 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -75.72 -25.15 56.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 126.248 2.217 . . . . 20.52 116.83 167.142 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -79.51 121.72 25.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.638 2.459 . . . . 7.1299999999999999 117.638 -179.043 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -128.4 151.6 49.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.438 -2.664 . . . . 36.390000000000001 107.137 157.493 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.6 mt -131.12 143.57 50.74 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.332 2.015 . . . . 9.5500000000000007 111.089 -169.943 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.4 mm -120.65 140.74 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.401 3.08 . . . . 13.9 105.476 -176.28 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -104.16 -55.02 2.44 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 124.404 2.049 . . . . 6.8600000000000003 108.93 155.643 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.66 107.62 3.22 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.488 -2.008 . . . . 11.15 107.716 -176.661 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.81 -69.96 0.75 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 126.634 2.064 . . . . 13.93 116.619 175.853 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -96.3 166.95 11.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 119.138 1.469 . . . . 23.920000000000002 114.254 -175.727 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -60.39 139.11 57.84 Favored 'General case' 0 N--CA 1.43 -1.47 1 N-CA-C 123.489 4.626 . . . . 23.23 123.489 172.887 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.2 mt -83.4 120.42 25.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.825 1.65 . . . . 9.1099999999999994 114.759 173.642 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -89.25 155.09 19.61 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.682 -2.511 . . . . 33.439999999999998 110.075 -174.803 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.09 -53.72 49.22 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.165 1.786 . . . . 28.370000000000001 112.999 -158.433 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.15 36.23 4.54 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 117.673 -1.626 . . . . 15.0 114.273 -173.71 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -107.2 147.39 30.2 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.401 -2.074 . . . . 25.5 105.401 174.171 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.315 32.2 p -77.89 169.74 17.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.179 1.55 . . . . 11.949999999999999 112.272 -178.48 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.08 -30.99 55.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 113.953 -1.476 . . . . 10.17 109.17 178.999 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -66.49 -49.87 65.16 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 131.039 3.736 . . . . 13.59 110.233 179.155 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 33.1 t70 -56.63 -43.3 80.12 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.137 -2.227 . . . . 11.699999999999999 116.553 174.796 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -69.72 -27.61 65.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 124.952 1.408 . . . . 12.949999999999999 110.176 176.778 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 70.69 46.6 0.51 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 129.045 2.938 . . . . 25.449999999999999 107.795 -175.509 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.15 119.9 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 112.249 -2.25 . . . . 14.6 106.58 162.578 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -107.64 -176.15 2.98 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.802 2.441 . . . . 33.229999999999997 111.205 -174.987 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.276 54.7 pttt -69.92 135.03 49.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.661 -1.899 . . . . 25.969999999999999 115.099 -172.024 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 73.46 38.62 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.109 2.164 . . . . 32.609999999999999 109.809 179.9 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.6 m -94.21 150.76 20.01 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 112.865 -6.147 . . . . 10.56 110.15 -169.95 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.433 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 99.0 m -98.63 123.35 42.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.33 -2.731 . . . . 5.3300000000000001 105.244 -175.717 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.27 4.8 mp -116.03 148.21 40.42 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.676 -3.14 . . . . 11.66 109.746 168.9 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -95.05 121.87 37.12 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.157 1.932 . . . . 16.300000000000001 114.716 173.185 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.539 HD23 HG22 ' A' ' 7' ' ' THR 0.274 44.5 tp -81.62 114.89 20.61 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.489 -4.507 . . . . 9.9600000000000009 113.385 171.27 . . . . . . . . 4 3 . 1 . 077 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.86 157.09 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.695 2.043 . . . . 9.7599999999999998 113.951 -178.529 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.1 tp . . . . . 0 N--CA 1.43 -1.462 0 N-CA-C 112.942 0.719 . . . . 19.57 112.942 177.148 . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 120.007 3.336 . . . . 17.170000000000002 120.007 . . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -94.08 136.48 34.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.675 -1.972 . . . . 21.890000000000001 105.675 -164.98 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 15' ' ' LEU . 7.0 pt -132.09 162.19 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 128.161 2.585 . . . . 10.83 110.731 168.666 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -113.58 143.29 44.81 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 124.346 2.022 . . . . 10.609999999999999 109.221 175.457 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -133.62 115.47 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.175 -4.703 . . . . 9.1300000000000008 104.881 175.832 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -94.01 126.89 39.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.911 -1.885 . . . . 20.550000000000001 105.911 179.013 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 69' ' ' LEU . 2.1 p -72.56 168.52 18.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.603 -1.936 . . . . 11.779999999999999 115.175 171.911 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.0 tp -66.82 -47.49 71.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.275 -1.515 . . . . 19.309999999999999 110.837 -175.463 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -73.58 -50.1 22.93 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.286 1.835 . . . . 23.140000000000001 115.068 -179.055 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.53 49.75 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 114.924 -3.513 . . . . 19.739999999999998 115.403 -169.906 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -138.71 137.17 36.54 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 116.945 -1.902 . . . . 21.93 110.698 165.047 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -95.82 103.24 15.11 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 125.224 1.577 . . . . 12.33 108.588 172.529 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.98 120.05 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.974 -2.954 . . . . 17.079999999999998 111.786 177.641 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -99.28 120.55 39.73 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.915 -3.616 . . . . 16.300000000000001 102.396 -176.069 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.425 ' HB2' HG13 ' A' ' 3' ' ' ILE . 14.4 mt -122.77 168.95 11.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.376 3.071 . . . . 15.880000000000001 110.883 -170.538 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -135.58 120.42 18.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.635 1.574 . . . . 28.899999999999999 107.5 179.859 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.82 168.81 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.302 -2.481 . . . . 12.050000000000001 104.302 -172.972 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.266 32.4 mt-10 -106.14 170.83 5.37 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 117.822 -3.048 . . . . 18.170000000000002 110.188 162.045 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 68.9 Cg_endo -81.11 5.04 6.5 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 CA-C-N 121.983 1.744 . . . . 8.1600000000000001 112.101 -179.325 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -93.95 -16.03 24.35 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.133 2.573 . . . . 11.130000000000001 108.797 -179.089 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -80.5 142.24 34.4 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.88 1.218 . . . . 18.030000000000001 113.497 -173.078 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -74.79 159.03 32.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.684 -1.885 . . . . 10.220000000000001 111.3 176.489 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mm -49.35 -40.72 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 119.425 -2.047 . . . . 12.300000000000001 115.042 170.059 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -47.82 -50.02 27.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 115.227 -2.321 . . . . 36.509999999999998 115.782 167.529 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -68.28 -29.68 68.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 123.496 2.862 . . . . 25.66 115.337 177.013 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.87 -37.62 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 115.734 -0.666 . . . . 8.1199999999999992 111.487 177.059 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -58.95 -34.77 72.15 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 120.045 3.35 . . . . 15.470000000000001 120.045 163.273 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.42 -37.32 65.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.042 -2.911 . . . . 11.449999999999999 110.887 -178.133 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -52.99 -45.02 67.66 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.17 2.188 . . . . 24.98 116.502 159.937 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.59 -48.09 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 1 O-C-N 115.813 -4.305 . . . . 9.4600000000000009 108.625 179.236 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -49.57 -50.44 42.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.007 1.854 . . . . 14.76 116.007 169.605 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -54.07 -49.05 69.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.535 1.68 . . . . 26.289999999999999 115.535 174.044 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -67.66 -57.65 6.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.007 -1.451 . . . . 30.059999999999999 113.433 -179.676 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -95.81 -36.82 11.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.582 2.753 . . . . 25.190000000000001 112.493 -161.763 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.23 0.3 50.85 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 116.938 -2.034 . . . . 7.4100000000000001 116.572 -178.116 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.3 mt -72.56 124.77 91.19 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 128.69 2.796 . . . . 9.4900000000000002 108.588 179.948 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.48 160.42 9.52 Favored 'Trans proline' 0 C--N 1.3 -2.013 1 C-N-CA 126.294 4.662 . . . . 11.42 116.28 -178.555 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.19 -7.25 18.83 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 123.668 2.912 . . . . 12.0 113.964 -161.715 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -76.65 -57.23 3.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 131.069 3.748 . . . . 35.549999999999997 106.469 -179.847 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -56.98 -45.3 83.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.361 1.986 . . . . 20.52 116.361 168.82 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -62.03 110.52 1.6 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.402 -3.311 . . . . 7.1299999999999999 116.715 175.451 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -110.18 130.56 55.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.119 1.437 . . . . 36.390000000000001 107.326 163.458 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.0 mt -110.83 128.77 55.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.819 2.247 . . . . 9.5500000000000007 106.828 179.906 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.65 152.74 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.323 -3.36 . . . . 13.9 103.857 173.413 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -96.04 -66.96 0.87 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.806 -2.434 . . . . 6.8600000000000003 104.923 162.26 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.283 . . -156.33 130.56 8.68 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 104.486 -2.413 . . . . 11.15 104.486 173.766 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.59 -49.94 1.17 Allowed Glycine 0 N--CA 1.43 -1.753 0 CA-C-O 116.863 -2.076 . . . . 13.93 112.953 154.011 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -145.13 172.55 12.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.62 2.71 . . . . 23.920000000000002 107.378 -172.476 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.256 5.4 pm0 -83.66 135.23 34.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.229 -2.17 . . . . 23.23 115.553 -175.847 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.4 mt -77.27 151.41 35.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.485 -3.259 . . . . 9.1099999999999994 111.924 175.885 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB2' ' CG ' ' A' ' 54' ' ' ARG . 40.7 mt-10 -79.4 155.46 28.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.927 -2.983 . . . . 33.439999999999998 111.706 175.791 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -77.9 -43.09 31.07 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 120.83 1.65 . . . . 28.370000000000001 113.406 -173.564 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.16 29.4 11.9 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 118.462 0.574 . . . . 15.0 112.115 -175.873 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.427 ' CG ' ' HB2' ' A' ' 51' ' ' GLU . 38.0 mmt180 -114.51 149.19 36.78 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.425 -2.065 . . . . 25.5 105.425 178.025 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.286 30.1 p -100.1 176.39 5.42 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 111.568 -2.56 . . . . 11.949999999999999 117.547 -164.372 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 26.7 mt -73.8 -8.25 55.3 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.268 -3.395 . . . . 10.17 114.1 168.181 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.0 m -94.9 -28.61 15.11 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.551 -3.843 . . . . 13.59 102.332 -172.796 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -62.43 -51.71 66.43 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 131.673 3.989 . . . . 11.699999999999999 116.553 169.574 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -90.17 -6.4 55.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.361 -2.199 . . . . 12.949999999999999 111.707 -177.829 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.326 35.2 m120 72.13 36.3 1.13 Allowed 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 116.001 -4.187 . . . . 25.449999999999999 113.264 174.25 . . . . . . . . 3 2 . 1 . 078 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.77 109.19 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.72 2.408 . . . . 14.6 107.867 -172.612 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.12 -178.37 3.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.564 2.602 . . . . 33.229999999999997 111.213 -179.772 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -49.89 148.89 2.89 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 118.853 -2.404 . . . . 25.969999999999999 116.685 175.972 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 35.1 mt-10 53.48 36.97 24.57 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.302 -3.374 . . . . 32.609999999999999 118.616 -172.637 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -97.57 144.39 27.3 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.171 -2.159 . . . . 10.56 105.171 178.752 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -101.22 105.86 17.02 Favored 'General case' 0 N--CA 1.43 -1.442 1 CA-C-O 128.844 4.164 . . . . 5.3300000000000001 110.583 175.595 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.57 150.3 21.79 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.542 -2.599 . . . . 11.66 111.832 173.777 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -103.36 127.5 50.7 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.825 -1.172 . . . . 16.300000000000001 112.128 178.274 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 7' ' ' THR . 15.2 tp -105.26 116.52 32.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.41 3.481 . . . . 9.9600000000000009 109.347 169.947 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.76 174.16 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 112.781 -2.009 . . . . 9.7599999999999998 110.996 -179.114 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.9 tp . . . . . 0 N--CA 1.43 -1.442 0 C-N-CA 127.788 2.435 . . . . 19.57 111.386 -175.748 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 116.746 2.128 . . . . 17.170000000000002 116.746 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.251 85.8 mt-30 -85.05 122.23 28.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.096 1.903 . . . . 21.890000000000001 113.331 177.168 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -113.09 159.92 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.12 -2.548 . . . . 10.83 104.12 175.916 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -111.87 127.15 55.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 123.586 1.66 . . . . 10.609999999999999 109.298 -177.756 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.7 t -122.85 109.6 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.204 1.954 . . . . 9.1300000000000008 110.93 179.528 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -90.48 144.2 26.02 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 113.235 -5.916 . . . . 20.550000000000001 115.914 176.054 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -85.61 164.25 17.84 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.148 2.979 . . . . 11.779999999999999 113.653 175.582 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.94 -26.23 68.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.311 -2.743 . . . . 19.309999999999999 114.795 168.401 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 38.9 p -75.38 -44.06 46.87 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.455 1.934 . . . . 23.140000000000001 112.339 178.632 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.8 38.6 0.23 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-N 115.08 -0.964 . . . . 19.739999999999998 112.291 169.458 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -103.08 125.79 49.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.188 -1.042 . . . . 21.93 108.188 172.353 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.4 m -91.66 128.05 37.35 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 102.339 -3.208 . . . . 12.33 102.339 168.965 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.254 28.7 mt -102.06 136.22 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 117.828 -3.045 . . . . 17.079999999999998 105.309 178.295 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.7 m -105.99 100.17 9.73 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 100.607 -3.849 . . . . 16.300000000000001 100.607 -175.095 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 mt -96.14 119.74 35.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.907 1.683 . . . . 15.880000000000001 110.334 -177.939 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -93.97 96.72 9.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.063 -2.569 . . . . 28.899999999999999 104.063 178.837 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.71 168.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.733 2.013 . . . . 12.050000000000001 108.831 179.178 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -116.22 154.27 48.68 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-N 120.011 1.278 . . . . 18.170000000000002 108.98 -169.98 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.79 -4.32 14.49 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 CA-C-N 122.56 1.95 . . . . 8.1600000000000001 115.185 -173.127 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.4 m -88.59 -12.39 42.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 125.238 1.586 . . . . 11.130000000000001 113.987 172.431 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.67 149.78 48.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.034 -2.916 . . . . 18.030000000000001 114.511 -179.462 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.284 37.2 p -90.55 175.34 7.09 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 111.245 -2.707 . . . . 10.220000000000001 107.699 -179.105 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 mm -73.55 -27.36 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 119.456 -2.027 . . . . 12.300000000000001 109.791 171.992 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.73 -52.16 65.39 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.509 -2.619 . . . . 36.509999999999998 108.532 170.333 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -47.58 -39.86 17.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.654 2.381 . . . . 25.66 115.807 172.87 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.66 -46.63 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 127.1 3.333 . . . . 8.1199999999999992 114.657 -171.572 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.46 -27.63 66.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.934 -2.979 . . . . 15.470000000000001 115.19 160.636 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.88 -19.84 60.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.369 2.35 . . . . 11.449999999999999 111.211 178.073 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -69.34 -30.53 68.58 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 112.739 -6.225 . . . . 24.98 112.373 165.449 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -87.76 -18.03 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 126.005 2.812 . . . . 9.4600000000000009 113.068 174.593 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -69.67 -33.24 72.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.52 -3.863 . . . . 14.76 110.558 167.662 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.85 -54.11 12.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.202 -2.811 . . . . 26.289999999999999 110.767 178.481 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -71.31 -62.94 1.22 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.178 -1.576 . . . . 30.059999999999999 113.432 -176.774 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -91.5 -33.37 15.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.435 2.541 . . . . 25.190000000000001 110.779 -174.051 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.73 59.28 2.24 Favored Glycine 0 N--CA 1.43 -1.751 2 O-C-N 114.577 -5.077 . . . . 7.4100000000000001 109.371 179.55 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 mt -118.48 146.48 39.78 Favored Pre-proline 0 N--CA 1.43 -1.459 0 N-CA-C 103.236 -2.876 . . . . 9.4900000000000002 103.236 -177.127 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.266 53.1 Cg_exo -75.1 138.79 23.24 Favored 'Trans proline' 0 C--N 1.3 -1.996 2 C-N-CA 128.48 6.12 . . . . 11.42 112.064 -176.295 . . . . . . . . 3 2 . 1 . 079 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.88 -29.18 89.49 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 C-N-CA 122.748 2.299 . . . . 12.0 112.711 175.425 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.31 7.8 p-10 -70.87 -38.28 73.09 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.523 1.965 . . . . 35.549999999999997 112.084 175.825 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -73.44 -35.41 65.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.6 2.36 . . . . 20.52 110.379 -176.469 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -69.12 116.93 10.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.54 2.736 . . . . 7.1299999999999999 110.781 169.319 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -110.76 129.12 55.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 128.612 3.695 . . . . 36.390000000000001 111.692 165.628 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 tp -116.45 133.37 56.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.408 -1.433 . . . . 9.5500000000000007 109.843 -172.691 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.5 mt -127.08 130.13 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 116.664 -3.772 . . . . 13.9 109.383 -175.108 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -89.87 -58.59 2.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 123.121 2.691 . . . . 6.8600000000000003 115.492 172.634 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.4 -73.94 0.63 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.19 1.396 . . . . 11.15 107.684 -178.608 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.25 -64.16 0.26 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 117.206 -2.426 . . . . 13.93 111.108 -173.569 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.275 17.6 ptmt -67.04 168.0 10.84 Favored 'General case' 0 N--CA 1.429 -1.491 2 CA-C-O 128.924 4.202 . . . . 23.920000000000002 113.496 171.961 . . . . . . . . 3 2 . 1 . 079 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -86.12 145.68 26.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.175 -2.739 . . . . 23.23 113.692 172.922 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -80.74 137.97 36.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.093 -1.629 . . . . 9.1099999999999994 107.793 -178.054 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -102.6 145.84 29.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.081 2.953 . . . . 33.439999999999998 107.884 -170.525 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -39.36 -73.97 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 119.77 3.248 . . . . 28.370000000000001 119.77 -174.692 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.02 17.52 41.28 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 129.073 3.225 . . . . 15.0 111.808 -164.16 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -96.4 163.66 12.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.687 -2.066 . . . . 25.5 105.46 173.395 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -101.55 163.89 12.04 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.42 -2.437 . . . . 11.949999999999999 104.42 -179.577 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.37 -26.46 66.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.358 -1.292 . . . . 10.17 114.424 162.592 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -65.93 -35.62 81.12 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 123.49 0.716 . . . . 13.59 111.895 168.421 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.8 -34.09 73.97 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 116.045 -4.159 . . . . 11.699999999999999 120.201 175.168 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -92.37 -22.26 19.78 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.476 -3.265 . . . . 12.949999999999999 105.79 -178.267 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.8 m120 71.89 75.44 0.17 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.5 2.72 . . . . 25.449999999999999 108.91 -177.563 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.2 mt -115.56 126.8 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 125.557 1.786 . . . . 14.6 106.637 -175.34 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.94 -178.79 4.54 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.398 -1.439 . . . . 33.229999999999997 109.323 179.848 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -66.61 156.06 36.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.948 2.309 . . . . 25.969999999999999 115.768 -168.231 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.291 46.7 mt-10 58.21 42.22 22.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.435 2.754 . . . . 32.609999999999999 118.435 -171.202 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 m -116.84 132.82 56.6 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.069 -1.826 . . . . 10.56 106.069 -175.759 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.6 m -84.09 140.41 31.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.984 -2.947 . . . . 5.3300000000000001 114.183 173.262 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -125.04 165.57 17.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.135 2.574 . . . . 11.66 110.096 174.344 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -110.27 104.4 13.2 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.271 1.952 . . . . 16.300000000000001 116.271 176.294 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.6 tp -73.06 118.74 16.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 123.876 0.735 . . . . 9.9600000000000009 110.236 165.817 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 m -129.64 155.53 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 105.592 -2.003 . . . . 9.7599999999999998 105.592 176.254 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 71' ' ' LEU . 17.9 mt . . . . . 0 N--CA 1.43 -1.466 0 N-CA-C 103.539 -2.763 . . . . 19.57 103.539 -166.558 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ptt? . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 124.582 2.134 . . . . 17.170000000000002 108.851 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -99.03 132.7 44.15 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 116.585 -3.822 . . . . 21.890000000000001 113.089 -169.551 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 pt -120.46 154.5 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.08 -1.013 . . . . 10.83 110.331 175.661 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -124.52 125.01 43.51 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.073 -1.642 . . . . 10.609999999999999 106.706 -174.315 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.476 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 22.7 t -109.54 102.56 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 124.46 2.076 . . . . 9.1300000000000008 110.335 -178.229 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -83.61 126.28 32.68 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 127.284 3.421 . . . . 20.550000000000001 116.311 172.725 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.6 p -78.96 174.31 11.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.928 2.299 . . . . 11.779999999999999 112.612 -175.745 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.48 HD13 HG12 ' A' ' 70' ' ' VAL . 12.5 tp -75.6 -36.23 60.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.61 -2.556 . . . . 19.309999999999999 109.889 -177.018 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -61.68 -37.63 84.82 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.076 -3.515 . . . . 23.140000000000001 116.678 170.519 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.36 43.28 0.6 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 120.227 1.376 . . . . 19.739999999999998 111.066 174.546 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -111.18 151.17 28.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.611 1.708 . . . . 21.93 115.611 161.911 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -97.36 115.51 27.85 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.214 -1.554 . . . . 12.33 113.568 171.577 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.476 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 10.0 mt -93.04 92.18 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 126.366 2.984 . . . . 17.079999999999998 111.165 170.699 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.3 m -82.91 105.22 13.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.551 -2.113 . . . . 16.300000000000001 113.122 -173.956 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.86 158.38 17.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.738 -2.69 . . . . 15.880000000000001 103.738 -169.938 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -110.97 133.29 53.5 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.395 -2.69 . . . . 28.899999999999999 108.437 164.146 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.92 169.15 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.006 -2.961 . . . . 12.050000000000001 103.006 -171.502 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.48 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 73.7 mm-40 -100.88 174.15 3.16 Favored Pre-proline 0 N--CA 1.429 -1.485 1 O-C-N 114.432 -5.168 . . . . 18.170000000000002 104.14 165.882 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 69.2 Cg_endo -78.29 -15.3 14.34 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 CA-C-N 123.239 2.192 . . . . 8.1600000000000001 116.133 168.937 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.7 p -77.91 -5.46 51.16 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.57 2.348 . . . . 11.130000000000001 114.688 176.366 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -70.84 148.25 48.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.588 -3.82 . . . . 18.030000000000001 112.456 178.428 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.9 p -93.0 148.01 22.35 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 129.477 4.236 . . . . 10.220000000000001 108.644 178.134 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.8 mm -52.21 -32.49 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 125.781 2.705 . . . . 12.300000000000001 116.144 173.144 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -67.61 -39.18 84.74 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.617 -3.802 . . . . 36.509999999999998 113.106 174.742 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -78.64 -6.76 56.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 114.483 -2.887 . . . . 25.66 110.548 -179.665 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.3 t -86.56 -43.59 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 130.762 3.625 . . . . 8.1199999999999992 110.026 171.806 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -51.25 -33.27 27.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.36 -3.338 . . . . 15.470000000000001 119.093 161.4 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.7 -19.04 63.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.327 -2.108 . . . . 11.449999999999999 114.407 177.849 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -78.89 -39.98 33.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.364 -1.347 . . . . 24.98 107.364 174.117 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 mt -74.36 -40.48 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.742 -1.849 . . . . 9.4600000000000009 107.965 -176.652 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -54.1 -45.44 71.82 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.99 -2.944 . . . . 14.76 110.714 173.014 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -64.81 -52.64 55.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.749 -1.844 . . . . 26.289999999999999 111.081 -176.65 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.58 -66.96 0.54 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.102 2.26 . . . . 30.059999999999999 117.102 -176.393 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -67.47 -49.73 62.25 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.507 2.379 . . . . 25.190000000000001 113.334 -172.174 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.85 13.34 16.39 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-N 113.22 -1.809 . . . . 7.4100000000000001 115.387 178.49 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.1 mt -89.08 127.15 56.62 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 126.926 2.091 . . . . 9.4900000000000002 108.801 -171.559 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -67.71 139.37 48.02 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-O 116.192 -1.67 . . . . 11.42 113.397 -177.878 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -73.34 -14.57 25.37 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 124.253 2.554 . . . . 12.0 118.301 -166.371 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -35.94 63.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 120.374 1.443 . . . . 35.549999999999997 111.299 172.172 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.55 -41.13 89.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 117.061 2.245 . . . . 20.52 117.061 166.688 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -63.65 117.53 6.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.904 3.282 . . . . 7.1299999999999999 109.375 -176.031 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.414 ' HB3' HG23 ' A' ' 70' ' ' VAL . 27.3 ttm180 -116.88 101.25 8.37 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.054 -2.904 . . . . 36.390000000000001 104.649 176.429 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.6 tp -96.43 115.33 27.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.749 3.219 . . . . 9.5500000000000007 108.95 -172.32 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -114.97 154.38 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.928 2.891 . . . . 13.9 110.761 -171.391 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.89 -91.4 0.24 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 116.58 -1.676 . . . . 6.8600000000000003 106.622 174.264 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.54 -75.46 0.6 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.183 2.177 . . . . 11.15 106.019 178.786 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.95 -32.57 3.77 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 109.347 -3.57 . . . . 13.93 117.407 -175.062 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 8.2 ptpt -99.08 152.08 20.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.758 3.17 . . . . 23.920000000000002 116.869 173.083 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -88.89 133.5 34.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.852 -2.405 . . . . 23.23 113.014 171.557 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.8 mt -89.82 123.71 34.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.343 -1.473 . . . . 9.1099999999999994 110.973 -176.485 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -95.62 138.48 33.23 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.302 2.241 . . . . 33.439999999999998 107.562 -169.174 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -34.27 -49.89 0.39 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.843 3.657 . . . . 28.370000000000001 120.668 -168.869 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.55 -8.46 59.63 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 119.899 -1.751 . . . . 15.0 115.657 -164.453 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -83.59 154.38 23.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.864 -2.551 . . . . 25.5 108.43 -175.903 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -89.27 166.77 13.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.839 1.781 . . . . 11.949999999999999 115.312 176.759 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.47 -31.6 71.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 118.976 2.954 . . . . 10.17 118.976 169.71 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -61.12 -30.71 70.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.032 2.133 . . . . 13.59 115.33 163.325 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -72.02 -42.86 65.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.865 1.793 . . . . 11.699999999999999 110.82 174.41 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -83.31 -17.04 43.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.796 2.517 . . . . 12.949999999999999 117.796 -174.612 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 28.0 m120 78.52 45.96 0.06 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 131.0 3.72 . . . . 25.449999999999999 109.941 -179.005 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -83.06 123.91 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.413 -2.679 . . . . 14.6 105.78 167.605 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -112.42 -157.07 0.61 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.861 -2.274 . . . . 33.229999999999997 104.861 -179.382 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -85.32 153.23 22.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.097 1.147 . . . . 25.969999999999999 114.097 -178.826 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 57.03 34.11 24.41 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.526 -3.234 . . . . 32.609999999999999 111.749 -176.747 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -77.88 138.85 39.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.077 -1.083 . . . . 10.56 108.077 -178.288 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 m -98.93 118.79 36.5 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.437 -1.32 . . . . 5.3300000000000001 107.437 167.801 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.7 mt -106.36 176.41 5.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 123.386 0.674 . . . . 11.66 109.992 169.994 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -136.55 135.91 38.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 103.577 -2.749 . . . . 16.300000000000001 103.577 -168.444 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.4 tp -117.17 119.97 36.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.967 -3.583 . . . . 9.9600000000000009 108.42 173.28 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.48 HG12 HD13 ' A' ' 8' ' ' LEU . 27.9 m -116.9 166.97 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.734 2.207 . . . . 9.7599999999999998 110.055 163.091 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.429 -1.481 0 O-C-N 120.211 -1.556 . . . . 19.57 108.992 179.673 . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.458 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 121.271 0.558 . . . . 17.170000000000002 111.406 . . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -77.69 126.47 30.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.593 -3.817 . . . . 21.890000000000001 112.39 -173.614 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -115.19 139.45 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 119.369 0.986 . . . . 10.83 110.569 168.601 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -99.91 109.13 21.51 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.568 2.604 . . . . 10.609999999999999 111.555 179.282 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.8 t -92.03 105.82 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 119.576 -1.953 . . . . 9.1300000000000008 106.195 175.411 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.281 71.8 mttt -86.3 138.08 32.11 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.974 1.102 . . . . 20.550000000000001 113.974 -179.867 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.273 8.7 p -99.93 176.05 5.56 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.516 -3.24 . . . . 11.779999999999999 112.702 -167.89 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.278 27.7 tp -71.58 -55.6 7.47 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.424 3.489 . . . . 19.309999999999999 115.158 -174.453 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.414 67.6 p -56.53 -63.3 1.24 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.059 -1.65 . . . . 23.140000000000001 113.727 165.142 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.64 60.49 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 122.502 3.761 . . . . 19.739999999999998 122.502 -177.979 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.15 166.51 13.85 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.753 -3.204 . . . . 21.93 105.882 175.543 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -117.51 130.24 56.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.036 2.236 . . . . 12.33 117.036 158.678 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.8 mt -101.37 112.05 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 117.373 -1.731 . . . . 17.079999999999998 110.027 175.214 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.272 90.6 m -93.57 115.36 27.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.891 -3.631 . . . . 16.300000000000001 110.99 177.768 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.28 50.9 mt -119.42 134.37 55.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.737 -1.579 . . . . 15.880000000000001 106.737 -173.455 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -96.94 94.68 7.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.918 3.287 . . . . 28.899999999999999 109.038 -179.53 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.9 m -119.45 159.2 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 118.01 -2.931 . . . . 12.050000000000001 105.477 -169.133 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -113.87 155.85 44.64 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 116.556 -3.84 . . . . 18.170000000000002 106.959 171.351 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.306 69.2 Cg_endo -65.54 -9.61 23.16 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 125.153 3.902 . . . . 8.1600000000000001 121.387 -164.203 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -94.61 -11.37 29.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.359 -1.463 . . . . 11.130000000000001 113.676 -179.612 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -64.22 143.52 57.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.158 2.183 . . . . 18.030000000000001 113.902 171.743 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -93.49 165.12 12.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.523 -1.361 . . . . 10.220000000000001 110.266 -166.464 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -66.91 -31.57 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 115.878 1.807 . . . . 12.300000000000001 115.878 171.235 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -49.51 -48.02 48.41 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.111 1.507 . . . . 36.509999999999998 113.39 166.766 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -81.11 -16.26 53.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.283 -1.326 . . . . 25.66 109.177 -178.375 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.81 -47.01 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 123.358 2.799 . . . . 8.1199999999999992 109.924 173.722 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -50.68 -38.52 47.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.289 2.235 . . . . 15.470000000000001 114.375 174.365 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.309 . . -62.53 -37.17 85.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.253 -2.308 . . . . 11.449999999999999 112.757 173.325 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -67.9 -49.06 64.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.382 1.446 . . . . 24.98 112.662 175.443 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.99 -36.86 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 O-C-N 115.978 -4.201 . . . . 9.4600000000000009 107.99 -179.096 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.43 -38.34 86.81 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.151 -3.468 . . . . 14.76 115.569 174.305 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -72.95 -43.51 62.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.242 1.942 . . . . 26.289999999999999 116.242 178.655 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -64.41 -69.86 0.26 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 120.847 3.647 . . . . 30.059999999999999 120.847 175.512 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -94.28 -2.56 52.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.068 -1.645 . . . . 25.190000000000001 111.966 -175.845 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.99 41.65 87.05 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 122.411 2.369 . . . . 7.4100000000000001 118.215 -178.302 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 mm -106.28 107.87 60.69 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 114.416 -2.707 . . . . 9.4900000000000002 108.972 -178.053 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.18 144.98 78.93 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 123.466 2.273 . . . . 11.42 117.319 177.165 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.34 -13.19 32.96 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 123.67 2.913 . . . . 12.0 112.0 -166.875 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -85.87 -9.38 57.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.839 3.255 . . . . 35.549999999999997 107.863 179.016 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -107.07 -15.45 14.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.53 -1.356 . . . . 20.52 114.413 171.088 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -81.47 99.26 8.66 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.613 -3.179 . . . . 7.1299999999999999 113.867 -179.258 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -91.88 107.1 18.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.685 -3.135 . . . . 36.390000000000001 107.011 170.56 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.9 134.47 41.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.742 -1.947 . . . . 9.5500000000000007 105.742 -177.685 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -123.39 132.91 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 130.257 3.423 . . . . 13.9 110.458 -179.522 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -107.98 112.06 24.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.536 -2.602 . . . . 6.8600000000000003 106.62 158.372 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.35 -86.84 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 131.927 4.091 . . . . 11.15 109.276 178.712 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.14 16.67 3.42 Favored Glycine 0 N--CA 1.43 -1.742 1 O-C-N 115.396 -4.565 . . . . 13.93 111.801 162.441 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.255 88.7 mttt -87.17 122.53 31.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.848 2.324 . . . . 23.920000000000002 111.105 172.988 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -84.86 106.48 16.42 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 121.099 1.772 . . . . 23.23 108.165 178.377 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.35 139.48 58.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.52 2.328 . . . . 9.1099999999999994 109.732 -174.015 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -100.35 140.74 34.16 Favored 'General case' 0 N--CA 1.43 -1.474 1 C-N-CA 131.735 4.014 . . . . 33.439999999999998 111.907 -175.785 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -54.88 -54.01 48.07 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.133 2.573 . . . . 28.370000000000001 113.661 -168.49 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.32 7.12 61.66 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 129.86 3.6 . . . . 15.0 114.978 -173.73 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -107.82 170.46 7.97 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.823 -1.177 . . . . 25.5 107.823 176.603 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.0 p -110.07 172.37 6.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.772 2.701 . . . . 11.949999999999999 115.877 -174.672 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 14.1 mt -59.2 -48.43 81.63 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.985 -2.947 . . . . 10.17 112.988 162.791 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.6 p -58.49 -23.18 57.22 Favored 'General case' 0 N--CA 1.43 -1.451 1 N-CA-C 123.196 4.517 . . . . 13.59 123.196 173.17 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.313 15.6 t70 -74.16 -50.47 19.19 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.741 -2.475 . . . . 11.699999999999999 110.989 177.106 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -73.62 -21.62 60.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.188 1.921 . . . . 12.949999999999999 116.188 177.92 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 67.8 m-20 80.78 47.93 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 127.958 3.742 . . . . 25.449999999999999 114.071 -176.604 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.7 mt -77.88 134.97 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.29 -2.756 . . . . 14.6 108.37 168.976 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -121.14 -158.11 0.75 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.296 1.622 . . . . 33.229999999999997 108.57 176.525 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 7.2 ptmm? -77.67 158.72 29.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.984 3.278 . . . . 25.969999999999999 113.334 170.814 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 64.91 24.69 12.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.032 -2.293 . . . . 32.609999999999999 109.333 168.658 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -91.35 148.51 22.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.031 -2.293 . . . . 10.56 109.62 -170.02 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -102.86 120.83 41.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.986 -1.696 . . . . 5.3300000000000001 109.156 173.921 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.28 160.27 16.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 102.932 -2.988 . . . . 11.66 102.932 174.025 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -122.54 134.18 54.55 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.026 -4.171 . . . . 16.300000000000001 105.332 179.395 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tp -100.52 129.93 46.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 128.613 3.696 . . . . 9.9600000000000009 105.663 167.788 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.66 168.32 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 101.833 -3.395 . . . . 9.7599999999999998 101.833 175.575 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.8 tp . . . . . 0 N--CA 1.431 -1.417 0 N-CA-C 117.403 2.371 . . . . 19.57 117.403 -176.151 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 CA--C 1.489 -1.387 0 CA-C-O 124.832 2.254 . . . . 17.170000000000002 113.517 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -105.46 148.39 27.24 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.649 -3.157 . . . . 21.890000000000001 106.38 179.405 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.1 pt -130.27 153.84 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.286 -2.487 . . . . 10.83 104.286 172.64 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -109.21 113.77 26.9 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.881 -1.509 . . . . 10.609999999999999 110.75 173.574 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -95.5 110.83 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.294 -1.002 . . . . 9.1300000000000008 108.294 170.599 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -102.57 142.71 33.3 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.46 1.124 . . . . 20.550000000000001 113.06 -176.334 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 p -87.43 174.65 8.39 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 110.779 -2.919 . . . . 11.779999999999999 114.816 175.522 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.32 -49.75 62.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.538 -2.601 . . . . 19.309999999999999 115.027 167.957 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.8 p -69.89 -46.09 66.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.769 1.622 . . . . 23.140000000000001 112.41 176.914 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.36 54.25 0.13 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 119.7 -1.875 . . . . 19.739999999999998 108.523 173.589 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.26 132.41 54.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.497 1.519 . . . . 21.93 112.059 159.023 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -99.25 112.71 24.81 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 121.12 1.782 . . . . 12.33 111.842 178.378 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 mt -85.98 109.22 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.269 -2.863 . . . . 17.079999999999998 103.269 176.314 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.2 m -104.08 101.02 10.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.016 -1.476 . . . . 16.300000000000001 107.016 -175.185 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.0 mt -97.93 131.59 44.25 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.719 1.748 . . . . 15.880000000000001 115.719 173.412 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -75.75 124.35 27.12 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.578 2.132 . . . . 28.899999999999999 105.997 160.999 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.1 169.33 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 104.701 -2.333 . . . . 12.050000000000001 104.701 -179.988 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -104.49 152.3 39.33 Favored Pre-proline 0 N--CA 1.43 -1.444 0 C-N-CA 124.093 0.957 . . . . 18.170000000000002 112.67 155.009 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -63.74 -9.95 20.52 Favored 'Trans proline' 0 N--CA 1.434 -2.005 1 C-N-CA 127.248 5.299 . . . . 8.1600000000000001 113.124 -179.378 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.5 m -90.93 -7.76 51.22 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.645 1.72 . . . . 11.130000000000001 115.645 170.429 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -67.31 159.79 28.53 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.709 1.719 . . . . 18.030000000000001 114.328 174.011 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.326 71.1 p -86.83 168.9 13.04 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.869 -1.144 . . . . 10.220000000000001 114.035 -177.398 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.426 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 29.1 mm -60.61 -36.29 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 119.219 -2.176 . . . . 12.300000000000001 115.504 158.311 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -57.47 -33.75 68.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 126.837 3.208 . . . . 36.509999999999998 114.61 171.961 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -79.76 -23.98 41.84 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.537 -5.727 . . . . 25.66 111.154 179.547 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 55.2 t -69.11 -51.46 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 115.485 -0.779 . . . . 8.1199999999999992 112.736 168.458 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -56.62 -31.76 64.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.92 1.688 . . . . 15.470000000000001 112.815 178.448 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.47 75.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.901 2.137 . . . . 11.449999999999999 114.457 176.9 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -80.09 -31.12 39.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.747 2.689 . . . . 24.98 112.485 178.321 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.28 -38.11 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 1 O-C-N 115.538 -4.477 . . . . 9.4600000000000009 110.59 171.399 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -69.7 -29.94 67.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.585 -3.197 . . . . 14.76 119.152 171.268 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -76.24 -57.6 3.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.401 1.572 . . . . 26.289999999999999 113.286 171.336 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -78.1 -66.96 0.78 Allowed 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 115.114 -4.742 . . . . 30.059999999999999 109.567 -167.155 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -72.03 -38.71 69.5 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.981 2.8 . . . . 25.190000000000001 116.848 -175.084 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.04 43.12 2.28 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.968 -2.333 . . . . 7.4100000000000001 114.952 178.796 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mm -98.66 117.25 64.8 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 112.786 -3.483 . . . . 9.4900000000000002 111.073 -179.792 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -68.27 165.11 29.82 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 CA-C-N 125.207 2.895 . . . . 11.42 114.8 -177.553 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -79.34 -28.17 3.83 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 121.791 1.675 . . . . 12.0 112.737 -153.84 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -79.55 -30.65 41.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 127.513 3.008 . . . . 35.549999999999997 107.251 177.191 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -74.0 -16.65 61.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.238 -3.414 . . . . 20.52 112.222 -178.314 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -86.68 118.6 26.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.145 2.402 . . . . 7.1299999999999999 112.815 176.714 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -108.22 125.81 52.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.515 -3.143 . . . . 36.390000000000001 102.515 160.665 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -102.03 123.82 46.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 110.999 -2.818 . . . . 9.5500000000000007 106.391 168.035 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.6 mm -121.62 140.83 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 100.975 -3.713 . . . . 13.9 100.975 -173.266 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -126.72 122.77 35.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 116.323 -1.799 . . . . 6.8600000000000003 106.773 165.053 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.67 -92.28 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.785 1.63 . . . . 11.15 112.383 -164.478 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.67 -7.28 5.73 Favored Glycine 0 N--CA 1.431 -1.678 0 C-N-CA 127.659 2.552 . . . . 13.93 109.394 -179.305 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -103.52 119.79 39.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 118.497 2.777 . . . . 23.920000000000002 118.497 -166.874 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -69.43 112.19 5.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.668 1.359 . . . . 23.23 114.668 -178.621 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.2 mt -80.46 112.14 17.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.562 0.696 . . . . 9.1099999999999994 112.017 -179.862 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -85.94 168.48 14.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.409 2.684 . . . . 33.439999999999998 109.83 -170.808 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.62 -46.86 62.54 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 113.359 -5.838 . . . . 28.370000000000001 115.351 -165.441 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.63 32.0 6.68 Favored Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 126.922 2.201 . . . . 15.0 116.418 -168.607 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.8 mtt-85 -130.68 159.09 38.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.594 -3.484 . . . . 25.5 101.594 -177.771 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 p -87.8 156.79 19.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 131.511 3.925 . . . . 11.949999999999999 111.815 174.046 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.86 -28.78 68.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.016 -1.447 . . . . 10.17 111.612 178.843 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.291 68.8 p -59.28 -36.58 75.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.03 2.233 . . . . 13.59 117.03 165.972 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -81.93 -29.3 32.35 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.686 -4.384 . . . . 11.699999999999999 106.158 -170.816 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -72.86 -20.79 61.05 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 121.187 3.773 . . . . 12.949999999999999 121.187 160.874 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.389 15.6 m120 70.86 34.65 1.91 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.386 -2.071 . . . . 25.449999999999999 112.892 -174.479 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -88.46 132.21 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 101.42 -3.548 . . . . 14.6 101.42 171.859 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.271 81.9 mt-30 -98.53 175.22 6.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 109.864 -3.335 . . . . 33.229999999999997 114.869 174.211 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -45.71 137.73 5.14 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.549 2.74 . . . . 25.969999999999999 111.963 160.467 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 60.04 24.34 13.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.915 2.561 . . . . 32.609999999999999 117.915 177.466 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -78.08 154.22 31.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.215 -2.178 . . . . 10.56 106.408 -168.049 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.4 m -98.0 108.71 21.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 117.246 -1.359 . . . . 5.3300000000000001 111.975 173.277 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.07 158.2 16.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 125.114 1.509 . . . . 11.66 109.457 175.781 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -121.71 130.86 53.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.115 -2.241 . . . . 16.300000000000001 113.079 -178.167 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -87.55 100.8 13.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.314 3.046 . . . . 9.9600000000000009 110.928 169.402 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 t -96.94 120.26 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.99 -1.694 . . . . 9.7599999999999998 113.031 174.05 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 tp . . . . . 0 N--CA 1.43 -1.459 0 O-C-N 116.541 -3.849 . . . . 19.57 108.655 -175.797 . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 117.664 2.468 . . . . 17.170000000000002 117.664 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -91.71 134.75 34.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 126.243 2.925 . . . . 21.890000000000001 113.688 179.971 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.4 pt -121.69 161.86 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 117.422 -3.299 . . . . 10.83 112.83 172.763 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -111.33 116.59 31.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 123.694 0.621 . . . . 10.609999999999999 111.589 179.806 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.6 HG21 HD12 ' A' ' 15' ' ' LEU . 15.5 t -103.56 108.6 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 118.728 -2.482 . . . . 9.1300000000000008 107.924 -175.383 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -97.5 119.96 37.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.41 2.052 . . . . 20.550000000000001 110.689 -172.108 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 2.2 p -76.66 175.35 9.41 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.568 -1.197 . . . . 11.779999999999999 111.931 -173.803 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.04 -40.52 75.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 124.219 1.961 . . . . 19.309999999999999 112.869 175.796 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 p -76.91 -21.14 55.34 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.483 2.313 . . . . 23.140000000000001 114.538 177.33 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.51 26.81 2.77 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 118.956 -1.592 . . . . 19.739999999999998 110.069 153.403 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -83.6 139.06 33.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 116.831 -1.556 . . . . 21.93 111.487 178.329 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -93.34 105.34 17.42 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.339 2.336 . . . . 12.33 109.837 168.161 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.18 119.94 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 125.013 2.339 . . . . 17.079999999999998 106.886 176.249 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.7 m -81.14 115.71 20.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.845 -2.409 . . . . 16.300000000000001 109.216 169.683 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.6 HD12 HG21 ' A' ' 5' ' ' VAL . 64.9 mt -123.41 144.65 49.35 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 113.186 -5.946 . . . . 15.880000000000001 106.922 177.361 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -89.99 108.78 19.93 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.051 1.74 . . . . 28.899999999999999 115.136 167.835 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.85 155.92 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 114.655 -1.157 . . . . 12.050000000000001 108.915 -179.412 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -109.06 152.4 42.47 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 101.081 -3.674 . . . . 18.170000000000002 101.081 163.148 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -65.83 -23.39 55.34 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 C-N-CA 126.271 4.647 . . . . 8.1600000000000001 112.34 -172.991 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.5 m -90.61 1.73 56.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.795 -3.066 . . . . 11.130000000000001 110.731 179.179 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -78.96 161.22 26.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 123.572 2.897 . . . . 18.030000000000001 104.177 175.374 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.0 p -108.03 167.36 10.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.803 -1.925 . . . . 10.220000000000001 105.803 -168.062 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.4 mm -74.62 -34.51 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 C-N-CA 128.921 2.888 . . . . 12.300000000000001 104.662 -171.587 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.87 -38.55 72.91 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.846 -4.284 . . . . 36.509999999999998 119.428 169.933 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -70.6 -19.3 62.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.006 -1.906 . . . . 25.66 114.839 169.916 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -79.14 -37.31 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 118.048 -1.461 . . . . 8.1199999999999992 110.948 175.884 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -67.96 -30.31 69.57 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 130.575 3.55 . . . . 15.470000000000001 111.033 176.568 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.69 -41.84 36.63 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.874 -2.391 . . . . 11.449999999999999 111.771 -175.755 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -61.21 -34.23 74.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.102 -2.874 . . . . 24.98 113.546 170.304 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.299 65.9 mt -65.17 -39.8 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 125.532 1.77 . . . . 9.4600000000000009 115.701 169.531 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -57.64 -53.41 58.51 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.728 -3.733 . . . . 14.76 112.541 173.78 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -67.83 -44.82 76.33 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.112 -2.313 . . . . 26.289999999999999 115.68 -177.6 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -83.02 -50.22 8.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.088 -1.434 . . . . 30.059999999999999 113.985 -178.678 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -94.76 -55.64 3.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.134 2.397 . . . . 25.190000000000001 111.438 -176.655 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.64 40.74 2.47 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 118.559 -1.781 . . . . 7.4100000000000001 117.141 -176.512 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.1 mm -90.04 131.17 39.87 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 118.275 -2.897 . . . . 9.4900000000000002 109.006 167.778 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -67.93 144.21 63.61 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 128.101 3.929 . . . . 11.42 118.298 -174.58 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -81.61 -3.59 11.96 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 124.082 3.188 . . . . 12.0 114.639 -163.502 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.83 -23.57 45.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.066 -1.646 . . . . 35.549999999999997 115.428 165.661 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -89.53 -24.18 21.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.35 1.86 . . . . 20.52 111.234 -179.754 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -78.8 96.63 5.67 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.195 -2.191 . . . . 7.1299999999999999 109.951 -173.177 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -109.28 127.05 53.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.408 -2.441 . . . . 36.390000000000001 104.408 171.706 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.571 ' HB3' HD12 ' A' ' 50' ' ' LEU . 14.8 mt -107.28 127.26 53.39 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 116.871 -1.538 . . . . 9.5500000000000007 108.672 -168.368 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 51.7 mm -117.92 137.79 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 125.323 1.639 . . . . 13.9 109.14 179.404 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -131.42 127.59 37.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 125.211 3.642 . . . . 6.8600000000000003 106.736 155.951 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.75 -106.89 0.35 Allowed 'General case' 0 N--CA 1.429 -1.482 1 C-N-CA 132.203 4.201 . . . . 11.15 113.649 -171.759 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.32 6.2 19.13 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.118 -2.239 . . . . 13.93 109.267 -177.761 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -122.4 142.1 50.89 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 116.068 -4.196 . . . . 23.920000000000002 107.989 -174.194 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -76.26 137.55 40.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.22 -1.355 . . . . 23.23 110.594 175.093 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.571 HD12 ' HB3' ' A' ' 43' ' ' LEU . 40.5 mt -86.04 112.85 21.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.0 -1.0 . . . . 9.1099999999999994 111.01 179.845 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -88.3 137.57 32.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 128.127 3.822 . . . . 33.439999999999998 109.907 -178.442 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.32 -62.44 1.48 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 110.023 -3.262 . . . . 28.370000000000001 116.372 -164.054 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.7 19.4 37.33 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 117.735 -3.103 . . . . 15.0 114.077 -171.73 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -92.38 171.08 9.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.452 2.019 . . . . 25.5 116.452 166.348 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 p -98.38 161.23 13.79 Favored 'General case' 0 N--CA 1.43 -1.459 1 CA-C-O 128.569 4.033 . . . . 11.949999999999999 110.269 178.856 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.325 5.5 mp -68.8 -36.99 78.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 111.362 -2.654 . . . . 10.17 110.604 172.377 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 p -50.92 -39.57 54.88 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.132 2.271 . . . . 13.59 117.132 162.865 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.9 -29.37 67.63 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.127 1.899 . . . . 11.699999999999999 116.127 -177.369 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -94.58 0.73 55.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.783 2.433 . . . . 12.949999999999999 115.382 178.002 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m120 68.05 33.0 4.73 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.299 -1.319 . . . . 25.449999999999999 113.701 -179.733 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.255 86.5 mt -78.47 116.4 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 124.848 1.259 . . . . 14.6 109.099 -174.065 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -93.05 173.35 7.78 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.117 -2.864 . . . . 33.229999999999997 109.974 -174.126 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -75.8 150.25 37.75 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.642 -3.161 . . . . 25.969999999999999 113.237 175.127 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.311 88.4 mt-10 64.83 39.97 5.78 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 131.568 3.947 . . . . 32.609999999999999 109.985 176.813 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.1 m -103.09 145.85 29.28 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.358 3.063 . . . . 10.56 112.064 -179.725 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -96.43 116.35 28.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 118.17 -1.412 . . . . 5.3300000000000001 112.828 -178.073 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.02 157.3 20.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.767 1.765 . . . . 11.66 115.767 165.364 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 10.9 m-70 -105.52 112.23 25.24 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.01 -2.931 . . . . 16.300000000000001 116.108 172.086 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 15.5 tp -96.21 104.86 16.85 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 119.857 -0.737 . . . . 9.9600000000000009 111.391 175.886 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.02 155.86 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 125.466 1.506 . . . . 9.7599999999999998 114.304 -166.259 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.3 tp . . . . . 0 N--CA 1.43 -1.436 0 O-C-N 118.662 -2.523 . . . . 19.57 115.384 -179.548 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 118.112 -0.947 . . . . 17.170000000000002 110.291 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -101.58 159.22 15.48 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.033 1.873 . . . . 21.890000000000001 113.826 165.719 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -135.8 157.29 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 126.227 1.811 . . . . 10.83 106.452 -179.696 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -112.07 117.46 32.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.874 -3.016 . . . . 10.609999999999999 112.809 175.613 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.7 t -99.15 122.26 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 102.919 -2.993 . . . . 9.1300000000000008 102.919 -175.435 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -122.87 120.87 34.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.136 -1.602 . . . . 20.550000000000001 112.071 -171.021 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -92.86 176.87 6.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.889 1.675 . . . . 11.779999999999999 109.626 -169.672 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -79.59 -31.8 41.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.863 -1.971 . . . . 19.309999999999999 113.027 -171.446 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.15 -62.88 1.36 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.047 1.739 . . . . 23.140000000000001 108.573 174.904 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.9 37.56 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.66 1 C-N-CA 113.35 -4.262 . . . . 19.739999999999998 106.365 156.921 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -88.77 130.33 35.38 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.105 -2.409 . . . . 21.93 109.646 -176.846 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -103.26 101.8 11.74 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.746 -1.575 . . . . 12.33 106.746 -178.11 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mt -93.19 131.82 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.892 -1.892 . . . . 17.079999999999998 105.892 -175.027 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 m -80.78 114.72 19.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.126 -1.805 . . . . 16.300000000000001 106.126 166.074 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 tp -127.89 125.28 39.34 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.954 2.101 . . . . 15.880000000000001 106.721 -177.946 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -103.26 133.63 48.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.945 -2.972 . . . . 28.899999999999999 110.937 -176.415 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -162.05 164.37 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 104.886 -2.264 . . . . 12.050000000000001 104.886 -160.252 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -126.64 141.25 39.68 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 117.594 -1.193 . . . . 18.170000000000002 111.244 177.953 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -67.17 -15.41 46.23 Favored 'Trans proline' 0 C--N 1.3 -1.98 1 C-N-CA 127.05 5.167 . . . . 8.1600000000000001 113.389 -166.739 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -89.49 -13.62 37.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 123.226 2.739 . . . . 11.130000000000001 112.27 -172.774 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.75 170.35 9.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.831 2.729 . . . . 18.030000000000001 108.019 -177.177 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -89.49 172.1 9.24 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.901 -2.999 . . . . 10.220000000000001 110.617 -164.496 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -70.83 -30.21 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.142 -2.224 . . . . 12.300000000000001 109.474 175.486 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -49.09 -39.06 26.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.513 -3.242 . . . . 36.509999999999998 115.702 161.711 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -64.63 -48.72 73.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.58 -1.95 . . . . 25.66 111.512 171.408 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.7 -44.51 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 117.899 2.555 . . . . 8.1199999999999992 117.899 173.322 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' NZ ' ' OD1' ' A' ' 52' ' ' ASP . 26.0 ttmt -53.69 -35.64 61.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.286 -2.759 . . . . 15.470000000000001 116.922 168.49 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.56 -21.65 61.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.02 2.6 . . . . 11.449999999999999 118.02 -177.98 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -86.52 -32.63 20.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 130.61 3.564 . . . . 24.98 108.432 -175.992 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.2 mt -76.81 -33.07 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 119.768 1.167 . . . . 9.4600000000000009 109.28 175.036 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -54.1 -36.53 63.31 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.509 2.04 . . . . 14.76 116.509 167.641 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.54 -54.9 4.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.475 1.287 . . . . 26.289999999999999 114.475 -178.658 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -71.15 -73.86 0.16 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.805 1.941 . . . . 30.059999999999999 112.107 -174.951 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.44 -37.18 82.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.015 2.228 . . . . 25.190000000000001 117.015 173.49 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.0 30.11 11.68 Favored Glycine 0 N--CA 1.43 -1.718 1 O-C-N 115.624 -4.423 . . . . 7.4100000000000001 115.611 -176.493 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mm -87.12 125.59 65.67 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-O 115.911 -1.995 . . . . 9.4900000000000002 116.221 169.692 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -83.87 161.91 13.99 Favored 'Trans proline' 0 C--N 1.3 -2.002 1 CA-C-N 129.345 4.373 . . . . 11.42 114.91 -172.799 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -86.02 -11.8 6.33 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 123.465 2.273 . . . . 12.0 114.333 -142.658 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -86.52 -4.5 59.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.873 3.669 . . . . 35.549999999999997 114.971 168.059 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.27 57.9 mt-30 -106.54 6.0 29.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.34 -1.475 . . . . 20.52 110.964 176.471 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -99.57 101.16 12.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.813 2.097 . . . . 7.1299999999999999 113.126 -177.002 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -99.15 109.81 22.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.355 1.074 . . . . 36.390000000000001 112.229 174.423 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 mt -103.92 136.22 43.98 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.642 -1.163 . . . . 9.5500000000000007 113.729 177.914 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.33 131.91 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.955 2.034 . . . . 13.9 106.267 -179.92 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.436 ' HB3' HD21 ' A' ' 50' ' ' LEU . 82.6 t80 -116.62 125.66 52.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.111 -1.44 . . . . 6.8600000000000003 107.111 163.884 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.346 . . 59.18 -106.09 0.28 Allowed 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.613 2.149 . . . . 11.15 116.112 -171.107 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.88 57.14 0.71 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 120.074 -1.641 . . . . 13.93 114.435 159.92 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -145.45 146.2 31.4 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.704 2.802 . . . . 23.920000000000002 108.803 178.817 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -93.48 130.65 39.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.864 2.603 . . . . 23.23 110.618 175.405 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 45' ' ' PHE . 43.3 mt -87.26 114.47 23.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.573 -3.204 . . . . 9.1099999999999994 110.73 -170.817 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.21 153.36 18.66 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.318 2.485 . . . . 33.439999999999998 109.331 -169.979 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 28.2 m-20 -52.61 -49.26 65.42 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 117.01 -3.556 . . . . 28.370000000000001 116.756 -159.036 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.18 4.52 77.65 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 119.74 -1.85 . . . . 15.0 114.709 -171.376 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -83.71 163.88 19.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.302 -2.881 . . . . 25.5 106.896 -178.373 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -102.66 173.55 6.28 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.424 2.009 . . . . 11.949999999999999 116.424 170.949 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 mt -79.39 -29.46 42.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.455 -1.403 . . . . 10.17 108.327 177.378 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.9 p -65.51 -27.84 68.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.434 -1.27 . . . . 13.59 111.953 177.715 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.28 -56.48 21.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.825 2.05 . . . . 11.699999999999999 110.143 177.62 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.433 ' HB2' HG13 ' A' ' 61' ' ' ILE . 49.7 m-85 -83.11 3.42 30.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.479 -1.237 . . . . 12.949999999999999 113.327 -173.443 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 m120 49.05 61.56 3.06 Favored 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 134.361 5.064 . . . . 25.449999999999999 112.343 -169.274 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 59' ' ' TYR . 74.9 mt -89.88 116.26 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 103.267 -2.864 . . . . 14.6 103.267 -177.604 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -99.19 -167.85 1.54 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.041 3.782 . . . . 33.229999999999997 110.816 -171.368 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -75.8 148.3 38.54 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 113.718 -5.614 . . . . 25.969999999999999 110.213 -177.411 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 35.17 63.55 0.49 Allowed 'General case' 0 N--CA 1.43 -1.459 2 C-N-CA 134.846 5.258 . . . . 32.609999999999999 115.463 -172.992 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.9 t -120.33 146.45 46.12 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 129.461 3.105 . . . . 10.56 108.602 -172.639 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.7 m -77.98 119.05 20.88 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.642 2.464 . . . . 5.3300000000000001 107.543 -175.266 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.96 132.0 53.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.029 -1.045 . . . . 11.66 108.2 158.128 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -85.58 141.23 29.99 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.987 -4.196 . . . . 16.300000000000001 110.71 174.802 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.2 tp -119.28 127.51 53.29 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.273 2.694 . . . . 9.9600000000000009 118.273 175.094 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.31 -160.73 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 123.463 1.601 . . . . 9.7599999999999998 108.548 -178.601 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp . . . . . 0 N--CA 1.429 -1.503 0 CA-C-N 112.535 -2.12 . . . . 19.57 114.161 -174.494 . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.36 0.3 OUTLIER . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 122.441 1.115 . . . . 17.170000000000002 110.066 . . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -88.65 115.67 26.34 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.451 3.1 . . . . 21.890000000000001 113.344 179.923 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.81 171.05 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 118.88 -2.388 . . . . 10.83 104.998 166.565 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -121.6 147.56 45.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.71 2.804 . . . . 10.609999999999999 106.24 173.615 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -128.68 120.92 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 104.009 -2.589 . . . . 9.1300000000000008 104.009 172.671 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -102.29 127.8 49.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.602 2.361 . . . . 20.550000000000001 110.994 -171.355 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.9 p -89.6 169.09 11.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.195 2.426 . . . . 11.779999999999999 109.223 -173.941 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.7 mt -51.55 -40.53 59.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.347 2.259 . . . . 19.309999999999999 115.488 164.384 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.8 p -94.54 -71.69 0.65 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 125.336 1.648 . . . . 23.140000000000001 111.861 -165.507 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.97 48.67 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 120.611 -1.306 . . . . 19.739999999999998 115.94 178.053 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -119.09 140.68 49.69 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.218 1.562 . . . . 21.93 115.218 170.077 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.5 m -104.8 105.85 16.1 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.074 -4.766 . . . . 12.33 108.817 174.181 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.5 mt -91.4 105.43 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 O-C-N 114.552 -5.093 . . . . 17.079999999999998 107.747 -171.539 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -82.52 122.8 28.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.674 1.731 . . . . 16.300000000000001 115.674 178.19 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.5 tp -123.86 154.92 38.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.101 2.228 . . . . 15.880000000000001 113.966 -167.221 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -112.35 129.14 56.4 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.203 1.954 . . . . 28.899999999999999 110.848 165.181 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -148.46 170.34 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 130.292 3.437 . . . . 12.050000000000001 107.781 -179.237 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -120.95 165.18 19.6 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 107.035 -1.468 . . . . 18.170000000000002 107.035 166.564 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -69.9 -21.44 32.82 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-O 127.374 2.989 . . . . 8.1600000000000001 117.789 -172.325 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 m -78.83 -4.91 51.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 111.374 -2.648 . . . . 11.130000000000001 113.279 177.411 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.291 69.3 m-20 -78.35 143.04 37.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.34 2.019 . . . . 18.030000000000001 114.12 173.888 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 2.3 p -89.05 156.59 18.75 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.003 -2.311 . . . . 10.220000000000001 111.524 -168.894 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.7 mm -61.86 -33.92 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 118.55 2.796 . . . . 12.300000000000001 118.55 -179.072 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -44.79 -45.86 10.27 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 120.124 3.379 . . . . 36.509999999999998 120.124 161.623 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -72.63 -44.76 61.5 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.675 2.39 . . . . 25.66 111.097 -177.991 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.92 -48.48 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 114.849 1.426 . . . . 8.1199999999999992 114.849 177.735 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -54.44 -44.34 72.4 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.719 2.008 . . . . 15.470000000000001 115.412 171.439 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.309 . . -48.21 -46.25 34.88 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 120.117 3.377 . . . . 11.449999999999999 120.117 160.663 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -68.7 -35.36 77.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.883 -3.011 . . . . 24.98 114.946 175.066 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.302 63.2 mt -51.62 -49.57 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 110.74 -2.936 . . . . 9.4600000000000009 111.227 172.641 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -64.52 -24.57 67.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.79 3.236 . . . . 14.76 114.704 -179.776 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.48 -30.76 69.68 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.198 -4.064 . . . . 26.289999999999999 111.799 168.882 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -79.3 -66.65 0.84 Allowed 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 116.169 -4.082 . . . . 30.059999999999999 107.588 -173.711 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -121.71 145.57 47.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 103.133 -2.914 . . . . 25.190000000000001 103.133 -173.705 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.64 64.56 4.27 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 117.444 -1.753 . . . . 7.4100000000000001 112.824 -169.84 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.9 mm -110.97 109.7 57.19 Favored Pre-proline 0 N--CA 1.43 -1.473 1 CA-C-O 109.491 -5.052 . . . . 9.4900000000000002 108.443 -173.658 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.12 135.56 69.39 Favored 'Trans proline' 0 C--N 1.299 -2.034 1 C-N-CA 125.445 4.096 . . . . 11.42 115.276 -173.954 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.89 -19.32 65.31 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 CA-C-N 125.3 2.929 . . . . 12.0 116.442 -177.313 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.16 -16.46 49.72 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.271 -1.518 . . . . 35.549999999999997 112.053 175.191 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -99.36 -15.18 18.88 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.162 -2.211 . . . . 20.52 106.447 -177.112 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -77.71 121.76 24.44 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.91 -2.369 . . . . 7.1299999999999999 111.884 -175.987 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -121.31 110.45 16.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.295 -3.378 . . . . 36.390000000000001 104.93 175.055 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.7 mt -94.22 105.48 17.46 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 103.644 -2.724 . . . . 9.5500000000000007 103.644 -174.831 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mm -88.22 133.98 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 126.945 2.098 . . . . 13.9 108.874 167.777 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.458 ' CE2' HG12 ' A' ' 61' ' ' ILE . 70.6 t80 -137.51 109.09 6.98 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 101.444 -3.539 . . . . 6.8600000000000003 101.444 -175.495 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.43 -108.0 0.22 Allowed 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 114.236 -1.347 . . . . 11.15 113.9 -164.784 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.67 -16.71 25.74 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-O 115.774 -2.681 . . . . 13.93 112.584 177.837 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -113.59 147.25 38.39 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.965 2.383 . . . . 23.920000000000002 112.947 -163.001 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -73.95 127.73 33.64 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 127.506 3.527 . . . . 23.23 113.899 159.389 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.32 83.7 mt -78.4 132.99 37.57 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.556 -1.965 . . . . 9.1099999999999994 107.278 170.787 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -106.37 151.27 25.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.628 2.156 . . . . 33.439999999999998 115.473 -170.164 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.35 3.6 m-20 -46.99 -55.05 8.82 Favored 'General case' 0 N--CA 1.43 -1.469 1 N-CA-C 123.673 4.694 . . . . 28.370000000000001 123.673 -164.766 . . . . . . . . 3 2 . 1 . 085 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 5.35 78.52 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 122.128 0.849 . . . . 15.0 113.016 -170.812 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -105.11 152.77 22.38 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.532 1.933 . . . . 25.5 111.626 -172.384 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 56.3 p -89.47 174.25 7.89 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 118.907 -0.568 . . . . 11.949999999999999 109.666 179.582 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.71 -34.91 60.39 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.021 0.915 . . . . 10.17 110.078 174.603 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.7 p -57.57 -40.93 80.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.507 3.523 . . . . 13.59 110.342 173.416 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.11 -44.92 32.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.654 -3.154 . . . . 11.699999999999999 115.904 174.952 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.313 98.3 m-85 -92.37 2.23 56.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.06 -2.9 . . . . 12.949999999999999 115.338 172.101 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.285 18.0 m120 65.38 38.99 5.45 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 117.724 2.491 . . . . 25.449999999999999 117.724 176.267 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.458 HG12 ' CE2' ' A' ' 45' ' ' PHE . 57.2 mt -74.19 138.67 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.665 2.386 . . . . 14.6 108.015 172.934 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -129.66 -167.07 1.75 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.83 -2.419 . . . . 33.229999999999997 108.125 -176.3 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -76.77 158.56 30.81 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.863 -3.023 . . . . 25.969999999999999 113.318 -173.836 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 68.05 20.32 9.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.967 -2.958 . . . . 32.609999999999999 113.306 177.043 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.8 t -106.56 143.49 34.6 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.106 2.962 . . . . 10.56 116.857 -172.682 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -100.97 129.44 46.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.696 0.998 . . . . 5.3300000000000001 113.696 -173.993 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -104.12 152.56 21.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.474 -1.676 . . . . 11.66 106.474 173.171 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -115.74 124.53 51.02 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 116.863 -3.648 . . . . 16.300000000000001 108.677 -176.726 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tp -103.66 107.69 18.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.13 -1.606 . . . . 9.9600000000000009 108.851 -170.075 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.89 158.81 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 124.874 1.359 . . . . 9.7599999999999998 109.739 -179.265 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.7 tp . . . . . 0 N--CA 1.43 -1.446 0 CA-C-O 124.557 2.123 . . . . 19.57 112.394 -178.925 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 121.559 0.695 . . . . 17.170000000000002 111.82 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -113.77 145.05 41.97 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.199 -4.688 . . . . 21.890000000000001 111.435 -172.196 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.26 161.55 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.339 -2.725 . . . . 10.83 109.15 169.799 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -105.11 145.33 30.68 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.259 2.624 . . . . 10.609999999999999 110.753 167.923 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -123.2 125.05 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.064 -1.648 . . . . 9.1300000000000008 107.854 171.996 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -97.92 143.09 28.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.352 -2.717 . . . . 20.550000000000001 111.481 176.549 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.2 p -97.2 -177.28 3.79 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 122.407 2.367 . . . . 11.779999999999999 109.236 -173.611 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tt -76.68 -45.34 30.07 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 117.626 -1.178 . . . . 19.309999999999999 110.666 177.466 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -66.97 -54.55 20.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.264 1.393 . . . . 23.140000000000001 112.939 174.805 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.83 84.48 0.13 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 129.394 3.378 . . . . 19.739999999999998 114.18 168.328 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -132.83 152.71 51.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.845 -2.177 . . . . 21.93 106.976 171.843 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.291 26.2 m -108.83 108.61 19.47 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.465 -1.698 . . . . 12.33 112.407 171.986 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 mt -91.81 137.18 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 104.668 -2.345 . . . . 17.079999999999998 104.668 174.695 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 m -116.65 120.58 39.1 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.964 1.705 . . . . 16.300000000000001 111.629 175.533 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 29' ' ' LYS . 22.7 mt -114.13 146.64 40.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.551 -3.218 . . . . 15.880000000000001 107.601 179.968 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.68 137.85 32.03 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 116.012 -2.275 . . . . 28.899999999999999 114.573 148.915 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 m -140.73 157.84 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.314 2.646 . . . . 12.050000000000001 104.719 -171.286 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.54 145.75 31.29 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 101.893 -3.373 . . . . 18.170000000000002 101.893 165.703 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -78.19 -7.6 16.2 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 N-CA-C 118.389 2.419 . . . . 8.1600000000000001 118.389 -174.453 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -100.46 14.64 30.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.957 -1.496 . . . . 11.130000000000001 110.614 178.566 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -107.9 160.47 15.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.912 2.142 . . . . 18.030000000000001 108.058 166.292 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -88.04 173.46 8.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 126.326 2.267 . . . . 10.220000000000001 112.748 -162.604 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mm -73.47 -26.8 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.26 -3.4 . . . . 12.300000000000001 110.027 -177.18 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.56 -21.95 66.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.45 -3.281 . . . . 36.509999999999998 117.159 169.914 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.29 -41.24 20.4 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 117.581 -1.2 . . . . 25.66 112.841 168.765 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.1 t -57.57 -40.94 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 127.547 3.03 . . . . 8.1199999999999992 116.936 173.944 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -63.73 -41.58 98.03 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 131.781 4.033 . . . . 15.470000000000001 113.183 170.694 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.71 -25.42 65.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.319 2.009 . . . . 11.449999999999999 113.495 176.458 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB3' HD22 ' A' ' 15' ' ' LEU . 48.3 mttm -79.17 -31.23 43.85 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.257 -1.527 . . . . 24.98 112.783 173.66 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.41 -34.87 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 125.401 2.524 . . . . 9.4600000000000009 112.504 170.249 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -60.0 -46.77 88.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.754 3.222 . . . . 14.76 115.849 166.671 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -54.07 -56.75 15.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.617 -3.177 . . . . 26.289999999999999 115.116 168.844 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -66.48 -80.29 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.402 -3.311 . . . . 30.059999999999999 116.829 171.703 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.89 -30.19 50.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 114.338 -5.226 . . . . 25.190000000000001 117.125 -178.126 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.18 5.17 50.06 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 125.011 3.55 . . . . 7.4100000000000001 117.148 179.524 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mm -69.92 128.83 91.5 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 114.684 1.364 . . . . 9.4900000000000002 114.684 -177.76 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -67.9 149.93 78.07 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 O-C-N 115.103 -3.157 . . . . 11.42 111.92 -170.428 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -73.68 -18.56 22.19 Favored 'Trans proline' 0 N--CA 1.433 -2.043 2 C-N-CA 127.794 5.663 . . . . 12.0 116.286 -175.853 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -68.86 -26.31 65.07 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.198 3.399 . . . . 35.549999999999997 115.258 168.797 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -95.08 -23.08 17.49 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.553 -1.658 . . . . 20.52 114.896 -172.598 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -85.75 118.43 25.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.678 -0.86 . . . . 7.1299999999999999 108.678 -171.895 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -108.79 116.14 31.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.612 1.965 . . . . 36.390000000000001 106.983 171.476 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.56 111.58 23.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.87 1.356 . . . . 9.5500000000000007 109.768 -176.788 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.93 125.09 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.062 -1.649 . . . . 13.9 106.789 179.562 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -117.71 127.16 53.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.381 2.991 . . . . 6.8600000000000003 108.84 168.39 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.31 -98.11 0.08 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.425 -3.922 . . . . 11.15 113.466 -153.503 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.07 33.96 1.69 Allowed Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 127.426 2.441 . . . . 13.93 110.432 -179.523 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -145.05 143.15 30.3 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.515 1.626 . . . . 23.920000000000002 109.437 173.273 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -80.37 124.91 29.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.575 1.655 . . . . 23.23 114.194 -178.419 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -66.24 131.59 46.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.545 2.116 . . . . 9.1099999999999994 109.184 172.813 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -82.71 158.85 22.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.633 -3.167 . . . . 33.439999999999998 113.107 178.158 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.22 -45.3 81.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.109 1.909 . . . . 28.370000000000001 115.304 -162.186 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.9 4.67 85.6 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 113.39 -1.732 . . . . 15.0 115.21 -178.434 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 -92.53 159.99 15.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 122.358 3.079 . . . . 25.5 108.735 178.969 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.4 p -86.57 171.19 11.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.72 1.248 . . . . 11.949999999999999 112.229 171.945 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.73 -33.76 66.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.334 -1.728 . . . . 10.17 106.334 172.222 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.5 p -65.7 -7.85 17.69 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 121.226 3.788 . . . . 13.59 121.226 174.179 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.11 -42.58 15.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.118 2.866 . . . . 11.699999999999999 109.518 -176.493 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -77.88 -13.56 59.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.678 2.391 . . . . 12.949999999999999 112.419 177.084 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 64.87 51.28 1.81 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.768 1.627 . . . . 25.449999999999999 112.956 -172.958 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -84.94 137.92 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.788 -2.301 . . . . 14.6 104.788 179.778 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -110.57 168.83 9.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.849 -2.407 . . . . 33.229999999999997 113.126 -175.369 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -66.81 155.41 38.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.511 -0.743 . . . . 25.969999999999999 111.569 174.221 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 50.2 mt-10 53.22 25.72 4.56 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.147 2.277 . . . . 32.609999999999999 117.147 -170.381 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 t -91.32 152.02 20.63 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.384 0.612 . . . . 10.56 110.765 169.695 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -107.98 121.37 44.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.45 3.9 . . . . 5.3300000000000001 113.145 179.664 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -97.38 163.69 12.77 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.22 1.962 . . . . 11.66 107.034 174.896 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -119.34 129.36 54.81 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.503 -4.498 . . . . 16.300000000000001 109.141 175.603 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.3 tp -105.61 119.95 40.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.293 2.637 . . . . 9.9600000000000009 112.013 179.928 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.458 ' HB ' ' H ' ' A' ' 71' ' ' LEU . 26.8 m -130.29 -160.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.412 1 CA-C-O 128.979 4.228 . . . . 9.7599999999999998 111.05 168.903 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.458 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 16.5 tp . . . . . 0 N--CA 1.43 -1.451 1 O-C-N 113.997 -5.439 . . . . 19.57 112.579 -168.842 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 123.704 1.716 . . . . 17.170000000000002 112.1 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -97.77 130.81 44.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.066 -2.896 . . . . 21.890000000000001 110.624 177.498 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.365 9.9 pt -129.67 157.67 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 124.752 1.221 . . . . 10.83 110.941 174.389 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -111.32 143.63 41.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.163 -1.791 . . . . 10.609999999999999 106.163 -177.134 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.68 127.5 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.482 -1.235 . . . . 9.1300000000000008 107.993 167.82 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -106.13 129.4 54.22 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.533 1.635 . . . . 20.550000000000001 113.862 170.448 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -82.37 -175.15 5.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.414 1.635 . . . . 11.779999999999999 115.414 179.65 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.348 5.9 tp -67.02 -40.03 87.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.87 2.174 . . . . 19.309999999999999 116.87 177.635 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -73.05 -22.12 60.67 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.08 2.552 . . . . 23.140000000000001 112.238 -171.244 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.68 40.59 3.83 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 127.67 2.557 . . . . 19.739999999999998 109.757 -174.961 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -104.64 126.98 52.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.517 -2.073 . . . . 21.93 108.557 164.395 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -94.0 116.37 28.8 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.714 2.006 . . . . 12.33 113.412 173.827 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 pt -113.15 148.33 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.365 -2.709 . . . . 17.079999999999998 106.882 -179.291 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.436 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 15.7 m -98.81 129.37 45.21 Favored 'General case' 0 N--CA 1.43 -1.475 1 C-N-CA 134.003 4.921 . . . . 16.300000000000001 113.615 -178.21 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.73 128.99 40.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.78 -3.075 . . . . 15.880000000000001 102.993 -177.494 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -87.16 93.97 9.52 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.721 2.808 . . . . 28.899999999999999 109.825 164.724 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.441 HG12 ' HD2' ' A' ' 29' ' ' LYS . 5.3 m -121.14 154.59 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 123.531 2.878 . . . . 12.050000000000001 109.494 175.973 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.88 140.09 37.43 Favored Pre-proline 0 N--CA 1.43 -1.426 0 C-N-CA 129.434 3.094 . . . . 18.170000000000002 110.841 -178.717 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -79.87 -3.56 12.86 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 124.518 2.649 . . . . 8.1600000000000001 109.432 -167.746 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -83.95 -26.02 29.61 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 114.929 -2.462 . . . . 11.130000000000001 113.368 -176.093 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -84.2 163.02 19.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.79 2.036 . . . . 18.030000000000001 114.25 -174.424 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -70.11 158.12 36.32 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.27 1.581 . . . . 10.220000000000001 115.27 -177.225 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mm -63.52 -19.94 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 125.762 2.696 . . . . 12.300000000000001 116.954 166.382 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -74.89 -27.37 60.2 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.83 -3.044 . . . . 36.509999999999998 113.878 179.869 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -70.11 -34.05 72.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.521 2.328 . . . . 25.66 112.912 175.049 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.49 -56.93 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 CA-C-O 129.166 4.317 . . . . 8.1199999999999992 110.717 175.967 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.14 -27.13 61.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.845 -3.034 . . . . 15.470000000000001 114.604 -171.854 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.19 83.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.72 2.2 . . . . 11.449999999999999 109.286 -178.898 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HD2' HG12 ' A' ' 17' ' ' VAL . 50.5 mttm -78.35 -35.65 47.17 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.285 -1.51 . . . . 24.98 108.576 -174.261 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mt -67.87 -32.26 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 125.796 2.712 . . . . 9.4600000000000009 108.233 177.183 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -69.04 -56.28 8.23 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 116.165 -4.084 . . . . 14.76 110.039 174.553 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -58.73 -24.07 60.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.061 1.744 . . . . 26.289999999999999 114.329 -178.871 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 14' ' ' THR . 50.6 mttm -78.13 -80.66 0.11 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.484 -2.01 . . . . 30.059999999999999 112.778 165.536 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -99.06 10.69 40.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.11 -3.494 . . . . 25.190000000000001 115.826 -161.124 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.87 3.5 90.46 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 117.995 -2.941 . . . . 7.4100000000000001 116.6 -175.736 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.6 mt -77.59 115.69 51.81 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 118.906 1.353 . . . . 9.4900000000000002 111.202 -169.599 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 40.4 Cg_exo -67.95 142.31 56.42 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 O-C-N 114.313 -3.572 . . . . 11.42 112.342 -179.355 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 65.3 Cg_exo -62.87 -21.68 73.29 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 N-CA-C 119.772 2.951 . . . . 12.0 119.772 -173.167 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -56.69 -39.06 73.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.665 1.586 . . . . 35.549999999999997 113.594 171.25 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -80.17 7.36 9.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.199 2.296 . . . . 20.52 117.199 -173.923 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -113.89 117.98 32.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 114.79 -2.529 . . . . 7.1299999999999999 110.642 -160.344 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -128.62 115.78 18.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.681 3.738 . . . . 36.390000000000001 113.011 170.985 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.9 mt -92.89 125.89 37.71 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 116.276 -4.015 . . . . 9.5500000000000007 111.81 -173.844 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -105.37 126.08 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.618 1.967 . . . . 13.9 109.518 172.132 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -110.22 120.0 41.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.896 3.236 . . . . 6.8600000000000003 105.401 171.886 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.409 . . 59.77 -91.07 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.548 -3.845 . . . . 11.15 118.394 -164.818 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.23 13.01 5.75 Favored Glycine 0 N--CA 1.43 -1.729 1 CA-C-O 111.115 -5.269 . . . . 13.93 109.957 160.847 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -93.31 135.86 34.13 Favored 'General case' 0 N--CA 1.43 -1.433 1 CA-C-N 124.549 4.175 . . . . 23.920000000000002 110.963 -176.918 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -75.07 99.92 4.06 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 113.938 -5.477 . . . . 23.23 113.324 167.354 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.6 mt -69.77 136.94 51.48 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.253 -3.404 . . . . 9.1099999999999994 113.912 178.265 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.48 136.18 38.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.286 -1.325 . . . . 33.439999999999998 113.475 -177.938 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.75 -30.79 68.47 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 115.055 1.502 . . . . 28.370000000000001 115.055 -156.27 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.5 23.54 12.27 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 115.716 -2.713 . . . . 15.0 115.316 179.727 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -125.42 174.48 8.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.085 2.943 . . . . 25.5 106.841 175.56 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -96.04 167.41 11.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.728 1.728 . . . . 11.949999999999999 114.875 179.949 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.575 HD12 ' H ' ' A' ' 56' ' ' LEU . 5.3 mp -56.39 -43.72 79.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.111 2.862 . . . . 10.17 114.383 162.535 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.3 p -61.1 -19.44 61.46 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 114.374 -5.204 . . . . 13.59 119.243 170.831 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -58.7 -52.38 65.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.308 2.336 . . . . 11.699999999999999 117.308 167.304 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -88.36 -13.33 40.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.596 3.558 . . . . 12.949999999999999 115.002 177.884 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 m120 73.92 58.08 0.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.332 -1.729 . . . . 25.449999999999999 106.332 167.749 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -85.73 121.61 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.861 2.267 . . . . 14.6 107.055 166.571 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -107.03 175.09 5.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 109.548 -3.478 . . . . 33.229999999999997 107.306 -174.913 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -58.61 137.08 57.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.005 -2.309 . . . . 25.969999999999999 116.862 -176.318 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 84.47 7.39 0.54 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.679 3.992 . . . . 32.609999999999999 113.96 170.18 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 t -72.46 134.38 45.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.131 -1.395 . . . . 10.56 110.678 -175.496 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.5 m -102.26 103.08 13.54 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.706 -3.746 . . . . 5.3300000000000001 113.418 -171.785 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.63 159.55 14.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.231 -3.248 . . . . 11.66 102.231 -165.085 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -101.73 140.85 35.46 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 118.181 -2.824 . . . . 16.300000000000001 108.92 170.897 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.5 tp -102.22 136.66 41.66 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 102.138 -3.282 . . . . 9.9600000000000009 102.138 169.369 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 m -134.71 175.01 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.615 2.366 . . . . 9.7599999999999998 105.991 173.576 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.6 tp . . . . . 0 N--CA 1.43 -1.447 0 CA-C-N 112.235 -2.257 . . . . 19.57 116.685 -171.341 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ptt? . . . . . 0 CA--C 1.491 -1.309 0 CA-C-O 125.056 2.36 . . . . 17.170000000000002 109.477 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -104.57 138.93 40.19 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.796 -2.456 . . . . 21.890000000000001 110.883 -172.822 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.284 44.0 pt -136.21 144.84 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 102.505 -3.146 . . . . 10.83 102.505 165.785 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -107.97 139.05 43.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.52 0.728 . . . . 10.609999999999999 109.647 173.903 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.7 t -121.58 114.38 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.657 -2.349 . . . . 9.1300000000000008 104.657 179.027 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -83.89 124.79 31.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.115 2.388 . . . . 20.550000000000001 105.405 166.283 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.323 17.7 p -77.85 178.24 7.57 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.962 2.315 . . . . 11.779999999999999 110.2 -174.886 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 tp -78.38 -32.7 49.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.274 -3.391 . . . . 19.309999999999999 111.705 171.947 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -74.79 -33.19 62.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.966 -2.333 . . . . 23.140000000000001 113.44 170.576 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.42 60.26 0.52 Allowed Glycine 0 N--CA 1.429 -1.77 0 CA-C-O 123.197 1.443 . . . . 19.739999999999998 115.124 169.436 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -118.54 152.5 35.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.563 1.945 . . . . 21.93 113.585 162.099 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -105.72 96.89 6.81 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.248 1.975 . . . . 12.33 108.813 174.084 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.286 3.4 pt -89.45 150.24 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.407 -3.308 . . . . 17.079999999999998 109.943 -179.98 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -111.22 124.4 52.14 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.819 -0.752 . . . . 16.300000000000001 110.573 -176.046 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.66 147.11 29.93 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.865 1.317 . . . . 15.880000000000001 108.045 176.897 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -105.35 90.36 3.4 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 130.051 3.34 . . . . 28.899999999999999 111.599 166.327 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.95 162.1 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 125.975 2.797 . . . . 12.050000000000001 112.528 175.979 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.43 147.83 33.55 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 119.461 -2.024 . . . . 18.170000000000002 106.601 173.738 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.37 -9.47 23.08 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-O 115.99 -1.754 . . . . 8.1600000000000001 111.939 -177.54 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.5 p -88.62 -3.92 58.68 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.258 2.623 . . . . 11.130000000000001 114.238 173.078 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -68.84 148.6 50.02 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.374 -2.454 . . . . 18.030000000000001 104.374 178.897 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.8 p -87.9 155.13 20.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.62 -1.173 . . . . 10.220000000000001 109.789 172.096 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.6 mm -52.08 -37.57 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 128.461 2.704 . . . . 12.300000000000001 110.69 176.605 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.83 -42.53 99.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.685 3.194 . . . . 36.509999999999998 114.978 174.924 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -67.06 -36.28 81.67 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.751 -2.022 . . . . 25.66 115.171 173.186 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.72 -37.33 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 114.569 1.322 . . . . 8.1199999999999992 114.569 177.663 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -57.51 -42.02 81.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.206 -2.809 . . . . 15.470000000000001 117.898 171.966 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.16 -31.68 61.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.128 2.269 . . . . 11.449999999999999 117.128 170.889 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -67.76 -36.2 80.08 Favored 'General case' 0 N--CA 1.43 -1.44 1 N-CA-C 122.081 4.104 . . . . 24.98 122.081 165.094 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.5 mt -57.71 -40.58 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 116.17 1.915 . . . . 9.4600000000000009 116.17 159.821 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -56.89 -40.68 76.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 113.617 -3.087 . . . . 14.76 117.224 162.481 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -65.77 -38.07 88.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.622 3.076 . . . . 26.289999999999999 111.694 177.717 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -73.88 -70.39 0.38 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.697 1.999 . . . . 30.059999999999999 115.191 178.226 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -92.4 -9.28 42.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.495 3.517 . . . . 25.190000000000001 120.495 -172.335 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.52 53.27 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 117.678 -3.139 . . . . 7.4100000000000001 109.777 177.535 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.6 mt -107.45 123.28 38.58 Favored Pre-proline 0 N--CA 1.43 -1.469 0 O-C-N 125.331 1.254 . . . . 9.4900000000000002 109.879 -178.518 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.02 127.72 27.23 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 124.098 3.199 . . . . 11.42 115.084 177.903 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -63.75 -7.61 13.43 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 125.059 3.839 . . . . 12.0 116.762 171.586 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -68.83 -28.62 66.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.716 2.487 . . . . 35.549999999999997 117.716 164.263 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -101.99 4.37 39.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.025 -3.547 . . . . 20.52 111.182 -172.324 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.436 ' HG2' HD11 ' A' ' 69' ' ' LEU . 70.7 mt-30 -95.02 134.32 37.83 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.285 1.993 . . . . 7.1299999999999999 113.04 -173.804 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.307 40.1 ttm180 -133.07 107.38 8.19 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.172 -1.831 . . . . 36.390000000000001 111.309 168.725 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.48 116.87 12.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 114.319 -2.753 . . . . 9.5500000000000007 112.867 170.979 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 49' ' ' GLN . 34.3 mm -109.07 135.95 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 123.151 2.705 . . . . 13.9 113.346 171.186 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -112.99 114.48 26.97 Favored 'General case' 0 N--CA 1.429 -1.475 2 O-C-N 113.141 -5.975 . . . . 6.8600000000000003 110.074 173.802 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.365 . . 68.18 -87.58 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.176 -3.452 . . . . 11.15 113.879 -170.012 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.64 5.03 6.2 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 126.253 1.882 . . . . 13.93 111.643 163.394 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -92.38 120.82 33.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 118.558 1.179 . . . . 23.920000000000002 113.638 -171.099 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HA ' HD13 ' A' ' 44' ' ' ILE . 32.6 tt0 -82.17 111.87 18.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.373 3.464 . . . . 23.23 112.88 173.058 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -69.53 139.74 53.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.209 -2.807 . . . . 9.1099999999999994 110.007 -173.232 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -81.54 156.73 25.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.832 -1.556 . . . . 33.439999999999998 109.593 169.156 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -84.03 -47.27 11.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.027 1.739 . . . . 28.370000000000001 111.847 -167.695 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.98 37.91 2.36 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 116.514 -3.866 . . . . 15.0 117.658 176.957 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HD2' ' CE2' ' A' ' 59' ' ' TYR . 77.6 mtt-85 -113.2 178.12 4.39 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.575 -2.72 . . . . 25.5 110.736 164.361 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.8 p -101.55 173.81 6.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.338 -1.476 . . . . 11.949999999999999 111.62 168.695 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 61' ' ' ILE . 35.6 mt -67.79 -26.92 66.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.344 1.069 . . . . 10.17 112.175 171.597 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.5 p -82.36 -25.14 34.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.096 1.358 . . . . 13.59 111.738 -175.992 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -58.05 -39.9 79.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 123.193 2.724 . . . . 11.699999999999999 116.453 162.339 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CE2' ' HD2' ' A' ' 54' ' ' ARG 0.297 24.3 m-85 -89.93 3.7 52.27 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.552 2.427 . . . . 12.949999999999999 117.552 175.843 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 73.4 m-20 67.82 38.73 2.81 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.475 1.51 . . . . 25.449999999999999 112.133 171.161 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.417 HD12 HD23 ' A' ' 56' ' ' LEU . 69.9 mt -89.71 108.84 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.167 -2.16 . . . . 14.6 105.167 178.847 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -83.67 174.85 10.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 128.069 3.795 . . . . 33.229999999999997 110.31 174.249 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -66.68 158.52 29.86 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.258 -3.401 . . . . 25.969999999999999 112.846 176.568 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.316 10.5 mt-10 57.28 20.76 6.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.357 2.263 . . . . 32.609999999999999 116.638 -179.919 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 m -80.57 129.8 34.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.227 2.611 . . . . 10.56 115.96 172.808 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 m -90.45 116.86 28.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.788 -3.07 . . . . 5.3300000000000001 111.354 172.836 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -91.6 155.61 18.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.403 -2.073 . . . . 11.66 105.403 174.123 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -106.23 152.23 23.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 114.325 -2.95 . . . . 16.300000000000001 110.39 169.088 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.436 HD11 ' HG2' ' A' ' 41' ' ' GLN . 28.4 tp -121.95 113.32 19.44 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.918 3.886 . . . . 9.9600000000000009 109.533 174.685 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 m -121.47 -172.43 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 128.617 2.767 . . . . 9.7599999999999998 104.897 178.17 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp . . . . . 0 N--CA 1.43 -1.466 0 CA-C-O 124.901 2.286 . . . . 19.57 110.123 -164.834 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.573 1.323 . . . . 17.170000000000002 114.573 . . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.68 129.73 38.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 126.911 3.243 . . . . 21.890000000000001 107.673 -167.98 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.301 24.9 pt -124.21 154.21 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 O-C-N 117.023 -3.548 . . . . 10.83 110.077 171.831 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -114.21 136.32 53.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.532 1.933 . . . . 10.609999999999999 114.092 -178.858 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.6 t -117.31 103.39 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 100.322 -3.955 . . . . 9.1300000000000008 100.322 178.309 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -94.42 152.78 18.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.104 -3.497 . . . . 20.550000000000001 110.105 -177.713 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.269 58.4 p -106.71 175.77 5.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 118.005 2.595 . . . . 11.779999999999999 118.005 -163.743 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.4 tp -77.52 -51.79 10.14 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.621 -1.172 . . . . 19.309999999999999 113.25 167.92 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 81.7 p -64.47 -59.71 4.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.197 -3.439 . . . . 23.140000000000001 115.252 174.773 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.77 -35.98 0.21 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 114.933 -3.148 . . . . 19.739999999999998 118.931 179.078 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -82.96 98.98 9.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 125.905 1.591 . . . . 21.93 110.107 -168.193 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -50.92 133.54 26.7 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.783 1.401 . . . . 12.33 114.783 178.441 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 mt -93.4 129.92 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 129.488 3.115 . . . . 17.079999999999998 106.891 176.426 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.3 m -119.6 111.43 18.06 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.854 -3.654 . . . . 16.300000000000001 108.493 -170.177 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.7 mt -113.8 149.62 34.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.499 -2.625 . . . . 15.880000000000001 111.82 178.22 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -104.67 136.34 44.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.329 -1.482 . . . . 28.899999999999999 110.65 163.172 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 m -132.82 172.64 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.021 -1.675 . . . . 12.050000000000001 107.641 -173.142 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -113.28 150.37 42.96 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 102.31 -3.218 . . . . 18.170000000000002 102.31 166.797 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.87 -2.97 13.21 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 CA-C-N 122.943 2.087 . . . . 8.1600000000000001 116.468 -175.547 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -70.82 -25.49 62.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 128.284 3.49 . . . . 11.130000000000001 117.078 159.037 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -67.81 150.45 48.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 129.407 3.083 . . . . 18.030000000000001 110.79 179.646 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -98.1 160.45 14.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.035 -2.888 . . . . 10.220000000000001 114.41 -173.865 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.7 mm -52.44 -32.53 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 121.668 2.031 . . . . 12.300000000000001 113.065 166.441 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.32 1.5 tt0 -51.78 -51.27 57.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 117.873 2.546 . . . . 36.509999999999998 117.873 160.761 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -63.71 -33.31 75.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 124.531 3.332 . . . . 25.66 111.036 177.344 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.12 -37.65 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.639 -1.913 . . . . 8.1199999999999992 109.564 177.595 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.794 1.775 . . . . 15.470000000000001 115.794 173.486 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.39 -19.25 62.29 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.736 1.614 . . . . 11.449999999999999 114.595 -179.079 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -91.21 -19.82 22.63 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.735 -3.103 . . . . 24.98 108.179 176.535 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.9 mt -76.71 -34.15 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 117.803 -3.061 . . . . 9.4600000000000009 108.476 167.098 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -52.86 -49.05 66.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.646 2.165 . . . . 14.76 110.962 169.823 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.04 -52.96 44.31 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.946 1.699 . . . . 26.289999999999999 110.427 -178.204 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -67.43 -69.23 0.33 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.196 -1.565 . . . . 30.059999999999999 115.052 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -87.81 -53.99 4.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.418 -2.676 . . . . 25.190000000000001 113.389 -175.518 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.05 54.21 0.39 Allowed Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 117.632 1.813 . . . . 7.4100000000000001 117.632 -165.601 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.43 123.61 27.56 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 128.377 3.046 . . . . 9.4900000000000002 104.859 176.022 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.69 125.25 18.41 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 124.837 3.691 . . . . 11.42 113.44 168.224 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.74 -28.17 55.84 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 121.336 3.552 . . . . 12.0 121.336 174.192 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.25 17.1 p-10 -51.73 -37.22 50.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.242 2.312 . . . . 35.549999999999997 117.242 167.174 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -86.91 -7.79 57.86 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.918 1.451 . . . . 20.52 114.918 -175.892 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -89.06 141.36 28.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.059 2.361 . . . . 7.1299999999999999 114.284 177.92 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -132.66 140.78 48.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.902 3.239 . . . . 36.390000000000001 106.155 164.018 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -118.81 130.59 55.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.674 -3.766 . . . . 9.5500000000000007 105.668 -177.683 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.7 tt -122.92 133.14 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.149 -3.47 . . . . 13.9 110.129 174.154 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -82.76 -66.75 0.85 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.193 1.949 . . . . 6.8600000000000003 109.458 174.389 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.81 -75.4 0.58 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.152 3.381 . . . . 11.15 115.547 -178.847 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.89 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.081 -0.963 . . . . 13.93 115.403 -174.306 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -83.51 138.06 33.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.596 1.665 . . . . 23.920000000000002 110.373 -172.938 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.21 133.87 36.06 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 118.484 2.772 . . . . 23.23 118.484 -169.757 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.3 mt -90.36 151.15 21.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.438 2.695 . . . . 9.1099999999999994 113.927 -169.724 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -100.59 137.31 39.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.409 3.083 . . . . 33.439999999999998 109.873 177.892 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -72.32 -50.35 27.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.439 -2.663 . . . . 28.370000000000001 104.969 -157.537 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.4 37.75 3.32 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 118.123 -2.861 . . . . 15.0 110.874 -169.623 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -93.14 152.51 19.2 Favored 'General case' 0 N--CA 1.431 -1.413 1 C-N-CA 132.929 4.491 . . . . 25.5 111.756 158.594 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.1 p -97.96 171.55 8.2 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.957 1.837 . . . . 11.949999999999999 106.416 -172.24 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.14 -47.42 68.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.558 1.647 . . . . 10.17 112.571 173.276 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -84.96 -11.35 55.71 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.477 3.111 . . . . 13.59 113.932 -173.17 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.1 -47.99 77.87 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.705 1.717 . . . . 11.699999999999999 108.657 164.277 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -93.0 12.45 23.94 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 114.837 -4.914 . . . . 12.949999999999999 112.214 -176.464 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 59.92 31.07 20.53 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.279 2.232 . . . . 25.449999999999999 111.205 171.954 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.3 mt -82.45 120.75 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 124.204 1.001 . . . . 14.6 108.535 177.384 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -100.7 -172.31 2.17 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.962 1.363 . . . . 33.229999999999997 113.284 179.419 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -69.15 151.15 46.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.403 -3.31 . . . . 25.969999999999999 115.829 177.342 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 28.4 mt-10 66.66 20.28 10.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.429 2.692 . . . . 32.609999999999999 112.214 177.711 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -88.07 144.08 26.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.431 1.892 . . . . 10.56 112.87 179.833 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -97.79 122.33 40.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.395 -1.729 . . . . 5.3300000000000001 107.371 -174.363 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mp -97.19 166.41 11.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.796 3.238 . . . . 11.66 108.418 159.238 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -137.57 132.17 32.73 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.496 -2.628 . . . . 16.300000000000001 111.656 174.411 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.6 tp -87.98 121.6 30.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.14 2.576 . . . . 9.9600000000000009 106.6 -171.069 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.9 t -113.69 113.2 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 128.266 2.626 . . . . 9.7599999999999998 112.312 175.42 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.6 tp . . . . . 0 N--CA 1.431 -1.423 1 O-C-N 115.819 -4.301 . . . . 19.57 112.128 -171.26 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 CA--C 1.489 -1.374 0 CA-C-O 120.865 0.364 . . . . 17.170000000000002 111.1 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -94.51 112.17 23.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.546 2.117 . . . . 21.890000000000001 111.099 -176.065 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 pt -120.31 150.99 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 116.379 -3.951 . . . . 10.83 111.833 174.039 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -116.27 150.52 37.46 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.606 -1.998 . . . . 10.609999999999999 105.606 -174.248 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.2 t -132.18 135.42 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 100.423 -3.917 . . . . 9.1300000000000008 100.423 -176.539 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -119.81 143.49 47.84 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.735 3.159 . . . . 20.550000000000001 107.17 175.36 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.2 p -83.85 -175.43 5.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.082 -3.511 . . . . 11.779999999999999 114.212 172.82 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.1 tp -66.57 -51.53 55.41 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.826 -0.435 . . . . 19.309999999999999 109.826 -176.9 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -75.07 -31.96 61.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.252 -1.356 . . . . 23.140000000000001 109.004 -177.567 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.11 71.62 0.6 Allowed Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 122.95 2.613 . . . . 19.739999999999998 116.206 174.012 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -118.81 147.9 43.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 100.471 -3.9 . . . . 21.93 100.471 159.915 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 m -104.06 116.15 31.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.316 1.446 . . . . 12.33 108.439 -179.488 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -81.07 128.92 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.793 -2.299 . . . . 17.079999999999998 104.793 166.122 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.0 m -104.74 135.02 46.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.645 0.657 . . . . 16.300000000000001 109.846 173.288 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.4 mt -122.43 119.67 31.67 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 118.572 2.805 . . . . 15.880000000000001 118.572 179.984 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -86.79 103.33 15.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.912 1.233 . . . . 28.899999999999999 108.715 167.509 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 m -110.23 169.59 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 129.574 3.15 . . . . 12.050000000000001 109.698 179.447 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -108.03 145.67 31.9 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 117.488 -1.244 . . . . 18.170000000000002 110.044 177.227 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.335 42.4 Cg_exo -47.51 -36.03 23.32 Favored 'Trans proline' 0 C--N 1.3 -2.02 1 N-CA-C 123.002 4.193 . . . . 8.1600000000000001 123.002 -175.238 . . . . . . . . 3 2 . 1 . 090 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.18 5.37 34.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.11 2.164 . . . . 11.130000000000001 114.567 176.947 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -62.1 132.38 52.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.082 -2.886 . . . . 18.030000000000001 116.212 176.623 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.266 8.0 p -67.14 161.84 23.74 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.857 -4.277 . . . . 10.220000000000001 107.591 171.915 . . . . . . . . 3 2 . 1 . 090 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -61.55 -41.29 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.007 -2.308 . . . . 12.300000000000001 115.498 171.064 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -64.2 -27.53 69.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.814 2.552 . . . . 36.509999999999998 112.725 172.665 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -70.14 -34.94 73.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.956 -1.715 . . . . 25.66 112.735 169.411 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.52 -41.89 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 1 O-C-N 115.419 -4.551 . . . . 8.1199999999999992 116.914 169.493 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -54.95 -29.46 56.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.532 2.733 . . . . 15.470000000000001 115.713 166.024 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.19 -32.47 66.85 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 118.431 -0.795 . . . . 11.449999999999999 110.991 -177.111 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -70.25 -20.33 63.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.959 1.838 . . . . 24.98 114.965 170.3 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -86.19 -28.47 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 O-C-N 115.537 -4.477 . . . . 9.4600000000000009 111.531 177.111 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -64.57 -40.35 95.4 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.744 4.018 . . . . 14.76 109.484 174.358 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.6 -50.49 15.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.107 -0.996 . . . . 26.289999999999999 111.064 173.922 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -73.15 -70.05 0.38 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.521 1.674 . . . . 30.059999999999999 115.521 -175.956 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.69 -50.88 55.35 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.853 0.751 . . . . 25.190000000000001 112.658 -177.64 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.54 21.72 10.29 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 118.332 2.093 . . . . 7.4100000000000001 118.332 -176.37 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 71' ' ' LEU . 17.1 mt -82.85 126.59 72.52 Favored Pre-proline 0 N--CA 1.43 -1.471 0 C-N-CA 127.082 2.153 . . . . 9.4900000000000002 108.9 168.743 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -72.63 167.96 25.72 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-O 117.187 -1.255 . . . . 11.42 110.195 -172.455 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 12.2 Cg_endo -86.08 -15.86 4.45 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 CA-C-N 124.557 2.663 . . . . 12.0 112.676 -169.302 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -73.14 -32.82 65.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.32 1.533 . . . . 35.549999999999997 115.059 171.258 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -76.32 -36.04 58.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.526 1.631 . . . . 20.52 114.779 -177.943 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.254 72.0 mt-30 -64.15 135.42 56.32 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.526 3.536 . . . . 7.1299999999999999 113.36 170.532 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -131.97 116.16 16.78 Favored 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 132.001 4.12 . . . . 36.390000000000001 108.893 169.784 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -97.24 144.22 27.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.558 1.786 . . . . 9.5500000000000007 109.51 176.569 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 tp -139.72 137.16 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 119.168 -2.208 . . . . 13.9 113.49 171.388 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.338 76.7 t80 -88.18 -62.06 1.57 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.266 -0.896 . . . . 6.8600000000000003 113.347 171.772 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.8 -89.17 0.28 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.881 -1.525 . . . . 11.15 106.881 -177.763 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.76 9.01 2.56 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-O 116.303 -2.387 . . . . 13.93 116.815 175.964 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -82.64 131.98 35.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 121.311 2.556 . . . . 23.920000000000002 110.121 162.798 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -75.13 114.0 13.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.364 2.03 . . . . 23.23 111.189 -177.928 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.335 10.2 mt -73.08 101.57 3.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 130.06 3.344 . . . . 9.1099999999999994 111.716 -177.924 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HB2' ' HG3' ' A' ' 54' ' ' ARG . 45.2 mt-10 -67.81 -172.92 0.3 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.908 -2.995 . . . . 33.439999999999998 116.475 170.172 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.58 -63.49 1.32 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.993 -4.192 . . . . 28.370000000000001 113.973 -176.143 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.96 40.32 2.85 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 125.574 1.559 . . . . 15.0 115.842 -170.625 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 51' ' ' GLU . 21.6 mmt180 -124.46 145.2 49.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.67 -1.974 . . . . 25.5 105.67 -174.061 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.528 1.1 p -89.36 157.15 18.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.747 3.641 . . . . 11.949999999999999 116.347 -169.032 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.7 mt -63.02 -36.33 83.19 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 116.041 -4.162 . . . . 10.17 110.346 174.418 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 t -65.39 -42.01 93.1 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.27 3.028 . . . . 13.59 112.077 -177.546 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.41 -14.43 57.14 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.602 2.144 . . . . 11.699999999999999 110.744 -171.262 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -103.27 4.64 36.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.708 -3.745 . . . . 12.949999999999999 103.93 176.919 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 50.51 47.2 24.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.576 2.751 . . . . 25.449999999999999 117.521 -176.461 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.0 mt -84.39 106.55 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 112.664 -2.062 . . . . 14.6 109.23 172.328 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -104.96 -174.17 2.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.083 -2.326 . . . . 33.229999999999997 110.958 -167.646 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -83.97 136.08 34.21 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.536 1.516 . . . . 25.969999999999999 112.399 -161.761 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.298 18.2 mt-10 81.38 20.75 0.37 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.296 1.838 . . . . 32.609999999999999 115.909 -169.368 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -70.54 131.82 44.58 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 116.679 -1.629 . . . . 10.56 111.972 172.081 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.4 m -103.57 125.82 50.34 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.246 -1.391 . . . . 5.3300000000000001 107.246 -179.536 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -109.52 164.16 12.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.397 -2.689 . . . . 11.66 106.562 -173.262 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -117.12 139.6 50.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.566 -3.209 . . . . 16.300000000000001 110.198 176.811 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -106.23 104.04 13.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.713 2.805 . . . . 9.9600000000000009 111.475 -178.222 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -97.05 140.4 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.345 -1.752 . . . . 9.7599999999999998 111.54 174.236 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.442 HD21 HG21 ' A' ' 36' ' ' ILE . 37.6 mt . . . . . 0 N--CA 1.43 -1.451 0 CA-C-N 119.718 1.145 . . . . 19.57 112.744 162.314 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 ttp . . . . . 0 CA--C 1.489 -1.374 0 CA-C-O 121.746 0.784 . . . . 17.170000000000002 112.989 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -84.77 121.35 27.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.396 -2.69 . . . . 21.890000000000001 110.293 -175.451 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -127.7 168.88 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 123.191 2.723 . . . . 10.83 110.974 160.187 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -120.47 147.69 44.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 125.064 1.477 . . . . 10.609999999999999 110.929 -176.635 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -117.08 118.93 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 C-N-CA 131.782 4.033 . . . . 9.1300000000000008 112.365 163.774 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -103.46 124.89 49.58 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.859 -2.401 . . . . 20.550000000000001 111.563 176.701 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.305 34.7 p -77.79 175.56 9.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.105 1.431 . . . . 11.779999999999999 113.44 -174.594 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.499 ' HA ' ' HE1' ' A' ' 68' ' ' HIS . 52.1 tp -65.07 -55.27 19.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.358 2.663 . . . . 19.309999999999999 115.378 -178.788 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.3 p -60.73 -62.75 1.63 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.881 1.219 . . . . 23.140000000000001 110.633 165.253 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.24 64.14 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 122.417 2.371 . . . . 19.739999999999998 115.092 176.875 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -118.7 128.26 54.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 114.019 -2.896 . . . . 21.93 106.885 178.197 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -109.46 115.37 29.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 125.471 3.76 . . . . 12.33 101.681 -173.866 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.27 132.07 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 119.002 -2.312 . . . . 17.079999999999998 109.888 178.102 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.9 m -98.38 119.65 37.43 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.109 -4.12 . . . . 16.300000000000001 111.196 179.361 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.9 mt -106.39 162.55 13.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.966 2.506 . . . . 15.880000000000001 109.928 -175.477 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -135.22 97.68 3.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 101.689 -3.449 . . . . 28.899999999999999 101.689 178.734 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 m -105.66 163.15 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 117.416 2.376 . . . . 12.050000000000001 117.416 -174.666 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.256 2.9 mp0 -73.46 138.57 77.86 Favored Pre-proline 0 N--CA 1.431 -1.422 0 CA-C-O 114.749 -2.548 . . . . 18.170000000000002 108.285 162.35 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -58.97 -24.53 73.6 Favored 'Trans proline' 0 C--N 1.299 -2.04 1 C-N-CA 128.073 5.848 . . . . 8.1600000000000001 119.442 -179.868 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -117.41 28.63 8.35 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 122.454 4.242 . . . . 11.130000000000001 122.454 173.437 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -77.18 170.7 16.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.402 -2.061 . . . . 18.030000000000001 113.802 -179.289 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.328 69.0 p -90.48 154.39 19.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.418 2.007 . . . . 10.220000000000001 116.418 -174.982 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.4 -19.84 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 119.447 1.021 . . . . 12.300000000000001 112.237 178.003 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -62.77 -39.43 94.16 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.138 -4.101 . . . . 36.509999999999998 106.359 166.435 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -82.01 -29.55 31.97 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.213 2.279 . . . . 25.66 112.457 -174.398 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.36 40.5 t -46.22 -62.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 118.012 -2.93 . . . . 8.1199999999999992 114.544 154.252 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -54.21 -39.67 66.93 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.039 2.237 . . . . 15.470000000000001 117.039 172.039 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.29 92.5 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.641 -4.412 . . . . 11.449999999999999 111.852 173.919 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -61.36 -38.82 88.38 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.417 2.377 . . . . 24.98 117.417 163.063 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.267 72.5 mt -63.35 -41.53 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 122.145 2.248 . . . . 9.4600000000000009 116.132 172.497 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.75 -40.49 92.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.067 1.747 . . . . 14.76 115.324 173.689 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.02 -50.18 74.76 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 125.828 2.728 . . . . 26.289999999999999 115.629 173.107 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -75.31 -68.27 0.57 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 109.405 -3.543 . . . . 30.059999999999999 115.377 -175.121 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -87.82 -16.3 34.45 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.743 3.617 . . . . 25.190000000000001 111.445 -170.729 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.39 13.15 83.56 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 120.534 2.974 . . . . 7.4100000000000001 120.534 -178.942 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -76.03 115.67 48.74 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 116.521 -1.704 . . . . 9.4900000000000002 110.622 176.84 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.07 155.43 45.04 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 C-N-CA 123.673 2.915 . . . . 11.42 109.805 -172.797 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.41 -25.66 17.97 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 124.071 2.49 . . . . 12.0 112.376 -167.782 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.84 -40.55 88.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.305 -3.372 . . . . 35.549999999999997 108.864 -175.087 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.432 ' OE1' HD23 ' A' ' 71' ' ' LEU . 7.2 tt0 -63.33 -23.75 67.55 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.519 -1.673 . . . . 20.52 114.446 -177.974 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -87.91 131.7 34.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 126.417 3.008 . . . . 7.1299999999999999 118.295 -173.628 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -120.06 106.16 11.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.126 -2.859 . . . . 36.390000000000001 110.23 166.629 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.52 132.75 36.07 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 115.56 -4.463 . . . . 9.5500000000000007 113.299 175.698 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.5 mt -106.88 141.92 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.516 2.327 . . . . 13.9 107.931 176.815 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -91.5 -83.03 0.29 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.328 2.489 . . . . 6.8600000000000003 107.792 163.04 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.05 -71.43 0.74 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.473 1.909 . . . . 11.15 115.887 176.459 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.74 -41.66 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 124.083 1.935 . . . . 13.93 114.207 -166.886 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -103.38 155.36 18.54 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 121.493 -1.004 . . . . 23.920000000000002 112.94 -169.594 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -86.59 132.08 33.99 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.016 2.599 . . . . 23.23 118.016 -156.396 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -92.84 146.2 23.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.395 2.309 . . . . 9.1099999999999994 109.93 -174.398 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.98 153.45 17.9 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.145 -3.472 . . . . 33.439999999999998 106.573 177.767 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.66 -63.17 1.3 Allowed 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.066 -4.772 . . . . 28.370000000000001 114.315 -178.906 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.06 35.55 3.4 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 119.229 -1.462 . . . . 15.0 110.451 -172.225 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -106.55 161.18 14.84 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.367 -5.196 . . . . 25.5 111.478 164.813 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -97.89 171.96 7.96 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 114.284 -5.26 . . . . 11.949999999999999 111.878 -166.842 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.79 -37.09 78.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 112.863 -1.971 . . . . 10.17 109.027 169.338 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 t -81.71 -10.7 59.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 123.881 0.872 . . . . 13.59 112.71 -169.012 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.13 -50.29 12.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.504 3.526 . . . . 11.699999999999999 114.815 173.694 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -82.8 -20.71 35.22 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.949 -4.845 . . . . 12.949999999999999 112.164 179.849 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 23.2 m-80 72.63 65.94 0.12 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.233 3.049 . . . . 25.449999999999999 119.233 179.862 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.7 mt -106.13 93.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 109.157 -3.656 . . . . 14.6 105.104 -178.894 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -85.3 -166.19 1.43 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.033 -3.542 . . . . 33.229999999999997 114.381 179.223 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.368 14.8 pttp -62.43 134.85 57.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.36 -3.338 . . . . 25.969999999999999 114.271 -177.068 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.322 21.5 mt-10 70.05 15.87 7.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.527 2.047 . . . . 32.609999999999999 116.527 169.23 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.7 m -61.45 140.32 58.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.068 3.347 . . . . 10.56 112.457 159.427 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -110.54 111.03 21.99 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 119.865 1.212 . . . . 5.3300000000000001 113.515 175.24 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.6 mt -78.86 153.46 30.56 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.276 -2.14 . . . . 11.66 108.605 173.589 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.499 ' HE1' ' HA ' ' A' ' 8' ' ' LEU . 11.9 t60 -121.79 137.56 54.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.323 2.011 . . . . 16.300000000000001 107.619 175.935 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.3 tp -116.19 124.91 51.46 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.454 -2.029 . . . . 9.9600000000000009 109.019 -174.668 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.8 t -112.08 139.68 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 125.039 1.336 . . . . 9.7599999999999998 110.068 -179.53 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.432 HD23 ' OE1' ' A' ' 40' ' ' GLN . 7.8 mp . . . . . 0 N--CA 1.43 -1.431 0 C-N-CA 115.861 -2.336 . . . . 19.57 113.942 -176.682 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 CA--C 1.491 -1.326 0 N-CA-C 114.308 1.225 . . . . 17.170000000000002 114.308 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -93.13 118.29 31.05 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 116.525 -1.702 . . . . 21.890000000000001 107.345 -174.228 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.295 19.4 pt -120.22 151.78 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 126.446 2.341 . . . . 10.83 108.51 169.926 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -118.55 149.18 41.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.244 -2.873 . . . . 10.609999999999999 103.244 178.073 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -111.03 140.6 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 110.376 -3.102 . . . . 9.1300000000000008 117.019 162.653 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -123.28 128.31 49.78 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.779 -4.325 . . . . 20.550000000000001 110.835 -178.363 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.264 39.7 p -91.33 174.1 7.56 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.518 -1.989 . . . . 11.779999999999999 112.247 -176.229 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.264 12.8 tp -63.94 -52.82 58.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.785 -2.462 . . . . 19.309999999999999 115.192 171.369 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.4 -58.69 3.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.995 -2.316 . . . . 23.140000000000001 115.85 -175.804 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.44 53.92 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 120.571 1.532 . . . . 19.739999999999998 111.909 167.745 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -112.74 136.65 52.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.121 -1.811 . . . . 21.93 109.473 163.599 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -104.23 110.86 23.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 128.334 3.521 . . . . 12.33 101.864 170.488 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.6 mt -102.42 129.96 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 101.142 -3.651 . . . . 17.079999999999998 101.142 -176.013 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 m -97.77 128.27 44.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.046 1.738 . . . . 16.300000000000001 107.462 177.089 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.455 HD22 ' HG2' ' A' ' 29' ' ' LYS . 58.2 mt -118.72 158.2 26.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.353 2.342 . . . . 15.880000000000001 110.993 170.735 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -102.6 122.18 43.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.144 -2.909 . . . . 28.899999999999999 103.144 165.092 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 m -137.46 177.62 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 117.989 -1.484 . . . . 12.050000000000001 110.147 176.451 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.26 157.82 34.59 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 105.863 -1.902 . . . . 18.170000000000002 105.863 173.904 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.307 18.5 Cg_endo -66.82 -15.02 46.03 Favored 'Trans proline' 0 C--N 1.3 -1.996 1 C-N-CA 126.829 5.019 . . . . 8.1600000000000001 110.502 168.273 . . . . . . . . 3 2 . 1 . 092 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.2 m -94.69 0.12 54.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.577 -2.577 . . . . 11.130000000000001 115.67 -175.888 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -78.18 145.32 35.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.724 -2.485 . . . . 18.030000000000001 114.224 178.116 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 p -81.12 148.88 29.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.38 -2.7 . . . . 10.220000000000001 104.201 176.589 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.7 mt -76.37 -26.61 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 121.261 -0.899 . . . . 12.300000000000001 111.06 -173.402 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.296 17.0 pt-20 -51.8 -35.69 45.09 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 117.104 -1.426 . . . . 36.509999999999998 114.68 161.488 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -77.7 -39.85 43.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 117.167 -1.397 . . . . 25.66 113.73 176.128 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.4 t -57.91 -40.32 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 121.086 1.766 . . . . 8.1199999999999992 109.472 176.875 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 55.8 mtmt -73.57 -35.67 65.48 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.499 1.12 . . . . 15.470000000000001 112.755 177.985 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.13 83.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 118.476 -1.289 . . . . 11.449999999999999 113.647 171.574 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' HD22 ' A' ' 15' ' ' LEU 0.347 29.8 ttmt -48.09 -40.38 23.14 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.219 -3.426 . . . . 24.98 112.022 161.382 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.1 -35.94 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 120.706 1.594 . . . . 9.4600000000000009 111.296 177.865 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -49.9 -47.85 51.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 115.607 -2.14 . . . . 14.76 114.188 163.424 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -63.33 -38.43 91.11 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.315 1.871 . . . . 26.289999999999999 113.951 177.65 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -72.48 -67.21 0.57 Allowed 'General case' 0 N--CA 1.429 -1.486 1 C-N-CA 131.868 4.067 . . . . 30.059999999999999 110.238 -178.686 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -97.84 -72.83 0.63 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.473 -2.017 . . . . 25.190000000000001 110.56 -166.859 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.47 64.73 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 118.427 2.131 . . . . 7.4100000000000001 118.427 169.714 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.6 mt -133.56 116.18 13.83 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 128.151 2.58 . . . . 9.4900000000000002 104.244 -168.359 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.39 156.34 26.45 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 123.731 2.368 . . . . 11.42 116.007 -172.325 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -78.66 -15.29 13.73 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 CA-C-N 124.39 2.604 . . . . 12.0 112.51 -172.596 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -75.08 -42.4 56.81 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.792 0.806 . . . . 35.549999999999997 110.753 175.268 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -68.56 -26.59 65.48 Favored 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 134.126 4.971 . . . . 20.52 111.784 -175.239 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.53 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 69.6 mt-30 -86.84 135.68 33.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.925 -2.36 . . . . 7.1299999999999999 110.213 178.239 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -121.35 118.63 29.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.42 -2.067 . . . . 36.390000000000001 105.42 166.684 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 50' ' ' LEU . 62.3 mt -93.46 120.97 34.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.482 3.113 . . . . 9.5500000000000007 111.849 177.86 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mt -109.29 134.07 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 117.119 -3.488 . . . . 13.9 107.488 173.957 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -91.27 -73.09 0.55 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 123.764 2.984 . . . . 6.8600000000000003 103.56 163.909 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.32 -140.19 0.2 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.475 2.083 . . . . 11.15 107.122 -172.387 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.03 -23.65 69.7 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 122.609 3.803 . . . . 13.93 122.609 -176.191 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -76.81 162.7 27.44 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.989 -4.242 . . . . 23.920000000000002 118.149 174.491 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.282 81.6 mm-40 -84.87 133.93 34.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.719 -1.238 . . . . 23.23 111.806 167.456 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 43' ' ' LEU . 60.4 mt -93.25 132.78 37.12 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.384 -0.822 . . . . 9.1099999999999994 110.733 177.328 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -93.27 122.34 35.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.012 2.125 . . . . 33.439999999999998 107.897 168.78 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.06 -25.12 65.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.459 1.904 . . . . 28.370000000000001 114.149 -168.794 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.78 -2.69 86.45 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 126.253 1.882 . . . . 15.0 117.723 -179.573 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -104.9 -176.61 3.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.908 1.337 . . . . 25.5 107.984 172.63 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.4 p -100.43 178.07 4.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.724 1.75 . . . . 11.949999999999999 115.724 -173.557 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.95 -35.95 81.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.97 3.308 . . . . 10.17 112.408 167.79 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 t -72.77 -36.71 67.7 Favored 'General case' 0 N--CA 1.431 -1.387 1 O-C-N 113.947 -5.471 . . . . 13.59 112.485 -179.052 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -66.98 -38.34 85.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.854 3.261 . . . . 11.699999999999999 110.938 176.11 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -88.57 -4.13 58.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.659 -1.9 . . . . 12.949999999999999 110.738 176.301 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 m120 57.68 58.85 3.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 131.508 3.923 . . . . 25.449999999999999 111.677 178.083 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mm -102.28 108.81 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.309 -2.108 . . . . 14.6 105.309 -178.113 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -108.79 169.23 8.8 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 127.361 2.913 . . . . 33.229999999999997 109.335 -171.577 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -44.68 138.69 3.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.587 2.613 . . . . 25.969999999999999 112.343 -176.345 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.281 18.1 mt-10 60.16 6.16 0.94 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.119 3.368 . . . . 32.609999999999999 115.296 175.702 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.6 m -62.73 140.83 58.75 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.183 -4.073 . . . . 10.56 113.354 160.838 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -103.91 122.32 44.94 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.493 3.517 . . . . 5.3300000000000001 110.557 -175.407 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -86.24 156.35 20.32 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.089 2.743 . . . . 11.66 113.608 170.85 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -121.46 120.32 34.6 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 123.089 2.677 . . . . 16.300000000000001 111.223 168.365 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.6 tp -84.46 124.08 30.96 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 126.582 2.426 . . . . 9.9600000000000009 116.702 173.962 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.3 127.8 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 103.433 -2.803 . . . . 9.7599999999999998 103.433 179.423 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.286 1.3 mm? . . . . . 0 N--CA 1.43 -1.427 0 O-C-N 119.867 -1.77 . . . . 19.57 115.212 175.43 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 113.766 1.024 . . . . 17.170000000000002 113.766 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -90.49 121.44 32.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.412 1.577 . . . . 21.890000000000001 113.795 -178.643 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.9 pt -123.54 151.92 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 O-C-N 114.145 -5.347 . . . . 10.83 108.653 168.449 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -115.93 137.01 52.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 119.484 1.038 . . . . 10.609999999999999 111.447 -179.451 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -109.82 130.23 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 130.134 3.374 . . . . 9.1300000000000008 109.028 168.049 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -122.84 137.61 54.88 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.586 -2.552 . . . . 20.550000000000001 107.097 -173.251 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.329 55.2 p -100.88 -173.38 2.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 119.696 1.134 . . . . 11.779999999999999 110.881 -170.085 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.4 mt -74.01 -41.27 62.13 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.855 -3.028 . . . . 19.309999999999999 111.982 177.62 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.95 -57.56 9.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.237 -1.54 . . . . 23.140000000000001 108.135 165.768 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.25 6.86 0.17 Allowed Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 117.618 -2.229 . . . . 19.739999999999998 115.436 177.55 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -77.29 149.46 35.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 122.661 3.231 . . . . 21.93 110.715 -161.786 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -113.72 110.73 20.64 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.974 -3.579 . . . . 12.33 105.939 -174.601 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.04 121.66 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 111.212 -2.722 . . . . 17.079999999999998 112.289 169.392 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.3 m -103.66 114.07 28.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 128.003 3.314 . . . . 16.300000000000001 106.832 -174.37 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -104.14 141.7 35.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.147 -1.596 . . . . 15.880000000000001 112.295 178.651 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -84.13 100.81 11.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.406 1.883 . . . . 28.899999999999999 107.87 164.592 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.93 151.34 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.295 -1.002 . . . . 12.050000000000001 108.295 179.103 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -91.23 164.08 26.4 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 116.906 -1.918 . . . . 18.170000000000002 106.394 171.263 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -82.76 -8.06 11.31 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.515 2.144 . . . . 8.1600000000000001 108.872 -177.635 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -86.67 -4.54 59.19 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.795 1.759 . . . . 11.130000000000001 115.717 171.722 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -83.13 137.74 33.95 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.499 -2.001 . . . . 18.030000000000001 107.282 -168.284 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 p -74.21 157.84 35.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.631 3.11 . . . . 10.220000000000001 112.57 174.169 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.8 mt -69.19 -21.4 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 1 O-C-N 115.907 -4.246 . . . . 12.300000000000001 110.499 175.6 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.06 -48.18 82.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.02 2.343 . . . . 36.509999999999998 115.328 161.752 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.76 -41.03 94.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.38 3.072 . . . . 25.66 114.566 173.037 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.44 -55.68 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 129.191 2.997 . . . . 8.1199999999999992 114.986 164.23 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -46.58 -44.89 18.49 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 114.683 -5.011 . . . . 15.470000000000001 118.73 164.964 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.96 -36.71 75.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 124.725 2.202 . . . . 11.449999999999999 115.768 -177.854 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -69.83 -34.9 74.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.269 -2.242 . . . . 24.98 110.951 178.602 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -59.36 -43.61 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 125.861 1.665 . . . . 9.4600000000000009 109.892 171.403 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -68.05 -42.93 79.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.072 -1.642 . . . . 14.76 108.752 -174.882 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.36 -46.92 87.31 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.399 2.28 . . . . 26.289999999999999 112.602 176.598 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -79.31 -57.25 3.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.703 2.112 . . . . 30.059999999999999 116.703 179.561 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -85.31 -54.64 4.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.708 -3.745 . . . . 25.190000000000001 116.003 -179.78 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.05 54.26 0.98 Allowed Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 124.509 1.052 . . . . 7.4100000000000001 115.161 -176.012 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.7 mt -119.48 125.57 27.44 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 104.585 -2.376 . . . . 9.4900000000000002 104.585 165.614 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 43.0 Cg_endo -75.32 159.17 40.48 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 123.721 2.948 . . . . 11.42 113.276 -176.672 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 41.8 Cg_exo -61.65 -11.41 20.27 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 124.952 3.768 . . . . 12.0 115.651 -179.765 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -85.7 -28.72 24.48 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 121.488 1.949 . . . . 35.549999999999997 106.414 -173.935 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -85.43 -28.66 24.94 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 115.365 -4.584 . . . . 20.52 110.222 -178.191 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -74.29 130.42 39.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.978 2.323 . . . . 7.1299999999999999 114.443 -177.858 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -132.89 126.86 33.11 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 112.81 -1.996 . . . . 36.390000000000001 111.172 164.584 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.2 mt -108.25 114.88 29.09 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 109.286 -3.597 . . . . 9.5500000000000007 113.89 -163.646 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.57 135.19 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 118.685 -2.51 . . . . 13.9 106.132 -172.217 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -96.02 -54.89 3.15 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.185 1.945 . . . . 6.8600000000000003 110.701 173.308 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.28 -126.35 0.27 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 108.899 -3.773 . . . . 11.15 108.026 -176.064 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.5 6.51 12.69 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 127.755 2.598 . . . . 13.93 107.55 -170.732 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -110.16 145.11 37.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.352 1.612 . . . . 23.920000000000002 115.352 -175.553 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -75.1 121.59 22.28 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.239 1.816 . . . . 23.23 111.919 -174.515 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.5 mt -94.68 120.7 35.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.393 2.677 . . . . 9.1099999999999994 110.496 176.61 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.74 143.26 28.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.81 -3.057 . . . . 33.439999999999998 107.641 -177.53 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -65.38 -39.48 92.3 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.027 -1.442 . . . . 28.370000000000001 112.076 -162.45 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.35 -11.77 81.6 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 120.289 2.875 . . . . 15.0 120.289 -168.672 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -91.26 173.57 7.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.657 -2.084 . . . . 25.5 105.765 -178.209 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.2 p -113.83 174.36 5.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.72 2.2 . . . . 11.949999999999999 108.142 -166.91 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.06 -31.11 72.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.444 -2.035 . . . . 10.17 113.989 173.164 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -67.77 -31.99 72.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.781 2.141 . . . . 13.59 116.781 175.716 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -61.92 -50.29 72.75 Favored 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.342 4.257 . . . . 11.699999999999999 110.214 176.811 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -89.87 -20.93 22.83 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 124.172 1.939 . . . . 12.949999999999999 115.198 -178.533 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.339 16.1 m120 85.65 41.73 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 127.346 2.258 . . . . 25.449999999999999 111.88 175.193 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.3 mm -79.31 115.52 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 124.323 2.011 . . . . 14.6 109.002 169.148 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -95.04 -174.16 3.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.405 -1.27 . . . . 33.229999999999997 111.941 -177.559 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -66.82 146.27 54.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.689 1.596 . . . . 25.969999999999999 112.583 175.853 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.461 65.3 mt-10 76.43 11.73 2.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.979 2.214 . . . . 32.609999999999999 116.979 -179.417 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.254 56.2 m -84.42 141.69 30.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.318 1.97 . . . . 10.56 116.318 -169.579 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.4 m -107.7 98.0 7.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.24 -2.162 . . . . 5.3300000000000001 109.843 -166.769 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -88.93 151.57 22.24 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.517 1.927 . . . . 11.66 107.594 -177.036 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.84 123.32 39.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.64 2.638 . . . . 16.300000000000001 108.228 -171.874 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -94.41 112.29 24.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.81 -2.45 . . . . 9.9600000000000009 110.591 -176.624 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.254 38.5 t -103.88 131.57 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 105.594 -2.002 . . . . 9.7599999999999998 105.594 -171.925 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.429 -1.481 0 O-C-N 117.789 -3.069 . . . . 19.57 112.7 -171.401 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.49 -1.344 0 N-CA-C 116.607 2.077 . . . . 17.170000000000002 116.607 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -90.87 144.2 25.93 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.97 -4.206 . . . . 21.890000000000001 112.444 -175.122 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.4 pt -122.09 155.16 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 126.023 2.82 . . . . 10.83 103.946 165.543 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -114.95 111.11 20.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.034 -3.542 . . . . 10.609999999999999 103.597 -172.302 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 67' ' ' LEU . 46.1 t -101.19 135.44 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 116.699 -3.751 . . . . 9.1300000000000008 107.736 179.648 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -115.15 122.79 47.16 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 125.715 1.606 . . . . 20.550000000000001 112.813 -172.491 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -77.02 172.69 12.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.19 -2.819 . . . . 11.779999999999999 115.112 177.675 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.518 HD23 ' CE1' ' A' ' 68' ' ' HIS . 40.8 mt -76.58 -23.74 53.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.274 2.694 . . . . 19.309999999999999 118.274 170.498 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -83.66 -24.8 31.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 115.805 -2.045 . . . . 23.140000000000001 113.501 166.613 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.33 49.8 0.35 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 113.636 -3.869 . . . . 19.739999999999998 113.786 161.388 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -114.69 140.16 49.08 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.665 2.038 . . . . 21.93 107.511 175.499 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -84.4 117.13 23.43 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 116.13 -4.106 . . . . 12.33 108.431 160.856 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -86.2 116.21 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.658 -2.349 . . . . 17.079999999999998 104.658 162.984 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.2 m -106.21 97.39 7.21 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 124.834 2.254 . . . . 16.300000000000001 108.808 -172.415 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 mt -103.45 116.08 31.73 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.892 -1.958 . . . . 15.880000000000001 112.224 -162.428 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.93 119.16 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.727 -1.579 . . . . 28.899999999999999 112.893 170.869 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.78 177.55 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.226 2.441 . . . . 12.050000000000001 109.387 -179.514 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.88 167.3 14.81 Favored Pre-proline 0 N--CA 1.43 -1.471 0 O-C-N 117.176 -3.452 . . . . 18.170000000000002 103.781 172.784 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -76.61 -19.35 14.68 Favored 'Trans proline' 0 C--N 1.3 -2.021 1 C-N-CA 125.595 4.196 . . . . 8.1600000000000001 114.985 179.713 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -79.89 -14.55 58.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.196 2.665 . . . . 11.130000000000001 118.196 171.755 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -72.58 144.83 47.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.303 -2.748 . . . . 18.030000000000001 106.263 -168.87 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.5 p -82.69 157.13 23.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.567 -1.253 . . . . 10.220000000000001 111.854 177.338 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.29 -21.54 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 CA-C-O 128.868 4.175 . . . . 12.300000000000001 114.979 -172.822 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -58.62 -53.77 54.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.488 -3.258 . . . . 36.509999999999998 114.612 157.899 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -50.73 -32.83 20.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.583 -3.823 . . . . 25.66 115.934 173.974 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.11 -53.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 128.496 2.718 . . . . 8.1199999999999992 108.971 173.092 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -65.28 -35.49 81.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.606 1.548 . . . . 15.470000000000001 112.849 -179.887 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.53 92.47 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.254 1.022 . . . . 11.449999999999999 112.318 169.88 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -53.0 -43.35 66.41 Favored 'General case' 0 N--CA 1.43 -1.458 2 O-C-N 113.938 -5.476 . . . . 24.98 113.802 169.866 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -64.88 -29.55 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 127.894 2.478 . . . . 9.4600000000000009 112.807 172.67 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -72.92 -45.79 56.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 123.48 2.854 . . . . 14.76 109.21 167.897 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -59.81 -37.04 78.05 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.165 -2.209 . . . . 26.289999999999999 114.997 177.551 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -85.69 -51.1 6.68 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.563 2.801 . . . . 30.059999999999999 118.563 171.107 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -102.91 -8.14 20.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.155 3.02 . . . . 25.190000000000001 119.155 -178.658 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.29 51.42 58.25 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 117.811 -3.055 . . . . 7.4100000000000001 114.768 -175.512 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.8 mt -111.02 106.25 57.45 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 128.337 2.655 . . . . 9.4900000000000002 108.625 165.775 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 74.6 Cg_exo -72.59 157.45 52.5 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 N-CA-C 118.134 2.321 . . . . 11.42 118.134 -172.048 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -71.84 -15.97 29.65 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-N 126.47 3.346 . . . . 12.0 119.467 -163.78 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.8 -24.43 67.55 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 120.713 3.597 . . . . 35.549999999999997 120.713 160.274 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.406 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 25.8 mt-30 -72.07 -28.93 63.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.903 2.592 . . . . 20.52 114.257 170.594 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -86.85 133.27 33.64 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.54 -3.225 . . . . 7.1299999999999999 115.534 -159.321 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -125.95 108.27 11.25 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.965 1.841 . . . . 36.390000000000001 108.516 167.317 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 43' ' ' LEU . 75.8 mt -87.39 113.94 23.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.444 -1.707 . . . . 9.5500000000000007 108.572 -179.021 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -116.85 134.82 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 1 O-C-N 115.844 -4.285 . . . . 13.9 103.137 175.614 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -103.79 -63.62 1.17 Allowed 'General case' 0 N--CA 1.431 -1.419 1 O-C-N 115.061 -4.774 . . . . 6.8600000000000003 109.952 166.832 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.95 -66.47 0.93 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.797 -3.69 . . . . 11.15 109.122 -168.453 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.11 -53.75 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 O-C-N 116.854 -3.654 . . . . 13.93 118.931 -174.065 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -71.91 169.19 16.36 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.725 2.12 . . . . 23.920000000000002 116.725 -170.035 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -88.46 129.28 35.48 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 114.77 -4.956 . . . . 23.23 106.177 -178.686 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.5 mt -84.47 127.2 33.89 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 111.891 -2.413 . . . . 9.1099999999999994 112.647 175.767 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.29 163.89 26.07 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 129.221 4.075 . . . . 33.439999999999998 111.709 166.493 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -91.07 -63.39 1.27 Allowed 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 115.539 -4.475 . . . . 28.370000000000001 108.936 -172.473 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.25 -5.87 9.1 Favored Glycine 0 N--CA 1.431 -1.667 1 C-N-CA 130.873 4.082 . . . . 15.0 113.561 -178.484 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -91.34 168.43 11.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.119 3.46 . . . . 25.5 110.759 174.763 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 29.6 p -94.72 170.02 9.75 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.237 4.215 . . . . 11.949999999999999 111.334 179.466 . . . . . . . . 3 2 . 1 . 094 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.61 -26.04 62.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.393 -3.942 . . . . 10.17 115.753 172.823 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -63.99 -49.75 71.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 111.447 -2.615 . . . . 13.59 111.119 172.762 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -45.14 -44.48 10.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.767 2.506 . . . . 11.699999999999999 117.767 169.533 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -88.54 3.66 49.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 116.622 -1.656 . . . . 12.949999999999999 114.647 179.257 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.336 3.7 m-80 57.01 52.93 8.55 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.747 3.24 . . . . 25.449999999999999 119.747 -175.227 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mt -115.19 122.8 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 113.926 -1.488 . . . . 14.6 108.214 -177.785 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -112.24 -150.55 0.47 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.37 -2.706 . . . . 33.229999999999997 113.252 175.417 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 64' ' ' GLU . 19.4 pttp -76.59 165.88 24.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.699 2.045 . . . . 25.969999999999999 111.996 -173.252 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.418 ' OE2' ' NZ ' ' A' ' 63' ' ' LYS . 51.4 mt-10 57.23 25.45 11.06 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 133.012 4.525 . . . . 32.609999999999999 109.668 174.528 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.286 52.6 m -76.29 121.94 23.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 129.507 3.123 . . . . 10.56 107.979 -176.709 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.4 m -90.8 116.75 28.88 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 124.697 1.248 . . . . 5.3300000000000001 111.313 175.885 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' A' ' 5' ' ' VAL . 5.8 mp -107.35 158.37 17.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.111 2.164 . . . . 11.66 107.502 178.889 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.518 ' CE1' HD23 ' A' ' 8' ' ' LEU . 5.9 t60 -114.84 131.79 56.72 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.446 1.593 . . . . 16.300000000000001 110.505 172.661 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.65 103.88 14.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 127.715 3.626 . . . . 9.9600000000000009 104.387 172.176 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 t -95.15 133.82 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 1 C-N-CA 135.459 5.504 . . . . 9.7599999999999998 109.94 171.824 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? . . . . . 0 N--CA 1.431 -1.408 0 N-CA-C 116.102 1.89 . . . . 19.57 116.102 -171.688 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 113.614 0.968 . . . . 17.170000000000002 113.614 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -91.98 132.5 36.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.746 1.387 . . . . 21.890000000000001 114.746 -170.772 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 pt -131.21 150.24 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 119.118 -2.239 . . . . 10.83 113.257 167.745 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -99.48 123.61 43.9 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 125.685 1.865 . . . . 10.609999999999999 108.529 -176.796 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.7 t -104.22 121.98 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 117.178 -1.809 . . . . 9.1300000000000008 107.786 171.835 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -103.21 105.98 16.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.112 2.965 . . . . 20.550000000000001 110.958 -170.026 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -69.96 177.39 3.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.832 1.419 . . . . 11.779999999999999 114.832 178.673 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.1 mt -66.29 -43.71 85.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 114.989 -2.434 . . . . 19.309999999999999 111.739 -170.295 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -67.48 -47.83 68.91 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 132.594 6.184 . . . . 23.140000000000001 106.708 172.928 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.32 41.77 0.62 Allowed Glycine 0 N--CA 1.43 -1.708 0 O-C-N 117.669 -3.145 . . . . 19.739999999999998 115.333 -176.879 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -83.38 135.23 34.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 101.889 -3.374 . . . . 21.93 101.889 175.356 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -90.11 101.93 14.64 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 122.183 2.265 . . . . 12.33 106.105 -177.934 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 mt -85.34 109.26 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.445 -0.784 . . . . 17.079999999999998 109.392 172.708 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -92.0 116.8 29.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.317 2.961 . . . . 16.300000000000001 111.302 -178.673 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.2 mt -116.13 137.04 52.47 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.818 -4.301 . . . . 15.880000000000001 111.475 -174.082 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -111.19 108.65 18.38 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.476 -2.64 . . . . 28.899999999999999 106.521 -175.331 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.86 164.62 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 125.116 1.51 . . . . 12.050000000000001 112.786 -172.448 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.33 154.79 37.93 Favored Pre-proline 0 N--CA 1.43 -1.464 0 O-C-N 116.952 -3.592 . . . . 18.170000000000002 110.663 165.419 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -60.55 -24.51 78.38 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 125.101 3.867 . . . . 8.1600000000000001 110.789 179.125 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -98.33 26.01 5.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.211 -1.556 . . . . 11.130000000000001 109.44 -179.408 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -94.86 158.91 15.28 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.998 -2.939 . . . . 18.030000000000001 112.247 161.951 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -105.09 169.8 8.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.447 1.594 . . . . 10.220000000000001 109.578 -170.775 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.11 -40.21 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.666 -2.521 . . . . 12.300000000000001 113.558 178.383 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -43.04 -41.62 3.56 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 121.082 3.734 . . . . 36.509999999999998 121.082 160.653 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -63.19 -60.7 3.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.397 -3.314 . . . . 25.66 111.948 174.913 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 t -46.94 -41.36 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 116.313 -3.992 . . . . 8.1199999999999992 117.182 170.939 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -56.3 -35.67 67.79 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.354 -1.466 . . . . 15.470000000000001 111.091 177.696 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.1 -24.23 60.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.922 -3.611 . . . . 11.449999999999999 114.341 -179.13 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -65.03 -30.1 71.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.416 2.747 . . . . 24.98 118.416 166.028 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.8 mt -78.24 -33.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 124.291 1.996 . . . . 9.4600000000000009 110.492 178.544 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -66.18 -31.33 72.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.87 -1.768 . . . . 14.76 115.073 169.093 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -62.41 -60.8 3.03 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.442 3.097 . . . . 26.289999999999999 109.218 173.251 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -79.87 -63.7 1.35 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 115.059 1.503 . . . . 30.059999999999999 115.059 -174.142 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 45.2 mm-40 -82.53 -28.88 30.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.239 3.051 . . . . 25.190000000000001 119.239 -177.28 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.98 7.79 49.45 Favored Glycine 0 N--CA 1.43 -1.75 1 O-C-N 116.056 -4.153 . . . . 7.4100000000000001 120.956 173.25 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.67 129.65 51.95 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 118.656 -2.673 . . . . 9.4900000000000002 111.815 -179.529 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -66.66 146.61 79.63 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 N-CA-C 118.411 2.427 . . . . 11.42 118.411 174.979 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -16.95 57.51 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 120.125 3.087 . . . . 12.0 120.125 -169.335 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.67 -19.85 34.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.587 -1.946 . . . . 35.549999999999997 110.738 176.766 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -91.6 -24.12 19.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.064 2.364 . . . . 20.52 107.843 -169.22 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -73.45 155.56 39.16 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.191 -3.443 . . . . 7.1299999999999999 111.391 175.171 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.291 51.5 ttt180 -139.5 120.0 14.03 Favored 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 132.471 4.308 . . . . 36.390000000000001 113.672 167.604 . . . . . . . . 3 2 . 1 . 095 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.84 132.77 49.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.809 -1.807 . . . . 9.5500000000000007 109.698 -179.471 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 3.6 mt -120.61 130.61 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.007 -1.108 . . . . 13.9 108.007 179.215 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -86.45 -77.5 0.31 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.43 -2.044 . . . . 6.8600000000000003 110.135 163.002 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.07 -73.37 0.67 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.053 1.341 . . . . 11.15 107.864 173.973 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.46 1.2 0.42 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 113.699 -3.834 . . . . 13.93 115.129 -171.733 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -105.54 166.83 10.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 123.875 3.838 . . . . 23.920000000000002 107.832 -167.176 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -97.31 139.94 32.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.818 1.645 . . . . 23.23 111.365 177.729 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -101.61 141.95 33.7 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.308 -0.86 . . . . 9.1099999999999994 108.881 -174.661 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.253 43.6 mt-10 -97.93 149.25 22.61 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.127 -2.233 . . . . 33.439999999999998 107.397 174.182 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.03 -31.21 71.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.303 2.241 . . . . 28.370000000000001 112.436 -175.299 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.71 36.26 4.52 Favored Glycine 0 N--CA 1.43 -1.728 1 N-CA-C 125.189 4.835 . . . . 15.0 125.189 -177.179 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -126.35 162.15 26.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.161 -2.376 . . . . 25.5 107.179 170.871 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.255 29.9 p -88.24 166.49 14.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.146 -2.846 . . . . 11.949999999999999 111.432 -175.479 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.57 -41.67 90.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.495 2.569 . . . . 10.17 111.301 164.789 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -58.51 -39.17 79.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.482 -3.261 . . . . 13.59 114.539 175.064 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -67.43 -36.71 81.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.228 1.966 . . . . 11.699999999999999 111.66 -174.256 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -85.32 -0.61 55.28 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.869 -3.019 . . . . 12.949999999999999 108.716 176.1 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.301 3.3 m120 56.67 36.87 28.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.884 2.179 . . . . 25.449999999999999 116.884 -179.329 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.5 mt -99.02 111.07 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 117.182 -1.39 . . . . 14.6 108.848 177.816 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.307 28.8 mm100 -96.0 -167.04 1.52 Allowed 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.927 3.267 . . . . 33.229999999999997 107.134 -167.294 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -57.33 159.92 4.34 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 117.161 2.282 . . . . 25.969999999999999 117.161 167.089 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 65.24 14.37 9.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.542 1.937 . . . . 32.609999999999999 113.546 -178.045 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -81.04 133.7 35.53 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.566 1.691 . . . . 10.56 115.566 -171.248 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.4 m -93.25 112.11 23.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.472 -1.694 . . . . 5.3300000000000001 108.737 -173.232 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.9 mt -98.06 133.48 42.45 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.379 -3.326 . . . . 11.66 106.163 176.248 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 15.3 t60 -94.75 119.09 32.8 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 126.67 1.988 . . . . 16.300000000000001 112.819 167.918 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.9 tp -103.81 121.51 43.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 126.153 2.882 . . . . 9.9600000000000009 114.418 -179.981 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.72 176.98 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 1 O-C-N 114.668 -5.02 . . . . 9.7599999999999998 103.104 -177.243 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 N--CA 1.43 -1.443 1 O-C-N 114.212 -5.305 . . . . 19.57 115.282 -179.049 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 116.981 -1.485 . . . . 17.170000000000002 112.864 . . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -101.67 149.42 24.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 114.51 -2.876 . . . . 21.890000000000001 113.934 -173.836 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.74 174.98 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 119.636 -1.915 . . . . 10.83 109.034 160.145 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -126.18 149.5 48.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 115.349 -2.54 . . . . 10.609999999999999 108.098 -175.319 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.8 t -112.94 127.59 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 104.659 -2.349 . . . . 9.1300000000000008 104.659 168.051 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -105.85 117.69 34.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.853 2.168 . . . . 20.550000000000001 116.853 164.58 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -92.05 169.54 10.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.723 3.154 . . . . 11.779999999999999 109.068 -168.966 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 mt -62.93 -38.36 90.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.499 -2.625 . . . . 19.309999999999999 111.668 166.501 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 m -61.37 -61.32 2.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.48 3.512 . . . . 23.140000000000001 112.718 -178.982 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.52 52.42 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 118.567 -1.778 . . . . 19.739999999999998 111.373 177.869 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -123.87 167.37 14.18 Favored 'General case' 0 N--CA 1.43 -1.454 1 CA-C-O 129.648 4.546 . . . . 21.93 108.18 179.759 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.2 m -131.06 108.28 9.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 110.368 -3.105 . . . . 12.33 103.155 166.771 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.8 mt -101.28 131.52 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 111.953 -3.88 . . . . 17.079999999999998 107.123 175.545 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.6 m -104.59 114.88 29.39 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 123.996 3.089 . . . . 16.300000000000001 106.551 173.846 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.3 mt -104.1 129.03 51.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.145 1.778 . . . . 15.880000000000001 111.824 174.074 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -87.03 106.3 17.75 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.657 3.122 . . . . 28.899999999999999 105.081 -178.545 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.19 155.7 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.031 -2.918 . . . . 12.050000000000001 110.418 -171.266 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -109.89 137.42 20.45 Favored Pre-proline 0 N--CA 1.43 -1.432 0 O-C-N 116.723 -3.735 . . . . 18.170000000000002 107.759 164.881 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.69 -10.25 13.11 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 124.828 3.686 . . . . 8.1600000000000001 113.074 -164.077 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -89.22 -12.98 39.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.024 2.345 . . . . 11.130000000000001 110.958 174.511 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -81.88 157.9 24.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.105 -1.407 . . . . 18.030000000000001 111.749 176.007 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -87.51 170.33 11.43 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.54 -2.6 . . . . 10.220000000000001 116.007 -150.895 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.0 mt -80.95 -27.3 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 118.3 -2.75 . . . . 12.300000000000001 110.892 -175.471 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -62.21 -45.14 94.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.767 -2.063 . . . . 36.509999999999998 112.619 166.98 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -64.25 -20.43 66.04 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 117.516 -1.23 . . . . 25.66 112.238 178.055 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.1 t -73.06 -40.4 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 122.16 2.255 . . . . 8.1199999999999992 111.82 168.473 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -66.94 -38.45 86.18 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.491 2.994 . . . . 15.470000000000001 113.989 176.807 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -64.44 -11.07 29.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.617 2.821 . . . . 11.449999999999999 118.617 169.564 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -84.04 -38.88 20.3 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.506 1.622 . . . . 24.98 113.506 166.35 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.7 -40.51 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 117.561 -3.212 . . . . 9.4600000000000009 115.545 160.618 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 22.4 tt0 -55.01 -35.34 64.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.15 -2.844 . . . . 14.76 114.438 170.289 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.4 -57.07 11.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.892 -1.755 . . . . 26.289999999999999 115.344 166.452 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -66.27 -65.11 0.72 Allowed 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 133.415 4.686 . . . . 30.059999999999999 109.714 -168.452 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -93.32 -26.53 17.26 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.903 1.811 . . . . 25.190000000000001 114.454 -173.471 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.8 28.6 9.32 Favored Glycine 0 N--CA 1.43 -1.709 1 O-C-N 114.152 -5.342 . . . . 7.4100000000000001 116.358 177.126 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 90.2 mt -120.12 118.54 31.41 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 116.256 -1.83 . . . . 9.4900000000000002 108.263 -162.62 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -73.05 162.0 41.99 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.867 3.488 . . . . 11.42 114.961 -164.004 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.63 -15.53 19.35 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 125.616 3.041 . . . . 12.0 114.338 -174.016 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.4 -29.78 42.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.599 2.454 . . . . 35.549999999999997 114.078 176.351 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -78.11 -23.63 47.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.653 1.981 . . . . 20.52 115.38 171.866 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -71.79 139.48 49.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.266 3.062 . . . . 7.1299999999999999 119.266 170.562 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.488 ' HB3' HG23 ' A' ' 70' ' ' VAL . 72.6 ttt180 -119.71 147.46 44.55 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.488 -2.007 . . . . 36.390000000000001 113.949 158.604 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -127.64 112.52 14.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.858 -2.401 . . . . 9.5500000000000007 111.047 179.419 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.6 mt -95.71 125.35 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.124 -3.485 . . . . 13.9 107.044 -175.663 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -98.1 -62.51 1.23 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.909 -3.62 . . . . 6.8600000000000003 105.952 178.107 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.69 -128.5 0.1 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.135 2.574 . . . . 11.15 104.497 177.976 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.04 7.07 32.81 Favored Glycine 0 N--CA 1.431 -1.699 0 O-C-N 121.043 -1.036 . . . . 13.93 114.609 -172.482 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -111.98 117.36 32.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.206 1.558 . . . . 23.920000000000002 115.206 169.661 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -68.6 129.3 39.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.319 2.009 . . . . 23.23 111.191 -170.345 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.37 153.3 35.89 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.61 -3.181 . . . . 9.1099999999999994 113.891 -176.687 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -101.65 150.41 23.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.107 0.956 . . . . 33.439999999999998 111.676 162.253 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -67.02 -43.99 81.42 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 120.44 3.496 . . . . 28.370000000000001 120.44 -178.145 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.73 48.04 1.85 Allowed Glycine 0 N--CA 1.43 -1.709 0 CA-C-O 123.777 1.765 . . . . 15.0 111.873 -178.449 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -127.39 162.22 26.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.8 -2.296 . . . . 25.5 104.8 174.544 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.2 p -91.09 169.42 10.87 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.77 -3.081 . . . . 11.949999999999999 108.605 178.097 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.7 -34.28 71.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.345 -3.347 . . . . 10.17 114.319 171.442 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 t -65.81 -34.69 78.75 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 128.358 3.536 . . . . 13.59 116.008 -178.482 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -56.58 -43.33 79.95 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.83 -1.794 . . . . 11.699999999999999 113.323 177.834 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -95.11 8.82 41.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 122.354 2.343 . . . . 12.949999999999999 113.437 -178.882 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.493 10.6 m120 66.0 41.23 3.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.847 2.059 . . . . 25.449999999999999 113.274 175.96 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.3 mt -91.05 138.09 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 106.632 -1.618 . . . . 14.6 106.632 -178.233 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -128.98 -177.28 4.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.943 -2.973 . . . . 33.229999999999997 112.426 -168.746 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.327 19.9 pttp -60.93 149.6 35.93 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 120.862 3.653 . . . . 25.969999999999999 120.862 168.916 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 48.1 27.49 1.26 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.965 3.306 . . . . 32.609999999999999 116.802 -171.905 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.334 54.5 m -92.99 144.94 24.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.409 -3.307 . . . . 10.56 114.986 177.277 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.5 m -99.91 120.99 40.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.057 -1.925 . . . . 5.3300000000000001 115.937 -171.761 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -103.51 137.92 40.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.11 -1.441 . . . . 11.66 107.11 174.567 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -93.6 114.44 26.78 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 114.445 1.276 . . . . 16.300000000000001 114.445 177.08 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.253 49.6 tp -83.4 115.2 21.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 124.288 0.992 . . . . 9.9600000000000009 110.353 -179.595 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 42' ' ' ARG . 3.3 m -119.57 -175.05 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 115.068 -0.969 . . . . 9.7599999999999998 110.102 166.92 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 mt . . . . . 0 N--CA 1.43 -1.432 0 CA-C-O 122.606 1.193 . . . . 19.57 113.147 172.334 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 116.08 -1.914 . . . . 17.170000000000002 113.758 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -104.24 131.58 51.4 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.267 2.23 . . . . 21.890000000000001 110.383 -179.08 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.38 152.51 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.182 -2.525 . . . . 10.83 104.182 -178.696 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -107.31 125.08 50.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.269 2.228 . . . . 10.609999999999999 111.289 -176.69 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 t -110.84 115.63 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.23 -2.794 . . . . 9.1300000000000008 109.221 176.513 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.262 31.3 tttt -97.79 130.59 44.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.741 0.781 . . . . 20.550000000000001 109.626 -171.535 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.271 13.9 p -74.92 166.25 23.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.841 -3.662 . . . . 11.779999999999999 115.12 -179.001 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.263 1.6 tp -54.96 -43.33 73.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.618 3.567 . . . . 19.309999999999999 106.288 171.607 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 p -89.49 -50.25 6.21 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.177 -3.452 . . . . 23.140000000000001 115.64 179.529 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.75 67.61 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.763 0 O-C-N 117.533 -3.23 . . . . 19.739999999999998 111.34 163.475 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -137.24 139.83 41.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.503 -2.763 . . . . 21.93 106.545 173.784 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -104.57 112.9 26.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.799 1.64 . . . . 12.33 107.655 -166.816 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 60.1 mt -91.03 144.22 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 118.17 -2.831 . . . . 17.079999999999998 107.348 179.328 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.1 m -108.5 121.01 44.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 122.799 2.545 . . . . 16.300000000000001 112.779 164.867 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 15' ' ' LEU . 91.4 mt -110.66 130.7 55.5 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.688 2.795 . . . . 15.880000000000001 111.715 -179.997 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -90.54 114.83 27.13 Favored 'General case' 0 N--CA 1.43 -1.453 1 CA-C-O 128.596 4.046 . . . . 28.899999999999999 108.81 173.687 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.61 171.63 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.56 -3.212 . . . . 12.050000000000001 110.89 -173.621 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.36 147.94 36.63 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 102.387 -3.19 . . . . 18.170000000000002 102.387 166.663 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -65.11 -14.07 43.19 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 121.695 1.597 . . . . 8.1600000000000001 113.938 171.671 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.34 -4.95 50.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.936 2.303 . . . . 11.130000000000001 116.142 171.895 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -81.18 146.47 30.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 114.596 -2.621 . . . . 18.030000000000001 109.753 178.919 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.0 p -79.75 166.71 21.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 125.717 3.871 . . . . 10.220000000000001 114.111 167.627 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.7 mm -49.77 -43.36 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 111.624 -2.534 . . . . 12.300000000000001 113.738 169.234 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.254 36.0 tt0 -54.11 -24.83 19.08 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.663 -2.113 . . . . 36.509999999999998 115.632 176.632 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -86.9 -34.71 19.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.156 2.408 . . . . 25.66 111.043 178.206 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.22 -48.4 88.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.457 2.075 . . . . 8.1199999999999992 108.521 178.677 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -61.31 -27.04 68.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 119.134 3.012 . . . . 15.470000000000001 119.134 175.278 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.258 . . -74.2 -29.51 61.78 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.83 -3.044 . . . . 11.449999999999999 109.827 -175.959 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HB3' HD22 ' A' ' 15' ' ' LEU . 68.7 mmtt -64.52 -36.75 85.22 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.399 2.523 . . . . 24.98 115.904 169.254 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.344 39.1 mt -65.08 -42.05 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 O-C-N 116.198 -4.063 . . . . 9.4600000000000009 110.701 171.766 . . . . . . . . 3 2 . 1 . 097 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.07 -29.83 68.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.914 -3.616 . . . . 14.76 118.367 168.211 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.65 -48.67 16.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 126.42 2.325 . . . . 26.289999999999999 111.194 -179.023 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -83.03 -57.48 3.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 126.21 2.194 . . . . 30.059999999999999 112.005 -169.883 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -78.32 -45.8 21.73 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.62 2.768 . . . . 25.190000000000001 111.537 177.757 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.2 50.15 5.59 Favored Glycine 0 N--CA 1.43 -1.763 0 O-C-N 119.407 -2.058 . . . . 7.4100000000000001 113.25 -169.126 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mt -113.31 140.81 24.81 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.114 -2.18 . . . . 9.4900000000000002 105.114 170.38 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -72.75 148.88 47.39 Favored 'Trans proline' 0 N--CA 1.433 -2.032 1 C-N-CA 125.885 4.39 . . . . 11.42 111.164 -176.837 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.8 -30.16 9.68 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 N-CA-C 116.44 1.669 . . . . 12.0 116.44 -165.3 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -66.23 -26.21 67.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 120.333 3.457 . . . . 35.549999999999997 120.333 172.356 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -78.09 -29.7 49.18 Favored 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 132.327 4.251 . . . . 20.52 108.528 -178.163 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.262 56.6 mt-30 -67.74 91.44 0.31 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.693 3.197 . . . . 7.1299999999999999 110.283 170.799 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -93.77 98.54 11.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 126.74 3.162 . . . . 36.390000000000001 109.51 171.417 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -98.22 130.52 44.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.08 2.848 . . . . 9.5500000000000007 104.496 -170.374 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mt -123.08 134.27 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.544 -3.847 . . . . 13.9 107.095 -173.72 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -115.54 103.36 10.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 102.491 -3.151 . . . . 6.8600000000000003 102.491 175.794 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.69 -97.48 0.06 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.407 2.283 . . . . 11.15 111.368 -172.679 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.58 16.23 9.05 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-O 124.083 1.935 . . . . 13.93 117.353 161.679 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -84.33 115.0 22.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.659 -3.26 . . . . 23.920000000000002 106.833 174.963 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -74.13 123.58 24.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 117.142 -1.409 . . . . 23.23 110.916 166.82 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.07 132.66 39.71 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 116.618 -2.033 . . . . 9.1099999999999994 108.648 -160.301 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -78.37 151.0 33.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.496 -3.877 . . . . 33.439999999999998 107.325 174.929 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.16 -36.85 75.0 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.485 2.088 . . . . 28.370000000000001 111.843 -169.572 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.03 25.15 27.23 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-O 125.415 2.675 . . . . 15.0 113.043 -160.754 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -115.56 142.19 47.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 124.288 1.994 . . . . 25.5 108.414 -174.231 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -76.31 153.89 35.51 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.166 2.412 . . . . 11.949999999999999 112.73 178.959 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.9 mt -70.9 -32.27 69.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.552 -3.217 . . . . 10.17 111.88 178.586 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.5 p -70.93 -17.58 62.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.347 -1.471 . . . . 13.59 114.844 168.843 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -77.73 -44.86 26.47 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 119.059 -2.275 . . . . 11.699999999999999 110.37 178.769 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -70.03 -25.44 63.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.799 -3.688 . . . . 12.949999999999999 115.76 173.975 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.501 20.3 t30 81.6 43.8 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 131.399 3.879 . . . . 25.449999999999999 115.905 -170.553 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.9 mt -94.13 94.25 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 105.68 -1.97 . . . . 14.6 105.68 174.009 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -93.07 -177.45 4.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.784 -1.553 . . . . 33.229999999999997 114.94 176.067 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -55.96 139.03 47.73 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.241 2.311 . . . . 25.969999999999999 117.241 -174.19 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 80.0 mt-10 68.98 12.27 8.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 128.634 3.709 . . . . 32.609999999999999 114.015 -179.854 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.275 16.1 m -64.69 144.05 57.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.392 1.477 . . . . 10.56 112.876 170.0 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 m -102.06 116.25 32.28 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 102.076 -3.305 . . . . 5.3300000000000001 102.076 -176.602 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.36 134.72 42.88 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.191 -1.568 . . . . 11.66 111.455 168.245 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -109.5 120.75 43.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 113.317 -3.23 . . . . 16.300000000000001 112.115 -163.993 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.7 tp -94.43 117.88 30.79 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.686 1.866 . . . . 9.9600000000000009 108.51 -170.292 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.55 149.3 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.293 -1.504 . . . . 9.7599999999999998 107.625 167.283 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.264 80.2 mt . . . . . 0 N--CA 1.43 -1.43 0 O-C-N 120.481 -1.387 . . . . 19.57 113.589 -179.06 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 114.311 1.226 . . . . 17.170000000000002 114.311 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.259 61.8 mt-30 -98.4 135.58 39.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.183 1.793 . . . . 21.890000000000001 107.28 171.306 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.313 18.3 pt -131.23 150.64 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.416 -2.053 . . . . 10.83 110.14 166.947 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.255 17.5 m-85 -115.78 111.57 20.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.108 2.163 . . . . 10.609999999999999 112.713 -172.675 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.4 t -96.92 121.51 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.65 -1.281 . . . . 9.1300000000000008 107.943 177.459 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.29 38.6 ttmt -114.27 133.68 55.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.144 -1.408 . . . . 20.550000000000001 113.107 -170.844 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.8 p -83.9 173.54 11.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 127.982 3.302 . . . . 11.779999999999999 114.429 178.248 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 mt -75.93 -29.48 58.39 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.642 2.46 . . . . 19.309999999999999 117.642 -178.686 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -68.07 -64.53 0.84 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.072 2.549 . . . . 23.140000000000001 107.367 169.846 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.26 51.72 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 104.656 -3.378 . . . . 19.739999999999998 104.656 170.016 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -97.13 125.64 41.76 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.161 2.984 . . . . 21.93 108.757 161.019 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -99.19 127.68 45.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.063 -2.273 . . . . 12.33 106.0 176.662 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.55 115.77 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 128.741 2.816 . . . . 17.079999999999998 111.297 161.576 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.3 m -84.8 124.74 31.91 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 119.327 0.967 . . . . 16.300000000000001 112.005 165.037 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.18 128.43 56.36 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 126.969 2.668 . . . . 15.880000000000001 104.733 -175.645 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -99.77 110.92 23.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.577 -2.749 . . . . 28.899999999999999 103.577 178.843 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.4 155.55 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 117.863 -1.065 . . . . 12.050000000000001 110.264 -169.477 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -104.08 139.23 19.9 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 115.933 -1.984 . . . . 18.170000000000002 112.153 171.166 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.66 -15.56 21.58 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 126.165 3.237 . . . . 8.1600000000000001 111.369 -158.484 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.3 p -82.45 -1.8 51.3 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 121.121 3.749 . . . . 11.130000000000001 121.121 -177.414 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -89.1 174.2 8.01 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.922 3.689 . . . . 18.030000000000001 110.384 -179.036 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.4 p -91.51 157.43 17.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.482 -3.261 . . . . 10.220000000000001 113.843 -173.671 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mt -73.89 -31.21 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.056 -2.572 . . . . 12.300000000000001 104.056 172.96 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -40.23 -48.74 2.63 Favored 'General case' 0 N--CA 1.43 -1.429 2 O-C-N 114.13 -5.356 . . . . 36.509999999999998 110.656 164.982 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.306 8.8 t-20 -61.73 -41.82 98.15 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.026 2.93 . . . . 25.66 112.956 177.744 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -59.35 -45.19 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 125.436 1.495 . . . . 8.1199999999999992 111.352 174.976 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -68.91 -40.63 78.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.686 3.194 . . . . 15.470000000000001 109.315 -179.087 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.32 -26.3 68.42 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.508 3.123 . . . . 11.449999999999999 111.886 176.493 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -72.18 -37.68 69.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.269 1.85 . . . . 24.98 111.594 172.496 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mt -76.49 -29.03 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 125.809 1.644 . . . . 9.4600000000000009 109.879 178.43 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.27 -50.34 74.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.885 -3.01 . . . . 14.76 110.641 165.873 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.09 -68.27 0.26 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 129.158 2.983 . . . . 26.289999999999999 112.712 179.974 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -71.68 -62.87 1.26 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 114.719 -2.562 . . . . 30.059999999999999 115.197 -176.541 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -72.1 -51.18 22.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.403 2.049 . . . . 25.190000000000001 113.549 -175.079 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.74 38.83 1.52 Allowed Glycine 0 N--CA 1.43 -1.718 0 O-C-N 116.716 -3.74 . . . . 7.4100000000000001 113.934 -179.509 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.272 78.9 mt -124.92 124.51 25.47 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 103.311 -2.848 . . . . 9.4900000000000002 103.311 -174.249 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -76.84 175.82 10.9 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-O 114.904 -2.207 . . . . 11.42 110.789 -171.38 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HA ' ' HG2' ' A' ' 41' ' ' GLN . 49.0 Cg_endo -74.85 -32.84 5.29 Favored 'Trans proline' 0 C--N 1.299 -2.027 1 C-N-CA 126.53 4.82 . . . . 12.0 110.759 171.925 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.272 11.6 t70 -58.26 -42.55 86.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.401 1.08 . . . . 35.549999999999997 113.809 176.322 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -79.54 -38.71 33.59 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.248 2.219 . . . . 20.52 112.314 -178.66 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 38' ' ' PRO . 5.6 pt20 -80.08 167.28 20.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 127.342 3.448 . . . . 7.1299999999999999 118.71 -175.31 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -131.43 121.8 25.18 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.612 -3.18 . . . . 36.390000000000001 111.975 162.086 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.3 tp -108.66 119.0 38.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.24 -1.393 . . . . 9.5500000000000007 107.24 -170.469 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 44' ' ' ILE . 56.1 mt -118.31 135.67 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.959 -2.963 . . . . 13.9 113.128 -169.68 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -118.7 109.54 16.22 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.879 -3.013 . . . . 6.8600000000000003 106.323 167.798 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.4 -92.85 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.385 3.074 . . . . 11.15 113.566 -172.371 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.04 -37.89 8.16 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 119.486 -2.009 . . . . 13.93 116.611 175.545 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -107.71 146.56 31.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 124.794 0.938 . . . . 23.920000000000002 112.546 -159.742 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -81.02 138.37 36.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.43 2.538 . . . . 23.23 112.699 171.9 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.2 mt -89.78 114.83 26.61 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.757 -3.715 . . . . 9.1099999999999994 112.306 -175.914 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.85 143.98 27.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.26 -2.15 . . . . 33.439999999999998 114.578 -173.084 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.8 -49.86 72.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.61 3.164 . . . . 28.370000000000001 112.447 -165.875 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.12 -4.63 77.78 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 118.325 2.09 . . . . 15.0 118.325 -163.303 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -84.06 178.94 7.64 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.776 3.179 . . . . 25.5 113.854 166.105 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.5 p -110.83 175.84 5.27 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.732 -3.105 . . . . 11.949999999999999 104.651 -177.667 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.49 -26.9 32.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.152 2.181 . . . . 10.17 105.374 -178.589 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.1 p -65.99 -36.33 83.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 131.461 3.905 . . . . 13.59 113.147 174.264 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.4 -52.84 63.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 126.972 2.67 . . . . 11.699999999999999 116.001 171.048 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -67.56 -17.49 64.66 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.767 1.627 . . . . 12.949999999999999 111.357 176.822 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 59.51 55.08 4.27 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.545 2.338 . . . . 25.449999999999999 111.754 -170.405 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 61' ' ' ILE . 57.0 mt -86.79 116.96 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 104.038 -2.579 . . . . 14.6 104.038 -178.417 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -98.3 159.69 14.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 126.925 2.641 . . . . 33.229999999999997 110.011 -178.212 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -52.18 131.98 32.97 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.878 2.071 . . . . 25.969999999999999 112.909 -178.051 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 73.09 32.57 1.29 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.716 -2.947 . . . . 32.609999999999999 111.938 176.666 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -75.66 141.49 42.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.843 1.783 . . . . 10.56 110.636 169.48 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -86.54 120.48 27.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.505 -2.035 . . . . 5.3300000000000001 105.505 171.63 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.86 146.73 38.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.754 1.622 . . . . 11.66 106.827 175.959 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -117.73 140.57 49.49 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.422 2.058 . . . . 16.300000000000001 108.134 -172.177 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 tp -119.68 135.69 54.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.024 -2.954 . . . . 9.9600000000000009 103.024 -174.534 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 71' ' ' LEU . 2.3 t -135.03 -176.6 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.381 2.672 . . . . 9.7599999999999998 105.283 174.805 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.568 ' H ' HG12 ' A' ' 70' ' ' VAL . 7.2 mt . . . . . 0 N--CA 1.431 -1.414 0 C-N-CA 126.792 2.037 . . . . 19.57 108.973 169.111 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tmm? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 112.485 0.55 . . . . 17.170000000000002 112.485 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -85.83 123.47 31.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.206 1.402 . . . . 21.890000000000001 108.066 -178.659 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.496 HD12 HD22 ' A' ' 67' ' ' LEU . 39.6 pt -106.29 161.01 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.871 -2.393 . . . . 10.83 109.769 151.855 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -114.23 131.81 56.35 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.851 -3.389 . . . . 10.609999999999999 101.851 -178.765 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.95 102.83 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 101.867 -3.383 . . . . 9.1300000000000008 101.867 -178.079 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -94.89 128.5 41.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.174 2.19 . . . . 20.550000000000001 116.403 -173.206 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.267 18.9 p -89.41 173.17 8.51 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.121 -2.862 . . . . 11.779999999999999 116.407 -177.012 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.95 -48.56 15.99 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.118 -2.239 . . . . 19.309999999999999 109.004 174.502 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -67.69 -46.98 70.72 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.929 3.291 . . . . 23.140000000000001 107.188 -168.54 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.63 24.58 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 116.074 -2.514 . . . . 19.739999999999998 118.799 173.083 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -110.89 124.91 53.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 120.082 1.941 . . . . 21.93 107.243 -174.489 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 m -105.53 114.1 28.06 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.729 -1.857 . . . . 12.33 109.846 171.745 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -95.34 122.1 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 103.698 -2.705 . . . . 17.079999999999998 103.698 -165.735 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -91.48 110.92 22.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.985 -2.969 . . . . 16.300000000000001 102.985 175.244 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.5 mt -106.26 136.77 45.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.986 1.314 . . . . 15.880000000000001 108.404 169.126 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -93.58 116.02 28.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.342 2.02 . . . . 28.899999999999999 108.938 169.275 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.85 167.57 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.529 3.132 . . . . 12.050000000000001 110.694 175.487 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -105.64 158.44 32.31 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 114.485 -2.674 . . . . 18.170000000000002 110.878 157.68 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -74.38 -25.12 13.54 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 126.174 3.241 . . . . 8.1600000000000001 117.478 -172.453 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -75.24 -11.4 60.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 131.223 3.809 . . . . 11.130000000000001 115.788 163.629 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -72.46 158.24 36.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.998 2.333 . . . . 18.030000000000001 113.522 178.382 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -92.98 161.41 14.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.244 -3.41 . . . . 10.220000000000001 112.478 -173.926 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.7 mt -82.82 -8.75 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 126.661 2.476 . . . . 12.300000000000001 111.224 -179.398 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -57.7 -54.91 41.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.941 -2.349 . . . . 36.509999999999998 111.313 166.421 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -61.27 -16.08 41.85 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 116.291 -4.005 . . . . 25.66 115.012 168.776 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -74.64 -43.93 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 CA-C-N 126.381 4.173 . . . . 8.1199999999999992 108.302 167.906 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -67.15 -32.29 73.3 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.311 1.869 . . . . 15.470000000000001 114.79 175.51 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.98 -25.14 58.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.108 1.892 . . . . 11.449999999999999 116.108 172.176 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -74.08 -30.58 62.44 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.493 1.497 . . . . 24.98 107.052 178.233 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.402 HG22 ' HB ' ' A' ' 36' ' ' ILE . 37.9 mm -69.9 -34.67 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 118.368 -0.825 . . . . 9.4600000000000009 111.857 173.639 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -65.13 -43.49 91.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.802 2.841 . . . . 14.76 109.741 173.466 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.02 -56.77 14.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 117.49 2.404 . . . . 26.289999999999999 117.49 176.311 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 14.7 mmtm -56.53 -65.16 0.66 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.875 3.27 . . . . 30.059999999999999 112.235 173.322 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -101.17 -36.03 9.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.682 -1.145 . . . . 25.190000000000001 113.133 -159.673 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.08 4.72 31.08 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 118.231 -2.793 . . . . 7.4100000000000001 114.078 -177.402 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.402 ' HB ' HG22 ' A' ' 30' ' ' ILE . 9.6 mt -88.34 112.25 48.6 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-O 116.831 -1.557 . . . . 9.4900000000000002 109.121 -173.02 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -81.74 -176.7 3.17 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 122.568 1.953 . . . . 11.42 114.472 -171.819 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -74.4 -16.31 21.91 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 122.412 2.074 . . . . 12.0 115.764 -178.924 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.42 -24.08 42.77 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.88 2.752 . . . . 35.549999999999997 116.614 -175.904 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -98.33 -35.52 10.29 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.501 -2.136 . . . . 20.52 110.057 -168.587 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -91.89 166.26 12.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.635 -1.29 . . . . 7.1299999999999999 108.515 -172.333 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.2 139.02 37.39 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 131.778 4.031 . . . . 36.390000000000001 104.102 165.632 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.1 mt -104.2 132.9 49.96 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.647 1.979 . . . . 9.5500000000000007 106.401 178.069 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.02 142.07 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.809 -1.807 . . . . 13.9 107.846 177.514 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -148.83 108.54 4.02 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.308 -2.12 . . . . 6.8600000000000003 108.484 -175.066 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 57.05 -114.31 0.81 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 120.541 3.534 . . . . 11.15 120.541 -158.54 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.34 -36.53 20.39 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.605 -1.31 . . . . 13.93 114.607 -178.901 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -116.06 170.49 8.46 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 120.729 2.264 . . . . 23.920000000000002 114.499 -162.54 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.19 146.54 24.99 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 102.799 -3.037 . . . . 23.23 102.799 -176.676 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.8 mt -99.86 128.79 45.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.489 -2.782 . . . . 9.1099999999999994 103.489 -166.397 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -75.3 153.81 37.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.736 1.614 . . . . 33.439999999999998 113.868 168.76 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.55 -61.69 1.73 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.782 -3.699 . . . . 28.370000000000001 108.56 -162.671 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.93 59.2 3.21 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 122.297 2.317 . . . . 15.0 111.147 -169.438 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -140.72 153.07 45.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.472 2.309 . . . . 25.5 106.987 -177.354 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.25 46.7 p -82.94 154.53 24.5 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.674 -2.516 . . . . 11.949999999999999 113.174 -173.151 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.631 HD23 HD12 ' A' ' 61' ' ' ILE . 17.5 mt -63.88 -39.52 94.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.933 -2.354 . . . . 10.17 111.642 165.503 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 p -54.59 -37.5 65.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.408 2.744 . . . . 13.59 118.408 172.578 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.37 -50.35 53.76 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.287 -5.258 . . . . 11.699999999999999 113.941 174.745 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -69.88 -14.09 62.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.295 2.638 . . . . 12.949999999999999 114.03 -177.909 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.492 27.6 m-20 75.23 41.15 0.3 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 116.963 2.209 . . . . 25.449999999999999 116.963 -176.289 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.631 HD12 HD23 ' A' ' 56' ' ' LEU . 71.7 mt -83.0 116.12 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 118.21 -2.806 . . . . 14.6 107.77 177.522 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -97.95 167.46 10.9 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.615 -0.721 . . . . 33.229999999999997 110.012 -176.65 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -70.23 144.65 51.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 120.874 1.67 . . . . 25.969999999999999 112.605 -174.86 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 67.16 21.5 10.04 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.661 3.6 . . . . 32.609999999999999 112.134 176.81 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 t -97.67 151.61 19.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.896 -2.378 . . . . 10.56 108.682 -178.081 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.8 m -101.47 111.3 23.5 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.244 2.618 . . . . 5.3300000000000001 113.07 -168.502 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.496 HD22 HD12 ' A' ' 3' ' ' ILE . 9.2 mp -90.88 145.89 24.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.293 2.637 . . . . 11.66 106.206 164.065 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -97.26 132.46 42.98 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 119.824 -0.75 . . . . 16.300000000000001 112.583 171.48 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 tp -95.03 121.01 36.22 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.432 -1.692 . . . . 9.9600000000000009 106.432 166.732 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.76 153.77 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 114.959 -2.448 . . . . 9.7599999999999998 105.596 178.699 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.6 mt . . . . . 0 N--CA 1.43 -1.465 0 CA-C-N 124.692 3.406 . . . . 19.57 107.465 175.541 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttp . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 123.704 1.716 . . . . 17.170000000000002 107.499 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -99.98 116.61 32.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.613 2.765 . . . . 21.890000000000001 111.036 175.776 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -124.83 167.69 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 106.79 -1.559 . . . . 10.83 106.79 178.884 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -122.48 115.82 22.88 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.663 -1.273 . . . . 10.609999999999999 110.823 -169.364 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.05 123.48 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 121.295 -0.878 . . . . 9.1300000000000008 109.128 171.351 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HD2' HG21 ' A' ' 66' ' ' THR . 85.2 mttt -117.38 137.17 52.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.171 1.788 . . . . 20.550000000000001 108.846 -175.907 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -102.94 -176.77 3.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.488 1.742 . . . . 11.779999999999999 109.035 -175.16 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.266 95.9 mt -69.93 -27.1 64.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.805 2.442 . . . . 19.309999999999999 116.698 -172.091 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -96.2 -89.08 0.26 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.451 2.3 . . . . 23.140000000000001 111.079 -177.679 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.74 36.85 0.47 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.811 -3.681 . . . . 19.739999999999998 111.321 168.765 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -97.04 137.96 35.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 116.732 -1.987 . . . . 21.93 109.721 179.423 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.3 m -123.26 121.97 37.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.36 1.552 . . . . 12.33 107.103 171.144 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.9 mt -101.38 119.35 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 103.382 -2.822 . . . . 17.079999999999998 103.382 179.96 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -89.36 105.34 17.73 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.237 1.494 . . . . 16.300000000000001 108.874 165.241 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.7 mt -92.13 146.12 23.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.602 3.572 . . . . 15.880000000000001 106.076 -178.32 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -95.2 108.56 20.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.284 -2.689 . . . . 28.899999999999999 112.33 171.272 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.86 -177.28 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.439 -1.689 . . . . 12.050000000000001 106.439 -176.183 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -132.63 159.9 70.58 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 119.157 -2.215 . . . . 18.170000000000002 107.279 164.547 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -77.48 -16.03 15.33 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 O-C-N 116.417 -2.464 . . . . 8.1600000000000001 114.691 -168.131 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 m -90.11 9.09 29.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 116.425 -2.11 . . . . 11.130000000000001 114.665 177.605 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -86.9 162.54 17.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.755 2.693 . . . . 18.030000000000001 113.703 165.048 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 69.2 p -99.56 169.79 9.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.84 2.733 . . . . 10.220000000000001 112.622 -170.7 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.372 36.8 mm -52.89 -32.72 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 116.164 1.913 . . . . 12.300000000000001 116.164 171.78 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.24 -28.65 69.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.933 -3.604 . . . . 36.509999999999998 116.263 170.769 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -75.79 -20.21 58.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.995 -2.315 . . . . 25.66 113.825 171.423 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.7 t -83.6 -45.33 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 116.694 -1.622 . . . . 8.1199999999999992 107.392 -179.491 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -63.58 -31.58 72.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.656 2.383 . . . . 15.470000000000001 110.94 173.682 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.6 -25.05 68.05 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 117.525 -1.67 . . . . 11.449999999999999 114.251 175.181 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -90.29 -15.24 31.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 116.702 -3.749 . . . . 24.98 115.768 173.3 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mm -80.44 -24.6 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 126.159 2.162 . . . . 9.4600000000000009 110.59 167.88 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -81.82 -26.77 34.06 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.524 1.93 . . . . 14.76 108.478 -177.537 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.89 -68.9 0.38 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.566 -3.208 . . . . 26.289999999999999 111.497 164.542 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -73.64 -49.36 26.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.11 1.893 . . . . 30.059999999999999 116.11 -169.375 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -86.81 -47.82 8.74 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.666 2.03 . . . . 25.190000000000001 113.396 178.95 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.06 59.11 1.51 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.288 3.804 . . . . 7.4100000000000001 107.152 169.33 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 40' ' ' GLN . 15.9 mm -102.41 140.0 20.74 Favored Pre-proline 0 N--CA 1.43 -1.469 0 O-C-N 129.099 3.47 . . . . 9.4900000000000002 104.004 177.79 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -62.07 161.22 26.99 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 O-C-N 114.304 -3.577 . . . . 11.42 115.953 173.582 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -72.66 -27.49 15.14 Favored 'Trans proline' 0 N--CA 1.434 -1.987 1 CA-C-N 128.85 4.196 . . . . 12.0 110.682 -168.408 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -87.13 -24.08 24.64 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.669 2.84 . . . . 35.549999999999997 118.669 179.425 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.408 ' HB3' HG22 ' A' ' 36' ' ' ILE . 11.0 tt0 -66.9 -42.06 86.08 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.828 2.529 . . . . 20.52 117.828 172.624 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -72.64 131.74 42.82 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.117 3.377 . . . . 7.1299999999999999 120.117 176.155 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -131.9 104.96 7.14 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.685 1.994 . . . . 36.390000000000001 108.624 -170.082 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.1 mt -83.84 112.43 20.11 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 115.22 -4.675 . . . . 9.5500000000000007 114.293 174.84 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.7 mt -99.89 115.81 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 114.041 -1.436 . . . . 13.9 111.585 175.402 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -108.21 120.65 42.96 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.06 -1.65 . . . . 6.8600000000000003 106.55 163.436 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.52 . . 69.21 -111.16 0.09 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.627 -2.546 . . . . 11.15 111.65 -176.77 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.69 6.15 12.6 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 116.507 -2.758 . . . . 13.93 108.58 172.027 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -86.39 139.22 31.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.468 -2.783 . . . . 23.920000000000002 111.702 -158.15 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -89.41 125.16 35.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 102.998 -2.964 . . . . 23.23 102.998 166.132 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 mt -94.33 144.18 25.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.544 2.116 . . . . 9.1099999999999994 110.447 -167.806 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -90.68 130.46 36.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.622 -2.549 . . . . 33.439999999999998 116.402 172.686 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -36.54 -51.1 0.82 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.992 4.517 . . . . 28.370000000000001 119.612 176.074 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.29 20.9 36.58 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 114.23 -1.35 . . . . 15.0 113.773 -169.341 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mtt-85 -93.3 163.91 13.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.146 -2.973 . . . . 25.5 110.468 160.872 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 38.0 p -104.74 158.16 16.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.037 -1.664 . . . . 11.949999999999999 108.276 -173.978 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -56.06 -35.88 67.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.728 2.68 . . . . 10.17 115.522 -179.648 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.7 p -63.04 -48.2 79.75 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 136.82 6.048 . . . . 13.59 113.653 169.663 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -60.35 -44.78 95.24 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.579 1.952 . . . . 11.699999999999999 112.896 176.803 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -74.7 -10.41 59.49 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 116.239 -4.038 . . . . 12.949999999999999 114.323 173.96 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.394 60.5 m-80 71.33 36.08 1.41 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.93 2.492 . . . . 25.449999999999999 112.313 178.803 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.9 mt -87.87 86.18 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 125.604 1.815 . . . . 14.6 109.52 -175.776 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -77.04 -178.1 4.81 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 125.708 1.88 . . . . 33.229999999999997 114.5 -173.408 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -72.29 135.72 46.05 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.797 1.639 . . . . 25.969999999999999 110.463 -178.69 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.306 47.6 mt-10 61.91 35.21 16.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.241 1.02 . . . . 32.609999999999999 112.377 -176.304 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.288 0.2 OUTLIER -105.47 147.23 28.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.466 -2.152 . . . . 10.56 109.587 172.224 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.439 HG21 ' HD2' ' A' ' 6' ' ' LYS . 61.9 m -122.65 120.42 33.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.728 2.204 . . . . 5.3300000000000001 112.586 -157.198 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -101.89 130.23 48.33 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 130.337 3.455 . . . . 11.66 109.959 -177.393 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -102.7 104.23 14.54 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.348 -3.97 . . . . 16.300000000000001 104.953 -174.208 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.5 tp -80.05 119.37 22.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.479 -2.045 . . . . 9.9600000000000009 105.479 172.957 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.06 141.01 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 126.223 2.202 . . . . 9.7599999999999998 108.361 170.739 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.43 -1.45 0 N-CA-C 112.99 0.737 . . . . 19.57 112.99 177.395 . . . . . . . . 0 0 . 1 . 101 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 115.456 1.65 . . . . 17.170000000000002 115.456 . . . . . . . . . 0 0 . 1 . 101 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -80.55 118.88 22.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.881 -3.012 . . . . 21.890000000000001 118.336 -179.924 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 pt -100.8 165.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 126.957 2.103 . . . . 10.83 111.819 168.937 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.294 15.8 m-30 -123.15 112.6 17.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.838 -2.414 . . . . 10.609999999999999 112.656 -176.016 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.3 t -90.91 105.38 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 117.972 -2.955 . . . . 9.1300000000000008 117.206 170.46 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -88.99 137.11 32.62 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 124.208 1.956 . . . . 20.550000000000001 115.343 -175.591 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.1 p -87.15 178.41 6.9 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 113.314 -5.866 . . . . 11.779999999999999 110.648 -176.183 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tp -58.63 -50.02 75.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.473 -3.892 . . . . 19.309999999999999 114.681 173.006 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -77.78 -38.63 46.25 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 116.211 -4.056 . . . . 23.140000000000001 112.99 -177.412 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.76 52.18 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.999 -1.688 . . . . 19.739999999999998 115.485 169.589 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -111.3 126.74 55.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.906 1.336 . . . . 21.93 107.924 179.331 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -86.06 116.08 24.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.573 -2.58 . . . . 12.33 111.789 169.936 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.4 mt -92.97 117.27 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 112.969 0.729 . . . . 17.079999999999998 112.969 168.254 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.0 m -88.11 122.26 31.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 119.118 -2.238 . . . . 16.300000000000001 109.936 177.865 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.8 mt -115.36 131.13 57.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.602 2.62 . . . . 15.880000000000001 111.52 172.553 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -87.75 103.25 15.44 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.504 2.722 . . . . 28.899999999999999 105.146 -177.068 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.405 HG12 ' HE3' ' A' ' 29' ' ' LYS . 28.4 m -119.33 167.8 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 105.662 -1.977 . . . . 12.050000000000001 105.662 -178.321 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -123.56 147.05 51.81 Favored Pre-proline 0 N--CA 1.431 -1.402 0 C-N-CA 126.471 1.908 . . . . 18.170000000000002 106.407 176.609 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -67.52 -22.5 44.71 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 O-C-N 115.796 -2.791 . . . . 8.1600000000000001 117.245 -158.094 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 m -94.53 33.85 1.38 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 123.934 3.061 . . . . 11.130000000000001 113.612 171.34 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -84.92 139.14 32.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 127.193 3.378 . . . . 18.030000000000001 113.243 162.665 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 p -80.05 163.07 24.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.651 -2.068 . . . . 10.220000000000001 112.614 176.275 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.91 -26.04 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.712 -1.868 . . . . 12.300000000000001 112.321 -179.624 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.398 15.2 pt-20 -60.58 -28.38 68.43 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.687 2.106 . . . . 36.509999999999998 116.687 168.959 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.293 5.7 t-20 -72.83 -37.92 67.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.955 3.302 . . . . 25.66 111.152 173.719 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 39.6 t -52.34 -53.93 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 129.213 3.005 . . . . 8.1199999999999992 111.59 173.55 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -69.76 -11.01 60.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.728 3.211 . . . . 15.470000000000001 112.184 -179.303 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.44 -44.7 70.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 121.423 1.919 . . . . 11.449999999999999 107.623 174.074 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HE3' HG12 ' A' ' 17' ' ' VAL . 64.0 mttm -76.0 -37.81 58.07 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.346 2.659 . . . . 24.98 106.023 -168.247 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.315 8.8 mm -57.37 -35.51 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 118.594 2.813 . . . . 9.4600000000000009 118.594 171.233 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -71.46 -40.4 70.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.473 2.709 . . . . 14.76 114.895 167.339 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -60.3 -67.26 0.41 Allowed 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 128.23 3.871 . . . . 26.289999999999999 111.495 169.687 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -72.62 -50.97 21.69 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 110.502 -7.624 . . . . 30.059999999999999 112.48 -160.629 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -97.1 -71.64 0.67 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.112 1.911 . . . . 25.190000000000001 111.479 175.104 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.41 26.01 0.5 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 116.276 -2.869 . . . . 7.4100000000000001 120.178 -175.662 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.53 133.5 28.09 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 115.323 -2.275 . . . . 9.4900000000000002 107.72 -178.519 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -73.49 160.09 45.07 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 126.566 3.381 . . . . 11.42 114.639 179.525 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.5 -16.06 9.53 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 123.552 2.835 . . . . 12.0 110.521 -162.266 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -82.03 -37.61 26.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 125.056 3.571 . . . . 35.549999999999997 114.474 -179.899 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -69.49 -27.57 65.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.636 2.458 . . . . 20.52 117.636 -178.139 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -87.65 139.24 30.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.33 -1.359 . . . . 7.1299999999999999 107.33 -174.318 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -106.63 142.59 36.03 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 105.007 -2.22 . . . . 36.390000000000001 105.007 165.526 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.4 mt -118.96 108.85 15.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.704 -3.122 . . . . 9.5500000000000007 112.879 171.119 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mt -92.82 137.86 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.441 -1.689 . . . . 13.9 106.441 -177.363 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -110.38 118.95 37.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.304 2.241 . . . . 6.8600000000000003 105.576 167.125 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.18 -96.63 0.05 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.919 1.288 . . . . 11.15 111.899 -167.277 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.86 5.55 6.13 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 117.36 -3.337 . . . . 13.93 112.065 172.769 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -82.03 152.65 26.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.609 -2.701 . . . . 23.920000000000002 110.487 -168.079 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -92.02 124.62 36.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.94 -1.505 . . . . 23.23 112.361 169.098 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.2 mt -104.72 168.7 8.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.693 1.246 . . . . 9.1099999999999994 112.467 -175.173 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -132.06 166.44 21.74 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.643 1.977 . . . . 33.439999999999998 107.374 -178.403 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -93.9 -42.86 8.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.913 -1.742 . . . . 28.370000000000001 111.104 -149.305 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.83 44.96 1.44 Allowed Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 118.462 -1.828 . . . . 15.0 115.193 -179.042 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -120.82 159.12 26.12 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.486 2.314 . . . . 25.5 107.748 173.293 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -97.98 160.31 14.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.384 1.564 . . . . 11.949999999999999 114.506 -169.461 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.52 -38.83 82.03 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.902 -1.749 . . . . 10.17 112.496 168.179 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 p -52.73 -45.6 67.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 118.498 2.777 . . . . 13.59 118.498 171.281 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.47 -41.68 96.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 114.549 -2.644 . . . . 11.699999999999999 114.92 176.436 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -78.91 -10.13 59.72 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.41 2.368 . . . . 12.949999999999999 115.13 172.966 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.422 1.0 OUTLIER 71.82 42.7 0.61 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.776 1.769 . . . . 25.449999999999999 115.776 -178.832 . . . . . . . . 3 3 . 1 . 101 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.5 mt -88.11 111.84 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 1 O-C-N 129.418 4.199 . . . . 14.6 108.756 -177.4 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.319 40.1 mt-30 -93.1 -175.55 3.89 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.876 -3.64 . . . . 33.229999999999997 110.671 -177.938 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttt -69.69 147.36 50.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.053 -1.655 . . . . 25.969999999999999 112.722 171.571 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 56.26 41.57 29.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.652 2.381 . . . . 32.609999999999999 116.786 -168.122 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.6 m -104.34 145.61 30.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 125.023 1.452 . . . . 10.56 107.441 178.82 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -105.81 124.02 48.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.593 2.14 . . . . 5.3300000000000001 106.221 -165.578 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.3 mt -104.34 143.03 33.53 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.108 -3.495 . . . . 11.66 106.751 168.499 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -98.84 111.33 23.75 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.264 1.95 . . . . 16.300000000000001 116.264 -179.524 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.88 108.36 5.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.251 -3.406 . . . . 9.9600000000000009 109.249 179.747 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 t -117.04 149.32 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 104.818 -2.29 . . . . 9.7599999999999998 104.818 177.206 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 tp . . . . . 0 N--CA 1.43 -1.464 0 N-CA-C 116.833 2.16 . . . . 19.57 116.833 171.212 . . . . . . . . 0 0 . 1 . 102 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 124.191 1.948 . . . . 17.170000000000002 111.683 . . . . . . . . . 0 0 . 1 . 102 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -76.85 119.51 20.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.397 -2.69 . . . . 21.890000000000001 110.334 -178.775 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.4 pt -112.06 154.66 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.614 -1.254 . . . . 10.83 107.614 169.548 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.24 133.02 52.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 126.568 3.08 . . . . 10.609999999999999 108.643 175.152 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -110.91 117.81 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 126.812 2.045 . . . . 9.1300000000000008 111.17 165.437 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.22 135.57 55.11 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.557 -1.339 . . . . 20.550000000000001 108.289 -170.752 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.8 p -95.32 179.81 5.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.803 1.287 . . . . 11.779999999999999 109.421 -163.501 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 tp -71.99 -46.46 57.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.111 1.91 . . . . 19.309999999999999 114.851 173.618 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -73.21 -40.14 64.98 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.259 -2.15 . . . . 23.140000000000001 115.546 175.842 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.17 64.65 0.15 Allowed Glycine 0 N--CA 1.431 -1.691 0 CA-C-O 122.897 1.276 . . . . 19.739999999999998 111.715 176.254 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -123.99 136.48 54.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.708 2.194 . . . . 21.93 108.016 159.263 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -105.01 108.22 19.62 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.973 -2.329 . . . . 12.33 112.69 168.451 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.02 126.21 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.041 -1.662 . . . . 17.079999999999998 109.054 178.64 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -96.91 111.63 23.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.875 1.065 . . . . 16.300000000000001 113.875 179.465 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.3 mt -96.59 138.57 33.97 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.119 -2.863 . . . . 15.880000000000001 110.498 -176.025 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -107.28 73.35 0.92 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.389 2.995 . . . . 28.899999999999999 110.915 -175.394 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -102.46 169.47 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 O-C-N 115.792 -4.318 . . . . 12.050000000000001 106.798 -175.143 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -95.87 159.09 33.13 Favored Pre-proline 0 N--CA 1.43 -1.453 1 O-C-N 130.002 4.564 . . . . 18.170000000000002 106.871 174.647 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.25 -26.68 20.64 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 O-C-N 126.268 2.72 . . . . 8.1600000000000001 110.964 172.645 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 p -72.64 -7.09 48.56 Favored 'General case' 0 N--CA 1.43 -1.453 1 CA-C-N 127.237 4.562 . . . . 11.130000000000001 112.742 175.915 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -77.67 154.14 32.43 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 123.196 2.725 . . . . 18.030000000000001 112.724 -175.19 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 64.4 p -89.34 151.33 22.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.302 3.041 . . . . 10.220000000000001 110.95 178.976 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.25 39.7 mm -56.97 -30.26 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.308 2.643 . . . . 12.300000000000001 114.198 178.691 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -49.25 -45.56 44.9 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.974 -2.954 . . . . 36.509999999999998 113.733 166.303 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -68.91 -37.0 78.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 124.249 0.968 . . . . 25.66 111.266 177.987 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.62 -40.31 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 113.741 1.015 . . . . 8.1199999999999992 113.741 -179.678 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.26 49.8 mtpt -59.1 -48.88 79.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.544 2.737 . . . . 15.470000000000001 112.823 174.521 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.87 -32.33 63.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.867 3.267 . . . . 11.449999999999999 111.094 172.581 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -74.27 -39.82 62.72 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 124.005 3.093 . . . . 24.98 109.455 -177.374 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD13 HD22 ' A' ' 69' ' ' LEU 0.326 81.8 mt -59.36 -37.52 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 129.991 3.317 . . . . 9.4600000000000009 112.732 173.928 . . . . . . . . 3 3 . 1 . 102 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -59.91 -54.36 47.08 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.555 1.525 . . . . 14.76 112.9 167.039 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.23 -51.41 68.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.702 1.239 . . . . 26.289999999999999 112.123 -173.723 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -78.17 -69.54 0.55 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.364 2.666 . . . . 30.059999999999999 114.351 179.398 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -87.29 -11.24 50.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.087 2.254 . . . . 25.190000000000001 117.087 -170.34 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.68 20.52 34.09 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 128.151 2.786 . . . . 7.4100000000000001 116.253 160.895 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mm -113.32 125.45 29.65 Favored Pre-proline 0 N--CA 1.43 -1.459 0 O-C-N 120.493 -1.592 . . . . 9.4900000000000002 110.036 -173.164 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.309 53.9 Cg_exo -76.55 167.58 25.29 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-O 115.423 -1.991 . . . . 11.42 116.61 -173.968 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -63.9 -23.5 68.29 Favored 'Trans proline' 0 C--N 1.3 -2.019 1 C-N-CA 126.533 4.822 . . . . 12.0 115.907 -170.445 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -89.89 -21.81 22.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 124.008 3.095 . . . . 35.549999999999997 112.258 177.277 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -75.72 -9.54 58.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.627 -2.606 . . . . 20.52 116.1 -176.893 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -112.1 150.54 30.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.102 2.751 . . . . 7.1299999999999999 114.656 -167.502 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -127.22 93.25 3.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.851 -1.781 . . . . 36.390000000000001 109.357 -176.518 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.9 mt -82.17 91.59 6.74 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 113.831 1.049 . . . . 9.5500000000000007 113.831 172.24 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.4 mt -91.07 135.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 118.764 -0.636 . . . . 13.9 110.202 -177.816 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -122.66 112.7 18.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.603 -2.369 . . . . 6.8600000000000003 104.603 179.65 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.86 -108.53 0.44 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.187 -2.196 . . . . 11.15 113.004 -169.721 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.91 -19.66 39.31 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 115.536 -2.813 . . . . 13.93 117.041 167.43 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -105.34 134.08 49.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.791 1.795 . . . . 23.920000000000002 114.414 -165.564 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.45 138.4 47.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.303 2.002 . . . . 23.23 112.327 167.636 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.86 141.78 31.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.222 2.209 . . . . 9.1099999999999994 111.185 -169.099 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -119.62 135.88 54.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.467 1.603 . . . . 33.439999999999998 112.791 -166.453 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -48.86 -58.95 4.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.883 2.873 . . . . 28.370000000000001 111.882 -160.376 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.57 -10.18 75.28 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 122.85 3.9 . . . . 15.0 122.85 -173.843 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 54' ' ' ARG . 16.4 mmt180 -79.66 156.59 27.52 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.548 1.969 . . . . 25.5 114.95 174.586 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.9 p -93.88 168.81 10.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.748 3.166 . . . . 11.949999999999999 108.663 -176.001 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mt -72.64 -40.04 66.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.685 -2.052 . . . . 10.17 106.615 -176.198 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -63.79 -28.66 70.02 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 127.853 3.22 . . . . 13.59 116.139 174.114 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.76 -50.38 69.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.177 3.791 . . . . 11.699999999999999 113.406 170.805 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -64.95 -30.73 71.74 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.917 1.821 . . . . 12.949999999999999 115.917 167.144 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 49.4 m-80 82.11 41.27 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.43 1 C-N-CA 131.939 4.096 . . . . 25.449999999999999 110.921 176.908 . . . . . . . . 3 2 . 1 . 102 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -78.82 92.53 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 CA-C-O 129.469 4.461 . . . . 14.6 108.935 170.919 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -84.66 175.65 9.08 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 113.202 -5.936 . . . . 33.229999999999997 111.168 179.707 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -54.03 127.76 27.79 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.278 1.99 . . . . 25.969999999999999 116.173 172.201 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 78.37 29.29 0.44 Allowed 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 132.744 4.418 . . . . 32.609999999999999 117.016 176.877 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.3 m -81.49 149.03 28.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.955 -1.498 . . . . 10.56 106.955 -169.693 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.7 m -94.43 118.01 31.0 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.701 -2.5 . . . . 5.3300000000000001 112.492 177.45 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.0 137.6 40.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.508 -3.245 . . . . 11.66 106.039 168.565 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -98.25 109.97 22.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.067 2.247 . . . . 16.300000000000001 117.067 169.868 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.422 HD22 HD13 ' A' ' 30' ' ' ILE . 14.2 tp -91.43 105.32 17.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.342 1.857 . . . . 9.9600000000000009 115.713 -179.944 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -109.32 162.68 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 101.81 -3.404 . . . . 9.7599999999999998 101.81 178.412 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 N--CA 1.429 -1.483 0 C-N-CA 127.267 2.227 . . . . 19.57 112.411 168.78 . . . . . . . . 0 0 . 1 . 103 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 123.628 1.68 . . . . 17.170000000000002 108.738 . . . . . . . . . 0 0 . 1 . 103 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -88.66 126.85 35.49 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 111.47 -2.604 . . . . 21.890000000000001 111.401 -179.68 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 3' ' ' ILE 0.256 20.8 pt -130.9 159.29 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 107.221 -1.4 . . . . 10.83 107.221 168.721 . . . . . . . . 3 3 . 1 . 103 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -106.89 132.92 52.3 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 118.433 -0.794 . . . . 10.609999999999999 109.481 179.414 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.4 t -101.19 112.89 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.219 2.438 . . . . 9.1300000000000008 111.704 160.325 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -95.73 127.17 41.53 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 113.129 -5.982 . . . . 20.550000000000001 112.99 177.274 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -76.87 -177.26 4.28 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.492 -4.505 . . . . 11.779999999999999 118.146 178.494 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 tp -79.53 -21.74 44.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.484 2.564 . . . . 19.309999999999999 113.658 178.849 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.372 0.1 OUTLIER -75.32 -48.23 24.09 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 116.055 -4.153 . . . . 23.140000000000001 108.72 174.219 . . . . . . . . 4 3 . 1 . 103 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.15 20.92 1.11 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 112.749 -2.023 . . . . 19.739999999999998 109.593 172.246 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -78.62 117.83 20.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.354 2.502 . . . . 21.93 110.751 173.581 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -88.26 110.96 21.15 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.693 -3.129 . . . . 12.33 114.241 -178.9 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 mt -99.61 107.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.901 2.08 . . . . 17.079999999999998 110.983 -172.268 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.2 m -71.97 127.29 32.09 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.101 -1.624 . . . . 16.300000000000001 112.835 173.524 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 mt -111.63 151.34 28.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.532 -1.355 . . . . 15.880000000000001 114.313 167.303 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -108.96 99.05 8.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.808 2.043 . . . . 28.899999999999999 111.253 177.325 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.15 166.13 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.188 -3.445 . . . . 12.050000000000001 103.882 -171.801 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -120.0 161.88 36.18 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 118.959 -2.338 . . . . 18.170000000000002 106.348 177.656 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.68 -8.54 8.21 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 127.501 3.715 . . . . 8.1600000000000001 107.73 -155.901 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -76.17 -9.63 58.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 130.153 3.381 . . . . 11.130000000000001 109.136 172.168 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -81.99 141.34 33.34 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.58 2.352 . . . . 18.030000000000001 112.67 -175.316 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.6 p -88.14 163.15 16.33 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.901 -1.749 . . . . 10.220000000000001 108.59 -171.576 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mm -76.42 -17.6 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 125.936 2.023 . . . . 12.300000000000001 109.081 -172.595 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -64.26 -30.19 71.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.562 -1.961 . . . . 36.509999999999998 116.243 162.259 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -76.17 -36.1 58.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.175 1.39 . . . . 25.66 109.696 -179.887 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.45 -48.74 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 128.865 2.866 . . . . 8.1199999999999992 115.959 172.752 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.02 -35.9 78.08 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.256 -1.831 . . . . 15.470000000000001 114.069 164.728 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.66 -39.25 80.09 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.752 2.978 . . . . 11.449999999999999 115.138 173.671 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -57.28 -42.78 82.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 124.371 3.259 . . . . 24.98 115.814 169.205 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.18 -29.79 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 O-C-N 114.18 -5.325 . . . . 9.4600000000000009 112.625 176.447 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -66.26 -52.7 44.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.603 -2.561 . . . . 14.76 108.504 167.804 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.337 34.1 t70 -51.81 -42.3 62.38 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 114.869 -2.491 . . . . 26.289999999999999 115.053 176.349 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -80.99 -86.06 0.09 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 128.944 3.903 . . . . 30.059999999999999 112.052 -178.151 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -72.51 -33.68 67.08 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.237 1.94 . . . . 25.190000000000001 116.237 -175.275 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.15 39.46 4.53 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.089 -3.507 . . . . 7.4100000000000001 114.218 -175.945 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mm -100.03 113.4 65.21 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 117.391 -3.417 . . . . 9.4900000000000002 110.601 175.849 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -64.85 151.56 85.33 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 124.811 3.674 . . . . 11.42 114.075 -176.49 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.23 -9.87 16.39 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-N 127.013 3.54 . . . . 12.0 114.836 -165.605 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.06 -28.56 61.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.216 2.436 . . . . 35.549999999999997 107.577 178.406 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -84.62 -20.34 31.53 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.198 -2.189 . . . . 20.52 112.018 -174.764 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -93.53 149.52 21.16 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.17 2.891 . . . . 7.1299999999999999 114.094 -172.873 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -141.64 126.31 17.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.324 -3.36 . . . . 36.390000000000001 108.175 167.146 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.83 121.06 43.98 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 110.048 -3.251 . . . . 9.5500000000000007 106.864 -175.556 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.7 mt -113.83 135.19 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 1 N-CA-C 98.916 -4.476 . . . . 13.9 98.916 -171.185 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -115.64 103.41 10.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 127.429 2.292 . . . . 6.8600000000000003 106.479 170.212 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.29 -105.16 0.07 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.154 1.782 . . . . 11.15 114.034 -174.7 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.14 27.29 9.16 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 115.54 -2.811 . . . . 13.93 116.289 170.561 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -147.49 158.97 44.21 Favored 'General case' 0 N--CA 1.43 -1.458 1 CA-C-N 124.363 4.082 . . . . 23.920000000000002 111.872 171.822 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.259 15.8 pt20 -85.31 137.81 32.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.501 1.52 . . . . 23.23 110.784 -175.84 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -83.67 131.05 34.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.218 -1.771 . . . . 9.1099999999999994 106.218 175.043 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -93.97 134.25 36.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.534 1.679 . . . . 33.439999999999998 115.534 -179.081 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.66 -46.52 49.81 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 132.073 4.149 . . . . 28.370000000000001 111.665 -168.859 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.78 -8.79 87.57 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 129.96 3.648 . . . . 15.0 112.148 -167.761 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -102.7 167.19 10.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.99 -4.241 . . . . 25.5 111.914 -179.522 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.9 p -89.67 170.95 10.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.903 -1.748 . . . . 11.949999999999999 108.296 176.327 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.0 mt -72.53 -30.92 64.89 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.629 3.172 . . . . 10.17 110.662 169.3 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 p -65.8 -30.87 71.57 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 132.488 4.315 . . . . 13.59 112.435 179.393 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.87 -44.58 96.54 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.558 -4.464 . . . . 11.699999999999999 111.261 175.757 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -78.03 -12.62 60.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.43 2.292 . . . . 12.949999999999999 113.017 -177.784 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.439 35.8 m120 65.69 31.53 9.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.64 2.376 . . . . 25.449999999999999 116.659 -166.078 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -79.69 125.89 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 1 O-C-N 116.252 -4.03 . . . . 14.6 103.888 -169.483 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -104.78 -173.94 2.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.269 3.427 . . . . 33.229999999999997 113.283 -169.447 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -67.74 137.46 55.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.961 3.304 . . . . 25.969999999999999 109.895 174.687 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 52.5 33.56 13.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.093 2.957 . . . . 32.609999999999999 111.288 179.373 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -76.21 151.52 36.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 114.204 -2.808 . . . . 10.56 110.422 163.909 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.9 m -110.17 112.54 24.58 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 133.046 6.466 . . . . 5.3300000000000001 110.166 179.555 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.1 mt -97.62 159.06 15.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 110.654 -2.976 . . . . 11.66 106.566 170.704 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -124.82 123.71 40.55 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 115.992 -1.956 . . . . 16.300000000000001 106.76 -169.266 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -112.33 125.18 53.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.937 2.153 . . . . 9.9600000000000009 109.315 -172.303 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.298 16.5 m -127.01 150.89 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 124.432 2.063 . . . . 9.7599999999999998 109.119 169.63 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 N--CA 1.43 -1.441 0 CA-C-N 113.023 -1.899 . . . . 19.57 110.86 -167.174 . . . . . . . . 0 0 . 1 . 104 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 107.668 -1.234 . . . . 17.170000000000002 107.668 . . . . . . . . . 0 0 . 1 . 104 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -112.08 140.58 46.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.802 -2.295 . . . . 21.890000000000001 104.802 -175.817 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -128.62 154.48 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 123.422 1.582 . . . . 10.83 111.083 167.764 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -113.37 107.84 16.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.48 -2.012 . . . . 10.609999999999999 110.823 -173.517 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t -102.04 106.26 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.473 -1.392 . . . . 9.1300000000000008 109.671 178.251 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -89.39 128.89 35.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.489 1.662 . . . . 20.550000000000001 115.489 179.557 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -78.63 164.45 24.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.86 -1.775 . . . . 11.779999999999999 110.572 171.103 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.0 mt -77.5 -22.41 51.28 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.485 -4.509 . . . . 19.309999999999999 110.833 -172.76 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -92.74 -67.84 0.83 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.425 -1.324 . . . . 23.140000000000001 107.425 176.583 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.12 76.75 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 114.521 -3.377 . . . . 19.739999999999998 121.496 -178.701 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -156.91 131.67 8.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.609 2.704 . . . . 21.93 106.577 171.556 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.0 m -105.76 108.17 19.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.52 1.629 . . . . 12.33 107.248 172.843 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 mt -86.71 117.03 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 105.509 -2.034 . . . . 17.079999999999998 105.509 176.311 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -93.88 127.31 39.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.408 1.693 . . . . 16.300000000000001 112.232 171.479 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -117.7 132.91 56.41 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.898 2.079 . . . . 15.880000000000001 112.816 -177.74 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -92.09 107.07 18.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.511 -1.663 . . . . 28.899999999999999 106.511 172.601 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.85 166.97 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 104.628 -2.36 . . . . 12.050000000000001 104.628 179.482 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -118.17 138.37 25.49 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 126.698 1.999 . . . . 18.170000000000002 109.069 168.872 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.652 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 38.0 Cg_endo -67.54 -10.0 27.26 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 124.579 3.519 . . . . 8.1600000000000001 117.965 -171.721 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -76.64 -14.32 59.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.984 1.846 . . . . 11.130000000000001 115.984 170.399 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -85.06 172.65 11.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.531 1.514 . . . . 18.030000000000001 108.455 -178.767 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 70.8 p -103.54 157.08 17.29 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 117.229 -1.367 . . . . 10.220000000000001 113.296 -176.731 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.427 HD12 HD13 ' A' ' 50' ' ' LEU . 13.6 mm -53.65 -36.59 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 122.065 2.211 . . . . 12.300000000000001 113.842 177.61 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -53.47 -25.55 16.75 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.095 -2.253 . . . . 36.509999999999998 116.191 169.525 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -87.62 -18.82 28.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 117.666 -1.159 . . . . 25.66 113.025 173.334 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -75.38 -44.03 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 122.136 2.244 . . . . 8.1199999999999992 112.486 176.196 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -62.84 -37.52 87.12 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 110.559 -3.019 . . . . 15.470000000000001 109.195 173.381 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.28 -19.43 61.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.387 -1.768 . . . . 11.449999999999999 114.084 173.309 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -77.2 -29.4 54.26 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.924 2.602 . . . . 24.98 110.628 171.313 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.7 mt -64.58 -45.6 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 116.615 -1.659 . . . . 9.4600000000000009 114.924 167.695 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -48.03 -49.95 29.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 121.292 3.812 . . . . 14.76 121.292 167.995 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -59.52 -65.56 0.65 Allowed 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 127.7 2.4 . . . . 26.289999999999999 115.484 170.849 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -74.62 -71.53 0.34 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.544 -3.847 . . . . 30.059999999999999 112.388 -177.725 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -71.51 -31.11 66.71 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.676 -6.265 . . . . 25.190000000000001 113.616 -170.132 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.08 52.16 4.42 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.353 2.882 . . . . 7.4100000000000001 110.704 178.56 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.85 143.02 28.26 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-N 119.959 1.88 . . . . 9.4900000000000002 106.18 168.125 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -72.5 168.33 24.63 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 125.266 2.917 . . . . 11.42 113.16 -173.34 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -81.91 -11.95 11.05 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.547 3.017 . . . . 12.0 112.546 177.699 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.94 -33.39 75.47 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.135 -2.228 . . . . 35.549999999999997 113.281 172.135 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.261 46.5 mt-30 -95.38 -8.85 34.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.044 2.831 . . . . 20.52 110.756 -167.731 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -87.05 122.01 30.29 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 111.902 -6.749 . . . . 7.1299999999999999 115.418 175.33 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -122.05 121.05 36.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.244 -2.16 . . . . 36.390000000000001 107.13 165.431 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.0 mt -105.98 139.04 41.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.677 -1.63 . . . . 9.5500000000000007 110.115 -177.58 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 44' ' ' ILE . 75.5 mt -117.21 141.98 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 100.433 -3.914 . . . . 13.9 100.433 -175.474 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -136.85 104.23 5.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.15 -2.167 . . . . 6.8600000000000003 105.15 172.7 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.266 . . 65.99 -127.83 0.27 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.758 -1.839 . . . . 11.15 111.927 -177.06 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.8 24.04 30.05 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 119.753 2.661 . . . . 13.93 119.753 -178.468 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.5 157.74 40.26 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 110.818 -2.691 . . . . 23.920000000000002 112.085 -168.018 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.88 152.56 23.12 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.155 -1.794 . . . . 23.23 106.155 -176.188 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.427 HD13 HD12 ' A' ' 23' ' ' ILE . 78.3 mt -88.59 146.76 24.94 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.767 2.222 . . . . 9.1099999999999994 111.014 -177.03 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.52 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 17.5 tt0 -100.77 139.36 36.56 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 126.545 1.938 . . . . 33.439999999999998 107.217 -176.706 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.44 -55.54 32.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.153 2.581 . . . . 28.370000000000001 111.992 -168.937 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.97 31.47 7.92 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 113.45 -1.705 . . . . 15.0 110.878 -162.667 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.52 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 29.6 mtt180 -103.89 170.06 8.14 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.689 -3.83 . . . . 25.5 104.004 169.57 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.4 p -85.93 158.68 19.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.012 2.925 . . . . 11.949999999999999 105.908 -179.196 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.652 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 1.2 mt -69.41 -32.36 71.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.757 -3.089 . . . . 10.17 116.215 171.385 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.6 p -53.41 -40.33 65.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.404 3.082 . . . . 13.59 115.98 167.643 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.93 -20.47 61.75 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.2 -2.812 . . . . 11.699999999999999 117.073 -176.597 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -91.64 -1.12 57.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.325 1.85 . . . . 12.949999999999999 110.844 174.037 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 44.05 63.32 1.65 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.53 -2.123 . . . . 25.449999999999999 115.171 -161.497 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.69 127.17 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.825 -1.546 . . . . 14.6 106.825 168.539 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -124.35 179.74 4.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.188 2.595 . . . . 33.229999999999997 106.28 -168.16 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -67.54 145.92 54.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.886 -3.634 . . . . 25.969999999999999 111.537 -172.315 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 51.46 26.53 3.23 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.447 2.018 . . . . 32.609999999999999 116.447 -175.847 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 m -56.18 145.79 25.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.937 -1.727 . . . . 10.56 113.201 167.628 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -98.58 120.56 39.21 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.142 -2.224 . . . . 5.3300000000000001 114.192 167.974 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -110.27 160.41 16.55 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.344 0.974 . . . . 11.66 110.547 169.669 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -112.87 133.4 54.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 102.424 -3.176 . . . . 16.300000000000001 102.424 176.271 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -103.12 117.48 34.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.437 1.895 . . . . 9.9600000000000009 113.313 166.633 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.0 t -116.62 123.21 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.931 -2.248 . . . . 9.7599999999999998 104.931 -173.567 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 N--CA 1.43 -1.436 0 O-C-N 119.677 -1.889 . . . . 19.57 113.75 -173.95 . . . . . . . . 0 0 . 1 . 105 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.26 7.9 ptt? . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 117.756 2.502 . . . . 17.170000000000002 117.756 . . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -113.29 130.64 56.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 105.844 -1.91 . . . . 21.890000000000001 105.844 -177.421 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 pt -131.29 160.02 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 100.569 -3.863 . . . . 10.83 100.569 -177.673 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -112.41 151.59 29.66 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.527 2.584 . . . . 10.609999999999999 106.785 -177.739 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.33 124.56 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 117.456 -3.277 . . . . 9.1300000000000008 109.66 166.745 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -136.66 135.7 38.48 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.772 -1.558 . . . . 20.550000000000001 109.934 -170.366 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -80.83 -174.25 4.67 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.448 2.547 . . . . 11.779999999999999 111.271 175.985 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.16 -43.42 74.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.027 -2.296 . . . . 19.309999999999999 111.47 177.077 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -76.62 -34.8 58.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.361 -2.257 . . . . 23.140000000000001 108.07 179.658 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.15 70.2 0.63 Allowed Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 126.523 2.011 . . . . 19.739999999999998 114.162 173.72 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -96.55 103.07 14.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 131.051 3.74 . . . . 21.93 106.877 160.491 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -100.08 135.81 40.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.21 2.433 . . . . 12.33 110.445 -178.866 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 pt -139.99 162.33 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.445 2.698 . . . . 17.079999999999998 111.79 175.054 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 m -126.81 119.47 26.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.794 1.309 . . . . 16.300000000000001 110.145 -172.218 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.42 134.13 48.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.218 -1.81 . . . . 15.880000000000001 107.83 -178.321 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -98.86 115.49 28.96 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.352 -2.833 . . . . 28.899999999999999 103.352 178.689 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.37 177.86 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.818 -1.549 . . . . 12.050000000000001 106.818 177.183 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -116.89 160.17 37.89 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 104.497 -2.408 . . . . 18.170000000000002 104.497 179.228 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -76.67 2.53 7.34 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 115.837 -2.309 . . . . 8.1600000000000001 116.427 -175.099 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.0 p -77.47 -13.8 59.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 124.871 1.357 . . . . 11.130000000000001 112.175 169.557 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.89 137.57 33.6 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 122.728 1.251 . . . . 18.030000000000001 111.805 -170.766 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -76.13 158.12 32.08 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 109.283 -3.599 . . . . 10.220000000000001 112.266 -169.781 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mm -52.93 -45.62 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 1 O-C-N 115.377 -4.577 . . . . 12.300000000000001 110.242 168.376 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -59.97 -32.09 70.51 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.278 -2.764 . . . . 36.509999999999998 118.176 168.887 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -63.84 -38.74 92.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.924 -2.985 . . . . 25.66 111.555 168.871 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.84 -47.18 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.014 1.326 . . . . 8.1199999999999992 108.771 171.9 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -58.81 -39.82 82.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.864 -1.772 . . . . 15.470000000000001 112.954 178.436 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.43 61.79 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.499 3.148 . . . . 11.449999999999999 119.499 171.326 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.26 4.6 tppt? -66.84 -44.07 82.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.151 2.881 . . . . 24.98 117.127 167.854 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -74.01 -43.12 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.659 2.384 . . . . 9.4600000000000009 107.416 179.144 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -48.27 -45.09 34.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.75 2.5 . . . . 14.76 117.75 169.67 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.03 -57.18 8.32 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.279 2.696 . . . . 26.289999999999999 118.279 169.502 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -64.67 -58.06 7.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.637 2.458 . . . . 30.059999999999999 117.637 173.32 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.45 -67.93 0.61 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.353 -1.467 . . . . 25.190000000000001 112.775 -176.475 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.82 27.01 2.88 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 122.53 1.072 . . . . 7.4100000000000001 111.731 -176.863 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.7 mt -88.23 125.79 62.78 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 114.063 -2.875 . . . . 9.4900000000000002 111.95 174.764 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.0 Cg_exo -71.13 154.81 62.06 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 CA-C-N 126.698 3.428 . . . . 11.42 112.827 -174.89 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 84.9 Cg_exo -70.18 -15.24 35.45 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.22 1.946 . . . . 12.0 110.068 -170.703 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -87.14 -16.58 35.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.828 1.775 . . . . 35.549999999999997 115.54 177.486 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -94.79 -34.86 12.33 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.06 -1.65 . . . . 20.52 108.687 -178.838 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.39 135.27 55.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.083 0.944 . . . . 7.1299999999999999 111.877 174.811 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.258 21.6 tpp180 -139.27 130.59 26.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.012 -2.93 . . . . 36.390000000000001 106.566 160.906 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.5 mt -94.33 135.66 35.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.95 2.5 . . . . 9.5500000000000007 112.779 -179.629 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.525 HG12 ' HG2' ' A' ' 49' ' ' GLN . 11.8 mt -127.09 132.09 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 1 N-CA-C 97.688 -4.931 . . . . 13.9 97.688 -172.28 . . . . . . . . 3 3 . 1 . 105 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -116.19 130.84 56.99 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.025 -2.297 . . . . 6.8600000000000003 107.368 166.563 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.83 -109.85 0.51 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.694 -2.504 . . . . 11.15 117.388 -172.059 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.17 -7.46 56.12 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 130.663 3.983 . . . . 13.93 114.636 174.844 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -127.05 144.86 50.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.588 3.194 . . . . 23.920000000000002 112.999 -159.532 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.525 ' HG2' HG12 ' A' ' 44' ' ' ILE . 65.1 mt-30 -98.44 124.19 43.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.476 -1.693 . . . . 23.23 106.643 -176.2 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.408 ' H ' HD22 ' A' ' 50' ' ' LEU . 1.1 mm? -88.69 143.29 27.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.953 -1.092 . . . . 9.1099999999999994 112.372 -167.552 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.256 74.1 mm-40 -85.62 149.87 25.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.408 2.744 . . . . 33.439999999999998 118.408 -178.435 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -40.75 -64.08 0.58 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 131.031 3.733 . . . . 28.370000000000001 118.798 -173.034 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.59 51.51 0.76 Allowed Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 123.284 1.491 . . . . 15.0 111.153 -171.081 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.273 13.7 mmt85 -123.83 173.35 8.23 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.743 -4.386 . . . . 25.5 108.775 173.693 . . . . . . . . 3 2 . 1 . 105 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 p -112.39 175.1 5.57 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.424 2.375 . . . . 11.949999999999999 113.525 175.201 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.3 mt -58.81 -41.08 85.94 Favored 'General case' 0 N--CA 1.43 -1.449 2 CA-C-N 106.801 -4.727 . . . . 10.17 113.648 169.322 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -70.52 -35.53 73.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.751 -1.218 . . . . 13.59 113.769 177.778 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -62.14 -48.56 79.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.407 -2.058 . . . . 11.699999999999999 114.261 178.979 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -72.86 -25.83 61.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.801 -3.687 . . . . 12.949999999999999 115.86 174.575 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.288 9.0 m120 83.16 67.2 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.013 2.125 . . . . 25.449999999999999 109.007 -173.424 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.49 117.12 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 101.81 -3.404 . . . . 14.6 101.81 172.208 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -102.55 -164.53 1.09 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.51 -2.619 . . . . 33.229999999999997 109.225 -179.893 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -72.72 131.32 42.21 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 131.601 3.961 . . . . 25.969999999999999 111.132 -172.171 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 60.71 24.66 14.48 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.785 1.63 . . . . 32.609999999999999 113.385 179.526 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.8 m -89.58 153.62 20.63 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 101.21 -3.626 . . . . 10.56 101.21 171.723 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -116.46 109.68 17.62 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.039 1.735 . . . . 5.3300000000000001 107.33 -167.142 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mp -90.88 131.74 36.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 120.0 1.273 . . . . 11.66 110.082 178.418 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -80.38 132.0 35.7 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 127.066 3.317 . . . . 16.300000000000001 107.796 -176.076 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.256 5.1 tp -102.03 116.63 33.11 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 115.353 -4.592 . . . . 9.9600000000000009 109.804 173.261 . . . . . . . . 3 2 . 1 . 105 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.0 t -106.09 109.96 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 127.574 2.35 . . . . 9.7599999999999998 114.924 168.883 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.431 -1.416 0 N-CA-C 102.836 -3.024 . . . . 19.57 102.836 -171.648 . . . . . . . . 0 0 . 1 . 106 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 121.011 0.434 . . . . 17.170000000000002 109.877 . . . . . . . . . 0 0 . 1 . 106 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -107.78 153.36 23.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.489 -2.141 . . . . 21.890000000000001 114.473 173.577 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -126.78 147.19 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 102.669 -3.086 . . . . 10.83 102.669 171.374 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.55 135.85 45.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.8 2.148 . . . . 10.609999999999999 116.8 156.768 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.57 141.97 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.603 1.961 . . . . 9.1300000000000008 107.081 174.241 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -140.02 130.97 26.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.57 2.348 . . . . 20.550000000000001 112.543 -163.719 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -91.36 -176.7 4.63 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.642 -1.911 . . . . 11.779999999999999 107.153 -176.334 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.98 -48.4 74.13 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.416 -2.678 . . . . 19.309999999999999 111.562 175.874 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.1 p -79.83 -62.57 1.64 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.385 -3.322 . . . . 23.140000000000001 110.585 -174.851 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.71 41.25 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 116.999 -2.524 . . . . 19.739999999999998 114.348 175.409 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.3 19.7 tptm -88.54 109.06 19.76 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.035 -1.469 . . . . 21.93 107.035 165.313 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -104.14 108.91 20.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.316 -1.49 . . . . 12.33 108.08 -179.619 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.264 36.6 pt -97.03 134.22 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 116.412 -1.756 . . . . 17.079999999999998 110.312 175.156 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 3.6 m -109.66 112.13 24.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.977 2.911 . . . . 16.300000000000001 107.745 -179.893 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -106.61 160.07 15.72 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.823 -3.048 . . . . 15.880000000000001 110.553 -176.084 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -115.44 132.26 56.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.756 -2.465 . . . . 28.899999999999999 109.296 176.024 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.52 167.24 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.294 2.237 . . . . 12.050000000000001 114.608 -167.756 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -90.97 140.5 26.1 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 119.087 -2.258 . . . . 18.170000000000002 115.623 155.762 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.65 -10.86 30.28 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 122.55 1.946 . . . . 8.1600000000000001 117.048 174.868 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.337 83.7 p -74.8 -14.55 60.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.736 2.865 . . . . 11.130000000000001 118.736 166.817 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -81.06 165.97 21.17 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.125 1.516 . . . . 18.030000000000001 114.936 -164.63 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 45.7 p -87.77 157.52 19.01 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.349 2.5 . . . . 10.220000000000001 112.31 -172.092 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.4 mm -68.91 -28.62 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.638 -3.164 . . . . 12.300000000000001 111.679 -178.057 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -48.71 -48.98 39.98 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.274 2.23 . . . . 36.509999999999998 115.528 153.116 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -75.09 1.62 12.71 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.79 -4.319 . . . . 25.66 119.687 175.012 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.6 t -82.91 -39.56 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.189 -2.152 . . . . 8.1199999999999992 105.189 160.545 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -63.97 -25.56 68.19 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.303 -3.998 . . . . 15.470000000000001 113.633 -179.109 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.33 92.06 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.434 -2.666 . . . . 11.449999999999999 114.926 170.74 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -72.78 -27.76 62.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.7 -3.125 . . . . 24.98 111.639 -177.285 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.44 -44.04 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 115.051 1.5 . . . . 9.4600000000000009 115.051 170.021 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -60.52 -45.18 94.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.782 1.401 . . . . 14.76 114.782 167.799 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -65.31 -43.92 89.53 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.656 2.48 . . . . 26.289999999999999 111.698 178.926 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -75.38 -67.16 0.69 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.858 2.17 . . . . 30.059999999999999 116.858 -179.027 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -82.69 -43.07 17.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.003 -2.311 . . . . 25.190000000000001 115.194 179.905 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.7 52.32 2.84 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-O 124.548 2.193 . . . . 7.4100000000000001 117.521 177.861 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.5 mt -111.97 125.74 29.7 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 102.145 -3.28 . . . . 9.4900000000000002 102.145 -178.386 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 64.8 Cg_endo -80.44 160.5 22.59 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 127.754 3.805 . . . . 11.42 113.098 -173.393 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 1.3 Cg_exo -77.04 -17.24 15.38 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 CA-C-N 127.949 3.874 . . . . 12.0 111.045 -148.168 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.54 -24.27 45.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.76 -3.088 . . . . 35.549999999999997 110.647 -171.721 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -90.01 -0.67 57.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.697 2.399 . . . . 20.52 110.764 -173.714 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -100.05 129.6 46.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.233 2.213 . . . . 7.1299999999999999 115.803 -177.728 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -130.76 114.48 15.4 Favored 'General case' 0 N--CA 1.431 -1.404 1 O-C-N 115.918 -4.238 . . . . 36.390000000000001 110.602 167.317 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.7 mt -103.54 137.87 41.02 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 116.576 -1.678 . . . . 9.5500000000000007 114.455 -174.666 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 mt -125.53 133.95 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 101.079 -3.675 . . . . 13.9 101.079 -164.703 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -118.12 96.15 5.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 101.441 -3.541 . . . . 6.8600000000000003 101.441 172.956 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.91 -93.96 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.653 -2.067 . . . . 11.15 113.262 -170.667 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.48 -16.64 45.43 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 116.812 -2.105 . . . . 13.93 116.525 174.389 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -105.57 126.35 52.04 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 126.323 1.837 . . . . 23.920000000000002 113.032 -157.72 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -98.39 123.83 42.73 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 125.379 1.674 . . . . 23.23 113.13 -167.023 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.24 125.65 36.99 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.827 -1.082 . . . . 9.1099999999999994 110.578 -158.378 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -87.63 152.21 22.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 131.608 3.963 . . . . 33.439999999999998 116.511 171.238 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -75.02 -49.12 20.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.382 2.515 . . . . 28.370000000000001 108.405 -152.227 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.69 34.76 4.08 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 117.548 -3.22 . . . . 15.0 114.342 -171.791 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -123.23 161.94 23.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 100.426 -3.916 . . . . 25.5 100.426 176.231 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.3 p -99.8 164.38 12.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.106 -1.621 . . . . 11.949999999999999 114.822 -179.809 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mt -48.06 -37.71 15.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.342 -3.349 . . . . 10.17 119.247 167.505 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -76.02 -14.92 60.21 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.539 -1.664 . . . . 13.59 113.025 174.963 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -74.92 -38.38 61.82 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 123.798 2.999 . . . . 11.699999999999999 110.552 172.205 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -91.82 2.13 56.71 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.396 -1.335 . . . . 12.949999999999999 107.396 -172.603 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m120 60.33 45.33 11.31 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.927 2.566 . . . . 25.449999999999999 117.927 179.98 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.4 mt -86.91 135.49 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 126.594 3.092 . . . . 14.6 106.399 -178.884 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -113.72 167.3 10.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.309 -2.119 . . . . 33.229999999999997 109.558 -163.864 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -55.22 114.37 1.76 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.531 1.634 . . . . 25.969999999999999 111.774 166.14 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 63.12 37.96 11.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 110.453 -3.067 . . . . 32.609999999999999 113.254 -175.383 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -72.18 148.62 45.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.464 1.484 . . . . 10.56 113.815 159.497 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.4 m -109.32 128.53 55.16 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.566 -3.209 . . . . 5.3300000000000001 110.16 179.77 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -101.85 140.3 36.33 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 116.214 1.931 . . . . 11.66 116.214 177.12 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -100.36 110.72 22.94 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 125.175 2.416 . . . . 16.300000000000001 111.704 -179.511 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -94.6 127.61 40.67 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.792 -2.443 . . . . 9.9600000000000009 110.49 -175.243 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.7 123.13 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.256 3.023 . . . . 9.7599999999999998 113.755 163.563 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.7 mt . . . . . 0 N--CA 1.43 -1.448 0 CA-C-O 128.325 3.917 . . . . 19.57 108.751 173.935 . . . . . . . . 0 0 . 1 . 107 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptt? . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 110.752 -0.092 . . . . 17.170000000000002 110.752 . . . . . . . . . 0 0 . 1 . 107 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -90.04 148.27 23.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 123.664 0.786 . . . . 21.890000000000001 111.232 177.464 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.31 141.61 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.701 -2.333 . . . . 10.83 104.701 -179.118 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -97.0 143.05 28.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.935 1.457 . . . . 10.609999999999999 114.935 170.169 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -128.86 112.04 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.232 2.92 . . . . 9.1300000000000008 107.165 177.841 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -109.2 130.66 55.49 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.594 -3.816 . . . . 20.550000000000001 115.164 -172.753 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 p -82.09 162.55 22.48 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.398 -5.813 . . . . 11.779999999999999 107.851 179.532 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mt -59.17 -39.03 81.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.293 -2.755 . . . . 19.309999999999999 115.274 169.019 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 p -65.58 -58.64 5.27 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.344 2.497 . . . . 23.140000000000001 112.662 -178.151 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.03 64.14 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 O-C-N 118.129 -2.857 . . . . 19.739999999999998 113.555 164.935 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -129.88 134.8 47.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 119.712 1.756 . . . . 21.93 107.606 157.408 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -105.57 121.35 43.78 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.84 1.781 . . . . 12.33 108.898 175.302 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.6 pt -111.23 144.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 118.082 -2.886 . . . . 17.079999999999998 105.837 -179.569 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -107.39 123.09 47.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.686 1.241 . . . . 16.300000000000001 110.627 -177.197 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -119.98 162.79 18.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.023 -1.103 . . . . 15.880000000000001 108.023 -177.027 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -106.35 133.41 51.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.197 1.799 . . . . 28.899999999999999 111.3 172.726 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.444 HG11 HG22 ' A' ' 26' ' ' VAL 0.262 16.1 m -147.96 162.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 119.448 -2.032 . . . . 12.050000000000001 106.365 167.344 . . . . . . . . 3 3 . 1 . 107 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -82.24 170.43 14.91 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 105.21 -2.144 . . . . 18.170000000000002 105.21 161.151 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.287 1.1 Cg_exo -69.84 -24.93 28.73 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 120.79 1.318 . . . . 8.1600000000000001 111.704 170.438 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -78.7 8.13 5.85 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 115.347 -2.264 . . . . 11.130000000000001 111.075 -174.265 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.255 75.2 m-20 -108.31 162.07 14.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 123.198 2.727 . . . . 18.030000000000001 107.33 -176.669 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.9 p -92.21 163.72 13.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.846 -3.034 . . . . 10.220000000000001 114.204 -171.556 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -69.44 -24.65 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 118.814 -2.429 . . . . 12.300000000000001 112.121 176.753 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -53.69 -48.77 69.2 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.69 -4.381 . . . . 36.509999999999998 114.303 162.458 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -62.97 -30.74 71.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.311 2.337 . . . . 25.66 117.311 169.661 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.444 HG22 HG11 ' A' ' 17' ' ' VAL . 37.2 t -65.68 -49.41 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 121.767 2.076 . . . . 8.1199999999999992 113.435 166.319 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HA ' HD12 ' A' ' 30' ' ' ILE . 49.6 mtmt -61.82 -31.53 71.77 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.709 1.604 . . . . 15.470000000000001 113.451 178.839 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -67.72 -35.33 78.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.145 2.578 . . . . 11.449999999999999 106.678 169.94 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -75.67 -21.26 57.81 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.862 -4.274 . . . . 24.98 116.901 177.05 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 27' ' ' LYS . 11.0 mt -69.44 -45.85 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.39 -2.069 . . . . 9.4600000000000009 110.316 164.599 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 66.0 tt0 -49.75 -39.98 39.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.583 2.611 . . . . 14.76 111.44 171.862 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.71 -64.16 1.06 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.233 -3.417 . . . . 26.289999999999999 110.464 -179.99 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -80.66 -27.47 37.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.45 -3.906 . . . . 30.059999999999999 114.359 -163.167 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -103.89 -56.05 2.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 113.946 1.091 . . . . 25.190000000000001 113.946 -177.728 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.28 26.79 2.59 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 126.963 2.221 . . . . 7.4100000000000001 116.89 172.841 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -94.42 135.36 24.29 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 108.127 -1.064 . . . . 9.4900000000000002 108.127 -176.438 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.48 157.4 61.91 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 115.221 -3.094 . . . . 11.42 112.885 -177.65 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -84.83 -11.32 7.89 Favored 'Trans proline' 0 C--N 1.299 -2.029 1 C-N-CA 128.157 5.905 . . . . 12.0 112.779 -175.198 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.82 -43.47 58.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.358 0.981 . . . . 35.549999999999997 111.567 173.392 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -72.12 12.01 0.48 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.785 -2.447 . . . . 20.52 114.588 -179.051 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -116.89 128.42 55.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.625 1.202 . . . . 7.1299999999999999 114.082 -164.613 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -129.13 130.06 45.96 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.793 -1.817 . . . . 36.390000000000001 106.184 171.763 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.5 mt -102.47 143.56 32.03 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 120.357 -0.537 . . . . 9.5500000000000007 111.546 171.617 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -124.82 127.95 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 128.036 2.534 . . . . 13.9 104.798 177.726 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -112.67 107.9 16.75 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.116 -2.865 . . . . 6.8600000000000003 104.504 177.201 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.388 . . 60.29 -91.45 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.188 -1.57 . . . . 11.15 115.017 -169.08 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.0 5.58 7.35 Favored Glycine 0 N--CA 1.43 -1.703 1 C-N-CA 131.064 4.173 . . . . 13.93 119.074 171.745 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -113.96 156.91 23.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.921 1.343 . . . . 23.920000000000002 108.319 175.384 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -84.11 151.8 24.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.385 -1.279 . . . . 23.23 111.937 175.742 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.2 mt -110.24 128.34 55.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.458 1.935 . . . . 9.1099999999999994 111.777 178.773 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -92.18 163.62 13.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.063 3.316 . . . . 33.439999999999998 105.983 179.096 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -63.26 -61.1 2.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 109.402 -3.544 . . . . 28.370000000000001 118.939 -171.938 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.54 15.55 13.13 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 119.476 2.55 . . . . 15.0 119.476 -171.849 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -101.45 156.85 17.22 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.398 -1.648 . . . . 25.5 110.116 173.46 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 35.5 p -94.37 167.43 11.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.406 -1.331 . . . . 11.949999999999999 107.406 -175.636 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mp -67.96 -25.94 65.69 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.348 2.259 . . . . 10.17 108.752 165.713 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.3 t -71.62 -43.29 66.45 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.653 2.381 . . . . 13.59 110.243 175.526 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -59.28 -44.74 92.44 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.945 -4.222 . . . . 11.699999999999999 116.768 175.316 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -79.89 -11.64 59.79 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.642 2.83 . . . . 12.949999999999999 118.642 169.734 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.315 31.0 m120 75.75 34.86 0.55 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.644 -3.16 . . . . 25.449999999999999 115.002 174.434 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 mt -73.47 118.91 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.347 -1.297 . . . . 14.6 110.757 167.619 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' SER . 45.5 mt-30 -90.75 169.91 10.57 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 124.155 1.931 . . . . 33.229999999999997 113.609 174.219 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -61.94 146.88 48.64 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.742 -4.349 . . . . 25.969999999999999 108.064 -174.32 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 85.7 mt-10 62.48 46.88 5.4 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.889 1.804 . . . . 32.609999999999999 113.167 174.273 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' GLN . 9.2 t -111.09 131.94 54.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.355 2.662 . . . . 10.56 103.994 -168.531 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -89.59 109.95 20.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.385 2.517 . . . . 5.3300000000000001 108.562 177.233 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.7 mt -89.74 150.58 22.23 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.776 2.03 . . . . 11.66 107.95 172.626 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -106.23 113.39 26.9 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 114.965 1.469 . . . . 16.300000000000001 114.965 -178.283 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.7 tp -89.93 120.2 30.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.276 1.988 . . . . 9.9600000000000009 114.493 177.152 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.81 145.58 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 112.651 -2.068 . . . . 9.7599999999999998 105.829 172.964 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.9 mt . . . . . 0 N--CA 1.43 -1.451 0 CA-C-O 123.372 1.558 . . . . 19.57 111.331 -176.258 . . . . . . . . 0 0 . 1 . 108 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 106.413 -1.699 . . . . 17.170000000000002 106.413 . . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -106.38 140.08 39.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.707 2.114 . . . . 21.890000000000001 116.707 -176.671 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.6 pt -119.17 143.88 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 129.036 2.934 . . . . 10.83 114.324 169.979 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -104.92 126.1 51.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.05 -2.906 . . . . 10.609999999999999 107.827 -179.409 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.38 109.75 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 127.67 3.605 . . . . 9.1300000000000008 105.94 -176.773 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -117.93 138.79 51.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 125.897 2.761 . . . . 20.550000000000001 108.969 -167.665 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 9.8 p -72.68 -179.09 2.92 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.956 -2.34 . . . . 11.779999999999999 117.051 163.805 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.404 ' H ' ' HB ' ' A' ' 7' ' ' THR . 63.4 tp -76.14 -39.83 54.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 131.118 3.767 . . . . 19.309999999999999 110.431 -160.66 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -73.17 -56.6 4.87 Favored 'General case' 0 N--CA 1.429 -1.488 1 C-N-CA 133.94 4.896 . . . . 23.140000000000001 105.93 175.67 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.04 30.98 0.34 Allowed Glycine 0 N--CA 1.43 -1.741 0 O-C-N 125.873 1.983 . . . . 19.739999999999998 115.003 173.204 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -79.32 109.77 13.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.287 2.043 . . . . 21.93 109.779 168.664 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -95.79 126.43 41.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.007 -2.308 . . . . 12.33 112.684 -176.387 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.313 28.4 pt -109.47 152.93 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.433 2.063 . . . . 17.079999999999998 108.241 165.863 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -122.53 125.6 46.07 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.321 -2.737 . . . . 16.300000000000001 110.672 -175.78 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.284 52.4 mt -119.1 144.16 46.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.315 2.339 . . . . 15.880000000000001 117.315 179.442 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -101.16 101.86 12.67 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.705 2.002 . . . . 28.899999999999999 112.17 -179.161 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.18 165.1 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 C-N-CA 134.028 4.931 . . . . 12.050000000000001 108.284 -165.301 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 9.0 mt-10 -112.67 173.37 2.89 Favored Pre-proline 0 N--CA 1.429 -1.486 0 N-CA-C 114.836 1.421 . . . . 18.170000000000002 114.836 162.305 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -74.07 -14.12 23.57 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 115.963 -2.704 . . . . 8.1600000000000001 112.763 -179.111 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -95.11 0.9 54.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.159 0.912 . . . . 11.130000000000001 110.311 177.688 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.267 35.2 m-20 -85.98 152.23 23.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.877 -3.639 . . . . 18.030000000000001 109.812 -173.308 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 71.0 p -100.63 160.76 14.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.334 2.492 . . . . 10.220000000000001 107.859 -160.714 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 mm -64.48 -40.22 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 124.65 2.167 . . . . 12.300000000000001 108.624 -174.419 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -56.24 -35.47 67.41 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.03 -2.919 . . . . 36.509999999999998 117.021 168.121 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -72.14 -31.49 66.04 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 113.362 -5.836 . . . . 25.66 112.613 167.55 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.79 -43.55 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.724 -1.584 . . . . 8.1199999999999992 106.724 -177.021 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.25 -35.96 72.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.763 1.625 . . . . 15.470000000000001 113.361 174.907 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.99 -42.29 76.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.221 -2.174 . . . . 11.449999999999999 116.0 175.824 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -75.17 -32.03 61.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.649 3.179 . . . . 24.98 112.89 -176.989 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -60.88 -48.1 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.529 2.585 . . . . 9.4600000000000009 113.029 174.253 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -52.53 -45.88 66.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 113.15 -3.31 . . . . 14.76 117.037 166.386 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.53 -62.93 1.18 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.721 3.138 . . . . 26.289999999999999 110.032 179.291 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -53.71 -57.16 11.85 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.412 -3.305 . . . . 30.059999999999999 112.093 -176.757 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -93.96 -64.63 1.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.534 2.05 . . . . 25.190000000000001 116.534 -173.64 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.79 23.71 0.86 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 120.9 3.12 . . . . 7.4100000000000001 120.9 -176.939 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.69 118.14 60.27 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 114.723 -2.56 . . . . 9.4900000000000002 106.945 -169.191 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 36.2 Cg_exo -51.89 147.16 26.35 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 121.238 3.515 . . . . 11.42 121.238 178.318 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 21.0 Cg_exo -68.69 -35.68 16.0 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 123.793 2.39 . . . . 12.0 113.261 -160.378 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -78.21 -27.34 47.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.904 -2.372 . . . . 35.549999999999997 113.971 -177.462 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -62.89 -39.16 93.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.173 2.189 . . . . 20.52 115.365 170.776 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -65.9 140.17 58.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.342 2.349 . . . . 7.1299999999999999 117.342 173.585 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -128.32 99.61 5.49 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.855 -2.403 . . . . 36.390000000000001 114.192 169.866 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -86.06 131.43 34.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.065 -2.334 . . . . 9.5500000000000007 109.629 -177.728 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 70' ' ' VAL . 31.6 mt -130.47 136.59 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 126.282 2.944 . . . . 13.9 103.253 -179.846 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -113.5 114.98 27.29 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 115.055 -4.778 . . . . 6.8600000000000003 107.897 164.393 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.277 . . 72.31 -86.33 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.738 2.815 . . . . 11.15 111.331 -179.221 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.38 22.71 1.71 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 109.121 -1.591 . . . . 13.93 109.121 165.42 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.259 81.6 mttt -103.69 124.57 49.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.473 -3.369 . . . . 23.920000000000002 105.365 176.282 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -91.72 132.9 36.06 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 123.295 1.521 . . . . 23.23 108.941 -179.929 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.4 mt -94.15 128.86 40.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 115.715 -2.394 . . . . 9.1099999999999994 109.794 -151.377 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -78.32 139.73 38.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 119.038 2.977 . . . . 33.439999999999998 119.038 172.166 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.57 -50.14 70.85 Favored 'General case' 0 N--CA 1.431 -1.394 1 N-CA-C 122.654 4.316 . . . . 28.370000000000001 122.654 -162.62 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.49 0.72 89.24 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.232 -2.793 . . . . 15.0 115.775 175.333 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -81.78 165.33 21.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.835 -1.979 . . . . 25.5 108.143 171.382 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.3 p -104.97 -178.2 3.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 116.447 -3.908 . . . . 11.949999999999999 111.353 -172.98 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.3 mt -81.48 -29.31 33.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.699 -1.593 . . . . 10.17 106.699 178.712 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.9 t -66.08 -38.12 87.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.409 -2.057 . . . . 13.59 111.355 -176.589 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -54.95 -40.89 70.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.347 3.059 . . . . 11.699999999999999 113.788 176.924 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -93.49 1.16 56.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.322 2.342 . . . . 12.949999999999999 117.322 174.995 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.459 3.7 m120 79.52 18.83 0.73 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.263 1.579 . . . . 25.449999999999999 115.263 174.494 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.9 mt -87.01 99.4 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 118.446 -2.659 . . . . 14.6 105.014 -174.477 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.36 10.4 mt-30 -112.39 -165.11 0.96 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.324 2.249 . . . . 33.229999999999997 112.02 -169.874 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -61.55 106.8 0.7 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.103 2.961 . . . . 25.969999999999999 113.4 -170.061 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 82.76 41.92 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.011 2.525 . . . . 32.609999999999999 111.749 172.003 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.6 m -92.27 142.69 27.19 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.582 1.953 . . . . 10.56 111.376 179.388 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 m -102.41 121.18 41.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.334 -2.104 . . . . 5.3300000000000001 112.365 178.387 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -85.26 160.09 19.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 117.403 -1.284 . . . . 11.66 110.228 167.814 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -105.41 136.03 45.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 127.5 3.0 . . . . 16.300000000000001 104.84 167.473 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.1 tp -116.11 111.57 20.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.749 -2.315 . . . . 9.9600000000000009 104.749 -179.639 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.605 HG21 HD12 ' A' ' 44' ' ' ILE . 1.9 t -103.46 140.87 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 127.3 2.24 . . . . 9.7599999999999998 106.275 -179.994 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 N--CA 1.43 -1.456 0 C-N-CA 129.357 3.063 . . . . 19.57 106.079 176.873 . . . . . . . . 0 0 . 1 . 109 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 108.139 -1.059 . . . . 17.170000000000002 108.139 . . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -100.11 116.17 31.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.549 1.166 . . . . 21.890000000000001 112.442 -177.37 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.1 pt -97.4 151.92 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.192 -1.367 . . . . 10.83 113.996 148.554 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.432 ' HB2' HG23 ' A' ' 66' ' ' THR . 77.8 m-85 -107.67 149.46 28.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.434 2.958 . . . . 10.609999999999999 110.951 174.66 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 30' ' ' ILE . 47.3 t -126.43 133.99 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 106.224 -1.769 . . . . 9.1300000000000008 106.224 162.092 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -108.73 139.45 43.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.742 2.017 . . . . 20.550000000000001 113.62 174.591 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 p -88.07 -169.54 2.61 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 114.973 1.471 . . . . 11.779999999999999 114.973 -171.659 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.87 -59.08 4.6 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 120.163 1.347 . . . . 19.309999999999999 113.435 179.175 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -69.6 -30.06 67.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.023 -1.673 . . . . 23.140000000000001 110.689 179.714 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.2 54.3 0.27 Allowed Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 129.168 3.27 . . . . 19.739999999999998 108.422 152.083 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -82.67 116.09 21.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.238 2.019 . . . . 21.93 108.839 167.623 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -84.32 112.02 19.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.691 -2.576 . . . . 12.33 115.898 176.285 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.61 162.22 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 122.357 2.344 . . . . 17.079999999999998 108.232 -172.848 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.5 m -123.75 98.22 5.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.492 2.717 . . . . 16.300000000000001 113.83 -174.504 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 29' ' ' LYS . 73.0 mt -92.68 160.3 15.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.025 0.83 . . . . 15.880000000000001 111.554 -170.62 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -106.13 103.91 13.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.372 1.442 . . . . 28.899999999999999 113.757 175.044 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.74 165.02 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.7 2.4 . . . . 12.050000000000001 108.347 -174.771 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.15 170.9 7.89 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-O 115.75 -2.071 . . . . 18.170000000000002 109.621 162.513 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.291 0.0 OUTLIER -66.7 -9.51 24.75 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 N-CA-C 120.205 3.117 . . . . 8.1600000000000001 120.205 179.83 . . . . . . . . 3 3 . 1 . 109 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -82.52 -21.58 35.36 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.207 -2.33 . . . . 11.130000000000001 113.927 176.474 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -57.75 146.29 31.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 119.745 3.239 . . . . 18.030000000000001 119.745 172.93 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.4 p -105.08 159.95 15.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.256 -3.403 . . . . 10.220000000000001 108.087 -178.013 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.62 -40.66 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 112.917 -1.947 . . . . 12.300000000000001 112.781 178.111 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -49.63 -41.88 43.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.509 1.924 . . . . 36.509999999999998 112.975 165.092 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -80.63 -21.31 41.59 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.565 -3.834 . . . . 25.66 116.942 176.14 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 t -59.91 -50.08 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.471 -2.643 . . . . 8.1199999999999992 107.782 165.375 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -59.56 -39.8 85.22 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.687 1.708 . . . . 15.470000000000001 113.013 -179.305 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.323 . . -71.58 -28.99 64.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.621 -1.627 . . . . 11.449999999999999 112.653 -176.996 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HB3' HD22 ' A' ' 15' ' ' LEU . 55.8 mttm -69.0 -31.29 70.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.086 3.355 . . . . 24.98 111.899 171.803 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.545 HD11 HG21 ' A' ' 5' ' ' VAL . 79.2 mt -79.51 -37.6 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.853 0.835 . . . . 9.4600000000000009 111.921 173.401 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -61.94 -38.64 89.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.157 1.932 . . . . 14.76 114.129 168.808 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.7 -55.62 25.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.794 1.405 . . . . 26.289999999999999 114.794 172.069 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -67.78 -58.01 5.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.664 -3.147 . . . . 30.059999999999999 115.807 -174.812 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -95.52 -52.29 4.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.28 2.238 . . . . 25.190000000000001 115.533 -168.202 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.59 38.18 0.86 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 116.58 -2.724 . . . . 7.4100000000000001 114.402 174.091 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.56 HG21 HD21 ' A' ' 71' ' ' LEU . 54.2 mt -114.56 120.86 37.0 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-O 111.936 -3.888 . . . . 9.4900000000000002 103.609 -176.007 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -72.46 157.82 52.3 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 125.124 2.866 . . . . 11.42 112.508 -173.992 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -73.8 -32.34 7.47 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 122.813 2.041 . . . . 12.0 110.674 -162.518 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -59.73 -41.87 91.89 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.006 1.854 . . . . 35.549999999999997 116.006 -178.058 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -65.64 -27.75 68.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.095 2.258 . . . . 20.52 117.095 179.258 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -74.97 155.32 37.51 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.236 3.05 . . . . 7.1299999999999999 119.236 177.849 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -143.71 97.16 3.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.084 2.153 . . . . 36.390000000000001 113.779 177.549 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.6 mt -91.69 129.49 37.66 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.666 2.65 . . . . 9.5500000000000007 116.104 -167.201 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -120.1 128.71 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 2 O-C-N 115.692 -4.38 . . . . 13.9 115.532 -169.048 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -118.06 119.57 35.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.902 -2.374 . . . . 6.8600000000000003 104.94 176.916 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.51 -96.6 0.05 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.774 3.23 . . . . 11.15 109.825 -168.622 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.94 21.31 4.43 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 126.727 2.108 . . . . 13.93 114.099 176.594 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -134.85 145.27 48.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.465 -1.609 . . . . 23.920000000000002 108.091 -170.164 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -95.73 139.38 32.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.443 2.339 . . . . 23.23 114.456 -168.955 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.2 mt -87.31 136.13 33.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.124 2.392 . . . . 9.1099999999999994 112.14 -166.846 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -96.3 147.96 23.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.374 -2.704 . . . . 33.439999999999998 112.65 176.036 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -62.25 -43.49 98.71 Favored 'General case' 0 N--CA 1.431 -1.413 1 CA-C-O 128.821 4.153 . . . . 28.370000000000001 117.607 -160.394 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.76 -23.39 75.66 Favored Glycine 0 N--CA 1.43 -1.727 0 O-C-N 117.939 -2.976 . . . . 15.0 112.766 -173.375 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 mmm-85 -84.39 151.35 24.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.517 2.658 . . . . 25.5 107.913 -158.856 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -81.13 171.92 14.31 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.457 -6.402 . . . . 11.949999999999999 114.208 175.721 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.2 mt -69.82 -24.72 63.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.371 -2.706 . . . . 10.17 115.061 166.102 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -56.82 -43.93 81.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.802 2.89 . . . . 13.59 118.802 167.722 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -57.72 -56.23 24.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 110.812 -2.904 . . . . 11.699999999999999 110.371 -176.562 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -75.38 -21.52 58.22 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.504 -2.134 . . . . 12.949999999999999 115.358 -177.028 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 62.15 55.37 2.47 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.969 3.307 . . . . 25.449999999999999 107.878 -171.787 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 mt -88.34 112.52 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 116.079 -1.915 . . . . 14.6 106.675 161.371 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -108.93 -158.37 0.65 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.118 2.266 . . . . 33.229999999999997 117.118 -179.195 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -61.47 124.95 22.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.287 3.435 . . . . 25.969999999999999 114.549 168.17 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.307 38.5 mt-10 78.14 2.99 2.81 Favored 'General case' 0 N--CA 1.43 -1.434 1 N-CA-C 122.164 4.135 . . . . 32.609999999999999 122.164 -169.47 . . . . . . . . 3 2 . 1 . 109 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -75.24 122.59 23.91 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.105 -4.122 . . . . 10.56 113.547 -175.752 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 4' ' ' PHE . 6.0 m -102.22 118.02 36.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.419 1.918 . . . . 5.3300000000000001 113.673 177.854 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.45 HD12 HG22 ' A' ' 5' ' ' VAL . 85.7 mt -88.18 159.4 18.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.684 -1.969 . . . . 11.66 105.684 -178.204 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -110.3 136.92 48.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.086 -2.259 . . . . 16.300000000000001 106.977 173.787 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -105.72 140.49 38.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.519 -1.988 . . . . 9.9600000000000009 107.41 170.506 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.273 28.4 t -114.6 140.17 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 128.003 2.521 . . . . 9.7599999999999998 106.737 167.998 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.56 HD21 HG21 ' A' ' 36' ' ' ILE . 64.9 mt . . . . . 0 N--CA 1.43 -1.465 0 C-N-CA 127.181 2.192 . . . . 19.57 108.707 178.986 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 11.2 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 117.94 2.57 . . . . 17.170000000000002 117.94 . . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.266 31.1 mt-30 -71.96 131.15 42.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.655 -3.153 . . . . 21.890000000000001 112.098 -178.813 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 pt -135.96 155.06 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 101.324 -3.584 . . . . 10.83 101.324 -169.795 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.29 118.66 37.31 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.826 2.05 . . . . 10.609999999999999 114.508 175.683 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -114.67 104.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 104.762 -2.31 . . . . 9.1300000000000008 104.762 -177.063 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -89.89 123.3 33.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.813 2.845 . . . . 20.550000000000001 112.66 -175.904 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -78.33 166.58 22.51 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.87 1.319 . . . . 11.779999999999999 113.619 -172.36 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.464 HD22 ' H ' ' A' ' 71' ' ' LEU . 32.5 tp -58.43 -47.64 83.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.405 -3.934 . . . . 19.309999999999999 115.03 175.112 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -63.02 -69.82 0.24 Allowed 'General case' 0 N--CA 1.43 -1.471 2 CA-C-O 111.163 -4.255 . . . . 23.140000000000001 108.804 176.26 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.66 45.27 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 O-C-N 126.706 2.504 . . . . 19.739999999999998 116.129 179.438 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -127.24 142.23 51.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.712 -1.464 . . . . 21.93 107.105 -172.766 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.5 m -112.44 131.75 55.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.391 1.567 . . . . 12.33 107.644 175.203 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 pt -122.56 145.4 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.654 -2.529 . . . . 17.079999999999998 105.38 171.149 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m -113.21 110.44 20.4 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.772 -3.705 . . . . 16.300000000000001 107.66 -166.991 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 mt -115.49 152.02 33.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 118.026 -0.988 . . . . 15.880000000000001 112.256 -170.52 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -97.86 125.63 42.83 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 127.088 3.327 . . . . 28.899999999999999 117.672 162.935 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.0 175.36 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 111.307 -2.679 . . . . 12.050000000000001 111.511 167.425 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -102.04 178.42 1.22 Allowed Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.647 -2.121 . . . . 18.170000000000002 107.628 168.012 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -71.84 -26.54 18.88 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 C-N-CA 122.297 1.998 . . . . 8.1600000000000001 115.235 163.966 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -83.14 -8.97 59.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.782 2.882 . . . . 11.130000000000001 118.782 177.133 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -69.11 155.34 40.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.934 2.198 . . . . 18.030000000000001 116.934 171.853 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.8 p -106.35 -172.83 2.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.651 -1.28 . . . . 10.220000000000001 107.731 -176.258 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.734 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 43.3 mm -81.38 -25.99 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 125.139 2.4 . . . . 12.300000000000001 111.895 -178.746 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -53.23 -43.3 67.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.192 -3.442 . . . . 36.509999999999998 112.705 164.139 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -75.33 -45.25 40.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.736 -2.477 . . . . 25.66 111.775 -178.443 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.1 t -50.37 -56.93 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 124.874 1.269 . . . . 8.1199999999999992 111.402 166.593 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -58.63 -32.33 68.94 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 119.84 3.274 . . . . 15.470000000000001 119.84 179.26 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.32 -49.09 59.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.87 -3.019 . . . . 11.449999999999999 109.718 173.051 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -46.64 -47.48 20.14 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.17 -2.831 . . . . 24.98 116.7 172.197 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.469 HD13 HD13 ' A' ' 69' ' ' LEU . 94.7 mt -54.94 -44.4 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.353 2.661 . . . . 9.4600000000000009 113.412 171.903 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -67.0 -50.64 61.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.738 2.415 . . . . 14.76 111.751 173.595 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.7 -56.83 17.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.228 -2.795 . . . . 26.289999999999999 113.909 173.307 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.262 35.4 tptt -57.93 -80.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.31 2.005 . . . . 30.059999999999999 116.043 174.334 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -68.25 -56.86 7.18 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 126.79 3.186 . . . . 25.190000000000001 112.787 -170.632 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.75 13.77 0.93 Allowed Glycine 0 N--CA 1.431 -1.666 1 O-C-N 115.361 -4.587 . . . . 7.4100000000000001 110.096 169.535 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.68 134.07 27.01 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 116.334 -1.793 . . . . 9.4900000000000002 112.713 -169.04 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -76.22 150.44 33.08 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 121.603 1.608 . . . . 11.42 109.487 177.041 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 89.3 Cg_endo -78.3 -9.56 16.34 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 123.799 3.0 . . . . 12.0 111.692 -170.384 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -65.13 -22.6 66.95 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 127.315 3.436 . . . . 35.549999999999997 111.348 165.442 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -90.78 -23.28 20.67 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.723 -4.36 . . . . 20.52 113.372 -173.969 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -89.06 131.29 35.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.025 -2.922 . . . . 7.1299999999999999 114.144 -166.053 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -121.84 126.85 49.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.013 -1.847 . . . . 36.390000000000001 106.013 156.995 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 43' ' ' LEU . 26.6 tp -106.96 127.05 53.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.119 1.367 . . . . 9.5500000000000007 112.778 178.974 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -129.25 138.17 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 126.9 2.08 . . . . 13.9 111.998 -165.988 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -120.62 122.04 39.66 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 114.914 -4.867 . . . . 6.8600000000000003 102.39 166.851 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.27 -85.51 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.067 2.147 . . . . 11.15 111.82 -174.927 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.59 23.08 1.34 Allowed Glycine 0 N--CA 1.429 -1.787 0 O-C-N 118.935 -2.353 . . . . 13.93 109.687 171.631 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -95.12 116.9 29.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.073 2.149 . . . . 23.920000000000002 114.136 168.196 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -70.36 119.22 14.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 118.817 2.895 . . . . 23.23 118.817 169.571 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.83 134.79 33.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.425 -3.297 . . . . 9.1099999999999994 116.899 -167.958 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -103.6 143.25 33.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.485 1.948 . . . . 33.439999999999998 115.426 -172.592 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.734 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 9.0 m-20 -50.46 -37.74 39.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.702 3.201 . . . . 28.370000000000001 119.272 -161.784 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.74 35.3 4.57 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 115.218 -2.99 . . . . 15.0 111.473 -178.425 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -110.77 153.91 24.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 122.566 3.183 . . . . 25.5 106.151 166.448 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.307 10.9 p -86.25 162.03 18.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.153 2.581 . . . . 11.949999999999999 107.1 -176.348 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.07 -32.63 73.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.287 -2.133 . . . . 10.17 115.37 169.014 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.1 t -60.08 -40.37 89.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.688 2.395 . . . . 13.59 112.762 167.199 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.5 -48.63 80.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.716 -2.49 . . . . 11.699999999999999 115.583 169.173 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.273 10.5 m-85 -82.46 4.88 22.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.752 1.39 . . . . 12.949999999999999 114.752 -179.979 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 59.37 28.31 17.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 114.805 -2.521 . . . . 25.449999999999999 114.79 -176.588 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.9 mt -76.18 126.58 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 124.21 3.186 . . . . 14.6 111.944 166.408 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -102.73 -179.29 3.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.221 2.439 . . . . 33.229999999999997 116.317 178.834 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -78.33 136.34 37.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 112.838 -1.983 . . . . 25.969999999999999 110.253 179.684 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.26 11.5 tt0 75.12 30.64 0.87 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.424 2.379 . . . . 32.609999999999999 117.424 -177.083 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -113.54 160.0 18.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.466 -2.021 . . . . 10.56 110.324 -175.965 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -109.39 115.25 29.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.203 2.601 . . . . 5.3300000000000001 113.869 -173.068 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.54 156.91 18.31 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 111.662 -2.517 . . . . 11.66 113.611 170.869 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -116.33 109.46 17.41 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 112.415 -2.175 . . . . 16.300000000000001 107.838 -176.03 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.469 HD13 HD13 ' A' ' 30' ' ' ILE . 10.8 tp -89.31 114.33 25.71 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.583 -3.198 . . . . 9.9600000000000009 103.674 179.177 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.3 t -114.51 132.27 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 118.07 -2.894 . . . . 9.7599999999999998 108.129 -178.697 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.464 ' H ' HD22 ' A' ' 8' ' ' LEU . 11.4 mt . . . . . 0 N--CA 1.43 -1.457 0 CA-C-O 124.419 2.056 . . . . 19.57 106.005 -165.332 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.457 ' SD ' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 121.102 0.477 . . . . 17.170000000000002 110.039 . . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -89.5 134.37 34.14 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.911 -1.743 . . . . 21.890000000000001 113.079 -171.302 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -115.18 139.2 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.072 -2.893 . . . . 10.83 112.062 160.595 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.285 12.3 m-85 -109.89 88.91 2.86 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.55 -5.094 . . . . 10.609999999999999 107.972 -169.248 . . . . . . . . 3 2 . 1 . 111 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.13 100.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 CA-C-O 129.184 4.326 . . . . 9.1300000000000008 113.522 173.353 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.28 46.7 mttt -83.31 148.57 27.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.15 -3.469 . . . . 20.550000000000001 113.752 178.536 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -104.27 -179.35 3.92 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.164 -2.21 . . . . 11.779999999999999 110.678 -168.322 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.325 1.9 tp -66.34 -41.18 89.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.996 1.48 . . . . 19.309999999999999 114.996 171.833 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.31 16.2 p -71.55 -66.22 0.66 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.589 2.614 . . . . 23.140000000000001 117.348 177.797 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.09 22.49 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 125.205 2.559 . . . . 19.739999999999998 119.451 -166.483 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -106.12 147.59 28.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.412 -2.394 . . . . 21.93 108.98 179.182 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -124.22 106.28 10.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.375 -2.454 . . . . 12.33 104.375 178.827 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -90.59 102.85 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 105.247 -2.131 . . . . 17.079999999999998 105.247 -177.933 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.2 m -81.14 121.65 26.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.081 -2.563 . . . . 16.300000000000001 104.081 -177.015 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.443 HD11 ' CG1' ' A' ' 30' ' ' ILE . 92.4 mt -112.37 133.97 54.17 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.38 2.363 . . . . 15.880000000000001 117.38 175.411 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.338 32.7 mt-10 -87.47 97.89 11.08 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.943 -4.223 . . . . 28.899999999999999 107.521 -177.677 . . . . . . . . 3 2 . 1 . 111 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -123.56 177.24 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.24 -1.538 . . . . 12.050000000000001 113.328 178.234 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -128.17 171.18 8.91 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.208 -1.853 . . . . 18.170000000000002 111.852 168.685 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -70.0 -16.37 36.54 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 C-N-CA 125.512 4.141 . . . . 8.1600000000000001 113.829 -174.312 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.2 m -92.96 -3.62 54.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.849 2.86 . . . . 11.130000000000001 110.919 179.476 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.54 154.72 40.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.368 -2.707 . . . . 18.030000000000001 115.348 176.507 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.8 p -93.65 156.5 16.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.286 -2.487 . . . . 10.220000000000001 104.286 -179.807 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -51.85 -36.5 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.637 -3.789 . . . . 12.300000000000001 113.52 167.561 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.67 -39.42 88.33 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.276 -2.765 . . . . 36.509999999999998 112.186 174.801 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -62.01 -47.17 85.98 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.764 -2.065 . . . . 25.66 113.049 170.421 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.5 t -44.83 -56.13 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 1 C-N-CA 131.915 4.086 . . . . 8.1199999999999992 111.068 172.213 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.95 -34.25 76.23 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.329 -3.357 . . . . 15.470000000000001 113.338 -174.024 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.55 85.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 114.68 1.363 . . . . 11.449999999999999 114.68 165.482 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -65.28 -32.2 73.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.072 -2.893 . . . . 24.98 113.012 173.669 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.443 ' CG1' HD11 ' A' ' 15' ' ' LEU . 87.5 mt -70.96 -44.75 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.147 -1.596 . . . . 9.4600000000000009 109.189 176.527 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -57.44 -52.4 65.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.861 -2.399 . . . . 14.76 110.906 169.076 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -48.62 -53.23 19.33 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.899 3.296 . . . . 26.289999999999999 119.899 171.622 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -82.67 -57.88 3.14 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.191 -4.068 . . . . 30.059999999999999 118.38 179.63 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -86.75 -25.47 24.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.893 1.442 . . . . 25.190000000000001 114.893 -172.563 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.44 23.0 38.31 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 126.703 2.502 . . . . 7.4100000000000001 119.004 -176.585 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.6 mt -96.95 127.23 39.71 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 113.016 -3.374 . . . . 9.4900000000000002 106.466 -175.223 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 94.9 Cg_endo -81.3 153.97 18.67 Favored 'Trans proline' 0 C--N 1.299 -2.034 2 C-N-CA 126.941 5.094 . . . . 11.42 112.736 179.038 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 45.1 Cg_endo -71.58 -18.19 29.33 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 124.679 3.586 . . . . 12.0 108.469 -159.982 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.261 41.4 m-20 -73.96 -22.97 59.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.1 2.125 . . . . 35.549999999999997 113.206 179.341 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -91.03 -3.57 57.11 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.68 2.487 . . . . 20.52 110.993 179.122 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -94.36 102.66 14.65 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.364 2.347 . . . . 7.1299999999999999 115.77 -166.256 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -90.83 100.6 13.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.392 -3.318 . . . . 36.390000000000001 107.38 158.405 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.0 tp -95.14 106.89 18.94 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.119 -1.855 . . . . 9.5500000000000007 109.659 174.435 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.11 127.24 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 127.619 2.367 . . . . 13.9 109.921 -168.681 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -118.77 111.82 18.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.481 -1.387 . . . . 6.8600000000000003 110.663 173.869 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.01 -103.14 0.11 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.264 2.626 . . . . 11.15 111.666 -165.663 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.42 20.53 3.71 Favored Glycine 0 N--CA 1.431 -1.697 0 O-C-N 118.314 -2.741 . . . . 13.93 107.239 166.469 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -85.93 133.77 33.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.987 2.327 . . . . 23.920000000000002 114.28 165.069 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -93.01 125.91 37.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.628 -1.624 . . . . 23.23 107.628 178.614 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -98.89 144.39 28.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.135 2.772 . . . . 9.1099999999999994 111.593 -174.389 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -113.01 149.51 33.23 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.216 1.96 . . . . 33.439999999999998 110.416 -175.655 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.32 -48.86 79.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.894 2.183 . . . . 28.370000000000001 116.894 -160.917 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.96 7.53 78.85 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 118.761 2.264 . . . . 15.0 118.761 -175.39 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -88.37 149.91 23.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.307 -0.946 . . . . 25.5 109.556 170.775 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -84.86 168.45 15.07 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.38 -2.075 . . . . 11.949999999999999 115.296 176.7 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.0 mt -73.13 -39.23 65.9 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 127.804 2.441 . . . . 10.17 110.605 178.451 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -68.54 -39.27 81.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.874 2.07 . . . . 13.59 112.651 178.383 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.56 -32.86 71.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 121.568 1.985 . . . . 11.699999999999999 109.506 175.739 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.27 -13.04 53.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 122.181 2.264 . . . . 12.949999999999999 106.331 176.358 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.327 59.7 m-20 80.66 28.0 0.23 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.968 2.507 . . . . 25.449999999999999 113.098 -178.471 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -81.66 109.33 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.517 -2.614 . . . . 14.6 110.196 -174.555 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -90.71 -178.97 5.41 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.831 2.453 . . . . 33.229999999999997 109.5 -177.282 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HA ' ' SD ' ' A' ' 1' ' ' MET 0.258 20.2 pttp -64.78 151.69 44.63 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.077 1.88 . . . . 25.969999999999999 116.077 173.174 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 69.01 19.62 8.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.254 3.421 . . . . 32.609999999999999 117.877 177.03 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -76.39 125.81 29.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.971 2.908 . . . . 10.56 111.654 -176.619 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.6 m -77.66 113.41 15.48 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.065 2.728 . . . . 5.3300000000000001 112.556 177.582 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.91 161.22 14.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.381 1.473 . . . . 11.66 113.62 167.315 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -106.35 132.92 51.82 Favored 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 131.727 4.011 . . . . 16.300000000000001 109.654 164.692 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -116.28 101.62 8.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.229 2.919 . . . . 9.9600000000000009 109.55 171.694 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -99.93 143.65 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 118.89 -2.381 . . . . 9.7599999999999998 108.618 170.704 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.43 -1.446 1 O-C-N 114.878 -4.889 . . . . 19.57 109.241 -178.012 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptt? . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 113.642 0.979 . . . . 17.170000000000002 113.642 . . . . . . . . . 0 0 . 1 . 112 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -103.59 121.71 43.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.08 2.371 . . . . 21.890000000000001 110.142 176.206 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -111.1 146.41 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.986 -2.321 . . . . 10.83 113.052 168.73 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -108.01 142.74 37.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.22 -1.809 . . . . 10.609999999999999 114.643 -176.876 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -131.41 119.47 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.847 -3.02 . . . . 9.1300000000000008 102.847 -172.957 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -118.31 115.82 25.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 112.896 -3.431 . . . . 20.550000000000001 110.304 -165.793 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -63.19 175.77 0.88 Allowed 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 129.917 4.51 . . . . 11.779999999999999 112.863 174.992 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.9 tp -67.82 -36.71 80.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.608 -0.724 . . . . 19.309999999999999 112.501 -179.677 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -86.17 -47.87 9.09 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.162 1.785 . . . . 23.140000000000001 107.182 -168.896 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.24 40.69 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 CA-C-O 123.165 1.425 . . . . 19.739999999999998 112.026 168.73 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -90.81 123.83 34.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.211 1.957 . . . . 21.93 111.305 163.101 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -99.54 106.73 18.76 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 111.946 -2.388 . . . . 12.33 108.868 -176.472 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.32 118.53 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.548 -1.345 . . . . 17.079999999999998 109.668 -177.949 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 m -100.19 121.93 42.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.395 -3.316 . . . . 16.300000000000001 105.033 -173.023 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 15' ' ' LEU . 23.4 mt -122.42 141.16 51.9 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.421 1.888 . . . . 15.880000000000001 108.357 -176.951 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -100.43 132.87 45.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 127.99 3.757 . . . . 28.899999999999999 107.702 174.24 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -137.23 174.51 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.328 -3.357 . . . . 12.050000000000001 109.456 -175.447 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -122.54 157.11 60.14 Favored Pre-proline 0 N--CA 1.43 -1.464 0 C-N-CA 123.928 0.891 . . . . 18.170000000000002 109.015 151.123 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.5 -25.17 75.69 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.363 2.709 . . . . 8.1600000000000001 113.703 -171.087 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -86.41 7.45 25.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.645 1.566 . . . . 11.130000000000001 112.471 -171.515 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -87.35 147.39 25.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.215 -2.178 . . . . 18.030000000000001 105.62 -172.145 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.4 p -82.77 151.63 26.05 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.301 -2.125 . . . . 10.220000000000001 112.685 -177.658 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -51.94 -43.22 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 130.607 3.563 . . . . 12.300000000000001 109.149 176.84 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.76 -37.74 79.86 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 125.96 2.037 . . . . 36.509999999999998 114.449 178.325 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.254 71.9 m-80 -72.83 -32.91 65.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.662 -2.524 . . . . 25.66 114.803 176.786 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.77 -36.03 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 127.127 2.171 . . . . 8.1199999999999992 110.771 167.188 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -70.69 -26.93 63.65 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.399 -2.688 . . . . 15.470000000000001 115.809 169.05 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.41 72.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.294 1.861 . . . . 11.449999999999999 109.999 167.923 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -63.87 -33.04 74.81 Favored 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 115.694 -4.378 . . . . 24.98 115.24 178.905 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 mt -69.77 -32.3 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.847 -2.408 . . . . 9.4600000000000009 108.682 172.651 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -69.98 -44.88 68.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.927 -3.608 . . . . 14.76 109.188 173.479 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -61.17 -46.03 92.17 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.736 2.208 . . . . 26.289999999999999 116.335 179.286 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -79.01 -60.82 2.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.742 -3.724 . . . . 30.059999999999999 116.647 -174.106 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -86.59 -53.86 4.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 126.182 2.176 . . . . 25.190000000000001 111.443 177.21 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.08 33.58 2.75 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 115.958 -2.579 . . . . 7.4100000000000001 113.958 -172.796 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.52 127.82 36.6 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 130.185 3.394 . . . . 9.4900000000000002 103.826 166.366 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -77.75 161.67 30.39 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-O 112.905 -3.04 . . . . 11.42 115.271 -177.498 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -66.84 -24.7 46.27 Favored 'Trans proline' 0 N--CA 1.434 -1.999 1 CA-C-N 129.772 4.526 . . . . 12.0 116.693 -172.079 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.06 -31.94 72.41 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.491 2.369 . . . . 35.549999999999997 113.418 -174.222 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.402 45.0 mt-30 -72.95 -16.91 61.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 119.427 3.121 . . . . 20.52 119.427 -179.53 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -102.68 110.16 22.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.105 -3.497 . . . . 7.1299999999999999 114.268 -155.521 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -94.14 103.94 15.97 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.178 -2.527 . . . . 36.390000000000001 104.178 169.178 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.08 118.46 31.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.086 2.374 . . . . 9.5500000000000007 110.114 174.773 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.1 mt -113.6 136.72 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 110.563 -3.017 . . . . 13.9 107.584 -179.393 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -120.36 113.35 20.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 101.494 -3.521 . . . . 6.8600000000000003 101.494 172.368 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.74 -117.14 0.47 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.085 -2.26 . . . . 11.15 111.314 -176.125 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.37 25.29 13.97 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 117.911 -2.993 . . . . 13.93 116.656 175.234 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -131.35 142.6 50.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.51 2.576 . . . . 23.920000000000002 109.305 -173.3 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -110.29 141.78 42.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.394 -2.691 . . . . 23.23 111.82 -177.284 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mt -95.2 140.54 29.96 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.134 2.397 . . . . 9.1099999999999994 110.606 -166.646 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -109.61 136.54 48.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.936 -1.938 . . . . 33.439999999999998 111.67 -172.359 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.7 -60.26 2.1 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.532 1.678 . . . . 28.370000000000001 115.532 -170.944 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.82 -4.03 61.04 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 118.797 -2.439 . . . . 15.0 117.805 -173.905 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -83.63 178.78 7.82 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 118.634 1.217 . . . . 25.5 110.689 170.883 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 76.6 p -106.09 178.44 4.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.333 -1.479 . . . . 11.949999999999999 109.958 177.058 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.9 mt -74.18 -33.89 63.6 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.591 1.156 . . . . 10.17 108.29 179.897 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -78.06 -27.35 48.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.389 3.076 . . . . 13.59 111.219 -175.007 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.02 -34.92 79.09 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 116.81 -1.567 . . . . 11.699999999999999 110.005 179.993 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -88.33 1.87 53.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.922 3.289 . . . . 12.949999999999999 114.103 167.521 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m120 58.31 49.07 11.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.25 1.204 . . . . 25.449999999999999 114.25 -178.098 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mm -79.18 113.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.22 -2.175 . . . . 14.6 106.767 170.436 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -87.62 -177.68 5.92 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.924 2.015 . . . . 33.229999999999997 112.42 174.087 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -64.03 134.42 54.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.667 -3.145 . . . . 25.969999999999999 115.408 164.508 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 69.84 31.22 3.53 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.757 2.217 . . . . 32.609999999999999 111.425 173.719 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.267 45.6 t -83.69 134.27 34.77 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.932 1.693 . . . . 10.56 108.54 166.499 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 m -103.96 122.84 46.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.716 -1.24 . . . . 5.3300000000000001 108.377 -179.573 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -81.99 138.71 34.85 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 115.135 -2.364 . . . . 11.66 116.073 165.185 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -88.5 114.61 25.29 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.172 2.17 . . . . 16.300000000000001 107.352 175.281 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.268 9.5 tp -92.55 106.45 18.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 117.672 -1.611 . . . . 9.9600000000000009 112.216 176.092 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.61 138.68 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.836 2.455 . . . . 9.7599999999999998 105.37 179.267 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 mt . . . . . 0 N--CA 1.43 -1.453 0 N-CA-C 116.485 2.032 . . . . 19.57 116.485 -171.897 . . . . . . . . 0 0 . 1 . 113 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.283 -0.636 . . . . 17.170000000000002 109.283 . . . . . . . . . 0 0 . 1 . 113 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -89.88 120.97 31.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.185 -0.672 . . . . 21.890000000000001 109.185 165.744 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -117.01 167.88 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 118.499 -2.626 . . . . 10.83 108.129 157.043 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.1 133.96 55.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.847 -2.408 . . . . 10.609999999999999 115.529 -176.163 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -112.62 117.76 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 123.875 1.798 . . . . 9.1300000000000008 110.661 175.323 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -96.58 151.86 19.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 112.278 -3.725 . . . . 20.550000000000001 110.771 177.142 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.6 p -85.21 -176.07 6.0 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 121.675 2.034 . . . . 11.779999999999999 113.327 159.88 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.252 36.5 mt -86.15 -17.93 33.62 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.407 1.003 . . . . 19.309999999999999 113.595 169.329 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 p -77.97 -69.56 0.54 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.575 2.35 . . . . 23.140000000000001 113.196 175.985 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.9 28.25 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.719 1 O-C-N 115.117 -4.739 . . . . 19.739999999999998 111.022 -177.504 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -109.06 130.65 55.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.116 -1.226 . . . . 21.93 111.085 179.091 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -111.17 115.99 30.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.015 -3.553 . . . . 12.33 108.151 173.577 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 pt -105.15 155.39 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 117.261 -1.776 . . . . 17.079999999999998 108.537 171.625 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.1 m -111.91 131.95 55.05 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.917 -2.623 . . . . 16.300000000000001 103.917 -177.287 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.3 tp -144.87 125.94 14.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.679 -2.513 . . . . 15.880000000000001 109.047 -164.885 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.82 103.47 15.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.045 -2.284 . . . . 28.899999999999999 110.996 -172.833 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -131.95 155.45 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 115.379 -0.828 . . . . 12.050000000000001 110.483 176.891 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -85.79 146.41 43.6 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 117.517 -1.23 . . . . 18.170000000000002 110.035 178.153 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.03 -10.69 21.53 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 N-CA-C 118.197 2.345 . . . . 8.1600000000000001 118.197 177.288 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 p -90.83 -7.19 53.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.363 2.665 . . . . 11.130000000000001 114.746 175.927 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -69.56 149.27 48.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.741 -1.224 . . . . 18.030000000000001 110.415 176.402 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -79.78 170.13 16.96 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 117.026 -1.464 . . . . 10.220000000000001 110.492 175.931 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -72.24 -29.04 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 127.062 2.145 . . . . 12.300000000000001 110.761 178.392 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -59.44 -47.39 85.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.369 -2.707 . . . . 36.509999999999998 113.246 163.483 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -62.63 -40.17 96.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.052 2.206 . . . . 25.66 115.163 170.499 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -56.59 -50.91 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 121.499 1.954 . . . . 8.1199999999999992 112.98 171.471 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -68.52 -30.19 68.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.256 -2.778 . . . . 15.470000000000001 112.892 -176.507 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.29 77.53 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.216 1.806 . . . . 11.449999999999999 109.844 174.088 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -80.48 -39.77 27.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.207 1.479 . . . . 24.98 109.882 -176.454 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.4 mt -56.32 -39.26 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.408 -3.932 . . . . 9.4600000000000009 113.665 162.746 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.351 17.6 tt0 -56.31 -51.65 67.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.131 2.972 . . . . 14.76 108.334 167.374 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.62 -37.75 76.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 121.711 2.051 . . . . 26.289999999999999 112.318 -168.181 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -83.01 -66.0 0.94 Allowed 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 129.212 4.07 . . . . 30.059999999999999 116.77 -178.399 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -93.48 -26.16 17.3 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.671 1.188 . . . . 25.190000000000001 112.748 -169.995 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.62 37.88 8.48 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.389 1.471 . . . . 7.4100000000000001 114.427 178.526 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.591 HD13 HD21 ' A' ' 71' ' ' LEU . 4.7 mt -88.9 128.86 50.54 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 118.739 -1.184 . . . . 9.4900000000000002 113.105 160.862 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.39 158.2 36.79 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 123.288 2.659 . . . . 11.42 111.815 170.186 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -90.31 0.28 5.35 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 116.808 -2.259 . . . . 12.0 109.916 -159.931 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -77.09 -29.73 55.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.665 -2.522 . . . . 35.549999999999997 110.755 169.626 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -71.23 -37.77 72.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.089 -2.257 . . . . 20.52 109.174 175.433 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -76.99 116.89 18.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.023 2.231 . . . . 7.1299999999999999 117.023 -164.909 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -115.59 120.31 39.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.1 1.905 . . . . 36.390000000000001 108.482 166.75 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -111.77 112.97 25.03 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.245 -4.034 . . . . 9.5500000000000007 110.442 -169.447 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.6 mm -102.89 137.84 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.479 -2.013 . . . . 13.9 110.026 -177.93 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -106.46 111.58 24.22 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.747 -5.596 . . . . 6.8600000000000003 108.079 153.786 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.44 -99.17 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.192 2.597 . . . . 11.15 115.615 -174.534 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -122.53 8.62 9.46 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 118.985 -2.322 . . . . 13.93 115.018 161.174 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -89.27 124.89 34.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.033 1.333 . . . . 23.920000000000002 114.546 172.475 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -85.47 131.51 34.37 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.145 -2.539 . . . . 23.23 104.145 -179.341 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -93.37 126.76 38.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.379 1.472 . . . . 9.1099999999999994 110.17 -175.653 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -121.0 150.45 41.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.911 2.141 . . . . 33.439999999999998 113.011 -164.77 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.365 67.2 m-20 -18.02 -74.7 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.432 1 C-N-CA 132.285 4.234 . . . . 28.370000000000001 120.039 -168.968 . . . . . . . . 3 2 . 1 . 113 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.38 34.34 5.19 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.713 -2.492 . . . . 15.0 116.339 -164.802 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -133.55 171.34 14.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.862 -1.964 . . . . 25.5 111.949 175.989 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -95.54 167.21 11.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.664 2.029 . . . . 11.949999999999999 112.889 -167.519 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.53 -34.25 76.54 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.53 -2.606 . . . . 10.17 112.908 166.828 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -38.22 79.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.426 1.269 . . . . 13.59 114.426 178.129 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -56.4 -50.38 71.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.596 -3.815 . . . . 11.699999999999999 114.044 177.914 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -77.78 8.42 4.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 127.576 3.048 . . . . 12.949999999999999 113.631 178.163 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 2.0 m120 54.4 40.33 31.69 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 131.748 4.019 . . . . 25.449999999999999 117.222 -179.519 . . . . . . . . 3 2 . 1 . 113 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.346 10.1 mt -77.77 115.72 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.407 -1.433 . . . . 14.6 109.307 178.962 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -91.85 176.06 6.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.207 -3.433 . . . . 33.229999999999997 108.473 176.361 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -69.38 146.91 51.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.346 -2.721 . . . . 25.969999999999999 114.023 176.817 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 71.35 18.59 5.55 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 129.652 3.181 . . . . 32.609999999999999 112.561 -179.102 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.8 m -76.69 148.95 36.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.199 -2.813 . . . . 10.56 112.507 178.949 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.4 m -90.96 106.09 18.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.472 2.309 . . . . 5.3300000000000001 115.735 170.507 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -91.44 152.24 20.46 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.422 2.289 . . . . 11.66 114.311 166.164 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -119.77 125.84 49.57 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.184 -2.822 . . . . 16.300000000000001 103.956 -169.76 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -102.2 123.53 46.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.723 2.409 . . . . 9.9600000000000009 108.053 177.915 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.76 130.6 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 113.41 -1.723 . . . . 9.7599999999999998 114.089 162.292 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.591 HD21 HD13 ' A' ' 36' ' ' ILE . 10.8 mt . . . . . 0 N--CA 1.43 -1.455 0 C-N-CA 129.486 3.114 . . . . 19.57 117.926 176.531 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ptt? . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 118.514 2.783 . . . . 17.170000000000002 118.514 . . . . . . . . . 0 0 . 1 . 114 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.371 36.7 mt-30 -69.01 128.48 36.85 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.253 -2.129 . . . . 21.890000000000001 105.253 170.569 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 pt -123.4 151.8 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.677 -2.056 . . . . 10.83 110.972 161.983 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -96.37 130.01 43.58 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.738 -0.785 . . . . 10.609999999999999 111.402 174.778 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 67' ' ' LEU . 76.3 t -119.26 125.14 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 103.126 -2.916 . . . . 9.1300000000000008 103.126 160.966 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -119.48 132.22 55.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 109.983 -3.28 . . . . 20.550000000000001 105.985 -175.942 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 69' ' ' LEU . 10.5 p -75.34 157.58 34.07 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.794 -3.066 . . . . 11.779999999999999 109.109 174.552 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.5 mt -61.59 -39.76 92.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.514 -3.241 . . . . 19.309999999999999 114.43 159.283 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -48.02 -34.57 9.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.001 2.12 . . . . 23.140000000000001 112.794 172.141 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.04 -62.88 0.32 Allowed Glycine 0 N--CA 1.43 -1.725 1 O-C-N 114.156 -5.34 . . . . 19.739999999999998 119.801 -178.638 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -80.78 160.76 24.78 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 115.296 -2.561 . . . . 21.93 117.084 -158.251 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.69 131.29 48.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.427 -1.42 . . . . 12.33 109.493 166.641 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 pt -112.9 144.54 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 129.216 3.006 . . . . 17.079999999999998 109.017 157.219 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -106.34 128.22 53.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.129 2.571 . . . . 16.300000000000001 104.97 179.231 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.15 129.33 54.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.577 1.551 . . . . 15.880000000000001 110.978 172.902 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -79.73 101.84 8.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 120.318 1.417 . . . . 28.899999999999999 113.451 159.899 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -111.22 166.76 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.624 -3.173 . . . . 12.050000000000001 115.221 173.996 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -95.76 154.96 38.97 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.926 -1.879 . . . . 18.170000000000002 105.926 167.838 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.252 14.1 Cg_exo -63.0 -21.56 73.3 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 N-CA-C 116.008 1.503 . . . . 8.1600000000000001 116.008 170.26 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.5 p -80.96 -2.48 47.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.878 1.671 . . . . 11.130000000000001 115.475 175.351 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.77 148.72 28.76 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.94 3.296 . . . . 18.030000000000001 106.533 -171.017 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 26' ' ' VAL . 57.9 p -91.18 164.12 14.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.256 -2.247 . . . . 10.220000000000001 105.551 -179.392 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.659 HG23 HD23 ' A' ' 43' ' ' LEU . 41.1 mm -72.48 -30.9 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 116.948 -1.501 . . . . 12.300000000000001 107.124 174.592 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -51.53 -50.96 59.0 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 125.47 3.759 . . . . 36.509999999999998 114.503 168.777 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -60.39 -28.28 68.1 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.388 2.366 . . . . 25.66 117.388 174.087 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 22' ' ' THR . 88.5 t -65.66 -47.86 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 129.251 3.02 . . . . 8.1199999999999992 110.825 172.018 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -70.48 -30.05 66.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.166 2.412 . . . . 15.470000000000001 109.794 178.402 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.62 74.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.365 -3.959 . . . . 11.449999999999999 109.783 -179.133 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -70.48 -27.81 64.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.302 -2.124 . . . . 24.98 108.601 -177.189 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.5 mt -78.17 -24.63 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 114.017 1.117 . . . . 9.4600000000000009 114.017 170.879 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 15.4 tt0 -62.45 -46.12 89.94 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 115.649 -4.407 . . . . 14.76 110.878 169.081 . . . . . . . . 3 3 . 1 . 114 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.5 -42.01 99.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.627 -1.296 . . . . 26.289999999999999 112.953 174.627 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -73.99 -67.81 0.57 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.521 -1.362 . . . . 30.059999999999999 110.711 -171.017 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -90.57 -29.69 17.68 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 113.74 -5.6 . . . . 25.190000000000001 113.191 -177.215 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.0 40.73 1.78 Allowed Glycine 0 N--CA 1.43 -1.752 0 O-C-N 120.082 -1.636 . . . . 7.4100000000000001 111.601 -177.085 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.455 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 2.7 mt -115.4 119.54 37.99 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 119.031 -2.452 . . . . 9.4900000000000002 111.539 -171.786 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -58.8 140.6 95.8 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.567 2.178 . . . . 11.42 113.313 177.69 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.36 -17.79 42.13 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 124.901 3.734 . . . . 12.0 118.441 179.458 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.8 -37.21 56.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.799 1.407 . . . . 35.549999999999997 114.799 179.386 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -61.4 -21.74 64.35 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 121.711 3.967 . . . . 20.52 121.711 167.193 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -88.6 101.73 14.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.482 2.401 . . . . 7.1299999999999999 117.482 -171.378 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -100.74 107.36 18.93 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 125.288 2.471 . . . . 36.390000000000001 110.982 177.072 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.659 HD23 HG23 ' A' ' 23' ' ' ILE . 8.7 tp -105.99 118.7 37.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.432 -2.667 . . . . 9.5500000000000007 107.375 -161.469 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 36.3 mm -111.99 124.48 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 128.969 2.908 . . . . 13.9 115.988 -166.351 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -112.87 87.13 2.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.651 -3.155 . . . . 6.8600000000000003 108.473 -179.314 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.283 . . 62.52 -93.16 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 114.39 -5.193 . . . . 11.15 110.291 -177.122 . . . . . . . . 3 2 . 1 . 114 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.43 -10.99 22.65 Favored Glycine 0 N--CA 1.43 -1.712 0 O-C-N 126.244 2.215 . . . . 13.93 111.253 176.653 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -88.6 137.27 32.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.417 3.087 . . . . 23.920000000000002 108.395 -172.779 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -107.3 117.93 35.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.354 2.026 . . . . 23.23 107.791 177.322 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -80.66 163.41 23.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.023 -1.673 . . . . 9.1099999999999994 111.989 -170.925 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -106.94 165.39 11.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.284 3.034 . . . . 33.439999999999998 105.447 179.443 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.337 23.7 m-20 -84.12 -54.39 4.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.03 2.348 . . . . 28.370000000000001 117.069 -168.549 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.87 50.79 2.26 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.682 -1.599 . . . . 15.0 116.056 177.749 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -133.39 156.05 48.37 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 100.11 -4.033 . . . . 25.5 100.11 175.811 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 30.2 p -86.04 158.54 19.81 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.258 1.98 . . . . 11.949999999999999 113.242 -170.218 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.28 -36.65 80.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.097 -2.252 . . . . 10.17 116.782 167.239 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.4 t -65.8 -38.14 88.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.341 1.856 . . . . 13.59 111.963 -179.519 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -63.36 -54.37 37.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.387 2.275 . . . . 11.699999999999999 112.129 178.721 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -64.14 -17.99 64.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 120.025 3.343 . . . . 12.949999999999999 120.025 170.588 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 69.9 43.4 0.93 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.399 2.37 . . . . 25.449999999999999 117.399 -172.742 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.01 112.47 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.339 -2.21 . . . . 14.6 112.132 165.416 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -83.31 -179.29 7.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.568 1.651 . . . . 33.229999999999997 108.706 -172.91 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.96 152.45 44.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.414 -1.429 . . . . 25.969999999999999 114.787 162.223 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 57.36 21.69 7.08 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.191 1.922 . . . . 32.609999999999999 116.191 -172.23 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 t -90.47 141.14 29.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.795 1.035 . . . . 10.56 113.795 -179.932 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 m -96.94 93.77 6.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.603 2.816 . . . . 5.3300000000000001 118.603 -174.682 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 5' ' ' VAL . 64.6 mt -79.02 161.57 26.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.107 -0.995 . . . . 11.66 109.221 174.893 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.486 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 79.0 m-70 -104.37 137.22 42.58 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.44 -2.059 . . . . 16.300000000000001 105.44 173.646 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 7' ' ' THR . 62.1 tp -95.02 119.49 33.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 127.491 2.994 . . . . 9.9600000000000009 112.655 160.231 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 t -104.25 120.56 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 106.226 -1.768 . . . . 9.7599999999999998 106.226 174.664 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.0 mt . . . . . 0 N--CA 1.429 -1.485 0 C-N-CA 129.699 3.2 . . . . 19.57 113.577 -171.155 . . . . . . . . 0 0 . 1 . 115 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptt? . . . . . 0 CA--C 1.49 -1.33 0 CA-C-O 117.706 -1.14 . . . . 17.170000000000002 113.719 . . . . . . . . . 0 0 . 1 . 115 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.22 144.17 45.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.621 2.153 . . . . 21.890000000000001 115.243 167.729 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.8 pt -127.32 163.29 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.529 -1.669 . . . . 10.83 107.861 175.03 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -123.18 130.13 52.34 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 115.28 -2.295 . . . . 10.609999999999999 111.147 -171.037 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.515 HG22 ' HB2' ' A' ' 67' ' ' LEU . 86.0 t -130.54 112.13 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 CA-C-N 126.331 4.151 . . . . 9.1300000000000008 102.718 -167.511 . . . . . . . . 3 3 . 1 . 115 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -81.94 144.0 31.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.494 1.517 . . . . 20.550000000000001 113.967 -176.849 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.302 81.8 p -98.91 -140.86 0.32 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.722 -2.486 . . . . 11.779999999999999 112.731 -178.45 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.8 -44.97 1.92 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 100.741 -3.8 . . . . 19.309999999999999 100.741 174.003 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -92.24 -74.45 0.51 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.552 1.541 . . . . 23.140000000000001 112.649 -169.692 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.94 -137.04 3.76 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 108.319 -1.913 . . . . 19.739999999999998 108.319 -157.99 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -91.7 160.45 15.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.651 2.167 . . . . 21.93 112.062 -172.512 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.6 m -77.01 116.72 17.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.651 -3.78 . . . . 12.33 109.691 172.098 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.3 pt -79.37 160.39 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.79 -2.444 . . . . 17.079999999999998 112.356 179.403 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -124.79 132.96 53.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.504 -2.622 . . . . 16.300000000000001 107.422 -175.893 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 mt -121.8 142.39 50.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.261 -0.644 . . . . 15.880000000000001 109.261 177.565 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -99.82 110.57 22.94 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.206 -2.184 . . . . 28.899999999999999 109.217 168.227 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.5 164.84 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 131.252 3.821 . . . . 12.050000000000001 109.915 -170.532 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.272 52.0 mm-40 -110.42 155.14 42.51 Favored Pre-proline 0 N--CA 1.43 -1.453 1 O-C-N 116.011 -4.181 . . . . 18.170000000000002 102.558 172.896 . . . . . . . . 3 2 . 1 . 115 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -66.07 -19.62 57.28 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 127.876 3.849 . . . . 8.1600000000000001 114.654 176.47 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 p -75.99 -5.63 47.2 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.751 2.021 . . . . 11.130000000000001 115.292 179.526 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -78.2 142.45 37.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.1 -1.0 . . . . 18.030000000000001 110.161 171.903 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 40.8 p -81.66 169.19 17.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.1 2.381 . . . . 10.220000000000001 113.501 177.359 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.38 -29.11 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.693 -2.504 . . . . 12.300000000000001 107.942 -178.438 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.18 -34.91 66.26 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.785 1.634 . . . . 36.509999999999998 113.627 175.886 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.6 -40.22 78.62 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.385 -2.721 . . . . 25.66 116.578 161.424 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.65 -38.26 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 123.143 1.449 . . . . 8.1199999999999992 108.369 176.468 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 89.6 mttt -57.29 -36.02 70.53 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 115.336 -4.603 . . . . 15.470000000000001 114.618 171.871 . . . . . . . . 3 3 . 1 . 115 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.91 94.06 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 130.376 4.797 . . . . 11.449999999999999 110.685 176.124 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.284 56.2 mttm -61.4 -42.41 98.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.771 1.623 . . . . 24.98 114.943 167.987 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 27' ' ' LYS . 63.8 mt -60.55 -32.71 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.733 -3.105 . . . . 9.4600000000000009 117.34 176.358 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -58.86 -48.94 79.61 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.979 -2.95 . . . . 14.76 115.475 167.497 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.54 -62.79 1.42 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.142 -3.474 . . . . 26.289999999999999 114.224 162.386 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -64.87 -42.03 95.18 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.673 2.101 . . . . 30.059999999999999 116.673 -170.528 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -106.59 -50.55 3.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.264 -1.522 . . . . 25.190000000000001 113.258 174.143 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.37 5.18 6.16 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 125.029 2.461 . . . . 7.4100000000000001 116.524 -178.039 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.1 mt -82.86 133.69 48.3 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 119.741 -2.035 . . . . 9.4900000000000002 109.655 -177.502 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -64.12 146.35 90.58 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 125.771 4.314 . . . . 11.42 118.021 174.278 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.525 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 72.4 Cg_exo -61.54 -20.71 69.75 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 124.273 2.562 . . . . 12.0 116.736 -173.057 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -82.44 -18.17 42.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.523 1.139 . . . . 35.549999999999997 112.922 -179.874 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -100.06 -4.44 29.88 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 117.592 -1.194 . . . . 20.52 113.709 -176.256 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.05 135.23 33.71 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.106 3.362 . . . . 7.1299999999999999 114.999 175.6 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -129.57 118.38 21.93 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.943 -1.723 . . . . 36.390000000000001 107.946 176.336 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mt -101.5 137.29 40.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.421 1.581 . . . . 9.5500000000000007 109.529 -177.338 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.9 mm -137.36 130.93 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 100.268 -3.975 . . . . 13.9 100.268 -173.191 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -119.94 121.18 38.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 113.377 -3.202 . . . . 6.8600000000000003 109.105 170.705 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.33 -116.26 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.931 2.605 . . . . 11.15 107.599 -174.664 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.5 34.41 4.55 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 118.739 -2.476 . . . . 13.93 113.091 164.375 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -113.36 123.98 51.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.644 -2.092 . . . . 23.920000000000002 108.681 -179.882 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -77.21 119.38 20.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.647 -2.533 . . . . 23.23 111.625 171.743 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.6 mt -90.52 136.16 33.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.995 -2.315 . . . . 9.1099999999999994 115.466 -174.89 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -96.45 128.67 43.59 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.111 -1.618 . . . . 33.439999999999998 114.082 178.855 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -31.72 -52.93 0.25 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.94 3.696 . . . . 28.370000000000001 117.037 -177.627 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.57 0.46 82.97 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 119.012 -2.305 . . . . 15.0 110.322 -165.161 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -91.33 168.35 11.64 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 118.145 0.972 . . . . 25.5 112.212 170.756 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 66.4 p -109.37 178.82 4.33 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.4 -3.312 . . . . 11.949999999999999 108.118 -176.11 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -75.32 -33.81 61.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.422 2.535 . . . . 10.17 111.003 179.579 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -35.89 77.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.445 -3.909 . . . . 13.59 109.242 168.383 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.27 -36.64 71.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 122.42 2.373 . . . . 11.699999999999999 112.798 -176.336 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -83.16 3.43 30.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.277 2.231 . . . . 12.949999999999999 109.794 -177.706 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 49.59 51.52 16.29 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 115.069 1.507 . . . . 25.449999999999999 115.069 -169.766 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mt -102.81 113.86 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 127.161 2.788 . . . . 14.6 113.092 -179.784 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -97.31 -175.25 3.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.778 3.18 . . . . 33.229999999999997 109.535 -174.377 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -73.3 154.5 40.12 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.426 -3.296 . . . . 25.969999999999999 112.889 -175.156 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 76.33 13.68 2.49 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.022 2.129 . . . . 32.609999999999999 109.303 170.499 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 m -87.41 141.77 28.38 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 127.214 2.821 . . . . 10.56 109.703 -172.901 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.1 m -83.94 115.55 22.36 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 123.528 1.632 . . . . 5.3300000000000001 112.804 176.116 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.515 ' HB2' HG22 ' A' ' 5' ' ' VAL . 63.4 mt -87.29 147.65 25.43 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.923 1.344 . . . . 11.66 110.906 162.674 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -105.36 131.06 53.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.97 -3.582 . . . . 16.300000000000001 109.661 172.85 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 tp -112.39 117.66 33.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.255 3.407 . . . . 9.9600000000000009 107.721 179.929 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.37 151.9 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 101.366 -3.568 . . . . 9.7599999999999998 101.366 -168.15 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 mm? . . . . . 0 N--CA 1.43 -1.438 0 O-C-N 117.702 -3.124 . . . . 19.57 109.431 -171.669 . . . . . . . . 0 0 . 1 . 116 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 118.71 2.856 . . . . 17.170000000000002 118.71 . . . . . . . . . 0 0 . 1 . 116 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -93.24 124.66 37.37 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.241 -4.037 . . . . 21.890000000000001 106.225 -174.043 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.327 0.9 OUTLIER -110.31 166.69 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 119.784 -1.822 . . . . 10.83 109.578 167.341 . . . . . . . . 3 3 . 1 . 116 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -117.56 120.74 39.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.636 2.16 . . . . 10.609999999999999 116.534 176.241 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -99.17 105.78 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.222 -2.799 . . . . 9.1300000000000008 114.941 176.766 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -102.94 133.89 47.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.802 -3.061 . . . . 20.550000000000001 109.39 -171.74 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.763 HG22 HD23 ' A' ' 69' ' ' LEU 0.316 17.1 p -93.29 -177.71 4.53 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.119 -4.113 . . . . 11.779999999999999 110.559 -172.77 . . . . . . . . 4 3 . 1 . 116 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.8 mt -74.42 -67.13 0.65 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.233 2.613 . . . . 19.309999999999999 105.322 175.947 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -125.76 129.42 49.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.309 2.256 . . . . 23.140000000000001 106.645 176.166 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.81 -114.06 0.73 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.506 -2.621 . . . . 19.739999999999998 108.492 176.994 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -158.43 163.54 37.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 126.948 3.261 . . . . 21.93 103.581 -178.01 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.7 m -92.38 135.17 34.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.195 -2.191 . . . . 12.33 112.669 178.31 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 pt -110.12 139.47 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.453 -3.28 . . . . 17.079999999999998 111.025 -174.517 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.4 m -101.5 121.11 41.36 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.033 -2.58 . . . . 16.300000000000001 104.033 -175.572 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 mt -119.95 172.42 7.74 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.169 -2.207 . . . . 15.880000000000001 111.504 179.995 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -120.42 120.43 35.91 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.264 -2.772 . . . . 28.899999999999999 114.085 178.062 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -138.2 167.65 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 126.763 2.539 . . . . 12.050000000000001 109.558 -177.756 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -122.96 158.34 57.7 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 121.05 1.75 . . . . 18.170000000000002 108.168 176.902 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.16 -19.58 66.22 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 O-C-N 113.932 -3.772 . . . . 8.1600000000000001 118.278 -179.838 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -82.9 -1.83 53.22 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 118.937 2.94 . . . . 11.130000000000001 118.937 177.577 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -78.78 144.69 34.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.703 -0.623 . . . . 18.030000000000001 109.4 173.719 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 p -76.42 173.84 10.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.206 -2.184 . . . . 10.220000000000001 114.97 165.012 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.6 mm -63.33 -42.99 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.869 1.795 . . . . 12.300000000000001 112.572 174.414 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -49.43 -39.29 32.41 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 131.006 3.723 . . . . 36.509999999999998 113.511 175.583 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -75.45 -17.02 60.26 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.664 -2.522 . . . . 25.66 115.374 172.271 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.54 -44.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.139 -1.601 . . . . 8.1199999999999992 114.234 167.463 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HA ' HD12 ' A' ' 30' ' ' ILE . 79.7 mttt -51.71 -22.89 3.85 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.227 1.936 . . . . 15.470000000000001 116.227 175.659 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.01 -27.3 23.3 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.209 0.913 . . . . 11.449999999999999 109.073 -174.847 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.26 -26.06 65.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.883 2.873 . . . . 24.98 113.428 167.352 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 27' ' ' LYS . 11.2 mt -89.35 -31.75 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.522 -1.986 . . . . 9.4600000000000009 111.261 175.1 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -57.26 -37.45 72.35 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.769 -4.332 . . . . 14.76 114.307 168.461 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -64.68 -55.64 18.83 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.289 -1.815 . . . . 26.289999999999999 112.205 168.191 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -75.97 -51.53 12.2 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.708 1.88 . . . . 30.059999999999999 114.592 -161.171 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -94.59 -42.92 8.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.008 2.813 . . . . 25.190000000000001 116.659 179.578 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.38 33.14 2.57 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 109.94 -3.3 . . . . 7.4100000000000001 113.563 161.388 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.465 HD12 HD21 ' A' ' 69' ' ' LEU . 87.6 mt -91.22 137.88 26.04 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 114.626 -2.607 . . . . 9.4900000000000002 109.399 -179.071 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -61.9 137.56 68.34 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 124.759 3.639 . . . . 11.42 114.087 178.985 . . . . . . . . 3 3 . 1 . 116 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.2 Cg_exo -64.42 -26.54 62.96 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 127.126 3.581 . . . . 12.0 118.241 -168.564 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -63.03 -31.41 72.54 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.26 2.224 . . . . 35.549999999999997 113.405 171.552 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -86.55 -25.78 24.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.229 2.212 . . . . 20.52 112.964 -179.909 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -73.54 118.0 15.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.674 -2.516 . . . . 7.1299999999999999 112.228 178.328 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.475 ' HD3' HD11 ' A' ' 44' ' ' ILE . 26.3 ttm180 -110.15 118.39 36.26 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.411 1.46 . . . . 36.390000000000001 111.45 166.418 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.3 mt -98.9 124.52 43.88 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.097 -2.186 . . . . 9.5500000000000007 105.097 178.719 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.475 HD11 ' HD3' ' A' ' 42' ' ' ARG . 51.4 mm -105.21 120.06 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 126.621 1.969 . . . . 13.9 110.9 173.126 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.73 111.32 22.42 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.37 2.51 . . . . 6.8600000000000003 105.277 167.853 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.342 . . 55.37 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.17 2.188 . . . . 11.15 116.189 -167.763 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.81 -23.5 6.47 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 116.33 1.292 . . . . 13.93 116.33 -177.294 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.44 167.8 9.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.938 -2.131 . . . . 23.920000000000002 114.393 -172.832 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -92.42 148.98 21.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.536 -2.12 . . . . 23.23 108.851 176.691 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -102.5 121.5 42.48 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.942 -2.349 . . . . 9.1099999999999994 111.517 177.317 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.276 35.2 mt-10 -103.56 139.99 38.13 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.189 -1.569 . . . . 33.439999999999998 114.494 -166.498 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -29.37 -67.43 0.08 Allowed 'General case' 0 N--CA 1.43 -1.453 1 N-CA-C 122.068 4.099 . . . . 28.370000000000001 122.068 -161.466 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.97 24.99 28.88 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.7 -1.875 . . . . 15.0 115.814 -175.658 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -99.58 146.73 26.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.586 3.168 . . . . 25.5 109.966 166.23 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -85.95 167.26 15.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.857 1.663 . . . . 11.949999999999999 110.24 -162.46 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.19 -12.33 59.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.039 -1.467 . . . . 10.17 107.039 176.729 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -68.47 -50.91 48.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.146 1.378 . . . . 13.59 111.037 175.991 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -56.48 -49.35 74.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.848 3.259 . . . . 11.699999999999999 108.738 176.287 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -71.18 -20.15 62.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.16 1.541 . . . . 12.949999999999999 115.16 -178.851 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.346 32.5 t30 51.05 68.63 0.76 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.308 -2.12 . . . . 25.449999999999999 109.891 -172.335 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.68 138.2 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 100.929 -3.73 . . . . 14.6 100.929 167.215 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -123.77 -173.29 2.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.621 -1.925 . . . . 33.229999999999997 111.014 -176.455 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -75.35 146.65 40.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.045 -2.284 . . . . 25.969999999999999 109.128 -177.369 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 65.12 22.79 12.33 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 128.118 2.567 . . . . 32.609999999999999 112.408 166.901 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 t -101.09 159.78 14.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.985 2.326 . . . . 10.56 112.031 -175.56 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.8 m -111.36 109.34 19.28 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.261 -4.649 . . . . 5.3300000000000001 111.168 -166.088 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.0 mt -84.86 146.86 27.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.177 -1.577 . . . . 11.66 110.445 162.565 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 14.7 m170 -106.9 125.69 51.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.068 -3.52 . . . . 16.300000000000001 107.433 179.841 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.763 HD23 HG22 ' A' ' 7' ' ' THR 0.256 47.3 tp -103.93 111.43 23.96 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 123.83 3.014 . . . . 9.9600000000000009 102.927 -172.832 . . . . . . . . 3 3 . 1 . 116 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.3 t -107.34 152.46 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 104.849 -2.278 . . . . 9.7599999999999998 104.849 -176.526 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp . . . . . 0 N--CA 1.43 -1.43 0 N-CA-C 104.8 -2.296 . . . . 19.57 104.8 165.809 . . . . . . . . 0 0 . 1 . 117 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 CA--C 1.49 -1.362 0 CA-C-O 125.934 2.778 . . . . 17.170000000000002 114.697 . . . . . . . . . 0 0 . 1 . 117 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.51 119.11 11.77 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 121.361 3.837 . . . . 21.890000000000001 121.361 168.191 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.417 29.7 pt -111.31 130.08 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 103.652 -2.721 . . . . 10.83 103.652 169.693 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -91.05 121.66 33.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.794 0.807 . . . . 10.609999999999999 111.986 171.92 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -116.75 106.61 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 O-C-N 114.882 -4.887 . . . . 9.1300000000000008 108.871 176.27 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 12' ' ' THR . 76.4 tttt -84.94 112.44 20.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 118.27 2.692 . . . . 20.550000000000001 118.27 169.753 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 m -76.84 134.88 38.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.034 -3.541 . . . . 11.779999999999999 107.398 163.971 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.93 -48.79 33.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.807 -3.058 . . . . 19.309999999999999 112.179 -175.23 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 m -93.48 98.26 11.08 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.186 -2.821 . . . . 23.140000000000001 107.546 161.879 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.57 -126.19 2.16 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 106.268 -2.733 . . . . 19.739999999999998 106.268 -175.973 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -156.77 170.44 22.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.793 -2.592 . . . . 21.93 109.879 173.641 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 41.6 m -79.97 104.61 10.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.024 2.345 . . . . 12.33 114.662 167.233 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.8 pt -90.42 165.6 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 124.321 2.01 . . . . 17.079999999999998 108.379 171.077 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 13.1 m -118.65 125.28 49.38 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.287 3.035 . . . . 16.300000000000001 107.431 179.064 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 mt -116.24 127.26 54.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.135 1.921 . . . . 15.880000000000001 107.658 -178.779 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -89.57 95.05 10.1 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.256 -4.653 . . . . 28.899999999999999 116.628 175.267 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.89 160.68 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.541 -1.974 . . . . 12.050000000000001 110.253 -171.575 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -97.82 147.41 33.0 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 118.968 -2.332 . . . . 18.170000000000002 108.526 163.176 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.3 -13.21 31.14 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 N-CA-C 120.779 3.338 . . . . 8.1600000000000001 120.779 -175.437 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 m -99.91 -7.95 24.62 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.369 -1.457 . . . . 11.130000000000001 113.752 -168.526 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.58 172.63 13.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.79 -2.444 . . . . 18.030000000000001 111.492 178.964 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -92.14 161.83 14.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.322 1.601 . . . . 10.220000000000001 115.322 178.07 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -65.63 -30.13 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.891 3.276 . . . . 12.300000000000001 111.482 -172.654 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -70.23 -22.7 62.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.97 1.708 . . . . 36.509999999999998 113.318 176.481 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -82.64 -18.48 40.95 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.65 2.38 . . . . 25.66 110.902 170.744 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.46 -43.42 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 121.034 1.743 . . . . 8.1199999999999992 107.709 176.966 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -54.86 -24.55 23.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 121.486 3.884 . . . . 15.470000000000001 121.486 173.441 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.271 . . -70.87 -29.44 65.54 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.659 2.783 . . . . 11.449999999999999 114.04 177.738 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -85.94 -35.12 20.67 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.968 -2.957 . . . . 24.98 107.132 -177.192 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 mt -54.29 -52.23 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 129.399 3.08 . . . . 9.4600000000000009 113.138 168.397 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -53.18 -49.29 66.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 131.13 3.772 . . . . 14.76 118.307 167.355 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -53.8 -57.95 9.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 121.85 2.114 . . . . 26.289999999999999 111.142 164.25 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -77.73 -54.9 5.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.957 -2.339 . . . . 30.059999999999999 116.291 -162.071 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -92.15 -35.9 13.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.19 -1.569 . . . . 25.190000000000001 112.82 178.782 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.53 69.86 1.15 Allowed Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 109.524 -1.43 . . . . 7.4100000000000001 109.524 -178.118 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.5 mt -138.12 123.41 12.36 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 102.352 -3.203 . . . . 9.4900000000000002 102.352 171.481 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -72.43 164.11 36.61 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 124.504 3.47 . . . . 11.42 111.807 179.366 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.14 -1.34 9.82 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 C-N-CA 123.042 2.495 . . . . 12.0 114.583 -163.319 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -93.94 -19.99 20.42 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.004 2.522 . . . . 35.549999999999997 109.732 173.757 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -84.62 -33.79 23.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 126.479 3.038 . . . . 20.52 112.727 175.833 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.36 143.44 51.94 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 126.366 2.984 . . . . 7.1299999999999999 117.815 177.983 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -154.13 123.88 6.7 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 114.111 -5.368 . . . . 36.390000000000001 100.41 179.813 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.87 126.84 50.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.6 3.16 . . . . 9.5500000000000007 107.428 -172.827 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.9 mm -118.41 132.98 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.451 -1.685 . . . . 13.9 106.451 -174.362 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -106.11 93.81 4.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 105.222 -2.14 . . . . 6.8600000000000003 105.222 178.151 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.98 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.535 2.334 . . . . 11.15 114.812 -171.813 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.14 -1.44 7.35 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 118.093 -2.88 . . . . 13.93 112.336 -179.578 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -90.65 147.8 23.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 115.807 -2.044 . . . . 23.920000000000002 116.075 170.547 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -98.94 138.74 35.62 Favored 'General case' 0 N--CA 1.43 -1.462 1 CA-C-O 129.351 4.405 . . . . 23.23 105.214 171.094 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.4 mt -88.62 151.96 22.13 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.434 -3.916 . . . . 9.1099999999999994 114.133 171.197 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -116.14 157.49 24.7 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.943 1.402 . . . . 33.439999999999998 110.806 178.098 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -63.51 -50.71 68.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.504 2.779 . . . . 28.370000000000001 118.504 -163.027 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.99 -2.05 90.46 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 118.402 2.121 . . . . 15.0 118.402 -161.127 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 65.5 mtp180 -101.8 158.85 15.82 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.521 2.105 . . . . 25.5 107.617 -169.979 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.301 45.0 p -83.74 159.1 21.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.3 -2.75 . . . . 11.949999999999999 111.029 -169.766 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.75 -43.97 69.57 Favored 'General case' 0 N--CA 1.43 -1.473 2 CA-C-O 129.674 4.559 . . . . 10.17 119.353 169.014 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 p -51.64 -42.87 62.36 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.603 -3.185 . . . . 13.59 117.543 166.684 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -56.7 -50.14 73.05 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.598 -3.189 . . . . 11.699999999999999 116.682 -179.942 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 47.9 m-85 -65.43 -29.1 69.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 111.832 -2.44 . . . . 12.949999999999999 117.077 169.604 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 m120 83.49 55.5 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 129.041 3.963 . . . . 25.449999999999999 112.125 174.722 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.334 72.7 mt -84.92 149.17 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.529 -1.982 . . . . 14.6 107.941 177.507 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -147.99 -162.44 1.55 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.702 -3.124 . . . . 33.229999999999997 108.022 -173.172 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -76.42 132.79 39.88 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.734 -1.229 . . . . 25.969999999999999 108.024 -170.268 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 74.42 10.26 4.25 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 131.346 3.858 . . . . 32.609999999999999 110.84 167.095 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -58.97 141.04 54.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.631 1.105 . . . . 10.56 112.799 170.139 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.0 m -112.3 102.52 10.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.72 -2.696 . . . . 5.3300000000000001 103.72 -168.345 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.17 148.86 22.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.845 3.658 . . . . 11.66 105.004 179.223 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -115.54 127.9 55.59 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.377 -1.452 . . . . 16.300000000000001 109.06 176.897 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.2 tp -95.27 116.05 28.24 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.336 2.493 . . . . 9.9600000000000009 107.213 -178.706 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.71 141.36 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 100.295 -3.965 . . . . 9.7599999999999998 100.295 -171.505 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.429 -1.477 0 O-C-N 118.892 -2.38 . . . . 19.57 113.906 174.962 . . . . . . . . 0 0 . 1 . 118 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 108.375 -0.972 . . . . 17.170000000000002 108.375 . . . . . . . . . 0 0 . 1 . 118 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -83.03 115.2 21.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.788 2.435 . . . . 21.890000000000001 110.424 -173.081 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pp -120.27 155.71 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.152 -2.536 . . . . 10.83 104.152 175.959 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -100.85 134.55 43.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.312 -3.367 . . . . 10.609999999999999 106.607 -176.338 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.88 117.69 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 121.111 -0.993 . . . . 9.1300000000000008 108.971 160.87 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -98.66 117.22 32.63 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.748 0.819 . . . . 20.550000000000001 111.694 -178.093 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 m -79.02 127.7 32.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.23 -2.169 . . . . 11.779999999999999 113.135 161.098 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.61 -59.79 2.57 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.207 -2.145 . . . . 19.309999999999999 105.207 -174.968 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.259 8.2 m -87.54 71.43 9.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 112.888 0.699 . . . . 23.140000000000001 112.888 168.346 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.11 -128.48 1.42 Allowed Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 109.627 -1.389 . . . . 19.739999999999998 109.627 -175.342 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.424 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU 0.258 20.6 pttm -132.45 179.45 6.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 131.107 3.763 . . . . 21.93 117.157 173.465 . . . . . . . . 3 3 . 1 . 118 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -105.52 119.16 38.4 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.167 -4.083 . . . . 12.33 108.709 178.098 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 pt -104.02 143.02 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 117.314 -3.366 . . . . 17.079999999999998 110.462 173.847 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -96.9 134.33 40.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.626 2.632 . . . . 16.300000000000001 107.129 170.811 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.7 mt -121.86 140.89 51.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.197 -2.274 . . . . 15.880000000000001 111.118 175.474 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -103.95 90.39 3.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.155 2.883 . . . . 28.899999999999999 111.968 177.596 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.56 176.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 C-N-CA 132.07 4.148 . . . . 12.050000000000001 111.504 -170.204 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.259 37.5 tt0 -134.34 144.06 49.54 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 117.703 -1.142 . . . . 18.170000000000002 112.862 167.551 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 88.9 Cg_endo -65.69 -16.92 55.37 Favored 'Trans proline' 0 C--N 1.3 -2.025 1 C-N-CA 126.876 5.051 . . . . 8.1600000000000001 115.184 -169.912 . . . . . . . . 3 3 . 1 . 118 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -66.83 -20.92 66.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.112 3.765 . . . . 11.130000000000001 117.245 166.165 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -73.04 159.65 33.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.141 1.924 . . . . 18.030000000000001 113.029 179.878 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.6 p -86.9 154.16 21.06 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.552 1.541 . . . . 10.220000000000001 109.225 166.062 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 mm -56.58 -51.15 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 125.016 1.448 . . . . 12.300000000000001 108.597 167.334 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.279 37.8 tp10 -37.25 -35.54 0.11 Allowed 'General case' 0 N--CA 1.43 -1.436 1 N-CA-C 123.37 4.582 . . . . 36.509999999999998 123.37 166.823 . . . . . . . . 3 2 . 1 . 118 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -74.84 -33.72 62.18 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 111.733 -6.854 . . . . 25.66 118.535 167.756 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -67.86 -45.22 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 128.36 2.664 . . . . 8.1199999999999992 106.623 175.678 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -55.47 -40.99 72.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.898 3.237 . . . . 15.470000000000001 111.107 176.358 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.33 -17.39 60.84 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 111.586 -6.946 . . . . 11.449999999999999 120.652 176.49 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -75.36 -34.54 61.17 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.098 -2.876 . . . . 24.98 112.708 173.198 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.3 mt -63.82 -43.23 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 119.601 -1.937 . . . . 9.4600000000000009 113.736 173.004 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -50.93 -51.05 56.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.805 2.566 . . . . 14.76 116.527 167.399 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.63 -42.7 70.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.619 1.967 . . . . 26.289999999999999 112.513 -169.281 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -76.32 -47.44 23.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.386 -1.768 . . . . 30.059999999999999 114.717 -178.682 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.424 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS . 59.3 mm-40 -102.78 -53.64 2.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 116.12 -1.895 . . . . 25.190000000000001 107.913 -169.267 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.91 -31.69 1.33 Allowed Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 122.549 2.431 . . . . 7.4100000000000001 112.08 -175.962 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 19.8 mt -61.32 115.9 16.96 Favored Pre-proline 0 N--CA 1.431 -1.403 1 O-C-N 131.579 4.929 . . . . 9.4900000000000002 117.089 -164.287 . . . . . . . . 3 2 . 1 . 118 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 38.0 Cg_endo -82.16 148.89 15.19 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 CA-C-N 129.263 4.344 . . . . 11.42 108.448 -169.825 . . . . . . . . 3 3 . 1 . 118 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 32.3 Cg_exo -61.5 -12.61 25.17 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 124.652 3.568 . . . . 12.0 119.642 -170.094 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -79.84 -33.51 40.14 Favored 'General case' 0 N--CA 1.43 -1.459 1 CA-C-O 131.789 5.566 . . . . 35.549999999999997 110.778 179.123 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -76.94 -20.41 56.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 110.019 -3.264 . . . . 20.52 112.671 -176.92 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -76.34 149.34 37.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.53 2.586 . . . . 7.1299999999999999 108.268 -178.795 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -145.29 95.89 2.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.739 -2.476 . . . . 36.390000000000001 111.741 161.549 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.2 mt -84.37 121.41 27.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.035 -0.984 . . . . 9.5500000000000007 113.296 -175.753 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.1 mm -107.2 136.47 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 122.886 1.327 . . . . 13.9 110.239 171.284 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB2' HD11 ' A' ' 50' ' ' LEU . 33.1 t80 -116.3 114.84 24.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.562 -2.014 . . . . 6.8600000000000003 105.562 167.674 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.82 -112.28 0.5 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.855 1.262 . . . . 11.15 113.431 -164.405 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.5 -4.49 43.3 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 126.211 2.195 . . . . 13.93 112.992 -174.398 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -93.89 121.64 35.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.076 2.551 . . . . 23.920000000000002 105.544 -175.912 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -83.81 102.45 12.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.67 1.988 . . . . 23.23 107.335 169.238 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 45' ' ' PHE . 23.8 mt -51.81 132.57 31.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.104 3.002 . . . . 9.1099999999999994 119.104 -173.511 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -109.23 139.89 43.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.618 2.628 . . . . 33.439999999999998 111.325 179.943 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -64.24 -43.23 95.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 109.893 -3.321 . . . . 28.370000000000001 116.065 -148.322 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.52 -6.15 88.86 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 127.652 2.549 . . . . 15.0 110.752 -171.787 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -86.9 158.45 19.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.405 3.002 . . . . 25.5 109.78 -177.464 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.9 p -89.81 158.65 17.39 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.627 -3.171 . . . . 11.949999999999999 110.45 179.658 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 30.5 mt -59.16 -45.0 92.13 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.797 -1.547 . . . . 10.17 113.951 175.056 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.377 71.5 p -43.57 -43.55 5.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.348 2.659 . . . . 13.59 114.509 165.7 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -63.25 -40.91 98.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.53 1.633 . . . . 11.699999999999999 115.198 179.829 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HB3' HG13 ' A' ' 61' ' ' ILE . 6.4 m-85 -82.58 -18.79 40.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.842 2.057 . . . . 12.949999999999999 110.564 -176.673 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.382 12.5 m120 80.8 32.41 0.15 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.145 2.178 . . . . 25.449999999999999 111.513 -179.09 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.406 HG13 ' HB3' ' A' ' 59' ' ' TYR . 66.4 mt -91.57 106.18 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 128.072 2.549 . . . . 14.6 109.165 179.177 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -103.18 -173.58 2.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.744 3.217 . . . . 33.229999999999997 110.755 -169.354 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -68.22 158.33 33.52 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.072 2.669 . . . . 25.969999999999999 114.248 178.022 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 41.1 mt-10 72.75 5.02 5.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.438 1.895 . . . . 32.609999999999999 108.528 169.004 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -70.01 149.69 47.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.659 -1.901 . . . . 10.56 115.854 169.507 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.6 m -120.08 121.7 39.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.124 2.392 . . . . 5.3300000000000001 105.265 -168.942 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.54 128.04 43.1 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.297 -4.627 . . . . 11.66 109.052 172.978 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.326 35.1 m80 -97.7 132.78 43.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.644 2.474 . . . . 16.300000000000001 113.699 175.465 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tt -108.45 112.63 25.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.21 1.481 . . . . 9.9600000000000009 109.482 -169.558 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 t -92.45 129.28 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 116.401 -1.762 . . . . 9.7599999999999998 110.491 164.46 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.43 -1.43 0 C-N-CA 127.527 2.331 . . . . 19.57 106.821 177.063 . . . . . . . . 0 0 . 1 . 119 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 114.839 1.422 . . . . 17.170000000000002 114.839 . . . . . . . . . 0 0 . 1 . 119 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.53 135.32 39.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.588 -3.82 . . . . 21.890000000000001 112.833 168.352 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.443 HD12 HD13 ' A' ' 67' ' ' LEU . 17.2 pt -127.63 160.0 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.43 3.014 . . . . 10.83 106.397 159.956 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -103.07 148.48 25.67 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 109.355 -3.566 . . . . 10.609999999999999 112.67 -178.473 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -125.03 119.58 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 121.086 1.766 . . . . 9.1300000000000008 108.616 167.465 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -95.43 85.67 4.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 125.261 1.601 . . . . 20.550000000000001 114.819 -176.977 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.5 m -83.32 141.47 31.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.45 -0.945 . . . . 11.779999999999999 108.45 171.962 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.1 mt -86.2 -54.1 4.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.965 1.306 . . . . 19.309999999999999 112.56 179.706 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -89.43 63.77 6.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.746 2.213 . . . . 23.140000000000001 107.054 -176.385 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.74 -135.15 3.71 Favored Glycine 0 N--CA 1.429 -1.77 1 CA-C-N 107.994 -4.184 . . . . 19.739999999999998 103.774 -174.035 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -143.45 174.2 10.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.363 2.357 . . . . 21.93 117.363 -178.148 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -92.31 117.65 30.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.952 2.575 . . . . 12.33 117.952 176.884 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 pt -102.95 156.32 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 128.824 2.85 . . . . 17.079999999999998 116.809 -172.536 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -127.72 104.02 7.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.939 -1.101 . . . . 16.300000000000001 110.89 -168.746 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.1 mt -104.02 138.11 41.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.241 1.817 . . . . 15.880000000000001 111.962 -165.645 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -108.0 86.99 2.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 128.122 3.82 . . . . 28.899999999999999 110.804 -170.247 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -101.73 172.98 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 111.971 -2.377 . . . . 12.050000000000001 114.437 -175.71 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.86 146.87 63.12 Favored Pre-proline 0 N--CA 1.431 -1.416 0 O-C-N 125.56 1.788 . . . . 18.170000000000002 108.452 171.339 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.3 -4.56 13.17 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 115.955 -1.769 . . . . 8.1600000000000001 116.406 -150.097 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 m -90.91 6.22 45.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.732 2.06 . . . . 11.130000000000001 111.172 172.598 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.91 154.68 20.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.5 2.778 . . . . 18.030000000000001 118.5 -176.252 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -91.45 163.05 14.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.062 -2.899 . . . . 10.220000000000001 111.669 -164.338 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mm -64.51 -34.89 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 117.342 -1.313 . . . . 12.300000000000001 108.315 -178.188 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -51.0 -49.32 60.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 114.294 1.22 . . . . 36.509999999999998 114.294 169.646 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.08 -25.07 62.46 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.915 2.931 . . . . 25.66 118.915 176.393 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.509 HG21 HD21 ' A' ' 56' ' ' LEU . 86.7 t -62.99 -44.79 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 116.249 -1.834 . . . . 8.1199999999999992 109.098 167.637 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -52.35 -48.97 65.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.823 3.638 . . . . 15.470000000000001 120.823 171.504 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.09 67.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.937 3.695 . . . . 11.449999999999999 114.975 170.594 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.98 -43.72 98.01 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.748 1.758 . . . . 24.98 115.748 170.455 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.6 -54.29 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.774 -1.829 . . . . 9.4600000000000009 112.931 174.505 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -41.7 -46.03 3.64 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.42 2.288 . . . . 14.76 113.045 172.573 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -76.03 -46.59 28.57 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.049 1.74 . . . . 26.289999999999999 111.586 -178.118 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -68.2 -62.43 1.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.321 -1.487 . . . . 30.059999999999999 113.852 -172.65 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -92.53 -49.57 6.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.573 -0.899 . . . . 25.190000000000001 108.573 -173.642 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.85 28.24 2.32 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 122.568 1.093 . . . . 7.4100000000000001 112.672 177.825 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mt -87.18 119.75 71.07 Favored Pre-proline 0 N--CA 1.431 -1.413 0 O-C-N 117.985 -3.068 . . . . 9.4900000000000002 104.075 -171.757 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -64.77 133.63 37.2 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 N-CA-C 121.633 3.666 . . . . 11.42 121.633 -176.068 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -78.9 -10.8 15.34 Favored 'Trans proline' 0 N--CA 1.433 -2.05 1 C-N-CA 128.698 6.266 . . . . 12.0 113.947 -159.039 . . . . . . . . 3 3 . 1 . 119 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -76.87 -36.07 57.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.01 1.732 . . . . 35.549999999999997 113.175 168.808 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.536 HE21 HD22 ' A' ' 71' ' ' LEU . 25.6 tt0 -74.55 -27.45 60.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.533 3.933 . . . . 20.52 112.63 -178.982 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 76.7 mt-30 -74.49 119.33 18.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.338 -2.101 . . . . 7.1299999999999999 110.466 172.968 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.325 40.5 ttm180 -114.65 108.8 17.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.048 2.539 . . . . 36.390000000000001 104.857 159.681 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.19 130.55 35.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.321 3.452 . . . . 9.5500000000000007 120.321 166.876 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.9 mm -117.83 131.61 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.018 2.127 . . . . 13.9 111.168 -174.538 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -128.17 123.63 34.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.639 -3.788 . . . . 6.8600000000000003 106.314 170.965 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.19 -99.65 0.1 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.705 -1.588 . . . . 11.15 112.727 -163.198 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.17 22.3 2.76 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 104.359 -3.496 . . . . 13.93 104.359 -176.736 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -107.47 135.27 49.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.403 3.481 . . . . 23.920000000000002 101.952 -177.282 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -97.98 118.6 34.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.463 -2.648 . . . . 23.23 109.623 177.297 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.3 mt -88.67 135.81 33.31 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.215 -2.803 . . . . 9.1099999999999994 109.246 -160.719 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -80.11 159.08 26.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.124 2.569 . . . . 33.439999999999998 111.924 179.286 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -75.75 -47.7 24.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 124.982 1.426 . . . . 28.370000000000001 111.973 -172.936 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.29 29.62 11.51 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 124.639 1.212 . . . . 15.0 113.046 -166.396 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.441 HH21 ' CG ' ' A' ' 58' ' ' ASP . 77.7 mtp180 -117.47 157.06 26.91 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 126.186 1.794 . . . . 25.5 108.818 177.727 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -96.2 162.38 13.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.096 2.628 . . . . 11.949999999999999 118.096 -169.705 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.509 HD21 HG21 ' A' ' 26' ' ' VAL . 42.6 mt -63.09 -33.4 75.36 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.919 -2.363 . . . . 10.17 113.75 170.367 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 p -66.61 -39.52 88.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.51 -3.869 . . . . 13.59 114.403 171.148 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.441 ' CG ' HH21 ' A' ' 54' ' ' ARG . 66.2 t0 -64.34 -54.53 31.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.246 2.618 . . . . 11.699999999999999 107.671 179.801 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -73.09 -15.32 61.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 115.313 -2.555 . . . . 12.949999999999999 108.887 -178.933 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.271 35.1 m120 85.91 37.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 127.255 3.407 . . . . 25.449999999999999 113.368 176.251 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.491 HG21 HD11 ' A' ' 67' ' ' LEU . 53.7 mt -95.78 79.85 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.478 1 O-C-N 116.243 -4.036 . . . . 14.6 110.413 -172.166 . . . . . . . . 3 3 . 1 . 119 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -59.33 174.17 0.43 Allowed 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.435 2.754 . . . . 33.229999999999997 118.435 172.719 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -62.57 141.02 58.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.111 1.522 . . . . 25.969999999999999 115.111 174.733 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 22.3 tt0 67.88 27.02 7.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.613 3.165 . . . . 32.609999999999999 114.672 -176.196 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -91.49 139.79 30.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.899 -3.625 . . . . 10.56 112.014 174.634 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -113.78 118.94 35.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.309 -1.357 . . . . 5.3300000000000001 111.883 -172.099 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 61' ' ' ILE . 5.5 mp -97.35 141.48 30.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 103.87 -2.641 . . . . 11.66 103.87 -176.109 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -108.49 135.1 50.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.254 -2.499 . . . . 16.300000000000001 104.254 -176.36 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.91 108.52 20.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.64 -1.985 . . . . 9.9600000000000009 105.64 -172.013 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.9 t -76.95 130.43 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 125.3 1.625 . . . . 9.7599999999999998 113.985 162.633 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.536 HD22 HE21 ' A' ' 40' ' ' GLN . 93.7 mt . . . . . 0 N--CA 1.429 -1.479 0 CA-C-O 125.325 2.488 . . . . 19.57 105.137 174.652 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptt? . . . . . 0 CA--C 1.489 -1.367 0 CA-C-O 123.587 1.66 . . . . 17.170000000000002 110.316 . . . . . . . . . 0 0 . 1 . 120 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -96.83 140.33 31.55 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.413 -2.055 . . . . 21.890000000000001 106.872 -179.195 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 pt -136.79 157.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 124.007 0.923 . . . . 10.83 108.793 177.467 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -112.61 133.94 54.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.55 -2.759 . . . . 10.609999999999999 103.55 -178.498 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.16 121.23 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 1 O-C-N 115.359 -4.588 . . . . 9.1300000000000008 106.859 165.713 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -105.66 115.9 31.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.084 2.115 . . . . 20.550000000000001 107.856 -167.569 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.335 0.2 OUTLIER -101.27 126.92 48.06 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.738 -1.949 . . . . 11.779999999999999 105.738 -168.471 . . . . . . . . 3 3 . 1 . 120 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.72 -49.65 8.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.157 -1.59 . . . . 19.309999999999999 107.468 -178.142 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 m -95.03 75.52 3.5 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.931 2.3 . . . . 23.140000000000001 112.71 172.556 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.47 -111.3 0.46 Allowed Glycine 0 N--CA 1.431 -1.695 0 O-C-N 119.394 -2.066 . . . . 19.739999999999998 110.329 -166.721 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -175.32 177.97 1.76 Allowed 'General case' 0 N--CA 1.43 -1.459 1 CA-C-N 124.497 4.148 . . . . 21.93 106.122 178.932 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -97.23 122.33 40.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.402 -2.061 . . . . 12.33 106.67 -176.771 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 pt -106.63 148.66 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 122.94 1.352 . . . . 17.079999999999998 108.329 -178.869 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.9 m -111.3 112.44 24.21 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.916 -2.253 . . . . 16.300000000000001 104.916 -175.357 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -111.33 142.7 43.21 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.501 2.096 . . . . 15.880000000000001 112.478 179.924 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -97.78 117.39 31.98 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.563 -3.211 . . . . 28.899999999999999 109.711 172.977 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.46 153.66 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.613 -3.179 . . . . 12.050000000000001 108.146 -171.797 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -105.54 137.97 19.45 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 112.491 -3.623 . . . . 18.170000000000002 107.281 173.428 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -75.25 -9.88 20.59 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 123.67 2.346 . . . . 8.1600000000000001 113.045 -158.588 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.8 m -84.1 -20.44 32.57 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 126.935 2.647 . . . . 11.130000000000001 113.947 -176.418 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -85.12 159.67 20.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.184 -2.198 . . . . 18.030000000000001 109.053 -169.284 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -78.86 163.58 25.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.18 -2.825 . . . . 10.220000000000001 109.935 -167.385 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.6 mm -64.46 -38.45 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.613 -1.929 . . . . 12.300000000000001 109.875 174.667 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -44.77 -36.57 3.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.017 2.927 . . . . 36.509999999999998 115.012 164.405 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -71.97 -44.56 63.36 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.971 1.708 . . . . 25.66 110.14 173.138 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 t -55.92 -43.24 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.614 2.366 . . . . 8.1199999999999992 112.497 173.055 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -62.98 -26.22 68.74 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.561 -3.212 . . . . 15.470000000000001 113.902 173.085 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -76.02 -36.04 59.29 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.983 -2.323 . . . . 11.449999999999999 107.605 177.517 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -73.26 -36.67 66.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.209 -1.557 . . . . 24.98 114.097 -178.241 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 mt -65.55 -34.62 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.713 1.605 . . . . 9.4600000000000009 113.569 168.237 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 58.9 tt0 -61.59 -52.22 65.32 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.227 1.489 . . . . 14.76 112.741 170.859 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.74 -46.67 88.42 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.367 2.267 . . . . 26.289999999999999 112.102 -179.652 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -65.58 -59.29 4.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.15 1.537 . . . . 30.059999999999999 115.15 178.309 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.378 65.9 mm-40 -87.98 -43.69 11.56 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.203 2.201 . . . . 25.190000000000001 111.84 -165.927 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.78 29.64 5.49 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-O 117.562 -1.688 . . . . 7.4100000000000001 109.878 -174.775 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.2 mt -104.49 99.83 19.75 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 130.189 3.396 . . . . 9.4900000000000002 109.203 175.886 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -58.77 160.62 17.26 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 115.628 -2.88 . . . . 11.42 115.628 173.406 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -102.15 12.1 0.39 Allowed 'Trans proline' 0 N--CA 1.434 -1.997 0 N-CA-C 121.517 3.622 . . . . 12.0 121.517 -163.811 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.11 -13.55 55.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 125.647 1.842 . . . . 35.549999999999997 114.669 151.044 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -90.86 -3.05 57.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.993 -2.317 . . . . 20.52 107.744 178.273 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -95.34 131.68 41.19 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.589 -2.569 . . . . 7.1299999999999999 113.179 -175.995 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -119.48 103.38 9.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.459 -2.422 . . . . 36.390000000000001 104.459 166.2 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.72 109.43 21.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.915 -2.99 . . . . 9.5500000000000007 107.057 -165.764 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.08 135.56 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 123.714 1.721 . . . . 13.9 107.581 -159.011 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -124.11 115.3 20.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.197 -2.814 . . . . 6.8600000000000003 103.846 176.816 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.282 . . 63.2 -103.14 0.11 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.414 1.886 . . . . 11.15 113.305 -169.17 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.69 40.84 1.54 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 118.406 -2.684 . . . . 13.93 113.016 168.704 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -147.37 137.46 23.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.542 2.337 . . . . 23.920000000000002 106.153 -178.103 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -76.44 158.51 31.27 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.798 -3.689 . . . . 23.23 111.377 -171.498 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD11 HD23 ' A' ' 67' ' ' LEU . 5.4 mt -97.07 147.36 24.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 113.346 0.869 . . . . 9.1099999999999994 113.346 165.224 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -95.38 167.92 11.04 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 123.614 0.571 . . . . 33.439999999999998 111.72 177.421 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.09 -46.21 13.07 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.054 -2.904 . . . . 28.370000000000001 114.538 -163.284 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.23 27.57 13.06 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.121 -2.862 . . . . 15.0 112.291 -176.33 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -106.43 166.63 10.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 115.621 -2.133 . . . . 25.5 111.486 173.097 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -104.1 176.87 5.01 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 121.763 2.074 . . . . 11.949999999999999 111.575 -175.288 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.38 -40.52 73.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.412 2.529 . . . . 10.17 106.511 173.251 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.3 p -78.79 -8.11 58.46 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.065 -2.272 . . . . 13.59 111.245 -171.966 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -75.26 -51.17 13.91 Favored 'General case' 0 N--CA 1.431 -1.406 2 O-C-N 115.315 -4.616 . . . . 11.699999999999999 104.477 174.422 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -82.22 -10.26 59.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.792 -2.442 . . . . 12.949999999999999 113.574 179.435 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 71.51 58.96 0.17 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.132 1.373 . . . . 25.449999999999999 109.962 -177.656 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mt -80.71 111.44 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.184 2.594 . . . . 14.6 110.567 159.925 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -97.53 175.04 6.36 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.397 -2.183 . . . . 33.229999999999997 110.17 174.401 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -58.79 143.07 48.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.702 3.201 . . . . 25.969999999999999 106.811 -178.679 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.317 3.2 mp0 60.96 20.2 10.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.829 2.159 . . . . 32.609999999999999 116.829 -178.871 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 m -72.37 147.23 46.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.242 2.312 . . . . 10.56 117.242 167.131 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.4 m -95.11 126.56 40.52 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.086 2.155 . . . . 5.3300000000000001 109.071 165.521 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.483 HD23 HD11 ' A' ' 50' ' ' LEU . 6.6 mp -100.59 152.26 20.63 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.141 -2.17 . . . . 11.66 105.141 164.623 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -105.78 128.43 53.71 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.08 -5.388 . . . . 16.300000000000001 108.675 179.164 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 tp -97.05 131.66 43.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 116.074 -2.25 . . . . 9.9600000000000009 108.717 179.53 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.5 t -107.84 129.38 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.789 -3.069 . . . . 9.7599999999999998 107.67 172.288 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.43 -1.447 0 CA-C-N 114.514 -1.221 . . . . 19.57 110.261 176.239 . . . . . . . . 0 0 . 1 . 121 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.349 0 CA-C-O 117.293 -1.336 . . . . 17.170000000000002 112.388 . . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -96.88 137.49 35.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.946 2.654 . . . . 21.890000000000001 111.169 176.956 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.29 172.02 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 126.919 2.088 . . . . 10.83 112.711 176.952 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -123.66 115.7 21.87 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.614 -2.735 . . . . 10.609999999999999 103.614 -167.89 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.72 115.35 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 102.623 -3.103 . . . . 9.1300000000000008 102.623 170.445 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -86.67 131.21 34.21 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.235 -3.416 . . . . 20.550000000000001 112.183 167.397 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -87.18 162.39 17.52 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.746 1.279 . . . . 11.779999999999999 114.231 172.104 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.9 tp -69.13 -28.42 66.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.419 2.687 . . . . 19.309999999999999 111.599 -174.935 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 53.3 m -59.1 -47.54 84.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.818 -2.515 . . . . 23.140000000000001 114.961 167.39 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.44 49.06 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 105.691 -2.964 . . . . 19.739999999999998 105.691 167.269 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.307 41.7 mttt -138.69 145.33 40.23 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.621 -5.047 . . . . 21.93 104.266 178.592 . . . . . . . . 3 2 . 1 . 121 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -99.85 116.01 30.93 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.494 -2.594 . . . . 12.33 106.394 168.722 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 pt -106.27 133.28 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 105.15 -2.166 . . . . 17.079999999999998 105.15 176.337 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 m -93.78 117.81 30.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 126.869 2.605 . . . . 16.300000000000001 110.082 -177.127 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.274 95.8 mt -119.15 141.76 48.54 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.978 -2.23 . . . . 15.880000000000001 104.978 -177.296 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -104.38 111.48 24.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.318 3.047 . . . . 28.899999999999999 112.955 172.346 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.5 169.15 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 124.719 2.199 . . . . 12.050000000000001 111.805 -178.132 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -92.13 154.88 43.25 Favored Pre-proline 0 N--CA 1.43 -1.446 0 O-C-N 117.283 -3.385 . . . . 18.170000000000002 107.163 167.308 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.01 -3.89 12.98 Favored 'Trans proline' 0 C--N 1.3 -1.99 1 CA-C-N 129.355 4.377 . . . . 8.1600000000000001 111.974 175.019 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -76.2 -22.19 55.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.311 -2.743 . . . . 11.130000000000001 114.325 169.614 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -67.76 151.25 47.52 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.618 2.152 . . . . 18.030000000000001 111.054 173.167 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.4 p -99.43 -170.93 1.98 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.469 2.557 . . . . 10.220000000000001 110.781 -173.86 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.7 mm -86.92 -17.43 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 O-C-N 115.975 -4.203 . . . . 12.300000000000001 108.662 -173.171 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.57 -26.56 55.22 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.613 -4.429 . . . . 36.509999999999998 110.501 174.142 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -73.06 -33.89 65.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.334 -0.947 . . . . 25.66 108.719 176.455 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.353 65.6 t -65.53 -47.43 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 124.622 1.169 . . . . 8.1199999999999992 113.695 178.034 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -55.36 -43.19 74.84 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.675 1.99 . . . . 15.470000000000001 113.869 171.944 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.5 90.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 120.732 3.604 . . . . 11.449999999999999 120.732 168.193 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -70.26 -38.87 75.19 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.589 -1.944 . . . . 24.98 111.701 174.968 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -66.66 -35.5 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 127.277 2.231 . . . . 9.4600000000000009 108.999 177.429 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -64.75 -39.4 93.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.725 -3.109 . . . . 14.76 107.834 174.929 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -72.85 -60.19 2.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.179 2.895 . . . . 26.289999999999999 111.094 -173.866 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -61.8 -49.72 75.21 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 120.677 3.584 . . . . 30.059999999999999 120.677 177.176 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -108.8 -18.29 13.73 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.208 -1.557 . . . . 25.190000000000001 111.9 -174.935 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.89 27.25 29.41 Favored Glycine 0 N--CA 1.429 -1.772 1 O-C-N 114.919 -4.863 . . . . 7.4100000000000001 113.657 170.972 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -91.65 133.56 30.78 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 118.52 -2.753 . . . . 9.4900000000000002 111.439 175.499 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.9 Cg_exo -70.54 153.87 65.05 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 O-C-N 115.784 -2.798 . . . . 11.42 117.741 -179.292 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 12.5 Cg_exo -75.31 -29.0 8.19 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 CA-C-N 122.863 2.058 . . . . 12.0 116.206 -166.477 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.99 -14.72 60.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.178 -2.826 . . . . 35.549999999999997 107.992 -169.733 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -109.55 3.2 20.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.385 -3.322 . . . . 20.52 111.828 -172.15 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -87.59 134.96 33.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.71 3.604 . . . . 7.1299999999999999 105.172 168.607 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -129.55 125.3 35.94 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 101.719 -3.438 . . . . 36.390000000000001 101.719 178.651 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.2 mt -126.1 132.91 51.79 Favored 'General case' 0 N--CA 1.43 -1.427 2 O-C-N 115.597 -4.439 . . . . 9.5500000000000007 99.45 -167.995 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 mm -119.31 134.75 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 109.74 -3.391 . . . . 13.9 111.824 -178.042 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -128.77 124.02 34.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 117.077 -1.44 . . . . 6.8600000000000003 112.244 163.18 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.61 -101.64 0.11 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.319 2.248 . . . . 11.15 106.773 -168.693 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.05 17.46 5.41 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 119.961 -1.712 . . . . 13.93 115.781 170.829 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -103.92 141.19 36.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.138 -1.801 . . . . 23.920000000000002 106.138 -172.906 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -83.18 124.29 30.38 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.605 2.362 . . . . 23.23 114.0 166.684 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.19 111.56 23.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.236 3.05 . . . . 9.1099999999999994 119.236 -174.647 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.83 140.17 58.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 120.519 3.526 . . . . 33.439999999999998 120.519 -178.714 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -49.24 -51.33 33.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.623 3.169 . . . . 28.370000000000001 118.289 -163.83 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.37 18.5 56.83 Favored Glycine 0 N--CA 1.43 -1.706 0 O-C-N 117.844 -3.035 . . . . 15.0 116.024 -178.154 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -97.62 148.02 23.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 122.83 3.315 . . . . 25.5 108.015 -177.196 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -78.56 151.15 32.59 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 115.785 -4.322 . . . . 11.949999999999999 110.32 179.908 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.0 mt -65.62 -30.81 71.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.571 -2.581 . . . . 10.17 112.809 179.38 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -59.42 -44.37 92.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.321 3.448 . . . . 13.59 112.083 170.952 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.72 -40.99 89.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.304 -3.372 . . . . 11.699999999999999 117.378 172.841 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -77.37 -21.24 53.56 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.534 -1.979 . . . . 12.949999999999999 111.505 175.496 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.5 t30 56.71 53.15 8.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.929 3.292 . . . . 25.449999999999999 117.009 -175.043 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.1 mm -64.38 121.8 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 118.671 -2.518 . . . . 14.6 112.266 164.387 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -96.67 167.5 11.08 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.632 2.634 . . . . 33.229999999999997 111.451 179.221 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -72.28 145.52 47.82 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 112.796 -6.19 . . . . 25.969999999999999 120.52 174.787 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 63.17 19.95 11.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.0 2.52 . . . . 32.609999999999999 115.688 -175.287 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.49 143.3 27.28 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.071 -2.786 . . . . 10.56 118.446 170.041 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.2 m -92.05 117.01 29.43 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.402 3.112 . . . . 5.3300000000000001 119.402 -179.756 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.83 143.51 26.27 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.554 1.524 . . . . 11.66 108.126 171.743 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -93.53 134.85 35.38 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.841 -2.412 . . . . 16.300000000000001 109.858 167.785 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 tt -106.24 132.5 52.22 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.399 -2.815 . . . . 9.9600000000000009 103.399 166.357 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -120.34 174.18 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 129.731 3.212 . . . . 9.7599999999999998 106.044 160.351 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.1 mt . . . . . 0 N--CA 1.43 -1.467 1 O-C-N 114.245 -5.284 . . . . 19.57 111.881 -173.265 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 CA--C 1.489 -1.368 0 CA-C-O 121.471 0.653 . . . . 17.170000000000002 110.859 . . . . . . . . . 0 0 . 1 . 122 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -106.1 129.83 54.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.576 -1.647 . . . . 21.890000000000001 115.36 175.319 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -123.46 169.39 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.621 -2.55 . . . . 10.83 105.475 170.784 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.68 140.81 52.62 Favored 'General case' 0 N--CA 1.429 -1.485 1 N-CA-C 99.994 -4.076 . . . . 10.609999999999999 99.994 -169.403 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 t -129.99 126.27 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 105.622 -1.992 . . . . 9.1300000000000008 105.622 175.227 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -102.35 125.82 49.17 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 124.9 1.375 . . . . 20.550000000000001 108.232 177.816 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -89.63 -166.26 1.55 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.521 -2.612 . . . . 11.779999999999999 112.656 -162.079 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.5 tp -73.44 -60.23 2.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.143 2.247 . . . . 19.309999999999999 112.449 -176.919 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 m -48.45 -49.6 34.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 110.218 -3.174 . . . . 23.140000000000001 110.08 174.332 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.36 64.15 0.16 Allowed Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 117.893 -1.504 . . . . 19.739999999999998 113.187 176.842 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -123.23 137.11 54.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.739 -1.578 . . . . 21.93 106.739 176.691 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -100.38 103.88 15.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.969 2.168 . . . . 12.33 111.737 176.394 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.438 16.9 pt -93.1 147.24 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 124.204 1.954 . . . . 17.079999999999998 109.806 -176.314 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 m -101.0 123.03 44.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.134 -2.229 . . . . 16.300000000000001 106.115 175.846 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -116.21 152.71 33.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.632 2.373 . . . . 15.880000000000001 111.582 176.261 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -111.76 114.03 26.76 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.189 -2.278 . . . . 28.899999999999999 108.278 177.145 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.62 173.77 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 113.417 -1.719 . . . . 12.050000000000001 110.521 -178.867 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -123.07 142.16 37.57 Favored Pre-proline 0 N--CA 1.43 -1.431 0 N-CA-C 107.889 -1.152 . . . . 18.170000000000002 107.889 175.481 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -68.84 -9.12 25.35 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 O-C-N 114.434 -3.508 . . . . 8.1600000000000001 116.228 -169.011 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -83.82 -19.86 34.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.649 2.022 . . . . 11.130000000000001 110.362 179.184 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -69.86 144.83 52.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.265 2.226 . . . . 18.030000000000001 112.392 172.871 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 27.1 p -82.75 172.04 13.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.597 -3.189 . . . . 10.220000000000001 115.768 -175.402 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mm -61.17 -41.97 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 117.653 2.464 . . . . 12.300000000000001 117.653 173.657 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -31.57 -61.4 0.22 Allowed 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.586 -3.196 . . . . 36.509999999999998 118.486 152.578 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -50.94 -39.58 55.2 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.698 2.11 . . . . 25.66 116.698 171.287 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 t -68.57 -43.83 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 118.516 -2.615 . . . . 8.1199999999999992 113.471 178.016 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.18 -34.67 76.87 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.479 2.029 . . . . 15.470000000000001 116.479 168.473 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.31 -32.86 63.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.079 -2.263 . . . . 11.449999999999999 110.767 178.017 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.253 66.6 mttt -64.65 -29.52 70.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.841 -2.412 . . . . 24.98 115.644 168.166 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.8 mt -67.97 -36.42 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.647 1.567 . . . . 9.4600000000000009 113.248 170.348 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -61.15 -42.16 98.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.448 -2.032 . . . . 14.76 113.728 169.027 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.63 -53.06 17.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.082 1.896 . . . . 26.289999999999999 107.702 -174.802 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -56.8 -62.8 1.49 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 116.164 -4.085 . . . . 30.059999999999999 114.35 173.573 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -92.33 -41.88 10.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 119.236 3.05 . . . . 25.190000000000001 119.236 -173.669 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.58 46.65 2.1 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 116.536 -2.258 . . . . 7.4100000000000001 112.706 -171.894 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.4 mt -109.99 116.37 53.73 Favored Pre-proline 0 N--CA 1.429 -1.479 0 C-N-CA 130.098 3.359 . . . . 9.4900000000000002 110.892 173.698 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.02 149.29 92.01 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 127.279 3.635 . . . . 11.42 115.223 -178.876 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -76.36 -24.81 10.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 120.336 1.156 . . . . 12.0 114.475 -164.114 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.28 -22.42 52.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.336 1.454 . . . . 35.549999999999997 110.618 -169.562 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.33 3.78 51.03 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 121.771 2.078 . . . . 20.52 108.94 176.184 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -86.38 135.13 33.62 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.949 -2.969 . . . . 7.1299999999999999 111.289 172.755 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.2 ttm105 -127.5 125.43 40.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.622 -1.924 . . . . 36.390000000000001 110.51 153.51 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.88 135.0 33.59 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 124.909 2.29 . . . . 9.5500000000000007 113.678 178.654 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.31 146.92 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 103.424 -2.806 . . . . 13.9 103.424 -178.954 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -122.47 125.91 46.79 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 114.595 -5.065 . . . . 6.8600000000000003 101.499 157.47 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.65 -94.46 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.487 1.613 . . . . 11.15 112.895 -178.186 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.22 22.42 1.4 Allowed Glycine 0 N--CA 1.43 -1.751 0 O-C-N 117.43 -3.294 . . . . 13.93 113.723 166.719 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -87.18 120.75 28.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.615 2.766 . . . . 23.920000000000002 112.123 167.32 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -78.44 129.29 34.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.23 -3.419 . . . . 23.23 113.543 176.98 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.1 mt -108.3 124.86 50.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.62 -2.55 . . . . 9.1099999999999994 105.494 -154.524 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -93.25 138.55 31.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.291 -2.756 . . . . 33.439999999999998 111.971 -175.187 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -43.73 -43.74 6.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.919 3.287 . . . . 28.370000000000001 119.67 -179.099 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.56 18.0 45.29 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.49 -2.631 . . . . 15.0 113.932 -169.855 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -95.38 149.22 21.61 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.288 1.518 . . . . 25.5 110.128 163.519 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 p -71.52 146.49 48.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 111.958 -2.383 . . . . 11.949999999999999 108.093 171.349 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -49.19 -49.35 43.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.947 1.832 . . . . 10.17 115.947 161.332 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 p -49.48 -35.27 19.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 119.014 2.968 . . . . 13.59 119.014 166.29 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.83 -26.73 54.68 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 127.639 3.59 . . . . 11.699999999999999 114.646 -178.452 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -87.51 1.52 53.28 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.699 2.481 . . . . 12.949999999999999 117.699 168.297 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 72.68 31.92 1.58 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.215 2.822 . . . . 25.449999999999999 112.127 172.411 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mm -89.1 118.78 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 121.326 -0.859 . . . . 14.6 109.698 -169.919 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -106.28 172.72 6.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.354 -1.466 . . . . 33.229999999999997 107.155 -179.416 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -70.3 160.86 31.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 118.437 -1.305 . . . . 25.969999999999999 113.563 -175.703 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.253 52.5 mt-10 65.69 9.09 5.67 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.569 2.433 . . . . 32.609999999999999 117.569 -168.622 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.0 m -69.48 135.2 49.85 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 112.445 -2.161 . . . . 10.56 113.179 171.939 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.8 m -110.97 122.03 46.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.768 -3.083 . . . . 5.3300000000000001 106.466 -174.593 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.29 164.92 11.4 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 100.793 -3.78 . . . . 11.66 100.793 -172.508 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -123.45 130.59 52.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.139 -1.886 . . . . 16.300000000000001 109.912 -179.691 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -84.69 134.19 34.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.569 2.062 . . . . 9.9600000000000009 116.569 169.719 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.52 164.66 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.68 -1.887 . . . . 9.7599999999999998 107.668 169.881 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.268 24.1 tp . . . . . 0 N--CA 1.429 -1.476 0 O-C-N 117.981 -2.949 . . . . 19.57 104.806 -172.059 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 117.614 2.45 . . . . 17.170000000000002 117.614 . . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -93.41 123.53 36.77 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 118.167 -0.92 . . . . 21.890000000000001 110.274 -163.945 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 pt -92.48 171.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 127.084 3.326 . . . . 10.83 109.394 165.567 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.556 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 26.1 m-85 -115.13 112.48 22.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.794 2.837 . . . . 10.609999999999999 107.688 169.545 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.5 t -105.71 118.43 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.858 -2.402 . . . . 9.1300000000000008 105.13 172.08 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -97.57 113.12 24.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.843 2.857 . . . . 20.550000000000001 112.826 175.218 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.456 26.7 p -66.45 161.52 22.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 119.65 3.204 . . . . 11.779999999999999 119.65 174.979 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 tp -70.12 -34.06 72.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.26 -3.4 . . . . 19.309999999999999 107.31 -178.267 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -68.63 -61.84 1.65 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.184 0.993 . . . . 23.140000000000001 110.174 170.826 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.71 46.45 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 117.26 -3.4 . . . . 19.739999999999998 114.369 -170.436 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -126.1 135.96 52.34 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.981 -2.482 . . . . 21.93 112.678 162.868 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.4 m -105.85 114.04 27.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.692 -3.755 . . . . 12.33 106.291 -179.678 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -97.78 129.01 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 130.954 3.702 . . . . 17.079999999999998 109.278 -177.844 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -98.22 102.92 14.8 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.426 2.536 . . . . 16.300000000000001 105.409 -178.725 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.88 124.04 45.07 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.212 -2.18 . . . . 15.880000000000001 110.521 -155.216 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.73 113.49 18.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.83 -2.441 . . . . 28.899999999999999 114.922 -176.413 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.57 156.03 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 125.191 2.424 . . . . 12.050000000000001 111.469 178.33 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -91.97 158.32 39.84 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 116.041 -1.933 . . . . 18.170000000000002 108.988 174.704 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -83.32 -22.13 4.11 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 126.379 3.314 . . . . 8.1600000000000001 118.027 -179.331 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 m -86.43 14.25 7.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 125.047 1.467 . . . . 11.130000000000001 114.483 -175.535 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -110.79 151.91 27.24 Favored 'General case' 0 N--CA 1.43 -1.449 1 C-N-CA 133.438 4.695 . . . . 18.030000000000001 111.334 -177.643 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 55.9 p -75.37 157.55 34.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 127.74 3.638 . . . . 10.220000000000001 113.046 -177.648 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.37 -28.24 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 126.03 2.824 . . . . 12.300000000000001 109.832 -179.137 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -69.24 -24.29 63.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.373 -3.954 . . . . 36.509999999999998 108.498 176.455 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -83.08 -38.98 21.76 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.192 2.997 . . . . 25.66 108.631 -179.077 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.8 t -55.84 -47.99 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 123.78 1.752 . . . . 8.1199999999999992 112.711 162.483 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -60.69 -39.04 87.04 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.717 -4.364 . . . . 15.470000000000001 114.997 177.052 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.15 -43.14 66.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.31 3.078 . . . . 11.449999999999999 119.31 164.57 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -65.18 -41.41 94.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.791 -1.818 . . . . 24.98 111.629 177.114 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -60.38 -44.02 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 126.55 1.94 . . . . 9.4600000000000009 113.151 172.482 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -51.12 -37.13 44.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.725 3.21 . . . . 14.76 113.988 167.615 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -83.76 -38.01 21.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.077 -1.639 . . . . 26.289999999999999 108.37 -176.921 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -63.93 -58.9 5.36 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.124 1.898 . . . . 30.059999999999999 116.124 177.4 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -100.14 -69.32 0.77 Allowed 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 124.724 2.202 . . . . 25.190000000000001 110.641 -171.351 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.49 46.07 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.766 0 O-C-N 117.418 -3.302 . . . . 7.4100000000000001 105.593 -175.34 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -106.32 130.9 22.24 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 116.932 -1.509 . . . . 9.4900000000000002 110.298 167.821 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 80.2 Cg_exo -76.21 154.66 37.04 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 119.79 2.958 . . . . 11.42 119.79 177.858 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 62.4 Cg_exo -70.5 -17.82 33.95 Favored 'Trans proline' 0 N--CA 1.434 -1.993 1 C-N-CA 126.142 4.561 . . . . 12.0 112.207 -169.229 . . . . . . . . 3 3 . 1 . 123 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -84.55 -21.01 30.62 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 115.267 -4.646 . . . . 35.549999999999997 114.408 176.451 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.95 -16.06 30.7 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.987 -1.695 . . . . 20.52 111.109 -175.549 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -86.1 153.13 22.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 118.834 -1.146 . . . . 7.1299999999999999 112.842 -174.613 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.458 ' HB3' HG23 ' A' ' 70' ' ' VAL . 21.2 ttm180 -140.98 125.57 17.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 102.362 -3.199 . . . . 36.390000000000001 102.362 169.35 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.3 mt -105.63 125.68 51.27 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.03 1.395 . . . . 9.5500000000000007 109.473 175.014 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mm -106.57 128.2 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 121.16 -0.963 . . . . 13.9 111.03 177.307 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -112.97 115.51 28.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 118.859 -1.136 . . . . 6.8600000000000003 109.476 160.8 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.307 . . 64.31 -101.28 0.09 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.859 2.463 . . . . 11.15 111.613 -170.911 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.63 2.19 23.31 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 130.057 3.694 . . . . 13.93 114.158 172.11 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.258 14.3 tppt? -102.7 132.86 48.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 119.916 1.858 . . . . 23.920000000000002 111.019 -177.97 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -91.6 138.16 31.79 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.902 -1.954 . . . . 23.23 110.88 176.819 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.287 3.3 mt -106.59 114.24 28.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.974 3.273 . . . . 9.1099999999999994 110.255 -166.018 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.37 130.27 35.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.271 -2.768 . . . . 33.439999999999998 114.063 -167.789 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -31.35 -67.35 0.1 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 121.245 3.795 . . . . 28.370000000000001 121.245 -164.336 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.56 21.9 43.15 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 115.177 -3.392 . . . . 15.0 111.334 -168.233 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -91.63 153.98 19.33 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.183 -4.716 . . . . 25.5 112.333 166.832 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 64.9 p -76.01 166.5 23.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.739 -2.476 . . . . 11.949999999999999 116.668 179.248 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 124.977 2.322 . . . . 10.17 116.758 163.526 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -60.94 -24.93 66.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 112.329 -3.701 . . . . 13.59 117.981 177.978 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -71.82 -38.55 70.16 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.497 2.408 . . . . 11.699999999999999 115.356 167.448 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -77.78 -2.99 39.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.673 -2.517 . . . . 12.949999999999999 114.709 170.645 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 2.6 m-80 52.62 49.05 21.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.58 3.086 . . . . 25.449999999999999 115.644 177.093 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.66 112.7 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 109.645 -3.434 . . . . 14.6 110.124 176.629 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -96.49 166.57 11.62 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.559 -2.588 . . . . 33.229999999999997 107.215 179.566 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -52.55 146.86 9.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.08 2.552 . . . . 25.969999999999999 114.704 171.507 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 57.81 38.69 27.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.856 3.693 . . . . 32.609999999999999 115.534 -178.516 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.254 72.5 m -102.35 131.21 49.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.833 -3.042 . . . . 10.56 110.206 -173.544 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 96.3 m -102.9 101.0 11.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.766 1.746 . . . . 5.3300000000000001 108.787 -164.309 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 mt -81.75 134.34 35.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.913 -3.617 . . . . 11.66 113.353 172.47 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -89.28 101.19 13.86 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 113.424 -3.179 . . . . 16.300000000000001 105.406 -179.521 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -71.2 114.76 9.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 124.458 3.299 . . . . 9.9600000000000009 114.489 169.602 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 42' ' ' ARG . 15.7 m -121.95 -174.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.35 2.976 . . . . 9.7599999999999998 107.622 -176.024 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 tp . . . . . 0 N--CA 1.431 -1.424 1 O-C-N 113.467 -5.771 . . . . 19.57 115.779 176.808 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.341 9.5 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 113.954 -2.927 . . . . 17.170000000000002 117.243 . . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -74.93 124.97 27.89 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 131.799 4.039 . . . . 21.890000000000001 113.684 165.054 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.4 pt -120.16 162.08 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 103.36 -2.83 . . . . 10.83 103.36 159.675 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -114.93 135.44 54.21 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.024 -1.843 . . . . 10.609999999999999 106.024 -179.371 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.39 106.34 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 1 O-C-N 113.024 -6.047 . . . . 9.1300000000000008 111.369 179.7 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -84.51 138.64 32.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.517 2.579 . . . . 20.550000000000001 112.947 179.957 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -106.9 174.79 5.73 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.31 -2.118 . . . . 11.779999999999999 106.872 -178.16 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -74.69 -50.11 18.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.202 2.201 . . . . 19.309999999999999 108.225 -169.396 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 p -71.43 -73.36 0.18 Allowed 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.131 1.9 . . . . 23.140000000000001 116.131 176.591 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.37 68.98 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.699 1 O-C-N 112.348 -6.47 . . . . 19.739999999999998 115.729 168.528 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -132.83 146.05 51.49 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.578 -1.542 . . . . 21.93 109.109 163.398 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.2 m -119.48 129.22 54.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.283 -1.767 . . . . 12.33 107.975 166.428 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.07 127.88 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 113.118 -1.855 . . . . 17.079999999999998 107.253 -177.209 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -86.39 128.87 34.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.22 -2.881 . . . . 16.300000000000001 103.22 169.007 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 tp -128.2 139.2 52.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.06 -1.427 . . . . 15.880000000000001 111.687 173.258 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -86.81 118.45 26.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.541 -1.35 . . . . 28.899999999999999 113.945 171.574 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -129.05 157.01 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.027 1.862 . . . . 12.050000000000001 116.027 173.266 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -103.78 140.05 20.69 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 125.572 1.549 . . . . 18.170000000000002 108.011 171.439 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -70.18 -18.13 35.23 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 122.356 1.877 . . . . 8.1600000000000001 111.884 -170.407 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.39 -8.81 58.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.771 2.429 . . . . 11.130000000000001 116.031 178.361 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.26 164.41 25.75 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.985 -4.197 . . . . 18.030000000000001 111.625 171.558 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 59.1 p -79.88 170.65 16.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.623 -2.548 . . . . 10.220000000000001 115.654 156.431 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -73.95 -26.19 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.707 2.003 . . . . 12.300000000000001 111.37 175.234 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -57.91 -39.2 77.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 116.598 -3.814 . . . . 36.509999999999998 114.237 166.68 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -76.35 -31.06 57.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.846 -3.659 . . . . 25.66 112.042 -175.334 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.72 -42.07 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.245 1.818 . . . . 8.1199999999999992 112.06 172.274 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -69.16 -23.8 63.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 119.708 3.225 . . . . 15.470000000000001 119.708 172.472 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.43 -23.45 67.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.77 2.428 . . . . 11.449999999999999 116.916 159.412 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -94.57 -19.21 20.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.444 1.592 . . . . 24.98 111.274 175.431 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.72 -34.97 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-O 116.314 -1.803 . . . . 9.4600000000000009 106.451 175.868 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -67.63 -29.09 68.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.625 1.679 . . . . 14.76 111.943 174.957 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.81 -47.71 51.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.729 -2.482 . . . . 26.289999999999999 115.79 172.928 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -78.81 -47.82 15.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.332 1.975 . . . . 30.059999999999999 116.332 -177.257 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -105.2 -17.28 14.52 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.996 -2.94 . . . . 25.190000000000001 116.612 -178.88 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.17 61.4 5.19 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 127.077 2.275 . . . . 7.4100000000000001 112.052 172.978 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -121.93 142.14 35.66 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 100.274 -3.972 . . . . 9.4900000000000002 100.274 170.834 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -65.49 157.71 56.81 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 124.834 2.762 . . . . 11.42 110.531 -177.389 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -64.41 -27.05 62.79 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 123.867 3.044 . . . . 12.0 114.697 -178.982 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.5 -31.7 65.57 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 115.953 -4.217 . . . . 35.549999999999997 108.748 -176.154 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -81.71 -23.17 36.93 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.113 -2.867 . . . . 20.52 113.74 -179.815 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -71.0 120.29 16.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.413 2.285 . . . . 7.1299999999999999 113.272 171.224 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -121.71 126.37 48.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 118.062 -0.97 . . . . 36.390000000000001 108.592 159.555 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.27 136.75 43.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.759 2.695 . . . . 9.5500000000000007 108.536 -179.077 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.7 mm -120.31 146.78 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.649 -2.532 . . . . 13.9 105.779 -178.064 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -127.02 127.26 44.5 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 100.427 -3.916 . . . . 6.8600000000000003 100.427 164.604 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.526 . . 59.34 -88.64 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 120.789 3.625 . . . . 11.15 120.789 -172.884 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.13 19.39 1.56 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 123.659 0.599 . . . . 13.93 112.029 153.025 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -77.38 132.99 38.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.732 0.777 . . . . 23.920000000000002 112.017 160.751 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -79.01 124.1 27.93 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.87 -3.644 . . . . 23.23 113.597 173.728 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.432 HD22 ' CD2' ' A' ' 59' ' ' TYR . 48.4 mt -99.48 120.82 40.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.091 -2.255 . . . . 9.1099999999999994 107.987 -178.91 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -102.79 153.12 20.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.426 2.953 . . . . 33.439999999999998 110.42 -178.146 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.09 -51.59 30.75 Favored 'General case' 0 N--CA 1.43 -1.441 1 N-CA-C 122.677 4.325 . . . . 28.370000000000001 122.677 -166.545 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.44 -5.07 85.46 Favored Glycine 0 N--CA 1.43 -1.753 0 O-C-N 124.955 1.41 . . . . 15.0 114.945 -176.624 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -78.53 150.11 32.93 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.427 1.108 . . . . 25.5 110.214 168.102 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.5 p -88.31 179.06 6.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.176 -1.829 . . . . 11.949999999999999 113.029 169.044 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 56' ' ' LEU . 94.6 mt -76.34 -45.03 33.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.944 -1.502 . . . . 10.17 106.944 -174.544 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 p -50.57 -41.63 54.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.938 2.895 . . . . 13.59 114.408 176.147 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.6 -38.35 90.77 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.198 1.799 . . . . 11.699999999999999 111.125 -174.277 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CD2' HD22 ' A' ' 50' ' ' LEU . 76.2 m-85 -96.15 17.0 16.57 Favored 'General case' 0 N--CA 1.43 -1.468 2 O-C-N 115.145 -4.722 . . . . 12.949999999999999 111.788 169.718 . . . . . . . . 3 3 . 1 . 124 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 47.36 55.32 8.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 127.693 3.616 . . . . 25.449999999999999 118.756 -172.558 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.4 mm -82.42 119.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 111.117 -2.765 . . . . 14.6 113.843 171.57 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -97.84 170.36 9.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.573 2.421 . . . . 33.229999999999997 110.191 -176.039 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -76.39 155.65 33.88 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 115.647 -2.12 . . . . 25.969999999999999 108.062 -179.482 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.354 46.7 mt-10 58.2 39.35 25.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.685 1.994 . . . . 32.609999999999999 116.089 177.94 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -124.14 136.36 54.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.921 -1.881 . . . . 10.56 105.921 -173.458 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.9 m -85.1 121.42 27.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.924 -1.988 . . . . 5.3300000000000001 109.692 -171.834 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.62 158.65 15.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.402 2.681 . . . . 11.66 108.88 174.118 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -111.88 113.26 25.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.063 1.301 . . . . 16.300000000000001 110.185 -179.55 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.9 tp -81.34 119.16 23.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.547 -1.216 . . . . 9.9600000000000009 111.063 173.355 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.77 166.73 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 118.75 -1.18 . . . . 9.7599999999999998 110.971 173.304 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 tp . . . . . 0 N--CA 1.43 -1.453 0 O-C-N 118.609 -2.557 . . . . 19.57 110.781 176.527 . . . . . . . . 0 0 . 1 . 125 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 CA--C 1.489 -1.366 0 N-CA-C 108.08 -1.081 . . . . 17.170000000000002 108.08 . . . . . . . . . 0 0 . 1 . 125 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -88.67 145.47 25.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.887 -2.383 . . . . 21.890000000000001 110.656 178.558 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.0 pt -133.17 164.69 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 104.785 -2.302 . . . . 10.83 104.785 166.677 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -121.44 142.6 49.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 128.372 3.545 . . . . 10.609999999999999 108.344 -175.195 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -118.31 116.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 111.652 -2.522 . . . . 9.1300000000000008 107.843 177.16 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -101.89 138.51 38.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.218 -2.176 . . . . 20.550000000000001 111.126 179.819 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.9 p -98.81 170.35 8.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.688 -2.051 . . . . 11.779999999999999 108.421 -172.487 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.3 tp -49.59 -60.63 2.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.738 2.496 . . . . 19.309999999999999 117.738 177.688 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.275 17.7 p -74.26 -32.81 63.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 111.587 -2.552 . . . . 23.140000000000001 112.144 -178.781 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.17 69.85 0.26 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 118.694 -2.504 . . . . 19.739999999999998 114.256 159.919 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -107.92 143.5 36.47 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.795 -0.826 . . . . 21.93 112.982 164.511 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -94.0 98.53 11.08 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.038 1.866 . . . . 12.33 116.038 167.874 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.5 mt -86.06 92.59 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 116.164 -4.085 . . . . 17.079999999999998 106.577 176.873 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 m -61.57 127.46 31.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 117.089 -1.434 . . . . 16.300000000000001 113.185 164.902 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.403 HD13 HG13 ' A' ' 26' ' ' VAL . 30.8 mt -110.34 150.3 28.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.953 2.901 . . . . 15.880000000000001 115.669 163.756 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -104.83 125.19 50.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.6 -3.188 . . . . 28.899999999999999 103.824 170.485 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -139.53 156.18 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.57 -2.581 . . . . 12.050000000000001 116.489 -171.195 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -105.43 149.3 37.63 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 117.973 -2.954 . . . . 18.170000000000002 111.242 168.054 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.68 -25.53 75.75 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 123.947 3.098 . . . . 8.1600000000000001 113.882 172.776 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 p -81.58 -5.76 58.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.844 1.258 . . . . 11.130000000000001 111.777 -175.537 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -74.66 145.93 42.79 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 118.334 2.716 . . . . 18.030000000000001 118.334 179.674 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -88.66 154.4 20.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.917 -2.364 . . . . 10.220000000000001 108.901 177.451 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 mm -63.29 -27.81 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.843 2.735 . . . . 12.300000000000001 112.786 179.511 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -54.06 -54.42 39.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.313 -3.992 . . . . 36.509999999999998 112.048 168.075 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.63 -41.34 98.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.583 1.698 . . . . 25.66 115.583 174.562 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 HD13 ' A' ' 15' ' ' LEU . 72.8 t -61.42 -46.14 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 119.597 -1.939 . . . . 8.1199999999999992 111.937 176.045 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -67.68 -20.67 65.32 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.254 -3.404 . . . . 15.470000000000001 114.47 177.986 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.4 -27.85 66.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.579 1.325 . . . . 11.449999999999999 114.579 174.361 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -83.75 -29.05 27.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.503 1.127 . . . . 24.98 110.906 175.658 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.95 -29.87 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 120.746 1.612 . . . . 9.4600000000000009 111.511 165.897 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -76.81 -45.19 29.65 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.47 1.655 . . . . 14.76 115.47 176.649 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.378 20.7 t70 -41.5 -54.97 2.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.521 2.328 . . . . 26.289999999999999 112.171 163.058 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -79.32 -61.88 1.87 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 121.377 3.843 . . . . 30.059999999999999 121.377 -177.145 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.63 -36.48 16.24 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 115.525 -4.485 . . . . 25.190000000000001 105.994 -171.226 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.22 81.15 0.46 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 118.932 -2.355 . . . . 7.4100000000000001 112.743 -171.112 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.3 mt -135.34 131.01 19.36 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 100.686 -3.82 . . . . 9.4900000000000002 100.686 170.58 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -69.29 149.43 69.91 Favored 'Trans proline' 0 N--CA 1.434 -2.022 1 CA-C-N 128.604 4.108 . . . . 11.42 115.213 -178.543 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -93.88 4.45 2.92 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 C-N-CA 115.992 -2.205 . . . . 12.0 112.651 -154.102 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.44 -38.97 21.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.523 3.129 . . . . 35.549999999999997 105.827 176.236 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -67.67 -37.72 82.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.064 2.946 . . . . 20.52 109.52 174.003 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.36 69.0 mt-30 -83.93 132.55 34.76 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 128.059 3.79 . . . . 7.1299999999999999 110.189 -176.163 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.416 ' HB3' HG23 ' A' ' 70' ' ' VAL . 45.0 ttt180 -127.31 133.77 50.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 110.786 -2.915 . . . . 36.390000000000001 108.997 175.229 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.3 mt -103.92 139.41 39.12 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-O 131.272 5.32 . . . . 9.5500000000000007 108.507 178.512 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.62 HD12 ' HG2' ' A' ' 49' ' ' GLN . 10.7 mm -123.06 137.22 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 1 O-C-N 115.974 -4.204 . . . . 13.9 111.762 172.449 . . . . . . . . 3 3 . 1 . 125 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -127.01 124.92 40.52 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.933 -4.229 . . . . 6.8600000000000003 102.629 165.363 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.9 -98.5 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 134.392 5.077 . . . . 11.15 117.717 -173.62 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.04 -18.61 36.37 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 124.71 1.148 . . . . 13.93 114.238 -174.564 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -128.96 133.03 47.67 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.991 2.219 . . . . 23.920000000000002 116.991 -166.761 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.62 ' HG2' HD12 ' A' ' 44' ' ' ILE . 33.1 mt-30 -83.04 134.33 35.04 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.08 -1.822 . . . . 23.23 106.08 -170.585 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.0 mt -92.39 132.21 36.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.24 -1.345 . . . . 9.1099999999999994 111.262 -166.417 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.37 164.76 11.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.872 -3.017 . . . . 33.439999999999998 108.163 -176.558 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.75 -57.2 12.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.703 -2.044 . . . . 28.370000000000001 115.339 -161.742 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.82 18.94 36.27 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 117.273 -1.849 . . . . 15.0 115.324 -174.711 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.4 mtt-85 -104.5 150.76 24.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.698 1.749 . . . . 25.5 108.615 -178.478 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 p -91.56 153.43 19.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.682 -2.511 . . . . 11.949999999999999 110.583 -164.432 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.1 mt -53.68 -35.68 61.35 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.257 2.623 . . . . 10.17 112.797 167.991 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.0 p -70.72 -37.99 73.57 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.662 1.696 . . . . 13.59 115.274 178.652 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -78.93 -29.68 44.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.23 -2.169 . . . . 11.699999999999999 109.502 173.45 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -77.79 -2.45 36.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 123.816 3.007 . . . . 12.949999999999999 116.882 166.133 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 61.38 34.74 18.18 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 126.039 2.828 . . . . 25.449999999999999 114.753 177.884 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.93 116.28 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 113.507 -1.679 . . . . 14.6 114.986 174.543 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -98.29 174.61 6.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.318 -2.845 . . . . 33.229999999999997 103.318 -175.234 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -65.5 147.23 53.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.49 1.293 . . . . 25.969999999999999 114.49 173.387 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 8.5 mt-10 55.3 25.74 7.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.803 -2.436 . . . . 32.609999999999999 113.252 179.73 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -93.96 151.55 19.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.174 -2.346 . . . . 10.56 110.859 169.908 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.5 m -114.09 125.44 53.97 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.138 2.149 . . . . 5.3300000000000001 108.731 -169.72 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -92.11 151.26 20.5 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 116.895 -3.628 . . . . 11.66 112.983 165.705 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -91.51 135.28 33.97 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.152 -2.536 . . . . 16.300000000000001 104.152 172.158 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.5 tp -84.86 125.95 33.06 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.638 -1.914 . . . . 9.9600000000000009 113.846 154.909 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 42' ' ' ARG . 24.9 m -114.17 165.58 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 127.597 2.359 . . . . 9.7599999999999998 112.036 168.476 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.0 tp . . . . . 0 N--CA 1.43 -1.454 0 O-C-N 118.904 -2.372 . . . . 19.57 114.319 170.943 . . . . . . . . 0 0 . 1 . 126 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 CA--C 1.49 -1.35 0 N-CA-C 117.855 2.539 . . . . 17.170000000000002 117.855 . . . . . . . . . 0 0 . 1 . 126 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -82.05 131.68 35.25 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.059 -1.924 . . . . 21.890000000000001 108.536 177.017 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -117.13 176.0 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 123.435 2.834 . . . . 10.83 107.719 160.071 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -135.89 109.79 8.18 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.862 -3.024 . . . . 10.609999999999999 111.654 179.659 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.73 128.95 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 120.171 1.351 . . . . 9.1300000000000008 111.271 -177.629 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -90.68 134.46 34.39 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.296 -1.503 . . . . 20.550000000000001 113.0 173.657 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.7 p -88.09 172.08 9.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.273 3.029 . . . . 11.779999999999999 113.09 -178.281 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.73 -36.96 79.07 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.204 -4.06 . . . . 19.309999999999999 116.772 177.14 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -70.81 -58.5 3.56 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 114.992 -4.817 . . . . 23.140000000000001 109.673 172.548 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.96 46.76 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 123.973 1.874 . . . . 19.739999999999998 112.241 -176.668 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -96.46 160.09 14.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 105.137 -2.171 . . . . 21.93 105.137 162.309 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.8 m -117.94 121.93 41.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.033 -1.667 . . . . 12.33 110.032 157.003 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.423 HD13 ' HG3' ' A' ' 34' ' ' GLU . 21.1 mt -105.79 120.07 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.021 -1.844 . . . . 17.079999999999998 106.021 -168.371 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m -84.44 94.72 8.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.534 -1.212 . . . . 16.300000000000001 109.189 -179.145 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 15' ' ' LEU . 96.9 mt -95.43 132.66 40.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 115.161 -2.352 . . . . 15.880000000000001 108.485 -175.941 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.273 26.0 tt0 -89.5 102.67 15.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.291 2.314 . . . . 28.899999999999999 114.295 173.692 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.411 HG21 HD13 ' A' ' 56' ' ' LEU . 4.1 m -115.5 155.19 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.493 1.951 . . . . 12.050000000000001 111.399 -166.999 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.18 152.8 39.83 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 115.72 -2.086 . . . . 18.170000000000002 107.671 170.511 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -85.88 -10.08 7.31 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 129.123 4.294 . . . . 8.1600000000000001 110.14 -164.513 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 p -85.77 -1.75 57.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 118.827 -1.149 . . . . 11.130000000000001 112.776 174.616 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -69.6 151.01 46.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.759 -3.713 . . . . 18.030000000000001 114.713 -178.878 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 10.2 p -77.26 161.76 27.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.044 -1.836 . . . . 10.220000000000001 106.044 177.356 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mm -57.94 -41.32 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 117.071 -3.518 . . . . 12.300000000000001 110.946 165.513 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.281 22.6 tt0 -42.42 -44.12 3.87 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.709 2.404 . . . . 36.509999999999998 115.215 164.254 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -65.86 -48.4 71.7 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.708 -3.12 . . . . 25.66 114.223 170.68 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.1 t -49.98 -38.77 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.291 -1.506 . . . . 8.1199999999999992 112.769 177.928 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -76.16 -21.63 56.32 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.417 2.006 . . . . 15.470000000000001 116.417 179.522 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.02 -23.82 62.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.921 2.888 . . . . 11.449999999999999 113.708 178.357 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -81.99 -33.32 30.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 126.644 3.116 . . . . 24.98 113.763 171.778 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.4 mt -68.72 -43.86 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.612 -1.93 . . . . 9.4600000000000009 112.529 165.083 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -45.23 -47.48 12.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.275 2.324 . . . . 14.76 117.275 165.188 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -75.85 -54.43 6.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.485 2.714 . . . . 26.289999999999999 114.775 -173.012 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -81.12 -70.43 0.53 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.185 1.394 . . . . 30.059999999999999 110.951 -169.57 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HG3' HD13 ' A' ' 13' ' ' ILE . 75.3 mm-40 -58.83 -43.35 90.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.002 2.223 . . . . 25.190000000000001 117.002 175.085 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.25 13.05 50.18 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 126.38 3.211 . . . . 7.4100000000000001 120.145 -168.001 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 56.7 mt -76.72 125.29 87.39 Favored Pre-proline 0 N--CA 1.43 -1.439 1 O-C-N 116.381 -4.011 . . . . 9.4900000000000002 114.019 174.443 . . . . . . . . 3 3 . 1 . 126 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 40.4 Cg_exo -78.06 158.82 30.53 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-O 113.999 -2.584 . . . . 11.42 113.545 -164.477 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -71.12 -23.85 24.29 Favored 'Trans proline' 0 C--N 1.3 -2.026 1 CA-C-N 128.988 4.246 . . . . 12.0 111.149 -170.519 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.46 0.27 30.18 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.509 3.152 . . . . 35.549999999999997 119.509 174.805 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.306 60.2 mt-30 -84.24 -25.42 29.43 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.141 -5.35 . . . . 20.52 108.346 169.687 . . . . . . . . 3 2 . 1 . 126 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -92.83 129.44 38.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.684 2.105 . . . . 7.1299999999999999 116.684 -152.205 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -142.03 120.82 12.68 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 115.689 -2.101 . . . . 36.390000000000001 108.803 168.953 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -104.43 138.55 40.66 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 122.593 2.451 . . . . 9.5500000000000007 110.988 -177.629 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mm -116.14 136.22 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 125.969 1.707 . . . . 13.9 110.75 -177.317 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -108.94 102.9 11.87 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 114.738 -4.976 . . . . 6.8600000000000003 106.453 161.663 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.2 -77.62 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.784 3.253 . . . . 11.15 119.784 -168.614 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.62 20.87 2.02 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.108 -1.597 . . . . 13.93 109.108 175.906 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -117.19 129.91 56.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.549 -2.736 . . . . 23.920000000000002 104.184 -179.588 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -76.48 143.59 40.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.069 -1.878 . . . . 23.23 112.575 179.515 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.2 mt -103.57 111.52 24.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 116.982 -1.485 . . . . 9.1099999999999994 107.936 -178.389 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -93.88 150.57 20.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.921 2.013 . . . . 33.439999999999998 111.733 -177.128 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -39.63 -63.4 0.58 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.635 3.084 . . . . 28.370000000000001 115.482 -169.727 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.38 -25.9 64.79 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.815 -1.803 . . . . 15.0 113.702 -159.022 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -83.93 164.35 19.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 114.582 -2.847 . . . . 25.5 112.866 -178.088 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 61.0 p -97.36 169.07 10.01 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.754 1.264 . . . . 11.949999999999999 113.836 -171.431 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 17' ' ' VAL . 48.2 mt -63.51 -41.92 98.49 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.193 1.397 . . . . 10.17 112.305 172.903 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 p -55.35 -43.82 75.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.898 2.136 . . . . 13.59 114.561 165.893 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.38 -35.91 76.29 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.245 -3.409 . . . . 11.699999999999999 111.676 -174.044 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.332 2.3 m-85 -91.55 6.23 46.48 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 127.975 3.297 . . . . 12.949999999999999 111.814 179.974 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.292 8.0 m120 58.87 40.78 22.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.163 2.653 . . . . 25.449999999999999 118.163 175.268 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 mm -75.06 131.59 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 104.928 -2.249 . . . . 14.6 104.928 178.361 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -92.21 175.48 6.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.247 -2.783 . . . . 33.229999999999997 113.452 169.159 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -63.64 124.0 20.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 131.629 3.972 . . . . 25.969999999999999 112.123 169.541 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 68.12 34.54 3.98 Favored 'General case' 0 N--CA 1.43 -1.461 2 O-C-N 112.188 -6.57 . . . . 32.609999999999999 107.317 175.907 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.356 61.7 m -90.86 143.72 26.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.783 2.083 . . . . 10.56 108.727 179.308 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 m -84.73 124.35 31.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.109 -2.869 . . . . 5.3300000000000001 111.754 -176.15 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.76 151.7 29.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.671 -1.893 . . . . 11.66 107.958 179.643 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.296 63.3 m170 -115.49 129.94 56.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.666 2.03 . . . . 16.300000000000001 113.546 170.307 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.6 tp -94.09 122.74 36.92 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.353 1.861 . . . . 9.9600000000000009 113.969 176.467 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 m -114.38 167.03 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 122.955 2.616 . . . . 9.7599999999999998 111.751 -175.666 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.7 tp . . . . . 0 N--CA 1.43 -1.463 0 O-C-N 124.626 1.204 . . . . 19.57 109.517 176.514 . . . . . . . . 0 0 . 1 . 127 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.49 -1.36 0 N-CA-C 114.273 1.212 . . . . 17.170000000000002 114.273 . . . . . . . . . 0 0 . 1 . 127 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -86.5 151.59 23.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.032 -2.211 . . . . 21.890000000000001 105.032 -175.288 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 pt -134.86 171.62 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 115.678 -4.389 . . . . 10.83 106.267 152.355 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -112.82 132.91 55.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.233 1.813 . . . . 10.609999999999999 107.417 -177.553 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.01 102.21 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.202 -2.518 . . . . 9.1300000000000008 104.202 176.429 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -87.02 127.26 35.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 128.355 3.931 . . . . 20.550000000000001 114.462 -178.967 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.9 p -81.04 170.8 15.76 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 116.043 -4.161 . . . . 11.779999999999999 119.149 -178.097 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.5 mt -57.69 -34.85 69.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.107 1.763 . . . . 19.309999999999999 114.199 171.012 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.8 p -69.26 -23.55 63.86 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.465 -3.272 . . . . 23.140000000000001 112.634 172.554 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.63 -5.18 40.27 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 118.036 -2.915 . . . . 19.739999999999998 117.529 -161.167 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -76.3 154.06 35.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 120.232 -0.587 . . . . 21.93 111.969 -177.334 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 m -113.1 126.39 55.42 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.559 -3.213 . . . . 12.33 108.868 175.239 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 mt -114.38 112.73 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 102.091 -3.3 . . . . 17.079999999999998 102.091 176.355 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.6 m -95.85 107.24 19.47 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 116.782 -3.699 . . . . 16.300000000000001 110.497 -174.706 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.3 mt -112.41 151.36 29.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.022 2.344 . . . . 15.880000000000001 115.751 -173.539 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.7 104.81 14.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.592 -1.317 . . . . 28.899999999999999 109.611 -177.511 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.28 172.22 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 112.862 0.69 . . . . 12.050000000000001 112.862 171.145 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -106.06 174.45 2.6 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 107.833 -1.173 . . . . 18.170000000000002 107.833 166.577 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -72.8 -17.73 25.44 Favored 'Trans proline' 0 C--N 1.299 -2.048 0 CA-C-O 116.527 -1.53 . . . . 8.1600000000000001 110.515 175.156 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 m -90.69 9.24 30.63 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 120.877 1.671 . . . . 11.130000000000001 112.161 -174.405 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -94.28 154.33 17.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.401 2.048 . . . . 18.030000000000001 107.821 -179.103 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -92.59 164.26 13.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 114.695 1.369 . . . . 10.220000000000001 114.695 -177.314 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.276 22.1 mm -56.07 -41.05 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 127.842 2.457 . . . . 12.300000000000001 112.487 175.296 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.08 -39.94 69.82 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.427 2.291 . . . . 36.509999999999998 115.172 173.285 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -57.46 -38.44 74.5 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 130.962 3.705 . . . . 25.66 115.516 165.622 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.76 -45.46 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 123.998 3.09 . . . . 8.1199999999999992 108.317 -175.146 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.329 17.9 mtmt -55.7 -36.26 66.98 Favored 'General case' 0 N--CA 1.43 -1.456 1 C-N-CA 132.498 4.319 . . . . 15.470000000000001 116.619 171.338 . . . . . . . . 3 2 . 1 . 127 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.35 -38.22 83.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.158 3.021 . . . . 11.449999999999999 119.158 167.693 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -76.24 -24.61 54.58 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 115.082 1.512 . . . . 24.98 115.082 176.162 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -79.24 -33.45 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 119.043 -2.286 . . . . 9.4600000000000009 111.184 178.57 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -62.07 -39.91 94.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.297 -1.32 . . . . 14.76 108.562 168.706 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.7 -40.63 79.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.582 2.438 . . . . 26.289999999999999 117.582 -176.696 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -82.31 -59.3 2.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 114.816 -2.516 . . . . 30.059999999999999 109.129 176.299 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -87.94 -46.28 9.52 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.333 2.271 . . . . 25.190000000000001 109.505 -160.495 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.72 45.12 4.99 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 107.815 -2.114 . . . . 7.4100000000000001 107.815 175.823 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.259 68.3 mt -98.86 121.22 56.68 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 103.993 -2.595 . . . . 9.4900000000000002 103.993 173.172 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.327 1.1 Cg_exo -71.79 166.21 30.2 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 127.599 3.75 . . . . 11.42 118.491 -171.007 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.48 -6.09 4.49 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 CA-C-N 124.47 2.632 . . . . 12.0 112.667 -157.398 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -82.71 -29.53 29.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.28 1.613 . . . . 35.549999999999997 108.445 172.099 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -80.75 -26.44 37.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.095 1.358 . . . . 20.52 112.744 -175.177 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -83.61 128.93 34.9 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.055 -0.975 . . . . 7.1299999999999999 112.263 175.906 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -126.1 131.2 52.15 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.971 -1.122 . . . . 36.390000000000001 107.971 167.663 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.62 137.9 34.04 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.424 3.49 . . . . 9.5500000000000007 105.742 176.978 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mt -134.2 136.37 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.102 2.561 . . . . 13.9 110.818 179.698 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -120.86 95.09 4.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.323 -1.732 . . . . 6.8600000000000003 106.323 -174.393 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.64 -82.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.739 2.415 . . . . 11.15 111.994 -163.223 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.39 -1.49 6.11 Favored Glycine 0 N--CA 1.429 -1.794 0 O-C-N 116.959 -3.588 . . . . 13.93 112.5 171.172 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -83.74 113.25 20.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.708 -2.642 . . . . 23.920000000000002 113.488 176.51 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -70.38 142.03 52.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.387 -3.321 . . . . 23.23 109.974 171.794 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -107.55 110.66 22.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.963 -1.495 . . . . 9.1099999999999994 106.963 -166.323 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -87.77 153.74 21.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.129 -2.857 . . . . 33.439999999999998 114.479 -175.906 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.366 1.7 m-20 -48.73 -58.92 4.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.781 2.511 . . . . 28.370000000000001 117.781 -160.621 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.96 51.86 0.7 Allowed Glycine 0 N--CA 1.43 -1.756 0 CA-C-O 127.514 3.841 . . . . 15.0 114.73 -171.515 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -128.18 158.78 37.13 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.66 -4.435 . . . . 25.5 109.63 174.459 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.7 p -88.16 159.47 18.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.483 2.087 . . . . 11.949999999999999 106.869 -171.184 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.63 -30.33 69.79 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 116.064 -4.147 . . . . 10.17 113.354 169.167 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.2 p -64.91 -20.1 66.27 Favored 'General case' 0 N--CA 1.43 -1.47 1 C-N-CA 135.493 5.517 . . . . 13.59 116.294 176.237 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -82.73 -39.04 22.45 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.466 1.907 . . . . 11.699999999999999 112.536 172.31 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -79.69 -19.7 48.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.414 -2.679 . . . . 12.949999999999999 117.849 163.079 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.496 32.3 m120 75.26 57.28 0.06 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.745 2.212 . . . . 25.449999999999999 113.782 174.187 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mm -85.64 126.79 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 129.048 2.939 . . . . 14.6 106.727 -178.7 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -104.18 167.89 9.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.532 -1.655 . . . . 33.229999999999997 106.532 172.981 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -60.5 148.64 37.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.658 2.783 . . . . 25.969999999999999 110.816 -175.494 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 60.25 28.48 18.08 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 116.041 1.867 . . . . 32.609999999999999 116.041 176.879 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 m -77.09 150.28 35.67 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.18 -1.045 . . . . 10.56 108.18 174.191 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.6 m -98.62 104.16 16.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.799 -2.297 . . . . 5.3300000000000001 104.799 168.143 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -85.88 133.77 33.94 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.178 -2.283 . . . . 11.66 105.043 168.746 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.262 47.5 p-80 -106.13 145.34 31.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.796 2.713 . . . . 16.300000000000001 112.917 176.826 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -104.36 127.47 52.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.687 -2.508 . . . . 9.9600000000000009 109.8 -171.063 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.75 164.27 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 124.018 3.099 . . . . 9.7599999999999998 109.52 177.6 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 71' ' ' LEU . 46.9 tp . . . . . 0 N--CA 1.429 -1.485 0 CA-C-N 113.205 -1.816 . . . . 19.57 108.319 -171.294 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.489 -1.37 0 N-CA-C 106.501 -1.666 . . . . 17.170000000000002 106.501 . . . . . . . . . 0 0 . 1 . 128 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -114.04 121.16 43.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.401 3.08 . . . . 21.890000000000001 104.636 -175.644 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -120.23 162.6 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 126.891 2.619 . . . . 10.83 106.023 165.048 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -124.94 130.06 51.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.006 -2.961 . . . . 10.609999999999999 103.006 -169.608 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.2 111.8 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 116.423 -2.111 . . . . 9.1300000000000008 108.435 172.798 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -78.41 124.32 27.99 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 124.598 3.363 . . . . 20.550000000000001 112.077 174.646 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -69.31 164.28 23.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.397 -2.69 . . . . 11.779999999999999 117.768 169.503 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.33 -19.37 65.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.373 1.99 . . . . 19.309999999999999 116.373 172.241 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -93.15 -20.68 20.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.823 1.786 . . . . 23.140000000000001 115.823 179.488 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.73 34.38 2.64 Favored Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 116.421 1.329 . . . . 19.739999999999998 116.421 175.374 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -99.62 129.52 45.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.758 1.623 . . . . 21.93 110.187 164.072 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -91.67 119.99 32.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.34 -2.1 . . . . 12.33 105.542 167.915 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.3 7.8 mt -86.11 104.89 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 126.994 2.118 . . . . 17.079999999999998 110.353 172.873 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.0 m -84.7 106.77 16.5 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.991 -1.484 . . . . 16.300000000000001 108.599 177.433 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.6 mt -110.34 139.84 45.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.913 -1.117 . . . . 15.880000000000001 110.01 -178.765 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -96.41 128.62 43.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.254 1.978 . . . . 28.899999999999999 106.464 174.215 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -137.11 155.15 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.378 -2.076 . . . . 12.050000000000001 108.333 -173.232 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -101.61 129.68 26.24 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 113.703 -3.046 . . . . 18.170000000000002 105.851 178.008 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.52 -16.17 46.02 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 CA-C-N 123.834 2.405 . . . . 8.1600000000000001 114.621 -168.825 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.6 p -94.55 -3.53 49.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 123.083 2.674 . . . . 11.130000000000001 110.668 -171.555 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.14 153.3 34.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 127.035 3.302 . . . . 18.030000000000001 115.93 175.883 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.7 p -75.36 162.88 28.01 Favored 'General case' 0 N--CA 1.43 -1.469 1 C-N-CA 131.787 4.035 . . . . 10.220000000000001 110.982 -178.456 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.293 6.3 mm -71.29 -34.74 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 1 O-C-N 115.392 -4.568 . . . . 12.300000000000001 112.546 178.754 . . . . . . . . 3 2 . 1 . 128 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -53.05 -43.27 66.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.241 1.817 . . . . 36.509999999999998 112.643 169.006 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -71.08 -22.66 62.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.898 2.184 . . . . 25.66 116.898 170.995 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.9 t -66.07 -43.76 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 1 CA-C-N 126.873 4.397 . . . . 8.1199999999999992 114.016 166.817 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -59.78 -39.12 83.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.963 2.105 . . . . 15.470000000000001 110.275 179.409 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.52 66.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.407 -3.308 . . . . 11.449999999999999 119.656 177.954 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -74.9 -33.45 62.04 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.834 2.454 . . . . 24.98 110.877 173.672 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 6.8 mt -75.19 -40.71 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.004 -2.935 . . . . 9.4600000000000009 110.289 175.322 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.48 -48.82 56.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.499 -2.625 . . . . 14.76 114.6 160.219 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -66.0 -42.85 89.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.588 1.995 . . . . 26.289999999999999 114.661 176.827 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -72.85 -69.58 0.4 Allowed 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.016 -2.303 . . . . 30.059999999999999 111.959 178.169 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -97.92 -2.01 41.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.523 1.929 . . . . 25.190000000000001 114.518 -164.428 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.51 21.43 79.5 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 118.579 2.191 . . . . 7.4100000000000001 118.579 174.526 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 98.0 mt -98.91 130.12 28.26 Favored Pre-proline 0 N--CA 1.431 -1.421 0 O-C-N 116.794 -3.768 . . . . 9.4900000000000002 102.623 -169.153 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -76.92 154.81 33.91 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 117.928 -1.67 . . . . 11.42 110.021 -172.105 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.344 9.7 Cg_endo -63.96 -30.16 66.94 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 123.463 2.775 . . . . 12.0 115.25 -169.525 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -63.63 -31.84 73.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.558 3.54 . . . . 35.549999999999997 120.558 -179.206 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -70.06 -34.53 73.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.853 -2.404 . . . . 20.52 114.39 166.777 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -64.25 103.79 0.67 Allowed 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.337 -4.602 . . . . 7.1299999999999999 121.327 178.743 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -102.77 125.25 49.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.556 -2.59 . . . . 36.390000000000001 110.897 163.332 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.7 mt -96.61 139.17 33.08 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.649 1.214 . . . . 9.5500000000000007 111.872 170.329 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.9 mt -133.13 122.26 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 129.337 3.055 . . . . 13.9 109.534 173.035 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -93.44 112.58 24.53 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.981 2.912 . . . . 6.8600000000000003 108.696 164.106 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.27 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 127.877 2.471 . . . . 11.15 114.128 -177.51 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 27.86 2.5 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 127.711 2.576 . . . . 13.93 111.757 166.431 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -104.95 137.09 43.24 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.975 2.91 . . . . 23.920000000000002 111.949 172.662 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -99.46 124.14 44.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.535 1.516 . . . . 23.23 112.415 -172.535 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.9 mt -97.59 137.35 36.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.575 -2.578 . . . . 9.1099999999999994 110.666 -171.307 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -118.69 135.17 54.62 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 127.128 3.346 . . . . 33.439999999999998 104.122 -166.193 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -43.53 -37.33 2.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 113.793 -3.003 . . . . 28.370000000000001 118.82 -166.502 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.6 11.66 27.95 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 107.001 -2.439 . . . . 15.0 107.001 -167.935 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -91.0 160.29 15.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.521 -3.929 . . . . 25.5 103.549 168.399 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.2 p -103.88 170.09 8.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.75 -1.843 . . . . 11.949999999999999 108.983 -170.329 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -57.64 -42.23 83.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 124.001 1.857 . . . . 10.17 114.226 168.751 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.3 p -62.89 -18.46 63.01 Favored 'General case' 0 N--CA 1.43 -1.459 1 N-CA-C 122.661 4.319 . . . . 13.59 122.661 173.303 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -77.96 -41.43 36.18 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.289 -4.632 . . . . 11.699999999999999 112.656 -173.667 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -86.08 -10.68 54.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.655 -1.612 . . . . 12.949999999999999 111.802 179.078 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.316 71.9 m-20 71.11 54.88 0.23 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.89 3.276 . . . . 25.449999999999999 113.232 -176.517 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.285 59.6 mt -89.28 108.6 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 127.933 3.27 . . . . 14.6 113.623 -179.352 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -89.34 176.24 7.01 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.515 3.526 . . . . 33.229999999999997 113.396 -166.404 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -69.14 139.32 54.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.474 2.027 . . . . 25.969999999999999 116.474 172.173 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 50.59 68.71 0.73 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.689 1.868 . . . . 32.609999999999999 112.771 -171.793 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -125.24 156.97 37.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.898 2.879 . . . . 10.56 103.536 176.485 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.0 m -126.37 124.81 41.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 124.413 1.071 . . . . 5.3300000000000001 109.292 -178.086 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.04 167.39 10.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.223 3.009 . . . . 11.66 109.332 -179.583 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -135.73 158.81 43.47 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.475 2.559 . . . . 16.300000000000001 112.184 179.056 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -118.04 136.82 53.31 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.162 -4.087 . . . . 9.9600000000000009 103.382 -168.597 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.81 172.95 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.295 -1.743 . . . . 9.7599999999999998 106.295 -175.522 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mt . . . . . 0 N--CA 1.431 -1.416 0 C-N-CA 115.845 -2.342 . . . . 19.57 111.773 176.787 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 124.209 1.957 . . . . 17.170000000000002 109.691 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -98.41 145.96 26.21 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 113.94 -5.475 . . . . 21.890000000000001 115.352 -176.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.9 pt -127.52 -176.49 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.414 -3.18 . . . . 10.83 102.414 172.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -121.61 130.47 53.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.901 -1.954 . . . . 10.609999999999999 116.084 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t -115.75 132.66 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 122.371 2.35 . . . . 9.1300000000000008 107.289 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -117.89 128.32 54.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 106.618 -1.623 . . . . 20.550000000000001 106.618 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.8 p -74.35 179.64 4.46 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.256 1.947 . . . . 11.779999999999999 116.256 170.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.03 -58.46 8.07 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.388 2.518 . . . . 19.309999999999999 117.571 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -62.94 -38.97 93.16 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 126.537 3.065 . . . . 23.140000000000001 114.55 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.27 49.57 0.27 Allowed Glycine 0 N--CA 1.431 -1.699 0 CA-C-N 111.589 -2.55 . . . . 19.739999999999998 115.667 174.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -89.74 129.55 36.13 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.613 -4.463 . . . . 21.93 109.235 160.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.2 m -92.01 126.7 37.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 117.316 -1.754 . . . . 12.33 114.243 169.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 94.8 mt -102.91 103.53 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 C-N-CA 132.39 4.276 . . . . 17.079999999999998 105.505 178.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.9 m -74.66 131.52 40.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.264 -2.773 . . . . 16.300000000000001 106.787 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 tp -143.3 128.62 18.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 115.979 -1.962 . . . . 15.880000000000001 115.735 -166.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -103.4 142.95 33.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.222 1.963 . . . . 28.899999999999999 114.383 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.414 HG11 HG22 ' A' ' 26' ' ' VAL . 6.8 m -157.72 165.37 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.167 1.937 . . . . 12.050000000000001 111.128 -158.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -125.47 124.35 25.07 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.673 -2.584 . . . . 18.170000000000002 111.819 -172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -79.29 -20.85 9.5 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 C-N-CA 124.267 3.311 . . . . 8.1600000000000001 116.677 -154.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 86.1 p -95.66 7.23 46.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.412 1.885 . . . . 11.130000000000001 113.687 171.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -98.94 177.29 5.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 105.129 -2.174 . . . . 18.030000000000001 105.129 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.7 p -104.31 173.23 6.39 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.596 2.141 . . . . 10.220000000000001 111.215 -158.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.38 26.1 mm -65.33 -29.48 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 127.825 3.679 . . . . 12.300000000000001 113.737 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -55.8 -40.66 73.02 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 115.276 -4.64 . . . . 36.509999999999998 114.526 164.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -66.98 -26.8 66.99 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 118.883 -1.127 . . . . 25.66 113.46 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.414 HG22 HG11 ' A' ' 17' ' ' VAL . 4.4 t -71.79 -43.22 69.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 115.145 -2.622 . . . . 8.1199999999999992 110.577 175.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -63.41 -33.62 75.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.534 -2.604 . . . . 15.470000000000001 117.2 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.23 -14.92 58.62 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.798 3.259 . . . . 11.449999999999999 119.798 173.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -84.97 -39.12 18.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.056 -2.278 . . . . 24.98 114.162 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.4 mt -63.3 -40.94 90.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 C-N-CA 130.066 3.347 . . . . 9.4600000000000009 112.666 170.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -68.03 -31.47 71.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 125.343 1.457 . . . . 14.76 114.07 170.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.257 43.2 t0 -71.1 -59.75 2.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.574 -3.204 . . . . 26.289999999999999 108.278 172.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.301 3.6 tppp? -51.08 -67.34 0.26 Allowed 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 121.251 3.797 . . . . 30.059999999999999 121.251 -176.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -89.51 -48.0 7.6 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 114.7 1.37 . . . . 25.190000000000001 114.7 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.52 71.77 1.09 Allowed Glycine 0 N--CA 1.43 -1.755 0 O-C-N 127.381 2.926 . . . . 7.4100000000000001 114.883 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 mt -128.75 132.37 24.32 Favored Pre-proline 0 N--CA 1.431 -1.424 0 N-CA-C 103.676 -2.713 . . . . 9.4900000000000002 103.676 175.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -82.96 158.31 15.62 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 CA-C-N 124.931 2.797 . . . . 11.42 112.9 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -73.85 -20.94 19.21 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 C-N-CA 123.373 2.715 . . . . 12.0 110.86 -153.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -65.64 -41.31 92.76 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.306 2.243 . . . . 35.549999999999997 112.755 167.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.61 -34.53 53.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.68 -1.263 . . . . 20.52 112.406 178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -59.13 124.17 19.06 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 121.123 3.749 . . . . 7.1299999999999999 121.123 165.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.7 ttt180 -127.35 120.2 27.98 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.612 1.195 . . . . 36.390000000000001 109.169 176.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.484 ' O ' HD22 ' A' ' 50' ' ' LEU . 83.3 mt -111.7 120.17 41.11 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.082 -2.261 . . . . 9.5500000000000007 106.68 -173.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.68 112.29 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 129.768 3.227 . . . . 13.9 112.944 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -99.2 120.85 40.19 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.939 2.304 . . . . 6.8600000000000003 106.403 165.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 65.29 -102.08 0.08 Allowed 'General case' 0 N--CA 1.431 -1.422 1 CA-C-O 129.27 4.367 . . . . 11.15 116.146 -177.591 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.34 55.18 0.59 Allowed Glycine 0 N--CA 1.43 -1.752 1 O-C-N 114.782 -4.949 . . . . 13.93 109.047 160.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.254 31.9 ttmt -135.08 139.23 44.57 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.9 1.68 . . . . 23.920000000000002 106.688 163.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -82.51 133.95 35.2 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 121.052 -1.03 . . . . 23.23 110.934 165.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.484 HD22 ' O ' ' A' ' 43' ' ' LEU . 1.2 mm? -77.79 131.01 37.41 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.073 1.879 . . . . 9.1099999999999994 116.073 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -75.68 160.02 30.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.813 2.72 . . . . 33.439999999999998 108.458 -175.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.81 -52.95 20.66 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.665 -4.397 . . . . 28.370000000000001 110.042 -167.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.37 23.65 35.07 Favored Glycine 0 N--CA 1.429 -1.78 0 C-N-CA 129.649 3.5 . . . . 15.0 112.588 -160.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.1 mtt-85 -116.65 160.7 20.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.808 2.122 . . . . 25.5 106.811 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 p -95.0 177.81 5.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.427 2.537 . . . . 11.949999999999999 113.438 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.17 -29.95 48.83 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.718 -3.114 . . . . 10.17 112.647 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.3 m -62.13 -19.56 63.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.347 1.61 . . . . 13.59 115.347 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -77.6 -46.27 22.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.525 -1.657 . . . . 11.699999999999999 106.525 -174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -73.5 -31.47 63.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.389 -1.732 . . . . 12.949999999999999 113.33 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 t30 87.1 53.16 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.486 3.514 . . . . 25.449999999999999 107.52 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.1 mt -101.34 132.3 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 102.412 -3.181 . . . . 14.6 102.412 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -128.27 177.11 7.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.001 2.52 . . . . 33.229999999999997 113.008 -173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -51.31 128.08 21.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.011 2.339 . . . . 25.969999999999999 116.807 172.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 63.72 52.24 2.25 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.361 2.029 . . . . 32.609999999999999 116.277 -177.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 63.7 m -113.45 146.04 40.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.084 2.954 . . . . 10.56 106.031 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.3 m -101.3 118.66 37.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.23 1.967 . . . . 5.3300000000000001 115.769 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.9 145.8 34.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.395 -3.316 . . . . 11.66 105.78 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -109.27 128.47 55.1 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 125.385 2.517 . . . . 16.300000000000001 113.659 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.3 tp -102.6 111.47 23.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.592 2.357 . . . . 9.9600000000000009 106.787 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.5 m -132.22 174.35 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 102.87 -3.011 . . . . 9.7599999999999998 102.87 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.4 mt -105.46 171.87 7.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.225 1.488 . . . . 19.57 113.687 -169.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -119.51 111.07 17.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.284 3.421 . . . . 35.079999999999998 107.403 167.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.8 mt -99.15 -139.5 0.31 Allowed 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 112.782 -6.199 . . . . 32.310000000000002 107.186 165.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.42 -69.81 0.68 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.463 -2.648 . . . . 42.75 110.393 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.73 174.31 54.81 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 120.019 -1.676 . . . . 36.310000000000002 112.642 -177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.772 0 N-CA-C 108.428 -1.869 . . . . 36.270000000000003 108.428 178.374 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.213 -0.662 . . . . 17.170000000000002 109.213 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -113.58 143.33 44.74 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 100.366 -3.938 . . . . 21.890000000000001 100.366 -170.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -119.32 164.91 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.447 -2.033 . . . . 10.83 108.352 170.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.521 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 65.9 m-85 -98.83 122.41 42.04 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.117 -2.92 . . . . 10.609999999999999 103.117 170.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.2 t -106.7 113.53 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.564 -2.585 . . . . 9.1300000000000008 108.36 154.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -84.61 134.58 34.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.842 -2.411 . . . . 20.550000000000001 113.309 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 18.6 p -89.56 179.73 5.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.297 -3.377 . . . . 11.779999999999999 106.377 175.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 tt -71.83 -44.53 63.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 128.171 3.843 . . . . 19.309999999999999 111.91 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.1 p -79.97 -78.52 0.16 Allowed 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 109.382 -3.554 . . . . 23.140000000000001 115.642 -168.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.24 50.1 0.21 Allowed Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 119.575 1.079 . . . . 19.739999999999998 113.377 -173.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 tttt -139.98 137.15 34.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.77 -1.429 . . . . 21.93 111.627 163.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -119.7 103.18 9.16 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.592 2.615 . . . . 12.33 110.535 171.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 83.8 mt -79.59 120.42 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 114.506 -2.664 . . . . 17.079999999999998 107.704 -165.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.7 p -105.12 94.04 5.02 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 123.364 2.802 . . . . 16.300000000000001 108.74 -172.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.2 tp -107.67 116.17 31.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.934 2.493 . . . . 15.880000000000001 109.031 -158.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.406 ' H ' ' HG2' ' A' ' 16' ' ' GLU . 7.1 pt-20 -73.41 119.32 17.48 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.123 1.369 . . . . 28.899999999999999 111.846 173.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.79 178.6 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 113.888 -1.505 . . . . 12.050000000000001 108.802 174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -117.17 158.33 44.67 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 126.524 2.39 . . . . 18.170000000000002 106.394 169.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -70.02 -3.76 12.84 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 N-CA-C 118.666 2.525 . . . . 8.1600000000000001 118.666 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 p -90.84 -0.51 57.74 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.121 4.168 . . . . 11.130000000000001 109.834 175.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.66 147.18 35.64 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.446 1.93 . . . . 18.030000000000001 112.06 -178.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.403 ' HB ' ' H ' ' A' ' 23' ' ' ILE . 41.5 p -92.0 -165.94 1.45 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.809 -2.432 . . . . 10.220000000000001 111.804 177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.403 ' H ' ' HB ' ' A' ' 22' ' ' THR . 37.3 mm -85.76 -39.24 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.278 2.631 . . . . 12.300000000000001 105.611 175.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -58.4 -33.24 69.42 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.265 -3.397 . . . . 36.509999999999998 116.65 167.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -63.02 -56.65 15.19 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 122.925 1.345 . . . . 25.66 110.8 176.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.3 t -53.17 -47.19 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 120.199 -1.563 . . . . 8.1199999999999992 113.7 178.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -54.53 -39.21 67.44 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.783 -3.073 . . . . 15.470000000000001 114.761 171.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.14 -32.92 71.13 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.241 -3.412 . . . . 11.449999999999999 114.73 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -81.14 -23.6 38.2 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 122.396 1.093 . . . . 24.98 109.45 -177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -74.36 -25.73 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 117.307 -3.371 . . . . 9.4600000000000009 113.184 169.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -75.49 -30.2 59.8 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.941 2.496 . . . . 14.76 109.675 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -63.7 -55.95 19.46 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.477 -2.014 . . . . 26.289999999999999 108.482 168.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.5 tptt -79.83 -43.31 22.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 116.545 -1.693 . . . . 30.059999999999999 112.333 -161.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -104.35 -44.05 5.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.462 1.028 . . . . 25.190000000000001 108.603 -177.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.34 37.99 4.14 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 121.109 -0.995 . . . . 7.4100000000000001 111.449 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.7 mt -101.58 135.74 19.74 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 108.036 -1.098 . . . . 9.4900000000000002 108.036 175.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -65.36 137.94 53.33 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 C-N-CA 123.258 2.639 . . . . 11.42 113.567 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -68.31 -19.54 43.8 Favored 'Trans proline' 0 C--N 1.3 -1.988 1 C-N-CA 126.065 4.51 . . . . 12.0 118.178 -172.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -87.74 -27.28 22.46 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.948 1.699 . . . . 35.549999999999997 112.769 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.07 -40.37 82.73 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.106 2.162 . . . . 20.52 109.471 165.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -59.91 129.75 43.37 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.699 2.852 . . . . 7.1299999999999999 118.699 167.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -130.44 129.16 42.65 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.94 -4.225 . . . . 36.390000000000001 110.823 168.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.2 mt -112.93 129.08 56.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 124.856 1.262 . . . . 9.5500000000000007 110.145 -173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.7 mt -130.5 140.09 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.988 1.852 . . . . 13.9 107.17 -177.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -95.57 -75.83 0.51 Allowed 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 114.738 -2.785 . . . . 6.8600000000000003 112.187 177.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.61 -66.06 1.01 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.319 -2.845 . . . . 11.15 103.319 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.85 10.11 2.09 Favored Glycine 0 N--CA 1.429 -1.773 0 C-N-CA 127.068 2.271 . . . . 13.93 115.523 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -112.26 142.1 45.16 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 122.287 1.042 . . . . 23.920000000000002 109.451 170.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -86.23 145.88 26.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.24 1.416 . . . . 23.23 107.784 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.03 130.12 45.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.067 -3.521 . . . . 9.1099999999999994 110.324 -171.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -103.89 151.32 23.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 118.31 -1.356 . . . . 33.439999999999998 109.979 -171.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -47.78 -53.53 15.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 118.733 2.864 . . . . 28.370000000000001 118.733 -152.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.94 50.82 0.74 Allowed Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 126.644 2.068 . . . . 15.0 114.465 -166.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.2 mtt-85 -127.21 160.04 32.49 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.423 1.889 . . . . 25.5 109.899 154.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.341 48.0 p -79.24 164.17 24.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.041 2.536 . . . . 11.949999999999999 111.269 -175.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.7 mt -65.86 -31.22 72.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.829 1.776 . . . . 10.17 111.875 165.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -68.15 -31.09 70.4 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.7 -2.5 . . . . 13.59 114.919 175.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -71.99 -48.2 46.55 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.335 1.854 . . . . 11.699999999999999 106.596 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -74.15 -11.3 60.26 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 118.67 2.841 . . . . 12.949999999999999 118.67 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 m120 69.24 49.01 0.63 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.753 2.021 . . . . 25.449999999999999 113.896 -177.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.4 mt -105.24 108.01 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 103.333 -2.839 . . . . 14.6 103.333 173.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -101.5 -172.81 2.22 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.638 3.589 . . . . 33.229999999999997 109.859 -166.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 ttpp -61.59 126.75 28.44 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.208 -3.432 . . . . 25.969999999999999 113.898 169.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 41.7 mt-10 64.78 27.8 12.96 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.403 2.742 . . . . 32.609999999999999 118.403 -178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.2 m -90.67 154.44 19.56 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.056 2.836 . . . . 10.56 105.073 174.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.521 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 10.9 m -98.76 126.98 44.54 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.361 -2.2 . . . . 5.3300000000000001 105.249 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.4 mt -102.48 149.66 24.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.44 -2.037 . . . . 11.66 113.259 153.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -93.71 129.09 40.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.081 2.219 . . . . 16.300000000000001 112.246 172.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.486 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 10.4 tp -96.31 126.3 41.42 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 129.153 2.981 . . . . 9.9600000000000009 109.466 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.71 126.21 75.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 113.713 -1.585 . . . . 9.7599999999999998 108.602 178.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 70.7 mt -106.97 -178.75 3.74 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.795 1.934 . . . . 19.57 110.865 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -82.24 111.61 18.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.593 -3.192 . . . . 35.079999999999998 110.792 -174.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 95.2 mt -101.36 -52.11 3.32 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.445 -3.539 . . . . 32.310000000000002 101.445 172.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -101.99 -73.19 0.66 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 116.402 -3.936 . . . . 42.75 114.242 -175.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.31 140.62 3.36 Favored Glycine 0 N--CA 1.43 -1.75 0 CA-C-O 117.194 -1.892 . . . . 36.310000000000002 110.253 -173.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.76 0 CA-C-N 120.235 2.018 . . . . 36.270000000000003 116.515 -169.438 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 122.143 0.973 . . . . 17.170000000000002 113.216 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -80.12 109.78 14.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.969 -2.332 . . . . 21.890000000000001 111.863 167.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -96.67 154.12 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 116.106 -1.902 . . . . 10.83 113.984 165.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.283 21.2 m-85 -101.79 113.56 26.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.252 1.842 . . . . 10.609999999999999 111.398 -178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.2 t -111.67 95.77 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 101.01 -3.7 . . . . 9.1300000000000008 101.01 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 12' ' ' THR 0.284 55.5 tttt -87.5 126.97 35.23 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 113.169 -1.832 . . . . 20.550000000000001 114.492 -167.04 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.1 p -83.46 158.04 22.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.265 1.983 . . . . 11.779999999999999 113.554 -173.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 tp -74.1 -27.66 60.99 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.101 -3.5 . . . . 19.309999999999999 107.996 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -62.25 -60.24 3.86 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.873 -4.267 . . . . 23.140000000000001 113.77 175.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.12 41.98 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.755 0 O-C-N 117.109 -3.494 . . . . 19.739999999999998 114.566 -179.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -140.21 163.11 33.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.868 2.834 . . . . 21.93 105.784 -178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 8.1 m -128.53 123.05 32.52 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.955 2.659 . . . . 12.33 106.073 174.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.8 mt -83.49 119.84 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.991 -1.693 . . . . 17.079999999999998 113.96 170.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 p -81.47 90.72 6.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.657 -2.527 . . . . 16.300000000000001 114.996 165.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 tp -94.39 118.9 32.33 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.387 2.275 . . . . 15.880000000000001 108.184 -167.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -81.51 109.4 15.93 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.544 -1.348 . . . . 28.899999999999999 112.456 170.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.07 171.5 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 C-N-CA 127.76 2.424 . . . . 12.050000000000001 110.243 167.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -108.27 173.94 2.74 Favored Pre-proline 0 N--CA 1.43 -1.438 0 C-N-CA 126.673 1.989 . . . . 18.170000000000002 107.273 158.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -71.32 -3.09 12.28 Favored 'Trans proline' 0 N--CA 1.434 -2.015 1 C-N-CA 125.601 4.201 . . . . 8.1600000000000001 113.136 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -88.7 -25.42 22.35 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 111.634 -2.53 . . . . 11.130000000000001 111.276 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.8 138.64 46.53 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 124.594 2.14 . . . . 18.030000000000001 113.121 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.7 p -91.2 177.7 6.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 113.267 -1.788 . . . . 10.220000000000001 108.309 175.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -82.26 -22.09 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 121.084 -1.01 . . . . 12.300000000000001 109.318 -176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -61.26 -37.74 84.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.665 1.986 . . . . 36.509999999999998 114.483 161.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -68.5 -25.8 65.14 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 118.931 -2.356 . . . . 25.66 115.452 167.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.1 t -64.79 -56.68 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 128.493 2.717 . . . . 8.1199999999999992 111.115 172.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -56.46 -30.1 62.48 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 117.336 2.347 . . . . 15.470000000000001 117.336 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.67 -45.53 64.91 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.308 2.243 . . . . 11.449999999999999 111.84 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -69.74 -34.91 74.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.797 2.439 . . . . 24.98 112.454 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.9 mt -73.02 -27.24 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 113.489 0.922 . . . . 9.4600000000000009 113.489 166.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.256 16.6 tt0 -66.9 -33.04 74.71 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.662 -5.649 . . . . 14.76 111.504 170.327 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -68.56 -58.46 4.25 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.45 2.7 . . . . 26.289999999999999 115.281 170.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -63.67 -71.97 0.15 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 114.808 1.411 . . . . 30.059999999999999 114.808 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -96.66 -22.39 17.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.326 -2.734 . . . . 25.190000000000001 113.222 -169.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.58 31.76 8.6 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 120.487 -1.383 . . . . 7.4100000000000001 114.484 171.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.6 mt -97.03 126.17 43.39 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 114.65 -2.595 . . . . 9.4900000000000002 106.606 173.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.26 0.1 OUTLIER -68.2 160.35 49.2 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 124.599 1.842 . . . . 11.42 114.969 -176.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_exo -74.9 -11.76 21.7 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 CA-C-N 123.321 2.222 . . . . 12.0 113.905 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -77.51 -7.84 56.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.987 -2.946 . . . . 35.549999999999997 112.969 171.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -110.22 -18.94 13.18 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.398 -2.064 . . . . 20.52 110.045 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 mt-30 -80.61 108.87 14.61 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 121.034 3.716 . . . . 7.1299999999999999 121.034 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.5 mtm180 -104.7 153.21 21.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.583 -1.189 . . . . 36.390000000000001 110.351 160.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.0 mt -127.46 141.99 51.52 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.444 -2.035 . . . . 9.5500000000000007 112.665 177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.6 pt -130.09 164.66 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 106.976 -1.491 . . . . 13.9 106.976 171.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.88 -88.77 0.17 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.325 2.266 . . . . 6.8600000000000003 111.345 167.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.98 -61.79 1.39 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.261 -3.399 . . . . 11.15 104.542 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.37 -37.84 0.9 Allowed Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 118.696 2.238 . . . . 13.93 118.696 172.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -71.38 128.98 37.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.312 2.338 . . . . 23.920000000000002 117.312 -176.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -75.29 118.17 17.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.515 -2.616 . . . . 23.23 112.005 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 72.7 mt -72.52 132.61 44.06 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.142 2.401 . . . . 9.1099999999999994 111.144 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.272 28.7 mt-10 -97.09 155.66 16.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.427 -2.064 . . . . 33.439999999999998 105.427 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -66.81 -62.1 1.62 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.56 3.144 . . . . 28.370000000000001 112.392 -166.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.38 21.72 30.55 Favored Glycine 0 N--CA 1.431 -1.67 0 CA-C-N 124.906 3.503 . . . . 15.0 115.249 -157.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.503 HH21 ' CG ' ' A' ' 58' ' ' ASP . 72.2 mtp180 -115.97 156.22 26.65 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 121.106 2.453 . . . . 25.5 108.375 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.9 p -84.73 163.65 19.03 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.007 -2.933 . . . . 11.949999999999999 111.206 -169.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.8 mt -73.34 -13.6 61.14 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.965 -4.834 . . . . 10.17 114.869 170.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.4 t -70.19 -39.14 75.39 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.499 -3.251 . . . . 13.59 108.665 167.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.503 ' CG ' HH21 ' A' ' 54' ' ' ARG . 16.7 t0 -63.29 -40.34 97.1 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.983 1.845 . . . . 11.699999999999999 115.983 176.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -79.4 -31.3 42.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 117.3 -1.333 . . . . 12.949999999999999 111.833 175.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.274 68.7 m-80 72.77 54.02 0.14 Allowed 'General case' 0 N--CA 1.43 -1.445 1 C-N-CA 132.365 4.266 . . . . 25.449999999999999 106.829 -176.835 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.3 mt -98.51 106.95 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 129.217 3.007 . . . . 14.6 107.704 169.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -102.94 -166.5 1.28 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.368 -2.083 . . . . 33.229999999999997 111.567 -165.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -66.33 135.62 54.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 125.425 1.49 . . . . 25.969999999999999 110.063 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.359 51.4 mt-10 65.37 40.91 4.52 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 115.229 1.566 . . . . 32.609999999999999 115.229 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 t -109.13 149.48 29.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.565 -3.834 . . . . 10.56 111.055 -173.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.295 78.2 m -97.66 109.55 22.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.814 1.646 . . . . 5.3300000000000001 110.1 -170.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.1 mt -108.13 155.11 20.77 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.745 -1.946 . . . . 11.66 105.745 171.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -120.3 137.34 54.31 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 120.143 -1.598 . . . . 16.300000000000001 113.569 176.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.1 tp -91.75 110.35 21.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.193 -1.367 . . . . 9.9600000000000009 111.611 -176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.9 t -87.97 144.79 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 C-N-CA 127.846 2.459 . . . . 9.7599999999999998 112.162 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -107.16 170.64 7.83 Favored 'General case' 0 N--CA 1.429 -1.477 1 O-C-N 115.205 -4.685 . . . . 19.57 110.483 -175.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -109.26 164.66 12.26 Favored 'General case' 0 N--CA 1.43 -1.434 1 N-CA-C 99.791 -4.152 . . . . 35.079999999999998 99.791 -175.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.2 tp -89.36 -61.44 1.7 Allowed 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.383 -2.08 . . . . 32.310000000000002 105.383 163.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 75' ' ' GLY . 16.4 tpp180 -167.44 -91.77 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.79 -3.693 . . . . 42.75 110.694 -166.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.413 ' H ' ' HB3' ' A' ' 74' ' ' ARG . . . -108.26 120.16 5.91 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 106.58 -2.608 . . . . 36.310000000000002 106.58 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.792 0 CA-C-O 113.971 -3.683 . . . . 36.270000000000003 107.32 -178.549 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.57 ' HB2' ' HG3' ' A' ' 63' ' ' LYS 0.25 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.331 0 N-CA-C 115.738 1.755 . . . . 17.170000000000002 115.738 . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.34 29.9 mt-30 -103.16 145.2 30.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.159 3.022 . . . . 21.890000000000001 119.159 174.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.32 29.3 pt -123.36 155.12 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 122.483 2.401 . . . . 10.83 106.679 166.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -112.12 137.43 50.18 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 112.396 -2.184 . . . . 10.609999999999999 108.505 -173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.4 t -127.22 123.07 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 123.023 1.392 . . . . 9.1300000000000008 111.253 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -100.14 125.79 46.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.001 -1.952 . . . . 20.550000000000001 113.434 -170.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.3 p -83.48 173.85 11.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.28 1.215 . . . . 11.779999999999999 114.28 175.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.7 tp -71.84 -43.06 66.18 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.836 1.779 . . . . 19.309999999999999 112.878 177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -67.56 -23.05 65.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.003 -1.061 . . . . 23.140000000000001 109.603 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.53 10.9 8.29 Favored Glycine 0 N--CA 1.429 -1.786 1 N-CA-C 123.781 4.272 . . . . 19.739999999999998 123.781 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -86.49 146.35 26.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 104.112 -2.551 . . . . 21.93 104.112 -171.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.8 m -110.16 104.62 13.49 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.588 0.709 . . . . 12.33 112.736 175.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.9 mt -84.04 129.23 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.69 2.796 . . . . 17.079999999999998 112.401 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.0 m -106.19 116.56 32.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.982 -2.324 . . . . 16.300000000000001 113.196 -174.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.271 0.6 OUTLIER -118.77 131.4 56.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.642 1.839 . . . . 15.880000000000001 106.177 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -94.49 122.09 36.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.197 -2.815 . . . . 28.899999999999999 108.46 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.3 m -134.18 174.38 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 114.059 -1.428 . . . . 12.050000000000001 113.462 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -103.05 -173.97 0.32 Allowed Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 103.829 -2.656 . . . . 18.170000000000002 103.829 173.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -74.41 -29.5 9.25 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 C-N-CA 127.309 5.34 . . . . 8.1600000000000001 110.184 160.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 94.7 p -68.25 -28.55 67.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 118.797 2.888 . . . . 11.130000000000001 118.797 -176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -71.86 162.35 29.58 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 122.728 1.251 . . . . 18.030000000000001 112.94 -177.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.6 p -104.61 175.25 5.55 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.83 -3.669 . . . . 10.220000000000001 112.389 -173.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -65.24 -25.39 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.652 -2.53 . . . . 12.300000000000001 113.122 176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.13 -37.76 88.47 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 117.726 2.491 . . . . 36.509999999999998 117.726 173.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 28.2 m120 -62.84 -43.4 98.89 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.363 1.246 . . . . 25.66 114.363 175.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.5 t -54.44 -38.2 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 126.095 1.758 . . . . 8.1199999999999992 107.506 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -75.72 -26.66 57.71 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.409 -1.432 . . . . 15.470000000000001 113.16 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.29 -37.11 74.75 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.964 -2.96 . . . . 11.449999999999999 109.073 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 50.4 mttm -72.23 -43.24 64.72 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.801 3.641 . . . . 24.98 114.424 -177.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.252 91.2 mt -55.25 -40.04 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-O 128.224 3.869 . . . . 9.4600000000000009 117.503 164.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -63.37 -44.28 95.24 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 110.904 -7.372 . . . . 14.76 114.584 178.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -63.14 -50.99 68.27 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.395 2.739 . . . . 26.289999999999999 118.395 168.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 tttp -67.49 -56.4 9.7 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.714 2.005 . . . . 30.059999999999999 115.582 -175.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -98.58 -22.78 15.79 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.688 1.595 . . . . 25.190000000000001 113.525 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.59 23.39 31.16 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 125.601 2.778 . . . . 7.4100000000000001 116.464 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 mt -102.7 120.11 53.78 Favored Pre-proline 0 N--CA 1.43 -1.441 1 O-C-N 115.553 -4.498 . . . . 9.4900000000000002 104.21 -168.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -66.6 150.39 83.87 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 CA-C-N 126.784 3.459 . . . . 11.42 116.95 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -85.98 -4.75 8.82 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 CA-C-O 115.513 -1.953 . . . . 12.0 114.244 -167.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -70.48 -36.37 73.82 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.38 1.9 . . . . 35.549999999999997 110.27 165.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -70.07 -28.43 65.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 128.053 2.541 . . . . 20.52 112.817 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -83.38 130.77 35.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 126.24 2.924 . . . . 7.1299999999999999 116.229 178.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -122.14 135.8 54.83 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 103.692 -2.707 . . . . 36.390000000000001 103.692 170.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.2 mt -113.67 137.33 51.76 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 124.253 0.97 . . . . 9.5500000000000007 109.643 178.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 pt -123.4 169.44 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 117.305 -1.758 . . . . 13.9 110.893 171.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.414 ' HB3' ' H ' ' A' ' 46' ' ' ALA . 17.5 t80 -85.61 -90.46 0.1 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 117.217 -1.793 . . . . 6.8600000000000003 106.681 161.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.414 ' H ' ' HB3' ' A' ' 45' ' ' PHE . . . -111.8 -16.55 13.15 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.023 1.86 . . . . 11.15 116.023 171.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -164.55 -32.63 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 O-C-N 117.782 -3.074 . . . . 13.93 115.931 172.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -76.99 135.24 38.68 Favored 'General case' 0 N--CA 1.43 -1.465 1 CA-C-O 129.406 4.431 . . . . 23.920000000000002 109.482 174.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -75.83 152.48 37.25 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 114.584 -5.073 . . . . 23.23 117.866 -176.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.0 mt -118.31 117.71 29.82 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.457 -2.027 . . . . 9.1099999999999994 106.19 -171.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -108.2 151.6 25.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.579 3.085 . . . . 33.439999999999998 114.73 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.335 2.1 m-20 -37.06 -70.48 0.09 Allowed 'General case' 0 N--CA 1.429 -1.484 1 C-N-CA 134.754 5.222 . . . . 28.370000000000001 113.827 -166.47 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.37 23.15 33.29 Favored Glycine 0 N--CA 1.43 -1.703 0 C-N-CA 116.958 -2.544 . . . . 15.0 117.04 -156.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -105.71 161.32 14.5 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 119.206 1.503 . . . . 25.5 111.477 169.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.3 p -91.03 170.18 10.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.678 -3.139 . . . . 11.949999999999999 112.465 -174.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.0 mt -67.64 -38.78 84.33 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 117.92 -2.987 . . . . 10.17 113.675 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -47.59 -39.21 16.14 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.438 -3.289 . . . . 13.59 112.153 162.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -82.69 -32.57 27.99 Favored 'General case' 0 N--CA 1.429 -1.503 0 O-C-N 119.7 -1.875 . . . . 11.699999999999999 112.281 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.287 77.0 m-85 -88.72 -7.78 55.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.676 1.58 . . . . 12.949999999999999 111.438 170.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.0 m120 81.23 29.83 0.16 Allowed 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 131.721 4.009 . . . . 25.449999999999999 108.415 166.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mt -75.99 132.54 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 117.72 -3.113 . . . . 14.6 104.099 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -96.43 -177.51 3.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.199 -1.819 . . . . 33.229999999999997 113.117 -171.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.57 ' HG3' ' HB2' ' A' ' 1' ' ' MET . 19.8 ttpp -69.51 131.08 44.16 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.653 -1.905 . . . . 25.969999999999999 106.551 175.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 53.29 59.34 4.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 125.208 1.403 . . . . 32.609999999999999 108.145 175.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.4 t -98.84 147.42 24.95 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 107.799 -1.186 . . . . 10.56 107.799 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.3 m -90.6 114.52 26.8 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.869 1.356 . . . . 5.3300000000000001 108.306 177.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.6 mt -100.76 154.63 18.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.927 -1.733 . . . . 11.66 109.473 167.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -108.7 132.21 54.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.254 2.454 . . . . 16.300000000000001 111.016 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.8 tp -102.0 128.39 48.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.53 -3.231 . . . . 9.9600000000000009 109.221 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.5 t -122.8 98.47 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 112.492 -2.14 . . . . 9.7599999999999998 107.031 -167.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.33 -159.3 0.3 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.486 2.402 . . . . 19.57 117.486 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -101.49 100.92 11.42 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 116.385 -3.947 . . . . 35.079999999999998 110.651 173.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.0 tp -102.73 -62.35 1.29 Allowed 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 119.677 1.126 . . . . 32.310000000000002 111.541 -171.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -144.32 -83.46 0.15 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 101.858 -3.386 . . . . 42.75 101.858 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -141.3 150.09 21.58 Favored Glycine 0 N--CA 1.431 -1.693 0 CA-C-N 122.871 2.578 . . . . 36.310000000000002 115.57 168.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 O-C-N 116.955 -3.674 . . . . 36.270000000000003 111.445 173.617 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 116.606 -1.664 . . . . 17.170000000000002 112.437 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.7 mt-30 -86.86 138.77 31.29 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 125.809 1.943 . . . . 21.890000000000001 109.868 174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.5 pt -119.97 148.52 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 129.797 3.239 . . . . 10.83 104.664 158.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -100.41 118.9 37.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.367 1.467 . . . . 10.609999999999999 112.944 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.81 122.52 62.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 116.891 -3.631 . . . . 9.1300000000000008 112.114 174.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.9 tttt -102.3 141.94 34.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 119.187 -1.005 . . . . 20.550000000000001 109.76 -173.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.6 p -84.66 176.15 8.76 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.089 -2.257 . . . . 11.779999999999999 110.8 171.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -60.74 -49.95 75.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.495 -2.628 . . . . 19.309999999999999 114.427 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.252 66.2 p -62.53 -57.36 11.45 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.901 3.68 . . . . 23.140000000000001 109.257 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.0 49.43 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 126.797 2.141 . . . . 19.739999999999998 110.767 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -93.17 143.73 25.97 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.794 -3.18 . . . . 21.93 112.01 161.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.272 25.1 m -108.85 107.28 17.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 126.285 2.945 . . . . 12.33 113.801 -176.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.6 mt -86.09 117.37 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-N 110.151 -3.204 . . . . 17.079999999999998 109.287 169.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.461 ' O ' HD13 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -102.47 131.2 49.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.921 -1.737 . . . . 16.300000000000001 109.333 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 14' ' ' THR . 1.6 mm? -123.55 134.37 53.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 107.892 -1.151 . . . . 15.880000000000001 107.892 176.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -109.7 114.57 28.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.772 -1.936 . . . . 28.899999999999999 105.772 -170.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -136.9 177.59 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 104.784 -2.302 . . . . 12.050000000000001 104.784 -152.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -111.42 171.1 4.6 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 126.828 2.051 . . . . 18.170000000000002 107.453 168.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -79.53 -14.15 13.04 Favored 'Trans proline' 0 C--N 1.3 -2.005 0 CA-C-N 123.142 2.158 . . . . 8.1600000000000001 107.647 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.7 m -93.54 9.74 35.46 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 115.541 1.682 . . . . 11.130000000000001 115.541 -175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -80.62 139.41 36.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.288 1.835 . . . . 18.030000000000001 114.522 162.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.3 p -90.49 170.34 10.29 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.442 -3.911 . . . . 10.220000000000001 107.901 -177.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.7 mm -71.38 -29.0 33.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 116.845 -3.659 . . . . 12.300000000000001 108.235 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -51.81 -51.51 55.97 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.284 3.033 . . . . 36.509999999999998 112.902 164.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -54.44 -43.34 71.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.729 2.862 . . . . 25.66 118.729 172.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -67.17 -43.15 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 117.88 -1.057 . . . . 8.1199999999999992 109.039 -175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.9 mtmt -57.96 -36.04 72.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.267 1.951 . . . . 15.470000000000001 116.267 166.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.22 -35.84 65.34 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.117 2.567 . . . . 11.449999999999999 115.741 170.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -81.26 -29.99 34.2 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 127.398 2.936 . . . . 24.98 109.446 174.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.7 mt -65.42 -43.3 94.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 121.256 1.844 . . . . 9.4600000000000009 115.951 172.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -53.95 -39.61 66.09 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.154 -2.355 . . . . 14.76 114.521 167.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.258 21.2 t70 -68.33 -53.44 24.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.386 2.357 . . . . 26.289999999999999 115.159 164.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.7 tttt -63.02 -43.8 97.74 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 120.191 3.404 . . . . 30.059999999999999 120.191 -169.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -100.28 -30.19 12.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.961 -2.337 . . . . 25.190000000000001 108.874 -173.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.4 37.46 12.23 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 112.715 -2.039 . . . . 7.4100000000000001 110.188 -175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.8 mt -102.68 128.47 27.91 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 118.627 -2.69 . . . . 9.4900000000000002 111.919 175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -67.85 146.15 71.08 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 124.914 3.743 . . . . 11.42 108.299 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -81.15 2.28 8.69 Favored 'Trans proline' 0 C--N 1.3 -2.005 1 C-N-CA 127.345 5.364 . . . . 12.0 114.533 -165.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -93.43 -47.56 6.81 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.67 -1.894 . . . . 35.549999999999997 107.818 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.5 mm100 -52.05 -29.44 21.22 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.967 1.84 . . . . 20.52 115.967 162.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -71.84 136.21 46.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.771 2.829 . . . . 7.1299999999999999 116.731 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -118.09 105.98 12.4 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.851 -1.537 . . . . 36.390000000000001 106.851 161.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.3 tp -102.11 120.75 40.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.546 -3.222 . . . . 9.5500000000000007 105.995 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 pt -127.24 170.94 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 125.323 1.449 . . . . 13.9 107.132 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -96.6 -55.57 2.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.058 1.743 . . . . 6.8600000000000003 113.364 169.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.44 -80.71 0.4 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 125.074 1.35 . . . . 11.15 113.75 -179.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.47 -12.81 2.98 Favored Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.545 -1.347 . . . . 13.93 115.578 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -97.18 124.94 41.4 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 114.604 -2.617 . . . . 23.920000000000002 113.673 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -52.25 119.36 4.31 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.962 1.71 . . . . 23.23 111.965 172.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.505 HD22 ' CE1' ' A' ' 59' ' ' TYR . 35.2 mt -81.76 142.72 32.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.836 2.732 . . . . 9.1099999999999994 114.364 -176.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -80.56 124.69 29.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.502 2.721 . . . . 33.439999999999998 107.288 176.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.319 36.4 m-20 -45.29 -56.28 5.05 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 119.323 3.083 . . . . 28.370000000000001 119.323 -177.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.59 10.84 65.77 Favored Glycine 0 N--CA 1.43 -1.735 0 CA-C-O 117.024 -1.987 . . . . 15.0 116.631 -157.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.41 HH21 ' CG ' ' A' ' 58' ' ' ASP . 83.3 mtp180 -98.87 152.07 20.15 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 118.155 0.978 . . . . 25.5 108.864 -176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 32.5 p -80.55 161.54 24.73 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 116.684 2.105 . . . . 11.949999999999999 116.684 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 HD12 ' A' ' 61' ' ' ILE . 7.6 mt -76.07 -29.71 58.08 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.084 -2.562 . . . . 10.17 104.084 -171.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.2 t -60.99 -46.88 88.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.119 2.137 . . . . 13.59 112.928 174.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CG ' HH21 ' A' ' 54' ' ' ARG . 20.6 t0 -58.32 -47.96 82.04 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.596 2.758 . . . . 11.699999999999999 111.085 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.505 ' CE1' HD22 ' A' ' 50' ' ' LEU . 9.6 m-85 -61.98 -34.23 75.78 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 131.391 3.876 . . . . 12.949999999999999 114.332 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.481 10.3 m120 92.49 29.53 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 126.038 2.086 . . . . 25.449999999999999 113.051 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.482 HD12 HD23 ' A' ' 56' ' ' LEU . 22.7 mt -89.11 108.64 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 127.542 2.337 . . . . 14.6 111.409 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -87.55 179.26 6.58 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.04 -4.162 . . . . 33.229999999999997 114.978 -169.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -63.31 126.19 26.61 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.497 3.046 . . . . 25.969999999999999 114.888 167.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.394 68.4 mt-10 75.43 42.8 0.22 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.881 3.273 . . . . 32.609999999999999 110.27 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 t -109.93 141.78 42.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.688 1.995 . . . . 10.56 107.969 -173.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.1 m -90.74 129.04 36.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.281 1.956 . . . . 5.3300000000000001 116.281 -178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -111.49 171.85 7.24 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 107.054 -1.462 . . . . 11.66 107.054 169.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -135.39 127.41 29.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.937 2.78 . . . . 16.300000000000001 105.285 -173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 63.7 tp -96.84 114.63 26.27 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.138 2.399 . . . . 9.9600000000000009 108.285 175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.252 37.6 t -101.25 151.58 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 101.543 -3.503 . . . . 9.7599999999999998 101.543 170.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.7 mt -100.49 -172.83 2.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.429 -1.323 . . . . 19.57 107.429 173.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -87.74 -46.38 9.52 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.533 2.587 . . . . 35.079999999999998 115.657 -168.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.8 tp -83.72 -75.2 0.34 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.31 -3.994 . . . . 32.310000000000002 113.83 -171.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -94.92 141.94 28.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 115.189 -0.914 . . . . 42.75 111.499 -172.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.77 -161.79 11.02 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 108.515 -1.834 . . . . 36.310000000000002 108.515 -178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 CA-C-O 116.245 -2.419 . . . . 36.270000000000003 113.315 178.068 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.268 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 118.151 2.649 . . . . 17.170000000000002 118.151 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -80.61 134.15 35.86 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.22 1.933 . . . . 21.890000000000001 116.22 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.6 pt -124.45 149.34 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 112.833 -1.985 . . . . 10.83 109.195 166.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.47 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 59.9 m-85 -103.96 132.68 49.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 102.567 -3.123 . . . . 10.609999999999999 102.567 -174.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.45 109.25 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 126.224 1.81 . . . . 9.1300000000000008 106.729 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -95.58 132.35 40.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 127.045 3.307 . . . . 20.550000000000001 108.693 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.2 p -91.29 175.91 6.76 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.316 -3.365 . . . . 11.779999999999999 114.287 -177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.638 HD11 ' H ' ' A' ' 71' ' ' LEU . 84.5 mt -75.47 -28.19 59.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 114.536 -1.211 . . . . 19.309999999999999 113.775 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.354 82.5 p -83.63 -24.33 31.46 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 120.496 1.498 . . . . 23.140000000000001 107.968 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.29 52.12 0.22 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.397 -2.689 . . . . 19.739999999999998 107.861 161.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -131.01 135.26 47.45 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.296 -4.061 . . . . 21.93 103.738 -175.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.7 m -106.65 107.45 18.47 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 125.309 2.48 . . . . 12.33 108.29 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.4 mt -98.99 133.02 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 128.416 2.687 . . . . 17.079999999999998 110.329 178.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.4 m -98.42 112.63 24.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.673 -1.232 . . . . 16.300000000000001 107.673 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -102.35 164.48 11.65 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.372 2.511 . . . . 15.880000000000001 107.338 172.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.67 106.28 9.61 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 115.302 -4.624 . . . . 28.899999999999999 102.326 -175.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.5 m -109.44 175.66 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 123.445 1.593 . . . . 12.050000000000001 109.726 173.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -115.89 143.48 30.87 Favored Pre-proline 0 N--CA 1.43 -1.46 1 CA-C-O 109.792 -4.909 . . . . 18.170000000000002 105.795 162.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -60.13 -11.12 14.62 Favored 'Trans proline' 0 N--CA 1.434 -2.023 2 CA-C-N 130.774 4.883 . . . . 8.1600000000000001 117.737 176.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.8 m -74.0 -19.09 60.76 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 127.252 2.221 . . . . 11.130000000000001 116.183 170.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -73.13 156.28 38.82 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.542 2.337 . . . . 18.030000000000001 111.039 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.1 p -107.95 163.61 12.99 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.775 -1.557 . . . . 10.220000000000001 115.072 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.4 mm -63.24 -26.02 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 CA-C-O 114.319 -2.753 . . . . 12.300000000000001 109.952 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -59.89 -44.96 93.93 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 125.586 1.803 . . . . 36.509999999999998 108.777 171.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -63.95 -47.53 80.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.819 -3.05 . . . . 25.66 111.776 -176.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.419 HG23 ' H ' ' A' ' 26' ' ' VAL . 1.5 t -60.8 -43.39 95.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 120.938 1.699 . . . . 8.1199999999999992 113.098 173.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mtpt -59.46 -32.16 69.98 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 115.682 -2.104 . . . . 15.470000000000001 114.657 170.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.09 -51.15 65.38 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.204 1.82 . . . . 11.449999999999999 110.881 169.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -61.05 -36.09 78.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.953 2.205 . . . . 24.98 116.953 177.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.3 mt -70.1 -39.66 77.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 CA-C-O 124.822 2.249 . . . . 9.4600000000000009 111.531 174.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -59.4 -36.93 76.74 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 111.811 -6.806 . . . . 14.76 113.791 168.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -75.18 -29.92 60.52 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 116.227 -4.046 . . . . 26.289999999999999 109.754 176.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -75.91 -47.12 26.52 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 117.837 2.532 . . . . 30.059999999999999 117.837 175.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -100.34 -27.1 13.65 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 114.71 -1.132 . . . . 25.190000000000001 113.406 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.92 6.4 54.19 Favored Glycine 0 N--CA 1.431 -1.668 0 O-C-N 116.77 -3.706 . . . . 7.4100000000000001 117.415 174.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.9 mm -99.05 137.04 20.4 Favored Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-N 120.657 2.229 . . . . 9.4900000000000002 106.206 -168.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -65.71 154.21 74.84 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 N-CA-C 119.094 2.69 . . . . 11.42 119.094 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -88.46 -7.49 5.74 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-N 125.953 3.162 . . . . 12.0 107.396 -155.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -82.39 -18.29 42.48 Favored 'General case' 0 N--CA 1.429 -1.483 1 C-N-CA 131.789 4.036 . . . . 35.549999999999997 112.248 167.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -85.81 -24.84 26.63 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.644 -1.91 . . . . 20.52 113.313 165.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -83.84 138.3 33.27 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 127.615 2.366 . . . . 7.1299999999999999 113.759 -177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -142.61 122.28 13.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.864 -1.902 . . . . 36.390000000000001 105.864 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.5 mt -101.23 125.96 47.91 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 126.363 1.865 . . . . 9.5500000000000007 108.533 176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 68' ' ' HIS . 5.8 pt -127.56 154.27 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.149 -2.908 . . . . 13.9 103.149 178.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -73.43 -63.31 1.22 Allowed 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.889 -1.757 . . . . 6.8600000000000003 113.382 173.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.58 -36.39 0.78 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.904 -2.373 . . . . 11.15 106.64 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -155.06 -14.72 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.109 1.814 . . . . 13.93 116.253 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -103.12 148.66 25.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.622 -2.031 . . . . 23.920000000000002 106.708 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -81.97 110.37 17.17 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 127.784 6.216 . . . . 23.23 127.784 -176.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.8 mt -87.32 112.87 22.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.9 -2.375 . . . . 9.1099999999999994 107.191 -169.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -110.11 148.49 31.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.542 2.591 . . . . 33.439999999999998 107.447 -159.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -44.07 -61.82 1.35 Allowed 'General case' 0 N--CA 1.431 -1.424 1 C-N-CA 131.815 4.046 . . . . 28.370000000000001 118.365 -169.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.37 -22.21 72.8 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 128.422 2.915 . . . . 15.0 110.326 -155.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.2 mtp180 -100.27 159.65 14.95 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.773 1.229 . . . . 25.5 112.814 -167.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -74.69 156.33 36.76 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 114.432 -2.699 . . . . 11.949999999999999 117.425 177.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.272 14.8 mt -54.39 -37.11 64.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 120.031 3.345 . . . . 10.17 120.031 160.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -64.1 -25.9 68.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.751 2.13 . . . . 13.59 116.751 171.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -73.02 -22.28 60.68 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 116.033 -1.937 . . . . 11.699999999999999 110.117 169.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -96.75 -12.5 23.63 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.534 1.97 . . . . 12.949999999999999 114.257 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.29 14.4 m120 59.5 46.0 12.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.666 3.986 . . . . 25.449999999999999 114.589 -172.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.411 HD13 HG21 ' A' ' 61' ' ' ILE . 69.1 mt -81.48 108.86 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.067 -2.896 . . . . 14.6 112.154 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -88.07 178.72 6.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.318 2.34 . . . . 33.229999999999997 117.318 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.2 ttmt -61.96 138.34 58.35 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 127.453 3.501 . . . . 25.969999999999999 113.103 -171.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 60.52 31.03 20.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.705 3.202 . . . . 32.609999999999999 115.276 176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.4 m -70.69 144.91 50.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.417 -1.719 . . . . 10.56 108.752 177.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.47 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 23.0 m -95.66 122.53 38.53 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 104.007 -2.59 . . . . 5.3300000000000001 104.007 174.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 24.3 mt -116.71 152.61 33.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 104.246 -2.501 . . . . 11.66 104.246 175.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.404 ' HB2' HG13 ' A' ' 44' ' ' ILE . 73.2 m80 -111.89 122.04 46.69 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-O 128.67 4.081 . . . . 16.300000000000001 107.748 -175.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.0 tp -85.51 135.62 33.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.827 -3.046 . . . . 9.9600000000000009 105.466 171.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.2 t -130.76 151.91 36.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 102.761 -3.052 . . . . 9.7599999999999998 102.761 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.638 ' H ' HD11 ' A' ' 8' ' ' LEU . 54.5 mt -114.23 157.39 22.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.24 -1.538 . . . . 19.57 110.952 170.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -63.29 -63.13 1.28 Allowed 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.572 2.42 . . . . 35.079999999999998 109.84 -165.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.0 tp -90.85 -50.23 6.0 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.387 1.875 . . . . 32.310000000000002 114.899 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -79.77 75.8 6.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.985 1.476 . . . . 42.75 114.985 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.98 161.7 16.27 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 119.561 2.584 . . . . 36.310000000000002 119.561 -173.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.755 0 O-C-N 121.422 -1.046 . . . . 36.270000000000003 115.481 176.423 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.607 1.336 . . . . 17.170000000000002 114.607 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -95.15 142.47 27.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.168 0.987 . . . . 21.890000000000001 111.595 -176.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.7 pt -133.29 168.57 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.346 -2.094 . . . . 10.83 105.346 159.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -118.34 158.04 25.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.862 1.792 . . . . 10.609999999999999 114.321 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.467 HG21 HD11 ' A' ' 30' ' ' ILE . 59.6 t -124.4 121.25 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.389 3.476 . . . . 9.1300000000000008 106.866 167.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -106.48 127.58 53.41 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 124.018 1.866 . . . . 20.550000000000001 107.772 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 p -88.84 166.24 14.12 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.678 1.704 . . . . 11.779999999999999 106.642 -173.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.2 mt -65.95 -45.35 82.11 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 129.703 3.201 . . . . 19.309999999999999 110.53 169.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.0 p -64.31 -29.67 70.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.901 2.481 . . . . 23.140000000000001 117.576 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.39 29.46 1.92 Allowed Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 114.157 -1.383 . . . . 19.739999999999998 109.916 167.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 mtpt -92.66 133.44 35.99 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.798 -3.766 . . . . 21.93 112.714 164.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.3 m -100.63 119.02 37.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.935 -1.876 . . . . 12.33 105.935 167.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.7 mt -113.3 115.5 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 117.99 -2.943 . . . . 17.079999999999998 105.94 -172.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 45.3 m -83.78 124.78 31.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 112.846 -3.454 . . . . 16.300000000000001 108.307 174.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -104.16 145.03 30.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 123.901 3.046 . . . . 15.880000000000001 111.211 167.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -98.87 131.74 44.74 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 118.816 -1.154 . . . . 28.899999999999999 112.225 167.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.4 m -137.08 171.94 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 125.889 1.676 . . . . 12.050000000000001 110.029 -166.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -118.6 171.79 4.88 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-N 122.105 2.23 . . . . 18.170000000000002 109.21 156.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -55.2 -30.57 72.05 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 N-CA-C 119.5 2.846 . . . . 8.1600000000000001 119.5 172.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.7 m -92.58 14.64 16.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.805 -3.059 . . . . 11.130000000000001 112.474 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -75.47 138.08 41.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.052 -3.53 . . . . 18.030000000000001 115.944 171.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.2 p -85.05 164.1 18.43 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 112.592 -2.095 . . . . 10.220000000000001 109.822 -171.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 23' ' ' ILE 0.351 3.9 mm -78.62 -17.6 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 117.876 -3.015 . . . . 12.300000000000001 111.29 -175.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -62.26 -51.73 66.56 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.902 2.881 . . . . 36.509999999999998 110.678 164.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -66.63 -25.29 66.52 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.411 -1.431 . . . . 25.66 110.693 -178.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -65.67 -56.2 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.595 2.072 . . . . 8.1199999999999992 116.595 167.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -50.6 -30.55 13.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.271 3.434 . . . . 15.470000000000001 120.271 164.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.83 -42.76 97.54 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.253 2.316 . . . . 11.449999999999999 117.253 170.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -61.78 -31.53 71.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.3 1.963 . . . . 24.98 116.3 171.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.467 HD11 HG21 ' A' ' 5' ' ' VAL . 63.2 mt -85.0 -40.52 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.092 1.757 . . . . 9.4600000000000009 111.143 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -48.24 -51.34 25.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.595 2.758 . . . . 14.76 116.915 164.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -56.58 -39.78 74.09 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.776 2.83 . . . . 26.289999999999999 112.662 166.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 tptp -87.42 -70.99 0.59 Allowed 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 116.051 -4.156 . . . . 30.059999999999999 109.209 -168.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -89.96 -26.47 20.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.117 -3.489 . . . . 25.190000000000001 117.802 -171.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.81 43.45 4.48 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 117.22 -1.878 . . . . 7.4100000000000001 115.75 -178.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mm -90.82 124.39 62.29 Favored Pre-proline 0 N--CA 1.43 -1.468 1 CA-C-O 110.872 -4.394 . . . . 9.4900000000000002 107.397 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -77.04 147.25 26.42 Favored 'Trans proline' 0 C--N 1.3 -2.022 1 CA-C-N 129.741 4.515 . . . . 11.42 112.033 -176.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -70.08 -21.03 32.59 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-O 117.3 -1.208 . . . . 12.0 114.153 -159.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -71.45 -27.86 63.56 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 123.563 2.892 . . . . 35.549999999999997 111.994 176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.277 88.4 mm-40 -77.24 -23.42 51.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.422 1.889 . . . . 20.52 111.096 177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -77.28 107.37 9.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 113.812 1.041 . . . . 7.1299999999999999 113.812 -176.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -112.78 114.23 26.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.346 2.022 . . . . 36.390000000000001 109.921 170.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.7 mt -100.2 117.85 35.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.892 -1.755 . . . . 9.5500000000000007 109.839 -178.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.531 HG13 ' HB2' ' A' ' 68' ' ' HIS . 36.5 pt -98.19 156.64 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.415 2.286 . . . . 13.9 112.797 166.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -79.86 -68.87 0.63 Allowed 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 123.396 1.569 . . . . 6.8600000000000003 107.929 162.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.54 -60.79 0.98 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 105.051 -2.203 . . . . 11.15 105.051 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.16 -25.18 1.71 Allowed Glycine 0 N--CA 1.43 -1.731 1 C-N-CA 134.965 6.031 . . . . 13.93 114.451 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 139.72 33.97 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.012 -3.052 . . . . 23.920000000000002 109.482 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -90.29 147.82 23.27 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 122.162 0.982 . . . . 23.23 112.661 -176.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.6 mt -99.71 118.72 36.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.118 1.767 . . . . 9.1099999999999994 110.391 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -95.21 147.85 23.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 118.939 -1.105 . . . . 33.439999999999998 111.002 -175.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -44.04 -47.62 8.77 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.435 3.094 . . . . 28.370000000000001 116.094 -166.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.19 31.61 7.81 Favored Glycine 0 N--CA 1.431 -1.694 1 CA-C-O 112.914 -4.27 . . . . 15.0 115.746 -165.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.0 mtp180 -129.42 171.63 12.33 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 122.797 3.299 . . . . 25.5 105.588 175.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.4 p -99.97 169.0 9.5 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.942 2.155 . . . . 11.949999999999999 112.223 -174.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.4 mt -54.6 -40.03 68.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 114.311 1.226 . . . . 10.17 114.311 170.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.9 t -63.83 -49.92 70.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 131.495 3.918 . . . . 13.59 112.384 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 38.6 m-20 -43.83 -58.0 2.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.665 3.186 . . . . 11.699999999999999 110.892 168.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.269 32.6 m-85 -54.58 -21.11 9.38 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 120.574 3.546 . . . . 12.949999999999999 120.574 171.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 m120 53.86 56.39 7.2 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.024 1.729 . . . . 25.449999999999999 112.234 -162.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.2 mt -93.74 132.07 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.77 -3.081 . . . . 14.6 110.024 165.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -105.6 -165.56 1.12 Allowed 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 119.76 -0.776 . . . . 33.229999999999997 111.506 -166.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -79.12 125.44 29.43 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 117.395 -1.722 . . . . 25.969999999999999 112.521 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.3 34.6 mt-10 68.22 27.43 6.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.115 2.166 . . . . 32.609999999999999 114.348 175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.3 m -74.7 153.99 38.63 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.905 -3.622 . . . . 10.56 116.503 163.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.1 m -93.27 125.7 38.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.375 2.297 . . . . 5.3300000000000001 111.447 -176.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -93.33 154.91 17.71 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.004 -2.591 . . . . 11.66 104.004 169.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.531 ' HB2' HG13 ' A' ' 44' ' ' ILE . 75.5 m80 -122.46 107.26 11.83 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 108.912 -0.773 . . . . 16.300000000000001 108.912 -176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.8 tp -78.24 120.71 23.41 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 122.876 1.322 . . . . 9.9600000000000009 109.545 175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.7 m -126.39 -179.65 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.737 2.415 . . . . 9.7599999999999998 107.421 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 46.9 mt -98.52 171.79 7.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.504 1.621 . . . . 19.57 112.789 178.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.6 ttt180 -83.74 -43.91 14.99 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.191 2.293 . . . . 35.079999999999998 117.191 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 tp -94.53 -55.28 3.2 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.058 1.503 . . . . 32.310000000000002 115.058 173.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.3 mtm105 -86.57 152.6 22.48 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 113.539 0.94 . . . . 42.75 113.539 -170.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.99 88.32 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.72 1 CA-C-O 128.175 4.208 . . . . 36.310000000000002 112.789 -175.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.754 0 C-N-CA 128.925 3.155 . . . . 36.270000000000003 109.773 -174.257 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptt? . . . . . 0 CA--C 1.49 -1.333 0 N-CA-C 109.027 -0.731 . . . . 17.170000000000002 109.027 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -100.09 125.4 46.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.929 -2.357 . . . . 21.890000000000001 105.251 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.7 pt -123.37 159.12 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.62 -3.175 . . . . 10.83 105.898 159.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -111.91 137.03 50.45 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.846 -3.034 . . . . 10.609999999999999 112.021 -173.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -112.07 125.41 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 111.504 -2.589 . . . . 9.1300000000000008 109.572 169.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -107.11 124.62 49.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.567 -3.208 . . . . 20.550000000000001 110.535 177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.1 p -89.88 163.61 14.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.76 1.743 . . . . 11.779999999999999 111.438 -177.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 70.2 mt -65.04 -39.95 94.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 125.628 1.571 . . . . 19.309999999999999 113.987 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.1 p -73.59 -33.04 64.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.376 3.07 . . . . 23.140000000000001 105.915 -175.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.42 48.33 0.47 Allowed Glycine 0 N--CA 1.431 -1.696 0 CA-C-O 122.622 1.124 . . . . 19.739999999999998 115.651 160.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -109.23 125.84 52.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.053 -3.027 . . . . 21.93 108.241 168.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.6 m -93.21 95.06 9.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.084 2.554 . . . . 12.33 112.309 169.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.4 mt -102.9 125.47 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 131.064 3.746 . . . . 17.079999999999998 106.677 -159.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.4 m -81.55 119.84 24.28 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.285 -3.384 . . . . 16.300000000000001 114.308 175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.2 142.71 36.5 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.884 -4.26 . . . . 15.880000000000001 109.465 174.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -110.28 105.52 14.59 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.4 3.88 . . . . 28.899999999999999 111.333 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 m -133.73 157.77 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-N 111.571 -2.559 . . . . 12.050000000000001 108.281 -170.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 3.1 mm-40 -88.9 168.11 16.52 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 124.547 1.154 . . . . 18.170000000000002 113.247 159.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 73.1 Cg_endo -70.56 -24.24 26.22 Favored 'Trans proline' 0 C--N 1.299 -2.036 1 O-C-N 112.537 -4.507 . . . . 8.1600000000000001 113.485 177.026 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -97.33 16.47 19.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.45 2.344 . . . . 11.130000000000001 116.106 178.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -67.89 136.76 54.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.712 2.805 . . . . 18.030000000000001 108.164 163.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.342 60.9 p -80.27 168.14 19.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.035 2.534 . . . . 10.220000000000001 107.145 -176.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 mm -75.9 -35.11 29.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 105.034 -2.21 . . . . 12.300000000000001 105.034 175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -44.17 -46.28 8.75 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.795 2.146 . . . . 36.509999999999998 116.795 161.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.269 11.4 m120 -69.24 -32.48 71.73 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 116.65 -3.781 . . . . 25.66 111.843 173.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.8 t -63.12 -38.67 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 N-CA-C 116.215 1.931 . . . . 8.1199999999999992 116.215 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -71.19 -22.34 62.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.065 -2.897 . . . . 15.470000000000001 116.085 173.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.86 72.91 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.029 -1.669 . . . . 11.449999999999999 114.333 171.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -70.97 -40.95 71.65 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 119.067 2.988 . . . . 24.98 119.067 166.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 74.8 mt -66.96 -32.28 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.622 -1.923 . . . . 9.4600000000000009 112.038 174.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -66.15 -43.1 88.0 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.674 2.39 . . . . 14.76 115.437 173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -78.49 -28.31 46.38 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.553 1.979 . . . . 26.289999999999999 115.747 168.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.8 tptt -73.24 -68.35 0.5 Allowed 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.095 -4.128 . . . . 30.059999999999999 110.101 172.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -81.97 -49.08 10.69 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.653 2.933 . . . . 25.190000000000001 110.352 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.66 7.85 13.02 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 118.645 -2.534 . . . . 7.4100000000000001 111.711 -170.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.7 mm -82.88 127.82 68.16 Favored Pre-proline 0 N--CA 1.43 -1.468 0 N-CA-C 116.25 1.945 . . . . 9.4900000000000002 116.25 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -64.14 150.49 88.24 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 CA-C-O 115.515 -1.952 . . . . 11.42 116.915 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -71.89 -20.82 25.39 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 123.98 2.457 . . . . 12.0 114.488 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -64.35 -39.36 93.74 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.458 -2.211 . . . . 35.549999999999997 115.645 165.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -78.03 -24.74 47.71 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 127.204 2.815 . . . . 20.52 110.657 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -70.6 119.17 14.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.522 2.329 . . . . 7.1299999999999999 112.358 168.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -130.94 103.1 6.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.421 -2.807 . . . . 36.390000000000001 103.421 169.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -92.13 118.27 30.67 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.144 -2.222 . . . . 9.5500000000000007 108.789 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.8 pt -90.21 -179.22 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 113.821 1.045 . . . . 13.9 113.821 159.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -111.68 -77.68 0.59 Allowed 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 105.061 -2.2 . . . . 6.8600000000000003 105.061 176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.73 -50.63 2.91 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.29 2.236 . . . . 11.15 112.489 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.55 -24.17 0.85 Allowed Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 126.782 2.134 . . . . 13.93 112.356 174.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -113.78 146.27 40.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.733 -2.039 . . . . 23.920000000000002 114.697 -167.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -78.12 152.4 32.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 127.305 3.431 . . . . 23.23 115.928 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.1 mt -114.5 136.25 53.22 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 102.928 -2.989 . . . . 9.1099999999999994 102.928 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -104.77 139.12 40.02 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 118.628 -2.545 . . . . 33.439999999999998 108.85 -173.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -28.2 -55.36 0.11 Allowed 'General case' 0 N--CA 1.429 -1.482 1 N-CA-C 123.444 4.609 . . . . 28.370000000000001 123.444 178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.93 -1.75 81.96 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.765 -2.459 . . . . 15.0 117.922 -164.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -93.35 167.61 11.61 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.879 3.271 . . . . 25.5 107.949 176.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -101.37 168.49 9.5 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.831 2.052 . . . . 11.949999999999999 111.811 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 94.1 mt -64.26 -25.87 68.25 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 131.713 4.005 . . . . 10.17 111.677 173.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.1 t -59.6 -46.45 88.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.363 -3.336 . . . . 13.59 114.744 170.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.8 -40.0 87.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.675 -2.057 . . . . 11.699999999999999 110.363 -175.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.444 ' HB2' HD12 ' A' ' 61' ' ' ILE . 25.9 m-85 -85.05 -2.38 57.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 121.789 0.804 . . . . 12.949999999999999 109.486 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m120 65.09 46.7 2.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.274 2.464 . . . . 25.449999999999999 112.724 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 59' ' ' TYR . 10.0 mt -90.02 114.12 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.985 -2.322 . . . . 14.6 110.175 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -97.16 166.18 11.7 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.194 2.998 . . . . 33.229999999999997 112.188 -175.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 ttpp -55.63 134.11 50.95 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 115.88 1.808 . . . . 25.969999999999999 115.88 170.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 55.55 58.12 4.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.179 -1.828 . . . . 32.609999999999999 111.78 -175.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 t -115.74 142.82 46.24 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.25 1.42 . . . . 10.56 108.972 173.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -98.5 124.18 43.08 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.66 1.695 . . . . 5.3300000000000001 115.47 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 mt -99.79 156.59 17.03 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.152 3.381 . . . . 11.66 107.681 172.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -129.07 122.21 29.47 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.44 -2.059 . . . . 16.300000000000001 105.44 -172.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.8 tp -87.43 105.76 17.5 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 112.886 -1.961 . . . . 9.9600000000000009 111.32 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 m -104.95 178.15 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 127.74 2.416 . . . . 9.7599999999999998 112.507 168.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.6 mt -75.93 174.18 10.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.877 2.275 . . . . 19.57 115.711 176.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -59.04 -65.4 0.67 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.668 -3.145 . . . . 35.079999999999998 112.907 -177.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.6 tp -89.9 -61.26 1.73 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 116.021 -0.536 . . . . 32.310000000000002 111.118 -172.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -87.47 142.35 27.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 117.666 2.469 . . . . 42.75 117.666 -168.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -162.38 156.78 28.52 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 119.235 -1.459 . . . . 36.310000000000002 112.627 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.764 0 CA-C-O 124.058 1.921 . . . . 36.270000000000003 116.181 176.308 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 ttp . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 122.407 1.098 . . . . 17.170000000000002 108.85 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -82.65 135.95 34.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.065 -1.647 . . . . 21.890000000000001 108.184 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.8 pt -127.77 166.46 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 124.789 1.236 . . . . 10.83 109.296 165.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -125.61 104.05 8.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 105.563 -2.014 . . . . 10.609999999999999 105.563 -167.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -95.43 105.12 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.515 -2.031 . . . . 9.1300000000000008 105.515 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.1 ttmt -108.68 126.15 52.67 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 121.474 0.654 . . . . 20.550000000000001 110.125 -174.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.6 p -80.69 -179.35 7.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.504 1.668 . . . . 11.779999999999999 115.504 -176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.0 tp -68.06 -43.32 78.9 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 116.004 -4.185 . . . . 19.309999999999999 112.056 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -84.99 -21.22 29.59 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 113.271 -1.786 . . . . 23.140000000000001 108.927 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.28 70.82 0.93 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-O 124.928 2.404 . . . . 19.739999999999998 115.957 166.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.8 tttt -116.66 118.48 32.68 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 110.398 -2.901 . . . . 21.93 106.724 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -90.39 103.7 16.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 127.245 2.841 . . . . 12.33 110.383 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.2 mt -94.42 98.79 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.746 2.418 . . . . 17.079999999999998 113.075 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.5 m -73.47 122.42 22.11 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 119.991 1.268 . . . . 16.300000000000001 113.068 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.95 147.87 37.82 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.765 -3.709 . . . . 15.880000000000001 102.816 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -105.32 134.92 47.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.819 1.771 . . . . 28.899999999999999 108.209 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -148.87 -174.52 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.57 3.148 . . . . 12.050000000000001 105.968 -178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -141.6 162.77 45.08 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 114.75 -2.548 . . . . 18.170000000000002 108.227 170.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -61.27 -23.23 76.64 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 C-N-CA 127.014 5.142 . . . . 8.1600000000000001 118.024 -169.15 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 5.3 p -94.28 -6.05 45.36 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.559 2.344 . . . . 11.130000000000001 110.683 -176.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -74.93 167.09 22.58 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.495 -3.878 . . . . 18.030000000000001 115.201 166.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 2.4 p -89.42 170.13 10.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.283 2.697 . . . . 10.220000000000001 118.283 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mt -87.63 -13.15 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 117.53 -1.668 . . . . 12.300000000000001 108.527 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -59.31 -47.51 85.14 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.01 1.324 . . . . 36.509999999999998 113.556 160.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -55.83 -40.67 73.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.134 -2.854 . . . . 25.66 116.104 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.9 t -52.63 -54.93 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 117.145 -3.472 . . . . 8.1199999999999992 113.213 167.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -61.22 -30.12 70.24 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 125.791 1.636 . . . . 15.470000000000001 114.955 172.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -30.24 70.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.528 3.531 . . . . 11.449999999999999 113.997 166.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -92.78 -14.4 27.9 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 116.742 -1.983 . . . . 24.98 112.174 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.27 67.8 mt -64.2 -36.18 76.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 123.398 1.57 . . . . 9.4600000000000009 114.418 158.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -67.76 -21.52 65.26 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 117.748 -3.095 . . . . 14.76 116.112 172.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.48 -58.63 2.66 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.085 -2.561 . . . . 26.289999999999999 104.085 -175.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.6 mtpp -64.83 -62.06 1.8 Allowed 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.112 2.565 . . . . 30.059999999999999 115.89 176.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -81.16 -58.15 3.19 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.302 1.864 . . . . 25.190000000000001 111.734 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.25 17.35 3.67 Favored Glycine 0 N--CA 1.43 -1.706 0 N-CA-C 109.111 -1.596 . . . . 7.4100000000000001 109.111 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.1 mt -90.58 131.21 38.65 Favored Pre-proline 0 N--CA 1.431 -1.418 0 CA-C-O 115.445 -2.217 . . . . 9.4900000000000002 109.085 -175.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -66.18 156.59 64.08 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 125.497 2.999 . . . . 11.42 116.606 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -68.73 -23.03 36.4 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 124.374 3.383 . . . . 12.0 112.319 -175.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.252 10.1 p-10 -77.85 -28.46 50.09 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.248 3.019 . . . . 35.549999999999997 107.801 -170.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -69.38 -35.4 75.78 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 120.192 -1.568 . . . . 20.52 110.841 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -96.39 133.56 40.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 118.237 -0.887 . . . . 7.1299999999999999 111.606 -151.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -111.61 131.87 54.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 103.274 -2.861 . . . . 36.390000000000001 103.274 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.9 mt -116.91 125.06 50.92 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.24 1.495 . . . . 9.5500000000000007 110.724 170.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 23.2 mm -95.11 132.32 39.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.288 2.235 . . . . 13.9 114.298 170.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -123.17 115.94 22.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.481 -2.637 . . . . 6.8600000000000003 109.013 173.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.84 -102.56 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 115.364 -0.835 . . . . 11.15 110.007 -172.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.42 34.2 2.39 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 118.822 -2.424 . . . . 13.93 113.017 164.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.345 21.2 ttmm -120.16 144.11 47.85 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 112.735 -1.732 . . . . 23.920000000000002 115.145 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -81.42 135.49 35.65 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.763 1.744 . . . . 23.23 113.372 171.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.8 mt -89.26 145.74 25.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.069 -2.197 . . . . 9.1099999999999994 105.069 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -87.12 160.78 18.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.013 -2.422 . . . . 33.439999999999998 114.41 159.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.95 -41.55 13.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.888 2.551 . . . . 28.370000000000001 117.888 -174.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.58 17.87 58.5 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 116.7 -2.667 . . . . 15.0 108.473 -170.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -90.18 165.92 13.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.163 -3.551 . . . . 25.5 109.817 161.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.9 p -102.13 174.26 6.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.849 3.214 . . . . 11.949999999999999 104.111 -176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -67.14 -37.5 83.91 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.691 2.796 . . . . 10.17 109.783 178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.254 67.7 m -61.5 -42.67 99.15 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 113.241 0.83 . . . . 13.59 113.241 176.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.1 m-20 -53.0 -44.45 67.26 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 121.057 3.725 . . . . 11.699999999999999 121.057 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -79.33 -15.76 57.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 125.715 1.884 . . . . 12.949999999999999 115.865 165.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.4 m120 68.56 71.57 0.29 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.357 2.663 . . . . 25.449999999999999 110.303 -169.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.274 82.4 mt -109.15 114.51 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 113.332 -3.347 . . . . 14.6 110.004 174.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -100.13 -166.39 1.32 Allowed 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.9 2.185 . . . . 33.229999999999997 116.9 -171.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.83 137.62 55.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.63 1.681 . . . . 25.969999999999999 112.197 -171.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.47 80.4 mt-10 72.74 12.12 5.35 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 116.703 -3.748 . . . . 32.609999999999999 118.091 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.1 t -86.46 137.66 32.37 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 125.763 1.914 . . . . 10.56 108.704 -165.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.5 m -87.25 115.34 24.59 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 113.234 -1.803 . . . . 5.3300000000000001 112.147 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.1 mt -93.13 149.69 21.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.402 -1.436 . . . . 11.66 109.368 167.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.572 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 77.7 m-70 -99.72 109.75 22.19 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 125.871 1.982 . . . . 16.300000000000001 109.972 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.1 tp -96.41 117.68 31.38 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.292 2.473 . . . . 9.9600000000000009 110.303 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.4 t -92.65 130.88 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 C-N-CA 128.607 2.763 . . . . 9.7599999999999998 106.339 164.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.5 mt -118.54 139.71 51.03 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 107.115 -1.439 . . . . 19.57 107.115 161.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -92.12 -54.09 3.98 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.615 2.366 . . . . 35.079999999999998 108.793 -159.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 98.2 mt -88.73 -68.4 0.77 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.801 2.715 . . . . 32.310000000000002 113.245 -168.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.8 ttt180 -86.25 -64.54 1.13 Allowed 'General case' 0 N--CA 1.431 -1.414 1 O-C-N 115.15 -4.719 . . . . 42.75 116.977 -178.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.37 -147.09 17.54 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.877 -0.889 . . . . 36.310000000000002 110.877 -161.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.761 0 O-C-N 121.298 -1.119 . . . . 36.270000000000003 114.487 176.237 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.4 ttp . . . . . 0 CA--C 1.49 -1.342 0 CA-C-O 121.162 0.506 . . . . 17.170000000000002 109.732 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -84.82 125.29 32.47 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.723 -2.486 . . . . 21.890000000000001 114.667 -178.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.264 8.7 pt -114.04 165.25 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 124.109 3.14 . . . . 10.83 104.415 167.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -106.47 138.43 42.66 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 111.0 -2.818 . . . . 10.609999999999999 111.96 166.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.0 t -118.67 103.41 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.657 3.122 . . . . 9.1300000000000008 105.77 166.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -88.42 134.92 33.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.544 -2.598 . . . . 20.550000000000001 111.101 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.563 HG22 HD23 ' A' ' 69' ' ' LEU . 71.4 p -81.56 -170.51 2.83 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 123.791 2.996 . . . . 11.779999999999999 114.46 169.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 18.7 tp -100.74 -27.72 13.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.399 2.047 . . . . 19.309999999999999 112.907 -171.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.1 p -69.33 -41.79 76.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.529 -3.232 . . . . 23.140000000000001 107.598 160.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.68 72.1 0.67 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 117.959 -2.963 . . . . 19.739999999999998 116.045 173.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -123.97 133.63 53.65 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 116.074 -1.917 . . . . 21.93 109.476 160.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.4 m -93.57 105.01 17.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.277 2.86 . . . . 12.33 109.313 -170.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.413 HG23 ' HD2' ' A' ' 33' ' ' LYS . 3.5 mt -95.34 118.86 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 CA-C-O 129.507 4.479 . . . . 17.079999999999998 110.267 178.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.42 102.77 14.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.017 -3.552 . . . . 16.300000000000001 112.609 -175.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -90.56 129.44 36.7 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.282 -2.136 . . . . 15.880000000000001 110.65 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -98.04 92.09 5.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 127.145 3.355 . . . . 28.899999999999999 106.667 177.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -102.81 174.25 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 130.979 3.712 . . . . 12.050000000000001 110.063 -173.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.349 73.6 mm-40 -115.36 141.53 27.34 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 112.594 -3.574 . . . . 18.170000000000002 105.51 163.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -56.25 -16.16 16.71 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 N-CA-C 119.879 2.992 . . . . 8.1600000000000001 119.879 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -82.15 -10.86 59.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.971 1.843 . . . . 11.130000000000001 111.922 175.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -74.0 142.94 45.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.58 -3.825 . . . . 18.030000000000001 118.028 173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 p -92.0 152.52 19.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.635 1.683 . . . . 10.220000000000001 108.25 -171.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.2 mm -57.68 -27.1 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 116.287 1.958 . . . . 12.300000000000001 116.287 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.318 37.0 tt0 -64.23 -45.21 89.22 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.616 1.674 . . . . 36.509999999999998 115.415 166.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.2 m-80 -73.04 -29.2 62.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.506 -3.871 . . . . 25.66 113.05 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.94 -46.85 84.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.244 -2.785 . . . . 8.1199999999999992 107.026 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -60.19 -18.19 46.44 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.991 1.716 . . . . 15.470000000000001 114.96 171.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.16 -24.09 40.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.556 -2.59 . . . . 11.449999999999999 112.17 169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.1 mttt -78.81 -36.02 43.29 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.757 -4.34 . . . . 24.98 107.666 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.3 mt -69.72 -37.45 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 125.994 2.059 . . . . 9.4600000000000009 109.82 174.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -54.64 -53.52 53.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.713 1.597 . . . . 14.76 114.468 157.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -64.77 -30.29 71.29 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 123.128 2.695 . . . . 26.289999999999999 116.688 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.413 ' HD2' HG23 ' A' ' 13' ' ' ILE . 15.0 mttm -61.24 -67.1 0.44 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 126.289 2.947 . . . . 30.059999999999999 113.857 168.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -95.83 -48.47 5.73 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.872 -2.392 . . . . 25.190000000000001 113.123 -160.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.45 12.57 10.52 Favored Glycine 0 N--CA 1.431 -1.68 0 CA-C-N 113.744 -1.571 . . . . 7.4100000000000001 114.108 -172.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.3 mt -97.0 113.48 63.06 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 107.881 -1.155 . . . . 9.4900000000000002 107.881 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 13.7 Cg_exo -76.91 164.1 30.3 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 CA-C-N 125.445 2.98 . . . . 11.42 109.813 -169.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 37' ' ' PRO 0.256 68.0 Cg_exo -63.33 -31.16 73.48 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 N-CA-C 120.827 3.357 . . . . 12.0 120.827 -166.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -97.95 9.0 43.84 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 118.331 -1.347 . . . . 35.549999999999997 111.38 -178.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -78.86 -24.49 44.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.361 2.346 . . . . 20.52 111.889 156.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -83.5 144.79 29.31 Favored 'General case' 0 N--CA 1.429 -1.481 1 N-CA-C 121.811 4.004 . . . . 7.1299999999999999 121.811 -175.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -136.19 111.4 9.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 103.965 -2.606 . . . . 36.390000000000001 103.965 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.6 mt -97.85 120.39 38.16 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 117.655 -1.618 . . . . 9.5500000000000007 115.282 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.7 mm -99.85 133.62 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 128.001 3.762 . . . . 13.9 109.924 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -125.69 114.88 19.25 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.025 -4.797 . . . . 6.8600000000000003 105.625 157.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.65 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 131.803 4.041 . . . . 11.15 109.17 -170.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -137.91 7.17 3.52 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 128.384 2.897 . . . . 13.93 112.332 172.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.307 24.5 ttmm -98.7 137.72 36.91 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 122.113 2.957 . . . . 23.920000000000002 108.483 -177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -96.53 127.95 43.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.428 -2.045 . . . . 23.23 107.398 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 99.2 mt -83.71 152.02 24.94 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 112.742 -2.026 . . . . 9.1099999999999994 106.69 -164.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -99.07 141.46 31.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.961 3.304 . . . . 33.439999999999998 117.355 177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.14 -43.96 98.08 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 121.612 3.93 . . . . 28.370000000000001 121.612 -171.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.22 35.37 5.06 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 125.421 1.486 . . . . 15.0 110.028 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mtt-85 -117.65 157.41 26.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 112.845 0.683 . . . . 25.5 112.845 161.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.3 p -101.54 164.97 11.49 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 126.068 2.842 . . . . 11.949999999999999 113.494 -169.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 24.0 mt -56.26 -41.95 76.6 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.144 -4.722 . . . . 10.17 115.467 176.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.1 t -63.77 -33.12 74.95 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 130.305 3.442 . . . . 13.59 114.884 -178.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -68.22 -50.13 56.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.926 2.89 . . . . 11.699999999999999 107.583 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -76.93 -1.84 30.64 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.217 -2.177 . . . . 12.949999999999999 113.514 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.9 t30 54.28 68.46 0.85 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.762 3.625 . . . . 25.449999999999999 110.11 -170.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -108.89 102.61 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 127.473 2.309 . . . . 14.6 108.17 168.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -90.74 -174.05 3.93 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 114.052 1.131 . . . . 33.229999999999997 114.052 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -59.02 154.88 14.65 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.605 -3.184 . . . . 25.969999999999999 115.218 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 64.97 25.57 12.71 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.535 4.334 . . . . 32.609999999999999 113.256 169.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -82.48 130.99 35.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 124.306 1.043 . . . . 10.56 109.647 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.6 m -83.11 113.04 20.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 108.178 -1.045 . . . . 5.3300000000000001 108.178 178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -102.52 149.57 24.26 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.758 -1.941 . . . . 11.66 105.758 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -113.99 116.69 29.61 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 120.531 -1.356 . . . . 16.300000000000001 111.714 -176.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.563 HD23 HG22 ' A' ' 7' ' ' THR . 44.7 tp -84.6 125.76 32.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.02 2.819 . . . . 9.9600000000000009 111.11 171.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -118.81 123.54 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 130.382 3.473 . . . . 9.7599999999999998 111.849 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.486 HD21 HD21 ' A' ' 69' ' ' LEU . 75.8 mt -95.6 146.34 24.55 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.745 1.736 . . . . 19.57 107.48 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -78.29 -62.22 1.75 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.783 2.23 . . . . 35.079999999999998 105.47 -164.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.8 mt -87.47 -44.5 11.27 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 118.627 2.825 . . . . 32.310000000000002 118.627 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -83.48 102.84 12.37 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.478 2.085 . . . . 42.75 116.195 -173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -95.1 37.75 3.32 Favored Glycine 0 N--CA 1.43 -1.739 1 C-N-CA 130.983 4.135 . . . . 36.310000000000002 109.029 -173.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.725 0 N-CA-C 108.708 -1.757 . . . . 36.270000000000003 108.708 174.06 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 120.912 0.387 . . . . 17.170000000000002 111.451 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.263 52.5 mt-30 -114.8 138.61 50.55 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.485 1.291 . . . . 21.890000000000001 114.485 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.413 HG13 ' HB2' ' A' ' 15' ' ' LEU . 10.9 pt -116.19 140.47 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 119.825 -1.797 . . . . 10.83 110.337 174.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -99.81 115.47 29.64 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.261 1.505 . . . . 10.609999999999999 111.069 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -100.36 107.42 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 CA-C-O 115.123 -2.37 . . . . 9.1300000000000008 107.98 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.264 19.5 ttmm -90.64 124.34 34.99 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 126.398 2.311 . . . . 20.550000000000001 110.943 -176.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.7 p -74.65 164.27 26.77 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 121.241 1.837 . . . . 11.779999999999999 109.595 174.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.1 tp -71.59 -22.57 61.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.64 1.348 . . . . 19.309999999999999 114.64 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.253 27.4 p -72.42 -78.55 0.08 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 128.602 2.761 . . . . 23.140000000000001 111.235 173.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.06 43.64 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.707 1 C-N-CA 132.117 4.675 . . . . 19.739999999999998 114.801 170.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -117.16 143.57 45.69 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 102.927 -2.99 . . . . 21.93 102.927 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.4 m -123.24 115.5 21.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 106.299 -1.741 . . . . 12.33 106.299 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.5 mp -97.73 132.64 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.084 -2.26 . . . . 17.079999999999998 109.396 176.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.3 m -101.85 100.54 10.87 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.736 -1.95 . . . . 16.300000000000001 105.736 -172.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.413 ' HB2' HG13 ' A' ' 3' ' ' ILE 0.277 62.0 mt -97.89 137.03 37.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.955 2.788 . . . . 15.880000000000001 104.108 179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -85.95 118.68 25.58 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.686 -3.134 . . . . 28.899999999999999 112.007 168.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 56' ' ' LEU . 31.6 m -131.02 158.46 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 103.738 -2.69 . . . . 12.050000000000001 103.738 -169.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -92.95 146.91 32.92 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 113.467 -3.158 . . . . 18.170000000000002 114.001 158.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.74 -7.92 22.09 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 CA-C-N 124.617 2.685 . . . . 8.1600000000000001 114.069 -173.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.0 p -90.92 -7.4 52.24 Favored 'General case' 0 N--CA 1.43 -1.457 1 C-N-CA 132.969 4.508 . . . . 11.130000000000001 113.654 174.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -68.78 153.11 44.37 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.231 -2.793 . . . . 18.030000000000001 114.666 175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -106.42 163.15 13.09 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 108.169 -1.049 . . . . 10.220000000000001 108.169 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 mm -65.9 -28.69 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 121.011 -1.055 . . . . 12.300000000000001 110.827 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -44.49 -41.31 6.27 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 120.78 3.622 . . . . 36.509999999999998 120.78 157.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -80.33 -29.22 38.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.009 -3.557 . . . . 25.66 113.499 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.97 -38.77 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 105.09 -2.189 . . . . 8.1199999999999992 105.09 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -70.91 -42.26 70.16 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.248 1.819 . . . . 15.470000000000001 113.543 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.8 -43.64 27.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 124.444 2.069 . . . . 11.449999999999999 111.789 169.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm -77.3 -31.66 54.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.79 -3.069 . . . . 24.98 109.032 -173.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.6 mt -70.61 -40.79 77.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.188 -3.445 . . . . 9.4600000000000009 115.834 171.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -50.26 -47.69 55.1 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 133.055 4.542 . . . . 14.76 109.435 172.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -60.28 -56.55 20.12 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 123.212 1.482 . . . . 26.289999999999999 113.744 171.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.5 mttm -74.15 -37.89 63.89 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.384 3.476 . . . . 30.059999999999999 120.384 -177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.2 mm-40 -107.83 -40.13 5.36 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.401 1.909 . . . . 25.190000000000001 114.233 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.2 44.23 4.45 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 120.598 1.545 . . . . 7.4100000000000001 112.963 -169.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.8 mt -111.68 126.6 28.24 Favored Pre-proline 0 N--CA 1.43 -1.426 0 N-CA-C 100.314 -3.958 . . . . 9.4900000000000002 100.314 175.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_exo -67.35 153.41 77.04 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 C-N-CA 126.335 4.69 . . . . 11.42 115.765 -174.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -78.27 -18.89 12.29 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 CA-C-N 126.412 3.326 . . . . 12.0 112.998 -172.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.9 -11.76 60.91 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 114.885 -2.483 . . . . 35.549999999999997 115.69 165.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.0 tp-100 -97.07 -16.73 20.39 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 121.901 2.137 . . . . 20.52 112.763 -177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 76.7 mt-30 -92.04 118.07 30.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.747 3.154 . . . . 7.1299999999999999 111.098 -176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -116.37 111.02 19.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 105.933 -1.877 . . . . 36.390000000000001 105.933 170.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.5 mt -86.75 113.94 23.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.879 2.752 . . . . 9.5500000000000007 110.638 176.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.2 mm -99.43 142.12 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 118.243 -2.786 . . . . 13.9 105.878 169.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.48 ' HB2' HD11 ' A' ' 50' ' ' LEU . 25.5 t80 -128.65 112.24 14.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.69 -1.881 . . . . 6.8600000000000003 108.08 171.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.33 . . 68.86 -91.65 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.343 -3.973 . . . . 11.15 117.354 -162.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.68 34.68 0.95 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 118.842 -1.646 . . . . 13.93 111.804 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -149.98 144.83 26.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 129.513 3.714 . . . . 23.920000000000002 113.709 173.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -73.43 134.41 43.98 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 125.832 2.73 . . . . 23.23 115.125 -176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.48 HD11 ' HB2' ' A' ' 45' ' ' PHE . 14.7 mt -86.51 151.1 23.78 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 110.727 -2.942 . . . . 9.1099999999999994 109.925 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -130.36 133.31 46.31 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.216 -3.428 . . . . 33.439999999999998 105.214 -158.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -40.45 -58.8 1.47 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 130.466 3.506 . . . . 28.370000000000001 117.789 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.7 14.16 43.6 Favored Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 121.055 1.752 . . . . 15.0 114.288 -169.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.5 mtt-85 -113.44 159.68 19.23 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.671 -2.664 . . . . 25.5 108.626 -172.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 p -114.27 -178.12 3.29 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.476 -3.265 . . . . 11.949999999999999 112.571 -172.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 17' ' ' VAL . 71.3 mt -74.51 -28.71 61.11 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 110.656 -2.975 . . . . 10.17 114.319 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.6 m -65.52 -31.11 72.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 119.167 3.025 . . . . 13.59 119.167 170.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -65.89 -45.63 81.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 127.62 3.075 . . . . 11.699999999999999 110.388 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -92.38 -8.41 44.97 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.695 -2.098 . . . . 12.949999999999999 109.51 -174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 60.35 54.24 4.0 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.508 3.051 . . . . 25.449999999999999 114.305 -179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.0 mt -93.44 108.39 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 109.602 -3.454 . . . . 14.6 105.744 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -88.2 -179.09 6.08 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 124.769 2.223 . . . . 33.229999999999997 111.419 178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.269 17.9 pttp -53.37 141.69 23.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.723 -3.111 . . . . 25.969999999999999 116.146 159.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 70.98 20.87 5.15 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.785 -3.072 . . . . 32.609999999999999 112.545 168.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -89.71 135.21 33.75 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.972 3.709 . . . . 10.56 114.786 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -95.0 117.71 30.6 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.869 2.914 . . . . 5.3300000000000001 118.869 -177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 mp -108.83 151.35 26.36 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 104.89 -2.263 . . . . 11.66 104.89 -178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -107.13 140.66 39.62 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 106.231 -1.766 . . . . 16.300000000000001 106.231 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.6 tp -106.37 106.48 17.02 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.535 1.772 . . . . 9.9600000000000009 111.952 169.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.3 t -94.42 134.33 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 126.948 2.655 . . . . 9.7599999999999998 107.029 173.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.9 mt -77.06 126.88 31.69 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.417 -0.811 . . . . 19.57 110.314 166.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.1 mtp180 -68.86 -82.31 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.286 2.946 . . . . 35.079999999999998 117.162 -179.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.8 tp -77.64 -42.42 34.9 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 112.528 -2.124 . . . . 32.310000000000002 109.813 -175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.1 mtp180 -68.81 143.08 54.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.409 2.683 . . . . 42.75 115.645 169.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.62 -53.64 4.57 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 128.984 3.183 . . . . 36.310000000000002 113.306 159.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.738 0 CA-C-O 116.067 -2.518 . . . . 36.270000000000003 108.106 -169.088 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 112.505 0.558 . . . . 17.170000000000002 112.505 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -102.73 147.86 26.32 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.517 3.532 . . . . 21.890000000000001 112.94 170.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.3 pt -128.6 163.66 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 1 O-C-N 115.802 -4.311 . . . . 10.83 103.908 169.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.57 101.67 7.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 105.057 -2.201 . . . . 10.609999999999999 105.057 -178.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.0 t -93.53 123.3 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 107.015 -1.476 . . . . 9.1300000000000008 107.015 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -124.36 152.75 42.78 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.246 1.839 . . . . 20.550000000000001 111.004 -171.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.1 p -88.42 -178.37 5.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 115.614 1.709 . . . . 11.779999999999999 115.614 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.269 36.1 tp -67.77 -40.08 84.04 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.719 2.859 . . . . 19.309999999999999 118.719 158.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.2 -56.55 7.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.899 -2.376 . . . . 23.140000000000001 111.74 -169.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.74 24.52 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 119.03 -2.294 . . . . 19.739999999999998 115.197 -177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -100.38 148.48 24.66 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.911 -3.111 . . . . 21.93 115.849 166.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.8 m -125.34 135.77 52.79 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.744 2.818 . . . . 12.33 104.883 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 52.6 mt -121.59 110.78 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 103.273 -2.862 . . . . 17.079999999999998 103.273 174.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.7 m -79.57 118.72 21.67 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.07 -1.644 . . . . 16.300000000000001 113.852 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.7 mt -112.68 145.12 41.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.425 -3.297 . . . . 15.880000000000001 113.119 -174.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -100.61 98.25 8.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.496 -1.668 . . . . 28.899999999999999 106.496 174.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.0 m -104.42 174.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 124.883 1.364 . . . . 12.050000000000001 113.025 174.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -121.02 152.02 55.96 Favored Pre-proline 0 N--CA 1.43 -1.462 0 C-N-CA 127.367 2.267 . . . . 18.170000000000002 106.213 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -68.35 -14.72 40.87 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 122.784 2.03 . . . . 8.1600000000000001 115.224 -172.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.255 53.3 p -99.8 1.34 43.0 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.737 2.815 . . . . 11.130000000000001 114.596 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.264 11.3 m-20 -71.0 155.23 41.08 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.882 2.277 . . . . 18.030000000000001 110.638 161.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.2 p -85.36 161.68 19.37 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.04 2.829 . . . . 10.220000000000001 108.487 173.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.9 mm -57.01 -29.12 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.161 -2.837 . . . . 12.300000000000001 115.068 163.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -62.68 -46.65 87.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.021 -3.55 . . . . 36.509999999999998 109.538 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.5 m-20 -52.85 -52.75 56.07 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 124.892 1.277 . . . . 25.66 113.325 177.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -45.12 -50.35 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 125.911 1.684 . . . . 8.1199999999999992 113.409 173.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -60.19 -36.21 77.12 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.038 1.875 . . . . 15.470000000000001 115.011 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.52 -38.97 82.36 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.641 -2.537 . . . . 11.449999999999999 116.408 170.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.7 mttm -63.92 -40.03 95.54 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 115.795 1.776 . . . . 24.98 115.795 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.5 mt -60.05 -45.2 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 1 C-N-CA 135.097 5.359 . . . . 9.4600000000000009 110.693 168.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -54.54 -48.23 72.25 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.991 1.717 . . . . 14.76 113.386 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.21 -35.57 80.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.535 2.05 . . . . 26.289999999999999 116.535 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -87.37 -46.31 9.77 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.637 1.684 . . . . 30.059999999999999 114.694 -172.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -78.63 -55.61 5.06 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 114.225 -1.352 . . . . 25.190000000000001 114.51 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.1 44.84 1.97 Allowed Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 110.066 -1.213 . . . . 7.4100000000000001 110.066 -175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.413 HG22 ' HB3' ' A' ' 40' ' ' GLN . 6.8 mt -125.38 127.24 25.0 Favored Pre-proline 0 N--CA 1.43 -1.44 0 N-CA-C 104.806 -2.294 . . . . 9.4900000000000002 104.806 179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 41.9 Cg_exo -67.22 160.36 47.92 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-O 115.998 -1.751 . . . . 11.42 116.052 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.6 Cg_exo -70.29 -27.34 24.05 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 C-N-CA 124.74 3.626 . . . . 12.0 110.993 -169.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -77.64 -37.2 50.49 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 117.92 -1.038 . . . . 35.549999999999997 109.457 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HB3' HG22 ' A' ' 36' ' ' ILE . 7.1 tp-100 -59.96 -33.08 71.45 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.559 2.344 . . . . 20.52 115.498 178.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -98.93 145.32 27.15 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.346 2.022 . . . . 7.1299999999999999 116.418 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 -115.03 153.71 30.18 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.692 2.797 . . . . 36.390000000000001 107.683 165.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.4 tp -133.93 114.89 13.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.413 1.085 . . . . 9.5500000000000007 108.966 -171.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.4 mm -103.71 128.57 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 117.26 -3.4 . . . . 13.9 112.452 -171.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -109.87 128.62 55.46 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.02 1.328 . . . . 6.8600000000000003 108.674 160.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.42 -108.25 0.42 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.81 -2.432 . . . . 11.15 112.262 -168.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.67 31.55 3.53 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 109.212 -1.555 . . . . 13.93 109.212 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.6 tttp -121.8 124.18 43.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.269 1.428 . . . . 23.920000000000002 111.054 -171.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -76.31 107.41 8.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.217 1.807 . . . . 23.23 110.682 175.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 70.7 mt -82.82 136.63 34.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.247 1.019 . . . . 9.1099999999999994 111.696 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -93.24 159.1 15.42 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 124.483 2.087 . . . . 33.439999999999998 111.101 -177.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -73.15 -42.07 63.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.226 -2.796 . . . . 28.370000000000001 108.764 -156.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.84 41.5 2.13 Favored Glycine 0 N--CA 1.43 -1.759 0 O-C-N 117.217 -3.427 . . . . 15.0 113.01 -165.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -122.37 159.71 26.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.158 2.328 . . . . 25.5 108.842 166.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.9 p -85.99 167.92 14.62 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.964 2.106 . . . . 11.949999999999999 116.396 169.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.0 mt -68.36 -26.66 65.7 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 120.794 -1.191 . . . . 10.17 111.416 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.0 t -76.37 -40.76 50.24 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 118.431 2.752 . . . . 13.59 118.431 173.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -43.16 -48.11 6.35 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.922 -2.361 . . . . 11.699999999999999 117.251 158.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -78.85 -6.99 57.49 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 120.575 3.546 . . . . 12.949999999999999 120.575 170.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 t30 53.75 40.06 31.04 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.064 2.616 . . . . 25.449999999999999 118.064 -169.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.8 mt -81.47 118.91 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 105.044 -2.206 . . . . 14.6 105.044 -177.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -81.31 -173.07 4.13 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.878 2.751 . . . . 33.229999999999997 113.79 -176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -74.42 146.06 43.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.009 -2.932 . . . . 25.969999999999999 112.605 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 65.57 30.16 10.7 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.364 1.665 . . . . 32.609999999999999 114.821 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -79.45 152.53 30.24 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 103.763 -2.68 . . . . 10.56 103.763 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.6 m -103.51 124.16 48.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.103 2.961 . . . . 5.3300000000000001 108.309 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.282 4.9 mp -117.11 162.13 18.32 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 126.106 1.762 . . . . 11.66 107.894 176.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -119.27 127.08 52.9 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.705 -2.497 . . . . 16.300000000000001 111.182 178.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -86.72 107.73 18.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.414 2.686 . . . . 9.9600000000000009 114.739 175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.0 t -122.12 121.34 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 108.057 -1.09 . . . . 9.7599999999999998 108.057 -171.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.402 HD11 HD13 ' A' ' 36' ' ' ILE . 7.9 mp -107.35 138.24 43.91 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 117.092 -1.843 . . . . 19.57 110.151 -177.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -65.48 -87.8 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.288 1.588 . . . . 35.079999999999998 115.288 -174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.5 tp -82.37 -63.52 1.36 Allowed 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 116.561 -1.685 . . . . 32.310000000000002 113.181 -172.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -92.57 150.55 20.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.692 -2.336 . . . . 42.75 104.692 -171.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.02 62.57 0.53 Allowed Glycine 0 N--CA 1.429 -1.772 0 N-CA-C 105.908 -2.877 . . . . 36.310000000000002 105.908 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.749 0 C-N-CA 125.63 1.586 . . . . 36.270000000000003 111.918 -171.71 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 112.747 0.647 . . . . 17.170000000000002 112.747 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -95.95 121.8 38.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.907 -1.886 . . . . 21.890000000000001 105.907 -176.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.6 pt -109.62 164.85 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 107.268 -1.382 . . . . 10.83 107.268 170.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -114.83 105.79 13.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.432 -2.433 . . . . 10.609999999999999 104.432 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.4 t -86.57 124.84 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 126.931 3.253 . . . . 9.1300000000000008 109.483 166.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -106.4 134.62 49.25 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.431 -2.668 . . . . 20.550000000000001 107.684 -173.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.253 47.5 p -75.79 161.14 29.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.775 2.03 . . . . 11.779999999999999 112.042 170.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.5 tp -59.28 -37.93 78.88 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.378 -3.326 . . . . 19.309999999999999 115.613 176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.8 p -68.1 -64.58 0.83 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.651 2.167 . . . . 23.140000000000001 115.085 169.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.51 71.55 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.743 0 O-C-N 117.113 -3.492 . . . . 19.739999999999998 107.826 174.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -104.02 160.14 15.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 118.549 1.174 . . . . 21.93 113.885 147.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.1 m -90.96 118.98 30.78 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 115.824 -4.298 . . . . 12.33 105.92 168.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mt -97.71 119.17 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-O 123.914 1.816 . . . . 17.079999999999998 107.737 156.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 84.7 m -98.96 108.65 21.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 111.595 -2.548 . . . . 16.300000000000001 106.723 177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.447 ' CD1' HG13 ' A' ' 26' ' ' VAL . 87.7 mt -107.2 116.87 32.69 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.598 2.359 . . . . 15.880000000000001 115.719 177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -78.31 112.42 15.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.531 -1.668 . . . . 28.899999999999999 110.211 167.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.29 158.32 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 123.284 0.634 . . . . 12.050000000000001 109.949 167.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 56.7 mt-10 -115.79 151.73 46.65 Favored Pre-proline 0 N--CA 1.429 -1.478 0 N-CA-C 102.834 -3.024 . . . . 18.170000000000002 102.834 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 22.1 Cg_exo -76.03 -16.4 18.02 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 CA-C-O 114.889 -2.213 . . . . 8.1600000000000001 113.456 -159.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -70.51 -14.83 62.68 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-N 127.26 4.573 . . . . 11.130000000000001 112.931 169.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 18.3 m-20 -78.32 146.8 34.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 116.703 -3.748 . . . . 18.030000000000001 106.19 -177.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.7 p -78.77 167.89 20.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.336 -3.978 . . . . 10.220000000000001 116.489 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.95 -39.88 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 117.427 -1.273 . . . . 12.300000000000001 110.234 173.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -51.1 -39.51 56.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 123.422 2.828 . . . . 36.509999999999998 113.233 170.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -57.57 -38.67 75.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.565 -1.335 . . . . 25.66 112.811 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.447 HG13 ' CD1' ' A' ' 15' ' ' LEU . 58.5 t -56.77 -54.42 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-O 125.925 2.774 . . . . 8.1199999999999992 111.183 176.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -56.57 -37.38 70.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.981 3.326 . . . . 15.470000000000001 119.981 171.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.23 -32.08 69.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.231 1.491 . . . . 11.449999999999999 112.475 175.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.2 mttm -80.22 -27.89 38.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 118.585 -1.246 . . . . 24.98 108.461 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.9 mt -58.65 -42.21 84.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 114.749 1.389 . . . . 9.4600000000000009 114.749 159.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -65.05 -24.91 67.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.867 -2.395 . . . . 14.76 115.96 173.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.23 -59.82 3.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.442 -3.287 . . . . 26.289999999999999 109.445 166.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -73.1 -56.83 4.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.331 2.715 . . . . 30.059999999999999 118.331 -175.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -93.95 -53.3 4.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 125.751 1.621 . . . . 25.190000000000001 115.094 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.52 2.9 6.21 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-O 125.173 2.54 . . . . 7.4100000000000001 115.995 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.5 mt -68.18 127.55 93.27 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-O 113.691 -3.052 . . . . 9.4900000000000002 112.767 -179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -70.63 155.57 62.82 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 126.974 3.527 . . . . 11.42 115.337 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -62.45 -39.45 45.78 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 CA-C-N 124.552 2.661 . . . . 12.0 110.636 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -63.73 -8.7 11.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.65 2.833 . . . . 35.549999999999997 118.65 170.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -94.68 -32.26 13.45 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 118.785 -2.447 . . . . 20.52 110.402 175.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.409 ' H ' ' HG2' ' A' ' 41' ' ' GLN . 16.1 pt20 -107.96 154.33 21.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.737 1.384 . . . . 7.1299999999999999 114.737 -172.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.0 mtt85 -134.55 164.34 27.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 117.823 -1.084 . . . . 36.390000000000001 108.222 157.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 60.6 mt -113.31 136.62 52.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.059 3.344 . . . . 9.5500000000000007 107.15 -174.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -115.76 122.72 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 107.131 -1.433 . . . . 13.9 107.131 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -113.63 111.14 21.35 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.968 -2.975 . . . . 6.8600000000000003 102.968 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.08 -75.83 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.446 -2.034 . . . . 11.15 114.972 -164.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.59 9.09 2.61 Favored Glycine 0 N--CA 1.429 -1.807 0 CA-C-N 121.021 1.737 . . . . 13.93 116.463 169.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -107.62 123.76 48.96 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.719 2.2 . . . . 23.920000000000002 108.249 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -82.19 121.34 26.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 110.362 -3.108 . . . . 23.23 111.721 173.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 mt -86.27 156.17 20.37 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 115.749 -2.072 . . . . 9.1099999999999994 110.547 -165.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -109.25 142.42 40.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 123.034 2.652 . . . . 33.439999999999998 111.265 -173.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.61 -48.75 79.93 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.374 2.67 . . . . 28.370000000000001 115.564 -163.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -75.29 -3.69 71.24 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 118.163 2.025 . . . . 15.0 118.163 -179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.8 mtt-85 -98.0 170.25 9.06 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.889 1.328 . . . . 25.5 110.286 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -106.43 162.04 14.05 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.927 -1.733 . . . . 11.949999999999999 112.521 -170.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.437 HD23 HD12 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -63.58 -25.37 68.2 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.884 -2.385 . . . . 10.17 114.611 175.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.96 -30.19 55.91 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.664 2.386 . . . . 13.59 112.493 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -63.73 -42.23 97.93 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.542 -3.223 . . . . 11.699999999999999 111.246 175.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -88.99 5.68 43.11 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.033 2.975 . . . . 12.949999999999999 119.033 170.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 66.4 m-80 55.36 59.64 3.82 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.833 2.453 . . . . 25.449999999999999 111.994 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.437 HD12 HD23 ' A' ' 56' ' ' LEU . 60.6 mt -96.38 122.94 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 106.125 -1.805 . . . . 14.6 106.125 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -102.34 -174.73 2.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 123.646 1.688 . . . . 33.229999999999997 111.978 175.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -56.03 149.33 15.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.148 -3.47 . . . . 25.969999999999999 115.919 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 39.2 mt-10 66.98 31.04 7.23 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.367 -2.708 . . . . 32.609999999999999 113.434 171.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.3 m -93.29 132.21 37.69 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.798 -2.001 . . . . 10.56 113.375 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.1 m -90.74 124.64 35.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.452 -2.655 . . . . 5.3300000000000001 108.09 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.322 11.2 mp -109.61 140.02 43.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.997 1.719 . . . . 11.66 111.838 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -98.48 135.36 40.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.135 2.243 . . . . 16.300000000000001 115.505 175.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.5 tp -98.14 125.43 43.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.44 1.59 . . . . 9.9600000000000009 110.189 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 m -133.37 148.08 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 121.032 -1.042 . . . . 9.7599999999999998 110.187 176.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mp -132.49 152.52 51.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.079 -2.193 . . . . 19.57 105.079 -170.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -90.38 -82.87 0.27 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.56 1.544 . . . . 35.079999999999998 111.761 -161.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.8 tp -88.11 -35.01 17.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 125.158 2.408 . . . . 32.310000000000002 115.573 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.7 mtp180 -110.65 168.81 9.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.121 -2.237 . . . . 42.75 111.82 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -177.09 98.54 0.12 Allowed Glycine 0 N--CA 1.43 -1.74 0 CA-C-N 119.491 1.042 . . . . 36.310000000000002 111.119 162.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.734 0 N-CA-C 103.768 -3.733 . . . . 36.270000000000003 103.768 -164.075 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.354 0 CA-C-O 122.931 1.348 . . . . 17.170000000000002 114.554 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -107.77 155.98 19.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 120.036 3.347 . . . . 21.890000000000001 120.036 172.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.7 pt -138.73 154.54 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 106.817 -1.549 . . . . 10.83 106.817 178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -106.83 126.73 52.69 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.401 -2.074 . . . . 10.609999999999999 105.401 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.8 t -112.01 108.83 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 120.09 1.314 . . . . 9.1300000000000008 109.581 175.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -96.97 135.66 38.65 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 114.735 -1.121 . . . . 20.550000000000001 109.568 -167.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -77.61 171.11 15.42 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.412 1.695 . . . . 11.779999999999999 112.007 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -51.5 -56.39 13.63 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 117.093 2.257 . . . . 19.309999999999999 117.093 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -85.93 -72.95 0.47 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.442 -2.036 . . . . 23.140000000000001 109.324 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.41 48.0 0.17 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 118.658 2.223 . . . . 19.739999999999998 118.658 -162.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.0 ttmt -110.85 156.27 21.38 Favored 'General case' 0 N--CA 1.43 -1.466 1 O-C-N 116.304 -4.056 . . . . 21.93 110.299 157.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 62.9 m -129.14 135.82 49.37 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 103.148 -2.908 . . . . 12.33 103.148 174.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.4 mt -121.54 112.97 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 CA-C-N 114.5 -1.227 . . . . 17.079999999999998 108.989 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.7 m -88.19 107.17 18.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 121.995 0.903 . . . . 16.300000000000001 111.479 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -110.92 112.35 24.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 120.233 3.42 . . . . 15.880000000000001 120.233 -173.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -83.59 117.74 23.36 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.723 -3.735 . . . . 28.899999999999999 111.892 -175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -136.62 177.84 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.547 -1.971 . . . . 12.050000000000001 109.377 -166.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -117.46 160.13 39.13 Favored Pre-proline 0 N--CA 1.43 -1.44 0 O-C-N 118.488 -2.633 . . . . 18.170000000000002 109.951 167.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -79.48 -6.78 14.72 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 C-N-CA 125.253 3.969 . . . . 8.1600000000000001 110.091 -166.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.1 m -88.58 -7.22 56.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.711 2.804 . . . . 11.130000000000001 115.064 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -69.49 169.74 11.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 118.703 0.683 . . . . 18.030000000000001 112.79 -175.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.5 p -107.9 164.91 11.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.421 2.288 . . . . 10.220000000000001 109.029 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.7 mm -55.83 -47.01 80.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 126.499 1.92 . . . . 12.300000000000001 112.37 173.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -60.99 -32.7 72.27 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.21 2.604 . . . . 36.509999999999998 115.642 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -67.04 -43.2 83.36 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 122.714 2.507 . . . . 25.66 115.38 162.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.89 -29.24 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 118.435 -2.666 . . . . 8.1199999999999992 113.004 174.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 mtmt -72.68 -34.68 67.35 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.968 2.507 . . . . 15.470000000000001 110.476 175.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.73 -34.92 73.56 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.788 2.835 . . . . 11.449999999999999 115.771 169.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -57.87 -52.14 66.72 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.939 2.896 . . . . 24.98 117.069 162.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.2 mt -60.6 -40.3 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 117.794 -3.066 . . . . 9.4600000000000009 113.404 174.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -50.45 -49.0 56.28 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.513 2.578 . . . . 14.76 112.006 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -65.11 -46.47 80.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.359 -3.963 . . . . 26.289999999999999 116.941 -178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -63.22 -82.53 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.063 -2.335 . . . . 30.059999999999999 114.954 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -58.97 -64.65 0.86 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.166 2.186 . . . . 25.190000000000001 113.663 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.54 62.24 0.33 Allowed Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 108.476 -1.849 . . . . 7.4100000000000001 108.476 -171.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.42 HD13 HD11 ' A' ' 71' ' ' LEU . 36.0 mt -127.84 114.05 20.58 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.326 -2.75 . . . . 9.4900000000000002 113.89 177.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -73.77 150.8 45.16 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 124.809 2.753 . . . . 11.42 113.737 -172.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -57.97 -35.07 99.01 Favored 'Trans proline' 0 N--CA 1.434 -2.003 2 C-N-CA 129.514 6.81 . . . . 12.0 117.451 -166.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.299 38.7 m-20 -74.21 -21.65 59.71 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 124.603 1.161 . . . . 35.549999999999997 111.15 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -78.23 -31.86 49.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.355 3.455 . . . . 20.52 114.097 177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -109.65 140.24 43.73 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 113.287 -5.883 . . . . 7.1299999999999999 111.203 -175.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -123.17 171.74 9.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 105.747 -1.945 . . . . 36.390000000000001 105.747 163.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.25 35.3 mt -123.32 143.32 50.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 125.773 1.92 . . . . 9.5500000000000007 107.519 -177.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.9 mt -129.88 138.68 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.431 2.062 . . . . 13.9 106.38 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -114.07 102.19 9.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.318 -2.739 . . . . 6.8600000000000003 107.882 171.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.297 . . 58.58 -98.33 0.08 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.735 1.754 . . . . 11.15 115.735 -166.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.47 -6.89 24.95 Favored Glycine 0 N--CA 1.43 -1.72 0 CA-C-N 120.704 1.593 . . . . 13.93 109.195 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -88.8 120.32 30.09 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 113.382 0.882 . . . . 23.920000000000002 113.382 -171.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -87.61 116.97 26.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.235 -3.416 . . . . 23.23 111.386 -172.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.0 mt -84.58 126.86 33.7 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.331 -1.481 . . . . 9.1099999999999994 112.315 -169.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -78.0 134.91 37.73 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.359 2.664 . . . . 33.439999999999998 114.084 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -61.52 -46.03 91.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.332 1.853 . . . . 28.370000000000001 112.657 -155.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.23 -8.02 86.95 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 125.818 1.675 . . . . 15.0 117.247 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.8 mtt-85 -76.64 148.18 37.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.035 -2.45 . . . . 25.5 112.122 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.2 p -81.66 166.41 20.18 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.729 -4.357 . . . . 11.949999999999999 110.034 -176.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.74 -19.28 63.54 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.957 1.836 . . . . 10.17 115.957 173.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 39.9 t -91.05 -18.21 24.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.753 2.821 . . . . 13.59 108.563 -172.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -66.78 -21.88 66.04 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.444 -4.535 . . . . 11.699999999999999 114.082 163.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -104.24 -20.68 13.71 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.66 -1.154 . . . . 12.949999999999999 111.582 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 66.44 61.03 0.58 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.419 1.888 . . . . 25.449999999999999 112.083 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.4 mt -101.29 103.46 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.241 1.816 . . . . 14.6 108.789 -176.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -83.49 -163.42 0.75 Allowed 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.348 1.61 . . . . 33.229999999999997 115.348 -169.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.0 ptpt -71.75 159.02 35.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.424 1.89 . . . . 25.969999999999999 112.756 170.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 54.04 22.14 3.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.749 2.82 . . . . 32.609999999999999 110.206 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -66.22 140.64 58.18 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.587 1.955 . . . . 10.56 116.08 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -90.75 116.99 29.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.677 3.991 . . . . 5.3300000000000001 106.498 171.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.8 mp -112.2 166.53 11.18 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 127.023 2.702 . . . . 11.66 110.498 176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -122.86 135.54 54.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 117.81 -1.091 . . . . 16.300000000000001 111.269 177.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 41.1 tp -94.16 133.4 37.7 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 122.974 1.369 . . . . 9.9600000000000009 107.411 178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.1 m -118.9 152.79 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 O-C-N 114.605 -5.059 . . . . 9.7599999999999998 106.735 161.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.42 HD11 HD13 ' A' ' 36' ' ' ILE . 7.3 mp -109.92 151.6 26.87 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 115.057 -2.402 . . . . 19.57 110.493 171.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -86.93 -80.43 0.25 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.572 1.987 . . . . 35.079999999999998 110.307 -164.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.269 65.4 mt -86.71 -44.44 11.8 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.431 -2.043 . . . . 32.310000000000002 113.476 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.6 mtp180 -73.67 -164.83 0.23 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.069 2.366 . . . . 42.75 116.683 178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.28 123.81 0.67 Allowed Glycine 0 N--CA 1.429 -1.774 0 O-C-N 117.638 -3.164 . . . . 36.310000000000002 108.746 -172.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.758 0 C-N-CA 117.239 -2.41 . . . . 36.270000000000003 111.88 -176.37 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 CA--C 1.49 -1.352 0 N-CA-C 114.464 1.283 . . . . 17.170000000000002 114.464 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -113.78 135.0 54.43 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.549 1.643 . . . . 21.890000000000001 109.123 -178.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.6 pt -124.19 158.09 30.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 112.463 -2.153 . . . . 10.83 105.513 177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -104.07 114.29 28.43 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.623 1.169 . . . . 10.609999999999999 113.38 172.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.5 t -97.23 116.0 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 116.724 -3.735 . . . . 9.1300000000000008 102.588 166.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -107.99 133.74 51.88 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.703 3.601 . . . . 20.550000000000001 109.97 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.392 17.6 p -79.88 -173.39 3.85 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.002 1.853 . . . . 11.779999999999999 116.002 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.5 tp -79.37 -42.41 25.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.889 2.757 . . . . 19.309999999999999 111.817 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.5 p -68.49 -70.2 0.28 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.343 4.257 . . . . 23.140000000000001 110.129 174.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.44 55.98 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.716 0 N-CA-C 104.089 -3.604 . . . . 19.739999999999998 104.089 -174.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -117.33 146.19 43.53 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 120.728 2.264 . . . . 21.93 108.76 159.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.3 m -114.48 117.58 31.38 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 118.286 -2.759 . . . . 12.33 110.392 178.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.453 ' N ' HD12 ' A' ' 13' ' ' ILE 0.27 0.3 OUTLIER -104.45 104.32 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 103.154 -2.906 . . . . 17.079999999999998 103.154 175.178 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.4 m -88.88 111.72 22.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.711 1.204 . . . . 16.300000000000001 110.796 -178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.4 mt -114.26 148.92 36.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 122.853 2.57 . . . . 15.880000000000001 107.875 -160.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -106.34 118.93 37.93 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.382 -1.449 . . . . 28.899999999999999 114.697 175.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.9 m -136.56 170.66 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-O 124.061 1.886 . . . . 12.050000000000001 112.425 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -107.99 164.24 15.21 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.07 -2.894 . . . . 18.170000000000002 109.445 167.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -71.06 -24.85 23.32 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 C-N-CA 122.263 1.975 . . . . 8.1600000000000001 112.447 -172.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.9 m -73.45 -8.08 54.43 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.727 2.811 . . . . 11.130000000000001 116.552 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -84.28 142.59 30.13 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.077 -1.874 . . . . 18.030000000000001 112.428 177.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.7 p -80.04 165.05 22.92 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 125.288 2.47 . . . . 10.220000000000001 113.807 -176.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.455 HD12 HD13 ' A' ' 50' ' ' LEU . 35.6 mm -69.73 -32.31 51.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 119.535 -1.978 . . . . 12.300000000000001 109.448 177.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -51.66 -35.89 44.16 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 115.777 1.769 . . . . 36.509999999999998 115.777 159.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -73.69 -35.91 65.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.405 2.526 . . . . 25.66 109.845 -175.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.4 t -65.05 -43.77 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 1 O-C-N 115.841 -4.287 . . . . 8.1199999999999992 109.785 174.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -56.64 -33.64 66.5 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.164 2.653 . . . . 15.470000000000001 118.164 171.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.77 -29.21 64.24 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.544 2.592 . . . . 11.449999999999999 109.281 -167.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -78.47 -34.08 47.85 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.794 2.037 . . . . 24.98 111.251 174.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.33 -33.57 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 123.859 1.79 . . . . 9.4600000000000009 110.769 176.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -59.4 -44.22 92.84 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.418 -2.676 . . . . 14.76 110.607 166.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -65.94 -41.47 91.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.446 1.098 . . . . 26.289999999999999 110.242 -172.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -78.96 -63.94 1.3 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 119.026 0.83 . . . . 30.059999999999999 110.041 172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -89.72 -20.88 23.06 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.561 2.06 . . . . 25.190000000000001 116.561 -158.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.39 34.24 23.51 Favored Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 118.632 2.213 . . . . 7.4100000000000001 118.632 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.1 mt -107.99 124.0 36.04 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 119.157 -0.449 . . . . 9.4900000000000002 111.598 174.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -66.0 148.02 85.25 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.636 2.224 . . . . 11.42 115.641 172.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -77.08 -21.48 12.09 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 123.162 2.575 . . . . 12.0 109.983 -148.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -70.28 -28.12 64.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.858 1.799 . . . . 35.549999999999997 115.858 173.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -81.81 -26.74 34.1 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.448 -2.033 . . . . 20.52 115.813 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -96.03 152.25 18.7 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 125.221 1.408 . . . . 7.1299999999999999 108.533 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -135.51 168.2 19.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 117.205 -1.378 . . . . 36.390000000000001 109.685 167.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 43' ' ' LEU . 35.2 mt -131.71 130.75 42.38 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 125.388 3.722 . . . . 9.5500000000000007 110.714 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mt -110.77 116.59 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 112.124 -2.307 . . . . 13.9 110.657 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -96.73 102.07 13.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.107 3.363 . . . . 6.8600000000000003 109.905 169.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.1 -95.84 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 126.746 2.018 . . . . 11.15 114.714 -165.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.03 -12.91 26.47 Favored Glycine 0 N--CA 1.43 -1.703 1 C-N-CA 131.204 4.24 . . . . 13.93 112.694 -175.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -104.25 150.14 24.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.705 -2.644 . . . . 23.920000000000002 115.354 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -109.79 149.33 29.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.151 2.405 . . . . 23.23 109.752 169.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.455 HD13 HD12 ' A' ' 23' ' ' ILE . 23.4 mt -90.03 118.84 29.89 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 126.878 2.071 . . . . 9.1099999999999994 113.234 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -79.04 150.68 31.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.993 1.378 . . . . 33.439999999999998 110.475 176.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -75.97 -24.66 55.43 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 115.474 -4.517 . . . . 28.370000000000001 112.284 -157.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.18 27.2 10.37 Favored Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 121.145 3.218 . . . . 15.0 121.145 -171.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -110.79 174.91 5.64 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.309 1.843 . . . . 25.5 111.278 162.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 81.2 p -95.88 167.32 11.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 113.661 0.986 . . . . 11.949999999999999 113.661 -178.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.0 mt -61.4 -33.66 74.05 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 114.637 1.347 . . . . 10.17 114.637 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.39 -39.65 84.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 125.698 1.599 . . . . 13.59 114.681 171.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.287 72.5 m-20 -57.57 -37.25 72.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.802 2.041 . . . . 11.699999999999999 114.976 179.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -110.41 4.92 21.04 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.822 -1.547 . . . . 12.949999999999999 106.822 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 t30 72.34 45.03 0.39 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.147 -2.22 . . . . 25.449999999999999 109.75 162.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.6 mt -94.59 119.89 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 128.11 3.814 . . . . 14.6 111.227 168.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -99.35 175.29 5.92 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.885 -4.259 . . . . 33.229999999999997 108.043 169.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.7 pttt -40.77 145.56 0.19 Allowed 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.347 -3.346 . . . . 25.969999999999999 117.446 165.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 70.76 9.5 6.85 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.155 3.382 . . . . 32.609999999999999 116.759 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.8 m -78.11 145.58 35.67 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.398 3.079 . . . . 10.56 108.824 -175.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.3 m -100.69 121.22 41.28 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.202 1.401 . . . . 5.3300000000000001 109.145 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.7 mt -104.8 149.36 25.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 108.317 -0.994 . . . . 11.66 108.317 164.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -99.86 108.42 20.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.577 2.351 . . . . 16.300000000000001 110.142 169.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tp -84.54 98.12 9.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.716 -1.865 . . . . 9.9600000000000009 109.347 171.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -101.2 156.18 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 119.332 -2.105 . . . . 9.7599999999999998 107.429 169.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp -112.09 155.25 24.18 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.741 2.686 . . . . 19.57 107.63 172.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -76.42 -51.1 12.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.711 3.226 . . . . 35.079999999999998 119.711 -169.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.6 mt -143.54 -56.32 0.39 Allowed 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.079 -2.934 . . . . 32.310000000000002 103.079 -161.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.2 mtp180 -76.43 156.22 33.3 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 114.132 -1.395 . . . . 42.75 112.997 174.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.87 135.45 1.86 Allowed Glycine 0 N--CA 1.429 -1.794 0 N-CA-C 109.383 -1.487 . . . . 36.310000000000002 109.383 177.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.777 0 N-CA-C 103.523 -3.831 . . . . 36.270000000000003 103.523 -178.179 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.338 18.0 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 119.101 3.0 . . . . 17.170000000000002 119.101 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -102.04 128.72 48.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 119.314 -0.954 . . . . 21.890000000000001 112.414 176.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.321 31.1 pt -118.42 169.33 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.377 1.471 . . . . 10.83 112.649 171.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -132.88 131.6 41.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.46 -2.65 . . . . 10.609999999999999 111.953 -172.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.4 t -106.01 114.5 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 103.822 -2.659 . . . . 9.1300000000000008 103.822 175.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -79.72 142.43 35.47 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.027 2.822 . . . . 20.550000000000001 109.548 167.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.276 17.0 p -93.67 -176.82 4.18 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.686 -2.509 . . . . 11.779999999999999 112.167 176.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 mt -86.66 -25.92 24.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 120.472 1.487 . . . . 19.309999999999999 113.169 -177.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -69.7 -55.45 9.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.02 2.343 . . . . 23.140000000000001 109.34 161.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.37 58.02 0.18 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 120.381 -1.45 . . . . 19.739999999999998 112.999 164.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.254 42.1 pttt -101.83 149.33 24.29 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.47 1.108 . . . . 21.93 113.878 172.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.1 m -74.83 114.01 12.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.105 -2.872 . . . . 12.33 118.149 164.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.8 mt -96.52 123.62 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 122.104 0.954 . . . . 17.079999999999998 109.052 160.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.5 m -110.5 121.15 44.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 102.508 -3.145 . . . . 16.300000000000001 102.508 -167.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 93.4 mt -115.07 146.49 41.25 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.742 -2.474 . . . . 15.880000000000001 113.074 176.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -113.35 103.74 11.61 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 128.701 2.801 . . . . 28.899999999999999 104.506 -172.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.2 169.37 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-O 115.523 -2.179 . . . . 12.050000000000001 108.57 -167.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -114.75 158.71 39.73 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 128.491 2.717 . . . . 18.170000000000002 104.21 161.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -91.22 -4.83 4.25 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 C-N-CA 115.615 -2.457 . . . . 8.1600000000000001 108.364 -167.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.287 33.1 m -72.67 -11.31 60.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.582 2.438 . . . . 11.130000000000001 117.582 164.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -84.22 159.57 20.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 121.451 1.932 . . . . 18.030000000000001 112.185 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.2 p -95.63 155.5 16.72 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.238 -2.164 . . . . 10.220000000000001 107.964 -169.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.24 -31.78 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 O-C-N 115.487 -4.508 . . . . 12.300000000000001 106.708 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -52.34 -38.89 59.82 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 115.652 -4.405 . . . . 36.509999999999998 112.051 166.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -75.41 -33.01 60.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.651 -2.53 . . . . 25.66 112.514 170.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.4 t -72.92 -41.43 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.133 -3.479 . . . . 8.1199999999999992 111.68 176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -67.32 -23.47 65.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.876 2.917 . . . . 15.470000000000001 118.876 166.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.76 -32.2 65.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.603 1.547 . . . . 11.449999999999999 114.485 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.254 37.0 mttm -59.3 -40.41 86.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.034 1.734 . . . . 24.98 113.694 163.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.351 55.6 mt -54.27 -43.24 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.773 -3.08 . . . . 9.4600000000000009 116.629 165.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -66.78 -42.56 85.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.939 1.696 . . . . 14.76 107.031 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -61.53 -59.44 5.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.898 -1.752 . . . . 26.289999999999999 113.206 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -61.09 -72.27 0.12 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.806 2.842 . . . . 30.059999999999999 112.121 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -77.25 -44.26 30.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 113.473 0.916 . . . . 25.190000000000001 113.473 -172.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.92 43.0 2.71 Favored Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 129.61 3.481 . . . . 7.4100000000000001 116.96 -176.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.9 mt -111.25 117.82 48.86 Favored Pre-proline 0 N--CA 1.43 -1.427 0 O-C-N 121.394 -1.062 . . . . 9.4900000000000002 111.195 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -77.66 160.2 31.49 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-O 124.828 1.928 . . . . 11.42 114.784 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.41 ' HA ' ' HG3' ' A' ' 41' ' ' GLN . 69.7 Cg_endo -86.57 -2.23 8.36 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 O-C-N 114.827 -3.302 . . . . 12.0 111.152 -155.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -88.63 -1.63 58.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 124.428 3.286 . . . . 35.549999999999997 112.142 164.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -99.22 -31.07 11.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.334 2.716 . . . . 20.52 118.334 169.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' HG3' ' HA ' ' A' ' 38' ' ' PRO . 5.4 pt20 -109.2 152.49 25.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.334 1.854 . . . . 7.1299999999999999 111.893 -176.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -148.45 154.25 39.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.822 -1.547 . . . . 36.390000000000001 106.822 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 62.7 mt -119.3 148.95 42.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.251 -1.759 . . . . 9.5500000000000007 106.251 178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 mt -127.06 136.64 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 114.161 -1.381 . . . . 13.9 107.537 171.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -114.46 107.94 16.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.766 1.746 . . . . 6.8600000000000003 107.769 169.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.289 . . 61.89 -68.01 0.06 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.159 3.384 . . . . 11.15 111.155 -173.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.41 ' H ' ' H ' ' A' ' 48' ' ' LYS . . . -148.53 -16.56 0.11 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 105.961 -2.856 . . . . 13.93 105.961 -172.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' H ' ' H ' ' A' ' 47' ' ' GLY . 51.3 mtpt -88.08 131.26 34.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 126.334 2.968 . . . . 23.920000000000002 115.349 174.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -88.6 120.86 30.38 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.422 -3.923 . . . . 23.23 108.483 -172.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.4 mt -82.72 145.02 29.81 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 117.051 2.241 . . . . 9.1099999999999994 117.051 -167.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -110.54 139.17 46.04 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.229 2.918 . . . . 33.439999999999998 106.388 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -73.22 -41.2 64.02 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.039 -1.891 . . . . 28.370000000000001 112.46 -159.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.11 31.74 4.94 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-N 121.476 1.944 . . . . 15.0 115.584 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -106.67 -175.33 2.76 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 128.043 2.849 . . . . 25.5 116.257 155.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.7 p -113.27 177.47 4.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.56 1.544 . . . . 11.949999999999999 111.311 -177.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.4 mt -78.84 -22.65 45.8 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.066 1.136 . . . . 10.17 114.066 170.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.9 t -74.93 -25.61 59.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.698 -3.126 . . . . 13.59 111.637 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -67.85 -53.77 24.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.092 -2.255 . . . . 11.699999999999999 114.481 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -81.56 -17.11 49.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 118.726 -0.654 . . . . 12.949999999999999 110.487 -174.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.25 0.3 OUTLIER 81.51 55.69 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.208 2.432 . . . . 25.449999999999999 106.214 -173.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -90.87 101.4 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 1 O-C-N 116.263 -4.023 . . . . 14.6 108.914 171.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.428 ' HG2' ' H ' ' A' ' 62' ' ' GLN 0.322 12.9 pt20 -90.99 176.0 6.76 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.247 0.967 . . . . 33.229999999999997 112.001 -171.156 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -70.69 148.08 48.4 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 120.944 3.683 . . . . 25.969999999999999 120.944 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.425 24.1 mt-10 51.59 32.64 9.34 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.107 2.861 . . . . 32.609999999999999 117.193 -171.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.91 166.55 10.39 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.365 1.866 . . . . 10.56 108.58 -174.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 75.0 m -115.99 132.66 56.59 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 112.625 -2.08 . . . . 5.3300000000000001 110.362 -171.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -109.45 150.0 28.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 131.148 3.779 . . . . 11.66 107.315 174.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.7 m170 -105.54 114.75 29.1 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 114.771 -1.104 . . . . 16.300000000000001 111.246 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 tp -78.18 130.8 36.76 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.202 -2.811 . . . . 9.9600000000000009 108.732 169.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.0 m -127.3 167.45 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 112.703 -2.044 . . . . 9.7599999999999998 111.251 156.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.52 178.72 5.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 105.457 -2.053 . . . . 19.57 105.457 -175.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -114.3 -63.11 1.5 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 117.798 -1.561 . . . . 35.079999999999998 111.666 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.7 mt -122.07 -69.71 0.82 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.792 2.037 . . . . 32.310000000000002 106.63 -164.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.9 mtp180 -89.23 149.91 22.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.028 -2.295 . . . . 42.75 114.216 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.62 -28.9 7.67 Favored Glycine 0 N--CA 1.431 -1.679 0 CA-C-N 109.239 -3.619 . . . . 36.310000000000002 112.598 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.728 0 CA-C-O 116.752 -2.138 . . . . 36.270000000000003 111.363 -173.458 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.289 0.8 OUTLIER . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 113.715 1.006 . . . . 17.170000000000002 113.715 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -79.01 135.87 37.02 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.087 -4.758 . . . . 21.890000000000001 113.134 169.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.5 pt -120.57 155.54 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.845 -2.409 . . . . 10.83 104.746 174.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -107.96 123.79 49.17 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.728 1.611 . . . . 10.609999999999999 114.594 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.6 t -109.37 114.9 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 126.087 2.117 . . . . 9.1300000000000008 111.554 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -101.18 122.61 43.93 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.379 -2.075 . . . . 20.550000000000001 111.38 178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -79.08 168.95 18.92 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.389 2.276 . . . . 11.779999999999999 114.016 -175.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -78.43 -16.35 57.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 118.866 2.913 . . . . 19.309999999999999 118.866 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.9 p -76.71 -50.68 13.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 113.647 -1.615 . . . . 23.140000000000001 112.393 166.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 133.94 39.87 0.19 Allowed Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 125.259 2.589 . . . . 19.739999999999998 118.911 162.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -99.27 124.85 44.68 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.692 2.397 . . . . 21.93 112.642 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.277 7.1 m -82.85 97.7 8.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.065 -2.272 . . . . 12.33 110.553 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.7 mt -72.89 123.18 27.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 106.527 -1.657 . . . . 17.079999999999998 106.527 170.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.6 p -101.21 110.66 22.7 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.228 2.211 . . . . 16.300000000000001 111.427 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.4 mt -118.51 143.82 46.47 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.697 -1.877 . . . . 15.880000000000001 106.913 -176.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -109.85 121.61 45.63 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.859 2.464 . . . . 28.899999999999999 106.891 170.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -134.94 172.73 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-O 122.141 0.972 . . . . 12.050000000000001 111.331 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -111.5 160.57 28.9 Favored Pre-proline 0 N--CA 1.43 -1.467 0 O-C-N 118.727 -2.483 . . . . 18.170000000000002 113.27 171.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -86.46 3.31 6.88 Favored 'Trans proline' 0 C--N 1.299 -2.037 0 CA-C-N 125.996 3.177 . . . . 8.1600000000000001 116.611 -162.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.3 m -92.98 4.65 53.61 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.274 2.23 . . . . 11.130000000000001 109.689 167.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -70.46 131.42 44.03 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.363 2.801 . . . . 18.030000000000001 117.262 161.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.1 p -74.3 158.94 33.11 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.358 -3.339 . . . . 10.220000000000001 114.542 174.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.508 ' HA ' HD13 ' A' ' 23' ' ' ILE . 30.1 mm -57.2 -28.62 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 112.178 0.436 . . . . 12.300000000000001 112.178 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -55.93 -46.26 78.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.83 2.728 . . . . 36.509999999999998 111.424 175.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -63.95 -45.22 90.13 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.307 -2.745 . . . . 25.66 112.399 -174.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.4 t -57.63 -44.91 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 120.038 -1.664 . . . . 8.1199999999999992 114.426 173.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -60.11 -32.29 70.85 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 119.246 3.054 . . . . 15.470000000000001 119.246 165.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.42 82.55 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.05 -4.156 . . . . 11.449999999999999 114.661 175.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.5 mttm -66.03 -21.54 66.39 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 120.02 3.341 . . . . 24.98 120.02 169.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.2 mt -74.72 -41.61 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 120.235 -1.541 . . . . 9.4600000000000009 112.252 169.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -52.91 -59.64 4.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.605 1.962 . . . . 14.76 114.405 167.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -42.7 -44.73 4.44 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 119.301 3.075 . . . . 26.289999999999999 119.301 161.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -76.78 -49.12 16.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.866 -1.771 . . . . 30.059999999999999 110.374 -173.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 mm-40 -114.01 -17.61 11.92 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 115.9 1.815 . . . . 25.190000000000001 115.9 -160.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.29 29.38 19.84 Favored Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 124.726 1.155 . . . . 7.4100000000000001 115.016 -178.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.7 mt -110.86 115.92 52.65 Favored Pre-proline 0 N--CA 1.43 -1.443 0 C-N-CA 129.067 2.947 . . . . 9.4900000000000002 109.603 -167.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.512 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 11.7 Cg_exo -62.53 141.68 87.26 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 N-CA-C 121.672 3.682 . . . . 11.42 121.672 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.1 Cg_exo -74.95 -5.11 16.38 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 127.306 3.645 . . . . 12.0 116.89 -162.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -96.99 -21.06 17.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.016 -2.302 . . . . 35.549999999999997 109.762 177.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -69.75 -41.58 75.04 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 127.127 2.767 . . . . 20.52 110.873 168.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -60.57 141.71 56.3 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 114.976 1.473 . . . . 7.1299999999999999 114.976 174.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -132.42 151.65 51.8 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 103.375 -2.824 . . . . 36.390000000000001 103.375 150.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.1 mt -110.96 141.92 43.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 111.503 -2.59 . . . . 9.5500000000000007 111.407 166.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.5 mt -109.53 142.87 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 126.577 1.951 . . . . 13.9 109.194 170.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -131.5 129.68 41.41 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 123.503 2.865 . . . . 6.8600000000000003 111.762 157.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.12 44.38 5.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.351 -2.093 . . . . 11.15 109.118 174.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.81 -30.46 4.62 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 130.49 3.9 . . . . 13.93 114.372 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -94.9 132.73 39.4 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.421 2.058 . . . . 23.920000000000002 112.522 -167.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -76.29 137.72 40.08 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.896 -3.002 . . . . 23.23 109.262 -173.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.9 mt -94.42 133.76 37.66 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.022 -2.298 . . . . 9.1099999999999994 112.658 -178.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.95 173.59 8.14 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 124.9 3.5 . . . . 33.439999999999998 111.254 170.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.77 -51.87 10.59 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 124.947 1.404 . . . . 28.370000000000001 113.099 -159.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -64.72 -28.76 73.75 Favored Glycine 0 N--CA 1.43 -1.75 1 O-C-N 131.946 5.779 . . . . 15.0 120.041 -162.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.0 mtt180 -105.66 169.96 8.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 121.421 2.61 . . . . 25.5 111.329 -163.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 27.0 p -83.69 169.73 14.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.634 2.635 . . . . 11.949999999999999 114.865 -174.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 92.2 mt -73.24 -34.03 65.64 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 120.026 -1.671 . . . . 10.17 110.857 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 t -57.74 -40.02 78.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.472 2.027 . . . . 13.59 116.472 163.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -64.27 -49.89 70.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 115.518 1.673 . . . . 11.699999999999999 115.518 175.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -57.71 -41.18 81.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.557 1.543 . . . . 12.949999999999999 111.194 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 81.96 60.5 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.46 3.504 . . . . 25.449999999999999 111.41 -172.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.5 mt -103.0 103.74 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 128.823 2.849 . . . . 14.6 108.878 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -84.88 -179.36 7.07 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.587 2.137 . . . . 33.229999999999997 112.075 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -65.39 158.19 27.29 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 116.863 -3.648 . . . . 25.969999999999999 117.05 174.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 36.9 mt-10 55.19 27.51 9.75 Favored 'General case' 0 N--CA 1.429 -1.507 0 C-N-CA 129.473 3.109 . . . . 32.609999999999999 114.622 176.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.335 21.8 m -83.22 157.08 22.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 125.427 1.705 . . . . 10.56 114.516 164.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -110.67 95.3 5.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.702 -1.874 . . . . 5.3300000000000001 113.427 -174.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.17 141.61 35.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.425 1.89 . . . . 11.66 112.316 179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -116.4 114.02 23.69 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 120.505 -1.372 . . . . 16.300000000000001 114.192 -167.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.6 tp -86.86 115.69 24.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.166 1.913 . . . . 9.9600000000000009 116.166 176.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.297 12.3 m -107.92 156.36 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 C-N-CA 129.786 3.234 . . . . 9.7599999999999998 107.386 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.456 ' HB3' ' H ' ' A' ' 72' ' ' ARG . 96.1 mt -120.23 -165.46 1.19 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.729 3.633 . . . . 19.57 106.821 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.456 ' H ' ' HB3' ' A' ' 71' ' ' LEU . 53.9 ttp180 -132.63 139.78 47.9 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 109.983 -3.28 . . . . 35.079999999999998 107.561 -179.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.6 tp -65.45 115.02 5.26 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.889 -1.505 . . . . 32.310000000000002 112.563 -176.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.8 ttp180 -100.96 -44.52 5.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.999 -1.852 . . . . 42.75 105.999 179.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 167.32 -91.1 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.761 1 C-N-CA 131.248 4.261 . . . . 36.310000000000002 108.146 176.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.744 0 N-CA-C 105.672 -2.971 . . . . 36.270000000000003 105.672 -176.287 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 CA--C 1.49 -1.352 0 CA-C-O 124.375 2.036 . . . . 17.170000000000002 110.69 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -94.03 135.97 34.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 104.198 -2.519 . . . . 21.890000000000001 104.198 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.2 pt -125.31 135.0 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-O 116.23 -1.843 . . . . 10.83 108.168 166.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -88.1 133.29 34.02 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.528 2.047 . . . . 10.609999999999999 116.528 166.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.6 t -126.9 109.14 20.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 108.55 -0.907 . . . . 9.1300000000000008 108.55 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -89.81 133.58 34.64 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.768 2.427 . . . . 20.550000000000001 113.644 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.6 p -89.54 -167.59 1.9 Allowed 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 114.596 -1.184 . . . . 11.779999999999999 108.142 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mt -70.47 -66.49 0.59 Allowed 'General case' 0 N--CA 1.43 -1.435 1 C-N-CA 135.113 5.365 . . . . 19.309999999999999 114.845 166.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.7 p -63.74 -81.96 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.563 -2.585 . . . . 23.140000000000001 117.265 -179.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.94 46.86 0.29 Allowed Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 117.908 -1.495 . . . . 19.739999999999998 110.798 -166.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -140.46 147.62 39.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 118.906 1.353 . . . . 21.93 110.758 176.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.4 m -129.51 137.03 50.57 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.203 2.43 . . . . 12.33 107.308 166.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 65.3 mt -105.62 121.7 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 118.821 -2.425 . . . . 17.079999999999998 106.009 -175.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.7 m -90.33 120.74 31.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 116.454 -1.736 . . . . 16.300000000000001 109.451 172.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.1 mt -119.17 134.33 55.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.357 -1.782 . . . . 15.880000000000001 109.839 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -88.44 132.03 34.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 114.938 -2.458 . . . . 28.899999999999999 107.379 163.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -132.27 173.32 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 C-N-CA 133.288 4.635 . . . . 12.050000000000001 110.702 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -123.53 143.53 41.78 Favored Pre-proline 0 N--CA 1.43 -1.429 1 O-C-N 116.082 -4.136 . . . . 18.170000000000002 110.694 174.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -63.71 -28.66 68.75 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 123.761 2.379 . . . . 8.1600000000000001 117.558 -159.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.2 p -87.34 4.83 41.4 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 125.836 1.96 . . . . 11.130000000000001 110.489 -176.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -72.88 151.81 41.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.856 3.025 . . . . 18.030000000000001 110.079 170.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.7 p -82.93 158.18 22.72 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 111.706 -2.497 . . . . 10.220000000000001 111.009 173.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.8 mm -67.6 -29.02 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.397 0 O-C-N 121.07 -1.019 . . . . 12.300000000000001 110.641 177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -48.99 -39.57 27.2 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 132.137 4.175 . . . . 36.509999999999998 116.834 158.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -89.32 -16.99 29.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.402 -3.936 . . . . 25.66 109.996 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.2 t -78.36 -35.28 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 1 O-C-N 115.51 -4.494 . . . . 8.1199999999999992 105.521 173.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -69.23 -29.58 67.54 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 125.675 2.655 . . . . 15.470000000000001 112.47 177.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.13 -34.19 69.98 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.012 -3.555 . . . . 11.449999999999999 114.932 175.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -84.17 -19.41 34.15 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.482 -2.145 . . . . 24.98 115.102 174.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mt -80.11 -35.02 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 1 O-C-N 116.048 -4.157 . . . . 9.4600000000000009 112.86 167.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.278 0.8 OUTLIER -54.11 -52.52 60.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.944 -2.348 . . . . 14.76 113.039 161.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -71.99 -27.17 62.58 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.835 2.107 . . . . 26.289999999999999 114.977 -174.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -74.4 -57.74 3.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.65 -3.156 . . . . 30.059999999999999 111.431 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.303 33.6 mm-40 -112.4 -29.08 7.64 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.676 -1.89 . . . . 25.190000000000001 110.926 -168.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.01 28.19 42.49 Favored Glycine 0 N--CA 1.429 -1.771 0 O-C-N 118.035 -2.916 . . . . 7.4100000000000001 117.314 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.427 HD13 HD21 ' A' ' 71' ' ' LEU . 43.4 mt -80.37 119.51 76.62 Favored Pre-proline 0 N--CA 1.43 -1.47 0 CA-C-O 115.318 -2.277 . . . . 9.4900000000000002 110.718 162.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -65.1 156.71 61.29 Favored 'Trans proline' 0 C--N 1.3 -2.021 0 CA-C-N 122.44 1.907 . . . . 11.42 114.003 174.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -11.96 33.74 Favored 'Trans proline' 0 N--CA 1.434 -2.021 1 C-N-CA 125.844 4.362 . . . . 12.0 120.671 -174.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -77.54 -38.22 49.17 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-O 125.206 2.431 . . . . 35.549999999999997 116.233 177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -61.74 -32.31 72.54 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.141 2.645 . . . . 20.52 118.141 169.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -70.95 123.27 21.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.716 2.006 . . . . 7.1299999999999999 115.118 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -132.38 117.09 17.66 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.241 1.837 . . . . 36.390000000000001 109.738 165.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.5 mt -89.74 115.89 27.43 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.006 1.322 . . . . 9.5500000000000007 111.988 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.6 mm -96.42 136.01 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 118.25 -0.881 . . . . 13.9 109.209 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -115.4 117.19 29.71 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.565 2.439 . . . . 6.8600000000000003 104.844 162.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.91 -93.08 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 129.075 2.95 . . . . 11.15 108.142 -178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.48 4.54 7.15 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 126.564 2.031 . . . . 13.93 109.051 171.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.39 144.1 31.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 121.653 2.727 . . . . 23.920000000000002 113.969 -171.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -69.46 137.99 53.09 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.399 2.37 . . . . 23.23 117.399 171.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -106.74 118.28 36.26 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.306 -3.996 . . . . 9.1099999999999994 108.62 174.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -85.41 151.04 24.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.017 1.865 . . . . 33.439999999999998 113.279 177.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -55.01 -49.12 72.33 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 118.038 2.607 . . . . 28.370000000000001 118.038 -170.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.49 -16.75 77.54 Favored Glycine 0 N--CA 1.431 -1.693 0 N-CA-C 119.792 2.677 . . . . 15.0 119.792 -175.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 36.0 mmt180 -76.33 170.56 16.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.75 -3.206 . . . . 25.5 113.104 178.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.252 69.8 p -100.0 167.36 10.54 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.678 2.18 . . . . 11.949999999999999 113.174 176.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mt -54.45 -45.87 73.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.338 2.255 . . . . 10.17 111.909 164.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.7 t -76.24 -22.18 55.48 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.841 -1.527 . . . . 13.59 112.689 -177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -67.43 -48.3 67.66 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.933 2.093 . . . . 11.699999999999999 109.152 175.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.519 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 55.5 m-85 -85.08 4.7 32.87 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.995 2.591 . . . . 12.949999999999999 117.995 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.9 m120 65.96 45.61 2.42 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.458 2.303 . . . . 25.449999999999999 110.079 175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.2 mt -98.18 108.62 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 127.034 2.134 . . . . 14.6 107.91 -177.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -107.93 -172.87 2.15 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.923 2.297 . . . . 33.229999999999997 106.619 -168.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -73.84 134.5 43.32 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.418 -5.176 . . . . 25.969999999999999 109.895 -173.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.326 88.8 mt-10 68.96 30.22 4.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.522 3.014 . . . . 32.609999999999999 113.536 -178.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.6 t -56.31 149.05 17.22 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 122.172 2.26 . . . . 10.56 110.56 167.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.0 m -106.71 110.94 23.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.536 2.397 . . . . 5.3300000000000001 104.794 159.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.8 mt -99.53 145.29 27.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.325 -2.734 . . . . 11.66 107.886 170.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -104.61 116.78 32.66 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.351 -1.468 . . . . 16.300000000000001 110.509 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.4 tp -95.62 115.26 27.17 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.497 1.498 . . . . 9.9600000000000009 107.8 -176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.5 m -109.04 143.92 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.761 1.743 . . . . 9.7599999999999998 109.278 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.427 HD21 HD13 ' A' ' 36' ' ' ILE . 46.9 mt -124.25 147.81 47.81 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.699 -1.591 . . . . 19.57 114.701 -168.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.8 ttp180 -84.03 139.56 32.43 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.826 -2.657 . . . . 35.079999999999998 103.826 175.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 tp -74.91 124.89 27.72 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.305 2.478 . . . . 32.310000000000002 113.605 -167.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -122.42 -38.65 2.64 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 125.925 1.69 . . . . 42.75 110.649 171.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.38 -59.51 0.18 Allowed Glycine 0 N--CA 1.43 -1.748 0 C-N-CA 116.421 -2.799 . . . . 36.310000000000002 119.402 170.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.777 1 O-C-N 115.664 -4.433 . . . . 36.270000000000003 105.364 -173.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.7 ptt? . . . . . 0 CA--C 1.49 -1.339 0 CA-C-O 120.436 0.16 . . . . 17.170000000000002 111.175 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -94.04 131.32 39.64 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 115.766 1.765 . . . . 21.890000000000001 115.766 170.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -103.13 152.55 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 103.741 -2.688 . . . . 10.83 103.741 163.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -101.82 146.82 27.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.861 2.743 . . . . 10.609999999999999 110.239 162.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -129.15 113.67 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 110.121 -3.218 . . . . 9.1300000000000008 104.489 176.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.272 9.2 ttmt -107.12 127.32 53.39 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.472 -3.268 . . . . 20.550000000000001 110.852 -178.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -95.97 170.38 9.33 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.93 -2.981 . . . . 11.779999999999999 109.736 -179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 66.7 mt -68.27 -31.83 71.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 116.447 2.017 . . . . 19.309999999999999 116.447 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 50.3 p -53.62 -64.63 0.76 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.704 -3.123 . . . . 23.140000000000001 111.823 166.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.87 76.1 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 106.57 -2.612 . . . . 19.739999999999998 106.57 170.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -140.74 153.89 46.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 113.351 -3.339 . . . . 21.93 104.036 163.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.1 m -108.75 87.79 2.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.048 2.718 . . . . 12.33 109.811 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -66.22 124.11 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 124.208 1.956 . . . . 17.079999999999998 112.305 168.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.5 m -99.71 111.1 23.47 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 112.019 -2.355 . . . . 16.300000000000001 111.826 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 mt -108.19 133.86 51.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 115.186 -2.34 . . . . 15.880000000000001 110.239 -178.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -96.1 106.68 18.89 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 116.667 -1.635 . . . . 28.899999999999999 110.727 173.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.48 158.82 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 128.187 3.429 . . . . 12.050000000000001 107.063 -174.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -108.94 157.85 35.79 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 107.139 -1.43 . . . . 18.170000000000002 107.139 173.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -77.82 -8.86 16.93 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 O-C-N 116.008 -2.68 . . . . 8.1600000000000001 114.239 -168.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.4 p -82.81 1.75 37.56 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 118.432 2.752 . . . . 11.130000000000001 118.432 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -83.52 156.88 22.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.726 -3.109 . . . . 18.030000000000001 111.116 169.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.9 p -93.83 164.23 13.2 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.471 -3.893 . . . . 10.220000000000001 115.048 -174.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.1 mm -65.67 -39.09 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 O-C-N 119.782 -1.824 . . . . 12.300000000000001 109.917 173.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -47.39 -43.78 23.73 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.214 2.672 . . . . 36.509999999999998 118.214 165.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -67.08 -43.19 83.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.628 2.085 . . . . 25.66 116.628 172.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.0 t -53.24 -52.99 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.029 1.732 . . . . 8.1199999999999992 110.469 169.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -70.79 -19.99 62.64 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.81 -3.681 . . . . 15.470000000000001 116.832 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.48 -25.08 65.69 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.872 -4.267 . . . . 11.449999999999999 115.056 178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -84.51 -28.02 27.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.033 2.933 . . . . 24.98 114.513 178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.7 mt -72.89 -44.91 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-N 114.168 -1.378 . . . . 9.4600000000000009 111.229 172.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -52.14 -50.13 62.35 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.862 2.912 . . . . 14.76 118.862 165.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -49.59 -48.47 48.73 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.974 1.842 . . . . 26.289999999999999 115.974 168.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.1 tttp -78.67 -71.76 0.42 Allowed 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.088 3.328 . . . . 30.059999999999999 115.488 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -74.15 -35.26 64.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.513 -3.867 . . . . 25.190000000000001 116.799 -174.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.47 42.73 7.72 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 127.676 3.931 . . . . 7.4100000000000001 113.433 174.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.4 mt -104.44 137.72 19.31 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 102.822 -3.029 . . . . 9.4900000000000002 102.822 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -82.48 146.78 13.83 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 CA-C-N 124.813 2.755 . . . . 11.42 108.821 -174.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -70.78 -3.37 12.55 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 124.265 2.559 . . . . 12.0 115.806 -162.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -92.42 -22.15 19.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.769 -2.457 . . . . 35.549999999999997 110.667 -176.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -80.16 -25.86 39.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.456 3.102 . . . . 20.52 109.794 176.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HB3' HD11 ' A' ' 69' ' ' LEU . 76.8 mt-30 -71.7 121.73 19.37 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.786 2.034 . . . . 7.1299999999999999 112.071 170.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -123.1 116.7 23.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.953 1.835 . . . . 36.390000000000001 111.268 177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.1 tp -102.61 116.41 32.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.953 -1.476 . . . . 9.5500000000000007 111.976 -166.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mm -103.79 117.17 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 C-N-CA 125.92 1.688 . . . . 13.9 109.022 -172.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -97.03 114.44 26.07 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 120.919 1.69 . . . . 6.8600000000000003 108.93 161.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.89 -98.09 0.06 Allowed 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 123.892 0.877 . . . . 11.15 111.397 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.85 12.06 8.25 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 127.321 2.391 . . . . 13.93 113.863 166.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -102.19 126.05 49.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 116.561 -3.905 . . . . 23.920000000000002 105.837 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -85.43 126.81 34.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 125.157 1.535 . . . . 23.23 108.059 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.8 mt -90.14 144.86 25.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.44 2.543 . . . . 9.1099999999999994 116.003 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -100.91 146.76 26.94 Favored 'General case' 0 N--CA 1.43 -1.463 1 O-C-N 115.666 -4.396 . . . . 33.439999999999998 110.077 -168.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -45.17 -54.45 6.87 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 129.114 2.965 . . . . 28.370000000000001 118.373 178.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.54 24.56 8.34 Favored Glycine 0 N--CA 1.43 -1.731 0 C-N-CA 129.324 3.345 . . . . 15.0 114.593 -174.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -115.63 171.75 7.55 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.849 -1.537 . . . . 25.5 106.849 172.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.8 p -104.86 -177.45 3.37 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 115.311 -0.859 . . . . 11.949999999999999 112.195 172.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.8 mt -80.31 -28.01 38.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.309 -1.769 . . . . 10.17 110.541 169.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -65.95 -43.18 88.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.72 -3.113 . . . . 13.59 116.437 170.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.298 10.8 m-20 -49.75 -39.84 38.98 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 118.241 2.682 . . . . 11.699999999999999 118.241 165.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -94.29 -18.72 21.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.549 -2.594 . . . . 12.949999999999999 116.88 -178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.1 m120 73.57 54.52 0.11 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.418 2.949 . . . . 25.449999999999999 110.104 177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 36.3 mt -93.83 120.7 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 113.73 -1.577 . . . . 14.6 109.487 -177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -89.48 168.76 11.94 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.992 1.853 . . . . 33.229999999999997 108.406 -167.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -64.12 153.95 36.11 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.815 -3.678 . . . . 25.969999999999999 109.764 169.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 41.23 35.11 0.37 Allowed 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 113.808 -5.557 . . . . 32.609999999999999 118.621 -169.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.7 t -91.88 129.24 37.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.572 -3.205 . . . . 10.56 108.341 172.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -87.77 122.54 31.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 113.832 1.049 . . . . 5.3300000000000001 113.832 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.341 1.5 mt -101.63 149.8 23.75 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.086 -2.259 . . . . 11.66 110.255 170.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -98.22 130.93 44.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.491 -1.38 . . . . 16.300000000000001 107.539 -176.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 41' ' ' GLN . 40.5 tp -114.46 115.58 27.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.47 -2.789 . . . . 9.9600000000000009 103.47 -171.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.9 m -113.11 164.98 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 N-CA-C 105.518 -2.03 . . . . 9.7599999999999998 105.518 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.6 mt -105.81 151.68 24.19 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 123.941 1.829 . . . . 19.57 109.787 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -62.6 132.59 52.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.414 2.005 . . . . 35.079999999999998 116.414 161.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.1 tp -97.91 130.23 44.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 115.143 1.535 . . . . 32.310000000000002 115.143 174.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -138.42 -111.38 0.17 Allowed 'General case' 0 N--CA 1.43 -1.431 1 C-N-CA 132.426 4.291 . . . . 42.75 105.135 169.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -156.86 122.87 1.22 Allowed Glycine 0 N--CA 1.43 -1.716 0 O-C-N 116.43 -3.919 . . . . 36.310000000000002 114.91 165.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.79 0 CA-C-O 115.927 -2.596 . . . . 36.270000000000003 116.225 -161.837 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 108.957 -0.757 . . . . 17.170000000000002 108.957 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -103.34 144.7 31.01 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 116.223 -4.048 . . . . 21.890000000000001 111.849 -176.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.83 160.69 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 109.095 -3.684 . . . . 10.83 107.901 164.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -125.19 112.56 16.59 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.088 2.743 . . . . 10.609999999999999 105.558 -166.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 67' ' ' LEU . 48.2 t -104.94 125.42 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 107.817 -1.179 . . . . 9.1300000000000008 107.817 -174.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' HG2' HG23 ' A' ' 12' ' ' THR . 79.6 mttt -121.3 127.18 51.07 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.419 2.372 . . . . 20.550000000000001 111.621 -167.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.439 HG22 HD23 ' A' ' 69' ' ' LEU . 30.3 p -70.67 169.86 13.52 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 112.642 -2.072 . . . . 11.779999999999999 111.047 168.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.3 mt -81.59 -12.69 58.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.921 -2.987 . . . . 19.309999999999999 112.55 -177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -91.27 -37.32 13.37 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 124.199 1.952 . . . . 23.140000000000001 110.431 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.39 38.05 0.35 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 116.53 -2.261 . . . . 19.739999999999998 111.871 169.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -98.99 138.74 35.66 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.741 -2.688 . . . . 21.93 103.741 172.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.445 HG23 ' HG2' ' A' ' 6' ' ' LYS . 76.1 m -114.97 122.81 47.41 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.603 -1.31 . . . . 12.33 108.572 -172.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.6 mt -101.47 128.76 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 101.721 -3.437 . . . . 17.079999999999998 101.721 -170.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.6 m -112.59 112.76 24.51 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.461 2.076 . . . . 16.300000000000001 111.999 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.264 73.0 mt -116.25 158.91 22.61 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 111.839 -2.437 . . . . 15.880000000000001 112.685 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -113.39 117.52 31.99 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.77 -2.678 . . . . 28.899999999999999 103.77 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -125.23 154.87 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 115.447 -0.797 . . . . 12.050000000000001 108.874 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -94.66 147.46 33.23 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 117.517 -1.23 . . . . 18.170000000000002 109.173 170.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -66.15 -8.66 20.9 Favored 'Trans proline' 0 C--N 1.299 -2.035 0 CA-C-N 127.629 3.76 . . . . 8.1600000000000001 118.994 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.8 m -100.18 12.5 36.85 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 129.642 4.339 . . . . 11.130000000000001 120.847 164.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.55 163.99 26.8 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 118.141 -1.424 . . . . 18.030000000000001 111.47 169.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.0 p -104.25 164.45 11.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.624 2.083 . . . . 10.220000000000001 116.624 176.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.1 mm -63.57 -36.09 75.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 127.943 2.497 . . . . 12.300000000000001 111.814 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -53.52 -45.08 69.62 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 115.48 1.659 . . . . 36.509999999999998 115.48 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.17 -41.52 94.58 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 128.822 2.849 . . . . 25.66 114.729 170.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -60.56 -52.99 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 118.682 -2.511 . . . . 8.1199999999999992 105.635 176.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -58.69 -35.37 72.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.579 2.609 . . . . 15.470000000000001 116.014 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.1 -44.28 94.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.776 -1.827 . . . . 11.449999999999999 114.447 174.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -74.28 -26.59 60.29 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 115.637 -2.125 . . . . 24.98 108.775 -174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.9 mt -66.92 -29.75 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 124.895 2.283 . . . . 9.4600000000000009 110.599 171.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -66.91 -48.3 69.13 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.96 -4.212 . . . . 14.76 114.463 175.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -62.36 -48.39 79.99 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 116.397 1.999 . . . . 26.289999999999999 116.397 176.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -69.95 -67.15 0.51 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.445 2.069 . . . . 30.059999999999999 109.707 175.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -84.04 -22.12 31.38 Favored 'General case' 0 N--CA 1.43 -1.425 1 O-C-N 115.838 -4.289 . . . . 25.190000000000001 118.75 -165.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.08 27.9 14.92 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 126.106 1.813 . . . . 7.4100000000000001 111.874 171.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 36' ' ' ILE . 11.1 mt -104.82 125.06 34.82 Favored Pre-proline 0 N--CA 1.43 -1.45 0 C-N-CA 125.908 1.683 . . . . 9.4900000000000002 109.35 -173.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.65 146.33 30.31 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-N 122.91 2.075 . . . . 11.42 114.748 -176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.98 -7.27 12.24 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 124.908 2.788 . . . . 12.0 111.269 -162.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -63.74 -19.04 64.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.024 2.93 . . . . 35.549999999999997 114.166 169.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -104.91 -10.32 17.38 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.558 2.743 . . . . 20.52 109.102 -175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -94.65 137.12 34.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.468 -2.02 . . . . 7.1299999999999999 106.068 -173.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 mtt180 -121.81 140.98 51.69 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.704 -1.591 . . . . 36.390000000000001 106.704 162.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.4 mt -123.26 136.64 54.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 118.922 -1.111 . . . . 9.5500000000000007 108.004 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.8 mm -118.34 129.46 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 127.058 2.143 . . . . 13.9 110.904 -173.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -128.46 117.23 20.98 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 116.835 -3.666 . . . . 6.8600000000000003 108.328 169.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.34 . . 58.37 -91.56 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.416 1.887 . . . . 11.15 114.338 -166.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.18 26.08 2.33 Favored Glycine 0 N--CA 1.43 -1.723 0 O-C-N 119.256 -2.153 . . . . 13.93 112.309 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -115.12 155.33 27.29 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.119 2.568 . . . . 23.920000000000002 104.177 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -114.14 137.09 52.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.145 -2.847 . . . . 23.23 106.163 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.521 HD22 ' CE2' ' A' ' 59' ' ' TYR . 30.1 mt -81.77 154.26 26.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.848 2.166 . . . . 9.1099999999999994 116.848 -167.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -102.11 157.31 16.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.994 2.33 . . . . 33.439999999999998 111.541 172.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -76.75 -52.34 9.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 118.789 2.885 . . . . 28.370000000000001 118.789 -161.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.82 24.49 5.15 Favored Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 116.908 -2.568 . . . . 15.0 118.384 175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -90.23 167.29 12.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 121.952 2.876 . . . . 25.5 111.125 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.1 p -90.24 166.85 13.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.694 -2.504 . . . . 11.949999999999999 116.083 171.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.483 HD22 ' H ' ' A' ' 56' ' ' LEU . 2.8 mm? -54.15 -31.94 53.95 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.658 -1.901 . . . . 10.17 114.346 158.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.0 m -74.72 -42.08 58.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.006 -1.077 . . . . 13.59 109.619 -169.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -47.95 -34.37 9.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 114.979 -2.438 . . . . 11.699999999999999 115.03 -178.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.521 ' CE2' HD22 ' A' ' 50' ' ' LEU . 93.3 m-85 -104.89 -0.87 26.64 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 121.96 2.164 . . . . 12.949999999999999 107.273 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.5 m120 71.6 46.25 0.41 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.738 2.815 . . . . 25.449999999999999 105.579 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mt -82.6 106.67 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 O-C-N 117.998 -2.939 . . . . 14.6 108.792 170.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -96.07 -175.11 3.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 125.148 1.53 . . . . 33.229999999999997 111.02 -176.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -65.76 141.91 58.16 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 124.674 3.397 . . . . 25.969999999999999 112.851 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.362 15.3 tt0 80.19 21.08 0.52 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.202 2.601 . . . . 32.609999999999999 113.993 174.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.6 m -80.69 144.76 32.0 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.243 3.417 . . . . 10.56 113.243 -174.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.5 m -98.78 101.97 13.55 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.212 2.605 . . . . 5.3300000000000001 115.009 -174.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' A' ' 5' ' ' VAL . 8.6 mp -99.94 130.8 46.15 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.119 -3.488 . . . . 11.66 109.233 -176.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.261 17.2 m-70 -101.01 142.91 31.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.786 -2.446 . . . . 16.300000000000001 108.755 -175.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.439 HD23 HG22 ' A' ' 7' ' ' THR . 19.1 tp -119.86 101.86 8.17 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.522 -0.763 . . . . 9.9600000000000009 109.929 -171.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.0 t -96.2 119.0 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 126.493 3.044 . . . . 9.7599999999999998 108.387 174.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 mt -84.52 130.44 34.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.036 -2.29 . . . . 19.57 105.551 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.6 ttp180 -61.56 116.7 4.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 122.875 0.47 . . . . 35.079999999999998 111.659 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.9 tp -79.71 122.82 27.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.896 -2.378 . . . . 32.310000000000002 110.611 176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -109.31 -55.03 2.47 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.918 2.087 . . . . 42.75 113.474 159.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.45 -53.13 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.687 0 CA-C-O 125.768 2.871 . . . . 36.310000000000002 109.058 175.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 N-CA-C 106.697 -2.561 . . . . 36.270000000000003 106.697 -171.051 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 122.937 1.351 . . . . 17.170000000000002 112.899 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -94.25 145.93 24.38 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 127.646 3.593 . . . . 21.890000000000001 108.254 177.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -130.88 167.5 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 103.777 -2.675 . . . . 10.83 103.777 172.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -126.81 137.18 53.16 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 102.841 -3.022 . . . . 10.609999999999999 102.841 -174.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -106.75 135.44 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 106.2 -1.778 . . . . 9.1300000000000008 106.2 171.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -135.38 135.46 40.69 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.486 2.403 . . . . 20.550000000000001 112.769 173.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.515 HG22 HD23 ' A' ' 69' ' ' LEU . 68.2 p -77.87 173.07 12.53 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 113.601 -1.636 . . . . 11.779999999999999 113.573 173.048 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 83.5 mt -72.73 -28.23 62.52 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.124 -2.86 . . . . 19.309999999999999 112.524 -172.541 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.6 p -75.11 -36.5 61.66 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.357 -3.339 . . . . 23.140000000000001 109.953 166.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.12 42.25 0.37 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 120.972 3.149 . . . . 19.739999999999998 120.972 170.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -88.98 115.51 26.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 115.844 1.794 . . . . 21.93 115.844 176.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.8 m -92.18 114.24 26.73 Favored 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.162 2.585 . . . . 12.33 108.343 -165.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.0 mt -105.07 102.83 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 106.343 -1.725 . . . . 17.079999999999998 106.343 172.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.2 m -87.42 115.52 24.89 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 116.062 1.875 . . . . 16.300000000000001 116.062 175.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.7 mt -123.95 151.44 43.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.246 -1.835 . . . . 15.880000000000001 115.396 -174.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -93.5 138.55 31.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 124.388 1.055 . . . . 28.899999999999999 109.651 176.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.305 0.1 OUTLIER -144.84 161.43 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 105.85 -1.907 . . . . 12.050000000000001 105.85 170.235 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -103.23 165.84 12.88 Favored Pre-proline 0 N--CA 1.429 -1.477 0 CA-C-O 115.685 -2.103 . . . . 18.170000000000002 106.721 164.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -79.39 -9.64 14.94 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 124.829 2.76 . . . . 8.1600000000000001 115.342 -178.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.0 p -84.13 -19.02 34.91 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 129.766 4.416 . . . . 11.130000000000001 109.263 169.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -61.17 149.84 36.2 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 118.44 -1.304 . . . . 18.030000000000001 114.395 167.257 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.292 35.5 p -78.17 174.8 10.79 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.068 -3.52 . . . . 10.220000000000001 116.06 171.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 50' ' ' LEU . 28.7 mt -93.59 -17.42 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 117.224 -3.423 . . . . 12.300000000000001 107.743 -176.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -72.46 -40.57 66.89 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 131.751 4.02 . . . . 36.509999999999998 107.298 172.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -51.41 -49.82 60.86 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 130.969 3.708 . . . . 25.66 112.457 169.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -57.18 -52.25 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 O-C-N 124.371 1.044 . . . . 8.1199999999999992 113.075 173.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.73 -29.55 70.08 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 126.45 1.9 . . . . 15.470000000000001 111.066 -178.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.77 -27.24 62.82 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 115.221 -2.591 . . . . 11.449999999999999 116.56 175.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -72.41 -18.65 61.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.531 1.678 . . . . 24.98 115.531 168.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.3 mt -75.38 -27.96 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 112.494 0.553 . . . . 9.4600000000000009 112.494 170.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.341 18.1 tt0 -52.31 -42.85 64.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.314 1.968 . . . . 14.76 116.314 160.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -78.11 -49.01 14.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.551 1.54 . . . . 26.289999999999999 110.116 -178.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 mtpp -79.63 -58.8 3.01 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.917 2.932 . . . . 30.059999999999999 118.917 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.313 6.6 mm-40 -74.53 -44.05 52.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 113.478 0.918 . . . . 25.190000000000001 113.478 -177.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.76 53.96 3.05 Favored Glycine 0 N--CA 1.43 -1.755 0 C-N-CA 128.369 2.89 . . . . 7.4100000000000001 107.372 -171.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.3 mt -118.18 120.1 32.68 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 102.384 -3.191 . . . . 9.4900000000000002 102.384 174.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -72.85 154.48 53.62 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 CA-C-N 122.825 2.045 . . . . 11.42 114.094 176.375 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -62.48 -16.47 52.27 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 N-CA-C 118.666 2.525 . . . . 12.0 118.666 -173.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.429 ' CG ' HH12 ' A' ' 72' ' ' ARG . 37.5 t70 -76.24 -31.32 58.28 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 117.607 -1.187 . . . . 35.549999999999997 111.948 -174.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -78.4 -18.07 55.53 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 127.4 2.937 . . . . 20.52 114.447 170.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -82.02 122.57 27.97 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.919 -1.738 . . . . 7.1299999999999999 114.577 179.409 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -111.29 120.8 43.46 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.412 -2.44 . . . . 36.390000000000001 104.412 166.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.7 mt -96.32 106.96 19.25 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.339 -2.1 . . . . 9.5500000000000007 112.26 164.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.5 mm -89.53 145.28 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 O-C-N 125.619 1.825 . . . . 13.9 108.059 173.066 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -122.83 107.78 12.26 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 106.086 -1.82 . . . . 6.8600000000000003 106.086 170.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.0 -89.65 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 130.4 3.48 . . . . 11.15 111.817 -160.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.74 1.08 9.33 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 116.629 -3.795 . . . . 13.93 114.937 -179.295 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -102.45 126.88 49.64 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.717 -2.637 . . . . 23.920000000000002 113.349 177.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -72.59 125.3 27.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.205 1.821 . . . . 23.23 111.168 171.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.506 HD22 ' CD2' ' A' ' 59' ' ' TYR . 63.4 mt -81.92 166.3 20.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.54 1.064 . . . . 9.1099999999999994 110.479 -174.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -98.65 158.18 15.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.868 -1.77 . . . . 33.439999999999998 113.02 167.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -71.58 -56.25 6.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.286 2.234 . . . . 28.370000000000001 112.163 -174.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.45 13.93 31.93 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 118.272 -2.768 . . . . 15.0 118.852 -175.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.1 mtt180 -106.79 159.15 16.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.619 2.368 . . . . 25.5 107.401 172.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -103.37 170.89 7.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 111.385 -2.643 . . . . 11.949999999999999 112.874 -173.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.411 HD22 ' H ' ' A' ' 56' ' ' LEU . 1.3 mm? -58.35 -43.14 88.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 126.18 2.175 . . . . 10.17 111.654 174.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.2 t -53.84 -35.2 61.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.686 2.794 . . . . 13.59 115.994 174.65 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 14.9 m-20 -80.91 -25.25 37.66 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 112.763 -3.494 . . . . 11.699999999999999 114.51 -171.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.506 ' CD2' HD22 ' A' ' 50' ' ' LEU . 80.4 m-85 -95.8 -10.32 29.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 128.879 3.862 . . . . 12.949999999999999 110.538 171.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.2 m120 77.72 45.64 0.07 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.542 3.537 . . . . 25.449999999999999 113.583 173.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.9 mt -74.56 140.23 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 127.788 2.435 . . . . 14.6 109.141 170.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -97.79 175.98 5.97 Favored 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 132.926 4.49 . . . . 33.229999999999997 108.759 178.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -68.35 156.11 38.44 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.094 1.887 . . . . 25.969999999999999 116.094 162.077 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 56.62 17.58 3.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.12 1.438 . . . . 32.609999999999999 114.1 -178.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.6 m -85.03 154.05 22.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.915 -2.991 . . . . 10.56 110.262 177.635 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.1 m -99.73 109.96 22.38 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 111.979 -2.373 . . . . 5.3300000000000001 114.517 -178.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -86.1 156.38 20.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 128.773 3.795 . . . . 11.66 110.111 171.262 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m-70 -112.07 140.57 46.64 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 116.915 -3.616 . . . . 16.300000000000001 109.014 178.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.515 HD23 HG22 ' A' ' 7' ' ' THR . 48.8 tp -110.53 119.55 39.54 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.854 -1.975 . . . . 9.9600000000000009 110.484 -177.694 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.45 135.18 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 101.855 -3.387 . . . . 9.7599999999999998 101.855 -178.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.9 mt -93.28 153.41 18.59 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 104.555 -2.387 . . . . 19.57 104.555 -179.016 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.429 HH12 ' CG ' ' A' ' 39' ' ' ASP . 52.2 ttp180 -79.43 119.57 22.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.042 1.877 . . . . 35.079999999999998 111.306 166.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.3 mt -92.18 91.79 7.92 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.426 -2.671 . . . . 32.310000000000002 112.023 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -86.06 -56.82 3.28 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.54 -1.35 . . . . 42.75 110.269 166.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.82 116.38 0.59 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 107.373 -2.291 . . . . 36.310000000000002 107.373 163.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.759 0 CA-C-O 123.42 1.567 . . . . 36.270000000000003 113.46 -165.081 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.347 0 CA-C-O 114.851 -2.5 . . . . 17.170000000000002 116.933 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -90.62 132.57 35.68 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 116.964 -1.493 . . . . 21.890000000000001 107.101 -179.267 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.2 pt -119.64 153.28 22.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 105.938 -1.875 . . . . 10.83 105.938 162.718 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -115.18 135.22 54.42 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.409 -2.682 . . . . 10.609999999999999 110.628 177.369 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.1 t -100.8 123.78 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.369 -2.707 . . . . 9.1300000000000008 107.487 176.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.7 mmtt -108.8 128.28 54.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 124.458 1.099 . . . . 20.550000000000001 108.117 -179.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.3 p -81.17 173.76 12.22 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 117.603 2.446 . . . . 11.779999999999999 117.603 -177.334 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.6 mt -67.56 -27.46 66.96 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.42 -2.05 . . . . 19.309999999999999 114.772 166.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.7 p -74.08 -48.78 27.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.501 2.32 . . . . 23.140000000000001 114.907 175.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 68.06 0.32 Allowed Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 109.483 -1.447 . . . . 19.739999999999998 109.483 178.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -139.63 160.35 40.08 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.927 -1.511 . . . . 21.93 111.259 164.101 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -124.27 109.61 13.59 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.008 2.068 . . . . 12.33 112.54 -166.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mp -96.96 132.01 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 104.477 -2.416 . . . . 17.079999999999998 104.477 -173.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.302 31.6 m -88.53 96.11 10.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.232 0.958 . . . . 16.300000000000001 112.891 -178.031 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.39 119.64 39.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.839 -1.944 . . . . 15.880000000000001 110.55 -169.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -88.79 123.01 32.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.958 -2.339 . . . . 28.899999999999999 114.772 169.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.8 m -134.34 154.06 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.744 2.818 . . . . 12.050000000000001 115.088 -172.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -107.57 158.33 33.54 Favored Pre-proline 0 N--CA 1.43 -1.435 0 CA-C-O 115.771 -2.061 . . . . 18.170000000000002 112.063 173.927 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.51 -21.45 40.07 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 123.314 2.219 . . . . 8.1600000000000001 117.216 -175.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -67.88 -11.84 59.46 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.692 3.597 . . . . 11.130000000000001 114.291 172.033 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -79.61 133.6 36.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.683 2.793 . . . . 18.030000000000001 113.592 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.8 p -74.2 154.43 39.04 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.881 1.672 . . . . 10.220000000000001 110.019 168.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 54' ' ' ARG . 4.3 mp -76.28 -9.24 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.528 -3.233 . . . . 12.300000000000001 114.778 174.12 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -75.01 -35.83 61.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 112.983 -3.389 . . . . 36.509999999999998 112.264 162.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.6 t30 -58.95 -42.28 89.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 125.17 2.414 . . . . 25.66 113.665 173.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.7 t -66.65 -34.38 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 113.472 -1.695 . . . . 8.1199999999999992 112.461 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -71.07 -30.5 66.65 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.971 2.319 . . . . 15.470000000000001 111.759 -179.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.09 -25.94 63.75 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.472 2.309 . . . . 11.449999999999999 114.917 174.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -88.22 -29.84 20.16 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 124.633 2.159 . . . . 24.98 109.1 -176.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.6 mt -74.65 -37.31 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 118.502 -2.624 . . . . 9.4600000000000009 116.048 169.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -47.42 -38.33 13.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 119.436 3.125 . . . . 14.76 119.436 159.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.273 10.9 t70 -71.77 -53.73 12.45 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 114.816 -2.516 . . . . 26.289999999999999 107.137 -176.14 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -71.75 -57.7 4.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.447 2.299 . . . . 30.059999999999999 112.483 -172.638 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -92.83 -38.5 11.72 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 108.567 -0.901 . . . . 25.190000000000001 108.567 -166.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.26 37.54 5.34 Favored Glycine 0 N--CA 1.429 -1.781 0 N-CA-C 120.619 3.008 . . . . 7.4100000000000001 120.619 -173.167 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -98.61 127.6 35.32 Favored Pre-proline 0 N--CA 1.429 -1.476 0 O-C-N 119.619 -2.106 . . . . 9.4900000000000002 108.594 171.477 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.13 139.21 54.81 Favored 'Trans proline' 0 C--N 1.3 -1.997 1 CA-C-O 110.134 -4.194 . . . . 11.42 110.816 175.266 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -82.5 -7.44 11.7 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 CA-C-N 127.836 3.834 . . . . 12.0 117.129 -161.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -67.36 -32.68 73.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 131.165 3.786 . . . . 35.549999999999997 113.412 169.603 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -68.7 -50.45 50.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 111.41 -2.632 . . . . 20.52 116.251 168.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -59.69 145.07 46.23 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 118.891 2.923 . . . . 7.1299999999999999 118.891 -168.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -123.65 120.95 34.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 124.434 3.288 . . . . 36.390000000000001 109.523 167.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 43' ' ' LEU . 35.6 mt -103.97 121.45 43.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.633 -1.988 . . . . 9.5500000000000007 105.633 -178.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.1 mt -118.13 129.26 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 102.436 -3.172 . . . . 13.9 102.436 -169.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -104.62 106.15 16.53 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.532 -3.855 . . . . 6.8600000000000003 106.77 170.09 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.3 . . 72.5 -91.09 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 125.255 2.455 . . . . 11.15 116.748 -171.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.64 -19.24 4.18 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 111.716 -2.493 . . . . 13.93 111.966 168.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -88.67 121.42 31.02 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 117.181 -3.541 . . . . 23.920000000000002 111.375 -166.136 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -80.12 122.22 26.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.323 -3.986 . . . . 23.23 109.191 -179.074 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.3 mt -71.52 134.92 46.84 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 128.35 3.531 . . . . 9.1099999999999994 115.593 175.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -95.56 130.18 42.5 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 129.542 3.137 . . . . 33.439999999999998 111.583 -178.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -54.12 -42.41 69.43 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 110.944 -2.844 . . . . 28.370000000000001 111.703 -165.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.6 4.84 85.18 Favored Glycine 0 N--CA 1.43 -1.732 0 O-C-N 118.762 -2.461 . . . . 15.0 114.888 -176.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.49 ' O ' HD12 ' A' ' 23' ' ' ILE 0.27 95.0 mtt180 -95.0 163.65 13.22 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 121.005 2.402 . . . . 25.5 106.554 176.679 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.0 p -95.15 166.35 11.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.9 1.815 . . . . 11.949999999999999 115.9 168.24 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.3 mt -64.18 -29.68 70.78 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.578 2.351 . . . . 10.17 111.835 168.006 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.251 8.5 t -67.73 -42.07 82.48 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.96 -4.213 . . . . 13.59 112.433 178.484 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -58.16 -42.84 86.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 117.19 2.293 . . . . 11.699999999999999 117.19 174.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -82.69 4.92 23.03 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 116.485 2.031 . . . . 12.949999999999999 116.485 170.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.5 m120 48.16 55.03 9.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.456 -2.653 . . . . 25.449999999999999 113.744 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.83 111.35 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 125.349 1.655 . . . . 14.6 106.744 -177.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -81.33 166.4 20.51 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.502 1.521 . . . . 33.229999999999997 111.343 174.059 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -63.06 158.87 18.5 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.553 1.541 . . . . 25.969999999999999 114.378 -171.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.289 38.5 mt-10 58.86 24.66 12.68 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.575 2.131 . . . . 32.609999999999999 116.534 -177.375 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.6 m -77.71 125.63 29.63 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.113 -1.617 . . . . 10.56 113.687 177.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.9 m -80.06 126.48 31.12 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 125.593 1.557 . . . . 5.3300000000000001 112.002 174.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.405 HD13 HD22 ' A' ' 43' ' ' LEU . 80.3 mt -103.69 150.2 24.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 124.569 1.148 . . . . 11.66 108.527 169.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -101.43 124.38 47.01 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 106.318 -1.734 . . . . 16.300000000000001 106.318 170.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 28.8 tp -96.86 128.09 43.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 106.282 -1.747 . . . . 9.9600000000000009 106.282 171.172 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.8 t -116.63 155.23 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.735 -2.32 . . . . 9.7599999999999998 104.735 168.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 43.5 mt -104.2 177.54 4.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 121.027 -1.045 . . . . 19.57 109.418 175.476 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -105.16 118.02 35.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.589 1.956 . . . . 35.079999999999998 112.75 -164.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.7 tp -100.84 112.16 24.53 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 114.993 1.479 . . . . 32.310000000000002 114.993 -175.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.95 -55.01 1.05 Allowed 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 126.254 2.221 . . . . 42.75 109.941 169.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.42 98.09 0.12 Allowed Glycine 0 N--CA 1.43 -1.763 1 C-N-CA 131.599 4.428 . . . . 36.310000000000002 109.468 169.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.762 1 CA-C-O 112.974 -4.237 . . . . 36.270000000000003 122.044 175.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ptt? . . . . . 0 CA--C 1.49 -1.363 0 CA-C-O 122.88 1.324 . . . . 17.170000000000002 111.403 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.76 110.65 21.99 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.134 -1.604 . . . . 21.890000000000001 108.132 -175.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.9 pt -84.81 145.96 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.195 -1.566 . . . . 10.83 110.841 153.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -123.15 89.21 3.06 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.489 -2.782 . . . . 10.609999999999999 103.489 -172.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 62.0 t -80.7 123.17 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 107.181 -1.414 . . . . 9.1300000000000008 107.181 179.309 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -114.21 119.26 36.43 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.497 3.522 . . . . 20.550000000000001 110.977 -172.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.7 p -77.91 161.56 27.48 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.082 -4.761 . . . . 11.779999999999999 113.004 -176.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.6 mt -78.83 -21.78 47.15 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 117.34 -1.744 . . . . 19.309999999999999 109.657 -175.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.0 p -70.55 -43.71 68.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.083 -2.886 . . . . 23.140000000000001 114.16 173.081 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.66 -2.26 0.21 Allowed Glycine 0 N--CA 1.431 -1.677 0 N-CA-C 118.173 2.029 . . . . 19.739999999999998 118.173 178.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -91.49 145.49 24.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.756 -1.222 . . . . 21.93 110.955 -167.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.6 m -115.63 115.35 26.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.873 -2.269 . . . . 12.33 104.873 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.492 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 15.8 mt -96.52 105.51 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.735 2.414 . . . . 17.079999999999998 107.318 179.321 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.9 m -74.59 119.92 19.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.563 1.649 . . . . 16.300000000000001 110.655 169.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.322 97.8 mt -130.46 134.62 47.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.333 2.968 . . . . 15.880000000000001 103.922 168.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.361 2.2 mt-10 -84.86 107.65 17.12 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 127.511 3.529 . . . . 28.899999999999999 113.678 169.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -116.87 171.34 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.031 -2.293 . . . . 12.050000000000001 108.978 177.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -114.72 160.29 33.94 Favored Pre-proline 0 N--CA 1.43 -1.429 0 C-N-CA 127.895 2.478 . . . . 18.170000000000002 108.03 176.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -68.3 -24.5 37.36 Favored 'Trans proline' 0 N--CA 1.434 -1.978 0 O-C-N 116.216 -2.57 . . . . 8.1600000000000001 112.726 -170.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.391 7.1 m -88.12 -2.52 58.65 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.917 -1.739 . . . . 11.130000000000001 114.686 -179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -72.96 158.14 36.05 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 128.328 3.918 . . . . 18.030000000000001 114.84 174.024 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.414 43.1 p -95.47 149.62 21.2 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.296 -2.229 . . . . 10.220000000000001 114.804 -176.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.5 mp -66.06 -37.3 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.513 -1.291 . . . . 12.300000000000001 107.513 173.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -50.27 -45.46 54.31 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.296 -2.128 . . . . 36.509999999999998 113.906 169.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -84.63 7.21 21.04 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 123.766 2.984 . . . . 25.66 112.797 177.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.269 23.5 t -77.42 -60.04 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 O-C-N 116.746 -3.721 . . . . 8.1199999999999992 107.255 159.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -43.65 -40.66 4.26 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 117.968 2.581 . . . . 15.470000000000001 117.968 175.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.315 . . -50.05 -47.47 53.38 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 128.079 2.552 . . . . 11.449999999999999 116.697 171.301 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.6 mttm -76.99 -30.94 56.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 119.102 -2.249 . . . . 24.98 108.252 -175.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.2 mt -69.84 -31.75 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 O-C-N 115.967 -4.208 . . . . 9.4600000000000009 112.86 174.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -69.01 -33.34 73.49 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.161 -1.587 . . . . 14.76 109.611 176.038 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -76.16 -51.92 11.17 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.728 1.611 . . . . 26.289999999999999 115.109 177.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.9 mttm -76.91 -42.34 39.92 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 119.669 3.211 . . . . 30.059999999999999 119.669 179.332 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 48.2 mm-40 -106.4 -25.6 11.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.391 1.682 . . . . 25.190000000000001 110.69 -178.252 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.4 18.82 51.74 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 120.305 2.882 . . . . 7.4100000000000001 120.305 175.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.2 mt -91.12 126.85 53.72 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 101.32 -3.585 . . . . 9.4900000000000002 101.32 -175.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -56.06 151.56 41.74 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 N-CA-C 120.639 3.284 . . . . 11.42 120.639 171.515 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -86.02 -22.22 2.36 Favored 'Trans proline' 0 C--N 1.3 -2.014 1 CA-C-N 130.077 4.635 . . . . 12.0 116.128 -161.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -84.12 -23.09 30.87 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.37 2.033 . . . . 35.549999999999997 110.821 -174.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -61.52 -28.15 69.11 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 128.201 2.6 . . . . 20.52 114.385 162.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -87.8 122.93 32.05 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 116.716 -1.612 . . . . 7.1299999999999999 112.34 -170.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 -113.97 131.24 56.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 122.363 2.347 . . . . 36.390000000000001 112.181 166.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -96.53 122.25 39.24 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.207 -3.433 . . . . 9.5500000000000007 114.698 171.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.7 mt -106.95 118.58 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.88 -2.267 . . . . 13.9 104.88 172.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' A' ' 50' ' ' LEU . 33.6 t80 -106.04 121.81 44.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.603 1.668 . . . . 6.8600000000000003 107.978 167.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.318 . . 52.55 -99.2 0.08 Allowed 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 116.098 1.888 . . . . 11.15 116.098 -174.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.26 -17.82 13.18 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 117.554 1.782 . . . . 13.93 117.554 -173.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -109.6 133.08 53.52 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.513 2.725 . . . . 23.920000000000002 111.236 -165.586 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -79.63 128.25 33.17 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.655 -1.278 . . . . 23.23 108.719 173.622 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.49 HD11 ' HB3' ' A' ' 45' ' ' PHE . 23.2 mt -95.05 126.52 40.44 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.782 2.083 . . . . 9.1099999999999994 115.856 -165.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.406 ' CD ' HH21 ' A' ' 54' ' ' ARG . 34.2 tt0 -82.28 139.38 34.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.786 2.232 . . . . 33.439999999999998 111.308 171.14 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.24 -50.16 61.69 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.157 2.583 . . . . 28.370000000000001 113.471 -160.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.03 3.93 86.53 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 127.385 2.421 . . . . 15.0 113.34 -162.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 51' ' ' GLU 0.284 22.6 mtt180 -85.5 162.52 18.9 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.988 2.115 . . . . 25.5 111.689 172.925 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.3 p -88.91 168.4 12.43 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 116.563 -2.055 . . . . 11.949999999999999 110.562 178.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.7 mt -72.94 -25.25 60.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.994 -1.912 . . . . 10.17 111.655 169.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.8 t -63.77 -41.61 97.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.652 2.093 . . . . 13.59 116.652 172.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -47.31 -46.93 25.63 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.626 2.631 . . . . 11.699999999999999 116.259 175.086 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -86.14 1.24 51.3 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.122 -2.236 . . . . 12.949999999999999 115.601 -179.601 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.37 17.3 m-20 75.98 32.45 0.64 Allowed 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.734 2.683 . . . . 25.449999999999999 113.501 169.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.5 mt -91.56 113.85 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.35 -2.719 . . . . 14.6 109.129 -170.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.1 mm-40 -111.29 -171.11 1.77 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.284 1.992 . . . . 33.229999999999997 109.182 -174.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -71.36 148.13 47.32 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 115.142 -2.361 . . . . 25.969999999999999 112.773 -168.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 49.65 29.48 3.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 119.728 3.233 . . . . 32.609999999999999 119.728 -165.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -68.66 148.26 50.69 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 116.091 1.885 . . . . 10.56 116.091 170.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 m -104.08 117.63 34.73 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 121.235 0.541 . . . . 5.3300000000000001 110.805 171.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -106.37 151.04 25.4 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.364 -3.335 . . . . 11.66 108.343 175.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.0 m-70 -93.77 130.03 39.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.35 1.656 . . . . 16.300000000000001 115.038 178.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.5 tp -109.69 95.12 5.4 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.315 2.007 . . . . 9.9600000000000009 112.611 178.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -97.24 126.37 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 128.13 2.572 . . . . 9.7599999999999998 111.807 176.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.3 mt -93.19 162.85 13.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.281 -1.512 . . . . 19.57 112.085 177.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.6 ttp180 -90.4 131.81 35.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.876 -2.39 . . . . 35.079999999999998 113.147 -178.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.313 84.5 mt -97.32 94.52 7.13 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 121.382 -0.824 . . . . 32.310000000000002 111.469 -178.658 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -114.71 -67.49 0.99 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.408 2.283 . . . . 42.75 113.043 -176.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.14 62.55 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.718 0 O-C-N 127.259 2.849 . . . . 36.310000000000002 108.387 -175.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.716 0 O-C-N 119.22 -2.341 . . . . 36.270000000000003 116.631 179.447 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 107.733 -1.21 . . . . 17.170000000000002 107.733 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -112.61 147.18 37.24 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.206 -1.559 . . . . 21.890000000000001 112.09 174.034 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.8 pt -127.98 170.77 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 N-CA-C 105.851 -1.907 . . . . 10.83 105.851 164.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -131.71 126.1 33.69 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.432 -3.292 . . . . 10.609999999999999 107.825 -175.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.0 t -97.77 118.76 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.983 -2.323 . . . . 9.1300000000000008 110.138 168.08 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 ttpt -103.56 137.23 41.91 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.452 -2.795 . . . . 20.550000000000001 103.452 -176.175 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 11' ' ' LYS . 48.9 p -97.84 179.79 4.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.504 -0.748 . . . . 11.779999999999999 111.685 -168.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.1 tp -67.94 -33.78 75.33 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.358 -2.714 . . . . 19.309999999999999 113.705 177.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 41.1 p -76.49 -32.13 58.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.176 -2.821 . . . . 23.140000000000001 105.643 175.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.54 30.03 4.81 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-O 124.096 1.942 . . . . 19.739999999999998 116.994 -166.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 7' ' ' THR . 58.8 tttm -84.97 138.92 32.18 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 114.427 -5.16 . . . . 21.93 107.525 160.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -109.14 129.11 55.48 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 129.1 2.96 . . . . 12.33 110.923 177.528 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -120.94 115.01 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.423 1.889 . . . . 17.079999999999998 109.183 -174.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.9 m -79.86 124.74 28.92 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.835 -2.416 . . . . 16.300000000000001 113.628 175.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.669 HD22 ' HB3' ' A' ' 29' ' ' LYS . 85.5 mt -128.26 134.07 48.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 106.324 -1.732 . . . . 15.880000000000001 106.324 -173.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -101.89 111.8 24.19 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.186 1.921 . . . . 28.899999999999999 116.186 -173.617 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.24 170.66 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 O-C-N 120.433 -1.417 . . . . 12.050000000000001 111.904 -165.541 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -120.95 162.54 34.62 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 113.696 -3.049 . . . . 18.170000000000002 107.584 177.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.32 51.1 Cg_exo -51.77 -21.58 11.79 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 N-CA-C 121.685 3.687 . . . . 8.1600000000000001 121.685 173.068 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.4 t -106.81 4.02 27.07 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.01 1.724 . . . . 11.130000000000001 113.466 -171.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -75.74 161.69 28.84 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.385 1.254 . . . . 18.030000000000001 114.385 159.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.1 p -103.96 175.41 5.49 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.565 -1.198 . . . . 10.220000000000001 113.797 -177.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.439 HD12 ' N ' ' A' ' 23' ' ' ILE . 2.4 mp -71.88 -31.63 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.181 -2.199 . . . . 12.300000000000001 109.713 -178.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -44.93 -41.69 7.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.547 2.425 . . . . 36.509999999999998 117.547 164.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -68.9 -26.91 65.34 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.979 -1.918 . . . . 25.66 114.713 177.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 89.3 t -80.16 -42.52 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 126.693 1.997 . . . . 8.1199999999999992 109.729 176.123 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -53.88 -44.27 70.31 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 115.334 1.605 . . . . 15.470000000000001 115.334 171.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.26 -38.48 41.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.145 2.646 . . . . 11.449999999999999 118.145 170.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.669 ' HB3' HD22 ' A' ' 15' ' ' LEU . 45.9 mttm -75.63 -29.0 59.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 124.598 1.186 . . . . 24.98 111.693 -177.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.6 mt -71.94 -33.56 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 122.591 1.186 . . . . 9.4600000000000009 109.033 175.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -64.26 -53.06 54.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.245 -1.798 . . . . 14.76 115.583 178.38 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -54.0 -53.06 58.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 111.147 -2.751 . . . . 26.289999999999999 115.039 165.774 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -78.43 -71.49 0.43 Allowed 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.119 1.438 . . . . 30.059999999999999 111.732 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -79.18 -25.04 42.83 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 115.692 -4.38 . . . . 25.190000000000001 114.94 -167.22 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.61 46.96 4.43 Favored Glycine 0 N--CA 1.429 -1.779 0 C-N-CA 128.87 3.128 . . . . 7.4100000000000001 115.666 -178.543 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.58 132.99 22.85 Favored Pre-proline 0 N--CA 1.429 -1.486 0 CA-C-N 118.793 1.297 . . . . 9.4900000000000002 113.271 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -67.35 147.77 78.5 Favored 'Trans proline' 0 N--CA 1.434 -2.006 1 CA-C-O 110.233 -4.153 . . . . 11.42 118.532 -178.763 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -64.78 -18.95 64.01 Favored 'Trans proline' 0 C--N 1.299 -2.027 2 C-N-CA 130.096 7.197 . . . . 12.0 108.429 -172.146 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.362 7.5 t70 -102.55 -33.39 9.5 Favored 'General case' 0 N--CA 1.429 -1.477 1 CA-C-N 126.383 4.174 . . . . 35.549999999999997 108.976 -169.105 . . . . . . . . 3 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -46.89 -41.36 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.809 2.444 . . . . 20.52 113.452 165.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB2' HD11 ' A' ' 69' ' ' LEU . 4.4 pt20 -97.96 148.21 23.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.616 2.627 . . . . 7.1299999999999999 113.86 178.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -136.06 137.51 41.18 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.38 -4.575 . . . . 36.390000000000001 108.408 173.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -108.93 143.43 38.18 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.107 -4.121 . . . . 9.5500000000000007 109.357 -172.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.3 mt -122.52 147.82 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 129.186 2.994 . . . . 13.9 109.342 -177.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -137.59 116.09 12.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 100.257 -3.979 . . . . 6.8600000000000003 100.257 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.29 -104.01 0.13 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.246 -1.797 . . . . 11.15 113.072 -164.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.06 16.53 5.24 Favored Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 107.312 -2.315 . . . . 13.93 107.312 171.063 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -100.89 143.43 31.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 120.878 2.339 . . . . 23.920000000000002 107.633 170.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -91.91 133.15 35.94 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.372 3.469 . . . . 23.23 113.447 178.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.7 mt -93.16 157.64 16.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.443 3.021 . . . . 9.1099999999999994 117.957 -175.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -90.83 154.23 19.65 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.846 2.26 . . . . 33.439999999999998 111.104 161.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -77.05 -47.95 19.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.299 -2.228 . . . . 28.370000000000001 108.219 -163.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -98.84 11.46 62.55 Favored Glycine 0 N--CA 1.43 -1.749 0 O-C-N 120.439 -1.413 . . . . 15.0 114.578 -159.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -101.95 146.91 27.19 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.371 2.268 . . . . 25.5 105.361 178.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 8.4 p -82.07 156.98 24.3 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.24 2.448 . . . . 11.949999999999999 113.959 -169.558 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 96.0 mt -58.56 -35.23 72.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.523 -3.236 . . . . 10.17 105.456 -177.105 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.5 t -69.04 -29.24 67.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.816 2.553 . . . . 13.59 113.884 174.139 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -59.44 -56.6 19.95 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.838 -4.289 . . . . 11.699999999999999 111.86 176.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -79.96 0.39 31.69 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.149 0.98 . . . . 12.949999999999999 112.677 -177.584 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.428 72.2 m-80 65.9 49.18 1.69 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.843 2.905 . . . . 25.449999999999999 118.843 -176.178 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.9 mt -93.34 110.27 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.122 2.569 . . . . 14.6 108.304 179.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -96.14 -168.03 1.68 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.602 -1.635 . . . . 33.229999999999997 110.407 -172.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -72.26 146.05 47.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.891 -1.049 . . . . 25.969999999999999 109.389 176.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 28.6 mt-10 73.3 30.01 1.59 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.737 -1.208 . . . . 32.609999999999999 107.737 170.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.3 m -90.18 116.89 28.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.567 2.127 . . . . 10.56 108.221 -170.271 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.8 m -72.21 108.08 5.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.486 -3.258 . . . . 5.3300000000000001 113.73 165.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -98.69 166.03 11.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.998 3.319 . . . . 11.66 102.884 173.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -121.19 138.77 54.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.049 -1.657 . . . . 16.300000000000001 113.506 179.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 41' ' ' GLN . 29.6 tp -103.04 121.76 43.23 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.157 -1.423 . . . . 9.9600000000000009 107.157 -179.249 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.3 t -116.91 131.36 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.995 -2.224 . . . . 9.7599999999999998 104.995 170.62 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.2 mt -104.61 144.64 31.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 122.31 1.052 . . . . 19.57 109.259 -177.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.1 ttp180 -79.51 143.13 35.16 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 124.341 1.056 . . . . 35.079999999999998 113.773 176.02 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.1 tp -83.08 87.62 6.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.982 3.313 . . . . 32.310000000000002 108.74 170.446 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -130.3 -76.51 0.54 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.242 2.448 . . . . 42.75 105.592 165.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.72 166.02 16.35 Favored Glycine 0 N--CA 1.429 -1.774 0 N-CA-C 120.762 3.065 . . . . 36.310000000000002 120.762 -175.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.781 0 CA-C-O 115.709 -2.717 . . . . 36.270000000000003 111.642 -175.522 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 114.604 1.335 . . . . 17.170000000000002 114.604 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -128.25 138.01 52.25 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 118.236 -1.386 . . . . 21.890000000000001 109.996 -173.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.44 HD13 HG21 ' A' ' 3' ' ' ILE . 42.3 pt -123.22 151.87 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 123.318 0.647 . . . . 10.83 111.886 170.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -106.71 134.74 49.39 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.153 -2.217 . . . . 10.609999999999999 106.684 -168.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 69.6 t -126.84 108.62 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 126.785 3.183 . . . . 9.1300000000000008 107.849 -175.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -91.65 129.76 37.57 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.283 -3.386 . . . . 20.550000000000001 116.895 -173.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.65 156.85 16.35 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.725 -1.954 . . . . 11.779999999999999 105.725 173.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.76 -49.3 40.21 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.471 -3.268 . . . . 19.309999999999999 113.148 -164.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.364 29.8 p -49.69 -79.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.908 2.483 . . . . 23.140000000000001 115.176 166.232 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.93 161.34 29.54 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 116.869 -3.645 . . . . 19.739999999999998 105.243 -177.629 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HE2' HG22 ' A' ' 13' ' ' ILE . 75.8 tttt 86.23 126.9 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.97 2.508 . . . . 21.93 115.585 166.642 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.7 m -120.22 105.67 11.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.57 2.348 . . . . 12.33 106.897 -175.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.417 HG22 ' HE2' ' A' ' 11' ' ' LYS . 12.0 pt -88.02 152.03 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 120.059 -1.65 . . . . 17.079999999999998 112.955 179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -111.5 113.06 25.23 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 113.225 -1.807 . . . . 16.300000000000001 110.145 -173.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 15' ' ' LEU . 1.3 mm? -108.62 139.38 43.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 125.951 2.786 . . . . 15.880000000000001 107.409 176.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -84.3 125.8 32.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.781 -3.075 . . . . 28.899999999999999 108.589 172.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -149.82 175.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 117.488 -3.257 . . . . 12.050000000000001 110.768 -176.913 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -115.34 148.92 41.88 Favored Pre-proline 0 N--CA 1.429 -1.493 1 O-C-N 116.277 -4.015 . . . . 18.170000000000002 109.279 176.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -64.6 -8.48 17.49 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 125.735 4.29 . . . . 8.1600000000000001 115.74 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.8 m -105.76 16.52 25.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.541 -2.022 . . . . 11.130000000000001 105.541 177.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -82.84 153.51 25.13 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.523 -2.611 . . . . 18.030000000000001 111.921 168.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 56.8 p -87.01 164.61 16.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.517 2.58 . . . . 10.220000000000001 105.249 -176.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -75.6 -21.9 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 116.708 -3.745 . . . . 12.300000000000001 109.796 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -57.29 -32.6 66.81 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.731 2.412 . . . . 36.509999999999998 113.057 163.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -88.37 -21.84 24.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.892 -1.049 . . . . 25.66 110.715 -177.692 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.9 t -73.92 -49.56 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.503 0 O-C-N 118.104 -2.873 . . . . 8.1199999999999992 107.023 169.55 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -46.57 -45.18 18.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.45 1.9 . . . . 15.470000000000001 112.071 170.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.14 95.68 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.634 2.774 . . . . 11.449999999999999 111.746 -175.007 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -62.5 -43.22 99.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 126.223 1.809 . . . . 24.98 113.638 169.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 mt -63.19 -38.83 83.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 116.879 2.177 . . . . 9.4600000000000009 116.879 171.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.1 -29.24 70.18 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 127.317 2.247 . . . . 14.76 111.102 177.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -79.93 -56.59 4.15 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.904 -2.372 . . . . 26.289999999999999 116.412 166.168 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -78.13 -48.43 15.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.622 -1.251 . . . . 30.059999999999999 107.622 -156.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 6.1 mm-40 -85.89 -45.66 11.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 113.931 1.086 . . . . 25.190000000000001 113.931 169.745 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.44 66.36 1.65 Allowed Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 121.789 0.66 . . . . 7.4100000000000001 111.73 -172.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 70.7 mt -112.36 118.99 44.68 Favored Pre-proline 0 N--CA 1.43 -1.469 0 N-CA-C 102.066 -3.309 . . . . 9.4900000000000002 102.066 166.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.53 154.64 63.28 Favored 'Trans proline' 0 C--N 1.3 -1.978 0 CA-C-N 124.767 2.738 . . . . 11.42 113.784 -178.244 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -73.52 -13.15 25.01 Favored 'Trans proline' 0 N--CA 1.434 -2.001 1 O-C-N 112.611 -4.468 . . . . 12.0 117.906 -165.259 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -92.91 -10.13 37.63 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 125.06 1.475 . . . . 35.549999999999997 112.069 175.839 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -84.14 -7.23 59.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.23 -1.544 . . . . 20.52 114.21 168.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -95.64 123.68 39.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 113.937 -2.935 . . . . 7.1299999999999999 108.663 -177.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.436 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 65.6 ttt180 -105.51 102.21 11.69 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.167 3.417 . . . . 36.390000000000001 106.877 165.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.8 mt -90.9 99.17 12.25 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 123.376 2.807 . . . . 9.5500000000000007 110.693 -177.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.4 mt -104.49 116.71 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 129.369 3.068 . . . . 13.9 109.608 -176.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -93.09 113.74 26.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.944 -2.613 . . . . 6.8600000000000003 103.944 165.257 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.12 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.527 2.584 . . . . 11.15 116.695 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.02 18.3 1.21 Allowed Glycine 0 N--CA 1.429 -1.775 1 O-C-N 116.049 -4.157 . . . . 13.93 117.054 176.067 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.0 tttp -135.18 142.8 46.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 101.139 -3.652 . . . . 23.920000000000002 101.139 171.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -96.35 165.89 11.98 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.613 -3.179 . . . . 23.23 113.528 173.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.08 156.96 17.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 127.156 2.785 . . . . 9.1099999999999994 112.329 -162.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.261 40.2 mt-10 -99.51 141.09 32.76 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.009 2.338 . . . . 33.439999999999998 112.14 -173.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -70.31 -51.26 31.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.668 -3.145 . . . . 28.370000000000001 115.615 -154.239 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.46 15.3 41.37 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 123.03 3.972 . . . . 15.0 123.03 171.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -101.44 162.72 12.69 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 127.47 2.308 . . . . 25.5 109.302 168.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.0 p -107.31 172.35 6.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 114.692 1.367 . . . . 11.949999999999999 114.692 -169.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 56' ' ' LEU . 93.8 mt -64.39 -35.41 80.81 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.081 -2.262 . . . . 10.17 114.917 166.169 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 t -54.25 -46.69 72.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.881 2.178 . . . . 13.59 116.881 161.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -59.07 -37.03 76.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 124.23 3.195 . . . . 11.699999999999999 115.447 176.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -90.55 12.7 17.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.363 -2.711 . . . . 12.949999999999999 115.385 173.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.52 6.5 t30 46.61 42.36 11.17 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.95 2.574 . . . . 25.449999999999999 117.95 -172.262 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -93.07 99.07 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 118.437 -2.665 . . . . 14.6 108.119 -178.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -79.93 176.13 10.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.225 2.61 . . . . 33.229999999999997 109.682 172.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -71.48 151.61 43.79 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.248 -2.782 . . . . 25.969999999999999 116.549 -174.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.29 45.2 mt-10 75.17 11.68 3.47 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 126.733 2.52 . . . . 32.609999999999999 114.687 -173.442 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.309 70.9 m -73.76 145.93 44.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 122.896 1.331 . . . . 10.56 112.199 -176.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 m -96.73 123.06 40.31 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.388 -2.695 . . . . 5.3300000000000001 113.288 173.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.305 65.7 tp -126.16 150.08 48.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.137 -2.852 . . . . 11.66 105.974 175.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -111.59 122.47 47.91 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.658 -2.526 . . . . 16.300000000000001 112.623 -167.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.8 tp -98.56 103.17 15.09 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.223 -2.88 . . . . 9.9600000000000009 103.223 -178.18 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 42' ' ' ARG 0.257 15.3 t -100.14 168.26 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 110.316 -3.129 . . . . 9.7599999999999998 111.496 170.998 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tp -78.77 138.37 38.18 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 107.746 -1.205 . . . . 19.57 107.746 176.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -106.25 128.1 53.71 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 127.056 3.312 . . . . 35.079999999999998 113.458 166.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 92.5 mt -93.9 154.87 17.48 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.138 -5.351 . . . . 32.310000000000002 111.533 173.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -82.32 122.64 28.22 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 127.011 3.291 . . . . 42.75 112.239 177.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.13 57.55 0.15 Allowed Glycine 0 N--CA 1.43 -1.742 1 N-CA-C 102.362 -4.295 . . . . 36.310000000000002 102.362 -171.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.749 0 CA-C-O 116.272 -2.404 . . . . 36.270000000000003 114.666 -170.392 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.1 ptt? . . . . . 0 CA--C 1.489 -1.367 0 CA-C-O 123.058 1.409 . . . . 17.170000000000002 111.717 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -96.66 137.29 35.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.978 2.799 . . . . 21.890000000000001 112.339 167.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.6 pt -119.5 162.29 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 117.349 -3.345 . . . . 10.83 105.87 175.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -119.73 136.39 54.45 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.219 2.208 . . . . 10.609999999999999 109.176 -177.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -128.35 103.02 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 N-CA-C 102.524 -3.139 . . . . 9.1300000000000008 102.524 -173.028 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -86.4 118.41 25.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.411 -2.056 . . . . 20.550000000000001 108.584 -176.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.0 p -84.07 -170.96 3.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 125.289 1.618 . . . . 11.779999999999999 109.267 -173.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 84.9 mt -91.0 -25.37 19.74 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.753 -4.342 . . . . 19.309999999999999 109.329 -171.417 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.7 p -90.43 -72.14 0.59 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.232 2.208 . . . . 23.140000000000001 115.695 -173.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -169.8 35.9 0.18 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-O 117.065 -1.964 . . . . 19.739999999999998 111.876 177.162 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -122.84 151.58 41.55 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.534 -2.025 . . . . 21.93 105.534 175.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 85.7 m -125.71 121.9 34.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.374 -2.084 . . . . 12.33 105.374 169.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.572 HD11 HG23 ' A' ' 30' ' ' ILE 0.305 48.5 pt -103.39 141.56 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 118.503 -2.623 . . . . 17.079999999999998 113.065 -178.61 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.6 m -104.08 116.03 31.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.969 -2.234 . . . . 16.300000000000001 104.969 -173.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.91 133.07 56.48 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.262 1.392 . . . . 15.880000000000001 111.256 175.227 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -106.95 118.21 36.09 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.459 2.552 . . . . 28.899999999999999 108.678 -176.739 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 m -139.71 145.3 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 131.469 3.908 . . . . 12.050000000000001 107.501 -152.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -93.2 147.85 34.55 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 125.305 1.442 . . . . 18.170000000000002 107.906 166.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -70.92 -26.3 22.3 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 123.746 2.964 . . . . 8.1600000000000001 114.565 -177.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.0 m -70.12 0.24 6.52 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.525 2.417 . . . . 11.130000000000001 117.525 161.054 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -70.72 142.3 51.47 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.704 -3.123 . . . . 18.030000000000001 117.674 163.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.269 7.3 p -73.9 158.61 34.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.644 2.778 . . . . 10.220000000000001 109.759 178.601 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.515 HG13 ' HB3' ' A' ' 50' ' ' LEU 0.284 26.9 mm -67.07 -34.45 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 119.283 0.947 . . . . 12.300000000000001 111.884 173.38 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -47.94 -42.7 28.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.623 -2.548 . . . . 36.509999999999998 115.306 162.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -71.91 -27.36 62.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.546 -3.846 . . . . 25.66 112.456 -178.335 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.9 t -68.38 -49.0 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 130.55 3.54 . . . . 8.1199999999999992 110.639 172.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.2 mttt -55.16 -38.62 68.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.569 2.063 . . . . 15.470000000000001 116.569 173.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.46 -35.71 53.11 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.13 -1.606 . . . . 11.449999999999999 114.974 173.245 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -76.9 -31.5 56.77 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 117.276 2.324 . . . . 24.98 117.276 176.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.572 HG23 HD11 ' A' ' 13' ' ' ILE . 1.2 mt -70.23 -32.63 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 125.58 1.552 . . . . 9.4600000000000009 109.282 172.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -74.14 -36.0 64.11 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 120.36 -1.462 . . . . 14.76 109.802 -178.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.99 -51.28 62.57 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.068 1.413 . . . . 26.289999999999999 112.476 177.508 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -80.62 -55.37 4.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.256 -3.403 . . . . 30.059999999999999 112.132 -168.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.403 ' HB2' HG13 ' A' ' 36' ' ' ILE . 69.3 mm-40 -94.73 -34.36 12.57 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.316 0.962 . . . . 25.190000000000001 111.485 -167.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.72 54.06 1.99 Allowed Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 127.114 2.292 . . . . 7.4100000000000001 113.276 -177.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.456 HD13 HG21 ' A' ' 36' ' ' ILE . 14.0 mt -113.37 103.45 55.5 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 113.671 -3.061 . . . . 9.4900000000000002 104.121 -175.601 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -57.56 141.45 95.24 Favored 'Trans proline' 0 C--N 1.3 -1.999 1 CA-C-N 131.862 5.272 . . . . 11.42 116.688 -178.522 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.267 19.7 Cg_endo -70.72 -18.82 32.23 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 125.018 3.812 . . . . 12.0 114.177 -159.785 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -76.26 -32.07 58.65 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.195 2.902 . . . . 35.549999999999997 108.552 -178.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -73.35 -5.73 41.6 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.493 -2.629 . . . . 20.52 116.322 172.156 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -105.39 139.86 39.38 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 122.709 1.243 . . . . 7.1299999999999999 108.682 -177.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ttm180 -138.58 118.04 12.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.703 -3.123 . . . . 36.390000000000001 109.276 162.497 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.2 mt -86.38 129.67 34.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 113.975 1.102 . . . . 9.5500000000000007 113.975 179.206 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mt -120.12 135.59 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-O 117.829 -1.082 . . . . 13.9 113.706 177.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -106.22 103.18 12.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 104.841 -2.281 . . . . 6.8600000000000003 104.841 172.803 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.359 . . 62.9 -110.89 0.35 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.242 1.817 . . . . 11.15 113.646 -170.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.19 -8.31 78.62 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 121.19 3.236 . . . . 13.93 121.19 169.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -115.47 115.65 26.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.745 1.26 . . . . 23.920000000000002 110.502 -165.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -71.73 133.93 45.92 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.714 2.406 . . . . 23.23 108.904 170.542 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.515 ' HB3' HG13 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -95.38 137.53 34.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.423 -2.227 . . . . 9.1099999999999994 112.332 -177.618 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HB3' ' HG3' ' A' ' 54' ' ' ARG . 38.7 tt0 -88.06 139.8 30.14 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 123.503 2.865 . . . . 33.439999999999998 109.14 174.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -32.39 -74.52 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 136.12 5.768 . . . . 28.370000000000001 113.407 172.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.03 43.13 3.14 Favored Glycine 0 N--CA 1.431 -1.671 0 C-N-CA 117.853 -2.118 . . . . 15.0 113.738 -171.403 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.402 ' HG3' ' HB3' ' A' ' 51' ' ' GLU . 18.4 mtt180 -130.49 157.25 43.17 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.861 2.064 . . . . 25.5 107.779 174.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.0 p -87.33 176.32 7.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 124.089 3.131 . . . . 11.949999999999999 113.243 -178.84 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.1 mt -65.21 -43.03 92.86 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 130.064 3.346 . . . . 10.17 106.848 161.244 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -64.67 -31.95 73.4 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 115.2 1.555 . . . . 13.59 115.2 178.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -60.78 -55.22 35.72 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.0 -2.313 . . . . 11.699999999999999 112.995 171.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -71.61 15.32 0.14 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 114.489 -2.672 . . . . 12.949999999999999 116.816 166.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 41.39 40.0 1.15 Allowed 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.98 2.627 . . . . 25.449999999999999 116.939 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 55.4 mt -82.15 116.35 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 106.011 -1.848 . . . . 14.6 106.011 -178.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.454 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 55.8 mt-30 -98.2 -150.59 0.36 Allowed 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.841 -2.412 . . . . 33.229999999999997 108.883 -175.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' H ' ' HB3' ' A' ' 62' ' ' GLN . 12.5 pttp -76.73 156.02 32.77 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.956 -1.474 . . . . 25.969999999999999 111.087 -167.413 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.279 16.8 mt-10 65.3 9.1 5.39 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.029 1.732 . . . . 32.609999999999999 112.843 164.025 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.6 m -65.29 132.79 49.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.135 -3.478 . . . . 10.56 117.96 177.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.291 85.3 m -82.97 113.55 20.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.132 1.901 . . . . 5.3300000000000001 116.132 169.161 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -103.79 156.0 18.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.147 2.403 . . . . 11.66 108.824 171.658 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -107.46 126.99 53.19 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 104.385 -2.45 . . . . 16.300000000000001 104.385 -171.622 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.6 tp -103.82 124.66 49.34 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 116.119 -4.113 . . . . 9.9600000000000009 110.26 178.119 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.267 46.0 t -111.92 147.86 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 101.968 -3.345 . . . . 9.7599999999999998 101.968 -171.916 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.2 mt -89.82 131.74 35.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 119.719 -0.181 . . . . 19.57 111.056 170.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 59.1 ttt180 -109.46 131.99 54.55 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 123.936 0.772 . . . . 35.079999999999998 112.321 -171.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 35.3 mt -93.34 161.81 14.24 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.857 -3.027 . . . . 32.310000000000002 107.175 178.459 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -73.45 157.95 35.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.358 -2.714 . . . . 42.75 109.398 177.305 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.16 51.67 3.67 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 125.302 1.429 . . . . 36.310000000000002 110.176 175.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.756 0 O-C-N 127.42 2.482 . . . . 36.270000000000003 113.482 179.44 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.48 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 14.1 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 113.616 0.969 . . . . 17.170000000000002 113.616 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.286 14.5 pt20 -90.53 134.15 34.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 121.558 1.981 . . . . 21.890000000000001 114.911 172.66 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.8 pt -132.06 166.61 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.671 -1.603 . . . . 10.83 106.671 177.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -107.3 131.73 53.89 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 116.401 -3.937 . . . . 10.609999999999999 112.484 177.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.0 t -116.57 109.32 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 118.258 -1.377 . . . . 9.1300000000000008 110.171 170.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -99.16 117.62 34.04 Favored 'General case' 0 N--CA 1.429 -1.481 1 CA-C-O 130.117 4.77 . . . . 20.550000000000001 110.098 -172.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 30.7 p -75.16 164.66 26.26 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 110.738 -7.477 . . . . 11.779999999999999 114.455 -171.94 . . . . . . . . 3 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 70' ' ' VAL . 4.8 tp -53.16 -52.08 59.93 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.177 2.191 . . . . 19.309999999999999 115.603 174.701 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -59.0 -70.4 0.15 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 128.783 3.802 . . . . 23.140000000000001 114.599 169.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.49 59.01 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.774 0 O-C-N 118.988 -2.32 . . . . 19.739999999999998 113.834 156.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.33 85.7 tttt -108.06 134.18 51.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.398 -2.236 . . . . 21.93 106.737 173.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.2 m -97.45 111.67 23.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.439 -1.71 . . . . 12.33 108.35 173.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.429 HD13 HG21 ' A' ' 13' ' ' ILE . 29.5 pt -108.75 127.33 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.312 -1.492 . . . . 17.079999999999998 113.178 172.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.3 m -86.33 122.51 30.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 125.572 1.549 . . . . 16.300000000000001 110.506 -178.365 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -110.53 123.04 49.19 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.251 3.021 . . . . 15.880000000000001 111.05 -172.723 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -102.89 117.4 34.54 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 126.638 3.113 . . . . 28.899999999999999 107.087 171.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -127.72 167.34 22.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 110.404 -3.089 . . . . 12.050000000000001 110.341 -174.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -110.81 164.88 13.81 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 113.885 -2.96 . . . . 18.170000000000002 115.782 165.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.283 60.7 Cg_endo -69.83 -24.91 28.82 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 CA-C-N 127.813 3.826 . . . . 8.1600000000000001 113.279 -171.408 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.256 3.9 m -82.99 -5.57 59.15 Favored 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 133.819 4.847 . . . . 11.130000000000001 114.464 -176.363 . . . . . . . . 3 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -59.67 126.41 27.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.377 2.271 . . . . 18.030000000000001 114.104 167.05 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.654 ' O ' HG23 ' A' ' 26' ' ' VAL . 72.4 p -77.3 158.15 30.35 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.056 -2.277 . . . . 10.220000000000001 111.59 170.609 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.544 HG23 HD12 ' A' ' 43' ' ' LEU 0.295 35.8 mm -60.91 -34.55 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 120.829 -1.169 . . . . 12.300000000000001 113.732 176.662 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -33.96 -60.69 0.38 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.99 -3.569 . . . . 36.509999999999998 117.775 157.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -70.67 -31.86 68.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 110.75 -2.932 . . . . 25.66 111.024 -177.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 22' ' ' THR . 90.9 t -66.21 -43.85 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 120.093 -1.629 . . . . 8.1199999999999992 112.435 -178.121 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -57.46 -42.79 83.23 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.149 2.18 . . . . 15.470000000000001 113.771 176.037 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.329 . . -64.45 -35.43 80.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.851 -2.406 . . . . 11.449999999999999 114.374 175.269 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -59.67 -35.02 73.61 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.274 2.94 . . . . 24.98 115.968 170.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.4 mt -75.74 -36.92 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.617 -2.552 . . . . 9.4600000000000009 109.281 172.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -56.32 -32.61 64.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.423 2.059 . . . . 14.76 113.326 174.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -72.64 -36.09 67.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 128.215 3.864 . . . . 26.289999999999999 111.463 -177.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -65.13 -51.4 61.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.063 -2.79 . . . . 30.059999999999999 115.196 171.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -110.67 -59.02 2.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.519 2.104 . . . . 25.190000000000001 112.018 -168.132 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.15 49.29 0.88 Allowed Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 126.942 2.211 . . . . 7.4100000000000001 110.509 -176.358 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -100.25 130.55 25.72 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 114.299 -2.762 . . . . 9.4900000000000002 107.732 169.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -71.25 148.98 56.69 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 124.417 2.613 . . . . 11.42 113.364 179.444 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_exo -68.99 -17.96 40.82 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 CA-C-N 125.55 3.018 . . . . 12.0 117.768 -172.843 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.262 1.1 m-20 -69.41 -20.64 63.8 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.926 2.775 . . . . 35.549999999999997 117.028 172.902 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -94.6 -23.26 17.71 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 126.225 2.917 . . . . 20.52 108.5 -177.639 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -84.17 119.67 25.28 Favored 'General case' 0 N--CA 1.431 -1.418 1 O-C-N 115.767 -4.333 . . . . 7.1299999999999999 116.791 178.114 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.2 ttm180 -113.57 106.59 14.72 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.068 2.947 . . . . 36.390000000000001 111.066 177.721 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.544 HD12 HG23 ' A' ' 23' ' ' ILE . 92.3 mt -88.3 124.27 33.72 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.096 -1.816 . . . . 9.5500000000000007 106.096 -175.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.9 mt -116.99 106.71 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 122.576 2.444 . . . . 13.9 108.534 176.825 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -95.66 108.94 21.27 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 125.628 2.632 . . . . 6.8600000000000003 111.876 170.565 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.426 . . 70.57 -96.95 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.465 -2.647 . . . . 11.15 116.692 -178.754 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.76 -2.36 19.08 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 120.508 -1.37 . . . . 13.93 112.57 170.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -109.06 126.54 53.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 122.501 1.143 . . . . 23.920000000000002 111.261 -166.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -93.31 130.73 38.95 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 112.487 -2.142 . . . . 23.23 109.109 -179.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.6 mt -96.46 149.95 21.15 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.762 2.134 . . . . 9.1099999999999994 116.762 -164.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -111.22 148.65 32.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.741 2.21 . . . . 33.439999999999998 111.041 -176.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -60.15 -47.28 86.59 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.276 2.695 . . . . 28.370000000000001 118.276 -166.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.83 26.67 8.08 Favored Glycine 0 N--CA 1.43 -1.735 0 C-N-CA 117.995 -2.05 . . . . 15.0 112.982 -166.406 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.2 mmt180 -113.68 154.35 27.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 131.136 3.775 . . . . 25.5 106.24 -176.186 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.4 p -90.29 168.41 11.92 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.594 1.701 . . . . 11.949999999999999 115.594 168.436 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 28.0 mt -73.28 -36.14 66.26 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 118.031 -0.985 . . . . 10.17 112.406 177.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -45.89 -53.33 9.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.602 3.064 . . . . 13.59 115.837 160.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -49.76 -44.07 48.43 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.251 -4.656 . . . . 11.699999999999999 117.205 179.78 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -79.35 -18.95 51.41 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.431 -2.043 . . . . 12.949999999999999 108.265 -173.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 66.07 71.83 0.4 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.316 2.246 . . . . 25.449999999999999 110.238 -170.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -115.82 117.94 57.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 102.855 -3.017 . . . . 14.6 102.855 178.401 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -100.41 174.44 6.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.447 3.499 . . . . 33.229999999999997 112.239 174.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 13.3 pttp -53.69 161.88 0.99 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.829 -4.92 . . . . 25.969999999999999 115.293 165.243 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 50.96 46.57 26.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.292 3.037 . . . . 32.609999999999999 109.461 174.083 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.6 t -130.53 155.9 45.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 117.767 -3.083 . . . . 10.56 102.694 179.414 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.6 m -119.16 118.65 31.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.043 -1.435 . . . . 5.3300000000000001 108.818 -155.14 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 mt -100.55 147.36 26.01 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.546 -2.391 . . . . 11.66 104.546 -173.773 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -108.8 133.89 52.23 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.625 -2.43 . . . . 16.300000000000001 111.41 167.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -106.34 97.79 7.55 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.682 1.734 . . . . 9.9600000000000009 115.682 -175.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.402 ' HA ' HD13 ' A' ' 8' ' ' LEU . 88.6 t -95.13 150.31 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.4 0 N-CA-C 101.493 -3.521 . . . . 9.7599999999999998 101.493 -171.383 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.1 mt -104.19 141.44 36.27 Favored 'General case' 0 N--CA 1.43 -1.442 1 CA-C-O 128.51 4.005 . . . . 19.57 106.772 173.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.0 ttt180 -77.58 135.79 38.2 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.555 -3.84 . . . . 35.079999999999998 115.705 -179.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.1 mt -122.67 131.49 53.83 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 114.326 -1.306 . . . . 32.310000000000002 109.583 161.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.4 mtp180 -76.69 125.41 29.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.72 -1.863 . . . . 42.75 110.218 -153.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.7 -93.02 0.12 Allowed Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 106.555 -2.618 . . . . 36.310000000000002 106.555 -175.787 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.767 0 CA-C-N 119.139 1.47 . . . . 36.270000000000003 113.1 171.714 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ptt? . . . . . 0 CA--C 1.49 -1.356 0 CA-C-O 118.366 -0.826 . . . . 17.170000000000002 113.012 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -98.75 142.0 30.84 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.478 2.361 . . . . 21.890000000000001 114.147 161.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.1 pt -128.04 153.94 38.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.14 -1.43 . . . . 10.83 107.14 176.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -100.2 105.31 16.88 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 117.586 2.439 . . . . 10.609999999999999 117.586 178.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.441 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 70.9 t -88.44 117.58 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 119.635 1.107 . . . . 9.1300000000000008 110.619 -179.832 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -93.23 129.36 39.3 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.992 2.917 . . . . 20.550000000000001 110.39 174.81 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -98.01 170.53 8.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.169 -1.378 . . . . 11.779999999999999 108.164 178.005 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.02 -49.72 75.9 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.705 1.742 . . . . 19.309999999999999 115.705 173.348 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 p -74.78 -73.21 0.25 Allowed 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.261 2.458 . . . . 23.140000000000001 111.507 -172.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 178.27 32.89 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 117.331 -3.355 . . . . 19.739999999999998 116.854 167.699 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -84.39 154.91 22.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.384 2.516 . . . . 21.93 110.054 167.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.9 m -112.18 113.52 25.82 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.117 -1.856 . . . . 12.33 106.376 163.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.441 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 12.6 mt -102.2 129.17 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 118.602 -2.561 . . . . 17.079999999999998 105.137 177.345 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.9 m -107.57 115.47 30.2 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.854 -2.404 . . . . 16.300000000000001 106.582 -169.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 tp -118.74 125.1 48.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.5 -2.625 . . . . 15.880000000000001 109.388 -156.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -95.34 119.53 33.99 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.468 -2.645 . . . . 28.899999999999999 114.873 178.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -140.7 158.18 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 106.903 -1.517 . . . . 12.050000000000001 106.903 -167.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -81.09 146.85 59.71 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 126.717 2.007 . . . . 18.170000000000002 109.9 175.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -82.87 -3.49 11.16 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 119.599 0.893 . . . . 8.1600000000000001 113.434 -165.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.1 t -113.59 7.91 17.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.937 2.153 . . . . 11.130000000000001 112.396 171.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -88.89 177.22 6.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.364 2.357 . . . . 18.030000000000001 117.364 -172.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.447 HG22 HG22 ' A' ' 55' ' ' THR . 48.1 p -92.8 159.94 15.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 118.293 2.701 . . . . 10.220000000000001 118.293 -167.658 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -67.17 -36.24 76.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 127.132 2.173 . . . . 12.300000000000001 107.741 179.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -54.73 -44.87 73.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.606 1.963 . . . . 36.509999999999998 112.967 172.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -69.63 -31.14 69.08 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.835 2.161 . . . . 25.66 116.835 170.553 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.1 -48.11 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 CA-C-N 122.091 2.223 . . . . 8.1199999999999992 113.71 164.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -60.79 -31.35 70.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.978 1.711 . . . . 15.470000000000001 113.529 173.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.269 . . -79.24 -28.7 42.47 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 115.654 1.724 . . . . 11.449999999999999 115.654 177.716 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -63.43 -45.71 89.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.841 -1.527 . . . . 24.98 114.496 174.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.3 mt -70.0 -35.48 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.42 -2.173 . . . . 9.4600000000000009 110.589 172.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -56.85 -29.68 63.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 125.974 3.988 . . . . 14.76 110.377 168.616 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.93 -50.73 7.76 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 114.857 -4.902 . . . . 26.289999999999999 111.439 -174.699 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 mmtm -65.54 -52.27 53.73 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.661 -2.525 . . . . 30.059999999999999 113.417 175.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -107.82 -39.65 5.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 108.504 -0.924 . . . . 25.190000000000001 108.504 -162.109 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.99 37.6 5.97 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 106.587 -2.605 . . . . 7.4100000000000001 106.587 176.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mt -106.74 123.66 37.93 Favored Pre-proline 0 N--CA 1.43 -1.446 1 N-CA-C 97.13 -5.137 . . . . 9.4900000000000002 97.13 -179.823 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -90.52 166.97 4.2 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 CA-C-N 125.278 2.921 . . . . 11.42 107.757 -168.564 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.26 36.4 Cg_endo -65.58 -24.83 55.45 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 122.793 2.328 . . . . 12.0 116.307 -169.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.282 18.0 m-20 -82.29 -22.33 35.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 114.516 -2.874 . . . . 35.549999999999997 111.476 178.906 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -91.56 -12.14 35.26 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 124.412 3.278 . . . . 20.52 112.77 -179.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -75.46 99.93 4.34 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.74 2.416 . . . . 7.1299999999999999 113.64 171.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -84.99 113.05 21.14 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 101.051 -3.685 . . . . 36.390000000000001 101.051 168.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.0 mt -101.31 115.24 30.05 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.405 -2.059 . . . . 9.5500000000000007 110.343 165.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 44' ' ' ILE . 5.5 mt -112.53 137.6 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 C-N-CA 131.717 4.007 . . . . 13.9 109.234 178.576 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -133.75 99.37 4.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.738 2.015 . . . . 6.8600000000000003 106.262 -171.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.394 . . 66.46 -108.65 0.13 Allowed 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 119.954 -1.716 . . . . 11.15 113.471 -158.658 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.59 17.53 11.11 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 126.522 2.01 . . . . 13.93 112.106 172.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.1 ttmt -107.06 119.74 40.18 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.661 3.23 . . . . 23.920000000000002 110.826 174.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -70.06 124.5 24.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.994 -2.941 . . . . 23.23 112.946 160.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.529 HD22 ' CD2' ' A' ' 59' ' ' TYR . 29.1 mt -79.41 162.74 25.31 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 125.352 1.461 . . . . 9.1099999999999994 112.106 -178.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -125.28 141.47 52.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 126.748 3.166 . . . . 33.439999999999998 104.105 -177.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.67 -48.29 72.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.331 2.252 . . . . 28.370000000000001 114.848 -152.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.32 0.96 88.45 Favored Glycine 0 N--CA 1.43 -1.706 0 O-C-N 119.094 -2.254 . . . . 15.0 116.827 -178.305 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.252 23.3 mmt180 -74.9 161.43 29.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 127.105 3.336 . . . . 25.5 111.458 170.329 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.447 HG22 HG22 ' A' ' 22' ' ' THR 0.343 31.0 p -87.75 163.62 16.39 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.503 -2.623 . . . . 11.949999999999999 112.624 178.121 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.9 mt -60.15 -32.03 70.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.021 1.86 . . . . 10.17 116.021 163.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -56.55 -38.26 71.65 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.243 2.449 . . . . 13.59 114.426 166.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -65.79 -32.51 74.09 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.35 -2.719 . . . . 11.699999999999999 116.472 -169.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.529 ' CD2' HD22 ' A' ' 50' ' ' LEU . 34.2 m-85 -104.39 1.88 30.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.029 -2.919 . . . . 12.949999999999999 112.596 175.369 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.252 81.0 m-20 70.99 48.96 0.36 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.379 2.363 . . . . 25.449999999999999 117.379 -177.271 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.1 mt -92.41 124.79 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 114.545 -2.862 . . . . 14.6 110.614 -174.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -108.87 169.95 8.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 123.941 0.775 . . . . 33.229999999999997 110.635 -169.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 143.87 57.24 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.694 2.797 . . . . 25.969999999999999 110.262 -170.033 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 57.67 23.42 9.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.646 -3.784 . . . . 32.609999999999999 115.957 -174.392 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.0 t -92.93 160.36 14.93 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.269 3.414 . . . . 10.56 110.151 -178.622 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.0 m -92.52 126.16 37.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.599 -3.188 . . . . 5.3300000000000001 114.749 -179.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -119.44 155.63 31.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.524 -2.399 . . . . 11.66 104.524 173.842 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -130.61 111.03 11.84 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 119.024 0.829 . . . . 16.300000000000001 111.329 -173.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tt -87.16 108.56 18.96 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 131.0 3.72 . . . . 9.9600000000000009 114.406 175.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.0 t -111.22 141.31 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 129.681 3.192 . . . . 9.7599999999999998 102.7 -173.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt -94.6 118.25 31.39 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.746 2.418 . . . . 19.57 109.187 -170.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -91.64 157.89 16.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 124.197 0.999 . . . . 35.079999999999998 110.445 167.843 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.7 mt -70.71 162.85 28.32 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.521 2.415 . . . . 32.310000000000002 117.521 168.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.5 ttt180 -95.32 96.67 9.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.112 2.565 . . . . 42.75 106.411 162.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.45 72.28 0.99 Allowed Glycine 0 N--CA 1.43 -1.736 0 O-C-N 124.941 1.401 . . . . 36.310000000000002 114.658 -166.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.785 2 CA-C-N 124.922 4.361 . . . . 36.270000000000003 105.12 -174.183 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 CA--C 1.49 -1.365 0 CA-C-O 116.449 -1.739 . . . . 17.170000000000002 109.209 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -88.38 140.59 29.32 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 123.247 2.749 . . . . 21.890000000000001 116.81 171.478 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.1 pt -110.41 167.83 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 102.628 -3.101 . . . . 10.83 102.628 173.082 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -109.03 139.2 44.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.403 -2.814 . . . . 10.609999999999999 103.403 167.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -122.85 123.17 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.435 -2.041 . . . . 9.1300000000000008 109.677 165.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -96.91 134.89 39.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.127 -0.942 . . . . 20.550000000000001 112.508 172.361 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.401 HG22 HD23 ' A' ' 69' ' ' LEU . 42.9 p -91.77 -173.97 3.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 126.37 2.986 . . . . 11.779999999999999 113.207 177.769 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.4 tp -65.49 -52.95 49.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.635 -3.791 . . . . 19.309999999999999 116.661 178.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -61.8 -40.5 95.45 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.325 -2.11 . . . . 23.140000000000001 110.204 171.075 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.01 37.15 0.44 Allowed Glycine 0 N--CA 1.43 -1.738 0 CA-C-O 115.186 -3.008 . . . . 19.739999999999998 116.837 177.209 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -86.17 141.05 29.63 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 123.483 3.641 . . . . 21.93 111.079 175.502 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.3 m -92.74 101.75 14.15 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 119.954 1.252 . . . . 12.33 108.995 175.711 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.6 mt -93.05 118.43 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 125.072 1.349 . . . . 17.079999999999998 111.149 179.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.5 m -86.66 105.58 17.01 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 126.471 1.908 . . . . 16.300000000000001 112.338 175.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 tp -120.57 116.24 24.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.73 -1.856 . . . . 15.880000000000001 110.329 -160.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -78.76 100.51 7.14 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.562 4.345 . . . . 28.899999999999999 120.351 178.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 m -122.93 148.46 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 CA-C-O 125.452 2.549 . . . . 12.050000000000001 109.138 -171.666 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mm-40 -94.64 141.73 23.8 Favored Pre-proline 0 N--CA 1.43 -1.474 1 O-C-N 116.277 -4.015 . . . . 18.170000000000002 106.01 162.542 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -65.49 -14.51 45.26 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-O 114.086 -2.548 . . . . 8.1600000000000001 111.091 -178.218 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.7 p -67.83 -9.88 48.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 120.931 3.678 . . . . 11.130000000000001 120.931 160.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -71.06 134.92 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.55 -3.843 . . . . 18.030000000000001 111.679 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.3 p -82.48 153.14 25.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 117.332 -1.318 . . . . 10.220000000000001 111.974 177.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.0 mm -51.61 -37.73 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 113.907 -2.949 . . . . 12.300000000000001 113.795 -179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -49.64 -43.56 46.9 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.959 3.704 . . . . 36.509999999999998 113.86 168.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -90.54 -25.56 20.17 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 129.693 3.197 . . . . 25.66 110.295 -176.848 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.46 -51.84 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.238 1.495 . . . . 8.1199999999999992 110.736 164.634 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -51.74 -31.92 28.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.66 -3.775 . . . . 15.470000000000001 115.183 170.639 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.05 -39.38 86.92 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.808 1.643 . . . . 11.449999999999999 113.018 171.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -69.19 -35.08 75.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 122.473 1.13 . . . . 24.98 108.4 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.5 mt -79.51 -35.59 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 118.833 -2.417 . . . . 9.4600000000000009 110.77 -173.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -49.41 -50.54 40.11 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.542 2.423 . . . . 14.76 117.542 158.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -58.56 -33.44 69.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.266 3.027 . . . . 26.289999999999999 113.91 170.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.6 mttm -73.69 -69.83 0.41 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.925 2.565 . . . . 30.059999999999999 117.925 173.378 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -90.42 -37.89 13.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 111.189 -2.732 . . . . 25.190000000000001 115.215 -172.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.35 46.39 1.85 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-N 120.743 1.61 . . . . 7.4100000000000001 110.784 176.452 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.8 mt -117.41 105.32 48.64 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-O 113.195 -3.288 . . . . 9.4900000000000002 105.031 -178.324 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -58.36 159.01 20.66 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.497 3.356 . . . . 11.42 113.62 -175.463 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -76.39 -20.4 14.23 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 122.826 2.045 . . . . 12.0 115.227 -161.828 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -72.33 -40.01 67.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.649 -1.907 . . . . 35.549999999999997 110.005 178.439 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -60.99 -29.8 69.91 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.812 -1.805 . . . . 20.52 111.697 172.075 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -78.98 140.9 37.91 Favored 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 117.865 -3.022 . . . . 7.1299999999999999 109.952 -177.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.432 ' HG3' ' HB2' ' A' ' 72' ' ' ARG . 51.0 mtp180 -123.12 124.43 43.06 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.563 -3.21 . . . . 36.390000000000001 107.393 158.078 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.2 mt -106.4 129.79 54.33 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 123.957 0.786 . . . . 9.5500000000000007 112.609 176.69 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 mt -126.1 109.82 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 125.991 1.716 . . . . 13.9 112.004 -171.462 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -94.09 129.52 40.6 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.346 -3.346 . . . . 6.8600000000000003 107.33 163.278 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.52 -97.92 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 119.019 2.97 . . . . 11.15 119.019 -169.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.84 27.82 3.81 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.44 -2.037 . . . . 13.93 113.819 -179.413 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttmt -138.93 128.39 24.4 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 105.903 -1.888 . . . . 23.920000000000002 105.903 -176.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -84.34 127.34 33.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 111.799 -2.455 . . . . 23.23 113.664 171.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.4 mt -87.02 137.16 32.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.074 -1.875 . . . . 9.1099999999999994 108.353 -161.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -106.26 140.41 39.25 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 121.31 -0.869 . . . . 33.439999999999998 111.936 -160.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -46.17 -54.03 9.43 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 121.3 3.815 . . . . 28.370000000000001 121.3 -162.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.11 -0.44 74.17 Favored Glycine 0 N--CA 1.429 -1.787 0 CA-C-O 117.906 -1.497 . . . . 15.0 112.706 -178.417 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -75.4 158.47 32.67 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.106 1.953 . . . . 25.5 114.308 169.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.9 p -93.68 173.46 7.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.746 2.212 . . . . 11.949999999999999 110.452 174.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 56.5 mt -66.39 -29.84 70.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.331 -3.356 . . . . 10.17 113.965 166.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.6 t -66.05 -39.73 90.38 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.856 -3.028 . . . . 13.59 110.892 177.415 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -61.2 -33.64 73.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.911 -1.743 . . . . 11.699999999999999 113.634 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.83 -20.44 30.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.187 0.81 . . . . 12.949999999999999 113.187 174.314 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.0 m120 72.47 51.78 0.18 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.604 3.962 . . . . 25.449999999999999 112.539 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.259 60.0 mt -80.79 121.94 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 CA-C-N 110.192 -3.185 . . . . 14.6 110.026 -178.288 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -106.54 -175.2 2.73 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 118.704 -1.198 . . . . 33.229999999999997 112.228 -175.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.427 0.0 OUTLIER -66.46 150.85 48.33 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.234 2.309 . . . . 25.969999999999999 117.234 173.219 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 48.24 39.0 11.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 126.047 2.832 . . . . 32.609999999999999 116.408 -168.697 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.373 63.9 m -94.29 137.21 33.72 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.013 -4.804 . . . . 10.56 107.826 173.841 . . . . . . . . 3 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.4 m -103.52 113.92 27.79 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 120.563 1.529 . . . . 5.3300000000000001 111.665 -176.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -84.78 146.54 27.32 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.238 2.215 . . . . 11.66 111.63 169.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -110.93 129.49 55.86 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.603 -1.936 . . . . 16.300000000000001 114.41 172.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.401 HD23 HG22 ' A' ' 7' ' ' THR . 17.7 tp -87.78 124.82 34.01 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.32 -2.474 . . . . 9.9600000000000009 104.32 170.313 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.7 t -114.12 146.03 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 112.816 -1.993 . . . . 9.7599999999999998 109.34 163.489 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.257 14.2 mt -91.75 148.39 22.28 Favored 'General case' 0 N--CA 1.431 -1.418 1 O-C-N 115.578 -4.451 . . . . 19.57 111.452 -176.253 . . . . . . . . 3 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.432 ' HB2' ' HG3' ' A' ' 42' ' ' ARG . 43.3 ttt180 -105.87 137.59 43.49 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.089 -2.882 . . . . 35.079999999999998 107.166 171.833 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.4 mp -87.09 176.6 7.53 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 115.407 -2.235 . . . . 32.310000000000002 109.94 178.019 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.1 ttt180 -101.28 114.86 29.22 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 115.523 1.675 . . . . 42.75 115.523 -178.174 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.24 -9.72 22.53 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-O 123.892 1.829 . . . . 36.310000000000002 116.635 -175.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.784 0 C-N-CA 127.339 2.399 . . . . 36.270000000000003 112.903 -178.838 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.348 0 CA-C-O 119.242 -0.409 . . . . 17.170000000000002 111.932 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -96.29 133.99 39.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 119.324 0.965 . . . . 21.890000000000001 113.157 -178.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 pt -114.63 171.24 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.703 -1.873 . . . . 10.83 111.024 168.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -107.82 135.95 48.36 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.563 1.649 . . . . 10.609999999999999 111.876 173.132 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.433 ' CG1' ' HB2' ' A' ' 69' ' ' LEU . 88.1 t -119.25 128.62 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 117.523 -3.235 . . . . 9.1300000000000008 102.288 175.025 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.3 tttt -120.89 121.74 38.73 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.068 1.413 . . . . 20.550000000000001 111.143 -178.741 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.458 HG22 HD23 ' A' ' 69' ' ' LEU . 12.5 p -69.79 164.06 24.42 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 127.539 2.336 . . . . 11.779999999999999 109.632 -174.245 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.4 tp -61.76 -44.19 97.39 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.092 1.901 . . . . 19.309999999999999 111.154 174.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 p -67.32 -51.57 50.85 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.765 -1.835 . . . . 23.140000000000001 113.045 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 138.56 59.9 0.05 OUTLIER Glycine 0 N--CA 1.429 -1.779 0 N-CA-C 119.439 2.536 . . . . 19.739999999999998 119.439 162.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -116.42 138.5 51.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.522 -0.918 . . . . 21.93 108.522 172.494 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.2 m -90.15 113.86 25.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 118.37 -0.824 . . . . 12.33 109.164 178.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.9 mt -96.39 137.57 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.694 -3.129 . . . . 17.079999999999998 106.872 -177.27 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.3 m -97.28 121.43 39.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 114.821 -2.514 . . . . 16.300000000000001 104.301 171.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 tp -121.97 138.37 54.44 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.648 2.166 . . . . 15.880000000000001 115.895 178.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.294 71.6 tt0 -100.1 111.16 23.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.339 -3.976 . . . . 28.899999999999999 109.1 -172.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -141.2 152.99 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 1 O-C-N 113.29 -5.881 . . . . 12.050000000000001 117.937 -172.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -117.36 161.03 35.32 Favored Pre-proline 0 N--CA 1.43 -1.446 1 O-C-N 116.154 -4.091 . . . . 18.170000000000002 119.327 170.467 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -66.59 -17.63 53.15 Favored 'Trans proline' 0 C--N 1.3 -2.009 1 CA-C-N 129.859 4.557 . . . . 8.1600000000000001 117.468 -175.117 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.4 m -76.74 -17.19 59.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.403 1.91 . . . . 11.130000000000001 114.414 177.46 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -67.98 151.78 46.55 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 125.925 2.774 . . . . 18.030000000000001 111.094 -179.758 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.8 p -97.82 158.77 15.33 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.778 -1.826 . . . . 10.220000000000001 112.012 179.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.269 4.7 mm -61.34 -31.52 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 CA-C-O 128.941 4.21 . . . . 12.300000000000001 116.294 -178.648 . . . . . . . . 3 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -50.21 -43.42 52.72 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.051 -3.531 . . . . 36.509999999999998 114.76 162.812 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -73.16 -19.37 61.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.643 -2.535 . . . . 25.66 117.2 173.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.263 94.5 t -66.36 -37.87 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 117.723 -3.11 . . . . 8.1199999999999992 111.813 176.802 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -68.67 -40.63 80.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 129.414 3.086 . . . . 15.470000000000001 112.56 176.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.11 -52.87 59.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 121.184 3.772 . . . . 11.449999999999999 121.184 167.752 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -56.86 -41.15 77.43 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 121.674 2.034 . . . . 24.98 115.797 165.321 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 66.6 mt -64.57 -36.8 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 125.202 2.43 . . . . 9.4600000000000009 110.585 178.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' O ' ' HA2' ' A' ' 35' ' ' GLY . 3.6 tt0 -53.92 -55.0 30.96 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.851 1.786 . . . . 14.76 113.285 171.135 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.259 29.4 t70 -57.89 -56.13 25.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.587 -2.571 . . . . 26.289999999999999 116.22 179.316 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -69.67 -65.35 0.73 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 125.865 2.745 . . . . 30.059999999999999 113.928 -176.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -86.39 -46.24 10.44 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.596 -4.44 . . . . 25.190000000000001 118.439 177.34 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 31' ' ' GLN . . . 102.28 28.72 6.31 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.107 -1.997 . . . . 7.4100000000000001 108.107 168.219 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.0 mt -83.35 118.97 73.15 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.005 -1.95 . . . . 9.4900000000000002 108.641 169.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -73.63 157.25 48.72 Favored 'Trans proline' 0 N--CA 1.433 -2.036 1 CA-C-N 128.467 4.06 . . . . 11.42 114.412 -166.375 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -64.42 -23.72 64.79 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 123.02 2.48 . . . . 12.0 116.659 -168.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -79.88 -28.53 39.89 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.317 1.969 . . . . 35.549999999999997 116.317 177.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -18.03 59.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.792 2.515 . . . . 20.52 117.792 170.481 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -79.98 138.41 37.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.063 -2.273 . . . . 7.1299999999999999 116.735 177.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -137.94 129.26 27.71 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 125.666 2.651 . . . . 36.390000000000001 106.423 164.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.6 mt -110.91 117.42 33.32 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 111.522 -2.581 . . . . 9.5500000000000007 112.584 -173.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 65.6 mt -119.15 131.19 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.984 2.114 . . . . 13.9 109.532 -178.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.587 ' HB3' HD21 ' A' ' 50' ' ' LEU . 11.5 t80 -122.75 107.4 11.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.826 -2.287 . . . . 6.8600000000000003 104.826 178.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.315 . . 69.93 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 125.572 1.795 . . . . 11.15 113.971 -177.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.9 -29.87 3.66 Favored Glycine 0 N--CA 1.43 -1.717 0 CA-C-O 118.419 -1.211 . . . . 13.93 112.796 175.557 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 tppt? -94.79 127.95 41.16 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 126.248 1.793 . . . . 23.920000000000002 115.116 -162.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -77.13 132.72 38.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.378 2.037 . . . . 23.23 115.533 166.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 45' ' ' PHE 0.26 7.6 mt -91.07 133.29 35.44 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.263 -2.773 . . . . 9.1099999999999994 113.125 -163.692 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -88.86 121.85 31.65 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.227 -1.545 . . . . 33.439999999999998 114.07 -176.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -29.49 -57.75 0.16 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 131.032 3.733 . . . . 28.370000000000001 115.941 -178.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.87 25.35 25.59 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 119.278 -2.139 . . . . 15.0 116.188 -168.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.1 mtt-85 -108.91 155.33 20.96 Favored 'General case' 0 N--CA 1.43 -1.463 1 C-N-CA 132.081 4.153 . . . . 25.5 113.216 170.123 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.44 23.9 p -80.69 158.93 25.43 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 128.292 3.901 . . . . 11.949999999999999 115.045 177.615 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.2 mp -68.86 -8.36 43.1 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.782 -5.574 . . . . 10.17 116.358 166.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.33 -42.85 18.21 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 112.686 -3.53 . . . . 13.59 103.294 177.52 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -62.47 -28.56 69.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 123.27 2.759 . . . . 11.699999999999999 114.466 179.919 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -94.32 -4.68 48.2 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.483 2.313 . . . . 12.949999999999999 112.088 175.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 m120 63.52 44.22 5.42 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 129.734 3.214 . . . . 25.449999999999999 110.007 169.303 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.7 mt -80.22 113.58 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 119.89 -1.756 . . . . 14.6 111.41 -178.256 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.261 14.6 mm100 -71.4 -179.56 2.53 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 124.644 2.164 . . . . 33.229999999999997 109.455 173.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -79.21 144.57 34.28 Favored 'General case' 0 N--CA 1.43 -1.443 1 CA-C-O 128.752 4.12 . . . . 25.969999999999999 109.95 165.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.366 65.8 mt-10 71.09 32.99 2.15 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.334 -2.666 . . . . 32.609999999999999 110.26 174.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.269 2.9 m -98.55 144.93 27.34 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 116.559 -3.838 . . . . 10.56 107.269 175.617 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -94.82 115.36 27.4 Favored 'General case' 0 N--CA 1.431 -1.423 1 C-N-CA 132.147 4.179 . . . . 5.3300000000000001 110.267 176.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.6 mt -85.69 129.83 34.72 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 106.62 -1.622 . . . . 11.66 106.62 170.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -81.1 105.91 12.68 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.932 -2.355 . . . . 16.300000000000001 108.413 168.563 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.458 HD23 HG22 ' A' ' 7' ' ' THR . 34.3 tp -84.93 108.72 17.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.226 2.61 . . . . 9.9600000000000009 109.893 168.154 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.2 m -113.74 168.59 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 127.237 2.215 . . . . 9.7599999999999998 106.264 178.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.9 tp -86.97 123.71 32.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 127.748 3.155 . . . . 19.57 108.886 -167.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -92.91 115.05 27.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.492 1.615 . . . . 35.079999999999998 108.544 173.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.9 mt -84.58 163.61 19.22 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.106 -1.406 . . . . 32.310000000000002 111.855 175.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -65.64 140.33 58.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.946 2.308 . . . . 42.75 113.396 172.239 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.58 78.47 1.22 Allowed Glycine 0 N--CA 1.43 -1.72 0 CA-C-O 116.184 -2.453 . . . . 36.310000000000002 114.725 -175.328 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.734 0 CA-C-O 115.717 -2.713 . . . . 36.270000000000003 111.833 -167.933 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.335 0 N-CA-C 104.455 -2.424 . . . . 17.170000000000002 104.455 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -114.3 160.12 19.44 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.938 -1.726 . . . . 21.890000000000001 115.459 173.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.4 pt -133.7 154.17 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 1 CA-C-O 129.434 4.445 . . . . 10.83 105.32 169.842 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -106.96 105.03 14.86 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.026 3.298 . . . . 10.609999999999999 102.872 177.073 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.32 105.19 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.009 -2.307 . . . . 9.1300000000000008 112.838 171.173 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -95.64 128.04 42.17 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.258 1.98 . . . . 20.550000000000001 111.499 -175.498 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -82.29 -179.16 7.31 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.939 -3.601 . . . . 11.779999999999999 113.845 -172.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.0 tp -75.22 -48.52 23.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.467 -3.896 . . . . 19.309999999999999 112.114 -176.701 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.0 p -70.22 -24.0 63.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.93 2.776 . . . . 23.140000000000001 116.647 -178.632 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.36 75.88 0.52 Allowed Glycine 0 N--CA 1.43 -1.757 0 O-C-N 118.657 -2.527 . . . . 19.739999999999998 110.517 170.916 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -142.16 139.38 32.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 102.882 -3.007 . . . . 21.93 102.882 170.141 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.3 m -106.52 104.19 13.82 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.296 1.438 . . . . 12.33 110.626 176.112 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.8 mt -92.31 118.21 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 118.468 -0.777 . . . . 17.079999999999998 109.636 176.817 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.5 m -95.83 122.72 38.92 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.229 -3.248 . . . . 16.300000000000001 102.229 179.005 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 tp -127.85 147.53 50.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 121.364 -0.835 . . . . 15.880000000000001 112.386 -176.216 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -95.87 122.73 38.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.284 -1.817 . . . . 28.899999999999999 108.787 178.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -128.23 168.06 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 128.196 2.599 . . . . 12.050000000000001 109.187 177.686 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -107.12 153.41 41.04 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 116.756 -3.715 . . . . 18.170000000000002 101.264 163.644 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.43 -12.96 32.49 Favored 'Trans proline' 0 N--CA 1.433 -2.036 2 C-N-CA 128.323 6.016 . . . . 8.1600000000000001 105.122 179.699 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.6 p -83.97 12.44 6.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.017 2.927 . . . . 11.130000000000001 114.387 171.538 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -93.34 146.12 23.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 105.599 -2.0 . . . . 18.030000000000001 105.599 176.82 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.9 p -89.1 168.58 12.21 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.852 -1.536 . . . . 10.220000000000001 106.852 -175.456 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -82.24 -28.08 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 116.151 1.908 . . . . 12.300000000000001 116.151 -173.671 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -48.27 -50.31 30.29 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 111.745 -2.48 . . . . 36.509999999999998 112.078 155.349 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -59.0 -53.03 63.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.239 2.681 . . . . 25.66 118.239 168.021 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.1 t -50.22 -37.99 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 116.552 2.056 . . . . 8.1199999999999992 116.552 171.087 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -68.33 -41.55 80.61 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 117.725 -1.131 . . . . 15.470000000000001 113.984 173.598 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.23 -37.69 70.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.907 3.299 . . . . 11.449999999999999 119.907 174.197 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mttm -61.89 -47.42 85.04 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.976 2.911 . . . . 24.98 113.002 170.17 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.2 mt -71.51 -35.0 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.982 -1.698 . . . . 9.4600000000000009 108.595 -176.814 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -62.02 -46.79 87.63 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.428 -3.295 . . . . 14.76 113.876 170.29 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -49.27 -58.97 4.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.458 2.762 . . . . 26.289999999999999 118.458 163.711 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -71.04 -67.41 0.51 Allowed 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.237 -2.789 . . . . 30.059999999999999 116.203 -178.58 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -85.33 -24.87 27.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.916 1.817 . . . . 25.190000000000001 114.077 -171.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.82 38.89 14.8 Favored Glycine 0 N--CA 1.43 -1.727 0 O-C-N 119.611 -1.931 . . . . 7.4100000000000001 115.235 -178.614 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 57.1 mt -102.98 109.91 62.42 Favored Pre-proline 0 N--CA 1.43 -1.452 0 CA-C-O 114.3 -2.762 . . . . 9.4900000000000002 109.013 -179.168 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -55.7 142.23 82.98 Favored 'Trans proline' 0 N--CA 1.434 -1.987 2 C-N-CA 127.181 5.254 . . . . 11.42 114.321 -171.649 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.47 -17.97 6.08 Favored 'Trans proline' 0 C--N 1.3 -1.99 0 CA-C-N 123.026 2.116 . . . . 12.0 109.946 -159.807 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.269 37.0 m-20 -60.49 -23.67 64.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 126.551 2.407 . . . . 35.549999999999997 116.486 161.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -84.3 -33.04 24.04 Favored 'General case' 0 N--CA 1.431 -1.388 0 O-C-N 117.261 -3.399 . . . . 20.52 115.263 176.595 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -67.41 138.03 56.37 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.026 3.343 . . . . 7.1299999999999999 120.026 -179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -136.71 132.09 34.39 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 105.181 -2.155 . . . . 36.390000000000001 105.181 161.441 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.253 11.4 mt -111.91 124.89 53.33 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 129.279 4.112 . . . . 9.5500000000000007 107.702 -174.621 . . . . . . . . 3 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.3 mt -117.79 117.84 56.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.704 2.402 . . . . 13.9 111.2 -173.165 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -94.55 102.97 14.92 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.567 -1.958 . . . . 6.8600000000000003 110.96 168.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.253 . . 61.99 -81.35 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.767 2.136 . . . . 11.15 116.767 -163.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -142.85 16.91 2.39 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 104.666 -3.374 . . . . 13.93 104.666 172.773 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -95.73 111.49 23.43 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 119.255 1.528 . . . . 23.920000000000002 114.671 171.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -76.73 116.55 17.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.836 -1.529 . . . . 23.23 111.721 -179.503 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.0 mt -87.26 138.64 31.31 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.457 -3.277 . . . . 9.1099999999999994 112.806 -164.909 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -97.21 161.23 13.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.428 2.01 . . . . 33.439999999999998 116.428 -175.894 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.269 7.8 m-20 -46.4 -68.78 0.16 Allowed 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 119.829 3.27 . . . . 28.370000000000001 119.829 -166.844 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.14 8.4 70.85 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 118.013 1.965 . . . . 15.0 118.013 -165.977 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.2 mmm180 -94.92 158.88 15.29 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 126.866 3.222 . . . . 25.5 112.092 -176.844 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.9 p -96.95 164.03 12.71 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 125.089 2.376 . . . . 11.949999999999999 109.229 -179.335 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mt -71.69 -18.92 62.14 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 112.762 -3.494 . . . . 10.17 113.207 171.482 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.3 m -71.22 -31.86 68.09 Favored 'General case' 0 N--CA 1.431 -1.396 0 O-C-N 126.046 2.091 . . . . 13.59 112.464 169.587 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -66.41 -53.1 39.63 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.55 -3.219 . . . . 11.699999999999999 109.269 179.012 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -66.42 -19.76 65.88 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.704 -3.122 . . . . 12.949999999999999 110.683 -179.454 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.6 m120 73.64 47.54 0.17 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 115.616 1.71 . . . . 25.449999999999999 115.616 -178.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.1 mt -98.72 111.65 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.179 2.419 . . . . 14.6 110.003 -177.021 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.0 mm100 -71.03 174.5 6.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 112.327 -2.215 . . . . 33.229999999999997 111.681 -176.17 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.6 pttt -52.46 133.22 35.48 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.561 3.171 . . . . 25.969999999999999 119.561 168.68 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 60.53 50.71 5.61 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.666 -3.146 . . . . 32.609999999999999 113.392 175.523 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 m -107.35 154.6 21.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.875 -1.511 . . . . 10.56 110.74 -179.426 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.4 m -102.08 126.68 49.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.377 3.548 . . . . 5.3300000000000001 107.244 -168.294 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.4 mt -112.23 145.9 39.1 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 117.524 -1.227 . . . . 11.66 109.243 178.339 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -101.59 123.84 46.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 106.495 -1.668 . . . . 16.300000000000001 106.495 177.942 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 tp -100.4 117.88 35.49 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.613 2.365 . . . . 9.9600000000000009 107.62 174.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -115.46 -165.15 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.602 2.075 . . . . 9.7599999999999998 116.602 171.903 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 tp -88.68 123.89 33.57 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.043 -1.661 . . . . 19.57 113.327 168.293 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.7 ttt180 -82.16 117.17 22.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.371 1.557 . . . . 35.079999999999998 108.439 174.637 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.1 mt -101.02 -174.16 2.55 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.027 -2.295 . . . . 32.310000000000002 107.98 172.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -126.19 156.73 39.73 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.225 -2.172 . . . . 42.75 108.246 -172.789 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.73 21.19 64.26 Favored Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 115.233 -2.982 . . . . 36.310000000000002 112.713 -162.512 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.761 0 CA-C-N 123.006 3.403 . . . . 36.270000000000003 121.026 177.174 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HG3' ' HG2' ' A' ' 63' ' ' LYS . 39.7 ttm . . . . . 0 CA--C 1.49 -1.365 0 N-CA-C 110.297 -0.26 . . . . 17.170000000000002 110.297 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -87.82 134.12 33.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.741 -1.85 . . . . 21.890000000000001 112.454 171.06 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.3 pt -122.09 171.22 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 119.162 0.892 . . . . 10.83 110.675 162.497 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -116.09 121.65 42.8 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.133 -2.854 . . . . 10.609999999999999 109.319 174.39 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.3 t -106.2 104.49 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 124.971 2.319 . . . . 9.1300000000000008 111.483 173.11 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -82.74 134.37 35.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.906 -3.621 . . . . 20.550000000000001 113.822 -177.804 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.7 p -87.12 176.22 7.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.364 1.665 . . . . 11.779999999999999 110.963 -174.376 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.7 tt -71.64 -44.4 64.42 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 124.75 1.22 . . . . 19.309999999999999 109.636 177.707 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -69.55 -63.7 1.02 Allowed 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 125.47 1.508 . . . . 23.140000000000001 114.231 -177.426 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.23 21.82 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 115.589 -3.196 . . . . 19.739999999999998 115.42 176.178 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -105.28 138.58 41.27 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.318 -1.364 . . . . 21.93 107.318 -173.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -105.43 118.45 36.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.717 -2.489 . . . . 12.33 107.182 168.713 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.2 mt -101.39 126.68 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 114.102 -2.856 . . . . 17.079999999999998 107.211 -173.553 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.3 m -101.37 125.69 48.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 102.888 -3.004 . . . . 16.300000000000001 102.888 -171.782 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 15' ' ' LEU . 15.6 tp -141.05 131.0 24.48 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 103.721 -2.696 . . . . 15.880000000000001 103.721 -154.91 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -114.85 107.13 15.01 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.025 -2.954 . . . . 28.899999999999999 103.025 -168.082 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.409 HG11 HG22 ' A' ' 26' ' ' VAL . 16.8 m -116.6 155.76 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 C-N-CA 128.541 2.737 . . . . 12.050000000000001 112.727 -177.412 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -89.47 143.86 31.28 Favored Pre-proline 0 N--CA 1.43 -1.443 1 CA-C-O 111.465 -4.112 . . . . 18.170000000000002 108.494 171.152 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.418 ' HA ' HD12 ' A' ' 56' ' ' LEU . 27.9 Cg_endo -87.47 -5.77 7.21 Favored 'Trans proline' 0 N--CA 1.433 -2.043 2 CA-C-N 129.132 4.297 . . . . 8.1600000000000001 105.628 -173.767 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.267 65.9 m -84.11 -6.51 59.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 119.014 -1.074 . . . . 11.130000000000001 113.726 171.817 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -107.91 161.14 15.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 128.16 3.838 . . . . 18.030000000000001 108.843 -179.132 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -77.23 166.9 22.61 Favored 'General case' 0 N--CA 1.43 -1.446 1 N-CA-C 121.849 4.018 . . . . 10.220000000000001 121.849 -176.006 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.2 mm -63.25 -32.85 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 125.039 1.335 . . . . 12.300000000000001 111.64 174.587 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -53.61 -44.15 69.25 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.109 -1.619 . . . . 36.509999999999998 112.032 172.537 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -79.84 -14.3 58.77 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.3 -3.375 . . . . 25.66 114.309 178.004 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.409 HG22 HG11 ' A' ' 17' ' ' VAL . 65.0 t -69.22 -47.62 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 119.251 -2.156 . . . . 8.1199999999999992 109.866 165.522 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.25 90.7 mttt -69.68 -28.39 65.81 Favored 'General case' 0 N--CA 1.429 -1.492 0 C-N-CA 126.07 1.748 . . . . 15.470000000000001 111.527 -179.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.271 . . -65.8 -38.04 87.92 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.832 2.053 . . . . 11.449999999999999 106.885 175.502 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -73.32 -31.69 64.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.004 2.638 . . . . 24.98 116.55 178.199 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.25 70.8 mt -72.34 -42.21 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.081 2.372 . . . . 9.4600000000000009 111.317 172.108 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -49.93 -35.63 24.72 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 116.475 2.028 . . . . 14.76 116.475 169.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -85.59 -55.28 4.07 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 105.814 -1.921 . . . . 26.289999999999999 105.814 -173.822 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -71.85 -44.46 63.8 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.507 -1.371 . . . . 30.059999999999999 112.774 -169.419 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -106.89 -33.09 7.64 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.529 -1.357 . . . . 25.190000000000001 109.589 -162.054 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.4 46.69 4.88 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 128.124 2.774 . . . . 7.4100000000000001 113.81 170.289 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.0 mt -106.93 128.6 25.79 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 101.364 -3.569 . . . . 9.4900000000000002 101.364 176.355 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -82.86 162.95 16.06 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 O-C-N 117.029 -2.143 . . . . 11.42 110.857 179.409 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -48.15 -23.23 4.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 N-CA-C 121.386 3.571 . . . . 12.0 121.386 166.087 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -68.08 -23.65 64.96 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.608 -2.557 . . . . 35.549999999999997 106.936 178.258 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -108.73 -12.94 14.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 127.266 3.412 . . . . 20.52 116.267 -179.304 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -86.84 115.46 24.27 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 115.678 -4.389 . . . . 7.1299999999999999 113.46 -177.384 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.8 ttm180 -111.89 117.24 32.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.297 -1.001 . . . . 36.390000000000001 108.297 163.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 mt -98.98 131.44 45.04 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 125.889 1.676 . . . . 9.5500000000000007 106.716 178.813 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.421 HD13 HG21 ' A' ' 44' ' ' ILE . 63.8 mt -131.2 140.51 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 119.487 -2.008 . . . . 13.9 107.062 177.397 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -101.28 100.92 11.49 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.228 3.811 . . . . 6.8600000000000003 108.678 161.674 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.09 -91.48 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.532 2.333 . . . . 11.15 116.704 -169.366 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.84 14.49 6.69 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 116.928 -2.04 . . . . 13.93 111.241 175.724 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -98.46 108.81 21.59 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 126.514 1.949 . . . . 23.920000000000002 106.785 173.899 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -79.74 102.28 8.93 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 119.963 3.32 . . . . 23.23 119.963 171.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.1 mt -65.12 146.18 55.32 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 124.737 2.208 . . . . 9.1099999999999994 114.729 -155.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -107.06 143.87 34.54 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.119 -4.113 . . . . 33.439999999999998 112.835 178.805 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -83.96 -38.95 20.35 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 114.571 -2.633 . . . . 28.370000000000001 114.313 -153.379 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.88 45.78 3.57 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 124.024 3.102 . . . . 15.0 113.818 163.901 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -131.46 162.51 30.04 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.119 -4.754 . . . . 25.5 105.252 170.622 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.9 p -108.26 172.86 6.6 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 117.591 -3.193 . . . . 11.949999999999999 114.82 -175.669 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 19' ' ' PRO . 11.2 mt -64.81 -37.87 89.07 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.16 1.457 . . . . 10.17 108.191 169.006 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.356 1.2 m -56.2 -36.95 68.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.468 3.507 . . . . 13.59 120.468 167.626 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -58.75 -42.67 89.39 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.351 -2.718 . . . . 11.699999999999999 114.009 165.527 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -81.07 -7.39 59.55 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 119.731 -1.855 . . . . 12.949999999999999 111.426 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.256 60.8 m-80 55.78 48.42 18.27 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.321 2.249 . . . . 25.449999999999999 116.023 -171.872 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 88.0 mt -84.32 140.47 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 C-N-CA 126.009 1.723 . . . . 14.6 113.014 175.625 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.5 mm-40 -109.1 -175.06 2.66 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.122 1.769 . . . . 33.229999999999997 106.879 -170.247 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' HG2' ' HG3' ' A' ' 1' ' ' MET 0.299 18.3 mtmm -72.63 147.53 45.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.662 -1.899 . . . . 25.969999999999999 112.532 174.97 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 78.51 20.85 0.83 Allowed 'General case' 0 N--CA 1.43 -1.441 1 C-N-CA 132.027 4.131 . . . . 32.609999999999999 106.863 166.341 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -88.48 159.97 17.72 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 116.08 -4.137 . . . . 10.56 109.779 -163.934 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.1 m -103.84 134.98 46.23 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 124.328 2.013 . . . . 5.3300000000000001 112.473 -175.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.7 mt -114.71 169.24 9.22 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 130.447 3.499 . . . . 11.66 108.302 165.222 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 54.4 m80 -123.62 136.5 54.54 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 114.775 -2.536 . . . . 16.300000000000001 107.753 174.002 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tp -97.04 113.95 25.54 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.542 2.428 . . . . 9.9600000000000009 113.96 159.572 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -116.96 -166.01 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 116.764 -3.71 . . . . 9.7599999999999998 108.542 162.515 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.559 ' H ' HD23 ' A' ' 71' ' ' LEU . 0.9 OUTLIER -84.85 145.16 27.97 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.345 2.258 . . . . 19.57 109.668 -172.359 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -103.29 124.16 48.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.388 -2.07 . . . . 35.079999999999998 106.115 -178.077 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 50.1 mt -124.58 136.1 53.68 Favored 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 133.039 4.535 . . . . 32.310000000000002 106.465 177.632 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 84.8 mtt-85 -52.47 -52.31 54.98 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.695 2.48 . . . . 42.75 117.695 -175.545 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.35 68.57 0.54 Allowed Glycine 0 N--CA 1.43 -1.743 0 O-C-N 117.977 -2.952 . . . . 36.310000000000002 108.749 152.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.744 0 CA-C-O 124.779 2.322 . . . . 36.270000000000003 112.164 163.667 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 CA--C 1.49 -1.346 0 N-CA-C 115.65 1.722 . . . . 17.170000000000002 115.65 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -86.75 133.62 33.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.967 3.707 . . . . 21.890000000000001 110.941 171.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pt -130.39 158.83 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 119.569 1.077 . . . . 10.83 108.376 172.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -105.93 145.09 31.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.324 1.059 . . . . 10.609999999999999 109.935 168.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.563 HG22 ' HB2' ' A' ' 67' ' ' LEU . 85.7 t -122.3 139.08 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 101.22 -3.622 . . . . 9.1300000000000008 101.22 168.994 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.7 tttt -117.6 124.5 48.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.162 -0.926 . . . . 20.550000000000001 112.843 177.245 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -79.69 166.84 21.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.073 -1.876 . . . . 11.779999999999999 115.563 -177.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.9 tt -74.5 -43.61 55.16 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.687 -4.383 . . . . 19.309999999999999 108.912 -172.948 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -60.06 -44.06 94.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.575 -3.203 . . . . 23.140000000000001 110.024 173.464 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.21 59.87 0.21 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 126.233 2.208 . . . . 19.739999999999998 111.123 177.37 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -107.53 127.16 53.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.453 1.101 . . . . 21.93 109.553 161.561 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.2 m -101.07 112.2 24.61 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 121.124 -0.985 . . . . 12.33 108.892 174.588 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.7 pt -109.94 134.98 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 125.963 2.792 . . . . 17.079999999999998 111.01 -172.397 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.2 m -89.25 115.22 26.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.512 -1.992 . . . . 16.300000000000001 109.142 -174.769 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 mt -104.0 167.23 9.9 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.373 -2.079 . . . . 15.880000000000001 114.629 170.015 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.321 9.2 tt0 -130.47 113.69 14.6 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.565 1.546 . . . . 28.899999999999999 115.169 168.45 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.76 145.28 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 125.957 1.703 . . . . 12.050000000000001 110.363 -173.176 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.84 148.17 94.59 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 117.267 -3.396 . . . . 18.170000000000002 113.018 158.596 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -65.97 -21.68 56.45 Favored 'Trans proline' 0 C--N 1.3 -2.019 3 C-N-CA 126.214 4.609 . . . . 8.1600000000000001 113.414 172.096 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.8 m -84.61 8.11 17.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 123.681 1.705 . . . . 11.130000000000001 115.483 173.756 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -87.82 157.98 18.86 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.546 -2.596 . . . . 18.030000000000001 109.248 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 55' ' ' THR . 23.6 p -95.1 167.7 11.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 129.091 2.957 . . . . 10.220000000000001 115.061 -176.975 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.3 mm -67.26 -26.35 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 116.211 1.93 . . . . 12.300000000000001 116.211 172.321 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -63.41 -47.52 81.64 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.073 -2.267 . . . . 36.509999999999998 112.03 175.264 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -66.91 -23.36 65.98 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 128.001 2.52 . . . . 25.66 113.738 176.096 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.6 t -65.31 -58.16 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.955 2.902 . . . . 8.1199999999999992 107.87 167.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -70.56 -17.99 62.92 Favored 'General case' 0 N--CA 1.43 -1.462 1 O-C-N 115.353 -4.592 . . . . 15.470000000000001 116.495 -173.896 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.55 -28.26 65.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.061 -1.65 . . . . 11.449999999999999 109.315 167.171 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -77.93 -33.36 51.76 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.497 1.499 . . . . 24.98 111.05 -177.036 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -76.1 -34.74 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 128.368 2.667 . . . . 9.4600000000000009 110.213 178.529 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.8 tt0 -56.75 -47.53 79.85 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 117.959 -1.02 . . . . 14.76 113.057 165.756 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -65.78 -57.95 6.8 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.059 2.614 . . . . 26.289999999999999 118.059 171.798 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.8 tttt -59.28 -52.16 66.87 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.46 3.133 . . . . 30.059999999999999 119.46 -173.359 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -107.09 -43.64 4.57 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 122.079 0.943 . . . . 25.190000000000001 109.681 176.418 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.32 47.43 2.02 Favored Glycine 0 N--CA 1.43 -1.741 0 O-C-N 118.264 -2.772 . . . . 7.4100000000000001 110.733 -173.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 mt -104.55 114.61 63.9 Favored Pre-proline 0 N--CA 1.43 -1.445 0 N-CA-C 101.516 -3.513 . . . . 9.4900000000000002 101.516 168.249 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -83.62 163.41 14.4 Favored 'Trans proline' 0 N--CA 1.433 -2.043 0 CA-C-O 111.719 -3.534 . . . . 11.42 116.55 -171.061 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -81.6 -3.61 11.96 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 130.279 4.707 . . . . 12.0 111.281 -162.265 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.51 -26.4 45.85 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.001 1.273 . . . . 35.549999999999997 112.945 176.215 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -69.24 -51.24 39.64 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 120.912 3.671 . . . . 20.52 120.912 158.062 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -68.45 116.5 9.07 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.787 2.708 . . . . 7.1299999999999999 115.858 -168.892 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.9 ttt180 -111.83 113.84 26.44 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.216 -4.678 . . . . 36.390000000000001 105.961 168.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.6 mt -83.61 127.65 33.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 121.155 1.798 . . . . 9.5500000000000007 110.88 -179.919 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.6 mm -121.45 139.81 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 125.947 1.699 . . . . 13.9 108.282 177.774 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -135.25 139.99 44.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 104.206 -2.516 . . . . 6.8600000000000003 104.206 157.207 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.266 . . 47.92 -98.86 0.05 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.504 2.721 . . . . 11.15 112.052 -164.899 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.91 31.05 1.35 Allowed Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 114.376 -3.773 . . . . 13.93 110.252 167.568 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -95.18 147.34 23.56 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.242 1.417 . . . . 23.920000000000002 108.11 166.689 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -99.62 139.46 35.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.927 -1.511 . . . . 23.23 110.692 170.595 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.258 0.4 OUTLIER -113.74 131.75 56.08 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.092 1.495 . . . . 9.1099999999999994 107.574 -163.756 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -101.08 157.36 16.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 125.333 1.646 . . . . 33.439999999999998 115.075 -162.71 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.259 33.6 m-20 -59.8 -53.72 54.69 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 121.447 3.869 . . . . 28.370000000000001 121.447 -165.283 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.86 33.93 5.24 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-N 121.109 1.777 . . . . 15.0 115.695 -179.408 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 81.4 mtp180 -113.92 150.34 33.85 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.18 -2.953 . . . . 25.5 105.092 169.712 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 22' ' ' THR . 16.0 p -90.16 171.48 9.49 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.939 2.78 . . . . 11.949999999999999 111.653 -170.21 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.7 mt -83.63 -30.49 26.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.978 -3.576 . . . . 10.17 108.722 -176.789 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 m -59.05 -39.83 83.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.792 2.837 . . . . 13.59 108.233 170.816 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -58.03 -59.92 4.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.631 -3.793 . . . . 11.699999999999999 111.247 179.496 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -70.74 -11.96 61.26 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 130.099 3.359 . . . . 12.949999999999999 112.056 -170.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 65.71 60.04 0.72 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.92 -2.988 . . . . 25.449999999999999 112.851 -179.193 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.3 mm -90.69 137.05 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.319 -2.738 . . . . 14.6 110.646 179.556 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -101.06 -175.8 2.98 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.507 -1.995 . . . . 33.229999999999997 114.883 -171.876 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 mttt -78.17 142.12 38.21 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 114.124 1.157 . . . . 25.969999999999999 114.124 178.661 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 61.11 30.84 19.65 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.214 2.206 . . . . 32.609999999999999 112.401 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.1 t -81.35 158.44 24.7 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 117.053 2.242 . . . . 10.56 117.053 -179.438 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.3 m -121.37 103.76 9.19 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.145 -2.222 . . . . 5.3300000000000001 107.805 -166.678 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.563 ' HB2' HG22 ' A' ' 5' ' ' VAL 0.273 91.6 mt -88.48 147.35 24.7 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 129.142 2.977 . . . . 11.66 107.438 175.542 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -100.84 137.72 38.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.303 2.252 . . . . 16.300000000000001 110.093 -178.625 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 mt -106.07 141.22 37.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.908 -1.745 . . . . 9.9600000000000009 111.778 165.122 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.85 -169.85 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 127.62 2.368 . . . . 9.7599999999999998 108.517 169.969 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.6 mt -94.79 126.08 39.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.369 3.868 . . . . 19.57 116.06 -173.103 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -104.31 148.86 25.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.852 -1.78 . . . . 35.079999999999998 112.764 170.313 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.8 mt -63.56 -64.45 0.9 Allowed 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 127.082 2.153 . . . . 32.310000000000002 110.055 173.639 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.312 29.7 ttt180 -155.67 -79.45 0.09 Allowed 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 116.922 -3.611 . . . . 42.75 112.661 173.755 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.83 50.88 0.85 Allowed Glycine 0 N--CA 1.43 -1.746 0 N-CA-C 109.473 -1.451 . . . . 36.310000000000002 109.473 -173.599 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 0 O-C-N 119.811 -1.994 . . . . 36.270000000000003 109.448 -170.21 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.2 ptt? . . . . . 0 CA--C 1.49 -1.361 0 CA-C-O 121.447 0.642 . . . . 17.170000000000002 110.874 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -89.39 152.07 21.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.239 1.971 . . . . 21.890000000000001 109.987 170.549 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.2 pt -126.33 168.71 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.668 2.787 . . . . 10.83 109.401 154.811 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -119.15 145.75 45.72 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.775 1.75 . . . . 10.609999999999999 110.927 164.255 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.9 t -118.9 123.53 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 116.618 -3.801 . . . . 9.1300000000000008 107.897 169.305 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.1 ttmm -93.09 121.14 34.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.884 3.23 . . . . 20.550000000000001 109.72 176.227 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.2 p -78.18 -176.88 4.83 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.098 -4.751 . . . . 11.779999999999999 111.663 -174.138 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.3 tp -81.9 -34.36 30.02 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 111.823 -6.798 . . . . 19.309999999999999 113.337 -175.666 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.1 p -88.15 -26.29 22.52 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.12 -2.238 . . . . 23.140000000000001 107.06 -173.18 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.82 47.41 0.21 Allowed Glycine 0 N--CA 1.43 -1.738 0 CA-C-N 118.968 0.804 . . . . 19.739999999999998 113.161 166.121 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -112.1 145.62 39.44 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.367 -1.666 . . . . 21.93 108.043 169.552 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.3 m -111.15 123.78 50.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.991 2.057 . . . . 12.33 106.743 176.08 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.6 pt -110.7 141.99 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 120.76 -1.212 . . . . 17.079999999999998 113.856 177.232 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.7 m -110.57 112.85 25.03 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 115.491 -4.506 . . . . 16.300000000000001 111.047 -174.782 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.49 HD11 HD11 ' A' ' 30' ' ' ILE . 45.6 mt -106.35 124.13 49.12 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.443 2.068 . . . . 15.880000000000001 108.967 -173.953 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -97.6 105.43 17.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.865 -3.022 . . . . 28.899999999999999 111.987 176.698 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -131.47 149.25 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.921 2.088 . . . . 12.050000000000001 107.677 -159.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -85.5 151.83 56.59 Favored Pre-proline 0 N--CA 1.43 -1.427 0 CA-C-O 112.592 -3.575 . . . . 18.170000000000002 113.182 176.334 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_endo -84.71 -6.06 9.8 Favored 'Trans proline' 0 N--CA 1.434 -2.028 1 CA-C-N 132.554 5.519 . . . . 8.1600000000000001 109.072 -168.866 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.8 m -98.64 5.68 47.57 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.559 -3.213 . . . . 11.130000000000001 110.117 176.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -75.76 157.73 33.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.79 3.186 . . . . 18.030000000000001 108.677 173.394 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.6 p -96.37 164.26 12.72 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.812 -3.68 . . . . 10.220000000000001 108.29 -175.972 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.1 mm -76.96 -16.6 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 119.516 -1.99 . . . . 12.300000000000001 111.692 -176.326 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -64.27 -46.88 81.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 106.343 -1.725 . . . . 36.509999999999998 106.343 172.865 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -65.77 -30.95 71.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.617 -2.552 . . . . 25.66 113.48 -178.296 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.4 t -68.77 -44.07 82.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 CA-C-O 126.707 3.146 . . . . 8.1199999999999992 108.265 179.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.5 ttmt -62.78 -39.25 93.64 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 120.67 3.581 . . . . 15.470000000000001 120.67 172.756 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.76 -41.1 77.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.741 2.817 . . . . 11.449999999999999 113.76 175.045 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.8 mttp -57.13 -32.47 66.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 124.847 1.259 . . . . 24.98 110.4 178.82 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.49 HD11 HD11 ' A' ' 15' ' ' LEU . 8.5 mt -82.41 -37.71 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 123.977 1.846 . . . . 9.4600000000000009 109.194 -173.075 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -62.1 -39.53 92.79 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 120.143 -1.598 . . . . 14.76 112.602 168.509 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -62.5 -55.16 30.13 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 115.621 -2.133 . . . . 26.289999999999999 113.052 175.236 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -78.52 -54.9 5.66 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 119.964 3.32 . . . . 30.059999999999999 119.964 -171.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -92.87 -36.13 12.98 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.548 -2.595 . . . . 25.190000000000001 112.115 176.991 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.84 55.98 2.56 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 117.763 -3.086 . . . . 7.4100000000000001 115.425 -174.849 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.0 mt -108.93 135.87 20.1 Favored Pre-proline 0 N--CA 1.43 -1.432 0 CA-C-O 116.111 -1.899 . . . . 9.4900000000000002 105.982 172.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -71.53 146.58 49.98 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-O 112.397 -3.251 . . . . 11.42 119.591 -170.149 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -91.53 8.57 3.1 Favored 'Trans proline' 0 N--CA 1.433 -2.049 0 CA-C-N 128.163 3.951 . . . . 12.0 112.96 -165.729 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -88.42 -44.19 10.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.799 2.839 . . . . 35.549999999999997 109.142 165.393 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -72.31 -42.11 65.81 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 113.826 -2.988 . . . . 20.52 111.555 175.253 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.268 72.6 mt-30 -66.45 108.97 2.57 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 126.616 3.103 . . . . 7.1299999999999999 115.67 -174.169 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.6 ttt180 -106.51 110.02 22.11 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.114 4.165 . . . . 36.390000000000001 105.278 -174.223 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.444 ' HG ' HD12 ' A' ' 50' ' ' LEU . 25.8 tp -100.27 108.87 21.04 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 126.037 2.827 . . . . 9.5500000000000007 108.182 -162.735 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.3 mm -106.66 145.82 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.141 -3.475 . . . . 13.9 113.09 -173.54 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -129.99 100.17 5.35 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.624 2.631 . . . . 6.8600000000000003 106.642 172.736 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.88 -75.51 0.07 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.638 -2.539 . . . . 11.15 115.63 -176.352 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.58 1.2 1.33 Allowed Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 126.527 2.013 . . . . 13.93 113.621 171.532 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 mmmt -99.13 146.55 26.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.201 -2.352 . . . . 23.920000000000002 110.079 173.659 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.296 10.0 tt0 -91.1 117.29 29.49 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.045 2.609 . . . . 23.23 118.045 164.119 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.444 HD12 ' HG ' ' A' ' 43' ' ' LEU . 19.4 mt -65.85 131.92 47.45 Favored 'General case' 0 N--CA 1.43 -1.432 1 C-N-CA 133.177 4.591 . . . . 9.1099999999999994 113.581 170.841 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -117.9 146.33 44.01 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.811 -1.181 . . . . 33.439999999999998 107.811 -169.084 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -61.65 -27.45 68.68 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.19 -2.277 . . . . 28.370000000000001 115.563 -158.65 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -103.04 24.43 30.53 Favored Glycine 0 N--CA 1.43 -1.729 1 O-C-N 114.526 -5.109 . . . . 15.0 117.353 -166.335 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.1 mtp180 -129.22 166.46 19.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.479 -0.934 . . . . 25.5 108.479 -176.137 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.295 22.2 p -92.93 157.91 16.1 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.251 1.501 . . . . 11.949999999999999 111.052 -173.708 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.2 mt -55.76 -34.04 64.87 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.449 1.595 . . . . 10.17 113.463 168.77 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 t -78.42 -25.43 46.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.895 3.278 . . . . 13.59 118.869 170.751 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -61.77 -47.58 84.56 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.734 -2.479 . . . . 11.699999999999999 113.044 166.871 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -81.76 -16.63 50.43 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.456 3.102 . . . . 12.949999999999999 111.271 -179.205 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 56.51 51.46 11.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.125 2.97 . . . . 25.449999999999999 109.39 -178.583 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -66.39 120.19 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 110.851 -2.886 . . . . 14.6 108.679 163.24 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -83.49 176.82 8.77 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.451 1.9 . . . . 33.229999999999997 110.365 -176.564 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.274 47.7 mttp -81.98 134.39 35.37 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.141 2.576 . . . . 25.969999999999999 109.55 179.81 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 56.83 34.03 24.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.787 2.835 . . . . 32.609999999999999 116.141 -175.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.6 t -72.14 127.44 32.55 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 127.591 3.567 . . . . 10.56 111.67 166.007 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.6 m -95.65 109.12 21.43 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 112.16 -2.291 . . . . 5.3300000000000001 112.499 179.297 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.4 mt -96.36 175.26 6.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.815 -1.178 . . . . 11.66 109.899 -172.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.2 m-70 -128.65 136.13 50.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 120.827 -1.171 . . . . 16.300000000000001 112.432 -175.478 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 tp -120.6 129.77 53.89 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.552 -1.967 . . . . 9.9600000000000009 108.004 -176.063 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.9 m -130.53 163.43 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 124.366 1.066 . . . . 9.7599999999999998 109.727 170.186 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 79.8 mt -102.43 155.21 18.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.182 -1.574 . . . . 19.57 109.548 -169.172 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.421 HH21 ' C ' ' A' ' 76' ' ' GLY . 26.7 ttt180 -149.72 164.42 35.29 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.673 1.989 . . . . 35.079999999999998 106.504 -171.627 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.9 mt -103.3 -164.97 1.12 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.869 -1.514 . . . . 32.310000000000002 111.245 164.166 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -94.37 -39.36 10.51 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.237 -3.414 . . . . 42.75 115.349 -164.263 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.71 69.5 0.22 Allowed Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 126.578 2.037 . . . . 36.310000000000002 115.292 179.072 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.421 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 N--CA 1.43 -1.732 0 N-CA-C 108.274 -1.93 . . . . 36.270000000000003 108.274 162.51 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.489 -1.366 0 CA-C-O 123.144 1.449 . . . . 17.170000000000002 108.774 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -108.29 138.06 45.22 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.202 -4.061 . . . . 21.890000000000001 108.74 -172.576 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -133.78 148.85 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.609 -2.557 . . . . 10.83 107.361 -179.842 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -107.68 110.88 22.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 116.729 2.122 . . . . 10.609999999999999 116.729 177.311 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 t -101.14 122.7 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 120.918 1.69 . . . . 9.1300000000000008 108.863 175.635 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HG2' HG23 ' A' ' 12' ' ' THR . 49.0 mttt -90.32 111.32 22.48 Favored 'General case' 0 N--CA 1.429 -1.495 1 C-N-CA 131.881 4.072 . . . . 20.550000000000001 113.247 175.249 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.3 p -76.93 159.49 29.94 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.253 1.945 . . . . 11.779999999999999 116.253 176.942 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.8 tp -53.52 -49.69 67.06 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.239 2.215 . . . . 19.309999999999999 110.981 -178.605 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.4 p -65.85 -38.1 87.95 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.533 3.533 . . . . 23.140000000000001 113.751 178.37 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.66 51.07 0.26 Allowed Glycine 0 N--CA 1.43 -1.739 0 C-N-CA 127.785 2.612 . . . . 19.739999999999998 116.496 -178.195 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.3 mtpt -121.53 128.92 52.54 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.961 -1.905 . . . . 21.93 108.764 165.645 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.415 HG23 ' HG2' ' A' ' 6' ' ' LYS . 85.6 m -99.59 108.22 20.57 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.697 -3.752 . . . . 12.33 105.9 171.199 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pt -105.15 140.79 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 130.25 3.42 . . . . 17.079999999999998 104.536 -171.818 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -109.14 131.22 55.28 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.143 -2.848 . . . . 16.300000000000001 108.624 -170.239 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.0 mt -113.3 140.55 47.9 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.89 -1.893 . . . . 15.880000000000001 105.89 -179.147 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -100.24 128.25 46.35 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 107.585 -1.265 . . . . 28.899999999999999 107.585 171.127 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.6 m -151.05 152.15 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 118.193 -2.817 . . . . 12.050000000000001 117.188 -168.847 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.26 32.5 mt-10 -97.03 148.78 34.89 Favored Pre-proline 0 N--CA 1.43 -1.456 1 O-C-N 115.795 -4.316 . . . . 18.170000000000002 105.863 172.246 . . . . . . . . 3 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -82.31 -8.57 11.7 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 O-C-N 124.687 1.888 . . . . 8.1600000000000001 111.899 -169.544 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -81.06 -12.47 59.31 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.944 2.097 . . . . 11.130000000000001 109.976 -179.086 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -90.7 154.36 19.61 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 126.457 3.027 . . . . 18.030000000000001 109.259 -176.582 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.9 p -83.11 175.83 9.69 Favored 'General case' 0 N--CA 1.43 -1.43 2 O-C-N 114.63 -5.043 . . . . 10.220000000000001 117.758 -170.386 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.0 mm -79.65 -25.79 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 1 O-C-N 113.432 -5.792 . . . . 12.300000000000001 111.862 178.647 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -47.58 -40.71 19.89 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.97 2.211 . . . . 36.509999999999998 116.97 165.978 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -70.29 -42.33 72.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.274 2.629 . . . . 25.66 111.855 176.711 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.443 HG21 HD21 ' A' ' 56' ' ' LEU . 68.4 t -67.86 -34.14 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 117.37 -3.331 . . . . 8.1199999999999992 110.592 178.309 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.256 35.5 mtmt -65.4 -37.19 86.23 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.977 2.111 . . . . 15.470000000000001 112.541 166.792 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.88 -24.34 64.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.083 2.114 . . . . 11.449999999999999 112.559 -174.516 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.3 mttp -71.22 -37.89 72.02 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 133.599 4.76 . . . . 24.98 109.096 175.215 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.403 ' CG2' HD12 ' A' ' 36' ' ' ILE . 52.6 mt -80.51 -31.02 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 120.322 -1.487 . . . . 9.4600000000000009 107.575 -174.535 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.06 -31.33 68.89 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 125.24 1.416 . . . . 14.76 112.971 177.201 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -82.28 -52.3 7.07 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.283 2.327 . . . . 26.289999999999999 117.283 -175.471 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -86.06 -54.55 4.41 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.269 1.985 . . . . 30.059999999999999 116.046 -177.657 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -72.32 -39.89 67.88 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.315 -1.491 . . . . 25.190000000000001 114.484 177.291 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.89 51.78 2.94 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 116.449 -3.907 . . . . 7.4100000000000001 115.9 174.064 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.403 HD12 ' CG2' ' A' ' 30' ' ' ILE . 63.9 mt -113.18 129.21 24.78 Favored Pre-proline 0 N--CA 1.431 -1.421 0 C-N-CA 127.304 2.242 . . . . 9.4900000000000002 107.909 -176.516 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -77.39 148.95 27.15 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 O-C-N 114.568 -3.438 . . . . 11.42 110.01 -164.682 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -71.3 -24.39 23.06 Favored 'Trans proline' 0 C--N 1.3 -1.985 0 C-N-CA 122.805 2.337 . . . . 12.0 113.919 -156.596 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.292 5.2 p-10 -63.61 -53.23 54.8 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.687 -2.508 . . . . 35.549999999999997 110.124 173.751 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -57.43 -13.81 4.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.522 -2.611 . . . . 20.52 117.376 -177.98 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -93.63 95.61 9.31 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.351 1.46 . . . . 7.1299999999999999 109.311 -178.737 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -89.89 142.79 27.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 118.448 -1.301 . . . . 36.390000000000001 109.927 156.49 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 43' ' ' LEU . 12.0 mt -120.29 135.67 54.93 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.36 -0.978 . . . . 9.5500000000000007 108.36 -177.19 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 49' ' ' GLN . 11.1 mm -120.31 138.22 51.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.667 2.787 . . . . 13.9 106.22 -179.685 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.431 ' HB2' HD11 ' A' ' 50' ' ' LEU . 25.4 t80 -112.76 114.72 27.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.995 2.918 . . . . 6.8600000000000003 106.439 165.632 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.62 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 116.912 2.19 . . . . 11.15 116.912 -173.649 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.51 8.01 2.04 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 129.115 3.245 . . . . 13.93 106.525 -175.571 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 ptpt -125.4 144.95 50.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.196 2.498 . . . . 23.920000000000002 111.927 -173.539 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.401 ' HA ' HD13 ' A' ' 44' ' ' ILE . 22.1 tt0 -103.13 134.5 46.45 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 122.884 1.326 . . . . 23.23 111.127 -161.682 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 45' ' ' PHE . 50.1 mt -84.68 143.89 28.91 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 115.882 -2.008 . . . . 9.1099999999999994 110.674 -176.105 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -135.11 156.37 49.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 126.529 2.393 . . . . 33.439999999999998 111.134 -173.059 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -73.79 -50.55 19.99 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 118.807 2.892 . . . . 28.370000000000001 118.807 -147.407 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -70.65 2.07 18.38 Favored Glycine 0 N--CA 1.43 -1.728 0 N-CA-C 121.078 3.191 . . . . 15.0 121.078 -177.964 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.9 ttt180 -106.92 148.89 28.05 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 123.269 1.509 . . . . 25.5 109.613 -174.415 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -90.85 159.26 16.34 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.027 2.531 . . . . 11.949999999999999 111.17 -162.023 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.443 HD21 HG21 ' A' ' 26' ' ' VAL . 8.4 mt -58.23 -45.23 88.09 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.809 2.844 . . . . 10.17 108.378 172.111 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -57.58 -50.14 74.08 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.798 2.09 . . . . 13.59 114.505 178.325 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -60.53 -35.89 77.09 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.524 -1.36 . . . . 11.699999999999999 113.509 174.61 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -79.11 2.31 21.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.361 -3.337 . . . . 12.949999999999999 116.554 177.941 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.376 4.2 m120 71.39 34.52 1.7 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.213 -1.554 . . . . 25.449999999999999 111.932 -179.602 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.5 mt -104.8 98.63 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 105.826 -1.916 . . . . 14.6 105.826 -165.84 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -107.13 -152.89 0.49 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.347 2.022 . . . . 33.229999999999997 112.16 -174.729 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.4 mttp -73.87 116.96 15.09 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.882 2.549 . . . . 25.969999999999999 117.882 -170.314 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 81.38 50.2 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.287 2.635 . . . . 32.609999999999999 106.468 163.601 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.41 152.66 25.05 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.983 1.713 . . . . 10.56 112.554 -169.859 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -94.58 115.91 28.13 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 130.483 3.513 . . . . 5.3300000000000001 112.754 -164.416 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -116.07 147.51 41.22 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.024 -3.548 . . . . 11.66 111.261 173.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -121.2 127.69 51.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.916 -2.253 . . . . 16.300000000000001 104.916 -175.618 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 tp -91.11 109.94 21.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 117.533 2.42 . . . . 9.9600000000000009 117.533 178.473 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.0 t -97.87 156.09 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 128.199 2.599 . . . . 9.7599999999999998 106.458 -172.763 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.7 tp -89.22 111.41 22.2 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.162 -2.211 . . . . 19.57 112.524 173.289 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -90.12 116.92 28.5 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.206 -0.934 . . . . 35.079999999999998 110.141 -175.055 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 91.5 mt -69.89 148.42 49.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 131.51 3.924 . . . . 32.310000000000002 112.111 169.492 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -83.81 118.37 23.89 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.729 -3.107 . . . . 42.75 118.419 177.072 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.21 79.62 0.55 Allowed Glycine 0 N--CA 1.43 -1.723 0 C-N-CA 127.226 2.346 . . . . 36.310000000000002 114.344 -177.329 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 N-CA-C 107.102 -2.399 . . . . 36.270000000000003 107.102 178.324 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.356 0 N-CA-C 115.061 1.504 . . . . 17.170000000000002 115.061 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -113.2 145.49 40.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.165 -2.21 . . . . 21.890000000000001 110.467 -174.654 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 pt -127.35 154.42 37.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.311 -1.737 . . . . 10.83 106.311 173.042 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -119.43 115.5 24.2 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.274 2.306 . . . . 10.609999999999999 106.987 -176.656 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.3 t -104.97 106.85 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.292 -1.505 . . . . 9.1300000000000008 113.471 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -83.56 110.2 18.03 Favored 'General case' 0 N--CA 1.43 -1.466 1 CA-C-O 128.648 4.07 . . . . 20.550000000000001 110.855 175.845 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.258 15.1 p -74.04 176.85 6.11 Favored 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 131.914 4.086 . . . . 11.779999999999999 113.238 -171.269 . . . . . . . . 3 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.9 tp -70.66 -46.93 62.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.843 2.259 . . . . 19.309999999999999 114.743 -170.844 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.3 p -74.88 -91.24 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.216 3.006 . . . . 23.140000000000001 109.339 179.355 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.18 33.55 0.34 Allowed Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 121.59 1.995 . . . . 19.739999999999998 113.454 -174.675 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -122.64 141.99 51.14 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.136 -3.567 . . . . 21.93 115.089 178.108 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -109.54 123.56 49.62 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.768 -1.832 . . . . 12.33 111.461 170.477 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.0 pt -101.0 144.9 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 117.554 -1.212 . . . . 17.079999999999998 110.556 178.86 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.8 m -104.55 114.45 28.69 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 115.186 -2.34 . . . . 16.300000000000001 107.86 176.309 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.547 ' CD1' HG13 ' A' ' 26' ' ' VAL 0.313 96.5 mt -106.76 158.31 17.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.144 2.878 . . . . 15.880000000000001 105.234 176.021 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.323 27.0 tt0 -104.64 121.19 43.04 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 113.165 -1.834 . . . . 28.899999999999999 108.914 173.206 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.1 m -141.39 154.71 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 120.064 -1.647 . . . . 12.050000000000001 107.501 -179.517 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -87.87 158.37 50.53 Favored Pre-proline 0 N--CA 1.43 -1.46 0 O-C-N 119.603 -1.936 . . . . 18.170000000000002 106.907 167.229 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.12 -1.6 11.75 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 CA-C-N 122.169 1.81 . . . . 8.1600000000000001 115.664 174.117 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.5 m -86.25 -16.57 37.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.834 3.272 . . . . 11.130000000000001 119.834 173.75 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -84.26 170.25 13.9 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.872 2.869 . . . . 18.030000000000001 109.196 -174.766 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.5 p -90.92 -176.77 4.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.463 -3.273 . . . . 10.220000000000001 116.615 -173.084 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -83.16 -19.3 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 116.419 -3.926 . . . . 12.300000000000001 108.703 173.986 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -73.0 -42.51 63.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.055 -2.903 . . . . 36.509999999999998 107.309 178.216 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -54.82 -26.67 36.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.203 -1.856 . . . . 25.66 111.337 174.34 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.547 HG13 ' CD1' ' A' ' 15' ' ' LEU . 20.0 t -67.24 -54.85 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 117.795 2.517 . . . . 8.1199999999999992 117.795 167.703 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -62.48 -30.55 71.34 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 118.306 -2.746 . . . . 15.470000000000001 116.092 -177.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.68 -49.79 56.46 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.827 3.651 . . . . 11.449999999999999 116.153 164.074 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -63.89 -35.89 82.14 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.381 2.672 . . . . 24.98 109.845 178.04 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.49 -43.39 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-O 122.806 1.288 . . . . 9.4600000000000009 112.372 177.521 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -72.43 -37.89 68.49 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 113.899 -2.953 . . . . 14.76 109.586 -179.479 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -74.68 -45.79 42.2 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.408 2.822 . . . . 26.289999999999999 111.18 179.398 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -88.49 -55.29 3.78 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 119.202 -0.999 . . . . 30.059999999999999 112.703 -168.926 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -75.62 -63.28 1.33 Allowed 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.094 1.426 . . . . 25.190000000000001 110.774 -176.214 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.11 40.3 0.45 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 125.376 1.465 . . . . 7.4100000000000001 115.099 173.804 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.0 mt -104.07 118.46 57.0 Favored Pre-proline 0 N--CA 1.429 -1.487 0 CA-C-O 116.581 -1.676 . . . . 9.4900000000000002 108.443 175.255 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -64.21 156.89 56.86 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 124.752 3.635 . . . . 11.42 112.11 -170.595 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -72.6 -18.78 25.24 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 N-CA-C 115.57 1.335 . . . . 12.0 115.57 -161.171 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -91.59 -13.23 32.33 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 127.132 3.349 . . . . 35.549999999999997 107.013 -165.269 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.99 -6.65 58.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 112.171 -2.286 . . . . 20.52 115.778 175.193 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -102.35 107.28 18.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 116.735 2.124 . . . . 7.1299999999999999 116.735 -162.723 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.7 ttm180 -117.77 125.3 50.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.693 -1.254 . . . . 36.390000000000001 107.9 172.754 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.3 mt -102.12 128.22 48.7 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.971 -2.33 . . . . 9.5500000000000007 111.302 179.43 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 55.8 mt -110.01 141.72 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.608 2.363 . . . . 13.9 108.246 169.811 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.431 ' HB3' HD21 ' A' ' 50' ' ' LEU . 21.0 t80 -136.09 131.35 34.71 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.233 -2.136 . . . . 6.8600000000000003 105.233 174.148 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.15 -97.54 0.07 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.303 1.841 . . . . 11.15 112.354 -167.633 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.66 5.15 7.06 Favored Glycine 0 N--CA 1.43 -1.765 0 O-C-N 119.914 -1.741 . . . . 13.93 115.901 171.61 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.1 pttt -111.71 143.88 41.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 130.947 3.699 . . . . 23.920000000000002 112.146 -175.817 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -90.41 132.83 35.4 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 114.641 1.349 . . . . 23.23 114.641 176.643 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.431 HD21 ' HB3' ' A' ' 45' ' ' PHE . 20.4 mt -87.86 139.74 30.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.756 2.422 . . . . 9.1099999999999994 113.855 -172.891 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -82.03 -176.25 6.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.028 2.531 . . . . 33.439999999999998 110.76 168.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -83.02 -69.54 0.62 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 116.397 -3.939 . . . . 28.370000000000001 113.743 -176.557 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.9 56.35 4.36 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 120.387 -1.445 . . . . 15.0 116.007 -167.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -148.5 138.78 22.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 114.584 -2.627 . . . . 25.5 106.438 -172.669 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 44.3 p -79.68 163.87 24.19 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.309 2.956 . . . . 11.949999999999999 112.043 -167.926 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 mt -61.51 -45.98 91.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 110.488 -3.051 . . . . 10.17 108.347 172.119 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.2 m -54.85 -39.47 68.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 125.56 1.787 . . . . 13.59 115.017 174.312 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -63.36 -53.5 51.63 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.306 -2.121 . . . . 11.699999999999999 113.213 176.199 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -70.25 -5.56 28.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.857 -1.065 . . . . 12.949999999999999 113.734 178.017 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 66.61 52.28 1.02 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 127.93 2.492 . . . . 25.449999999999999 110.595 179.237 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -104.9 119.13 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.041 -2.207 . . . . 14.6 105.041 175.758 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -120.05 -172.47 2.36 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.163 2.585 . . . . 33.229999999999997 108.72 -163.93 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 mttm -64.24 115.93 5.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 112.926 -3.416 . . . . 25.969999999999999 116.246 -174.368 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 76.93 18.7 1.5 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.986 3.314 . . . . 32.609999999999999 114.181 -176.164 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.0 m -61.12 145.27 51.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.643 -3.161 . . . . 10.56 115.68 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -94.42 126.29 39.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.705 -2.497 . . . . 5.3300000000000001 115.899 171.457 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 45' ' ' PHE 0.251 22.0 mt -108.31 152.81 24.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.727 1.01 . . . . 11.66 113.727 172.62 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 -114.45 131.59 56.55 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.919 -3.613 . . . . 16.300000000000001 111.656 -177.928 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 52.6 tp -109.56 122.6 47.79 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 118.457 -0.782 . . . . 9.9600000000000009 109.705 -178.85 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.86 -168.77 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 106.413 -1.699 . . . . 9.7599999999999998 106.413 -170.522 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.0 tp -90.25 129.82 36.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 105.405 -2.072 . . . . 19.57 105.405 -169.742 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -90.95 120.21 31.77 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 116.19 -2.204 . . . . 35.079999999999998 111.348 157.384 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.9 mt -101.99 145.07 29.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 110.409 -3.087 . . . . 32.310000000000002 105.661 179.197 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 -55.53 111.4 0.88 Allowed 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.292 -4.005 . . . . 42.75 114.499 -178.975 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.78 69.91 0.34 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 121.146 3.218 . . . . 36.310000000000002 121.146 -170.667 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 O-C-N 129.068 3.451 . . . . 36.270000000000003 112.492 -167.849 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ptt? . . . . . 0 CA--C 1.49 -1.34 0 N-CA-C 119.589 3.181 . . . . 17.170000000000002 119.589 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -65.37 140.33 58.64 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 117.049 2.241 . . . . 21.890000000000001 117.049 163.354 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.4 pt -124.6 159.91 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 O-C-N 119.517 -1.99 . . . . 10.83 111.45 166.262 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -110.41 122.12 46.95 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-O 115.679 -2.105 . . . . 10.609999999999999 115.555 170.478 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.6 t -110.43 110.1 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 101.827 -3.397 . . . . 9.1300000000000008 101.827 -179.096 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 mtmt -75.72 134.86 40.41 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.187 2.195 . . . . 20.550000000000001 114.124 175.684 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.6 p -98.42 -169.14 1.75 Allowed 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.944 -1.132 . . . . 11.779999999999999 107.944 -172.963 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.6 tp -91.01 -38.33 12.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.254 -1.758 . . . . 19.309999999999999 106.254 -168.353 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.328 62.1 p -71.67 -69.77 0.36 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.067 1.877 . . . . 23.140000000000001 116.067 171.858 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 169.5 42.36 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 O-C-N 116.977 -3.577 . . . . 19.739999999999998 119.417 177.895 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -112.48 129.42 56.34 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 114.317 -2.754 . . . . 21.93 104.96 -172.517 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.5 m -88.71 105.72 17.88 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 125.726 2.679 . . . . 12.33 109.862 165.266 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.0 mt -86.12 110.91 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 116.616 -3.802 . . . . 17.079999999999998 111.427 175.253 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.9 m -100.55 113.75 26.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.274 1.852 . . . . 16.300000000000001 114.712 -172.925 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.4 mt -116.26 139.39 50.42 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.359 0.982 . . . . 15.880000000000001 111.886 -167.014 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -96.73 109.13 21.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.434 -2.042 . . . . 28.899999999999999 110.808 -179.164 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -118.42 156.13 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 118.266 -2.771 . . . . 12.050000000000001 108.645 -174.629 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -107.55 136.79 19.59 Favored Pre-proline 0 N--CA 1.43 -1.466 0 O-C-N 120.243 -1.536 . . . . 18.170000000000002 110.172 170.576 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -79.11 -5.45 14.46 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 122.578 2.185 . . . . 8.1600000000000001 113.275 -155.425 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.8 m -93.12 -8.81 41.59 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 112.187 -3.768 . . . . 11.130000000000001 110.876 179.248 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -77.71 177.57 8.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 128.628 3.705 . . . . 18.030000000000001 115.204 166.415 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 42.2 p -115.62 -178.23 3.34 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.383 -2.698 . . . . 10.220000000000001 109.615 -169.401 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.485 HD12 HD13 ' A' ' 50' ' ' LEU 0.308 11.9 mm -63.09 -35.53 72.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 116.939 -3.601 . . . . 12.300000000000001 113.09 175.725 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -53.2 -33.17 51.62 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.157 -4.089 . . . . 36.509999999999998 114.629 174.953 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -64.97 -39.24 93.18 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.294 -2.129 . . . . 25.66 111.832 174.857 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.6 t -73.91 -45.63 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.843 -1.785 . . . . 8.1199999999999992 107.27 -174.228 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.288 38.9 ttmt -63.9 -30.63 71.7 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.709 -3.744 . . . . 15.470000000000001 111.478 -178.766 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.5 -38.03 89.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.696 2.799 . . . . 11.449999999999999 117.328 171.021 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.5 mttm -71.97 -21.86 61.52 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.527 2.417 . . . . 24.98 117.527 174.127 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.2 mt -75.24 -30.84 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 127.675 3.607 . . . . 9.4600000000000009 114.077 164.217 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -62.92 -47.53 82.87 Favored 'General case' 0 N--CA 1.431 -1.409 1 O-C-N 115.529 -4.482 . . . . 14.76 111.798 168.08 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -76.94 -47.24 21.51 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.321 -1.487 . . . . 26.289999999999999 111.678 -172.711 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -74.18 -76.84 0.12 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 116.825 -1.559 . . . . 30.059999999999999 112.373 -176.332 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -80.26 -38.34 31.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.829 3.251 . . . . 25.190000000000001 108.099 -161.564 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.01 50.83 3.36 Favored Glycine 0 N--CA 1.429 -1.804 0 CA-C-O 123.952 1.862 . . . . 7.4100000000000001 111.669 -176.144 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.1 mt -101.66 120.01 55.58 Favored Pre-proline 0 N--CA 1.43 -1.468 1 O-C-N 114.703 -4.998 . . . . 9.4900000000000002 109.605 165.216 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.9 158.66 56.35 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-N 126.883 3.494 . . . . 11.42 114.671 -174.27 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -88.85 -7.83 5.24 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 CA-C-N 128.995 4.248 . . . . 12.0 110.977 -157.618 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -70.83 -32.26 69.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.767 2.827 . . . . 35.549999999999997 106.626 175.521 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -88.02 -11.79 46.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 117.981 -2.949 . . . . 20.52 113.755 177.994 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -84.74 122.51 29.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.853 2.861 . . . . 7.1299999999999999 112.818 176.577 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -129.95 146.96 51.66 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.147 -2.221 . . . . 36.390000000000001 105.014 154.061 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.3 mp -115.85 122.19 44.64 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 123.16 1.457 . . . . 9.5500000000000007 107.72 -173.371 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -110.22 131.69 60.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 128.298 2.639 . . . . 13.9 111.907 -179.412 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -126.02 118.75 26.0 Favored 'General case' 0 N--CA 1.431 -1.41 1 O-C-N 114.417 -5.177 . . . . 6.8600000000000003 103.763 176.386 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.395 . . 65.8 -98.8 0.06 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.483 2.031 . . . . 11.15 116.483 -164.944 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.13 13.82 4.35 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 127.759 2.599 . . . . 13.93 109.951 -173.861 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.2 pttt -132.02 147.28 52.44 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.217 -2.343 . . . . 23.920000000000002 113.025 -177.408 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -85.76 146.34 26.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.293 2.473 . . . . 23.23 110.533 -179.824 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.485 HD13 HD12 ' A' ' 23' ' ' ILE . 94.1 mt -93.55 148.4 22.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.673 -2.517 . . . . 9.1099999999999994 110.987 178.049 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.305 10.0 pt-20 -80.69 -168.86 1.91 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.572 1.949 . . . . 33.439999999999998 110.111 175.969 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -105.77 -47.39 3.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.111 3.338 . . . . 28.370000000000001 113.186 174.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.93 59.92 1.01 Allowed Glycine 0 N--CA 1.43 -1.715 1 O-C-N 115.394 -4.566 . . . . 15.0 115.088 -173.022 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.7 ttt180 -139.42 139.29 37.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.387 -1.338 . . . . 25.5 107.387 179.806 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 50.1 p -80.07 163.75 23.92 Favored 'General case' 0 N--CA 1.43 -1.45 1 CA-C-O 128.903 4.192 . . . . 11.949999999999999 111.351 -166.887 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.0 mt -67.3 -37.52 83.53 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.619 -4.425 . . . . 10.17 114.342 -179.761 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -72.53 -27.13 62.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.802 1.641 . . . . 13.59 115.064 176.187 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -73.13 -39.16 65.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.073 -3.517 . . . . 11.699999999999999 107.019 172.483 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -77.06 -0.07 23.28 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 124.453 1.101 . . . . 12.949999999999999 111.779 178.801 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.2 t30 51.09 60.12 4.11 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.363 -2.711 . . . . 25.449999999999999 114.685 179.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.0 mm -104.28 132.9 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 C-N-CA 127.971 2.509 . . . . 14.6 109.191 170.592 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -111.1 -179.82 3.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.007 1.861 . . . . 33.229999999999997 114.362 -179.07 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.2 mttp -59.33 118.7 6.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.087 -1.87 . . . . 25.969999999999999 114.902 172.55 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.321 55.7 mt-10 76.27 35.0 0.48 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.437 -3.914 . . . . 32.609999999999999 112.874 173.464 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -90.63 141.92 28.28 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.094 1.757 . . . . 10.56 109.818 -175.553 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 p -87.55 128.14 35.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 113.878 -1.51 . . . . 5.3300000000000001 113.528 176.239 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -119.57 149.35 42.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.144 2.978 . . . . 11.66 104.693 174.357 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -119.78 135.41 54.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 121.088 -1.008 . . . . 16.300000000000001 111.598 176.304 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 tp -105.75 110.98 23.47 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.051 1.405 . . . . 9.9600000000000009 112.609 177.584 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -99.18 -174.85 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.207 2.432 . . . . 9.7599999999999998 108.837 -178.653 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 tp -101.12 110.83 22.91 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 115.796 -4.315 . . . . 19.57 106.706 -177.437 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.253 58.0 ttt180 -78.05 133.63 37.9 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 128.433 2.693 . . . . 35.079999999999998 111.127 172.63 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 mt -101.62 -163.64 1.03 Allowed 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.645 -1.284 . . . . 32.310000000000002 107.757 -174.356 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -86.35 135.37 33.54 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 115.128 1.529 . . . . 42.75 115.128 169.546 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.24 -82.7 0.33 Allowed Glycine 0 N--CA 1.43 -1.765 0 CA-C-O 122.016 0.787 . . . . 36.310000000000002 113.522 -174.713 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.735 0 N-CA-C 118.54 2.176 . . . . 36.270000000000003 118.54 -170.358 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 117.057 2.243 . . . . 17.170000000000002 117.057 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' HA ' ' O ' ' A' ' 15' ' ' LEU . 81.9 mt-30 -80.92 135.63 35.93 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 116.084 -4.135 . . . . 21.890000000000001 111.73 -176.107 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 pt -125.71 153.24 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.177 -2.527 . . . . 10.83 104.177 161.049 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.279 50.2 m-85 -115.06 121.86 44.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 126.798 2.561 . . . . 10.609999999999999 111.634 -174.085 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -111.07 112.69 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 116.501 -3.875 . . . . 9.1300000000000008 110.504 -173.288 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -95.45 147.28 23.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 124.919 2.295 . . . . 20.550000000000001 106.36 -176.437 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.3 p -89.06 -178.14 5.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.785 -3.072 . . . . 11.779999999999999 106.635 174.109 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.2 tp -63.37 -47.8 80.59 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 117.912 -1.042 . . . . 19.309999999999999 112.87 168.576 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.7 p -55.63 -50.16 70.93 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.103 2.561 . . . . 23.140000000000001 111.16 171.319 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.9 49.78 0.3 Allowed Glycine 0 N--CA 1.43 -1.717 0 O-C-N 118.887 -2.383 . . . . 19.739999999999998 109.311 169.391 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -90.42 124.48 34.99 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 103.179 -2.897 . . . . 21.93 103.179 176.918 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.7 m -97.67 115.13 27.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.345 2.498 . . . . 12.33 109.068 -175.672 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.5 mt -105.81 113.88 43.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 CA-C-N 112.29 -2.232 . . . . 17.079999999999998 106.249 178.419 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -88.49 133.69 34.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.604 -3.185 . . . . 16.300000000000001 111.342 173.298 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 58.0 mt -120.6 172.25 7.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.986 2.054 . . . . 15.880000000000001 108.937 -175.101 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.7 tp10 -128.26 114.65 17.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.094 -1.628 . . . . 28.899999999999999 108.748 170.182 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.7 m -127.37 152.53 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 125.801 1.938 . . . . 12.050000000000001 108.366 -177.812 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -89.26 140.22 28.67 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-O 114.21 -2.805 . . . . 18.170000000000002 113.799 157.641 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 73.3 Cg_endo -81.7 -4.69 12.25 Favored 'Trans proline' 0 N--CA 1.434 -2.015 0 CA-C-N 123.987 2.46 . . . . 8.1600000000000001 111.258 -169.722 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 21.3 m -82.68 4.09 26.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 118.85 2.907 . . . . 11.130000000000001 118.85 163.553 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -99.94 176.86 5.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.015 2.189 . . . . 18.030000000000001 106.572 173.876 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.369 11.0 p -89.3 -169.92 2.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 114.48 -1.236 . . . . 10.220000000000001 113.827 -166.404 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 mm -81.05 -18.28 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.672 2.389 . . . . 12.300000000000001 115.258 161.478 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -71.32 -29.64 65.27 Favored 'General case' 0 N--CA 1.431 -1.399 0 C-N-CA 123.88 0.872 . . . . 36.509999999999998 109.08 173.659 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -60.57 -45.67 93.05 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.047 1.739 . . . . 25.66 110.819 169.29 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 67.6 t -65.29 -35.56 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 119.16 0.891 . . . . 8.1199999999999992 109.198 -175.496 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -65.15 -37.59 87.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 114.857 1.429 . . . . 15.470000000000001 114.857 168.889 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.274 . . -70.0 -33.02 71.5 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.299 2.703 . . . . 11.449999999999999 118.299 172.469 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -65.93 -33.04 74.9 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.358 -3.964 . . . . 24.98 110.775 173.729 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.5 mt -65.98 -44.87 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 117.051 -3.53 . . . . 9.4600000000000009 108.386 167.122 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -59.76 -38.65 82.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.959 1.709 . . . . 14.76 112.344 176.099 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -72.99 -46.87 49.79 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 121.304 -0.872 . . . . 26.289999999999999 110.871 179.316 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -77.01 -57.78 3.65 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 116.498 -2.081 . . . . 30.059999999999999 113.059 -173.362 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -91.5 -52.14 4.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 122.908 1.337 . . . . 25.190000000000001 109.267 -167.934 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.22 30.02 3.05 Favored Glycine 0 N--CA 1.43 -1.708 1 C-N-CA 132.061 4.648 . . . . 7.4100000000000001 115.037 173.534 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.5 mt -81.34 135.15 50.64 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 119.068 -2.431 . . . . 9.4900000000000002 106.055 175.071 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -68.88 137.67 38.71 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-O 114.203 -2.499 . . . . 11.42 116.354 177.819 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.39 -12.14 22.81 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 C-N-CA 124.158 3.239 . . . . 12.0 113.933 -175.532 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -74.56 -26.82 60.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.583 1.992 . . . . 35.549999999999997 113.826 167.655 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.2 mm-40 -95.37 3.81 54.01 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 128.008 2.523 . . . . 20.52 113.138 178.25 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' HG2' HD11 ' A' ' 69' ' ' LEU . 72.8 mt-30 -99.06 133.66 43.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.264 -2.148 . . . . 7.1299999999999999 114.751 178.201 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -113.4 121.0 43.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.187 2.595 . . . . 36.390000000000001 109.947 158.63 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.1 mt -100.67 140.85 34.36 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 118.269 -2.77 . . . . 9.5500000000000007 109.829 174.945 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mt -141.73 138.62 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 105.013 -2.217 . . . . 13.9 105.013 -169.36 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -123.46 117.99 26.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.07 -1.019 . . . . 6.8600000000000003 111.027 172.871 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.299 . . 74.63 -108.01 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 104.525 -2.398 . . . . 11.15 104.525 176.002 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.34 6.18 5.63 Favored Glycine 0 N--CA 1.429 -1.773 0 O-C-N 119.031 -2.293 . . . . 13.93 113.629 168.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.283 38.3 pttt -81.12 135.52 35.8 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.671 2.1 . . . . 23.920000000000002 116.671 159.79 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -82.76 162.31 21.77 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.462 -3.899 . . . . 23.23 107.908 172.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.6 mt -110.42 133.5 53.22 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 124.23 1.967 . . . . 9.1099999999999994 115.044 175.104 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -92.79 153.08 19.09 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.739 2.126 . . . . 33.439999999999998 116.739 163.856 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.23 -30.63 60.62 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 131.306 3.842 . . . . 28.370000000000001 116.819 -160.213 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.94 34.48 4.64 Favored Glycine 0 N--CA 1.43 -1.714 0 O-C-N 126.244 2.215 . . . . 15.0 117.665 177.312 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -140.2 146.86 39.25 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 118.547 1.173 . . . . 25.5 109.109 -170.874 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.448 ' O ' ' HB2' ' A' ' 59' ' ' TYR . 68.4 p -89.66 164.18 14.83 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.537 1.517 . . . . 11.949999999999999 114.537 -173.088 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 11.9 mt -55.19 -46.28 75.85 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 130.522 3.529 . . . . 10.17 110.878 166.372 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.6 m -58.53 -52.12 67.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.621 1.568 . . . . 13.59 109.717 173.481 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.93 -32.82 30.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.493 2.406 . . . . 11.699999999999999 109.965 -168.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 55' ' ' THR . 0.6 OUTLIER -61.88 -34.5 76.12 Favored 'General case' 0 N--CA 1.43 -1.45 1 N-CA-C 122.269 4.174 . . . . 12.949999999999999 122.269 161.873 . . . . . . . . 4 4 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 66.8 m-80 90.35 59.86 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.108 2.163 . . . . 25.449999999999999 109.781 177.415 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 4.8 mm -107.53 108.84 26.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.496 0 CA-C-N 113.253 -1.794 . . . . 14.6 106.621 -179.927 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.313 10.0 pt20 -83.84 176.65 8.76 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 118.108 -2.87 . . . . 33.229999999999997 117.858 -178.223 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -68.73 125.08 25.46 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 130.487 3.515 . . . . 25.969999999999999 110.533 168.574 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 64.63 39.28 6.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 130.516 3.526 . . . . 32.609999999999999 115.922 -171.216 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.8 m -78.18 165.03 24.43 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 113.308 0.855 . . . . 10.56 113.308 172.165 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.4 m -106.01 139.04 41.16 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 126.534 1.933 . . . . 5.3300000000000001 106.855 170.52 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.38 156.78 41.49 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.86 -3.025 . . . . 11.66 107.707 171.235 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -112.69 117.7 32.96 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.173 -3.455 . . . . 16.300000000000001 107.436 -175.887 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.419 HD11 ' HG2' ' A' ' 41' ' ' GLN 0.257 12.4 tp -101.37 121.39 41.83 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.524 -2.61 . . . . 9.9600000000000009 114.97 169.206 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.307 10.7 m -121.4 158.52 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 130.425 3.49 . . . . 9.7599999999999998 102.83 177.945 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 tp -64.01 139.52 58.78 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.672 -1.149 . . . . 19.57 113.881 166.641 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.343 63.2 ttt180 -76.56 127.22 32.4 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.063 2.616 . . . . 35.079999999999998 118.063 173.284 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 32.3 mt -113.4 165.44 12.45 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 122.455 2.389 . . . . 32.310000000000002 107.576 -175.796 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 mmt180 -66.24 105.23 1.36 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.527 1.531 . . . . 42.75 113.096 168.272 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.59 87.4 0.06 OUTLIER Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 113.881 -1.509 . . . . 36.310000000000002 113.753 -178.576 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.758 0 O-C-N 125.077 1.104 . . . . 36.270000000000003 111.988 -166.401 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.491 -1.32 0 CA-C-O 118.34 -0.838 . . . . 17.170000000000002 112.882 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.09 150.07 23.62 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.537 -3.852 . . . . 21.890000000000001 109.156 177.202 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.282 32.0 pt -131.45 159.03 43.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 128.59 2.756 . . . . 10.83 109.815 169.345 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -110.95 141.87 43.81 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.696 -1.965 . . . . 10.609999999999999 105.696 173.41 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 HD11 ' A' ' 30' ' ' ILE . 4.9 t -108.47 120.02 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 120.457 1.48 . . . . 9.1300000000000008 108.851 161.205 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -103.03 125.18 49.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.557 2.343 . . . . 20.550000000000001 110.851 -179.135 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -88.01 148.23 24.62 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.215 1.006 . . . . 11.779999999999999 112.751 177.889 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.338 14.5 tp -51.16 -40.2 58.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.659 2.384 . . . . 19.309999999999999 110.825 162.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.5 m -64.58 -50.77 65.95 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 121.105 1.775 . . . . 23.140000000000001 112.481 -179.19 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.0 19.34 0.07 OUTLIER Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 123.787 1.771 . . . . 19.739999999999998 116.675 169.351 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.9 ttmt -103.37 138.42 40.14 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.243 -3.504 . . . . 21.93 112.417 177.864 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.9 m -99.59 124.73 45.07 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.244 -2.16 . . . . 12.33 108.796 162.894 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 13' ' ' ILE . 42.8 mt -119.75 119.38 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 126.41 1.884 . . . . 17.079999999999998 110.093 -171.053 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.3 m -82.76 119.08 23.89 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.08 -3.512 . . . . 16.300000000000001 106.446 -169.047 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.6 mt -106.27 159.39 16.15 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 116.226 -4.046 . . . . 15.880000000000001 111.352 169.378 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -99.45 134.92 41.62 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 121.605 2.002 . . . . 28.899999999999999 109.5 154.735 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.69 156.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 125.416 2.532 . . . . 12.050000000000001 106.589 175.727 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.9 mm-40 -96.94 153.18 38.65 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-N 112.354 -2.203 . . . . 18.170000000000002 110.633 173.922 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -70.11 -24.16 28.37 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 127.251 3.625 . . . . 8.1600000000000001 111.319 178.997 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.7 p -81.21 -13.88 58.11 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.404 3.002 . . . . 11.130000000000001 111.49 -171.736 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -67.19 151.23 47.92 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 114.729 -4.982 . . . . 18.030000000000001 113.809 176.785 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.275 22.3 p -80.66 153.36 27.97 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 120.282 3.438 . . . . 10.220000000000001 120.282 162.973 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.3 mm -64.75 -26.61 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-O 125.772 2.701 . . . . 12.300000000000001 112.123 -179.218 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.257 20.4 tt0 -44.37 -46.63 9.48 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.855 -4.278 . . . . 36.509999999999998 116.345 162.663 . . . . . . . . 3 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -69.32 -37.82 77.92 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.012 2.925 . . . . 25.66 111.329 172.097 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.256 58.5 t -63.44 -47.36 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 119.398 0.999 . . . . 8.1199999999999992 113.167 170.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.0 mttt -49.24 -43.24 42.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.167 2.284 . . . . 15.470000000000001 117.167 168.315 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.37 -28.6 69.81 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 117.915 2.561 . . . . 11.449999999999999 117.915 173.496 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -83.32 -29.09 28.57 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 114.603 1.334 . . . . 24.98 114.603 175.304 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.426 HD11 HG21 ' A' ' 5' ' ' VAL . 69.4 mt -70.68 -36.3 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 114.837 -1.074 . . . . 9.4600000000000009 108.202 169.61 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -65.12 -37.75 88.46 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 116.547 -1.692 . . . . 14.76 115.337 171.025 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -71.16 -43.62 67.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.703 2.047 . . . . 26.289999999999999 111.334 179.619 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -70.7 -76.16 0.11 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.032 2.133 . . . . 30.059999999999999 115.347 177.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -81.44 -28.75 34.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.16 2.584 . . . . 25.190000000000001 108.974 -169.725 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.63 43.57 6.08 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 116.437 -2.313 . . . . 7.4100000000000001 113.64 -176.231 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.4 mt -105.25 121.63 45.69 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-O 115.966 -1.968 . . . . 9.4900000000000002 114.671 176.18 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -68.5 149.8 74.78 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 126.436 3.334 . . . . 11.42 115.292 -175.288 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -73.67 -18.4 22.36 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 127.075 3.562 . . . . 12.0 118.291 -168.378 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -71.06 -32.64 69.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.409 -2.682 . . . . 35.549999999999997 111.672 179.194 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.4 mm-40 -91.92 2.76 56.33 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 117.211 -1.376 . . . . 20.52 111.856 -179.693 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -89.17 119.72 29.91 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.698 3.199 . . . . 7.1299999999999999 116.164 177.619 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -138.7 119.62 14.34 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 123.865 0.866 . . . . 36.390000000000001 108.957 171.701 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -101.12 136.7 40.55 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 123.953 1.835 . . . . 9.5500000000000007 113.822 -177.557 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.1 mt -114.61 127.81 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 C-N-CA 134.338 5.055 . . . . 13.9 107.213 -179.46 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -116.32 106.04 13.21 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.56 -1.274 . . . . 6.8600000000000003 107.56 166.551 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.05 -71.97 0.07 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 116.364 1.987 . . . . 11.15 116.364 -170.298 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.32 -14.0 0.97 Allowed Glycine 0 N--CA 1.429 -1.79 0 C-N-CA 128.571 2.986 . . . . 13.93 116.33 174.458 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -101.74 144.63 30.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.019 2.91 . . . . 23.920000000000002 111.028 -167.382 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.265 15.2 pt20 -65.49 123.12 18.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.744 2.818 . . . . 23.23 113.539 167.067 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.9 mt -94.42 139.32 31.28 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 101.325 -3.583 . . . . 9.1099999999999994 101.325 -174.853 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -83.88 176.61 8.77 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.328 2.251 . . . . 33.439999999999998 111.213 168.241 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.31 -53.41 3.78 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.36 -2.712 . . . . 28.370000000000001 112.619 -172.251 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 53.05 4.82 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 118.035 -2.915 . . . . 15.0 119.118 175.222 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -132.03 139.3 48.53 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 119.44 1.62 . . . . 25.5 110.123 166.951 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.286 56.9 p -75.33 150.77 38.36 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.757 -1.839 . . . . 11.949999999999999 112.977 -172.098 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 98.1 mt -51.44 -33.41 30.63 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 128.289 2.636 . . . . 10.17 114.601 165.443 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.309 22.7 t -59.9 -50.05 75.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.479 3.511 . . . . 13.59 110.216 168.328 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -86.1 -32.63 21.24 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.363 -2.088 . . . . 11.699999999999999 105.363 -163.618 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -60.16 -25.42 65.52 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.172 -2.83 . . . . 12.949999999999999 113.341 167.093 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.8 m-80 68.65 54.56 0.5 Allowed 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 131.679 3.992 . . . . 25.449999999999999 113.027 -179.058 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.0 mm -90.03 131.39 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 105.596 -2.001 . . . . 14.6 105.596 174.307 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -108.01 -171.66 1.91 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 114.579 1.326 . . . . 33.229999999999997 114.579 178.099 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -76.83 134.82 38.94 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.009 2.596 . . . . 25.969999999999999 118.009 -174.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 53.12 45.43 28.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 116.937 2.199 . . . . 32.609999999999999 116.937 -166.835 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.357 49.3 m -94.85 139.59 31.09 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 100.303 -3.962 . . . . 10.56 100.303 -175.356 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.2 m -98.83 122.47 42.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.092 0.86 . . . . 5.3300000000000001 108.952 179.465 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mp -98.03 147.39 24.57 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 120.576 -1.327 . . . . 11.66 111.393 167.118 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.9 t60 -103.92 127.43 51.45 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.243 -3.41 . . . . 16.300000000000001 119.215 172.366 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 24.5 tp -90.09 132.54 35.36 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.402 -2.061 . . . . 9.9600000000000009 113.883 175.163 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.28 -176.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 125.383 1.473 . . . . 9.7599999999999998 109.437 168.418 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.3 tp -86.73 135.18 33.47 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 116.402 -3.936 . . . . 19.57 110.986 175.403 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -89.64 116.19 27.58 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 125.206 1.566 . . . . 35.079999999999998 109.55 172.076 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.9 mt -97.57 167.16 11.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 103.592 -2.744 . . . . 32.310000000000002 103.592 -174.693 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -87.29 131.27 34.3 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.079 -1.638 . . . . 42.75 110.209 -178.542 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.62 -37.94 1.02 Allowed Glycine 0 N--CA 1.431 -1.661 1 O-C-N 129.191 4.057 . . . . 36.310000000000002 107.729 -174.26 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.738 0 C-N-CA 124.715 1.15 . . . . 36.270000000000003 115.142 176.096 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 118.551 2.797 . . . . 17.170000000000002 118.551 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -93.3 113.15 25.27 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 101.864 -3.384 . . . . 21.890000000000001 101.864 178.467 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -120.1 149.74 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 104.331 -2.47 . . . . 10.83 104.331 170.936 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -107.05 121.28 44.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.189 1.471 . . . . 10.609999999999999 109.629 -172.103 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.2 t -100.12 117.46 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 1 O-C-N 115.15 -4.719 . . . . 9.1300000000000008 102.129 175.312 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -100.56 123.95 45.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.654 -2.529 . . . . 20.550000000000001 111.127 176.902 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.4 p -86.5 -176.54 5.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.422 -2.674 . . . . 11.779999999999999 109.28 -174.12 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 tp -70.55 -50.08 41.24 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.225 2.21 . . . . 19.309999999999999 110.075 178.633 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.4 p -72.93 -29.57 63.21 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.261 -1.755 . . . . 23.140000000000001 106.261 -178.065 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.2 54.03 0.31 Allowed Glycine 0 N--CA 1.43 -1.753 0 O-C-N 118.692 -2.505 . . . . 19.739999999999998 107.67 162.626 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -107.54 135.7 48.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.536 2.112 . . . . 21.93 109.608 171.473 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -96.42 109.61 22.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.629 -1.919 . . . . 12.33 106.046 -173.803 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 mt -102.22 96.26 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 126.424 3.011 . . . . 17.079999999999998 105.512 178.816 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 63.9 m -88.83 117.43 27.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.345 -3.347 . . . . 16.300000000000001 108.989 -172.969 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 mt -109.71 137.49 47.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.903 -2.373 . . . . 15.880000000000001 112.259 -167.549 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -106.66 101.44 10.89 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.696 -1.878 . . . . 28.899999999999999 109.47 177.311 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -129.26 163.01 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 118.802 -2.436 . . . . 12.050000000000001 109.396 -175.318 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -85.55 164.9 38.31 Favored Pre-proline 0 N--CA 1.43 -1.461 0 O-C-N 118.44 -2.663 . . . . 18.170000000000002 109.493 173.4 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.82 -4.45 3.33 Favored 'Trans proline' 0 N--CA 1.433 -2.044 0 C-N-CA 123.223 2.616 . . . . 8.1600000000000001 111.573 -174.463 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.5 p -87.85 -6.45 58.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.006 2.923 . . . . 11.130000000000001 111.838 175.665 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.48 159.03 18.15 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.273 -3.392 . . . . 18.030000000000001 114.443 -179.323 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.2 p -90.44 165.67 13.69 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.394 1.569 . . . . 10.220000000000001 111.985 -173.964 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.6 mm -69.17 -20.42 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-O 127.415 3.483 . . . . 12.300000000000001 113.636 171.905 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -66.11 -43.34 87.47 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.047 -5.408 . . . . 36.509999999999998 112.759 174.037 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.2 m-20 -70.93 -32.53 69.47 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.061 -1.447 . . . . 25.66 113.717 178.362 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 65.2 t -61.08 -38.61 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 131.231 3.813 . . . . 8.1199999999999992 111.927 169.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -67.01 -42.44 84.95 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.742 -1.599 . . . . 15.470000000000001 114.43 165.401 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.02 -37.28 74.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 117.56 2.429 . . . . 11.449999999999999 117.56 172.098 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.281 57.5 mmtt -46.26 -35.91 5.69 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 126.073 2.844 . . . . 24.98 117.712 165.398 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.2 mt -93.95 -34.47 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 117.776 -3.077 . . . . 9.4600000000000009 111.429 -172.695 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.0 -48.01 81.29 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 123.76 0.824 . . . . 14.76 111.961 160.842 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.279 12.5 t70 -53.52 -57.76 9.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 124.149 1.928 . . . . 26.289999999999999 114.246 169.942 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.8 tptp -81.16 -51.64 8.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.659 -1.275 . . . . 30.059999999999999 112.364 -170.506 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -96.43 -42.09 8.28 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 116.814 -3.679 . . . . 25.190000000000001 101.791 -163.257 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.88 42.9 3.7 Favored Glycine 0 N--CA 1.43 -1.744 1 O-C-N 115.935 -4.228 . . . . 7.4100000000000001 115.852 -170.502 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 90.6 mt -111.12 120.36 43.39 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 113.393 -3.194 . . . . 9.4900000000000002 107.94 177.077 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -66.96 148.89 82.72 Favored 'Trans proline' 0 N--CA 1.434 -1.975 0 CA-C-N 125.778 3.099 . . . . 11.42 114.425 -178.093 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -74.05 -18.86 20.92 Favored 'Trans proline' 0 C--N 1.3 -2.023 0 CA-C-N 123.645 2.338 . . . . 12.0 117.868 -161.815 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -60.63 -18.86 55.94 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.815 2.524 . . . . 35.549999999999997 117.815 173.962 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -97.33 -12.57 22.68 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 127.03 2.132 . . . . 20.52 114.002 -175.139 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -98.91 141.07 32.16 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 119.48 -2.013 . . . . 7.1299999999999999 111.713 -169.356 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -143.73 108.1 4.81 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 114.015 -2.897 . . . . 36.390000000000001 107.472 -177.89 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.9 mt -91.78 144.96 24.96 Favored 'General case' 0 N--CA 1.43 -1.426 1 CA-C-N 126.2 4.091 . . . . 9.5500000000000007 112.837 -175.67 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.5 mt -128.24 138.84 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.628 1.971 . . . . 13.9 109.886 -176.935 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.408 ' HB2' HD11 ' A' ' 50' ' ' LEU . 70.3 t80 -122.19 112.74 18.55 Favored 'General case' 0 N--CA 1.429 -1.487 1 O-C-N 115.082 -4.761 . . . . 6.8600000000000003 100.446 175.055 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.34 -74.96 0.07 Allowed 'General case' 0 N--CA 1.431 -1.41 1 CA-C-O 111.436 -4.126 . . . . 11.15 113.967 177.758 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -158.76 21.62 0.32 Allowed Glycine 0 N--CA 1.43 -1.729 1 O-C-N 130.178 4.674 . . . . 13.93 114.342 167.685 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -115.45 131.03 57.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 106.396 -1.705 . . . . 23.920000000000002 106.396 174.955 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -71.48 147.51 47.72 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.327 1.421 . . . . 23.23 114.593 173.924 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.408 HD11 ' HB2' ' A' ' 45' ' ' PHE . 21.3 mt -101.13 109.16 21.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.376 1.87 . . . . 9.1099999999999994 112.821 170.95 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -95.77 142.84 27.57 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 113.493 0.923 . . . . 33.439999999999998 113.493 179.186 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -22.01 -68.05 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.433 1 C-N-CA 134.421 5.088 . . . . 28.370000000000001 118.893 179.255 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.69 62.58 4.58 Favored Glycine 0 N--CA 1.43 -1.723 0 CA-C-N 122.54 2.427 . . . . 15.0 115.676 -174.778 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -160.91 156.59 25.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.525 -2.162 . . . . 25.5 107.834 164.156 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.316 82.8 p -82.08 150.82 27.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.39 -3.319 . . . . 11.949999999999999 114.355 -172.56 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.3 mt -65.51 -46.21 80.55 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.799 -1.188 . . . . 10.17 112.882 -173.002 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.1 t -58.11 -43.64 87.3 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 124.279 0.987 . . . . 13.59 111.829 171.075 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -69.01 -17.11 63.87 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.714 -3.741 . . . . 11.699999999999999 111.186 -172.899 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -84.49 -17.75 38.04 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.929 2.892 . . . . 12.949999999999999 114.956 169.523 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.354 16.5 m120 87.61 39.02 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 129.311 3.045 . . . . 25.449999999999999 112.267 177.437 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -107.9 105.97 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 124.59 2.138 . . . . 14.6 105.932 -172.717 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.51 -162.96 0.83 Allowed 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 116.127 -4.108 . . . . 33.229999999999997 112.288 -174.861 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.252 37.9 tttp -64.37 120.93 13.16 Favored 'General case' 0 N--CA 1.431 -1.424 2 O-C-N 114.976 -4.827 . . . . 25.969999999999999 112.39 -173.741 . . . . . . . . 3 2 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.338 20.6 mt-10 65.23 51.79 1.56 Allowed 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.494 1.918 . . . . 32.609999999999999 108.857 -174.143 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.285 63.0 m -95.45 155.44 16.74 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 121.766 2.076 . . . . 10.56 107.75 168.948 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.4 m -119.68 128.94 54.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 126.092 2.12 . . . . 5.3300000000000001 106.388 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.3 mt -113.44 116.36 29.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.27 1.828 . . . . 11.66 111.519 -177.41 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -93.17 125.13 37.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.489 2.404 . . . . 16.300000000000001 113.103 -175.829 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -101.33 123.58 45.65 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.804 2.042 . . . . 9.9600000000000009 111.062 -169.842 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -121.23 -178.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 126.15 2.881 . . . . 9.7599999999999998 112.747 173.76 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.7 tp -92.15 124.18 36.04 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 116.539 -3.851 . . . . 19.57 119.369 175.863 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -75.84 110.23 10.11 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 129.248 3.019 . . . . 35.079999999999998 114.217 175.298 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.272 40.3 mt -96.92 174.18 6.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 104.573 -2.38 . . . . 32.310000000000002 104.573 -174.444 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 87.5 mtt180 -92.03 46.48 1.27 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.707 -1.87 . . . . 42.75 112.686 -179.443 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.43 66.23 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.732 0 O-C-N 119.121 -2.237 . . . . 36.310000000000002 116.466 178.489 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.752 0 C-N-CA 126.606 2.051 . . . . 36.270000000000003 112.825 177.032 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' HA ' ' A' ' 16' ' ' GLU . 10.8 ptt? . . . . . 0 CA--C 1.49 -1.355 0 N-CA-C 113.433 0.901 . . . . 17.170000000000002 113.433 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -94.92 125.52 39.64 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 113.826 1.047 . . . . 21.890000000000001 113.826 178.963 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -124.3 162.88 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 C-N-CA 125.148 1.379 . . . . 10.83 112.627 167.76 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -118.62 139.81 50.9 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 117.82 -3.05 . . . . 10.609999999999999 107.178 176.393 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.4 t -120.66 118.7 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.381 1.873 . . . . 9.1300000000000008 106.152 172.086 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -116.93 143.6 45.52 Favored 'General case' 0 N--CA 1.43 -1.438 1 CA-C-O 128.74 4.114 . . . . 20.550000000000001 114.07 -171.896 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.1 p -81.88 172.78 12.91 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 114.743 -4.973 . . . . 11.779999999999999 111.472 179.767 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.1 mt -71.2 -33.69 70.16 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.555 2.057 . . . . 19.309999999999999 116.555 176.787 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -72.19 -69.53 0.39 Allowed 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 113.966 1.099 . . . . 23.140000000000001 113.966 171.547 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 172.14 31.8 0.03 OUTLIER Glycine 0 N--CA 1.429 -1.787 0 C-N-CA 118.319 -1.896 . . . . 19.739999999999998 114.305 -175.797 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -106.86 121.98 45.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.162 1.458 . . . . 21.93 112.686 176.728 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.1 m -97.37 127.94 43.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.516 -1.99 . . . . 12.33 108.841 176.951 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.4 mt -101.75 116.8 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 102.437 -3.172 . . . . 17.079999999999998 102.437 172.757 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.9 m -93.38 131.73 38.28 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.913 -1.742 . . . . 16.300000000000001 109.502 173.361 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.7 mt -125.61 143.26 51.1 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.833 -1.792 . . . . 15.880000000000001 109.427 -179.59 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 1' ' ' MET . 42.9 mt-10 -99.13 77.71 2.18 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.546 3.138 . . . . 28.899999999999999 116.342 165.183 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -104.83 147.72 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 126.72 3.152 . . . . 12.050000000000001 106.987 -177.995 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.1 mm-40 -83.82 149.1 55.96 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 117.748 -3.095 . . . . 18.170000000000002 108.712 178.391 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -88.42 -6.29 6.17 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 127.172 3.597 . . . . 8.1600000000000001 109.543 -157.38 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.7 m -84.6 -14.06 49.84 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.624 3.106 . . . . 11.130000000000001 114.49 -179.492 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -80.12 163.67 23.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.859 2.54 . . . . 18.030000000000001 117.859 -167.982 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.322 22.1 p -79.34 158.19 27.51 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.618 2.367 . . . . 10.220000000000001 111.621 -172.16 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.67 -36.44 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 114.224 -1.353 . . . . 12.300000000000001 107.772 178.631 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -45.16 -45.84 11.67 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 117.504 2.409 . . . . 36.509999999999998 117.504 160.01 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -78.23 -14.32 59.49 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.808 -4.307 . . . . 25.66 116.163 173.472 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.6 t -62.8 -48.94 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-O 124.607 2.146 . . . . 8.1199999999999992 112.377 162.334 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -63.7 -32.45 73.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 126.107 2.86 . . . . 15.470000000000001 112.04 178.287 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.54 -13.27 61.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.863 -2.398 . . . . 11.449999999999999 117.472 -177.007 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.7 mttp -79.1 -36.43 40.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.324 2.265 . . . . 24.98 115.13 166.33 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.9 mt -69.72 -26.26 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 121.149 -0.969 . . . . 9.4600000000000009 113.405 176.162 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -65.48 -39.83 92.4 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 112.437 -2.165 . . . . 14.76 110.539 173.366 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -70.93 -46.26 62.78 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.85 2.167 . . . . 26.289999999999999 116.85 171.394 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -76.73 -67.2 0.72 Allowed 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 119.09 -2.256 . . . . 30.059999999999999 108.918 -171.536 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -94.17 -20.5 19.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 123.839 3.018 . . . . 25.190000000000001 107.14 -164.363 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.42 34.83 9.99 Favored Glycine 0 N--CA 1.429 -1.818 0 C-N-CA 126.753 2.121 . . . . 7.4100000000000001 114.445 173.867 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 38.2 mt -110.91 130.62 22.75 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 118.342 -2.858 . . . . 9.4900000000000002 104.181 -169.206 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -85.15 153.26 10.94 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 112.509 -4.528 . . . . 11.42 114.485 -167.418 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -71.05 -14.48 32.05 Favored 'Trans proline' 0 N--CA 1.433 -2.045 1 C-N-CA 125.308 4.005 . . . . 12.0 113.444 -162.56 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.69 -39.12 73.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 113.442 0.904 . . . . 35.549999999999997 113.442 168.851 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -77.97 -26.32 48.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.79 2.885 . . . . 20.52 118.79 175.171 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -72.15 118.95 15.67 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.739 1.216 . . . . 7.1299999999999999 111.502 -177.261 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.3 ttm180 -102.97 121.43 42.52 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.455 -3.278 . . . . 36.390000000000001 105.807 169.532 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.8 mt -106.11 123.06 47.41 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 130.674 3.59 . . . . 9.5500000000000007 115.24 170.02 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -123.21 110.31 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 128.954 2.902 . . . . 13.9 114.893 -174.646 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -94.8 117.88 30.86 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 107.222 -1.399 . . . . 6.8600000000000003 107.222 169.977 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.36 -84.3 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.42 1 C-N-CA 132.35 4.26 . . . . 11.15 110.507 -169.704 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.44 31.05 1.28 Allowed Glycine 0 N--CA 1.43 -1.764 0 CA-C-O 124.078 1.932 . . . . 13.93 112.239 169.952 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.8 mttp -99.13 142.11 31.03 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.968 -3.078 . . . . 23.920000000000002 109.539 174.706 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -88.08 108.74 19.39 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 116.577 2.066 . . . . 23.23 116.577 173.405 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.339 85.4 mt -71.47 118.26 14.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 118.078 -2.889 . . . . 9.1099999999999994 116.907 -162.171 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -74.31 114.94 13.25 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.72 2.408 . . . . 33.439999999999998 109.271 178.423 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.32 -33.93 76.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 126.405 1.882 . . . . 28.370000000000001 114.472 -162.895 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.05 15.49 60.85 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 127.031 2.253 . . . . 15.0 113.37 -175.849 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 88.3 mtt180 -99.25 171.02 8.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 126.693 3.139 . . . . 25.5 108.961 160.928 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.9 p -102.72 -178.92 3.82 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.105 -4.122 . . . . 11.949999999999999 114.231 174.805 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 66.1 mt -80.64 -17.7 50.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.937 -2.977 . . . . 10.17 110.073 178.989 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.3 t -69.48 -42.36 74.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.065 -2.272 . . . . 13.59 109.672 177.319 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -54.68 -45.22 73.89 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.87 2.468 . . . . 11.699999999999999 114.412 178.849 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -92.58 0.6 57.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.756 -2.465 . . . . 12.949999999999999 109.48 -174.616 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 50.27 51.23 17.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 130.973 3.709 . . . . 25.449999999999999 112.134 -171.177 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mt -98.38 114.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 120.418 1.463 . . . . 14.6 107.722 179.429 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -99.54 -173.14 2.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.391 3.076 . . . . 33.229999999999997 110.785 -169.424 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -70.05 147.39 50.09 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.601 1.191 . . . . 25.969999999999999 109.892 -174.182 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.377 86.7 mt-10 70.89 16.41 6.58 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.187 1.795 . . . . 32.609999999999999 113.668 174.047 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.16 136.75 34.33 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 116.631 -1.652 . . . . 10.56 111.657 179.23 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.2 m -92.81 130.48 38.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 115.373 -2.251 . . . . 5.3300000000000001 110.655 -178.358 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -104.97 172.07 6.98 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.806 2.443 . . . . 11.66 110.628 166.941 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -111.99 145.16 40.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.799 2.714 . . . . 16.300000000000001 111.421 171.842 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.1 tp -120.11 132.97 55.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.435 -3.916 . . . . 9.9600000000000009 109.069 176.12 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.0 t -144.56 131.03 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 125.905 1.682 . . . . 9.7599999999999998 108.993 -172.87 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.6 mt -73.17 116.31 13.55 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.815 -1.803 . . . . 19.57 109.002 166.878 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -90.84 168.9 11.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 115.155 -2.355 . . . . 35.079999999999998 111.414 177.956 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.3 mt -94.9 151.42 19.22 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.678 2.486 . . . . 32.310000000000002 107.031 159.975 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.256 67.2 mtp180 -108.51 162.13 14.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.466 2.555 . . . . 42.75 110.382 179.599 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.36 62.48 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 106.275 -2.73 . . . . 36.310000000000002 106.275 -175.261 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.751 0 C-N-CA 116.807 -2.616 . . . . 36.270000000000003 110.685 169.061 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 125.768 2.699 . . . . 17.170000000000002 113.851 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -114.54 137.32 52.01 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 112.983 -6.073 . . . . 21.890000000000001 110.738 -177.7 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.591 HD12 HD13 ' A' ' 67' ' ' LEU . 37.3 pt -129.07 178.21 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 O-C-N 118.018 -2.926 . . . . 10.83 109.239 164.942 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -125.55 137.86 53.94 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.299 2.952 . . . . 10.609999999999999 107.91 -179.66 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.27 116.11 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 105.054 -2.202 . . . . 9.1300000000000008 105.054 167.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -102.97 126.31 50.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 127.079 2.152 . . . . 20.550000000000001 113.911 176.372 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.526 15.7 p -67.99 175.15 3.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.312 1.845 . . . . 11.779999999999999 115.43 -178.201 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.8 mt -74.44 -45.57 45.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.276 -2.765 . . . . 19.309999999999999 114.306 177.053 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -63.85 -56.31 16.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.768 2.699 . . . . 23.140000000000001 117.065 175.56 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.05 54.21 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 117.963 -2.065 . . . . 19.739999999999998 115.352 172.854 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -114.08 140.8 48.18 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.426 -1.75 . . . . 21.93 110.806 165.005 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -103.67 129.91 51.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.032 2.708 . . . . 12.33 110.092 165.69 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -96.73 104.93 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 128.335 2.654 . . . . 17.079999999999998 106.223 169.431 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.2 m -79.97 114.91 19.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 120.48 1.491 . . . . 16.300000000000001 114.7 170.783 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 15' ' ' LEU . 18.0 tp -121.78 133.21 54.91 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 113.647 -1.615 . . . . 15.880000000000001 113.547 -166.623 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -90.94 112.86 24.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.345 1.858 . . . . 28.899999999999999 114.612 -175.602 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.8 m -128.59 178.84 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.121 -2.862 . . . . 12.050000000000001 107.318 -168.968 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -123.94 168.14 13.5 Favored Pre-proline 0 N--CA 1.431 -1.416 0 CA-C-O 114.598 -2.62 . . . . 18.170000000000002 104.549 168.654 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.73 -14.89 43.12 Favored 'Trans proline' 0 C--N 1.3 -2.01 2 CA-C-N 129.076 4.277 . . . . 8.1600000000000001 108.853 173.311 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.6 m -93.05 -3.56 54.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.782 2.083 . . . . 11.130000000000001 115.084 -169.725 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -72.68 141.86 48.25 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 125.354 1.462 . . . . 18.030000000000001 108.759 -179.909 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -86.93 160.66 18.61 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.264 2.626 . . . . 10.220000000000001 104.525 178.722 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.592 HD12 HD13 ' A' ' 50' ' ' LEU . 24.8 mm -69.29 -30.06 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-O 122.593 1.187 . . . . 12.300000000000001 112.849 177.675 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -65.94 -41.83 90.81 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.52 2.728 . . . . 36.509999999999998 110.532 177.539 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -66.52 -43.28 85.66 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.712 -1.959 . . . . 25.66 105.712 -179.918 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 t -62.79 -45.77 98.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 125.876 1.67 . . . . 8.1199999999999992 114.004 -178.051 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -57.6 -33.19 67.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.622 2.153 . . . . 15.470000000000001 113.09 172.532 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.46 -26.89 60.32 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 115.674 1.731 . . . . 11.449999999999999 115.674 179.355 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.315 52.6 mttp -75.07 -31.74 61.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 115.84 -2.344 . . . . 24.98 112.277 171.944 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.1 mt -63.71 -34.51 68.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 124.898 2.285 . . . . 9.4600000000000009 116.554 175.326 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -62.19 -41.81 98.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.135 -1.848 . . . . 14.76 113.419 165.592 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -72.49 -48.3 41.79 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.087 -1.633 . . . . 26.289999999999999 112.969 -179.263 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -60.83 -66.82 0.47 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.121 -2.237 . . . . 30.059999999999999 114.022 174.146 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -87.37 -26.69 23.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.809 -3.057 . . . . 25.190000000000001 111.243 -162.499 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.29 11.35 48.86 Favored Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 119.341 -1.409 . . . . 7.4100000000000001 114.086 -178.672 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.2 mt -80.79 130.7 62.92 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 117.461 -3.376 . . . . 9.4900000000000002 111.596 -168.421 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_exo -74.02 147.75 39.04 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 128.126 3.938 . . . . 11.42 113.066 -167.383 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -73.48 -16.59 24.27 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 CA-C-N 122.903 2.073 . . . . 12.0 113.4 -174.935 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -66.63 -30.53 70.82 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.622 -3.799 . . . . 35.549999999999997 118.285 163.647 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -75.46 -21.6 57.98 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.3 1.409 . . . . 20.52 113.392 177.819 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -83.43 114.9 21.78 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 115.947 -1.978 . . . . 7.1299999999999999 111.634 -160.58 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -119.37 108.1 14.17 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.401 2.524 . . . . 36.390000000000001 114.227 164.893 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mt -88.54 129.81 35.38 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.762 2.22 . . . . 9.5500000000000007 109.363 179.218 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.1 mt -116.83 139.71 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 119.182 -2.199 . . . . 13.9 106.027 177.052 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -126.53 112.14 15.21 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 107.013 -1.477 . . . . 6.8600000000000003 107.013 172.814 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.271 . . 81.29 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.938 1.695 . . . . 11.15 111.194 -174.537 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.12 43.39 0.23 Allowed Glycine 0 N--CA 1.43 -1.735 0 O-C-N 120.304 -1.498 . . . . 13.93 116.181 173.993 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.28 155.09 46.98 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.148 2.579 . . . . 23.920000000000002 111.42 164.58 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.262 9.3 tt0 -79.93 129.58 34.61 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.3 -2.125 . . . . 23.23 111.953 -176.727 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.592 HD13 HD12 ' A' ' 23' ' ' ILE 0.252 98.4 mt -83.71 121.51 27.38 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.685 -1.884 . . . . 9.1099999999999994 109.916 172.704 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -99.14 154.51 18.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.437 -1.69 . . . . 33.439999999999998 106.437 -168.534 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -69.09 -32.04 71.2 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.281 2.326 . . . . 28.370000000000001 117.281 -162.438 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.95 21.66 43.75 Favored Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 120.788 1.631 . . . . 15.0 112.065 -169.673 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -118.36 -179.48 3.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.369 -1.665 . . . . 25.5 113.858 164.225 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.7 p -108.91 176.27 5.16 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.897 2.76 . . . . 11.949999999999999 118.332 178.01 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.6 mt -71.03 -35.02 71.83 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 113.775 -1.557 . . . . 10.17 113.223 176.026 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.0 t -57.3 -45.93 83.69 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.668 1.987 . . . . 13.59 113.667 165.756 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -61.99 -35.33 78.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.495 2.718 . . . . 11.699999999999999 114.757 175.056 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.4 -4.19 42.26 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 114.666 -2.587 . . . . 12.949999999999999 111.976 -174.638 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.2 m120 72.79 43.4 0.43 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 123.539 2.882 . . . . 25.449999999999999 110.396 173.831 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 71.1 mt -102.99 115.62 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.383 -2.073 . . . . 14.6 111.349 179.936 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -95.82 -177.89 4.19 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.161 1.934 . . . . 33.229999999999997 111.79 175.207 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.258 21.7 ptmt -53.75 138.15 36.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 131.163 3.785 . . . . 25.969999999999999 116.686 175.747 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 71.89 24.53 3.31 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 123.118 1.437 . . . . 32.609999999999999 113.243 171.897 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -92.89 142.5 27.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.983 -1.073 . . . . 10.56 112.071 -178.774 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.6 m -101.89 97.91 8.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.244 2.618 . . . . 5.3300000000000001 112.713 -172.973 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.591 HD13 HD12 ' A' ' 3' ' ' ILE . 9.6 mp -84.48 145.55 28.07 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 126.73 2.519 . . . . 11.66 110.478 174.924 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.8 m170 -109.02 134.03 52.2 Favored 'General case' 0 N--CA 1.43 -1.425 1 O-C-N 115.646 -4.408 . . . . 16.300000000000001 100.537 -169.768 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.8 tp -104.78 125.75 51.16 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.607 1.194 . . . . 9.9600000000000009 109.729 170.979 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 94.6 t -113.79 152.3 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 126.738 3.161 . . . . 9.7599999999999998 106.329 179.947 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.1 mt -121.47 111.56 17.44 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.678 -2.514 . . . . 19.57 110.97 -179.306 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.18 161.7 18.56 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 130.115 3.366 . . . . 35.079999999999998 111.026 -172.498 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.2 mt -80.36 159.15 25.84 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.615 -4.428 . . . . 32.310000000000002 109.823 171.28 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -84.42 132.74 34.54 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.357 -3.34 . . . . 42.75 117.698 -164.3 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.5 -105.42 0.19 Allowed Glycine 0 N--CA 1.43 -1.727 0 CA-C-O 126.653 3.363 . . . . 36.310000000000002 118.29 -172.068 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.783 0 CA-C-O 114.64 -3.311 . . . . 36.270000000000003 111.23 -173.092 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 127.171 3.367 . . . . 17.170000000000002 104.451 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -93.22 123.7 36.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.234 -2.257 . . . . 21.890000000000001 105.241 177.924 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.5 pt -117.59 166.96 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 118.322 -2.736 . . . . 10.83 106.414 170.149 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -117.86 100.94 7.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.411 -3.306 . . . . 10.609999999999999 115.01 -176.049 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.8 t -102.44 105.89 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 118.89 -2.381 . . . . 9.1300000000000008 109.394 -163.265 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.5 mtpt -99.45 132.69 44.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.612 -1.176 . . . . 20.550000000000001 111.042 -172.345 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 p -98.11 -177.88 3.88 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.226 2.21 . . . . 11.779999999999999 113.194 -178.555 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.3 mt -83.6 -33.52 25.33 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 118.838 -2.414 . . . . 19.309999999999999 111.637 -164.304 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.9 p -88.49 -66.79 0.88 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.73 2.012 . . . . 23.140000000000001 112.523 -177.038 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 179.24 48.76 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.722 0 C-N-CA 117.505 -2.283 . . . . 19.739999999999998 109.665 -174.031 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 ttmt -136.07 119.37 16.74 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.012 2.339 . . . . 21.93 105.506 176.379 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.4 m -92.23 106.87 18.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.376 2.989 . . . . 12.33 111.832 163.666 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 mt -88.46 114.89 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.661 -2.063 . . . . 17.079999999999998 106.308 -179.717 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.3 m -94.18 125.14 38.64 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 109.698 -0.482 . . . . 16.300000000000001 109.698 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 tp -153.8 135.86 14.72 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.965 -2.959 . . . . 15.880000000000001 115.212 -157.232 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.9 97.32 11.11 Favored 'General case' 0 N--CA 1.43 -1.439 1 C-N-CA 132.398 4.279 . . . . 28.899999999999999 117.021 -177.287 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.0 m -113.69 150.57 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.674 2.39 . . . . 12.050000000000001 111.714 179.158 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -87.04 152.77 53.77 Favored Pre-proline 0 N--CA 1.429 -1.494 0 CA-C-O 112.867 -3.444 . . . . 18.170000000000002 109.394 176.671 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -71.99 -23.49 21.76 Favored 'Trans proline' 0 C--N 1.299 -2.033 0 CA-C-N 123.321 2.222 . . . . 8.1600000000000001 112.949 173.682 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.8 m -81.44 2.27 29.45 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.97 3.919 . . . . 11.130000000000001 113.821 168.22 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -72.05 148.48 45.78 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 124.529 3.332 . . . . 18.030000000000001 110.887 165.08 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 73.4 p -84.54 173.25 10.97 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.767 -1.833 . . . . 10.220000000000001 109.522 177.344 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.5 mm -63.43 -23.18 32.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 124.525 2.107 . . . . 12.300000000000001 112.263 168.407 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -80.88 -37.93 28.92 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.031 -4.168 . . . . 36.509999999999998 109.749 176.433 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 28' ' ' ALA 0.321 17.1 m120 -73.68 -35.12 65.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.62 -1.3 . . . . 25.66 112.26 179.773 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.604 HG21 HD11 ' A' ' 56' ' ' LEU 0.489 81.4 t -45.83 -59.96 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 129.937 3.295 . . . . 8.1199999999999992 113.619 163.106 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.9 mtmt -60.67 -30.53 69.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.177 3.391 . . . . 15.470000000000001 113.051 174.144 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.7 -42.59 88.99 Favored 'General case' 0 N--CA 1.429 -1.48 1 CA-C-O 131.011 5.196 . . . . 11.449999999999999 118.047 163.297 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -75.5 -35.97 60.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.72 -3.737 . . . . 24.98 111.764 -179.065 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mt -64.57 -41.87 93.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 125.381 1.675 . . . . 9.4600000000000009 114.53 168.46 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -50.16 -57.88 6.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.66 2.171 . . . . 14.76 115.421 174.545 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -47.81 -60.96 2.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.546 3.538 . . . . 26.289999999999999 114.627 167.962 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -65.73 -58.4 5.76 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.252 1.025 . . . . 30.059999999999999 109.975 -168.737 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -83.93 -48.81 9.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.807 2.151 . . . . 25.190000000000001 116.807 179.988 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.08 9.86 5.94 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 129.683 3.516 . . . . 7.4100000000000001 112.617 179.424 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mt -85.81 128.93 56.5 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-N 121.356 2.578 . . . . 9.4900000000000002 108.115 -162.799 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.83 153.86 29.75 Favored 'Trans proline' 0 C--N 1.3 -2.016 1 CA-C-O 109.941 -4.275 . . . . 11.42 114.439 -166.732 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -70.6 -24.1 26.22 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 124.13 3.22 . . . . 12.0 117.671 -168.881 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.475 ' HB2' ' HD2' ' A' ' 74' ' ' ARG . 12.2 p-10 -80.63 -6.68 58.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.338 3.055 . . . . 35.549999999999997 112.733 171.843 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -93.46 -36.79 12.29 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.298 -2.126 . . . . 20.52 111.412 169.565 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -72.51 144.78 47.88 Favored 'General case' 0 N--CA 1.429 -1.48 1 N-CA-C 123.509 4.633 . . . . 7.1299999999999999 123.509 179.975 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -160.74 135.41 7.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 108.776 -0.824 . . . . 36.390000000000001 108.776 175.465 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.526 HD21 HD13 ' A' ' 69' ' ' LEU . 49.7 mt -117.51 116.44 27.14 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.149 1.928 . . . . 9.5500000000000007 108.6 -170.372 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.582 HD12 HG21 ' A' ' 70' ' ' VAL . 33.9 mt -110.52 133.54 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 126.767 2.027 . . . . 13.9 111.066 175.117 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -118.37 118.95 33.17 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 102.269 -3.234 . . . . 6.8600000000000003 102.269 177.854 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.92 -62.69 0.07 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.263 3.425 . . . . 11.15 118.32 -176.551 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.99 7.89 0.79 Allowed Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 115.895 1.118 . . . . 13.93 115.895 178.684 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -153.81 154.89 34.8 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.741 2.686 . . . . 23.920000000000002 105.76 177.84 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -66.76 150.04 49.67 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 130.377 3.471 . . . . 23.23 113.648 -179.227 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.6 mt -112.61 134.47 54.12 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.481 2.312 . . . . 9.1099999999999994 105.519 -173.986 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -97.55 130.67 44.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.835 2.731 . . . . 33.439999999999998 111.248 -171.524 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -34.2 -42.95 0.14 Allowed 'General case' 0 N--CA 1.43 -1.445 1 N-CA-C 122.704 4.335 . . . . 28.370000000000001 122.704 178.365 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.95 -15.84 69.05 Favored Glycine 0 N--CA 1.43 -1.716 0 O-C-N 120.237 -1.539 . . . . 15.0 113.664 -168.485 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -87.73 147.18 25.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.36 2.664 . . . . 25.5 109.845 178.175 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 37.6 p -81.88 163.77 22.04 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.303 2.241 . . . . 11.949999999999999 110.088 173.017 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.604 HD11 HG21 ' A' ' 26' ' ' VAL . 39.2 mt -61.29 -37.31 82.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.674 1.702 . . . . 10.17 115.43 171.798 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.9 m -45.77 -46.17 15.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.36 -3.338 . . . . 13.59 118.448 161.888 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -55.98 -13.6 2.01 Favored 'General case' 0 N--CA 1.43 -1.463 2 O-C-N 114.084 -5.385 . . . . 11.699999999999999 118.058 166.044 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -121.17 -7.73 9.33 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 115.894 -2.003 . . . . 12.949999999999999 107.134 -174.352 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.4 m120 74.58 34.68 0.74 Allowed 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 135.935 5.694 . . . . 25.449999999999999 107.955 176.664 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.1 mt -82.6 106.42 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 106.42 -1.696 . . . . 14.6 106.42 -175.827 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -92.01 -175.39 4.08 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.468 2.707 . . . . 33.229999999999997 113.725 174.944 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.9 pttt -58.65 153.13 17.14 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.276 -3.39 . . . . 25.969999999999999 115.023 179.6 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 74.66 -1.16 3.16 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 125.996 2.06 . . . . 32.609999999999999 115.332 171.356 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.3 m -61.51 141.94 57.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 120.517 3.525 . . . . 10.56 120.517 178.05 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.3 m -98.63 109.76 22.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 126.085 2.116 . . . . 5.3300000000000001 107.628 -170.604 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.3 mt -110.25 141.29 43.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.173 -2.158 . . . . 11.66 105.173 -173.278 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -104.91 118.83 37.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 123.06 1.41 . . . . 16.300000000000001 109.967 -177.539 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.526 HD13 HD21 ' A' ' 43' ' ' LEU . 19.8 tp -95.55 99.24 11.14 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.814 2.446 . . . . 9.9600000000000009 108.273 176.572 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.582 HG21 HD12 ' A' ' 44' ' ' ILE . 61.7 t -87.1 110.26 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.986 3.315 . . . . 9.7599999999999998 111.06 174.124 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.77 112.94 20.96 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 103.592 -2.744 . . . . 19.57 103.592 -178.137 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -129.1 168.4 16.16 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.859 1.429 . . . . 35.079999999999998 114.859 -172.324 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.258 78.5 mt -90.52 156.18 18.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 116.408 -1.758 . . . . 32.310000000000002 111.072 173.672 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.475 ' HD2' ' HB2' ' A' ' 39' ' ' ASP . 60.4 ttt180 -82.09 109.47 16.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.528 3.018 . . . . 42.75 115.138 -171.841 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.25 -70.22 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 O-C-N 117.935 -2.978 . . . . 36.310000000000002 110.409 177.64 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.77 0 N-CA-C 105.869 -2.893 . . . . 36.270000000000003 105.869 -174.561 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ptt? . . . . . 0 CA--C 1.491 -1.317 0 N-CA-C 111.202 0.075 . . . . 17.170000000000002 111.202 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -104.44 141.48 36.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.043 -2.286 . . . . 21.890000000000001 109.741 178.158 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.2 pt -119.56 159.84 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 131.295 3.838 . . . . 10.83 108.694 170.984 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -114.58 92.06 3.83 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.094 2.158 . . . . 10.609999999999999 107.123 -175.139 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.0 t -93.74 108.61 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 119.112 -2.242 . . . . 9.1300000000000008 106.952 175.765 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -102.96 145.09 30.38 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 122.729 1.252 . . . . 20.550000000000001 113.697 -171.706 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 46.8 p -90.94 171.89 8.97 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.744 -2.074 . . . . 11.779999999999999 110.81 177.145 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.95 -51.66 68.33 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 129.116 4.01 . . . . 19.309999999999999 115.16 171.351 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.251 78.9 p -46.33 -48.98 18.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 125.274 3.67 . . . . 23.140000000000001 113.186 161.24 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.19 52.62 0.56 Allowed Glycine 0 N--CA 1.43 -1.72 1 C-N-CA 132.526 4.869 . . . . 19.739999999999998 108.909 176.138 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 tttt -84.98 132.18 34.38 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 116.618 -2.033 . . . . 21.93 106.512 161.826 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -103.65 110.06 21.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 128.342 3.925 . . . . 12.33 109.733 -178.468 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.467 HG22 ' HB2' ' A' ' 15' ' ' LEU . 61.8 mt -81.54 109.31 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 O-C-N 112.222 -6.549 . . . . 17.079999999999998 105.751 177.651 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.7 p -83.14 66.27 8.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.958 2.103 . . . . 16.300000000000001 108.532 -178.23 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.467 ' HB2' HG22 ' A' ' 13' ' ' ILE . 12.8 tp -94.29 127.12 39.95 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.764 -3.085 . . . . 15.880000000000001 116.744 -164.313 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -103.51 102.46 12.36 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 115.595 -4.44 . . . . 28.899999999999999 115.663 -163.72 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.9 m -125.0 167.96 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.734 1.255 . . . . 12.050000000000001 109.455 -172.106 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.289 27.8 mt-10 -98.15 170.6 6.84 Favored Pre-proline 0 N--CA 1.43 -1.456 0 O-C-N 118.369 -2.707 . . . . 18.170000000000002 108.898 161.568 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.15 -4.35 9.56 Favored 'Trans proline' 0 N--CA 1.433 -2.03 0 O-C-N 117.288 -2.006 . . . . 8.1600000000000001 108.673 -175.038 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.5 m -95.03 18.69 11.62 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.112 -1.44 . . . . 11.130000000000001 107.112 178.908 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -93.7 139.42 30.83 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.52 -1.987 . . . . 18.030000000000001 108.779 175.143 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 14.6 p -84.72 165.77 17.58 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 120.05 1.295 . . . . 10.220000000000001 114.198 173.809 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.463 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 43.5 mm -71.95 -27.38 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.904 2.082 . . . . 12.300000000000001 106.869 -167.346 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -58.73 -50.09 75.22 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.929 2.892 . . . . 36.509999999999998 116.848 167.354 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -69.78 -22.11 63.36 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 118.584 2.809 . . . . 25.66 118.584 169.608 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.307 21.1 t -66.0 -55.93 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 C-N-CA 132.041 4.136 . . . . 8.1199999999999992 107.522 166.791 . . . . . . . . 3 2 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 51.5 mtmt -61.88 -44.29 97.11 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 117.441 2.385 . . . . 15.470000000000001 117.441 173.059 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.57 -32.05 64.8 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.602 -2.561 . . . . 11.449999999999999 113.676 174.093 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -66.68 -38.78 87.5 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.445 3.022 . . . . 24.98 110.677 176.206 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.7 mt -70.36 -33.87 55.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.998 -2.939 . . . . 9.4600000000000009 113.877 177.963 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.291 27.3 tt0 -52.81 -49.82 64.89 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.845 3.212 . . . . 14.76 113.83 171.915 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.66 -53.44 47.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.891 2.876 . . . . 26.289999999999999 112.92 174.039 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -68.27 -76.09 0.09 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.063 2.945 . . . . 30.059999999999999 112.185 -179.224 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -62.95 -51.4 67.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 124.625 3.375 . . . . 25.190000000000001 118.356 175.041 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.01 28.92 9.46 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 120.221 -1.549 . . . . 7.4100000000000001 113.63 -174.741 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.1 mt -96.67 117.54 65.89 Favored Pre-proline 0 N--CA 1.429 -1.513 0 C-N-CA 131.537 3.935 . . . . 9.4900000000000002 105.205 177.114 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_exo -69.04 158.34 58.28 Favored 'Trans proline' 0 C--N 1.299 -2.049 0 CA-C-N 125.503 3.001 . . . . 11.42 112.45 -171.731 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -78.36 -24.12 8.11 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 C-N-CA 122.485 2.123 . . . . 12.0 112.017 -149.649 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -65.98 -17.0 64.39 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 128.294 2.638 . . . . 35.549999999999997 113.295 -173.905 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -92.61 -26.0 18.06 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.63 1.972 . . . . 20.52 115.108 -172.905 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -70.88 86.74 0.7 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 121.063 3.727 . . . . 7.1299999999999999 121.063 -179.243 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.483 ' HB3' ' HB ' ' A' ' 70' ' ' VAL . 20.6 ttt180 -79.17 112.17 16.12 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.839 -3.663 . . . . 36.390000000000001 117.439 167.146 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mp -108.16 109.44 20.84 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 116.007 -4.183 . . . . 9.5500000000000007 112.013 -173.932 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.2 mm -103.67 125.95 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 118.764 -2.46 . . . . 13.9 110.047 176.732 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -102.65 117.86 35.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 112.644 -2.071 . . . . 6.8600000000000003 106.121 166.714 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.7 -110.93 0.53 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.935 -2.353 . . . . 11.15 113.01 178.14 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.95 17.12 25.12 Favored Glycine 0 N--CA 1.429 -1.776 0 C-N-CA 118.984 -1.579 . . . . 13.93 113.498 168.187 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -119.83 139.3 52.57 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 130.27 3.428 . . . . 23.920000000000002 108.519 -161.588 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -104.71 128.03 52.66 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 103.418 -2.808 . . . . 23.23 103.418 -166.487 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -86.65 128.75 35.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.097 -2.877 . . . . 9.1099999999999994 111.749 -176.844 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.256 43.1 mt-10 -107.28 158.66 16.96 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 117.479 -1.688 . . . . 33.439999999999998 111.092 -176.716 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -58.54 -53.46 58.06 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.468 3.507 . . . . 28.370000000000001 113.956 -155.264 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.81 -2.91 71.45 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 113.548 -1.66 . . . . 15.0 111.887 -161.936 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -88.28 155.26 19.83 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 113.889 -2.958 . . . . 25.5 113.583 166.383 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 82.0 p -92.72 173.05 7.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.565 2.346 . . . . 11.949999999999999 114.198 178.923 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.3 mt -49.52 -46.0 47.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.782 2.512 . . . . 10.17 117.782 160.216 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -54.86 -46.38 74.67 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.739 2.816 . . . . 13.59 117.291 170.912 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -48.2 -63.94 0.93 Allowed 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.566 1.946 . . . . 11.699999999999999 109.56 172.438 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -73.36 3.96 5.28 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 115.215 -2.326 . . . . 12.949999999999999 116.015 179.726 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.468 66.8 t30 67.72 54.0 0.67 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 127.555 3.034 . . . . 25.449999999999999 112.42 171.114 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.71 103.47 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 127.051 2.14 . . . . 14.6 111.636 -174.647 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -68.25 168.58 12.07 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 131.224 3.81 . . . . 33.229999999999997 106.561 174.293 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.34 154.2 14.01 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 115.424 1.639 . . . . 25.969999999999999 115.424 172.293 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 56.75 41.1 28.68 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.808 2.567 . . . . 32.609999999999999 114.873 176.802 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.263 47.2 m -86.78 126.9 34.91 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.489 1.916 . . . . 10.56 108.607 173.326 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -72.52 127.15 31.68 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 117.088 -1.845 . . . . 5.3300000000000001 115.212 163.748 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mt -114.62 164.86 13.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.702 3.62 . . . . 11.66 111.851 159.627 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.1 m-70 -120.45 121.31 38.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.875 -2.639 . . . . 16.300000000000001 103.875 -172.886 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -91.47 108.74 20.1 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.247 -2.131 . . . . 9.9600000000000009 105.247 173.201 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HB ' ' HB3' ' A' ' 42' ' ' ARG . 19.3 t -96.61 144.28 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-O 126.056 2.836 . . . . 9.7599999999999998 107.224 168.931 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 71' ' ' LEU . 80.0 mt -115.8 115.78 26.87 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.514 -3.866 . . . . 19.57 111.333 -179.087 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -121.87 -178.68 3.9 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.762 -1.563 . . . . 35.079999999999998 107.296 -177.126 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 mt -107.56 171.92 7.12 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.806 2.717 . . . . 32.310000000000002 103.739 164.978 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -76.12 138.19 40.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 112.296 -2.229 . . . . 42.75 111.766 -173.5 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.6 -119.99 0.69 Allowed Glycine 0 N--CA 1.43 -1.717 0 N-CA-C 106.896 -2.482 . . . . 36.310000000000002 106.896 -179.193 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.77 1 CA-C-O 108.926 -6.486 . . . . 36.270000000000003 108.461 -165.677 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptt? . . . . . 0 CA--C 1.491 -1.323 0 CA-C-O 124.233 1.968 . . . . 17.170000000000002 108.446 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -98.47 140.8 32.17 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.011 -2.931 . . . . 21.890000000000001 109.778 176.838 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.471 HD13 HD12 ' A' ' 67' ' ' LEU . 2.2 pp -131.16 166.4 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 112.22 -2.264 . . . . 10.83 109.403 168.02 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -115.3 145.79 42.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.786 -3.071 . . . . 10.609999999999999 108.692 177.659 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -102.43 118.55 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.358 2.663 . . . . 9.1300000000000008 112.724 163.935 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.0 tptt -111.68 110.9 21.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.391 2.996 . . . . 20.550000000000001 112.488 179.271 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.8 p -76.72 171.26 15.0 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.647 -4.408 . . . . 11.779999999999999 113.102 -170.179 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.9 mt -52.8 -54.26 36.66 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.898 -1.049 . . . . 19.309999999999999 111.506 174.778 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.4 p -56.93 -31.5 65.0 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.575 2.35 . . . . 23.140000000000001 116.86 167.989 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.91 27.28 4.36 Favored Glycine 0 N--CA 1.429 -1.782 0 O-C-N 120.006 -1.684 . . . . 19.739999999999998 113.685 168.219 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -80.24 131.84 35.75 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 121.05 2.425 . . . . 21.93 105.074 175.978 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -85.42 109.5 18.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.082 2.153 . . . . 12.33 112.452 163.85 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mt -103.06 123.43 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 114.806 -1.088 . . . . 17.079999999999998 108.786 171.949 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.1 m -84.74 121.82 28.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 117.24 -1.362 . . . . 16.300000000000001 112.341 173.852 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 tp -129.91 121.17 26.11 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 125.126 1.37 . . . . 15.880000000000001 110.7 -172.959 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.0 tt0 -87.5 122.76 31.64 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.768 1.747 . . . . 28.899999999999999 108.873 173.204 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -130.44 149.68 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 129.707 3.203 . . . . 12.050000000000001 108.782 -179.491 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.2 mt-10 -87.0 149.01 46.72 Favored Pre-proline 0 N--CA 1.43 -1.426 0 C-N-CA 127.253 2.221 . . . . 18.170000000000002 106.248 166.683 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 61.4 Cg_exo -73.55 -15.03 24.8 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 115.847 -2.302 . . . . 8.1600000000000001 111.44 -173.983 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.2 m -87.73 3.65 47.21 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 116.028 -4.17 . . . . 11.130000000000001 118.02 172.831 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -77.3 150.8 35.22 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.346 -1.471 . . . . 18.030000000000001 113.092 167.654 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 24.8 p -96.01 177.67 5.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.395 1.685 . . . . 10.220000000000001 109.438 -172.729 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.48 -23.73 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 121.424 1.92 . . . . 12.300000000000001 113.344 -177.019 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -52.5 -48.51 65.94 Favored 'General case' 0 N--CA 1.431 -1.394 1 C-N-CA 133.101 4.561 . . . . 36.509999999999998 111.021 158.071 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.556 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 40.5 m-20 -72.01 -27.39 62.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 116.65 2.093 . . . . 25.66 116.65 179.661 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.4 t -73.2 -41.06 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 128.081 2.552 . . . . 8.1199999999999992 112.563 175.958 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -59.63 -31.01 69.11 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-O 117.25 -1.357 . . . . 15.470000000000001 111.886 165.085 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.556 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -71.85 -41.84 67.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.931 1.395 . . . . 11.449999999999999 109.669 -177.822 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.285 21.1 mmtp -63.38 -28.12 69.77 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 129.814 3.246 . . . . 24.98 113.059 173.96 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.7 mt -87.48 -41.71 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 1 O-C-N 113.91 -5.494 . . . . 9.4600000000000009 112.726 178.973 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -46.22 -47.14 17.94 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.847 -2.408 . . . . 14.76 114.806 159.126 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -72.31 -25.51 61.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.015 1.857 . . . . 26.289999999999999 116.015 -178.437 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -87.73 -52.81 5.11 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 116.914 2.19 . . . . 30.059999999999999 116.914 178.837 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -98.77 -25.28 14.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.085 1.354 . . . . 25.190000000000001 112.011 -168.832 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.01 17.11 28.56 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-O 118.262 -1.299 . . . . 7.4100000000000001 115.267 168.276 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.2 mt -94.77 126.5 47.05 Favored Pre-proline 0 N--CA 1.43 -1.437 0 C-N-CA 130.715 3.606 . . . . 9.4900000000000002 108.254 -168.855 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.51 139.68 54.59 Favored 'Trans proline' 0 N--CA 1.433 -2.051 0 C-N-CA 124.322 3.348 . . . . 11.42 113.349 -179.504 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.04 -2.63 12.79 Favored 'Trans proline' 0 C--N 1.3 -2.019 1 C-N-CA 126.415 4.743 . . . . 12.0 114.108 -166.538 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.273 9.5 p-10 -84.61 -31.98 23.98 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 122.678 2.49 . . . . 35.549999999999997 111.182 174.178 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -76.91 -13.17 60.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.041 2.088 . . . . 20.52 114.183 -179.274 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -88.98 121.62 31.52 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 111.504 -2.589 . . . . 7.1299999999999999 114.677 177.924 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -111.95 118.09 34.52 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 115.544 -2.169 . . . . 36.390000000000001 113.66 166.034 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.7 mt -109.93 123.48 49.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.335 1.647 . . . . 9.5500000000000007 108.142 -174.376 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.2 mm -114.14 127.09 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 126.946 2.098 . . . . 13.9 106.731 -174.813 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -103.77 114.11 28.12 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 106.58 -1.637 . . . . 6.8600000000000003 106.58 169.061 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.01 -96.98 0.05 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.92 2.488 . . . . 11.15 110.338 178.115 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.82 -7.71 17.07 Favored Glycine 0 N--CA 1.43 -1.716 0 C-N-CA 125.37 1.462 . . . . 13.93 115.781 173.865 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.1 mtpt -90.89 130.62 36.82 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 128.426 3.965 . . . . 23.920000000000002 108.429 -171.131 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -98.52 157.96 15.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 111.285 -2.689 . . . . 23.23 104.812 166.947 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.3 mt -122.01 166.48 14.42 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.619 -1.628 . . . . 9.1099999999999994 111.533 -155.9 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -101.27 176.94 5.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 107.141 -1.429 . . . . 33.439999999999998 107.141 166.569 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -102.44 -53.14 2.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.372 1.469 . . . . 28.370000000000001 111.043 -168.135 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.04 16.38 7.23 Favored Glycine 0 N--CA 1.431 -1.685 0 N-CA-C 118.791 2.276 . . . . 15.0 118.791 -170.139 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -116.62 153.55 32.08 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.514 1.925 . . . . 25.5 110.938 -173.142 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 20.3 p -88.57 170.67 10.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 113.851 1.056 . . . . 11.949999999999999 113.851 -173.328 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.1 mt -66.52 -31.25 71.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 123.774 1.749 . . . . 10.17 108.418 177.69 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.6 t -70.48 -43.2 70.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.101 1.76 . . . . 13.59 111.78 -175.928 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -59.39 -28.11 66.6 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 128.467 3.984 . . . . 11.699999999999999 118.24 176.884 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -82.06 -27.11 33.15 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 113.558 -5.714 . . . . 12.949999999999999 121.078 169.784 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 t30 71.95 48.66 0.27 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 125.508 2.575 . . . . 25.449999999999999 117.372 -157.503 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mt -94.75 99.66 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 118.452 -2.655 . . . . 14.6 104.995 174.35 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.45 -175.73 2.94 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.701 -1.874 . . . . 33.229999999999997 107.134 -165.121 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.305 20.3 pttm -67.13 148.38 51.91 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 120.295 1.407 . . . . 25.969999999999999 112.247 -178.396 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 76.57 7.22 3.36 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.557 2.343 . . . . 32.609999999999999 114.451 178.962 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 t -63.96 140.68 58.89 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.689 1.366 . . . . 10.56 114.689 -177.488 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.9 m -93.9 104.21 16.29 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.517 -3.239 . . . . 5.3300000000000001 113.117 170.949 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.471 HD12 HD13 ' A' ' 3' ' ' ILE . 35.7 mt -84.45 128.18 34.44 Favored 'General case' 0 N--CA 1.429 -1.488 1 O-C-N 114.531 -5.106 . . . . 11.66 110.131 169.718 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.9 m80 -106.22 125.27 50.79 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.374 -2.079 . . . . 16.300000000000001 111.668 -172.183 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.25 12.1 tp -92.22 134.16 35.14 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.764 -1.569 . . . . 9.9600000000000009 106.764 -177.961 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.1 t -116.31 112.04 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 126.709 3.147 . . . . 9.7599999999999998 109.153 162.407 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.0 tp -97.57 112.68 24.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.811 -2.431 . . . . 19.57 114.022 -167.382 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -156.27 -161.58 1.15 Allowed 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.408 -2.683 . . . . 35.079999999999998 106.013 -158.548 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.3 mt -110.69 166.05 11.33 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 114.892 -4.88 . . . . 32.310000000000002 110.582 171.296 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.3 ttt180 -57.79 131.95 51.87 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 117.123 2.268 . . . . 42.75 117.123 -176.603 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.38 -114.29 1.38 Allowed Glycine 0 N--CA 1.43 -1.753 0 CA-C-O 125.982 2.99 . . . . 36.310000000000002 107.453 -173.385 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.729 0 CA-C-N 111.195 -2.503 . . . . 36.270000000000003 113.022 -179.981 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 123.624 1.678 . . . . 17.170000000000002 112.04 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -101.79 131.09 48.3 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 115.583 -4.448 . . . . 21.890000000000001 109.057 -171.584 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -116.81 156.78 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.469 -3.269 . . . . 10.83 105.089 162.686 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -120.28 126.32 50.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 125.94 2.781 . . . . 10.609999999999999 108.629 -178.513 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -112.49 105.86 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 O-C-N 119.17 -2.206 . . . . 9.1300000000000008 112.826 -179.32 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -92.42 151.12 20.4 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.56 -1.338 . . . . 20.550000000000001 112.289 -176.264 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.4 p -104.18 -166.57 1.26 Allowed 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.098 1.759 . . . . 11.779999999999999 113.383 -178.003 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.35 -62.48 1.38 Allowed 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 115.57 -2.157 . . . . 19.309999999999999 114.1 172.23 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.2 p -63.19 -35.14 79.33 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.319 2.647 . . . . 23.140000000000001 111.576 177.898 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.49 53.87 0.67 Allowed Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 127.029 3.572 . . . . 19.739999999999998 111.769 167.209 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -89.44 139.58 30.37 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.563 -4.492 . . . . 21.93 102.121 162.216 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.1 m -83.48 110.68 18.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 115.813 -2.042 . . . . 12.33 113.457 161.399 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.0 mt -88.04 123.99 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 126.197 2.185 . . . . 17.079999999999998 107.238 169.858 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.7 m -94.45 115.43 27.61 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 107.751 -1.203 . . . . 16.300000000000001 107.751 177.883 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.0 mt -109.37 134.42 51.85 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.592 -3.817 . . . . 15.880000000000001 115.71 168.782 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.69 109.12 20.93 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 105.599 -2.0 . . . . 28.899999999999999 105.599 175.217 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -121.6 152.06 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 C-N-CA 133.583 4.753 . . . . 12.050000000000001 112.388 -177.015 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -90.4 146.25 34.16 Favored Pre-proline 0 N--CA 1.429 -1.495 0 O-C-N 117.805 -3.059 . . . . 18.170000000000002 108.288 164.546 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -62.3 -18.4 62.4 Favored 'Trans proline' 0 C--N 1.299 -2.06 1 C-N-CA 128.245 5.964 . . . . 8.1600000000000001 111.788 172.758 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 56.7 p -83.9 -7.42 59.44 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.791 1.636 . . . . 11.130000000000001 110.113 174.607 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -81.01 165.88 21.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.078 2.672 . . . . 18.030000000000001 111.606 178.448 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.6 p -85.36 164.24 18.07 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 128.948 2.899 . . . . 10.220000000000001 113.365 168.395 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.0 mm -67.28 -35.61 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 C-N-CA 126.355 1.862 . . . . 12.300000000000001 110.199 178.914 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -50.91 -48.95 60.44 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.16 -2.213 . . . . 36.509999999999998 115.998 168.11 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -59.98 -32.79 71.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.941 -3.6 . . . . 25.66 118.203 169.281 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.5 t -63.91 -54.31 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 C-N-CA 124.966 1.306 . . . . 8.1199999999999992 108.273 169.654 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.7 mtmt -56.95 -36.72 70.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.006 2.225 . . . . 15.470000000000001 117.006 178.349 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.29 -24.12 64.71 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.05 2.982 . . . . 11.449999999999999 119.05 173.078 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -69.99 -56.99 5.54 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.514 -1.991 . . . . 24.98 113.096 173.516 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.6 mt -51.42 -46.85 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 C-N-CA 127.228 2.211 . . . . 9.4600000000000009 110.517 169.394 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -49.49 -41.93 42.08 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.427 2.01 . . . . 14.76 116.427 171.894 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -81.01 -77.53 0.2 Allowed 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 126.905 3.241 . . . . 26.289999999999999 106.352 -178.893 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -64.4 -42.01 96.33 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.519 -5.113 . . . . 30.059999999999999 114.148 -162.574 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -94.61 -43.04 8.48 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.169 -3.457 . . . . 25.190000000000001 115.316 178.897 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.18 41.62 3.69 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.018 -2.301 . . . . 7.4100000000000001 114.863 176.609 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.9 mt -109.55 113.15 58.34 Favored Pre-proline 0 N--CA 1.43 -1.441 0 N-CA-C 103.952 -2.61 . . . . 9.4900000000000002 103.952 168.351 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_exo -57.7 159.3 17.51 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 C-N-CA 126.424 4.749 . . . . 11.42 112.953 -173.726 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -86.42 -1.34 8.39 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 C-N-CA 124.8 3.667 . . . . 12.0 112.22 -169.916 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -87.39 -26.86 23.11 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.397 2.936 . . . . 35.549999999999997 111.747 169.319 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -67.03 -31.05 71.32 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.352 1.612 . . . . 20.52 115.352 175.03 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -83.44 136.23 34.39 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.441 2.015 . . . . 7.1299999999999999 116.441 -173.726 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.0 ttt180 -132.07 143.36 49.97 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 115.198 -2.601 . . . . 36.390000000000001 110.143 140.763 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.7 mt -94.05 128.31 40.34 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 112.792 -2.004 . . . . 9.5500000000000007 111.824 -178.51 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.5 mm -113.4 138.47 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 107.367 -1.346 . . . . 13.9 107.367 -176.596 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -114.89 100.99 8.62 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.274 2.464 . . . . 6.8600000000000003 109.797 171.251 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.501 . . 82.34 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.626 -3.796 . . . . 11.15 110.646 172.919 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.04 3.47 6.86 Favored Glycine 0 N--CA 1.429 -1.768 0 CA-C-N 113.262 -1.79 . . . . 13.93 112.745 159.367 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.7 mttm -89.03 124.88 34.7 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 120.727 2.264 . . . . 23.920000000000002 113.193 178.798 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -89.82 118.88 29.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.245 -2.159 . . . . 23.23 110.616 179.817 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 89.5 mt -74.98 159.37 31.87 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 125.109 2.385 . . . . 9.1099999999999994 110.117 -164.843 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 -121.42 142.19 50.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.742 -1.572 . . . . 33.439999999999998 113.98 175.942 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.04 -45.31 95.31 Favored 'General case' 0 N--CA 1.43 -1.473 1 N-CA-C 122.535 4.272 . . . . 28.370000000000001 122.535 -162.678 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -67.24 -4.78 31.27 Favored Glycine 0 N--CA 1.43 -1.721 1 N-CA-C 124.44 4.536 . . . . 15.0 124.44 172.71 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.5 mtt180 -100.37 171.75 7.57 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.36 2.029 . . . . 25.5 111.164 -176.819 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.27 30.8 p -94.4 157.35 16.06 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.524 -2.61 . . . . 11.949999999999999 114.167 179.82 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.88 -46.83 60.59 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 117.571 2.434 . . . . 10.17 117.571 163.074 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -56.4 -33.45 65.79 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 120.382 3.475 . . . . 13.59 120.382 169.003 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -58.88 -37.64 77.03 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.187 -2.82 . . . . 11.699999999999999 113.656 172.746 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -88.78 -13.17 40.09 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.935 -4.228 . . . . 12.949999999999999 110.112 177.35 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.439 40.8 t30 62.03 72.42 0.5 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 129.055 2.942 . . . . 25.449999999999999 114.379 -165.231 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -111.16 106.17 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 N-CA-C 99.478 -4.267 . . . . 14.6 99.478 -179.785 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -100.33 -173.98 2.55 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 121.586 -0.697 . . . . 33.229999999999997 110.675 -178.848 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.262 25.1 pttt -55.25 131.74 46.15 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.771 2.428 . . . . 25.969999999999999 113.981 179.656 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 58.99 45.54 14.76 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 127.215 3.388 . . . . 32.609999999999999 115.232 -176.313 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 7.5 t -110.28 137.18 48.36 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.884 -2.385 . . . . 10.56 107.798 179.208 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.8 m -105.16 129.47 53.55 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 126.932 2.093 . . . . 5.3300000000000001 107.614 -159.396 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 mt -118.48 150.42 39.63 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 128.086 3.803 . . . . 11.66 106.271 179.12 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -112.03 124.37 52.25 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.149 -2.219 . . . . 16.300000000000001 105.201 -178.643 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.8 tp -90.45 124.78 35.25 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 129.148 4.03 . . . . 9.9600000000000009 108.629 -178.496 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.6 m -99.1 151.62 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.992 2.517 . . . . 9.7599999999999998 109.065 167.192 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 mt -87.76 151.93 22.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.508 -2.62 . . . . 19.57 109.487 163.13 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -135.42 177.49 7.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.527 -1.358 . . . . 35.079999999999998 109.174 175.69 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.7 mt -77.33 142.64 39.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.457 -2.027 . . . . 32.310000000000002 109.131 -173.961 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -81.77 163.02 22.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 116.417 2.006 . . . . 42.75 116.417 -168.055 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.29 -82.35 0.35 Allowed Glycine 0 N--CA 1.43 -1.701 0 O-C-N 118.229 -2.794 . . . . 36.310000000000002 115.161 -172.939 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.735 0 O-C-N 118.98 -2.482 . . . . 36.270000000000003 108.333 -174.208 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 123.46 1.6 . . . . 17.170000000000002 114.12 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -82.39 138.06 34.56 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.422 -4.549 . . . . 21.890000000000001 107.75 168.556 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 17' ' ' VAL . 6.9 pt -118.95 177.48 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 124.849 1.26 . . . . 10.83 109.69 157.904 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -134.89 112.02 10.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 116.429 2.011 . . . . 10.609999999999999 116.429 -173.915 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.1 t -94.96 115.0 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 125.87 2.748 . . . . 9.1300000000000008 110.493 177.547 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.263 28.2 tttp -107.32 140.56 40.04 Favored 'General case' 0 N--CA 1.43 -1.473 1 O-C-N 115.977 -4.202 . . . . 20.550000000000001 113.588 -179.866 . . . . . . . . 3 2 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.5 p -102.09 172.7 6.76 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.983 -2.323 . . . . 11.779999999999999 109.797 -179.429 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.9 -46.75 88.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.501 3.12 . . . . 19.309999999999999 111.853 172.081 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 p -69.38 -26.86 64.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.905 -2.372 . . . . 23.140000000000001 114.185 171.77 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.4 62.29 0.95 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 116.717 1.447 . . . . 19.739999999999998 116.717 162.97 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -103.13 175.18 5.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.929 2.092 . . . . 21.93 107.905 155.389 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.2 m -128.46 134.12 48.67 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.3 -3.375 . . . . 12.33 105.792 172.817 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 mt -114.57 117.4 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 107.896 -1.15 . . . . 17.079999999999998 107.896 174.566 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.9 m -85.36 107.79 17.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.227 -2.26 . . . . 16.300000000000001 105.955 -175.581 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.0 mt -102.67 135.93 43.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.088 2.375 . . . . 15.880000000000001 115.185 172.668 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -99.7 129.34 45.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.779 -3.701 . . . . 28.899999999999999 110.63 173.248 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 3' ' ' ILE . 4.2 m -151.09 159.63 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 125.842 1.657 . . . . 12.050000000000001 109.458 -167.628 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 62.2 mm-40 -107.08 159.63 29.3 Favored Pre-proline 0 N--CA 1.43 -1.468 0 O-C-N 120.554 -1.341 . . . . 18.170000000000002 110.328 163.132 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -72.7 -6.58 19.29 Favored 'Trans proline' 0 C--N 1.299 -2.04 0 C-N-CA 124.856 3.704 . . . . 8.1600000000000001 112.374 -176.66 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.8 p -72.64 -26.0 61.49 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 125.355 1.66 . . . . 11.130000000000001 114.338 171.779 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -64.82 157.75 26.87 Favored 'General case' 0 N--CA 1.43 -1.456 1 N-CA-C 124.425 4.972 . . . . 18.030000000000001 124.425 174.687 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 62.5 p -101.29 167.64 10.06 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 114.074 -2.869 . . . . 10.220000000000001 113.899 -173.49 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.317 7.0 mm -64.65 -35.41 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 125.392 1.682 . . . . 12.300000000000001 109.65 172.001 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -44.55 -48.82 10.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 120.683 3.586 . . . . 36.509999999999998 120.683 160.049 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -62.79 -40.72 98.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 125.122 1.514 . . . . 25.66 109.255 174.375 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.299 57.6 t -55.07 -59.76 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 116.721 -1.609 . . . . 8.1199999999999992 113.652 171.371 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -61.79 -27.48 68.78 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.073 1.76 . . . . 15.470000000000001 112.735 176.875 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.48 -32.53 62.59 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 122.549 2.431 . . . . 11.449999999999999 115.148 175.923 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.1 mttt -70.04 -26.65 64.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.303 -3.373 . . . . 24.98 109.375 176.189 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 30' ' ' ILE . 17.4 mm -70.48 -37.87 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.224 1.409 . . . . 9.4600000000000009 110.988 168.723 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -43.84 78.37 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.301 -2.124 . . . . 14.76 111.612 -178.033 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -50.35 -69.09 0.12 Allowed 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 126.948 2.655 . . . . 26.289999999999999 110.984 170.443 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.0 tttp -69.73 -52.32 26.52 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.835 -3.041 . . . . 30.059999999999999 118.485 -171.093 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -84.53 -65.51 1.0 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.877 -1.764 . . . . 25.190000000000001 107.589 -178.272 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.01 17.79 1.0 Allowed Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 122.64 2.473 . . . . 7.4100000000000001 113.884 -175.048 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.8 mt -97.3 131.19 27.85 Favored Pre-proline 0 N--CA 1.431 -1.41 0 N-CA-C 116.07 1.878 . . . . 9.4900000000000002 116.07 -175.61 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -68.86 154.79 70.4 Favored 'Trans proline' 0 C--N 1.299 -2.047 0 CA-C-N 124.157 2.521 . . . . 11.42 109.549 -178.946 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -77.93 -17.69 13.6 Favored 'Trans proline' 0 N--CA 1.434 -1.989 0 N-CA-C 117.221 1.97 . . . . 12.0 117.221 -170.716 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -79.26 -15.64 57.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.216 1.484 . . . . 35.549999999999997 110.704 178.111 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -86.96 -33.18 19.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.74 2.816 . . . . 20.52 113.036 176.462 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -71.03 139.02 50.33 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 116.231 1.937 . . . . 7.1299999999999999 116.231 171.013 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -131.67 131.7 43.35 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.015 2.341 . . . . 36.390000000000001 114.497 160.008 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.1 mt -109.37 125.95 52.9 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 115.154 -4.716 . . . . 9.5500000000000007 110.881 -170.993 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.7 mm -116.45 112.62 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.531 -1.355 . . . . 13.9 110.132 -176.038 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -102.06 116.38 32.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.879 2.276 . . . . 6.8600000000000003 112.348 163.578 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.447 . . 63.1 -81.81 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.91 1.818 . . . . 11.15 115.91 -167.252 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.95 15.94 1.18 Allowed Glycine 0 N--CA 1.431 -1.687 0 CA-C-O 125.204 2.558 . . . . 13.93 112.569 174.517 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -101.09 131.39 47.03 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 120.607 -1.525 . . . . 23.920000000000002 110.976 -175.004 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 -75.97 120.82 21.83 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 114.658 -1.155 . . . . 23.23 112.955 170.308 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.0 mt -89.56 121.29 31.62 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 120.179 -1.576 . . . . 9.1099999999999994 111.49 -172.893 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -80.95 143.55 32.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 115.248 1.573 . . . . 33.439999999999998 115.248 172.407 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -62.78 -42.19 99.59 Favored 'General case' 0 N--CA 1.43 -1.472 1 C-N-CA 132.04 4.136 . . . . 28.370000000000001 110.538 -171.812 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.76 -7.69 88.3 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 127.238 2.352 . . . . 15.0 114.012 -170.476 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -101.6 155.68 17.94 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 125.742 1.617 . . . . 25.5 109.62 -169.875 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 71.4 p -95.11 167.06 11.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.04 -2.288 . . . . 11.949999999999999 110.256 -174.487 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 mt -57.69 -56.34 23.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.52 3.128 . . . . 10.17 111.886 174.306 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.406 6.6 t -36.13 -37.88 0.13 Allowed 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.673 3.589 . . . . 13.59 118.822 156.283 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -72.3 -46.66 54.73 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 114.829 -4.919 . . . . 11.699999999999999 110.829 -176.828 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -67.96 -3.44 9.97 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 120.028 3.344 . . . . 12.949999999999999 120.028 167.26 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.0 m120 64.69 27.45 13.14 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.461 1.504 . . . . 25.449999999999999 114.381 -175.71 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.5 mt -85.27 116.29 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.215 1.483 . . . . 14.6 109.059 -174.277 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -97.8 -165.21 1.22 Allowed 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 126.902 3.239 . . . . 33.229999999999997 110.598 -176.733 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.6 pttt -76.35 150.11 36.9 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.436 -4.54 . . . . 25.969999999999999 112.979 -174.356 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 50.6 mt-10 54.6 35.64 24.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 125.344 1.652 . . . . 32.609999999999999 113.411 -174.763 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.7 m -86.71 133.97 33.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.053 1.882 . . . . 10.56 108.731 -174.668 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m -95.38 118.4 32.05 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.911 -2.368 . . . . 5.3300000000000001 107.725 -177.498 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -109.31 144.58 37.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 100.827 -3.768 . . . . 11.66 100.827 -178.802 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -117.36 126.86 53.39 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.307 -3.996 . . . . 16.300000000000001 104.945 -177.164 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.4 tp -100.11 119.8 38.87 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.567 1.547 . . . . 9.9600000000000009 108.044 -176.446 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.7 m -117.99 159.14 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 O-C-N 120.051 -1.656 . . . . 9.7599999999999998 113.384 169.368 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 84.7 mt -92.34 112.77 24.84 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.705 -1.591 . . . . 19.57 106.705 -179.276 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -99.92 -179.8 4.28 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.423 -2.673 . . . . 35.079999999999998 114.271 170.396 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.288 96.0 mt -74.43 159.71 31.94 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 122.678 1.228 . . . . 32.310000000000002 108.548 166.059 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.9 mtp180 -80.47 122.72 27.35 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.422 -2.049 . . . . 42.75 113.489 -172.372 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.5 147.06 8.3 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 124.839 1.337 . . . . 36.310000000000002 110.16 169.883 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.778 0 C-N-CA 125.123 1.344 . . . . 36.270000000000003 110.024 -173.442 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 CA--C 1.491 -1.327 0 N-CA-C 117.601 2.445 . . . . 17.170000000000002 117.601 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -98.85 134.52 41.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 115.785 -2.055 . . . . 21.890000000000001 113.459 170.308 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -130.77 155.53 41.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 125.546 2.594 . . . . 10.83 107.18 172.078 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -119.29 105.16 11.05 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.577 -3.827 . . . . 10.609999999999999 107.489 -161.221 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.68 100.15 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 1 O-C-N 129.64 4.338 . . . . 9.1300000000000008 107.705 177.177 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -92.03 120.27 32.51 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 113.834 -1.53 . . . . 20.550000000000001 109.975 -177.455 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -74.18 -174.01 1.82 Allowed 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.872 2.069 . . . . 11.779999999999999 113.739 -178.967 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.2 tp -77.76 -32.25 52.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.932 2.197 . . . . 19.309999999999999 116.932 177.334 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.8 p -70.67 -31.15 67.95 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.542 2.337 . . . . 23.140000000000001 114.637 170.75 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.8 20.15 8.23 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 117.758 -1.579 . . . . 19.739999999999998 114.538 179.849 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.292 44.4 pttt -89.07 142.96 27.19 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 124.733 1.213 . . . . 21.93 111.747 169.357 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 38.7 m -98.29 130.89 44.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.817 -1.802 . . . . 12.33 108.669 178.0 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.9 mt -106.56 104.64 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 1 N-CA-C 99.737 -4.171 . . . . 17.079999999999998 99.737 171.508 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 m -73.89 119.52 18.21 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.284 -1.51 . . . . 16.300000000000001 111.702 173.559 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.553 ' CD1' HG13 ' A' ' 26' ' ' VAL . 67.5 mt -100.17 126.07 46.39 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 114.964 -4.835 . . . . 15.880000000000001 114.13 170.588 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -78.93 92.83 4.96 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 125.797 1.936 . . . . 28.899999999999999 113.349 174.805 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.286 16.3 m -132.8 165.26 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-N 121.903 2.138 . . . . 12.050000000000001 111.325 -175.701 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -97.07 165.31 16.03 Favored Pre-proline 0 N--CA 1.429 -1.483 0 O-C-N 116.36 -3.963 . . . . 18.170000000000002 109.461 174.409 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.85 -23.66 73.16 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.811 3.111 . . . . 8.1600000000000001 119.539 164.833 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.5 p -63.38 -22.39 66.85 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.04 2.536 . . . . 11.130000000000001 112.823 174.748 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -75.18 148.69 39.36 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.315 -2.74 . . . . 18.030000000000001 109.492 -172.174 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 7.8 p -86.91 171.77 10.56 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.46 2.076 . . . . 10.220000000000001 109.425 179.145 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.4 mm -76.93 -22.93 14.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.064 -2.897 . . . . 12.300000000000001 107.204 176.407 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -54.82 -46.79 74.59 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.737 -1.852 . . . . 36.509999999999998 110.828 171.132 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 72.4 m-20 -70.64 -21.49 62.61 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.238 2.615 . . . . 25.66 115.784 -179.612 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.553 HG13 ' CD1' ' A' ' 15' ' ' LEU . 7.8 t -83.72 -57.22 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 112.413 -2.176 . . . . 8.1199999999999992 107.113 174.191 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -45.19 -39.73 6.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.121 -2.862 . . . . 15.470000000000001 117.024 169.714 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.6 -44.35 89.86 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 119.722 3.23 . . . . 11.449999999999999 119.722 173.047 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -62.31 -36.0 80.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 116.113 1.894 . . . . 24.98 116.113 169.127 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mm -69.43 -31.32 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.924 -1.735 . . . . 9.4600000000000009 107.624 -179.11 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -72.17 -44.67 62.69 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.417 -2.677 . . . . 14.76 113.182 169.709 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -54.64 -45.36 73.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.102 2.561 . . . . 26.289999999999999 114.57 177.511 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -91.46 -56.93 2.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.455 -2.028 . . . . 30.059999999999999 114.061 -177.994 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.269 52.6 mm-40 -85.81 -31.07 22.51 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.564 -4.46 . . . . 25.190000000000001 114.53 -175.156 . . . . . . . . 3 2 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.76 7.55 59.99 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 119.568 -1.958 . . . . 7.4100000000000001 112.902 173.702 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.1 mt -75.2 116.95 59.22 Favored Pre-proline 0 N--CA 1.429 -1.485 0 CA-C-O 114.856 -2.497 . . . . 9.4900000000000002 113.819 177.415 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -63.94 150.74 87.72 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 125.227 3.952 . . . . 11.42 114.08 -172.074 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -73.95 -20.69 19.25 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 O-C-N 114.941 -3.241 . . . . 12.0 113.843 -166.964 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -80.61 -18.73 47.3 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.685 -1.969 . . . . 35.549999999999997 105.685 178.596 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -89.93 -18.34 26.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.753 -1.842 . . . . 20.52 113.478 176.744 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -72.95 137.33 45.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.71 -2.494 . . . . 7.1299999999999999 109.163 -177.485 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.517 ' HB3' HG23 ' A' ' 70' ' ' VAL . 28.0 ttt180 -130.89 129.54 42.38 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.668 1.576 . . . . 36.390000000000001 109.837 168.878 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.47 ' HB3' HD12 ' A' ' 50' ' ' LEU . 22.9 mt -118.95 124.32 46.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.704 -1.135 . . . . 9.5500000000000007 111.33 -173.928 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 21.7 mm -118.01 134.38 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.171 2.588 . . . . 13.9 106.647 -171.071 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.409 ' HB2' HD11 ' A' ' 50' ' ' LEU . 82.2 t80 -121.24 113.32 19.79 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.324 2.342 . . . . 6.8600000000000003 117.324 161.245 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.86 -98.44 0.08 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.786 1.402 . . . . 11.15 114.786 -164.725 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.21 4.04 9.62 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 124.762 1.172 . . . . 13.93 113.875 166.116 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -90.98 139.24 30.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.294 1.521 . . . . 23.920000000000002 109.56 177.809 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -87.73 117.07 26.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.204 2.202 . . . . 23.23 110.386 178.721 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.47 HD12 ' HB3' ' A' ' 43' ' ' LEU . 83.2 mt -83.61 129.27 34.96 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.962 2.905 . . . . 9.1099999999999994 107.898 -178.553 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -111.74 154.43 25.02 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.224 -1.807 . . . . 33.439999999999998 109.245 -173.995 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.38 -48.57 67.02 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.49 1.614 . . . . 28.370000000000001 110.876 -158.404 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.58 15.75 44.58 Favored Glycine 0 N--CA 1.43 -1.742 0 C-N-CA 125.972 1.749 . . . . 15.0 114.605 177.279 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -100.36 167.8 10.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 105.79 -1.93 . . . . 25.5 105.79 171.005 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 11.4 p -105.04 176.86 5.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.514 -1.991 . . . . 11.949999999999999 107.955 -177.865 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.8 mt -65.78 -43.55 88.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 126.957 2.661 . . . . 10.17 115.272 164.856 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.2 t -51.85 -43.74 63.35 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.414 2.686 . . . . 13.59 113.663 173.717 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -67.17 -29.24 68.88 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 117.147 2.277 . . . . 11.699999999999999 117.147 -173.914 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -88.07 -10.23 50.83 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 119.441 3.126 . . . . 12.949999999999999 119.441 171.296 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.4 m120 85.06 56.69 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.471 1 C-N-CA 133.679 4.791 . . . . 25.449999999999999 107.244 172.466 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.7 mt -104.92 101.38 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 N-CA-C 99.375 -4.305 . . . . 14.6 99.375 -172.844 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -91.07 -177.48 4.92 Favored 'General case' 0 N--CA 1.43 -1.433 2 C-N-CA 134.561 5.144 . . . . 33.229999999999997 107.265 179.973 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -66.57 145.57 55.46 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 125.001 1.32 . . . . 25.969999999999999 114.37 -179.311 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.381 17.0 mt-10 66.64 52.56 0.99 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 126.715 3.15 . . . . 32.609999999999999 117.337 176.866 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.1 t -131.76 134.01 45.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.689 -3.132 . . . . 10.56 113.166 -153.227 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.2 m -77.25 117.08 18.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.745 2.528 . . . . 5.3300000000000001 115.16 -179.231 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -115.05 138.37 50.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 115.388 -2.244 . . . . 11.66 108.305 165.39 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.43 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 80.5 m-70 -100.49 122.64 43.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 119.766 1.166 . . . . 16.300000000000001 111.288 -177.329 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.4 tp -96.69 117.46 31.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.099 2.381 . . . . 9.9600000000000009 110.197 172.575 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 42' ' ' ARG . 0.3 OUTLIER -126.85 176.7 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 130.596 3.558 . . . . 9.7599999999999998 109.266 172.772 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 mp -122.43 144.1 49.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.688 -1.882 . . . . 19.57 115.858 175.441 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -118.84 -177.87 3.42 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.529 2.585 . . . . 35.079999999999998 106.649 177.579 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.1 mt -81.26 155.93 25.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.552 3.072 . . . . 32.310000000000002 111.741 172.497 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -79.32 155.37 28.5 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 113.523 -5.736 . . . . 42.75 117.303 -169.054 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 169.41 -81.58 0.09 OUTLIER Glycine 0 N--CA 1.431 -1.695 0 O-C-N 128.016 3.323 . . . . 36.310000000000002 113.393 168.465 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.771 0 CA-C-O 126.348 3.193 . . . . 36.270000000000003 110.757 -173.039 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 104.832 -2.284 . . . . 17.170000000000002 104.832 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -116.3 130.51 56.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.815 -2.291 . . . . 21.890000000000001 104.815 -175.6 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -117.68 154.45 19.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.785 -2.302 . . . . 10.83 104.785 161.161 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.314 98.1 m-85 -116.14 152.06 34.43 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.603 -3.186 . . . . 10.609999999999999 106.121 176.801 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.0 t -125.41 113.18 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 106.746 -1.575 . . . . 9.1300000000000008 106.746 177.942 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -122.4 150.95 41.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 124.699 1.249 . . . . 20.550000000000001 113.234 -169.357 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -89.7 176.2 6.95 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.242 1.817 . . . . 11.779999999999999 108.246 176.65 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 mt -68.79 -38.82 80.23 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.124 -2.235 . . . . 19.309999999999999 107.064 -175.4 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -83.83 -61.84 1.72 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.771 -2.456 . . . . 23.140000000000001 114.268 -172.832 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.55 68.69 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.715 0 C-N-CA 117.737 -2.173 . . . . 19.739999999999998 109.402 177.42 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.4 tmmm? -120.09 121.25 38.45 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 103.112 -2.922 . . . . 21.93 103.112 155.407 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.0 m -111.88 112.03 23.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.709 -2.495 . . . . 12.33 108.093 -173.73 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.26 136.73 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 105.468 -2.049 . . . . 17.079999999999998 105.468 173.654 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.2 m -101.78 119.8 39.35 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.721 -1.214 . . . . 16.300000000000001 107.721 -171.283 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.6 mt -103.84 134.91 46.35 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 119.279 3.066 . . . . 15.880000000000001 119.279 178.943 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -96.18 109.49 21.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.205 -1.56 . . . . 28.899999999999999 108.686 178.691 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.8 m -130.1 148.68 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 116.765 -3.709 . . . . 12.050000000000001 112.291 -169.884 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -97.44 146.68 31.81 Favored Pre-proline 0 N--CA 1.43 -1.449 0 O-C-N 118.997 -2.315 . . . . 18.170000000000002 109.312 171.34 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.8 -17.74 17.6 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 CA-C-O 112.393 -3.253 . . . . 8.1600000000000001 107.602 -172.651 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.6 m -85.29 7.37 22.48 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 123.896 3.044 . . . . 11.130000000000001 112.042 177.035 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -92.71 171.81 8.76 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.213 -2.804 . . . . 18.030000000000001 107.217 -174.717 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.0 p -112.48 153.45 27.41 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 120.046 -1.659 . . . . 10.220000000000001 109.975 -169.12 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.458 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 3.0 mt -74.21 -20.74 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 C-N-CA 128.209 2.604 . . . . 12.300000000000001 106.383 -174.311 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -58.94 -44.87 91.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 124.283 1.033 . . . . 36.509999999999998 112.101 169.614 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 -66.37 -34.96 79.14 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.293 3.437 . . . . 25.66 109.66 174.439 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 97.6 t -62.84 -49.77 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 119.852 -1.78 . . . . 8.1199999999999992 111.948 177.703 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -65.7 -27.63 68.48 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 126.468 2.355 . . . . 15.470000000000001 110.429 -172.802 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.81 -28.35 67.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.562 2.345 . . . . 11.449999999999999 110.02 177.932 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.2 tptt -93.04 -28.94 16.07 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 121.719 2.054 . . . . 24.98 108.26 -178.253 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.9 mt -65.1 -42.13 93.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 O-C-N 118.687 -2.508 . . . . 9.4600000000000009 111.377 164.763 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -59.36 -51.84 68.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.109 -3.495 . . . . 14.76 117.691 168.087 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -46.24 -50.08 16.39 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 122.268 2.303 . . . . 26.289999999999999 115.018 174.324 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.2 tttp -68.68 -63.76 1.0 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.496 2.719 . . . . 30.059999999999999 117.109 174.16 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -88.24 -29.82 20.16 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 116.64 2.089 . . . . 25.190000000000001 116.64 -174.092 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.13 14.83 59.94 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 119.058 2.383 . . . . 7.4100000000000001 119.058 -178.44 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 tt -103.15 115.31 64.2 Favored Pre-proline 0 N--CA 1.43 -1.468 0 CA-C-O 114.903 -2.475 . . . . 9.4900000000000002 106.536 -178.275 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_exo -60.27 170.03 4.47 Favored 'Trans proline' 0 N--CA 1.434 -1.988 2 C-N-CA 131.058 7.839 . . . . 11.42 116.256 -168.977 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.88 -21.09 7.17 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 125.365 2.952 . . . . 12.0 108.126 -164.307 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -75.43 -33.92 60.95 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 118.445 -2.66 . . . . 35.549999999999997 113.005 175.946 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -73.59 -37.52 65.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.516 -3.24 . . . . 20.52 113.929 176.265 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -54.74 124.55 16.8 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.967 -2.333 . . . . 7.1299999999999999 114.269 173.952 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -124.32 99.34 6.16 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.369 1.44 . . . . 36.390000000000001 108.43 -178.123 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.3 mt -96.93 107.33 19.82 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 126.384 1.874 . . . . 9.5500000000000007 110.705 -173.131 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.421 HG13 HG21 ' A' ' 70' ' ' VAL . 17.2 mm -110.37 120.41 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 128.471 2.708 . . . . 13.9 105.67 -175.406 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -107.95 115.93 31.02 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.734 -2.03 . . . . 6.8600000000000003 108.022 169.132 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.29 -94.04 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 112.32 -2.218 . . . . 11.15 113.306 -164.168 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.72 12.56 4.53 Favored Glycine 0 N--CA 1.43 -1.746 0 C-N-CA 129.361 3.362 . . . . 13.93 113.149 169.997 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 mtmt -117.91 148.79 41.82 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 120.757 2.279 . . . . 23.920000000000002 108.843 -179.82 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -110.77 114.71 28.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.217 -1.031 . . . . 23.23 108.217 -169.115 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.771 HD22 ' H ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -68.55 157.67 35.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.94 -2.35 . . . . 9.1099999999999994 115.108 -171.947 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -100.21 154.95 18.04 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.775 -1.194 . . . . 33.439999999999998 107.775 178.465 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -75.87 -50.0 16.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.013 -2.899 . . . . 28.370000000000001 116.309 -160.23 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.9 52.93 2.94 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 123.197 2.726 . . . . 15.0 111.855 179.726 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.259 6.7 mmt180 -121.41 160.3 24.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 103.874 -2.639 . . . . 25.5 103.874 171.207 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.303 66.2 p -86.62 151.85 23.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.33 1.452 . . . . 11.949999999999999 111.971 175.937 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.252 33.3 mt -47.51 -50.78 22.62 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.677 1.191 . . . . 10.17 111.699 165.545 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.0 p -54.12 -26.73 28.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.328 1.973 . . . . 13.59 116.328 176.866 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -61.35 -43.45 98.86 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.396 -2.69 . . . . 11.699999999999999 110.505 173.455 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.23 -16.01 28.32 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 126.601 2.438 . . . . 12.949999999999999 115.724 176.532 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 70.63 36.95 1.51 Allowed 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.601 1.561 . . . . 25.449999999999999 113.381 -172.226 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.6 mt -68.63 101.43 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.49 -2.006 . . . . 14.6 116.121 170.901 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 -76.52 163.43 26.93 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 118.82 2.896 . . . . 33.229999999999997 118.82 -175.829 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.0 pttt -61.35 147.85 43.41 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.605 2.817 . . . . 25.969999999999999 118.605 169.593 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.333 26.2 mt-10 68.74 23.98 6.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.07 1.89 . . . . 32.609999999999999 112.773 179.916 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -84.79 152.39 23.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 127.275 3.417 . . . . 10.56 107.945 -179.997 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.8 m -110.41 97.81 7.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 110.766 -2.925 . . . . 5.3300000000000001 107.887 175.825 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.0 mp -80.81 152.26 28.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.267 3.027 . . . . 11.66 112.119 165.446 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -104.41 140.15 38.33 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.253 -2.78 . . . . 16.300000000000001 106.376 -178.136 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 tp -102.73 104.27 14.57 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.994 2.33 . . . . 9.9600000000000009 110.225 156.939 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.421 HG21 HG13 ' A' ' 44' ' ' ILE . 3.4 t -91.53 138.21 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 117.357 -3.34 . . . . 9.7599999999999998 108.047 -176.62 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.6 tp -87.38 127.14 35.21 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.79 -2.444 . . . . 19.57 105.769 172.632 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.9 ttp180 -126.94 148.78 50.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 128.162 3.414 . . . . 35.079999999999998 113.133 164.752 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 mt -76.54 140.16 41.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.779 -2.45 . . . . 32.310000000000002 110.386 -179.496 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.6 ttp180 -79.35 127.9 32.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 126.541 1.936 . . . . 42.75 108.267 -175.926 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -176.31 -58.56 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.746 0 O-C-N 121.101 -0.999 . . . . 36.310000000000002 113.279 -162.182 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 CA-C-O 117.218 -1.879 . . . . 36.270000000000003 109.756 169.008 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 ptt? . . . . . 0 CA--C 1.49 -1.328 0 CA-C-O 125.08 2.372 . . . . 17.170000000000002 114.308 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -104.92 131.1 52.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.539 -3.851 . . . . 21.890000000000001 111.92 166.162 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.297 2.3 pp -124.08 162.52 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 1 O-C-N 114.61 -5.056 . . . . 10.83 105.283 169.679 . . . . . . . . 3 2 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.5 m-30 -107.04 128.39 54.33 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.484 3.113 . . . . 10.609999999999999 106.607 -175.189 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -125.59 104.89 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 100.319 -3.956 . . . . 9.1300000000000008 100.319 -177.859 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 tttt -89.4 162.22 15.89 Favored 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 131.913 4.085 . . . . 20.550000000000001 108.661 175.008 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.484 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 17.8 p -101.99 -151.72 0.42 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.818 -2.426 . . . . 11.779999999999999 105.899 173.703 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.484 ' H ' ' HB ' ' A' ' 7' ' ' THR . 51.3 mt -91.58 -42.39 10.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 120.004 1.275 . . . . 19.309999999999999 111.459 170.07 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -66.53 -36.66 83.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.875 -1.766 . . . . 23.140000000000001 113.182 174.455 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.01 22.13 1.28 Allowed Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 120.057 2.783 . . . . 19.739999999999998 120.057 158.053 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -72.99 106.02 4.7 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.216 2.206 . . . . 21.93 116.438 168.261 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -81.13 130.33 34.97 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.818 -1.083 . . . . 12.33 109.69 173.511 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -107.38 157.25 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 119.912 -1.743 . . . . 17.079999999999998 106.871 158.79 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.7 m -125.57 106.59 9.87 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.315 -1.735 . . . . 16.300000000000001 106.315 -169.147 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.261 86.5 mt -125.24 144.95 50.21 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.829 -0.545 . . . . 15.880000000000001 112.047 -168.345 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -97.1 105.69 17.88 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 118.375 2.731 . . . . 28.899999999999999 118.375 -171.005 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 m -125.61 161.33 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 127.375 2.27 . . . . 12.050000000000001 108.146 -168.476 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -103.92 169.58 7.13 Favored Pre-proline 0 N--CA 1.429 -1.476 1 O-C-N 113.232 -5.917 . . . . 18.170000000000002 106.653 167.72 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -77.96 -17.25 13.83 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 116.301 -2.526 . . . . 8.1600000000000001 107.74 174.639 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 m -75.85 -6.44 50.76 Favored 'General case' 0 N--CA 1.431 -1.395 0 O-C-N 117.788 -3.07 . . . . 11.130000000000001 112.654 173.02 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -77.26 145.01 37.77 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.98 -3.575 . . . . 18.030000000000001 108.935 174.76 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.324 20.1 p -77.76 151.75 33.93 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 133.175 4.59 . . . . 10.220000000000001 110.655 176.458 . . . . . . . . 3 2 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.429 HD13 ' HB3' ' A' ' 50' ' ' LEU . 65.0 mt -63.5 -38.96 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 120.264 -1.523 . . . . 12.300000000000001 113.031 175.431 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -46.13 -45.37 16.47 Favored 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 132.463 4.305 . . . . 36.509999999999998 113.72 168.591 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -74.57 -23.12 58.72 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.721 -3.737 . . . . 25.66 114.26 174.738 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.36 -44.93 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 119.503 -1.998 . . . . 8.1199999999999992 110.576 174.28 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -56.17 -40.24 73.59 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 125.485 1.514 . . . . 15.470000000000001 114.008 173.426 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.06 -42.11 65.47 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.232 2.308 . . . . 11.449999999999999 117.232 167.648 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -79.54 -14.26 58.98 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 116.151 -4.093 . . . . 24.98 116.259 179.037 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -88.1 -26.29 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.892 -1.755 . . . . 9.4600000000000009 110.17 168.119 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -63.97 -48.9 74.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.642 -3.161 . . . . 14.76 115.933 162.876 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -42.4 -51.42 4.94 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.0 3.333 . . . . 26.289999999999999 120.0 157.209 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -90.67 -68.11 0.81 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 121.347 -0.845 . . . . 30.059999999999999 111.326 -166.474 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -86.78 -34.43 19.58 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.303 1.441 . . . . 25.190000000000001 112.648 -176.249 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.55 67.27 1.57 Allowed Glycine 0 N--CA 1.43 -1.723 0 N-CA-C 115.997 1.159 . . . . 7.4100000000000001 115.997 173.797 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.58 HD11 HD13 ' A' ' 71' ' ' LEU . 10.5 tt -126.9 133.55 25.15 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-N 110.138 -3.031 . . . . 9.4900000000000002 110.97 164.864 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.45 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 10.7 Cg_endo -74.44 157.36 45.18 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 123.924 3.083 . . . . 11.42 113.368 -172.435 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 84.1 Cg_exo -72.85 -15.5 26.53 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 CA-C-O 112.567 -3.181 . . . . 12.0 114.171 -153.775 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -88.49 -17.63 29.93 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 128.639 3.712 . . . . 35.549999999999997 106.068 -176.216 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -89.11 -27.17 20.94 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.781 -3.074 . . . . 20.52 104.832 -178.711 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -78.62 109.61 12.99 Favored 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 117.006 -3.559 . . . . 7.1299999999999999 111.541 -175.538 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -100.44 104.52 15.93 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 104.107 -2.553 . . . . 36.390000000000001 104.107 174.587 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.5 mt -96.45 140.56 30.93 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.855 -2.403 . . . . 9.5500000000000007 109.16 179.014 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -134.88 146.58 30.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 123.722 1.725 . . . . 13.9 107.815 -173.073 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -121.84 104.5 9.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.702 2.001 . . . . 6.8600000000000003 106.482 166.376 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.36 -102.64 0.16 Allowed 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 116.064 -4.147 . . . . 11.15 113.975 173.147 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -90.11 -25.05 27.72 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 124.461 3.3 . . . . 13.93 113.233 171.526 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.1 mttt -83.8 136.81 34.0 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.95 1.357 . . . . 23.920000000000002 113.364 -173.021 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -78.67 147.52 33.51 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.644 -3.16 . . . . 23.23 111.146 163.056 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.429 ' HB3' HD13 ' A' ' 23' ' ' ILE . 9.8 mt -110.42 110.45 21.22 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 114.662 -2.59 . . . . 9.1099999999999994 104.914 -172.282 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.296 20.8 mt-10 -81.08 145.41 31.11 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 130.714 3.606 . . . . 33.439999999999998 113.47 177.427 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -62.59 -49.56 74.74 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 119.847 3.277 . . . . 28.370000000000001 119.847 -158.429 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.17 15.32 56.48 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.589 -3.819 . . . . 15.0 116.345 -174.045 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.2 mtt-85 -93.87 161.21 14.4 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.627 1.204 . . . . 25.5 109.147 169.292 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.1 p -91.52 173.77 7.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.101 1.905 . . . . 11.949999999999999 111.211 177.183 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.8 mt -76.5 -24.82 53.75 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.38 -1.45 . . . . 10.17 109.434 173.133 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.5 t -72.5 -36.32 68.35 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.805 -1.809 . . . . 13.59 113.132 -177.196 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -59.01 -39.93 83.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.318 2.261 . . . . 11.699999999999999 114.724 173.762 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -84.73 2.08 43.63 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.761 -3.087 . . . . 12.949999999999999 113.551 -179.874 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.292 29.3 m120 54.47 51.49 14.03 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.061 2.615 . . . . 25.449999999999999 118.061 -168.829 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -99.11 112.53 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 122.741 2.518 . . . . 14.6 107.752 -179.808 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -103.24 176.94 4.98 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.889 1.676 . . . . 33.229999999999997 108.527 -173.975 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.3 pttp -73.79 148.76 42.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.021 -2.299 . . . . 25.969999999999999 112.897 -173.674 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 61.81 19.75 10.86 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 111.367 -2.651 . . . . 32.609999999999999 110.802 -173.456 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.2 m -82.39 160.66 22.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 105.217 -2.142 . . . . 10.56 105.217 179.31 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -116.68 120.55 38.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 126.185 2.898 . . . . 5.3300000000000001 104.766 -171.994 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.41 64.2 mt -100.37 155.55 17.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.489 -2.141 . . . . 11.66 108.508 169.207 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -107.52 131.51 54.24 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.562 1.69 . . . . 16.300000000000001 115.562 173.482 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.6 tp -92.0 107.61 19.33 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.433 1.893 . . . . 9.9600000000000009 106.096 178.915 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -100.82 152.75 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.049 -1.657 . . . . 9.7599999999999998 107.47 172.629 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.58 HD13 HD11 ' A' ' 36' ' ' ILE . 10.0 tp -101.55 125.89 48.27 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.165 -2.209 . . . . 19.57 105.164 172.679 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -130.8 132.73 45.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 128.343 3.925 . . . . 35.079999999999998 107.35 170.626 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.8 mt -73.57 -155.28 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.321 -3.987 . . . . 32.310000000000002 112.628 178.666 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.9 mtp180 -92.68 145.18 24.62 Favored 'General case' 0 N--CA 1.429 -1.487 1 CA-C-O 129.253 4.359 . . . . 42.75 115.396 -178.995 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.14 -103.18 0.18 Allowed Glycine 0 N--CA 1.43 -1.737 0 O-C-N 117.979 -2.951 . . . . 36.310000000000002 115.24 177.954 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.777 0 N-CA-C 104.048 -3.621 . . . . 36.270000000000003 104.048 -171.555 . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.8 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 114.518 1.303 . . . . 17.170000000000002 114.518 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -79.55 127.04 31.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 117.094 -1.432 . . . . 21.890000000000001 114.475 178.36 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -119.25 159.65 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 122.161 2.255 . . . . 10.83 113.943 159.011 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -113.64 135.6 53.75 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 104.479 -2.415 . . . . 10.609999999999999 104.479 -172.052 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.63 119.03 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 105.408 -2.071 . . . . 9.1300000000000008 105.408 174.743 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.494 ' HG2' HG23 ' A' ' 12' ' ' THR . 61.0 mttt -107.38 136.49 47.09 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 105.15 -2.167 . . . . 20.550000000000001 105.15 -171.523 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.272 72.0 p -97.62 172.95 7.39 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 126.371 2.986 . . . . 11.779999999999999 107.52 -172.02 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 mt -77.78 -35.72 51.22 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.096 -1.866 . . . . 19.309999999999999 115.845 176.875 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -65.42 -69.78 0.27 Allowed 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 121.697 2.044 . . . . 23.140000000000001 106.243 170.405 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.84 68.81 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.75 0 CA-C-N 113.418 -1.719 . . . . 19.739999999999998 113.556 178.623 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -132.75 150.07 52.2 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 102.776 -3.046 . . . . 21.93 102.776 170.346 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.494 HG23 ' HG2' ' A' ' 6' ' ' LYS . 34.6 m -127.33 90.98 3.22 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 116.573 -1.68 . . . . 12.33 107.211 -178.219 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.5 pt -77.07 125.37 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 C-N-CA 128.377 2.671 . . . . 17.079999999999998 110.964 -179.784 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.7 m -97.47 117.11 30.99 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 125.126 1.516 . . . . 16.300000000000001 113.047 177.008 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -99.12 144.41 28.29 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.037 -1.097 . . . . 15.880000000000001 108.037 178.618 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -87.08 112.69 22.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.669 -3.144 . . . . 28.899999999999999 113.873 165.427 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m -123.68 -176.25 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.416 1 O-C-N 115.917 -4.24 . . . . 12.050000000000001 114.374 176.438 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -132.06 141.47 41.58 Favored Pre-proline 0 N--CA 1.431 -1.425 0 O-C-N 116.849 -3.657 . . . . 18.170000000000002 111.717 169.696 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.87 -18.19 41.41 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 119.296 2.768 . . . . 8.1600000000000001 119.296 -170.79 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -76.65 -10.31 59.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.223 1.934 . . . . 11.130000000000001 116.223 173.535 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.271 10.9 t0 -94.43 164.77 12.87 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 119.496 -2.003 . . . . 18.030000000000001 114.173 -175.76 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.7 p -75.49 161.41 29.22 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.819 -2.425 . . . . 10.220000000000001 114.828 -170.197 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.426 HD13 ' HB3' ' A' ' 50' ' ' LEU . 22.0 mt -77.83 -31.21 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.891 -3.006 . . . . 12.300000000000001 112.389 177.855 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -49.3 -48.0 46.51 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.384 2.274 . . . . 36.509999999999998 112.385 167.404 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -74.1 -13.66 60.87 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.372 1.869 . . . . 25.66 113.066 179.657 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.95 -49.27 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 116.553 -3.842 . . . . 8.1199999999999992 108.034 165.368 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -62.96 -33.22 74.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.376 2.67 . . . . 15.470000000000001 110.601 -179.236 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.63 -44.78 85.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.491 3.043 . . . . 11.449999999999999 107.953 -177.087 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.277 65.9 mttm -63.66 -35.06 79.29 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 120.503 3.52 . . . . 24.98 120.503 173.391 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.93 -28.06 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.54 3.067 . . . . 9.4600000000000009 111.15 178.911 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -70.88 -50.36 35.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.499 -3.25 . . . . 14.76 106.056 177.992 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -48.38 -46.64 37.32 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.703 3.62 . . . . 26.289999999999999 114.895 178.159 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -82.49 -56.96 3.57 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.034 -2.348 . . . . 30.059999999999999 109.517 -165.614 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -100.1 -22.82 15.06 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 119.598 3.184 . . . . 25.190000000000001 119.598 -174.841 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.31 27.64 8.04 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 117.228 -3.42 . . . . 7.4100000000000001 115.238 170.204 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 tt -111.98 135.14 21.26 Favored Pre-proline 0 N--CA 1.431 -1.42 0 CA-C-O 113.686 -3.054 . . . . 9.4900000000000002 107.073 -168.426 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.55 167.21 27.05 Favored 'Trans proline' 0 C--N 1.299 -2.045 1 CA-C-O 109.448 -4.48 . . . . 11.42 113.307 -174.383 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.18 -11.12 7.6 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 126.026 3.188 . . . . 12.0 111.833 -179.924 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -71.93 -18.66 62.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.611 -2.556 . . . . 35.549999999999997 110.796 173.036 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -92.03 -17.77 24.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 116.562 -1.685 . . . . 20.52 110.43 172.724 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -89.02 128.25 35.71 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 122.81 1.29 . . . . 7.1299999999999999 112.768 -168.516 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 ttm180 -140.66 143.94 35.42 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 112.562 -2.108 . . . . 36.390000000000001 107.324 152.274 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.4 mt -110.23 136.31 49.64 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.712 2.405 . . . . 9.5500000000000007 106.092 -171.92 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.7 mm -128.13 136.02 61.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 116.658 -3.776 . . . . 13.9 105.874 -170.314 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -120.9 108.01 13.39 Favored 'General case' 0 N--CA 1.431 -1.424 1 N-CA-C 98.938 -4.467 . . . . 6.8600000000000003 98.938 -177.076 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.53 -64.91 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 131.41 3.884 . . . . 11.15 115.056 178.181 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.64 -0.81 1.73 Allowed Glycine 0 N--CA 1.43 -1.712 0 N-CA-C 116.906 1.522 . . . . 13.93 116.906 169.208 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -119.11 153.28 35.06 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 120.552 2.176 . . . . 23.920000000000002 107.575 -169.603 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -84.52 137.28 33.42 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 122.56 1.171 . . . . 23.23 113.676 177.256 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HB3' HD13 ' A' ' 23' ' ' ILE . 27.1 mt -94.15 120.55 34.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.152 1.381 . . . . 9.1099999999999994 107.31 -178.547 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -78.85 141.26 37.84 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.009 1.861 . . . . 33.439999999999998 113.894 177.499 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -48.7 -63.5 1.07 Allowed 'General case' 0 N--CA 1.43 -1.453 1 C-N-CA 132.157 4.183 . . . . 28.370000000000001 115.386 -179.588 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -69.15 4.32 6.21 Favored Glycine 0 N--CA 1.43 -1.704 0 C-N-CA 128.103 2.763 . . . . 15.0 119.569 -179.003 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -105.89 165.82 10.92 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 125.165 2.412 . . . . 25.5 106.439 -177.882 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.6 p -94.38 177.2 6.02 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 118.11 -2.869 . . . . 11.949999999999999 117.64 172.048 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.38 -25.96 38.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 126.606 1.962 . . . . 10.17 108.849 179.242 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.8 m -76.2 -24.86 54.71 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 121.293 1.86 . . . . 13.59 112.962 172.259 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -54.61 -38.95 67.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.712 1.745 . . . . 11.699999999999999 115.712 171.595 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -99.19 -11.99 20.84 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 128.37 2.668 . . . . 12.949999999999999 111.428 -175.359 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.8 m120 57.12 60.07 3.13 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.625 1.97 . . . . 25.449999999999999 114.68 -162.499 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -92.31 118.43 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 126.899 2.08 . . . . 14.6 106.336 173.679 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -103.75 -174.76 2.62 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 115.166 1.543 . . . . 33.229999999999997 115.166 178.486 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -69.54 155.77 39.95 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.041 -2.287 . . . . 25.969999999999999 108.948 176.193 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 53.9 40.01 31.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 127.88 2.472 . . . . 32.609999999999999 112.021 -178.283 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 71.0 m -92.93 136.43 33.26 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 129.156 2.983 . . . . 10.56 106.23 176.715 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.4 m -81.13 110.47 16.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 104.707 -2.331 . . . . 5.3300000000000001 104.707 171.027 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.99 148.85 25.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 123.489 2.859 . . . . 11.66 108.451 165.989 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -111.24 138.6 47.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 105.024 -2.213 . . . . 16.300000000000001 105.024 -179.733 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tp -116.45 122.25 44.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.17 -2.529 . . . . 9.9600000000000009 104.17 -179.39 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -108.52 171.47 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 O-C-N 124.811 1.32 . . . . 9.7599999999999998 110.759 -179.617 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 tp -83.49 133.61 34.88 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.084 -2.885 . . . . 19.57 113.287 167.335 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -91.32 112.14 23.93 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.31 2.005 . . . . 35.079999999999998 112.175 -178.501 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.9 mt -79.43 149.03 31.72 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 112.176 -6.578 . . . . 32.310000000000002 109.159 169.894 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.4 ttt85 -85.55 125.89 33.44 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.036 -2.29 . . . . 42.75 113.811 -168.014 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.54 -75.58 0.14 Allowed Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 107.058 -2.417 . . . . 36.310000000000002 107.058 -172.336 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.745 0 N-CA-C 104.108 -3.597 . . . . 36.270000000000003 104.108 167.771 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ptt? . . . . . 0 CA--C 1.489 -1.377 0 N-CA-C 120.027 3.343 . . . . 17.170000000000002 120.027 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -92.03 132.9 36.2 Favored 'General case' 0 N--CA 1.431 -1.395 1 O-C-N 116.017 -4.177 . . . . 21.890000000000001 109.216 -176.908 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.8 pt -135.68 150.66 28.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 116.646 -3.784 . . . . 10.83 105.795 174.836 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -111.3 134.46 52.87 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.36 -1.291 . . . . 10.609999999999999 109.498 -177.102 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -115.02 120.25 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 119.478 -2.014 . . . . 9.1300000000000008 109.901 173.695 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -89.98 128.48 36.26 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.711 2.672 . . . . 20.550000000000001 114.46 167.151 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.9 p -80.48 -167.51 1.37 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.125 -2.234 . . . . 11.779999999999999 109.711 -165.731 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.5 tp -60.2 -55.65 31.14 Favored 'General case' 0 N--CA 1.429 -1.508 0 C-N-CA 128.554 2.742 . . . . 19.309999999999999 112.682 169.409 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -91.04 -34.65 15.03 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.077 1.751 . . . . 23.140000000000001 110.785 -164.341 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.26 79.02 0.2 Allowed Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 128.776 3.084 . . . . 19.739999999999998 111.223 170.023 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -141.76 137.59 31.71 Favored 'General case' 0 N--CA 1.43 -1.451 1 N-CA-C 97.533 -4.988 . . . . 21.93 97.533 177.682 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -109.38 101.23 10.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.846 -1.168 . . . . 12.33 107.846 174.803 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 pt -83.42 153.91 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 130.242 3.417 . . . . 17.079999999999998 110.283 164.251 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.3 m -120.03 139.87 51.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.41 -1.7 . . . . 16.300000000000001 106.41 -176.17 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.302 96.0 mt -134.63 152.2 51.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 121.436 1.925 . . . . 15.880000000000001 112.294 173.362 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -102.48 117.58 35.02 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 120.132 1.333 . . . . 28.899999999999999 112.761 176.838 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -131.68 172.3 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 121.704 2.047 . . . . 12.050000000000001 112.769 -178.892 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -111.99 155.64 43.03 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 104.969 -2.234 . . . . 18.170000000000002 104.969 170.252 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.271 21.6 Cg_exo -71.22 -12.08 29.58 Favored 'Trans proline' 0 N--CA 1.433 -2.033 1 C-N-CA 126.115 4.543 . . . . 8.1600000000000001 111.631 -175.273 . . . . . . . . 3 2 . 1 . 052 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 p -92.42 -1.88 56.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 127.646 3.091 . . . . 11.130000000000001 108.379 179.401 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -71.79 143.48 49.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 127.846 3.689 . . . . 18.030000000000001 113.948 170.071 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -86.53 169.42 12.81 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 109.631 -3.44 . . . . 10.220000000000001 110.598 -169.649 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mp -69.73 -37.48 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 107.434 -1.321 . . . . 12.300000000000001 107.434 175.619 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -54.3 -50.68 66.75 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.503 -1.998 . . . . 36.509999999999998 113.653 171.3 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -61.09 -34.1 74.4 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 122.843 2.565 . . . . 25.66 115.472 173.196 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.388 75.9 t -54.02 -54.53 19.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 O-C-N 124.597 1.186 . . . . 8.1199999999999992 113.553 169.124 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -53.3 -24.25 11.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.968 3.307 . . . . 15.470000000000001 119.507 170.266 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.72 -38.78 58.26 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.695 3.617 . . . . 11.449999999999999 111.033 176.489 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.2 mmtt -68.29 -33.08 73.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.071 -3.518 . . . . 24.98 115.471 174.361 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.1 mt -75.02 -47.25 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.782 2.033 . . . . 9.4600000000000009 107.412 175.462 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -46.06 -48.43 16.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 114.704 -2.569 . . . . 14.76 113.37 169.46 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -69.65 -48.12 60.98 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 120.398 1.453 . . . . 26.289999999999999 114.39 -176.472 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.2 tttm -71.88 -52.8 15.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 116.956 -1.497 . . . . 30.059999999999999 113.324 -172.948 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -91.67 -41.61 10.63 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 126.502 2.376 . . . . 25.190000000000001 113.989 -167.271 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.71 40.61 1.56 Allowed Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 119.11 -0.828 . . . . 7.4100000000000001 113.551 173.54 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 tt -113.49 139.86 23.8 Favored Pre-proline 0 N--CA 1.43 -1.43 0 CA-C-O 114.826 -2.511 . . . . 9.4900000000000002 106.271 -179.511 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -68.77 153.04 73.79 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-N 126.964 3.523 . . . . 11.42 109.582 177.624 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -60.01 -22.82 70.81 Favored 'Trans proline' 0 C--N 1.299 -2.03 1 C-N-CA 127.894 5.729 . . . . 12.0 119.356 176.814 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -77.84 -24.59 48.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 103.762 -2.681 . . . . 35.549999999999997 103.762 -171.381 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -86.15 -25.02 25.96 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.424 -1.423 . . . . 20.52 114.114 -171.225 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -74.95 117.9 17.32 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.504 -1.998 . . . . 7.1299999999999999 116.101 179.742 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.0 ttm180 -108.71 110.6 22.05 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 127.564 2.345 . . . . 36.390000000000001 111.223 167.598 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.0 mt -90.69 135.58 33.62 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.141 3.015 . . . . 9.5500000000000007 119.141 173.955 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.4 mm -121.13 137.15 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 124.107 1.908 . . . . 13.9 110.626 176.202 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -117.08 130.0 56.37 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.293 -2.754 . . . . 6.8600000000000003 105.67 164.417 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 48.25 -94.62 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 115.902 1.816 . . . . 11.15 115.902 -176.028 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.03 15.14 7.4 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 118.578 -2.576 . . . . 13.93 114.365 165.307 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.9 mttp -103.4 138.33 40.28 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.695 -3.238 . . . . 23.920000000000002 108.916 -174.553 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -91.27 114.19 26.65 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.422 2.289 . . . . 23.23 112.688 173.075 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 mt -74.99 129.47 37.71 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 124.527 1.142 . . . . 9.1099999999999994 111.576 -171.469 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -71.81 143.34 49.53 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.179 2.659 . . . . 33.439999999999998 118.179 172.72 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.416 ' CG ' HH12 ' A' ' 72' ' ' ARG . 61.7 m-20 -53.78 -54.49 37.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.543 3.137 . . . . 28.370000000000001 113.302 -169.347 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.86 18.8 55.38 Favored Glycine 0 N--CA 1.43 -1.704 0 CA-C-O 116.479 -2.29 . . . . 15.0 116.498 -172.321 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 -92.92 168.84 10.88 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.134 1.967 . . . . 25.5 112.206 169.345 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.9 p -100.81 166.01 11.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 113.974 1.101 . . . . 11.949999999999999 113.974 170.488 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.9 mt -71.59 -25.31 62.13 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 114.411 -2.709 . . . . 10.17 112.66 -177.044 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -70.07 -31.17 68.63 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.852 3.261 . . . . 13.59 110.887 176.224 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -67.84 -33.51 74.91 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.154 1.797 . . . . 11.699999999999999 111.337 175.962 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -91.16 13.38 17.17 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.775 -6.203 . . . . 12.949999999999999 115.343 166.116 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.3 m120 57.73 27.52 14.5 Favored 'General case' 0 N--CA 1.43 -1.428 1 O-C-N 114.904 -4.873 . . . . 25.449999999999999 114.693 179.334 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -81.6 121.98 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 116.973 -3.579 . . . . 14.6 107.127 -174.15 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -109.92 179.08 4.22 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 128.21 2.604 . . . . 33.229999999999997 108.302 -169.653 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 pttp -48.76 145.32 3.82 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.734 1.613 . . . . 25.969999999999999 110.733 172.551 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.257 54.0 mt-10 67.64 30.62 6.47 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 113.008 -1.906 . . . . 32.609999999999999 115.121 165.039 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -108.28 141.48 40.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.234 1.969 . . . . 10.56 110.335 -175.015 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.0 m -89.13 105.82 18.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.746 -2.024 . . . . 5.3300000000000001 107.093 -174.789 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.11 148.42 34.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.147 3.379 . . . . 11.66 108.361 158.213 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.9 m80 -115.3 134.5 55.07 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.933 -1.73 . . . . 16.300000000000001 110.209 170.753 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.7 tp -106.67 116.97 32.85 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.96 1.413 . . . . 9.9600000000000009 109.674 -176.127 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.6 m -127.26 -173.14 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 103.542 -2.762 . . . . 9.7599999999999998 103.542 175.699 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.2 mt -100.53 138.24 37.86 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.859 -1.775 . . . . 19.57 109.996 -173.532 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.416 HH12 ' CG ' ' A' ' 52' ' ' ASP . 59.5 ttt180 -88.7 135.06 33.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.257 2.317 . . . . 35.079999999999998 117.257 178.484 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 mt -90.45 155.46 18.9 Favored 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 128.461 2.704 . . . . 32.310000000000002 109.263 174.999 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -77.12 143.52 39.11 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 109.403 -0.591 . . . . 42.75 109.403 154.689 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.62 -67.72 3.68 Favored Glycine 0 N--CA 1.43 -1.745 1 C-N-CA 131.088 4.185 . . . . 36.310000000000002 116.424 -174.935 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.762 0 CA-C-N 113.388 -1.406 . . . . 36.270000000000003 112.741 -166.361 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ptt? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 114.407 1.262 . . . . 17.170000000000002 114.407 . . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -109.66 149.51 29.62 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.086 1.884 . . . . 21.890000000000001 116.086 178.84 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -133.08 157.28 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 117.331 -3.356 . . . . 10.83 112.205 163.6 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -109.29 131.7 54.82 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 128.293 3.496 . . . . 10.609999999999999 106.425 179.669 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -135.75 131.81 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 117.071 -3.518 . . . . 9.1300000000000008 106.986 -176.37 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -103.41 147.13 27.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.126 -2.234 . . . . 20.550000000000001 109.738 -179.283 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.6 p -85.48 -178.19 6.63 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 123.24 1.495 . . . . 11.779999999999999 108.394 172.297 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.0 tp -60.06 -47.45 85.8 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.049 1.74 . . . . 19.309999999999999 113.485 172.936 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.1 p -93.29 -79.42 0.4 Allowed 'General case' 0 N--CA 1.429 -1.501 0 O-C-N 118.226 -2.796 . . . . 23.140000000000001 112.718 -172.408 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.19 63.62 0.32 Allowed Glycine 0 N--CA 1.43 -1.727 0 C-N-CA 127.157 2.313 . . . . 19.739999999999998 115.111 -177.362 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.4 tttt -140.87 129.54 22.84 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.056 1.884 . . . . 21.93 110.825 172.265 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.9 m -110.79 109.89 20.29 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.259 -3.401 . . . . 12.33 103.908 178.41 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.441 HD11 HG12 ' A' ' 30' ' ' ILE . 1.8 pt -98.88 142.79 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 C-N-CA 127.097 2.159 . . . . 17.079999999999998 111.692 178.531 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.9 m -115.31 112.47 22.45 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.222 -2.174 . . . . 16.300000000000001 110.709 -178.61 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -103.64 155.11 18.81 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.01 1.862 . . . . 15.880000000000001 106.952 -172.278 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -102.56 121.67 42.84 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.021 2.343 . . . . 28.899999999999999 111.667 165.425 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.462 HG12 ' HE3' ' A' ' 29' ' ' LYS . 5.6 m -134.73 164.88 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 103.082 -2.933 . . . . 12.050000000000001 103.082 -175.838 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -120.8 153.42 57.02 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 115.798 -2.049 . . . . 18.170000000000002 109.196 165.103 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -67.61 -13.76 39.94 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 C-N-CA 124.859 3.706 . . . . 8.1600000000000001 115.759 -172.612 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.274 75.2 m -79.73 -2.33 42.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.976 2.91 . . . . 11.130000000000001 116.375 166.501 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -74.21 132.93 42.63 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 102.567 -3.123 . . . . 18.030000000000001 102.567 172.734 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 23.6 p -78.06 154.36 31.44 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.379 3.072 . . . . 10.220000000000001 106.463 165.026 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.8 mm -69.07 -28.15 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 118.507 -0.759 . . . . 12.300000000000001 110.024 178.531 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -51.06 -43.09 60.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 121.523 1.965 . . . . 36.509999999999998 113.883 163.529 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -70.48 -33.64 71.48 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.816 1.643 . . . . 25.66 113.132 173.118 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.5 t -63.24 -40.37 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 123.203 1.478 . . . . 8.1199999999999992 109.477 176.19 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -69.61 -35.27 75.12 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.129 -3.482 . . . . 15.470000000000001 114.065 179.257 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.69 -33.66 76.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.02 -2.925 . . . . 11.449999999999999 112.541 171.121 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HE3' HG12 ' A' ' 17' ' ' VAL . 35.2 mttm -70.62 -39.49 73.69 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.357 2.027 . . . . 24.98 108.452 -179.224 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.441 HG12 HD11 ' A' ' 13' ' ' ILE . 45.7 mt -65.68 -38.24 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 120.263 -1.523 . . . . 9.4600000000000009 111.105 176.203 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -51.27 -48.95 62.06 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.99 -3.569 . . . . 14.76 117.098 165.195 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -68.67 -42.04 78.41 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 121.178 1.808 . . . . 26.289999999999999 111.174 178.309 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -68.26 -57.16 6.4 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 123.652 2.933 . . . . 30.059999999999999 113.052 -179.947 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -103.46 -19.69 14.32 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 116.434 2.013 . . . . 25.190000000000001 116.434 -161.624 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.63 58.23 3.6 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 128.453 2.93 . . . . 7.4100000000000001 112.858 176.042 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.2 tt -127.65 136.41 28.92 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 127.353 2.261 . . . . 9.4900000000000002 108.451 -179.596 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -83.41 161.46 14.93 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 122.922 2.079 . . . . 11.42 107.321 -166.672 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -80.06 -18.35 10.12 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 CA-C-O 114.264 -2.473 . . . . 12.0 115.546 -170.757 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.259 16.3 t0 -66.41 -42.4 87.84 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.343 3.857 . . . . 35.549999999999997 108.179 176.851 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -65.36 -30.32 71.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.484 -2.635 . . . . 20.52 116.022 174.973 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -82.95 121.52 27.09 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 120.621 1.555 . . . . 7.1299999999999999 113.785 -168.88 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -117.7 101.99 8.78 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 102.99 -2.967 . . . . 36.390000000000001 102.99 167.905 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.5 mt -80.11 113.38 18.23 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.859 1.314 . . . . 9.5500000000000007 113.745 171.271 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -93.93 127.89 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 O-C-N 118.335 -2.728 . . . . 13.9 111.711 171.555 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -105.54 114.25 28.31 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.276 2.235 . . . . 6.8600000000000003 107.792 162.793 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.54 -106.51 0.09 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.037 -2.914 . . . . 11.15 110.502 178.38 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.31 20.34 8.44 Favored Glycine 0 N--CA 1.43 -1.707 0 O-C-N 128.67 3.732 . . . . 13.93 116.554 170.957 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -115.52 139.0 50.47 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 102.348 -3.204 . . . . 23.920000000000002 102.348 -173.502 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -89.25 133.46 34.44 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 111.234 -2.712 . . . . 23.23 110.405 170.633 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.55 133.61 54.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 125.703 1.601 . . . . 9.1099999999999994 109.012 -168.278 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -111.08 170.89 7.8 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.73 2.059 . . . . 33.439999999999998 113.434 -176.589 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -76.75 -43.21 38.04 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.919 2.488 . . . . 28.370000000000001 112.399 -156.725 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -71.84 -2.32 51.01 Favored Glycine 0 N--CA 1.431 -1.676 0 N-CA-C 118.81 2.284 . . . . 15.0 118.81 179.149 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -121.12 170.64 9.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.782 -2.599 . . . . 25.5 113.677 -175.91 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.6 p -101.74 -172.46 2.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 105.879 -1.897 . . . . 11.949999999999999 105.879 -161.228 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.4 ' H ' ' HB ' ' A' ' 55' ' ' THR . 12.4 mt -79.32 -37.5 37.46 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.118 -1.401 . . . . 10.17 110.782 172.276 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.6 p -61.4 -31.61 71.53 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.787 2.884 . . . . 13.59 118.787 172.173 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.76 -39.05 93.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.319 2.248 . . . . 11.699999999999999 109.551 -179.613 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -92.31 -0.17 57.41 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 131.143 3.777 . . . . 12.949999999999999 113.785 178.509 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.6 m120 72.99 35.6 0.95 Allowed 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.478 2.311 . . . . 25.449999999999999 108.761 173.733 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.7 mt -95.32 114.61 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 125.349 2.499 . . . . 14.6 109.036 -178.079 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -113.44 -179.43 3.64 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 112.357 -6.464 . . . . 33.229999999999997 109.307 178.61 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.1 ptmt -47.67 147.03 1.99 Allowed 'General case' 0 N--CA 1.43 -1.474 1 N-CA-C 123.952 4.797 . . . . 25.969999999999999 123.952 179.339 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 55.88 29.34 13.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.542 -3.849 . . . . 32.609999999999999 116.383 -177.091 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -82.38 139.98 33.75 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 115.864 -2.017 . . . . 10.56 111.626 174.565 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.9 m -83.49 122.41 28.49 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.996 2.06 . . . . 5.3300000000000001 112.605 166.754 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.31 157.1 25.51 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 106.022 -1.844 . . . . 11.66 106.022 172.132 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -129.45 127.04 40.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 114.23 1.196 . . . . 16.300000000000001 114.23 177.777 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 mt -77.06 120.38 22.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 116.779 -3.701 . . . . 9.9600000000000009 112.356 163.893 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -110.79 -178.85 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 N-CA-C 104.87 -2.27 . . . . 9.7599999999999998 104.87 -170.126 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.8 tp -86.41 119.79 27.05 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.189 2.18 . . . . 19.57 113.815 172.935 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -98.75 114.21 26.65 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 115.815 1.783 . . . . 35.079999999999998 115.815 177.436 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.8 tp -92.45 139.2 30.83 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.047 2.939 . . . . 32.310000000000002 107.603 167.411 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -81.65 132.63 35.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.681 -1.887 . . . . 42.75 112.841 177.29 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.9 53.14 0.19 Allowed Glycine 0 N--CA 1.43 -1.734 1 C-N-CA 131.021 4.153 . . . . 36.310000000000002 108.313 -172.303 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.741 0 C-N-CA 124.749 1.166 . . . . 36.270000000000003 111.497 -178.678 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 108.651 -0.87 . . . . 17.170000000000002 108.651 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.262 29.7 mt-30 -94.22 130.26 40.52 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.579 -1.201 . . . . 21.890000000000001 113.745 177.742 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -120.35 150.21 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 125.97 1.708 . . . . 10.83 106.722 170.526 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -106.01 141.73 36.9 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.713 -2.492 . . . . 10.609999999999999 106.681 -172.69 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.49 128.57 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 117.21 -1.796 . . . . 9.1300000000000008 107.864 -179.462 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -105.62 110.87 23.35 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 115.719 -4.363 . . . . 20.550000000000001 103.631 -173.992 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 39.1 p -72.41 166.85 21.76 Favored 'General case' 0 N--CA 1.429 -1.491 0 C-N-CA 126.132 1.773 . . . . 11.779999999999999 107.964 -175.044 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.9 tp -75.43 -41.01 56.92 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.05 -2.281 . . . . 19.309999999999999 113.293 -172.257 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.9 p -56.92 -57.82 10.85 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 123.373 1.559 . . . . 23.140000000000001 112.401 168.194 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.24 68.0 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.834 1.797 . . . . 19.739999999999998 114.372 171.765 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -127.79 129.96 47.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.595 -2.709 . . . . 21.93 108.681 165.349 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.6 m -81.44 96.29 7.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 121.141 -0.974 . . . . 12.33 112.366 173.283 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.5 pt -92.43 142.2 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.583 -1.948 . . . . 17.079999999999998 113.793 -178.019 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 92.4 m -96.08 128.54 43.07 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 120.188 -1.57 . . . . 16.300000000000001 113.686 178.307 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 77.3 mt -124.12 133.13 53.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.99 -2.944 . . . . 15.880000000000001 107.578 -178.739 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.361 13.7 mt-10 -84.41 113.58 21.28 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.796 3.238 . . . . 28.899999999999999 113.093 162.816 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -133.83 155.72 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 1 N-CA-C 99.556 -4.239 . . . . 12.050000000000001 99.556 175.572 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -89.46 144.65 32.45 Favored Pre-proline 0 N--CA 1.429 -1.492 1 O-C-N 116.229 -4.044 . . . . 18.170000000000002 105.482 163.764 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -78.16 4.67 6.01 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-O 113.662 -2.724 . . . . 8.1600000000000001 117.022 -175.97 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 41.1 m -91.52 -9.61 43.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.594 3.361 . . . . 11.130000000000001 110.958 171.411 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -80.19 171.0 15.65 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 125.262 3.664 . . . . 18.030000000000001 109.353 -179.318 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.7 p -80.75 159.03 25.31 Favored 'General case' 0 N--CA 1.43 -1.426 1 C-N-CA 133.274 4.629 . . . . 10.220000000000001 113.526 173.445 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.275 31.0 mm -67.13 -17.02 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 125.007 2.337 . . . . 12.300000000000001 111.031 -179.409 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -55.22 -37.26 66.92 Favored 'General case' 0 N--CA 1.429 -1.491 1 O-C-N 116.146 -4.096 . . . . 36.509999999999998 117.495 171.711 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -67.43 -41.61 84.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.189 2.996 . . . . 25.66 112.435 169.644 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.41 -43.73 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.274 -2.766 . . . . 8.1199999999999992 111.188 174.224 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.258 79.8 mttt -62.89 -39.03 93.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.78 -2.45 . . . . 15.470000000000001 111.277 172.84 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.79 -44.13 86.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.628 1.971 . . . . 11.449999999999999 111.309 -178.768 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.0 mmtt -61.78 -37.59 84.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 116.739 2.126 . . . . 24.98 116.739 169.203 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 23.8 mt -72.84 -32.16 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 118.939 -1.104 . . . . 9.4600000000000009 109.568 170.615 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -58.95 -48.41 81.63 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 116.388 -3.945 . . . . 14.76 113.389 172.136 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.48 -39.43 90.9 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 131.307 3.843 . . . . 26.289999999999999 110.713 -177.376 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -75.9 -55.1 5.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.617 3.191 . . . . 30.059999999999999 119.617 174.994 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -104.68 -37.87 6.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 114.129 -2.843 . . . . 25.190000000000001 111.066 -167.254 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.28 10.68 31.16 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 122.684 2.493 . . . . 7.4100000000000001 110.205 173.858 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.477 HD13 HD21 ' A' ' 69' ' ' LEU 0.368 14.1 tt -75.47 115.38 45.06 Favored Pre-proline 0 N--CA 1.429 -1.501 0 C-N-CA 130.683 3.593 . . . . 9.4900000000000002 116.834 169.839 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -80.66 159.26 21.93 Favored 'Trans proline' 0 N--CA 1.434 -2.027 2 CA-C-N 130.411 4.754 . . . . 11.42 110.351 -172.378 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -62.12 -22.61 74.5 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 C-N-CA 124.954 3.769 . . . . 12.0 114.715 -168.827 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.5 ' CG ' HH22 ' A' ' 74' ' ' ARG . 27.7 t70 -65.83 -36.26 82.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 125.334 1.453 . . . . 35.549999999999997 111.937 -175.805 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -91.57 -15.63 28.37 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.68 3.133 . . . . 20.52 110.493 -171.525 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -77.85 131.24 37.45 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.215 -2.803 . . . . 7.1299999999999999 116.451 170.756 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -120.8 122.4 40.25 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.386 -3.321 . . . . 36.390000000000001 108.701 162.518 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.9 mt -114.03 105.44 13.22 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.796 -2.44 . . . . 9.5500000000000007 111.85 -171.728 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.1 mm -90.27 136.51 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 127.773 2.429 . . . . 13.9 112.194 179.639 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -122.83 94.01 4.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.415 2.286 . . . . 6.8600000000000003 106.657 -178.951 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.297 . . 73.44 -77.75 0.05 Allowed 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.565 -2.584 . . . . 11.15 111.23 -172.517 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -154.29 16.76 0.59 Allowed Glycine 0 N--CA 1.43 -1.726 0 CA-C-N 114.214 -1.357 . . . . 13.93 111.889 -177.757 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.3 ptmt -120.98 164.67 16.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 129.442 3.097 . . . . 23.920000000000002 113.391 170.845 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -119.29 120.53 37.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 122.183 -0.323 . . . . 23.23 110.699 -167.441 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.59 147.86 28.35 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.511 2.1 . . . . 9.1099999999999994 110.897 -167.535 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -110.8 167.12 10.48 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.647 -2.533 . . . . 33.439999999999998 104.749 -168.17 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -74.16 -66.72 0.69 Allowed 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 122.989 1.376 . . . . 28.370000000000001 113.682 -169.038 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -74.63 18.64 2.22 Favored Glycine 0 N--CA 1.43 -1.705 0 N-CA-C 116.394 1.318 . . . . 15.0 116.394 -170.472 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -115.94 154.95 28.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.938 -2.615 . . . . 25.5 103.938 -176.151 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -87.67 146.28 25.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.605 3.557 . . . . 11.949999999999999 120.605 -179.456 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.1 mt -55.04 -43.72 74.01 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 118.712 2.856 . . . . 10.17 118.712 173.717 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 p -66.26 -33.45 75.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.996 2.591 . . . . 13.59 117.996 170.052 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.77 -36.46 80.54 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 122.607 2.458 . . . . 11.699999999999999 112.663 177.038 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -69.62 -18.03 63.57 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.808 3.243 . . . . 12.949999999999999 113.817 174.808 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 m120 65.09 51.69 1.63 Allowed 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.51 1.524 . . . . 25.449999999999999 111.822 -174.801 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -94.7 111.41 25.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-O 123.62 1.676 . . . . 14.6 108.392 174.92 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -101.72 165.62 11.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 111.5 -2.591 . . . . 33.229999999999997 108.98 -162.775 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttp -61.73 133.85 56.05 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.628 -2.545 . . . . 25.969999999999999 116.298 178.729 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 49.9 mt-10 71.59 25.41 3.34 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 117.289 2.329 . . . . 32.609999999999999 117.289 -177.539 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.5 m -94.29 146.29 24.13 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.676 2.472 . . . . 10.56 117.676 174.94 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -104.32 116.93 33.02 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.996 -4.19 . . . . 5.3300000000000001 108.931 -163.737 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.5 mp -92.37 132.59 36.62 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.867 2.467 . . . . 11.66 110.088 167.636 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -81.93 127.79 33.4 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.16 -3.462 . . . . 16.300000000000001 116.173 159.747 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.477 HD21 HD13 ' A' ' 36' ' ' ILE . 60.7 tp -94.79 103.03 14.92 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 125.129 1.518 . . . . 9.9600000000000009 110.695 159.013 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.4 m -94.38 -177.05 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.475 0 C-N-CA 117.819 -1.552 . . . . 9.7599999999999998 107.252 -179.676 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.4 tp -76.68 138.04 39.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 110.798 -2.91 . . . . 19.57 107.282 170.73 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -92.97 125.36 37.53 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.746 -3.096 . . . . 35.079999999999998 112.335 173.141 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 67.3 mt -104.5 132.34 50.86 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.298 -2.126 . . . . 32.310000000000002 107.801 166.137 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.5 HH22 ' CG ' ' A' ' 39' ' ' ASP . 21.8 mmt180 -80.41 139.46 36.48 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.276 3.43 . . . . 42.75 107.331 -176.452 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 148.77 -75.51 0.26 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 118.184 -2.823 . . . . 36.310000000000002 106.19 -166.357 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.778 1 C-N-CA 134.18 5.657 . . . . 36.270000000000003 111.66 -178.79 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 CA--C 1.49 -1.344 0 CA-C-O 122.832 1.301 . . . . 17.170000000000002 107.949 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -87.67 135.83 33.2 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.929 2.196 . . . . 21.890000000000001 116.929 160.752 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -125.99 142.41 42.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 128.739 2.815 . . . . 10.83 105.694 -175.223 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -102.45 143.09 32.62 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.897 1.808 . . . . 10.609999999999999 106.713 175.917 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.8 t -124.46 130.94 73.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.311 -1.768 . . . . 9.1300000000000008 110.777 162.811 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -96.2 126.19 41.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.791 1.632 . . . . 20.550000000000001 111.261 168.099 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 69' ' ' LEU 0.259 72.2 p -89.73 176.26 6.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.67 3.188 . . . . 11.779999999999999 114.36 -171.168 . . . . . . . . 3 3 . 1 . 055 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.423 HD22 HD21 ' A' ' 71' ' ' LEU . 51.0 tp -79.48 -54.93 5.43 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.264 -2.148 . . . . 19.309999999999999 112.613 -178.174 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.2 p -38.06 -72.34 0.06 Allowed 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.312 2.708 . . . . 23.140000000000001 118.312 161.418 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.84 45.79 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.232 -3.418 . . . . 19.739999999999998 112.944 167.771 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.0 mtpt -119.08 149.25 42.0 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.485 -1.302 . . . . 21.93 107.485 179.717 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.2 m -110.26 101.15 9.92 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 104.254 -2.499 . . . . 12.33 104.254 171.405 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.411 HD11 HG12 ' A' ' 30' ' ' ILE . 28.6 pt -94.86 126.3 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 127.256 3.408 . . . . 17.079999999999998 112.193 -176.389 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.275 3.2 m -74.91 114.4 13.32 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.332 -3.355 . . . . 16.300000000000001 117.369 161.994 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.2 mt -122.42 149.16 44.21 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 116.014 -4.179 . . . . 15.880000000000001 106.623 174.475 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -102.4 125.75 49.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.509 2.576 . . . . 28.899999999999999 108.621 -178.291 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.536 HG11 HG22 ' A' ' 26' ' ' VAL . 8.9 m -147.77 165.1 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 118.492 -2.63 . . . . 12.050000000000001 106.945 -178.118 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -102.28 170.84 5.88 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 125.675 2.655 . . . . 18.170000000000002 110.093 161.852 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -56.89 -41.68 72.7 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 O-C-N 114.801 -3.315 . . . . 8.1600000000000001 117.374 166.46 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.2 p -70.68 -3.51 18.84 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 128.591 2.757 . . . . 11.130000000000001 115.223 176.239 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -83.88 153.54 23.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.32 -2.113 . . . . 18.030000000000001 113.894 167.552 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.6 p -95.16 176.53 6.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.689 -3.757 . . . . 10.220000000000001 115.846 -172.493 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.8 mm -66.55 -43.55 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 118.86 -2.4 . . . . 12.300000000000001 107.607 173.923 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -47.82 -46.09 30.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.795 2.517 . . . . 36.509999999999998 117.795 168.535 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -75.75 -28.72 58.58 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.99 -1.068 . . . . 25.66 110.26 -178.685 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.536 HG22 HG11 ' A' ' 17' ' ' VAL . 83.9 t -59.65 -54.54 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 117.666 -3.146 . . . . 8.1199999999999992 110.881 169.867 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -58.74 -24.32 61.4 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.545 -1.972 . . . . 15.470000000000001 115.951 179.159 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.253 . . -76.4 -28.29 56.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 121.321 -0.862 . . . . 11.449999999999999 111.29 -177.738 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -68.83 -49.25 60.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.186 2.595 . . . . 24.98 105.346 176.901 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 13' ' ' ILE . 39.9 mt -61.42 -39.32 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 127.89 3.709 . . . . 9.4600000000000009 114.261 -178.533 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -58.4 -39.7 80.39 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.124 -4.11 . . . . 14.76 115.647 171.517 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -67.31 -70.41 0.25 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.436 -1.69 . . . . 26.289999999999999 106.436 178.149 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -77.8 -33.87 52.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.708 2.114 . . . . 30.059999999999999 116.708 -161.277 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -99.22 -63.13 1.15 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 120.991 1.723 . . . . 25.190000000000001 109.248 179.203 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.94 89.02 1.22 Allowed Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.505 -1.997 . . . . 7.4100000000000001 111.61 174.501 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.418 ' CD1' HD21 ' A' ' 69' ' ' LEU . 38.5 mt -146.18 128.45 7.81 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 115.856 -2.021 . . . . 9.4900000000000002 106.898 179.669 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -61.49 145.5 97.88 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 125.132 2.869 . . . . 11.42 117.998 176.681 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -79.26 -15.34 12.78 Favored 'Trans proline' 0 N--CA 1.434 -1.994 0 C-N-CA 123.568 2.845 . . . . 12.0 116.252 -166.506 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -83.35 -35.07 25.44 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 124.113 1.911 . . . . 35.549999999999997 108.748 174.545 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -72.86 -30.06 63.69 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 116.576 -3.828 . . . . 20.52 108.896 -179.737 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -64.57 134.95 55.42 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.225 -2.797 . . . . 7.1299999999999999 115.953 173.787 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -129.08 114.8 16.81 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.775 2.226 . . . . 36.390000000000001 112.299 167.907 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.6 mt -93.87 119.8 33.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.453 -3.067 . . . . 9.5500000000000007 112.643 179.709 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.6 mm -108.9 130.74 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 CA-C-O 123.575 1.655 . . . . 13.9 108.597 -179.816 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -111.19 104.96 13.51 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.534 2.587 . . . . 6.8600000000000003 113.204 166.051 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.292 . . 71.6 -83.82 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.219 -3.425 . . . . 11.15 109.575 -168.489 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.59 28.82 0.85 Allowed Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 107.847 -2.101 . . . . 13.93 107.847 166.624 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -107.53 111.89 24.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 104.366 -2.457 . . . . 23.920000000000002 104.366 175.911 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -70.32 130.39 41.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.687 2.184 . . . . 23.23 109.359 176.852 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -91.7 123.86 35.41 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 114.369 -1.287 . . . . 9.1099999999999994 114.155 -171.391 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -74.79 136.85 41.65 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 116.467 2.025 . . . . 33.439999999999998 116.467 173.198 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -39.29 -60.83 0.86 Allowed 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.351 2.723 . . . . 28.370000000000001 118.351 175.38 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -65.52 -10.19 47.8 Favored Glycine 0 N--CA 1.431 -1.691 0 O-C-N 117.057 -3.527 . . . . 15.0 121.2 -177.936 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.3 mtt-85 -96.1 165.02 12.44 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 120.53 2.165 . . . . 25.5 114.803 -172.298 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 15.5 p -88.57 158.51 18.26 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.929 -4.232 . . . . 11.949999999999999 109.271 -172.073 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.518 HD21 HG21 ' A' ' 26' ' ' VAL . 1.6 mt -62.74 -40.45 97.25 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.61 -0.723 . . . . 10.17 111.978 171.101 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.5 p -47.85 -36.72 12.46 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.735 -2.478 . . . . 13.59 116.755 168.981 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -72.3 -42.08 65.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.825 1.65 . . . . 11.699999999999999 108.532 -166.679 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -84.15 0.52 48.27 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 119.904 -1.747 . . . . 12.949999999999999 111.533 179.937 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.8 m120 73.03 41.68 0.49 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 124.043 0.937 . . . . 25.449999999999999 108.908 174.142 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.5 mt -85.85 122.18 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 116.877 -1.535 . . . . 14.6 113.392 177.577 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -112.75 175.31 5.49 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 119.429 1.013 . . . . 33.229999999999997 111.86 -175.125 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.295 19.2 pttp -66.3 151.33 47.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.523 3.058 . . . . 25.969999999999999 108.916 175.763 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 63.35 4.58 1.73 Allowed 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 120.09 3.367 . . . . 32.609999999999999 120.09 -172.22 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -72.08 162.21 29.78 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.297 -1.774 . . . . 10.56 107.265 172.601 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.8 m -130.64 121.34 25.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 116.844 -1.551 . . . . 5.3300000000000001 108.994 -177.074 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.1 mt -92.51 150.33 20.82 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.739 2.685 . . . . 11.66 112.422 172.62 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.1 t-160 -108.46 127.68 54.13 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.845 -3.659 . . . . 16.300000000000001 110.149 -178.088 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.418 HD21 ' CD1' ' A' ' 36' ' ' ILE . 53.6 tp -94.2 103.81 15.84 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.181 -0.918 . . . . 9.9600000000000009 112.309 -171.963 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.317 18.4 m -116.98 -169.0 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 N-CA-C 106.369 -1.715 . . . . 9.7599999999999998 106.369 -174.981 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.423 HD21 HD22 ' A' ' 8' ' ' LEU . 8.7 mt -112.83 147.56 36.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.97 1.708 . . . . 19.57 110.285 -168.46 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -98.54 123.27 42.6 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 120.571 -1.33 . . . . 35.079999999999998 111.23 176.507 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.8 mt -111.07 166.29 11.18 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 127.787 2.435 . . . . 32.310000000000002 106.852 175.235 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.469 68.8 mtt-85 -70.99 155.94 40.23 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 126.013 2.071 . . . . 42.75 115.639 -168.831 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.14 -72.5 0.25 Allowed Glycine 0 N--CA 1.43 -1.767 0 CA-C-N 122.522 2.419 . . . . 36.310000000000002 113.023 178.868 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.706 0 CA-C-O 124.735 2.297 . . . . 36.270000000000003 112.969 -168.614 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.512 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 4.9 ptm . . . . . 0 CA--C 1.49 -1.336 0 N-CA-C 118.434 2.753 . . . . 17.170000000000002 118.434 . . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -87.47 125.62 34.41 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.744 -1.848 . . . . 21.890000000000001 107.089 -174.897 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.0 pt -115.91 163.69 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 112.069 -2.332 . . . . 10.83 107.168 174.034 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -124.72 132.94 53.34 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.147 2.579 . . . . 10.609999999999999 106.532 -177.354 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.24 117.63 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 121.142 -0.974 . . . . 9.1300000000000008 109.57 176.661 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -109.94 141.22 43.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.341 -2.724 . . . . 20.550000000000001 115.745 -179.62 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.4 p -83.59 -171.87 3.83 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.295 1.22 . . . . 11.779999999999999 114.295 179.744 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 tp -72.62 -35.07 67.74 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.729 -3.107 . . . . 19.309999999999999 109.802 -178.34 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 p -87.15 -49.16 7.48 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 104.247 -2.501 . . . . 23.140000000000001 104.247 -178.083 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.98 59.48 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 117.403 -1.776 . . . . 19.739999999999998 116.599 166.156 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -96.51 125.41 40.98 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.706 -3.442 . . . . 21.93 101.706 166.687 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -105.23 122.37 45.78 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.976 -2.601 . . . . 12.33 103.976 -175.853 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.2 pt -108.49 130.76 60.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 125.808 2.718 . . . . 17.079999999999998 116.06 168.759 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.2 m -86.34 116.45 24.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.664 -3.772 . . . . 16.300000000000001 107.915 179.513 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 27.0 mt -121.39 156.38 32.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.906 -2.371 . . . . 15.880000000000001 109.319 -179.341 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -130.98 129.99 42.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.097 -2.557 . . . . 28.899999999999999 104.097 179.995 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.9 m -148.57 179.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 C-N-CA 125.882 1.673 . . . . 12.050000000000001 108.652 177.009 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 17.9 mm-40 -107.58 169.14 7.01 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 119.677 -1.889 . . . . 18.170000000000002 107.533 174.953 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 43.7 Cg_endo -83.67 -2.24 10.33 Favored 'Trans proline' 0 C--N 1.299 -2.044 0 C-N-CA 124.712 3.608 . . . . 8.1600000000000001 113.021 -173.103 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.273 73.4 m -101.68 -0.44 34.6 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 126.266 2.229 . . . . 11.130000000000001 110.499 174.14 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -71.4 145.15 49.52 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.396 -3.315 . . . . 18.030000000000001 110.099 173.029 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.6 p -79.63 164.51 23.74 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.066 -2.271 . . . . 10.220000000000001 113.848 173.038 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.0 mm -57.21 -38.52 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 126.668 1.987 . . . . 12.300000000000001 109.604 171.08 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -47.65 -51.97 19.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.001 1.721 . . . . 36.509999999999998 114.066 167.943 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -72.65 -12.38 61.01 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 125.458 1.503 . . . . 25.66 114.288 176.565 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.4 t -80.03 -50.05 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 104.165 -2.531 . . . . 8.1199999999999992 104.165 172.668 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.298 62.7 mttt -47.78 -38.65 16.12 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.415 2.686 . . . . 15.470000000000001 113.875 170.039 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.56 -44.34 93.31 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 128.672 2.789 . . . . 11.449999999999999 115.136 -178.271 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -69.89 -40.4 75.68 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.814 2.846 . . . . 24.98 107.731 178.307 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.45 -33.58 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 124.454 1.096 . . . . 9.4600000000000009 109.153 179.484 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.42 -44.03 92.95 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.153 -2.217 . . . . 14.76 114.139 172.708 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -59.7 -61.21 2.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.572 1.949 . . . . 26.289999999999999 113.855 171.727 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.99 -52.02 67.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 121.059 3.725 . . . . 30.059999999999999 121.059 -179.991 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -108.97 -29.87 8.37 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 114.584 1.327 . . . . 25.190000000000001 114.584 -157.584 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.19 41.21 8.11 Favored Glycine 0 N--CA 1.43 -1.765 0 N-CA-C 110.201 -1.16 . . . . 7.4100000000000001 110.201 177.244 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.1 mt -102.73 120.06 53.89 Favored Pre-proline 0 N--CA 1.431 -1.424 0 CA-C-O 115.461 -2.209 . . . . 9.4900000000000002 111.678 169.055 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 95.1 Cg_exo -59.14 146.25 95.06 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 CA-C-N 126.305 3.287 . . . . 11.42 114.227 172.424 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -59.24 -29.53 90.59 Favored 'Trans proline' 0 C--N 1.299 -2.027 1 C-N-CA 125.333 4.022 . . . . 12.0 116.438 179.93 . . . . . . . . 4 4 . 1 . 056 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -64.9 -42.37 94.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 116.988 -3.57 . . . . 35.549999999999997 113.266 168.851 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.403 ' HG2' HD22 ' A' ' 71' ' ' LEU 0.287 12.7 tt0 -64.95 -35.17 80.3 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.748 2.019 . . . . 20.52 112.618 173.092 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -81.14 136.81 35.94 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.418 -2.676 . . . . 7.1299999999999999 115.647 -177.462 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -128.94 117.46 21.01 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 128.062 3.351 . . . . 36.390000000000001 110.031 167.077 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 39.8 mt -91.68 121.91 33.76 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.493 -1.717 . . . . 9.5500000000000007 109.24 179.599 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mt -111.05 133.27 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 124.525 3.329 . . . . 13.9 108.262 178.041 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -115.38 107.59 15.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.148 2.979 . . . . 6.8600000000000003 107.147 172.196 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 63.38 -96.07 0.05 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.331 2.652 . . . . 11.15 111.823 -166.545 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.71 -5.5 9.11 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 123.675 1.708 . . . . 13.93 109.541 -178.372 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -98.75 126.55 44.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.49 -3.947 . . . . 23.920000000000002 105.985 -166.832 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -90.61 141.31 28.9 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 127.712 3.625 . . . . 23.23 106.344 176.071 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.365 97.1 mt -104.52 133.77 48.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.748 -3.72 . . . . 9.1099999999999994 114.312 -168.827 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -74.63 154.83 38.35 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.687 2.395 . . . . 33.439999999999998 112.231 174.881 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -73.16 -55.57 6.29 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 130.053 3.341 . . . . 28.370000000000001 112.346 -167.131 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.73 18.47 30.09 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 119.136 2.415 . . . . 15.0 119.136 -172.766 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.0 mtt-85 -114.01 146.6 39.95 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.606 2.146 . . . . 25.5 109.897 169.763 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.264 73.3 p -75.99 162.82 27.74 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 128.937 2.895 . . . . 11.949999999999999 116.866 -179.105 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.9 mt -58.43 -49.57 76.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 128.807 3.817 . . . . 10.17 109.92 174.873 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.357 88.9 p -57.54 -43.96 84.77 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.795 3.238 . . . . 13.59 119.487 178.698 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -53.81 -53.42 52.58 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 121.588 3.921 . . . . 11.699999999999999 121.588 162.924 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -62.44 -21.01 65.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.66 2.467 . . . . 12.949999999999999 117.66 169.325 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.347 58.2 t30 60.04 67.64 0.85 Allowed 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 116.508 2.04 . . . . 25.449999999999999 116.508 -161.556 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.4 mt -118.5 117.39 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.5 -2.778 . . . . 14.6 103.5 170.198 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -93.35 -163.15 1.01 Allowed 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.48 2.562 . . . . 33.229999999999997 112.685 -175.536 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.512 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 38.1 pttt -76.0 156.71 33.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.213 -3.43 . . . . 25.969999999999999 115.427 168.548 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.85 23.33 13.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.31 2.244 . . . . 32.609999999999999 110.741 176.663 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -85.36 122.53 29.65 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 126.071 1.748 . . . . 10.56 113.335 175.631 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.9 m -88.52 98.9 11.91 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 116.132 -1.89 . . . . 5.3300000000000001 112.498 170.667 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -87.96 140.04 29.9 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.704 2.002 . . . . 11.66 109.015 -179.966 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -98.64 107.61 20.1 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 120.428 -1.42 . . . . 16.300000000000001 113.49 -173.267 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.8 tp -82.88 109.78 17.31 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 129.156 2.982 . . . . 9.9600000000000009 112.368 -177.172 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.9 m -121.58 161.76 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 116.726 -3.733 . . . . 9.7599999999999998 106.912 177.981 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.403 HD22 ' HG2' ' A' ' 40' ' ' GLN . 29.8 mt -81.28 138.67 35.71 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.591 -1.263 . . . . 19.57 107.591 -173.087 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -109.78 107.38 17.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.579 2.751 . . . . 35.079999999999998 104.525 171.048 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.404 ' HB3' ' H ' ' A' ' 74' ' ' ARG . 1.2 mm? -91.35 -142.68 0.18 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.303 -3.998 . . . . 32.310000000000002 108.778 168.951 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.404 ' H ' ' HB3' ' A' ' 73' ' ' LEU . 32.6 mmt180 -96.11 171.93 8.3 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.202 1.953 . . . . 42.75 108.379 174.03 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.4 -62.74 4.04 Favored Glycine 0 N--CA 1.43 -1.743 0 CA-C-N 111.496 -2.593 . . . . 36.310000000000002 115.428 -170.876 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 C-N-CA 115.121 -3.418 . . . . 36.270000000000003 110.618 -176.13 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.454 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 13.6 ptt? . . . . . 0 CA--C 1.49 -1.347 0 N-CA-C 106.484 -1.672 . . . . 17.170000000000002 106.484 . . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.273 4.2 pt20 -113.28 127.69 56.23 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.712 -2.493 . . . . 21.890000000000001 112.773 176.189 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.0 pt -120.34 174.48 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-O 125.293 2.473 . . . . 10.83 108.102 171.883 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -120.96 145.9 47.23 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 112.744 -2.026 . . . . 10.609999999999999 109.802 -176.78 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.5 t -132.99 122.53 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 107.402 -1.333 . . . . 9.1300000000000008 107.402 173.218 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -136.05 142.21 44.37 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 116.394 -3.941 . . . . 20.550000000000001 115.338 -164.33 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.278 80.7 p -80.85 -171.5 3.2 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 126.533 3.064 . . . . 11.779999999999999 110.03 -170.612 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.6 tp -74.89 -40.5 60.87 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 131.556 3.943 . . . . 19.309999999999999 114.266 166.945 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.18 -47.6 49.51 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.544 -3.223 . . . . 23.140000000000001 111.031 173.606 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.91 35.91 0.23 Allowed Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 114.637 -3.313 . . . . 19.739999999999998 115.593 172.782 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -88.03 121.58 30.6 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 113.746 -3.026 . . . . 21.93 110.701 178.784 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.4 m -108.19 137.57 45.94 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 121.695 2.043 . . . . 12.33 114.037 -172.331 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.1 pt -124.6 136.78 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 118.532 -1.267 . . . . 17.079999999999998 107.804 172.776 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.3 m -82.81 120.89 26.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 130.176 3.39 . . . . 16.300000000000001 108.564 168.862 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.7 mt -115.17 132.73 56.51 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.966 -2.334 . . . . 15.880000000000001 107.123 174.504 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -107.82 115.09 29.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.191 -2.818 . . . . 28.899999999999999 108.762 -178.681 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.31 162.04 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 124.559 1.162 . . . . 12.050000000000001 109.473 -166.928 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -90.7 155.08 45.89 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 120.374 -1.454 . . . . 18.170000000000002 107.444 159.512 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_exo -60.95 -23.39 77.17 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 122.722 2.282 . . . . 8.1600000000000001 112.674 168.536 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.0 m -69.39 -18.32 63.76 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.003 2.638 . . . . 11.130000000000001 113.498 173.427 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -65.53 147.15 53.89 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 123.525 2.875 . . . . 18.030000000000001 108.574 179.162 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.8 p -85.08 172.91 10.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 115.933 1.827 . . . . 10.220000000000001 115.933 179.061 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 13.1 mm -78.15 -27.11 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 124.053 0.846 . . . . 12.300000000000001 109.326 178.432 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -50.81 -59.54 4.0 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.386 -2.188 . . . . 36.509999999999998 114.143 167.634 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.468 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 7.3 t-20 -55.14 -45.77 75.65 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.98 3.712 . . . . 25.66 109.984 176.082 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -60.4 -50.32 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.363 -2.086 . . . . 8.1199999999999992 113.156 -176.508 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.7 mttt -63.39 -37.19 86.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 124.014 1.864 . . . . 15.470000000000001 110.354 176.584 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.38 -13.12 36.05 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 115.324 -4.61 . . . . 11.449999999999999 114.206 174.726 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 25' ' ' ASN . 13.7 mtpt -80.04 -49.24 12.07 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.909 -2.994 . . . . 24.98 117.487 169.189 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.9 mt -60.23 -30.26 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 126.096 2.855 . . . . 9.4600000000000009 112.523 171.944 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -70.7 -43.35 69.17 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.346 -3.971 . . . . 14.76 117.143 172.969 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -56.33 -49.53 74.09 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.793 2.516 . . . . 26.289999999999999 117.793 159.313 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -79.94 -74.73 0.29 Allowed 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 116.266 -4.021 . . . . 30.059999999999999 111.274 -176.606 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -64.94 -43.3 93.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 120.322 1.419 . . . . 25.190000000000001 113.824 -173.509 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.69 68.83 1.19 Allowed Glycine 0 N--CA 1.43 -1.744 0 N-CA-C 107.06 -2.416 . . . . 7.4100000000000001 107.06 179.53 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.2 mt -127.8 128.44 23.87 Favored Pre-proline 0 N--CA 1.43 -1.458 0 CA-C-N 113.393 -1.403 . . . . 9.4900000000000002 108.644 176.643 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -66.69 143.53 68.3 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-O 114.342 -2.441 . . . . 11.42 115.015 -174.596 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.81 -14.69 42.34 Favored 'Trans proline' 0 N--CA 1.434 -1.988 0 C-N-CA 122.841 2.361 . . . . 12.0 113.027 -163.68 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.5 p-10 -95.96 -22.31 17.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 123.021 2.646 . . . . 35.549999999999997 110.318 -179.66 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.378 32.9 mt-30 -71.47 -22.6 61.8 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 117.645 -1.169 . . . . 20.52 112.87 164.355 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -79.33 124.58 28.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.955 -2.609 . . . . 7.1299999999999999 103.955 175.601 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 52.6 mtp180 -110.89 122.13 47.09 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.978 3.311 . . . . 36.390000000000001 109.685 156.217 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.3 mt -113.78 133.23 55.5 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.368 2.509 . . . . 9.5500000000000007 105.435 178.101 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.0 mm -130.39 119.4 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 111.033 -2.803 . . . . 13.9 103.733 -163.244 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -93.98 108.88 20.65 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 125.453 1.501 . . . . 6.8600000000000003 110.773 158.194 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.53 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.48 -2.637 . . . . 11.15 112.118 179.825 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.88 36.72 1.21 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 126.192 1.853 . . . . 13.93 110.756 165.965 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -108.28 123.74 49.25 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.5 -2.177 . . . . 23.920000000000002 113.68 162.581 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -81.57 136.07 35.57 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.186 -3.446 . . . . 23.23 109.386 166.246 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.73 127.98 35.31 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 124.776 1.231 . . . . 9.1099999999999994 111.071 179.595 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -78.43 133.14 37.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.954 2.576 . . . . 33.439999999999998 117.954 -178.214 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 47.1 m-20 -49.14 -45.37 43.6 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.363 -3.335 . . . . 28.370000000000001 116.288 -168.129 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.73 4.49 75.8 Favored Glycine 0 N--CA 1.429 -1.808 0 CA-C-N 119.981 1.264 . . . . 15.0 112.586 -169.107 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.3 40.0 mtt180 -95.19 166.17 12.04 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 117.069 -3.607 . . . . 25.5 109.262 -178.495 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.8 p -92.66 156.24 17.2 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.161 -2.212 . . . . 11.949999999999999 106.475 -178.516 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 75.4 mt -51.14 -45.25 61.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.971 -3.581 . . . . 10.17 113.726 164.7 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.4 t -57.12 -36.6 70.85 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.826 2.051 . . . . 13.59 108.316 -177.391 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -64.59 -30.9 71.93 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.289 -2.132 . . . . 11.699999999999999 113.512 -167.486 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -87.27 0.61 55.13 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 114.165 -1.38 . . . . 12.949999999999999 113.044 178.423 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 62.23 49.21 4.44 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.837 1.655 . . . . 25.449999999999999 112.605 -178.742 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.8 mm -91.94 112.07 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.895 2.478 . . . . 14.6 109.85 172.037 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.1 mm100 -84.68 -162.57 0.7 Allowed 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.375 2.036 . . . . 33.229999999999997 112.222 178.087 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 22.5 pttp -88.06 164.86 15.53 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.779 -3.7 . . . . 25.969999999999999 111.141 172.815 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.381 37.3 mt-10 73.54 1.1 3.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.683 1.593 . . . . 32.609999999999999 112.439 173.7 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.346 8.7 t -88.06 140.13 29.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.363 -2.71 . . . . 10.56 112.277 -168.581 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.0 m -100.68 113.93 27.21 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 126.059 2.837 . . . . 5.3300000000000001 108.826 -178.507 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.1 mt -87.6 144.99 26.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 118.515 2.783 . . . . 11.66 118.515 165.519 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -96.39 120.59 36.97 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.318 -3.989 . . . . 16.300000000000001 112.501 179.522 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.7 tp -94.08 120.99 35.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.167 -2.288 . . . . 9.9600000000000009 110.43 -177.325 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 44.1 t -118.27 138.22 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 C-N-CA 129.735 3.214 . . . . 9.7599999999999998 111.254 -173.56 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.3 tp -96.35 151.29 19.68 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 126.867 2.604 . . . . 19.57 106.535 176.615 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -118.14 139.94 50.51 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 117.657 -1.164 . . . . 35.079999999999998 108.418 148.583 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.264 77.7 mt -73.38 167.74 20.63 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.407 2.942 . . . . 32.310000000000002 115.434 173.071 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -78.38 143.61 36.69 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.765 1.745 . . . . 42.75 110.299 172.398 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.5 84.85 1.83 Allowed Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 106.718 -2.553 . . . . 36.310000000000002 106.718 -178.693 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.748 0 CA-C-N 113.086 -1.557 . . . . 36.270000000000003 110.96 177.518 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.491 -1.325 0 CA-C-O 121.382 0.61 . . . . 17.170000000000002 109.687 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.92 133.76 35.78 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.139 -3.475 . . . . 21.890000000000001 112.836 171.012 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -118.94 147.89 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 1 CA-C-O 128.599 4.047 . . . . 10.83 116.021 164.664 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -97.17 128.16 43.81 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.893 -3.63 . . . . 10.609999999999999 108.323 176.391 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.7 t -118.58 131.61 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.153 -2.536 . . . . 9.1300000000000008 104.153 173.214 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.7 mmtp -105.82 157.17 17.65 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.331 -3.355 . . . . 20.550000000000001 109.607 173.749 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.251 56.1 p -99.79 178.32 4.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.742 3.217 . . . . 11.779999999999999 109.403 175.517 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.4 tp -77.2 -36.9 54.46 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.517 -2.614 . . . . 19.309999999999999 110.84 178.744 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -38.18 72.24 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.96 -1.713 . . . . 23.140000000000001 111.991 160.662 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.51 33.72 2.23 Favored Glycine 0 N--CA 1.43 -1.73 0 N-CA-C 117.382 1.713 . . . . 19.739999999999998 117.382 171.529 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -80.8 119.44 23.38 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 127.919 2.487 . . . . 21.93 105.807 -179.775 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -81.34 104.51 11.84 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 127.693 3.121 . . . . 12.33 116.578 169.833 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.8 pt -100.83 147.4 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 124.622 1.169 . . . . 17.079999999999998 112.583 174.587 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.3 m -111.28 99.47 8.28 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 104.816 -2.291 . . . . 16.300000000000001 104.816 -172.248 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.7 mt -97.33 118.67 34.31 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.799 -3.688 . . . . 15.880000000000001 110.412 179.288 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -80.82 128.37 33.58 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.734 -1.229 . . . . 28.899999999999999 108.142 165.302 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.5 m -147.72 164.35 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 103.794 -2.669 . . . . 12.050000000000001 103.794 -178.48 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -105.81 140.72 21.49 Favored Pre-proline 0 N--CA 1.43 -1.464 0 CA-C-O 116.44 -1.743 . . . . 18.170000000000002 109.103 171.91 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -82.44 -5.71 11.79 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 CA-C-N 124.767 2.738 . . . . 8.1600000000000001 113.036 -167.046 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.4 p -69.28 -26.2 64.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 123.744 0.818 . . . . 11.130000000000001 112.483 169.522 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -75.73 178.28 6.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 117.522 2.415 . . . . 18.030000000000001 117.522 174.935 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 52' ' ' ASP . 9.2 p -106.76 178.8 4.45 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.719 -3.113 . . . . 10.220000000000001 111.617 -165.71 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 51' ' ' GLU . 11.3 mm -69.81 -35.47 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 116.854 -3.654 . . . . 12.300000000000001 114.261 168.479 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -52.31 -44.59 65.16 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 117.124 -1.417 . . . . 36.509999999999998 114.431 167.051 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -52.49 -49.36 64.89 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 114.947 -2.454 . . . . 25.66 114.612 163.477 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.18 -43.34 97.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 122.091 2.223 . . . . 8.1199999999999992 109.37 -177.084 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.66 -35.54 70.69 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.161 2.282 . . . . 15.470000000000001 117.161 172.883 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 32' ' ' ASP . . . -70.21 -25.65 63.51 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 126.898 3.237 . . . . 11.449999999999999 116.968 170.662 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -75.2 -27.35 59.55 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.792 -2.458 . . . . 24.98 111.786 175.758 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.2 mt -80.47 -37.51 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 118.057 -2.902 . . . . 9.4600000000000009 107.923 178.851 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.11 -52.49 62.4 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 115.205 -2.331 . . . . 14.76 107.769 -178.773 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 28' ' ' ALA . 2.2 t0 -52.99 -45.52 67.88 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 128.981 2.912 . . . . 26.289999999999999 113.495 173.362 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -74.33 -95.84 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.277 4.231 . . . . 30.059999999999999 112.643 176.879 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -71.36 -9.41 58.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.122 2.237 . . . . 25.190000000000001 111.449 -162.608 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.46 52.66 5.92 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 119.51 -1.994 . . . . 7.4100000000000001 117.105 179.975 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 61.4 mt -126.68 110.62 22.69 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 114.086 -2.864 . . . . 9.4900000000000002 106.321 -170.876 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -59.06 147.03 92.24 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 128.782 4.172 . . . . 11.42 111.531 -177.58 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -75.12 -8.19 19.72 Favored 'Trans proline' 0 N--CA 1.434 -1.996 0 C-N-CA 121.397 1.398 . . . . 12.0 112.925 -161.943 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -74.81 -39.86 61.43 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.201 1.953 . . . . 35.549999999999997 115.167 -174.299 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -66.95 -28.05 67.96 Favored 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 132.691 4.397 . . . . 20.52 114.913 173.12 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -70.4 117.54 12.07 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.955 2.788 . . . . 7.1299999999999999 114.489 -169.969 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -111.55 98.37 7.4 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.512 -3.243 . . . . 36.390000000000001 107.499 176.727 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.1 mt -91.05 122.3 33.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 111.779 -2.464 . . . . 9.5500000000000007 111.59 176.466 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.1 mm -112.26 144.37 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 124.119 1.914 . . . . 13.9 110.424 -177.887 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -123.31 114.17 19.85 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.854 2.74 . . . . 6.8600000000000003 107.962 161.394 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.306 . . 70.6 -88.05 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.677 -2.514 . . . . 11.15 115.889 -177.046 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -143.22 8.28 2.13 Favored Glycine 0 N--CA 1.431 -1.69 0 C-N-CA 126.4 1.952 . . . . 13.93 110.291 165.073 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -88.29 149.96 23.51 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 114.704 -4.998 . . . . 23.920000000000002 108.173 168.5 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -109.96 146.99 34.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.961 -3.348 . . . . 23.23 101.961 -179.02 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.9 mt -104.25 137.87 41.53 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.589 1.699 . . . . 9.1099999999999994 115.589 -171.819 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' O ' ' HB ' ' A' ' 23' ' ' ILE . 19.4 tp10 -97.4 155.46 16.9 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 120.524 1.511 . . . . 33.439999999999998 112.735 -169.661 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' O ' ' HB ' ' A' ' 22' ' ' THR . 15.0 m-20 -69.52 -61.39 1.81 Allowed 'General case' 0 N--CA 1.431 -1.423 0 N-CA-C 114.374 1.25 . . . . 28.370000000000001 114.374 -162.448 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.16 42.46 2.74 Favored Glycine 0 N--CA 1.43 -1.719 0 N-CA-C 117.08 1.592 . . . . 15.0 117.08 -179.962 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.6 mtt180 -131.59 154.93 48.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 119.141 1.47 . . . . 25.5 107.44 175.393 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 p -88.67 146.22 25.2 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 121.325 3.824 . . . . 11.949999999999999 121.325 -176.913 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.7 mt -54.74 -38.19 66.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.078 1.751 . . . . 10.17 114.984 171.854 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.1 t -51.62 -55.19 20.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 119.486 3.143 . . . . 13.59 119.486 166.861 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.74 -49.12 73.94 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 127.796 2.438 . . . . 11.699999999999999 115.093 176.923 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -71.53 -6.55 41.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 130.339 3.456 . . . . 12.949999999999999 112.825 173.72 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 54.32 44.21 29.33 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 116.949 2.203 . . . . 25.449999999999999 116.949 -179.961 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 26.0 mm -80.0 120.55 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 129.593 3.157 . . . . 14.6 105.179 171.763 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -103.68 170.38 7.97 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.955 -1.716 . . . . 33.229999999999997 109.555 -178.205 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -47.06 141.12 4.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.506 2.378 . . . . 25.969999999999999 110.863 167.355 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 66.6 mt-10 51.9 20.37 1.19 Allowed 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 118.818 2.896 . . . . 32.609999999999999 118.818 -175.674 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 t -75.18 165.21 25.57 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.078 2.551 . . . . 10.56 110.815 171.901 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.5 m -122.47 101.77 7.69 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 112.877 -3.44 . . . . 5.3300000000000001 108.021 -164.496 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -86.94 156.98 19.59 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 125.661 1.851 . . . . 11.66 110.506 163.313 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -118.73 119.9 35.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.019 -2.301 . . . . 16.300000000000001 112.817 -177.452 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.7 tp -92.39 98.45 11.49 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.505 -2.622 . . . . 9.9600000000000009 111.42 -175.969 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.4 t -94.48 156.84 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 O-C-N 125.386 1.679 . . . . 9.7599999999999998 110.198 167.652 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.2 mt -136.26 139.86 43.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.321 -2.112 . . . . 19.57 111.645 -172.871 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -112.42 176.94 4.81 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.905 4.082 . . . . 35.079999999999998 115.985 165.723 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.9 mt -108.05 -161.99 0.8 Allowed 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 124.206 1.955 . . . . 32.310000000000002 106.394 -171.188 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -94.15 152.62 18.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 124.295 1.998 . . . . 42.75 109.717 173.991 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.14 -45.3 1.16 Allowed Glycine 0 N--CA 1.431 -1.672 0 O-C-N 120.284 -1.51 . . . . 36.310000000000002 111.616 175.348 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.773 0 N-CA-C 105.294 -3.122 . . . . 36.270000000000003 105.294 -172.323 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.49 -1.332 0 N-CA-C 115.445 1.646 . . . . 17.170000000000002 115.445 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.51 132.78 46.96 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.649 -2.532 . . . . 21.890000000000001 105.738 171.842 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 pt -110.2 156.77 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 113.752 -1.567 . . . . 10.83 109.851 170.005 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -98.0 135.76 39.23 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 118.292 -0.861 . . . . 10.609999999999999 109.706 177.727 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.36 121.67 68.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 N-CA-C 99.337 -4.32 . . . . 9.1300000000000008 99.337 171.197 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -102.81 128.83 49.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 126.791 2.557 . . . . 20.550000000000001 109.072 177.063 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 69' ' ' LEU . 77.7 p -96.09 176.59 6.03 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.497 -2.627 . . . . 11.779999999999999 112.511 -170.563 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 55.1 tp -80.61 -30.32 36.8 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.644 -5.035 . . . . 19.309999999999999 111.116 -173.658 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.7 p -68.33 -69.74 0.31 Allowed 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.42 2.748 . . . . 23.140000000000001 118.42 162.538 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.98 38.39 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.712 0 O-C-N 119.891 -1.756 . . . . 19.739999999999998 112.144 174.226 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.7 tttt -99.6 132.33 45.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 119.388 1.594 . . . . 21.93 110.856 171.646 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.2 m -111.74 111.28 22.15 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.612 -2.736 . . . . 12.33 103.612 172.862 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.6 mt -96.35 145.46 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-N 112.934 -1.939 . . . . 17.079999999999998 110.11 -178.736 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 43.7 m -106.33 112.22 25.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.964 -1.085 . . . . 16.300000000000001 113.593 178.613 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.1 mt -111.54 130.12 55.84 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.366 1.467 . . . . 15.880000000000001 109.196 -175.132 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -97.58 132.33 43.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.316 -1.49 . . . . 28.899999999999999 109.621 173.898 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.2 m -155.88 162.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 119.389 -2.07 . . . . 12.050000000000001 113.191 -168.396 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -93.72 153.94 41.06 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 126.113 1.765 . . . . 18.170000000000002 109.026 177.378 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -60.83 -26.1 82.45 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 O-C-N 116.343 -2.503 . . . . 8.1600000000000001 115.941 171.667 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.0 p -82.16 -16.44 49.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.18 1.792 . . . . 11.130000000000001 114.78 -177.625 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.2 m-20 -60.77 143.01 55.39 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.705 1.241 . . . . 18.030000000000001 113.273 170.185 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -97.84 158.78 15.33 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.053 -2.279 . . . . 10.220000000000001 109.587 -175.79 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.0 mm -53.19 -46.44 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 128.558 2.743 . . . . 12.300000000000001 111.722 171.501 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -45.82 -55.54 6.49 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 115.362 1.615 . . . . 36.509999999999998 115.362 161.962 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -54.65 -34.53 62.3 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.102 3.761 . . . . 25.66 112.851 173.643 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.34 -33.39 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 O-C-N 119.199 -2.188 . . . . 8.1199999999999992 110.028 177.79 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -67.28 -35.78 80.19 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 123.84 0.856 . . . . 15.470000000000001 111.81 179.898 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.01 -36.1 82.43 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 132.212 4.205 . . . . 11.449999999999999 118.102 166.319 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -64.68 -50.31 67.51 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.422 -3.924 . . . . 24.98 111.417 169.935 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.8 mt -53.06 -48.23 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 113.112 -3.328 . . . . 9.4600000000000009 110.927 170.103 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -37.45 78.42 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 124.903 3.501 . . . . 14.76 116.363 176.996 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -77.34 -38.46 50.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.057 -2.277 . . . . 26.289999999999999 111.734 -177.661 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -81.25 -42.44 20.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.279 2.309 . . . . 30.059999999999999 110.96 -176.194 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -99.57 -44.2 6.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 124.012 1.863 . . . . 25.190000000000001 114.899 -169.179 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.74 45.46 4.56 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 118.424 -2.673 . . . . 7.4100000000000001 108.91 -177.489 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.7 mt -102.7 133.6 20.35 Favored Pre-proline 0 N--CA 1.43 -1.437 0 N-CA-C 107.021 -1.474 . . . . 9.4900000000000002 107.021 161.714 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 3.2 Cg_exo -78.77 157.06 27.75 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 121.697 1.642 . . . . 11.42 113.464 175.83 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 81.8 Cg_exo -68.67 -24.01 35.68 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.969 3.112 . . . . 12.0 118.406 -169.127 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.73 -24.76 65.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 112.034 -2.348 . . . . 35.549999999999997 111.36 172.918 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -75.77 -31.82 59.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 117.288 -3.382 . . . . 20.52 111.132 175.521 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -94.72 89.2 5.63 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.104 -1.623 . . . . 7.1299999999999999 111.037 -145.257 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 -88.34 115.2 25.67 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.994 -3.566 . . . . 36.390000000000001 106.284 171.527 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.6 mt -91.26 121.83 33.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 103.471 -2.789 . . . . 9.5500000000000007 103.471 177.157 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.3 mm -109.65 132.24 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 124.501 2.096 . . . . 13.9 110.61 176.208 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -107.21 105.48 15.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.459 -3.276 . . . . 6.8600000000000003 107.866 166.754 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.309 . . 60.49 -76.42 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.617 2.367 . . . . 11.15 115.838 -168.554 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.03 -20.0 3.48 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 126.689 2.09 . . . . 13.93 117.413 173.347 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.278 50.3 pttt -109.42 142.03 40.97 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 122.378 3.089 . . . . 23.920000000000002 105.118 -160.919 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -79.82 140.09 36.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.439 1.114 . . . . 23.23 109.782 -176.767 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 mt -84.3 128.7 34.73 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.617 -3.802 . . . . 9.1099999999999994 112.847 177.432 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -83.6 136.83 34.09 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.117 2.967 . . . . 33.439999999999998 108.635 -174.68 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.277 0.9 OUTLIER -42.84 -63.53 0.77 Allowed 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 122.332 4.197 . . . . 28.370000000000001 122.332 -174.063 . . . . . . . . 4 3 . 1 . 059 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.97 37.11 2.34 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 128.974 3.178 . . . . 15.0 115.191 -171.517 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -132.06 148.25 52.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.984 2.216 . . . . 25.5 116.984 178.338 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.7 p -88.62 157.54 18.54 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 123.512 1.625 . . . . 11.949999999999999 113.126 -172.236 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 68.9 mt -71.69 -28.36 63.66 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.513 3.53 . . . . 10.17 110.685 -174.46 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.6 t -68.05 -44.42 76.44 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 118.042 -2.911 . . . . 13.59 113.004 173.386 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -56.35 -40.51 74.62 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.364 1.866 . . . . 11.699999999999999 111.79 177.179 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -85.34 -17.83 35.61 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 114.849 1.425 . . . . 12.949999999999999 114.849 175.632 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.508 12.9 m120 83.89 44.41 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.929 -2.357 . . . . 25.449999999999999 112.772 172.799 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 32.7 mm -79.24 117.12 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 113.965 -1.47 . . . . 14.6 112.685 174.837 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.3 mm-40 -91.72 178.47 5.91 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.069 -3.519 . . . . 33.229999999999997 108.351 -178.821 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -65.57 154.8 37.67 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 115.492 -2.483 . . . . 25.969999999999999 112.005 172.874 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 63.47 36.42 11.32 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.115 -2.241 . . . . 32.609999999999999 110.645 172.075 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.5 t -109.1 142.27 40.08 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 125.828 1.955 . . . . 10.56 112.437 -174.708 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -97.62 115.97 28.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 116.011 -1.947 . . . . 5.3300000000000001 113.158 -170.883 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -95.31 141.43 28.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.022 1.451 . . . . 11.66 107.389 167.376 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -110.2 113.22 25.73 Favored 'General case' 0 N--CA 1.43 -1.433 1 CA-C-O 129.145 4.307 . . . . 16.300000000000001 107.803 -170.546 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 7' ' ' THR . 58.9 tp -81.84 105.53 13.04 Favored 'General case' 0 N--CA 1.431 -1.394 0 O-C-N 117.287 -3.383 . . . . 9.9600000000000009 110.843 -178.016 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.19 113.52 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 123.329 1.538 . . . . 9.7599999999999998 112.615 174.064 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 77.5 mt -89.5 143.55 26.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.229 -2.794 . . . . 19.57 115.467 -178.333 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -108.18 154.36 21.86 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.599 2.142 . . . . 35.079999999999998 107.624 178.133 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 mt -78.56 145.26 34.92 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.683 -3.136 . . . . 32.310000000000002 105.355 -179.319 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -64.29 120.62 12.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 115.035 1.494 . . . . 42.75 115.035 -167.259 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.45 29.84 8.56 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 126.473 2.358 . . . . 36.310000000000002 114.688 171.216 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.735 0 O-C-N 125.861 1.565 . . . . 36.270000000000003 114.299 -170.244 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptt? . . . . . 0 CA--C 1.49 -1.328 0 N-CA-C 116.686 2.106 . . . . 17.170000000000002 116.686 . . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -112.77 147.09 37.62 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 117.124 -1.417 . . . . 21.890000000000001 110.268 178.478 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.0 pt -125.93 156.23 35.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.638 -2.727 . . . . 10.83 103.638 160.727 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -99.11 117.25 33.19 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 112.001 -2.363 . . . . 10.609999999999999 115.196 169.233 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.8 t -107.05 111.43 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.108 -3.495 . . . . 9.1300000000000008 109.291 179.796 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -90.23 113.48 25.3 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 113.63 -1.623 . . . . 20.550000000000001 111.479 -171.727 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.391 9.0 p -70.72 172.55 8.54 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.533 -2.605 . . . . 11.779999999999999 115.302 173.672 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.4 HD13 ' CE1' ' A' ' 68' ' ' HIS . 26.1 tp -98.23 3.85 48.88 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.901 3.239 . . . . 19.309999999999999 109.48 177.763 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -85.59 -71.22 0.54 Allowed 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.663 -3.773 . . . . 23.140000000000001 106.34 168.937 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.36 13.67 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.725 0 O-C-N 126.452 2.345 . . . . 19.739999999999998 114.499 -174.502 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -98.37 132.48 43.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.533 -3.333 . . . . 21.93 108.208 179.68 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -104.91 103.1 12.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 116.483 -3.885 . . . . 12.33 115.294 165.485 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.5 mt -80.36 136.82 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.538 -2.601 . . . . 17.079999999999998 111.091 179.206 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.0 m -107.76 135.84 48.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.286 3.422 . . . . 16.300000000000001 106.13 175.733 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.1 mt -132.47 157.15 45.36 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.386 -2.696 . . . . 15.880000000000001 107.163 -176.691 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -112.21 111.28 22.05 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 127.265 2.226 . . . . 28.899999999999999 108.195 -176.341 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.22 155.78 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 124.248 1.975 . . . . 12.050000000000001 110.466 -168.23 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -94.94 165.67 16.57 Favored Pre-proline 0 N--CA 1.43 -1.429 1 O-C-N 115.36 -4.587 . . . . 18.170000000000002 106.179 165.814 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -62.8 -22.56 73.98 Favored 'Trans proline' 0 N--CA 1.434 -1.995 0 C-N-CA 123.155 2.57 . . . . 8.1600000000000001 115.528 168.394 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.9 m -87.07 3.51 45.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 127.021 3.296 . . . . 11.130000000000001 115.147 -178.429 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -77.87 145.59 36.15 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.179 -5.326 . . . . 18.030000000000001 109.32 171.533 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.2 p -78.14 170.89 15.86 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.2 1.926 . . . . 10.220000000000001 116.2 173.172 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -61.85 -35.61 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.506 0 C-N-CA 125.316 1.446 . . . . 12.300000000000001 112.228 161.76 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -63.12 -43.63 97.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.803 -2.435 . . . . 36.509999999999998 111.92 174.368 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 -61.02 -32.59 72.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.169 2.285 . . . . 25.66 117.169 170.741 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.333 95.6 t -60.2 -53.66 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.366 3.066 . . . . 8.1199999999999992 113.626 167.584 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -55.68 -44.53 77.4 Favored 'General case' 0 N--CA 1.43 -1.442 1 N-CA-C 121.924 4.046 . . . . 15.470000000000001 121.924 169.886 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.51 -34.26 64.49 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 125.942 2.782 . . . . 11.449999999999999 117.57 175.93 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -82.12 -27.35 32.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.199 -2.148 . . . . 24.98 105.199 -171.796 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.1 mt -73.67 -29.94 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 103.416 -2.809 . . . . 9.4600000000000009 103.416 -176.127 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -62.13 -51.3 68.44 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.221 3.009 . . . . 14.76 110.608 170.393 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -55.43 -43.35 75.29 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.191 1.922 . . . . 26.289999999999999 116.191 173.069 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -84.04 -71.86 0.49 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 113.094 -1.866 . . . . 30.059999999999999 108.312 -169.138 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -74.28 -54.09 8.4 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.791 2.71 . . . . 25.190000000000001 115.526 -170.893 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 149.11 -24.78 1.27 Allowed Glycine 0 N--CA 1.43 -1.725 0 O-C-N 119.136 -2.227 . . . . 7.4100000000000001 112.158 -177.975 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.548 HD13 HD21 ' A' ' 71' ' ' LEU . 3.7 mt -69.87 122.97 87.68 Favored Pre-proline 0 N--CA 1.43 -1.456 0 CA-C-O 116.658 -1.639 . . . . 9.4900000000000002 112.801 -160.802 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.44 153.39 65.83 Favored 'Trans proline' 0 C--N 1.3 -1.993 1 C-N-CA 126.326 4.684 . . . . 11.42 110.979 176.378 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -66.95 -21.95 49.16 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 C-N-CA 124.627 3.552 . . . . 12.0 118.743 -168.702 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -65.58 -37.37 86.45 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.361 3.464 . . . . 35.549999999999997 111.127 178.695 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.26 65.7 mt-30 -76.49 -16.7 59.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.553 2.341 . . . . 20.52 113.917 -177.37 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -97.85 124.5 42.28 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 117.403 -3.311 . . . . 7.1299999999999999 110.715 -165.783 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.401 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 59.4 mtp180 -101.97 126.98 49.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 116.513 -3.867 . . . . 36.390000000000001 105.969 160.121 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mt -115.48 132.0 56.76 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.578 -1.326 . . . . 9.5500000000000007 107.697 177.504 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.5 mm -128.57 134.24 65.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 126.554 1.941 . . . . 13.9 109.681 -159.266 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -140.68 116.48 10.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 123.733 1.73 . . . . 6.8600000000000003 107.938 179.848 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.71 -93.92 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.739 3.216 . . . . 11.15 110.223 -178.027 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.86 11.11 7.43 Favored Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.683 -2.511 . . . . 13.93 116.625 178.591 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -128.92 153.02 47.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.222 -2.929 . . . . 23.920000000000002 112.46 -178.01 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -89.15 138.81 31.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 104.173 -2.529 . . . . 23.23 104.173 169.319 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.8 mt -84.68 126.11 33.1 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 111.378 -2.646 . . . . 9.1099999999999994 115.499 -176.997 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -83.56 140.97 31.93 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 121.343 1.883 . . . . 33.439999999999998 109.967 -173.355 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -57.39 -62.43 1.78 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.798 3.639 . . . . 28.370000000000001 115.493 -158.377 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.83 28.04 3.69 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 118.568 -2.582 . . . . 15.0 111.965 -177.078 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.3 mmt85 -103.95 154.07 20.08 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.828 -2.572 . . . . 25.5 107.134 174.72 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.4 p -97.0 177.59 5.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 126.709 3.147 . . . . 11.949999999999999 103.769 -170.559 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 29.9 mt -69.78 -34.16 73.37 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 112.567 -6.333 . . . . 10.17 117.764 172.894 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 m -64.15 -21.43 66.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.592 -1.67 . . . . 13.59 112.588 174.237 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.16 -39.64 54.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.388 1.475 . . . . 11.699999999999999 111.698 177.72 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -90.15 3.15 54.27 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 118.845 2.906 . . . . 12.949999999999999 118.845 171.239 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.379 17.9 m120 73.18 25.49 2.26 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.739 2.416 . . . . 25.449999999999999 116.11 171.304 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.3 mt -83.83 127.74 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 128.855 2.862 . . . . 14.6 109.304 -176.692 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -126.37 -155.59 0.69 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.178 0.924 . . . . 33.229999999999997 110.157 179.451 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.6 pttt -83.33 144.87 29.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.598 -1.939 . . . . 25.969999999999999 112.412 179.673 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.4 tt0 87.0 6.93 0.26 Allowed 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.289 3.836 . . . . 32.609999999999999 108.23 176.625 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 t -84.5 151.6 24.49 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 115.894 -4.254 . . . . 10.56 109.768 -167.657 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.452 5.2 m -93.24 112.56 24.53 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.345 2.658 . . . . 5.3300000000000001 116.258 172.87 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.4 mt -90.52 168.28 11.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.375 -3.328 . . . . 11.66 107.324 168.336 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.4 ' CE1' HD13 ' A' ' 8' ' ' LEU . 9.6 t60 -130.43 133.02 46.01 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.73 -2.481 . . . . 16.300000000000001 104.316 177.078 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -102.03 133.34 47.0 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.02 1.728 . . . . 9.9600000000000009 113.405 177.887 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.458 HG12 ' N ' ' A' ' 71' ' ' LEU . 88.3 t -131.71 161.17 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.867 -2.271 . . . . 9.7599999999999998 104.867 174.066 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.548 HD21 HD13 ' A' ' 36' ' ' ILE . 64.2 mt -113.85 159.82 19.41 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 121.848 2.113 . . . . 19.57 110.594 178.981 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -135.41 168.25 19.56 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 129.734 3.214 . . . . 35.079999999999998 106.83 176.119 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 tp -94.8 -51.35 4.74 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 126.157 2.884 . . . . 32.310000000000002 107.049 -174.957 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -142.1 151.77 42.64 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.627 -4.421 . . . . 42.75 110.219 174.154 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.66 160.05 27.89 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 119.319 -1.419 . . . . 36.310000000000002 111.047 -177.751 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.747 0 N-CA-C 110.696 -0.961 . . . . 36.270000000000003 110.696 -168.735 . . . . . . . . 0 0 . 1 . 061 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 CA--C 1.49 -1.358 0 N-CA-C 106.795 -1.557 . . . . 17.170000000000002 106.795 . . . . . . . . . 0 0 . 1 . 061 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -82.85 151.6 25.96 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 105.871 -1.899 . . . . 21.890000000000001 105.871 -178.278 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.8 pt -134.5 167.42 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 CA-C-O 124.593 2.139 . . . . 10.83 108.595 169.663 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -121.14 130.69 53.84 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.191 -2.818 . . . . 10.609999999999999 109.738 177.657 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.3 t -110.62 124.49 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 1 O-C-N 113.774 -5.579 . . . . 9.1300000000000008 105.848 161.041 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.252 77.8 tttt -109.15 134.0 52.29 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.386 -2.696 . . . . 20.550000000000001 115.752 -179.39 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -71.0 170.29 13.11 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 125.966 2.794 . . . . 11.779999999999999 110.678 178.745 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.4 tp -78.11 -29.82 49.11 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 111.33 -2.668 . . . . 19.309999999999999 114.956 177.801 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.3 p -58.6 -56.01 27.69 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 122.198 2.272 . . . . 23.140000000000001 112.547 165.35 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.41 38.16 0.11 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 128.709 3.052 . . . . 19.739999999999998 113.799 163.302 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -92.79 132.11 37.26 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 126.837 2.139 . . . . 21.93 106.42 -179.421 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.7 m -105.89 126.58 52.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.03 2.348 . . . . 12.33 110.572 -175.692 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mt -97.06 118.86 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 111.291 -2.686 . . . . 17.079999999999998 105.905 174.864 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 34.7 m -82.54 128.9 34.74 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.817 -1.802 . . . . 16.300000000000001 115.137 166.523 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.3 mt -123.55 148.91 45.88 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.695 -1.224 . . . . 15.880000000000001 107.695 -179.895 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -118.77 116.89 27.48 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.616 2.366 . . . . 28.899999999999999 106.485 177.799 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.293 34.1 m -141.29 -179.22 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 126.394 2.309 . . . . 12.050000000000001 106.443 -177.329 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -117.13 157.86 45.76 Favored Pre-proline 0 N--CA 1.43 -1.447 0 O-C-N 118.502 -2.624 . . . . 18.170000000000002 108.582 171.418 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -64.3 -8.85 17.85 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-N 126.161 3.236 . . . . 8.1600000000000001 118.029 178.818 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.1 m -88.99 -1.94 58.35 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.741 1.616 . . . . 11.130000000000001 113.976 -178.149 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -89.35 164.9 14.69 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 122.357 1.075 . . . . 18.030000000000001 108.976 176.831 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -87.96 168.07 13.18 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.826 2.45 . . . . 10.220000000000001 114.846 -179.624 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.52 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 22.3 mm -75.1 -26.35 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 115.393 1.627 . . . . 12.300000000000001 115.393 172.65 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -61.77 -43.35 99.03 Favored 'General case' 0 N--CA 1.43 -1.452 2 C-N-CA 133.994 4.918 . . . . 36.509999999999998 106.999 166.113 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -65.07 -33.92 77.18 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.017 2.599 . . . . 25.66 118.017 169.647 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 t -60.19 -44.42 95.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.668 -1.27 . . . . 8.1199999999999992 111.501 171.38 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -75.25 -39.79 59.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.368 -3.332 . . . . 15.470000000000001 111.433 -175.691 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.53 -23.5 64.53 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 119.274 -2.141 . . . . 11.449999999999999 116.737 172.972 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -63.99 -45.22 90.01 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 125.095 3.588 . . . . 24.98 107.672 169.625 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.566 ' HB ' HE22 ' A' ' 41' ' ' GLN . 92.6 mt -67.09 -30.74 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.468 -2.645 . . . . 9.4600000000000009 109.952 177.36 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -60.45 -41.32 93.86 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.805 2.842 . . . . 14.76 113.963 171.777 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -68.3 -59.7 3.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.084 1.883 . . . . 26.289999999999999 116.084 163.294 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.7 mttm -63.57 -58.38 7.17 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 120.122 3.379 . . . . 30.059999999999999 120.122 -171.802 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -88.72 -55.26 3.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.718 2.007 . . . . 25.190000000000001 113.429 -174.565 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.37 20.89 2.6 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 112.077 -2.329 . . . . 7.4100000000000001 117.202 -178.152 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.0 mt -100.34 117.25 63.37 Favored Pre-proline 0 N--CA 1.43 -1.463 0 O-C-N 119.007 -2.467 . . . . 9.4900000000000002 110.829 178.641 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 6.6 Cg_endo -73.43 154.7 50.77 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-N 127.732 3.797 . . . . 11.42 112.774 -175.694 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 94.4 Cg_exo -69.85 -22.58 31.46 Favored 'Trans proline' 0 C--N 1.299 -2.046 0 CA-C-O 117.682 -1.049 . . . . 12.0 113.217 -167.287 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -54.09 -41.23 68.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.649 -2.596 . . . . 35.549999999999997 117.092 175.302 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -77.38 -36.03 53.91 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.024 2.703 . . . . 20.52 111.854 170.221 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.566 HE22 ' HB ' ' A' ' 30' ' ' ILE . 69.8 mt-30 -69.32 115.07 8.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.16 2.652 . . . . 7.1299999999999999 118.16 -176.476 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HB2' ' HB ' ' A' ' 70' ' ' VAL . 59.7 mtp180 -102.87 121.66 42.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.952 -1.499 . . . . 36.390000000000001 107.335 161.083 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 43.1 mt -99.15 132.43 44.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.382 1.901 . . . . 9.5500000000000007 109.382 175.971 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.4 mm -125.56 122.74 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.739 2.416 . . . . 13.9 109.523 -170.001 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -104.3 120.0 40.21 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.185 1.357 . . . . 6.8600000000000003 109.19 168.76 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.49 . . 62.98 -102.59 0.11 Allowed 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.941 -1.1 . . . . 11.15 113.457 -167.717 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.75 16.85 5.3 Favored Glycine 0 N--CA 1.43 -1.738 0 O-C-N 117.424 -3.298 . . . . 13.93 107.497 171.306 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -95.52 131.64 41.49 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.778 2.831 . . . . 23.920000000000002 109.335 177.209 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -87.99 133.0 34.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 124.872 1.358 . . . . 23.23 110.355 178.665 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.7 mt -93.13 120.47 33.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 124.662 1.185 . . . . 9.1099999999999994 110.998 -175.116 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -78.55 139.0 38.66 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 125.607 1.563 . . . . 33.439999999999998 113.576 169.024 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.52 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 5.8 m-20 -64.75 -40.23 94.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.372 2.269 . . . . 28.370000000000001 113.33 -165.575 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -86.53 29.14 5.0 Favored Glycine 0 N--CA 1.43 -1.759 0 N-CA-C 116.725 1.45 . . . . 15.0 116.725 177.23 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.5 mmt180 -109.75 164.09 12.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.903 -2.528 . . . . 25.5 107.27 162.873 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -93.31 165.17 12.92 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 123.772 1.748 . . . . 11.949999999999999 114.06 173.581 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -59.48 -35.24 73.72 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.748 -1.845 . . . . 10.17 112.669 174.473 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.6 t -66.55 -32.01 73.08 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 119.807 3.262 . . . . 13.59 119.807 174.085 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -63.37 -39.22 93.92 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-O 123.615 1.674 . . . . 11.699999999999999 110.638 175.571 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -88.14 -4.53 58.74 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.351 2.26 . . . . 12.949999999999999 112.376 178.727 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.8 m120 50.96 56.05 8.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.666 1.986 . . . . 25.449999999999999 114.504 -168.43 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.0 mt -103.16 103.57 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 101.204 -3.628 . . . . 14.6 101.204 178.278 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -89.74 -171.85 3.33 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 128.501 2.72 . . . . 33.229999999999997 111.288 -177.444 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -69.06 143.77 54.17 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 105.461 -2.051 . . . . 25.969999999999999 105.461 -170.831 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 25.3 mt-10 64.67 26.43 13.15 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.951 2.204 . . . . 32.609999999999999 116.951 172.673 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.5 t -93.34 144.5 25.26 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 104.383 -2.451 . . . . 10.56 104.383 -173.535 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.6 m -110.78 124.15 51.45 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-N 114.277 -1.329 . . . . 5.3300000000000001 110.737 -171.951 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.2 mt -95.22 140.94 29.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.114 3.365 . . . . 11.66 108.136 174.603 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -89.03 143.26 26.97 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.142 1.449 . . . . 16.300000000000001 108.952 165.894 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -119.51 119.82 34.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.167 -2.16 . . . . 9.9600000000000009 105.167 -171.989 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.425 ' HB ' ' HB2' ' A' ' 42' ' ' ARG . 71.1 t -109.76 132.42 58.01 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 CA-C-N 114.563 -1.199 . . . . 9.7599999999999998 110.568 -179.778 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.1 mt -98.13 118.59 35.09 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.231 -2.793 . . . . 19.57 113.569 174.716 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.498 HH12 ' C ' ' A' ' 76' ' ' GLY . 30.3 ptt180 -92.87 170.03 10.0 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 107.673 -1.232 . . . . 35.079999999999998 107.673 163.585 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.1 tp -79.63 -85.62 0.08 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 116.242 1.942 . . . . 32.310000000000002 116.242 173.776 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -153.41 141.88 20.73 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.005 1.73 . . . . 42.75 110.165 167.814 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.59 -82.58 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.757 0 CA-C-O 125.21 2.561 . . . . 36.310000000000002 114.931 176.064 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.498 ' C ' HH12 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.261 1.783 0 CA-C-N 111.542 -2.329 . . . . 36.270000000000003 112.937 168.984 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 116.845 2.165 . . . . 17.170000000000002 116.845 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -80.64 128.46 33.64 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.496 -2.628 . . . . 21.890000000000001 108.77 172.221 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.4 pt -124.01 173.33 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 117.935 -2.978 . . . . 10.83 103.548 163.901 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.269 77.5 m-85 -128.18 136.3 50.91 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 108.782 -0.821 . . . . 10.609999999999999 108.782 -176.31 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.7 t -113.62 117.16 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-O 125.971 2.796 . . . . 9.1300000000000008 106.768 175.401 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 11' ' ' LYS . 19.9 ttpt -95.91 136.77 35.9 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 113.343 -1.753 . . . . 20.550000000000001 111.117 174.666 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -88.89 -169.29 2.47 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 128.15 3.833 . . . . 11.779999999999999 111.51 -175.34 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 23.3 tp -80.57 -44.15 19.47 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.691 -3.755 . . . . 19.309999999999999 110.543 -176.71 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.98 -62.28 1.93 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.417 1.887 . . . . 23.140000000000001 110.006 168.562 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.84 41.34 0.11 Allowed Glycine 0 N--CA 1.431 -1.687 0 O-C-N 119.139 -2.226 . . . . 19.739999999999998 111.593 169.63 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 21.1 tptm -84.29 142.9 29.89 Favored 'General case' 0 N--CA 1.431 -1.397 0 O-C-N 128.94 3.377 . . . . 21.93 113.833 166.489 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.5 m -106.94 112.21 25.07 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.593 1.663 . . . . 12.33 109.466 -176.254 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.483 HD13 ' HG3' ' A' ' 34' ' ' GLU . 34.3 mt -104.27 108.91 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 119.562 -1.961 . . . . 17.079999999999998 110.358 -174.974 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -87.82 123.09 32.25 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.489 -1.382 . . . . 16.300000000000001 108.564 -174.164 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.3 mt -120.17 158.26 27.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.087 2.155 . . . . 15.880000000000001 116.29 179.636 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.6 tp10 -120.77 89.33 3.11 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 126.556 3.074 . . . . 28.899999999999999 114.893 177.377 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -109.55 164.39 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 119.86 -1.775 . . . . 12.050000000000001 114.473 -178.624 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 82.2 mm-40 -98.26 159.69 30.04 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 116.551 -2.059 . . . . 18.170000000000002 106.444 167.793 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.461 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 79.5 Cg_endo -73.53 -17.68 23.37 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 O-C-N 116.012 -2.678 . . . . 8.1600000000000001 110.066 174.904 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.1 m -59.78 -20.25 55.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.005 2.522 . . . . 11.130000000000001 116.19 164.785 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -71.57 142.3 50.04 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 125.562 2.601 . . . . 18.030000000000001 112.0 175.964 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.7 p -79.94 165.64 22.43 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.09 -4.131 . . . . 10.220000000000001 107.932 167.233 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.1 mm -66.18 -24.69 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 126.589 1.955 . . . . 12.300000000000001 108.558 177.637 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.29 35.0 tt0 -65.73 -39.85 91.57 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 118.19 -0.91 . . . . 36.509999999999998 108.596 174.19 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -72.25 -24.31 61.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 121.895 2.134 . . . . 25.66 114.237 179.109 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.2 t -72.77 -42.06 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 O-C-N 118.385 -2.697 . . . . 8.1199999999999992 110.834 175.189 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.274 93.0 mttt -51.57 -36.88 47.13 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 117.581 2.438 . . . . 15.470000000000001 117.581 163.512 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.07 -35.76 61.8 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 120.504 -1.372 . . . . 11.449999999999999 111.265 -177.232 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -58.67 -47.98 82.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.164 2.986 . . . . 24.98 113.814 175.487 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -69.92 -34.16 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.553 -1.658 . . . . 9.4600000000000009 109.147 175.401 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -60.59 -46.71 89.22 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 122.144 2.247 . . . . 14.76 110.794 172.978 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -56.26 -58.7 6.86 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 119.759 -1.838 . . . . 26.289999999999999 111.305 -177.308 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -75.61 -55.43 5.67 Favored 'General case' 0 N--CA 1.43 -1.46 1 C-N-CA 132.805 4.442 . . . . 30.059999999999999 111.264 -168.068 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.483 ' HG3' HD13 ' A' ' 13' ' ' ILE . 27.1 mm-40 -89.43 -31.8 17.55 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.968 -2.333 . . . . 25.190000000000001 115.241 -179.016 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.01 11.42 20.57 Favored Glycine 0 N--CA 1.43 -1.715 0 N-CA-C 121.269 3.268 . . . . 7.4100000000000001 121.269 179.536 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.307 71.5 mt -109.5 135.16 20.35 Favored Pre-proline 0 N--CA 1.431 -1.407 0 N-CA-C 102.447 -3.168 . . . . 9.4900000000000002 102.447 -153.502 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -61.44 158.03 38.22 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 124.079 3.186 . . . . 11.42 117.481 179.605 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -78.53 -13.35 14.93 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 127.847 3.838 . . . . 12.0 118.066 179.932 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -67.92 -17.8 64.58 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 113.996 -1.457 . . . . 35.549999999999997 114.93 -178.634 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -86.2 -22.38 26.98 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 124.07 1.89 . . . . 20.52 111.24 178.025 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -89.07 108.01 19.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.819 2.525 . . . . 7.1299999999999999 117.819 -163.303 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -104.49 100.15 9.84 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 107.994 -1.113 . . . . 36.390000000000001 107.994 171.517 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.482 ' HB3' HD12 ' A' ' 50' ' ' LEU . 13.6 mt -81.81 130.33 35.03 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.182 -2.824 . . . . 9.5500000000000007 112.884 178.33 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mm -128.8 136.06 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 104.148 -2.538 . . . . 13.9 104.148 -167.739 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -135.08 133.5 39.35 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.843 -1.539 . . . . 6.8600000000000003 106.843 176.604 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.262 . . 49.98 -111.34 0.49 Allowed 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.844 2.535 . . . . 11.15 117.844 -164.163 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.36 2.53 37.27 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 119.007 -0.885 . . . . 13.93 114.405 169.341 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -105.7 126.33 52.03 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.237 3.015 . . . . 23.920000000000002 111.024 -161.508 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -80.54 130.41 35.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 114.523 -1.217 . . . . 23.23 110.49 171.712 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.482 HD12 ' HB3' ' A' ' 43' ' ' LEU . 34.3 mt -86.47 166.01 15.84 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 117.61 -1.186 . . . . 9.1099999999999994 113.756 -167.908 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -132.48 128.91 38.4 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 114.791 -2.528 . . . . 33.439999999999998 109.085 -170.4 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -56.05 -44.49 78.89 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 127.157 2.785 . . . . 28.370000000000001 115.573 -162.954 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -61.55 -8.72 14.89 Favored Glycine 0 N--CA 1.43 -1.741 0 C-N-CA 128.546 2.974 . . . . 15.0 118.634 -179.394 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -95.8 150.92 19.87 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 116.234 -4.098 . . . . 25.5 110.851 178.583 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.7 p -78.53 161.68 26.86 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.298 2.475 . . . . 11.949999999999999 112.144 168.041 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 19.9 mt -65.29 -42.88 92.64 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.0 -5.438 . . . . 10.17 111.904 172.348 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.8 m -42.14 -40.27 2.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 118.626 2.824 . . . . 13.59 118.626 160.685 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.34 -22.82 67.11 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.193 -2.192 . . . . 11.699999999999999 116.531 172.677 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -101.82 3.59 39.52 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 120.023 -1.673 . . . . 12.949999999999999 111.276 -178.75 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.478 26.9 m120 63.37 32.12 14.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.127 2.87 . . . . 25.449999999999999 118.191 -174.204 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.6 mt -95.51 123.06 47.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 119.026 -2.296 . . . . 14.6 106.38 -171.493 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -124.78 -171.17 2.3 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 128.093 2.557 . . . . 33.229999999999997 107.305 -168.673 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -76.33 150.68 36.86 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.512 -1.992 . . . . 25.969999999999999 115.949 -169.001 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 63.15 15.34 8.46 Favored 'General case' 0 N--CA 1.43 -1.464 1 CA-C-O 128.535 4.017 . . . . 32.609999999999999 118.894 -169.711 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 m -75.37 147.34 40.13 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 112.884 -6.135 . . . . 10.56 113.981 172.47 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.8 m -108.15 123.37 48.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.612 1.565 . . . . 5.3300000000000001 114.486 -176.823 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.25 166.51 10.91 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.666 0.746 . . . . 11.66 110.163 174.313 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.9 t60 -126.27 144.96 50.6 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.076 -2.89 . . . . 16.300000000000001 108.295 -175.769 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.3 tp -121.55 102.47 8.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 124.965 1.306 . . . . 9.9600000000000009 108.747 -165.026 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.9 t -87.9 128.84 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 123.105 0.562 . . . . 9.7599999999999998 110.226 176.265 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 63.6 mt -105.07 161.77 13.94 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.425 -2.805 . . . . 19.57 103.425 -169.637 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -166.39 179.14 5.74 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.842 -1.072 . . . . 35.079999999999998 109.73 -178.735 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.8 mt -109.0 149.88 28.58 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 125.925 1.69 . . . . 32.310000000000002 113.899 179.163 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttt180 -56.39 126.02 24.53 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.643 2.46 . . . . 42.75 117.643 -173.461 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.0 -54.64 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 116.992 1.557 . . . . 36.310000000000002 116.992 177.369 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.743 0 CA-C-O 114.317 -3.491 . . . . 36.270000000000003 106.104 169.258 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 ptt? . . . . . 0 CA--C 1.49 -1.338 0 CA-C-O 123.909 1.814 . . . . 17.170000000000002 114.597 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -74.92 125.29 28.55 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.386 -3.321 . . . . 21.890000000000001 114.092 168.465 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.2 pt -120.88 161.95 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 112.965 -1.925 . . . . 10.83 112.064 170.048 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -119.76 125.34 48.37 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.573 1.654 . . . . 10.609999999999999 111.615 -177.259 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -111.1 111.84 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 121.118 -0.988 . . . . 9.1300000000000008 110.237 174.632 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.2 tttt -88.37 138.52 31.36 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.608 -3.182 . . . . 20.550000000000001 118.261 179.088 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.264 28.2 p -87.25 175.79 7.87 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.301 2.334 . . . . 11.779999999999999 117.301 178.672 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.8 tp -75.39 -38.21 60.06 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.729 -2.082 . . . . 19.309999999999999 115.095 173.978 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 63.0 p -70.64 -52.77 19.05 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 114.486 -2.673 . . . . 23.140000000000001 116.688 161.036 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.7 58.17 0.06 OUTLIER Glycine 0 N--CA 1.43 -1.71 0 CA-C-N 124.927 3.512 . . . . 19.739999999999998 110.899 158.494 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -97.14 147.11 24.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.29 -1.712 . . . . 21.93 110.485 165.411 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.7 m -93.62 108.41 20.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 122.208 1.004 . . . . 12.33 109.632 167.175 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.7 mt -75.93 127.7 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 117.738 -3.101 . . . . 17.079999999999998 107.605 166.185 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.6 p -114.15 127.46 55.92 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.742 -3.099 . . . . 16.300000000000001 111.97 177.573 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.1 mt -127.81 133.19 49.41 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 128.172 3.42 . . . . 15.880000000000001 113.759 -171.567 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -95.75 91.7 6.21 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 132.242 4.217 . . . . 28.899999999999999 109.42 -179.516 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -126.52 167.47 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 106.513 -1.662 . . . . 12.050000000000001 106.513 178.927 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -102.44 154.19 37.61 Favored Pre-proline 0 N--CA 1.43 -1.429 0 O-C-N 117.39 -3.319 . . . . 18.170000000000002 105.838 174.255 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -68.99 -5.33 15.46 Favored 'Trans proline' 0 N--CA 1.433 -2.037 0 CA-C-N 124.079 2.493 . . . . 8.1600000000000001 117.631 -173.494 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 m -98.37 4.38 48.56 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 124.442 1.089 . . . . 11.130000000000001 108.298 174.963 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -67.49 147.3 53.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.902 2.186 . . . . 18.030000000000001 116.902 162.052 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 7.5 p -89.67 158.84 17.41 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.318 -1.765 . . . . 10.220000000000001 106.681 -173.665 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.2 mm -64.7 -32.69 59.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 118.385 -2.697 . . . . 12.300000000000001 114.486 -178.766 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -44.21 -50.81 8.63 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 129.206 3.002 . . . . 36.509999999999998 109.783 162.238 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -74.12 -21.24 59.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.936 -2.977 . . . . 25.66 117.128 178.333 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.401 HG21 HD21 ' A' ' 56' ' ' LEU . 55.8 t -71.63 -43.61 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 123.25 1.5 . . . . 8.1199999999999992 109.838 172.909 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -61.51 -30.65 70.76 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.087 2.995 . . . . 15.470000000000001 119.087 168.66 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.37 -34.65 61.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.88 -3.013 . . . . 11.449999999999999 112.922 171.204 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.85 -49.04 76.66 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 127.063 3.316 . . . . 24.98 116.103 167.953 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.6 mt -57.79 -42.23 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 117.645 -3.16 . . . . 9.4600000000000009 113.528 166.54 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -63.2 -39.55 94.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.426 -3.921 . . . . 14.76 116.176 172.977 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -68.05 -50.56 54.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.12 0.887 . . . . 26.289999999999999 113.121 176.126 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mmtt -70.14 -66.02 0.65 Allowed 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 114.112 1.152 . . . . 30.059999999999999 114.112 176.889 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -76.96 -35.28 57.36 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 118.856 2.909 . . . . 25.190000000000001 118.856 -170.221 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.01 60.16 1.79 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 119.827 -1.796 . . . . 7.4100000000000001 111.246 -173.169 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -132.99 119.54 15.82 Favored Pre-proline 0 N--CA 1.43 -1.439 0 C-N-CA 125.151 1.38 . . . . 9.4900000000000002 108.091 178.255 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.49 154.41 45.1 Favored 'Trans proline' 0 N--CA 1.433 -2.059 1 C-N-CA 125.893 4.395 . . . . 11.42 111.716 -172.218 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.299 52.3 Cg_endo -64.27 -14.3 43.09 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 O-C-N 123.891 1.469 . . . . 12.0 111.507 174.726 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -67.29 -34.34 77.2 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.361 2.505 . . . . 35.549999999999997 113.779 176.605 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -96.58 -37.74 10.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.012 -2.305 . . . . 20.52 108.639 -164.684 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -75.21 136.89 40.98 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 117.067 2.247 . . . . 7.1299999999999999 117.067 -176.345 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.433 ' HB3' HG23 ' A' ' 70' ' ' VAL . 37.3 ttm180 -120.06 133.25 55.58 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.197 -3.26 . . . . 36.390000000000001 102.197 161.339 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.7 mt -108.53 141.93 39.7 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.386 -2.071 . . . . 9.5500000000000007 106.389 179.903 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 82.1 mt -126.83 138.54 54.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 130.214 3.406 . . . . 13.9 103.367 -170.476 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -121.03 121.24 37.53 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 122.974 1.369 . . . . 6.8600000000000003 111.471 161.185 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.61 -78.58 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.719 -2.488 . . . . 11.15 114.843 -174.613 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -149.25 -4.94 0.24 Allowed Glycine 0 N--CA 1.43 -1.735 0 CA-C-N 123.882 3.037 . . . . 13.93 110.638 -177.998 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -113.07 146.03 39.86 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.747 2.419 . . . . 23.920000000000002 112.689 -173.391 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -89.52 156.07 18.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.597 1.959 . . . . 23.23 110.288 -171.773 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -118.86 127.24 53.32 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 129.455 4.222 . . . . 9.1099999999999994 107.8 -170.413 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -103.14 165.07 11.24 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.837 -3.04 . . . . 33.439999999999998 112.384 -172.118 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -69.91 -58.13 4.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.477 -2.639 . . . . 28.370000000000001 113.848 -157.645 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.35 31.03 5.95 Favored Glycine 0 N--CA 1.43 -1.708 0 CA-C-O 117.919 -1.489 . . . . 15.0 115.523 -167.714 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -107.96 162.09 14.34 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.94 1.696 . . . . 25.5 114.202 159.831 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 29.2 p -92.72 173.48 7.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.305 1.526 . . . . 11.949999999999999 107.626 -171.65 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 26' ' ' VAL . 12.5 mt -65.67 -44.26 86.81 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.026 -0.988 . . . . 10.17 110.469 171.729 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.1 m -63.89 -32.21 73.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 117.198 2.295 . . . . 13.59 117.198 178.704 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -58.21 -42.81 87.03 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 120.267 3.432 . . . . 11.699999999999999 120.267 173.54 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -70.5 -13.89 62.3 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 117.46 -1.257 . . . . 12.949999999999999 114.275 163.849 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.26 30.2 m120 68.68 38.59 2.2 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 128.474 2.71 . . . . 25.449999999999999 114.265 -171.61 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -80.16 129.16 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.053 2.095 . . . . 14.6 110.339 164.557 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -132.44 -173.77 3.26 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 129.128 2.971 . . . . 33.229999999999997 108.944 -164.217 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -65.26 136.22 56.34 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 116.57 -3.831 . . . . 25.969999999999999 111.14 172.629 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 55.42 53.19 10.16 Favored 'General case' 0 N--CA 1.43 -1.455 1 CA-C-N 108.039 -4.164 . . . . 32.609999999999999 113.442 -170.889 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -96.37 150.67 20.33 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.057 -4.152 . . . . 10.56 110.121 -178.136 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.5 m -103.46 111.1 23.38 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 127.4 2.937 . . . . 5.3300000000000001 108.444 -174.9 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -100.07 162.09 13.19 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 108.293 -1.002 . . . . 11.66 108.293 176.215 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -122.75 128.06 50.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.35 -1.469 . . . . 16.300000000000001 111.347 170.422 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -93.92 121.9 35.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 113.737 1.014 . . . . 9.9600000000000009 113.737 176.638 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 42' ' ' ARG . 18.7 m -121.68 155.87 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 105.778 -1.934 . . . . 9.7599999999999998 105.778 174.445 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.2 mt -101.17 117.64 35.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.872 -2.393 . . . . 19.57 109.787 172.056 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -92.13 177.71 6.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.918 2.487 . . . . 35.079999999999998 109.673 178.876 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.6 mt -112.01 176.94 4.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.442 1.497 . . . . 32.310000000000002 108.844 158.253 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.8 ttt85 -67.63 136.16 53.97 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 119.664 1.12 . . . . 42.75 112.139 -172.477 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.3 -120.42 0.96 Allowed Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 116.722 -2.154 . . . . 36.310000000000002 108.575 -169.371 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.748 0 CA-C-N 118.961 1.381 . . . . 36.270000000000003 110.455 179.964 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.8 ptt? . . . . . 0 CA--C 1.489 -1.378 0 N-CA-C 111.932 0.345 . . . . 17.170000000000002 111.932 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -89.74 115.26 26.96 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.569 1.548 . . . . 21.890000000000001 113.084 -175.662 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.48 18.0 pt -107.29 155.27 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 126.076 1.75 . . . . 10.83 115.593 168.874 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -121.2 116.57 25.16 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 128.333 2.653 . . . . 10.609999999999999 105.681 -178.006 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.9 t -114.32 109.36 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 118.064 -2.897 . . . . 9.1300000000000008 108.26 172.074 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.1 tttp -101.29 132.67 46.7 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.281 1.515 . . . . 20.550000000000001 107.12 -173.798 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -87.12 171.56 10.6 Favored 'General case' 0 N--CA 1.429 -1.486 1 O-C-N 115.732 -4.355 . . . . 11.779999999999999 113.495 177.708 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.4 tp -70.23 -42.2 72.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 127.047 3.308 . . . . 19.309999999999999 109.495 177.699 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.6 p -56.81 -31.69 64.96 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.751 -3.093 . . . . 23.140000000000001 116.928 167.889 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.62 37.29 2.09 Favored Glycine 0 N--CA 1.431 -1.685 0 CA-C-N 122.632 2.469 . . . . 19.739999999999998 113.137 173.235 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -99.55 152.9 19.5 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 103.451 -2.796 . . . . 21.93 103.451 167.446 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.0 m -110.97 106.23 15.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 114.06 1.133 . . . . 12.33 114.06 160.246 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 36.5 mt -81.27 108.25 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.876 -1.765 . . . . 17.079999999999998 108.571 169.973 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 39.9 p -78.39 137.8 38.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.49 -2.006 . . . . 16.300000000000001 111.039 172.34 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.2 139.32 44.42 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 125.197 1.561 . . . . 15.880000000000001 110.366 -177.166 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -95.46 111.6 23.46 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.298 2.639 . . . . 28.899999999999999 109.784 164.579 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.252 29.0 m -135.51 162.26 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 1 O-C-N 114.446 -5.159 . . . . 12.050000000000001 107.344 175.133 . . . . . . . . 3 2 . 1 . 064 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -97.95 166.05 14.23 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 120.239 -1.538 . . . . 18.170000000000002 107.967 179.682 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.74 -19.9 48.59 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 CA-C-N 123.721 2.365 . . . . 8.1600000000000001 118.1 174.184 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.7 m -98.5 12.94 33.53 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 125.032 1.458 . . . . 11.130000000000001 112.066 -172.182 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.34 131.16 34.73 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.429 -2.044 . . . . 18.030000000000001 108.87 176.952 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 52' ' ' ASP 0.314 65.1 p -59.26 163.55 3.77 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 115.913 1.82 . . . . 10.220000000000001 115.913 164.889 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 37.2 mm -76.05 -17.1 15.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 1 O-C-N 116.291 -4.005 . . . . 12.300000000000001 106.335 -179.72 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 36.7 tt0 -69.12 -47.24 65.64 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.074 -1.642 . . . . 36.509999999999998 107.538 172.127 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.273 70.4 m-80 -66.49 -29.43 69.54 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 119.508 3.151 . . . . 25.66 119.508 175.677 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.269 60.2 t -51.4 -51.56 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 N-CA-C 114.155 1.168 . . . . 8.1199999999999992 114.155 163.621 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -71.61 -40.48 69.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.556 1.942 . . . . 15.470000000000001 110.618 -174.995 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.264 . . -52.34 -49.34 64.5 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.336 3.054 . . . . 11.449999999999999 109.809 170.051 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 20.8 tttt -62.51 -36.72 83.45 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.556 -3.215 . . . . 24.98 116.812 172.836 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.6 mt -58.91 -47.25 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 117.763 -3.086 . . . . 9.4600000000000009 111.538 167.455 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 -55.86 -35.78 66.84 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.231 2.678 . . . . 14.76 118.231 173.931 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.9 -43.06 69.08 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 106.992 -1.485 . . . . 26.289999999999999 106.992 -179.894 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -79.03 -57.47 3.72 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.785 -1.822 . . . . 30.059999999999999 115.31 -173.935 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.9 mm-40 -85.74 -49.7 7.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 112.779 -2.01 . . . . 25.190000000000001 111.572 -173.947 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.6 28.66 5.91 Favored Glycine 0 N--CA 1.429 -1.777 0 O-C-N 116.396 -3.94 . . . . 7.4100000000000001 110.885 -169.436 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.23 122.9 41.4 Favored Pre-proline 0 N--CA 1.429 -1.5 1 CA-C-O 111.541 -4.076 . . . . 9.4900000000000002 105.997 176.161 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -87.63 159.77 7.83 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-O 114.543 -2.357 . . . . 11.42 112.199 -165.369 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -64.26 -9.48 20.01 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 122.912 2.408 . . . . 12.0 116.227 -175.626 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -82.36 -34.61 28.36 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 124.165 3.166 . . . . 35.549999999999997 109.907 -169.568 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -83.19 -19.45 36.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.539 1.536 . . . . 20.52 108.467 -174.775 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -90.95 127.96 36.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 119.054 2.983 . . . . 7.1299999999999999 119.054 -166.839 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -120.4 123.61 43.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 128.273 3.892 . . . . 36.390000000000001 111.174 168.674 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.0 mt -112.42 141.37 46.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.538 -2.601 . . . . 9.5500000000000007 112.541 177.923 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.91 134.91 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.484 -1.673 . . . . 13.9 106.484 -164.796 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -117.46 112.43 20.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 102.959 -2.978 . . . . 6.8600000000000003 102.959 171.608 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.321 . . 60.48 -108.29 0.35 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.068 1.889 . . . . 11.15 113.537 -167.748 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.17 -12.2 22.4 Favored Glycine 0 N--CA 1.43 -1.709 0 CA-C-N 113.08 -1.873 . . . . 13.93 109.97 170.141 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -74.17 107.97 6.68 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.387 3.593 . . . . 23.920000000000002 112.835 179.618 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -73.8 122.36 22.32 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.239 -4.663 . . . . 23.23 110.897 176.528 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.274 6.5 mt -90.67 127.28 36.25 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.861 2.911 . . . . 9.1099999999999994 118.861 -165.244 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -83.55 143.58 30.07 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.35 -2.094 . . . . 33.439999999999998 114.926 173.005 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 36.0 m-20 -65.31 -41.44 94.04 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.755 2.217 . . . . 28.370000000000001 114.985 -163.977 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.51 21.46 38.32 Favored Glycine 0 N--CA 1.43 -1.715 0 O-C-N 118.614 -2.554 . . . . 15.0 113.58 -174.411 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtt180 -106.23 165.29 11.35 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.391 -1.337 . . . . 25.5 107.391 162.892 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -104.49 178.15 4.64 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 127.086 2.155 . . . . 11.949999999999999 111.54 -173.333 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 88.2 mt -80.1 -36.84 34.82 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.546 3.138 . . . . 10.17 106.445 173.945 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -51.77 -38.91 57.45 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.934 2.152 . . . . 13.59 114.931 163.509 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -70.96 -54.73 10.26 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.6 3.56 . . . . 11.699999999999999 109.234 -179.179 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -77.19 0.03 23.35 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.59 1.181 . . . . 12.949999999999999 113.213 -178.979 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 48.97 46.43 22.35 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.537 2.589 . . . . 25.449999999999999 117.034 -176.902 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mt -84.88 120.05 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 111.962 -2.381 . . . . 14.6 108.577 176.909 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -107.69 172.84 6.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.972 1.844 . . . . 33.229999999999997 113.831 177.96 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -60.14 141.73 55.4 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.423 -2.673 . . . . 25.969999999999999 113.038 179.462 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.313 12.2 mt-10 71.29 20.68 4.93 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 126.238 2.923 . . . . 32.609999999999999 117.876 177.863 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 68.1 m -87.63 124.72 33.82 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.448 -2.033 . . . . 10.56 109.958 173.833 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.1 m -74.26 100.93 3.86 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.383 2.04 . . . . 5.3300000000000001 112.157 177.698 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.4 mt -84.75 141.95 30.18 Favored 'General case' 0 N--CA 1.431 -1.393 0 O-C-N 117.659 -3.15 . . . . 11.66 113.508 167.144 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -107.16 128.2 54.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.264 1.983 . . . . 16.300000000000001 109.754 -178.808 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.7 tp -97.58 128.44 44.31 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.207 -3.433 . . . . 9.9600000000000009 109.2 173.367 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.0 t -124.07 136.52 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 126.303 2.954 . . . . 9.7599999999999998 105.084 171.015 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt -102.03 115.08 29.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.975 -2.953 . . . . 19.57 109.572 179.054 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -85.82 -176.95 6.22 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.673 -2.517 . . . . 35.079999999999998 112.751 -170.237 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.5 mt -107.29 160.41 15.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 115.936 -2.306 . . . . 32.310000000000002 108.688 149.198 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.291 0.5 OUTLIER -67.46 90.1 0.24 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.574 2.35 . . . . 42.75 111.202 -167.879 . . . . . . . . 3 3 . 1 . 064 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.94 106.75 0.22 Allowed Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 119.382 -1.389 . . . . 36.310000000000002 111.049 -174.308 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.752 0 CA-C-O 117.062 -1.966 . . . . 36.270000000000003 110.025 -168.932 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' HG23 ' A' ' 17' ' ' VAL . 19.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 CA-C-O 117.795 -1.098 . . . . 17.170000000000002 111.997 . . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.336 2.8 pt20 -95.87 145.29 25.49 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.794 2.088 . . . . 21.890000000000001 115.928 166.472 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.1 pt -138.39 167.26 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 103.361 -2.829 . . . . 10.83 103.361 174.865 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -122.22 145.28 48.36 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.891 -2.413 . . . . 10.609999999999999 108.272 179.177 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 30' ' ' ILE . 78.5 t -128.66 111.12 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 103.457 -2.794 . . . . 9.1300000000000008 103.457 176.937 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -107.26 137.49 45.21 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.676 2.655 . . . . 20.550000000000001 112.293 179.415 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.418 HG22 HD23 ' A' ' 69' ' ' LEU . 44.9 p -79.38 -166.45 0.96 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.916 -2.365 . . . . 11.779999999999999 105.541 -173.489 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.5 tp -81.59 -47.13 13.45 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.653 -1.904 . . . . 19.309999999999999 109.277 173.129 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.62 -31.2 61.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.711 2.804 . . . . 23.140000000000001 109.07 -170.059 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.43 42.17 0.47 Allowed Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 125.579 3.809 . . . . 19.739999999999998 115.226 174.326 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.3 tttm -108.27 133.98 51.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 102.27 -3.233 . . . . 21.93 102.27 168.358 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.9 m -104.54 113.17 26.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 124.888 1.368 . . . . 12.33 108.64 168.934 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -87.6 100.45 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 126.331 1.852 . . . . 17.079999999999998 112.562 166.618 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.9 m -77.23 136.51 38.54 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 118.143 -0.932 . . . . 16.300000000000001 108.879 177.778 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.296 32.0 mt -134.64 128.08 32.4 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 121.901 2.137 . . . . 15.880000000000001 105.519 178.548 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -88.26 132.33 34.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.367 -3.333 . . . . 28.899999999999999 107.676 161.296 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.525 HG23 ' HG3' ' A' ' 1' ' ' MET . 18.2 m -133.27 171.32 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 1 C-N-CA 132.194 4.198 . . . . 12.050000000000001 113.118 -164.146 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -108.0 148.06 36.7 Favored Pre-proline 0 N--CA 1.43 -1.445 0 C-N-CA 129.109 2.964 . . . . 18.170000000000002 112.604 161.753 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -59.6 -23.12 69.99 Favored 'Trans proline' 0 N--CA 1.434 -2.017 1 C-N-CA 126.162 4.575 . . . . 8.1600000000000001 115.364 173.086 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -86.58 -7.16 58.59 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 115.145 1.535 . . . . 11.130000000000001 115.145 -179.101 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -73.61 146.53 44.59 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 118.039 -2.913 . . . . 18.030000000000001 110.452 179.33 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.8 p -99.28 -176.81 3.41 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 104.331 -2.47 . . . . 10.220000000000001 104.331 -172.507 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -70.45 -34.61 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 127.353 2.261 . . . . 12.300000000000001 109.569 -177.638 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -55.23 -43.33 74.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.695 2.798 . . . . 36.509999999999998 110.822 172.209 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -70.68 -34.92 72.49 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.755 2.502 . . . . 25.66 117.755 174.346 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 50.3 t -55.24 -48.81 76.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 1 C-N-CA 132.031 4.133 . . . . 8.1199999999999992 108.058 174.002 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt -63.81 -27.86 69.47 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 129.036 2.934 . . . . 15.470000000000001 115.066 177.488 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.34 -31.06 54.24 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.542 1.974 . . . . 11.449999999999999 110.997 177.374 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -65.04 -44.88 87.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 118.64 -2.538 . . . . 24.98 109.414 178.734 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 HG11 ' A' ' 5' ' ' VAL . 15.6 mt -65.59 -24.11 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 116.729 2.122 . . . . 9.4600000000000009 116.729 173.189 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -64.89 -57.42 8.85 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 116.798 -3.689 . . . . 14.76 114.342 162.276 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -52.24 -60.62 3.0 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.517 3.527 . . . . 26.289999999999999 114.729 175.757 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -79.5 -39.73 31.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.913 2.085 . . . . 30.059999999999999 112.612 -166.432 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -106.87 -42.2 5.0 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.029 1.732 . . . . 25.190000000000001 110.009 -163.287 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.63 7.09 30.22 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 117.709 -2.186 . . . . 7.4100000000000001 117.85 -173.118 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.6 mm -90.97 126.91 53.82 Favored Pre-proline 0 N--CA 1.431 -1.408 0 CA-C-N 122.25 3.025 . . . . 9.4900000000000002 108.917 -170.314 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -68.51 152.97 74.69 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 122.261 1.843 . . . . 11.42 111.867 -178.617 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -92.98 -10.53 1.9 Allowed 'Trans proline' 0 C--N 1.3 -2.017 0 CA-C-O 113.241 -2.9 . . . . 12.0 111.797 -151.995 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -85.85 -28.43 24.44 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 128.671 3.732 . . . . 35.549999999999997 111.356 174.872 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -85.17 -17.35 37.44 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 118.884 -0.579 . . . . 20.52 111.625 -171.807 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -66.85 115.66 6.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.593 2.757 . . . . 7.1299999999999999 111.049 171.866 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.7 ttm180 -114.64 124.11 51.01 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.317 2.008 . . . . 36.390000000000001 108.772 171.967 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.7 mt -103.35 134.9 45.96 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.041 -2.287 . . . . 9.5500000000000007 107.221 -177.854 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.424 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 7.5 mm -112.38 122.62 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 130.522 3.529 . . . . 13.9 115.144 171.053 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -108.8 118.81 37.77 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.755 -1.202 . . . . 6.8600000000000003 107.755 170.965 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.55 -78.37 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 131.134 3.774 . . . . 11.15 113.611 -170.545 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.47 40.41 0.28 Allowed Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 107.193 -2.363 . . . . 13.93 107.193 -179.808 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -137.2 139.33 41.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.525 -2.75 . . . . 23.920000000000002 111.473 159.7 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -67.79 167.52 13.24 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 117.518 2.414 . . . . 23.23 117.518 175.361 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 mt -114.49 149.83 35.77 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.679 2.392 . . . . 9.1099999999999994 107.508 178.41 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -123.9 146.92 48.1 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 123.528 0.518 . . . . 33.439999999999998 109.786 -177.665 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.74 -47.27 41.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 120.577 3.547 . . . . 28.370000000000001 120.577 -158.651 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -117.56 53.7 0.63 Allowed Glycine 0 N--CA 1.429 -1.77 0 O-C-N 117.068 -3.52 . . . . 15.0 111.131 -170.338 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -120.62 159.27 25.64 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 117.574 -1.65 . . . . 25.5 106.997 155.969 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -85.12 165.38 17.5 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.969 2.508 . . . . 11.949999999999999 112.348 -169.914 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.6 mt -72.09 -38.04 69.45 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.685 -1.885 . . . . 10.17 110.012 -176.639 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -54.09 -49.15 69.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 114.891 -2.48 . . . . 13.59 113.105 169.706 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -44.53 -50.05 9.73 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 124.989 3.54 . . . . 11.699999999999999 113.787 174.702 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -76.93 -7.63 55.9 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.669 -2.519 . . . . 12.949999999999999 116.839 -178.981 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 69.19 37.47 2.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.966 3.307 . . . . 25.449999999999999 115.258 -179.42 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.2 mt -85.01 109.19 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 130.878 3.671 . . . . 14.6 105.677 -172.867 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -91.07 165.26 13.61 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 125.826 2.727 . . . . 33.229999999999997 113.035 -179.751 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.01 147.25 12.83 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.798 -3.689 . . . . 25.969999999999999 115.532 168.308 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 58.37 32.23 21.84 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.046 2.61 . . . . 32.609999999999999 118.046 -170.762 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -98.74 142.63 30.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.495 1.747 . . . . 10.56 108.796 177.071 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.2 m -93.24 102.91 15.2 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 131.137 3.775 . . . . 5.3300000000000001 115.636 169.473 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -84.25 153.58 23.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.842 -2.281 . . . . 11.66 104.842 168.602 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.424 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 89.2 m-70 -92.04 152.96 19.72 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 114.735 1.383 . . . . 16.300000000000001 114.735 168.191 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.418 HD23 HG22 ' A' ' 7' ' ' THR . 22.2 tp -120.01 108.78 14.71 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.977 2.111 . . . . 9.9600000000000009 110.998 169.082 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.327 16.0 m -119.65 168.74 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 O-C-N 126.922 2.639 . . . . 9.7599999999999998 112.505 171.495 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.2 mt -98.32 147.46 24.64 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-O 125.534 2.588 . . . . 19.57 106.591 179.053 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttp180 -85.15 112.75 20.97 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 112.951 -1.931 . . . . 35.079999999999998 112.951 176.654 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.2 mt -91.69 178.2 5.99 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.341 -3.349 . . . . 32.310000000000002 112.26 -178.117 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.4 tpp180 -82.01 83.66 7.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.351 1.432 . . . . 42.75 114.759 -162.548 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -164.82 -84.5 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 117.206 -2.426 . . . . 36.310000000000002 110.827 176.025 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.746 0 N-CA-C 106.818 -2.513 . . . . 36.270000000000003 106.818 156.757 . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ptt? . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 108.119 -1.067 . . . . 17.170000000000002 108.119 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -83.15 132.93 35.06 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.919 -2.363 . . . . 21.890000000000001 114.764 175.734 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.8 pt -131.84 163.14 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 124.716 1.26 . . . . 10.83 110.039 172.489 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -124.67 166.27 16.44 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 102.282 -3.229 . . . . 10.609999999999999 102.282 -174.949 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -150.18 143.17 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 100.877 -3.749 . . . . 9.1300000000000008 100.877 179.464 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -119.2 139.05 52.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.467 1.939 . . . . 20.550000000000001 106.271 -178.649 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.0 p -81.81 167.84 18.63 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 125.744 1.903 . . . . 11.779999999999999 107.565 178.654 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.3 tp -56.17 -54.8 40.83 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 130.014 3.326 . . . . 19.309999999999999 113.132 -178.946 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.3 p -62.62 -53.76 49.72 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.891 2.476 . . . . 23.140000000000001 110.57 175.727 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.18 70.61 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.768 0 CA-C-O 117.601 -1.666 . . . . 19.739999999999998 112.768 169.587 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -125.78 124.42 40.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.909 1.855 . . . . 21.93 109.665 176.858 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -79.57 106.03 11.31 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 114.383 -5.198 . . . . 12.33 111.177 177.387 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.7 mt -81.35 115.07 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 123.259 1.504 . . . . 17.079999999999998 107.139 171.934 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -94.47 104.11 16.08 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 114.344 -5.222 . . . . 16.300000000000001 114.818 171.518 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.5 mt -97.35 162.29 13.4 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.436 -4.54 . . . . 15.880000000000001 112.244 179.378 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -116.22 118.99 34.34 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 102.913 -2.995 . . . . 28.899999999999999 102.913 174.322 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.6 m -128.27 165.55 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 121.844 2.111 . . . . 12.050000000000001 112.707 173.653 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -104.57 161.78 21.79 Favored Pre-proline 0 N--CA 1.43 -1.46 0 N-CA-C 105.658 -1.979 . . . . 18.170000000000002 105.658 164.169 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -81.17 -6.29 12.96 Favored 'Trans proline' 0 N--CA 1.433 -2.045 0 C-N-CA 123.978 3.119 . . . . 8.1600000000000001 109.311 -169.412 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -88.22 2.97 51.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 131.54 3.936 . . . . 11.130000000000001 113.379 168.0 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -87.15 152.71 22.11 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.21 -3.431 . . . . 18.030000000000001 109.91 -178.859 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.3 p -94.86 164.05 13.08 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 123.149 2.704 . . . . 10.220000000000001 110.7 -167.042 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.5 mm -69.37 -34.87 64.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 1 O-C-N 115.489 -4.507 . . . . 12.300000000000001 109.164 -179.864 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.24 -42.78 77.91 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.737 2.866 . . . . 36.509999999999998 118.737 168.045 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -71.21 -32.43 68.81 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.02 2.128 . . . . 25.66 110.403 175.643 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.359 44.4 t -52.06 -61.27 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 O-C-N 118.98 -2.325 . . . . 8.1199999999999992 111.094 165.396 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -52.59 -35.43 54.11 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 127.109 2.164 . . . . 15.470000000000001 114.479 177.772 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.6 -35.37 70.47 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.296 -2.753 . . . . 11.449999999999999 109.481 -178.302 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -62.27 -41.65 98.66 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 121.145 -0.972 . . . . 24.98 112.925 171.846 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.7 mt -63.71 -36.34 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 127.459 2.974 . . . . 9.4600000000000009 114.348 179.428 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -53.91 -33.19 55.92 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.509 3.924 . . . . 14.76 117.834 166.643 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -79.68 -51.48 9.18 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 124.12 1.914 . . . . 26.289999999999999 108.841 178.053 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.5 mmtt -56.46 -63.15 1.29 Allowed 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.274 1.987 . . . . 30.059999999999999 114.991 -176.771 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -110.91 -13.51 14.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.693 -3.129 . . . . 25.190000000000001 114.28 -172.765 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.47 43.78 43.86 Favored Glycine 0 N--CA 1.43 -1.708 0 N-CA-C 119.524 2.57 . . . . 7.4100000000000001 119.524 -172.623 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.1 mm -95.6 115.9 65.85 Favored Pre-proline 0 N--CA 1.43 -1.425 0 CA-C-O 115.154 -2.355 . . . . 9.4900000000000002 105.903 169.575 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -66.32 152.43 81.03 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 CA-C-N 126.906 3.502 . . . . 11.42 113.57 -177.856 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.14 -0.26 10.6 Favored 'Trans proline' 0 N--CA 1.434 -2.003 0 C-N-CA 123.06 2.506 . . . . 12.0 112.92 -166.109 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -90.66 -54.79 3.83 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.836 3.207 . . . . 35.549999999999997 109.123 -173.897 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -84.28 -8.56 58.99 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.252 2.315 . . . . 20.52 117.252 -174.616 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -88.85 157.33 18.49 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.942 -2.974 . . . . 7.1299999999999999 109.923 171.52 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -143.46 144.69 32.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 120.018 -1.676 . . . . 36.390000000000001 107.593 168.637 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.8 mt -97.59 140.07 32.55 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.017 1.327 . . . . 9.5500000000000007 113.673 -175.983 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mm -134.52 139.35 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 104.009 -2.589 . . . . 13.9 104.009 -173.707 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.445 ' HB2' HD11 ' A' ' 50' ' ' LEU . 5.2 t80 -111.93 108.36 17.69 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.559 2.344 . . . . 6.8600000000000003 107.834 173.389 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.41 -88.6 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 126.362 2.289 . . . . 11.15 112.781 -169.99 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.42 -8.48 4.89 Favored Glycine 0 N--CA 1.43 -1.7 0 O-C-N 117.012 -3.555 . . . . 13.93 109.953 175.841 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -81.56 141.07 34.1 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 118.032 0.916 . . . . 23.920000000000002 111.32 -177.345 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -94.61 120.84 35.47 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 125.272 1.429 . . . . 23.23 108.168 -178.168 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.445 HD11 ' HB2' ' A' ' 45' ' ' PHE . 14.7 mt -91.84 133.25 35.82 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 126.593 1.957 . . . . 9.1099999999999994 110.588 -165.138 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -94.84 136.25 35.37 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.772 -2.455 . . . . 33.439999999999998 114.92 179.098 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.82 -38.23 64.62 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.205 2.298 . . . . 28.370000000000001 117.205 -143.214 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.85 11.95 4.16 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 120.904 3.121 . . . . 15.0 120.904 164.66 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.6 mtt180 -106.18 172.88 6.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.39 2.595 . . . . 25.5 112.586 172.367 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.4 p -98.69 171.45 8.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 124.478 2.085 . . . . 11.949999999999999 115.436 176.128 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.0 mt -62.01 -40.35 95.37 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 127.434 2.294 . . . . 10.17 109.391 173.394 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.0 m -60.41 -33.68 72.86 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 118.856 2.91 . . . . 13.59 118.856 173.17 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.286 28.5 m-20 -68.06 -44.78 75.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 115.629 1.715 . . . . 11.699999999999999 115.629 174.046 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -76.02 -32.55 59.43 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 125.424 1.489 . . . . 12.949999999999999 114.57 175.897 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t30 83.08 67.93 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.471 1 C-N-CA 131.884 4.073 . . . . 25.449999999999999 108.978 177.951 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.4 mt -101.49 118.15 47.84 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 127.485 2.314 . . . . 14.6 107.985 -177.916 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -89.25 177.92 6.48 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.097 -1.041 . . . . 33.229999999999997 110.518 -171.314 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -70.61 149.76 46.73 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 120.138 1.335 . . . . 25.969999999999999 110.882 175.916 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 70.03 51.41 0.41 Allowed 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.778 3.231 . . . . 32.609999999999999 107.508 170.374 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -126.38 132.26 51.59 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.798 3.239 . . . . 10.56 115.398 -169.045 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.361 6.8 m -103.02 106.15 16.61 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.895 1.68 . . . . 5.3300000000000001 115.48 -172.751 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.6 mt -83.67 156.13 22.81 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 127.346 3.451 . . . . 11.66 107.523 177.854 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.5 m-70 -111.39 157.8 19.82 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.028 -3.545 . . . . 16.300000000000001 106.979 -174.971 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -126.85 106.86 9.63 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.923 1.344 . . . . 9.9600000000000009 109.853 -169.696 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 m -118.88 171.49 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 100.896 -3.742 . . . . 9.7599999999999998 100.896 -166.99 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.6 tt -97.1 147.1 24.39 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.606 -3.809 . . . . 19.57 101.851 -177.54 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -97.59 119.69 36.62 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.622 -3.174 . . . . 35.079999999999998 112.316 175.956 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.3 mt -91.41 164.66 13.75 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 116.12 1.896 . . . . 32.310000000000002 116.12 168.472 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.8 tpp180 -74.98 134.24 41.53 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.428 2.061 . . . . 42.75 114.401 -179.052 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 153.71 -74.08 0.25 Allowed Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 113.359 -1.746 . . . . 36.310000000000002 114.367 171.419 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.794 0 O-C-N 120.48 -1.6 . . . . 36.270000000000003 111.327 170.864 . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.5 ptt? . . . . . 0 CA--C 1.49 -1.358 0 CA-C-O 118.873 -0.585 . . . . 17.170000000000002 111.193 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -96.57 138.76 33.67 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.001 -2.312 . . . . 21.890000000000001 113.455 170.324 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.8 pt -115.04 154.15 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 127.231 2.212 . . . . 10.83 105.249 165.803 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -113.18 114.31 26.58 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.839 -1.788 . . . . 10.609999999999999 107.17 -176.991 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -105.8 105.93 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 N-CA-C 105.504 -2.036 . . . . 9.1300000000000008 105.504 177.784 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -101.03 152.43 20.6 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.827 -2.657 . . . . 20.550000000000001 103.827 -172.73 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -97.11 172.19 7.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.135 -0.978 . . . . 11.779999999999999 110.803 178.348 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.5 tp -45.72 -57.17 4.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 116.424 2.009 . . . . 19.309999999999999 116.424 170.191 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.06 -42.78 77.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 131.562 3.945 . . . . 23.140000000000001 111.235 175.13 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.1 55.86 0.47 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 126.811 3.451 . . . . 19.739999999999998 109.653 172.407 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -115.2 135.82 53.76 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.231 -2.334 . . . . 21.93 107.815 175.058 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -106.79 119.5 39.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.214 -3.429 . . . . 12.33 117.102 -164.544 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.2 mt -104.14 102.69 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 119.047 -2.283 . . . . 17.079999999999998 111.283 -172.567 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.8 m -84.76 118.27 24.34 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 125.967 1.707 . . . . 16.300000000000001 106.812 -176.714 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.415 HD11 HG13 ' A' ' 30' ' ' ILE . 58.3 mt -115.52 131.32 56.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.611 -2.556 . . . . 15.880000000000001 106.952 -173.919 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -100.06 91.04 4.6 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 115.727 1.751 . . . . 28.899999999999999 115.727 179.824 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.6 m -121.77 163.88 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 CA-C-O 128.053 3.787 . . . . 12.050000000000001 112.208 -171.44 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -92.45 157.12 40.78 Favored Pre-proline 0 N--CA 1.43 -1.455 0 O-C-N 118.791 -2.443 . . . . 18.170000000000002 106.478 167.799 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.54 -3.61 14.01 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 114.748 -3.343 . . . . 8.1600000000000001 111.39 176.749 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.3 p -87.59 -7.55 57.36 Favored 'General case' 0 N--CA 1.431 -1.387 0 O-C-N 118.732 -2.48 . . . . 11.130000000000001 111.007 175.33 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -68.74 137.57 54.18 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.147 1.379 . . . . 18.030000000000001 109.531 176.127 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 p -85.28 164.11 18.22 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.341 2.256 . . . . 10.220000000000001 109.136 -173.131 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.605 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 35.8 mm -62.29 -37.83 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 1 O-C-N 114.669 -5.02 . . . . 12.300000000000001 110.559 178.299 . . . . . . . . 3 3 . 1 . 067 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.27 19.1 tt0 -52.54 -54.05 37.96 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.49 1.916 . . . . 36.509999999999998 115.421 169.463 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.253 15.2 t-20 -55.68 -45.76 77.69 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.422 1.889 . . . . 25.66 112.568 170.889 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -57.39 -42.95 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 125.294 1.438 . . . . 8.1199999999999992 112.747 175.16 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -68.41 -33.45 74.26 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.658 2.481 . . . . 15.470000000000001 108.609 179.8 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.2 -30.75 71.67 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 116.124 1.898 . . . . 11.449999999999999 116.124 178.773 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -70.28 -33.59 71.75 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 117.234 -1.365 . . . . 24.98 112.047 173.454 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.415 HG13 HD11 ' A' ' 15' ' ' LEU . 25.6 mt -71.26 -45.62 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 119.56 1.073 . . . . 9.4600000000000009 112.717 169.372 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.309 36.5 tt0 -44.04 -52.93 6.73 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.79 1.636 . . . . 14.76 115.239 166.617 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -55.7 -39.49 71.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.623 -1.923 . . . . 26.289999999999999 115.123 173.56 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.2 mttm -88.81 -67.74 0.82 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 124.338 2.018 . . . . 30.059999999999999 114.932 -165.518 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -88.78 -43.49 11.22 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.35 2.5 . . . . 25.190000000000001 109.552 -168.119 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.24 19.83 3.45 Favored Glycine 0 N--CA 1.43 -1.701 0 CA-C-N 113.032 -1.895 . . . . 7.4100000000000001 110.283 168.424 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.2 mt -90.31 120.19 69.12 Favored Pre-proline 0 N--CA 1.43 -1.428 0 CA-C-N 121.616 2.708 . . . . 9.4900000000000002 104.219 -167.501 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 23.3 Cg_endo -81.16 162.66 20.21 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 CA-C-N 123.152 2.161 . . . . 11.42 115.27 -179.88 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 19.4 Cg_endo -84.57 -8.34 9.47 Favored 'Trans proline' 0 N--CA 1.433 -2.032 0 N-CA-C 116.286 1.61 . . . . 12.0 116.286 -161.452 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -79.03 -20.88 47.86 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 124.101 3.137 . . . . 35.549999999999997 114.791 164.972 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -79.71 -37.66 35.16 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.695 2.188 . . . . 20.52 112.961 -178.306 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -102.61 136.44 42.44 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.961 -4.212 . . . . 7.1299999999999999 110.211 -172.834 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -115.44 148.67 39.12 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.199 1.399 . . . . 36.390000000000001 110.346 164.826 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.9 mt -114.8 125.43 53.68 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.664 -1.607 . . . . 9.5500000000000007 111.578 -178.021 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.4 mm -103.8 139.14 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 125.931 2.019 . . . . 13.9 106.624 174.241 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -122.17 138.12 54.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 116.335 -1.793 . . . . 6.8600000000000003 113.482 162.668 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.325 . . 52.26 -99.17 0.08 Allowed 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 121.368 1.895 . . . . 11.15 112.955 -174.707 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.13 51.71 0.58 Allowed Glycine 0 N--CA 1.43 -1.748 1 O-C-N 115.468 -4.52 . . . . 13.93 108.484 169.78 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -153.83 165.26 36.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 127.408 2.475 . . . . 23.920000000000002 115.485 177.039 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.3 tt0 -91.7 127.97 37.35 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 129.071 2.948 . . . . 23.23 115.7 -174.47 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.9 mt -90.79 123.9 34.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.025 -2.297 . . . . 9.1099999999999994 114.453 175.099 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -97.93 131.83 44.04 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.801 2.04 . . . . 33.439999999999998 112.818 -171.793 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.605 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 1.9 m-20 -32.36 -50.04 0.22 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 131.382 3.873 . . . . 28.370000000000001 118.369 176.942 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.98 -12.44 76.89 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 119.133 2.413 . . . . 15.0 119.133 -174.14 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -91.23 167.78 12.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 119.428 -2.219 . . . . 25.5 111.35 -178.418 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.0 p -88.13 160.68 17.67 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 127.313 2.883 . . . . 11.949999999999999 112.301 173.081 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -68.01 -30.7 70.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.999 2.592 . . . . 10.17 117.999 169.031 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 29.4 m -56.19 -41.73 75.99 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 131.02 3.728 . . . . 13.59 110.062 168.352 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.95 -32.49 74.01 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.303 -2.123 . . . . 11.699999999999999 114.95 -176.347 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -82.8 -31.76 28.01 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.221 2.608 . . . . 12.949999999999999 109.448 178.7 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.6 m120 74.03 58.96 0.09 Allowed 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 129.216 4.073 . . . . 25.449999999999999 115.498 -166.845 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.7 mt -104.6 135.47 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 117.813 -3.055 . . . . 14.6 106.571 -176.748 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -117.49 -168.28 1.46 Allowed 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 125.124 1.37 . . . . 33.229999999999997 113.348 -155.354 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -83.34 134.59 34.9 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.184 -2.197 . . . . 25.969999999999999 109.947 168.488 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 69.21 38.09 1.97 Allowed 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.917 2.77 . . . . 32.609999999999999 113.938 -176.781 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.4 m -98.33 133.71 42.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.034 1.873 . . . . 10.56 107.682 -173.918 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.6 m -95.73 123.47 39.31 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.064 -1.648 . . . . 5.3300000000000001 111.212 -174.236 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -109.5 132.93 53.68 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 130.637 3.575 . . . . 11.66 108.611 -179.339 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -104.18 105.87 16.18 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 121.298 1.863 . . . . 16.300000000000001 112.067 -175.225 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 tt -79.36 120.97 24.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.346 2.658 . . . . 9.9600000000000009 111.39 -179.466 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -126.49 173.73 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.447 3.023 . . . . 9.7599999999999998 104.08 -173.503 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.2 tp -85.48 129.45 34.81 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.703 -2.498 . . . . 19.57 110.342 174.291 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.0 ttt180 -86.4 129.77 34.74 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 122.953 1.358 . . . . 35.079999999999998 108.029 165.21 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 90.0 mt -104.38 -179.04 3.83 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 107.243 -1.391 . . . . 32.310000000000002 107.243 170.32 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -78.31 141.94 38.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.343 -1.313 . . . . 42.75 111.181 161.929 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 146.35 -94.8 0.17 Allowed Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 117.267 -2.397 . . . . 36.310000000000002 108.793 178.638 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.732 0 N-CA-C 110.579 -1.009 . . . . 36.270000000000003 110.579 179.881 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 117.505 2.409 . . . . 17.170000000000002 117.505 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -130.41 145.74 51.86 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 108.589 -0.893 . . . . 21.890000000000001 108.589 174.629 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.8 pt -139.68 162.43 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 117.64 -3.162 . . . . 10.83 107.601 174.523 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -121.09 127.21 51.43 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.674 -0.861 . . . . 10.609999999999999 108.674 -178.536 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.502 HG11 HD12 ' A' ' 69' ' ' LEU . 60.5 t -96.32 120.33 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 128.181 3.425 . . . . 9.1300000000000008 107.959 170.231 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -125.46 145.27 50.16 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.524 3.059 . . . . 20.550000000000001 108.743 178.734 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 41.7 p -94.55 -161.53 0.86 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 112.405 -2.18 . . . . 11.779999999999999 113.88 174.941 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' H ' ' HB ' ' A' ' 7' ' ' THR . 9.6 tt -77.64 -47.58 18.91 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 115.555 -2.164 . . . . 19.309999999999999 109.56 -170.292 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.4 p -71.08 -47.59 57.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.347 2.022 . . . . 23.140000000000001 111.194 175.848 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.54 63.09 0.17 Allowed Glycine 0 N--CA 1.43 -1.723 0 O-C-N 118.505 -2.622 . . . . 19.739999999999998 109.156 176.213 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -91.51 116.26 28.71 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.957 2.903 . . . . 21.93 111.153 167.985 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -88.29 106.82 18.47 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 121.083 1.765 . . . . 12.33 114.567 -173.389 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 mt -104.99 104.86 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 C-N-CA 125.663 1.585 . . . . 17.079999999999998 107.495 -178.435 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.3 m -90.88 125.06 35.63 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 114.97 -4.831 . . . . 16.300000000000001 108.701 -172.357 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.266 87.6 mt -127.84 147.64 50.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 120.474 3.509 . . . . 15.880000000000001 120.474 -179.589 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -107.18 117.06 33.06 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.15 -1.426 . . . . 28.899999999999999 107.15 -166.972 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -143.72 158.24 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 131.414 3.886 . . . . 12.050000000000001 112.297 -170.944 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -121.11 160.36 45.61 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 114.821 -2.514 . . . . 18.170000000000002 105.773 172.73 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -72.19 -19.85 25.51 Favored 'Trans proline' 0 N--CA 1.434 -2.026 1 CA-C-N 128.496 4.07 . . . . 8.1600000000000001 111.195 -159.253 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.9 m -84.58 3.18 38.0 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.885 -3.009 . . . . 11.130000000000001 112.561 -177.197 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -75.88 144.32 41.24 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 117.323 -1.751 . . . . 18.030000000000001 115.225 175.138 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.269 69.2 p -82.45 159.4 22.94 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.754 2.692 . . . . 10.220000000000001 113.794 -173.153 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 31.9 mm -64.45 -35.89 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 O-C-N 117.896 -3.003 . . . . 12.300000000000001 113.103 176.409 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.278 54.9 tt0 -37.72 -65.07 0.35 Allowed 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 128.119 2.568 . . . . 36.509999999999998 112.221 160.88 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -57.81 -34.91 70.16 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.194 2.197 . . . . 25.66 114.521 -177.642 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.1 t -62.63 -52.94 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 O-C-N 126.05 2.094 . . . . 8.1199999999999992 110.129 179.664 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -64.31 -30.55 71.6 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.605 3.098 . . . . 15.470000000000001 113.398 -177.287 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.35 -40.28 74.23 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.575 -4.453 . . . . 11.449999999999999 113.949 179.266 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -62.56 -47.93 81.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.181 1.792 . . . . 24.98 111.079 169.516 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.444 ' HB ' HE22 ' A' ' 41' ' ' GLN . 70.9 mt -63.88 -41.55 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 127.011 2.124 . . . . 9.4600000000000009 112.384 -176.094 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -62.33 -56.91 13.86 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.156 -2.215 . . . . 14.76 114.948 168.625 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.67 -40.66 92.63 Favored 'General case' 0 N--CA 1.43 -1.472 1 O-C-N 116.274 -4.017 . . . . 26.289999999999999 116.32 -176.027 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.3 mmtm -89.25 -64.29 1.16 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.607 -3.808 . . . . 30.059999999999999 110.407 -172.184 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -83.75 -29.6 27.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.848 -3.657 . . . . 25.190000000000001 109.286 -173.302 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.92 46.17 2.12 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-N 123.367 2.803 . . . . 7.4100000000000001 108.724 159.779 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.2 mt -114.96 113.94 44.0 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.462 -2.051 . . . . 9.4900000000000002 105.462 -176.374 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -76.98 156.52 34.33 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 C-N-CA 123.111 2.541 . . . . 11.42 112.581 -158.957 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -80.28 -8.49 13.97 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 C-N-CA 123.907 3.071 . . . . 12.0 108.984 -161.88 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.341 4.0 p30 -79.39 -25.47 42.13 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 123.263 1.506 . . . . 35.549999999999997 109.503 175.889 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -95.06 -38.51 10.6 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.208 1.48 . . . . 20.52 111.707 -166.946 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.444 HE22 ' HB ' ' A' ' 30' ' ' ILE . 26.4 pt20 -83.57 147.2 27.89 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.488 -2.007 . . . . 7.1299999999999999 114.038 178.034 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -144.55 145.18 31.69 Favored 'General case' 0 N--CA 1.43 -1.454 1 N-CA-C 99.998 -4.075 . . . . 36.390000000000001 99.998 166.055 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.97 130.61 55.51 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 120.739 -1.226 . . . . 9.5500000000000007 113.696 179.645 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.1 mm -116.5 138.86 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 103.264 -2.865 . . . . 13.9 103.264 173.148 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.437 ' HB2' HD11 ' A' ' 50' ' ' LEU . 86.3 t80 -126.53 119.05 26.17 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.931 -1.486 . . . . 6.8600000000000003 109.099 169.964 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.11 -54.13 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 132.614 4.365 . . . . 11.15 116.108 -163.558 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.99 19.56 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 127.953 2.692 . . . . 13.93 112.08 177.417 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -104.36 146.16 29.22 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.051 -2.203 . . . . 23.920000000000002 105.051 164.012 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.257 10.8 tt0 -87.45 125.09 34.08 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 126.281 1.832 . . . . 23.23 111.969 176.241 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 45' ' ' PHE . 64.2 mt -97.08 107.29 19.79 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 116.53 2.048 . . . . 9.1099999999999994 116.53 -170.619 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -69.49 141.75 53.87 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.055 2.097 . . . . 33.439999999999998 113.92 -173.904 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -24.34 -75.95 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 1 N-CA-C 123.682 4.697 . . . . 28.370000000000001 123.682 176.251 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.91 28.54 14.01 Favored Glycine 0 N--CA 1.43 -1.737 1 O-C-N 114.817 -4.927 . . . . 15.0 113.003 -157.186 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.8 mtt-85 -107.79 153.79 22.47 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.015 1.388 . . . . 25.5 113.366 177.566 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -90.39 161.07 15.75 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 115.504 -2.479 . . . . 11.949999999999999 109.242 -172.21 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -59.42 -31.45 69.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.996 2.119 . . . . 10.17 113.045 170.311 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.27 8.6 t -55.34 -59.2 5.12 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 131.05 3.74 . . . . 13.59 116.744 167.489 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.8 -33.72 74.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.386 3.106 . . . . 11.699999999999999 119.386 172.531 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -82.77 3.62 28.59 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 117.718 -3.114 . . . . 12.949999999999999 114.506 174.577 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.1 m120 65.84 30.21 10.11 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.864 3.666 . . . . 25.449999999999999 114.965 172.668 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.4 mt -91.05 104.88 15.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.485 -2.634 . . . . 14.6 115.657 -173.517 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -101.6 -178.16 3.64 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.084 1.897 . . . . 33.229999999999997 112.757 -169.462 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.329 15.1 pttp -54.38 146.92 14.66 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 115.893 1.812 . . . . 25.969999999999999 115.893 -172.113 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 39.79 45.57 1.5 Allowed 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.368 2.267 . . . . 32.609999999999999 116.933 -166.407 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.9 m -84.05 138.3 33.14 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 127.584 3.564 . . . . 10.56 108.051 178.265 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.9 m -84.46 111.09 19.16 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 110.649 -2.978 . . . . 5.3300000000000001 109.37 176.356 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.401 9.2 mp -94.65 119.73 33.75 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.166 -3.459 . . . . 11.66 118.467 172.12 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -93.53 99.26 11.75 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 126.195 2.902 . . . . 16.300000000000001 105.964 -172.411 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.502 HD12 HG11 ' A' ' 5' ' ' VAL . 7.8 tt -82.65 116.83 22.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.559 -2.564 . . . . 9.9600000000000009 109.929 174.516 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.272 2.7 m -114.89 166.04 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 124.65 2.167 . . . . 9.7599999999999998 112.997 -167.169 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.8 tp -71.22 123.71 22.83 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.018 -2.926 . . . . 19.57 115.156 173.313 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.6 ttt180 -101.44 131.43 47.55 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.077 -3.515 . . . . 35.079999999999998 114.601 -176.653 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.0 mt -128.92 162.71 26.92 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.117 -1.401 . . . . 32.310000000000002 109.51 -172.609 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -67.02 148.29 52.13 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 117.424 2.379 . . . . 42.75 117.424 -176.52 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 131.09 -53.37 0.81 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 127.185 2.326 . . . . 36.310000000000002 112.992 178.261 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.781 0 N-CA-C 110.982 -0.847 . . . . 36.270000000000003 110.982 176.707 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 122.77 1.271 . . . . 17.170000000000002 114.182 . . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.0 tt0 -105.78 124.0 48.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 130.353 3.461 . . . . 21.890000000000001 108.068 -163.333 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.301 13.1 pt -118.18 163.55 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 C-N-CA 128.723 2.809 . . . . 10.83 114.606 179.311 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -133.73 117.6 17.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.206 -2.809 . . . . 10.609999999999999 112.274 -164.572 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.1 t -120.78 114.31 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 124.546 2.117 . . . . 9.1300000000000008 106.932 -174.127 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -94.71 136.77 34.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.071 -1.643 . . . . 20.550000000000001 109.112 177.37 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.262 7.8 p -80.24 -169.62 2.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 126.613 1.965 . . . . 11.779999999999999 112.917 -177.82 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.8 mt -73.29 -56.88 4.49 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.213 1.006 . . . . 19.309999999999999 113.238 166.029 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.3 p -61.45 -62.44 1.82 Allowed 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 115.416 1.636 . . . . 23.140000000000001 115.416 -173.458 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 158.89 40.66 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 122.935 1.297 . . . . 19.739999999999998 116.152 -170.692 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -118.11 140.72 49.36 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 120.241 -1.741 . . . . 21.93 112.024 172.069 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.8 m -117.12 115.05 24.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 106.532 -1.655 . . . . 12.33 106.532 -178.409 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -98.1 126.43 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 124.983 1.427 . . . . 17.079999999999998 109.564 -170.98 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -96.82 135.43 38.8 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.667 -2.521 . . . . 16.300000000000001 105.903 178.474 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.489 HD11 HG13 ' A' ' 30' ' ' ILE . 11.7 mt -125.67 155.77 40.32 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 103.918 -2.623 . . . . 15.880000000000001 103.918 173.706 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -118.62 132.38 56.18 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.853 -1.536 . . . . 28.899999999999999 106.853 167.961 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 m -148.73 165.03 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 126.322 2.263 . . . . 12.050000000000001 105.336 -162.563 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -117.93 145.37 36.57 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 127.72 2.408 . . . . 18.170000000000002 106.224 173.872 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -69.5 -24.1 31.24 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 124.944 3.763 . . . . 8.1600000000000001 115.288 -165.562 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.6 p -77.91 -0.51 27.8 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.926 2.641 . . . . 11.130000000000001 117.027 173.326 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -90.55 152.31 20.96 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.675 -1.89 . . . . 18.030000000000001 112.082 177.924 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.9 p -82.22 174.85 10.78 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 117.175 2.287 . . . . 10.220000000000001 117.175 -177.992 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.7 mm -69.17 -32.26 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.695 2.798 . . . . 12.300000000000001 103.647 175.962 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -57.83 -31.19 66.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 124.396 3.271 . . . . 36.509999999999998 119.288 174.557 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -76.62 -30.4 56.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.178 2.191 . . . . 25.66 109.156 179.757 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.496 HG21 HD21 ' A' ' 56' ' ' LEU . 59.8 t -76.46 -38.59 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-O 115.651 -2.118 . . . . 8.1199999999999992 108.316 177.222 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -60.77 -57.49 12.46 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 125.17 1.543 . . . . 15.470000000000001 110.81 175.564 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.22 -48.02 17.84 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.984 2.914 . . . . 11.449999999999999 115.089 169.923 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HB3' HD22 ' A' ' 15' ' ' LEU . 38.1 mttt -75.16 -30.28 60.69 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 121.265 1.848 . . . . 24.98 114.304 -179.27 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.489 HG13 HD11 ' A' ' 15' ' ' LEU . 44.1 mt -55.84 -56.36 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 114.103 1.149 . . . . 9.4600000000000009 114.103 161.209 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -45.49 -45.55 13.26 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.179 2.592 . . . . 14.76 112.11 179.328 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -59.29 -34.95 72.91 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 118.454 2.761 . . . . 26.289999999999999 118.454 173.233 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 mttt -71.93 -72.61 0.22 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 116.074 1.879 . . . . 30.059999999999999 116.074 166.846 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -87.89 -30.65 19.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 119.877 3.288 . . . . 25.190000000000001 119.877 -176.432 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.66 73.44 0.98 Allowed Glycine 0 N--CA 1.43 -1.724 0 CA-C-O 123.926 1.848 . . . . 7.4100000000000001 115.1 -173.226 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.507 HD13 HG21 ' A' ' 36' ' ' ILE . 94.3 mt -124.91 127.73 25.04 Favored Pre-proline 0 N--CA 1.43 -1.473 0 CA-C-O 112.36 -3.686 . . . . 9.4900000000000002 105.51 178.515 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_exo -63.94 146.94 92.0 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 127.782 3.815 . . . . 11.42 114.98 -166.714 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -69.29 -20.98 36.33 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 119.718 2.93 . . . . 12.0 119.718 179.058 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -81.3 -30.13 34.05 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 126.854 3.216 . . . . 35.549999999999997 113.05 172.999 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.9 tt0 -71.97 -47.6 50.98 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 116.897 -3.627 . . . . 20.52 113.041 175.396 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -72.54 161.56 30.63 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 116.079 -4.138 . . . . 7.1299999999999999 116.818 -179.808 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -147.22 136.93 22.97 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.136 2.174 . . . . 36.390000000000001 111.988 170.864 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 mt -105.33 122.38 45.83 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 116.333 -1.794 . . . . 9.5500000000000007 114.505 178.822 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mm -93.6 140.74 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 131.607 3.963 . . . . 13.9 111.026 167.753 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -134.71 117.22 15.8 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.118 2.967 . . . . 6.8600000000000003 112.503 167.158 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.84 -105.74 0.23 Allowed 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.134 2.574 . . . . 11.15 111.531 -159.853 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.81 27.24 5.47 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.838 -1.164 . . . . 13.93 114.65 -172.337 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -153.69 141.87 20.45 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 126.535 3.064 . . . . 23.920000000000002 110.64 -179.706 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -70.45 165.06 23.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 112.469 -2.151 . . . . 23.23 112.605 172.879 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.363 12.0 mt -110.1 161.78 15.21 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.766 -1.834 . . . . 9.1099999999999994 110.049 -172.665 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -108.47 132.5 53.74 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.38 2.3 . . . . 33.439999999999998 109.971 179.228 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -45.48 -50.49 12.66 Favored 'General case' 0 N--CA 1.43 -1.439 1 N-CA-C 122.379 4.214 . . . . 28.370000000000001 122.379 -169.022 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.51 14.52 45.99 Favored Glycine 0 N--CA 1.429 -1.771 0 CA-C-N 111.701 -2.5 . . . . 15.0 113.848 -175.664 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.9 mmt180 -99.37 155.15 17.68 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 116.902 -1.523 . . . . 25.5 111.747 174.744 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.9 p -87.34 161.46 17.91 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 125.129 1.518 . . . . 11.949999999999999 109.63 -177.119 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.496 HD21 HG21 ' A' ' 26' ' ' VAL . 14.7 mt -57.38 -44.38 84.41 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.961 2.791 . . . . 10.17 112.897 169.592 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.3 t -64.76 -15.45 61.62 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 116.303 -3.998 . . . . 13.59 115.486 -179.663 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -79.96 -44.7 19.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.57 -2.581 . . . . 11.699999999999999 110.583 179.951 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -85.6 -4.18 59.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 123.056 1.408 . . . . 12.949999999999999 112.64 174.746 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.435 22.9 m120 82.62 36.32 0.06 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.091 -3.505 . . . . 25.449999999999999 108.97 171.127 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.3 mt -89.44 98.12 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 119.601 -1.937 . . . . 14.6 109.277 -176.482 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -86.68 -172.25 3.92 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 117.341 2.348 . . . . 33.229999999999997 117.341 -171.044 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -73.26 138.74 45.7 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 121.941 0.877 . . . . 25.969999999999999 112.149 176.697 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 62.86 12.51 5.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.801 -2.437 . . . . 32.609999999999999 116.793 -171.977 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.7 m -78.04 134.88 37.7 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 119.8 3.259 . . . . 10.56 119.8 169.019 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.4 m -87.16 123.84 32.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 120.676 1.58 . . . . 5.3300000000000001 109.549 -177.061 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mp -93.49 163.36 13.6 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.339 -2.1 . . . . 11.66 114.518 153.755 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.5 m80 -123.62 119.23 29.25 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.778 -1.556 . . . . 16.300000000000001 114.556 177.583 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 tt -88.82 128.97 35.66 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 117.956 -1.021 . . . . 9.9600000000000009 111.373 177.517 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.4 m -127.43 -167.33 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 127.648 3.092 . . . . 9.7599999999999998 107.281 179.707 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 23.9 tp -111.81 142.32 44.31 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 105.744 -1.947 . . . . 19.57 105.744 -172.665 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -97.07 117.39 31.15 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 114.485 -1.234 . . . . 35.079999999999998 107.776 179.571 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.8 mt -107.65 134.52 50.52 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.423 -2.048 . . . . 32.310000000000002 113.137 159.46 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.281 3.8 tpp180 -72.96 115.51 12.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 120.135 -1.603 . . . . 42.75 110.482 -173.937 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.82 -51.16 0.43 Allowed Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 109.685 -1.366 . . . . 36.310000000000002 109.685 -173.091 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.814 0 CA-C-O 124.17 1.983 . . . . 36.270000000000003 109.528 171.957 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttm . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 107.315 -1.365 . . . . 17.170000000000002 107.315 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -100.19 161.17 13.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.891 -3.63 . . . . 21.890000000000001 111.506 169.734 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 65' ' ' SER . 12.4 pt -152.96 157.7 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 C-N-CA 129.083 2.953 . . . . 10.83 110.401 172.587 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -115.29 108.46 16.59 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 114.917 -4.864 . . . . 10.609999999999999 113.148 -172.557 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.3 t -103.13 114.59 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.596 -2.565 . . . . 9.1300000000000008 109.705 -176.667 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -98.06 146.02 25.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 123.625 1.678 . . . . 20.550000000000001 114.163 -173.863 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.311 81.4 p -86.56 -176.84 5.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.75 1.262 . . . . 11.779999999999999 109.41 172.678 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.4 tp -68.32 -62.37 1.43 Allowed 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.692 2.797 . . . . 19.309999999999999 110.49 168.114 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 72.4 p -60.79 -68.77 0.27 Allowed 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 116.857 -3.652 . . . . 23.140000000000001 119.409 176.418 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.4 46.28 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 O-C-N 116.549 -3.844 . . . . 19.739999999999998 109.611 -173.552 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -118.88 141.15 48.91 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 121.673 -0.898 . . . . 21.93 110.415 157.95 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.0 m -110.41 124.9 52.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.612 -1.625 . . . . 12.33 106.612 169.077 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mt -84.39 108.6 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 C-N-CA 128.437 2.695 . . . . 17.079999999999998 107.994 169.188 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.4 m -96.64 97.94 9.78 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.128 -2.858 . . . . 16.300000000000001 111.95 -176.405 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -99.18 147.18 25.38 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.149 -2.844 . . . . 15.880000000000001 112.053 -169.125 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -111.16 133.05 53.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 123.485 1.612 . . . . 28.899999999999999 111.992 162.07 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 m -142.04 158.08 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 2 CA-C-N 107.04 -4.618 . . . . 12.050000000000001 111.592 -167.441 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -95.71 160.86 29.37 Favored Pre-proline 0 N--CA 1.43 -1.442 0 O-C-N 123.925 0.766 . . . . 18.170000000000002 112.035 159.145 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -87.85 -2.35 7.29 Favored 'Trans proline' 0 N--CA 1.433 -2.046 0 CA-C-N 124.498 2.642 . . . . 8.1600000000000001 108.689 -175.561 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 m -81.8 -18.38 44.24 Favored 'General case' 0 N--CA 1.429 -1.497 0 C-N-CA 129.396 3.078 . . . . 11.130000000000001 111.709 170.208 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -77.24 153.08 34.36 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 115.019 1.489 . . . . 18.030000000000001 115.019 177.327 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 26' ' ' VAL . 41.7 p -89.69 172.76 8.71 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 124.532 1.133 . . . . 10.220000000000001 110.468 -173.967 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.0 mm -70.24 -24.32 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 118.526 -1.27 . . . . 12.300000000000001 111.597 171.26 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.53 -39.7 85.04 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.76 1.267 . . . . 36.509999999999998 113.414 171.336 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -65.53 -37.28 86.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.359 -3.963 . . . . 25.66 114.035 167.735 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 22' ' ' THR . 79.0 t -73.85 -34.18 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 122.716 2.507 . . . . 8.1199999999999992 108.746 -171.679 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -67.88 -41.26 83.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 131.147 3.779 . . . . 15.470000000000001 108.557 172.837 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.54 -33.52 66.9 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.713 2.405 . . . . 11.449999999999999 112.403 -177.666 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.2 mttm -61.97 -33.73 74.84 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.715 -3.116 . . . . 24.98 114.597 166.887 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 80.4 mt -73.0 -41.69 59.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 117.034 -1.46 . . . . 9.4600000000000009 110.333 173.157 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -56.98 -42.12 79.64 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 127.606 2.362 . . . . 14.76 113.797 178.407 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -67.01 -43.46 82.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 112.974 -3.393 . . . . 26.289999999999999 110.825 179.806 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -100.79 -43.13 6.21 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 124.395 3.27 . . . . 30.059999999999999 118.33 -173.209 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.1 mm-40 -91.75 -38.06 12.61 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 123.461 0.705 . . . . 25.190000000000001 109.429 -175.977 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.27 21.84 9.12 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 120.373 -1.454 . . . . 7.4100000000000001 114.61 170.847 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.8 mt -91.73 122.44 65.53 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 113.392 -3.194 . . . . 9.4900000000000002 109.263 -175.718 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -65.87 147.72 85.45 Favored 'Trans proline' 0 N--CA 1.434 -2.014 1 CA-C-N 129.786 4.531 . . . . 11.42 114.501 -179.972 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -79.58 -8.42 14.8 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 122.395 2.063 . . . . 12.0 112.792 -162.61 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -83.84 -34.65 24.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.999 -3.563 . . . . 35.549999999999997 109.065 179.045 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -83.87 -28.41 28.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 131.072 3.749 . . . . 20.52 112.04 -167.696 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -92.05 155.5 18.05 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.584 2.611 . . . . 7.1299999999999999 112.793 166.3 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -142.16 142.45 32.72 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.052 -2.28 . . . . 36.390000000000001 109.998 167.708 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.5 mt -101.1 111.14 23.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 116.561 2.06 . . . . 9.5500000000000007 116.561 176.904 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.7 mm -95.71 132.1 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 126.432 2.332 . . . . 13.9 111.705 172.148 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -111.86 123.0 49.33 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 125.818 2.723 . . . . 6.8600000000000003 105.949 169.677 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.451 . . 59.61 -99.36 0.09 Allowed 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 116.255 -1.831 . . . . 11.15 115.66 -170.338 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.98 18.39 4.5 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 106.426 -2.669 . . . . 13.93 106.426 179.67 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -124.21 130.42 52.5 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.236 2.214 . . . . 23.920000000000002 110.301 -173.636 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -91.3 125.72 36.15 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.342 -2.096 . . . . 23.23 105.342 -169.977 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.533 HD22 ' CD2' ' A' ' 59' ' ' TYR . 92.9 mt -86.28 148.5 25.59 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 124.095 0.958 . . . . 9.1099999999999994 112.275 -179.296 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -123.42 148.76 45.81 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.182 -2.824 . . . . 33.439999999999998 116.87 -171.171 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -19.15 -76.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 133.491 4.716 . . . . 28.370000000000001 121.387 178.691 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.49 16.22 61.19 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 117.458 1.743 . . . . 15.0 117.458 -168.474 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.7 mtt180 -99.11 160.99 13.87 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.955 -2.497 . . . . 25.5 110.32 167.351 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 51.4 p -103.76 168.26 9.25 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 104.792 -2.299 . . . . 11.949999999999999 104.792 -178.829 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -55.88 -36.59 67.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 112.617 -2.083 . . . . 10.17 115.994 167.768 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 t -61.63 -43.69 98.38 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.123 -2.861 . . . . 13.59 117.114 167.35 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -64.64 -26.64 68.48 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.095 1.887 . . . . 11.699999999999999 116.095 -177.182 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.533 ' CD2' HD22 ' A' ' 50' ' ' LEU . 66.9 m-85 -83.94 -32.34 25.12 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 116.912 -3.618 . . . . 12.949999999999999 111.043 170.717 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.301 26.2 m120 96.25 51.83 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.98 2.112 . . . . 25.449999999999999 114.379 -175.271 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.0 mt -103.78 125.63 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 125.067 1.48 . . . . 14.6 113.96 177.837 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -110.03 177.27 4.76 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 115.972 1.841 . . . . 33.229999999999997 115.972 -176.957 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -60.41 145.75 46.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 124.404 3.275 . . . . 25.969999999999999 119.066 -174.54 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 67.74 32.19 5.52 Favored 'General case' 0 N--CA 1.431 -1.409 1 C-N-CA 132.129 4.171 . . . . 32.609999999999999 111.466 178.558 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.468 ' H ' HG22 ' A' ' 3' ' ' ILE . 22.7 t -89.35 151.7 21.93 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.685 -3.134 . . . . 10.56 110.145 -174.95 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.3 m -92.2 120.81 33.13 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.88 2.072 . . . . 5.3300000000000001 112.584 -172.32 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.9 mt -117.77 159.99 22.11 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 126.222 2.915 . . . . 11.66 105.582 172.758 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.5 m-70 -116.99 117.51 29.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.45 -3.281 . . . . 16.300000000000001 113.577 177.503 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -91.72 116.46 28.9 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 120.168 -1.583 . . . . 9.9600000000000009 111.191 174.487 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.6 m -112.27 134.15 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 127.819 2.448 . . . . 9.7599999999999998 106.193 178.551 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.9 mt -101.55 144.31 30.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.309 2.004 . . . . 19.57 106.481 -175.783 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -79.64 116.15 19.66 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.579 2.437 . . . . 35.079999999999998 117.579 -172.783 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 93.1 mt -108.85 169.04 8.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.754 2.822 . . . . 32.310000000000002 108.355 -179.856 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -80.2 -44.21 20.15 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 114.267 -1.333 . . . . 42.75 113.943 -167.2 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.36 50.36 0.8 Allowed Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 130.459 3.885 . . . . 36.310000000000002 107.673 -174.793 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.739 0 CA-C-N 119.241 1.521 . . . . 36.270000000000003 110.399 176.332 . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 117.454 2.39 . . . . 17.170000000000002 117.454 . . . . . . . . . 0 0 . 1 . 071 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -90.36 133.49 34.95 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 115.07 -4.769 . . . . 21.890000000000001 106.708 -179.462 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.8 pt -118.04 164.89 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 104.456 -2.424 . . . . 10.83 104.456 163.369 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -119.29 127.29 53.08 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 111.885 -2.416 . . . . 10.609999999999999 105.038 -174.561 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -113.5 139.13 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.159 -2.534 . . . . 9.1300000000000008 104.159 176.202 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 mmtt -125.23 133.63 52.64 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.325 -3.36 . . . . 20.550000000000001 116.029 178.742 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.2 p -77.98 171.79 14.47 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 127.128 3.347 . . . . 11.779999999999999 111.277 175.558 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.3 tp -79.35 -24.05 42.98 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.514 -2.13 . . . . 19.309999999999999 110.95 -172.993 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.8 p -77.21 -69.16 0.55 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 122.902 1.334 . . . . 23.140000000000001 108.338 170.181 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.23 66.19 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.714 0 O-C-N 119.143 -2.223 . . . . 19.739999999999998 112.018 169.303 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -99.76 134.26 42.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 125.54 1.536 . . . . 21.93 114.041 155.686 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.7 m -80.06 119.91 23.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.357 -1.464 . . . . 12.33 113.124 164.597 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.5 mt -115.49 95.67 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 C-N-CA 128.519 2.727 . . . . 17.079999999999998 107.53 -171.844 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.0 m -89.82 99.23 12.28 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.206 -1.035 . . . . 16.300000000000001 108.206 -165.137 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.295 47.0 mt -104.49 149.12 25.74 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.602 -3.186 . . . . 15.880000000000001 110.653 -170.788 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -108.0 123.33 48.49 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 121.66 2.027 . . . . 28.899999999999999 113.664 173.356 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 m -135.27 162.53 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.582 -1.948 . . . . 12.050000000000001 107.262 -164.839 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -101.69 165.31 14.24 Favored Pre-proline 0 N--CA 1.429 -1.486 0 O-C-N 118.421 -2.674 . . . . 18.170000000000002 108.334 165.299 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -64.06 -23.71 67.13 Favored 'Trans proline' 0 C--N 1.3 -2.012 2 C-N-CA 125.721 4.281 . . . . 8.1600000000000001 112.597 174.053 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.6 m -87.68 3.15 48.98 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 119.987 -1.695 . . . . 11.130000000000001 109.907 -174.627 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -88.89 148.02 24.06 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.331 1.062 . . . . 18.030000000000001 109.286 -178.286 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.3 p -91.76 169.47 10.68 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.01 -1.904 . . . . 10.220000000000001 110.048 -175.828 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mm -46.65 -49.83 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 127.972 2.509 . . . . 12.300000000000001 114.46 160.513 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.301 23.8 tt0 -42.53 -43.21 3.63 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 117.03 2.233 . . . . 36.509999999999998 117.03 165.577 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -69.22 -30.32 68.46 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.402 1.91 . . . . 25.66 112.637 172.78 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.1 -56.2 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.568 -3.833 . . . . 8.1199999999999992 113.585 175.909 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.0 mtmt -49.15 -46.13 44.75 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 130.439 3.496 . . . . 15.470000000000001 112.292 171.592 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.8 -36.95 76.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.339 -3.35 . . . . 11.449999999999999 114.828 -178.419 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -68.63 -33.8 74.64 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 114.986 1.476 . . . . 24.98 114.986 173.507 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.5 mt -70.39 -42.77 78.58 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.662 -4.399 . . . . 9.4600000000000009 111.167 175.528 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -55.75 -43.24 76.47 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.97 -1.706 . . . . 14.76 110.001 170.358 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.263 21.5 t70 -48.95 -67.31 0.28 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 130.075 3.35 . . . . 26.289999999999999 114.683 177.751 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -93.99 -46.66 7.05 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 119.061 2.986 . . . . 30.059999999999999 119.061 178.847 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -70.98 -33.08 70.08 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 116.283 -1.818 . . . . 25.190000000000001 111.294 -171.591 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.74 18.68 46.99 Favored Glycine 0 N--CA 1.43 -1.747 0 CA-C-O 116.446 -2.308 . . . . 7.4100000000000001 115.213 -179.164 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.43 HG22 HE21 ' A' ' 41' ' ' GLN . 21.4 mt -99.71 121.38 54.69 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-N 119.737 1.768 . . . . 9.4900000000000002 108.879 175.158 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -68.36 157.07 63.38 Favored 'Trans proline' 0 N--CA 1.434 -1.973 0 C-N-CA 122.982 2.455 . . . . 11.42 117.958 178.328 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.02 -28.53 10.97 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 C-N-CA 122.417 2.078 . . . . 12.0 111.675 -170.083 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -70.64 -31.43 68.37 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 126.108 2.13 . . . . 35.549999999999997 110.427 173.41 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -72.64 -15.95 61.71 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.363 -2.711 . . . . 20.52 115.413 -175.488 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.43 HE21 HG22 ' A' ' 36' ' ' ILE . 6.2 pt20 -118.15 161.08 20.45 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.695 2.497 . . . . 7.1299999999999999 112.563 -168.999 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -138.09 133.66 33.74 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 106.772 -1.566 . . . . 36.390000000000001 106.772 164.223 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -96.29 129.72 43.55 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.932 -2.355 . . . . 9.5500000000000007 107.306 178.666 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.7 mm -116.04 133.58 62.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 120.366 -1.459 . . . . 13.9 109.898 -178.579 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -114.26 115.31 27.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.088 -3.508 . . . . 6.8600000000000003 108.143 165.032 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 40.25 -83.46 0.0 OUTLIER 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.273 2.323 . . . . 11.15 117.273 -176.385 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.25 -36.7 5.6 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 116.981 -3.574 . . . . 13.93 111.444 -178.328 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -105.42 148.49 27.08 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.62 1.341 . . . . 23.920000000000002 114.62 -162.599 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.409 ' HG2' ' H ' ' A' ' 49' ' ' GLN . 23.4 pt20 -92.95 131.15 38.21 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.126 -4.734 . . . . 23.23 108.592 173.403 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 15.9 mt -74.25 143.3 45.13 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.531 1.678 . . . . 9.1099999999999994 115.531 -176.584 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -120.56 133.49 55.38 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.231 -1.543 . . . . 33.439999999999998 108.043 -168.739 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -30.72 -53.58 0.19 Allowed 'General case' 0 N--CA 1.429 -1.476 1 N-CA-C 124.261 4.912 . . . . 28.370000000000001 124.261 -173.014 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.98 17.41 44.94 Favored Glycine 0 N--CA 1.43 -1.715 0 CA-C-N 121.305 1.866 . . . . 15.0 116.23 -160.443 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -115.71 145.15 43.02 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.869 -2.491 . . . . 25.5 113.449 -173.341 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.352 5.8 p -82.5 165.91 19.76 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 122.486 2.403 . . . . 11.949999999999999 114.354 -171.855 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.6 mt -78.14 -22.11 49.27 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.158 -2.214 . . . . 10.17 112.69 177.947 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.267 3.7 t -70.31 -37.84 74.83 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 127.937 3.732 . . . . 13.59 114.983 175.32 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -55.97 -43.78 77.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.891 2.876 . . . . 11.699999999999999 111.205 164.605 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -86.62 -3.22 59.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 115.484 1.661 . . . . 12.949999999999999 115.484 -176.736 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.5 m120 54.96 51.61 13.28 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.529 2.732 . . . . 25.449999999999999 112.12 -178.298 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.6 mt -103.28 116.6 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 116.92 -3.612 . . . . 14.6 106.566 173.223 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -94.44 -160.32 0.77 Allowed 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 118.581 -2.574 . . . . 33.229999999999997 109.214 178.944 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.6 pttp -83.11 161.61 21.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 108.12 -1.067 . . . . 25.969999999999999 108.12 -173.143 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.357 27.9 mt-10 55.42 28.65 11.89 Favored 'General case' 0 N--CA 1.431 -1.389 0 C-N-CA 127.752 2.421 . . . . 32.609999999999999 112.97 178.336 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.1 t -87.93 154.6 20.38 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.662 1.985 . . . . 10.56 113.191 172.27 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.306 1.3 m -121.45 90.34 3.3 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 125.481 1.738 . . . . 5.3300000000000001 113.603 -160.342 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -92.53 150.78 20.54 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 124.815 2.245 . . . . 11.66 107.604 176.65 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 77.2 m80 -116.67 139.31 50.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.001 2.81 . . . . 16.300000000000001 108.271 -176.964 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.25 113.87 27.32 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 112.301 -2.227 . . . . 9.9600000000000009 113.373 170.449 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 m -110.14 171.44 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-N 113.086 -1.87 . . . . 9.7599999999999998 106.443 175.194 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.6 mt -83.08 154.68 24.26 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.393 -2.067 . . . . 19.57 112.431 172.227 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -112.27 122.98 49.27 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.161 -1.587 . . . . 35.079999999999998 109.094 176.981 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.07 168.09 12.62 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.12 -2.862 . . . . 32.310000000000002 109.739 -178.477 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -75.95 -60.15 2.45 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.949 -1.719 . . . . 42.75 111.772 165.625 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.46 79.35 0.8 Allowed Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 128.008 2.718 . . . . 36.310000000000002 113.456 168.1 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.785 0 C-N-CA 127.882 2.658 . . . . 36.270000000000003 114.41 -177.093 . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 ptt? . . . . . 0 CA--C 1.491 -1.322 0 N-CA-C 105.93 -1.878 . . . . 17.170000000000002 105.93 . . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -108.46 158.8 17.21 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 104.041 -2.577 . . . . 21.890000000000001 104.041 168.088 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.6 pt -125.78 172.04 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 129.097 2.959 . . . . 10.83 105.511 171.585 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -123.9 146.78 48.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.71 -1.869 . . . . 10.609999999999999 109.808 167.906 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 t -120.3 125.88 74.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.587 1.955 . . . . 9.1300000000000008 106.153 175.71 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.5 mmtt -105.67 140.66 38.39 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 123.187 1.47 . . . . 20.550000000000001 107.326 177.51 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.7 p -81.89 -164.07 0.75 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.034 2.35 . . . . 11.779999999999999 112.429 172.364 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.3 tp -82.93 -48.47 10.65 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.364 -3.335 . . . . 19.309999999999999 114.613 177.121 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 55.7 p -65.86 -40.94 92.13 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 120.325 -1.484 . . . . 23.140000000000001 113.288 171.033 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.07 62.57 0.26 Allowed Glycine 0 N--CA 1.429 -1.775 0 N-CA-C 117.768 1.867 . . . . 19.739999999999998 117.768 175.41 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -112.48 145.97 39.28 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 106.096 -1.816 . . . . 21.93 106.096 167.495 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.2 m -112.73 106.62 15.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 101.908 -3.367 . . . . 12.33 101.908 -166.315 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.8 mt -92.1 117.62 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 101.186 -3.635 . . . . 17.079999999999998 101.186 -172.317 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 99.9 m -94.05 130.11 40.33 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 116.795 -1.962 . . . . 16.300000000000001 109.976 174.628 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.6 mt -129.9 142.63 50.63 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 124.649 1.218 . . . . 15.880000000000001 111.058 178.301 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -97.1 128.25 43.85 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.4 -2.687 . . . . 28.899999999999999 114.811 179.673 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.481 HG21 HD13 ' A' ' 56' ' ' LEU 0.263 6.9 m -149.22 176.85 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 120.123 -1.611 . . . . 12.050000000000001 111.424 -174.068 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -110.74 179.64 0.78 Allowed Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 119.845 1.202 . . . . 18.170000000000002 111.663 168.123 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -71.2 -22.56 25.55 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 CA-C-N 123.274 2.205 . . . . 8.1600000000000001 109.019 173.886 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.0 m -95.36 1.75 54.42 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.04 1.4 . . . . 11.130000000000001 110.534 -165.052 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -85.19 139.6 31.55 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.227 -4.671 . . . . 18.030000000000001 108.705 -176.419 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 79.6 p -76.4 166.58 23.23 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 114.129 1.159 . . . . 10.220000000000001 114.129 173.021 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.1 mm -70.5 -18.86 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 119.345 -0.942 . . . . 12.300000000000001 108.785 -179.127 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -69.54 -31.16 69.19 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.39 -2.694 . . . . 36.509999999999998 115.245 172.635 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -66.1 -42.13 89.7 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.788 2.835 . . . . 25.66 109.461 167.676 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.5 t -63.63 -51.2 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 125.546 1.779 . . . . 8.1199999999999992 110.835 176.237 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.63 -19.97 64.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.789 1.774 . . . . 15.470000000000001 115.789 -174.697 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.78 -27.54 66.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.48 1.912 . . . . 11.449999999999999 114.764 172.488 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -93.4 -20.52 20.26 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.321 -1.733 . . . . 24.98 106.321 -176.269 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 30' ' ' ILE . 75.3 mt -75.12 -44.43 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 119.927 -1.733 . . . . 9.4600000000000009 113.557 167.307 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -56.91 -30.6 64.1 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.253 -2.78 . . . . 14.76 114.428 167.31 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -72.4 -52.88 14.05 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.627 -4.421 . . . . 26.289999999999999 108.523 178.53 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -66.13 -59.76 3.46 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 117.519 2.415 . . . . 30.059999999999999 117.519 172.23 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -97.53 -11.97 23.12 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 119.142 3.016 . . . . 25.190000000000001 119.142 -169.215 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.87 27.05 65.45 Favored Glycine 0 N--CA 1.43 -1.719 0 O-C-N 118.198 -2.814 . . . . 7.4100000000000001 115.489 -176.442 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.483 HG22 HE21 ' A' ' 41' ' ' GLN . 44.2 mt -103.23 109.38 61.55 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 108.207 -1.035 . . . . 9.4900000000000002 108.207 -174.613 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -76.73 166.79 26.52 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 122.669 1.989 . . . . 11.42 116.14 -167.253 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -75.02 -20.86 16.41 Favored 'Trans proline' 0 N--CA 1.434 -2.002 0 CA-C-N 123.126 2.152 . . . . 12.0 114.77 -156.277 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -83.61 -17.49 41.42 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.817 3.198 . . . . 35.549999999999997 114.795 178.686 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.423 ' HG2' HD22 ' A' ' 71' ' ' LEU . 49.4 tt0 -79.1 -31.72 44.37 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.844 2.59 . . . . 20.52 105.39 -179.53 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.483 HE21 HG22 ' A' ' 36' ' ' ILE . 3.9 pt20 -111.41 176.01 5.19 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.589 1.995 . . . . 7.1299999999999999 115.285 -170.426 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.461 ' HD2' ' HG3' ' A' ' 72' ' ' ARG . 42.7 mtp180 -131.8 146.09 51.94 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 113.02 -3.371 . . . . 36.390000000000001 109.649 169.887 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 43' ' ' LEU . 8.1 mt -109.16 134.5 51.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 125.723 1.889 . . . . 9.5500000000000007 106.649 172.449 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.3 mm -121.23 143.17 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.697 -2.705 . . . . 13.9 103.697 -169.576 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -130.31 100.79 5.5 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 128.491 2.716 . . . . 6.8600000000000003 113.519 163.748 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.52 -107.28 0.19 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.997 1.719 . . . . 11.15 110.768 -165.708 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.29 -20.96 10.38 Favored Glycine 0 N--CA 1.43 -1.736 0 CA-C-O 115.958 -2.579 . . . . 13.93 111.042 177.044 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -77.54 122.1 24.79 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 127.31 3.433 . . . . 23.920000000000002 104.772 -170.293 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -89.02 138.22 31.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.629 -3.169 . . . . 23.23 107.004 178.605 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.7 mt -106.03 127.68 53.34 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.112 -3.492 . . . . 9.1099999999999994 112.673 -161.236 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.4 mm-40 -77.37 146.14 36.84 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.187 2.595 . . . . 33.439999999999998 105.74 -175.111 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -65.74 -45.51 82.38 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.302 -2.124 . . . . 28.370000000000001 112.684 -171.667 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -89.82 41.85 2.98 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 117.496 -1.724 . . . . 15.0 114.354 177.883 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.9 mmt180 -124.75 157.5 35.56 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 119.884 1.842 . . . . 25.5 108.584 168.315 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 44.0 p -91.16 164.16 14.01 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.028 -3.545 . . . . 11.949999999999999 117.085 -177.204 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.481 HD13 HG21 ' A' ' 17' ' ' VAL . 24.9 mt -54.36 -43.57 71.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 113.505 -1.68 . . . . 10.17 112.677 163.77 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.1 t -55.39 -42.29 73.82 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.286 -3.384 . . . . 13.59 118.271 167.596 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -56.97 -39.28 74.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.865 -1.772 . . . . 11.699999999999999 113.712 179.237 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -83.65 -13.58 53.87 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.599 1.333 . . . . 12.949999999999999 114.599 175.446 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.7 m120 60.55 52.34 4.64 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 116.084 1.883 . . . . 25.449999999999999 116.084 -167.384 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.296 11.8 mt -87.64 123.78 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 102.276 -3.231 . . . . 14.6 102.276 176.733 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.273 23.1 mt-30 -100.92 179.76 4.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.621 -1.924 . . . . 33.229999999999997 114.709 179.427 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -64.3 147.17 53.09 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.585 -2.572 . . . . 25.969999999999999 110.691 -174.097 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 48.76 37.51 9.89 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.156 2.583 . . . . 32.609999999999999 116.883 179.899 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 t -108.19 151.36 26.03 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.487 1.915 . . . . 10.56 108.621 -169.366 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.324 41.1 p -102.23 115.52 30.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.642 -2.536 . . . . 5.3300000000000001 111.099 -165.587 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -96.51 149.52 21.66 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.419 3.088 . . . . 11.66 103.429 172.39 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.9 m170 -114.6 130.8 56.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.695 -1.253 . . . . 16.300000000000001 108.94 178.366 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 tt -105.18 120.93 42.74 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.004 1.722 . . . . 9.9600000000000009 110.249 -178.437 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 147.53 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 101.74 -3.43 . . . . 9.7599999999999998 101.74 -177.212 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.423 HD22 ' HG2' ' A' ' 40' ' ' GLN . 16.5 mt -81.81 152.88 26.71 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 123.87 1.795 . . . . 19.57 109.101 177.892 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.461 ' HG3' ' HD2' ' A' ' 42' ' ' ARG . 74.8 ttt180 -79.39 122.42 26.37 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 116.051 -1.928 . . . . 35.079999999999998 108.899 -167.993 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 73.1 mt -93.04 162.24 14.12 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 113.518 -3.134 . . . . 32.310000000000002 111.56 179.883 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -93.01 116.12 28.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 122.41 2.368 . . . . 42.75 109.218 -166.432 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.5 67.96 0.52 Allowed Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 108.9 -1.68 . . . . 36.310000000000002 108.9 -167.996 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.7 2 O-C-N 131.923 5.131 . . . . 36.270000000000003 105.145 155.653 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 ttp . . . . . 0 CA--C 1.49 -1.353 0 CA-C-O 124.829 2.252 . . . . 17.170000000000002 113.606 . . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -89.46 126.28 35.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 126.29 2.948 . . . . 21.890000000000001 111.897 178.834 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.1 pt -128.31 147.22 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 O-C-N 116.83 -3.669 . . . . 10.83 109.199 176.364 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 53.0 m-85 -100.79 137.86 38.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.34 3.856 . . . . 10.609999999999999 105.87 175.669 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -126.45 110.46 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 117.076 -1.44 . . . . 9.1300000000000008 111.106 170.743 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.4 tttt -93.61 143.22 26.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 116.813 -1.565 . . . . 20.550000000000001 111.122 -176.167 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.526 HG22 HD23 ' A' ' 69' ' ' LEU . 42.6 p -96.53 174.16 6.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 120.807 1.64 . . . . 11.779999999999999 107.1 -175.488 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.3 tp -59.84 -51.3 70.32 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.744 -2.472 . . . . 19.309999999999999 114.617 177.582 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.1 p -67.32 -40.25 85.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.584 1.953 . . . . 23.140000000000001 115.841 172.351 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.15 59.89 0.3 Allowed Glycine 0 N--CA 1.43 -1.748 0 O-C-N 127.309 2.88 . . . . 19.739999999999998 114.315 151.449 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -95.17 126.27 40.38 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-O 115.625 -2.131 . . . . 21.93 108.638 163.667 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 36.7 m -95.8 113.22 24.83 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 116.916 -1.914 . . . . 12.33 107.025 179.271 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.1 pt -91.59 141.29 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.997 1.719 . . . . 17.079999999999998 107.374 178.276 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.1 m -107.3 124.97 50.56 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.749 -1.22 . . . . 16.300000000000001 111.529 178.821 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.25 141.87 51.71 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.725 -2.484 . . . . 15.880000000000001 106.445 177.876 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -108.47 107.76 18.42 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.885 2.474 . . . . 28.899999999999999 107.172 179.246 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.87 -177.52 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.733 -2.321 . . . . 12.050000000000001 104.733 -173.006 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -104.96 159.2 30.15 Favored Pre-proline 0 N--CA 1.43 -1.461 0 C-N-CA 129.759 3.224 . . . . 18.170000000000002 108.475 170.49 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -81.04 -10.11 12.71 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 C-N-CA 123.409 2.74 . . . . 8.1600000000000001 110.989 -172.051 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.0 m -94.68 2.2 55.57 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 127.227 2.829 . . . . 11.130000000000001 111.965 175.685 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -75.83 161.61 28.86 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 123.749 2.977 . . . . 18.030000000000001 111.945 178.415 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.6 p -87.31 164.64 16.16 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 118.398 -2.689 . . . . 10.220000000000001 116.633 179.479 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.7 mm -68.15 -39.6 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-N 120.194 1.361 . . . . 12.300000000000001 109.005 174.473 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -53.43 -45.08 69.29 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.429 -2.045 . . . . 36.509999999999998 111.684 174.304 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -58.31 -42.64 87.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.863 2.542 . . . . 25.66 117.863 170.489 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.8 -54.22 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 118.301 -2.75 . . . . 8.1199999999999992 109.011 171.434 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.505 ' HA ' HD12 ' A' ' 30' ' ' ILE . 34.7 mtmt -58.87 -28.18 65.88 Favored 'General case' 0 N--CA 1.429 -1.495 0 O-C-N 116.768 -3.707 . . . . 15.470000000000001 118.449 -177.153 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -40.16 94.6 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.498 2.719 . . . . 11.449999999999999 113.471 168.211 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.5 mttm -71.43 -39.34 71.1 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.526 -2.609 . . . . 24.98 111.661 -178.663 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' A' ' 27' ' ' LYS . 21.3 mt -60.52 -36.87 72.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 128.228 2.611 . . . . 9.4600000000000009 109.1 173.771 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -66.85 -52.08 47.84 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.923 1.344 . . . . 14.76 113.432 175.882 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -50.53 -45.31 56.69 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.932 -2.98 . . . . 26.289999999999999 115.889 170.177 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -79.95 -51.61 8.87 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.777 -3.077 . . . . 30.059999999999999 115.404 -165.891 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -102.02 -30.9 10.92 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 124.428 1.091 . . . . 25.190000000000001 110.673 -175.107 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.55 34.08 5.92 Favored Glycine 0 N--CA 1.429 -1.791 0 C-N-CA 127.977 2.703 . . . . 7.4100000000000001 110.182 164.805 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.0 mt -91.64 125.15 58.59 Favored Pre-proline 0 N--CA 1.43 -1.466 0 C-N-CA 127.194 2.197 . . . . 9.4900000000000002 106.021 -174.809 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -61.65 171.57 4.43 Favored 'Trans proline' 0 C--N 1.3 -2.002 0 CA-C-N 126.233 3.262 . . . . 11.42 115.511 -179.234 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -76.41 -27.17 8.04 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 124.209 3.273 . . . . 12.0 114.059 -173.678 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -81.6 -20.32 40.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.951 -3.593 . . . . 35.549999999999997 114.618 -173.504 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -86.0 -45.93 11.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 126.505 1.922 . . . . 20.52 110.613 179.913 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -51.23 113.32 0.91 Allowed 'General case' 0 N--CA 1.43 -1.452 1 N-CA-C 123.674 4.694 . . . . 7.1299999999999999 123.674 163.153 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -117.0 119.58 35.74 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.562 -2.586 . . . . 36.390000000000001 109.198 157.494 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.6 tp -93.38 128.34 39.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.196 -2.275 . . . . 9.5500000000000007 109.565 -177.441 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.417 HD13 ' HA ' ' A' ' 44' ' ' ILE 0.29 23.8 mm -118.58 148.99 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.942 2.897 . . . . 13.9 105.637 -177.684 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.401 ' HB3' ' H ' ' A' ' 46' ' ' ALA . 1.0 OUTLIER -85.19 -83.58 0.16 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.1 0.864 . . . . 6.8600000000000003 112.459 177.252 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 45' ' ' PHE . . . -98.93 -71.16 0.7 Allowed 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 106.651 -1.611 . . . . 11.15 106.651 166.668 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.2 -4.52 5.45 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 119.983 2.753 . . . . 13.93 119.983 172.652 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -101.69 160.18 14.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 112.485 -1.858 . . . . 23.920000000000002 115.435 171.918 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -87.66 170.77 10.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.828 -2.42 . . . . 23.23 115.999 -171.269 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.3 mt -131.23 105.81 7.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 122.995 1.379 . . . . 9.1099999999999994 108.683 176.086 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -72.76 140.51 47.81 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 121.711 3.967 . . . . 33.439999999999998 121.711 166.153 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -36.93 -66.3 0.24 Allowed 'General case' 0 N--CA 1.43 -1.434 1 C-N-CA 135.199 5.4 . . . . 28.370000000000001 119.958 -170.462 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.88 13.25 9.08 Favored Glycine 0 N--CA 1.43 -1.726 0 C-N-CA 129.841 3.591 . . . . 15.0 116.857 -165.458 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -117.61 141.95 47.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.33 1.452 . . . . 25.5 111.989 -168.064 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.0 p -87.22 161.51 17.98 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.643 2.639 . . . . 11.949999999999999 111.03 -179.937 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' A' ' 61' ' ' ILE . 1.1 mt -49.09 -50.52 36.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.923 3.289 . . . . 10.17 113.565 176.126 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.0 t -50.58 -48.71 57.55 Favored 'General case' 0 N--CA 1.429 -1.492 1 O-C-N 129.544 4.277 . . . . 13.59 115.585 172.416 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -61.06 -38.56 86.63 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 126.514 1.926 . . . . 11.699999999999999 112.219 177.276 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -85.8 -2.04 57.83 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 117.92 2.563 . . . . 12.949999999999999 117.92 171.483 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 m120 65.82 48.47 1.86 Allowed 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 127.278 2.861 . . . . 25.449999999999999 113.055 176.31 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 56' ' ' LEU . 82.4 mt -94.57 108.0 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 C-N-CA 129.942 3.297 . . . . 14.6 103.555 177.133 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -101.6 176.88 5.08 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.069 2.366 . . . . 33.229999999999997 110.871 177.568 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -60.61 146.18 46.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.713 -3.117 . . . . 25.969999999999999 117.124 -173.18 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.306 35.5 mt-10 71.94 -1.26 2.91 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 127.025 2.703 . . . . 32.609999999999999 117.25 174.09 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.316 56.0 m -48.39 138.56 9.95 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 128.37 2.668 . . . . 10.56 116.833 162.549 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.479 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 24.4 m -103.13 124.96 49.56 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.124 -1.61 . . . . 5.3300000000000001 111.007 167.253 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -109.73 169.28 8.81 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 103.858 -2.645 . . . . 11.66 103.858 -177.955 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -139.37 132.44 29.58 Favored 'General case' 0 N--CA 1.43 -1.444 1 CA-C-O 130.053 4.74 . . . . 16.300000000000001 113.324 -169.868 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.526 HD23 HG22 ' A' ' 7' ' ' THR . 34.8 tp -115.81 107.74 15.43 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.387 -2.696 . . . . 9.9600000000000009 107.385 -168.187 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.6 172.09 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 2 C-N-CA 132.415 4.286 . . . . 9.7599999999999998 112.012 -171.011 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.8 tp -84.66 148.11 26.59 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 123.016 1.388 . . . . 19.57 112.463 -178.73 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.2 ttp180 -92.86 135.3 34.26 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.745 -3.097 . . . . 35.079999999999998 112.996 176.033 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.4 tt -123.5 113.45 18.76 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.249 1.976 . . . . 32.310000000000002 107.605 153.081 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.2 ttt180 -76.65 -53.72 7.63 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.461 -2.649 . . . . 42.75 116.023 -164.941 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.04 -83.6 1.19 Allowed Glycine 0 N--CA 1.429 -1.776 0 CA-C-N 120.105 1.32 . . . . 36.310000000000002 114.753 172.893 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.752 0 C-N-CA 127.375 2.417 . . . . 36.270000000000003 112.745 -173.969 . . . . . . . . 0 0 . 1 . 074 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 CA--C 1.49 -1.346 0 CA-C-O 125.05 2.357 . . . . 17.170000000000002 110.327 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -92.13 150.84 20.71 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 103.566 -2.753 . . . . 21.890000000000001 103.566 -177.821 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.5 pt -127.37 155.32 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 124.797 1.239 . . . . 10.83 109.848 159.736 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -105.82 158.05 17.03 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.649 -1.282 . . . . 10.609999999999999 109.174 174.649 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -148.32 120.33 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 N-CA-C 99.302 -4.333 . . . . 9.1300000000000008 99.302 -178.213 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -108.82 121.78 45.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.41 2.284 . . . . 20.550000000000001 116.978 -178.512 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.2 p -73.21 -178.41 2.9 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.222 1.963 . . . . 11.779999999999999 113.68 -169.074 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.257 15.1 tp -51.88 -57.04 10.54 Favored 'General case' 0 N--CA 1.431 -1.401 1 C-N-CA 134.109 4.964 . . . . 19.309999999999999 108.942 178.356 . . . . . . . . 3 2 . 1 . 074 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 58.9 p -73.28 -54.11 9.19 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.44 -4.537 . . . . 23.140000000000001 112.444 175.595 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.11 45.61 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 114.245 -3.531 . . . . 19.739999999999998 113.104 177.983 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -96.01 100.54 12.2 Favored 'General case' 0 N--CA 1.43 -1.472 2 C-N-CA 132.072 4.149 . . . . 21.93 103.536 178.097 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -82.87 102.21 11.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 126.7 2.0 . . . . 12.33 106.186 -177.975 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.255 3.5 pt -90.28 170.09 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 128.492 2.717 . . . . 17.079999999999998 106.327 178.584 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.3 m -121.53 149.91 42.4 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 130.085 3.354 . . . . 16.300000000000001 105.981 177.061 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.7 mt -143.38 145.09 32.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.013 -2.304 . . . . 15.880000000000001 105.18 171.954 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -106.11 104.84 14.64 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.142 1.925 . . . . 28.899999999999999 111.723 -177.936 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.251 20.9 m -120.38 128.67 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 120.171 -1.58 . . . . 12.050000000000001 114.57 -162.041 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -88.62 134.93 33.07 Favored Pre-proline 0 N--CA 1.43 -1.427 0 N-CA-C 104.515 -2.402 . . . . 18.170000000000002 104.515 171.89 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.87 -0.52 10.01 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 120.864 1.344 . . . . 8.1600000000000001 114.241 -171.087 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.8 m -70.07 -26.36 63.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.252 3.056 . . . . 11.130000000000001 119.252 169.308 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -81.79 176.36 9.67 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 114.761 1.393 . . . . 18.030000000000001 114.761 179.347 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.9 p -76.38 157.14 32.63 Favored 'General case' 0 N--CA 1.43 -1.455 1 N-CA-C 123.324 4.564 . . . . 10.220000000000001 123.324 173.371 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 mm -73.66 -28.08 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 117.746 -3.096 . . . . 12.300000000000001 113.307 173.614 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -52.08 -36.48 50.83 Favored 'General case' 0 N--CA 1.431 -1.403 0 O-C-N 116.742 -3.724 . . . . 36.509999999999998 113.551 163.583 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -80.02 -22.08 42.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 125.803 1.641 . . . . 25.66 115.17 -177.811 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.47 -49.78 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 119.96 3.319 . . . . 8.1199999999999992 119.96 153.673 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.251 55.9 mtmt -70.98 -30.37 66.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 124.299 1.039 . . . . 15.470000000000001 113.199 -175.773 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.81 78.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.117 -1.615 . . . . 11.449999999999999 112.296 175.796 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.269 35.3 tptt -77.69 -21.52 51.9 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 124.548 1.139 . . . . 24.98 112.423 -175.766 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.7 mt -74.06 -40.75 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 128.061 2.545 . . . . 9.4600000000000009 109.013 170.389 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -65.86 -32.72 74.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.188 1.555 . . . . 14.76 111.999 177.71 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -70.35 -58.16 4.05 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.19 -2.194 . . . . 26.289999999999999 112.28 172.59 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.8 tttt -57.72 -60.82 3.11 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 119.883 3.29 . . . . 30.059999999999999 119.883 -177.975 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -101.8 -48.34 4.31 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 129.575 3.15 . . . . 25.190000000000001 108.311 -171.248 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.11 24.59 5.66 Favored Glycine 0 N--CA 1.43 -1.75 0 C-N-CA 127.375 2.417 . . . . 7.4100000000000001 118.593 177.554 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.0 mt -92.04 103.94 9.44 Favored Pre-proline 0 N--CA 1.43 -1.453 1 CA-C-O 111.516 -4.088 . . . . 9.4900000000000002 108.476 -170.711 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.51 154.16 72.27 Favored 'Trans proline' 0 N--CA 1.434 -2.002 1 CA-C-N 130.542 4.801 . . . . 11.42 116.481 -168.31 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -60.32 -19.88 60.11 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 N-CA-C 119.048 2.672 . . . . 12.0 119.048 -174.344 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -77.35 -21.03 53.93 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 122.221 2.282 . . . . 35.549999999999997 115.106 173.04 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -83.27 -13.01 56.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.379 1.992 . . . . 20.52 116.379 168.865 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 75.6 mt-30 -96.17 119.15 34.14 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 116.199 -4.063 . . . . 7.1299999999999999 111.225 -173.638 . . . . . . . . 3 2 . 1 . 074 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 ttt180 -90.95 116.86 29.08 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 101.639 -3.467 . . . . 36.390000000000001 101.639 164.584 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.9 tp -105.58 113.91 27.77 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.623 2.011 . . . . 9.5500000000000007 110.946 -179.799 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 64.3 mt -116.2 152.54 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 125.572 2.606 . . . . 13.9 104.625 -164.748 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -82.41 -80.49 0.16 Allowed 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.199 -4.063 . . . . 6.8600000000000003 112.789 162.871 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -112.3 -72.71 0.7 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.193 2.197 . . . . 11.15 109.001 172.105 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.97 -27.32 4.91 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 125.951 2.973 . . . . 13.93 117.144 174.085 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -106.64 150.83 25.82 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 119.366 -2.255 . . . . 23.920000000000002 109.786 -165.76 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -102.19 144.77 30.31 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.018 -2.926 . . . . 23.23 106.629 -170.197 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.1 mt -77.84 145.65 36.17 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 111.462 -2.608 . . . . 9.1099999999999994 111.19 179.764 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -110.55 151.59 27.41 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 125.105 1.362 . . . . 33.439999999999998 110.211 -175.256 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -56.36 -59.51 4.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 128.541 2.736 . . . . 28.370000000000001 112.24 -161.422 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.08 33.12 5.8 Favored Glycine 0 N--CA 1.43 -1.741 0 O-C-N 116.635 -3.791 . . . . 15.0 116.442 -168.912 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -121.76 160.47 24.5 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 106.518 -1.66 . . . . 25.5 106.518 174.363 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 35.4 p -104.56 173.47 6.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 125.95 2.786 . . . . 11.949999999999999 117.194 -174.32 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.6 -25.56 41.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.073 -2.267 . . . . 10.17 114.046 -177.926 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.7 m -59.58 -59.14 5.91 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.661 1.696 . . . . 13.59 110.789 168.523 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -67.0 -32.56 73.88 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.347 -2.096 . . . . 11.699999999999999 114.494 -173.186 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -69.43 -19.36 63.79 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.257 1.823 . . . . 12.949999999999999 113.019 171.902 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.299 42.5 m-80 58.98 50.36 8.42 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 126.514 1.926 . . . . 25.449999999999999 114.962 -173.232 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 34.1 mt -95.43 125.76 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 107.296 -1.372 . . . . 14.6 107.296 174.516 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -85.48 174.0 9.82 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.481 -3.887 . . . . 33.229999999999997 109.998 177.393 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.9 pttt -72.53 152.5 41.83 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 125.125 2.393 . . . . 25.969999999999999 113.881 174.016 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 55.52 41.48 30.74 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 130.664 3.586 . . . . 32.609999999999999 111.232 -171.564 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.5 t -107.73 142.05 38.32 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 127.22 3.39 . . . . 10.56 103.048 -179.062 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.9 m -98.94 123.56 43.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-N 110.632 -2.985 . . . . 5.3300000000000001 114.175 -179.119 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.6 mt -95.9 144.12 26.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.041 2.829 . . . . 11.66 108.045 174.838 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -111.14 124.89 53.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.414 -2.679 . . . . 16.300000000000001 114.449 -169.44 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.9 mt -100.78 126.86 47.38 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.123 1.44 . . . . 9.9600000000000009 110.441 -179.584 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.3 m -121.04 177.82 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 107.411 -1.329 . . . . 9.7599999999999998 107.411 162.539 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 52.2 tp -85.05 122.97 30.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.463 -2.023 . . . . 19.57 106.827 175.123 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -93.89 148.29 22.28 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.026 3.33 . . . . 35.079999999999998 110.112 171.774 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.5 mt -85.81 172.56 10.68 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.401 -2.062 . . . . 32.310000000000002 111.876 172.252 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -75.37 -65.21 0.92 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 120.638 -1.289 . . . . 42.75 111.596 -167.506 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 72.82 -82.81 0.6 Allowed Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 124.974 1.274 . . . . 36.310000000000002 112.096 -165.259 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.752 1 CA-C-O 112.21 -4.661 . . . . 36.270000000000003 107.882 -178.371 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.329 4.1 ptt? . . . . . 0 CA--C 1.491 -1.319 0 CA-C-O 122.438 1.113 . . . . 17.170000000000002 109.809 . . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -113.83 145.32 41.61 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 123.283 1.516 . . . . 21.890000000000001 107.237 177.684 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -123.75 -175.1 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 119.793 -1.817 . . . . 10.83 107.423 160.224 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.294 0.7 OUTLIER -129.59 140.21 51.25 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 127.013 2.695 . . . . 10.609999999999999 109.051 171.146 . . . . . . . . 3 3 . 1 . 075 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.1 t -112.58 137.52 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 1 O-C-N 114.382 -5.199 . . . . 9.1300000000000008 111.819 169.353 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -100.66 115.29 29.87 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 124.215 3.189 . . . . 20.550000000000001 109.783 162.352 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 p -67.41 -164.7 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 127.459 2.975 . . . . 11.779999999999999 116.692 -169.458 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 90.4 mt -62.32 -56.54 17.45 Favored 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 131.922 4.089 . . . . 19.309999999999999 110.232 -179.487 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.7 p -76.35 -41.89 46.7 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.776 2.227 . . . . 23.140000000000001 111.601 -176.53 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.28 72.78 0.39 Allowed Glycine 0 N--CA 1.43 -1.725 0 C-N-CA 127.405 2.431 . . . . 19.739999999999998 114.417 -174.419 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.33 80.1 tttt -135.34 124.4 24.31 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 124.421 1.088 . . . . 21.93 108.107 170.785 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.5 m -88.11 118.12 27.47 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.95 -2.968 . . . . 12.33 112.125 -179.21 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.5 pt -111.69 148.02 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 O-C-N 115.788 -4.32 . . . . 17.079999999999998 109.53 -173.829 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -98.21 137.55 36.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.839 -1.541 . . . . 16.300000000000001 106.839 -177.363 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.6 mt -124.57 159.01 31.61 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 127.476 2.31 . . . . 15.880000000000001 107.185 178.994 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -123.06 126.85 47.87 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 105.508 -2.034 . . . . 28.899999999999999 105.508 173.986 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.7 m -139.07 169.18 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.032 -2.581 . . . . 12.050000000000001 104.032 -174.269 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -109.16 156.95 38.38 Favored Pre-proline 0 N--CA 1.43 -1.441 0 C-N-CA 125.338 1.455 . . . . 18.170000000000002 107.938 165.077 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.19 -16.03 31.77 Favored 'Trans proline' 0 C--N 1.299 -2.031 0 C-N-CA 116.711 -1.726 . . . . 8.1600000000000001 114.106 176.942 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.0 m -72.7 -15.54 61.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.437 -1.32 . . . . 11.130000000000001 107.437 179.586 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -76.83 141.27 40.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.354 -2.716 . . . . 18.030000000000001 115.466 -170.961 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.1 p -70.58 168.51 16.21 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 121.67 3.952 . . . . 10.220000000000001 121.67 170.685 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.37 5.7 mm -62.43 -40.45 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 120.444 -1.41 . . . . 12.300000000000001 111.816 174.173 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -51.02 -31.84 19.5 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.48 2.03 . . . . 36.509999999999998 116.48 168.051 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -81.81 -29.42 32.66 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.024 -1.048 . . . . 25.66 111.097 176.665 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.27 4.0 t -62.1 -54.1 38.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 124.754 1.221 . . . . 8.1199999999999992 109.529 174.613 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -56.38 -37.45 70.12 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.824 2.157 . . . . 15.470000000000001 116.824 176.565 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.72 81.71 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.83 2.159 . . . . 11.449999999999999 116.83 175.284 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.7 mttt -71.71 -29.01 64.08 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 117.076 2.25 . . . . 24.98 117.076 168.888 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.342 48.5 mt -73.11 -43.25 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.191 -1.781 . . . . 9.4600000000000009 106.191 172.734 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -67.77 -26.67 66.22 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 116.734 2.124 . . . . 14.76 116.734 178.72 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -70.99 -51.53 25.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.484 -1.689 . . . . 26.289999999999999 114.117 169.381 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -64.99 -66.08 0.59 Allowed 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 131.78 4.032 . . . . 30.059999999999999 115.64 -179.896 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -95.71 -25.97 15.89 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.515 1.672 . . . . 25.190000000000001 115.515 -172.872 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.07 -27.51 8.56 Favored Glycine 0 N--CA 1.431 -1.688 0 O-C-N 120.75 -1.219 . . . . 7.4100000000000001 115.385 -178.967 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.3 mt -52.38 125.59 35.48 Favored Pre-proline 0 N--CA 1.43 -1.451 1 C-N-CA 131.807 4.043 . . . . 9.4900000000000002 109.237 -172.512 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -64.65 164.33 24.3 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-O 115.324 -2.032 . . . . 11.42 115.18 -178.44 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -80.98 -16.98 9.7 Favored 'Trans proline' 0 C--N 1.3 -2.022 0 CA-C-N 126.245 3.266 . . . . 12.0 114.239 -177.219 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -86.3 -5.1 59.25 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.876 -2.39 . . . . 35.549999999999997 106.865 -175.259 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.62 -28.19 22.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.046 -2.284 . . . . 20.52 112.278 171.676 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -88.05 123.13 32.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.961 1.097 . . . . 7.1299999999999999 113.961 -165.182 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -114.92 117.19 29.97 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.045 2.138 . . . . 36.390000000000001 115.365 160.86 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.17 112.89 24.93 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 123.565 1.65 . . . . 9.5500000000000007 109.31 -169.079 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mm -100.43 143.85 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 O-C-N 115.828 -4.295 . . . . 13.9 107.297 175.841 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -81.06 -92.07 0.06 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.106 1.763 . . . . 6.8600000000000003 112.35 169.848 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.28 -48.97 3.85 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 121.199 1.818 . . . . 11.15 109.51 162.017 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.9 9.12 0.73 Allowed Glycine 0 N--CA 1.43 -1.721 0 O-C-N 119.792 -1.818 . . . . 13.93 115.607 -177.419 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.2 tttp -112.17 134.89 53.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.806 -1.924 . . . . 23.920000000000002 105.806 175.613 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -74.49 148.32 41.1 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.815 -1.803 . . . . 23.23 112.125 168.765 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 mt -91.83 127.0 37.13 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.016 -2.303 . . . . 9.1099999999999994 105.865 -177.486 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -79.46 131.89 36.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.412 1.885 . . . . 33.439999999999998 113.734 177.878 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -51.7 -51.91 52.39 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.343 2.257 . . . . 28.370000000000001 111.77 -162.189 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.94 9.56 59.82 Favored Glycine 0 N--CA 1.43 -1.755 0 O-C-N 119.741 -1.849 . . . . 15.0 116.927 -174.862 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -101.57 158.62 15.95 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.453 -3.969 . . . . 25.5 112.545 177.334 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -84.15 158.1 21.46 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.365 1.866 . . . . 11.949999999999999 112.402 -178.09 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -62.41 -32.14 72.94 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.676 -4.39 . . . . 10.17 111.294 164.749 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.6 t -57.86 -45.72 85.89 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.592 2.357 . . . . 13.59 116.648 174.252 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -68.98 -35.56 76.85 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.81 -1.541 . . . . 11.699999999999999 114.447 -178.444 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -79.79 2.9 21.27 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.263 -1.523 . . . . 12.949999999999999 111.839 169.698 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.7 t30 40.79 40.93 1.06 Allowed 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 127.582 2.353 . . . . 25.449999999999999 116.006 -168.761 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.8 mt -74.74 126.08 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 N-CA-C 104.324 -2.473 . . . . 14.6 104.324 175.452 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -115.21 165.75 12.59 Favored 'General case' 0 N--CA 1.429 -1.491 1 C-N-CA 132.636 4.374 . . . . 33.229999999999997 114.191 179.881 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.345 45.8 pttt -55.25 157.67 3.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.498 3.519 . . . . 25.969999999999999 115.213 -172.829 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 75.01 0.22 3.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.98 2.112 . . . . 32.609999999999999 113.977 168.63 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 t -91.61 157.44 16.98 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.72 -2.488 . . . . 10.56 110.771 -173.287 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.6 m -99.55 116.83 32.59 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 127.043 2.715 . . . . 5.3300000000000001 109.416 178.459 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.7 mt -99.98 152.61 19.99 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.073 1.749 . . . . 11.66 107.817 174.297 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -116.03 142.68 46.48 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.614 -1.624 . . . . 16.300000000000001 106.614 -166.659 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tp -111.41 112.16 23.72 Favored 'General case' 0 N--CA 1.431 -1.425 1 O-C-N 115.832 -4.293 . . . . 9.9600000000000009 111.383 -175.541 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.0 t -102.86 139.03 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 104.67 -2.345 . . . . 9.7599999999999998 104.67 -173.701 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 tp -66.52 127.94 34.29 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.558 -2.589 . . . . 19.57 114.217 177.53 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 ttp180 -93.57 126.67 38.85 Favored 'General case' 0 N--CA 1.431 -1.408 0 O-C-N 119.615 -1.928 . . . . 35.079999999999998 108.158 -170.961 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.276 26.5 mt -79.09 -75.06 0.25 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 121.777 2.08 . . . . 32.310000000000002 115.111 176.313 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -103.04 -50.22 3.56 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.88 2.472 . . . . 42.75 107.687 -158.24 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 171.31 -178.37 43.71 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 122.929 1.294 . . . . 36.310000000000002 112.182 -177.263 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 C-N-CA 129.598 3.475 . . . . 36.270000000000003 112.962 165.25 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.327 0 N-CA-C 109.464 -0.569 . . . . 17.170000000000002 109.464 . . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -75.43 126.4 30.94 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.709 -1.244 . . . . 21.890000000000001 112.736 -179.06 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.7 pt -107.73 141.27 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-O 125.277 2.465 . . . . 10.83 104.902 151.552 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 43.3 m-85 -101.06 144.48 29.92 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.876 -2.39 . . . . 10.609999999999999 107.007 165.665 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.287 58.1 t -106.54 124.0 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-O 116.735 -1.602 . . . . 9.1300000000000008 111.772 169.484 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -102.41 113.92 27.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 119.701 1.137 . . . . 20.550000000000001 111.825 -178.181 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.374 3.1 p -63.5 -174.43 0.09 Allowed 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.135 2.642 . . . . 11.779999999999999 118.135 176.509 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.4 mt -81.54 -60.28 2.32 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.236 -2.79 . . . . 19.309999999999999 110.819 175.944 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.297 62.2 p -71.89 -64.45 0.93 Allowed 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 116.062 -1.923 . . . . 23.140000000000001 114.566 -174.188 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -179.18 54.72 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.765 1 CA-C-N 126.13 4.059 . . . . 19.739999999999998 114.639 -175.584 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -135.49 138.46 43.15 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 128.057 2.857 . . . . 21.93 107.847 -176.192 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.288 72.9 m -139.79 107.58 5.66 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.225 -2.139 . . . . 12.33 105.225 -179.874 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 4' ' ' PHE . 17.9 pt -112.36 161.06 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 124.254 1.978 . . . . 17.079999999999998 108.345 -166.692 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.7 m -117.38 126.78 53.24 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.726 -1.859 . . . . 16.300000000000001 111.885 -174.54 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.3 mt -111.06 163.11 14.2 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.988 -1.07 . . . . 15.880000000000001 110.992 172.543 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -116.4 110.15 18.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 104.859 -2.275 . . . . 28.899999999999999 104.859 179.395 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.46 154.08 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 119.047 -2.283 . . . . 12.050000000000001 113.437 -176.833 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -97.34 153.08 38.53 Favored Pre-proline 0 N--CA 1.43 -1.437 0 CA-C-O 114.862 -2.494 . . . . 18.170000000000002 113.973 167.142 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -59.96 -22.04 67.26 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 CA-C-N 125.728 3.081 . . . . 8.1600000000000001 116.856 -179.834 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 m -76.72 -9.04 58.39 Favored 'General case' 0 N--CA 1.43 -1.457 1 C-N-CA 132.073 4.149 . . . . 11.130000000000001 116.875 170.758 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.72 127.5 33.0 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.77 -3.706 . . . . 18.030000000000001 114.971 175.583 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.291 45.1 p -68.53 159.09 32.51 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.257 2.623 . . . . 10.220000000000001 112.719 179.045 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.259 45.2 mm -57.25 -35.33 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.27 1.828 . . . . 12.300000000000001 112.461 168.021 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -60.79 -52.9 63.11 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.206 1.821 . . . . 36.509999999999998 115.337 173.46 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.271 33.0 m-80 -60.65 -36.05 77.72 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 115.34 -2.267 . . . . 25.66 113.328 174.497 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.421 50.1 t -46.81 -48.02 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 131.262 3.825 . . . . 8.1199999999999992 113.905 167.781 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -76.01 -20.72 57.59 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.79 -1.55 . . . . 15.470000000000001 110.868 -169.887 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.77 -28.75 55.82 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 112.631 0.604 . . . . 11.449999999999999 112.631 174.293 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -70.03 -32.45 70.6 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 113.471 0.915 . . . . 24.98 113.471 173.181 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.5 mt -69.95 -35.0 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 123.936 1.827 . . . . 9.4600000000000009 109.594 172.33 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -69.63 -29.11 66.53 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.878 -2.389 . . . . 14.76 113.508 174.205 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -67.5 -54.3 21.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.289 -2.132 . . . . 26.289999999999999 112.604 168.575 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -64.38 -63.35 1.16 Allowed 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 117.229 -1.367 . . . . 30.059999999999999 109.599 -175.955 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -87.74 -48.53 7.79 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.298 2.333 . . . . 25.190000000000001 117.298 177.916 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.46 52.02 1.63 Allowed Glycine 0 N--CA 1.431 -1.694 0 O-C-N 117.474 -3.266 . . . . 7.4100000000000001 115.585 -171.915 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.0 mt -113.99 127.72 26.53 Favored Pre-proline 0 N--CA 1.43 -1.44 1 N-CA-C 99.132 -4.396 . . . . 9.4900000000000002 99.132 -169.399 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -72.7 157.86 51.47 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 O-C-N 117.053 -2.13 . . . . 11.42 109.075 -170.335 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -77.38 -29.1 5.07 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 C-N-CA 125.027 3.818 . . . . 12.0 111.639 -153.001 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -79.16 -26.79 42.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 130.579 3.552 . . . . 35.549999999999997 108.3 175.367 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -80.19 -26.99 38.98 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 116.477 -3.89 . . . . 20.52 111.596 -176.078 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -71.48 138.55 49.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.386 2.041 . . . . 7.1299999999999999 110.314 174.685 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.5 ttm180 -142.16 137.42 30.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.881 -2.387 . . . . 36.390000000000001 110.676 161.519 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -104.34 135.19 46.25 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.434 2.54 . . . . 9.5500000000000007 111.933 178.654 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.6 mm -111.25 138.92 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 113.408 -1.724 . . . . 13.9 110.957 163.823 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.31 5.6 t80 -70.09 -87.82 0.02 OUTLIER 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.892 1.677 . . . . 6.8600000000000003 109.742 167.762 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -109.23 -62.94 1.41 Allowed 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 121.179 -0.951 . . . . 11.15 108.867 165.873 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.86 -24.87 2.21 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 126.033 1.778 . . . . 13.93 110.333 177.311 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.269 0.1 OUTLIER -74.36 123.52 24.78 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.147 -1.427 . . . . 23.920000000000002 107.147 -178.047 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.269 16.2 pt20 -70.39 122.09 18.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.786 2.554 . . . . 23.23 111.137 164.292 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.3 mt -95.37 150.45 20.26 Favored 'General case' 0 N--CA 1.429 -1.507 0 O-C-N 118.343 -2.723 . . . . 9.1099999999999994 111.282 -171.354 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -120.14 141.37 49.91 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 126.801 3.191 . . . . 33.439999999999998 116.019 -169.263 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.01 -52.97 56.71 Favored 'General case' 0 N--CA 1.43 -1.451 2 O-C-N 115.653 -4.404 . . . . 28.370000000000001 112.943 -156.988 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.88 29.59 7.85 Favored Glycine 0 N--CA 1.429 -1.78 0 CA-C-N 124.216 3.189 . . . . 15.0 115.034 -169.862 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.4 mtt-85 -114.88 147.3 40.1 Favored 'General case' 0 N--CA 1.429 -1.494 0 C-N-CA 127.2 2.2 . . . . 25.5 109.332 177.359 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.5 p -94.19 173.04 7.84 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 129.584 3.154 . . . . 11.949999999999999 112.229 179.37 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.5 mt -86.28 -18.17 32.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 104.498 -2.408 . . . . 10.17 104.498 -173.259 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.18 -41.47 77.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.397 -2.064 . . . . 13.59 110.137 168.617 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -65.71 -41.43 92.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.95 2.1 . . . . 11.699999999999999 112.676 -177.585 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -78.44 -28.72 46.73 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 115.575 -2.45 . . . . 12.949999999999999 116.563 173.142 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.288 29.8 t30 74.5 56.36 0.08 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.63 3.172 . . . . 25.449999999999999 112.544 -168.242 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.562 HD13 HD21 ' A' ' 67' ' ' LEU . 31.4 mt -99.9 101.94 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 104.435 -2.432 . . . . 14.6 104.435 170.898 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -100.35 -156.28 0.55 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 127.522 2.329 . . . . 33.229999999999997 108.084 -172.113 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -61.41 157.6 16.48 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 116.905 -3.622 . . . . 25.969999999999999 119.336 174.799 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 71.78 15.98 5.73 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 121.016 -1.053 . . . . 32.609999999999999 112.603 163.623 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 m -101.22 142.78 32.15 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.742 2.526 . . . . 10.56 108.371 -156.999 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.3 m -111.58 129.26 56.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 116.8 -3.687 . . . . 5.3300000000000001 107.09 -178.3 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.562 HD21 HD13 ' A' ' 61' ' ' ILE . 66.8 mt -103.61 164.09 11.89 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.31 -1.366 . . . . 11.66 107.31 168.715 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -122.13 124.16 43.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.729 2.412 . . . . 16.300000000000001 110.966 -177.936 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.1 tp -106.01 110.78 23.16 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 119.598 -1.939 . . . . 9.9600000000000009 109.379 -172.032 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 m -114.53 174.38 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 117.966 -2.959 . . . . 9.7599999999999998 107.207 -174.743 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.6 mt -81.95 141.96 32.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 123.621 1.677 . . . . 19.57 111.007 168.151 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 -75.89 103.31 5.91 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 119.06 -2.275 . . . . 35.079999999999998 111.695 159.814 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 69.7 mt -99.68 92.98 5.59 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.546 2.338 . . . . 32.310000000000002 114.6 171.604 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -123.37 -74.58 0.61 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.486 -1.384 . . . . 42.75 110.145 179.634 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.33 49.16 1.34 Allowed Glycine 0 N--CA 1.43 -1.71 0 CA-C-O 125.505 2.725 . . . . 36.310000000000002 113.775 -170.18 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.812 0 CA-C-N 111.404 -2.398 . . . . 36.270000000000003 112.232 -165.12 . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.1 ttp . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 115.505 1.669 . . . . 17.170000000000002 115.505 . . . . . . . . . 0 0 . 1 . 077 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -93.47 133.33 36.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.057 2.208 . . . . 21.890000000000001 107.923 -175.522 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pt -119.85 150.83 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 118.655 -2.528 . . . . 10.83 111.106 175.126 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.433 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 21.2 m-85 -112.31 100.68 8.99 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 127.61 2.364 . . . . 10.609999999999999 116.896 176.867 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.3 t -92.63 114.86 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 120.294 -0.562 . . . . 9.1300000000000008 111.227 179.731 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -98.88 125.03 44.18 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.067 -2.896 . . . . 20.550000000000001 112.662 177.269 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.539 HG22 HD23 ' A' ' 69' ' ' LEU . 82.3 p -84.24 -179.07 7.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.488 -1.233 . . . . 11.779999999999999 113.481 -179.373 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.0 tt -50.72 -47.94 59.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 130.045 3.338 . . . . 19.309999999999999 112.573 179.405 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.6 p -93.15 -66.8 0.9 Allowed 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.049 2.139 . . . . 23.140000000000001 107.287 -165.752 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.56 75.57 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 104.062 -3.615 . . . . 19.739999999999998 104.062 161.9 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -115.15 116.97 29.25 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 108.839 -0.8 . . . . 21.93 108.839 164.001 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.285 28.1 m -83.87 93.94 8.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.098 2.559 . . . . 12.33 109.689 173.907 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.8 mt -85.78 105.45 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 123.769 1.747 . . . . 17.079999999999998 107.394 -174.922 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -87.07 110.4 20.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 116.054 -4.154 . . . . 16.300000000000001 108.37 179.98 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.0 mt -113.05 140.62 47.69 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.944 -1.873 . . . . 15.880000000000001 105.944 176.272 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -104.23 131.2 51.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 122.32 1.057 . . . . 28.899999999999999 111.812 167.781 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.24 178.94 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 115.142 -0.936 . . . . 12.050000000000001 109.529 -178.612 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -85.1 163.15 46.82 Favored Pre-proline 0 N--CA 1.429 -1.479 0 O-C-N 118.426 -2.671 . . . . 18.170000000000002 110.949 163.98 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.257 0.1 OUTLIER -76.24 -12.35 19.16 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 125.148 2.874 . . . . 8.1600000000000001 114.169 179.812 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.9 m -102.89 2.53 35.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 126.421 2.325 . . . . 11.130000000000001 108.063 -168.617 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -76.33 154.62 34.87 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.017 1.858 . . . . 18.030000000000001 116.017 169.298 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 55.9 p -93.06 169.65 10.25 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.823 2.527 . . . . 10.220000000000001 117.823 -179.316 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.3 mm -65.54 -42.72 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 126.026 2.079 . . . . 12.300000000000001 116.185 -178.627 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.569 ' HA ' ' HD3' ' A' ' 27' ' ' LYS . 5.7 mm-40 -29.47 -50.3 0.1 Allowed 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.9 2.48 . . . . 36.509999999999998 114.791 158.446 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.41 -37.91 63.23 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 119.161 -2.212 . . . . 25.66 108.092 -175.899 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.74 -43.46 87.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 124.379 2.038 . . . . 8.1199999999999992 111.613 176.083 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.569 ' HD3' ' HA ' ' A' ' 24' ' ' GLU . 50.0 mtpt -62.78 -36.79 84.27 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 119.276 -2.14 . . . . 15.470000000000001 115.392 173.659 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.36 -39.46 89.15 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 127.994 2.518 . . . . 11.449999999999999 113.176 175.473 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -71.45 -30.3 65.87 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 124.391 1.076 . . . . 24.98 110.083 -178.095 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.5 mt -71.39 -39.15 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 114.327 -1.306 . . . . 9.4600000000000009 111.274 174.092 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -62.92 -40.59 98.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.887 -2.383 . . . . 14.76 109.35 170.476 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -72.19 -43.82 63.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 115.952 -1.975 . . . . 26.289999999999999 110.681 -171.664 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.542 ' HB3' ' HG2' ' A' ' 34' ' ' GLU 0.303 28.8 tptt -69.25 -51.14 40.53 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.554 1.645 . . . . 30.059999999999999 113.516 -176.785 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HB3' ' A' ' 33' ' ' LYS . 76.8 mm-40 -106.02 -32.7 8.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.268 3.027 . . . . 25.190000000000001 113.833 -157.818 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.42 56.71 4.17 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 128.429 2.919 . . . . 7.4100000000000001 113.329 -175.072 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.0 mt -110.87 124.19 33.58 Favored Pre-proline 0 N--CA 1.43 -1.436 0 N-CA-C 103.824 -2.658 . . . . 9.4900000000000002 103.824 -178.456 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -60.98 139.62 85.71 Favored 'Trans proline' 0 N--CA 1.433 -2.036 0 C-N-CA 124.071 3.181 . . . . 11.42 117.085 175.589 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -63.95 -14.84 45.69 Favored 'Trans proline' 0 C--N 1.3 -2.008 1 C-N-CA 127.422 5.415 . . . . 12.0 111.474 -174.757 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.401 2.5 p30 -81.37 -24.73 36.84 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 117.119 2.266 . . . . 35.549999999999997 117.119 178.351 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -75.72 -25.15 56.36 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 126.248 2.217 . . . . 20.52 116.83 167.142 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -79.51 121.72 25.57 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.638 2.459 . . . . 7.1299999999999999 117.638 -179.043 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -128.4 151.6 49.18 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.438 -2.664 . . . . 36.390000000000001 107.137 157.493 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.6 mt -131.12 143.57 50.74 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 124.332 2.015 . . . . 9.5500000000000007 111.089 -169.943 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.4 mm -120.65 140.74 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.401 3.08 . . . . 13.9 105.476 -176.28 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -104.16 -55.02 2.44 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 124.404 2.049 . . . . 6.8600000000000003 108.93 155.643 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.66 107.62 3.22 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.488 -2.008 . . . . 11.15 107.716 -176.661 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.81 -69.96 0.75 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 126.634 2.064 . . . . 13.93 116.619 175.853 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -96.3 166.95 11.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 119.138 1.469 . . . . 23.920000000000002 114.254 -175.727 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -60.39 139.11 57.84 Favored 'General case' 0 N--CA 1.43 -1.47 1 N-CA-C 123.489 4.626 . . . . 23.23 123.489 172.887 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 58.2 mt -83.4 120.42 25.86 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.825 1.65 . . . . 9.1099999999999994 114.759 173.642 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -89.25 155.09 19.61 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.682 -2.511 . . . . 33.439999999999998 110.075 -174.803 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -63.09 -53.72 49.22 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.165 1.786 . . . . 28.370000000000001 112.999 -158.433 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.15 36.23 4.54 Favored Glycine 0 N--CA 1.43 -1.752 0 CA-C-O 117.673 -1.626 . . . . 15.0 114.273 -173.71 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -107.2 147.39 30.2 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 105.401 -2.074 . . . . 25.5 105.401 174.171 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.315 32.2 p -77.89 169.74 17.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 125.179 1.55 . . . . 11.949999999999999 112.272 -178.48 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.7 mt -77.08 -30.99 55.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 113.953 -1.476 . . . . 10.17 109.17 178.999 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -66.49 -49.87 65.16 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 131.039 3.736 . . . . 13.59 110.233 179.155 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 33.1 t70 -56.63 -43.3 80.12 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.137 -2.227 . . . . 11.699999999999999 116.553 174.796 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -69.72 -27.61 65.12 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 124.952 1.408 . . . . 12.949999999999999 110.176 176.778 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 70.69 46.6 0.51 Allowed 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 129.045 2.938 . . . . 25.449999999999999 107.795 -175.509 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -79.15 119.9 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 CA-C-N 112.249 -2.25 . . . . 14.6 106.58 162.578 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -107.64 -176.15 2.98 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 127.802 2.441 . . . . 33.229999999999997 111.205 -174.987 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.276 54.7 pttt -69.92 135.03 49.04 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.661 -1.899 . . . . 25.969999999999999 115.099 -172.024 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 73.46 38.62 0.63 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.109 2.164 . . . . 32.609999999999999 109.809 179.9 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.6 m -94.21 150.76 20.01 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 112.865 -6.147 . . . . 10.56 110.15 -169.95 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.433 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 99.0 m -98.63 123.35 42.77 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.33 -2.731 . . . . 5.3300000000000001 105.244 -175.717 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.27 4.8 mp -116.03 148.21 40.42 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.676 -3.14 . . . . 11.66 109.746 168.9 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.5 m80 -95.05 121.87 37.12 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 124.157 1.932 . . . . 16.300000000000001 114.716 173.185 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.539 HD23 HG22 ' A' ' 7' ' ' THR 0.274 44.5 tp -81.62 114.89 20.61 Favored 'General case' 0 N--CA 1.429 -1.478 1 O-C-N 115.489 -4.507 . . . . 9.9600000000000009 113.385 171.27 . . . . . . . . 4 3 . 1 . 077 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.4 m -117.86 157.09 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 CA-C-N 121.695 2.043 . . . . 9.7599999999999998 113.951 -178.529 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.1 tp -73.29 122.41 21.93 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 112.942 0.719 . . . . 19.57 112.942 177.148 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -78.21 115.1 17.69 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 126.565 1.946 . . . . 35.079999999999998 114.32 170.201 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.3 mt -113.72 79.01 1.19 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.218 1.961 . . . . 32.310000000000002 109.403 179.65 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -130.12 171.43 12.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.031 -1.895 . . . . 42.75 110.473 177.468 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.48 77.71 0.29 Allowed Glycine 0 N--CA 1.43 -1.715 0 CA-C-O 124.001 1.889 . . . . 36.310000000000002 115.698 175.256 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.762 0 N-CA-C 107.049 -2.42 . . . . 36.270000000000003 107.049 -165.767 . . . . . . . . 0 0 . 1 . 078 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.491 -1.318 0 N-CA-C 120.007 3.336 . . . . 17.170000000000002 120.007 . . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -94.08 136.48 34.33 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.675 -1.972 . . . . 21.890000000000001 105.675 -164.98 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.425 HG13 ' HB2' ' A' ' 15' ' ' LEU . 7.0 pt -132.09 162.19 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 128.161 2.585 . . . . 10.83 110.731 168.666 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -113.58 143.29 44.81 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 124.346 2.022 . . . . 10.609999999999999 109.221 175.457 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -133.62 115.47 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.505 1 O-C-N 115.175 -4.703 . . . . 9.1300000000000008 104.881 175.832 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt -94.01 126.89 39.49 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 105.911 -1.885 . . . . 20.550000000000001 105.911 179.013 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.4 HG22 HD23 ' A' ' 69' ' ' LEU . 2.1 p -72.56 168.52 18.43 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.603 -1.936 . . . . 11.779999999999999 115.175 171.911 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.0 tp -66.82 -47.49 71.88 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.275 -1.515 . . . . 19.309999999999999 110.837 -175.463 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.3 p -73.58 -50.1 22.93 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 126.286 1.835 . . . . 23.140000000000001 115.068 -179.055 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 152.53 49.75 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 114.924 -3.513 . . . . 19.739999999999998 115.403 -169.906 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -138.71 137.17 36.54 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 116.945 -1.902 . . . . 21.93 110.698 165.047 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 m -95.82 103.24 15.11 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 125.224 1.577 . . . . 12.33 108.588 172.529 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.0 mt -86.98 120.05 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 O-C-N 117.974 -2.954 . . . . 17.079999999999998 111.786 177.641 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.3 m -99.28 120.55 39.73 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.915 -3.616 . . . . 16.300000000000001 102.396 -176.069 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.425 ' HB2' HG13 ' A' ' 3' ' ' ILE . 14.4 mt -122.77 168.95 11.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.376 3.071 . . . . 15.880000000000001 110.883 -170.538 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -135.58 120.42 18.51 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.635 1.574 . . . . 28.899999999999999 107.5 179.859 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.82 168.81 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 N-CA-C 104.302 -2.481 . . . . 12.050000000000001 104.302 -172.972 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.266 32.4 mt-10 -106.14 170.83 5.37 Favored Pre-proline 0 N--CA 1.431 -1.418 0 O-C-N 117.822 -3.048 . . . . 18.170000000000002 110.188 162.045 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 68.9 Cg_endo -81.11 5.04 6.5 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 CA-C-N 121.983 1.744 . . . . 8.1600000000000001 112.101 -179.325 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -93.95 -16.03 24.35 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.133 2.573 . . . . 11.130000000000001 108.797 -179.089 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -80.5 142.24 34.4 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 119.88 1.218 . . . . 18.030000000000001 113.497 -173.078 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -74.79 159.03 32.48 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 119.684 -1.885 . . . . 10.220000000000001 111.3 176.489 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mm -49.35 -40.72 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 119.425 -2.047 . . . . 12.300000000000001 115.042 170.059 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -47.82 -50.02 27.28 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 115.227 -2.321 . . . . 36.509999999999998 115.782 167.529 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -68.28 -29.68 68.52 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 123.496 2.862 . . . . 25.66 115.337 177.013 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 t -71.87 -37.62 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-N 115.734 -0.666 . . . . 8.1199999999999992 111.487 177.059 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttt -58.95 -34.77 72.15 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 120.045 3.35 . . . . 15.470000000000001 120.045 163.273 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.42 -37.32 65.94 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.042 -2.911 . . . . 11.449999999999999 110.887 -178.133 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -52.99 -45.02 67.66 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.17 2.188 . . . . 24.98 116.502 159.937 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.59 -48.09 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 1 O-C-N 115.813 -4.305 . . . . 9.4600000000000009 108.625 179.236 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -49.57 -50.44 42.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 116.007 1.854 . . . . 14.76 116.007 169.605 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -54.07 -49.05 69.91 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.535 1.68 . . . . 26.289999999999999 115.535 174.044 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -67.66 -57.65 6.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.007 -1.451 . . . . 30.059999999999999 113.433 -179.676 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -95.81 -36.82 11.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.582 2.753 . . . . 25.190000000000001 112.493 -161.763 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.23 0.3 50.85 Favored Glycine 0 N--CA 1.43 -1.722 0 CA-C-O 116.938 -2.034 . . . . 7.4100000000000001 116.572 -178.116 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.3 mt -72.56 124.77 91.19 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 128.69 2.796 . . . . 9.4900000000000002 108.588 179.948 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.48 160.42 9.52 Favored 'Trans proline' 0 C--N 1.3 -2.013 1 C-N-CA 126.294 4.662 . . . . 11.42 116.28 -178.555 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.19 -7.25 18.83 Favored 'Trans proline' 0 N--CA 1.434 -1.987 0 C-N-CA 123.668 2.912 . . . . 12.0 113.964 -161.715 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -76.65 -57.23 3.98 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 131.069 3.748 . . . . 35.549999999999997 106.469 -179.847 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -56.98 -45.3 83.03 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 116.361 1.986 . . . . 20.52 116.361 168.82 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -62.03 110.52 1.6 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.402 -3.311 . . . . 7.1299999999999999 116.715 175.451 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -110.18 130.56 55.52 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 123.119 1.437 . . . . 36.390000000000001 107.326 163.458 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.0 mt -110.83 128.77 55.9 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.819 2.247 . . . . 9.5500000000000007 106.828 179.906 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.1 mm -119.65 152.74 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.323 -3.36 . . . . 13.9 103.857 173.413 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -96.04 -66.96 0.87 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.806 -2.434 . . . . 6.8600000000000003 104.923 162.26 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.283 . . -156.33 130.56 8.68 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 104.486 -2.413 . . . . 11.15 104.486 173.766 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.59 -49.94 1.17 Allowed Glycine 0 N--CA 1.43 -1.753 0 CA-C-O 116.863 -2.076 . . . . 13.93 112.953 154.011 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -145.13 172.55 12.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 121.62 2.71 . . . . 23.920000000000002 107.378 -172.476 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.256 5.4 pm0 -83.66 135.23 34.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.229 -2.17 . . . . 23.23 115.553 -175.847 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.4 mt -77.27 151.41 35.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.485 -3.259 . . . . 9.1099999999999994 111.924 175.885 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.427 ' HB2' ' CG ' ' A' ' 54' ' ' ARG . 40.7 mt-10 -79.4 155.46 28.36 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.927 -2.983 . . . . 33.439999999999998 111.706 175.791 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -77.9 -43.09 31.07 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 120.83 1.65 . . . . 28.370000000000001 113.406 -173.564 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.16 29.4 11.9 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 118.462 0.574 . . . . 15.0 112.115 -175.873 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.427 ' CG ' ' HB2' ' A' ' 51' ' ' GLU . 38.0 mmt180 -114.51 149.19 36.78 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.425 -2.065 . . . . 25.5 105.425 178.025 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.286 30.1 p -100.1 176.39 5.42 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 111.568 -2.56 . . . . 11.949999999999999 117.547 -164.372 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 26.7 mt -73.8 -8.25 55.3 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.268 -3.395 . . . . 10.17 114.1 168.181 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 46.0 m -94.9 -28.61 15.11 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 116.551 -3.843 . . . . 13.59 102.332 -172.796 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -62.43 -51.71 66.43 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 131.673 3.989 . . . . 11.699999999999999 116.553 169.574 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -90.17 -6.4 55.37 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.361 -2.199 . . . . 12.949999999999999 111.707 -177.829 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.326 35.2 m120 72.13 36.3 1.13 Allowed 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 116.001 -4.187 . . . . 25.449999999999999 113.264 174.25 . . . . . . . . 3 2 . 1 . 078 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.7 mt -102.77 109.19 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.72 2.408 . . . . 14.6 107.867 -172.612 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -102.12 -178.37 3.68 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 125.564 2.602 . . . . 33.229999999999997 111.213 -179.772 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -49.89 148.89 2.89 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 118.853 -2.404 . . . . 25.969999999999999 116.685 175.972 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.294 35.1 mt-10 53.48 36.97 24.57 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.302 -3.374 . . . . 32.609999999999999 118.616 -172.637 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -97.57 144.39 27.3 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 105.171 -2.159 . . . . 10.56 105.171 178.752 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.3 m -101.22 105.86 17.02 Favored 'General case' 0 N--CA 1.43 -1.442 1 CA-C-O 128.844 4.164 . . . . 5.3300000000000001 110.583 175.595 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.57 150.3 21.79 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 118.542 -2.599 . . . . 11.66 111.832 173.777 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -103.36 127.5 50.7 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.825 -1.172 . . . . 16.300000000000001 112.128 178.274 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.4 HD23 HG22 ' A' ' 7' ' ' THR . 15.2 tp -105.26 116.52 32.09 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.41 3.481 . . . . 9.9600000000000009 109.347 169.947 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.76 174.16 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 112.781 -2.009 . . . . 9.7599999999999998 110.996 -179.114 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.9 tp -96.47 123.81 40.25 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.788 2.435 . . . . 19.57 111.386 -175.748 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -73.8 139.71 45.35 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.2 -1.562 . . . . 35.079999999999998 114.634 -176.091 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.6 mt -86.38 -53.49 4.97 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 115.081 -4.762 . . . . 32.310000000000002 108.29 -176.04 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.3 mtm-85 -119.49 -80.3 0.61 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.364 -3.335 . . . . 42.75 111.265 -167.115 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -169.08 -57.27 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.734 0 O-C-N 126.377 2.298 . . . . 36.310000000000002 110.459 -175.58 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.733 0 C-N-CA 125.679 1.609 . . . . 36.270000000000003 112.737 -178.434 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 116.746 2.128 . . . . 17.170000000000002 116.746 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.251 85.8 mt-30 -85.05 122.23 28.97 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.096 1.903 . . . . 21.890000000000001 113.331 177.168 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.8 pt -113.09 159.92 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.12 -2.548 . . . . 10.83 104.12 175.916 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -111.87 127.15 55.75 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 123.586 1.66 . . . . 10.609999999999999 109.298 -177.756 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.7 t -122.85 109.6 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.204 1.954 . . . . 9.1300000000000008 110.93 179.528 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -90.48 144.2 26.02 Favored 'General case' 0 N--CA 1.429 -1.49 1 O-C-N 113.235 -5.916 . . . . 20.550000000000001 115.914 176.054 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 15.7 p -85.61 164.25 17.84 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.148 2.979 . . . . 11.779999999999999 113.653 175.582 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 29.4 mt -62.94 -26.23 68.72 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.311 -2.743 . . . . 19.309999999999999 114.795 168.401 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 38.9 p -75.38 -44.06 46.87 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.455 1.934 . . . . 23.140000000000001 112.339 178.632 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.8 38.6 0.23 Allowed Glycine 0 N--CA 1.43 -1.711 0 CA-C-N 115.08 -0.964 . . . . 19.739999999999998 112.291 169.458 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.1 ttmt -103.08 125.79 49.96 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 108.188 -1.042 . . . . 21.93 108.188 172.353 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.4 m -91.66 128.05 37.35 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 102.339 -3.208 . . . . 12.33 102.339 168.965 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.254 28.7 mt -102.06 136.22 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 117.828 -3.045 . . . . 17.079999999999998 105.309 178.295 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.7 m -105.99 100.17 9.73 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 100.607 -3.849 . . . . 16.300000000000001 100.607 -175.095 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 mt -96.14 119.74 35.17 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 125.907 1.683 . . . . 15.880000000000001 110.334 -177.939 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -93.97 96.72 9.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 104.063 -2.569 . . . . 28.899999999999999 104.063 178.837 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.71 168.65 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.733 2.013 . . . . 12.050000000000001 108.831 179.178 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -116.22 154.27 48.68 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-N 120.011 1.278 . . . . 18.170000000000002 108.98 -169.98 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -70.79 -4.32 14.49 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 CA-C-N 122.56 1.95 . . . . 8.1600000000000001 115.185 -173.127 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.4 m -88.59 -12.39 42.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 125.238 1.586 . . . . 11.130000000000001 113.987 172.431 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -68.67 149.78 48.7 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.034 -2.916 . . . . 18.030000000000001 114.511 -179.462 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.284 37.2 p -90.55 175.34 7.09 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 111.245 -2.707 . . . . 10.220000000000001 107.699 -179.105 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 mm -73.55 -27.36 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 O-C-N 119.456 -2.027 . . . . 12.300000000000001 109.791 171.992 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -61.73 -52.16 65.39 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.509 -2.619 . . . . 36.509999999999998 108.532 170.333 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m-20 -47.58 -39.86 17.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 127.654 2.381 . . . . 25.66 115.807 172.87 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -78.66 -46.63 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 127.1 3.333 . . . . 8.1199999999999992 114.657 -171.572 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -59.46 -27.63 66.26 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.934 -2.979 . . . . 15.470000000000001 115.19 160.636 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.88 -19.84 60.59 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 122.369 2.35 . . . . 11.449999999999999 111.211 178.073 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.7 mmtt -69.34 -30.53 68.58 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 112.739 -6.225 . . . . 24.98 112.373 165.449 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 86.9 mt -87.76 -18.03 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-O 126.005 2.812 . . . . 9.4600000000000009 113.068 174.593 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -69.67 -33.24 72.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.52 -3.863 . . . . 14.76 110.558 167.662 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.85 -54.11 12.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.202 -2.811 . . . . 26.289999999999999 110.767 178.481 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -71.31 -62.94 1.22 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 120.178 -1.576 . . . . 30.059999999999999 113.432 -176.774 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -91.5 -33.37 15.21 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.435 2.541 . . . . 25.190000000000001 110.779 -174.051 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.73 59.28 2.24 Favored Glycine 0 N--CA 1.43 -1.751 2 O-C-N 114.577 -5.077 . . . . 7.4100000000000001 109.371 179.55 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.3 mt -118.48 146.48 39.78 Favored Pre-proline 0 N--CA 1.43 -1.459 0 N-CA-C 103.236 -2.876 . . . . 9.4900000000000002 103.236 -177.127 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.266 53.1 Cg_exo -75.1 138.79 23.24 Favored 'Trans proline' 0 C--N 1.3 -1.996 2 C-N-CA 128.48 6.12 . . . . 11.42 112.064 -176.295 . . . . . . . . 3 2 . 1 . 079 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -58.88 -29.18 89.49 Favored 'Trans proline' 0 N--CA 1.434 -1.982 0 C-N-CA 122.748 2.299 . . . . 12.0 112.711 175.425 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.31 7.8 p-10 -70.87 -38.28 73.09 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.523 1.965 . . . . 35.549999999999997 112.084 175.825 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -73.44 -35.41 65.77 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.6 2.36 . . . . 20.52 110.379 -176.469 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -69.12 116.93 10.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.54 2.736 . . . . 7.1299999999999999 110.781 169.319 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -110.76 129.12 55.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 128.612 3.695 . . . . 36.390000000000001 111.692 165.628 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 tp -116.45 133.37 56.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.408 -1.433 . . . . 9.5500000000000007 109.843 -172.691 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 74.5 mt -127.08 130.13 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 116.664 -3.772 . . . . 13.9 109.383 -175.108 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -89.87 -58.59 2.46 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 123.121 2.691 . . . . 6.8600000000000003 115.492 172.634 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -124.4 -73.94 0.63 Allowed 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 125.19 1.396 . . . . 11.15 107.684 -178.608 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -120.25 -64.16 0.26 Allowed Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 117.206 -2.426 . . . . 13.93 111.108 -173.569 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.275 17.6 ptmt -67.04 168.0 10.84 Favored 'General case' 0 N--CA 1.429 -1.491 2 CA-C-O 128.924 4.202 . . . . 23.920000000000002 113.496 171.961 . . . . . . . . 3 2 . 1 . 079 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -86.12 145.68 26.92 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.175 -2.739 . . . . 23.23 113.692 172.922 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -80.74 137.97 36.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 120.093 -1.629 . . . . 9.1099999999999994 107.793 -178.054 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -102.6 145.84 29.05 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 129.081 2.953 . . . . 33.439999999999998 107.884 -170.525 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -39.36 -73.97 0.04 OUTLIER 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 119.77 3.248 . . . . 28.370000000000001 119.77 -174.692 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.02 17.52 41.28 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 129.073 3.225 . . . . 15.0 111.808 -164.16 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 -96.4 163.66 12.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 119.687 -2.066 . . . . 25.5 105.46 173.395 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.9 p -101.55 163.89 12.04 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.42 -2.437 . . . . 11.949999999999999 104.42 -179.577 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 mt -60.37 -26.46 66.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.358 -1.292 . . . . 10.17 114.424 162.592 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 t -65.93 -35.62 81.12 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 123.49 0.716 . . . . 13.59 111.895 168.421 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -60.8 -34.09 73.97 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 116.045 -4.159 . . . . 11.699999999999999 120.201 175.168 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -92.37 -22.26 19.78 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.476 -3.265 . . . . 12.949999999999999 105.79 -178.267 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.8 m120 71.89 75.44 0.17 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 128.5 2.72 . . . . 25.449999999999999 108.91 -177.563 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.2 mt -115.56 126.8 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 O-C-N 125.557 1.786 . . . . 14.6 106.637 -175.34 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -126.94 -178.79 4.54 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 120.398 -1.439 . . . . 33.229999999999997 109.323 179.848 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -66.61 156.06 36.13 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.948 2.309 . . . . 25.969999999999999 115.768 -168.231 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.291 46.7 mt-10 58.21 42.22 22.32 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.435 2.754 . . . . 32.609999999999999 118.435 -171.202 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.1 m -116.84 132.82 56.6 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 106.069 -1.826 . . . . 10.56 106.069 -175.759 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.6 m -84.09 140.41 31.82 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.984 -2.947 . . . . 5.3300000000000001 114.183 173.262 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -125.04 165.57 17.94 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.135 2.574 . . . . 11.66 110.096 174.344 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.1 m170 -110.27 104.4 13.2 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 116.271 1.952 . . . . 16.300000000000001 116.271 176.294 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.6 tp -73.06 118.74 16.38 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 123.876 0.735 . . . . 9.9600000000000009 110.236 165.817 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 m -129.64 155.53 41.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 105.592 -2.003 . . . . 9.7599999999999998 105.592 176.254 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 71' ' ' LEU . 17.9 mt -112.0 169.31 8.94 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 103.539 -2.763 . . . . 19.57 103.539 -166.558 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.3 ttp180 -84.1 123.55 30.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.335 -1.302 . . . . 35.079999999999998 114.073 -178.9 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.0 mt -93.86 -72.48 0.61 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 101.16 -3.644 . . . . 32.310000000000002 101.16 -175.858 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -121.13 -51.56 2.1 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.267 1.984 . . . . 42.75 109.235 170.351 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 149.42 151.3 5.45 Favored Glycine 0 N--CA 1.43 -1.758 0 N-CA-C 105.362 -3.095 . . . . 36.310000000000002 105.362 174.569 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.745 0 C-N-CA 118.595 -1.764 . . . . 36.270000000000003 111.51 174.787 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ptt? . . . . . 0 CA--C 1.49 -1.336 0 CA-C-O 124.582 2.134 . . . . 17.170000000000002 108.851 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -99.03 132.7 44.15 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 116.585 -3.822 . . . . 21.890000000000001 113.089 -169.551 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 pt -120.46 154.5 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.08 -1.013 . . . . 10.83 110.331 175.661 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -124.52 125.01 43.51 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 120.073 -1.642 . . . . 10.609999999999999 106.706 -174.315 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.476 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 22.7 t -109.54 102.56 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 124.46 2.076 . . . . 9.1300000000000008 110.335 -178.229 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -83.61 126.28 32.68 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 127.284 3.421 . . . . 20.550000000000001 116.311 172.725 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.6 p -78.96 174.31 11.66 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 124.928 2.299 . . . . 11.779999999999999 112.612 -175.745 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.48 HD13 HG12 ' A' ' 70' ' ' VAL . 12.5 tp -75.6 -36.23 60.36 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.61 -2.556 . . . . 19.309999999999999 109.889 -177.018 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -61.68 -37.63 84.82 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.076 -3.515 . . . . 23.140000000000001 116.678 170.519 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.36 43.28 0.6 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 120.227 1.376 . . . . 19.739999999999998 111.066 174.546 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -111.18 151.17 28.52 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.611 1.708 . . . . 21.93 115.611 161.911 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.3 m -97.36 115.51 27.85 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 120.214 -1.554 . . . . 12.33 113.568 171.577 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.476 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 10.0 mt -93.04 92.18 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 126.366 2.984 . . . . 17.079999999999998 111.165 170.699 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.3 m -82.91 105.22 13.73 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 112.551 -2.113 . . . . 16.300000000000001 113.122 -173.956 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.86 158.38 17.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 103.738 -2.69 . . . . 15.880000000000001 103.738 -169.938 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -110.97 133.29 53.5 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.395 -2.69 . . . . 28.899999999999999 108.437 164.146 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.92 169.15 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 103.006 -2.961 . . . . 12.050000000000001 103.006 -171.502 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.48 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 73.7 mm-40 -100.88 174.15 3.16 Favored Pre-proline 0 N--CA 1.429 -1.485 1 O-C-N 114.432 -5.168 . . . . 18.170000000000002 104.14 165.882 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 18' ' ' GLU . 69.2 Cg_endo -78.29 -15.3 14.34 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 CA-C-N 123.239 2.192 . . . . 8.1600000000000001 116.133 168.937 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.7 p -77.91 -5.46 51.16 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.57 2.348 . . . . 11.130000000000001 114.688 176.366 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -70.84 148.25 48.04 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.588 -3.82 . . . . 18.030000000000001 112.456 178.428 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.9 p -93.0 148.01 22.35 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 129.477 4.236 . . . . 10.220000000000001 108.644 178.134 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.8 mm -52.21 -32.49 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 125.781 2.705 . . . . 12.300000000000001 116.144 173.144 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -67.61 -39.18 84.74 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 116.617 -3.802 . . . . 36.509999999999998 113.106 174.742 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -78.64 -6.76 56.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 114.483 -2.887 . . . . 25.66 110.548 -179.665 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.3 t -86.56 -43.59 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 C-N-CA 130.762 3.625 . . . . 8.1199999999999992 110.026 171.806 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -51.25 -33.27 27.51 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.36 -3.338 . . . . 15.470000000000001 119.093 161.4 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.7 -19.04 63.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.327 -2.108 . . . . 11.449999999999999 114.407 177.849 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -78.89 -39.98 33.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 107.364 -1.347 . . . . 24.98 107.364 174.117 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.6 mt -74.36 -40.48 49.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 O-C-N 119.742 -1.849 . . . . 9.4600000000000009 107.965 -176.652 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -54.1 -45.44 71.82 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.99 -2.944 . . . . 14.76 110.714 173.014 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -64.81 -52.64 55.73 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.749 -1.844 . . . . 26.289999999999999 111.081 -176.65 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.58 -66.96 0.54 Allowed 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.102 2.26 . . . . 30.059999999999999 117.102 -176.393 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -67.47 -49.73 62.25 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 126.507 2.379 . . . . 25.190000000000001 113.334 -172.174 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.85 13.34 16.39 Favored Glycine 0 N--CA 1.43 -1.753 0 CA-C-N 113.22 -1.809 . . . . 7.4100000000000001 115.387 178.49 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.1 mt -89.08 127.15 56.62 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 126.926 2.091 . . . . 9.4900000000000002 108.801 -171.559 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -67.71 139.37 48.02 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 CA-C-O 116.192 -1.67 . . . . 11.42 113.397 -177.878 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -73.34 -14.57 25.37 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 CA-C-N 124.253 2.554 . . . . 12.0 118.301 -166.371 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -35.94 63.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 120.374 1.443 . . . . 35.549999999999997 111.299 172.172 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -59.55 -41.13 89.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 117.061 2.245 . . . . 20.52 117.061 166.688 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -63.65 117.53 6.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.904 3.282 . . . . 7.1299999999999999 109.375 -176.031 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.414 ' HB3' HG23 ' A' ' 70' ' ' VAL . 27.3 ttm180 -116.88 101.25 8.37 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 118.054 -2.904 . . . . 36.390000000000001 104.649 176.429 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.6 tp -96.43 115.33 27.26 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.749 3.219 . . . . 9.5500000000000007 108.95 -172.32 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 76.6 mt -114.97 154.38 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 C-N-CA 128.928 2.891 . . . . 13.9 110.761 -171.391 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -96.89 -91.4 0.24 Allowed 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 116.58 -1.676 . . . . 6.8600000000000003 106.622 174.264 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.54 -75.46 0.6 Allowed 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 126.183 2.177 . . . . 11.15 106.019 178.786 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -105.95 -32.57 3.77 Favored Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 109.347 -3.57 . . . . 13.93 117.407 -175.062 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.27 8.2 ptpt -99.08 152.08 20.24 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 126.758 3.17 . . . . 23.920000000000002 116.869 173.083 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -88.89 133.5 34.27 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.852 -2.405 . . . . 23.23 113.014 171.557 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.8 mt -89.82 123.71 34.03 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.343 -1.473 . . . . 9.1099999999999994 110.973 -176.485 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -95.62 138.48 33.23 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.302 2.241 . . . . 33.439999999999998 107.562 -169.174 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -34.27 -49.89 0.39 Allowed 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.843 3.657 . . . . 28.370000000000001 120.668 -168.869 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.55 -8.46 59.63 Favored Glycine 0 N--CA 1.431 -1.684 0 O-C-N 119.899 -1.751 . . . . 15.0 115.657 -164.453 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -83.59 154.38 23.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.864 -2.551 . . . . 25.5 108.43 -175.903 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -89.27 166.77 13.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.839 1.781 . . . . 11.949999999999999 115.312 176.759 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -61.47 -31.6 71.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 118.976 2.954 . . . . 10.17 118.976 169.71 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -61.12 -30.71 70.53 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.032 2.133 . . . . 13.59 115.33 163.325 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -72.02 -42.86 65.89 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.865 1.793 . . . . 11.699999999999999 110.82 174.41 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -83.31 -17.04 43.85 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 117.796 2.517 . . . . 12.949999999999999 117.796 -174.612 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 28.0 m120 78.52 45.96 0.06 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 131.0 3.72 . . . . 25.449999999999999 109.941 -179.005 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -83.06 123.91 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.413 -2.679 . . . . 14.6 105.78 167.605 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -112.42 -157.07 0.61 Allowed 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 104.861 -2.274 . . . . 33.229999999999997 104.861 -179.382 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.6 pttm -85.32 153.23 22.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.097 1.147 . . . . 25.969999999999999 114.097 -178.826 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 57.03 34.11 24.41 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.526 -3.234 . . . . 32.609999999999999 111.749 -176.747 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -77.88 138.85 39.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.077 -1.083 . . . . 10.56 108.077 -178.288 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.5 m -98.93 118.79 36.5 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 107.437 -1.32 . . . . 5.3300000000000001 107.437 167.801 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.7 mt -106.36 176.41 5.18 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 123.386 0.674 . . . . 11.66 109.992 169.994 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -136.55 135.91 38.87 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 103.577 -2.749 . . . . 16.300000000000001 103.577 -168.444 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.4 tp -117.17 119.97 36.86 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 116.967 -3.583 . . . . 9.9600000000000009 108.42 173.28 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.48 HG12 HD13 ' A' ' 8' ' ' LEU . 27.9 m -116.9 166.97 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 124.734 2.207 . . . . 9.7599999999999998 110.055 163.091 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt -106.72 124.5 49.7 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 120.211 -1.556 . . . . 19.57 108.992 179.673 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -58.2 108.34 0.59 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.841 1.793 . . . . 35.079999999999998 115.841 178.908 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.3 mt -86.02 -145.75 0.11 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.275 -2.141 . . . . 32.310000000000002 111.68 167.074 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.5 mmt180 -124.31 96.77 5.04 Favored 'General case' 0 N--CA 1.43 -1.442 1 C-N-CA 133.614 4.766 . . . . 42.75 108.376 -167.547 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -178.22 -121.73 0.71 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 105.074 -3.21 . . . . 36.310000000000002 105.074 -168.33 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.751 0 CA-C-O 115.672 -2.738 . . . . 36.270000000000003 114.904 179.47 . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HB2' ' HB3' ' A' ' 63' ' ' LYS . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 121.271 0.558 . . . . 17.170000000000002 111.406 . . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -77.69 126.47 30.93 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 116.593 -3.817 . . . . 21.890000000000001 112.39 -173.614 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -115.19 139.45 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 119.369 0.986 . . . . 10.83 110.569 168.601 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -99.91 109.13 21.51 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 125.568 2.604 . . . . 10.609999999999999 111.555 179.282 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.8 t -92.03 105.82 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 O-C-N 119.576 -1.953 . . . . 9.1300000000000008 106.195 175.411 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.281 71.8 mttt -86.3 138.08 32.11 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.974 1.102 . . . . 20.550000000000001 113.974 -179.867 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.273 8.7 p -99.93 176.05 5.56 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.516 -3.24 . . . . 11.779999999999999 112.702 -167.89 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.278 27.7 tp -71.58 -55.6 7.47 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.424 3.489 . . . . 19.309999999999999 115.158 -174.453 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.414 67.6 p -56.53 -63.3 1.24 Allowed 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.059 -1.65 . . . . 23.140000000000001 113.727 165.142 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.64 60.49 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.724 0 N-CA-C 122.502 3.761 . . . . 19.739999999999998 122.502 -177.979 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.15 166.51 13.85 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.753 -3.204 . . . . 21.93 105.882 175.543 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -117.51 130.24 56.3 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.036 2.236 . . . . 12.33 117.036 158.678 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 77.8 mt -101.37 112.05 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 117.373 -1.731 . . . . 17.079999999999998 110.027 175.214 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.272 90.6 m -93.57 115.36 27.84 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.891 -3.631 . . . . 16.300000000000001 110.99 177.768 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.28 50.9 mt -119.42 134.37 55.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 106.737 -1.579 . . . . 15.880000000000001 106.737 -173.455 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -96.94 94.68 7.34 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 129.918 3.287 . . . . 28.899999999999999 109.038 -179.53 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.9 m -119.45 159.2 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 118.01 -2.931 . . . . 12.050000000000001 105.477 -169.133 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -113.87 155.85 44.64 Favored Pre-proline 0 N--CA 1.43 -1.445 0 O-C-N 116.556 -3.84 . . . . 18.170000000000002 106.959 171.351 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.306 69.2 Cg_endo -65.54 -9.61 23.16 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 C-N-CA 125.153 3.902 . . . . 8.1600000000000001 121.387 -164.203 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 m -94.61 -11.37 29.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 120.359 -1.463 . . . . 11.130000000000001 113.676 -179.612 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -64.22 143.52 57.82 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 127.158 2.183 . . . . 18.030000000000001 113.902 171.743 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.3 p -93.49 165.12 12.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.523 -1.361 . . . . 10.220000000000001 110.266 -166.464 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.5 mm -66.91 -31.57 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 115.878 1.807 . . . . 12.300000000000001 115.878 171.235 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -49.51 -48.02 48.41 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.111 1.507 . . . . 36.509999999999998 113.39 166.766 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -81.11 -16.26 53.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 114.283 -1.326 . . . . 25.66 109.177 -178.375 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.9 t -76.81 -47.01 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-N 123.358 2.799 . . . . 8.1199999999999992 109.924 173.722 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.9 mtpt -50.68 -38.52 47.19 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.289 2.235 . . . . 15.470000000000001 114.375 174.365 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.309 . . -62.53 -37.17 85.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.253 -2.308 . . . . 11.449999999999999 112.757 173.325 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -67.9 -49.06 64.09 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 120.382 1.446 . . . . 24.98 112.662 175.443 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -63.99 -36.86 78.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 O-C-N 115.978 -4.201 . . . . 9.4600000000000009 107.99 -179.096 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -61.43 -38.34 86.81 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.151 -3.468 . . . . 14.76 115.569 174.305 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -72.95 -43.51 62.24 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.242 1.942 . . . . 26.289999999999999 116.242 178.655 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -64.41 -69.86 0.26 Allowed 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 120.847 3.647 . . . . 30.059999999999999 120.847 175.512 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -94.28 -2.56 52.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.068 -1.645 . . . . 25.190000000000001 111.966 -175.845 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.99 41.65 87.05 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-N 122.411 2.369 . . . . 7.4100000000000001 118.215 -178.302 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.9 mm -106.28 107.87 60.69 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 114.416 -2.707 . . . . 9.4900000000000002 108.972 -178.053 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.18 144.98 78.93 Favored 'Trans proline' 0 N--CA 1.434 -2.011 0 CA-C-N 123.466 2.273 . . . . 11.42 117.319 177.165 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -70.34 -13.19 32.96 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 C-N-CA 123.67 2.913 . . . . 12.0 112.0 -166.875 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -85.87 -9.38 57.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 129.839 3.255 . . . . 35.549999999999997 107.863 179.016 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -107.07 -15.45 14.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.53 -1.356 . . . . 20.52 114.413 171.088 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -81.47 99.26 8.66 Favored 'General case' 0 N--CA 1.429 -1.499 0 O-C-N 117.613 -3.179 . . . . 7.1299999999999999 113.867 -179.258 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 72' ' ' ARG . 44.5 ttt-85 -91.88 107.1 18.97 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.685 -3.135 . . . . 36.390000000000001 107.011 170.56 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.4 mt -98.9 134.47 41.72 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 105.742 -1.947 . . . . 9.5500000000000007 105.742 -177.685 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.5 mm -123.39 132.91 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 130.257 3.423 . . . . 13.9 110.458 -179.522 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -107.98 112.06 24.45 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.536 -2.602 . . . . 6.8600000000000003 106.62 158.372 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.35 -86.84 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.447 1 C-N-CA 131.927 4.091 . . . . 11.15 109.276 178.712 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -138.14 16.67 3.42 Favored Glycine 0 N--CA 1.43 -1.742 1 O-C-N 115.396 -4.565 . . . . 13.93 111.801 162.441 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.255 88.7 mttt -87.17 122.53 31.1 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 120.848 2.324 . . . . 23.920000000000002 111.105 172.988 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -84.86 106.48 16.42 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 121.099 1.772 . . . . 23.23 108.165 178.377 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.8 mt -63.35 139.48 58.78 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.52 2.328 . . . . 9.1099999999999994 109.732 -174.015 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -100.35 140.74 34.16 Favored 'General case' 0 N--CA 1.43 -1.474 1 C-N-CA 131.735 4.014 . . . . 33.439999999999998 111.907 -175.785 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -54.88 -54.01 48.07 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.133 2.573 . . . . 28.370000000000001 113.661 -168.49 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.32 7.12 61.66 Favored Glycine 0 N--CA 1.43 -1.751 0 C-N-CA 129.86 3.6 . . . . 15.0 114.978 -173.73 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -107.82 170.46 7.97 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.823 -1.177 . . . . 25.5 107.823 176.603 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.0 p -110.07 172.37 6.9 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.772 2.701 . . . . 11.949999999999999 115.877 -174.672 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.401 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 14.1 mt -59.2 -48.43 81.63 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.985 -2.947 . . . . 10.17 112.988 162.791 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.6 p -58.49 -23.18 57.22 Favored 'General case' 0 N--CA 1.43 -1.451 1 N-CA-C 123.196 4.517 . . . . 13.59 123.196 173.17 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.313 15.6 t70 -74.16 -50.47 19.19 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.741 -2.475 . . . . 11.699999999999999 110.989 177.106 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -73.62 -21.62 60.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.188 1.921 . . . . 12.949999999999999 116.188 177.92 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 67.8 m-20 80.78 47.93 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 127.958 3.742 . . . . 25.449999999999999 114.071 -176.604 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 87.7 mt -77.88 134.97 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.29 -2.756 . . . . 14.6 108.37 168.976 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -121.14 -158.11 0.75 Allowed 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 125.296 1.622 . . . . 33.229999999999997 108.57 176.525 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 1' ' ' MET . 7.2 ptmm? -77.67 158.72 29.57 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.984 3.278 . . . . 25.969999999999999 113.334 170.814 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 64.91 24.69 12.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.032 -2.293 . . . . 32.609999999999999 109.333 168.658 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -91.35 148.51 22.28 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.031 -2.293 . . . . 10.56 109.62 -170.02 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -102.86 120.83 41.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 119.986 -1.696 . . . . 5.3300000000000001 109.156 173.921 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.28 160.27 16.27 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 102.932 -2.988 . . . . 11.66 102.932 174.025 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.6 m80 -122.54 134.18 54.55 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.026 -4.171 . . . . 16.300000000000001 105.332 179.395 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.6 tp -100.52 129.93 46.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 128.613 3.696 . . . . 9.9600000000000009 105.663 167.788 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.7 m -128.66 168.32 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 101.833 -3.395 . . . . 9.7599999999999998 101.833 175.575 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.8 tp -88.8 126.21 35.25 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.403 2.371 . . . . 19.57 117.403 -176.151 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.491 ' HB2' ' HB2' ' A' ' 42' ' ' ARG . 53.5 ttt180 -87.6 136.35 32.98 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 113.573 0.953 . . . . 35.079999999999998 113.573 -171.132 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.3 mt -110.86 134.32 52.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.38 2.672 . . . . 32.310000000000002 106.106 174.996 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -82.8 164.06 20.83 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 124.699 2.19 . . . . 42.75 116.109 173.441 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 138.29 -86.53 0.22 Allowed Glycine 0 N--CA 1.43 -1.703 0 CA-C-N 110.364 -3.107 . . . . 36.310000000000002 107.505 -151.879 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.756 0 N-CA-C 108.213 -1.955 . . . . 36.270000000000003 108.213 177.291 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptt? . . . . . 0 CA--C 1.489 -1.387 0 CA-C-O 124.832 2.254 . . . . 17.170000000000002 113.517 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -105.46 148.39 27.24 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 117.649 -3.157 . . . . 21.890000000000001 106.38 179.405 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.1 pt -130.27 153.84 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 104.286 -2.487 . . . . 10.83 104.286 172.64 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -109.21 113.77 26.9 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 113.881 -1.509 . . . . 10.609999999999999 110.75 173.574 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -95.5 110.83 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 N-CA-C 108.294 -1.002 . . . . 9.1300000000000008 108.294 170.599 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 mttm -102.57 142.71 33.3 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 122.46 1.124 . . . . 20.550000000000001 113.06 -176.334 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.1 p -87.43 174.65 8.39 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 110.779 -2.919 . . . . 11.779999999999999 114.816 175.522 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.6 tp -67.32 -49.75 62.9 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.538 -2.601 . . . . 19.309999999999999 115.027 167.957 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.8 p -69.89 -46.09 66.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 120.769 1.622 . . . . 23.140000000000001 112.41 176.914 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.36 54.25 0.13 Allowed Glycine 0 N--CA 1.429 -1.767 0 O-C-N 119.7 -1.875 . . . . 19.739999999999998 108.523 173.589 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.26 132.41 54.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 125.497 1.519 . . . . 21.93 112.059 159.023 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.8 m -99.25 112.71 24.81 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 121.12 1.782 . . . . 12.33 111.842 178.378 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.3 mt -85.98 109.22 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 103.269 -2.863 . . . . 17.079999999999998 103.269 176.314 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.2 m -104.08 101.02 10.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.016 -1.476 . . . . 16.300000000000001 107.016 -175.185 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.0 mt -97.93 131.59 44.25 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.719 1.748 . . . . 15.880000000000001 115.719 173.412 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -75.75 124.35 27.12 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.578 2.132 . . . . 28.899999999999999 105.997 160.999 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -143.1 169.33 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 104.701 -2.333 . . . . 12.050000000000001 104.701 -179.988 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -104.49 152.3 39.33 Favored Pre-proline 0 N--CA 1.43 -1.444 0 C-N-CA 124.093 0.957 . . . . 18.170000000000002 112.67 155.009 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -63.74 -9.95 20.52 Favored 'Trans proline' 0 N--CA 1.434 -2.005 1 C-N-CA 127.248 5.299 . . . . 8.1600000000000001 113.124 -179.378 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.5 m -90.93 -7.76 51.22 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.645 1.72 . . . . 11.130000000000001 115.645 170.429 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 64.3 m-20 -67.31 159.79 28.53 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 123.709 1.719 . . . . 18.030000000000001 114.328 174.011 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.326 71.1 p -86.83 168.9 13.04 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.869 -1.144 . . . . 10.220000000000001 114.035 -177.398 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.426 ' O ' ' HB ' ' A' ' 26' ' ' VAL . 29.1 mm -60.61 -36.29 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 119.219 -2.176 . . . . 12.300000000000001 115.504 158.311 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -57.47 -33.75 68.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 126.837 3.208 . . . . 36.509999999999998 114.61 171.961 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -79.76 -23.98 41.84 Favored 'General case' 0 N--CA 1.43 -1.468 1 O-C-N 113.537 -5.727 . . . . 25.66 111.154 179.547 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.426 ' HB ' ' O ' ' A' ' 23' ' ' ILE . 55.2 t -69.11 -51.46 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 115.485 -0.779 . . . . 8.1199999999999992 112.736 168.458 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -56.62 -31.76 64.64 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.92 1.688 . . . . 15.470000000000001 112.815 178.448 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.33 -33.47 75.32 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 121.901 2.137 . . . . 11.449999999999999 114.457 176.9 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -80.09 -31.12 39.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.747 2.689 . . . . 24.98 112.485 178.321 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -66.28 -38.11 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 1 O-C-N 115.538 -4.477 . . . . 9.4600000000000009 110.59 171.399 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -69.7 -29.94 67.47 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.585 -3.197 . . . . 14.76 119.152 171.268 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -76.24 -57.6 3.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.401 1.572 . . . . 26.289999999999999 113.286 171.336 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -78.1 -66.96 0.78 Allowed 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 115.114 -4.742 . . . . 30.059999999999999 109.567 -167.155 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -72.03 -38.71 69.5 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 125.981 2.8 . . . . 25.190000000000001 116.848 -175.084 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.04 43.12 2.28 Favored Glycine 0 N--CA 1.43 -1.739 0 O-C-N 118.968 -2.333 . . . . 7.4100000000000001 114.952 178.796 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.4 mm -98.66 117.25 64.8 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 112.786 -3.483 . . . . 9.4900000000000002 111.073 -179.792 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -68.27 165.11 29.82 Favored 'Trans proline' 0 C--N 1.3 -1.998 0 CA-C-N 125.207 2.895 . . . . 11.42 114.8 -177.553 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -79.34 -28.17 3.83 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 CA-C-N 121.791 1.675 . . . . 12.0 112.737 -153.84 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.4 p-10 -79.55 -30.65 41.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 127.513 3.008 . . . . 35.549999999999997 107.251 177.191 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -74.0 -16.65 61.06 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 117.238 -3.414 . . . . 20.52 112.222 -178.314 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -86.68 118.6 26.2 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.145 2.402 . . . . 7.1299999999999999 112.815 176.714 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 44.0 ttt180 -108.22 125.81 52.08 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.515 -3.143 . . . . 36.390000000000001 102.515 160.665 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 79.6 mt -102.03 123.82 46.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 110.999 -2.818 . . . . 9.5500000000000007 106.391 168.035 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.6 mm -121.62 140.83 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 N-CA-C 100.975 -3.713 . . . . 13.9 100.975 -173.266 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -126.72 122.77 35.81 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 116.323 -1.799 . . . . 6.8600000000000003 106.773 165.053 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.67 -92.28 0.03 OUTLIER 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 120.785 1.63 . . . . 11.15 112.383 -164.478 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.67 -7.28 5.73 Favored Glycine 0 N--CA 1.431 -1.678 0 C-N-CA 127.659 2.552 . . . . 13.93 109.394 -179.305 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -103.52 119.79 39.59 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 118.497 2.777 . . . . 23.920000000000002 118.497 -166.874 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -69.43 112.19 5.79 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 114.668 1.359 . . . . 23.23 114.668 -178.621 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.2 mt -80.46 112.14 17.53 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.562 0.696 . . . . 9.1099999999999994 112.017 -179.862 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -85.94 168.48 14.13 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.409 2.684 . . . . 33.439999999999998 109.83 -170.808 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -70.62 -46.86 62.54 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 113.359 -5.838 . . . . 28.370000000000001 115.351 -165.441 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.63 32.0 6.68 Favored Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 126.922 2.201 . . . . 15.0 116.418 -168.607 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 64.8 mtt-85 -130.68 159.09 38.26 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.594 -3.484 . . . . 25.5 101.594 -177.771 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.9 p -87.8 156.79 19.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 131.511 3.925 . . . . 11.949999999999999 111.815 174.046 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.86 -28.78 68.61 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.016 -1.447 . . . . 10.17 111.612 178.843 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.291 68.8 p -59.28 -36.58 75.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.03 2.233 . . . . 13.59 117.03 165.972 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -81.93 -29.3 32.35 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.686 -4.384 . . . . 11.699999999999999 106.158 -170.816 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -72.86 -20.79 61.05 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 121.187 3.773 . . . . 12.949999999999999 121.187 160.874 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.389 15.6 m120 70.86 34.65 1.91 Allowed 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.386 -2.071 . . . . 25.449999999999999 112.892 -174.479 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.8 mt -88.46 132.21 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 101.42 -3.548 . . . . 14.6 101.42 171.859 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.271 81.9 mt-30 -98.53 175.22 6.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 109.864 -3.335 . . . . 33.229999999999997 114.869 174.211 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.0 pttm -45.71 137.73 5.14 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.549 2.74 . . . . 25.969999999999999 111.963 160.467 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 60.04 24.34 13.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 117.915 2.561 . . . . 32.609999999999999 117.915 177.466 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -78.08 154.22 31.54 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.215 -2.178 . . . . 10.56 106.408 -168.049 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.4 m -98.0 108.71 21.47 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 117.246 -1.359 . . . . 5.3300000000000001 111.975 173.277 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -100.07 158.2 16.01 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 125.114 1.509 . . . . 11.66 109.457 175.781 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -121.71 130.86 53.74 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.115 -2.241 . . . . 16.300000000000001 113.079 -178.167 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.3 tp -87.55 100.8 13.05 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.314 3.046 . . . . 9.9600000000000009 110.928 169.402 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.1 t -96.94 120.26 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.99 -1.694 . . . . 9.7599999999999998 113.031 174.05 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.6 tp -75.57 116.13 15.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.541 -3.849 . . . . 19.57 108.655 -175.797 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.274 9.2 ttt180 -101.58 152.58 20.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 126.82 2.048 . . . . 35.079999999999998 112.515 -174.281 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.276 7.6 tp -89.64 163.39 15.17 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.27 2.628 . . . . 32.310000000000002 116.203 173.385 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ptp180 -88.54 141.72 28.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.807 -1.808 . . . . 42.75 110.958 167.815 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.52 57.74 3.79 Favored Glycine 0 N--CA 1.429 -1.801 0 O-C-N 119.87 -1.769 . . . . 36.310000000000002 113.081 -165.585 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.78 0 O-C-N 121.231 -1.158 . . . . 36.270000000000003 114.687 -168.924 . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 117.664 2.468 . . . . 17.170000000000002 117.664 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -91.71 134.75 34.44 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 126.243 2.925 . . . . 21.890000000000001 113.688 179.971 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.4 pt -121.69 161.86 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 O-C-N 117.422 -3.299 . . . . 10.83 112.83 172.763 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -111.33 116.59 31.24 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 123.694 0.621 . . . . 10.609999999999999 111.589 179.806 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.6 HG21 HD12 ' A' ' 15' ' ' LEU . 15.5 t -103.56 108.6 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 118.728 -2.482 . . . . 9.1300000000000008 107.924 -175.383 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -97.5 119.96 37.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.41 2.052 . . . . 20.550000000000001 110.689 -172.108 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.554 ' HA ' ' HB3' ' A' ' 69' ' ' LEU . 2.2 p -76.66 175.35 9.41 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.568 -1.197 . . . . 11.779999999999999 111.931 -173.803 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.04 -40.52 75.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 124.219 1.961 . . . . 19.309999999999999 112.869 175.796 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.1 p -76.91 -21.14 55.34 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 127.483 2.313 . . . . 23.140000000000001 114.538 177.33 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.51 26.81 2.77 Favored Glycine 0 N--CA 1.43 -1.744 0 C-N-CA 118.956 -1.592 . . . . 19.739999999999998 110.069 153.403 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -83.6 139.06 33.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 116.831 -1.556 . . . . 21.93 111.487 178.329 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -93.34 105.34 17.42 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 122.339 2.336 . . . . 12.33 109.837 168.161 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.18 119.94 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 125.013 2.339 . . . . 17.079999999999998 106.886 176.249 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.7 m -81.14 115.71 20.7 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.845 -2.409 . . . . 16.300000000000001 109.216 169.683 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.6 HD12 HG21 ' A' ' 5' ' ' VAL . 64.9 mt -123.41 144.65 49.35 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 113.186 -5.946 . . . . 15.880000000000001 106.922 177.361 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -89.99 108.78 19.93 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.051 1.74 . . . . 28.899999999999999 115.136 167.835 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.2 m -113.85 155.92 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 114.655 -1.157 . . . . 12.050000000000001 108.915 -179.412 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -109.06 152.4 42.47 Favored Pre-proline 0 N--CA 1.43 -1.47 0 N-CA-C 101.081 -3.674 . . . . 18.170000000000002 101.081 163.148 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -65.83 -23.39 55.34 Favored 'Trans proline' 0 C--N 1.299 -2.028 1 C-N-CA 126.271 4.647 . . . . 8.1600000000000001 112.34 -172.991 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.5 m -90.61 1.73 56.51 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.795 -3.066 . . . . 11.130000000000001 110.731 179.179 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -78.96 161.22 26.82 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 123.572 2.897 . . . . 18.030000000000001 104.177 175.374 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.0 p -108.03 167.36 10.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.803 -1.925 . . . . 10.220000000000001 105.803 -168.062 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.4 mm -74.62 -34.51 35.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 C-N-CA 128.921 2.888 . . . . 12.300000000000001 104.662 -171.587 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -56.87 -38.55 72.91 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 115.846 -4.284 . . . . 36.509999999999998 119.428 169.933 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -70.6 -19.3 62.85 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 113.006 -1.906 . . . . 25.66 114.839 169.916 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.1 t -79.14 -37.31 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 118.048 -1.461 . . . . 8.1199999999999992 110.948 175.884 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -67.96 -30.31 69.57 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 130.575 3.55 . . . . 15.470000000000001 111.033 176.568 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.69 -41.84 36.63 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.874 -2.391 . . . . 11.449999999999999 111.771 -175.755 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -61.21 -34.23 74.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.102 -2.874 . . . . 24.98 113.546 170.304 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.299 65.9 mt -65.17 -39.8 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 O-C-N 125.532 1.77 . . . . 9.4600000000000009 115.701 169.531 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -57.64 -53.41 58.51 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 116.728 -3.733 . . . . 14.76 112.541 173.78 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -67.83 -44.82 76.33 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.112 -2.313 . . . . 26.289999999999999 115.68 -177.6 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -83.02 -50.22 8.75 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.088 -1.434 . . . . 30.059999999999999 113.985 -178.678 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -94.76 -55.64 3.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 125.134 2.397 . . . . 25.190000000000001 111.438 -176.655 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.64 40.74 2.47 Favored Glycine 0 N--CA 1.43 -1.737 0 C-N-CA 118.559 -1.781 . . . . 7.4100000000000001 117.141 -176.512 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.1 mm -90.04 131.17 39.87 Favored Pre-proline 0 N--CA 1.429 -1.481 0 O-C-N 118.275 -2.897 . . . . 9.4900000000000002 109.006 167.778 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -67.93 144.21 63.61 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 128.101 3.929 . . . . 11.42 118.298 -174.58 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -81.61 -3.59 11.96 Favored 'Trans proline' 0 N--CA 1.434 -2.017 0 C-N-CA 124.082 3.188 . . . . 12.0 114.639 -163.502 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -78.83 -23.57 45.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.066 -1.646 . . . . 35.549999999999997 115.428 165.661 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -89.53 -24.18 21.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 126.35 1.86 . . . . 20.52 111.234 -179.754 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 -78.8 96.63 5.67 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.195 -2.191 . . . . 7.1299999999999999 109.951 -173.177 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -109.28 127.05 53.98 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.408 -2.441 . . . . 36.390000000000001 104.408 171.706 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.571 ' HB3' HD12 ' A' ' 50' ' ' LEU . 14.8 mt -107.28 127.26 53.39 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 116.871 -1.538 . . . . 9.5500000000000007 108.672 -168.368 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 51.7 mm -117.92 137.79 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 125.323 1.639 . . . . 13.9 109.14 179.404 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -131.42 127.59 37.76 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 125.211 3.642 . . . . 6.8600000000000003 106.736 155.951 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.75 -106.89 0.35 Allowed 'General case' 0 N--CA 1.429 -1.482 1 C-N-CA 132.203 4.201 . . . . 11.15 113.649 -171.759 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.32 6.2 19.13 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.118 -2.239 . . . . 13.93 109.267 -177.761 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -122.4 142.1 50.89 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 116.068 -4.196 . . . . 23.920000000000002 107.989 -174.194 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -76.26 137.55 40.01 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.22 -1.355 . . . . 23.23 110.594 175.093 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.571 HD12 ' HB3' ' A' ' 43' ' ' LEU . 40.5 mt -86.04 112.85 21.63 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 115.0 -1.0 . . . . 9.1099999999999994 111.01 179.845 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -88.3 137.57 32.21 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 128.127 3.822 . . . . 33.439999999999998 109.907 -178.442 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.32 -62.44 1.48 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 110.023 -3.262 . . . . 28.370000000000001 116.372 -164.054 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.7 19.4 37.33 Favored Glycine 0 N--CA 1.43 -1.705 0 O-C-N 117.735 -3.103 . . . . 15.0 114.077 -171.73 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.7 mtt-85 -92.38 171.08 9.28 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.452 2.019 . . . . 25.5 116.452 166.348 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.8 p -98.38 161.23 13.79 Favored 'General case' 0 N--CA 1.43 -1.459 1 CA-C-O 128.569 4.033 . . . . 11.949999999999999 110.269 178.856 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.325 5.5 mp -68.8 -36.99 78.96 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 111.362 -2.654 . . . . 10.17 110.604 172.377 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.8 p -50.92 -39.57 54.88 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.132 2.271 . . . . 13.59 117.132 162.865 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -68.9 -29.37 67.63 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 116.127 1.899 . . . . 11.699999999999999 116.127 -177.369 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -94.58 0.73 55.43 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.783 2.433 . . . . 12.949999999999999 115.382 178.002 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.4 m120 68.05 33.0 4.73 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 114.299 -1.319 . . . . 25.449999999999999 113.701 -179.733 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.255 86.5 mt -78.47 116.4 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 124.848 1.259 . . . . 14.6 109.099 -174.065 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -93.05 173.35 7.78 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.117 -2.864 . . . . 33.229999999999997 109.974 -174.126 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -75.8 150.25 37.75 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 117.642 -3.161 . . . . 25.969999999999999 113.237 175.127 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.311 88.4 mt-10 64.83 39.97 5.78 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 131.568 3.947 . . . . 32.609999999999999 109.985 176.813 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.1 m -103.09 145.85 29.28 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 129.358 3.063 . . . . 10.56 112.064 -179.725 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -96.43 116.35 28.91 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 118.17 -1.412 . . . . 5.3300000000000001 112.828 -178.073 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -85.02 157.3 20.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.767 1.765 . . . . 11.66 115.767 165.364 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.558 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 10.9 m-70 -105.52 112.23 25.24 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.01 -2.931 . . . . 16.300000000000001 116.108 172.086 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.554 ' HB3' ' HA ' ' A' ' 7' ' ' THR . 15.5 tp -96.21 104.86 16.85 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 119.857 -0.737 . . . . 9.9600000000000009 111.391 175.886 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.02 155.86 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 125.466 1.506 . . . . 9.7599999999999998 114.304 -166.259 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.3 tp -71.42 102.45 2.65 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 118.662 -2.523 . . . . 19.57 115.384 -179.548 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.4 ttt180 -63.82 129.75 41.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.683 1.706 . . . . 35.079999999999998 115.292 177.876 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.9 tp -105.76 130.76 53.69 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 100.329 -3.952 . . . . 32.310000000000002 100.329 170.827 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -62.12 151.91 34.4 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.188 1.921 . . . . 42.75 116.188 -176.396 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 173.66 -129.1 1.59 Allowed Glycine 0 N--CA 1.43 -1.75 0 N-CA-C 107.887 -2.085 . . . . 36.310000000000002 107.887 177.338 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.789 1 CA-C-O 111.36 -5.134 . . . . 36.270000000000003 106.685 -178.355 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 118.112 -0.947 . . . . 17.170000000000002 110.291 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -101.58 159.22 15.48 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 124.033 1.873 . . . . 21.890000000000001 113.826 165.719 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -135.8 157.29 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 126.227 1.811 . . . . 10.83 106.452 -179.696 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -112.07 117.46 32.7 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.874 -3.016 . . . . 10.609999999999999 112.809 175.613 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.7 t -99.15 122.26 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 102.919 -2.993 . . . . 9.1300000000000008 102.919 -175.435 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -122.87 120.87 34.76 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.136 -1.602 . . . . 20.550000000000001 112.071 -171.021 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.6 p -92.86 176.87 6.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 125.889 1.675 . . . . 11.779999999999999 109.626 -169.672 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.3 tp -79.59 -31.8 41.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.863 -1.971 . . . . 19.309999999999999 113.027 -171.446 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -74.15 -62.88 1.36 Allowed 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.047 1.739 . . . . 23.140000000000001 108.573 174.904 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.9 37.56 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.66 1 C-N-CA 113.35 -4.262 . . . . 19.739999999999998 106.365 156.921 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -88.77 130.33 35.38 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.105 -2.409 . . . . 21.93 109.646 -176.846 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -103.26 101.8 11.74 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.746 -1.575 . . . . 12.33 106.746 -178.11 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.6 mt -93.19 131.82 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 105.892 -1.892 . . . . 17.079999999999998 105.892 -175.027 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.9 m -80.78 114.72 19.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.126 -1.805 . . . . 16.300000000000001 106.126 166.074 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 tp -127.89 125.28 39.34 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.954 2.101 . . . . 15.880000000000001 106.721 -177.946 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -103.26 133.63 48.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.945 -2.972 . . . . 28.899999999999999 110.937 -176.415 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -162.05 164.37 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 104.886 -2.264 . . . . 12.050000000000001 104.886 -160.252 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -126.64 141.25 39.68 Favored Pre-proline 0 N--CA 1.429 -1.48 0 CA-C-O 117.594 -1.193 . . . . 18.170000000000002 111.244 177.953 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -67.17 -15.41 46.23 Favored 'Trans proline' 0 C--N 1.3 -1.98 1 C-N-CA 127.05 5.167 . . . . 8.1600000000000001 113.389 -166.739 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.1 m -89.49 -13.62 37.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 123.226 2.739 . . . . 11.130000000000001 112.27 -172.774 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -96.75 170.35 9.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 125.831 2.729 . . . . 18.030000000000001 108.019 -177.177 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -89.49 172.1 9.24 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 117.901 -2.999 . . . . 10.220000000000001 110.617 -164.496 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mm -70.83 -30.21 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 119.142 -2.224 . . . . 12.300000000000001 109.474 175.486 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.1 tp10 -49.09 -39.06 26.51 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.513 -3.242 . . . . 36.509999999999998 115.702 161.711 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -64.63 -48.72 73.8 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.58 -1.95 . . . . 25.66 111.512 171.408 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.7 t -56.7 -44.51 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 117.899 2.555 . . . . 8.1199999999999992 117.899 173.322 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' NZ ' ' OD1' ' A' ' 52' ' ' ASP . 26.0 ttmt -53.69 -35.64 61.33 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 118.286 -2.759 . . . . 15.470000000000001 116.922 168.49 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.56 -21.65 61.85 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 118.02 2.6 . . . . 11.449999999999999 118.02 -177.98 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -86.52 -32.63 20.64 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 130.61 3.564 . . . . 24.98 108.432 -175.992 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.2 mt -76.81 -33.07 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-N 119.768 1.167 . . . . 9.4600000000000009 109.28 175.036 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -54.1 -36.53 63.31 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.509 2.04 . . . . 14.76 116.509 167.641 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -84.54 -54.9 4.43 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 114.475 1.287 . . . . 26.289999999999999 114.475 -178.658 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -71.15 -73.86 0.16 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 125.805 1.941 . . . . 30.059999999999999 112.107 -174.951 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -61.44 -37.18 82.61 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.015 2.228 . . . . 25.190000000000001 117.015 173.49 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.0 30.11 11.68 Favored Glycine 0 N--CA 1.43 -1.718 1 O-C-N 115.624 -4.423 . . . . 7.4100000000000001 115.611 -176.493 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.8 mm -87.12 125.59 65.67 Favored Pre-proline 0 N--CA 1.43 -1.461 0 CA-C-O 115.911 -1.995 . . . . 9.4900000000000002 116.221 169.692 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -83.87 161.91 13.99 Favored 'Trans proline' 0 C--N 1.3 -2.002 1 CA-C-N 129.345 4.373 . . . . 11.42 114.91 -172.799 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -86.02 -11.8 6.33 Favored 'Trans proline' 0 N--CA 1.434 -2.007 0 CA-C-N 123.465 2.273 . . . . 12.0 114.333 -142.658 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.478 ' CG ' HH21 ' A' ' 74' ' ' ARG . 5.4 p-10 -86.52 -4.5 59.18 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.873 3.669 . . . . 35.549999999999997 114.971 168.059 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.27 57.9 mt-30 -106.54 6.0 29.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 120.34 -1.475 . . . . 20.52 110.964 176.471 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -99.57 101.16 12.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 121.813 2.097 . . . . 7.1299999999999999 113.126 -177.002 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 ttt-85 -99.15 109.81 22.46 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 122.355 1.074 . . . . 36.390000000000001 112.229 174.423 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.5 mt -103.92 136.22 43.98 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 114.642 -1.163 . . . . 9.5500000000000007 113.729 177.914 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.4 mm -117.33 131.91 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 125.955 2.034 . . . . 13.9 106.267 -179.92 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.436 ' HB3' HD21 ' A' ' 50' ' ' LEU . 82.6 t80 -116.62 125.66 52.12 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 107.111 -1.44 . . . . 6.8600000000000003 107.111 163.884 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.346 . . 59.18 -106.09 0.28 Allowed 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.613 2.149 . . . . 11.15 116.112 -171.107 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.88 57.14 0.71 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 120.074 -1.641 . . . . 13.93 114.435 159.92 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.7 ttmm -145.45 146.2 31.4 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 128.704 2.802 . . . . 23.920000000000002 108.803 178.817 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -93.48 130.65 39.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.864 2.603 . . . . 23.23 110.618 175.405 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 45' ' ' PHE . 43.3 mt -87.26 114.47 23.9 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.573 -3.204 . . . . 9.1099999999999994 110.73 -170.817 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -93.21 153.36 18.66 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 125.318 2.485 . . . . 33.439999999999998 109.331 -169.979 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' OD1' ' NZ ' ' A' ' 27' ' ' LYS . 28.2 m-20 -52.61 -49.26 65.42 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 117.01 -3.556 . . . . 28.370000000000001 116.756 -159.036 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.18 4.52 77.65 Favored Glycine 0 N--CA 1.431 -1.694 0 O-C-N 119.74 -1.85 . . . . 15.0 114.709 -171.376 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.5 mmt180 -83.71 163.88 19.97 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.302 -2.881 . . . . 25.5 106.896 -178.373 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -102.66 173.55 6.28 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 116.424 2.009 . . . . 11.949999999999999 116.424 170.949 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.5 mt -79.39 -29.46 42.08 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.455 -1.403 . . . . 10.17 108.327 177.378 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.9 p -65.51 -27.84 68.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.434 -1.27 . . . . 13.59 111.953 177.715 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -57.28 -56.48 21.32 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.825 2.05 . . . . 11.699999999999999 110.143 177.62 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.433 ' HB2' HG13 ' A' ' 61' ' ' ILE . 49.7 m-85 -83.11 3.42 30.73 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.479 -1.237 . . . . 12.949999999999999 113.327 -173.443 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.3 m120 49.05 61.56 3.06 Favored 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 134.361 5.064 . . . . 25.449999999999999 112.343 -169.274 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 59' ' ' TYR . 74.9 mt -89.88 116.26 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 N-CA-C 103.267 -2.864 . . . . 14.6 103.267 -177.604 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -99.19 -167.85 1.54 Allowed 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 128.041 3.782 . . . . 33.229999999999997 110.816 -171.368 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -75.8 148.3 38.54 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 113.718 -5.614 . . . . 25.969999999999999 110.213 -177.411 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 66.9 mt-10 35.17 63.55 0.49 Allowed 'General case' 0 N--CA 1.43 -1.459 2 C-N-CA 134.846 5.258 . . . . 32.609999999999999 115.463 -172.992 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.9 t -120.33 146.45 46.12 Favored 'General case' 0 N--CA 1.429 -1.496 0 C-N-CA 129.461 3.105 . . . . 10.56 108.602 -172.639 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 66.7 m -77.98 119.05 20.88 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 126.642 2.464 . . . . 5.3300000000000001 107.543 -175.266 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.96 132.0 53.4 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.029 -1.045 . . . . 11.66 108.2 158.128 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -85.58 141.23 29.99 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 115.987 -4.196 . . . . 16.300000000000001 110.71 174.802 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.2 tp -119.28 127.51 53.29 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 118.273 2.694 . . . . 9.9600000000000009 118.273 175.094 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.31 -160.73 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 123.463 1.601 . . . . 9.7599999999999998 108.548 -178.601 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.5 tp -98.27 126.97 43.98 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 112.535 -2.12 . . . . 19.57 114.161 -174.494 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -99.5 142.41 31.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 119.25 -2.156 . . . . 35.079999999999998 106.264 176.852 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.1 mp -101.21 153.26 19.76 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 119.195 -2.191 . . . . 32.310000000000002 105.396 170.007 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.478 HH21 ' CG ' ' A' ' 39' ' ' ASP . 7.6 ptp180 -88.14 156.18 19.39 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 115.841 -2.344 . . . . 42.75 113.238 -175.258 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 101.52 50.53 1.19 Allowed Glycine 0 N--CA 1.429 -1.782 0 CA-C-O 122.898 1.277 . . . . 36.310000000000002 112.895 -177.299 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.752 0 CA-C-O 115.199 -3.001 . . . . 36.270000000000003 105.687 -168.705 . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.36 0.3 OUTLIER . . . . . 0 CA--C 1.491 -1.321 0 CA-C-O 122.441 1.115 . . . . 17.170000000000002 110.066 . . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -88.65 115.67 26.34 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 129.451 3.1 . . . . 21.890000000000001 113.344 179.923 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.0 pt -109.81 171.05 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 118.88 -2.388 . . . . 10.83 104.998 166.565 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -121.6 147.56 45.68 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.71 2.804 . . . . 10.609999999999999 106.24 173.615 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -128.68 120.92 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 104.009 -2.589 . . . . 9.1300000000000008 104.009 172.671 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -102.29 127.8 49.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.602 2.361 . . . . 20.550000000000001 110.994 -171.355 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.9 p -89.6 169.09 11.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.195 2.426 . . . . 11.779999999999999 109.223 -173.941 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.7 mt -51.55 -40.53 59.89 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 127.347 2.259 . . . . 19.309999999999999 115.488 164.384 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.8 p -94.54 -71.69 0.65 Allowed 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 125.336 1.648 . . . . 23.140000000000001 111.861 -165.507 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.97 48.67 0.07 OUTLIER Glycine 0 N--CA 1.43 -1.738 0 O-C-N 120.611 -1.306 . . . . 19.739999999999998 115.94 178.053 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -119.09 140.68 49.69 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 115.218 1.562 . . . . 21.93 115.218 170.077 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.5 m -104.8 105.85 16.1 Favored 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 115.074 -4.766 . . . . 12.33 108.817 174.181 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.5 mt -91.4 105.43 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 1 O-C-N 114.552 -5.093 . . . . 17.079999999999998 107.747 -171.539 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 m -82.52 122.8 28.53 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 115.674 1.731 . . . . 16.300000000000001 115.674 178.19 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.5 tp -123.86 154.92 38.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.101 2.228 . . . . 15.880000000000001 113.966 -167.221 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -112.35 129.14 56.4 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.203 1.954 . . . . 28.899999999999999 110.848 165.181 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -148.46 170.34 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 130.292 3.437 . . . . 12.050000000000001 107.781 -179.237 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -120.95 165.18 19.6 Favored Pre-proline 0 N--CA 1.43 -1.467 0 N-CA-C 107.035 -1.468 . . . . 18.170000000000002 107.035 166.564 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -69.9 -21.44 32.82 Favored 'Trans proline' 0 N--CA 1.434 -2.016 0 CA-C-O 127.374 2.989 . . . . 8.1600000000000001 117.789 -172.325 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 m -78.83 -4.91 51.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 111.374 -2.648 . . . . 11.130000000000001 113.279 177.411 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.291 69.3 m-20 -78.35 143.04 37.24 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.34 2.019 . . . . 18.030000000000001 114.12 173.888 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 2.3 p -89.05 156.59 18.75 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 119.003 -2.311 . . . . 10.220000000000001 111.524 -168.894 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.7 mm -61.86 -33.92 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 118.55 2.796 . . . . 12.300000000000001 118.55 -179.072 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -44.79 -45.86 10.27 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 120.124 3.379 . . . . 36.509999999999998 120.124 161.623 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -72.63 -44.76 61.5 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.675 2.39 . . . . 25.66 111.097 -177.991 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.92 -48.48 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 N-CA-C 114.849 1.426 . . . . 8.1199999999999992 114.849 177.735 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -54.44 -44.34 72.4 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 126.719 2.008 . . . . 15.470000000000001 115.412 171.439 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.309 . . -48.21 -46.25 34.88 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 120.117 3.377 . . . . 11.449999999999999 120.117 160.663 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.6 mttm -68.7 -35.36 77.08 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.883 -3.011 . . . . 24.98 114.946 175.066 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.302 63.2 mt -51.62 -49.57 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 CA-C-N 110.74 -2.936 . . . . 9.4600000000000009 111.227 172.641 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -64.52 -24.57 67.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 129.79 3.236 . . . . 14.76 114.704 -179.776 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -68.48 -30.76 69.68 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.198 -4.064 . . . . 26.289999999999999 111.799 168.882 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.1 mmtt -79.3 -66.65 0.84 Allowed 'General case' 0 N--CA 1.43 -1.432 1 O-C-N 116.169 -4.082 . . . . 30.059999999999999 107.588 -173.711 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -121.71 145.57 47.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 103.133 -2.914 . . . . 25.190000000000001 103.133 -173.705 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.64 64.56 4.27 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 117.444 -1.753 . . . . 7.4100000000000001 112.824 -169.84 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.9 mm -110.97 109.7 57.19 Favored Pre-proline 0 N--CA 1.43 -1.473 1 CA-C-O 109.491 -5.052 . . . . 9.4900000000000002 108.443 -173.658 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -55.12 135.56 69.39 Favored 'Trans proline' 0 C--N 1.299 -2.034 1 C-N-CA 125.445 4.096 . . . . 11.42 115.276 -173.954 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -61.89 -19.32 65.31 Favored 'Trans proline' 0 N--CA 1.434 -1.997 0 CA-C-N 125.3 2.929 . . . . 12.0 116.442 -177.313 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -82.16 -16.46 49.72 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.271 -1.518 . . . . 35.549999999999997 112.053 175.191 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -99.36 -15.18 18.88 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.162 -2.211 . . . . 20.52 106.447 -177.112 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -77.71 121.76 24.44 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.91 -2.369 . . . . 7.1299999999999999 111.884 -175.987 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 68.1 ttt180 -121.31 110.45 16.14 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.295 -3.378 . . . . 36.390000000000001 104.93 175.055 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.7 mt -94.22 105.48 17.46 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 103.644 -2.724 . . . . 9.5500000000000007 103.644 -174.831 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.8 mm -88.22 133.98 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 C-N-CA 126.945 2.098 . . . . 13.9 108.874 167.777 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.458 ' CE2' HG12 ' A' ' 61' ' ' ILE . 70.6 t80 -137.51 109.09 6.98 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 101.444 -3.539 . . . . 6.8600000000000003 101.444 -175.495 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.43 -108.0 0.22 Allowed 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 114.236 -1.347 . . . . 11.15 113.9 -164.784 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -100.67 -16.71 25.74 Favored Glycine 0 N--CA 1.43 -1.74 0 CA-C-O 115.774 -2.681 . . . . 13.93 112.584 177.837 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -113.59 147.25 38.39 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 120.965 2.383 . . . . 23.920000000000002 112.947 -163.001 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -73.95 127.73 33.64 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 127.506 3.527 . . . . 23.23 113.899 159.389 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.32 83.7 mt -78.4 132.99 37.57 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 119.556 -1.965 . . . . 9.1099999999999994 107.278 170.787 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -106.37 151.27 25.1 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 124.628 2.156 . . . . 33.439999999999998 115.473 -170.164 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.35 3.6 m-20 -46.99 -55.05 8.82 Favored 'General case' 0 N--CA 1.43 -1.469 1 N-CA-C 123.673 4.694 . . . . 28.370000000000001 123.673 -164.766 . . . . . . . . 3 2 . 1 . 085 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -83.58 5.35 78.52 Favored Glycine 0 N--CA 1.431 -1.684 0 CA-C-O 122.128 0.849 . . . . 15.0 113.016 -170.812 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.1 mtt-85 -105.11 152.77 22.38 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.532 1.933 . . . . 25.5 111.626 -172.384 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.567 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 56.3 p -89.47 174.25 7.89 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 118.907 -0.568 . . . . 11.949999999999999 109.666 179.582 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.2 mt -75.71 -34.91 60.39 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 122.021 0.915 . . . . 10.17 110.078 174.603 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.7 p -57.57 -40.93 80.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 130.507 3.523 . . . . 13.59 110.342 173.416 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -48.11 -44.92 32.31 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 117.654 -3.154 . . . . 11.699999999999999 115.904 174.952 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.313 98.3 m-85 -92.37 2.23 56.77 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.06 -2.9 . . . . 12.949999999999999 115.338 172.101 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.285 18.0 m120 65.38 38.99 5.45 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 117.724 2.491 . . . . 25.449999999999999 117.724 176.267 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.458 HG12 ' CE2' ' A' ' 45' ' ' PHE . 57.2 mt -74.19 138.67 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.665 2.386 . . . . 14.6 108.015 172.934 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -129.66 -167.07 1.75 Allowed 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.83 -2.419 . . . . 33.229999999999997 108.125 -176.3 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -76.77 158.56 30.81 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.863 -3.023 . . . . 25.969999999999999 113.318 -173.836 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 68.05 20.32 9.09 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 117.967 -2.958 . . . . 32.609999999999999 113.306 177.043 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.8 t -106.56 143.49 34.6 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 129.106 2.962 . . . . 10.56 116.857 -172.682 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -100.97 129.44 46.81 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 113.696 0.998 . . . . 5.3300000000000001 113.696 -173.993 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -104.12 152.56 21.96 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 106.474 -1.676 . . . . 11.66 106.474 173.171 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -115.74 124.53 51.02 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 116.863 -3.648 . . . . 16.300000000000001 108.677 -176.726 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tp -103.66 107.69 18.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 120.13 -1.606 . . . . 9.9600000000000009 108.851 -170.075 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 m -112.89 158.81 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 124.874 1.359 . . . . 9.7599999999999998 109.739 -179.265 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.7 tp -81.24 113.38 19.33 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.557 2.123 . . . . 19.57 112.394 -178.925 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -59.55 140.02 56.66 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.516 2.579 . . . . 35.079999999999998 113.389 170.003 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.4 tp -97.25 142.78 28.73 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 130.285 3.434 . . . . 32.310000000000002 105.769 173.769 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.3 mtt180 -80.93 161.56 24.29 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 119.509 -1.994 . . . . 42.75 110.436 -179.718 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.46 -61.79 0.64 Allowed Glycine 0 N--CA 1.43 -1.731 0 N-CA-C 107.544 -2.223 . . . . 36.310000000000002 107.544 -172.916 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.77 0 O-C-N 126.026 1.662 . . . . 36.270000000000003 111.217 173.832 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 121.559 0.695 . . . . 17.170000000000002 111.82 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -113.77 145.05 41.97 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.199 -4.688 . . . . 21.890000000000001 111.435 -172.196 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.9 pt -128.26 161.55 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 118.339 -2.725 . . . . 10.83 109.15 169.799 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -105.11 145.33 30.68 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.259 2.624 . . . . 10.609999999999999 110.753 167.923 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -123.2 125.05 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.064 -1.648 . . . . 9.1300000000000008 107.854 171.996 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 tppt? -97.92 143.09 28.86 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.352 -2.717 . . . . 20.550000000000001 111.481 176.549 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 68.2 p -97.2 -177.28 3.79 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 122.407 2.367 . . . . 11.779999999999999 109.236 -173.611 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tt -76.68 -45.34 30.07 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 117.626 -1.178 . . . . 19.309999999999999 110.666 177.466 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.5 p -66.97 -54.55 20.81 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 120.264 1.393 . . . . 23.140000000000001 112.939 174.805 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 137.83 84.48 0.13 Allowed Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 129.394 3.378 . . . . 19.739999999999998 114.18 168.328 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.9 mtpt -132.83 152.71 51.77 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 111.845 -2.177 . . . . 21.93 106.976 171.843 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.291 26.2 m -108.83 108.61 19.47 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 113.465 -1.698 . . . . 12.33 112.407 171.986 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 mt -91.81 137.18 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 104.668 -2.345 . . . . 17.079999999999998 104.668 174.695 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 m -116.65 120.58 39.1 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 125.964 1.705 . . . . 16.300000000000001 111.629 175.533 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 HD22 ' HB3' ' A' ' 29' ' ' LYS . 22.7 mt -114.13 146.64 40.02 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 117.551 -3.218 . . . . 15.880000000000001 107.601 179.968 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -91.68 137.85 32.03 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 116.012 -2.275 . . . . 28.899999999999999 114.573 148.915 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.7 m -140.73 157.84 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 128.314 2.646 . . . . 12.050000000000001 104.719 -171.286 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -104.54 145.75 31.29 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 101.893 -3.373 . . . . 18.170000000000002 101.893 165.703 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -78.19 -7.6 16.2 Favored 'Trans proline' 0 C--N 1.3 -1.999 0 N-CA-C 118.389 2.419 . . . . 8.1600000000000001 118.389 -174.453 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.0 m -100.46 14.64 30.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.957 -1.496 . . . . 11.130000000000001 110.614 178.566 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -107.9 160.47 15.74 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 121.912 2.142 . . . . 18.030000000000001 108.058 166.292 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -88.04 173.46 8.85 Favored 'General case' 0 N--CA 1.431 -1.404 0 O-C-N 126.326 2.267 . . . . 10.220000000000001 112.748 -162.604 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.4 mm -73.47 -26.8 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 117.26 -3.4 . . . . 12.300000000000001 110.027 -177.18 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -65.56 -21.95 66.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 117.45 -3.281 . . . . 36.509999999999998 117.159 169.914 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.29 -41.24 20.4 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 117.581 -1.2 . . . . 25.66 112.841 168.765 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.1 t -57.57 -40.94 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 O-C-N 127.547 3.03 . . . . 8.1199999999999992 116.936 173.944 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -63.73 -41.58 98.03 Favored 'General case' 0 N--CA 1.43 -1.437 1 C-N-CA 131.781 4.033 . . . . 15.470000000000001 113.183 170.694 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.71 -25.42 65.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 124.319 2.009 . . . . 11.449999999999999 113.495 176.458 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HB3' HD22 ' A' ' 15' ' ' LEU . 48.3 mttm -79.17 -31.23 43.85 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.257 -1.527 . . . . 24.98 112.783 173.66 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 79.7 mt -66.41 -34.87 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 125.401 2.524 . . . . 9.4600000000000009 112.504 170.249 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -60.0 -46.77 88.4 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.754 3.222 . . . . 14.76 115.849 166.671 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -54.07 -56.75 15.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.617 -3.177 . . . . 26.289999999999999 115.116 168.844 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.2 mttm -66.48 -80.29 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.402 -3.311 . . . . 30.059999999999999 116.829 171.703 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.89 -30.19 50.63 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 114.338 -5.226 . . . . 25.190000000000001 117.125 -178.126 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.18 5.17 50.06 Favored Glycine 0 N--CA 1.43 -1.755 0 CA-C-N 125.011 3.55 . . . . 7.4100000000000001 117.148 179.524 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mm -69.92 128.83 91.5 Favored Pre-proline 0 N--CA 1.43 -1.449 0 N-CA-C 114.684 1.364 . . . . 9.4900000000000002 114.684 -177.76 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -67.9 149.93 78.07 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 O-C-N 115.103 -3.157 . . . . 11.42 111.92 -170.428 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -73.68 -18.56 22.19 Favored 'Trans proline' 0 N--CA 1.433 -2.043 2 C-N-CA 127.794 5.663 . . . . 12.0 116.286 -175.853 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -68.86 -26.31 65.07 Favored 'General case' 0 N--CA 1.431 -1.417 0 C-N-CA 130.198 3.399 . . . . 35.549999999999997 115.258 168.797 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -95.08 -23.08 17.49 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.553 -1.658 . . . . 20.52 114.896 -172.598 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.5 mt-30 -85.75 118.43 25.25 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 108.678 -0.86 . . . . 7.1299999999999999 108.678 -171.895 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.2 ttt180 -108.79 116.14 31.42 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 126.612 1.965 . . . . 36.390000000000001 106.983 171.476 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -102.56 111.58 23.96 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.87 1.356 . . . . 9.5500000000000007 109.768 -176.788 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.9 mm -102.93 125.09 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.062 -1.649 . . . . 13.9 106.789 179.562 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -117.71 127.16 53.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 126.381 2.991 . . . . 6.8600000000000003 108.84 168.39 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.31 -98.11 0.08 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.425 -3.922 . . . . 11.15 113.466 -153.503 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.07 33.96 1.69 Allowed Glycine 0 N--CA 1.429 -1.8 0 C-N-CA 127.426 2.441 . . . . 13.93 110.432 -179.523 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -145.05 143.15 30.3 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 123.515 1.626 . . . . 23.920000000000002 109.437 173.273 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -80.37 124.91 29.28 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 123.575 1.655 . . . . 23.23 114.194 -178.419 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -66.24 131.59 46.48 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 124.545 2.116 . . . . 9.1099999999999994 109.184 172.813 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -82.71 158.85 22.74 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.633 -3.167 . . . . 33.439999999999998 113.107 178.158 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -66.22 -45.3 81.18 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.109 1.909 . . . . 28.370000000000001 115.304 -162.186 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.9 4.67 85.6 Favored Glycine 0 N--CA 1.431 -1.683 0 CA-C-N 113.39 -1.732 . . . . 15.0 115.21 -178.434 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.4 mmt-85 -92.53 159.99 15.25 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 122.358 3.079 . . . . 25.5 108.735 178.969 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 69.4 p -86.57 171.19 11.23 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 122.72 1.248 . . . . 11.949999999999999 112.229 171.945 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 13.3 mt -72.73 -33.76 66.61 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.334 -1.728 . . . . 10.17 106.334 172.222 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.5 p -65.7 -7.85 17.69 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 121.226 3.788 . . . . 13.59 121.226 174.179 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -84.11 -42.58 15.91 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.118 2.866 . . . . 11.699999999999999 109.518 -176.493 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -77.88 -13.56 59.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 127.678 2.391 . . . . 12.949999999999999 112.419 177.084 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 64.87 51.28 1.81 Allowed 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.768 1.627 . . . . 25.449999999999999 112.956 -172.958 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.1 mt -84.94 137.92 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.788 -2.301 . . . . 14.6 104.788 179.778 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -110.57 168.83 9.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.849 -2.407 . . . . 33.229999999999997 113.126 -175.369 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -66.81 155.41 38.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 121.511 -0.743 . . . . 25.969999999999999 111.569 174.221 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 50.2 mt-10 53.22 25.72 4.56 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 117.147 2.277 . . . . 32.609999999999999 117.147 -170.381 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 t -91.32 152.02 20.63 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.384 0.612 . . . . 10.56 110.765 169.695 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -107.98 121.37 44.65 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 131.45 3.9 . . . . 5.3300000000000001 113.145 179.664 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -97.38 163.69 12.77 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.22 1.962 . . . . 11.66 107.034 174.896 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -119.34 129.36 54.81 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.503 -4.498 . . . . 16.300000000000001 109.141 175.603 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.3 tp -105.61 119.95 40.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.293 2.637 . . . . 9.9600000000000009 112.013 179.928 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.458 ' HB ' ' H ' ' A' ' 71' ' ' LEU . 26.8 m -130.29 -160.04 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.412 1 CA-C-O 128.979 4.228 . . . . 9.7599999999999998 111.05 168.903 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.458 ' H ' ' HB ' ' A' ' 70' ' ' VAL . 16.5 tp -91.44 142.21 27.91 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 113.997 -5.439 . . . . 19.57 112.579 -168.842 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.409 HH21 ' C ' ' A' ' 76' ' ' GLY . 44.5 ttt180 -110.71 135.14 51.76 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 125.23 1.581 . . . . 35.079999999999998 114.439 174.575 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.2 mt -90.59 143.18 26.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.032 2.133 . . . . 32.310000000000002 110.991 161.898 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 43.6 mtp180 -77.73 125.93 30.09 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 119.065 -2.272 . . . . 42.75 108.396 -171.956 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 161.51 -29.36 0.3 Allowed Glycine 0 N--CA 1.429 -1.775 0 C-N-CA 114.377 -3.773 . . . . 36.310000000000002 112.686 174.809 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.409 ' C ' HH21 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.731 0 N-CA-C 106.419 -2.672 . . . . 36.270000000000003 106.419 177.062 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ptt? . . . . . 0 CA--C 1.49 -1.345 0 CA-C-O 123.704 1.716 . . . . 17.170000000000002 112.1 . . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -97.77 130.81 44.7 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.066 -2.896 . . . . 21.890000000000001 110.624 177.498 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.365 9.9 pt -129.67 157.67 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 C-N-CA 124.752 1.221 . . . . 10.83 110.941 174.389 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -111.32 143.63 41.79 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.163 -1.791 . . . . 10.609999999999999 106.163 -177.134 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.68 127.5 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 CA-C-N 114.482 -1.235 . . . . 9.1300000000000008 107.993 167.82 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.0 tttt -106.13 129.4 54.22 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 123.533 1.635 . . . . 20.550000000000001 113.862 170.448 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -82.37 -175.15 5.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 115.414 1.635 . . . . 11.779999999999999 115.414 179.65 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.348 5.9 tp -67.02 -40.03 87.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.87 2.174 . . . . 19.309999999999999 116.87 177.635 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -73.05 -22.12 60.67 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.08 2.552 . . . . 23.140000000000001 112.238 -171.244 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.68 40.59 3.83 Favored Glycine 0 N--CA 1.43 -1.72 0 C-N-CA 127.67 2.557 . . . . 19.739999999999998 109.757 -174.961 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -104.64 126.98 52.25 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 116.517 -2.073 . . . . 21.93 108.557 164.395 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -94.0 116.37 28.8 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 126.714 2.006 . . . . 12.33 113.412 173.827 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.4 pt -113.15 148.33 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.365 -2.709 . . . . 17.079999999999998 106.882 -179.291 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.436 ' O ' ' HE3' ' A' ' 33' ' ' LYS . 15.7 m -98.81 129.37 45.21 Favored 'General case' 0 N--CA 1.43 -1.475 1 C-N-CA 134.003 4.921 . . . . 16.300000000000001 113.615 -178.21 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.0 mt -131.73 128.99 40.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.78 -3.075 . . . . 15.880000000000001 102.993 -177.494 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -87.16 93.97 9.52 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.721 2.808 . . . . 28.899999999999999 109.825 164.724 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.441 HG12 ' HD2' ' A' ' 29' ' ' LYS . 5.3 m -121.14 154.59 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 123.531 2.878 . . . . 12.050000000000001 109.494 175.973 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -84.88 140.09 37.43 Favored Pre-proline 0 N--CA 1.43 -1.426 0 C-N-CA 129.434 3.094 . . . . 18.170000000000002 110.841 -178.717 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -79.87 -3.56 12.86 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 CA-C-N 124.518 2.649 . . . . 8.1600000000000001 109.432 -167.746 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.8 m -83.95 -26.02 29.61 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 114.929 -2.462 . . . . 11.130000000000001 113.368 -176.093 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -84.2 163.02 19.98 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 126.79 2.036 . . . . 18.030000000000001 114.25 -174.424 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.7 p -70.11 158.12 36.32 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 115.27 1.581 . . . . 10.220000000000001 115.27 -177.225 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.0 mm -63.52 -19.94 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 CA-C-O 125.762 2.696 . . . . 12.300000000000001 116.954 166.382 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -74.89 -27.37 60.2 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.83 -3.044 . . . . 36.509999999999998 113.878 179.869 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -70.11 -34.05 72.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 127.521 2.328 . . . . 25.66 112.912 175.049 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.6 t -48.49 -56.93 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.439 1 CA-C-O 129.166 4.317 . . . . 8.1199999999999992 110.717 175.967 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -57.14 -27.13 61.58 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 117.845 -3.034 . . . . 15.470000000000001 114.604 -171.854 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.19 83.58 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.72 2.2 . . . . 11.449999999999999 109.286 -178.898 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HD2' HG12 ' A' ' 17' ' ' VAL . 50.5 mttm -78.35 -35.65 47.17 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.285 -1.51 . . . . 24.98 108.576 -174.261 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.8 mt -67.87 -32.26 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 125.796 2.712 . . . . 9.4600000000000009 108.233 177.183 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.9 tt0 -69.04 -56.28 8.23 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 116.165 -4.084 . . . . 14.76 110.039 174.553 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -58.73 -24.07 60.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.061 1.744 . . . . 26.289999999999999 114.329 -178.871 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 14' ' ' THR . 50.6 mttm -78.13 -80.66 0.11 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.484 -2.01 . . . . 30.059999999999999 112.778 165.536 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -99.06 10.69 40.94 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.11 -3.494 . . . . 25.190000000000001 115.826 -161.124 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.87 3.5 90.46 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 117.995 -2.941 . . . . 7.4100000000000001 116.6 -175.736 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 55.6 mt -77.59 115.69 51.81 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-N 118.906 1.353 . . . . 9.4900000000000002 111.202 -169.599 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.458 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 40.4 Cg_exo -67.95 142.31 56.42 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 O-C-N 114.313 -3.572 . . . . 11.42 112.342 -179.355 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 65.3 Cg_exo -62.87 -21.68 73.29 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 N-CA-C 119.772 2.951 . . . . 12.0 119.772 -173.167 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.434 ' CG ' HH22 ' A' ' 74' ' ' ARG . 9.7 m-20 -56.69 -39.06 73.15 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.665 1.586 . . . . 35.549999999999997 113.594 171.25 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -80.17 7.36 9.47 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 117.199 2.296 . . . . 20.52 117.199 -173.923 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -113.89 117.98 32.91 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 114.79 -2.529 . . . . 7.1299999999999999 110.642 -160.344 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -128.62 115.78 18.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 128.681 3.738 . . . . 36.390000000000001 113.011 170.985 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.9 mt -92.89 125.89 37.71 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 116.276 -4.015 . . . . 9.5500000000000007 111.81 -173.844 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.2 mm -105.37 126.08 60.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 126.618 1.967 . . . . 13.9 109.518 172.132 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -110.22 120.0 41.06 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-O 126.896 3.236 . . . . 6.8600000000000003 105.401 171.886 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.409 . . 59.77 -91.07 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 116.548 -3.845 . . . . 11.15 118.394 -164.818 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.23 13.01 5.75 Favored Glycine 0 N--CA 1.43 -1.729 1 CA-C-O 111.115 -5.269 . . . . 13.93 109.957 160.847 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -93.31 135.86 34.13 Favored 'General case' 0 N--CA 1.43 -1.433 1 CA-C-N 124.549 4.175 . . . . 23.920000000000002 110.963 -176.918 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -75.07 99.92 4.06 Favored 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 113.938 -5.477 . . . . 23.23 113.324 167.354 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.6 mt -69.77 136.94 51.48 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.253 -3.404 . . . . 9.1099999999999994 113.912 178.265 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -97.48 136.18 38.28 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-N 114.286 -1.325 . . . . 33.439999999999998 113.475 -177.938 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.75 -30.79 68.47 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 115.055 1.502 . . . . 28.370000000000001 115.055 -156.27 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.5 23.54 12.27 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 115.716 -2.713 . . . . 15.0 115.316 179.727 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 35.1 mtt180 -125.42 174.48 8.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 122.085 2.943 . . . . 25.5 106.841 175.56 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.3 p -96.04 167.41 11.24 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.728 1.728 . . . . 11.949999999999999 114.875 179.949 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.575 HD12 ' H ' ' A' ' 56' ' ' LEU . 5.3 mp -56.39 -43.72 79.55 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 126.111 2.862 . . . . 10.17 114.383 162.535 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.3 p -61.1 -19.44 61.46 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 114.374 -5.204 . . . . 13.59 119.243 170.831 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -58.7 -52.38 65.91 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 117.308 2.336 . . . . 11.699999999999999 117.308 167.304 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -88.36 -13.33 40.91 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.596 3.558 . . . . 12.949999999999999 115.002 177.884 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 15.2 m120 73.92 58.08 0.09 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 106.332 -1.729 . . . . 25.449999999999999 106.332 167.749 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.3 mt -85.73 121.61 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 CA-C-O 124.861 2.267 . . . . 14.6 107.055 166.571 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -107.03 175.09 5.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 109.548 -3.478 . . . . 33.229999999999997 107.306 -174.913 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.4 pttt -58.61 137.08 57.71 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.005 -2.309 . . . . 25.969999999999999 116.862 -176.318 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 84.47 7.39 0.54 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 131.679 3.992 . . . . 32.609999999999999 113.96 170.18 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.8 t -72.46 134.38 45.31 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 114.131 -1.395 . . . . 10.56 110.678 -175.496 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.5 m -102.26 103.08 13.54 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.706 -3.746 . . . . 5.3300000000000001 113.418 -171.785 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.1 mt -99.63 159.55 14.96 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 102.231 -3.248 . . . . 11.66 102.231 -165.085 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -101.73 140.85 35.46 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 118.181 -2.824 . . . . 16.300000000000001 108.92 170.897 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 46.5 tp -102.22 136.66 41.66 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 102.138 -3.282 . . . . 9.9600000000000009 102.138 169.369 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 m -134.71 175.01 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 127.615 2.366 . . . . 9.7599999999999998 105.991 173.576 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.6 tp -82.31 127.82 33.6 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 112.235 -2.257 . . . . 19.57 116.685 -171.341 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -89.74 126.89 35.83 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.937 -2.977 . . . . 35.079999999999998 108.355 169.211 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.4 mt -91.64 155.94 17.97 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.815 2.446 . . . . 32.310000000000002 111.126 170.229 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.434 HH22 ' CG ' ' A' ' 39' ' ' ASP 0.358 50.4 ttm-85 -82.75 117.94 23.02 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 115.027 -4.795 . . . . 42.75 107.652 -174.299 . . . . . . . . 4 3 . 1 . 087 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 158.88 50.17 0.01 OUTLIER Glycine 0 N--CA 1.431 -1.7 0 O-C-N 126.588 2.43 . . . . 36.310000000000002 115.419 169.5 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.755 1 C-N-CA 130.712 4.006 . . . . 36.270000000000003 105.149 176.859 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ptt? . . . . . 0 CA--C 1.491 -1.309 0 CA-C-O 125.056 2.36 . . . . 17.170000000000002 109.477 . . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -104.57 138.93 40.19 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 111.796 -2.456 . . . . 21.890000000000001 110.883 -172.822 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.284 44.0 pt -136.21 144.84 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 102.505 -3.146 . . . . 10.83 102.505 165.785 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -107.97 139.05 43.17 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.52 0.728 . . . . 10.609999999999999 109.647 173.903 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.7 t -121.58 114.38 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 104.657 -2.349 . . . . 9.1300000000000008 104.657 179.027 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.4 mttm -83.89 124.79 31.35 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.115 2.388 . . . . 20.550000000000001 105.405 166.283 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.323 17.7 p -77.85 178.24 7.57 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 124.962 2.315 . . . . 11.779999999999999 110.2 -174.886 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.4 tp -78.38 -32.7 49.0 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 117.274 -3.391 . . . . 19.309999999999999 111.705 171.947 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 p -74.79 -33.19 62.2 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.966 -2.333 . . . . 23.140000000000001 113.44 170.576 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.42 60.26 0.52 Allowed Glycine 0 N--CA 1.429 -1.77 0 CA-C-O 123.197 1.443 . . . . 19.739999999999998 115.124 169.436 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -118.54 152.5 35.86 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.563 1.945 . . . . 21.93 113.585 162.099 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -105.72 96.89 6.81 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 124.248 1.975 . . . . 12.33 108.813 174.084 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.286 3.4 pt -89.45 150.24 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 117.407 -3.308 . . . . 17.079999999999998 109.943 -179.98 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.4 m -111.22 124.4 52.14 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.819 -0.752 . . . . 16.300000000000001 110.573 -176.046 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.66 147.11 29.93 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.865 1.317 . . . . 15.880000000000001 108.045 176.897 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -105.35 90.36 3.4 Favored 'General case' 0 N--CA 1.429 -1.499 0 C-N-CA 130.051 3.34 . . . . 28.899999999999999 111.599 166.327 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.95 162.1 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 125.975 2.797 . . . . 12.050000000000001 112.528 175.979 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -96.43 147.83 33.55 Favored Pre-proline 0 N--CA 1.43 -1.453 0 O-C-N 119.461 -2.024 . . . . 18.170000000000002 106.601 173.738 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.37 -9.47 23.08 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-O 115.99 -1.754 . . . . 8.1600000000000001 111.939 -177.54 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 65.5 p -88.62 -3.92 58.68 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.258 2.623 . . . . 11.130000000000001 114.238 173.078 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -68.84 148.6 50.02 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.374 -2.454 . . . . 18.030000000000001 104.374 178.897 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.8 p -87.9 155.13 20.01 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 114.62 -1.173 . . . . 10.220000000000001 109.789 172.096 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.6 mm -52.08 -37.57 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 C-N-CA 128.461 2.704 . . . . 12.300000000000001 110.69 176.605 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -61.83 -42.53 99.15 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.685 3.194 . . . . 36.509999999999998 114.978 174.924 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -67.06 -36.28 81.67 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 112.751 -2.022 . . . . 25.66 115.171 173.186 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -69.72 -37.33 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 114.569 1.322 . . . . 8.1199999999999992 114.569 177.663 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -57.51 -42.02 81.95 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.206 -2.809 . . . . 15.470000000000001 117.898 171.966 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.16 -31.68 61.53 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.128 2.269 . . . . 11.449999999999999 117.128 170.889 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.6 tttp -67.76 -36.2 80.08 Favored 'General case' 0 N--CA 1.43 -1.44 1 N-CA-C 122.081 4.104 . . . . 24.98 122.081 165.094 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.5 mt -57.71 -40.58 76.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 N-CA-C 116.17 1.915 . . . . 9.4600000000000009 116.17 159.821 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -56.89 -40.68 76.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 113.617 -3.087 . . . . 14.76 117.224 162.481 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -65.77 -38.07 88.03 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.622 3.076 . . . . 26.289999999999999 111.694 177.717 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 mtpp -73.88 -70.39 0.38 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.697 1.999 . . . . 30.059999999999999 115.191 178.226 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -92.4 -9.28 42.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 120.495 3.517 . . . . 25.190000000000001 120.495 -172.335 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.72 34.52 53.27 Favored Glycine 0 N--CA 1.43 -1.713 0 O-C-N 117.678 -3.139 . . . . 7.4100000000000001 109.777 177.535 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.6 mt -107.45 123.28 38.58 Favored Pre-proline 0 N--CA 1.43 -1.469 0 O-C-N 125.331 1.254 . . . . 9.4900000000000002 109.879 -178.518 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -56.02 127.72 27.23 Favored 'Trans proline' 0 C--N 1.3 -2.01 0 C-N-CA 124.098 3.199 . . . . 11.42 115.084 177.903 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -63.75 -7.61 13.43 Favored 'Trans proline' 0 C--N 1.299 -2.028 0 C-N-CA 125.059 3.839 . . . . 12.0 116.762 171.586 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -68.83 -28.62 66.9 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.716 2.487 . . . . 35.549999999999997 117.716 164.263 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -101.99 4.37 39.84 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 117.025 -3.547 . . . . 20.52 111.182 -172.324 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.436 ' HG2' HD11 ' A' ' 69' ' ' LEU . 70.7 mt-30 -95.02 134.32 37.83 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 124.285 1.993 . . . . 7.1299999999999999 113.04 -173.804 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.307 40.1 ttm180 -133.07 107.38 8.19 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 113.172 -1.831 . . . . 36.390000000000001 111.309 168.725 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.48 116.87 12.33 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 114.319 -2.753 . . . . 9.5500000000000007 112.867 170.979 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 49' ' ' GLN . 34.3 mm -109.07 135.95 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 123.151 2.705 . . . . 13.9 113.346 171.186 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -112.99 114.48 26.97 Favored 'General case' 0 N--CA 1.429 -1.475 2 O-C-N 113.141 -5.975 . . . . 6.8600000000000003 110.074 173.802 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.365 . . 68.18 -87.58 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.176 -3.452 . . . . 11.15 113.879 -170.012 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.64 5.03 6.2 Favored Glycine 0 N--CA 1.43 -1.724 0 C-N-CA 126.253 1.882 . . . . 13.93 111.643 163.394 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -92.38 120.82 33.26 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 118.558 1.179 . . . . 23.920000000000002 113.638 -171.099 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HA ' HD13 ' A' ' 44' ' ' ILE . 32.6 tt0 -82.17 111.87 18.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 127.373 3.464 . . . . 23.23 112.88 173.058 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -69.53 139.74 53.84 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 118.209 -2.807 . . . . 9.1099999999999994 110.007 -173.232 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 59.9 mt-10 -81.54 156.73 25.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 116.832 -1.556 . . . . 33.439999999999998 109.593 169.156 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -84.03 -47.27 11.13 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.027 1.739 . . . . 28.370000000000001 111.847 -167.695 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -80.98 37.91 2.36 Favored Glycine 0 N--CA 1.43 -1.734 0 O-C-N 116.514 -3.866 . . . . 15.0 117.658 176.957 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HD2' ' CE2' ' A' ' 59' ' ' TYR . 77.6 mtt-85 -113.2 178.12 4.39 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.575 -2.72 . . . . 25.5 110.736 164.361 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 72.8 p -101.55 173.81 6.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.338 -1.476 . . . . 11.949999999999999 111.62 168.695 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.417 HD23 HD12 ' A' ' 61' ' ' ILE . 35.6 mt -67.79 -26.92 66.33 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 122.344 1.069 . . . . 10.17 112.175 171.597 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 86.5 p -82.36 -25.14 34.1 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 125.096 1.358 . . . . 13.59 111.738 -175.992 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -58.05 -39.9 79.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-N 123.193 2.724 . . . . 11.699999999999999 116.453 162.339 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.4 ' CE2' ' HD2' ' A' ' 54' ' ' ARG 0.297 24.3 m-85 -89.93 3.7 52.27 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 117.552 2.427 . . . . 12.949999999999999 117.552 175.843 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 73.4 m-20 67.82 38.73 2.81 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 125.475 1.51 . . . . 25.449999999999999 112.133 171.161 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.417 HD12 HD23 ' A' ' 56' ' ' LEU . 69.9 mt -89.71 108.84 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 N-CA-C 105.167 -2.16 . . . . 14.6 105.167 178.847 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -83.67 174.85 10.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 128.069 3.795 . . . . 33.229999999999997 110.31 174.249 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -66.68 158.52 29.86 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.258 -3.401 . . . . 25.969999999999999 112.846 176.568 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.316 10.5 mt-10 57.28 20.76 6.06 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.357 2.263 . . . . 32.609999999999999 116.638 -179.919 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.9 m -80.57 129.8 34.74 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.227 2.611 . . . . 10.56 115.96 172.808 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.4 m -90.45 116.86 28.71 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.788 -3.07 . . . . 5.3300000000000001 111.354 172.836 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.0 mp -91.6 155.61 18.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.403 -2.073 . . . . 11.66 105.403 174.123 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -106.23 152.23 23.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 114.325 -2.95 . . . . 16.300000000000001 110.39 169.088 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.436 HD11 ' HG2' ' A' ' 41' ' ' GLN . 28.4 tp -121.95 113.32 19.44 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 128.918 3.886 . . . . 9.9600000000000009 109.533 174.685 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 m -121.47 -172.43 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 C-N-CA 128.617 2.767 . . . . 9.7599999999999998 104.897 178.17 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.2 tp -104.68 146.47 28.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.901 2.286 . . . . 19.57 110.123 -164.834 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -113.73 140.67 48.07 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.495 1.918 . . . . 35.079999999999998 107.752 176.404 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 14.9 mt -101.78 155.37 18.17 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.828 -1.795 . . . . 32.310000000000002 109.683 170.354 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -58.19 111.85 1.34 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 118.317 -2.739 . . . . 42.75 111.968 172.934 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.13 -46.08 0.23 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-N 114.141 -1.39 . . . . 36.310000000000002 112.988 174.068 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.759 0 C-N-CA 124.86 1.219 . . . . 36.270000000000003 110.839 176.474 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 114.573 1.323 . . . . 17.170000000000002 114.573 . . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -92.68 129.73 38.52 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 126.911 3.243 . . . . 21.890000000000001 107.673 -167.98 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.301 24.9 pt -124.21 154.21 31.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 0 O-C-N 117.023 -3.548 . . . . 10.83 110.077 171.831 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -114.21 136.32 53.09 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 126.532 1.933 . . . . 10.609999999999999 114.092 -178.858 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.6 t -117.31 103.39 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 100.322 -3.955 . . . . 9.1300000000000008 100.322 178.309 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -94.42 152.78 18.34 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.104 -3.497 . . . . 20.550000000000001 110.105 -177.713 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.269 58.4 p -106.71 175.77 5.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 118.005 2.595 . . . . 11.779999999999999 118.005 -163.743 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 30.4 tp -77.52 -51.79 10.14 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.621 -1.172 . . . . 19.309999999999999 113.25 167.92 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 81.7 p -64.47 -59.71 4.0 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.197 -3.439 . . . . 23.140000000000001 115.252 174.773 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.77 -35.98 0.21 Allowed Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 114.933 -3.148 . . . . 19.739999999999998 118.931 179.078 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -82.96 98.98 9.52 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 125.905 1.591 . . . . 21.93 110.107 -168.193 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -50.92 133.54 26.7 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 114.783 1.401 . . . . 12.33 114.783 178.441 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 32.0 mt -93.4 129.92 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 129.488 3.115 . . . . 17.079999999999998 106.891 176.426 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 61.3 m -119.6 111.43 18.06 Favored 'General case' 0 N--CA 1.43 -1.475 0 O-C-N 116.854 -3.654 . . . . 16.300000000000001 108.493 -170.177 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.7 mt -113.8 149.62 34.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.499 -2.625 . . . . 15.880000000000001 111.82 178.22 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -104.67 136.34 44.38 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.329 -1.482 . . . . 28.899999999999999 110.65 163.172 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.3 m -132.82 172.64 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.021 -1.675 . . . . 12.050000000000001 107.641 -173.142 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -113.28 150.37 42.96 Favored Pre-proline 0 N--CA 1.43 -1.471 0 N-CA-C 102.31 -3.218 . . . . 18.170000000000002 102.31 166.797 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.87 -2.97 13.21 Favored 'Trans proline' 0 C--N 1.3 -2.011 0 CA-C-N 122.943 2.087 . . . . 8.1600000000000001 116.468 -175.547 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.5 p -70.82 -25.49 62.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 128.284 3.49 . . . . 11.130000000000001 117.078 159.037 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -67.81 150.45 48.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 129.407 3.083 . . . . 18.030000000000001 110.79 179.646 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.7 p -98.1 160.45 14.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.035 -2.888 . . . . 10.220000000000001 114.41 -173.865 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.7 mm -52.44 -32.53 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-N 121.668 2.031 . . . . 12.300000000000001 113.065 166.441 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.32 1.5 tt0 -51.78 -51.27 57.63 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 117.873 2.546 . . . . 36.509999999999998 117.873 160.761 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -63.71 -33.31 75.35 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 124.531 3.332 . . . . 25.66 111.036 177.344 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.0 t -64.12 -37.65 80.41 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 O-C-N 119.639 -1.913 . . . . 8.1199999999999992 109.564 177.595 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.2 mttt -66.52 -36.65 83.23 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.794 1.775 . . . . 15.470000000000001 115.794 173.486 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.39 -19.25 62.29 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.736 1.614 . . . . 11.449999999999999 114.595 -179.079 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.8 mttm -91.21 -19.82 22.63 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.735 -3.103 . . . . 24.98 108.179 176.535 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.9 mt -76.71 -34.15 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 O-C-N 117.803 -3.061 . . . . 9.4600000000000009 108.476 167.098 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -52.86 -49.05 66.59 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 124.646 2.165 . . . . 14.76 110.962 169.823 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -66.04 -52.96 44.31 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 125.946 1.699 . . . . 26.289999999999999 110.427 -178.204 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -67.43 -69.23 0.33 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.196 -1.565 . . . . 30.059999999999999 115.052 -179.727 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -87.81 -53.99 4.48 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 118.418 -2.676 . . . . 25.190000000000001 113.389 -175.518 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.05 54.21 0.39 Allowed Glycine 0 N--CA 1.429 -1.782 0 N-CA-C 117.632 1.813 . . . . 7.4100000000000001 117.632 -165.601 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.9 mt -121.43 123.61 27.56 Favored Pre-proline 0 N--CA 1.43 -1.437 0 O-C-N 128.377 3.046 . . . . 9.4900000000000002 104.859 176.022 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -54.69 125.25 18.41 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 C-N-CA 124.837 3.691 . . . . 11.42 113.44 168.224 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -54.74 -28.17 55.84 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 121.336 3.552 . . . . 12.0 121.336 174.192 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.25 17.1 p-10 -51.73 -37.22 50.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.242 2.312 . . . . 35.549999999999997 117.242 167.174 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -86.91 -7.79 57.86 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 114.918 1.451 . . . . 20.52 114.918 -175.892 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -89.06 141.36 28.57 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.059 2.361 . . . . 7.1299999999999999 114.284 177.92 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -132.66 140.78 48.32 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.902 3.239 . . . . 36.390000000000001 106.155 164.018 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -118.81 130.59 55.85 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.674 -3.766 . . . . 9.5500000000000007 105.668 -177.683 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.7 tt -122.92 133.14 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.149 -3.47 . . . . 13.9 110.129 174.154 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -82.76 -66.75 0.85 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.193 1.949 . . . . 6.8600000000000003 109.458 174.389 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -116.81 -75.4 0.58 Allowed 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 130.152 3.381 . . . . 11.15 115.547 -178.847 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -152.89 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 CA-C-N 115.081 -0.963 . . . . 13.93 115.403 -174.306 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -83.51 138.06 33.59 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.596 1.665 . . . . 23.920000000000002 110.373 -172.938 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.21 133.87 36.06 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 118.484 2.772 . . . . 23.23 118.484 -169.757 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.3 mt -90.36 151.15 21.58 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 128.438 2.695 . . . . 9.1099999999999994 113.927 -169.724 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -100.59 137.31 39.16 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.409 3.083 . . . . 33.439999999999998 109.873 177.892 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -72.32 -50.35 27.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 O-C-N 118.439 -2.663 . . . . 28.370000000000001 104.969 -157.537 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.4 37.75 3.32 Favored Glycine 0 N--CA 1.43 -1.756 0 O-C-N 118.123 -2.861 . . . . 15.0 110.874 -169.623 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 75.0 mtt-85 -93.14 152.51 19.2 Favored 'General case' 0 N--CA 1.431 -1.413 1 C-N-CA 132.929 4.491 . . . . 25.5 111.756 158.594 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.1 p -97.96 171.55 8.2 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.957 1.837 . . . . 11.949999999999999 106.416 -172.24 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.9 mt -53.14 -47.42 68.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 123.558 1.647 . . . . 10.17 112.571 173.276 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -84.96 -11.35 55.71 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.477 3.111 . . . . 13.59 113.932 -173.17 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.1 -47.99 77.87 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.705 1.717 . . . . 11.699999999999999 108.657 164.277 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -93.0 12.45 23.94 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 114.837 -4.914 . . . . 12.949999999999999 112.214 -176.464 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 59.92 31.07 20.53 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.279 2.232 . . . . 25.449999999999999 111.205 171.954 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.3 mt -82.45 120.75 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 124.204 1.001 . . . . 14.6 108.535 177.384 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -100.7 -172.31 2.17 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.962 1.363 . . . . 33.229999999999997 113.284 179.419 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -69.15 151.15 46.72 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.403 -3.31 . . . . 25.969999999999999 115.829 177.342 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.267 28.4 mt-10 66.66 20.28 10.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 128.429 2.692 . . . . 32.609999999999999 112.214 177.711 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -88.07 144.08 26.71 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.431 1.892 . . . . 10.56 112.87 179.833 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.3 m -97.79 122.33 40.77 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 113.395 -1.729 . . . . 5.3300000000000001 107.371 -174.363 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 mp -97.19 166.41 11.58 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.796 3.238 . . . . 11.66 108.418 159.238 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -137.57 132.17 32.73 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.496 -2.628 . . . . 16.300000000000001 111.656 174.411 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.6 tp -87.98 121.6 30.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.14 2.576 . . . . 9.9600000000000009 106.6 -171.069 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.9 t -113.69 113.2 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 C-N-CA 128.266 2.626 . . . . 9.7599999999999998 112.312 175.42 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.6 tp -83.23 119.53 24.67 Favored 'General case' 0 N--CA 1.431 -1.423 1 O-C-N 115.819 -4.301 . . . . 19.57 112.128 -171.26 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -111.21 150.35 29.67 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 128.389 2.676 . . . . 35.079999999999998 112.309 177.811 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.6 tp -83.26 -64.3 1.2 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.293 2.237 . . . . 32.310000000000002 115.683 176.283 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.9 tpp180 -152.32 154.49 35.79 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 106.172 -1.788 . . . . 42.75 106.172 173.521 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.07 -177.45 46.31 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.24 -2.787 . . . . 36.310000000000002 111.434 171.658 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.796 0 C-N-CA 125.582 1.563 . . . . 36.270000000000003 115.477 -171.75 . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 CA--C 1.489 -1.374 0 CA-C-O 120.865 0.364 . . . . 17.170000000000002 111.1 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -94.51 112.17 23.93 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.546 2.117 . . . . 21.890000000000001 111.099 -176.065 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 pt -120.31 150.99 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 O-C-N 116.379 -3.951 . . . . 10.83 111.833 174.039 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -116.27 150.52 37.46 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.606 -1.998 . . . . 10.609999999999999 105.606 -174.248 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.2 t -132.18 135.42 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 N-CA-C 100.423 -3.917 . . . . 9.1300000000000008 100.423 -176.539 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.3 mttm -119.81 143.49 47.84 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 126.735 3.159 . . . . 20.550000000000001 107.17 175.36 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.2 p -83.85 -175.43 5.8 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.082 -3.511 . . . . 11.779999999999999 114.212 172.82 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.1 tp -66.57 -51.53 55.41 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.826 -0.435 . . . . 19.309999999999999 109.826 -176.9 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.6 p -75.07 -31.96 61.38 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 117.252 -1.356 . . . . 23.140000000000001 109.004 -177.567 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.11 71.62 0.6 Allowed Glycine 0 N--CA 1.43 -1.718 0 CA-C-N 122.95 2.613 . . . . 19.739999999999998 116.206 174.012 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 pttt -118.81 147.9 43.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 100.471 -3.9 . . . . 21.93 100.471 159.915 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.4 m -104.06 116.15 31.71 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 125.316 1.446 . . . . 12.33 108.439 -179.488 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.1 mt -81.07 128.92 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 0 N-CA-C 104.793 -2.299 . . . . 17.079999999999998 104.793 166.122 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.0 m -104.74 135.02 46.9 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 118.645 0.657 . . . . 16.300000000000001 109.846 173.288 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.4 mt -122.43 119.67 31.67 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 118.572 2.805 . . . . 15.880000000000001 118.572 179.984 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -86.79 103.33 15.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 119.912 1.233 . . . . 28.899999999999999 108.715 167.509 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.4 m -110.23 169.59 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 129.574 3.15 . . . . 12.050000000000001 109.698 179.447 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -108.03 145.67 31.9 Favored Pre-proline 0 N--CA 1.429 -1.483 0 CA-C-O 117.488 -1.244 . . . . 18.170000000000002 110.044 177.227 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.335 42.4 Cg_exo -47.51 -36.03 23.32 Favored 'Trans proline' 0 C--N 1.3 -2.02 1 N-CA-C 123.002 4.193 . . . . 8.1600000000000001 123.002 -175.238 . . . . . . . . 3 2 . 1 . 090 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.18 5.37 34.39 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.11 2.164 . . . . 11.130000000000001 114.567 176.947 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -62.1 132.38 52.66 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.082 -2.886 . . . . 18.030000000000001 116.212 176.623 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.266 8.0 p -67.14 161.84 23.74 Favored 'General case' 0 N--CA 1.429 -1.493 1 O-C-N 115.857 -4.277 . . . . 10.220000000000001 107.591 171.915 . . . . . . . . 3 2 . 1 . 090 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -61.55 -41.29 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 119.007 -2.308 . . . . 12.300000000000001 115.498 171.064 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -64.2 -27.53 69.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.814 2.552 . . . . 36.509999999999998 112.725 172.665 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -70.14 -34.94 73.67 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.956 -1.715 . . . . 25.66 112.735 169.411 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.52 -41.89 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 1 O-C-N 115.419 -4.551 . . . . 8.1199999999999992 116.914 169.493 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -54.95 -29.46 56.61 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.532 2.733 . . . . 15.470000000000001 115.713 166.024 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.19 -32.47 66.85 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 118.431 -0.795 . . . . 11.449999999999999 110.991 -177.111 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -70.25 -20.33 63.07 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.959 1.838 . . . . 24.98 114.965 170.3 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.8 mt -86.19 -28.47 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 1 O-C-N 115.537 -4.477 . . . . 9.4600000000000009 111.531 177.111 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -64.57 -40.35 95.4 Favored 'General case' 0 N--CA 1.43 -1.461 1 C-N-CA 131.744 4.018 . . . . 14.76 109.484 174.358 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.6 -50.49 15.37 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 121.107 -0.996 . . . . 26.289999999999999 111.064 173.922 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -73.15 -70.05 0.38 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 115.521 1.674 . . . . 30.059999999999999 115.521 -175.956 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -67.69 -50.88 55.35 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 118.853 0.751 . . . . 25.190000000000001 112.658 -177.64 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.54 21.72 10.29 Favored Glycine 0 N--CA 1.43 -1.726 0 N-CA-C 118.332 2.093 . . . . 7.4100000000000001 118.332 -176.37 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 71' ' ' LEU . 17.1 mt -82.85 126.59 72.52 Favored Pre-proline 0 N--CA 1.43 -1.471 0 C-N-CA 127.082 2.153 . . . . 9.4900000000000002 108.9 168.743 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -72.63 167.96 25.72 Favored 'Trans proline' 0 C--N 1.3 -2.008 0 CA-C-O 117.187 -1.255 . . . . 11.42 110.195 -172.455 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 12.2 Cg_endo -86.08 -15.86 4.45 Favored 'Trans proline' 0 C--N 1.3 -1.992 0 CA-C-N 124.557 2.663 . . . . 12.0 112.676 -169.302 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -73.14 -32.82 65.15 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 123.32 1.533 . . . . 35.549999999999997 115.059 171.258 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -76.32 -36.04 58.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 123.526 1.631 . . . . 20.52 114.779 -177.943 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.254 72.0 mt-30 -64.15 135.42 56.32 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-O 127.526 3.536 . . . . 7.1299999999999999 113.36 170.532 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -131.97 116.16 16.78 Favored 'General case' 0 N--CA 1.431 -1.416 1 C-N-CA 132.001 4.12 . . . . 36.390000000000001 108.893 169.784 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.8 mt -97.24 144.22 27.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.558 1.786 . . . . 9.5500000000000007 109.51 176.569 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 tp -139.72 137.16 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 119.168 -2.208 . . . . 13.9 113.49 171.388 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.338 76.7 t80 -88.18 -62.06 1.57 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 121.266 -0.896 . . . . 6.8600000000000003 113.347 171.772 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -136.8 -89.17 0.28 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.881 -1.525 . . . . 11.15 106.881 -177.763 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -141.76 9.01 2.56 Favored Glycine 0 N--CA 1.43 -1.713 0 CA-C-O 116.303 -2.387 . . . . 13.93 116.815 175.964 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -82.64 131.98 35.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 121.311 2.556 . . . . 23.920000000000002 110.121 162.798 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.6 tt0 -75.13 114.0 13.12 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 124.364 2.03 . . . . 23.23 111.189 -177.928 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.335 10.2 mt -73.08 101.57 3.31 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 130.06 3.344 . . . . 9.1099999999999994 111.716 -177.924 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HB2' ' HG3' ' A' ' 54' ' ' ARG . 45.2 mt-10 -67.81 -172.92 0.3 Allowed 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 117.908 -2.995 . . . . 33.439999999999998 116.475 170.172 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -85.58 -63.49 1.32 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.993 -4.192 . . . . 28.370000000000001 113.973 -176.143 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -92.96 40.32 2.85 Favored Glycine 0 N--CA 1.43 -1.706 0 C-N-CA 125.574 1.559 . . . . 15.0 115.842 -170.625 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.431 ' HG3' ' HB2' ' A' ' 51' ' ' GLU . 21.6 mmt180 -124.46 145.2 49.65 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.67 -1.974 . . . . 25.5 105.67 -174.061 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.528 1.1 p -89.36 157.15 18.28 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 127.747 3.641 . . . . 11.949999999999999 116.347 -169.032 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.7 mt -63.02 -36.33 83.19 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 116.041 -4.162 . . . . 10.17 110.346 174.418 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 t -65.39 -42.01 93.1 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 129.27 3.028 . . . . 13.59 112.077 -177.546 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -81.41 -14.43 57.14 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.602 2.144 . . . . 11.699999999999999 110.744 -171.262 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -103.27 4.64 36.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.708 -3.745 . . . . 12.949999999999999 103.93 176.919 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 50.51 47.2 24.5 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.576 2.751 . . . . 25.449999999999999 117.521 -176.461 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.0 mt -84.39 106.55 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-N 112.664 -2.062 . . . . 14.6 109.23 172.328 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.8 mm100 -104.96 -174.17 2.47 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.083 -2.326 . . . . 33.229999999999997 110.958 -167.646 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.1 pttm -83.97 136.08 34.21 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.536 1.516 . . . . 25.969999999999999 112.399 -161.761 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.298 18.2 mt-10 81.38 20.75 0.37 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.296 1.838 . . . . 32.609999999999999 115.909 -169.368 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.3 m -70.54 131.82 44.58 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 116.679 -1.629 . . . . 10.56 111.972 172.081 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.4 m -103.57 125.82 50.34 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.246 -1.391 . . . . 5.3300000000000001 107.246 -179.536 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -109.52 164.16 12.77 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.397 -2.689 . . . . 11.66 106.562 -173.262 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.7 t60 -117.12 139.6 50.53 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.566 -3.209 . . . . 16.300000000000001 110.198 176.811 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.2 tp -106.23 104.04 13.65 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 128.713 2.805 . . . . 9.9600000000000009 111.475 -178.222 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -97.05 140.4 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-N 113.345 -1.752 . . . . 9.7599999999999998 111.54 174.236 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.442 HD21 HG21 ' A' ' 36' ' ' ILE . 37.6 mt -101.8 150.94 22.64 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.718 1.145 . . . . 19.57 112.744 162.314 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.292 43.4 ttp180 -113.71 134.39 54.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 115.414 -0.812 . . . . 35.079999999999998 109.186 -175.811 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.1 tp -93.02 -80.9 0.37 Allowed 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.895 -2.378 . . . . 32.310000000000002 110.913 174.281 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -163.35 130.73 3.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.379 -2.452 . . . . 42.75 104.379 -176.602 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.75 -120.87 0.61 Allowed Glycine 0 N--CA 1.43 -1.743 0 CA-C-O 117.078 -1.957 . . . . 36.310000000000002 110.697 177.635 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.761 0 CA-C-O 116.072 -2.516 . . . . 36.270000000000003 114.506 175.677 . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.1 ttp . . . . . 0 CA--C 1.489 -1.374 0 CA-C-O 121.746 0.784 . . . . 17.170000000000002 112.989 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -84.77 121.35 27.57 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.396 -2.69 . . . . 21.890000000000001 110.293 -175.451 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.6 pt -127.7 168.88 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 123.191 2.723 . . . . 10.83 110.974 160.187 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -120.47 147.69 44.79 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 125.064 1.477 . . . . 10.609999999999999 110.929 -176.635 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -117.08 118.93 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 1 C-N-CA 131.782 4.033 . . . . 9.1300000000000008 112.365 163.774 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -103.46 124.89 49.58 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.859 -2.401 . . . . 20.550000000000001 111.563 176.701 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.305 34.7 p -77.79 175.56 9.86 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.105 1.431 . . . . 11.779999999999999 113.44 -174.594 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.499 ' HA ' ' HE1' ' A' ' 68' ' ' HIS . 52.1 tp -65.07 -55.27 19.8 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 128.358 2.663 . . . . 19.309999999999999 115.378 -178.788 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.3 p -60.73 -62.75 1.63 Allowed 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 119.881 1.219 . . . . 23.140000000000001 110.633 165.253 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.24 64.14 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.742 0 CA-C-N 122.417 2.371 . . . . 19.739999999999998 115.092 176.875 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -118.7 128.26 54.34 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 114.019 -2.896 . . . . 21.93 106.885 178.197 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 m -109.46 115.37 29.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 125.471 3.76 . . . . 12.33 101.681 -173.866 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.27 132.07 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.489 0 O-C-N 119.002 -2.312 . . . . 17.079999999999998 109.888 178.102 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.9 m -98.38 119.65 37.43 Favored 'General case' 0 N--CA 1.43 -1.454 1 O-C-N 116.109 -4.12 . . . . 16.300000000000001 111.196 179.361 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.9 mt -106.39 162.55 13.6 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.966 2.506 . . . . 15.880000000000001 109.928 -175.477 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -135.22 97.68 3.78 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 101.689 -3.449 . . . . 28.899999999999999 101.689 178.734 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.1 m -105.66 163.15 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 N-CA-C 117.416 2.376 . . . . 12.050000000000001 117.416 -174.666 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.256 2.9 mp0 -73.46 138.57 77.86 Favored Pre-proline 0 N--CA 1.431 -1.422 0 CA-C-O 114.749 -2.548 . . . . 18.170000000000002 108.285 162.35 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -58.97 -24.53 73.6 Favored 'Trans proline' 0 C--N 1.299 -2.04 1 C-N-CA 128.073 5.848 . . . . 8.1600000000000001 119.442 -179.868 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.6 m -117.41 28.63 8.35 Favored 'General case' 0 N--CA 1.43 -1.471 1 N-CA-C 122.454 4.242 . . . . 11.130000000000001 122.454 173.437 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -77.18 170.7 16.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.402 -2.061 . . . . 18.030000000000001 113.802 -179.289 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.328 69.0 p -90.48 154.39 19.68 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.418 2.007 . . . . 10.220000000000001 116.418 -174.982 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.8 mt -71.4 -19.84 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 CA-C-N 119.447 1.021 . . . . 12.300000000000001 112.237 178.003 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -62.77 -39.43 94.16 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 116.138 -4.101 . . . . 36.509999999999998 106.359 166.435 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -82.01 -29.55 31.97 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 122.213 2.279 . . . . 25.66 112.457 -174.398 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.36 40.5 t -46.22 -62.8 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 O-C-N 118.012 -2.93 . . . . 8.1199999999999992 114.544 154.252 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -54.21 -39.67 66.93 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.039 2.237 . . . . 15.470000000000001 117.039 172.039 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.89 -40.29 92.5 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.641 -4.412 . . . . 11.449999999999999 111.852 173.919 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -61.36 -38.82 88.38 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.417 2.377 . . . . 24.98 117.417 163.063 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.267 72.5 mt -63.35 -41.53 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-N 122.145 2.248 . . . . 9.4600000000000009 116.132 172.497 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -60.75 -40.49 92.63 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 126.067 1.747 . . . . 14.76 115.324 173.689 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -60.02 -50.18 74.76 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 125.828 2.728 . . . . 26.289999999999999 115.629 173.107 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 44.2 tptt -75.31 -68.27 0.57 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 109.405 -3.543 . . . . 30.059999999999999 115.377 -175.121 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -87.82 -16.3 34.45 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 130.743 3.617 . . . . 25.190000000000001 111.445 -170.729 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 78.39 13.15 83.56 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 120.534 2.974 . . . . 7.4100000000000001 120.534 -178.942 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.1 mt -76.03 115.67 48.74 Favored Pre-proline 0 N--CA 1.43 -1.429 0 CA-C-O 116.521 -1.704 . . . . 9.4900000000000002 110.622 176.84 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -60.07 155.43 45.04 Favored 'Trans proline' 0 C--N 1.3 -2.016 0 C-N-CA 123.673 2.915 . . . . 11.42 109.805 -172.797 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.41 -25.66 17.97 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 124.071 2.49 . . . . 12.0 112.376 -167.782 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.84 -40.55 88.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.305 -3.372 . . . . 35.549999999999997 108.864 -175.087 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.432 ' OE1' HD23 ' A' ' 71' ' ' LEU . 7.2 tt0 -63.33 -23.75 67.55 Favored 'General case' 0 N--CA 1.431 -1.405 0 CA-C-N 113.519 -1.673 . . . . 20.52 114.446 -177.974 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -87.91 131.7 34.48 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 126.417 3.008 . . . . 7.1299999999999999 118.295 -173.628 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -120.06 106.16 11.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.126 -2.859 . . . . 36.390000000000001 110.23 166.629 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.52 132.75 36.07 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 115.56 -4.463 . . . . 9.5500000000000007 113.299 175.698 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 72.5 mt -106.88 141.92 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 127.516 2.327 . . . . 13.9 107.931 176.815 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -91.5 -83.03 0.29 Allowed 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.328 2.489 . . . . 6.8600000000000003 107.792 163.04 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.05 -71.43 0.74 Allowed 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 126.473 1.909 . . . . 11.15 115.887 176.459 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.74 -41.66 0.08 OUTLIER Glycine 0 N--CA 1.43 -1.744 0 CA-C-O 124.083 1.935 . . . . 13.93 114.207 -166.886 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 mtmt -103.38 155.36 18.54 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 121.493 -1.004 . . . . 23.920000000000002 112.94 -169.594 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -86.59 132.08 33.99 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 118.016 2.599 . . . . 23.23 118.016 -156.396 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -92.84 146.2 23.82 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.395 2.309 . . . . 9.1099999999999994 109.93 -174.398 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.98 153.45 17.9 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 117.145 -3.472 . . . . 33.439999999999998 106.573 177.767 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.66 -63.17 1.3 Allowed 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.066 -4.772 . . . . 28.370000000000001 114.315 -178.906 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.06 35.55 3.4 Favored Glycine 0 N--CA 1.431 -1.675 0 C-N-CA 119.229 -1.462 . . . . 15.0 110.451 -172.225 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.7 mtt-85 -106.55 161.18 14.84 Favored 'General case' 0 N--CA 1.429 -1.489 1 O-C-N 114.367 -5.196 . . . . 25.5 111.478 164.813 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.3 p -97.89 171.96 7.96 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 114.284 -5.26 . . . . 11.949999999999999 111.878 -166.842 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.0 mt -59.79 -37.09 78.14 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 112.863 -1.971 . . . . 10.17 109.027 169.338 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 t -81.71 -10.7 59.31 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 123.881 0.872 . . . . 13.59 112.71 -169.012 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -78.13 -50.29 12.27 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 127.504 3.526 . . . . 11.699999999999999 114.815 173.694 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -82.8 -20.71 35.22 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.949 -4.845 . . . . 12.949999999999999 112.164 179.849 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.357 23.2 m-80 72.63 65.94 0.12 Allowed 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.233 3.049 . . . . 25.449999999999999 119.233 179.862 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.7 mt -106.13 93.55 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-N 109.157 -3.656 . . . . 14.6 105.104 -178.894 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -85.3 -166.19 1.43 Allowed 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 117.033 -3.542 . . . . 33.229999999999997 114.381 179.223 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.368 14.8 pttp -62.43 134.85 57.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.36 -3.338 . . . . 25.969999999999999 114.271 -177.068 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.322 21.5 mt-10 70.05 15.87 7.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.527 2.047 . . . . 32.609999999999999 116.527 169.23 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.7 m -61.45 140.32 58.08 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.068 3.347 . . . . 10.56 112.457 159.427 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -110.54 111.03 21.99 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-N 119.865 1.212 . . . . 5.3300000000000001 113.515 175.24 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.6 mt -78.86 153.46 30.56 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 119.276 -2.14 . . . . 11.66 108.605 173.589 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.499 ' HE1' ' HA ' ' A' ' 8' ' ' LEU . 11.9 t60 -121.79 137.56 54.72 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 124.323 2.011 . . . . 16.300000000000001 107.619 175.935 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 31.3 tp -116.19 124.91 51.46 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.454 -2.029 . . . . 9.9600000000000009 109.019 -174.668 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 68.8 t -112.08 139.68 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 C-N-CA 125.039 1.336 . . . . 9.7599999999999998 110.068 -179.53 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.432 HD23 ' OE1' ' A' ' 40' ' ' GLN . 7.8 mp -95.05 139.0 32.02 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 115.861 -2.336 . . . . 19.57 113.942 -176.682 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -119.67 157.03 29.33 Favored 'General case' 0 N--CA 1.431 -1.423 1 N-CA-C 100.046 -4.057 . . . . 35.079999999999998 100.046 -162.928 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.3 tp -113.79 -54.27 2.61 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 125.979 2.8 . . . . 32.310000000000002 105.042 177.237 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -159.63 123.61 3.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 112.846 -1.979 . . . . 42.75 111.04 177.627 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.47 25.2 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.702 0 C-N-CA 118.44 -1.838 . . . . 36.310000000000002 117.448 171.012 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.79 0 C-N-CA 118.029 -2.034 . . . . 36.270000000000003 109.45 164.476 . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 CA--C 1.491 -1.326 0 N-CA-C 114.308 1.225 . . . . 17.170000000000002 114.308 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -93.13 118.29 31.05 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 116.525 -1.702 . . . . 21.890000000000001 107.345 -174.228 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.295 19.4 pt -120.22 151.78 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 126.446 2.341 . . . . 10.83 108.51 169.926 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -118.55 149.18 41.75 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 103.244 -2.873 . . . . 10.609999999999999 103.244 178.073 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -111.03 140.6 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-N 110.376 -3.102 . . . . 9.1300000000000008 117.019 162.653 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.1 ttmt -123.28 128.31 49.78 Favored 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.779 -4.325 . . . . 20.550000000000001 110.835 -178.363 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.264 39.7 p -91.33 174.1 7.56 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 119.518 -1.989 . . . . 11.779999999999999 112.247 -176.229 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.264 12.8 tp -63.94 -52.82 58.01 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.785 -2.462 . . . . 19.309999999999999 115.192 171.369 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.4 -58.69 3.12 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.995 -2.316 . . . . 23.140000000000001 115.85 -175.804 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.44 53.92 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.717 0 CA-C-N 120.571 1.532 . . . . 19.739999999999998 111.909 167.745 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 mtpt -112.74 136.65 52.09 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 120.121 -1.811 . . . . 21.93 109.473 163.599 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.0 m -104.23 110.86 23.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 128.334 3.521 . . . . 12.33 101.864 170.488 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.6 mt -102.42 129.96 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 N-CA-C 101.142 -3.651 . . . . 17.079999999999998 101.142 -176.013 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 m -97.77 128.27 44.3 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.046 1.738 . . . . 16.300000000000001 107.462 177.089 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.455 HD22 ' HG2' ' A' ' 29' ' ' LYS . 58.2 mt -118.72 158.2 26.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.353 2.342 . . . . 15.880000000000001 110.993 170.735 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -102.6 122.18 43.89 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 103.144 -2.909 . . . . 28.899999999999999 103.144 165.092 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 m -137.46 177.62 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 C-N-CA 117.989 -1.484 . . . . 12.050000000000001 110.147 176.451 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -107.26 157.82 34.59 Favored Pre-proline 0 N--CA 1.43 -1.458 0 N-CA-C 105.863 -1.902 . . . . 18.170000000000002 105.863 173.904 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.307 18.5 Cg_endo -66.82 -15.02 46.03 Favored 'Trans proline' 0 C--N 1.3 -1.996 1 C-N-CA 126.829 5.019 . . . . 8.1600000000000001 110.502 168.273 . . . . . . . . 3 2 . 1 . 092 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.2 m -94.69 0.12 54.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.577 -2.577 . . . . 11.130000000000001 115.67 -175.888 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -78.18 145.32 35.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.724 -2.485 . . . . 18.030000000000001 114.224 178.116 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.7 p -81.12 148.88 29.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.38 -2.7 . . . . 10.220000000000001 104.201 176.589 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.7 mt -76.37 -26.61 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 121.261 -0.899 . . . . 12.300000000000001 111.06 -173.402 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.296 17.0 pt-20 -51.8 -35.69 45.09 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 117.104 -1.426 . . . . 36.509999999999998 114.68 161.488 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -77.7 -39.85 43.33 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 117.167 -1.397 . . . . 25.66 113.73 176.128 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.4 t -57.91 -40.32 75.76 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 CA-C-N 121.086 1.766 . . . . 8.1199999999999992 109.472 176.875 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' HD2' ' HB2' ' A' ' 41' ' ' GLN . 55.8 mtmt -73.57 -35.67 65.48 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 124.499 1.12 . . . . 15.470000000000001 112.755 177.985 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.13 83.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 118.476 -1.289 . . . . 11.449999999999999 113.647 171.574 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG2' HD22 ' A' ' 15' ' ' LEU 0.347 29.8 ttmt -48.09 -40.38 23.14 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 117.219 -3.426 . . . . 24.98 112.022 161.382 . . . . . . . . 3 3 . 1 . 092 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.1 -35.94 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 120.706 1.594 . . . . 9.4600000000000009 111.296 177.865 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -49.9 -47.85 51.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 115.607 -2.14 . . . . 14.76 114.188 163.424 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -63.33 -38.43 91.11 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 121.315 1.871 . . . . 26.289999999999999 113.951 177.65 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -72.48 -67.21 0.57 Allowed 'General case' 0 N--CA 1.429 -1.486 1 C-N-CA 131.868 4.067 . . . . 30.059999999999999 110.238 -178.686 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -97.84 -72.83 0.63 Allowed 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.473 -2.017 . . . . 25.190000000000001 110.56 -166.859 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.47 64.73 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 118.427 2.131 . . . . 7.4100000000000001 118.427 169.714 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.6 mt -133.56 116.18 13.83 Favored Pre-proline 0 N--CA 1.43 -1.446 0 C-N-CA 128.151 2.58 . . . . 9.4900000000000002 104.244 -168.359 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -57.39 156.34 26.45 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 CA-C-N 123.731 2.368 . . . . 11.42 116.007 -172.325 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -78.66 -15.29 13.73 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 CA-C-N 124.39 2.604 . . . . 12.0 112.51 -172.596 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -75.08 -42.4 56.81 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 121.792 0.806 . . . . 35.549999999999997 110.753 175.268 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -68.56 -26.59 65.48 Favored 'General case' 0 N--CA 1.43 -1.454 1 C-N-CA 134.126 4.971 . . . . 20.52 111.784 -175.239 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.53 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 69.6 mt-30 -86.84 135.68 33.25 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.925 -2.36 . . . . 7.1299999999999999 110.213 178.239 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 ttt180 -121.35 118.63 29.94 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 105.42 -2.067 . . . . 36.390000000000001 105.42 166.684 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.538 ' O ' HD12 ' A' ' 50' ' ' LEU . 62.3 mt -93.46 120.97 34.37 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.482 3.113 . . . . 9.5500000000000007 111.849 177.86 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.5 mt -109.29 134.07 52.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 O-C-N 117.119 -3.488 . . . . 13.9 107.488 173.957 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -91.27 -73.09 0.55 Allowed 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 123.764 2.984 . . . . 6.8600000000000003 103.56 163.909 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.32 -140.19 0.2 Allowed 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 124.475 2.083 . . . . 11.15 107.122 -172.387 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.03 -23.65 69.7 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 122.609 3.803 . . . . 13.93 122.609 -176.191 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -76.81 162.7 27.44 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 115.989 -4.242 . . . . 23.920000000000002 118.149 174.491 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.282 81.6 mm-40 -84.87 133.93 34.3 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.719 -1.238 . . . . 23.23 111.806 167.456 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.538 HD12 ' O ' ' A' ' 43' ' ' LEU . 60.4 mt -93.25 132.78 37.12 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 121.384 -0.822 . . . . 9.1099999999999994 110.733 177.328 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -93.27 122.34 35.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.012 2.125 . . . . 33.439999999999998 107.897 168.78 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -68.06 -25.12 65.2 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 126.459 1.904 . . . . 28.370000000000001 114.149 -168.794 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -85.78 -2.69 86.45 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 126.253 1.882 . . . . 15.0 117.723 -179.573 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 85.3 mtt-85 -104.9 -176.61 3.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 122.908 1.337 . . . . 25.5 107.984 172.63 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.4 p -100.43 178.07 4.85 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 115.724 1.75 . . . . 11.949999999999999 115.724 -173.557 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -66.95 -35.95 81.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.97 3.308 . . . . 10.17 112.408 167.79 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.2 t -72.77 -36.71 67.7 Favored 'General case' 0 N--CA 1.431 -1.387 1 O-C-N 113.947 -5.471 . . . . 13.59 112.485 -179.052 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -66.98 -38.34 85.88 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.854 3.261 . . . . 11.699999999999999 110.938 176.11 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -88.57 -4.13 58.65 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.659 -1.9 . . . . 12.949999999999999 110.738 176.301 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.3 m120 57.68 58.85 3.49 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 131.508 3.923 . . . . 25.449999999999999 111.677 178.083 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.2 mm -102.28 108.81 24.76 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 105.309 -2.108 . . . . 14.6 105.309 -178.113 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -108.79 169.23 8.8 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 127.361 2.913 . . . . 33.229999999999997 109.335 -171.577 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.2 pttp -44.68 138.69 3.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 125.587 2.613 . . . . 25.969999999999999 112.343 -176.345 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.281 18.1 mt-10 60.16 6.16 0.94 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 130.119 3.368 . . . . 32.609999999999999 115.296 175.702 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.6 m -62.73 140.83 58.75 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 116.183 -4.073 . . . . 10.56 113.354 160.838 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.6 m -103.91 122.32 44.94 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.493 3.517 . . . . 5.3300000000000001 110.557 -175.407 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -86.24 156.35 20.32 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 127.089 2.743 . . . . 11.66 113.608 170.85 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -121.46 120.32 34.6 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-N 123.089 2.677 . . . . 16.300000000000001 111.223 168.365 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.6 tp -84.46 124.08 30.96 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 126.582 2.426 . . . . 9.9600000000000009 116.702 173.962 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.3 127.8 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 103.433 -2.803 . . . . 9.7599999999999998 103.433 179.423 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.286 1.3 mm? -65.36 136.53 56.64 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.867 -1.77 . . . . 19.57 115.212 175.43 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -119.36 150.61 39.88 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 126.035 2.826 . . . . 35.079999999999998 111.473 -178.341 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.323 28.9 mt -84.66 -67.69 0.78 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 114.64 -5.037 . . . . 32.310000000000002 111.828 169.463 . . . . . . . . 3 2 . 1 . 092 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.7 ttm-85 -153.03 144.65 23.44 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.866 -3.022 . . . . 42.75 108.519 -176.915 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.57 -73.78 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.726 0 O-C-N 117.462 -3.273 . . . . 36.310000000000002 119.339 175.298 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.759 0 N-CA-C 109.648 -1.381 . . . . 36.270000000000003 109.648 -161.671 . . . . . . . . 0 0 . 1 . 093 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.3 ptt? . . . . . 0 CA--C 1.49 -1.345 0 N-CA-C 113.766 1.024 . . . . 17.170000000000002 113.766 . . . . . . . . . 0 0 . 1 . 093 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -90.49 121.44 32.45 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 123.412 1.577 . . . . 21.890000000000001 113.795 -178.643 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.9 pt -123.54 151.92 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 O-C-N 114.145 -5.347 . . . . 10.83 108.653 168.449 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -115.93 137.01 52.5 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 119.484 1.038 . . . . 10.609999999999999 111.447 -179.451 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 t -109.82 130.23 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 130.134 3.374 . . . . 9.1300000000000008 109.028 168.049 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -122.84 137.61 54.88 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 111.586 -2.552 . . . . 20.550000000000001 107.097 -173.251 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.329 55.2 p -100.88 -173.38 2.37 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 119.696 1.134 . . . . 11.779999999999999 110.881 -170.085 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.4 mt -74.01 -41.27 62.13 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.855 -3.028 . . . . 19.309999999999999 111.982 177.62 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.95 -57.56 9.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.237 -1.54 . . . . 23.140000000000001 108.135 165.768 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 150.25 6.86 0.17 Allowed Glycine 0 N--CA 1.43 -1.762 0 C-N-CA 117.618 -2.229 . . . . 19.739999999999998 115.436 177.55 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -77.29 149.46 35.36 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 122.661 3.231 . . . . 21.93 110.715 -161.786 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.3 m -113.72 110.73 20.64 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.974 -3.579 . . . . 12.33 105.939 -174.601 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -103.04 121.66 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 CA-C-N 111.212 -2.722 . . . . 17.079999999999998 112.289 169.392 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.3 m -103.66 114.07 28.06 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 128.003 3.314 . . . . 16.300000000000001 106.832 -174.37 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.4 mt -104.14 141.7 35.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.147 -1.596 . . . . 15.880000000000001 112.295 178.651 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.2 tp10 -84.13 100.81 11.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 126.406 1.883 . . . . 28.899999999999999 107.87 164.592 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -120.93 151.34 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 108.295 -1.002 . . . . 12.050000000000001 108.295 179.103 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -91.23 164.08 26.4 Favored Pre-proline 0 N--CA 1.429 -1.484 0 C-N-CA 116.906 -1.918 . . . . 18.170000000000002 106.394 171.263 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -82.76 -8.06 11.31 Favored 'Trans proline' 0 C--N 1.3 -1.996 0 C-N-CA 122.515 2.144 . . . . 8.1600000000000001 108.872 -177.635 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.5 m -86.67 -4.54 59.19 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-O 123.795 1.759 . . . . 11.130000000000001 115.717 171.722 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -83.13 137.74 33.95 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.499 -2.001 . . . . 18.030000000000001 107.282 -168.284 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.1 p -74.21 157.84 35.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 126.631 3.11 . . . . 10.220000000000001 112.57 174.169 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 53.8 mt -69.19 -21.4 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 1 O-C-N 115.907 -4.246 . . . . 12.300000000000001 110.499 175.6 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -60.06 -48.18 82.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.02 2.343 . . . . 36.509999999999998 115.328 161.752 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -60.76 -41.03 94.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.38 3.072 . . . . 25.66 114.566 173.037 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -57.44 -55.68 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 129.191 2.997 . . . . 8.1199999999999992 114.986 164.23 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -46.58 -44.89 18.49 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 114.683 -5.011 . . . . 15.470000000000001 118.73 164.964 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.96 -36.71 75.45 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 124.725 2.202 . . . . 11.449999999999999 115.768 -177.854 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.5 tttt -69.83 -34.9 74.29 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.269 -2.242 . . . . 24.98 110.951 178.602 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -59.36 -43.61 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 125.861 1.665 . . . . 9.4600000000000009 109.892 171.403 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -68.05 -42.93 79.79 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.072 -1.642 . . . . 14.76 108.752 -174.882 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.36 -46.92 87.31 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.399 2.28 . . . . 26.289999999999999 112.602 176.598 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -79.31 -57.25 3.8 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.703 2.112 . . . . 30.059999999999999 116.703 179.561 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -85.31 -54.64 4.47 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.708 -3.745 . . . . 25.190000000000001 116.003 -179.78 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.05 54.26 0.98 Allowed Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 124.509 1.052 . . . . 7.4100000000000001 115.161 -176.012 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 59.7 mt -119.48 125.57 27.44 Favored Pre-proline 0 N--CA 1.43 -1.442 0 N-CA-C 104.585 -2.376 . . . . 9.4900000000000002 104.585 165.614 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 43.0 Cg_endo -75.32 159.17 40.48 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 C-N-CA 123.721 2.948 . . . . 11.42 113.276 -176.672 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 41.8 Cg_exo -61.65 -11.41 20.27 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 C-N-CA 124.952 3.768 . . . . 12.0 115.651 -179.765 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -85.7 -28.72 24.48 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 121.488 1.949 . . . . 35.549999999999997 106.414 -173.935 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -85.43 -28.66 24.94 Favored 'General case' 0 N--CA 1.43 -1.47 1 O-C-N 115.365 -4.584 . . . . 20.52 110.222 -178.191 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -74.29 130.42 39.68 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.978 2.323 . . . . 7.1299999999999999 114.443 -177.858 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.0 ttt180 -132.89 126.86 33.11 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 112.81 -1.996 . . . . 36.390000000000001 111.172 164.584 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.2 mt -108.25 114.88 29.09 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-N 109.286 -3.597 . . . . 9.5500000000000007 113.89 -163.646 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.0 mt -129.57 135.19 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 O-C-N 118.685 -2.51 . . . . 13.9 106.132 -172.217 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -96.02 -54.89 3.15 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.185 1.945 . . . . 6.8600000000000003 110.701 173.308 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.28 -126.35 0.27 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 108.899 -3.773 . . . . 11.15 108.026 -176.064 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.5 6.51 12.69 Favored Glycine 0 N--CA 1.43 -1.756 0 C-N-CA 127.755 2.598 . . . . 13.93 107.55 -170.732 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -110.16 145.11 37.8 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 115.352 1.612 . . . . 23.920000000000002 115.352 -175.553 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -75.1 121.59 22.28 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 126.239 1.816 . . . . 23.23 111.919 -174.515 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.5 mt -94.68 120.7 35.32 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.393 2.677 . . . . 9.1099999999999994 110.496 176.61 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.74 143.26 28.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.81 -3.057 . . . . 33.439999999999998 107.641 -177.53 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -65.38 -39.48 92.3 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.027 -1.442 . . . . 28.370000000000001 112.076 -162.45 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.35 -11.77 81.6 Favored Glycine 0 N--CA 1.43 -1.735 0 N-CA-C 120.289 2.875 . . . . 15.0 120.289 -168.672 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -91.26 173.57 7.85 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.657 -2.084 . . . . 25.5 105.765 -178.209 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.2 p -113.83 174.36 5.97 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 124.72 2.2 . . . . 11.949999999999999 108.142 -166.91 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.06 -31.11 72.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.444 -2.035 . . . . 10.17 113.989 173.164 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -67.77 -31.99 72.26 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.781 2.141 . . . . 13.59 116.781 175.716 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -61.92 -50.29 72.75 Favored 'General case' 0 N--CA 1.43 -1.444 1 C-N-CA 132.342 4.257 . . . . 11.699999999999999 110.214 176.811 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -89.87 -20.93 22.83 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 124.172 1.939 . . . . 12.949999999999999 115.198 -178.533 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.339 16.1 m120 85.65 41.73 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.409 0 C-N-CA 127.346 2.258 . . . . 25.449999999999999 111.88 175.193 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.3 mm -79.31 115.52 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 CA-C-O 124.323 2.011 . . . . 14.6 109.002 169.148 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -95.04 -174.16 3.16 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.405 -1.27 . . . . 33.229999999999997 111.941 -177.559 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.5 ptmt -66.82 146.27 54.6 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 125.689 1.596 . . . . 25.969999999999999 112.583 175.853 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.461 65.3 mt-10 76.43 11.73 2.71 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 116.979 2.214 . . . . 32.609999999999999 116.979 -179.417 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.254 56.2 m -84.42 141.69 30.64 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.318 1.97 . . . . 10.56 116.318 -169.579 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.4 m -107.7 98.0 7.65 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 119.24 -2.162 . . . . 5.3300000000000001 109.843 -166.769 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -88.93 151.57 22.24 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.517 1.927 . . . . 11.66 107.594 -177.036 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -124.84 123.32 39.68 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.64 2.638 . . . . 16.300000000000001 108.228 -171.874 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.1 tp -94.41 112.29 24.07 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.81 -2.45 . . . . 9.9600000000000009 110.591 -176.624 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.254 38.5 t -103.88 131.57 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 N-CA-C 105.594 -2.002 . . . . 9.7599999999999998 105.594 -171.925 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -99.57 115.23 28.9 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.789 -3.069 . . . . 19.57 112.7 -171.401 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.0 ttp180 -75.86 153.44 36.78 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 110.582 -3.008 . . . . 35.079999999999998 117.714 -160.227 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.9 mt -81.66 -99.33 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 117.008 -3.558 . . . . 32.310000000000002 112.812 158.551 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 -135.26 155.94 49.8 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.939 -1.028 . . . . 42.75 109.739 173.95 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.75 177.17 37.79 Favored Glycine 0 N--CA 1.43 -1.761 0 O-C-N 125.344 1.652 . . . . 36.310000000000002 110.538 175.998 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.759 0 C-N-CA 126.039 1.781 . . . . 36.270000000000003 111.228 -179.461 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.49 -1.344 0 N-CA-C 116.607 2.077 . . . . 17.170000000000002 116.607 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -90.87 144.2 25.93 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.97 -4.206 . . . . 21.890000000000001 112.444 -175.122 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 39.4 pt -122.09 155.16 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 126.023 2.82 . . . . 10.83 103.946 165.543 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -114.95 111.11 20.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.034 -3.542 . . . . 10.609999999999999 103.597 -172.302 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.462 HG22 ' HB2' ' A' ' 67' ' ' LEU . 46.1 t -101.19 135.44 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 116.699 -3.751 . . . . 9.1300000000000008 107.736 179.648 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -115.15 122.79 47.16 Favored 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 125.715 1.606 . . . . 20.550000000000001 112.813 -172.491 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -77.02 172.69 12.79 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 118.19 -2.819 . . . . 11.779999999999999 115.112 177.675 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.518 HD23 ' CE1' ' A' ' 68' ' ' HIS . 40.8 mt -76.58 -23.74 53.5 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 118.274 2.694 . . . . 19.309999999999999 118.274 170.498 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.9 p -83.66 -24.8 31.18 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 115.805 -2.045 . . . . 23.140000000000001 113.501 166.613 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.33 49.8 0.35 Allowed Glycine 0 N--CA 1.43 -1.725 0 CA-C-O 113.636 -3.869 . . . . 19.739999999999998 113.786 161.388 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -114.69 140.16 49.08 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 126.665 2.038 . . . . 21.93 107.511 175.499 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.0 m -84.4 117.13 23.43 Favored 'General case' 0 N--CA 1.43 -1.444 1 O-C-N 116.13 -4.106 . . . . 12.33 108.431 160.856 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.9 mt -86.2 116.21 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.658 -2.349 . . . . 17.079999999999998 104.658 162.984 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.2 m -106.21 97.39 7.21 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 124.834 2.254 . . . . 16.300000000000001 108.808 -172.415 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.3 mt -103.45 116.08 31.73 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.892 -1.958 . . . . 15.880000000000001 112.224 -162.428 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -71.93 119.16 15.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.727 -1.579 . . . . 28.899999999999999 112.893 170.869 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.7 m -135.78 177.55 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-O 125.226 2.441 . . . . 12.050000000000001 109.387 -179.514 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -122.88 167.3 14.81 Favored Pre-proline 0 N--CA 1.43 -1.471 0 O-C-N 117.176 -3.452 . . . . 18.170000000000002 103.781 172.784 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -76.61 -19.35 14.68 Favored 'Trans proline' 0 C--N 1.3 -2.021 1 C-N-CA 125.595 4.196 . . . . 8.1600000000000001 114.985 179.713 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 t -79.89 -14.55 58.55 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.196 2.665 . . . . 11.130000000000001 118.196 171.755 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -72.58 144.83 47.75 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.303 -2.748 . . . . 18.030000000000001 106.263 -168.87 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.5 p -82.69 157.13 23.46 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 118.567 -1.253 . . . . 10.220000000000001 111.854 177.338 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 93.4 mt -72.29 -21.54 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 CA-C-O 128.868 4.175 . . . . 12.300000000000001 114.979 -172.822 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -58.62 -53.77 54.56 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.488 -3.258 . . . . 36.509999999999998 114.612 157.899 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -50.73 -32.83 20.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 116.583 -3.823 . . . . 25.66 115.934 173.974 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.3 t -65.11 -53.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 128.496 2.718 . . . . 8.1199999999999992 108.971 173.092 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -65.28 -35.49 81.18 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.606 1.548 . . . . 15.470000000000001 112.849 -179.887 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.53 92.47 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 124.254 1.022 . . . . 11.449999999999999 112.318 169.88 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -53.0 -43.35 66.41 Favored 'General case' 0 N--CA 1.43 -1.458 2 O-C-N 113.938 -5.476 . . . . 24.98 113.802 169.866 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -64.88 -29.55 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 127.894 2.478 . . . . 9.4600000000000009 112.807 172.67 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -72.92 -45.79 56.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 123.48 2.854 . . . . 14.76 109.21 167.897 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -59.81 -37.04 78.05 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.165 -2.209 . . . . 26.289999999999999 114.997 177.551 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -85.69 -51.1 6.68 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 118.563 2.801 . . . . 30.059999999999999 118.563 171.107 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -102.91 -8.14 20.94 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.155 3.02 . . . . 25.190000000000001 119.155 -178.658 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.29 51.42 58.25 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 117.811 -3.055 . . . . 7.4100000000000001 114.768 -175.512 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.8 mt -111.02 106.25 57.45 Favored Pre-proline 0 N--CA 1.43 -1.468 0 C-N-CA 128.337 2.655 . . . . 9.4900000000000002 108.625 165.775 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HD2' ' OE1' ' A' ' 40' ' ' GLN . 74.6 Cg_exo -72.59 157.45 52.5 Favored 'Trans proline' 0 C--N 1.3 -2.017 0 N-CA-C 118.134 2.321 . . . . 11.42 118.134 -172.048 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -71.84 -15.97 29.65 Favored 'Trans proline' 0 N--CA 1.433 -2.047 0 CA-C-N 126.47 3.346 . . . . 12.0 119.467 -163.78 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -64.8 -24.43 67.55 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 120.713 3.597 . . . . 35.549999999999997 120.713 160.274 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.406 ' OE1' ' HD2' ' A' ' 37' ' ' PRO . 25.8 mt-30 -72.07 -28.93 63.65 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 122.903 2.592 . . . . 20.52 114.257 170.594 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -86.85 133.27 33.64 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.54 -3.225 . . . . 7.1299999999999999 115.534 -159.321 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -125.95 108.27 11.25 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.965 1.841 . . . . 36.390000000000001 108.516 167.317 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 43' ' ' LEU . 75.8 mt -87.39 113.94 23.55 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.444 -1.707 . . . . 9.5500000000000007 108.572 -179.021 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.0 mt -116.85 134.82 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 1 O-C-N 115.844 -4.285 . . . . 13.9 103.137 175.614 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -103.79 -63.62 1.17 Allowed 'General case' 0 N--CA 1.431 -1.419 1 O-C-N 115.061 -4.774 . . . . 6.8600000000000003 109.952 166.832 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.95 -66.47 0.93 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 116.797 -3.69 . . . . 11.15 109.122 -168.453 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -151.11 -53.75 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.759 0 O-C-N 116.854 -3.654 . . . . 13.93 118.931 -174.065 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -71.91 169.19 16.36 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 116.725 2.12 . . . . 23.920000000000002 116.725 -170.035 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -88.46 129.28 35.48 Favored 'General case' 0 N--CA 1.43 -1.451 1 O-C-N 114.77 -4.956 . . . . 23.23 106.177 -178.686 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 65.5 mt -84.47 127.2 33.89 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 111.891 -2.413 . . . . 9.1099999999999994 112.647 175.767 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -77.29 163.89 26.07 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 129.221 4.075 . . . . 33.439999999999998 111.709 166.493 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -91.07 -63.39 1.27 Allowed 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 115.539 -4.475 . . . . 28.370000000000001 108.936 -172.473 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -62.25 -5.87 9.1 Favored Glycine 0 N--CA 1.431 -1.667 1 C-N-CA 130.873 4.082 . . . . 15.0 113.561 -178.484 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 76.1 mtt180 -91.34 168.43 11.58 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 123.119 3.46 . . . . 25.5 110.759 174.763 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 29.6 p -94.72 170.02 9.75 Favored 'General case' 0 N--CA 1.431 -1.414 1 C-N-CA 132.237 4.215 . . . . 11.949999999999999 111.334 179.466 . . . . . . . . 3 2 . 1 . 094 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.9 mt -71.61 -26.04 62.42 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.393 -3.942 . . . . 10.17 115.753 172.823 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.3 m -63.99 -49.75 71.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 111.447 -2.615 . . . . 13.59 111.119 172.762 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.6 m-20 -45.14 -44.48 10.71 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.767 2.506 . . . . 11.699999999999999 117.767 169.533 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -88.54 3.66 49.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 116.622 -1.656 . . . . 12.949999999999999 114.647 179.257 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.336 3.7 m-80 57.01 52.93 8.55 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 119.747 3.24 . . . . 25.449999999999999 119.747 -175.227 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.1 mt -115.19 122.8 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 113.926 -1.488 . . . . 14.6 108.214 -177.785 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -112.24 -150.55 0.47 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.37 -2.706 . . . . 33.229999999999997 113.252 175.417 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.418 ' NZ ' ' OE2' ' A' ' 64' ' ' GLU . 19.4 pttp -76.59 165.88 24.17 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 121.699 2.045 . . . . 25.969999999999999 111.996 -173.252 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.418 ' OE2' ' NZ ' ' A' ' 63' ' ' LYS . 51.4 mt-10 57.23 25.45 11.06 Favored 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 133.012 4.525 . . . . 32.609999999999999 109.668 174.528 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.286 52.6 m -76.29 121.94 23.69 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 129.507 3.123 . . . . 10.56 107.979 -176.709 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.4 m -90.8 116.75 28.88 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 124.697 1.248 . . . . 5.3300000000000001 111.313 175.885 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.462 ' HB2' HG22 ' A' ' 5' ' ' VAL . 5.8 mp -107.35 158.37 17.21 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.111 2.164 . . . . 11.66 107.502 178.889 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.518 ' CE1' HD23 ' A' ' 8' ' ' LEU . 5.9 t60 -114.84 131.79 56.72 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 123.446 1.593 . . . . 16.300000000000001 110.505 172.661 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.65 103.88 14.19 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 127.715 3.626 . . . . 9.9600000000000009 104.387 172.176 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 t -95.15 133.82 34.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 1 C-N-CA 135.459 5.504 . . . . 9.7599999999999998 109.94 171.824 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -98.08 113.58 25.5 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 116.102 1.89 . . . . 19.57 116.102 -171.688 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.254 27.7 ttp85 -83.08 160.0 22.01 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 129.243 3.017 . . . . 35.079999999999998 113.24 -157.106 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 63.7 mt -87.38 133.01 33.78 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 113.019 -1.901 . . . . 32.310000000000002 106.887 177.148 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.1 mmt180 -74.43 139.4 43.95 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 114.369 1.248 . . . . 42.75 114.369 -174.85 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.79 85.07 0.84 Allowed Glycine 0 N--CA 1.43 -1.746 1 C-N-CA 130.959 4.123 . . . . 36.310000000000002 105.0 165.11 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.801 0 O-C-N 129.415 3.656 . . . . 36.270000000000003 111.052 178.963 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.2 ptt? . . . . . 0 CA--C 1.49 -1.339 0 N-CA-C 113.614 0.968 . . . . 17.170000000000002 113.614 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -91.98 132.5 36.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 114.746 1.387 . . . . 21.890000000000001 114.746 -170.772 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 pt -131.21 150.24 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 O-C-N 119.118 -2.239 . . . . 10.83 113.257 167.745 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -99.48 123.61 43.9 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 125.685 1.865 . . . . 10.609999999999999 108.529 -176.796 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.7 t -104.22 121.98 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 117.178 -1.809 . . . . 9.1300000000000008 107.786 171.835 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.8 mmtp -103.21 105.98 16.39 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 129.112 2.965 . . . . 20.550000000000001 110.958 -170.026 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -69.96 177.39 3.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 114.832 1.419 . . . . 11.779999999999999 114.832 178.673 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.1 mt -66.29 -43.71 85.55 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 114.989 -2.434 . . . . 19.309999999999999 111.739 -170.295 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -67.48 -47.83 68.91 Favored 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 132.594 6.184 . . . . 23.140000000000001 106.708 172.928 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.32 41.77 0.62 Allowed Glycine 0 N--CA 1.43 -1.708 0 O-C-N 117.669 -3.145 . . . . 19.739999999999998 115.333 -176.879 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.2 mtmt -83.38 135.23 34.78 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 101.889 -3.374 . . . . 21.93 101.889 175.356 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.5 m -90.11 101.93 14.64 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 122.183 2.265 . . . . 12.33 106.105 -177.934 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.0 mt -85.34 109.26 18.03 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 121.445 -0.784 . . . . 17.079999999999998 109.392 172.708 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.0 m -92.0 116.8 29.23 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.317 2.961 . . . . 16.300000000000001 111.302 -178.673 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.2 mt -116.13 137.04 52.47 Favored 'General case' 0 N--CA 1.429 -1.481 1 O-C-N 115.818 -4.301 . . . . 15.880000000000001 111.475 -174.082 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -111.19 108.65 18.38 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 118.476 -2.64 . . . . 28.899999999999999 106.521 -175.331 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -125.86 164.62 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 O-C-N 125.116 1.51 . . . . 12.050000000000001 112.786 -172.448 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -97.33 154.79 37.93 Favored Pre-proline 0 N--CA 1.43 -1.464 0 O-C-N 116.952 -3.592 . . . . 18.170000000000002 110.663 165.419 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -60.55 -24.51 78.38 Favored 'Trans proline' 0 C--N 1.3 -1.988 0 C-N-CA 125.101 3.867 . . . . 8.1600000000000001 110.789 179.125 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -98.33 26.01 5.78 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 120.211 -1.556 . . . . 11.130000000000001 109.44 -179.408 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.3 m-20 -94.86 158.91 15.28 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.998 -2.939 . . . . 18.030000000000001 112.247 161.951 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.2 p -105.09 169.8 8.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 123.447 1.594 . . . . 10.220000000000001 109.578 -170.775 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.11 -40.21 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 118.666 -2.521 . . . . 12.300000000000001 113.558 178.383 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -43.04 -41.62 3.56 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 121.082 3.734 . . . . 36.509999999999998 121.082 160.653 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -63.19 -60.7 3.06 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.397 -3.314 . . . . 25.66 111.948 174.913 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.7 t -46.94 -41.36 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 O-C-N 116.313 -3.992 . . . . 8.1199999999999992 117.182 170.939 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -56.3 -35.67 67.79 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 120.354 -1.466 . . . . 15.470000000000001 111.091 177.696 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.1 -24.23 60.62 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 116.922 -3.611 . . . . 11.449999999999999 114.341 -179.13 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -65.03 -30.1 71.06 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.416 2.747 . . . . 24.98 118.416 166.028 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 60.8 mt -78.24 -33.9 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 124.291 1.996 . . . . 9.4600000000000009 110.492 178.544 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -66.18 -31.33 72.1 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.87 -1.768 . . . . 14.76 115.073 169.093 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.4 t0 -62.41 -60.8 3.03 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 129.442 3.097 . . . . 26.289999999999999 109.218 173.251 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -79.87 -63.7 1.35 Allowed 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 115.059 1.503 . . . . 30.059999999999999 115.059 -174.142 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 45.2 mm-40 -82.53 -28.88 30.75 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 119.239 3.051 . . . . 25.190000000000001 119.239 -177.28 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.98 7.79 49.45 Favored Glycine 0 N--CA 1.43 -1.75 1 O-C-N 116.056 -4.153 . . . . 7.4100000000000001 120.956 173.25 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.5 mt -86.67 129.65 51.95 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 118.656 -2.673 . . . . 9.4900000000000002 111.815 -179.529 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -66.66 146.61 79.63 Favored 'Trans proline' 0 C--N 1.3 -2.006 0 N-CA-C 118.411 2.427 . . . . 11.42 118.411 174.979 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.0 OUTLIER -65.13 -16.95 57.51 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 N-CA-C 120.125 3.087 . . . . 12.0 120.125 -169.335 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -83.67 -19.85 34.61 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 119.587 -1.946 . . . . 35.549999999999997 110.738 176.766 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -91.6 -24.12 19.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.064 2.364 . . . . 20.52 107.843 -169.22 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -73.45 155.56 39.16 Favored 'General case' 0 N--CA 1.431 -1.402 0 O-C-N 117.191 -3.443 . . . . 7.1299999999999999 111.391 175.171 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.291 51.5 ttt180 -139.5 120.0 14.03 Favored 'General case' 0 N--CA 1.43 -1.459 1 C-N-CA 132.471 4.308 . . . . 36.390000000000001 113.672 167.604 . . . . . . . . 3 2 . 1 . 095 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 45.3 mt -103.84 132.77 49.78 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.809 -1.807 . . . . 9.5500000000000007 109.698 -179.471 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 68' ' ' HIS . 3.6 mt -120.61 130.61 74.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 108.007 -1.108 . . . . 13.9 108.007 179.215 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -86.45 -77.5 0.31 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.43 -2.044 . . . . 6.8600000000000003 110.135 163.002 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -104.07 -73.37 0.67 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.053 1.341 . . . . 11.15 107.864 173.973 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -150.46 1.2 0.42 Allowed Glycine 0 N--CA 1.43 -1.763 0 CA-C-O 113.699 -3.834 . . . . 13.93 115.129 -171.733 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -105.54 166.83 10.17 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 123.875 3.838 . . . . 23.920000000000002 107.832 -167.176 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -97.31 139.94 32.52 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 120.818 1.645 . . . . 23.23 111.365 177.729 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 93.1 mt -101.61 141.95 33.7 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.308 -0.86 . . . . 9.1099999999999994 108.881 -174.661 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.253 43.6 mt-10 -97.93 149.25 22.61 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.127 -2.233 . . . . 33.439999999999998 107.397 174.182 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -67.03 -31.21 71.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.303 2.241 . . . . 28.370000000000001 112.436 -175.299 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.71 36.26 4.52 Favored Glycine 0 N--CA 1.43 -1.728 1 N-CA-C 125.189 4.835 . . . . 15.0 125.189 -177.179 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 32.0 mmt180 -126.35 162.15 26.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 119.161 -2.376 . . . . 25.5 107.179 170.871 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.255 29.9 p -88.24 166.49 14.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.146 -2.846 . . . . 11.949999999999999 111.432 -175.479 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.3 mp -59.57 -41.67 90.7 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 125.495 2.569 . . . . 10.17 111.301 164.789 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.8 t -58.51 -39.17 79.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.482 -3.261 . . . . 13.59 114.539 175.064 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -67.43 -36.71 81.75 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.228 1.966 . . . . 11.699999999999999 111.66 -174.256 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -85.32 -0.61 55.28 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.869 -3.019 . . . . 12.949999999999999 108.716 176.1 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.301 3.3 m120 56.67 36.87 28.28 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 116.884 2.179 . . . . 25.449999999999999 116.884 -179.329 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 98.5 mt -99.02 111.07 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 CA-C-O 117.182 -1.39 . . . . 14.6 108.848 177.816 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.307 28.8 mm100 -96.0 -167.04 1.52 Allowed 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 127.927 3.267 . . . . 33.229999999999997 107.134 -167.294 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -57.33 159.92 4.34 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 117.161 2.282 . . . . 25.969999999999999 117.161 167.089 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 65.24 14.37 9.37 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.542 1.937 . . . . 32.609999999999999 113.546 -178.045 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.3 m -81.04 133.7 35.53 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.566 1.691 . . . . 10.56 115.566 -171.248 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.4 m -93.25 112.11 23.95 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 113.472 -1.694 . . . . 5.3300000000000001 108.737 -173.232 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.9 mt -98.06 133.48 42.45 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.379 -3.326 . . . . 11.66 106.163 176.248 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.426 ' HB3' ' HB ' ' A' ' 44' ' ' ILE . 15.3 t60 -94.75 119.09 32.8 Favored 'General case' 0 N--CA 1.429 -1.493 0 C-N-CA 126.67 1.988 . . . . 16.300000000000001 112.819 167.918 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.9 tp -103.81 121.51 43.19 Favored 'General case' 0 N--CA 1.429 -1.487 0 CA-C-O 126.153 2.882 . . . . 9.9600000000000009 114.418 -179.981 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.72 176.98 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.406 1 O-C-N 114.668 -5.02 . . . . 9.7599999999999998 103.104 -177.243 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.3 mp -98.18 157.19 16.3 Favored 'General case' 0 N--CA 1.43 -1.443 1 O-C-N 114.212 -5.305 . . . . 19.57 115.282 -179.049 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.8 ttp85 -90.58 149.18 22.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 115.478 1.659 . . . . 35.079999999999998 115.478 170.768 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.2 mt -105.2 121.1 43.14 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.365 2.031 . . . . 32.310000000000002 107.705 174.274 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.1 mtm180 -111.67 162.43 15.21 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.017 2.927 . . . . 42.75 118.213 -162.923 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 159.89 -73.68 0.21 Allowed Glycine 0 N--CA 1.43 -1.734 0 C-N-CA 126.605 2.05 . . . . 36.310000000000002 109.79 -177.995 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.753 0 CA-C-O 114.812 -3.216 . . . . 36.270000000000003 113.173 174.952 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.331 0 CA-C-O 116.981 -1.485 . . . . 17.170000000000002 112.864 . . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -101.67 149.42 24.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 114.51 -2.876 . . . . 21.890000000000001 113.934 -173.836 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.74 174.98 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 119.636 -1.915 . . . . 10.83 109.034 160.145 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -126.18 149.5 48.96 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 115.349 -2.54 . . . . 10.609999999999999 108.098 -175.319 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.8 t -112.94 127.59 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 104.659 -2.349 . . . . 9.1300000000000008 104.659 168.051 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -105.85 117.69 34.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.853 2.168 . . . . 20.550000000000001 116.853 164.58 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -92.05 169.54 10.56 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 126.723 3.154 . . . . 11.779999999999999 109.068 -168.966 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.7 mt -62.93 -38.36 90.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.499 -2.625 . . . . 19.309999999999999 111.668 166.501 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 m -61.37 -61.32 2.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.48 3.512 . . . . 23.140000000000001 112.718 -178.982 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 143.52 52.42 0.03 OUTLIER Glycine 0 N--CA 1.431 -1.676 0 C-N-CA 118.567 -1.778 . . . . 19.739999999999998 111.373 177.869 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -123.87 167.37 14.18 Favored 'General case' 0 N--CA 1.43 -1.454 1 CA-C-O 129.648 4.546 . . . . 21.93 108.18 179.759 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 16.2 m -131.06 108.28 9.66 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 110.368 -3.105 . . . . 12.33 103.155 166.771 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.8 mt -101.28 131.52 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 111.953 -3.88 . . . . 17.079999999999998 107.123 175.545 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.6 m -104.59 114.88 29.39 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 123.996 3.089 . . . . 16.300000000000001 106.551 173.846 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.3 mt -104.1 129.03 51.78 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.145 1.778 . . . . 15.880000000000001 111.824 174.074 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -87.03 106.3 17.75 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 126.657 3.122 . . . . 28.899999999999999 105.081 -178.545 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.19 155.7 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 118.031 -2.918 . . . . 12.050000000000001 110.418 -171.266 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -109.89 137.42 20.45 Favored Pre-proline 0 N--CA 1.43 -1.432 0 O-C-N 116.723 -3.735 . . . . 18.170000000000002 107.759 164.881 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -80.69 -10.25 13.11 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 C-N-CA 124.828 3.686 . . . . 8.1600000000000001 113.074 -164.077 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 m -89.22 -12.98 39.28 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.024 2.345 . . . . 11.130000000000001 110.958 174.511 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -81.88 157.9 24.19 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.105 -1.407 . . . . 18.030000000000001 111.749 176.007 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.9 p -87.51 170.33 11.43 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 118.54 -2.6 . . . . 10.220000000000001 116.007 -150.895 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.0 mt -80.95 -27.3 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 118.3 -2.75 . . . . 12.300000000000001 110.892 -175.471 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 52.7 tt0 -62.21 -45.14 94.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.767 -2.063 . . . . 36.509999999999998 112.619 166.98 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -64.25 -20.43 66.04 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 117.516 -1.23 . . . . 25.66 112.238 178.055 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.1 t -73.06 -40.4 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 122.16 2.255 . . . . 8.1199999999999992 111.82 168.473 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -66.94 -38.45 86.18 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 127.491 2.994 . . . . 15.470000000000001 113.989 176.807 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.455 ' HA ' ' HB3' ' A' ' 31' ' ' GLN . . . -64.44 -11.07 29.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.617 2.821 . . . . 11.449999999999999 118.617 169.564 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.2 mmtm -84.04 -38.88 20.3 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 123.506 1.622 . . . . 24.98 113.506 166.35 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.6 mt -54.7 -40.51 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 O-C-N 117.561 -3.212 . . . . 9.4600000000000009 115.545 160.618 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 28' ' ' ALA . 22.4 tt0 -55.01 -35.34 64.29 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.15 -2.844 . . . . 14.76 114.438 170.289 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -63.4 -57.07 11.48 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.892 -1.755 . . . . 26.289999999999999 115.344 166.452 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -66.27 -65.11 0.72 Allowed 'General case' 0 N--CA 1.43 -1.446 1 C-N-CA 133.415 4.686 . . . . 30.059999999999999 109.714 -168.452 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.4 mm-40 -93.32 -26.53 17.26 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.903 1.811 . . . . 25.190000000000001 114.454 -173.471 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.8 28.6 9.32 Favored Glycine 0 N--CA 1.43 -1.709 1 O-C-N 114.152 -5.342 . . . . 7.4100000000000001 116.358 177.126 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 90.2 mt -120.12 118.54 31.41 Favored Pre-proline 0 N--CA 1.43 -1.447 0 CA-C-O 116.256 -1.83 . . . . 9.4900000000000002 108.263 -162.62 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -73.05 162.0 41.99 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-N 126.867 3.488 . . . . 11.42 114.961 -164.004 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.63 -15.53 19.35 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 CA-C-N 125.616 3.041 . . . . 12.0 114.338 -174.016 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -79.4 -29.78 42.16 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 122.599 2.454 . . . . 35.549999999999997 114.078 176.351 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -78.11 -23.63 47.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.653 1.981 . . . . 20.52 115.38 171.866 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -71.79 139.48 49.02 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.266 3.062 . . . . 7.1299999999999999 119.266 170.562 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.488 ' HB3' HG23 ' A' ' 70' ' ' VAL . 72.6 ttt180 -119.71 147.46 44.55 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.488 -2.007 . . . . 36.390000000000001 113.949 158.604 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 90.0 mt -127.64 112.52 14.95 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.858 -2.401 . . . . 9.5500000000000007 111.047 179.419 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.6 mt -95.71 125.35 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.124 -3.485 . . . . 13.9 107.044 -175.663 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -98.1 -62.51 1.23 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.909 -3.62 . . . . 6.8600000000000003 105.952 178.107 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.69 -128.5 0.1 Allowed 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.135 2.574 . . . . 11.15 104.497 177.976 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.04 7.07 32.81 Favored Glycine 0 N--CA 1.431 -1.699 0 O-C-N 121.043 -1.036 . . . . 13.93 114.609 -172.482 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -111.98 117.36 32.48 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 115.206 1.558 . . . . 23.920000000000002 115.206 169.661 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -68.6 129.3 39.53 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 124.319 2.009 . . . . 23.23 111.191 -170.345 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -76.37 153.3 35.89 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.61 -3.181 . . . . 9.1099999999999994 113.891 -176.687 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -101.65 150.41 23.14 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.107 0.956 . . . . 33.439999999999998 111.676 162.253 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -67.02 -43.99 81.42 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 120.44 3.496 . . . . 28.370000000000001 120.44 -178.145 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -95.73 48.04 1.85 Allowed Glycine 0 N--CA 1.43 -1.709 0 CA-C-O 123.777 1.765 . . . . 15.0 111.873 -178.449 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -127.39 162.22 26.82 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.8 -2.296 . . . . 25.5 104.8 174.544 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.2 p -91.09 169.42 10.87 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 117.77 -3.081 . . . . 11.949999999999999 108.605 178.097 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -58.7 -34.28 71.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.345 -3.347 . . . . 10.17 114.319 171.442 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 t -65.81 -34.69 78.75 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 128.358 3.536 . . . . 13.59 116.008 -178.482 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -56.58 -43.33 79.95 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 119.83 -1.794 . . . . 11.699999999999999 113.323 177.834 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -95.11 8.82 41.77 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 122.354 2.343 . . . . 12.949999999999999 113.437 -178.882 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.493 10.6 m120 66.0 41.23 3.75 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.847 2.059 . . . . 25.449999999999999 113.274 175.96 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.3 mt -91.05 138.09 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 106.632 -1.618 . . . . 14.6 106.632 -178.233 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -128.98 -177.28 4.15 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.943 -2.973 . . . . 33.229999999999997 112.426 -168.746 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.327 19.9 pttp -60.93 149.6 35.93 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 120.862 3.653 . . . . 25.969999999999999 120.862 168.916 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 48.1 27.49 1.26 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.965 3.306 . . . . 32.609999999999999 116.802 -171.905 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.334 54.5 m -92.99 144.94 24.75 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 117.409 -3.307 . . . . 10.56 114.986 177.277 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.5 m -99.91 120.99 40.64 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 116.057 -1.925 . . . . 5.3300000000000001 115.937 -171.761 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.3 mt -103.51 137.92 40.93 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 107.11 -1.441 . . . . 11.66 107.11 174.567 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -93.6 114.44 26.78 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 114.445 1.276 . . . . 16.300000000000001 114.445 177.08 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.253 49.6 tp -83.4 115.2 21.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 124.288 0.992 . . . . 9.9600000000000009 110.353 -179.595 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 42' ' ' ARG . 3.3 m -119.57 -175.05 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-N 115.068 -0.969 . . . . 9.7599999999999998 110.102 166.92 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.7 mt -94.73 154.1 17.47 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 122.606 1.193 . . . . 19.57 113.147 172.334 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.1 ttp85 -88.25 130.4 35.1 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.964 2.209 . . . . 35.079999999999998 116.964 170.968 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 36.6 tp -86.56 109.37 19.08 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.969 -2.234 . . . . 32.310000000000002 104.969 -178.745 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 67.8 mtm180 -92.68 150.42 20.7 Favored 'General case' 0 N--CA 1.429 -1.488 0 CA-C-O 124.088 1.899 . . . . 42.75 115.224 -170.473 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.35 95.0 1.98 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 120.762 -1.211 . . . . 36.310000000000002 110.542 173.402 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.773 0 C-N-CA 125.429 1.49 . . . . 36.270000000000003 110.97 171.798 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 CA--C 1.49 -1.329 0 CA-C-O 116.08 -1.914 . . . . 17.170000000000002 113.758 . . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -104.24 131.58 51.4 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.267 2.23 . . . . 21.890000000000001 110.383 -179.08 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 26.5 pt -121.38 152.51 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 N-CA-C 104.182 -2.525 . . . . 10.83 104.182 -178.696 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -107.31 125.08 50.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.269 2.228 . . . . 10.609999999999999 111.289 -176.69 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.5 t -110.84 115.63 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 118.23 -2.794 . . . . 9.1300000000000008 109.221 176.513 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.262 31.3 tttt -97.79 130.59 44.72 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 121.741 0.781 . . . . 20.550000000000001 109.626 -171.535 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.271 13.9 p -74.92 166.25 23.95 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 116.841 -3.662 . . . . 11.779999999999999 115.12 -179.001 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.263 1.6 tp -54.96 -43.33 73.37 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 130.618 3.567 . . . . 19.309999999999999 106.288 171.607 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 p -89.49 -50.25 6.21 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.177 -3.452 . . . . 23.140000000000001 115.64 179.529 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.75 67.61 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.763 0 O-C-N 117.533 -3.23 . . . . 19.739999999999998 111.34 163.475 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt -137.24 139.83 41.26 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.503 -2.763 . . . . 21.93 106.545 173.784 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.0 m -104.57 112.9 26.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 125.799 1.64 . . . . 12.33 107.655 -166.816 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 60.1 mt -91.03 144.22 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.488 0 O-C-N 118.17 -2.831 . . . . 17.079999999999998 107.348 179.328 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.1 m -108.5 121.01 44.08 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 122.799 2.545 . . . . 16.300000000000001 112.779 164.867 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 15' ' ' LEU . 91.4 mt -110.66 130.7 55.5 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 128.688 2.795 . . . . 15.880000000000001 111.715 -179.997 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -90.54 114.83 27.13 Favored 'General case' 0 N--CA 1.43 -1.453 1 CA-C-O 128.596 4.046 . . . . 28.899999999999999 108.81 173.687 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.8 m -133.61 171.63 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.56 -3.212 . . . . 12.050000000000001 110.89 -173.621 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -108.36 147.94 36.63 Favored Pre-proline 0 N--CA 1.429 -1.479 0 N-CA-C 102.387 -3.19 . . . . 18.170000000000002 102.387 166.663 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -65.11 -14.07 43.19 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 121.695 1.597 . . . . 8.1600000000000001 113.938 171.671 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.34 -4.95 50.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.936 2.303 . . . . 11.130000000000001 116.142 171.895 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -81.18 146.47 30.49 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 114.596 -2.621 . . . . 18.030000000000001 109.753 178.919 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.0 p -79.75 166.71 21.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 125.717 3.871 . . . . 10.220000000000001 114.111 167.627 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.7 mm -49.77 -43.36 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-N 111.624 -2.534 . . . . 12.300000000000001 113.738 169.234 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.254 36.0 tt0 -54.11 -24.83 19.08 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 115.663 -2.113 . . . . 36.509999999999998 115.632 176.632 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -86.9 -34.71 19.31 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 125.156 2.408 . . . . 25.66 111.043 178.206 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.3 t -60.22 -48.4 88.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 CA-C-O 124.457 2.075 . . . . 8.1199999999999992 108.521 178.677 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -61.31 -27.04 68.2 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 119.134 3.012 . . . . 15.470000000000001 119.134 175.278 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.258 . . -74.2 -29.51 61.78 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.83 -3.044 . . . . 11.449999999999999 109.827 -175.959 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.402 ' HB3' HD22 ' A' ' 15' ' ' LEU . 68.7 mmtt -64.52 -36.75 85.22 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.399 2.523 . . . . 24.98 115.904 169.254 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.344 39.1 mt -65.08 -42.05 93.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 1 O-C-N 116.198 -4.063 . . . . 9.4600000000000009 110.701 171.766 . . . . . . . . 3 2 . 1 . 097 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -60.07 -29.83 68.81 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 116.914 -3.616 . . . . 14.76 118.367 168.211 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -77.65 -48.67 16.25 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 126.42 2.325 . . . . 26.289999999999999 111.194 -179.023 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -83.03 -57.48 3.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 126.21 2.194 . . . . 30.059999999999999 112.005 -169.883 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -78.32 -45.8 21.73 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.62 2.768 . . . . 25.190000000000001 111.537 177.757 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.2 50.15 5.59 Favored Glycine 0 N--CA 1.43 -1.763 0 O-C-N 119.407 -2.058 . . . . 7.4100000000000001 113.25 -169.126 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mt -113.31 140.81 24.81 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.114 -2.18 . . . . 9.4900000000000002 105.114 170.38 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -72.75 148.88 47.39 Favored 'Trans proline' 0 N--CA 1.433 -2.032 1 C-N-CA 125.885 4.39 . . . . 11.42 111.164 -176.837 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -73.8 -30.16 9.68 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 N-CA-C 116.44 1.669 . . . . 12.0 116.44 -165.3 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -66.23 -26.21 67.26 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 120.333 3.457 . . . . 35.549999999999997 120.333 172.356 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -78.09 -29.7 49.18 Favored 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 132.327 4.251 . . . . 20.52 108.528 -178.163 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.262 56.6 mt-30 -67.74 91.44 0.31 Allowed 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.693 3.197 . . . . 7.1299999999999999 110.283 170.799 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -93.77 98.54 11.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-O 126.74 3.162 . . . . 36.390000000000001 109.51 171.417 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 tp -98.22 130.52 44.95 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.08 2.848 . . . . 9.5500000000000007 104.496 -170.374 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mt -123.08 134.27 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.544 -3.847 . . . . 13.9 107.095 -173.72 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -115.54 103.36 10.66 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 102.491 -3.151 . . . . 6.8600000000000003 102.491 175.794 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.69 -97.48 0.06 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.407 2.283 . . . . 11.15 111.368 -172.679 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -121.58 16.23 9.05 Favored Glycine 0 N--CA 1.43 -1.759 0 CA-C-O 124.083 1.935 . . . . 13.93 117.353 161.679 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -84.33 115.0 22.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.659 -3.26 . . . . 23.920000000000002 106.833 174.963 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -74.13 123.58 24.7 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 117.142 -1.409 . . . . 23.23 110.916 166.82 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.07 132.66 39.71 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 116.618 -2.033 . . . . 9.1099999999999994 108.648 -160.301 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -78.37 151.0 33.07 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.496 -3.877 . . . . 33.439999999999998 107.325 174.929 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.16 -36.85 75.0 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 124.485 2.088 . . . . 28.370000000000001 111.843 -169.572 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.03 25.15 27.23 Favored Glycine 0 N--CA 1.43 -1.707 0 CA-C-O 125.415 2.675 . . . . 15.0 113.043 -160.754 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.6 mmt180 -115.56 142.19 47.06 Favored 'General case' 0 N--CA 1.431 -1.406 0 CA-C-O 124.288 1.994 . . . . 25.5 108.414 -174.231 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.3 p -76.31 153.89 35.51 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.166 2.412 . . . . 11.949999999999999 112.73 178.959 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.9 mt -70.9 -32.27 69.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.552 -3.217 . . . . 10.17 111.88 178.586 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.5 p -70.93 -17.58 62.68 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 120.347 -1.471 . . . . 13.59 114.844 168.843 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -77.73 -44.86 26.47 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 119.059 -2.275 . . . . 11.699999999999999 110.37 178.769 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -70.03 -25.44 63.57 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 116.799 -3.688 . . . . 12.949999999999999 115.76 173.975 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.501 20.3 t30 81.6 43.8 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 131.399 3.879 . . . . 25.449999999999999 115.905 -170.553 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.9 mt -94.13 94.25 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 105.68 -1.97 . . . . 14.6 105.68 174.009 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -93.07 -177.45 4.49 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 113.784 -1.553 . . . . 33.229999999999997 114.94 176.067 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -55.96 139.03 47.73 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.241 2.311 . . . . 25.969999999999999 117.241 -174.19 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.265 80.0 mt-10 68.98 12.27 8.57 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 128.634 3.709 . . . . 32.609999999999999 114.015 -179.854 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.275 16.1 m -64.69 144.05 57.5 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.392 1.477 . . . . 10.56 112.876 170.0 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 m -102.06 116.25 32.28 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 102.076 -3.305 . . . . 5.3300000000000001 102.076 -176.602 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mp -100.36 134.72 42.88 Favored 'General case' 0 N--CA 1.431 -1.412 0 O-C-N 120.191 -1.568 . . . . 11.66 111.455 168.245 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -109.5 120.75 43.45 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 113.317 -3.23 . . . . 16.300000000000001 112.115 -163.993 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 62.7 tp -94.43 117.88 30.79 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 125.686 1.866 . . . . 9.9600000000000009 108.51 -170.292 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.55 149.3 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 120.293 -1.504 . . . . 9.7599999999999998 107.625 167.283 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.264 80.2 mt -97.8 151.07 20.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 120.481 -1.387 . . . . 19.57 113.589 -179.06 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 ptt180 -137.52 172.03 13.58 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.866 -1.771 . . . . 35.079999999999998 107.906 164.005 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.34 41.7 mt -96.77 -82.66 0.4 Allowed 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 120.303 -1.498 . . . . 32.310000000000002 114.041 174.253 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 tpp180 -107.99 -42.54 4.65 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 118.703 -2.498 . . . . 42.75 113.14 -171.612 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -163.18 169.4 38.29 Favored Glycine 0 N--CA 1.429 -1.767 0 C-N-CA 118.85 -1.643 . . . . 36.310000000000002 109.349 -176.546 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 0 CA-C-O 117.633 -1.648 . . . . 36.270000000000003 110.843 179.246 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.3 ptt? . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 114.311 1.226 . . . . 17.170000000000002 114.311 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.259 61.8 mt-30 -98.4 135.58 39.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.183 1.793 . . . . 21.890000000000001 107.28 171.306 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.313 18.3 pt -131.23 150.64 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 119.416 -2.053 . . . . 10.83 110.14 166.947 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.255 17.5 m-85 -115.78 111.57 20.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 127.108 2.163 . . . . 10.609999999999999 112.713 -172.675 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 75.4 t -96.92 121.51 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 O-C-N 120.65 -1.281 . . . . 9.1300000000000008 107.943 177.459 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.29 38.6 ttmt -114.27 133.68 55.48 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 117.144 -1.408 . . . . 20.550000000000001 113.107 -170.844 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 53.8 p -83.9 173.54 11.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 127.982 3.302 . . . . 11.779999999999999 114.429 178.248 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 mt -75.93 -29.48 58.39 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.642 2.46 . . . . 19.309999999999999 117.642 -178.686 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.5 p -68.07 -64.53 0.84 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 128.072 2.549 . . . . 23.140000000000001 107.367 169.846 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.26 51.72 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 104.656 -3.378 . . . . 19.739999999999998 104.656 170.016 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -97.13 125.64 41.76 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.161 2.984 . . . . 21.93 108.757 161.019 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -99.19 127.68 45.2 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 119.063 -2.273 . . . . 12.33 106.0 176.662 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.1 mp -94.55 115.77 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 128.741 2.816 . . . . 17.079999999999998 111.297 161.576 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.3 m -84.8 124.74 31.91 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 119.327 0.967 . . . . 16.300000000000001 112.005 165.037 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 83.9 mt -114.18 128.43 56.36 Favored 'General case' 0 N--CA 1.429 -1.498 0 O-C-N 126.969 2.668 . . . . 15.880000000000001 104.733 -175.645 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -99.77 110.92 23.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 103.577 -2.749 . . . . 28.899999999999999 103.577 178.843 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -134.4 155.55 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 CA-C-O 117.863 -1.065 . . . . 12.050000000000001 110.264 -169.477 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -104.08 139.23 19.9 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 115.933 -1.984 . . . . 18.170000000000002 112.153 171.166 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -74.66 -15.56 21.58 Favored 'Trans proline' 0 N--CA 1.434 -2.023 0 CA-C-N 126.165 3.237 . . . . 8.1600000000000001 111.369 -158.484 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.3 p -82.45 -1.8 51.3 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 121.121 3.749 . . . . 11.130000000000001 121.121 -177.414 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -89.1 174.2 8.01 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 130.922 3.689 . . . . 18.030000000000001 110.384 -179.036 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 45.4 p -91.51 157.43 17.03 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.482 -3.261 . . . . 10.220000000000001 113.843 -173.671 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.7 mt -73.89 -31.21 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.056 -2.572 . . . . 12.300000000000001 104.056 172.96 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -40.23 -48.74 2.63 Favored 'General case' 0 N--CA 1.43 -1.429 2 O-C-N 114.13 -5.356 . . . . 36.509999999999998 110.656 164.982 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.306 8.8 t-20 -61.73 -41.82 98.15 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 129.026 2.93 . . . . 25.66 112.956 177.744 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.4 t -59.35 -45.19 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 C-N-CA 125.436 1.495 . . . . 8.1199999999999992 111.352 174.976 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -68.91 -40.63 78.99 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 129.686 3.194 . . . . 15.470000000000001 109.315 -179.087 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.32 -26.3 68.42 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.508 3.123 . . . . 11.449999999999999 111.886 176.493 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -72.18 -37.68 69.25 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.269 1.85 . . . . 24.98 111.594 172.496 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.4 mt -76.49 -29.03 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 125.809 1.644 . . . . 9.4600000000000009 109.879 178.43 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -59.27 -50.34 74.38 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.885 -3.01 . . . . 14.76 110.641 165.873 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.09 -68.27 0.26 Allowed 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 129.158 2.983 . . . . 26.289999999999999 112.712 179.974 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -71.68 -62.87 1.26 Allowed 'General case' 0 N--CA 1.43 -1.432 0 CA-C-O 114.719 -2.562 . . . . 30.059999999999999 115.197 -176.541 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -72.1 -51.18 22.7 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.403 2.049 . . . . 25.190000000000001 113.549 -175.079 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.74 38.83 1.52 Allowed Glycine 0 N--CA 1.43 -1.718 0 O-C-N 116.716 -3.74 . . . . 7.4100000000000001 113.934 -179.509 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.272 78.9 mt -124.92 124.51 25.47 Favored Pre-proline 0 N--CA 1.43 -1.457 0 N-CA-C 103.311 -2.848 . . . . 9.4900000000000002 103.311 -174.249 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -76.84 175.82 10.9 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-O 114.904 -2.207 . . . . 11.42 110.789 -171.38 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HA ' ' HG2' ' A' ' 41' ' ' GLN . 49.0 Cg_endo -74.85 -32.84 5.29 Favored 'Trans proline' 0 C--N 1.299 -2.027 1 C-N-CA 126.53 4.82 . . . . 12.0 110.759 171.925 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.272 11.6 t70 -58.26 -42.55 86.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 124.401 1.08 . . . . 35.549999999999997 113.809 176.322 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -79.54 -38.71 33.59 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.248 2.219 . . . . 20.52 112.314 -178.66 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 38' ' ' PRO . 5.6 pt20 -80.08 167.28 20.6 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 127.342 3.448 . . . . 7.1299999999999999 118.71 -175.31 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -131.43 121.8 25.18 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 117.612 -3.18 . . . . 36.390000000000001 111.975 162.086 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.3 tp -108.66 119.0 38.24 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 107.24 -1.393 . . . . 9.5500000000000007 107.24 -170.469 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 44' ' ' ILE . 56.1 mt -118.31 135.67 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 117.959 -2.963 . . . . 13.9 113.128 -169.68 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -118.7 109.54 16.22 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.879 -3.013 . . . . 6.8600000000000003 106.323 167.798 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.4 -92.85 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.385 3.074 . . . . 11.15 113.566 -172.371 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -87.04 -37.89 8.16 Favored Glycine 0 N--CA 1.43 -1.729 0 O-C-N 119.486 -2.009 . . . . 13.93 116.611 175.545 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -107.71 146.56 31.93 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 124.794 0.938 . . . . 23.920000000000002 112.546 -159.742 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -81.02 138.37 36.02 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 125.43 2.538 . . . . 23.23 112.699 171.9 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.2 mt -89.78 114.83 26.61 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.757 -3.715 . . . . 9.1099999999999994 112.306 -175.914 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -85.85 143.98 27.95 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 119.26 -2.15 . . . . 33.439999999999998 114.578 -173.084 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -55.8 -49.86 72.07 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.61 3.164 . . . . 28.370000000000001 112.447 -165.875 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.12 -4.63 77.78 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 118.325 2.09 . . . . 15.0 118.325 -163.303 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.3 mtt-85 -84.06 178.94 7.64 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.776 3.179 . . . . 25.5 113.854 166.105 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.5 p -110.83 175.84 5.27 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 117.732 -3.105 . . . . 11.949999999999999 104.651 -177.667 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.1 mp -82.49 -26.9 32.16 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.152 2.181 . . . . 10.17 105.374 -178.589 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.1 p -65.99 -36.33 83.01 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 131.461 3.905 . . . . 13.59 113.147 174.264 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -60.4 -52.84 63.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 O-C-N 126.972 2.67 . . . . 11.699999999999999 116.001 171.048 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -67.56 -17.49 64.66 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 125.767 1.627 . . . . 12.949999999999999 111.357 176.822 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 59.51 55.08 4.27 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.545 2.338 . . . . 25.449999999999999 111.754 -170.405 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 61' ' ' ILE . 57.0 mt -86.79 116.96 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 N-CA-C 104.038 -2.579 . . . . 14.6 104.038 -178.417 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -98.3 159.69 14.78 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 126.925 2.641 . . . . 33.229999999999997 110.011 -178.212 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -52.18 131.98 32.97 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 126.878 2.071 . . . . 25.969999999999999 112.909 -178.051 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 73.09 32.57 1.29 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-N 110.716 -2.947 . . . . 32.609999999999999 111.938 176.666 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.6 m -75.66 141.49 42.76 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 123.843 1.783 . . . . 10.56 110.636 169.48 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.6 m -86.54 120.48 27.9 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.505 -2.035 . . . . 5.3300000000000001 105.505 171.63 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.86 146.73 38.38 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 125.754 1.622 . . . . 11.66 106.827 175.959 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.2 m170 -117.73 140.57 49.49 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 124.422 2.058 . . . . 16.300000000000001 108.134 -172.177 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.3 tp -119.68 135.69 54.72 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 103.024 -2.954 . . . . 9.9600000000000009 103.024 -174.534 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 71' ' ' LEU . 2.3 t -135.03 -176.6 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 128.381 2.672 . . . . 9.7599999999999998 105.283 174.805 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.568 ' H ' HG12 ' A' ' 70' ' ' VAL . 7.2 mt -92.11 167.49 12.03 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 126.792 2.037 . . . . 19.57 108.973 169.111 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -105.2 115.08 29.66 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 123.699 1.714 . . . . 35.079999999999998 108.716 171.108 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.4 tp -67.02 -61.31 2.0 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 115.508 -2.187 . . . . 32.310000000000002 112.44 178.9 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 tpp180 -146.84 -104.13 0.09 Allowed 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 122.825 2.557 . . . . 42.75 108.182 172.313 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.05 157.81 28.34 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 108.952 -1.659 . . . . 36.310000000000002 108.952 171.544 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.729 0 CA-C-O 117.179 -1.901 . . . . 36.270000000000003 112.833 -169.624 . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 tmm? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 112.485 0.55 . . . . 17.170000000000002 112.485 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -85.83 123.47 31.22 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 125.206 1.402 . . . . 21.890000000000001 108.066 -178.659 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.496 HD12 HD22 ' A' ' 67' ' ' LEU . 39.6 pt -106.29 161.01 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.871 -2.393 . . . . 10.83 109.769 151.855 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -114.23 131.81 56.35 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 101.851 -3.389 . . . . 10.609999999999999 101.851 -178.765 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.95 102.83 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 N-CA-C 101.867 -3.383 . . . . 9.1300000000000008 101.867 -178.079 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.5 tttt -94.89 128.5 41.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.174 2.19 . . . . 20.550000000000001 116.403 -173.206 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.267 18.9 p -89.41 173.17 8.51 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.121 -2.862 . . . . 11.779999999999999 116.407 -177.012 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.0 mt -77.95 -48.56 15.99 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.118 -2.239 . . . . 19.309999999999999 109.004 174.502 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.2 p -67.69 -46.98 70.72 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 129.929 3.291 . . . . 23.140000000000001 107.188 -168.54 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.63 24.58 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.711 0 CA-C-O 116.074 -2.514 . . . . 19.739999999999998 118.799 173.083 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -110.89 124.91 53.0 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 120.082 1.941 . . . . 21.93 107.243 -174.489 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 58.4 m -105.53 114.1 28.06 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 119.729 -1.857 . . . . 12.33 109.846 171.745 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -95.34 122.1 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 N-CA-C 103.698 -2.705 . . . . 17.079999999999998 103.698 -165.735 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.4 m -91.48 110.92 22.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 102.985 -2.969 . . . . 16.300000000000001 102.985 175.244 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 73.5 mt -106.26 136.77 45.4 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 124.986 1.314 . . . . 15.880000000000001 108.404 169.126 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -93.58 116.02 28.52 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.342 2.02 . . . . 28.899999999999999 108.938 169.275 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.5 m -110.85 167.57 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.529 3.132 . . . . 12.050000000000001 110.694 175.487 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -105.64 158.44 32.31 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 114.485 -2.674 . . . . 18.170000000000002 110.878 157.68 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -74.38 -25.12 13.54 Favored 'Trans proline' 0 N--CA 1.434 -2.028 0 CA-C-N 126.174 3.241 . . . . 8.1600000000000001 117.478 -172.453 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -75.24 -11.4 60.06 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 131.223 3.809 . . . . 11.130000000000001 115.788 163.629 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -72.46 158.24 36.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.998 2.333 . . . . 18.030000000000001 113.522 178.382 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -92.98 161.41 14.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.244 -3.41 . . . . 10.220000000000001 112.478 -173.926 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.7 mt -82.82 -8.75 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 126.661 2.476 . . . . 12.300000000000001 111.224 -179.398 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -57.7 -54.91 41.49 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.941 -2.349 . . . . 36.509999999999998 111.313 166.421 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -61.27 -16.08 41.85 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 116.291 -4.005 . . . . 25.66 115.012 168.776 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 91.7 t -74.64 -43.93 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 1 CA-C-N 126.381 4.173 . . . . 8.1199999999999992 108.302 167.906 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -67.15 -32.29 73.3 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 121.311 1.869 . . . . 15.470000000000001 114.79 175.51 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.98 -25.14 58.63 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.108 1.892 . . . . 11.449999999999999 116.108 172.176 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 mttp -74.08 -30.58 62.44 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 120.493 1.497 . . . . 24.98 107.052 178.233 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.402 HG22 ' HB ' ' A' ' 36' ' ' ILE . 37.9 mm -69.9 -34.67 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-O 118.368 -0.825 . . . . 9.4600000000000009 111.857 173.639 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.4 tt0 -65.13 -43.49 91.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.802 2.841 . . . . 14.76 109.741 173.466 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -63.02 -56.77 14.18 Favored 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 117.49 2.404 . . . . 26.289999999999999 117.49 176.311 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.405 ' HD3' ' HA ' ' A' ' 33' ' ' LYS . 14.7 mmtm -56.53 -65.16 0.66 Allowed 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.875 3.27 . . . . 30.059999999999999 112.235 173.322 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -101.17 -36.03 9.09 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.682 -1.145 . . . . 25.190000000000001 113.133 -159.673 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.08 4.72 31.08 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 118.231 -2.793 . . . . 7.4100000000000001 114.078 -177.402 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.402 ' HB ' HG22 ' A' ' 30' ' ' ILE . 9.6 mt -88.34 112.25 48.6 Favored Pre-proline 0 N--CA 1.43 -1.442 0 CA-C-O 116.831 -1.557 . . . . 9.4900000000000002 109.121 -173.02 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -81.74 -176.7 3.17 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 122.568 1.953 . . . . 11.42 114.472 -171.819 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -74.4 -16.31 21.91 Favored 'Trans proline' 0 N--CA 1.434 -2.005 0 C-N-CA 122.412 2.074 . . . . 12.0 115.764 -178.924 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -79.42 -24.08 42.77 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.88 2.752 . . . . 35.549999999999997 116.614 -175.904 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -98.33 -35.52 10.29 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 112.501 -2.136 . . . . 20.52 110.057 -168.587 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -91.89 166.26 12.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.635 -1.29 . . . . 7.1299999999999999 108.515 -172.333 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.2 139.02 37.39 Favored 'General case' 0 N--CA 1.43 -1.473 1 C-N-CA 131.778 4.031 . . . . 36.390000000000001 104.102 165.632 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.1 mt -104.2 132.9 49.96 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 126.647 1.979 . . . . 9.5500000000000007 106.401 178.069 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.6 mt -128.02 142.07 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 O-C-N 119.809 -1.807 . . . . 13.9 107.846 177.514 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.9 t80 -148.83 108.54 4.02 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.308 -2.12 . . . . 6.8600000000000003 108.484 -175.066 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.302 . . 57.05 -114.31 0.81 Allowed 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 120.541 3.534 . . . . 11.15 120.541 -158.54 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.34 -36.53 20.39 Favored Glycine 0 N--CA 1.43 -1.76 0 O-C-N 120.605 -1.31 . . . . 13.93 114.607 -178.901 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -116.06 170.49 8.46 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 120.729 2.264 . . . . 23.920000000000002 114.499 -162.54 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -97.19 146.54 24.99 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 102.799 -3.037 . . . . 23.23 102.799 -176.676 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.8 mt -99.86 128.79 45.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 103.489 -2.782 . . . . 9.1099999999999994 103.489 -166.397 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -75.3 153.81 37.7 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 125.736 1.614 . . . . 33.439999999999998 113.868 168.76 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -84.55 -61.69 1.73 Allowed 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.782 -3.699 . . . . 28.370000000000001 108.56 -162.671 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.93 59.2 3.21 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-N 122.297 2.317 . . . . 15.0 111.147 -169.438 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -140.72 153.07 45.77 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.472 2.309 . . . . 25.5 106.987 -177.354 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.25 46.7 p -82.94 154.53 24.5 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.674 -2.516 . . . . 11.949999999999999 113.174 -173.151 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.631 HD23 HD12 ' A' ' 61' ' ' ILE . 17.5 mt -63.88 -39.52 94.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.933 -2.354 . . . . 10.17 111.642 165.503 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.1 p -54.59 -37.5 65.62 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 118.408 2.744 . . . . 13.59 118.408 172.578 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -68.37 -50.35 53.76 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 114.287 -5.258 . . . . 11.699999999999999 113.941 174.745 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -69.88 -14.09 62.57 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 128.295 2.638 . . . . 12.949999999999999 114.03 -177.909 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.492 27.6 m-20 75.23 41.15 0.3 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 116.963 2.209 . . . . 25.449999999999999 116.963 -176.289 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.631 HD12 HD23 ' A' ' 56' ' ' LEU . 71.7 mt -83.0 116.12 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 O-C-N 118.21 -2.806 . . . . 14.6 107.77 177.522 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -97.95 167.46 10.9 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.615 -0.721 . . . . 33.229999999999997 110.012 -176.65 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -70.23 144.65 51.79 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 120.874 1.67 . . . . 25.969999999999999 112.605 -174.86 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 67.16 21.5 10.04 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 127.661 3.6 . . . . 32.609999999999999 112.134 176.81 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.5 t -97.67 151.61 19.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.896 -2.378 . . . . 10.56 108.682 -178.081 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.8 m -101.47 111.3 23.5 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 128.244 2.618 . . . . 5.3300000000000001 113.07 -168.502 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.496 HD22 HD12 ' A' ' 3' ' ' ILE . 9.2 mp -90.88 145.89 24.37 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.293 2.637 . . . . 11.66 106.206 164.065 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -97.26 132.46 42.98 Favored 'General case' 0 N--CA 1.429 -1.5 0 C-N-CA 119.824 -0.75 . . . . 16.300000000000001 112.583 171.48 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.8 tp -95.03 121.01 36.22 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 106.432 -1.692 . . . . 9.9600000000000009 106.432 166.732 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -129.76 153.77 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 114.959 -2.448 . . . . 9.7599999999999998 105.596 178.699 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.6 mt -112.18 176.05 5.18 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 124.692 3.406 . . . . 19.57 107.465 175.541 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.4 mtt180 -107.93 143.12 37.01 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 118.909 2.929 . . . . 35.079999999999998 118.909 -174.398 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.1 tp -84.15 -60.88 1.96 Allowed 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 117.042 -1.863 . . . . 32.310000000000002 108.267 -173.854 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -96.61 -38.39 9.97 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 124.757 1.223 . . . . 42.75 109.191 -171.181 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.87 -51.13 0.51 Allowed Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 106.522 -2.631 . . . . 36.310000000000002 106.522 -179.448 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.781 0 O-C-N 119.118 -2.401 . . . . 36.270000000000003 108.94 -175.358 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttp . . . . . 0 CA--C 1.49 -1.334 0 CA-C-O 123.704 1.716 . . . . 17.170000000000002 107.499 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -99.98 116.61 32.42 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.613 2.765 . . . . 21.890000000000001 111.036 175.776 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -124.83 167.69 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 N-CA-C 106.79 -1.559 . . . . 10.83 106.79 178.884 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -122.48 115.82 22.88 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.663 -1.273 . . . . 10.609999999999999 110.823 -169.364 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.8 t -106.05 123.48 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 O-C-N 121.295 -0.878 . . . . 9.1300000000000008 109.128 171.351 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.439 ' HD2' HG21 ' A' ' 66' ' ' THR . 85.2 mttt -117.38 137.17 52.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 126.171 1.788 . . . . 20.550000000000001 108.846 -175.907 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -102.94 -176.77 3.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 125.488 1.742 . . . . 11.779999999999999 109.035 -175.16 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.266 95.9 mt -69.93 -27.1 64.49 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 127.805 2.442 . . . . 19.309999999999999 116.698 -172.091 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -96.2 -89.08 0.26 Allowed 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 127.451 2.3 . . . . 23.140000000000001 111.079 -177.679 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -159.74 36.85 0.47 Allowed Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.811 -3.681 . . . . 19.739999999999998 111.321 168.765 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -97.04 137.96 35.31 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 116.732 -1.987 . . . . 21.93 109.721 179.423 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.3 m -123.26 121.97 37.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.36 1.552 . . . . 12.33 107.103 171.144 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.9 mt -101.38 119.35 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 N-CA-C 103.382 -2.822 . . . . 17.079999999999998 103.382 179.96 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -89.36 105.34 17.73 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.237 1.494 . . . . 16.300000000000001 108.874 165.241 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.7 mt -92.13 146.12 23.98 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 127.602 3.572 . . . . 15.880000000000001 106.076 -178.32 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -95.2 108.56 20.7 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 111.284 -2.689 . . . . 28.899999999999999 112.33 171.272 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.2 m -128.86 -177.28 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 106.439 -1.689 . . . . 12.050000000000001 106.439 -176.183 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -132.63 159.9 70.58 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 119.157 -2.215 . . . . 18.170000000000002 107.279 164.547 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -77.48 -16.03 15.33 Favored 'Trans proline' 0 N--CA 1.434 -2.009 0 O-C-N 116.417 -2.464 . . . . 8.1600000000000001 114.691 -168.131 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 m -90.11 9.09 29.6 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 116.425 -2.11 . . . . 11.130000000000001 114.665 177.605 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -86.9 162.54 17.66 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 125.755 2.693 . . . . 18.030000000000001 113.703 165.048 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 69.2 p -99.56 169.79 9.05 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.84 2.733 . . . . 10.220000000000001 112.622 -170.7 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.372 36.8 mm -52.89 -32.72 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 116.164 1.913 . . . . 12.300000000000001 116.164 171.78 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.24 -28.65 69.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 116.933 -3.604 . . . . 36.509999999999998 116.263 170.769 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -75.79 -20.21 58.39 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.995 -2.315 . . . . 25.66 113.825 171.423 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.7 t -83.6 -45.33 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 CA-C-O 116.694 -1.622 . . . . 8.1199999999999992 107.392 -179.491 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 mtmt -63.58 -31.58 72.78 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.656 2.383 . . . . 15.470000000000001 110.94 173.682 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.6 -25.05 68.05 Favored 'General case' 0 N--CA 1.431 -1.391 0 C-N-CA 117.525 -1.67 . . . . 11.449999999999999 114.251 175.181 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.8 mttm -90.29 -15.24 31.61 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 116.702 -3.749 . . . . 24.98 115.768 173.3 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mm -80.44 -24.6 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 126.159 2.162 . . . . 9.4600000000000009 110.59 167.88 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -81.82 -26.77 34.06 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 126.524 1.93 . . . . 14.76 108.478 -177.537 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -69.89 -68.9 0.38 Allowed 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.566 -3.208 . . . . 26.289999999999999 111.497 164.542 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -73.64 -49.36 26.39 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 116.11 1.893 . . . . 30.059999999999999 116.11 -169.375 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -86.81 -47.82 8.74 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 121.666 2.03 . . . . 25.190000000000001 113.396 178.95 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.06 59.11 1.51 Allowed Glycine 0 N--CA 1.43 -1.701 0 C-N-CA 130.288 3.804 . . . . 7.4100000000000001 107.152 169.33 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.408 HG22 ' HB3' ' A' ' 40' ' ' GLN . 15.9 mm -102.41 140.0 20.74 Favored Pre-proline 0 N--CA 1.43 -1.469 0 O-C-N 129.099 3.47 . . . . 9.4900000000000002 104.004 177.79 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -62.07 161.22 26.99 Favored 'Trans proline' 0 N--CA 1.433 -2.056 0 O-C-N 114.304 -3.577 . . . . 11.42 115.953 173.582 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -72.66 -27.49 15.14 Favored 'Trans proline' 0 N--CA 1.434 -1.987 1 CA-C-N 128.85 4.196 . . . . 12.0 110.682 -168.408 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -87.13 -24.08 24.64 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.669 2.84 . . . . 35.549999999999997 118.669 179.425 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.408 ' HB3' HG22 ' A' ' 36' ' ' ILE . 11.0 tt0 -66.9 -42.06 86.08 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 117.828 2.529 . . . . 20.52 117.828 172.624 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -72.64 131.74 42.82 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.117 3.377 . . . . 7.1299999999999999 120.117 176.155 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.3 ttt180 -131.9 104.96 7.14 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 126.685 1.994 . . . . 36.390000000000001 108.624 -170.082 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.1 mt -83.84 112.43 20.11 Favored 'General case' 0 N--CA 1.43 -1.471 1 O-C-N 115.22 -4.675 . . . . 9.5500000000000007 114.293 174.84 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.7 mt -99.89 115.81 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 CA-C-N 114.041 -1.436 . . . . 13.9 111.585 175.402 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -108.21 120.65 42.96 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.06 -1.65 . . . . 6.8600000000000003 106.55 163.436 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.52 . . 69.21 -111.16 0.09 Allowed 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 118.627 -2.546 . . . . 11.15 111.65 -176.77 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.69 6.15 12.6 Favored Glycine 0 N--CA 1.43 -1.71 0 C-N-CA 116.507 -2.758 . . . . 13.93 108.58 172.027 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.2 mttt -86.39 139.22 31.14 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.468 -2.783 . . . . 23.920000000000002 111.702 -158.15 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 -89.41 125.16 35.04 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 102.998 -2.964 . . . . 23.23 102.998 166.132 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.3 mt -94.33 144.18 25.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 124.544 2.116 . . . . 9.1099999999999994 110.447 -167.806 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -90.68 130.46 36.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.622 -2.549 . . . . 33.439999999999998 116.402 172.686 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -36.54 -51.1 0.82 Allowed 'General case' 0 N--CA 1.43 -1.451 1 C-N-CA 132.992 4.517 . . . . 28.370000000000001 119.612 176.074 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.29 20.9 36.58 Favored Glycine 0 N--CA 1.429 -1.783 0 CA-C-N 114.23 -1.35 . . . . 15.0 113.773 -169.341 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.2 mtt-85 -93.3 163.91 13.42 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.146 -2.973 . . . . 25.5 110.468 160.872 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 38.0 p -104.74 158.16 16.7 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.037 -1.664 . . . . 11.949999999999999 108.276 -173.978 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.2 mt -56.06 -35.88 67.44 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.728 2.68 . . . . 10.17 115.522 -179.648 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 44.7 p -63.04 -48.2 79.75 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 136.82 6.048 . . . . 13.59 113.653 169.663 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -60.35 -44.78 95.24 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 126.579 1.952 . . . . 11.699999999999999 112.896 176.803 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -74.7 -10.41 59.49 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 116.239 -4.038 . . . . 12.949999999999999 114.323 173.96 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.394 60.5 m-80 71.33 36.08 1.41 Allowed 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 127.93 2.492 . . . . 25.449999999999999 112.313 178.803 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.9 mt -87.87 86.18 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.487 0 O-C-N 125.604 1.815 . . . . 14.6 109.52 -175.776 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -77.04 -178.1 4.81 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 125.708 1.88 . . . . 33.229999999999997 114.5 -173.408 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -72.29 135.72 46.05 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.797 1.639 . . . . 25.969999999999999 110.463 -178.69 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.306 47.6 mt-10 61.91 35.21 16.45 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 122.241 1.02 . . . . 32.609999999999999 112.377 -176.304 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.288 0.2 OUTLIER -105.47 147.23 28.53 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 112.466 -2.152 . . . . 10.56 109.587 172.224 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.439 HG21 ' HD2' ' A' ' 6' ' ' LYS . 61.9 m -122.65 120.42 33.65 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.728 2.204 . . . . 5.3300000000000001 112.586 -157.198 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 82.0 mt -101.89 130.23 48.33 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 130.337 3.455 . . . . 11.66 109.959 -177.393 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -102.7 104.23 14.54 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.348 -3.97 . . . . 16.300000000000001 104.953 -174.208 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.5 tp -80.05 119.37 22.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.479 -2.045 . . . . 9.9600000000000009 105.479 172.957 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.06 141.01 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 126.223 2.202 . . . . 9.7599999999999998 108.361 170.739 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.5 mt -95.72 146.8 24.23 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 112.99 0.737 . . . . 19.57 112.99 177.395 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 49.3 mtt180 -97.25 158.01 15.67 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 106.706 -1.59 . . . . 35.079999999999998 106.706 179.174 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 mt -67.96 -61.94 1.64 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.916 -2.99 . . . . 32.310000000000002 115.807 166.535 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.8 ttt-85 -83.25 -36.94 24.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.904 -1.748 . . . . 42.75 114.682 -169.973 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.48 51.44 3.29 Favored Glycine 0 N--CA 1.43 -1.726 0 O-C-N 119.541 -1.975 . . . . 36.310000000000002 117.089 -177.694 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.715 0 C-N-CA 117.364 -2.351 . . . . 36.270000000000003 112.36 -176.876 . . . . . . . . 0 0 . 1 . 101 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 CA--C 1.49 -1.338 0 N-CA-C 115.456 1.65 . . . . 17.170000000000002 115.456 . . . . . . . . . 0 0 . 1 . 101 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -80.55 118.88 22.53 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.881 -3.012 . . . . 21.890000000000001 118.336 -179.924 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.7 pt -100.8 165.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 126.957 2.103 . . . . 10.83 111.819 168.937 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.294 15.8 m-30 -123.15 112.6 17.9 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.838 -2.414 . . . . 10.609999999999999 112.656 -176.016 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.3 t -90.91 105.38 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 117.972 -2.955 . . . . 9.1300000000000008 117.206 170.46 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -88.99 137.11 32.62 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-O 124.208 1.956 . . . . 20.550000000000001 115.343 -175.591 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.1 p -87.15 178.41 6.9 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 113.314 -5.866 . . . . 11.779999999999999 110.648 -176.183 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 tp -58.63 -50.02 75.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 116.473 -3.892 . . . . 19.309999999999999 114.681 173.006 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -77.78 -38.63 46.25 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 116.211 -4.056 . . . . 23.140000000000001 112.99 -177.412 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 139.76 52.18 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.999 -1.688 . . . . 19.739999999999998 115.485 169.589 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -111.3 126.74 55.22 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.906 1.336 . . . . 21.93 107.924 179.331 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 30.0 m -86.06 116.08 24.05 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 118.573 -2.58 . . . . 12.33 111.789 169.936 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.4 mt -92.97 117.27 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 112.969 0.729 . . . . 17.079999999999998 112.969 168.254 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.0 m -88.11 122.26 31.47 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 119.118 -2.238 . . . . 16.300000000000001 109.936 177.865 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 64.8 mt -115.36 131.13 57.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.602 2.62 . . . . 15.880000000000001 111.52 172.553 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -87.75 103.25 15.44 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 128.504 2.722 . . . . 28.899999999999999 105.146 -177.068 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.405 HG12 ' HE3' ' A' ' 29' ' ' LYS . 28.4 m -119.33 167.8 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 105.662 -1.977 . . . . 12.050000000000001 105.662 -178.321 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -123.56 147.05 51.81 Favored Pre-proline 0 N--CA 1.431 -1.402 0 C-N-CA 126.471 1.908 . . . . 18.170000000000002 106.407 176.609 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -67.52 -22.5 44.71 Favored 'Trans proline' 0 N--CA 1.434 -1.986 0 O-C-N 115.796 -2.791 . . . . 8.1600000000000001 117.245 -158.094 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.8 m -94.53 33.85 1.38 Allowed 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 123.934 3.061 . . . . 11.130000000000001 113.612 171.34 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -84.92 139.14 32.06 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 127.193 3.378 . . . . 18.030000000000001 113.243 162.665 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.7 p -80.05 163.07 24.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 112.651 -2.068 . . . . 10.220000000000001 112.614 176.275 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.91 -26.04 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 O-C-N 119.712 -1.868 . . . . 12.300000000000001 112.321 -179.624 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.398 15.2 pt-20 -60.58 -28.38 68.43 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 116.687 2.106 . . . . 36.509999999999998 116.687 168.959 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.293 5.7 t-20 -72.83 -37.92 67.29 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.955 3.302 . . . . 25.66 111.152 173.719 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 39.6 t -52.34 -53.93 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 129.213 3.005 . . . . 8.1199999999999992 111.59 173.55 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt -69.76 -11.01 60.52 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 129.728 3.211 . . . . 15.470000000000001 112.184 -179.303 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.44 -44.7 70.76 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 121.423 1.919 . . . . 11.449999999999999 107.623 174.074 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' HE3' HG12 ' A' ' 17' ' ' VAL . 64.0 mttm -76.0 -37.81 58.07 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.346 2.659 . . . . 24.98 106.023 -168.247 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.315 8.8 mm -57.37 -35.51 49.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 118.594 2.813 . . . . 9.4600000000000009 118.594 171.233 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -71.46 -40.4 70.34 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 128.473 2.709 . . . . 14.76 114.895 167.339 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -60.3 -67.26 0.41 Allowed 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 128.23 3.871 . . . . 26.289999999999999 111.495 169.687 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.4 mmtt -72.62 -50.97 21.69 Favored 'General case' 0 N--CA 1.431 -1.422 1 O-C-N 110.502 -7.624 . . . . 30.059999999999999 112.48 -160.629 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -97.1 -71.64 0.67 Allowed 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 124.112 1.911 . . . . 25.190000000000001 111.479 175.104 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.41 26.01 0.5 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 116.276 -2.869 . . . . 7.4100000000000001 120.178 -175.662 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mm -93.53 133.5 28.09 Favored Pre-proline 0 N--CA 1.43 -1.455 0 CA-C-O 115.323 -2.275 . . . . 9.4900000000000002 107.72 -178.519 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_exo -73.49 160.09 45.07 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 CA-C-N 126.566 3.381 . . . . 11.42 114.639 179.525 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -81.5 -16.06 9.53 Favored 'Trans proline' 0 C--N 1.299 -2.034 0 C-N-CA 123.552 2.835 . . . . 12.0 110.521 -162.266 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -82.03 -37.61 26.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 125.056 3.571 . . . . 35.549999999999997 114.474 -179.899 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -69.49 -27.57 65.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 117.636 2.458 . . . . 20.52 117.636 -178.139 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -87.65 139.24 30.73 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 107.33 -1.359 . . . . 7.1299999999999999 107.33 -174.318 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -106.63 142.59 36.03 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 105.007 -2.22 . . . . 36.390000000000001 105.007 165.526 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.4 mt -118.96 108.85 15.27 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.704 -3.122 . . . . 9.5500000000000007 112.879 171.119 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 40.5 mt -92.82 137.86 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 106.441 -1.689 . . . . 13.9 106.441 -177.363 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -110.38 118.95 37.67 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.304 2.241 . . . . 6.8600000000000003 105.576 167.125 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.18 -96.63 0.05 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 124.919 1.288 . . . . 11.15 111.899 -167.277 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -129.86 5.55 6.13 Favored Glycine 0 N--CA 1.43 -1.754 0 O-C-N 117.36 -3.337 . . . . 13.93 112.065 172.769 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.4 mttm -82.03 152.65 26.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.609 -2.701 . . . . 23.920000000000002 110.487 -168.079 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -92.02 124.62 36.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.94 -1.505 . . . . 23.23 112.361 169.098 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.2 mt -104.72 168.7 8.9 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 124.693 1.246 . . . . 9.1099999999999994 112.467 -175.173 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -132.06 166.44 21.74 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.643 1.977 . . . . 33.439999999999998 107.374 -178.403 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -93.9 -42.86 8.85 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.913 -1.742 . . . . 28.370000000000001 111.104 -149.305 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.83 44.96 1.44 Allowed Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 118.462 -1.828 . . . . 15.0 115.193 -179.042 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.4 mmt85 -120.82 159.12 26.12 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 127.486 2.314 . . . . 25.5 107.748 173.293 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.3 p -97.98 160.31 14.39 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 123.384 1.564 . . . . 11.949999999999999 114.506 -169.461 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.52 -38.83 82.03 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 119.902 -1.749 . . . . 10.17 112.496 168.179 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.9 p -52.73 -45.6 67.06 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 118.498 2.777 . . . . 13.59 118.498 171.281 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.47 -41.68 96.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 114.549 -2.644 . . . . 11.699999999999999 114.92 176.436 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -78.91 -10.13 59.72 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 122.41 2.368 . . . . 12.949999999999999 115.13 172.966 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.422 1.0 OUTLIER 71.82 42.7 0.61 Allowed 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.776 1.769 . . . . 25.449999999999999 115.776 -178.832 . . . . . . . . 3 3 . 1 . 101 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.5 mt -88.11 111.84 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 1 O-C-N 129.418 4.199 . . . . 14.6 108.756 -177.4 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.319 40.1 mt-30 -93.1 -175.55 3.89 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 116.876 -3.64 . . . . 33.229999999999997 110.671 -177.938 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttt -69.69 147.36 50.68 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.053 -1.655 . . . . 25.969999999999999 112.722 171.571 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 56.26 41.57 29.05 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 127.652 2.381 . . . . 32.609999999999999 116.786 -168.122 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.6 m -104.34 145.61 30.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 125.023 1.452 . . . . 10.56 107.441 178.82 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -105.81 124.02 48.89 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.593 2.14 . . . . 5.3300000000000001 106.221 -165.578 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.3 mt -104.34 143.03 33.53 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 117.108 -3.495 . . . . 11.66 106.751 168.499 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -98.84 111.33 23.75 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 116.264 1.95 . . . . 16.300000000000001 116.264 -179.524 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 32.5 tp -71.88 108.36 5.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.251 -3.406 . . . . 9.9600000000000009 109.249 179.747 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.7 t -117.04 149.32 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 104.818 -2.29 . . . . 9.7599999999999998 104.818 177.206 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.4 tp -95.83 135.23 37.82 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.833 2.16 . . . . 19.57 116.833 171.212 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -87.65 155.58 19.88 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.732 3.145 . . . . 35.079999999999998 109.433 -179.707 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 42.8 tp -86.81 -62.47 1.5 Allowed 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.566 2.439 . . . . 32.310000000000002 111.716 -176.163 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -77.32 -43.85 31.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.513 1.052 . . . . 42.75 112.054 177.338 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.79 17.91 59.07 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-O 116.936 -2.036 . . . . 36.310000000000002 115.685 -175.496 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.775 0 CA-C-N 123.226 3.513 . . . . 36.270000000000003 104.872 177.737 . . . . . . . . 0 0 . 1 . 102 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 CA--C 1.489 -1.373 0 CA-C-O 124.191 1.948 . . . . 17.170000000000002 111.683 . . . . . . . . . 0 0 . 1 . 102 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -76.85 119.51 20.71 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 118.397 -2.69 . . . . 21.890000000000001 110.334 -178.775 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.4 pt -112.06 154.66 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 N-CA-C 107.614 -1.254 . . . . 10.83 107.614 169.548 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -107.24 133.02 52.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 126.568 3.08 . . . . 10.609999999999999 108.643 175.152 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.1 t -110.91 117.81 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 C-N-CA 126.812 2.045 . . . . 9.1300000000000008 111.17 165.437 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -121.22 135.57 55.11 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.557 -1.339 . . . . 20.550000000000001 108.289 -170.752 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 62.8 p -95.32 179.81 5.05 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 122.803 1.287 . . . . 11.779999999999999 109.421 -163.501 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 tp -71.99 -46.46 57.19 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 124.111 1.91 . . . . 19.309999999999999 114.851 173.618 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.9 p -73.21 -40.14 64.98 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.259 -2.15 . . . . 23.140000000000001 115.546 175.842 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.17 64.65 0.15 Allowed Glycine 0 N--CA 1.431 -1.691 0 CA-C-O 122.897 1.276 . . . . 19.739999999999998 111.715 176.254 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -123.99 136.48 54.32 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.708 2.194 . . . . 21.93 108.016 159.263 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.0 m -105.01 108.22 19.62 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.973 -2.329 . . . . 12.33 112.69 168.451 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 mp -99.02 126.21 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.041 -1.662 . . . . 17.079999999999998 109.054 178.64 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.7 m -96.91 111.63 23.75 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 113.875 1.065 . . . . 16.300000000000001 113.875 179.465 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.3 mt -96.59 138.57 33.97 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 118.119 -2.863 . . . . 15.880000000000001 110.498 -176.025 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -107.28 73.35 0.92 Allowed 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 126.389 2.995 . . . . 28.899999999999999 110.915 -175.394 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.0 m -102.46 169.47 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 O-C-N 115.792 -4.318 . . . . 12.050000000000001 106.798 -175.143 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -95.87 159.09 33.13 Favored Pre-proline 0 N--CA 1.43 -1.453 1 O-C-N 130.002 4.564 . . . . 18.170000000000002 106.871 174.647 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -71.25 -26.68 20.64 Favored 'Trans proline' 0 N--CA 1.433 -2.034 0 O-C-N 126.268 2.72 . . . . 8.1600000000000001 110.964 172.645 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.1 p -72.64 -7.09 48.56 Favored 'General case' 0 N--CA 1.43 -1.453 1 CA-C-N 127.237 4.562 . . . . 11.130000000000001 112.742 175.915 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -77.67 154.14 32.43 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 123.196 2.725 . . . . 18.030000000000001 112.724 -175.19 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 64.4 p -89.34 151.33 22.13 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 129.302 3.041 . . . . 10.220000000000001 110.95 178.976 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.25 39.7 mm -56.97 -30.26 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 128.308 2.643 . . . . 12.300000000000001 114.198 178.691 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -49.25 -45.56 44.9 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.974 -2.954 . . . . 36.509999999999998 113.733 166.303 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -68.91 -37.0 78.69 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 124.249 0.968 . . . . 25.66 111.266 177.987 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.62 -40.31 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 113.741 1.015 . . . . 8.1199999999999992 113.741 -179.678 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.26 49.8 mtpt -59.1 -48.88 79.99 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.544 2.737 . . . . 15.470000000000001 112.823 174.521 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.87 -32.33 63.59 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.867 3.267 . . . . 11.449999999999999 111.094 172.581 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -74.27 -39.82 62.72 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 124.005 3.093 . . . . 24.98 109.455 -177.374 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD13 HD22 ' A' ' 69' ' ' LEU 0.326 81.8 mt -59.36 -37.52 69.88 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 C-N-CA 129.991 3.317 . . . . 9.4600000000000009 112.732 173.928 . . . . . . . . 3 3 . 1 . 102 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -59.91 -54.36 47.08 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.555 1.525 . . . . 14.76 112.9 167.039 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -56.23 -51.41 68.22 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 122.702 1.239 . . . . 26.289999999999999 112.123 -173.723 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -78.17 -69.54 0.55 Allowed 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 128.364 2.666 . . . . 30.059999999999999 114.351 179.398 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -87.29 -11.24 50.14 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.087 2.254 . . . . 25.190000000000001 117.087 -170.34 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.68 20.52 34.09 Favored Glycine 0 N--CA 1.43 -1.736 0 C-N-CA 128.151 2.786 . . . . 7.4100000000000001 116.253 160.895 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.7 mm -113.32 125.45 29.65 Favored Pre-proline 0 N--CA 1.43 -1.459 0 O-C-N 120.493 -1.592 . . . . 9.4900000000000002 110.036 -173.164 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.309 53.9 Cg_exo -76.55 167.58 25.29 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 CA-C-O 115.423 -1.991 . . . . 11.42 116.61 -173.968 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -63.9 -23.5 68.29 Favored 'Trans proline' 0 C--N 1.3 -2.019 1 C-N-CA 126.533 4.822 . . . . 12.0 115.907 -170.445 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -89.89 -21.81 22.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 124.008 3.095 . . . . 35.549999999999997 112.258 177.277 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -75.72 -9.54 58.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 114.627 -2.606 . . . . 20.52 116.1 -176.893 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -112.1 150.54 30.59 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 127.102 2.751 . . . . 7.1299999999999999 114.656 -167.502 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -127.22 93.25 3.69 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 119.851 -1.781 . . . . 36.390000000000001 109.357 -176.518 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.9 mt -82.17 91.59 6.74 Favored 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 113.831 1.049 . . . . 9.5500000000000007 113.831 172.24 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 53.4 mt -91.07 135.99 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-O 118.764 -0.636 . . . . 13.9 110.202 -177.816 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -122.66 112.7 18.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 104.603 -2.369 . . . . 6.8600000000000003 104.603 179.65 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.86 -108.53 0.44 Allowed 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.187 -2.196 . . . . 11.15 113.004 -169.721 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -91.91 -19.66 39.31 Favored Glycine 0 N--CA 1.429 -1.773 0 CA-C-O 115.536 -2.813 . . . . 13.93 117.041 167.43 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -105.34 134.08 49.04 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 119.791 1.795 . . . . 23.920000000000002 114.414 -165.564 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -72.45 138.4 47.06 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 124.303 2.002 . . . . 23.23 112.327 167.636 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.86 141.78 31.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.222 2.209 . . . . 9.1099999999999994 111.185 -169.099 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -119.62 135.88 54.62 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 123.467 1.603 . . . . 33.439999999999998 112.791 -166.453 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -48.86 -58.95 4.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 128.883 2.873 . . . . 28.370000000000001 111.882 -160.376 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.57 -10.18 75.28 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 122.85 3.9 . . . . 15.0 122.85 -173.843 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 54' ' ' ARG . 16.4 mmt180 -79.66 156.59 27.52 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 126.548 1.969 . . . . 25.5 114.95 174.586 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.9 p -93.88 168.81 10.74 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 126.748 3.166 . . . . 11.949999999999999 108.663 -176.001 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mt -72.64 -40.04 66.72 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 112.685 -2.052 . . . . 10.17 106.615 -176.198 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.2 p -63.79 -28.66 70.02 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 127.853 3.22 . . . . 13.59 116.139 174.114 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.76 -50.38 69.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 131.177 3.791 . . . . 11.699999999999999 113.406 170.805 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -64.95 -30.73 71.74 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.917 1.821 . . . . 12.949999999999999 115.917 167.144 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 49.4 m-80 82.11 41.27 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.43 1 C-N-CA 131.939 4.096 . . . . 25.449999999999999 110.921 176.908 . . . . . . . . 3 2 . 1 . 102 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 62.7 mt -78.82 92.53 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.441 1 CA-C-O 129.469 4.461 . . . . 14.6 108.935 170.919 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -84.66 175.65 9.08 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 113.202 -5.936 . . . . 33.229999999999997 111.168 179.707 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -54.03 127.76 27.79 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 124.278 1.99 . . . . 25.969999999999999 116.173 172.201 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 78.37 29.29 0.44 Allowed 'General case' 0 N--CA 1.43 -1.448 1 C-N-CA 132.744 4.418 . . . . 32.609999999999999 117.016 176.877 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.3 m -81.49 149.03 28.92 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 106.955 -1.498 . . . . 10.56 106.955 -169.693 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.7 m -94.43 118.01 31.0 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 118.701 -2.5 . . . . 5.3300000000000001 112.492 177.45 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -102.0 137.6 40.07 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.508 -3.245 . . . . 11.66 106.039 168.565 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -98.25 109.97 22.64 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 117.067 2.247 . . . . 16.300000000000001 117.067 169.868 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.422 HD22 HD13 ' A' ' 30' ' ' ILE . 14.2 tp -91.43 105.32 17.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.342 1.857 . . . . 9.9600000000000009 115.713 -179.944 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -109.32 162.68 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 101.81 -3.404 . . . . 9.7599999999999998 101.81 178.412 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -116.39 145.68 43.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.267 2.227 . . . . 19.57 112.411 168.78 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -68.34 127.56 33.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.63 2.085 . . . . 35.079999999999998 116.63 159.804 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.0 tp -64.52 -50.44 67.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.53 -1.981 . . . . 32.310000000000002 111.049 171.822 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.78 -70.45 0.8 Allowed 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 124.353 1.061 . . . . 42.75 109.135 -176.547 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -167.91 -144.34 4.13 Favored Glycine 0 N--CA 1.43 -1.714 0 N-CA-C 105.513 -3.035 . . . . 36.310000000000002 105.513 -178.232 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.74 0 O-C-N 118.533 -2.745 . . . . 36.270000000000003 111.819 -162.825 . . . . . . . . 0 0 . 1 . 103 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ptt? . . . . . 0 CA--C 1.49 -1.34 0 CA-C-O 123.628 1.68 . . . . 17.170000000000002 108.738 . . . . . . . . . 0 0 . 1 . 103 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -88.66 126.85 35.49 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 111.47 -2.604 . . . . 21.890000000000001 111.401 -179.68 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 3' ' ' ILE 0.256 20.8 pt -130.9 159.29 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 N-CA-C 107.221 -1.4 . . . . 10.83 107.221 168.721 . . . . . . . . 3 3 . 1 . 103 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -106.89 132.92 52.3 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 118.433 -0.794 . . . . 10.609999999999999 109.481 179.414 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.4 t -101.19 112.89 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.219 2.438 . . . . 9.1300000000000008 111.704 160.325 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.2 tttt -95.73 127.17 41.53 Favored 'General case' 0 N--CA 1.43 -1.459 1 O-C-N 113.129 -5.982 . . . . 20.550000000000001 112.99 177.274 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -76.87 -177.26 4.28 Favored 'General case' 0 N--CA 1.43 -1.458 1 O-C-N 115.492 -4.505 . . . . 11.779999999999999 118.146 178.494 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 51.9 tp -79.53 -21.74 44.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 125.484 2.564 . . . . 19.309999999999999 113.658 178.849 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.372 0.1 OUTLIER -75.32 -48.23 24.09 Favored 'General case' 0 N--CA 1.429 -1.48 1 O-C-N 116.055 -4.153 . . . . 23.140000000000001 108.72 174.219 . . . . . . . . 4 3 . 1 . 103 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.15 20.92 1.11 Allowed Glycine 0 N--CA 1.431 -1.692 0 CA-C-N 112.749 -2.023 . . . . 19.739999999999998 109.593 172.246 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -78.62 117.83 20.15 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.354 2.502 . . . . 21.93 110.751 173.581 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.8 m -88.26 110.96 21.15 Favored 'General case' 0 N--CA 1.431 -1.411 0 O-C-N 117.693 -3.129 . . . . 12.33 114.241 -178.9 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.6 mt -99.61 107.18 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 126.901 2.08 . . . . 17.079999999999998 110.983 -172.268 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.2 m -71.97 127.29 32.09 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.101 -1.624 . . . . 16.300000000000001 112.835 173.524 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.3 mt -111.63 151.34 28.92 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 120.532 -1.355 . . . . 15.880000000000001 114.313 167.303 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -108.96 99.05 8.43 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.808 2.043 . . . . 28.899999999999999 111.253 177.325 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -135.15 166.13 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.188 -3.445 . . . . 12.050000000000001 103.882 -171.801 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -120.0 161.88 36.18 Favored Pre-proline 0 N--CA 1.43 -1.444 0 O-C-N 118.959 -2.338 . . . . 18.170000000000002 106.348 177.656 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.68 -8.54 8.21 Favored 'Trans proline' 0 N--CA 1.434 -2.025 0 CA-C-N 127.501 3.715 . . . . 8.1600000000000001 107.73 -155.901 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 m -76.17 -9.63 58.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 130.153 3.381 . . . . 11.130000000000001 109.136 172.168 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -81.99 141.34 33.34 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 127.58 2.352 . . . . 18.030000000000001 112.67 -175.316 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 35.6 p -88.14 163.15 16.33 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.901 -1.749 . . . . 10.220000000000001 108.59 -171.576 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mm -76.42 -17.6 15.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 125.936 2.023 . . . . 12.300000000000001 109.081 -172.595 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -64.26 -30.19 71.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.562 -1.961 . . . . 36.509999999999998 116.243 162.259 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 t30 -76.17 -36.1 58.87 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 125.175 1.39 . . . . 25.66 109.696 -179.887 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.45 -48.74 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 128.865 2.866 . . . . 8.1199999999999992 115.959 172.752 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.02 -35.9 78.08 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 116.256 -1.831 . . . . 15.470000000000001 114.069 164.728 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.66 -39.25 80.09 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-N 123.752 2.978 . . . . 11.449999999999999 115.138 173.671 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.3 mmtt -57.28 -42.78 82.3 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 124.371 3.259 . . . . 24.98 115.814 169.205 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.5 mt -67.18 -29.79 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 1 O-C-N 114.18 -5.325 . . . . 9.4600000000000009 112.625 176.447 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -66.26 -52.7 44.96 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.603 -2.561 . . . . 14.76 108.504 167.804 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.337 34.1 t70 -51.81 -42.3 62.38 Favored 'General case' 0 N--CA 1.43 -1.475 0 CA-C-O 114.869 -2.491 . . . . 26.289999999999999 115.053 176.349 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -80.99 -86.06 0.09 Allowed 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 128.944 3.903 . . . . 30.059999999999999 112.052 -178.151 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -72.51 -33.68 67.08 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 116.237 1.94 . . . . 25.190000000000001 116.237 -175.275 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.15 39.46 4.53 Favored Glycine 0 N--CA 1.43 -1.752 0 O-C-N 117.089 -3.507 . . . . 7.4100000000000001 114.218 -175.945 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.2 mm -100.03 113.4 65.21 Favored Pre-proline 0 N--CA 1.429 -1.475 0 O-C-N 117.391 -3.417 . . . . 9.4900000000000002 110.601 175.849 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.1 OUTLIER -64.85 151.56 85.33 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 124.811 3.674 . . . . 11.42 114.075 -176.49 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.23 -9.87 16.39 Favored 'Trans proline' 0 C--N 1.3 -2.001 0 CA-C-N 127.013 3.54 . . . . 12.0 114.836 -165.605 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.06 -28.56 61.46 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.216 2.436 . . . . 35.549999999999997 107.577 178.406 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -84.62 -20.34 31.53 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.198 -2.189 . . . . 20.52 112.018 -174.764 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -93.53 149.52 21.16 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 126.17 2.891 . . . . 7.1299999999999999 114.094 -172.873 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -141.64 126.31 17.95 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.324 -3.36 . . . . 36.390000000000001 108.175 167.146 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.1 mt -107.83 121.06 43.98 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 110.048 -3.251 . . . . 9.5500000000000007 106.864 -175.556 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 59.7 mt -113.83 135.19 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 1 N-CA-C 98.916 -4.476 . . . . 13.9 98.916 -171.185 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -115.64 103.41 10.68 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 127.429 2.292 . . . . 6.8600000000000003 106.479 170.212 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.29 -105.16 0.07 Allowed 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.154 1.782 . . . . 11.15 114.034 -174.7 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.14 27.29 9.16 Favored Glycine 0 N--CA 1.43 -1.73 0 CA-C-O 115.54 -2.811 . . . . 13.93 116.289 170.561 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.7 pttt -147.49 158.97 44.21 Favored 'General case' 0 N--CA 1.43 -1.458 1 CA-C-N 124.363 4.082 . . . . 23.920000000000002 111.872 171.822 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.259 15.8 pt20 -85.31 137.81 32.72 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 125.501 1.52 . . . . 23.23 110.784 -175.84 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.4 mt -83.67 131.05 34.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 106.218 -1.771 . . . . 9.1099999999999994 106.218 175.043 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -93.97 134.25 36.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 115.534 1.679 . . . . 33.439999999999998 115.534 -179.081 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.66 -46.52 49.81 Favored 'General case' 0 N--CA 1.43 -1.465 1 C-N-CA 132.073 4.149 . . . . 28.370000000000001 111.665 -168.859 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -78.78 -8.79 87.57 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 129.96 3.648 . . . . 15.0 112.148 -167.761 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -102.7 167.19 10.06 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.99 -4.241 . . . . 25.5 111.914 -179.522 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 32.9 p -89.67 170.95 10.02 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.903 -1.748 . . . . 11.949999999999999 108.296 176.327 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 30.0 mt -72.53 -30.92 64.89 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.629 3.172 . . . . 10.17 110.662 169.3 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 p -65.8 -30.87 71.57 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 132.488 4.315 . . . . 13.59 112.435 179.393 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.87 -44.58 96.54 Favored 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 115.558 -4.464 . . . . 11.699999999999999 111.261 175.757 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -78.03 -12.62 60.0 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.43 2.292 . . . . 12.949999999999999 113.017 -177.784 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.439 35.8 m120 65.69 31.53 9.68 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 127.64 2.376 . . . . 25.449999999999999 116.659 -166.078 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 58.2 mt -79.69 125.89 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 1 O-C-N 116.252 -4.03 . . . . 14.6 103.888 -169.483 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -104.78 -173.94 2.42 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 130.269 3.427 . . . . 33.229999999999997 113.283 -169.447 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -67.74 137.46 55.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 129.961 3.304 . . . . 25.969999999999999 109.895 174.687 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 52.5 33.56 13.58 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.093 2.957 . . . . 32.609999999999999 111.288 179.373 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.5 t -76.21 151.52 36.85 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 114.204 -2.808 . . . . 10.56 110.422 163.909 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.9 m -110.17 112.54 24.58 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 133.046 6.466 . . . . 5.3300000000000001 110.166 179.555 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.1 mt -97.62 159.06 15.16 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 110.654 -2.976 . . . . 11.66 106.566 170.704 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -124.82 123.71 40.55 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 115.992 -1.956 . . . . 16.300000000000001 106.76 -169.266 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 44.5 tp -112.33 125.18 53.91 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 121.937 2.153 . . . . 9.9600000000000009 109.315 -172.303 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.298 16.5 m -127.01 150.89 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-O 124.432 2.063 . . . . 9.7599999999999998 109.119 169.63 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 45.5 mt -110.63 167.81 9.94 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 113.023 -1.899 . . . . 19.57 110.86 -167.174 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.482 HH12 ' C ' ' A' ' 76' ' ' GLY . 73.6 mtp180 -126.34 177.84 6.19 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.052 -2.905 . . . . 35.079999999999998 107.04 -172.924 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.5 tp -70.21 -62.88 1.22 Allowed 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 117.752 2.501 . . . . 32.310000000000002 117.752 171.256 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.5 mtp-105 -132.56 -51.98 0.93 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.123 -2.236 . . . . 42.75 112.941 175.396 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 151.97 178.88 27.12 Favored Glycine 0 N--CA 1.429 -1.769 0 CA-C-N 122.405 2.366 . . . . 36.310000000000002 109.948 -177.511 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.482 ' C ' HH12 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.755 0 O-C-N 118.702 -2.646 . . . . 36.270000000000003 107.66 -172.893 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 107.668 -1.234 . . . . 17.170000000000002 107.668 . . . . . . . . . 0 0 . 1 . 104 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -112.08 140.58 46.65 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 104.802 -2.295 . . . . 21.890000000000001 104.802 -175.817 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.2 pt -128.62 154.48 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-O 123.422 1.582 . . . . 10.83 111.083 167.764 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -113.37 107.84 16.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 119.48 -2.012 . . . . 10.609999999999999 110.823 -173.517 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t -102.04 106.26 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 O-C-N 120.473 -1.392 . . . . 9.1300000000000008 109.671 178.251 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.3 mttm -89.39 128.89 35.97 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 115.489 1.662 . . . . 20.550000000000001 115.489 179.557 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.9 p -78.63 164.45 24.63 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 119.86 -1.775 . . . . 11.779999999999999 110.572 171.103 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.0 mt -77.5 -22.41 51.28 Favored 'General case' 0 N--CA 1.43 -1.474 1 O-C-N 115.485 -4.509 . . . . 19.309999999999999 110.833 -172.76 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.8 p -92.74 -67.84 0.83 Allowed 'General case' 0 N--CA 1.429 -1.495 0 N-CA-C 107.425 -1.324 . . . . 23.140000000000001 107.425 176.583 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 177.12 76.75 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.755 0 CA-C-O 114.521 -3.377 . . . . 19.739999999999998 121.496 -178.701 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.6 tttt -156.91 131.67 8.83 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.609 2.704 . . . . 21.93 106.577 171.556 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 42.0 m -105.76 108.17 19.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.52 1.629 . . . . 12.33 107.248 172.843 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 mt -86.71 117.03 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 105.509 -2.034 . . . . 17.079999999999998 105.509 176.311 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -93.88 127.31 39.57 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.408 1.693 . . . . 16.300000000000001 112.232 171.479 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -117.7 132.91 56.41 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 126.898 2.079 . . . . 15.880000000000001 112.816 -177.74 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -92.09 107.07 18.94 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.511 -1.663 . . . . 28.899999999999999 106.511 172.601 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 m -122.85 166.97 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 104.628 -2.36 . . . . 12.050000000000001 104.628 179.482 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -118.17 138.37 25.49 Favored Pre-proline 0 N--CA 1.43 -1.463 0 C-N-CA 126.698 1.999 . . . . 18.170000000000002 109.069 168.872 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.652 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 38.0 Cg_endo -67.54 -10.0 27.26 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 C-N-CA 124.579 3.519 . . . . 8.1600000000000001 117.965 -171.721 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 t -76.64 -14.32 59.98 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.984 1.846 . . . . 11.130000000000001 115.984 170.399 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -85.06 172.65 11.1 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.531 1.514 . . . . 18.030000000000001 108.455 -178.767 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 70.8 p -103.54 157.08 17.29 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 117.229 -1.367 . . . . 10.220000000000001 113.296 -176.731 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.427 HD12 HD13 ' A' ' 50' ' ' LEU . 13.6 mm -53.65 -36.59 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 122.065 2.211 . . . . 12.300000000000001 113.842 177.61 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -53.47 -25.55 16.75 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.095 -2.253 . . . . 36.509999999999998 116.191 169.525 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -87.62 -18.82 28.79 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 117.666 -1.159 . . . . 25.66 113.025 173.334 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 74.3 t -75.38 -44.03 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-N 122.136 2.244 . . . . 8.1199999999999992 112.486 176.196 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -62.84 -37.52 87.12 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 110.559 -3.019 . . . . 15.470000000000001 109.195 173.381 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.28 -19.43 61.68 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 116.387 -1.768 . . . . 11.449999999999999 114.084 173.309 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -77.2 -29.4 54.26 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 122.924 2.602 . . . . 24.98 110.628 171.313 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.7 mt -64.58 -45.6 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 116.615 -1.659 . . . . 9.4600000000000009 114.924 167.695 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -48.03 -49.95 29.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 121.292 3.812 . . . . 14.76 121.292 167.995 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -59.52 -65.56 0.65 Allowed 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 127.7 2.4 . . . . 26.289999999999999 115.484 170.849 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -74.62 -71.53 0.34 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 116.544 -3.847 . . . . 30.059999999999999 112.388 -177.725 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -71.51 -31.11 66.71 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.676 -6.265 . . . . 25.190000000000001 113.616 -170.132 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.08 52.16 4.42 Favored Glycine 0 N--CA 1.43 -1.709 0 C-N-CA 128.353 2.882 . . . . 7.4100000000000001 110.704 178.56 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -112.85 143.02 28.26 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-N 119.959 1.88 . . . . 9.4900000000000002 106.18 168.125 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -72.5 168.33 24.63 Favored 'Trans proline' 0 N--CA 1.434 -1.993 0 CA-C-N 125.266 2.917 . . . . 11.42 113.16 -173.34 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -81.91 -11.95 11.05 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 CA-C-N 125.547 3.017 . . . . 12.0 112.546 177.699 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.94 -33.39 75.47 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.135 -2.228 . . . . 35.549999999999997 113.281 172.135 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.261 46.5 mt-30 -95.38 -8.85 34.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.044 2.831 . . . . 20.52 110.756 -167.731 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -87.05 122.01 30.29 Favored 'General case' 0 N--CA 1.429 -1.484 1 O-C-N 111.902 -6.749 . . . . 7.1299999999999999 115.418 175.33 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.8 ttm180 -122.05 121.05 36.09 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.244 -2.16 . . . . 36.390000000000001 107.13 165.431 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.0 mt -105.98 139.04 41.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 116.677 -1.63 . . . . 9.5500000000000007 110.115 -177.58 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 44' ' ' ILE . 75.5 mt -117.21 141.98 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 100.433 -3.914 . . . . 13.9 100.433 -175.474 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -136.85 104.23 5.42 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 105.15 -2.167 . . . . 6.8600000000000003 105.15 172.7 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.266 . . 65.99 -127.83 0.27 Allowed 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.758 -1.839 . . . . 11.15 111.927 -177.06 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.8 24.04 30.05 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 119.753 2.661 . . . . 13.93 119.753 -178.468 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.5 157.74 40.26 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-N 110.818 -2.691 . . . . 23.920000000000002 112.085 -168.018 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -105.88 152.56 23.12 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 106.155 -1.794 . . . . 23.23 106.155 -176.188 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.427 HD13 HD12 ' A' ' 23' ' ' ILE . 78.3 mt -88.59 146.76 24.94 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 124.767 2.222 . . . . 9.1099999999999994 111.014 -177.03 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.52 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 17.5 tt0 -100.77 139.36 36.56 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 126.545 1.938 . . . . 33.439999999999998 107.217 -176.706 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -56.44 -55.54 32.4 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 128.153 2.581 . . . . 28.370000000000001 111.992 -168.937 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.97 31.47 7.92 Favored Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 113.45 -1.705 . . . . 15.0 110.878 -162.667 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.52 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 29.6 mtt180 -103.89 170.06 8.14 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 116.689 -3.83 . . . . 25.5 104.004 169.57 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.4 p -85.93 158.68 19.85 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.012 2.925 . . . . 11.949999999999999 105.908 -179.196 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.652 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 1.2 mt -69.41 -32.36 71.3 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 117.757 -3.089 . . . . 10.17 116.215 171.385 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.6 p -53.41 -40.33 65.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.404 3.082 . . . . 13.59 115.98 167.643 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -71.93 -20.47 61.75 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.2 -2.812 . . . . 11.699999999999999 117.073 -176.597 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -91.64 -1.12 57.57 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.325 1.85 . . . . 12.949999999999999 110.844 174.037 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 44.05 63.32 1.65 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 112.53 -2.123 . . . . 25.449999999999999 115.171 -161.497 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.8 mt -86.69 127.17 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 106.825 -1.546 . . . . 14.6 106.825 168.539 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -124.35 179.74 4.79 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 128.188 2.595 . . . . 33.229999999999997 106.28 -168.16 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.0 pttp -67.54 145.92 54.44 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 116.886 -3.634 . . . . 25.969999999999999 111.537 -172.315 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 51.46 26.53 3.23 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.447 2.018 . . . . 32.609999999999999 116.447 -175.847 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.6 m -56.18 145.79 25.26 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 119.937 -1.727 . . . . 10.56 113.201 167.628 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.0 m -98.58 120.56 39.21 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.142 -2.224 . . . . 5.3300000000000001 114.192 167.974 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.1 mp -110.27 160.41 16.55 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 119.344 0.974 . . . . 11.66 110.547 169.669 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -112.87 133.4 54.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 102.424 -3.176 . . . . 16.300000000000001 102.424 176.271 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 50.7 tp -103.12 117.48 34.66 Favored 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 126.437 1.895 . . . . 9.9600000000000009 113.313 166.633 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 95.0 t -116.62 123.21 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 N-CA-C 104.931 -2.248 . . . . 9.7599999999999998 104.931 -173.567 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.3 mt -98.65 132.46 44.03 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 119.677 -1.889 . . . . 19.57 113.75 -173.95 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.55 HH12 ' C ' ' A' ' 76' ' ' GLY . 43.4 mtp180 -112.47 -177.4 3.14 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.172 2.26 . . . . 35.079999999999998 114.211 -175.11 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.54 -178.57 7.01 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 114.535 -5.103 . . . . 32.310000000000002 107.524 178.465 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.3 mtt-85 -92.61 82.13 4.8 Favored 'General case' 0 N--CA 1.429 -1.492 0 O-C-N 117.455 -3.278 . . . . 42.75 110.671 173.098 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.63 -67.36 0.01 OUTLIER Glycine 0 N--CA 1.43 -1.713 0 O-C-N 116.608 -3.807 . . . . 36.310000000000002 112.545 -173.635 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.55 ' C ' HH12 ' A' ' 72' ' ' ARG . . . . . . . . 0 C--O 1.26 1.741 0 CA-C-N 121.93 2.865 . . . . 36.270000000000003 112.23 -171.804 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.26 7.9 ptt? . . . . . 0 CA--C 1.49 -1.329 0 N-CA-C 117.756 2.502 . . . . 17.170000000000002 117.756 . . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -113.29 130.64 56.2 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 105.844 -1.91 . . . . 21.890000000000001 105.844 -177.421 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.6 pt -131.29 160.02 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 100.569 -3.863 . . . . 10.83 100.569 -177.673 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -112.41 151.59 29.66 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.527 2.584 . . . . 10.609999999999999 106.785 -177.739 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.3 t -128.33 124.56 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 O-C-N 117.456 -3.277 . . . . 9.1300000000000008 109.66 166.745 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -136.66 135.7 38.48 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 113.772 -1.558 . . . . 20.550000000000001 109.934 -170.366 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.1 p -80.83 -174.25 4.67 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-O 125.448 2.547 . . . . 11.779999999999999 111.271 175.985 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.16 -43.42 74.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.027 -2.296 . . . . 19.309999999999999 111.47 177.077 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -76.62 -34.8 58.35 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 115.361 -2.257 . . . . 23.140000000000001 108.07 179.658 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.15 70.2 0.63 Allowed Glycine 0 N--CA 1.43 -1.707 0 C-N-CA 126.523 2.011 . . . . 19.739999999999998 114.162 173.72 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -96.55 103.07 14.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 131.051 3.74 . . . . 21.93 106.877 160.491 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -100.08 135.81 40.94 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 125.21 2.433 . . . . 12.33 110.445 -178.866 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.0 pt -139.99 162.33 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 C-N-CA 128.445 2.698 . . . . 17.079999999999998 111.79 175.054 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.5 m -126.81 119.47 26.92 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 124.794 1.309 . . . . 16.300000000000001 110.145 -172.218 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.42 134.13 48.13 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-N 113.218 -1.81 . . . . 15.880000000000001 107.83 -178.321 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -98.86 115.49 28.96 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 103.352 -2.833 . . . . 28.899999999999999 103.352 178.689 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -145.37 177.86 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.818 -1.549 . . . . 12.050000000000001 106.818 177.183 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -116.89 160.17 37.89 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 104.497 -2.408 . . . . 18.170000000000002 104.497 179.228 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -76.67 2.53 7.34 Favored 'Trans proline' 0 N--CA 1.434 -1.99 0 C-N-CA 115.837 -2.309 . . . . 8.1600000000000001 116.427 -175.099 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.0 p -77.47 -13.8 59.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 124.871 1.357 . . . . 11.130000000000001 112.175 169.557 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.89 137.57 33.6 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 122.728 1.251 . . . . 18.030000000000001 111.805 -170.766 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -76.13 158.12 32.08 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 109.283 -3.599 . . . . 10.220000000000001 112.266 -169.781 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mm -52.93 -45.62 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 1 O-C-N 115.377 -4.577 . . . . 12.300000000000001 110.242 168.376 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -59.97 -32.09 70.51 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 118.278 -2.764 . . . . 36.509999999999998 118.176 168.887 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -63.84 -38.74 92.23 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 117.924 -2.985 . . . . 25.66 111.555 168.871 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.84 -47.18 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 125.014 1.326 . . . . 8.1199999999999992 108.771 171.9 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -58.81 -39.82 82.28 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.864 -1.772 . . . . 15.470000000000001 112.954 178.436 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.11 -19.43 61.79 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 119.499 3.148 . . . . 11.449999999999999 119.499 171.326 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.26 4.6 tppt? -66.84 -44.07 82.02 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 126.151 2.881 . . . . 24.98 117.127 167.854 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -74.01 -43.12 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 C-N-CA 127.659 2.384 . . . . 9.4600000000000009 107.416 179.144 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -48.27 -45.09 34.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.75 2.5 . . . . 14.76 117.75 169.67 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -66.03 -57.18 8.32 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.279 2.696 . . . . 26.289999999999999 118.279 169.502 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -64.67 -58.06 7.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 117.637 2.458 . . . . 30.059999999999999 117.637 173.32 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -75.45 -67.93 0.61 Allowed 'General case' 0 N--CA 1.431 -1.398 0 O-C-N 120.353 -1.467 . . . . 25.190000000000001 112.775 -176.475 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.82 27.01 2.88 Favored Glycine 0 N--CA 1.43 -1.748 0 CA-C-O 122.53 1.072 . . . . 7.4100000000000001 111.731 -176.863 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 74.7 mt -88.23 125.79 62.78 Favored Pre-proline 0 N--CA 1.43 -1.44 0 CA-C-O 114.063 -2.875 . . . . 9.4900000000000002 111.95 174.764 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.0 Cg_exo -71.13 154.81 62.06 Favored 'Trans proline' 0 C--N 1.3 -1.997 0 CA-C-N 126.698 3.428 . . . . 11.42 112.827 -174.89 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 84.9 Cg_exo -70.18 -15.24 35.45 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 C-N-CA 122.22 1.946 . . . . 12.0 110.068 -170.703 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -87.14 -16.58 35.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 123.828 1.775 . . . . 35.549999999999997 115.54 177.486 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -94.79 -34.86 12.33 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.06 -1.65 . . . . 20.52 108.687 -178.838 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -64.39 135.27 55.96 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 122.083 0.944 . . . . 7.1299999999999999 111.877 174.811 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.258 21.6 tpp180 -139.27 130.59 26.86 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.012 -2.93 . . . . 36.390000000000001 106.566 160.906 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.5 mt -94.33 135.66 35.49 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 127.95 2.5 . . . . 9.5500000000000007 112.779 -179.629 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.525 HG12 ' HG2' ' A' ' 49' ' ' GLN . 11.8 mt -127.09 132.09 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 1 N-CA-C 97.688 -4.931 . . . . 13.9 97.688 -172.28 . . . . . . . . 3 3 . 1 . 105 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -116.19 130.84 56.99 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.025 -2.297 . . . . 6.8600000000000003 107.368 166.563 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.83 -109.85 0.51 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.694 -2.504 . . . . 11.15 117.388 -172.059 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.17 -7.46 56.12 Favored Glycine 0 N--CA 1.43 -1.749 0 C-N-CA 130.663 3.983 . . . . 13.93 114.636 174.844 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -127.05 144.86 50.92 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 122.588 3.194 . . . . 23.920000000000002 112.999 -159.532 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.525 ' HG2' HG12 ' A' ' 44' ' ' ILE . 65.1 mt-30 -98.44 124.19 43.0 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.476 -1.693 . . . . 23.23 106.643 -176.2 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.408 ' H ' HD22 ' A' ' 50' ' ' LEU . 1.1 mm? -88.69 143.29 27.02 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 120.953 -1.092 . . . . 9.1099999999999994 112.372 -167.552 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.256 74.1 mm-40 -85.62 149.87 25.03 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 118.408 2.744 . . . . 33.439999999999998 118.408 -178.435 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -40.75 -64.08 0.58 Allowed 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 131.031 3.733 . . . . 28.370000000000001 118.798 -173.034 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.59 51.51 0.76 Allowed Glycine 0 N--CA 1.43 -1.751 0 CA-C-O 123.284 1.491 . . . . 15.0 111.153 -171.081 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.273 13.7 mmt85 -123.83 173.35 8.23 Favored 'General case' 0 N--CA 1.43 -1.455 1 O-C-N 115.743 -4.386 . . . . 25.5 108.775 173.693 . . . . . . . . 3 2 . 1 . 105 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 75.2 p -112.39 175.1 5.57 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 122.424 2.375 . . . . 11.949999999999999 113.525 175.201 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.3 mt -58.81 -41.08 85.94 Favored 'General case' 0 N--CA 1.43 -1.449 2 CA-C-N 106.801 -4.727 . . . . 10.17 113.648 169.322 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.0 t -70.52 -35.53 73.24 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.751 -1.218 . . . . 13.59 113.769 177.778 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -62.14 -48.56 79.55 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.407 -2.058 . . . . 11.699999999999999 114.261 178.979 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -72.86 -25.83 61.24 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.801 -3.687 . . . . 12.949999999999999 115.86 174.575 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.288 9.0 m120 83.16 67.2 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 127.013 2.125 . . . . 25.449999999999999 109.007 -173.424 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -112.49 117.12 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 101.81 -3.404 . . . . 14.6 101.81 172.208 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -102.55 -164.53 1.09 Allowed 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.51 -2.619 . . . . 33.229999999999997 109.225 -179.893 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -72.72 131.32 42.21 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 131.601 3.961 . . . . 25.969999999999999 111.132 -172.171 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 60.71 24.66 14.48 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 120.785 1.63 . . . . 32.609999999999999 113.385 179.526 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.8 m -89.58 153.62 20.63 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 101.21 -3.626 . . . . 10.56 101.21 171.723 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -116.46 109.68 17.62 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 126.039 1.735 . . . . 5.3300000000000001 107.33 -167.142 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mp -90.88 131.74 36.33 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 120.0 1.273 . . . . 11.66 110.082 178.418 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -80.38 132.0 35.7 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 127.066 3.317 . . . . 16.300000000000001 107.796 -176.076 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.256 5.1 tp -102.03 116.63 33.11 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 115.353 -4.592 . . . . 9.9600000000000009 109.804 173.261 . . . . . . . . 3 2 . 1 . 105 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.0 t -106.09 109.96 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 127.574 2.35 . . . . 9.7599999999999998 114.924 168.883 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -93.42 121.89 35.28 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 102.836 -3.024 . . . . 19.57 102.836 -171.648 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -63.35 139.46 58.77 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 116.798 2.147 . . . . 35.079999999999998 116.798 179.986 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 28.9 tp -91.4 -42.4 10.34 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 115.729 -4.357 . . . . 32.310000000000002 110.96 179.407 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpp180 -158.72 -50.54 0.06 Allowed 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.266 -2.146 . . . . 42.75 111.287 164.157 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.04 134.14 2.25 Favored Glycine 0 N--CA 1.43 -1.742 0 O-C-N 118.513 -2.617 . . . . 36.310000000000002 112.256 -174.708 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.768 0 C-N-CA 127.033 2.254 . . . . 36.270000000000003 113.62 175.049 . . . . . . . . 0 0 . 1 . 106 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.351 0 CA-C-O 121.011 0.434 . . . . 17.170000000000002 109.877 . . . . . . . . . 0 0 . 1 . 106 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -107.78 153.36 23.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 112.489 -2.141 . . . . 21.890000000000001 114.473 173.577 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 pt -126.78 147.19 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 N-CA-C 102.669 -3.086 . . . . 10.83 102.669 171.374 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -104.55 135.85 45.2 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.8 2.148 . . . . 10.609999999999999 116.8 156.768 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.4 t -114.57 141.97 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 C-N-CA 126.603 1.961 . . . . 9.1300000000000008 107.081 174.241 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -140.02 130.97 26.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.57 2.348 . . . . 20.550000000000001 112.543 -163.719 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -91.36 -176.7 4.63 Favored 'General case' 0 N--CA 1.431 -1.407 0 O-C-N 119.642 -1.911 . . . . 11.779999999999999 107.153 -176.334 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.1 tp -64.98 -48.4 74.13 Favored 'General case' 0 N--CA 1.429 -1.486 0 O-C-N 118.416 -2.678 . . . . 19.309999999999999 111.562 175.874 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.1 p -79.83 -62.57 1.64 Allowed 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 117.385 -3.322 . . . . 23.140000000000001 110.585 -174.851 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.71 41.25 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 116.999 -2.524 . . . . 19.739999999999998 114.348 175.409 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.3 19.7 tptm -88.54 109.06 19.76 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 107.035 -1.469 . . . . 21.93 107.035 165.313 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.4 m -104.14 108.91 20.51 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.316 -1.49 . . . . 12.33 108.08 -179.619 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.264 36.6 pt -97.03 134.22 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 116.412 -1.756 . . . . 17.079999999999998 110.312 175.156 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 3.6 m -109.66 112.13 24.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.977 2.911 . . . . 16.300000000000001 107.745 -179.893 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -106.61 160.07 15.72 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.823 -3.048 . . . . 15.880000000000001 110.553 -176.084 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -115.44 132.26 56.67 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.756 -2.465 . . . . 28.899999999999999 109.296 176.024 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -141.52 167.24 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 C-N-CA 127.294 2.237 . . . . 12.050000000000001 114.608 -167.756 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -90.97 140.5 26.1 Favored Pre-proline 0 N--CA 1.431 -1.415 0 O-C-N 119.087 -2.258 . . . . 18.170000000000002 115.623 155.762 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.65 -10.86 30.28 Favored 'Trans proline' 0 N--CA 1.434 -2.006 0 CA-C-N 122.55 1.946 . . . . 8.1600000000000001 117.048 174.868 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.337 83.7 p -74.8 -14.55 60.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.736 2.865 . . . . 11.130000000000001 118.736 166.817 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -81.06 165.97 21.17 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 125.125 1.516 . . . . 18.030000000000001 114.936 -164.63 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 45.7 p -87.77 157.52 19.01 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 125.349 2.5 . . . . 10.220000000000001 112.31 -172.092 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.4 mm -68.91 -28.62 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 O-C-N 117.638 -3.164 . . . . 12.300000000000001 111.679 -178.057 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -48.71 -48.98 39.98 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.274 2.23 . . . . 36.509999999999998 115.528 153.116 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -75.09 1.62 12.71 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.79 -4.319 . . . . 25.66 119.687 175.012 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.6 t -82.91 -39.56 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 105.189 -2.152 . . . . 8.1199999999999992 105.189 160.545 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -63.97 -25.56 68.19 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 116.303 -3.998 . . . . 15.470000000000001 113.633 -179.109 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.18 -43.33 92.06 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 118.434 -2.666 . . . . 11.449999999999999 114.926 170.74 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -72.78 -27.76 62.19 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 117.7 -3.125 . . . . 24.98 111.639 -177.285 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.5 mt -65.44 -44.04 94.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 N-CA-C 115.051 1.5 . . . . 9.4600000000000009 115.051 170.021 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -60.52 -45.18 94.76 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 114.782 1.401 . . . . 14.76 114.782 167.799 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -65.31 -43.92 89.53 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 122.656 2.48 . . . . 26.289999999999999 111.698 178.926 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.9 tptt -75.38 -67.16 0.69 Allowed 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.858 2.17 . . . . 30.059999999999999 116.858 -179.027 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -82.69 -43.07 17.31 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.003 -2.311 . . . . 25.190000000000001 115.194 179.905 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.7 52.32 2.84 Favored Glycine 0 N--CA 1.429 -1.779 0 CA-C-O 124.548 2.193 . . . . 7.4100000000000001 117.521 177.861 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.5 mt -111.97 125.74 29.7 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 102.145 -3.28 . . . . 9.4900000000000002 102.145 -178.386 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 64.8 Cg_endo -80.44 160.5 22.59 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 127.754 3.805 . . . . 11.42 113.098 -173.393 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 1.3 Cg_exo -77.04 -17.24 15.38 Favored 'Trans proline' 0 C--N 1.3 -2.019 0 CA-C-N 127.949 3.874 . . . . 12.0 111.045 -148.168 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -78.54 -24.27 45.78 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.76 -3.088 . . . . 35.549999999999997 110.647 -171.721 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -90.01 -0.67 57.71 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.697 2.399 . . . . 20.52 110.764 -173.714 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -100.05 129.6 46.12 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.233 2.213 . . . . 7.1299999999999999 115.803 -177.728 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.7 tpp180 -130.76 114.48 15.4 Favored 'General case' 0 N--CA 1.431 -1.404 1 O-C-N 115.918 -4.238 . . . . 36.390000000000001 110.602 167.317 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.7 mt -103.54 137.87 41.02 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 116.576 -1.678 . . . . 9.5500000000000007 114.455 -174.666 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.7 mt -125.53 133.95 67.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 N-CA-C 101.079 -3.675 . . . . 13.9 101.079 -164.703 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -118.12 96.15 5.21 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 101.441 -3.541 . . . . 6.8600000000000003 101.441 172.956 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.91 -93.96 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 112.653 -2.067 . . . . 11.15 113.262 -170.667 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.48 -16.64 45.43 Favored Glycine 0 N--CA 1.43 -1.706 0 CA-C-O 116.812 -2.105 . . . . 13.93 116.525 174.389 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.3 mttt -105.57 126.35 52.04 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 126.323 1.837 . . . . 23.920000000000002 113.032 -157.72 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -98.39 123.83 42.73 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 125.379 1.674 . . . . 23.23 113.13 -167.023 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.5 mt -92.24 125.65 36.99 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 117.827 -1.082 . . . . 9.1099999999999994 110.578 -158.378 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -87.63 152.21 22.35 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 131.608 3.963 . . . . 33.439999999999998 116.511 171.238 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -75.02 -49.12 20.87 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.382 2.515 . . . . 28.370000000000001 108.405 -152.227 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -90.69 34.76 4.08 Favored Glycine 0 N--CA 1.43 -1.718 0 O-C-N 117.548 -3.22 . . . . 15.0 114.342 -171.791 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -123.23 161.94 23.57 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 100.426 -3.916 . . . . 25.5 100.426 176.231 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 39.3 p -99.8 164.38 12.06 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 120.106 -1.621 . . . . 11.949999999999999 114.822 -179.809 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 mt -48.06 -37.71 15.69 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.342 -3.349 . . . . 10.17 119.247 167.505 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.0 m -76.02 -14.92 60.21 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.539 -1.664 . . . . 13.59 113.025 174.963 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -74.92 -38.38 61.82 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 123.798 2.999 . . . . 11.699999999999999 110.552 172.205 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -91.82 2.13 56.71 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.396 -1.335 . . . . 12.949999999999999 107.396 -172.603 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.5 m120 60.33 45.33 11.31 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 117.927 2.566 . . . . 25.449999999999999 117.927 179.98 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.4 mt -86.91 135.49 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 126.594 3.092 . . . . 14.6 106.399 -178.884 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.6 mt-30 -113.72 167.3 10.73 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 119.309 -2.119 . . . . 33.229999999999997 109.558 -163.864 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -55.22 114.37 1.76 Allowed 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 123.531 1.634 . . . . 25.969999999999999 111.774 166.14 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 63.12 37.96 11.09 Favored 'General case' 0 N--CA 1.431 -1.411 0 CA-C-N 110.453 -3.067 . . . . 32.609999999999999 113.254 -175.383 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.4 m -72.18 148.62 45.44 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 120.464 1.484 . . . . 10.56 113.815 159.497 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 78.4 m -109.32 128.53 55.16 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.566 -3.209 . . . . 5.3300000000000001 110.16 179.77 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -101.85 140.3 36.33 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 116.214 1.931 . . . . 11.66 116.214 177.12 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -100.36 110.72 22.94 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 125.175 2.416 . . . . 16.300000000000001 111.704 -179.511 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.4 tp -94.6 127.61 40.67 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.792 -2.443 . . . . 9.9600000000000009 110.49 -175.243 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -94.7 123.13 46.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 C-N-CA 129.256 3.023 . . . . 9.7599999999999998 113.755 163.563 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 81.7 mt -86.23 129.28 34.9 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 128.325 3.917 . . . . 19.57 108.751 173.935 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.0 ttp180 -77.19 133.57 38.89 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.657 -3.152 . . . . 35.079999999999998 106.26 179.943 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.1 tp -121.82 -59.4 1.68 Allowed 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 123.184 1.468 . . . . 32.310000000000002 109.233 172.734 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -98.77 -63.67 1.1 Allowed 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.925 -1.943 . . . . 42.75 112.39 177.907 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -157.54 161.21 31.18 Favored Glycine 0 N--CA 1.43 -1.726 1 N-CA-C 102.094 -4.402 . . . . 36.310000000000002 102.094 171.067 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.774 0 C-N-CA 114.935 -3.507 . . . . 36.270000000000003 114.27 169.316 . . . . . . . . 0 0 . 1 . 107 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 ptt? . . . . . 0 CA--C 1.49 -1.33 0 N-CA-C 110.752 -0.092 . . . . 17.170000000000002 110.752 . . . . . . . . . 0 0 . 1 . 107 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -90.04 148.27 23.16 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 123.664 0.786 . . . . 21.890000000000001 111.232 177.464 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.31 141.61 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.701 -2.333 . . . . 10.83 104.701 -179.118 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -97.0 143.05 28.23 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.935 1.457 . . . . 10.609999999999999 114.935 170.169 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.8 t -128.86 112.04 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 CA-C-O 126.232 2.92 . . . . 9.1300000000000008 107.165 177.841 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -109.2 130.66 55.49 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 116.594 -3.816 . . . . 20.550000000000001 115.164 -172.753 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.0 p -82.09 162.55 22.48 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.398 -5.813 . . . . 11.779999999999999 107.851 179.532 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mt -59.17 -39.03 81.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.293 -2.755 . . . . 19.309999999999999 115.274 169.019 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.3 p -65.58 -58.64 5.27 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-O 125.344 2.497 . . . . 23.140000000000001 112.662 -178.151 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.03 64.14 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.727 0 O-C-N 118.129 -2.857 . . . . 19.739999999999998 113.555 164.935 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -129.88 134.8 47.73 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-N 119.712 1.756 . . . . 21.93 107.606 157.408 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -105.57 121.35 43.78 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 123.84 1.781 . . . . 12.33 108.898 175.302 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.6 pt -111.23 144.8 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 O-C-N 118.082 -2.886 . . . . 17.079999999999998 105.837 -179.569 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -107.39 123.09 47.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.686 1.241 . . . . 16.300000000000001 110.627 -177.197 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.8 mt -119.98 162.79 18.62 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 108.023 -1.103 . . . . 15.880000000000001 108.023 -177.027 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -106.35 133.41 51.09 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 126.197 1.799 . . . . 28.899999999999999 111.3 172.726 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.444 HG11 HG22 ' A' ' 26' ' ' VAL 0.262 16.1 m -147.96 162.26 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 O-C-N 119.448 -2.032 . . . . 12.050000000000001 106.365 167.344 . . . . . . . . 3 3 . 1 . 107 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -82.24 170.43 14.91 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 105.21 -2.144 . . . . 18.170000000000002 105.21 161.151 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.287 1.1 Cg_exo -69.84 -24.93 28.73 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 120.79 1.318 . . . . 8.1600000000000001 111.704 170.438 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.7 m -78.7 8.13 5.85 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 115.347 -2.264 . . . . 11.130000000000001 111.075 -174.265 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.255 75.2 m-20 -108.31 162.07 14.42 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 123.198 2.727 . . . . 18.030000000000001 107.33 -176.669 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 60.9 p -92.21 163.72 13.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 117.846 -3.034 . . . . 10.220000000000001 114.204 -171.556 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -69.44 -24.65 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 118.814 -2.429 . . . . 12.300000000000001 112.121 176.753 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -53.69 -48.77 69.2 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 115.69 -4.381 . . . . 36.509999999999998 114.303 162.458 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -62.97 -30.74 71.82 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 117.311 2.337 . . . . 25.66 117.311 169.661 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.444 HG22 HG11 ' A' ' 17' ' ' VAL . 37.2 t -65.68 -49.41 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 CA-C-N 121.767 2.076 . . . . 8.1199999999999992 113.435 166.319 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HA ' HD12 ' A' ' 30' ' ' ILE . 49.6 mtmt -61.82 -31.53 71.77 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 125.709 1.604 . . . . 15.470000000000001 113.451 178.839 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -67.72 -35.33 78.58 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 128.145 2.578 . . . . 11.449999999999999 106.678 169.94 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -75.67 -21.26 57.81 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.862 -4.274 . . . . 24.98 116.901 177.05 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 27' ' ' LYS . 11.0 mt -69.44 -45.85 77.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.39 -2.069 . . . . 9.4600000000000009 110.316 164.599 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.433 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 66.0 tt0 -49.75 -39.98 39.41 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 125.583 2.611 . . . . 14.76 111.44 171.862 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.71 -64.16 1.06 Allowed 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.233 -3.417 . . . . 26.289999999999999 110.464 -179.99 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -80.66 -27.47 37.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 116.45 -3.906 . . . . 30.059999999999999 114.359 -163.167 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -103.89 -56.05 2.27 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 113.946 1.091 . . . . 25.190000000000001 113.946 -177.728 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.28 26.79 2.59 Favored Glycine 0 N--CA 1.43 -1.752 0 C-N-CA 126.963 2.221 . . . . 7.4100000000000001 116.89 172.841 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 52.7 mt -94.42 135.36 24.29 Favored Pre-proline 0 N--CA 1.43 -1.465 0 N-CA-C 108.127 -1.064 . . . . 9.4900000000000002 108.127 -176.438 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -67.48 157.4 61.91 Favored 'Trans proline' 0 C--N 1.3 -1.986 0 O-C-N 115.221 -3.094 . . . . 11.42 112.885 -177.65 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -84.83 -11.32 7.89 Favored 'Trans proline' 0 C--N 1.299 -2.029 1 C-N-CA 128.157 5.905 . . . . 12.0 112.779 -175.198 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.82 -43.47 58.65 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 119.358 0.981 . . . . 35.549999999999997 111.567 173.392 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.468 ' HG2' ' H ' ' A' ' 72' ' ' ARG . 7.2 tt0 -72.12 12.01 0.48 Allowed 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.785 -2.447 . . . . 20.52 114.588 -179.051 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -116.89 128.42 55.22 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.625 1.202 . . . . 7.1299999999999999 114.082 -164.613 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 tpp180 -129.13 130.06 45.96 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 119.793 -1.817 . . . . 36.390000000000001 106.184 171.763 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 48.5 mt -102.47 143.56 32.03 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 120.357 -0.537 . . . . 9.5500000000000007 111.546 171.617 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.5 mt -124.82 127.95 72.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 128.036 2.534 . . . . 13.9 104.798 177.726 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -112.67 107.9 16.75 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.116 -2.865 . . . . 6.8600000000000003 104.504 177.201 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.388 . . 60.29 -91.45 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 120.188 -1.57 . . . . 11.15 115.017 -169.08 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.0 5.58 7.35 Favored Glycine 0 N--CA 1.43 -1.703 1 C-N-CA 131.064 4.173 . . . . 13.93 119.074 171.745 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -113.96 156.91 23.18 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 122.921 1.343 . . . . 23.920000000000002 108.319 175.384 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -84.11 151.8 24.7 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 114.385 -1.279 . . . . 23.23 111.937 175.742 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.2 mt -110.24 128.34 55.46 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.458 1.935 . . . . 9.1099999999999994 111.777 178.773 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -92.18 163.62 13.86 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.063 3.316 . . . . 33.439999999999998 105.983 179.096 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -63.26 -61.1 2.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 109.402 -3.544 . . . . 28.370000000000001 118.939 -171.938 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -79.54 15.55 13.13 Favored Glycine 0 N--CA 1.43 -1.741 0 N-CA-C 119.476 2.55 . . . . 15.0 119.476 -171.849 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 -101.45 156.85 17.22 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.398 -1.648 . . . . 25.5 110.116 173.46 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 35.5 p -94.37 167.43 11.53 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.406 -1.331 . . . . 11.949999999999999 107.406 -175.636 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mp -67.96 -25.94 65.69 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.348 2.259 . . . . 10.17 108.752 165.713 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.3 t -71.62 -43.29 66.45 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.653 2.381 . . . . 13.59 110.243 175.526 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -59.28 -44.74 92.44 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.945 -4.222 . . . . 11.699999999999999 116.768 175.316 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -79.89 -11.64 59.79 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 118.642 2.83 . . . . 12.949999999999999 118.642 169.734 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.315 31.0 m120 75.75 34.86 0.55 Allowed 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.644 -3.16 . . . . 25.449999999999999 115.002 174.434 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.7 mt -73.47 118.91 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 114.347 -1.297 . . . . 14.6 110.757 167.619 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 65' ' ' SER . 45.5 mt-30 -90.75 169.91 10.57 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 124.155 1.931 . . . . 33.229999999999997 113.609 174.219 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -61.94 146.88 48.64 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 115.742 -4.349 . . . . 25.969999999999999 108.064 -174.32 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.295 85.7 mt-10 62.48 46.88 5.4 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 123.889 1.804 . . . . 32.609999999999999 113.167 174.273 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 62' ' ' GLN . 9.2 t -111.09 131.94 54.67 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.355 2.662 . . . . 10.56 103.994 -168.531 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.8 m -89.59 109.95 20.86 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 125.385 2.517 . . . . 5.3300000000000001 108.562 177.233 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.7 mt -89.74 150.58 22.23 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 126.776 2.03 . . . . 11.66 107.95 172.626 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -106.23 113.39 26.9 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 114.965 1.469 . . . . 16.300000000000001 114.965 -178.283 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 59.7 tp -89.93 120.2 30.95 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.276 1.988 . . . . 9.9600000000000009 114.493 177.152 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 99.0 t -104.81 145.58 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-N 112.651 -2.068 . . . . 9.7599999999999998 105.829 172.964 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.9 mt -125.23 137.36 54.11 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 123.372 1.558 . . . . 19.57 111.331 -176.258 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.468 ' H ' ' HG2' ' A' ' 40' ' ' GLN . 51.8 ttp180 -84.92 146.34 27.31 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 117.905 -2.997 . . . . 35.079999999999998 115.803 -166.357 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.8 tp -82.92 -84.72 0.12 Allowed 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.291 1.836 . . . . 32.310000000000002 108.277 -172.506 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.3 ttt-85 -91.41 -48.82 6.68 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.727 -2.483 . . . . 42.75 113.118 -165.154 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 175.81 169.35 37.33 Favored Glycine 0 N--CA 1.431 -1.692 0 O-C-N 118.277 -2.765 . . . . 36.310000000000002 110.309 178.929 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.791 1 N-CA-C 102.033 -4.427 . . . . 36.270000000000003 102.033 158.714 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.489 -1.367 0 N-CA-C 106.413 -1.699 . . . . 17.170000000000002 106.413 . . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -106.38 140.08 39.86 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 116.707 2.114 . . . . 21.890000000000001 116.707 -176.671 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.6 pt -119.17 143.88 29.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 C-N-CA 129.036 2.934 . . . . 10.83 114.324 169.979 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -104.92 126.1 51.63 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.05 -2.906 . . . . 10.609999999999999 107.827 -179.409 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 t -120.38 109.75 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-O 127.67 3.605 . . . . 9.1300000000000008 105.94 -176.773 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt -117.93 138.79 51.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-O 125.897 2.761 . . . . 20.550000000000001 108.969 -167.665 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.404 ' HB ' ' H ' ' A' ' 8' ' ' LEU . 9.8 p -72.68 -179.09 2.92 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.956 -2.34 . . . . 11.779999999999999 117.051 163.805 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.404 ' H ' ' HB ' ' A' ' 7' ' ' THR . 63.4 tp -76.14 -39.83 54.12 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 131.118 3.767 . . . . 19.309999999999999 110.431 -160.66 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.7 p -73.17 -56.6 4.87 Favored 'General case' 0 N--CA 1.429 -1.488 1 C-N-CA 133.94 4.896 . . . . 23.140000000000001 105.93 175.67 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.04 30.98 0.34 Allowed Glycine 0 N--CA 1.43 -1.741 0 O-C-N 125.873 1.983 . . . . 19.739999999999998 115.003 173.204 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -79.32 109.77 13.98 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 120.287 2.043 . . . . 21.93 109.779 168.664 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -95.79 126.43 41.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 119.007 -2.308 . . . . 12.33 112.684 -176.387 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.313 28.4 pt -109.47 152.93 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 124.433 2.063 . . . . 17.079999999999998 108.241 165.863 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 85.4 m -122.53 125.6 46.07 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.321 -2.737 . . . . 16.300000000000001 110.672 -175.78 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.284 52.4 mt -119.1 144.16 46.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.315 2.339 . . . . 15.880000000000001 117.315 179.442 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -101.16 101.86 12.67 Favored 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 126.705 2.002 . . . . 28.899999999999999 112.17 -179.161 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.8 m -117.18 165.1 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 1 C-N-CA 134.028 4.931 . . . . 12.050000000000001 108.284 -165.301 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 9.0 mt-10 -112.67 173.37 2.89 Favored Pre-proline 0 N--CA 1.429 -1.486 0 N-CA-C 114.836 1.421 . . . . 18.170000000000002 114.836 162.305 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -74.07 -14.12 23.57 Favored 'Trans proline' 0 C--N 1.3 -2.024 0 O-C-N 115.963 -2.704 . . . . 8.1600000000000001 112.763 -179.111 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.0 m -95.11 0.9 54.73 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 124.159 0.912 . . . . 11.130000000000001 110.311 177.688 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.267 35.2 m-20 -85.98 152.23 23.1 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.877 -3.639 . . . . 18.030000000000001 109.812 -173.308 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 71.0 p -100.63 160.76 14.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 125.334 2.492 . . . . 10.220000000000001 107.859 -160.714 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 mm -64.48 -40.22 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 124.65 2.167 . . . . 12.300000000000001 108.624 -174.419 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -56.24 -35.47 67.41 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.03 -2.919 . . . . 36.509999999999998 117.021 168.121 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -72.14 -31.49 66.04 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 113.362 -5.836 . . . . 25.66 112.613 167.55 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -68.79 -43.55 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.724 -1.584 . . . . 8.1199999999999992 106.724 -177.021 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -58.25 -35.96 72.52 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 125.763 1.625 . . . . 15.470000000000001 113.361 174.907 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.99 -42.29 76.13 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.221 -2.174 . . . . 11.449999999999999 116.0 175.824 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -75.17 -32.03 61.15 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 129.649 3.179 . . . . 24.98 112.89 -176.989 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.7 mt -60.88 -48.1 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 CA-C-O 125.529 2.585 . . . . 9.4600000000000009 113.029 174.253 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -52.53 -45.88 66.49 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 113.15 -3.31 . . . . 14.76 117.037 166.386 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.53 -62.93 1.18 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 127.721 3.138 . . . . 26.289999999999999 110.032 179.291 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -53.71 -57.16 11.85 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.412 -3.305 . . . . 30.059999999999999 112.093 -176.757 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -93.96 -64.63 1.06 Allowed 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.534 2.05 . . . . 25.190000000000001 116.534 -173.64 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.79 23.71 0.86 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 120.9 3.12 . . . . 7.4100000000000001 120.9 -176.939 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.6 mt -101.69 118.14 60.27 Favored Pre-proline 0 N--CA 1.43 -1.457 0 CA-C-O 114.723 -2.56 . . . . 9.4900000000000002 106.945 -169.191 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 36.2 Cg_exo -51.89 147.16 26.35 Favored 'Trans proline' 0 C--N 1.3 -2.012 0 N-CA-C 121.238 3.515 . . . . 11.42 121.238 178.318 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 21.0 Cg_exo -68.69 -35.68 16.0 Favored 'Trans proline' 0 N--CA 1.434 -2.014 0 CA-C-N 123.793 2.39 . . . . 12.0 113.261 -160.378 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -78.21 -27.34 47.76 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.904 -2.372 . . . . 35.549999999999997 113.971 -177.462 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -62.89 -39.16 93.63 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 127.173 2.189 . . . . 20.52 115.365 170.776 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -65.9 140.17 58.33 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 117.342 2.349 . . . . 7.1299999999999999 117.342 173.585 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 tpp180 -128.32 99.61 5.49 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 118.855 -2.403 . . . . 36.390000000000001 114.192 169.866 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.9 mt -86.06 131.43 34.27 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 112.065 -2.334 . . . . 9.5500000000000007 109.629 -177.728 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.605 HD12 HG21 ' A' ' 70' ' ' VAL . 31.6 mt -130.47 136.59 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 CA-C-O 126.282 2.944 . . . . 13.9 103.253 -179.846 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -113.5 114.98 27.29 Favored 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 115.055 -4.778 . . . . 6.8600000000000003 107.897 164.393 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.277 . . 72.31 -86.33 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.425 0 C-N-CA 128.738 2.815 . . . . 11.15 111.331 -179.221 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -146.38 22.71 1.71 Allowed Glycine 0 N--CA 1.429 -1.78 0 N-CA-C 109.121 -1.591 . . . . 13.93 109.121 165.42 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.259 81.6 mttt -103.69 124.57 49.1 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.473 -3.369 . . . . 23.920000000000002 105.365 176.282 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -91.72 132.9 36.06 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-O 123.295 1.521 . . . . 23.23 108.941 -179.929 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 76.4 mt -94.15 128.86 40.82 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 115.715 -2.394 . . . . 9.1099999999999994 109.794 -151.377 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -78.32 139.73 38.83 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 119.038 2.977 . . . . 33.439999999999998 119.038 172.166 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -55.57 -50.14 70.85 Favored 'General case' 0 N--CA 1.431 -1.394 1 N-CA-C 122.654 4.316 . . . . 28.370000000000001 122.654 -162.62 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -84.49 0.72 89.24 Favored Glycine 0 N--CA 1.43 -1.737 0 O-C-N 118.232 -2.793 . . . . 15.0 115.775 175.333 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.2 mmm180 -81.78 165.33 21.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 119.835 -1.979 . . . . 25.5 108.143 171.382 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 16.3 p -104.97 -178.2 3.59 Favored 'General case' 0 N--CA 1.429 -1.483 0 O-C-N 116.447 -3.908 . . . . 11.949999999999999 111.353 -172.98 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.3 mt -81.48 -29.31 33.74 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 106.699 -1.593 . . . . 10.17 106.699 178.712 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.9 t -66.08 -38.12 87.49 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 119.409 -2.057 . . . . 13.59 111.355 -176.589 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -54.95 -40.89 70.44 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 129.347 3.059 . . . . 11.699999999999999 113.788 176.924 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -93.49 1.16 56.88 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 117.322 2.342 . . . . 12.949999999999999 117.322 174.995 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.459 3.7 m120 79.52 18.83 0.73 Allowed 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 115.263 1.579 . . . . 25.449999999999999 115.263 174.494 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.9 mt -87.01 99.4 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.413 0 O-C-N 118.446 -2.659 . . . . 14.6 105.014 -174.477 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.36 10.4 mt-30 -112.39 -165.11 0.96 Allowed 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.324 2.249 . . . . 33.229999999999997 112.02 -169.874 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -61.55 106.8 0.7 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.103 2.961 . . . . 25.969999999999999 113.4 -170.061 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 82.76 41.92 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 128.011 2.525 . . . . 32.609999999999999 111.749 172.003 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.6 m -92.27 142.69 27.19 Favored 'General case' 0 N--CA 1.431 -1.423 0 C-N-CA 126.582 1.953 . . . . 10.56 111.376 179.388 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.7 m -102.41 121.18 41.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.334 -2.104 . . . . 5.3300000000000001 112.365 178.387 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -85.26 160.09 19.93 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 117.403 -1.284 . . . . 11.66 110.228 167.814 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 92.4 m-70 -105.41 136.03 45.72 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 127.5 3.0 . . . . 16.300000000000001 104.84 167.473 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.1 tp -116.11 111.57 20.45 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 104.749 -2.315 . . . . 9.9600000000000009 104.749 -179.639 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.605 HG21 HD12 ' A' ' 44' ' ' ILE . 1.9 t -103.46 140.87 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.418 0 C-N-CA 127.3 2.24 . . . . 9.7599999999999998 106.275 -179.994 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.8 mt -93.87 136.06 34.54 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 129.357 3.063 . . . . 19.57 106.079 176.873 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.254 49.9 ttp180 -74.54 132.92 42.24 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 121.295 1.861 . . . . 35.079999999999998 114.765 174.648 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.8 tp -88.04 -67.15 0.85 Allowed 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 113.369 -1.741 . . . . 32.310000000000002 111.195 176.345 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.287 32.4 ttp-105 -104.01 -109.41 0.26 Allowed 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 116.658 -1.639 . . . . 42.75 112.209 -176.144 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.06 -158.01 10.42 Favored Glycine 0 N--CA 1.431 -1.696 1 CA-C-N 126.765 4.348 . . . . 36.310000000000002 115.069 167.323 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.751 1 O-C-N 115.47 -4.547 . . . . 36.270000000000003 107.348 -178.829 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 108.139 -1.059 . . . . 17.170000000000002 108.139 . . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -100.11 116.17 31.51 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 122.549 1.166 . . . . 21.890000000000001 112.442 -177.37 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.1 pt -97.4 151.92 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 114.192 -1.367 . . . . 10.83 113.996 148.554 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.432 ' HB2' HG23 ' A' ' 66' ' ' THR . 77.8 m-85 -107.67 149.46 28.09 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 127.434 2.958 . . . . 10.609999999999999 110.951 174.66 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.545 HG21 HD11 ' A' ' 30' ' ' ILE . 47.3 t -126.43 133.99 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.425 0 N-CA-C 106.224 -1.769 . . . . 9.1300000000000008 106.224 162.092 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -108.73 139.45 43.52 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 126.742 2.017 . . . . 20.550000000000001 113.62 174.591 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 p -88.07 -169.54 2.61 Favored 'General case' 0 N--CA 1.431 -1.425 0 N-CA-C 114.973 1.471 . . . . 11.779999999999999 114.973 -171.659 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.8 tp -64.87 -59.08 4.6 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 120.163 1.347 . . . . 19.309999999999999 113.435 179.175 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.9 p -69.6 -30.06 67.73 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 120.023 -1.673 . . . . 23.140000000000001 110.689 179.714 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.2 54.3 0.27 Allowed Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 129.168 3.27 . . . . 19.739999999999998 108.422 152.083 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -82.67 116.09 21.9 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 120.238 2.019 . . . . 21.93 108.839 167.623 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 m -84.32 112.02 19.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 114.691 -2.576 . . . . 12.33 115.898 176.285 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -102.61 162.22 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-N 122.357 2.344 . . . . 17.079999999999998 108.232 -172.848 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.5 m -123.75 98.22 5.72 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 128.492 2.717 . . . . 16.300000000000001 113.83 -174.504 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 29' ' ' LYS . 73.0 mt -92.68 160.3 15.05 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 119.025 0.83 . . . . 15.880000000000001 111.554 -170.62 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -106.13 103.91 13.5 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 120.372 1.442 . . . . 28.899999999999999 113.757 175.044 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.74 165.02 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 C-N-CA 127.7 2.4 . . . . 12.050000000000001 108.347 -174.771 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -124.15 170.9 7.89 Favored Pre-proline 0 N--CA 1.43 -1.434 0 CA-C-O 115.75 -2.071 . . . . 18.170000000000002 109.621 162.513 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.291 0.0 OUTLIER -66.7 -9.51 24.75 Favored 'Trans proline' 0 C--N 1.3 -2.003 0 N-CA-C 120.205 3.117 . . . . 8.1600000000000001 120.205 179.83 . . . . . . . . 3 3 . 1 . 109 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -82.52 -21.58 35.36 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.207 -2.33 . . . . 11.130000000000001 113.927 176.474 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -57.75 146.29 31.77 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 119.745 3.239 . . . . 18.030000000000001 119.745 172.93 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.4 p -105.08 159.95 15.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 117.256 -3.403 . . . . 10.220000000000001 108.087 -178.013 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.4 mm -56.62 -40.66 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 112.917 -1.947 . . . . 12.300000000000001 112.781 178.111 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -49.63 -41.88 43.54 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 126.509 1.924 . . . . 36.509999999999998 112.975 165.092 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -80.63 -21.31 41.59 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 116.565 -3.834 . . . . 25.66 116.942 176.14 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 t -59.91 -50.08 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.471 -2.643 . . . . 8.1199999999999992 107.782 165.375 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -59.56 -39.8 85.22 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.687 1.708 . . . . 15.470000000000001 113.013 -179.305 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.323 . . -71.58 -28.99 64.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 113.621 -1.627 . . . . 11.449999999999999 112.653 -176.996 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HB3' HD22 ' A' ' 15' ' ' LEU . 55.8 mttm -69.0 -31.29 70.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 130.086 3.355 . . . . 24.98 111.899 171.803 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.545 HD11 HG21 ' A' ' 5' ' ' VAL . 79.2 mt -79.51 -37.6 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 CA-C-O 121.853 0.835 . . . . 9.4600000000000009 111.921 173.401 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -61.94 -38.64 89.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-O 124.157 1.932 . . . . 14.76 114.129 168.808 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -62.7 -55.62 25.13 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 114.794 1.405 . . . . 26.289999999999999 114.794 172.069 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.8 tttp -67.78 -58.01 5.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.664 -3.147 . . . . 30.059999999999999 115.807 -174.812 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -95.52 -52.29 4.19 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 126.28 2.238 . . . . 25.190000000000001 115.533 -168.202 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.59 38.18 0.86 Allowed Glycine 0 N--CA 1.43 -1.718 0 C-N-CA 116.58 -2.724 . . . . 7.4100000000000001 114.402 174.091 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.56 HG21 HD21 ' A' ' 71' ' ' LEU . 54.2 mt -114.56 120.86 37.0 Favored Pre-proline 0 N--CA 1.43 -1.439 0 CA-C-O 111.936 -3.888 . . . . 9.4900000000000002 103.609 -176.007 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -72.46 157.82 52.3 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 CA-C-N 125.124 2.866 . . . . 11.42 112.508 -173.992 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -73.8 -32.34 7.47 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 CA-C-N 122.813 2.041 . . . . 12.0 110.674 -162.518 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -59.73 -41.87 91.89 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 116.006 1.854 . . . . 35.549999999999997 116.006 -178.058 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -65.64 -27.75 68.61 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.095 2.258 . . . . 20.52 117.095 179.258 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -74.97 155.32 37.51 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.236 3.05 . . . . 7.1299999999999999 119.236 177.849 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -143.71 97.16 3.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 127.084 2.153 . . . . 36.390000000000001 113.779 177.549 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.6 mt -91.69 129.49 37.66 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 125.666 2.65 . . . . 9.5500000000000007 116.104 -167.201 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.1 mt -120.1 128.71 75.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 2 O-C-N 115.692 -4.38 . . . . 13.9 115.532 -169.048 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -118.06 119.57 35.15 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.902 -2.374 . . . . 6.8600000000000003 104.94 176.916 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.51 -96.6 0.05 Allowed 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 129.774 3.23 . . . . 11.15 109.825 -168.622 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.94 21.31 4.43 Favored Glycine 0 N--CA 1.43 -1.73 0 C-N-CA 126.727 2.108 . . . . 13.93 114.099 176.594 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -134.85 145.27 48.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 120.465 -1.609 . . . . 23.920000000000002 108.091 -170.164 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -95.73 139.38 32.05 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.443 2.339 . . . . 23.23 114.456 -168.955 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 97.2 mt -87.31 136.13 33.05 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.124 2.392 . . . . 9.1099999999999994 112.14 -166.846 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -96.3 147.96 23.24 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.374 -2.704 . . . . 33.439999999999998 112.65 176.036 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -62.25 -43.49 98.71 Favored 'General case' 0 N--CA 1.431 -1.413 1 CA-C-O 128.821 4.153 . . . . 28.370000000000001 117.607 -160.394 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -68.76 -23.39 75.66 Favored Glycine 0 N--CA 1.43 -1.727 0 O-C-N 117.939 -2.976 . . . . 15.0 112.766 -173.375 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.0 mmm-85 -84.39 151.35 24.74 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 121.517 2.658 . . . . 25.5 107.913 -158.856 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.5 p -81.13 171.92 14.31 Favored 'General case' 0 N--CA 1.43 -1.448 1 O-C-N 112.457 -6.402 . . . . 11.949999999999999 114.208 175.721 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.2 mt -69.82 -24.72 63.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.371 -2.706 . . . . 10.17 115.061 166.102 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -56.82 -43.93 81.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 118.802 2.89 . . . . 13.59 118.802 167.722 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -57.72 -56.23 24.63 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 110.812 -2.904 . . . . 11.699999999999999 110.371 -176.562 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -75.38 -21.52 58.22 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.504 -2.134 . . . . 12.949999999999999 115.358 -177.028 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 62.15 55.37 2.47 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.969 3.307 . . . . 25.449999999999999 107.878 -171.787 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.9 mt -88.34 112.52 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 CA-C-O 116.079 -1.915 . . . . 14.6 106.675 161.371 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -108.93 -158.37 0.65 Allowed 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 117.118 2.266 . . . . 33.229999999999997 117.118 -179.195 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -61.47 124.95 22.07 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 130.287 3.435 . . . . 25.969999999999999 114.549 168.17 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.307 38.5 mt-10 78.14 2.99 2.81 Favored 'General case' 0 N--CA 1.43 -1.434 1 N-CA-C 122.164 4.135 . . . . 32.609999999999999 122.164 -169.47 . . . . . . . . 3 2 . 1 . 109 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 t -75.24 122.59 23.91 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.105 -4.122 . . . . 10.56 113.547 -175.752 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 4' ' ' PHE . 6.0 m -102.22 118.02 36.01 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-N 121.419 1.918 . . . . 5.3300000000000001 113.673 177.854 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.45 HD12 HG22 ' A' ' 5' ' ' VAL . 85.7 mt -88.18 159.4 18.19 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 105.684 -1.969 . . . . 11.66 105.684 -178.204 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -110.3 136.92 48.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 119.086 -2.259 . . . . 16.300000000000001 106.977 173.787 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -105.72 140.49 38.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 119.519 -1.988 . . . . 9.9600000000000009 107.41 170.506 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.273 28.4 t -114.6 140.17 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 C-N-CA 128.003 2.521 . . . . 9.7599999999999998 106.737 167.998 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.56 HD21 HG21 ' A' ' 36' ' ' ILE . 64.9 mt -118.31 131.51 56.33 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 127.181 2.192 . . . . 19.57 108.707 178.986 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -81.42 170.43 15.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 127.452 2.97 . . . . 35.079999999999998 109.697 169.373 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.1 tp -109.42 -40.58 4.85 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 125.376 1.47 . . . . 32.310000000000002 110.372 -175.943 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.5 ttt-85 -157.98 -100.04 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 115.229 -2.32 . . . . 42.75 109.548 -171.897 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.71 142.46 16.06 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 125.535 3.788 . . . . 36.310000000000002 111.401 -173.924 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.771 0 N-CA-C 105.691 -2.963 . . . . 36.270000000000003 105.691 151.929 . . . . . . . . 0 0 . 1 . 110 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 11.2 ptt? . . . . . 0 CA--C 1.49 -1.348 0 N-CA-C 117.94 2.57 . . . . 17.170000000000002 117.94 . . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.266 31.1 mt-30 -71.96 131.15 42.55 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.655 -3.153 . . . . 21.890000000000001 112.098 -178.813 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.0 pt -135.96 155.06 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 101.324 -3.584 . . . . 10.83 101.324 -169.795 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -107.29 118.66 37.31 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 126.826 2.05 . . . . 10.609999999999999 114.508 175.683 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -114.67 104.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 N-CA-C 104.762 -2.31 . . . . 9.1300000000000008 104.762 -177.063 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -89.89 123.3 33.71 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.813 2.845 . . . . 20.550000000000001 112.66 -175.904 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.8 p -78.33 166.58 22.51 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.87 1.319 . . . . 11.779999999999999 113.619 -172.36 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.464 HD22 ' H ' ' A' ' 71' ' ' LEU . 32.5 tp -58.43 -47.64 83.29 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 116.405 -3.934 . . . . 19.309999999999999 115.03 175.112 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 p -63.02 -69.82 0.24 Allowed 'General case' 0 N--CA 1.43 -1.471 2 CA-C-O 111.163 -4.255 . . . . 23.140000000000001 108.804 176.26 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.66 45.27 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.705 0 O-C-N 126.706 2.504 . . . . 19.739999999999998 116.129 179.438 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -127.24 142.23 51.53 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 120.712 -1.464 . . . . 21.93 107.105 -172.766 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.5 m -112.44 131.75 55.4 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-O 123.391 1.567 . . . . 12.33 107.644 175.203 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.5 pt -122.56 145.4 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 118.654 -2.529 . . . . 17.079999999999998 105.38 171.149 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.9 m -113.21 110.44 20.4 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.772 -3.705 . . . . 16.300000000000001 107.66 -166.991 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 mt -115.49 152.02 33.74 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 118.026 -0.988 . . . . 15.880000000000001 112.256 -170.52 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -97.86 125.63 42.83 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 127.088 3.327 . . . . 28.899999999999999 117.672 162.935 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 m -126.0 175.36 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 111.307 -2.679 . . . . 12.050000000000001 111.511 167.425 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -102.04 178.42 1.22 Allowed Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 115.647 -2.121 . . . . 18.170000000000002 107.628 168.012 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -71.84 -26.54 18.88 Favored 'Trans proline' 0 N--CA 1.433 -2.041 0 C-N-CA 122.297 1.998 . . . . 8.1600000000000001 115.235 163.966 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -83.14 -8.97 59.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 118.782 2.882 . . . . 11.130000000000001 118.782 177.133 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -69.11 155.34 40.54 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.934 2.198 . . . . 18.030000000000001 116.934 171.853 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.8 p -106.35 -172.83 2.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.651 -1.28 . . . . 10.220000000000001 107.731 -176.258 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.734 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 43.3 mm -81.38 -25.99 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 CA-C-O 125.139 2.4 . . . . 12.300000000000001 111.895 -178.746 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -53.23 -43.3 67.18 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 117.192 -3.442 . . . . 36.509999999999998 112.705 164.139 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -75.33 -45.25 40.68 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.736 -2.477 . . . . 25.66 111.775 -178.443 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.1 t -50.37 -56.93 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 124.874 1.269 . . . . 8.1199999999999992 111.402 166.593 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -58.63 -32.33 68.94 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 119.84 3.274 . . . . 15.470000000000001 119.84 179.26 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.32 -49.09 59.0 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 117.87 -3.019 . . . . 11.449999999999999 109.718 173.051 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -46.64 -47.48 20.14 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 118.17 -2.831 . . . . 24.98 116.7 172.197 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.469 HD13 HD13 ' A' ' 69' ' ' LEU . 94.7 mt -54.94 -44.4 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 C-N-CA 128.353 2.661 . . . . 9.4600000000000009 113.412 171.903 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -67.0 -50.64 61.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 127.738 2.415 . . . . 14.76 111.751 173.595 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.7 -56.83 17.1 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.228 -2.795 . . . . 26.289999999999999 113.909 173.307 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.262 35.4 tptt -57.93 -80.52 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 124.31 2.005 . . . . 30.059999999999999 116.043 174.334 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -68.25 -56.86 7.18 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 126.79 3.186 . . . . 25.190000000000001 112.787 -170.632 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 136.75 13.77 0.93 Allowed Glycine 0 N--CA 1.431 -1.666 1 O-C-N 115.361 -4.587 . . . . 7.4100000000000001 110.096 169.535 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.5 mt -93.68 134.07 27.01 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 116.334 -1.793 . . . . 9.4900000000000002 112.713 -169.04 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -76.22 150.44 33.08 Favored 'Trans proline' 0 N--CA 1.434 -2.01 0 CA-C-N 121.603 1.608 . . . . 11.42 109.487 177.041 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.251 89.3 Cg_endo -78.3 -9.56 16.34 Favored 'Trans proline' 0 N--CA 1.434 -2.024 0 C-N-CA 123.799 3.0 . . . . 12.0 111.692 -170.384 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 -65.13 -22.6 66.95 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 127.315 3.436 . . . . 35.549999999999997 111.348 165.442 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -90.78 -23.28 20.67 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 115.723 -4.36 . . . . 20.52 113.372 -173.969 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -89.06 131.29 35.29 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 118.025 -2.922 . . . . 7.1299999999999999 114.144 -166.053 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt-85 -121.84 126.85 49.68 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.013 -1.847 . . . . 36.390000000000001 106.013 156.995 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 43' ' ' LEU . 26.6 tp -106.96 127.05 53.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 125.119 1.367 . . . . 9.5500000000000007 112.778 178.974 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mt -129.25 138.17 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 126.9 2.08 . . . . 13.9 111.998 -165.988 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -120.62 122.04 39.66 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 114.914 -4.867 . . . . 6.8600000000000003 102.39 166.851 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.27 -85.51 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.067 2.147 . . . . 11.15 111.82 -174.927 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.59 23.08 1.34 Allowed Glycine 0 N--CA 1.429 -1.787 0 O-C-N 118.935 -2.353 . . . . 13.93 109.687 171.631 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -95.12 116.9 29.32 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.073 2.149 . . . . 23.920000000000002 114.136 168.196 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.4 tt0 -70.36 119.22 14.21 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 118.817 2.895 . . . . 23.23 118.817 169.571 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.83 134.79 33.62 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 117.425 -3.297 . . . . 9.1099999999999994 116.899 -167.958 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -103.6 143.25 33.0 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.485 1.948 . . . . 33.439999999999998 115.426 -172.592 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.734 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 9.0 m-20 -50.46 -37.74 39.96 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.702 3.201 . . . . 28.370000000000001 119.272 -161.784 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.74 35.3 4.57 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-O 115.218 -2.99 . . . . 15.0 111.473 -178.425 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -110.77 153.91 24.68 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 122.566 3.183 . . . . 25.5 106.151 166.448 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.307 10.9 p -86.25 162.03 18.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.153 2.581 . . . . 11.949999999999999 107.1 -176.348 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.6 mt -68.07 -32.63 73.1 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 119.287 -2.133 . . . . 10.17 115.37 169.014 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.1 t -60.08 -40.37 89.36 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 127.688 2.395 . . . . 13.59 112.762 167.199 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -59.5 -48.63 80.91 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.716 -2.49 . . . . 11.699999999999999 115.583 169.173 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.273 10.5 m-85 -82.46 4.88 22.51 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 114.752 1.39 . . . . 12.949999999999999 114.752 -179.979 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.6 m120 59.37 28.31 17.63 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 114.805 -2.521 . . . . 25.449999999999999 114.79 -176.588 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.9 mt -76.18 126.58 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-N 124.21 3.186 . . . . 14.6 111.944 166.408 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mm-40 -102.73 -179.29 3.92 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.221 2.439 . . . . 33.229999999999997 116.317 178.834 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -78.33 136.34 37.68 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 112.838 -1.983 . . . . 25.969999999999999 110.253 179.684 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.26 11.5 tt0 75.12 30.64 0.87 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.424 2.379 . . . . 32.609999999999999 117.424 -177.083 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 t -113.54 160.0 18.98 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 119.466 -2.021 . . . . 10.56 110.324 -175.965 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.7 m -109.39 115.25 29.61 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 128.203 2.601 . . . . 5.3300000000000001 113.869 -173.068 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.54 156.91 18.31 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 111.662 -2.517 . . . . 11.66 113.611 170.869 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.9 m170 -116.33 109.46 17.41 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 112.415 -2.175 . . . . 16.300000000000001 107.838 -176.03 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.469 HD13 HD13 ' A' ' 30' ' ' ILE . 10.8 tp -89.31 114.33 25.71 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.583 -3.198 . . . . 9.9600000000000009 103.674 179.177 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.3 t -114.51 132.27 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 O-C-N 118.07 -2.894 . . . . 9.7599999999999998 108.129 -178.697 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.464 ' H ' HD22 ' A' ' 8' ' ' LEU . 11.4 mt -113.01 156.5 22.95 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 124.419 2.056 . . . . 19.57 106.005 -165.332 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.273 30.5 ptt180 -81.93 143.77 31.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 113.296 -1.775 . . . . 35.079999999999998 112.275 -177.162 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.6 tp -84.01 -45.4 13.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 125.826 1.954 . . . . 32.310000000000002 110.144 167.726 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.592 ' HA ' ' HE ' ' A' ' 74' ' ' ARG . 0.2 OUTLIER -159.9 140.78 12.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 118.155 -2.84 . . . . 42.75 106.477 -178.278 . . . . . . . . 3 3 . 1 . 110 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 80.07 -73.67 2.42 Favored Glycine 0 N--CA 1.429 -1.78 0 O-C-N 118.043 -2.911 . . . . 36.310000000000002 115.786 173.182 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.744 0 CA-C-O 114.654 -3.303 . . . . 36.270000000000003 117.12 -170.03 . . . . . . . . 0 0 . 1 . 111 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' SD ' ' HA ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.343 0 CA-C-O 121.102 0.477 . . . . 17.170000000000002 110.039 . . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -89.5 134.37 34.14 Favored 'General case' 0 N--CA 1.431 -1.418 0 O-C-N 119.911 -1.743 . . . . 21.890000000000001 113.079 -171.302 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -115.18 139.2 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.072 -2.893 . . . . 10.83 112.062 160.595 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.285 12.3 m-85 -109.89 88.91 2.86 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 114.55 -5.094 . . . . 10.609999999999999 107.972 -169.248 . . . . . . . . 3 2 . 1 . 111 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -76.13 100.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 1 CA-C-O 129.184 4.326 . . . . 9.1300000000000008 113.522 173.353 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.28 46.7 mttt -83.31 148.57 27.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.15 -3.469 . . . . 20.550000000000001 113.752 178.536 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -104.27 -179.35 3.92 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.164 -2.21 . . . . 11.779999999999999 110.678 -168.322 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.325 1.9 tp -66.34 -41.18 89.94 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 114.996 1.48 . . . . 19.309999999999999 114.996 171.833 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.31 16.2 p -71.55 -66.22 0.66 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 125.589 2.614 . . . . 23.140000000000001 117.348 177.797 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.09 22.49 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 125.205 2.559 . . . . 19.739999999999998 119.451 -166.483 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -106.12 147.59 28.8 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 111.412 -2.394 . . . . 21.93 108.98 179.182 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.0 m -124.22 106.28 10.17 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.375 -2.454 . . . . 12.33 104.375 178.827 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 mt -90.59 102.85 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 N-CA-C 105.247 -2.131 . . . . 17.079999999999998 105.247 -177.933 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 41.2 m -81.14 121.65 26.38 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 104.081 -2.563 . . . . 16.300000000000001 104.081 -177.015 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.443 HD11 ' CG1' ' A' ' 30' ' ' ILE . 92.4 mt -112.37 133.97 54.17 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 117.38 2.363 . . . . 15.880000000000001 117.38 175.411 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.338 32.7 mt-10 -87.47 97.89 11.08 Favored 'General case' 0 N--CA 1.429 -1.485 1 O-C-N 115.943 -4.223 . . . . 28.899999999999999 107.521 -177.677 . . . . . . . . 3 2 . 1 . 111 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -123.56 177.24 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 120.24 -1.538 . . . . 12.050000000000001 113.328 178.234 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -128.17 171.18 8.91 Favored Pre-proline 0 N--CA 1.43 -1.449 0 CA-C-O 116.208 -1.853 . . . . 18.170000000000002 111.852 168.685 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -70.0 -16.37 36.54 Favored 'Trans proline' 0 N--CA 1.434 -2.004 1 C-N-CA 125.512 4.141 . . . . 8.1600000000000001 113.829 -174.312 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 73.2 m -92.96 -3.62 54.16 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.849 2.86 . . . . 11.130000000000001 110.919 179.476 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.54 154.72 40.66 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.368 -2.707 . . . . 18.030000000000001 115.348 176.507 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.8 p -93.65 156.5 16.67 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.286 -2.487 . . . . 10.220000000000001 104.286 -179.807 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.1 mm -51.85 -36.5 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 O-C-N 116.637 -3.789 . . . . 12.300000000000001 113.52 167.561 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -60.67 -39.42 88.33 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 118.276 -2.765 . . . . 36.509999999999998 112.186 174.801 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -62.01 -47.17 85.98 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 115.764 -2.065 . . . . 25.66 113.049 170.421 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.5 t -44.83 -56.13 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.408 1 C-N-CA 131.915 4.086 . . . . 8.1199999999999992 111.068 172.213 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -67.95 -34.25 76.23 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.329 -3.357 . . . . 15.470000000000001 113.338 -174.024 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.55 85.14 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 114.68 1.363 . . . . 11.449999999999999 114.68 165.482 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 mttm -65.28 -32.2 73.74 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.072 -2.893 . . . . 24.98 113.012 173.669 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.443 ' CG1' HD11 ' A' ' 15' ' ' LEU . 87.5 mt -70.96 -44.75 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 120.147 -1.596 . . . . 9.4600000000000009 109.189 176.527 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -57.44 -52.4 65.53 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 118.861 -2.399 . . . . 14.76 110.906 169.076 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -48.62 -53.23 19.33 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 119.899 3.296 . . . . 26.289999999999999 119.899 171.622 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -82.67 -57.88 3.14 Favored 'General case' 0 N--CA 1.431 -1.421 1 O-C-N 116.191 -4.068 . . . . 30.059999999999999 118.38 179.63 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -86.75 -25.47 24.67 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 114.893 1.442 . . . . 25.190000000000001 114.893 -172.563 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.44 23.0 38.31 Favored Glycine 0 N--CA 1.43 -1.735 0 O-C-N 126.703 2.502 . . . . 7.4100000000000001 119.004 -176.585 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 35.6 mt -96.95 127.23 39.71 Favored Pre-proline 0 N--CA 1.43 -1.453 0 CA-C-O 113.016 -3.374 . . . . 9.4900000000000002 106.466 -175.223 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 94.9 Cg_endo -81.3 153.97 18.67 Favored 'Trans proline' 0 C--N 1.299 -2.034 2 C-N-CA 126.941 5.094 . . . . 11.42 112.736 179.038 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 45.1 Cg_endo -71.58 -18.19 29.33 Favored 'Trans proline' 0 N--CA 1.434 -1.992 0 C-N-CA 124.679 3.586 . . . . 12.0 108.469 -159.982 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.261 41.4 m-20 -73.96 -22.97 59.43 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 126.1 2.125 . . . . 35.549999999999997 113.206 179.341 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -91.03 -3.57 57.11 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 126.68 2.487 . . . . 20.52 110.993 179.122 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -94.36 102.66 14.65 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 122.364 2.347 . . . . 7.1299999999999999 115.77 -166.256 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -90.83 100.6 13.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 117.392 -3.318 . . . . 36.390000000000001 107.38 158.405 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.0 tp -95.14 106.89 18.94 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 113.119 -1.855 . . . . 9.5500000000000007 109.659 174.435 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.6 mt -111.11 127.24 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 127.619 2.367 . . . . 13.9 109.921 -168.681 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -118.77 111.82 18.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.481 -1.387 . . . . 6.8600000000000003 110.663 173.869 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.01 -103.14 0.11 Allowed 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 128.264 2.626 . . . . 11.15 111.666 -165.663 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -135.42 20.53 3.71 Favored Glycine 0 N--CA 1.431 -1.697 0 O-C-N 118.314 -2.741 . . . . 13.93 107.239 166.469 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -85.93 133.77 33.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.987 2.327 . . . . 23.920000000000002 114.28 165.069 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -93.01 125.91 37.83 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.628 -1.624 . . . . 23.23 107.628 178.614 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.1 mt -98.89 144.39 28.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 127.135 2.772 . . . . 9.1099999999999994 111.593 -174.389 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -113.01 149.51 33.23 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 124.216 1.96 . . . . 33.439999999999998 110.416 -175.655 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.32 -48.86 79.96 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 116.894 2.183 . . . . 28.370000000000001 116.894 -160.917 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -91.96 7.53 78.85 Favored Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 118.761 2.264 . . . . 15.0 118.761 -175.39 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mmm-85 -88.37 149.91 23.48 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-N 114.307 -0.946 . . . . 25.5 109.556 170.775 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -84.86 168.45 15.07 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 119.38 -2.075 . . . . 11.949999999999999 115.296 176.7 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.0 mt -73.13 -39.23 65.9 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 127.804 2.441 . . . . 10.17 110.605 178.451 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 t -68.54 -39.27 81.18 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.874 2.07 . . . . 13.59 112.651 178.383 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.56 -32.86 71.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 121.568 1.985 . . . . 11.699999999999999 109.506 175.739 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -84.27 -13.04 53.61 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 122.181 2.264 . . . . 12.949999999999999 106.331 176.358 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.327 59.7 m-20 80.66 28.0 0.23 Allowed 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.968 2.507 . . . . 25.449999999999999 113.098 -178.471 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.9 mt -81.66 109.33 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 O-C-N 118.517 -2.614 . . . . 14.6 110.196 -174.555 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -90.71 -178.97 5.41 Favored 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 127.831 2.453 . . . . 33.229999999999997 109.5 -177.282 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.457 ' HA ' ' SD ' ' A' ' 1' ' ' MET 0.258 20.2 pttp -64.78 151.69 44.63 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 116.077 1.88 . . . . 25.969999999999999 116.077 173.174 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 69.01 19.62 8.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 130.254 3.421 . . . . 32.609999999999999 117.877 177.03 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -76.39 125.81 29.86 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 128.971 2.908 . . . . 10.56 111.654 -176.619 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 37.6 m -77.66 113.41 15.48 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 127.065 2.728 . . . . 5.3300000000000001 112.556 177.582 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.91 161.22 14.64 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.381 1.473 . . . . 11.66 113.62 167.315 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -106.35 132.92 51.82 Favored 'General case' 0 N--CA 1.43 -1.466 1 C-N-CA 131.727 4.011 . . . . 16.300000000000001 109.654 164.692 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 43.6 tp -116.28 101.62 8.84 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 126.229 2.919 . . . . 9.9600000000000009 109.55 171.694 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.5 t -99.93 143.65 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.474 0 O-C-N 118.89 -2.381 . . . . 9.7599999999999998 108.618 170.704 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.2 mt -101.96 145.5 29.18 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 114.878 -4.889 . . . . 19.57 109.241 -178.012 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -123.07 -158.21 0.78 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 126.246 2.216 . . . . 35.079999999999998 106.02 173.348 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.5 tt -108.37 -55.79 2.34 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 124.327 3.24 . . . . 32.310000000000002 110.889 168.611 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.8 mtt-85 -155.25 -175.13 5.28 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 102.981 -2.97 . . . . 42.75 102.981 178.303 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.81 -117.52 4.9 Favored Glycine 0 N--CA 1.429 -1.767 0 O-C-N 120.806 -1.184 . . . . 36.310000000000002 111.603 177.204 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.774 1 N-CA-C 102.41 -4.276 . . . . 36.270000000000003 102.41 -173.548 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptt? . . . . . 0 CA--C 1.489 -1.379 0 N-CA-C 113.642 0.979 . . . . 17.170000000000002 113.642 . . . . . . . . . 0 0 . 1 . 112 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -103.59 121.71 43.48 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 125.08 2.371 . . . . 21.890000000000001 110.142 176.206 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.0 pt -111.1 146.41 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.492 0 O-C-N 118.986 -2.321 . . . . 10.83 113.052 168.73 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -108.01 142.74 37.7 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 113.22 -1.809 . . . . 10.609999999999999 114.643 -176.876 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -131.41 119.47 43.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 102.847 -3.02 . . . . 9.1300000000000008 102.847 -172.957 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -118.31 115.82 25.5 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 112.896 -3.431 . . . . 20.550000000000001 110.304 -165.793 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -63.19 175.77 0.88 Allowed 'General case' 0 N--CA 1.43 -1.475 1 O-C-N 129.917 4.51 . . . . 11.779999999999999 112.863 174.992 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.9 tp -67.82 -36.71 80.88 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 115.608 -0.724 . . . . 19.309999999999999 112.501 -179.677 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -86.17 -47.87 9.09 Favored 'General case' 0 N--CA 1.43 -1.459 0 C-N-CA 126.162 1.785 . . . . 23.140000000000001 107.182 -168.896 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.24 40.69 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.789 0 CA-C-O 123.165 1.425 . . . . 19.739999999999998 112.026 168.73 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -90.81 123.83 34.67 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.211 1.957 . . . . 21.93 111.305 163.101 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.0 m -99.54 106.73 18.76 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 111.946 -2.388 . . . . 12.33 108.868 -176.472 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.8 mt -96.32 118.53 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.548 -1.345 . . . . 17.079999999999998 109.668 -177.949 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.8 m -100.19 121.93 42.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.395 -3.316 . . . . 16.300000000000001 105.033 -173.023 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 15' ' ' LEU . 23.4 mt -122.42 141.16 51.9 Favored 'General case' 0 N--CA 1.431 -1.39 0 C-N-CA 126.421 1.888 . . . . 15.880000000000001 108.357 -176.951 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -100.43 132.87 45.57 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 127.99 3.757 . . . . 28.899999999999999 107.702 174.24 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -137.23 174.51 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 117.328 -3.357 . . . . 12.050000000000001 109.456 -175.447 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -122.54 157.11 60.14 Favored Pre-proline 0 N--CA 1.43 -1.464 0 C-N-CA 123.928 0.891 . . . . 18.170000000000002 109.015 151.123 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.5 -25.17 75.69 Favored 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.363 2.709 . . . . 8.1600000000000001 113.703 -171.087 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.4 m -86.41 7.45 25.73 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 120.645 1.566 . . . . 11.130000000000001 112.471 -171.515 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -87.35 147.39 25.5 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.215 -2.178 . . . . 18.030000000000001 105.62 -172.145 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.4 p -82.77 151.63 26.05 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.301 -2.125 . . . . 10.220000000000001 112.685 -177.658 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -51.94 -43.22 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 130.607 3.563 . . . . 12.300000000000001 109.149 176.84 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.76 -37.74 79.86 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 125.96 2.037 . . . . 36.509999999999998 114.449 178.325 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.254 71.9 m-80 -72.83 -32.91 65.83 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 118.662 -2.524 . . . . 25.66 114.803 176.786 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.0 t -62.77 -36.03 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 127.127 2.171 . . . . 8.1199999999999992 110.771 167.188 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -70.69 -26.93 63.65 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.399 -2.688 . . . . 15.470000000000001 115.809 169.05 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.18 -37.41 72.16 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 121.294 1.861 . . . . 11.449999999999999 109.999 167.923 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -63.87 -33.04 74.81 Favored 'General case' 0 N--CA 1.429 -1.475 1 O-C-N 115.694 -4.378 . . . . 24.98 115.24 178.905 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.4 mt -69.77 -32.3 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 O-C-N 118.847 -2.408 . . . . 9.4600000000000009 108.682 172.651 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -69.98 -44.88 68.53 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.927 -3.608 . . . . 14.76 109.188 173.479 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -61.17 -46.03 92.17 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 124.736 2.208 . . . . 26.289999999999999 116.335 179.286 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 tptt -79.01 -60.82 2.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 O-C-N 116.742 -3.724 . . . . 30.059999999999999 116.647 -174.106 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -86.59 -53.86 4.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 126.182 2.176 . . . . 25.190000000000001 111.443 177.21 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.08 33.58 2.75 Favored Glycine 0 N--CA 1.43 -1.729 0 CA-C-O 115.958 -2.579 . . . . 7.4100000000000001 113.958 -172.796 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 65.2 mt -97.52 127.82 36.6 Favored Pre-proline 0 N--CA 1.43 -1.434 0 C-N-CA 130.185 3.394 . . . . 9.4900000000000002 103.826 166.366 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -77.75 161.67 30.39 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 CA-C-O 112.905 -3.04 . . . . 11.42 115.271 -177.498 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -66.84 -24.7 46.27 Favored 'Trans proline' 0 N--CA 1.434 -1.999 1 CA-C-N 129.772 4.526 . . . . 12.0 116.693 -172.079 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -62.06 -31.94 72.41 Favored 'General case' 0 N--CA 1.43 -1.426 0 O-C-N 126.491 2.369 . . . . 35.549999999999997 113.418 -174.222 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.402 45.0 mt-30 -72.95 -16.91 61.53 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 119.427 3.121 . . . . 20.52 119.427 -179.53 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -102.68 110.16 22.0 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 117.105 -3.497 . . . . 7.1299999999999999 114.268 -155.521 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.9 mtt180 -94.14 103.94 15.97 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.178 -2.527 . . . . 36.390000000000001 104.178 169.178 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.08 118.46 31.93 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-O 125.086 2.374 . . . . 9.5500000000000007 110.114 174.773 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.1 mt -113.6 136.72 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 CA-C-N 110.563 -3.017 . . . . 13.9 107.584 -179.393 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -120.36 113.35 20.23 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 101.494 -3.521 . . . . 6.8600000000000003 101.494 172.368 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.74 -117.14 0.47 Allowed 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 119.085 -2.26 . . . . 11.15 111.314 -176.125 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.37 25.29 13.97 Favored Glycine 0 N--CA 1.43 -1.758 0 O-C-N 117.911 -2.993 . . . . 13.93 116.656 175.234 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.2 ttmm -131.35 142.6 50.11 Favored 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 125.51 2.576 . . . . 23.920000000000002 109.305 -173.3 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -110.29 141.78 42.82 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.394 -2.691 . . . . 23.23 111.82 -177.284 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 mt -95.2 140.54 29.96 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 125.134 2.397 . . . . 9.1099999999999994 110.606 -166.646 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -109.61 136.54 48.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 112.936 -1.938 . . . . 33.439999999999998 111.67 -172.359 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.7 -60.26 2.1 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 115.532 1.678 . . . . 28.370000000000001 115.532 -170.944 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -72.82 -4.03 61.04 Favored Glycine 0 N--CA 1.43 -1.75 0 O-C-N 118.797 -2.439 . . . . 15.0 117.805 -173.905 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -83.63 178.78 7.82 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 118.634 1.217 . . . . 25.5 110.689 170.883 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 76.6 p -106.09 178.44 4.56 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.333 -1.479 . . . . 11.949999999999999 109.958 177.058 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.9 mt -74.18 -33.89 63.6 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.591 1.156 . . . . 10.17 108.29 179.897 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.8 t -78.06 -27.35 48.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.389 3.076 . . . . 13.59 111.219 -175.007 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -64.02 -34.92 79.09 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-O 116.81 -1.567 . . . . 11.699999999999999 110.005 179.993 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -88.33 1.87 53.71 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 129.922 3.289 . . . . 12.949999999999999 114.103 167.521 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m120 58.31 49.07 11.55 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 114.25 1.204 . . . . 25.449999999999999 114.25 -178.098 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.2 mm -79.18 113.47 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 119.22 -2.175 . . . . 14.6 106.767 170.436 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -87.62 -177.68 5.92 Favored 'General case' 0 N--CA 1.43 -1.44 0 O-C-N 125.924 2.015 . . . . 33.229999999999997 112.42 174.087 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -64.03 134.42 54.95 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.667 -3.145 . . . . 25.969999999999999 115.408 164.508 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 69.6 mt-10 69.84 31.22 3.53 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 124.757 2.217 . . . . 32.609999999999999 111.425 173.719 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.267 45.6 t -83.69 134.27 34.77 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.932 1.693 . . . . 10.56 108.54 166.499 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 46.7 m -103.96 122.84 46.05 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 120.716 -1.24 . . . . 5.3300000000000001 108.377 -179.573 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.1 mt -81.99 138.71 34.85 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 115.135 -2.364 . . . . 11.66 116.073 165.185 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.1 m170 -88.5 114.61 25.29 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.172 2.17 . . . . 16.300000000000001 107.352 175.281 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.268 9.5 tp -92.55 106.45 18.43 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 117.672 -1.611 . . . . 9.9600000000000009 112.216 176.092 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.0 t -105.61 138.68 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 C-N-CA 127.836 2.455 . . . . 9.7599999999999998 105.37 179.267 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 mt -103.13 139.93 37.99 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 116.485 2.032 . . . . 19.57 116.485 -171.897 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ptt180 -123.18 173.92 7.59 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 113.855 1.057 . . . . 35.079999999999998 113.855 171.908 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.0 tt -76.45 -75.51 0.19 Allowed 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 117.655 -1.618 . . . . 32.310000000000002 111.92 175.522 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.4 mmt180 -134.06 -172.23 2.94 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 125.285 2.469 . . . . 42.75 105.441 170.267 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.51 -113.13 3.96 Favored Glycine 0 N--CA 1.43 -1.718 0 CA-C-O 127.471 3.817 . . . . 36.310000000000002 111.416 166.733 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.759 0 O-C-N 118.276 -2.896 . . . . 36.270000000000003 116.414 -166.286 . . . . . . . . 0 0 . 1 . 113 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptt? . . . . . 0 CA--C 1.49 -1.334 0 N-CA-C 109.283 -0.636 . . . . 17.170000000000002 109.283 . . . . . . . . . 0 0 . 1 . 113 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -89.88 120.97 31.57 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 109.185 -0.672 . . . . 21.890000000000001 109.185 165.744 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pp -117.01 167.88 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 118.499 -2.626 . . . . 10.83 108.129 157.043 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -114.1 133.96 55.2 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 118.847 -2.408 . . . . 10.609999999999999 115.529 -176.163 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.3 t -112.62 117.76 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-O 123.875 1.798 . . . . 9.1300000000000008 110.661 175.323 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.8 mttp -96.58 151.86 19.19 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 112.278 -3.725 . . . . 20.550000000000001 110.771 177.142 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.6 p -85.21 -176.07 6.0 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 121.675 2.034 . . . . 11.779999999999999 113.327 159.88 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.252 36.5 mt -86.15 -17.93 33.62 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 119.407 1.003 . . . . 19.309999999999999 113.595 169.329 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.7 p -77.97 -69.56 0.54 Allowed 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 127.575 2.35 . . . . 23.140000000000001 113.196 175.985 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 167.9 28.25 0.02 OUTLIER Glycine 0 N--CA 1.43 -1.719 1 O-C-N 115.117 -4.739 . . . . 19.739999999999998 111.022 -177.504 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -109.06 130.65 55.48 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 121.116 -1.226 . . . . 21.93 111.085 179.091 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.6 m -111.17 115.99 30.32 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.015 -3.553 . . . . 12.33 108.151 173.577 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 pt -105.15 155.39 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 C-N-CA 117.261 -1.776 . . . . 17.079999999999998 108.537 171.625 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 86.1 m -111.91 131.95 55.05 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 103.917 -2.623 . . . . 16.300000000000001 103.917 -177.287 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.3 tp -144.87 125.94 14.58 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 118.679 -2.513 . . . . 15.880000000000001 109.047 -164.885 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -94.82 103.47 15.36 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 119.045 -2.284 . . . . 28.899999999999999 110.996 -172.833 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -131.95 155.45 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-N 115.379 -0.828 . . . . 12.050000000000001 110.483 176.891 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -85.79 146.41 43.6 Favored Pre-proline 0 N--CA 1.43 -1.441 0 CA-C-O 117.517 -1.23 . . . . 18.170000000000002 110.035 178.153 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.03 -10.69 21.53 Favored 'Trans proline' 0 C--N 1.299 -2.029 0 N-CA-C 118.197 2.345 . . . . 8.1600000000000001 118.197 177.288 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.6 p -90.83 -7.19 53.0 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 128.363 2.665 . . . . 11.130000000000001 114.746 175.927 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -69.56 149.27 48.37 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.741 -1.224 . . . . 18.030000000000001 110.415 176.402 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.0 p -79.78 170.13 16.96 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 117.026 -1.464 . . . . 10.220000000000001 110.492 175.931 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -72.24 -29.04 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 C-N-CA 127.062 2.145 . . . . 12.300000000000001 110.761 178.392 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -59.44 -47.39 85.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 118.369 -2.707 . . . . 36.509999999999998 113.246 163.483 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -62.63 -40.17 96.13 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 122.052 2.206 . . . . 25.66 115.163 170.499 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.9 t -56.59 -50.91 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 CA-C-N 121.499 1.954 . . . . 8.1199999999999992 112.98 171.471 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mtmt -68.52 -30.19 68.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.256 -2.778 . . . . 15.470000000000001 112.892 -176.507 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.68 -34.29 77.53 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 126.216 1.806 . . . . 11.449999999999999 109.844 174.088 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -80.48 -39.77 27.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-O 123.207 1.479 . . . . 24.98 109.882 -176.454 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.4 mt -56.32 -39.26 59.37 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 O-C-N 116.408 -3.932 . . . . 9.4600000000000009 113.665 162.746 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.351 17.6 tt0 -56.31 -51.65 67.41 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.131 2.972 . . . . 14.76 108.334 167.374 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.62 -37.75 76.97 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 121.711 2.051 . . . . 26.289999999999999 112.318 -168.181 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -83.01 -66.0 0.94 Allowed 'General case' 0 N--CA 1.43 -1.465 1 O-C-N 129.212 4.07 . . . . 30.059999999999999 116.77 -178.399 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -93.48 -26.16 17.3 Favored 'General case' 0 N--CA 1.43 -1.436 0 C-N-CA 124.671 1.188 . . . . 25.190000000000001 112.748 -169.995 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.62 37.88 8.48 Favored Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 125.389 1.471 . . . . 7.4100000000000001 114.427 178.526 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.591 HD13 HD21 ' A' ' 71' ' ' LEU . 4.7 mt -88.9 128.86 50.54 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 118.739 -1.184 . . . . 9.4900000000000002 113.105 160.862 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.39 158.2 36.79 Favored 'Trans proline' 0 N--CA 1.434 -1.984 0 C-N-CA 123.288 2.659 . . . . 11.42 111.815 170.186 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -90.31 0.28 5.35 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 O-C-N 116.808 -2.259 . . . . 12.0 109.916 -159.931 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -77.09 -29.73 55.05 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.665 -2.522 . . . . 35.549999999999997 110.755 169.626 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -71.23 -37.77 72.0 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.089 -2.257 . . . . 20.52 109.174 175.433 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -76.99 116.89 18.05 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 117.023 2.231 . . . . 7.1299999999999999 117.023 -164.909 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -115.59 120.31 39.01 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.1 1.905 . . . . 36.390000000000001 108.482 166.75 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.5 tp -111.77 112.97 25.03 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 116.245 -4.034 . . . . 9.5500000000000007 110.442 -169.447 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.6 mm -102.89 137.84 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 O-C-N 119.479 -2.013 . . . . 13.9 110.026 -177.93 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -106.46 111.58 24.22 Favored 'General case' 0 N--CA 1.43 -1.456 1 O-C-N 113.747 -5.596 . . . . 6.8600000000000003 108.079 153.786 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.44 -99.17 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.408 0 C-N-CA 128.192 2.597 . . . . 11.15 115.615 -174.534 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -122.53 8.62 9.46 Favored Glycine 0 N--CA 1.43 -1.721 0 O-C-N 118.985 -2.322 . . . . 13.93 115.018 161.174 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.3 tppp? -89.27 124.89 34.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 C-N-CA 125.033 1.333 . . . . 23.920000000000002 114.546 172.475 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -85.47 131.51 34.37 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 104.145 -2.539 . . . . 23.23 104.145 -179.341 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.6 mt -93.37 126.76 38.68 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.379 1.472 . . . . 9.1099999999999994 110.17 -175.653 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -121.0 150.45 41.11 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 121.911 2.141 . . . . 33.439999999999998 113.011 -164.77 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.365 67.2 m-20 -18.02 -74.7 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.432 1 C-N-CA 132.285 4.234 . . . . 28.370000000000001 120.039 -168.968 . . . . . . . . 3 2 . 1 . 113 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -97.38 34.34 5.19 Favored Glycine 0 N--CA 1.43 -1.731 0 O-C-N 118.713 -2.492 . . . . 15.0 116.339 -164.802 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.0 mtt180 -133.55 171.34 14.22 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.862 -1.964 . . . . 25.5 111.949 175.989 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.3 p -95.54 167.21 11.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 121.664 2.029 . . . . 11.949999999999999 112.889 -167.519 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.53 -34.25 76.54 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.53 -2.606 . . . . 10.17 112.908 166.828 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -38.22 79.17 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 114.426 1.269 . . . . 13.59 114.426 178.129 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -56.4 -50.38 71.77 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 116.596 -3.815 . . . . 11.699999999999999 114.044 177.914 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -77.78 8.42 4.56 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 127.576 3.048 . . . . 12.949999999999999 113.631 178.163 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 2.0 m120 54.4 40.33 31.69 Favored 'General case' 0 N--CA 1.43 -1.436 1 C-N-CA 131.748 4.019 . . . . 25.449999999999999 117.222 -179.519 . . . . . . . . 3 2 . 1 . 113 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.346 10.1 mt -77.77 115.72 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 O-C-N 120.407 -1.433 . . . . 14.6 109.307 178.962 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -91.85 176.06 6.66 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.207 -3.433 . . . . 33.229999999999997 108.473 176.361 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 pttp -69.38 146.91 51.72 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 118.346 -2.721 . . . . 25.969999999999999 114.023 176.817 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 71.35 18.59 5.55 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 129.652 3.181 . . . . 32.609999999999999 112.561 -179.102 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 59.8 m -76.69 148.95 36.5 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 118.199 -2.813 . . . . 10.56 112.507 178.949 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 42.4 m -90.96 106.09 18.28 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 127.472 2.309 . . . . 5.3300000000000001 115.735 170.507 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mt -91.44 152.24 20.46 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.422 2.289 . . . . 11.66 114.311 166.164 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m170 -119.77 125.84 49.57 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.184 -2.822 . . . . 16.300000000000001 103.956 -169.76 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -102.2 123.53 46.2 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 127.723 2.409 . . . . 9.9600000000000009 108.053 177.915 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.7 t -106.76 130.6 58.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.429 0 CA-C-N 113.41 -1.723 . . . . 9.7599999999999998 114.089 162.292 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.591 HD21 HD13 ' A' ' 36' ' ' ILE . 10.8 mt -98.71 140.89 32.24 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.486 3.114 . . . . 19.57 117.926 176.531 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.266 38.3 ttt180 -73.38 138.53 45.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 115.535 1.68 . . . . 35.079999999999998 115.535 179.188 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.264 76.1 mt -104.68 170.43 7.89 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 106.028 -1.841 . . . . 32.310000000000002 106.028 176.413 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -75.86 159.69 30.71 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 121.197 -0.939 . . . . 42.75 112.643 176.493 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 38.18 74.34 0.12 Allowed Glycine 0 N--CA 1.43 -1.734 0 N-CA-C 117.907 1.923 . . . . 36.310000000000002 117.907 -171.086 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.726 0 CA-C-N 109.112 -3.544 . . . . 36.270000000000003 112.7 -175.218 . . . . . . . . 0 0 . 1 . 114 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ptt? . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 118.514 2.783 . . . . 17.170000000000002 118.514 . . . . . . . . . 0 0 . 1 . 114 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.371 36.7 mt-30 -69.01 128.48 36.85 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 105.253 -2.129 . . . . 21.890000000000001 105.253 170.569 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.8 pt -123.4 151.8 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.677 -2.056 . . . . 10.83 110.972 161.983 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -96.37 130.01 43.58 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.738 -0.785 . . . . 10.609999999999999 111.402 174.778 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.499 HG22 ' HB2' ' A' ' 67' ' ' LEU . 76.3 t -119.26 125.14 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.433 0 N-CA-C 103.126 -2.916 . . . . 9.1300000000000008 103.126 160.966 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.8 tttt -119.48 132.22 55.74 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 109.983 -3.28 . . . . 20.550000000000001 105.985 -175.942 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.46 HG22 HD23 ' A' ' 69' ' ' LEU . 10.5 p -75.34 157.58 34.07 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 117.794 -3.066 . . . . 11.779999999999999 109.109 174.552 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.5 mt -61.59 -39.76 92.35 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 117.514 -3.241 . . . . 19.309999999999999 114.43 159.283 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -48.02 -34.57 9.65 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 127.001 2.12 . . . . 23.140000000000001 112.794 172.141 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 157.04 -62.88 0.32 Allowed Glycine 0 N--CA 1.43 -1.725 1 O-C-N 114.156 -5.34 . . . . 19.739999999999998 119.801 -178.638 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -80.78 160.76 24.78 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 115.296 -2.561 . . . . 21.93 117.084 -158.251 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.69 131.29 48.02 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.427 -1.42 . . . . 12.33 109.493 166.641 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.6 pt -112.9 144.54 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 129.216 3.006 . . . . 17.079999999999998 109.017 157.219 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.1 m -106.34 128.22 53.85 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 128.129 2.571 . . . . 16.300000000000001 104.97 179.231 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.15 129.33 54.86 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 125.577 1.551 . . . . 15.880000000000001 110.978 172.902 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -79.73 101.84 8.67 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 120.318 1.417 . . . . 28.899999999999999 113.451 159.899 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -111.22 166.76 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 117.624 -3.173 . . . . 12.050000000000001 115.221 173.996 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -95.76 154.96 38.97 Favored Pre-proline 0 N--CA 1.43 -1.435 0 N-CA-C 105.926 -1.879 . . . . 18.170000000000002 105.926 167.838 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.252 14.1 Cg_exo -63.0 -21.56 73.3 Favored 'Trans proline' 0 C--N 1.299 -2.042 0 N-CA-C 116.008 1.503 . . . . 8.1600000000000001 116.008 170.26 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.5 p -80.96 -2.48 47.98 Favored 'General case' 0 N--CA 1.429 -1.478 0 C-N-CA 125.878 1.671 . . . . 11.130000000000001 115.475 175.351 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.77 148.72 28.76 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 129.94 3.296 . . . . 18.030000000000001 106.533 -171.017 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 26' ' ' VAL . 57.9 p -91.18 164.12 14.02 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.256 -2.247 . . . . 10.220000000000001 105.551 -179.392 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.659 HG23 HD23 ' A' ' 43' ' ' LEU . 41.1 mm -72.48 -30.9 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.473 0 CA-C-O 116.948 -1.501 . . . . 12.300000000000001 107.124 174.592 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -51.53 -50.96 59.0 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 125.47 3.759 . . . . 36.509999999999998 114.503 168.777 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -60.39 -28.28 68.1 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 117.388 2.366 . . . . 25.66 117.388 174.087 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 22' ' ' THR . 88.5 t -65.66 -47.86 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 129.251 3.02 . . . . 8.1199999999999992 110.825 172.018 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -70.48 -30.05 66.74 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 125.166 2.412 . . . . 15.470000000000001 109.794 178.402 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.33 -34.62 74.91 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.365 -3.959 . . . . 11.449999999999999 109.783 -179.133 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.2 ttmt -70.48 -27.81 64.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 119.302 -2.124 . . . . 24.98 108.601 -177.189 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 89.5 mt -78.17 -24.63 13.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 114.017 1.117 . . . . 9.4600000000000009 114.017 170.879 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.455 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 15.4 tt0 -62.45 -46.12 89.94 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 115.649 -4.407 . . . . 14.76 110.878 169.081 . . . . . . . . 3 3 . 1 . 114 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.5 -42.01 99.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 120.627 -1.296 . . . . 26.289999999999999 112.953 174.627 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -73.99 -67.81 0.57 Allowed 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 120.521 -1.362 . . . . 30.059999999999999 110.711 -171.017 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -90.57 -29.69 17.68 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 113.74 -5.6 . . . . 25.190000000000001 113.191 -177.215 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.0 40.73 1.78 Allowed Glycine 0 N--CA 1.43 -1.752 0 O-C-N 120.082 -1.636 . . . . 7.4100000000000001 111.601 -177.085 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.455 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 2.7 mt -115.4 119.54 37.99 Favored Pre-proline 0 N--CA 1.43 -1.443 0 O-C-N 119.031 -2.452 . . . . 9.4900000000000002 111.539 -171.786 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -58.8 140.6 95.8 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 C-N-CA 122.567 2.178 . . . . 11.42 113.313 177.69 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -59.36 -17.79 42.13 Favored 'Trans proline' 0 N--CA 1.434 -1.983 0 C-N-CA 124.901 3.734 . . . . 12.0 118.441 179.458 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -76.8 -37.21 56.17 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 114.799 1.407 . . . . 35.549999999999997 114.799 179.386 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -61.4 -21.74 64.35 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 121.711 3.967 . . . . 20.52 121.711 167.193 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -88.6 101.73 14.25 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 117.482 2.401 . . . . 7.1299999999999999 117.482 -171.378 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -100.74 107.36 18.93 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 125.288 2.471 . . . . 36.390000000000001 110.982 177.072 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.659 HD23 HG23 ' A' ' 23' ' ' ILE . 8.7 tp -105.99 118.7 37.29 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 118.432 -2.667 . . . . 9.5500000000000007 107.375 -161.469 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.486 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 36.3 mm -111.99 124.48 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 C-N-CA 128.969 2.908 . . . . 13.9 115.988 -166.351 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -112.87 87.13 2.51 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.651 -3.155 . . . . 6.8600000000000003 108.473 -179.314 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.283 . . 62.52 -93.16 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.44 1 O-C-N 114.39 -5.193 . . . . 11.15 110.291 -177.122 . . . . . . . . 3 2 . 1 . 114 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.43 -10.99 22.65 Favored Glycine 0 N--CA 1.43 -1.712 0 O-C-N 126.244 2.215 . . . . 13.93 111.253 176.653 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -88.6 137.27 32.47 Favored 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 129.417 3.087 . . . . 23.920000000000002 108.395 -172.779 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -107.3 117.93 35.38 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.354 2.026 . . . . 23.23 107.791 177.322 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 84.8 mt -80.66 163.41 23.61 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.023 -1.673 . . . . 9.1099999999999994 111.989 -170.925 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -106.94 165.39 11.37 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 129.284 3.034 . . . . 33.439999999999998 105.447 179.443 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.337 23.7 m-20 -84.12 -54.39 4.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 125.03 2.348 . . . . 28.370000000000001 117.069 -168.549 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.87 50.79 2.26 Favored Glycine 0 N--CA 1.43 -1.734 0 CA-C-N 113.682 -1.599 . . . . 15.0 116.056 177.749 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -133.39 156.05 48.37 Favored 'General case' 0 N--CA 1.43 -1.464 1 N-CA-C 100.11 -4.033 . . . . 25.5 100.11 175.811 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.251 30.2 p -86.04 158.54 19.81 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 124.258 1.98 . . . . 11.949999999999999 113.242 -170.218 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -61.28 -36.65 80.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.097 -2.252 . . . . 10.17 116.782 167.239 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.4 t -65.8 -38.14 88.17 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 126.341 1.856 . . . . 13.59 111.963 -179.519 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -63.36 -54.37 37.93 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 127.387 2.275 . . . . 11.699999999999999 112.129 178.721 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -64.14 -17.99 64.01 Favored 'General case' 0 N--CA 1.429 -1.486 0 N-CA-C 120.025 3.343 . . . . 12.949999999999999 120.025 170.588 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 69.9 43.4 0.93 Allowed 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 117.399 2.37 . . . . 25.449999999999999 117.399 -172.742 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.8 mt -84.01 112.47 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.339 -2.21 . . . . 14.6 112.132 165.416 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -83.31 -179.29 7.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 123.568 1.651 . . . . 33.229999999999997 108.706 -172.91 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.96 152.45 44.44 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 120.414 -1.429 . . . . 25.969999999999999 114.787 162.223 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 57.36 21.69 7.08 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 116.191 1.922 . . . . 32.609999999999999 116.191 -172.23 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 t -90.47 141.14 29.05 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 113.795 1.035 . . . . 10.56 113.795 -179.932 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.7 m -96.94 93.77 6.81 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 118.603 2.816 . . . . 5.3300000000000001 118.603 -174.682 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.499 ' HB2' HG22 ' A' ' 5' ' ' VAL . 64.6 mt -79.02 161.57 26.51 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 121.107 -0.995 . . . . 11.66 109.221 174.893 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.486 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 79.0 m-70 -104.37 137.22 42.58 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 105.44 -2.059 . . . . 16.300000000000001 105.44 173.646 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.46 HD23 HG22 ' A' ' 7' ' ' THR . 62.1 tp -95.02 119.49 33.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 127.491 2.994 . . . . 9.9600000000000009 112.655 160.231 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 t -104.25 120.56 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 N-CA-C 106.226 -1.768 . . . . 9.7599999999999998 106.226 174.664 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.0 mt -92.41 178.05 5.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 C-N-CA 129.699 3.2 . . . . 19.57 113.577 -171.155 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -160.19 175.93 12.34 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 108.488 -0.93 . . . . 35.079999999999998 108.488 167.86 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.1 mt -98.63 -169.98 1.87 Allowed 'General case' 0 N--CA 1.43 -1.455 1 C-N-CA 132.053 4.141 . . . . 32.310000000000002 105.108 163.179 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.254 88.4 mtt-85 -83.48 -64.76 1.11 Allowed 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.998 -2.314 . . . . 42.75 110.261 -179.946 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.28 76.99 0.66 Allowed Glycine 0 N--CA 1.431 -1.662 0 O-C-N 128.693 3.746 . . . . 36.310000000000002 110.34 -167.483 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.776 1 O-C-N 130.334 4.196 . . . . 36.270000000000003 108.052 -174.526 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 ptt? . . . . . 0 CA--C 1.49 -1.33 0 CA-C-O 117.706 -1.14 . . . . 17.170000000000002 113.719 . . . . . . . . . 0 0 . 1 . 115 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.22 144.17 45.96 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 124.621 2.153 . . . . 21.890000000000001 115.243 167.729 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.8 pt -127.32 163.29 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 113.529 -1.669 . . . . 10.83 107.861 175.03 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -123.18 130.13 52.34 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 115.28 -2.295 . . . . 10.609999999999999 111.147 -171.037 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.515 HG22 ' HB2' ' A' ' 67' ' ' LEU . 86.0 t -130.54 112.13 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 1 CA-C-N 126.331 4.151 . . . . 9.1300000000000008 102.718 -167.511 . . . . . . . . 3 3 . 1 . 115 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -81.94 144.0 31.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 125.494 1.517 . . . . 20.550000000000001 113.967 -176.849 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.302 81.8 p -98.91 -140.86 0.32 Allowed 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.722 -2.486 . . . . 11.779999999999999 112.731 -178.45 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.8 -44.97 1.92 Allowed 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 100.741 -3.8 . . . . 19.309999999999999 100.741 174.003 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 m -92.24 -74.45 0.51 Allowed 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 125.552 1.541 . . . . 23.140000000000001 112.649 -169.692 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -84.94 -137.04 3.76 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 108.319 -1.913 . . . . 19.739999999999998 108.319 -157.99 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.2 pttm -91.7 160.45 15.35 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 124.651 2.167 . . . . 21.93 112.062 -172.512 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.6 m -77.01 116.72 17.92 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 116.651 -3.78 . . . . 12.33 109.691 172.098 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.3 pt -79.37 160.39 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.79 -2.444 . . . . 17.079999999999998 112.356 179.403 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.4 m -124.79 132.96 53.3 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 118.504 -2.622 . . . . 16.300000000000001 107.422 -175.893 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.1 mt -121.8 142.39 50.26 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 109.261 -0.644 . . . . 15.880000000000001 109.261 177.565 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -99.82 110.57 22.94 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 119.206 -2.184 . . . . 28.899999999999999 109.217 168.227 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -130.5 164.84 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 C-N-CA 131.252 3.821 . . . . 12.050000000000001 109.915 -170.532 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.272 52.0 mm-40 -110.42 155.14 42.51 Favored Pre-proline 0 N--CA 1.43 -1.453 1 O-C-N 116.011 -4.181 . . . . 18.170000000000002 102.558 172.896 . . . . . . . . 3 2 . 1 . 115 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -66.07 -19.62 57.28 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 CA-C-N 127.876 3.849 . . . . 8.1600000000000001 114.654 176.47 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.9 p -75.99 -5.63 47.2 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 126.751 2.021 . . . . 11.130000000000001 115.292 179.526 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -78.2 142.45 37.92 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 121.1 -1.0 . . . . 18.030000000000001 110.161 171.903 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 40.8 p -81.66 169.19 17.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 125.1 2.381 . . . . 10.220000000000001 113.501 177.359 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -67.38 -29.11 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 118.693 -2.504 . . . . 12.300000000000001 107.942 -178.438 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -73.18 -34.91 66.26 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 125.785 1.634 . . . . 36.509999999999998 113.627 175.886 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -57.6 -40.22 78.62 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.385 -2.721 . . . . 25.66 116.578 161.424 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -66.65 -38.26 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-O 123.143 1.449 . . . . 8.1199999999999992 108.369 176.468 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 38' ' ' PRO . 89.6 mttt -57.29 -36.02 70.53 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 115.336 -4.603 . . . . 15.470000000000001 114.618 171.871 . . . . . . . . 3 3 . 1 . 115 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.39 -40.91 94.06 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 130.376 4.797 . . . . 11.449999999999999 110.685 176.124 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.284 56.2 mttm -61.4 -42.41 98.68 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.771 1.623 . . . . 24.98 114.943 167.987 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.48 HD12 ' HA ' ' A' ' 27' ' ' LYS . 63.8 mt -60.55 -32.71 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 O-C-N 117.733 -3.105 . . . . 9.4600000000000009 117.34 176.358 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -58.86 -48.94 79.61 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.979 -2.95 . . . . 14.76 115.475 167.497 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -53.54 -62.79 1.42 Allowed 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.142 -3.474 . . . . 26.289999999999999 114.224 162.386 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -64.87 -42.03 95.18 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 116.673 2.101 . . . . 30.059999999999999 116.673 -170.528 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -106.59 -50.55 3.11 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 120.264 -1.522 . . . . 25.190000000000001 113.258 174.143 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 126.37 5.18 6.16 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-O 125.029 2.461 . . . . 7.4100000000000001 116.524 -178.039 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 58.1 mt -82.86 133.69 48.3 Favored Pre-proline 0 N--CA 1.43 -1.431 0 O-C-N 119.741 -2.035 . . . . 9.4900000000000002 109.655 -177.502 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -64.12 146.35 90.58 Favored 'Trans proline' 0 N--CA 1.434 -2.027 1 C-N-CA 125.771 4.314 . . . . 11.42 118.021 174.278 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.525 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 72.4 Cg_exo -61.54 -20.71 69.75 Favored 'Trans proline' 0 C--N 1.3 -1.991 0 CA-C-N 124.273 2.562 . . . . 12.0 116.736 -173.057 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -82.44 -18.17 42.74 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 124.523 1.139 . . . . 35.549999999999997 112.922 -179.874 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -100.06 -4.44 29.88 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 117.592 -1.194 . . . . 20.52 113.709 -176.256 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -86.05 135.23 33.71 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 130.106 3.362 . . . . 7.1299999999999999 114.999 175.6 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.2 ttt180 -129.57 118.38 21.93 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.943 -1.723 . . . . 36.390000000000001 107.946 176.336 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.1 mt -101.5 137.29 40.02 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 123.421 1.581 . . . . 9.5500000000000007 109.529 -177.338 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.9 mm -137.36 130.93 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 100.268 -3.975 . . . . 13.9 100.268 -173.191 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -119.94 121.18 38.43 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 113.377 -3.202 . . . . 6.8600000000000003 109.105 170.705 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.33 -116.26 0.56 Allowed 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 122.931 2.605 . . . . 11.15 107.599 -174.664 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.5 34.41 4.55 Favored Glycine 0 N--CA 1.43 -1.722 0 O-C-N 118.739 -2.476 . . . . 13.93 113.091 164.375 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -113.36 123.98 51.38 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 119.644 -2.092 . . . . 23.920000000000002 108.681 -179.882 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -77.21 119.38 20.79 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 118.647 -2.533 . . . . 23.23 111.625 171.743 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 59.6 mt -90.52 136.16 33.24 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.995 -2.315 . . . . 9.1099999999999994 115.466 -174.89 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -96.45 128.67 43.59 Favored 'General case' 0 N--CA 1.429 -1.502 0 O-C-N 120.111 -1.618 . . . . 33.439999999999998 114.082 178.855 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -31.72 -52.93 0.25 Allowed 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 130.94 3.696 . . . . 28.370000000000001 117.037 -177.627 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -88.57 0.46 82.97 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 119.012 -2.305 . . . . 15.0 110.322 -165.161 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -91.33 168.35 11.64 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 118.145 0.972 . . . . 25.5 112.212 170.756 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 66.4 p -109.37 178.82 4.33 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 117.4 -3.312 . . . . 11.949999999999999 108.118 -176.11 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -75.32 -33.81 61.18 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-O 125.422 2.535 . . . . 10.17 111.003 179.579 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.55 -35.89 77.11 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 116.445 -3.909 . . . . 13.59 109.242 168.383 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -71.27 -36.64 71.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 122.42 2.373 . . . . 11.699999999999999 112.798 -176.336 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -83.16 3.43 30.87 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.277 2.231 . . . . 12.949999999999999 109.794 -177.706 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 49.59 51.52 16.29 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 115.069 1.507 . . . . 25.449999999999999 115.069 -169.766 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.5 mt -102.81 113.86 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 127.161 2.788 . . . . 14.6 113.092 -179.784 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -97.31 -175.25 3.17 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 126.778 3.18 . . . . 33.229999999999997 109.535 -174.377 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -73.3 154.5 40.12 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 117.426 -3.296 . . . . 25.969999999999999 112.889 -175.156 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 76.33 13.68 2.49 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 127.022 2.129 . . . . 32.609999999999999 109.303 170.499 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.3 m -87.41 141.77 28.38 Favored 'General case' 0 N--CA 1.431 -1.406 0 O-C-N 127.214 2.821 . . . . 10.56 109.703 -172.901 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.1 m -83.94 115.55 22.36 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 123.528 1.632 . . . . 5.3300000000000001 112.804 176.116 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.515 ' HB2' HG22 ' A' ' 5' ' ' VAL . 63.4 mt -87.29 147.65 25.43 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-O 122.923 1.344 . . . . 11.66 110.906 162.674 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -105.36 131.06 53.28 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 116.97 -3.582 . . . . 16.300000000000001 109.661 172.85 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.0 tp -112.39 117.66 33.05 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 127.255 3.407 . . . . 9.9600000000000009 107.721 179.929 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.2 t -121.37 151.9 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 101.366 -3.568 . . . . 9.7599999999999998 101.366 -168.15 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.68 139.96 38.23 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 117.702 -3.124 . . . . 19.57 109.431 -171.669 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -140.01 156.39 46.65 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-O 123.727 1.727 . . . . 35.079999999999998 110.897 173.05 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.7 mt -99.05 -171.16 2.04 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 127.583 3.563 . . . . 32.310000000000002 105.01 -175.658 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -82.87 -49.3 9.81 Favored 'General case' 0 N--CA 1.43 -1.43 1 O-C-N 115.114 -4.741 . . . . 42.75 109.632 178.464 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.92 71.65 2.72 Favored Glycine 0 N--CA 1.431 -1.681 0 O-C-N 120.245 -1.535 . . . . 36.310000000000002 111.971 -177.551 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.737 0 N-CA-C 106.819 -2.512 . . . . 36.270000000000003 106.819 -158.288 . . . . . . . . 0 0 . 1 . 116 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ptt? . . . . . 0 CA--C 1.49 -1.353 0 N-CA-C 118.71 2.856 . . . . 17.170000000000002 118.71 . . . . . . . . . 0 0 . 1 . 116 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -93.24 124.66 37.37 Favored 'General case' 0 N--CA 1.43 -1.441 1 O-C-N 116.241 -4.037 . . . . 21.890000000000001 106.225 -174.043 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.327 0.9 OUTLIER -110.31 166.69 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 119.784 -1.822 . . . . 10.83 109.578 167.341 . . . . . . . . 3 3 . 1 . 116 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -117.56 120.74 39.0 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-O 124.636 2.16 . . . . 10.609999999999999 116.534 176.241 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -99.17 105.78 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.222 -2.799 . . . . 9.1300000000000008 114.941 176.766 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -102.94 133.89 47.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.802 -3.061 . . . . 20.550000000000001 109.39 -171.74 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.763 HG22 HD23 ' A' ' 69' ' ' LEU 0.316 17.1 p -93.29 -177.71 4.53 Favored 'General case' 0 N--CA 1.43 -1.453 1 O-C-N 116.119 -4.113 . . . . 11.779999999999999 110.559 -172.77 . . . . . . . . 4 3 . 1 . 116 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 48.8 mt -74.42 -67.13 0.65 Allowed 'General case' 0 N--CA 1.431 -1.415 0 C-N-CA 128.233 2.613 . . . . 19.309999999999999 105.322 175.947 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.0 m -125.76 129.42 49.44 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 126.309 2.256 . . . . 23.140000000000001 106.645 176.166 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.81 -114.06 0.73 Allowed Glycine 0 N--CA 1.43 -1.73 0 O-C-N 118.506 -2.621 . . . . 19.739999999999998 108.492 176.994 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -158.43 163.54 37.09 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-O 126.948 3.261 . . . . 21.93 103.581 -178.01 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 34.7 m -92.38 135.17 34.26 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 119.195 -2.191 . . . . 12.33 112.669 178.31 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 pt -110.12 139.47 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 O-C-N 117.453 -3.28 . . . . 17.079999999999998 111.025 -174.517 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 62.4 m -101.5 121.11 41.36 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 104.033 -2.58 . . . . 16.300000000000001 104.033 -175.572 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 mt -119.95 172.42 7.74 Favored 'General case' 0 N--CA 1.431 -1.417 0 O-C-N 119.169 -2.207 . . . . 15.880000000000001 111.504 179.995 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -120.42 120.43 35.91 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 118.264 -2.772 . . . . 28.899999999999999 114.085 178.062 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -138.2 167.65 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 O-C-N 126.763 2.539 . . . . 12.050000000000001 109.558 -177.756 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -122.96 158.34 57.7 Favored Pre-proline 0 N--CA 1.43 -1.463 0 CA-C-N 121.05 1.75 . . . . 18.170000000000002 108.168 176.902 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.16 -19.58 66.22 Favored 'Trans proline' 0 N--CA 1.434 -1.998 0 O-C-N 113.932 -3.772 . . . . 8.1600000000000001 118.278 -179.838 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.7 p -82.9 -1.83 53.22 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 118.937 2.94 . . . . 11.130000000000001 118.937 177.577 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -78.78 144.69 34.91 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.703 -0.623 . . . . 18.030000000000001 109.4 173.719 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.4 p -76.42 173.84 10.98 Favored 'General case' 0 N--CA 1.431 -1.421 0 O-C-N 119.206 -2.184 . . . . 10.220000000000001 114.97 165.012 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.6 mm -63.33 -42.99 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 CA-C-O 123.869 1.795 . . . . 12.300000000000001 112.572 174.414 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -49.43 -39.29 32.41 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 131.006 3.723 . . . . 36.509999999999998 113.511 175.583 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -75.45 -17.02 60.26 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.664 -2.522 . . . . 25.66 115.374 172.271 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.54 -44.77 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 120.139 -1.601 . . . . 8.1199999999999992 114.234 167.463 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' HA ' HD12 ' A' ' 30' ' ' ILE . 79.7 mttt -51.71 -22.89 3.85 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.227 1.936 . . . . 15.470000000000001 116.227 175.659 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.01 -27.3 23.3 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 119.209 0.913 . . . . 11.449999999999999 109.073 -174.847 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -68.26 -26.06 65.48 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 128.883 2.873 . . . . 24.98 113.428 167.352 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.441 HD12 ' HA ' ' A' ' 27' ' ' LYS . 11.2 mt -89.35 -31.75 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 O-C-N 119.522 -1.986 . . . . 9.4600000000000009 111.261 175.1 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -57.26 -37.45 72.35 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.769 -4.332 . . . . 14.76 114.307 168.461 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -64.68 -55.64 18.83 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 116.289 -1.815 . . . . 26.289999999999999 112.205 168.191 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.7 tppt? -75.97 -51.53 12.2 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 125.708 1.88 . . . . 30.059999999999999 114.592 -161.171 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.1 mm-40 -94.59 -42.92 8.55 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.008 2.813 . . . . 25.190000000000001 116.659 179.578 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.38 33.14 2.57 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 109.94 -3.3 . . . . 7.4100000000000001 113.563 161.388 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.465 HD12 HD21 ' A' ' 69' ' ' LEU . 87.6 mt -91.22 137.88 26.04 Favored Pre-proline 0 N--CA 1.43 -1.433 0 CA-C-O 114.626 -2.607 . . . . 9.4900000000000002 109.399 -179.071 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -61.9 137.56 68.34 Favored 'Trans proline' 0 N--CA 1.434 -2.02 0 C-N-CA 124.759 3.639 . . . . 11.42 114.087 178.985 . . . . . . . . 3 3 . 1 . 116 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 51.2 Cg_exo -64.42 -26.54 62.96 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 CA-C-N 127.126 3.581 . . . . 12.0 118.241 -168.564 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -63.03 -31.41 72.54 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 127.26 2.224 . . . . 35.549999999999997 113.405 171.552 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -86.55 -25.78 24.87 Favored 'General case' 0 N--CA 1.431 -1.412 0 C-N-CA 127.229 2.212 . . . . 20.52 112.964 -179.909 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -73.54 118.0 15.98 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 118.674 -2.516 . . . . 7.1299999999999999 112.228 178.328 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.475 ' HD3' HD11 ' A' ' 44' ' ' ILE . 26.3 ttm180 -110.15 118.39 36.26 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 120.411 1.46 . . . . 36.390000000000001 111.45 166.418 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.3 mt -98.9 124.52 43.88 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.097 -2.186 . . . . 9.5500000000000007 105.097 178.719 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.475 HD11 ' HD3' ' A' ' 42' ' ' ARG . 51.4 mm -105.21 120.06 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 C-N-CA 126.621 1.969 . . . . 13.9 110.9 173.126 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -110.73 111.32 22.42 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 125.37 2.51 . . . . 6.8600000000000003 105.277 167.853 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.342 . . 55.37 -93.61 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.17 2.188 . . . . 11.15 116.189 -167.763 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.81 -23.5 6.47 Favored Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 116.33 1.292 . . . . 13.93 116.33 -177.294 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -104.44 167.8 9.51 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 111.938 -2.131 . . . . 23.920000000000002 114.393 -172.832 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -92.42 148.98 21.68 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.536 -2.12 . . . . 23.23 108.851 176.691 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.1 mt -102.5 121.5 42.48 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.942 -2.349 . . . . 9.1099999999999994 111.517 177.317 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.276 35.2 mt-10 -103.56 139.99 38.13 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 120.189 -1.569 . . . . 33.439999999999998 114.494 -166.498 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -29.37 -67.43 0.08 Allowed 'General case' 0 N--CA 1.43 -1.453 1 N-CA-C 122.068 4.099 . . . . 28.370000000000001 122.068 -161.466 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.97 24.99 28.88 Favored Glycine 0 N--CA 1.43 -1.748 0 O-C-N 119.7 -1.875 . . . . 15.0 115.814 -175.658 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.7 mtp180 -99.58 146.73 26.11 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 128.586 3.168 . . . . 25.5 109.966 166.23 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.3 p -85.95 167.26 15.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 125.857 1.663 . . . . 11.949999999999999 110.24 -162.46 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.19 -12.33 59.2 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 107.039 -1.467 . . . . 10.17 107.039 176.729 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -68.47 -50.91 48.95 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 125.146 1.378 . . . . 13.59 111.037 175.991 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -56.48 -49.35 74.91 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.848 3.259 . . . . 11.699999999999999 108.738 176.287 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -71.18 -20.15 62.32 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 115.16 1.541 . . . . 12.949999999999999 115.16 -178.851 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.346 32.5 t30 51.05 68.63 0.76 Allowed 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.308 -2.12 . . . . 25.449999999999999 109.891 -172.335 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.68 138.2 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 100.929 -3.73 . . . . 14.6 100.929 167.215 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -123.77 -173.29 2.71 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 119.621 -1.925 . . . . 33.229999999999997 111.014 -176.455 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -75.35 146.65 40.73 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 119.045 -2.284 . . . . 25.969999999999999 109.128 -177.369 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 65.12 22.79 12.33 Favored 'General case' 0 N--CA 1.429 -1.487 0 C-N-CA 128.118 2.567 . . . . 32.609999999999999 112.408 166.901 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.9 t -101.09 159.78 14.94 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-O 124.985 2.326 . . . . 10.56 112.031 -175.56 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.8 m -111.36 109.34 19.28 Favored 'General case' 0 N--CA 1.43 -1.437 1 O-C-N 115.261 -4.649 . . . . 5.3300000000000001 111.168 -166.088 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.0 mt -84.86 146.86 27.09 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 120.177 -1.577 . . . . 11.66 110.445 162.565 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 14.7 m170 -106.9 125.69 51.33 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.068 -3.52 . . . . 16.300000000000001 107.433 179.841 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.763 HD23 HG22 ' A' ' 7' ' ' THR 0.256 47.3 tp -103.93 111.43 23.96 Favored 'General case' 0 N--CA 1.43 -1.432 0 CA-C-N 123.83 3.014 . . . . 9.9600000000000009 102.927 -172.832 . . . . . . . . 3 3 . 1 . 116 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.3 t -107.34 152.46 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 104.849 -2.278 . . . . 9.7599999999999998 104.849 -176.526 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.2 mp -93.4 136.53 33.58 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 104.8 -2.296 . . . . 19.57 104.8 165.809 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -95.03 133.11 39.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 120.363 -1.46 . . . . 35.079999999999998 110.255 163.707 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' A' ' 74' ' ' ARG . 5.0 tp -104.49 -164.07 1.02 Allowed 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 107.14 -1.429 . . . . 32.310000000000002 107.14 176.173 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.431 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 40.4 mmt180 -68.04 150.55 48.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 119.327 -2.108 . . . . 42.75 115.448 178.251 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.23 -71.48 0.3 Allowed Glycine 0 N--CA 1.43 -1.728 0 O-C-N 120.243 -1.536 . . . . 36.310000000000002 116.161 176.287 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.455 ' C ' HH22 ' A' ' 42' ' ' ARG . . . . . . . . 0 C--O 1.26 1.78 0 N-CA-C 105.68 -2.968 . . . . 36.270000000000003 105.68 -173.73 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptt? . . . . . 0 CA--C 1.49 -1.362 0 CA-C-O 125.934 2.778 . . . . 17.170000000000002 114.697 . . . . . . . . . 0 0 . 1 . 117 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -67.51 119.11 11.77 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 121.361 3.837 . . . . 21.890000000000001 121.361 168.191 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.417 29.7 pt -111.31 130.08 65.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 N-CA-C 103.652 -2.721 . . . . 10.83 103.652 169.693 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -91.05 121.66 33.05 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.794 0.807 . . . . 10.609999999999999 111.986 171.92 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -116.75 106.61 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 1 O-C-N 114.882 -4.887 . . . . 9.1300000000000008 108.871 176.27 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 12' ' ' THR . 76.4 tttt -84.94 112.44 20.58 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 118.27 2.692 . . . . 20.550000000000001 118.27 169.753 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 m -76.84 134.88 38.91 Favored 'General case' 0 N--CA 1.43 -1.469 0 O-C-N 117.034 -3.541 . . . . 11.779999999999999 107.398 163.971 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.1 mt -72.93 -48.79 33.94 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 117.807 -3.058 . . . . 19.309999999999999 112.179 -175.23 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 m -93.48 98.26 11.08 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.186 -2.821 . . . . 23.140000000000001 107.546 161.879 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 149.57 -126.19 2.16 Favored Glycine 0 N--CA 1.43 -1.763 0 N-CA-C 106.268 -2.733 . . . . 19.739999999999998 106.268 -175.973 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.0 pttm -156.77 170.44 22.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.793 -2.592 . . . . 21.93 109.879 173.641 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 41.6 m -79.97 104.61 10.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.024 2.345 . . . . 12.33 114.662 167.233 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 41.8 pt -90.42 165.6 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 CA-C-O 124.321 2.01 . . . . 17.079999999999998 108.379 171.077 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 13.1 m -118.65 125.28 49.38 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 129.287 3.035 . . . . 16.300000000000001 107.431 179.064 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.6 mt -116.24 127.26 54.6 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-O 124.135 1.921 . . . . 15.880000000000001 107.658 -178.779 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -89.57 95.05 10.1 Favored 'General case' 0 N--CA 1.43 -1.439 1 O-C-N 115.256 -4.653 . . . . 28.899999999999999 116.628 175.267 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.0 m -105.89 160.68 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 O-C-N 119.541 -1.974 . . . . 12.050000000000001 110.253 -171.575 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -97.82 147.41 33.0 Favored Pre-proline 0 N--CA 1.43 -1.448 0 O-C-N 118.968 -2.332 . . . . 18.170000000000002 108.526 163.176 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.3 -13.21 31.14 Favored 'Trans proline' 0 N--CA 1.433 -2.033 0 N-CA-C 120.779 3.338 . . . . 8.1600000000000001 120.779 -175.437 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 m -99.91 -7.95 24.62 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 120.369 -1.457 . . . . 11.130000000000001 113.752 -168.526 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -80.58 172.63 13.51 Favored 'General case' 0 N--CA 1.429 -1.481 0 O-C-N 118.79 -2.444 . . . . 18.030000000000001 111.492 178.964 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -92.14 161.83 14.58 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 115.322 1.601 . . . . 10.220000000000001 115.322 178.07 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.0 mm -65.63 -30.13 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 C-N-CA 129.891 3.276 . . . . 12.300000000000001 111.482 -172.654 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -70.23 -22.7 62.87 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 125.97 1.708 . . . . 36.509999999999998 113.318 176.481 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -82.64 -18.48 40.95 Favored 'General case' 0 N--CA 1.431 -1.407 0 C-N-CA 127.65 2.38 . . . . 25.66 110.902 170.744 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.46 -43.42 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 121.034 1.743 . . . . 8.1199999999999992 107.709 176.966 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.5 mtpt -54.86 -24.55 23.68 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 121.486 3.884 . . . . 15.470000000000001 121.486 173.441 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.271 . . -70.87 -29.44 65.54 Favored 'General case' 0 N--CA 1.431 -1.411 0 C-N-CA 128.659 2.783 . . . . 11.449999999999999 114.04 177.738 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -85.94 -35.12 20.67 Favored 'General case' 0 N--CA 1.429 -1.487 0 O-C-N 117.968 -2.957 . . . . 24.98 107.132 -177.192 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.4 mt -54.29 -52.23 40.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 C-N-CA 129.399 3.08 . . . . 9.4600000000000009 113.138 168.397 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -53.18 -49.29 66.99 Favored 'General case' 0 N--CA 1.43 -1.428 0 C-N-CA 131.13 3.772 . . . . 14.76 118.307 167.355 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -53.8 -57.95 9.03 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 121.85 2.114 . . . . 26.289999999999999 111.142 164.25 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -77.73 -54.9 5.82 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.957 -2.339 . . . . 30.059999999999999 116.291 -162.071 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -92.15 -35.9 13.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 O-C-N 120.19 -1.569 . . . . 25.190000000000001 112.82 178.782 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.53 69.86 1.15 Allowed Glycine 0 N--CA 1.43 -1.747 0 N-CA-C 109.524 -1.43 . . . . 7.4100000000000001 109.524 -178.118 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.5 mt -138.12 123.41 12.36 Favored Pre-proline 0 N--CA 1.429 -1.476 0 N-CA-C 102.352 -3.203 . . . . 9.4900000000000002 102.352 171.481 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -72.43 164.11 36.61 Favored 'Trans proline' 0 N--CA 1.434 -2.021 0 C-N-CA 124.504 3.47 . . . . 11.42 111.807 179.366 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -84.14 -1.34 9.82 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 C-N-CA 123.042 2.495 . . . . 12.0 114.583 -163.319 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -93.94 -19.99 20.42 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.004 2.522 . . . . 35.549999999999997 109.732 173.757 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -84.62 -33.79 23.24 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-O 126.479 3.038 . . . . 20.52 112.727 175.833 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -70.36 143.44 51.94 Favored 'General case' 0 N--CA 1.431 -1.397 0 CA-C-O 126.366 2.984 . . . . 7.1299999999999999 117.815 177.983 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.1 ttm180 -154.13 123.88 6.7 Favored 'General case' 0 N--CA 1.43 -1.449 1 O-C-N 114.111 -5.368 . . . . 36.390000000000001 100.41 179.813 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.7 mt -102.87 126.84 50.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.6 3.16 . . . . 9.5500000000000007 107.428 -172.827 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.9 mm -118.41 132.98 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 106.451 -1.685 . . . . 13.9 106.451 -174.362 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -106.11 93.81 4.83 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 105.222 -2.14 . . . . 6.8600000000000003 105.222 178.151 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 59.98 -85.42 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 127.535 2.334 . . . . 11.15 114.812 -171.813 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -126.14 -1.44 7.35 Favored Glycine 0 N--CA 1.43 -1.725 0 O-C-N 118.093 -2.88 . . . . 13.93 112.336 -179.578 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -90.65 147.8 23.05 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 115.807 -2.044 . . . . 23.920000000000002 116.075 170.547 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -98.94 138.74 35.62 Favored 'General case' 0 N--CA 1.43 -1.462 1 CA-C-O 129.351 4.405 . . . . 23.23 105.214 171.094 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.4 mt -88.62 151.96 22.13 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 116.434 -3.916 . . . . 9.1099999999999994 114.133 171.197 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -116.14 157.49 24.7 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 124.943 1.402 . . . . 33.439999999999998 110.806 178.098 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -63.51 -50.71 68.55 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 118.504 2.779 . . . . 28.370000000000001 118.504 -163.027 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -81.99 -2.05 90.46 Favored Glycine 0 N--CA 1.43 -1.721 0 N-CA-C 118.402 2.121 . . . . 15.0 118.402 -161.127 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.418 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 65.5 mtp180 -101.8 158.85 15.82 Favored 'General case' 0 N--CA 1.431 -1.425 0 CA-C-O 124.521 2.105 . . . . 25.5 107.617 -169.979 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.301 45.0 p -83.74 159.1 21.54 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 118.3 -2.75 . . . . 11.949999999999999 111.029 -169.766 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.4 mt -53.75 -43.97 69.57 Favored 'General case' 0 N--CA 1.43 -1.473 2 CA-C-O 129.674 4.559 . . . . 10.17 119.353 169.014 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.4 p -51.64 -42.87 62.36 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.603 -3.185 . . . . 13.59 117.543 166.684 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.0 t0 -56.7 -50.14 73.05 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.598 -3.189 . . . . 11.699999999999999 116.682 -179.942 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 47.9 m-85 -65.43 -29.1 69.75 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 111.832 -2.44 . . . . 12.949999999999999 117.077 169.604 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.1 m120 83.49 55.5 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 129.041 3.963 . . . . 25.449999999999999 112.125 174.722 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.334 72.7 mt -84.92 149.17 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 0 O-C-N 119.529 -1.982 . . . . 14.6 107.941 177.507 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -147.99 -162.44 1.55 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 117.702 -3.124 . . . . 33.229999999999997 108.022 -173.172 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.8 ptmt -76.42 132.79 39.88 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 120.734 -1.229 . . . . 25.969999999999999 108.024 -170.268 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 74.42 10.26 4.25 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 131.346 3.858 . . . . 32.609999999999999 110.84 167.095 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.4 m -58.97 141.04 54.89 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 119.631 1.105 . . . . 10.56 112.799 170.139 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 54.0 m -112.3 102.52 10.67 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 103.72 -2.696 . . . . 5.3300000000000001 103.72 -168.345 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -91.17 148.86 22.07 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 130.845 3.658 . . . . 11.66 105.004 179.223 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -115.54 127.9 55.59 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 120.377 -1.452 . . . . 16.300000000000001 109.06 176.897 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.2 tp -95.27 116.05 28.24 Favored 'General case' 0 N--CA 1.43 -1.429 0 CA-C-O 125.336 2.493 . . . . 9.9600000000000009 107.213 -178.706 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.71 141.36 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 100.295 -3.965 . . . . 9.7599999999999998 100.295 -171.505 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 62.8 mt -87.64 119.29 27.8 Favored 'General case' 0 N--CA 1.429 -1.477 0 O-C-N 118.892 -2.38 . . . . 19.57 113.906 174.962 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -105.57 141.54 36.86 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 117.512 -3.242 . . . . 35.079999999999998 112.4 -176.692 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.8 tp -96.17 -122.27 0.12 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 114.934 -2.46 . . . . 32.310000000000002 106.954 173.621 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.4 mmt180 -136.24 152.69 51.01 Favored 'General case' 0 N--CA 1.43 -1.457 1 CA-C-N 126.007 4.003 . . . . 42.75 103.868 178.535 . . . . . . . . 2 2 . 1 . 117 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.55 -55.07 4.16 Favored Glycine 0 N--CA 1.43 -1.749 0 CA-C-N 113.822 -1.535 . . . . 36.310000000000002 110.643 -177.688 . . . . . . . . 1 1 . 1 . 117 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.781 0 O-C-N 118.496 -2.767 . . . . 36.270000000000003 109.237 -175.61 . . . . . . . . 0 0 . 1 . 118 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.8 ptt? . . . . . 0 CA--C 1.49 -1.343 0 N-CA-C 108.375 -0.972 . . . . 17.170000000000002 108.375 . . . . . . . . . 0 0 . 1 . 118 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -83.03 115.2 21.75 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.788 2.435 . . . . 21.890000000000001 110.424 -173.081 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pp -120.27 155.71 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 104.152 -2.536 . . . . 10.83 104.152 175.959 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -100.85 134.55 43.67 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 117.312 -3.367 . . . . 10.609999999999999 106.607 -176.338 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.4 t -113.88 117.69 56.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 O-C-N 121.111 -0.993 . . . . 9.1300000000000008 108.971 160.87 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -98.66 117.22 32.63 Favored 'General case' 0 N--CA 1.431 -1.406 0 C-N-CA 123.748 0.819 . . . . 20.550000000000001 111.694 -178.093 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.3 m -79.02 127.7 32.33 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 119.23 -2.169 . . . . 11.779999999999999 113.135 161.098 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.61 -59.79 2.57 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 105.207 -2.145 . . . . 19.309999999999999 105.207 -174.968 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.259 8.2 m -87.54 71.43 9.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 112.888 0.699 . . . . 23.140000000000001 112.888 168.346 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 175.11 -128.48 1.42 Allowed Glycine 0 N--CA 1.43 -1.71 0 N-CA-C 109.627 -1.389 . . . . 19.739999999999998 109.627 -175.342 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.424 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU 0.258 20.6 pttm -132.45 179.45 6.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 131.107 3.763 . . . . 21.93 117.157 173.465 . . . . . . . . 3 3 . 1 . 118 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 m -105.52 119.16 38.4 Favored 'General case' 0 N--CA 1.43 -1.452 1 O-C-N 116.167 -4.083 . . . . 12.33 108.709 178.098 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 21.1 pt -104.02 143.02 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 O-C-N 117.314 -3.366 . . . . 17.079999999999998 110.462 173.847 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.0 m -96.9 134.33 40.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.626 2.632 . . . . 16.300000000000001 107.129 170.811 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.7 mt -121.86 140.89 51.84 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.197 -2.274 . . . . 15.880000000000001 111.118 175.474 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -103.95 90.39 3.6 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 126.155 2.883 . . . . 28.899999999999999 111.968 177.596 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.56 176.57 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 1 C-N-CA 132.07 4.148 . . . . 12.050000000000001 111.504 -170.204 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.259 37.5 tt0 -134.34 144.06 49.54 Favored Pre-proline 0 N--CA 1.43 -1.426 0 CA-C-O 117.703 -1.142 . . . . 18.170000000000002 112.862 167.551 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.416 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 88.9 Cg_endo -65.69 -16.92 55.37 Favored 'Trans proline' 0 C--N 1.3 -2.025 1 C-N-CA 126.876 5.051 . . . . 8.1600000000000001 115.184 -169.912 . . . . . . . . 3 3 . 1 . 118 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -66.83 -20.92 66.03 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 131.112 3.765 . . . . 11.130000000000001 117.245 166.165 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -73.04 159.65 33.29 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 124.141 1.924 . . . . 18.030000000000001 113.029 179.878 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.6 p -86.9 154.16 21.06 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.552 1.541 . . . . 10.220000000000001 109.225 166.062 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 mm -56.58 -51.15 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 125.016 1.448 . . . . 12.300000000000001 108.597 167.334 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.279 37.8 tp10 -37.25 -35.54 0.11 Allowed 'General case' 0 N--CA 1.43 -1.436 1 N-CA-C 123.37 4.582 . . . . 36.509999999999998 123.37 166.823 . . . . . . . . 3 2 . 1 . 118 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -74.84 -33.72 62.18 Favored 'General case' 0 N--CA 1.431 -1.411 1 O-C-N 111.733 -6.854 . . . . 25.66 118.535 167.756 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.3 t -67.86 -45.22 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 128.36 2.664 . . . . 8.1199999999999992 106.623 175.678 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt -55.47 -40.99 72.34 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 126.898 3.237 . . . . 15.470000000000001 111.107 176.358 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.33 -17.39 60.84 Favored 'General case' 0 N--CA 1.43 -1.436 1 O-C-N 111.586 -6.946 . . . . 11.449999999999999 120.652 176.49 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -75.36 -34.54 61.17 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 118.098 -2.876 . . . . 24.98 112.708 173.198 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 21.3 mt -63.82 -43.23 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 O-C-N 119.601 -1.937 . . . . 9.4600000000000009 113.736 173.004 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -50.93 -51.05 56.03 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.805 2.566 . . . . 14.76 116.527 167.399 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -70.63 -42.7 70.56 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 126.619 1.967 . . . . 26.289999999999999 112.513 -169.281 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.7 tttp -76.32 -47.44 23.56 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.386 -1.768 . . . . 30.059999999999999 114.717 -178.682 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.424 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS . 59.3 mm-40 -102.78 -53.64 2.81 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 116.12 -1.895 . . . . 25.190000000000001 107.913 -169.267 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 147.91 -31.69 1.33 Allowed Glycine 0 N--CA 1.43 -1.757 0 CA-C-N 122.549 2.431 . . . . 7.4100000000000001 112.08 -175.962 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.265 19.8 mt -61.32 115.9 16.96 Favored Pre-proline 0 N--CA 1.431 -1.403 1 O-C-N 131.579 4.929 . . . . 9.4900000000000002 117.089 -164.287 . . . . . . . . 3 2 . 1 . 118 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.471 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 38.0 Cg_endo -82.16 148.89 15.19 Favored 'Trans proline' 0 N--CA 1.434 -2.009 1 CA-C-N 129.263 4.344 . . . . 11.42 108.448 -169.825 . . . . . . . . 3 3 . 1 . 118 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 32.3 Cg_exo -61.5 -12.61 25.17 Favored 'Trans proline' 0 C--N 1.3 -2.014 0 C-N-CA 124.652 3.568 . . . . 12.0 119.642 -170.094 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -79.84 -33.51 40.14 Favored 'General case' 0 N--CA 1.43 -1.459 1 CA-C-O 131.789 5.566 . . . . 35.549999999999997 110.778 179.123 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -76.94 -20.41 56.19 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 110.019 -3.264 . . . . 20.52 112.671 -176.92 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -76.34 149.34 37.02 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.53 2.586 . . . . 7.1299999999999999 108.268 -178.795 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -145.29 95.89 2.75 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.739 -2.476 . . . . 36.390000000000001 111.741 161.549 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.2 mt -84.37 121.41 27.5 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.035 -0.984 . . . . 9.5500000000000007 113.296 -175.753 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 36.1 mm -107.2 136.47 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 CA-C-O 122.886 1.327 . . . . 13.9 110.239 171.284 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB2' HD11 ' A' ' 50' ' ' LEU . 33.1 t80 -116.3 114.84 24.9 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 105.562 -2.014 . . . . 6.8600000000000003 105.562 167.674 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.82 -112.28 0.5 Allowed 'General case' 0 N--CA 1.43 -1.435 0 C-N-CA 124.855 1.262 . . . . 11.15 113.431 -164.405 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -104.5 -4.49 43.3 Favored Glycine 0 N--CA 1.431 -1.698 0 O-C-N 126.211 2.195 . . . . 13.93 112.992 -174.398 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.8 mtmt -93.89 121.64 35.56 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 128.076 2.551 . . . . 23.920000000000002 105.544 -175.912 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -83.81 102.45 12.34 Favored 'General case' 0 N--CA 1.43 -1.426 0 C-N-CA 126.67 1.988 . . . . 23.23 107.335 169.238 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.501 HD11 ' HB2' ' A' ' 45' ' ' PHE . 23.8 mt -51.81 132.57 31.67 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 119.104 3.002 . . . . 9.1099999999999994 119.104 -173.511 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -109.23 139.89 43.56 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.618 2.628 . . . . 33.439999999999998 111.325 179.943 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -64.24 -43.23 95.55 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 109.893 -3.321 . . . . 28.370000000000001 116.065 -148.322 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -82.52 -6.15 88.86 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 127.652 2.549 . . . . 15.0 110.752 -171.787 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -86.9 158.45 19.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 126.405 3.002 . . . . 25.5 109.78 -177.464 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 48.9 p -89.81 158.65 17.39 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 117.627 -3.171 . . . . 11.949999999999999 110.45 179.658 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.416 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 30.5 mt -59.16 -45.0 92.13 Favored 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 113.797 -1.547 . . . . 10.17 113.951 175.056 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.377 71.5 p -43.57 -43.55 5.68 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 128.348 2.659 . . . . 13.59 114.509 165.7 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -63.25 -40.91 98.75 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 123.53 1.633 . . . . 11.699999999999999 115.198 179.829 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.406 ' HB3' HG13 ' A' ' 61' ' ' ILE . 6.4 m-85 -82.58 -18.79 40.08 Favored 'General case' 0 N--CA 1.429 -1.483 0 C-N-CA 126.842 2.057 . . . . 12.949999999999999 110.564 -176.673 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.382 12.5 m120 80.8 32.41 0.15 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.145 2.178 . . . . 25.449999999999999 111.513 -179.09 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.406 HG13 ' HB3' ' A' ' 59' ' ' TYR . 66.4 mt -91.57 106.18 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 C-N-CA 128.072 2.549 . . . . 14.6 109.165 179.177 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -103.18 -173.58 2.35 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 129.744 3.217 . . . . 33.229999999999997 110.755 -169.354 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.5 pttp -68.22 158.33 33.52 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 123.072 2.669 . . . . 25.969999999999999 114.248 178.022 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.262 41.1 mt-10 72.75 5.02 5.14 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 126.438 1.895 . . . . 32.609999999999999 108.528 169.004 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -70.01 149.69 47.43 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 119.659 -1.901 . . . . 10.56 115.854 169.507 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.6 m -120.08 121.7 39.44 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.124 2.392 . . . . 5.3300000000000001 105.265 -168.942 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -96.54 128.04 43.1 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.297 -4.627 . . . . 11.66 109.052 172.978 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.326 35.1 m80 -97.7 132.78 43.02 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 122.644 2.474 . . . . 16.300000000000001 113.699 175.465 . . . . . . . . 2 2 . 1 . 118 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 tt -108.45 112.63 25.13 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 123.21 1.481 . . . . 9.9600000000000009 109.482 -169.558 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.1 t -92.45 129.28 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 116.401 -1.762 . . . . 9.7599999999999998 110.491 164.46 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.7 mt -89.56 121.8 32.11 Favored 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.527 2.331 . . . . 19.57 106.821 177.063 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -113.61 168.76 9.49 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 119.151 3.019 . . . . 35.079999999999998 119.151 -172.462 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.8 mt -105.73 -174.25 2.49 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 116.439 -1.743 . . . . 32.310000000000002 106.373 174.825 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.6 mtt180 -92.8 171.56 8.9 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.746 2.212 . . . . 42.75 116.621 177.693 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.11 28.4 1.85 Allowed Glycine 0 N--CA 1.429 -1.79 0 CA-C-N 112.692 -2.049 . . . . 36.310000000000002 113.757 -178.61 . . . . . . . . 1 1 . 1 . 118 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.741 0 C-N-CA 114.214 -3.851 . . . . 36.270000000000003 112.941 174.804 . . . . . . . . 0 0 . 1 . 119 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ptt? . . . . . 0 CA--C 1.49 -1.349 0 N-CA-C 114.839 1.422 . . . . 17.170000000000002 114.839 . . . . . . . . . 0 0 . 1 . 119 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -76.53 135.32 39.29 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 116.588 -3.82 . . . . 21.890000000000001 112.833 168.352 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.443 HD12 HD13 ' A' ' 67' ' ' LEU . 17.2 pt -127.63 160.0 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 CA-C-O 126.43 3.014 . . . . 10.83 106.397 159.956 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -103.07 148.48 25.67 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 109.355 -3.566 . . . . 10.609999999999999 112.67 -178.473 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.9 t -125.03 119.58 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 0 CA-C-N 121.086 1.766 . . . . 9.1300000000000008 108.616 167.465 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -95.43 85.67 4.28 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 125.261 1.601 . . . . 20.550000000000001 114.819 -176.977 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.5 m -83.32 141.47 31.78 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.45 -0.945 . . . . 11.779999999999999 108.45 171.962 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.1 mt -86.2 -54.1 4.66 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.965 1.306 . . . . 19.309999999999999 112.56 179.706 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -89.43 63.77 6.51 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 124.746 2.213 . . . . 23.140000000000001 107.054 -176.385 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 162.74 -135.15 3.71 Favored Glycine 0 N--CA 1.429 -1.77 1 CA-C-N 107.994 -4.184 . . . . 19.739999999999998 103.774 -174.035 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -143.45 174.2 10.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 117.363 2.357 . . . . 21.93 117.363 -178.148 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.7 m -92.31 117.65 30.11 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 117.952 2.575 . . . . 12.33 117.952 176.884 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.7 pt -102.95 156.32 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 C-N-CA 128.824 2.85 . . . . 17.079999999999998 116.809 -172.536 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.7 m -127.72 104.02 7.62 Favored 'General case' 0 N--CA 1.431 -1.413 0 O-C-N 120.939 -1.101 . . . . 16.300000000000001 110.89 -168.746 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.1 mt -104.02 138.11 41.02 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 126.241 1.817 . . . . 15.880000000000001 111.962 -165.645 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -108.0 86.99 2.39 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 128.122 3.82 . . . . 28.899999999999999 110.804 -170.247 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 m -101.73 172.98 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.476 0 CA-C-N 111.971 -2.377 . . . . 12.050000000000001 114.437 -175.71 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.86 146.87 63.12 Favored Pre-proline 0 N--CA 1.431 -1.416 0 O-C-N 125.56 1.788 . . . . 18.170000000000002 108.452 171.339 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -80.3 -4.56 13.17 Favored 'Trans proline' 0 N--CA 1.434 -2.022 0 CA-C-O 115.955 -1.769 . . . . 8.1600000000000001 116.406 -150.097 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.0 m -90.91 6.22 45.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 121.732 2.06 . . . . 11.130000000000001 111.172 172.598 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -88.91 154.68 20.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 118.5 2.778 . . . . 18.030000000000001 118.5 -176.252 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.0 p -91.45 163.05 14.31 Favored 'General case' 0 N--CA 1.43 -1.448 0 O-C-N 118.062 -2.899 . . . . 10.220000000000001 111.669 -164.338 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.5 mm -64.51 -34.89 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-O 117.342 -1.313 . . . . 12.300000000000001 108.315 -178.188 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -51.0 -49.32 60.62 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 114.294 1.22 . . . . 36.509999999999998 114.294 169.646 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -71.08 -25.07 62.46 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 118.915 2.931 . . . . 25.66 118.915 176.393 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.509 HG21 HD21 ' A' ' 56' ' ' LEU . 86.7 t -62.99 -44.79 99.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 116.249 -1.834 . . . . 8.1199999999999992 109.098 167.637 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 mtpt -52.35 -48.97 65.22 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.823 3.638 . . . . 15.470000000000001 120.823 171.504 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.17 -44.09 67.6 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 130.937 3.695 . . . . 11.449999999999999 114.975 170.594 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -62.98 -43.72 98.01 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 115.748 1.758 . . . . 24.98 115.748 170.455 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -60.6 -54.29 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 O-C-N 119.774 -1.829 . . . . 9.4600000000000009 112.931 174.505 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -41.7 -46.03 3.64 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 127.42 2.288 . . . . 14.76 113.045 172.573 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -76.03 -46.59 28.57 Favored 'General case' 0 N--CA 1.429 -1.475 0 C-N-CA 126.049 1.74 . . . . 26.289999999999999 111.586 -178.118 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -68.2 -62.43 1.4 Allowed 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 120.321 -1.487 . . . . 30.059999999999999 113.852 -172.65 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -92.53 -49.57 6.05 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 108.573 -0.899 . . . . 25.190000000000001 108.573 -173.642 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.85 28.24 2.32 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-O 122.568 1.093 . . . . 7.4100000000000001 112.672 177.825 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 mt -87.18 119.75 71.07 Favored Pre-proline 0 N--CA 1.431 -1.413 0 O-C-N 117.985 -3.068 . . . . 9.4900000000000002 104.075 -171.757 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -64.77 133.63 37.2 Favored 'Trans proline' 0 C--N 1.3 -2.009 0 N-CA-C 121.633 3.666 . . . . 11.42 121.633 -176.068 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 0.4 OUTLIER -78.9 -10.8 15.34 Favored 'Trans proline' 0 N--CA 1.433 -2.05 1 C-N-CA 128.698 6.266 . . . . 12.0 113.947 -159.039 . . . . . . . . 3 3 . 1 . 119 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -76.87 -36.07 57.0 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.01 1.732 . . . . 35.549999999999997 113.175 168.808 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.536 HE21 HD22 ' A' ' 71' ' ' LEU . 25.6 tt0 -74.55 -27.45 60.52 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 131.533 3.933 . . . . 20.52 112.63 -178.982 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 76.7 mt-30 -74.49 119.33 18.54 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.338 -2.101 . . . . 7.1299999999999999 110.466 172.968 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.325 40.5 ttm180 -114.65 108.8 17.29 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 128.048 2.539 . . . . 36.390000000000001 104.857 159.681 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.2 mt -80.19 130.55 35.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 120.321 3.452 . . . . 9.5500000000000007 120.321 166.876 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.9 mm -117.83 131.61 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 C-N-CA 127.018 2.127 . . . . 13.9 111.168 -174.538 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -128.17 123.63 34.81 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 116.639 -3.788 . . . . 6.8600000000000003 106.314 170.965 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.19 -99.65 0.1 Allowed 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.705 -1.588 . . . . 11.15 112.727 -163.198 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.17 22.3 2.76 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 104.359 -3.496 . . . . 13.93 104.359 -176.736 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -107.47 135.27 49.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 130.403 3.481 . . . . 23.920000000000002 101.952 -177.282 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -97.98 118.6 34.94 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.463 -2.648 . . . . 23.23 109.623 177.297 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.3 mt -88.67 135.81 33.31 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.215 -2.803 . . . . 9.1099999999999994 109.246 -160.719 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -80.11 159.08 26.22 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.124 2.569 . . . . 33.439999999999998 111.924 179.286 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -75.75 -47.7 24.85 Favored 'General case' 0 N--CA 1.431 -1.422 0 O-C-N 124.982 1.426 . . . . 28.370000000000001 111.973 -172.936 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.29 29.62 11.51 Favored Glycine 0 N--CA 1.429 -1.768 0 O-C-N 124.639 1.212 . . . . 15.0 113.046 -166.396 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.441 HH21 ' CG ' ' A' ' 58' ' ' ASP . 77.7 mtp180 -117.47 157.06 26.91 Favored 'General case' 0 N--CA 1.431 -1.41 0 C-N-CA 126.186 1.794 . . . . 25.5 108.818 177.727 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -96.2 162.38 13.55 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 118.096 2.628 . . . . 11.949999999999999 118.096 -169.705 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.509 HD21 HG21 ' A' ' 26' ' ' VAL . 42.6 mt -63.09 -33.4 75.36 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.919 -2.363 . . . . 10.17 113.75 170.367 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 p -66.61 -39.52 88.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.51 -3.869 . . . . 13.59 114.403 171.148 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.441 ' CG ' HH21 ' A' ' 54' ' ' ARG . 66.2 t0 -64.34 -54.53 31.55 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.246 2.618 . . . . 11.699999999999999 107.671 179.801 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -73.09 -15.32 61.49 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 115.313 -2.555 . . . . 12.949999999999999 108.887 -178.933 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.271 35.1 m120 85.91 37.07 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 127.255 3.407 . . . . 25.449999999999999 113.368 176.251 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.491 HG21 HD11 ' A' ' 67' ' ' LEU . 53.7 mt -95.78 79.85 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.478 1 O-C-N 116.243 -4.036 . . . . 14.6 110.413 -172.166 . . . . . . . . 3 3 . 1 . 119 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -59.33 174.17 0.43 Allowed 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 118.435 2.754 . . . . 33.229999999999997 118.435 172.719 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -62.57 141.02 58.65 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 115.111 1.522 . . . . 25.969999999999999 115.111 174.733 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.263 22.3 tt0 67.88 27.02 7.42 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 129.613 3.165 . . . . 32.609999999999999 114.672 -176.196 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 75.5 m -91.49 139.79 30.37 Favored 'General case' 0 N--CA 1.43 -1.455 0 O-C-N 116.899 -3.625 . . . . 10.56 112.014 174.634 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.2 m -113.78 118.94 35.68 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 118.309 -1.357 . . . . 5.3300000000000001 111.883 -172.099 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 61' ' ' ILE . 5.5 mp -97.35 141.48 30.38 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 103.87 -2.641 . . . . 11.66 103.87 -176.109 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -108.49 135.1 50.32 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 104.254 -2.499 . . . . 16.300000000000001 104.254 -176.36 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.91 108.52 20.08 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.64 -1.985 . . . . 9.9600000000000009 105.64 -172.013 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.9 t -76.95 130.43 36.28 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 O-C-N 125.3 1.625 . . . . 9.7599999999999998 113.985 162.633 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.536 HD22 HE21 ' A' ' 40' ' ' GLN . 93.7 mt -95.19 112.77 24.44 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-O 125.325 2.488 . . . . 19.57 105.137 174.652 . . . . . . . . 2 2 . 1 . 119 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -95.24 157.28 15.96 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 112.472 -2.149 . . . . 35.079999999999998 113.325 -156.024 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.4 mt -94.21 155.37 17.08 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 113.067 -1.879 . . . . 32.310000000000002 113.207 172.605 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.0 mtt-85 -83.26 -169.58 2.61 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 121.84 2.109 . . . . 42.75 110.419 -165.096 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.23 59.8 3.78 Favored Glycine 0 N--CA 1.429 -1.769 0 O-C-N 117.862 -3.024 . . . . 36.310000000000002 114.034 172.565 . . . . . . . . 1 1 . 1 . 119 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.787 0 CA-C-O 114.725 -3.264 . . . . 36.270000000000003 111.55 175.336 . . . . . . . . 0 0 . 1 . 120 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 ptt? . . . . . 0 CA--C 1.489 -1.367 0 CA-C-O 123.587 1.66 . . . . 17.170000000000002 110.316 . . . . . . . . . 0 0 . 1 . 120 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -96.83 140.33 31.55 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 119.413 -2.055 . . . . 21.890000000000001 106.872 -179.195 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 pt -136.79 157.05 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 C-N-CA 124.007 0.923 . . . . 10.83 108.793 177.467 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -112.61 133.94 54.39 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 103.55 -2.759 . . . . 10.609999999999999 103.55 -178.498 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.1 t -105.16 121.23 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.417 1 O-C-N 115.359 -4.588 . . . . 9.1300000000000008 106.859 165.713 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.4 tttp -105.66 115.9 31.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 126.084 2.115 . . . . 20.550000000000001 107.856 -167.569 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.335 0.2 OUTLIER -101.27 126.92 48.06 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 105.738 -1.949 . . . . 11.779999999999999 105.738 -168.471 . . . . . . . . 3 3 . 1 . 120 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mp -84.72 -49.65 8.3 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 120.157 -1.59 . . . . 19.309999999999999 107.468 -178.142 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.5 m -95.03 75.52 3.5 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 124.931 2.3 . . . . 23.140000000000001 112.71 172.556 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 163.47 -111.3 0.46 Allowed Glycine 0 N--CA 1.431 -1.695 0 O-C-N 119.394 -2.066 . . . . 19.739999999999998 110.329 -166.721 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 pttm -175.32 177.97 1.76 Allowed 'General case' 0 N--CA 1.43 -1.459 1 CA-C-N 124.497 4.148 . . . . 21.93 106.122 178.932 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.6 m -97.23 122.33 40.13 Favored 'General case' 0 N--CA 1.429 -1.48 0 O-C-N 119.402 -2.061 . . . . 12.33 106.67 -176.771 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.8 pt -106.63 148.66 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 CA-C-O 122.94 1.352 . . . . 17.079999999999998 108.329 -178.869 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.9 m -111.3 112.44 24.21 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 104.916 -2.253 . . . . 16.300000000000001 104.916 -175.357 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.9 mt -111.33 142.7 43.21 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 124.501 2.096 . . . . 15.880000000000001 112.478 179.924 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -97.78 117.39 31.98 Favored 'General case' 0 N--CA 1.429 -1.485 0 O-C-N 117.563 -3.211 . . . . 28.899999999999999 109.711 172.977 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 m -130.46 153.66 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.613 -3.179 . . . . 12.050000000000001 108.146 -171.797 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 61.1 tt0 -105.54 137.97 19.45 Favored Pre-proline 0 N--CA 1.43 -1.467 0 CA-C-O 112.491 -3.623 . . . . 18.170000000000002 107.281 173.428 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -75.25 -9.88 20.59 Favored 'Trans proline' 0 C--N 1.299 -2.03 0 CA-C-N 123.67 2.346 . . . . 8.1600000000000001 113.045 -158.588 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.8 m -84.1 -20.44 32.57 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 126.935 2.647 . . . . 11.130000000000001 113.947 -176.418 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -85.12 159.67 20.11 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 119.184 -2.198 . . . . 18.030000000000001 109.053 -169.284 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -78.86 163.58 25.19 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 118.18 -2.825 . . . . 10.220000000000001 109.935 -167.385 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.6 mm -64.46 -38.45 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 119.613 -1.929 . . . . 12.300000000000001 109.875 174.667 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -44.77 -36.57 3.27 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.017 2.927 . . . . 36.509999999999998 115.012 164.405 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -71.97 -44.56 63.36 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 125.971 1.708 . . . . 25.66 110.14 173.138 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.6 t -55.92 -43.24 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 C-N-CA 127.614 2.366 . . . . 8.1199999999999992 112.497 173.055 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -62.98 -26.22 68.74 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 117.561 -3.212 . . . . 15.470000000000001 113.902 173.085 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -76.02 -36.04 59.29 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.983 -2.323 . . . . 11.449999999999999 107.605 177.517 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -73.26 -36.67 66.41 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 120.209 -1.557 . . . . 24.98 114.097 -178.241 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.3 mt -65.55 -34.62 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 C-N-CA 125.713 1.605 . . . . 9.4600000000000009 113.569 168.237 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.417 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 58.9 tt0 -61.59 -52.22 65.32 Favored 'General case' 0 N--CA 1.429 -1.48 0 CA-C-O 123.227 1.489 . . . . 14.76 112.741 170.859 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.74 -46.67 88.42 Favored 'General case' 0 N--CA 1.43 -1.438 0 C-N-CA 127.367 2.267 . . . . 26.289999999999999 112.102 -179.652 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -65.58 -59.29 4.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 115.15 1.537 . . . . 30.059999999999999 115.15 178.309 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.378 65.9 mm-40 -87.98 -43.69 11.56 Favored 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 127.203 2.201 . . . . 25.190000000000001 111.84 -165.927 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.78 29.64 5.49 Favored Glycine 0 N--CA 1.429 -1.777 0 CA-C-O 117.562 -1.688 . . . . 7.4100000000000001 109.878 -174.775 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.2 mt -104.49 99.83 19.75 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 130.189 3.396 . . . . 9.4900000000000002 109.203 175.886 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -58.77 160.62 17.26 Favored 'Trans proline' 0 C--N 1.3 -2.025 0 O-C-N 115.628 -2.88 . . . . 11.42 115.628 173.406 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -102.15 12.1 0.39 Allowed 'Trans proline' 0 N--CA 1.434 -1.997 0 N-CA-C 121.517 3.622 . . . . 12.0 121.517 -163.811 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -83.11 -13.55 55.42 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 125.647 1.842 . . . . 35.549999999999997 114.669 151.044 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -90.86 -3.05 57.66 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 118.993 -2.317 . . . . 20.52 107.744 178.273 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -95.34 131.68 41.19 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.589 -2.569 . . . . 7.1299999999999999 113.179 -175.995 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.2 mtt180 -119.48 103.38 9.39 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 104.459 -2.422 . . . . 36.390000000000001 104.459 166.2 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.72 109.43 21.2 Favored 'General case' 0 N--CA 1.43 -1.428 0 O-C-N 117.915 -2.99 . . . . 9.5500000000000007 107.057 -165.764 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.8 mm -112.08 135.56 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.407 0 CA-C-O 123.714 1.721 . . . . 13.9 107.581 -159.011 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -124.11 115.3 20.92 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.197 -2.814 . . . . 6.8600000000000003 103.846 176.816 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.282 . . 63.2 -103.14 0.11 Allowed 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 126.414 1.886 . . . . 11.15 113.305 -169.17 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.69 40.84 1.54 Allowed Glycine 0 N--CA 1.429 -1.777 0 O-C-N 118.406 -2.684 . . . . 13.93 113.016 168.704 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -147.37 137.46 23.12 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 127.542 2.337 . . . . 23.920000000000002 106.153 -178.103 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -76.44 158.51 31.27 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 116.798 -3.689 . . . . 23.23 111.377 -171.498 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD11 HD23 ' A' ' 67' ' ' LEU . 5.4 mt -97.07 147.36 24.11 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 113.346 0.869 . . . . 9.1099999999999994 113.346 165.224 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -95.38 167.92 11.04 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 123.614 0.571 . . . . 33.439999999999998 111.72 177.421 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.09 -46.21 13.07 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 118.054 -2.904 . . . . 28.370000000000001 114.538 -163.284 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.23 27.57 13.06 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.121 -2.862 . . . . 15.0 112.291 -176.33 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -106.43 166.63 10.41 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 115.621 -2.133 . . . . 25.5 111.486 173.097 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -104.1 176.87 5.01 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 121.763 2.074 . . . . 11.949999999999999 111.575 -175.288 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mt -70.38 -40.52 73.91 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 125.412 2.529 . . . . 10.17 106.511 173.251 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.3 p -78.79 -8.11 58.46 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.065 -2.272 . . . . 13.59 111.245 -171.966 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -75.26 -51.17 13.91 Favored 'General case' 0 N--CA 1.431 -1.406 2 O-C-N 115.315 -4.616 . . . . 11.699999999999999 104.477 174.422 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -82.22 -10.26 59.2 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.792 -2.442 . . . . 12.949999999999999 113.574 179.435 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 71.51 58.96 0.17 Allowed 'General case' 0 N--CA 1.429 -1.476 0 C-N-CA 125.132 1.373 . . . . 25.449999999999999 109.962 -177.656 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.2 mt -80.71 111.44 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 C-N-CA 128.184 2.594 . . . . 14.6 110.567 159.925 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -97.53 175.04 6.36 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 112.397 -2.183 . . . . 33.229999999999997 110.17 174.401 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -58.79 143.07 48.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 129.702 3.201 . . . . 25.969999999999999 106.811 -178.679 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.317 3.2 mp0 60.96 20.2 10.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 116.829 2.159 . . . . 32.609999999999999 116.829 -178.871 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 m -72.37 147.23 46.46 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 117.242 2.312 . . . . 10.56 117.242 167.131 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 27.4 m -95.11 126.56 40.52 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 127.086 2.155 . . . . 5.3300000000000001 109.071 165.521 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.483 HD23 HD11 ' A' ' 50' ' ' LEU . 6.6 mp -100.59 152.26 20.63 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 105.141 -2.17 . . . . 11.66 105.141 164.623 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -105.78 128.43 53.71 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 114.08 -5.388 . . . . 16.300000000000001 108.675 179.164 . . . . . . . . 2 2 . 1 . 120 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 tp -97.05 131.66 43.62 Favored 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 116.074 -2.25 . . . . 9.9600000000000009 108.717 179.53 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 98.5 t -107.84 129.38 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 O-C-N 117.789 -3.069 . . . . 9.7599999999999998 107.67 172.288 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.6 mt -104.59 137.95 41.67 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 114.514 -1.221 . . . . 19.57 110.261 176.239 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.8 ptm180 -120.95 174.3 6.71 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 123.276 1.512 . . . . 35.079999999999998 115.03 -163.105 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.2 mt -69.0 128.97 38.58 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.015 3.326 . . . . 32.310000000000002 107.035 162.005 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.51 162.71 24.22 Favored 'General case' 0 N--CA 1.429 -1.484 0 N-CA-C 107.372 -1.344 . . . . 42.75 107.372 -162.11 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.03 119.4 0.64 Allowed Glycine 0 N--CA 1.43 -1.712 0 C-N-CA 129.114 3.245 . . . . 36.310000000000002 115.134 168.55 . . . . . . . . 1 1 . 1 . 120 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.765 0 N-CA-C 106.619 -2.592 . . . . 36.270000000000003 106.619 169.605 . . . . . . . . 0 0 . 1 . 121 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.349 0 CA-C-O 117.293 -1.336 . . . . 17.170000000000002 112.388 . . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -96.88 137.49 35.89 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 126.946 2.654 . . . . 21.890000000000001 111.169 176.956 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 pt -129.29 172.02 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 126.919 2.088 . . . . 10.83 112.711 176.952 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -123.66 115.7 21.87 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 103.614 -2.735 . . . . 10.609999999999999 103.614 -167.89 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -103.72 115.35 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 102.623 -3.103 . . . . 9.1300000000000008 102.623 170.445 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -86.67 131.21 34.21 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 117.235 -3.416 . . . . 20.550000000000001 112.183 167.397 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.0 p -87.18 162.39 17.52 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 124.746 1.279 . . . . 11.779999999999999 114.231 172.104 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 60.9 tp -69.13 -28.42 66.45 Favored 'General case' 0 N--CA 1.43 -1.46 0 C-N-CA 128.419 2.687 . . . . 19.309999999999999 111.599 -174.935 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.277 53.3 m -59.1 -47.54 84.89 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 114.818 -2.515 . . . . 23.140000000000001 114.961 167.39 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.44 49.06 0.1 OUTLIER Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 105.691 -2.964 . . . . 19.739999999999998 105.691 167.269 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.307 41.7 mttt -138.69 145.33 40.23 Favored 'General case' 0 N--CA 1.43 -1.435 1 O-C-N 114.621 -5.047 . . . . 21.93 104.266 178.592 . . . . . . . . 3 2 . 1 . 121 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -99.85 116.01 30.93 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-N 111.494 -2.594 . . . . 12.33 106.394 168.722 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 16.2 pt -106.27 133.28 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 105.15 -2.166 . . . . 17.079999999999998 105.15 176.337 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 m -93.78 117.81 30.59 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 126.869 2.605 . . . . 16.300000000000001 110.082 -177.127 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.274 95.8 mt -119.15 141.76 48.54 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 104.978 -2.23 . . . . 15.880000000000001 104.978 -177.296 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -104.38 111.48 24.13 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 129.318 3.047 . . . . 28.899999999999999 112.955 172.346 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.5 169.15 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 CA-C-O 124.719 2.199 . . . . 12.050000000000001 111.805 -178.132 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -92.13 154.88 43.25 Favored Pre-proline 0 N--CA 1.43 -1.446 0 O-C-N 117.283 -3.385 . . . . 18.170000000000002 107.163 167.308 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.01 -3.89 12.98 Favored 'Trans proline' 0 C--N 1.3 -1.99 1 CA-C-N 129.355 4.377 . . . . 8.1600000000000001 111.974 175.019 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 8.7 m -76.2 -22.19 55.56 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.311 -2.743 . . . . 11.130000000000001 114.325 169.614 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -67.76 151.25 47.52 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 124.618 2.152 . . . . 18.030000000000001 111.054 173.167 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.4 p -99.43 -170.93 1.98 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 125.469 2.557 . . . . 10.220000000000001 110.781 -173.86 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.7 mm -86.92 -17.43 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.456 1 O-C-N 115.975 -4.203 . . . . 12.300000000000001 108.662 -173.171 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -76.57 -26.56 55.22 Favored 'General case' 0 N--CA 1.429 -1.476 1 O-C-N 115.613 -4.429 . . . . 36.509999999999998 110.501 174.142 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -73.06 -33.89 65.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 119.334 -0.947 . . . . 25.66 108.719 176.455 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.353 65.6 t -65.53 -47.43 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.415 0 C-N-CA 124.622 1.169 . . . . 8.1199999999999992 113.695 178.034 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 67.9 mttt -55.36 -43.19 74.84 Favored 'General case' 0 N--CA 1.429 -1.479 0 C-N-CA 126.675 1.99 . . . . 15.470000000000001 113.869 171.944 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.16 -39.5 90.34 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 120.732 3.604 . . . . 11.449999999999999 120.732 168.193 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -70.26 -38.87 75.19 Favored 'General case' 0 N--CA 1.431 -1.41 0 O-C-N 119.589 -1.944 . . . . 24.98 111.701 174.968 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -66.66 -35.5 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 C-N-CA 127.277 2.231 . . . . 9.4600000000000009 108.999 177.429 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -64.75 -39.4 93.55 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.725 -3.109 . . . . 14.76 107.834 174.929 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -72.85 -60.19 2.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 126.179 2.895 . . . . 26.289999999999999 111.094 -173.866 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.4 ttmm -61.8 -49.72 75.21 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 120.677 3.584 . . . . 30.059999999999999 120.677 177.176 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -108.8 -18.29 13.73 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.208 -1.557 . . . . 25.190000000000001 111.9 -174.935 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.89 27.25 29.41 Favored Glycine 0 N--CA 1.429 -1.772 1 O-C-N 114.919 -4.863 . . . . 7.4100000000000001 113.657 170.972 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.5 mt -91.65 133.56 30.78 Favored Pre-proline 0 N--CA 1.43 -1.435 0 O-C-N 118.52 -2.753 . . . . 9.4900000000000002 111.439 175.499 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 12.9 Cg_exo -70.54 153.87 65.05 Favored 'Trans proline' 0 C--N 1.3 -2.004 0 O-C-N 115.784 -2.798 . . . . 11.42 117.741 -179.292 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 12.5 Cg_exo -75.31 -29.0 8.19 Favored 'Trans proline' 0 N--CA 1.434 -1.981 0 CA-C-N 122.863 2.058 . . . . 12.0 116.206 -166.477 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -75.99 -14.72 60.23 Favored 'General case' 0 N--CA 1.429 -1.479 0 O-C-N 118.178 -2.826 . . . . 35.549999999999997 107.992 -169.733 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -109.55 3.2 20.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 117.385 -3.322 . . . . 20.52 111.828 -172.15 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 -87.59 134.96 33.54 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 130.71 3.604 . . . . 7.1299999999999999 105.172 168.607 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -129.55 125.3 35.94 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 101.719 -3.438 . . . . 36.390000000000001 101.719 178.651 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.2 mt -126.1 132.91 51.79 Favored 'General case' 0 N--CA 1.43 -1.427 2 O-C-N 115.597 -4.439 . . . . 9.5500000000000007 99.45 -167.995 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.4 mm -119.31 134.75 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.475 0 CA-C-N 109.74 -3.391 . . . . 13.9 111.824 -178.042 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -128.77 124.02 34.4 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 117.077 -1.44 . . . . 6.8600000000000003 112.244 163.18 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.61 -101.64 0.11 Allowed 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 127.319 2.248 . . . . 11.15 106.773 -168.693 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.05 17.46 5.41 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 119.961 -1.712 . . . . 13.93 115.781 170.829 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -103.92 141.19 36.59 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 106.138 -1.801 . . . . 23.920000000000002 106.138 -172.906 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -83.18 124.29 30.38 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.605 2.362 . . . . 23.23 114.0 166.684 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.19 111.56 23.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 119.236 3.05 . . . . 9.1099999999999994 119.236 -174.647 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -62.83 140.17 58.77 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 120.519 3.526 . . . . 33.439999999999998 120.519 -178.714 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -49.24 -51.33 33.98 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 129.623 3.169 . . . . 28.370000000000001 118.289 -163.83 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -94.37 18.5 56.83 Favored Glycine 0 N--CA 1.43 -1.706 0 O-C-N 117.844 -3.035 . . . . 15.0 116.024 -178.154 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -97.62 148.02 23.72 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 122.83 3.315 . . . . 25.5 108.015 -177.196 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.4 p -78.56 151.15 32.59 Favored 'General case' 0 N--CA 1.43 -1.457 1 O-C-N 115.785 -4.322 . . . . 11.949999999999999 110.32 179.908 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 40.0 mt -65.62 -30.81 71.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.571 -2.581 . . . . 10.17 112.809 179.38 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 p -59.42 -44.37 92.88 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 130.321 3.448 . . . . 13.59 112.083 170.952 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.72 -40.99 89.87 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 117.304 -3.372 . . . . 11.699999999999999 117.378 172.841 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -77.37 -21.24 53.56 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 119.534 -1.979 . . . . 12.949999999999999 111.505 175.496 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.5 t30 56.71 53.15 8.66 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 129.929 3.292 . . . . 25.449999999999999 117.009 -175.043 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.1 mm -64.38 121.8 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 118.671 -2.518 . . . . 14.6 112.266 164.387 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -96.67 167.5 11.08 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 125.632 2.634 . . . . 33.229999999999997 111.451 179.221 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -72.28 145.52 47.82 Favored 'General case' 0 N--CA 1.431 -1.415 1 O-C-N 112.796 -6.19 . . . . 25.969999999999999 120.52 174.787 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 63.17 19.95 11.98 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 128.0 2.52 . . . . 32.609999999999999 115.688 -175.287 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.49 143.3 27.28 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 111.071 -2.786 . . . . 10.56 118.446 170.041 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.2 m -92.05 117.01 29.43 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 119.402 3.112 . . . . 5.3300000000000001 119.402 -179.756 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -93.83 143.51 26.27 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 120.554 1.524 . . . . 11.66 108.126 171.743 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.9 m170 -93.53 134.85 35.38 Favored 'General case' 0 N--CA 1.43 -1.439 0 O-C-N 118.841 -2.412 . . . . 16.300000000000001 109.858 167.785 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.0 tt -106.24 132.5 52.22 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 103.399 -2.815 . . . . 9.9600000000000009 103.399 166.357 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.0 m -120.34 174.18 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 129.731 3.212 . . . . 9.7599999999999998 106.044 160.351 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.1 mt -103.55 140.2 37.85 Favored 'General case' 0 N--CA 1.43 -1.467 1 O-C-N 114.245 -5.284 . . . . 19.57 111.881 -173.265 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -95.51 128.39 42.33 Favored 'General case' 0 N--CA 1.43 -1.446 1 O-C-N 114.629 -5.044 . . . . 35.079999999999998 106.343 177.02 . . . . . . . . 2 2 . 1 . 121 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 61.8 mt -96.42 152.66 18.4 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-O 125.806 2.717 . . . . 32.310000000000002 108.484 172.38 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.6 mtm180 -64.74 117.48 7.54 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 117.477 2.399 . . . . 42.75 117.477 170.298 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 143.75 -30.87 1.92 Allowed Glycine 0 N--CA 1.43 -1.754 0 C-N-CA 125.425 1.488 . . . . 36.310000000000002 114.118 -162.552 . . . . . . . . 1 1 . 1 . 121 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.786 0 O-C-N 120.352 -1.675 . . . . 36.270000000000003 111.992 179.145 . . . . . . . . 0 0 . 1 . 122 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 CA--C 1.489 -1.368 0 CA-C-O 121.471 0.653 . . . . 17.170000000000002 110.859 . . . . . . . . . 0 0 . 1 . 122 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -106.1 129.83 54.11 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.576 -1.647 . . . . 21.890000000000001 115.36 175.319 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.2 pt -123.46 169.39 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 118.621 -2.55 . . . . 10.83 105.475 170.784 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -123.68 140.81 52.62 Favored 'General case' 0 N--CA 1.429 -1.485 1 N-CA-C 99.994 -4.076 . . . . 10.609999999999999 99.994 -169.403 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.3 t -129.99 126.27 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 105.622 -1.992 . . . . 9.1300000000000008 105.622 175.227 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -102.35 125.82 49.17 Favored 'General case' 0 N--CA 1.43 -1.447 0 O-C-N 124.9 1.375 . . . . 20.550000000000001 108.232 177.816 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 p -89.63 -166.26 1.55 Allowed 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 118.521 -2.612 . . . . 11.779999999999999 112.656 -162.079 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.5 tp -73.44 -60.23 2.34 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.143 2.247 . . . . 19.309999999999999 112.449 -176.919 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.7 m -48.45 -49.6 34.72 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 110.218 -3.174 . . . . 23.140000000000001 110.08 174.332 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.36 64.15 0.16 Allowed Glycine 0 N--CA 1.43 -1.733 0 CA-C-O 117.893 -1.504 . . . . 19.739999999999998 113.187 176.842 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -123.23 137.11 54.95 Favored 'General case' 0 N--CA 1.43 -1.458 0 N-CA-C 106.739 -1.578 . . . . 21.93 106.739 176.691 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -100.38 103.88 15.29 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.969 2.168 . . . . 12.33 111.737 176.394 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.438 16.9 pt -93.1 147.24 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-O 124.204 1.954 . . . . 17.079999999999998 109.806 -176.314 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 64.8 m -101.0 123.03 44.56 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 119.134 -2.229 . . . . 16.300000000000001 106.115 175.846 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.9 mt -116.21 152.71 33.22 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 127.632 2.373 . . . . 15.880000000000001 111.582 176.261 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -111.76 114.03 26.76 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 112.189 -2.278 . . . . 28.899999999999999 108.278 177.145 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.62 173.77 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 CA-C-N 113.417 -1.719 . . . . 12.050000000000001 110.521 -178.867 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -123.07 142.16 37.57 Favored Pre-proline 0 N--CA 1.43 -1.431 0 N-CA-C 107.889 -1.152 . . . . 18.170000000000002 107.889 175.481 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -68.84 -9.12 25.35 Favored 'Trans proline' 0 C--N 1.3 -2.026 0 O-C-N 114.434 -3.508 . . . . 8.1600000000000001 116.228 -169.011 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.3 m -83.82 -19.86 34.23 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 121.649 2.022 . . . . 11.130000000000001 110.362 179.184 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -69.86 144.83 52.43 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 127.265 2.226 . . . . 18.030000000000001 112.392 172.871 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.301 27.1 p -82.75 172.04 13.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 117.597 -3.189 . . . . 10.220000000000001 115.768 -175.402 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.8 mm -61.17 -41.97 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 117.653 2.464 . . . . 12.300000000000001 117.653 173.657 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -31.57 -61.4 0.22 Allowed 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 117.586 -3.196 . . . . 36.509999999999998 118.486 152.578 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -50.94 -39.58 55.2 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 116.698 2.11 . . . . 25.66 116.698 171.287 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.0 t -68.57 -43.83 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 118.516 -2.615 . . . . 8.1199999999999992 113.471 178.016 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.18 -34.67 76.87 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 116.479 2.029 . . . . 15.470000000000001 116.479 168.473 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.31 -32.86 63.02 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 119.079 -2.263 . . . . 11.449999999999999 110.767 178.017 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.253 66.6 mttt -64.65 -29.52 70.52 Favored 'General case' 0 N--CA 1.43 -1.451 0 O-C-N 118.841 -2.412 . . . . 24.98 115.644 168.166 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.8 mt -67.97 -36.42 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 CA-C-N 120.647 1.567 . . . . 9.4600000000000009 113.248 170.348 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -61.15 -42.16 98.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 119.448 -2.032 . . . . 14.76 113.728 169.027 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -70.63 -53.06 17.34 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 124.082 1.896 . . . . 26.289999999999999 107.702 -174.802 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -56.8 -62.8 1.49 Allowed 'General case' 0 N--CA 1.43 -1.438 1 O-C-N 116.164 -4.085 . . . . 30.059999999999999 114.35 173.573 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -92.33 -41.88 10.12 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 119.236 3.05 . . . . 25.190000000000001 119.236 -173.669 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.58 46.65 2.1 Favored Glycine 0 N--CA 1.43 -1.741 0 CA-C-O 116.536 -2.258 . . . . 7.4100000000000001 112.706 -171.894 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.4 mt -109.99 116.37 53.73 Favored Pre-proline 0 N--CA 1.429 -1.479 0 C-N-CA 130.098 3.359 . . . . 9.4900000000000002 110.892 173.698 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.02 149.29 92.01 Favored 'Trans proline' 0 C--N 1.3 -1.995 0 CA-C-N 127.279 3.635 . . . . 11.42 115.223 -178.876 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -76.36 -24.81 10.41 Favored 'Trans proline' 0 N--CA 1.434 -2.008 0 CA-C-N 120.336 1.156 . . . . 12.0 114.475 -164.114 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -77.28 -22.42 52.07 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.336 1.454 . . . . 35.549999999999997 110.618 -169.562 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -97.33 3.78 51.03 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 121.771 2.078 . . . . 20.52 108.94 176.184 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -86.38 135.13 33.62 Favored 'General case' 0 N--CA 1.431 -1.414 0 O-C-N 117.949 -2.969 . . . . 7.1299999999999999 111.289 172.755 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 25.2 ttm105 -127.5 125.43 40.43 Favored 'General case' 0 N--CA 1.43 -1.47 0 O-C-N 119.622 -1.924 . . . . 36.390000000000001 110.51 153.51 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.3 mt -87.88 135.0 33.59 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 124.909 2.29 . . . . 9.5500000000000007 113.678 178.654 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.5 mm -120.31 146.92 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 N-CA-C 103.424 -2.806 . . . . 13.9 103.424 -178.954 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -122.47 125.91 46.79 Favored 'General case' 0 N--CA 1.431 -1.42 1 O-C-N 114.595 -5.065 . . . . 6.8600000000000003 101.499 157.47 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.65 -94.46 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.487 1.613 . . . . 11.15 112.895 -178.186 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -148.22 22.42 1.4 Allowed Glycine 0 N--CA 1.43 -1.751 0 O-C-N 117.43 -3.294 . . . . 13.93 113.723 166.719 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.2 mtmt -87.18 120.75 28.78 Favored 'General case' 0 N--CA 1.431 -1.419 0 C-N-CA 128.615 2.766 . . . . 23.920000000000002 112.123 167.32 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -78.44 129.29 34.74 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 117.23 -3.419 . . . . 23.23 113.543 176.98 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.1 mt -108.3 124.86 50.98 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 118.62 -2.55 . . . . 9.1099999999999994 105.494 -154.524 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -93.25 138.55 31.53 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.291 -2.756 . . . . 33.439999999999998 111.971 -175.187 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -43.73 -43.74 6.18 Favored 'General case' 0 N--CA 1.43 -1.448 0 C-N-CA 129.919 3.287 . . . . 28.370000000000001 119.67 -179.099 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.56 18.0 45.29 Favored Glycine 0 N--CA 1.43 -1.745 0 O-C-N 118.49 -2.631 . . . . 15.0 113.932 -169.855 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -95.38 149.22 21.61 Favored 'General case' 0 N--CA 1.43 -1.425 0 CA-C-O 123.288 1.518 . . . . 25.5 110.128 163.519 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 p -71.52 146.49 48.47 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 111.958 -2.383 . . . . 11.949999999999999 108.093 171.349 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.5 mt -49.19 -49.35 43.19 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 115.947 1.832 . . . . 10.17 115.947 161.332 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.2 p -49.48 -35.27 19.26 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 119.014 2.968 . . . . 13.59 119.014 166.29 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.83 -26.73 54.68 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 127.639 3.59 . . . . 11.699999999999999 114.646 -178.452 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -87.51 1.52 53.28 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 117.699 2.481 . . . . 12.949999999999999 117.699 168.297 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 72.68 31.92 1.58 Allowed 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 127.215 2.822 . . . . 25.449999999999999 112.127 172.411 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.7 mm -89.1 118.78 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 O-C-N 121.326 -0.859 . . . . 14.6 109.698 -169.919 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 60.4 mt-30 -106.28 172.72 6.66 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 120.354 -1.466 . . . . 33.229999999999997 107.155 -179.416 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -70.3 160.86 31.46 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 118.437 -1.305 . . . . 25.969999999999999 113.563 -175.703 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.253 52.5 mt-10 65.69 9.09 5.67 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 117.569 2.433 . . . . 32.609999999999999 117.569 -168.622 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.0 m -69.48 135.2 49.85 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 112.445 -2.161 . . . . 10.56 113.179 171.939 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.8 m -110.97 122.03 46.85 Favored 'General case' 0 N--CA 1.43 -1.43 0 O-C-N 117.768 -3.083 . . . . 5.3300000000000001 106.466 -174.593 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -104.29 164.92 11.4 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 100.793 -3.78 . . . . 11.66 100.793 -172.508 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -123.45 130.59 52.92 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 116.139 -1.886 . . . . 16.300000000000001 109.912 -179.691 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.4 tp -84.69 134.19 34.36 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 116.569 2.062 . . . . 9.9600000000000009 116.569 169.719 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.7 m -121.52 164.66 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.466 0 O-C-N 119.68 -1.887 . . . . 9.7599999999999998 107.668 169.881 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.268 24.1 tp -94.27 132.59 38.69 Favored 'General case' 0 N--CA 1.429 -1.476 0 O-C-N 117.981 -2.949 . . . . 19.57 104.806 -172.059 . . . . . . . . 2 2 . 1 . 122 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -101.37 137.22 40.0 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 127.364 2.265 . . . . 35.079999999999998 113.196 166.828 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.8 mt -114.91 -159.12 0.69 Allowed 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 131.388 3.875 . . . . 32.310000000000002 101.902 -178.05 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -99.4 128.76 45.54 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 124.767 2.222 . . . . 42.75 114.732 -176.572 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 129.85 3.49 4.96 Favored Glycine 0 N--CA 1.43 -1.714 0 CA-C-O 116.205 -2.441 . . . . 36.310000000000002 112.292 156.168 . . . . . . . . 1 1 . 1 . 122 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.723 0 CA-C-N 122.334 3.067 . . . . 36.270000000000003 115.431 -173.641 . . . . . . . . 0 0 . 1 . 123 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.49 -1.341 0 N-CA-C 117.614 2.45 . . . . 17.170000000000002 117.614 . . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -93.41 123.53 36.77 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 118.167 -0.92 . . . . 21.890000000000001 110.274 -163.945 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.7 pt -92.48 171.4 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-O 127.084 3.326 . . . . 10.83 109.394 165.567 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.556 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 26.1 m-85 -115.13 112.48 22.62 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 128.794 2.837 . . . . 10.609999999999999 107.688 169.545 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.5 t -105.71 118.43 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.858 -2.402 . . . . 9.1300000000000008 105.13 172.08 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -97.57 113.12 24.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.843 2.857 . . . . 20.550000000000001 112.826 175.218 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.456 26.7 p -66.45 161.52 22.59 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 119.65 3.204 . . . . 11.779999999999999 119.65 174.979 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.2 tp -70.12 -34.06 72.62 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.26 -3.4 . . . . 19.309999999999999 107.31 -178.267 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -68.63 -61.84 1.65 Allowed 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 124.184 0.993 . . . . 23.140000000000001 110.174 170.826 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.71 46.45 0.05 OUTLIER Glycine 0 N--CA 1.43 -1.751 0 O-C-N 117.26 -3.4 . . . . 19.739999999999998 114.369 -170.436 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -126.1 135.96 52.34 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 118.981 -2.482 . . . . 21.93 112.678 162.868 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.4 m -105.85 114.04 27.96 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 116.692 -3.755 . . . . 12.33 106.291 -179.678 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.4 mt -97.78 129.01 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 C-N-CA 130.954 3.702 . . . . 17.079999999999998 109.278 -177.844 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -98.22 102.92 14.8 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-O 125.426 2.536 . . . . 16.300000000000001 105.409 -178.725 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.0 tp -119.88 124.04 45.07 Favored 'General case' 0 N--CA 1.43 -1.429 0 O-C-N 119.212 -2.18 . . . . 15.880000000000001 110.521 -155.216 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.73 113.49 18.96 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 111.83 -2.441 . . . . 28.899999999999999 114.922 -176.413 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.57 156.03 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 0 CA-C-O 125.191 2.424 . . . . 12.050000000000001 111.469 178.33 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -91.97 158.32 39.84 Favored Pre-proline 0 N--CA 1.43 -1.446 0 CA-C-O 116.041 -1.933 . . . . 18.170000000000002 108.988 174.704 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -83.32 -22.13 4.11 Favored 'Trans proline' 0 N--CA 1.434 -2.019 0 CA-C-N 126.379 3.314 . . . . 8.1600000000000001 118.027 -179.331 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.6 m -86.43 14.25 7.01 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 125.047 1.467 . . . . 11.130000000000001 114.483 -175.535 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -110.79 151.91 27.24 Favored 'General case' 0 N--CA 1.43 -1.449 1 C-N-CA 133.438 4.695 . . . . 18.030000000000001 111.334 -177.643 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 55.9 p -75.37 157.55 34.06 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 127.74 3.638 . . . . 10.220000000000001 113.046 -177.648 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.6 mm -71.37 -28.24 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-O 126.03 2.824 . . . . 12.300000000000001 109.832 -179.137 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -69.24 -24.29 63.98 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.373 -3.954 . . . . 36.509999999999998 108.498 176.455 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -83.08 -38.98 21.76 Favored 'General case' 0 N--CA 1.43 -1.439 0 C-N-CA 129.192 2.997 . . . . 25.66 108.631 -179.077 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 88.8 t -55.84 -47.99 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-O 123.78 1.752 . . . . 8.1199999999999992 112.711 162.483 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -60.69 -39.04 87.04 Favored 'General case' 0 N--CA 1.431 -1.416 1 O-C-N 115.717 -4.364 . . . . 15.470000000000001 114.997 177.052 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.15 -43.14 66.78 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.31 3.078 . . . . 11.449999999999999 119.31 164.57 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -65.18 -41.41 94.62 Favored 'General case' 0 N--CA 1.43 -1.461 0 O-C-N 119.791 -1.818 . . . . 24.98 111.629 177.114 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 61.0 mt -60.38 -44.02 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.468 0 C-N-CA 126.55 1.94 . . . . 9.4600000000000009 113.151 172.482 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -51.12 -37.13 44.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 129.725 3.21 . . . . 14.76 113.988 167.615 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -83.76 -38.01 21.89 Favored 'General case' 0 N--CA 1.43 -1.438 0 O-C-N 120.077 -1.639 . . . . 26.289999999999999 108.37 -176.921 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -63.93 -58.9 5.36 Favored 'General case' 0 N--CA 1.431 -1.416 0 N-CA-C 116.124 1.898 . . . . 30.059999999999999 116.124 177.4 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -100.14 -69.32 0.77 Allowed 'General case' 0 N--CA 1.429 -1.475 0 CA-C-O 124.724 2.202 . . . . 25.190000000000001 110.641 -171.351 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 135.49 46.07 0.09 OUTLIER Glycine 0 N--CA 1.43 -1.766 0 O-C-N 117.418 -3.302 . . . . 7.4100000000000001 105.593 -175.34 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -106.32 130.9 22.24 Favored Pre-proline 0 N--CA 1.43 -1.471 0 CA-C-O 116.932 -1.509 . . . . 9.4900000000000002 110.298 167.821 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.417 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 80.2 Cg_exo -76.21 154.66 37.04 Favored 'Trans proline' 0 N--CA 1.434 -2.012 0 N-CA-C 119.79 2.958 . . . . 11.42 119.79 177.858 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 62.4 Cg_exo -70.5 -17.82 33.95 Favored 'Trans proline' 0 N--CA 1.434 -1.993 1 C-N-CA 126.142 4.561 . . . . 12.0 112.207 -169.229 . . . . . . . . 3 3 . 1 . 123 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -84.55 -21.01 30.62 Favored 'General case' 0 N--CA 1.431 -1.417 1 O-C-N 115.267 -4.646 . . . . 35.549999999999997 114.408 176.451 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.95 -16.06 30.7 Favored 'General case' 0 N--CA 1.431 -1.405 0 O-C-N 119.987 -1.695 . . . . 20.52 111.109 -175.549 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -86.1 153.13 22.31 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 118.834 -1.146 . . . . 7.1299999999999999 112.842 -174.613 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.458 ' HB3' HG23 ' A' ' 70' ' ' VAL . 21.2 ttm180 -140.98 125.57 17.81 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 102.362 -3.199 . . . . 36.390000000000001 102.362 169.35 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 38.3 mt -105.63 125.68 51.27 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 123.03 1.395 . . . . 9.5500000000000007 109.473 175.014 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.0 mm -106.57 128.2 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 O-C-N 121.16 -0.963 . . . . 13.9 111.03 177.307 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -112.97 115.51 28.52 Favored 'General case' 0 N--CA 1.43 -1.434 0 C-N-CA 118.859 -1.136 . . . . 6.8600000000000003 109.476 160.8 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.307 . . 64.31 -101.28 0.09 Allowed 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 127.859 2.463 . . . . 11.15 111.613 -170.911 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.63 2.19 23.31 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 130.057 3.694 . . . . 13.93 114.158 172.11 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.258 14.3 tppt? -102.7 132.86 48.55 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-N 119.916 1.858 . . . . 23.920000000000002 111.019 -177.97 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -91.6 138.16 31.79 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-N 112.902 -1.954 . . . . 23.23 110.88 176.819 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.287 3.3 mt -106.59 114.24 28.23 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 126.974 3.273 . . . . 9.1099999999999994 110.255 -166.018 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.37 130.27 35.04 Favored 'General case' 0 N--CA 1.43 -1.471 0 O-C-N 118.271 -2.768 . . . . 33.439999999999998 114.063 -167.789 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -31.35 -67.35 0.1 Allowed 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 121.245 3.795 . . . . 28.370000000000001 121.245 -164.336 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -96.56 21.9 43.15 Favored Glycine 0 N--CA 1.43 -1.705 0 C-N-CA 115.177 -3.392 . . . . 15.0 111.334 -168.233 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -91.63 153.98 19.33 Favored 'General case' 0 N--CA 1.43 -1.469 1 O-C-N 115.183 -4.716 . . . . 25.5 112.333 166.832 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 64.9 p -76.01 166.5 23.41 Favored 'General case' 0 N--CA 1.43 -1.468 0 O-C-N 118.739 -2.476 . . . . 11.949999999999999 116.668 179.248 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.9 mt -61.4 -41.73 97.6 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-O 124.977 2.322 . . . . 10.17 116.758 163.526 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 99.6 p -60.94 -24.93 66.44 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 112.329 -3.701 . . . . 13.59 117.981 177.978 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -71.82 -38.55 70.16 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 122.497 2.408 . . . . 11.699999999999999 115.356 167.448 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -77.78 -2.99 39.13 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 118.673 -2.517 . . . . 12.949999999999999 114.709 170.645 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 2.6 m-80 52.62 49.05 21.22 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 126.58 3.086 . . . . 25.449999999999999 115.644 177.093 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.2 mm -76.66 112.7 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 109.645 -3.434 . . . . 14.6 110.124 176.629 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -96.49 166.57 11.62 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.559 -2.588 . . . . 33.229999999999997 107.215 179.566 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 4.6 pttm -52.55 146.86 9.23 Favored 'General case' 0 N--CA 1.43 -1.465 0 C-N-CA 128.08 2.552 . . . . 25.969999999999999 114.704 171.507 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 57.81 38.69 27.32 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-O 127.856 3.693 . . . . 32.609999999999999 115.534 -178.516 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.254 72.5 m -102.35 131.21 49.12 Favored 'General case' 0 N--CA 1.431 -1.424 0 O-C-N 117.833 -3.042 . . . . 10.56 110.206 -173.544 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 96.3 m -102.9 101.0 11.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 123.766 1.746 . . . . 5.3300000000000001 108.787 -164.309 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.1 mt -81.75 134.34 35.44 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 116.913 -3.617 . . . . 11.66 113.353 172.47 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -89.28 101.19 13.86 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 113.424 -3.179 . . . . 16.300000000000001 105.406 -179.521 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.5 tp -71.2 114.76 9.59 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 124.458 3.299 . . . . 9.9600000000000009 114.489 169.602 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.458 HG23 ' HB3' ' A' ' 42' ' ' ARG . 15.7 m -121.95 -174.36 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 CA-C-O 126.35 2.976 . . . . 9.7599999999999998 107.622 -176.024 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 tp -94.38 127.57 40.35 Favored 'General case' 0 N--CA 1.431 -1.424 1 O-C-N 113.467 -5.771 . . . . 19.57 115.779 176.808 . . . . . . . . 2 2 . 1 . 123 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -94.05 119.49 32.99 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-O 126.188 2.899 . . . . 35.079999999999998 110.674 167.23 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 78.9 mt -103.17 152.09 21.85 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.708 2.803 . . . . 32.310000000000002 110.674 162.069 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -73.53 154.14 39.99 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 128.508 2.723 . . . . 42.75 111.641 176.524 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 86.69 30.15 21.97 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 116.485 1.354 . . . . 36.310000000000002 116.485 -167.953 . . . . . . . . 1 1 . 1 . 123 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.767 0 N-CA-C 107.771 -2.132 . . . . 36.270000000000003 107.771 172.074 . . . . . . . . 0 0 . 1 . 124 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.341 9.5 ptt? . . . . . 0 CA--C 1.489 -1.369 0 CA-C-O 113.954 -2.927 . . . . 17.170000000000002 117.243 . . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -74.93 124.97 27.89 Favored 'General case' 0 N--CA 1.43 -1.452 1 C-N-CA 131.799 4.039 . . . . 21.890000000000001 113.684 165.054 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.4 pt -120.16 162.08 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 N-CA-C 103.36 -2.83 . . . . 10.83 103.36 159.675 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -114.93 135.44 54.21 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 106.024 -1.843 . . . . 10.609999999999999 106.024 -179.371 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.39 106.34 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.425 1 O-C-N 113.024 -6.047 . . . . 9.1300000000000008 111.369 179.7 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -84.51 138.64 32.66 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-O 125.517 2.579 . . . . 20.550000000000001 112.947 179.957 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.6 p -106.9 174.79 5.73 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 119.31 -2.118 . . . . 11.779999999999999 106.872 -178.16 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.4 tp -74.69 -50.11 18.78 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.202 2.201 . . . . 19.309999999999999 108.225 -169.396 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 p -71.43 -73.36 0.18 Allowed 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 116.131 1.9 . . . . 23.140000000000001 116.131 176.591 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 173.37 68.98 0.05 OUTLIER Glycine 0 N--CA 1.431 -1.699 1 O-C-N 112.348 -6.47 . . . . 19.739999999999998 115.729 168.528 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -132.83 146.05 51.49 Favored 'General case' 0 N--CA 1.431 -1.42 0 O-C-N 120.578 -1.542 . . . . 21.93 109.109 163.398 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.2 m -119.48 129.22 54.62 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.283 -1.767 . . . . 12.33 107.975 166.428 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.7 mp -98.07 127.88 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 CA-C-N 113.118 -1.855 . . . . 17.079999999999998 107.253 -177.209 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.8 m -86.39 128.87 34.99 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 103.22 -2.881 . . . . 16.300000000000001 103.22 169.007 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 tp -128.2 139.2 52.6 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 114.06 -1.427 . . . . 15.880000000000001 111.687 173.258 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -86.81 118.45 26.21 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.541 -1.35 . . . . 28.899999999999999 113.945 171.574 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.8 m -129.05 157.01 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 116.027 1.862 . . . . 12.050000000000001 116.027 173.266 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -103.78 140.05 20.69 Favored Pre-proline 0 N--CA 1.43 -1.447 0 C-N-CA 125.572 1.549 . . . . 18.170000000000002 108.011 171.439 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -70.18 -18.13 35.23 Favored 'Trans proline' 0 C--N 1.299 -2.027 0 CA-C-N 122.356 1.877 . . . . 8.1600000000000001 111.884 -170.407 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -77.39 -8.81 58.29 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 127.771 2.429 . . . . 11.130000000000001 116.031 178.361 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -71.26 164.41 25.75 Favored 'General case' 0 N--CA 1.43 -1.46 1 O-C-N 115.985 -4.197 . . . . 18.030000000000001 111.625 171.558 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 59.1 p -79.88 170.65 16.19 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 118.623 -2.548 . . . . 10.220000000000001 115.654 156.431 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.5 mm -73.95 -26.19 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 C-N-CA 126.707 2.003 . . . . 12.300000000000001 111.37 175.234 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -57.91 -39.2 77.38 Favored 'General case' 0 N--CA 1.43 -1.467 0 O-C-N 116.598 -3.814 . . . . 36.509999999999998 114.237 166.68 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -76.35 -31.06 57.87 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 116.846 -3.659 . . . . 25.66 112.042 -175.334 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.72 -42.07 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.449 0 C-N-CA 126.245 1.818 . . . . 8.1199999999999992 112.06 172.274 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -69.16 -23.8 63.99 Favored 'General case' 0 N--CA 1.43 -1.439 0 N-CA-C 119.708 3.225 . . . . 15.470000000000001 119.708 172.472 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.43 -23.45 67.29 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.77 2.428 . . . . 11.449999999999999 116.916 159.412 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -94.57 -19.21 20.7 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-O 123.444 1.592 . . . . 24.98 111.274 175.431 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.6 mt -75.72 -34.97 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 0 CA-C-O 116.314 -1.803 . . . . 9.4600000000000009 106.451 175.868 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -67.63 -29.09 68.32 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 123.625 1.679 . . . . 14.76 111.943 174.957 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -71.81 -47.71 51.42 Favored 'General case' 0 N--CA 1.43 -1.458 0 O-C-N 118.729 -2.482 . . . . 26.289999999999999 115.79 172.928 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 38.0 tptt -78.81 -47.82 15.96 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 116.332 1.975 . . . . 30.059999999999999 116.332 -177.257 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -105.2 -17.28 14.52 Favored 'General case' 0 N--CA 1.43 -1.427 0 O-C-N 117.996 -2.94 . . . . 25.190000000000001 116.612 -178.88 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.17 61.4 5.19 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 127.077 2.275 . . . . 7.4100000000000001 112.052 172.978 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 mt -121.93 142.14 35.66 Favored Pre-proline 0 N--CA 1.43 -1.466 0 N-CA-C 100.274 -3.972 . . . . 9.4900000000000002 100.274 170.834 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 0.2 OUTLIER -65.49 157.71 56.81 Favored 'Trans proline' 0 N--CA 1.434 -2.004 0 CA-C-N 124.834 2.762 . . . . 11.42 110.531 -177.389 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -64.41 -27.05 62.79 Favored 'Trans proline' 0 C--N 1.3 -1.987 0 C-N-CA 123.867 3.044 . . . . 12.0 114.697 -178.982 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -72.5 -31.7 65.57 Favored 'General case' 0 N--CA 1.43 -1.431 1 O-C-N 115.953 -4.217 . . . . 35.549999999999997 108.748 -176.154 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -81.71 -23.17 36.93 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.113 -2.867 . . . . 20.52 113.74 -179.815 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -71.0 120.29 16.35 Favored 'General case' 0 N--CA 1.43 -1.468 0 C-N-CA 127.413 2.285 . . . . 7.1299999999999999 113.272 171.224 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -121.71 126.37 48.78 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 118.062 -0.97 . . . . 36.390000000000001 108.592 159.555 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.5 mt -104.27 136.75 43.29 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-O 125.759 2.695 . . . . 9.5500000000000007 108.536 -179.077 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.7 mm -120.31 146.78 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.453 0 O-C-N 118.649 -2.532 . . . . 13.9 105.779 -178.064 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -127.02 127.26 44.5 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 100.427 -3.916 . . . . 6.8600000000000003 100.427 164.604 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.526 . . 59.34 -88.64 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 120.789 3.625 . . . . 11.15 120.789 -172.884 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -147.13 19.39 1.56 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 123.659 0.599 . . . . 13.93 112.029 153.025 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -77.38 132.99 38.81 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-O 121.732 0.777 . . . . 23.920000000000002 112.017 160.751 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -79.01 124.1 27.93 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 116.87 -3.644 . . . . 23.23 113.597 173.728 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.432 HD22 ' CD2' ' A' ' 59' ' ' TYR . 48.4 mt -99.48 120.82 40.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 119.091 -2.255 . . . . 9.1099999999999994 107.987 -178.91 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -102.79 153.12 20.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 O-C-N 127.426 2.953 . . . . 33.439999999999998 110.42 -178.146 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -49.09 -51.59 30.75 Favored 'General case' 0 N--CA 1.43 -1.441 1 N-CA-C 122.677 4.325 . . . . 28.370000000000001 122.677 -166.545 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -77.44 -5.07 85.46 Favored Glycine 0 N--CA 1.43 -1.753 0 O-C-N 124.955 1.41 . . . . 15.0 114.945 -176.624 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -78.53 150.11 32.93 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.427 1.108 . . . . 25.5 110.214 168.102 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 58.5 p -88.31 179.06 6.42 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-N 113.176 -1.829 . . . . 11.949999999999999 113.029 169.044 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 56' ' ' LEU . 94.6 mt -76.34 -45.03 33.99 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.944 -1.502 . . . . 10.17 106.944 -174.544 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.8 p -50.57 -41.63 54.59 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 128.938 2.895 . . . . 13.59 114.408 176.147 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -63.6 -38.35 90.77 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 126.198 1.799 . . . . 11.699999999999999 111.125 -174.277 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.432 ' CD2' HD22 ' A' ' 50' ' ' LEU . 76.2 m-85 -96.15 17.0 16.57 Favored 'General case' 0 N--CA 1.43 -1.468 2 O-C-N 115.145 -4.722 . . . . 12.949999999999999 111.788 169.718 . . . . . . . . 3 3 . 1 . 124 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 47.36 55.32 8.37 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 127.693 3.616 . . . . 25.449999999999999 118.756 -172.558 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 28.4 mm -82.42 119.96 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 111.117 -2.765 . . . . 14.6 113.843 171.57 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -97.84 170.36 9.02 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 126.573 2.421 . . . . 33.229999999999997 110.191 -176.039 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 19.3 pttt -76.39 155.65 33.88 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 115.647 -2.12 . . . . 25.969999999999999 108.062 -179.482 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.354 46.7 mt-10 58.2 39.35 25.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 126.685 1.994 . . . . 32.609999999999999 116.089 177.94 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.8 m -124.14 136.36 54.16 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 105.921 -1.881 . . . . 10.56 105.921 -173.458 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.9 m -85.1 121.42 27.84 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-O 115.924 -1.988 . . . . 5.3300000000000001 109.692 -171.834 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.0 mp -96.62 158.65 15.33 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 128.402 2.681 . . . . 11.66 108.88 174.118 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -111.88 113.26 25.47 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 120.063 1.301 . . . . 16.300000000000001 110.185 -179.55 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.9 tp -81.34 119.16 23.32 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 117.547 -1.216 . . . . 9.9600000000000009 111.063 173.355 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.77 166.73 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 C-N-CA 118.75 -1.18 . . . . 9.7599999999999998 110.971 173.304 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.0 tp -85.12 119.97 26.1 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.609 -2.557 . . . . 19.57 110.781 176.527 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -97.53 134.45 40.74 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 124.275 1.03 . . . . 35.079999999999998 111.563 166.921 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.29 99.0 mt -94.65 174.54 7.06 Favored 'General case' 0 N--CA 1.431 -1.4 0 O-C-N 120.824 -1.173 . . . . 32.310000000000002 111.5 172.148 . . . . . . . . 2 2 . 1 . 124 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.7 mmt180 -74.39 158.81 33.27 Favored 'General case' 0 N--CA 1.43 -1.436 0 O-C-N 117.678 -3.139 . . . . 42.75 112.222 166.534 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 155.27 -83.26 0.15 Allowed Glycine 0 N--CA 1.43 -1.711 0 C-N-CA 130.212 3.768 . . . . 36.310000000000002 112.604 175.271 . . . . . . . . 1 1 . 1 . 124 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.761 0 CA-C-O 117.817 -1.546 . . . . 36.270000000000003 109.747 176.461 . . . . . . . . 0 0 . 1 . 125 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ptt? . . . . . 0 CA--C 1.489 -1.366 0 N-CA-C 108.08 -1.081 . . . . 17.170000000000002 108.08 . . . . . . . . . 0 0 . 1 . 125 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -88.67 145.47 25.64 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 118.887 -2.383 . . . . 21.890000000000001 110.656 178.558 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.0 pt -133.17 164.69 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 104.785 -2.302 . . . . 10.83 104.785 166.677 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -121.44 142.6 49.87 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 128.372 3.545 . . . . 10.609999999999999 108.344 -175.195 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.1 t -118.31 116.03 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 111.652 -2.522 . . . . 9.1300000000000008 107.843 177.16 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -101.89 138.51 38.77 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.218 -2.176 . . . . 20.550000000000001 111.126 179.819 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.9 p -98.81 170.35 8.82 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 112.688 -2.051 . . . . 11.779999999999999 108.421 -172.487 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.3 tp -49.59 -60.63 2.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 117.738 2.496 . . . . 19.309999999999999 117.738 177.688 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.275 17.7 p -74.26 -32.81 63.1 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 111.587 -2.552 . . . . 23.140000000000001 112.144 -178.781 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.17 69.85 0.26 Allowed Glycine 0 N--CA 1.43 -1.746 0 O-C-N 118.694 -2.504 . . . . 19.739999999999998 114.256 159.919 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -107.92 143.5 36.47 Favored 'General case' 0 N--CA 1.431 -1.425 0 O-C-N 121.795 -0.826 . . . . 21.93 112.982 164.511 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -94.0 98.53 11.08 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 116.038 1.866 . . . . 12.33 116.038 167.874 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.5 mt -86.06 92.59 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 116.164 -4.085 . . . . 17.079999999999998 106.577 176.873 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.1 m -61.57 127.46 31.58 Favored 'General case' 0 N--CA 1.429 -1.494 0 CA-C-O 117.089 -1.434 . . . . 16.300000000000001 113.185 164.902 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.403 HD13 HG13 ' A' ' 26' ' ' VAL . 30.8 mt -110.34 150.3 28.98 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.953 2.901 . . . . 15.880000000000001 115.669 163.756 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -104.83 125.19 50.62 Favored 'General case' 0 N--CA 1.431 -1.415 0 O-C-N 117.6 -3.188 . . . . 28.899999999999999 103.824 170.485 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -139.53 156.18 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.464 0 O-C-N 118.57 -2.581 . . . . 12.050000000000001 116.489 -171.195 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -105.43 149.3 37.63 Favored Pre-proline 0 N--CA 1.43 -1.462 0 O-C-N 117.973 -2.954 . . . . 18.170000000000002 111.242 168.054 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.68 -25.53 75.75 Favored 'Trans proline' 0 N--CA 1.434 -2.0 0 C-N-CA 123.947 3.098 . . . . 8.1600000000000001 113.882 172.776 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.3 p -81.58 -5.76 58.33 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 124.844 1.258 . . . . 11.130000000000001 111.777 -175.537 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 -74.66 145.93 42.79 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 118.334 2.716 . . . . 18.030000000000001 118.334 179.674 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -88.66 154.4 20.34 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 118.917 -2.364 . . . . 10.220000000000001 108.901 177.451 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 mm -63.29 -27.81 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 125.843 2.735 . . . . 12.300000000000001 112.786 179.511 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -54.06 -54.42 39.63 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 116.313 -3.992 . . . . 36.509999999999998 112.048 168.075 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -62.63 -41.34 98.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 115.583 1.698 . . . . 25.66 115.583 174.562 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 HD13 ' A' ' 15' ' ' LEU . 72.8 t -61.42 -46.14 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 O-C-N 119.597 -1.939 . . . . 8.1199999999999992 111.937 176.045 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -67.68 -20.67 65.32 Favored 'General case' 0 N--CA 1.43 -1.465 0 O-C-N 117.254 -3.404 . . . . 15.470000000000001 114.47 177.986 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.4 -27.85 66.58 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 114.579 1.325 . . . . 11.449999999999999 114.579 174.361 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -83.75 -29.05 27.77 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 124.503 1.127 . . . . 24.98 110.906 175.658 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.9 mt -61.95 -29.87 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 120.746 1.612 . . . . 9.4600000000000009 111.511 165.897 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -76.81 -45.19 29.65 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 115.47 1.655 . . . . 14.76 115.47 176.649 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.378 20.7 t70 -41.5 -54.97 2.99 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 127.521 2.328 . . . . 26.289999999999999 112.171 163.058 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -79.32 -61.88 1.87 Allowed 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 121.377 3.843 . . . . 30.059999999999999 121.377 -177.145 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -88.63 -36.48 16.24 Favored 'General case' 0 N--CA 1.43 -1.429 1 O-C-N 115.525 -4.485 . . . . 25.190000000000001 105.994 -171.226 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.22 81.15 0.46 Allowed Glycine 0 N--CA 1.43 -1.715 0 O-C-N 118.932 -2.355 . . . . 7.4100000000000001 112.743 -171.112 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.3 mt -135.34 131.01 19.36 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 100.686 -3.82 . . . . 9.4900000000000002 100.686 170.58 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -69.29 149.43 69.91 Favored 'Trans proline' 0 N--CA 1.434 -2.022 1 CA-C-N 128.604 4.108 . . . . 11.42 115.213 -178.543 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -93.88 4.45 2.92 Favored 'Trans proline' 0 N--CA 1.433 -2.042 0 C-N-CA 115.992 -2.205 . . . . 12.0 112.651 -154.102 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -83.44 -38.97 21.18 Favored 'General case' 0 N--CA 1.43 -1.451 0 C-N-CA 129.523 3.129 . . . . 35.549999999999997 105.827 176.236 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -67.67 -37.72 82.74 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 129.064 2.946 . . . . 20.52 109.52 174.003 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.36 69.0 mt-30 -83.93 132.55 34.76 Favored 'General case' 0 N--CA 1.43 -1.469 0 CA-C-O 128.059 3.79 . . . . 7.1299999999999999 110.189 -176.163 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.416 ' HB3' HG23 ' A' ' 70' ' ' VAL . 45.0 ttt180 -127.31 133.77 50.08 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 110.786 -2.915 . . . . 36.390000000000001 108.997 175.229 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.3 mt -103.92 139.41 39.12 Favored 'General case' 0 N--CA 1.43 -1.451 1 CA-C-O 131.272 5.32 . . . . 9.5500000000000007 108.507 178.512 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.62 HD12 ' HG2' ' A' ' 49' ' ' GLN . 10.7 mm -123.06 137.22 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.438 1 O-C-N 115.974 -4.204 . . . . 13.9 111.762 172.449 . . . . . . . . 3 3 . 1 . 125 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -127.01 124.92 40.52 Favored 'General case' 0 N--CA 1.43 -1.461 1 O-C-N 115.933 -4.229 . . . . 6.8600000000000003 102.629 165.363 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.9 -98.5 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.438 1 C-N-CA 134.392 5.077 . . . . 11.15 117.717 -173.62 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -94.04 -18.61 36.37 Favored Glycine 0 N--CA 1.431 -1.684 0 C-N-CA 124.71 1.148 . . . . 13.93 114.238 -174.564 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -128.96 133.03 47.67 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 116.991 2.219 . . . . 23.920000000000002 116.991 -166.761 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.62 ' HG2' HD12 ' A' ' 44' ' ' ILE . 33.1 mt-30 -83.04 134.33 35.04 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 106.08 -1.822 . . . . 23.23 106.08 -170.585 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 38.0 mt -92.39 132.21 36.93 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.24 -1.345 . . . . 9.1099999999999994 111.262 -166.417 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -101.37 164.76 11.61 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 117.872 -3.017 . . . . 33.439999999999998 108.163 -176.558 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.75 -57.2 12.83 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.703 -2.044 . . . . 28.370000000000001 115.339 -161.742 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -87.82 18.94 36.27 Favored Glycine 0 N--CA 1.43 -1.762 0 CA-C-O 117.273 -1.849 . . . . 15.0 115.324 -174.711 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 52.4 mtt-85 -104.5 150.76 24.3 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 119.698 1.749 . . . . 25.5 108.615 -178.478 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.5 p -91.56 153.43 19.76 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.682 -2.511 . . . . 11.949999999999999 110.583 -164.432 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 33.1 mt -53.68 -35.68 61.35 Favored 'General case' 0 N--CA 1.429 -1.477 0 C-N-CA 128.257 2.623 . . . . 10.17 112.797 167.991 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.0 p -70.72 -37.99 73.57 Favored 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 123.662 1.696 . . . . 13.59 115.274 178.652 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -78.93 -29.68 44.23 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 119.23 -2.169 . . . . 11.699999999999999 109.502 173.45 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -77.79 -2.45 36.46 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 123.816 3.007 . . . . 12.949999999999999 116.882 166.133 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 61.38 34.74 18.18 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 126.039 2.828 . . . . 25.449999999999999 114.753 177.884 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.93 116.28 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 113.507 -1.679 . . . . 14.6 114.986 174.543 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -98.29 174.61 6.41 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 103.318 -2.845 . . . . 33.229999999999997 103.318 -175.234 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.4 pttp -65.5 147.23 53.77 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 114.49 1.293 . . . . 25.969999999999999 114.49 173.387 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.251 8.5 mt-10 55.3 25.74 7.81 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.803 -2.436 . . . . 32.609999999999999 113.252 179.73 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.1 m -93.96 151.55 19.47 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-O 115.174 -2.346 . . . . 10.56 110.859 169.908 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.5 m -114.09 125.44 53.97 Favored 'General case' 0 N--CA 1.43 -1.435 0 O-C-N 126.138 2.149 . . . . 5.3300000000000001 108.731 -169.72 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -92.11 151.26 20.5 Favored 'General case' 0 N--CA 1.429 -1.489 0 O-C-N 116.895 -3.628 . . . . 11.66 112.983 165.705 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -91.51 135.28 33.97 Favored 'General case' 0 N--CA 1.43 -1.447 0 N-CA-C 104.152 -2.536 . . . . 16.300000000000001 104.152 172.158 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.5 tp -84.86 125.95 33.06 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 119.638 -1.914 . . . . 9.9600000000000009 113.846 154.909 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 42' ' ' ARG . 24.9 m -114.17 165.58 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.411 0 C-N-CA 127.597 2.359 . . . . 9.7599999999999998 112.036 168.476 . . . . . . . . 2 2 . 1 . 125 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 20.0 tp -84.16 149.18 26.34 Favored 'General case' 0 N--CA 1.43 -1.454 0 O-C-N 118.904 -2.372 . . . . 19.57 114.319 170.943 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -114.04 126.03 54.66 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 113.496 0.924 . . . . 35.079999999999998 113.496 169.011 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.4 mt -86.67 153.68 21.56 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 120.022 -1.674 . . . . 32.310000000000002 106.63 179.807 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 52.3 ttt180 -86.87 100.5 12.6 Favored 'General case' 0 N--CA 1.431 -1.389 0 O-C-N 117.681 -3.137 . . . . 42.75 111.197 173.04 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.52 38.79 1.86 Allowed Glycine 0 N--CA 1.431 -1.689 0 CA-C-N 109.701 -3.408 . . . . 36.310000000000002 108.622 173.686 . . . . . . . . 1 1 . 1 . 125 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.809 0 CA-C-O 116.14 -2.478 . . . . 36.270000000000003 110.759 -171.902 . . . . . . . . 0 0 . 1 . 126 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 CA--C 1.49 -1.35 0 N-CA-C 117.855 2.539 . . . . 17.170000000000002 117.855 . . . . . . . . . 0 0 . 1 . 126 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -82.05 131.68 35.25 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-O 116.059 -1.924 . . . . 21.890000000000001 108.536 177.017 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.3 pt -117.13 176.0 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 CA-C-N 123.435 2.834 . . . . 10.83 107.719 160.071 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -135.89 109.79 8.18 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 117.862 -3.024 . . . . 10.609999999999999 111.654 179.659 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 72.5 t -98.73 128.95 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 120.171 1.351 . . . . 9.1300000000000008 111.271 -177.629 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -90.68 134.46 34.39 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 120.296 -1.503 . . . . 20.550000000000001 113.0 173.657 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 55.7 p -88.09 172.08 9.79 Favored 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 129.273 3.029 . . . . 11.779999999999999 113.09 -178.281 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 20.0 tp -68.73 -36.96 79.07 Favored 'General case' 0 N--CA 1.43 -1.45 1 O-C-N 116.204 -4.06 . . . . 19.309999999999999 116.772 177.14 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.4 p -70.81 -58.5 3.56 Favored 'General case' 0 N--CA 1.43 -1.433 1 O-C-N 114.992 -4.817 . . . . 23.140000000000001 109.673 172.548 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.96 46.76 0.04 OUTLIER Glycine 0 N--CA 1.43 -1.719 0 CA-C-O 123.973 1.874 . . . . 19.739999999999998 112.241 -176.668 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -96.46 160.09 14.59 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 105.137 -2.171 . . . . 21.93 105.137 162.309 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 95.8 m -117.94 121.93 41.94 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 120.033 -1.667 . . . . 12.33 110.032 157.003 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.423 HD13 ' HG3' ' A' ' 34' ' ' GLU . 21.1 mt -105.79 120.07 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.021 -1.844 . . . . 17.079999999999998 106.021 -168.371 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.9 m -84.44 94.72 8.58 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 114.534 -1.212 . . . . 16.300000000000001 109.189 -179.145 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 15' ' ' LEU . 96.9 mt -95.43 132.66 40.26 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-O 115.161 -2.352 . . . . 15.880000000000001 108.485 -175.941 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.273 26.0 tt0 -89.5 102.67 15.35 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 122.291 2.314 . . . . 28.899999999999999 114.295 173.692 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.411 HG21 HD13 ' A' ' 56' ' ' LEU . 4.1 m -115.5 155.19 16.82 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 121.493 1.951 . . . . 12.050000000000001 111.399 -166.999 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -105.18 152.8 39.83 Favored Pre-proline 0 N--CA 1.43 -1.462 0 CA-C-O 115.72 -2.086 . . . . 18.170000000000002 107.671 170.511 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -85.88 -10.08 7.31 Favored 'Trans proline' 0 C--N 1.3 -2.018 1 CA-C-N 129.123 4.294 . . . . 8.1600000000000001 110.14 -164.513 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 p -85.77 -1.75 57.53 Favored 'General case' 0 N--CA 1.43 -1.469 0 C-N-CA 118.827 -1.149 . . . . 11.130000000000001 112.776 174.616 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -69.6 151.01 46.45 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 116.759 -3.713 . . . . 18.030000000000001 114.713 -178.878 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 10.2 p -77.26 161.76 27.87 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 106.044 -1.836 . . . . 10.220000000000001 106.044 177.356 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mm -57.94 -41.32 79.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 O-C-N 117.071 -3.518 . . . . 12.300000000000001 110.946 165.513 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.281 22.6 tt0 -42.42 -44.12 3.87 Favored 'General case' 0 N--CA 1.43 -1.474 0 C-N-CA 127.709 2.404 . . . . 36.509999999999998 115.215 164.254 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -65.86 -48.4 71.7 Favored 'General case' 0 N--CA 1.431 -1.419 0 O-C-N 117.708 -3.12 . . . . 25.66 114.223 170.68 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.1 t -49.98 -38.77 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 O-C-N 120.291 -1.506 . . . . 8.1199999999999992 112.769 177.928 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -76.16 -21.63 56.32 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 116.417 2.006 . . . . 15.470000000000001 116.417 179.522 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.02 -23.82 62.24 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 128.921 2.888 . . . . 11.449999999999999 113.708 178.357 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.6 mttp -81.99 -33.32 30.2 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 126.644 3.116 . . . . 24.98 113.763 171.778 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.4 mt -68.72 -43.86 82.71 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 O-C-N 119.612 -1.93 . . . . 9.4600000000000009 112.529 165.083 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -45.23 -47.48 12.7 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 117.275 2.324 . . . . 14.76 117.275 165.188 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -75.85 -54.43 6.93 Favored 'General case' 0 N--CA 1.43 -1.458 0 C-N-CA 128.485 2.714 . . . . 26.289999999999999 114.775 -173.012 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -81.12 -70.43 0.53 Allowed 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 125.185 1.394 . . . . 30.059999999999999 110.951 -169.57 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HG3' HD13 ' A' ' 13' ' ' ILE . 75.3 mm-40 -58.83 -43.35 90.66 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 117.002 2.223 . . . . 25.190000000000001 117.002 175.085 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.25 13.05 50.18 Favored Glycine 0 N--CA 1.429 -1.775 0 CA-C-O 126.38 3.211 . . . . 7.4100000000000001 120.145 -168.001 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 56.7 mt -76.72 125.29 87.39 Favored Pre-proline 0 N--CA 1.43 -1.439 1 O-C-N 116.381 -4.011 . . . . 9.4900000000000002 114.019 174.443 . . . . . . . . 3 3 . 1 . 126 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 40.4 Cg_exo -78.06 158.82 30.53 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 CA-C-O 113.999 -2.584 . . . . 11.42 113.545 -164.477 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -71.12 -23.85 24.29 Favored 'Trans proline' 0 C--N 1.3 -2.026 1 CA-C-N 128.988 4.246 . . . . 12.0 111.149 -170.519 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.46 0.27 30.18 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 119.509 3.152 . . . . 35.549999999999997 119.509 174.805 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.306 60.2 mt-30 -84.24 -25.42 29.43 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 114.141 -5.35 . . . . 20.52 108.346 169.687 . . . . . . . . 3 2 . 1 . 126 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -92.83 129.44 38.75 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 116.684 2.105 . . . . 7.1299999999999999 116.684 -152.205 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -142.03 120.82 12.68 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 115.689 -2.101 . . . . 36.390000000000001 108.803 168.953 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 85.3 mt -104.43 138.55 40.66 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 122.593 2.451 . . . . 9.5500000000000007 110.988 -177.629 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mm -116.14 136.22 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.48 0 C-N-CA 125.969 1.707 . . . . 13.9 110.75 -177.317 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -108.94 102.9 11.87 Favored 'General case' 0 N--CA 1.43 -1.426 1 O-C-N 114.738 -4.976 . . . . 6.8600000000000003 106.453 161.663 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.2 -77.62 0.02 OUTLIER 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 119.784 3.253 . . . . 11.15 119.784 -168.614 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.62 20.87 2.02 Favored Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.108 -1.597 . . . . 13.93 109.108 175.906 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -117.19 129.91 56.25 Favored 'General case' 0 N--CA 1.43 -1.474 0 O-C-N 118.549 -2.736 . . . . 23.920000000000002 104.184 -179.588 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -76.48 143.59 40.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 CA-C-N 113.069 -1.878 . . . . 23.23 112.575 179.515 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.2 mt -103.57 111.52 24.02 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 116.982 -1.485 . . . . 9.1099999999999994 107.936 -178.389 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -93.88 150.57 20.26 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 125.921 2.013 . . . . 33.439999999999998 111.733 -177.128 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -39.63 -63.4 0.58 Allowed 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 127.635 3.084 . . . . 28.370000000000001 115.482 -169.727 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -76.38 -25.9 64.79 Favored Glycine 0 N--CA 1.43 -1.744 0 O-C-N 119.815 -1.803 . . . . 15.0 113.702 -159.022 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -83.93 164.35 19.45 Favored 'General case' 0 N--CA 1.43 -1.441 0 C-N-CA 114.582 -2.847 . . . . 25.5 112.866 -178.088 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 61.0 p -97.36 169.07 10.01 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 122.754 1.264 . . . . 11.949999999999999 113.836 -171.431 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.411 HD13 HG21 ' A' ' 17' ' ' VAL . 48.2 mt -63.51 -41.92 98.49 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 125.193 1.397 . . . . 10.17 112.305 172.903 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.8 p -55.35 -43.82 75.38 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 121.898 2.136 . . . . 13.59 114.561 165.893 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -69.38 -35.91 76.29 Favored 'General case' 0 N--CA 1.429 -1.49 0 O-C-N 117.245 -3.409 . . . . 11.699999999999999 111.676 -174.044 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.332 2.3 m-85 -91.55 6.23 46.48 Favored 'General case' 0 N--CA 1.43 -1.457 0 O-C-N 127.975 3.297 . . . . 12.949999999999999 111.814 179.974 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.292 8.0 m120 58.87 40.78 22.33 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 118.163 2.653 . . . . 25.449999999999999 118.163 175.268 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.6 mm -75.06 131.59 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.43 0 N-CA-C 104.928 -2.249 . . . . 14.6 104.928 178.361 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -92.21 175.48 6.84 Favored 'General case' 0 N--CA 1.43 -1.472 0 O-C-N 118.247 -2.783 . . . . 33.229999999999997 113.452 169.159 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.0 pttp -63.64 124.0 20.28 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 131.629 3.972 . . . . 25.969999999999999 112.123 169.541 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 68.12 34.54 3.98 Favored 'General case' 0 N--CA 1.43 -1.461 2 O-C-N 112.188 -6.57 . . . . 32.609999999999999 107.317 175.907 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.356 61.7 m -90.86 143.72 26.44 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 121.783 2.083 . . . . 10.56 108.727 179.308 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 m -84.73 124.35 31.43 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.109 -2.869 . . . . 5.3300000000000001 111.754 -176.15 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.1 mp -112.76 151.7 29.98 Favored 'General case' 0 N--CA 1.43 -1.466 0 O-C-N 119.671 -1.893 . . . . 11.66 107.958 179.643 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.296 63.3 m170 -115.49 129.94 56.71 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 121.666 2.03 . . . . 16.300000000000001 113.546 170.307 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 35.6 tp -94.09 122.74 36.92 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 126.353 1.861 . . . . 9.9600000000000009 113.969 176.467 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 m -114.38 167.03 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.469 0 CA-C-N 122.955 2.616 . . . . 9.7599999999999998 111.751 -175.666 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.7 tp -85.77 113.63 22.09 Favored 'General case' 0 N--CA 1.43 -1.463 0 O-C-N 124.626 1.204 . . . . 19.57 109.517 176.514 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 ttp180 -75.59 110.22 9.8 Favored 'General case' 0 N--CA 1.43 -1.453 2 C-N-CA 133.071 4.548 . . . . 35.079999999999998 108.765 -178.098 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.314 16.8 mt -112.67 114.47 27.09 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 117.485 -3.26 . . . . 32.310000000000002 106.185 178.528 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.49 ' HE ' ' C ' ' A' ' 76' ' ' GLY . 49.4 ttt180 -125.28 128.02 47.6 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.091 -1.818 . . . . 42.75 106.091 179.689 . . . . . . . . 2 2 . 1 . 126 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.69 -40.36 9.76 Favored Glycine 0 N--CA 1.429 -1.796 0 C-N-CA 119.326 -1.416 . . . . 36.310000000000002 110.78 176.038 . . . . . . . . 1 1 . 1 . 126 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.49 ' C ' ' HE ' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.26 1.756 0 N-CA-C 109.173 -1.571 . . . . 36.270000000000003 109.173 -173.0 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 CA--C 1.49 -1.36 0 N-CA-C 114.273 1.212 . . . . 17.170000000000002 114.273 . . . . . . . . . 0 0 . 1 . 127 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -86.5 151.59 23.37 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 105.032 -2.211 . . . . 21.890000000000001 105.032 -175.288 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.9 pt -134.86 171.62 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 1 O-C-N 115.678 -4.389 . . . . 10.83 106.267 152.355 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -112.82 132.91 55.07 Favored 'General case' 0 N--CA 1.43 -1.445 0 C-N-CA 126.233 1.813 . . . . 10.609999999999999 107.417 -177.553 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.6 t -118.01 102.21 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.202 -2.518 . . . . 9.1300000000000008 104.202 176.429 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -87.02 127.26 35.1 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-O 128.355 3.931 . . . . 20.550000000000001 114.462 -178.967 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.9 p -81.04 170.8 15.76 Favored 'General case' 0 N--CA 1.43 -1.464 1 O-C-N 116.043 -4.161 . . . . 11.779999999999999 119.149 -178.097 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.5 mt -57.69 -34.85 69.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 126.107 1.763 . . . . 19.309999999999999 114.199 171.012 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 32.8 p -69.26 -23.55 63.86 Favored 'General case' 0 N--CA 1.43 -1.442 0 O-C-N 117.465 -3.272 . . . . 23.140000000000001 112.634 172.554 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.63 -5.18 40.27 Favored Glycine 0 N--CA 1.43 -1.751 0 O-C-N 118.036 -2.915 . . . . 19.739999999999998 117.529 -161.167 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -76.3 154.06 35.41 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 120.232 -0.587 . . . . 21.93 111.969 -177.334 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 m -113.1 126.39 55.42 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 117.559 -3.213 . . . . 12.33 108.868 175.239 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.2 mt -114.38 112.73 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.409 0 N-CA-C 102.091 -3.3 . . . . 17.079999999999998 102.091 176.355 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.6 m -95.85 107.24 19.47 Favored 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 116.782 -3.699 . . . . 16.300000000000001 110.497 -174.706 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 69.3 mt -112.41 151.36 29.94 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-O 125.022 2.344 . . . . 15.880000000000001 115.751 -173.539 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -107.7 104.81 14.42 Favored 'General case' 0 N--CA 1.43 -1.443 0 O-C-N 120.592 -1.317 . . . . 28.899999999999999 109.611 -177.511 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.28 172.22 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.445 0 N-CA-C 112.862 0.69 . . . . 12.050000000000001 112.862 171.145 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mt-10 -106.06 174.45 2.6 Favored Pre-proline 0 N--CA 1.431 -1.422 0 N-CA-C 107.833 -1.173 . . . . 18.170000000000002 107.833 166.577 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -72.8 -17.73 25.44 Favored 'Trans proline' 0 C--N 1.299 -2.048 0 CA-C-O 116.527 -1.53 . . . . 8.1600000000000001 110.515 175.156 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.2 m -90.69 9.24 30.63 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 120.877 1.671 . . . . 11.130000000000001 112.161 -174.405 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -94.28 154.33 17.58 Favored 'General case' 0 N--CA 1.43 -1.438 0 CA-C-O 124.401 2.048 . . . . 18.030000000000001 107.821 -179.103 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.0 p -92.59 164.26 13.49 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 114.695 1.369 . . . . 10.220000000000001 114.695 -177.314 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.276 22.1 mm -56.07 -41.05 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 C-N-CA 127.842 2.457 . . . . 12.300000000000001 112.487 175.296 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -55.08 -39.94 69.82 Favored 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.427 2.291 . . . . 36.509999999999998 115.172 173.285 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -57.46 -38.44 74.5 Favored 'General case' 0 N--CA 1.43 -1.47 0 C-N-CA 130.962 3.705 . . . . 25.66 115.516 165.622 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.76 -45.46 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 CA-C-N 123.998 3.09 . . . . 8.1199999999999992 108.317 -175.146 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.329 17.9 mtmt -55.7 -36.26 66.98 Favored 'General case' 0 N--CA 1.43 -1.456 1 C-N-CA 132.498 4.319 . . . . 15.470000000000001 116.619 171.338 . . . . . . . . 3 2 . 1 . 127 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.35 -38.22 83.13 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 119.158 3.021 . . . . 11.449999999999999 119.158 167.693 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -76.24 -24.61 54.58 Favored 'General case' 0 N--CA 1.429 -1.481 0 N-CA-C 115.082 1.512 . . . . 24.98 115.082 176.162 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.4 mt -79.24 -33.45 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.45 0 O-C-N 119.043 -2.286 . . . . 9.4600000000000009 111.184 178.57 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -62.07 -39.91 94.01 Favored 'General case' 0 N--CA 1.429 -1.479 0 CA-C-N 114.297 -1.32 . . . . 14.76 108.562 168.706 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -68.7 -40.63 79.94 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 117.582 2.438 . . . . 26.289999999999999 117.582 -176.696 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.8 mttm -82.31 -59.3 2.59 Favored 'General case' 0 N--CA 1.43 -1.454 0 CA-C-O 114.816 -2.516 . . . . 30.059999999999999 109.129 176.299 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -87.94 -46.28 9.52 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 126.333 2.271 . . . . 25.190000000000001 109.505 -160.495 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.72 45.12 4.99 Favored Glycine 0 N--CA 1.43 -1.738 0 N-CA-C 107.815 -2.114 . . . . 7.4100000000000001 107.815 175.823 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.259 68.3 mt -98.86 121.22 56.68 Favored Pre-proline 0 N--CA 1.429 -1.494 0 N-CA-C 103.993 -2.595 . . . . 9.4900000000000002 103.993 173.172 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.327 1.1 Cg_exo -71.79 166.21 30.2 Favored 'Trans proline' 0 C--N 1.3 -2.018 0 CA-C-N 127.599 3.75 . . . . 11.42 118.491 -171.007 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -90.48 -6.09 4.49 Favored 'Trans proline' 0 C--N 1.3 -1.984 0 CA-C-N 124.47 2.632 . . . . 12.0 112.667 -157.398 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -82.71 -29.53 29.78 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 125.28 1.613 . . . . 35.549999999999997 108.445 172.099 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -80.75 -26.44 37.32 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 125.095 1.358 . . . . 20.52 112.744 -175.177 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -83.61 128.93 34.9 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 115.055 -0.975 . . . . 7.1299999999999999 112.263 175.906 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.7 ttt180 -126.1 131.2 52.15 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 107.971 -1.122 . . . . 36.390000000000001 107.971 167.663 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.7 mt -95.62 137.9 34.04 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 130.424 3.49 . . . . 9.5500000000000007 105.742 176.978 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.8 mt -134.2 136.37 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 C-N-CA 128.102 2.561 . . . . 13.9 110.818 179.698 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -120.86 95.09 4.57 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 106.323 -1.732 . . . . 6.8600000000000003 106.323 -174.393 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.64 -82.31 0.01 OUTLIER 'General case' 0 N--CA 1.43 -1.449 0 C-N-CA 127.739 2.415 . . . . 11.15 111.994 -163.223 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.39 -1.49 6.11 Favored Glycine 0 N--CA 1.429 -1.794 0 O-C-N 116.959 -3.588 . . . . 13.93 112.5 171.172 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -83.74 113.25 20.76 Favored 'General case' 0 N--CA 1.431 -1.416 0 O-C-N 118.708 -2.642 . . . . 23.920000000000002 113.488 176.51 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -70.38 142.03 52.13 Favored 'General case' 0 N--CA 1.43 -1.445 0 O-C-N 117.387 -3.321 . . . . 23.23 109.974 171.794 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -107.55 110.66 22.62 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.963 -1.495 . . . . 9.1099999999999994 106.963 -166.323 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -87.77 153.74 21.11 Favored 'General case' 0 N--CA 1.43 -1.453 0 O-C-N 118.129 -2.857 . . . . 33.439999999999998 114.479 -175.906 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.366 1.7 m-20 -48.73 -58.92 4.03 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 117.781 2.511 . . . . 28.370000000000001 117.781 -160.621 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.96 51.86 0.7 Allowed Glycine 0 N--CA 1.43 -1.756 0 CA-C-O 127.514 3.841 . . . . 15.0 114.73 -171.515 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -128.18 158.78 37.13 Favored 'General case' 0 N--CA 1.43 -1.445 1 O-C-N 115.66 -4.435 . . . . 25.5 109.63 174.459 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.7 p -88.16 159.47 18.17 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-O 124.483 2.087 . . . . 11.949999999999999 106.869 -171.184 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.8 mt -60.63 -30.33 69.79 Favored 'General case' 0 N--CA 1.43 -1.442 1 O-C-N 116.064 -4.147 . . . . 10.17 113.354 169.167 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 64.2 p -64.91 -20.1 66.27 Favored 'General case' 0 N--CA 1.43 -1.47 1 C-N-CA 135.493 5.517 . . . . 13.59 116.294 176.237 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -82.73 -39.04 22.45 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 126.466 1.907 . . . . 11.699999999999999 112.536 172.31 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -79.69 -19.7 48.32 Favored 'General case' 0 N--CA 1.43 -1.473 0 O-C-N 118.414 -2.679 . . . . 12.949999999999999 117.849 163.079 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.496 32.3 m120 75.26 57.28 0.06 Allowed 'General case' 0 N--CA 1.43 -1.452 0 CA-C-O 124.745 2.212 . . . . 25.449999999999999 113.782 174.187 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.4 mm -85.64 126.79 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 C-N-CA 129.048 2.939 . . . . 14.6 106.727 -178.7 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -104.18 167.89 9.46 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.532 -1.655 . . . . 33.229999999999997 106.532 172.981 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -60.5 148.64 37.03 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 128.658 2.783 . . . . 25.969999999999999 110.816 -175.494 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 60.25 28.48 18.08 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 116.041 1.867 . . . . 32.609999999999999 116.041 176.879 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.6 m -77.09 150.28 35.67 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.18 -1.045 . . . . 10.56 108.18 174.191 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.6 m -98.62 104.16 16.17 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.799 -2.297 . . . . 5.3300000000000001 104.799 168.143 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.0 mt -85.88 133.77 33.94 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 112.178 -2.283 . . . . 11.66 105.043 168.746 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.262 47.5 p-80 -106.13 145.34 31.61 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-O 125.796 2.713 . . . . 16.300000000000001 112.917 176.826 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.7 tp -104.36 127.47 52.02 Favored 'General case' 0 N--CA 1.43 -1.452 0 O-C-N 118.687 -2.508 . . . . 9.9600000000000009 109.8 -171.063 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -135.75 164.27 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 124.018 3.099 . . . . 9.7599999999999998 109.52 177.6 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 71' ' ' LEU . 46.9 tp -89.62 142.89 27.26 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 113.205 -1.816 . . . . 19.57 108.319 -171.294 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -70.61 136.14 48.96 Favored 'General case' 0 N--CA 1.431 -1.414 1 N-CA-C 122.081 4.104 . . . . 35.079999999999998 122.081 174.975 . . . . . . . . 2 2 . 1 . 127 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 27.3 mt -68.46 -51.22 45.88 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 128.456 2.702 . . . . 32.310000000000002 116.51 -175.417 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.8 ptt-85 -80.72 164.08 23.06 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 124.92 2.295 . . . . 42.75 111.836 166.92 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.96 63.86 0.55 Allowed Glycine 0 N--CA 1.43 -1.71 0 O-C-N 117.876 -3.015 . . . . 36.310000000000002 110.462 175.563 . . . . . . . . 1 1 . 1 . 127 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.76 0 N-CA-C 108.166 -1.974 . . . . 36.270000000000003 108.166 165.257 . . . . . . . . 0 0 . 1 . 128 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 CA--C 1.489 -1.37 0 N-CA-C 106.501 -1.666 . . . . 17.170000000000002 106.501 . . . . . . . . . 0 0 . 1 . 128 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -114.04 121.16 43.01 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 129.401 3.08 . . . . 21.890000000000001 104.636 -175.644 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.7 pt -120.23 162.6 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 O-C-N 126.891 2.619 . . . . 10.83 106.023 165.048 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -124.94 130.06 51.6 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 103.006 -2.961 . . . . 10.609999999999999 103.006 -169.608 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -114.2 111.8 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 116.423 -2.111 . . . . 9.1300000000000008 108.435 172.798 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -78.41 124.32 27.99 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 124.598 3.363 . . . . 20.550000000000001 112.077 174.646 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.0 p -69.31 164.28 23.21 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 118.397 -2.69 . . . . 11.779999999999999 117.768 169.503 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 tp -64.33 -19.37 65.4 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 116.373 1.99 . . . . 19.309999999999999 116.373 172.241 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -93.15 -20.68 20.25 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 115.823 1.786 . . . . 23.140000000000001 115.823 179.488 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.73 34.38 2.64 Favored Glycine 0 N--CA 1.43 -1.757 0 N-CA-C 116.421 1.329 . . . . 19.739999999999998 116.421 175.374 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -99.62 129.52 45.77 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 125.758 1.623 . . . . 21.93 110.187 164.072 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 88.1 m -91.67 119.99 32.03 Favored 'General case' 0 N--CA 1.43 -1.456 0 O-C-N 119.34 -2.1 . . . . 12.33 105.542 167.915 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.3 7.8 mt -86.11 104.89 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 0 C-N-CA 126.994 2.118 . . . . 17.079999999999998 110.353 172.873 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.0 m -84.7 106.77 16.5 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 117.991 -1.484 . . . . 16.300000000000001 108.599 177.433 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.6 mt -110.34 139.84 45.13 Favored 'General case' 0 N--CA 1.43 -1.432 0 O-C-N 120.913 -1.117 . . . . 15.880000000000001 110.01 -178.765 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -96.41 128.62 43.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 124.254 1.978 . . . . 28.899999999999999 106.464 174.215 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -137.11 155.15 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 O-C-N 119.378 -2.076 . . . . 12.050000000000001 108.333 -173.232 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -101.61 129.68 26.24 Favored Pre-proline 0 N--CA 1.429 -1.49 0 CA-C-O 113.703 -3.046 . . . . 18.170000000000002 105.851 178.008 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -61.52 -16.17 46.02 Favored 'Trans proline' 0 N--CA 1.433 -2.04 0 CA-C-N 123.834 2.405 . . . . 8.1600000000000001 114.621 -168.825 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.6 p -94.55 -3.53 49.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 123.083 2.674 . . . . 11.130000000000001 110.668 -171.555 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.14 153.3 34.35 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-O 127.035 3.302 . . . . 18.030000000000001 115.93 175.883 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.7 p -75.36 162.88 28.01 Favored 'General case' 0 N--CA 1.43 -1.469 1 C-N-CA 131.787 4.035 . . . . 10.220000000000001 110.982 -178.456 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.293 6.3 mm -71.29 -34.74 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.446 1 O-C-N 115.392 -4.568 . . . . 12.300000000000001 112.546 178.754 . . . . . . . . 3 2 . 1 . 128 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -53.05 -43.27 66.51 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 126.241 1.817 . . . . 36.509999999999998 112.643 169.006 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -71.08 -22.66 62.08 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 116.898 2.184 . . . . 25.66 116.898 170.995 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.9 t -66.07 -43.76 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.408 1 CA-C-N 126.873 4.397 . . . . 8.1199999999999992 114.016 166.817 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -59.78 -39.12 83.86 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 126.963 2.105 . . . . 15.470000000000001 110.275 179.409 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.97 -24.52 66.81 Favored 'General case' 0 N--CA 1.43 -1.462 0 O-C-N 117.407 -3.308 . . . . 11.449999999999999 119.656 177.954 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -74.9 -33.45 62.04 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 127.834 2.454 . . . . 24.98 110.877 173.672 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.253 6.8 mt -75.19 -40.71 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 O-C-N 118.004 -2.935 . . . . 9.4600000000000009 110.289 175.322 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -50.48 -48.82 56.63 Favored 'General case' 0 N--CA 1.43 -1.459 0 O-C-N 118.499 -2.625 . . . . 14.76 114.6 160.219 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -66.0 -42.85 89.21 Favored 'General case' 0 N--CA 1.43 -1.445 0 CA-C-N 121.588 1.995 . . . . 26.289999999999999 114.661 176.827 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.5 mmtt -72.85 -69.58 0.4 Allowed 'General case' 0 N--CA 1.429 -1.488 0 O-C-N 119.016 -2.303 . . . . 30.059999999999999 111.959 178.169 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -97.92 -2.01 41.59 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.523 1.929 . . . . 25.190000000000001 114.518 -164.428 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.51 21.43 79.5 Favored Glycine 0 N--CA 1.43 -1.727 0 N-CA-C 118.579 2.191 . . . . 7.4100000000000001 118.579 174.526 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 98.0 mt -98.91 130.12 28.26 Favored Pre-proline 0 N--CA 1.431 -1.421 0 O-C-N 116.794 -3.768 . . . . 9.4900000000000002 102.623 -169.153 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -76.92 154.81 33.91 Favored 'Trans proline' 0 C--N 1.3 -2.015 0 O-C-N 117.928 -1.67 . . . . 11.42 110.021 -172.105 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.344 9.7 Cg_endo -63.96 -30.16 66.94 Favored 'Trans proline' 0 N--CA 1.433 -2.031 0 C-N-CA 123.463 2.775 . . . . 12.0 115.25 -169.525 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -63.63 -31.84 73.14 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 120.558 3.54 . . . . 35.549999999999997 120.558 -179.206 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -70.06 -34.53 73.32 Favored 'General case' 0 N--CA 1.43 -1.434 0 O-C-N 118.853 -2.404 . . . . 20.52 114.39 166.777 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -64.25 103.79 0.67 Allowed 'General case' 0 N--CA 1.43 -1.447 1 O-C-N 115.337 -4.602 . . . . 7.1299999999999999 121.327 178.743 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.5 ttt180 -102.77 125.25 49.44 Favored 'General case' 0 N--CA 1.43 -1.449 0 O-C-N 118.556 -2.59 . . . . 36.390000000000001 110.897 163.332 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.7 mt -96.61 139.17 33.08 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 122.649 1.214 . . . . 9.5500000000000007 111.872 170.329 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.9 mt -133.13 122.26 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.465 0 C-N-CA 129.337 3.055 . . . . 13.9 109.534 173.035 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -93.44 112.58 24.53 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 128.981 2.912 . . . . 6.8600000000000003 108.696 164.106 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.27 -93.04 0.04 OUTLIER 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 127.877 2.471 . . . . 11.15 114.128 -177.51 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -140.22 27.86 2.5 Favored Glycine 0 N--CA 1.43 -1.732 0 C-N-CA 127.711 2.576 . . . . 13.93 111.757 166.431 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 71.9 mttt -104.95 137.09 43.24 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 128.975 2.91 . . . . 23.920000000000002 111.949 172.662 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -99.46 124.14 44.35 Favored 'General case' 0 N--CA 1.429 -1.481 0 CA-C-N 120.535 1.516 . . . . 23.23 112.415 -172.535 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 98.9 mt -97.59 137.35 36.64 Favored 'General case' 0 N--CA 1.43 -1.425 0 O-C-N 118.575 -2.578 . . . . 9.1099999999999994 110.666 -171.307 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -118.69 135.17 54.62 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-O 127.128 3.346 . . . . 33.439999999999998 104.122 -166.193 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -43.53 -37.33 2.41 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-O 113.793 -3.003 . . . . 28.370000000000001 118.82 -166.502 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.6 11.66 27.95 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 107.001 -2.439 . . . . 15.0 107.001 -167.935 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -91.0 160.29 15.69 Favored 'General case' 0 N--CA 1.43 -1.446 0 O-C-N 116.521 -3.929 . . . . 25.5 103.549 168.399 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.2 p -103.88 170.09 8.13 Favored 'General case' 0 N--CA 1.43 -1.437 0 O-C-N 119.75 -1.843 . . . . 11.949999999999999 108.983 -170.329 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 mt -57.64 -42.23 83.0 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-O 124.001 1.857 . . . . 10.17 114.226 168.751 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 76.3 p -62.89 -18.46 63.01 Favored 'General case' 0 N--CA 1.43 -1.459 1 N-CA-C 122.661 4.319 . . . . 13.59 122.661 173.303 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -77.96 -41.43 36.18 Favored 'General case' 0 N--CA 1.43 -1.434 1 O-C-N 115.289 -4.632 . . . . 11.699999999999999 112.656 -173.667 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -86.08 -10.68 54.48 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 113.655 -1.612 . . . . 12.949999999999999 111.802 179.078 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.316 71.9 m-20 71.11 54.88 0.23 Allowed 'General case' 0 N--CA 1.43 -1.466 0 C-N-CA 129.89 3.276 . . . . 25.449999999999999 113.232 -176.517 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.285 59.6 mt -89.28 108.6 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 O-C-N 127.933 3.27 . . . . 14.6 113.623 -179.352 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -89.34 176.24 7.01 Favored 'General case' 0 N--CA 1.43 -1.467 0 C-N-CA 130.515 3.526 . . . . 33.229999999999997 113.396 -166.404 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -69.14 139.32 54.68 Favored 'General case' 0 N--CA 1.43 -1.443 0 N-CA-C 116.474 2.027 . . . . 25.969999999999999 116.474 172.173 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 50.59 68.71 0.73 Allowed 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 125.689 1.868 . . . . 32.609999999999999 112.771 -171.793 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 m -125.24 156.97 37.68 Favored 'General case' 0 N--CA 1.429 -1.481 0 C-N-CA 128.898 2.879 . . . . 10.56 103.536 176.485 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.0 m -126.37 124.81 41.09 Favored 'General case' 0 N--CA 1.43 -1.444 0 O-C-N 124.413 1.071 . . . . 5.3300000000000001 109.292 -178.086 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.9 mp -109.04 167.39 10.13 Favored 'General case' 0 N--CA 1.43 -1.455 0 C-N-CA 129.223 3.009 . . . . 11.66 109.332 -179.583 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -135.73 158.81 43.47 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-O 125.475 2.559 . . . . 16.300000000000001 112.184 179.056 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -118.04 136.82 53.31 Favored 'General case' 0 N--CA 1.43 -1.427 1 O-C-N 116.162 -4.087 . . . . 9.9600000000000009 103.382 -168.597 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.81 172.95 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.295 -1.743 . . . . 9.7599999999999998 106.295 -175.522 . . . . . . . . 2 2 . 1 . 128 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.5 mt -74.01 150.51 40.65 Favored 'General case' 0 N--CA 1.431 -1.416 0 C-N-CA 115.845 -2.342 . . . . 19.57 111.773 176.787 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.0 ttp85 -104.35 116.29 31.89 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 130.064 3.346 . . . . 35.079999999999998 111.209 175.589 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 65.6 tp -78.0 -43.07 30.61 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 116.894 2.183 . . . . 32.310000000000002 116.894 -175.433 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -81.4 140.35 34.75 Favored 'General case' 0 N--CA 1.43 -1.432 0 C-N-CA 127.25 2.22 . . . . 42.75 113.871 -172.056 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.07 2.61 59.84 Favored Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 120.413 2.925 . . . . 36.310000000000002 120.413 -172.618 . . . . . . . . 1 1 . 1 . 128 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.741 0 N-CA-C 107.797 -2.121 . . . . 36.270000000000003 107.797 176.669 . . . . . . . . 0 0 . 1 stop_ save_